<SEC-DOCUMENT>0001628280-23-042245.txt : 20231220
<SEC-HEADER>0001628280-23-042245.hdr.sgml : 20231220
<ACCEPTANCE-DATETIME>20231220163432
ACCESSION NUMBER:		0001628280-23-042245
CONFORMED SUBMISSION TYPE:	F-1
PUBLIC DOCUMENT COUNT:		259
FILED AS OF DATE:		20231220
DATE AS OF CHANGE:		20231220

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ASPEN INSURANCE HOLDINGS LTD
		CENTRAL INDEX KEY:			0001267395
		STANDARD INDUSTRIAL CLASSIFICATION:	FIRE, MARINE & CASUALTY INSURANCE [6331]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276163
		FILM NUMBER:		231501722

	BUSINESS ADDRESS:	
		STREET 1:		141 FRONT STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM 19
		BUSINESS PHONE:		1 441 297 9301

	MAIL ADDRESS:	
		STREET 1:		141 FRONT STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM 19
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1
<SEQUENCE>1
<FILENAME>ahl-20231220.htm
<DESCRIPTION>F-1
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:c8bdf706-6073-4046-a439-e42c560d7bb0,g:8520f5b6-a319-4843-ab2c-4a3e439c5aeb,d:74bc390671ae44c18dcd3f802f6097fb--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ahl="http://www.aspen.co/20231220" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ahl-20231220</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-4">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-5">0001267395</ix:nonNumeric><ix:nonNumeric contextRef="c-77" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-489">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-19" name="us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList" id="f-1704">http://fasb.org/us-gaap/2022#AccumulatedOtherComprehensiveIncomeLossNetOfTax</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ahl-20231220.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloOriginatingPartnershipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloRealEstateFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:AssetManagementArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:AssetManagementArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ManagementConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ManagementConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:RelatedPartyInvestmentIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:AssetManagementArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:AssetManagementArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:AssetManagementArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ManagementConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ManagementConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ManagementConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnInvestmentsMember1</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ClassABNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="period"><xbrli:measure>ahl:period</xbrli:measure></xbrli:unit><xbrli:unit id="segement"><xbrli:measure>ahl:segement</xbrli:measure></xbrli:unit><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:UnitedStatesAndCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:UnitedStatesAndCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:UnitedStatesAndCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:WorldwideIncludingUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:WorldwideIncludingUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:WorldwideIncludingUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ahl:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShorttermInvestmentTradingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShorttermInvestmentTradingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShorttermInvestmentTradingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:CatastropheBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:CatastropheBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:CatastropheBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ahl:BeneAssicurazioniMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ahl:BeneAssicurazioniMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ahl:BeneAssicurazioniMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ahl:CropReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ahl:CropReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ahl:CropReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:TradingFixedMaturityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:CatastropheBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:SecuritiesassetbackedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalSecuritiesCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:TotalTradingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:TradingFixedMaturityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:CatastropheBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:SecuritiesassetbackedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:TotalTradingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:ApartmentBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:ApartmentBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:ApartmentBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:ApartmentBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:HotelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:HotelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:HotelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:HotelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:RetailMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:RetailMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:RetailMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:RetailMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:IndustrialPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:IndustrialPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:IndustrialPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:IndustrialPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:NonperformingFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatioLessthan50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatioLessthan50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio50to60PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio50to60PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio61to70PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio61to70PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioGreaterThan1.2xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioGreaterThan1.2xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatio1.00to1.20xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatio1.00to1.20xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioLessThan1.00xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioLessThan1.00xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:NonperformingFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:IndustrialServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:IndustrialServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:IndustrialServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:IndustrialServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerDiscretionaryServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerDiscretionaryServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerDiscretionaryServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerDiscretionaryServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EnergyCommoditiesAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EnergyCommoditiesAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EnergyCommoditiesAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EnergyCommoditiesAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerStaplesServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerStaplesServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerStaplesServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerStaplesServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatioLessthan50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatioLessthan50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio50to60PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio50to60PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio61to70PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio61to70PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio71to80PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio71to80PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebtToValueRatioGreaterThan100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebtToValueRatioGreaterThan100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioGreaterThan1.2xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioGreaterThan1.2xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatio1.00to1.20xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatio1.00to1.20xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioLessThan1.00xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioLessThan1.00xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:RealEstateFundDec2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:RealEstateFundDec2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:RealEstateFundSept2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:RealEstateFundSept2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap-supplement:InvestmentIdentifierAxis"><us-gaap-supplement:InvestmentIdentifierAxis.domain>Unfunded Commitment, Real Estate Fund (Sept 2021)</us-gaap-supplement:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloRealEstateFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap-supplement:InvestmentIdentifierAxis"><us-gaap-supplement:InvestmentIdentifierAxis.domain>Unfunded Commitment, Apollo Real Estate Fund</us-gaap-supplement:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:InfrastructureFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:InfrastructureFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap-supplement:InvestmentIdentifierAxis"><us-gaap-supplement:InvestmentIdentifierAxis.domain>Unfunded Commitment, Infrastructure fund</us-gaap-supplement:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>ahl:security</xbrli:measure></xbrli:unit><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security2"><xbrli:measure>ahl:Security</xbrli:measure></xbrli:unit><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="investment"><xbrli:measure>ahl:Investment</xbrli:measure></xbrli:unit><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-574"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-575"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-578"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-580"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-581"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-584"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-588"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="quotesperinvestment"><xbrli:measure>ahl:quotesPerInvestment</xbrli:measure></xbrli:unit><xbrli:context id="c-608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ahl:ValuationTechniqueLiquidationMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:CostApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-620"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-632"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-633"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:EnstarMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>LPT net losses reinsured</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-10</xbrli:startDate><xbrli:endDate>2022-01-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Loss Portfolio Transfer Agreement Limit</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-10</xbrli:startDate><xbrli:endDate>2022-01-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:EnstarMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>LPT premium paid</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-638"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:EnstarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Funds withheld credited with interest for periods after October 1, 2022</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:DerivativeAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-641"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:DerivativeAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-642"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:LiabilitiesUnderDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:LiabilitiesUnderDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:LiabilitiesUnderDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-645"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:LiabilitiesUnderDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-647"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:DerivativeAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:DerivativeAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:LiabilitiesUnderDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-651"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:LiabilitiesUnderDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-655"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-656"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ahl:NetchangefromcurrentperiodhedgedtransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ahl:NetchangefromcurrentperiodhedgedtransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>LPT</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Retroactive Reinsurance</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Retroactive Reinsurance</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:SuretySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-662"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AccidentAndHealthInsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-663"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-664"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-665"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-666"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-668"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-670"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-671"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="integer"><xbrli:measure>ahl:Integer</xbrli:measure></xbrli:unit><xbrli:context id="c-673"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-674"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-675"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-676"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-677"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-678"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-679"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-682"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-687"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-689"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-690"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-691"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-692"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-694"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-695"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-696"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-697"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-700"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-707"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-708"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-732"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-733"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-734"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-737"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-738"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-739"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-740"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-742"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-743"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-745"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-747"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-748"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-749"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-750"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-751"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-752"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-753"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-754"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-755"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-756"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-758"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-759"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-760"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-761"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-762"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-763"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-764"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-765"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-766"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-767"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-768"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-769"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-771"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-772"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-773"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-774"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-775"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-776"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-777"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-778"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-779"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-780"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-781"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-782"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-784"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-785"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-786"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-787"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-788"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-790"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-791"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-792"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-793"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-794"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-795"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-796"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-798"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-799"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-800"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-820"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-825"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-832"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-834"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-835"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-836"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-837"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-838"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-839"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-840"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-841"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-843"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-844"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-845"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-846"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-848"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-852"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-853"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-854"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-855"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-856"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-857"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-859"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-861"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-862"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-863"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-864"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-865"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-866"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-867"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-869"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-870"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-871"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-872"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-873"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-874"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-875"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-876"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-878"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-879"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-880"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-882"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-883"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-884"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-886"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-887"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-888"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-889"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-890"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-891"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-892"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-893"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-894"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-895"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-896"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-897"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-898"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-899"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-900"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-907"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-913"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-920"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-932"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-933"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-934"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-935"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-936"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-937"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-938"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-939"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-940"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-941"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-942"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-943"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-944"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-945"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-946"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-947"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-948"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-949"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-950"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-951"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-952"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-953"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-954"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-955"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-956"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-957"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-958"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-959"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-960"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-961"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-962"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-963"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-964"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-965"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-966"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-967"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-968"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-969"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-970"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-971"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-972"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-973"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-974"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-975"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-976"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-977"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-978"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-979"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-980"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-981"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-982"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-983"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-984"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-985"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-986"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-987"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-988"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-989"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-990"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-991"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-992"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-993"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-994"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-995"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-996"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-997"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-998"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-999"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1000"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1005"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1006"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1009"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1010"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1016"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1017"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1032"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1033"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1034"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1035"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1036"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1037"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1038"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1039"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1040"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1041"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1042"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1043"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1044"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1045"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1046"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1047"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1048"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1049"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1050"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1051"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1052"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1053"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1054"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1055"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1056"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:CasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1057"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:MarineAviationandEnergyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1058"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:FinancialandProfessionalCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1059"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1060"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1061"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1062"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1063"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedSpecialtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1064"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:OtherShortdurationInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1065"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:OtherShortdurationInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1066"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:OtherLongdurationInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1067"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:OtherLongdurationInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1068"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:AssumedPropertyandCasualtyCommercialInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1069"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:OfficeOfTheTaxCommissionerBermudaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1070"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1071"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:OfficeOfTheTaxCommissionerBermudaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1072"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:OfficeOfTheTaxCommissionerBermudaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1074"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1075"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:USOperatingSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1076"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1077"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ahl:LloydsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1078"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1079"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1080"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1081"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:USOperatingSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1082"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUKMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1083"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1084"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1085"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:LloydsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1086"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:LloydsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1087"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:OtherJuridictionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1088"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:HerMajestysRevenueAndCustomsHMRCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:OtherJuridictionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1089"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1090"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1091"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1092"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:USOperatingSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1093"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1094"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1095"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1096"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1097"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1098"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1099"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-02</xbrli:startDate><xbrli:endDate>2013-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-20</xbrli:startDate><xbrli:endDate>2016-09-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-09-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-13</xbrli:startDate><xbrli:endDate>2019-08-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-13</xbrli:startDate><xbrli:endDate>2019-08-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatutoryAccountingPracticesByJurisdictionAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="c-1117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatutoryAccountingPracticesByJurisdictionAxis">country:BM</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatutoryAccountingPracticesByJurisdictionAxis">country:BM</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatutoryAccountingPracticesByJurisdictionAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatutoryAccountingPracticesByJurisdictionAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatutoryAccountingPracticesByJurisdictionAxis">country:BM</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatutoryAccountingPracticesByJurisdictionAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:SubsidiariesOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatutoryAccountingPracticesByJurisdictionAxis">country:BM</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:SubsidiariesOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-15</xbrli:startDate><xbrli:endDate>2023-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-15</xbrli:startDate><xbrli:endDate>2023-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-15</xbrli:startDate><xbrli:endDate>2023-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-14</xbrli:startDate><xbrli:endDate>2023-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-18</xbrli:startDate><xbrli:endDate>2017-12-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenSpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ahl:BlueWatersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-10-31</xbrli:startDate><xbrli:endDate>2016-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ahl:AspenTrademarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnInvestmentsMember1</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ApolloOriginatingPartnershipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassANotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassBNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassANotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ClassABNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:UsMultiBeneficiaryTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenBermudaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenBermudaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:UsMultiBeneficiaryTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:UsSurplusLinesTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:UsSurplusLinesTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:CanadianTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="c-1181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:CanadianTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:AustralianTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="aud"><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unit><xbrli:context id="c-1183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:AustralianTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:SwissTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="chf"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:context id="c-1185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:SwissTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:SingaporeTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sgd"><xbrli:measure>iso4217:SGD</xbrli:measure></xbrli:unit><xbrli:context id="c-1187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:SingaporeTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CreditRatingAMBestAxis">srt:AMBestAPlusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAAMinusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:MunichReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CreditRatingAMBestAxis">srt:AMBestAPlusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAAMinusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:MunichReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAPlusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingAMBestAxis">srt:AMBestAPlusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:EverestReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAPlusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingAMBestAxis">srt:AMBestAPlusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:EverestReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAPlusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:LloydsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingAMBestAxis">srt:AMBestARatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAPlusRatingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:LloydsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingAMBestAxis">srt:AMBestARatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:AonCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:AonCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:AonCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:MarshAndMcLennanCompaniesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:MarshAndMcLennanCompaniesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:MarshAndMcLennanCompaniesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:WillisGroupHoldingsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:WillisGroupHoldingsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:WillisGroupHoldingsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:OthersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:OthersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:OthersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ahl:CitibankEuropeplcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ahl:CitibankEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ahl:CitibankEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:AspenEuropeanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:AspenEuropeanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:LloydsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUnderwritingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:LloydsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUnderwritingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:LloydsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUnderwritingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:LloydsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUnderwritingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:DeutscheMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenBermudaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis">srt:FederalHomeLoanBankOfBostonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenSpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AAICMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis">srt:FederalHomeLoanBankOfBostonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenBermudaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:NatixisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenBermudaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:HSBCBankUSANationalAssociationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenBermudaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:CitibankEuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:DeutscheMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenUKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-11-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-11-13</xbrli:startDate><xbrli:endDate>2013-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ShortTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PremiumsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PremiumsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PremiumsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PremiumsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PremiumsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PremiumsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PremiumsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloOriginatingPartnershipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloRealEstateFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:AssetManagementArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ManagementConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:RelatedPartyInvestmentIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:RelatedPartyInvestmentIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:AssetManagementArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:AssetManagementArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ManagementConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ManagementConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnInvestmentsMember1</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ClassABNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnInvestmentsMember1</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ClassABNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ahl:AdditionalPaidInCapitalExcludingPreferenceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ahl:AdditionalPaidInCapitalExcludingPreferenceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ahl:AdditionalPaidInCapitalExcludingPreferenceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ahl:AdditionalPaidInCapitalExcludingPreferenceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:ReinsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShorttermInvestmentTradingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShorttermInvestmentTradingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:CatastropheBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:CatastropheBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:TradingFixedMaturityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:CatastropheBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:SecuritiesassetbackedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalSecuritiesCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:TotalTradingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:ApartmentBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:ApartmentBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:HotelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:HotelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:RetailMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:RetailMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:IndustrialPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:IndustrialPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:NonperformingFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatioLessthan50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio50to60PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio61to70PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioGreaterThan1.2xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatio1.00to1.20xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioLessThan1.00xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:IndustrialServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:IndustrialServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerDiscretionaryServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ahl:ConsumerDiscretionaryServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EnergyCommoditiesAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EnergyCommoditiesAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ahl:InvestmentNetCarryingValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatioLessthan50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio50to60PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ahl:DebttoValueRatio61to70PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioGreaterThan1.2xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatio1.00to1.20xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ahl:DebtServiceCoverageRatioAxis">ahl:DebtServiceCoverageRatioLessThan1.00xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:MultiLineReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ahl:DigitalRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:RealEstateFundDec2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:RealEstateFundSept2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap-supplement:InvestmentIdentifierAxis"><us-gaap-supplement:InvestmentIdentifierAxis.domain>Unfunded Commitment, Real Estate Fund (Sept 2021)</us-gaap-supplement:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap-supplement:InvestmentIdentifierAxis"><us-gaap-supplement:InvestmentIdentifierAxis.domain>Unfunded Commitment, Apollo Real Estate Fund</us-gaap-supplement:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:InfrastructureFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap-supplement:InvestmentIdentifierAxis"><us-gaap-supplement:InvestmentIdentifierAxis.domain>Unfunded Commitment, Infrastructure fund</us-gaap-supplement:InvestmentIdentifierAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:HighYieldLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsTradingAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ahl:NonagencycommercialmortgagebackedsecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ahl:FairValueOfDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:CostApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ahl:ValuationTechniqueLiquidationMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ahl:ValuationTechniqueLiquidationMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ahl:ValuationTechniqueLiquidationMethodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:MiddlemarketloansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1574"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1575"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1578"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:GlobalCorporateSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ahl:ShortTermInvestmentsPrivatelyHeldInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1580"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:DerivativeAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1581"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:LiabilitiesUnderDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1582"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:LiabilitiesUnderDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1584"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:DerivativeAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1587"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1588"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ahl:NetchangefromcurrentperiodhedgedtransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ahl:NetchangefromcurrentperiodhedgedtransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ahl:LossPortfolioTransferMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ahl:FairValueOfDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ahl:EnstarMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>LPT losses reinsured]</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1593"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Retroactive Reinsurance</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>LPT, deferred gain</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1595"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ahl:InsuranceMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>LPT, offset post-LPT years</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ahl:LIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-15</xbrli:startDate><xbrli:endDate>2023-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-15</xbrli:startDate><xbrli:endDate>2023-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-15</xbrli:startDate><xbrli:endDate>2023-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnInvestmentsMember1</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ApolloOriginatingPartnershipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GainLossOnInvestmentsMember1</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ahl:ApolloOriginatingPartnershipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassANotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassBNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1620"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassANotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassANotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ahl:PrivatelyheldinvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ApolloClassBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:UsMultiBeneficiaryTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ahl:AspenBermudaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:UsSurplusLinesTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:CanadianTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1632"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:AustralianTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1633"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:SwissTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ahl:SingaporeTrustFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-1635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ahl:MajorRatingAgenciesAxis">ahl:AAOrHigherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ahl:MajorRatingAgenciesAxis">ahl:AAOrLowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ahl:MajorRatingAgenciesAxis">ahl:AAOrHigherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1638"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ahl:MajorRatingAgenciesAxis">ahl:AAOrLowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:EverestReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:EverestReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1641"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:MunichReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1642"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:MunichReMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:LloydsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ahl:LloydsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1645"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1647"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1648"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-1650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001267395</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i74bc390671ae44c18dcd3f802f6097fb_33"></div><div style="min-height:18pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> As filed with the Securities and Exchange Commission on December 20, 2023. </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">F-1</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UNDER </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">THE SECURITIES ACT OF 1933 </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:21pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-2">ASPEN INSURANCE HOLDINGS LIMITED</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter) </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Bermuda</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6331</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">98-0501000</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(State or Other Jurisdiction <br/>of Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Primary Standard Industrial <br/>Classification Code Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">141 Front Street</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hamilton, HM19</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Bermuda</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Telephone: (441) 295-8201 </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices) </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cogency Global Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">122 East 42nd Street, 18th Floor</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">New York, New York 10168</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Telephone: (212) 947-7200 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Name, Address, Including Zip Code, and Telephone Number, Including Area Code,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">of Agent For Service) </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Copies to: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Samir A. Gandhi<br/>Robert A. Ryan<br/>Adam M. Gross<br/>Sidley Austin LLP<br/>787 Seventh Avenue<br/>New York, New York 10019<br/>(212) 839-5300</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sarah Demerling<br/>Natalie Neto<br/>Rachel Nightingale<br/>Walkers (Bermuda) Limited<br/>Park Place<br/>55 Par La Ville Road, Third Floor<br/>Hamilton HM11<br/>Bermuda<br/>(441) 242-1500</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marc D. Jaffe<br/>Erika L. Weinberg<br/>Latham &amp; Watkins LLP<br/>1271 Avenue of the Americas<br/>New York, New York 10020<br/>(212) 906-1200</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, please check the following box.&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earliest effective registration statement for the same offering.&#160;&#160;&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-3">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 7(a)(2)(B) of the Securities Act.&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;padding-left:4.5pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:0.06pt">The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to Section 8(a), may determine.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_40"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#de1a1e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The information in this preliminary prospectus is not complete and may be changed. We and the selling shareholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </span></div><div style="text-align:center"><span style="color:#de1a1e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Subject to Completion, Dated December 20, 2023 </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary Prospectus </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-style:italic;font-weight:400;line-height:120%">Ordinary Shares </span></div><div style="margin-top:6pt;text-align:center"><img src="ahl-20231220_g1.jpg" alt="aspenlogo.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"/></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-style:italic;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This is the initial public offering of the ordinary shares, par value $0.01 per share, of Aspen Insurance Holdings Limited (the &#8220;ordinary shares&#8221;). We are offering&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares and the selling shareholders identified in this prospectus are offering an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares. We will not receive any of the proceeds from the sale of the ordinary shares by the selling shareholders. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to this offering, there has been no public market for our ordinary shares. It is currently estimated that the initial public offering price will be between $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share. We intend to apply to list our ordinary shares on the  &#160;&#160;&#160;&#160;  under the symbol &#8220;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .&#8221; </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a &#8220;foreign private issuer&#8221; as defined under the U.S. federal securities laws and, as such, will be subject to reduced public company reporting and stock exchange governance requirements. See &#8220;Management and Corporate Governance&#8212;Foreign Private Issuer Exemption&#8221; for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Following this offering, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc. (collectively with its subsidiaries, &#8220;Apollo&#8221;), will beneficially own approximately&#160;&#160;&#160;&#160;&#160;% of our ordinary shares (or&#160;&#160;&#160;&#160;&#160;% if the underwriters exercise in full their option to purchase additional ordinary shares from us and the selling shareholders). As a result, we will be a &#8220;controlled company&#8221; under the corporate governance rules of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; applicable to listed companies, and therefore are permitted to elect not to comply with certain corporate governance requirements thereunder. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing in our ordinary shares involves a high degree of risk. Before investing in our ordinary shares, you should carefully read the &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_297">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221; beginning on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_297">28</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> of this prospectus. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.881%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.881%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.975%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per ordinary share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Initial public offering price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting discount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds, before expenses, to us</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds, before expenses, to the selling shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We have agreed to reimburse the underwriters for certain expenses in connection with this offering. See &#8220;Underwriting (Conflicts of Interest)&#8221; for a description of all compensation payable to the underwriters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters have an option to purchase up to an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares from us and up to an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares from the selling shareholders at the initial public offering price less the underwriting discount for 30 days from the date of this prospectus.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters expect to deliver the ordinary shares against payment in New York, New York on or about&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Goldman Sachs &amp; Co. LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Citigroup</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Jefferies</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.596%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Apollo Global Securities</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prospectus dated&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_46"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_53">ABOUT THIS PROSPECTUS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_53">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_1066">SUMMARY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_1066">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7250">THE OFFERING</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7250">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_4012">SUMMARY FINANCIAL AND OPERATING DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_4012">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_297">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_297">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_78">USE OF PROCEEDS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_78">73</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_84">DIVIDEND POLICY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_84">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_90">CAPITALIZATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_90">75</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_96">DILUTION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_96">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_102">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_102">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_120">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_120">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_549755815478">BUSINESS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_549755815478">160</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_6482">MANAGEMENT AND CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_6482">189</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_139">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_139">198</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_146">PRINCIPAL AND SELLING SHAREHOLDERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_146">199</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_152">MATERIAL CONTRACTS AND RELATED PARTY TRANSACTIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_152">201</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_6485">DESCRIPTION OF SHARE CAPITAL</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_6485">206</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_6509">COMPARISON OF SHAREHOLDER RIGHTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_6509">217</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_171">SHARES ELIGIBLE FOR FUTURE SALE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_171">225</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_177">CERTAIN REGULATORY CONSIDERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_177">227</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_183">CERTAIN TAX CONSIDERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_183">250</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_189">UNDERWRITING (CONFLICTS OF INTEREST)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_189">261</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_3800">EXPENSES OF THE OFFERING</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_3800">267</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_195">LEGAL MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_195">268</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_201">EXPERTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_201">268</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_207">WHERE PROSPECTIVE INVESTORS CAN FIND ADDITIONAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_207">268</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_973">INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_973">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_973">1</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_53"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS PROSPECTUS</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_4027"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About This Prospectus</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the selling shareholders and the underwriters have not authorized anyone to provide any information different from that contained in this prospectus or in any free writing prospectuses prepared by us or on our behalf or to which we have referred prospective investors. We, the selling shareholders and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give prospective investors. This prospectus is an offer to sell only the ordinary shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is accurate only at the date on the front cover of this prospectus, regardless of the time of delivery of this prospectus or any sale of our ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the registration statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation, warranty or covenant made to prospective investors or for the benefit of prospective investors. Moreover, such representations, warranties or covenants were accurate only at the date they were made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2222"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Defined Terms</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References in this prospectus to the &#8220;Company,&#8221; &#8220;Aspen,&#8221; the &#8220;Aspen Group,&#8221; &#8220;Group,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Aspen Insurance Holdings Limited (&#8220;Aspen Holdings&#8221;) or Aspen Holdings and its consolidated subsidiaries, as the context requires. Our principal operating subsidiaries are: Aspen Bermuda Limited (&#8220;Aspen Bermuda&#8221;), Aspen Specialty Insurance Company (&#8220;Aspen Specialty&#8221;), Aspen American Insurance Company (&#8220;AAIC&#8221;), Aspen Insurance UK Limited (&#8220;Aspen UK&#8221;) and Aspen Underwriting Limited (&#8220;AUL&#8221;) (as corporate member of our Lloyd&#8217;s operations, Lloyd&#8217;s Syndicate 4711 (&#8220;Syndicate 4711&#8221;), which are managed by Aspen Managing Agency Limited (&#8220;AMAL&#8221;) (together, &#8220;Aspen Lloyd&#8217;s&#8221;)), each referred to herein as an &#8220;Operating Subsidiary&#8221; and collectively referred to as the &#8220;Operating Subsidiaries.&#8221; References to &#8220;Aspen Capital Markets&#8221; or &#8220;ACM&#8221; means business conducted by our subsidiaries that participate in alternative reinsurance markets, including Peregrine Reinsurance Ltd (&#8220;Peregrine&#8221;) and related management entities, including Aspen Capital Management, Ltd. (&#8220;ACML&#8221;). ACM forms part of the Aspen Capital Partners platform, in recognition of the synergies between ACM and the Company&#8217;s outwards reinsurance teams.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our underwriting operations as two distinct business segments, insurance and reinsurance. Reference in this prospectus to our &#8220;Insurance segment&#8221; or &#8220;Aspen Insurance&#8221; refer to our insurance segment and references to the &#8220;Reinsurance segment&#8221; or &#8220;Aspen Re&#8221; refer to our reinsurance segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law there is no concept of &#8220;outstanding&#8221; share capital, however, to align with U.S. share capital terminology and for the avoidance of doubt, references to &#8220;outstanding&#8221; with respect to our share capital refer to our &#8220;issued&#8221; share capital under Bermuda law.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2234"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Control</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ordinary shares may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act of 2003, as amended, the Bermuda Companies Act 1981, as amended (the &#8220;Companies Act&#8221;), and the Exchange Control Act 1972, as amended (the &#8220;Exchange Control Act&#8221;), and related regulations of Bermuda that regulate the sale of securities in Bermuda. In addition, specific permission is required from the Bermuda Monetary Authority (the &#8220;BMA&#8221;), pursuant to the provisions of the Exchange Control Act and related regulations, for all issuances and transfers of securities of Bermuda companies, other than in cases where the BMA has granted a general permission. The BMA in its policy dated June 1, 2005 provides that where any equity securities of a Bermuda company are listed on an appointed stock exchange ( &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; is such an exchange), general permission is given for the issue and subsequent transfer of any securities of the company (which includes the ordinary shares </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">described herein) from and/or to a non-resident of Bermuda, for as long as any equity securities of the company remain so listed. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2244"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service of Process and Enforcement of Civil Liberties</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a Bermuda exempted company. As a result, the rights of holders of our ordinary shares will be governed by Bermuda law and our memorandum of association (our &#8220;memorandum of association&#8221;) and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our amended and restated bye-laws (our &#8220;bye-laws&#8221;). The rights of shareholders under Bermuda law may differ from the rights of shareholders of companies incorporated in other jurisdictions. In addition, certain of our directors and officers reside outside the United States, and a substantial portion of our assets and the assets of such persons are located in jurisdictions outside the United States. As such, it may be difficult or impossible to effect service of process upon us or those persons in the United States or to recover against us or them on judgments of U.S. courts, including judgments predicated upon civil liability provisions of the U.S. federal securities laws. It is doubtful whether courts in Bermuda will enforce judgments obtained in other jurisdictions, including the United States, against us or our directors or officers under the securities laws of those jurisdictions or entertain actions in Bermuda against us or our directors or officers under the securities laws of other jurisdictions.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2254"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investors Outside the United States</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither we nor the selling shareholders have done anything that would permit the possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our ordinary shares and the distribution of this prospectus outside of the United States.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2267"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registered Trademarks and Trademark Applications</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own or have rights to use trademarks, service marks or trade names that we use in connection with the operation of our business. Other trademarks, service marks and trade names appearing in this prospectus are the property of their respective owners. Solely for convenience, the trademarks, service marks, trade names and copyrights referred to in this prospectus are listed without the &#169;, &#174; and &#8482; symbols, but we will assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, trade names and copyrights.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2277"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market &amp; Industry Data and Forecasts </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain market and industry data and forecasts included in this prospectus were obtained from independent market research, industry publications and surveys, governmental agencies and publicly available information. Industry surveys, publications and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable, but that the accuracy and completeness of such information is not guaranteed. We have not independently verified any of the data from third-party sources, nor have we ascertained the underlying assumptions relied upon therein. Similarly, independent market research and industry forecasts, which we believe to be reliable based upon our management&#8217;s knowledge of the industry, have not been independently verified. While we are not aware of any material misstatements regarding the market or industry data presented herein, our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#8220;Risk Factors.&#8221;</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2287"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information included herein has been derived from the financial statements and accounting records of the Company and has been prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). Amounts in this prospectus and the financial statements included in this prospectus are presented in U.S. dollars, unless otherwise noted. Certain amounts presented in tables are subject to rounding adjustments and, as a result, the totals in such tables may not sum.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3935"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Performance Measures and Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In presenting Aspen&#8217;s results, management has included key performance measures and discussed certain measurements that are considered &#8220;non-GAAP financial measures&#8221; under SEC rules and regulations. Management believes that these non-GAAP financial measures, which may be defined differently by other companies, help explain and enhance the understanding of Aspen&#8217;s results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with GAAP. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross written premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represents the total insurance premium for policies written or assumed during a specific period of time before the reduction for policy acquisition costs or other deductions. Gross written premiums is a volume measure commonly used in the insurance industry to compare sales performance by period.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net written premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are gross written premiums less ceded written premiums. Ceded written premiums are the amounts recognized for the purchases of reinsurance or retrocessional coverage, and are accounted for using the same methodology as gross written premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net earned premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are the earned portion of an insurance contract. Net written premium is earned/recognized proportionately over the coverage period and associated risk patterns. Premiums written which are not yet recognized as earned are recorded on the balance sheet as unearned premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represents the amount paid or expected to be paid to claimants, including the cost of investigating, resolving and processing these claims, net of recoveries under the reinsurance and retrocession agreements. This can be broken out into the following categories:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Current accident year losses, excluding catastrophe losses, represents the losses arising in the current financial period, excluding any prior year reserve development and catastrophe losses; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Catastrophe losses are losses that arise from various unpredictable events, including but not limited to, weather-related natural catastrophes, pandemic or contagious disease and man-made events such as acts of war and terrorism.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior year adverse/(favorable) reserve development - post LPT years:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year adverse/(favorable) reserve development represents the strengthening/(releases) in net ultimate loss reserves and claim adjustment expense reserves at each reporting date for claims which occurred in previous calendar years/periods.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen entered into a loss portfolio transfer (the &#8220;LPT&#8221;) with a subsidiary of Enstar Group Limited (&#8220;Enstar&#8221;). Under the terms of the LPT, Enstar&#8217;s subsidiary will reinsure net losses incurred on or prior to December 31, 2019 on all of Aspen&#8217;s net loss reserves of $3.12 billion as of September 30, 2021. The LPT provides a limit of $3.57 billion for 2019 and prior accident year loss development. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year reserve development post LPT years represents the performance of our business for accident years 2020 onwards, reflecting the underlying underwriting performance of the ongoing business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a non-GAAP financial measure. It is the sum of current accident year losses, catastrophe losses and prior year reserve strengthening/(releases) post LPT years. Adjusted losses and loss adjustment expenses excludes the change in the deferred gain on retroactive reinsurance contracts and represents the performance of our business for accident years 2020 onwards, which management believes reflects the underlying underwriting performance of the ongoing business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of LPT and changes in retroactive reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represents the deferral of a portion of loss recoveries on 2019 and prior accident year loss development as per accounting requirements for retroactive reinsurance under  GAAP. The LPT contract with Enstar is a retroactive reinsurance contract. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting result or income/ loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a non-GAAP financial measure.&#160;Income or loss for each of the business segments is measured by underwriting income or loss. Underwriting income or loss is the excess of net earned </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">premiums over the underwriting expenses. Underwriting expenses are the sum of losses and loss adjustment expenses, acquisition costs and general and administrative expenses. Underwriting income or loss provides a basis for management to evaluate the segment&#8217;s underwriting performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted underwriting income or loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a non-GAAP financial measure. It is the underwriting profit or loss adjusted for the change in deferred gain on retroactive reinsurance contracts in order to economically match the loss recoveries under the adverse development cover (&#8220;ADC&#8221;)/LPT contracts with the underlying loss development of the assumed net loss reserves for the subject business of 2019 and prior accident years. Adjusted underwriting income or loss also excludes certain costs related to the LPT contract with Enstar that closed in the second quarter of 2022. Adjusted underwriting income represents the performance of our business for accident years 2020 onwards, which reflects the underlying underwriting performance of the ongoing portfolio.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the sum of current year net losses, catastrophe losses, prior year reserve strengthening/(releases), and the impact of LPT and changes in retroactive reinsurance as a percentage of net earned premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted loss ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a non-GAAP financial measure. It is the sum of current year net losses, catastrophe losses and prior year reserve strengthening/(releases) post LPT years, as a percentage of net earned premiums. Adjusted loss ratio excludes the change in the deferred gain on retroactive reinsurance contracts and represents the performance of our business for accident years 2020 onwards, which management believes reflects the underlying underwriting performance of the ongoing business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the sum of the loss ratio and expense ratio. The loss ratio is calculated by dividing losses and loss adjustment expenses by net earned premiums. The expense ratio is calculated by dividing the sum of acquisition costs and general and administrative expenses, by net earned premiums.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a non-GAAP financial measure. It is the sum of the adjusted loss ratio and the expense ratio. The adjusted loss ratio is calculated by dividing the adjusted losses and loss adjustment expenses by net earned premiums. The expense ratio is calculated by dividing the sum of acquisition costs and general and administrative expenses, by net earned premium.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a non-GAAP financial measure. Operating income is an internal performance measure used by Aspen in the management of its operations and represents after-tax operating results. Operating income includes an adjustment for the change in deferred gain on retroactive reinsurance contracts in order to economically match the loss recoveries under the ADC/LPT contracts with the underlying loss development of the assumed net loss reserves for the subject business of 2019 and prior accident years. Operating income also excludes certain costs related to the LPT contract with Enstar that closed in the second quarter of 2022, net foreign exchange gains or losses, including net realized and unrealized gains and losses from foreign exchange contracts, net realized gains or losses on investments and non-operating expenses and income. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Average equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a non-GAAP financial measure and is calculated by taking the arithmetic average of total shareholders&#8217; equity on a quarterly basis for the stated periods excluding&#160;the average value of Preference Shares (as defined below) less issue expenses. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ratio of debt and hybrids to total capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is calculated by adding total Preference Shares and outstanding debt and dividing by total capital. Total capital is defined as shareholders&#8217; equity plus outstanding debt.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total annualized return on average cash and investments, pre-tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represents total annualized pre-tax return/(loss) on investments as a percentage of average beginning and ending total cash and investments during the period. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_1066"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who We Are</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading specialty (re)insurer focused</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on total value creation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for all of our stakeholders. With $4,339 million of gross written premiums in 2022, we are a scaled multinational business with a diverse product mix balanced across our primary specialty insurance and opportunistic reinsurance franchises, which are both supported by our fee generating capital markets capabilities. We go to market with a single view of risk through our &#8216;One Aspen&#8217; approach, which is designed to cater to complex, bespoke solutions that bring together our expertise spanning different lines of business, segments and platforms, enabling us to develop enhanced and differentiated offerings for our distribution partners and customers. We are focused on underwriting excellence and profitable growth to consistently deliver top quartile results, targeting mid-teen annualized operating return on equity across market cycles. This is demonstrated by our combined ratio of 83.8%, annualized return on average equity adjusted for Preference Share dividends of 22.9% and annualized operating return on average equity (&#8220;Op. ROE&#8221;) of 22.2% for the six months ended June 30, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary specialty insurance product set is centered around niche &#8220;specialty&#8221; lines, such as professional liability, credit and political risk, cyber and environmental, where we can apply our extensive underwriting and industry expertise. Our opportunistic reinsurance business is centered around both specialty and traditional reinsurance lines where we apply risk selection criteria to create unique risk profiles rather than an index of the market as other larger peers may do. Our size presents a distinct advantage, providing us with enough scale to be relevant while still maintaining the ability to be nimble and decisive, which enables us to enter, exit or change the nature of our underwriting positions faster and with greater precision.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our &#8216;One Aspen&#8217; approach, we actively manage our insurance and reinsurance portfolios across market cycles and identify the most attractive risk versus return opportunities to allocate capital. We adopt a dynamic capital allocation approach, utilizing our strong balance sheet and our multiple platforms across the United States, the United Kingdom, Lloyd&#8217;s of London (&#8220;Lloyd&#8217;s&#8221;) and Bermuda to match risk with the most appropriate source of capital, and to drive efficiencies and optimal outcomes for our customers. Our ability to offer our broker and client partners holistic and customized solutions across our entire platform provides us the opportunity to execute larger, more complex deals which frequently result in more attractive terms and conditions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, we wrote $2,125 million in gross written premiums across our Insurance and Reinsurance segments, at a combined ratio of 83.8%. Our shareholders&#8217; equity, excluding accumulated other comprehensive income/(loss) (&#8220;AOCI&#8221;) of $(492) million and Preference Shares, net of issuance costs, with a total value of $754 million, was $2,288 million as of June 30, 2023. For the six months ended June 30, 2023, we generated $219 million of net income, representing a 22.9% annualized return on average equity adjusted for Preference Share dividends and $191 million of operating income, representing a 22.2% Op. ROE.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2022, we wrote $4,339 million in gross written premiums across our Insurance and Reinsurance segments, at a combined ratio of 93.0%. Our shareholders&#8217; equity, excluding AOCI of $(506) million and Preference Shares, net of issuance costs, with a total value of $754 million, was $2,111 million as of December 31, 2022. For the twelve months ended December 31, 2022, we generated $51 million of net income, representing a 0.4% annualized return on average equity adjusted for Preference Share dividends and $202 million of operating income, representing a 11.9% Op. ROE.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Transformation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have undertaken a comprehensive transformation of the business since our acquisition by Apollo in February 2019, centered around a clear strategic vision that has four core tenets: (1) focused underwriting; (2) reduced volatility; (3) improved operational efficiency; and (4) culture. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Focused Underwriting: We have significantly reduced the breadth of our Insurance and Reinsurance product offerings to focus on core lines of business where we have a distinct relevance and leading market positions and believe we can achieve superior underwriting results with successful long-term track records. Since our acquisition by Apollo in 2019, we have exited twelve Insurance and five Reinsurance lines of </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business as part of the strategic repositioning of our underwriting portfolio, which accounted for approximately $911 million of gross written premiums for the twelve months ended December 31, 2018. We have classified $820 million of this as &#8220;Legacy&#8221; (as defined in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Key Performance Measures and Non-GAAP Financial Measures&#8212;Summary of Continuing and Legacy Business&#8221;) business for purposes of reporting on historical legacy underwriting results as these lines of business were exited during the main underwriting remediation period from 2018 to 2021. There were additional exits of two Reinsurance lines of business in 2022, which were part of further refinements to our underwriting strategy, but not classified as part of Legacy underwriting results. We have delivered significant growth in our continuing lines of business, with gross written premiums of $4,299 million in 2022, having grown at an average annual rate of 13% from 2018 to 2022. At the same time, we improved our underwriting performance, as illustrated by our combined ratio decreasing by 17 percentage points over the same period. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g2.jpg" alt="Summary1b.jpg" style="height:347px;margin-bottom:5pt;vertical-align:text-bottom;width:307px"/></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduced Volatility: We have taken extensive action to reduce volatility within both our existing in-force and go-forward businesses. We have dramatically decreased our property catastrophe exposure, with July 1, 2023 net 250-year probable maximum loss (&#8220;PML&#8221;) exposure of $293 million, which has declined by approximately 69% relative to the start of 2018. This allowed us to generate an 11.9% operating return on average equity for the twelve months ended December 31, 2022, despite the highest level of global natural catastrophe insured losses observed since 2017, according to Swiss Re. We also entered into the LPT with Enstar in May 2022 to limit our exposure to adverse development on the carried reserves for the accident years prior to 2020. This provides substantial ongoing protection against both social and economic inflation, while freeing up capital for our underwriters to deploy into the current attractive pricing environment and allowing our management team to focus on delivering profitable growth from within our </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continuing lines of business. Our use of ACM is also highly strategic to our business as a tool to manage net line size and overall volatility, while generating more stable fee income. </span></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><img src="ahl-20231220_g3.jpg" alt="Summary2a.jpg" style="height:359px;margin-bottom:5pt;vertical-align:text-bottom;width:349px"/></div><div style="padding-left:103.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________</span></div><div style="padding-left:121.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">2023 PML as of July 1, 2023.</span></div><div style="padding-left:121.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents Occurrence Exceedance Probability PML for all perils worldwide.</span></div><div style="margin-bottom:9pt;padding-left:121.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Guy Carpenter U.S. Property CAT Rate-On-Line Index.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Improved Operational Efficiency: We have significantly rationalized our operating footprint, reducing our office locations from 30 to 19, while growing our gross written premiums per employee by 53% from 2018 to 2022, and driving a reduction in our expense ratio to 30.5% in 2022 from 32.9% in 2018. We continue to invest in operational efficiencies, which we believe will bring meaningful cost benefits in the medium term through traditional operational expense reductions, as well as improvements to our loss ratio achieved through enhanced underwriting systems and data analytics. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Culture: We have undertaken a transformation so that we can execute our go-forward strategy in adherence with our values. Since Apollo&#8217;s acquisition in 2019, to align with our culture and mission, each member of Aspen&#8217;s executive team has been newly appointed, through either internal promotions or new external hires. Our culture is defined by our core values to be open minded, to do the right thing, to be in it together, to own it, and to innovate. We empower our decision makers, who bring to bear their expertise for clients, and build our reputation as thought leaders in our market spaces. Our employees are challenged to be not just risk allocators, but considered risk managers who demonstrate underwriting judgment, exercising restraint in soft markets and pursuing growth in favorable market conditions. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The result of this transformation has been a significant shift in our culture, and a strategic repositioning of the underwriting portfolio that is now being reflected in our financial results, providing a dynamic platform on which to execute our go-forward strategy of growing our core lines of business.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our underwriting operations as two distinct business segments: Insurance and Reinsurance. We have a diversified yet complementary portfolio across these segments, constructed through the lens of our &#8216;One Aspen&#8217; approach, where we balance risk on an aggregate basis and tactically deploy capital to the lines of business </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and platforms that we believe will generate the best returns for the Aspen Group. Our Insurance and Reinsurance segments both leverage third-party capital through ACM, which utilizes our capabilities in the third-party capital space (namely, the Insurance Linked Securities markets) to provide our core Insurance and Reinsurance segments with enhanced capital flexibility and operating leverage. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our size provides an advantage relative to our larger peers, allowing us to be nimble and decisive; entering, exiting or changing the nature of our underwriting positions faster and with greater precision. For instance, as part of our active portfolio management process for the 2023 planning year, we made the decision to step back from the aviation, space and bloodstock reinsurance markets as we did not see medium-term returns meeting our targets, while also reducing our risk appetite for mortgage reinsurance. In addition, in the Insurance segment we actively managed down from our original 2023 planned growth within selected U.S. management liability and professional liability lines of business, where we have observed a softening rate environment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strength of our Insurance and Reinsurance businesses is evidenced by our numerous nominations for industry awards in 2023, including being shortlisted for Insurance Insider&#8217;s (Re)insurer of the Year, shortlisted for Insider Honours&#8217; Diversity &amp; Inclusion and Carrier of the Year, and our CEO and Executive Chair, Mark Cloutier, being awarded Inside P&amp;C&#8217;s CEO of the Year. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our Insurance segment underwrites primary specialty risks across a diversified set of property and casualty lines of business. We focus on market segments with high barriers to entry that require bespoke underwriting and industry expertise and customized solutions to address client needs. We have long-standing relationships with key distribution partners, primarily comprised of a diversified group of leading retail brokers and wholesale brokers, along with a select number of managing general agents (&#8220;MGAs&#8221;). We believe our experience in these niche markets has cemented our role as a partner of choice for many of our distributors, as we are able to leverage our capabilities to develop one-stop custom solutions across multiple lines of business, platforms and geographies. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have niche underwriting capabilities across multiple platforms, including: U.S. admitted lines; U.S. excess and surplus (&#8220;E&amp;S&#8221;) lines; Lloyd&#8217;s; the U.K. Company Market and Bermuda. The breadth of our capabilities across these platforms allows for solutions that can be tailored to our clients&#8217; needs while also allowing us to optimize returns based upon prevailing market conditions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specialty is at the heart of our capabilities and product offerings. We define our specialty orientation to include the following: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product spaces which are non-commoditized where bespoke underwriting expertise and innate sector knowledge is required and serves as a true differentiator; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Clients that have complex business challenges requiring customized insurance solutions to fit their specific risk transfer needs; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks that are underwritten on an individual basis, frequently requiring advanced analysis and modeling as well as specialized active claims management. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Insurance segment is organized into four portfolios of business: (1) financial and professional lines; (2) casualty and liability lines; (3) first party / property lines; and (4) specialty lines. Each portfolio has multiple product offerings which are overseen by experienced teams of underwriters who are experts in their given niche. The </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">composition of our Insurance product offering is included below with percentages based on gross written premiums for the twelve months ended December 31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g4.jpg" alt="Summary3b.jpg" style="height:320px;margin-bottom:5pt;vertical-align:text-bottom;width:336px"/></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specific examples of our expertise and differentiated approach across product lines include: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Specialized Expert Underwriters. We employ underwriters who are experts in their respective fields, with the requisite sector knowledge to best assess, select and price risk. For example, the team that handles our ocean marine product line includes former members of the Merchant Marines; our credit and political risk business is led by former bankers who understand the nuanced complexity associated with credit risk, while our cyber and tech liability teams are trained to field-recognized designations that would traditionally sit outside the insurance industry. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Customized Product Offering. We have significantly narrowed our focus to concentrate on niche offerings, seeking to underwrite beyond the traditional lines of business that would result in a portfolio that stands and performs as just an index of the market. Examples of some of our specific product offerings include: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Credit and Political Risk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Bespoke contracts for complex credit and project finance deals underwritten by an experienced team of underwriters, supported by dedicated in-house credit analysts, offering one of the widest product suites in the market; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Cyber and Tech Liability:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A team of global underwriters providing robust risk selection capabilities, who are all required to pass a credentialed network security exam (Certified Information Privacy Professional or Certified Information Privacy Technologist) to ensure consistent risk assessment expertise across the team;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Environmental:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Specialist liability products to mitigate the financial impacts of environmental financial claims with a team of over 25 underwriters with experience across law, engineering, consulting and risk management, that provide global capabilities from eight cities around the world;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Inland Marine:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Within this business line, we underwrite both fine arts and construction. Fine arts is underwritten by a dedicated underwriting team with members having over ten years of experience on average. Our construction team has industry relationships with Engineering News </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Record Top 25 General Contractors, supported by an on-staff engineer, who provides clients access to risk control review, industry recommendations and best practice health checks;   </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">U.K. Property &amp; Construction:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Structured as three underwriting teams across property investors, business &amp; public sector, and construction, our U.K. property &amp; construction team excels at unusual and special circumstances. We work in collaboration with our U.K. &amp; international casualty underwriters to provide cross-class solutions for our clients and broker partners; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">U.S. Management Liability:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A portfolio tactically balanced between open market writings (with greater exposure to fluctuations in market conditions) and delegated underwriting authority business in the small and midsize enterprise space (which is more stable and less price sensitive). As a subset of our management liability portfolio, transactional liability is a true specialty class where we have longstanding partnerships with two of the most respected underwriting facilities in the market, Ambridge Partners and Euclid Transactional.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Tailored Portfolio Solutions. We have designed bespoke portfolio solutions across multiple lines of business for a number of our long-term trading partners. We continue to leverage our multiple operating platforms, bringing the &#8216;One Aspen&#8217; approach to market, where our Reinsurance and ACM capabilities facilitate support of and alignment with our Insurance offerings. An example of this is a binder agreement we have with a leading wholesaler, whereby we provide underwriting capacity to multiple specialty programs across both the United States and Europe, utilizing our multiple operating platforms. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This approach has been the foundation for establishing a long-term track record of underwriting profitability across numerous lines of business. For example, we have achieved aggregate comb</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ined ratios of below 90% fro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m 2016 through 2022 in our U.S. professional liability, U.K. property and construction, environmental, cyber, U.K. liability, international energy and construction and international credit and political risk lines, representing over $5,000 million of gross written premiums across that period. We strive to maintain this caliber of underwriting performance in these lines, while building our track record within our other primary insurance lines of business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, our Insurance segment had $1,250 million of gross written premiums, generated $98 million of underwriting income and had a combined ratio of 86.4%. For the five-year period 2018 to 2022, continuing lines within our Insurance segment grew at an average annual growth rate of 12.7%. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Within this segment, we offer expertise in a variety of global reinsurance lines including property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance. We implement a simple, yet effective, distribution model targeting long-term relationships and product spaces that have demonstrated strong underwriting returns through market cycles. Our focus goes beyond traditional reinsurance, as we seek to provide our clients with innovative solutions, through both traditional retrocession, and the utilization of third-party capital through ACM alongside our own Aspen balance sheet capital. We are opportunistic yet disciplined in our approach, positioned to benefit from market dislocations and underwriting modest lines to reduce volatility from loss events with the aim of generating highly attractive risk-adjusted returns, as opposed to returns that just track the market index. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Reinsurance segment is organized into four portfolios: (1) property catastrophe reinsurance; (2) other property reinsurance; (3) casualty reinsurance; and (4) specialty reinsurance.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Property Catastrophe Reinsurance: Our success in the property catastrophe market is based on strong risk controls and deep, embedded relationships with our clients, giving us differentiated insights to manage exposures. We utilize advanced models, analytical tools and our experienced global underwriting teams to set terms and deliver timely capacity. Our opportunistic strategy in this line has allowed us to take advantage of a hard market cycle, using price increases, improvement in terms and ACM to enhance our underwriting margins and reshape our exposures. Importantly, we have used the hard market conditions not just for premium growth, but to reduce volatility, as evidenced by a significant reduction in PMLs from 2018 to 2023.</span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other Property Reinsurance: We provide tailored solutions for a broad spectrum of property risks worldwide through our dual distribution approach, writing business both directly to ceding firms and through brokers. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Casualty Reinsurance: Our casualty treaty team operates on a global basis, and our analysis of market-wide trends in key territories, supported by close coordination with our claims, legal and actuarial teams, gives us insights that we believe will enable us to succeed in the changing liability landscape. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Specialty Reinsurance: We target niche or unusual risks and are focused on offering tailor-made risk transfer solutions for several specialty lines. We believe our global expertise is well recognized and our team of underwriters across London, Singapore, Zurich and the United States give us valuable regional and global expertise to support our clients. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of our Reinsurance business mix based on gross written premiums for the twelve months ended December 31, 2022 is included in the following chart:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g5.jpg" alt="Summary5a.jpg" style="height:191px;margin-bottom:5pt;vertical-align:text-bottom;width:191px"/></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, our Reinsurance segment had $876 million of gross written premiums, generated $111 million of underwriting income and had a combined ratio of 80.7%. For the five-year period 2018 to 2022, continuing lines within our Reinsurance segment grew at an average annual growth rate of 13.7%. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACM:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We participate in the alternative reinsurance market through ACM, which acts as a conduit between Aspen&#8217;s balance sheet and third-party investors and supports each of our Insurance and Reinsurance segments. Through reinsurance sidecar investments, ACM provides investors direct access to our underwriting expertise and earns underwriting, management and performance fees for Aspen from other third-party investors primarily through the placement and management of side cars, insurance linked securities (&#8220;ILS&#8221;) funds and other offerings. ACM is highly strategic to our business, providing a unique set of capabilities and tactical optionality to manage risk and improve our returns. Unlike other offerings in the market that are predominantly property catastrophe reinsurance focused, ACM offers investors a broader product suite that provides direct, fully aligned participation to risk underwritten by Aspen&#8217;s primary specialty insurance and reinsurance portfolios, including actively managed fund products and sidecars. Notably, ACM&#8217;s capabilities in longer-tail lines of business bring greater stability to our fee income, and thus our underwriting results, as this fee income is associated with &#8220;stickier&#8221; third-party capital structured over multiple years. As of June 30, 2023, approximately 50% of third-party capital within ACM supported longer-tail products. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACM is a core differentiator for Aspen, bringing our expertise in capital markets alongside that of our traditional outwards reinsurance capabilities, providing us with increased optionality across cycles in terms of access to capital, complementing our dynamic capital allocation approach. The ACM portfolio generally mirrors our own through collateralized quota share arrangements that provide third-party investors with aligned participation to our Insurance and Reinsurance underwriting. ACM is recognized as an innovator across both catastrophe and non-catastrophe risks and was one of the leaders in developing ILS capabilities for cyber risk. Our strong relationships and reputation in the market have enabled ACM to achieve significant growth since 2018, including in recent years where many insurance capital markets players reduced capacity. The following charts reflect the fee income </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generated by ACM for each of the twelve months ended December 31, 2018 through December 31, 2022 and the diversification of ACM&#8217;s fee income for the twelve months ended December 31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fee Income (2018-2022)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diversification of Fee Income (2022)</span></td></tr><tr style="height:134pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g6.jpg" alt="Summary7a.jpg" style="height:138px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"/></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g7.jpg" alt="ACM Pie Chart.jpg" style="height:165px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"/></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACM generated $104 million in fee income for the twelve months ended December 31, 2022. This fee income is primarily reflected as an offset to our acquisition costs and is therefore embedded in our underwriting results. For the five-year period from 2018 to 2022, third-party capital grew at a compounded annual growth rate (&#8220;CAGR&#8221;) of 17.1%, from $667 million in 2018 to $1,253 million as of December 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our investment strategy is focused on delivering stable investment income and total return through all market cycles, while maintaining high credit quality and portfolio liquidity. We manage a conservative investment portfolio that is appropriately balanced between our liquidity needs and investment returns, with an average credit rating of AA- and duration of 2.7 years of fixed income securities within our portfolio, as of June 30, 2023. We have access to world-class investment managers and execute this strategy through thoughtful allocations of investment assets to our key investment management partners. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To enhance investment returns, we tactically calibrate asset allocation and the duration of our investment portfolio, taking into account the duration of our insurance and reinsurance liabilities, as well as our view of interest rates, the yield curve, credit spreads and other general market conditions. Since Apollo&#8217;s acquisition in 2019, we have strengthened our investment approach and yields through deploying capital into a broader range of asset classes, including asset-backed securities, high yield loans, and privately held investments, and by increasing our allocation to alternative investments. As of June 30, 2023, we allocated 24% of our investment portfolio, representing $1.8 billion of our investments, to this strategy.</span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, we had $7.3 billion of total cash and investments, excluding catastrophe bonds, net receivables for securities sold and accrued interest receivable, on our balance sheet and for the six months ended June 30, 2023, we generated $129 million of net investment income.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g8.jpg" alt="Summary8a.jpg" style="height:290px;margin-bottom:5pt;vertical-align:text-bottom;width:643px"/></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our aggregate portfolio reflected in the chart above (including the characterization of our investments as available for sale and trading), please refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Balance Sheet&#8212;Total cash and investments.&#8221; </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our competitive strengths include:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8216;One Aspen&#8217; Approach, Supported by Dynamic Capital Allocation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our &#8216;One Aspen&#8217; approach, we can actively manage our portfolio across counter-cyclical pricing environments in the insurance and reinsurance markets, shifting capital between our two segments and being opportunistic in markets where we perceive advantageous risk versus return opportunities. The markets we serve require capabilities that are not easily replicated and we come to market in a way that allows us to bring our product offerings together and execute on large new deals across different lines of business, platforms and segments. This provides us with greater control over capital allocation and underwriting outcomes, and is a key pillar of our go-forward offering and growth strategy.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating and risk allocation strategy has been carefully designed to optimize the use of both our own assets, as well as third-party capital. Business sourced is carefully analyzed and directed to the appropriate underwriting platform, taking into account client characteristics, as well as operational and efficiency considerations.  We have a scaled but nimble (re)insurance presence across the most important global underwriting hubs for our lines of business, including the U.S. admitted, U.S. E&amp;S, Bermuda, Lloyd&#8217;s and the U.K. Company Market, all leveraging our third-party capital markets capabilities (through ACM).  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Niche Primary Insurance Platform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance strategy is focused on underwriting complex, highly curated, niche lines of business with high barriers to entry. Our Insurance segment generated $2,532 million in gross written premiums for the twelve months ended December 31, 2022. We only participate in lines of business in which our underwriters have deep, technical expertise and where they can be well supported by our platforms and strong capabilities, allowing us to provide innovative and coordinated solutions to clients. From 2018 to 2022, we experienced aggregate rate increases of </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56.8% in our portfolio, driven by pricing improvements from our core lines of business. We adopt an efficient tactical use of outwards reinsurance, enabling us to write higher exposure policies while appropriately managing our net retained exposure.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since being acquired by Apollo, we have exited a number of lines of business (legacy business) while also achieving strong growth in our continuing lines of business generating attractive profitability. The average premium growth rate within these continuing lines of business has been 12.7% since 2018 and the loss ratio and combined ratio have improved from 63.6% and 99.1% in 2018, to 62.3% and 91.4% in 2022, respectively.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opportunistic Specialist Reinsurance Franchise</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a nimble reinsurance strategy focused on core lines of business within property, casualty and specialty. Our Reinsurance segment generated $1,807 million in gross premiums for the twelve months ended December 31, 2022 and is positioned to capitalize on dislocation within a broad set of markets. Our strategy is to underwrite modest line sizes to limit exposure from large loss events, and our property catastrophe portfolio has been optimized to generate higher risk-adjusted returns and manage overall volatility. The average premium growth rate within these continuing lines of business has been 13.7% since 2018 and combined ratio has improved from 104.6% in 2018, to 94.2% in 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our opportunistic approach has allowed us to take upside from attractive reinsurance underwriting conditions, where we have experienced strong rate increases in a hard market cycle. We have experienced cumulative rate increases of 43.8% from 2018 to 2022, and we continued to benefit from an attractive pricing environment through the first half of 2023, with a rate increase of 19.2% through June 30, 2023. Our strength in reinsurance is bolstered through the deployment of third-party capital through ACM, which provides us with differentiated access to capital and allows us to &#8220;flex&#8221; into attractive market opportunities.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Growing and Highly Complementary Capital Markets Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception in 2013, ACM uses our capabilities in the third-party capital markets, to increase the flexibility Aspen&#8217;s Insurance and Reinsurance underwriters have in allocating risk to the best source of capital. ACM leverages the full breadth of our expertise across distribution, underwriting, modelling, actuarial and claims, to create attractive opportunities for our investor partners. ACM has experienced significant growth, with third-party capital growing from $667 million in 2018 to $1,253 million at the end of 2022, and generating $104 million in fee income for Aspen in 2022. We believe we have driven innovation in this market and have cultivated close relationships with third-party capital investors. ACM is a differentiated capability and highly strategic to our business, allowing us to support our Insurance and Reinsurance segments with third-party capital, and serving as a mechanism for tactical de-risking as we leverage fee income from our on-balance sheet underwriting risk. This capability provides us with the ability to &#8220;flex&#8221; into attractive opportunities in accordance with underwriting cycles and enhances our go-to-market strategy.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deep Trading Partner Relationships</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have seasoned and diversified relationships with partners across our (re)insurance segments. The distribution strategy within our Insurance segment is focused on specialized intermediaries with whom we have long-standing relationships. Our distributors are experts in their field and know our products and risk appetite well. We have flexibility across retail brokers, wholesale brokers and MGAs to drive value and maintain deep relationships without being overly reliant on any one large partner. Our Reinsurance segment is characterized by the longevity of our relationships with cedants, as 89% of our current cedants have been doing business with Aspen Re for over ten years, and we believe we are viewed as a strong, reliable counterparty.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong Balance Sheet</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an efficient capital structure and strong capitalization with $2,849 million of total capital as of June 30, 2023. Additionally, we have strong financial strength ratings from both A.M. Best Company, Inc. (&#8220;A.M. Best&#8221;) (&#8220;A&#8221;) and Standard &amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;) (&#8220;A-&#8221;) and maintain Group BMA Bermuda Solvency </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital Requirement (&#8220;BSCR&#8221;) of 237% as of December 31, 2022. We maintain our Group BMA BSCR significantly in excess of regulatory minimums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strong positioning as a go-forward business is supported by the LPT transaction with Enstar, which provides protection against deterioration on pre-2020 accident year carried reserves, significantly limiting Aspen&#8217;s exposure to the risk of unfavorable development from these periods while still retaining the scale, market relationships, and operational infrastructure to capitalize on current market conditions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart shows our pre-2020 accident year carried reserves, as well as the LPT coverage above such carried reserves, as of September 30, 2021 and June 30, 2023.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g9.jpg" alt="Summary9d.jpg" style="height:346px;margin-bottom:5pt;vertical-align:text-bottom;width:441px"/></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Highly Experienced Management Team</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Led by our CEO and Executive Chair, Mark Cloutier, we have an experienced executive leadership team from diverse backgrounds, each with a specific role and purpose to drive the transformation of our business. Since Apollo&#8217;s acquisition in 2019, to align with our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">culture and mission, each member of Aspen&#8217;s executive team has been newly appointed, through either internal promotions or new external hires. Our team has an average o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f 28 years of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">experience across all facets of the global specialty property &amp; casualty (re)insurance and financial services sectors, including underwriting, claims, technology, investment management, risk management, finance, brokering, actuarial, people and operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strategy </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an institution we aim to bring &#8220;Clarity from Complexity.&#8221; We seek to transform complex risks into opportunities through efficient and innovative solutions, leveraging our multi-platform capabilities across our Insurance and Reinsurance segments, both of which are supported by ACM. We believe we are a market leader in our industry that provides our clients with confidence and the best possible outcomes. Our culture, which prioritizes collaboration, accountability and service, allows us to provide intelligent, swift solutions in the face of challenges. Whatever the challenge is, we are &#8216;One Aspen&#8217;.</span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our vision statement is &#8216;to be a top quartile specialty risk (re)insurer focused on total value creation through underwriting profit and investment performance.&#8217; Our ability to achieve this goal is based on three key pillars, which we believe create a virtuous cycle for success:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Continued profitable growth. Profitability is paramount to the focus of our business and core to our strategic direction. We continue to scale up the business in our core markets achieving operating and expense efficiencies. Our current size and balanced, nimble positioning ensure there are ample opportunities to grow the business with additional scope in current lines of business as well as expansion into new lines. We are focused on profitable growth in both the current and future periods, and take a long-term approach when optimizing both the liability and asset sides of our balance sheet. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Build a sustainable business. We actively manage risk to further the sustainability of our business across cycles, flexing exposure based on the market cycle. We have implemented strategies to mitigate overall volatility, as evidenced by our significant reduction in PMLs and strategic exits of various insurance and reinsurance lines. Our approach to risk management is backed by resilient technology and human expertise, which begins at the individual employee level and extends up to our Board of Directors (the &#8220;Board&#8221;). We believe that building a sustainable business also includes supporting our communities and creating a nurturing, diverse and inclusive working environment for our colleagues. We are committed to building a business that appropriately embraces key Environmental, Social and Governance (&#8220;ESG&#8221;) principles in how we operate and how we interact with our stakeholders.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Build our market reputation. Our goal is to continue to be a trusted partner, built upon the mutual respect laid out in our values and culture and delivering consistency within our chosen markets. We approach challenges with an open mind and leadership mindset, promoting innovative solutions to achieve the best outcome as a team for our customers. We are empowered decision makers, who bring clients expertise, with the goal of exceeding expectations in our market spaces. We believe this will ensure an enduring franchise. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology strategy is underpinned by our mission to underwrite excellent business and to automate and digitize operations from ingestion to downstream functions. As part of our strategy, we amplify underwriting and claims results through the use of data and technology insights. Underlying data is key to our decision making and we have extensively invested in enterprise-wide data and analytics capabilities. We are transitioning to a single, comprehensive enterprise-wide data repository, built on over 20 years of underwriting history, which we expect will form the foundation for our reporting, business intelligence, analytics and other advanced data capabilities. We believe this agile platform will allow us to develop our real time access to analytics and provide us with an advantage in managing our risk and better claims / portfolio management. In addition, we have invested in a variety of application programming interface and cloud capabilities, which give us greater flexibility in integrating our multi-national underwriting operations and leveraging software as a service and third-party data sources to ensure a competitive advantage. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Underpinning all of this is our ability to maintain a strong balance sheet and manage our capital prudently. We have a highly efficient capital structure and our capitalization is strong, as evidenced by our strong financial strength ratings. We are constantly monitoring rating agency guidelines, changes in our regulatory environment and market opportunities to ensure that our capital structure is appropriate for our strategic ambitions. We maintain robust procedures for setting loss reserves and actively managing risk in our portfolio. Our reserve confidence was further strengthened by the previously mentioned LPT transaction executed in May 2022. In today&#8217;s attractive underwriting environment, we see ample opportunity to deploy excess capital into both our Insurance and Reinsurance segments, but through the cycle we may return capital to shareholders when opportunities are limited during soft insurance markets. See &#8220;Dividend Policy.&#8221; </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are guided by the phrase &#8220;One Aspen Team, Creating Value,&#8221; which is underpinned by our core set of values &#8211; to be open minded, to do the right thing, to be in it together, to own it, and to innovate. We have built </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen&#8217;s culture around these guiding principles to foster an environment that promotes innovation, collaboration, inclusiveness and accountability.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g10.jpg" alt="Summary10a.jpg" style="height:222px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Markets and Opportunity</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate within the global (re)insurance market, where we have significant opportunities to capture attractive risk-adjusted returns across the cycle through our multi-platform capabilities. The global macroeconomic and social environment continues to drive demand for increasingly complex (re)insurance solutions delivered as a joined-up offering, which is where we thrive. In recent years, rate increases have been driven by the increased frequency and severity of natural catastrophe events globally (impacted by changing weather patterns), inflation (both social and economic), increased geopolitical tensions and other risks that have grown and emerged, increasing the demand for specialty solutions. As a result, the global commercial insurance industry has seen 24 consecutive quarters of price increases according to Marsh&#8217;s Global Insurance Market Index Q3&#8217;2023.   </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect these hard market conditions will persist, as they are driven by uncorrelated and continuing macroeconomic and social dynamics. This will provide opportunities for us to deliver profitable growth as we target new business and clients at favorable rates and with improved terms and conditions, while maintaining disciplined risk selection. Furthermore, our chosen lines of business within Insurance have high barriers to entry requiring the bespoke tailoring of products and the need for specialized and experienced underwriters with tenured distribution relationships.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The higher interest rate environment provides additional tailwinds for our business. Higher returns from our fixed income portfolio complement our underwriting income with attractive investment income and contribute to our ability to generate strong risk-adjusted returns for our shareholders. With a low-risk fixed income portfolio of relatively short duration 2.7 years as of June 30, 2023, we are well placed to take advantage of attractive investment yields as we rotate and reinvest.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global Insurance Market</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within Insurance, we operate within both the U.S. specialty and international insurance markets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">U.S. Specialty</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen operates within the broadly defined U.S. commercial lines market, which generated annual industry premiums of approximately $446 billion as for the twelve months ended December 31, 2022.  The industry has experienced improved underwriting performance following the COVID-19 pandemic and wider economic uncertainty. Within commercial insurance, the excess and surplus (&#8220;E&amp;S,&#8221; &#8220;non-admitted&#8221; or &#8220;surplus lines&#8221;) market has demonstrated strong growth, with highly attractive rate increases and improvement in terms and conditions. For the twelve months ended December 31, 2022 we wrote $951 million of gross premiums in the E&amp;S market. A.M. Best estimates that this market segment is approaching $100 billion in annual premiums, nearly doubling since 2018. Driving this growth is the macroeconomic and social environment and challenges within the </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">admitted space, which continues to drive demand for specialized insurance solutions due to both increasing and more complex risks from the commercial market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E&amp;S carriers are generally permitted to craft insurance terms to suit the particular risk they are assuming as the underlying risks tend to have unique qualities. Consequently, in this space we are able to provide tailored contracts and limit exposure to loss by either excluding coverage or providing a sub-limit on coverage. This customized approach provides the opportunity to achieve attractive long-term profitability. From 2001 to 2020, E&amp;S loss ratios have outperformed admitted loss ratios by approximately 4% according to A.M. Best.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We underwrite business in the United States through Aspen American Insurance Company and Aspen Specialty Insurance Company on an admitted and excess and surplus basis, respectively. For the twelve months ended December 31, 2022, we generated $1,974 million of gross written premiums in this market.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">International Insurance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international insurance products are underwritten in the London Market, through both our Lloyd&#8217;s and U.K. Company Market platforms. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lloyd&#8217;s is the world&#8217;s largest specialty insurance marketplace, underwriting &#163;29 billion of premiums during the six months ended June 30, 2023, up 22% from the same period in the prior year. The Lloyd&#8217;s global distribution network is where many of the world&#8217;s most complex risks are placed, across more than 60 specialty lines of business. Over 50 leading insurance companies participate in the market with more than 380 registered Lloyd&#8217;s brokers and a global network of over 4,000 local coverholders. We have a significant presence at Lloyd&#8217;s through our integrated Lloyd&#8217;s vehicle, comprising Syndicate 4711, managed by Aspen Managing Agency Limited with fully aligned capital, which in addition to access to complex risks also provides us (re)insurance licensing access for 80 territories (and an additional 20 territories on a reinsurance only basis) across the Americas, the United Kingdom, Europe, and Asia Pacific. Aspen is well positioned within Lloyd&#8217;s, returning top five syndicate performance in 2022 with a reported combined rati</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o of 75.4% and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> significantly increased underwriting capacity for 2023. For the twelve months ended December 31, 2022, we wrote $1,062 million of gross premiums in the Lloyd&#8217;s market, placing us inside the top 20 largest syndicates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.K. Company Market is an important market for global specialty insurance, with companies and individuals worldwide turning to this market to protect against niche and hard-to-place risks, ranging from liability and professional lines, to cyber and renewable energy exposures. Gross premium written in this market stood at &#163;44 billion in 2022, up 33.0% from &#163;33</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> billion in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2020. While there is no standard definition of this market, there is a general agreement that the core of its activity is internationally traded non-life, commercial and specialty insurance and reinsurance business written by standalone insurers operating outside Lloyd&#8217;s, but within its wider ecosystem. This is mostly P&amp;C (re)insurance, with an increasing emphasis on high-exposure risks. The diversity and expertise of insurers and underwriting talent, as well as the ecosystem of service providers, make this a highly attractive market to write our U.K.-centric lines of business. We write business in this market through Aspen Insurance UK Limited. For the twelve months ended December 31, 2022, we </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">wrote </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$465 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of gross written premiums in this market.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global Reinsurance Market</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global reinsurance market has approximately $709 billion of capital committed as of June 30, 2023, a decrease of 2.2% from December 31, 2021. We believe the market is witnessing an opportunity for margin expansion.  There is a supply and demand imbalance in global reinsurance due to limited new capacity entering the market, retreating rated reinsurers, reduced ILS capacity for traditional property catastrophe focused managers, increased exposure from inflation, and reduced capital positions as a result of unrealized losses on fixed income portfolios. While the opportunity is currently led by property catastrophe pricing, which has seen an approximately 29% increase in rates in 2023 according to Guy Carpenter&#8217;s Global Property Rate-On-Line Index, along with significantly better terms and conditions and primary retention, there remains broader opportunity to cross sell to quality, non-retreating carriers. Our global underwriting platforms in reinsurance, and differentiated, diverse ACM capabilities provide us with an opportunity to react quickly to market conditions and benefit from the current market cycle. </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Reinsurance business segment is underwritten through four core platforms, which include AAIC, Aspen UK, Syndicate 4711 and Aspen Bermuda, and our branch offices including our European hub in Zurich and Asia Pacific hub in Singapore. For the twelve months ended December 31, 2022, we wrote $1,807 million of gross written premiums in the reinsurance market.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Sustainability Principles</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to be a diverse and inclusive business, providing strong risk-adjusted returns as we work towards a goal of having a deep sense of social responsibility, whether that be supporting the local communities in which we operate or proactively managing the environmental footprint of our direct operations. Sustainability and ESG are closely linked, and we expect to play our part pragmatically in the transition to net zero. Our vision is to bring &#8220;Clarity from Complexity&#8221; and this is reflected in the approach we take and how we deliver our long-term objectives in respect of sustainability. We believe our heritage of deep sector expertise, strong culture and our proven ability to apply the full breadth of our capabilities to solve problems created by new and changing risks, makes us uniquely positioned to be a relevant partner as the energy and other sectors work towards this transition. Our philosophy is centered around three pillars: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Environmental:  We have calculated our Scope 1, Scope 2 and, in relation to certain categories, Scope 3 greenhouse gas emissions utilizing estimates, methodologies and conversion factors aligned to the Greenhouse Gas Protocol for our industry. As we work towards carbon reductions across our value chain, we also make use of offsetting projects accredited by the Verified Carbon Standard (&#8220;VCS&#8221;) and Gold Standard (&#8220;GS&#8221;) to compensate for 100% of our Scope 1 and 2 greenhouse gas emissions, along with all calculated Scope 3 categories (i.e., fuel and energy related activities, waste generated in our operations, business travel and employee commuting (including working from home)) directly relating to our employees. We plan to continue our carbon offsets program to continue addressing our overall carbon footprint. Our sustainability development and focus is enabling us to be more data-led when determining projects to fund, where we invest and how to consider clients&#8217; sustainability in our underwriting;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Social: Our policies are designed to empower our staff to support their own charitable passions, with the goal of providing opportunities for future success in our global and local communities. We develop collaborative engagement with our employees and our third sector partners, instilling a sense of pride in current staff and building a platform to attract future talent. In tandem with attracting talent, we have a clear workplan that is led by people from across our business and championed by executive sponsors to foster a diverse and inclusive culture; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Governance: In an age of increased risks, we employ a comprehensive risk management framework, which provides the foundation through which we evaluate and manage business opportunities and related risks in a disciplined manner across the Group. Strong governance is the bedrock of our focus on offering value to our clients, employees and communities around us and we have a clear structure in place to deliver on this. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2590"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Risk Factors </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing in our ordinary shares involves risks. Prospective investors should carefully consider the risks described in &#8220;Risk Factors&#8221; below, as well as other information contained in this prospectus before making a decision to invest in our ordinary shares. Any of the factors set forth under &#8220;Risk Factors&#8221; could materially adversely affect our business, financial condition, results of operations or cash flows and could impact any forward-looking statements. Prospective investors should note that such risks are not the only ones we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect us in the future. Among these important risks are the following:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial condition and operating results may be adversely affected by the occurrence of natural disasters and other catastrophe events, as well as outbreaks of pandemic or contagious diseases;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">global climate change, as well as increasing laws, regulation and litigation in the area of climate change, may have an adverse effect on our results of operations, financial condition or liquidity;</span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could face unanticipated losses from war, terrorism and political unrest, government action that is hostile to commercial interests and from sovereign, sub-sovereign and corporate defaults, and these or other unanticipated losses could have a material adverse effect on our financial condition or operating results;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our results may fluctuate as a result of many factors, including cyclical changes in the reinsurance and insurance industries;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reinsurers may not reimburse us for claims on a timely basis, or at all, which may materially and adversely affect our business, results of operations and financial condition;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a material proportion of our business relies on the assessment and pricing of individual risks by third parties;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of any risk management and loss limitation methods we employ could have a material adverse effect on our financial condition and operating results;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial condition and operating results may be adversely affected if actual claims exceed our loss reserves;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be adversely impacted by economic inflation;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our investments are subject to interest rate, credit, and real estate related risks, which may adversely affect our net income and may adversely affect the adequacy of our capital</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our operating results may be adversely affected by the failure of policyholders, brokers or other intermediaries or reinsurers to honor their payment obligations;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition and consolidation in the (re)insurance industry could reduce our growth and profitability;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Operating Subsidiaries are rated and our Lloyd&#8217;s business benefits from a rating by one or more of A.M. Best and S&amp;P and a decline in any of these ratings could adversely affect our standing among brokers and customers and cause our premiums and earnings to decrease, or may otherwise result in an adverse effect on our business, financial condition and operating results;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we depend on a few brokers for a large portion of our insurance and reinsurance revenues and the loss of business provided by any one of those brokers could adversely affect us;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political, regulatory, governmental and industry initiatives may have a material adverse effect on our business, financial condition, results of operations, liquidity, cash flows and prospects;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our internal controls over financial reporting have gaps or other deficiencies;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could be adversely affected by the loss of one or more of our senior underwriters or other members of our senior management team or by an inability to attract and retain senior staff;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as a foreign private issuer and &#8220;controlled company&#8221; within the meaning of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance rules, we are permitted to, and we will, rely on exemptions from certain of the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance standards and our reliance on such exemptions may afford less protection to holders of our ordinary shares;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a failure in our data security and/or technology systems or infrastructure or those of third parties, including those caused by security breaches or cyber-attacks could disrupt our business, damage our reputation and cause losses; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other factors identified under &#8220;Risk Factors&#8221; in this prospectus. </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Corporate Structure</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated on May 23, 2002 in Bermuda as a holding company operating under the laws of Bermuda. Our principal office is located at 141 Front Street, Hamilton, HM19, Bermuda. Our telephone number is +1 441-295-8201 and our website address is www.aspen.co. Information contained on, or that can be accessed through, our website is not part of and is not incorporated by reference into this prospectus, and you should not consider information on our website to be part of this prospectus. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, Highlands Bermuda Holdco, Ltd., an affiliate of certain investment funds managed by affiliates of Apollo, owned all of our ordinary shares. The following diagram sets forth a simplified view of our corporate structure after giving effect to this offering. This chart is for illustrative purposes only and does not represent all legal entities affiliated with the entities depicted. Unless otherwise noted, each entity is wholly-owned by its immediate parent.</span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_73667279069914"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:4.50pt 18.00pt 18.00pt 18.00pt"><div style="margin-top:6pt;text-align:center"><img src="ahl-20231220_g11.jpg" alt="Summary 10e.jpg" style="height:648px;margin-bottom:5pt;vertical-align:text-bottom;width:892px"/></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">See &#8220;Principal and Selling Shareholders&#8221; for detail of the percentage ownership prior to this offering, as well as the percentage ownership following this offering.</span></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8831"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Implications of Being a Foreign Private Issuer</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are considered a &#8220;foreign private issuer&#8221; and report under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) as a non-U.S. company with foreign private issuer status. This means that, as long as we qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and  </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (i) the majority of our executive officers or directors are U.S. citizens or residents, (ii) more than 50% of our assets are located in the United States or (iii) our business is administered principally in the United States.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a foreign private issuer, the Company is also entitled to rely on exceptions from certain corporate governance requirements of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . As a result, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this prospectus, we have taken advantage of certain of the reduced reporting requirements as a result of being a foreign private issuer. Accordingly, the information contained herein may be different than the information you receive from other public companies in which you hold equity securities.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Apollo and Controlled Company Status</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2019, the Company completed its merger with Highlands Merger Sub, Ltd. (&#8220;Merger Sub&#8221;), a wholly owned subsidiary of Highlands Bermuda Holdco, Ltd. Merger Sub merged with and into the Company, with the Company continuing as the surviving company and as a wholly owned subsidiary of Highlands Bermuda Holdco, Ltd. Highlands Bermuda Holdco, Ltd. is an affiliate of certain investment funds managed by affiliates of Apollo. Apollo is a leading global investment manager and had total assets under management of $631.2 billion as of September 30, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this offering, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, an affiliate of certain investment funds managed by affiliates of Apollo, will control a majority of the combined voting power of our outstanding shares, making us a &#8220;controlled company&#8221; within the meaning of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance rules. A &#8220;controlled company&#8221; under the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance rules is a company of which more than 50% of the voting power for the election of directors is held by an individual, group or another company. In the event we no longer qualify as a foreign private issuer, if then applicable, we may rely on the &#8220;controlled company&#8221; exemption under the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance rules. As a controlled company, we are eligible to, and, in the event we no longer qualify as a foreign private issuer, we may, elect not to comply with certain requirements of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance standards, including (i) the requirement that a majority of the board of directors consist of independent directors, (ii) the requirement that we have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities and (iii) the requirement that our director nominations be made, or recommended to the Board, by a nominating committee that consists entirely of independent directors and that we adopt a written charter addressing the nominations process. We may take advantage of certain of these exemptions, and, as a result, you may not have the same protections afforded to shareholders of companies that are subject to all of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance requirements. In the event that we cease to be a &#8220;controlled company,&#8221; we will be required to comply with these provisions within the transition periods specified in the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance rules.</span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7250"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE OFFERING</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary highlights information presented in greater detail elsewhere in this prospectus. This summary is not complete and does not contain all the information you should consider before investing in our ordinary shares. You should carefully read this entire prospectus before investing in our ordinary shares including &#8220;Risk Factors&#8221; and our consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Insurance Holdings Limited.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares offered by us</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares offered by the selling shareholders</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriters&#8217; option to purchase additional ordinary shares.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The underwriters have an option to purchase up to an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares from us and up to an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares from the selling shareholders at the initial public offering price less the underwriting discount for 30 days from the date of this prospectus.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares to be outstanding after this offering</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares if the underwriters exercise in full their option to purchase additional ordinary shares from us and the selling shareholders). </span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of proceeds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We expect to receive total estimated net proceeds of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million if the underwriters exercise their option to purchase additional ordinary shares in full, based on an assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, the midpoint of the price range set forth on the cover page of this prospectus, and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us. We will not receive any proceeds from the sale of ordinary shares by the selling shareholders (including any proceeds from any sale of ordinary shares pursuant to the underwriters&#8217; option to purchase additional ordinary shares from the selling shareholders).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The principal purposes of this offering of ordinary shares by us are expected to be to increase our financial flexibility, create a public market for our ordinary shares, enhance our capitalization and facilitate our future access to the capital markets. We currently intend to use the net proceeds we receive from this offering for general corporate purposes, which may include working capital, operating expenses and capital expenditures, as well as to support our Operating Subsidiaries to enable us to continue to take advantage of ongoing favorable market conditions, in line with our corporate strategy. See &#8220;Use of Proceeds.&#8221;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Voting rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In general, subject to the adjustments regarding voting set forth in &#8220;Description of Share Capital&#8212;Voting Power Adjustments,&#8221; holders of our ordinary shares have one vote for each ordinary share held by them and are entitled to vote, on a non-cumulative basis, at all meetings of shareholders. </span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Listing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We intend to apply to list our ordinary shares on the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; under the symbol &#8220;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.&#8221;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend policy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The declaration, amount and payment of any dividends on our ordinary shares will be at the sole discretion of the Board, which may take into account general and economic conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions and implications on the payment of dividends by us to our shareholders or by our subsidiaries to us, including restrictions under any of our then outstanding indebtedness, the terms of our Preference Shares and such other factors as the Board may deem relevant. If we elect to pay dividends in the future, we may reduce or discontinue entirely the payment of such dividends at any time. See &#8220;Dividend Policy.&#8221;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Controlled company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Following this offering, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , an affiliate of certain investment funds managed by affiliates of Apollo, will beneficially own approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our ordinary shares (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% if the underwriters exercise in full their option to purchase additional ordinary shares from us and the selling shareholders). As a result, we will be a &#8220;controlled company&#8221; under the corporate governance rules of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; applicable to listed companies, and therefore are permitted to elect not to comply with certain corporate governance requirements thereunder. See &#8220;Management and Corporate Governance&#8212;Controlled Company Status.&#8221;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk factors</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_297">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and the other information included in this prospectus for a discussion of factors you should consider before deciding to invest in our ordinary shares.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conflicts of interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apollo Global Securities, LLC, an affiliate of Apollo, is an underwriter in this offering. Affiliates of Apollo beneficially own in excess of 10% of our issued and outstanding ordinary shares. As a result, Apollo Global Securities, LLC is deemed to have a &#8220;conflict of interest&#8221; under Rule 5121 (&#8220;Rule 5121&#8221;) of the Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;). Accordingly, this offering will be conducted in compliance with the requirements of Rule 5121. Pursuant to that rule, the appointment of a &#8220;qualified independent underwriter&#8221; is not required in connection with this offering as the members primarily responsible for managing the public offering do not have a conflict of interest, are not affiliates of any member that has a conflict of interest and meet the requirements of paragraph (f)(12)(E) of Rule 5121. See &#8220;Underwriting (Conflicts of Interest).&#8221;</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, all information contained in this prospectus assumes:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no exercise of the option granted to the underwriters to purchase up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional ordinary shares in connection with the offering; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share, which is the midpoint of the price range set forth on the cover page of this prospectus.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of ordinary shares that will be outstanding after this offering is based on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares outstanding as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023 and excludes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_4012"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY FINANCIAL AND OPERATING DATA</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our summary financial and operating data for the periods ended and as of the dates indicated. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summary income statement data for the six months ended June 30, 2023 and 2022, and the summary balance sheet data as of June 30, 2023 and 2022 are derived from our unaudited consolidated financial statements included elsewhere in this prospectus. In the opinion of management, the unaudited consolidated financial data for the interim periods included in this prospectus include all normal and recurring adjustments that we consider necessary for the fair presentation of such data for the respective interim period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summary income statement data for the twelve months ended December 31, 2022, 2021 and 2020, and the summary consolidated balance sheet data as of December 31, 2022, 2021 and 2020 are derived from our audited consolidated financial statements. Our historical results are not necessarily indicative of the results that should be expected in any future period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read the following summary financial and operating data in conjunction with our audited and unaudited consolidated financial statements and related notes, as well as &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; included elsewhere in this prospectus.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Summary Income Statement Data</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,351.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,338.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,698.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(717.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(767.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,680.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,693.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income/(loss) after income tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.524%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.524%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.524%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.524%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.529%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at  December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Summary Balance Sheet Data</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,333.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,414.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,045.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,831.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,502.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting premiums receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,676.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid losses recoverable from reinsurers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,658.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,393.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,661.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,157.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,844.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,090.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and loss adjustment expense reserves</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,740.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,511.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,611.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,165.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for unearned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,457.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,112.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term/long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,844.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,192.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,799.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,069.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,203.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages and per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Key Performance Measures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted combined ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted underwriting income/(loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income/(loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized operating return on average equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total annualized return on average cash and investments, pre-tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Book Value per Ordinary Share (&#8220;BVPS&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Growth in BVPS adjusted for ordinary dividends </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding (millions)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Adjusted combined ratio, underwriting income/(loss), adjusted underwriting income/(loss), operating income/(loss) and annualized operating return on average equity are non-GAAP financial measures as defined in Regulation G. The reconciliations to the most comparable GAAP financial measures and a discussion of the rationale for the presentation of these items are provided in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Key Performance Measures and Non-GAAP Financial Measures.&#8221;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes capital contributions of $45.0 million and $268.0 million for the period ended December 31, 2021 and 2020, respectively.</span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_297"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our ordinary shares involves risks. Prospective investors should carefully consider the risks described below, as well as other information contained in this prospectus before making a decision to invest in our ordinary shares. The risks described below are not the only ones we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect us in the future. Any of the following risks could materially adversely affect our business, financial condition, results of operations or cash flows and could impact any forward-looking statements. See &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221; In such case, the trading price of our ordinary shares may decline and investors may lose all or part of their original investments.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7284"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Re)insurance Risks </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial condition and operating results may be adversely affected by the occurrence of natural disasters and other catastrophe events, as well as outbreaks of pandemic or contagious diseases.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our insurance and reinsurance operations, we assume substantial exposure to losses resulting from weather-related natural catastrophes, other natural disasters and other catastrophe events. Catastrophes can be caused by various unpredictable events, including, but not limited to, tropical storms, cyclones, hurricanes, winter storms, tornadoes, hailstorms, floods, wildfires, drought, pandemic or contagious disease, volcanic eruptions, earthquakes and tsunamis. For example, we have experienced exposure to Hurricane Ian, and floods in Australia and South Africa, as well as COVID-19.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophes can also be man-made such as acts of war, acts of terrorism and other intentionally destructive acts, including those involving nuclear, biological, chemical or radiological events, cyber-attacks, explosions, infrastructure failures and losses resulting from political instability, government action that is hostile to commercial interests and sovereign, sub-sovereign and corporate defaults. For example, we have experienced exposure to the Russia/Ukraine war. In addition, though the current and ongoing conflict in Israel and Gaza has not impacted our business to date, it has the potential to escalate into an event which could impact our cash flows and results of operations as well as for the insurance and reinsurance industry generally.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The incidence, severity and magnitude of catastrophes are inherently unpredictable and our losses from such catastrophes have been and can be substantial. In addition, we expect that increases in the values and concentrations of insured property will increase the severity of such occurrences in the future and that global climate change may increase the frequency and severity of severe weather events, wildfires and flooding. Similarly, changes in global political and economic conditions may increase both the frequency and severity of man-made catastrophe events in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we attempt to manage our exposure, including the accumulation of risk exposures, to such events through a multitude of approaches (including geographic diversification, geographic limits, individual policy limits, exclusions or limitations from coverage, purchase of reinsurance, expansion of supportive collateralized capacity and adherence to Group-level risk tolerance criteria and key risk limits), the availability of these management tools may be dependent on market factors and, to the extent available, may not respond in the way that we expect. In addition, a single catastrophic event could affect multiple geographic zones or the frequency or severity of catastrophic events could exceed our estimates. As a result, the occurrence of one or more catastrophic events or an unusual frequency of smaller events may result in substantial volatility in, and may materially adversely affect, our business, financial condition or operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen has material man-made and natural peril catastrophe risks in different areas which are all managed within strict risk limits. As of July 1, 2023, our top natural peril risk is California Earthquake, with modelled one in 100 year and one in 250 year occurrence net PML exposures of $163.7 million and $187.6 million, respectively. Other top natural peril accumulations include Florida and Southeast Windstorm, Texas and Gulf Windstorm, U.S. Northeast and Mid-Atlantic Windstorm, European Windstorm and Japan Windstorm and Earthquake.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global climate change, as well as increasing laws, regulation and litigation in the area of climate change, may have an adverse effect on our results of operations, financial condition or liquidity.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is widespread consensus in the scientific community that there is a long-term upward trend in global air and sea temperatures that, along with shifting demographic trends in catastrophe exposed regions, has increased the severity and frequency of severe weather events and other natural catastrophes, and is likely to further increase the average economic value of expected losses in the future. Rising sea levels are also expected to increase the risk of coastal flooding in many geographical areas. Extreme weather events can disrupt business continuity by negatively impacting our infrastructure, systems and processes including, but not limited to, outsourcing arrangements in geographical locations exposed to severe weather events.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our property coverages may be adversely impacted by climate change. Large-scale climate change could also increase both the frequency and severity of natural catastrophes and our loss costs associated with property damage and business interruption due to storms, floods, wildfires and other weather-related events. In addition, global climate change could impair our ability to predict the costs associated with future weather events. We cannot predict with certainty the frequency or severity of hurricanes, tropical cyclones, wildfires or other natural catastrophes, and our risk assessments may not accurately reflect shifting environmental and climate related risks. Unanticipated factors could lead to additional insured losses that exceed our current estimates, resulting in disruptions to or adverse impacts on our business, the market or our clients. Further, some of our investments, such as catastrophe-linked securities or other managed investment portfolios, could also be adversely impacted by climate change and may ultimately impact our asset-liability management practices. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the scientific uncertainty of predicting the effect of climate cycles and global climate change on the frequency and severity of natural catastrophes and the lack of adequate predictive tools, we may not be able to adequately model the associated exposures and potential losses in connection with such catastrophes, which could have a material adverse effect on our business, financial condition or operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be exposed to liability risks. Liability risks relate to losses or damages suffered by our insureds from physical or transition risks, such as losses stemming from climate-related litigation in liability lines. These risks could arise from management and boards of directors not fully considering or responding to the impacts of climate change, or not appropriately disclosing current and future risks.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, global climate change could impair our ability to predict the costs associated with future weather events and could also give rise to new environmental liability claims in the energy, manufacturing and other industries we serve. For example, a single catastrophic event could affect multiple geographic zones in unprecedented ways or the frequency or severity of such events could exceed our estimates, driving loss costs higher than we could have predicted.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to exposure to the physical risks of climate change, there are transition risks associated with climate change that could impact our business and investment portfolio. Transition risks arise from the process of adjustment towards a low-carbon economy, including from the proliferation of governmental and regulatory scrutiny related to climate change and greenhouse gases and other factors, including international, federal, state, and local regulations, scrutiny, and enforcement and societal changes. A range of factors influence this adjustment, including climate-related developments in policy and regulation, the emergence of disruptive technology or business models, shifting sentiment and societal preferences, or evolving evidence, frameworks and legal interpretations. Climate change could also give rise to new environmental liability claims in the energy, manufacturing and other industries we serve, as those that have suffered losses seek compensation. In addition, the transition to a less polluting, greener economy could impact the value of our investments in impacted sectors, or demand for insurance in our casualty classes or energy exposed lines. Our investment assets could be affected by a market shift away from carbon-intensive industries or businesses, increased costs or fees associated with the production of greenhouse gases and decreased profitability in sectors that produce or use carbon-based fuels. For example, a sudden change in investment conditions could constrain our available investment universe, such as a climate event that changes global interest rate conditions leading to a change in bond prices, or a change in credit spreads contributing to capital requirement increases. Additionally, a rapid technological change, such as the development of electric vehicles or renewable energy technology, may affect the value of financial assets in these sectors; and companies in the wider </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">economy that fail to mitigate, adapt or disclose the financial risks from climate change may be exposed to climate-related litigation, potentially leading to higher liability claims. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, demand and supply of insurance and reinsurance coverage could be negatively impacted to the extent that carbon-intensive businesses are impacted by this transition, and certain claims and losses related to those industries could increase, either of which could have a material negative effect on our business and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More broadly, ESG and sustainability have become major topics that encompass a wide range of issues, including climate change and other environmental risks. We are subject to complex and changing laws, regulations and public policy debates relating to climate change which are difficult to predict and quantify and may have an adverse impact on our business. Changes in regulations relating to climate change or our own leadership decisions implemented as a result of assessing the impact of climate change on our business may result in an increase in the cost of doing business or a decrease in premiums. For further information, see &#8220;&#8212;Strategic Risks&#8212;Increasing scrutiny and evolving expectations from investors, customers, regulators, policymakers and other stakeholders regarding environmental, social and governance matters may adversely affect our reputation or otherwise adversely impact our business and results of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, concerns over the negative impacts of climate change have led and will continue to lead to new regulatory responses. New laws and regulations relating to ESG, sustainability and climate change are under consideration for monitoring and/or adoption, which may include specific disclosure requirements, restrictions, or obligations, including, but not limited to, underwriting and exposure data, and this may result in additional investments and implementation of new practices and reporting processes, all entailing additional compliance costs and risk. As an example, refer to &#8220;Certain Regulatory Considerations&#8212;Bermuda Insurance Regulation&#8212;Management of Climate Change Risks&#8221; for information regarding the BMA&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consultation Paper - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guidance Note: Management of Climate Risk for Commercial Insurers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Climate Change Guidance Notes&#8221;). In addition, these emerging changes can vary by jurisdiction in the geographies in which we and our customers operate. It is not possible to predict the impact of such regulatory and legislative changes, but they may affect the way we conduct our business and manage our capital and risk profile, which in turn could affect our results of operations, financial condition and liquidity.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could face unanticipated losses from war, terrorism and political unrest, government action that is hostile to commercial interests and from sovereign, sub-sovereign and corporate defaults, and these or other unanticipated losses could have a material adverse effect on our financial condition or operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have substantial exposure to unexpected, large losses resulting from man-made catastrophic events such as, but not limited to, acts of war, such as the Russian invasion of Ukraine in 2022, acts of terrorism and losses resulting from political instability, government action that is hostile to commercial interests and sovereign, sub-sovereign and corporate defaults. These risks are inherently unpredictable as it is difficult to predict their occurrence with statistical certainty or to estimate the amount of loss such an occurrence may generate. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Terrorist events could generate greater interest in political violence insurance coverage and greater awareness of the risks multinational corporations face in conflict-prone regions. We closely monitor the amount and types of coverage we provide for terrorism risk under insurance policies and reinsurance treaties. Even in cases where we have deliberately sought to exclude such coverage, there can be no assurance that a court or arbitration panel will interpret policy language or issue a ruling favorable to us. Accordingly, we may not be able to eliminate our exposure to terrorist events and there remains a risk that our reserves will not be adequate to cover such losses should they materialize. Notably, the Terrorism Risk Insurance Program Reauthorization Act of 2019 (the &#8220;TRIA Reauthorization&#8221;) does not provide coverage for reinsurance losses. In addition, we have limited terrorism coverage for exposure to catastrophe losses related to acts of terrorism in the reinsurance that we purchase. Although the TRIA Reauthorization provides benefits in the event of certain acts of terrorism occurring in the United States, those benefits are subject to a deductible and other limitations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit and political risk insurance line of business protects insureds with interests in foreign jurisdictions in the event governmental action prevents them from exercising their contractual rights and may also protect their </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets against physical damage perils. The insurance provided may include cover for loss arising from expropriation, forced abandonment, license cancellation, trade embargo, contract frustration, non-payment, war on land or political violence (including terrorism, revolution, insurrection and civil unrest).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit and political risk line of business also provides non-payment coverage on specific loan obligations. We insure sovereign non-payment and corporate non-payment as a result of commercial as well as political risk events. The vast majority of the corporate non-payment credit insurance provided is for single-named illiquid risks, primarily in the form of senior bank loans that can be individually analyzed and underwritten. We also aim to avoid terms in our credit insurance contracts which introduce liquidity risk, most notably, in the form of a collateralization requirement upon a ratings downgrade. We also attempt to manage our exposure, by among other things, setting credit limits by country, region, industry and individual counterparty and regularly reviewing our aggregate exposures. However, due to globalization, political instability in one region can spread to other regions. Geopolitical uncertainty regarding a variety of domestic and international matters, such as the U.S. political and regulatory environment, could lead to the potential default by one or more European sovereign debt issuers.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of emerging claim and coverage issues in our business and social inflation are uncertain.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As industry practices and legislative, regulatory, judicial, socio-economic, financial, technological and other environmental conditions change, unexpected and unintended issues related to claims liabilities and coverage may emerge. These issues may adversely affect our business by either extending coverage beyond our underwriting intent or by increasing the frequency and severity of claims.  Moreover, legislative, regulatory, judicial or social influences may impose new obligations on insurers or reinsurers in connection with climate change that extend coverage beyond the intended contractual obligations, or result in an increase in the frequency or severity of claims beyond expected levels, as described in &#8220;&#8212;Global climate change, as well as increasing laws, regulation and litigation in the area of climate change, may have an adverse effect on our results of operations, financial condition or liquidity.&#8221; </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, increasing fraud and abuses at the primary claims level, as well as other forms of social inflation, including increased litigation, expanded theories of liability and rising settlement amounts and jury awards, have affected our reserving practices and loss exposures, and these trends may continue. In some instances, these changes may not become apparent until after we have issued insurance or reinsurance contracts that are affected by the changes. We regularly review the impact of these trends on loss reserves for notified claims to ensure our reserved position aligns to the latest information. In addition, actual losses may vary materially from the current estimate of losses based on a number of factors, as described elsewhere in these risk factors. As a result, the full extent of liability under our insurance or reinsurance contracts may not be known for many years after issuance.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our results may fluctuate as a result of many factors, including cyclical changes in the reinsurance and insurance industries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the performance of the property and casualty reinsurance and insurance industries has tended to fluctuate in cyclical periods of price competition and excess underwriting capacity, followed by periods of high premium rates and shortages of underwriting capacity. Although an individual reinsurance and insurance company&#8217;s performance is dependent on its own specific business characteristics, the profitability of most property and casualty reinsurance and insurance companies tends to follow this market cycle. Further, this cyclical market pattern can be more pronounced in the reinsurance market in which Aspen Re competes and in the excess and surplus market in which Aspen Insurance primarily competes than in the standard insurance market. In addition, compared with historical cyclical periods, a cycle of increased price competition and excess underwriting capacity may continue for a prolonged period of time as new and existing reinsurance and insurance market participants and products continue to enter the reinsurance and insurance markets. Unfavorable market conditions may affect the ability of our reinsurance and insurance subsidiaries to write business at rates they consider appropriate relative to the risk assumed. If we cannot write business at appropriate rates, our business would be significantly and adversely affected. We are currently in a hard market cycle that has impacted a number of lines of business that we write, and we cannot predict whether or for how long such market cycle will continue in the future. This hard market cycle has been supported by the increased frequency and severity of natural catastrophe events, inflation and geopolitical tensions. Our business may be significantly and adversely affected if these conditions do not persist.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When premium rates are high and there is a shortage of capacity in the standard insurance market, growth in the excess and surplus market can be significantly more rapid than growth in the standard insurance market. Similarly, when there is price competition and excess underwriting capacity in the standard insurance market, many customers that were previously driven into the excess and surplus market may return to the standard insurance market, exacerbating the effects of price competition. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for reinsurance is influenced significantly by underwriting and investment results in both the standard insurance and the excess and surplus markets and market conditions. The supply of reinsurance is related to prevailing prices, the levels of insured losses and the levels of reinsurance industry surplus, among other factors. These in turn may fluctuate in response to changes in rates of return on investments being earned in the reinsurance industry. In addition, the supply of reinsurance is affected by a reinsurer&#8217;s confidence in its ability to accurately assess the probability of expected underwriting outcomes, particularly with respect to catastrophe losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since cyclicality is due in large part to the collective actions of insurers and reinsurers, general economic conditions and the occurrence of unpredictable events, we cannot predict the timing or duration of changes in the market cycle. These cyclical patterns cause our revenues and net earnings to fluctuate, which could have a material adverse effect on our financial condition or operating results.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reinsurers may not reimburse us for claims on a timely basis, or at all, which may materially and adversely affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reinsurance contracts that we enter into to help manage our risks require us to pay premiums to the reinsurance carriers who will in turn reimburse us for a portion of covered policy claims. In many cases, a reinsurer will be called upon to reimburse us for policy claims many years after we have paid reinsurance premiums to the reinsurer. Although reinsurance makes the reinsurer liable to us to the extent the risk is transferred or ceded to the reinsurer, it does not relieve us (the ceding insurer) of our primary liability to our policyholders. Our current reinsurance program is designed to limit our financial risk. However, our reinsurers may not pay claims we incur on a timely basis, or they may not pay some or any of these claims at all. For example, reinsurers may default in their financial obligations to us in the event of insolvency, insufficient liquidity, operational failure, political and/or  regulatory prohibitions, fraud (including in relation to any collateral fraudulently provided), asserted defenses based on agreement wordings or the principle of utmost good faith, asserted deficiencies in the documentation of agreements or other reasons. Any disputes with reinsurers regarding coverage under reinsurance contracts could be time-consuming, costly and may not be resolved successfully. These risks could cause us to incur increased net  losses, and, therefore, adversely affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A material proportion of our business relies on the assessment and pricing of individual risks by third parties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We authorize managing general agents, general agents and other producers to write business on our behalf from time to time within underwriting authorities we prescribe. We rely on the underwriting controls of these agents and producers to write business within the underwriting authorities we provide. Although we monitor our underwriting on an ongoing basis, our monitoring efforts may not be adequate and our agents and producers may exceed their underwriting authorities or otherwise breach obligations owed to us. There is also the risk that we may be held responsible for obligations that arise from the acts or omissions of third parties if they are deemed to have acted on our behalf. In addition, our agents, producers, insureds or other third parties may commit fraud or otherwise breach their obligation to us. To the extent that our agents, producers, insureds or other third parties exceed their authorities, commit fraud or otherwise breach obligations owed to us, our operating results and financial condition may be materially adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on third-party assessment and pricing of individual risk extends to our reinsurance treaty business. Similar to other reinsurers, we do not separately evaluate each of the individual risks assumed under most reinsurance treaties. We are therefore largely dependent on the original underwriting decisions made by ceding companies. We are subject to the risk that the ceding companies may not have adequately evaluated the risks to be reinsured and that the premiums ceded to us may not adequately compensate us for the risks we assume and the losses we may incur. As a result of this reliance on ceding companies, our operating results and financial condition may be materially adversely affected.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The failure of any risk management and loss limitation methods we employ could have a material adverse effect on our financial condition and operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ various risk management and loss limitation methods. We seek to manage our loss exposure by maintaining disciplined underwriting processes designed to guide the pricing, terms and acceptance of risk. These processes, which may include the use of pricing models, are intended to ensure that premiums received are sufficient to cover the expected levels of attritional losses and a contribution to the cost of catastrophes and large losses, where necessary. We also seek to mitigate our loss exposure by writing a number of our insurance and reinsurance contracts on an excess of loss basis, such that we only pay losses that exceed a specified retention. We also seek to limit certain risks, such as catastrophes and political risks, by geographic diversification. Geographic zone limitations involve significant underwriting judgments, including the determination of zone boundaries and the allocation of policy limits to zones. In the case of proportional (also known as pro rata) property reinsurance treaties, we often seek per occurrence limitations or loss and loss expense ratio caps to limit the impact of losses from any one event, although we may not be able to obtain such limits in certain markets. Various provisions in our policies intended to limit our risks, such as limitations or exclusions from certain coverage and choice of forum, may not always be enforceable. Purchasing reinsurance is another loss limitation method we employ which may not always respond in the way intended due to disputes relating to coverage terms, exclusions or counterparty credit risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are inherent limitations in all of these actions and it is possible that an event or series of events could result in loss levels that could have an adverse effect on our financial condition and results of operations. It is also possible that our controls and monitoring efforts may be ineffective, permitting one or more underwriters to exceed their underwriting authority and cause us to (re)insure risks outside the agreed upon guidelines or that losses could manifest themselves in ways that we do not anticipate and that our risk mitigation strategies are not designed to address. Additionally, various provisions in our policies, such as limitations or exclusions from coverage or choice of forum negotiated to limit our risk may not be enforceable in the manner we intend. As a result, one or more natural catastrophes and/or terrorism or other events could result in claims that substantially exceed our expectations, which could have a material adverse effect on our financial condition or operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, Aspen Holdings and certain of its subsidiaries entered into the LPT with a subsidiary of Enstar. See &#8220;Material Contracts and Related Party Transactions&#8212;Loss Portfolio Transfer Agreement&#8221; for additional information. The LPT represents a repositioning of the adverse development cover previously entered into between the Company and Enstar in March 2020. The LPT transaction successfully closed in May 2022. The nature and structure of the LPT present certain risks to us, including claims, marketing, credit and reserving risks, as well as general management risks and the risk of differences in interpretation between the parties of the availability, scope and terms of coverage, all or any of which may have an uncertain impact across multiple operational functions and on our business generally.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The reinsurance that we purchase may not always be available on favorable terms or we may choose to retain a higher proportion of particular risks compared to previous years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, market conditions have limited, and in some cases prevented, insurers and reinsurers from obtaining the types and amounts of reinsurance that they consider adequate for their business needs. Accordingly, we may not be able to obtain our desired amount of reinsurance or retrocession protection on terms that are acceptable to us from entities with a satisfactory credit rating or which is collateralized. Even if such capacity is available, we may also choose to retain a higher proportion of particular risks than in previous years due to pricing, terms and conditions or strategic emphasis. We may also seek alternative means of transferring risk, including expanded participation via our ACM platform in alternative reinsurance structures. These solutions may not provide commensurate levels of protection compared to traditional retrocession. Our inability to obtain adequate reinsurance or other protection for our own account at favorable prices and on acceptable terms could have a material adverse effect on our business, operating results and financial condition.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial condition and operating results may be adversely affected if actual claims exceed our loss reserves.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use projections of possible losses from future catastrophic events of varying types and magnitudes as a strategic underwriting tool. Our operating results and financial condition depend on our ability to accurately assess </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the potential losses associated with the risks that we (re)insure. While we believe that our loss reserves as of June 30, 2023 are adequate, establishing an appropriate level of loss reserves is an inherently uncertain process and requires a considerable amount of judgment. There are many factors that would cause our reserves to increase or decrease, which include, but are not limited to, changes in claim severity, changes in the expected level of reported claims, judicial action changing the scope and/or liability of coverage, changes in the legislative, regulatory, social and economic environment and unexpected changes in loss inflation. To the extent actual claims exceed our expectations, we will be required to recognize the less favorable experience immediately which could cause a material increase in our provisions for liabilities and a reduction in our profitability, including operating losses and reduction of capital.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot estimate losses from widespread catastrophic events, such as hurricanes, earthquakes or pandemic events like COVID-19, using traditional actuarial methods. The magnitude and complexity of losses associated with certain of these events inherently increase the level of uncertainty and, therefore, there is a significant level of management judgment involved in arriving at loss reserve estimates. Similarly, our estimate of ultimate losses related to the COVID-19 pandemic continues to be subject to significant uncertainty. This uncertainty is driven by the inherent difficulty in making assumptions around the impact of the COVID-19 pandemic due to the lack of comparable events, the ongoing nature of the event, lack of clarity as to how courts will rule on matters of coverage interpretation across different jurisdictions, and to the far-reaching impact of the pandemic to world-wide economies and the health of the global population. As a result, actual losses for these events may ultimately differ materially from current estimates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that our historical experience is capable of providing us with meaningful actuarial indications, estimates and judgments for new (re)insurance lines of business are more difficult to make than those made for more mature lines of business because we have more limited historical information through June 30, 2023. A significant portion of our current loss reserves is in respect of incurred but not reported (&#8220;IBNR&#8221;) reserves. This IBNR reserve is based almost entirely on estimates involving actuarial and statistical projections of our expectations of the ultimate loss and claims handling expenses. In addition to limited historical information for certain lines of business, we utilize actuarial models as well as historical insurance industry loss development patterns to establish loss reserves. Accordingly, actual claims and claim expenses paid may deviate, perhaps substantially, from our reserve estimates, which could materially adversely affect our financial results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only reserves applicable to losses and loss adjustment expenses incurred up to the reporting date may be set aside in our financial statements, with no allowance for future losses. Our estimates of reserves for losses and loss expenses also include assumptions about future payments for settlement of claims and claims-handling expenses, such as medical treatment, awards for pain and suffering and litigation costs. We write casualty business in certain jurisdictions and other territories where claims inflation has for many years run at higher rates than general inflation. To the extent economic or social inflation, such as through outsized court awards, particularly in the United States, causes these costs to increase above reserves established for these claims, we will be required to increase our loss reserves with a corresponding reduction in our net income in the period in which the deficiency is identified, which could materially adversely affect our financial results.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely impacted by economic inflation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations, like those of other (re)insurers, are susceptible to the effects of economic inflation because premiums are established before the ultimate amounts of losses and loss expenses are known. Although we consider the potential effects of economic inflation when setting premium rates, premiums may not fully offset the effects of inflation and thereby essentially result in underpricing the risks we insure and reinsure. Loss reserves include assumptions about future payments for settlement of claims and claims-handling expenses, such as the cost of replacing property, associated labor costs and litigation costs for the property business we write. To the extent inflation causes costs to increase above loss reserves established for claims, we will be required to increase loss reserves with a corresponding reduction in net income in the period in which the deficiency is identified, which may have a material adverse effect on our results of operations or financial condition. Unanticipated higher inflation could also lead to higher interest rates, which would negatively impact the value of our fixed income securities and potentially other investments.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2023, economic inflation reached and stayed unusually high in many parts of the world, and central banks in the United States and other countries aggressively raised interest rates to counter inflation by slowing economic activity. Monetary policy tightening actions were ongoing throughout 2023, and their long-term impact on financial markets and the real economy is still uncertain. Uncertainty and market turmoil has affected and may in the future affect, among other aspects of our business, the demand for and claims made under our products, the ability of customers, counterparties and others to establish or maintain their relationships with us, our ability to access and efficiently use internal and external capital resources and our investment performance and portfolio. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, steps taken by central banks to control inflation and/or governments to stabilize financial markets and improve economic conditions may be ineffective, and actual or anticipated efforts to continue to unwind some of such steps could disrupt financial markets and/or could adversely impact the value of our investment portfolio. Further increases in interest rates would decrease unrealized gains and/or increase unrealized losses on our debt securities portfolio. Higher inflation could lead to even higher interest rates, which would continue to negatively impact the value of our existing fixed income or other investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the risk that the principal markets in which we operate could continue to experience increased inflationary conditions, which would, among other things, cause policyholder loss costs to increase, and negatively impact the performance of our investment portfolio. Inflation related to medical costs, wage costs, construction costs and tort issues in particular have impacted and continue to impact the property and casualty industry, and broader market inflation has increased and may continue to increase overall loss costs. The impact of inflation on loss costs could be more pronounced for those lines of business that are considered to be long-tail in nature, as they require a relatively long period of time to finalize and settle claims. We also provide coverage to the mortgage industry through insurance and reinsurance of mortgage insurance companies and U.S. government sponsored entity credit risk sharing transactions, and deteriorating economic conditions could cause mortgage insurance losses to increase and adversely affect our results of operations or financial condition. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to these inflationary impacts, we continue to assess and, where appropriate, initiate new or enhanced modeling and monitoring approaches to forecast and manage our results; however, there can be no assurance these approaches will shield us from the negative effects of rising inflation, which could materially and adversely impact our results of operations or financial condition.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increases in the frequency and severity of cyber-attacks on our policyholders could adversely affect our financial condition and operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The area of cybersecurity is one where the threat landscape is evolving, and there is a risk that increases in the frequency and severity of cyber-attacks on our policyholders could adversely affect our financial condition and operating results. This risk is also dependent on our policyholders&#8217; cybersecurity defenses, and our issuance of policy terms which respond to the evolving threat landscape. In addition, our exposure to cyber-attacks includes exposure to silent cyber risks, meaning risks and potential losses associated with policies where cyber risk is not specifically included nor excluded in the policies. Even in cases where we attempt to exclude losses from cyber-related risks, there can be no assurance that a court or arbitration panel will interpret policy language, or otherwise issue a ruling, favorable to us.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7304"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market and Liquidity Risks </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments are subject to interest rate, credit, and real estate related risks, which may adversely affect our net income and may adversely affect the adequacy of our capital.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest the net premiums we receive until such time as, we pay out losses and/or until they are made available for distribution to ordinary and preferred shareholders, to pay interest on or redemption of debt and preferred shares or otherwise used for general corporate purposes. Investment income comprises a substantial portion of our Group income. We therefore are exposed to significant financial and capital market risks, including changes in interest rates, credit spreads, credit defaults, foreign exchange rates, market volatility impacting the valuation of our investments, the performance of the economy in general and other factors outside our control. The impact of geopolitical tension, such as a deterioration in the bilateral relationship between the United States and China or an escalated or prolonged conflict between Russia and Ukraine and Israel and Gaza, including any resulting </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sanctions, export controls or other restrictive actions that may be imposed by the United States and/or other countries against governmental or other entities in, for example, Russia, also could lead to disruption, instability and volatility in the global markets, which may have an impact on our investments across negatively impacted sectors or geographies.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our investments could be influenced by changes in interest rates across a number of geographies. Interest rates are highly sensitive to many factors, including fiscal and monetary policies of major economies, inflation, economic and political conditions and other factors outside our control. Changes in interest rates can negatively affect net investment income in that, in a declining interest rate environment, investments in fixed maturities and short-term investments (fixed maturity portfolio) would earn interest income at lower rates. In a declining interest rate environment, the market value of our fixed income portfolio would increase. However, in a rising interest rate environment, the market value of our fixed income portfolio will decline, which we experienced in 2022. Furthermore, depending on our liquidity needs and investment strategy, we may liquidate investments prior to maturity at a loss in order to cover liabilities as they become due or to invest in other investment opportunities that have better expected longer term profitability.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022 and 2023, many central banks have raised interest rates, which could act as a countervailing force against some inflationary pressures. Historic increases in interest rates have driven significant short-term mark-to-market losses in our investment portfolio. We expect to see a reversal of the mark-to-market losses from accretion to par for certain securities that we hold to maturity. However, interest rates are highly sensitive to many factors, including fiscal and monetary policies of major economies, inflation, economic and political conditions and other factors outside our control.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed maturity portfolio is primarily invested in high quality, investment grade securities, including collateralized loan obligations (&#8220;CLOs&#8221;). However, we invest a portion of the portfolio in securities that are below investment grade. We also invest a portion of our portfolio in other investments such as unrated private fixed and floating rate investments, and other specialty asset classes. These securities generally pay a higher rate of interest or return and may have a higher degree of credit or default risk. These securities may also be less liquid in times of economic weakness or market disruptions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we invest directly and indirectly in private loans and real estate assets, which, as described more fully below, are subject to additional risks.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may be negatively impacted by adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions and the potential contagion impact to, and resulting stress on, the financial services sector generally.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. Such events could include the failure of financial institutions, such as the closure of Silicon Valley Bank on March 10, 2023 by the California Department of Financial Protection and Innovation.   </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we assess our banking relationships as we believe necessary or appropriate, we cannot guarantee that the banks or other financial institutions that hold our funds will not experience liquidity issues or failures in the future. We cannot predict whether such events may occur in the future, or what impact such events would have on the financial services sector and any heightened macroeconomic or political instability that may follow, including any regulatory changes. This could include impacts on the availability of our existing cash and cash equivalents or market value of our investments, or those of our trading partners such as regional program managers. In addition, we could be exposed to losses through our underwriting segments, including, but not limited to, within our financial and professional lines portfolio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, widespread investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, or result in breaches of our financial and/or contractual obligations. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our current and/or projected business operations and financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business may be adversely impacted by these developments in ways that we cannot predict at this time and we cannot guarantee that we will be able to avoid negative consequences directly or indirectly from any failure of one or more banks or other financial institutions. Any of the foregoing could have a material adverse effect on our business, financial condition, liquidity and results of operations. In addition, the foregoing may have the effect of triggering or intensifying many of the risks described elsewhere in this &#8220;Risk Factors&#8221; section.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investments in private, secured commercial mortgage loans (&#8220;CML&#8221;) and private, secured middle market loans (&#8220;MML&#8221;) are subject to credit risk, market risk, servicing risk, loss from catastrophic events and other risks, which could diminish the value that we obtain from such investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, $397.1 million of our total invested assets were invested in private, secured CMLs and in private, secured MMLs. Defaults by borrowers in the payment or performance of their obligations underlying these assets could reduce our investment income and realized investment gains or result in the recognition of investment losses. For example, the value of our real estate-related assets depends in part on the financial condition of the borrowers, the value of the real properties underlying the mortgages and, for commercial properties, the financial condition of the tenants of the properties underlying those mortgages, as well as general and specific economic trends affecting the overall default rate. An unexpectedly high rate of default on commercial mortgages and/or middle market loans may limit substantially the ability of the issuer of such securities to make payments to the loan holders, reducing the value of those securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CML and MML portfolios that we hold, face both default and delinquency risk. An increase in the delinquency or default rate of our CML/MML portfolios or geographic or sector concentration within our CML/MML portfolios could materially and adversely impact our financial condition and results of operations. Any failure to manage these risks effectively could materially and adversely affect our financial condition and results of operations. In general, any significant weakness in the broader macro economy or significant problems in a particular real estate market or corporate market may cause a decline in the value of the real estate market and corporate assets securing the loans in that market, thereby increasing the risk of delinquency, default and foreclosure. This could, in turn, have a material adverse effect on our credit loss experience. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our CML and MML investments, which we also refer to as &#8220;privately-held investments,&#8221; refer to &#8220;Note 4&#8212;Investments&#8221; to our audited consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A portion of our invested assets are relatively illiquid and we may fail to realize profits from these assets for a considerable period of time, or lose some or all of the principal amount we invest in these assets if we are required to sell our invested assets at a loss to meet our insurance, reinsurance or other obligations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to configure our investment portfolio to provide and maintain sufficient liquidity to support our insurance, reinsurance and other obligations. However, in order to provide necessary long-term returns and to achieve our strategic goals, at times a portion of our assets may be relatively illiquid. A portion of our investments are in securities that are not publicly traded or that otherwise lack liquidity, such as our privately-held fixed maturity and floating rate securities, below investment grade securities and alternative investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record our relatively illiquid types of investments at fair value. If we were forced to sell some or all of these assets, there can be no assurance that we would be able to sell them for the values at which such assets are recorded and we might consequently sell these assets at significantly lower values to the recorded value. When we hold a security or position, it is vulnerable to price and value fluctuations and may experience losses if we are unable to sell or hedge the position. Thus, it may be impossible or costly for us to liquidate positions rapidly in order to meet unexpected obligations. This potential mismatch between the liquidity of our assets and liabilities could have a material and adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also invest in CLOs and control over the CLOs in which we invest is exercised through collateral managers, who may take actions that could adversely affect our interests, and we may not have the right to direct collateral management. There may also be less information available to us regarding the underlying debt instruments held by CLOs than if we had invested directly in the debt of the underlying companies. Our investments in CLOs are also subject to liquidity risk as there is a less liquid market for CLOs. Accordingly, we may suffer unrealized depreciation and could incur realized losses in connection with the sale of our CLO investments.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Volatility and uncertainty in general economic conditions and in financial and mortgage markets could adversely impact our business prospects, operating results, financial position and liquidity.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022 and 2023, due to significant inflation, the rapid and strong rise in interest rates and ongoing uncertainty with respect thereto, the possibility of a recession, ongoing uncertainty as to the emergence of potential new COVID-19 variants, the collapse of Silicon Valley Bank, ongoing stress on the financial services sector, the ongoing Russian invasion of Ukraine and the conflict between Israel and Gaza, global financial markets have been characterized by volatility and uncertainty. Unfavorable economic conditions could increase our funding costs, limit our access to the capital markets or make credit harder to obtain. Uncertainties in the financial and mortgage markets may also affect our counterparties which could adversely affect their ability to meet their obligations to us. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deterioration or volatility in the financial markets or general economic and political conditions could result in a prolonged economic downturn or trigger another recession and our operating results, financial position and liquidity could be materially and adversely affected. Further, unfavorable economic conditions could have a material adverse effect on certain or any of the lines of business we write, including, but not limited to, credit and political risks and professional liability risks.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide credit reinsurance to mortgage guaranty insurers and commercial credit insurers. We are exposed to the risk that losses from mortgage insurance materially exceed the net premiums that are received to cover such risks, which may, subject to liability caps, result in operating and economic losses to us. Mortgage insurance underwriting losses that have the potential to exceed our risk appetite are associated with the systemic impacts of severe mortgage defaults, driven by large scale economic downturns and high unemployment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such matters may have the effect of triggering or intensifying many of the risks described elsewhere in this &#8220;Risk Factors&#8221; section.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The determination of the amount of allowances and impairments taken on our investments is highly subjective and could materially impact our operating results or financial position. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform a detailed analysis each reporting period end to assess declines in the fair values of available for sale debt securities in accordance with applicable accounting guidance regarding the recognition and presentation of current expected losses. The process of determining an allowance for available for sale securities requires judgment and involves analyzing many factors. For additional information regarding this process, and the changes to the applicable accounting policies, refer to &#8220;Note 2(c)&#8212;Basis of Presentation and Significant Accounting Policies&#8212;Accounting for Investments, Cash and Cash Equivalents&#8221; and &#8220;Note 2(m)&#8212;Basis of Presentation and Significant Accounting Policies&#8212;Accounting Pronouncements&#8221; to our audited consolidated financial statements and &#8220;Note 2&#8212;Basis of Presentation and Significant Accounting Policies&#8221; to our unaudited consolidated financial statements. Assessing the accuracy of the allowances reflected in our financial statements is inherently uncertain given the subjective nature of the process. Furthermore, additional impairments may need to be taken or allowances provided in the future with respect to events that may impact specific investments. While our current allowance is not material, the current allowance may not be indicative of future impairments or allowances. Thus, future material impairments themselves or any error in accurately accounting for them may have a material adverse effect on our financial condition or results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial condition or operating results may be adversely affected by currency fluctuations that we may not be effective at mitigating.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting currency is the U.S. dollar. However, a significant portion of our operations is conducted outside the United States in a variety of foreign (non-U.S.) currencies. Accordingly, we are subject to legal, economic and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market risks associated with devaluations and fluctuations in currency exchange rates. Our assets and liabilities denominated in foreign currencies are therefore exposed to changes in currency exchange rates, which may be material. The principal currencies creating foreign exchange risk are the British Pound, the Euro, the Swiss Franc, the Australian Dollar, the Canadian Dollar and the Singapore Dollar. At June 30, 2023, 26.3% of gross written premiums were denominated in non-U.S. currencies. We employ various strategies, including the use of foreign exchange forward contracts and other derivative financial instruments, to manage our exposure to foreign currency exchange risk. To the extent that these exposures are not fully offset or hedged, or the hedges are ineffective at mitigating adverse effects, our financial results and condition may be negatively impacted by fluctuations in foreign currency exchange rates.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7320"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risks </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may be adversely affected by the failure of policyholders, brokers or other intermediaries or reinsurers to honor their payment obligations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with industry practice, we generally pay amounts owed on claims under our insurance and reinsurance contracts to brokers and these brokers, in turn, pay these amounts to the policyholders that purchased insurance and reinsurance from us. In some jurisdictions where we write a significant amount of business, if a broker fails to make such a payment it is highly likely that we will be liable to the policyholder for the deficiency because of local laws or contractual obligations. Likewise, when the policyholder pays premiums for policies to brokers for payment to us, these premiums are generally considered to have been paid and, in most cases, the policyholder will no longer be liable to us for those amounts whether or not we have actually received the premiums. Consequently, we assume a degree of credit risk associated with brokers with respect to most of our (re)insurance business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, bankruptcy, liquidity problems, distressed financial conditions or the general effects of economic recession may increase the risk that policyholders may not pay a part of, or the full amount of, premiums owed to us despite an obligation to do so. The terms of our contracts or local law may not permit us to cancel our insurance even if we have not received payment. If non-payment becomes widespread, whether as a result of bankruptcy, lack of liquidity, adverse economic conditions, operational failure, delay due to litigation, bad faith and fraud or other events, it could have a material adverse impact on our business and operating results. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase reinsurance for our own account in order to mitigate the effect of certain large and multiple losses upon our financial condition. Our reinsurers or capital market counterparts are dependent on their ratings in order to continue to write business and some have suffered downgrades in ratings in the past as a result of their exposures. Our reinsurers or capital market counterparties may also be affected by adverse developments in the financial markets, which could adversely affect their ability to meet their obligations to us. Insolvency of these counterparties, their inability to continue to write business or reluctance to make timely payments under the terms of their agreements with us could have a material adverse effect on us because we remain liable to our insureds or cedants in respect of the reinsured risks. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During periods of economic uncertainty, such as the current environment, our consolidated credit risk to these parties may materially increase.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7336"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Risks</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition and consolidation in the (re)insurance industry could reduce our growth and profitability.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance and reinsurance markets are highly competitive. We compete on an international and regional basis with major U.S., Bermuda, European and other international (re)insurers and underwriting syndicates, including Lloyd's, some of which have greater financial, marketing and management resources than we do. We also compete with new companies that continue to be formed to enter the (re)insurance markets. In addition, capital market participants have created alternative products that are intended to compete with reinsurance products. Until recently, new and alternative capital inflows in the (re)insurance market and the retention by cedants of more business had caused an excess supply of (re)insurance capital and may again in the future. We have sought to address this risk by developing our own capital markets capability through ACM. See &#8220;&#8212;We are exposed to risks in connection with </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our management of alternative reinsurance platforms on behalf of investors in any entities ACM manages or could manage in the future.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has also been a large volume of merger and acquisition activity in the (re)insurance sector in recent years which may continue and we may experience increased competition as a result of that consolidation with consolidated entities having enhanced market power. As the (re)insurance industry consolidates, competition for customers will become more intense and the importance of acquiring and properly servicing each customer will become greater.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased competition could result in fewer submissions, lower premium rates, less favorable policy terms and conditions and greater expenses relating to customer acquisition and retention, which could have a material adverse impact on our operating results or financial condition.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Operating Subsidiaries are rated and our Lloyd&#8217;s business benefits from a rating by one or more of A.M. Best and S&amp;P and a decline in any of these ratings could adversely affect our standing among brokers and customers and cause our premiums and earnings to decrease, or may otherwise result in an adverse effect on our business, financial condition and operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ratings have become an increasingly important factor in establishing the competitive position of insurance and reinsurance companies and will also impact the cost and availability of capital to an insurance company. Rating agencies represent independent opinions of the financial strength of insurers and reinsurers and their ability to meet policyholder obligations. Our existing ratings by A.M. Best and S&amp;P represent an important consideration in maintaining customer confidence in us and in our ability to market insurance products. Rating organizations regularly analyze the financial performance and condition of insurers and some policyholders are required to obtain insurance coverage from insurance companies that have an &#8220;A-&#8221; (Strong) rating or higher.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The S&amp;P financial strength and issuer credit ratings of Aspen Bermuda, AAIC and Aspen UK are &#8220;A-&#8221; (Strong), while the long-term issuer credit rating of Aspen Holdings is &#8220;BBB.&#8221; The outlook assigned to all these ratings is stable, with the exception of Aspen Holdings which was placed on credit watch with negative implications on November 17, 2023 following S&amp;P&#8217;s publication of a new ratings methodology on November 15, 2023 (as described below). Aspen Specialty is not currently rated by S&amp;P and has a financial strength rating of &#8220;A&#8221; (Excellent) by A.M. Best with a stable outlook. On April 30, 2021, A.M. Best affirmed the financial strength rating of &#8220;A&#8221; (Excellent) for Aspen Bermuda, Aspen UK, Aspen Specialty and AAIC and upgraded its outlook to stable from negative, and both the rating and outlook were affirmed on May 26, 2022 and June 16, 2023. Aspen Lloyd&#8217;s benefits from the Lloyd&#8217;s market financial strength rating of &#8220;A&#8221; (Excellent) with a stable outlook by A.M. Best and &#8220;AA-&#8221; (Very Strong) with a stable outlook by S&amp;P.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ratings of our Operating Subsidiaries are subject to periodic review by, and may be placed on credit watch, revised downward or revoked at the sole discretion of, A.M. Best or S&amp;P. For more information, see &#8220;Business&#8212;Ratings.&#8221; These ratings are intended to measure a company&#8217;s ability to repay its obligations and are based upon criteria established by the rating agencies. Ratings may be solicited or unsolicited.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a result of their rating of Highlands Holdings Bond Issuer, Ltd. and Highlands Holdings Bond Co-Issuer, Inc. (the &#8220;Issuers&#8221;), each of which is an affiliate of Highlands Bermuda Holdco, Ltd., and the $500 million aggregate principal amount of their 7.625% / 8.375% Senior Secured PIK Toggle Notes due 2025 (the &#8220;Notes&#8221;), S&amp;P takes into consideration the Issuers in their view of the wider Aspen Group when evaluating the adequacy of our capital reserves for purposes of determining financial strength and issuer credit ratings accorded to our Operating Subsidiaries. In addition, S&amp;P expects us to maintain capital adequacy above the &#8220;AAA&#8221; level to maintain our &#8220;A-&#8221; rating. Should we experience weaker than-expected underwriting performance, should our capital adequacy position decline and remain below the &#8220;AAA&#8221; level for a prolonged period, should our financial leverage materially increase or liquidity materially decrease, among other factors, we may be required to maintain a greater amount of capital in order to maintain our existing ratings or become subject to a ratings downgrade.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rating agencies with whom we maintain an interactive rating relationship for the purposes of the solicited ratings, currently A.M. Best and S&amp;P, continuously evaluate us to confirm that we continue to meet the criteria of the rating assigned to us. Our ratings may be revised downward or revoked at the sole discretion of the rating </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agencies at any time. The financial strength ratings assigned by rating agencies to insurance or reinsurance companies are based upon factors relevant to cedants, which include factors not entirely within our control, including factors impacting the financial services, insurance and reinsurance industries generally. Financial strength ratings by rating agencies are not ratings of securities or recommendations to buy, hold or sell any security, including our ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our Operating Subsidiaries&#8217; or if Lloyd&#8217;s ratings are reduced from their current levels by either A.M. Best or S&amp;P, our competitive position in the (re)insurance industry might suffer and it may be more difficult for us to market our products, expand our (re)insurance portfolio and renew our existing (re)insurance policies and agreements. A rating downgrade may also require us to establish trusts or post letters of credit for ceding company clients and could trigger provisions allowing some clients to terminate their (re)insurance contracts with us. Some contracts also provide for the return of premium to the ceding client in the event of a rating downgrade. It is increasingly common for our reinsurance contracts to contain such terms. Whether a cedant would exercise any of these rights could depend on various factors, such as the reason for and the extent of such downgrade, the prevailing market conditions and the pricing and availability of replacement reinsurance coverage. A downgrade could result in a substantial loss of business as ceding companies and brokers that place such business move to other reinsurers with higher ratings and therefore such downgrade may materially and adversely impact our business, operating results, liquidity and financial flexibility.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a downgrade of the financial strength rating of Aspen UK, Aspen Bermuda, AAIC or Aspen Specialty by A.M. Best below &#8220;B++&#8221; would constitute an event of default under one or more of our financing facilities. Additionally, the cost and availability of unsecured financing are generally dependent on the borrower&#8217;s long-term and short-term debt ratings. A lower rating may lead to higher borrowing costs, thereby adversely impacting our liquidity and financial flexibility and by extension our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2023, S&amp;P published the final insurance criteria &#8220;Insurer Risk-Based Capital Adequacy &#8211; Methodology and Assumptions&#8221; for analyzing the risk-based capital adequacy of insurers and reinsurers that is used as a key rating factor in determining a company&#8217;s financial strength rating. The new methodology represents a wholesale change from the previous criteria which was last updated in 2010. Certain issuers have been placed under criteria observation that may result in a change in their financial strength rating. Aspen has not been placed under criteria observation because S&amp;P does not expect to take rating actions as a result of the updated criteria. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2023, S&amp;P also published a note placing ratings on 15 non-operating holding companies of Bermuda-based (re)insurers on credit watch with negative implications, including Aspen Holdings. S&amp;P are reviewing their base case assumption on the potential regulatory restrictions to payments from Bermuda-based operating (re)insurance companies to non-operating holding companies, as well as the possible mitigants to these restrictions according to their group rating methodology. The impact will either be an affirmation of the non-operating holding company issuer rating or a one notch rating downgrade.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing scrutiny and evolving expectations from investors, customers, regulators, policymakers and other stakeholders regarding environmental, social and governance matters may adversely affect our reputation or otherwise adversely impact our business and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal and external stakeholders, including regulators and investors, have placed increased and rapidly evolving importance on how we are addressing ESG issues. Reputational risks can be assessed through the insurance coverage provided to policyholders that conduct business activities with negative impacts on the climate or from investments held in these sectors. In addition, regulators have adopted and likely will continue to adopt ESG-related rules and guidance, which may conflict with one another and impose additional costs and operational burdens on us. ESG encompasses a wide range of issues, including climate change and other environmental risks. We cannot predict whether our business strategy, decisions, and disclosures relating to climate change and other ESG issues will meet the expectations or requirements of relevant stakeholders, including regulators. Additionally, failure to communicate a clear strategy to manage these risks and/or lacking progress on the implementation of a comprehensive climate risk management framework can also pose a reputational risk. A lack of harmonization globally and within jurisdictions in relation to ESG legal and regulatory reform leads to a risk of fragmentation in </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">group level priorities as a result of the different pace of sustainability transition across global jurisdictions. This may create conflicts across our global business which could risk inhibiting our future implementation of, and compliance with, rapidly developing ESG standards and requirements, and potentially pose litigation and/or reputational risks. If we are unable to meet targets, standards, or expectations, whether established by us or third parties, it could result in adverse publicity, reputational harm, or loss of customer and/or investor confidence, which could adversely affect our business and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any future acquisitions, growth of our operations through the addition of new lines of (re)insurance business, expansion into new geographic regions and/or joint ventures or partnerships may expose us to risks.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our long-term strategy, we have pursued, and may continue to pursue, growth through acquisitions and/or strategic investments in new businesses or entering into strategic ventures with third parties. The negotiation of these transactions as well as the integration of an acquired business or new personnel could result in a substantial diversion of management resources. Successful integration depends, among other things, on our ability to effectively integrate acquired businesses or new personnel into our existing risk management and financial and operational reporting systems, establish satisfactory budgetary and other financial controls, manage any regulatory issues created by our entry into new markets and geographic locations, retain key personnel and obtain personnel required for expanded operations. The failure to integrate successfully or to manage the challenges presented by the integration process may have an adverse effect on our business, financial condition or results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that the integration of acquired businesses or new personnel will be successful, that we will realize anticipated synergies, cost savings and operational efficiencies, or that the business acquired will prove to be profitable or sustainable. The failure to integrate acquired businesses successfully or to manage the challenges presented by the integration process may adversely impact our financial results. Acquisitions could involve numerous additional risks such as potential losses from unanticipated litigation or levels of claims and inability to generate sufficient revenue to offset acquisition costs. In addition, the value of assets acquired may be lower than expected or may diminish due to credit defaults or changes in interest rates or the liabilities assumed may be greater than expected. Our ability to grow through acquisitions will depend, in part, on our success in addressing these risks. Our failure to manage successfully any of the foregoing challenges and risks may adversely impact our results of operations. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on a few brokers for a large portion of our insurance and reinsurance revenues and the loss of business provided by any one of those brokers could adversely affect us. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our (re)insurance worldwide primarily through (re)insurance brokers and derive a significant portion of our business from a limited number of brokers. For the twelve months ended December 31, 2022, three brokers, Aon Corporation, Marsh &amp; McLennan Companies, Inc. and Arthur J. Gallagher and Company, accounted for  30.3%, 32.4%, and 10.6%, respectively, of our reinsurance gross written premiums. For the twelve months ended December 31, 2022, in our insurance business, ten brokers collectively accounted for 73.5% of our gross written premiums, with Aon Corporation and Marsh &amp; McLennan Companies, Inc. accounting for 16.6% and 14.3%, respectively. Refer to &#8220;Business&#8212;Business Distribution&#8221; below for our principal brokers by segment. Our relationships with our brokers and agents are based on the quality of our underwriting and claim services, as well as our financial strength ratings. Any deterioration in these factors could result in the brokers advising our clients to place their business with other (re)insurers. In addition, these brokers and agents also have, or may in the future acquire, ownership interests in insurance and reinsurance companies that may compete with us and these brokers may favor their own (re)insurers over other companies. Loss of all or a substantial portion of the business provided by one or more of these brokers could have a material adverse impact on our business and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there has been a trend of increased consolidation of agents and brokers and of agents and brokers reducing the numbers of insurers with which they do business to gain efficiency for their placement efforts. As we distribute most of our products through agents and brokers, consolidation could impact our ability to access business and our relationships with, and fees paid to, agents and brokers. In the Lloyd&#8217;s market, independent London wholesalers continue to be acquired by larger global brokers, which may result in enhanced market power for these larger brokers in placing (re)insurance. Consolidation of distributors may also increase the likelihood that distributors will try to renegotiate the terms of existing selling agreements to terms less favorable to us. As brokers </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">merge with or acquire each other, any resulting failure or inability of brokers to market our products successfully, or the loss of a substantial portion of the business sourced by one or more of our key brokers, could have a material adverse effect on our business and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to risks in connection with our management of alternative reinsurance platforms on behalf of investors in any entities ACM manages or could manage in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those of our subsidiaries that are engaged in the management of alternative reinsurance platforms as part of our ACM division may owe certain legal duties and obligations to third-party investors (including reporting obligations) and are subject to a variety of often complex laws and regulations relating to the management of those structures. Although we continually monitor our policies and procedures to ensure compliance, faulty judgments, simple errors or mistakes, or the failure of our personnel to adhere to established policies and procedures could result in our failure to comply with applicable laws or regulations which could result in significant liabilities, penalties or other losses and significantly harm our business and results of operations. Additionally, ACM also raises capital from third-party investors that may be invested in a vehicle that is a reinsurer of an Aspen entity but may be managed by a third-party administrator.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our third-party investors may decide to redeem their interests, which could materially impact the financial condition of the entities supporting our underwriting. Certain of our third-party capital investors provide significant capital investment. The loss or alteration of this capital support could be detrimental to our financial condition and results of operations. Moreover, we can provide no assurance that we may be able to attract and raise additional third-party capital for our existing entities or for potential new entities and therefore we may forego existing and/or potential attractive fee income and other income-generating opportunities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, notwithstanding any capital holdback, we may decide to return to our investors all or a portion of their capital held as collateral prior to the maturity specified in the terms of the particular underlying transactional documents. A return of capital to our investors is final. As a result, if we release collateral early and capital is returned to our investors, we may not have sufficient collateral to pay the claims associated with such losses in the event losses are significantly larger than we anticipated. In addition, the value of any collateral held may be impacted by macroeconomic, geopolitical or other factors that could lead to investment volatility. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require additional capital in the future, which may not be available or may only be available on unfavorable terms. We may have to raise capital following significant insured losses, potentially resulting in capital being raised at valuations significantly below the original ordinary share price.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements depend on many factors, including our ability to write new business successfully, deploy capital into more profitable business lines, identify acquisition opportunities, manage investments and preserve capital in volatile markets, and establish premium rates and reserves at levels sufficient to cover losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require liquidity to: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay claims; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fund our operating expenses; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the extent declared, pay dividends (including the payment of dividends to the holders of our Preference Shares); </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fund liquidity needs caused by investment losses; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">replace or improve capital in the event of a depletion of our capital as a result of significant reinsurance losses; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">meet rating agency or regulatory capital requirements; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">respond to competitive pressures; and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">service our debt. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our funds are insufficient or unavailable to fund future operating requirements or cover claims losses, whether due to regulatory or contractual restrictions, underwriting or investment losses or otherwise, we may need to raise additional funds through corporate finance transactions or curtail our growth and reduce our liabilities. Any such financing, if available at all, may be on terms that are not favorable to us. Additionally, in a rising interest rate environment such as the one prevailing recently, such financing may result in a higher cost of capital. Our ability to raise such capital successfully would depend upon the facts and circumstances at the time, including our financial position and operating results, market conditions and applicable regulatory filings and legal issues. If we cannot obtain adequate capital on favorable terms, or obtain it at all, our business, financial condition and operating results could be adversely affected. Furthermore, financial markets have experienced extreme volatility and disruption due in part to financial stresses affecting the liquidity of the banking system and the financial markets generally. These circumstances have reduced access to the public and private equity and debt markets at such times.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may not achieve the desired regulatory capital treatment for any potential issuance of debt or equity securities due to changing solvency capital eligibility requirements under the Bermuda Insurance (Group Supervision) Rules 2011 (the &#8220;Group Supervision Rules&#8221;) to which we are subject. For these instruments to continue to receive the intended regulatory capital treatment, their terms must reflect the criteria contained in the Group Supervision Rules and any amendments thereto. If the BMA applies any changes to the Group Supervision Rules governing eligible capital such that our outstanding Preference Shares no longer receive their intended capital treatment under the Group Supervision Rules, we may be unable to maintain adequate regulatory capital. If we cannot obtain adequate capital or credit, our business, results of operations and financial condition could be adversely affected by, among other things, our inability to finance future acquisitions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our debt, credit and International Swaps and Derivatives Association (&#8220;ISDA&#8221;) agreements may limit our financial and operational flexibility, which may affect our financial condition, liquidity and ability to conduct our business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred indebtedness and may incur additional indebtedness in the future. Additionally, we have incurred indebtedness under the Term Loan Credit Agreement (as defined below) and have entered into credit facilities with various institutions which provide revolving lines of credit to us and our Operating Subsidiaries and issue letters of credit to our clients in the ordinary course of business. We have also entered into ISDA agreements relating to derivative transactions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements relating to our debt, including the Term Loan Credit Agreement, credit facilities and our ISDA agreements contain covenants that may limit our ability, among other things, to borrow money, make particular types of investments or other restricted payments, sell assets, merge or consolidate. Such agreements also typically contain reporting and disclosure affirmative covenants. Some of these agreements also require us to maintain specified ratings and financial ratios, including a minimum net worth covenant. If we fail to comply with these covenants or meet required financial ratios, the lenders or counterparties under these agreements could declare a default and demand immediate repayment of all amounts owed to them and require collateralization of any current or future obligations of the Company. Additionally, a default under our debt, credit facilities or ISDA agreements could limit our ability to obtain credit or enter into such transactions on favorable terms, or at all. As a result, our business, financial condition and operating results could be adversely affected. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are in default under the terms of these agreements, we may also be restricted in our ability to declare or pay any dividends, redeem, purchase or acquire any shares or make a liquidation payment and are at risk of cross-default on other arrangements. In addition, the cost and availability of these arrangements vary and any adverse change in the cost or availability of such arrangements could adversely impact our business, financial condition and operating results. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7352"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Risks</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Political, regulatory, governmental and industry initiatives may have a material adverse effect on our business, financial condition, results of operations, liquidity, cash flows and prospects.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the laws and regulations to which our Operating Subsidiaries are subject are summarized under &#8220;Certain Regulatory Considerations.&#8221; Changes in the laws and regulations relevant to our business may have a material adverse effect on our business, financial condition, results of operations, liquidity, cash flows and prospects. The laws and regulations of the jurisdictions in which our insurance and reinsurance subsidiaries are domiciled require, among other things, maintenance of minimum levels of statutory capital, surplus, and liquidity; various solvency standards; and periodic examinations of subsidiaries&#8217; financial condition. In some jurisdictions, laws and regulations also restrict payments of dividends and reductions of capital and require prior approval in connection with a potential acquisition or change of control. Applicable statutes, regulations, and policies may also restrict the ability of these subsidiaries to write insurance and reinsurance policies, to make certain investments, and to distribute funds. In addition, as industry practices and legislative, regulatory, judicial, social, financial, technological and other environmental conditions change, unexpected and unintended issues related to claims and coverage may emerge. These issues may adversely affect our business by either extending coverage beyond our underwriting intent or by increasing the frequency and severity of claims. In some instances, these changes may not become apparent until after we have issued insurance or reinsurance contracts that are affected by the changes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these authorities regularly consider enhanced or new regulatory requirements intended to prevent future crises or otherwise assure the stability of institutions under their supervision. These authorities may also seek to exercise their supervisory authority in new and more robust ways, and new regulators could become authorized to oversee parts of our business. The purpose of insurance laws and regulations generally is to protect policyholders and ceding insurance companies, not our shareholders or other securityholders. Failure to comply with or obtain appropriate authorizations and/or exemptions under any applicable laws and regulations could result in restrictions on our ability to do business or undertake activities that are regulated in one or more of the jurisdictions in which we conduct business and could subject us to fines, other sanctions and reputational injury. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to predict all future impacts of political, regulatory, governmental or industry changes but they could affect the way we conduct our business and manage our capital, and may require us to satisfy increased capital requirements or to incur additional expenses, any of which, in turn, could affect our results of operations, financial condition and liquidity. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foreign and U.S. federal and state laws and regulations that are applicable to our operations are complex and may increase the costs of regulatory compliance or subject our business to the possibility of regulatory actions or proceedings. In addition to insurance and financial industry regulations, our activities are also subject to relevant economic and trade sanctions administered by the U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, and other relevant sanctions authorities, as well as money laundering regulations and anti-corruption laws including the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act 2010, which may increase the costs of regulatory compliance, limit or restrict our ability to do business or engage in certain regulated activities, or subject us to the possibility of regulatory actions, proceedings and fines. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain policies and procedures designed to comply with applicable anti-corruption laws and regulations.  However, we cannot provide assurance that our internal controls and compliance systems will always protect us from liability for acts committed by employees, agents or business partners of ours (or of businesses we acquire or partner with) that would violate U.S. and/or non-U.S. laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and other related laws. Any such improper actions or allegations of such acts could subject us to significant sanctions, including civil or criminal fines and penalties, disgorgement of profits, injunctions and debarment from government contracts, as well as related shareholder lawsuits and other remedial measures, all of which could adversely affect our reputation, business, financial condition and results of operations.  Investigations of alleged violations can also be disruptive and cause us to incur significant legal and investigatory fees. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to the risk of violating, or being accused of violating, economic and trade sanctions laws and regulations. As part of our business, we may, from time to time, engage in limited sales and transactions involving certain countries, entities and individuals that are targets of economic sanctions, provided that such sales and transactions are authorized pursuant to applicable economic sanctions laws and regulations. However, we cannot predict the nature, scope or effect of future regulatory requirements, including changes that may affect existing regulatory authorizations, and we cannot predict the manner in which existing laws and regulations might be administered or interpreted. Further, while we maintain policies and procedures designed to maintain compliance with applicable economic and trade sanctions, there can be no guarantee that our policies and procedures will be effective in preventing violations, which could adversely affect our reputation, business, financial condition or results of operations. If in the future we are found to be in violation of U.S. or other applicable economic sanctions or export control laws, it could result in substantial fines and penalties for us, including criminal fines, imprisonment, civil fines, disgorgement of profits, injunctions and other remedial measures. Investigations of alleged violations can be expensive and disruptive. The insurance industry is also affected by political, judicial, and legal developments that may create new and expanded regulations and theories of liability. The current economic and financial climates present additional uncertainties and risks relating to increased regulation and the potential for increased involvement of the United States and other governments in the financial services industry.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, and in response to changes to U.S. credit for reinsurance rules arising from the 2017 Covered Agreement between the United States and European Union and the 2018 Covered Agreement between the United States and the United Kingdom, Aspen Bermuda obtained reciprocal jurisdiction reinsurer status with Texas as its lead state. Reinsurers licensed in reciprocal jurisdictions (which include the United Kingdom, E.U. member states, Bermuda, Japan and Switzerland) are not required to post reinsurance collateral to U.S. cedants if approved as reciprocal jurisdiction reinsurers in the cedant&#8217;s U.S. state of domicile. With its approval from Texas, Aspen Bermuda was able to facilitate passporting applications in additional U.S. states throughout 2022 and renewed the same for 2023. &#8220;Passporting&#8221; refers to the process under which a U.S. state has the discretion to defer to the determination by another U.S. state that a reinsurer is a reciprocal jurisdiction reinsurer, thereby excusing the approved reinsurer from collateral requirements in such state. Aspen Bermuda also retains its status as a certified reinsurer in a number of U.S. states, enabling it to provide reduced collateral for historical risks written. There is no guarantee that Aspen Bermuda will maintain its reciprocal jurisdiction reinsurer or certified reinsurer status, and changes in laws and regulations applicable to the provision of collateral by offshore or unauthorized reinsurers such as Aspen Bermuda may have a material adverse impact on our capital management approach, financial condition, results of operations, liquidity, cash flows and prospects. Refer to &#8220;Certain Regulatory Considerations&#8212;U.S. Insurance Regulation&#8212;Credit for Reinsurance&#8221; for more information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event or absence of changes in applicable laws and regulations in particular jurisdictions, we may from time to time face challenges, or changes in approach to oversight of our business from insurance or other regulators, including challenges resulting from implementing new or additional processes or procedures that cannot be quickly adapted to address new regulatory requirements. Moreover, we could be, or our employees acting on our behalf, could be found to have violated existing laws, rules or regulations. Our regulators have the ability to make regulatory interventions using their powers, including through investigations, requests for data and analysis, interviews or reviews (including skilled persons reports under section 166 of the U.K. Financial Services and Markets Act 2000 (&#8220;FSMA&#8221;)), which regulatory intervention may require specific remediation, including via guidance on a confidential basis, in respect of historical practices, changes to our existing practices, public censure, the loss or restriction of regulatory permissions necessary to carry out our business in the same manner as before, and/or additional regulatory capital to be held. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in periodic meetings with, and reviews by, regulators, pursuant to which they review our business and provide challenges in order to test and validate the supervisory and work plan adopted by their supervisory teams. Through such processes, our regulators may validate and/or challenge, among other things, our strategy, business plans, internal governance, risk and capital management and compliance frameworks. Our regulators have required us, and we are under continuing obligations, to remediate failures, weaknesses and other issues that they have identified, including, but not limited to, with respect to our underwriting performance, reserving risk and capital management and governance, which, if we are unsuccessful in remediating could result in greater regulatory intrusion, enforcement action and/or the exercise of our regulators&#8217; own initiative powers </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(including imposing restrictions on our underwriting and/or a requirement to maintain additional capital, which would reduce our underwriting capacity). We are currently in the process of implementing initiatives to improve our business, including our underwriting performance, risk and capital management and governance, which, if we are unable to successfully implement could result in greater regulatory intrusion and/or enforcement action or the exercise of our regulators&#8217; own initiative powers, which could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe it is likely there will continue to be increased regulation of, and other forms of government participation in, our industry in the future, which could materially adversely affect our business by, among other things: providing reinsurance capacity in markets and to policyholders that we target or requiring our participation in industry pools and guaranty associations; further restricting our operational or capital flexibility; expanding the scope of coverage under existing policies; regulating the terms of our (re)insurance policies; adopting further or changing compliance requirements which may result in additional costs which may adversely impact our results of operation; or disproportionately benefiting the companies domiciled in one country over those domiciled in another.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in regulations that adversely affect the U.S. mortgage insurance and reinsurance market could affect our operations significantly and could reduce the demand for mortgage insurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the general regulatory risks to which we are subject, the reinsurance we write could also be indirectly affected by various additional regulations relating particularly to our U.S. mortgage reinsurance operations. U.S. federal and state regulations affect the scope of operations of mortgage guaranty insurers and commercial credit insurers, to whom we provide credit reinsurance. Legislative and regulatory changes could cause demand for private mortgage insurance to decrease, which could have an adverse impact on our U.S. mortgage reinsurance operations. Increases in the maximum loan amount that the U.S. Federal Housing Administration can insure, and reductions in the mortgage insurance premiums it charges, can reduce the demand for private mortgage insurance. Decreases in the maximum loan amounts government-sponsored enterprises, such as the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac) (the &#8220;GSEs&#8221;), will purchase or guarantee, increases in GSE fees, or decreases in the maximum loan-to-value ratio for loans the GSEs will purchase, can also reduce demand for private mortgage insurance. Changes in these laws or regulations could have an indirect adverse impact on the profitability of our U.S. mortgage reinsurance business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The United Kingdom&#8217;s withdrawal from the European Union has had, and may continue to have, an adverse impact on our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to face regulatory costs and challenges as a result of Brexit. The United Kingdom left the European Union as of January 31, 2020 and economic relations between the United Kingdom and the European Union are now governed by a Trade and Cooperation Agreement (&#8220;TCA&#8221;). Following a report published by the European Affairs Committee in June 2022, which found that the TCA is limited in scope and silent as to E.U. equivalence in decisions over financial services, a Memorandum of Understanding (&#8220;MoU&#8221;) on regulatory cooperation between the United Kingdom and the European Union was signed in June 2023. However, the MoU does not impose binding substantive commitments nor is there any mention of taking forward the commitment in the Political Declaration accompanying the TCA regarding mutual equivalence. As a result of Brexit, Aspen UK has lost its financial services passports which provided it the license to operate across borders within the European Economic Area (the &#8220;EEA&#8221;) without obtaining local regulatory approval where insurers and cedants are located. The Company&#8217;s Lloyd&#8217;s operations are able to continue in the EEA through Lloyd&#8217;s Insurance Company, S.A. (&#8220;Lloyd&#8217;s Brussels&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, operational and capital requirements relating thereto might result in increased costs or Funds at Lloyd&#8217;s (as defined below) and might not provide the same access to markets that the Company formerly enjoyed to conduct business in the EEA. In addition, the ability to access the EEA market through</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Syndicate 4711</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> depends on Lloyd's being able to comply with E.U. regulations through its Belgium subsidiary. Lloyd&#8217;s continues to engage in discussions with the Belgium Financial Services Markets Authority (the &#8220;Belgium FSMA&#8221;) and the National Bank of Belgium (&#8220;NBB&#8221;) regarding the Lloyd&#8217;s Brussels operating model and the activities performed for it by managing agents (through an outsourcing agreement between AMAL and Lloyd&#8217;s) and the question of whether it is possible </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that they could be construed as constituting insurance distribution under Directive (EU) 2016/97 (the &#8220;Insurance Distribution Directive&#8221;), which would therefore require them to be authorized within the EEA.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks related to changes in Bermuda law and regulations, and the political environment in Bermuda.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are incorporated and headquartered in Bermuda and one of our principal Operating Subsidiaries, Aspen Bermuda, is domiciled in Bermuda. Therefore, changes in Bermuda law and regulation may have an adverse impact on our operations, such as the imposition of tax liability, increased regulatory supervision or changes in regulation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to changes in the political environment in Bermuda, which could make it difficult to operate in, or attract talent to, Bermuda. In addition, Bermuda, which is currently an overseas territory of the United Kingdom, may consider changes to its relationship with the United Kingdom in the future. These changes could adversely affect Bermuda or the international reinsurance market focused there, either of which could adversely impact us commercially.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in current accounting practices and future pronouncements may materially impact our reported financial results. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unanticipated developments in accounting practices may require us to incur considerable additional expenses to comply with such developments, particularly if we are required to prepare information relating to prior periods for comparative purposes or to apply the new requirements retroactively. Such developments may also significantly impact the presentation of such financial statements and may require restatements. The impact of changes in current accounting practices and future pronouncements cannot be predicted but they may affect the calculation of net income, net equity and other relevant financial statement line items.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7368"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Operational Risks</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our internal controls over financial reporting have gaps or other deficiencies. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational risk and losses can result from, among other things, fraud, errors, failure to document transactions properly or to obtain proper internal authorization, failure to comply with regulatory requirements, information technology failures and failure to appropriately transition new hires or external events. We continue to enhance our operating procedures and internal controls (including information technology initiatives and controls over financial reporting) to effectively support our business and our regulatory and reporting requirements. Our management does not expect that our disclosure controls or our internal controls will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. As a result of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons or by collusion of two or more people. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. As a result of the inherent limitations in a cost-effective control system, misstatement due to error or fraud may occur and not be detected. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required, pursuant to the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), to furnish a report from management on, among other things, the effectiveness of our internal control over financial reporting in connection with the filing of our annual report on Form 20-F that is filed with the SEC. We also expect, assuming that we will become an accelerated filer, that our auditors will be required to express an opinion on the effectiveness of our internal control over financial reporting beginning with our first annual report on Form 20-F following this offering. We are currently required to report, among other things, control deficiencies that constitute a &#8220;material weakness&#8221; or changes in internal controls that, or that are reasonably likely to, materially affect internal controls over financial reporting. A &#8220;material weakness&#8221; is a deficiency, or a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. A &#8220;significant deficiency&#8221; is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of our financial reporting. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. In 2022 and 2021, as a result of material weaknesses in our internal control over financial reporting, management concluded that our internal controls over financial reporting were ineffective as of December 31, 2022 and 2021, respectively. All but one of the material weaknesses identified in 2021 have been remediated, with management identifying an ongoing material weakness in 2022 in internal control over financial reporting relating to insufficient resources with appropriate level of knowledge within our outwards reinsurance operations and accounting team to effectively design and execute our process level controls around reinsurance premiums payable and reinsurance receivables, and associated disclosure controls.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To remediate this identified material weakness in our internal control over financial reporting described above, during the course of 2022 and 2023, we engaged external consulting support, deployed various tactical processes and procedural enhancements including the realignment of resources and hiring new employees to the outwards reinsurance accounting and operations teams, together with scoping out medium to longer-term remedial activities. We have therefore partially implemented these remedial measures, though they are not yet fully completed. Remediation activities, which remain ongoing, include, but are not limited to the following: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">further strengthening the reinsurance team by hiring additional accounting and operational resources to help ensure that we have a sufficient number of personnel with skills and experience commensurate with the size and complexity of the organization who can effectively design and execute our process level procedures and controls around reinsurance premiums payable and reinsurance receivables, and associated disclosure controls; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthening the documentation of reinsurance premiums payable and reinsurance receivables processes and procedures relating to the reconciliation of and cash matching controls, enhancing the scope of existing outward reinsurance credit controls while also implementing new outwards reinsurance credit control processes and procedures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These controls will need to be in operation for a sufficient period of time before management has concluded, through testing, that these new controls are operating effectively. We will evaluate and assess these controls as part of our evaluation of the effectiveness of our internal control over financial reporting in connection with the filing of our year ended December 31, 2023 annual report on Form 20-F that will be filed with the SEC.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implementation of the remediation measures may not fully address the material weakness in our internal controls over financial reporting, and therefore we might not be able to conclude that it has been fully remediated in the future. Any such gaps or deficiencies may require significant resources to remediate and may also expose us to litigation, regulatory fines or penalties, or other losses. Inadequate process design or a failure in operating effectiveness could result in a material misstatement of our financial statements due to, but not limited to, poorly designed systems, changes in end-user computing, poorly designed information technology reports, ineffective oversight of outsourced processes, failure to perform relevant management reviews, accounting errors or duplicate payments, any of which could result in a restatement of financial accounts.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There can be no guarantee that this material weakness will not recur, that additional material weaknesses will not develop, or that our remediation efforts will be successful.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we identify any additional material weaknesses in our internal control over financial reporting, fail to properly remediate the existing material weaknesses identified, or are unable to comply with the requirements of Section 404 of the Sarbanes-Oxley Act or assert that our internal control over financial reporting is effective in the future, if we are required to make restatements of our financial statements, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may lose confidence in the accuracy, completeness or reliability of our financial reports and the trading price of our ordinary shares may be adversely affected, and we could become subject to sanctions or investigations by the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , the SEC or other regulatory authorities, which could require additional financial and management resources. In addition, if we fail to remedy any material weakness, our financial statements could be inaccurate and we could face restricted access to the capital markets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be adversely affected by the loss of one or more of our senior underwriters or other members of our senior management team or by an inability to attract and retain senior staff. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success has depended and will continue to depend, in substantial part, on our ability to attract and retain our teams of underwriters in various business lines and other key employees. The loss of one or more of our senior underwriters could adversely impact our business by, for example, making it more difficult to retain clients or other business contacts whose relationship depends in part on the service of the departing personnel. In general, the loss of key services of any members of our current underwriting teams may adversely affect our business and operating results. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely substantially upon the services of our senior management team. Although we have employment agreements with all members of our senior management team, if we were to unexpectedly lose the services of one or more of our senior management team or other key personnel, our business or ratings could be adversely affected. For example, an unplanned change in our senior management team could cause a risk of disruption to our business including, but not limited to, our underwriting, claims handling, reserving and financial reporting functions. We do not currently maintain key-man life insurance policies with respect to any of our employees.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may be adversely affected if third-party outsourced service providers fail to satisfactorily perform certain technology and business process functions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We outsource certain technology and business process functions to third parties including offshore and cloud service providers and may increasingly do so in the future. If we do not effectively develop, implement and monitor our outsourcing strategy, third-party providers do not perform as anticipated or we experience technological or other problems with a transition, we may not realize productivity improvements or cost efficiencies and may experience operational difficulties, increased costs and loss of business. Our outsourcing of certain technology and business processes and functions to third parties may expose us to enhanced risks related to data security, which could result in monetary and reputational damages. In addition, our ability to receive services from third-party providers may be impacted by cultural differences, political instability, unanticipated regulatory requirements or policies. As a result, our ability to conduct our business may be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be exposed to general employee and third-party litigation risks, which could harm our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we may be involved in various litigation matters, including but not limited to commercial disputes, employee claims and class actions (including, by way of example, employee allegations of improper termination and discrimination and claims related to violations of applicable government laws regarding religious freedom, advertising and intellectual property) and from time to time may be involved in governmental or regulatory investigations or similar matters arising out of our current or future business. Any claims asserted against us, regardless of merit or eventual outcome, could harm our reputation and have an adverse impact on our relationship with our customers, partners and other third parties and could lead to additional related claims. Our insurance or indemnities may not cover all claims that may be asserted against us, and any claims asserted against us, regardless of merit or eventual outcome, may harm our reputation and cause us to expend resources in our defense. Furthermore, there is no guarantee that we will be successful in defending ourselves in future litigation or similar matters under various laws. If judgments or settlements in any future litigation or investigation significantly exceed our insurance coverage, our business, financial condition, and results of operations could be adversely affected. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management turnover creates uncertainties and could harm our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely heavily on our executive officers to manage our operations for the success of our business. Management must have a thorough understanding of our various business lines, as well as the skills and experience necessary to manage our organization. Often, the appointment of new executives leads to changes in strategic or operating goals, which can create uncertainty and negatively impact our ability to execute quickly and effectively, and may ultimately be unsuccessful. In addition, executive leadership transition periods are often difficult as the new executives gain detailed knowledge of our operations, and friction can result from changes in strategy and management style. Management turnover inherently causes some loss of institutional knowledge, which can negatively affect strategy and execution. If we do not integrate new executives successfully, we may be unable to manage and grow our business, and our financial condition and profitability may suffer as a result. In addition, to the extent we experience additional management turnover, competition for top management is high and it may take time to find a candidate that meets our requirements. If we are unable to attract and retain qualified management personnel, our business could suffer. We are unable to predict with certainty the impact that any leadership changes may have on our business operations, prospects, financial results, retention of key professionals and other employees or morale.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a foreign private issuer and &#8220;controlled company&#8221; within the meaning of the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance rules, we are permitted to, and we will, rely on exemptions from certain of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance standards. Our reliance on such exemptions may afford less protection to holders of our ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The corporate governance rules of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; require listed companies to have, among other things, a majority of independent directors and independent director oversight of executive compensation, nomination of directors and corporate governance matters. Although the Board is currently comprised of a majority of independent directors, as a foreign private issuer, we are permitted to, and we will, follow home country practice in lieu of the above requirements. As long as we rely on the foreign private issuer exemption to certain of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance standards, a majority of the directors on the Board are not required to be independent directors, we are not required to have a compensation committee composed entirely of independent directors and director nominations are not required to be made, or recommended to the Board, by a nominating committee that consists entirely of independent directors. Therefore, the Board&#8217;s approach to governance may be different from other companies, and, as a result, management oversight of the Company may be more limited than if we were subject to all of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance standards. We are also subject to certain reduced disclosure obligations as a result of being a foreign private issuer. As such, investors will not have access to the same information as for similar companies that are not foreign private issuers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event we no longer qualify as a foreign private issuer, if then applicable, we may rely on the &#8220;controlled company&#8221; exemption under the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance rules. A &#8220;controlled company&#8221; under the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance rules is a company of which more than 50% of the voting power for the election of directors is held by an individual, group or another company. Following this offering, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; will control a majority of the combined voting power of our outstanding shares, making us a &#8220;controlled company&#8221; within the meaning of the  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance rules. As a controlled company, we are eligible to, and, in the event we no longer qualify as a foreign private issuer, we may, elect not to comply with certain requirements of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance standards, including (i) the requirement that a majority of the board of directors consist of independent directors, (ii) the requirement that we have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities and (iii) the requirement that our director nominations be made, or recommended to the Board, by a nominating committee that consists entirely of independent directors and that we adopt a written charter addressing the nominations process.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our shareholders will not have the same protection afforded to shareholders of companies that are subject to all of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance standards, and the ability of our independent directors to influence our business policies and affairs may be reduced.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may lose our foreign private issuer status which would then require us to comply with the Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal, accounting and other expenses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For so long as we qualify as a foreign private issuer, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. We may no longer be a foreign private issuer as early as June 30, 2024 (the last business day of the second fiscal quarter of 2024), which would require us to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers as of January 1, 2025. In order to maintain our current status as a foreign private issuer, either (a) a majority of our voting, ordinary securities must be either directly or indirectly owned of record by non-residents of the United States or (b)(i) a majority of our executive officers or directors cannot be U.S. citizens or residents, (ii) more than 50% of our assets must be located outside the United States and (iii) our business must be administered principally outside the United States. If we lose our status as a foreign private issuer, we would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required to make changes in our corporate governance practices in accordance with various SEC and  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rules. As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers. Should we lose our foreign private issuer status, we will incur significant additional legal, accounting and other expenses that we would not incur as a foreign private issuer, which could have a material adverse effect on our business, nature of operations and financial results. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a foreign private issuer, there is less required publicly available information concerning us than there would be if we were a U.S. public company.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a &#8220;foreign private issuer,&#8221; as defined in the SEC&#8217;s rules and regulations and, consequently, we are not subject to all of the disclosure requirements applicable to public companies organized within the United States. For example, we are exempt from certain rules under the Exchange Act that regulate disclosure obligations and procedural requirements related to the solicitation of proxies, consents or authorizations applicable to a security registered under the Exchange Act, including the U.S. proxy rules under Section 14 of the Exchange Act. In addition, our senior management and directors are exempt from the reporting and &#8220;short-swing&#8221; profit recovery provisions of Section 16 of the Exchange Act and related rules with respect to their purchases and sales of ordinary shares or our other securities. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. public companies.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on the execution of internal processes to maintain our operations and the operational risks that are inherent to our business, including those resulting from fraud or employee errors or omissions, may result in financial losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on the effective execution of internal processes to maintain our operations. We seek to monitor and control our exposure to risks arising from these processes through a risk control framework encompassing a variety of reporting systems, internal controls, management review processes and other mechanisms. We cannot provide absolute assurance that these processes and procedures will effectively control all known risks or effectively identify unforeseen risks, or that our employees and third-party agents will effectively implement them. Loss may result from, among other things, fraud, errors, failure to document transactions properly, failure to obtain proper internal authorization, failure to comply with underwriting or other internal guidelines or failure to comply with regulatory requirements. Loss from these risks could adversely affect our business, results of operations and financial condition. In addition, insurance policies that we have in place with third parties may not protect us in the event that we experience a significant loss from these risks.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A failure in our data security and/or technology systems or infrastructure or those of third parties, including those caused by security breaches or cyber-attacks could disrupt our business, damage our reputation and cause losses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations rely on the secure processing, storage, and transmission of confidential and other information and assets, including in our computer systems and networks. Our business, including our ability to adequately price products and services, establish reserves, provide an effective and secure service to our customers, value our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investments and report our financial results in a timely and accurate manner, depends significantly on the integrity, availability and timeliness of the data we maintain, as well as the data and assets held through third-party outsourcers, service providers and systems. Cybersecurity and technology threats can include phishing scams, account takeovers, introductions of malware (including ransomware), attempts at electronic break-ins, and the computerized submission of fraudulent and/or duplicative payment requests. Any such breaches or interference (including attempted breaches or interference) by third parties or by insiders that may occur in the future could have a material adverse impact on our business, reputation, financial condition or results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an effort to ensure the integrity of such data, we implement new security measures and systems and improve or upgrade our existing security measures and systems on a continuing basis. Although we have implemented administrative and technical controls and take protective actions to reduce the risk of cyber incidents and to protect our information technology and assets, and we endeavor to modify such procedures as circumstances warrant and negotiate agreements with third-party providers to protect our assets, such measures may be insufficient to prevent, among other things, unauthorized access, computer viruses, malware or other malicious code or cyber-attack, catastrophic events, system failures and disruptions (including in relation to new security measures and systems), employee errors or malfeasance, third-party (including outsourced service providers) errors or malfeasance, loss of assets and other security events (each, a &#8220;Security Event&#8221;). Like other global companies, we have from time to time experienced, and are likely to continue to be subject to, Security Events, none of which to date have had a material adverse impact on our business, results of operations or financial condition. If additional Security Events occur, these events may jeopardize our or our policyholders&#8217; or counterparties&#8217; confidential and other information processed and stored with us, and transmitted through our computer systems and networks potentially resulting in a violation of applicable privacy, data protection or other laws, or otherwise cause interruptions, delays, or malfunctions in our, our policyholders&#8217;, counterparties&#8217; or third parties&#8217; operations, or result in data loss or loss of assets which could result in significant losses and/or fines, reputational damage or a material adverse effect on our business, financial condition or operating results. We may be required to expend significant additional resources to modify our protective measures or to investigate and remediate vulnerabilities or other exposures and to pursue recovery of lost data or assets and we may be subject to litigation and financial losses. We currently maintain cyber liability insurance that provides third-party or first party liability coverages to protect us, subject to policy limits and coverages, against certain events that could be a Security Event. However, a Security Event could nonetheless have a material adverse effect on our operating results or financial condition. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the contingency plans and facilities we have in place and our efforts to observe the regulatory requirements surrounding information security, our ability to conduct business may be adversely affected by a disruption of the infrastructure that supports our business in the communities in which we are located, or of outsourced services or functions, including a disruption involving electrical, communications, transportation, or other services we use. If a disruption occurs in one location and our employees in that location are unable to conduct business or communicate with other locations, our ability to service and interact with policyholders may suffer and we may not be able to successfully implement contingency plans that depend on communication. If sustained or repeated, such business interruption, system failure, service denial or data loss and/or damage could result in a deterioration of our ability to write and process business, provide customer service, pay claims in a timely fashion or perform other necessary business functions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with ever evolving national, federal, state, and international laws relating to the handling of information collected from or about individuals involves significant expenditure and resources, and any failure by us or our vendors to comply may result in significant liability, negative publicity and/or an erosion of trust, which could materially adversely affect our business, results of operations and financial condition. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive, store, handle, transmit, use and otherwise process business information and information related to individuals, including from and about actual and prospective customers, policy holders, as well as our employees and service providers. We also depend on a number of third party vendors in relation to the operation of our business, a number of which process data on our behalf.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a range of data privacy and cyber security laws globally including those that apply generally to the handling of information about individuals, and those that are specific to certain industries, sectors, contexts or locations. These requirements, and their application, interpretation and amendment are constantly evolving and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">developing as set out in &#8220;Certain Regulatory Considerations&#8212;Bermuda Insurance Regulation&#8212;Privacy and Cyber Security Laws,&#8221; &#8220;&#8212;U.K. and E.U. Insurance Regulation&#8212;Cybersecurity and Privacy Laws and Regulations&#8221; and &#8220;&#8212;U.S. Insurance Regulation&#8212;Cybersecurity and Privacy Laws and Regulations.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is also subject to the Bermuda Personal Information Protection 2016 Act (&#8220;PIPA&#8221;). For more information, refer to &#8220;Certain Regulatory Considerations&#8212;Bermuda Insurance Regulation&#8212;Privacy and Cyber Security Laws.&#8221; In addition to U.K./E.U. and Bermuda privacy laws, our business is subject to various U.S. state and federal privacy legislation, including both state financial privacy and insurance laws which apply specifically to our business lines, and potentially more generally applicable state privacy laws, with the most comprehensive having been enacted in California. The applicability of these state comprehensive laws to the business of insurance is not yet settled. U.S. state legislatures, attorneys general, and insurance and other regulatory bodies continue to develop and implement further standards and governance requirements. Such evolving privacy and data security regulations could expose our business to reputational harm and cause losses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on a number of third parties in relation to the operation of our business, a number of which process personal data on our behalf. There can be no assurances that the privacy and security-related measures and safeguards we have put in place in relation to these third parties will be effective to protect us and/or the relevant personal data from the risks associated with the third-party processing, storage and transmission of such data. Any violation of data or security laws, or of our relevant measures and safeguards, by our third party processors could have a material adverse effect on our business, result in applicable fines and penalties, damage our reputation and/or result in civil claims.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to evolving E.U. and U.K. privacy laws on cookies, tracking technologies and e-marketing. Recent European court and regulator decisions are driving increased attention to cookies and tracking technologies. If the trend of increasing enforcement by regulators of the strict approach to opt-in consent for all but essential use cases as seen in recent guidance and decisions continues, this could lead to substantial costs, require significant systems changes, limit the effectiveness of our marketing activities, divert the attention of our technology personnel, adversely affect our margins and subject us to additional liabilities. In light of the complex and evolving nature of E.U., E.U. Member State and U.K. privacy laws on cookies and tracking technologies, there can be no assurances that we will be successful in our efforts to comply with such laws; violations of such laws could result in regulatory investigations, fines, orders to cease/change our use of such technologies, as well as civil claims including class actions and reputational damage.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We use analytical models to assist our decision making in key areas such as underwriting, claims, reserving and catastrophe risks but actual results could differ materially from the model outputs and related analyses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made substantial investments to develop proprietary analytic and modeling capabilities to facilitate our underwriting, risk management, capital modeling and allocation and risk assessments relating to the risks we assume. We also use vendor models where available and, where appropriate, we use our proprietary model in combination with vendor models. These models and other tools help us to manage our risks, understand our capital utilization and risk aggregation, inform management and other stakeholders of capital requirements and seek to improve the risk/return profile or optimize the efficiency of the amount of capital we apply to cover the risks in the individual contracts we sell and in our portfolio as a whole. However, given the inherent uncertainty of modeling techniques and the application of such techniques, the possibility of human or systems error, the challenges inherent in consistent application of complex methodologies in a fluid business environment and other factors, our models, tools and databases may not accurately address the risks we currently cover or the emergence of new matters which might be deemed to impact certain of our coverages. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, there are risks associated with catastrophic events, which are either poorly represented or not represented at all by analytical models. Each modeling assumption or un-modeled risk introduces uncertainty into the estimates that management must consider. These uncertainties can include, but are not limited to, the following: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The models do not address all the possible hazard characteristics of a catastrophe peril (e.g., the precise path and wind speed of a hurricane); </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The models may not accurately reflect the true frequency of events; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The models may not accurately reflect a risk&#8217;s vulnerability or susceptibility to damage for a given event characteristic; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The models may not accurately represent loss potential to reinsurance contract coverage limits, terms and conditions; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The models may not accurately reflect the impact on the economy of the area affected or the financial, judicial, political, or regulatory impact on insurance claim payments during or following a catastrophe event.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our models may understate the exposures we are assuming. Conversely, our models may prove too conservative and contribute to factors which may impede our ability to grow in respect of new markets or perils or in connection with our current portfolio of coverages or the loss environment otherwise may prove more benign than our capital loading for catastrophes or other modeled losses. In such case of excess capital, we would make a judgment about redeploying the capital in lines of businesses or pursuing other capital management activities, such as dividends or share repurchases, which judgment will also depend on modeling techniques and results. If capital models prove inadequate, our result of operations and financial condition may be materially adversely impacted. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8494"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Ordinary Shares and this Offering</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our controlling shareholder controls us and has the power to determine the affairs of the Company, including in ways that may not be favorable to us or other holders of our ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this offering,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, an affiliate of certain investment funds managed by affiliates of Apollo, will beneficially own approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our ordinary shares (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% if the underwriters exercise in full their option to purchase additional ordinary shares from us and the selling shareholders). As a result, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; has the power to elect our directors and to determine the outcome of any action requiring shareholder approval. Such shareholder&#8217;s interests may differ from the interests of other holders of our ordinary shares and, given such shareholder&#8217;s controlling interest in the Company, circumstances may arise under which it may exercise its control in a manner that is not favorable to the interests of other holders of our ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, for so long as &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; continues to own a significant percentage of our ordinary shares,  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;will be able to cause or prevent a change of control of the Company or a change in the composition of the Board, and could preclude any unsolicited acquisition of the Company. The concentration of ownership could deprive you of an opportunity to receive a premium for your ordinary shares as part of a sale of the Company and ultimately might affect the market price of our ordinary shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our holding company structure and certain Companies Act, regulatory and other constraints may limit our ability to pay dividends on our securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Holdings is a holding company and, as such, it does not have any significant operations. Aspen Holdings&#8217; assets primarily consist of ownership of the shares of its subsidiaries, including our Operating Subsidiaries, a portfolio of fixed income securities and cash and cash equivalents. Dividends and other permitted distributions and loans from our Operating Subsidiaries are expected to be our sole source of funds to meet ongoing cash requirements, including our debt service payments and other expenses, and dividend payments to our ordinary shareholders or preference shareholders, as appropriate. Our Operating Subsidiaries are subject to capital, regulatory and other requirements that inform their ability to declare and pay dividends and make loans to other Aspen Group companies. See &#8220;Certain Regulatory Considerations&#8212;Bermuda Insurance Regulation&#8212;Restrictions on Dividends, Distributions and Reduction of Capital,&#8221; &#8220;Certain Regulatory Considerations&#8212;U.K. and E.U. Insurance Regulation&#8212;Restriction on Dividend Payments by Insurers,&#8221; and &#8220;Certain Regulatory Considerations&#8212;U.S. Insurance Regulation&#8212;State Dividend Limitations,&#8221; &#8220;Dividend Policy&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8221; for more information on our ability to pay dividends. These and other requirements may mean that our Operating Subsidiaries are unable to pay sufficient dividends to enable us to meet our ongoing cash requirements, which could materially adversely affect our liquidity or financial condition. As we are a holding company, our right, and hence the right of our creditors and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shareholders, to participate in any distribution of assets by any of our subsidiaries, upon our liquidation or reorganization or otherwise, is subject to the prior claims of policyholders and creditors of these subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are subject to Bermuda regulatory constraints that affect our ability to pay dividends and make other distributions on our ordinary shares, Preference Shares or other securities. Under the Companies Act, we may declare or pay a dividend only if we have reasonable grounds to believe that we are, and would after the payment be, able to meet our liabilities as they become due and if the realizable value of our assets would thereby not be less than our liabilities. See &#8220;Certain Regulatory Considerations&#8212;Bermuda Insurance Regulation&#8212;Restrictions on Dividends, Distributions and Reduction of Capital,&#8221; &#8220;Dividend Policy,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8221; and &#8220;Note 13&#8212;Statutory Requirements and Dividends Restrictions&#8221; to our audited consolidated financial statements for more information on our ability to pay dividends. Additionally, agreements relating to our debt, including our revolving credit facility and 2026 Term Loan (as defined below), contain covenants that may limit our ability to pay cash dividends on our ordinary shares if a default or event of default has occurred and is continuing or would result therefrom. If we are unable to pay a cash dividend, or the Board determines not to pay a cash dividend on our ordinary shares, your ability to achieve a return on your investment will depend on the appreciation in the price of our ordinary shares, which may never occur. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot pay a dividend on our ordinary shares unless the full dividends for the most recently ended dividend period on all outstanding Preference Shares have been declared and paid.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Preference Shares rank senior to our ordinary shares with respect to the payment of dividends. As a result, unless the full dividends for the most recently ended dividend period on all outstanding Preference Shares have been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside), we cannot declare or pay a dividend on our ordinary shares. Accordingly, the ability of holders of our ordinary shares to receive dividends may be restricted by the terms of our Preference Shares. See &#8220;Description of Share Capital&#8212;Outstanding Series of Preference Shares&#8221; for more information.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No market currently exists for our ordinary shares, and an active, liquid trading market for our ordinary shares may not develop, which may cause our ordinary shares to trade at a discount from the initial offering price and make it difficult to sell our ordinary shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, there has not been a public trading market for our ordinary shares. We cannot predict the extent to which investor interest in us will lead to the development of a trading market or how active and liquid that market may become. If an active and liquid trading market does not develop or continue, investors may have difficulty selling their ordinary shares at an attractive price or at all. The initial public offering price per ordinary share will be determined by negotiations between us, the selling shareholders and the underwriters, and may not be indicative of the price at which our ordinary shares will trade in the public market following the consummation of this offering. The market price of our ordinary shares may decline below the initial offering price and investors may not be able to sell their ordinary shares at or above the price they paid in this offering, or at all. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price per ordinary share may change significantly following this offering, and investors may not be able to resell their ordinary shares at or above the price they paid or at all, and investors could lose all or part of their investment as a result. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the selling shareholders and the underwriters will negotiate to determine the initial public offering price. Investors may not be able to resell their ordinary shares at or above the initial public offering price due to a number of factors such as those listed in this &#8220;Risk Factors&#8221; section and the following: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">occurrence of a large catastrophic loss; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of operations that vary from the expectations of securities analysts and investors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of operations that vary from those of our competitors compared to market expectations; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in expectations as to our future financial performance, including financial estimates and investment recommendations by securities analysts and investors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in market valuations of, or earnings and other announcements by, companies in the (re)insurance industry; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">declines in the market prices of stocks generally, particularly those in the (re)insurance industry; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant contracts, new products or technologies, acquisitions, joint ventures, other strategic relationships or capital commitments; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in general economic or market conditions or trends in the (re)insurance industry or the economy as a whole and, in particular, in the softening of rates; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in business or regulatory conditions which adversely affect the (re)insurance industry or our business; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future issuances, exchanges or sales, or expected issuances, exchanges or sales of our ordinary shares or our other securities; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investor perceptions of, or the investment opportunity associated with, our ordinary shares relative to other investment alternatives; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the market&#8217;s reaction to our reduced disclosure and other requirements as a result of being treated as a &#8220;foreign private issuer&#8221;; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the public&#8217;s response to press releases or other public announcements by us or third parties, including our filings with the SEC; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">guidance, if any, that we provide to the public, any changes in this guidance or our failure to meet this guidance; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development and sustainability of an active trading market for our ordinary shares; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other events or factors, including those resulting from informational technology system failures and disruptions, natural disasters, war, acts of terrorism or responses to these events. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the stock market has experienced and is likely to continue to experience extreme volatility and significant price and volume fluctuations that, in some cases, have been and may be unrelated or disproportionate to the operating performance of particular companies. These broad market and industry fluctuations may adversely affect the market price of our ordinary shares, regardless of our actual operating performance. In addition, price volatility may be greater if the public float and trading volume of our ordinary shares is low. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, following periods of market volatility, shareholders have instituted securities class action litigation. If we were to become involved in securities litigation, it could have a substantial cost and divert resources and the attention of executive management from our business regardless of the outcome of such litigation. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research or reports about our business or if they downgrade our ordinary shares or the (re)insurance industry generally, or if there is any fluctuation in our ratings, the price of our ordinary shares and trading volume could decline. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our ordinary shares will rely in part on the research and reports that industry or financial analysts publish about us and our business. We do not control these analysts. Furthermore, if one or more of the analysts who do cover us downgrade our ordinary shares or the (re)insurance industry, or the stock of any of our competitors, or publish inaccurate or unfavorable research about our business, the price of our ordinary shares could decline. If one or more of these analysts stop covering us or fail to publish reports on us regularly, we could lose visibility in the market, which in turn could cause the price or trading volume of our ordinary shares to decline. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, any fluctuation in our ratings may impact our ability to access debt markets in the future or increase the cost of future debt, which could have a material adverse effect on our operations and financial condition, which in return may adversely affect the trading price of our ordinary shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our controlling shareholder sell additional ordinary shares after this offering or are perceived by the public markets as intending to sell additional ordinary shares, the market price of our ordinary shares could decline. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale of substantial amounts of our ordinary shares in the public market, or the perception that such sales could occur, could harm the prevailing market price of our ordinary shares. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell ordinary shares in the future at a time and at a price that we deem appropriate. Upon consummation of this offering, we will have a total of&#160;&#160;&#160;&#160;&#160;ordinary shares outstanding, assuming no exercise by the underwriters of their option to purchase additional shares. All of our ordinary shares sold in this offering will be freely tradable without restriction or further registration under the Securities Act, by persons other than our &#8220;affiliates,&#8221; as that term is defined under Rule 144 of the Securities Act. The remaining ordinary shares that will be outstanding after this offering are &#8220;restricted securities&#8221; within the meaning of Rule 144 under the Securities Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our officers, directors and certain holders of our ordinary shares, including the selling shareholders, will  agree with the underwriters, subject to certain exceptions, not to dispose of or hedge any of our ordinary shares or securities convertible into or exchangeable for our ordinary shares during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus, except with the prior written consent of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Upon the expiration of these lock-up agreements, all of such ordinary shares will be eligible for resale in the public market, subject, in the case of ordinary shares held by our affiliates, to volume, manner of sale and other limitations under Rule 144 and Rule 701. The market price of our ordinary shares may decline when the restrictions on resale lapse. A decline in the price of our ordinary shares might impede our ability to raise capital through the issuance of additional ordinary shares or other equity securities. For more information, see &#8220;Description of Share Capital&#8221; and &#8220;Shares Eligible for Future Sale.&#8221; </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will have broad discretion in the use of the net proceeds to us from this offering and may not use them effectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will have broad discretion in the application of the net proceeds to us from this offering, including for any of the purposes described in the section titled &#8220;Use of Proceeds,&#8221; and you will not have the opportunity as part of your investment decision to assess whether the net proceeds are being used appropriately. Because of the number and variability of factors that will determine our use of the net proceeds from this offering, our ultimate use may vary substantially from our currently intended use. Investors will need to rely upon the judgment of our management with respect to the use of the net proceeds from this offering. If we do not use the net proceeds that we receive in this offering effectively, our business, financial condition and operating results could be harmed and the market price of our ordinary shares could decline. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There are provisions in our bye-laws which may reduce or increase the voting rights of our ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, and except as provided below, shareholders have one vote for each ordinary share held by them and are entitled to vote at all meetings of shareholders. However, if, and so long as, the ordinary shares of a shareholder in the Company are treated as &#8220;controlled shares&#8221; (as defined in our bye-laws by reference to Sections 957 and 958 of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)) of any U.S. person (as that term is defined in the Code) and such &#8220;controlled shares&#8221; constitute 9.5% or more of the voting power of all the ordinary shares of the Company and such person would be generally required to recognize income with respect to the Company under Section 951(a)(1) of the Code, if the Company were a controlled foreign corporation as defined in Section 957 of the Code and if the ownership threshold under Section 951(b) of the Code were 9.5% (&#8220;9.5% U.S. Shareholder&#8221;), the voting rights with respect to the controlled shares owned by such U.S. person shall be limited, in the aggregate, to a voting power of less than 9.5% under a formula specified in our bye-laws. The formula is applied repeatedly until the voting power of all 9.5% U.S. Shareholders has been reduced to less than 9.5%. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Board may limit a shareholder&#8217;s voting rights when it deems it appropriate to do so to (1) avoid the existence of any 9.5% U.S. Shareholder; and (2) avoid adverse tax, legal or regulatory consequences to the Company, any of its subsidiaries, any shareholder or its affiliates or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a shareholder of ours. &#8220;Controlled shares&#8221; includes all ordinary shares of the Company that such U.S. person is deemed to own directly, indirectly or constructively (within the meaning of Sections 957 and 958 of the Code). Pursuant to our bye-laws the amount of any reduction of votes that occurs by operation of the above limitations will generally be reallocated proportionately among all other shareholders of the Company whose shares were not &#8220;controlled shares&#8221; of any 9.5% U.S. Shareholder so long as such reallocation does not cause any person to become a 9.5% U.S. Shareholder.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these provisions, certain shareholders may have their voting rights limited to less than one vote per share, while other shareholders may have voting rights in excess of one vote per share. See &#8220;Description of Share Capital&#8212;Voting Power Adjustments&#8221; for more information. Moreover, these provisions could have the effect of reducing the votes of certain shareholders who would not otherwise be subject to the 9.5% limitation by virtue of their direct share ownership. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the authority to request from any shareholder, and such shareholder is required to provide, such information that we may reasonably request for the purposes of determining whether any shareholder&#8217;s voting rights are to be adjusted pursuant to the voting adjustment provisions in our bye-laws described above. If any shareholder fails to respond to this request or submits incomplete or inaccurate information, we may, in our reasonable discretion, eliminate or reduce the shareholder&#8217;s voting rights. All information provided by the shareholder shall be treated by us as confidential information and shall be used by us solely for the purpose of establishing whether any 9.5% U.S. Shareholder exists (except as otherwise required by applicable law or regulation).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There are provisions in our bye-laws which may restrict the ability to transfer ordinary shares and which may require shareholders to sell their ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may decline to register a transfer of any ordinary shares if it appears to the Board, in its sole discretion, after taking into account the limitations on voting rights contained in our bye-laws, that any non-de minimis adverse tax, regulatory or legal consequences to us, any of our subsidiaries, any of our shareholders or their affiliates or any direct or indirect investor in, or beneficial owner of an interest in, a shareholder of ours would result from such transfer. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our bye-laws and subject to Bermuda law, we have the option, but not the obligation, to require a shareholder to sell to us or a third party at fair market value, as determined in the good faith discretion of the Board, the minimum number of ordinary shares which is necessary to eliminate any material adverse tax consequences to us, our subsidiaries, our shareholders or their affiliates or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a shareholder of ours if the Board unanimously determines that failure to exercise such option would result in such material adverse tax consequences. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of the provisions in our bye-laws and in the laws and regulations of the jurisdictions where we conduct business could delay or deter a takeover attempt that shareholders might consider desirable and may make it more difficult to replace members of our Board.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bye-laws contain provisions that may entrench directors and make it more difficult for shareholders to replace directors even if shareholders consider it beneficial to do so. These provisions could delay or prevent a change of control that shareholders might consider favorable. For example, these provisions may prevent a shareholder from receiving the benefit from any premium over the market price of our ordinary shares offered by a bidder in a potential takeover. Even in the absence of an attempt to effect a change in management or a takeover attempt, these provisions may adversely affect the prevailing market price of our ordinary shares if they are viewed as discouraging changes in management and takeover attempts in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, our bye-laws contain the following provisions that could have such an effect:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">directors may decline to approve or register a transfer of any ordinary shares if it appears to the Board, in its sole discretion, after taking into account the limitations on voting rights contained in our bye-laws, that any </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">non-de minimis adverse tax, regulatory or legal consequences to us, any of our subsidiaries, any of our shareholders or their affiliates or any direct or indirect investor in, or beneficial owner of an interest in, a shareholder of ours would result from such transfer;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Board has the option, but not the obligation, to require a shareholder to sell to us or a third party at fair market value, as determined in the good faith discretion of the Board, the minimum number of ordinary shares which is necessary to eliminate any material adverse tax consequences to us, our subsidiaries, our shareholders or their affiliates or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a shareholder of ours if the Board unanimously determines that failure to exercise such option would result in such material adverse tax consequences; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if our ordinary shares of any U.S. person constitute 9.5% or more of the votes conferred by our issued shares, the voting rights with respect to the controlled shares of such U.S. person shall be limited, in the aggregate, to a voting power of less than 9.5%.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, as described under &#8220;Certain Regulatory Considerations&#8212;Bermuda Insurance Regulation&#8212;Fit and Proper Controllers,&#8221; prospective shareholders are required to notify our regulators on becoming &#8220;controllers&#8221; of any of our Operating Subsidiaries through ownership of ordinary shares above certain thresholds, typically 10% of outstanding ordinary shares. Some regulators may require their approval prior to such shareholder becoming a &#8220;controller.&#8221; Other regulators may serve a notice of objection or are entitled to injunctive relief. There can be no assurance that the applicable regulatory body would agree that a shareholder who owned greater than 10% of our ordinary shares did not, because of the limitation on the voting power of such shares, control the applicable Operating Subsidiary.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws may discourage potential acquisition proposals and may delay, deter or prevent a change of control of the Company, including through transactions, and in particular unsolicited transactions, that some or all of our shareholders might consider to be desirable. If these restrictions delay, deter or prevent a change of control, such restrictions may make it more difficult to replace members of the Board and may have the effect of entrenching management regardless of their performance.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ordinary shares rank junior to all our debts and liabilities and our Preference Shares in the event of our liquidation, dissolution or winding-up.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of our liquidation, dissolution or winding-up, the holders of our ordinary shares are entitled to share equally and ratably in our assets, if any remain after the payment of all our debts and liabilities and the liquidation preference of any outstanding preference shares, including our Preference Shares. In such an event, there may not be sufficient assets remaining after payments to holders of our debts and liabilities and Preference Shares to ensure payments to holders of our ordinary shares. See &#8220;Description of Share Capital&#8212;Ordinary Shares&#8221; and &#8220;Description of Share Capital&#8212;Outstanding Series of Preference Shares&#8221; for more information.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future offerings of debt or equity securities which would rank senior to our ordinary shares may adversely affect the market price of our ordinary shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, in the future, we decide to issue debt or equity securities that rank senior to our ordinary shares, it is likely that such securities will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. Additionally, any convertible or exchangeable securities that we may issue in the future may have rights, preferences and privileges more favorable than those of our ordinary shares and may result in dilution to owners of our ordinary shares. We and, indirectly, our shareholders, will bear the cost of issuing and servicing such securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the decision to issue debt or equity securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of such future offerings. Thus, holders of ordinary shares will bear the risk of future offerings reducing the market price of our ordinary shares and diluting the value of their holdings in us. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You will experience immediate and substantial dilution in the net tangible book value of our ordinary shares you purchase in this offering.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial public offering price of our ordinary shares will be substantially higher than the as adjusted net tangible book value per ordinary share immediately after this offering. If you purchase ordinary shares in this offering, you will suffer immediate dilution of $&#160;&#160;&#160;&#160;&#160;per share, or $&#160;&#160;&#160;&#160;&#160;per share if the underwriters exercise their option to purchase additional ordinary shares in full, representing the difference between our as adjusted net tangible book value per share as of June 30, 2023 after giving effect to the sale of ordinary shares in this offering and the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;per share, the midpoint of the price range set forth on the cover page of this prospectus. See &#8220;Dilution.&#8221;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. persons who own our ordinary shares may have more difficulty in protecting their interests than U.S. persons who are shareholders of a U.S. corporation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Companies Act, which applies to us, differs in some material respects from laws generally applicable to U.S. corporations and their shareholders. These differences include, but are not limited to, the manner in which directors must disclose transactions in which they have an interest, the rights of shareholders to bring class action and derivative lawsuits, the scope of indemnification available to directors and officers and provisions relating to the amalgamations, mergers and acquisitions and takeovers. Holders of our ordinary shares may therefore have more difficulty protecting their interests than would shareholders of a corporation incorporated in a jurisdiction within the United States.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the duties of directors and officers of a Bermuda company are owed to the company only. Shareholders of Bermuda companies typically do not have rights to take action against directors or officers of the company and may only do so in limited circumstances. Class actions and derivative actions are typically not available to shareholders under Bermuda law. The Bermuda courts, however, would ordinarily be expected to permit a shareholder to commence an action in the name of a company to remedy a wrong to the company where the act complained of is alleged to be beyond the corporate power of the company or illegal, or would result in the violation of the company&#8217;s memorandum of association or bye-laws. Furthermore, consideration would be given by a Bermuda court to acts that are alleged to constitute a fraud against the minority shareholders or, for instance, where an act requires the approval of a greater percentage of the company&#8217;s shareholders than that which actually approved it. When the affairs of a company are being conducted in a manner that is oppressive or prejudicial to the interests of some shareholders, one or more shareholders may apply to the Supreme Court of Bermuda, which may make such order as it sees fit, including an order regulating the conduct of the company&#8217;s affairs in the future or ordering the purchase of the shares of any shareholders by other shareholders or by the company. Additionally, under our bye-laws and as permitted by Bermuda law, each shareholder has waived any claim or right of action against our directors or officers for any action taken by directors or officers in the performance of their duties, except for actions involving fraud or dishonesty. In addition, the rights of holders of our securities and the fiduciary responsibilities of our directors under Bermuda law are not as clearly established as under statutes or judicial precedent in U.S. jurisdictions, particularly the State of Delaware.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Comparison of Shareholder Rights&#8221; for a summary of certain significant provisions of the Companies Act and our bye-laws that differ in certain respects from provisions of Delaware corporate law.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Members of the Board will be permitted to participate in decisions in which they have interests that are different from those of the other shareholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law, directors are not required to recuse themselves from voting on matters in which they have an interest. The directors may have interests that are different from, or in addition to, the interests of the shareholders. Provided the directors disclose their interests in a matter under consideration by the Board in accordance with Bermuda law and our bye-laws, they will be entitled to participate in the deliberation on and vote in respect of that matter.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a Bermuda company and it may be difficult to effect service of process on us or enforce judgments against us or our directors and executive officers in the United States. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are incorporated under the laws of Bermuda and our business is based in Bermuda. In addition, certain of our directors and officers reside outside the United States, and a substantial portion of our assets and the assets of such persons are located in jurisdictions outside the United States. As such, it may be difficult or impossible to effect service of process upon us or those persons in the United States or to recover against us or them on judgments of U.S. courts, including judgments predicated upon civil liability provisions of the U.S. federal securities laws.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been advised by Bermuda counsel that currently there is no treaty in force between the United States and Bermuda providing for the reciprocal recognition and enforcement of judgments in civil and commercial matters. As a result, whether a U.S. judgment would be enforceable in Bermuda against us or our directors and officers depends on whether the U.S. court that entered the judgment is recognized by the Bermuda court as having jurisdiction over us or our directors and officers, as determined by reference to Bermuda conflict of law rules. A judgment debt from a U.S. court that is final and for a sum certain based on U.S. federal securities laws will not be enforceable in Bermuda unless the judgment debtor had submitted to the jurisdiction of the U.S. court, and the issue of submission and jurisdiction is a matter of Bermuda (not U.S.) law. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to and irrespective of jurisdictional issues, the Bermuda courts will not enforce a U.S. federal securities law that is either penal or contrary to public policy in Bermuda. It is the advice of our Bermuda counsel that an action brought pursuant to a public or penal law, the purpose of which is the enforcement of a sanction, power or right at the instance of the state in its sovereign capacity, will not be entertained by a Bermuda court. Certain remedies available under the laws of U.S. jurisdictions, including certain remedies under U.S. federal securities laws, would not be available under Bermuda law or enforceable in a Bermuda court, as they would be contrary to Bermuda public policy. Further, no claim may be brought in Bermuda against us or our directors and officers in the first instance for violation of U.S. federal securities laws because these laws have no extraterritorial jurisdiction under Bermuda law and do not have force of law in Bermuda. A Bermuda court may, however, impose civil liability on us or our directors and officers if the facts alleged in a complaint constitute or give rise to a cause of action under Bermuda law.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our bye-laws contain an exclusive jurisdiction provision that may discourage lawsuits against us and our directors and officers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless we consent in writing to the selection of an alternative forum, in the event that any dispute arises concerning the Companies Act or out of or in connection with our bye-laws, including any question regarding the existence and scope of any bye-law and/or whether there has been any breach of the Companies Act or our bye-laws by one of our officer or directors (whether or not such a claim is brought in the name of a shareholder or in the name of the Company), any such dispute shall be subject to the exclusive jurisdiction of the Supreme Court of Bermuda.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This exclusive jurisdiction provision may limit the ability of our shareholders to bring a claim in a judicial forum that such shareholders find favorable for disputes with us or our directors or officers, which may discourage such lawsuits against us and our directors and officers. Alternatively, if a court were to find this exclusive forum provision inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings described above, we may incur additional costs associated with resolving such matters in other jurisdictions, which could negatively affect our business, results of operations and financial condition.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7384"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Taxation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our structure involves complex provisions of tax law for which no clear precedent or authority may be available, and is subject to ongoing future potential legislative, judicial or administrative and differing interpretations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax treatment of our structure and transactions undertaken by us depends in some instances on determinations of fact and interpretations of complex provisions of tax law for which no clear precedent or authority may be available. In addition, tax rules are constantly under review, which frequently results in revised interpretations of established concepts, statutory changes, revisions to regulations and other modifications and interpretations. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether any particular proposed legislation will be enacted or, if enacted, what the specific provisions or the effective date of any such legislation would be, or whether it would have any effect on us. As such, we cannot assure you that future legislative, administrative or judicial developments will not result in an increase in the amount of tax payable by us, our subsidiaries or investors in our ordinary shares. If any such developments occur, our business, results of operations and cash flows could be adversely affected and such developments could have an adverse effect on your investment in our ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate and tax liability is based on the application of current income tax laws, regulations and treaties. These laws, regulations and treaties are complex, and the manner in which they apply to us and our subsidiaries is sometimes open to interpretation. Significant management judgment is required in determining our provision for income taxes and our deferred tax assets and liabilities. Although management believes its application of current laws, regulations and treaties to be correct and sustainable upon examination by the tax authorities, the tax authorities could challenge our interpretation and the final determination of tax upon resolution of any such challenge could be materially different from our historical tax provisions and accruals. Should additional material taxes be assessed, there could be an adverse effect on our results of operations and cash flows in the period or periods for which that determination is made.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The application of recently enacted U.S. tax reform and regulations promulgated thereunder to us is complex, and may have a material adverse effect on your investment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (the &#8220;2017 Act&#8221;) was passed by the U.S. Congress and signed into law on December 22, 2017, with certain provisions intended to eliminate certain perceived tax advantages of companies (including insurance companies) that have legal domiciles outside the U.S., but have certain U.S. connections, and U.S. persons investing in such companies. Among other things, the 2017 Act revised the rules applicable to passive foreign investment companies (&#8220;PFICs&#8221;) and controlled foreign corporations (&#8220;CFCs&#8221;) in ways that could affect the timing or amount of U.S. federal income taxes imposed on certain investors that are U.S. persons. Further, it is possible that other legislation could be introduced and enacted by the current Congress or future Congresses that could have an adverse impact on Aspen Holdings and its subsidiaries or U.S. shareholders. Additionally, tax laws and interpretations regarding whether a company is engaged in a U.S. trade or business or whether a company is a CFC or a PFIC or has related person insurance income (&#8220;RPII&#8221;) are subject to change, possibly on a retroactive basis. The Treasury Department recently issued final and proposed regulations intended to clarify the application of the insurance income exception to the classification of a non-U.S. insurer as a PFIC and provide guidance on a range of issues relating to PFICs, and recently issued proposed regulations that would expand the scope of the RPII rules. New regulations or pronouncements interpreting or clarifying such rules may be forthcoming as well. We cannot be certain if, when, or in what form such regulations or pronouncements may be provided and whether such guidance will have a retroactive effect.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our non-U.S. companies may be subject to U.S. taxes, which may have a material adverse effect on our operating results and your investment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Holdings and its non-U.S. subsidiaries (other than AUL and Aspen UK) intend to manage their business so that they are not treated as engaged in a trade or business within the United States and thus not subject to U.S. federal income tax on their net income. However, because there is considerable uncertainty as to the activities which constitute being engaged in a trade or business within the United States, we cannot be certain that the U.S. Internal Revenue Service (&#8220;IRS&#8221;) will not contend successfully that one or more of these companies is engaged in a trade or business in the United States. If any of these companies is considered to be engaged in a trade or business in the United States during a taxable year, it generally will be subject to U.S. federal income tax (including an additional branch profits tax) on its net income that is treated as effectively connected with the conduct of a U.S. trade or business for such year (except to the extent an applicable income tax treaty provides otherwise), in which case its operating results could be materially adversely affected. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. corporations not engaged in a trade or business within the United States are nonetheless subject to United States income tax imposed by withholding on certain &#8220;fixed or determinable annual or periodic gains, profits and income&#8221; derived from sources within the United States (such as dividends and certain interest on investments), subject to exemption under the Code or reduction by applicable treaties.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States also imposes an excise tax on insurance and reinsurance premiums (&#8220;FET&#8221;) paid to non-U.S. insurers or reinsurers that are not eligible for the benefits of a U.S. income tax treaty that provides for an exemption from the FET with respect to risks (i) of a U.S. entity or individual, located wholly or partially within the United States and (ii) of a non-U.S. entity or individual engaged in a trade or business in the U.S., located within the United States. The rates of tax are 4% for property casualty insurance premiums and 1% for reinsurance premiums.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our non-U.K. companies may be subject to U.K. tax, which may have a material adverse effect on our operating results and your investment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of us should be treated as being resident in the United Kingdom for corporation tax purposes except for our subsidiaries that are incorporated in the United Kingdom (the &#8220;U.K. Subsidiaries&#8221;) and APJ Asset Protection Jersey Limited, a Jersey registered insurance company (&#8220;APJ Jersey&#8221;), which, although not incorporated in the United Kingdom, is treated as tax resident in the United Kingdom. A company which is not incorporated in the United Kingdom should not be treated as being tax resident in the United Kingdom unless its central management and control is exercised in the United Kingdom. The concept of central management and control is indicative of the highest level of control of a company, and determining where this is exercised is wholly a question of fact. Each of us, other than the U.K. Subsidiaries and APJ Jersey, currently intends to manage our affairs so that none of us, other than the U.K. Subsidiaries and APJ Jersey, is resident in the United Kingdom for tax purposes, including through compliance with established tax operating guidelines, where applicable. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company that is not resident in the United Kingdom for corporation tax purposes can nevertheless be subject to U.K. corporation tax if it carries on a trade in the United Kingdom through a permanent establishment in the United Kingdom, but, in that case, the charge to U.K. corporation tax is limited to profits (both revenue profits and capital gains) attributable directly or indirectly to such permanent establishment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of us, other than the U.K. Subsidiaries and APJ Jersey, currently intends to operate in such a manner that none of us (other than the U.K. Subsidiaries and APJ Jersey) carries on a trade in the United Kingdom through a permanent establishment in the United Kingdom. Nevertheless, because neither case law nor U.K. statute completely defines the activities that constitute trading in the United Kingdom through a permanent establishment in the United Kingdom, His Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) might contend successfully that any of us (other than the U.K. Subsidiaries and APJ Jersey) are trading in the United Kingdom through a permanent establishment in the United Kingdom.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom has no comprehensive tax treaty with Bermuda. There are circumstances in which companies that are neither tax resident in the United Kingdom nor carrying on a trade in the United Kingdom through a permanent establishment in the United Kingdom (and are therefore not subject to U.K. corporation tax) but are not entitled to the protection afforded by a tax treaty between the United Kingdom and the jurisdiction in which they are a resident may nonetheless be exposed to income tax in the United Kingdom on the profits of a trade carried on there, even if that trade is not carried on through a permanent establishment. However, each of us intends to operate in such a manner that none of us falls within this charge to income tax in the United Kingdom. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of us, other than the U.K. Subsidiaries and APJ Jersey, were treated as being resident in the United Kingdom for U.K. corporation tax purposes, or as carrying on a trade in the United Kingdom, whether or not through a permanent establishment, our operating results could be materially adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our U.K. operations may be affected by recent changes in U.K. tax law. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.K. Subsidiaries and APJ Jersey should be treated as resident in the United Kingdom and accordingly be subject to U.K. tax in respect of their worldwide income and gains. Any change in the basis or rate of U.K. corporation tax or HMRC&#8217;s practice and interpretation of U.K. tax law could materially adversely affect the business, prospects, financial condition or results of operations of the U.K. resident companies or their ability to provide returns to shareholders. The U.K. corporation tax rate is currently 25%.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Organization for Economic Co-operation and Development (&#8220;OECD&#8221;) published its final reports on Base Erosion and Profit Shifting (&#8220;BEPS Reports&#8221;) in October 2015, containing recommendations on measures to coordinate multilateral action on international tax rules. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implementation of recommendations arising from the action points comprising BEPS has resulted in significant changes to local tax legislation and international tax treaties over recent years. For example, BEPS has resulted in jurisdictions implementing laws which (among other things): limit deductibility of interest payments; expand the scope of permanent establishments (thereby extending the scope of jurisdictions&#8217; taxing rights); counteract hybrid mismatch arrangements; and strengthen &#8220;Controlled Foreign Company&#8221; rules. U.K. domestic legislation introduced in relation to hybrid mismatches came into effect on January 1, 2017, and legislation to restrict tax deductions for interest expenses of large groups was brought into effect from April 1, 2017. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BEPS Reports included a recommendation that groups should be required to report details of their operations and intra-group transactions in each jurisdiction, known as country by country reporting (&#8220;CBCR&#8221;). The United Kingdom has implemented these recommendations with effect from January 1, 2016. It is possible that our approach to transfer pricing may become subject to greater scrutiny from the tax authorities in the jurisdictions in which we operate as a result of such reporting, which may lead to transfer pricing audits in the future. Any transfer pricing adjustment could adversely impact the tax charge suffered by the relevant entities of the Aspen Group.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, domestic law implementation of BEPS has resulted in taxpayers and/or their advisers and intermediaries being required to engage in discussions and disclose information to tax authorities regarding their tax affairs and transactions. Accordingly, Aspen Group may be required to enter into discussions with and provide information to tax authorities which may require the disclosure of transactions and operations of the Aspen Group, in addition to its obligations under the related information reporting measures (including E.U. and other mandatory disclosure regimes, such as Council Directive 2014/107/EU of 9 December 2014 and Council Directive 2018/822 EU of 25 May 2018) (commonly known as &#8220;DAC 6&#8221;) and the U.K. domestic MDR). At the end of the Brexit transition period on December 31, 2020, obligations requiring the United Kingdom to implement DAC 6 fell away and temporary legislation (effective December 31, 2020) was published, narrowing the scope of the United Kingdom&#8217;s DAC 6 regulations. On January 17, 2023, HMRC published final regulations (to replace the United Kingdom&#8217;s DAC 6) which are broadly in line with the OECD&#8217;s mandatory disclosure rules (&#8220;MDR&#8221;) and which took effect from March 28, 2023. The regulations require taxpayers and intermediaries to disclose information regarding certain types of OECD Common Reporting Standard avoidant arrangements and opaque offshore structures to HMRC. Under the MDR regime as now in effect, the Company or any of its advisors or intermediaries may be required to enter into discussions with, or make certain disclosures to, HMRC regarding its arrangements and structure.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of these changes to U.K. tax law in response to the BEPS Reports is still playing out, and it is expected that further reforms will be made in response to the proposed extensions of BEPS (i.e., BEPS: Pillar One and Two, commonly known as &#8220;BEPS 2.0&#8221;). For more information, see &#8220;&#8212;Measures taken in response to the OECD&#8217;s BEPS Reports and initiatives to limit harmful tax competition may result in higher taxation and increased complexity, burden and cost of compliance.&#8221;  BEPS and BEPS 2.0 may (depending on their final implementation) have a material adverse effect on our intra-group arrangements, our operations, and our results. Relevant to our U.K. Subsidiaries and APJ Jersey, the U.K. enacted legislation in July 2023 which implements one aspect of Pillar Two (the income inclusion rule imposing top-up tax on a parent entity in respect of the low-taxed income of a constituent entity) via a &#8220;multinational top-up tax,&#8221; together with a &#8220;domestic top-up tax.&#8221; Broadly, the multinational top-up tax and domestic top-up tax will apply to multinational groups with revenues of at least &#8364;750 million for accounting periods beginning on or after December 31, 2023.  HMRC released draft guidance in relation to these rules on June 15, 2023 which continues to be subject to review and may be amended by HMRC following consultation. Further legislation in the Finance Bill 2023-24 has been proposed in order to make certain technical amendments to the way in which the &#8220;multinational top-up tax&#8221; and &#8220;domestic top-up tax&#8221; will operate; such legislation is presently making its way through the U.K. Parliament. In addition, draft legislation has been put forward to implement an undertaxed payments rule. The U.K. Government has indicated that the U.K.&#8217;s undertaxed payments rule is expected to take effect for accounting periods beginning on or after December 31, 2024. The U.K. legislation implementing (or proposing to implement) the BEPS 2.0 reforms is complex and in particular may be affected by the implementation (or lack thereof) of similar rules in other jurisdiction in which we operate (for example, see &#8220;&#8212;Measures taken in response to the OECD&#8217;s BEPS Reports and initiatives to limit harmful tax competition may result in higher taxation and increased complexity, burden and cost of compliance&#8221;).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislation restricting the amount of U.K. profit in any particular accounting period that can be offset by historical tax losses was brought into effect from April 1, 2017. Should utilization of any tax losses be delayed or restricted as a result of this legislation, this could have a material adverse effect on our results. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.K. diverted profits tax (&#8220;DPT&#8221;) is separate from U.K. corporation tax and is currently charged at a higher rate of 31%. The DPT is an anti-avoidance measure aimed at protecting the U.K. tax base against the artificial diversion of profits that are being earned by activities carried out in the United Kingdom but which are not otherwise being taxed in the United Kingdom, in particular as a result of arrangements amongst companies in the same multinational group. The United Kingdom&#8217;s network of tax treaties does not offer protection from a DPT charge. In the event that the rules apply to certain arrangements, then upfront payment of HMRC&#8217;s estimate of the deemed tax liability may be required. If any of our U.K. or non-U.K. companies is liable for DPT as a result of intra-group arrangements, this could have a material adverse effect on our results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2023, HMRC announced a consultation regarding potential reforms to three areas of the United Kingdom&#8217;s international tax legislation (transfer pricing, permanent establishment and DPT) with a view to achieving closer alignment with international tax rules and simplification and clarification of certain aspects of these rules. Although it is not yet possible to predict whether and to what extent the consultation could impact us, any extension of the scope of the U.K.&#8217;s transfer pricing rules or broadening of the U.K.&#8217;s definition of permanent establishment could have adverse effects on our results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our U.K. and U.S. operations may be adversely affected by a transfer pricing adjustment in computing U.K. or U.S. taxable profits. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any arrangements between U.K.-resident entities of the Aspen Group and other members of the Aspen Group are subject to the U.K. transfer pricing regime. Consequently, if any agreement (including any reinsurance agreements) between a U.K.-resident entity of the Aspen Group and any other Aspen Group entity (whether that entity is resident in or outside the United Kingdom) is found not to be on arm&#8217;s length terms and as a result a U.K. tax advantage is being or has been obtained, an adjustment will be required to compute U.K. taxable profits as if such an agreement were or had been on arm&#8217;s length terms. Similar rules apply in the United States and would have a similar impact on our U.S. resident entities if transfer pricing adjustments were required. Any transfer pricing adjustment could adversely impact the tax charge suffered by the relevant U.K. or U.S. resident entities of the Aspen Group.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent and future changes in U.S. federal income tax law or the manner in which it is interpreted could materially adversely affect our results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) contains a number of tax-related provisions, including a 15% corporate alternative minimum tax imposed on certain corporations that meet an income-based test, as well as a 1% nondeductible excise tax on certain stock repurchases. It is unclear how these provisions of the IRA will be applied and what impact the IRA will have on our tax liability. We will continue to evaluate the IRA&#8217;s impact as further information becomes available. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that other legislation could be introduced and enacted by the current Congress or future Congresses of the United States, or that regulations or other interpretations could be issued, possibly with retroactive effect, that could have an adverse impact on us or our shareholders. These recent and potential future changes in law or interpretation could materially adversely affect our business, access to capital, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. persons who hold 10% or more of the total voting power or value of our ordinary shares may be subject to U.S. federal income taxation on our undistributed earnings. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, a &#8220;10% U.S. Shareholder&#8221; (as defined below) of a non-U.S. corporation that is a CFC at any time during a taxable year must include in its gross income for U.S. federal income tax purposes its pro rata share of the CFC&#8217;s &#8220;subpart F income&#8221; and &#8220;tested income&#8221; (with various adjustments) with respect to any shares that such 10% U.S. Shareholder owns in such non-U.S. corporation (directly or indirectly through certain entities) on the last day in the non-U.S. corporation&#8217;s taxable year on which it is a CFC, even if the subpart F income or tested income is not </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distributed. A &#8220;10% U.S. Shareholder&#8221; generally is a U.S. person that owns (directly, indirectly through non-U.S. entities or by attribution by application of the constructive ownership rules of section 958(b) of the Code (i.e., &#8220;constructively&#8221;)) at least 10% of the total combined voting power or value of all classes of stock of a non-U.S. corporation. &#8220;Subpart F income&#8221; of a CFC generally includes &#8220;foreign personal holding company income&#8221; (such as interest, dividends and other types of passive income), as well as insurance and reinsurance income (including underwriting and investment income), and tested income is generally any income of the CFC other than subpart F income and certain other categories of income. An entity treated as a foreign corporation for U.S. federal income tax purposes generally is considered a CFC if 10% U.S. Shareholders own (directly, indirectly through non-U.S. entities or constructively), in the aggregate, more than 50% of the total combined voting power of all classes of voting stock of that non-U.S. corporation or more than 50% of the total value of all stock of that non-U.S. corporation. However, for the purposes of taking into account insurance income, these 50% thresholds are generally reduced to 25%. Further, special rules apply for purposes of taking into account any RPII of a non-U.S. corporation, as described below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whether Aspen Holdings is a CFC for a taxable year will depend upon facts regarding our direct and indirect shareholders, about which we have limited information. Accordingly, no assurance can be provided that Aspen Holdings will not be a CFC. Further, regardless of whether Aspen Holdings is a CFC, most or all of our non-U.S. subsidiaries are generally treated as CFCs because our U.S. subsidiaries generally are treated as constructively owning the stock of our non-U.S. subsidiaries. Accordingly, any 10% U.S. Shareholders of Aspen Holdings may be required to include in gross income for U.S. federal income tax purposes for each taxable year their pro rata shares of all or a portion of the subpart F income and tested income generated by our non-U.S. companies (with various adjustments), regardless of whether any distributions are made to them. Any such 10% U.S. Shareholders should consult their own tax advisors regarding the application of these rules to them.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. persons who hold ordinary shares may be subject to U.S. federal income taxation at ordinary income rates on their proportionate share of our related person insurance income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, if a non-U.S. corporation is a &#8220;RPII CFC&#8221; (as defined below) at any time during a taxable year, a U.S. person who owns (directly or indirectly through certain entities) any shares of the non-U.S. corporation (a &#8220;U.S. RPII Shareholder&#8221;) must include in its gross income for U.S. federal income tax purposes its pro rata share of the non-U.S. corporation&#8217;s RPII with respect to any shares that such U.S. RPII Shareholder owns (directly or indirectly through certain entities) on the last day in the non-U.S. corporation&#8217;s taxable year, even if the RPII is not distributed. Further, a U.S. RPII Shareholder&#8217;s pro rata share of any RPII is determined as if all RPII for the taxable year were distributed proportionately only to U.S. RPII Shareholders on that date but generally may not exceed the U.S. RPII Shareholder&#8217;s pro rata share of the non-U.S. corporation&#8217;s earnings and profits for the taxable year. In addition, a U.S. RPII Shareholder is required to comply with certain reporting requirements, regardless of the number of shares owned by the U.S. RPII Shareholder.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these purposes, a &#8220;RPII CFC&#8221; is any non-U.S. corporation if, on any day of its taxable year, U.S. RPII Shareholders collectively own (directly, indirectly through non-U.S. entities or constructively) 25% or more of the total combined voting power of all classes of stock of such corporation entitled to vote or 25% or more of the total value of the stock of such corporation. However, the RPII rules generally do not apply with respect to a non-U.S. corporation if either (i) at all times during its taxable year less than 20% of the total combined voting power of all classes of stock of the corporation entitled to vote and less than 20% of the total value of the corporation is owned (directly or indirectly) by persons who are (directly or indirectly) insured under any policy of insurance or reinsurance issued by the corporation or who are related persons to any such person (the &#8220;ownership exception&#8221;), or (ii) the RPII (determined on a gross basis) of the corporation for the taxable year is less than 20% of its gross insurance income for the taxable year (the &#8220;de minimis exception&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that each of our non-U.S. Operating Subsidiaries and each of Peregrine and APJ Jersey is a RPII CFC. Nonetheless, we expect that each such company will qualify for one or both of the ownership exception and the de minimis exception in the current taxable year and for the foreseeable future. However, the RPII provisions have never been interpreted by the courts, and regulations interpreting the RPII provisions exist only in proposed form. Certain recently issued proposed regulations would expand the scope of RPII. It is not certain whether any of these regulations will be adopted in their proposed form or what changes or clarifications might ultimately be made </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">thereto or whether any such changes, as well as any interpretation or application of the RPII rules by the IRS, the courts, or otherwise, might have retroactive effect. The U.S. Treasury Department has authority to impose, among other things, additional reporting requirements with respect to RPII. Accordingly, the meaning of the RPII provisions and the application thereof to us is uncertain. Further, the applicability of the ownership and de minimis exceptions and the RPII rules more generally depends upon facts regarding our direct and indirect shareholders and insureds, about which we have limited information. Accordingly, no assurances can be provided that any of our companies will satisfy either exception. Moreover, to the extent the exceptions do not apply, we may be unable to correctly determine the amount of RPII that any U.S. RPII Shareholder is required to take into account.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. persons who dispose of ordinary shares may be subject to U.S. federal income taxation at the rates applicable to dividends on a portion of such disposition. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 1248 of the Code may apply to a disposition of our shares. Section 1248 provides that if a U.S. person sells or exchanges stock in a non-U.S. corporation and such person owned, directly, indirectly through certain non-U.S. entities or constructively, 10% or more of the voting power of the corporation at any time during the five-year period ending on the date of disposition when the corporation was a CFC, any gain from the sale or exchange of the shares will be treated as a dividend to the extent of the CFC&#8217;s earnings and profits (determined under U.S. federal income tax principles) during the period that the shareholder held the shares and while the corporation was a CFC (with certain adjustments). As described above, our bye-laws may reduce the voting power of our ordinary shares in certain circumstances, although it is unclear if such reduction would be respected for purposes of Section 1248 of the Code.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, Section 1248, in conjunction with the RPII rules, generally provides that if a U.S. person disposes of shares in a RPII CFC (determined without regard to the ownership or de minimis exceptions) that would be taxable as an insurance company under the Code if it were a U.S. corporation, any gain from the disposition will generally be treated as a dividend to the extent of the holder&#8217;s share of the corporation&#8217;s undistributed earnings and profits that were accumulated during the period that the holder owned the shares (whether or not such earnings and profits are attributable to RPII). In addition, such a holder will be required to comply with certain reporting requirements, regardless of the number of shares owned by the holder. These RPII rules should not apply to dispositions of our ordinary shares because Aspen Holdings will not itself be directly engaged in the insurance business. However, as discussed above, there is uncertainty in the interpretation of the RPII provisions and thus no assurances can be provided. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. persons who hold ordinary shares may be subject to adverse tax consequences if we are considered to be a passive foreign investment company. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Aspen Holdings is characterized as a PFIC, a U.S. person holding shares of Aspen Holdings generally would be subject to an increased tax liability at the time of the sale at a gain of, or receipt of an &#8220;excess distribution&#8221; with respect to, their ordinary shares. In addition, if Aspen Holdings is considered a PFIC, upon the death of any U.S. individual owning ordinary shares, such individual&#8217;s heirs or estate would not be entitled to a &#8220;step-up&#8221; in the basis of the ordinary shares that might otherwise be available under U.S. federal income tax laws. Further, a distribution paid by Aspen Holdings to U.S. shareholders that is characterized as a dividend and is not characterized as an excess distribution will not be eligible for reduced rates of tax as qualified dividend income if Aspen Holdings is considered a PFIC in the taxable year in which such dividend is paid or was a PFIC in the preceding taxable year. A U.S. shareholder may also be subject to additional information reporting requirements, including the filing of an IRS Form 8621, if Aspen Holdings is a PFIC. These rules generally will apply to a U.S. person if Aspen Holdings was a PFIC at any time during the U.S. person&#8217;s holding period with respect to our ordinary shares. Different consequences may apply if the U.S. person has elected to treat Aspen Holdings as a &#8220;qualified electing fund&#8221; or if the U.S. person is a 10% U.S. Shareholder of Aspen Holdings and Aspen Holdings is a CFC. Further, if Aspen Holdings is considered a PFIC for any taxable year and the ordinary shares are treated as &#8220;marketable stock&#8221; in such year, then a U.S. shareholder may make a mark-to-market election with respect to its ordinary shares. The ordinary shares will be marketable if they are regularly traded on certain qualifying stock exchanges, including the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. However, there can be no assurance that such election will be available. Additionally, because a mark-to-market election usually cannot be made for any lower-tier PFICs, a U.S. holder will generally continue to be subject to the special tax rules discussed above with respect its indirect interest in any non-U.S. subsidiary of Aspen Holdings </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">classified as a PFIC. As a result, it is possible that any mark-to-market election with respect to the ordinary shares will be of limited benefit. In general, if a U.S. holder of ordinary shares were to make a timely and effective mark-to-market election, such holder would include in its taxable income each year the excess, if any, of the fair market value of its ordinary shares at the end of the taxable year over its adjusted basis in such shares. Amounts included in taxable income are treated as gains on the sale of the ordinary shares and are taxed as ordinary income. Any gain recognized by such holder on the sale or other disposition of ordinary shares would be ordinary income, and any loss would be an ordinary loss to the extent of the net amount of previously included income as a result of the mark-to-market election and, thereafter, a capital loss. U.S. investors are urged to consult with their tax advisors regarding the availability and consequences of making a mark-to-market election with respect to our ordinary shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, a non-U.S. corporation will be a PFIC during a given year if (i) 75% or more of its gross income constitutes &#8220;passive income&#8221; (the &#8220;75% test&#8221;) or (ii) 50% or more of its assets produce (or are held for the production of) passive income (the &#8220;50% test&#8221;). For these purposes, passive income generally includes interest, dividends, annuities and other investment income. However, the PFIC provisions contain a look-through rule under which a non-U.S. corporation that directly or indirectly owns at least 25% of the value of the stock of another corporation generally is treated, for purposes of determining whether it is a PFIC, as if it received directly its proportionate share of the income, and held its proportionate share of the assets, of the other corporation (the &#8220;look-through rule&#8221;). As a result, it is expected that the PFIC status of Aspen Holdings should generally depend on the application of the look-through rule to its subsidiaries and whether the income and assets of its subsidiaries will be characterized as passive or active for this purpose. In addition, pursuant to an insurance exception, (a) passive income does not include income that a qualifying insurance corporation (&#8220;QIC&#8221;) derives in the active conduct of an insurance business or income of a qualifying domestic insurance corporation (&#8220;QDIC&#8221;) (generally, a U.S. corporation with respect to which the look-through rule applies that is taxable as an insurance company and is subject to U.S. federal income tax on its net income), and (b) passive assets do not include assets of a QIC available to satisfy liabilities of the QIC related to its insurance business, if the QIC is engaged in the active conduct of an insurance business, or assets of a QDIC. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, a non-U.S. corporation will be a QIC for a taxable year if it would be taxable as an insurance company if it were a U.S. corporation and its applicable insurance liabilities constitute more than 25% of its total assets for a taxable year. Further, under recently proposed regulations (the &#8220;2021 Proposed Regulations&#8221;), a QIC is engaged in the &#8220;active conduct&#8221; of an insurance business only if it satisfies either a &#8220;factual requirements test&#8221; or an &#8220;active conduct percentage test.&#8221; The factual requirements test requires that the officers and employees of the QIC carry out substantial managerial and operational activities on a regular and continuous basis with respect to its core functions (generally its underwriting activities, investment activities, contract and claims management activities and sales activities) and that they perform virtually all of the active decision-making functions relevant to underwriting functions. The active conduct percentage test generally requires that (i) the total costs incurred by the QIC with respect to its officers and employees for services rendered with respect to its core functions (other than investment activities) equal or exceed 50% of the total costs incurred by the QIC with respect to its officers and employees and any other person or entities for services rendered with respect to its core functions (other than investment activities) and (ii) to the extent the QIC outsources any part of its core functions to unrelated entities, officers and employees of the QIC with experience and relevant expertise must select and supervise the person that performs the outsourced functions, establish objectives for performance of the outsourced functions and prescribe rigorous guidelines relating to the outsourced functions which are routinely evaluated and updated. Under certain exceptions, however, a QIC that has no or only a nominal number of employees or that is a vehicle that has the effect of securitizing or collateralizing insurance risks underwritten by other insurance or reinsurance companies or is an insurance linked securities fund that invests in securitization vehicles generally is deemed not engaged in the active conduct of an insurance business. The officers and employees of certain related entities generally may be taken into account for these purposes, provided that the QIC exercises regular oversight and supervision over the services performed by the related entity&#8217;s officers and employees. The 2021 Proposed Regulations will not be effective unless and until adopted in final form, but taxpayers may rely on them for taxable years beginning after December 31, 2017 if they are consistently followed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, based on the implementation of our current business plan and the application of the insurance exception, our non-U.S. insurance subsidiaries should be considered QICs engaged in the active conduct of an </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance business under one or both of the &#8220;factual requirements test&#8221; or the &#8220;active conduct percentage test,&#8221; our U.S. insurance subsidiaries should be considered QDICs and none of the income or assets of such insurance subsidiaries should be treated as passive. In addition, the income and assets attributable to our non-U.S. subsidiaries that are not insurance subsidiaries are minimal, relative to the income and assets attributable to our other subsidiaries. As a result, based on the application of the look-through rule, we believe that Aspen Holdings should not be characterized as a PFIC for the current year or the foreseeable future. However, because of legal uncertainties with respect to the interpretation of the PFIC rules and whether the 2021 Proposed Regulations will be adopted as final regulations in their current form, and factual uncertainties with respect to our planned operations, there is a risk that Aspen Holdings will be characterized as a PFIC in one or more years. If Aspen Holdings is considered a PFIC, it could have material adverse tax consequences for an investor that is subject to U.S. federal income taxation. Prospective investors should consult their tax advisors as to the effects of the PFIC rules on an investment in our ordinary shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. tax-exempt organizations who own ordinary shares may recognize unrelated business taxable income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A U.S. tax-exempt organization generally will recognize unrelated business taxable income if the organization is required to include in gross income any of our insurance income under the CFC rules described above (including the RPII provisions). U.S. tax-exempt organizations are advised to consult their own tax advisors regarding the applicability of these rules to their ownership of ordinary shares. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of Bermuda&#8217;s letter of commitment to the OECD to eliminate harmful tax practices is uncertain and could adversely affect our tax status in Bermuda.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The OECD has published reports and launched a global dialogue among member and non-member countries on measures to limit harmful tax competition. These measures are largely directed at counteracting the effects of tax havens and preferential tax regimes in countries around the world. In the OECD&#8217;s progress report dated April 2, 2009, Bermuda was designated as an OECD &#8220;White List&#8221; jurisdiction that has substantially implemented the internationally agreed tax standards. The standards for the OECD compliance are to have at least 12 signed Tax Information Exchange Agreements (&#8220;TIEAs&#8221;) with other OECD members or non-OECD members. Bermuda has signed approximately 41 TIEAs, which exceeds the requisite amount and demonstrates Bermuda&#8217;s commitment to preserve the standards. In April 2016, Bermuda agreed to participate in the Tax Sharing requirements for CBCR. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the European Union initiated similar measures and identified certain jurisdictions, including Bermuda, which it considered had tax systems that facilitated offshore structuring by attracting profits without commensurate economic activity. The European Union did temporarily add Bermuda to its &#8220;blacklist&#8221; of non-cooperative jurisdictions for tax purposes from March 2019 until May 2019, when Bermuda adopted economic substance legislation that the European Union deemed compliant with its requirements. The European Union also temporarily added Bermuda to its &#8220;greylist&#8221; from February 2022 until October 2022. The &#8220;greylist&#8221; is a list of jurisdictions that have made sufficient commitments to reform their tax policies but remain subject to close monitoring while they are executing on their commitments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda remains committed to tax transparency, which is evidenced by adopting economic substance legislation, which has been deemed compliant by the European Union and was designed to implement the work of the Forum on Harmful Tax Practices under Action 5 of the OECD's BEPS Reports. Any changes in the tax law of an OECD member state or in response to a change in E.U. policies could subject us to additional taxes, and we are unable to predict at this time whether it would have a material adverse impact on our operations and results.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measures taken in response to the OECD&#8217;s BEPS Reports and initiatives to limit harmful tax competition may result in higher taxation and increased complexity, burden and cost of compliance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2016, the E.U.&#8217;s ministers of Finance and Economic Affairs unanimously approved the Anti-Tax Avoidance Directive to harmonize potential BEPS changes in the European Union. These measures are largely directed at counteracting the effects of tax havens and preferential tax regimes in countries around the world. We expect that countries may change their tax laws in response to this project, and several countries have already changed or proposed changes to their tax laws. Council Directive (EU) 2017/952 of 29 May 2017 amending Council Directive (EU) 2016/1164 (commonly known as &#8220;ATAD II&#8221;) was introduced (with effect from January 1, 2022) to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prevent hybrid mismatches giving rise to a double deduction or to a deduction without taxation in different tax jurisdictions. In certain cases, taxpayers may be denied the right to recognize tax deductible costs on payments subject to a double deduction. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2021, the European Union published the draft Anti-Tax Avoidance Directive III (&#8220;ATAD III&#8221;) designed to impose new minimum substance rules to prevent the misuse of shell entities for improper tax purposes. ATAD III proposes to introduce reporting requirements for certain E.U. tax resident companies with mobile and/or passive income (such as interest, dividends and royalty income) in order to determine whether they have inadequate economic substance (as prescribed under ATAD III). If an entity fails to meet these substance requirements, it will be denied benefits under tax treaties and various E.U. directives. The European Parliament approved the European Commission&#8217;s draft directive on ATAD III, which now requires the unanimous approval of the Council of the European Union before being implemented by member states of the European Union. Until the draft directive receives approval and a final directive is published, it is not possible to provide definitive guidance on the impact of the proposal on our tax position (if any).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the OECD is continuing to work on a two-pillar initiative, &#8220;BEPS 2.0,&#8221; which is aimed at (1) shifting taxing rights to the jurisdiction of the consumer (&#8220;Pillar One&#8221;) and (2) ensuring all companies pay a global minimum tax (&#8220;Pillar Two&#8221;). Pillar One will, broadly, re-allocate taxing rights over 25% of the residual profits of multinational enterprises (&#8220;MNEs&#8221;) with global turnover in excess of 20 billion euros to the jurisdictions where the customers and users of those MNEs are located. The text of the Multilateral Convention (&#8220;MLC&#8221;) to implement &#8220;Amount A&#8221; of Pillar One released by the OECD on October 11, 2023 contains an exclusion for &#8220;regulated financial institutions,&#8221; which relevantly includes &#8220;insurance institutions&#8221; (i.e. entities which are licensed to carry on insurance or reinsurance business). It is currently unclear whether the text of the MLC released by the OECD represents the final version which will be ultimately adopted and ratified by jurisdictions relevant to us; it is further unclear as to how these relevant jurisdictions will implement the text of the MLC into domestic legislation and approach interpretation of these rules. Pillar Two will, broadly, consist of two interlocking domestic rules (together the Global anti-Base Erosion Rules (the &#8220;GloBE Rules&#8221;)): (i) an Income Inclusion Rule (&#8220;IIR&#8221;), which imposes top-up tax on a parent entity in respect of the low-taxed income of a constituent entity; and (ii) an Undertaxed Payment Rule, which denies deductions or requires an equivalent adjustment to the extent the low-taxed income of a constituent entity is not subject to tax under an IIR. There will also be a treaty-based Subject To Tax Rule that allows source jurisdictions to impose limited source taxation on certain related party payments subject to tax below a minimum rate.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For countries other than the United States, the OECD recommended model GloBE Rules for Pillar Two in late 2021. The OECD also released further guidance on the model GloBE Rules during 2022 and has continued to release guidance on a rolling basis throughout 2023. This includes the release in early February 2023 of further technical guidance which comments in particular on the interaction between the model GloBE Rules and current U.S. tax law and the release in July 2023 of agreed administrative guidance which contains details of how to calculate tax for the purposes of Pillar Two. The OECD has previously indicated that the Two-Pillar Solution will not come into force until 2024 at the earliest. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relevant to our U.K. Subsidiaries and APJ Jersey, as both are U.K. tax resident entities, the U.K. enacted legislation in July 2023 which implements the IIR via a &#8220;multinational top-up tax&#8221; (alongside a U.K. domestic top-up tax). The U.K.&#8217;s multinational top-up tax will apply to multinational enterprises for accounting periods beginning on or after December 31, 2023. For further information, see &#8220;&#8212;Our U.K. operations may be affected by recent changes in U.K. tax law.&#8221; </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, in the European Union the Council Directive (EU) 2022/2523, adopted on December 15, 2022, requires that E.U. Member States implement the Pillar Two rules into domestic law by December 31, 2023. The Bermuda Government has responded to the Pillar Two initiative by recently passing legislation to introduce a corporate income tax on certain Bermuda entities with effect from January 1, 2025. For more information, see &#8220;&#8212;Changes to Bermuda tax policies may impact our financial position.&#8221;  The implications of this proposal for our business remain uncertain, both at a domestic level in Bermuda and in terms of how any such Bermuda corporate income tax regime (once it comes into effect) might interact with the U.K.&#8217;s multinational top-up tax and undertaxed payments rule or other Pillar Two implementing legislation in relevant jurisdictions in which we operate. The </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda corporate income tax legislation will be effective for tax years beginning on or after January 1, 2025, which means that there is (on current proposed timings) a period of at least one year in which the U.K. multinational top-up tax is expected to apply to our group before any changes are effected in Bermuda. Based on the final Bermuda legislation, it is also not certain that any new Bermuda corporate income tax regime (once it comes into effect) would interact appropriately with U.K. or other Pillar Two legislation which may be applicable to the Aspen Group. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing, scope and implementation of these provisions into domestic law in the United Kingdom, Bermuda and other countries in which we operate remains subject to significant uncertainty. Depending on how the relevant jurisdictions implement the model GloBE Rules or such rules are clarified by additional commentary or guidance in the future, they may result in additional tax being payable by the Aspen Group. Changes to tax laws and additional reporting requirements could increase the complexity, burden and cost of doing business with our Bermuda companies and/or subject our Bermuda companies to increased tax and compliance burdens.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to Bermuda tax policies may impact our financial position.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current Bermuda law, we are not subject to tax on income, profits, withholding, capital gains or capital transfers. Furthermore, we obtained from the Minister of Finance of Bermuda under the Exempted Undertakings Tax Protection Act 1966 (as amended) (the &#8220;EUTP Act&#8221;) an assurance that, in the event Bermuda enacts legislation imposing tax computed on profits, income, any capital asset, gain or appreciation, or any tax in the nature of estate duty or inheritance tax, then the imposition of the tax will not be applicable to us or our operations or to our ordinary shares, debentures or other obligations except insofar as such tax applies to persons ordinarily resident in Bermuda or to any taxes payable by us in respect of real property owned or leased by us in Bermuda until March 31, 2035. As a result of changes made to the EUTP Act by the CIT Act (as defined below), this assurance has been made subject to the application of any taxes pursuant to the CIT Act, as described further below. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the 2023 Budget, the Bermuda government announced the formation of an International Tax Working Group consisting of specialists in international tax matters and representatives of various bodies whose members may be directly impacted by such to examine how Bermuda can appropriately implement the Global Minimum Tax initiative. The Working Group reported its findings and provided recommendations to the Bermuda Government in July 2023. The Bermuda Government subsequently issued three public consultation papers as part of its considerations on the introduction of a corporate income tax in Bermuda, on August 8, 2023, October 5, 2023 and November 10, 2023. On December 15, 2023, the Bermuda House of Assembly passed the Corporate Income Tax Act, 2023 (the &#8220;CIT Act&#8221;) which was also passed by the Senate on December 18, 2023 and will become fully operative with respect to the imposition of corporate income tax on January 1, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under the CIT Act, Bermuda corporate income tax will be chargeable in respect of fiscal years beginning on or after January 1, 2025 and will apply only to Bermuda entities that are part of MNE groups with EUR 750 million or more in annual revenues in at least two of the four fiscal years immediately preceding the fiscal year in question (&#8220;Bermuda Constituent Entity Group&#8221;). Where corporate income tax is chargeable to a Bermuda Constituent Entity Group, the amount of corporate income tax chargeable for a fiscal year shall be (1) 15% of the net taxable income of the Bermuda Constituent Entity Group less (2) tax credits applicable to the Bermuda Constituent Entity Group under Part 4 of the CIT Act, or as prescribed. The CIT Act introduces certain &#8220;qualified refundable tax credits&#8221; which are set to be developed during 2024 to incentivize </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies to support Bermuda residents through investments in key areas such as education, healthcare, housing, and other projects to help develop Bermuda&#8217;s workforce. Bermuda will continue to monitor further developments around the world as other jurisdictions address the OECD&#8217;s standards.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The imposition of a Bermuda corporate income tax could, if applicable to the Company (or any Bermuda incorporated subsidiary of the Company), have a material adverse effect on the Company&#8217;s financial condition and results of operations.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_78"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF PROCEEDS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to receive total estimated net proceeds of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million if the underwriters exercise their option to purchase additional ordinary shares in full, based on an assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  per share, the midpoint of the price range set forth on the cover page of this prospectus, and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us. We will not receive any proceeds from the sale of ordinary shares by the selling shareholders (including any proceeds from any sale of ordinary shares pursuant to the underwriters&#8217; option to purchase additional ordinary shares from the selling shareholders). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1.00 increase (decrease) in the public offering price per ordinary share would increase (decrease) our net proceeds by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million, assuming the number of ordinary shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discount and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1,000,000 ordinary shares offered by us would increase (decrease) the net proceeds to us from this offering by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share remains the same, and after deducting the estimated underwriting discount and estimated offering expenses payable by us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal purposes of this offering of ordinary shares by us are expected to be to increase our financial flexibility, create a public market for our ordinary shares, enhance our capitalization and facilitate our future access to the capital markets. We currently intend to use the net proceeds we receive from this offering for general corporate purposes, which may include working capital, operating expenses and capital expenditures, as well as to support our Operating Subsidiaries to enable us to continue to take advantage of ongoing favorable market conditions, in line with our corporate strategy. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this prospectus, this expected use of net proceeds from this offering represents our intentions based on our current plans and business conditions, which could change in the future as our plans and business conditions evolve. As a result, our management will have broad discretion over the uses of the net proceeds from this offering and investors will be relying on the judgment of our management regarding the application of the net proceeds from this offering.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_84"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIVIDEND POLICY</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration, amount and payment of any dividends on our ordinary shares will be at the sole discretion of the Board, which may take into account general and economic conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions and implications on the payment of dividends by us to our shareholders or by our subsidiaries to us, including restrictions under any of our then outstanding indebtedness, the terms of our Preference Shares (as defined below) and such other factors as the Board may deem relevant. If we elect to pay dividends in the future, we may reduce or discontinue entirely the payment of such dividends at any time. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Board&#8217;s discretion, we declare and pay quarterly dividends on our Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares (&#8220;AHL PRC Shares&#8221;), our 5.625% Perpetual Non-Cumulative Preference Shares (&#8220;AHL PRD Shares&#8221;) and our 5.625% Perpetual Non-Cumulative Preference Shares (&#8220;AHL PRE Shares&#8221; and, together with our AHL PRC Shares and our AHL PRD Shares, the &#8220;Preference Shares&#8221;), which are represented by depositary shares, each representing a 1/1000th interest in an AHL PRE Share (&#8220;Depositary Shares&#8221;). Such Preference Shares rank senior to our ordinary shares with respect to the payment of dividends and distributions of assets upon our liquidation, dissolution or winding-up. During the twelve months ended December 31, 2022, we paid aggregate dividends of $16.4 million, $14.1 million and $14.1 million on our AHL PRC Shares, AHL PRD Shares and AHL PRE Shares, respectively. During the six months ended June 30, 2023, we paid aggregate dividends of $8.2 million, $7.0 million and $7.0 million on our AHL PRC Shares, AHL PRD Shares and AHL PRE Shares, respectively. The terms of our Preference Shares contain restrictions on our ability to pay dividends to holders of our ordinary shares. For a more detailed description of our Preference Shares, see &#8220;Description of Share Capital&#8212;Outstanding Series of Preference Shares.&#8221; </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the twelve months ended December 31, 2022 and six months ended June 30, 2023, we paid aggregate dividends of  $40.0 million and $20.0 million, respectively, on our ordinary shares to Highlands Bermuda Holdco, Ltd., the holder of all of our ordinary shares prior to this offering. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Holdings is a holding company and, as such, it does not have any significant operations. Aspen Holdings&#8217; assets primarily consist of ownership of the shares of its subsidiaries, including our Operating Subsidiaries, a portfolio of fixed income securities and cash and cash equivalents. As a result, we may not be able to pay any dividends to the holders of our ordinary shares unless our Operating Subsidiaries make distributions in an amount sufficient to cover the dividend that may be declared by us. Our Operating Subsidiaries are subject to capital, regulatory and other requirements that inform their ability to declare and pay dividends and make loans to other Aspen Group companies, which may limit their ability to declare and pay dividends to us. Refer to &#8220;Certain Regulatory Considerations&#8212;Bermuda Insurance Regulation&#8212;Restrictions on Dividends, Distributions and Reduction of Capital,&#8221; &#8220;Certain Regulatory Considerations&#8212;U.K. and E.U. Insurance Regulation&#8212;Restriction on Dividend Payments by Insurers,&#8221; and &#8220;Certain Regulatory Considerations&#8212;U.S. Insurance Regulation&#8212;State Dividend Limitations&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8221; for more information on our ability to pay dividends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we are subject to Bermuda regulatory constraints that affect our ability to pay dividends and make other distributions on our ordinary shares or other securities. Under the Companies Act, we may declare or pay a dividend only if we have reasonable grounds to believe that we are, and would after the payment be, able to meet our liabilities as they become due and if the realizable value of our assets would thereby not be less than our liabilities. Additionally, as the BMA is the group supervisor for the Aspen Group for insurance group solvency and reporting requirements, we may not be able to declare or pay a dividend if we are or, after giving effect to such payment, would be in breach of applicable group solvency and liquidity requirements or our target level of capital above the applicable group enhanced capital requirements (&#8220;ECR&#8221;) or such other applicable rules, regulations or restrictions as may from time to time be issued or imposed by the BMA (or any successor agency or other then applicable regulatory authority) pursuant to the terms of the Bermuda Insurance Act 1978, as amended (the &#8220;Insurance Act&#8221;) or any successor legislation or other then applicable law or regulation. For more information regarding risk factors that could materially and adversely affect us and our ability to pay dividends on our ordinary shares, please see &#8220;Risk Factors.&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_90"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAPITALIZATION</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our cash and cash equivalents and consolidated capitalization as of June 30, 2023: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on an actual basis; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on an as-adjusted basis to give effect to our issuance and sale of our ordinary shares in this offering at an assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share, the midpoint of the price range set forth on the cover page of this prospectus, and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us. We will not receive any proceeds from the sale of our ordinary shares by the selling shareholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read the following table in conjunction with the sections entitled &#8220;Summary Financial and Operating Data,&#8221; &#8220;Use of Proceeds&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; as well as our consolidated financial statements and accompanying notes included elsewhere in this prospectus.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actual</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Adjusted</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except for share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term and Short-term Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.650% Senior Notes due 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-term and Short-term Debt Obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,395,839 ordinary shares of par value $0.01 issued and outstanding, and 70,000,000 ordinary shares authorized, actual;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares of par value $0.01 issued and outstanding and 70,000,000 ordinary shares authorized, as adjusted</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference Shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000,000 Fixed-to-Floating Rate Preference Shares of par value 0.15144558&#162; per share (liquidation preference $25 each)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000 5.625% Preference Shares of par value 0.15144558&#162; per share (liquidation preference $25 per share)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 5.625% Preference Shares of par value 0.15144558&#162; per share (liquidation preference $25,000 per share)(represented by depositary shares, each with a liquidation preference of $25 per share)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid-in Capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shareholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Capitalization</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,848.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Does not reflect letters of credit outstanding under our letter of credit facilities and revolving credit facility. For a discussion of the letter of credit facilities, revolving credit facility and our $300.0 million 4.65% Senior Notes due November 15, 2023 (the &#8220;2023 Senior Notes&#8221;) we have entered into or issued, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation&#8212;Liquidity and Capital Resources&#8221; and &#8220;Note 23&#8212;Credit Facilities and Short-term Debt&#8221; to our audited consolidated financial statements included elsewhere in this prospectus.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of June 30, 2023, we had undrawn commitments available for borrowings under our revolving credit facility of up to $300.0 million (after giving effect to $0 of outstanding letters of credit under such facility). We have the option to increase the aggregate amount of the revolving credit facility by up to $100.0 million, subject to certain conditions.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">On July 26, 2023, the Company entered into a $300.0 million term loan facility at a borrowing rate of term SOFR plus an applicable margin pursuant to a term loan credit agreement among the Company, the several lenders from time to time party thereto, HSBC Bank Bermuda Limited, as structuring agent, Lloyds Bank Plc, as syndication agent, and Citibank, N.A., as administrative agent (the &#8220;Term Loan Credit Agreement&#8221;).  On November 9, 2023, the Company drew down $300.0 million on the term loan due November 9, 2026 (the &#8220;2026 Term Loan&#8221;) and the proceeds were used to redeem the 2023 Senior Notes.  Subject to applicable law, the 2026 Term Loan will be the senior unsecured obligations of Aspen Holdings and will rank equally in right of payment with all of our other senior unsecured indebtedness from time to time outstanding.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above does not include up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares issuable by us upon the underwriters&#8217; exercise in full of their option to purchase additional ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A $1.00 increase (decrease) in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per ordinary share, the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) each of our as adjusted cash and cash equivalents, additional paid-in capital, total shareholders&#8217; equity and total capitalization by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million, assuming the number of ordinary shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us. Similarly, each increase (decrease) of 1,000,000 shares offered by us would increase (decrease) each of our as adjusted cash and cash equivalents, additional paid-in capital, total shareholders&#8217; equity and total capitalization by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million, assuming the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  per ordinary share remains the same, and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_96"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DILUTION</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you invest in our ordinary shares in this offering, your ownership interest will be immediately diluted to the extent of the difference between the initial public offering price per ordinary share and the as adjusted net tangible book value per ordinary share after this offering. As of June 30, 2023, we had a total net tangible book value of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, corresponding to a net tangible book value of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share. Net tangible book value represents the amount of our total assets less our total liabilities, excluding goodwill and other intangible assets. Net tangible book value per ordinary share represents net tangible book value attributable to ordinary shares divided by&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, the total number of our ordinary shares outstanding at June 30, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After giving further effect to the sale by us of the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares offered by us in this offering, and assuming an offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share (the midpoint of the price range set forth on the cover page of this prospectus), after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us, our total as adjusted net tangible book value estimated at June 30, 2023 would have been $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, representing $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share. This represents an immediate increase in net tangible book value of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share to existing shareholders and an immediate dilution in net tangible book value of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share to new investors purchasing ordinary shares in this offering. Dilution for this purpose represents the difference between the price per ordinary share paid by these purchasers and net tangible book value per ordinary share immediately after the completion of this offering. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates this dilution to new investors purchasing ordinary shares in this offering. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed initial public offering price per ordinary share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tangible book value per ordinary share as of June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in net tangible book value per ordinary share attributable to new investors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As adjusted net tangible book value per ordinary share after this offering</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilution per ordinary share to new investors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilution information discussed above is illustrative only and may change based on the actual initial public offering price and other terms of this offering. A $1.00 increase (decrease) in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share, the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) our as adjusted net tangible book value per ordinary share after this offering by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share and increase (decrease) the immediate dilution to new investors by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share, in each case assuming the number of ordinary shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us. Similarly, each increase of 1,000,000 shares in the number of ordinary shares offered by us would increase our as adjusted net tangible book value by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share and decrease the dilution to new investors by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share, and each decrease of 1,000,000 shares in the number of ordinary shares offered by us would increase our as adjusted net tangible book value by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share and decrease the dilution to new investors by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, in each case assuming the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share remains the same and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the underwriters exercise their option to purchase an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares from us in full, the as adjusted net tangible book value per share after the offering would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share, the increase in as adjusted net tangible book value attributable to ordinary shares would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million and the dilution to investors purchasing ordinary shares in this offering would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share, in each case at an initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share (the midpoint of the price range set forth on the cover page of this prospectus).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, as of June 30, 2023, on an adjusted basis as described above, the number of our ordinary shares, the total consideration and the average price per share (1) paid to us by existing shareholders and (2) to be paid by new investors acquiring our ordinary shares in this offering at an assumed initial public </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, the midpoint of the price range set forth on the cover page of this prospectus, before deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing shareholders</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New investors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1.00 increase (decrease) in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share, the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the total consideration paid by new investors and total consideration paid by all shareholders by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming that the number of ordinary shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us. Similarly, each increase (decrease) of 1,000,000 shares in the number of ordinary shares offered by us would increase (decrease) the total consideration paid by new investors and total consideration paid by all shareholders by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ordinary share remains the same and after deducting the estimated underwriting discount and estimated expenses of this offering that are payable by us.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_102"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus contains forward-looking statements that are intended to enhance the reader&#8217;s ability to assess our future financial and business performance. These statements are based on the beliefs and assumptions of our management, and are subject to known and unknown risks and uncertainties. Generally, statements that are not about historical facts, including statements concerning our possible or assumed future actions or results of operations, are forward-looking statements. In particular, statements that use the words such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;assume,&#8221; &#8220;objective,&#8221; &#8220;target,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;aim,&#8221; &#8220;likely,&#8221; &#8220;continue,&#8221; &#8220;intend,&#8221; &#8220;guidance,&#8221; &#8220;outlook,&#8221; &#8220;trends,&#8221; &#8220;future,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;on track&#8221; or their negatives or variations and similar terminology and words of similar import generally involve forward-looking statements. These statements reflect our current views with respect to future events and because our business is subject to numerous risks, uncertainties and other factors, our actual results could differ materially from those anticipated in the forward-looking statements. We believe that these factors include, but are not limited to, the following:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the occurrence of natural disasters and other catastrophic events;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">global climate change;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">war, terrorism and political unrest, government action that is hostile to commercial interests and from sovereign, sub-sovereign and corporate defaults;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">emerging claim and coverage issues in our business and social inflation;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cyclical changes in the insurance and reinsurance industries;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reinsurers may not reimburse us for claims on a timely basis, or at all;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the reliance on third parties for the assessment and pricing of individual risks;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of any risk management and loss limitation methods we employ;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the reinsurance that we purchase may not always be available on favorable terms or we may choose to retain a higher proportion of particular risks compared to previous years;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual claims exceeding our loss reserves;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic inflation;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in the frequency and severity of cyber-attacks on our policyholders; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interest rate risk, credit risk, real estate related risks, market risk, servicing risk, loss from catastrophic events and other risks;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse developments affecting the financial services industry and the potential contagion impact to, and resulting stress on, the financial services sector generally;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failing to realize profits from or losing some or all of the principal amount of our invested assets if we are required to sell our invested assets at a loss to meet our insurance, reinsurance or other obligations;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility and uncertainty in general economic conditions and in financial and mortgage markets;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the determination of the amount of allowances and impairments taken on our investments;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">currency fluctuations that we may not be effective at mitigating;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of policyholders, brokers or other intermediaries or reinsurers to honor their payment obligations;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition and consolidation in the (re)insurance industry;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decline in any of the ratings of our Operating Subsidiaries could adversely affect our standing among brokers and customers and cause our premiums and earnings to decrease;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing scrutiny and evolving expectations from investors, customers, regulators, policymakers and other stakeholders regarding environmental, social and governance matters;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future acquisitions, growth of our operations through the addition of new lines of (re)insurance business, expansion into new geographic regions and/or joint ventures or partnerships;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss of business provided by brokers that account for a large portion of our insurance and reinsurance revenues;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our management of alternative reinsurance platforms on behalf of investors in any entities ACM manages or could manage in the future;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to obtain additional capital or to only obtain capital on unfavorable terms;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our debt, credit and ISDA agreements may limit our financial and operational flexibility;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political, regulatory, governmental and industry initiatives;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulations that adversely affect the U.S. mortgage insurance and reinsurance market;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the United Kingdom&#8217;s withdrawal from the European Union;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in Bermuda law and regulations, and the political environment in Bermuda;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in current accounting practices and future pronouncements;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our internal controls over financial reporting have gaps or other deficiencies;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss of one or more of our senior underwriters or other members of our senior management team or an inability to attract and retain senior staff;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party outsourced service providers failing to satisfactorily perform certain technology and business process functions;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general employee and third-party litigation risks;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">management turnover;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss of our foreign private issuer or &#8220;controlled company&#8221; status;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the execution of internal processes to maintain our operations and the operational risks that are inherent to our business, including those resulting from fraud or employee errors or omissions;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure in our data security and/or technology systems or infrastructure or those of third parties, including those caused by security breaches or cyber-attacks;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with ever evolving national, federal, state, and international laws relating to the handling of information;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual results differing materially from model outputs and related analyses;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the influence that our controlling shareholder will continue to have over us;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our holding company structure and certain regulatory and other constraints may limit our ability to pay dividends;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">ontents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. persons who own our securities may have more difficulty in protecting their interests than U.S. persons who are shareholders of a U.S. corporation;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government regulations or tax laws in jurisdictions where we conduct business; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other risk factors discussed in this prospectus under &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_297">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements included in this prospectus are expressly qualified in their entirety by these cautionary statements. The foregoing list should not be construed as exhaustive and should be read in conjunction with other information included in this prospectus. We do not intend, and do not undertake, any obligation to update any forward-looking statements to reflect future events or circumstances after the date of this prospectus. You should review carefully the section captioned &#8220;Risk Factors&#8221; in this prospectus for a more complete discussion of risks and uncertainties before making a decision to invest in our ordinary shares.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_120"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_1948"></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read together with the section entitled &#8220;Summary Financial and Operating Data&#8221; and the consolidated financial statements and related notes that appear elsewhere in this prospectus. In addition to historical financial information, this prospectus contains &#8220;forward-looking statements.&#8221; You should review the &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; and &#8220;Risk Factors&#8221; sections of this prospectus for factors and uncertainties that may cause our actual future results to be materially different from those in our forward-looking statements. Forward-looking statements in this prospectus are based on information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading specialty (re)insurer focused on total value creation for all of our stakeholders. With $4,339 million of gross written premiums in 2022, we are a scaled multinational business with a diverse product mix balanced across our primary specialty insurance and opportunistic reinsurance franchises, which are both supported by our fee generating capital markets capabilities. We go to market with a single view of risk through our &#8216;One Aspen' approach, which is designed to cater to complex, bespoke solutions that bring together our expertise spanning different lines of business, segments and platforms, enabling us to develop enhanced and differentiated offerings for our distribution partners and customers. We are focused on underwriting excellence and profitable growth to consistently deliver top quartile results, targeting mid-teen annualized operating return on equity across market cycles. This is demonstrated by our combined ratio of 83.8%, annualized return on average equity adjusted for Preference Share dividends of 22.9% and Op. ROE of 22.2% for the six months ended June 30, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary specialty insurance product set is centered around niche &#8220;specialty&#8221; lines, such as professional liability, credit and political risk, cyber and environmental, where we can apply our extensive underwriting and industry expertise. Our opportunistic reinsurance business is centered around both specialty and traditional reinsurance lines where we apply risk selection criteria to create unique risk profiles rather than an index of the market as other larger peers may do. Our size presents a distinct advantage, providing us with enough scale to be relevant while still maintaining the ability to be nimble and decisive, which enables us to enter, exit or change the nature of our underwriting positions faster and with greater precision.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our &#8216;One Aspen&#8217; approach, we actively manage our insurance and reinsurance portfolios across market cycles and identify the most attractive risk versus return opportunities to allocate capital. We adopt a dynamic capital allocation approach, utilizing our strong balance sheet and our multiple platforms across the United States, the United Kingdom, Lloyd&#8217;s and Bermuda to match risk with the most appropriate source of capital, and to drive efficiencies and optimal outcomes for our customers. Our ability to offer our broker and client partners holistic and customized solutions across our entire platform provides us the opportunity to execute larger, more complex deals which frequently result in more attractive terms and conditions. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Business Initiatives</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of 2022 and 2023, we continued to implement a number of strategic initiatives including: strengthening our consolidated balance sheet through a significant loss portfolio transfer transaction; expanding our scale of business written via our Lloyd&#8217;s syndicate; and other simplifications of our business model.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LPT Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2022, the Company entered into the LPT. The LPT resulted in Enstar assuming net loss reserves of $3,120.0 million, for losses with dates of loss on or prior to December 31, 2019, subject to a limit of $3,570.0 million. The existing ADC between the parties that closed in June 2020 was absorbed into the LPT. The LPT transaction closed on May 20, 2022, following receipt of regulatory approvals and satisfaction of various other closing conditions.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LPT transaction has positively impacted the Aspen Group&#8217;s overall capital position and enabled the deployment of capital into the continued attractive market environment, while significantly improving the protection of its balance sheet and future earnings from the potential impact of the reserve volatility on 2019 and prior accident years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, we estimate that we have approximately $420 million of remaining limit, net of foreign exchange, available under the terms of the LPT.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Increased Lloyd&#8217;s Capacity</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following a successful business planning process with Lloyd&#8217;s, Aspen received approval to significantly grow its Lloyd&#8217;s capacity to &#163;1,115.0 million for the 2023 year of account. In 2022, the Company expanded the scale of business written via its Lloyd&#8217;s syndicate, including a significant book of reinsurance that was previously written by Aspen UK, which was in line with our strategy to simplify our operations and more strategically align our platforms. This increased the relevance and scale in the important Lloyd&#8217;s market. Growing our presence in Lloyd&#8217;s is a critical part of our overall balance sheet simplification strategy. It also allows us to better utilize the advantages of the Lloyd&#8217;s platform, both for capital efficiencies and ease of access. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Leadership, Talent and Culture</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to strive to establish a culture at Aspen that attracts and retains the very best talent. Of critical importance is that we continue to build a diverse and inclusive environment that encourages and empowers our people, while also taking steps to consider how we can best manage our impact on the environment and positively affect the communities we serve.  In 2022, work continued to build a more diverse, equitable and inclusive business. We established employee-led gender and ethnicity communities across the United Kingdom, the United States and Bermuda. We started collecting ethnicity data for our employees to better understand our workforce and build a more inclusive working environment. In 2023, we published our second Environmental Social and Governance (ESG) Report, building on the work started in 2021. We believe the report shows steady progress across all three pillars of ESG, and the continued focus on embedding ESG and sustainability into Aspen&#8217;s strategy and values.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2775"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operational and Financial Review </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:27.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross written premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,125.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,351.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,338.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,938.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,698.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,350.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,896.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,587.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,577.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,287.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,327.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,688.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,410.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,527.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(717.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(767.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,680.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,693.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,840.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(192.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(216.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(431.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(414.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(465.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(169.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(186.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(333.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(308.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Income and Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange (losses)/gains </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income/(loss) before income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income/(loss) </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preference share dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income/(loss) attributable to ordinary shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Selected Key Performance Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted underwriting income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Annualized operating return on average equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total annualized return on average cash and investments, pre-tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These are non-GAAP financial measures as defined in Regulation G. The reconciliations to the most comparable  GAAP financial measures and a discussion of the rationale for the presentation of these items are provided  in &#8220;&#8212;Key Performance Measures and Non-GAAP Financial Measures.&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8234"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating highlights for the six months ended June&#160;30, 2023</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross written premiums of $2,125.2 million&#160;in the six months ended June&#160;30, 2023, a  decrease of 9.6% from the six months ended June&#160;30, 2022, primarily due to management&#8217;s decision to optimize the portfolio and reduce exposure, offset by rate increases.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Overall underwriting income of $208.4 million (combined ratio of 83.8%) for the six months ended June&#160;30, 2023, including $53.4 million, or 4.1 percentage points, of pre-tax catastrophe losses related to significant industry events, including floods in New Zealand, Cyclone Gabrielle, wildfires in Chile and other weather-related events. Underwriting income of $156.5 million (combined ratio of 88.2%) for the six months ended June&#160;30, 2022, which included $93.0 million or 7.0 percentage points of pre-tax catastrophe losses, related to significant industry events, including floods in Australia and South Africa, the Russia/Ukraine war and other weather-related events.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net favorable development on prior year loss reserves for the six months ended June&#160;30, 2023 of $6.4 million, or 0.5 combined ratio points, compared with net favorable development for the six months ended June&#160;30, 2022 of $7.3 million, or 0.6 combined ratio points. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted underwriting income of  $196.0 million (adjusted combined ratio of 84.8% for the six months ended June&#160;30, 2023) excludes a gain of $12.4 million for the change in deferred gain on retroactive reinsurance contracts to economically match the loss recoveries under the LPT with the covered reserves. Adjusted underwriting income represents the performance of our business for accident years 2020 onwards, which reflects the underlying underwriting performance of the ongoing portfolio. Adjusted underwriting income of $130.6 million and adjusted combined ratio of 90.2% for the six months ended June&#160;30, 2022 included a net gain of $25.9 million for the change in deferred gain on retroactive reinsurance contracts, net of certain costs related to the LPT contract.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our capital markets business contributed total fee income of $60.6 million in the six months ended June&#160;30, 2023, an increase of $13.6&#160;million compared to $47.0&#160;million in the six months ended June&#160;30, 2022. Total sourced third party capital grew to more than $1,339.0&#160;million as at June&#160;30, 2023, compared with $999.2&#160;million at June&#160;30, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Annualized operating return on average equity was 22.2% for the six months ended June&#160;30, 2023 compared with 14.0% in the six months ended June&#160;30, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total shareholders&#8217; equity increased by $190.7 million from $2,358.0 million as at December&#160;31, 2022 to $2,548.7 million as at June&#160;30, 2023, the most significant movements of which were as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $14.0 million in other comprehensive income which included $10.7 million of net unrealized gains on available for sale investments, a $7.6 million gain in foreign currency translation on unrealized investments classified as available-for-sale and a $4.3 million net loss in the value of hedged foreign exchange contracts; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $176.7 million in retained earnings due to a net income of $218.9 million off-set by the payments of $20.0 million in dividends on our Ordinary Shares and $22.2 million in dividends on our Preference Shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, our total shareholders&#8217; equity included Preference Shares with a total value as measured by their liquidation preferences of $775.0 million less issue costs of $21.5 million (December&#160;31, 2022 &#8212; $775.0 million less issue costs of $21.5 million). </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6410"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating highlights for the twelve months ended December&#160;31, 2022</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross written premiums of $4,338.7 million&#160;in 2022, an  increase of 10.2% in 2021, primarily due to rate improvement and growth in both of our underwriting segments.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Overall underwriting income of $190.4 million (combined ratio of 93.0%) for 2022, including $306.8 million, or 11.4 percentage points, of pre-tax catastrophe losses related to significant industry events, including Hurricane Ian, floods in Australia and South Africa, the Russia/Ukraine war and other weather-related events. Underwriting loss of $30.0 million (combined ratio of 101.2%) for 2021, which included $326.7 million or 13.6 percentage points of pre-tax catastrophe losses, related to significant industry events, including Hurricane Ida, European floods and U.S. winter storms.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net unfavorable development on prior year loss reserves for 2022 of $28.1 million, or 1.0 combined ratio points, compared with net unfavorable development for 2021 of $45.1 million, or 1.9 combined ratio points. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted underwriting income of  $205.5 million (adjusted combined ratio of 92.4% for 2022) includes an adjustment of $15.1 million for the change in deferred gain on retroactive reinsurance contracts to economically match the loss recoveries under the LPT with the covered reserves excludes certain costs related to the LPT contract. Adjusted underwriting income represents the performance of our business for accident years 2020 onwards, which reflects the underlying underwriting performance of the ongoing portfolio.  Adjusted underwriting income of $28.3 million and adjusted combined ratio of 98.8% for 2021 included an adjustment of $58.3 million for the change in deferred gain on retroactive reinsurance contracts. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our capital markets business contributed total fee income of $103.9 million in the twelve months ended December&#160;31, 2022, an increase of $42.5&#160;million compared to $61.4&#160;million in 2021. Income from ACM&#8217;s activities is primarily allocated to the ceded line of business and serves to reduce acquisition expenses for that business. Total sourced third party capital grew to more than $1,252.7&#160;million as at December&#160;31, 2022, compared with $917.7&#160;million at December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating return on average equity was 11.9% for 2022 compared with 2.4% in  2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total shareholders&#8217; equity decreased by $416.8 million from $2,774.8 million as at December&#160;31, 2021 to $2,358.0 million as at December&#160;31, 2022, the most significant movements of which were as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a reduction of $383.3 million in other comprehensive income which included $367.8 million of net unrealized losses on available for sale investments, a $30.9 million loss in foreign currency translation on unrealized investments classified as available-for-sale and a $15.4 million net gain in the value of hedged foreign exchange contracts; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease of $33.5 million in retained earnings primarily due to a net income of $51.1 million off-set by the payments of $40.0 million in dividends on our Ordinary Shares and $44.6 million in dividends on our Preference Shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, our total shareholders&#8217; equity included Preference Shares with a total value as measured by their liquidation preferences of $775.0 million less issue costs of $21.5 million (2021 &#8212; $775.0 million less issue costs of $21.5 million). </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2689"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Key Performance Measures and Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In presenting Aspen&#8217;s results, management has included key performance measures and discussed certain measurements that are considered &#8220;non-GAAP financial measures&#8221; under SEC rules and regulations. Management believes that these non-GAAP financial measures, which may be defined differently by other companies, help explain and enhance the understanding of Aspen&#8217;s results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with GAAP. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross written premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represents the total insurance premium for policies written or assumed during a specific period of time before the reduction for policy acquisition costs or other deductions. Gross written premiums is a volume measure commonly used in the insurance industry to compare sales performance by period.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net written premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are gross written premiums less ceded written premiums. Ceded written premiums are the amounts recognized for the purchases of reinsurance or  retrocessional coverage, and are accounted for using the same methodology as gross written premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net earned premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are the earned portion of an insurance contract. Net written premium is earned/recognized proportionately over the coverage period and associated risk patterns. Premiums written which are not yet recognized as earned are recorded on the balance sheet as unearned premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represents the amount paid or expected to be paid to claimants, including the cost of investigating, resolving and processing these claims, net of recoveries under the reinsurance and retrocession agreements. This can be broken out into the following categories:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Current accident year losses, excluding catastrophe losses, represents the losses arising in the current financial period, excluding any prior year reserve development and catastrophe losses; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Catastrophe losses are losses that arise from various unpredictable events, including but not limited to, weather-related natural catastrophes, pandemic or contagious disease and man-made events such as acts of war and terrorism.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior year adverse/(favorable) reserve development - post LPT years:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year adverse/(favorable) reserve development represents the strengthening/(releases) in net ultimate loss reserves and claim adjustment expense reserves at each reporting date for claims which occurred in previous calendar years/periods.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen entered into the LPT with a subsidiary of Enstar. Under the terms of the LPT, Enstar&#8217;s subsidiary will reinsure net losses incurred on or prior to December 31, 2019 on all of Aspen&#8217;s net loss reserves of $3.12 billion as of September 30, 2021. The LPT provides a limit of $3.57 billion for 2019 and prior accident year loss development. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year reserve development post LPT years represents the performance of our business for accident years 2020 onwards, reflecting the underlying underwriting performance of the ongoing business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted losses and loss adjustment expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a non-GAAP financial measure. It is the sum of current accident year losses, catastrophe losses and prior year reserve strengthening/(releases) post LPT years. Adjusted losses and loss adjustment expenses excludes the change in the deferred gain on retroactive reinsurance contracts and represents the performance of our business for accident years 2020 onwards, which management believes  reflects the underlying underwriting performance of the ongoing business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of LPT and changes in retroactive reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represents the deferral of a portion of loss recoveries on 2019 and prior accident year loss development as per accounting requirements for retroactive reinsurance under  GAAP. The LPT contract with Enstar is a retroactive reinsurance contract. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting result or income/ loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a non-GAAP financial measure.&#160;Income or loss for each of the business segments is measured by underwriting income or loss. Underwriting income or loss is the excess of net earned premiums over the underwriting expenses. Underwriting expenses are the sum of losses and loss adjustment </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses, acquisition costs and general and administrative expenses. Underwriting income or loss provides a basis for management to evaluate the segment&#8217;s underwriting performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted underwriting income or loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a non-GAAP financial measure. It is the underwriting profit or loss adjusted for the change in deferred gain on retroactive reinsurance contracts in order to economically match the loss recoveries under the ADC/LPT contracts with the underlying loss development of the assumed net loss reserves for the subject business of 2019 and prior accident years. Adjusted underwriting income or loss also excludes certain costs related to the LPT contract with Enstar that closed in the second quarter of 2022. Adjusted underwriting income represents the performance of our business for accident years 2020 onwards, which reflects the underlying underwriting performance of the ongoing portfolio.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the sum of current year net losses, catastrophe losses, prior year reserve strengthening/(releases), and the impact of LPT and changes in retroactive reinsurance as a percentage of net earned premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted loss ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a non-GAAP financial measure. It is the sum of current year net losses, catastrophe losses and prior year reserve strengthening/(releases) post LPT years, as a percentage of net earned premiums. Adjusted loss ratio excludes the change in the deferred gain on retroactive reinsurance contracts and represents the performance of our business for accident years 2020 onwards, which management believes reflects the underlying underwriting performance of the ongoing business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the sum of the loss ratio and expense ratio. The loss ratio is calculated by dividing losses and loss adjustment expenses by net earned premiums. The expense ratio is calculated by dividing the sum of acquisition costs and general and administrative expenses, by net earned premiums.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a non-GAAP financial measure. It is the sum of the adjusted loss ratio and the expense ratio. The adjusted loss ratio is calculated by dividing the adjusted losses and loss adjustment expenses by net earned premiums. The expense ratio is calculated by dividing the sum of acquisition costs and general and administrative expenses, by net earned premium.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Combined ratios differ from U.S. statutory combined ratios primarily due to the deferral of certain third-party acquisition expenses for GAAP reporting purposes and the use of net earned premiums rather than net written premiums in the denominator when calculating the acquisition expense and the general and administrative expense ratios.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted Combined Ratio </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earned premium</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year adverse/(favorable) reserve development - post LPT years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted loss and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the LPT and changes in retroactive reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted underwriting income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.9&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The adjustment in 2023 removes the impact of the change in the deferred gain on retroactive reinsurance contracts to economically match the loss recoveries under the LPT with the covered years. Adjusted underwriting income and combined ratio represents the performance of our business for accident years 2020 onwards, which we believe better reflects the underlying underwriting performance of the ongoing portfolio.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted Combined Ratio </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earned premium</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year (favorable)/adverse reserve development, post LPT years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted loss and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,664.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the LPT and changes in retroactive reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted underwriting income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The adjustment in 2022 removes the impact of the change in the deferred gain on retroactive reinsurance contracts to economically match the loss recoveries under the LPT with the covered years. Adjusted underwriting income and combined ratio represents the performance of our business for accident years 2020 onwards, which we believe better reflects the underlying underwriting performance of the ongoing portfolio.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted Combined Ratio </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earned premium</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,118.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year (favorable)/adverse reserve development, post ADC years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted loss and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the ADC and changes in retroactive reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,693.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,440.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted underwriting income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The adjustment in 2021 removes the impact of the change in the deferred gain on retroactive reinsurance contracts to economically match the loss recoveries under the ADC with the covered years. Adjusted underwriting income and combined ratio represents the performance of our business for accident years 2020 onwards, which we believe better reflects the underlying underwriting performance of the ongoing portfolio.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted Combined Ratio </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earned premium</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe losses (including COVID)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year (favorable)/adverse reserve development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the LPT and changes in retroactive reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,299.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted underwriting loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted combined ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">LPT/ADC was not in effect in 2020 and therefore there is no LPT/ADC impact in the period. Adjusted underwriting loss is calculated on the same basis as underwriting loss, and adjusted combined ratio is calculated on the same basis as combined ratio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a non-GAAP financial measure. Operating income is an internal performance measure used by Aspen in the management of its operations and represents after-tax operating results. Operating income includes an adjustment for the change in deferred gain on retroactive reinsurance contracts in order to economically match the loss recoveries under the ADC/LPT contracts with the underlying loss development of the assumed net loss reserves for the subject business of 2019 and prior accident years. Operating income also excludes certain costs related to the LPT contract with Enstar that closed in the second quarter of 2022, net foreign exchange gains or losses, including net realized and unrealized gains and losses from foreign exchange contracts, net realized gains or losses on investments and non-operating expenses and income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen excludes the items above from its calculation of operating income because they are not reflective of underlying performance or the amount of these gains or losses is heavily influenced by, and fluctuates according to prevailing investment market and interest rate movements. Aspen believes these amounts are either largely independent of its business and underwriting process, not aligned with the economics of transactions undertaken, or including them, would distort the analysis of trends in its operations. In addition to presenting net income determined in accordance with GAAP, Aspen believes that showing operating income enables users of its financial information to analyze Aspen&#8217;s results of operations in a manner similar to how management analyzes Aspen&#8217;s underlying business performance. Operating income should not be viewed as a substitute for GAAP net income. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Income Reconciliation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2018</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income as reported </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference share dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss) attributable to ordinary shareholders  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add/(deduct) before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange (gains)/losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized investment (gains)/losses </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add change in deferred gain on retroactive reinsurance contracts, net of certain costs related to the  LPT contract with Enstar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income tax expense/(benefit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income/(loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Average equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a non-GAAP financial measure and is calculated by taking the arithmetic average of total shareholders&#8217; equity on a quarterly basis for the stated periods excluding the average value of Preference Shares less issue expenses. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,640.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference shares less issue expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,795.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,874.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss) after tax as reported</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference share dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss) attributable to ordinary shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income/(loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized operating return on average equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized net income, adjusted for preference share dividends, on average equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ratio of debt and hybrids to total capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is calculated by adding total Preference Shares and outstanding debt and dividing by total capital. Total capital is defined as shareholders&#8217; equity plus outstanding debt.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Investment Return and Total Investment Return Percentage </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total annualized return on average cash and investments, pre-tax represents total annualized pre-tax return/(loss) on investments as a percentage of average beginning and ending total cash and investments during the period. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized gains/(losses) recognized in net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized gains/(losses) on available for sale securities held (gross of tax)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total return/(loss) on investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(381.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average cash and investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,189.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,622.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,438.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,666.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,652.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total annualized return on average cash and investments, pre-tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Average cash and investments is calculated by taking the average of the opening and closing fair values for the period for total investments plus cash and cash equivalents.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Continuing and Legacy Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present supplementary financial information regarding our two reporting segments, Reinsurance and Insurance, for the twelve months ended December 31, 2022, 2021, 2020, 2019 and 2018 to show the impact on our financial performance from the business which we have ceased underwriting and has been classified as &#8220;Legacy.&#8221; &#8220;Legacy&#8221; business has been represented on a like for like basis, meaning all the same lines of business have been included as Legacy in all the tables. We believe this presentation provides for a more complete understanding of the impact that these lines of business have had on our underlying performance. The following tables show U.S. dollars in millions, except for percentages.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.641%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Group Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross written premium</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,796.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,807.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,503.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,531.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,338.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,224.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,251.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,427.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,436.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,688.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">770.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">889.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">909.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,680.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">252.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">179.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">431.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">142.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">244.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Underwriting income/(loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">86.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">103.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">190.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(71.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(36.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">188.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(182.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(80.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(43.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(20.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(27.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">78.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year ex. catastrophe loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">46.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">53.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year catastrophe loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">61.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">62.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Policy acquisition expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expense ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">29.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Combined ratio </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">93.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">305.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">92.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">93.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year combined ratio </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">97.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">86.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">92.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Group Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross written premium</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,597.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,254.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,341.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,938.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,118.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,256.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,291.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,410.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">705.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">988.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,693.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">221.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">192.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">414.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">121.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">211.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">333.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Underwriting income/(loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">70.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(100.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(64.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(20.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">147.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">56.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(47.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(35.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">40.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">29.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year ex. catastrophe loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">52.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">57.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">54.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year catastrophe loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">289.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">76.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">70.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Policy acquisition expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expense ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Combined ratio </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">93.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">107.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year combined ratio </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">105.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">93.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">99.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Group Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross written premium</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,299.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,656.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,837.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,042.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,698.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,004.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">283.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,287.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,239.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,527.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">958.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">728.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">882.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,840.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">246.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">219.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">465.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">197.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">308.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Underwriting (loss)/income</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(27.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(59.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(87.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(70.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(32.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">154.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">98.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(27.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(65.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(33.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(38.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(56.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year ex. catastrophe loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">58.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">58.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">58.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year catastrophe loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">74.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">72.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Policy acquisition expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expense ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">33.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">102.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">104.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">103.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year combined ratio </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">99.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">107.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">103.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.640%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Group Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,084.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,485.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,675.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,956.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,442.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span id="id0d401546d4c4a0eba6080a60681990c_7-0-1-1-317916"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,255.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,038.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,293.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">917.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">761.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,679.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">264.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">147.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">412.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">111.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">229.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">341.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Underwriting (loss)/income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(39.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(120.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(101.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(140.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(54.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(125.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">197.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">97.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of loan notes issued by variable interest entities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(144.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(218.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(241.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year ex. catastrophe loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">67.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">60.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">64.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year catastrophe loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">73.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">73.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">73.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Policy acquisition expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">21.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expense ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">36.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">103.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">109.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">106.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year combined ratio </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">107.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">99.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">103.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.640%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 5.5pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Legacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Group Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,495.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,552.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">398.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,951.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,446.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,256.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">657.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">958.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,214.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">305.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">927.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">646.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,573.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">260.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">371.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">118.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">239.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">357.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Underwriting (loss)/income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(37.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(87.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(56.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(77.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">198.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(174.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of loan notes issued by variable interest entities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(31.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(25.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) before tax </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(156.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(145.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year ex. catastrophe loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">61.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year catastrophe loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">73.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">67.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Policy acquisition expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expense ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">25.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">36.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">104.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">104.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">103.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accident year combined ratio </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">109.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">108.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">108.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: &#8220;Legacy&#8221; reflects business we have elected to cease underwriting following a series of strategic underwriting reviews. These are consistent across all five years shown in these tables.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Legacy (reinsurance) represents:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.52pt">U.S. crop insurance business which was previously written on a reinsurance basis through a strategic partnership until disposed of in the fourth quarter of 2020;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">our global credit and surety reinsurance business that we ceased underwriting during the third quarter of 2019; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:4.52pt">our U.S. Agricultural business written via AgriLogic which was sold in December 2017.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Legacy (insurance) represents:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.52pt">U.S. food and beverage product recall business, the renewal rights to which was sold to a third party in December 2020;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">U.S. surety business, which in July 2020 was subject to a renewal rights transaction;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:4.52pt">includes international marine and energy liability products, and our global accident and health line of business, which, following a strategic review of our underwriting portfolio that began in December 2019, we determined to cease underwriting and started to wind down in February 2020 and March 2020, respectively;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.02pt">professional liability and property and casualty coverages for small to medium sized U.K.-based businesses that were bound through our managing general agent, Aspen Risk Management Limited that we placed into runoff during the third quarter of 2019;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">international cargo insurance that we ceased underwriting during the fourth quarter of 2018;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.02pt">our aviation line of business, which ceased underwriting during the third quarter of 2018;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.52pt">marine hull insurance written through the Lloyd&#8217;s platform that we ceased underwriting during the third quarter of 2018;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:0.02pt">international property insurance previously written via a joint underwriting initiative that we ceased underwriting during the first quarter of 2017; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.02pt">employers and public liability lines previously written that we ceased underwriting during the fourth quarter of 2015.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-operating expenses includes costs related to severance, retention awards, amortization of intangible assets and other non-operating expenses.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The general and administrative expense ratio in the total column excludes corporate and non-operating expenses.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2674"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments and Activity </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial information for the three and nine months ended September 30, 2023 and September 30, 2022 has not been reviewed by our independent registered public accounting firm and such financial information is therefore subject to adjustment. Such financial information may also be revised as a result of management&#8217;s further review of such information and any adjustments that may result from the completion of the audit of our consolidated financial statements for the 2023 fiscal year.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Highlights for the Three and Nine Months Ended September 30, 2023</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">982.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,107.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,461.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">628.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,979.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,290.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">660.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,947.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">256.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted underwriting income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized investment (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(85.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">305.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income/(loss) attributable to ordinary shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">269.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted combined ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income/(loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized operating return on average equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total annualized return on average cash and investments, pre-tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This is a non-GAAP financial measure as defined in Regulation G. The reconciliations to the most comparable GAAP financial measures are provided below in &#8220;&#8212;Non-GAAP Measures for the Three and Nine Months Ended September 30, 2023&#8221; and &#8220;&#8212;Investment Performance.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant improvement in underwriting and investment performance drove results for the three and nine months ended September 30, 2023.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Highlights for the Three Months Ended September 30, 2023</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net income attributable to ordinary shareholders increased by $245 million to $73 million, driven by strong improvement in underwriting results, improved investment income and lower net realized and unrealized investment and foreign exchange gains/losses.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased to $79 million in the quarter, with Aspen achieving an annualized operating return on average equity of 17.6%.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Underwriting income increased to $48 million, resulting in a 17.6 percentage point improvement in the combined ratio to 92.7%.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted underwriting income increased to $55 million, resulting in a 14.4 percentage point improvement in the adjusted combined ratio to 91.7%.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management&#8217;s planned initiatives to mitigate exposure as part of our continued portfolio optimization, including our decision to reduce writing certain programs, partially offset by strong new business activity in continuing lines and rate increases, resulted in $128 million lower gross written premiums.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased investment income reflects higher interest rates and reinvestment of maturing assets into higher yielding core fixed income assets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Highlights for the Nine Months Ended September 30, 2023</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net income attributable to ordinary shareholders increased significantly to $269 million, driven by strong improvement in underwriting results, improved investment income and lower net realized and unrealized investment and foreign exchange gains/losses.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased to $270 million in the period, with Aspen achieving an annualized operating return on average equity of 20.8%.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Underwriting income increased to $256 million, resulting in an 8.9 percentage point improvement in the combined ratio to 86.8%. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted underwriting income increased to $251 million resulting in an 8.5 percentage point improvement in the adjusted combined ratio to 87.1%.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued growth in capital sourced by ACM to $1,476 million as at September 30, 2023 resulted in a 25% increase in fee income to $92 million.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Corporate and other expenses increased by $15 million due to higher letter of credit fees and non-recurring project costs associated with improving our operating model, partially offset by favorable general and administrative expenses allocated to underwriting activities.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense increased by $18 million in the period, due to interest costs on the funds withheld account on the LPT contract with a subsidiary of Enstar.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Tax expense increased by $31 million to $41 million in the period, driven by higher pre-tax profits in our taxable jurisdictions.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Segment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Highlights for the Three and Nine Months Ended September 30, 2023</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross written premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">367.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">509.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,243.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,555.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net written premiums</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">261.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">866.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">291.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">863.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current accident year net losses and loss expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">144.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">404.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">40.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">76.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year reserve development, post LPT years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted loss and loss adjustment expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">185.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">272.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">481.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of the LPT and changes in retroactive reinsurance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(30.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(29.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total net losses and loss expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">154.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">451.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">606.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">54.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">160.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">29.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">88.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">52.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">163.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted underwriting income/(loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">133.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current accident year loss ratio, excluding catastrophe losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">46.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current accident year loss ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year reserve development ratio, post LPT years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted loss ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of the LPT and changes in retroactive reinsurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">53.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">52.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">82.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">81.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted combined ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">92.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">84.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This is a non-GAAP financial measure as defined in Regulation G. The reconciliations to the most comparable GAAP financial measures are provided in the table above.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Impact of the LPT and changes in retroactive reinsurance represents the net impact of changes in the deferral of a portion of loss recoveries on 2019 and prior accident year loss development as per accounting requirements for retroactive reinsurance under U.S. GAAP. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance Segment Highlights for the Three Months Ended September 30, 2023</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Underwriting income increased by $55 million to $53 million (adjusted underwriting income increased by $60 million to $22 million).</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Repositioning of the portfolio into higher attachment points and significant rate increase helped reduce the loss ratio which fell by 18.5 percentage points compared with prior year, with an improvement of 29.4 percentage points on the catastrophe loss ratio (note that the prior period was notably impacted by Hurricane Ian). This was partially offset by a higher attritional loss in the current year and lower favorable prior years&#8217; reserve development compared to the prior year.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The favorable impact of the LPT of $30 million represents the deferral of a portion of loss recoveries on 2019 and prior accident year loss development as per accounting requirements for retroactive reinsurance under GAAP.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management&#8217;s planned initiatives to reduce exposure as part of our continued portfolio optimization resulted in lower gross written premiums, primarily related to reductions in mortgage and property pro rata business as well as our previously announced exit from space, aviation, and bloodstock. These planned reductions were partially offset by strong rate increases.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance Segment Highlights for the Nine Months Ended September 30, 2023</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Underwriting income increased by $128 million to $163 million (adjusted underwriting income increased by $147 million to $134 million).</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management&#8217;s planned initiatives to reduce exposure as part of our continued portfolio optimization led to a decrease in gross written premiums of $312&#160;million, or 20%, primarily related to reductions in mortgage and property pro rata business as well as our previously announced exit from space, aviation, and bloodstock. These planned reductions were partially offset by strong rate increases.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net catastrophe exposure have been further reduced through increased cessions to ACM on our property reinsurance lines, with premiums ceded to reinsurers as a percentage of gross written premium in the period, increasing to 30% compared with 22% in the prior period.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The catastrophe loss ratio improved by 14.5 percentage points due to lower catastrophe losses in the period. The prior period catastrophe losses were adversely impacted, primarily due to Hurricane Ian, by $102&#160;million.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The acquisition cost ratio improved by 1.2 percentage points due to changes in business mix, partially offset by an increase in profit commissions due to favorable loss performance.   </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Segment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Highlights for the Three and Nine Months Ended September 30, 2023</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross written premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">615.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,864.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,906.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net written premiums</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">367.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,112.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earned premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">368.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,083.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current accident year net losses and loss expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">213.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">624.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year reserve development, post LPT years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted loss and loss adjustment expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">238.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">672.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">657.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of the LPT and changes in retroactive reinsurance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">36.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">23.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total net losses and loss expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">275.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">695.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">708.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">39.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">126.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">57.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">168.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underwriting (loss)/income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">93.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted underwriting income/(loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">116.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current accident year loss ratio, excluding catastrophe losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">58.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">57.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current accident year loss ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">62.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">60.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior year reserve development ratio, post LPT years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted loss ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">64.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">62.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of the LPT and changes in retroactive reinsurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">74.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">64.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted combined ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">89.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This is a non-GAAP financial measure as defined in Regulation G. The reconciliations to the most comparable GAAP financial measures are provided in the table above.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Impact of the LPT and changes in retroactive reinsurance represents the net impact of changes in the deferral of a portion of loss recoveries on 2019 and prior accident year loss development as per accounting requirements for retroactive reinsurance under U.S. GAAP. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Segment Highlights for the Three Months Ended September 30, 2023</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Underwriting income increased by $63 million to $(5) million (adjusted underwriting income increased by $36 million to $32 million).</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross written premiums increased by $14 million or 2%,  primarily due to strong new business activity within financial and professional lines, partially offset by our decision to reduce writing certain programs within our casualty and liability insurance portfolio.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The adjusted loss ratio improved by 5.2 percentage points, driven by reduced catastrophe losses and a reduction in adverse development on prior years&#8217; losses, partially offset by increased provisions in our current accident year loss ratios to proactively recognize the potential impact of higher economic uncertainty and inflation as well as the impact in business mix changes.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The adverse impact of the LPT of $37 million represents the net impact of changes in the deferral of a portion of loss recoveries on 2019 and prior accident year loss development as per accounting requirements for retroactive reinsurance under GAAP. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased cessions to ACM resulted in increased fee income which, combined with the exiting of programs with higher acquisition cost ratios, contributed to the 3.1 percentage point reduction of the insurance segment&#8217;s acquisition cost ratio to 10.7%.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Segment Highlights for the Nine Months Ended September 30, 2023</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Underwriting income increased by $42 million to $93 million (adjusted underwriting income increased by $15 million to $117 million).</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased cessions to ACM resulted in increased fee income which, combined with the exiting of programs with higher acquisition cost ratios, contributed to a 1.4 percentage point reduction in the insurance segment&#8217;s acquisition cost ratio.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our strategy to reduce property exposure in our insurance segment helped to limit the impact of industry catastrophe events during 2023, reducing the loss ratio by 2.6 percentage points with prior year heavily impacted by Hurricane Ian. This has been partially offset by increased provisions in our current accident year loss ratios to proactively recognize the potential impact of higher economic uncertainty and inflation, the impact of business mix changes and an increase in estimated claims handling costs.  </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Performance</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized gains/(losses) from trading portfolios recognized in net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized gains/(losses) on available for sale securities held (gross of tax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total return/(loss) on investments </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(143.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">190.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(497.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average cash and investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,312.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,311.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,168.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,519.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total annualized return on average cash and investments, pre-tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes net unrealized gains of $6.8 million for the quarter (2022 &#8212; $(52.0) million), and $28.6 million gains for the nine months ended September 30, 2023 (2022 &#8212; $(142.9) million).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The tax impact of the change in unrealized gains/(losses) on available for sale investments was an expense of $0.2 million for the quarter (2022 &#8212; $24.9 million), and an expense of $1.8 million for the nine months ended September 30, 2023 (2022 &#8212; benefit of $4.6 million).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Average cash and investments are calculated by taking the average of the opening period and closing period balances for total investments plus cash and cash equivalents.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides additional detail regarding our investment performance during the period:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net investment income of $78 million in the quarter, increased by $30 million, or 63%, compared to the third quarter of 2022, as a result of active repositioning of our investments to take advantage of higher interest rates.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net unrealized gains/(losses) on available for sale investments recognized as other comprehensive income was a loss of $45 million for the three months ended September 30, 2023. The change in net realized and unrealized investment gains and losses is a result of valuation changes, predominantly driven by the higher interest rates in the quarter. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The total return, pre-tax, on Aspen&#8217;s cash and investments was 1.7% in the quarter, compared to (7.9)% in the third quarter of 2022, and reflects the increase in net investment income and the impact of changes in net realized and unrealized gains and losses.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary Condensed Consolidated Balance Sheet (Unaudited)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shows our unaudited condensed consolidated balance sheet as of September 30, 2023:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,303.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,085.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">988.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,429.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,635.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,760.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,661.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">708.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,190.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,157.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,770.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,592.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,457.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,992.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,331.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">299.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,655.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,799.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference shares </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">753.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">761.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,578.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(558.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,535.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,190.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #00000a;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #00000a;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,157.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #00000a;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders&#8217; Equity and Debt</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total shareholders&#8217; equity was $2,535 million as of September 30, 2023, an increase of $197 million, compared with $2,358 million as of December 31, 2022. This is primarily due to net income of $305 million, partially offset by ordinary and preference dividends totaling $76 million and other comprehensive loss of $52 million primarily in relation to valuation changes related to investments classified as available for sale.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2023, the Company drew down  $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="ahl:DelayedDrawTermLoanFacility" format="ixt:num-dot-decimal" scale="6" id="f-6">300</ix:nonFraction>&#160;million on the 2026 Term Loan and the proceeds were used to redeem the 2023 Senior Notes.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-GAAP Measures for the Three and Nine Months Ended September 30, 2023 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss) attributable to ordinary shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(172.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">269.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(146.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add (deduct) items before tax </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange (gains)/losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized investment (gains)/losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred gain on retroactive reinsurance contracts, net of certain costs related to the LPT contract with Enstar</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit)/expense related to non-operating income/(expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income/(loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjusted Combined Ratio</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted Combined Ratio</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earned premium</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">660.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,947.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current accident year net losses and loss expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">358.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,028.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year reserve development, post LPT years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted loss and loss adjustment expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">423.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,153.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the LPT and changes in retroactive reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,147.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">287.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">256.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">612.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,691.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting income/(loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">256.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted underwriting income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted combined ratio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Impact of the LPT and changes in retroactive reinsurance represents the deferral of a portion of loss recoveries on 2019 and prior accident year loss development as per accounting requirements for retroactive reinsurance under U.S. GAAP. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Return on Average Equity</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference shares less issue expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized operating return on average equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized net income/(loss) attributable to ordinary shareholders on average equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Highlights</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, our investment portfolio had the following characteristics by asset class and rating:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g12.jpg" alt="MDA1a.jpg" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"/></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart shows our pre-2020 accident year carried reserves, as well as the LPT coverage above such carried reserves, as of September 30, 2021 and September 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g13.jpg" alt="MDA2b.jpg" style="height:322px;margin-bottom:5pt;vertical-align:text-bottom;width:403px"/></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart shows the composition of our capital structure as of September 30, 2023:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g14.jpg" alt="MD&amp;A3a.jpg" style="height:288px;margin-bottom:5pt;vertical-align:text-bottom;width:474px"/></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8224"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations for the six months ended June 30, 2023 and 2022</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion and analysis of our financial condition and results of operations for the six months ended June&#160;30, 2023 and 2022. This discussion and analysis should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included elsewhere in this prospectus as well as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in conjunction with the consolidated financial statements and notes thereto for the twelve months ended December 31, 2022 included elsewhere in this prospectus.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8239"></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Group Results </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross written premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the overall change in gross written premiums for our two business segments in the six months ended June&#160;30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Written Premiums for the Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,351.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall gross written premiums decreased by 9.6% in the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. Gross written premiums in our reinsurance segment decreased by 16.2% in the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022 mainly due to management&#8217;s decision to discontinue certain lines of business, as well as the impact of planned exposure management initiatives and portfolio optimization, offset by strong rate increases. Gross written premiums in our insurance segment decreased by 4.3% primarily due to management&#8217;s decision to reduce writing certain programs, which did not meet our profitability expectations, offset by favorable market conditions, evidenced with new business activity and a strong rate environment. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ceded written premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the overall change in ceded written premiums for our two business segments in the six months ended June&#160;30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ceded Written Premiums for the  Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums in the six months ended June&#160;30, 2023 decreased by $70.5 million, or 8.3%, compared to the six months ended June&#160;30, 2022. Changes in our reinsurance program decreased our retention ratio, which is defined as net written premiums as a percentage of gross written premiums, from 64.1% in the six months ended June&#160;30, 2022 to 63.5% in the six months ended June&#160;30, 2023. Ceded reinsurance premiums increased for our reinsurance segment, primarily due to an increase in the level of reinsurance purchased to protect our property catastrophe reinsurance business line. Ceded reinsurance premiums decreased for our insurance segment primarily within casualty and liability, and financial and professional lines due to a change in business mix and the decision to restructure a portion of our outwards reinsurance renewals. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net earned premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the overall change in net earned premiums for our two business segments in the six months ended June&#160;30, 2023 and 2022: </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earned Premiums for the  Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums decreased by $39.8 million, or 3.0%, in the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022 due to a $10.9 million increase in gross earned premiums offset by a $50.7 million increase in ceded earned premiums. </span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Losses and loss adjustment expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have presented the different components of the loss ratios, including adjusting for the impact of the LPT, which includes changes in retroactive reinsurance contracts as we believe that the presentation of adjusted loss ratios more appropriately reflects the underlying performance. Additionally, we have also presented current year loss ratios, the impact of catastrophe losses and prior year development for accident years that are not covered by the LPT. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Loss Ratio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">%&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">259.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">410.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior year (favorable)/ adverse reserve development &#8212; Post-LPT years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted losses and loss adjustment expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">296.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">433.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of LPT and changes in retroactive reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total losses and loss adjustment expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">419.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">717.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">682.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior year (favorable)/ adverse reserve development &#8212; Post-LPT years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjusted losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">382.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">411.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">793.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impact of LPT and changes in retroactive deferred gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total losses and loss adjustment expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">369.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">398.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">This is a non-GAAP financial measure as defined in Regulation G. The reconciliations to the most comparable GAAP financial measures and a discussion of the rationale for the presentation of these items are provided in &#8220;&#8212;Key Performance Measures and Non-GAAP Financial Measures.&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The overall loss ratio for the six months ended June&#160;30, 2023 of 55.7% improved by 2.1 percentage points compared to the six months ended June&#160;30, 2022 and losses and loss adjustment expenses decreased from $767.7 million in the six months ended June&#160;30, 2022 to $717.1 million in the six months ended June&#160;30, 2023. This was mainly due to the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Current accident year losses excluding catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current accident year losses excluding catastrophe losses contributed $670.1 million or 52.1% percentage points for the six months ended June&#160;30, 2023 compared to $682.0 million or 51.4% percentage points for the six months ended June&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe losses contributed $53.4 million or 4.1 percentage points for the six months ended June&#160;30, 2023 compared to $93.0 million or 7.0 percentage points for the six months ended June&#160;30, 2022. Catastrophe losses in the six months ended June&#160;30, 2023 include losses associated with Cyclone Gabrielle, floods in New Zealand, wildfires in Chile and other weather-related events. Catastrophe losses in the six months ended June&#160;30, 2022 were defined as losses associated with floods in Australia and South Africa, the Russia/Ukraine war and other weather-related events. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prior year development on post-LPT years</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve development for accident years 2020 onwards, for the six months ended June&#160;30, 2023, contributed an adverse development of 0.5% towards the overall loss ratio, while for the six months ended June&#160;30, 2022, contributed an adverse development of 1.4% towards the overall loss ratio. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjusted losses and loss adjustment expenses and related losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjusted losses and loss adjustment expenses relate to the post-LPT accident years and exclude the change in deferred gain associated with retroactive reinsurance contracts. Adjusted losses and loss adjustment expenses and related losses represents the performance of our business for accident years 2020 onwards, which we believe better reflects the underlying underwriting performance of the ongoing portfolio. The adjusted losses and loss adjustment expenses is the basis on which we report adjusted underwriting income and adjusted combined ratio, as well as the basis in which underwriting income contributes to operating income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Impact of LPT</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impact of LPT includes the change in the deferred gain recognized in 2023 in relation to the LPT, totaling $12.4 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition, general and administrative expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the ratio of expenses to net earned premium as a measure of the cost effectiveness of our acquisition costs, and general and administrative expenses. The tables below present the contribution of the acquisition costs and general and administrative expenses to the net expense ratios for the six months ended June&#160;30, 2023, and 2022. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratios Based on Net Earned Premium</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net acquisition cost ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratios Based on Net Earned Premium</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total &#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net acquisition cost ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net acquisition cost ratio improved from 16.3% in the six months ended June&#160;30, 2022 to 15.0% in the six months ended June&#160;30, 2023. This improvement was primarily driven by an increase in fee income derived from ACM, which increased by $13.6 million in comparison to the prior period. Fee income from ACM&#8217;s activities is primarily allocated to the ceded line of business and serves to reduce acquisition expenses for that business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense ratio improved from 14.1% in the six months ended June&#160;30, 2022 to 13.1% in the six months ended June&#160;30, 2023. This decrease of $17.5 million from $186.5 million in the six months ended June&#160;30, 2022 to $169.0 million in the six months ended June&#160;30, 2023 is primarily driven by the favorable year over year foreign exchange rates, coupled with various cost saving initiatives. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ACM</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACM sources capital and develops alternative reinsurance structures to leverage the Company&#8217;s underwriting and analytical expertise and earns underwriting, management and performance fees from third party investors primarily through the placement and management of side cars, ILS funds and other offerings. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of fee income and third-party capital with respect to our ACM activity, for the six months ended June&#160;30, 2023 and 2022. The increase in fee income is due to the growth achieved in the third-party capital and earned premium.  </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACM (in $ millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party capital</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Fee income earned through third party capital is primarily recorded through underwriting income/(loss) as a decrease to acquisition expenses. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Combined ratio</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the ratio of losses and loss adjustment expenses, acquisition costs and general and administrative expenses to net earned premium (the &#8220;combined ratio&#8221;) as a measure of relative performance. The combined ratios for our two business segments for the six months ended June&#160;30, 2023 and 2022  were as follows: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Combined&#160;Ratios&#160;for&#160;the Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted total combined ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The total combined ratio excludes the impact from corporate expenses and non-operating expenses. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Adjusted combined ratio removes the impact of the change in deferred gain on retroactive reinsurance contracts in order to match the loss recoveries under the LPT contract with the underlying loss development of the subject business of 2019 and prior accident years. Adjusted losses and loss adjustment expenses and related losses represents the performance of our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">business for accident years 2020 onwards, which we believe better reflects the underlying underwriting performance of the ongoing portfolio. Adjusted combined ratio is a non-GAAP financial measure as defined in Regulation G. The reconciliation to the most comparable GAAP financial measure and a discussion of the rationale for the presentation of this item is provided in &#8220;&#8212;Key Performance Measures and Non-GAAP Financial Measures.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjusted combined ratio for the six months ended June&#160;30, 2023 of 84.8% improved from 90.2% in the six months ended June&#160;30, 2022 due to decreases in the loss ratio, net acquisition cost ratio, and general and administrative expense ratio. The decrease in the loss ratio was primarily due to a reduction in current accident year losses and a decrease in catastrophe losses. The decrease in the net acquisition cost ratio was primarily driven by an increase in fee income derived from ACM, which increased by $13.6 million in comparison to the prior period. The decrease in the general and administrative expense ratio was primarily driven by the favorable year over year foreign exchange rates, coupled with various cost saving initiatives. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the six months ended June&#160;30, 2023, we incurred corporate expenses of $53.1 million (June&#160;30, 2022 &#8212; $43.3 million). The increase in corporate expense in the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022 was due to higher staff costs, higher temporary contractors in relation to IT and organizational change related costs, and higher letter of credit charges.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment gains</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net realized and unrealized investment gains for the six months ended June&#160;30, 2023 were $18.0 million (June&#160;30, 2022 &#8212; losses of $126.4 million), which included $16.2 million of unrealized gains (June&#160;30, 2022 &#8212; losses of $80.7 million). The change in net realized and unrealized investment gains and losses is a result of mark to market valuations, predominantly driven by credit spread reduction in our government, corporate bond and structured credit portfolios and lower allocations to rate sensitive asset classes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net investment income</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the six months ended June&#160;30, 2023, net investment income was $129.4 million, an increase of 45.9% from the prior year (June&#160;30, 2022&#160;&#8212; $88.7 million), largely as a result of active repositioning of our investments during 2022 and continuing benefits from a higher rate environment, higher income from floating rate assets and the reinvestment of maturing assets.  The investment portfolio in  the six months ended June&#160;30, 2023 comprised largely of interest income generating fixed income securities.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in fair value of derivatives</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use foreign exchange contracts to manage foreign currency risk. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of our assets and liabilities denominated in foreign currencies, but rather allow us to establish a rate of exchange for a future point in time. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, we held foreign exchange contracts that were not designated as hedging under ASC 815 - &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; with a notional amount of $1,884.0 million (December&#160;31, 2022 &#8212; $1,675.3 million). The foreign exchange contracts are recorded as derivative assets or derivative liabilities in the consolidated balance sheet with changes recorded as a change in fair value of derivatives in the statement of operations. For the six months ended June&#160;30, 2023, the impact of foreign exchange contracts on net income was a gain of $19.6 million  (June&#160;30, 2022&#160;&#8212; loss of $84.9 million), attributable to foreign exchange contracts that had a gain of $11.3&#160;million, and an additional  gain  within the LPT embedded derivative of $8.3&#160;million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, we held foreign exchange contracts that were designated as hedges under ASC 815 with an aggregate notional amount of $54.7 million (December&#160;31, 2022 &#8212; $109.7 million). The foreign exchange contracts are recorded as derivative assets in the consolidated balance sheet with the effective portion recorded in other comprehensive income and the ineffective portion recorded as a change in fair value of derivatives in the consolidated statement of operations. The contracts are effective and therefore the movement in other </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprehensive income representing the effective portion for the six months ended June&#160;30, 2023 was a loss of $4.3&#160;million (June&#160;30, 2022&#160;&#8212; loss of $6.4&#160;million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the foreign exchange contracts settle, the realized gain or loss is reclassified from other comprehensive income into general administrative and corporate expenses of the consolidated statement of operations and other comprehensive income. For the six months ended June&#160;30, 2023, the amount recognized within general, administration and corporate expenses for settled foreign exchange contracts was a realized loss of $3.7&#160;million (June&#160;30, 2022 &#8212; gain of $2.8&#160;million).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $42.9&#160;million in the six months ended June&#160;30, 2023 represents the interest on the 2023 Senior Notes of $7.2&#160;million and interest payable of 1.75% plus a variable interest charge on the funds withheld account on the LPT contract with Enstar of $35.7&#160;million. Interest expense of $9.1&#160;million in the six months ended June&#160;30, 2022 represents the interest on the 2023 Senior Notes of $7.2 million and interest payable on the funds withheld account on the LPT contract with Enstar of $1.9&#160;million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income before tax</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In six months ended June&#160;30, 2023, income before tax was $255.1 million (June&#160;30, 2022 &#8212; income of $53.1 million).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income tax expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was an income tax expense for the six months ended June&#160;30, 2023 of $36.2&#160;million compared to an income tax expense of $4.7&#160;million in the six months ended June&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate (defined as the tax charge or credit, divided by the profit or loss before tax), for the six months ended June&#160;30, 2023, on profit before tax was 14.2% (June&#160;30, 2022 &#8212; 8.9%). Prior to 2023, the effective tax rate on U.S. profits was decreased by the utilization of brought forward net operating losses that had a full valuation allowance recorded.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate is impacted by the relative profitability of the business underwritten in Bermuda, the United Kingdom and the United States, all of which have different corporate/federal tax rates.&#160;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other comprehensive income</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other comprehensive income increased by $14.0&#160;million (June&#160;30, 2022 &#8212; $312.0&#160;million decrease), net of taxes, for the six months ended June&#160;30, 2023. The increase in total other comprehensive income includes a net unrealized gain of $10.7&#160;million in the available for sale investment portfolio (June&#160;30, 2022 &#8212; $286.5&#160;million net unrealized loss). The net unrealized loss in June&#160;30, 2022 was  attributable to the impact of rising interest rates on our bond portfolios. The increase was further due to an unrealized gain in foreign currency translation on available for sale investments of $7.6&#160;million (June&#160;30, 2022 &#8212; $19.7&#160;million unrealized loss) largely attributable to the impact from the continued strengthening of the British Pound and the Euro against the U.S. dollar, offset by a $4.3&#160;million unrealized loss (June&#160;30, 2022 &#8212; $5.8&#160;million unrealized loss) on the hedged derivative contracts.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8248"></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Results by Business Segment </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are organized into two business segments, namely Reinsurance and Insurance. We have determined our reportable segments, Reinsurance and Insurance, by taking into account the manner in which the chief operating decision maker determines operating decisions and assesses operating performance. Profit or loss for each of the business segments is measured by underwriting income or loss. Underwriting profit is the excess of net earned premiums over the sum of losses and loss expenses, acquisition costs and general and administrative expenses. Underwriting income or loss provides a basis for management to evaluate the segment&#8217;s underwriting performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management measures segment results on the basis of the combined ratio, which is obtained by dividing the sum of the losses and loss expenses, acquisition costs and operating and administrative expenses by net earned </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">premiums. Other than corporate expenses, indirect operating and administrative expenses are allocated to business segments predominantly based on each segment&#8217;s proportional share of gross earned premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-underwriting disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We provide additional disclosures for corporate and other (non-operating) income and expenses. Corporate and other income and expenses include net investment income, net realized and unrealized investment gains or losses, expenses associated with managing the Aspen Group, certain strategic and other costs, changes in fair value of derivatives and changes in fair value of loan notes issued by variable interest entities, interest expense, net realized and unrealized foreign exchange gains or losses and income taxes, which are not allocated to the business segments. Corporate expenses are not allocated to our business segments as they typically do not fluctuate with the levels of premiums written and are not directly related to our segment operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not allocate our assets by business segment as we evaluate underwriting results of each segment separately from the results of our investment portfolio. Segment profit or loss for each of our business segments is measured by underwriting income or loss. Refer to &#8220;Note 3&#8212;Segment Reporting&#8221; of our unaudited condensed consolidated financial statements for information on gross and net written premiums and earned, underwriting income or loss, and combined ratios and reserves for each of our business segments. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8258"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reinsurance segment consists of property catastrophe reinsurance, other property reinsurance, casualty reinsurance and specialty reinsurance. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross written premiums</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows our gross written premiums for each line of business in our reinsurance segment for the six months ended June&#160;30, 2023 and 2022 and the percentage change in gross written premiums for each line of business: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lines of Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property catastrophe reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other property reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in gross written premiums in the six months ended June&#160;30, 2023 compared to June&#160;30, 2022 in property catastrophe reinsurance was primarily due to a stronger rate environment. The decrease in other property reinsurance, casualty reinsurance and specialty reinsurance is mainly due to management&#8217;s decision to discontinue writing space, aviation, and bloodstock business since June 30, 2022, as well as the impact of planned exposure management initiatives and portfolio optimization, which have been offset by strong rate increases.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ceded written premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums in the six months ended June&#160;30, 2023 were $270.7&#160;million, an increase of $8.8 million compared to June&#160;30, 2022. This was due to an increase in the level of reinsurance purchased protecting our property catastrophe reinsurance business lines, reflecting the increase in exposures assumed. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net earned premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums decreased by $28.8 million, or 4.8%, in the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022, reflecting the decrease in gross written premiums and increase in the level of reinsurance to reduce exposure volatility.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Losses and loss adjustment expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net loss ratio was 52.0% in the six months ended June&#160;30, 2023, a decrease of 9.4 percentage points compared to 61.4% in the six months ended June&#160;30, 2022. This was mainly due to the following: </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Current accident year loss ratio excluding catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current accident year loss ratio excluding catastrophe losses for the six months ended June&#160;30, 2023 of 45.4%, decreased by 2.4 percentage points compared to the six months ended June&#160;30, 2022 of 47.8%, primarily due to improved current accident year result, including the impact of favorable premium adjustments and underlying claim performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe losses decreased from $73.3 million in the six months ended June&#160;30, 2022 to $35.5 million in the six months ended June&#160;30, 2023, improving the loss ratio by 6.0 percentage points. In the six months ended June&#160;30, 2023, there were $35.5 million of net catastrophe losses, including $6.8 million from Cyclone Gabrielle, $7.7 million from floods in New Zealand, $4.6 million from wildfires in Chile and $16.4&#160;million of other weather-related events.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the six months ended June&#160;30, 2022, the net catastrophe losses of $73.3 million included $21.5 million from the Russia/Ukraine war, $26.5 million from Australian floods, $8.5 million from South African floods and $16.8 million of other weather-related events.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prior year development on post-LPT years</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year development on post-LPT years totaled unfavorable development of $1.3 million in the current period compared with unfavorable development of $22.4 million in the six months ended June&#160;30, 2022. This reduction in unfavorable development resulted in a reduction in the loss ratio of 3.5 percentage points.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Impact of LPT</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impact of LPT includes an unfavorable movement of $0.8 million in the current period compared with favorable development of $13.6 million in the six months ended June&#160;30, 2022. This reflects the movement in the deferred gain on retroactive contracts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition, general and administrative expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net acquisition costs were $105.7 million for the six months ended June&#160;30, 2023, equivalent to 18.5% of net earned premiums (June&#160;30, 2022 &#160;&#8212; $124.1 million or 20.7% of net earned premiums). The $18.4&#160;million decrease in the acquisition costs were mainly attributable to reductions in net acquisition costs in specialty reinsurance and other property reinsurance lines of business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses decreased by $11.3&#160;million from $69.7 million in the six months ended June&#160;30, 2022 to $58.4 million in the six months ended June&#160;30, 2023.  Our general and administrative expense ratio was 10.2% in the six months ended June&#160;30, 2023 compared to 11.6% in the six months ended June&#160;30, 2022 largely driven by the favorable year over year foreign exchange rates, coupled with various cost saving initiatives. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8253"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance segment consists of casualty and liability insurance, first party insurance, specialty insurance, financial and professional lines insurance, and Carbon Syndicate. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross written premiums</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows our gross written premiums for each line of business for the six months ended June&#160;30, 2023 and 2022  and the percentage change in gross written premiums for each line: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lines of Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First party insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty and liability insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial and professional lines insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon Syndicate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Relates to gross written premium written by Aspen Underwriting Limited via Carbon Syndicate 4747. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross written premiums in the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022 in first party insurance was largely attributable to our decision to reduce writing certain programs, which did not meet our profitability expectations, this was offset by favorable market conditions in U.S. property. The increase in gross written premiums in specialty insurance was due to new business activity and a strong rate environment. The decrease in gross written premiums in casualty and liability insurance was primarily due to managements planned initiatives to reduce exposure and optimize the portfolio, and an overall slowdown and increased competition in certain lines of business. The decrease in financial and professional lines insurance was mainly attributable to, among other factors, the withdrawal from specific binders, and experiencing softening market conditions, resulting in lower renewal retention and a declining rate, partially offset by additional premium from new cross class binders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ceded written premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums for the six months ended June&#160;30, 2023 was $504.0&#160;million, a decrease of $79.3&#160;million from the six months ended June&#160;30, 2022. Retention ratio increased from 55.3% in the six months ended June&#160;30, 2022 to 59.7% in the six months ended June&#160;30, 2023 as a result of changes in our reinsurance program. Ceded written premiums decreased primarily within casualty and liability, and financial and professional lines due to a change in business mix and the decision to restructure a portion of our outwards reinsurance renewals. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net earned premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums decreased by $11.0 million, or 1.5%, in the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022 largely due to a decrease in gross written premium written within the period, offset by a reduction in ceded written premium.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Losses and loss adjustment expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net loss ratio in the six months ended June&#160;30, 2023 was 58.7%, an increase of 3.8 percentage points compared to 54.9% in the six months ended June&#160;30, 2022. This was mainly due to the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Current accident year loss ratio excluding catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current accident year loss ratio excluding catastrophe losses for the six months ended June&#160;30, 2023 of 57.3% increased by 2.9 percentage points compared to the six months ended June&#160;30, 2022 primarily due to an increase in claims handling provision and higher losses due to the potential impact of social and economic inflation, in comparison to the six months ended June&#160;30, 2022.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe losses decreased from $19.7 million in the six months ended June&#160;30, 2022 to $17.9 million in 2023, improving the loss ratio by 0.2 percentage points. In the six months ended June&#160;30, 2023, the net catastrophe losses of $17.9 million included weather-related events, while the six months ended June&#160;30, 2022 included $3.5 million from Storm Dudley and $15.0 million from other weather-related events.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prior year development on post-LPT years</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year development on post-LPT years totaled unfavorable development of $4.7 million in the current period compared with favorable development of $3.8 million in the six months ended June&#160;30, 2022. This reduction in favorable development resulted in an increase in the loss ratio of 1.2 percentage points, primarily due to unfavorable underlying loss experience.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Impact of LPT </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impact of LPT includes a favorable movement of $13.2 million or 1.8 percentage points in the current period compared with favorable development of $12.3 million in the six months ended June&#160;30, 2022. This reflects the movement in the deferred gain on retroactive contracts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition, general and administrative expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net acquisition costs were $87.2 million in the six months ended June&#160;30, 2023, equivalent to 12.2% of net earned premiums (June&#160;30, 2022 &#8212; $92.4 million or 12.7% of net earned premiums). The decrease in the acquisition cost ratio in the six months ended June&#160;30, 2023 was primarily driven by an increase in fee income derived from ACM, partially offset by an increase in acquisition costs in financial and professional lines. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses decreased by $6.2&#160;million to $110.6 million in the six months ended June&#160;30, 2023 from $116.8 million in the six months ended June&#160;30, 2022. Our general and administrative expense ratio was 15.5% in the six months ended June&#160;30, 2023 compared to 16.1% in the six months ended June&#160;30, 2022 due to favorable year over year foreign exchange rates and a reduction in IT related costs.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2790"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations for the twelve months ended December 31, 2022, 2021 and 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with GAAP. The discussions that follow include tables and commentary relating to our consolidated income statement and our segmental operating results for the twelve months ended December&#160;31, 2022, 2021 and 2020 and should be read in conjunction with our audited consolidated financial statements and related notes included elsewhere in this prospectus. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6405"></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Group Results</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross written premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the overall change in gross written premiums for our two business segments in the twelve months ended December&#160;31, 2022, 2021 and 2020: </span></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Written Premiums for the Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,042.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,338.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,698.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall gross written premiums increased by 10.2% in 2022 compared to 2021. Gross written premiums in our reinsurance segment increased by 13.1% in 2022 compared to 2021 mainly due to rate improvements, significant new business and high retention rates within our casualty reinsurance and specialty reinsurance segment, offset by a decrease in property reinsurance primarily due to management&#8217;s decision to decrease exposure, by reducing capacity and not renewing business with large loss volatility. Gross written premiums in our insurance segment increased by 8.1% primarily due to strong performance across renewal business, positive rate improvements and new business across both financial and professional insurance lines and casualty and liability insurance lines, partially offset by the decrease in first party insurance and specialty insurance due to our decision to cease underwriting in accident and health and the decision to withdraw from certain first party insurance program business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall gross written premiums increased by 6.5% in 2021 compared to 2020. Gross written premiums in our reinsurance segment decreased by 3.6% in 2021 compared to 2020 mainly due to the CGB Sale (as defined below) which contributed $334.8 million of our U.S. agricultural business in 2020 in specialty reinsurance lines, partially offset by an increase in property catastrophe, casualty reinsurance and other property reinsurance lines premiums. Gross written premiums in our insurance segment increased by 14.7% primarily due to rate improvements in both financial and professional insurance lines and casualty and liability insurance lines, partially offset by the decrease in first party and specialty insurance due to our decision to cease underwriting in accident and health, international marine and energy liability business which are currently part of our legacy lines.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ceded written premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the overall change in ceded written premiums for our two business segments in the twelve months ended December&#160;31, 2022, 2021 and 2020: </span></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ceded Written Premiums for the Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,442.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums in 2022 increased by $92.0 million, or 6.8%, compared to 2021. Changes in our reinsurance program increased our retention ratio, which is defined as net written premiums as a percentage of gross written premiums, from 65.7% in 2021 to 66.7% in 2022. Ceded reinsurance premiums decreased for our reinsurance segment, primarily due to a decrease in the level of reinsurance purchased to protect our reduced property catastrophe reinsurance business line. Ceded reinsurance premiums increased for our insurance segment primarily within casualty and liability, and financial and professional lines due to increase in gross written premium and consequently increase in the proportion of business ceded via quota share arrangements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums in 2021 increased by $230.0 million compared to 2020. Changes in our reinsurance program decreased our retention ratio, which is defined as net written premiums as a percentage of gross written premiums, from 69.7% in 2020 to 65.7% in 2021. Ceded reinsurance premiums increased for our reinsurance segment, primarily due to an increase in the level of reinsurance purchased to protect our property catastrophe reinsurance business line. Ceded reinsurance premiums increased for our insurance segment primarily due to an increase in gross written premiums and consequently an increase in the proportion of business ceded to quota share contracts from excess of loss contracts.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net earned premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the overall change in net earned premiums for our two business segments in the twelve months ended December&#160;31, 2022, 2021 and 2020: </span></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earned Premiums for the Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,118.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums increased by $278.2 million, or 11.5%, in 2022 compared to 2021 due to a $369.7 million increase in gross earned premiums offset by a $91.5 million increase in ceded earned premiums primarily due to the increase in gross written premium in the twelve months ended December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums decreased by $117.0 million, or 4.6%, in 2021 compared to 2020 due to a $20.1 million decrease in gross earned premiums and a $96.9 million increase in ceded earned premiums. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Losses and loss adjustment expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have presented the different components of the loss ratios, including adjusting for the impact of the ADC/LPT, which came into effect in 2021 and includes changes in retroactive reinsurance contracts as we believe that the presentation of adjusted loss ratios more appropriately reflects the underlying performance. Additionally, we have also presented current year loss ratios, the impact of catastrophe losses and prior year development for accident years that are not covered by the ADC/LPT. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">584.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">761.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,345.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">306.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior year (favorable)/ adverse reserve development &#8212; Post-LPT years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">804.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">860.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,664.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of LPT and changes in retroactive reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total losses and loss adjustment expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">909.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,680.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">584.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">736.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,321.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior year (favorable)/ adverse reserve development &#8212; Post-LPT years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(175.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">971.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,635.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of ADC and changes in retroactive deferred gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total losses and loss adjustment expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">988.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,693.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net Loss Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Loss Ratio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current accident year losses, excluding catastrophe losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">730.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Catastrophe losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">360.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior year (favorable)/adverse reserve development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total losses and loss adjustment expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">958.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">882.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,840.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The overall loss ratio for 2022 of 62.5% improved by 7.7 percentage points compared to 2021 and losses and loss adjustment expenses decreased from $1,693.3 million in 2021 to $1,680.0 million in 2022. This was mainly due to the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Current accident year losses excluding catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current accident year loss ratio excluding catastrophe losses for 2022 of 50.0% improved by 4.7 percentage points compared to 2021 due to improved underlying loss experience and improved pricing within our first party insurance, specialty insurance and casualty and specialty lines. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe losses contributed $306.8 million or 11.4 percentage points for the twelve months ended December 31, 2022 compared to $326.7 million or 13.6 percentage points for the twelve months ended December 31, 2021. Catastrophe losses in 2022 include losses associated with Hurricane Ian, floods in Australia and South Africa, the Russia/Ukraine war and other weather-related events. Catastrophe losses in 2021 were defined as losses associated with Texas winter storms, Hurricane Ida, European floods and other weather-related events. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prior year development on post-LPT years</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve development related to 2020 and 2021 accident years, which for the twelve months ended December 31, 2022, contributed an adverse development of 0.5% towards the overall loss ratio, while for the twelve months ended December 31, 2021, including reserve development for 2020 accident year, contributed a favorable development of 0.5% towards the overall loss ratio. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjusted losses and loss adjustment expenses and related losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjusted losses and loss adjustment expenses relate to the post-LPT accident years and exclude the cost of the LPT recognized in 2022, as well as the change in deferred gain associated with retroactive reinsurance contracts. Adjusted losses and loss adjustment expenses and related losses represents the performance of our business for accident years 2020 onwards, which reflects the underlying underwriting performance of the ongoing portfolio. The adjusted losses and loss adjustment expenses is the basis on which we report adjusted underwriting income and adjusted combined ratio, as well as the basis in which underwriting income contributes to operating income. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Impact of LPT</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impact of LPT includes the one-off associated costs in relation to the LPT recognized in 2022 and changes in retroactive reinsurance contracts, totaling $15.1 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The overall loss ratio for 2021 of 70.2% improved by 2.6 percentage points compared to 2020 and losses and loss adjustment expenses decreased from $1,840.8 million in 2020 to $1,693.3 million in 2021. his was mainly due to the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Current accident year losses excluding catastrophe losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current accident year loss ratio excluding catastrophe losses includes $9.8 million of recoveries from the ADC and other retroactive contracts. The adjusted accident year loss ratio for 2021 of 68.3%, includes the full economic benefit arising on the ADC, including the $58.3 million (2.4 percentage points) currently recognized as a deferred gain within reinsurance recoverables on the balance sheet. The adjusted loss ratio improved by 4.5% percentage points compared to 2020 primarily due to the recoveries on the ADC for 2019 and improved current year underlying claims performance. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Catastrophe Losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe losses contributed $326.7 million or 13.6 percentage points for the twelve months ended December 31, 2021, compared to $360.8 million, or 14.2 percentage points for the twelve months ended December 31, 2020. Catastrophe losses in 2021 were defined as losses associated with Texas winter storms, Hurricane Ida, European floods and other weather-related events. Catastrophe losses in 2020 were defined as losses associated with </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19, Hurricanes Isaias and Laura, wildfires in California and other weather-related events.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prior year development</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, prior year reserve strengthening totaled $45.1 million in 2021, compared with net favorable reserve development of $0.9 million in 2020. Reserve releases in the reinsurance segment in 2021 were $134.4 million compared to $36.1 million in 2020 and came primarily from casualty reinsurance and specialty reinsurance. Net unfavorable reserve development in the insurance segment in 2021 was $179.5 million compared to net unfavorable reserve development of $35.2 million in 2020 and came primarily from casualty insurance lines and first party and specialty lines. Current prior year reserve strengthening includes $9.8 million of ADC recoveries. The remaining ADC recoveries of $58.3 million is currently recognized as a deferred gain within reinsurance recoverables on the balance sheet and, if included within the income statement, we would recognize overall favorable prior year reserve development for accident years 2020 and 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This was mainly due to improved current year underlying claims performance offset by a $46.0 million unfavorable movement in prior year development, from a release of $0.9 million in 2020 to a strengthening of $45.1 million in 2021. Furthermore, there was a decrease in large losses of $7.2 million and a $34.1 million decrease in catastrophe losses, from $360.8 million in 2020 to $326.7 million in 2021. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the ratio of expenses to net earned premium as a measure of the cost effectiveness of our acquisition costs, and general and administrative expenses. The tables below present the contribution of the acquisition costs and general and administrative expenses to the net expense ratios for the twelve months ended December&#160;31, 2022, 2021 and 2020. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratios Based on Net Earned Premium</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net acquisition cost ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratios Based on Net Earned Premium</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total &#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net acquisition cost ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, and administrative expense ratio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratios Based on Net Earned Premium</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net acquisition cost ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General administrative expense ratio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expense ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net acquisition cost ratio improved to 16.1% in 2022 from 17.2% in 2021. This improvement was primarily within our insurance segment due to a greater proportion of our business being ceded to ACM businesses, partially offset by higher expenses incurred within reinsurance lines due to changes in the mix of business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense ratio increased to 14.4% in 2022 from 13.8% in 2021. This increase of $53.4 million from $333.1 million in 2021 to $386.5 million in 2022 is due to increased staff costs, higher professional and consulting fees, an increase in IT and organizational change related costs and an increase in Lloyd&#8217;s related costs due to increased capacity in the year. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net acquisition cost ratio decreased to 17.2% in 2021 from 18.4% in 2020. This decrease of $51.6 million in 2021 compared to 2020 was primarily due to underwriters achieving favorable brokerage terms and higher ceded commission on quota share contracts within insurance lines of business, partially offset by higher expenses incurred within reinsurance lines due to changes in the mix of business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense ratio increased to 13.8% in 2021 from 12.2% in 2020. This increase of $25.1 million from $308.0 million in 2020 to $333.1 million in 2021 was primarily due to an increase in IT managed services and hosting costs, increase in Lloyd&#8217;s syndicate fees as a result of higher premiums written through the Lloyd&#8217;s platform, additional expenses due to the inclusion of our investment in Carbon Syndicate and increased spend on consulting and professional services. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ACM</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACM sources capital and develops alternative reinsurance structures to leverage the Company&#8217;s underwriting and analytical expertise and earns underwriting, management and performance fees from third party investors primarily through the placement and management of side cars, ILS funds and other offerings. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of fee income and third-party capital with respect to our ACM activity, for the twelve months ended December&#160;31, 2022 and 2021, with 2020 comparatives provided for trend purposes. The increase in fee income is due to the growth achieved in the third-party capital and earned premium.  </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACM  (in $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party capital </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Fee income earned through third party capital is primarily recorded through underwriting income/(loss) as a decrease to acquisition expenses. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Combined ratio</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the ratio of losses and loss adjustment expenses, acquisition costs and general and administrative expenses to net earned premium (the &#8220;combined ratio&#8221;) as a measure of relative performance. The combined ratios for our two business segments for the twelve months ended December&#160;31, 2022, 2021 and 2020 were as follows: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Combined&#160;Ratios&#160;for&#160;the Twelve Months Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted total combined ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The total combined ratio excludes the impact from corporate expenses and non-operating expenses. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Adjusted combined ratio removes the impact of the change in deferred gain on retroactive reinsurance contracts in order to match the loss recoveries under the ADC/LPT contracts with the underlying loss development of the subject business of 2019 and prior accident years and also excludes the cost of the LPT contract with Enstar that closed in the second quarter  in 2022. Adjusted losses and loss adjustment expenses and related losses represents the performance of our business for accident years 2020 onwards, which reflects the underlying underwriting performance of the ongoing portfolio. Adjusted combined ratio is a non-GAAP financial measure as defined in Regulation G. The reconciliation to the most comparable GAAP financial measure and a discussion of the rationale for the presentation of this item is provided in &#8220;&#8212;Key Performance Measures and Non-GAAP Financial Measures.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjusted combined ratio for 2022 of 92.4% improved from 98.8% in 2021 due to a decrease in both the loss ratio and net acquisition cost ratio, partially offset by an increase in the general and administrative expense ratio. The decrease in loss ratio was primarily due to a reduction in current accident year losses and a decrease in catastrophe losses. The decrease in net acquisition expenses was primarily within our insurance segment, due to a greater proportion of our business being ceded to ACM businesses. The increase in expense ratio was due to increased staff costs, higher professional and consulting fees, an increase in IT and organizational change related costs and an increase in Lloyd&#8217;s related costs due to increased capacity in the year. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjusted combined ratio for 2021 of 98.8% improved by 4.6 percentage points compared to 2020 due to a decrease in both the loss ratio and net policy acquisition expense ratio, offset by an increase in the general and administrative expense ratio. The decrease in loss ratio was primarily due to the recovery on the ADC for 2019 and prior year deterioration and a reduction in current accident year losses. The decrease in net acquisition expenses was </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to underwriters achieving favorable brokerage terms and higher ceded commission on quota share contracts. The increase in expense ratio was due to an increase in IT costs, increase in Lloyd&#8217;s syndicate fees, additional expenses due to the inclusion of Aspen&#8217;s investment in Carbon Syndicate and increased spend on consulting and professional services. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we incurred corporate expenses of $71.7 million (2021 &#8212; $64.3 million). The increase in corporate expense in 2022 compared to 2021 was due to higher staff costs, higher professional and consulting fees and an increase in IT and organizational change related costs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, corporate expenses decreased to $64.3 million compared to $70.2 million in 2020, due to lower staff costs, decreased facilities costs and other corporate expenses. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-operating expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022, 2021 and 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we incurred non-operating expenses of $36.0&#160;million which included $32.7&#160;million in relation to fixed assets, including capitalized project costs written off, $10.0&#160;million of severance, consulting and professional services in relation to non-recurring projects and other costs, offset by $6.7&#160;million of write backs related to leased office space. Non-operating costs in 2021 of $20.6 million included $19.3 million of severance, consulting and professional services in relation to non-recurring projects and other costs, $0.4 million of impairment charges related to lease assets as a result of exiting certain office space and $0.9 million of amortization of intangible assets and other non-operating expenses. In 2020, non-operating expenses totaled $32.7 million, which included $18.2 million severance, retention awards and other costs, $12.9 million of impairment charges related to lease assets as a result of sub-leasing certain office space, and $1.6 million of amortization of intangible assets and other non-operating expenses. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other income and other expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we earned other income of $8.2 million (2021 &#8212; $14.7 million), which included $5.3 million of ACM other income (2021 &#8212; $1.1 million). We incurred other expenses totaling $20.1 million (2021 &#8212; $10.8 million), which primarily included letter of credit and revolving credit facility charges of $19.3 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, other income of $14.7 million (2020 &#8212; $49.8 million) included a gain of $9.7 million in relation to the prior year&#8217;s sale of our surety business, based upon having met certain premium production levels prescribed in the sale agreement, partially offset by other expenses totaling $10.8 million (2020 &#8212; $10.8 million).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment gains</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net realized and unrealized investment losses for the twelve months ended December&#160;31, 2022 were $177.6 million (2021 &#8212; gains of $8.8 million), which included $106.3 million of unrealized losses (2021 &#8212; gains of $5.0 million) caused by the mark to market valuation impact from higher interest rate and credit spread widening. These unrealized losses will unwind as the investments mature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net realized and unrealized investment gains for the twelve months ended December&#160;31, 2021 were $8.8 million (2020 &#8212; gains of $71.1 million), driven primarily by mark to market gains in our fixed income portfolios. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net investment income</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we generated net investment income of $188.1 million, an increase of 27.5% from the prior year (2021&#160;&#8212; $147.5 million), largely as a result of interest rate increases in the United States which led to higher income on floating rate assets. The higher rate environment, and credit spread widening, led to higher income from the reinvestment of maturing assets. Investment portfolio in 2022 is comprised primarily of interest on our fixed income securities portfolio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we generated net investment income of $147.5 million, a decrease of 4.6% from the prior year (2020&#160;&#8212; $154.6 million), largely as a result of redeploying $770.0 million of the investment portfolio to the adverse development cover. Net investment income in 2021 is comprised primarily of interest on our fixed income securities portfolio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in fair value of derivatives</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use foreign exchange contracts to manage foreign currency risk. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of our assets and liabilities denominated in foreign currencies, but rather allow us to establish a rate of exchange for a future point in time. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, we held foreign exchange contracts that were not designated as hedging under ASC 815 &#8212; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with a notional amount of $1,675.3 million (2021 &#8212; $1,545.7 million). The foreign exchange contracts are recorded as derivatives at fair value in the consolidated balance sheet with changes recorded as a change in fair value of derivatives in the statement of operations. For the twelve months ended December&#160;31, 2022, the impact of foreign exchange contracts on net income was a loss of $80.5 million (2021&#160;&#8212; loss of $35.9 million), attributable to foreign exchange contracts that had a loss of $65.9 million, which included an additional loss within the LPT embedded derivative of $14.6 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, we held foreign exchange contracts that were designated as hedges under ASC 815 with an aggregate notional amount of $109.7 million (2021 &#8212; $143.1 million). The foreign exchange contracts are recorded as assets or liabilities under derivative contracts in the consolidated balance sheet with the effective portion recorded in other comprehensive income and the ineffective portion recorded as a change in fair value of derivatives in the consolidated statement of operations. The contracts are effective and therefore the movement in other comprehensive income representing the effective portion for the twelve months ended December&#160;31, 2022 was a gain of $15.4 million (December&#160;31, 2021&#160;&#8212; loss of $6.2 million). </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the foreign exchange contracts settle, the realized gain or loss is reclassified from other comprehensive income into general administrative and corporate expenses of the consolidated statement of operations and other comprehensive income. For the twelve months ended December&#160;31, 2022, the amount recognized within general, administration and corporate expenses for settled foreign exchange contracts was a realized gain of $5.9 million (December&#160;31, 2021 &#8212; loss of $5.7 million).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2019, the Company entered into fixed for floating interest rate swaps with a total notional amount of $3,138.0&#160;million due to mature between January 18, 2021 and January 18, 2034. The interest rate swaps were used in the ordinary course of the Company&#8217;s investments activities to partially mitigate any negative impact of rises in interest rates on the market value of the Company&#8217;s fixed income portfolio. During 2020, we unwound the remaining $1,250.0 million of our interest rate swaps. For the twelve months ended December&#160;31, 2020, there was a loss of $81.1 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2021, we held foreign exchange contracts that were not designated as hedging under ASC 815 &#8212; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with a notional amount of $1,545.7 million (2020 &#8212; $1,402.3 million). The foreign exchange contracts are recorded as derivatives at fair value in the balance sheet with changes recorded as a change in fair value of derivatives in the statement of operations. For the twelve months ended December&#160;31, 2021, the impact of foreign exchange contracts on net income was a loss of $35.9 million (December&#160;31, 2020&#160;&#8212; gain of $16.0 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2021, we held foreign exchange contracts that were designated as hedging under ASC 815 with a notional amount of $143.1 million (2020 &#8212; $90.6 million). The foreign exchange contracts are recorded as derivatives at fair value with the effective portion recorded in other comprehensive income and the ineffective portion recorded as a change in fair value of derivatives in the statement of operations. The contracts are considered to be effective and therefore the movement in other comprehensive income representing the effective portion was reflected as a loss of $6.2 million for the twelve months ended December&#160;31, 2021 (December&#160;31, 2020&#160;&#8212; gain of $0.3 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the foreign exchange contracts settle, the realized gain or loss is reclassified from other comprehensive income into general administrative and corporate expenses of the statement of operations and other comprehensive income. For the twelve months ended December&#160;31, 2021, the amount recognized within general, administration and corporate expenses for settled foreign exchange contracts was a realized loss of $5.7 million (December&#160;31, 2020 &#8212; loss of $3.2 million recognized within general, administrative and corporate expenses).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value of derivatives in 2021 was attributable to fixed for floating interest rate swaps that had a loss of $Nil  (2020 &#8212; loss of $81.1 million), which was partly offset by a loss on foreign exchange contracts of $35.9 million (2020 &#8212; gain of $16.0 million).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $43.7 million in the twelve months ended December&#160;31, 2022 represents the interest on the 2023 Senior Notes of $14.3 million and interest payable on the funds withheld account on the LPT contract with Enstar of $29.4 million. This compared to $14.3 million of interest expense for the twelve months ended December&#160;31, 2021,  due to the interest payable on the LPT funds withheld account. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense in 2021 decreased compared to $33.9 million of interest expense for the twelve months ended December&#160;31, 2020, which included interest on the 2023 Senior Notes together with $19.6 million of interest paid on deferred premium payments on the ADC.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(Loss)/Income before tax</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022, 2021 and 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the twelve months ended December 31, 2022, loss before tax was $27.0 million (2021 &#8212; income of $35.1 million, 2020 &#8212; loss of $38.0 million).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income tax expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022, 2021 and 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was an income tax benefit for the twelve months ended December&#160;31, 2022 of $78.1 million compared to an income tax expense of $5.3 million in 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate (defined as the tax charge or credit, divided by the profit or loss before tax), for the twelve months ended December&#160;31, 2022, on profit before tax was 289.3% (2021 &#8212; 15.1%), driven by a change in judgment about the recoverability of deferred tax assets in the U.S. operating subsidiaries, resulting in a $94.2 million tax credit from the reversal of brought forward valuation allowance. We believe that the deferred tax assets of our U.S. operating subsidiaries will more likely than not be fully utilized over time, and therefore the previously recognized valuation allowance in relation to U.S. operating subsidiaries has been reversed. The effective tax rate is impacted by the relative profitability of the business underwritten in Bermuda, the United Kingdom and the United States, all of which have different corporate/federal tax rates.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was an income tax expense or the twelve months ended December&#160;31, 2021 of $5.3 million as well as an income tax expense of $18.4 million in 2020. The effective tax rate (defined as the tax charge or credit, divided by the profit or loss before tax), for the twelve months ended December&#160;31, 2021 on our profit before tax was 15.1% (2020 &#8212; (48.4)% ). The effective tax rate is driven by Base Erosion and Anti-abuse Tax in our U.S. operations and foreign taxes on profits in branches of U.K. entities that are subsequently unable to utilize foreign tax credits arising from their branches. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate is subject to revision in future periods if circumstances change and depends on the relative profitability of the business underwritten in Bermuda (where the rate of tax on corporate profits is zero), the United Kingdom (where the corporation tax rate was 19% for 2021)&#160;and the United States&#160;(where the federal income tax rate was 21% for 2021).&#160; The tax in each of the years is representative of the geographic spread of our business between taxable and non-taxable jurisdictions in such years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net income/(loss) after tax</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported net income after taxes of $51.1 million in 2022 compared to a net income of $29.8 million in 2021. The difference in net income was primarily due to an improvement in underwriting result of $220.4 million, reversal of brought forward deferred taxation valuation allowance, resulting in a $94.2 million tax credit, offset by a change in net realized and unrealized investment losses of $186.4 million, movement in change in fair value of derivatives of $44.6 million and movement in interest expense of $29.4 million. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2021, we reported a net income after taxes of $29.8 million compared to a net loss of $56.4 million in 2020. The difference in net income was primarily due to the $57.0 million improvement in the underwriting result, a reduction in non-operating expenses of $12.1 million and the increase in </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other income due the contingency gain of $9.7 million in relation to the prior year&#8217;s sale of our surety business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other comprehensive income</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other comprehensive income decreased by $383.3 million (2021 &#8212; $142.7 million decrease), net of taxes, for the twelve months ended December&#160;31, 2022. The decrease in total other comprehensive income includes a net unrealized loss of $423.3 million in the available for sale investment portfolio (2021 &#8212; $137.5 million net unrealized loss) attributable to the impact of rising interest rates on our bond portfolios, a $55.5 million reclassification of net realized loss to net income (2021 &#8212; $20.4 million reclassified realized gains), a $15.4 million unrealized gain (2021 &#8212; $6.2 million unrealized loss) on the hedged derivative contracts, and an unrealized loss in foreign currency translation on available for sale investments of $30.9 million (2021 &#8212; $21.4 million unrealized gain) largely attributable to the impact from the continued strengthening of the U.S. dollar against the British Pound and the Euro.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2021, total other comprehensive income decreased by $142.7 million (2020 &#8212; $96.4 million increase), net of taxes. The decrease in total other comprehensive income includes a net unrealized loss of $137.2 million in the available for sale investment portfolio (2020 &#8212; $175.1 million net unrealized gain) largely attributable to the impact of rising interest rates on our bond portfolios, a $20.4 million reclassification of net realized gains to net income (2020  &#8212; $67.1 million reclassified realized gains), a $6.2 million unrealized loss (2020 &#8212; $0.3 million unrealized gain) on the hedged derivative contracts and an unrealized gain in foreign currency translation of $21.4 million (2020  &#8212; $11.9 million unrealized loss) largely attributable to the impact from the continued strengthening of the U.S. dollar. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6444"></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Results by Business Segment </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are organized into two business segments, namely Reinsurance and Insurance. We have determined our reportable segments, Reinsurance and Insurance, by taking into account the manner in which the chief operating decision maker determines operating decisions and assesses operating performance. Profit or loss for each of the business segments is measured by underwriting income or loss. Underwriting profit is the excess of net earned premiums over the sum of losses and loss expenses, acquisition costs and general and administrative expenses. Underwriting income or loss provides a basis for management to evaluate the segment&#8217;s underwriting performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management measures segment results on the basis of the combined ratio, which is obtained by dividing the sum of the losses and loss expenses, acquisition costs and operating and administrative expenses by net earned premiums. Other than corporate expenses, indirect operating and administrative expenses are allocated to business segments predominantly based on each segment&#8217;s proportional share of gross earned premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-underwriting disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We provide additional disclosures for corporate and other (non-operating) income and expenses. Corporate and other income and expenses include net investment income, net realized and unrealized investment gains or losses, expenses associated with managing the Aspen Group, certain strategic and other costs, changes in fair value of derivatives and changes in fair value of loan notes issued by variable interest entities, interest expense, net realized and unrealized foreign exchange gains or losses and income taxes, which are not allocated to the business segments. Corporate expenses are not allocated to our business segments as they typically do not fluctuate with the levels of premiums written and are not directly related to our segment operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not allocate our assets by business segment as we evaluate underwriting results of each segment separately from the results of our investment portfolio. Segment profit or loss for each of our business segments is measured by underwriting income or loss. Refer to &#8220;Note 3&#8212;Segment Reporting&#8221; of our audited consolidated financial statements for information on gross and net written premiums and earned, underwriting income or loss, and combined ratios and reserves for each of our business segments. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6439"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reinsurance segment consists of property catastrophe reinsurance, other property reinsurance, casualty reinsurance and specialty reinsurance. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross written premiums</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows our gross written premiums for each line of business in our reinsurance segment for the twelve months ended December&#160;31, 2022, 2021 and 2020 and the percentage change in gross written premiums for each line of business: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lines of Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property catastrophe reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other property reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross written premiums in 2022 compared to 2021 in property catastrophe and other property reinsurance was primarily due to management&#8217;s decision to reduce exposure, notwithstanding increased rates achieved. The increase in gross written premiums in casualty reinsurance was primarily due to rate improvements, significant new business and higher retention rates. The increase in gross written premiums in specialty reinsurance was primarily due to increased new business in our mortgage business. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in gross written premiums in 2021 compared to 2020 in property catastrophe reinsurance was primarily due to an increase in reinstatement premiums owing to material catastrophe events such as U.S. winter storms, Hurricane Ida and European floods. The increase in gross written premiums in other property reinsurance was primarily due to underlying improvements in pricing, compounded by an increase in reinstatement premium owing to current year catastrophe experience.  The increase in gross written premiums in casualty reinsurance was primarily due to material rate improvements in U.S. casualty lines and organic growth. The decrease in gross written premiums in specialty reinsurance was primarily due to the sale of our interest in Crop Re Services LLC (&#8220;Crop Re&#8221;) to CGB Diversified Services, Inc. (&#8220;CGB DS&#8221;), which contributed $334.8 million in gross written premiums in 2020. This has been offset by organic growth within our mortgage business.  In 2020 and prior, specialty reinsurance included U.S. crop insurance business written on a reinsurance basis through our strategic partnership with CGB DS via Crop Re, a Delaware limited liability company responsible for directing the placement of reinsurance on behalf of CGB DS and CGB Insurance Company (&#8220;CGBIC&#8221;), an Indiana insurance company affiliate of CGB DS. In September 2020, we received notice from CGB DS that its controlling parent entered into a definitive agreement for the sale of CGB DS to a third party. The sale of CGB DS triggered an option for CGB DS to purchase Aspen&#8217;s 23.2% ownership interest in Crop Re. CGB DS exercised this right and purchased Aspen&#8217;s interest in Crop Re on December 14, 2020 (the &#8220;CGB Sale&#8221;). The CGB Sale resulted in a material diminution of our U.S. agricultural business in 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ceded written premiums</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums in 2022 were $380.6 million, a decrease of $17.4 million compared to 2021. This was due to a decrease in the level of reinsurance purchased protecting our property catastrophe reinsurance business lines, reflecting the decrease in exposures assumed. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums in 2021 were $398.0 million, an increase of $39.3 million compared to 2020. The increase in ceded written premiums was due to an increase in the level of reinsurance purchased protecting our property catastrophe reinsurance business lines. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net earned premiums</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums increased by $133.0 million, or 11.9%, in 2022 compared to 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums decreased by $168.9 million, or 13.1%, in 2021 compared to 2020 largely due to an increase in ceded premiums as a result of increased cession rates on property catastrophe reinsurance and lower gross written premiums. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Losses and loss adjustment expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss ratio was <ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-7">61.5</ix:nonFraction>% in 2022, a decrease of 1.5 percentage points compared to <ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-8">63.0</ix:nonFraction>% in 2021. This was mainly as a result of the current accident year loss ratio for 2022 of 46.6% which improved by 5.6 percentage points compared to 2021, due to improved underlying loss experience and improved pricing mainly from our casualty and specialty reinsurance business lines. Additionally, large losses experienced in our reinsurance segment during 2022 of $10.4 million, which primarily comprised of fire damage related losses. Large losses experienced in our reinsurance segment during 2021 were $21.7 million, comprised of $4.7 million of satellite related losses, $12.5 million of fire damage related losses and $4.5 million of cyber related losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catastrophe losses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe losses decreased from $255.0 million in 2021 to $245.1 million in 2022, improving the loss ratio by 3.2 percentage points. In 2022, the net catastrophe losses of $245.1 million included $95.0 million from Hurricane Ian, $31.9 million from Australia floods, $10.8 million from South Africa floods and $52.4 million of other weather-related events. 2022 also included $55.0 million of losses from the Russia/Ukraine war. Large losses experienced in our reinsurance segment during 2022 were $10.4 million, which primarily comprised of fire damage related losses. In 2021, the net catastrophe losses of $255.0 million included, $97.5 million from Hurricane Ida, $61.1 million from U.S. winter storms, $65.7 million from European floods and $30.7 million of other weather-related events. Large losses experienced in our reinsurance segment during 2021 were $21.7 million, comprised of $4.7 million of satellite related losses, $12.5 million of fire damage related losses and $4.5 million of cyber related losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior year development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Favorable prior year development totaled $24.6 million in the twelve months ended December 31, 2022 compared to $175.8 million in the twelve months ended December&#160;31, 2021. Reserve releases in 2022 were primarily from casualty reinsurance and property catastrophe. The reserve releases in 2021 were primarily from specialty reinsurance and casualty reinsurance. There is no net development for the 2019 and prior accident years, since loss development remains within the LPT reinsured limits. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of LPT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included a favorable movement of $34.2 million or 2.7 percentage points in the twelve months ended December&#160;31, 2022 compared with an unfavorable movement arising from the ADC and other retroactive contracts, of $41.4 million or 3.7 percentage points in the twelve months ended December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss ratio of <ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-9">63.0</ix:nonFraction>% in 2021 decreased by 11.4 percentage points compared to 74.4% in 2020. The decrease in the loss ratio was mainly due to $98.3 million increase in reserve releases, offset by an increase in catastrophe losses of $11.0 million and a $7.4 million increase in large losses. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catastrophe losses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our reinsurance segment experienced $244.0 million of net catastrophe losses, including $128.7&#160;million of losses from COVID-19, $35.3&#160;million from Hurricane Laura, $9.5&#160;million from California wildfires, $4.7&#160;million from Hurricane Isaias and $65.8&#160;million from other weather-related events. Large losses experienced in our reinsurance segment during 2020 were $14.3&#160;million, comprised of $1.6&#160;million of aviation losses, $4.1&#160;million of fire-related losses, $1.6&#160;million of water damage-related losses and $7.0&#160;million of business interruption losses unrelated to COVID-19. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior year development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year reserve releases totaled $134.4 million in 2021 compared with $36.1 million in the twelve months ended December&#160;31, 2020. Reserve releases in 2021 were primarily from specialty reinsurance and casualty reinsurance. The reserve releases in 2020 were primarily from casualty reinsurance, property catastrophe reinsurance and specialty reinsurance, partially offset by strengthening on other property reinsurance lines. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition, general and administrative expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition costs were $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" format="ixt:num-dot-decimal" scale="6" id="f-10">252.4</ix:nonFraction> million for the twelve months ended December&#160;31, 2022, equivalent to <ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-11">20.2</ix:nonFraction>% of net earned premiums (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" format="ixt:num-dot-decimal" scale="6" id="f-12">221.6</ix:nonFraction> million or <ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-13">19.8</ix:nonFraction>% of net earned premiums). The increase in the acquisition costs were mainly attributable to higher ceded commissions on casualty reinsurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses increased by $21.2 million from $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-14">121.3</ix:nonFraction> million in 2021 to $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-15">142.5</ix:nonFraction> million in 2022.  Our general and administrative expense ratio was <ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-16">11.4</ix:nonFraction>% in 2022 compared to <ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-17">10.8</ix:nonFraction>% in 2021 largely driven by an increase in Lloyd&#8217;s related costs due to increase in capacity, higher professional and consulting fees and an increase in IT and organizational change related costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition costs were $221.6 million for the twelve months ended December&#160;31, 2021, equivalent to 19.8% of net earned premiums (2020&#160;&#8212; $246.0 million or 19.1% of net earned premiums). The increase in the acquisition ratio was due to changes in the mix of business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses increased by $10.5 million from $110.8 million in 2020 to $121.3 million in 2021.  Our general and administrative expense ratio was 10.8% in 2021 compared to 8.6% in 2020 due to an increase in indirect costs such as IT managed services and hosting costs. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6434"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance segment consists of casualty and liability insurance, first party insurance, specialty insurance, financial and professional lines insurance, and Carbon Syndicate.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross written premiums</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows our gross written premiums for each line of business for the twelve months ended December&#160;31, 2022, 2021 and 2020 and the percentage change in gross written premiums for each line: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lines of Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 5.5pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;($&#160;in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($&#160;in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First party insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty and liability insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial and professional lines insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon Syndicate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,042.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refers to the premium made from an investment in a new start up, Carbon Syndicate 4747.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross written premiums in first party insurance and specialty insurance was largely attributable to our decision to cease underwriting in accident and health and the decision to withdraw from certain first party insurance program business. The increase in gross written premiums in 2022 compared to 2021 in casualty and liability insurance was attributable to strong performance across the retention of existing business, positive rate improvements and new business across our U.S. and U.K. platforms. The increase in gross written premiums in financial and professional lines insurance was largely attributable to new business benefiting from the stronger professional service market, resulting in increased premium on our management and professional liability lines and increase on major programs with strong rate improvements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in gross written premiums in 2021 compared to 2020 in casualty and liability insurance was attributable to strong performance across retention, rate improvements and new business across our U.S. and U.K. platforms. The increase in gross written premiums in financial and professional lines insurance was largely attributable to stronger professional service market in 2021 resulting in increased premium on management and professional liability lines of business and increased lines on major programs. The decrease in gross written premiums in specialty insurance was largely attributable to our decision to cease underwriting in accident and health and international marine and energy liability business which are currently part of our legacy lines.  The increase in first party insurance was due to rate increases and new business in U.K. commercial property lines and U.S. programs business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ceded written premiums</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums for 2022 was $1,062.1 million, an increase of $109.4 million from 2021. Ceded written premiums increased primarily within casualty and liability, and financial and professional lines due to increase in gross written premium and consequently increase in the proportion of business ceded to quota share programs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total ceded written premiums for 2021 was $952.7 million, an increase of $190.7 million from 2020. Ceded written premiums increased primarily within the financial and professional lines due to increase in gross written premium and consequently increase in the proportion of business ceded to quota share from excess of loss contracts. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net earned premiums</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums increased by $145.2 million, or 11.2%, in 2022 compared to 2021 largely due to increased gross written premium written within the year.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earned premiums increased by $51.9 million, or 4.2%, in 2021 compared to 2020 largely due to increased gross written premium written within the year.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Losses and loss adjustment expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss ratio in 2022 was <ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-18">63.3</ix:nonFraction>%, a decrease of 13.2 percentage points compared to <ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-19">76.5</ix:nonFraction>% in 2021. This was mainly due to the following:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current accident year loss ratio. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current accident year loss ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for 2022 of 53.0% improved by 4.0 percentage points compared to 2021 due to improved underlying loss experience and improved pricing mainly from our first party insurance, specialty insurance and casualty and liability business lines. Additionally large losses experienced during 2022 included $31.0 million, comprised of $9.8 million of terror related losses, $13.5 million of fire related losses, $3.8 million of property damage related losses and $3.9 million related to professional liability related losses. Large losses experienced during 2021 included $34.6 million, comprised of $13.7 million of fire related losses, $5.9 million of property damage related losses, $6.0 million of terror related losses and $9.0 million related to cyber-crime.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catastrophe losses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe losses decreased from $71.7 million in 2021 to $61.7 million 2022 improving the loss ratio by 1.3 percentage points. In 2022, the net catastrophe losses of $61.7 million included, $29.8 million from Hurricane Ian and $24.4 million from other weather-related events. 2022 also included $7.5 million of losses from the Russia/Ukraine war. In 2021, the net catastrophe losses of $71.7 million included $25.6 million from U.S. winter storm losses, $23.2 million from Hurricane Ida and $22.9 million from other weather-related events.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior year development on post-LPT years. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year development on post-LPT years totaled unfavorable development of $37.6 million in the twelve months ended December 31, 2022 compared with unfavorable development of $162.6 million in the twelve months ended December&#160;31, 2021. This reduction in unfavorable development resulted in an improvement in loss ratio of 10.0 percentage points.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of LPT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included an unfavorable movement of $49.3 million or 3.4 percentage points in the current period compared with unfavorable development of $16.9 million in the twelve months ended December&#160;31, 2021. This mainly reflects the one-off costs in relation to the LPT recognized in 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss ratio in 2021 was 76.5% compared to 71.1% in 2020. The increase in the loss ratio in 2021 was primarily due to a $144.3 million of unfavorable reserve development, from $35.2 million strengthening in 2020 to $179.5 million strengthening in 2021, mainly due to deterioration of legacy lines business including international marine and energy liability and accident and health, plus further deterioration within continuing U.S. primary casualty lines and the recognition of opioid provision. This has been offset by reserve releases on a number of classes following good claims experience and recognition of recoveries on the ADC, increase in net earned premiums of $51.9 million, $14.6 million decrease in large losses and a $45.1 million decrease in catastrophe losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catastrophe losses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the insurance segment experienced $71.7 million of net catastrophe losses, due to $25.6 million from U.S. winter storm losses, $23.2 million from Hurricane Ida and $22.9 million from other weather-related events. Large losses experienced during 2021 included $34.6 million, comprised of $13.7 million of fire related losses, $5.9 million of property damage related losses, $6.0 million of crisis related losses and $9.0 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million related to cyber crime. In 2020, the insurance segment experienced $116.8 million of net catastrophe losses, due to $52.5&#160;million from COVID-19 losses and $64.3&#160;million from other weather-related events.  Large losses experienced during 2020 included $49.2&#160;million, comprised of $12.9&#160;million of construction related losses, $4.0&#160;million of property damage related losses, $15.3 million of credit risk related losses, $14.5&#160;million of accident and health related losses and  $2.5&#160;million related to cyber crime.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior year development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, there was net unfavorable reserve development of $179.5 million compared with $35.2 million in the twelve months ended December&#160;31, 2020. The net unfavorable reserve development was primarily from deterioration of legacy lines business including international marine and energy liability and accident and health, plus further deterioration within continuing U.S. primary casualty lines and the recognition of opioid provision. This has been offset by reserve releases on a number of classes following good claims experience and recognition of recoveries on the ADC.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reserve strengthening in 2020 was primarily from our first party insurance, specialty insurance and casualty insurance lines. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition, general and administrative expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 compared to 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition costs were $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" format="ixt:num-dot-decimal" scale="6" id="f-20">179.4</ix:nonFraction> million in 2022, equivalent to <ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-21">12.5</ix:nonFraction>% of net earned premiums (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" format="ixt:num-dot-decimal" scale="6" id="f-22">192.5</ix:nonFraction> million or <ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-23">14.9</ix:nonFraction>% of net earned premiums). The decrease in the acquisition cost ratio in 2022 compared with 2021 was due to a greater proportion of our business being ceded to ACM businesses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses increased by $32.2 million&#160;to $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-24">244.0</ix:nonFraction> million in 2022 from $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-25">211.8</ix:nonFraction> million in 2021. Our general and administrative expense ratio was <ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-26">17.0</ix:nonFraction>% in 2022 compared to <ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-27">16.4</ix:nonFraction>% in 2021 due to increased staff costs, higher professional and consulting fees and additional expenses arising from investment in Carbon Syndicate and organizational change.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 compared to 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition costs were $192.5 million in 2021, equivalent to 14.9% of net earned premiums (2020 &#8212; $219.7 million or 17.7% of net earned premiums).  The decrease in the acquisition expense ratio in 2021 compared with 2020 was due to underwriters achieving favorable brokerage terms and higher ceded commission on quota share contracts. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses increased by $14.6 million&#160;to $211.8 million in 2021 from $197.2 million in 2020.  Our general and administrative expense ratio was 16.4% in 2021 compared to 15.9% in 2020 due to increased IT and staff costs and additional expenses rising from the investment in carbon syndicate. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8280"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance Sheet</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total cash and investments </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023 and December&#160;31, 2022, total cash and investments, including accrued interest receivable were $7.4 billion and $7.1 billion, respectively. Total cash and investments increased mainly due to an increase in operating cash flow compared to prior year, the increase in the fair value of investments during the year, including $12.3 million unrealized gain on available for sale investments, $18.0 million unrealized/realized gain on trading investments and available for sale investments, offset by payments of ordinary and preference dividends of $42.2&#160;million. Our investment&#160;strategy is focused on&#160;delivering&#160;stable investment income and total&#160;return through all market cycles while maintaining appropriate portfolio liquidity and credit quality to meet the requirements of our customers, rating agencies and regulators.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, a significant majority of funds available for investment were deployed in a widely diversified portfolio of high quality, investment grade securities, including U.S. government, corporate and U.S. agency mortgage-backed bonds. As part of our strategic asset allocation, we also invest a portion of our portfolio in return seeking assets such as unrated private fixed and floating rate investments, and other specialty classes. These </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities generally pay a higher rate of interest or return and may have a higher degree of credit or default risk, or less liquidity. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The duration of total fixed income securities (the aggregate of available for sale and trading) as at June&#160;30, 2023 was 2.7 years compared to 3.0 years as at December&#160;31, 2022. In addition, as at June&#160;30, 2023, the average credit rating of these fixed income securities was &#8220;AA-,&#8221; with 84.7% being rated &#8220;A&#8221; or higher. As at December&#160;31, 2022, the average credit rating of our fixed income securities portfolio was &#8220;AA-,&#8221; with 85.4% being rated &#8220;A&#8221; or higher. The average credit rating is calculated using the Bloomberg Barclays Index credit quality methodology.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;Managed Portfolio&#8221; is comprised of our cash and investments, excluding catastrophe bonds and funds held by variable interest entities. As at June&#160;30, 2023, the Company had a 2.9% allocation to real estate funds and a 5.4% allocation to middle market loans (&#8220;MML&#8221;) and commercial mortgage loans (&#8220;CML&#8221;), representing in total 8.3% of our Managed Portfolio. As at December&#160;31, 2022, the Company had a 3.1% allocation to real estate funds and a 6.0% allocation to MML and CML representing in total 9.1% of our Managed Portfolio. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative unrealized losses in the available for sale investment portfolio, net of taxes, were $322.5 million as at June&#160;30, 2023, a decrease of $10.7 million from the net $333.2&#160;million unrealized losses as at December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, we had investments in three entities classified as other investments, equity method: a micro-insurance incubator (&#8220;MVI&#8221;), a multi-line reinsurer (&#8220;Multi-line Reinsurer&#8221;) and Digital Risk Resources, LLC. During 2023, the Company invested additional capital of $0.4&#160;million in Multi-line Reinsurer (December&#160;31, 2022 &#8212; $1.6&#160;million). The aggregate value of these investments as at June&#160;30, 2023, was $7.0&#160;million (December&#160;31, 2022 &#8212; $6.2&#160;million). For further information regarding these investments, refer to &#8220;Note 4&#8212;Investments&#8221; of our unaudited condensed consolidated financial statements for additional details. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the aggregate current fair value of the real estate funds investments was $213.4 million (December&#160;31, 2022 &#8212; $221.3 million).  For further information regarding these investments, refer to &#8220;Note 4&#8212;Investments&#8221; of our unaudited condensed consolidated financial statements for additional details.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of our cash and investments as at June 30, 2023 and December 31, 2022 is summarized below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Estimated Fair&#160;Value</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Percentage&#160;of Total&#160;Cash&#160;and Investments </span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Estimated Fair&#160;Value</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Percentage&#160;of Total&#160;Cash&#160;and Investments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Fixed Income Securities&#160;&#8212; Available for Sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,013.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">953.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,875.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,845.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">269.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">213.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Fixed Income Securities&#160;&#8212; Available for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,908.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,788.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Fixed Income Securities&#160;&#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">235.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">165.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">924.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">896.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Fixed Income&#160;Securities &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,478.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,475.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other investments, equity method</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">221.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total catastrophe bonds &#8212; trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">482.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total short-term investments &#8212; available for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total short-term investments &#8212; trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">959.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Cash and Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,333.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,045.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net (payable)/receivable for securities sold</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29.5)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued interest receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Investable Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,352.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,096.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total other investments represents our investments in real estate, infrastructure and direct lending funds. For further information refer to &#8220;Note 4&#8212;Investments&#8221; of our consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company had invested $12.1 million in equity securities in privately-held investments, as part of the Company&#8217;s strategic asset allocation (December 31, 2022 &#8212; $6.6 million). We had no other investments in equity securities as at June&#160;30, 2023 (December 31, 2022 &#8212; no other investments in equity securities).</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8270"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reserves for Losses and Loss Adjustment Expenses  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision is made at the end of each year for the estimated ultimate cost of claims incurred but not settled at the balance sheet date, including the cost of IBNR claims and development of existing reported claims. The estimated cost of claims includes expenses to be incurred in settling claims and a deduction for the expected value of salvage and other recoveries. Estimated amounts recoverable from reinsurers on unpaid losses and loss adjustment expenses are calculated to arrive at a net claims reserve. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves by Segment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, we had total net loss and loss adjustment expense reserves of $3,082.9 million (December&#160;31, 2022&#160;&#8212; $2,813.2 million). This amount represented our best estimate of the ultimate liability for payment of losses and loss adjustment expenses. Of the total gross reserves for unpaid losses of $7,740.9 million at the balance sheet date of June&#160;30, 2023, a total of $4,454.2 million, or 57.5%, represented IBNR claims (December&#160;31, 2022&#160;&#8212; $4,323.1 million and 56.1%, respectively). The following tables analyze gross and net loss and loss adjustment expense reserves by business segment as at June&#160;30, 2023 and December&#160;31, 2022, respectively:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance<br/>Recoverable</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,830.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,469.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,827.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total losses and loss expense reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,740.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,658.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance<br/>Recoverable</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,989.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,360.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,907.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,452.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total losses and loss expense reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,897.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within reinsurance recoverables we have recognized $1,877.3&#160;million of recoverables on the LPT as at June&#160;30, 2023 (December&#160;31, 2022&#160;&#8212; $2,132.0&#160;million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross reserves may be further analyzed between outstanding claims and IBNR as at June&#160;30, 2023 and December&#160;31, 2022 as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Case Reserves&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IBNR&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reserve&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;IBNR&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,469.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total losses and loss expense reserves</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,286.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,740.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Case Reserves&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IBNR&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reserve&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;IBNR&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total losses and loss expense reserves</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,387.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,323.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior Year Loss Reserves</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">For the six months ended June&#160;30, 2023 and 2022</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023, there was an overall (decrease) in our estimate of ultimate net claims to be paid in respect of prior accident years. An analysis of this overall net increase/(decrease) by business segment is as follows for each of the six months ended June&#160;30, 2023 and 2022. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total losses and loss expense reserves changes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">For the six months ended June&#160;30, 2023</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The analysis of the development by each segment is as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net reserve strengthening of $2.1 million in the six months ended June&#160;30, 2023, primarily from adverse prior year development of $1.3 million within the property catastrophe and other reinsurance lines of business and the unfavorable movement of the deferred gain on 2019 and prior accident years of $0.8 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net favorable reserve development of $8.5 million in the six months ended June&#160;30, 2023, mainly due to the favorable movement of $13.2 million in the deferred gain on retroactive contracts, offset by adverse prior year development of $4.7 million on accident years 2020 onwards. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">For the six months ended June&#160;30, 2022</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The analysis of the development by each segment is as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net reserve strengthening of $8.8 million in the six months ended June&#160;30, 2022, due to adverse prior year development of $22.4 million offset by the favorable movement of $13.6 million on the deferred gain on the LPT.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net favorable reserve development of $16.1 million in the six months ended June&#160;30, 2022, due to favorable prior year development of $3.8 million on accident years 2020 onwards, together with a favorable movement on the deferred gain on the LPT of $12.3 million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not make any significant changes in methodologies used in our reserving process between the six months ended June&#160;30, 2022 and six months ended June&#160;30, 2023. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Twelve months ended December&#160;31, 2022, 2021 and 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, there was an overall (decrease) in our estimate of ultimate net claims to be paid in respect of prior accident years. An analysis of this overall net increase/(decrease) by business segment is as follows for each of the twelve months ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total losses and loss expense reserves changes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">For the twelve months ended December&#160;31, 2022 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The analysis of the development by each segment is as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net reserve releases of $58.8 million in 2022, primarily from favorable reserve development on accident years 2020 and 2021 of $24.6 million on casualty reinsurance and other property reinsurance lines and the favorable impact of the LPT of $34.2 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net unfavorable reserve development of $86.9 million in 2022, mainly due to adverse prior year development on accident years 2020 and 2021 within international marine and energy liability, U.S. management and professional liability and excess and U.S. casualty of $37.6 million and the unfavorable movement of $49.3 million due to the impact of the LPT, mainly reflecting the one-off costs in relation to the LPT recognized in 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">For the twelve months ended December&#160;31, 2021</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The analysis of the development by each segment is as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net reserve releases of $134.4 million in 2021 were mainly due to releases on casualty reinsurance and specialty reinsurance. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net unfavorable reserve development of $179.5 million in 2021 was primarily from casualty insurance, first party insurance lines and specialty insurance lines. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not make any significant changes in methodologies used in our reserving process between 2021 and 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">For the twelve months ended December&#160;31, 2020</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The analysis of the development by each segment is as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net reserve releases of $36.1 million in 2020 were mainly due to releases on casualty reinsurance, property catastrophe reinsurance and specialty reinsurance, partially offset by strengthening on other property reinsurance lines.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Net unfavorable reserve development of $35.2 million in 2020 was primarily from our casualty lines.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not make any significant changes in methodologies used in our reserving process between 2020 and 2021.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8265"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Premiums Payable </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance Premiums Payable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;As at June&#160;30, 2023, we had reinsurance premiums payables totaling $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ReinsurancePayable" format="ixt:num-dot-decimal" scale="6" id="f-28">1,833.7</ix:nonFraction> million compared to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsurancePayable" format="ixt:num-dot-decimal" scale="6" id="f-29">1,980.1</ix:nonFraction> million as at December&#160;31, 2022, a decrease of $146.4&#160;million, primarily driven by the reduction in the funds withheld related to the LPT contract.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2855"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity is a measure of a company&#8217;s ability to generate cash flows sufficient to meet short-term and long-term cash requirements of its business operations. Management monitors the liquidity of Aspen Holdings and of each of its Operating Subsidiaries and arranges credit facilities to enhance short-term liquidity and capital resources on a stand-by basis. As a holding company, Aspen Holdings relies on dividends and other distributions from its Operating Subsidiaries to provide cash flow to meet ongoing cash requirements, including claims settlements, any future debt service payments and other expenses, and to pay dividends, if any, to our preference and ordinary shareholders. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, Aspen Holdings held $92.6 million (December&#160;31, 2022&#160;&#8212; $84.9 million) of cash, cash equivalents and investments. Management considers the current cash and cash equivalents, together with dividends declared or expected to be declared by subsidiary companies and our credit facilities, sufficient to appropriately satisfy planned and expected liquidity requirements of Aspen Holdings for at least the next twelve months. Aspen Holdings&#8217; liquidity depends on dividends, capital distributions and interest payments from our Operating Subsidiaries. See &#8220;Risk Factors&#8212;Risks Related to Our Ordinary Shares and this Offering&#8212;Our holding company structure and certain Companies Act, regulatory and other constraints may limit our ability to pay dividends on our securities&#8221; and &#8220;Dividend Policy&#8221; for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Subsidiaries</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Operating Subsidiaries held $1,181.6 million (December&#160;31, 2022&#160;&#8212; $869.1 million) in cash and short-term investments that are readily realizable securities. Management monitors the value, currency and duration of cash and investments held by the Operating Subsidiaries to ensure they are able to meet their insurance and other liabilities as they become due and was satisfied that there was a comfortable margin of liquidity as at June&#160;30, 2023 and for the foreseeable future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, our Operating Subsidiaries&#8217; sources of funds primarily consist of premiums written, investment income and proceeds from sales and redemptions of investments. Cash is used primarily to pay reinsurance premiums, losses and loss adjustment expenses, brokerage commissions, general and administrative expenses, taxes, interest and dividends and to purchase new investments. The potential for individual large claims and for accumulations of claims from single events means that substantial and unpredictable payments may need to be made within relatively short periods of time. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We ensure that sufficient cash and short-term investments are held to enable us to meet potential claims without liquidating long term investments and adversely affecting our investment return. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage these risks by making regular forecasts of the timing and amount of expected cash outflows and ensuring that we maintain sufficient balances in cash and short-term investments to meet these estimates. Notwithstanding this policy, if these cash flow forecasts are incorrect, we could be forced to liquidate investments prior to maturity, potentially at a material loss. Historically, we have not had to liquidate investments at a material loss to maintain sufficient levels of liquidity. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where we incur losses in currencies which are not normally held, we will convert funds into the appropriate currencies to mitigate our currency risk and also make funds available to settle claims in local currencies as and when they become due.&#160;For local regulatory reasons, we hold assets in trusts which limits our liquidity to some degree. The process of matching assets with liabilities in currency means, however, that at any one time we will hold cash and short-term assets in all major currencies which are available to settle claims. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liquidity of our Operating Subsidiaries is also affected by the terms of our contractual obligations to policyholders and by undertakings to certain regulatory authorities to facilitate the issue of letters of credit or maintain certain balances in trust funds for the benefit of policyholders, or restricted for other reasons. The </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">following table shows the forms of collateral or other security provided in respect of these obligations and undertakings as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory trusts and deposits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated transactions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,773.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit / guarantees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets (excluding illiquid assets)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,657.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments &#8212; illiquid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets and illiquid assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,870.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,217.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total as percent of cash and invested assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated cash flows for the six months ended June&#160;30, 2023</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net cash flow from operations for the six months ended June&#160;30, 2023 was $264.6 million, a $159.8 million increase in cash flow from the equivalent period in 2022. We paid net claims of $469.4 million in 2023 and utilized cash of $124.5 million for investing during the period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow from financing activities were an outflow of $42.2 million, due to the payment of ordinary and Preference Share dividends of $42.2 million. At June&#160;30, 2023, we had a balance of cash and cash equivalents of $1,061.5 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated cash flows for the twelve months ended December&#160;31, 2022 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net cash flow used in operations for the twelve months ended December&#160;31, 2022 was $55.0 million, a $579.5 million decrease in cash flow from the equivalent period in 2021. The decrease in cash generated through operating activities was mainly due to an increase in reinsurance recoverables, for payments made on gross claims and not yet collected from the reinsurer, and the repayment of our credit facility. We paid net claims of $1,291.1 million in 2022 and utilized cash of $196.5 million for investing during the period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow from financing activities were an outflow of $84.6 million, due to the payment of ordinary and Preference Share dividends of $84.6 million. At December&#160;31, 2022, we had a balance of cash and cash equivalents of $959.2 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated cash flows for the twelve months ended December&#160;31, 2021 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net cash flow generated in operations for the twelve months ended December&#160;31, 2021 was $524.7 million, an  increase in cash from the equivalent period in 2020. The increase in cash generated in operations for the twelve months ended December&#160;31, 2021 was mainly attributable to the cash outflow in 2020 due to the purchase of the adverse development cover. We paid net claims of $1,309.8 million in 2021 and utilized cash of $950.3 million for investing during the period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow from financing activities were $0.5 million, including additional capital contribution of $45.0 million, offset by Preference Share dividends of $44.5 million. At December&#160;31, 2021, we had a balance of cash and cash equivalents of $1,314.1 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated cash flows for the twelve months ended December&#160;31, 2020&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net cash flow used in operations for the twelve months ended December 31, 2020 was $672.7 million, a $334.9 million increase in cash used from the equivalent period in 2019. The increase in cash used in operations for the twelve months ended December&#160;31, 2020 was mainly attributable the purchase of the adverse development cover. For the twelve months ended December&#160;31, 2020, the cash flows used in operations required funds to be </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">realized from the investment portfolio. We paid net claims of $1,764.6 million in 2020, and generated cash inflows of $1,151.2 million from investing during the period.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow from financing activities were $223.5 million, including additional capital contribution of $268.0 million, offset by Preference Share dividends of $44.5 million. At December&#160;31, 2020, we had a balance of cash and cash equivalents of $1,747.3 million.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain our capital at an appropriate level as determined by our internal risk appetite and the financial strength required by our customers, regulators and rating agencies, sufficient to address such capital requirements for at least the next twelve months. We monitor and review the Aspen Group and the Operating Entities&#8217; capital and liquidity positions on an ongoing basis.&#160;The following table shows our capital structures as at June&#160;30, 2023 compared to December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital, additional paid-in capital, retained income and accumulated other comprehensive income attributable to ordinary shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,795.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference shares (liquidation preferences net of issue costs)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,848.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,657.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, total shareholders&#8217; equity was $2,548.7 million compared to $2,358.0 million as at December&#160;31, 2022. Our total shareholders&#8217; equity as at June&#160;30, 2023 includes three classes of Preference Shares with a total value as measured by their respective liquidation preferences of $775.0 million less issuance costs of $21.5 million (December&#160;31, 2022&#160;&#8212; $775.0 million, three classes of Preference Shares less issuance costs of $21.5 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Preference Shares are classified in our balance sheet as equity but may receive a different treatment in some cases under the capital adequacy assessments made by certain rating agencies. Such securities are often referred to as &#8220;hybrids&#8221; as they have certain attributes of both debt and equity. Management monitors the ratio of the total of debt and hybrids to total capital which was 37.0% as of June&#160;30, 2023 (December&#160;31, 2022&#160;&#8212; 39.6%). Total capital is defined as being shareholders&#8217; equity plus outstanding debt.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, Aspen Holdings&#8217; material debt outstanding was our 2023 Senior Notes, which were fully repaid in November 2023 using the proceeds from the $300.0 million 2026 Term Loan. As at June&#160;30, 2023 and December&#160;31, 2022, the value of debt less amortization expenses was $299.9 million and $299.9 million, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management monitors the ratio of debt to total capital which was 10.5% as at June&#160;30, 2023 (December 31, 2022 &#8212; 11.3%). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no principal capital management transactions during the six months ended June&#160;30, 2023. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2026 Term Loan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2023, the Company entered into a $300.0 million term loan facility at a borrowing rate of term SOFR plus an applicable margin pursuant to the Term Loan Credit Agreement. On November 9, 2023, the Company drew down $300.0 million on the 2026 Term Loan due November 9, 2026 and the proceeds were used to redeem the 2023 Senior Notes.  Subject to applicable law, the 2026 Term Loan will be the senior unsecured obligations of Aspen Holdings and will rank equally in right of payment with all of our other senior unsecured indebtedness from time to time outstanding. Under the Term Loan Credit Agreement, the Company must not permit (a) consolidated tangible net worth as at the last day of each fiscal quarter of the Company to be less than the sum of (i) $2,019,600,000, (ii) 25% of consolidated net income during the period from January 1, 2021 to and including such </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">last day of such fiscal quarter (if positive) and (iii) 25% of the aggregate net cash proceeds of all issuances by the Company of shares of its capital stock during the period from January 1, 2021 to and including such last day of such fiscal quarter, but excluding (x) any amount included in the Company&#8217;s accumulated other comprehensive income or loss related to unrealized gains or losses on available for sale securities and (y) during the period from January 1, 2022, any amount included in net unrealized investment gains or losses, related to unrealized gains or losses on trading securities, (b) the ratio of its total consolidated debt to the sum of such debt plus our consolidated tangible net worth to exceed 35% as at the last day of any fiscal quarter of the Company or (c) any material insurance subsidiary to have a financial strength rating of less than &#8220;B++&#8221; from A.M. Best. The Credit Agreement contains other customary affirmative and negative covenants, including (subject to various exceptions) restrictions on the ability of the Company and its subsidiaries to incur indebtedness, create or permit liens on their assets, engage in mergers or consolidations, dispose of assets, pay dividends or other distributions, purchase or redeem the Company&#8217;s equity securities, make investments and enter into transactions with affiliates. In addition, the Term Loan Credit Agreement has customary events of default, including (subject to certain materiality thresholds and grace periods) payment default, failure to comply with covenants, material inaccuracy of representation or warranty, bankruptcy or insolvency proceedings, change of control and cross-default to other debt agreements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Access to capital</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are in part dependent on our financial strength, the opinions of the independent rating agencies thereof as discussed elsewhere in this prospectus and the market&#8217;s perception thereof, as measured by total shareholders&#8217; equity, which was $2,548.7 million as at June&#160;30, 2023 (December&#160;31, 2022&#160;&#8212; $2,358.0 million). Our ability to access the capital markets is dependent on, among other things, our operating results, market conditions and our perceived financial strength. We regularly monitor our capital and financial position, as well as investment and securities market conditions, both in general and with respect to Aspen Holdings&#8217; securities. Our Preference Shares and depositary shares are listed on the New York Stock Exchange (the &#8220;NYSE&#8221;).</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2885"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we are principally exposed to three types of market risk: interest rate risk, foreign currency risk and credit risk. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment portfolio consists primarily of fixed income securities. Fluctuations in interest rates have a direct impact on the market valuation of these securities. Accordingly, our primary market risk exposure is to changes in interest rates. As interest rates rise, the market value of our fixed-income portfolio falls and the converse is also true. We manage interest rate risk by maintaining a short to medium duration to reduce the effect of interest rate changes on book value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below depicts interest rate change scenarios and the effect on our interest rate sensitive invested assets as at June&#160;30, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of Changes in Interest Rates on Portfolio Given a Parallel Shift in the Yield Curve</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Movement in Rates in Basis Points</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-100</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-50&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">100</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,199.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,974.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,899.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of Portfolio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corresponding percentage at December&#160;31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Market value includes our fixed income portfolio, short term investments and privately held investments. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign currency risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and the functional currency of our operations is the U.S.&#160;dollar. As at June&#160;30, 2023, approximately 89.9% of our cash and investments was held in U.S.&#160;dollars (December&#160;31, 2022&#160;&#8212; 61.2%), and approximately 10.1% was in currencies other than the U.S.&#160;dollar (December&#160;31, 2022&#160;&#8212; 38.8%). For the six months ended June&#160;30, 2023, 26.3% of our gross premiums were written in currencies other than the U.S.&#160;dollar (December&#160;31, 2022&#160;&#8212; 22.9%) and we expect that a similar proportion will be written in currencies other than the U.S.&#160;dollar in the remainder of 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other foreign currency amounts are remeasured to U.S.&#160;dollars and the resulting foreign exchange gains or losses are reflected in the statement of operations. The remeasurement is calculated using current exchange rates for the balance sheets and average exchange rates for the statement of operations. We may experience exchange losses to the extent that our foreign currency exposure is not properly managed or otherwise hedged which would in turn adversely affect our results of operations and financial condition. Management estimates that a 10% change in the exchange rate between British pounds and U.S.&#160;dollars, as an example, as at June&#160;30, 2023 would have impacted reported net comprehensive income by approximately $40.0 million (December&#160;31, 2022&#160;&#8212; $35.9 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to manage our foreign currency risk by seeking to match our liabilities under insurance and reinsurance policies that are payable in foreign currencies with investments that are denominated in those currencies, which may involve the use of forward exchange contracts. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of our assets and liabilities denominated in foreign currencies but rather allow us to establish a rate of exchange for a future point in time. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, we held foreign exchange contracts that were not designated as hedging under ASC 815, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; with an aggregate notional value of $1,884.0 million (December&#160;31, 2022 &#8212; $1,675.3 million). The foreign exchange contracts are recorded as derivatives at fair value in the balance sheet with changes recorded as a change in fair value of derivatives in the statement of operations. For the six months ended June&#160;30, 2023, the impact of foreign exchange contracts on net income was a gain of $19.6 million (twelve months ended December&#160;31, 2022&#160;&#8212; loss of $80.5 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, we held foreign exchange contracts that were designated as hedging under ASC 815 with an aggregate notional value of $54.7 million (December&#160;31, 2022 &#8212; $109.7 million). The foreign exchange contracts are recorded as liabilities under derivative contracts in the balance sheet with the effective portion recorded in other comprehensive income and the ineffective portion recorded as a change in fair value of derivatives in the statement of operations. The contracts are considered to be effective and the movement in other comprehensive income representing the effective portion was a loss of $4.3 million for the six months ended June&#160;30, 2023 (December&#160;31, 2022&#160;&#8212; gain of $15.4 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the foreign exchange contracts settle, the realized gain or loss is reclassified from other comprehensive income into general, administration and corporate expenses of the statement of operations and other comprehensive income. For the six months ended June&#160;30, 2023, the amount recognized within general, administration and corporate expenses for settled foreign exchange contracts was a realized loss of $3.7 million (December&#160;31, 2022 &#8212; gain of $5.9 million).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have exposure to credit risk primarily as a holder of fixed income securities and private securities. Our risk management strategy and investment policy is to invest mainly in debt instruments of high credit quality issuers. We also invest a portion of the portfolio in securities that are below investment grade or in unrated private securities and other specialty asset classes. We reduce the amount of credit exposure by setting limits with respect to particular ratings categories, business sectors and any one issuer. As at June&#160;30, 2023, the average rating of fixed income maturities in our investment portfolio was &#8220;AA-&#8221; (December&#160;31, 2022&#160;&#8212; &#8220;AA-&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are exposed to the credit risk of our insurance and reinsurance brokers to whom we make claims payments for our policyholders, as well as to the credit risk of our reinsurers and retrocessionaires who assume </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business from us. Other than fully collateralized reinsurance, the substantial majority of our reinsurers have a rating of &#8220;A&#8221; (Excellent), the third highest of fifteen rating levels, or better by A.M.&#160;Best and the minimum rating of any of our material reinsurers is &#8220;A-&#8221; (Excellent), the fourth highest of fifteen rating levels, by A.M.&#160;Best. The total amount recoverable by the Company from reinsurers as at June&#160;30, 2023 was $4,658.0 million (December&#160;31, 2022&#160;&#8212; $4,897.7 million). Of the Company&#8217;s reinsurance recoverable balance at June&#160;30, 2023, 56.0% is collateralized by our reinsurers, 43.5% is recoverable from reinsurers rated A- or higher by major rating agencies and 0.5% is recoverable from reinsurers rated lower than A- by major rating agencies (December&#160;31, 2022 &#8212; 57.9%, 42.0% and 0.1%, respectively). As at June&#160;30, 2023, the Company&#8217;s largest collateralized exposures to individual reinsurers represent 16.0% (December&#160;31, 2022&#160;&#8212;16.3%), 9.2% (December&#160;31, 2022&#160;&#8212; 9.7%), and 7.8% (December&#160;31, 2022&#160;&#8212; 8.2%).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the current expected credit loss model (&#8220;CECL&#8221;), the Company recognized a provision against reinsurance recoverables of $3.3 million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $3.7 million). For the six months ended June&#160;30, 2023 there was a decrease in the CECL allowance on reinsurance recoverables of $0.4 million (December&#160;31, 2022  &#8212; $0.4 million increase).</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6461"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the following are critical accounting policies used in the preparation of our consolidated financial statements. A statement of all the significant accounting policies we use to prepare our financial statements is included in the Notes to the consolidated financial statements. If factors such as those described in &#8220;Risk Factors&#8221; cause actual events to differ from the assumptions used in applying the accounting policies and calculating financial results, there could be a material adverse effect on our operating results, financial condition and liquidity. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Written Premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written premiums comprise the estimated premiums on contracts of insurance and reinsurance entered into in the reporting period, except in the case of proportional reinsurance contracts, where written premiums relate only to our estimated proportional share of premiums due on contracts entered into by the ceding company prior to the end of the reporting period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All premium estimates are reviewed regularly, comparing actual reported premiums to expected ultimate premiums along with a review of the collectability of premiums receivable. Based on management&#8217;s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the periods in which they become known. Adjustments to original premium estimates could be material and these adjustments may directly and significantly impact earnings in the period they are determined because the subject premium may be fully or substantially earned. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer to premiums receivable which are not fixed at the inception of the contract as adjustment premiums. The proportion of adjustment premiums included in the premium estimates varies between business lines with the largest adjustment premiums associated with property and casualty reinsurance business and the smallest with property and liability insurance lines. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustment premiums are most significant in relation to reinsurance contracts. Different considerations apply to non-proportional and proportional treaties as follows: </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-proportional treaties</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A large number of the reinsurance contracts we write are written on a non-proportional or excess of loss treaty basis. As the ultimate level of business written by each cedant can only be estimated at the time the reinsurance is placed, the reinsurance contracts generally stipulate a minimum and deposit premium payable under the contract with an adjustable premium determined by variables such as the number of contracts covered by the reinsurance, the total premium received by the cedant and the nature of the exposures assumed. Minimum and deposit premiums generally cover the majority of premiums due under such treaty reinsurance contracts and the adjustable portion of the premium is usually a small portion of the total premium receivable. For excess of loss contracts, the minimum and deposit premium, as defined in the contract, is generally considered to be the best estimate of the contract&#8217;s </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">written premium at inception. Accordingly, this is the amount we generally record as written premium in the period the underlying risks incept. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the life of a contract, notifications from cedants and brokers may affect the estimate of ultimate premium and result in either increases or reductions in reported revenue. Changes in estimated adjustable premiums do not generally have a significant impact on short-term liquidity as the payment of adjustment premiums generally occurs after the expiration of a contract. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many non-proportional treaties also include a provision for the payment to us by the cedant of reinstatement premiums based on loss experience under such contracts. Reinstatement premiums are the premiums charged for the restoration of the reinsurance limit of an excess of loss contract to its full amount after payment by the reinsurer of losses as a result of an occurrence. These premiums relate to the future coverage obtained during the remainder of the initial policy term and are included in revenue in the same period as the corresponding losses. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proportional treaties (&#8220;treaty pro rata&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates of premiums assumed under treaty pro rata reinsurance contracts are recorded in the period in which the underlying risks are expected to incept and are based on information provided by brokers and ceding companies and estimates of the underlying economic conditions at the time the risk is underwritten. We estimate premiums receivable initially and update our premium estimates regularly throughout the contract term based on treaty statements received from the ceding company. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reported gross written premiums for treaty pro rata business include estimates of premiums due to us but not yet reported by the cedant because of time delays between contracts being written by our cedants and their submission of treaty statements to us. This additional premium is normally described as pipeline premium. Treaty statements disclose information on the underlying contracts of insurance written by our cedants and are generally submitted on a monthly or quarterly basis, from 30 to 90&#160;days in arrears. In order to report all risks incepting prior to a period end, we estimate the premiums written between the last submitted treaty statement and the period end. Treaty pro rata premiums are written predominantly in our other property, specialty and casualty reinsurance lines of business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most likely drivers of change in our premium estimates in decreasing order of magnitude are: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">changes in renewal rate or rate of new business acceptances by cedant insurance companies leading to lower or greater volumes of ceded premiums than our estimate, which could result from changes in the relevant primary market that could affect more than one of our cedants or could be a consequence of changes in marketing strategy or risk appetite by a particular cedant; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">changes in the rates being charged by cedants;&#160;and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">differences between the pattern of inception dates assumed in our estimate and the actual pattern of inception dates. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Earned premiums</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as earned over the policy exposure periods. The premium related to the unexpired portion of each policy at the end of the reporting period is included in the balance sheet as unearned premiums. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for retroactive reinsurance agreements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retroactive reinsurance agreements are reinsurance agreements under which a reinsurer agrees to reimburse the Company as a result of past insurable events. For these agreements, the excess of the amounts ultimately collectible under the agreement over the consideration paid is recognized as a deferred gain liability which is amortized into income over the settlement period of the ceded reserves once the paid losses have exceeded the minimum retention. The amount of the deferral is recalculated each period based on actual loss payments and updated estimates of ultimate losses. If the consideration paid exceeds the ultimate losses collectible under the agreement, the net loss on the retroactive reinsurance agreement is recognized within income immediately.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums payable for retroactive reinsurance coverage and meeting the conditions of reinsurance accounting are reported as reinsurance recoverables to the extent that those amounts do not exceed recorded liabilities relating to underlying reinsurance contracts. To the extent that recorded liabilities on an underlying reinsurance contract exceed premiums payable for retroactive coverage, a deferred gain is recognized.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements contain certain amounts that are inherently subjective in nature and require management to make assumptions and best estimates to determine the reported values. We believe that the following critical accounting estimates are the most significant estimates used in the preparation of our consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserving Approach</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required by U.S.&#160;GAAP to establish loss reserves for the estimated unpaid portion of the ultimate liability for losses and loss expenses (&#8220;ultimate losses&#8221;) under the terms of our policies and agreements with our insured and reinsured customers. Our loss reserves comprise the following components: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the cost of claims reported to us but not yet paid known as case reserves (&#8220;case reserves&#8221;); </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Reserves to cover the anticipated cost of IBNR claims. Within this, we also include the potential development of reported claims; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the expenses associated with settling claims, including legal and other fees and the general expenses of administering the claims adjustment process, known as the loss adjustment expenses (&#8220;LAE&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Case Reserves</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reported claims, reserves are established on a case-by-case basis within the parameters of coverage provided in the insurance policy or reinsurance agreement. The method of establishing case reserves for reported claims differs among our operations. With respect to our insurance operations, we are advised of potential insured losses and our claims handlers&#8217; record reserves for the estimated amount of the expected indemnity settlement, loss adjustment expenses and cost of defense where appropriate. The reserve estimate reflects the judgment of the claims personnel and is based on claim information obtained to date, general reserving practices, the experience and knowledge of the claims personnel regarding the nature of the specific claim and where appropriate and available, advice from legal counsel, loss adjusters and other claims experts. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to our reinsurance claims operations, claims handlers set case reserves for reported claims generally based on the claims reports received from our ceding companies and take into consideration our cedants&#8217; own reserve recommendations and our prior loss experience with the cedant. Additional case reserves (&#8220;ACR&#8221;), in addition to the cedants&#8217; own recommended reserves, may be established by us to reflect our estimated ultimate cost of a loss. ACRs are generally the result of either a claims handler&#8217;s own experience and knowledge of handling similar claims, general reserving practices or the result of reserve recommendations following an audit of cedants&#8217; reserves. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Case reserves are based on a subjective judgment of facts and circumstances and are established for the purposes of internal reserving only. Accordingly, they do not represent a commitment to any course of conduct or admission of liability on our behalf in relation to any specific claim. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IBNR Reserves</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The need for IBNR reserves arises from time lags between when a loss occurs and when it is actually reported and settled. By definition, we do not have specific information on IBNR claims so they need to be estimated by actuarial methodologies. IBNR reserves are therefore generally calculated at a class of business level and cannot generally be identified as reserves for a particular loss or contract. We calculate IBNR reserves by class of business within each line of business. Where appropriate, analyses may be conducted on sub-sets of a class of business. IBNR reserves are calculated by projecting our ultimate losses on each class of business and subtracting paid losses and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">case reserves. IBNR reserves also cover the anticipated cost of claims incurred but not reported, within this we also include any potential development of reported claims. Over recent years, we have begun to place greater reliance on our actual actuarial experience for our long-tail lines of business that we have written since our inception in 2002. We believe that our earliest accident years are now capable of providing us with meaningful actuarial indications. Estimates and judgments for new insurance and reinsurance lines of business are more difficult to make than those made for more mature lines of business because we have more limited historical information through December&#160;31, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sources of Information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims information received typically includes the loss date, details of the claim, the recommended reserve and reports from the loss adjusters dealing with the claim. In respect of pro rata treaties and any business written through managing general agents, we receive regular statements (bordereaux) which provide paid and outstanding claims information, often with large losses separately identified. Following widely reported loss events, such as catastrophes, we adopt a proactive approach to establish our likely exposure to claims by reviewing policy listings and contacting brokers and policyholders as appropriate. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Actuarial Methodologies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The main projection methodologies that are used by our actuaries are as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.25pt">Initial expected loss ratio (&#8220;IELR&#8221;) method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;This method calculates an estimate of ultimate losses by applying an estimated loss ratio to an estimate of ultimate earned premium for each accident year. The estimated loss ratio may be based on pricing information and/or industry data and/or historical claims experience revalued to the year under review. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.25pt">Bornhuetter-Ferguson (&#8220;BF&#8221;) method:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The BF method uses as a starting point an assumed IELR and blends in the loss ratio, which is implied by the claims experience to date using benchmark loss development patterns on paid claims data (&#8220;Paid BF&#8221;) or reported claims data (&#8220;Reported BF&#8221;). Although the method tends to provide less volatile indications at early stages of development and reflects changes in the external environment, it can be slow to react to emerging loss development and can, if the IELR proves to be inaccurate, produce loss estimates which take longer to converge with the final settlement value of loss. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.25pt">Loss development (&#8220;Chain Ladder&#8221;) method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;This method uses actual loss data and the historical development profiles on older accident years to project more recent, less developed years to their ultimate position. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.25pt">Exposure-based method:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;This method is typically used for specific large catastrophic events such as a major hurricane. All exposure is identified and we work with known market information and information from our cedants to determine a percentage of the exposure to be taken as the ultimate loss. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to these methodologies, our actuaries may use other approaches depending upon the characteristics of the class of business and available data. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general terms, the IELR method is most appropriate for classes of business and/or accident years where the actual paid or reported loss experience is not yet mature enough to modify our initial expectations of the ultimate loss ratios. Typical examples would be recent accident years for classes of business in casualty reinsurance. The BF method is generally appropriate where there are few reported claims and a relatively less stable pattern of reported losses. Typical examples would be our treaty risk excess class of business in our reinsurance segment and marine hull class of business in our insurance segment. The Chain Ladder method is appropriate when there are relatively stable patterns of loss emergence and a relatively large number of reported claims. Typical examples are the U.K. commercial property and U.K. commercial liability classes of business in our international insurance business. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reserving Procedures and Process</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our actuaries calculate the IELR, BF and Chain Ladder and, if appropriate, other methods for each class of business and each accident year. They then calculate a single point actuarial central estimate (&#8220;ultimate&#8221;) for each class of business. The actuarial methodologies involve significant subjective judgments reflecting many factors, including but not limited to, changes in legislative conditions, changes in judicial interpretation of legal liability policy coverages and heightened inflation. Our actuaries collaborate with our underwriting, claims, legal and finance teams in identifying factors which are incorporated in their range of ultimates in which management&#8217;s best estimate is most likely to fall. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no differences between our year-end and our quarterly internal reserving procedures and processes because our actuaries perform the basic projections and analyses described above for each class of business quarterly. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selection of Reported Gross Reserves</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Reserve Committee signs off on the group-level reserves, which reflects, amongst other matters, key areas of reserving uncertainty within the group actuarial central estimate and levels of uncertainty are factored into the management best estimate, which provides the basis for management&#8217;s recommendation to the Audit Committee and the Board regarding the reserve amounts to be recorded in the financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Reserve Committee was chaired by the Group Chief Actuarial Officer and its membership includes members of senior management from various functions of the business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each significant class of business is reviewed in detail by management through its Reserve Committee at least once a year. The timing of such reviews varies throughout the year. Additionally, we review the emergence of actual losses relative to expectations every fiscal quarter for all classes of business. If warranted from this analysis, we may accelerate the timing of our detailed actuarial reviews. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Uncertainties</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the management selected reserves make a reasonable provision for unpaid loss and loss adjustment expense obligations, we note that the process of estimating required reserves, by its very nature, involves uncertainty and therefore the ultimate claims may fall outside the actuarial range. The level of uncertainty can be influenced by such factors as the existence of coverage with long duration reporting patterns and changes in claims handling practices, as well as the other factors described above. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given many of the coverages underwritten involve claims that may not be ultimately settled for many years after they are incurred, subjective judgments as to the ultimate exposure to losses are an integral and necessary component of the loss reserving process. We review our reserves regularly, using a variety of statistical and actuarial techniques to analyze current claims costs, frequency and severity data, and prevailing economic, social and legal factors. Reserves established in prior periods are adjusted as claims experience develops and new information becomes available. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates of IBNR are generally subject to a greater degree of uncertainty than estimates of the cost of settling claims already notified to us, where more information about the claim event is generally available. IBNR claims often may not be apparent to the insured until many years after the event giving rise to the claims has happened. Classes of business where the IBNR proportion of the total reserve is high, such as casualty insurance, will typically display greater variations between initial estimates and final outcomes because of the greater degree of difficulty of estimating these reserves. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Classes of business where claims are typically reported relatively quickly after the claim event tend to display lower levels of volatility between initial estimates and final outcomes. Reinsurance claims are subject to a longer time lag both in their reporting and in their time to final settlement. The time lag is a factor which is included in the projections to ultimate claims within the actuarial analyses and helps to explain why in general a higher proportion of the initial reinsurance reserves are represented by IBNR than for insurance reserves for business in the same class. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delays in receiving information from cedants are an expected part of normal business operations and are included within the statistical estimate of IBNR to the extent that current levels of backlog are consistent with historical data. Currently, there are no processing backlogs which would materially affect our financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance is made, however, for changes or uncertainties which may create distortions in the underlying statistics or which might cause the cost of unsettled claims to increase or reduce when compared with the cost of previously settled claims, including: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">changes in our processes which might accelerate or slow down the development and/or recording of paid or incurred claims; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">changes in the legal environment (including challenges to tort reform); </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the effects of inflation, which has risen rapidly in recent months; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">changes in the mix of business; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the impact of large losses;&#160;and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">changes in our cedants&#8217; reserving methodologies. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These factors are incorporated in the management&#8217;s best estimate of reserves. We take all reasonable steps to ensure that we utilize all appropriate information and actuarial techniques in establishing our IBNR reserves. However, given the uncertainty in establishing claims liabilities, it is likely that the final outcome will prove to be different from the original provision established at the balance sheet date. Changes to our previous estimates of prior period loss reserves impact the reported calendar year underwriting results by worsening our reported results if the prior year reserves prove to be deficient or improving our reported results if the prior year reserves prove to be redundant. As at December&#160;31, 2022, a 5% change in the gross reserve for IBNR losses would have equated to a change of approximately $216.2 million (2021 &#8212; $198.1 million)  in loss reserves. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A 5% change in our net loss reserves equates to $140.7 million and represents 6.0% of shareholders&#8217; equity as at December&#160;31, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are specific areas of our selected reserves which have additional uncertainty associated with them. See &#8220;Risk Factors&#8212;Risks Related to Our Business&#8212;(Re)insurance Risks&#8212;Our financial condition and operating results may be adversely affected if actual claims exceed our loss reserves&#8221; for a discussion of the specific areas of our selected reserves which have additional uncertainty. In each case, management believes they have selected an appropriate best estimate based on current information and current analyses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loss Reserving Sensitivity Analysis</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant key assumptions identified in the reserving process are that (i)&#160;the historic loss development and trend experience is assumed to be indicative of future loss development and trends, (ii)&#160;the information developed from internal and independent external sources can be used to develop meaningful estimates of the initial expected ultimate loss ratios, and (iii)&#160;no significant losses or types of losses will emerge that are not represented in either the initial expected loss ratios or the historical development patterns.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that there is potentially significant risk in estimating loss reserves for long-tail lines of business and for immature accident years that may not be adequately captured through traditional actuarial projection methodologies. As discussed above, these methodologies usually rely heavily on projections of prior year trends into the future. In selecting our best estimate of future liabilities, we consider both the results of actuarial point estimates of loss reserves in addition to the stochastic distribution of reserves. In determining the appropriate best estimate, we review (i)&#160;the result of bottom up analysis by accident year reflecting the impact of parameter uncertainty in actuarial calculations, and (ii)&#160;specific qualitative information on events that may have an effect on future claims development but which may not have been adequately reflected in actuarial best estimates, such as the potential for outstanding litigation or claims practices of cedants to have an adverse impact.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effect if Actual Results Differ From Assumptions</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the risks and uncertainties associated with the process for estimating reserves for losses and loss expenses, management has performed an evaluation of the potential variability in loss reserves and the impact this variability may have on reported results, financial condition and liquidity. Because of the inherent uncertainties discussed above, we have developed a reserving philosophy which attempts to incorporate prudent assumptions and estimates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s best estimate of the net reserve for losses and loss expenses as at December&#160;31, 2022 was $2,813.2 million. The following tables show the effect on estimated net reserves for losses and loss expenses as at December&#160;31, 2022 of a change in two of the most critical assumptions in establishing reserves: (i)&#160;loss emergence patterns, accelerated or decelerated by three and six months; and (ii)&#160;expected loss ratios varied by plus or minus five and ten percent. Accelerated loss emergence patterns indicates a higher development percentage of losses, therefore requiring lower IBNR than previously expected and hence resulting in a lower ultimate. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that these scenarios present a reasonable range of variability around the booked reserves using standard actuarial techniques. Loss reserves may vary beyond these scenarios in periods of heightened or reduced claim activity. The reserves resulting from the changes in the assumptions are not additive and should be considered separately. The following tables vary the assumptions employed therein independently. In addition, the tables below do not adjust any parameters other than the ones described above. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net reserve for losses and loss expenses as at December&#160;31, 2022 &#8212; Sensitivity to loss emergence patterns</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in assumption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reserve for losses and loss expenses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six month acceleration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,586.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three month acceleration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,690.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No change (selected)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three month deceleration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,951.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six month deceleration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,129.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net reserve for losses and loss expenses as at December&#160;31, 2022 &#8212; Sensitivity to expected loss ratios</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in assumption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reserve for losses and loss expenses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% favorable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,544.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5% favorable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,678.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No change (selected)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5% unfavorable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% unfavorable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant variance in the above scenarios (i.e., a 10% unfavorable movement in expected loss ratios) would have the effect of increasing losses and loss expenses by $269.2 million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the reserve for losses and loss expenses are sufficient to cover expected claims incurred before the reporting date on the basis of the methodologies and judgments used to support its estimates. However, there can be no assurance that actual payments will not vary significantly from total reserves. The reserve for losses and loss expenses and the methodology of estimating such reserve are regularly reviewed and updated as new information becomes known. Any resulting adjustments are reflected in income in the period in which they become known.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Deferred Tax Asset</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. deferred tax benefit recognized in 2022 of $102.9 million was mainly due to a change in judgment about the realizability of the deferred tax asset in the U.S. operating subsidiaries. In assessing recoverability of deferred tax assets, and the recognition/de-recognition of associated valuation allowances, the Company considered a number of factors that required significant judgement, such as successive years of achieving three-year cumulative net taxable income, recent operating trends, growth and profitability forecasts, premium and investment return assumptions, etc. when making its determination. Management believe that the deferred tax assets of our U.S. operating subsidiaries will more likely than not be fully utilized over time, and therefore the previously recognized valuation allowance in relation to U.S. operating subsidiaries has been reversed in 2022. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Investments Measured Using Significant Unobservable Inputs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of fair value for financial assets and liabilities are based on the framework established in the fair value accounting guidance included in ASC Topic 820, &#8220;Fair Value Measurements and Disclosures.&#8221; The framework prioritizes the inputs, which refer broadly to assumptions market participants would use in pricing an asset or liability.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for actively traded securities to be derived based on quoted prices in an active market for identical assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for other securities that may not be as actively traded which are priced via pricing services, vendors and broker-dealers, or with reference to interest rates and yield curves, to be derived based on inputs that are observable for the asset, either directly or indirectly.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers securities, other financial instruments, privately-held investments and derivative insurance contracts subject to fair value measurement whose valuation is derived by internal valuation models to be based largely on unobservable inputs. Unobservable inputs are assumptions used by the Company using the best available information at the time of making these valuation assumptions. Level 3 financial instruments have the least use of observable market inputs used to determine fair value. As at December&#160;31, 2022, the Company classified privately-held investments of $533.0 million as Level 3 as a result of significant unobservable inputs used to determine fair value (2021 &#8212; $307.1 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Privately-held investments are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using discounted cash flow models. These models include inputs that are specific to each investment. The inputs used in the fair value measurements include dividend or interest rates and appropriate discount rates. The selection of an appropriate discount rate is judgmental and is the most significant unobservable input used in the valuation of these securities. A significant increase (decrease) in this input in isolation could result in significantly lower (higher) fair value measurement for privately-held investments. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow models, the Company maintains an understanding of current market conditions, issuer specific information that may impact future cash flows as well as collaboration with independent vendors for most securities to assess the reasonableness of the discount rate being used.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other investments represent our investments in real estate funds and other special purpose vehicles. Adjustments to the fair values are made based on the net asset value of the investments. The net valuation criteria established by the manager of such investments are established in accordance with the governing documents and the asset manager&#8217;s valuation guidelines, which include: the discounted cash flows method and the performance multiple approach, which uses a multiple derived from market data of comparable companies or assets to produce operating performance metrics. Alternative valuation methodologies may be employed for investments with unusual characteristics.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See also &#8220;&#8212;Quantitative and Qualitative Disclosures About Market Risk&#8221; in this prospectus for further details on interest rate and credit spread risk and a sensitivity analysis of interest rate on the valuation of the Company&#8217;s investment. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_2742"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2017-04&#8221;). Among other things, ASU 2017-04 requires the following: (1) the elimination of step two of the goodwill impairment test; entities will no longer utilize the implied fair value of their assets and liabilities for purposes of testing goodwill for impairment, and (2) the quantitative portion of the goodwill impairment test will be performed by comparing the fair value of a reporting unit with its carrying amount; an impairment charge is to be recognized for the excess of carrying amount over fair value, but only to the extent of the amount of goodwill allocated to that reporting unit. The effective date for this ASU was amended via ASU 2019-10, Effective Dates, and became effective for annual periods beginning after December 15, 2022. The adoption of this ASU did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued Accounting Standards Update No. ASU 2022-02, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; This update is as a result of a post implementation review done on the issued ASU No.2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> addressing &#8220;troubled debt restructuring by creditors&#8221; and &#8220;vintage disclosures.&#8221; This update will be effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued Accounting Standards Update No. ASU 2022-01, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging, Portfolio Layer Method.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; This update addresses concerns from entities and practitioners regarding the &#8216;last-of-layer&#8217; method of accounting incorporated in update No. ASU 2017-12, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; issued on 28 August, 2017. This method is meant to achieve fair value hedge accounting for interest rate risk hedges of portfolios of &#8216;prepayable financial assets&#8217;. This ASU will be effective for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued Accounting Standards Update No. ASU 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Fair Value Measurement (Topic 820</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#8221; This update is for entities that have investments in equity securities, measured at fair value, which are subject to a contractual sale restriction. This update will be effective for fiscal years beginning after December 15, 2024 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued Accounting Standards Update No. ASU 2022-04, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities- Supplier Finance Programs (Subtopic 405-50).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; The update has been issued to enhance the transparency of supplier finance program disclosure for all entities that use these programs in connection with the purchase of goods and services. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that the update has no impact, as the Company does not enter into any such agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued Accounting Standards Update No. ASU 2022-05, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Services- Insurance (Topic 944).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; This update reduces the implementation costs and complexity with the adoption of Long Duration Insurance contracts (&#8220;LDTI&#8221;) that have been derecognized in accordance with the amendments in this update. These changes eliminate the need to reclassify a portion of previously recognized gains or losses to the LDTI transition adjustment as suggested in the previous ASU issued 2020-11. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that the update has no impact, as the Company does not write long-duration business.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued Accounting Standards Update No. ASU 2022-06, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; This update defers the sunset date of Topic 848 (ASU 2020-04) from Dec 31, 2022 to Dec 31, 2024, after which entities will no longer be allowed to use the relief offered in Topic 848. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accounting pronouncements were issued during the twelve months ended December&#160;31, 2022 which were either not applicable to the Company or did not impact the Company&#8217;s consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_549755815478"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who We Are</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading specialty (re)insurer focused on total value creation for all of our stakeholders.  With $4,339 million of gross written premiums in 2022, we are a scaled multinational business with a diverse product mix balanced across our primary specialty insurance and opportunistic reinsurance franchises, which are both supported by our fee generating capital markets capabilities.  We go to market with a single view of risk through our &#8216;One Aspen&#8217; approach, which is designed to cater to complex, bespoke solutions that bring together our expertise spanning different lines of business, segments and platforms, enabling us to develop enhanced and differentiated offerings for our distribution partners and customers. We are focused on underwriting excellence and profitable growth to consistently deliver top quartile results, targeting mid-teen annualized operating return on equity across market cycles. This is demonstrated by our combined ratio of 83.8%, annualized return on average equity adjusted for Preference Share dividends of 22.9% and Op. ROE of 22.2% for the six months ended June 30, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary specialty insurance product set is centered around niche &#8220;specialty&#8221; lines, such as professional liability, credit and political risk, cyber and environmental, where we can apply our extensive underwriting and industry expertise. Our opportunistic reinsurance business is centered around both specialty and traditional reinsurance lines where we apply risk selection criteria to create unique risk profiles rather than an index of the market as other larger peers may do.  Our size presents a distinct advantage, providing us with enough scale to be relevant while still maintaining the ability to be nimble and decisive, which enables us to enter, exit or change the nature of our underwriting positions faster and with greater precision.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our &#8216;One Aspen&#8217; approach, we actively manage our insurance and reinsurance portfolios across market cycles and identify the most attractive risk versus return opportunities to allocate capital. We adopt a dynamic capital allocation approach, utilizing our strong balance sheet and our multiple platforms across the United States, the United Kingdom, Lloyd&#8217;s and Bermuda to match risk with the most appropriate source of capital, and to drive efficiencies and optimal outcomes for our customers. Our ability to offer our broker and client partners holistic and customized solutions across our entire platform provides us the opportunity to execute larger, more complex deals which frequently result in more attractive terms and conditions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, we wrote $2,125 million in gross written premiums across our Insurance and Reinsurance segments, at a combined ratio of 83.8%. Our shareholders&#8217; equity, excluding AOCI of $(492) million and Preference Shares, net of issuance costs, with a total value of $754 million, was $2,288 million as of June 30, 2023.  For the six months ended June 30, 2023, we generated $219 million of net income, representing a 22.9% annualized return on average equity adjusted for Preference Share dividends and $191 million of operating income, representing a 22.2% Op. ROE. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2022, we wrote $4,339 million in gross written premiums across our Insurance and Reinsurance segments, at a combined ratio of 93.0%.  Our shareholders&#8217; equity, excluding AOCI of $(506) million and Preference Shares, net of issuance costs, with a total value of $754 million, was $2,111 million as of December 31, 2022.  For the twelve months ended December 31, 2022, we generated $51 million of net income, representing a 0.4% annualized return on average equity adjusted for Preference Share dividends and $202 million of operating income, representing a 11.9% Op. ROE. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Transformation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have undertaken a comprehensive transformation of the business since our acquisition by Apollo in February 2019, centered around a clear strategic vision that has four core tenets: (1) focused underwriting; (2) reduced volatility; (3) improved operational efficiency; and (4) culture. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Focused Underwriting: We have significantly reduced the breadth of our Insurance and Reinsurance product offerings to focus on core lines of business where we have a distinct relevance and leading market positions and believe we can achieve superior underwriting results with successful long-term track records. Since our acquisition by Apollo in 2019, we have exited twelve Insurance and five Reinsurance lines of business as part of the strategic repositioning of our underwriting portfolio, which accounted for </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximately $911 million of gross written premiums for the twelve months ended December 31, 2018. We have classified $820 million of this as Legacy business for purposes of reporting on historical legacy underwriting results as these lines of business were exited during the main underwriting remediation period from 2018 to 2021. There were additional exits of two Reinsurance lines of business in 2022, which were part of further refinements to our underwriting strategy, but not classified as part of Legacy underwriting results. We have delivered significant growth in our continuing lines of business, with gross written premiums of $4,299 million in 2022, having grown at an average annual rate of 13% from 2018 to 2022. At the same time, we improved our underwriting performance, as illustrated by our combined ratio decreasing by 17 percentage points over the same period. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g2.jpg" alt="Business1b.jpg" style="height:347px;margin-bottom:5pt;vertical-align:text-bottom;width:307px"/></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduced Volatility: We have taken extensive action to reduce volatility within both our existing in-force and go-forward businesses.  We have dramatically decreased our property catastrophe exposure, with July 1, 2023 net 250-year PML exposure of $293 million, which has declined by approximately 69% relative to the start of 2018. This allowed us to generate an 11.9% operating return on average equity for the twelve months ended December 31, 2022, despite the highest level of global natural catastrophe insured losses observed since 2017, according to Swiss Re. We also entered into the LPT with Enstar in May 2022 to limit our exposure to adverse development on the carried reserves for the accident years prior to 2020. This provides substantial ongoing protection against both social and economic inflation, while freeing up capital for our underwriters to deploy into the current attractive pricing environment and allowing our management team to focus on delivering profitable growth from within our continuing lines of business. Our use of ACM is also highly strategic to our business as a tool to manage net line size and overall volatility, while generating more stable fee income.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="padding-right:-18pt;text-align:center;text-indent:18pt"><img src="ahl-20231220_g3.jpg" alt="Business2a.jpg" style="height:359px;margin-bottom:5pt;vertical-align:text-bottom;width:349px"/></div><div style="padding-left:121.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="padding-left:139.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">2023 PML as of July 1, 2023.</span></div><div style="padding-left:139.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents Occurrence Exceedance Probability PML for all perils worldwide.</span></div><div style="margin-bottom:9pt;padding-left:139.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Guy Carpenter U.S. Property CAT Rate-On-Line Index.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Improved Operational Efficiency: We have significantly rationalized our operating footprint, reducing our office locations from 30 to 19, while growing our gross written premiums per employee by 53% from 2018 to 2022, and driving a reduction in our expense ratio to 30.5% in 2022 from 32.9% in 2018. We continue to invest in operational efficiencies, which we believe will bring meaningful cost benefits in the medium term through traditional operational expense reductions, as well as improvements to our loss ratio achieved through enhanced underwriting systems and data analytics. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Culture: We have undertaken a transformation so that we can execute our go-forward strategy in adherence with our values. Since Apollo&#8217;s acquisition in 2019, to align with our culture and mission, each member of Aspen&#8217;s executive team has been newly appointed, through either internal promotions or new external hires. Our culture is defined by our core values to be open minded, to do the right thing, to be in it together, to own it, and to innovate.  We empower our decision makers, who bring to bear their expertise for clients, and build our reputation as thought leaders in our market spaces. Our employees are challenged to be not just risk allocators, but considered risk managers who demonstrate underwriting judgment, exercising restraint in soft markets and pursuing growth in favorable market conditions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The result of this transformation has been a significant shift in our culture, and a strategic repositioning of the underwriting portfolio that is now being reflected in our financial results, providing a dynamic platform on which to execute our go-forward strategy of growing our core lines of business.  </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Key Performance Highlights</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since Apollo&#8217;s acquisition in 2019, we have undergone a complete transformation of our business. Selected financial highlights include:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Gross written premiums increased from $3,447 million for the twelve months ended December 31, 2018 to $4,339 million for the twelve months ended December 31, 2022;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Loss ratio decreased from 71.0% for the twelve months ended December 31, 2018 (12.1% attributable to catastrophe losses) to 62.5% (adjusted loss ratio to 61.9%) for the twelve months ended December 31, 2022 (11.4% attributable to catastrophe losses); </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Expense ratio decreased from 32.9% for the twelve months ended December 31, 2018 to 30.5% for the twelve months ended December 31, 2022;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">ACM fee income increased from $24 million for the twelve months ended December 31, 2018 to $104 million for the twelve months ended December 31, 2022; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Net (loss)/income increased from $(146) million for the twelve months ended December 31, 2018 to $51 million for the twelve months ended December 31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Operating income increased from $0.3 million for the twelve months ended December 31, 2018 to $202 million for the twelve months ended December 31, 2022; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Annualized return on average equity adjusted for Preference Share dividends increased from (7.7)% for the twelve months ended December 31, 2018 to 0.4% for the twelve months ended December 31, 2022; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Annualized operating return on average equity was flat for the twelve months ended December 31, 2018 and increased to 11.9% for the twelve months ended December 31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our underwriting operations as two distinct business segments: Insurance and Reinsurance. We have a diversified yet complementary portfolio across these segments, constructed through the lens of our &#8216;One Aspen&#8217; approach, where we balance risk on an aggregate basis and tactically deploy capital to the lines of business and platforms that we believe will generate the best returns for the Aspen Group. Our Insurance and Reinsurance segments both leverage third-party capital through ACM, which utilizes our capabilities in the third-party capital space (namely, the Insurance Linked Securities markets) to provide our core Insurance and Reinsurance segments with enhanced capital flexibility and operating leverage. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our size provides an advantage relative to our larger peers, allowing us to be nimble and decisive; entering, exiting or changing the nature of our underwriting positions faster and with greater precision. For instance, as part of our active portfolio management process for the 2023 planning year, we made the decision to step back from the aviation, space and bloodstock reinsurance markets as we did not see medium-term returns meeting our targets, while also reducing our risk appetite for mortgage reinsurance. In addition, in the Insurance segment we actively managed down from our original 2023 planned growth within selected U.S. management liability and professional liability lines of business, where we have observed a softening rate environment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strength of our Insurance and Reinsurance businesses is evidenced by our numerous nominations for industry awards in 2023, including being shortlisted for Insurance Insider&#8217;s (Re)insurer of the Year, shortlisted for Insider Honours&#8217; Diversity &amp; Inclusion and Carrier of the Year, and our CEO and Executive Chair, Mark Cloutier, being awarded Inside P&amp;C&#8217;s CEO of the Year. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Insurance segment underwrites primary specialty risks across a diversified set of property and casualty lines of business. We focus on market segments with high barriers to entry that require bespoke underwriting and industry expertise and customized solutions to address client needs. We have long-standing relationships with key distribution partners, primarily comprised of a diversified group of leading retail brokers and wholesale brokers, along with a select number of MGAs. We believe our experience in these niche markets has cemented our role as a partner of choice for many of our distributors, as we are able to leverage our capabilities to develop one-stop custom solutions across multiple lines of business, platforms and geographies. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have niche underwriting capabilities across multiple platforms, including: U.S. admitted lines; U.S. E&amp;S lines; Lloyd&#8217;s; the U.K. Company Market and Bermuda. The breadth of our capabilities across these platforms allows for solutions that can be tailored to our clients&#8217; needs while also allowing us to optimize returns based upon prevailing market conditions. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specialty is at the heart of our capabilities and product offerings. We define our specialty orientation to include the following: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product spaces which are non-commoditized where bespoke underwriting expertise and innate sector knowledge is required and serves as a true differentiator; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Clients that have complex business challenges requiring customized insurance solutions to fit their specific risk transfer needs; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks that are underwritten on an individual basis, frequently requiring advanced analysis and modeling as well as specialized active claims management. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Insurance segment is organized into four portfolios of business: (1) financial and professional lines; (2) casualty and liability lines; (3) first party / property lines; and (4) specialty lines. Each portfolio has multiple product offerings which are overseen by experienced teams of underwriters who are experts in their given niche. The composition of our Insurance product offering is included below with percentages based on gross written premiums for the twelve months ended December 31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g4.jpg" alt="Business3b.jpg" style="height:320px;margin-bottom:5pt;vertical-align:text-bottom;width:336px"/></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specific examples of our expertise and differentiated approach across product lines include: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Specialized Expert Underwriters. We employ underwriters who are experts in their respective fields, with the requisite sector knowledge to best assess, select and price risk. For example, the team that handles our ocean marine product line includes former members of the Merchant Marines; our credit and political risk business is led by former bankers who understand the nuanced complexity associated with credit risk, while our cyber and tech liability teams are trained to field-recognized designations that would traditionally sit outside the insurance industry. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Customized Product Offering. We have significantly narrowed our focus to concentrate on niche offerings, seeking to underwrite beyond the traditional lines of business that would result in a portfolio that stands and performs as just an index of the market. Examples of some of our specific product offerings include: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Credit and Political Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Bespoke contracts for complex credit and project finance deals underwritten by an experienced team of underwriters, supported by dedicated in-house credit analysts, offering one of the widest product suites in the market; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">164</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Cyber and Tech Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: A team of global underwriters providing robust risk selection capabilities, who are all required to pass a credentialed network security exam (Certified Information Privacy Professional or Certified Information Privacy Technologist) to ensure consistent risk assessment expertise across the team;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Environmental</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Specialist liability products to mitigate the financial impacts of environmental financial claims with a team of over 25 underwriters with experience across law, engineering, consulting and risk management, that provide global capabilities from eight cities around the world;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Inland Marine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Within this business line, we underwrite both fine arts and construction. Fine arts is underwritten by a dedicated underwriting team with members having over ten years of experience on average . Our construction team has industry relationships with Engineering News Record Top 25 General Contractors, supported by an on-staff engineer, who provides clients access to risk control review, industry recommendations and best practice health checks;   </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">U.K. Property &amp; Construction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Structured as three underwriting teams across property investors, business &amp; public sector, and construction, our U.K. property &amp; construction team excels at unusual and special circumstances. We work in collaboration with our U.K. &amp; international casualty underwriters to provide cross-class solutions for our clients and broker partners; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">U.S. Management Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: A portfolio tactically balanced between open market writings (with greater exposure to fluctuations in market conditions) and delegated underwriting authority business in the small and midsize enterprise space (which is more stable and less price sensitive). As a subset of our management liability portfolio, transactional liability is a true specialty class where we have longstanding partnerships with two of the most respected underwriting facilities in the market, Ambridge Partners and Euclid Transactional.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Tailored Portfolio Solutions. We have designed bespoke portfolio solutions across multiple lines of business for a number of our long-term trading partners. We continue to leverage our multiple operating platforms, bringing the &#8216;One Aspen&#8217; approach to market, where our Reinsurance and ACM capabilities facilitate support of and alignment with our Insurance offerings. An example of this is a binder agreement we have with a leading wholesaler, whereby we provide underwriting capacity to multiple specialty programs across both the United States and Europe, utilizing our multiple operating platforms. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This approach has been the foundation for establishing a long-term track record of underwriting profitability across numerous lines of business. For example, we have achieved aggregate combined ratios of below 90% from 2016 through 2022 in our U.S. professional liability, U.K. property and construction, environmental, cyber, U.K. liability, international energy and construction and international credit and political risk lines, representing over $5,000 million of gross written premiums across that period.  We strive to maintain this caliber of underwriting performance in these lines, while building our track record within our other primary insurance lines of business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, our Insurance segment had $1,250 million of gross written premiums, generated $98 million of underwriting income and had a combined ratio of 86.4%.  For the five-year period 2018 to 2022, continuing lines within our Insurance segment grew at an average annual growth rate of 12.7%. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Within this segment, we offer expertise in a variety of global reinsurance lines including property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance. We implement a simple, yet effective, distribution model targeting long-term relationships and product spaces that have demonstrated strong underwriting returns through market cycles. Our focus goes beyond traditional reinsurance, as we seek to provide our clients with innovative solutions, through both traditional retrocession, and the utilization of third-party capital through ACM alongside our own Aspen balance sheet capital. We are opportunistic yet disciplined in our approach, positioned to benefit from market dislocations and underwriting modest lines to reduce volatility from loss events with the aim of generating highly attractive risk-adjusted returns, as opposed to returns that just track the market index. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Reinsurance segment is organized into four portfolios: (1) property catastrophe reinsurance; (2) other property reinsurance; (3) casualty reinsurance; and (4) specialty reinsurance.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Property Catastrophe Reinsurance: Our success in the property catastrophe market is based on strong risk controls and deep, embedded relationships with our clients, giving us differentiated insights to manage exposures.  We utilize advanced models, analytical tools and our experienced global underwriting teams to set terms and deliver timely capacity.  Our opportunistic strategy in this line has allowed us to take advantage of a hard market cycle, using price increases, improvement in terms and ACM to enhance our underwriting margins and reshape our exposures.  Importantly, we have used the hard market conditions not just for premium growth, but to reduce volatility, as evidenced by a significant reduction in PMLs from 2018 to 2023.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other Property Reinsurance: We provide tailored solutions for a broad spectrum of property risks worldwide through our dual distribution approach, writing business both directly to ceding firms and through brokers.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Casualty Reinsurance: Our casualty treaty team operates on a global basis, and our analysis of market-wide trends in key territories, supported by close coordination with our claims, legal and actuarial teams, gives us insights that we believe will enable us to succeed in the changing liability landscape. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Specialty Reinsurance: We target niche or unusual risks and are focused on offering tailor-made risk transfer solutions for several specialty lines.  We believe our global expertise is well recognized and our team of underwriters across London, Singapore, Zurich and the United States give us valuable regional and global expertise to support our clients. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of our Reinsurance business mix based on gross written premiums for the twelve months ended December 31, 2022 is included in the following chart:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g5.jpg" alt="Business3a.jpg" style="height:191px;margin-bottom:5pt;vertical-align:text-bottom;width:191px"/></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, our Reinsurance segment had $876 million of gross written premiums, generated $111 million of underwriting income and had a combined ratio of 80.7%. For the five-year period 2018 to 2022, continuing lines within our Reinsurance segment grew at an average annual growth rate of 13.7% .  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACM:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We participate in the alternative reinsurance market through ACM, which acts as a conduit between Aspen&#8217;s balance sheet and third-party investors and supports each of our Insurance and Reinsurance segments. Through reinsurance sidecar investments, ACM provides investors direct access to our underwriting expertise and earns underwriting, management and performance fees for Aspen from other third-party investors primarily through the placement and management of side cars, ILS funds and other offerings.  ACM is highly strategic to our business, providing a unique set of capabilities and tactical optionality to manage risk and improve our returns.  Unlike other offerings in the market that are predominantly property catastrophe reinsurance focused, ACM offers investors a broader product suite that provides direct, fully aligned participation to risk underwritten by Aspen&#8217;s primary specialty insurance and reinsurance portfolios, including actively managed fund products and  sidecars.  Notably, ACM&#8217;s capabilities in longer-tail lines of business bring greater stability to our fee income, and thus our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">underwriting results, as this fee income is associated with &#8220;stickier&#8221; third-party capital structured over multiple years.  As of June 30, 2023, approximately 50% of third-party capital within ACM supported longer-tail products. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACM is a core differentiator for Aspen, bringing our expertise in capital markets alongside that of our traditional outwards reinsurance capabilities, providing us with increased optionality across cycles in terms of access to capital, complementing our dynamic capital allocation approach.  The ACM portfolio generally mirrors our own through collateralized quota share arrangements that provide third-party investors with aligned participation to our Insurance and Reinsurance underwriting.  ACM is recognized as an innovator across both catastrophe and non-catastrophe risks and was one of the leaders in developing ILS capabilities for cyber risk. Our strong relationships and reputation in the market have enabled ACM to achieve significant growth since 2018, including in recent years where many insurance capital markets players reduced capacity. The following charts reflect the fee income generated by ACM for each of the twelve months ended December 31, 2018 through December 31, 2022 and the diversification of ACM&#8217;s fee income for the twelve months ended December 31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fee Income (2018-2022)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diversification of Fee Income (2022)</span></td></tr><tr style="height:155pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g6.jpg" alt="Business5a.jpg" style="height:138px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"/></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g7.jpg" alt="ACM Pie Chart.jpg" style="height:194px;margin-bottom:5pt;vertical-align:text-bottom;width:225px"/></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACM generated $104 million in fee income for the twelve months ended December 31, 2022. This fee income is primarily reflected as an offset to our acquisition costs and is therefore embedded in our underwriting results.  For the five-year period from 2018 to 2022, third-party capital grew at a CAGR of  17.1%, from $667 million in 2018 to $1,253 million  as of December 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our investment strategy is focused on delivering stable investment income and total return through all market cycles, while maintaining high credit quality and portfolio liquidity. We manage a conservative investment portfolio that is appropriately balanced between our liquidity needs and investment returns, with an average credit rating of AA- and duration of 2.7 years of fixed income securities within our portfolio, as of June 30, 2023. We have access to world-class investment managers and execute this strategy through thoughtful allocations of investment assets to our key investment management partners. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To enhance investment returns, we tactically calibrate asset allocation and the duration of our investment portfolio, taking into account the duration of our insurance and reinsurance liabilities, as well as our view of interest rates, the yield curve, credit spreads and other general market conditions. Since Apollo&#8217;s acquisition in 2019, we have strengthened our investment approach and yields through deploying capital into a broader range of asset classes, including asset-backed securities, high yield loans, and privately held investments, and by increasing our allocation to alternative investments. As of June 30, 2023, we allocated 24% of our investment portfolio, representing $1.8 billion of our investments, to this strategy. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, we had $7.3 billion of total cash and investments, excluding catastrophe bonds, net receivables for securities sold and accrued interest receivable, on our balance sheet and for the six months ended June 30, 2023, we generated $129 million of net investment income.</span></div><div style="margin-bottom:9pt;text-align:center"><img src="ahl-20231220_g8.jpg" alt="Business6a.jpg" style="height:281px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our aggregate portfolio reflected in the chart above (including the characterization of our investments as available for sale and trading), please refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Balance Sheet&#8212;Total cash and investments.&#8221; </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our competitive strengths include:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8216;One Aspen&#8217; Approach, Supported by Dynamic Capital Allocation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our &#8216;One Aspen&#8217; approach, we can actively manage our portfolio across counter-cyclical pricing environments in the insurance and reinsurance markets, shifting capital between our two segments and being opportunistic in markets where we perceive advantageous risk versus return opportunities. The markets we serve require capabilities that are not easily replicated and we come to market in a way that allows us to bring our product offerings together and execute on large new deals across different lines of business, platforms and segments. This provides us with greater control over capital allocation and underwriting outcomes, and is a key pillar of our go-forward offering and growth strategy.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating and risk allocation strategy has been carefully designed to optimize the use of both our own assets, as well as third-party capital. Business sourced is carefully analyzed and directed to the appropriate underwriting platform, taking into account client characteristics, as well as operational and efficiency considerations.  We have a scaled but nimble (re)insurance presence across the most important global underwriting hubs for our lines of business, including the U.S. admitted, U.S. E&amp;S, Bermuda, Lloyd&#8217;s and the U.K. Company Market, all leveraging our third-party capital markets capabilities (through ACM).  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Niche Primary Insurance Platform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance strategy is focused on underwriting complex, highly curated, niche lines of business with high barriers to entry. Our Insurance segment generated $2,532 million in gross written premiums for the twelve months ended December 31, 2022. We only participate in lines of business in which our underwriters have deep, technical expertise and where they can be well supported by our platforms and strong capabilities, allowing us to provide innovative and coordinated solutions to clients. From 2018 to 2022, we experienced aggregate rate increases of 56.8% in our portfolio, driven by pricing improvements from our core lines of business. We adopt an efficient </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tactical use of outwards reinsurance, enabling us to write higher exposure policies while appropriately managing our net retained exposure.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since being acquired by Apollo, we have exited a number of lines of business (legacy business) while also achieving strong growth in our continuing lines of business generating attractive profitability.  The average premium growth rate within these continuing lines of business has been 12.7% since 2018 and the loss ratio and combined ratio have improved from 63.6% and 99.1% in 2018, to 62.3% and 91.4% in 2022, respectively.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opportunistic Specialist Reinsurance Franchise</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a nimble reinsurance strategy focused on core lines of business within property, casualty and specialty.  Our Reinsurance segment generated $1,807 million in gross premiums for the twelve months ended December 31, 2022 and is positioned to capitalize on dislocation within a broad set of markets. Our strategy is to underwrite modest line sizes to limit exposure from large loss events, and our property catastrophe portfolio has been optimized to generate higher risk-adjusted returns and manage overall volatility.  The average premium growth rate within these continuing lines of business has been 13.7% since 2018 and combined ratio has improved from 104.6% in 2018, to 94.2% in 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our opportunistic approach has allowed us to take upside from attractive reinsurance underwriting conditions, where we have experienced strong rate increases in a hard market cycle. We have experienced cumulative rate increases of 43.8% from 2018 to 2022, and we continued to benefit from an attractive pricing environment through the first half of 2023, with a rate increase of 19.2% through June 30, 2023. Our strength in reinsurance is bolstered through the deployment of third-party capital through ACM, which provides us with differentiated access to capital and allows us to &#8220;flex&#8221; into attractive market opportunities.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Growing and Highly Complementary Capital Markets Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception in 2013, ACM uses our capabilities in the third-party capital markets, to increase the flexibility Aspen&#8217;s Insurance and Reinsurance underwriters have in allocating risk to the best source of capital. ACM leverages the full breadth of our expertise across distribution, underwriting, modelling, actuarial and claims, to create attractive opportunities for our investor partners. ACM has experienced significant growth, with third-party capital growing from $667 million in 2018 to $1,253 million at the end of 2022, and generating $104 million in fee income for Aspen in 2022.  We believe we have driven innovation in this market and have cultivated close relationships with third-party capital investors. ACM is a differentiated capability and highly strategic to our business, allowing us to support our Insurance and Reinsurance segments with third-party capital, and serving as a mechanism for tactical de-risking as we leverage fee income from our on-balance sheet underwriting risk.  This capability provides us with the ability to &#8220;flex&#8221; into attractive opportunities in accordance with underwriting cycles and enhances our go-to-market strategy.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deep Trading Partner Relationships</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have seasoned and diversified relationships with partners across our (re)insurance segments. The distribution strategy within our Insurance segment is focused on specialized intermediaries with whom we have long-standing relationships.  Our distributors are experts in their field and know our products and risk appetite well. We have flexibility across retail brokers, wholesale brokers and MGAs to drive value and maintain deep relationships without being overly reliant on any one large partner. Our Reinsurance segment is characterized by the longevity of our relationships with cedants, as 89% of our current cedants have been doing business with Aspen Re for over ten years, and we believe we are viewed as a strong, reliable counterparty.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong Balance Sheet</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an efficient capital structure and strong capitalization with $2,849 million of total capital as of June 30, 2023. Additionally, we have strong financial strength ratings from both A.M. Best (&#8220;A&#8221;) and S&amp;P (&#8220;A-&#8221;) and maintain Group BMA BSCR of 237% as of December 31, 2022. We maintain our Group BMA BSCR significantly in excess of regulatory minimums. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strong positioning as a go-forward business is supported by the LPT transaction with Enstar, which provides protection against deterioration on pre-2020 accident year carried reserves, significantly limiting Aspen&#8217;s exposure to the risk of unfavorable development from these periods while still retaining the scale, market relationships, and operational infrastructure to capitalize on current market conditions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart shows our pre-2020 accident year carried reserves, as well as the LPT coverage above such carried reserves, as of September 30, 2021 and June 30, 2023.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g9.jpg" alt="Business7d.jpg" style="height:346px;margin-bottom:5pt;vertical-align:text-bottom;width:441px"/></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Highly Experienced Management Team</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Led by our CEO and Executive Chair, Mark Cloutier, we have an experienced executive leadership team from diverse backgrounds, each with a specific role and purpose to drive the transformation of our business. Since Apollo&#8217;s acquisition in 2019, to align with our corporate culture and mission, each member of Aspen&#8217;s executive team has been newly appointed, through either internal promotions or new external hires. Our team has an average of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 28 yea</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rs of experience across all facets of the global specialty property &amp; casualty (re)insurance and financial services sectors, including underwriting, claims, technology, investment management, risk management, finance, brokering, actuarial, people and operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strategy </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an institution we aim to bring &#8220;Clarity from Complexity.&#8221;  We seek to transform complex risks into opportunities through efficient and innovative solutions, leveraging our multi-platform capabilities across our Insurance and Reinsurance segments, both of which are supported by ACM. We believe we are a market leader in our industry that provides our clients with confidence and the best possible outcomes.  Our culture, which prioritizes collaboration, accountability and service, allows us to provide intelligent, swift solutions in the face of challenges. Whatever the challenge is, we are &#8216;One Aspen&#8217;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our vision statement is &#8216;to be a top quartile specialty risk (re)insurer focused on total value creation through underwriting profit and investment performance.&#8217;  Our ability to achieve this goal is based on three key pillars, which we believe create a virtuous cycle for success:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Continued profitable growth. Profitability is paramount to the focus of our business and core to our strategic direction. We continue to scale up the business in our core markets achieving operating and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expense efficiencies. Our current size and balanced, nimble positioning ensure there are ample opportunities to grow the business with additional scope in current lines of business as well as expansion into new lines. We are focused on profitable growth in both the current and future periods, and take a long-term approach when optimizing both the liability and asset sides of our balance sheet. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Build a sustainable business. We actively manage risk to further the sustainability of our business across cycles, flexing exposure based on the market cycle. We have implemented strategies to mitigate overall volatility, as evidenced by our significant reduction in PMLs and strategic exits of various insurance and reinsurance lines.  Our approach to risk management is backed by resilient technology and human expertise, which begins at the individual employee level and extends up to the Board. We believe that building a sustainable business also includes supporting our communities and creating a nurturing, diverse and inclusive working environment for our colleagues. We are committed to building a business that appropriately embraces key ESG principles in how we operate and how we interact with our stakeholders.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Build our market reputation. Our goal is to continue to be a trusted partner, built upon the mutual respect laid out in our values and culture and delivering consistency within our chosen markets. We approach challenges with an open mind and leadership mindset, promoting innovative solutions to achieve the best outcome as a team for our customers. We are empowered decision makers, who bring clients expertise, with the goal of exceeding expectations in our market spaces. We believe this will ensure an enduring franchise. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology strategy is underpinned by our mission to underwrite excellent business and to automate and digitize operations from ingestion to downstream functions. As part of our strategy, we amplify underwriting and claims results through the use of data and technology insights.  Underlying data is key to our decision making and we have extensively invested in enterprise-wide data and analytics capabilities. We are transitioning to a single, comprehensive enterprise-wide data repository, built on over 20 years of underwriting history, which we expect will form the foundation for our reporting, business intelligence, analytics and other advanced data capabilities. We believe this agile platform will allow us to develop our real time access to analytics and provide us with an advantage in managing our risk and better claims / portfolio management. In addition, we have invested in a variety of application programming interface and cloud capabilities, which give us greater flexibility in integrating our multi-national underwriting operations and leveraging software as a service and third-party data sources to ensure a competitive advantage. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Underpinning all of this is our ability to maintain a strong balance sheet and manage our capital prudently. We have a highly efficient capital structure and our capitalization is strong, as evidenced by our strong financial strength ratings.  We are constantly monitoring rating agency guidelines, changes in our regulatory environment and market opportunities to ensure that our capital structure is appropriate for our strategic ambitions. We maintain robust procedures for setting loss reserves and actively managing risk in our portfolio. Our reserve confidence was further strengthened by the previously mentioned LPT transaction executed in May 2022. In today&#8217;s attractive underwriting environment, we see ample opportunity to deploy excess capital into both our Insurance and Reinsurance segments, but through the cycle we may return capital to shareholders when opportunities are limited during soft insurance markets. See &#8220;Dividend Policy.&#8221; </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are guided by the phrase &#8220;One Aspen Team, Creating Value,&#8221; which is underpinned by our core set of values &#8211; to be open minded, to do the right thing, to be in it together, to own it, and to innovate.  We have built </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen&#8217;s culture around these guiding principles to foster an environment that promotes innovation, collaboration, inclusiveness and accountability.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><img src="ahl-20231220_g10.jpg" alt="Business8a.jpg" style="height:222px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Markets and Opportunity</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate within the global (re)insurance market, where we have significant opportunities to capture attractive risk-adjusted returns across the cycle through our multi-platform capabilities. The global macroeconomic and social environment continues to drive demand for increasingly complex (re)insurance solutions delivered as a joined-up offering, which is where we thrive.  In recent years, rate increases have been driven by the increased frequency and severity of natural catastrophe events globally (impacted by changing weather patterns), inflation (both social and economic), increased geopolitical tensions and other risks that have grown and emerged, increasing the demand for specialty solutions.  As a result, the global commercial insurance industry has seen 24 consecutive quarters of price increases according to Marsh&#8217;s Global Insurance Market Index Q3&#8217;2023.   </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect these hard market conditions will persist, as they are driven by uncorrelated and continuing macroeconomic and social dynamics. This will provide opportunities for us to deliver profitable growth as we target new business and clients at favorable rates and with improved terms and conditions, while maintaining disciplined risk selection. Furthermore, our chosen lines of business within Insurance have high barriers to entry requiring the bespoke tailoring of products and the need for specialized and experienced underwriters with tenured distribution relationships.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The higher interest rate environment provides additional tailwinds for our business. Higher returns from our fixed income portfolio complement our underwriting income with attractive investment income and contribute to our ability to generate strong risk-adjusted returns for our shareholders. With a low-risk fixed income portfolio of relatively short duration 2.7 years as of June 30, 2023, we are well placed to take advantage of attractive investment yields as we rotate and reinvest.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global Insurance Market</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within Insurance, we operate within both the U.S. specialty and international insurance markets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">U.S. Specialty</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen operates within the broadly defined U.S. commercial lines market, which generated annual industry premiums of approximately $446 billion as for the twelve months ended December 31, 2022.  The industry has experienced improved underwriting performance following the COVID-19 pandemic and wider economic uncertainty. Within commercial insurance, the excess and surplus (&#8220;E&amp;S,&#8221; &#8220;non-admitted&#8221; or &#8220;surplus lines&#8221;) market has demonstrated strong growth, with highly attractive rate increases and improvement in terms and conditions. For the twelve months ended December 31, 2022 we wrote $951 million of gross premiums in the E&amp;S market.  A.M. Best estimates that this market segment is approaching $100 billion in annual premiums, nearly doubling since 2018.  Driving this growth is the macroeconomic and social environment and challenges within the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">admitted space, which continues to drive demand for specialized insurance solutions due to both increasing and more complex risks from the commercial market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E&amp;S carriers are generally permitted to craft insurance terms to suit the particular risk they are assuming as the underlying risks tend to have unique qualities.  Consequently, in this space we are able to provide tailored contracts and limit exposure to loss by either excluding coverage or providing a sub-limit on coverage.  This customized approach provides the opportunity to achieve attractive long-term profitability. From 2001 to 2020, E&amp;S loss ratios have outperformed admitted loss ratios by approximately 4% according to A.M. Best.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We underwrite business in the United States through Aspen American Insurance Company and Aspen Specialty Insurance Company on an admitted and excess and surplus basis, respectively. For the twelve months ended December 31, 2022, we generated $1,974 million of gross written premiums in this market.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">International Insurance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international insurance products are underwritten in the London Market, through both our Lloyd&#8217;s and U.K. Company Market platforms. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lloyd&#8217;s is the world&#8217;s largest specialty insurance marketplace, underwriting &#163;29 billion of premiums during the six months ended June 30, 2023, up 22% from the same period in the prior year. The Lloyd&#8217;s global distribution network is where many of the world&#8217;s most complex risks are placed, across more than 60 specialty lines of business.  Over 50 leading insurance companies participate in the market with more than 380 registered Lloyd&#8217;s brokers and a global network of over 4,000 local coverholders.  We have a significant presence at Lloyd&#8217;s through our integrated Lloyd&#8217;s vehicle, comprising Syndicate 4711, managed by Aspen Managing Agency Limited with fully aligned capital, which in addition to access to complex risks also provides us (re)insurance licensing access for 80 territories (and an additional 20 territories on a reinsurance only basis) across the Americas, the United Kingdom, Europe, and Asia Pacific.  Aspen is well positioned within Lloyd&#8217;s, returning top five syndicate performance in 2022 with a reported combined ratio of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75.4%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and significantly increased underwriting capacity for 2023. For the twelve months ended December 31, 2022, we wrote $1,062 million of gross premiums in the Lloyd&#8217;s market, placing us inside the top 20 largest syndicates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.K. Company Market is an important market for global specialty insurance, with companies and individuals worldwide turning to this market to protect against niche and hard-to-place risks, ranging from liability and professional lines, to cyber and renewable energy exposures.  Gross premium written in this market stood at &#163;44 billion in 2022, up 33.0% from &#163;33 billion in 2020.  While there is no standard definition of this market, there is a general agreement that the core of its activity is internationally traded non-life, commercial and specialty insurance and reinsurance business written by standalone insurers operating outside Lloyd&#8217;s, but within its wider ecosystem. This is mostly P&amp;C (re)insurance, with an increasing emphasis on high-exposure risks.  The diversity and expertise of insurers and underwriting talent, as well as the ecosystem of service providers, make this a highly attractive market to write our U.K.-centric lines of business.  We write business in this market through Aspen Insurance UK Limited. For the twelve months ended December 31, 2022, we wrote $465 million of gross written premiums in this market.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global Reinsurance Market</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global reinsurance market has approximately $709 billion of capital committed as of June 30, 2023, a decrease of 2.2% from December 31, 2021. We believe the market is witnessing an opportunity for margin expansion.  There is a supply and demand imbalance in global reinsurance due to limited new capacity entering the market, retreating rated reinsurers, reduced ILS capacity for traditional property catastrophe focused managers, increased exposure from inflation, and reduced capital positions as a result of unrealized losses on fixed income portfolios. While the opportunity is currently led by property catastrophe pricing, which has seen an approximately 29% increase in rates in 2023 according to Guy Carpenter&#8217;s Global Property Rate-On-Line Index, along with significantly better terms and conditions and primary retention, there remains broader opportunity to cross sell to quality, non-retreating carriers.  Our global underwriting platforms in reinsurance, and differentiated, diverse ACM capabilities provide us with an opportunity to react quickly to market conditions and benefit from the current market cycle. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Reinsurance business segment is underwritten through four core platforms, which include AAIC, Aspen  UK, Syndicate 4711 and Aspen Bermuda, and our branch offices including our European hub in Zurich and Asia Pacific hub in Singapore. For the twelve months ended December 31, 2022, we wrote $1,807 million of gross written premiums in the reinsurance market.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Sustainability Principles</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to be a diverse and inclusive business, providing strong risk-adjusted returns as we work towards a goal of having a deep sense of social responsibility, whether that be supporting the local communities in which we operate or proactively managing the environmental footprint of our direct operations. Sustainability and ESG are closely linked, and we expect to play our part pragmatically in the transition to net zero. Our vision is to bring &#8220;Clarity from Complexity&#8221; and this is reflected in the approach we take and how we deliver our long-term objectives in respect of sustainability. We believe our heritage of deep sector expertise, strong culture and our proven ability to apply the full breadth of our capabilities to solve problems created by new and changing risks, makes us uniquely positioned to be a relevant partner as the energy and other sectors work towards this transition. Our philosophy is centered around three pillars: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Environmental:  We have calculated our Scope 1, Scope 2 and, in relation to certain categories, Scope 3 greenhouse gas emissions utilizing estimates, methodologies and conversion factors aligned to the Greenhouse Gas Protocol for our industry. As we work towards carbon reductions across our value chain, we also make use of offsetting projects accredited by the VCS and GS to compensate for 100% of our Scope 1 and 2 greenhouse gas emissions, along with all calculated Scope 3 categories (i.e., fuel and energy related activities, waste generated in our operations, business travel and employee commuting (including working from home)) directly relating to our employees. We plan to continue our carbon offsets program to continue addressing our overall carbon footprint. Our sustainability development and focus is enabling us to be more data-led when determining projects to fund, where we invest and how to consider clients&#8217; sustainability in our underwriting;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Social: Our policies are designed to empower our staff to support their own charitable passions, with the goal of providing opportunities for future success in our global and local communities. We develop collaborative engagement with our employees and our third sector partners, instilling a sense of pride in current staff and building a platform to attract future talent. In tandem with attracting talent, we have a clear workplan that is led by people from across our business and championed by executive sponsors to foster a diverse and inclusive culture; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Governance: In an age of increased risks, we employ a comprehensive risk management framework, which provides the foundation through which we evaluate and manage business opportunities and related risks in a disciplined manner across the Group. Strong governance is the bedrock of our focus on offering value to our clients, employees and communities around us and we have a clear structure in place to deliver on this. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3010"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Underwriting and Reinsurance Purchasing </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our objective is to create a diversified portfolio of insurance and reinsurance risks, spread across lines of business, products, geographic areas of coverage, cedants and sources. The acceptance of appropriately priced risk is the core of our business. Underwriting requires judgment, based on important assumptions about matters that are inherently unpredictable and beyond our control, and for which historical experience and probability analysis may not provide sufficient guidance. We view underwriting quality and risk management as critical to our success. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We underwrite according to the following principles:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strive to build a diverse portfolio of risk that generates attractive returns by deploying capital in a targeted and efficient manner to deliver enhanced underwriting profitability;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operate within agreed boundaries as defined by the business plan for the relevant class of business; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">174</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operate within prescribed maximum underwriting authority limits, which we delegate to individual underwriters in accordance with an understanding of each individual underwriter&#8217;s capabilities, tailored to the classes of business written by the particular underwriter; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluate the underlying data provided by clients and adjust such data where we believe it does not adequately reflect the underlying exposure; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price each submission based on our experience in the class of business, and where appropriate, by deploying one or more actuarial models either developed internally or licensed from third-party providers; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain a peer review process to sustain high standards of underwriting discipline and consistency and a sampling methodology for simpler insurance risks;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage in peer reviews for more complex risk by several underwriters and input from catastrophe risk management specialists, our team of actuaries and senior management; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refer risks outside of agreed underwriting authority limits to the Group Underwriting Committee or relevant entity executive or board of directors as exceptions for approval before we accept the risks. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Purchasing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase reinsurance and retrocession to mitigate and diversify our risk exposure to a level consistent with our risk appetite and to increase our insurance and reinsurance underwriting capacity. These agreements provide for recovery of a portion of our losses and loss adjustment expenses from our reinsurers. The amount and type of reinsurance that we purchase varies from year to year and is dependent on a variety of factors, including, but not limited to, the cost and terms of a particular reinsurance contract and the nature of our gross exposures assumed, with the aim of securing cost-effective protection. We have a centralized ceded reinsurance department which coordinates the placement of all of our treaty reinsurance placements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reinsurance covers in place for the majority of our insurance classes of business on an excess-of-loss basis and/or proportional treaty basis. The excess of loss covers provide protection in various layers and excess of varying attachment points according to the scope of cover provided. The proportional cover provides protection on the basis of a percentage sharing of both premiums and claims with the reinsurer (known as quota share reinsurance).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to natural perils coverage, we buy protections that cover both our insurance and reinsurance lines of business&#160;through a variety of products, including, but not limited to, excess of loss reinsurance, facultative reinsurance, aggregate covers, whole account covers and collateralized products which can be on either an indemnity or an index linked basis. For example, we may purchase industry loss warranty reinsurance which provides retrocessional coverage when insurance industry losses for a defined event exceed a certain level. We expect the type and level of coverage that we purchase will vary over time, reflecting our view of the changing dynamics of the underlying exposure and the reinsurance markets.&#160; We manage our risk by seeking to limit the amount of exposure assumed from any one reinsured and the amount of the aggregate exposure to catastrophe losses from a single event in any one geographical zone. Additionally, Aspen Re continues to purchase quota share and retrocessional reinsurance protection for a range of international perils and worldwide catastrophe losses through ACM and other collateralized reinsurance arrangements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although reinsurance agreements contractually obligate our reinsurers to reimburse us for an agreed-upon portion of our gross paid losses, we remain liable to our insureds to the extent that our reinsurers do not meet their obligations under these agreements. As a result, and in line with our risk management objectives, we evaluate the financial condition of our reinsurers and monitor concentrations of credit risk on an on-going basis. In general, we seek to place our reinsurance with highly rated companies with which we have a strong trading relationship or have fully collateralized arrangements in place. We maintain a list of authorized reinsurers graded for short, medium and long tail business which is regularly reviewed and updated.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2022, the Aspen Group entered into the LPT through an Amended and Restated Reinsurance Agreement with a subsidiary of Enstar, which amended and restated an adverse development cover reinsurance agreement, dated as of March 2, 2020, previously entered into between Enstar and the Aspen Group (the &#8220;Original Agreement&#8221;). Under the terms of the LPT, Enstar reinsured net losses with a date of loss incurred on or prior to December 31, 2019 on Aspen&#8217;s diverse mix of property, liability and specialty lines across the United States, the United Kingdom and other jurisdictions (the &#8220;Subject Business&#8221;) having net loss reserves of $3.12 billion as of September 30, 2021. The LPT provides for a limit of $3,570.0 million in consideration for a premium of $3,160.0 million. The amount of net loss reserves ceded, as well as the premium and limit amounts provided under the LPT, have been adjusted for claims paid between October 1, 2021 and the closing date of the transaction on May 20, 2022. The premium includes $770.0 million of premium previously paid with respect to reserves ceded under the Original Agreement, which will continue to be held in trust accounts to secure Enstar&#8217;s obligations under the LPT. The incremental new premium will initially be held in funds withheld accounts in their original currencies maintained by Aspen but will be released to the trust accounts maintained by Enstar no later than September 30, 2025. The funds withheld by Aspen will be credited with interest at an annual rate of 1.75% plus, for periods after October 1, 2022, an additional amount equal to 50% of the amount by which the total return on the investments and cash and cash equivalents of the Company and its subsidiaries exceeds 1.75%. Under the LPT, the Enstar subsidiary has assumed claims control of the Subject Business, pursuant to the provisions of an administrative services agreement subsequently entered into between the parties on June 30, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Agreement includes customary representations and warranties, indemnification obligations, covenants and termination rights of the parties. Following receipt of applicable regulatory approvals, the transaction closed on May 20, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen has a comprehensive risk management framework that defines the corporate risk appetite, risk strategy and the policies in place to monitor, manage and mitigate the risk inherent in our business.&#160; Our risk management framework covers all risks in our risk universe, on a current and forward-looking basis, and is implemented in a consistent manner across the Aspen Group. It is the basis through which we protect our franchise value and seek to enable sustained profitable growth. Below is a summary of our current corporate governance bodies and risk management strategy:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Governance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board of Directors</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board considers effective identification, measurement, monitoring, management and reporting of the risks facing our business to be key elements of its responsibilities and those of the Group Chief Executive Officer and management. Matters relating to risk management that are reserved for the Board include approval of the internal controls and risk management framework and any changes to the Aspen Group&#8217;s risk appetite statement and key risk limits. The Risk Committee of the Board also receives regular reports covering risk management processes, which include, among others, the design, operation, use and limitations of the internal model. The internal model is an economic capital model which has been developed internally for use in certain business decision-making processes, the assessment of risk-based capital requirements and for various regulatory purposes. As a result of these arrangements and processes, the Board, assisted by management and the various standing committees of the Board (the &#8220;Board Committees&#8221;), is able to exercise effective oversight of the operation of the risk management strategy described in &#8220;&#8212;Risk Management Strategy&#8221; below. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board Committees</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board delegates oversight of the management of certain key risks to its Risk, Audit, Conflicts and Investment Committees, as well as, upon completion of this offering, the Compensation Committee and the Nominating and Corporate Governance Committee. The Audit Committee and Conflicts Committee are comprised entirely of independent directors and all Board Committees are structured to ensure appropriate and objective challenge of, and discussion with, management. The chairs of the Board Committees report regularly to the Board on the committees&#8217; discussions, and in any event at each of the regular meetings of the Board. In addition, the Board </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees may facilitate informational calls with management from time to time where required and in accordance with the Company&#8217;s operating guidelines.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Risk Committee assists the Board in its oversight of the framework that governs risk management and solvency assessment practices group-wide as articulated in the Board approved Group Risk Policy. This specifically includes oversight of processes undertaken by management to identify, evaluate and mitigate the material risks to the Group&#8217;s strategic objectives, as well as monitoring adherence to the Board approved risk appetite framework, solvency indicators, risk tolerance criteria, and key risk limits. The matters considered by the Risk Committee include cyber security trends and events as well as data privacy matters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee is primarily responsible for assisting the Board in its oversight of the integrity of the financial statements. The Audit Committee is also responsible for reviewing the adequacy and effectiveness of the Company&#8217;s internal controls, relating to the accounting and financial reporting process of the Company and audits of the Company&#8217;s financial statements, and oversight of both internal and external auditors. In addition, the Audit Committee oversees the Company&#8217;s compliance with applicable laws and regulations, as well as conflict of interest matters (to the extent not within the remit of the Conflicts Committee). The members of the Audit Committee regularly meet with management, the Group Head of Internal Audit and the Company&#8217;s independent, registered public accounting firm to review matters relating to the quality of financial reporting and internal accounting controls, including the nature, extent and results of their audit. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conflicts Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Conflicts Committee reviews certain material transactions between Aspen Holdings and/or its subsidiaries and Apollo or Apollo&#8217;s non-Aspen affiliates that may present a conflict of interest.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Committee supports the Board in its oversight responsibilities by reviewing and monitoring the management and performance of the investment function of the Aspen Group, including the review of the investment strategy and annual investment plan and the ongoing monitoring of the Aspen Group&#8217;s investment managers, including the governance and control framework in place in connection therewith.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of this offering, the Board will establish and put into effect a Compensation Committee, which will assist the Board in its oversight duties in respect of the compensation philosophy and strategy of the Company and its subsidiaries, including, but not limited to, approval of the Group&#8217;s policies relating to the compensation of its employees, the approval of any issuance of equity or equity-based securities and oversight of the compensation of the Company&#8217;s Group Chief Executive Officer, key senior employees, executive officers and non-employee directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nominating and Corporate Governance Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of this offering, the Board will establish and put into effect a Nominating and Corporate Governance Committee, which will assist the Board in its oversight of the evaluation of management and the Board, including the Board Committees, corporate governance matters and practices and make recommendations to the Board in relation thereto, and identify, evaluate and nominate individuals qualified to become Board members and to recommend to the Board director nominees for approval by shareholders at the annual general meetings of shareholders.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Management Committees</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group Chief Executive Officer maintains an executive committee (the &#8220;Group Executive Committee&#8221;), which is the primary executive committee of the Company. It is comprised of global heads of key functions and other key business leads and is responsible for advising the Group Chief Executive Officer and assisting in the execution of his responsibilities to the Board, including with respect to matters relating to the overall strategy and conduct of the Aspen Group&#8217;s business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are various standing committees (the &#8220;Executive Management Committees&#8221;) of the Group Executive Committee, which have oversight of certain business, operational and risk management processes and support the Group Executive Committee in the achievement of its objectives. Membership of the Executive Management Committees includes members of the Group Executive Committee, and the structure of the meetings of the Group Executive Committee contemplates appropriate reporting and feedback from the Executive Management Committees. As of the date of this prospectus, these included:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underwriting Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The primary purpose of the Underwriting Committee is to assist the Group Executive Committee through oversight of the design, implementation and operation of the strategic direction of the underwriting function of the Aspen Group, including the review and management of overall underwriting risk and appetite across the Insurance and Reinsurance underwriting segments and all underwriting platforms and legal entities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk and Capital Committee </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The primary purpose of the Risk and Capital Committee is to assist the Group Executive Committee through oversight of the internal control and risk management framework of the Aspen Group. In particular, the Risk and Capital Committee has specific responsibilities in relation to the review of the internal model, monitoring of solvency, capital and liquidity considerations and risk limits for accumulating underwriting and investment exposures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Claims Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The primary purpose of the Claims Committee is to support the Group Executive Committee in its oversight of the strategy, transformation and management of the global claims function of the Aspen Group, across both Insurance and Reinsurance, including the monitoring of adherence to claims management policies, reporting procedures and standards and the development of an annual strategic plan for the claims function.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The primary purpose of the Operating Committee is to assist the Group Executive Committee through oversight of the operational activities of the Aspen Group, including both in-house and outsourced activities, and the interaction of the operations function with other business function of the Company, including the oversight of the operational risks associated with such functions, to ensure that they are strategically aligned with each other in order to provide coordinated, efficient and cost-effective operational support to the execution of the Aspen Group&#8217;s strategic objectives.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The primary purpose of the Change Board is to assist the Group Executive Committee through oversight of the definition, prioritization and initiation of change projects in connection with the change program of Aspen Group and as part of the overall corporate strategy.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing and Communications Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The primary purpose of the Marketing and Communications Committee is to oversee the design, implementation and operation of the Aspen Group&#8217;s marketing and communications strategies. This includes the development and maintenance of the Company&#8217;s strategic innovation and cultural framework, in collaboration with other function leads of the Group Executive Committee, including monitoring the interaction of the marketing and communications function with other functions of the Aspen Group.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset and Liability Management Committee </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Asset and Liability Management Committee has oversight of the operation of the investment portfolio of the Aspen Group, including the development of, and monitoring the adherence to, the Aspen Group&#8217;s investment management policies, procedures and standards, development of an annual strategic plan for the investments function, in collaboration with the underwriting segments and all underwriting platforms.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">178</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation Committee </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary purpose of the Valuation Committee is to assist the Group Executive Committee, in particular, the Group Chief Financial Officer, in its oversight of the valuation framework of the investment portfolio of the Aspen Group, including, but not limited to, hard-to-value and illiquid investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sustainability Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The primary purpose of the Sustainability Committee is to support the Group Executive Committee and its standing sub-committees and oversee the design, strategy, coordination and management of the sustainability practices of Aspen, including, but not limited to, ESG matters, and the integration thereof within the Group&#8217;s business functions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserve Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The primary purpose of the Reserve Committee is to support the Group Executive Committee in its oversight of the Aspen Group-level reserves, including consideration of key areas of reserving uncertainty within the Aspen Group-level actuarial central estimate and the management best estimate, which provides the basis for management&#8217;s recommendation to the Audit Committee and the Board regarding the reserve amounts to be recorded in the financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Group Executive Committee, the Group Chief Executive Officer maintains a Group Disclosure Committee, which assists the Group Chief Executive Officer and the Group Chief Financial Officer, as the Company&#8217;s certifying officers, in fulfilling their duties for oversight of the accuracy and timeliness of any disclosures made by the Company to ensure that the Company meets its legal and regulatory obligations. This includes the review and approval of disclosures and reports, in accordance with its governance framework, and the maintenance and oversight of a management committee responsible for overseeing compliance with the Sarbanes-Oxley Act to the extent applicable.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management Strategy</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate an integrated enterprise-wide risk management strategy designed to protect shareholder value in a sustainable and efficient manner while providing a high level of policyholder protection and regulatory compliance. The execution of our integrated risk management strategy is based on:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the establishment and maintenance of an internal control and risk management system based on a three lines of defense approach to the allocation of responsibilities between risk accepting units (first line), risk management activity and oversight from other central control functions (second line) and independent assurance (internal audit) (third line);</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identifying material risks to the achievement of the Aspen Group&#8217;s objectives including emerging risks;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the articulation at Group level of our risk appetite and a consistent set of key risk limits which translate the risk appetite into measurable criteria and provides the primary control for accumulated risk exposures;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cascading of risk appetite and key risk limits for material risks to each risk-assuming operating subsidiary;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">measuring, monitoring, managing and reporting risk positions and trends;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the use, subject to an understanding of its limitations, of the internal model to test strategic and tactical business decisions and to assess compliance with the risk appetite statement; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">stress and scenario testing, including reverse stress testing, designed to help us better understand and develop contingency plans for the likely effects of extreme events or combinations of events on capital adequacy and liquidity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Appetite Statement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk appetite statement is a central component of the Aspen Group&#8217;s overall risk management framework and is approved by the Board. It sets out, at a high level, how we think about risk in the context of our business model, Aspen Group objectives and strategy, and provides the foundation for decision making during the implementation of our strategy and business plans. It sets out boundary conditions and limits for the level of risk we </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assume, together with a statement of the reward we aim to receive for this level of risk. Our risk appetite statement comprises the following components:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk preferences:&#160;&#160;a high level description of the types of risks we prefer to assume and those we prefer to minimize or avoid;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Return objective:&#160;&#160;a description of the return on capital we seek to achieve, subject to our risk constraints;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility objective:&#160;&#160;a description of earnings volatility tolerance;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Capital objective:&#160;&#160;a description of the target level of risk adjusted capital; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Liquidity objective: a description of the target level of liquidity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Components</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The main types of risks that we face are summarized as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance risk &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The risk that underwriting results vary from their expected amounts, including the risk that reserves established in respect of prior periods differ significantly from the level of reserves included in the Aspen Group&#8217;s financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market risk &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The risk of variations in the valuation of investments due to changes in macroeconomic factors and the general uncertainty related to any investment decision.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit risk &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The risk of diminution in the value of insurance receivables as a result of counter-party default. This principally comprises default and concentration risks relating to amounts receivable from intermediaries, policyholders and reinsurers. We include credit risks related to our investment portfolio under market risk. We include credit risks related to insurance contracts (e.g., credit and political risk policies) under insurance risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity risk &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The risks of failing to maintain sufficient liquid financial resources to meet liabilities as they fall due or to provide collateral as required for commercial or regulatory purposes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operational risk &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The risk of loss resulting from inadequate or failed internal processes, personnel or systems, or from external events. This includes the risk of material misstatement in financial reporting and non-compliance with regulatory requirements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic risk &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The risk of adverse impact on shareholder value or income and capital of adverse business decisions, poor execution or failure to respond to market changes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emerging risk &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The risk that events or issues not previously identified or fully understood impact the operations or financial results of the Aspen Group. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We distinguish between &#8220;core&#8221; and &#8220;non-core&#8221; risks. Core risks comprise those risks which are inherent in the operation and value creation strategy of our business, including insurance risks in respect of our underwriting operations and market risks in respect of our investment activity. We actively seek core risks with a view to generating shareholder value but seek to manage the resulting volatility in our earnings and financial condition within the limits defined by our risk appetite. However, these core risks are intrinsically difficult to measure and manage and we may not, therefore, be successful in this respect. All other risks are classified as non-core. We seek, to the extent we regard as reasonably practicable and economically viable, to avoid or minimize our exposure to non-core risks.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Limits Frameworks</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen&#8217;s Risk Limit Framework translates the risk appetite objectives into measurable criteria. Limits provide primary control for Group-wide accumulated risk exposures and establishes the connections to business planning and monitoring by placing constraints on risk taking decisions. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">180</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Limits are established for the most important drivers of risk at the Group level and express the maximum level of allowable exposure per risk driver. At the highest level, risk limits are approved by the Board. Monitoring of the Group position against these limits is included in regular reporting to the Board or one or more of the Board Committees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Natural Catastrophe Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of the Company&#8217;s natural catastrophe PMLs information contains forward-looking statements based upon assumptions and expectations concerning the potential effect of future events that are subject to uncertainties. See &#8220;Risk Factors&#8221; for further information. Any of these risk factors could result in actual losses that are materially different from the Company&#8217;s PML estimates below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natural catastrophe risk is a source of significant aggregate exposure for the Company and is managed by setting risk tolerance and limits, as discussed above. Natural catastrophe perils can impact geographic regions of varying size and can have economic repercussions beyond the geographic region directly impacted.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers a peril zone to be an area within a geographic region, continent or country in which losses from insurance exposures are likely to be highly correlated to a single catastrophic event. The Company defines peril zones to capture the vast majority of exposures likely to be incorporated by typical modeled events. There is, however, no industry standard and the Company&#8217;s definitions of peril zones may differ from those of other parties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has exposures in other peril zones that can potentially generate losses greater than the PML estimates below. The Company&#8217;s PMLs represent an estimate of loss for a single event for a given return period. The table below discloses the Company&#8217;s 1-in-100 and 1-in-250 year return period estimated loss for a single occurrence of a natural catastrophe event in a one-year period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s single occurrence and worldwide estimated net PML exposures (net of retrocession and reinstatement premiums) of the major peril zones and worldwide as at July 1, 2023 were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at July 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-in-100 year PML </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-in-100 year PML as % of Shareholders&#8217; Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-in-250 year PML </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-in-250 year PML as % of Shareholders&#8217; Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">World Wide All Perils</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan All Perils</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northeast and Mid-Atlantic Windstorm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas and Gulf Windstorm</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida and Southeast Windstorm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California Earthquake</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Based on total shareholders&#8217; equity of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-30">2,548.7</ix:nonFraction> million as at June 30, 2023. The estimates reflect Aspen&#8217;s view of the modelled maximum losses at the return periods shown which include input from various third party vendor models and Aspen&#8217;s proprietary adjustments to these models and planned reinsurance purchases. Catastrophe loss experience may materiality differ from the modelled PMLs due to limitations in one or more of the models or uncertainties in the application of policy terms and limits.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes all natural catastrophe perils where Aspen has identified an appropriate stochastic model, such as hurricanes, typhoons, wildfire, earthquakes, etc., and includes a loading for non-modelled classes for our most material peril regions.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3030"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Distribution</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is produced principally through brokers and reinsurance intermediaries. The brokerage distribution channel provides us with access to an efficient, global distribution system without the significant time and expense which would be otherwise incurred in creating wholly-owned distribution networks. The brokers and reinsurance </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">181</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intermediaries typically act in the interest of insureds, ceding clients or insurers and are instrumental to our continued relationship with our clients. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show our gross written premiums by broker for each of our business segments for the twelve months ended December 31, 2022, 2021 and 2020: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Written Premiums</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Written Premiums</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Written</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Premiums&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aon Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marsh &amp; McLennan Companies, Inc,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ryan Specialty</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arthur J. Gallagher and Company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euclid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brown &amp; Brown Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmWINS Group Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lockton Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRC Swett</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arthur J Gallagher (UK) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Risk Partners</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Risks Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,042.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The prior periods are re-presented to ensure consistency and replicate the current year breakdown for the addition of new material brokers. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Written Premiums</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Written Premiums</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Written</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Premiums&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total&#160;</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aon Corporation </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marsh&#160;&amp; McLennan Companies, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arthur J. Gallagher and Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2020 includes gross written premium of $334.8 million related to CGB DS. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8899"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Operations </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our investment&#160;strategy is focused on&#160;delivering stable&#160;investment income and total&#160;return through all market cycles while maintaining appropriate portfolio liquidity and credit quality to meet the requirements of our customers, rating agencies and regulators.&#160;To enhance investment returns where possible, we&#160;tactically&#160;adjust&#160;the duration of the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">182</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment portfolio and asset allocation taking into account the average liability duration of our reinsurance and insurance risks and our views of interest rates, the yield curve, credit spreads and markets for different assets.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, we maintained an Asset and Liability Management Committee, which reports into the Group Executive Committee. The Chair of the Asset and Liability Management Committee also provides updates to the Investment Committee of the Board at its regular meetings, which in turn reports up to the Board. The Asset and Liability Management Committee develops and oversees adherence to the Company&#8217;s investment management policies, procedures and standards, including monitoring performance against our overall investment results and performance against our investment objectives, guidelines and key performance indicators. The Asset and Liability Management Committee supervises our investment activity, in accordance with the investment plan, which includes the investment strategy, for the Company as determined by the Board. The investment guidelines set by the Board specify minimum criteria on the overall credit quality and liquidity characteristics of the portfolio, and include limitations on the size of certain holdings and restrictions on purchasing certain types of securities. The Asset and Liability Management Committee and other members of management review our investment performance and assess credit and market risk concentrations and exposures to issuers. We follow an investment strategy designed to emphasize the preservation of capital and provide sufficient liquidity for the prompt payment of claims. In addition, the Company maintains a Valuation Committee, which meets quarterly to oversee and review the valuations of holdings in the investment portfolio of the Company.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information concerning our investments, refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Note 4&#8212;Investments&#8221; and &#8220;Note 6&#8212;Fair Value Measurements&#8221; of our consolidated financial statements. For additional information concerning Current Expected Credit Losses (&#8220;CECL&#8221;) on investments, refer to &#8220;Note 2(c)&#8212;Basis of Presentation and Significant Accounting Policies&#8212;Accounting for Investments, Cash and Cash Equivalents&#8221; of our consolidated financial statements. For additional information concerning investment management arrangements, refer to &#8220;Material Contracts and Related Party Transactions&#8212;Relationships and Related Party Transactions with Apollo or its Affiliates&#8212;Investment Management Relationships.&#8221;</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3050"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Claims Management</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Groups Claims Team are a separate function within Aspen. We have a staff of experienced claims professionals who are structured into three core teams being Insurance, Reinsurance and Claims Operations. The Insurance and Reinsurance teams are organized by portfolio with the Claims Operations team working across both teams. The Group Claims team operates under a global structure designed to achieve consistency and efficiencies across all lines of business. We have developed processes and internal business controls for identifying, tracking and settling claims, and authority levels have been established for all individuals involved in the reserving and settlement of claims. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key responsibilities of our claims management departments include:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">processing, managing and resolving reported insurance or reinsurance claims efficiently and accurately to ensure the proper application of intended coverage, reserving in a timely fashion for the probable ultimate cost of both indemnity and expense and making timely payments in the appropriate amount on those claims for which we are legally obligated to pay; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">selecting appropriate counsel and experts for claims, manage claims-related litigation and regulatory compliance; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">contributing to the underwriting process by collaborating with underwriting teams and senior management in terms of the evolution of policy language and endorsements and providing claim-specific feedback and education regarding claims activity; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">contributing to the analysis and reporting of financial data and forecasts by collaborating with the finance and actuarial functions relating to the drivers of actual claim reserve developments and potential for financial exposures on known claims. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">183</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On those facilities and accounts where it is applicable and permitted, external auditing firms in conjunction with a team of in-house claims professionals oversee and regularly audit claims handled under claims delegated authority and outsourcing agreements. The audits may involve a team of in-house claims professionals and that generally applies in relation to the audits of cedants on reinsurance. In addition any referrals on claims in excess of the authority provided under a claims delegated authority arrangement, whether financial or coverage related, will be managed by the relevant claims handler as required under the terms of those agreements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior management receives a regular report on the status of our reserves and settlement of claims. We recognize that fair interpretation of our reinsurance agreements and insurance policies with our customers, and timely payment of valid claims, are a valuable service to our clients and enhance our reputation. Under the terms of the LPT with Enstar, Enstar has assumed claims control of the subject business since closing of the transaction and entrance on June 30, 2022 into an administrative services agreement, which sets forth the operational framework for the handling of the subject business. Claims Handling Guidelines were entered into setting out the management and oversight of the subject business. These guidelines ensure Enstar&#8217;s claims handling aligns to Aspen&#8217;s claims processes, procedures and philosophy with Enstar operating within Aspen&#8217;s claims handling systems. Aspen continues to handle certain claims on the subject business under &#8220;shared services.&#8221; The transaction presents certain operational and reputational risks for the Company, including in respect of claims management. For a description of the risks, refer to &#8220;Risk Factors&#8212;Risks Related to Our Business&#8212;Other Operational Risks&#8212;We rely on the execution of internal processes to maintain our operations and the operational risks that are inherent to our business, including those resulting from fraud or employee errors or omissions, may result in financial losses.&#8221;</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3070"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reserves</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under GAAP and applicable insurance laws and regulations in the countries where we operate, we are required to establish loss reserves for the estimated unpaid portion of the ultimate liability for losses and loss expenses under the terms of our policies and agreements with our insured and reinsured customers. The process of estimating these reserves involves a considerable degree of judgment and, as of any given date, is inherently uncertain. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Estimates&#8212;Reserving Approach&#8221; for more information. The Reserve Committee oversees the development of the Aspen Group-level reserves.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3090"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The insurance and reinsurance industries are mature and highly competitive. Competition varies significantly on the basis of product and geography. Insurance and reinsurance companies compete on the basis of many factors, including premium charges, general reputation and perceived financial strength, the terms and conditions of the products offered, ratings assigned by independent rating agencies, speed of claims payments, reputation and experience in the particular risk to be underwritten, quality of service, the jurisdiction where the reinsurer or insurer is licensed or otherwise authorized, capacity and coverages offered and various other factors.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with major U.S., U.K., Bermuda based, European and other international insurers and reinsurers and underwriting syndicates from Lloyd&#8217;s, some of which have longer operating histories, more capital and/or more favorable financial strength ratings than we do, as well as greater marketing, management and business resources. This also includes new companies that enter the insurance and reinsurance industries. In addition, we compete with capital market participants that create alternative products, such as catastrophe bonds, that are intended to compete with traditional reinsurance products.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased competition could result in fewer submissions for our products and services, lower rates charged, slower premium growth and less favorable policy terms and conditions, any of which could adversely impact our growth and profitability. For a further discussion on the risks related to competition in our industry, please refer to &#8220;Risk Factors&#8212;Risks Related to Our Business&#8212;Strategic Risks&#8212;Competition and consolidation in the (re)insurance industry could reduce our growth and profitability.&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3110"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Corporate Structure  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated on May 23, 2002 in Bermuda as a holding company operating under the laws of Bermuda. Our principal office is located at 141 Front Street, Hamilton, HM19, Bermuda. Our telephone number is +1 441-295-8201 and our website address is www.aspen.co. Information contained on, or that can be accessed through, our website is not part of and is not incorporated by reference into this prospectus, and you should not consider information on our website to be part of this prospectus. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, Highlands Bermuda Holdco, Ltd., an affiliate of certain investment funds managed by affiliates of Apollo, owned all of our ordinary shares. The following diagram sets forth a simplified view of our corporate structure after giving effect to this offering. This chart is for illustrative purposes only and does not represent all legal entities affiliated with the entities depicted. Unless otherwise noted, each entity is wholly-owned by its immediate parent.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_73667279069940"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><img src="ahl-20231220_g11.jpg" alt="busniess10e.jpg" style="height:652px;margin-bottom:5pt;vertical-align:text-bottom;width:899px"/></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">See &#8220;Principal and Selling Shareholders&#8221; for detail of the percentage ownership prior to this offering, as well as the percentage ownership following this offering.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3130"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal Operating Subsidiaries at June 30, 2023 were as follows which are also reflected in the chart above: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.814%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Subsidiary</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ultimate Ownership Interest Held by Aspen Holdings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Insurance UK Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Bermuda Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Specialty Insurance Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Dakota</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen American Insurance Company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Underwriting Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ratings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ratings by independent agencies are an important factor in establishing the competitive position of (re)insurance companies and are important to our ability to market and sell our products and services. Rating organizations continually review the financial positions of insurers, including us. As of the date of this prospectus, the financial strength ratings of our Operating Subsidiaries were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rating Agency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rated Operating Subsidiary</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agency&#8217;s Rating Definition</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ranking of Rating</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard &amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A- (Strong - Stable outlook) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen UK, Aspen Bermuda, and AAIC*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strong capacity to meet financial commitments but somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than those in higher-rated categories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The &#8216;A&#8217; grouping is the third highest of ten major rating categories. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.M. Best Company, Inc. (&#8220;A.M. Best&#8221;)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A (Excellent) (Stable)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen UK, Aspen Bermuda, Aspen Specialty and AAIC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An excellent ability to meet ongoing insurance obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The &#8216;A&#8217; grouping is the second highest of seven major rating categories. </span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">*Note that Aspen Specialty does not maintain its own rating from S&amp;P.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These ratings reflect the respective opinions of S&amp;P and A.M.&#160;Best regarding the ability of the relevant Operating Subsidiary to pay claims and are not evaluations directed to our investors or recommendations to buy, sell or hold our securities. These ratings are subject to periodic review by, and may be revised downward or revoked, at the sole discretion of, S&amp;P and A.M.&#160;Best, respectively. Additionally, rating organizations may change their rating methodology, which could have a material impact on our financial strength ratings.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of some potential risks relating to the ratings of our Operating Subsidiaries, refer to &#8220;Risk Factors&#8212;Risks Related to Our Business&#8212;Strategic Risks&#8212;Our Operating Subsidiaries are rated and our Lloyd&#8217;s business benefits from a rating by one or more of A.M. Best and S&amp;P and a decline in any of these ratings could adversely affect our standing among brokers and customers and cause our premiums and earnings to decrease, or may otherwise result in an adverse effect on our business, financial condition and operating results.&#8221;&#160;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">187</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3150"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employees</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, we employed 946&#160;persons in the following countries:  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the number of employees in 2022 compared to 2021 was primarily in the United Kingdom and the United States and was driven by the increased business growth. We believe that relations with our employees, none of which are subject to collective bargaining agreements, are good.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3170"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facilities </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease office space in Hamilton, Bermuda, where we are headquartered. In addition, we and our subsidiaries lease office space in the United States, the United Kingdom, Puerto Rico, Singapore and Switzerland. We renew and enter into leases in the ordinary course of business as required. For more information on our leasing arrangements, refer to &#8220;Note 18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating Leases&#8221; of our audited consolidated financial statements.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3222"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to the rest of the insurance and reinsurance industry, we are subject to litigation and arbitration in the ordinary course of our business, which could include matters relating to notable natural catastrophe and man-made loss events, such as in relation to the Russian invasion of Ukraine and COVID-19. Our subsidiaries are regularly engaged in the investigation, conduct and defense of disputes, or potential disputes, resulting from questions of insurance and reinsurance coverage or claims activities. Pursuant to our insurance and reinsurance arrangements, many of these disputes are resolved by arbitration or other forms of alternative dispute resolution. In some jurisdictions, notably the United States, a failure to deal with such disputes or potential disputes in an appropriate manner could result in an award of &#8220;bad faith&#8221; punitive damages against our Operating Subsidiaries. In addition, we may be subject to lawsuits and regulatory actions in the normal course of business that do not arise from, or directly relate to, insurance and reinsurance coverage or claims. This category of litigation typically involves, among other things, allegations of underwriting errors or omissions, employment claims or regulatory activity.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While any legal or arbitration proceedings contain an element of uncertainty, we do not believe that the eventual outcome of any specific litigation, arbitration or alternative dispute resolution proceedings to which we are currently a party will have a material adverse effect on the financial condition of our business as a whole.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6482"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT AND CORPORATE GOVERNANCE</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6673"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors and Executive Officers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, as of the date of this prospectus, the names, ages and positions of the individuals who are expected to serve as our directors and executive officers at the time of this offering of our ordinary shares as set forth in this prospectus. The current business address for our directors and executive officers is 141 Front Street, Hamilton, HM19, Bermuda.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.279%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Cloutier</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Executive Chair and Group Chief Executive Officer </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Altmaier *</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chair of the Compensation Committee&#8224;, Member of the Risk, Audit and Conflicts Committees</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albert J. Beer *</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chair of the Conflicts Committee, Member of Audit, Investment and Risk Committees</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Theresa Froehlich *</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chair of Risk Committee, Member of Compensation and Nominating and Corporate Governance Committees&#8224;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexander Humphreys &#94;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Member of Risk and Compensation Committees&#8224;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard Lightowler *</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chair of Audit Committee, Member of Conflicts Committee</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gernot Lohr &#94;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tammy L. Richardson-Augustus *</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chair of Investment Committee, Chair of Nominating and Corporate Governance Committee&#8224;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Saffer &#94;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Member of Risk, Investment and Nominating and Corporate Governance Committees&#8224;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Officers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Cloutier</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Executive Chair and Group Chief Executive Officer </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Amaro</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group General Counsel &amp; Company Secretary</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher Coleman</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christian Dunleavy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Chief Underwriting Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce Eisler</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Underwriting Officer - Insurance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rob Houghton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Chief Operating Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aileen Mathieson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Chief Investment Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Pickering</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Chief Capital Management Officer &amp; Group Treasurer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian Tobben</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer of Aspen Capital Partners</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Welch</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Underwriting Officer - Reinsurance</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.5pt">Independent, Non-Executive Director</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-Executive Director</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8224;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">Upon completion of this offering, the Board will establish and put into effect the Compensation Committee and the Nominating and Corporate Governance Committee</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biographical Information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biographical information on our directors and executive officers is set forth below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mark Cloutier</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Cloutier was appointed Executive Chair and Group Chief Executive Officer of Aspen in February 2019. He had previously been Executive Chairman of the Brit Group, a Lloyd&#8217;s of London insurer, since January 2017 and prior to this, he was Chief Executive Officer of the Brit Group from October 2011 following its acquisition by Apollo and certain other private equity firms. As Chief Executive Officer of the Brit Group, Mr. Cloutier led a major restructuring of Brit&#8217;s global business, the successful listing on the London Stock Exchange </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">through an initial public offering in 2014 as well as the subsequent acquisition of the business by Fairfax Financial Holdings in 2015.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With over 35 years&#8217; experience working in the international insurance and reinsurance sector in multiple jurisdictions including Canada, the United States, the United Kingdom, Bermuda, continental Europe, Asia, China and South Africa, Mr. Cloutier has held a number of senior executive positions, including Chief Executive Officer of the Alea Group, Chief Executive Officer of Overseas Partners Re and President of E.W. Blanch Insurance Services Inc. He served as a member of the Franchise Board and Audit Committee of the Society of Lloyd&#8217;s between February 2015 and June 2020 and was appointed to the Nomination and Governance Committee in February 2017. Mr. Cloutier has worked with a variety of private equity investors including Apollo, CVC Capital Partners, Kohlberg Kravis Roberts &amp; Co. L.P. and Fortress Investment Group LLC. He started his career in British Columbia, Canada with Brouwer and company independent loss adjusters before moving on to found his own firm, Maxwell Cloutier Adjusters Ltd. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">He currently serves on the Board of Overseers of the Maurice R. Greenberg School of Risk Management, Insurance and Actuarial Science in New York. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe Mr. Cloutier is qualified to serve as Executive Chair of the Board due to his extensive leadership experience in the insurance and reinsurance industries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David Altmaier</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Altmaier was appointed to our Board in March 2023. Since March 2023, Mr. Altmaier has worked as a consultant at The Southern Group, a full-service lobbying firm. Prior to joining The Southern Group, Mr. Altmaier was the Commissioner of Insurance for the State of Florida from 2016 to 2022. In this role, Mr. Altmaier led the Office of Insurance Regulation (the &#8220;OIR&#8221;) and worked to cultivate a market in Florida in which insurance products are reliable, available and affordable. He started at the OIR in 2008, serving in a number of increasingly senior roles, including as Director of Property &amp; Casualty Financial Oversight and, prior to assuming the role of Commissioner, as Deputy Commissioner of Property and Casualty Insurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other market leadership roles, Mr. Altmaier is a member of Florida&#8217;s Blockchain Task Force and, during the COVID-19 pandemic, was selected as a member of Florida&#8217;s Re-Open Florida Task Force Industry Working Group on Agriculture, Finance, Government, Healthcare, Management and Professional Services. Mr. Altmaier has also held multiple leadership positions within The National Association of Insurance Commissioners, most recently as President. We believe Mr. Altmaier is qualified to serve as a member of the Board due to his experience as an insurance regulator and his broad knowledge of the insurance industry.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Albert J. Beer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Beer was appointed to the Board in July 2019 after having previously served on the Board from February 2011 to February 2019. Since July 2014, he has also served as a director of Aspen Bermuda Limited. Mr. Beer previously held various executive roles at Munich Reinsurance America, which included the active supervision of principal financial and accounting officers. Mr. Beer has over 40 years of actuarial and management experience in the insurance industry. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Beer is the Michael J. Kevany/XL Professor of Risk Management, Insurance and Actuarial Science at The Peter J. Tobin College of Business School of Risk Management, Insurance and Actuarial Science at St. John&#8217;s University. Mr. Beer graduated Phi Betta Kappa from Manhattan College with a B.S. in Mathematics and holds an M.A. in Mathematics from the University of Colorado. We believe Mr. Beer is qualified to serve as a member of the Board due to his significant experience in the insurance industry.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Theresa Froehlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Ms. Froehlich was appointed to the Board in June 2020. She has over 25 years of management experience in the financial services industry. From 2010 to 2016, Ms. Froehlich held senior roles at Lloyd&#8217;s of London, including interim director of performance management, where she was responsible for all commercial aspects of oversight of the marketplace and setting underwriting standards and also head of underwriting performance. Prior to working at Lloyd&#8217;s of London, she worked in Zurich as a Managing Director for Swiss Reinsurance Company Ltd., holding various senior management roles which included portfolio management of structured reinsurance products, driving transformation and strategic initiatives and serving as the Head of Transactions UK at Admin Re.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">She currently serves as a Non-executive Director of Aegon U.K. PLC and other companies in that group and has served as a Non-executive Director and Chair of the Audit Committee of Managing Agency Partners Ltd since 2017. From 2017 to 2020, Ms. Froehlich served as a Non-executive Director of Starr International Europe Limited </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Starr Managing Agents Limited, where she chaired the Remuneration Committee and was a member of the Audit and Risk and Capital Committees. In addition, Ms. Froehlich has served as the Chair of Aspen Insurance U.K. Limited since November 2019 and as a Non-executive Director of Aspen Managing Agency Limited, where she chaired the Risk Management Committee from November 2019 to June 2022 and the Board since November 2021. Ms. Froehlich started her career as a commercial solicitor in Scotland before moving into mergers and acquisitions and structured finance. We believe Ms. Froehlich is qualified to serve on the Board due to her experience serving on the boards of directors of insurance companies and her overall knowledge operating in the insurance industry.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alexander Humphreys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Humphreys was appointed to the Board in February 2019. Mr. Humphreys is a Partner at Apollo, which he joined in 2008. Prior to this, Mr. Humphreys worked at Goldman Sachs &amp; Co. LLC on its financial institutions mergers and acquisitions team. Mr. Humphreys also currently serves on the boards of various Apollo portfolio companies, including Athora Holding, Ltd, Catalina Holdings (Bermuda) Ltd., and Miller Homes. He previously served on the board of directors of HD Finance Holdings Limited (parent of Haydock Finance Holdings Limited), Latecoere S.A., Seguradoras Unidas S.A. (parent of Tranquilidade), Luminescence Cooperatief U.A., and Amissima Holdings, S.r.l. We believe Mr. Humphreys is qualified to serve on the Board due to his experience serving on the boards of directors of insurance companies and his experience in the private equity and financial services industries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Richard Lightowler</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Lightowler was appointed to the Board in December 2020. Mr. Lightowler has over 25 years&#8217; experience in financial services public accounting focused on reinsurance and insurance clients, including non-life and life, primary and reinsurance, run-off as well as specialized risk vehicles. He was a Partner at KPMG from 1998 to 2016, where he spent over 16 years serving as global lead audit partner for reinsurance groups listed on the New York and London Stock Exchanges. Mr. Lightowler also served as Head of the KPMG Bermuda Insurance Practice.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Lightowler has significant private and public equity and debt offering experience and has worked on many cross-border mergers and acquisitions. Mr. Lightowler is currently a non-executive director of Hansa Investment Company Limited, Geneva Re Limited and Oakley Capital Investments Limited and Pheonix Re Limited. We believe Mr. Lightowler is qualified to serve on the Board due to his experience in the financial services and insurance industries, as well as his status as an audit committee financial expert pursuant to the rules and regulations of the SEC.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gernot Lohr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Lohr was appointed to the Board in February 2019. Mr. Lohr joined Apollo in May 2007, where he is a Partner and Co-Chair of the Global Financial Institutions Group. Prior to joining Apollo, Mr. Lohr was a founding partner at Infinity Point LLC, Apollo&#8217;s joint venture partner for the financial services industry, since 2005. Before that time, Mr. Lohr spent eight years in financial services investment banking at Goldman Sachs &amp; Co. LLC in New York and also worked at McKinsey &amp; Company and B. Metzler Corporate Finance in Frankfurt. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, Mr. Lohr serves on the board of directors of Athene Holding Ltd., Athora Holding, Ltd. and Catalina Holdings. Mr. Lohr has previously served on the board of directors of Oldenburgische Landesbank, Seguradoras Unidas, S.A. (f/k/a Companhia de Seguros Tranquilidade, S.A.), Amissima Vita S.p.A., Amissima Assicurazioni S.p.A., Nova Kreditna banka Maribor d.d. and KBS Banka d.d.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Lohr has a joint Master&#8217;s Degree in Economics and Engineering from the University of Karlsruhe, Germany, and he received a Master of Business Administration from the MIT Sloan School of Management. We believe Mr. Lohr is qualified to serve on the Board due to his experience serving on the boards of directors of insurance companies and his experience in the private equity and financial services industries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tammy L. Richardson-Augustus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Ms. Richardson-Augustus was appointed to the Board in March 2021. Ms. Richardson-Augustus has 25 years of legal experience and since 2007 has been a partner and a member of the Bermuda corporate department of Appleby, a leading global provider of offshore legal and fiduciary services. Ms. Richardson-Augustus provides transactional and corporate governance advice to corporate clients (including but not limited to developing a framework of prudent and effective policies for board committees). Ms. Richardson-Augustus maintains a diversified business transactions practice, with emphasis on domestic and international mergers and acquisitions, joint ventures, capital markets and securities, secured and unsecured lending transactions </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and general corporate governance matters. She has extensive experience working with clients in a wide range of industries, including in energy, oil and gas exploration, and maritime shipping. Ms. Richardson-Augustus currently serves on numerous boards, including on the regulatory board (Bermuda Monetary Authority), statutory board (Bermuda Deposit Insurance Corporation) and on the board of Polaris (a company listed on the Bermuda Stock Exchange) and is a member of the Bermuda Bar Association and is a justice of the peace. We believe Ms. Richardson-Augustus is qualified to serve on the Board due to her legal and transactional experience.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Michael Saffer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Saffer was appointed to the Board in February 2019. Mr. Saffer joined Apollo in 2015, where he is a Principal in the London Private Equity team. Prior to joining Apollo, he was a member of the mergers and acquisitions group at Credit Suisse in London. Mr. Saffer has been involved in various private equity transactions across several industries, including the insurance industry. He also serves on the boards of directors of Covis Group S.a.r.l. and Lottomatica S.p.A. (f/k/a Gamenet Group S.p.A.). Mr. Saffer graduated from the University of Nottingham with a BSc in Economics. We believe Mr. Saffer is qualified to serve on the Board due to his experience operating and investing in a variety of market sectors, including the insurance industry.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David Amaro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Amaro was appointed as Group General Counsel &amp; Company Secretary in January 2023. He joined Aspen in July 2021 as General Counsel of Aspen Bermuda and assumed the role of Group Head of Legal &amp; Company Secretary as of January 2022. Before joining Aspen, Mr. Amaro spent seven years with Hamilton Insurance Group and Hamilton Re, most recently, until June 2021 as Vice President and Associate General Counsel for Hamilton Re. Prior to that, he was an in-house solicitor with Ark Syndicate Management in London, having previously completed his training contract at Clyde &amp; Co LLP&#8217;s London office. Mr. Amaro is a member of the Group Executive Committee and the Executive Committee of Aspen Bermuda.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Amaro is a member in good standing of the Bermuda Bar Association and the Law Society of England &amp; Wales.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Christopher Coleman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Coleman was appointed Group Chief Financial Officer in October 2021. Mr. Coleman was most recently Chief Financial Officer of Third Point Re until its merger with Sirius Group. Mr. Coleman has strong transaction and capital markets experience, including the recent acquisition of Sirius Group by Third Point Re, Third Point Re&#8217;s IPO as well as having had key roles in a number of other merger, debt and equity transactions during his career. Mr. Coleman also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">served as CFO of Alterra Bermuda Limited, was Chief Accounting Officer for Harbor Point Limited and held a senior audit manager role with PwC.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Christian Dunleavy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Dunleavy was appointed Group Chief Underwriting Officer in January 2022. He serves as a director of Aspen Bermuda. Mr. Dunleavy also previously served as Chief Underwriting Officer of Aspen Re and Chief Executive Officer and Chief Underwriting Officer of Aspen Bermuda.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Dunleavy joined Aspen in 2015 as Head of Global Property Catastrophe. He had previously been at Axis Re where he was a Senior Vice President, responsible for U.S. Property Treaty, Caribbean Property and Workers Compensation Catastrophe business. Mr. Dunleavy is a Director of the Association of Bermuda International Companies, Association of Bermuda Insurers and Reinsurers and an Independent Director of CG Insurance Group.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bruce Eisler</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Eisler was appointed Chief Executive Officer U.S. and Chief Underwriting Officer, Aspen Insurance in June 2020. Mr. Eisler has held various senior level roles with Reliance National, ACE USA and Liberty International Underwriters - part of Liberty Mutual Group - where he was the Senior Vice President of Professional Liability Underwriting before joining Aspen in January 2010.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rob Houghton</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Houghton joined Aspen as Group Chief Operating Officer in January 2022. In his role, he oversees Aspen&#8217;s group operations and IT strategy. Mr. Houghton joined from MS Amlin, where he was Group Chief Operating Officer and, more recently, MS Amlin Business Services&#8217; Chief Executive Officer. He has more than 20 years of operations, IT and transformation experience across a range of sectors, including strong insurance experience. Mr. Houghton has lived and operated on a global basis with recent experience across North America and Europe.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">192</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aileen Mathieson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Mathieson joined Aspen in November 2021, as the Group Chief Investment Officer and is based in the London office. She brings more than 15 years of investment and financial experience, and previously served at Aberdeen Standard Investments where she was Global Head of Insurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this, Ms. Mathieson was Chief Investment Officer, UK Life for Zurich and during her career also held senior finance roles at Nucleus Financial Group plc, Standard Life Group, Diageo plc and EMI Music. Ms. Mathieson started her career at KPMG.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mark Pickering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Pickering has over 20 years of experience in the reinsurance industry, having joined Aspen in September 2015. He was appointed as Group Treasurer in September 2015 and subsequently also appointed as Group Chief Capital Management Officer in 2021. In addition, he also assumed the role of Chief Executive Officer of Aspen Bermuda Limited in January 2022. Prior to joining Aspen, Mr. Pickering was Senior Vice President, Treasurer with Platinum Underwriters Holdings, Ltd. from 2006 to 2015. Mr. Pickering is also a Director of Aspen Bermuda Limited and previously held the role of Chief Financial Officer of Aspen Bermuda Limited. Mr. Pickering is a Chartered Financial Analyst, Chartered Professional Accountant and also an Associate in Reinsurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brian Tobben</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Tobben was appointed Chief Executive Officer of Aspen Capital Partners in June 2021. Prior to this, he served as the Chief Executive Officer for Aspen Capital Markets. Before joining Aspen, Mr. Tobben was at Partner Reinsurance for almost 10 years, most recently as Head of Insurance Linked Securities, where he managed a portfolio of catastrophe insurance-linked securities, life insurance-linked securities, weather and commodity investments. Prior to his time at Partner Reinsurance, Mr. Tobben was at Aquila Energy where he held a number of roles, including Vice President, Business Development, Weather. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">John Welch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Welch was appointed Chief Underwriting Officer, Reinsurance in June 2023. Mr. Welch has over 30 years of global experience in reinsurance and insurance, including executive roles across global companies. Most recently, from January 2020 to August 2022, Mr. Welch was Chief Executive, Domestic Markets at AXA XL Re, where he led local reinsurance underwriting teams around the world. Mr. Welch previously held a number of senior roles at AXA XL, XL Catlin Group and XL Group.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6694"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a foreign private issuer, under the listing requirements and rules of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; we are not required to have independent directors on the Board, except to the extent that our Audit Committee is required to consist fully of independent directors. The listing standards of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;applicable to U.S. domestic issuers require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation and nominating and corporate governance committees be independent, following a phase-in period. In addition, the listing standards of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;require that audit committee members satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act and that compensation committee members satisfy independence criteria set forth in the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Nevertheless, the listing standards further provide that a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of that company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has affirmatively determined that each of David Altmaier, Albert Beer, Theresa Froehlich, Richard Lightowler and Tammy Richardson-Augustus meet the definition of &#8220;independent director&#8221; under the applicable rules of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. In making this determination, the Board considered the relationships that each such non-employee director has with the Company and all other facts and circumstances that the Board deemed relevant in determining such director&#8217;s independence, including beneficial ownership of ordinary shares. Accordingly, a majority of our directors are independent.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6752"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Family Relationships</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no family relationship between any director or executive officer and any other director or executive officer.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">193</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6733"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Composition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and affairs are managed under the direction of the Board.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bye-laws provide that the Board shall consist of not less than six and not more than 15 directors. Subject to our bye-laws, Bermuda law and to the director appointing rights contained in the Certificates of Designation relating to the Preference Shares, the directors shall be elected by holders of ordinary shares. Each director serving on the Board is elected annually at each annual general meeting of shareholders and serves for a term ending at the next annual general meeting of shareholders, subject to any rights to waive the annual general meeting pursuant to the Companies Act. In addition, notwithstanding the foregoing, each director shall hold office until such director&#8217;s successor shall have been duly elected or until such director is removed from office or such office is otherwise vacated. In no event will a decrease in the number of directors shorten the term of any incumbent director.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Description of Share Capital&#8212;Bye-Laws&#8212;The Board and Corporate Action.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When considering whether directors and nominees have the experience, qualifications, attributes or skills, taken as a whole, to enable the Board to satisfy its oversight responsibilities effectively in light of our business and structure, the Board focused primarily on each person&#8217;s background and experience as reflected in the information discussed in each of the directors&#8217; individual biographies set forth in &#8220;&#8212;Biographical Information&#8221; above. We believe that our directors provide an appropriate mix of experience and skills relevant to the size and nature of our business.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6714"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of the Board in Risk Oversight</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board considers effective identification, measurement, monitoring, management and reporting of the risks facing our business to be key elements of its responsibilities and those of the Group Chief Executive Officer and management. Matters relating to risk management that are reserved for the Board include approval of the internal control and risk management framework and the Aspen Group&#8217;s risk appetite statement and key risk limits. The Risk Committee of the Board also receives reports covering risk management processes including the design, operation, use and limitations of the internal model. The internal model is an economic capital model which has been developed internally for use in certain business decision-making processes, the assessment of risk-based capital requirements and for various regulatory purposes. As a result of these arrangements and processes, the Board, assisted by management and the Board Committees, is able to exercise oversight of the operation of our risk management strategy.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6774"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Private Issuer Exemption</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a &#8220;foreign private issuer,&#8221; as defined by the SEC, we are permitted to follow, and do follow, home country corporate governance practices instead of certain corporate governance practices required for U.S. domestic issuers, provided that we disclose which requirements we are not following and the equivalent requirement in Bermuda (i.e., its home country). We intend to maintain compliance as a foreign private issuer under the applicable corporate governance requirements of the Sarbanes-Oxley Act, the rules adopted by the SEC, and the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance rules and listing standards.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on the foreign private issuer exemption to certain of the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance standards with respect to matters related to our independent director oversight of executive compensation, proxy solicitation, quorum and shareholder approval. We may decide to rely upon the foreign private issuer exemption for purposes of opting out of some or all of the corporate governance rules applicable from time to time to U.S. domestic companies. Currently, the following identifies the significant differences between our corporate governance practices and the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  corporate governance standards applicable to U.S. issuers listed on the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; :</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; requires U.S. issuer listed companies to have a nominating and corporate governance committee composed entirely of independent directors and a committee charter detailing the committee&#8217;s purpose and responsibilities and an annual performance evaluation of the committee. Foreign private issuers and controlled companies, however, are exempt from this requirement. Under Bermuda law and our bye-laws, we are not required to have an entirely independent nominating and corporate governance committee. Upon </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">completion of this offering, we will establish and put into effect the Nominating and Corporate Governance Committee and formally adopt its Charter; however the Nominating and Corporate Governance Committee will not be composed entirely of independent directors.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; requires U.S. issuer listed companies to have a compensation committee composed entirely of independent directors and a committee charter detailing the committee&#8217;s purpose and responsibilities, an annual performance evaluation of the committee and the rights and responsibilities of the committee with respect to retaining or obtaining advice from an independent adviser. Foreign private issuers and controlled companies, however, are exempt from this requirement. Under Bermuda law and our bye-laws, we are not required to have an entirely independent compensation committee. Upon completion of this offering, we will establish and put into effect the Compensation Committee and formally adopt its Charter; however the Compensation Committee will not be composed entirely of independent directors.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, because we are a foreign private issuer, our directors and senior management will not be subject to short-swing profit and insider trading reporting obligations under Section 16 of the Exchange Act. All shareholders, however, will be subject to the obligations to report changes in share ownership under Section 13 of the Exchange Act and related SEC rules. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. public companies</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controlled Company Status</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this offering, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, an affiliate of certain investment funds managed by affiliates of Apollo, will beneficially own approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our ordinary shares (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% if the underwriters exercise in full their option to purchase additional ordinary shares from us and the selling shareholders). As a result, we will be a &#8220;controlled company&#8221; under the corporate governance rules of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; applicable to listed companies, and therefore are permitted to elect not to comply with certain corporate governance requirements thereunder. Under the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance rules, a company of which more than 50% of the voting power for the election of directors is held by an individual, group or another company is a &#8220;controlled company&#8221; and may elect not to comply with certain requirements of the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance standards, including (i) the requirement that a majority of the board of directors consist of independent directors, (ii) the requirement that we have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities and (iii) the requirement that our director nominations be made, or recommended to the Board, by a nominating committee that consists entirely of independent directors and that we adopt a written charter  addressing the nominations process. We may take advantage of certain of these exemptions, and, as a result, you may not have the same protections afforded to shareholders of companies that are subject to all of the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;corporate governance requirements. In the event that we cease to be a &#8220;controlled company,&#8221; we will be required to comply with these provisions within the transition periods specified in the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; corporate governance rules.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6794"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committees of the Board</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has an Audit Committee, Conflicts Committee, Investment Committee and a Risk Committee and, upon completion of this offering, will also have a Compensation Committee and a Nominating and Corporate Governance Committee. The Board may establish such other ad hoc or standing committees as it shall determine in its discretion from time to time. Each of the committees of the Board has, or will have, the composition and responsibilities described below. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee is comprised of Messrs. Lightowler (Chair), Beer and Altmaier, each of whom is independent for purposes of the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rules and Rule 10A-3 under the Exchange Act. Pursuant to its charter, the Audit Committee has general responsibility to assist the Board in its oversight of: (i) the integrity of the Company&#8217;s financial statements, including the accounting and financial reporting process of the Company and audits of the Company&#8217;s financial statements; (ii) the Company&#8217;s compliance with legal and regulatory requirements, as well as conflict of interest matters (to the extent not within the remit of the Conflicts Committee); (iii) the independent auditors&#8217; qualifications, performance and independence; and (iv) the performance of the Company&#8217;s internal audit </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">function. Among other things, the Audit Committee annually reviews and makes recommendations to the Board as to their selection and reviews the plan, fees (as otherwise determined by management) and results of the audit of the independent auditors, as well as the fees (as otherwise determined by management)  and proposed scope of any non-audit services to be provided by the independent auditor.  Such matters may be considered pursuant to the terms of the pre-approval policy adopted by the Board.  The Audit Committee also is directly responsible for the appointment, compensation, retention and oversight of the work of the Company&#8217;s independent auditors (including resolution of disagreements between management and the auditor regarding financial reporting), and the Company&#8217;s independent auditors must report directly to the Audit Committee.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board determined that each of the members of the Audit Committee are financially literate as such term is defined by applicable &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; and SEC requirements. In addition, the Board has determined that Mr. Lightowler qualifies as having accounting or related financial management expertise pursuant to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; requirements and is an &#8220;audit committee financial expert&#8221; pursuant to the rules and regulations of the SEC.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of this offering, the Board will establish and put into effect the Compensation Committee and formally adopt its charter. The Compensation Committee will be comprised of Mr. Altmaier (Chair), Ms. Froehlich and Mr. Humphreys. Pursuant to its written charter, the Compensation Committee will, among other things, assist the Board in its oversight duties in respect of the compensation philosophy and strategy of the Company and its subsidiaries, including, but not limited to, approval of the Group&#8217;s policies relating to the compensation of its employees, the approval of any issuance of equity or equity-based securities and oversight of the compensation of the Company&#8217;s Group Chief Executive Officer, key senior employees, executive officers and non-employee directors.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of this offering, the Board will establish and put into effect the Nominating and Corporate Governance Committee and formally adopt its charter. The Nominating and Corporate Governance Committee will be comprised of Ms. Richardson-Augustus (Chair), Ms. Froehlich and Mr. Saffer. Pursuant to its written charter, the Nominating and Corporate Governance Committee will, among other things, assist the Board in its oversight of the evaluation of management and the Board, including the Board Committees, corporate governance matters and practices and make recommendations to the Board in relation thereto, and identify, evaluate and nominate individuals qualified to become Board members and to recommend to the Board director nominees for approval by shareholders at the annual general meetings of shareholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conflicts Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Conflicts Committee is comprised of Messrs. Beer (Chair), Altmaier and Lightowler, each of whom is an independent director under &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rules. The Conflicts Committee reviews certain material transactions between Aspen Holdings and/or its subsidiaries and Apollo or Apollo&#8217;s non-Aspen affiliates that may present a conflict of interest.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Committee is comprised of Ms. Richardson-Augustus (Chair), Mr. Beer and Mr. Saffer. The Investment Committee supports the Board in its oversight responsibilities by reviewing and monitoring the management and performance of the investment function of the Aspen Group, including the review of the investment strategy and annual investment plan and the ongoing monitoring of the Aspen Group&#8217;s investment managers, including the governance and control framework in place in connection therewith.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Committee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Risk Committee is comprised of Ms. Froehlich (Chair) and Messrs. Beer, Altmaier, Saffer and Humphreys. The Risk Committee assists the Board in its oversight of the framework that governs risk management and solvency assessment practices group-wide as articulated in the Board approved Group Risk Policy. This specifically includes </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">196</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oversight of processes undertaken by management to identify, evaluate and mitigate the material risks to the Group&#8217;s strategic objectives, as well as monitoring adherence to the Board approved risk appetite framework, solvency indicators, risk tolerance criteria, and key risk limits. The matters considered by the Risk Committee include oversight of cybersecurity threats and the process for prevention, detection, mitigation and remediation of cybersecurity incidents, as well as data privacy matters. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Ethics</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a code of ethics entitled &#8220;Code of Conduct&#8221; which applies to all of our employees, officers and directors. Copies of our Code of Conduct can be found on our website at www.aspen.co. We will make any legally required disclosures regarding amendments to, or waivers of, provisions of our Code of Conduct on our website. The reference to our website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this prospectus.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">197</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_139"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3313"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Compensation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid approximately $1.8 million as aggregate compensation to non-executive directors for their services to the Company during 2022. In the case of Albert Beer and Theresa Froehlich, this also includes fees paid for their services as directors of certain of the Company&#8217;s subsidiaries. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Cloutier, our Group Chief Executive Officer and Executive Chair of the Board, did not receive any compensation for his services as a director or committee chair in 2022. Likewise, Messrs. Black, Humphreys, Lohr, and Saffer did not receive any compensation for their services as a director. All directors are reimbursed for travel and other related expenses incurred while attending Board meetings.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note that David Altmaier was appointed to the Board with effect from March 7, 2023 and, accordingly, does not count towards the fees detailed above.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Management Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the members of senior management identified as executive officers in &#8220;Management and Corporate Governance&#8212;Directors and Executive Officers&#8221; (including Mr. Cloutier) received approximately $16.9 million in aggregate compensation. This is comprised of: (i) base salary of approximately $5.5 million; (ii) discretionary bonuses, which include annual bonuses paid in 2023 for service during 2022 of approximately $9.6 million; and (iii) pension, retirement, and other benefits of approximately $1.8 million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">198</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_146"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL AND SELLING SHAREHOLDERS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information relating to the beneficial ownership of our ordinary shares as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023 by: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each person, or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding ordinary shares;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our directors and executive officers;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all of our directors and executive officers as a group; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the selling shareholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will identify the selling shareholders in an amendment to the registration statement of which this prospectus forms a part. As of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, we had&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares outstanding. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of ordinary shares beneficially owned by each entity, person, director or executive officer is determined in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any ordinary shares over which the individual has sole or shared voting power or investment power as well as any such ordinary shares that the individual has the right to acquire within 60 days of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023 through the exercise of any option or other right. Except as otherwise indicated, and subject to applicable community property laws, we believe that the persons named in the table have sole voting and investment power with respect to all ordinary shares held by that person based on information provided to us by such person. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of outstanding ordinary shares beneficially owned before this offering is computed on the basis of the number of such ordinary shares outstanding as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023. Ordinary shares that a person has the right to acquire within 60 days of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023 are deemed outstanding for purposes of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership of all directors and executive officers as a group. Unless otherwise indicated below, the business address for each beneficial owner is 141 Front Street, Hamilton, HM19, Bermuda. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of ordinary shares beneficially owned after this offering is based on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares to be outstanding after the completion of this offering and assumes no exercise of the underwriters&#8217; option to purchase additional ordinary shares from us or the selling shareholders. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of any material relationship that our principal shareholder has had with us or any of our affiliates within the past three years is included under &#8220;Material Contracts and Related Party Transactions&#8212;Relationships and Related Party Transactions with Apollo or its Affiliates.&#8221; The principal shareholder listed below does not have voting rights with respect to its ordinary shares that are different from the voting rights of other holders of our ordinary shares.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">199</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023, to our knowledge, there are no direct U.S. record holders of our outstanding ordinary shares.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares Beneficially Owned Prior to this Offering</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares Offered Hereby</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares Beneficially Owned after this Offering</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholder</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Ordinary Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5% or Greater Shareholders and the Selling Shareholders:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Highlands Bermuda Holdco, Ltd. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors and Executive Officers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Cloutier</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Altmaier</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albert J. Beer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Theresa Froehlich</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexander Humphreys</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard Lightowler</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gernot Lohr</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tammy L. Richardson-Augustus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Saffer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Amaro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher Coleman</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christian Dunleavy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce Eisler</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rob Houghton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aileen Mathieson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Pickering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian Tobben</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Welch</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors and executive officers as a group (18 individuals)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.5pt">Represents beneficial ownership of less than 1% of the outstanding ordinary shares.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Highlands Bermuda Holdco, Ltd., a Bermuda exempted company, is an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc. Decisions by Highlands Bermuda Holdco, Ltd. to vote or dispose of our ordinary shares require the approval of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. The address of Highlands Bermuda Holdco, Ltd. is Park Place, 3rd Floor, 55&#160;Par-la-Ville Road, Hamilton HM11, Bermuda. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">200</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_152"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MATERIAL CONTRACTS AND RELATED PARTY TRANSACTIONS</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7194"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Relationships and Related Party Transactions with Apollo or its Affiliates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, Highlands Bermuda Holdco, Ltd., an affiliate of certain investment funds managed by affiliates of Apollo, owned all of our issued ordinary shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain of our directors are employees of Apollo and its affiliates. Namely, Messrs. Humphreys, Lohr, and Saffer are employees of Apollo.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo&#8217;s indirect subsidiary, Apollo Asset Management Europe PC LLP (&#8220;AAME&#8221;), is the investment manager for the Company and certain of the Company&#8217;s subsidiaries, and Apollo&#8217;s indirect subsidiary, Apollo Management Holdings, L.P. (&#8220;Apollo Management&#8221;), provides the Company with management consulting services and advisory services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of relationships and transactions that have existed or that the Company and certain of the Company&#8217;s subsidiaries has entered into with Apollo and its affiliates are described below.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Management Relationships </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAME provides centralized asset management investment advisory and risk services for the portfolio of the Company&#8217;s investments and investments of such subsidiaries pursuant to the investment management agreements (&#8220;IMAs&#8221;) that have been entered into with AAME.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the IMAs, AAME may engage sub-advisors or delegates to provide certain of the investment advisory and management services to the Company&#8217;s subsidiaries. Such sub-advisors may include affiliates of AAME.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under each of the IMAs, AAME will be paid an annual investment management fee (the &#8220;Management Fee&#8221;) which will be based on a cost-plus structure. The &#8220;cost&#8221; is comprised of the direct and indirect fees, costs, expenses and other liabilities arising in or otherwise connected with the services provided under the IMAs. The &#8220;plus&#8221; component will be a mark-up in an amount of up to 25% determined based on an applicable transfer pricing study. The Management Fee will be subject to certain maximum threshold levels, including an annual fee cap of 15 basis points of the total amount of investable assets. Affiliated sub-advisors, including Apollo Management International and Apollo Capital Management L.P., will also earn additional fees for sub-advisory services rendered.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company recognized IMA fees of $5.2 million, of which $2.4 million remains payable to AAME as of June 30, 2023. Additionally, the Company recognized IMA fees of $4.9 million, $5.8 million and $5.3 million for the years ended December 31, 2022, 2021 and 2020, respectively. None of the IMA fees recognized for the years ended December 31, 2022 , 2021 and 2020 remain payable. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management Consulting Agreement with Apollo Management</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company entered into a Management Consulting Agreement (the &#8220;Management Consulting Agreement&#8221;), by and between the Company and Apollo Management. Pursuant to the Management Consulting Agreement, Apollo Management will provide the Aspen Group with management consulting and advisory services related to the business and affairs of the Aspen Group and Aspen will pay to Apollo Management in consideration for its services under the Management Consulting Agreement an annual management consulting fee equal to the greater of (1) 1% of the consolidated net income of the Aspen Group for the applicable fiscal year and (2) $5 million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company recognized management consulting fees of $2.5 million, of which $2.5 million remains payable to Apollo Management as of June 30, 2023. Additionally, the Company recognized management consulting fees of $5.0 million, $5.0&#160;million and  $5.0 million for the years ended December 31, 2022, 2021 and 2020, respectively. None of the management consulting fees recognized for the years ended December 31, 2022 , 2021 and 2020 remain payable. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Investments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company bought or held the following securities or investments in Apollo originated and managed investments:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Apollo U.S. Real Estate Fund II LP</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company&#8217;s investment in Apollo U.S. Real Estate Fund II LP had a fair value of $22.9 million (December&#160;31, 2022&#160;&#8212; $25.3&#160;million). This investment is included in other investments on the consolidated balance sheet. For the twelve months ended December 31, 2021 and 2020, there was no such investment in Apollo U.S. Real Estate Fund II LP. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company incurred losses of $1.3 million (June&#160;30, 2022&#160;&#8212; $Nil). As at  December&#160;31, 2022, income earned on this investment was $1.6&#160;million (December 31, 2021 and 2020 &#8212; $Nil). These are included in net investment income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Apollo Origination Partnership (&#8220;AOP&#8221;) Fund </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company&#8217;s investment in the AOP Fund had a fair value of $12.6 million (December&#160;31, 2022&#160;&#8212;$12.7&#160;million). This investment is included in other investments on the consolidated balance sheet. For the twelve months ended December 31, 2021 and 2020,  there was no such investment in AOP Fund.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company incurred losses of $0.4 million (June&#160;30, 2022&#160;&#8212; $0.2 million). As at December&#160;31, 2022, the Company incurred gains of $1.5&#160;million (December 31, 2021 and 2020 &#8212; $Nil). These are included in net investments income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">AOP Class A notes and AOP Class B notes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company&#8217;s investment in AOP Class A notes had a fair value of $28.6 million (December&#160;31, 2022&#160;&#8212;$30.0&#160;million). For the twelve months ended December 31, 2021 and 2020, there was no such investment in AOP Class A notes. As at June&#160;30, 2023, the Company&#8217;s investment in AOP Class B notes had a fair value of $14.0 million (December&#160;31, 2022&#160;&#8212;$14.8&#160;million). For the twelve months ended December 31, 2021 and 2020, there was no such investment in AOP Class B notes. These investments are included in privately-held investments on the consolidated balance sheet.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company earned income of $1.3&#160;million (June&#160;30, 2022&#160;&#8212; $0.5 million) and $0.7&#160;million (June&#160;30, 2022&#160;&#8212; $0.3 million) on AOP Class A and B notes, respectively. As at December&#160;31, 2022, the Company incurred losses of $0.2&#160;million and $0.2&#160;million (2021 and 2020 &#8212; $Nil) on AOP Class A and B notes, respectively. These are included in realized and unrealized investment losses on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no expenses incurred relating to any of these investments as at June&#160;30, 2023 and 2022, and December&#160;31, 2022, 2021 and 2020. The above transactions were entered into at arm&#8217;s length.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Payables to Related Parties</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company had an intercompany payable balance of $2.2&#160;million (December&#160;31, 2022 &#8212; $2.0&#160;million, 2021 &#8212; $0.6&#160;million, 2020 &#8212; $18.1 million), due to its parent, Highlands Bermuda Holdco, Ltd. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7205"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Technology Outsourcing Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, Aspen Insurance UK Services Limited, Aspen Insurance U.S. Services Inc. and Aspen Bermuda entered into an Outsourcing Agreement (the &#8220;Original IT Outsourcing Agreement&#8221;) with Cognizant Worldwide Limited, a company registered in England (&#8220;Cognizant&#8221;). Pursuant to the Original IT Outsourcing Agreement, Cognizant provided the Company with information technology services to enable us to deliver greater operating effectiveness and efficiencies. The Original IT Outsourcing Agreement became effective in August 2018 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">202</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and had an initial term period of five years beginning in October 2018. The Company had the right to extend the IT Outsourcing Agreement for an additional two-year term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, Aspen Insurance UK Services Limited, Aspen Insurance U.S. Services Inc. and Aspen Bermuda entered into a new Outsourcing Agreement (the &#8220;IT Outsourcing Agreement&#8221;) with Cognizant, which replaced and superseded the Original IT Outsourcing Agreement and significantly reduced the information technology services provided thereunder. The IT Outsourcing Agreement became effective in December 2020 and has an initial term of four years. The Company has the right to extend the IT Outsourcing Agreement for an additional two-year term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company paid Cognizant approximately $10.5&#160;million (2021 &#8212; $11.6&#160;million, 2020 &#8212; $16.2&#160;million) for services rendered under these agreements. During the six months ended June 30, 2023, the Company paid Cognizant approximately $5.1&#160;million for services rendered under these agreements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IT Outsourcing Agreement contains customary representations and warranties and indemnity, termination and default provisions. We may terminate the IT Outsourcing Agreement for any reason by providing ninety days&#8217; prior written notice. In addition, we may terminate the IT Outsourcing Agreement on shorter notice as a result of, among other things, a material breach if not cured within a specified time, insolvency, persistent breaches, failure to meet key milestones, material adverse change as defined in the IT Outsourcing Agreement or particular circumstances constituting a change in control.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7214"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Process Outsourcing Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, Aspen Insurance UK Services Limited, Aspen Insurance U.S. Services, Inc. and Aspen Bermuda entered into an Outsourcing Agreement (the &#8220;BPO Outsourcing Agreement&#8221;) with Genpact (UK) Limited, a company incorporated in England, United Kingdom (&#8220;Genpact&#8221;). Pursuant to the agreement, Genpact will provide us with a range of operational business processes, primarily from their offshore service center in Gurugram, India, to enable us to deliver greater operating effectiveness and efficiencies. Under the BPO Outsourcing Agreement, Genpact provides a range of operational services across core and support functions, including, but not limited to, Insurance and Reinsurance, Finance, Actuarial and Compliance. The BPO Outsourcing Agreement has minimum service levels that Genpact must meet or exceed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BPO Outsourcing Agreement became effective in March 2023 and has an initial term period of three years. We have the right to extend the BPO Outsourcing Agreement for three additional one-year terms. This agreement extended the relationship with Genpact that was contracted in the 2018 agreement for a five year period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation structure under the BPO Outsourcing Agreement includes a combination of fixed and variable fees which may fluctuate, as set forth in the BPO Outsourcing Agreement, based on our actual use of Genpact&#8217;s services. In 2022, the Company paid Genpact approximately $8.5&#160;million (2021 &#8212; $9.1&#160;million, 2020 &#8212; $10.5&#160;million) for services rendered under the BPO Outsourcing Agreement. During the six months ended June 30, 2023, the Company paid Genpact approximately $5.0&#160;million for services rendered under the BPO Outsourcing Agreement.  Additionally, we have the right to periodically compare the charges under the BPO Outsourcing Agreement to the market prices for comparable services, commencing in March 2024.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BPO Outsourcing Agreement contains customary representations and warranties and indemnity, termination and default provisions. We may terminate the BPO Outsourcing Agreement for any reason by providing 90 days&#8217; prior written notice with no termination fee. In addition, we may terminate the BPO Outsourcing Agreement as a result of, among other things, a material breach if not cured within a specified time, persistent breaches, insolvency, change of control, failure to meet key milestones or material adverse change as defined in the BPO Outsourcing Agreement.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7223"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IT Infrastructure Outsourcing Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, Aspen Insurance UK Services Limited entered into a Master Services Agreement: ITO Services  (the &#8220;IT Infrastructure Outsourcing Agreement&#8221;) with Mindtree Limited, a company incorporated in India (&#8220;LTIMindtree&#8221;). Pursuant to the IT Infrastructure Outsourcing Agreement, LTIMindtree will provide us with a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">203</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">range of IT infrastructure and cybersecurity-related services, including, but not limited to, in relation to network services, database service, cybersecurity management and protection and cloud-related services. Such services will be provided primarily from their offshore service center in Bangalore, India, to enable us to deliver greater operating effectiveness and efficiencies.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IT Infrastructure Outsourcing Agreement became effective in June 2022 and has an initial term period of three years. We have the right to extend the initial term on the IT Infrastructure Outsourcing Agreement by up to two further periods of one year from the expiry of the initial term, by giving written notice to the service provider at least 90 days prior to the expiry of the initial term or an extension period, as applicable.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IT Infrastructure Outsourcing Agreement has minimum service levels that LTIMindtree must meet or exceed. The compensation structure under the IT Infrastructure Outsourcing Agreement includes a combination of fixed and variable fees which are both applicable and may fluctuate based on our actual use of LTIMindtree&#8217;s services, as set forth in the IT Infrastructure Outsourcing Agreement. In 2022, the Company paid LTIMindtree approximately $1 million for services rendered under the IT Infrastructure Outsourcing Agreement. During the six months ended June 30, 2023, the Company paid LTIMindtree approximately $1.5&#160;million for services rendered under the IT Infrastructure Outsourcing Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IT Infrastructure Outsourcing Agreement contains customary representations and warranties and indemnity, termination and default provisions. We may terminate the IT Infrastructure Outsourcing Agreement for any reason by providing three months&#8217; prior written notice and by paying for (i) the services satisfactorily performed and accepted by Aspen up to the effective date of such termination and (ii) any other pre-agreed termination charges ranging from $0 to $750,000, depending on the circumstances. In addition, we may terminate the IT Infrastructure Outsourcing Agreement as a result of, among other things, a material breach if not cured within a specified time, persistent breaches, insolvency, change of control, failure to meet key milestones or material adverse change as defined in the IT Infrastructure Outsourcing Agreement.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7232"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Portfolio Transfer Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, Aspen Holdings and certain of its subsidiaries entered into an Amended and Restated Reinsurance Agreement with a subsidiary of Enstar, which we refer to as the LPT, which amended and restated the Adverse Development Cover Agreement, dated as of March 2, 2020, previously entered into between Enstar and the Aspen Group (the &#8220;Original Agreement&#8221;). The transaction successfully closed in May 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the LPT, Enstar&#8217;s subsidiary will reinsure net losses incurred on or prior to December 31, 2019 on all of the Company&#8217;s net loss reserves of $3.12 billion as of September 30, 2021. The LPT provides for a limit of $3.57 billion in consideration for a premium of $3.16 billion. The amount of net loss reserves ceded, as well as the premium and limit amounts provided under the LPT, will be adjusted for claims paid between October 1, 2021 and the closing date of the transaction. The premium includes $770.0 million of premium previously paid with respect to reserves ceded under the Original Agreement, which will continue to be held in trust accounts to secure the Enstar subsidiary&#8217;s obligations under the LPT. The incremental new premium will initially be held in funds withheld accounts in their original currencies maintained by the Company but will be released to the trust accounts maintained by the Enstar subsidiary no later than September 30, 2025. The funds withheld by the Company will be credited with interest at an annual rate of 1.75% plus, for periods after October 1, 2022, an additional amount equal to 50% of the amount by which the total return on the Company&#8217;s investments and cash and cash equivalents exceeds 1.75%. Under the LPT, the Enstar subsidiary has assumed claims control, pursuant to the provisions of an administrative services agreement subsequently entered into between the parties in June 2022.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7241"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policies and Procedures for Approval of Related Person Transactions</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a related party transactions policy pursuant to which certain related parties, including our affiliates, any unconsolidated enterprise in which we or one of our subsidiaries has a significant influence or which has significant influence over us or one of our subsidiaries, any individual owning, directly or indirectly, 10% or more of the total voting power of the Company or otherwise exercising significant influence over the Company, and immediate family members of such individual, and our directors and officers (each a &#8220;Related Party&#8221;), will not be permitted to enter into a related party transaction (as defined below) with us without the consent of our Audit </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committee or, in the case of certain transactions and agreements with Apollo or certain of its affiliates, our Conflicts Committee, both of which are independent committees of the Board. Any request for us to enter into any transaction or loan with any Related Party that is (1) material to us or the Related Party, or unusual in its nature or conditions, involving goods, services, or tangible or intangible assets, and (2) where the aggregate amount involved will or may be expected to exceed $120,000 in any fiscal year (a &#8220;related party transaction&#8221;) will require the approval of our Audit Committee or Conflicts Committee, as the case may be and except for transactions which have been pre-approved by such committees. All of our directors, officers and other Related Parties will be required to report to the Group General Counsel of the Company any such related party transaction. In approving or rejecting the proposed transaction, our Audit Committee and Conflicts Committee will take into account, among other factors it deems appropriate, whether the transaction is entered into on terms no less favorable to the Company than terms generally available to an unaffiliated third-party under the same or similar circumstances or is otherwise fair and reasonable to the Company, the results of an appraisal, if any, whether there was a bidding process and the results thereof, review of the valuation methodology used and alternative approaches to valuation of the transaction and the extent of the Related Party&#8217;s interest in the transaction. Under the related party transactions policy, if we should discover related party transactions that have not been approved, our Audit Committee or Conflicts Committee, as applicable, will evaluate all options available to the Company, including ratification, revision or termination of the transaction.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6485"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF SHARE CAPITAL</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following description of our share capital summarizes certain provisions of our memorandum of association (our &#8220;memorandum of association&#8221;) and our amended and restated bye-laws (our &#8220;bye-laws&#8221;). Such summaries do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of our memorandum of association and our bye-laws, copies of which will be filed as exhibits to the registration statement of which this prospectus forms apart, and applicable Bermuda law. Prospective investors are urged to read the exhibits for a complete understanding of our memorandum of association and our bye-laws. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6488"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an exempted company limited by shares incorporated under the laws of Bermuda. We are incorporated under the name &#8220;Aspen Insurance Holdings Limited.&#8221; Our registered office is at 141 Front Street, Hamilton, Bermuda HM19. Our agent for service of process in the United States in connection with this offering is Cogency Global Inc., 122 East 42nd Street, 18th Floor, New York, New York 10168. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objects for which we are formed and incorporated are unrestricted and we have the capacity, rights, powers and privileges of a natural person. We therefore are able to undertake activities without restriction on our capacity. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6491"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Capital</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of this offering, our authorized share capital will consist of 70,000,000 ordinary shares, par value $0.01 per share, and 30,000,000 preference shares, par value 0.15144558&#162; per share, and there will be&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of our ordinary shares outstanding and 11,000,000 of our AHL PRC Shares, 10,000,000 of our AHL PRD Shares and 10,000 of our AHL PRE Shares outstanding. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6494"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ordinary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, subject to the adjustments regarding voting set forth in &#8220;&#8212;Voting Power Adjustments&#8221; below, holders of our ordinary shares have one vote for each ordinary share held by them and are entitled to vote, on a non-cumulative basis, at all meetings of shareholders. Holders of our ordinary shares are entitled to receive dividends as may be lawfully declared from time to time by the Board. Our ordinary shares have no pre-emptive rights or other rights to subscribe for additional shares. Holders of our ordinary shares have no redemption, conversion or sinking fund rights. In the event of our liquidation, dissolution or winding-up, the holders of our ordinary shares are entitled to share equally and ratably in our assets, if any remain after the payment of all our debts and liabilities and the liquidation preference of any outstanding preference shares, including the Preference Shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our outstanding ordinary shares, including the outstanding ordinary shares covered by this prospectus, are fully paid and non-assessable. For additional information regarding certain provisions relating to our ordinary shares under the Companies Act, our memorandum of association and our bye-laws, compared to a Delaware corporation, see &#8220;Comparison of Shareholder Rights.&#8221; </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may decline to register a transfer of any ordinary shares if it appears to the Board, in its sole discretion, after taking into account, among other things, the limitations on voting rights contained in our bye-laws, that any non-de minimis adverse tax, regulatory or legal consequences to us, any of our subsidiaries, any of our shareholders or their affiliates or any direct or indirect investor in, or beneficial owner of an interest in, a shareholder of ours would result from such transfer. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No prediction can be made as to the effect, if any, future sales of shares, or the availability of shares for future sales, will have on the market price of our ordinary shares prevailing from time to time. The sale of substantial amounts of our ordinary shares in the public market, or the perception that such sales could occur, could harm the prevailing market price of our ordinary shares.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6497"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting Power Adjustments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, and except as provided below, shareholders have one vote for each ordinary share held by them and are entitled to vote at all meetings of shareholders. However, if, and so long as, the shares of a shareholder in the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company are treated as &#8220;controlled shares&#8221; (as defined in our bye-laws by reference to Sections 957 and 958 of the Code) of any U.S. person (as that term is defined in the Code) and such &#8220;controlled shares&#8221; constitute 9.5% or more of the voting power of all shares of the Company and such person would be generally required to recognize income with respect to the Company under Section 951(a)(1) of the Code, if the Company were a controlled foreign corporation as defined in Section 957 of the Code and if the ownership threshold under Section 951(b) of the Code were 9.5% (&#8220;9.5% U.S. Shareholder&#8221;), the voting rights with respect to the controlled shares owned by such U.S. person shall be limited, in the aggregate, to a voting power of less than 9.5% under a formula specified in our bye-laws. The formula is applied repeatedly until the voting power of all 9.5% U.S. Shareholders has been reduced to less than 9.5%. In addition, the Board may limit a shareholder&#8217;s voting rights when it deems it appropriate to do so to (1) avoid the existence of any 9.5% U.S. Shareholder; and (2) avoid adverse tax, legal or regulatory consequences to the Company, any of its subsidiaries, any shareholder or its affiliates or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a shareholder of ours. &#8220;Controlled shares&#8221; includes all shares of the Company that such U.S. person is deemed to own directly, indirectly or constructively (within the meaning of Sections 957 and 958 of the Code). Pursuant to our bye-laws the amount of any reduction of votes that occurs by operation of the above limitations will generally be reallocated proportionately among all other shareholders of the Company whose shares were not &#8220;controlled shares&#8221; of any 9.5% U.S. Shareholder so long as such reallocation does not cause any person to become a 9.5% U.S. Shareholder.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these provisions, certain shareholders may have their voting rights limited to less than one vote per share, while other shareholders may have voting rights in excess of one vote per share.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, these provisions could have the effect of reducing the votes of certain shareholders who would not otherwise be subject to the 9.5% limitation by virtue of their direct share ownership. Our bye-laws provide that shareholders may be notified of their voting interests prior to any vote to be taken by them.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the authority to request from any shareholder, and such shareholder is required to provide, such information that we may reasonably request for the purposes of determining whether any shareholder&#8217;s voting rights are to be adjusted pursuant to the voting adjustment provisions in our bye-laws described above. If any shareholder fails to respond to this request or submits incomplete or inaccurate information, we may, in our reasonable discretion, eliminate or reduce the shareholder&#8217;s voting rights. All information provided by the shareholder shall be treated by us as confidential information and shall be used by us solely for the purpose of establishing whether any 9.5% U.S. Shareholder exists (except as otherwise required by applicable law or regulation).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any ordinary shares will not carry any right to vote to the extent that the Board unanimously determines, in its sole discretion, that it is necessary in order to avoid material adverse tax, legal or regulatory consequences to the Company, any of its subsidiaries or any other shareholder or its affiliates, or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a shareholder of ours, provided that (1) no adjustment in these circumstances shall be made if it would cause any person to become a 9.5% U.S. Shareholder or the Company to become a United Kingdom controlled foreign corporation and (2) prior to making such determination, the Board shall first have (x) consulted with the relevant shareholder and explored alternatives to avoid such consequences and (y) in the case of such determination with respect to Apollo or certain of its affiliates, obtained the prior written consent of Apollo or such affiliates.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6500"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Ordinary Shares by the Company</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our bye-laws and subject to Bermuda law, we have the option, but not the obligation, to require a shareholder to sell to us or a third party at fair market value, as determined in the good faith discretion of the Board, the minimum number of ordinary shares which is necessary to eliminate any material adverse tax consequences to us, our subsidiaries, our shareholders or their affiliates or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a shareholder of ours if the Board unanimously determines that failure to exercise such option would result in such material adverse tax consequences. For purposes of determining the fair market value of such ordinary shares, (1) if the shares are not traded on a securities exchange in or outside the United States, the fair market value per share shall be determined by the Board without a minority discount but with an appropriate liquidity discount, such value and liquidity discount, if any, as determined by the Board, or (2) if the shares are traded on a securities exchange in or outside the United States, the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair market value per share shall be determined by the Board based on the average of the last sales price per share or if there is none, the average of the bid and asked price per share, without a minority discount or a liquidity discount, in each case for the eight business days prior to the repurchase date.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6503"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance of Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with our bye-laws, the Board has the power to issue any unissued shares of the Company, except that with respect to preference shares having voting rights or powers together with the holders of any other class of the share capital of the Company to elect one or more directors of the Company (other than any mandatory voting rights or powers required under the Companies Act), the Board may only issue such preference shares if a resolution authorizing such issuance is approved by the holders of ordinary shares (but not any other class of shares) then outstanding (taking into consideration any adjustment of voting power under our bye-laws).</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bye-laws</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides a summary of some of the other important provisions of our bye-laws.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Board and Corporate Action</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bye-laws provide that the Board shall consist of not less than six and not more than 15 directors, as determined by the Board. Subject to our bye-laws, Bermuda law and to the director appointing rights contained in the Certificates of Designation relating to the Preference Shares, the directors shall be elected by holders of ordinary shares. Each director serving on the Board is elected annually at each annual general meeting of shareholders and serves for a term ending at the next annual general meeting of shareholders, subject to any rights to waive the annual general meeting pursuant to the Companies Act. In addition, notwithstanding the foregoing, each director shall hold office until such director&#8217;s successor shall have been duly elected or until such director is removed from office or such office is otherwise vacated. In no event will a decrease in the number of directors shorten the term of any incumbent director.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the affirmative vote of a majority of the directors present at any meeting at which a quorum is present shall be required to authorize corporate action. Corporate action may also be taken by a unanimous written resolution of the Board without a meeting and with no need to give notice. The quorum necessary for the transaction of business of the Board may be fixed by the Board and, unless so fixed at any other number, shall be a majority of directors in office from time to time and in no event less than two directors.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Removal of Directors and Vacancies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our ordinary shares may, at any general meeting convened and held in accordance with our bye-laws, remove a director by the affirmative vote of shareholders holding at least a majority of the total combined voting power of all of our issued and authorized shares (taking into account any adjustment of voting power under our bye-laws); provided that the notice of any such meeting convened for the purpose of removing a director must contain a statement of the intention to remove a director and be served upon such director not less than 14 days before the meeting and at such meeting such director shall be entitled to be heard on the motion for such director&#8217;s removal. Any vacancy on the Board created by the removal of a director under the provisions of our bye-laws described above may be filled by our shareholders at the meeting at which such director is removed or, in the absence of such election or appointment, the Board may fill the vacancy in accordance with the provisions described below. A director so elected or appointed by our shareholders or, in absence thereof, the Board shall hold office until the next annual general meeting or until such director&#8217;s office is otherwise vacated and shall serve within the same class of directors as the predecessor. At such next annual general meeting, our shareholders shall elect a director to fill such vacancy to serve the remaining term, if any, of such predecessor.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board shall have the power from time to time and at any time, by the affirmative vote of at least a majority of the directors then in office, to appoint any person as a director to fill a vacancy on the Board. A director so appointed shall hold office until the next annual general meeting or until such director&#8217;s office is otherwise vacated and shall serve within the same class of Directors as the predecessor. At such next annual general meeting, following </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">208</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a vacancy filled by the Board, the shareholders shall elect a Director to fill such vacancy to serve the remaining term, if any, of such predecessor.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The office of a director shall be vacated upon the happening of any of the following events: (1) if the director resigns such director&#8217;s office by notice in writing; (2) if the director becomes of unsound mind or a patient for any purpose of any statute or applicable law relating to mental health and the Board resolves that such director&#8217;s office is vacated; (3) if the director becomes bankrupt under the laws of any country or compounds with such directors&#8217; creditors; (4) if the director is prohibited by law from being a director; or (5) if the director ceases to be a director by virtue of the Companies Act or is removed from office pursuant to our bye-laws.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Meetings of Shareholders </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual General Meetings </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An annual general meeting will be held in each year at such time and place or in such form as the Board determines, unless waived in accordance with the Companies Act. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Special General Meetings </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may convene a special general meeting whenever in its judgment such a meeting is necessary and in accordance with the procedures set out in our bye-laws. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Requisitioned General Meetings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders holding not less than 10% of the paid-up voting share capital of the Company carrying the right to vote at general meetings may requisition the Board to convene a special general meeting in accordance with the provisions of the Companies Act and in accordance with the procedures set out in our bye-laws.&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Action</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise required by the Companies Act and our bye-laws, any question proposed for the consideration of the shareholders at any general meeting shall be decided by the affirmative vote of a majority of the voting power of votes cast at such meeting (in each case, after taking into account voting power adjustments under our bye-laws). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice of an annual general meeting and special general meeting must be given to shareholders at least five days before the date of such meeting, stating the date, place and time at which the meeting is to be held and the nature of the business to be considered.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A general meeting may be called on shorter notice provided that (1) in the case of an annual general meeting, all of the shareholders entitled to attend and vote at such meeting so agree and (2) in the case of a special general meeting, a majority in number of the shareholders entitled to attend and vote at such meeting, being a majority together holding not less than 95% in nominal value of the shares entitled to be voted at such meeting, so agree. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the Companies Act, all or any of the special rights attached to any class or series of shares issued may from time to time (whether or not the Company is being wound up) be altered or abrogated with the consent in writing of the holders of not less than seventy-five percent (75%) of the voting power of the issued shares of that class or series (taking into account any adjustment of voting power under our bye-laws) or with the sanction of a resolution passed by the holders of not less than seventy-five percent (75%) of the voting power of the shares in issue at a separate general meeting (taking into account any adjustment of voting power under our bye-laws). </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bye-laws may be revoked or amended by a majority of the Board then in office and eligible to vote on such resolution, but no revocation or amendment shall be operative unless and until it is approved at a subsequent general meeting of the Company by the shareholders by resolution passed by an affirmative vote of a majority of the voting </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">209</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">power of votes cast at such meeting (in each case, after taking into account voting power adjustments under our bye-laws) or such greater majority as required by our bye-laws.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting of Non-U.S. Subsidiary Shares </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the voting rights of any shares of the Company are adjusted and we are required or entitled to vote at a general meeting of any of our non-U.S. subsidiaries (together, the &#8220;Non-U.S. Subsidiaries,&#8221; but excluding for these purposes any subsidiary that has elected to be treated as a &#8220;U.S. person&#8221; for federal income tax purposes pursuant to Section 953(d) of the Code), and the subject matter of the vote is (a) the appointment, removal or remuneration of directors of a non-U.S. Subsidiary of the Company or (b) any other subject matter with respect to a Non-U.S. Subsidiary that legally requires the approval of the shareholders of such Non-U.S. Subsidiary, our directors shall refer the subject matter of the vote to our shareholders and seek direction from such shareholders in a general meeting of the Company as to how they should vote on the resolution proposed by the Non-U.S. Subsidiary. Substantially similar provisions are or will be contained in the bye-laws (or equivalent governing documents) of the Non-U.S. Subsidiaries. If the Board, in its discretion, determines that the application of this paragraph with respect to a particular vote is not necessary to achieve the purposes of this paragraph, it may waive the application of this paragraph with respect to such vote.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Reduction </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a reduction of capital, our bye-laws permit such reduction to apply to part of a class of shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Purpose </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our memorandum of association and our bye-laws do not restrict our corporate purpose and objects.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification of Directors and Officers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 98 of the Companies Act provides generally that a Bermuda company may indemnify its directors, officers and auditors against any liability which by virtue of any rule of law would otherwise be imposed on them in respect of any negligence, default, breach of duty or breach of trust, except in cases where such liability arises from fraud or dishonesty of which such director, officer or auditor may be guilty in relation to the company. Section 98 further provides that a Bermuda company may indemnify its directors, officers and auditors against any liability incurred by them in defending any proceedings, whether civil or criminal, in which judgment is awarded in their favor or in which they are acquitted or granted relief by the Supreme Court of Bermuda pursuant to Section 281 of the Companies Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bye-Law 145 of our bye-laws provides, among other things, that, subject to certain provisos, our directors, officers, resident representative, member of a committee duly constituted under our bye-laws and any liquidator, manager or trustee for the time being acting in relation to the affairs of the Company, and such persons heirs, executors and administrators (each, an &#8220;Indemnified Person&#8221;) shall be indemnified and held harmless out of the assets of the Company against all actions, costs, charges, liabilities, loss, damage or expense (including but not limited to liabilities under contract, tort and statute or any applicable foreign law or regulation and all reasonable legal and other costs and expenses properly payable) incurred or suffered by such person by or by reason of any act done, conceived in or omitted in the conduct of the Company&#8217;s business or in the discharge of his/her duties. The indemnity contained in Bye-Law 145 extends to any Indemnified Person of the Company acting in any office or trust in the reasonable belief that such person has been appointed or elected to such office or trust notwithstanding any defect in such appointment or election provided that the indemnity contained in Bye-Law 145 shall not extend to any matter which would render it void under the Companies Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bye-Law 149 of our bye-laws provides that each shareholder and the Company agree to waive any claim or right of action he or it may at any time have, whether individually or by or in the right of the Company, against any Indemnified Person on account of any action taken by such Indemnified Person or the failure of such Indemnified Person to take any action in the performance of such person&#8217;s duties with or for the Company. Such waiver shall not apply to any claims or rights of action arising out of the fraud of such Indemnified Person or to recover any gain, personal profit or advantage to which such Indemnified Person is not legally entitled.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Companies Act provides that a Bermuda company may in its bye-laws or in any contract or arrangement between the company and any officer (including a director) exempt such officer or person from, or indemnify him or her in respect of, any loss arising or liability attaching to them as a result of any negligence, default, breach of duty or breach of trust of which they may be guilty in relation to the company or any subsidiary thereof. However, the Companies Act also provides that any provision, whether contained in the company&#8217;s bye-laws or in a contract or arrangement between the Company and the officer, indemnifying such officer against any liability which would attach to him in respect of his fraud or dishonesty in relation to the company will be void.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into indemnification agreements with each director of the Company, pursuant to which the Company has agreed to provide such indemnitee with full indemnification against litigation risks and expenses, subject to certain contractual exceptions, such as in circumstances where such indemnitee has acted fraudulently and/or dishonestly, or failed to act in good faith or otherwise in the best interests of the Company.  The form of the indemnification agreements will be filed as an exhibit to the registration statement of which this prospectus forms a part, and this description of the indemnification agreements is qualified in its entirety by reference thereto.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 98A of the Companies Act permits us to purchase and maintain insurance for the benefit of any officer or director in respect of any loss or liability attaching to him in respect of any negligence, default, breach of duty or breach of trust, whether or not we may otherwise indemnify such officer or director. We have purchased and maintain a directors&#8217; and officers&#8217; liability policy for such purpose.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Opportunities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the fullest extent permitted by applicable law, the Company, on behalf of itself and its subsidiaries, other than its subsidiaries that are insurance companies which are regulated by a governmental entity (&#8220;Insurance Subsidiaries&#8221;), waives and renounces any right, interest or expectancy of the Company and/or its subsidiaries, other than its Insurance Subsidiaries, in, or in being offered an opportunity to participate in, business opportunities of any kind, nature or description that are from time to time presented to (x) any member of the Apollo Group (as defined below) or an affiliate of any member of the Apollo Group (other than the Company and its subsidiaries), (y) any of the Company&#8217;s directors or any of their respective affiliates (other than the Company and its subsidiaries), or (z) any officer, employee or agent of the Company, or any director, officer, employee or agent of any of the Company&#8217;s subsidiaries, who is also, and is presented such business opportunity in his or her capacity as, an officer, director, employee, managing director, general or limited partner, manager, member, shareholder, agent or other affiliate of any member of the Apollo Group or of any affiliate of any member of the Apollo Group (other than the Company and its subsidiaries) (the persons described in clauses (x), (y) and (z), &#8220;Specified Parties&#8221; and each, a &#8220;Specified Party&#8221;), or of which any Specified Parties have or gain knowledge, whether or not the opportunity is competitive with the business of the Company or its subsidiaries or in the same or similar lines of business as the Company or its subsidiaries or one that the Company or its subsidiaries might reasonably be deemed to have pursued or had the ability or desire to pursue if granted the opportunity to do so, and each Specified Party shall have no duty (statutory, fiduciary, contractual or otherwise) to communicate or offer such business opportunity to the Company and, to the fullest extent permitted by applicable law, shall not be liable to the Company or any of its subsidiaries, other than its Insurance Subsidiaries, for breach of any statutory, fiduciary, contractual or other duty, as a director, officer, employee or agent of the Company, or a director, officer, employee or agent of any of the Company&#8217;s subsidiaries, as the case may be, or otherwise, by reason of the fact that such Specified Party pursues or acquires such business opportunity, directs such business opportunity to another person or fails to present or communicate such business opportunity, or information regarding such business opportunity, to the Company or its subsidiaries. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Company and its subsidiaries do not renounce any right, interest or expectancy in any business opportunity offered to a Specified Party who is a director or officer of the Company if such business opportunity is expressly offered for the Company or its subsidiaries to such person solely in his or her capacity as a director or officer of the Company (a &#8220;Company Opportunity&#8221;); provided, however, that all of the protections in our bye-laws shall otherwise apply to the Specified Parties with respect to such Company Opportunity, including the ability of the Specified Parties to pursue or acquire such Company Opportunity, directly or indirectly, or to direct such Company Opportunity to another person, if and to the extent that the Company or the applicable subsidiary of the Company, as applicable, determines not to pursue such Company Opportunity or if it is subsequently determined by the Board or any committee thereof (or board of directors or other governing body of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">211</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such subsidiary or any committee thereof), or by any court of competent jurisdiction, that the business opportunity was not in the line of business of the Company or such subsidiary, as applicable, was not of material or practical advantage to the Company or such subsidiary, as applicable, or was one that the Company or such subsidiary, as applicable, was not financially capable of undertaking. For the avoidance of doubt, notwithstanding anything to the contrary set forth herein or otherwise, to the fullest extent permitted by applicable law, the Company, on behalf of itself and its subsidiaries, other than its Insurance Subsidiaries, hereby waives and renounces any right, interest or expectancy of the Company or its subsidiaries to participate in or be offered an opportunity to participate in any business or business opportunity of any member of the Apollo Group or its affiliates (other than the Company and its subsidiaries), except to the extent such right, interest or expectancy is expressly granted to the Company or any of its subsidiaries under a binding agreement between or among the Company and/or its subsidiaries, on the one hand, and any member of the Apollo Group or its affiliates (other than the Company and its subsidiaries), on the other hand.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person purchasing or otherwise acquiring any interest in any shares of the Company shall be deemed to have notice of and to have consented to these provisions of our bye-laws.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, under no circumstances will the provisions of our bye-laws described above apply to (or result in or be deemed to result in a limitation or elimination of) any duty (contractual, fiduciary or otherwise, whether at law or in equity) owed by any Specified Party who is also an officer, employee or agent of the Company, or any director, officer, employee or agent of any of the Company&#8217;s subsidiaries (other than any such Specified Party who is also an officer, director, employee, managing director, general or limited partner, manager, member, shareholder, agent or other affiliate of any member of the Apollo Group or of any affiliate of any member of the Apollo Group (other than the Company and its subsidiaries)), and any business opportunity waived or renounced by any person will be expressly reserved and maintained (and will not be waived or renounced) by such person as to any such Specified Party.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing provisions of our bye-laws may not be rescinded, altered or amended (1) unless in accordance with the Companies Act and (2) until the same has been approved by the Board and at least a majority of the voting power of shares entitled to vote at a meeting of the Company&#8217;s shareholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this section, &#8220;Apollo Group&#8221; means Apollo Global Management, LLC and its subsidiaries and certain other specified entities and affiliates.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusive Jurisdiction</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless we consent in writing to the selection of an alternative forum, in the event that any dispute arises concerning the Companies Act or out of or in connection with our bye-laws, including any question regarding the existence and scope of any bye-law and/or whether there has been any breach of the Companies Act or our bye-laws by one of our officer or directors (whether or not such a claim is brought in the name of a shareholder or in the name of the Company), any such dispute shall be subject to the exclusive jurisdiction of the Supreme Court of Bermuda.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span id="i2babf1d8cda04b11ada3f8564f6c8a24_88808"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Series of Preference Shares</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares (&#8220;AHL PRC Shares&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2013, the Board authorized the issuance and sale of our AHL PRC Shares, with a liquidation preference of $25 per share. In May 2013, we issued 11,000,000 AHL PRC Shares for an aggregate amount of $275.0 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on our AHL PRC Shares are payable on a non-cumulative basis only when, as and if declared by the Board, at a floating annual rate equal to 3-month LIBOR plus 4.06%, payable quarterly in cash on January 1, April 1, July 1 and October 1 of each year. Given the cessation of LIBOR as from the final publication on June 30, 2023 and the failure of any qualifying banks to provide quotes to the appointed calculation agent as contemplated by the floating rate determination language set forth in the certificate of designations for the AHL PRC Shares, in accordance with the provisions of such instrument, the floating rate to be applied to dividends on the AHL PRC Shares will equal 3-month LIBOR on June 29, 2023 (representing 3-month LIBOR for the previous floating rate period at the applicable determination date), plus 4.06%, being, in the case of the first floating rate dividend period </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning July 1, 2023 and payable on October 1, 2023, a coupon rate payable of 9.59343%.  It is expected, but not certain, that the banks will continue to be unable to provide quotes and this coupon rate will remain at 9.59343% for future dividend periods, as contemplated by the terms of the certificate of designations for the AHL PRC Shares. Generally, unless the full dividends for the most recently ended dividend period on all outstanding AHL PRC Shares have been declared and paid, we cannot declare or pay a dividend on our ordinary shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever dividends on any AHL PRC Shares have not been declared and paid for the equivalent of any six dividend periods, whether or not consecutive (a &#8220;nonpayment&#8221;), subject to certain conditions, the holders of the AHL PRC Shares, acting together as a single class with holders of any and all other series of preference shares having similar appointing rights then outstanding (including the AHL PRD Shares and the AHL PRE Shares), will be entitled, at a special meeting called at the request of record holders of at least 20% of the aggregate liquidation preference of the AHL PRC Shares or of any other series of appointing preference shares then outstanding (including the AHL PRD Shares and the AHL PRE Shares) to the appointment of a total of two directors and the number of directors that comprise the Board will be increased by the number of directors so appointed. These appointing rights and the terms of the directors so appointed will continue until dividends on the AHL PRC Shares and any such series of voting preference shares following the nonpayment shall have been fully paid for at least four consecutive dividend periods. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the affirmative vote or consent of the holders of at least 66 2/3% of the aggregate liquidation preference of outstanding AHL PRC Shares and any series of appointing preference shares (including the AHL PRD Shares and the AHL PRE Shares), acting together as a single class, will be required for the authorization or issuance of any class or series of senior shares (or any security convertible into or exchangeable for senior shares) ranking senior to the AHL PRC Shares as to dividend rights or rights upon liquidation, winding up or dissolution and for amendments to our memorandum of association or our bye-laws that would materially adversely affect the rights of holders of our AHL PRC Shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may redeem the AHL PRC Shares at our option, in whole or in part, at a redemption price equal to $25 per AHL PRC Share, plus any declared and unpaid dividends, if any (i) on July 1, 2023 and on any dividend payment date thereafter and (ii) on any dividend payment date following the occurrence of a tax event (as defined in the certificate of designations for the AHL PRC Shares) or on the dividend payment date following the occurrence of a capital disqualification redemption event (as defined in the certificate of designations for the AHL PRC Shares). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AHL PRC Shares are listed on the NYSE under the symbol &#8220;AHLPRC.&#8221; </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">5.625% Perpetual Non-Cumulative Preference Shares (&#8220;AHL PRD Shares&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, the Board authorized the issuance and sale of our AHL PRD Shares, with a liquidation preference of $25 per share. In September 2016, we issued 10,000,000 AHL PRD Shares for an aggregate amount of $250.0 million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on our AHL PRD Shares are payable on a non-cumulative basis only when, as and if declared by the Board at the annual rate of 5.625% of the $25 liquidation preference of each AHL PRD Share, payable quarterly in cash on January 1, April 1, July 1 and October 1 of each year. In the event of our liquidation, winding up or dissolution, our ordinary shares will rank junior to our AHL PRD Shares. Generally, unless the full dividends for the most recently ended dividend period on all outstanding AHL PRD Shares have been declared and paid, we cannot declare or pay a dividend on our ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever dividends on any AHL PRD Shares have not been declared and paid for the equivalent of any six dividend periods, whether or not consecutive, subject to certain conditions, the holders of our AHL PRD Shares, acting together as a single class with holders of any and all other series of preference shares having similar appointing rights then outstanding (including the AHL PRC Shares and the AHL PRE Shares), will be entitled to the appointment of a total of two directors and the number of directors that comprise the Board will be increased by the number of directors so appointed. These appointing rights and the terms of the directors so appointed will continue until dividends on our AHL PRD Shares and any such series of voting preference shares following the nonpayment shall have been fully paid for at least four consecutive dividend periods. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the affirmative vote or consent of the holders of at least 66 2/3% of the aggregate liquidation preference of outstanding AHL PRD Shares and any series of appointing preference shares (including the AHL PRC Shares and the AHL PRE Shares), voting together as a single class, will be required for the authorization or issuance of any class or series of senior shares (or any security convertible into or exchangeable for senior shares) ranking senior to our AHL PRD Shares as to dividend rights or rights upon our liquidation and for amendments to our memorandum of association or our bye-laws that would materially adversely affect the rights of holders of our AHL PRD Shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may redeem our AHL PRD Shares at our option, in whole or in part, at a redemption price equal to $25 per AHL PRD Share, plus any declared and unpaid dividends, if any, (i) on January 1, 2027 and any dividend payment date thereafter and (ii) on any dividend payment date following the occurrence of a tax event (as defined in the certificate of designations for the AHL PRD Shares) or on the dividend payment date following the occurrence of a capital disqualification redemption event (as defined in the certificate of designations for the AHL PRD Shares).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time prior to January 1, 2027, we may redeem our AHL PRD Shares at our option, upon not less than 30 nor more than 60 days&#8217; written notice, at a redemption price equal to $26 per AHL PRD Share, plus any declared and unpaid dividends, if any, if we submit a proposal to our ordinary shareholders concerning an amalgamation or submit any proposal for any other matter that requires, as a result of a change in Bermuda law after September 13, 2016, the approval of the holders of our AHL PRD Shares, whether voting as a separate series or together with any other series of preference shares as a single class.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AHL PRD Shares are listed on the NYSE under the symbol &#8220;AHLPRD.&#8221;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">5.625% Perpetual Non-Cumulative Preference Shares (&#8220;AHL PRE Shares&#8221;) Represented by Depositary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Board authorized the issuance and sale of our AHL PRE Shares, with a liquidation preference of $25,000 per share, and Depositary Shares each representing a 1/1000th interest in a share of an AHL PRE Share. In August 2019, we issued 10,000 AHL PRE Shares represented by 10,000,000 Depositary Shares for an aggregate amount of $250.0 million. Each Depositary Share is evidenced by a depositary receipt. The underlying AHL PRE Shares are deposited with Computershare Inc. and Computershare Trust Company, N.A., acting as depositary (together in such capacity, the &#8220;Depositary&#8221;), pursuant to a deposit agreement among us, Computershare Inc. and Computershare Trust Company, N.A., acting jointly as Depositary, and the holders from time to time of the depositary receipts (the &#8220;Deposit Agreement&#8221;). Subject to the terms of the Deposit Agreement, each owner of a depositary receipt is entitled, in proportion to the fractional interest of an AHL PRE Share evidenced by that depositary receipt, to all the rights and preferences of AHL PRE Shares represented by those  Depositary Shares (including any dividend, liquidation, redemption and voting rights). If the AHL PRE Shares  are exchanged for new securities, each Depositary Share will represent the same percentage interest in such new security, and will be evidenced by a depositary receipt.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on our AHL PRE Shares are payable on a non-cumulative basis only when, as and if declared by the Board at the annual rate of 5.625% of the $25,000 liquidation preference of each AHL PRE Share, payable quarterly in cash on January 1, April 1, July 1 and October 1 of each year. In the event of our liquidation, winding up or dissolution, our ordinary shares will rank junior to our AHL PRE Shares and Depositary Shares. Generally, unless the full dividends for the most recently ended dividend period on all outstanding AHL PRE Shares have been declared and paid, we cannot declare or pay a dividend on our ordinary shares. Any dividend or other distribution (including upon our voluntary or involuntary liquidation, dissolution or winding-up) paid in respect of a Depositary Share will be in an amount equal to 1/1,000th of the dividend declared or distribution payable, as the case may be, on the underlying share of our AHL PRE Shares. The Depositary will distribute all cash dividends and other cash distributions received on our AHL PRE Shares to the holders of record of the Depositary Shares in proportion to the number of Depositary Shares held by each holder on the relevant record date. In the event of a distribution other than in cash, the Depositary will distribute property received by it to the holders of record of the Depositary Shares in proportion to the number of  Depositary Shares held by each holder, unless the Depositary determines that this distribution is not feasible, in which case the Depositary may, with our approval, adopt a method of distribution that </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">214</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">it deems practicable, including the sale of the property and distribution of the net proceeds of that sale to the holders of the Depositary Shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Record dates for the payment of dividends and other matters relating to the Depositary Shares will be the same as the corresponding record dates for our AHL PRE Shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever dividends on any AHL PRE Shares have not been declared and paid for the equivalent of any six dividend periods, whether or not consecutive, subject to certain conditions, the holders of our AHL PRE Shares, acting together as a single class with holders of any and all other series of preference shares having similar appointing rights then outstanding (including the AHL PRC Shares and the AHL PRD Shares), will be entitled to the appointment of a total of two directors and the number of directors that comprise the Board will be increased by the number of directors so appointed. These appointing rights and the terms of the directors so appointed will continue until dividends on our AHL PRE Shares and any such series of voting preference shares following the nonpayment shall have been fully paid for at least four consecutive dividend periods. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the affirmative vote or consent of the holders of at least 66 2/3% of the aggregate liquidation preference of outstanding AHL PRE Shares and any series of appointing preference shares (including the AHL PRC Shares and the AHL PRD Shares), voting together as a single class, will be required for the authorization or issuance of any class or series of senior shares (or any security convertible into or exchangeable for senior shares) ranking senior to our AHL PRE Shares as to dividend rights or rights upon our liquidation and for amendments to our memorandum of association or our bye-laws that would materially adversely affect the rights of holders of our AHL PRE Shares. Because each Depositary Share represents a 1/1,000th interest in an AHL PRE Share, holders of depositary receipts are entitled to 1/1,000th of a vote per share of our AHL PRE Shares under those limited circumstances in which holders of our AHL PRE Shares are entitled to vote. Holders of the  Depositary Shares must act through the Depositary to exercise any voting rights in respect of our AHL PRE Shares. Although each  Depositary Share is entitled to 1/1,000th of a vote, the Depositary can vote only whole shares of our AHL PRE Shares. While the Depositary will vote the maximum number of whole AHL PRE Shares in accordance with the instructions it receives, any remaining votes of holders of Depositary Shares will not be voted. Holders of the  Depositary Shares will not have any voting rights, except for the limited voting rights described above.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2024 and at any time thereafter, we may redeem our AHL PRE Shares, in whole or in part, at a redemption price of $25,000 per AHL PRE Share (equivalent to $25 per Depositary Share or 1/1,000th of the redemption price per AHL PRE Share), plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the date of redemption, without accumulation of any undeclared dividends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain conditions, at any time prior to October 1, 2024, we may redeem our AHL PRE Shares, in whole or in part, at a redemption price of $25,000 per AHL PRE Share (equivalent to $25 per Depositary Share or 1/1,000th of the redemption price per AHL PRE Share), plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the date of redemption, without accumulation of any undeclared dividends, at any time within 90 days of the date on which we have reasonably determined that a capital disqualification redemption event (as defined in the certificate of designations for the AHL PRE Shares) has occurred. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain conditions, at any time prior to October 1, 2024, we may redeem our AHL PRE Shares, in whole or in part, at a redemption price of $25,000 per AHL PRE Share (equivalent to $25 per Depositary Share or 1/1,000th of the redemption price per AHL PRE Share), plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the date of redemption, without accumulation of any undeclared dividends, at any time following the occurrence of a tax event (as defined in the certificate of designations for the AHL PRE Shares). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain conditions, at any time prior to October 1, 2024, if we submit to the holders of our ordinary shares a proposal for an amalgamation or merger or if we submit any proposal for any other matter that requires, as a result of a change in Bermuda law after August 6, 2019, for its validation or effectuation an affirmative vote of the holders of our AHL PRE Shares at the time in issue, we will have the option to redeem all of our issued AHL PRE </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares at a redemption price of $26,000 per AHL PRE Share (equivalent to $26 per Depositary Share or 1/1,000th of the redemption price per AHL PRE Share), plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the date of redemption, without accumulation of any undeclared dividends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain conditions, at any time prior to October 1, 2024, our AHL PRE Shares are redeemable at our option, in whole, at a redemption price of $25,500 per AHL PRE Share (equivalent to $25.50 per Depositary Share or 1/1,000th of the redemption price per AHL PRE Share), plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the date of redemption, without accumulation of any undeclared dividends, within 90 days after the occurrence of certain adverse rating agency events, including the lowering of the equity credit assigned by a rating agency to our AHL PRE Shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our AHL PRE Shares are redeemed, in whole or in part, a corresponding number of Depositary Shares will be redeemed as of the same redemption date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Depositary Shares are listed on the NYSE under the symbol &#8220;AHLPRE.&#8221;</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6886"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Listing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to apply to list our ordinary shares on the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; under the symbol &#8220;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.&#8221;</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6866"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent and Registrar </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and registrar for our ordinary shares will be Computershare Trust Company, N.A.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6509"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPARISON OF SHAREHOLDER RIGHTS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prospective investors should be aware that the Companies Act, which applies to us, differs in certain material respects from laws generally applicable to U.S. corporations and their shareholders. In order to highlight these differences, set forth below is a summary of certain significant provisions of the Companies Act (including modifications adopted pursuant to our bye-laws) applicable to us which differ in certain respects from provisions of the Delaware General Corporation Law. Because the following statements are summaries, they do not address all aspects of Bermuda law that may be relevant to us and our shareholders.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6971"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Duties of Directors</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law and at common law, members of a board of directors owe statutory and fiduciary duties to the company to act in good faith in their dealings with or on behalf of the company and exercise their powers and fulfill the duties of their office honestly. Under common law a director&#8217;s fiduciary duty has the following essential elements: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a duty to act in good faith in the best interests of the company;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a duty not to make a personal profit from opportunities that arise from the office of director;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a duty to avoid conflicts of interest; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a duty to exercise powers for the purpose for which such powers were intended.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Companies Act imposes a duty on directors and officers of a Bermuda company: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to act honestly and in good faith with a view to the best interests of the company; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to exercise the care, diligence and skill that a reasonably prudent person would exercise in comparable circumstances.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Companies Act imposes various duties on officers of a company with respect to certain matters of management and administration of the company.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Companies Act provides that in any proceedings for negligence, default, breach of duty or breach of trust against any officer, if it appears to a court that such officer is or may be liable in respect of negligence, default, breach of duty or breach of trust, but that he has acted honestly and reasonably, and that, having regard to all the circumstances of the case, including those connected with his appointment, he ought fairly to be excused for the negligence, default, breach of duty or breach of trust, that court may relieve him, either wholly or partly, from any liability on such terms as the court may think fit. This provision has been interpreted to apply only to actions brought by or on behalf of the company against such officers. Our bye-laws, however, provide that the shareholders agree to waive any claim or right of action that they might have, individually or in the right of the Company, against any director or officer of the Company for any act or failure to act in the performance of such director&#8217;s or officer&#8217;s duties, except this waiver does not extend to any claims or rights of action that arise out of fraud on the part of such director or officer or with respect to the recovery of any gain, personal profit or advantage to which the officer or director is not legally entitled.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, the business and affairs of a corporation are managed by or under the direction of its board of directors. In exercising their powers, directors are charged with a fiduciary duty of care and a fiduciary duty of loyalty. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The duty of care requires that directors act in an informed and deliberative manner and inform themselves, prior to making a business decision, of all material information reasonably available to them. The duty of care also requires that directors exercise care in overseeing and investigating the conduct of corporate employees. The duty of loyalty may be summarized as the duty to act in good faith, not out of self-interest, and in a manner which the director reasonably believes to be in the best interests of the corporation and its stockholders.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A party challenging the propriety of a decision of a board of directors bears the burden of rebutting the applicability of the presumptions afforded to directors by the &#8220;business judgment rule.&#8221; The business judgment rule is a presumption that in making a business decision, the directors of a corporation acted on an informed basis, in good faith and in the honest belief that the action taken was in the best interest of the corporation. Unless a plaintiff is able to provide evidence rebutting the presumptions of the business judgment rule, the challenged business decision will be upheld by the courts so long as it can be attributed to any rational business purpose. Where, however, the presumptions are rebutted, the directors bear the burden of demonstrating the entire fairness of the relevant transaction. Notwithstanding the foregoing, Delaware courts subject directors&#8217; conduct to enhanced scrutiny in respect of defensive actions taken in response to a threat to corporate policy and effectiveness and approval of a transaction resulting in a sale of control of the corporation. This means the directors bear the initial burden to demonstrate the reasonableness of their actions before they will be entitled to the protections of the business judgment rule.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_6988"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interested Directors</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law and our bye-laws, any transaction entered into by us in which a director has an interest is not voidable by us nor can such director be accountable to us for any benefit realized under that transaction provided the nature of the interest is disclosed at the first opportunity at a meeting of directors, or in writing to the directors. In addition, our bye-laws allow a director to be taken into account in determining whether a quorum is present and to vote on a transaction in which he has an interest unless the majority of the disinterested directors determine otherwise. Under Delaware law, such transaction would not be voidable if (i) the material facts as to such interested director&#8217;s relationship or interests are disclosed or are known to the board of directors and the board of directors in good faith authorizes the transaction by the affirmative vote of a majority of the disinterested directors, (ii) such material facts are disclosed or are known to the shareholders entitled to vote on such transaction and the transaction is specifically approved in good faith by vote of the majority of shares entitled to vote thereon or (iii) the transaction is fair as to the corporation as of the time it is authorized, approved or ratified. Under Delaware law, such interested director could be held liable for a transaction in which such director derived an improper personal benefit. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committees of the Board of Directors </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bye-laws provide, as permitted by Bermuda law, that the board of directors may delegate any of its powers, authorities and discretions to committees, consisting of such person or persons (whether a member or members of its body or not) as it thinks fit. Delaware law allows the board of directors of a corporation to delegate many of its powers to committees, but those committees may consist only of directors and no such committee may have the power or authority to (i) approve or adopt, or recommend to the shareholders, any action or matter (other than the election or removal of directors) expressly required by the Delaware General Corporation Law to be submitted to shareholders for approval or (ii) adopt, amend or repeal any bylaw of the corporation. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7003"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting Rights and Quorum Requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law, the voting rights of our shareholders are regulated by our bye-laws and, in certain circumstances, the Companies Act. Under our bye-laws, at any general meeting, one or more shareholders holding at least 50% of our shareholders&#8217; aggregate voting power in the ordinary shares shall constitute a quorum for the transaction of business. In general, except for the removal of the Company&#8217;s auditors or directors, any action that we may take by resolution in a general meeting may, without a meeting, be taken by a resolution in writing signed by the shareholders (or the holders of such class of shares) who at the date of the notice of the resolution in writing represents the majority of the votes that would be required if the resolution had been voted on at a meeting of the shareholders. Except as otherwise required by the Companies Act and our bye-laws, any question proposed for the consideration of the shareholders at any general meeting shall be decided by the affirmative votes of a majority of the votes cast in accordance with our bye-laws. Any individual shareholder who is present at a meeting may vote in person, as may any corporate shareholder which is present by a duly authorized representative. Our bye-laws also permit votes by proxy, provided the instrument appointing the proxy, together with evidence of its due execution, is satisfactory to the Board.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, unless otherwise provided in the company&#8217;s certificate of incorporation, each stockholder is entitled to one vote for each share of stock held by the stockholder. Delaware law provides that a majority of the shares entitled to vote, present in person or represented by proxy, constitutes a quorum at a meeting of stockholders unless the certificate of incorporation or bylaws specify otherwise, but in no event may a quorum consist of less than one-third of the shares entitled to vote at the meeting. In matters other than the election of directors, with the exception of special voting requirements related to extraordinary transactions, the affirmative vote of a majority of shares present in person or represented by proxy at the meeting and entitled to vote is required for stockholder action, and the affirmative vote of a plurality of shares is required for the election of directors, in each case unless another vote is specified by the certificate of incorporation or, if the action to be voted on is not one for which the Delaware General Corporation Law specifies the required vote, the bylaws.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda law does not permit payment of dividends or distributions of contributed surplus by a company if there are reasonable grounds for believing that the company is, or after the payment is made, would be unable to pay its liabilities as they become due, or the realizable value of the company&#8217;s assets would be less, as a result of the payment, than the aggregate of its liabilities. The excess of the consideration paid on issue of shares over the aggregate par value of such shares must (except in certain limited circumstances) be credited to a share premium account. Share premium may be distributed in certain limited circumstances, for example to pay up unissued shares which may be distributed to shareholders in proportion to their holdings, but is otherwise subject to limitation. In addition, our and Aspen Bermuda Limited&#8217;s ability to pay dividends or make distributions of contributed surplus is subject to Bermuda insurance laws and regulatory constraints, including insurance group regulatory constraints.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, subject to any restrictions contained in the company&#8217;s certificate of incorporation, a corporation may pay dividends out of surplus or, if there is no surplus, out of net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year. &#8220;Surplus&#8221; means the excess, if any, at any given time of the net assets of the corporation over the amount determined to be capital, which in general may not be less than the aggregate par value of the issued shares. Delaware law also provides that dividends may not be paid out of net profits if, after the payment of the dividend, capital is less than the capital represented by the outstanding stock of all classes having a preference upon the distribution of assets.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7018"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amalgamations, Mergers and Similar Arrangements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may acquire the business of another Bermuda exempted company or a company incorporated outside Bermuda when conducting such business would benefit the Company and would be conducive to attaining our objectives contained within our memorandum of association. In the event we were to merge or amalgamate with another company, the holders of all of our shares are entitled to vote on such merger or amalgamation together pursuant to the Companies Act provided that the holders of any class of shares would be entitled to vote as a separate class, if the merger or amalgamation agreement contains a provision that would constitute a variation of the rights of such class of shares. In the case of an amalgamation or merger, any shareholder who is not satisfied that it has been offered fair value for its shares and who has not voted in favor of the approval and adoption of the merger or amalgamation agreement and the merger or amalgamation, may exercise its appraisal rights under the Companies Act to have the fair value of its shares appraised by the Supreme Court of Bermuda. The court ordinarily would not disapprove the transaction on that ground absent evidence of fraud or bad faith.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, with certain exceptions, a merger, consolidation or sale of all or substantially all the assets of a corporation must be approved by the board of directors and a majority of the outstanding shares entitled to vote thereon. Under Delaware law, a stockholder may, under certain circumstances, be entitled to appraisal rights in connection with a merger, consolidation or conversion to another entity form pursuant to which such stockholder may receive payment in cash of the &#8220;fair value&#8221; of such stockholder&#8217;s shares, exclusive of any element of value arising from the accomplishment or expectation of the merger, consolidation or conversion, together with interest, if any, to be paid on the amount determined to be the fair value, in each case as determined by the Delaware Court of Chancery, in lieu of the consideration such stockholder would otherwise receive in the transaction.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">219</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7033"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Takeovers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda law provides that where a scheme or contract involving the transfer of shares or any class of shares in a company has, within four months after the making of the offer, been approved by the holders of not less than nine tenths in value of the shares whose transfer is involved (other than shares already held at the date of the offer by the offeror, its nominee or subsidiary), the offeror may, at any time within two months beginning with the date on which such approval is obtained, by notice require the non-tendering shareholders to transfer their shares on the terms of the offer. Dissenting shareholders may apply to the court within one month of the notice objecting to the transfer. The burden is on the dissenting shareholders to show that the court should exercise its discretion to enjoin the required transfer, which the court will be unlikely to do unless there is evidence of fraud or bad faith or collusion between the offeror and the holders of the shares who have accepted the offer as a means of unfairly forcing out minority shareholders. Bermuda law also provides that where the holders of not less than 95% of the shares or any class of shares in a company give notice to the remaining shareholders or class of shareholders of their intention to acquire the outstanding shares not held by them, and, within one month of the notice, the offerors may acquire all the shares or cancel the notice given. Dissenting shareholders may apply to the court within the one month period of the notice seeking that the court appraise the value of the shares to be acquired. Any difference between the share price paid to the dissenting shareholders and the price determined by the court shall be paid or the offerors may cancel the notice and return any shares acquired and the dissenting shareholders shall repay any share purchase price received.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware law provides that a parent corporation, by resolution of its board of directors and without any stockholder vote, may merge with any subsidiary of which it owns at least 90% of each class of capital stock. Upon any such merger, stockholders of the subsidiary would have appraisal rights.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Transactions with Significant Shareholders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Bermuda company, we may enter into certain business transactions with our significant shareholders, including asset sales, in which a significant shareholder receives, or could receive, a financial benefit that is greater than that received, or to be received, by other shareholders with prior approval from the board of directors but without obtaining prior approval from our shareholders. Amalgamations and mergers require the approval of the board of directors and, except for certain mergers or amalgamations, a resolution of shareholders approved by at least a majority of the votes cast (after taking account of any voting power adjustments under our bye-laws).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 203 of the Delaware General Corporation Law prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder for a period of three years after the time that the person became an interested stockholder, unless the business combination is approved in a prescribed manner, which, among other possibilities, may include the affirmative vote, at a meeting and not by consent, of stockholders holding at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder. A &#8220;business combination&#8221; is defined by the statute for this purpose as including, among other things, certain mergers, asset sales or the receipt by the interested stockholder of any financial benefit, and an &#8220;interested stockholder&#8221; is defined as a person who is the owner, or any person who is an affiliate or associate of the corporation and at any time within the prior three years has owned, 15% or more of the corporation's outstanding voting stock, together with the affiliates and associates of such person. However, a corporation may opt out of these restrictions on business combinations by a provision in its certificate of incorporation or by a bylaw adopted by the stockholders expressly electing not to be governed by Section 203 of the Delaware General Corporation Law.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7048"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholders&#8217; Suits</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights of shareholders under Bermuda law are not as extensive as the rights of shareholders under legislation or judicial precedent in many U.S. jurisdictions. Class actions and derivative actions are generally not available to shareholders under the laws of Bermuda. However, the Bermuda courts ordinarily would be expected to follow English case law precedent, which would permit a shareholder to commence an action in our name to remedy a wrong done to us where the act complained of is alleged to be beyond our corporate power or is illegal or would result in the violation of our memorandum of association or our bye-laws. Furthermore, consideration would be given by the court to acts that are alleged to constitute a fraud against the minority shareholders or where an act </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">220</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requires the approval of a greater percentage of our shareholders than actually approved it. The winning party in such an action generally would be able to recover a portion of attorneys&#8217; fees incurred in connection with such action. Our bye-laws provide that shareholders agree to waive all claims or rights of action that they might have, individually or in the right of the Company, against any director or officer for any action or failure to act in the performance of such director&#8217;s or officer&#8217;s duties, except such waiver shall not extend to claims or rights of action that arise out of any fraud of such director or officer or with respect to the recovery of any gain, personal profit or advantage to which the officer or director is not legally entitled.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class actions and derivative actions generally are available to stockholders under Delaware law for, among other things, breach of fiduciary duty, corporate waste and actions not taken in accordance with applicable law. In such action, the court generally has discretion to permit the winning party to recover attorneys&#8217; fees incurred in connection with such action.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7063"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification of Directors and Officers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law and our bye-laws, we may indemnify and hold harmless Indemnified Persons against all actions, costs, charges, liabilities, loss, damage or expense (including but not limited to liabilities under contract, tort and statute or any applicable foreign law or regulation and all reasonable legal and other costs and expenses properly payable) incurred or suffered by such person by or by reason of any act done, conceived in or omitted in the conduct of the Company&#8217;s business or in the discharge of his/her duties; provided that such indemnification shall not extend to any matter which would render it void under the Companies Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, a corporation may indemnify a director or officer of the corporation against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement (other than judgments or settlements in an action by or in the right of the corporation to procure a judgment in its favor) actually and reasonably incurred in defense of an action, suit or proceeding by reason of such position if (i) such director or officer acted in good faith and in a manner he/she reasonably believed to be in or not opposed to the best interests of the corporation and (ii) with respect to any criminal action or proceeding, such director or officer had no reasonable cause to believe his/her conduct was unlawful.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitation of Liability of Directors and Officers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bye-laws provide that our shareholders and the Company agree to waive any claim or right of action that they might have, whether individually or by or in the right of the Company, against any Indemnified Person on account of any action taken by such Indemnified Person or the failure of such Indemnified Person to take any action in the performance of his duties with or for the Company. However, such waiver does not apply to any claims or rights of action that arise out of fraud of such Indemnified Person or to recover any gain, personal profit or advantage to which such Indemnified Person is not legally entitled. This waiver may have the effect of barring claims arising under U.S. federal securities laws.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, a corporation may include in its certificate of incorporation provisions eliminating or limiting the personal liability of its directors or officers to the corporation or its stockholders for monetary damages for many types of breach of fiduciary duty. However, these provisions may not eliminate or limit the liability of: (i) a director or officer for any breach of the director&#8217;s or officer&#8217;s duty of loyalty to the corporation or its stockholders; (ii) a director or officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii) a director for the authorization of unlawful stock dividends or share repurchases; (iv) a director or officer for any transaction from which the director or officer derived an improper personal benefit; or (v) an officer in any action by or in the right of the corporation.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7092"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inspection of Corporate Records</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of the general public have the right to inspect our public documents available at the office of the Registrar of Companies in Bermuda and our registered office in Bermuda, which will include our memorandum of association (including its objects and powers) and any alteration to our memorandum of association and documents relating to any increase or reduction of authorized capital. Our shareholders have the additional right to inspect our bye-laws, minutes of general meetings and financial statements, which must be presented to the annual general </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">221</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">meeting of shareholders. Our register of shareholders is also open to inspection by shareholders without charge, and to members of the public for a fee. We are required to maintain our register of shareholders in Bermuda but may establish a branch register outside of Bermuda, the location of which shall be notified to the Bermuda Registrar of Companies. We are required to keep at our registered office a register of our directors and officers which is open for inspection by members of the public without charge. Bermuda law does not, however, provide a general right for shareholders to inspect or obtain copies of any other corporate records.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware law permits any stockholder to inspect or obtain copies of a corporation&#8217;s stockholder list and its other books and records for any purpose reasonably related to such person&#8217;s interest as a stockholder.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7078"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Proposals</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law, the Companies Act provides that shareholders may, as set forth below and at their own expense (unless a company otherwise resolves), require a company to give notice of any resolution that the shareholders can properly propose at the next annual general meeting and/or to circulate a statement prepared by the requesting shareholders in respect of any matter referred to in a proposed resolution or any business to be conducted at a general meeting. The number of shareholders necessary for such a requisition is either that number of shareholders representing at least 5% of the total voting rights of all shareholders having a right to vote at the meeting to which the requisition relates or not less than 100 shareholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, a corporation&#8217;s bylaws may provide that if the corporation solicits proxies with respect to an election of directors, it may be required, to the extent and subject to such procedures or conditions as may be provided in the bylaws, to include in its proxy solicitation materials, in addition to individuals nominated by the board of directors, one or more individuals nominated by a stockholder. Furthermore, the corporation&#8217;s bylaws may provide for the reimbursement by the corporation of expenses incurred by a stockholder in soliciting proxies in connection with an election of directors, subject to certain procedures and conditions. The Delaware General Corporation Law does not include a provision restricting the manner in which nominations for directors may be made by stockholders or the manner in which other business may be brought before a meeting, but provisions in a corporation's certificate of incorporation or bylaws requiring compliance with reasonable procedures for giving advance notice of director nominations or other proposals are permitted as a matter of Delaware common law.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7108"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Calling of Special Shareholders Meetings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our bye-laws, a special general meeting may be called by the Board. Under Bermuda law, a special meeting may also be called by the shareholders when requisitioned by the holders of at least 10% of the paid-up voting share capital of the Company as provided by the Companies Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware law permits the board of directors or any person who is authorized under a corporation&#8217;s certificate of incorporation or bylaws to call a special meeting of stockholders.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7123"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice of Shareholder Meetings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda law and our bye-laws require that shareholders be given at least five days&#8217; advance notice of any general meeting.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, a company is generally required to give written notice of any meeting not less than ten days or more than sixty days before the date of the meeting to each shareholder entitled to vote at the meeting.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Approval of Corporate Matters by Written Consent</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law and our bye-laws, the Companies Act provides that shareholders may take action by resolution in writing (except in the case of the removal of auditors or directors) signed by the shareholders of the company who at the date of the notice of the resolutions in writing represent such majority of votes as would be required if the resolution had been voted on at a meeting of the shareholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise provided in a corporation&#8217;s certificate of incorporation, Delaware law permits stockholders to take action by consent in lieu of a meeting by the holders of outstanding stock having not less than the minimum </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of votes that would be necessary to authorize or take such action at a meeting of stockholders at which all shares entitled to vote thereon were present and voted.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7138"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendment of Memorandum of Association</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda law provides that the memorandum of association of a company may be amended by a resolution passed at a general meeting of shareholders of which due notice has been given.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law, the holders of an aggregate of not less than 20% in par value of a company&#8217;s issued share capital have the right to apply to the Bermuda courts for an annulment of any amendment of the memorandum of association adopted by shareholders at any general meeting, other than an amendment which alters or reduces a company&#8217;s share capital as provided in the Companies Act. Where such an application is made, the amendment becomes effective only to the extent that it is confirmed by the Bermuda court. An application for an annulment of an amendment of the memorandum of association must be made within 21 days after the date on which the resolution altering the company&#8217;s memorandum of association is passed and may be made on behalf of persons entitled to make the application by one or more of their designees as such holders may appoint in writing for such purpose. No application may be made by the shareholders voting in favor of the amendment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, amendment of the certificate of incorporation, which is the equivalent of a memorandum of association, of a corporation must be made by a resolution of the board of directors setting forth the amendment, declaring its advisability, and either calling a special meeting of the stockholders entitled to vote or directing that the amendment proposed be considered at the next annual meeting of the stockholders. Delaware law requires that, unless a higher percentage is provided for in the certificate of incorporation, a majority of the outstanding shares entitled to vote thereon is required to approve the amendment of the certificate of incorporation. If the amendment would alter the number of authorized shares or par value or otherwise adversely affect the rights or preference of any class of a corporation&#8217;s stock, the holders of the outstanding shares of such affected class, regardless of whether such holders are entitled to vote by the certificate of incorporation, are entitled to vote as a class upon the proposed amendment. However, the number of authorized shares of any class may be increased or decreased, to the extent not falling below the number of shares then outstanding, by the affirmative vote of the holders of a majority of the stock entitled to vote, if so provided in the corporation&#8217;s certificate of incorporation. If any proposed amendment would alter or change the powers, preferences, or special rights of one or more series of any class so as to affect them adversely, but shall not so affect the entire class, then the shares of the series so affected by the amendment are entitled to vote as a class regardless of whether such holders are entitled to vote by the certificate of incorporation.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7167"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendment of Bye-laws</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bye-laws may be revoked or amended by the Board, which may from time to time revoke or amend them in any way by a resolution of the Board passed by a majority of the directors then in office and eligible to vote on the resolution. However, no revocation or amendment shall be operative unless and until it is approved at a subsequent general meeting of the Company by the shareholders by resolution passed by a majority of the voting power of votes cast at such meeting (in each case, after taking into account voting power adjustments under our bye-laws) or such greater majority as required by bye-laws.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, holders of a majority of the voting power of the outstanding shares entitled to vote (unless another percentage is specified in the certificate of incorporation or bylaws) and, if so provided in the certificate of incorporation, the directors of the corporation, have the power to adopt, amend and repeal the bylaws of a corporation.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7153"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissolution</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Bermuda law, a solvent company may be wound up by way of a shareholders&#8217; voluntary liquidation. Prior to the company entering liquidation, a majority of the directors are each required to make a statutory declaration, which states that the directors have made a full inquiry into the affairs of the company and have formed the opinion that the company will be able to pay its debts within a period of 12 months of the commencement of the winding-up and must file the statutory declaration with the Registrar of Companies in Bermuda. The general meeting is required to be convened primarily for the purposes of passing a resolution that the company be wound up </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voluntarily and appointing a liquidator. The winding-up of the company is deemed to commence at the time of the passing of the resolution.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, a corporation may voluntarily dissolve (i) if a majority of the board of directors adopts a resolution to that effect and the holders of a majority of the issued and outstanding shares entitled to vote thereon vote for such dissolution; or (ii) if all shareholders entitled to vote thereon consent in writing to such dissolution.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_171"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHARES ELIGIBLE FOR FUTURE SALE</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3627"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the listing of our ordinary shares on the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, there has been no public market for our ordinary shares and we cannot assure prospective investors that a significant public market for our ordinary shares will develop or be sustained after the initial listing of our ordinary shares on the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. No prediction can be made as to the effect, if any, that future sales of ordinary shares or the availability of ordinary shares for future sale will have on the market price of our ordinary shares prevailing from time to time. Sales of substantial amounts of our ordinary shares in the public market, or the perception that such sales could occur, could adversely affect the prevailing market price of our ordinary shares. Furthermore, because only a limited number of ordinary shares will be available for sale shortly after this offering due to contractual and legal restrictions on resale as described below, there may be sales of substantial amounts of our ordinary shares in the public market after the restrictions lapse. This may adversely affect the prevailing market price and our ability to raise equity capital in the future.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3637"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Restricted Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of our ordinary shares are issued and outstanding. We are offering&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares if the underwriters exercise their option to purchase additional ordinary shares from us in full). The selling shareholders are offering&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares if the underwriters exercise their option to purchase additional ordinary shares from the selling shareholders in full). After giving effect to the offering, there will be&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares outstanding,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the underwriters exercise their option to purchase additional ordinary shares from us and the selling shareholders in full) of which will be freely tradable without restriction under the Securities Act, unless purchased by our &#8220;affiliates,&#8221; as that term is defined in Rule 144 under the Securities Act. The remaining ordinary shares that will be outstanding after this offering are &#8220;restricted securities&#8221; within the meaning of Rule 144 under the Securities Act. Restricted securities may be sold in the public market only if registered under the Securities Act or if they qualify for an exemption from registration, including an exemption under Rule 144 or Rule 701, which are summarized below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of our ordinary shares outstanding immediately following this offering,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares if the underwriters exercise their option to purchase additional ordinary shares from us and the selling shareholders in full) are restricted securities, as that term is defined in Rule 144 under the Securities Act, or are subject to lock-up agreements as described herein.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As defined in Rule 144, an &#8220;affiliate&#8221; of an issuer is a person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the issuer.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_4146"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lock-up Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our officers, directors and certain holders of our ordinary shares, including the selling shareholders, will agree with the underwriters, subject to certain exceptions, not to dispose of or hedge any of our ordinary shares or securities convertible into or exchangeable for our ordinary shares during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus, except with the prior written consent of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.  These agreements are described below under the section captioned &#8220;Underwriting (Conflicts of Interest).&#8221;</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3653"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rule 144</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, a person who has beneficially owned our ordinary shares that are restricted securities for at least six months would be entitled to sell such securities, provided that (i) such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90 days preceding, the sale and (ii) we are subject to, and in compliance with certain of, the Exchange Act periodic reporting requirements for at least 90 days before the sale. If such person has beneficially owned such ordinary shares for at least one year, then the requirement in clause (ii) will not apply to the sale.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Persons who have beneficially owned our ordinary shares that are restricted securities for at least six months but who are our affiliates at the time of, or any time during the 90 days preceding, a sale, would be subject to additional </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">225</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of either of the following:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1% of the number of our ordinary shares then outstanding, which will equal approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares immediately after this offering; or</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the average weekly trading volume of our ordinary shares on the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided, in each case, that we are subject to, and in compliance with certain of, the Exchange Act periodic reporting requirements for at least 90 days before the sale. Such sales must also comply with the manner of sale and notice provisions of Rule 144.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3661"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rule 701</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of our employees, officers or directors who acquired our ordinary shares under a written compensatory plan or contract may be entitled to sell them in reliance on Rule 701. Rule 701 permits affiliates to sell their Rule 701 ordinary shares under Rule 144 without complying with the holding period requirements of Rule 144. Rule 701 further provides that non-affiliates may sell these ordinary shares in reliance on Rule 144 without complying with the holding period, public information, volume limitation or notice provisions of Rule 144. All holders of Rule 701 ordinary shares are required to wait until 90 days after the date of this prospectus before selling such ordinary shares. However, our ordinary shares issued under Rule 701 that are subject to lock-up agreements will become eligible for sale only when the 180-day lock-up agreements expire.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3669"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation S</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation S under the Securities Act (&#8220;Regulation S&#8221;) provides that our ordinary shares owned by any person may be sold without registration in the United States, provided that the sale is effected in an offshore transaction and no directed selling efforts are made in the United States (as these terms are defined in Regulation S), subject to certain other conditions. In general, this means that our ordinary shares may be sold outside the United States without registration in the United States being required.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_177"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN REGULATORY CONSIDERATIONS</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business of insurance and reinsurance is regulated in most countries, although the degree and type of regulation varies significantly from one jurisdiction to another. Compliance obligations are increasing in most jurisdictions as the focus on insurance regulatory controls has escalated in recent years, with particular emphasis on regulation of solvency, risk management and internal controls. The discussion below summarizes the material laws and regulations applicable to our Operating Subsidiaries and, where relevant, Peregrine. Our companies have met or exceeded the solvency margins and ratios applicable to them under relevant laws and regulations as at June 30, 2023.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3693"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bermuda Insurance Regulation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides a more in-depth discussion of the applicable Bermuda regulation given Aspen Bermuda&#8217;s incorporation in Bermuda and the BMA as the group supervisor of the Aspen Group.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance Act and related rules and regulations, provides that no person shall carry on insurance business in or from within Bermuda unless registered as an insurer under the Insurance Act by the BMA.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda, an Operating Subsidiary of the Company, is registered as a Class 4 insurer pursuant to the Insurance Act. Certain significant aspects of the Bermuda insurance regulatory framework applicable to Class 4 insurers are set forth below.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual Financial Statements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Class 4 insurer, Aspen Bermuda is required to prepare and submit, on an annual basis, audited financial statements which have been prepared under generally accepted accounting principles or international financial reporting standards (&#8220;GAAP financial statements&#8221;) and audited statutory financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance Act prescribes rules for the preparation and substance of statutory financial statements (which include, in statutory form, a balance sheet, an income statement, a statement of capital and surplus and notes thereto). The statutory financial statements include detailed information and analysis regarding premiums, claims, reinsurance and investments of the insurer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The insurer&#8217;s annual GAAP financial statements and the auditor&#8217;s report thereon, and the statutory financial statements are required to be filed with the BMA within four months from the end of the relevant financial year (unless specifically extended with the approval of the BMA). The statutory financial statements do not form a part of the public records maintained by the BMA, but the GAAP financial statements are available for public inspection.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual Statutory Financial Return and Annual Capital and Solvency Return</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Class 4 insurer, Aspen Bermuda is required to file with the BMA a statutory financial return no later than four months after its financial year end (unless specifically extended with the approval of the BMA).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The statutory financial return of a Class 4 insurer shall consist of (i) an insurer information sheet, (ii) an auditor&#8217;s report, (iii) the statutory financial statements and (iv) notes to the statutory financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, each year the insurer is required to file with the BMA a capital and solvency return along with its annual statutory financial return. The prescribed form of capital and solvency return comprises the insurer&#8217;s Bermuda Solvency Capital Requirement (&#8220;BSCR&#8221;) model or an approved internal capital model in lieu thereof (more fully described below), together with such schedules as prescribed by the Insurance (Prudential Standards) (Class 4 and Class 3B Solvency Requirement) Rules 2008, as amended from time to time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither the statutory financial return nor the capital and solvency return is available for public inspection.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enhanced Capital Requirements </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to the Group requirements, in order to minimize the risk of a shortfall in capital arising from an unexpected adverse deviation, the BMA expects Class 4 insurers such as Aspen Bermuda to maintain a target capital level (&#8220;TCL&#8221;) equal to 120% of its ECR. As at June 30, 2023, Aspen Bermuda holds capital in excess of its TCL.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minimum Solvency Margin and Liquidity Ratio</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda is also required to comply with a minimum solvency margin (&#8220;MSM&#8221;) and minimum liquidity ratio in respect of its business. The MSM is the greater of: (i) $100,000,000; or (ii) 50% of net written premiums (being gross written premiums less any premiums ceded (not exceeding 25% of gross premiums)) in its current financial year; or (iii) 15% of net losses and loss expense provisions and other insurance reserves; or (iv) 25% of the ECR reported at the end of its relevant year. The minimum liquidity ratio requires that the value of relevant assets not be less than 75% of the amount of relevant liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any applicable insurer which at any time fails to meet the MSM requirements must, upon becoming aware of such failure, immediately notify the BMA and, within 14 days thereafter, file a written report with the BMA describing the circumstances that gave rise to the failure and setting out its plan detailing specific actions to be taken and the expected time frame in which the company intends to rectify the failure.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any applicable insurer which at any time fails to meet the ECR applicable to it must, upon becoming aware of that failure, or of having reason to believe that such a failure has occurred, immediately notify the BMA in writing. In addition, within 14 days of such notification, the insurer must file with the BMA a written report describing the circumstances leading to the failure and a remediation plan, including specific actions to be taken to rectify the failure. Further, within 45 days of becoming aware of that failure, or of having reason to believe that such a failure has occurred, the impacted insurer must furnish the BMA with: (1) unaudited statutory economic balance sheets and unaudited interim financial statements prepared in accordance with GAAP covering such period as the BMA may require, (2) the opinion of a loss reserve specialist, where applicable, (3) a general business solvency certificate in respect of those financial statements, where applicable, (4) a capital and solvency return reflecting an ECR prepared using post-failure data, where applicable, (5) a long-term business solvency certificate in respect of those statements, where applicable and (6) the opinion of an approved actuary, where applicable. An insurer to whom this applies shall not declare or pay any dividends until the failure is rectified.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BMA implemented an economic balance sheet (&#8220;EBS&#8221;) framework, which is used as the basis to determine the ECR for all commercial insurers, including Aspen Bermuda. The EBS framework applies prudential filters and other EBS valuation adjustments to an insurer&#8217;s GAAP balance sheet to produce an economic valuation of the assets and liabilities of the insurer. The Insurance (Prudential Standards) Amendment Rules 2018 provide updates to certain aspects of the EBS framework and increase the ECR over a three-year transition period for general business and a 10-year transition period for long-term business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eligible Capital</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To enable the BMA to better assess the quality of the insurer&#8217;s capital resources, a Class 4 insurer is required to disclose the makeup of its capital in accordance with the recently introduced &#8220;3-tiered eligible capital system.&#8221; Under this system, all of the insurer&#8217;s capital instruments will be classified as either basic or ancillary capital which in turn will be classified into one of three tiers based on their &#8220;loss absorbency&#8221; characteristics. Highest-quality capital will be classified as Tier 1 Capital, and lesser-quality capital will be classified as either Tier 2 Capital or Tier 3 Capital. Under this regime, up to certain specified percentages of Tier 1, Tier 2 and Tier 3 Capital may be used to support the Class 4 insurer&#8217;s MSM, ECR and target capital level.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The characteristics of the capital instruments that must be satisfied to qualify as Tier 1, Tier 2 and Tier 3 Capital are set out in the Insurance (Eligible Capital) Rules 2012, and amendments thereto. Under these rules, Tier 1, Tier 2 and Tier 3 Capital may, until January 1, 2026, include capital instruments that do not satisfy the requirement that the instrument is non-redeemable or settled only with the issuance of an instrument of equal or higher quality upon a breach, or if it would cause a breach, of the ECR.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">228</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where the BMA has previously approved the use of certain instruments for capital purposes, the BMA&#8217;s consent will need to be obtained if such instruments are to remain eligible for use in satisfying the MSM and the ECR.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Code of Conduct</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance Code of Conduct (the &#8220;Insurance Code of Conduct&#8221;) prescribes the duties, standards, procedures, and sound business principles with which all insurers registered under the Insurance Act must comply, including any activities which are delegated or outsourced. With respect to outsourcing, the Insurance Code of Conduct provides that where the insurer outsources functions, the board of the insurer should ensure that there is oversight and clear accountability for all outsourced functions as if these functions were performed internally and subject to the insurer&#8217;s own standards on governance and internal controls. The board of the insurer must also ensure that the service agreement includes terms on compliance with jurisdictional laws and regulations, cooperation with the BMA and access to data and records in a timely fashion. Where a function is outsourced or proposed to be outsourced, the board must assess the impact on the insurer and should not outsource a function which may adversely affect the insurer&#8217;s ability to operate in a prudent manner.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BMA will assess an insurer&#8217;s compliance with the Insurance Code of Conduct in a proportional manner relative to the nature, scale and complexity of its business. Failure to comply with the requirements of the Insurance Code of Conduct will be taken into account by the BMA in determining whether an insurer is conducting its business in a sound and prudent manner as prescribed by the Insurance Act and may result in the BMA exercising its powers of intervention and investigation (see &#8220;&#8212;Group Supervision&#8221; below) and will be a factor in calculating the operational risk charge under the insurer&#8217;s BSCR or approved internal model.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyber Risk Code of Conduct</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BMA has recognized that cyber incidents can cause significant financial losses and/or reputational impacts across the insurance industry and has implemented the Insurance Sector Operational Cyber Risk Management Code of Conduct (the &#8220;Cyber Risk Code&#8221;) to ensure that those operating in the Bermuda insurance sector can mitigate such risks. The Cyber Risk Code prescribes the duties, requirements, standards, procedures and principles which all insurers, insurance managers and insurance intermediaries (agents, brokers and insurance marketplace providers) registered under the Insurance Act must comply. The Cyber Risk Code is designed to promote the stable and secure management of information technology systems of regulated entities and requires that all registrants implement their own technology risk programs, determine what their top risks are and develop an appropriate risk response. This requires all registrants to develop a cyber risk policy which is to be delivered pursuant to an operational cyber risk management program and appoint an appropriately qualified member of staff or outsourced resource to the role of Chief Information Security Officer. The role of the Chief Information Security Officer is to deliver the operational cyber risk management program.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fit and Proper Controllers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BMA maintains supervision over controllers of all Bermuda registered insurers. For these purposes, a controller includes (1) the managing director of the registered insurer or its parent company, (2) the chief executive officer of the registered insurer or of its parent company, (3) a &#8220;shareholder controller&#8221; (as defined below) and (4) any person in accordance with whose directions or instructions the directors of the registered insurers or its parent company are accustomed to act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definition of &#8220;shareholder controller&#8221; is set out in the Insurance Act but generally refers to (1) a person who holds 10% or more of the shares carrying rights to vote at a shareholders&#8217; meeting of the registered insurer or its parent company, (2) a person who is entitled to exercise 10% or more of the voting power at any shareholders&#8217; meeting of such registered insurer or its parent company or (3) a person who is able to exercise significant influence over the management of the registered insurer or its parent company by virtue of its shareholding or its entitlement to exercise, or control the exercise of, the voting power at any shareholders&#8217; meeting.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where the shares of a registered insurer or special purpose insurer, or the shares of its parent company, are traded on a recognized stock exchange (as is the case for Aspen Bermuda and Peregrine), and a person becomes, or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ceases to be, a 10%, 20%, 33%, or 50% shareholder controller of the insurer, that shareholder shall, within 45 days, notify the BMA in writing that such shareholder has become, or as a result of a disposition ceased to be, a shareholder controller of any such category. Accordingly, Aspen Bermuda and Peregrine must notify the BMA in writing if any person becomes, or ceases to be, a 10%, 20%, 33%, or 50% shareholder controller within 45 days of the acquisition or disposition.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notification of Material Changes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All registered insurers, including Aspen Bermuda and Peregrine, are required to give notice to the BMA of their intention to affect a material change within the meaning of the Insurance Act. For the purposes of the Insurance Act, the following changes are material: (i) the transfer or acquisition of insurance business being part of a scheme falling under section 25 of the Insurance Act or section 99 of the Companies Act, (ii) the amalgamation with or acquisition of another firm, (iii) engaging in unrelated business that is retail business, (iv) the acquisition of a controlling interest in an undertaking that is engaged in non-insurance business which offers services and products to persons who are not affiliates of the insurer, (v) outsourcing all or substantially all of the company&#8217;s actuarial, risk management, compliance or internal audit functions, (vi) outsourcing all or a material part of an insurer&#8217;s underwriting activity, (vii) the transfer, other than by way of reinsurance, of all or substantially all of a line of business, (viii) the expansion into a material new line of business, (ix) the sale of an insurer and (x) outsourcing of an officer role.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No registered insurer shall take any steps to give effect to a material change unless it has first served notice on the BMA that it intends to effect such material change and before the end of 30 days, either the BMA has notified such company in writing that it has no objection to such change or that period has elapsed without the BMA having issued a notice of objection.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before issuing a notice of objection, the BMA is required to serve upon the person concerned a preliminary written notice stating the BMA&#8217;s intention to issue a formal notice of objection. Upon receipt of the preliminary written notice, the person served may, within 28 days, file written representations with the BMA which will be taken into account by the BMA in making its final determination.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Group Supervision</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BMA may, in respect of an insurance group, determine whether it is appropriate for it to act as its group supervisor and has done so for Aspen Group. An insurance group is defined as a group of companies that conducts insurance business. The BMA may make such determination where it ascertains that (i) the group is headed by a &#8220;specified insurer&#8221; (that is to say, it is headed by either a Class 3A, Class 3B or Class 4 general business insurer or a Class C, Class D or Class E long-term insurer or another class of insurer designated by order of the BMA); or (ii) where the insurance group is not headed by a &#8220;specified insurer,&#8221; where it is headed by a parent company which is incorporated in Bermuda or (iii) where the parent company of the group is not a Bermuda company, in circumstances where the BMA is satisfied that the insurance group is directed and managed from Bermuda or the insurer with the largest balance sheet total is a specified insurer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where the BMA determines that it should act as the group supervisor, it shall designate a specified insurer that is a member of the insurance group to be the designated insurer (the &#8220;Designated Insurer&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As group supervisor, the BMA will perform a number of supervisory functions including (i) coordinating the gathering and dissemination of relevant or essential information for going concerns and emergency situations, including the dissemination of information which is of importance for the supervisory task of other competent authorities; (ii) carrying out supervisory reviews and assessments of the insurance group; (iii) carrying out a assessments of the insurance group&#8217;s compliance with the rules on solvency, risk concentration, intra-group transactions and good governance procedures; (iv) planning and coordinating through regular meetings held at least annually (or by other appropriate means) with other competent authorities, supervisory activities in respect of the insurance group, both as a going concern and in emergency situations; (v) coordinating enforcement actions that may need to be taken against the insurance group or any of its members; and (vi) planning and coordinating meetings of colleges of supervisors in order to facilitate the carrying out of the functions described above.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">230</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda has been designated by the BMA as the Designated Insurer of the Aspen Group and as such is currently subject to group supervision at the level of the Company (covering all its direct and indirect subsidiaries, including Aspen Bermuda). As the Designated Insurer of the Aspen Group, Aspen Bermuda is required to facilitate and maintain compliance by the Aspen Group with the Insurance Act and related group supervision regulations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restrictions on Dividends, Distributions and Reduction of Capital</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda may not declare or pay any dividends during any financial year if it would cause the insurer to fail to meet its relevant solvency margins, ECR or liquidity ratio, and an insurer which fails to meet its relevant margins on the last day of any financial year may not, without the approval of the BMA, declare or pay any dividends during the next financial year. In addition, as a Class 4 insurer, Aspen Bermuda may not in any financial year pay dividends which would exceed 25% of its total statutory capital and surplus, as shown on its statutory balance sheet in relation to the previous financial year, unless it files with the BMA a solvency affidavit at least seven days in advance of payment. Further, Aspen Bermuda must obtain the prior approval of the BMA before reducing by 15% or more its total statutory capital as set out in its previous year&#8217;s financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance Amendment (No. 2) Act 2018 amended the Insurance Act to provide for the prior payment of unsecured policyholders&#8217; liabilities ahead of general unsecured creditors in the event of the liquidation or winding up of an insurer. The amendments provide among other matters that, subject to certain statutorily preferred debts, the insurance debts of an insurer must be paid in priority to all other unsecured debts of the insurer. Insurance debt is defined as a debt to which an insurer is or may become liable pursuant to an insurance contract excluding debts owed to an insurer under an insurance contract where the insurer is the person insured.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our Bermuda companies, including Aspen Holdings and Aspen Bermuda, must comply with the provisions of the Companies Act which, among other matters, regulates the payment of dividends and distributions. A Bermuda company may not declare or pay a dividend or make a distribution out of contributed surplus if there are reasonable grounds for believing that: (i) the company is, or would after the payment be, unable to pay its liabilities as they become due; or (ii) the realizable value of the company&#8217;s assets would thereby be less than its liabilities.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peregrine</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peregrine is registered as a special purpose insurer (&#8220;SPI&#8221;) under the Insurance Act and licensed to carry on special purpose business. Special purpose business is defined under the Insurance Act as insurance business under which an insurer fully collateralizes its liabilities to the persons insured, in the forms contemplated by the Insurance Act. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPIs are required to file electronic statutory financial returns and the BMA has the discretion to modify such insurer&#8217;s statutory filings requirements under the Insurance Act. Like other reinsurers, the principal representative of an SPI has a duty to inform the BMA in relation to solvency matters, where applicable.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peregrine is also registered as a segregated accounts company under the Segregated Accounts Companies Act 2000, as amended. As a segregated accounts company, Peregrine is required to segregate the assets and liabilities linked to their respective segregated accounts from the assets and liabilities linked to their other respective segregated accounts and from their general account assets and liabilities. The segregated account representative of a segregated accounts company has the duty to inform the Bermuda Registrar of Companies in relation to solvency matters and non-compliance, where applicable.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic Substance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Highlands Bermuda Holdco, Ltd., the Company and certain of our Bermuda-domiciled subsidiaries are also subject to the Economic Substance Act 2018, as amended, and the Economic Substance Regulations 2018, as amended (together the &#8220;ESA&#8221;). The ESA was enacted to demonstrate Bermuda&#8217;s commitment to comply with international standards with respect to cooperation for tax purposes and to ensure that Bermuda does not facilitate the use of structures which attract profits, but which do not reflect real economic activity within Bermuda. The ESA provides that a registered entity other than an entity which is a resident for tax purposes in certain jurisdictions outside Bermuda (&#8220;non-resident entity&#8221;) that carries on as a business any one or more of the &#8220;relevant activities&#8221; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">231</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">referred to in the ESA must comply with economic substance requirements. The list of &#8220;relevant activities&#8221; includes carrying on any one or more of the following activities: banking, insurance, fund management, financing and leasing, headquarters, shipping, distribution and service center, intellectual property and holding entities. Under the ESA, if an entity is engaged in one or more &#8220;relevant activities,&#8221; it is required to maintain a substantial economic presence in Bermuda and to comply with the economic substance requirements set forth in the ESA. An entity will comply with those economic substance requirements if it: (a) is managed and directed in Bermuda; (b) undertakes &#8220;core income generating activities&#8221; (as may be prescribed under the ESA) in Bermuda in respect of the relevant activity; (c) maintains adequate physical presence in Bermuda; (d) has adequate senior executives, employees or other persons in Bermuda with suitable qualifications; and (e) incurs adequate operating expenditure in Bermuda in relation to the relevant activity undertaken by it.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESA requires entities subject to it to make annual filings with the Bermuda Registrar of Companies to demonstrate the economic substance of the entity&#8217;s activities and business in Bermuda. Companies that are licensed to and carry on insurance as a relevant activity are generally considered to operate in Bermuda with adequate substance, with respect to their insurance business, if they comply with the existing provisions of (a) the Companies Act relating to corporate governance; and (b) the Insurance Act, that are applicable to the economic substance requirements, and the Bermuda Registrar of Companies will have regard to such companies&#8217; compliance with the Insurance Act (in addition to compliance with the Companies Act) in its assessment of compliance with the economic substance requirements. For those Aspen Group entities subject to the ESA, we expect that the filings will continue to meet the ESA requirements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privacy and Cyber Security Laws</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PIPA regulates how any individual, entity or public authority may use personal information. PIPA reflects a set of internationally accepted privacy principles and good business practices for the use of personal information. Although PIPA was passed on July 27, 2016, the sections that are currently in effect are limited to those that relate to the establishment and appointment of the Privacy commissioner (&#8220;Privacy Commissioner&#8221;), the hiring of the Privacy Commissioner&#8217;s staff, and the general authority of the Privacy Commissioner to inform the public about PIPA. Following the Privacy Commissioner&#8217;s appointment, effective January 20, 2020, the PIPA Commissioner&#8217;s office has begun communications with the public and stakeholders regarding full implementation of PIPA. On October 30, 2020 the Privacy Commissioner issued guidance regarding privacy safeguarding of personal information by public companies, however, PIPA&#8217;s remaining provisions have not been fully implemented and regulations under PIPA have not yet been provided. The Privacy Commissioner has recommended that organizations in Bermuda start to conduct data due diligence across their existing business lines as a first stage towards PIPA compliance. The remaining provisions of PIPA will be brought into full effect on January 1, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Insurance Amendment Act of 2020 became operative in August 2020 and requires entities regulated by the BMA to provide notice to the BMA of certain cybersecurity events. As a result, the BMA&#8217;s Cyber Risk Code, which includes a series of minimum and recommended cybersecurity standards, became effective on January 1, 2021. The Cyber Risk Code is designed to promote the stable and secure management of information technology systems of regulated entities and requires that all registrants implement their own technology risk programs, determine what their top risks are and develop an appropriate risk response. This requires all registrants to develop a cyber risk policy which is to be delivered pursuant to an operation cyber risk management program and appoint an appropriately qualified member of staff or outsourced resource to the role of Chief Information Security Officer. The role of the Chief Information Security Officer is to deliver the operational cyber risk management program. The Insurance (Group Supervision) Amendment Rules 2022, effective January 1, 2023, enhance the regime by imposing a requirement to report cyber events when an insurance group has knowledge, or reason to believe, that an event resulting in a significant adverse impact to the group's operations, policyholders or clients has occurred within, at most, 72 hours and additionally within 14 days of the notification, the group must furnish the BMA with a report setting out known particulars of the case.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the board of directors of Aspen Bermuda approved a cyber risk policy. The board of directors of Aspen Bermuda must review and approve such policy on at least an annual basis, and reaffirmed its approval of the cyber risk policy in November 2023. The BMA will assess a registrant&#8217;s compliance with the Cyber Risk Code in a proportionate manner relative to the nature, scale and complexity of its business. While it is </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">232</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acknowledged that some registrants will use a third party to provide technology services and that they may outsource their information technology resources (for example, to an insurance manager where applicable), when so outsourced, the overall responsibility for the outsourced functions will remain with the registrant&#8217;s board of directors. Failure to comply with the requirements of the Cyber Risk Code will be taken into account by the BMA in determining whether a registrant is conducting its business in a sound and prudent manner as prescribed by the Insurance Act and may result in the BMA exercising its powers of intervention and investigation.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management of Climate Change Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11 2022, the BMA published the Climate Change Guidance Notes, with the final the Climate Change Guidance Notes published in March 2023. The Climate Change Guidance Notes apply to the Aspen Group and Aspen Bermuda and outline the BMA&#8217;s expectations regarding management and reporting of climate change risks. The Climate Change Guidance Notes focus on corporate governance and risk management practices for climate risk in the context of environmental, social and governance risks of insurance business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Climate Change Guidance Notes focus on how climate change impacts risks that are transferred to insurers, the BMA expects insurers to also specifically consider their own external impact on climate change as it may also revert back and affect in short, mid or long-term their own financial performance, reputation and operations and, by extension, the financial soundness of the sector as a whole.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Climate Change Guidance Notes seek to take into account the diversity of such insurers in the market. While it targets minimum standards the BMA expects insurers to embed into their operations, the BMA&#8217;s expectations continue to be based on the principle of proportionality. Therefore, the application to the Aspen Group and Aspen Bermuda will be dependent on the nature of our operations and the scale, complexity and risk profile of our insurance business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally in September 2023, the BMA published a Discussion Paper &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Climate Change Risks for Commercial Insurers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Climate Change Disclosures&#8221;) outlining the BMA&#8217;s proposal for insurers to publicly disclose their climate risk exposure, mitigation and monitoring activities, on an annual basis. Aligned to the Task Force on Climate-Related Disclosures (&#8220;TCFD&#8221;) framework, the proposed Climate Change Disclosures focus on four pillars: governance, strategy, risk management and metrics and targets and would require Aspen Group to comply within financial reporting year ended December 31, 2024 and Aspen Bermuda within year ended December 31, 2025. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on future developments in this area, the BMA may seek to incorporate elements from the International Sustainability Standards Board&#8217;s (&#8220;ISSB&#8221;) first two IFRS Sustainability Disclosure Standards, IFRS S1 General Requirements for Disclosure of Sustainability-related Financial Information and IFRS S2 Climate-related Disclosures. The ISSB standards may be sought at the forthcoming consultation paper stage, noting that in 2024, ISSB will succeed the monitoring of companies&#8217; progress on climate-related disclosures from TCFD. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3702"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.K. and E.U. Insurance Regulation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial services industry in the United Kingdom is currently regulated by the Financial Conduct Authority (&#8220;FCA&#8221;) and the Prudential Regulation Authority (&#8220;PRA&#8221;) (collectively, the &#8220;U.K. Regulators&#8221;). The PRA authorizes &#8220;dual-regulated&#8221; firms such as insurers and managing agents (e.g., Aspen UK and AMAL) and performs the prudential regulation and supervision in respect of these entities. The FCA authorizes and supervises all &#8220;solo-regulated&#8221; firms such as insurance intermediaries (e.g., Aspen UK Syndicate Services Limited) and is the conduct regulator for all regulated firms in the United Kingdom. AMAL is also subject to Lloyd&#8217;s regulation. For more information, see &#8220;&#8212;Lloyd&#8217;s Regulation&#8221; below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary statutory objectives of the PRA in relation to its supervision of insurers and managing agents are: (1) to promote their safety and soundness; and (2) to contribute to the securing of an appropriate degree of protection for policyholders or those who may become policyholders. The PRA also has secondary objectives to facilitate: (i) effective competition in the markets for services provided by PRA-authorized firms, and (ii) subject to aligning with </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">233</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relevant international standards, the international competitiveness of the economy of the U.K. and its growth in the medium to long term. Further, the FCA has a general objective to secure an appropriate degree of protection for consumers, along with the further general objectives to protect and enhance the integrity of the U.K. financial system and to promote effective competition for the benefit of consumers, as well as a similar international competitiveness and growth objective. The U.K. Regulators have extensive powers to intervene in the affairs of insurance businesses and insurance mediation activities that they regulate and to monitor compliance with their objectives. Their enforcement tools include: (i) amending (including by imposing restrictions on) or withdrawing a firm&#8217;s authorization; (ii) prohibiting, restricting or suspending firms or individuals from carrying on or undertaking regulated activities; and (iii) publicly censuring and warning, fining or requiring compensation from firms and individuals who breach their rules.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.K. authorized insurers and managing agents must comply with the PRA&#8217;s requirements (as set out in the PRA Rulebook) and insurers, managing agents and insurance intermediaries must comply with the FCA&#8217;s requirements (as set out in the FCA Handbook), which include the PRA&#8217;s Fundamental Rules and the FCA&#8217;s Principles for Businesses. In particular, under both Fundamental Rule 7 and Principle 11, firms must  deal with the U.K. Regulators in an open and cooperative way, and must disclose to the U.K. Regulators anything of which they would reasonably expect notice. Such notifications may include where the firm has reason to believe that it has materially failed to comply with any requirement or if a senior manager is involved in any prohibited activity. U.K. authorized insurers, managing agents and insurance intermediaries must also adhere to a wide range of U.K. insurance legislation. The most notable of such legislation is the FSMA, which includes the requirements for becoming authorized to conduct regulated insurance activities, regulated and prohibited activities of an insurance company and an insurance intermediary, the approval process for the acquisition or disposal of control of insurance companies and insurance intermediaries, rules on financial promotions, transfers of insurance portfolios and market abuse provisions. This is complemented by a range of statutory instruments on certain subjects, for example, the authorization or exemption process. Legislation based on U.K. Solvency II is also relevant (as described in more detail under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.K. Prudential Regime for Insurers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reforms Post Brexit&#8221; below). In addition, U.K. companies carrying out insurance activities must comply with general legislation, such as the U.K. Companies Act 2006.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FCA&#8217;s Insurance: Conduct of Business Sourcebook of the FCA Handbook (&#8220;ICOBS&#8221;) outlines high-level standards that apply to all non-investment insurance product sales such as that of Aspen UK and AMAL from an establishment in the United Kingdom and regulates the standard of day-to-day conduct of business. The overall aim of ICOBS is to ensure that customers within its scope are treated fairly, products and services provide fair price and fair value and to provide customers with clear, fair information when insurance policies are sold. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICOBS applies to business with retail customers, which means it will not apply to &#8220;contracts of large risk&#8221; sold to commercial customers or other contracts of large risk where the risk is located outside the United Kingdom. Nor does it apply to activities connected to the distribution of group insurance policies or the extension of these policies to new members. ICOBS therefore applies to a broad range of &#8220;non-large risk&#8221; commercial business as well as to consumers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A new &#8220;consumer duty&#8221; was set out by the FCA&#8217;s policy statement published in July 2022 which aims to have a material impact on how financial services companies including insurance companies, managing agents and insurance intermediaries interact with retail customers and set higher standards of care to retail customers over the lifecycle of their products. The rules build on existing product governance and pricing rules and require in-scope companies to define, monitor and evidence how the business models, actions and culture are delivering good customer outcomes in the four areas of products and services, price and value, consumer understanding and consumer support. The consumer duty applies to broadly the same types of customers as ICOBS, and non-large commercial customers as well as consumers. Firms were required to have implemented the consumer duty from July 31, 2023 for new and existing products and services that are open to sale or renewal and will have until July 31, 2024 to apply to those held in closed books. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FCA has indicated that it will use its supervisory tools to compel the delivery of better outcomes for consumers. The U.K. general insurance market has already seen significant interventions in relation to specific products and business lines where the FCA believes retail customers are not receiving fair value and/or that commissions levels received by distributors cannot be justified by the services they provide.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">234</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK, AMAL, and Aspen UK Syndicate Services Limited are subject to the FCA&#8217;s consumer duty rules. In preparation for the introduction of the new rules, an implementation plan was developed with reference to the four consumer duty outcomes: products and services; prices and value; customer understanding; and customer support. A number of activities were undertaken in order to ensure compliance with the consumer duty rules which included enhancements to governance, management information and reporting, product governance arrangements, delegated underwriting arrangements (including the binding authority agreements entered into with managing general agents) and the appointment of a board-level consumer duty champion for each of the regulated entities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All persons who effectively run the insurance undertakings, managing agents and insurance intermediaries or have other key functions must at all times be fit and proper and notified to the PRA/FCA and Lloyd&#8217;s (where applicable). The U.K.&#8217;s framework for ensuring the standards of such persons is the Senior Managers and Certification Regime (&#8220;SM&amp;CR&#8221;). The SM&amp;CR consists of three parts: the Senior Managers Regime, the Certification Regime and the Conduct Rules. The application of SM&amp;CR depends on the individual&#8217;s role and level of seniority in a business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FCA and PRA have published a joint discussion paper (DP23/3 and DP1/23) on the review of the SM&amp;CR. The discussion paper considers the effectiveness, scope, and proportionality of the regulatory regime and aims to identify ways to improve the regime to help it work better for firms and regulators. His Majesty&#8217;s Treasury (the &#8220;HM Treasury&#8221;) has, in parallel, launched a Call for Evidence and is also seeking feedback on the SM&amp;CR. The PRA and FCA are considering the responses and continuing to work together with HM Treasury to decide next steps (which may result in changes to the SM&amp;CR). </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.K. Authorized Firms </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK is authorized by the PRA to effect and carry out (re)insurance contracts in the United Kingdom in classes of general (non-life) business and is regulated by both the PRA, with respect to prudential matters, and by the FCA with respect to the conduct of its business. AMAL is authorized by the PRA and regulated by the PRA, with respect to prudential matters, and the FCA with respect to the conduct of its business. It is also subject to regulation and direction from Lloyd&#8217;s. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK Syndicate Services Limited is authorized and regulated by the FCA. Aspen UK Syndicate Services Limited is subject to the Insurance Distribution Directive (&#8220;IDD&#8221;) as adopted into U.K. law. HM Treasury has announced its plans to repeal the IDD delegated acts and for the requirements of the regulations to be included in the FCA&#8217;s Handbook. In response, the FCA has issued a consultation paper (CP23/19) on the future regulatory framework for the IDD. The FCA was seeking feedback on its proposals for transferring part of the regulatory requirements on insurance firms from current legislation into its rules. The FCA is currently considering the feedback and will in due course publish its final rules. Aspen UK Syndicate Services Limited is subject to ongoing monitoring and annual reporting obligations. Accordingly, Aspen UK Syndicate Services Limited is required to submit annual reports to the FCA which provide information relating to their controllers and close links, client money and assets, accounts, market data, product sales data, remuneration data and reporting complaints. These reports are also applicable to Aspen UK and AMAL. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change of Control</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under FSMA, the prior approval from the PRA and/or FCA is required before any person or entity, together with its associates, acquires &#8220;control&#8221; of or increases its control over a regulated company, or over the parent undertaking of a regulated company. In relation to Aspen UK and AMAL (which is an authorized insurer and managing agent respectively), in summary, a &#8220;controller&#8221; is defined for these purposes as a person who holds (either alone or in concert with others) 10% or more of the shares or voting power in the relevant regulated entity or its parent undertaking, or holds significant influence over the management of such regulated entity by virtue of their shareholding or voting power. Thereafter, the prior approval of the PRA and/or FCA is required if any person or entity (or two or more persons acting in concert) proposes to acquire shares or voting power in a regulated entity or the parent undertaking of a regulated entity, such that they cross one of the following shareholding or voting power thresholds: (i) 20% or more but less than 30%; (ii) 30% or more but less than 50%; or (iii) 50% or more. In relation </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Aspen UK Syndicate Services Limited (which is an authorized insurance intermediary), the test for control is the same, however, there is only one relevant threshold of 20% or more. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to PRA and/or FCA approval, an entity seeking to acquire &#8220;control&#8221; of or increase its control over AMAL is required to obtain Lloyd&#8217;s prior consent (and the same thresholds noted above apply in this context). Any entity seeking to acquire &#8220;control&#8221; of or increase its control over AUL is required to obtain Lloyd&#8217;s prior consent (again, the same thresholds noted above apply in this context). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Controllers must notify the PRA and/or FCA, and/or Lloyd&#8217;s (as applicable) in writing of a reduction or cessation of control before effecting the change, although regulatory approval is not required.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brexit Transition Update</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the U.K.&#8217;s decision to withdraw from the E.U. customs union and single market, an insurance company or insurance intermediary with authorization to write insurance business in the United Kingdom could provide cross-border services in other member states of the EEA subject to having notified the appropriate EEA host state regulator via the PRA/FCA prior to commencement of the provision of services and the appropriate EEA host state regulator not having good reason to refuse consent. Aspen UK had notified the Financial Services Authority (the PRA/FCA&#8217;s predecessor) of its intention to write insurance and reinsurance business in all other EEA member states. As a result, prior to Brexit, Aspen UK was licensed to write insurance business under the &#8220;freedom of services&#8221; within all EEA member states (freedom of services and freedom of establishment rights together, &#8220;Passporting Rights&#8221;). Also prior to Brexit, as a general insurer, Aspen UK was also able to carry out reinsurance business on a cross-border services basis across the EEA. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of Brexit concluding on December 31, 2020, Aspen UK lost its EEA financial services Passporting Rights. However, AMAL continues to be able to access the EEA market through Lloyd&#8217;s Brussels. Lloyd&#8217;s Brussels commenced underwriting all non-life risks from non-U.K. EEA countries from January 1, 2019.  Our business written through Lloyd&#8217;s Brussels stamp 5383 is 100% reinsured by Syndicate 4711.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, Aspen UK contacted all thirty EEA regulators where Aspen UK had written policies to advise them that Aspen UK had ceased writing insurance business in their jurisdiction, and that Aspen UK would not actively underwrite new insurance risks, renew risks, or make mid-term adjustments to existing policies in their jurisdiction.  Aspen UK requested their permission to continue to collect premiums and pay claims (including those that arise in the future) without requiring local authorization. Sweden is the only jurisdiction where the regulator objected to Aspen UK&#8217;s request, where it has live policies and claims outstanding. Action (including novation) is being taken and further options evaluated to ensure that valid claims on Swedish policies can be settled. Aspen UK did not receive a response from two of the regulators, however Aspen UK does not have any live policies or claims in these jurisdictions.  Aspen UK has written to all EEA regulators who have requested further information (e.g., run-off plans) to comply with their temporary transitional arrangements. The temporary transition regimes in Denmark, Spain and The Netherlands expired on December 31, 2021, December 31, 2022, and March 17, 2023, respectively; Aspen UK took steps to ensure that all policies were to have expired and claims where it is the lead insurer settled prior to these dates. Following the March 17, 2023 deadline in The Netherlands, however, we were subsequently made aware that the novation of one coverholder risk had not in fact completed before the deadline; this has been reported to DNB (the Dutch regulator). We were informed on July 28, 2023 that the matter had been referred to the DNB&#8217;s enforcement team, but as of November 2023 the DNB have taken no further action. Cancellation and re-writing of the risk onto Lloyd&#8217;s Brussels with a March 17, 2023 effective date was completed to resolve the situation, and the DNB so informed. Aspen UK has further updated the DNB as to the small number of outstanding claims where Aspen UK is a follow insurer and not a decision-making party. For more information, see &#8220;Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risks Related to Our Business&#8212;Regulatory Risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s withdrawal from the European Union has had, and may continue to have, an adverse impact on our business, results of operations and financial condition.&#8221;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.K. Prudential Regime for Insurers &#8211; Reforms Post Brexit</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK and AMAL (by virtue of being a managing agent at Lloyd&#8217;s) are required to meet economic risk-based solvency requirements that were originally set out by the E.U. directive covering the capital adequacy, risk </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">236</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management and regulatory reporting for insurers (the &#8220;Solvency II Directive&#8221;).  The Solvency II Directive, together with European Commission delegated and implementing acts and guidance issued by the European Insurance and Occupational Pensions Authority, has been adopted by the PRA in the United Kingdom and sets out classification and eligibility requirements, including the features which capital must display in order to qualify as regulatory capital.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the Brexit transitional period coming to an end, the European Union (Withdrawal) Act 2018, as amended, has retained all directly applicable E.U. legislation into domestic U.K. law (legislation which applied directly in the United Kingdom before 11:00 pm on December 31, 2020) and preserved the U.K. transposition of E.U. directives at that point, thus ensuring the continuing application of the regulatory framework brought about by the Solvency II Directive under the U.K.&#8217;s financial services regulatory regime (&#8220;U.K. Solvency II&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, the Financial Services and Markets Act 2023 (&#8220;FSMA 2023&#8221;) received royal assent. FSMA 2023 provides a framework for the revocation of retained E.U. law in financial services (including U.K. Solvency II) and its replacement with corresponding regulators&#8217; rules (in the case of Solvency II, mainly in the PRA&#8217;s Rulebook). Since the transition period, the U.K. Solvency II has been subject to a major review in its application in the United Kingdom, corresponding with a parallel review in the European Union (known as the 2020 review).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the release of HM Treasury&#8217;s consultation paper in April 2022, it published its response in November 2022 which sets out the U.K. Government&#8217;s final reform package on the Solvency II framework in the United Kingdom. Significant changes to be introduced by these reforms include the reduction in risk margin by 30% for non-life insurers and the proposal to remove branch capital requirements. This will benefit branches of foreign insurers based in the United Kingdom immediately upon implementation, as well as reduce barriers for foreign insurers wishing to establish a U.K. branch in the future. The U.K. Government has also decided to introduce a new mobilization scheme for insurers which would create an optional stage in a prospective insurer&#8217;s entry to the market, including adjusted entry requirements such as a lower capital floor, lower expectations for key personnel and governance structures, and exemptions from certain reporting requirements. This should help start-up firms to: (i) raise the capital they need for authorization and market entry; and (ii) boost competition in the sector; and support firms to launch new innovative products. The U.K. Government has also decided to increase the thresholds for the size and complexity of insurers before U.K. Solvency II applies to &#163;15 million in annual gross written premiums and to &#163;50 million in gross technical provisions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, HM Treasury published draft legislation focusing on changes to the risk margin and the PRA issued the first of two consultations (the second was published at the end of September 2023) covering reform proposals for insurers. It is expected that the reforms forming part of &#8220;Solvency UK&#8221; will be in place by the end of 2024. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the U.K. Parliament, via its Industry and Regulators Committee, launched an inquiry and with it a &#8220;Call for Evidence&#8221; into the U.K. insurance and reinsurance industry and, specifically, into the regulation of the London market, the U.K.&#8217;s market for commercial and wholesale specialty risks. The purpose of the inquiry was to &#8220;explore the extent to which regulatory policy is well-designed and proportionately applied and the possibilities for optimizing policy following Brexit.&#8221; The inquiry will further consider the roles of the current regulators, such as the FCA and the Bank of England, as well as the appropriateness of regulation. Following its inquiry, the Industry and Regulators Committee wrote to the then Economic Secretary to the Treasury, John Glen MP, outlining industry concerns regarding the lack of proportionality in the regulation of the London Market by the PRA and FCA, which was described as overly burdensome and demanding. The Industry and Regulators Committee explained industry concerns that an overly inflexible culture within the regulators may inhibit new forms of business within the U.K. commercial re(insurance) industry, proposing that the government&#8217;s secondary objective of growth and competitiveness  needs to be reinforced with clear criteria and appropriate performance measures for the regulators to report on. The result of these reviews by the U.K. Government may have an impact on whether the U.K. is granted Solvency II equivalence status by the European Union in any of the three areas to which equivalence applies.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Requirements under the U.K. Prudential Regime</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK and AMAL are required to maintain a minimum margin of solvency (known as &#8220;own funds&#8221;) equivalent to their Solvency Capital Requirement (&#8220;SCR&#8221;) at all times, the calculation of which depends on the type and amount of insurance business written as well as reserve, credit, market and operational risks. The financial resources maintained in support of the SCR must be adequate, both as to amount and quality, to ensure that there is no significant risk that an entity&#8217;s liabilities cannot be met as they fall due. If the PRA with respect to Aspen UK or Lloyd&#8217;s with respect to AMAL considers that there are insufficient capital resources, it can impose additional requirements in relation to the amount and quality of the resources it considers necessary.  Any failure to comply with such requirements introduced by regulators can result in intervention by regulators or the imposition of sanctions, which could have an adverse effect on Aspen UK&#8217;s and/or AMAL&#8217;s results and financial position.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SCR is calculated by an approved internal capital model or by a standard formula prescribed by U.K. Solvency II. Aspen UK has received approval from the PRA, and AMAL has received approval from Lloyd&#8217;s, to use an agreed internal model to calculate their respective SCR (the &#8220;Internal Model&#8221;).  Aspen UK and AMAL are required to ensure that the Internal Model operates properly on a continuous basis and that it continues to comply with the &#8220;Solvency Capital Requirements - Internal Models&#8221; provisions as set out in the PRA Rulebook and U.K. Solvency II, and, with respect to AMAL, within the Lloyd&#8217;s regulatory framework, including the principles for doing business at Lloyd&#8217;s. If Aspen UK fails to comply with these requirements, the PRA may revoke its approval for Aspen UK to use the Internal Model.  In addition, failure to adequately capture areas of risk (including as may be identified in the Own Risk and Solvency Assessment (&#8220;ORSA&#8221;)) in the calculation of the SCR may result in the PRA applying a capital add-on to the SCR calculated by the Internal Model. Aspen UK must also maintain the ability to calculate its SCR using the Standard Formula as prescribed by U.K. Solvency II.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Aspen UK is required to submit quarterly and annual filings with the PRA including an annual Solvency and Financial Condition Report (&#8220;SFCR&#8221;), which must be posted on Aspen&#8217;s website. Aspen UK must submit an annual ORSA to the PRA and AMAL must submit an ORSA policy at an agent level to Lloyd&#8217;s and an ORSA report (covering the syndicate under management) to Lloyd&#8217;s. The ORSA report is produced annually and provides a summary of all the activity and processes during the preceding year to assess and report on risks and ensure that our overall solvency needs are met at all times, and which will include a forward-looking assessment. It also explains the linkages between business strategy, business planning and capital and risk management processes. Further, Aspen UK and AMAL may need to perform an additional ORSA and submit the corresponding ORSA report to the PRA and/or Lloyd&#8217;s, following any significant change in its risk profile. In 2021, the PRA granted Aspen UK a waiver for five years absolving it from the requirement to produce certain regulatory returns at the U.K.-sub-group level due to Aspen Bermuda being subject to equivalent group supervision.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Outsourcing Requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.K. insurance regulation, an outsourcing arrangement is material if it is of such importance that weakness, or failure, of the service provider would cast serious doubt upon the firm&#8217;s continuing satisfaction of the U.K. Regulators&#8217; threshold conditions for authorization and their Fundamental Rules/Principles. The U.K. Regulators require insurers and managing agents to apply adequate governance and controls in respect of material outsourcing agreements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most prominent &#8220;material outsourcing&#8221; rules that apply to Aspen UK and AMAL are set out in the PRA&#8217;s recent supervisory statements, &#8220;Outsourcing and third party risk management&#8221; (SS2/21) and &#8220;Operational resilience: Impact tolerances for important business services&#8221; (SS1/21). Aspen UK and AMAL are also subject to a number of related rules that derive from U.K. Solvency II. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to these rules, certain rights pertaining to Aspen UK and AMAL must be included in any material outsourcing agreements, including: (i) the right for Aspen UK and AMAL to receive information from the service provider about the performance of the services; (ii) the right for Aspen UK and AMAL to instruct the service provider in respect of these functions; and (iii) the right for Aspen UK and AMAL, their external auditors and the U.K. Regulators to audit the service provider. See &#8220;Material Contracts and Related Party Transactions.&#8221; Aspen UK and AMAL are also required to notify the U.K. Regulators of any new material outsourcing arrangement or material </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendments to current material outsourcing agreements and obtain their &#8220;non-objection&#8221; in relation to them before they can be executed or be materially amended by the parties. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK and AMAL must ensure that its board of directors and senior management set appropriate risk management policies, systems and controls in respect of Aspen UK and AMAL&#8217;s outsourcing and third-party arrangements and must ensure that they are properly carried out. In particular, these individuals should receive clear, consistent, robust and timely management information relating to each service provider&#8217;s performance which will enable them to effectively oversee these activities and provide challenge in relation to them. If a service provider does not adhere to predetermined performance standards, Aspen UK and AMAL must be able to implement effective remediation procedures or exit strategies. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK and AMAL must also ensure that its systems and controls specifically identify and prioritize &#8220;important business services,&#8221; and consider and monitor whether it has dedicated appropriate resources to ensure that it has sufficient operational resilience in the event of any potential material disruption to the services provider (for example, by preparing and maintaining a business continuity or disaster recovery plan covering such circumstances).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restriction on Dividend Payments by Insurers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company law of England and Wales prohibits English companies, including Aspen UK, AMAL, AUL and Aspen UK Syndicate Services Limited from declaring dividends to their shareholders unless they have profits available for distribution. The determination of whether a company has profits available for distribution is based on its accumulated realized profits and other distributable reserves less its accumulated realized losses. While the U.K. insurance regulatory rules impose no general restrictions on a general insurer&#8217;s ability to declare a dividend, the PRA&#8217;s rules require each authorized insurance company within its jurisdiction to maintain its solvency margin at all times, and any action to declare or pay a dividend in breach of SCR without a PRA waiver may result in the firm&#8217;s shares being rendered ineligible for Tier 1 treatment. Accordingly, Aspen UK, AMAL, AUL and Aspen UK Syndicate Services Limited may not pay a dividend if the payment of such dividend would result in their SCR coverage ratio falling below certain levels.  In addition, any future changes regarding regulatory requirements, including those described above, may restrict the ability of Aspen UK, AMAL, AUL and Aspen UK Syndicate Services Limited to pay dividends in the future. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental, Social and Governance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESG continues to be an area of focus among our global regulatory authorities including but not limited to the PRA, FCA, Lloyd&#8217;s and BMA. The regulators have indicated that ESG will remain a supervisory priority and firms are required to comply with existing and emerging ESG-related requirements. Existing environmental regulations such as the PRA&#8217;s supervisory statement SS3/19 &#8220;Enhancing banks&#8217; and insurers&#8217; approaches to managing the financial risks from climate change&#8221; require Aspen UK and AMAL to: (i) fully embed consideration of climate-related risks into its governance arrangements; incorporate climate-related financial risks into existing risk management practices; (ii) utilize scenario analysis to inform strategy setting, risk assessment and risk identification; and (iii) develop and maintain an appropriate approach to the disclosure of climate-related financial risks. Aspen UK and AMAL are also required to allocate responsibility for managing climate-related risk to a senior manager under SM&amp;CR. Similar climate-related regulations exist for Aspen Group and Aspen Bermuda under the BMA&#8217;s Climate Change Guidance Notes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Lloyd&#8217;s published their Guidance for managing agents (such as AMAL) on best practices for establishing an ESG strategy and framework. The Guidance focuses on integrating ESG within business planning and operations, engagement with the value chain, and policies and conditions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2023, the FCA published Policy Statement 23/16 on sustainability disclosure requirements and investment labels regime. The FCA is, among other things, introducing a general &#8216;anti&#8209;greenwashing&#8217; rule, which will be applicable to Aspen UK and AMAL, to clarify that sustainability-related claims must be clear, fair and not misleading. The general &#8216;anti-greenwashing&#8217; rule comes into force on May 31, 2024 and the FCA is also consulting on new guidance on the expectations for FCA-authorized firms subject to the general &#8216;anti-greenwashing rule&#8217; which will take effect at the same time. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">239</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2023, the PRA and FCA issued a joint consultation paper (CP18/23 and CP23/20) on diversity and inclusion applicable to Aspen UK and AMAL. Among other requirements, the PRA and FCA are seeking to require firms to: (i) develop a diversity and inclusion strategy; (ii) set out how the firm will meet its objectives and goals; (iii) collect, report and disclose certain data; and (iv) set targets to address under representation. For further information refer to &#8220;Risk Factors&#8212;Risks Related to Our Business&#8212;Strategic Risks&#8212;Increasing scrutiny and evolving expectations from investors, customers, regulators, policymakers and other stakeholders regarding environmental, social and governance matters may adversely affect our reputation or otherwise adversely impact our business and results of operations.&#8221;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lloyd&#8217;s Regulation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operations of Syndicate 4711 are subject to regulation and supervision of the PRA, FCA and the Council of Lloyd&#8217;s. AMAL is the managing agent for Syndicate 4711 and AUL provides underwriting capacity to Syndicate 4711 and is a Lloyd&#8217;s corporate member. The FCA and PRA both regulate insurers, insurance intermediaries and Lloyd&#8217;s itself.  Lloyd&#8217;s establishes its own bylaws and regulations, including requirements made under those bylaws for all managing agents to maintain that they are designed to meet applicable regulatory requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Solvency Requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Underwriting capacity of a member of Lloyd&#8217;s must be supported by providing a deposit (referred to as &#8220;Funds at Lloyd&#8217;s&#8221;) in the form of cash, securities or letters of credit in an amount determined in accordance with Lloyd&#8217;s requirements and the Solvency II regime. The amount of such deposit is calculated for each member through the completion of an annual capital adequacy exercise. Under these requirements, Lloyd&#8217;s must demonstrate that each member has sufficient assets to meet its underwriting liabilities plus a required solvency margin. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intervention Powers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Council of Lloyd&#8217;s has wide discretionary powers to regulate members&#8217; underwriting at Lloyd&#8217;s. It may, for instance, change the basis on which syndicate expenses are allocated or vary the Funds at Lloyd&#8217;s or the investment criteria applicable to the provision of Funds at Lloyd&#8217;s. Exercising any of these powers might affect the return on an investment of the corporate member in a given underwriting year. Further, the annual business plans of a syndicate are subject to the review and approval by Lloyd&#8217;s.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each member of Lloyd&#8217;s is required to contribute a percentage of that member&#8217;s underwriting capacity for the relevant year of account to the Lloyd&#8217;s central fund (the &#8220;Central Fund&#8221;). If a member of Lloyd&#8217;s is unable to pay its debts to policyholders, such debts may be payable by the Central Fund, which in many respects acts as an equivalent to a state guaranty fund in the United States. If Lloyd&#8217;s determines that the Central Fund needs to be increased, it has the power to assess premium levies on current Lloyd&#8217;s members. The Council of Lloyd&#8217;s has discretion to call or assess up to an additional 5% of a member&#8217;s underwriting capacity in any one year as a Central Fund contribution. Our syndicate capacity for the 2023 underwriting year is &#163;1,115.0 million (2022 &#8212; &#163;900.0 million).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lloyd&#8217;s Brussels</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lloyd&#8217;s Brussels is authorized and regulated by the NBB and regulated by the Belgium FSMA. Lloyd&#8217;s Brussels is an authorized insurance company licensed to write non-life risks across the EEA and the United Kingdom and also maintains 19 branches across Europe. The use of Lloyd&#8217;s Brussels provides AMAL with access to the European market to write non-life insurance risks for, and on behalf of, Syndicate 4711. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Principles for Doing Business at Lloyd&#8217;s (the &#8220;Principles&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Replacing the Lloyd&#8217;s Minimum Standards (the previous regime which set out the Lloyd&#8217;s regulatory requirements for Lloyd&#8217;s managing agents) and effective from Q3 2022, the Principles set out the fundamental responsibilities expected of all managing agents, including AMAL and is the basis against which Lloyd&#8217;s will review and categorize all syndicates and managing agents in terms of their capacity and performance.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">240</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brexit and the U.K. GDPR</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the United Kingdom&#8217;s departure from the European Union, commonly referred to as Brexit, the European Union General Data Protection Regulation&#8217;s (the &#8220;E.U. GDPR&#8221;) data protection obligations continue to apply to the United Kingdom in substantially unvaried form under the so-called &#8220;U.K. GDPR.&#8221; The U.K. GDPR exists alongside the U.K. Data Protection Act 2018 which implements certain derogations in the U.K. GDPR into U.K. law. Under the U.K. GDPR, companies not established in the United Kingdom but who process personal data in relation to the offering of goods or services to individuals in the United Kingdom, or to monitor their behavior will be subject to the U.K. GDPR and will be required to meet certain U.K. specific requirements, including to appoint a data protection representative in the United Kingdom, provided certain exceptions are not met. Otherwise, the requirements of the U.K. GDPR are virtually identical to those of the E.U. GDPR and as such, may lead to similar compliance and operational costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Brexit has implications for transfers of personal data between the United Kingdom and the European Union and vice versa. Transfers of personal data from the United Kingdom to the European Union and vice versa are unrestricted and do not require additional safeguards since the European Union has formally declared the U.K.&#8217;s data protection regime as &#8220;adequate&#8221; and similarly the United Kingdom has formally approved the adequacy of the European Union and all 12 nations deemed adequate by the European Union. As a result, transfers of personal data from the EEA to the United Kingdom, and vice versa, remain unrestricted and do not require any additional safeguards. The duration of the current adequacy decision will expire on June 27, 2025, at which point the European Commission can decide whether to extend the adequacy decision for a further period up to a maximum of another four years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity and Privacy Laws and Regulations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Europe and the United Kingdom, we are subject to the E.U. GDPR and to the United Kingdom General Data Protection Regulation and Data Protection Act 2018 (collectively, the &#8220;U.K. GDPR&#8221;) (the E.U. GDPR and U.K. GDPR together referred to as the &#8220;GDPR&#8221;). The GDPR imposes comprehensive data privacy compliance obligations in relation to our collection, processing, sharing, disclosure, transfer and other use of data relating to an identifiable living individual or &#8220;personal data,&#8221; including a principal of accountability and the obligation to demonstrate compliance through policies, procedures, training and audits.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some of the personal data we process in respect to individual customers, policy holders or beneficiaries is special category or sensitive personal data under the GDPR, and subject to additional compliance obligations and to local law derogations. We may be subject to diverging requirements under E.U. member state laws and U.K. law, such as whether consent can be used as the legal basis for processing. As these laws develop, we may need to make operational changes to adapt to these diverging rules, which could increase our costs and adversely affect our business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with the GDPR could result in penalties for noncompliance. Since we are subject to the supervision of relevant data protection authorities under both the E.U. GDPR and the U.K. GDPR, we could be fined under each of those regimes independently in respect of the same breach. Penalties for certain breaches are up to the greater of EUR 20 million/GBP 17.5 million or 4% of our global annual turnover. In addition to fines, a breach of the GDPR may result in regulatory investigations, reputational damage, orders to cease/change our data processing activities, enforcement notices, assessment notices (for a compulsory audit) and/or civil claims (including class actions).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The E.U. GDPR and U.K. GDPR regulate cross-border transfers of personal data out of the EEA and the United Kingdom. Case law from the Court of Justice of the European Union (&#8220;CJEU&#8221;) states that reliance on the standard contractual clauses &#8211; a standard form of contract approved by the European Commission as an adequate personal data transfer mechanism &#8211; alone may not necessarily be sufficient in all circumstances, and that transfers must be assessed on a case-by-case basis. On October 7, 2022, President Biden signed an Executive Order on &#8216;Enhancing Safeguards for United States Intelligence Activities&#8217; which introduced new redress mechanisms and binding safeguards to address the concerns raised by the CJEU in relation to data transfers from the EEA to the United States and which formed the basis of the new E.U.-U.S. Data Privacy Framework (&#8220;DPF&#8221;), as released on December 13, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022. The European Commission adopted its adequacy decision in relation to the DPF on July 10, 2023, rendering the DPF effective as an E.U. GDPR transfer mechanism to U.S. entities self-certified under the DPF. On October 12, 2023, the U.K. Extension to the DPF came into effect (as approved by the U.K. Government) as a U.K. GDPR data transfer mechanism to U.S. entities self-certified under the U.K. Extension to the DPF. We currently rely on the E.U. standard contractual clauses and the U.K. Addendum to the EU standard contractual clauses and the U.K. International Data Transfer Agreement, as relevant, to transfer personal data outside the EEA and the U.K. with respect to both intragroup and third party transfers. We expect the existing legal complexity and uncertainty regarding international personal data transfers to continue. In particular, we expect the DPF Adequacy Decision to be challenged and international transfers to the United States and to other jurisdictions more generally to continue to be subject to enhanced scrutiny by regulators. As the regulatory guidance and enforcement landscape in relation to data transfers continue to develop, we could suffer additional costs, complaints and/or regulatory investigations or fines; we may have to stop using certain tools and vendors and make other operational changes; we will have to implement revised standard contractual clauses for existing intragroup, customer and vendor arrangements within required time frames; and/or it could otherwise affect the manner in which we provide our services, and could adversely affect our business, operations and financial condition.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8510"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Insurance Regulation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. operations are subject to extensive governmental regulation and supervision by the states and jurisdictions in which our insurance entities operating in the United States are domiciled, licensed and/or eligible to conduct business. AAIC is licensed to write insurance on an admitted basis in all 50 U.S. states, the District of Columbia, Puerto Rico, Guam and the U.S. Virgin Islands. Aspen Specialty is licensed in North Dakota and is eligible to write surplus lines policies in all 50 U.S. states, Puerto Rico and the District of Columbia.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK and Syndicate 4711 are not licensed to write insurance on an admitted basis in any state in the United States, but are alien insurers eligible to write surplus lines business in all 50 U.S. states, the District of Columbia, Puerto Rico and other U.S. jurisdictions based on their listing in the Quarterly Listing of Alien Insurers of the International Insurers Department (&#8220;IID&#8221;) of the National Association of Insurance Commissioners (&#8220;NAIC&#8221;), the organization that works to promote standardization of best practices and assists state insurance regulatory authorities and insurers in the United States by promulgating model insurance laws and regulations for adoption by the states. However, model insurance laws and regulations are only effective when adopted by the states. Pursuant to IID requirements, Aspen UK and Syndicate 4711 have established a U.S. surplus lines trust fund to secure obligations under U.S. surplus lines policies. As of June 30, 2023, Aspen UK&#8217;s and Syndicate 4711&#8217;s surplus lines trust fund was $141.0 million (December&#160;31, 2022 &#8212; $215.1 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The insurance laws and regulations of our U.S. subsidiaries&#8217; domiciliary states have the most significant impact on our U.S. operations as well as the lead state regulator of an insurance holding company system. AAIC is domiciled in Texas and Aspen Specialty is domiciled in North Dakota. AAIC and Aspen Specialty are part of the Apollo Global Management Group holding company system. The lead state insurance regulator for the Apollo Global Management Group holding company system is the Iowa Insurance Division.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, U.S. states regulate insurance holding companies to assure the fairness of inter-affiliate transactions, the propriety of dividends paid to corporate parents and the benefits of any proposed change of control transaction. States also regulate insurer solvency, accounting matters and risk management, as well as a range of operational matters, including authorized lines of business, permitted investments, policy forms and premium rates for admitted companies, maximum single policy risks, adequacy of reserves for losses and unearned premiums and maintenance of in-state deposits for the benefit of policyholders. To monitor compliance, state insurance departments perform periodic market conduct examinations and financial fitness examinations and require the filing of annual and other reports relating to the financial condition of companies and other matters. Certain U.S. regulatory requirements are highlighted below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the U.S. federal government does not directly regulate the insurance business, federal legislation and administrative policies in several areas can significantly affect the insurance business. The Dodd-Frank Wall Street </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) established the Federal Insurance Office (the &#8220;FIO&#8221;) within the U.S. Department of the Treasury headed by a Director appointed by the Treasury Secretary. While currently not having a general supervisory or regulatory authority over the business of insurance, the Director of the FIO performs various functions with respect to insurance. The Director of the FIO has also submitted reports to the U.S. Congress on, among other things, (i) modernization of U.S. insurance regulation (provided in December 2013) and (ii) the U.S. and global reinsurance market (provided in November 2013 and January 2015, respectively). Such reports could ultimately lead to changes in the regulation of insurers and reinsurers in the United States. In addition, AAIC is a certified surety company approved by the U.S. Department of the Treasury and is subject to federal regulations related to Treasury certified sureties.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State&#160;Insurance Holding Company Acts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All U.S. states have laws regulating insurance holding company systems. These laws require insurance companies, which are formed and chartered in the state (referred to as &#8220;domestic insurers&#8221;), to register with the state department of insurance (referred to as their &#8220;domestic state or regulator&#8221;) and file information concerning the operations of companies within the holding company system that may materially affect the operations, management or financial condition of the insurers within the system. Insurance holding company regulations principally relate to (i) state insurance approval of the acquisition of domestic insurers, (ii) prior review or approval of certain transactions between the domestic insurer and its affiliates, and (iii) regulation of dividends made by the domestic insurer. All transactions within a holding company system affecting domestic insurers must be determined to be fair and reasonable.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the NAIC&#8217;s Solvency Modernization Effort, which dates back to 2008, in 2014, the NAIC adopted the Corporate Governance Annual Disclosure Model Act, which has been enacted by our lead state of Iowa, as well as our domestic states of Texas and North Dakota. The model law requires insurers to make an annual confidential filing regarding their corporate governance policies. In addition, the NAIC adopted the Risk Management and Own Risk and Solvency Assessment Model Act (&#8220;ORSA&#8221;), which also has been adopted by Iowa, Texas and North Dakota. ORSA requires insurers to maintain a risk management framework and conduct an internal risk and solvency assessment of the insurer&#8217;s material risks in normal and stressed environments. Many state insurance holding company laws, including those of Iowa, Texas and North Dakota, have also been amended to require insurers to file an annual confidential enterprise risk report with their lead state regulator, disclosing material risks within the entire holding company system that could pose an enterprise risk to the insurer.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change of Control</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The insurance holding company laws and regulations generally provide that no person, corporation, or other entity may acquire control of a domestic insurance company, or a controlling interest in any parent company of such insurance company, without the prior approval of the insurance company&#8217;s domestic state regulator.  A person who acquires, directly or indirectly, 10% or more of the voting interests of an insurance company is presumptively considered to have acquired control of the insurer, although such presumption may be rebutted by a showing that control does not in fact exist. The domestic state regulator may also find that control exists in circumstances in which a person owns or controls less than 10% of voting interest. To obtain approval of any change in control, the proposed acquirer must file an application disclosing, among other information, its background, financial condition, the financial condition of its affiliates, the source and amount of funds by which it will affect the acquisition, the criteria used in determining the nature and amount of consideration to be paid for the acquisition, proposed changes in the management and operations of the insurance company and other related matters.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span id="ic3f441ef888846e8908831713c9a1d36_36696"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Dividend Limitations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Texas and North Dakota law, respectively, AAIC and Aspen Specialty may only pay dividends out of earned surplus as distinguished from contributed surplus. In addition, under Texas and North Dakota law, an insurance company&#8217;s policyholder surplus after payment of a dividend must be reasonable in relation to its outstanding liabilities and adequate for its financial needs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Texas and North Dakota law generally limit the ability of AAIC or Aspen Specialty to pay dividends above a specified level, without prior regulatory approval. Dividends or distributions in excess of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specified level are deemed &#8220;extraordinary&#8221; and are subject to prior notice to and approval of the applicable state insurance regulator.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen U.S.&#160;Holdings, Inc. (&#8220;Aspen U.S. Holdings&#8221;) must also meet its own dividend eligibility requirements under Delaware corporate law in order to distribute any dividends received from AAIC. In particular, any dividend paid by Aspen U.S. Holdings must be declared out of surplus or net profits.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Risk-Based Capital Regulations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. insurers are subject to risk-based capital (&#8220;RBC&#8221;) guidelines that provide a method to measure the total adjusted capital (statutory capital and surplus plus other adjustments) taking into account the specific risk characteristics of the insurer&#8217;s investments and products. The risk-based capital requirement for property and casualty insurers measures: (i) underwriting risk, which is the risk of errors in pricing and reserves; (ii) asset risk, which is the risk of asset default for fixed assets and loss-in-market value for equity assets; (iii) credit risk, which is the risk of losses from unrecoverable reinsurance and the inability of insurers to collect agents&#8217; balances and other receivables; and (iv) off-balance sheet risk, which is primarily the risk created by excessive growth. The capital requirements for each risk category are determined by applying specified factors to assets, premiums, reserves and other items, with higher factors for items with greater underlying risk and lower factors for items with less risk. The formula is used by insurance regulators as an early warning tool to identify deteriorating or weakly capitalized companies for the purpose of initiating corrective company action or regulatory action. Insurers having less statutory surplus than required by the RBC model formula will be subject to varying degrees of regulatory action depending on the level of capital inadequacy. As of December&#160;31, 2022, AAIC and Aspen Specialty exceeded the levels that would require company action or regulatory action.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments and Residual Market Mechanisms</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most states require licensed insurance companies to participate in guaranty funds in order to provide funds for payment of losses for insurers which have become insolvent. Assessments are generally between 1% and 2% of annual premium written in the state. Some states also require licensed and admitted&#160;insurers to participate in various state residual market mechanisms whose goal is to provide affordability and availability of insurance to those clients who may not otherwise be able to obtain insurance, including, for example catastrophe insurance in high-risk areas. If losses exceed the funds, the pool is available to pay those losses. The pools have the ability to assess insurers to provide additional funds to the pool. The amounts of the assessment for each company are normally based upon the proportion of each insurer&#8217;s (and in some cases the insurer&#8217;s and its affiliates&#8217;) written premium for coverages similar to those provided by the pool, and are frequently uncapped.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity and Privacy Laws and Regulations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various laws and regulations that require financial institutions and other businesses to protect and safeguard personal and other sensitive information and provide notice of their practices relating to the collection, disclosure and other processing of personal information. We also are subject to U.S. federal and state laws and regulations concerning unfair or deceptive acts or practices, as well as those requiring notification to affected individuals and regulators of security incidents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among various relevant cybersecurity and privacy laws and regulations The Gramm-Leach-Bliley Act (&#8220;GLBA&#8221;) requires financial institutions to safeguard the confidentiality and security of nonpublic personal information. In 2017, new cybersecurity rules were finalized for financial institutions, insurers and certain other companies supervised by the New York Department of Financial Services (the &#8220;NYDFS Cybersecurity Regulation&#8221;), such as AAIC, which is licensed in New York. The NYDFS Cybersecurity Regulation includes requirements which, among other things, require covered entities to implement a cybersecurity program designed to protect information systems. On November 1, 2023, NYDFS announced its adoption of the second amendment of the NYDFS Cybersecurity Regulation, which includes updated requirements related to: governance requirements; controls to prevent unauthorized access to information systems; risk and vulnerability assessment requirements; notification requirements; and cybersecurity training.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">244</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the NAIC also adopted the Insurance Data Security Model Law (the &#8220;Cybersecurity Model Law&#8221;). The Cybersecurity Model Law requires insurers, insurance producers and other entities licensed under state insurance laws to comply with certain cybersecurity requirements, such as developing and maintaining a written information security program, conducting risk assessments, and overseeing the data security practices of third-party vendors. The Cybersecurity Model Law has been adopted by more than 20 U.S. states. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, California enacted the California Consumer Privacy Act (&#8220;CCPA&#8221;), which came into effect on January 1, 2020, and broadly regulates the collection, processing and disclosure of the personal information of California residents  The CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. Failure to comply with the CCPA risks regulatory fines, and the CCPA grants a private right of action and statutory damages for an unauthorized access and exfiltration, theft, or disclosure of certain types of personal information resulting from the company&#8217;s violation of a duty to maintain reasonable security procedures and practices. The CCPA was expanded on January 1, 2023, when the California Privacy Rights Act of 2020 (&#8220;CPRA&#8221;) amendments to the CCPA became fully operative. The amended CCPA, among other things, gives California residents the ability to limit use of certain sensitive personal information, further restricts the use of cross-contextual advertising, establishes restrictions on the retention of personal information, expands the types of data breaches subject to the CCPA&#8217;s private right of action, provides for increased penalties for CCPA violations concerning California residents under the age of 16, and establishes a new California Privacy Protection Agency to implement and enforce the new law.  While there is currently an exception for personal information that is subject to the GLBA and the California Financial Information Privacy Act, the CCPA may impact certain of our business activities. Additionally, this exception does not apply to the private cause of action afforded to individuals for information security incidents.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Multiple states have followed California to legislate comprehensive privacy laws with data privacy rights. For example, on March 2, 2021, the Virginia Consumer Data Protection Act was signed into law, which went into effect on January 1, 2023, on May 10 2022, the Connecticut Data Privacy Act, was signed into law, which went into effect on July 1, 2023, and on July 8, 2021, the Colorado Privacy Act, was signed into law, which went into effect on July 1, 2023. Multiple states have enacted similar legislation which will go into effect in the coming years. While these new laws generally include exemptions for GLBA-covered, they add layers of complexity to compliance in the U.S. market, and could increase our compliance costs and adversely affect our business</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operations of Aspen UK and Syndicate 4711</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As stated above, Aspen UK and Syndicate 4711, are eligible to write surplus lines business as alien, non-admitted insurers in all 50 U.S.&#160;states, the District of Columbia and other U.S. jurisdictions. Because Aspen UK and Syndicate 4711 are not licensed under the laws of any U.S. state, U.S.&#160;solvency regulation tools otherwise applicable to admitted insurers do not generally apply to them. However, Aspen UK and Syndicate 4711 are subject to federal and state incidental regulations in areas such as those pertaining to federal and state reporting related to terrorism coverage and post-disaster emergency orders.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit for Reinsurance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK and Aspen Bermuda also provide reinsurance to U.S. cedants. &#160;In general, a U.S. domiciled ceding company that obtains reinsurance from a reinsurer that is licensed, accredited or approved by the jurisdiction in which the ceding company is domiciled is permitted to reflect in its statutory financial statements a credit in an aggregate amount equal to the liability for unearned premiums and loss reserves and loss expense reserves ceded to the reinsurer. Many jurisdictions also permit ceding companies to take credit on their statutory financial statements for reinsurance obtained from unlicensed or non-admitted reinsurers if certain prescribed security arrangements are made. Aspen UK and Aspen Bermuda have obtained approval of a multi-beneficiary trust arrangement that satisfies the credit for reinsurance requirements for their U.S. customers. Generally, the minimum trust fund amount is $20.0&#160;million plus an amount equal to 100% of a reinsurer&#8217;s U.S.&#160;reinsurance liabilities collateralized under this arrangement. Aspen Bermuda has obtained approval to post reduced collateral with respect to obligations owed to cedants domiciled in Florida, New York and North Dakota (i.e., 50% versus 100%).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dodd-Frank Act authorized the U.S. Department of the Treasury and the Office of the U.S. Trade Representative to negotiate covered agreements governing certain matters relating to insurance with foreign jurisdictions, including reinsurance collateral, group supervision and exchange of information between supervisory authorities. Such covered agreements could pre-empt state insurance laws. Pursuant to this authority, in September 2017, the U.S. federal authorities and the European Union signed a covered agreement (the &#8220;E.U. Covered Agreement&#8221;) to address, among other things, group supervision and reinsurance collateral requirements and, in anticipation of Brexit, the United States and the United Kingdom signed a covered agreement in December 2018 consistent with the U.S. and E.U. agreement (the &#8220;U.K. Covered Agreement&#8221; and, together with the E.U. Covered Agreement, the &#8220;Covered Agreements&#8221;). The United States also released a &#8220;Statement of the United States on the Covered Agreement with the European Union&#8221; (the &#8220;Policy Statement&#8221;) providing the U.S.&#8217;s interpretation of certain provisions in the E.U. Covered Agreement. In terms of reinsurance, both Covered Agreements eliminate collateral and local presence requirements for alien reinsurers that satisfy certain criteria, including being domiciled in a &#8220;reciprocal jurisdiction.&#8221; Under the Covered Agreements, U.S. state regulators were required to adopt reinsurance reforms removing reinsurance collateral requirements for reinsurers covered under such agreements that meet the prescribed minimum conditions set forth in the applicable Covered Agreement prior to September 1, 2022 or state laws imposing such reinsurance collateral requirements may be subject to federal preemption. In 2019, the NAIC adopted additional revisions to its Credit for Reinsurance Model Law and Model Regulation (together, the &#8220;2019 Amended Credit for Reinsurance Model Act&#8221;) to conform to the reinsurance collateral elimination requirements of the covered Agreements. Texas and North Dakota adopted the 2019 Amended Credit for Reinsurance Model Act. The NAIC has approved Bermuda as a &#8220;reciprocal jurisdiction.&#8221; As of the date of this prospectus, Aspen Bermuda has been approved as a reciprocal jurisdiction reinsurer eligible for zero collateral in all 50 states.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Developing International Matters and Group Capital</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the International Association of Insurance Supervisors (IAIS) adopted the Common Framework for the Supervision of Internationally Active Insurance Groups (ComFrame). ComFrame is applicable to entities that meet the IAIS&#8217;s criteria for internationally active insurance groups (IAIGs) and are designated as such. ComFrame establishes international standards for the designation of a group-wide supervisor for each IAIG and for the imposition of group supervision, group capital requirements, uniform standards for insurer corporate governance, enterprise risk management and other control functions and resolution planning applicable to an IAIG in addition to the current legal entity capital requirements imposed by relevant insurance laws and regulations. The NAIC has also promulgated amendments to the insurance holding company system model law that addresses supervision of IAIGs to allow state insurance regulators in the United States to be designated as group-wide supervisors for U.S.-based IAIGs or acknowledge another regulatory official acting as the group wide supervisor of an IAIG. In November 2019, the IAIS also adopted a revised version of the risk-based global insurance capital standard (ICS), which is the group capital component of ComFrame. In December 2020, the NAIC adopted a group capital calculation tool (&#8220;GCC&#8221;) using an RBC aggregation methodology for all entities within an insurance holding company system group, including non-U.S. entities, and is seeking effective equivalency of such tool to the ICS for U.S.-based IAIGs. The NAIC has also adopted changes to the insurance holding company system model law to require, subject to certain exceptions, the ultimate controlling person of every insurer subject to the holding company registration requirement to file an annual GCC with its lead state regulator. The goal is to provide U.S. regulators with a method to aggregate the available capital and the minimum capital of each entity in a group in a way that applies to all groups regardless of their structure. The Policy Statement with respect to the U.S. participation under the Covered Agreements also provides that the United States expects that the GCC will satisfy the group capital assessment requirement under each of the Covered Agreements. The NAIC has stated that the calculation will be a regulatory tool and will not constitute a requirement or standard. It is not possible to predict what impact any such regulatory tool may have on our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that Apollo becomes an IAIG, we may be subject to a group capital calculation consistent with or comparable to international capital standards in that context. It is possible that the development of these international standards will have an impact on our capital position and capital structure in the future. We cannot predict with any degree of certainty the additional capital requirements, compliance costs or other burdens these requirements may impose on us.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">246</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other U.S. Regulated Entities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment adviser regulation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Up until January 17, 2023, our subsidiary Aspen Capital Advisors Inc. (&#8220;Aspen Advisors&#8221;) was registered with the SEC as a registered investment adviser.&#160;Aspen Advisors served as the investment adviser to a private investment fund, Aspen Cat Fund Ltd (&#8220;ACF&#8221;), that primarily invested in securities tied to weather, natural disasters or other insurance risks as well as certain collateralized property catastrophe reinsurance contracts. In the future, Aspen Advisors may form and manage additional privately offered pooled investment vehicles, customize funds for single investors or groups of investors or manage separately managed accounts of other qualified clients on a limited basis. Aspen Advisors net assets under management as at December&#160;31, 2022 were $55.9 million (December&#160;31, 2021 &#8212; $64.8 million), all of which were managed on a discretionary basis. The amount disclosed differs from Aspen Advisors &#8220;regulatory assets under management&#8221; disclosed in Part 1 of its Form ADV, which is calculated in accordance with the requirements of that form.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Advisors was, up until January 17, 2023, subject to regulation as an investment adviser by the SEC. Federal and state securities laws and regulations are primarily intended to protect investors in the securities markets and generally grant regulatory agencies broad rulemaking and enforcement powers, including the power to limit or restrict the conduct of business for failure to comply with such laws and regulations. The SEC and state securities regulatory authorities from time to time may make inquiries and conduct examinations regarding compliance by Aspen Advisors with securities and other laws and regulations. We intend to cooperate with such inquiries and examinations and take corrective action when warranted. Aspen Advisors may also be subject to similar laws and regulations in foreign countries if it provided investment advisory services, offers products similar to those described above or conducts other activities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2023, ACF ceased offering participating shares to investors and subsequently applied for and received cancellation of its registration as a private fund with the BMA, effective January 23, 2023. Concurrently, Aspen Advisors filed a de-registration notice with the SEC, which took effect on January 17, 2023. Aspen Advisors was subsequently dissolved by the Secretary of State of the state of Delaware on July 13, 2023.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8177"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Branch Regulations</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK and Aspen Bermuda are required to meet local capital requirements and make required local regulatory filings in connection with their respective branch office operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Switzerland</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Aspen Bermuda established a branch in Zurich, Switzerland to write property and casualty reinsurance and specialty reinsurance with inception dates from January 1, 2020. A branch that writes only reinsurance is not currently subject to supervision under the Insurance Supervision Act (Switzerland) by the Financial Markets Supervisory Authority (&#8220;FINMA&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK established a property and casualty reinsurance branch in Zurich, Switzerland in 2007. In 2010, Aspen UK established an insurance branch in Zurich, Switzerland, which was regulated by FINMA pursuant to the Insurance Supervision Act (Switzerland). In 2017, Aspen UK discontinued writing insurance business via the insurance branch in Switzerland. In 2020, Aspen UK ceased writing reinsurance via the reinsurance branch in Switzerland, however, FINMA maintains supervision over the Aspen UK branch while the business is in run off.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Singapore</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Aspen Bermuda received approval from the Monetary Authority of Singapore (&#8220;MAS&#8221;) and established a reinsurance branch in Singapore. The activities of this branch are regulated by the MAS pursuant to The Insurance Act of Singapore. Aspen Bermuda is also regulated by the Accounting and Corporate Regulatory Authority (&#8220;ACRA&#8221;) as a foreign company in Singapore.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">247</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK has a reinsurance branch in Singapore that is regulated by the MAS and pursuant to The Insurance Act of Singapore and by ACRA as a foreign company in Singapore. Action was taken in 2021 to transition the business currently written through our Aspen UK Singapore branch to the Aspen Bermuda branch in Singapore and it is no longer binding new business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMAL set up a subsidiary company, Aspen Singapore Pte. Ltd. (&#8220;ASPL&#8221;), to access insurance business in Singapore and regulatory approval for ASPL to act as an intermediary was received from MAS in 2015. ASPL was incorporated by ACRA in 2015 as a local company regulated by the Companies Act of Singapore. ASPL went into run-off in September 2021, and was subsequently de-authorized on a voluntary basis with effect from August 31, 2023, in accordance with local regulatory requirements. Work is now proceeding towards the corporate dissolution of ASPL, which is anticipated to take effect in the first half of 2024.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Canada</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK established a Canadian branch in 2006 whose activities are regulated by the Office of the Superintendent of Financial Institutions (&#8220;OSFI&#8221;). OSFI is the federal regulatory authority that supervises Canadian and non-Canadian insurance companies operating in Canada pursuant to the Insurance Companies Act (Canada). In addition, the branch is subject to the laws and regulations of each of the provinces and territories in which it is licensed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Australia</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2008, Aspen UK received authorization from the Australian Prudential Regulation Authority (&#8220;APRA&#8221;) to establish a branch in Australia. The activities of the Australian branch are regulated by APRA pursuant to the Insurance Act of Australia 1973. Aspen UK is also registered by the Australian Securities and Investments Commission as a foreign company in Australia under the Corporations Act of Australia 2001.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company formed Aspen Australia Service Company Pty Limited (&#8220;AASC&#8221;), a coverholder which underwrote reinsurance business on behalf of Syndicate 4711 at Lloyd&#8217;s. As at December 31, 2021, Aspen UK&#8217;s Australia branch ceased underwriting new or renewal business and the Company intended for the Aspen UK Australia branch to go into run-off in accordance with APRA regulation. Subsequently, in August 2022, the Company decided to cease writing new or renewal business in AASC effective as at October 31, 2022. AASC&#8217;s office in Australia closed as at March 31, 2023 and the Company intends ultimately to dissolve AASC in accordance with applicable law and regulation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our branches, refer to &#8220;Note 20&#8212;Commitments and Contingent Liabilities&#8221; to our audited consolidated financial statements and &#8220;Note 12&#8212;Commitments and Contingent Liabilities&#8221; to our unaudited consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Regulated Firms</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK Syndicate Services Limited (previously APJ Services Limited) is authorized and regulated by the U.K.&#8217;s FCA and is subject to a separate prudential regime and other requirements for insurance intermediaries under the FCA Handbook.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8186"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jersey Regulation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2010, we purchased APJ Asset Protection Jersey Limited (&#8220;APJ Jersey&#8221;).  APJ Jersey is a Jersey registered company, which formerly held a Category B Insurer permit from the Jersey Financial Services Commission (&#8220;JFSC&#8221;). APJ Jersey ceased underwriting new and renewal business in April 2020 and was placed into run-off in June 2020. APJ Jersey&#8217;s last policy expired in May 2022, and its Category B insurer permit from the JFSC was voluntarily revoked as of October 14, 2022.  Following settlement of its remaining intra-group company positions, APJ Jersey will be subject to a summary winding up in accordance with Jersey law, which it is anticipated will be completed in the first half of 2024.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we identified that APJ Jersey, in connection with an intra-group outsourcing arrangement with Aspen UK Syndicate Services Limited (&#8220;AUKSSL,&#8221; previously APJ Services Limited), had potentially carried out the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">248</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulated activities of effecting and carrying out contracts of insurance as principal in contravention of U.K. law as it did not have the necessary licenses and/or authorizations to undertake these activities in the United Kingdom. We therefore stopped writing new business via APJ Jersey, and contracts that were in run-off were handled by an outsourced provider authorized to do so. We made the required regulatory notifications and, in February 2022, the FCA and the JFSC were provided with a full review of the APJ Jersey operating model and AUKSSL&#8217;s U.K. permissions undertaken by a third-party U.K. law firm. The FCA and JFSC replied that they had no further questions in relation to the review and the FCA confirmed that it would not be pursuing APJ Jersey or AUKSSL for retroactive fees, and the JFSC confirmed that it would be taking no further action regarding the review.  As noted above, the JFSC has agreed to the voluntary revocation of APJ Jersey&#8217;s Category B permit, and preparations for its dissolution are underway.  </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8195"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the European Commission opened an investigation into alleged anti-competitive practices in the aviation insurance segment by Aspen UK and other carriers and brokers in the market, but subsequently confirmed in 2021 that it had discontinued its investigation. A similar investigation was opened by the Competition and Consumer Commission of Singapore (&#8220;CCCS&#8221;) in early 2021, and Aspen UK provided initial responses to the CCCS. No specific feedback or request for further information has been received since such time and it appears that the matter has been removed from the Singapore public register on enforcement actions and investigations. In addition, a similar investigation was commenced in 2017 by the Brazilian anti-trust regulator, CADE, and, in 2022, formal allegations of anti-competitive practices in this segment were alleged against Aspen UK and others in the market, including both brokers and carriers. A formal defense has been lodged by Aspen UK, but has been rejected by CADE.  Aspen UK has also filed expert evidence. We continue to engage with local and onshore counsel to address the questions raised by CADE and progress through the dispute resolution process.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">249</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_183"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN TAX CONSIDERATIONS</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3722"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">United States Taxation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary sets forth the material U.S. federal income tax considerations related to the purchase, ownership and disposition of the Company&#8217;s ordinary shares. Unless otherwise stated, this summary deals only with shareholders who are U.S. Persons (as defined below) who purchase ordinary shares. The following discussion is only a discussion of the material U.S. federal income tax matters as described herein and does not purport to address all of the U.S. federal income tax consequences that may be relevant to a particular shareholder in light of such shareholder&#8217;s specific circumstances. In addition, the following summary does not address the U.S. federal income tax consequences that may be relevant to special classes of shareholders, such as financial institutions, insurance companies, regulated investment companies, real estate investment trusts, financial asset securitization investment trusts, dealers or traders in securities or currencies, tax-exempt organizations, U.S. expatriates, partnerships or other pass-through entities (or investors in such entities), persons whose functional currency is not the U.S. dollar, persons subject to any alternative minimum tax, accrual basis taxpayers subject to special tax accounting rules under Section 451(b) of the Code, or persons who hold their ordinary shares as part of a hedging or conversion transaction or as part of a short-sale or straddle, who may be subject to special rules or treatment under the Code. This discussion is based upon the Code, the Treasury Regulations promulgated thereunder and any relevant administrative rulings or pronouncements or judicial decisions, all as in effect on the date hereof and as currently interpreted, and does not take into account possible changes in such tax laws or interpretations thereof, which may apply retroactively. This discussion does not include any description of the tax laws of any state or local governments within the United States or of any non-U.S. government. Persons owning or considering making an investment in the ordinary shares should consult their own tax advisors concerning the application of the U.S. federal tax laws to their particular situations as well as any tax consequences arising under the laws of any state, local or foreign taxing jurisdiction prior to making such investment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a partnership (or other entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds our ordinary shares, the tax treatment of the partners will generally depend on the status of the partner, the activities of the partnership, and certain determinations made at the partner level. If you are a partner in a partnership owning our ordinary shares, you should consult your tax advisor. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this discussion, the term &#8220;U.S. Person&#8221; means: a beneficial owner of the ordinary shares that is (i) an individual citizen or resident of the United States, (ii) a corporation created in or organized under the laws of the United States, or organized under the laws of any political subdivision thereof, (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source, (iv) a trust if either (x) a court within the United States is able to exercise primary supervision over the administration of such trust and one or more U.S. Persons have the authority to control all substantial decisions of such trust or (y) the trust has a valid election in effect to be treated as a U.S. Person for U.S. federal income tax purposes or (v) any other person or entity that is treated for U.S. federal income tax purposes as if it were one of the foregoing.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxation of the Company</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Holdings and its non-U.S. subsidiaries (other than AUL and Aspen UK) intend to manage their business so that they are not treated as engaged in a trade or business within the United States and thus not subject to U.S. federal income tax on their net income. However, because there is considerable uncertainty as to the activities which constitute being engaged in a trade or business within the United States, we cannot be certain that the IRS will not contend successfully that one or more of these companies is engaged in a trade or business in the United States. If any of these companies is considered to be engaged in a trade or business in the United States during a taxable year, it generally will be subject to U.S. federal income tax (including an additional branch profits tax) on its net income that is treated as effectively connected with the conduct of a U.S. trade or business for such year (except to the extent an applicable income tax treaty provides otherwise), in which case its operating results could be materially adversely affected. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. corporations not engaged in a trade or business within the United States are nonetheless subject to United States income tax imposed by withholding on certain &#8220;fixed or determinable annual or periodic gains, profits </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">250</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and income&#8221; derived from sources within the United States (such as dividends and certain interest on investments), subject to exemption under the Code or reduction by applicable treaties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States also imposes an excise tax on insurance and reinsurance premiums (&#8220;FET&#8221;) paid to non-U.S. insurers or reinsurers that are not eligible for the benefits of a U.S. income tax treaty that provides for an exemption from the FET with respect to risks (i) of a U.S. entity or individual, located wholly or partially within the United States and (ii) of a non-U.S. entity or individual engaged in a trade or business in the U.S., located within the United States. The rates of tax are 4% for property casualty insurance premiums and 1% for reinsurance premiums.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxation of Distributions </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the discussions below relating to the potential application of the CFC, RPII and PFIC rules, cash distributions, if any, made with respect to ordinary shares will constitute dividends for U.S. federal income tax purposes to the extent paid out of current or accumulated earnings and profits of Aspen Holdings (as computed using U.S. tax principles). To the extent such distributions exceed Aspen Holdings&#8217; earnings and profits, they will be treated first as a return of the U.S. Person&#8217;s basis in their shares to the extent thereof, and then as gain from the sale of a capital asset. If, as expected, Aspen Holdings does not compute its earnings and profits under U.S. tax principles, all distributions generally will be treated as dividends for U.S. federal income tax purposes. Dividends paid by us to U.S. Persons who are corporations generally will not be eligible for a dividends received deduction. We believe dividends paid by us on our ordinary shares to non-corporate U.S. Persons should be eligible for reduced rates of taxation as &#8220;qualified dividend income&#8221; if, as is intended, our ordinary shares remain listed on the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and provided certain requirements, including stock holding period requirements, are satisfied. Qualified dividend income is subject to tax at long-term capital gains rates rather than the higher rates applicable to ordinary income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends that exceed certain thresholds in relation to a U.S. Person&#8217;s tax basis in the ordinary shares could be characterized as &#8220;extraordinary dividends&#8221; under the Code. A non-corporate U.S. Person that receives an extraordinary dividend will be required to treat any losses on the sale of such shares as long-term capital losses to the extent of the extraordinary dividends such U.S. Person receives that are treated as qualified dividend income.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classification of Aspen Holdings or Its Non-U.S. Subsidiaries as CFCs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each 10% U.S. Shareholder of a non-U.S. corporation that is a CFC at any time during a taxable year must include in its gross income for U.S. federal income tax purposes its pro rata share of the CFC&#8217;s subpart F income and tested income (with various adjustments) with respect to any shares that such 10% U.S. Shareholder owns in such non-U.S. corporation (directly or indirectly through certain entities) on the last day in the non-U.S. corporation&#8217;s taxable year on which it is a CFC, even if the subpart F income or tested income is not distributed. A &#8220;10% U.S. Shareholder&#8221; generally is a U.S. person that owns (directly, indirectly through non-U.S. entities or by attribution by application of the constructive ownership rules of section 958(b) of Code (i.e., &#8220;constructively&#8221;)) at least 10% of the total combined voting power or value of all classes of stock of a non-U.S. corporation. Subpart F income of a CFC generally includes &#8220;foreign personal holding company income&#8221; (such as interest, dividends and other types of passive income), as well as insurance and reinsurance income (including underwriting and investment income), and tested income is generally any income of the CFC other than subpart F income and certain other categories of income. An entity treated as a foreign corporation for U.S. federal income tax purposes is generally considered a CFC if 10% U.S. Shareholders own (directly, indirectly through non-U.S. entities or constructively), in the aggregate, more than 50% of the total combined voting power of all classes of stock of that non-U.S. corporation or more than 50% of the total value of all stock of that non-U.S. corporation. However, for purposes of taking into account insurance income, these 50% thresholds are generally reduced to 25%. Further, special rules apply for purposes of taking into account any RPII of a non-U.S. corporation, as described below. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whether Aspen Holdings is a CFC for a taxable year will depend upon facts regarding our direct and indirect shareholders, about which we have limited information. Accordingly, no assurance can be provided that Aspen Holdings will not be a CFC. Further, regardless of whether Aspen Holdings is a CFC, most or all of our non-U.S. subsidiaries are generally treated as CFCs because our U.S. subsidiaries generally are treated as constructively owning the stock of our non-U.S. subsidiaries. Accordingly, any 10% U.S. Shareholders of Aspen Holdings may be required to include in gross income for U.S. federal income tax purposes for each taxable year their pro rata shares </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">251</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of all or a portion of the subpart F and tested income generated by our non-U.S. companies (with various adjustments), regardless of whether any distributions are made to them. Any U.S. Person should consult their own tax advisors regarding the application of these rules to them.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The RPII CFC Provisions</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, if a non-U.S. corporation is a RPII CFC at any time during a taxable year, a U.S. RPII Shareholder must include in its gross income for U.S. federal income tax purposes its pro rata share of the non-U.S. corporation&#8217;s RPII with respect to any shares that such U.S. RPII Shareholder owns (directly or indirectly through certain entities) on the last day in the non-U.S. corporation&#8217;s taxable year, even if the RPII is not distributed. Further, a U.S. RPII Shareholder&#8217;s pro rata share of any RPII is determined as if all RPII for the taxable year were distributed proportionately only to U.S. RPII Shareholders on that date but generally may not exceed the U.S. RPII Shareholder&#8217;s pro rata share of the non-U.S. corporation&#8217;s earnings and profits for the taxable year. In addition, a U.S. RPII Shareholder is required to comply with certain reporting requirements, regardless of the number of shares owned by the U.S. RPII Shareholder.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these purposes, a &#8220;RPII CFC&#8221; is any non-U.S. corporation if, on any day of its taxable year, U.S. RPII Shareholders collectively own (directly, indirectly through non-U.S. entities or constructively) 25% or more of the total combined voting power of all classes of stock of such corporation entitled to vote or 25% or more of the total value of the stock of such corporation. A &#8220;U.S. RPII Shareholder&#8221; is any U.S. person who owns (directly or indirectly through certain entities) any shares of the non-U.S. corporation. &#8220;RPII&#8221; is any &#8220;insurance income&#8221; (as described below) attributable to policies of insurance or reinsurance with respect to which the person (directly or indirectly) insured is a U.S. RPII Shareholder or a &#8220;related person&#8221; (as defined below) to such U.S. RPII Shareholder. In general, and subject to certain limitations, &#8220;insurance income&#8221; is income (including premium and investment income) attributable to the issuing of any insurance or reinsurance contract which would be taxed under the portions of the Code relating to insurance companies if the income were the income of a U.S. insurance company. Generally, the term &#8220;related person&#8221; for this purpose means someone who controls or is controlled by the U.S. RPII Shareholder or someone who is controlled by the same person or persons who control the U.S. RPII Shareholder. Control generally is measured by a greater than 50% ownership interest, applying certain constructive ownership principles. However, the RPII rules generally do not apply with respect to a non-U.S. corporation if either (i) at all times during its taxable year less than 20% of the total combined voting power of all classes of stock of the corporation entitled to vote and less than 20% of the total value of the corporation is owned (directly or indirectly) by persons who are (directly or indirectly) insured under any policy of insurance or reinsurance issued by the corporation or who are related persons to any such person (the &#8220;ownership exception&#8221;), or (ii) the RPII (determined on a gross basis) of the corporation for the taxable year is less than 20% of its gross insurance income for the taxable year (the &#8220;de minimis exception&#8221;). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that each of our non-U.S. Operating Subsidiaries and each of Peregrine and APJ Jersey is a RPII CFC. Nonetheless, we expect that each such company will qualify for one or both of the ownership exception and the de minimis exception in the current taxable year and for the foreseeable future. However, no assurances can be provided that any of our companies will satisfy either exception.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Computation of RPII</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to determine how much RPII, if any, a non-U.S. insurance subsidiary (including for this purpose, Peregrine and APJ Jersey) has earned in each taxable year, our non-U.S. insurance subsidiaries may obtain and rely upon information from their insureds and reinsureds to determine whether any of the insureds, reinsureds or persons related thereto own (directly or indirectly through non-U.S. entities) shares of Aspen Holdings and are U.S. Persons. Aspen Holdings may not be able to determine whether any of the underlying direct or indirect insureds to which our non-U.S. insurance subsidiaries provide insurance or reinsurance are direct or indirect shareholders or related persons to such shareholders. Consequently, Aspen Holdings may not be able to determine accurately the gross amount of RPII earned by each of our non-U.S. insurance subsidiaries in a given taxable year. For any year in which the special RPII CFC inclusion rules apply, Aspen Holdings may also seek information from its shareholders as to whether beneficial owners of ordinary shares at the end of the year are U.S. Persons so that the RPII may be determined and apportioned among such persons; to the extent Aspen Holdings is unable to determine whether a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">252</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beneficial owner of ordinary shares is a U.S. Person, Aspen Holdings may assume that such owner is not a U.S. Person, thereby increasing the per share RPII amount for all known U.S. RPII Shareholders.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis Adjustments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A U.S. RPII Shareholder&#8217;s tax basis in its shares will be increased by the amount of any RPII that the shareholder includes in income. The U.S. RPII Shareholder may exclude from income the amount of any distributions by Aspen Holdings out of previously taxed RPII income. The U.S. RPII Shareholder&#8217;s tax basis in its shares will be reduced by the amount of such distributions that are excluded from income. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertainty as to Application of RPII Provisions</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RPII provisions have never been interpreted by the courts, and regulations interpreting the RPII provisions exist only in proposed form. It is not certain whether these regulations will be adopted in their proposed form or what changes or clarifications might ultimately be made thereto or whether any such changes, as well as any interpretation or application of the RPII provisions by the IRS, the courts or otherwise, might have retroactive effect. The U.S. Treasury Department has authority to impose, among other things, additional reporting requirements with respect to RPII. Accordingly, the meaning of the RPII provisions and the application thereof to us is uncertain. Further, the applicability of the ownership and de minimis exceptions and the RPII rules more generally depends upon facts regarding our direct and indirect shareholders and insureds, about which we have limited information. Accordingly, no assurances can be provided that any of our companies will satisfy either exception. Moreover, to the extent the exceptions do not apply, we may be unable to correctly determine the amount of RPII that any U.S. RPII Shareholder is required to take into account. Any U.S. Person considering an investment in our ordinary shares should consult their tax advisors as to the effects of these uncertainties.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Information Reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under certain circumstances, U.S. Persons owning stock in a non-U.S. corporation are required to file IRS Form 5471 with their U.S. federal income tax returns. Generally, information reporting on IRS Form 5471 is required by (i) a person who is treated as a U.S. RPII Shareholder, (ii) a 10% U.S. Shareholder of a non-U.S. corporation that is a CFC at any time during the taxable year and who owned the stock on the last day of that year on which it was a CFC and (iii) under certain circumstances, a U.S. Person who acquires stock in a non-U.S. corporation and as a result thereof owns 10% or more of the voting power or value of such non-U.S. corporation, whether or not such non-U.S. corporation is a CFC. Aspen Holdings will, upon request, provide to all U.S. Persons registered as shareholders of its ordinary shares the relevant information necessary to complete Form 5471 in the event Aspen Holdings determines this is necessary. Failure to file IRS Form 5471 may result in penalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Persons should consider their possible obligation to file FinCEN Form 114, Report of Foreign Bank and Financial Accounts, with respect to the ordinary shares. Additionally, such U.S. Persons should consider their possible obligations to annually report certain information with respect to the Form with their U.S. federal income tax returns. Certain U.S. Persons who are individuals (and certain entities) that hold an interest in &#8220;specified foreign financial assets&#8221; (which may include the ordinary shares) are required to report information (on IRS Form 8938) relating to such assets, subject to certain exceptions (including an exception for ordinary shares held in accounts maintained by certain financial institutions). U.S. Persons who fail to report the required information could be subject to substantial penalties, and, in such circumstances, the statute of limitations for assessment of tax could be suspended, in whole or part. U.S. Persons should consult their tax advisors with respect to these or any other reporting requirements which may apply with respect to their purchase, holding and sale of the ordinary shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain U.S. Persons may be required to file an IRS Form 926 (Return of a U.S. Transferor of Property to a Foreign Corporation) to report a transfer of property, including cash, to Aspen Holdings. Substantial penalties may be imposed on a U.S. Person  that fails to comply with this reporting requirement. Each U.S. Person is urged to consult with its own tax advisors regarding this reporting obligation.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax-Exempt Shareholders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tax-exempt U.S. Person generally will recognize unrelated business taxable income if it is required to include in gross income any of our insurance income under the CFC rules described above (including the RPII provisions). U.S. Persons that are tax-exempt entities are urged to consult their tax advisors as to the potential impact of the unrelated business taxable income provisions of the Code. A tax-exempt organization that is treated as a 10% U.S. Shareholder or a U.S. RPII Shareholder also must file IRS Form 5471 in the circumstances described above.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions of Ordinary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the discussions below relating to the potential application of Section 1248 of the Code and the PFIC rules, U.S. Persons that hold ordinary shares generally should recognize capital gain or loss for U.S. federal income tax purposes on the sale, exchange or other disposition of such shares in the same manner as on the sale, exchange or other disposition of any other shares held as capital assets. If the holding period for these shares exceeds one year, under current law any gain will be subject to tax at the rates applicable to long-term capital gain. Moreover, gain, if any, generally will be U.S. source gain and generally will constitute &#8220;passive category income&#8221; for foreign tax credit limitation purposes.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 1248 of the Code provides that if a U.S. Person sells or exchanges stock in a non-U.S. corporation and such person owned, directly, indirectly through certain non-U.S. entities or constructively, 10% or more of the voting power of the corporation at any time during the five-year period ending on the date of disposition when the corporation was a CFC, any gain from the sale or exchange of the shares will be treated as a dividend to the extent of the CFC&#8217;s earnings and profits (determined under U.S. federal income tax principles) during the period that the shareholder held the shares and while the corporation was a CFC (with certain adjustments). A U.S. Person who owns or owned, directly, indirectly through certain non-U.S. entities or constructively, 10% or more of the voting power of Aspen Holdings may be subject to these rules if Aspen Holdings is or was treated as a CFC. As described above, our bye-laws may reduce the voting power of our ordinary shares in certain circumstances, although it is unclear if such reduction would be respected for purposes of Section 1248 of the Code.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A 10% U.S. Shareholder may in certain circumstances be required to report a disposition of shares of a CFC by attaching IRS Form 5471 to the U.S. federal income tax or information return that it would normally file for the taxable year in which the disposition occurs. In the event this is determined necessary, Aspen Holdings will provide upon request the relevant information necessary to complete the Form. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the RPII provisions, Section 1248 of the Code also generally applies if a U.S. Person disposes of shares in a RPII CFC (determined without regard to the ownership or de minimis exceptions) that would be taxable as an insurance company under the Code if it were a U.S. corporation, in which case any gain from the disposition generally will be treated as a dividend to the extent of the U.S. Person&#8217;s share of the corporation&#8217;s undistributed earnings and profits that were accumulated during the period that the U.S. Person owned the shares (whether or not such earnings and profits are attributable to RPII). In addition, such a U.S. Person will be required to comply with certain reporting requirements, regardless of the number of shares owned by the U.S. Person. Existing proposed regulations do not address whether Section 1248 of the Code would apply if a non-U.S. corporation is not an insurance company but the non-U.S. corporation has a subsidiary that is a CFC and that would be taxed as an insurance company if it were a domestic corporation. We believe that these rules should not apply to dispositions of ordinary shares because Aspen Holdings will not itself be directly engaged in the insurance business. We cannot be certain, however, that the IRS will not interpret the RPII provisions in a contrary manner or that the U.S. Treasury Department will not adopt regulations that provide that these rules will apply to dispositions of ordinary shares. U.S. Persons should consult their tax advisors regarding the effects of these rules on a disposition of ordinary shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax on Net Investment Income</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A U.S. Person that is an individual, estate or a trust that does not fall into a special class of trusts that is exempt from such tax will be subject to a 3.8% tax on the lesser of (1) the U.S. Person&#8217;s &#8220;net investment income&#8221; (or &#8220;undistributed net investment income&#8221; in the case of estates and trusts) for the relevant taxable year and (2) the excess of the U.S. Person&#8217;s modified adjusted gross income for the taxable year over a certain threshold (which in the case of an individual will be between $125,000 and $250,000, depending on the individual&#8217;s circumstances). A </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Person&#8217;s net investment income will generally include its dividend income and its net gains from the disposition of ordinary shares, unless such dividend income or net gains are derived in the ordinary course of the conduct of a trade or business (other than a trade or business that consists of certain passive or trading activities). Unless a U.S. Person elects otherwise or holds ordinary shares in connection with certain trades or businesses, the CFC and PFIC provisions generally will not apply for purposes of determining a U.S. Peron&#8217;s net investment income with respect to the ordinary shares. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Passive Foreign Investment Companies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, a non-U.S. corporation will be a PFIC during a given year if (i) 75% or more of its gross income constitutes &#8220;passive income&#8221; (the &#8220;75% test&#8221;) or (ii) 50% or more of its assets produce (or are held for the production of) passive income (the &#8220;50% test&#8221;). For these purposes, passive income generally includes interest, dividends, annuities and other investment income. However, the PFIC provisions contain a look-through rule under which a non-U.S. corporation that directly or indirectly owns at least 25% of the value of the stock of another corporation generally is treated, for purposes of determining whether it is a PFIC, as if it received directly its proportionate share of the income, and held its proportionate share of the assets, of the other corporation (the &#8220;look-through rule&#8221;). As a result, it is expected that the PFIC status of Aspen Holdings should generally depend on the application of the look-through rule to its subsidiaries and whether the income and assets of its subsidiaries will be characterized as passive or active for this purpose. In addition, pursuant to an insurance exception, (a) passive income does not include income that a qualifying insurance corporation (a &#8220;QIC&#8221;) derives in the active conduct of an insurance business or income of a qualifying domestic insurance corporation (a &#8220;QDIC&#8221;) (generally, a U.S. corporation with respect to which the look-through rule applies that is taxable as an insurance company and is subject to U.S. federal income tax on its net income), and (b) passive assets do not include assets of a QIC available to satisfy liabilities of the QIC related to its insurance business, if the QIC is engaged in the active conduct of an insurance business, or assets of a QDIC.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, a non-U.S. corporation will be a QIC for a taxable year if it would be taxable as an insurance company if it were a U.S. corporation and its applicable insurance liabilities constitute more than 25% of its total assets for a taxable year. Further, under the 2021 Proposed Regulations, a QIC is in the &#8220;active conduct&#8221; of an insurance business only if it satisfies either a &#8220;factual requirements test&#8221; or an &#8220;active conduct percentage test.&#8221; The factual requirements test requires that the officers and employees of the QIC carry out substantial managerial and operational activities on a regular and continuous basis with respect to its core functions (generally its underwriting activities, investment activities, contract and claims management activities and sales activities) and that they perform virtually all of the active decision-making functions relevant to underwriting functions. The active conduct percentage test generally requires that (i) the total costs incurred by the QIC with respect to its officers and employees for services rendered with respect to its core functions (other than investment activities) equal or exceed 50% of the total costs incurred by the QIC with respect to its officers and employees and any other person or entities for services rendered with respect to its core functions (other than investment activities) and (ii) to the extent the QIC outsources any part of its core functions to unrelated entities, officers and employees of the QIC with experience and relevant expertise must select and supervise the person that performs the outsourced functions, establish objectives for performance of the outsourced functions and prescribe rigorous guidelines relating to the outsourced functions which are routinely evaluated and updated. Under certain exceptions, however, a QIC that has no or only a nominal number of employees or that is a vehicle that has the effect of securitizing or collateralizing insurance risks underwritten by other insurance or reinsurance companies or is an insurance linked securities fund that invests in securitization vehicles generally is deemed not engaged in the active conduct of an insurance business. The officers and employees of certain related entities generally may be taken into account for these purposes, provided that the QIC exercises regular oversight and supervision over the services performed by the related entity&#8217;s officers and employees. The 2021 Proposed Regulations will not be effective unless and until adopted in final form, but taxpayers may rely on them for taxable years beginning after December 31, 2017 if they are consistently followed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, based on the implementation of our current business plan and the application of the insurance exception, our non-U.S. insurance subsidiaries should be considered QICs engaged in the active conduct of an insurance business under one or both of the &#8220;factual requirements test&#8221; or the &#8220;active conduct percentage test,&#8221; our U.S. insurance subsidiaries should be considered QDICs and none of the income or assets of such insurance </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">255</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsidiaries should be treated as passive. In addition, the income and assets attributable to our non-U.S. subsidiaries that are not insurance subsidiaries are minimal, relative to the income and assets attributable to our other subsidiaries. As a result, based on the application of the look-through rule, we believe that Aspen Holdings should not be characterized as a PFIC for the current year or the foreseeable future. However, because of legal uncertainties with respect to the interpretation of the PFIC rules and whether the 2021 Proposed Regulations will be adopted as final regulations in their current form, and factual uncertainties with respect to our planned operations, there is a risk that Aspen Holdings will be characterized as a PFIC in one or more years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Aspen Holdings is characterized as a PFIC for any year during which a U.S. Person holds ordinary shares of Aspen Holdings, it generally will continue to be treated as a PFIC for the years during which such U.S. Person holds such shares unless the U.S. Person has made a &#8220;qualified electing fund&#8221; election, described below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Aspen Holdings were characterized as a PFIC during a given year, each U.S. Person holding ordinary shares of Aspen Holdings generally would be subject to a penalty tax at the time of the sale at a gain of, or receipt of an &#8220;excess distribution&#8221; with respect to, their ordinary shares, unless such person is a 10% U.S. Shareholder subject to tax under the CFC rules or such person made a &#8220;qualified electing fund&#8221; election or &#8220;mark-to-market&#8221; election (which mark-to-market election would generally require the shareholder to include as ordinary income any appreciation in the value of its shares at the end of a taxable year and allow a shareholder to deduct any depreciation in the value of its shares (up to the amount of prior gain inclusions) at the close of the taxable year). If Aspen Holdings is considered a PFIC for any taxable year and the ordinary shares are treated as &#8220;marketable stock&#8221; in such year, then a U.S. Person may make a mark-to-market election with respect to its ordinary shares. The ordinary shares will be marketable if they are regularly traded on certain qualifying stock exchanges, including the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. However, there can be no assurance that such election will be available. Additionally, because a mark-to-market election usually cannot be made for any lower-tier PFICs, a U.S. Person will generally continue to be subject to the special tax rules discussed above with respect to its indirect interest in any non-U.S. subsidiary of Aspen Holdings classified as a PFIC. As a result, it is possible that any mark-to-market election with respect to the ordinary shares will be of limited benefit.  Further, it is uncertain whether Aspen Holdings would be able to provide its shareholders with the information necessary for a U.S. Person to make a &#8220;qualified electing fund&#8221; election. In addition, if Aspen Holdings were considered a PFIC, upon the death of any U.S. individual owning ordinary shares, such individual&#8217;s heirs or estate would not be entitled to a &#8220;step-up&#8221; in the basis of the shares that might otherwise be available under U.S. federal income tax laws. In general, a shareholder receives an &#8220;excess distribution&#8221; if the amount of the distribution is more than 125% of the average distribution with respect to the shares during the three preceding taxable years (or shorter period during which the taxpayer held the shares). In general, the penalty tax is equivalent to the taxes that are deemed due during the period the shareholder owned the shares, computed by assuming that the excess distribution or gain (in the case of a sale) with respect to the shares was earned in equal portions and taxable at the highest applicable tax rate on ordinary income throughout the shareholder&#8217;s period of ownership, and an interest charge for the failure to pay such taxes for prior periods. The interest charge is equal to the applicable rate imposed on underpayments of U.S. federal income tax for such periods. In addition, a distribution paid by Aspen Holdings to U.S. shareholders that is characterized as a dividend and is not characterized as an excess distribution would not be eligible for reduced rates of tax as qualified dividend income if Aspen Holdings were considered a PFIC in the taxable year in which such dividend is paid or in the preceding taxable year. A U.S. Person that is a shareholder in a PFIC may also be subject to additional information reporting requirements, including the filing of an IRS Form 8621.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. investors are urged to consult with their tax advisors and to consider making a &#8220;protective&#8221; QEF election with respect to the ordinary shares to preserve the possibility of making a retroactive QEF election. A U.S. Person that makes a QEF election with respect to a PFIC is currently taxable on its pro rata share of the ordinary earnings and net capital gain of such company during the years it is a PFIC (at ordinary income and capital gain rates, respectively), regardless of whether or not distributions were received. In addition, any of the PFIC&#8217;s losses for a taxable year will not be available to U.S. Persons and may not be carried back or forward in computing the PFIC&#8217;s ordinary earnings and net capital gain in other taxable years. A U.S. Person generally increases the basis of its PFIC shares, and the basis of any other property of the U.S. Person by reason of which such U.S. Person is considered to indirectly own PFIC shares, by amounts included in such U.S. Person&#8217;s gross income pursuant to the QEF election. Therefore, an electing U.S. Person will generally increase the basis of its ordinary shares by amounts included in the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">256</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Person&#8217;s gross income pursuant to the QEF election. Distributions of income that had previously been taxed pursuant to the QEF election will result in a corresponding reduction of basis in the ordinary shares and will not be taxed again as a distribution to the U.S. Person. A U.S. Person holding ordinary shares will generally be required to file an IRS Form 8621 (which is a form that is required to be filed by holders of equity in a PFIC) for each tax year that it holds such shares and we are characterized as a PFIC, regardless of whether such U.S. Person has a QEF election in effect or receives an excess distribution.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Aspen Holdings is a PFIC for any taxable year, a U.S. Person who holds ordinary shares would be treated as owning a proportionate amount of the shares of any PFICs in which Aspen Holdings directly, or in certain cases indirectly, owns an interest, and the PFIC rules described above generally would apply with respect to the U.S. Person&#8217;s indirect ownership of such PFICs. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Tax Credit</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If U.S. Persons own a majority of our shares, only a portion of the current income inclusions, if any, under the CFC, RPII and PFIC rules and of dividends paid by us (including any gain from the sale of shares that is treated as a dividend under Section 1248 of the Code) will be treated as foreign source income for purposes of computing a shareholder&#8217;s U.S. foreign tax credit limitations. We will consider providing shareholders with information regarding the portion of such amounts constituting foreign source income to the extent such information is reasonably available. It is also likely that substantially all of the &#8220;subpart F income,&#8221; RPII and dividends that are foreign source income will constitute &#8220;passive category income&#8221; for foreign tax credit limitation purposes. Additionally, tested income will constitute a separate basket for foreign tax credit purposes. There are also significant and complex limits on a U.S. Person&#8217;s ability to claim foreign tax credits, and recently issued U.S. Treasury Regulations that apply to foreign income taxes paid or accrued in taxable years beginning on or after December 28, 2021 restrict the availability of foreign tax credits based on the nature of the tax imposed by the foreign jurisdiction. Through subsequently issued guidance, the IRS suspended the application of these rules for periods beginning on or after December 28, 2021, and ending on or before December 31, 2023 (the &#8220;relief period&#8221;), and subsequently further extended such relief until the publication of notice or other guidance suspending the relief period. Thus, it may not be possible for most shareholders to utilize excess foreign tax credits to reduce U.S. tax on such income. The rules relating to the determination of the U.S. foreign tax credit are complex, and U.S. Persons should consult their tax advisors regarding the availability of a foreign tax credit in their particular circumstances and the possibility of claiming an itemized deduction (in lieu of the foreign tax credit) for any foreign taxes paid or accrued.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Information Reporting and Backup Withholding on Distributions and Disposition Proceeds</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information returns may be filed with the IRS in connection with distributions on ordinary shares and the proceeds from a sale or other disposition of ordinary shares unless the holder of such shares establishes an exemption from the information reporting rules. A holder of ordinary shares that does not establish such an exemption may be subject to U.S. backup withholding tax on these payments if the holder is not a corporation or other exempt recipient or fails to provide its taxpayer identification number or otherwise comply with the backup withholding rules. The amount of any backup withholding from a payment to a U.S. Person will be allowed as a credit against the U.S. Person&#8217;s U.S. federal income tax liability and may entitle the U.S. Person to a refund, provided that the required information is furnished to the IRS. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Section 6038D of the Code, certain U.S. Persons who are individuals may be required to report information relating to an interest in the ordinary shares, subject to certain exceptions (including an exception for shares held in accounts maintained by certain financial institutions). U.S. Persons should consult their tax advisors regarding the potential application of this and any other applicable information reporting requirements to their ownership of ordinary shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible Changes in U.S. Tax Law</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Act was passed by the U.S. Congress and signed into law on December 22, 2017, with certain provisions intended to eliminate certain perceived tax advantages of companies (including insurance companies) that have legal domiciles outside the United States, but have certain U.S. connections, and U.S. persons investing in such </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">257</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies. Among other things, the 2017 Act revised the rules applicable to PFICs and CFCs in ways that could affect the timing or amount of U.S. federal income taxes imposed on certain U.S. Persons. Further, it is possible that other legislation that may be introduced and enacted by the current Congress or future Congresses, could have an adverse impact on us or holders of ordinary shares. Any such legislation or interpretations could have a retroactive effect. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the U.S. federal income tax laws and interpretations regarding whether a company is engaged in a trade or business within the United States or is a PFIC, or whether U.S. Persons would be required to include in their gross income the &#8220;subpart F income,&#8221; &#8220;tested income&#8221; or RPII of a CFC, are subject to change, possibly on a retroactive basis. Certain of the regulations regarding the application of the PFIC rules to insurance companies and the regulations regarding RPII are still in proposed form. New regulations or pronouncements interpreting or clarifying such rules may be forthcoming. We cannot be certain if, when or in what form such regulations or pronouncements may be provided and whether such guidance will have a retroactive effect.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Reporting Standard</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The common reporting standard (&#8220;CRS&#8221;) has been introduced as an initiative by the OECD and is imposed on members of the European Union by the European Directive on Administrative Co-operation. Similar to the legislation commonly known as the Foreign Account Tax Compliance Act introduced by the United States, the CRS requires financial institutions which are subject to the rules to report certain financial information in respect of account holders. The CRS became effective as of January 1, 2016 and E.U. member states generally began to exchange the required information pursuant to the CRS from the end of September 2017 onwards. We intend to operate in compliance with CRS. </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3731"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bermuda Taxation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, there is no Bermuda income, corporate or profits tax or withholding tax, capital gains tax or capital transfer tax, estate or inheritance tax payable by holders of our ordinary shares, other than shareholders ordinarily resident in Bermuda, if any. However, on December 15, 2023, the Bermuda House of Assembly passed the CIT Act which was also passed by the Senate on December 18, 2023 and will become fully operative with respect to the imposition of corporate income tax on January 1, 2025. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the CIT Act, Bermuda corporate income tax will be chargeable in respect of fiscal years beginning on or after January 1, 2025 and will apply only to Bermuda entities that are part of Bermuda Constituent Entity Groups. Where corporate income tax is chargeable to a Bermuda Constituent Entity Group, the amount of corporate income tax chargeable for a fiscal year shall be (1) 15% of the net taxable income of the Bermuda Constituent Entity Group less (2) tax credits applicable to the Bermuda Constituent Entity Group under Part 4 of the CIT Act, or as prescribed. The CIT Act introduces certain &#8220;qualified refundable tax credits&#8221; which are set to be developed during 2024 to incentivize </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies to support Bermuda residents through investments in key areas such as education, healthcare, housing and other projects to help develop Bermuda&#8217;s workforce. Bermuda will continue to monitor further developments around the world as other jurisdictions address the OECD&#8217;s standards.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Payroll Tax Act 1995 and the Payroll Tax Rates Act 1995 of Bermuda (together, the &#8220;Payroll Tax Act&#8221;), an employer is required to pay payroll tax on remuneration paid to each employee, up to a maximum of $1 million (no tax liability accrues on sums above $1 million). Liability for payroll tax is calculated by reference to services provided wholly or mainly in Bermuda during four tax periods, being periods of three months commencing on the first day of April, July, October and January. The meaning of &#8220;employee&#8221; under the Payroll Tax Act includes deemed employees and covers a broad range of employment structures. Subject to certain express exclusions, &#8220;remuneration&#8221; is also very broadly defined, to capture any benefit of any kind paid to employees or deemed employees, whether in cash or otherwise. This includes, for example, any gain obtained by the exercise, assignment or release of any option awarded under any option plans. Payroll tax is levied on employers and employees separately, with different marginal rates; however, employers are liable to pay the full amount of payroll tax and are permitted to deduct and remit to the Bermuda Tax Commissioner the amount of the employee&#8217;s liability from their remuneration. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">258</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3739"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">United Kingdom Taxation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following section is intended only as a general guide and does not purport to be a complete analysis of all potential U.K. tax consequences of acquiring, holding and disposing of ordinary shares. It is based on current U.K. tax law and on the current published practice of HMRC (which is not a statement of law and which may not be binding on HMRC), as of the date of this prospectus, both of which are subject to change at any time, possibly with retrospective effect. It is intended to address only certain U.K. tax consequences of the acquisition, holding and disposal of ordinary shares by persons who:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">are not resident in the United Kingdom for U.K. tax purposes (and, in the case of individuals, are not temporarily non-resident) (&#8220;Non-U.K. Holders&#8221;);</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">are the absolute beneficial owners of their ordinary shares (and any dividends paid on them); and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hold their ordinary shares as investments and not in connection with a trade or business carried on to any extent in the United Kingdom. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section does not address the U.K. tax consequences which may be relevant to certain classes of holders of ordinary shares, such as: market makers, intermediaries, traders, brokers or dealers in securities; financial institutions; insurance companies; investment companies; collective investment schemes; charities or tax-exempt organizations; pension schemes; trustees; persons who are connected with the Company or any member of a group of which the Company forms part; persons holding their ordinary shares as part of hedging or conversion transactions; and persons who have (or are deemed to have) acquired their ordinary shares by virtue of an office or employment or who have been officers employees of the Company or a company forming part of a group of which the Company forms part.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section is written on the basis that the Company is not resident in any jurisdiction for tax purposes other than Bermuda and does not (and will not) directly or indirectly derive 75% or more of its value from U.K. real estate. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is intended as a general guide and is not intended to be, nor should it be considered to be, legal or tax advice to any particular prospective subscriber for, or purchaser of, ordinary shares. Accordingly, prospective subscribers for, or purchasers of, ordinary shares should consult their own tax advisors with respect to the U.K. tax consequences of the acquisition, ownership and disposal of ordinary shares in their specific circumstances.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxation of Dividends Paid on Ordinary Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding Tax</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends paid by the Company in respect of ordinary shares will not be subject to any withholding or deduction at source for or on account of U.K. tax.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Tax</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An individual Non-U.K. Holder should not be chargeable to U.K. income tax on dividends received from the Company, unless he or she carries on (whether solely or in partnership) any trade, profession, or vocation in the United Kingdom through a branch or agency in the United Kingdom in connection with which his or her ordinary shares are held. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporation Tax</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A corporate Non-U.K. Holder should not be subject to U.K. corporation tax on dividends received from the Company, unless it carries on a trade in the United Kingdom through a permanent establishment in the United Kingdom to which its ordinary shares are attributable. A corporate Non-U.K. Holder who is carrying on a trade in the United Kingdom through a permanent establishment in the United Kingdom to which its ordinary shares are attributable will be subject to U.K. corporation tax on any dividend received from the Company, unless the dividend qualifies for exemption and certain conditions are met (including anti-avoidance conditions). Whether the dividend </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">259</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">qualifies for exemption will depend on the circumstances of the particular corporate Non-U.K. Holder, although it is generally expected that dividends paid by the Company would normally qualify.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxation of Disposal of Ordinary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Non-U.K. Holder who does not carry on a trade in the United Kingdom through a branch or agency in the United Kingdom (in the case of individual Non-U.K. Holders) or a permanent establishment in the United Kingdom (in the case of corporate Non-U.K. Holders) to which the ordinary shares are attributable should not be liable for U.K. tax on capital gains realized on a sale or other disposal of ordinary shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.K. Stamp Duty and Stamp Duty Reserve Tax (&#8220;SDRT&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section is intended as a general guide to the current position relating to U.K. stamp duty and SDRT and applies to any holders of ordinary shares irrespective of whether they are resident in the United Kingdom for U.K. tax purposes. It is written on the basis that HMRC regards the Depository Trust Company (&#8220;DTC&#8221;) as a clearance service for the purposes of U.K. stamp duty and SDRT and that no applicable election under section 97A(1) Finance Act 1986 has been made. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issuance of Ordinary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No stamp duty or SDRT should be payable on the issuance of ordinary shares by the Company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer of Ordinary Shares within the facilities of DTC</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A transfer of ordinary shares within the facilities of DTC should not attract a charge to U.K. stamp duty or SDRT provided there is no written instrument of transfer. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer of Ordinary Shares outside the facilities of DTC</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If ordinary shares are withdrawn from the facilities of DTC, the U.K. stamp duty and SDRT treatment of a subsequent transfer of such ordinary shares outside the facilities of DTC is discussed below. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company is not incorporated in the United Kingdom, no SDRT should be payable on the transfer of, or an agreement to transfer, ordinary shares provided that the ordinary shares are not registered in a register kept in the United Kingdom by or on behalf of the Company and are not paired with any shares issued by a U.K. incorporated company. It is not intended that such a register will be kept in the United Kingdom or that the ordinary shares will be so paired.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A transfer of ordinary shares should not attract a charge to U.K. stamp duty provided the relevant instrument of transfer is executed and retained outside the United Kingdom and does not relate to any property situated in the United Kingdom or to any matter or thing done or to be done in the United Kingdom. If the relevant instrument of transfer is executed in the United Kingdom or relates to any property situated, or to any matter or thing done or to be done, in the United Kingdom, then U.K. stamp duty will technically be payable at the rate of 0.5% of the consideration for the transfer (rounded up to the nearest &#163;5). However, an exemption may be available if the amount or value of the consideration for such transfer is &#163;1,000 or less. Further, even where an instrument of transfer is technically subject to U.K. stamp duty, such stamp duty may not need to be paid in practice unless it is necessary to rely on the instrument of transfer for legal purposes (for example, to register a change of ownership or in litigation in a U.K. court) and provided that the ordinary shares are not registered in a register kept in the United Kingdom. As a practical matter, therefore, a purchaser of ordinary shares may generally not have to pay U.K. stamp duty on a mandatory basis.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">260</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_189"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDERWRITING (CONFLICTS OF INTEREST) </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the selling shareholders and the underwriters named below have entered into an underwriting agreement with respect to the ordinary shares being offered. Subject to certain conditions, each underwriter has severally agreed to purchase the number of ordinary shares indicated in the following table. Goldman Sachs &amp; Co. LLC, Citigroup Global Markets Inc. and Jefferies LLC are the representatives of the underwriters.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Underwriters</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Ordinary Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goldman Sachs &amp; Co. LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citigroup Global Markets Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jefferies LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apollo Global Securities, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters are committed to take and pay for all of the ordinary shares being offered, if any are taken, other than the ordinary shares covered by the option described below unless and until this option is exercised.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters have an option to purchase up to an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares from us and up to an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ordinary shares from the selling shareholders to cover sales by the underwriters of a greater number of ordinary shares than the total number set forth in the table above. They may exercise that option for 30 days from the date of this prospectus. If any ordinary shares are purchased pursuant to this option to purchase additional ordinary shares, the underwriters will severally purchase ordinary shares in approximately the same proportion as set forth in the table above.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the per ordinary share and total underwriting discount to be paid to the underwriters by us and the selling shareholders. Such amounts are shown assuming both no exercise and full exercise of the underwriters&#8217; option to purchase additional ordinary shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid by Us</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No Exercise</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Full Exercise</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per Ordinary Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid by the Selling Shareholders</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No Exercise</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Full Exercise</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per Ordinary Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ordinary shares sold by the underwriters to the public will initially be offered at the initial public offering price set forth on the cover of this prospectus. Any ordinary shares sold by the underwriters to securities dealers may be sold at a discount of up to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per ordinary share from the initial public offering price. After the initial offering of the ordinary shares, the representatives of the underwriters may change the offering price and the other selling terms. Sales of ordinary shares made outside of the United States may be made by affiliates of the underwriters. The offering of our ordinary shares by the underwriters is subject to receipt and acceptance and subject to the underwriters&#8217; right to reject any order in whole or in part.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">261</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our officers, directors and certain holders of our ordinary shares, including the selling shareholders, will agree with the underwriters, subject to certain exceptions, not to dispose of or hedge any of our ordinary shares or securities convertible into or exchangeable for our ordinary shares during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus, except with the prior written consent of  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. This agreement does not apply to any existing employee benefit plans. See the section titled &#8220;Shares Eligible for Future Sale&#8221; for a discussion of certain transfer restrictions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to this offering, there has been no public market for our ordinary shares. The initial public offering price has been negotiated among us, the selling shareholders and the representatives of the underwriters. Among the factors to be considered in determining the initial public offering price of our ordinary shares, in addition to prevailing market conditions, will be our historical performance, estimates of our business potential and earnings prospects, an assessment of our management and the consideration of the above factors in relation to market valuation of companies in related businesses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The address of Goldman Sachs &amp; Co. LLC is 200 West Street, New York, NY 10282. The address of Citigroup Global Markets Inc. is 388 Greenwich Street, New York, NY 10013. The address of Jefferies LLC is 520 Madison Avenue, New York, NY 10022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to apply to list our ordinary shares on the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; under the symbol &#8220;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, the underwriters may purchase and sell our ordinary shares in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of ordinary shares than they are required to purchase in this offering, and a short position represents the amount of such sales that have not been covered by subsequent purchases. A &#8220;covered short position&#8221; is a short position that is not greater than the amount of additional ordinary shares for which the underwriters&#8217; option described above may be exercised. The underwriters may cover any covered short position by either exercising their option to purchase additional ordinary shares or purchasing ordinary shares in the open market. In determining the source of ordinary shares to cover the covered short position, the underwriters will consider, among other things, the price of ordinary shares available for purchase in the open market as compared to the price at which they may purchase additional ordinary shares pursuant to the option described above. &#8220;Naked&#8221; short sales are any short sales that create a short position greater than the amount of additional ordinary shares for which the option described above may be exercised. The underwriters must cover any such naked short position by purchasing ordinary shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of our ordinary shares in the open market after pricing that could adversely affect investors who purchase in this offering. Stabilizing transactions consist of various bids for or purchases of our ordinary shares made by the underwriters in the open market prior to the completion of this offering. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased ordinary shares sold by or for the account of such underwriter in stabilizing or short covering transactions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases to cover a short position and stabilizing transactions, as well as other purchases by the underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of our ordinary shares, and together with the imposition of the penalty bid, may stabilize, maintain or otherwise affect the market price of our ordinary shares. As a result, the price of our ordinary shares may be higher than the price that otherwise might exist in the open market. The underwriters are not required to engage in these activities and may end any of these activities at any time. These transactions may be effected on the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, in the over-the-counter market or otherwise. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that our share of the total expenses of the offering, excluding the underwriting discount, will be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. We have agreed to reimburse the underwriters for certain of their expenses for an amount up to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and the selling shareholders have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">262</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include sales and trading, commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and non-financial activities and services. Certain of the underwriters and their respective affiliates have provided, and may in the future provide, a variety of these services to us and to persons and entities with relationships with us, for which they received or will receive customary fees and expenses. In particular, an affiliate of Citigroup Global Markets Inc. is a lender under our committed letter of credit facility and uncommitted letter of credit facility. Additionally, affiliates of Goldman Sachs &amp; Co. LLC and Citigroup Global Markets Inc. are lenders under our Term Loan Credit Agreement, and an affiliate of Citigroup Global Markets Inc. is also administrative agent under such agreement. In addition, affiliates of Apollo Global Securities, LLC, an underwriter, also received certain fees relating to management consulting and advisory services provided under the IMAs and Management Consulting Agreement. See &#8220;Material Contracts and Related Party Transactions&#8212;Relationships and Related Party Transactions with Apollo or its Affiliates.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of their various business activities, the underwriters and their respective affiliates, officers, directors and employees may purchase, sell or hold a broad array of investments and actively traded securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments for their own account and for the accounts of their customers, and such investment and trading activities may involve or relate to assets, securities and/or instruments of ours (directly, as collateral securing other obligations or otherwise) and/or persons and entities with relationships with us. The underwriters and their respective affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such assets, securities or instruments and may at any time hold, or recommend to clients that they should acquire, long and/or short positions in such assets, securities and instruments.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conflict of Interest </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo Global Securities, LLC, an affiliate of Apollo, is an underwriter in this offering. Affiliates of Apollo beneficially own in excess of 10% of our issued and outstanding ordinary shares. As a result, Apollo Global Securities, LLC is deemed to have a &#8220;conflict of interest&#8221; under FINRA Rule 5121. Accordingly, this offering will be conducted in compliance with the requirements of Rule 5121. Pursuant to that rule, the appointment of a &#8220;qualified independent underwriter&#8221; is not required in connection with this offering as the members primarily responsible for managing the public offering do not have a conflict of interest, are not affiliates of any member that has a conflict of interest and meet the requirements of paragraph (f)(12)(E) of Rule 5121. Apollo Global Securities, LLC will not confirm sales of the securities to any account over which it exercises discretionary authority without the specific written approval of the account holder.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3790"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling Restrictions</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">European Economic Area</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to each Member State of the European Economic Area (each, a &#8220;Relevant State&#8221;), no ordinary shares have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the ordinary shares which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that the ordinary shares may be offered to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to any legal entity which is a qualified investor as defined under the Prospectus Regulation;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer; or </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">263</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that no such offer of the ordinary shares shall require us or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation and each person who initially acquires any ordinary shares or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with each of the underwriters and the Company that it is a &#8220;qualified investor&#8221; within the meaning of Article 2(e) of the Prospectus Regulation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the ordinary shares in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any ordinary shares to be offered so as to enable an investor to decide to purchase or subscribe for any  ordinary shares, and the term &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017/1129.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United Kingdom </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All applicable provisions of the FSMA must be complied with in respect to anything done by any person in relation to the ordinary shares in, from or otherwise involving the United Kingdom.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to the United Kingdom, no ordinary shares have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior to the publication of a prospectus in relation to the ordinary shares which has been approved by the Financial Conduct Authority in accordance with the UK Prospectus Regulation, except that the ordinary shares may be offered to the public in the United Kingdom at any time under the following exemptions under the UK Prospectus Regulation:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to any legal entity which is a qualified investor as defined under the UK Prospectus Regulation;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under the UK Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer; or</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in any other circumstances falling within Article 1(4) of the UK Prospectus Regulation,</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that no such offer of the ordinary shares shall require us or any underwriter to publish a prospectus pursuant to Article 3 of the UK Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United Kingdom, the offering is only addressed to, and is directed only at, &#8220;qualified investors&#8221; within the meaning of Article 2(e) of the UK Prospectus Regulation, who are also (i) persons having professional experience in matters relating to investments who fall within the definition of &#8220;investment professionals&#8221; in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the &#8220;Order&#8221;); (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order; or (iii) persons to whom it may otherwise lawfully be communicated (all such persons being referred to as &#8220;relevant persons&#8221;). This prospectus must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this prospectus relates is available only to relevant persons and will be engaged in only with relevant persons.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the ordinary shares in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offer and any ordinary shares to be offered so as to enable an investor to decide to purchase or subscribe for any ordinary shares, and the expression &#8220;UK Prospectus Regulation&#8221; means the UK version of Regulation (EU) No 2017/1129 as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Canada</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ordinary shares may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions, and Ongoing Registrant Obligations. Any resale of the ordinary </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares must be made in accordance with an exemption form, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory of these rights or consult with a legal advisor.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hong Kong</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ordinary shares have not and will not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32, Laws of Hong Kong), or (ii) to &#8220;professional investors&#8221; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) (the &#8220;SFO&#8221;) and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a &#8220;prospectus&#8221; within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32, Laws of Hong Kong); and no advertisement, invitation or document relating to the ordinary shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to ordinary shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; within the meaning of the SFO and any rules made thereunder.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Japan </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No registration pursuant to Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948, as amended) (the &#8220;FIEL&#8221;) has been made or will be made with respect to the solicitation of the application for the acquisition of the ordinary shares. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, the ordinary shares have not been, directly or indirectly, offered or sold and will not be, directly or indirectly, offered or sold in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan) or to others for re-offering or re-sale, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan except pursuant to an exemption from the registration requirements, and otherwise in compliance with, the FIEL and the other applicable laws and regulations of Japan. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">For Qualified Institutional Investors (&#8220;QII&#8221;)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that the solicitation for newly issued or secondary securities (each as described in Paragraph 2, Article 4 of the FIEL) in relation to the ordinary shares constitutes either a &#8220;QII only private placement&#8221; or a &#8220;QII only secondary distribution&#8221; (each as described in Paragraph 1, Article 23-13 of the FIEL). Disclosure regarding any such solicitation, as is otherwise prescribed in Paragraph 1, Article 4 of the FIEL, has not been made in relation to the ordinary shares. The ordinary shares may only be transferred to QIIs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">For Non-QII Investors</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that the solicitation for newly issued or secondary securities (each as described in Paragraph 2, Article 4 of the FIEL) in relation to the ordinary shares constitutes either a &#8220;small number private placement&#8221; or a &#8220;small number private secondary distribution&#8221; (each as is described in Paragraph 4, Article 23-13 of the FIEL). Disclosure regarding any such solicitation, as is otherwise prescribed in Paragraph 1, Article 4 of the FIEL, has not </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">265</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">been made in relation to the ordinary shares. The ordinary shares may only be transferred en bloc without subdivision to a single investor. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Singapore </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the ordinary shares may not be circulated or distributed, nor may the ordinary shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the &#8220;SFA&#8221;), (ii) to a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275, of the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where the ordinary shares are subscribed or purchased under Section 275 of the SFA by a relevant person which is (i) a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or (ii) a trust (where the trustee is not an accredited investor) the sole purpose of which is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, securities (as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the ordinary shares pursuant to an offer made under Section 275 of the SFA except: (i) to an institutional investor or to a relevant person defined in Section 275(2) of the SFA, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(c)(ii) of the SFA; (ii) where no consideration is or will be given for the transfer; (iii) where the transfer is by operation of law; (iv) as specified in Section 276(7) of the SFA; or (v) as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations 2018. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solely for the purposes of our obligations pursuant to Section 309B of the SFA, we have determined, and hereby notify all relevant persons (as defined in the CMP Regulations 2018), that the shares are &#8220;prescribed capital markets products&#8221; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_3800"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPENSES OF THE OFFERING </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is an itemization of the total expenses, excluding the underwriting discount, which are expected to be incurred in connection with the sale of ordinary shares in this offering. With the exception of the registration fee payable to the SEC, the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;listing fee and the FINRA filing fee, all amounts are estimates. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC registration fee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Listing fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FINRA filing fee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer agent&#8217;s fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal fees and expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting fees and expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director and officer insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous fees and expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.5pt">To be filed by amendment.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_195"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL MATTERS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The validity of our ordinary shares and certain other matters of Bermuda law will be passed upon for us by Walkers (Bermuda) Limited. Certain legal matters relating to this offering will be passed upon for us by Sidley Austin LLP. Certain legal matters relating to this offering will be passed upon for the underwriters by Latham &amp; Watkins LLP.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_201"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPERTS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and related financial statement schedules I to V of the Company as of December 31, 2021 and for each of the years in the two-year period ended December 31, 2021, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. The registered business address of KPMG LLP is 15 Canada Square, London E14 5GL.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and related financial statement schedules I to V of the Company, at and for the year ended December 31, 2022, appearing in this prospectus and registration statement, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein. Such consolidated financial statements and related audit report are included herein in reliance upon such report given on the authority of such firm as experts in accounting and auditing. The registered business address of Ernst &amp; Young LLP is 1 More London Place, London SE1 2AF.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_207"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE PROSPECTIVE INVESTORS CAN FIND ADDITIONAL INFORMATION</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed with the SEC a registration statement on Form F-1, including exhibits, schedules and amendments thereto, of which this prospectus is a part, under the Securities Act with respect to our ordinary shares covered by this prospectus. This prospectus does not contain all of the information set forth in the registration statement and exhibits and schedules to the registration statement. For further information with respect to the Company and our ordinary shares covered by this prospectus, reference is made to the registration statement, including the exhibits and schedules thereto. Statements contained in this prospectus as to the contents of any contract or other document referred to in this prospectus are not necessarily complete and, where that contract or other document has been filed as an exhibit to the registration statement, each statement in this prospectus is qualified in all respects by the exhibit to which the reference relates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Exchange Act. Accordingly, we are required to file reports and other information with the SEC, including annual reports on Form 20-F and reports on Form 6-K. The SEC maintains an internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that website is http://www.sec.gov.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a website at https://www.aspen.co/. We will make the information filed with or furnished to the SEC available free of charge through our website as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information contained on, or accessible through our website is not incorporated by reference into and does not constitute a part of this prospectus or any other report or documents we file with or furnish to the SEC.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">268</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_973"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AUDITED ACCOUNTS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_8723">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (ERNST &amp; YOUNG LLP)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_8723">F-2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_8735">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (KPMG LLP)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_8735">F-4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_441">CONSOLIDATED BALANCE SHEETS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_441">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_441">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_469">CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_469">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_469">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_485">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_485">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_485">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_511">CONSOLIDATED STATEMENTS OF CASH FLOWS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_511">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_511">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_526">NOTES TO THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_526">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_526">10</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UNAUDITED ACCOUNTS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7465">CONDENSED CONSOLIDATED BALANCE SHEETS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7465">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7465">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7493">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS A</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7493">N</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7493">D OTHER COMPREHENSIVE INCOME</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7493"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7493">(LOSS)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7493">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7493">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7509">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7509">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7509">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7537">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7537">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7537">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7552">NOTES TO THE </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7552">CONSOLIDATED FINANCIAL STATEMENTS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7552">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_7552">91</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7400"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8723"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the Shareholders and the Board of Directors of Aspen Insurance Holdings Limited   </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheet of Aspen Insurance Holdings Limited (the Company) as of December 31, 2022, the related consolidated statements of operations and other comprehensive income (loss), changes in shareholders&#8217; equity and cash flows for the year ended December 31, 2022, and the related notes and financial statement schedules I to V (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and the results of its operations and its cash flows for the year ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management.  Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation of incurred but not reported reserve estimates, gross and net of reinsurance</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2022, the Company&#8217;s reserves for losses and loss adjustment expenses, net of reinsurance, was $2,813 million, of which a significant proportion is incurred but not reported reserves (&#8216;IBNR&#8217;). As described in Notes 2(b) and 10 of the consolidated financial statements, losses and loss adjustment expenses represents management&#8217;s estimate of the ultimate costs of all reported and unreported losses incurred through the balance sheet date.  There is significant uncertainty inherent in estimating the IBNR, gross and net of reinsurance. In particular, management&#8217;s estimate is sensitive to the actuarial methods selected and the significant assumptions applied, including the impact of catastrophe events and other large losses, reinsurance assumptions incorporated into net loss ratios, expected trends in claims severity and frequency, and expected duration of the respective claim&#8217;s development period.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auditing management&#8217;s estimate for IBNR reserve estimates, gross and net of reinsurance, was complex and required the involvement of our actuarial specialists, due to the sensitivity of the estimate to the actuarial methods selected and the judgmental nature of the significant assumptions used in the valuation of the estimate, including the netting of IBNR for reinsurance. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To assess the actuarial methodologies applied, with the assistance of our actuarial specialists, we compared management&#8217;s methods to those used in the industry for similar lines of business. To evaluate the significant assumptions used in the Company&#8217;s estimates, with the assistance of our actuarial specialists, our procedures included, among others, comparing the significant assumptions, such as incurred to ultimate loss ratios, and industry loss levels specifically for the catastrophe events and other large losses, expected trends in claims severity and frequency and expected duration of the respective claim&#8217;s development period, as well as reinsurance assumptions, to current industry benchmarks. Our procedures also included using the Company&#8217;s historical data to develop our own independent projections and a range of reasonable reserve estimates for selected classes of business. We compared our independent projections and range of reasonable reserve estimates to the Company&#8217;s recorded losses and loss adjustment expense reserves, both gross and net of reinsurance. </span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Valuation of privately&#8211;held investments</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2022, the fair value of the Company&#8217;s privately-held investments totaled $533 million. The fair values are based on internally developed discounted cash flow models as discussed in Note 6 to the consolidated financial statements. The discount and dividend or interest rates used by management in the cash flow models are significant unobservable inputs, which create greater subjectivity when determining the fair value of these investments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auditing the fair value of the privately-held investments was challenging due to the judgmental nature of the inputs and assumptions used, including discount, dividend, interest rates and timing of cash flows, as these were not directly observable in the market.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To test the fair value estimates, among other procedures, we involved our valuation specialists to independently determine a range of fair values for a sample of securities, which we compared to management&#8217;s estimates of fair value for the selected securities. In developing our independent estimates, we, together with our valuation specialists, compared management&#8217;s assumptions such as discount, dividend and interest rates, as well as timing of cashflows, to comparable publicly available market information, comparable instruments and other valuation techniques, if available. We also compared the fair value of the privately-held investments to independent third-party vendor pricing, where available.  </span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">London, United Kingdom </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;20, 2023</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8735"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Shareholders of Aspen Insurance Holdings Limited  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheet of Aspen Insurance Holdings Limited and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021, the related consolidated statements of operations and other comprehensive income, changes in shareholders&#8217; equity, and cash flows for each of the years in the two&#8209;year period ended December 31, 2021, and the related notes and financial statement schedules I to V (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for each of the years in the two&#8209;year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ KPMG  LLP</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We served as the Company&#8217;s auditor from 2002 to 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">London, United Kingdom </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">May 16, 2022</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_441"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As at December&#160;31, 2022 and December&#160;31, 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions, except share and per share amounts)</span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed income maturities, available for sale (amortized cost &#8212; 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-31">4,131.3</ix:nonFraction> and 2021: $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-32">4,823.5</ix:nonFraction> net of allowance for expected credit losses 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="f-33">7.7</ix:nonFraction> and 2021: $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="f-34">2.7</ix:nonFraction>)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-35">3,788.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-36">4,881.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed income maturities, trading at fair value (amortized cost &#8212;  2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-37">1,576.7</ix:nonFraction> and 2021:  $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-38">1,155.5</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:TradingSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-39">1,475.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:TradingSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-40">1,157.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, available for sale (amortized cost  &#8212;  2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:Shortterminvestmentsavailableforsaleamortizedcost" scale="6" id="f-41">52.4</ix:nonFraction> and 2021: $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:Shortterminvestmentsavailableforsaleamortizedcost" scale="6" id="f-42">10.1</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ShortTermInvestmentsAvailableForSale" scale="6" id="f-43">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="ahl:ShortTermInvestmentsAvailableForSale" scale="6" id="f-44">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, trading at fair value (amortized cost  &#8212;  2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ShortTermInvestmentsTradingAmortizedCost" scale="6" id="f-45">6.3</ix:nonFraction> and 2021: $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:ShortTermInvestmentsTradingAmortizedCost" scale="6" id="f-46">2.0</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ShortTermInvestmentsTradingAtFairValue" scale="6" id="f-47">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="ahl:ShortTermInvestmentsTradingAtFairValue" scale="6" id="f-48">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Catastrophe bonds, trading at fair value (amortized cost &#8212;  2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-49">5.1</ix:nonFraction> and 2021: $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-50">5.3</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CatastropheBond" scale="6" id="f-51">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:CatastropheBond" scale="6" id="f-52">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Privately-held investments, trading at fair value (amortized cost &#8212; 2022:  $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:Privatelyheldinvestmentsamortizedcosttradingatfairvalue" scale="6" id="f-53">537.7</ix:nonFraction> and 2021: $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:Privatelyheldinvestmentsamortizedcosttradingatfairvalue" scale="6" id="f-54">309.2</ix:nonFraction>) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:PrivatelyheldInvestments" scale="6" id="f-55">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:PrivatelyheldInvestments" scale="6" id="f-56">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments, equity method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-57">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-58">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments, at fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OtherInvestments" scale="6" id="f-59">221.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OtherInvestments" scale="6" id="f-60">151.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:InvestmentsExcludingDerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="f-61">6,085.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:InvestmentsExcludingDerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="f-62">6,516.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents (including cash within consolidated variable interest entities of &#8212;  2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" scale="6" id="f-63">65.7</ix:nonFraction> and 2021: $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" scale="6" id="f-64">75.2</ix:nonFraction>) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-65">959.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-66">1,314.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unpaid losses recoverable from reinsurers (net of allowance for expected credit losses of  2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="f-67">3.7</ix:nonFraction> &#8212; 2021: $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="f-68">3.3</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="f-69">4,897.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="f-70">3,298.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ceded unearned premiums</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PrepaidReinsurancePremiums" scale="6" id="f-71">737.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:PrepaidReinsurancePremiums" scale="6" id="f-72">596.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Underwriting premiums receivables (net of allowance for expected credit losses of  2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="f-73">25.0</ix:nonFraction> &#8212; 2021: $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="f-74">30.2</ix:nonFraction>) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-75">1,482.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-76">1,304.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OtherReceivables" scale="6" id="f-77">179.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OtherReceivables" scale="6" id="f-78">153.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Funds withheld</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:FundsHeldUnderReinsuranceAgreementsAsset" scale="6" id="f-79">102.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:FundsHeldUnderReinsuranceAgreementsAsset" scale="6" id="f-80">103.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="f-81">319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="f-82">290.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives at fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-83">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-84">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivables for securities sold</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReceivablesFromBrokersDealersAndClearingOrganizations" scale="6" id="f-85">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReceivablesFromBrokersDealersAndClearingOrganizations" scale="6" id="f-86">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Office properties and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-87">81.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-88">114.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-89">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-90">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes refundable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:IncomeTaxReceivable" scale="6" id="f-91">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:IncomeTaxReceivable" scale="6" id="f-92">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-93">120.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:fixed-zero" scale="6" id="f-94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OtherAssets" scale="6" id="f-95">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OtherAssets" scale="6" id="f-96">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets and goodwill</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-97">21.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-98">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-99">15,157.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-100">13,844.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-101">7,710.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-102">7,611.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:UnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="f-103">2,457.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:UnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="f-104">2,112.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total insurance reserves</span></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:InsuranceReserves" format="ixt:num-dot-decimal" scale="6" id="f-105">10,168.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:InsuranceReserves" format="ixt:num-dot-decimal" scale="6" id="f-106">9,724.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reinsurance premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsurancePayable" format="ixt:num-dot-decimal" scale="6" id="f-107">1,980.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsurancePayable" scale="6" id="f-108">575.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes payable </span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-109">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-110">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-111">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-112">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses and other payables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="f-113">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="f-114">289.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payables for securities purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="6" id="f-115">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="6" id="f-116">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-117">95.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-118">115.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities under derivative contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-119">34.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-120">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt </span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-121">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="f-122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="f-123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-124">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-125">12,799.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-126">11,069.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingent liabilities (see Note&#160;20)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="6" id="f-127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="6" id="f-128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SHAREHOLDERS&#8217; EQUITY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-129">60,395,839</ix:nonFraction> ordinary shares of par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-130">0.01</ix:nonFraction> each (December&#160;31, 2021 &#8212; <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-131">60,395,839</ix:nonFraction> shares) </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-132">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-133">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-134">1,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-135">1,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-136">1,349.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-137">1,382.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss)</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-138">506.3</ix:nonFraction>)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-139">123.0</ix:nonFraction>)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-140">2,358.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-141">2,774.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-142">15,157.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-143">13,844.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Privately-held investments includes related party investments totaling $<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-144">44.8</ix:nonFraction>&#160;million. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments includes related party investments of $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-145">25.3</ix:nonFraction>&#160;million in Apollo Real Estate Fund and $<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-146">12.7</ix:nonFraction>&#160;million in Apollo Origination Partnership.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Cash and cash equivalents includes restricted cash of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-147">232.1</ix:nonFraction>&#160;million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-148">364.9</ix:nonFraction>&#160;million) which are held in trusts. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes amounts due to related parties of $<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-149">4.5</ix:nonFraction>&#160;million for investment management fees (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-150">3.2</ix:nonFraction>&#160;million), and $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-151">1.3</ix:nonFraction>&#160;million for management consulting fees (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:fixed-zero" scale="0" id="f-152">Nil</ix:nonFraction>).</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_469"></div><hr style="page-break-after:always"/><div style="min-height:126pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For The Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions, except share and per share amounts)</span></div></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premium </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-153">2,688.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-154">2,410.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-155">2,527.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-156">188.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-157">147.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-158">154.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-159">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-160">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-161">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="f-162">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="f-163">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="f-164">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-165">2,890.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-166">2,628.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-167">2,830.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-168">1,680.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-169">1,693.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-170">1,840.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-171">431.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-172">414.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-173">465.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-174">494.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-175">418.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-176">410.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-177">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-178">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-179">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-180">80.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-181">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-182">65.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-183">182.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-184">47.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-185">27.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange (gains)/losses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-186">15.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-187">40.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-188">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-189">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-190">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-191">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:Expense" format="ixt:num-dot-decimal" scale="6" id="f-192">2,917.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:Expense" format="ixt:num-dot-decimal" scale="6" id="f-193">2,593.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:Expense" format="ixt:num-dot-decimal" scale="6" id="f-194">2,868.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss)/income from operations before income taxes </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-195">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-196">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-197">38.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit/(expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-198">78.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-199">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-200">18.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss) </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-201">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-202">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-203">56.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income/(loss) attributable to Aspen Insurance Holdings Limited&#8217;s ordinary shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-204">51.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-205">29.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-206">56.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Comprehensive (Loss)/Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification adjustment for net realized gains/(losses) on investments included in net income/(loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-207">55.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-208">20.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-209">67.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in net unrealized (losses)/gains on available for sale securities held</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="f-210">447.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="f-211">137.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="f-212">175.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change from current period hedged transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-213">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-214">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-215">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in foreign currency translation adjustment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="f-216">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="f-217">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="f-218">11.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss)/income, before income taxes </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-219">407.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-220">142.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-221">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit/(expense) thereon:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in net unrealized gains on available for sale securities held </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="f-222">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="f-223">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="f-224">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total income tax benefit/(expense) allocated to other comprehensive (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-225">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-226">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-227">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss)/income, net of income taxes </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-228">383.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-229">142.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-230">96.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive (loss)/income attributable to Aspen Insurance Holdings Limited&#8217;s ordinary shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-231">332.2</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-232">112.9</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-233">40.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Net investment income includes related party investment income of $<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-234">3.1</ix:nonFraction>&#160;million and related party investment management fees of $<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-235">4.9</ix:nonFraction>&#160;million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-236">5.8</ix:nonFraction>&#160;million, 2020 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-237">5.3</ix:nonFraction> million). </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">General, administrative and corporate expenses includes related party management consulting fees of $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-238">5.0</ix:nonFraction>&#160;million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-239">5.0</ix:nonFraction>&#160;million; 2020 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-240">5.0</ix:nonFraction>&#160;million).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Realized and unrealized investments losses includes $<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-241">0.4</ix:nonFraction>&#160;million loss on related party investments.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_485"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For The Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions)</span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-242">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-243">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-244">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-245">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-246">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-247">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-248">1,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-249">1,469.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-250">1,201.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:AdjustmentToAdditionalPaidInCapitalCapitalContribution" format="ixt:fixed-zero" scale="6" id="f-251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:AdjustmentToAdditionalPaidInCapitalCapitalContribution" scale="6" id="f-252">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:AdjustmentToAdditionalPaidInCapitalCapitalContribution" scale="6" id="f-253">268.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-254">1,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-255">1,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-256">1,469.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-257">1,382.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-258">1,397.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-259">1,502.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss) for the year </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-260">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-261">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-262">56.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-263">40.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:Dividends" format="ixt:fixed-zero" scale="6" id="f-264">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:Dividends" format="ixt:fixed-zero" scale="6" id="f-265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preference shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-266">44.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-267">44.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-268">44.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening credit losses (&#8220;CECL&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-271">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-272">1,349.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-273">1,382.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-274">1,397.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-275">156.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-276">177.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-277">165.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change for the year, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-278">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-279">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-280">11.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-281">186.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-282">156.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-283">177.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-284">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-285">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-286">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-287">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-288">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-289">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-290">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-291">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-292">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized appreciation on available for sale investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-293">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-294">192.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-295">84.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change for the year, net of income taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-296">367.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-297">157.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-298">108.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-299">333.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-300">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-301">192.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive (loss)/income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-302">506.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-303">123.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-304">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-305">2,358.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-306">2,774.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-307">2,887.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Additional paid-in capital includes $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:AggregateLiquidationPreferences" format="ixt:num-dot-decimal" scale="6" id="f-308">775.0</ix:nonFraction> million less issue costs of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-309">21.5</ix:nonFraction> million of share premium in relation to preference shares (December&#160;31, 2021 and 2020&#160;&#8212;&#160;$<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:AggregateLiquidationPreferences" format="ixt:num-dot-decimal" scale="6" id="f-310">775.0</ix:nonFraction> million&#160;less issue costs of $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-311">21.5</ix:nonFraction> million) </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In 2020, the $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-312">4.3</ix:nonFraction> million relates to the cumulative effect-adjustment to opening retained earnings as a result of the recognition of current expected credit losses (&#8216;CECL&#8217;) in the Company&#8217;s available-for-sale investment portfolio and reinsurance recoverables following the adoption of ASU 2016-13.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_511"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For The Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions) </span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows (used in)/from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss) </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-313">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-314">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-315">56.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income/(loss) to net cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="f-316">43.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="f-317">53.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="f-318">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-319">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-320">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-321">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-322">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-323">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-324">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:Interestonoperatingleaseliabilities" scale="6" id="f-325">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="ahl:Interestonoperatingleaseliabilities" scale="6" id="f-326">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="ahl:Interestonoperatingleaseliabilities" scale="6" id="f-327">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-328">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-329">56.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-330">98.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-331">182.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-332">47.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-333">27.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-334">104.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-335">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-336">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized investment foreign exchange (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:GainsLossesOnInvestmentAndForeignExchange" scale="6" id="f-337">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="ahl:GainsLossesOnInvestmentAndForeignExchange" scale="6" id="f-338">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:GainsLossesOnInvestmentAndForeignExchange" scale="6" id="f-339">25.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfDerivatives" scale="6" id="f-340">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:GainLossOnSaleOfDerivatives" scale="6" id="f-341">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfDerivatives" scale="6" id="f-342">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (gain) on real estate funds in net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" scale="6" id="f-343">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" scale="6" id="f-344">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="f-345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" scale="6" id="f-346">99.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" scale="6" id="f-347">483.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" scale="6" id="f-348">146.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncreaseDecreaseInUnearnedPremiums" scale="6" id="f-349">345.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInUnearnedPremiums" scale="6" id="f-350">310.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInUnearnedPremiums" scale="6" id="f-351">68.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:UnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="f-352">1,599.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:UnpaidLosses" scale="6" id="f-353">109.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:UnpaidLosses" scale="6" id="f-354">864.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidReinsurancePremiums" scale="6" id="f-355">141.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidReinsurancePremiums" scale="6" id="f-356">143.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidReinsurancePremiums" scale="6" id="f-357">9.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="f-358">26.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="f-359">19.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="f-360">17.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts" scale="6" id="f-361">28.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts" scale="6" id="f-362">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts" scale="6" id="f-363">13.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance premiums payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncreaseDecreaseInReinsurancePayables" format="ixt:num-dot-decimal" scale="6" id="f-364">1,404.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInReinsurancePayables" scale="6" id="f-365">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInReinsurancePayables" scale="6" id="f-366">129.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funds withheld</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" scale="6" id="f-367">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" scale="6" id="f-368">5.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" scale="6" id="f-369">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="f-370">177.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="f-371">142.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="f-372">79.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-373">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-374">7.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-375">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-376">87.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-377">73.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-378">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives and settlement of liabilities under derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" scale="6" id="f-379">21.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="ahl:FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" scale="6" id="f-380">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" scale="6" id="f-381">87.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and loan notes issued by variable interest entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:IncreaseDecreaseInLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:IncreaseDecreaseInLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:IncreaseDecreaseInLongTermDebt" scale="6" id="f-384">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-385">15.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-386">17.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-387">17.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-388">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-389">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-390">6.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash (used in)/from operating activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-391">55.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-392">524.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-393">672.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For The Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions) </span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows (used in)/from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of fixed income securities &#8212; Available for sale</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-394">1,613.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-395">2,217.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-396">1,632.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of fixed income securities &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" scale="6" id="f-397">724.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" scale="6" id="f-398">866.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" scale="6" id="f-399">281.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of fixed income securities &#8212; Available for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-400">2,212.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-401">1,538.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-402">2,415.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of fixed income securities &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-403">293.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-404">548.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-405">554.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds from catastrophe bonds &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:PurchasesOfProceedsFromCatastropheBonds" scale="6" id="f-406">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="ahl:PurchasesOfProceedsFromCatastropheBonds" scale="6" id="f-407">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="ahl:PurchasesOfProceedsFromCatastropheBonds" scale="6" id="f-408">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of short-term investments &#8212; Available for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PaymentsforAvailableforsaleSecuritiesShortterm" scale="6" id="f-409">55.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:PaymentsforAvailableforsaleSecuritiesShortterm" scale="6" id="f-410">17.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:PaymentsforAvailableforsaleSecuritiesShortterm" scale="6" id="f-411">216.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments &#8212; Available for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:ProceedsfromAvailableforsaleSecuritiesShortterm" scale="6" id="f-412">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:ProceedsfromAvailableforsaleSecuritiesShortterm" scale="6" id="f-413">99.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:ProceedsfromAvailableforsaleSecuritiesShortterm" scale="6" id="f-414">246.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of short-term investments &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="6" id="f-415">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="6" id="f-416">26.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="6" id="f-417">58.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="6" id="f-418">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="6" id="f-419">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="6" id="f-420">103.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of privately-held investments &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PaymentstoAcquirePrivatelyheldInvestments" scale="6" id="f-421">377.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:PaymentstoAcquirePrivatelyheldInvestments" scale="6" id="f-422">205.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:PaymentstoAcquirePrivatelyheldInvestments" scale="6" id="f-423">92.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of privately-held investments &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:ProceedsfromSaleofPrivatelyheldInvestments" scale="6" id="f-424">147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:ProceedsfromSaleofPrivatelyheldInvestments" scale="6" id="f-425">182.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:ProceedsfromSaleofPrivatelyheldInvestments" scale="6" id="f-426">64.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in (payable)/receivable for securities (purchased)/sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" scale="6" id="f-427">31.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" scale="6" id="f-428">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" scale="6" id="f-429">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of other investments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-430">62.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-431">20.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="f-432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds from sales of other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:PaymentsforProceedsfromInvestingActivitiesNetofCash" scale="6" id="f-433">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:PaymentsforProceedsfromInvestingActivitiesNetofCash" format="ixt:fixed-zero" scale="6" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="ahl:PaymentsforProceedsfromInvestingActivitiesNetofCash" scale="6" id="f-435">71.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales/(purchases) of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="6" id="f-436">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="6" id="f-437">64.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="6" id="f-438">40.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Multiline reinsurer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:InvestmentInMultilineReinsurer" scale="6" id="f-439">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:InvestmentInMultilineReinsurer" scale="6" id="f-440">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:InvestmentInMultilineReinsurer" scale="6" id="f-441">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (purchases)/sales of investments, equity method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PaymentsForProceedsFromOtherInvestments" scale="6" id="f-442">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:PaymentsForProceedsFromOtherInvestments" scale="6" id="f-443">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="ahl:PaymentsForProceedsFromOtherInvestments" scale="6" id="f-444">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash (used in)/from investing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-445">196.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-446">950.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-447">1,151.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows used in/from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contribution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProceedsFromContributedCapital" format="ixt:fixed-zero" scale="6" id="f-448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProceedsFromContributedCapital" scale="6" id="f-449">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ProceedsFromContributedCapital" scale="6" id="f-450">268.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-451">40.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:fixed-zero" scale="6" id="f-452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:fixed-zero" scale="6" id="f-453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on preference shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="6" id="f-454">44.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="6" id="f-455">44.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="6" id="f-456">44.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash (used in)/from financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-457">84.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-458">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-459">223.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate movements on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-460">18.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-461">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-462">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease)/increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-463">354.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-464">433.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-465">716.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-466">1,314.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-467">1,747.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-468">1,030.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="f-469">959.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-470">1,314.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-471">1,747.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash paid during the period for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-472">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-473">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-474">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="f-475">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="f-476">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="f-477">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Cash and cash equivalents includes restricted cash of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-478">232.1</ix:nonFraction>&#160;million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-479">364.9</ix:nonFraction>&#160;million, 2020 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-480">296.0</ix:nonFraction>&#160;million) which are held in trusts.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_526"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For The Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions, except share and per share amounts)&#160;</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_538"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-481" continuedAt="f-481-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">History and Organization</span></ix:nonNumeric></div><ix:continuation id="f-481-1" continuedAt="f-481-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">History and Organization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited (&#8220;Aspen Holdings&#8221;) was incorporated on May&#160;23, 2002 as a holding company headquartered in Bermuda. We underwrite specialty insurance and reinsurance on a global basis through our Operating Subsidiaries (as defined below) based in Bermuda, the United States and the United Kingdom: Aspen Bermuda Limited (&#8220;Aspen Bermuda&#8221;), Aspen Specialty Insurance Company (&#8220;Aspen Specialty&#8221;), Aspen American Insurance Company (&#8220;AAIC&#8221;), Aspen Insurance UK Limited (&#8220;Aspen UK&#8221;) and Aspen Underwriting Limited (&#8220;AUL&#8221;) (as corporate member of our Lloyd&#8217;s operations, Syndicate 4711, which are managed by Aspen Managing Agency Limited (&#8220;AMAL&#8221;) (together, &#8220;Aspen Lloyd&#8217;s&#8221;)), each referred to herein as an &#8220;Operating Subsidiary&#8221; and collectively referred to as the &#8220;Operating Subsidiaries&#8221;. We also have branches in Australia, Canada, Singapore and Switzerland. We established Aspen Capital Management, Ltd. (&#8220;ACML&#8221;) and other related entities (collectively, &#8220;ACM&#8221;) to leverage our existing underwriting franchise, increase our operational flexibility and provide third-party investors direct access to our capital markets and underwriting expertise. References to the &#8220;Company,&#8221; the &#8220;Group,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Aspen Holdings or Aspen Holdings and its consolidated subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2019, the Company has been a wholly-owned subsidiary of Highlands Bermuda Holdco, Ltd. (&#8220;Parent&#8221;), which holds all of the Company&#8217;s ordinary shares. Parent, a Bermuda exempted company, is an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc., a leading global investment manager (collectively with its subsidiaries, &#8220;Apollo&#8221;). The Company&#8217;s preference shares and depositary shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the following symbols: AHL PRC, AHL PRD and AHL PRE.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_550"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccounting" id="f-482" continuedAt="f-482-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Basis of Presentation and Significant Accounting Policies</span></ix:nonNumeric></div><ix:continuation id="f-482-1" continuedAt="f-482-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Aspen Holdings are prepared in accordance with United States Generally Accepted Accounting Principles (&#8220;U.S.&#160;GAAP&#8221;) and are presented on a consolidated basis including the transactions of all operating subsidiaries in which the Company has a controlling financial interest and variable interest entities (&#8220;VIE&#8221;) in which the Company is considered to be the primary beneficiary. Transactions between Aspen Holdings and its subsidiaries are eliminated within the consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on a going concern basis. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-483" continuedAt="f-483-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Use of Estimates </span></ix:nonNumeric></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-483-1">Assumptions and estimates made by management have a significant effect on the amounts reported within the consolidated financial statements. The most significant of these relate to losses and loss adjustment expenses, reinsurance recoverables, gross written premiums and commissions which have not been reported to the Company such as those relating to proportional treaty reinsurance contracts, unrecognized tax benefits, recoverability of deferred tax assets, the fair value of derivatives and the fair value of other and privately-held investments. All material assumptions and estimates are regularly reviewed and adjustments made as necessary but actual results could be significantly different from those expected when the assumptions or estimates were made.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)</span><ix:nonNumeric contextRef="c-1" name="ahl:AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" id="f-484" continuedAt="f-484-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Accounting for Insurance and Reinsurance Operations </span></ix:nonNumeric></div><ix:continuation id="f-484-1" continuedAt="f-484-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums Earned.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Premiums are recorded as written on the inception date of a policy. Premiums are recognized as revenues proportionately over the coverage period. Premiums earned are recorded in the consolidated statements of operations, net of the cost of purchased reinsurance. Premiums written which are not yet recognized as earned premium are recorded in the consolidated balance sheet as unearned premiums. Written and earned premiums and the related costs include estimates for premiums which have not been finally determined. These relate mainly to contractual provisions for the payment of adjustment or additional premiums, premiums payable under proportional treaties and delegated underwriting authorities, and reinstatement premiums. </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-484-2" continuedAt="f-484-3"><ix:continuation id="f-482-2" continuedAt="f-482-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustment and additional premiums are premiums charged which relate to experience during the policy term. The proportion of adjustable premiums included in the premium estimates varies between business lines with the largest adjustment premiums being in property and casualty reinsurance, marine, aviation and energy insurance and the smallest in property and casualty insurance. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums under proportional treaty contracts and delegated underwriting authorities are generally not reported to the Company until after the reinsurance coverage is in force. As a result, an estimate of these &#8220;pipeline&#8221; premiums is recorded. The Company estimates pipeline premiums based on projections of ultimate premium taking into account reported premiums and expected development patterns. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinstatement premiums on assumed excess of loss reinsurance contracts are provided based on experience under such contracts. Reinstatement premiums are the premiums charged for the restoration of the reinsurance limit of an excess of loss contract to its full amount after payment by the reinsurer of losses as a result of an occurrence. The original premiums are recognized as revenue in full at the date of loss, with the reinstatement premiums recognized as revenue over the remaining cover term. Reinstatement premiums provide future insurance cover for the remainder of the initial policy term. An allowance for uncollectible premiums is established for possible non-payment of premium receivables, as deemed necessary. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses on Underwriting Premiums Receivable. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Underwriting premium receivable balances are reported net of an allowance for expected credit losses. The allowance, based on ongoing review and monitoring of amounts outstanding, historical loss data, including write-offs and other relevant factors, is charged to net income in the period the receivable is recorded and revised in subsequent periods to reflect changes in the Company&#8217;s estimate of expected credit losses. Credit risk is partially mitigated by the Company&#8217;s ability to cancel the policy if the policyholder does not pay the premium.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Losses and Loss Adjustment Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Losses represent the amount paid or expected to be paid to claimants in respect of events that have occurred on or before the balance sheet date. The costs of investigating, resolving and processing these claims are known as loss adjustment expenses (&#8220;LAE&#8221;). The consolidated statements of operations records these losses net of reinsurance, meaning that gross losses and loss adjustment expenses incurred are reduced by the amounts recovered or expected to be recovered under reinsurance contracts. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Written premiums, earned premiums, incurred claims, LAE and the acquisition costs all reflect the net effect of assumed and ceded reinsurance transactions. Assumed reinsurance refers to the Company&#8217;s acceptance of certain insurance risks that other insurance companies have underwritten. Ceded reinsurance arises from contracts under which other insurance companies agree to share certain risks with the Company. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance accounting is followed when there is significant timing risk, significant underwriting risk and a reasonable possibility of significant loss. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outward reinsurance premiums, which are paid when the Company purchases reinsurance or retrocessional coverage, are accounted for using the same accounting methodology as the Company uses for inwards premiums. Premiums payable under reinsurance contracts that operate on a &#8220;losses occurring during&#8221; basis are expensed over the period of coverage while those arising from &#8220;risks attaching during&#8221; policies are expensed over the earnings period of the underlying premiums written from the reinsured business. Adjustment premiums and reinstatement premiums in relation to outward reinsurance are accrued when it is determined that the ultimate losses will trigger a payment and recognized within premiums payable. Reinsurance and retrocession does not isolate the ceding company from its obligations to policyholders. In the event that a reinsurer or retrocessionaire fails to meet its obligations, the ceding company&#8217;s obligations remain. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Retroactive Reinsurance Agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Retroactive reinsurance agreements are reinsurance agreements under which a reinsurer agrees to reimburse the Company as a result of past insurable events. For retroactive reinsurance purchased by the Company, the excess of the amounts ultimately collectible under the agreement over the consideration paid is recognized as a deferred gain liability which is amortized into income over the settlement period of the ceded reserves once the paid losses have exceeded the minimum retention. The amount </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-484-3" continuedAt="f-484-4"><ix:continuation id="f-482-3" continuedAt="f-482-4"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the deferral is recalculated each period based on actual loss payments and updated estimates of ultimate losses. If the consideration paid exceeds the ultimate losses collectible under the agreement, the net loss on the retroactive reinsurance agreement is recognized within income immediately.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums payable for retroactive reinsurance coverage and meeting the conditions of reinsurance accounting are reported as reinsurance recoverables to the extent that those amounts do not exceed recorded liabilities relating to underlying reinsurance contracts. Premiums paid in excess of accounts receivable are charged to income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserves.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Insurance reserves are established for the total unpaid cost of claims and LAE in respect of events that have occurred by the balance sheet date, including the Company&#8217;s estimates of the total cost of claims incurred but not yet reported (&#8220;IBNR&#8221;). Claim reserves are reduced for estimated amounts of salvage and subrogation recoveries. Estimated amounts recoverable from reinsurers on unpaid losses and LAE are reflected as assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reported claims, reserves are established on a case-by-case basis within the parameters of coverage provided in the insurance policy or reinsurance agreement. For IBNR claims, reserves are estimated using a number of established actuarial methods to establish a range of estimates from which a management best estimate is selected. Both case and IBNR reserve estimates consider variables such as past loss experience, changes in legislative conditions, changes in judicial interpretation of legal liability, policy coverages and inflation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As many of the coverages underwritten involve claims that may not be ultimately settled for many years after they are incurred, subjective judgments as to the ultimate exposure to losses are an integral and necessary component of the loss reserving process. The Company regularly reviews its reserves, using a variety of statistical and actuarial techniques to analyze current claims costs, frequency and severity data, and prevailing economic, social and legal factors. Reserves established in prior periods are adjusted as claim experience develops and new information becomes available. Adjustments to previously estimated reserves are reflected in the financial results of the period in which the adjustments are made. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of estimating required reserves does, by its very nature, involve considerable uncertainty. The level of uncertainty can be influenced by factors such as the existence of coverage with long duration payment patterns and changes in claims handling practices, as well as the factors noted above. Ultimate actual payments for claims and LAE could turn out to be significantly different from the Company&#8217;s estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses on Reinsurance Recoverables. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability with the reinsured business. The Company evaluates the financial condition of its reinsurers and retrocessionaires, and monitors concentration of credit risk to minimize its exposure to significant losses from individual reinsurers. To further reduce credit exposure on reinsurance recoverables, the Company has received collateral, including letters of credit and trust accounts, from certain reinsurers. Following the adoption of ASC 326, an allowance is established for expected credit losses to be recognized over the life of the reinsurance recoverable. The allowance considers the current financial strength of the individual reinsurer and the amount of collateral held. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition Costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The costs directly related to writing a (re)insurance policy are referred to as acquisition expenses and include commissions, premium taxes and profit commissions. With the exception of profit commissions, these expenses are incurred when a policy is issued, and only the costs directly related to the successful acquisition of new and renewal insurance and reinsurance contracts are deferred and amortized over the same period as the corresponding premiums are recorded as revenues. Profit commissions are estimated and accrued based on the related performance criteria evaluated at the balance sheet date, with subsequent changes to those estimates recognized when they occur. Commissions received related to reinsurance premiums ceded are netted against broker commissions in determining acquisition costs eligible for deferral. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a regular basis a premium deficiency analysis is performed of the deferred acquisition costs in relation to the expected recognition of revenues, including anticipated investment income, and adjustments, if any, are reflected as period costs. Should the analysis indicate that the acquisition costs are unrecoverable, further analyses are performed to determine if a reserve is required to provide for losses which may exceed the related unearned premium. </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-482-4" continuedAt="f-482-5"><ix:continuation id="f-484-4" continuedAt="f-484-5"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;These costs represent the expenses incurred in running the business and include, but are not limited to compensation costs for employees, rental costs, IT development and professional and consultancy fees. General and administrative costs directly attributable to the successful acquisition of business are deferred and amortized over the same period as the corresponding premiums are recorded as revenues. When reporting the results for its business segments, the Company includes expenses which are directly attributable to the segment plus an allocation of central administrative costs.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="f-484-5" continuedAt="f-484-6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Expenses.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-484-6"> Corporate expenses are not allocated to the Company&#8217;s business segments as they typically do not fluctuate with the levels of premium written and are related to the Company&#8217;s operations which include group executive costs, group finance costs, group legal and actuarial costs and certain strategic and other costs.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span id="i49191d5207d3440b905b4734b36cf7a6_36276"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c)</span><ix:nonNumeric contextRef="c-1" name="ahl:AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" id="f-485" continuedAt="f-485-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.91pt">Accounting for Investments, Cash and Cash Equivalents </span></ix:nonNumeric></div><ix:continuation id="f-485-1" continuedAt="f-485-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed Income Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fixed income securities portfolio comprises securities issued by governments and government agencies, corporate bonds, mortgage and other asset-backed securities and bank loans. Investments in fixed income securities are classified as available for sale or trading and are reported at estimated fair value in the consolidated balance sheet. Investment transactions are recorded on the trade date with balances pending settlement reflected in the consolidated balance sheet under receivables for securities sold and other payables for securities purchased, respectively. Fair values are based on quoted market prices and other data provided by third-party pricing services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Short-term investments primarily comprise highly liquid debt securities with a maturity greater than three months but less than one year from the date of purchase and are held as part of the investment portfolio of the Company. Short-term investments are classified as either trading or available for sale and reported at estimated fair value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catastrophe Bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in catastrophe bonds are classified as trading and are reported on the consolidated balance sheet at estimated fair value.&#160;The fair values are based on independent broker-dealer quotes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Privately-held Investments.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s privately-held investments primarily comprise commercial mortgage loans, middle market loans, asset-backed securities, global corporate securities and equity securities.&#160;These investments are classified as trading and are reported on the consolidated balance sheet at estimated fair value.&#160;Privately-held investments are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are primarily determined using internally developed discounted cash flow models. &#160;Interest income is accrued on the principal amount of the loan based on its contractual interest rate subject to it being probable that we will receive interest on that particular underlying loan. Interest income, amortization of premiums and discounts, and prepayment fees are reported in net investment income on the consolidated statements of income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments, Equity Method.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Other investments represent the Company&#8217;s investments that are recorded using the equity method of accounting. Adjustments to the fair value of these investments are made based on the net asset value of the investment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments represent the Company&#8217;s investments in real estate funds and other special purpose vehicles. Adjustments to the fair value are made based on the net asset value of the investment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Cash and cash equivalents are reported at fair value. Cash and cash equivalents comprise cash on hand, deposits held on call with banks and other short-term highly liquid investments due to mature within three months from the date of purchase and which are subject to insignificant risk of change in fair value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gains and Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Realized gains or losses on the sale of investments are determined on the basis of the first in first out cost method and are recorded in revenue or expenses respectively. Unrealized gains and losses represent the difference between the cost, or the cost as adjusted by amortization of any difference between its cost and its </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-482-5" continuedAt="f-482-6"><ix:continuation id="f-485-2" continuedAt="f-485-3"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">redemption value (&#8220;amortized cost&#8221;), of the security and its fair value at the reporting date and are included within other comprehensive income for securities classified as available for sale and in realized and unrealized investment gains or losses in the consolidated statement of operations for securities classified as trading. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses on Available for Sale Debt Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Following Aspen&#8217;s adoption of ASU 2016-13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Financial Instruments - Credit Losses (Topic 326)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, effective January 1, 2020, current expected credit losses (CECL) are recognized through an allowance account for available for sale debt securities, thereby permitting reversals of previously recognized credit losses through net income in the period they occur. Write-offs (of any previously recognized allowance for credit losses) are recorded when amounts are deemed uncollectible, or Aspen intends to sell (or more likely than not will be required to sell) the debt security before recovery of the amortized cost basis. The amortized cost basis will be written down to the debt securities fair value through earnings. Credit losses are limited to the difference between the debt securities amortized cost basis and fair value (&#8216;fair-value floor&#8217;). Any decline in the debt securities fair value below the amortized cost basis that is not a result of a credit loss is recorded through other comprehensive income, net of applicable taxes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit loss models employ a discounted cash flow approach to evaluate whether a credit loss exists at the individual security level and are reviewed at each reporting period. This analysis excludes investments in U.S. Government / Agency bonds and U.S. Government Agency mortgage-backed securities due to being of &#8216;high credit quality&#8217; based on the absence of risk. Available for sale debt securities that were initially purchased with credit deterioration (PCD), the amortized cost basis shall be considered to be the purchase price, plus any allowance for credit losses. Estimated credit losses shall be discounted at the rate that equates the present value of the purchaser&#8217;s estimate of the security&#8217;s future cash flows with the purchase price of the asset. Holding gains or losses are recognition through other comprehensive income, net of applicable taxes. No changes in the estimate of credit losses have taken place during the period. </span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="f-485-3" continuedAt="f-485-4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-485-4">&#160;Investment income includes amounts received and accrued in respect of periodic interest (&#8220;coupons&#8221;) payable to the Company by the issuer of fixed income securities, equity dividends and interest credited on cash and cash equivalents. It also includes amortization of premium and accretion of discount in respect of fixed income securities. Investment income also includes changes in fair value from investments in real estate funds. Investment management and custody fees are charged against net investment income reported in the consolidated statement of operations.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-486" continuedAt="f-486-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Accounting for Derivative Financial Instruments </span></ix:nonNumeric></div><ix:continuation id="f-486-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into derivative instruments such as interest rate swaps and forward exchange contracts in order to manage certain market and credit risks. The Company records derivative instruments at fair value on the Company&#8217;s consolidated balance sheet as either assets or liabilities, depending on their rights and obligations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting for the gain or loss due to the changes in the fair value of these instruments is dependent on whether the derivative qualifies as a hedge. If the derivative does not qualify as a hedge, the gains or losses are reported in the consolidated statement of operations when they occur. If the derivative qualifies as a hedge, the accounting treatment varies based on the type of risk being hedged. Gains and losses on the effective portion of such contracts are recognized in other comprehensive income. As the contracts settle, the realized gain or loss is reclassified from other comprehensive income into the consolidated statement of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss portfolio transfer contract includes a funds withheld arrangement that provides variable interest expense based on Aspen&#8217;s investment performance. As a result, this funds withheld arrangements is considered an embedded derivative and accounted for as an option-based derivative. Since the economic characteristics and risks of an embedded derivative feature are not clearly and closely related to the economic characteristics and risks of the host contract, the embedded derivative is bifurcated and accounted for separately at fair value. The Company records subsequent changes in the embedded derivative fair value in the consolidated statement of operations.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-482-6" continuedAt="f-482-7"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(e)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="f-487" continuedAt="f-487-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.91pt">Accounting for Intangible Assets </span></ix:nonNumeric></div><ix:continuation id="f-487-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are held in the consolidated balance sheet at cost less amortization and impairment. Amortization applies on a straight-line basis in respect of assets having a finite estimated useful economic life. Finite intangibles are assessed on an annual basis for impairment, or more frequently where circumstances indicate the carrying value may not be recoverable. For intangible assets considered to have an indefinite life, the Company performs a qualitative assessment annually to determine whether it is more likely than not that an intangible asset is impaired. Goodwill is assessed annually for impairment or more frequently if circumstances indicate an impairment may have occurred.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(f)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-488" continuedAt="f-488-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.01pt">Accounting for Office Properties and Equipment </span></ix:nonNumeric></div><ix:continuation id="f-488-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office properties and equipment are reported at cost less accumulated depreciation. These assets are depreciated on a straight-line basis over the estimated useful lives of the assets. Computer equipment is depreciated between <span style="-sec-ix-hidden:f-489">three</span> and <ix:nonNumeric contextRef="c-78" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-490">five years</ix:nonNumeric>, furniture and fittings are depreciated over <ix:nonNumeric contextRef="c-79" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-491">four years</ix:nonNumeric> and leasehold improvements are depreciated over the lesser of <ix:nonNumeric contextRef="c-80" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-492">15</ix:nonNumeric> years or the lease term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IT development costs that are directly associated with the development of identifiable and unique software products and that are anticipated to generate economic benefits exceeding costs beyond one year, are recognized within office properties and equipment. Costs include external consultants&#8217; fees, certain qualifying internal staff costs and other costs incurred to develop software programs. Software is depreciated over their estimated useful life, between three and five years, on a straight-line basis and is subject to impairment testing annually. Depreciation commences when the asset becomes operational. Other non-qualifying costs are expensed as incurred.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(g)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-493" continuedAt="f-493-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Accounting for Leases </span></ix:nonNumeric></div><ix:continuation id="f-493-1" continuedAt="f-493-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of the business, the Company renews and enters into new leases for office real estate and other assets. At the lease inception date, the Company determines whether a contract contains a lease and recognizes operating lease Right-of-use assets and operating lease liabilities based on the present value of future minimum lease payments. As our leases do not provide an implicit interest rate, we use our incremental borrowing rate based on the information available at the commencement date to determine the present value of future payments. For all office real estate leases, rent incentives, including reduced-rent and rent free periods and contractually agreed rent increases during the lease term, have been included when determining the present value of future cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Right-of-use operating lease assets are reported at cost less accumulated depreciation on the consolidated balance sheet and depreciated over the lease term. The Company does not record office property and equipment leases with an initial term of 12 months or less (short-term) in the Company's consolidated balance sheets. Such short-term leases are expensed through the consolidated statement of operations.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-493-2">Right-of-use operating lease assets are tested for impairments whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If the carrying value of an asset is impaired, it is reduced to the recoverable amount by an immediate charge to the income statement. The recoverable amount is the higher of an asset&#8217;s fair value less costs to sell and value in use.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(h)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-494" continuedAt="f-494-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.78pt">Accounting for Foreign Currencies Translation </span></ix:nonNumeric></div><ix:continuation id="f-494-1" continuedAt="f-494-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting currency of the Company is the U.S.&#160;Dollar. Effective January 1, 2022, management reassessed its functional currency determination in accordance with ASC 830, Foreign Currency Matters, as a result of significant changes in the Group&#8217;s economic facts and circumstances, and concluded that the functional currency of certain of its foreign operations had changed. Consequently, the Company has concluded that the U.S. Dollar is now the functional currency for all its branches and overseas entities. The change in the Company&#8217;s functional currency determination has been applied on a prospective basis in accordance with ASC 830. Therefore, any translation gains and losses that were previously recorded in accumulated other comprehensive income through December 31, 2021 remain unchanged through December 31, 2021. From January 1, 2022, any net realized and unrealized gains/(losses) on translation are recognized in the consolidated statements of operations and other comprehensive income (loss). </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-482-7" continuedAt="f-482-8"><ix:continuation id="f-494-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments classified as available-for-sale are recorded at fair value, the portion attributable to movements in exchange rates continues to be included within accumulated other comprehensive income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency are measured at the exchange rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in non-functional currencies are remeasured at the exchange rate prevailing at the balance sheet date and any resulting foreign exchange gains or losses are reflected in the consolidated statement of operations. Non-monetary assets and liabilities are remeasured to functional currency at historic exchange rates.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-495" continuedAt="f-495-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Accounting for Income Taxes </span></ix:nonNumeric></div><ix:continuation id="f-495-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. When the Company does not believe that, on the basis of available information, it is more likely than not that deferred tax assets will be fully recovered, it recognizes a valuation allowance against its deferred tax assets to reduce the deferred tax assets to the amount more likely than not to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, a tax benefit from a tax position may be recognized in the financial statements only if it is more-likely-than-not that the position is sustainable, based solely on its technical merits and consideration of the relevant tax authority&#8217;s widely understood administrative practices and precedents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a portfolio approach to release the income tax effects in accumulated other comprehensive income. Under this approach, the income tax effects upon the sale of an available-for-sale debt security, settlement of hedged transactions and upon foreign currency translation adjustments for each period, are determined under the intraperiod tax allocation approach. Any tax effects remaining in accumulated other comprehensive income are only released when the entire portfolio is liquidated, sold or extinguished.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(j)</span><ix:nonNumeric contextRef="c-1" name="ahl:PreferenceSharesPolicyTextBlock" id="f-496" continuedAt="f-496-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Accounting for Preference Shares </span></ix:nonNumeric></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-496-1">The Company had at the balance sheet date in issue three classes of preference shares. The Company has no obligation to pay interest on these securities but they carry entitlements to dividends payable at the discretion of the Board of Directors. In the event of non-payment of dividends for <ix:nonFraction unitRef="period" contextRef="c-19" decimals="INF" name="ahl:NonPaymentOfDividendsNumberOfPeriods" format="ixt-sec:numwordsen" scale="0" id="f-497">six</ix:nonFraction> consecutive periods, holders of preference shares have director appointment rights. The preference shares are therefore accounted for as equity instruments and included within total shareholders&#8217; equity.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(k)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-498" continuedAt="f-498-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Accounting for Long-Term Incentive Plans </span></ix:nonNumeric></div><ix:continuation id="f-498-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates an employee long-term incentive plan, comprised of Performance Units and Exit Units, the terms and conditions of which are described in Note 16. The Company applies a fair-value based measurement method in calculating the compensation costs of Performance Units which are recognized on a straight-line basis over the vesting period.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(l)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-499" continuedAt="f-499-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Accounting for Business Combinations</span></ix:nonNumeric></div><ix:continuation id="f-499-1" continuedAt="f-499-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for a transaction as a business combination where the assets acquired and liabilities assumed following a transaction constitute a business. An acquired entity must have inputs and processes that make it capable of generating a return or economic benefit to be considered a business. If the assets acquired are not a business, the Company accounts the transaction as an asset acquisition. The Company recognizes and measures at fair value 100 percent of the assets and liabilities of any acquired business. Goodwill is recognized and measured as the difference between the consideration paid or payable less the fair value of assets acquired. </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-482-8" continuedAt="f-482-9"><ix:continuation id="f-499-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the disposal of subsidiary undertakings when it ceases to control the subsidiary&#8217;s assets and liabilities or the group of assets. A gain or loss is recognized and measured as the difference between the fair value of consideration received or receivable and the value of assets, liabilities and equity components de-recognized, related to that subsidiary or group of assets when deconsolidated.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs that are directly related to a business combination transaction are expensed in the periods in which the costs are incurred and the services are received.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span id="i49191d5207d3440b905b4734b36cf7a6_36275"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(m)</span><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-500" continuedAt="f-500-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.57pt">Accounting Pronouncements </span></ix:nonNumeric></div><ix:continuation id="f-500-1" continuedAt="f-500-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Pronouncements Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. ASU 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Financial Instruments&#8212;Credit Losses (Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#8221;. This update is as a result of a post implementation review done on the issued ASU No.2016-13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, addressing &#8220;troubled debt restructuring by creditors&#8221; and &#8220;vintage disclosures&#8221;. This update will be effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued Accounting Standards Update No. ASU 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Derivatives and Hedging (Topic 815): Fair Value Hedging, Portfolio Layer Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. This update addresses concerns from entities and practitioners regarding the &#8216;last-of-layer&#8217; method of accounting incorporated in update No. ASU 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, issued on 28 August, 2017. This method is meant to achieve fair value hedge accounting for interest rate risk hedges of portfolios of &#8216;prepayable financial assets&#8217;. This ASU will be effective for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued Accounting Standards Update No. ASU 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Fair Value Measurement (Topic 820</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#8221;. This update is for entities that have investments in equity securities, measured at fair value, which are subject to a contractual sale restriction. This update will be effective for fiscal years beginning after December 15, 2024 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued Accounting Standards Update No. ASU 2022-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Liabilities- Supplier Finance Programs (Subtopic 405-50)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The update has been issued to enhance the transparency of supplier finance program disclosure for all entities that use these programs in connection with the purchase of goods and services. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that the update has no impact, as the Company does not enter into any such agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued Accounting Standards Update No. ASU 2022-05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, &#8220;Financial Services- Insurance (Topic 944</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#8221;. This update reduces the implementation costs and complexity with the adoption of Long Duration Insurance contracts (LDTI) that have been derecognized in accordance with the amendments in this update. These changes eliminate the need to reclassify a portion of previously recognized gains or losses to the LDTI transition adjustment as suggested in the previous ASU issued 2020-11. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that the update has no impact, as the Company does not write long-duration business.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-500-2" continuedAt="f-500-3"><ix:continuation id="f-482-9" continuedAt="f-482-10"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued Accounting Standards Update No. ASU 2022-06,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Reference Rate Reform (Topic 848)&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This update defers the sunset date of Topic 848 (ASU 2020-04) from Dec 31, 2022 to Dec 31, 2024, after which entities will no longer be allowed to use the relief offered in Topic 848. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accounting pronouncements were issued during the year ended December&#160;31, 2022 which were either not applicable to the Company or did not impact the Company&#8217;s consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_562"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-501" continuedAt="f-501-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Segment Reporting</span></ix:nonNumeric></div><ix:continuation id="f-501-1" continuedAt="f-501-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its underwriting operations as <ix:nonFraction unitRef="segement" contextRef="c-19" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-502">two</ix:nonFraction> business segments: Aspen Reinsurance and Aspen Insurance. The Company has determined its reportable segments by taking into account the manner in which management makes operating decisions and assesses operating performance. Profit or loss for each of the Company&#8217;s business segments is measured by underwriting income or loss. Underwriting profit is the excess of net earned premiums over the sum of losses and loss expenses, acquisition costs and general and administrative expenses. Underwriting income or loss provides a basis for management to evaluate the segment&#8217;s underwriting performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance Segment. &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reinsurance segment consists of property catastrophe reinsurance, other property reinsurance, casualty reinsurance and specialty reinsurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The insurance segment consists of first party and specialty insurance, casualty and liability insurance and financial and professional lines insurance. Additionally, the insurance segment includes Aspen Underwriting Limited&#8217;s participation as a corporate member in Carbon Syndicate 4747 (&#8220;Carbon Syndicate&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-underwriting Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company provides additional disclosures for corporate and other (non-operating) income and expenses. Corporate and other income and expenses include: corporate expenses, net investment income, net realized and unrealized investment gains or losses, other strategic and other costs, changes in fair value of derivatives or the loan notes issued by variable interest entities, interest expenses, net realized and unrealized foreign exchange gains or losses, asset impairments and income taxes. These income and expense items are not allocated to the Company&#8217;s business segments as they are not directly related to the Company&#8217;s business segment operations and is consistent with how management measures the performance of its segments. The Company does not allocate its assets by business segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses underwriting ratios as measures of performance. The loss ratio is the ratio of losses and loss adjustment expenses to net earned premiums. The acquisition cost ratio is the ratio of acquisition costs to net earned premiums. The general and administrative expense ratio is the ratio of general and administrative expenses to net earned premiums. The combined ratio is the sum of the loss ratio, the acquisition cost ratio and the general and administrative expense ratio. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-503" continuedAt="f-503-1" escape="true"><ix:continuation id="f-501-2" continuedAt="f-501-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of gross and net written and earned premiums, underwriting income or loss, ratios and reserves for each of the Company&#8217;s business segments for the twelve months ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-504">1,807.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-505">2,531.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-506">4,338.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-507">1,426.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-508">1,469.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-509">2,896.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-510">1,617.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-511">2,370.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-512">3,988.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-513">1,251.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-514">1,436.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-515">2,688.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-516">770.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-517">909.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-518">1,680.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-519">252.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-520">179.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-521">431.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-522">142.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-523">244.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-524">386.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-525">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-526">103.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-527">190.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:CorporateExpenses" scale="6" id="f-528">71.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-529">36.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-530">188.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-531">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-532">182.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-533">80.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-534">43.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-535">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="f-536">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-537">20.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-538">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-539">78.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-540">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-541">1,360.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-542">1,452.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-543">2,813.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-544">61.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-545">63.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-546">62.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-547">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-548">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-549">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-550">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-551">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-552">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-553">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-554">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-555">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-556">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-557">92.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-558">93.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-operating expenses includes $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:NonOperatingExpensesRelatedToFixedIncomeWriteoff" format="ixt:num-dot-decimal" scale="6" id="f-559">32.7</ix:nonFraction> million in relation to fixed assets written off, $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" format="ixt:num-dot-decimal" scale="6" id="f-560">10.0</ix:nonFraction> million of severance, consulting and professional services in relation to non-recurring projects and other costs, offset by $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" format="ixt:num-dot-decimal" scale="6" id="f-561">6.7</ix:nonFraction> million of write backs related to leased office space.</span></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-503-1" continuedAt="f-503-2"><ix:continuation id="f-501-3" continuedAt="f-501-4"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-562">1,597.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-563">2,341.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-564">3,938.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-565">1,199.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-566">1,388.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-567">2,587.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-568">1,479.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-569">2,139.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-570">3,618.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-571">1,118.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-572">1,291.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-573">2,410.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-574">705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-575">988.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-576">1,693.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-577">221.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-578">192.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-579">414.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-580">121.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-581">211.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-582">333.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income/(loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-583">70.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" sign="-" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-584">100.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-585">30.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:CorporateExpenses" scale="6" id="f-586">64.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-587">20.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-588">147.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-589">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-590">47.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-591">35.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-592">14.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-593">40.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="f-594">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-595">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-596">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-597">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-598">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-599">2,148.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-600">2,165.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-601">4,313.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-602">63.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-603">76.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-604">70.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-605">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-606">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-607">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-608">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-609">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-610">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-611">30.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-612">31.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-613">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-614">93.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-615">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-616">101.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-operating expenses includes $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:NonoperatingexpensesrelatedtoMergerAgreement" format="ixt:num-dot-decimal" scale="6" id="f-617">19.3</ix:nonFraction> million of costs related to consulting and professional services in relation to non-recurring projects and other costs, $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" format="ixt:num-dot-decimal" scale="6" id="f-618">0.4</ix:nonFraction> million of impairment charges related to lease assets as a result of exiting certain office space and $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" format="ixt:num-dot-decimal" scale="6" id="f-619">0.9</ix:nonFraction> million of amortization of intangible assets and other non-operating expenses.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-503-2" continuedAt="f-503-3"><ix:continuation id="f-501-4" continuedAt="f-501-5"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-620">1,656.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-621">2,042.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-622">3,698.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-623">1,297.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-624">1,280.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-625">2,577.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-626">1,612.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-627">2,026.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:PremiumsEarnedGross" format="ixt:num-dot-decimal" scale="6" id="f-628">3,638.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-629">1,287.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-630">1,239.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-631">2,527.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-632">958.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-633">882.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-634">1,840.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-635">246.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-636">219.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-637">465.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-638">110.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-639">197.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-640">308.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" sign="-" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-641">27.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" sign="-" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-642">59.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-643">87.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:CorporateExpenses" scale="6" id="f-644">70.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-645">32.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-646">154.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-647">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-648">27.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-649">65.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-650">33.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-651">13.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="f-652">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-653">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) before income taxes </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-654">38.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-655">18.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-656">56.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-657">2,095.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-658">1,874.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-659">3,970.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-660">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-661">71.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-27" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-662">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-663">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-664">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-27" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-665">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-666">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-667">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-27" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-668">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-669">27.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-670">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-27" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-671">30.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-672">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-673">104.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-27" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-674">103.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-operating expenses includes $<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" format="ixt:num-dot-decimal" scale="6" id="f-675">18.2</ix:nonFraction> million of expenses related to severance, retention and other costs, $<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" format="ixt:num-dot-decimal" scale="6" id="f-676">12.9</ix:nonFraction> million of impairment charges related to lease assets as a result of sub-leasing certain office space and $<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" format="ixt:num-dot-decimal" scale="6" id="f-677">1.6</ix:nonFraction> million of amortization of intangible assets and other non-operating expenses.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-501-5" continuedAt="f-501-6"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="f-678" continuedAt="f-678-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Geographical Areas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following summary presents the Company&#8217;s gross written premiums based on the location of the insured risk for the twelve months ended December&#160;31, 2022, 2021 and 2020. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia/Asia</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-679">257.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-680">275.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-681">259.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-682">194.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-683">140.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-684">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-685">485.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-686">393.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-687">369.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States&#160;&amp; Canada </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-688">2,715.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-689">2,301.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-690">2,267.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide excluding United States </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-691">24.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-692">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-693">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide including United States </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-694">541.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-695">592.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-696">501.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-697">119.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-698">203.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-699">185.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-700">4,338.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-701">3,938.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-702">3,698.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">&#8220;United States and Canada&#8221; comprises individual policies that insure risks specifically in the United States and/or Canada, but not elsewhere. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">&#8220;Worldwide excluding the United States&#8221; consists of individual policies that insure global risks with the specific exclusion of the United States. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">&#8220;Worldwide including the United States&#8221; consists of individual policies that insure global risks with the specific inclusion of the United States. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-678-1" continuedAt="f-678-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="f-678-2">&#8220;Other&#8221; comprises individual policies that insure risk in other countries including, but not limited to, the Caribbean, South America and Middle East.</ix:continuation> </span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_574"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="f-703" continuedAt="f-703-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Investments</span></ix:nonNumeric></div><ix:continuation id="f-703-1" continuedAt="f-703-2"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Statement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net investment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. &#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentIncomeTextBlock" id="f-704" continuedAt="f-704-1" escape="true">The following table summarizes investment income for the twelve months ended December&#160;31, 2022, 2021 and 2020:</ix:nonNumeric></span></div><ix:continuation id="f-704-1" continuedAt="f-704-2"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities&#160;&#8212; Available for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-705">95.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-706">87.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-707">106.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities&#160;&#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-708">57.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-709">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-710">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments&#160;&#8212; Available for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-711">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-712">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-713">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments&#160;&#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-714">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" format="ixt:fixed-zero" scale="6" id="f-715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-716">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed term deposits (included in cash and cash equivalents)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-717">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-718">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-719">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe bonds &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-720">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-721">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-722">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-723">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-724">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-725">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments, at fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-726">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-727">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-728">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-729">198.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-730">159.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-731">167.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="f-732">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="f-733">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="f-734">12.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-735">188.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-736">147.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-737">154.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents the Company&#8217;s investments in real estate funds and other special purpose vehicles. The movement in the year represents the change in fair value of the investment and has been included as part of our investment income.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RealizedGainLossOnInvestmentsTableTextBlock" id="f-738" continuedAt="f-738-1" escape="true"><ix:continuation id="f-703-2" continuedAt="f-703-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net realized and unrealized investment gains and losses recorded in the consolidated statement of operations and the change in unrealized gains and losses on investments recorded in other comprehensive income for the twelve months ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized gains</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-739">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-740">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-741">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-742">58.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-743">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-744">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-745">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-746">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-747">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-748">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-749">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-750">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in expected credit (losses)/gains </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" scale="6" id="f-751">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="ahl:DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" scale="6" id="f-752">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" scale="6" id="f-753">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-754">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-755">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-756">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-757">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-758">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-759">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" format="ixt:fixed-zero" scale="6" id="f-760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-761">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-762">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" format="ixt:fixed-zero" scale="6" id="f-763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-764">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-765">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-766">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-767">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" format="ixt:fixed-zero" scale="6" id="f-768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-769">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-770">13.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" format="ixt:fixed-zero" scale="6" id="f-771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; net unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-772">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-773">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-774">20.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe bonds &#8212; net unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:TradingSecuritiesCatastropheBondsGainLoss" scale="6" id="f-775">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="ahl:TradingSecuritiesCatastropheBondsGainLoss" scale="6" id="f-776">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:TradingSecuritiesCatastropheBondsGainLoss" format="ixt:fixed-zero" scale="6" id="f-777">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; net unrealized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-778">113.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-779">23.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments &#8212; equity method:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized and unrealized gains/(losses) in MVI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-782">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-783">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized (losses)/gains in Multi-Line Reinsurer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-784">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-785">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized and unrealized (losses)/gains in Digital Risk</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-789">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gain on sale of Bene</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="f-790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="f-791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-792">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gain on sale of Crop Re</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="f-793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="f-794">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-795">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net realized and unrealized investment (losses)/gains recorded in the consolidated statement of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:NetRealizedAndUnrealizedInvestmentGainsLosses" scale="6" id="f-796">177.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:NetRealizedAndUnrealizedInvestmentGainsLosses" scale="6" id="f-797">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:NetRealizedAndUnrealizedInvestmentGainsLosses" scale="6" id="f-798">71.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in available for sale net unrealized (losses)/gains:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" scale="6" id="f-799">391.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="ahl:AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" scale="6" id="f-800">157.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" scale="6" id="f-801">108.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit/(expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" scale="6" id="f-802">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" scale="6" id="f-803">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" scale="6" id="f-804">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in net unrealized (losses)/gains, net of taxes recorded in other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-805">367.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-806">157.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-807">108.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-3" continuedAt="f-703-4"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities and Short-Term Investments &#8212; Available For Sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-808" continuedAt="f-808-1" escape="true">The following tables present the cost or amortized cost, gross unrealized gains and losses and estimated fair market value of available for sale investments in fixed income securities and short-term investments as at December&#160;31, 2022 and December&#160;31, 2021:</ix:nonNumeric></span></div><ix:continuation id="f-808-1" continuedAt="f-808-2"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost&#160;or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Credit </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-809">1,003.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-811">50.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-813">953.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-814">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-816">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-817">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-818">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-819">159.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-821">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-822">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-823">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-824">2,016.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-825">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-826">169.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-827">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-828">1,845.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-829">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-831">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-832">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-833">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-834">225.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-835">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-836">11.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-837">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-838">213.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-839">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-840">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-841">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-843">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-844">590.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-845">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-846">87.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-848">502.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-849">4,131.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-850">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-851">338.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-852">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-853">3,788.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-854">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-856">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-858">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-859">4,183.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-860">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-861">339.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-862">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-863">3,840.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the twelve months ended December&#160;31, 2022, there was an increase in the CECL allowance on available-for-sale investments of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-864">5.0</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-865">2.5</ix:nonFraction> million decrease).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost&#160;or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance <br/>for Credit <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-866">1,066.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-867">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-868">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-870">1,084.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-871">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-872">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-875">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-876">81.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-877">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-878">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-879">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-880">82.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-881">2,176.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-882">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-883">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-884">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-885">2,208.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-886">138.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-887">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-888">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-890">136.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-891">250.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-892">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-893">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-894">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-895">250.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-896">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-898">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-900">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-901">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-902">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-903">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-904">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-905">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-906">1,082.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-907">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-908">12.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-909">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-910">1,090.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-911">4,823.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-912">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-913">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-914">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-915">4,881.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-916">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-917">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-920">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-921">4,833.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-922">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-923">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-924">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-925">4,891.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-4" continuedAt="f-703-5"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities, Short Term Investments, Equities, Catastrophe Bonds and Privately-held Investments &#8212; Trading.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; <ix:nonNumeric contextRef="c-1" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="f-926" continuedAt="f-926-1" escape="true">The following tables present the cost or amortized cost, gross unrealized gains and losses, and estimated fair market value of trading investments in fixed income securities, short-term investments, equity securities, catastrophe bonds and privately-held investments as at December&#160;31, 2022 and December&#160;31, 2021:</ix:nonNumeric></span></div><ix:continuation id="f-926-1" continuedAt="f-926-2"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Income Securities &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-927">267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-928">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-929">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-930">261.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-931">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-933">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-934">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-935">175.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-936">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-937">13.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-938">162.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-939">90.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-940">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-941">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-942">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-943">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-945">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-946">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-947">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-948">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-949">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-950">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-951">970.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-952">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-953">74.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-954">896.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-955">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-957">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-958">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-959">1,576.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-960">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-961">101.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-962">1,475.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-963">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-966">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-967">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-969">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-970">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-971">312.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-972">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-973">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-974">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-975">109.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-976">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-977">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-978">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-979">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-980">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-981">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-982">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-983">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-984">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-985">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-986">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-987">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-988">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-989">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-990">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-991">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-994">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-995">537.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-996">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-997">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-998">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-999">2,125.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1000">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1001">109.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1002">2,017.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-5" continuedAt="f-703-6"><ix:continuation id="f-926-2" continuedAt="f-926-3"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Income Securities &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1003">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1004">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1005">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1006">116.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1007">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1008">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1010">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1011">95.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1012">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1013">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1014">96.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1015">77.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1016">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1017">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1018">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1019">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1020">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1021">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1022">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1023">34.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1024">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1025">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1026">34.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1027">784.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1028">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1029">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1030">785.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1031">30.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1032">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1033">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1034">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-1035">1,155.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1036">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1037">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1038">1,157.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1039">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1040">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1042">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1043">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1045">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1046">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1047">212.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1048">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1049">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1050">211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1051">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1053">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1054">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1055">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1057">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1058">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1059">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1060">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-1061">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1062">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-1063">309.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1064">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1065">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1066">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-1067">1,472.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-1068">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-1069">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1070">1,470.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Catastrophe bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in catastrophe bonds with a total value of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CatastropheBond" format="ixt:num-dot-decimal" scale="6" id="f-1071">2.9</ix:nonFraction> million as at December&#160;31, 2022 (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:CatastropheBond" format="ixt:num-dot-decimal" scale="6" id="f-1072">3.4</ix:nonFraction> million).&#160;The bonds are either zero-coupon notes or receive quarterly interest payments based on variable interest rates with scheduled maturities ranging from 2023 to 2026.&#160;The redemption value of the bonds will adjust based on the occurrence or aggregate occurrence of a covered event, such as windstorms and earthquakes in the United States, Canada, the North Atlantic, South America, Europe, Japan or Australia.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privately-held investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has invested in privately-held investments, which primarily include commercial mortgage loans of $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1073">312.1</ix:nonFraction> million and middle market loans of $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1074">106.9</ix:nonFraction> million as at December&#160;31, 2022 (December&#160;31, 2021 &#8212; commercial mortgage loans of $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1075">211.5</ix:nonFraction> million; middle market loans of $<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1076">65.4</ix:nonFraction> million). Privately-held investments also includes investments in asset-backed securities, equity securities and other short term investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Mortgage Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The commercial mortgage loans are related to investments in properties including apartments, hotels, office and retail buildings, other commercial properties and industrial properties. The commercial mortgage loan portfolio is diversified by property type, geographic region and issuer to reduce risks. As part of our investment process, we evaluate factors such as size, property type, and security to determine that </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-6" continuedAt="f-703-7"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">properties are performing at a consistent and acceptable level to secure the related debt.&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfParticipatingMortgageLoansTextBlock" id="f-1077" continuedAt="f-1077-1" escape="true">The following table presents the type of commercial mortgage loans and geographic region as at December&#160;31, 2022 and December&#160;31, 2021:</ix:nonNumeric></span></div><ix:continuation id="f-1077-1" continuedAt="f-1077-2"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property type</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apartment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1078">115.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1079">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1080">101.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1081">48.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hotels</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1082">108.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-201" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1083">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1084">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-203" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1085">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1086">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1087">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1088">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1089">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1090">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-209" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1091">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1092">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-211" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1093">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1094">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-213" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1095">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="f-1097">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1098">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-217" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1099">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="f-1101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1102">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1103">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1104">211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-221" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1105">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1106">269.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1107">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1108">183.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1109">86.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1110">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1111">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1112">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1113">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1114">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1115">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1116">211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1117">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary credit quality indicator of commercial mortgage loans is loan performance. Non-performing commercial mortgage loans are generally 90 days or more past due. As of December&#160;31, 2022, <ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1118">none</ix:nonFraction> of our commercial mortgage loans were non-performing.&#160;Loan-to-value and debt service coverage ratios are measures we use to assess the risk and quality of commercial mortgage loans. The loan-to-value ratio is expressed as a percentage of the value of the loan relative to the value of the underlying property. <ix:nonNumeric contextRef="c-1" name="us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock" id="f-1119" continuedAt="f-1119-1" escape="true">A loan-to-value ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The following table represents the loan-to-value ratio of the commercial mortgage loan portfolio as at December&#160;31, 2022 and December&#160;31, 2021:</ix:nonNumeric></span></div><ix:continuation id="f-1119-1" continuedAt="f-1119-2"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 50%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1120">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50% to 60%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1122">248.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1123">131.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61% to 70%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1124">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1125">80.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1126">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1127">211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt-service coverage ratio is measured by a property&#8217;s net operating income as a multiple of its debt re-payments. A ratio of less than 1.0 reflects a property&#8217;s operations is not sufficient to cover its debt payments. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-1128" continuedAt="f-1128-1" escape="true">The following table represents the debt-service coverage ratio of the commercial mortgage loan portfolio, excluding </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-7" continuedAt="f-703-8"><ix:continuation id="f-1128-1" continuedAt="f-1128-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">those that are non-performing and construction loans which are still under development, as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 1.20x</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1129">106.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1130">66.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 - 1.20x</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1131">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1132">62.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00x</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1133">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1134">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial mortgage loans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="ahl:CMLLessNonPerformingOrFutureConstruction" scale="6" id="f-1135">292.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="ahl:CMLLessNonPerformingOrFutureConstruction" scale="6" id="f-1136">147.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div></ix:continuation><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-1128-2" continuedAt="f-1128-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="f-1128-3" continuedAt="f-1128-4">As at December&#160;31, 2022, we have non-performing loans of $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1137">Nil</ix:nonFraction> (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1138">Nil</ix:nonFraction>) and construction loans of $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" format="ixt:num-dot-decimal" scale="6" id="f-1139">19.9</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" format="ixt:num-dot-decimal" scale="6" id="f-1140">64.0</ix:nonFraction> million) which only generate income when the construction is completed. As no income is currently being generated on these loans, they are not included in the table above. The total value of commercial mortgage loans is $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1141">312.1</ix:nonFraction> million as at December&#160;31, 2022 (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1142">211.5</ix:nonFraction> million).</ix:continuation> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Middle Market Loans.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The middle market loans are investments in senior secured loan positions with full covenants, focused on the middle market in both U.S., Europe and the Caribbean. The middle market loan portfolio is diversified by industry type, geographic region and issuer to reduce risks. As part of our investment process, we evaluate factors such as size, industry and security to determine that loans are performing at a consistent and acceptable level to secure the related debt. <ix:continuation id="f-1077-2" continuedAt="f-1077-3">The following table presents the type of middle market loans and geographic region as at December&#160;31, 2022 and December&#160;31, 2021:</ix:continuation></span></div><ix:continuation id="f-1077-3" continuedAt="f-1077-4"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industry type</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1143">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-247" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1144">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1145">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-249" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1146">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1147">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-251" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1148">49.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1149">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-253" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1150">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1151">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-255" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1152">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1153">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-257" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1154">28.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer discretionary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1155">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-259" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1156">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1157">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-261" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1158">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Energy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1159">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-263" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1160">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1161">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-265" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1162">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer staples</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-267" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="f-1164">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1165">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-269" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1166">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1167">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-271" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1168">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1169">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-273" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1170">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total middle market mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1171">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1172">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1173">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1174">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geographic Region</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1175">64.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1176">59.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1177">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1178">85.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1179">42.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-281" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1180">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1181">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-283" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1182">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1183">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-284" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1184">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1185">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-285" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1186">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary credit quality indicator of middle market loans is loan performance. Non-performing middle market loans are generally 90 days or more past due. As of December&#160;31, 2022, all of our middle market loans were performing. Loan-to-enterprise-value and fixed charge coverage ratios are measures we use to assess the risk and quality of middle market loans. The loan-to-enterprise-value ratio is expressed as a percentage of the value of the loan relative to the value of the business. A loan-to-enterprise-value ratio in excess of 100% indicates the unpaid </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-8" continuedAt="f-703-9"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loan amount exceeds the value of the underlying business. <ix:continuation id="f-1119-2" continuedAt="f-1119-3">The following table represents the loan-to-enterprise-value ratio of the middle market loan portfolio as at December&#160;31, 2022 and December&#160;31, 2021:</ix:continuation></span></div><ix:continuation id="f-1119-3" continuedAt="f-1119-4"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 50%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1187">63.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1188">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50% to 60%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1189">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1190">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61% to 70%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1191">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1192">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71% to 80%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1193">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1194">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81% to 100%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1195">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1196">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 100%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1198">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1199">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1200">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fixed charge coverage ratio, based upon the most recent financial statements, is expressed as a percentage of a firm&#8217;s earnings plus fixed charges to its fixed charges. Fixed charges include debt repayments, interest and equipment lease expenses. A fixed charge coverage ratio of less than 1.0 indicates a firm&#8217;s operations do not generate enough income to cover its fixed charges. <ix:continuation id="f-1128-4" continuedAt="f-1128-5">The following represents the fixed charge coverage ratio of the middle market loan portfolio as at December&#160;31, 2022 and December&#160;31, 2021:</ix:continuation></span></div><ix:continuation id="f-1128-5" continuedAt="f-1128-6"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 1.20x</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1201">95.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1202">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 - 1.20x</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1203">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1204">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00x</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1205">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1206">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1207">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1208">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has individually assessed each of the middle market loans with the fixed charge coverage ratio of less than 1.00x. This is mainly due to increased capital investment to support the increased business post COVID-19. These investments have been performing with the fixed charged increasing over the year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Asset-backed securities represent interests in underlying pools of diversified referenced assets that are collateralised and backed by future cash flows and these securities are performing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global corporate securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Global corporates portfolio consists of debt securities with a non-U.S. debt issuer that are backed by the cash flows generated from real estate holdings and these securities are performing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Equity securities consists of a single non-U.S. private issuer that is a special purpose vehicle designed to grant a first lien right to the underlying senior notes. The underlying issuer is a financial services lender to middle market companies and this security is performing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments &#8212; Equity Method. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2015, the Company, along with seven other insurance companies, established a micro-insurance venture consortium and micro-insurance incubator (&#8220;MVI&#8221;) domiciled in Bermuda. The MVI is a social impact organization that provides micro-insurance products to assist global emerging consumers. In March 2021, the Company committed an additional $<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-1209">0.8</ix:nonFraction> million equity contribution to MVI over a 2 year period and paid $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-1210">0.4</ix:nonFraction> million in the period ending December&#160;31, 2022 (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-1211">0.4</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2017, the Company purchased through its wholly-owned subsidiary, Aspen U.S. Holdings, Inc. (&#8220;Aspen U.S. Holdings&#8221;), a <ix:nonFraction unitRef="number" contextRef="c-305" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1212">49</ix:nonFraction>% share of Digital Risk Resources, LLC (&#8220;Digital Re&#8221;), a U.S.-based enterprise engaged in the business of developing, marketing and servicing turnkey information security and privacy liability insurance products for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="f-1213">2.3</ix:nonFraction> million. The investment is accounted for under the equity </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-9" continuedAt="f-703-10"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">method and adjustments to the carrying value of this investment are made based on the Company&#8217;s share of capital, including share of income and expenses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2019, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1214">5.0</ix:nonFraction> million as an equity investment in the holding company of a multi-line reinsurer. The strategy for the multi-line reinsurer is to combine a diversified reinsurance business, focused primarily on long-tailed lines of property and casualty business and, potentially to a lesser extent, life business, with a diversified investment strategy. During the period ending December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-1215">1.6</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-1216">2.5</ix:nonFraction> million) capital was invested in multi-line reinsurer. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-1217" continuedAt="f-1217-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the Company&#8217;s investments in MVI, Multi-Line Reinsurer and Digital Re for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MVI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Multi-Line Reinsurer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Digital Re</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening undistributed value of investment as at January&#160;1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1218">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1219">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1220">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1221">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-1222">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-1223">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:fixed-zero" scale="6" id="f-1224">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-1225">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-1226">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-1227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-1228">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-1229">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (loss)/gain for the twelve months to December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-1230">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-1231">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:fixed-zero" scale="6" id="f-1232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-1233">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing value of investment as at December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1234">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1235">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1236">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1237">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening undistributed value of investment as at January&#160;1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:fixed-zero" scale="6" id="f-1238">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1239">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1240">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1241">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-1242">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-1243">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-1244">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-1245">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-1246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-1247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="f-1248">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="f-1249">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain for the twelve months to December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-1250">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-1251">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:fixed-zero" scale="6" id="f-1252">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-1253">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing value of investments at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1254">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1255">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1256">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-1257">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2017, the Company committed to, and during 2018 invested $<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-1258">100.0</ix:nonFraction> million as a limited partner to a real estate fund, classified as other investments. As at December&#160;31, 2022, the current fair value of the fund is $<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1259">134.6</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1260">129.9</ix:nonFraction>&#160;million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-1261">20.0</ix:nonFraction> million as a limited partner to a third party managed real estate fund. The Partnership was established to make equity and equity related investments in multifamily and other commercial real estate properties located in the United States and its territories, with the goal of generating superior risk-adjusted returns. The Partnership seeks to acquire commercial real estate assets including real estate assets (or interests therein) that may have management or operational problems and require improvements or lack sufficient capital, including mortgage loans and development or redevelopment properties. On April 1, 2022, the Company committed an additional $<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-1262">10.0</ix:nonFraction>&#160;million to the fund. As at December&#160;31, 2022, the current fair value of the fund is $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1263">40.6</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1264">21.4</ix:nonFraction> million) and the unfunded commitment is $<ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-1265">3.3</ix:nonFraction> million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-1266">30.0</ix:nonFraction> million as a limited partner to a related party managed real estate fund. The Partnership was established to pursue investment opportunities to acquire, recapitalize, restructure and reposition real estate assets, portfolios and companies primarily in the United States. As at December&#160;31, 2022, the current fair value of the fund is $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1267">25.3</ix:nonFraction> million and the unfunded commitment is $<ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-1268">5.3</ix:nonFraction> million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2022, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-1269">15.0</ix:nonFraction> million as a limited partner to a third party managed infrastructure fund. The Partnership was established to make investments in value added infrastructure investments </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-10" continuedAt="f-703-11"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in environmental services, transportation, communications and digital, energy/energy transition and other infrastructure sectors primarily in North America. As at December&#160;31, 2022, the current fair value of the fund is $<ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1270">8.2</ix:nonFraction> million and the unfunded commitment is $<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-1271">8.4</ix:nonFraction> million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the aggregate current fair value of the real estate funds investments described above is $<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1272">221.3</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1273">151.3</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on the real estate funds, refer to Note 20(a) in these consolidated financial statements, &#8220;Commitments and Contingencies.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed income maturities, Available for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The scheduled maturity distribution of the Company&#8217;s available for sale fixed income securities as at December&#160;31, 2022 and December&#160;31, 2021 is set forth below. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-1274" continuedAt="f-1274-1" escape="true">Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties.</ix:nonNumeric></span></div><ix:continuation id="f-1274-1" continuedAt="f-1274-2"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost&#160;or&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>S&amp;P Ratings&#160;by<br/>Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="f-1275">179.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="f-1276">176.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" id="f-1277">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-1278">2,526.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1279">2,385.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" id="f-1280">AA-</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="f-1281">815.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="f-1282">707.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" id="f-1283">A+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="6" id="f-1284">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="f-1285">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" id="f-1286">A-</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total &#8212; Government and corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-1287">3,534.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1288">3,280.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-1289">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-1290">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-340" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-1291">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-1292">590.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-1293">502.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-341" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-1294">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-1295">4,131.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1296">3,788.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost&#160;or&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>S&amp;P Ratings&#160;by<br/>Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="f-1297">545.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="f-1298">549.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-116" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" id="f-1299">AA-</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-1300">2,057.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1301">2,087.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-116" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" id="f-1302">AA-</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-1303">1,090.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1304">1,106.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-116" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" id="f-1305">A+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="6" id="f-1306">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="f-1307">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-116" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" id="f-1308">A-</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total &#8212; Government and corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-1309">3,733.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1310">3,784.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-1311">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-1312">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-344" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-1313">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-1314">1,082.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1315">1,090.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-345" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-1316">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-1317">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-1318">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-346" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-1319">AAA</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-1320">4,823.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1321">4,881.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guaranteed Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As at December&#160;31, 2022 and December&#160;31, 2021, the Company held <ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:InvestmentFunds" format="ixt:fixed-zero" scale="0" id="f-1322">no</ix:nonFraction> investments which are guaranteed by mono-line insurers, excluding those with explicit government guarantees. The Company&#8217;s exposure to other third-party guaranteed debt is primarily to investments backed by non-U.S.&#160;government guaranteed issuers.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-11" continuedAt="f-703-12"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross unrealized losses, available for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="f-1323" continuedAt="f-1323-1" escape="true">The following tables summarize, by type of security, the aggregate fair value and gross unrealized loss by length of time the security has been in an unrealized loss position for the Company&#8217;s available for sale portfolio as at December&#160;31, 2022 and December&#160;31, 2021:</ix:nonNumeric></span></div><ix:continuation id="f-1323-1" continuedAt="f-1323-2"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0-12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Over 12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1324">741.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1325">30.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1326">203.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1327">20.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1328">944.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1329">50.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-151" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1330">118</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1331">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1332">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1333">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1335">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1336">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-152" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1337">5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1338">133.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1339">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1340">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1341">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1342">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1343">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-153" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1344">59</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1345">1,104.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1346">77.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1347">568.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1348">91.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1349">1,672.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1350">169.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-154" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1351">701</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1352">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1353">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1354">99.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1355">8.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1356">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1357">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-155" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1358">16</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1359">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1360">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1361">135.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1362">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1363">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1364">11.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-156" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1365">45</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1366">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1367">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-1368">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1370">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1371">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-157" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1372">1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1373">202.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1374">24.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1375">299.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1376">62.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1377">501.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1378">87.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-158" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1379">220</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1380">2,269.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1381">145.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1382">1,323.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1383">193.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1384">3,593.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1385">338.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security2" contextRef="c-348" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="f-1386">1,165</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1387">51.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1388">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-1389">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1391">51.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1392">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-177" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1393">1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1394">2,321.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1395">145.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1396">1,323.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1397">193.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1398">3,645.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1399">339.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-12" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="f-1400">1,166</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-703-12" continuedAt="f-703-13"><ix:continuation id="f-1323-2" continuedAt="f-1323-3"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0-12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Over 12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1401">309.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1402">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1403">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1404">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1405">338.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1406">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-162" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1407">51</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1408">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-1409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-1410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1412">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-163" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1414">5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1415">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1416">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-1417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1419">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1420">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-164" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1421">20</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1422">804.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1423">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1424">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1425">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1426">828.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1427">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-165" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1428">400</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1429">114.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1430">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-1431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1433">114.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1434">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-166" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1435">10</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1436">181.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1437">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1438">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1440">184.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1441">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-167" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1442">35</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1443">564.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1444">11.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1445">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1446">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1447">580.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1448">12.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-170" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1449">116</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1450">2,010.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1451">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1452">72.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1453">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1454">2,082.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1455">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security2" contextRef="c-349" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1456">637</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-1457">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-1458">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-1459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-1461">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-1462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security2" contextRef="c-18" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1463">7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1464">2,014.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-1465">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-1466">72.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-1467">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-1468">2,086.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-1469">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-13" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-1470">644</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in gross unrealized losses is largely attributable to the impact of rising interest rates on our bond portfolio and mortgage-backed securities.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_586"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-1471" continuedAt="f-1471-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Variable Interest Entities</span></ix:nonNumeric></div><ix:continuation id="f-1471-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company held an investment in <ix:nonFraction unitRef="investment" contextRef="c-12" decimals="INF" name="ahl:NumberOfInvestmentsInVariableInterestEntities" format="ixt-sec:numwordsen" scale="0" id="f-1472">one</ix:nonFraction> (December&#160;31, 2021 &#8212; <ix:nonFraction unitRef="investment" contextRef="c-13" decimals="INF" name="ahl:NumberOfInvestmentsInVariableInterestEntities" format="ixt-sec:numwordsen" scale="0" id="f-1473">one</ix:nonFraction>) variable interest entity (&#8220;VIE&#8221;), namely Peregrine Reinsurance Ltd (&#8220;Peregrine&#8221;). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peregrine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In November 2016, Peregrine, a subsidiary of the Company, was registered as a segregated accounts company under the Segregated Accounts Companies Act 2000, as amended. As at December&#160;31, 2022, Peregrine had six segregated accounts which were funded by third-party investors, which are not consolidated, and two segregated accounts which are funded by Aspen and are consolidated within the financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that Peregrine has the characteristics of a VIE as addressed by the guidance in ASC&#160;810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The six segregated accounts have not been consolidated as part of the Company&#8217;s consolidated&#160;financial statements because the Company is not the primary beneficiary of those accounts.&#160;The Company has, however, concluded that it is the primary beneficiary of the Peregrine general fund and, similar to prior reporting periods, the results of the Peregrine general fund are included in the Company&#8217;s consolidated financial statements.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_598"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-1474" continuedAt="f-1474-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Fair Value Measurements</span></ix:nonNumeric></div><ix:continuation id="f-1474-1" continuedAt="f-1474-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of fair value for financial assets and liabilities are based on the framework established in the fair value accounting guidance included in ASC Topic 820, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; The framework prioritizes the inputs, which refer broadly to assumptions market participants would use in pricing an asset or liability, into three levels.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for actively traded securities to be derived based on quoted prices in an active market for identical assets, which are Level&#160;1 inputs in the fair value hierarchy. The majority of these securities are valued using prices supplied by pricing services.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1474-2" continuedAt="f-1474-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for other securities that may not be as actively traded which are priced via pricing services, vendors and broker-dealers, or with reference to interest rates and yield curves, to be derived based on inputs that are observable for the asset, either directly or indirectly, which are Level&#160;2 inputs in the fair value hierarchy. The majority of these securities are also valued using prices supplied by pricing services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers securities, other financial instruments, privately-held investments and derivative insurance contracts subject to fair value measurement whose valuation is derived by internal valuation models to be based largely on unobservable inputs, which are Level&#160;3 inputs in the fair value hierarchy.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-1475" continuedAt="f-1475-1" escape="true"><ix:continuation id="f-1474-3" continuedAt="f-1474-4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the level within the fair value hierarchy at which the Company&#8217;s financial assets and liabilities are measured on a recurring basis as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available for sale financial assets, at fair value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1476">953.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1478">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1479">953.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1481">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1483">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1485">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1486">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1487">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1489">1,845.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1491">1,845.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1493">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1494">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1495">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1496">145.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1497">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1499">213.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1500">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1501">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1505">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1506">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1507">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1509">502.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1510">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1511">502.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1512">1,098.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1513">2,690.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1515">3,788.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1516">51.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1517">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1519">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Held for trading financial assets, at fair value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1520">261.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1523">261.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1525">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1527">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1528">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1529">162.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1531">162.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1533">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1534">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1535">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1537">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1538">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1539">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1540">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1541">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1542">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1543">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1544">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1545">896.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1546">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1547">896.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-422" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1548">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1549">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1550"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1551">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1552">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1553">272.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1554">1,203.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1555">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1556">1,475.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1557">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1560">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-1562">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-1564">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:fixed-zero" scale="6" id="f-1565">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:fixed-zero" scale="6" id="f-1566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1567">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1568">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1569">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1570">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1571">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1572">221.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial assets and liabilities, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives at fair value &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-1573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-1574">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-1575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-1576">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities under derivative contracts &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-1577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-1578">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-1579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-1580">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities under derivative contracts &#8212; loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-1581">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-1582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-1583">31.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-1584">31.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-449" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-1585">1,428.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-1586">3,949.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1587">501.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-1588">6,100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1475-1" continuedAt="f-1475-2"><ix:continuation id="f-1474-4" continuedAt="f-1474-5"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents our investments in real estate and other special purpose vehicles and are measured at fair value using the net asset value per share practical expedient. As a result this has not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheets. The investment in the real estate and other funds is subject to restrictions as detailed in Note 20(a), &#8220;Commitments and Contingencies.&#8221;</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The loss portfolio transfer contract includes a funds withheld arrangement that provides variable interest expense based on Aspen&#8217;s investment performance. As a result, this funds withheld arrangement is considered an embedded derivative and accounted for as an option-based derivative. </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1475-2" continuedAt="f-1475-3"><ix:continuation id="f-1474-5" continuedAt="f-1474-6"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available for sale financial assets, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1589">1,084.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1590">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-456" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1592">1,084.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1594">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1596">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1598">82.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1600">82.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1602">2,208.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1603">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1604">2,208.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-469" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1605">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1606">136.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1607">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1608">136.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1609">164.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1610">86.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1611">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-476" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1612">250.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-477" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1613">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1614">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1616">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1617">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1618">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1619">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1620">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1622">1,090.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1623">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1624">1,090.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1625">1,248.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1626">3,632.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-492" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1628">4,881.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-493" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1629">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-494" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1630">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-495" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1632">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Held for trading financial assets, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1633">116.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-498" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1635">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1636">116.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1638">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1639">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1640">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-505" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-506" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1642">96.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-507" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1643">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-508" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1644">96.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-509" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1645">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-510" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1646">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-511" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1648">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1649">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1650">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-515" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-516" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1652">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-517" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1653">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-518" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1654">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1656">34.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1657">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1658">785.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1660">785.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-525" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-526" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1662">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-527" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1663">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-528" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1664">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1665">128.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1666">1,029.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1667">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-1668">1,157.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1669">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1670">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1672">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:fixed-zero" scale="6" id="f-1673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:fixed-zero" scale="6" id="f-1674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1675">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1676">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1677">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-1678">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1679">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-1680">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1681">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-538" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-1683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-1684">151.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial assets and liabilities, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives at fair value &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-1685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-1686">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-1687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-1688">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities under derivative contracts &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-1689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-545" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-1690">13.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-546" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-1691">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-547" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-1692">13.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-548" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-1693">1,384.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-549" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-1694">4,669.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-550" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1695">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-551" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-1696">6,512.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents our investments in real estate funds and are measured at fair value using the net asset value per share practical expedient. As a result this has not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheets. The investment in the real estate funds is subject to restrictions as detailed in Note 20(a), &#8220;Commitments and Contingencies.&#8221;</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1474-6" continuedAt="f-1474-7"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers of assets into or out of a particular level are recorded at their fair values as of the end of each reporting period consistent with the date of the determination of fair value. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1697">Nil</ix:nonFraction> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:num-dot-decimal" scale="6" id="f-1698">19.5</ix:nonFraction> million was transferred into Level 3) was transferred in or out of Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, there were privately-held investments carried at $<ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:num-dot-decimal" scale="6" id="f-1699">533.0</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:num-dot-decimal" scale="6" id="f-1700">307.1</ix:nonFraction> million) classified as Level 3. As a result of loans sold by Aspen and loans repaid to Aspen by borrowers, a net settlement of $<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:num-dot-decimal" scale="6" id="f-1701">147.4</ix:nonFraction> million occurred during the year. Additionally as at December&#160;31, 2022, there was an embedded derivative as part of the loss portfolio transfer agreement worth $<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="f-1702">31.7</ix:nonFraction>&#160;million classified as Level 3. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-1703" continuedAt="f-1703-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the beginning and ending balances for all assets and liabilities measured at fair value on a recurring basis using Lev</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">el 3 inputs for the twelve months ended December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchases and issuances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers in/(out)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements and sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase/(decrease) in fair value including net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1704">Change in unrealized investment gains (losses) relating to assets held at end of year</span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="45" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; trading</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-554" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1705">211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1706">215.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1707">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1708">113.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1709">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-556" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1710">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-557" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-1711">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-558" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1712">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1713">61.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1715">19.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1716">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-560" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1717">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-561" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-1718">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-562" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1719">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1720">54.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1721">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1722">12.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1723">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-564" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1724">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-565" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-1725">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-566" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1727">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="f-1729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1730">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-568" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1731">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-569" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-1732">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-570" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1733">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1734">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1736">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1737">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-572" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1738">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-573" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-1739">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-574" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1741">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="f-1743">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="f-1744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-576" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1745">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-577" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-1746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Level 3 assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-578" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1747">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1748">378.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1750">147.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1751">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1752">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-579" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-1753">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities under derivative contracts - loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-580" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="f-1754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="f-1755">17.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1756">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" format="ixt:fixed-zero" scale="6" id="f-1757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-1758">14.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-582" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-1759">31.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-1760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Level 3 liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-583" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="f-1761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="f-1762">17.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" format="ixt:fixed-zero" scale="6" id="f-1764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-1765">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-585" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-1766">31.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-1767">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="45" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; trading</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-586" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1768">163.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-587" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1769">169.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-587" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-587" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1771">122.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-587" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1772">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-588" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1773">211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-589" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-1774">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-590" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1775">112.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-591" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1776">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-591" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1777">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-591" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1778">56.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-591" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1779">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-592" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1780">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-593" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-1781">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-594" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1782">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-595" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1783">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-595" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1784">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-595" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1785">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-595" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1786">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-596" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1787">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-597" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-1788">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-598" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1789">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-599" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1790">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-599" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-1791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-599" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1792">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-599" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1793">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-600" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1794">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-601" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-1795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-602" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1797">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="f-1798">19.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="f-1799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="f-1800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-603" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-1801">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-604" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-1802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Level 3 assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-605" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1803">299.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-606" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-1804">205.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-606" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="f-1805">19.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-606" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-1806">182.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-606" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-1807">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-550" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-1808">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-607" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-1809">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="f-1703-1" continuedAt="f-1703-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Fixed Income Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. &#160;</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1703-2" continuedAt="f-1703-3">The Company&#8217;s fixed income securities are classified as either</ix:continuation> available for sale or trading and are reported at fair value. As at December&#160;31, 2022 and December&#160;31, 2021, the Company&#8217;s fixed income securities were valued by pricing services or broker-dealers using standard market conventions. The market conventions utilize market quotations, market transactions in comparable instruments and </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1474-7" continuedAt="f-1474-8"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">various relationships between instruments including, but not limited to, yield to maturity, dollar prices and spread prices in determining value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Pricing Services.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying methodology used to determine the fair value of securities in the Company&#8217;s available for sale and trading portfolios is by the pricing services. Pricing services will gather observable pricing inputs from multiple external sources, including buy and sell-side contacts and broker-dealers, in order to develop their internal prices. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing services provide pricing for less complex, liquid securities based on market quotations in active markets. Pricing services supply prices for a broad range of securities including those for actively traded securities, such as Treasury and other Government securities, in addition to those that trade less frequently or where valuation includes reference to credit spreads, pay down and pre-pay features and other observable inputs. These securities include Government agency, municipals, corporate and asset-backed securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For securities that may trade less frequently or do not trade on a listed exchange, these pricing services may use matrix pricing consisting of observable market inputs to estimate the fair value of a security. These observable market inputs include reported trades, benchmark yields, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and industry and economic factors. Additionally, pricing services may use a valuation model such as an option adjusted spread model commonly used for estimating fair values of mortgage-backed and asset-backed securities. The Company does not derive dollar prices using an index as a pricing input for any individual security.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broker-Dealers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company obtains quotes from broker-dealers who are active in the corresponding markets when prices are unavailable from independent pricing services or index providers. Generally, broker-dealers value securities through their trading desks based on observable market inputs. Their pricing methodologies include mapping securities based on trade data, bids or offers, observed spreads and performance of newly issued securities. They may also establish pricing through observing secondary trading of similar securities. Quotes from broker-dealers are non-binding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company obtains prices for all of its fixed income investment securities via its third-party accounting service provider, and in the majority of cases receiving a number of quotes so as to obtain the most comprehensive information available to determine a security&#8217;s fair value. A single valuation is applied to each security based on the vendor hierarchy maintained by the Company&#8217;s third-party accounting service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company obtained an average of <ix:nonFraction unitRef="quotesperinvestment" contextRef="c-12" decimals="1" name="ahl:FairValueInputsOfferedQuotesPerFixedIncomeInvestment" scale="0" id="f-1810">2.9</ix:nonFraction> quotes per fixed income investment compared to <ix:nonFraction unitRef="quotesperinvestment" contextRef="c-13" decimals="1" name="ahl:FairValueInputsOfferedQuotesPerFixedIncomeInvestment" scale="0" id="f-1811">3.0</ix:nonFraction> quotes at December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, in conjunction with its third-party accounting service provider, obtains an understanding of the methods, models and inputs used by the third-party pricing service and index providers to assess the ongoing appropriateness of vendors&#8217; prices. The Company and its third-party accounting service provider also have controls in place to validate that amounts provided represent fair values. Processes to validate and review pricing include, but are not limited to:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">quantitative analysis (e.g., comparing the quarterly return for each managed portfolio to its target benchmark, with significant differences identified and investigated);</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comparison of market values obtained from pricing services and broker-dealers against alternative price sources for each security where further investigation is completed when significant differences exist for pricing of individual securities between pricing sources;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">initial and ongoing evaluation of methodologies used by outside parties to calculate fair value;&#160;and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comparison of the fair value estimates to the Company&#8217;s knowledge of the current market.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1474-8" continuedAt="f-1474-9"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prices obtained from pricing services and broker-dealers are not adjusted by us; however, prices provided by a pricing service, or broker-dealer in certain instances may be challenged based on market or information available from internal sources, including those available to the Company&#8217;s third-party investment accounting service provider. Subsequent to any challenge, revisions made by the pricing service or broker-dealer to the quotes are supplied to the Company&#8217;s investment accounting service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the vendor hierarchy maintained by the Company&#8217;s third-party accounting service provider in order to determine which price source provides the most appropriate fair value (i.e., a price obtained from a pricing service with more seniority in the hierarchy will be used over a less senior one in all cases). The hierarchy level assigned to each security in the Company&#8217;s available for sale and trading portfolios is based upon its assessment of the transparency and reliability of the inputs used in the valuation as of the measurement date. The hierarchy of pricing services is determined using various qualitative and quantitative points arising from reviews of the vendors conducted by the Company&#8217;s third-party accounting service provider. Vendor reviews include annual due diligence meetings with index providers and pricing services vendors covering valuation methodology, operational walkthroughs and legal and compliance updates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities are traded on the over-the-counter (&#8220;OTC&#8221;) market based on prices provided by one or more market makers in each security. Securities such as U.S.&#160;Government, U.S.&#160;Agency, Foreign Government and investment grade corporate bonds have multiple market makers in addition to readily observable market value indicators such as expected credit spread, except for Treasury securities, over the yield curve. The Company uses a variety of pricing sources to value fixed income securities including those securities that have pay down/prepay features such as mortgage-backed securities and asset-backed securities in order to ensure fair and accurate pricing. The fair value estimates for the investment grade securities in the Company&#8217;s portfolio do not use significant unobservable inputs or modeling techniques.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Government and Agency Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;U.S.&#160;government and agency securities consist primarily of bonds issued by the U.S.&#160;Treasury and corporate debt issued by agencies such as the Federal National Mortgage Association (&#8220;FNMA&#8221;), the Federal Home Loan Mortgage Corporation (&#8220;FHLMC&#8221;) and the Federal Home Loan Bank. As the fair values of U.S.&#160;Treasury securities are based on unadjusted market prices in active markets, they are classified within Level&#160;1. The fair values of U.S.&#160;government agency securities are priced using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of U.S.&#160;government agency securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Municipal Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s municipal portfolio consist of bonds issued by U.S.&#160;domiciled state and municipality entities. The fair value of these securities is determined using spreads obtained from broker-dealers, trade prices and the new issue market which are Level&#160;2 inputs in the fair value hierarchy. Consequently, these securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-U.S. Government.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The issuers for securities in this category are non-U.S.&#160;governments and their agents including, but not limited to, the U.K., Australia, Canada, France and Germany. The fair values of certain non-U.S.&#160;government bonds, primarily sourced from international indices, are based on unadjusted market prices in active markets and are therefore classified within Level&#160;1. The remaining non-U.S. government bonds are classified within level 2 as they are not actively traded. The fair values of the non-U.S.&#160;agency securities, again primarily sourced from international indices, are priced using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of non-U.S.&#160;agency securities are classified within Level&#160;2. In addition, foreign government securities include a portion of the Emerging Market Debt (&#8220;EMD&#8221;) portfolio which is also classified within Level 2. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate securities consist primarily of short-term, medium-term and long-term debt issued by U.S.&#160;and foreign corporations covering a variety of industries and are generally priced by index providers and pricing vendors. Some issuers may participate in&#160;government programs which guarantee timely payment of principal and interest in the event of a default. The fair values of these securities are generally determined using the spread above the risk-free yield curve. Inputs used in the evaluation of these securities include credit data, interest rate data, market observations and sector news, broker-dealer quotes and trade volumes. In addition, corporate securities </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1474-9" continuedAt="f-1474-10"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">include a portion of the EMD portfolio. The Company classifies these securities across Level 1 and 2, with majority of them being in Level 1.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-backed Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Residential and commercial mortgage-backed securities consist of bonds issued by the Government National Mortgage Association, the FNMA and the FHLMC as well as private non-agency issuers. The fair values of these securities are determined through the use of a pricing model (including Option Adjusted Spread) which uses prepayment speeds and spreads to determine the appropriate average life of the mortgage-backed security. These spreads are generally obtained from broker-dealers, trade prices and the new issue market. As the significant inputs used to price mortgage-backed securities are observable market inputs, these securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Asset-backed securities are securities backed by notes or receivables against assets other than real estate. The underlying collateral for the Company&#8217;s asset-backed securities consists mainly of student loans, automobile loans and credit card receivables. These securities are primarily priced by index providers and pricing vendors. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, interest rate data and credit spreads. The Company classifies these securities within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privately-Held Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Privately-held investments are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models. These models include inputs that are specific to each investment. The inputs used in the fair value measurements include dividend or interest rates and appropriate discount rates. The selection of an appropriate discount rate is judgmental and is the most significant unobservable input used in the valuation of these securities. A significant increase (decrease) in this input in isolation could result in significantly lower (higher) fair value measurement for privately-held investments. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow models, the Company maintains an understanding of current market conditions, issuer specific information that may impact future cash flows as well as collaboration with independent vendors for most securities to assess the reasonableness of the discount rate being used.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial mortgage loans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial mortgage loans consists in investments in properties including apartments, hotels, office and retail buildings, other commercial properties and industrial properties. The commercial mortgage loan portfolio is diversified by property type, geographic region and issuer to reduce risks. Commercial Mortgage Loans are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The middle market loans consist in investments in senior secured loan positions with full covenants, focused on the middle market in both U.S., Europe and the Caribbean. The middle market loan portfolio is diversified by industry type, geographic region and issuer to reduce risks. Middle Market Loans are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Asset-backed securities represent interests in underlying pools of diversified referenced assets that are collateralised and backed by future cash flows and these securities are performing. The fair values of these securities are determined by using discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global corporate securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The global corporates portfolio consists of debt securities with a non-U.S. debt issuer that are backed by the cash flows generated from real estate holdings and these securities are performing. The fair value of these securities are determined by using discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Equity securities consists of a single non-U.S. based issuer that is a special purpose vehicle designed to grant a first lien right to the underlying senior notes within the structure. The underlying issuer is a financial services lender to middle market companies and this security is performing. The valuation of the investments is DCF and the securities are classified as Level 3. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1474-10" continuedAt="f-1474-11"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Short-term investments consist of highly liquid debt securities with a maturity greater than three months but less than one year from the date of purchase. Short-term investments are classified as either trading or available for sale according to the facts and circumstances of the investment held. Short-term investments are valued in a manner similar to the Company&#8217;s fixed maturity investments and are classified within Levels 1 and 2.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-1812" continuedAt="f-1812-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the quantitative inputs and assumptions used for financial assets and liabilities investments categorized as Level 3 under the fair value hierarchy as at December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Techniques</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable (U) inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ranges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-608" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1813">200.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-609" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1814">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-610" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1815">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-611" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1816">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-612" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1817">85.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-613" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1818">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidation method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-614" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1819">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-615" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1820">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-616" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1821">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-617" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1822">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-618" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1823">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-619" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1824">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-620" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1825">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-621" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1826">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-622" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1827">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-623" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1828">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-624" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1829">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-625" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1830">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-626" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1831">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-627" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1832">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-628" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1833">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-629" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1834">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-630" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1835">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-631" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1836">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-632" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1837">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-633" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1838">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-634" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-1839">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-1840">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Catastrophe Bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe bonds are variable rate fixed income instruments with redemption values adjusted based on the occurrence of a covered event, usually windstorms and earthquakes. Catastrophe bonds are classified as trading and reported at fair value.&#160;Catastrophe bonds are priced using an average of multiple broker-dealer quotes and as such, are considered Level 2.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; The foreign exchange contracts which the Company uses to mitigate currency risk are characterized as OTC due to their customized nature and the fact that they do not trade on a major exchange. These instruments trade in a very deep liquid market, providing substantial price transparency and accordingly are classified as Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liabilities under derivative contracts - loss portfolio transfer. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LPT embedded derivative is valued in a Black-Scholes framework. The two primary inputs of this policy are expected claim settlement patterns and expected return of the investment portfolio above a fixed minimum rate over the specified time horizon. The expected claim settlement pattern is determined on an actuarial basis for the cohort of business within scope of the LPT and is consistent with the patterns used in the valuation of technical provisions. The expected return of the investment portfolio, above a fixed minimum rate, directly impacts on the LPT derivative valuation and is subject to changes in the market conditions. In order to assess the reasonableness of the inputs, the company updates the expected claim settlement patterns on a regular basis whilst maintaining an understanding of the current market conditions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other investments represent our investments in real estate funds and other special purpose vehicles. Adjustments to the fair values are made based on the net asset value of the investments. The net valuation criteria established by the manager of such investments are established in accordance with the governing documents and the asset manager&#8217;s valuation guidelines, which include: the discounted cash flows method and the performance multiple approach, which uses a multiple derived from market data of comparable </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1474-11" continuedAt="f-1474-12"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies or assets to produce operating performance metrics. Alternative valuation methodologies may be employed for investments with unusual characteristics.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_610"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:ReinsuranceTextBlock" id="f-1841" continuedAt="f-1841-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Reinsurance</span></ix:nonNumeric></div><ix:continuation id="f-1841-1" continuedAt="f-1841-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases retrocession and reinsurance to limit and diversify the Company&#8217;s risk exposure and to increase its own insurance and reinsurance underwriting capacity. These agreements provide for recovery of losses and loss adjustment expenses from reinsurers. The Company remains liable to the extent that reinsurers do not meet their obligations under these agreements. In line with its risk management objectives, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balances pertaining to reinsurance transactions are reported &#8220;gross&#8221; on the consolidated balance sheet, meaning that reinsurance recoverable on unpaid losses and ceded unearned premiums are not deducted from insurance reserves but are recorded as assets. For more information on reinsurance recoverables, refer to Note&#160;21, &#8220;Concentrations of Credit Risk&#160;&#8212; Reinsurance recoverables&#8221; and Note 10, &#8220;Reserves for Losses and Loss Adjustment Expenses&#8221; of these consolidated financial statements. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EffectsOfReinsuranceTableTextBlock" id="f-1842" continuedAt="f-1842-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of assumed and ceded reinsurance on premiums written, premiums earned and insurance losses and loss adjustment expenses for the twelve months ended December 31, 2022, 2021 and 2020 was as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve&#160;Months&#160;Ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums written:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DirectPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1843">2,531.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DirectPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1844">2,341.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DirectPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1845">2,042.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:AssumedPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1846">1,807.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AssumedPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1847">1,597.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AssumedPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1848">1,656.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1849">1,442.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1850">1,350.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-1851">1,120.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums written</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-1852">2,896.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-1853">2,587.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-1854">2,577.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums earned:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1855">2,370.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1856">2,139.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1857">2,026.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:AssumedPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1858">1,617.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AssumedPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1859">1,479.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AssumedPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1860">1,612.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:CededPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1861">1,299.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CededPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1862">1,207.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CededPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-1863">1,110.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums earned</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-1864">2,688.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-1865">2,410.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-1866">2,527.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance losses and loss adjustment expenses: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="f-1867">1,574.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="f-1868">1,499.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="f-1869">1,479.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="f-1870">939.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" format="ixt:num-dot-decimal" scale="6" id="f-1871">1,000.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" format="ixt:num-dot-decimal" scale="6" id="f-1872">1,134.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="f-1873">833.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="f-1874">807.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="f-1875">773.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net insurance losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-1876">1,680.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-1877">1,693.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="f-1878">1,840.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2022, Aspen Holdings and certain of its subsidiaries (&#8220;Aspen&#8221;) entered into an Amended and Restated Reinsurance Agreement with a subsidiary of Enstar Group Limited (together, &#8220;Enstar&#8221;) (the &#8220;LPT&#8221;), which amended and restated the Adverse Development Cover Agreement, dated as of March 2, 2020, previously entered into between Enstar and Aspen Group (the &#8220;Original Agreement)&#8221;. Under the terms of the LPT, Enstar&#8217;s subsidiary will reinsure net losses incurred on or prior to December 31, 2019 on all of Aspen&#8217;s net loss reserves of $<ix:nonFraction unitRef="usd" contextRef="c-635" decimals="-5" name="us-gaap:ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent" format="ixt:num-dot-decimal" scale="6" id="f-1879">3,120.0</ix:nonFraction> million as of September 30, 2021. The LPT provides for a limit of $<ix:nonFraction unitRef="usd" contextRef="c-636" decimals="-5" name="us-gaap:ReinsuranceRetentionAmountRetainedPerEvent" format="ixt:num-dot-decimal" scale="6" id="f-1880">3,570.0</ix:nonFraction> million in consideration for a premium of $<ix:nonFraction unitRef="usd" contextRef="c-637" decimals="-5" name="ahl:ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" format="ixt:num-dot-decimal" scale="6" id="f-1881">3,160.0</ix:nonFraction> million. The amount of net loss reserves ceded, as well as the premium and limit amounts provided under the LPT, was adjusted for claims paid between October 1, 2021 and the closing date of the transaction. The premium includes $<ix:nonFraction unitRef="usd" contextRef="c-638" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-1882">770</ix:nonFraction> million of premium previously paid with respect to reserves ceded under the Original </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1841-2" continuedAt="f-1841-3"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement, which will continue to be held in trust accounts to secure the Enstar subsidiary&#8217;s obligations under the LPT. The incremental new premium will initially be held in funds withheld accounts in their original currencies maintained by Aspen but will be released to the trust accounts maintained by the Enstar subsidiary no later than September 30, 2025. The funds withheld by Aspen will be credited with interest at an annual rate of <ix:nonFraction unitRef="number" contextRef="c-639" decimals="INF" name="ahl:ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" scale="-2" id="f-1883">1.75</ix:nonFraction>% plus, for periods after October 1, 2022, an additional amount equal to 50% of the amount by which the total return on Aspen&#8217;s investments and cash and cash equivalents exceeds <ix:nonFraction unitRef="number" contextRef="c-639" decimals="INF" name="ahl:ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" scale="-2" id="f-1884">1.75</ix:nonFraction>%. Under the LPT, the Enstar subsidiary assumed claims control, pursuant to the provisions of an administrative services agreement subsequently entered into between the parties on June 30, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current expected loss model (&#8220;CECL&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On June 16, 2016, the FASB issued ASU 2016-13, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; which introduced a new impairment model, known as the current expected loss model (&#8220;CECL&#8221;), which is based on expected losses rather than incurred losses. Following the adoption of CECL with effect from January 1, 2020, the Company recognized a reduction in the Company&#8217;s reinsurance recoverables by $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1885">3.7</ix:nonFraction> million as at December&#160;31, 2022 (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1886">3.3</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022 there was an increase in the CECL allowance on reinsurance recoverables of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-1887">0.4</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-1888">0.5</ix:nonFraction> million decrease).</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1841-3" continuedAt="f-1841-4">The Company is potentially exposed to concentrations of credit risk in respect of amounts recoverable from reinsurers, refer to Note&#160;21, &#8220;Concentrations of Credit Risk&#160;&#8212; Reinsurance recoverables&#8221; of these consolidated financial statements for more detail.</ix:continuation> </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_622"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-1889" continuedAt="f-1889-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Derivative Contracts</span></ix:nonNumeric></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-1890" continuedAt="f-1890-1" escape="true"><ix:continuation id="f-1889-1" continuedAt="f-1889-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information on the location and amounts of derivative fair values on the consolidated balance sheet as at December&#160;31, 2022 and 2021: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments<br/>Under ASC&#160;815</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives at Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-640" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-1891">945.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-640" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1892">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-641" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-1893">759.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-641" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1894">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities under Derivative Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-642" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-1895">729.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-642" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1896">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-643" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-1897">785.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-643" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1898">12.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Portfolio Transfer Liability - Embedded Derivative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities under Derivative Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-644" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-1899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-644" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1900">31.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-645" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-1901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-645" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="f-1902">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Fair value is net of $<ix:nonFraction unitRef="usd" contextRef="c-646" decimals="-5" name="us-gaap:CollateralAlreadyPostedAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1903">3.7</ix:nonFraction> million of cash collateral (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-647" decimals="-5" name="us-gaap:CollateralAlreadyPostedAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1904">2.1</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The LPT contains an embedded derivative within the contract in relation to the variable interest crediting rate. Refer to Note 7 for further information.</span></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1889-2" continuedAt="f-1889-3"><ix:continuation id="f-1890-1" continuedAt="f-1890-2"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments Under ASC&#160;815</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives at Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-1905">109.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1906">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-649" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-1907">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-649" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="f-1908">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities under Derivative Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-650" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-1909">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-650" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="f-1910">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-651" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-1911">143.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-651" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-1912">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="f-1913" continuedAt="f-1913-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the unrealized and realized gains/(losses) recorded in the consolidated statements of operations and other comprehensive income for derivatives that are not designated or designated as hedging instruments under ASC 815 &#8212; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the twelve months ended December&#160;31, 2022 and 2021: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of (Loss)/Gain Recognized on Derivatives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss) <br/>Recognized on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Fair Value of Derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-652" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-1914">80.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-653" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-1915">35.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses in consolidated statement of operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-654" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="f-1916">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-655" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="f-1917">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions in other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-656" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="f-1918">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-657" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="f-1919">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company uses foreign exchange contracts to manage foreign currency risk associated with our operating expenses but also foreign exchange risk associated with net assets or liabilities in currencies other than the U.S. dollar. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of the Company&#8217;s assets and liabilities denominated in foreign currencies but rather allow it to establish a rate of exchange for a future point in time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company held foreign exchange contracts that were not designated as hedges under ASC 815 with an aggregate nominal amount of $<ix:nonFraction unitRef="usd" contextRef="c-646" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1920">1,675.3</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-647" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1921">1,545.7</ix:nonFraction> million). The foreign exchange contracts are recorded as derivatives at fair value in the consolidated balance sheet with changes recorded as a change in fair value of derivatives in the consolidated statement of operations. For the twelve months ended December&#160;31, 2022, the impact of foreign exchange contracts on net income was a loss of $<ix:nonFraction unitRef="usd" contextRef="c-652" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="f-1922">80.5</ix:nonFraction> million (December&#160;31, 2021&#160;&#8212; loss of $<ix:nonFraction unitRef="usd" contextRef="c-653" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="f-1923">35.9</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company held foreign exchange contracts that were designated as hedges under ASC 815 with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1924">109.7</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-651" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1925">143.1</ix:nonFraction> million). The foreign exchange contracts are recorded as assets or liabilities under derivative contracts in the consolidated balance sheet with the effective portion recorded in other comprehensive income and the ineffective portion recorded as a change in fair value of derivatives in the consolidated statement of operations. The contracts are effective and therefore the movement in other comprehensive income representing the effective portion for the twelve months ended December&#160;31, 2022 was a gain of $<ix:nonFraction unitRef="usd" contextRef="c-656" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-1926">15.4</ix:nonFraction> million (December&#160;31, 2021&#160;&#8212; loss of $<ix:nonFraction unitRef="usd" contextRef="c-657" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-1927">6.2</ix:nonFraction> million). </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1889-3" continuedAt="f-1889-4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the foreign exchange contracts settle, the realized gain or loss is reclassified from other comprehensive income into general, administration and corporate expenses of the consolidated statement of operations. For the twelve months ended December&#160;31, 2022, the amount recognized within general, administration and corporate expenses for settled foreign exchange contracts was a realized gain of $<ix:nonFraction unitRef="usd" contextRef="c-654" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-1928">5.9</ix:nonFraction> million (December&#160;31, 2021 &#8212; loss of $<ix:nonFraction unitRef="usd" contextRef="c-655" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-1929">5.7</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded derivative on loss portfolio contract. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss portfolio transfer contract includes a funds withheld arrangement that provides returns to the reinsurer based on Aspen&#8217;s investment performance, guaranteeing a minimum of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-639" decimals="INF" name="ahl:ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" scale="-2" id="f-1930">1.75</ix:nonFraction>%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> return. Such funds withheld arrangements are examples of embedded derivatives and therefore this instrument is accounted for as an option-based derivative. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, the amount recognized as a change in fair value of derivatives in the consolidated statement of operations is $<ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="6" id="f-1931">14.5</ix:nonFraction> million.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_634"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredPolicyAcquisitionCostsTextBlock1" id="f-1932" continuedAt="f-1932-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Deferred Policy Acquisition Costs</span></ix:nonNumeric></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock" id="f-1933" escape="true"><ix:continuation id="f-1932-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of beginning and ending deferred acquisition costs for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="f-1934">290.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="f-1935">306.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs deferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostsAdditions" scale="6" id="f-1936">460.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostsAdditions" scale="6" id="f-1937">398.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-1938">431.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-1939">414.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="f-1940">319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="f-1941">290.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_646"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><ix:nonNumeric contextRef="c-1" name="ahl:ReservesForLossAndAdjustmentExpensesTextBlock" id="f-1942" continuedAt="f-1942-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reserves for Losses and Loss Adjustment Expenses</span></ix:nonNumeric></div><ix:continuation id="f-1942-1" continuedAt="f-1942-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="f-1943" continuedAt="f-1943-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of beginning and ending consolidated loss and LAE reserves for the twelve months ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the start of the year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1944">7,611.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1945">7,165.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1946">6,951.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:ReinsuranceRecoverablesAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-1947">3,298.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="ahl:ReinsuranceRecoverablesAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-1948">3,195.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="ahl:ReinsuranceRecoverablesAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-1949">2,319.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE at the start of the year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-1950">4,313.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-1951">3,970.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-1952">4,632.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE expenses disposed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="ahl:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" format="ixt:num-dot-decimal" scale="6" id="f-1953">1,840.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" format="ixt:fixed-zero" scale="6" id="f-1954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="ahl:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" scale="6" id="f-1955">818.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in net provision for losses and LAE for claims incurred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1956">1,651.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1957">1,648.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1958">1,841.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-1959">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-1960">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-1961">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="f-1962">1,680.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="f-1963">1,693.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="f-1964">1,840.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Losses and LAE payments for claims incurred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="f-1965">192.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="f-1966">729.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="f-1967">404.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="f-1968">1,098.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="f-1969">580.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="f-1970">1,359.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1971">1,291.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1972">1,309.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1973">1,764.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" scale="6" id="f-1974">49.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" scale="6" id="f-1975">39.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" scale="6" id="f-1976">80.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses and LAE reserves at the end of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-1977">2,813.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-1978">4,313.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-1979">3,970.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus reinsurance recoverable on unpaid losses at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-1980">4,897.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-1981">3,298.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-1982">3,195.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the end of the year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1983">7,710.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1984">7,611.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1985">7,165.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div></ix:nonNumeric><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-1943-1" continuedAt="f-1943-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="f-1943-2" continuedAt="f-1943-3">Net loss and LAE expenses disposed of $<ix:nonFraction unitRef="usd" contextRef="c-658" decimals="-5" name="ahl:ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1986">1,840.1</ix:nonFraction> million represent the net loss reserves as at May 20, 2022 (&#8220;Closing Date&#8221;) for losses in relation to 2019 and prior accident years, in addition to the $<ix:nonFraction unitRef="usd" contextRef="c-638" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-1987">770.0</ix:nonFraction> million of ceded reserves under the previous </ix:continuation>ADC agreement, recognizing a total recoverable of $<ix:nonFraction unitRef="usd" contextRef="c-658" decimals="-5" name="ahl:ReinsuranceRecoverablesTotalRecoverable" format="ixt:num-dot-decimal" scale="6" id="f-1988">2,610.1</ix:nonFraction>&#160;million. These reserves were rolled forward from the initial effective date of September 30, 2021, at which time the net losses reserves were $<ix:nonFraction unitRef="usd" contextRef="c-635" decimals="-5" name="us-gaap:ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent" format="ixt:num-dot-decimal" scale="6" id="f-1989">3,120.0</ix:nonFraction> million. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As at December&#160;31, 2022 the total amount recoverable from Enstar under the LPT was $<ix:nonFraction unitRef="usd" contextRef="c-659" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-1990">2,132.0</ix:nonFraction> million (As at December 31, 2021 recoverable from Enstar on the ADC was &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-660" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-1991">838.1</ix:nonFraction> million) which includes claims paid and reserve development since the Closing Date. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss and LAE expenses disposed in 2020 includes the transfer of reserves under the ADC agreement providing $<ix:nonFraction unitRef="usd" contextRef="c-638" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-1992">770.0</ix:nonFraction> million of cover and the loss portfolio transfer transactions for our surety insurance book of $<ix:nonFraction unitRef="usd" contextRef="c-661" decimals="-5" name="ahl:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" format="ixt:num-dot-decimal" scale="6" id="f-1993">42.0</ix:nonFraction>&#160;million and our U.S. accident and health book of $<ix:nonFraction unitRef="usd" contextRef="c-662" decimals="-5" name="ahl:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" format="ixt:num-dot-decimal" scale="6" id="f-1994">6.5</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, there was an increase of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1995">28.1</ix:nonFraction> million in the Company&#8217;s estimate of the ultimate claims to be paid in respect of prior accident years compared to an increase of $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1996">45.1</ix:nonFraction> million for the twelve months ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, prior year reserve strengthening totaled $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1997">28.1</ix:nonFraction> million in 2022, compared with net unfavorable development of $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1998">45.1</ix:nonFraction> million in 2021. Prior year reserve strengthening excludes the full economic benefit of the recoveries from the ADC of $58.3 million which is currently within reinsurance recoverables on unpaid losses. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1942-2" continuedAt="f-1942-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Net reserve releases of $58.8 million in 2022 were mainly due to releases on prior year development on post-LPT years of $24.6 million and the favorable impact of the LPT of $34.2 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Net unfavorable reserve development of $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1999">86.9</ix:nonFraction> million in 2022 included adverse prior year development on post-LPT years of $37.6 million and the unfavorable movement of $49.3 million due to the impact of the LPT, mainly reflecting the one-off costs in relation to the LPT recognized in 2022 and the change from ADC on a fixed allocation basis to the LPT.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_658"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" id="f-2000" continuedAt="f-2000-1" escape="true"><ix:continuation id="f-1942-3" continuedAt="f-1942-4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show an analysis of incurred claims and allocated loss adjustment expenses, net of reinsurance and cumulative paid claims and allocated claim adjustment expenses, net of reinsurance as at December 31, 2022, 2021, 2020, 2019 2018, 2017, 2016, 2015, 2014 and 2013. Under the LPT agreement, the Company has reinsured net losses incurred on all accident years 2019 and prior. This has resulted in total incurred claims, IBNR and loss adjustment expenses in the loss development triangles for 2019 and prior to be Nil. The loss development triangles are derived from all business written by the Company as although a limited number of contracts are written which have durations of greater than one year the contracts do not meet the definition of a long duration contract. All amounts included in the following tables related to transactions denominated in a foreign currency have been translated into U.S. Dollars using the exchange rates in effect at December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has chosen to disaggregate the business in its Insurance segment, for the purposes of these loss development triangles as: Property; Casualty; Marine Aviation and Energy; and Financial and Professional insurance lines. The Company considers that this presentation of its Insurance lines loss development triangles more precisely reflects meaningful trending information. The Company presents its loss development triangles for the Reinsurance segment in line with the reportable reinsurance lines: Property Catastrophe and Other Property; Casualty; and Specialty.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Insurance Lines</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="5" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-663" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2001">126.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-664" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2002">114.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-665" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2003">114.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-666" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2004">109.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-667" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2005">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-668" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2006">109.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-669" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2007">109.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-670" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2008">109.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-671" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2009">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-672" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2010">106.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-672" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2011">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-672" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:fixed-zero" scale="6" id="f-2012">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-673" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2013">162.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-674" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2014">154.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-675" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2015">132.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-676" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2016">133.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-677" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2017">132.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-678" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2018">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-679" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2019">130.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-680" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2020">125.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-681" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2021">131.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-681" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2022">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-681" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2023">9,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-682" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2024">233.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-683" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2025">199.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-684" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2026">193.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-685" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2027">196.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-686" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2028">196.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-687" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2029">193.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-688" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2030">179.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-689" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2031">189.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-689" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2032">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-689" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2033">11,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-690" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2034">233.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-691" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2035">245.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-692" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2036">240.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-693" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2037">241.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-694" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2038">242.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-695" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2039">233.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-696" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2040">244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-696" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-696" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2042">10,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-697" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2043">290.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-698" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2044">253.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-699" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2045">246.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-700" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2046">248.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-701" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2047">280.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2048">247.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-702" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2050">9,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2051">196.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2052">198.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2053">182.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-706" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2054">196.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-707" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2055">177.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-707" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-707" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2057">8,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-708" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2058">122.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-709" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2059">126.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-710" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2060">104.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-711" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2061">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-711" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2062">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-711" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2063">6,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-712" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2064">199.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-713" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2065">195.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-714" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2066">205.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-714" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2067">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-714" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2068">7,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-715" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2069">204.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-716" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2070">199.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-716" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2071">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-716" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2072">6,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-717" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2073">163.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-717" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2074">62.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-717" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2075">4,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2076">1,772.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-2000-1" continuedAt="f-2000-2"><ix:continuation id="f-1942-4" continuedAt="f-1942-5"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Insurance Lines</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-663" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2077">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-664" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2078">73.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-665" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2079">86.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-666" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2080">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-667" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2081">103.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-668" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2082">105.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-669" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2083">107.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-670" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2084">107.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-671" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2085">106.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-672" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2086">106.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-673" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2087">39.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-674" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2088">85.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-675" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2089">112.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-676" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2090">122.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-677" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2091">126.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-678" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2092">127.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-679" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2093">128.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-680" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2094">129.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-681" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2095">131.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-682" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2096">56.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-683" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2097">138.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-684" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2098">165.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-685" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2099">174.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-686" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2100">190.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-687" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2101">188.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-688" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2102">190.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-689" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2103">189.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-690" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2104">65.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-691" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2105">166.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-692" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2106">198.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-693" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2107">219.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-694" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2108">228.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-695" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2109">233.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-696" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2110">244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-697" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2111">95.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-698" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2112">185.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-699" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2113">217.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-700" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2114">237.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-701" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2115">242.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-702" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2116">247.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-703" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2117">60.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-704" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2118">153.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-705" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2119">176.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-706" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2120">173.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-707" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2121">177.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-708" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2122">48.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-709" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2123">88.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-710" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2124">99.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-711" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2125">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-712" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2126">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-713" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2127">122.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-714" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2128">150.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-715" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2129">58.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-716" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2130">118.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-717" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2131">40.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2132">1,513.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" scale="6" id="f-2133">259.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" format="ixt:fixed-zero" scale="6" id="f-2134">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2135">259.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Casualty Insurance Lines</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="5" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-719" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2136">128.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-720" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2137">112.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-721" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2138">111.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-722" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2139">116.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-723" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2140">99.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-724" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2141">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-725" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2142">101.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-726" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2143">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-727" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2144">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-728" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2145">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-728" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2146">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-728" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2147">3,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-729" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2148">139.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-730" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2149">122.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-731" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2150">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-732" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2151">124.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-733" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2152">131.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-734" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2153">134.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-735" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2154">131.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-736" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2155">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-737" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2156">107.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-737" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-737" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2158">3,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-738" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2159">197.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-739" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2160">217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-740" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2161">180.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-741" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2162">197.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-742" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2163">230.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-743" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2164">228.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-744" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2165">250.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-745" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2166">197.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-745" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-745" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2168">4,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-746" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2169">211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-747" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2170">182.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-748" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2171">177.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-749" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2172">184.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-750" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2173">195.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-751" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2174">247.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-752" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2175">163.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-752" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2176">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-752" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2177">4,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-753" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2178">176.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-754" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2179">169.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-755" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2180">173.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-756" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2181">190.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-757" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2182">234.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-758" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2183">154.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-758" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2184">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-758" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2185">5,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-759" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2186">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-760" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2187">122.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-761" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2188">132.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2189">169.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-763" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2190">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-763" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2191">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-763" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2192">5,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-764" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2193">122.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-765" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2194">144.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-766" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2195">155.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2196">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-767" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2198">5,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-768" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2199">131.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-769" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2200">139.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-770" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2201">138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-770" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2202">72.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-770" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2203">3,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-771" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2204">170.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2205">185.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2206">119.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2207">3,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-773" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2208">201.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-773" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2209">132.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-773" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2210">2,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2211">1,417.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-2000-2" continuedAt="f-2000-3"><ix:continuation id="f-1942-5" continuedAt="f-1942-6"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Casualty Insurance Lines</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-719" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2212">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-720" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2213">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-721" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2214">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-722" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2215">51.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-723" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2216">65.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-724" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2217">77.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-725" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2218">82.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-726" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2219">83.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-727" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2220">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-728" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2221">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-729" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2222">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-730" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2223">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-731" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2224">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-732" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2225">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-733" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2226">70.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-734" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2227">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-735" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2228">105.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-736" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2229">104.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-737" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2230">107.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-738" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2231">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-739" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2232">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-740" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2233">55.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-741" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2234">90.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-742" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2235">135.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-743" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2236">163.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-744" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2237">174.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-745" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2238">197.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-746" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2239">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-747" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2240">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-748" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2241">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-749" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2242">79.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-750" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2243">106.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-751" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2244">128.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-752" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2245">163.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-753" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2246">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-754" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2247">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-755" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2248">51.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-756" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2249">93.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-757" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2250">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-758" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2251">154.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-759" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2252">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-760" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2253">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-761" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2254">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-762" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2255">65.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-763" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2256">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-764" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2257">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-765" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2258">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-766" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2259">68.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-767" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2260">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-768" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:fixed-zero" scale="6" id="f-2261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-769" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2262">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-770" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2263">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-771" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2264">3.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-772" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2265">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-773" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2266">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2267">959.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" scale="6" id="f-2268">457.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" format="ixt:fixed-zero" scale="6" id="f-2269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2270">457.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marine, Aviation and Energy Insurance Lines</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-775" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2271">319.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-776" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2272">332.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-777" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2273">340.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-778" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2274">324.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-779" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2275">331.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-780" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2276">345.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-781" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2277">343.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-782" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2278">338.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-783" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2279">346.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-784" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2280">319.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-784" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2281">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-784" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2282">4,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-785" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2283">308.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-786" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2284">312.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-787" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2285">297.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-788" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2286">308.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-789" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2287">304.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-790" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2288">311.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-791" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2289">300.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-792" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2290">317.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-793" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2291">279.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-793" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2292">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-793" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2293">4,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-794" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2294">295.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-795" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2295">297.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-796" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2296">279.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-797" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2297">283.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-798" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2298">307.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-799" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2299">309.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-800" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2300">327.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-801" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2301">302.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-801" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-801" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2303">4,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-802" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2304">258.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2305">229.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2306">227.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-805" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2307">227.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-806" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2308">217.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-807" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2309">224.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-808" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2310">199.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-808" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-808" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2312">4,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-809" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2313">209.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-810" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2314">199.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-811" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2315">206.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2316">213.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2317">231.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-814" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2318">205.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-814" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-814" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2320">6,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-815" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2321">170.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-816" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2322">207.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-817" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2323">207.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2324">238.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2325">169.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2326">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-819" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2327">5,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-820" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2328">145.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-821" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2329">152.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-822" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2330">151.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-823" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2331">124.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-823" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-823" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2333">3,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-824" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2334">110.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-825" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2335">111.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-826" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2336">125.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-826" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2337">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-826" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2338">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-827" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2339">93.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-828" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2340">96.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-828" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2341">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-828" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2342">4,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-829" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2343">107.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-829" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2344">58.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-829" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2345">3,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2346">1,929.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-2000-3" continuedAt="f-2000-4"><ix:continuation id="f-1942-6" continuedAt="f-1942-7"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marine, Aviation and Energy Insurance Lines </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-775" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2347">41.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-776" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2348">130.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-777" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2349">203.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-778" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2350">234.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-779" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2351">263.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-780" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2352">283.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-781" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2353">299.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-782" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2354">309.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-783" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2355">309.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-784" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2356">319.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-785" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2357">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-786" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2358">116.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-787" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2359">188.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-788" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2360">208.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-789" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2361">231.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-790" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2362">249.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-791" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2363">261.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-792" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2364">274.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-793" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2365">279.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-794" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2366">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-795" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2367">122.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-796" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2368">172.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-797" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2369">192.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-798" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2370">220.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-799" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2371">255.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-800" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2372">277.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-801" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2373">302.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-802" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2374">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-803" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2375">81.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-804" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2376">141.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-805" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2377">163.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-806" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2378">189.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-807" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2379">197.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-808" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2380">199.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-809" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2381">40.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-810" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2382">97.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-811" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2383">139.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-812" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2384">167.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-813" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2385">155.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-814" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2386">205.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-815" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2387">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-816" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2388">104.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-817" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2389">132.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-818" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2390">154.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-819" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2391">169.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-820" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2392">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-821" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2393">72.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-822" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2394">117.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-823" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2395">124.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-824" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2396">28.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-825" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2397">66.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-826" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2398">88.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-827" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2399">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-828" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2400">52.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-829" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2401">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2402">1,765.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" scale="6" id="f-2403">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" format="ixt:fixed-zero" scale="6" id="f-2404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2405">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial and Professional Insurance Lines</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-831" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2406">104.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-832" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2407">98.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-833" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2408">103.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-834" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2409">99.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-835" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2410">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-836" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2411">89.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-837" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2412">88.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-838" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2413">95.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-839" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2414">101.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-840" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2415">82.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-840" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-840" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2417">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-841" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2418">133.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-842" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2419">128.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-843" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2420">127.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-844" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2421">117.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-845" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2422">128.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-846" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2423">118.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-847" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2424">118.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-848" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2425">124.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-849" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2426">118.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-849" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-849" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2428">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-850" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2429">171.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-851" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2430">173.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-852" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2431">183.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-853" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2432">187.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-854" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2433">188.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-855" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2434">183.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-856" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2435">189.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-857" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2436">163.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-857" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-857" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2438">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-858" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2439">188.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-859" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2440">209.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-860" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2441">213.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-861" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2442">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-862" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2443">182.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-863" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2444">189.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-864" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2445">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-864" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-864" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2447">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2448">203.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-866" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2449">179.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2450">184.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-868" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2451">185.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-869" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2452">208.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2453">166.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-870" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2455">1,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2456">153.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-872" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2457">169.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2458">151.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-874" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2459">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-875" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2460">125.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-875" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2461">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-875" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2462">4,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2463">246.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-877" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2464">259.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-878" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2465">253.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2466">195.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2467">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-879" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2468">23,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-880" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2469">346.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2470">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-882" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2471">336.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-882" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2472">118.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-882" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2473">105,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2474">284.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-884" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2475">302.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-884" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2476">170.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-884" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2477">34,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2478">314.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2479">265.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2480">3,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2481">1,970.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-2000-4" continuedAt="f-2000-5"><ix:continuation id="f-1942-7" continuedAt="f-1942-8"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial and Professional Insurance Lines</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-831" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2482">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-832" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2483">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-833" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2484">30.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-834" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2485">64.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-835" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2486">62.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-836" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2487">71.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-837" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2488">73.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-838" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2489">76.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-839" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2490">79.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-840" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2491">82.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-841" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2492">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-842" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2493">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-843" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2494">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-844" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2495">71.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-845" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2496">78.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-846" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2497">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-847" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2498">90.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-848" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2499">102.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-849" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2500">118.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-850" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2501">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-851" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2502">43.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-852" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2503">69.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-853" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2504">88.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-854" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2505">108.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-855" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2506">137.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-856" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2507">144.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-857" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2508">163.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-858" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2509">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-859" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2510">70.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-860" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2511">100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-861" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2512">128.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-862" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2513">124.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-863" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2514">133.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-864" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2515">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-865" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2516">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-866" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2517">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-867" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2518">83.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-868" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2519">116.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-869" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2520">135.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-870" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2521">166.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-871" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2522">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-872" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2523">71.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-873" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2524">97.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-874" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2525">113.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-875" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2526">125.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-876" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2527">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-877" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2528">86.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-878" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2529">136.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-879" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2530">195.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-880" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2531">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-881" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2532">120.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-882" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2533">174.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-883" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2534">42.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-884" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2535">90.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-885" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2536">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2537">1,298.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" scale="6" id="f-2538">671.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" format="ixt:fixed-zero" scale="6" id="f-2539">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2540">671.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_670"></div><ix:continuation id="f-2000-5" continuedAt="f-2000-6"><ix:continuation id="f-1942-8" continuedAt="f-1942-9"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Catastrophe and Other Property Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-887" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2541">212.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-888" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2542">193.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-889" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2543">184.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-890" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2544">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-891" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2545">171.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-892" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2546">168.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-893" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2547">165.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-894" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2548">162.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-895" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2549">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-896" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2550">156.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-896" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2551">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-896" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2552">832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-897" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2553">185.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-898" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2554">172.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-899" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2555">157.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-900" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2556">145.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-901" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2557">145.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-902" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2558">141.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-903" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2559">141.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-904" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2560">140.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-905" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2561">138.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-905" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-905" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2563">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-906" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2564">210.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-907" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2565">183.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-908" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2566">173.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-909" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2567">153.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-910" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2568">168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-911" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2569">168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-912" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2570">177.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-913" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2571">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-913" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-913" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2573">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-914" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2574">264.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-915" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2575">264.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-916" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2576">263.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-917" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2577">242.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-918" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2578">237.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-919" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2579">230.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-920" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2580">229.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-920" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2581">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-920" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2582">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-921" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2583">550.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-922" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2584">529.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-923" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2585">511.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-924" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2586">500.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-925" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2587">595.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-926" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2588">447.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-926" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2589">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-926" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2590">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-927" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2591">323.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-928" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2592">362.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-929" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2593">356.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-930" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2594">571.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-931" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2595">304.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-931" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-931" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2597">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-932" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2598">237.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-933" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2599">249.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-934" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2600">358.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-935" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2601">203.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-935" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-935" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2603">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-936" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2604">317.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-937" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2605">402.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-938" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2606">348.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-938" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2607">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-938" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2608">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-939" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2609">647.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-940" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2610">472.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-940" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2611">196.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-940" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2612">1,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-941" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2613">392.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-941" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2614">266.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-941" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2615">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2616">2,854.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-2000-6" continuedAt="f-2000-7"><ix:continuation id="f-1942-9" continuedAt="f-1942-10"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Catastrophe and Other Property Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-887" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2617">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-888" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2618">95.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-889" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2619">142.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-890" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2620">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-891" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2621">158.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-892" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2622">160.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-893" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2623">161.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-894" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2624">156.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-895" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2625">156.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-896" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2626">156.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-897" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2627">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-898" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2628">98.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-899" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2629">124.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-900" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2630">133.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-901" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2631">137.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-902" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2632">136.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-903" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2633">137.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-904" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2634">137.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-905" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2635">138.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-906" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2636">35.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-907" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2637">93.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-908" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2638">124.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-909" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2639">136.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-910" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2640">153.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-911" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2641">155.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-912" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2642">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-913" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2643">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-914" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2644">55.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-915" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2645">160.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-916" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2646">200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-917" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2647">211.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-918" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2648">224.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-919" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2649">230.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-920" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2650">229.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-921" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2651">123.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-922" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2652">355.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-923" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2653">413.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-924" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2654">437.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-925" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2655">433.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-926" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2656">447.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-927" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2657">122.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-928" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2658">290.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-929" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2659">296.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-930" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2660">315.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-931" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2661">304.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-932" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2662">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-933" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2663">143.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-934" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2664">191.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-935" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2665">203.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-936" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2666">41.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-937" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2667">165.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-938" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2668">237.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-939" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2669">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-940" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2670">233.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-941" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2671">65.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2672">2,176.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" scale="6" id="f-2673">677.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" format="ixt:fixed-zero" scale="6" id="f-2674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2675">677.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Casualty Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-943" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2676">211.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-944" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2677">226.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-945" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2678">221.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-946" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2679">219.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-947" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2680">202.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-948" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2681">197.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-949" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2682">200.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-950" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2683">197.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-951" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2684">191.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-952" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2685">151.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-952" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-952" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2687">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-953" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2688">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-954" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2689">204.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-955" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2690">212.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-956" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2691">205.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-957" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2692">199.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-958" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2693">202.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-959" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2694">198.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-960" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2695">191.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-961" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2696">144.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-961" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-961" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2698">1,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-962" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2699">191.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-963" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2700">197.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-964" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2701">207.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-965" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2702">209.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-966" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2703">207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-967" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2704">203.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-968" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2705">198.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-969" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2706">135.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-969" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2707">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-969" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2708">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-970" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2709">229.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-971" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2710">241.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-972" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2711">241.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-973" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2712">251.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-974" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2713">258.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-975" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2714">258.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-976" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2715">174.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-976" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2716">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-976" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2717">2,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-977" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2718">241.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-978" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2719">239.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-979" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2720">249.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-980" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2721">248.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-981" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2722">265.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-982" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2723">147.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-982" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-982" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2725">2,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-983" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2726">226.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-984" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2727">255.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-985" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2728">262.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-986" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2729">264.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-987" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2730">130.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-987" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-987" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2732">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-988" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2733">232.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-989" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2734">253.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-990" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2735">252.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-991" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2736">82.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-991" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2737">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-991" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2738">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-992" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2739">252.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-993" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2740">233.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-994" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2741">197.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-994" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2742">123.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-994" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2743">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-995" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2744">205.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-996" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2745">215.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-996" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2746">135.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-996" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2747">815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-997" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2748">248.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-997" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2749">179.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-997" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2750">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2751">1,628.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-2000-7" continuedAt="f-2000-8"><ix:continuation id="f-1942-10" continuedAt="f-1942-11"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Casualty Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-943" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2752">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-944" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2753">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-945" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2754">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-946" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2755">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-947" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2756">91.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-948" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2757">113.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-949" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2758">126.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-950" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2759">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-951" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2760">144.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-952" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2761">151.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-953" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2762">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-954" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2763">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-955" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2764">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-956" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2765">59.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-957" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2766">85.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-958" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2767">105.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-959" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2768">123.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-960" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2769">133.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-961" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2770">144.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-962" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2771">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-963" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2772">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-964" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2773">37.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-965" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2774">64.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-966" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2775">88.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-967" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2776">107.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-968" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2777">121.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-969" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2778">135.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-970" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2779">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-971" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2780">32.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-972" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2781">62.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-973" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2782">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-974" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2783">124.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-975" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2784">145.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-976" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2785">174.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-977" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2786">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-978" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2787">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-979" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2788">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-980" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2789">96.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-981" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2790">115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-982" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2791">147.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-983" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2792">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-984" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2793">33.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-985" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2794">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-986" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2795">103.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-987" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2796">130.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-988" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2797">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-989" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2798">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-990" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2799">60.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-991" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2800">82.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-992" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2801">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-993" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2802">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-994" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2803">44.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-995" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2804">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-996" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2805">37.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-997" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2806">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2807">1,057.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" scale="6" id="f-2808">571.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" format="ixt:fixed-zero" scale="6" id="f-2809">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2810">571.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-999" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2811">140.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1000" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2812">135.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1001" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2813">127.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1002" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2814">116.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1003" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2815">115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1004" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2816">111.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1005" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2817">111.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1006" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2818">108.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1007" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2819">104.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1008" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2820">98.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1008" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1008" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2822">579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1009" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2823">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1010" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2824">137.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1011" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2825">129.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1012" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2826">120.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1013" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2827">123.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1014" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2828">122.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1015" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2829">118.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1016" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2830">116.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1017" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2831">105.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1017" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1017" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2833">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1018" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2834">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1019" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2835">166.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1020" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2836">161.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1021" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2837">155.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1022" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2838">154.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1023" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2839">150.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1024" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2840">150.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1025" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2841">132.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1025" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1025" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2843">774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1026" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2844">235.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1027" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2845">236.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1028" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2846">234.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1029" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2847">227.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1030" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2848">222.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1031" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2849">218.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1032" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2850">197.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1032" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1032" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2852">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1033" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2853">375.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1034" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2854">388.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1035" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2855">372.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1036" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2856">361.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1037" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2857">364.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1038" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2858">325.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1038" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1038" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2860">1,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1039" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2861">392.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1040" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2862">391.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1041" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2863">390.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1042" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2864">419.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1043" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2865">342.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1043" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2866">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1043" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2867">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1044" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2868">470.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1045" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2869">493.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1046" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2870">397.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1047" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2871">423.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1047" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:fixed-zero" scale="6" id="f-2872">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1047" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2873">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1048" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2874">412.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1049" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2875">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1050" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2876">374.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1050" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2877">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1050" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2878">1,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1051" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2879">156.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1052" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2880">151.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1052" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2881">55.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1052" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="0" id="f-2882">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1053" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2883">193.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1053" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="f-2884">107.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="integer" contextRef="c-1053" decimals="INF" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" scale="0" id="f-2885">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1054" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2886">2,344.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-2000-8"><ix:continuation id="f-1942-11" continuedAt="f-1942-12"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-999" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2887">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1000" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2888">68.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1001" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2889">84.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1002" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2890">91.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1003" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2891">98.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1004" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2892">98.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1005" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2893">99.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1006" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2894">99.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1007" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2895">98.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1008" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2896">98.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1009" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2897">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1010" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2898">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1011" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2899">79.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1012" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2900">87.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1013" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2901">98.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1014" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2902">100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1015" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2903">102.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1016" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2904">104.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1017" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2905">105.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1018" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2906">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1019" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2907">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1020" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2908">102.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1021" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2909">119.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1022" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2910">128.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1023" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2911">131.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1024" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2912">131.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1025" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2913">132.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1026" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2914">58.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1027" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2915">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1028" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2916">163.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1029" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2917">181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1030" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2918">191.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1031" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2919">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1032" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2920">197.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1033" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2921">94.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1034" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2922">237.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1035" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2923">268.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1036" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2924">303.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1037" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2925">314.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1038" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2926">325.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1039" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2927">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1040" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2928">279.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1041" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2929">312.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1042" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2930">328.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1043" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2931">342.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1044" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2932">272.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1045" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2933">379.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1046" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2934">398.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1047" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2935">423.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1048" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2936">212.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1049" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2937">269.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1050" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2938">290.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1051" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2939">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1052" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2940">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1053" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2941">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1054" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2942">1,994.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1054" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" scale="6" id="f-2943">350.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1054" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" format="ixt:fixed-zero" scale="6" id="f-2944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1054" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2945">350.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-55</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_694"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-1942-12" continuedAt="f-1942-13"><ix:nonNumeric contextRef="c-1" name="us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" id="f-2946" continuedAt="f-2946-1" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of Incurred and Paid Claims Development to total Provision for Losses and LAE </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net outstanding liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Property insurance lines</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-718" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2947">259.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1055" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2948">289.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Casualty insurance lines</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-774" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2949">457.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1056" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2950">725.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Marine, aviation and energy insurance lines</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-830" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2951">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1057" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2952">427.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Financial and professional insurance lines</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-886" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2953">671.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1058" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2954">808.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total insurance lines</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1059" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2955">1,551.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1060" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2956">2,251.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance lines </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Property catastrophe and other property reinsurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-942" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2957">677.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1061" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2958">784.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Casualty reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-998" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2959">571.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1062" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2960">975.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Specialty reinsurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1054" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2961">350.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1063" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="f-2962">472.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reinsurance lines</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1064" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2963">1,599.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1065" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2964">2,232.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2965">3,151.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-2966">4,484.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverable on unpaid losses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1059" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-2967">2,907.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1060" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-2968">2,117.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance lines </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1064" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-2969">1,989.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1065" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-2970">1,180.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reinsurance recoverable on unpaid losses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-2971">4,897.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-2972">3,298.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain on retroactive contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1066" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="f-2973">42.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1067" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="f-2974">58.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated claims incurred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense" scale="6" id="f-2975">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense" scale="6" id="f-2976">56.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other reinsurance balances recoverable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1066" decimals="-5" name="ahl:ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" scale="6" id="f-2977">429.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1067" decimals="-5" name="ahl:ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" scale="6" id="f-2978">286.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon syndicate reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" scale="6" id="f-2979">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" scale="6" id="f-2980">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" scale="6" id="f-2981">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" scale="6" id="f-2982">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" scale="6" id="f-2983">338.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" sign="-" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" scale="6" id="f-2984">170.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the end of the year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-2985">7,710.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-2986">7,611.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div></ix:nonNumeric><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-2946-1" continuedAt="f-2946-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="f-2946-2">Other reinsurance balances recoverable primarily include short term recoverables to be collected.</ix:continuation> </span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_706"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock" id="f-2987" escape="true"><ix:continuation id="f-1942-13" continuedAt="f-1942-14"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne" scale="-2" id="f-2988">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo" scale="-2" id="f-2989">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree" scale="-2" id="f-2990">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour" scale="-2" id="f-2991">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive" scale="-2" id="f-2992">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix" scale="-2" id="f-2993">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven" scale="-2" id="f-2994">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight" scale="-2" id="f-2995">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine" scale="-2" id="f-2996">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1059" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen" scale="-2" id="f-2997">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne" scale="-2" id="f-2998">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo" scale="-2" id="f-2999">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree" scale="-2" id="f-3000">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour" scale="-2" id="f-3001">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive" scale="-2" id="f-3002">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix" scale="-2" id="f-3003">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven" scale="-2" id="f-3004">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight" scale="-2" id="f-3005">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine" scale="-2" id="f-3006">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1068" decimals="3" name="us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen" scale="-2" id="f-3007">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-56</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_718"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-3008" continuedAt="f-3008-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Income Taxes </span></ix:nonNumeric></div><ix:continuation id="f-3008-1" continuedAt="f-3008-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Holdings and Aspen Bermuda are incorporated under the laws of Bermuda. Under Bermuda law, the corporate tax rate is <ix:nonFraction unitRef="number" contextRef="c-1069" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-3009">zero</ix:nonFraction> and, as a result, Aspen Holdings and Aspen Bermuda are not taxed on any Bermudian income or capital gains. In the event of any Bermudian income or capital gains taxes being imposed, Aspen Holdings and Aspen Bermuda have received an assurance from the Bermuda Minister of Finance that such entities will be exempt from those taxes until March 31, 2035. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S.&#160;operating companies were subject to a U.S. federal income tax rate of <ix:nonFraction unitRef="number" contextRef="c-19" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-3010">21</ix:nonFraction>%. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.K. operating companies were taxed at the U.K. corporate tax rate of <ix:nonFraction unitRef="number" contextRef="c-1070" decimals="INF" name="ahl:CorporateTaxRate" scale="-2" id="f-3011">19</ix:nonFraction>%. </span></div><ix:nonNumeric contextRef="c-1" name="ahl:ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" id="f-3012" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total income tax (benefit)/expense for the twelve months ended December&#160;31, 2022, 2021 and 2020 was allocated as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit)/expense allocated to net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3013">78.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3014">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3015">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit)/expense allocated to other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-3016">23.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-3017">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-3018">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit)/expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation" scale="6" id="f-3019">102.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation" scale="6" id="f-3020">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation" scale="6" id="f-3021">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3008-2" continuedAt="f-3008-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-3022" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Loss)/income from operations before income taxes and income tax expense/(benefit) attributable to that (loss)/income for the twelve months ended December&#160;31, 2022, 2021 and 2020 is provided in the tables below:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Loss)/income<br/>before tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current&#160;tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;income tax<br/>(benefit)/expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1069" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3023">103.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1069" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3024">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1069" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1069" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" format="ixt:fixed-zero" scale="6" id="f-3026">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-3027">34.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-3028">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-3029">102.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3030">88.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1070" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3031">62.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1070" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-3032">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1070" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3033">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1070" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3034">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3035">20.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-3036">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-3037">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3038">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-3039">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-3040">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-3041">104.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3042">78.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income/(loss)<br/>before tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current&#160;tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;income tax<br/>(benefit)/expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1071" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3043">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1071" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1071" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3045">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1071" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" format="ixt:fixed-zero" scale="6" id="f-3046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-3047">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-3048">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3050">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1072" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3051">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1072" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1072" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-3053">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1072" decimals="-5" sign="-" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3054">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3055">67.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-3056">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-3057">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3058">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-3059">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-3060">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-3061">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3062">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Loss)/income<br/>before tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current&#160;tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;income tax<br/>(benefit)/expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1073" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3063">81.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1073" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3064">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1073" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1073" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" format="ixt:fixed-zero" scale="6" id="f-3066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-3067">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-3068">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3069">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3070">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1074" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3071">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1074" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-3072">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1074" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3073">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1074" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3074">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-3075">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-3076">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-3077">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-3078">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-3079">38.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-3080">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-3081">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3082">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The U.S. current tax expense of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" format="ixt:num-dot-decimal" scale="6" id="f-3083">14.8</ix:nonFraction> million includes $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationBeatAmount" format="ixt:num-dot-decimal" scale="6" id="f-3084">2.3</ix:nonFraction>&#160;million of Base Erosion and Anti-abuse Tax (2021&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-3085">5.8</ix:nonFraction>&#160;million), of which $<ix:nonFraction unitRef="usd" contextRef="c-1075" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationBeatAmount" format="ixt:num-dot-decimal" scale="6" id="f-3086">1.1</ix:nonFraction> million relates to the U.S. operating subsidiaries and $<ix:nonFraction unitRef="usd" contextRef="c-1076" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationBeatAmount" format="ixt:num-dot-decimal" scale="6" id="f-3087">1.2</ix:nonFraction> million to Aspen UK&#8217;s U.S. branch. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The U.S. deferred tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-3088">102.9</ix:nonFraction> million is mainly due to a change in judgment about the realizability of the deferred tax asset in the U.S. operating subsidiaries. The decrease in valuation allowance relating to our U.S. operations is driven by a change in judgment about the recoverability of deferred tax assets in the U.S. operating subsidiaries. We have concluded that the deferred tax assets of our U.S. operating subsidiaries will more likely than not be fully utilized over time, and therefore the previously recognized valuation allowance in relation to U.S. operating subsidiaries has been reversed. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The U.K. current tax expense of $<ix:nonFraction unitRef="usd" contextRef="c-1070" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-3089">7.0</ix:nonFraction> million results from an intraperiod tax allocation.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Current tax expense and deferred tax (benefit) in &#8220;Other&#8221; mostly relates to the Swiss branches of Aspen UK and withholding taxes payable in Australia.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, the tax rate in Bermuda, the Company&#8217;s country of domicile, is <ix:nonFraction unitRef="number" contextRef="c-1069" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-3090">zero</ix:nonFraction>. Application of the statutory income tax rate for operations in other jurisdictions produces a differential to the expected income tax (benefit)/expense as shown in the table below. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-3091" continuedAt="f-3091-1" escape="true">The reconciliation between the income tax (benefit)/expense and the </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3008-3" continuedAt="f-3008-4"><ix:continuation id="f-3091-1" continuedAt="f-3091-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount that would result from applying the statutory rate for the Company for the twelve months ended December&#160;31, 2022, 2021 and 2020 is provided in the table below:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Reconciliation</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit at statutory tax rate of zero percent</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:fixed-zero" scale="6" id="f-3092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:fixed-zero" scale="6" id="f-3093">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:fixed-zero" scale="6" id="f-3094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overseas statutory tax rates differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-3095">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-3096">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-3097">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base erosion and anti-abuse tax (BEAT) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationBeatAmount" scale="6" id="f-3098">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationBeatAmount" scale="6" id="f-3099">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationBeatAmount" scale="6" id="f-3100">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="6" id="f-3101">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="6" id="f-3102">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="6" id="f-3103">25.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-3104">98.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-3105">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-3106">40.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of unrecognized tax benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:fixed-zero" scale="6" id="f-3107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:fixed-zero" scale="6" id="f-3108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:fixed-zero" scale="6" id="f-3109">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australian non-resident withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" scale="6" id="f-3110">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" scale="6" id="f-3111">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" scale="6" id="f-3112">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingenciesForeign" scale="6" id="f-3113">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingenciesForeign" scale="6" id="f-3114">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxContingenciesForeign" scale="6" id="f-3115">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="6" id="f-3116">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="6" id="f-3117">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="6" id="f-3118">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of changes in statutory tax rates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-3119">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-3120">11.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-3121">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of OCI in income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" scale="6" id="f-3122">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" format="ixt:fixed-zero" scale="6" id="f-3123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" format="ixt:fixed-zero" scale="6" id="f-3124">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit)/expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3125">78.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3126">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-3127">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The submission dates for filing income tax returns for the Company&#8217;s U.S. and U.K. operating subsidiaries are after the submission date of this report. Accordingly, the final tax liabilities may differ from the estimated income tax expense included in this report and may result in prior year adjustments being reported. The prior period adjustments for the twelve months ended December 31, 2022 predominantly relate to the determination of the results of the branches of the U.K. operating subsidiaries. The prior period adjustments for the twelve months ended December 31, 2021 and 2020 predominantly relate to the determination of results in the U.K.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The 2022 valuation allowance movement includes <ix:nonFraction unitRef="usd" contextRef="c-1077" decimals="-5" name="ahl:EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" format="ixt:fixed-zero" scale="6" id="f-3128">nil</ix:nonFraction> relating to U.K deferred tax assets in U.K. operating subsidiaries, $4.8&#160;million decrease relating to deferred tax assets in the branches of the U.K. and Bermuda operating subsidiaries, and $94.1&#160;million decrease from U.S. operations. The decrease in valuation allowance relating to our U.S. operations is driven by a change in judgment about the recoverability of deferred tax assets in the U.S. operating subsidiaries. We have concluded that the deferred tax assets of our U.S. operating subsidiaries will more likely than not be fully utilized over time, and therefore the previously recognized valuation allowance in relation to U.S. operating subsidiaries has been reversed.</span></div></ix:continuation><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-3091-2" continuedAt="f-3091-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="f-3091-3">In 2022, the Company did not have any unrecognized tax benefits.</ix:continuation> </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income tax returns that have been filed by the Company&#8217;s U.S.&#160;Operating Subsidiaries are subject to examination for 2019 and later tax years. The Company&#8217;s U.K. operating subsidiaries&#8217; income tax returns are potentially subject to examination for 2021 and later tax years as these periods are considered &#8220;open&#8221; by the U.K. Tax Authority. The Company accrues interest and penalties related to an underpayment of income taxes, if applicable, as income tax expenses. The Company does not believe it will be subject to any penalties in any open tax years and has not accrued any such amounts for the twelve months ended December 31, 2022.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The U.K. tax rate has changed from April 1, 2023 from <ix:nonFraction unitRef="number" contextRef="c-1070" decimals="INF" name="ahl:CorporateTaxRate" scale="-2" id="f-3129">19</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-1078" decimals="INF" name="ahl:CorporateTaxRate" scale="-2" id="f-3130">25</ix:nonFraction>%. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3008-4" continuedAt="f-3008-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-3131" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and deferred tax liabilities are presented in the following table as at December 31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-3132">167.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-3133">170.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="6" id="f-3134">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="6" id="f-3135">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves: Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" scale="6" id="f-3136">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" scale="6" id="f-3137">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" scale="6" id="f-3138">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" format="ixt:fixed-zero" scale="6" id="f-3139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="f-3140">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="f-3141">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="f-3142">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="f-3143">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves: Unearned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DeferredTaxAssetsUnearnedPremiums" scale="6" id="f-3144">36.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DeferredTaxAssetsUnearnedPremiums" scale="6" id="f-3145">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="f-3146">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:fixed-zero" scale="6" id="f-3147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office properties and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DeferredTaxAssetsTimingDifferencesOnFixedAssets" scale="6" id="f-3148">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DeferredTaxAssetsTimingDifferencesOnFixedAssets" scale="6" id="f-3149">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DeferredTaxAssetsOperatingLeaseLiability" scale="6" id="f-3150">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DeferredTaxAssetsOperatingLeaseLiability" scale="6" id="f-3151">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-3152">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-3153">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="f-3154">322.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="f-3155">277.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-3156">145.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-3157">225.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets, net of valuation allowance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="f-3158">176.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="f-3159">51.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" format="ixt:fixed-zero" scale="6" id="f-3160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" scale="6" id="f-3161">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:fixed-zero" scale="6" id="f-3162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="f-3163">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" scale="6" id="f-3164">37.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" scale="6" id="f-3165">28.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DeferredTaxLiabilitiesOperatingLeaseAssets" scale="6" id="f-3166">13.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DeferredTaxLiabilitiesOperatingLeaseAssets" scale="6" id="f-3167">10.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves: Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DeferredTaxLiabilitiesGAAPDifferences" scale="6" id="f-3168">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DeferredTaxLiabilitiesGAAPDifferences" scale="6" id="f-3169">8.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="f-3170">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="f-3171">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax (liabilities)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-3172">57.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-3173">54.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax assets/(liabilities)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="f-3174">119.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="f-3175">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities and assets represent the tax effect of carryforwards and temporary differences between the value of assets and liabilities for financial statement purposes and such values as measured by U.K., U.S. and other&#160;tax laws and regulations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences and carry forwards become deductible or creditable. Management considers the scheduled reversal of existing taxable temporary differences, carryback availability, projected future taxable income, and tax-planning strategies in making this assessment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company has net operating losses carryforwards for U.S.&#160;federal income tax purposes of $<ix:nonFraction unitRef="usd" contextRef="c-1079" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3176">376.5</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1080" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3177">443.1</ix:nonFraction> million), of which $<ix:nonFraction unitRef="usd" contextRef="c-1081" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3178">309.4</ix:nonFraction> million relates to the U.S. operating subsidiaries and $<ix:nonFraction unitRef="usd" contextRef="c-1082" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3179">67.1</ix:nonFraction> million to Aspen UK&#8217;s U.S. branch. The Company also has net operating losses carryforwards for U.K. corporate tax purposes of $<ix:nonFraction unitRef="usd" contextRef="c-1083" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3180">280.5</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1084" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3181">168.9</ix:nonFraction> million), deferred syndicate profits </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3008-5" continuedAt="f-3008-6"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $<ix:nonFraction unitRef="usd" contextRef="c-1085" decimals="-5" name="ahl:DeferredTaxLossesOperatingLossCarryforward" format="ixt:num-dot-decimal" scale="6" id="f-3182">19.9</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1086" decimals="-5" name="ahl:DeferredTaxLossesOperatingLossCarryforward" format="ixt:num-dot-decimal" scale="6" id="f-3183">66.2</ix:nonFraction> million losses), and losses in other jurisdictions of $<ix:nonFraction unitRef="usd" contextRef="c-1087" decimals="-5" name="ahl:DeferredTaxLossesOperatingLossCarryforward" format="ixt:num-dot-decimal" scale="6" id="f-3184">118.8</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1088" decimals="-5" name="ahl:DeferredTaxLossesOperatingLossCarryforward" format="ixt:num-dot-decimal" scale="6" id="f-3185">103.9</ix:nonFraction>&#160;million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $<ix:nonFraction unitRef="usd" contextRef="c-1079" decimals="-5" name="ahl:DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" format="ixt:num-dot-decimal" scale="6" id="f-3186">376.5</ix:nonFraction> million that are available to offset future U.S.&#160;federal taxable income will expire between <ix:nonNumeric contextRef="c-1089" name="ahl:Operatinglosscarryforwardsdateofexpiration" id="f-3187">2032</ix:nonNumeric> and <ix:nonNumeric contextRef="c-1090" name="ahl:Operatinglosscarryforwardsdateofexpiration" id="f-3188">2041</ix:nonNumeric>. The amount of pre-merger net operating losses carryforwards that can be used each year is limited by section 382 to $<ix:nonFraction unitRef="usd" contextRef="c-1082" decimals="-5" name="ahl:DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" format="ixt:num-dot-decimal" scale="6" id="f-3189">6.5</ix:nonFraction> million per year for Aspen UK&#8217;s U.S. branch, and $39.2 million in 2023, $23.1 million in 2024, and $<ix:nonFraction unitRef="usd" contextRef="c-1081" decimals="-5" name="ahl:DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" format="ixt:num-dot-decimal" scale="6" id="f-3190">20.8</ix:nonFraction> million per year for the 15 years thereafter for the U.S. operating subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net operating losses in the U.K. and other jurisdictions are available to offset future corporate income in those jurisdictions over an indefinite period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. federal income tax purposes, the Company has capital loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-1091" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3191">31.7</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="c-1092" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3192">15.0</ix:nonFraction> million relates to the U.S. operating subsidiaries and $<ix:nonFraction unitRef="usd" contextRef="c-1093" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3193">16.7</ix:nonFraction> million to Aspen UK&#8217;s branch, expiring between 2026 and 2027 and <ix:nonFraction unitRef="usd" contextRef="c-1079" decimals="-5" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" format="ixt:fixed-zero" scale="6" id="f-3194">nil</ix:nonFraction> charitable contribution carryforwards (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1080" decimals="-5" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-3195">0.1</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.K. corporate tax purposes, the Company has foreign tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-1083" decimals="-5" name="ahl:DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" format="ixt:num-dot-decimal" scale="6" id="f-3196">19.8</ix:nonFraction>&#160;million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1084" decimals="-5" name="ahl:DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" format="ixt:num-dot-decimal" scale="6" id="f-3197">20.2</ix:nonFraction>&#160;million) which are available to offset future U.K. corporate tax arising on the same foreign source of income over an indefinite period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-1079" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-3198">18.0</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1080" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-3199">119.7</ix:nonFraction> million) on U.S.&#160;deferred tax assets (which includes these loss carryforwards) has been recognized at December&#160;31, 2022 relating to Aspen UK&#8217;s U.S. branch. The valuation allowance relating to the deferred tax assets of the U.S. operating companies has been reversed as a result of a change in judgment over the likelihood that a tax benefit will be realized. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-1083" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-3200">106.7</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1084" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-3201">88.7</ix:nonFraction> million) has been established against U.K. deferred tax assets. </span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-3008-6">The U.K., U.S. and other jurisdictions valuation allowance combined total is $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-3202">145.7</ix:nonFraction>&#160;million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-3203">225.9</ix:nonFraction> million).</ix:continuation> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-61</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_742"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-3204" continuedAt="f-3204-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Capital Structure</span></ix:nonNumeric></div><ix:continuation id="f-3204-1" continuedAt="f-3204-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockByClassTextBlock" id="f-3205" continuedAt="f-3205-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company&#8217;s authorized and issued share capital as at December&#160;31, 2022 and 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in<br/>Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in<br/>Thousands</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized share capital:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-3206">0.01</ix:nonFraction> per share (2021 &#8212; $<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-3207">0.01</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-3208">70,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ahl:CommonStockValueAuthorized" scale="3" id="f-3209">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-3210">70,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ahl:CommonStockValueAuthorized" scale="3" id="f-3211">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference Shares&#160;<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-3212">0.15144558</ix:nonFraction>&#162; per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-3213">30,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ahl:PreferredStockValueAuthorized" scale="3" id="f-3214">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-3215">30,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ahl:PreferredStockValueAuthorized" scale="3" id="f-3216">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total authorized share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ahl:AuthorizedShareCapital" scale="3" id="f-3217">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ahl:AuthorizedShareCapital" scale="3" id="f-3218">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued share capital:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued ordinary shares $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-3219">0.01</ix:nonFraction> per share (2021 &#8212; $<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-3220">0.01</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3221">60,395,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-3222">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3223">60,395,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-3224">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued <ix:nonFraction unitRef="number" contextRef="c-1094" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3225"><ix:nonFraction unitRef="number" contextRef="c-1095" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3226">5.950</ix:nonFraction></ix:nonFraction>% preference shares of <ix:nonFraction unitRef="usdPerShare" contextRef="c-1096" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-3227"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1097" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-3228">0.15144558</ix:nonFraction></ix:nonFraction>&#162; each with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1098" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3229"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1099" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3230">25</ix:nonFraction></ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1096" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3231">11,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1096" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" scale="3" id="f-3232">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1097" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3233">11,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1097" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" scale="3" id="f-3234">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued <ix:nonFraction unitRef="number" contextRef="c-1100" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3235"><ix:nonFraction unitRef="number" contextRef="c-1101" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3236">5.625</ix:nonFraction></ix:nonFraction>% preference shares of <ix:nonFraction unitRef="usdPerShare" contextRef="c-1098" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-3237"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1099" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-3238">0.15144558</ix:nonFraction></ix:nonFraction>&#162; each with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1098" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3239"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1099" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3240">25</ix:nonFraction></ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1098" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3241">10,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1098" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" scale="3" id="f-3242">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1099" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3243">10,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1099" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" scale="3" id="f-3244">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued <ix:nonFraction unitRef="number" contextRef="c-1102" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3245"><ix:nonFraction unitRef="number" contextRef="c-1103" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3246">5.625</ix:nonFraction></ix:nonFraction>% preference shares of <ix:nonFraction unitRef="usdPerShare" contextRef="c-1104" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-3247"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1105" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-3248">0.15144558</ix:nonFraction></ix:nonFraction>&#162; represented by depositary shares, each with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1104" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3249"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1105" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3250">25</ix:nonFraction></ix:nonFraction> per share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1104" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-3251">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1104" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" format="ixt:fixed-zero" scale="3" id="f-3252">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1105" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-3253">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1105" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" format="ixt:fixed-zero" scale="3" id="f-3254">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total issued share capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ahl:IssuedShareCapital" scale="3" id="f-3255">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ahl:IssuedShareCapital" scale="3" id="f-3256">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Each depositary share represents a 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in a share of the <ix:nonFraction unitRef="number" contextRef="c-1102" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3257"><ix:nonFraction unitRef="number" contextRef="c-1103" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3258">5.625</ix:nonFraction></ix:nonFraction>% preference shares.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Ordinary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issued Ordinary Shares.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s issued ordinary shares of par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-3259">0.01</ix:nonFraction> at both December&#160;31, 2022 and 2021 was <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3260">60,395,839</ix:nonFraction>. The Company did not acquire any ordinary shares for the twelve months ended December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Preference Shares&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preference Shares Issuance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On May 2, 2013, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-1106" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3261">11,000,000</ix:nonFraction> <ix:nonFraction unitRef="number" contextRef="c-1094" decimals="5" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3262">5.950</ix:nonFraction>% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1106" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3263">25</ix:nonFraction> per share (the &#8220;<ix:nonFraction unitRef="number" contextRef="c-1094" decimals="5" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3264">5.950</ix:nonFraction>% Preference Shares&#8221;). Net proceeds were $<ix:nonFraction unitRef="usd" contextRef="c-1107" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-3265">270.6</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="c-1106" decimals="-5" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="6" id="f-3266">275.0</ix:nonFraction> million of total liquidation preference less $<ix:nonFraction unitRef="usd" contextRef="c-1107" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-3267">4.4</ix:nonFraction> million of issuance expenses. The <ix:nonFraction unitRef="number" contextRef="c-1094" decimals="5" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3268">5.950</ix:nonFraction>% Preference Shares are listed on the NYSE under symbol &#8220;AHLPRC&#8221;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2016, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-1098" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3269">10,000,000</ix:nonFraction> shares of <ix:nonFraction unitRef="number" contextRef="c-1108" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3270">5.625</ix:nonFraction>% Perpetual Non-Cumulative Preference Shares (the &#8220;<ix:nonFraction unitRef="number" contextRef="c-1108" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3271">5.625</ix:nonFraction>% Preference Shares&#8221;). The <ix:nonFraction unitRef="number" contextRef="c-1108" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3272">5.625</ix:nonFraction>% Preference Shares have a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1109" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3273">25</ix:nonFraction> per share. Net proceeds were $<ix:nonFraction unitRef="usd" contextRef="c-1108" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-3274">241.3</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="c-1110" decimals="-5" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="6" id="f-3275">250.0</ix:nonFraction> million of total liquidation preference less $<ix:nonFraction unitRef="usd" contextRef="c-1111" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-3276">8.7</ix:nonFraction> million of issuance expenses. The <ix:nonFraction unitRef="number" contextRef="c-1108" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3277">5.625</ix:nonFraction>% Preference Shares are listed on the NYSE under the symbol &#8220;AHL PRD&#8221;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-1112" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3278">10,000,000</ix:nonFraction> depositary shares, each of which represents 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> interest in a share of the newly designated <ix:nonFraction unitRef="number" contextRef="c-1113" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3279">5.625</ix:nonFraction>% Perpetual Non-Cumulative Preference Shares. The depositary shares have a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1112" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-3280">25</ix:nonFraction> per share. Net proceeds were $<ix:nonFraction unitRef="usd" contextRef="c-1114" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-3281">241.6</ix:nonFraction> million, comprising $<ix:nonFraction unitRef="usd" contextRef="c-1115" decimals="-5" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="6" id="f-3282">250.0</ix:nonFraction> million </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3204-2" continuedAt="f-3204-3"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of total liquidation preference less $<ix:nonFraction unitRef="usd" contextRef="c-1113" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-3283">8.4</ix:nonFraction> million of issuance expenses. The depositary shares are listed on the NYSE under the symbol &#8220;AHL PRE&#8221;.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">Additional Paid-in Capital&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital as at December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-3284">1,514.7</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-3285">1,514.7</ix:nonFraction> million). Included within additional paid-in capital is the aggregate liquidation preferences of the Company&#8217;s preference shares of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:AggregateLiquidationPreferences" format="ixt:num-dot-decimal" scale="6" id="f-3286">775.0</ix:nonFraction> million less issue costs of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-3287">21.5</ix:nonFraction> million (December&#160;31, 2021&#160;&#8212;&#160;$<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:AggregateLiquidationPreferences" format="ixt:num-dot-decimal" scale="6" id="f-3288">775.0</ix:nonFraction> million&#160;less issue costs of $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-3289">21.5</ix:nonFraction> million).</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_766"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock" id="f-3290" continuedAt="f-3290-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Statutory Requirements and Dividends Restrictions </span></ix:nonNumeric></div><ix:continuation id="f-3290-1" continuedAt="f-3290-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a holding company, the Company relies on dividends and other distributions from its Operating Subsidiaries to provide cash flow to meet ongoing cash requirements, including any future debt service payments and other expenses, and to pay dividends, if any, to our preference and ordinary shareholders. The Company must comply with the provisions of the Bermuda Companies Act 1981, as amended, (the &#8220;Companies Act&#8221;) regulating the payment of dividends and distributions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the Company&#8217;s Operating Subsidiaries to pay the Company dividends or other distributions is subject to the laws and regulations applicable to each jurisdiction, as well as the Operating Subsidiaries&#8217; need to maintain capital requirements adequate to maintain their insurance and reinsurance operations and their financial strength ratings issued by independent rating agencies.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company law of England and Wales prohibits Aspen UK, AMAL or AUL from declaring a dividend to its shareholders unless it has &#8220;profits available for distribution&#8221;. The determination of whether a company has profits available for distribution is based on its accumulated realized profits and other distributable reserves less its accumulated realized losses. While the U.K. insurance regulatory laws impose no statutory restrictions on a general insurer&#8217;s ability to declare a dividend, the rules of the Prudential Regulation Authority (the &#8220;PRA&#8221;) require each insurance company within its jurisdiction to maintain its solvency margin at all times. Accordingly, Aspen UK, AMAL and AUL may not pay a dividend if the payment of such dividend would result in their SCR coverage ratio falling below certain levels. In addition, any future changes regarding regulatory requirements, including those described above, may restrict the ability of Aspen UK, AMAL and AUL to pay dividends in the future.&#160;As at December&#160;31, 2022, Aspen UK had an accumulated balance of retained losses of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1116" decimals="-5" name="us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" format="ixt:num-dot-decimal" scale="6" id="f-3291">467.4</ix:nonFraction> million and AUL had an accumulated balance of retained losses of approximately &#163;<ix:nonFraction unitRef="gbp" contextRef="c-1116" decimals="-5" name="us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" format="ixt:num-dot-decimal" scale="6" id="f-3292">62.2</ix:nonFraction> million. Aspen UK held a capital contribution reserve of $<ix:nonFraction unitRef="usd" contextRef="c-1116" decimals="-5" name="ahl:CapitalReserves" format="ixt:num-dot-decimal" scale="6" id="f-3293">655.0</ix:nonFraction> million as at December&#160;31, 2022 which, under certain circumstances, could be distributable. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda must comply with the provisions of the Companies Act and the Insurance Act regulating the payment of dividends and distributions.&#160;Aspen Bermuda may not in any financial year pay dividends which would exceed <ix:nonFraction unitRef="number" contextRef="c-1117" decimals="INF" name="ahl:DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" scale="-2" id="f-3294">25</ix:nonFraction>% of its total statutory capital and surplus, as shown on its statutory balance sheet in relation to the previous financial year, unless it files with the BMA a solvency affidavit at least seven days in advance of payment. As at December&#160;31, 2022, <ix:nonFraction unitRef="number" contextRef="c-1117" decimals="INF" name="ahl:DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" scale="-2" id="f-3295">25</ix:nonFraction>% of Aspen Bermuda&#8217;s statutory capital and surplus amounted to $<ix:nonFraction unitRef="usd" contextRef="c-1118" decimals="-5" name="us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" format="ixt:num-dot-decimal" scale="6" id="f-3296">262.1</ix:nonFraction> million. Aspen Bermuda must also obtain the prior approval of the BMA before reducing its total statutory capital as set out in its previous year&#8217;s financial statements by <ix:nonFraction unitRef="number" contextRef="c-1117" decimals="3" name="ahl:StatutoryCapitalandSurplusPercentReductionRequiringApproval" scale="-2" id="f-3297">15</ix:nonFraction>% or more.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under both North Dakota and Texas law, insurance companies may only pay dividends out of earned surplus as distinguished from contributed surplus. As such, Aspen Specialty and AAIC could not pay a dividend as at December&#160;31, 2022 without prior regulatory approval.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3290-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual and required statutory capital and surplus for the principal Operating Subsidiaries of the Company, excluding its Lloyd&#8217;s syndicate, as at December&#160;31, 2022 and December&#160;31, 2021 were estimated as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bermuda</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.K.&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Required statutory capital and surplus</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1119" decimals="-5" name="ahl:DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" scale="6" id="f-3298">513.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1118" decimals="-5" name="ahl:DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" scale="6" id="f-3299">536.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1116" decimals="-5" name="ahl:DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" scale="6" id="f-3300">771.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual statutory capital and surplus</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1119" decimals="-5" name="us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" scale="6" id="f-3301">838.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1118" decimals="-5" name="us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" format="ixt:num-dot-decimal" scale="6" id="f-3302">1,426.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1116" decimals="-5" name="us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" scale="6" id="f-3303">802.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bermuda</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.K.&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Required statutory capital and surplus</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1120" decimals="-5" name="ahl:DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" scale="6" id="f-3304">561.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1121" decimals="-5" name="ahl:DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" scale="6" id="f-3305">683.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1122" decimals="-5" name="ahl:DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" scale="6" id="f-3306">800.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual statutory capital and surplus</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1120" decimals="-5" name="us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" scale="6" id="f-3307">889.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1121" decimals="-5" name="us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" format="ixt:num-dot-decimal" scale="6" id="f-3308">1,141.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1122" decimals="-5" name="us-gaap:DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" scale="6" id="f-3309">963.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the sole corporate member of our Lloyd&#8217;s Syndicate, AUL was required to hold capital at Lloyd&#8217;s of $<ix:nonFraction unitRef="usd" contextRef="c-1123" decimals="-5" name="ahl:FundsMaintainedAtSyndicate" format="ixt:num-dot-decimal" scale="6" id="f-3310">968.7</ix:nonFraction> million as at December&#160;31, 2022, adjusting funding to meet this level on an annual basis in the following Q2 and not holding less than 90% of this amount at any time. As at December&#160;31, 2022, AUL had capital at Lloyd&#8217;s of $<ix:nonFraction unitRef="usd" contextRef="c-1123" decimals="-5" name="us-gaap:FundsHeldForClients" format="ixt:num-dot-decimal" scale="6" id="f-3311">1,045.9</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="c-1124" decimals="-5" name="us-gaap:FundsHeldForClients" format="ixt:num-dot-decimal" scale="6" id="f-3312">479.6</ix:nonFraction> million was provided as Funds at Lloyd&#8217;s by Aspen Bermuda. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Bermuda Monetary Authority&#160;is the group supervisor of the Company. The laws and regulations of Bermuda require that the Company maintain a minimum amount of group statutory capital and surplus based on the enhanced capital requirement using the group standardized risk-based capital model of the Bermuda Monetary Authority.&#160;The Company is also subject to an early-warning level based on <ix:nonFraction unitRef="number" contextRef="c-1117" decimals="INF" name="ahl:PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" scale="-2" id="f-3313">120</ix:nonFraction>% of the enhanced capital requirement which may trigger additional reporting requirements or other enhanced oversight. The statutory capital requirements of the Company&#8217;s Operating Subsidiaries are set out above. To the extent that these requirements are met, the Company do not anticipate any dividend restrictions arising as a result of the Company&#8217;s enhanced capital requirement.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_778"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-3314" continuedAt="f-3314-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Dividends </span></ix:nonNumeric></div><ix:continuation id="f-3314-1" continuedAt="f-3314-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDividendsPayableTextBlock" id="f-3315" continuedAt="f-3315-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On March 1, 2023, the Company&#8217;s Board of Directors declared the following dividends:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payable&#160;on:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record&#160;Date:</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1125" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3316">5.950</ix:nonFraction>% Preference Shares (AHL PRC)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1126" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-3317">0.3719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1127" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-3318">April 1, 2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1125" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-3319">March 15, 2023</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1128" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3320">5.625</ix:nonFraction>% Preference Shares (AHL PRD)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1129" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-3321">0.3516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1130" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-3322">April 1, 2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1128" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-3323">March 15, 2023</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1131" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3324">5.625</ix:nonFraction>% Preference Shares, represented by depositary shares (AHL PRE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1132" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-3325">351.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1133" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-3326">April 1, 2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1131" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-3327">March 15, 2023</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The <ix:nonFraction unitRef="number" contextRef="c-1131" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3328">5.625</ix:nonFraction>% Preference Shares are represented by depositary shares, each representing a 1/1000th interest in a share of the <ix:nonFraction unitRef="number" contextRef="c-1131" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-3329">5.625</ix:nonFraction>% Preference Shares.&#160;The dividend paid per depositary share is likewise 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of the declared dividend, equivalent to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1132" decimals="INF" name="ahl:DepositaryShareDividend" scale="0" id="f-3330">0.35156</ix:nonFraction> per depositary share.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the twelve months ended December&#160;31, 2022, the Company paid an ordinary shares dividend of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" format="ixt:num-dot-decimal" scale="6" id="f-3331">40</ix:nonFraction>&#160;million to Highlands Bermuda Holdco, Ltd., the holder of all the Company&#8217;s ordinary shares. The Company also paid an ordinary shares dividend of $<ix:nonFraction unitRef="usd" contextRef="c-1134" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" format="ixt:num-dot-decimal" scale="6" id="f-3332">20</ix:nonFraction>&#160;million to Highlands Bermuda Holdco, Ltd. on April 3, 2023.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_802"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="f-3333" continuedAt="f-3333-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Retirement Plans </span></ix:nonNumeric></div><ix:continuation id="f-3333-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates defined contribution retirement plans for the majority of its employees at varying rates of their salaries. Total contributions by the Company to the retirement plans were $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-3334">12.5</ix:nonFraction> million in the twelve months ended December&#160;31, 2022 (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-3335">13.5</ix:nonFraction> million, 2020 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-3336">12.1</ix:nonFraction> million).</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-64</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_814"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-3337" continuedAt="f-3337-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Share-Based Payments and Long-Term Incentive Plan</span></ix:nonNumeric></div><ix:continuation id="f-3337-1" continuedAt="f-3337-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company implemented a new long-term incentive scheme, under which annual awards are split equally between Performance Units and Exit Units. Performance units vesting conditions have been amended in the current year and vest after two years subject to the Company achieving certain thresholds of operating income over a two year period. Exit Units vest upon change of control (sale or IPO) and achieving predetermined multiplies of invested capital return targets. Both Performance Units and Exit Units are cash-based awards.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-3337-2">The Company&#8217;s total share-based compensation/long-term incentive plan expense for the twelve months ended December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:SharebasedpaymentandLTIPexpense" format="ixt:num-dot-decimal" scale="6" id="f-3338">0.6</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:SharebasedpaymentandLTIPexpense" format="ixt:num-dot-decimal" scale="6" id="f-3339">0.5</ix:nonFraction> million), which is related to a charge of $<ix:nonFraction unitRef="usd" contextRef="c-1135" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-3340">0.6</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1136" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-3341">0.5</ix:nonFraction> million) in relation to Performance Units. The income tax effect of this is not considered to be material.</ix:continuation> </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_827"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-3342" continuedAt="f-3342-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Intangible Assets and Goodwill</span></ix:nonNumeric></div><ix:continuation id="f-3342-1" continuedAt="f-3342-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="f-3343" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company&#8217;s intangible assets for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning of the Year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions/(Disposals)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">End of the Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1137" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3344">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1138" decimals="-5" name="ahl:FinitelivedIntangibleAssetsAcquiredDisposed" format="ixt:fixed-zero" scale="6" id="f-3345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1139" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-3346">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1139" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="f-3347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1140" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3348">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1141" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3349">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1142" decimals="-5" name="ahl:FinitelivedIntangibleAssetsAcquiredDisposed" format="ixt:fixed-zero" scale="6" id="f-3350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1142" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="f-3351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1142" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="f-3352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1143" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3353">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-3354">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="f-3355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-3356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-3357">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-3358">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:IntangibleAssetsandGoodwillAcquiredDisposed" format="ixt:fixed-zero" scale="6" id="f-3359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-3360">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="6" id="f-3361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-3362">21.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning of the Year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions/(Disposals)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">End of the Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1144" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3363">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1145" decimals="-5" name="ahl:FinitelivedIntangibleAssetsAcquiredDisposed" format="ixt:fixed-zero" scale="6" id="f-3364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1145" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-3365">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1145" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="f-3366">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1137" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3367">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency Relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1146" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3368">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1147" decimals="-5" name="ahl:FinitelivedIntangibleAssetsAcquiredDisposed" format="ixt:fixed-zero" scale="6" id="f-3369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1147" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-3370">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1147" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="f-3371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1148" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="f-3372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1149" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3373">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1150" decimals="-5" name="ahl:FinitelivedIntangibleAssetsAcquiredDisposed" format="ixt:fixed-zero" scale="6" id="f-3374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1150" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="f-3375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1150" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="f-3376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1141" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-3377">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-3378">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="f-3379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-3380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-3381">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-3382">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:IntangibleAssetsandGoodwillAcquiredDisposed" format="ixt:fixed-zero" scale="6" id="f-3383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-3384">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="6" id="f-3385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-3386">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen&#8217;s intangible assets relate to trademarks, contracts to sell products through independent broker and agents (Agency Relationships), an agreement for renewal rights with Liberty Specialty Markets Limited, non-compete agreements and licenses to trade in the U.S. and U.K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2010, the Company acquired licenses with a value of $<ix:nonFraction unitRef="usd" contextRef="c-1151" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-3387">10.0</ix:nonFraction> million. The total value of the licenses as at December 31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1143" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-3388">16.7</ix:nonFraction> million. This includes $<ix:nonFraction unitRef="usd" contextRef="c-1152" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-3389">4.5</ix:nonFraction> million of acquired licenses held by Aspen Specialty and $<ix:nonFraction unitRef="usd" contextRef="c-1153" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-3390">2.1</ix:nonFraction> million of acquired licenses held by Aspen UK. The insurance licenses are considered to have an indefinite life and are not being amortized. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Aspen has recognized goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-1154" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="f-3391">2.1</ix:nonFraction> million on the acquisition of equity voting interest of Blue Waters, a specialist marine insurance agency in October 2016 and of $<ix:nonFraction unitRef="usd" contextRef="c-1155" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="f-3392">1.8</ix:nonFraction> million on the purchase in January 2017 of <ix:nonFraction unitRef="number" contextRef="c-305" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-3393">49</ix:nonFraction>% share of Digital Re, a digital risk and specialty insurer. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-3342-2"> The &#8220;Aspen&#8221; trademark, valued at $<ix:nonFraction unitRef="usd" contextRef="c-1156" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-3394">1.2</ix:nonFraction> million, goodwill and insurance licenses are considered to have an indefinite life and are tested annually for impairment or when events or changes in circumstances indicate that these assets might be impaired. For the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company performed its annual qualitative assessment and determined that it was more likely than not that these were not impaired.</ix:continuation> </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_839"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-3395" continuedAt="f-3395-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Operating Leases </span></ix:nonNumeric></div><ix:continuation id="f-3395-1" continuedAt="f-3395-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company has recognized right-of-use operating lease assets of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-3396">72.8</ix:nonFraction> million, net of impairment and operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-3397">95.5</ix:nonFraction> million. Right-of-use operating lease assets comprise primarily of leased office real estate globally and other assets. For all office real estate leases, rent incentives, including reduced-rent and rent-free periods and contractually agreed rent increases during the lease term, have been included when determining the present value of future cash flows. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company&#8217;s operating effectiveness and efficiency program, the Company has consolidated its office space. Where negotiations are either in advanced stages of discussion and it is probable that the sub-lease transactions will be completed, or the Company has agreed terms to sub-lease our office space, the Company has assessed the right-of-use lease assets for impairment and have recognized a $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" format="ixt:num-dot-decimal" scale="6" id="f-3398">6.7</ix:nonFraction> million credit (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" format="ixt:num-dot-decimal" scale="6" id="f-3399">0.4</ix:nonFraction> million) charge within the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes its office space is sufficient to conduct its operations for the foreseeable future in these locations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no lease transactions between related parties.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-3400" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating lease charge.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The following table summarizes the operating lease charge for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization charge on right-of-use operating leased assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-3401">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-3402">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-3403">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-3404">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease charge</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-3405">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-3406">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3395-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-3407" continuedAt="f-3407-1" escape="true">The following table summarizes the maturity of lease liabilities under non-cancellable leases as of December&#160;31, 2022 and 2021:</ix:nonNumeric></span></div><ix:continuation id="f-3407-1"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases &#8212; maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" format="ixt:fixed-zero" scale="6" id="f-3408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" scale="6" id="f-3409">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-3410">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-3411">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-3412">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-3413">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-3414">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-3415">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-3416">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-3417">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-3418">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-3419">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Later years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-3420">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-3421">48.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-3422">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-3423">143.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-3424">23.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-3425">28.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-3426">95.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-3427">115.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other lease information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="c-1" name="ahl:SummaryofOtherLeaseInformationTableTextBlock" id="f-3428" continuedAt="f-3428-1" escape="true">The following table summarizes the cash flows on operating leases for the twelve months ended December&#160;31, 2022 and 2021, and other supplemental information:</ix:nonNumeric></span></div><ix:continuation id="f-3428-1"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating cash outflow from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-3429">15.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-3430">17.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-3431">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-3432">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction to Right-of-use assets resulting from reductions to lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-3433">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-3434">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Averages</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating leases, remaining lease terms (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-12" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-3435">8.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-13" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-3436">8.8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating leases, average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-3437">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-3438">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_851"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-3439" continuedAt="f-3439-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Related Party Transactions</span></ix:nonNumeric></div><ix:continuation id="f-3439-1" continuedAt="f-3439-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo&#8217;s indirect subsidiary, Apollo Asset Management Europe PC LLP (&#8220;AAME&#8221;), serves as the investment manager for the Company and certain of the Company&#8217;s subsidiaries, and Apollo&#8217;s indirect subsidiary, Apollo Management Holdings, L.P. (&#8220;AMH&#8221;), provides the Company with management consulting services and advisory services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain employees of Apollo and its affiliates serve on the Board. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3439-2" continuedAt="f-3439-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of relationships and transactions that have existed or that the Company and certain of the Company&#8217;s subsidiaries has entered into with Apollo and its affiliates are described below. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Management Relationships</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAME provides centralized asset management investment advisory and risk services for the portfolio of the Company&#8217;s investments and investments of such subsidiaries pursuant to the investment management agreements (&#8220;IMAs&#8221;) that have been entered into with AAME. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the IMAs, AAME may engage sub-advisors or delegates to provide certain of the investment advisory and management services to the Company&#8217;s subsidiaries. Such sub-advisors may include affiliates of AAME.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under each of the IMAs, AAME will be paid an annual investment management fee (the &#8220;Management Fee&#8221;) which will be based on a cost-plus structure. The &#8220;cost&#8221; is comprised of the direct and indirect fees, costs, expenses and other liabilities arising in or otherwise connected with the services provided under the IMAs. The &#8220;plus&#8221; component will be a mark-up in an amount of up to <ix:nonFraction unitRef="number" contextRef="c-19" decimals="2" name="ahl:RelatedPartyTransactionRateofInterest" scale="-2" id="f-3440">25</ix:nonFraction>% determined based on an applicable transfer pricing study. The Management Fee will be subject to certain maximum threshold levels, including an annual fee cap of <ix:nonFraction unitRef="number" contextRef="c-19" decimals="2" name="ahl:RelatedPartyTransactionMaximumRateIncrease" scale="-2" id="f-3441">15</ix:nonFraction> bps of the total amount of investable assets. Affiliated sub-advisors, including AMI and AMC, will also earn additional fees for sub-advisory services rendered. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company recognized IMA fees of $<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3442">4.9</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3443">5.8</ix:nonFraction> million; 2020 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3444">5.3</ix:nonFraction> million), of which $<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-3445">4.5</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-3446">3.2</ix:nonFraction>&#160;million) remains payable to AAME at year end.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management Consulting Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Company entered into a Management Consulting Agreement, dated March 28, 2019 (the &#8220;Management Consulting Agreement&#8221;), with AMH. Pursuant to the Management Consulting Agreement, AMH will provide the Company management consulting and advisory services related to the business and affairs of the Company and its subsidiaries. The Company will pay AMH in consideration for its services under the Management Consulting Agreement, an annual management consulting fee equal to the greater of (i) <ix:nonFraction unitRef="number" contextRef="c-1157" decimals="2" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="f-3447">1</ix:nonFraction>% of the consolidated net income of the Company and its subsidiaries for the applicable fiscal year, or (ii) $<ix:nonFraction unitRef="usd" contextRef="c-1158" decimals="-6" name="us-gaap:DueFromOfficersOrStockholdersCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3448">5</ix:nonFraction> million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company recognized Management Consulting fees of $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3449">5.0</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3450">5.0</ix:nonFraction>&#160;million; 2020 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3451">5.0</ix:nonFraction> million), of which $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-3452">1.3</ix:nonFraction> million remains payable to AMH at year end (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:fixed-zero" scale="6" id="f-3453">Nil</ix:nonFraction>).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Investments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year, the Company bought or held the following securities or investments in Apollo:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apollo Real Estate Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As at December&#160;31, 2022, the Company&#8217;s investment in Apollo Real Estate Fund had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-3454">25.3</ix:nonFraction>&#160;million. This investment is included in other investments on the consolidated balance sheet. Income earned on this investment was $<ix:nonFraction unitRef="usd" contextRef="c-1159" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3455">1.6</ix:nonFraction>&#160;million and is included in net investment income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apollo Origination Partnership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;AOP&#8221;) Fund. As at December&#160;31, 2022, the Company&#8217;s investment in the AOP Fund had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-3456">12.7</ix:nonFraction>&#160;million. This investment is included in other investments on the consolidated balance sheet. The Company incurred gains of $<ix:nonFraction unitRef="usd" contextRef="c-1160" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3457">1.5</ix:nonFraction>&#160;million and is included in net investments income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOP Class A notes;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AOP Class B notes. As at December&#160;31, 2022, the Company&#8217;s investment in AOP Class A notes had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-1161" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-3458">30.0</ix:nonFraction>&#160;million. As at December&#160;31, 2022, the Company&#8217;s investment in AOP Class B notes had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-1162" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-3459">14.8</ix:nonFraction>&#160;million. The Company incurred losses of $<ix:nonFraction unitRef="usd" contextRef="c-1163" decimals="-5" name="ahl:PrivatelyHeldInvestmentLossesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-3460">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-1164" decimals="-5" name="ahl:PrivatelyHeldInvestmentLossesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-3461">0.2</ix:nonFraction>&#160;million on AOP Class A and B notes, respectively, and is included in realized and unrealized investment losses on the consolidated statement </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3439-3" continuedAt="f-3439-4"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of operations and other comprehensive income. These investments are included in privately-held investments on the consolidated balance sheet.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022 there were <ix:nonFraction unitRef="usd" contextRef="c-1165" decimals="-5" name="ahl:PrivatelyHeldInvestmentLossesIncurred" format="ixt:fixed-zero" scale="0" id="f-3462">no</ix:nonFraction> expenses incurred relating to any of these investments. The above transactions were entered into at arm&#8217;s length.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Payables to Related Parties</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-3439-4" continuedAt="f-3439-5">As at year end December&#160;31, 2022, the Company had an intercompany payable balance of $<ix:nonFraction unitRef="usd" contextRef="c-1166" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3463">2.0</ix:nonFraction>&#160;million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1167" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3464">0.6</ix:nonFraction>&#160;million), due to its parent, Highlands Bermuda Holdco, Ltd.</ix:continuation> </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_863"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-3465" continuedAt="f-3465-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Commitments and Contingent Liabilities</span></ix:nonNumeric></div><ix:continuation id="f-3465-1" continuedAt="f-3465-2"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">Restricted assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s subsidiaries are obliged by the terms of its contractual obligations to U.S.&#160;policyholders and by obligations to certain regulatory authorities to facilitate issue of letters of credit or maintain certain balances in trust funds for the benefit of policyholders.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="f-3466" continuedAt="f-3466-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the forms and value of Company&#8217;s material restricted assets as at December&#160;31, 2022 and 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory trusts and deposits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated transactions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1168" decimals="-5" name="ahl:RestrictedAssets" scale="6" id="f-3467">707.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1169" decimals="-5" name="ahl:RestrictedAssets" scale="6" id="f-3468">891.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1170" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-3469">2,817.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1171" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-3470">3,099.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit / guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:RestrictedAssets" scale="6" id="f-3471">471.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:RestrictedAssets" scale="6" id="f-3472">539.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets (excluding illiquid assets)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:RestrictedAssetsExcludingIlliquidAssets" format="ixt:num-dot-decimal" scale="6" id="f-3473">3,996.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:RestrictedAssetsExcludingIlliquidAssets" format="ixt:num-dot-decimal" scale="6" id="f-3474">4,530.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments &#8212; illiquid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1172" decimals="-5" name="us-gaap:OtherInvestments" scale="6" id="f-3475">221.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1173" decimals="-5" name="us-gaap:OtherInvestments" scale="6" id="f-3476">151.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets and illiquid assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:TotalRestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-3477">4,217.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:TotalRestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-3478">4,682.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total as percent of cash and invested assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="ahl:CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" scale="-2" id="f-3479">59.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="ahl:CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" scale="-2" id="f-3480">59.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As at December&#160;31, 2022, the Company had pledged funds of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-3481">471.3</ix:nonFraction> million (December&#160;31, 2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-3482">539.8</ix:nonFraction> million) as collateral for the secured letters of credit.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Investable assets comprise total investments, cash and cash equivalents, accrued interest, receivables for securities sold and payables for securities purchased.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Funds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We invest in real estate funds which, as is typical for this type of investment, have lock-up periods. A lock-up period is the initial amount of time an investor is contractually required to remain invested before having the ability to redeem. As at December&#160;31, 2022, the lock-up periods across these funds range from one quarter to several years. Thereafter these funds could also be redeemed on a pro-rata basis depending on the liquidity position of the fund. There are no assurances as to when the Company may be able to withdraw, in whole or in part, its redemption request from the fund.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments - Equity Method.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 23, 2019, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-3483">5.0</ix:nonFraction> million as an equity investment in the holding company of a multi-line reinsurer. The strategy for the multi-line reinsurer is to combine a diversified reinsurance business, focused primarily on long-tailed lines of property and casualty business and, potentially to a lesser extent, life business, with a diversified investment strategy. During the period ending December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-3484">1.6</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-3485">2.5</ix:nonFraction> million) capital was invested in multi-line reinsurer.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3465-2" continuedAt="f-3465-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current arrangements with our bankers for the issue of letters of credit require us to provide collateral in the form of cash and investments for the full amount of all secured and undrawn letters of credit that are outstanding. We monitor the proportion of our otherwise liquid assets that are committed to trust funds or to the collateralization of letters of credit. As at December&#160;31, 2022 and 2021, these funds amounted to approximately <ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="ahl:CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" scale="-2" id="f-3486">59.4</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-8" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="9" id="f-3487">7.1</ix:nonFraction> billion and approximately <ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="ahl:CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" scale="-2" id="f-3488">59.7</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-8" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="9" id="f-3489">7.8</ix:nonFraction> billion of investable assets held by the Company, respectively. We do not consider that this unduly restricts our liquidity at this time. For more information on our credit facilities and long-term debt arrangements, refer to Note&#160;23, &#8220;Credit Facility and Short-term Debt&#8221; of these consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Funds at Lloyd&#8217;s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AUL operates at Lloyd&#8217;s as the corporate member for Syndicate 4711. AUL also participates in underwriting activities of Carbon Syndicate 4747. Lloyd&#8217;s determines required regulatory capital by considering the underwriting activities that AUL participates in. Such capital, called Funds at Lloyd&#8217;s, consists of investable assets as at December&#160;31, 2022 in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AssetsHeldByInsuranceRegulators" format="ixt:num-dot-decimal" scale="6" id="f-3490">489.5</ix:nonFraction> million (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AssetsHeldByInsuranceRegulators" format="ixt:num-dot-decimal" scale="6" id="f-3491">565.8</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided as Funds at Lloyd&#8217;s will be drawn upon and become a liability of the Company in the event of Syndicate 4711 declaring a loss at a level that cannot be funded from other resources, or if Syndicate 4711 requires funds to cover a short-term liquidity gap. The amount which the Company provides as Funds at Lloyd&#8217;s is not available for distribution to the Company for the payment of dividends. Aspen Managing Agency Limited, the managing agent to Syndicate 4711, is also required by Lloyd&#8217;s to maintain a minimum level of capital which as at December&#160;31, 2022 was &#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-5" name="srt:MinimumNetCapitalRequired1" format="ixt:num-dot-decimal" scale="6" id="f-3492">0.4</ix:nonFraction> million (December&#160;31, 2021&#160;&#8212; &#163;<ix:nonFraction unitRef="gbp" contextRef="c-13" decimals="-5" name="srt:MinimumNetCapitalRequired1" format="ixt:num-dot-decimal" scale="6" id="f-3493">0.4</ix:nonFraction> million). This is not available for distribution by the Company for the payment of dividends.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Reinsurance Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;For its U.S.&#160;reinsurance activities, Aspen UK has established and must retain a multi-beneficiary U.S.&#160;trust fund for the benefit of its U.S.&#160;cedants so that they may take financial statement credit without the need to post cedant-specific security. The minimum trust fund amount is $<ix:nonFraction unitRef="usd" contextRef="c-1174" decimals="-5" name="ahl:MinimumTrustFund" format="ixt:num-dot-decimal" scale="6" id="f-3494">20.0</ix:nonFraction> million plus an amount equal to <ix:nonFraction unitRef="number" contextRef="c-12" decimals="INF" name="ahl:PercentageOfReinsuranceLiabilities" scale="-2" id="f-3495">100</ix:nonFraction>% of Aspen UK&#8217;s U.S.&#160;reinsurance liabilities, which were $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ReinsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-3496">1,166.4</ix:nonFraction> million as at December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:ReinsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-3497">1,470.5</ix:nonFraction> million as at December&#160;31, 2021. As at December&#160;31, 2022, the balance (including applicable letter of credit facilities) held in the trust was $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3498">1,389.5</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3499">1,581.9</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda has also established and must retain a multi-beneficiary U.S.&#160;trust fund for the benefit of its U.S.&#160;cedants so that they may take financial statement credit without the need to post cedant-specific security. The minimum trust fund amount is $<ix:nonFraction unitRef="usd" contextRef="c-1174" decimals="-5" name="ahl:MinimumTrustFund" format="ixt:num-dot-decimal" scale="6" id="f-3500">20.0</ix:nonFraction> million plus an amount equal to <ix:nonFraction unitRef="number" contextRef="c-1175" decimals="INF" name="ahl:PercentageOfReinsuranceLiabilities" scale="-2" id="f-3501">100</ix:nonFraction>% of Aspen Bermuda&#8217;s liabilities to its U.S. cedants which was $<ix:nonFraction unitRef="usd" contextRef="c-1175" decimals="-5" name="ahl:ReinsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-3502">380.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1176" decimals="-5" name="ahl:ReinsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-3503">450.4</ix:nonFraction> million as at December&#160;31, 2022 and 2021, respectively. As at December&#160;31, 2022, the balance held in the U.S. trust fund and other Aspen Bermuda trusts was $<ix:nonFraction unitRef="usd" contextRef="c-1174" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3504">509.2</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1177" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3505">519.7</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Surplus Lines Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK and Syndicate 4711 have also established a U.S.&#160;surplus lines trust fund with a U.S.&#160;bank to secure liabilities under U.S.&#160;surplus lines policies. The balance held in trust as at December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1178" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3506">215.1</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1179" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3507">216.0</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Regulatory Deposits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As at December&#160;31, 2022, Aspen Specialty had a total of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:RegulatoryDeposits" format="ixt:num-dot-decimal" scale="6" id="f-3508">6.7</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:RegulatoryDeposits" format="ixt:num-dot-decimal" scale="6" id="f-3509">6.9</ix:nonFraction> million) on deposit with six U.S.&#160;states in order to satisfy state regulations for writing business in those states. AAIC had a further $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DepositWithStates" format="ixt:num-dot-decimal" scale="6" id="f-3510">6.5</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:DepositWithStates" format="ixt:num-dot-decimal" scale="6" id="f-3511">6.4</ix:nonFraction> million) on deposit with twelve U.S.&#160;states. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a Canadian trust fund with a Canadian bank to secure a Canadian insurance license. As at December&#160;31, 2022, the balance held in trust was CAD$<ix:nonFraction unitRef="cad" contextRef="c-1180" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3512">185.8</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1180" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3513">137.2</ix:nonFraction> million) (2021&#160;&#8212; CAD$<ix:nonFraction unitRef="cad" contextRef="c-1181" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3514">196.8</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Australian Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established an Australian trust fund with an Australian bank to secure policyholder liabilities and as a condition for maintaining an Australian insurance license. As at December&#160;31, 2022, the balance held in trust was AUD$<ix:nonFraction unitRef="aud" contextRef="c-1182" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3515">183.9</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1182" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3516">124.7</ix:nonFraction> million) (2021&#160;&#8212; AUD$<ix:nonFraction unitRef="aud" contextRef="c-1183" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3517">226.6</ix:nonFraction> million).</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3465-3" continuedAt="f-3465-4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Swiss Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a Swiss trust fund with a Swiss bank to secure policyholder liabilities and as a condition for maintaining a Swiss insurance license. As at December&#160;31, 2022, the balance held in trust was CHF<ix:nonFraction unitRef="chf" contextRef="c-1184" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3518">9.4</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1184" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3519">10.2</ix:nonFraction> million) (2021 &#8212; CHF<ix:nonFraction unitRef="chf" contextRef="c-1185" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3520">8.0</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Singapore Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a segregated Singaporean bank account to secure policyholder liabilities and as a condition for maintaining a Singaporean insurance license and meet local solvency requirements. As at December&#160;31, 2022, the balance in the account was SGD$<ix:nonFraction unitRef="sgd" contextRef="c-1186" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3521">174.7</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1186" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3522">130.3</ix:nonFraction> million) (2021&#160;&#8212; SGD$<ix:nonFraction unitRef="sgd" contextRef="c-1187" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-3523">178.0</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Contingent liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In common with the rest of the insurance and reinsurance industry, the Company is also subject to litigation and arbitration in the ordinary course of business. The Company&#8217;s Operating Subsidiaries are regularly engaged in the investigation, conduct and defense of disputes, or potential disputes, resulting from questions of insurance or reinsurance coverage or claims activities. Pursuant to insurance and reinsurance arrangements, many of these disputes are resolved by arbitration or other forms of alternative dispute resolution. Such legal proceedings are considered in connection with estimating the Company&#8217;s Insurance Reserves &#8212; Loss and Loss Adjustment Expenses, as provided on the Company&#8217;s consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some jurisdictions, noticeably the U.S., a failure to deal with such disputes or potential disputes in an appropriate manner could result in an award of &#8220;bad faith&#8221; punitive damages against the Company&#8217;s Operating Subsidiaries. In accordance with ASC 450-20-50-4b, for (a) reasonably possible losses for which no accrual is made because any of the conditions for accrual in ASC 450-20-25-2 are not met and (b) reasonably possible losses in excess of the amounts accrued pursuant to ASC 450-20-30-1, the Company will provide an estimate of the possible loss or range of possible loss or state that such an estimate cannot be made.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, it was the opinion of the Company&#8217;s management based on available information that the probability of the ultimate resolution of pending or threatened litigation or arbitrations having a material effect on the Company&#8217;s financial condition, results of operations or liquidity would be remote.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_875"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="f-3524" continuedAt="f-3524-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Concentrations of Credit Risk </span></ix:nonNumeric></div><ix:continuation id="f-3524-1" continuedAt="f-3524-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is potentially exposed to concentrations of credit risk in respect of amounts recoverable from reinsurers, investments and cash and cash equivalents, and insurance and reinsurance balances owed by the brokers with whom the Company transacts business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defines credit risk tolerances in line with the risk appetite set by our Board and they, together with the Group&#8217;s risk management function, monitor exposures to individual counterparties. Any exceptions are reported to senior management and the Risk Committee of the Board of Directors. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance recoverables </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount recoverable by the Company from reinsurers as at December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-3525">4,897.7</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-3526">3,298.1</ix:nonFraction> million) of which $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ReinsuranceRecoverablesUncollateralized" format="ixt:num-dot-decimal" scale="6" id="f-3527">2,092.4</ix:nonFraction> million was uncollateralized (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:ReinsuranceRecoverablesUncollateralized" format="ixt:num-dot-decimal" scale="6" id="f-3528">1,981.4</ix:nonFraction> million). As at December&#160;31, 2022, of the Company&#8217;s uncollateralized reinsurance recoverables <ix:nonFraction unitRef="number" contextRef="c-1188" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-3529">9.7</ix:nonFraction>% (2021&#160;&#8212; <ix:nonFraction unitRef="number" contextRef="c-1189" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-3530">10.8</ix:nonFraction>%) were with Munich Re which is rated A+ by A.M. Best and AA- by S&amp;P, <ix:nonFraction unitRef="number" contextRef="c-1190" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-3531">16.3</ix:nonFraction>% (2021&#160;&#8212;<ix:nonFraction unitRef="number" contextRef="c-1191" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-3532">15.9</ix:nonFraction>% ) were with Everest Re which is rated A+ by A.M Best and A+ by S&amp;P, and <ix:nonFraction unitRef="number" contextRef="c-1192" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-3533">8.2</ix:nonFraction>% (2021&#160;&#8212; <ix:nonFraction unitRef="number" contextRef="c-1193" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-3534">9.3</ix:nonFraction>%) were with Lloyd&#8217;s which is rated A by A.M. Best and A+ by S&amp;P. These are the Company&#8217;s largest exposures to individual reinsurers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2016, the FASB issued ASU 2016-13, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; which introduced a new impairment model, known as the current expected loss model (&#8220;CECL&#8221;), which is based on expected losses rather than incurred losses. Under the new credit loss model, the Company would recognize an allowance for its estimate of expected credit losses and this would apply to reinsurance receivables. Following the adoption of this ASU with effect from January 1, 2020, the Company recognized a reduction in the Company&#8217;s reinsurance recoverables by $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" format="ixt:num-dot-decimal" scale="6" id="f-3535">3.7</ix:nonFraction> million as at December&#160;31, 2022 (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" format="ixt:num-dot-decimal" scale="6" id="f-3536">3.3</ix:nonFraction> million). For the twelve months </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3524-2" continuedAt="f-3524-3"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended December&#160;31, 2022 there was an increase in the CECL allowance on reinsurance recoverables of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-3537">0.4</ix:nonFraction> million (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-3538">0.5</ix:nonFraction> million decrease).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting premium receivables </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total underwriting premium receivable by the Company as at December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-3539">1,482.4</ix:nonFraction> million (2021&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-3540">1,304.6</ix:nonFraction> million). As at December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PremiumsReceivableNonCurrent" format="ixt:num-dot-decimal" scale="6" id="f-3541">18.3</ix:nonFraction> million of the total underwriting premium receivable balance has been due for settlement for more than one year. The Company assesses the recoverability of premium receivables through a review of policies and the concentration of receivables by broker. Allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="f-3542">25.0</ix:nonFraction> million as at December&#160;31, 2022 (2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="f-3543">30.2</ix:nonFraction> million) for underwriting premiums unlikely to be collected. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments and cash and cash equivalents </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment policies include specific provisions that limit the allowable holdings of a single issue and issuer. As at December&#160;31, 2022, there were no investments in any single issuer, other than the U.S.&#160;government and the Canadian government in excess of <ix:nonFraction unitRef="number" contextRef="c-19" decimals="INF" name="ahl:PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" scale="-2" id="f-3544">2</ix:nonFraction>% of the aggregate investment portfolio.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business through brokers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company underwrites a significant amount of its business through brokers and a credit risk exists should any of these brokers be unable to fulfill their contractual obligations in respect of insurance or reinsurance balances due to the Company. <ix:nonNumeric contextRef="c-1" name="ahl:ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" id="f-3545" continuedAt="f-3545-1" escape="true">The following table shows the largest brokers that the Company transacted business within the three years ended December&#160;31, 2022 and the proportion of gross written premiums from each of those brokers. </ix:nonNumeric></span></div><ix:continuation id="f-3545-1" continuedAt="f-3545-2"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aon Corporation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1194" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3546">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1195" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3547">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1196" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3548">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marsh&#160;&amp; McLennan Companies, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1197" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3549">21.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1198" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3550">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1199" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3551">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Willis Group Holdings, Ltd.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1200" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3552">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1201" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3553">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1202" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3554">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other brokers/non-broker sources </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1203" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3555">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1204" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3556">55.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1205" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3557">58.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3558">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3559">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-27" decimals="3" name="ahl:PremiumsWrittenGrossPercentage" scale="-2" id="f-3560">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums ($ millions)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-3561">4,338.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-3562">3,938.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-3563">3,698.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div></ix:continuation><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-3545-2" continuedAt="f-3545-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="f-3545-3">No other individual broker accounted for more than <ix:nonFraction unitRef="number" contextRef="c-19" decimals="INF" name="ahl:PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" scale="-2" id="f-3564">10</ix:nonFraction>% of total gross written premiums.</ix:continuation> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-72</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_887"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-3565" continuedAt="f-3565-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reclassifications from Accumulated Other Comprehensive Income</span></ix:nonNumeric></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-3566" continuedAt="f-3566-1" escape="true"><ix:continuation id="f-3565-1" continuedAt="f-3565-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets out the components of the Company&#8217;s AOCI that are reclassified into the condensed consolidated statement of operations for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about the AOCI Components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected&#160;Line&#160;Item&#160;in&#160;the&#160;<br/>Consolidated Statement of Operations</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized (gains) on sale of securities and cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1206" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="6" id="f-3567">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1207" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="6" id="f-3568">24.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized losses on sale of securities and cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1206" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="f-3569">58.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1207" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="f-3570">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1206" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-3571">55.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1207" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-3572">20.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income/(loss) from operations before income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on net realized gains of securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1206" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1207" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1206" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-3575">55.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1207" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-3576">20.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized derivatives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gains on settled derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1208" decimals="-5" sign="-" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-3577">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1209" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-3578">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on settled derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1208" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1209" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3580">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1208" decimals="-5" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-3581">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1209" decimals="-5" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-3582">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications from AOCI to the statement of operations, net of income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1210" decimals="-5" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-3583">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1211" decimals="-5" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-3584">26.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr></table></div></ix:continuation></ix:nonNumeric><div id="i74bc390671ae44c18dcd3f802f6097fb_899"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-3585" continuedAt="f-3585-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Credit Facilities and Short-term Debt </span></ix:nonNumeric></div><ix:continuation id="f-3585-1" continuedAt="f-3585-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of its operations, the Company enters into agreements with financial institutions to obtain financing through secured and unsecured credit facilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 1, 2021, Aspen Holdings and certain of its direct or indirect subsidiaries (collectively, the &#8220;Borrowers&#8221;) entered into a Third Amended and Restated Credit Agreement, as further amended from time to time (the &#8220;Credit Agreement&#8221;) with various lenders and Barclays Bank plc, as administrative agent, which amends and restates the Amended and Restated Credit Agreement, dated as of June 12, 2013 and the Second Amended and Restated Credit Agreement, dated as of March 27, 2017, among Aspen Holdings, certain subsidiaries thereof, various lenders and Barclays Bank plc, as administrative agent. The Credit Agreement will be used by the Borrowers to finance the working capital needs of the Aspen Holdings and its subsidiaries, for letters of credit in connection with the insurance and reinsurance businesses of the Company and its subsidiaries and borrowings for other general corporate purposes. Initial availability under the Credit Agreement is $<ix:nonFraction unitRef="usd" contextRef="c-1212" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="0" id="f-3586">300,000,000</ix:nonFraction> and the Company has the right to request (subject to the terms and conditions of the Credit Agreement) an increase to the credit facility by up to $<ix:nonFraction unitRef="usd" contextRef="c-1213" decimals="INF" name="ahl:LineOfCreditFacilityIncreasableCapacity" format="ixt:num-dot-decimal" scale="0" id="f-3587">100,000,000</ix:nonFraction>. The Credit Agreement will expire on December 1, 2026. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, there were no borrowings outstanding under the Credit Agreement. The fees and interest rates on the loans and the fees on the letters of credit payable by the Borrowers under the Credit Agreement are based upon the credit ratings for the Company&#8217;s long-term unsecured senior, non-credit enhanced debt rating of the Company, as determined by S&amp;P and Moody&#8217;s. In addition, the fees for a letter of credit vary based upon whether the applicable Borrower has provided collateral (in the form of cash or qualifying debt securities) to secure its reimbursement obligations with respect to such letter of credit.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3585-2" continuedAt="f-3585-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Agreement, the Company must not permit (a)&#160;consolidated tangible net worth as at the last day of each fiscal quarter of the Company to be less than the sum of (i) $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="INF" name="ahl:LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" format="ixt:num-dot-decimal" scale="0" id="f-3588">2,019,600,000</ix:nonFraction>, (ii) <ix:nonFraction unitRef="number" contextRef="c-19" decimals="INF" name="ahl:LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" scale="-2" id="f-3589">25</ix:nonFraction>% of consolidated net income during the period from January 1, 2021 to and including such last day of such fiscal quarter (if positive) and (iii) <ix:nonFraction unitRef="number" contextRef="c-19" decimals="INF" name="ahl:LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" scale="-2" id="f-3590">25</ix:nonFraction>% of the aggregate net cash proceeds of all issuances by the Company of shares of its capital stock during the period from January 1, 2021 to and including such last day of such fiscal quarter, but excluding (x) any amount included in the Company&#8217;s accumulated other comprehensive income or loss related to unrealized gains or losses on available for sale securities and (y) during the period from January 1, 2022, any amount included in net unrealized investment gains or losses, related to unrealized gains or losses on trading securities, (b)&#160;the ratio of its total consolidated debt to the sum of such debt plus our consolidated tangible net worth to exceed <ix:nonFraction unitRef="number" contextRef="c-19" decimals="INF" name="ahl:PercentageOfConsolidatedLeverageRatioPermitted" scale="-2" id="f-3591">35</ix:nonFraction>% as at the last day of any fiscal quarter of the Company or (c)&#160;any material insurance subsidiary to have a financial strength rating of less than &#8220;B++&#8221; from A.M. Best. The Credit Agreement contains other customary affirmative and negative covenants, including (subject to various exceptions) restrictions on the ability of the Company and its subsidiaries to incur indebtedness, create or permit liens on their assets, engage in mergers or consolidations, dispose of assets, pay dividends or other distributions, purchase or redeem the Company&#8217;s equity securities, make investments and enter into transactions with affiliates. In addition, the Credit Agreement has customary events of default, including (subject to certain materiality thresholds and grace periods) payment default, failure to comply with covenants, material inaccuracy of representation or warranty, bankruptcy or insolvency proceedings, change of control and cross-default to other debt agreements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Credit Facilities. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">On March 2, 2023, Aspen Bermuda and Citibank Europe plc (&#8220;Citi Europe&#8221;) amended the committed letter of credit facility, dated July 30, 2012, as amended with effect on June 30, 2014, June 30, 2016, June 30, 2018, September 20, 2019, June 26, 2020 and June 29, 2022 (the &#8220;LOC Facility&#8221;). The June 29, 2022 amendment to the LOC Facility extends the term to June 30, 2024. The maximum aggregate amount available under the LOC Facility is $<ix:nonFraction unitRef="usd" contextRef="c-1214" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-3592">400.0</ix:nonFraction>&#160;million. Under the LOC Facility, Aspen Bermuda will pay to Citi Europe (a) a letter of credit fee based on the available amounts of each letter of credit and (b) a commitment fee, which varies based upon usage, on the unutilized portion of the LOC Facility. Aspen Bermuda will also pay interest on the amount drawn by any beneficiary under the LOC Facility at a certain specific rate from the date of drawing until the date of reimbursement by Aspen Bermuda. In addition, Aspen Bermuda and Citi Europe entered into an uncommitted letter of credit facility whereby Aspen Bermuda has the ability to request letters of credit under this facility subject to the prior approval of Citi Europe. The fee associated with the uncommitted facility is a letter of credit fee based on the available amounts of each letter of credit issued under the uncommitted facility. Both the LOC Facility and the uncommitted facility are used to secure obligations of Aspen Bermuda to its policyholders. In addition to these facilities, we also use regulatory trusts to secure our obligations to policyholders.&#160; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of a pledge agreement between Aspen Bermuda and Citi Europe (pursuant to an assignment agreement dated October&#160;11, 2006) dated January&#160;17, 2006, as amended, were also amended on December 18, 2014 to change the types of securities or other assets that are acceptable as collateral under the LOC Facility and again on June 29, 2022 to change the representations and warranties granted by Aspen Bermuda in relation to the collateral provided under the LOC Facility. All other agreements relating to Aspen Bermuda&#8217;s LOC Facility, which now apply to the LOC Facility with Citi Europe, as previously filed with the SEC, remain in full force and effect. As at December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="c-1215" decimals="-5" name="ahl:LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-3593">416.8</ix:nonFraction> million of outstanding collateralized letters of credit under the LOC Facility (December&#160;31, 2021 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1216" decimals="-5" name="ahl:LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-3594">452.4</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.8pt">On February 7, 2019, Aspen European and Aspen Holdings (acting as guarantor of Aspen European) entered into a letter of credit facility for the purpose of obtaining a letter of credit in favor of Aspen UK for a sum not to exceed $<ix:nonFraction unitRef="usd" contextRef="c-1217" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-3595">100</ix:nonFraction>&#160;million to provide approved regulatory capital for Aspen UK. A letter of credit was issued in favor of Aspen UK for a sum of $<ix:nonFraction unitRef="usd" contextRef="c-1217" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-3596">100</ix:nonFraction>&#160;million. This facility was amended and restated with respect to February 7, 2023, pursuant to which the $<ix:nonFraction unitRef="usd" contextRef="c-1218" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-3597">100</ix:nonFraction>&#160;million letter of credit was extended to February 11, 2027.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3585-3" continuedAt="f-3585-4"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.03pt">On October 27, 2022, AUL and Aspen Holdings (acting as guarantor of AUL), effected an amendment to a letter of credit facility agreement for the account of AUL, pursuant to which a syndicate of lenders issued a several letter of credit in an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-1219" decimals="INF" name="ahl:LetterOfCreditToSupportFundsAtLloyds" format="ixt:num-dot-decimal" scale="0" id="f-3598">285,000,000</ix:nonFraction>, for the benefit of Lloyd&#8217;s, to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2023 year of account at Lloyd&#8217;s. This further amended the letter of credit facility agreement, dated November 3, 2020, entered into between AUL, Aspen Holdings (acting as guarantor of AUL) and various lenders, for the account of AUL, pursuant to which a lender provided a maximum aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-1220" decimals="INF" name="ahl:LetterOfCreditToSupportFundsAtLloyds" format="ixt:num-dot-decimal" scale="0" id="f-3599">235,000,000</ix:nonFraction>, to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2021 year of account at Lloyd&#8217;s, as amended on May 7, 2021, November 1, 2021 and May 6, 2022, in connection with the 2021 and 2022 underwriting years of account at Lloyd&#8217;s, as applicable. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.57pt">On December 1, 2022, AUL and Aspen Holdings (acting as guarantor of AUL) amended a Funds at Lloyd&#8217;s Facility Agreement dated November 25, 2020, as amended on December 2, 2021, for the account of AUL. This facility provides that a maximum aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-1221" decimals="INF" name="ahl:FundsAtLloydsFacilityAgreement" format="ixt:num-dot-decimal" scale="6" id="f-3600">80.0</ix:nonFraction>&#160;million of acceptable securities may be deposited with, and for the benefit of, Lloyd&#8217;s on behalf of AUL to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2023 year of account at Lloyd&#8217;s.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">On December 1, 2022, AUL and Aspen Bermuda (acting as AUL&#8217;s guarantor) amended and restated a Funds a Lloyd&#8217;s Facility Agreement dated November 30, 2020, as amended on November 30, 2021, for the account of AUL. This facility provides that a maximum aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-1222" decimals="INF" name="ahl:FundsAtLloydsFacilityAgreement" format="ixt:num-dot-decimal" scale="6" id="f-3601">150</ix:nonFraction>&#160;million of acceptable securities may be deposited with, and for the benefit of, Lloyd&#8217;s on behalf of AUL to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2023 year of account at Lloyd&#8217;s. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.57pt">On November 5, 2021, Aspen Bermuda entered into an uncommitted Continuing Agreement for Standby Letters of Credit and Demand Guarantees, as amended on April 1, 2022, where Aspen Bermuda has the ability to request letters of credit to be used in support of policyholder obligations with the consent of the lender. The fee associated with this facility is a facility fee based on the aggregate face amount of outstanding letters of credit. As at December&#160;31, 2022 we had $<ix:nonFraction unitRef="usd" contextRef="c-1223" decimals="-5" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-3602">120</ix:nonFraction>&#160;million of outstanding collateralized letters of credit under this facility.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.8pt">On April 1, 2021, the Company&#8217;s subsidiaries, AAIC and Aspen Specialty, each established a secured line of credit at Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;). Advances may be used to support general corporate purposes. The maximum amount available under these facilities will vary based on the borrower&#8217;s net admitted assets or reserve assets (total invested assets) and the lender&#8217;s underwriting criteria. Aspen Specialty&#8217;s maximum borrowing capacity available from FHLBB upon initial application is <ix:nonFraction unitRef="number" contextRef="c-1224" decimals="3" name="ahl:PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" scale="-2" id="f-3603">15</ix:nonFraction>% of net admitted assets or approximately $<ix:nonFraction unitRef="usd" contextRef="c-1224" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-3604">223</ix:nonFraction>&#160;million, and is subject to North Dakota approval. Under Texas state insurance law, without the prior consent of the Texas Department of Insurance, the amount of assets AAIC may pledge to secure debt obligations is limited to <ix:nonFraction unitRef="number" contextRef="c-1225" decimals="3" name="ahl:PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" scale="-2" id="f-3605">10</ix:nonFraction>% of its reserve assets, resulting in a maximum borrowing capacity for AAIC under its FHLBB facility of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1225" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-3606">141</ix:nonFraction>&#160;million. Neither AAIC nor Aspen Specialty expects to draw on these facilities in the near future. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.03pt">On November 5, 2021, Aspen Holdings entered into a letter of credit facility agreement. The letter of credit issued under this facility is the for the benefit of Aspen Bermuda, as beneficiary, and has been applied towards the eligible capital of Aspen Bermuda, and classified as ancillary Tier 3 capital of such entity, in accordance with applicable Bermuda laws and regulations. The total commitment under the facility is $<ix:nonFraction unitRef="usd" contextRef="c-1226" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="0" id="f-3607">100,000,000</ix:nonFraction>. A letter of credit in the full amount of the available commitment has been issued to Aspen Holdings under this facility. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.57pt">On December 29, 2021, Aspen Holdings entered into a committed letter of credit facility agreement. The letter of credit issued under this facility is for the benefit of Aspen Bermuda, as beneficiary, and has been applied towards the eligible capital of Aspen Bermuda, and classified as ancillary Tier 3 capital of such entity, in accordance with applicable Bermuda laws and regulations. The total commitment under the facility is $<ix:nonFraction unitRef="usd" contextRef="c-1227" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="0" id="f-3608">75,000,000</ix:nonFraction>. A letter of credit in the full amount of the available commitment has been issued to Aspen Holdings under this facility.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:continuation id="f-3585-4" continuedAt="f-3585-5"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">On June 17, 2022, AUL and Aspen Holdings (acting as AUL&#8217;s guarantor) entered into a securities lending transaction, pursuant to a global master securities lending agreement. This facility provides that a maximum aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-1228" decimals="-5" name="ahl:SecuritiesLendingTransactionToSupportFundsAtLloyds" format="ixt:num-dot-decimal" scale="6" id="f-3609">50</ix:nonFraction>&#160;million of eligible securities may be loaned to AUL, for the benefit of, Lloyd&#8217;s, on behalf of AUL to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2023 year of account at Lloyd&#8217;s. As at December&#160;31, 2022, the market value of the loaned securities under this facility was approximately $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:SecuritiesLendingTransactionToSupportFundsAtLloyds" format="ixt:num-dot-decimal" scale="0" id="f-3610">50,000,000</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.57pt">On December 21, 2022, Aspen Bermuda entered into an uncommitted Continuing Letter of Credit Agreement (For Standby Letters of Credit), where Aspen Bermuda has the ability to request letters of credit to be used in support of policyholder collateral obligations with the consent of the lender. The fee associated with this facility is a facility fee based on the aggregate face amount of outstanding letters of credit. As at December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="c-1229" decimals="-5" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-3611">100</ix:nonFraction>&#160;million of outstanding collateralized letters of credit under this facility. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.8pt">On November 13, 2002, Aspen UK entered into an uncommitted secured letter of credit facility agreement, where Aspen UK has the ability to issue letters of credit to be used in support of policyholder collateral obligations with the consent of the lender. The fee associated with this facility is a facility fee based on the aggregate face amount of outstanding letters of credit. As at December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="c-1230" decimals="-5" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-3612">75.1</ix:nonFraction>&#160;million of outstanding collateralized letters of credit under this facility.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.03pt">On January 27, 2021, Aspen UK entered into an uncommitted unsecured letter of credit facility agreement, where Aspen UK has the ability to issue letters of credit to be used in support of policyholder and internal reinsurance collateral obligations with the consent of the lender. The fee associated with this facility is a facility fee based on the aggregate face amount of outstanding letters of credit. As at December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="c-1231" decimals="-5" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-3613">22.8</ix:nonFraction>&#160;million of outstanding collateralized letters of credit under this facility.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above credit facilities include certain restrictive covenants customary for facilities of this type, including restrictions on indebtedness, consolidated tangible net worth, and minimum financial strength ratings, with such financial covenants largely consistent with these set forth in the Credit Agreement. In addition, the agreements include default covenants, which could require the Company to fully secure the outstanding amounts thereunder and/or result in the Company not being allowed to issue any new letters of credit.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;13, 2013, the Company closed its offering of $<ix:nonFraction unitRef="usd" contextRef="c-1232" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-3614">300.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="c-1232" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-3615">4.65</ix:nonFraction>% Senior Notes due November 15, 2023 (the &#8220;2023 Senior Notes&#8221;). The net proceeds from the 2023 Senior Notes offering, before offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="c-1233" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-3616">299.7</ix:nonFraction> million and a portion of the proceeds was used to redeem the then outstanding 2014 Senior Notes. Subject to applicable law, the 2023 Senior Notes will be the senior unsecured obligations of Aspen Holdings and will rank equally in right of payment with all of our other senior unsecured indebtedness from time to time outstanding. In light of the impending maturity of the 2023 Senior Notes, the Company continues to monitor the capital markets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, so long as any of the senior notes described above remain outstanding, the Company has agreed that neither the Company nor any of its subsidiaries will (i)&#160;create a lien on any shares of capital stock of any designated subsidiary (currently Aspen UK and Aspen Bermuda, as defined in the Indenture), or (ii)&#160;issue, sell, assign, transfer or otherwise dispose of any shares of capital stock of any designated subsidiary. Certain events will constitute an event of default under the Indenture, including default in payment at maturity of any of our other indebtedness in excess of $<ix:nonFraction unitRef="usd" contextRef="c-1234" decimals="INF" name="ahl:DebtDefaultMinimum" format="ixt:num-dot-decimal" scale="6" id="f-3617">50.0</ix:nonFraction> million.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-3618" escape="true"><ix:continuation id="f-3585-5"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual obligations under short-term debt as at December&#160;31, 2022. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments Due By Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Contractual Basis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than 1&#160;year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term Debt Obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1235" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-3619">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod" scale="6" id="f-3620">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Notes obligation disclosed above does not include the $<ix:nonFraction unitRef="usd" contextRef="c-1234" decimals="-5" name="us-gaap:LineOfCreditFacilityPeriodicPaymentInterest" format="ixt:num-dot-decimal" scale="6" id="f-3621">14.3</ix:nonFraction> million annual interest payable associated with the Senior Notes.</span></div></ix:continuation></ix:nonNumeric><div id="i74bc390671ae44c18dcd3f802f6097fb_911"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">24.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:AllowanceForCreditLossesTextBlock" id="f-3622" continuedAt="f-3622-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Allowance for Expected Credit Losses</span></ix:nonNumeric></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock" id="f-3623" escape="true"><ix:continuation id="f-3622-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s allowance for expected credit losses for the twelve months ended December&#160;31, 2022 in investments, reinsurance recoverables and receivables following the adoption of ASU 2016-13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Recoverables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Receivables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening value as at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="f-3624">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="f-3625">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-3626">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:TotalAllowanceForCreditLoss" scale="6" id="f-3627">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement of the allowance for credit losses during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="f-3628">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="f-3629">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" scale="6" id="f-3630">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" scale="6" id="f-3631">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing value as at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="f-3632">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="f-3633">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-3634">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:TotalAllowanceForCreditLoss" scale="6" id="f-3635">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Recoverables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Receivables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening value as at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="f-3636">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="f-3637">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-3638">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="ahl:TotalAllowanceForCreditLoss" scale="6" id="f-3639">38.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement of the allowance for credit losses during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="f-3640">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="f-3641">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" scale="6" id="f-3642">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="ahl:TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" scale="6" id="f-3643">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing value as at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="f-3644">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="f-3645">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-3646">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:TotalAllowanceForCreditLoss" scale="6" id="f-3647">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:nonNumeric><div id="i74bc390671ae44c18dcd3f802f6097fb_915"></div><div style="margin-bottom:9pt;margin-top:6pt"><span id="i611fc19c089846c0941fa9200d998dee_992"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-3648" continuedAt="f-3648-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Subsequent Events</span></ix:nonNumeric></div><ix:continuation id="f-3648-1" continuedAt="f-3648-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company declared and paid an ordinary shares dividend of $<ix:nonFraction unitRef="usd" contextRef="c-1134" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" format="ixt:num-dot-decimal" scale="6" id="f-3649">20</ix:nonFraction>&#160;million to Highlands Bermuda Holdco, Ltd., the holder of all the Company&#8217;s ordinary shares, on April 3, 2023.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-77</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_313"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX OF FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_325">Schedule&#160;I&#160;&#8212; Investments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_325">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_325">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_337">Schedule&#160;II&#160;&#8212;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_337"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_337">Condensed Financial Information of Registrant</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_337">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_337">80</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_362">Schedule&#160;III&#160;&#8212;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_362"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_362">Supplementary Insurance Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_362">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_362">83</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_378">Schedule&#160;IV&#160;&#8212;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_378"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_378">Reinsurance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_378">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_378">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_390">Schedule&#160;V&#160;&#8212;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_390"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_390">Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_390">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_390">85</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-78</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_325"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><ix:nonNumeric contextRef="c-19" name="srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock" id="f-3650" continuedAt="f-3650-1" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;I&#160;- INVESTMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Twelve Months Ended December&#160;31, 2022, 2021 and 2020 </span></div></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-3650-1">The Company&#8217;s investments comprise investments in subsidiaries.</ix:continuation> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-79</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_337"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </span></div><ix:nonNumeric contextRef="c-19" name="us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" id="f-3651" continuedAt="f-3651-1" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;II&#160; - CONDENSED FINANCIAL INFORMATION OF REGISTRANT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BALANCE SHEETS </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As at December&#160;31, 2022 and 2021</span></div></ix:nonNumeric></div><ix:continuation id="f-3651-1" continuedAt="f-3651-2"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income maturities (trading)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-3652">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-3653">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3654">44.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3655">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in subsidiaries </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-3656">2,767.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-3657">3,142.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany funds due from affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:DueFromAffiliates" scale="6" id="f-3658">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:DueFromAffiliates" scale="6" id="f-3659">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-3660">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-3661">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:OtherAssets" scale="6" id="f-3662">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:OtherAssets" scale="6" id="f-3663">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-3664">2,862.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-3665">3,241.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="f-3666">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="f-3667">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany funds due to affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" scale="6" id="f-3668">180.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" scale="6" id="f-3669">139.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-3670">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="f-3671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="f-3672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-3673">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-3674">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-3675">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:Liabilities" scale="6" id="f-3676">504.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:Liabilities" scale="6" id="f-3677">466.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1236" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3678">60,395,839</ix:nonFraction> shares of par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1236" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="-2" id="f-3679"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1237" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="-2" id="f-3680">0.01</ix:nonFraction></ix:nonFraction> each (December&#160;31, 2021 &#8212; <ix:nonFraction unitRef="shares" contextRef="c-1237" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-3681">60,395,839</ix:nonFraction>)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-3682">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-3683">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-3684">1,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-3685">1,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-3686">1,349.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-3687">1,382.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (loss)/gains on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-3688">333.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-3689">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/(loss) on derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="ahl:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" scale="6" id="f-3690">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" sign="-" name="ahl:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" scale="6" id="f-3691">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative (losses) on foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="f-3692">186.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="f-3693">156.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-3694">506.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-3695">123.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-3696">2,358.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-3697">2,774.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-3698">2,862.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-3699">3,241.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s investment in subsidiaries is accounted for under the equity method and adjustments to the carrying value of these investments are made based on the Company&#8217;s share of capital, including share of income and expenses. Changes in the value were recognized in realized and unrealized investment gains and losses in the statement of operations. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-80</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_8543"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;II&#160; - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Continued </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div></div><ix:continuation id="f-3651-2" continuedAt="f-3651-3"><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings/(losses) of subsidiaries and other investments, equity method </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="ahl:EquityInNetEarningsOfSubsidiaries" scale="6" id="f-3700">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="ahl:EquityInNetEarningsOfSubsidiaries" scale="6" id="f-3701">90.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="ahl:EquityInNetEarningsOfSubsidiaries" scale="6" id="f-3702">108.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-3703">121.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-3704">193.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-3705">141.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized investment (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="f-3706">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="f-3707">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="f-3708">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="f-3709">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:OtherIncome" format="ixt:fixed-zero" scale="6" id="f-3710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:OtherIncome" format="ixt:fixed-zero" scale="6" id="f-3711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-3712">132.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-3713">102.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-3714">35.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-3715">62.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-3716">54.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-3717">74.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-3718">14.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-3719">14.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-3720">14.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-3721">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-3722">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:OtherExpenses" scale="6" id="f-3723">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income/(loss) from operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-3724">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-3725">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-3726">56.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3727">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-3729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income /(loss) </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-3730">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-3731">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-3732">56.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-3733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-3734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-3735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income/(loss) attributable to Aspen Insurance Holdings Limited ordinary shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-3736">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-3737">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-3738">56.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss)/income, net of taxes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized (losses)/gains on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-3739">367.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-3740">158.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-3741">108.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-3742">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-3743">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-3744">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in foreign currency translation adjustment </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-3745">30.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-3746">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-3747">11.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss)/income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-3748">383.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-3749">143.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-3750">96.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive (Loss) / Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-3751">332.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-3752">113.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-3753">40.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;II&#160; - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Continued </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENTS OF CASH FLOWS </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div></div><ix:continuation id="f-3651-3"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (excluding equity in net earnings of subsidiaries)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="ahl:NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" scale="6" id="f-3754">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="ahl:NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" scale="6" id="f-3755">120.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="ahl:NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" scale="6" id="f-3756">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized losses/(gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="ahl:NetRealizedAndUnrealizedGainsLosses" scale="6" id="f-3757">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="ahl:NetRealizedAndUnrealizedGainsLosses" scale="6" id="f-3758">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="ahl:NetRealizedAndUnrealizedGainsLosses" scale="6" id="f-3759">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on derivative contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:DerivativeLossOnDerivative" scale="6" id="f-3760">15.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:DerivativeLossOnDerivative" scale="6" id="f-3761">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="us-gaap:DerivativeLossOnDerivative" scale="6" id="f-3762">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-3763">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-3764">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-3765">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-3766">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-3767">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-3768">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="ahl:ChangeInOtherAssets" scale="6" id="f-3769">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="ahl:ChangeInOtherAssets" scale="6" id="f-3770">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="ahl:ChangeInOtherAssets" scale="6" id="f-3771">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued expenses and other payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="f-3772">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="f-3773">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="f-3774">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in intercompany activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="ahl:IncreaseDecreaseInIntercompanyActivities" scale="6" id="f-3775">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="ahl:IncreaseDecreaseInIntercompanyActivities" scale="6" id="f-3776">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="ahl:IncreaseDecreaseInIntercompanyActivities" scale="6" id="f-3777">41.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in right-of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-3778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-3779">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-3780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-3781">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:OperatingLeasePayments" scale="6" id="f-3782">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:fixed-zero" scale="6" id="f-3783">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash generated by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-3784">81.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-3785">154.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-3786">111.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From/(Used in) Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases)/proceeds of fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-3787">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-3788">42.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-3789">75.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of fixed maturities, trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-3790">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:fixed-zero" scale="6" id="f-3791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:fixed-zero" scale="6" id="f-3792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="f-3793">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="f-3794">115.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="f-3795">87.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash from/(used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-3796">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-3797">157.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-3798">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows (Used in) Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-3799">84.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-3800">44.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-3801">44.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease)/increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1238" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-3802">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1239" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-3803">47.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1240" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-3804">55.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents&#160;&#8212; beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3805">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1241" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3806">92.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1242" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3807">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents&#160;&#8212; end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1236" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3808">44.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1237" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3809">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1241" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3810">92.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-82</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_362"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><ix:nonNumeric contextRef="c-19" name="srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock" id="f-3811" continuedAt="f-3811-1" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;III&#160;- SUPPLEMENTARY INSURANCE INFORMATION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div></ix:nonNumeric></div><ix:continuation id="f-3811-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplementary Information </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">($ in millions) </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.803%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Policy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisition</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Costs&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reserves</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">for&#160;Losses</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and LAE&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Reserves<br/>for<br/>Unearned<br/>Premiums</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Premiums</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Earned </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Investment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Losses&#160;and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LAE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Policy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisition</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Premium</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Written&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">General</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Administrative</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3812">227.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3813">1,360.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" scale="6" id="f-3814">862.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3815">1,251.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" scale="6" id="f-3816">770.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3817">252.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3818">1,426.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3819">142.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3820">91.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3821">1,452.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" scale="6" id="f-3822">857.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3823">1,436.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" scale="6" id="f-3824">909.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3825">179.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3826">1,469.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3827">244.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3828">319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3829">2,813.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="f-3830">1,720.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3831">2,688.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationNetInvestmentIncome" scale="6" id="f-3832">188.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" format="ixt:num-dot-decimal" scale="6" id="f-3833">1,680.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3834">431.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3835">2,896.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3836">386.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.803%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year to date December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Policy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisition</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Costs&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reserves</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">for&#160;Losses</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and LAE&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Reserves<br/>for<br/>Unearned<br/>Premiums</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Premiums<br/>Earned</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Investment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Losses&#160;and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LAE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Policy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisition</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Premium</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Written</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">General</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Administrative</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3837">205.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3838">2,148.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" scale="6" id="f-3839">688.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3840">1,118.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" scale="6" id="f-3841">705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3842">221.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3843">1,199.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3844">121.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3845">85.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3846">2,165.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" scale="6" id="f-3847">827.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3848">1,291.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" scale="6" id="f-3849">988.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3850">192.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3851">1,388.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3852">211.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3853">290.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3854">4,313.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="f-3855">1,516.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3856">2,410.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationNetInvestmentIncome" scale="6" id="f-3857">147.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" format="ixt:num-dot-decimal" scale="6" id="f-3858">1,693.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3859">414.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3860">2,587.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3861">333.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.803%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year to date December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Policy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisition</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Costs&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reserves</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">for&#160;Losses</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and LAE&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Reserves<br/>for<br/>Unearned<br/>Premiums</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Premiums</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Earned </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Investment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Losses&#160;and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LAE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Policy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisition</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Premium</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Written&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">General</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Administrative</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3862">206.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3863">2,095.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" scale="6" id="f-3864">617.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3865">1,287.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" scale="6" id="f-3866">958.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3867">246.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3868">1,297.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3869">110.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3870">99.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3871">1,874.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" scale="6" id="f-3872">746.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3873">1,239.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" scale="6" id="f-3874">882.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3875">219.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3876">1,280.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3877">197.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" scale="6" id="f-3878">306.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-3879">3,970.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationUnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="f-3880">1,363.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3881">2,527.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationNetInvestmentIncome" scale="6" id="f-3882">154.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:LossesAndLossAdjustmentExpenses" format="ixt:num-dot-decimal" scale="6" id="f-3883">1,840.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ahl:DeferredPolicyAcquisitionCostOtherExpenses" scale="6" id="f-3884">465.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3885">2,577.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="f-3886">308.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-83</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_378"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><ix:nonNumeric contextRef="c-19" name="srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" id="f-3887" continuedAt="f-3887-1" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;IV&#160;- REINSURANCE </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div></ix:nonNumeric></div><ix:continuation id="f-3887-1"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Premiums Written </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Direct&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assumed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ceded&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Amount</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DirectPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3888">2,531.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:AssumedPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3889">1,807.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3890">1,442.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3891">2,896.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DirectPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3892">2,341.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AssumedPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3893">1,597.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3894">1,350.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3895">2,587.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DirectPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3896">2,042.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AssumedPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3897">1,656.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-3898">1,120.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-3899">2,577.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Premiums Earned</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross&#160;Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assumed&#160;From<br/>Other<br/>Companies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ceded&#160;to&#160;Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Companies</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assumed</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">to Net</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3900">2,370.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:AssumedPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3901">1,617.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:CededPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3902">1,299.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3903">2,688.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="us-gaap:PremiumsPercentageAssumedToNet" scale="-2" id="f-3904">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3905">2,139.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AssumedPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3906">1,479.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CededPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3907">1,207.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3908">2,410.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="us-gaap:PremiumsPercentageAssumedToNet" scale="-2" id="f-3909">61.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3910">2,026.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AssumedPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3911">1,612.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CededPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-3912">1,110.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-3913">2,527.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-27" decimals="3" name="us-gaap:PremiumsPercentageAssumedToNet" scale="-2" id="f-3914">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-84</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_390"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><ix:nonNumeric contextRef="c-19" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="f-3915" continuedAt="f-3915-1" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;V&#160;- VALUATION AND QUALIFYING ACCOUNTS </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Twelve Months Ended December 31, 2022, 2021 and 2020 </span></div></ix:nonNumeric></div><ix:continuation id="f-3915-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the movement in the Company&#8217;s bad debt provision during the twelve months ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160; of<br/>Year&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expenses&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160; Year</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions for Bad Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums receivable from underwriting activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1243" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-3916">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1244" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-3917">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1244" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-3918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1244" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-3919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1245" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-3920">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1246" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="f-3921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1247" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="6" id="f-3922">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1247" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-3923">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1247" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-3924">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1248" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="f-3925">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums receivable from underwriting activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1249" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-3926">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1250" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-3927">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1250" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-3928">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1250" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-3929">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1243" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-3930">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1251" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="f-3931">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1252" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-3932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1252" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-3933">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1246" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="f-3934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums receivable from underwriting activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1253" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-3935">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1254" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-3936">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1254" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-3937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1254" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-3938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1249" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-3939">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1255" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="f-3940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1256" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="f-3941">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1256" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="f-3942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1251" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="f-3943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-85</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7455"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As at June&#160;30, 2023 and December&#160;31, 2022 </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions, except share and per share amounts)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7465"></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed income maturities, available for sale (amortized cost &#8212; 2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-3944">4,231.2</ix:nonFraction> and 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-3945">4,131.3</ix:nonFraction> net of allowance for expected credit losses 2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="f-3946">4.0</ix:nonFraction> and 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="f-3947">7.7</ix:nonFraction>)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1257" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-3948">3,908.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-3949">3,788.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed income maturities, trading at fair value (amortized cost &#8212; 2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-3950">1,552.7</ix:nonFraction> and 2022:  $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-3951">1,576.7</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1258" decimals="-5" name="us-gaap:TradingSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-3952">1,478.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:TradingSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-3953">1,475.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, available for sale (amortized cost  &#8212; 2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:Shortterminvestmentsavailableforsaleamortizedcost" scale="6" id="f-3954">169.3</ix:nonFraction> and 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:Shortterminvestmentsavailableforsaleamortizedcost" scale="6" id="f-3955">52.4</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:ShortTermInvestmentsAvailableForSale" scale="6" id="f-3956">169.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:ShortTermInvestmentsAvailableForSale" scale="6" id="f-3957">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, trading at fair value (amortized cost  &#8212; 2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:ShortTermInvestmentsTradingAmortizedCost" scale="6" id="f-3958">11.0</ix:nonFraction> and 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ShortTermInvestmentsTradingAmortizedCost" scale="6" id="f-3959">6.3</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:ShortTermInvestmentsTradingAtFairValue" scale="6" id="f-3960">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:ShortTermInvestmentsTradingAtFairValue" scale="6" id="f-3961">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Catastrophe bonds, trading at fair value (amortized cost &#8212; 2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-3962">2.4</ix:nonFraction> and 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-3963">5.1</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:CatastropheBond" scale="6" id="f-3964">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CatastropheBond" scale="6" id="f-3965">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Privately-held investments, trading at fair value (amortized cost &#8212; 2023: $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:Privatelyheldinvestmentsamortizedcosttradingatfairvalue" scale="6" id="f-3966">496.1</ix:nonFraction> and 2022: $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:Privatelyheldinvestmentsamortizedcosttradingatfairvalue" scale="6" id="f-3967">537.7</ix:nonFraction>)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:PrivatelyheldInvestments" scale="6" id="f-3968">482.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:PrivatelyheldInvestments" scale="6" id="f-3969">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments, equity method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-3970">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-3971">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:OtherInvestments" scale="6" id="f-3972">213.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OtherInvestments" scale="6" id="f-3973">221.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:InvestmentsExcludingDerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="f-3974">6,272.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:InvestmentsExcludingDerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="f-3975">6,085.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents (including cash within consolidated variable interest entities of &#8212;  2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" scale="6" id="f-3976">11.4</ix:nonFraction> and 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="ahl:CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" scale="6" id="f-3977">65.7</ix:nonFraction>)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-3978">1,061.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-3979">959.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unpaid losses recoverable from reinsurers (net of allowance for expected credit losses of  2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="f-3980">3.3</ix:nonFraction> &#8212; 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="f-3981">3.7</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="f-3982">4,658.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="f-3983">4,897.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ceded unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:PrepaidReinsurancePremiums" scale="6" id="f-3984">837.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PrepaidReinsurancePremiums" scale="6" id="f-3985">737.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Underwriting premiums receivables (net of allowance for expected credit losses of  2023: $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="f-3986">21.6</ix:nonFraction> &#8212; 2022: $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="f-3987">25.0</ix:nonFraction>) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-3988">1,676.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-3989">1,482.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:OtherReceivables" scale="6" id="f-3990">160.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OtherReceivables" scale="6" id="f-3991">179.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Funds withheld</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:FundsHeldUnderReinsuranceAgreementsAsset" scale="6" id="f-3992">59.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:FundsHeldUnderReinsuranceAgreementsAsset" scale="6" id="f-3993">102.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="f-3994">353.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="f-3995">319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-3996">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-3997">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivables for securities sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ReceivablesFromBrokersDealersAndClearingOrganizations" scale="6" id="f-3998">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReceivablesFromBrokersDealersAndClearingOrganizations" scale="6" id="f-3999">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" scale="6" id="f-4000">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" scale="6" id="f-4001">140.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:OtherMiscellaneousAssets" scale="6" id="f-4002">148.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:OtherMiscellaneousAssets" scale="6" id="f-4003">161.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets and goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-4004">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-4005">21.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-4006">15,393.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-4007">15,157.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-4008">7,740.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-4009">7,710.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:UnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="f-4010">2,623.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:UnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="f-4011">2,457.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total insurance reserves</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:InsuranceReserves" format="ixt:num-dot-decimal" scale="6" id="f-4012">10,364.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:InsuranceReserves" format="ixt:num-dot-decimal" scale="6" id="f-4013">10,168.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reinsurance premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ReinsurancePayable" format="ixt:num-dot-decimal" scale="6" id="f-4014">1,833.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsurancePayable" format="ixt:num-dot-decimal" scale="6" id="f-4015">1,980.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" scale="6" id="f-4016">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" scale="6" id="f-4017">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses and other payables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="f-4018">171.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="f-4019">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payables for securities purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="6" id="f-4020">46.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="6" id="f-4021">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-4022">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-4023">95.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-4024">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-4025">34.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-4026">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-4027">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-4028">12,844.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-4029">12,799.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingent liabilities (see Note&#160;12)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="6" id="f-4030">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="6" id="f-4031">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SHAREHOLDERS&#8217; EQUITY </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-4032">60,395,839</ix:nonFraction> ordinary shares of par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-4033"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-4034">0.01</ix:nonFraction></ix:nonFraction> each (December&#160;31, 2022 &#8212; <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-4035">60,395,839</ix:nonFraction> shares) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-4036">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-4037">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preference shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:PreferredStockValue" scale="6" id="f-4038">753.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PreferredStockValue" scale="6" id="f-4039">753.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:AdditionalPaidInCapitalExcludingPreferenceShares" scale="6" id="f-4040">761.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:AdditionalPaidInCapitalExcludingPreferenceShares" scale="6" id="f-4041">761.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-4042">1,525.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-4043">1,349.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-4044">492.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-4045">506.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-4046">2,548.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-4047">2,358.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-4048">15,393.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-4049">15,157.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Privately-held investments includes related party investments totaling $<ix:nonFraction unitRef="usd" contextRef="c-1259" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4050">42.7</ix:nonFraction>&#160;million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4051">44.8</ix:nonFraction>&#160;million).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments includes related party investments of $<ix:nonFraction unitRef="usd" contextRef="c-1260" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4052">22.9</ix:nonFraction>&#160;million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4053">25.3</ix:nonFraction>&#160;million) in Apollo Real Estate Fund and $<ix:nonFraction unitRef="usd" contextRef="c-1259" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4054">12.6</ix:nonFraction>&#160;million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4055">12.7</ix:nonFraction>&#160;million) in Apollo Origination Partnership.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Cash and cash equivalents includes restricted cash of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-4056">312.1</ix:nonFraction>&#160;million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-4057">232.1</ix:nonFraction>&#160;million ) which are held in trusts.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As at June&#160;30, 2023 and December&#160;31, 2022 </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions, except share and per share amounts)</span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes amounts due to related parties of $<ix:nonFraction unitRef="usd" contextRef="c-1261" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-4058">2.4</ix:nonFraction>&#160;million for investment management fees (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-4059">4.5</ix:nonFraction>&#160;million), and $<ix:nonFraction unitRef="usd" contextRef="c-1262" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-4060">2.5</ix:nonFraction>&#160;million for management consulting fees (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-4061">1.3</ix:nonFraction>&#160;million).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Preference shares of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:AggregateLiquidationPreferences" format="ixt:num-dot-decimal" scale="6" id="f-4062">775.0</ix:nonFraction> million, less issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-4063">21.5</ix:nonFraction> million (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:AggregateLiquidationPreferences" format="ixt:num-dot-decimal" scale="6" id="f-4064">775.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-4065">21.5</ix:nonFraction> million) were previously presented within additional paid-in capital.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-87</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7493"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND OTHER COMPREHENSIVE INCOME (LOSS)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions)</span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premium </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-4066">1,287.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-4067">1,327.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-4068">129.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-4069">88.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-4070">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-4071">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-4072">1,452.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-4073">1,418.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-4074">717.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-4075">767.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-4076">192.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-4077">216.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and other expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-4078">232.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-4079">233.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-4080">42.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-4081">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-4082">19.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-4083">84.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-4084">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-4085">128.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange losses/(gains) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-4086">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-4087">75.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:Expense" format="ixt:num-dot-decimal" scale="6" id="f-4088">1,197.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:Expense" format="ixt:num-dot-decimal" scale="6" id="f-4089">1,365.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations before income taxes </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-4090">255.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-4091">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-4092">36.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-4093">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-4094">218.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-4095">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preference shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1264" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-4096">22.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1265" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-4097">22.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Aspen Insurance Holdings Limited&#8217;s ordinary shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-4098">196.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-4099">26.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Comprehensive Income/(Loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification adjustment for net realized gains on investments included in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-4100">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="f-4101">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains/(losses) on available for sale securities held</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="f-4102">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="f-4103">343.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-4104">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="f-4105">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in foreign currency translation adjustment </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="f-4106">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="f-4107">19.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), before income taxes </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-4108">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-4109">342.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit thereon:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains on available for sale securities held </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="f-4110">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="f-4111">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="f-4112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-4113">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (expense)/benefit allocated to other comprehensive income/(loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-4114">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-4115">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net of income taxes </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-4116">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-4117">312.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income/(loss) attributable to Aspen Insurance Holdings Limited&#8217;s ordinary shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-4118">210.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-4119">285.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Net investment income includes related party investment losses of $<ix:nonFraction unitRef="usd" contextRef="c-1266" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-4120">1.7</ix:nonFraction>&#160;million (June 30, 2022 &#8212; $$<ix:nonFraction unitRef="usd" contextRef="c-1267" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-4121">0.2</ix:nonFraction>&#160;million) and related party investment management fees of $<ix:nonFraction unitRef="usd" contextRef="c-1268" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-4122">5.2</ix:nonFraction>&#160;million (June 30, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1269" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-4123">0.6</ix:nonFraction>&#160;million).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">General, administrative and other expenses includes related party management consulting fees of $<ix:nonFraction unitRef="usd" contextRef="c-1270" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-4124">2.5</ix:nonFraction>&#160;million (June 30, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1271" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-4125">2.5</ix:nonFraction>&#160;million).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">General, administrative and other expenses comprises general and administrative expenses, corporate and other expenses, and non-operating expenses. Corporate and other expenses includes other income/expenses, which were previously presented separately.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Realized and unrealized investments losses includes $<ix:nonFraction unitRef="usd" contextRef="c-1272" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-4126">2.0</ix:nonFraction>&#160;million loss on related party investments (June 30, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1273" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-4127">0.8</ix:nonFraction> million loss).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-88</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7509"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions)</span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4128">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4129">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1274" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4130">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1275" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4131">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1276" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4132">753.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1277" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4133">753.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1278" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4134">753.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1279" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4135">753.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1280" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4136">761.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1281" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4137">761.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1282" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4138">761.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1283" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4139">761.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-4140">1,349.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-4141">1,382.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income for the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-4142">218.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-4143">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1284" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-4144">20.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1285" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-4145">20.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preference shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1286" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-4146">22.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1287" decimals="-5" name="us-gaap:Dividends" scale="6" id="f-4147">22.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1288" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-4148">1,525.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1289" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-4149">1,388.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4150">186.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4151">156.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change for the  period, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1290" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-4152">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1291" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-4153">19.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1292" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4154">179.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1293" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4155">175.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4156">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4157">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1294" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-4158">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1295" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-4159">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1294" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4160">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1295" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4161">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized appreciation on available for sale investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4162">333.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4163">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change for the period, net of income taxes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1296" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-4164">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1297" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="f-4165">286.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1298" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4166">322.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1299" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4167">251.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-4168">492.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1300" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-4169">435.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-4170">2,548.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1300" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-4171">2,469.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Preference shares of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:AggregateLiquidationPreferences" format="ixt:num-dot-decimal" scale="6" id="f-4172">775.0</ix:nonFraction> million, less issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-4173">21.5</ix:nonFraction> million (June&#160;30, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:AggregateLiquidationPreferences" format="ixt:num-dot-decimal" scale="6" id="f-4174">775.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-4175">21.5</ix:nonFraction> million) were previously presented within additional paid-in capital.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-89</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7537"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions)</span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows (used in)/from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4176">218.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-4177">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="f-4178">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="f-4179">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-4180">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-4181">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ahl:Interestonoperatingleaseliabilities" scale="6" id="f-4182">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:Interestonoperatingleaseliabilities" scale="6" id="f-4183">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (additions) of right-to-use operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" scale="6" id="f-4184">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" format="ixt:fixed-zero" scale="6" id="f-4185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net  disposals of lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ahl:NetAdditionsdisposalsOfLeaseLiabilities" scale="6" id="f-4186">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:NetAdditionsdisposalsOfLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="f-4187">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease repayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="6" id="f-4188">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:fixed-zero" scale="6" id="f-4189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-4190">36.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-4191">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-4192">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-4193">128.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expense/(benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-4194">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-4195">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized investment foreign exchange (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:GainsLossesOnInvestmentAndForeignExchange" scale="6" id="f-4196">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:GainsLossesOnInvestmentAndForeignExchange" scale="6" id="f-4197">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnSaleOfDerivatives" scale="6" id="f-4198">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:GainLossOnSaleOfDerivatives" scale="6" id="f-4199">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss/(gain) on real estate funds in net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ahl:UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" scale="6" id="f-4200">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" scale="6" id="f-4201">13.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" scale="6" id="f-4202">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" scale="6" id="f-4203">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInUnearnedPremiums" scale="6" id="f-4204">166.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncreaseDecreaseInUnearnedPremiums" scale="6" id="f-4205">381.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ahl:UnpaidLosses" scale="6" id="f-4206">239.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:UnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="f-4207">1,708.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded unearned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidReinsurancePremiums" scale="6" id="f-4208">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidReinsurancePremiums" scale="6" id="f-4209">220.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="f-4210">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="f-4211">15.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts" scale="6" id="f-4212">34.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts" scale="6" id="f-4213">24.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance premiums payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInReinsurancePayables" scale="6" id="f-4214">146.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncreaseDecreaseInReinsurancePayables" format="ixt:num-dot-decimal" scale="6" id="f-4215">1,844.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funds withheld</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" scale="6" id="f-4216">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" scale="6" id="f-4217">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="f-4218">194.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="f-4219">275.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-4220">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-4221">6.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-4222">30.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-4223">20.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets and derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ahl:FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" scale="6" id="f-4224">40.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" scale="6" id="f-4225">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-4226">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-4227">7.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash from operating activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-4228">264.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-4229">104.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows (used in)/from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of fixed income securities &#8212; Available for sale</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="f-4230">789.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="f-4231">695.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of fixed income securities &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" scale="6" id="f-4232">254.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" scale="6" id="f-4233">370.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of fixed income securities &#8212; Available for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="f-4234">685.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-4235">1,003.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of fixed income securities &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-4236">283.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-4237">134.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of short-term investments &#8212; Available for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:PaymentsforAvailableforsaleSecuritiesShortterm" scale="6" id="f-4238">215.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:PaymentsforAvailableforsaleSecuritiesShortterm" scale="6" id="f-4239">28.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments &#8212; Available for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:ProceedsfromAvailableforsaleSecuritiesShortterm" scale="6" id="f-4240">101.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:ProceedsfromAvailableforsaleSecuritiesShortterm" scale="6" id="f-4241">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of short-term investments  &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="6" id="f-4242">15.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:fixed-zero" scale="6" id="f-4243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments  &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="6" id="f-4244">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="6" id="f-4245">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of privately-held investments &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:PaymentstoAcquirePrivatelyheldInvestments" scale="6" id="f-4246">23.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:PaymentstoAcquirePrivatelyheldInvestments" scale="6" id="f-4247">175.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of privately-held investments &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:ProceedsfromSaleofPrivatelyheldInvestments" scale="6" id="f-4248">58.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:ProceedsfromSaleofPrivatelyheldInvestments" scale="6" id="f-4249">79.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in (payable)/receivable for securities (purchased)/sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" scale="6" id="f-4250">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" scale="6" id="f-4251">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases) of other investments </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-4252">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-4253">46.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds from sales of other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ahl:PaymentsforProceedsfromInvestingActivitiesNetofCash" scale="6" id="f-4254">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:PaymentsforProceedsfromInvestingActivitiesNetofCash" format="ixt:fixed-zero" scale="6" id="f-4255">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (purchases) of fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="6" id="f-4256">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="6" id="f-4257">13.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Multiline reinsurer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:InvestmentInMultilineReinsurer" scale="6" id="f-4258">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:InvestmentInMultilineReinsurer" scale="6" id="f-4259">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (purchases) of investments, equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:PaymentsForProceedsFromOtherInvestments" format="ixt:fixed-zero" scale="6" id="f-4260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:PaymentsForProceedsFromOtherInvestments" scale="6" id="f-4261">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash (used in) investing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-4262">124.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-4263">92.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows (used in)/from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-4264">20.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-4265">20.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on preference shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="6" id="f-4266">22.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="6" id="f-4267">22.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash (used in) financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-4268">42.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-4269">42.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate movements on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-4270">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-4271">18.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase/(decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-4272">102.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-4273">49.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="f-4274">959.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-4275">1,314.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-4276">1,061.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1300" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="f-4277">1,264.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Cash and cash equivalents includes restricted cash of  $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-4278">312.1</ix:nonFraction>&#160;million (June 30, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1300" decimals="-5" name="ahl:CashAndCashEquivalentsIncludesRestrictedCash" format="ixt:num-dot-decimal" scale="6" id="f-4279">387.3</ix:nonFraction>&#160;million) which are held in trusts.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-90</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7552"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7564"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><ix:continuation id="f-481-2" continuedAt="f-481-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">History and Organization</span></ix:continuation></div><ix:continuation id="f-481-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">History and Organization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited (&#8220;Aspen Holdings&#8221;) was incorporated on May&#160;23, 2002 as a holding company headquartered in Bermuda. We underwrite specialty insurance and reinsurance on a global basis through our Operating Subsidiaries (as defined below) based in Bermuda, the United States and the United Kingdom: Aspen Bermuda Limited (&#8220;Aspen Bermuda&#8221;), Aspen Specialty Insurance Company (&#8220;Aspen Specialty&#8221;), Aspen American Insurance Company (&#8220;AAIC&#8221;), Aspen Insurance UK Limited (&#8220;Aspen UK&#8221;) and Aspen Underwriting Limited (&#8220;AUL&#8221;) (as corporate member of our Lloyd&#8217;s operations, Syndicate 4711, which are managed by Aspen Managing Agency Limited (&#8220;AMAL&#8221;) (together, &#8220;Aspen Lloyd&#8217;s&#8221;)), each referred to herein as an &#8220;Operating Subsidiary&#8221; and collectively referred to as the &#8220;Operating Subsidiaries&#8221;.  We also have branches in Canada, Singapore and Switzerland. We established Aspen Capital Management, Ltd. (&#8220;ACML&#8221;) and other related entities (collectively, &#8220;ACM&#8221;) to leverage our existing underwriting franchise, increase our operational flexibility and provide third-party investors direct access to our capital markets and  underwriting expertise. References to the &#8220;Company,&#8221; the &#8220;Group,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Aspen Holdings or Aspen Holdings and its consolidated subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2019, the Company has been a wholly-owned subsidiary of Highlands Bermuda Holdco, Ltd. (&#8220;Parent&#8221;), which holds all of the Company&#8217;s ordinary shares. Parent, a Bermuda exempted company, is an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc., a leading global investment manager (collectively with its subsidiaries, &#8220;Apollo&#8221;). The Company&#8217;s preference shares and depositary shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the following symbols: AHL PRC, AHL PRD and AHL PRE.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_7576"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><ix:continuation id="f-482-10" continuedAt="f-482-11"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Basis of Presentation and Significant Accounting Policies</span></ix:continuation></div><ix:continuation id="f-482-11" continuedAt="f-482-12"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (&#8220;U.S.&#160;GAAP&#8221;) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Results for the six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ended December 31, 2023. The unaudited condensed consolidated financial statements include the accounts of Aspen Holdings and its subsidiaries. Transactions between Aspen Holdings and its subsidiaries are eliminated within the unaudited condensed consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet as at December 31, 2022 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2022 contained within this prospectus.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions and estimates made by management have a significant effect on the amounts reported within the unaudited condensed consolidated financial statements. The most significant of these assumptions and estimates relate to losses and loss adjustment expenses, reinsurance recoverables, gross written premiums and commissions which have not been reported to the Company such as those relating to proportional treaty reinsurance contracts, unrecognized tax benefits, the fair value of derivatives and the fair value of other investments. All material assumptions and estimates are regularly reviewed and adjustments made as necessary, but actual results could differ significantly from those expected when the assumptions or estimates were made.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To facilitate period-to-period comparisons, certain reclassifications have been made to prior year consolidated financial statement amounts to conform to the current year presentation. There was no effect on net income from this change in presentation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared on a going concern basis. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-500-3"><ix:continuation id="f-482-12"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2023</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2017-04&#8221;). Among other things, ASU 2017-04 requires the following: (1) the elimination of step two of the goodwill impairment test; entities will no longer utilize the implied fair value of their assets and liabilities for purposes of testing goodwill for impairment, and (2) the quantitative portion of the goodwill impairment test will be performed by comparing the fair value of a reporting unit with its carrying amount; an impairment charge is to be recognized for the excess of carrying amount over fair value, but only to the extent of the amount of goodwill allocated to that reporting unit. The effective date for this ASU was amended via ASU 2019-10, Effective Dates, and became effective for annual periods beginning after December 15, 2022. The adoption of this ASU did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_7588"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><ix:continuation id="f-501-6" continuedAt="f-501-7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Segment Reporting</span></ix:continuation></div><ix:continuation id="f-501-7" continuedAt="f-501-8"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its underwriting operations as <ix:nonFraction unitRef="segement" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-4280">two</ix:nonFraction> business segments: Aspen Reinsurance and Aspen Insurance. The Company has determined its reportable segments by taking into account the manner in which management makes operating decisions and assesses operating performance. Profit or loss for each of the Company&#8217;s business segments is measured by underwriting income or loss. Underwriting profit is the excess of net earned premiums over the sum of losses and loss expenses, acquisition costs and general and administrative expenses. Underwriting income or loss provides a basis for management to evaluate the segment&#8217;s underwriting performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The reinsurance segment consists of property catastrophe reinsurance, other property reinsurance, casualty reinsurance and specialty reinsurance. For a more detailed description of this business segment, refer to  &#8220;Business&#8212;Our Business&#8212;Reinsurance&#8221; in this prospectus.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The insurance segment consists of first party insurance, specialty insurance, casualty and liability insurance and financial and professional lines insurance. Additionally, the insurance segment includes Aspen Underwriting Limited&#8217;s participation as a corporate member in Carbon Syndicate 4747 (&#8220;Carbon Syndicate&#8221;). For a more detailed description of this business segment, refer to &#8220;Business&#8212;Our Business&#8212;Insurance&#8221; in this prospectus.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-underwriting Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company provides additional disclosures for corporate and other (non-operating) income and expenses. Corporate and other income and expenses include: corporate expenses, net investment income, net realized and unrealized investment gains or losses, other strategic and other costs, changes in fair value of derivatives or the loan notes issued by variable interest entities, interest expenses, net realized and unrealized foreign exchange gains or losses, asset impairments and income taxes. These income and expense items are not allocated to the Company&#8217;s business segments as they are not directly related to the Company&#8217;s business segment operations and is consistent with how management measures the performance of its segments. The Company does not allocate its assets by business segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses underwriting ratios as measures of performance. The loss ratio is the ratio of losses and loss adjustment expenses to net earned premiums. The acquisition cost ratio is the ratio of acquisition costs to net earned premiums. The general and administrative expense ratio is the ratio of general and  administrative expenses to net earned premiums. The combined ratio is the sum of the loss ratio, the acquisition cost ratio and the general and administrative expense ratio.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-503-3" continuedAt="f-503-4"><ix:continuation id="f-501-8" continuedAt="f-501-9"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of gross and net written and earned premiums, underwriting income or loss, ratios and reserves for each of the Company&#8217;s business segments for six months ended June&#160;30, 2023 and  2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1301" decimals="-5" name="us-gaap:PremiumsWrittenGross" scale="6" id="f-4281">875.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1302" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-4282">1,249.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-4283">2,125.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1301" decimals="-5" name="us-gaap:PremiumsWrittenNet" scale="6" id="f-4284">605.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1302" decimals="-5" name="us-gaap:PremiumsWrittenNet" scale="6" id="f-4285">745.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-4286">1,350.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1301" decimals="-5" name="us-gaap:PremiumsEarnedNet" scale="6" id="f-4287">572.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1302" decimals="-5" name="us-gaap:PremiumsEarnedNet" scale="6" id="f-4288">715.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-4289">1,287.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1301" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-4290">297.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1302" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-4291">419.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-4292">717.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1301" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-4293">105.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1302" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-4294">87.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-4295">192.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1301" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-4296">58.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1302" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-4297">110.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-4298">169.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1301" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-4299">110.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1302" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-4300">97.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-4301">208.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:CorporateExpenses" scale="6" id="f-4302">53.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-4303">10.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-4304">129.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-4305">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-4306">18.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-4307">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-4308">42.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-4309">13.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-4310">255.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-4311">36.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-4312">218.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1303" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-4313">1,441.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1304" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-4314">1,641.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-4315">3,082.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1305" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-4316">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1306" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-4317">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-4318">55.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1305" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-4319">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1306" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-4320">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-4321">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1305" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-4322">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1306" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-4323">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-4324">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1305" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-4325">28.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1306" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-4326">27.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-4327">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1305" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-4328">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1306" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-4329">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-4330">83.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate and other operating expenses includes other income/expenses, which were previously presented separately.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-503-4"><ix:continuation id="f-501-9"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">( $ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1307" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-4331">1,045.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1308" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-4332">1,305.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PremiumsWrittenGross" format="ixt:num-dot-decimal" scale="6" id="f-4333">2,351.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1307" decimals="-5" name="us-gaap:PremiumsWrittenNet" scale="6" id="f-4334">783.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1308" decimals="-5" name="us-gaap:PremiumsWrittenNet" scale="6" id="f-4335">722.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-4336">1,506.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1307" decimals="-5" name="us-gaap:PremiumsEarnedNet" scale="6" id="f-4337">600.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1308" decimals="-5" name="us-gaap:PremiumsEarnedNet" scale="6" id="f-4338">726.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-4339">1,327.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1307" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-4340">369.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1308" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-4341">398.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-4342">767.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1307" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-4343">124.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1308" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-4344">92.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="f-4345">216.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1307" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-4346">69.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1308" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-4347">116.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-4348">186.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1307" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-4349">38.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1308" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-4350">118.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:UnderwritingIncomeLoss" scale="6" id="f-4351">156.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:CorporateExpenses" scale="6" id="f-4352">37.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-4353">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-4354">88.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:GainLossOnInvestments" scale="6" id="f-4355">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesGainLoss" scale="6" id="f-4356">128.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="f-4357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of loan notes issued by variable interest entities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="ahl:GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" format="ixt:fixed-zero" scale="6" id="f-4358">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-4359">84.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-4360">9.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-4361">75.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:OtherNonoperatingIncome" scale="6" id="f-4362">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:OtherNonoperatingExpense" scale="6" id="f-4363">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-4364">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-4365">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-4366">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1309" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-4367">1,190.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1310" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-4368">1,314.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1300" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-4369">2,505.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1311" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-4370">61.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1312" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-4371">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1263" decimals="3" name="us-gaap:LossRatio" scale="-2" id="f-4372">57.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1311" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-4373">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1312" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-4374">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1263" decimals="3" name="us-gaap:AcquisitionCostRatio" scale="-2" id="f-4375">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1311" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-4376">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1312" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-4377">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1263" decimals="3" name="us-gaap:GeneralAndAdministrativeExpenseRatio" scale="-2" id="f-4378">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1311" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-4379">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1312" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-4380">28.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1263" decimals="3" name="us-gaap:UnderwritingExpenseRatio" scale="-2" id="f-4381">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1311" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-4382">93.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1312" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-4383">83.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1263" decimals="3" name="us-gaap:CombinedRatio" scale="-2" id="f-4384">88.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate and other operating expenses includes other income/expenses, which were previously presented separately.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-94</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7600"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><ix:continuation id="f-703-13" continuedAt="f-703-14"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Investments</span></ix:continuation></div><ix:continuation id="f-703-14" continuedAt="f-703-15"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Statement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net investment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. &#160;<ix:continuation id="f-704-2" continuedAt="f-704-3">The following table summarizes investment income for the six months ended June&#160;30, 2023 and 2022;</ix:continuation></span></div><ix:continuation id="f-704-3" continuedAt="f-704-4"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities&#160;&#8212; Available for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1313" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4385">55.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1314" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4386">44.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities&#160;&#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1315" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4387">47.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1316" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4388">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments&#160;&#8212; Available for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1317" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4389">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1318" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" format="ixt:fixed-zero" scale="6" id="f-4390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments&#160;&#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1319" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4391">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1320" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" format="ixt:fixed-zero" scale="6" id="f-4392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed term deposits (included in cash and cash equivalents)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1321" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4393">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1322" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4394">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe bonds &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1323" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4395">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1324" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4396">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1325" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4397">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1326" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4398">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments, at fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1327" decimals="-5" sign="-" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4399">10.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1328" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4400">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4401">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="f-4402">93.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="f-4403">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="f-4404">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-4405">129.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:NetInvestmentIncome" scale="6" id="f-4406">88.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div></ix:continuation><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-704-4" continuedAt="f-704-5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="f-704-5">Other investments represents the Company&#8217;s investments in real estate, infrastructure and direct lending funds. The movement in the periods represent the change in fair value of the investment and has been included as part of our investment income.</ix:continuation> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-738-1"><ix:continuation id="f-703-15" continuedAt="f-703-16"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net realized and unrealized investment gains and losses recorded in the consolidated statement of operations and the change in unrealized gains and losses on investments recorded in other comprehensive income for the six months ended June&#160;30, 2023 and  2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized gains</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-4407">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-4408">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-4409">6.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-4410">29.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1317" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-4411">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1318" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="6" id="f-4412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1321" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-4413">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1322" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="f-4414">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1321" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-4415">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1322" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" scale="6" id="f-4416">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in expected credit gains/(losses) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" scale="6" id="f-4417">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" scale="6" id="f-4418">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-4419">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" format="ixt:fixed-zero" scale="6" id="f-4420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-4421">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-4422">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1321" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-4423">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1322" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" format="ixt:fixed-zero" scale="6" id="f-4424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1321" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" scale="6" id="f-4425">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1322" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedLoss" format="ixt:fixed-zero" scale="6" id="f-4426">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212;  gross realized gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1325" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-4427">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1326" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGain" scale="6" id="f-4428">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212;  net unrealized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1325" decimals="-5" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-4429">9.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1326" decimals="-5" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-4430">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe bonds &#8212; net unrealized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ahl:TradingSecuritiesCatastropheBondsGainLoss" scale="6" id="f-4431">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:TradingSecuritiesCatastropheBondsGainLoss" scale="6" id="f-4432">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; net unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-4433">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" scale="6" id="f-4434">89.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments &#8212; equity method:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in realized and unrealized gains  in Multi-Line Reinsurer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1329" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-4435">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1330" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-4436">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net realized and unrealized investment gains/(losses) recorded in the consolidated statement of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:NetRealizedAndUnrealizedInvestmentGainsLosses" scale="6" id="f-4437">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:NetRealizedAndUnrealizedInvestmentGainsLosses" scale="6" id="f-4438">126.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in available for sale net unrealized gains/(losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities gains/(losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" scale="6" id="f-4439">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" scale="6" id="f-4440">316.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" scale="6" id="f-4441">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" scale="6" id="f-4442">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in net unrealized gains/(losses), net of taxes recorded in other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-4443">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-4444">286.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-16" continuedAt="f-703-17"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance Sheet</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities and Short-Term Investments &#8212; Available For Sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;<ix:continuation id="f-808-2" continuedAt="f-808-3">The following tables present the cost or amortized cost, gross unrealized gains and losses and estimated fair market value of available for sale investments in fixed income securities and short-term investments as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-808-3"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost&#160;or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4445">1,064.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4447">51.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4449">1,013.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4450">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4452">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4454">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4455">159.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4456">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4457">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4458">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4459">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4460">2,031.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-4461">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4462">155.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4463">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4464">1,875.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4465">119.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4466">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4467">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4469">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4470">281.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4472">12.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4473">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4474">269.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4475">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4477">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4478">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4479">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4480">559.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4482">84.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4484">475.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4485">4,231.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-4486">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4487">321.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4488">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4489">3,908.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1339" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4490">169.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1340" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1340" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1340" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4494">169.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1341" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4495">4,400.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1341" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-4496">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1341" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4497">321.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1341" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4498">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1341" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4499">4,077.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the six  months ended June&#160;30, 2023, there was a decrease in the CECL allowance on available-for-sale investments of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-4500">3.7</ix:nonFraction> million (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-4501">5.0</ix:nonFraction> million increase).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost&#160;or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4502">1,003.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4504">50.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4506">953.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4507">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4509">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4510">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4511">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4512">159.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4514">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4515">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4516">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4517">2,016.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-4518">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4519">169.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4520">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4521">1,845.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4522">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4524">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4525">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4526">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4527">225.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-4528">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4529">11.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4530">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4531">213.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4532">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4534">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4536">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4537">590.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4538">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4539">87.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4541">502.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4542">4,131.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-4543">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4544">338.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4545">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4546">3,788.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4547">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-4548">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4549">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="f-4550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4551">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4552">4,183.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-4553">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-4554">339.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="f-4555">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4556">3,840.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-17" continuedAt="f-703-18"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities, Short-Term Investments, Equities, Catastrophe Bonds and Privately-held Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; <ix:continuation id="f-926-3" continuedAt="f-926-4">The following tables present the cost or amortized cost, gross unrealized gains and losses, and estimated fair market value of trading investments in fixed income securities, short-term investments, equity securities, catastrophe bonds and privately-held investments as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-926-4" continuedAt="f-926-5"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Income Securities &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4557">241.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4559">6.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4560">235.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4561">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4563">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4564">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4565">176.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4566">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4567">11.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4568">165.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1342" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4569">86.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1342" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4570">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1342" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4571">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1342" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4572">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4573">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4575">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4576">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4577">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4579">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4580">34.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1343" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4581">975.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1343" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4582">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1343" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4583">51.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1343" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4584">924.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4585">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4587">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4588">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1344" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-4589">1,552.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1344" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4590">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1344" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4591">76.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1344" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4592">1,478.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4593">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4596">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1346" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4597">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1346" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1346" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1346" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4600">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4601">305.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4602">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4603">11.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4604">295.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4605">104.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4607">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4608">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1349" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4609">59.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1349" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1349" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4611">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1349" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4612">58.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1350" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4613">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1350" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4614">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1350" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4615">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1350" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4616">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1351" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4617">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1351" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4618">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1351" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4619">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1351" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4620">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1352" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4621">496.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1352" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4622">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1352" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4623">15.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1352" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4624">482.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1353" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-4625">2,062.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1353" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4626">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1353" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4627">91.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1353" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4628">1,974.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-18" continuedAt="f-703-19"><ix:continuation id="f-926-5"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Income Securities &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4629">267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4631">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4632">261.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4633">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4635">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4636">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4637">175.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4638">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4639">13.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4640">162.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4641">90.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4642">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4643">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4644">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4645">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4646">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4647">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4648">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4649">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4651">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4652">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4653">970.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4654">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4655">74.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4656">896.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4657">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4659">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4660">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-4661">1,576.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4662">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4663">101.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4664">1,475.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4665">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4667">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4668">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4669">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4670">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4671">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4672">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4673">312.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4674">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4675">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4676">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4677">109.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4679">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4680">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4681">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4683">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4684">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4685">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4687">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4688">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4689">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4690">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4691">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4692">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4693">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" format="ixt:fixed-zero" scale="6" id="f-4695">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4696">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" scale="6" id="f-4697">537.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4698">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4699">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4700">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:TradingSecuritiesDebtAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-4701">2,125.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" scale="6" id="f-4702">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="ahl:TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" scale="6" id="f-4703">109.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4704">2,017.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catastrophe bonds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company has invested in catastrophe bonds with a total value of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:CatastropheBond" format="ixt:num-dot-decimal" scale="6" id="f-4705">2.4</ix:nonFraction> million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:CatastropheBond" format="ixt:num-dot-decimal" scale="6" id="f-4706">2.9</ix:nonFraction> million).&#160;The bonds are either zero-coupon notes or receive quarterly interest payments based on variable interest rates with scheduled maturities ranging from 2023 to 2026.&#160;The redemption value of the bonds will adjust based on the occurrence or aggregate occurrence of a covered event, such as windstorms and earthquakes in the United States, Canada, the North Atlantic, South America, Europe, Japan or Australia.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Privately-held investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has invested in privately-held investments, which primarily include commercial mortgage loans of $<ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4707">295.0</ix:nonFraction> million and middle market loans of $<ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4708">102.1</ix:nonFraction> million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; commercial mortgage loans of $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4709">312.1</ix:nonFraction> million; middle market loans of $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4710">106.9</ix:nonFraction> million). Privately-held investments also includes investments in asset-backed securities, equity securities and other short-term investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Mortgage Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The commercial mortgage loans are related to investments in properties including apartments, hotels, office and retail buildings, other commercial properties and industrial properties. The commercial mortgage loan portfolio is diversified by property type, geographic region and issuer to reduce risks. As part of our investment process, we evaluate factors such as size, property type, and security to determine that </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-19" continuedAt="f-703-20"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">properties are performing at a consistent and acceptable level to secure the related debt.&#160;<ix:continuation id="f-1077-4" continuedAt="f-1077-5">The following table presents the type of commercial mortgage loans and geographic region as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-1077-5" continuedAt="f-1077-6"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property type</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apartment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1354" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4711">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1355" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4712">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4713">115.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4714">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hotels</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1356" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4715">98.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1357" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4716">33.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4717">108.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-201" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4718">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1358" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4719">45.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1359" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4720">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4721">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4722">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1360" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4723">37.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1361" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4724">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4725">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-209" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4726">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1362" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4727">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1363" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4728">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4729">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-213" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4730">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1364" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4731">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1365" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4732">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4733">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-217" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4734">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4735">295.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1366" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4736">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4737">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4738">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Region</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1367" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4739">263.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1368" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4740">89.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4741">269.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4742">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1369" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4743">31.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1370" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4744">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4745">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4746">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4747">295.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1371" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4748">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4749">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4750">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary credit quality indicator of commercial mortgage loans is loan performance. Non-performing commercial mortgage loans are generally 90 days or more past due. As of June&#160;30, 2023, <ix:nonFraction unitRef="usd" contextRef="c-1372" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-4751">none</ix:nonFraction> of our commercial mortgage loans were non-performing.&#160;Loan-to-value and debt service coverage ratios are measures we use to assess the risk and quality of commercial mortgage loans. The loan-to-value ratio is expressed as a percentage of the value of the loan relative to the value of the underlying property. A loan-to-value ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. <ix:continuation id="f-1119-4" continuedAt="f-1119-5">The following table represents the loan-to-value ratio of the commercial mortgage loan portfolio as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-1119-5" continuedAt="f-1119-6"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 50%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1373" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4752">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4753">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50% to 60%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1374" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4754">227.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4755">248.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61% to 70%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1375" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4756">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4757">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4758">295.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4759">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt-service coverage ratio is measured by a property&#8217;s net operating income as a multiple of its debt re-payments. A ratio of less than 1.0 reflects a property&#8217;s operations is not sufficient to cover its debt payments. <ix:continuation id="f-1128-6" continuedAt="f-1128-7">The following table represents the debt-service coverage ratio of the commercial mortgage loan portfolio, excluding those that are non-performing and construction loans which are still under development, as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-1128-7" continuedAt="f-1128-8"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 1.20x</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1376" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4760">112.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4761">106.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 - 1.20x</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1377" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4762">182.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4763">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00x</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1378" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-4764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-4765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial mortgage loans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="ahl:CMLLessNonPerformingOrFutureConstruction" scale="6" id="f-4766">295.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="ahl:CMLLessNonPerformingOrFutureConstruction" scale="6" id="f-4767">292.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-20" continuedAt="f-703-21"><ix:continuation id="f-1128-8" continuedAt="f-1128-9"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As at June&#160;30, 2023, we have non-performing loans of $<ix:nonFraction unitRef="usd" contextRef="c-1372" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-4768">Nil</ix:nonFraction> (December&#160;31, 2022  &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-4769">Nil</ix:nonFraction>) and construction loans of $<ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="us-gaap:DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" format="ixt:fixed-zero" scale="6" id="f-4770">Nil</ix:nonFraction> (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" format="ixt:num-dot-decimal" scale="6" id="f-4771">19.9</ix:nonFraction> million) which only generate income when the construction is completed. As no income is currently being generated on these loans, they are not included in the table above. The total value of commercial mortgage loans is $<ix:nonFraction unitRef="usd" contextRef="c-1347" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4772">295.0</ix:nonFraction> million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4773">312.1</ix:nonFraction> million). </span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Middle Market Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The middle market loans are investments in senior secured loan positions with full covenants, focused on the middle market in the U.S., Europe and the Caribbean. The middle market loan portfolio is diversified by industry type, geographic region and issuer to reduce risks. As part of our investment process, we evaluate factors such as size, industry and security to determine that loans are performing at a consistent and acceptable level to secure the related debt. <ix:continuation id="f-1077-6" continuedAt="f-1077-7">The following table presents the type of middle market loans and geographic region as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-1077-7"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industry type</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1379" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4774">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1380" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4775">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4776">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-247" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4777">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1381" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4778">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1382" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4779">47.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4780">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-251" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4781">49.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1383" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4782">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1384" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4783">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4784">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-255" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4785">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer discretionary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1385" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4786">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1386" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4787">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4788">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-259" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4789">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Energy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1387" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4790">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1388" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4791">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4792">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-263" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4793">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1389" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4794">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1390" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4795">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4796">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-271" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4797">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total middle market mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4798">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1391" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4799">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4800">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4801">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1392" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4802">59.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1393" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4803">58.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4804">64.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4805">59.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1394" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4806">42.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1395" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4807">41.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4808">42.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-281" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4809">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4810">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1396" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4811">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4812">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-284" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-4813">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loan-to-enterprise-value and fixed charge coverage ratios are measures we use to assess the risk and quality of middle market loans. The loan-to-enterprise-value ratio is expressed as a percentage of the value of the loan relative to the value of the business. A loan-to-enterprise-value ratio in excess of 100% indicates the unpaid loan amount exceeds the value of the underlying business. <ix:continuation id="f-1119-6" continuedAt="f-1119-7">The following table represents the loan-to-enterprise-value ratio of the middle market loan portfolio as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-1119-7"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 50%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1397" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4814">63.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4815">63.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50% to 60%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1398" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4816">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4817">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61% to 70%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1399" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4818">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4819">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4820">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4821">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fixed charge coverage ratio, based upon the most recent financial statements, is expressed as a percentage of a firm&#8217;s earnings plus fixed charges to its fixed charges. Fixed charges include debt repayments, interest and equipment lease expenses. A fixed charge coverage ratio of less than 1.0 indicates a firm&#8217;s operations do not </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-21" continuedAt="f-703-22"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generate enough income to cover its fixed charges. <ix:continuation id="f-1128-9" continuedAt="f-1128-10">The following represents the fixed charge coverage ratio of the middle market loan portfolio as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-1128-10"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 1.20x</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1400" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4822">78.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4823">95.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 - 1.20x</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1401" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4824">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4825">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00x</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1402" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4826">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4827">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1348" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4828">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-4829">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has individually assessed each of the middle market loans with the fixed charge coverage ratio of less than 1.00x. This is mainly due to increased capital investment to support the increased business post COVID-19. These investments have been performing with the fixed charged increasing over the year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Asset-backed securities represent interests in underlying pools of diversified referenced assets that are collateralized and backed by future cash flows and these securities are performing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global corporate securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Global corporates portfolio consists of debt securities with a non-U.S. debt issuer that are backed by the cash flows generated from real estate holdings and these securities are performing.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Equity securities consists of a single non-U.S. private issuer that is a special purpose vehicle designed to grant a first lien right to the underlying senior notes. The underlying issuer is a financial services lender to middle market companies and this security is performing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments &#8212; Equity Method.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In January 2015, the Company, along with seven other insurance companies, established a micro-insurance venture consortium and micro-insurance incubator (&#8220;MVI&#8221;) domiciled in Bermuda. The MVI is a social impact organization that provides micro-insurance products to assist global emerging consumers. In March 2021, the Company committed an additional $<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-4830">0.8</ix:nonFraction> million equity contribution to MVI over a 2 year period and paid $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-4831">0.4</ix:nonFraction> million in the period ending December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2017, the Company purchased through its wholly-owned subsidiary, Aspen U.S. Holdings, Inc. (&#8220;Aspen U.S. Holdings&#8221;), a <ix:nonFraction unitRef="number" contextRef="c-305" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-4832">49</ix:nonFraction>% share of Digital Risk Resources, LLC (&#8220;Digital Re&#8221;), a U.S.-based enterprise engaged in the business of developing, marketing and servicing turnkey information security and privacy liability insurance products for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="f-4833">2.3</ix:nonFraction> million. The investment is accounted for under the equity method and adjustments to the carrying value of this investment are made based on the Company&#8217;s share of capital, including share of income and expenses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2019, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4834">5.0</ix:nonFraction> million as an equity investment in the holding company of a multi-line reinsurer. The strategy for the multi-line reinsurer is to combine a diversified reinsurance business, focused primarily on long-tailed lines of property and casualty business and, potentially to a lesser extent, life business, with a diversified investment strategy. During the period ending June&#160;30, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-1329" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-4835">0.4</ix:nonFraction> million (December&#160;31, 2022 &#8212;$<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="f-4836">1.6</ix:nonFraction> million) capital was invested in multi-line reinsurer. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-22" continuedAt="f-703-23"><ix:continuation id="f-1217-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the Company&#8217;s investments in MVI, Multi-Line Reinsurer and Digital Re for the six months ended June&#160;30, 2023 and the twelve months ended December 31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MVI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Multi-Line Reinsurer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Digital Re</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening undistributed value of investment as at January&#160;1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4837">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4838">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4839">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4840">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1403" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:fixed-zero" scale="6" id="f-4841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1329" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-4842">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1404" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:fixed-zero" scale="6" id="f-4843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-4844">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain for the period to June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1405" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:fixed-zero" scale="6" id="f-4845">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1406" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-4846">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1407" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:fixed-zero" scale="6" id="f-4847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1408" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-4848">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing value of investment as at June 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1409" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4849">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1410" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4850">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1411" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4851">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4852">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="21" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening undistributed value of investment as at January&#160;1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4853">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4854">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4855">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4856">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-4857">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-4858">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" format="ixt:fixed-zero" scale="6" id="f-4859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates" scale="6" id="f-4860">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (loss)/gain for the period to December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-4861">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-4862">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:fixed-zero" scale="6" id="f-4863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="f-4864">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing value of investments at December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4865">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4866">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4867">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="f-4868">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  On December 20, 2017, the Company committed to, and during 2018 invested $<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-4869">100.0</ix:nonFraction> million as a limited partner to a real estate fund, classified as other investments. As at June&#160;30, 2023, the current fair value of the fund is $<ix:nonFraction unitRef="usd" contextRef="c-1412" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-4870">125.2</ix:nonFraction> million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-4871">134.6</ix:nonFraction>&#160;million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-4872">20.0</ix:nonFraction> million as a limited partner to a third party managed real estate fund. The Partnership was established to make equity and equity related investments in multifamily and other commercial real estate properties located in the United States and its territories, with the goal of generating superior risk-adjusted returns. The Partnership seeks to acquire commercial real estate assets including real estate assets (or interests therein) that may have management or operational problems and require improvements or lack sufficient capital, including mortgage loans and development or redevelopment properties. On April 1, 2022, the Company committed an additional $<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-4873">10.0</ix:nonFraction>&#160;million to the fund. As at June&#160;30, 2023, the current fair value of the fund is $<ix:nonFraction unitRef="usd" contextRef="c-1413" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-4874">39.2</ix:nonFraction> million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-4875">40.6</ix:nonFraction> million) and the unfunded commitment is $<ix:nonFraction unitRef="usd" contextRef="c-1414" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-4876">3.3</ix:nonFraction> million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-4877">3.3</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-4878">30.0</ix:nonFraction> million as a limited partner to a related party managed real estate fund. The Partnership was established to pursue investment opportunities to acquire, recapitalize, restructure and reposition real estate assets, portfolios and companies primarily in the United States. As at June&#160;30, 2023, the current fair value of the fund is $<ix:nonFraction unitRef="usd" contextRef="c-1260" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4879">22.9</ix:nonFraction>&#160;million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-4880">25.3</ix:nonFraction>&#160;million) and the unfunded commitment is $<ix:nonFraction unitRef="usd" contextRef="c-1415" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-4881">5.3</ix:nonFraction> million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-4882">5.3</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2022, the Company committed $<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-4883">15.0</ix:nonFraction> million as a limited partner to a third party managed infrastructure fund. The Partnership was established to make investments in value added infrastructure investments in environmental services, transportation, communications and digital, energy/energy transition and other infrastructure sectors primarily in North America. As at June&#160;30, 2023, the current fair value of the fund is $<ix:nonFraction unitRef="usd" contextRef="c-1416" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-4884">11.7</ix:nonFraction>&#160;million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-4885">8.2</ix:nonFraction>&#160;million)  and the unfunded commitment is $<ix:nonFraction unitRef="usd" contextRef="c-1417" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-4886">6.4</ix:nonFraction> million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="f-4887">8.4</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the aggregate current fair value of the fund investments described above is $<ix:nonFraction unitRef="usd" contextRef="c-1418" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-4888">213.4</ix:nonFraction> million (December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-4889">221.3</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on the funds, refer to Note 12(a) in these consolidated financial statements, &#8220;Commitments and Contingencies.&#8221;</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-23" continuedAt="f-703-24"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed income maturities, Available for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:continuation id="f-1274-2" continuedAt="f-1274-3">The scheduled maturity distribution of the Company&#8217;s available for sale fixed income securities as at June&#160;30, 2023 and December&#160;31, 2022 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties.</ix:continuation></span></div><ix:continuation id="f-1274-3"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost&#160;or&#160;Cost</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>S&amp;P Ratings&#160;by<br/>Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="f-4890">242.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="f-4891">236.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1315" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" id="f-4892">AA</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-4893">2,736.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="f-4894">2,594.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1315" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" id="f-4895">AA-</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="f-4896">684.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="f-4897">595.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1315" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" id="f-4898">A+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="6" id="f-4899">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="f-4900">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1315" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" id="f-4901">BB</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total &#8212; Government and corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4902">3,665.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1419" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4903">3,427.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4904">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4905">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1420" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-4906">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4907">559.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4908">475.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1421" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-4909">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1422" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4910">4,231.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1422" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4911">3,908.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost&#160;or&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>S&amp;P Ratings&#160;by<br/>Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="f-4912">179.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="f-4913">176.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" id="f-4914">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="f-4915">2,526.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="f-4916">2,385.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" id="f-4917">AA-</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="f-4918">815.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="f-4919">707.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" id="f-4920">A+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="6" id="f-4921">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="f-4922">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="ahl:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" id="f-4923">A-</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total &#8212; Government and corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4924">3,534.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4925">3,280.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4926">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4927">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-340" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-4928">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-4929">590.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-4930">502.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-341" name="ahl:AvailableForSaleSecuritiesAverageRatingsByMaturity" id="f-4931">AA+</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-4932">4,131.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-4933">3,788.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guaranteed Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;As at June&#160;30, 2023 and December&#160;31, 2022, the Company held <ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:InvestmentFunds" format="ixt:fixed-zero" scale="0" id="f-4934"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:InvestmentFunds" format="ixt:fixed-zero" scale="0" id="f-4935">no</ix:nonFraction></ix:nonFraction> investments which are guaranteed by mono-line insurers, excluding those with explicit government guarantees. The Company&#8217;s exposure to other third-party guaranteed debt is primarily to investments backed by non-U.S.&#160;government guaranteed issuers.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-24" continuedAt="f-703-25"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross unrealized losses, available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;<ix:continuation id="f-1323-3" continuedAt="f-1323-4">The following tables summarize, by type of security, the aggregate fair value and gross unrealized loss by length of time the security has been in an unrealized loss position for the Company&#8217;s available for sale portfolio as at June&#160;30, 2023 and December&#160;31, 2022:</ix:continuation></span></div><ix:continuation id="f-1323-4"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0-12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Over 12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-4936">494.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-4937">12.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-4938">519.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-4939">38.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-4940">1,013.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4941">51.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-4942">105</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-4943">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-4944">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-4945">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-4946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-4947">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1332" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4948">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1332" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-4949">4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-4950">90.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-4951">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-4952">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-4953">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-4954">149.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1333" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4955">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1333" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-4956">60</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-4957">467.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-4958">13.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-4959">1,254.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-4960">142.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-4961">1,722.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1334" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4962">155.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1334" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-4963">727</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-4964">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-4965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-4966">105.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-4967">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-4968">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1335" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4969">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1335" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-4970">16</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-4971">80.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-4972">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-4973">182.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-4974">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-4975">262.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1336" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4976">12.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1336" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-4977">61</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-4978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-4979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-4980">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-4981">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-4982">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1337" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4983">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1337" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-4984">1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-4985">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-4986">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-4987">455.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-4988">83.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-4989">474.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1338" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4990">84.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1338" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-4991">214</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1423" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-4992">1,163.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1423" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-4993">32.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1423" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-4994">2,582.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1423" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-4995">288.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1423" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-4996">3,746.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1423" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-4997">321.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security2" contextRef="c-1423" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="f-4998">1,188</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-4999">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-5000">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-5001">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-5002">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5003">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1345" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-5004">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-1345" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5005">5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5006">1,175.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5007">32.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5008">2,582.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5009">288.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5010">3,758.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5011">321.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-11" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="f-5012">1,193</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0-12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Over 12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-5013">741.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5014">30.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-5015">203.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5016">20.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5017">944.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5018">50.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-151" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5019">118</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-5020">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5021">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-5022">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-5023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5024">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5025">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-152" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5026">5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-5027">133.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5028">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-5029">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5030">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5031">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5032">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-153" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5033">59</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5034">1,104.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5035">77.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-5036">568.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5037">91.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5038">1,672.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5039">169.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-154" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5040">701</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-5041">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5042">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-5043">99.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5044">8.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5045">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5046">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-155" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5047">16</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-5048">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5049">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-5050">135.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5051">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5052">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5053">11.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-156" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5054">45</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-5055">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5056">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-5057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-5058">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5059">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5060">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-157" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5061">1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-5062">202.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5063">24.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" scale="6" id="f-5064">299.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5065">62.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5066">501.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5067">87.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-158" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5068">220</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5069">2,269.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5070">145.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5071">1,323.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5072">193.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5073">3,593.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5074">338.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security2" contextRef="c-348" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="f-5075">1,165</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" scale="6" id="f-5076">51.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5077">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:fixed-zero" scale="6" id="f-5078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-5079">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" scale="6" id="f-5080">51.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5081">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security2" contextRef="c-177" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-5082">1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5083">2,321.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-5084">145.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5085">1,323.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-5086">193.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" format="ixt:num-dot-decimal" scale="6" id="f-5087">3,645.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-5088">339.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="c-12" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="f-5089">1,166</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-703-25"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The overall gross unrealized loss position is largely attributable to the impact of rising interest rates on our bond portfolio and mortgage-backed securities.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_7624"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><ix:continuation id="f-1474-12" continuedAt="f-1474-13"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Fair Value Measurements</span></ix:continuation></div><ix:continuation id="f-1474-13" continuedAt="f-1474-14"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of fair value for financial assets and liabilities are based on the framework established in the fair value accounting guidance included in ASC Topic 820, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; The framework prioritizes the inputs, which refer broadly to assumptions market participants would use in pricing an asset or liability, into three levels.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for actively traded securities to be derived based on quoted prices in an active market for identical assets, which are Level&#160;1 inputs in the fair value hierarchy. The majority of these securities are valued using prices supplied by pricing services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for other securities that may not be as actively traded which are priced via pricing services, vendors and broker-dealers, or with reference to interest rates and yield curves, to be derived based on inputs that are observable for the asset, either directly or indirectly, which are Level&#160;2 inputs in the fair value hierarchy. The majority of these securities are also valued using prices supplied by pricing services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers securities, other financial instruments, privately-held investments and derivative insurance contracts subject to fair value measurement whose valuation is derived by internal valuation models to be based largely on unobservable inputs, which are Level&#160;3 inputs in the fair value hierarchy.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1475-3" continuedAt="f-1475-4"><ix:continuation id="f-1474-14" continuedAt="f-1474-15"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the level within the fair value hierarchy at which the Company&#8217;s financial assets and liabilities are measured on a recurring basis as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed income securities, available for sale. at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1424" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5090">1,013.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1425" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5091">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1426" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1427" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5093">1,013.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1428" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1429" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5095">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1430" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1431" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5097">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1432" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5098">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1433" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5099">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1434" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1435" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5101">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1436" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5102">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1437" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5103">1,875.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1438" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5104">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1439" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5105">1,875.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1440" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5106">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1441" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5107">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1442" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1443" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5109">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1444" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5110">192.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1445" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5111">76.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1446" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1447" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5113">269.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1448" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1449" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5115">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1450" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5116">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1451" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5117">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1452" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1453" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5119">475.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1454" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5120">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1455" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5121">475.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1456" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5122">1,206.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1457" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5123">2,701.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1458" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5124">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1459" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5125">3,908.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1460" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5126">169.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1461" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5127">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1462" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1463" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5129">169.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed income securities, trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1464" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5130">235.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1465" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1466" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1467" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5133">235.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1468" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5134">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1469" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5135">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1470" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1471" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5137">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1472" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1473" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5139">165.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1474" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5140">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1475" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5141">165.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1476" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1477" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5143">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1478" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1479" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5145">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1480" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5146">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1481" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5147">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1482" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5148">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1483" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5149">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1484" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5150">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1485" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5151">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1486" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5152">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1487" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5153">34.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1488" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1489" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5155">924.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1490" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5156">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1491" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5157">924.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1492" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5158">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1493" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5159">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1494" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5160"><ix:nonFraction unitRef="usd" contextRef="c-1495" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5161">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1496" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5162">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1497" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5163">247.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1498" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5164">1,230.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1494" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1499" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5166">1,478.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1500" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5167">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1501" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5168">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1502" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1503" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5170">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1497" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:fixed-zero" scale="6" id="f-5171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1498" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:fixed-zero" scale="6" id="f-5172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1494" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5173">482.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1499" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5174">482.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1497" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5175">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1498" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-5176">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1494" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1499" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-5178">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1504" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5179">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1505" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1506" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1418" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5182">213.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial assets and liabilities, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1507" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-5183">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1508" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-5184">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1509" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-5185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1510" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-5186">13.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1511" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-5187">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1512" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-5188">13.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities &#8212; loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1513" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-5189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1514" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-5190">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1515" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-5191">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1516" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-5192">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1517" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-5193">1,632.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1518" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-5194">3,940.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1519" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5195">459.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1520" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-5196">6,245.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents our investments in real estate, infrastructure and direct lending funds and are measured at fair value using the net asset value per share practical expedient. As a result this has not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheets. The investment in the real estate and other funds is subject to restrictions as detailed in Note 12(a), &#8220;Commitments and Contingencies.&#8221;</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1475-4" continuedAt="f-1475-5"><ix:continuation id="f-1474-15" continuedAt="f-1474-16"><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The loss portfolio transfer contract includes a funds withheld arrangement that provides variable interest expense based on Aspen&#8217;s investment performance. As a result, this funds withheld arrangement is considered an embedded derivative and accounted for as an option-based derivative. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed income securities, available for sale. at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5197">953.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5199">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5200">953.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5202">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5203">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5204">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5206">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5208">149.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5210">1,845.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5211">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5212">1,845.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5213">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5214">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5215">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5216">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5217">145.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5218">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5220">213.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1521" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5221">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1522" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5222">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1523" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5223">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1524" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5224">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5226">502.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5228">502.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5229">1,098.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5230">2,690.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5231">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5232">3,788.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5233">51.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5234">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5236">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed income securities, trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5237">261.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5238">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5239">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5240">261.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5242">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5244">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5246">162.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5248">162.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5250">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5252">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5254">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5255">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5256">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5257">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5258">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5259">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5260">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5262">896.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5263">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5264">896.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-422" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5266">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5268">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5269">272.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5270">1,203.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-5272">1,475.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5273">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5275">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5276">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:fixed-zero" scale="6" id="f-5277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:fixed-zero" scale="6" id="f-5278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5279">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5280">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5281">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-5282">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-5" name="ahl:CatastropheBondsFairValueDisclosure" scale="6" id="f-5284">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5286">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-5287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-5288">221.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial assets and liabilities, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-5289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-5290">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-5291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-5292">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-5293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-5294">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-5295">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-5296">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities &#8212; loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-5297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-5298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-5299">31.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-5300">31.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-449" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-5301">1,428.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-5302">3,949.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5303">501.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="f-5304">6,100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents our investments in real estate, infrastructure and direct lending funds and are measured at fair value using the net asset value per share practical expedient. As a result this has not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1474-16" continuedAt="f-1474-17"><ix:continuation id="f-1475-5"><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">hierarchy to the amounts presented in the consolidated balance sheets. The investment in the real estate funds is subject to restrictions as detailed in Note 12(a), &#8220;Commitments and Contingencies.&#8221;</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers of assets into or out of a particular level are recorded at their fair values as of the end of each reporting period consistent with the date of the determination of fair value. During the six months ended June&#160;30, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-1525" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:num-dot-decimal" scale="6" id="f-5305">6.7</ix:nonFraction> million (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1526" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5306">Nil</ix:nonFraction>) was transferred out of Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, there were privately-held investments carried at $<ix:nonFraction unitRef="usd" contextRef="c-1494" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:num-dot-decimal" scale="6" id="f-5307">482.4</ix:nonFraction> million (December&#160;31, 2022  &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" format="ixt:num-dot-decimal" scale="6" id="f-5308">533.0</ix:nonFraction> million) classified as Level 3. As a result of loans sold by Aspen and loans repaid to Aspen by borrowers, a net settlement of $<ix:nonFraction unitRef="usd" contextRef="c-1525" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:num-dot-decimal" scale="6" id="f-5309">58.4</ix:nonFraction> million occurred during the period (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:num-dot-decimal" scale="6" id="f-5310">147.4</ix:nonFraction> million). Additionally as at June&#160;30, 2023, there was an embedded derivative as part of the loss portfolio transfer agreement worth $<ix:nonFraction unitRef="usd" contextRef="c-1515" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="f-5311">23.4</ix:nonFraction>&#160;million classified as Level 3 (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="f-5312">31.7</ix:nonFraction> million). </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1474-17" continuedAt="f-1474-18"><ix:continuation id="f-1703-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the beginning and ending balances for all assets and liabilities measured at fair value on a recurring basis using Level 3 inputs for the six months ended June&#160;30, 2023 and the twelve months ended December 31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchases and issuances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers (out)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements and sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase/(decrease) in fair value including net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in unrealized investment gains (losses) relating to assets held at end of period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Privately-held investments &#8212; trading</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1527" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5313">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1528" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5314">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1528" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1528" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5316">23.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1528" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5317">9.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1529" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5318">295.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1530" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5319">10.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1531" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5320">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1532" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5321">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1532" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1532" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5323">5.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1532" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5324">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1533" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5325">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1534" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5326">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1535" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5327">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1536" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" format="ixt:fixed-zero" scale="6" id="f-5328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1536" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="f-5329">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1536" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5330">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1536" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5331">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1537" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5332">58.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1538" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5333">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1539" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5334">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1540" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" format="ixt:fixed-zero" scale="6" id="f-5335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1540" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5336">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1540" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5337">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1540" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="f-5338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1541" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5339">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1542" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5340">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1543" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5341">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1544" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5342">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1544" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="f-5343">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1544" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5344">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1544" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5345">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1545" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5346">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1546" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1547" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5348">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" format="ixt:fixed-zero" scale="6" id="f-5349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5351">25.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1548" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="f-5352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1549" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-5353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1550" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Level 3 assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1551" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5355">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1525" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5356">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1525" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="f-5357">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1525" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5358">58.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1525" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5359">8.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1519" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5360">482.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1552" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5361">13.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative liabilities - loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-582" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-5362">31.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1553" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="f-5363">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1553" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1553" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" format="ixt:fixed-zero" scale="6" id="f-5365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1554" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-5366">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1555" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-5367">23.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1553" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5368">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Level 3 liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-585" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-5369">31.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="f-5370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" format="ixt:fixed-zero" scale="6" id="f-5372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-5373">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1557" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-5374">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1556" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Privately-held investments &#8212; trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-554" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5376">211.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5377">215.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5379">113.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5380">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-556" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5381">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-557" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5382">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-558" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5383">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5384">61.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5386">19.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5387">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-560" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5388">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-561" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5389">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-562" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5390">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5391">54.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5393">12.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5394">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-564" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5395">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-565" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5396">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-566" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-5397">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5398">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5399">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="f-5400">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5401">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-568" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5402">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-569" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-570" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5404">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5405">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5407">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5408">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-572" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5409">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-573" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-574" decimals="-5" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="f-5411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5412">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="f-5414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-575" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="f-5415">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-576" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5416">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-577" decimals="-5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Level 3 assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-578" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5418">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="f-5419">378.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-5421">147.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-5422">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-5" name="us-gaap:TradingSecurities" scale="6" id="f-5423">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-579" decimals="-5" sign="-" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="f-5424">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative liabilities - loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-580" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="f-5425">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="f-5426">17.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" format="ixt:fixed-zero" scale="6" id="f-5428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-5429">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-582" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-5430">31.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-581" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Level 3 liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-583" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="f-5432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="f-5433">17.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="f-5434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" format="ixt:fixed-zero" scale="6" id="f-5435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-5436">14.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-585" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-5437">31.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-584" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-5438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Fixed Income Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fixed income securities are classified as either available for sale or trading and are reported at fair value. As at June&#160;30, 2023 and December&#160;31, 2022, the Company&#8217;s fixed income securities were valued by pricing services or broker-dealers using standard market conventions. The market conventions utilize market quotations, market transactions in comparable instruments and various relationships between instruments including, but not limited to, yield to maturity, dollar prices and spread prices in determining value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Pricing Services.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying methodology used to determine the fair value of securities in the Company&#8217;s available for sale and trading portfolios is by the pricing services. Pricing services will gather observable </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1474-18" continuedAt="f-1474-19"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pricing inputs from multiple external sources, including buy and sell-side contacts and broker-dealers, in order to develop their internal prices. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing services provide pricing for less complex, liquid securities based on market quotations in active markets. Pricing services supply prices for a broad range of securities including those for actively traded securities, such as Treasury and other Government securities, in addition to those that trade less frequently or where valuation includes reference to credit spreads, pay down and pre-pay features and other observable inputs. These securities include Government agency, municipals, corporate and asset-backed securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For securities that may trade less frequently or do not trade on a listed exchange, these pricing services may use matrix pricing consisting of observable market inputs to estimate the fair value of a security. These observable market inputs include reported trades, benchmark yields, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and industry and economic factors. Additionally, pricing services may use a valuation model such as an option adjusted spread model commonly used for estimating fair values of mortgage-backed and asset-backed securities. The Company does not derive dollar prices using an index as a pricing input for any individual security.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broker-Dealers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company obtains quotes from broker-dealers who are active in the corresponding markets when prices are unavailable from independent pricing services or index providers. Generally, broker-dealers value securities through their trading desks based on observable market inputs. Their pricing methodologies include mapping securities based on trade data, bids or offers, observed spreads and performance of newly issued securities. They may also establish pricing through observing secondary trading of similar securities. Quotes from broker-dealers are non-binding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company obtains prices for all of its fixed income investment securities via its third-party accounting service provider, and in the majority of cases receiving a number of quotes so as to obtain the most comprehensive information available to determine a security&#8217;s fair value. A single valuation is applied to each security based on the vendor hierarchy maintained by the Company&#8217;s third-party accounting service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company obtained an average of <ix:nonFraction unitRef="quotesperinvestment" contextRef="c-11" decimals="1" name="ahl:FairValueInputsOfferedQuotesPerFixedIncomeInvestment" scale="0" id="f-5439">2.8</ix:nonFraction> quotes per fixed income investment compared to <ix:nonFraction unitRef="quotesperinvestment" contextRef="c-12" decimals="1" name="ahl:FairValueInputsOfferedQuotesPerFixedIncomeInvestment" scale="0" id="f-5440">2.9</ix:nonFraction> quotes at December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, in conjunction with its third-party accounting service provider, obtains an understanding of the methods, models and inputs used by the third-party pricing service and index providers to assess the ongoing appropriateness of vendors&#8217; prices. The Company and its third-party accounting service provider also have controls in place to validate that amounts provided represent fair values. Processes to validate and review pricing include, but are not limited to:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">quantitative analysis (e.g., comparing the quarterly return for each managed portfolio to its target benchmark, with significant differences identified and investigated);</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comparison of market values obtained from pricing services and broker-dealers against alternative price sources for each security where further investigation is completed when significant differences exist for pricing of individual securities between pricing sources;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">initial and ongoing evaluation of methodologies used by outside parties to calculate fair value;&#160;and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comparison of the fair value estimates to the Company&#8217;s knowledge of the current market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prices obtained from pricing services and broker-dealers are not adjusted by us; however, prices provided by a pricing service, or broker-dealer in certain instances may be challenged based on market or information available from internal sources, including those available to the Company&#8217;s third-party investment accounting service provider. Subsequent to any challenge, revisions made by the pricing service or broker-dealer to the quotes are supplied to the Company&#8217;s investment accounting service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the vendor hierarchy maintained by the Company&#8217;s third-party accounting service provider in order to determine which price source provides the most appropriate fair value (i.e., a price obtained </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1474-19" continuedAt="f-1474-20"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from a pricing service with more seniority in the hierarchy will be used over a less senior one in all cases). The hierarchy level assigned to each security in the Company&#8217;s available for sale and trading portfolios is based upon its assessment of the transparency and reliability of the inputs used in the valuation as of the measurement date. The hierarchy of pricing services is determined using various qualitative and quantitative points arising from reviews of the vendors conducted by the Company&#8217;s third-party accounting service provider. Vendor reviews include annual due diligence meetings with index providers and pricing services vendors covering valuation methodology, operational walkthroughs and legal and compliance updates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities are traded on the over-the-counter (&#8220;OTC&#8221;) market based on prices provided by one or more market makers in each security. Securities such as U.S.&#160;Government, U.S.&#160;Agency, Foreign Government and investment grade corporate bonds have multiple market makers in addition to readily observable market value indicators such as expected credit spread, except for Treasury securities, over the yield curve. The Company uses a variety of pricing sources to value fixed income securities including those securities that have pay down/prepay features such as mortgage-backed securities and asset-backed securities in order to ensure fair and accurate pricing. The fair value estimates for the investment grade securities in the Company&#8217;s portfolio do not use significant unobservable inputs or modeling techniques.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Government and Agency Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;U.S.&#160;government and agency securities consist primarily of bonds issued by the U.S.&#160;Treasury and corporate debt issued by agencies such as the Federal National Mortgage Association (&#8220;FNMA&#8221;), the Federal Home Loan Mortgage Corporation (&#8220;FHLMC&#8221;) and the Federal Home Loan Bank. As the fair values of U.S.&#160;Treasury securities are based on unadjusted market prices in active markets, they are classified within Level&#160;1. The fair values of U.S.&#160;government agency securities are priced using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of U.S.&#160;government agency securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Municipal Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s municipal portfolio consist of bonds issued by U.S.&#160;domiciled state and municipality entities. The fair value of these securities is determined using spreads obtained from broker-dealers, trade prices and the new issue market which are Level&#160;2 inputs in the fair value hierarchy. Consequently, these securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-U.S. Government.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The issuers for securities in this category are non-U.S.&#160;governments and their agents including, but not limited to, the U.K., Australia, Canada, France and Germany. The fair values of certain non-U.S.&#160;government bonds, primarily sourced from international indices, are based on unadjusted market prices in active markets and are therefore classified within Level&#160;1. The remaining non-U.S. government bonds are classified within level 2 as they are not actively traded. The fair values of the non-U.S.&#160;agency securities, again primarily sourced from international indices, are priced using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of non-U.S.&#160;agency securities are classified within Level&#160;2. In addition, foreign government securities include a portion of the Emerging Market Debt (&#8220;EMD&#8221;) portfolio which is also classified within Level 2. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate securities consist primarily of short-term, medium-term and long-term debt issued by U.S.&#160;and foreign corporations covering a variety of industries and are generally priced by index providers and pricing vendors. Some issuers may participate in&#160;government programs which guarantee timely payment of principal and interest in the event of a default. The fair values of these securities are generally determined using the spread above the risk-free yield curve. Inputs used in the evaluation of these securities include credit data, interest rate data, market observations and sector news, broker-dealer quotes and trade volumes. In addition, corporate securities include a portion of the EMD portfolio. The Company classifies these securities across Level 1 and 2, with majority of them being in Level 1.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-backed Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Residential and commercial mortgage-backed securities consist of bonds issued by the Government National Mortgage Association, the FNMA and the FHLMC as well as private non-agency issuers. The fair values of these securities are determined through the use of a pricing model (including Option Adjusted Spread) which uses prepayment speeds and spreads to determine the appropriate average life of the mortgage-backed security. These spreads are generally obtained from broker-dealers, trade prices and the new issue market. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1474-20" continuedAt="f-1474-21"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the significant inputs used to price mortgage-backed securities are observable market inputs, these securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Asset-backed securities are securities backed by notes or receivables against assets other than real estate. The underlying collateral for the Company&#8217;s asset-backed securities consists mainly of student loans, automobile loans and credit card receivables. These securities are primarily priced by index providers and pricing vendors. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, interest rate data and credit spreads. The Company classifies these securities within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privately-Held Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Privately-held investments are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models. These models include inputs that are specific to each investment. The inputs used in the fair value measurements include dividend or interest rates and appropriate discount rates. The selection of an appropriate discount rate is judgmental and is the most significant unobservable input used in the valuation of these securities. A significant increase (decrease) in this input in isolation could result in significantly lower (higher) fair value measurement for privately-held investments. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow models, the Company maintains an understanding of current market conditions, issuer specific information that may impact future cash flows as well as collaboration with independent vendors for most securities to assess the reasonableness of the discount rate being used.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial mortgage loans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial mortgage loans consists in investments in properties including apartments, hotels, office and retail buildings, other commercial properties and industrial properties. The commercial mortgage loan portfolio is diversified by property type, geographic region and issuer to reduce risks. Commercial Mortgage Loans are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The middle market loans consist in investments in senior secured loan positions with full covenants, focused on the middle market in both U.S., Europe and the Caribbean. The middle market loan portfolio is diversified by industry type, geographic region and issuer to reduce risks. Middle Market Loans are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Asset-backed securities represent interests in underlying pools of diversified referenced assets that are collateralized and backed by future cash flows and these securities are performing. The fair values of these securities are determined by using discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global corporate securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The global corporates portfolio consists of debt securities with a non-U.S. debt issuer that are backed by the cash flows generated from real estate holdings and these securities are performing. The fair value of these securities are determined by using discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Equity securities consists of a single non-U.S. based issuer that is a special purpose vehicle designed to grant a first lien right to the underlying senior notes within the structure. The underlying issuer is a financial services lender to middle market companies and this security is performing. The valuation of the investments is DCF and the securities are classified as Level 3. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Short-term investments consist of highly liquid debt securities with a maturity greater than three months but less than one year from the date of purchase. Short-term investments are classified as either trading or available for sale according to the facts and circumstances of the investment held. Short-term investments are valued in a manner similar to the Company&#8217;s fixed maturity investments and are classified within Levels 1 and 2.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1474-21"><ix:continuation id="f-1812-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the quantitative inputs and assumptions used for financial assets and liabilities investments categorized as Level 3 under the fair value hierarchy as at June&#160;30, 2023:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:23.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Techniques</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable (U) inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ranges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1558" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5441">270.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1559" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5442">3.7</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1560" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5443">11.2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1561" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5444">6.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1562" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5445">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3rd party NAV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1563" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5446">102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1564" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5447">7.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1565" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5448">20.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1566" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5449">10.8</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1567" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5450">58.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1568" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5451">5.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1569" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5452">9.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1570" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5453">6.8</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1571" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5454">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1572" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5455">6.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1573" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5456">7.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1574" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5457">6.4</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1575" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5458">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1576" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5459">8.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1577" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5460">8.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1578" decimals="3" name="us-gaap:DebtSecuritiesTradingMeasurementInput" scale="-2" id="f-5461">8.6</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1579" decimals="-5" name="ahl:PrivatelyheldInvestmentsatfairvalue" scale="6" id="f-5462">482.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Catastrophe Bonds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe bonds are variable rate fixed income instruments with redemption values adjusted based on the occurrence of a covered event, usually windstorms and earthquakes. Catastrophe bonds are classified as trading and reported at fair value.&#160;Catastrophe bonds are priced using an average of multiple broker-dealer quotes and as such, are considered Level 2.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The foreign exchange contracts which the Company uses to mitigate currency risk are characterized as OTC due to their customized nature and the fact that they do not trade on a major exchange. These instruments trade in a very deep liquid market, providing substantial price transparency and accordingly are classified as Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Liabilities - Loss Portfolio Transfer.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The LPT embedded derivative is valued using the Black-Scholes model. The two primary inputs of this model are expected claim settlement patterns and expected return of the investment portfolio above a fixed minimum rate over the specified time horizon. The expected claim settlement pattern is determined on an actuarial basis for the cohort of business within scope of the LPT and is consistent with the patterns used in the valuation of technical provisions. The expected return of the investment portfolio, above a fixed minimum rate, directly impacts on the LPT derivative valuation and is subject to changes in the market conditions. In order to assess the reasonableness of the inputs, the Company updates the expected claim settlement patterns on a regular basis whilst maintaining an understanding of the current market conditions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other investments represent our investments in real estate, infrastructure and direct lending funds. Adjustments to the fair values are made based on the net asset value of the investments. The net valuation criteria established by the manager of such investments are established in accordance with the governing documents and the asset manager&#8217;s valuation guidelines, which include: the discounted cash flows method and the performance multiple approach, which uses a multiple derived from market data of comparable companies or assets to produce operating performance metrics. Alternative valuation methodologies may be employed for investments with unusual characteristics.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_7636"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><ix:continuation id="f-1841-4" continuedAt="f-1841-5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Reinsurance</span></ix:continuation></div><ix:continuation id="f-1841-5" continuedAt="f-1841-6"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases retrocession and reinsurance to limit the Company&#8217;s risk exposure and to increase its own insurance and reinsurance underwriting capacity. These agreements provide for recovery of losses and loss adjustment expenses from reinsurers. The Company remains liable to the extent that reinsurers do not meet their obligations under these agreements. In line with its risk management objectives, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1841-6"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balances pertaining to reinsurance transactions are reported &#8220;gross&#8221; on the consolidated balance sheet, meaning that reinsurance recoverable on unpaid losses and ceded unearned premiums are not deducted from insurance reserves but are recorded as assets. For more information on reinsurance recoverables, refer to Note 13, &#8220;Concentrations of Credit Risk &#8212;Reinsurance recoverables&#8221; and Note 8, &#8220;Reserves for Losses and Loss Adjustment Expenses&#8221; of these unaudited condensed consolidated financial statements.</span></div><ix:continuation id="f-1842-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of ceded reinsurance on premiums written, premiums earned and insurance losses and loss adjustment expenses for the six months ended June&#160;30, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums written:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DirectPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-5463">1,249.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DirectPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-5464">1,305.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AssumedPremiumsWritten" scale="6" id="f-5465">875.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:AssumedPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="f-5466">1,045.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CededPremiumsWritten" scale="6" id="f-5467">774.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:CededPremiumsWritten" scale="6" id="f-5468">845.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums written</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-5469">1,350.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PremiumsWrittenNet" format="ixt:num-dot-decimal" scale="6" id="f-5470">1,506.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums earned:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-5471">1,203.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="f-5472">1,171.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AssumedPremiumsEarned" scale="6" id="f-5473">755.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:AssumedPremiumsEarned" scale="6" id="f-5474">776.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CededPremiumsEarned" scale="6" id="f-5475">671.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:CededPremiumsEarned" scale="6" id="f-5476">621.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums earned</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-5477">1,287.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="f-5478">1,327.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance losses and loss adjustment expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" scale="6" id="f-5479">691.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" scale="6" id="f-5480">719.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="f-5481">353.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="f-5482">402.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="f-5483">328.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="f-5484">353.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net insurance losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-5485">717.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="f-5486">767.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7648"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><ix:continuation id="f-1889-4" continuedAt="f-1889-5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Derivative Contracts</span></ix:continuation></div><ix:continuation id="f-1890-2" continuedAt="f-1890-3"><ix:continuation id="f-1889-5" continuedAt="f-1889-6"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information on the location and amounts of derivative fair values on the consolidated balance sheet as at June&#160;30, 2023 and December 31, 2022: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging<br/>Instruments<br/>Under ASC&#160;815</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1580" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-5487">670.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1580" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5488">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-640" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-5489">945.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-640" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5490">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1581" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-5491">1,213.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1581" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5492">13.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-642" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-5493">729.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-642" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5494">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Portfolio Transfer Liability - Embedded Derivative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1582" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-5495">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1582" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5496">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-644" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-5497">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-644" decimals="-5" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5498">31.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Fair value is net of $<ix:nonFraction unitRef="usd" contextRef="c-1583" decimals="-5" name="us-gaap:CollateralAlreadyPostedAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5499">2.7</ix:nonFraction> million of cash collateral (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-646" decimals="-5" name="us-gaap:CollateralAlreadyPostedAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="f-5500">3.7</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The LPT contains an embedded derivative within the contract in relation to the variable interest crediting rate. </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1889-6" continuedAt="f-1889-7"><ix:continuation id="f-1890-3"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging<br/>Instruments Under ASC&#160;815</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1584" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-5501">54.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1584" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5502">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-5503">109.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-5" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="f-5504">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><ix:continuation id="f-1913-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the unrealized and realized gains/(losses) recorded in the consolidated statements of operations and other comprehensive income for derivatives that are not designated or designated as hedging instruments under ASC 815 &#8212; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for the six months ended June&#160;30, 2023 and 2022: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)<br/>Recognized on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Fair Value of Derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1585" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-5505">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1586" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-5506">84.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses in consolidated statement of operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1587" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="f-5507">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1588" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="f-5508">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions in other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1589" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="f-5509">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1590" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" scale="6" id="f-5510">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The Company uses foreign exchange contracts to manage foreign currency risk associated with our operating expenses but also foreign exchange risk associated with net assets or liabilities in currencies other than the U.S. dollar. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of the Company&#8217;s assets and liabilities denominated in foreign currencies but rather allow it to establish a rate of exchange for a future point in time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company held foreign exchange contracts that were not designated as hedges under ASC 815 with an aggregate nominal amount of $<ix:nonFraction unitRef="usd" contextRef="c-1583" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-5511">1,884.0</ix:nonFraction> million (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-646" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-5512">1,675.3</ix:nonFraction> million). The foreign exchange contracts are recorded as derivative assets or derivative liabilities in the consolidated balance sheet with changes recorded as a change in fair value of derivatives in the consolidated statement of operations. For the six months ended June&#160;30, 2023, the impact of foreign exchange contracts on net income was a gain of $<ix:nonFraction unitRef="usd" contextRef="c-1585" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="f-5513">19.6</ix:nonFraction> million (June&#160;30, 2022&#160;&#8212; loss of $<ix:nonFraction unitRef="usd" contextRef="c-1586" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="f-5514">84.9</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company held foreign exchange contracts that were designated as hedges under ASC 815 with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="c-1584" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-5515">54.7</ix:nonFraction> million (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-648" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-5516">109.7</ix:nonFraction>&#160;million). The foreign exchange contracts are recorded as derivative assets in the consolidated balance sheet with the effective portion recorded in other comprehensive income and the ineffective portion recorded as a change in fair value of derivatives in the consolidated statement of operations. The contracts are effective and therefore the movement in other comprehensive income representing the effective portion for the six months ended June&#160;30, 2023 was a loss of $<ix:nonFraction unitRef="usd" contextRef="c-1589" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-5517">4.3</ix:nonFraction> million (June&#160;30, 2022&#160;&#8212; loss of $<ix:nonFraction unitRef="usd" contextRef="c-1590" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-5518">6.4</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the foreign exchange contracts settle, the realized gain or loss is reclassified from other comprehensive income into general, administration and corporate expenses of the consolidated statement of operations. For the six months ended June&#160;30, 2023, the amount recognized within general, administration and corporate expenses for settled foreign exchange contracts was a realized loss of $<ix:nonFraction unitRef="usd" contextRef="c-1587" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-5519">3.7</ix:nonFraction> million (June&#160;30, 2022 &#8212; gain of $<ix:nonFraction unitRef="usd" contextRef="c-1588" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" format="ixt:num-dot-decimal" scale="6" id="f-5520">2.8</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded derivative on loss portfolio contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The loss portfolio transfer contract includes a funds withheld arrangement that provides returns to the reinsurer based on Aspen&#8217;s investment performance, guaranteeing a minimum of <ix:nonFraction unitRef="number" contextRef="c-639" decimals="INF" name="ahl:ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" scale="-2" id="f-5521">1.75</ix:nonFraction>% return. Such funds withheld arrangements are examples of embedded derivatives and therefore this instrument is accounted for as an option-based derivative. For the six months ended June&#160;30, 2023, the amount </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1889-7"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized as a change in fair value of derivatives in the consolidated statement of operations is $<ix:nonFraction unitRef="usd" contextRef="c-1554" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="6" id="f-5522">8.3</ix:nonFraction> million (June&#160;30, 2022 &#8212;  $<ix:nonFraction unitRef="usd" contextRef="c-1591" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="f-5523">Nil</ix:nonFraction>).</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_7672"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><ix:continuation id="f-1942-14" continuedAt="f-1942-15"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Reserves for Losses and Loss Adjustment Expenses</span></ix:continuation></div><ix:continuation id="f-1942-15"><ix:continuation id="f-1943-3" continuedAt="f-1943-4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of beginning and ending consolidated loss and LAE reserves for the six months at June&#160;30, 2023 and June 30, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the start of the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5524">7,710.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5525">7,611.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ReinsuranceRecoverablesAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-5526">4,897.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="ahl:ReinsuranceRecoverablesAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-5527">3,298.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE at the start of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-5528">2,813.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-5529">4,313.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE expenses transferred </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" format="ixt:fixed-zero" scale="6" id="f-5530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" format="ixt:num-dot-decimal" scale="6" id="f-5531">1,840.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in net provision for losses and LAE for claims incurred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-5532">723.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-5533">775.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-5534">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-5535">7.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="f-5536">717.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="f-5537">767.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Losses and LAE payments for claims incurred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="f-5538">30.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="f-5539">35.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="f-5540">438.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="f-5541">616.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="f-5542">469.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="f-5543">652.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" scale="6" id="f-5544">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" scale="6" id="f-5545">83.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses and LAE reserves at the end of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-5546">3,082.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1300" decimals="-5" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-5547">2,505.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus reinsurance recoverable on unpaid losses at the end of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-5548">4,658.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1300" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-5549">5,006.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5550">7,740.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1300" decimals="-5" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5551">7,511.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div></ix:continuation><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-1943-4" continuedAt="f-1943-5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="f-1943-5">Net loss and LAE expenses transferred of $<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="ahl:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" format="ixt:num-dot-decimal" scale="6" id="f-5552">1,840.1</ix:nonFraction>&#160;million relates to the LPT with Enstar and represents the net loss reserves as at May 20, 2022 (&#8220;Closing Date&#8221;) for losses in relation to 2019 and prior accident years, in addition to the $<ix:nonFraction unitRef="usd" contextRef="c-638" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-5553">770.0</ix:nonFraction> million of ceded reserves under the previous ADC agreement, recognizing a total recoverable of $<ix:nonFraction unitRef="usd" contextRef="c-658" decimals="-5" name="ahl:ReinsuranceRecoverablesTotalRecoverable" format="ixt:num-dot-decimal" scale="6" id="f-5554">2,610.1</ix:nonFraction>&#160;million. These reserves were rolled forward from the initial effective date of September 30, 2021, at which time the net losses reserves were $<ix:nonFraction unitRef="usd" contextRef="c-1592" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-5555">3,120.0</ix:nonFraction> million.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023 the total amount recoverable from Enstar under the LPT was $<ix:nonFraction unitRef="usd" contextRef="c-1593" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-5556">1,877.3</ix:nonFraction>&#160;million (As at December 31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-659" decimals="-5" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-5557">2,132.0</ix:nonFraction>&#160;million) which includes claims paid and reserve development since the Closing Date. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023, there was a reduction of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5558">6.4</ix:nonFraction> million in the Company&#8217;s estimate of the ultimate claims to be paid in respect of prior accident years compared to a reduction of $<ix:nonFraction unitRef="usd" contextRef="c-1263" decimals="-5" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5559">7.3</ix:nonFraction> million for the six months ended June&#160;30, 2022.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Net unfavorable reserve development of $<ix:nonFraction unitRef="usd" contextRef="c-1305" decimals="-5" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5560">2.1</ix:nonFraction> million in the six months ended June&#160;30, 2023 were mainly due to reserve strengthening in property catastrophe and reinsurance lines of business, offset by reserve releases from casualty reinsurance and specialty reinsurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Net reserve releases of $<ix:nonFraction unitRef="usd" contextRef="c-1306" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5561">8.5</ix:nonFraction> million in the six months ended June&#160;30, 2023 included favorable development of $<ix:nonFraction unitRef="usd" contextRef="c-1594" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5562">13.2</ix:nonFraction> million representing the movement on the deferred gain on the LPT, offset by unfavorable development on post-LPT years of $<ix:nonFraction unitRef="usd" contextRef="c-1595" decimals="-5" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-5563">4.7</ix:nonFraction> million.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-117</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7768"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><ix:continuation id="f-3204-3" continuedAt="f-3204-4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Capital Structure</span></ix:continuation></div><ix:continuation id="f-3204-4" continuedAt="f-3204-5"><ix:continuation id="f-3205-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company&#8217;s authorized and issued share capital as at June&#160;30, 2023 and December 31, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in<br/>Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in<br/>Thousands</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized share capital:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares $<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5564"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5565">0.01</ix:nonFraction></ix:nonFraction> per share (2022 &#8212; $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5566">0.01</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-5567">70,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="ahl:CommonStockValueAuthorized" scale="3" id="f-5568">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-5569">70,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ahl:CommonStockValueAuthorized" scale="3" id="f-5570">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference Shares&#160;<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-5571">0.15144558</ix:nonFraction>&#162; per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-5572">30,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="ahl:PreferredStockValueAuthorized" scale="3" id="f-5573">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-5574">30,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ahl:PreferredStockValueAuthorized" scale="3" id="f-5575">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total authorized share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="ahl:AuthorizedShareCapital" scale="3" id="f-5576">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ahl:AuthorizedShareCapital" scale="3" id="f-5577">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued share capital:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued ordinary shares $<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5578"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5579">0.01</ix:nonFraction></ix:nonFraction> per share (2022 &#8212; $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5580">0.01</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5581"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5582">60,395,839</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-5583">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5584">60,395,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-5585">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued <ix:nonFraction unitRef="number" contextRef="c-1596" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5586"><ix:nonFraction unitRef="number" contextRef="c-1596" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5587">5.950</ix:nonFraction></ix:nonFraction>% preference shares of <ix:nonFraction unitRef="usdPerShare" contextRef="c-1597" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-5588"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1597" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-5589">0.15144558</ix:nonFraction></ix:nonFraction>&#162; each with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1598" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5590"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1598" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5591">25</ix:nonFraction></ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1597" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5592">11,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1597" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" scale="3" id="f-5593">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1096" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5594">11,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1096" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" scale="3" id="f-5595">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued <ix:nonFraction unitRef="number" contextRef="c-1599" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5596"><ix:nonFraction unitRef="number" contextRef="c-1599" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5597">5.625</ix:nonFraction></ix:nonFraction>% preference shares of <ix:nonFraction unitRef="usdPerShare" contextRef="c-1598" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-5598"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1598" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-5599">0.15144558</ix:nonFraction></ix:nonFraction>&#162; each with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1598" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5600"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1598" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5601">25</ix:nonFraction></ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1598" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5602">10,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1598" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" scale="3" id="f-5603">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1098" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5604">10,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1098" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" scale="3" id="f-5605">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued <ix:nonFraction unitRef="number" contextRef="c-1600" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5606"><ix:nonFraction unitRef="number" contextRef="c-1600" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5607">5.625</ix:nonFraction></ix:nonFraction>% preference shares of <ix:nonFraction unitRef="usdPerShare" contextRef="c-1601" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-5608"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1601" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-5609">0.15144558</ix:nonFraction></ix:nonFraction>&#162; represented by depositary shares, each with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1601" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5610"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1601" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5611">25</ix:nonFraction></ix:nonFraction> per share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1601" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-5612">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1601" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" format="ixt:fixed-zero" scale="3" id="f-5613">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1104" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-5614">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1104" decimals="-3" name="us-gaap:PreferredStockSharesSubscribedButUnissuedValue" format="ixt:fixed-zero" scale="3" id="f-5615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total issued share capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="ahl:IssuedShareCapital" scale="3" id="f-5616">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ahl:IssuedShareCapital" scale="3" id="f-5617">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Each depositary share represents a 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in a share of the <ix:nonFraction unitRef="number" contextRef="c-1600" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5618"><ix:nonFraction unitRef="number" contextRef="c-1600" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5619">5.625</ix:nonFraction></ix:nonFraction>% preference shares.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Ordinary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issued Ordinary Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s issued ordinary shares of par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5620"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-5621">0.01</ix:nonFraction></ix:nonFraction> at both June&#160;30, 2023 and December&#160;31, 2022 was <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5622"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5623">60,395,839</ix:nonFraction></ix:nonFraction>. The Company did not acquire any ordinary shares for the six months ended June&#160;30, 2023.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Preference Shares&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preference Shares Issuance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On May 2, 2013, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-1106" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5624">11,000,000</ix:nonFraction> <ix:nonFraction unitRef="number" contextRef="c-1596" decimals="5" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5625">5.950</ix:nonFraction>% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1106" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5626">25</ix:nonFraction> per share (the &#8220;<ix:nonFraction unitRef="number" contextRef="c-1596" decimals="5" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5627">5.950</ix:nonFraction>% Preference Shares&#8221;). Net proceeds were $<ix:nonFraction unitRef="usd" contextRef="c-1107" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-5628">270.6</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="c-1106" decimals="-5" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="6" id="f-5629">275.0</ix:nonFraction> million of total liquidation preference less $<ix:nonFraction unitRef="usd" contextRef="c-1107" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-5630">4.4</ix:nonFraction> million of issuance expenses. The first floating rate-period commenced on July 1, 2023 (payable on October 1, 2023), where the floating rate was tied to <ix:nonNumeric contextRef="c-1602" name="ahl:PreferredStockLiquidationPreferenceValueFixedForFloatingRate" id="f-5631">LIBOR</ix:nonNumeric>, being 3-month LIBOR, and as contemplated by the governing instrument, 3-month LIBOR was the rate for 3-month deposits in U.S. dollars on June 29, 2023. The <ix:nonFraction unitRef="number" contextRef="c-1596" decimals="5" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5632">5.950</ix:nonFraction>% Preference Shares are listed on the NYSE under symbol &#8220;AHLPRC&#8221;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2016, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-1109" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5633">10,000,000</ix:nonFraction> shares of <ix:nonFraction unitRef="number" contextRef="c-1108" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5634">5.625</ix:nonFraction>% Perpetual Non-Cumulative Preference Shares (the &#8220;<ix:nonFraction unitRef="number" contextRef="c-1108" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5635">5.625</ix:nonFraction>% Preference Shares&#8221;). The <ix:nonFraction unitRef="number" contextRef="c-1108" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5636">5.625</ix:nonFraction>% Preference Shares have a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1109" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5637">25</ix:nonFraction> per share. Net proceeds were $<ix:nonFraction unitRef="usd" contextRef="c-1108" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-5638">241.3</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="c-1109" decimals="-5" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="6" id="f-5639">250.0</ix:nonFraction> million of total liquidation preference less $<ix:nonFraction unitRef="usd" contextRef="c-1108" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-5640">8.7</ix:nonFraction> million of issuance expenses. The <ix:nonFraction unitRef="number" contextRef="c-1108" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5641">5.625</ix:nonFraction>% Preference Shares are listed on the NYSE under the symbol &#8220;AHL PRD&#8221;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-1112" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-5642">10,000,000</ix:nonFraction> depositary shares, each of which represents 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> interest in a share of the newly designated <ix:nonFraction unitRef="number" contextRef="c-1113" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5643">5.625</ix:nonFraction>% Perpetual Non-Cumulative Preference Shares. The depositary </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-3204-5"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares have a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1112" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-5644">25</ix:nonFraction> per share. Net proceeds were $<ix:nonFraction unitRef="usd" contextRef="c-1114" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-5645">241.6</ix:nonFraction> million, comprising $<ix:nonFraction unitRef="usd" contextRef="c-1115" decimals="-5" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="6" id="f-5646">250.0</ix:nonFraction> million of total liquidation preference less $<ix:nonFraction unitRef="usd" contextRef="c-1113" decimals="-5" name="ahl:PreferredStockIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="f-5647">8.4</ix:nonFraction> million of issuance expenses. The depositary shares are listed on the NYSE under the symbol &#8220;AHL PRE&#8221;.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_7804"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><ix:continuation id="f-3314-2" continuedAt="f-3314-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Dividends</span></ix:continuation></div><ix:continuation id="f-3315-1"><ix:continuation id="f-3314-3" continuedAt="f-3314-4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;On June 1, 2023, the Company&#8217;s Board of Directors declared the following dividends:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payable&#160;on:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record&#160;Date:</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1603" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5648">5.950</ix:nonFraction>% Preference Shares (AHL PRC)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1604" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-5649">0.3719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1605" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-5650">July 1, 2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1603" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-5651">June 15, 2023</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1606" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5652">5.625</ix:nonFraction>% Preference Shares (AHL PRD)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1607" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-5653">0.3516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1608" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-5654">July 1, 2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1606" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-5655">June 15, 2023</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1609" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5656">5.625</ix:nonFraction>% Preference Shares, represented by depositary shares (AHL PRE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1610" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-5657">351.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1611" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-5658">July 1, 2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1609" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="f-5659">June 15, 2023</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The <ix:nonFraction unitRef="number" contextRef="c-1609" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5660">5.625</ix:nonFraction>% Preference Shares are represented by depositary shares, each representing a 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in a share of the <ix:nonFraction unitRef="number" contextRef="c-1609" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="f-5661">5.625</ix:nonFraction>% Preference Shares.&#160;The dividend paid per depositary share is likewise 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of the declared dividend, equivalent to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1610" decimals="INF" name="ahl:DepositaryShareDividend" scale="0" id="f-5662">0.35156</ix:nonFraction> per depositary share.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-3314-4">In the six months ended June&#160;30, 2023, the Company paid an ordinary shares dividend of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" format="ixt:num-dot-decimal" scale="6" id="f-5663">20.0</ix:nonFraction>&#160;million to Highlands Bermuda Holdco, Ltd., the holder of all the Company&#8217;s ordinary shares.</ix:continuation> </span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7877"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><ix:continuation id="f-3439-5" continuedAt="f-3439-6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Related Party Transactions</span></ix:continuation></div><ix:continuation id="f-3439-6" continuedAt="f-3439-7"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo&#8217;s indirect subsidiary, Apollo Asset Management Europe PC LLP (&#8220;AAME&#8221;), serves as the investment manager for the Company and certain of the Company&#8217;s subsidiaries, and Apollo&#8217;s indirect subsidiary, Apollo Management Holdings, L.P. (&#8220;AMH&#8221;), provides the Company with management consulting services and advisory services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain employees of Apollo and its affiliates serve on the Board. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of relationships and transactions that have existed or that the Company and certain of the Company&#8217;s subsidiaries has entered into with Apollo and its affiliates are described below. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Management Relationships</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAME provides centralized asset management investment advisory and risk services for the portfolio of the Company&#8217;s investments and investments of such subsidiaries pursuant to the investment management agreements (&#8220;IMAs&#8221;) that have been entered into with AAME. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the IMAs, AAME may engage sub-advisors or delegates to provide certain of the investment advisory and management services to the Company&#8217;s subsidiaries. Such sub-advisors may include affiliates of AAME.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under each of the IMAs, AAME will be paid an annual investment management fee (the &#8220;Management Fee&#8221;) which will be based on a cost-plus structure up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="ahl:RelatedPartyTransactionRateofInterest" scale="-2" id="f-5664">25</ix:nonFraction>% based on an applicable transfer pricing study. The Management Fee will be subject to certain maximum threshold levels, including an annual fee cap of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="ahl:RelatedPartyTransactionMaximumRateIncrease" scale="-2" id="f-5665">15</ix:nonFraction> bps of the total amount of investable assets. Affiliated sub-advisors, including AMI and AMC, will also earn additional fees for sub-advisory services rendered. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, the Company recognized IMA fees of $<ix:nonFraction unitRef="usd" contextRef="c-1268" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5666">5.2</ix:nonFraction> million (June&#160;30, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1269" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5667">0.6</ix:nonFraction> million), of which $<ix:nonFraction unitRef="usd" contextRef="c-1261" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-5668">2.4</ix:nonFraction> million (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-5669">4.5</ix:nonFraction>&#160;million) remains payable to AAME as at June&#160;30, 2023.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management Consulting Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Company entered into a Management Consulting Agreement, dated March 28, 2019 (the &#8220;Management Consulting Agreement&#8221;), with AMH. Pursuant to the Management Consulting Agreement, </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-3439-7"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMH will provide the Company management consulting and advisory services related to the business and affairs of the Company and its subsidiaries. The Company will pay AMH in consideration for its services under the Management Consulting Agreement, an annual management consulting fee equal to the greater of (i) <ix:nonFraction unitRef="number" contextRef="c-1612" decimals="2" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="f-5670">1</ix:nonFraction>% of the consolidated net income of the Company and its subsidiaries for the applicable fiscal year, or (ii) $<ix:nonFraction unitRef="usd" contextRef="c-1613" decimals="-6" name="us-gaap:DueFromOfficersOrStockholdersCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5671">5</ix:nonFraction> million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, the Company recognized Management Consulting fees of $<ix:nonFraction unitRef="usd" contextRef="c-1270" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5672">2.5</ix:nonFraction> million (June&#160;30, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1271" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5673">2.5</ix:nonFraction>&#160;million), of which $<ix:nonFraction unitRef="usd" contextRef="c-1262" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-5674">2.5</ix:nonFraction> million remains payable to AMH as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-5675">1.3</ix:nonFraction>&#160;million).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Investments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, the Company bought or held the following securities or investments in Apollo originated and managed investments:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apollo U.S. Real Estate Fund II LP.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As at June&#160;30, 2023, the Company&#8217;s investment in Apollo U.S. Real Estate Fund II LP had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-1260" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-5676">22.9</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-5677">25.3</ix:nonFraction>&#160;million). This investment is included in other investments on the consolidated balance sheet. The Company incurred losses of $<ix:nonFraction unitRef="usd" contextRef="c-1614" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5678">1.3</ix:nonFraction> million (June&#160;30, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1615" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:fixed-zero" scale="6" id="f-5679">Nil</ix:nonFraction>) and is included in net investment income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apollo Origination Partnership (&#8220;AOP&#8221;) Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As at June&#160;30, 2023, the Company&#8217;s investment in the AOP Fund had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-1259" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-5680">12.6</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212;$<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:OtherInvestments" format="ixt:num-dot-decimal" scale="6" id="f-5681">12.7</ix:nonFraction>&#160;million). This investment is included in other investments on the consolidated balance sheet. The Company incurred losses of $<ix:nonFraction unitRef="usd" contextRef="c-1616" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5682">0.4</ix:nonFraction> million (June&#160;30, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1617" decimals="-5" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5683">0.2</ix:nonFraction> million) and is included in net investments income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOP Class A notes; AOP Class B notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As at June&#160;30, 2023, the Company&#8217;s investment in AOP Class A notes had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-1618" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-5684">28.6</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212;$<ix:nonFraction unitRef="usd" contextRef="c-1161" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-5685">30.0</ix:nonFraction>&#160;million). As at June&#160;30, 2023, the Company&#8217;s investment in AOP Class B notes had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-1619" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-5686">14.0</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212;$<ix:nonFraction unitRef="usd" contextRef="c-1162" decimals="-5" name="ahl:PrivatelyheldInvestments" format="ixt:num-dot-decimal" scale="6" id="f-5687">14.8</ix:nonFraction>&#160;million). The Company earned income of $<ix:nonFraction unitRef="usd" contextRef="c-1620" decimals="-5" name="ahl:PrivatelyHeldInvestmentLossesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-5688">1.3</ix:nonFraction>&#160;million (June&#160;30, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1621" decimals="-5" name="ahl:PrivatelyHeldInvestmentLossesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-5689">0.5</ix:nonFraction> million) and $<ix:nonFraction unitRef="usd" contextRef="c-1622" decimals="-5" name="ahl:PrivatelyHeldInvestmentLossesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-5690">0.7</ix:nonFraction>&#160;million (June&#160;30, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1623" decimals="-5" name="ahl:PrivatelyHeldInvestmentLossesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-5691">0.3</ix:nonFraction> million) on AOP Class A and B notes, respectively, and is included in realized and unrealized investment losses on the consolidated statement of operations and other comprehensive income. These investments are included in privately-held investments on the consolidated balance sheet.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, there were no expenses incurred relating to any of these investments (June&#160;30, 2022&#160;&#8212; $Nil). The above transactions were entered into at arm&#8217;s length.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Payables to Related Parties</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company had an intercompany payable balance of $<ix:nonFraction unitRef="usd" contextRef="c-1624" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5692">2.2</ix:nonFraction>&#160;million (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1166" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5693">2.0</ix:nonFraction>&#160;million), due to its parent, Highlands Bermuda Holdco, Ltd.</span></div></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_7889"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><ix:continuation id="f-3465-4" continuedAt="f-3465-5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Commitments and Contingent Liabilities</span></ix:continuation></div><ix:continuation id="f-3465-5" continuedAt="f-3465-6"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Restricted assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s subsidiaries are obliged by the terms of its contractual obligations to U.S.&#160;policyholders and by obligations to certain regulatory authorities to facilitate issue of letters of credit or maintain certain balances in trust funds for the benefit of policyholders.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-3465-6" continuedAt="f-3465-7"><ix:continuation id="f-3466-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the forms and value of Company&#8217;s material restricted assets as at June&#160;30, 2023 and December 31, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory trusts and deposits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated transactions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1625" decimals="-5" name="ahl:RestrictedAssets" scale="6" id="f-5694">617.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1168" decimals="-5" name="ahl:RestrictedAssets" scale="6" id="f-5695">707.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1626" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-5696">2,773.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1170" decimals="-5" name="ahl:RestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-5697">2,817.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit / guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:RestrictedAssets" scale="6" id="f-5698">266.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:RestrictedAssets" scale="6" id="f-5699">471.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets (excluding illiquid assets)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:RestrictedAssetsExcludingIlliquidAssets" format="ixt:num-dot-decimal" scale="6" id="f-5700">3,657.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:RestrictedAssetsExcludingIlliquidAssets" format="ixt:num-dot-decimal" scale="6" id="f-5701">3,996.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments &#8212; illiquid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1627" decimals="-5" name="us-gaap:OtherInvestments" scale="6" id="f-5702">213.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1172" decimals="-5" name="us-gaap:OtherInvestments" scale="6" id="f-5703">221.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets and illiquid assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:TotalRestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-5704">3,870.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:TotalRestrictedAssets" format="ixt:num-dot-decimal" scale="6" id="f-5705">4,217.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total as percent of cash and investable assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="ahl:CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" scale="-2" id="f-5706">52.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="ahl:CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" scale="-2" id="f-5707">59.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As at June&#160;30, 2023, the Company had pledged funds as collateral for the secured letters of credit of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-5708">266.5</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-5709">471.3</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Investable assets comprise total investments, cash and cash equivalents, accrued interest, receivables for securities sold and payables for securities purchased.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s banking arrangements related to letters of credit, require the Company to provide collateral in the form of cash and securities for the full amount of all secured and undrawn letters of credit that are outstanding. The Company monitors the proportion of liquid assets that are committed to trust funds or to the collateralization of letters of credit. As at June&#160;30, 2023 and December&#160;31, 2022, these funds amounted to approximately <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="ahl:CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" scale="-2" id="f-5710">52.6</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-8" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="9" id="f-5711">7.4</ix:nonFraction> billion and approximately <ix:nonFraction unitRef="number" contextRef="c-19" decimals="3" name="ahl:CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" scale="-2" id="f-5712">59.4</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-8" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="9" id="f-5713">7.1</ix:nonFraction> billion of investable assets held by the Company, respectively. We do not consider that this unduly restricts our liquidity at this time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Funds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company invests in real estate funds which have lock-up periods, being the initial amount of time an investor is contractually required to remain invested before having the ability to redeem. As at June&#160;30, 2023, the lock-up periods across these funds range from one quarter to several years. Thereafter these funds may be redeemed on a pro-rata basis depending on the liquidity position of the fund. There are no assurances as to when the Company may receive, in whole or in part, its redemption request from the fund.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Funds at Lloyd&#8217;s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AUL operates at Lloyd&#8217;s as the corporate member for Syndicate 4711. AUL also participates in underwriting activities of Carbon Syndicate 4747. Lloyd&#8217;s determines required regulatory capital by considering the underwriting activities of AUL, called Funds at Lloyd&#8217;s and consists of investable assets as at June&#160;30, 2023 in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AssetsHeldByInsuranceRegulators" format="ixt:num-dot-decimal" scale="6" id="f-5714">551.0</ix:nonFraction> million (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AssetsHeldByInsuranceRegulators" format="ixt:num-dot-decimal" scale="6" id="f-5715">489.5</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Funds at Lloyd&#8217;s will be drawn upon and become a liability of the Company in the event of Syndicate 4711 declaring a loss at a level that cannot be funded from other resources, or if Syndicate 4711 requires funds to cover a short-term liquidity gap. The amount which the Company provides as Funds at Lloyd&#8217;s is not available for distribution to the Company for the payment of dividends. Aspen Managing Agency Limited, the managing agent to Syndicate 4711, is also required by Lloyd&#8217;s to maintain a minimum level of capital which as at June&#160;30, 2023 was &#163;<ix:nonFraction unitRef="gbp" contextRef="c-11" decimals="-5" name="srt:MinimumNetCapitalRequired1" format="ixt:num-dot-decimal" scale="6" id="f-5716">0.4</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; &#163;<ix:nonFraction unitRef="gbp" contextRef="c-12" decimals="-5" name="srt:MinimumNetCapitalRequired1" format="ixt:num-dot-decimal" scale="6" id="f-5717">0.4</ix:nonFraction> million). This is not available for distribution by the Company for the payment of dividends.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Reinsurance Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;For its U.S.&#160;reinsurance activities, Aspen UK has established and must retain a multi-beneficiary U.S.&#160;trust fund for the benefit of its U.S.&#160;cedants so that they may take financial statement credit without the need to post cedant-specific security. The minimum trust fund amount is $<ix:nonFraction unitRef="usd" contextRef="c-1628" decimals="-5" name="ahl:MinimumTrustFund" format="ixt:num-dot-decimal" scale="6" id="f-5718">20.0</ix:nonFraction> million plus an amount equal to <ix:nonFraction unitRef="number" contextRef="c-11" decimals="INF" name="ahl:PercentageOfReinsuranceLiabilities" scale="-2" id="f-5719">100</ix:nonFraction>% of Aspen UK&#8217;s U.S.&#160;reinsurance liabilities, which were $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:ReinsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5720">1,009.3</ix:nonFraction> million as at June&#160;30, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:ReinsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5721">1,166.4</ix:nonFraction> million as at December&#160;31, 2022. As at June&#160;30, 2023, the balance (including applicable letter of credit facilities) held in the trust was $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5722">1,167.8</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5723">1,389.5</ix:nonFraction> million). </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-3465-7"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda has also established and must retain a multi-beneficiary U.S.&#160;trust fund for the benefit of its U.S.&#160;cedants so that they may take financial statement credit without the need to post cedant-specific security. The minimum trust fund amount is $<ix:nonFraction unitRef="usd" contextRef="c-1628" decimals="-5" name="ahl:MinimumTrustFund" format="ixt:num-dot-decimal" scale="6" id="f-5724">20.0</ix:nonFraction>&#160;million plus an amount equal to <ix:nonFraction unitRef="number" contextRef="c-1629" decimals="INF" name="ahl:PercentageOfReinsuranceLiabilities" scale="-2" id="f-5725">100</ix:nonFraction>% of Aspen Bermuda&#8217;s liabilities to its U.S. cedants which was $<ix:nonFraction unitRef="usd" contextRef="c-1629" decimals="-5" name="ahl:ReinsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5726">306.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1175" decimals="-5" name="ahl:ReinsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-5727">380.3</ix:nonFraction> million as at June&#160;30, 2023 and December&#160;31, 2022, respectively. As at June&#160;30, 2023, the balance held in the U.S. trust fund and other Aspen Bermuda trusts was $<ix:nonFraction unitRef="usd" contextRef="c-1628" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5728">383.2</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1174" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5729">509.2</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Surplus Lines Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK and Syndicate 4711 have also established a U.S.&#160;surplus lines trust fund with a U.S.&#160;bank to secure liabilities under U.S.&#160;surplus lines policies. The balance held in trust as at June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-1630" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5730">141.0</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-1178" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5731">215.1</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Regulatory Deposits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As at June&#160;30, 2023, Aspen Specialty had a total of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:RegulatoryDeposits" format="ixt:num-dot-decimal" scale="6" id="f-5732">10.3</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:RegulatoryDeposits" format="ixt:num-dot-decimal" scale="6" id="f-5733">6.7</ix:nonFraction> million) on deposit with six U.S.&#160;states in order to satisfy state regulations for writing business in those states. AAIC had a further $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="ahl:DepositWithStates" format="ixt:num-dot-decimal" scale="6" id="f-5734">6.7</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="ahl:DepositWithStates" format="ixt:num-dot-decimal" scale="6" id="f-5735">6.5</ix:nonFraction> million) on deposit with twelve U.S.&#160;states. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a Canadian trust fund with a Canadian bank to secure a Canadian insurance license. As at June&#160;30, 2023, the balance held in trust was CAD$<ix:nonFraction unitRef="cad" contextRef="c-1631" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5736">200.9</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1631" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5737">151.8</ix:nonFraction> million) (December&#160;31, 2022&#160;&#8212; CAD$<ix:nonFraction unitRef="cad" contextRef="c-1180" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5738">185.8</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Australian Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established an Australian trust fund with an Australian bank to secure policyholder liabilities and as a condition for maintaining an Australian insurance license. As at June&#160;30, 2023, the balance held in trust was AUD$<ix:nonFraction unitRef="aud" contextRef="c-1632" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5739">153.2</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1632" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5740">102.0</ix:nonFraction> million) (December&#160;31, 2022&#160;&#8212; AUD$<ix:nonFraction unitRef="aud" contextRef="c-1182" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5741">183.9</ix:nonFraction> million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Swiss Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a Swiss trust fund with a Swiss bank to secure policyholder liabilities and as a condition for maintaining a Swiss insurance license. As at June&#160;30, 2023, the balance held in trust was CHF$<ix:nonFraction unitRef="chf" contextRef="c-1633" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5742">9.5</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1633" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5743">10.6</ix:nonFraction> million) (December&#160;31, 2022 &#8212; CHF<ix:nonFraction unitRef="chf" contextRef="c-1184" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5744">9.4</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Singapore Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a segregated Singaporean bank account to secure policyholder liabilities and as a condition for maintaining a Singaporean insurance license and meet local solvency requirements. As at June&#160;30, 2023, the balance in the account was SGD$<ix:nonFraction unitRef="sgd" contextRef="c-1634" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5745">172.6</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="c-1634" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5746">127.5</ix:nonFraction> million) (December&#160;31, 2022&#160;&#8212; SGD$<ix:nonFraction unitRef="sgd" contextRef="c-1186" decimals="-5" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="f-5747">174.7</ix:nonFraction> million). </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Contingent liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In common with the rest of the insurance and reinsurance industry, the Company is also subject to litigation and arbitration in the ordinary course of business. The Company&#8217;s Operating Subsidiaries are regularly engaged in the investigation, conduct and defense of disputes, or potential disputes, resulting from questions of insurance or reinsurance coverage or claims activities. Pursuant to insurance and reinsurance arrangements, many of these disputes are resolved by arbitration or other forms of alternative dispute resolution. Such legal proceedings are considered in connection with estimating the Company&#8217;s Insurance Reserves &#8212; Loss and Loss Adjustment Expenses, as provided on the Company&#8217;s consolidated balance sheet.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some jurisdictions, noticeably the U.S., a failure to deal with such disputes or potential disputes in an appropriate manner could result in an award of &#8220;bad faith&#8221; punitive damages against the Company&#8217;s Operating Subsidiaries. In accordance with ASC 450-20-50-4b, for (a) reasonably possible losses for which no accrual is made because any of the conditions for accrual in ASC 450-20-25-2 are not met and (b) reasonably possible losses in excess of the amounts accrued pursuant to ASC 450-20-30-1, the Company will provide an estimate of the possible loss or range of possible loss or state that such an estimate cannot be made.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, it was the opinion of the Company&#8217;s management based on available information that the probability of the ultimate resolution of pending or threatened litigation or arbitrations having a material effect on the Company&#8217;s financial condition, results of operations or liquidity would be remote.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-122</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7901"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><ix:continuation id="f-3524-3" continuedAt="f-3524-4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Concentrations of Credit Risk </span></ix:continuation></div><ix:continuation id="f-3524-4"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is potentially exposed to concentrations of credit risk in respect of amounts recoverable from reinsurers, investments and cash and cash equivalents, and insurance and reinsurance balances owed by the brokers with whom the Company transacts business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defines credit risk tolerances in line with the risk appetite set by our Board and they, together with the Group&#8217;s risk management function, monitor exposures to individual counterparties. Any exceptions are reported to senior management and the Risk Committee of the Board of Directors. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance recoverables </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2023, the total amount recoverable by the Company from reinsurers was $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-5748">4,658.0</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="f-5749">4,897.7</ix:nonFraction> million). Of the Company&#8217;s reinsurance recoverable balance at June&#160;30, 2023, <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="ahl:ReinsuranceRecoverablesCollateralizedPercent" scale="-2" id="f-5750">56.0</ix:nonFraction>% is collateralized by our reinsurers, <ix:nonFraction unitRef="number" contextRef="c-1635" decimals="INF" name="ahl:ReinsuranceRecoverablesCollateralizedPercent" scale="-2" id="f-5751">43.5</ix:nonFraction>% is recoverable from reinsurers rated A- or higher by major rating agencies and <ix:nonFraction unitRef="number" contextRef="c-1636" decimals="INF" name="ahl:ReinsuranceRecoverablesCollateralizedPercent" scale="-2" id="f-5752">0.5</ix:nonFraction>% is recoverable from reinsurers rated lower than A- by major rating agencies (December&#160;31, 2022 &#8212; <ix:nonFraction unitRef="number" contextRef="c-19" decimals="INF" name="ahl:ReinsuranceRecoverablesCollateralizedPercent" scale="-2" id="f-5753">57.9</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-1637" decimals="INF" name="ahl:ReinsuranceRecoverablesCollateralizedPercent" scale="-2" id="f-5754">42.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-1638" decimals="INF" name="ahl:ReinsuranceRecoverablesCollateralizedPercent" scale="-2" id="f-5755">0.1</ix:nonFraction>%, respectively). As at June&#160;30, 2023, the Company&#8217;s largest collateralized exposures to individual reinsurers represent <ix:nonFraction unitRef="number" contextRef="c-1639" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-5756">16.0</ix:nonFraction>% (December&#160;31, 2022&#160;&#8212;<ix:nonFraction unitRef="number" contextRef="c-1640" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-5757">16.3</ix:nonFraction>%), <ix:nonFraction unitRef="number" contextRef="c-1641" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-5758">9.2</ix:nonFraction>% (December&#160;31, 2022&#160;&#8212; <ix:nonFraction unitRef="number" contextRef="c-1642" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-5759">9.7</ix:nonFraction>%), and <ix:nonFraction unitRef="number" contextRef="c-1643" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-5760">7.8</ix:nonFraction>% (December&#160;31, 2022&#160;&#8212; <ix:nonFraction unitRef="number" contextRef="c-1644" decimals="3" name="ahl:ConcentrationRiskThresholdPercentage" scale="-2" id="f-5761">8.2</ix:nonFraction>%).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the current expected credit loss model (&#8220;CECL&#8221;), the Company recognized a provision against reinsurance recoverables of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" format="ixt:num-dot-decimal" scale="6" id="f-5762">3.3</ix:nonFraction> million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ReinsuranceRecoverablesAllowance" format="ixt:num-dot-decimal" scale="6" id="f-5763">3.7</ix:nonFraction> million). For the six months ended June&#160;30, 2023 there was a decrease in the CECL allowance on reinsurance recoverables of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-5764">0.4</ix:nonFraction> million (December&#160;31, 2022  &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-5765">0.4</ix:nonFraction> million increase).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting premium receivables </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total underwriting premium receivable by the Company as at June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-5766">1,676.8</ix:nonFraction> million (December&#160;31, 2022&#160;&#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-5767">1,482.4</ix:nonFraction> million). As at June&#160;30, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ahl:PremiumsReceivableNonCurrent" format="ixt:num-dot-decimal" scale="6" id="f-5768">5.9</ix:nonFraction> million of the total underwriting premium receivable balance has been due for settlement for more than one year. The Company assesses the recoverability of premium receivables through a review of policies and the concentration of receivables by broker. Allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="f-5769">21.6</ix:nonFraction> million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="f-5770">25.0</ix:nonFraction> million) for underwriting premiums unlikely to be collected. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments and cash and cash equivalents </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment policies include specific provisions that limit the allowable holdings of a single issue and issuer. As at June&#160;30, 2023, there were no investments in any single issuer, other than the U.S.&#160;government and the Canadian government in excess of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="ahl:PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" scale="-2" id="f-5771">2</ix:nonFraction>% of the aggregate investment portfolio.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-123</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_7913"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_46">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><ix:continuation id="f-3565-2" continuedAt="f-3565-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reclassifications from Accumulated Other Comprehensive Income</span></ix:continuation></div><ix:continuation id="f-3566-1"><ix:continuation id="f-3565-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets out the components of the Company&#8217;s AOCI that are reclassified into the condensed consolidated statement of operations for the six months ended June&#160;30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about the AOCI Components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected&#160;Line&#160;Item&#160;in&#160;the&#160;<br/>Consolidated Statement of Operations</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized gains on sale of securities and cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1645" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="6" id="f-5772">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1646" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="6" id="f-5773">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized losses on sale of securities and cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1645" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="f-5774">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1646" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="f-5775">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1645" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-5776">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1646" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-5777">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income/(loss) from operations before income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on net realized gains of securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1645" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-5778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1646" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-5779">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1645" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-5780">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1646" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-5781">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized derivatives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized loss on settled derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1647" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-5782">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1648" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-5783">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on settled derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1647" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-5784">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1648" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-5785">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1647" decimals="-5" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-5786">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1648" decimals="-5" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-5787">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income/(loss)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications from AOCI to the statement of operations, net of income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1649" decimals="-5" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-5788">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1650" decimals="-5" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-5789">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr></table></div></ix:continuation></ix:continuation><div id="i74bc390671ae44c18dcd3f802f6097fb_7942"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><ix:continuation id="f-3648-2" continuedAt="f-3648-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Subsequent Events</span></ix:continuation></div><ix:continuation id="f-3648-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, we entered into a delayed draw term loan facility for $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="ahl:DelayedDrawTermLoanFacility" format="ixt:num-dot-decimal" scale="6" id="f-5790">300</ix:nonFraction>&#160;million, which remains undrawn.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-124</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_421"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:30pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:120%">Ordinary Shares</span></div><div style="margin-bottom:15pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited</span></div><div style="margin-bottom:20pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.378%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:20pt;text-align:center"><img src="ahl-20231220_g1.jpg" alt="aspenlogo.jpg" style="height:96px;margin-bottom:5pt;vertical-align:text-bottom;width:336px"/></div><div style="margin-bottom:24pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.378%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:120%">Goldman Sachs &amp; Co. LLC </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:120%">Citigroup</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:120%">Jefferies</span></div><div style="margin-bottom:80pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:120%">Apollo Global Securities</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.378%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:56pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through and including&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_1216"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION NOT REQUIRED IN PROSPECTUS</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_4155"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Indemnification of Directors and Officers </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 98 of the Companies Act 1981, as amended (the &#8220;Companies Act&#8221;) provides generally that a Bermuda company may indemnify its directors, officers and auditors against any liability which by virtue of any rule of law would otherwise be imposed on them in respect of any negligence, default, breach of duty or breach of trust, except in cases where such liability arises from fraud or dishonesty of which such director, officer or auditor may be guilty in relation to the company. Section 98 further provides that a Bermuda company may indemnify its directors, officers and auditors against any liability incurred by them in defending any proceedings, whether civil or criminal, in which judgment is awarded in their favor or in which they are acquitted or granted relief by the Supreme Court of Bermuda pursuant to Section 281 of the Companies Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bye-Law 145 of the bye-laws of Aspen Insurance Holdings Limited (&#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or the &#8220;Company&#8221;) provides, among other things, that, subject to certain provisos, our directors, officers, resident representative, member of a committee duly constituted under the bye-laws of the Company and any liquidator, manager or trustee for the time being acting in relation to the affairs of the Company, and his heirs, executors and administrators (each, an &#8220;Indemnified Person&#8221;) shall be indemnified and held harmless out of the assets of the Company against all actions, costs, charges, liabilities, loss, damage or expense (including but not limited to liabilities under contract, tort and statute or any applicable foreign law or regulation and all reasonable legal and other costs and expenses properly payable) incurred or suffered by him by or by reason of any act done, conceived in or omitted in the conduct of the Company&#8217;s business or in the discharge of his duties. The indemnity contained in Bye-Law 145 extends to any Indemnified Person of the Company acting in any office or trust in the reasonable belief that he has been appointed or elected to such office or trust notwithstanding any defect in such appointment or election provided that the indemnity contained in Bye-Law 145 shall not extend to any matter which would render it void under the Companies Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bye-Law 149 of the Company&#8217;s bye-laws provides that each shareholder and the Company agree to waive any claim or right of action he or it may at any time have, whether individually or by or in the right of the Company, against any Indemnified Person on account of any action taken by such Indemnified Person or the failure of such Indemnified Person to take any action in the performance of his duties with or for the Company. Such waiver shall not apply to any claims or rights of action arising out of the fraud of such Indemnified Person or to recover any gain, personal profit or advantage to which such Indemnified Person is not legally entitled.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Companies Act  provides that a Bermuda company may in its bye-laws or in any contract or arrangement between the company and any officer (including a director) exempt such officer or person from, or indemnify him or her in respect of, any loss arising or liability attaching to them as a result of any negligence, default, breach of duty or breach of trust of which they may be guilty in relation to the company or any subsidiary thereof. However, the Companies Act also provides that any provision, whether contained in the company&#8217;s bye-laws or in a contract or arrangement between the Company and the officer, indemnifying such officer against any liability which would attach to him in respect of his fraud or dishonesty in relation to the company will be void.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 98A of the Companies Act permits us to purchase and maintain insurance for the benefit of any officer or director in respect of any loss or liability attaching to him in respect of any negligence, default, breach of duty or breach of trust, whether or not we may otherwise indemnify such officer or director. We have purchased and maintain a directors&#8217; and officers&#8217; liability policy for such purpose The Company has also entered into indemnification agreements with its directors, a form of which is filed as an exhibit to this registration statement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriting agreement that the Company expects to enter into in connection with an offering of securities pursuant to this registration statement may include provisions providing that the underwriters are obligated, under certain circumstances, to indemnify the directors, certain officers and the controlling persons of the Company against certain liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-1</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_4167"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Recent Sales of Unregistered Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i74bc390671ae44c18dcd3f802f6097fb_4176"></div><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Exhibits and Financial Statement Schedules</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Exhibits</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Underwriting Agreement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31-fx1.htm">Certificate of Incorporation, Certificate of Incorporation on Change of Name and Memorandum of Association</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32-fx1.htm">Altered Memorandum of Association</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit33-fx1.htm">Amended and Restated Bye-laws</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit34-fx1.htm">Certificate of Designation</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit34-fx1.htm"> of the Company&#8217;s Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, dated May 2, 2013</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit35-fx1.htm">Specimen Certificate for the Company&#8217;s Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit36-fx1.htm">Certificate of Designation of the Company&#8217;s 5.625% Perpetual Non-Cumulative Preference Shares, dated September 20, 2016</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit37-fx1.htm">Specimen Certificate for the Company&#8217;s 5.625% Perpetual Non-Cumulative Preference Shares</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit38-fx1.htm">Certificate of Designation for the Company&#8217;s 5.625% Perpetual Non-Cumulative Preference Shares represented by Depositary Shares, each such Depositary Share representing a 1/1000th interest in a 5.625% Perpetual Non-Cumulative Preference Share, dated August 13, 2019</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit39-fx1.htm">Specimen Share Certificate evidencing the 5.625% Perpetual Non-Cumulative Preference Shares represented by Depositary Shares</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opinion of Walkers (Bermuda) Limited, counsel to the Company</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-fx1.htm">Deposit Agreement dated as of August 13, 2019 among the Company, Computershare Inc. and Computershare Trust Company, N.A.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-fx1.htm">Form of Depositary Receipt</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103-fx1.htm">Indenture, dated August 16, 2004, between the Company and Deutsche Bank Trust Company Americas, as trustee</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit104-fx1.htm">Third Supplemental Indenture, dated November 13, 2013, between the Company, as issuer, and Deutsche Bank Trust Company Americas, as trustee</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit105-fx1.htm">Fourth Supplemental Indenture, dated June 27, 2019, between the Company and Deutsche Bank Trust Company Americas, as trustee</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit106-fx1.htm">Agreement and Plan of Merger, dated as of August 27, 2018, by and among Aspen Insurance Holdings Limited, Highlands Holdings, Ltd, and Highlands Merger Sub, Ltd.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit107-fx1.htm">Service Agreement, dated February 19, 2019, by and among Mark Cloutier, Aspen Insurance Holdings Limited and Aspen Bermuda Limited</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit108-fx1.htm">Management Consulting Agreement, dated March 28, 2019, between Aspen Insurance Holdings Limited and Apollo Management Holdings, L.P.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit109-fx1.htm">Aspen Insurance U.S. Services Inc. Nonqualified Deferred Compensation Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1010-fx1.htm">Amended and Restated Aspen Insurance U.S. Services Inc. Nonqualified Deferred Compensation Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1011-fx1.htm">Second Amended and Restated Credit Agreement, dated March 27, 2017, among the Company, various subsidiaries therefor, various lenders and Barclays Bank plc, as administrative agent</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1012-fx1.htm">First Amendment to Second Amended and Restated Credit Agreement, dated March 11, 2020, among the Company, various lenders and Barclays Bank plc, as administrative agent</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1013-fx1.htm">Second Amendment to Second Amended and Restated Credit Agreement, dated April 28, 2020, among the Company, various lenders and Barclays Bank plc, as administrative agent</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1014-fx1.htm">Third Amended and Restated Credit Agreement, dated as of December 1, 2021, among the Company, various subsidiaries therefor, various lenders and Barclays Bank plc, as administrative agent</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1015-fx1.htm">Insurance Letters of Credit - Master Agreement, dated December 15, 2003, between Aspen Bermuda Limited (formerly known as Aspen Insurance Limited) and Citibank Ireland Financial Services plc</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1016-fx1.htm">Assignment Agreement, dated October 11, 2006, among Aspen Bermuda Limited (formerly known as Aspen Insurance Limited), Citibank, N.A., Citibank Europe plc and The Bank of New York</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1017-fx1.htm">Reinsurance Deposit Agreement, dated October 11, 2006, between Aspen Bermuda Limited (formerly known as Aspen Insurance Limited) and Citibank Europe plc</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1018-fx1.htm">Committed Letter of Credit Facility, dated July 30, 2012, between Aspen Bermuda Limited and Citibank Europe plc</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1019-fx1.htm">Committed Letter of Credit Facility, dated June 30, 2014, between Aspen Bermuda Limited and Citibank Europe plc</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1020-fx1.htm">Committed Letter of Credit Facility, dated June 30, 2016, between Aspen Bermuda Limited and Citibank Europe plc</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1021-fx1.htm">Deed of Amendment, dated June 29, 2018, between Aspen Bermuda Limited and Citibank Europe plc</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1022-fx1.htm">Deed of Amendment, dated September 20, 2019, between Aspen Bermuda Limited and Citibank Europe plc</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1023-fx1.htm">Deed of Amendment, dated June 26, 2020, between Aspen Bermuda Limited and Citibank Europe plc</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1024-fx1.htm">Amended and Restated Pledge Agreement, dated December 18, 2014, between Aspen Bermuda Limited and Citibank Europe plc, as successor by assignment to Citibank, N.A.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourcing Agreement between Aspen Insurance UK Services Limited, Aspen Insurance U.S. Services, Inc., Aspen Bermuda Limited and Genpact (UK) Limited</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourcing Agreement between Aspen Insurance UK Services Limited, Aspen Insurance U.S. Services Inc., Aspen Bermuda Limited and Cognizant Worldwide Limited</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1027-fx1.htm">Amended and Restated Reinsurance Agreement, dated January 10, 2022, among the Company, various subsidiaries therefor, and Cavello Bay Reinsurance Limited</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1028-fx1.htm">Master Services Agreement: ITO Services, dated May 27, 2022, between Aspen Insurance UK Services Limited and Mindtree Limited</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Credit Agreement among Aspen Insurance Holdings Limited, the several lenders from time to time parties thereto, Citibank, N.A., as administrative agent, and the other parties thereto, dated July 26, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnification Agreement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211-fx1.htm">List of subsidiaries of the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-fx1.htm">Consent of Independent Registered Public Accounting Firm &#8211; KPMG LLP</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit232-fx1.htm">Consent of Independent Registered Public Accounting Firm &#8211; Ernst &amp; Young LLP</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Walkers (Bermuda) Limited (included in the opinion filed as Exhibit 5.1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i74bc390671ae44c18dcd3f802f6097fb_434">Power of Attorney (included on signature page of the Registration Statement)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit107-filingfeesxfx1.htm">Filing Fees Table</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.5pt">To be filed by amendment.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;Certain portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K on the basis that the Company customarily and actually treats that information as private or confidential and the omitted information is not material. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8224;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">Identifies management contract or compensatory plan or arrangement </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Financial Statement Schedules</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All schedules have been omitted because the information required to be set forth therein is not applicable or has been included in our consolidated financial statements and notes thereto.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-3</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_4185"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Undertakings</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The undersigned registrant hereby undertakes to provide to the underwriters, at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The undersigned registrant hereby undertakes that:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-4</span></div></div></div><div id="i74bc390671ae44c18dcd3f802f6097fb_434"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Hamilton, Bermuda, on this 20th day of December, 2023. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.987%"><tr><td style="width:1.0%"></td><td style="width:5.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Mark Cloutier</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Mark Cloutier</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: Director, Executive Chair and Group Chief Executive Officer </span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned constitutes and appoints each of Christopher Coleman and David Amaro, each acting alone, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all capacities, to sign this Registration Statement on Form F-1, or other appropriate form, and all amendments thereto, including post-effective amendments, of Aspen Insurance Holdings Limited, and to file the same, with all exhibits thereto, and other document in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that any such attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Mark Cloutier</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Executive Chair and Group Chief Executive Officer<br/>(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Cloutier</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Christopher Coleman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Chief Financial Officer<br/>(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher Coleman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Marc MacGillivray</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer<br/>(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marc MacGillivray</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/David Altmaier</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Altmaier</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Albert J. Beer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albert J. Beer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Theresa Froehlich</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Theresa Froehlich</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Alexander Humphreys</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexander Humphreys</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Richard Lightowler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard Lightowler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Gernot Lohr</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gernot Lohr</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Tammy L. Richardson-Augustus</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:23pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tammy L. Richardson-Augustus</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Michael Saffer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 20, 2023</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Saffer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AUTHORIZED REPRESENTATIVE </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, the undersigned, the duly authorized representative in the United States of Aspen Insurance Holdings Limited, has signed this registration statement on December 20, 2023. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.987%"><tr><td style="width:1.0%"></td><td style="width:5.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COGENCY GLOBAL INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Colleen A. De Vries</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Colleen A. De Vries</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: Senior Vice President for and on behalf of Cogency Global Inc.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-6</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exhibit107-filingfeesxfx1.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic53987308577425290ffe31c45c5a463_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 107</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Calculation of Filing Fee Tables</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form F-1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Form Type)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aspen Insurance Holdings Limited</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact Name of Registrant as Specified in its Memorandum of Association)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table 1&#58; Newly Registered and Carry Forward Securities</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.218%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.406%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Security Type</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Security<br>Class <br>Title</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fee <br>Calculation <br>or Carry Forward <br>Rule</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount Registered</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proposed Maximum Offering Price Per Unit</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maximum Aggregate Offering Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fee <br>Rate</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Registration Fee</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carry Forward Form Type</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carry Forward File Number</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carry Forward Initial Effective Date</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</font></td></tr><tr><td colspan="39" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newly Registered Securities</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees to be Paid</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares, </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">par value $0.01 per share</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457(o)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100,000,000</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00014760</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,760.00</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees Previously Paid</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="39" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carry Forward Securities</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carry Forward Securities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Offering Amounts</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100,000,000</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,760.00</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Fees Previously Paid</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Fee Offsets</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Fee Due</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,760.00</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Includes offering price of additional ordinary shares that the underwriters have the option to purchase.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>exhibit31-fx1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i807399f6b24e4844abe17de5facbf37f_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">REGISTRATION NO. 32164</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;LOGO OMITTED&#93;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">BERMUDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">CERTIFICATE OF INCORPORATION</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">I hereby in accordance with section 14 of the Companies Act 1981 issue this Certificate of Incorporation and do certify that on the 23rd day of May, 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">EXALI REINSURANCE HOLDINGS LIMITED</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">was registered by me in the Register maintained by me under the provisions of the said section and that the status of the said company is that of an EXEMPTED company.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;SEAL OMITTED&#93;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Given under my hand and the Seal of the</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRAR OF COMPANIES this 23rd day of May,</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2002</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TINA TUCKER</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acting Registrar of Companies</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FORM NO. 16A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRATION NO. 32164</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;LOGO OMITTED&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">BERMUDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">CERTIFICATE OF REGISTRATION OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">ALTERATION OF DENOMINATION OF CAPITAL</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">THIS IS TO CERTIFY that an Alteration of Denomination of Share Capital of</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.993%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">EXALI REINSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">was delivered to the Registrar of Companies on the 19th day of June, 2002 in accordance with the Companies Act 1981 (&#34;the Act&#34;).</font></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;SEAL OMITTED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#125;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Given under my hand and seal of the</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRAR OF COMPANIES this 21st day of</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June, 2002 MARIA BOODRAM</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for ACTING REGISTRAR OF COMPANIES</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.391%"><tr><td style="width:1.0%"></td><td style="width:68.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital before Conversion&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US$12,000.00</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.070%"><tr><td style="width:1.0%"></td><td style="width:68.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital after Conversion&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP 7,976.60</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FORM NO. 7a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration No.32164</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;LOGO OMITTED&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">BERMUDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">CERTIFICATE OF DEPOSIT OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">MEMORANDUM OF INCREASE OF SHARE CAPITAL</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">THIS IS TO CERTIFY that a Memorandum of Increase of Share Capital of</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.993%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">EXALI REINSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">was delivered to the Registrar of Companies on the 18th day of July, 2002 in accordance with section 45(3) of the Companies Act 1981 (&#34;the Act&#34;).</font></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;SEAL OMITTED&#93;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Given under my hand and Seal of the</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRAR OF COMPANIES this 22nd day of</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July, 2002</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PAMELA ADAMS</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACTING REGISTRAR OF COMPANIES</font></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.019%"><tr><td style="width:1.0%"></td><td style="width:62.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital prior to increase&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP 7,976.60</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.660%"><tr><td style="width:1.0%"></td><td style="width:61.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of increase&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP62,023.40</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.660%"><tr><td style="width:1.0%"></td><td style="width:61.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present Capital&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP70,000.00</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">Registration No. 32164</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;LOGO OMITTED&#93;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">BERMUDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">CERTIFICATE OF INCORPORATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">ON CHANGE OF NAME</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">I HEREBY CERTIFY that in accordance with section 10 of the Companies Act 1981 EXALI REINSURANCE HOLDINGS LIMITED by resolution and with the approval of the Registrar of Companies has changed its name and was registered as ASPEN INSURANCE HOLDINGS LIMITED on the 22nd day of November, 2002.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;SEAL OMITTED&#93;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Given under my hand and the Seal of the</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRAR OF COMPANIES this 26th day of</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November, 2002</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PAMELA ADAMS</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for Registrar of Companies</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FORM NO. 7a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration No. 32164</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;LOGO OMITTED&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">BERMUDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">CERTIFICATE OF DEPOSIT OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">MEMORANDUM OF INCREASE OF SHARE CAPITAL</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">THIS IS TO CERTIFY that a Memorandum of Increase of Share Capital of</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.429%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">was delivered to the Registrar of Companies on the 6th day of December, 2002 in accordance with section 45(3) of the Companies Act 1981 (&#34;the Act&#34;).</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;SEAL OMITTED&#93;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Given under my hand and Seal of the</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRAR OF COMPANIES this 10th day of</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December, 2002</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pamela Adams</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR REGISTRAR OF COMPANIES</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.500%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital prior to increase&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP 70,000.00</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.217%"><tr><td style="width:1.0%"></td><td style="width:62.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of increase&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP 6,416.91</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.500%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present Capital&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP 76,416.91</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FORM NO. 7a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration No. 32164</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;LOGO OMITTED&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">BERMUDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">CERTIFICATE OF DEPOSIT OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">MEMORANDUM OF INCREASE OF SHARE CAPITAL</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">THIS IS TO CERTIFY that a Memorandum of Increase of Share Capital of</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.429%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">was delivered to the Registrar of Companies on the 21st day of August, 2003 in accordance with section 45(3) of the Companies Act 1981 (&#34;the Act&#34;).</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;SEAL OMITTED&#93;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Given under my hand and Seal of the</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRAR OF COMPANIES this 22nd day</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of August, 2003</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MARIA BOODRAM</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for Acting Registrar of Companies</font></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.820%"><tr><td style="width:1.0%"></td><td style="width:60.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital prior to increase&#58;</font></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP 76,416.91</font></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.384%"><tr><td style="width:1.0%"></td><td style="width:56.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of increase&#58;</font></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP 1,000,000.00</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.743%"><tr><td style="width:1.0%"></td><td style="width:57.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present Capital&#58;</font></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP1,076,416.91</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FORM NO. 16A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRATION NO. 32164</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;LOGO OMITTED&#93;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">BERMUDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">CERTIFICATE OF REGISTRATION OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">ALTERATION OF DENOMINATION OF CAPITAL</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">THIS IS TO CERTIFY that an Alteration of Denomination of Share Capital of</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.692%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Aspen Insurance Holdings Limited</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">was delivered to the Registrar of Companies on the 2nd day of September, 2003 in accordance with the Companies Act 1981 (&#34;the Act&#34;).</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;SEAL OMITTED&#93;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Given under my hand and seal of the</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGISTRAR OF COMPANIES this 9th day of</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October, 2003</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MARIA BOODRAM</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for Registrar of Companies</font></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.230%"><tr><td style="width:1.0%"></td><td style="width:60.131%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital before Conversion&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP 1,076,416.91</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.910%"><tr><td style="width:1.0%"></td><td style="width:60.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.222%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital after Conversion&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US$ 1,630,185.83</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:11.378%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REISSUED</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">FORM No. 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;Conformed Copy&#93;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">&#91;LOGO Omitted&#93;</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">BERMUDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">THE COMPANIES ACT 1981</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">MEMORANDUM OF ASSOCIATION OF COMPANY LIMITED BY SHARES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">SECTION 7(1) AND (2)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">MEMORANDUM OF ASSOCIATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">OF</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.429%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">(hereinafter referred to as &#34;the Company&#34;)</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:10.13pt">The liability of the members of the Company is limited to the amount (if any) for the time being unpaid on the shares respectively held by them.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:10.13pt">We, the undersigned, namely,</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name and Address</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermudian Status</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nationality</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Shares</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Yes or No)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscribed</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Edwin C. Jackson</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar House, 41 Cedar Avenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hamilton HM 12, Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ruby L. Rawlins</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar House, 41 Cedar Avenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hamilton HM 12, Bermuda </font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marcia Gilbert</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar House, 41 Cedar Avenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hamilton HM 12, Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trinidadian</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antoinette Simmons</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar House, 41 Cedar Avenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hamilton HM 12, Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr></table></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">do hereby respectively agree to take such number of shares of the Company as maybe allotted to us respectively by the provisional directors of the Company, not exceeding the number of shares for which we have respectively subscribed, and to satisfy such calls as may be made by the directors, provisional directors or promoters of the Company in respect of the shares allotted to us respectively.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:70pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:10.13pt">The Company is to be an Exempted Company as defined by the Companies Act 1981.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:10.13pt">The Company, with the consent of the Minister of Finance, has power to hold land situate in Bermuda not exceeding __ in all, including the following parcels&#58;- .</font></div><div style="margin-bottom:50pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">NOT APPLICABLE.</font></div><div style="margin-bottom:70pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:10.13pt">The authorised share capital of the Company is US$1,630,185.83 divided into 1,076,416,910 shares of par value US$0.015144558 each. The minimum subscribed share capital of the Company is 12,000.00 in United States Currency.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:10.13pt">The objects for which the Company is formed and incorporated are&#58;- </font></div><div style="margin-bottom:50pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">As set forth in paragraphs (b) to (n) and (p) to (u) inclusive of the Second Schedule to the Companies Act 1981.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:10.13pt">The Company has the powers set out in The Schedule annexed hereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">_&#160;&#160;&#160;&#160;&#160;Signed by each subscriber in the presence of at least one witness attesting the signature thereof,</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.352%"><tr><td style="width:1.0%"></td><td style="width:31.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.C. (Ned) Jackson</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Janice Holdipp</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ruby L. Rawlins</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Janice Holdipp</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marcia Gilbert</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Janice Holdipp</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antoinette Simmons</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Janice Holdipp</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; E. C. Jackson</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Janice Holdipp</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ruby L. Rawlins</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Janice Holdipp</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Marcia Gilbert</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Janice Holdipp</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Antoinette Simmons</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Janice Holdipp</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Subscribers)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Witnesses)</font></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscribed this 23rd day of May 2002</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">STAMP DUTY (To be affixed)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> Not Applicable</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">THE SCHEDULE</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.929%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(referred to in Clause 7 of the Memorandum of Association,)</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:15.36pt">to borrow and raise money in any currency or currencies and to secure or discharge any debt or obligation in any manner and in particular (without prejudice to the generality of the foregoing) by mortgages of or charges upon all or any part of the undertaking, property and assets (present and future) and uncalled capital of the company or by the creation and issue of securities&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.77pt">to enter into any guarantee, contract of indemnity or suretyship and in particular (without prejudice to the generality of the foregoing) to guarantee, support or secure, with or without consideration, whether by personal obligation or by mortgaging or charging all or any part of the undertaking, property and assets (present and future) and uncalled capital of the company or by both such methods or in any other manner, the performance of any obligations or commitments of, and the repayment or payment of the principal amounts of and any premiums, interest, dividends and other moneys payable on or in respect of any securities or liabilities of, any person, including (without prejudice to the generality of the foregoing) any company which is for the time being a subsidiary or a holding company of the company or another subsidiary of a holding company of the company or otherwise associated with the company&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:15.36pt">to accept, draw, make, create, issue, execute, discount, endorse, negotiate and deal in bills of exchange, promissory notes, and other instruments and securities, whether negotiable or otherwise&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.77pt">to sell, exchange, mortgage, charge, let on rent, share of profit, royalty or otherwise, grant licences, easements, options, servitudes and other rights over, and in any other manner deal with or dispose of, all or any part of the undertaking, property and assets (present and future) of the company for any consideration and in particular (without prejudice to the generality of the foregoing) for any securities&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:15.36pt">to issue and allot securities of the company for cash or in payment or part payment for any real or personal property purchased or otherwise acquired by the company or any services rendered to the company or as security for any obligation or amount (even if less than the nominal amount of such securities) or for any other purpose&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:16.53pt">to grant pensions, annuities, or other allowances, including allowances on death, to any directors, officers or employees or former directors, officers or employees of the company or any company which at any time is or was a subsidiary or a holding company or another subsidiary of a holding company of the company or otherwise associated with the company or of any predecessor in business of any of them, and to the relations, connections or dependants of any such persons, and to other persons whose service or services have directly or indirectly been of benefit to the company or whom the company considers have any moral claim on the company or to their relations connections or dependants, and to establish or support any associations, institutions, clubs, schools, building and housing schemes, funds and trusts, and to make payment towards insurance or other arrangements likely to benefit any such persons or otherwise advance the interests of the company or of its members or for any national, charitable, benevolent, educational, social, public, general or useful object&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.77pt">subject to the provisions of Section 42 of the Companies Act 1981, to issue preference shares which at the option of the holders thereof are to be liable to be redeemed&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.77pt">to purchase its own shares in accordance with the provisions of Section 42A of the Companies Act 1981.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>4
<FILENAME>exhibit32-fx1.htm
<DESCRIPTION>EX-3.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9568e76a0bdb40dab9136bdac8ad4a4b_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 3.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM No. 2 </font></div><div style="margin-bottom:12pt;text-align:center"><img alt="exhibit32logo.jpg" src="exhibit32logo.jpg" style="height:141px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">BERMUDA</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">THE COMPANIES ACT 1981 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">MEMORANDUM OF ASSOCIATION OF COMPANY LIMITED BY SHARES </font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">Section 7(1) and (2) </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">MEMORANDUM OF ASSOCIATION </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(hereinafter referred to as the &#34;Company&#34;)</font></div><div style="margin-bottom:24pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">The liability of the members of the Company is limited to the amount (if any) for the time being unpaid on the shares respectively held by them.</font></div><div style="margin-bottom:24pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">We, the undersigned, namely,</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name and Address</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermudian Status (Yes or No)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nationality</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Shares Subscribed</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Edwin C. Jackson</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar House, 41 Cedar Avenue</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hamilton HM 12, Bermuda </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ruby L. Rawlins</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar House, 41 Cedar Avenue</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hamilton HM 12, Bermuda</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marcia Gilbert</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar House, 41 Cedar Avenue</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hamilton HM 12, Bermuda</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trinidadian</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antoinette Simmons</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar House, 41 Cedar Avenue</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hamilton HM 12, Bermuda</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">do respectively hereby agree to take such number of shares of the Company as may be allotted to us respectively by the provisional directors of the Company, not exceeding the number of shares for which we have respectively subscribed, and to satisfy such calls as may be made by the directors, provisional directors or promoters of the Company in respect of the shares allotted to us respectively. </font></div><div style="margin-bottom:36pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">The Company is to be an exempted Company as defined by the Companies Act 1981.</font></div><div style="margin-bottom:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">The Company, with the consent of the Minister of Finance, has the power to hold land situate in Bermuda not exceeding ___ in all, including the following parcels&#58;-</font></div><div style="margin-bottom:36pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOT APPLICABLE.</font></div><div style="margin-bottom:24pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">The authorised share capital of the Company is US$745,433.674 divided into 70,000,000 ordinary shares of par value US$0.01 each and 30,000,000 preference shares of par value US$0.0015144558 each.</font></div><div style="margin-bottom:24pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">Subject to any provision of law, including a provision in the Companies Act or any other act, and any provision of this memorandum, the objects for which the Company is formed and incorporated are unrestricted.</font></div><div style="margin-bottom:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">The Company shall have the capacity, rights, powers and privilege of a natural person and the additional powers set in The Schedule annexed hereto&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i9568e76a0bdb40dab9136bdac8ad4a4b_113"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Signed by each subscriber in the presence of at least one witness attesting the signature thereof,</font></div><div style="text-align:justify;text-indent:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.C. (Ned) Jackson&#160;&#160;&#160;&#160;Janice Holdipp</font></div><div style="text-align:justify;text-indent:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ruby L. Rawlins&#160;&#160;&#160;&#160;Janice Holdipp</font></div><div style="text-align:justify;text-indent:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marcia Gilbert&#160;&#160;&#160;&#160;Janice Holdipp</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Antoinette Simmons&#160;&#160;&#160;&#160;Janice Holdipp</font></div><div style="margin-bottom:42pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.185%"><tr><td style="width:1.0%"></td><td style="width:48.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.880%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47; s &#47; E. C. Jackson&#160;&#160;&#160;&#160;&#160;&#47; s &#47; Janice Holdipp</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47; s &#47; Ruby L. Rawling&#160;&#160;&#160;&#160;&#160;&#47; s &#47; Janice Holdipp</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47; s &#47; Marcia Gilbert&#160;&#160;&#160;&#160;&#160;&#47; s &#47; Janice Holdipp</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47; s &#47; Antoinette Simmons&#160;&#160;&#160;&#160;&#160;&#47; s &#47; Janice Holdipp</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 85pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Subscribers)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Witnesses)</font></td></tr></table></div><div style="margin-bottom:80pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscribed this 23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> day of May 2002</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">STAMP DUTY (To be affixed)</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i9568e76a0bdb40dab9136bdac8ad4a4b_92"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE SCHEDULE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(referred to in Clause 7 of the Memorandum of Association,)</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.250%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">the power, pursuant to Section 42 of the Companies Act, to issue preference shares which are liable to be redeemed at the option of the holder&#59;</font></div><div style="margin-bottom:24pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">the power, pursuant to Section 42A of the Companies Act, to purchase it's own shares&#59; and</font></div><div style="margin-bottom:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">the power, pursuant to Section 42B of the Companies Act, to acquire it's own shares, to be held as treasury shares, for cash or any other consideration.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>5
<FILENAME>exhibit33-fx1.htm
<DESCRIPTION>EX-3.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2405130ec9b841d0a1749511b9b645ae_59"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 3.3</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A M E N D E D A N D R E S T A T E D B Y E &#8212; L A W S </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INTERPRETATION</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;In these Bye-Laws, unless the context otherwise requires&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.1&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, in relation to any undertaking, any other undertaking that controls, is controlled by or is under common control with such first undertaking. For the purpose of this definition, the term &#8220;control&#8221; means the power to direct the management and policies of an undertaking, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise&#59; and, except when used in the term &#8220;Controlled Shares&#8221; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 66 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">below, the terms &#8220;controlled&#8221; and &#8220;controlling&#8221; have meanings correlative to the foregoing&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.2&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Apollo Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i)&#160;Apollo Global Management, LLC and its subsidiaries, (ii)&#160;Highlands Holdings, Ltd., (iii) any investment fund or other collective investment vehicle whose general partner or managing member is owned or controlled, directly or indirectly, by Apollo Global Management, LLC or by one or more of Apollo Global Management, LLC&#8217;s subsidiaries, (iv) BRH Holdings GP, Ltd. and its shareholders, and (v)&#160;any Affiliate of a person described in clauses&#160;(i) - (iv) above&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, none of the Company or its subsidiaries, nor any person employed by the Company or its subsidiaries, shall be deemed to be a member of the Apollo Group. For avoidance of doubt, any person managed by Apollo Global Management, LLC or by one or more of Apollo Global Management, LLC&#8217;s subsidiaries pursuant to a managed account agreement (or similar arrangement) without Apollo Global Management, LLC or by one or more of Apollo Global Management, LLC&#8217;s subsidiaries controlling such person as a general partner or managing member shall not be part of the Apollo Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.3&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bermuda</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Islands of Bermuda&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.4&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company or the Directors present at a meeting of Directors at which there is a quorum&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.5&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a day (excluding Saturdays and Sundays) on which banks generally are open in New York, London and Bermuda for the transaction of normal banking business&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.6&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended, of the United States of America&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.7&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Companies Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Companies Act 1981 of Bermuda as amended from time to time and any legislation enacted to supersede the same and every Bermuda statute from time to time in force concerning companies insofar as the same applies to the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.8&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the company incorporated in Bermuda under the name of Aspen Insurance Holdings Limited on 23 August 2018, as such name may be changed from time to time in accordance with Bermuda law&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.9&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a director of the Company as of the date these Bye-Laws are adopted and such person or persons as shall be elected to the Board from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 86 and 87 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or appointed to the Board from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.10&#8220;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any Director, Officer, Resident Representative, member of a committee duly constituted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 106 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and any liquidator, manager or trustee for the time being acting in relation to the affairs of the Company, and his heirs, executors and administrators&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.11&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Merger Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Agreement and Plan of Merger, dated as of August 27, 2018, by and among Highlands Merger Sub, Ltd., Highlands Holdings, Ltd. and Aspen Insurance Holdings Limited. </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.12&#8220;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Merger Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Closing Date (as defined in the Merger Agreement).</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.13&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a person appointed by the Board pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 118 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and shall not include an auditor of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.14&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Ordinary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means ordinary shares in the capital of the Company having the rights and restrictions contained in these Bye-Laws&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.15&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">paid up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means paid up or credited as paid up&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.16&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means preference shares in the capital of the Company, which shall have the rights, terms, restrictions and preferences set out in or determined in accordance with these Bye-Laws&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.17&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Register of Shareholders of the Company and except in Bye-Laws 10 and 20, includes any branch register&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.18&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Registered Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the registered office in Bermuda for the time being of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.19&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Resident Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means (if any) the individual (or, if permitted in accordance with the Companies Act, a company) appointed to perform </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the duties of resident representative set out in the Companies Act and includes any assistant or deputy Resident Representative appointed by the Board to perform any of the duties of the Resident Representative&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.20&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means a resolution of the Shareholders passed in general meeting or, where required, of a separate class or separate classes of shareholders passed in a separate general meeting or in either case adopted by resolution in writing, in accordance with the provisions of these Bye-Laws&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.21&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Seal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the common seal of the Company and includes any authorised duplicate thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.22&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Secretary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">includes a temporary or assistant or deputy Secretary and any person appointed by the Board to perform any of the duties of the Secretary&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.23&#160;&#160;&#160;&#160;&#8220;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">hare</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means share in the capital of the Company and includes a fraction of a share&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.24&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means a shareholder or member of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.25&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">the Bye-Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means these Bye-Laws in their present form or as from time to time amended&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.26&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, in relation to any share, (i) when used as a verb, to sell, assign, dispose of, exchange, pledge, hypothecate or otherwise transfer such share or any beneficial interest therein, whether directly or indirectly, or agree or commit to do any of the foregoing and (ii) when used as a noun, a direct or indirect sale, assignment, disposition, exchange, pledge, hypothecation or other transfer of such share or any beneficial interest therein or any agreement or commitment to do any of the foregoing&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.27&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Trigger Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date on which the Apollo Group no longer collectively beneficially hold 50.1% of the Corporation&#8217;s outstanding shares entitled to vote generally in the election of directors&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.28&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">undertaking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a company or partnership or an unincorporated association situated in any jurisdiction and, in relation to an undertaking which is not a company, expressions in these Bye-Laws appropriate to companies shall be construed as references to the corresponding persons, officers, documents or organs (as the case may be) appropriate to undertakings of that description.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;For the purposes of these Bye-Laws&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.1&#160;&#160;&#160;&#160;a corporation which is a shareholder shall be deemed to be present in person at a general meeting if its representative duly authorised pursuant to the Companies Act is present&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.2&#160;&#160;&#160;&#160;words importing only the singular number include the plural number and vice versa&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.3&#160;&#160;&#160;&#160;words importing only the masculine gender include the feminine and neuter genders respectively&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.4&#160;&#160;&#160;&#160;words importing persons include companies or associations or bodies of persons, whether corporate or un-incorporate&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.5&#160;&#160;&#160;&#160;a reference to writing shall include typewriting, printing, lithography, photography and electronic record&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.6&#160;&#160;&#160;&#160;any words or expressions defined in the Companies Act in force at the date when these Bye-Laws or any part thereof are adopted shall bear the same meaning in these Bye-Laws or such part (as the case may be)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.7&#160;&#160;&#160;&#160;a company is a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; of another company, its &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">holding company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;, if such other company owns either directly or indirectly through its subsidiaries shares of stock or other ownership interests having a majority of the voting power in electing the board of directors thereof or other persons performing a similar function&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.8&#160;&#160;&#160;&#160;a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">member of the same group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; as a body corporate means a subsidiary or holding company of the body corporate or a subsidiary of a holding company of the body corporate.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3&#160;&#160;&#160;&#160;A reference to anything being done by electronic means includes it being done by any electronic or other communications equipment or facilities and reference to any communication being delivered or received, or being delivered or received at a particular place, includes the transmission of an electronic record, and to a recipient identified in such manner or by such means as the Board may from time to time approve or prescribe, either generally or for a particular purpose.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;A reference to a signature or to anything being signed or executed includes such forms of electronic signature or other means of verifying the authenticity of an electronic record as the Board may from time to time approve or prescribe, either generally or for a particular purpose.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.5&#160;&#160;&#160;&#160;A reference to any statute or statutory provision (whether in Bermuda or elsewhere) includes a reference to any modification or re-enactment of it and to every rule, regulation or order made under it (or under any such modification or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">re-enactment) and any reference to any rule, regulation or order made under any such statute or statutory provision includes a reference to any modification or replacement of such rule, regulation or order.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6&#160;&#160;&#160;&#160;In these Bye-Laws&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6.1&#160;&#160;&#160;&#160;powers of delegation shall not be restrictively construed but the widest lawful interpretation shall be given thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6.2&#160;&#160;&#160;&#160;the term &#8220;Board&#8221; in the context of the exercise of any power contained in these Bye-Laws includes any committee consisting of one or more Directors, any Director holding an executive office and any manager or agent of the Company to which or, as the case may be, to whom the power in question has been delegated&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6.3&#160;&#160;&#160;&#160;no power of delegation shall be limited by the existence or, except where expressly provided by the terms of delegation, the exercise of any other power of delegation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6.4&#160;&#160;&#160;&#160;except where expressly provided by the terms of delegation, the delegation of a power shall not exclude the concurrent exercise of that power by any other body or person who is for the time being authorised to exercise it under these Bye-Laws or under another delegation of the powers by the Board.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REGISTERED OFFICE</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Registered Office shall be at such place in Bermuda as the Board shall from time to time appoint.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;SHARE CAPITAL</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Division of Share Capital</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to any special rights previously conferred on the holders of any existing shares or class of shares, the share capital of the Company shall be divided into shares of two classes, being 70,000,000 Ordinary Shares and 30,000,000 Preference Shares, as adjusted in the event of any share split, stock dividend, subdivision, combination, reclassification or other similar transaction, and as such share capital may be changed from time to time in accordance with Bermuda law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Ordinary Shares</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Ordinary Shares shall, subject to the other provisions in the Bye-Laws, entitle the holders thereof to the following rights&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2.1&#160;&#160;&#160;&#160;as regards dividend&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(subject to the provisions of the Companies Act) after making all necessary provisions, where relevant, for payment of any preferred dividend in respect of any Preference Shares then in issue, the Company shall apply any profits or reserves which the Board resolves to distribute in paying such profits or reserves to the holders of the Ordinary Shares in respect of their holding of such shares </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and pro rata to the number of Ordinary Shares held by each of them&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2.2&#160;&#160;&#160;&#160;as regards capital&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">on a return of assets on liquidation, reduction of capital or otherwise, the holders of the Ordinary Shares shall be entitled to be paid the surplus assets of the Company remaining after payment of its liabilities (subject to the rights of the holders of any Preference Shares then in issue having preferred rights on the return of capital) in respect of their holdings of Ordinary Shares </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and pro rata to the number of Ordinary Shares held by each of them&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2.3&#160;&#160;&#160;&#160;as regards voting in general meetings&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the holders of Ordinary Shares shall be entitled to receive notice of, and to attend and vote at, general meetings of the Company&#59; every holder of Ordinary Shares present in person or by proxy shall on a poll have one vote for each Ordinary Share held by him (subject to modification to take into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.3&#160;&#160;&#160;&#160;&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Preference Shares</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.1&#160;&#160;&#160;&#160;The Board is authorized, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 3.4.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and any limitations prescribed by applicable law, to issue Preference Shares in one or more series, and to fix the rights, preferences, privileges and restrictions thereof, including but not limited to dividend rates, conversion rights, voting rights, terms of redemption (including sinking fund provisions), redemption prices and liquidation preferences, and the number of shares constituting and the designation of any such series, without further vote or action by the Shareholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2&#160;&#160;&#160;&#160;The authority of the Board with respect to each series of Preference Shares shall include, but not be limited to, determination of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2.1&#160;&#160;&#160;&#160;the distinctive designation of such series and the number of Preference Shares constituting such series, which number (except as otherwise provided by the Board in the resolution establishing such series) may be increased or decreased (but not below the number of shares of such series then outstanding) from time to time by like action of the Board&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2.2&#160;&#160;&#160;&#160;the rights in respect of dividends, if any, of such series of Preference Shares, the extent of the preference or relation, if any, of such dividends to the dividends payable on any other class or classes or any other series of the same or other class or classes of shares of the Company, and whether such dividends shall be cumulative or non-cumulative&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2.3&#160;&#160;&#160;&#160;the voting powers, if any, of the holders of such series of Preference Shares generally or with respect to any particular matter, which may be less than, equal to or greater than one vote per share, and which may, without limiting the generality of the foregoing, include the right, voting as a series by itself or together with the holders of any other series of Preference Shares or all series of Preference Shares as a class, or together with the holders of any other class of the capital stock of the Company to elect one or more directors of the Company (which, without limiting the generality of the foregoing, may include a specified number or portion of the then-existing number of authorized directorships of the Company or a specified number or portion of directorships in addition to the then-existing number of authorized directorships of the Company), generally or under such specific circumstances and on such conditions, as shall be provided in the resolution or resolutions of the Board adopted pursuant hereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2.4&#160;&#160;&#160;&#160;whether such series of Preference Shares may be redeemed and, if so, the terms and conditions on which they may be redeemed (including, without limitation, the dates upon or after which they may be redeemed, which price or prices may be different in different circumstances or at different redemption dates), and whether they may be redeemed at the option of the Company, at the option of the holder, or at the option of both the Company and the holder&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2.5&#160;&#160;&#160;&#160;the right, if any, of the holders of such series of Preference Shares to convert the same into, or exchange the same for, shares of any other class or classes or of any other series of the same or any other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">class or classes of shares of the Company and the terms and conditions of such conversion or exchange, including, without limitation, whether or not the number of shares of such other class or series into which shares of such series may be converted or exchanged shall be adjusted in the event of any share split, stock dividend, subdivision, combination, reclassification or other transaction or series of transactions affecting the class or series into which such series of Preference Shares may be converted or exchanged&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2.6&#160;&#160;&#160;&#160;the amounts, if any, payable upon such series of Preference Shares in the event of voluntary liquidation, dissolution or winding up of the Company in preference of any other class or series of shares or in the event of any merger or consolidation of or sale of assets by the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2.7&#160;&#160;&#160;&#160;the terms of any sinking fund or redemption or purchase account, if any, to be provided for shares of such series of Preference Shares&#59; and</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.2.8&#160;&#160;&#160;&#160;any other relative rights, preferences, limitations and powers of such series of Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:130.5pt;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.3&#160;&#160;&#160;&#160;Notwithstanding the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 3.4.2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Board may issue Preference Shares having voting rights or powers together with the holders of any other class of the share capital of the Company to elect one or more directors of the Company (other than any mandatory voting rights or powers under the Companies Act) only if such issuance is approved by a Resolution of the holders of Ordinary Shares (but not any other class of shares) then outstanding (taking into consideration the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ALTERATION OF CAPITAL</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The Company may from time to time increase its capital by such sum to be divided into shares of such par value as the Company by Resolution (taking into consideration the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall prescribe and in any manner permitted by the Companies Act.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Subject to the Companies Act, the Memorandum of Association of the Company and any confirmation or consent required by applicable law or these Bye-Laws, the Company may from time to time by Resolution (taking into consideration the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) authorise the reduction of its issued share capital or any share premium account in any manner. In relation to any such reduction, the Company may by Resolution (taking into consideration the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) determine the terms upon which </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such reduction is to be effected, including in the case of a reduction of part of a class of shares, those shares to be affected.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;The Company may from time to time by Resolution (taking into consideration the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and in any manner permitted by the Companies Act&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1&#160;&#160;&#160;&#160;divide its shares into several classes or series and attach thereto respectively any preferential, deferred, qualified or special rights, privileges or conditions&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2&#160;&#160;&#160;&#160;consolidate and divide all or any of its share capital into shares of larger par value than its existing shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3&#160;&#160;&#160;&#160;sub-divide its shares or any of them into shares of smaller par value than is fixed by its Memorandum of Association, so, however, that in the sub-division the proportion between the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in the case of the share from which the reduced share is derived&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.4&#160;&#160;&#160;&#160;make provision for the issue and allotment of shares which do not carry any voting rights&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.5&#160;&#160;&#160;&#160;cancel shares which, at the date of the passing of the Resolution in that behalf, have not been taken or agreed to be taken by any person, and diminish the amount of its share capital by the amount of the shares so cancelled&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.6&#160;&#160;&#160;&#160;change the currency domination of its share capital.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Where any difficulty arises in regard to any division, consolidation, or sub-division under this Bye-Law, the Board may settle the same as it thinks expedient and, in particular, may arrange for the sale of the shares representing fractions and the distribution of the net proceeds of sale in due proportion amongst the Shareholders who would have been entitled to the fractions, and for this purpose the Board may authorise some person to transfer the shares representing fractions to the purchaser thereof, who shall not be bound to see to the application of the purchase money nor shall his title to the shares be affected by any irregularity or invalidity in the proceedings relating to the sale.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;7.1&#160;&#160;&#160;&#160;The Board may, without the sanction of a Resolution, authorise the purchase by the Company of its own shares, of any class or series, at any price (whether at par or above or below par), and any shares to be so purchased may be selected in any manner whatsoever, upon such terms as the Board may in its discretion determine, provided always that such purchase is effected in accordance with the provisions of the Companies Act and any other applicable laws. The whole or any part of the amount payable on any such purchase </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">may be paid or satisfied otherwise than in cash, to the extent permitted by the Companies Act.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.2&#160;&#160;&#160;&#160;The Board may, at its discretion and without the sanction of a Resolution, authorise the acquisition by the Company of its own shares, of any class, at any price (whether at par or above or below par), and any shares to be so purchased may be selected in any manner whatsoever, to be held as treasury shares, upon such terms as the Board may in its discretion determine, provided always that such acquisition is effected in accordance with the provisions of the Companies Act. The whole or any part of the amount payable on any such acquisition may be paid or satisfied otherwise than in cash, to the extent permitted by the Companies Act. The Company shall be entered in the Register as a Shareholder in respect of the shares held by the Company as treasury shares and shall be a Shareholder of the Company but subject always to the provisions of the Companies Act and for the avoidance of doubt the Company shall not exercise any rights and shall not enjoy or participate in any of the rights attaching to those shares save as expressly provided for in the Companies Act.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SHARES</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.1&#160;&#160;&#160;&#160;Subject to the restrictions, if any, that are provided for in these Bye-Laws from time to time and without prejudice to any special rights previously conferred on the holders of any existing shares or class or series of shares, the Board shall have power to issue any unissued shares of the Company on such terms and conditions as it may determine. Further, the Board may create and issue shares of any existing class or series of shares. The Board may also issue options, warrants or other rights to purchase or acquire shares or, subject to Section 43 of the Companies Act, securities convertible into or exchangeable for shares (including any employee benefit plan providing for the issue of shares or options or rights in respect thereof), at such times, for such consideration and on such terms and conditions as it may determine.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2&#160;&#160;&#160;&#160;Subject to the provisions of these Bye-Laws, any shares of the Company held by the Company as treasury shares shall be at the disposal of the Board, which may hold all or any of the shares, dispose of or transfer all or any of the shares for cash or other consideration, or cancel all or any of the shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;The Board may in connection with the issue of any shares exercise all powers of paying commission and brokerage conferred or permitted by law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;Except as ordered by a court of competent jurisdiction or as required by applicable law, no person shall be recognised by the Company as holding any share upon trust and the Company shall not be bound by or required in any way to recognise (even when having notice thereof) any equitable, contingent, future or partial interest in any share or in any fractional part of a share or (except only as otherwise provided in these Bye-Laws or by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">law) any other right in respect of any share except an absolute right to the entirety thereof in the registered holder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;The Company shall not give, whether directly or indirectly, whether by means of loan, guarantee, provision of security or otherwise, any financial assistance for the purpose of a purchase or subscription made or to be made by any person of or for any shares in the Company, but nothing in this Bye-Law shall prohibit transactions mentioned in Sections 39A, 39B and 39C of the Companies Act.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;Notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Board may not grant options, warrants or other rights to acquire shares to directors, officers or employees of the Company at an exercise price less than the fair market value of any such shares on the date of grant, or an average over a several-day period around the date of grant.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MODIFICATION OF RIGHTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;Subject to the Companies Act, all or any of the special rights for the time being attached to any class or series of shares for the time being issued may from time to time (whether or not the Company is being wound up) be altered or abrogated with the consent in writing of the holders of not less than seventy-five percent (75%) of the voting power of the issued shares of that class or series (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or with the sanction of a Resolution passed by the holders of not less than seventy-five percent (75%) of the voting power of the outstanding shares in issue at a separate general meeting (taking into account the provisions by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). In respect of any such separate general meeting, all the provisions of these Bye-Laws as to general meetings of the Company shall </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">mutatis mutandis </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">apply, but so that the necessary quorum shall be one or more persons holding or representing by proxy any of the shares of the relevant class or series, that every holder of shares of the relevant class or series shall be entitled on a poll to one vote for every such share held by him (subject to modification to take into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and that any holder of shares of the relevant class or series present in person or by proxy may demand a poll.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;For the purpose of this Bye-Law, unless otherwise expressly provided by the rights attaching to or the terms of issue of such shares or class or series of shares, such rights or terms, as the case may be, shall not be deemed altered by&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.1&#160;&#160;&#160;&#160;the creation or issue of further shares ranking </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> therewith&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.2&#160;&#160;&#160;&#160;the creation or issue for full value (as determined by the Board) of further shares ranking as regards participation in the profits or assets of the Company or otherwise in priority to them&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.3&#160;&#160;&#160;&#160;the purchase or redemption by the Company of any of its own shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;The preparation, issue and delivery of certificates shall be governed by the Companies Act. In the case of a share held jointly by several persons, delivery of a certificate to one of several joint holders shall be sufficient delivery to all.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;If a share certificate is defaced, lost or destroyed, it may be replaced without fee but on such terms (if any) as to evidence and indemnity and to payment of the costs and out of pocket expenses of the Company in investigating such evidence and preparing such indemnity as the Board may think fit and, in case of defacement, on delivery of the old certificate to the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;All certificates for share or loan capital or other securities of the Company (other than letters of allotment, scrip certificates and other like documents) shall, except to the extent that the terms and conditions for the time being relating thereto otherwise provide, be in such form as the Board may determine and issued under the Seal or signed by a Director, the Secretary or any person authorised by the Board for that purpose. The Board may by resolution determine, either generally or in any particular case, that any signatures on any such certificates need not be autographic but may be affixed to such certificates by some mechanical means or may be printed thereon or that such certificates need not be signed by any persons and may determine that a representation of the Seal may be printed on any such certificates. If any person holding an office in the Company who has signed, or whose facsimile signature has been used on any certificate, ceases for any reason to hold his office, such certificate may nevertheless be issued as though that person had not ceased to hold such office.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;Nothing in these Bye-Laws shall prevent title to any securities of the Company from being evidenced and&#47;or transferred without a written instrument in accordance with regulations made from time to time in this regard under the Companies Act, and (i) the Board shall have power to implement any arrangements which it may think fit for such evidencing and&#47;or transfer which accord with those regulations and (ii) any such transfer shall be subject to the applicable provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REGISTER OF SHAREHOLDERS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;The Register shall be kept at the Registered Office or at such other place in Bermuda as the Board may from time to time direct, in the manner prescribed by the Companies Act. Subject to the provisions of the Companies Act, the Company may keep one or more branch registers in any place, and the Board may make, amend and revoke any resolutions as it may think fit respecting the keeping of such registers.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;The Register or any branch register may be closed at such times and for such period as the Board may from time to time decide, subject to the Companies Act and any other applicable law. Except during such time as it is closed, the Register and each branch register shall be open to inspection in the manner prescribed by the Companies Act between 10&#58;00 a.m. and 12&#58;00 noon (or between such times as the Board from time to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">time determines) on every Business Day. Unless the Board so determines, no Shareholder or intending Shareholder shall be entitled to have entered in the Register or any branch register any indication of any trust or any equitable, contingent, future or partial interest in any share or fractional part of a share and if any such entry exists or is permitted by the Board it shall not be deemed to abrogate any of the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REGISTER OF DIRECTORS AND OFFICERS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;The Secretary shall establish and maintain a register of the Directors and Officers of the Company as required by the Companies Act. The register of Directors and Officers shall be open to inspection in the manner prescribed by the Companies Act between 10&#58;00 a.m. and 12&#58;00 noon on every Business Day.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRANSFER OF SHARES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.&#160;&#160;&#160;&#160;Subject to the Companies Act and to such of the restrictions contained in these Bye-Laws as may be applicable, any Shareholder may transfer all or any of its shares by an instrument of transfer in the usual common form or by any other method permissible under applicable law, in either case as may be approved by the Board&#59; provided, however, that, prior to the Trigger Date, no such approval shall be required in the case of a transfer by an Ordinary Shareholder to any of its Affiliates (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Affiliate Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). No such instrument shall be required on the redemption of a share or on the purchase by the Company of a share.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.&#160;&#160;&#160;&#160;The instrument of transfer of legal title in a share shall be signed by or on behalf of the transferor and where any share is not fully-paid, the transferee. The transferor shall be deemed to remain the holder of the share until the name of the transferee is entered in the Register in respect thereof. All instruments of transfer when registered may be retained by the Company. The Board may, in its absolute discretion and without assigning any reason therefor, decline to register any transfer of any share which is not a fully-paid share. The Board may also decline to register any transfer unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.1&#160;&#160;&#160;&#160;the instrument of transfer is duly stamped and lodged with the Company, at such place as the Board shall appoint for the purpose, accompanied by the certificate for the shares to which it relates, and such other evidence as the Board may reasonably require to show the right of the transferor to make the transfer&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.2&#160;&#160;&#160;&#160;the instrument of transfer is in respect of only one class or series of shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.3&#160;&#160;&#160;&#160;the instrument of transfer does not result in joint holders of the shares to be transferred&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.4&#160;&#160;&#160;&#160;it is satisfied that all applicable consents, authorisations, permissions or approvals of any governmental body or agency in Bermuda or any other applicable jurisdiction required to be obtained under relevant law prior to such transfer have been obtained.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to any directions of the Board from time to time in force, the Secretary may exercise the powers and discretions of the Board under this Bye-Law and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 22 and 25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24.&#160;&#160;&#160;&#160;Except in the case of an Affiliate Transfer prior to the Trigger Date (which the Board shall approve and register), the Board may decline to approve or register any transfer of shares to the extent that the Board determines, in its sole discretion, after taking into account, among other things, the limitation on voting rights contained in these Bye-Laws, that any non-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">de minimis </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">adverse tax, regulatory or legal consequences to the Company, any subsidiary of the Company, any other Shareholder or its Affiliates, or any direct or indirect investor in, or beneficial owner of an interest in, a Shareholder would result from such transfer (including, without limitation, if such consequence arises as a result of any U.S. person becoming a 9.5% U.S. Shareholder (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 66</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), provided, however, that (i) such determination shall only be made after giving effect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, (ii) prior to declining to approve or register such transfer, the Board shall first have consulted with the relevant Shareholder and explored alternatives to avoid such consequences and (iii) the power of the Board to decline to approve or register such transfer shall be applied only to the extent, and for such number of shares, as is necessary to avoid such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">non-de minimis </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">adverse tax, regulatory or legal consequences. The Board shall have the authority to request from any Shareholder, and each such Shareholder shall provide such information as the Board may reasonably request for the purpose of determining whether any transfer should be permitted.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25.&#160;&#160;&#160;&#160;If the Board declines to register a transfer it shall, within one (1) month after the date on which the instrument of transfer was lodged, send to the transferee notice of such refusal.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26.&#160;&#160;&#160;&#160;No fee shall be charged by the Company for registering any transfer, probate, letters of administration, certificate of death or marriage, power of attorney, order of court or other instrument relating to or affecting the title to any share, or otherwise making an entry in the Register relating to any share (except that the Company may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed on it in connection with such transfer or entry).</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRANSMISSION OF SHARES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27.&#160;&#160;&#160;&#160;In the case of the death of an individual Shareholder, the survivor or survivors, where the deceased was a joint holder, and the estate representative, where he was sole holder, shall be the only person recognised by the Company as having any title to his shares&#59; but nothing herein contained shall release the estate of a deceased holder (whether the sole or joint) from any liability in respect of any share held by him solely or jointly with other persons. For the purpose of this Bye-Law, estate representative means the person to whom probate or letters of administration has or have been granted in Bermuda or, failing any such person, such other person as the Board may in its absolute discretion determine to be the person recognised by the Company for the purpose of this Bye-Law. For greater certainty, where two or more persons are registered as joint holders of a share or shares, then in the event of the death of any joint holder or holders, the remaining joint holder or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">holders shall be absolutely entitled to the said share or shares and the Company shall recognize no claim in respect of the estate of any joint holder except in the case of the last survivor of such joint holders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">28.&#160;&#160;&#160;&#160;Any person becoming entitled to a share in consequence of the death of a Shareholder or otherwise by operation of applicable law may, subject as hereafter provided and upon such evidence being produced as may from time to time be required by the Board as to his entitlement, either be registered himself as the holder of the share or elect to have some person nominated by him registered as the transferee thereof. If the person so becoming entitled elects to be registered himself, he shall deliver or send to the Company a notice in writing signed by him stating that he so elects. If he shall elect to have his nominee registered, he shall signify his election by signing an instrument of transfer of such share in favour of his nominee. All the limitations, restrictions and provisions of these Bye-Laws relating to the right to transfer and the registration of transfer of shares shall be applicable to any such notice or instrument of transfer as aforesaid as if the death of such Shareholder or other event giving rise to the transmission had not occurred and the notice or instrument of transfer was an instrument of transfer signed by such Shareholder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29.&#160;&#160;&#160;&#160;A person becoming entitled to a share in consequence of the death of an individual Shareholder or otherwise by operation of applicable law shall (upon such evidence being produced as may from time to time be required by the Board as to his entitlement) be entitled to receive and may give a discharge for any dividends or other monies payable in respect of the share, but he shall not be entitled in respect of the share to receive notices of or to attend or vote at general meetings of the Company or, save as aforesaid, to exercise in respect of the share any of the rights or privileges of a Shareholder until he shall have become registered as the holder thereof. The Board may at any time give notice requiring such person to elect either to be registered himself or to transfer the share and, if the notice is not complied with within sixty days, the Board may thereafter withhold payment of all dividends and other monies payable in respect of the shares until the requirements of the notice have been complied with.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30.&#160;&#160;&#160;&#160;Subject to any directions of the Board from time to time in force, the Secretary may exercise the powers and discretions of the Board under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 27-29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GENERAL MEETINGS AND RESOLUTIONS IN WRITING</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">31.&#160;&#160;&#160;&#160;Subject to any rights to waive the Annual General Meeting pursuant to the Companies Act, the Board shall convene and the Company shall hold general meetings as Annual General Meetings in accordance with the requirements of the Companies Act at such times and places as the Board shall appoint.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">32.&#160;&#160;&#160;&#160;The Board may, whenever it thinks fit, and shall, when required by the provisions of Companies Act, convene general meetings other than Annual General Meetings which shall be called Special General Meetings.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33.&#160;&#160;&#160;&#160;33.1&#160;&#160;&#160;&#160;Except in the case of the removal of auditors or Directors, anything which may be done by resolution of the Shareholders in general meeting or by resolution of any class of Shareholders in a separate general meeting may be done by resolution in writing, signed by the Shareholders (or the holders of such class of shares) who at the date of the notice of the resolution in writing represent the majority of votes that would be required if the resolution had been voted on at a meeting of the Shareholders. Such resolution in writing may be signed by the Shareholder or its proxy, or in the case of a Shareholder that is a corporation (whether or not a company within the meaning of the Companies Act) by its representative on behalf of such Shareholder, in as many counterparts as may be necessary.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33.2&#160;&#160;&#160;&#160;Notice of any resolution in writing to be made under this Bye-Law shall be given to all the Shareholders who would be entitled to attend a meeting and vote on the resolution. The requirement to give notice of any resolution in writing to be made under this Bye-Law to such Shareholders shall be satisfied by giving to those Shareholders a copy of that resolution in writing in the same manner as that required for a notice of a general meeting of the Company at which the resolution could have been considered, except that the length of the period of notice shall not apply. The date of the notice shall be set out in the copy of the resolution in writing.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33.3&#160;&#160;&#160;&#160;The accidental omission to give notice, in accordance with this Bye-Law, of a resolution in writing to, or the non-receipt of such notice by, any person entitled to receive such notice shall not invalidate the passing of the resolution in writing</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33.4&#160;&#160;&#160;&#160;For the purposes of this Bye-Law, the date of the Resolution in writing is the date when the Resolution in writing is signed by, or on behalf of, the Shareholder who establishes the majority of votes required for the passing of the resolution in writing and any reference in any enactment to the date of passing of a Resolution is, in relation to a Resolution in writing made in accordance with this Bye-Law, a reference to such date.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33.5&#160;&#160;&#160;&#160;A Resolution in writing made in accordance with this Bye-Law is as valid as if it had been passed by the Company in general meeting or, if applicable, by a meeting of the relevant class or series of Shareholders, as the case may be. A Resolution in writing made in accordance with this Bye-Law shall constitute minutes for the purposes of the Companies Act and these Bye-Laws.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTICE OF GENERAL MEETINGS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">34.&#160;&#160;&#160;&#160;An Annual General Meeting shall be called by not less than five (5) days notice in writing and a Special General Meeting shall be called by not less than five (5) days notice in writing. The notice period shall be exclusive of the day on which it is served or deemed to be served and of the day for which it is given, and the notice shall specify the place, day and time of the meeting, and, the nature of the business to be considered. Notice of every general meeting shall be given in any manner permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">141-143 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to all Shareholders other than such as, under the provisions of these Bye-Laws or the terms of issue of the shares they hold, are not entitled to vote at such general meeting and every Director and to any Resident Representative who or which has delivered a written notice upon the Registered Office requiring that such notice be sent to him or it.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35.&#160;&#160;&#160;&#160;Notwithstanding that a meeting of the Company is called by shorter notice than that specified in this Bye-Law, it shall be deemed to have been duly called if it is so agreed&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35.1&#160;&#160;&#160;&#160;in the case of a meeting called as an Annual General Meeting, by all the Shareholders entitled to attend and vote thereat&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35.2&#160;&#160;&#160;&#160;in the case of any other meeting, by a majority in number of the Shareholders having the right to attend and vote at the meeting, being a majority together holding not less than ninety-five percent (95%) in nominal value of the shares giving that right.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">36.&#160;&#160;&#160;&#160;A Shareholder present, either in person or by proxy, at any meeting of the Company or of the holders of any class or series of shares present in person or by proxy shall be deemed to have received notice of the meeting and, where requisite, of the purposes for which it was called.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">37.&#160;&#160;&#160;&#160;Subject to the Companies Act, the Board may cancel or postpone a meeting of the Shareholders after it has been convened and notice of such cancellation or postponement shall be served in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 141 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">upon all Shareholders entitled to notice of the meeting so cancelled or postponed setting out, where the meeting is postponed to a specific date, notice of the new meeting in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 34</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">38.&#160;&#160;&#160;&#160;The accidental omission to give notice of a meeting or (in cases where instruments of proxy are sent out with the notice) the accidental omission to send such instrument of proxy to, or the non-receipt of notice of a meeting or such instrument of proxy by, any person entitled to receive such notice shall not invalidate the proceedings at that meeting.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROCEEDINGS AT GENERAL MEETINGS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">39.&#160;&#160;&#160;&#160;No business shall be transacted at any general meeting unless a quorum is present when the meeting proceeds to business, but the absence of a quorum shall not preclude the appointment, choice or election of a chairman, which shall not be treated as part of the business of the meeting. Save as otherwise provided by these Bye-Laws, one or more Shareholders holding at least fifty percent (50%) of the voting power of the Ordinary Shares (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) in issue present in person or by proxy and entitled to vote shall be a quorum for all purposes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">40.&#160;&#160;&#160;&#160;If within five minutes (or such longer time as the chairman of the meeting may determine to wait) after the time appointed for the meeting, a quorum is not present in person or by proxy, the meeting, if convened on the requisition of Shareholders, shall be dissolved. In any other case, it shall stand adjourned to such other day and such other time and place as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the chairman of the meeting may determine and at such adjourned meeting one or more Shareholders present in person or by proxy and holding at least ten percent (10%) in aggregate of the voting power of shares entitled to vote at such meeting (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be a quorum. The Company shall give not less than five (5) days notice of any meeting adjourned through want of a quorum and such notice shall state that one or more Shareholders present in person or by proxy and holding at least ten percent (10%) of the voting power of shares entitled to vote at such meeting (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) shall be a quorum.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">41.&#160;&#160;&#160;&#160;In accordance with section 71(5) of the Companies Act, a general meeting may be held with only one (1) person present provided that the requirement for a quorum is satisfied.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">42.&#160;&#160;&#160;&#160;A meeting of the Shareholders or any class or series thereof may be held by means of such telephone, electronic or other communication facilities (including, without limiting the generality of the foregoing, by telephone, or by video conferencing) as permit all persons participating in the meeting to communicate with each other simultaneously and instantaneously, and participation in such a meeting shall constitute presence in person at such meeting.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.&#160;&#160;&#160;&#160;43.1&#160;&#160;&#160;&#160;Subject to the Companies Act, a Resolution may only be put to a vote at a general meeting of the Company or of any class or series of Shareholders if&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.1.1&#160;&#160;&#160;&#160;is proposed by or at the direction of the Board&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.1.2&#160;&#160;&#160;&#160;is proposed at the direction of a court of competent jurisdiction&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.1.3&#160;&#160;&#160;&#160;is proposed on the requisition in writing of such number of Shareholders as is prescribed by, and is made in accordance with, the relevant provisions of the Companies Act&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.1.4&#160;&#160;&#160;&#160;chairman of the meeting in his absolute discretion decides that the Resolution may properly be regarded as within the scope of the meeting&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.1.5&#160;&#160;&#160;&#160;Resolution concerns a matter described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 84</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.2&#160;&#160;&#160;&#160;No amendment may be made to a Resolution, at or before the time when it is put to a vote, unless the chairman of the meeting in his absolute discretion decides that the amendment or the amended Resolution may properly be put to a vote at that meeting.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.3&#160;&#160;&#160;&#160;If the chairman of the meeting rules a Resolution or an amendment to a Resolution admissible or out of order (as the case may be), the proceedings of the meeting or on the Resolution in question shall not be invalidated by any error in his ruling. Any ruling by the chairman of the meeting in relation to a Resolution or an amendment to a Resolution shall be final and conclusive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">44.&#160;&#160;&#160;&#160;Each Director, and upon giving the notice referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 34 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">above, the Resident Representative, if any, shall be entitled to attend and speak at any general meeting of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45.&#160;&#160;&#160;&#160;The Board may choose one of their number to preside as chairman at every general meeting. If there is no such chairman, or if at any meeting the chairman is not present within five (5) minutes after the time appointed for holding the meeting, or if neither of them is willing to act as chairman, the Directors present shall choose one of their number to act or if only one Director is present he shall preside as chairman if willing to act. If no Director is present, or if each of the Directors present declines to take the chair, the persons present and entitled to vote on a poll shall elect one of their number to be chairman.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46.&#160;&#160;&#160;&#160;The chairman of the meeting may, with the consent by Resolution of the persons present at any meeting at which a quorum is present (and shall if so directed by the meeting), adjourn the meeting from time to time and from place to place but no business shall be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting from which the adjournment took place. Subject to the Companies Act, in addition to any other power of adjournment conferred by law, the chairman of the meeting may at any time without consent of the persons present at the meeting adjourn the meeting (whether or not it has commenced or a quorum is present) to another time and&#47;or place if, in his opinion, it would facilitate the conduct of the business of the meeting to do so or if he is so directed (prior to or at the meeting) by the Board. When a meeting is adjourned for three (3) months or more, notice of the adjourned meeting shall be given as in the case of an original meeting. Save as expressly provided by these Bye-Laws, it shall not be necessary to give any notice of an adjournment or of the business to be transacted at an adjourned meeting.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47.&#160;&#160;&#160;&#160;&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VOTING</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">48.&#160;&#160;&#160;&#160;Except as otherwise required by the Companies Act and these Bye-Laws, any question proposed for the consideration of the Shareholders at any general meeting shall be decided by the affirmative vote of a majority of the voting power of votes cast at such meeting (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and in the case of an equality of voting power of votes cast, the Resolution shall fail. Any amendment to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 48 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall be approved by the affirmative vote of at least a majority of the voting power of shares entitled to vote at a meeting of Shareholders (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">49.&#160;&#160;&#160;&#160;&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">50.&#160;&#160;&#160;&#160;&#91;Reserved&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">51.&#160;&#160;&#160;&#160;At any general meeting, a Resolution put to the vote of the meeting shall be decided on a show of hands or by a count of votes received in the form of electronic records, unless (before or on the declaration of the result of the show of hands or count of votes received as electronic record or on the withdrawal of any other demand for a poll) a poll is demanded by&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">51.1&#160;&#160;&#160;&#160;the chairman of the meeting&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">51.2&#160;&#160;&#160;&#160;any Shareholder or Shareholders present in person or represented by proxy and holding between them not less than one tenth of the total voting power of shares entitled to vote at such meeting (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">51.3&#160;&#160;&#160;&#160;a Shareholder or Shareholders present in person or represented by proxy holding shares conferring the right to vote at such meeting, being shares on which an aggregate sum has been paid up equal to not less than one tenth of the total sum paid up on all such shares conferring such right.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">52.&#160;&#160;&#160;&#160;The demand for a poll may be withdrawn by the person or any of the persons making it at any time prior to the declaration of the result but only with the consent of the chairman and a demand so withdrawn shall not be taken to have invalidated the result of a show of hands or count of votes received as electronic records declared before a poll was made. Unless a poll is so demanded and the demand is not withdrawn, a declaration by the chairman that a Resolution has, on a show of hands or count of votes received as electronic records, been carried or carried unanimously or by a particular majority or not carried by a particular majority or lost shall be final and conclusive, and an entry to that effect in the minute book of the Company shall be conclusive evidence of the fact without proof of the number or proportion of votes recorded for or against such Resolution.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">53.&#160;&#160;&#160;&#160;If a poll is duly demanded, the result of the poll shall be deemed to be the Resolution of the meeting at which the poll is demanded.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">54.&#160;&#160;&#160;&#160;A poll demanded on the election of a chairman, or on a question of adjournment, shall be taken forthwith. A poll demanded on any other question shall be taken in such manner and either forthwith or at such time later in the meeting as the chairman shall direct and the chairman may appoint scrutineers (who need not be Shareholders) and fix a time and place for declaring the result of the poll. It shall not be necessary (unless the chairman otherwise directs) for notice to be given of a poll.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">55.&#160;&#160;&#160;&#160;The demand for a poll shall not prevent the continuance of a meeting for the transaction of any business other than the question on which the poll has been demanded and it may be withdrawn at any time before the close of the meeting or the taking of the poll, whichever is the earlier.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">56.&#160;&#160;&#160;&#160;On a poll, votes may be cast either personally or by proxy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">57.&#160;&#160;&#160;&#160;A person entitled to more than one vote on a poll need not use all his votes or cast all the votes he uses in the same way.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">58.&#160;&#160;&#160;&#160;In the case of an equality of votes at a general meeting, whether on a show of hands or on a poll, the chairman of such meeting shall not be entitled to a second or casting vote and the Resolution shall fail.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59.&#160;&#160;&#160;&#160;In the case of joint holders of a share, the vote of the senior who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders, and for this purpose seniority shall be determined by the order in which the names stand in the Register in respect of the joint holding.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60.&#160;&#160;&#160;&#160;A Shareholder who is a patient for any purpose of any statute or applicable law relating to mental health or in respect of whom an order has been made by any Court having jurisdiction for the protection or management of the affairs of persons incapable of managing their own affairs may vote, whether on a show of hands or on a poll, by his receiver, committee, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">curator bonis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or other person in the nature of a receiver, committee or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">curator bonis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> appointed by such Court and such receiver, committee, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">curator bonis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or other person may vote on a poll by proxy, and may otherwise act and be treated as such Shareholder for the purpose of general meetings.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61.&#160;&#160;&#160;&#160;No Shareholder shall, unless the Board otherwise determines, be entitled to vote at any general meeting unless all calls or other sums presently payable by him in respect of shares in the Company have been paid.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62.&#160;&#160;&#160;&#160;If&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62.1&#160;&#160;&#160;&#160;any objection shall be raised to the qualification of any voter&#59; or,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62.2&#160;&#160;&#160;&#160;any votes have been counted which ought not to have been counted or which might have been rejected&#59; or,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62.3&#160;&#160;&#160;&#160;any votes are not counted which ought to have been counted,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the objection or error shall not vitiate the decision of the meeting or adjourned meeting on any Resolution unless the same is raised or pointed out at the meeting or, as the case may be, the adjourned meeting at which the vote objected to is given or tendered or at which the error occurs. Any objection or error shall be referred to the chairman of the meeting and shall only vitiate the decision of the meeting on any Resolution if the chairman decides that the same may have affected the decision of the meeting. The decision of the chairman on such matters shall be final and conclusive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ADJUSTMENT OF VOTING POWER</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">63.&#160;&#160;&#160;&#160;The voting power of all shares is hereby adjusted (and shall be automatically adjusted in the future) to the extent necessary so that there is no 9.5% U.S. Shareholder. The Board shall implement the foregoing in the manner provided herein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">64.&#160;&#160;&#160;&#160;The Board shall from time to time, including prior to any time at which a vote of Shareholders is taken, take all reasonable steps necessary to ascertain, including those specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 68</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, through communications with Shareholders or otherwise, whether there exists, or will exist at the time any vote of Shareholders is taken, a Tentative 9.5% U.S. Shareholder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">65.&#160;&#160;&#160;&#160;In the event that a Tentative 9.5% U.S. Shareholder exists, the aggregate votes conferred by shares held by a Shareholder and treated as Controlled Shares of that Tentative 9.5% U.S. Shareholder shall be reduced to the extent necessary such that the Controlled Shares of the Tentative 9.5% U.S. Shareholder will constitute less than 9.5% of the voting power of all shares. In applying the previous sentence where shares held by more than one Shareholder are treated as Controlled Shares of such Tentative 9.5% U.S. Shareholder, the reduction in votes shall apply to such Shareholders in descending order according to their respective Attribution Percentages, provided that, in the event of a tie, the reduction shall apply first to the Shareholder whose shares are Controlled Shares of the Tentative 9.5% U.S. Shareholder by virtue of the Tentative 9.5% U.S. Shareholder&#8217;s economic interest in (as opposed to voting control with respect to) such shares. The votes of Shareholders owning no shares treated as Controlled Shares of any Tentative 9.5% U.S. Shareholder shall, in the aggregate, be increased by the same number of votes subject to reduction as described above. Such increase shall apply to all such Shareholders in proportion to their voting power at that time, provided that such increase shall be limited to the extent necessary to avoid causing any person to be a 9.5% U.S. Shareholder. The adjustments of voting power described in this Bye-Law shall apply repeatedly until there is no 9.5% U.S. Shareholder. The Board may deviate from any of the principles described in this Bye-Law and determine that shares held by a Shareholder shall carry different voting rights as it determines appropriate (1) to avoid the existence of any 9.5% U.S. Shareholder or (2) to avoid adverse tax, legal or regulatory consequences to the Company, any subsidiary of the Company, any other Shareholder or its Affiliates, or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a Shareholder. For the avoidance of doubt, in applying the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-75</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a share may carry a fraction of a vote.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">66.&#160;&#160;&#160;&#160;In these Bye-Laws&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Controlled Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; in reference to any person means all shares of the Company directly, indirectly or constructively owned by such person as determined pursuant to Sections 957 and 958 of the Code.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.5% U.S. Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a &#8220;United States person&#8221; as defined in the Code (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">U.S. person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) whose Controlled Shares constitute nine and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">one-half percent (9.5%) or more of the voting power of all shares of the Company and who would be generally required to recognize income with respect to the Company under Section 951(a)(1) of the Code, if the Company were a controlled foreign corporation as defined in Section 957 of the Code and if the ownership threshold under Section 951(b) of the Code were 9.5%.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Tentative 9.5% U.S. Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a U.S. person that, but for adjustments to the voting rights of shares pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, would be a 9.5% U.S. Shareholder.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Attribution Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to a Shareholder and a Tentative 9.5% U.S. Shareholder, the percentage of the Shareholders&#8217; shares that are treated as Controlled Shares of such Tentative 9.5% U.S. Shareholder.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OTHER ADJUSTMENTS OF VOTING POWER</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">67.&#160;&#160;&#160;&#160;In addition to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-66</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, any shares shall not carry any right to vote to the extent that the Board unanimously determines, in its sole discretion, that it is necessary that such shares should not carry the right to vote in order to avoid material adverse tax, legal or regulatory consequences to the Company, any of its subsidiaries or any other Shareholder or its Affiliates, or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a Shareholder, provided that (i) no adjustment pursuant to this sentence shall be made if it would cause any person to become a 9.5% U.S. Shareholder or the Company to become a United Kingdom controlled foreign corporation and (ii) prior to making such determination, the Board shall first have (x) consulted with the relevant Shareholder and explored alternatives to avoid such consequences and (y) in the case of such determination with respect to any member of the Apollo Group, obtained the prior written consent of such member.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTIFICATION OF VOTING POWER</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">68.&#160;&#160;&#160;&#160;Prior to any date on which Shareholders shall vote on any matter, the Board shall if it considers it necessary or appropriate (i) (x) retain the services of an internationally recognised accounting firm or organisation with comparable professional capabilities in order to assist the Company in applying the principles of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63 through 75 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and (y) obtain from such firm or organisation a statement setting forth the information obtained, procedures followed and determinations made with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63 through 75</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, or (ii) notify each Shareholder of the voting power conferred by its shares determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63 through 75</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REQUIREMENT TO PROVIDE INFORMATION AND NOTICE</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">69.&#160;&#160;&#160;&#160;The Company shall have the authority to request from any holder of shares, and such holder of shares shall provide, such information as the Company may reasonably request for the purpose of determining whether any holder&#8217;s voting rights are to be adjusted pursuant to these Bye-Laws. If a Shareholder fails to respond to a request for information from the Company pursuant to this Bye-Law, or submits incomplete or inaccurate information in response to such a request, the Company may in its reasonable discretion (after considering the circumstances described in any response to the request by the Shareholder and providing such Shareholder with a cure period of such length, if any, as the Company in its reasonable discretion shall determine to be reasonable under the circumstances) determine that such Shareholder&#8217;s shares shall carry no or reduced, as the case may be, voting rights until otherwise determined by the Company in its reasonable discretion.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">70.&#160;&#160;&#160;&#160;Any holder of shares shall give notice to the Company within ten days following the date that such holder acquires actual knowledge that it is, or caused another person to become, a Tentative 9.5% U.S. Shareholder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">71.&#160;&#160;&#160;&#160;Notwithstanding the foregoing, no Shareholder shall be liable to any other Shareholder or the Company for any losses or damages resulting from such Shareholder&#8217;s failure to respond to, or submission of incomplete or inaccurate information in response to, a request under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 69 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or from such Shareholder&#8217;s failure to give notice under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 70</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">72.&#160;&#160;&#160;&#160;Any information provided by a Shareholder to the Company pursuant to this Bye-Law, or other information provided pursuant to this Bye-Law or for purposes of making the analysis required by, for purposes of implementing, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 24 and 63 through 75</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, shall be deemed confidential information (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and shall be used by the Company solely for the purposes contemplated by those Bye-Laws (except as may be required otherwise by applicable law or regulation). The Company shall hold such Confidential Information that it receives in strict confidence and shall not disclose any Confidential Information that it receives, except (i) to the United States Internal Revenue Service (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) if and to the extent the Confidential Information is required by the Service, (ii) to any outside legal counsel or accounting firm engaged by the Company to make determinations regarding the relevant Bye-Laws, or (iii) as otherwise required by applicable law or regulation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">73.&#160;&#160;&#160;&#160;The Company shall take all measures practicable to ensure the continued confidentiality of the Confidential Information and shall grant the persons referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 72(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">above access to the Confidential Information only to the extent necessary to allow them to assist the Company in any analysis required by, or for purposes of implementing, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 24 and 63 through 75 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or to determine whether the Company would realise any income that would be included in the income of any Shareholder (or any interest holder, whether direct or indirect, of any Shareholder) by operation of Section 953(c) of the Code. Prior to granting access to the Confidential Information to such persons or to any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">officer or employee as set forth below, the Company shall inform them of its confidential nature and of the provisions of this Bye-Law and shall require them to abide by all the provisions hereof. The Company shall not disclose the Confidential Information to any Director, except following compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 74 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to the extent required under applicable law or regulation. For the avoidance of doubt, the Company shall be permitted to disclose to the Shareholders and others the relative voting percentages of the Shareholders after application by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. At the written request of a Shareholder, the Confidential Information of such Shareholder shall be destroyed or returned to such Shareholder after the later to occur of (i) such Shareholder no longer being a Shareholder or (ii) the expiration of the applicable statute of limitations with respect to any Confidential Information for purposes of engaging in any tax related analysis.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">74.&#160;&#160;&#160;&#160;The Company (i) shall notify a Shareholder immediately of the existence, terms and circumstances surrounding any request made to the Company to disclose any Confidential Information provided by or with respect to such Shareholder and, prior to such disclosure, shall permit such Shareholder a reasonable period of time to seek a protective order or other appropriate remedy and&#47;or waive compliance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 73</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and (ii) may, in the absence of a protective order, make such disclosure without liability hereunder, provided that the Company shall furnish only that portion of the Confidential Information which is legally required, shall give such Shareholder notice of the information to be disclosed as far in advance of its disclosure as practicable and, upon the request of such Shareholder and at its expense, shall use best efforts to ensure that confidential treatment will be accorded all such disclosed information.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">75.&#160;&#160;&#160;&#160;The Company and the Board may rely exclusively on the analysis, deliberation, reports and other communications of the persons specified in (ii) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 72 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">above with respect to the collection, disclosure or use of the Confidential Information, including, but not limited to implementing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 24, 84 or 85 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or determining whether the Company would realize any income that would be included in the income of any Shareholder (or any interest holder, whether direct or indirect, of any Shareholder) by operation of Section 953(c) of the Code.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURCHASE OF SHARES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">76.&#160;&#160;&#160;&#160;If the Board unanimously determines that share ownership by any person may result in material adverse tax consequences to the Company, any subsidiary of the Company, any other holder of shares or its Affiliates, or any direct or indirect investor in, or any other person holding a direct or indirect beneficial or economic ownership interest in, a Shareholder (including if such consequence arises as a result of any such U.S. person owning Controlled Shares of 9.5% or more of the value of the Company or the voting shares of the Company (provided that this Bye-Law shall only apply after the application of the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63 through 75</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), the Company will have the option but not the obligation to purchase or assign to a third party the right to purchase the minimum number of shares held by such person solely to the extent, and for the number of shares, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that it is necessary to eliminate such material adverse tax consequence at a price determined in the good faith discretion of the Board to represent such shares&#8217; fair market value&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that (i) if the shares are not traded on a securities exchange in or outside the United States, the fair market value per share shall be determined by the Board without a minority discount but with an appropriate liquidity discount, such value and liquidity discount, if any, as determined by the Board, or (ii) if the shares are traded on a securities exchange in or outside the United States, the fair market value per share shall be determined by the Board based on the average of the last sales price per share or if there is none, the average of the bid and asked price per share, without a minority discount or a liquidity discount, in each case for the eight business days prior to the repurchase date. If a Shareholder disagrees with the price so determined by the Board, the fair market value per share and the liquidity discount, if any, will be determined by an independent firm of internationally recognised chartered accountants acting as experts and not arbiters (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Expert</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and retained jointly by the Company and the Shareholder at the expense of the Company and if they cannot agree within 10 days of such disagreement such Expert shall be appointed by the president for the time being of the Institute of Chartered Accountants.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXIES AND CORPORATE REPRESENTATIVES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">77.&#160;&#160;&#160;&#160;A Shareholder may appoint one or more persons as his proxy, with or without the power of substitution, to represent him and vote on his behalf in respect of all or some of his shares at any general meeting (including an adjourned meeting). A proxy need not be a Shareholder. The instrument appointing a proxy or corporate representative shall be in writing executed by the appointor or his attorney authorised by him in writing or, if the appointor is a corporation, either under its seal or executed by an officer, attorney or other person authorised to sign the same.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">78.&#160;&#160;&#160;&#160;A Shareholder which is a corporation may, by written authorisation, appoint any person (or two (2) or more persons in the alternative) as its representative to represent it and vote on its behalf at any general meeting (including an adjourned meeting) and such a corporate representative may exercise the same powers on behalf of the corporation which he represents as that corporation could exercise if it were an individual Shareholder and the Shareholder shall for the purposes of these Bye-Laws be deemed to be present in person at any such meeting if a person so authorised is present at it. Notwithstanding the foregoing, the chairman of the meeting may accept such assurances as he thinks fit as to the right of any person to attend and vote at general meetings on behalf of a corporation that is a Shareholder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">79.&#160;&#160;&#160;&#160;Any Shareholder may appoint a proxy or (if a corporation) representative for a specific general meeting, and adjournments thereof, or may appoint a standing proxy or (if a corporation) representative, by serving on the Company, in accordance with the manner provided for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 141 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">at the Registered Office, or at such place or places as the Board may otherwise specify for the purpose, a proxy or (if a corporation) an authorisation. For purposes of service on the Company pursuant to this Bye-Law, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 141 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as to service on Shareholders shall </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">mutatis mutandis </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">apply to service on the Company. Any standing proxy or authorisation shall be valid for all general meetings and adjournments thereof or Resolutions in writing, as the case may be, until notice of revocation is received at the Registered Office or at such place or places as the Board may otherwise specify for the purpose. Where a standing proxy or authorisation exists, its operation shall be deemed to have been suspended at any general meeting of the Company or adjournment thereof at which the Shareholder is present or in respect to which the Shareholder has specially appointed a proxy or representative. The Board may from time to time require such evidence as it shall deem necessary as to the due execution and continuing validity of any standing proxy or authorisation and the operation of any such standing proxy or authorisation shall be deemed to be suspended until such time as the Board determines that it has received the requested evidence or other evidence satisfactory to it.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">80.&#160;&#160;&#160;&#160;Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 78 and 79</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the instrument appointing a proxy or corporate representative together with such other evidence as to its due execution as the Board may from time to time require, shall be delivered at the Registered Office (or at such place as may be specified in the notice convening the meeting or in any notice of any adjournment or, in either case or the case of a written Resolution, in any document sent therewith) by such date and time specified in the notice prior to the holding of the relevant meeting or adjourned meeting at which the person named in the instrument proposes to vote or, in the case of a poll taken subsequently to the date of a meeting or adjourned meeting, before the time appointed for the taking of the poll, or, in the case of a written Resolution, prior to the effective date of the written Resolution and in default the instrument of proxy or authorisation shall not be treated as valid.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">81.&#160;&#160;&#160;&#160;Instruments of proxy or authorisation shall be in any common form or in such other form as the Board may approve and the Board may, if it thinks fit, send out with the notice of any meeting or any written Resolution forms of instruments of proxy or authorisation for use at that meeting or in connection with that written Resolution. The instrument of proxy shall be deemed to confer authority to demand or join in demanding a poll, to speak at the meeting and to vote on any amendment of a written Resolution or amendment of a Resolution put to the meeting for which it is given as the proxy thinks fit. The instrument of proxy or authorisation shall, unless the contrary is stated therein, be valid as well for any adjournment of the meeting as for the meeting to which it relates. If the terms of the appointment of a proxy include a power of substitution, any proxy appointed by substitution under such power shall be deemed to be the proxy of the Shareholder who conferred such power. All the provisions of these Bye-Laws relating to the execution and delivery of an instrument or other form of communication appointing or evidencing the appointment of a proxy shall apply, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, to the instrument or other form of communication effecting or evidencing such an appointment by substitution.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">82.&#160;&#160;&#160;&#160;A vote given in accordance with the terms of an instrument of proxy or authorisation shall be valid notwithstanding the previous death or unsoundness of mind of the principal, or revocation of the instrument of proxy or of the corporate authority, provided </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that no intimation in writing of such death, unsoundness of mind or revocation shall have been received by the Company at the Registered Office (or such other place as may be specified for the delivery of instruments of proxy or authorisation in the notice convening the meeting or other documents sent therewith) at least one hour before the commencement of the meeting or adjourned meeting, or the taking of the poll, or the day before the effective date of any written Resolution at which the instrument of proxy or authorisation is used.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">83.&#160;&#160;&#160;&#160;Subject to the Companies Act, the Board may at its discretion waive any of the provisions of these Bye-Laws related to proxies or authorisations and, in particular, may accept such verbal or other assurances as it thinks fit as to the right of any person to attend, speak and vote on behalf of any Shareholder at general meetings or to sign written Resolutions.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTAIN SUBSIDIARIES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">84.&#160;&#160;&#160;&#160;Voting of Subsidiary Shares</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">84.1&#160;&#160;&#160;&#160;Notwithstanding any other provision of these Bye-Laws to the contrary, if the voting rights of any shares of the Company are adjusted pursuant to Bye-Laws 63-67 (inclusive) and the Company is required or entitled to vote at a general meeting of any subsidiary of the Company organized under the laws of a jurisdiction outside the United States of America (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Non-U.S. Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;, but excluding for these purposes any subsidiary that has elected to be treated as a &#8220;U.S. person&#8221; for federal income tax purposes pursuant to Section 953(d) of the Code), and the subject matter of the vote is (a) the appointment, removal or remuneration of directors of a non-U.S. Subsidiary of the Company or (b) any other subject matter with respect to a non-U.S. Subsidiary that legally requires the approval of the shareholders of such non-U.S. Subsidiary, the Directors shall refer the subject matter of the vote to the Shareholders of the Company on a poll (subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 48-75</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and seek authority from the Shareholders in a general meeting of the Company for the Company&#8217;s corporate representative or proxy to vote in favor of the resolution proposed by the Non-U.S. Subsidiary. The Directors shall cause the Company&#8217;s corporate representative or proxy to vote the Company&#8217;s shares in the Non-U.S. Subsidiary pro rata to the votes received at the general meeting of the Company (as determined subject to Bye-Laws 48-75, to the extend relevant), with votes for or against the directing resolution being taken, respectively, as an instruction for the Company&#8217;s corporate representative or proxy to vote the appropriate proportion of its shares for and the appropriate proportion of its shares against the resolution proposed by the Non-U.S. Subsidiary.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">84.2&#160;&#160;&#160;&#160;If the Board, in its discretion, determines that the application of Bye-law 84.1 with respect to a particular vote is not necessary to achieve the purposes of this Bye-law 84, it may waive the application of Bye-law 84.1 with respect to such vote.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">85.&#160;&#160;&#160;&#160;Bye-Laws or Articles of Association of Certain Subsidiaries</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Board shall ensure (subject to the laws of the relevant jurisdiction) that the bye-laws, articles of association or other constitutive documents of each Non-U.S. Subsidiary (for the purpose of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 85</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Relevant Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) contain provisions substantially similar to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 84-85 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">herein (provided that the bye-laws, articles of association or other constitutive documents of such Relevant Subsidiary need not necessarily include provisions substantially similar to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 48-75 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">herein) requiring all shares held by such Relevant Subsidiary in any other Non-U.S. Subsidiary to be voted in the appropriate proportions to the votes received from the shareholders of such Relevant Subsidiary at its general meeting for or against the resolution instructing such Relevant Subsidiary.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ELECTION OF DIRECTORS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">86.&#160;&#160;&#160;&#160;The Board shall consist of not less than six (6) and not more than fifteen (15) Directors (as determined by resolution of the Board of Directors) or such number as the Shareholders may from time to time determine. The Board of Directors shall initially consist of eight (8) Directors.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">87.&#160;&#160;&#160;&#160;The initial Directors shall serve for an initial term ending on the date of the first annual general meeting of Shareholders following Merger Date, after which Directors shall be elected by the Shareholders and shall serve a term ending on the date of the first annual general meeting of Shareholders next following the annual general meeting at which such Director was elected, subject to any rights to waive the Annual General Meeting pursuant to the Companies Act. In addition, notwithstanding the foregoing, each Director shall hold office until such Director&#8217;s successor shall have been duly elected or until such Director is removed from office pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 88 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or such office is otherwise vacated. In no event will a decrease in the number of Directors shorten the term of any incumbent Director.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REMOVAL OF DIRECTORS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">88.&#160;&#160;&#160;&#160;The Shareholders may, at any general meeting convened and held in accordance with these Bye-Laws, remove a Director by the affirmative vote of Shareholders holding at least a majority of the total combined voting power of all of the issued and outstanding shares of the Company (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#59; provided that the notice of any such meeting convened for the purpose of removing a Director shall contain a statement of the intention so to do and be served upon such Director not less than 14 days before the meeting and at such meeting such Director shall be entitled to be heard on the motion for such Director&#8217;s removal.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">89.&#160;&#160;&#160;&#160;A vacancy on the Board created by the removal of a Director under the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 88 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">may be filled by the Shareholders at the meeting at which such Director is removed or, in the absence of such election or appointment, the Board may fill the vacancy in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Director so elected or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">appointed by the Shareholders or, in absence thereof, the Board pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 89 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall hold office until the next annual general meeting or until such Director&#8217;s office is otherwise vacated and shall serve within the same class of Directors as the predecessor. At such next annual general meeting, the Shareholders shall elect a Director to fill such vacancy to serve the remaining term, if any, of such predecessor.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VACANCIES ON THE BOARD</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">90.&#160;&#160;&#160;&#160;The Board shall have the power from time to time and at any time, by the affirmative vote of at least a majority of the Directors then in office, to appoint any person as a Director to fill a vacancy on the Board. A Director so appointed shall hold office until the next annual general meeting or until such Director&#8217;s office is otherwise vacated and shall serve within the same class of Directors as the predecessor. At such next annual general meeting, following a vacancy filled by the Board, the Shareholders shall elect a Director to fill such vacancy to serve the remaining term, if any, of such predecessor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">91.&#160;&#160;&#160;&#160;The office of a Director shall be vacated upon the happening of any of the following events&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">91.1&#160;&#160;&#160;&#160;if he resigns his office by notice in writing delivered to the Registered Office or tendered at a meeting of the Board&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">91.2&#160;&#160;&#160;&#160;if he becomes of unsound mind or a patient for any purpose of any statute or applicable law relating to mental health and the Board resolves that his office is vacated&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">91.3&#160;&#160;&#160;&#160;if he becomes bankrupt under the laws of any country or compounds with his creditors&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">91.4&#160;&#160;&#160;&#160;if he is prohibited by law from being a Director&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">91.5&#160;&#160;&#160;&#160;if he ceases to be a Director by virtue of the Companies Act or is removed from office pursuant to these Bye-Laws.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ALTERNATE DIRECTORS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">92.&#160;&#160;&#160;&#160;A Director (other than an Alternate Director) may appoint and remove his own Alternate Director. Any appointment or removal of an Alternate Director by a Director shall be effected by depositing a notice of appointment or removal with the Secretary at the Registered Office, signed by such Director, and such appointment or removal shall become effective on the date of receipt by the Secretary. Any Alternate Director may be removed by resolution of the Board. Subject as aforesaid, the office of Alternate Director shall continue until the next annual election of Directors or, if earlier, the date on which the relevant Director ceases to be a Director. An Alternate Director may also be a Director in his own right and may act as alternate to more than one Director.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">93.&#160;&#160;&#160;&#160;An Alternate Director shall cease to be an Alternate Director&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">93.1&#160;&#160;&#160;&#160;if his appointor ceases to be a Director&#59; but, if a Director retires by rotation or otherwise but is reappointed or deemed to have been reappointed at the meeting at which he retires, any appointment of an Alternate Director made by him which was in force immediately prior to his retirement shall continue after his reappointment&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">93.2&#160;&#160;&#160;&#160;on the happening of any event which, if he were a Director, would cause him to vacate his office as Director&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">93.3&#160;&#160;&#160;&#160;if he is removed from office pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 92</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">93.4&#160;&#160;&#160;&#160;if he resigns his office by notice to the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">94.&#160;&#160;&#160;&#160;An Alternate Director shall be entitled to receive notices of all meetings of Directors, to attend, be counted in the quorum and vote at any such meeting at which any Director to whom he is alternate is not personally present, and generally to perform all the functions of any Director to whom he is alternate in his absence.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">95.&#160;&#160;&#160;&#160;Every person acting as an Alternate Director shall (except as regards powers to appoint an alternate and remuneration) be subject in all respects to the provisions of these Bye-Laws relating to Directors and shall alone be responsible to the Company for his acts and defaults and shall not be deemed to be the agent of or for any Director for whom he is alternate. An Alternate Director may be paid expenses and shall be entitled to be indemnified by the Company to the same extent </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as if he were a Director.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">96.&#160;&#160;&#160;&#160;Every person acting as an Alternate Director shall have one vote for each Director for whom he acts as alternate (in addition to his own vote if he is also a Director). The signature of an Alternate Director to any resolution in writing of the Board or a committee of the Board shall, unless the terms of his appointment provide to the contrary, be as effective as the signature of the Director or Directors to whom he is alternate.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REMUNERATION OF DIRECTORS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">97.&#160;&#160;&#160;&#160;The remuneration (if any) of the Directors shall be determined by the Board and shall be deemed to accrue from day to day. The Directors may also be paid all travel, hotel and other expenses properly incurred by them in attending and returning from meetings of the Board, any committee appointed by the Board, general meetings of the Company, or in connection with the business of the Company or their duties as Directors generally.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DIRECTORS&#8217; INTERESTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">98.&#160;&#160;&#160;&#160;Contracts and Disclosure of Directors&#8217; Interests</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">98.1&#160;&#160;&#160;&#160;Any Director, or any Director&#8217;s firm, partner or any company with whom any Director is associated, may act in a professional capacity for the Company and such Director or such Director&#8217;s firm, partner or such company shall be entitled to remuneration for professional services as if such Director were not a Director, provided that nothing herein contained shall authorise a Director or Director&#8217;s firm, partner or such company to act as Auditor of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">98.2&#160;&#160;&#160;&#160;A Director who is directly or indirectly interested in a contract or proposed contract or arrangement with the Company shall declare the nature of such interest as required by the Companies Act.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">98.3&#160;&#160;&#160;&#160;Following a declaration being made pursuant to this Bye-Law, and unless disqualified by a majority of the disinterested Directors present at the relevant Board meeting, a Director may vote in respect of any contract or proposed contract or arrangement in which such Director is interested and may be counted in the quorum at such meeting. To the fullest extent permitted by the Companies Act in the event that one or more interested Directors are disqualified or elect to be recused from voting on a matter, or one or more Directors are later found to have an interest or conflict that should have been declared, the matter shall be approved or stand approved if it is or was approved by a majority of the votes cast by the Directors that do not have any interest or conflict in the matter, even if less than a quorum.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">98.4&#160;&#160;&#160;&#160;Subject to the Companies Act and any further disclosure required thereby, a general notice to the Directors by a Director or officer declaring that he is a director or officer or has an interest in any business entity and is to be regarded as interested in any transaction or arrangement made with that business entity shall be sufficient declaration of interest in relation to any transaction or arrangement so made.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">POWERS AND DUTIES OF THE BOARD</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">99.&#160;&#160;&#160;&#160;Subject to the provisions of the Companies Act and these Bye-Laws the Board shall manage and control all of the business of the Company and may pay all expenses incurred in promoting and incorporating the Company and may exercise all the powers of the Company. No alteration of these Bye-Laws and no direction given by the Company by Resolution, if any, shall invalidate any prior act of the Board which would have been valid if that alteration had not been made or that direction had not been given. The powers given by this Bye-Law shall not be limited by any special power given to the Board by these Bye-Laws and a meeting of the Board at which a quorum is present shall be competent to exercise all the powers, authorities and discretions for the time being vested in or exercisable by the Board.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">100.&#160;&#160;&#160;&#160;The Board may exercise all the powers of the Company except those powers that are required by the Companies Act or these Bye-Laws to be exercised by the Shareholders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">101.&#160;&#160;&#160;&#160;All cheques, promissory notes, drafts, bills of exchange and other instruments, whether negotiable or transferable or not, and all receipts for money paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed, as the case may be, in such manner as the Board shall from time to time by resolution determine.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">102.&#160;&#160;&#160;&#160;The Board on behalf of the Company may provide benefits, whether by the payment of gratuities or pensions or otherwise, for any person including any Director or former Director who has held any executive office or employment with the Company or with anybody corporate which is or has been a subsidiary or Affiliate of the Company or a predecessor in the business of the Company or of any such subsidiary or Affiliate, and to any member of his family or any person who is or was dependent on him, and may contribute to any fund and pay premiums for the purchase or provision of any such gratuity, pension or other benefit, or for the insurance of any such person.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">103.&#160;&#160;&#160;&#160;The Board may from time to time appoint one or more of its body to be a managing director, joint managing director or an assistant managing director or to hold any other employment or executive office with the Company for such period and upon such terms as the Board may determine and may revoke or terminate any such appointments. Any such revocation or termination as aforesaid shall be without prejudice to any claim for damages that such Director may have against the Company or the Company may have against such Director for any breach of any contract of service between him and the Company which may be involved in such revocation or termination. Any person so appointed shall receive such remuneration (if any) (whether by way of salary, commission, participation in profits or otherwise) as the Board may determine, and either in addition to or in lieu of his remuneration as a Director.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DELEGATION OF THE BOARD&#8217;S POWERS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">104.&#160;&#160;&#160;&#160;The Board may by proxy or power of attorney appoint any company, firm or person or any fluctuating body of persons to be the attorney or attorneys of the Company for such purposes and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Board under these Bye-Laws) and for such period and subject to such conditions as it may think fit, and any such proxy or power of attorney may contain such provisions for the protection and convenience of persons dealing with any such proxy&#47;attorney and of such proxy&#47;attorney as the Board may think fit, and may also authorise any such proxy&#47;attorney to sub-delegate all or any of the powers, authorities and discretions vested in him. Such attorney may, if so authorised by the power of attorney, execute any deed, instrument or other document on behalf of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">105.&#160;&#160;&#160;&#160;The Board may entrust to and confer upon any Director, Officer or, without prejudice to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 104</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, other individual any of the powers, authorities and discretions exercisable by it upon such terms and conditions with such restrictions as it thinks fit, and either collaterally with, or to the exclusion of, its own powers, and may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">from time to time revoke or vary all or any of such powers, authorities and discretions but no person dealing in good faith and without notice of such revocation or variation shall be affected thereby.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">106.&#160;&#160;&#160;&#160;The Board may delegate any of its powers, authorities and discretions to committees, consisting of such person or persons (whether a member or members of its body or not) as it thinks fit. Any committee so formed shall, in the exercise of the powers, authorities and discretions so delegated, and in conducting its proceedings conform to any regulations which may be imposed upon it by the Board. If no regulations are imposed by the Board the proceedings of a committee with two (2) or more members shall be, as far as is practicable, governed by the Bye-Laws regulating the proceedings of the Board.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROCEEDINGS OF THE BOARD</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">107.&#160;&#160;&#160;&#160;The Board may meet for the despatch of business, adjourn and otherwise regulate its meetings as it thinks fit. Questions arising at any meeting shall be determined by a majority of votes. In the case of an equality of votes, the motion shall be deemed to have been lost. A Director may, and the Secretary on the requisition of a Director shall, at any time summon a meeting of the Board.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">108.&#160;&#160;&#160;&#160;Notice of a meeting of the Board shall be deemed to be duly given to a Director if it is given to him personally or by word of mouth or sent to him by post, cable, telex, facsimile, email or other mode of representing or reproducing words in a legible and non-transitory form or as an electronic record at his last known address or any other address given by him to the Company for this purpose and the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 141 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall apply to any notice so given as to the deemed date of service of such notice. A Director may retrospectively waive the requirement for notice of any meeting by consenting in writing to the business conducted at the meeting.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">109.&#160;&#160;&#160;&#160;The quorum necessary for the transaction of the business of the Board may be fixed by the Board and, unless so fixed at any other number, shall be a majority of Directors in office from time to time and in no event shall be less than two Directors. Any Director who ceases to be a Director at a meeting of the Board may continue to be present and to act as a Director and be counted in the quorum until the termination of the meeting if no other Director objects and if otherwise a quorum of Directors would not be present.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">110.&#160;&#160;&#160;&#160;The Resident Representative shall, upon delivering written notice of an address for the purposes of receipt of notice to the Registered Office, be entitled to receive notice of, attend and be heard at, and to receive minutes of all meetings of the Board.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">111.&#160;&#160;&#160;&#160;So long as a quorum of Directors remains in office, the continuing Directors may act notwithstanding any vacancy in the Board but, if no such quorum remains, the continuing Directors or a sole continuing Director may act only for the purpose of calling a general meeting or preserving the assets of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">112.&#160;&#160;&#160;&#160;The Board may choose one of their number to preside as chairman at every meeting of the Board. If there is no such chairman, or if at any meeting the chairman is not present within five (5) minutes after the time appointed for holding the meeting, or is not willing to act as chairman, the Directors present may choose one of their number to be chairman of the meeting.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">113.&#160;&#160;&#160;&#160;The meetings and proceedings of any committee consisting of two or more members shall be governed by the provisions contained in these Bye-Laws for regulating the meetings and proceedings of the Board so far as the same are applicable and are not superseded by any regulations imposed by the Board.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">114.&#160;&#160;&#160;&#160;A resolution in writing signed by all the Directors for the time being entitled to receive notice of a meeting of the Board (or by an Alternate Director, as provided for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 92</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or by all the members of a committee for the time being shall be as valid and effectual as a resolution passed at a meeting of the Board or, as the case may be, of such committee duly called and constituted. Such resolution may be contained in one document or in several documents in the like form each signed by one or more of the Directors or members of the committee concerned.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">115.&#160;&#160;&#160;&#160;A meeting of the Board or a committee appointed by the Board may be held by means of such telephone, electronic or other communication facilities (including, without limiting the generality of the foregoing, by telephone or by video conferencing) as permit all persons participating in the meeting to communicate with each other simultaneously and instantaneously and participation in such a meeting shall constitute presence in person at such meeting. Such a meeting shall be deemed to take place where the largest group of those Directors participating in the meeting is physically assembled, or, if there is no such group, where the chairman of the meeting then is.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">116.&#160;&#160;&#160;&#160;All acts done by the Board or by any committee or by any person acting as a Director or member of a committee or any person duly authorised by the Board or any committee shall, notwithstanding that it is afterwards discovered that there was some defect in the appointment of any member of the Board or such committee or person acting as aforesaid or that they or any of them were disqualified or had vacated their office, be as valid as if every such person had been duly appointed and was qualified and had continued to be a Director, member of such committee or person so authorised.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">117.&#160;&#160;&#160;&#160;If a question arises at a meeting of the Board or a committee of the Board as to the entitlement of a Director (including the chairman) to vote or be counted in a quorum, the question may, before the conclusion of the meeting, be determined by a resolution of the Board (on which such Director shall not vote) and such resolution shall be final and conclusive except in a case where the nature or extent of the interests of the Director concerned have not been fairly disclosed.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OFFICERS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">118.&#160;&#160;&#160;&#160;The Officers of the Company who may or may not be Directors may be appointed by the Board at any time. The Chief Executive Officer who shall be an Officer for purposes of these Bye-Laws and the Companies Act may be appointed from time to time by the Board as provided in the immediately preceding sentence or by Resolution, and the Chief Executive Officer shall, subject to the control of the Board, supervise and administer all of the general business and affairs of the Company. Any person appointed pursuant to this Bye-Law shall hold office for such period and upon such terms as the Board may determine and the Board may revoke or terminate any such election or appointment. Any such revocation or termination shall be without prejudice to any claim for damages that such Officer may have against the Company or the Company may have against such Officer for any breach of any contract of service between him and the Company which may be involved in such revocation or termination. Save as provided in the Companies Act or these Bye-Laws, the powers and duties of the Officers of the Company shall be such (if any) as are determined from time to time by the Board.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MINUTES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">119.&#160;&#160;&#160;&#160;The Board shall cause minutes to be made and books kept for the purpose of recording&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">119.1&#160;&#160;&#160;&#160;all appointments of Officers made by the Board&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">119.2&#160;&#160;&#160;&#160;the names of the Directors and other persons (if any) present at each meeting of the Board&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">119.3&#160;&#160;&#160;&#160;all proceedings at meetings of the Company, of the holders of any class or series of shares in the Company and of the Board&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">119.4&#160;&#160;&#160;&#160;all proceedings of its managers (if any).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shareholders shall only be entitled to see the Register of Directors and Officers, the Register, the financial information provided for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 139 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and the minute books relating to meetings of the Shareholders of the Company. Such minute books shall be maintained in Bermuda.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECRETARY AND RESIDENT REPRESENTATIVE</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">120.&#160;&#160;&#160;&#160;The Secretary (including one or more deputy or assistant secretaries) and, if required, the Resident Representative, shall be appointed by the Board at such remuneration (if any) and upon such terms as it may think fit and any Secretary and Resident Representative so appointed may be removed by the Board. The duties of the Secretary and the duties of the Resident Representative shall be those prescribed by the Companies Act together with such other duties as shall from time to time be prescribed by the Board.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">121.&#160;&#160;&#160;&#160;A provision of the Companies Act or these Bye-Laws requiring or authorising a thing to be done by or to a Director and the Secretary shall not be satisfied by its being done by or to the same person acting both as Director and as, or in the place of, the Secretary.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THE SEAL</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">122.&#160;&#160;&#160;&#160;The Board may authorise the production of a common Seal of the Company and one or more duplicate common Seals of the Company, which shall consist of a circular metal device with the name of the Company around the outer margin thereof and the country and year of registration in Bermuda across the centre thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">123.&#160;&#160;&#160;&#160;Any document required to be under Seal or executed as a deed on behalf of the Company may be</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">123.1&#160;&#160;&#160;&#160;executed under the Seal in accordance with these Bye-Laws&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">123.2&#160;&#160;&#160;&#160;signed or executed by any person authorised by the Board for that purpose, without the use of the Seal.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">124.&#160;&#160;&#160;&#160;The Board shall provide for the custody of every Seal. A Seal shall only be used by authority of the Board or of a committee constituted by the Board. Subject to these Bye-Laws, any instrument to which a Seal is affixed shall be signed by either a Director, or by the Secretary or by any one person authorised by the Board for that purpose.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DIVIDENDS AND OTHER PAYMENTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">125.&#160;&#160;&#160;&#160;The Board may from time to time declare dividends or distributions out of contributed surplus to be paid to the Shareholders according to their rights and interests, including such interim dividends as appear to the Board to be justified by the position of the Company. The Board, in its discretion, may determine that any dividend shall be paid in cash or shall be satisfied, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 133</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in paying up in full shares in the Company to be issued to the Shareholders credited as fully paid or partly paid or partly in one way and partly the other. The Board may also pay any fixed cash dividend which is payable on any shares of the Company half yearly or on such other dates, whenever the position of the Company, in the opinion of the Board, justifies such payment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">126.&#160;&#160;&#160;&#160;Except insofar as the rights attaching to, or the terms of issue of, any share otherwise provide&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">126.1&#160;&#160;&#160;&#160;all dividends or distributions out of contributed surplus may be declared and paid according to the amounts paid up on the shares in respect of which the dividend or distribution is paid, and an amount paid up on a share in advance of calls may be treated for the purpose of this Bye-Law as paid-up on the share&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">126.2&#160;&#160;&#160;&#160;dividends or distributions out of contributed surplus may be apportioned and paid pro rata according to the amounts paid-up on the shares during any portion or portions of the period in respect of which the dividend or distribution is paid.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">127.&#160;&#160;&#160;&#160;The Board may deduct from any dividend, distribution or other monies payable to a Shareholder by the Company on or in respect of any shares all sums of money (if any) presently payable by him to the Company on account of calls or otherwise in respect of shares of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">128.&#160;&#160;&#160;&#160;No dividend, distribution or other monies payable by the Company on or in respect of any share shall bear interest against the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">129.&#160;&#160;&#160;&#160;Any dividend, distribution or interest, or part thereof payable in cash, or any other sum payable in cash to the holder of shares may be paid by cheque or warrant sent through the post or by courier addressed to the holder at his address in the Register or, in the case of joint holders, addressed to the holder whose name stands first in the Register in respect of the shares at his registered address as appearing in the Register or addressed to such person at such address as the holder or joint holders may in writing direct. Every such cheque or warrant shall, unless the holder or joint holders otherwise direct, be made payable to the order of the holder or, in the case of joint holders, to the order of the holder whose name stands first in the Register in respect of such shares, and shall be sent at his or their risk and payment of the cheque or warrant by the bank on which it is drawn shall constitute a good discharge to the Company. Any one of two (2) or more joint holders may give effectual receipts for any dividends, distributions or other monies payable or property distributable in respect of the shares held by such joint holders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">130.&#160;&#160;&#160;&#160;Any dividend or distribution out of contributed surplus unclaimed for a period of six (6) years from the date of declaration of such dividend or distribution shall be forfeited and shall revert to the Company and the payment by the Board of any unclaimed dividend, distribution, interest or other sum payable on or in respect of the share into a separate account shall not constitute the Company a trustee in respect thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">131.&#160;&#160;&#160;&#160;Subject to approval by a Resolution, the Board may also, in addition to its other powers, direct payment or satisfaction of any dividend or distribution out of contributed surplus wholly or in part by the distribution of specific assets, and in particular of paid-up shares or debentures of any other company, and where any difficulty arises in regard to such distribution or dividend, the Board may settle it as it thinks expedient, and in particular, may authorise any person to sell and transfer any fractions or may ignore fractions altogether, and may fix the value for distribution or dividend purposes of any such specific assets and may determine that cash payments shall be made to any Shareholders upon the footing of the values so fixed in order to secure equality of distribution and may vest any such specific assets in trustees as may seem expedient to the Board, provided that such dividend or distribution may not be satisfied by the distribution of any partly paid shares or debentures of any company without the sanction of a Resolution.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESERVES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">132.&#160;&#160;&#160;&#160;The Board may, before declaring any dividend or distribution out of contributed surplus, set aside such sums as it thinks proper as reserves which shall, at the discretion of the Board, be applicable for any purpose of the Company and pending such application may, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">also at such discretion, either be employed in the business of the Company or be invested in such investments as the Board may from time to time think fit. The Board may also without placing the same to reserve carry forward any sums which it may think it prudent not to distribute.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CAPITALISATION OF PROFITS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">133.&#160;&#160;&#160;&#160;The Board may from time to time resolve to capitalise all or any part of any amount for the time being standing to the credit of any reserve or fund which is available for distribution or to the credit of any share premium account and accordingly that such amount be set free for distribution amongst the Shareholders or any class or series of Shareholders or holders of any options over shares who would be entitled thereto if distributed by way of dividend and in the same proportions, on the footing that the same shall not be paid in cash but be applied either in or towards paying up amounts for the time being unpaid on any shares in the Company held by such Shareholders respectively or in payment up in full of unissued shares, debentures or other obligations of the Company, to be allotted and distributed credited as fully paid. amongst such Shareholders, or partly in one way and partly in the other, provided that for the purpose of this Bye-Law, a share premium account may be applied only in paying up of unissued shares to be issued to such Shareholders credited as fully paid.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">134.&#160;&#160;&#160;&#160;Where any difficulty arises in regard to any distribution under the last preceding Bye-Law, the Board may settle the same as it thinks expedient and, in particular, may authorise any person to sell and transfer any fractions or may resolve that the distribution should be as nearly as may be practicable in the correct proportion but not exactly so or may ignore fractions altogether, and may determine that cash payments should be made to any Shareholder, as may seem expedient to the Board. The Board may appoint any person to sign on behalf of the persons entitled to participate in the distribution any contract necessary or desirable for giving effect thereto and such appointment shall be effective and binding upon the Shareholders.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECORD DATES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">135.&#160;&#160;&#160;&#160;Notwithstanding any other provisions of these Bye-Laws, the Company may (by resolution of the Board) fix any date as the record date for any dividend, distribution, allotment or issue and for the purpose of identifying the persons entitled to receive notices of general meetings. Any such record date may be on or at any time before or after any date on which such dividend, distribution, allotment or issue is declared, paid or made or such notice is despatched.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">136.&#160;&#160;&#160;&#160;In relation to any general meeting of the Company or of any class or series of Shareholder or to any adjourned meeting or any poll taken at a meeting or adjourned meeting of which notice is given, the Board may specify in the notice of meeting or adjourned meeting or in any document sent to Shareholders by or on behalf of the Board in relation to the meeting, a time and date (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">record date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) prior to the date fixed for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meeting (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">meeting date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and, notwithstanding any provision in these Bye-Laws to the contrary, in such case&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">136.1&#160;&#160;&#160;&#160;each person entered in the Register at the record date as a Shareholder, or a Shareholder of the relevant class or series (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">record date holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be entitled to attend and to vote at the relevant meeting and to exercise all of the rights or privileges of a Shareholder, or a Shareholder of the relevant class or series (in each case subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) in relation to that meeting in respect of the shares, or the shares of the relevant class or series, registered in his name at the record date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">136.2&#160;&#160;&#160;&#160;regards any shares, or shares of the relevant class or series, which are registered in the name of a record date holder at the record date but are not so registered at the meeting date (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">relevant share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">s&#8221;), each holder of any relevant shares at the meeting date shall be deemed to have irrevocably appointed that record date holder as his proxy for the purpose of attending and voting in respect of those relevant shares at the relevant meeting (with power to appoint, or to authorise the appointment of, some other person as proxy), in such manner as the record date holder in his absolute discretion may determine&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">136.3&#160;&#160;&#160;&#160;accordingly, except through his proxy pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 136.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a holder of relevant shares at the meeting date shall not be entitled to attend or to vote at the relevant meeting, or to exercise any of the rights or privileges of a Shareholder, or a Shareholder of the relevant class or series, in respect of the relevant shares at that meeting.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The entry of the name of a person in the Register as a record date holder shall be sufficient evidence of his appointment as proxy in respect of any relevant shares for the purposes of this paragraph, but all the provisions of these Bye-Laws relating to the execution and deposit of an instrument appointing a proxy or any ancillary matter (including the Board&#8217;s powers and discretions relevant to such matter) shall apply to any instrument appointing any person other than the record date holder as proxy in respect of any relevant shares.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ACCOUNTING RECORDS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">137.&#160;&#160;&#160;&#160;The Board shall cause to be kept accounting records sufficient to give a true and fair view of the state of the Company&#8217;s affairs and to show and explain its transactions, in accordance with the Companies Act.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">138.&#160;&#160;&#160;&#160;The records of account shall be kept at the Registered Office or at such other place or places as the Board thinks fit, and shall at all times be open to inspection by the Directors, provided that if the records of account are kept at some place outside Bermuda, there shall be kept at an office of the Company in Bermuda such records as will enable the Directors to ascertain with reasonable accuracy the financial position of the Company at the end of each three month period. No Shareholder (other than an Officer of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company) shall have any right to inspect any accounting record or book or document of the Company except as conferred by law or authorised by the Board or by Resolution.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">139.&#160;&#160;&#160;&#160;A copy of every balance sheet and statement of income and expenditure, including every document required by law to be annexed thereto, which is to be laid before the Company in general meeting, together with a copy of the auditors&#8217; report, shall be sent to each person entitled thereto in accordance with the requirements of the Companies Act.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AUDIT</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">140.&#160;&#160;&#160;&#160;Save and to the extent that an audit is waived in the manner permitted by the Companies Act, auditors shall be appointed and their duties regulated in accordance with the Companies Act, any other applicable law and such requirements not inconsistent with the Companies Act as the Board may from time to time determine.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SERVICE OF NOTICES AND OTHER DOCUMENTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">141.&#160;&#160;&#160;&#160;Any notice or other document (including but not limited to a share certificate, any notice of a general meeting of the Company, any instrument of proxy and any document to be sent in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 139</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) may be sent to, served on or delivered to any Shareholder by the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">141.1&#160;&#160;&#160;&#160;personally&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">141.2&#160;&#160;&#160;&#160;by sending it through the post (by airmail where applicable) in a pre-paid letter addressed to such Shareholder at his address as appearing in the Register&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">141.3&#160;&#160;&#160;&#160;by sending it by courier to or leaving it at the Shareholder&#8217;s address appearing in the Register&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">141.4&#160;&#160;&#160;&#160;by, where applicable, by sending it by email or facsimile or other mode of representing or reproducing words in a legible and non-transitory form or by sending an electronic record of it by electronic means, in each case to an address or number supplied by such Shareholder for the purposes of communication in such manner&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">141.5&#160;&#160;&#160;&#160;by publication of an electronic record of it on a website and notification of such publication (which shall include the address of the website, the place on the website where the document may be found, and how the document may be accessed on the website) by any of the methods set out in paragraphs 141.1, 141.2, 141.3 or 141.4 of this Bye-Law, in accordance with the Companies Act.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the case of joint holders of a share, service or delivery of any notice or other document on or to one of the joint holders shall for all purposes be deemed as sufficient service on or delivery to all the joint holders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">142.&#160;&#160;&#160;&#160;Any notice or other document shall be deemed to have been served on or delivered to any Shareholder by the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">142.1&#160;&#160;&#160;&#160;if sent by personal delivery, at the time of delivery&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">142.2&#160;&#160;&#160;&#160;if sent by post, forty-eight (48) hours after it was put in the post&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">142.3&#160;&#160;&#160;&#160;if sent by courier or facsimile, twenty-four (24) hours after sending&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">142.4&#160;&#160;&#160;&#160;if sent by email or other mode of representing or reproducing words in a legible and non-transitory form or as an electronic record by electronic means, twelve (12) hours after sending&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">142.5&#160;&#160;&#160;&#160;if published as an electronic record on a website, at the time that the notification of such publication shall be deemed to have been delivered to such Shareholder,</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and in proving such service or delivery, it shall be sufficient to prove that the notice or document was properly addressed and stamped and put in the post, published on a website in accordance with the Companies Act and the provisions of these Bye-Laws, or sent by courier, facsimile, email or as an electronic record by electronic means, as the case may be, in accordance with these Bye-Laws.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Shareholder and each person becoming a Shareholder subsequent to the adoption of these Bye-Laws, by virtue of its holding or its acquisition and continued holding of a share, as applicable, shall be deemed to have acknowledged and agreed that any notice or other document (excluding a share certificate) may be provided by the Company by way of accessing them on a website instead of being provided by other means.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">143.&#160;&#160;&#160;&#160;If any time, by reason of the suspension or curtailment of postal services within Bermuda or any other territory, the Company is unable effectively to convene a general meeting by notices sent through the post, a general meeting may be convened by a notice advertised in at least one national newspaper published in the territory concerned and such notice shall be deemed to have been duly served on each person entitled to receive it in that territory on the day, or on the first day, on which the advertisement appears. In any such case the Company shall send confirmatory copies of the notice by post if at least five (5) clear days before the meeting the posting of notices to addresses throughout that territory again becomes practicable.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WINDING UP</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">144.&#160;&#160;&#160;&#160;If the Company shall be wound up, the liquidator may, with the sanction of a Resolution and any other sanction required by the Companies Act, divide amongst the Shareholders in specie or kind the whole or any part of the assets of the Company (whether they shall consist of property of the same kind or not) and may for such purposes set such values as he deems fair upon any property to be divided as aforesaid and may determine how such division shall be carried out as between the Shareholders or different classes or series of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shareholders. The liquidator may, with the like sanction, vest the whole or any part of such assets in trustees upon such trust for the benefit of the contributories as the liquidator, with the like sanction, shall think fit, but so that no Shareholder shall be compelled to accept any shares or other assets upon which there is any liability.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INDEMNITY AND INSURANCE</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">145.&#160;&#160;&#160;&#160;Subject to the proviso below, every Indemnified Person shall be indemnified and held harmless out of the assets of the Company against all actions, costs, charges, liabilities, loss, damage or expense (including but not limited to liabilities under contract, tort and statute or any applicable foreign law or regulation and all reasonable legal and other costs and expenses properly payable) incurred or suffered by him by or by reason of any act done, conceived in or omitted in the conduct of the Company&#8217;s business or in the discharge of his duties and the indemnity contained in this Bye-Law shall extend to any Indemnified Person acting in any office or trust in the reasonable belief that he has been appointed or elected to such office or trust notwithstanding any defect in such appointment or election provided always that the indemnity contained in this Bye-Law shall not extend to any matter which would render it void pursuant to the Companies Act.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">146.&#160;&#160;&#160;&#160;No Indemnified Person shall be liable to the Company for the acts, defaults or omissions of any other Indemnified Person. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">147.&#160;&#160;&#160;&#160;Without limiting the generality of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 145</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, every Indemnified Person shall be indemnified out of the assets of the Company against all liabilities incurred by him by or by reason of any act done, conceived in or omitted in the conduct of the Company&#8217;s business or in the discharge of his duties in defending any proceedings, whether civil or criminal, in which judgement is given in his favour, or in which he is acquitted, or in connection with any application under the Companies Act in which relief from liability is granted to him by the court.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">148.&#160;&#160;&#160;&#160;To the extent that any Indemnified Person is entitled to claim an indemnity pursuant to these Bye-Laws in respect of amounts paid or discharged by him, the relevant indemnity shall take effect as an obligation of the Company to reimburse the person making such payment or effecting such discharge.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">149.&#160;&#160;&#160;&#160;Each Shareholder and the Company agree to waive any claim or right of action he or it may at any time have, whether individually or by or in the right of the Company, against any Indemnified Person on account of any action taken by such Indemnified Person or the failure of such Indemnified Person to take any action in the performance of his duties with or for the Company provided however that such waiver shall not apply to any claims or rights of action arising out of the fraud of such Indemnified Person or to recover any gain, personal profit or advantage to which such Indemnified Person is not legally entitled.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">150.&#160;&#160;&#160;&#160;Expenses incurred in defending any civil or criminal action or proceeding for which indemnification is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 145 and 147 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall be paid by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company in advance of the final disposition of such action or proceeding upon receipt of an undertaking by or on behalf of the Indemnified Person to repay such amount if any allegation of fraud or dishonesty is proved against the Indemnified Person. Provided that, no monies shall be paid hereunder unless payment of the same shall be authorized in the specific case upon a determination that indemnification of the Director or Officer would be proper in the circumstances because he has met the standard of conduct which would entitle him to the indemnification thereby provided and such determination shall be made&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">150.1&#160;&#160;&#160;&#160;by the Board, by a majority vote at a meeting duly constituted by a quorum of Directors not party to the proceedings or matter with regard to which the indemnification is, or would be, claimed&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">150.2&#160;&#160;&#160;&#160;in the case such a meeting cannot be constituted by lack of disinterested quorum, by independent legal counsel in a written opinion&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">150.3&#160;&#160;&#160;&#160;by a Resolution of the Shareholders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">151.&#160;&#160;&#160;&#160;Each Shareholder of the Company, by virtue of its acquisition and continued holding of a share, shall be deemed to have acknowledged and agreed that the advances of funds may be made by the Company as aforesaid, and when made by the Company under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 151</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> are made to meet expenditures incurred for the purpose of enabling such Indemnified Person to properly perform his or her duties to the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">152.&#160;&#160;&#160;&#160;Without prejudice to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 145 and 147</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Board shall have the power to purchase and maintain insurance for or for the benefit of any Indemnified Person or any persons who are or were at any time Directors, Officers, or employees of the Company, or of any other company which is its holding company or in which the Company or such holding company has any interest whether direct or indirect or which is in any way allied to or associated with the Company, or of any subsidiary undertaking of the Company or any such other company, or who are or were at any time trustees of any pension fund in which employees of the Company or any such other company or subsidiary undertaking are interested, including (without prejudice to the generality of the foregoing) insurance against any liability incurred by such persons in respect of any act or omission in the actual or purported execution or discharge of their duties or in the exercise or purported exercise of their powers or otherwise in relation to their duties, powers or offices in relation to the Company or any such other company, subsidiary undertaking or pension fund.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">153.&#160;&#160;&#160;&#160;The Company hereby acknowledges that the Indemnified Persons may have certain rights to indemnification, advancement of expenses and&#47;or insurance provided by shareholders, members of the Apollo Group, or other Affiliates of the Company or Affiliates of members of the Apollo Group (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shareholder Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) separate from the indemnification and advancement of expenses provided by the Company under these Bye-Laws. The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to the Indemnified Persons under these Bye-laws are primary and any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">obligation of any Shareholder Affiliate to advance expenses or to provide indemnification for the same expenses or liabilities incurred by the Indemnified Persons are secondary), (ii) that the Company shall be required to advance the full amount of expenses incurred by the Indemnified Persons and shall be liable for the full amount of all expenses and liabilities paid in settlement to the extent legally permitted and as required by these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 145-156</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, without regard to any rights the Indemnified Persons may have against any Shareholder Affiliate, and (iii) that the Company irrevocably waives, relinquishes and releases the Shareholder Affiliates from any and all claims against the Shareholder Affiliates for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by any Shareholder Affiliate on behalf of an Indemnified Person with respect to any claim for which such Indemnified Person has sought indemnification from the Company pursuant to these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 145-156 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall affect the foregoing and the Shareholder Affiliates shall have a right of contribution and&#47;or be subrogated to the extent of such advancement or payment to all of the rights of recovery of the Indemnified Person against the Company. </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the avoidance of doubt, no person providing directors&#8217; or officers&#8217; or similar insurance obtained or maintained by or on behalf of the Company, and of its Affiliates or any of the foregoing&#8217;s respective subsidiaries, including any person providing such insurance obtained or maintained pursuant to these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 145-156</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, shall be, or be deemed to be, a Shareholder Affiliate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">154.&#160;&#160;&#160;&#160;These </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">145-156</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall provide the broadest indemnity allowable at law, and to the extent any indemnification hereunder is prohibited, unenforceable or not authorized under applicable law, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 145-156 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall be interpreted as broadly as possible without invalidating the remaining provisions hereof. Specifically, to the extent prohibited by Bermuda law, these Bye-Laws shall not result in indemnification of any person, including an Indemnified Person, to the extent he is guilty of fraud or dishonesty.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">155.&#160;&#160;&#160;&#160;No amendment or repeal of any provision of these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 145-156 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall alter, to the detriment of any Indemnified Person, the rights of such Indemnified Person to the advancement of expenses or indemnification related to a claim based on an act or failure to act which took place prior to such amendment, repeal or termination.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">156.&#160;&#160;&#160;&#160;No Director shall be personally liable either to the Company or to any of its Shareholders for monetary damages for breach of fiduciary duty as a Director, except to the extent such exemption from liability or limitation thereof is not permitted under the Companies Act as the same exists or may hereafter be amended. If the Companies Act is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Company shall be eliminated or limited to the fullest extent permitted by the Companies Act, as so amended.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BUSINESS OPPORTUNITIES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">157.&#160;&#160;&#160;&#160;To the fullest extent permitted by applicable law, the Company, on behalf of itself and its subsidiaries, other than its subsidiaries that are insurance companies which are regulated </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by a governmental entity (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Insurance Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), waives and renounces any right, interest or expectancy of the Company and&#47;or its subsidiaries, other than its Insurance Subsidiaries, in, or in being offered an opportunity to participate in, business opportunities of any kind, nature or description that are from time to time presented to (x) any member of the Apollo Group or an Affiliate of any member of the Apollo Group (other than the Company and its subsidiaries), (y) any of the Directors or any of their respective Affiliates (other than the Company and its subsidiaries), or (z) any Officer, employee or agent of the Company, or any director, officer, employee or agent of any of the Company&#8217;s subsidiaries, who is also, and is presented such business opportunity in his or her capacity as, an officer, director, employee, managing director, general or limited partner, manager, member, shareholder, agent or other Affiliate of any member of the Apollo Group or of any Affiliate of any member of the Apollo Group (other than the Company and its subsidiaries), (the persons described in clauses (x), (y) and (z), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Specified Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Specified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or of which any Specified Parties have or gain knowledge, whether or not the opportunity is competitive with the business of the Company or its subsidiaries or in the same or similar lines of business as the Company or its subsidiaries or one that the Company or its subsidiaries might reasonably be deemed to have pursued or had the ability or desire to pursue if granted the opportunity to do so, and each Specified Party shall have no duty (statutory, fiduciary, contractual or otherwise) to communicate or offer such business opportunity to the Company and, to the fullest extent permitted by applicable law, shall not be liable to the Company or any of its subsidiaries, other than its Insurance Subsidiaries, for breach of any statutory, fiduciary, contractual or other duty, as a Director, Officer, employee or agent of the Company, or a director, officer, employee or agent of any of the Company&#8217;s subsidiaries, as the case may be, or otherwise, by reason of the fact that such Specified Party pursues or acquires such business opportunity, directs such business opportunity to another person or fails to present or communicate such business opportunity, or information regarding such business opportunity, to the Company or its subsidiaries. Notwithstanding the foregoing, the Company and its subsidiaries do not renounce any right, interest or expectancy in any business opportunity offered to a Specified Party who is a Director or Officer if such business opportunity is expressly offered for the Company or its subsidiaries to such person solely in his or her capacity as a Director or Officer (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company Opportunity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; provided, however, that all of the protections of these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 157-162</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall otherwise apply to the Specified Parties with respect to such Company Opportunity, including the ability of the Specified Parties to pursue or acquire such Company Opportunity, directly or indirectly, or to direct such Company Opportunity to another person, if and to the extent that the Company or the applicable subsidiary of the Company, as applicable, determines not to pursue such Company Opportunity or if it is subsequently determined by the Board or any committee thereof (or board of directors or other governing body of such subsidiary or any committee thereof), or by any court of competent jurisdiction, that the business opportunity was not in the line of business of the Company or such subsidiary, as applicable, was not of material or practical advantage to the Company or such subsidiary, as applicable, or was one that the Company or such subsidiary, as applicable, was not financially capable of undertaking. For the avoidance of doubt, notwithstanding anything to the contrary set forth herein or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">otherwise, to the fullest extent permitted by applicable law, the Company, on behalf of itself and its subsidiaries, other than its Insurance Subsidiaries, hereby waives and renounces any right, interest or expectancy of the Company or its subsidiaries to participate in or be offered an opportunity to participate in any business or business opportunity of any member of the Apollo Group or its Affiliates (other than the Company and its subsidiaries), except to the extent such right, interest or expectancy is expressly granted to the Company or any of its subsidiaries under a binding agreement between or among the Company and&#47;or its subsidiaries, on the one hand, and any member of the Apollo Group or its Affiliates (other than the Company and its subsidiaries), on the other hand.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">158.&#160;&#160;&#160;&#160;No amendment, modification or repeal of these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 157-162 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or any provision hereof or, to the fullest extent permitted by applicable law, any modification of applicable law, shall in any manner terminate, reduce or impair the right of any person under and in accordance with the provisions of these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 157-162 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as in effect immediately prior to such amendment, modification or repeal with respect to claims arising from or relating to matters occurring, in whole or in part, prior to such amendment, modification or repeal, regardless of when such claims may arise or be asserted.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">159.&#160;&#160;&#160;&#160;These </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 157-162 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall not limit any protections or defenses available to, or indemnification or advancement rights of, any Specified Party under any agreement, these Bye-laws, vote of the Board, applicable law or otherwise.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">160.&#160;&#160;&#160;&#160;Any person purchasing or otherwise acquiring any interest in any shares of the Company shall be deemed to have notice of and to have consented to the provisions of these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 157-162.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">161.&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein, under no circumstances shall the provisions of these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 157-162</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (other than this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-law 160</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) apply to (or result in or be deemed to result in a limitation or elimination of) any duty (contractual, fiduciary or otherwise, whether at law or in equity) owed by any Specified Party who is also an Officer, employee or agent of the Company, or any director, officer, employee or agent of any of its subsidiaries (other than any such Specified Party who is also an officer, director, employee, managing director, general or limited partner, manager, member, shareholder, agent or other Affiliate of any member of the Apollo Group or of any Affiliate of any member of the Apollo Group (other than the Company and its subsidiaries)), and any business opportunity waived or renounced by any person pursuant to such other provisions of these </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 157-162 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall be expressly reserved and maintained (and shall not be waived or renounced) by such person as to any such Specified Party.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">162.&#160;&#160;&#160;&#160;These </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 157-162 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">may not be rescinded, altered or amended (a) unless in accordance with the Act and (b) until the same has been approved by the Board and at least a majority of the voting power of shares entitled to vote at a meeting of Shareholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXCLUSIVE JURISDICTION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">163.&#160;&#160;&#160;&#160;Unless the Company consents in writing to the selection of an alternative forum, in the event that any dispute arises concerning the Companies Act or out of or in connection with these Bye-laws, including any question regarding the existence and scope of any Bye-Law and&#47;or whether there has been any breach of the Companies Act or these Bye-Laws by an Officer or Director (whether or not such a claim is brought in the name of a Shareholder or in the name of the Company), any such dispute shall be subject to the exclusive jurisdiction of the Supreme Court of Bermuda.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ALTERATION OF BYE-LAWS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">164.&#160;&#160;&#160;&#160;These Bye-Laws may be revoked or amended by the Board, which may from time to time revoke or amend them in any way by a resolution of the Board passed by a majority of the Directors then in office and eligible to vote on the resolution, but no revocation or amendment shall be operative unless and until it is approved at a subsequent general meeting of the Company by the Shareholders by Resolution passed by an affirmative vote of a majority of the voting power of votes cast at such meeting (taking into account the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Laws 63-67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) or such greater majority as required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bye-Law 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">48</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>6
<FILENAME>exhibit34-fx1.htm
<DESCRIPTION>EX-3.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9c0fdd92909e40c89f1b11a0560cac61_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 3.4</font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF DESIGNATION</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.95% FIXED-TO-FLOATING RATE PERPETUAL NON-CUMULATIVE PREFERENCE SHARES </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), HEREBY CERTIFIES that pursuant to resolutions of duly authorized Directors adopted on April&#160;25, 2013, the creation of the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, with a liquidation preference of $25 per share (the &#8220;Preference Shares&#8221;) were authorized and the designations, preferences and privileges, voting rights, relative, participating, optional and other special rights, and qualifications, limitations and restrictions of the Preference Shares, in addition to those set forth in the Memorandum of Association and Bye-Laws of the Company, were fixed as follows&#58; </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Designation&#59; Amount of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The designation of this series of Preference Shares shall be &#8220;5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares&#8221;, and the number of shares constituting this series shall be 11,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if the Company elects to issue additional Preference Shares after the date of this Certificate of Designation, any such additional shares are not treated as &#8220;disqualified preferred stock&#8221; within the meaning of Section&#160;1059(f)(2) of the United States Internal Revenue Code of 1986, as amended, and such additional shares are otherwise treated as fungible with the Preference Shares for United States federal income tax purposes. The additional shares would form a single series with the Preference Shares. The Preference Shares shall have a liquidation preference of $25 per Preference Share (the &#8220;Liquidation Preference&#8221;). Each Preference Share shall be identical in all respects to every other Preference Share, except for the issue price, date of issuance and, in some cases, the initial Dividend Payment Date (as defined in Section&#160;4(a)). Any Preference Shares retired by purchase or redemption, or otherwise acquired by the Company, will have the status of authorized but unissued Preference Shares and may be reissued as part of the same class or series or may be reclassified and reissued by the Board of Directors in the same manner as any other authorized and unissued shares. The number of authorized Preference Shares may be reduced (but not below the number of Preference Shares then issued and outstanding) by further resolution duly adopted by the Board of Directors. No such reduction shall affect the due authorization of any issued and outstanding Preference Shares. </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As used herein with respect to the Preference Shares&#58; </font></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#8220;3-month LIBOR&#8221; means, with respect to any LIBOR Determination Date&#58; </font></div><div style="margin-bottom:9pt;margin-top:4.5pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the rate for 3-month deposits in U.S. dollars as that rate appears on the Reuters Page LIBOR01 (as described below) as of 11&#58;00 a.m. (London time) on the LIBOR Determination Date for that Floating Rate Period, unless fewer than two such offered rates so appear&#59; </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) if fewer than two offered rates appear, or no rate appears, as the case may be, on the LIBOR Determination Date for that Floating Rate Period on the Reuters Page LIBOR01, the rate calculated by the Calculation Agent based on two offered quotations after requesting the principal London offices of each of four major reference banks in the London interbank market to provide the Calculation Agent with offered quotations for deposits in U.S. dollars for the period of three months, commencing on the first day of that Floating Rate Period, to prime banks in the London interbank markets at approximately 11&#58;00 a.m. (London time) on that date and in a principal amount that is representative for a single transaction in U.S. dollars in that market at that time&#59; </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) if fewer than two offered quotations referred to in clause (ii)&#160;are provided as requested, the rate calculated by the Calculation Agent as the arithmetic mean of the rates quoted at approximately 11&#58;00 a.m. (New York City time) on the LIBOR Determination Date for that Floating Rate Period by three major banks (which will not include affiliates of the Company) in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York City selected by the Calculation Agent for loans in U.S. dollars to leading European banks for a period of three months and in a principal amount that is representative for a single transaction in U.S. dollars in that market at that time&#59; or </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) if the banks so selected by the Calculation Agent are not quoting as mentioned in clause (iii), the rate equal to the 3-month LIBOR for the previous Floating Rate Period. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#8220;7.250% Perpetual Preference Shares&#8221; means the 7.250% Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162;&#160;per share, of the Company designated as the 7.250% Perpetual Non-Cumulative Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) &#8220;7.401% Perpetual Preference Shares&#8221; means the 7.401% Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162;&#160;per share, of the Company designated as the 7.401% Perpetual Non-Cumulative Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) &#8220;Additional Amounts&#8221; has the meaning assigned to such term in Section&#160;5(a). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) &#8220;Agent Members&#8221; has the meaning assigned to such term in Section&#160;14(a). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) &#8220;Appointing Preference Shares&#8221; means any other class or series of preference shares of the Company, including the 7.250% Perpetual Preference Shares, the 7.401% Perpetual Preference Shares, Perpetual PIERS and the Perpetual Preference Shares issuable upon conversion of the Perpetual PIERS, if any, ranking equally with the Preference Shares either as to dividend rights or rights upon liquidation, winding-up or dissolution and upon which like Appointing Rights have been conferred and are exercisable. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) &#8220;Appointing Rights&#8221; has the meaning assigned to such term in Section&#160;10(b). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) &#8220;Board of Directors&#8221; means the Board of Directors of the Company. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) &#8220;Business Day&#8221; means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City generally are authorized or obligated by law or executive order to close. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j) &#8220;Bye-Laws&#8221; means the amended and restated bye-laws of the Company, as they may be amended from time to time. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k) &#8220;Calculation Agent&#8221; means the nationally recognized calculation agent appointed by the Company prior to any notice of redemption and prior to July&#160;1, 2023. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l) &#8220;Capital Adequacy Regulations&#8221; means the solvency margins, capital adequacy regulations or any other regulatory capital rules applicable to the Company from time to time on an individual or group basis pursuant to Bermuda law and&#47;or the laws of any other relevant jurisdiction and which set out the requirements to be satisfied by financial instruments to qualify as solvency margin or additional solvency margin or regulatory capital (or any equivalent terminology employed by the then-applicable capital adequacy regulations). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m) &#8220;Capital Disqualification Change Event&#8221; means that the Preference Shares do not qualify, in whole or in part (including as a result of any transitional or grandfathering provisions or otherwise), for purposes of determining the solvency margin, capital adequacy ratio or any other comparable ratio, regulatory capital resource or level, of the Company or any subsidiary thereof, where capital is subdivided into tiers, as Tier 1 capital securities under then-applicable Capital Adequacy Regulations imposed upon the Company by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority) (which would include, without limitation, the Company&#8217;s individual and group enhanced capital requirements under Bermuda Monetary Authority capital regulations), except as a result of any applicable limitation on the amount of such capital. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n) &#8220;Capital Disqualification Redemption Event&#8221; means that the Preference Shares qualify, in whole or in part (including as a result of any transitional or grandfathering provisions), for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level, of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 2 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company or any subsidiary thereof, where capital is subdivided into tiers, as neither Tier 1 nor Tier 2 capital securities under then-applicable Capital Adequacy Regulations imposed upon the Company by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority) (which would include, without limitation, the Company&#8217;s individual and group enhanced capital requirements under Bermuda Monetary Authority capital regulations), except as a result of any applicable limitation on the amount of such capital. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o) &#8220;Certificate of Designation&#8221; means this Certificate of Designation relating to the Preference Shares, as it may be amended from time to time. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p) &#8220;Change in Tax Law&#8221; means (a)&#160;a change in or amendment to laws, regulations or rulings of any Relevant Taxing Jurisdiction, (b)&#160;a change in the official application or interpretation of those laws, regulations or rulings, (c)&#160;any execution of or amendment to any treaty affecting taxation to which any Relevant Taxing Jurisdiction is party after April&#160;25, 2013, or (d)&#160;a decision rendered by a court of competent jurisdiction in any Relevant Taxing Jurisdiction, whether or not such decision was rendered with respect to the Company, in each case, described in (a)-(d)&#160;above occurring after April&#160;25, 2013&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that in the case of a Relevant Taxing Jurisdiction other than Bermuda in which a Successor Corporation is organized, such Change in Tax Law must occur after the Succession Date. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q) &#8220;Comparable Treasury Issue&#8221; means the United States treasury security selected by the Calculation Agent as having a maturity comparable to the term remaining to the July&#160;1, 2023 Dividend Payment Date that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate perpetual preferred stock having similar terms as the Preference Shares with respect to the payment of dividends and distributions of assets upon liquidation, dissolution or winding-up of the issuer of such preferred stock. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r) &#8220;Comparable Treasury Price&#8221; means, with respect to any Redemption Date for the Preference Shares, the average of the Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest of such Reference Treasury Dealer Quotations, or if the Calculation Agent obtains fewer than five such Reference Treasury Dealer Quotations, the average of all such quotations. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s) &#8220;Dividend Payment Date&#8221; has the meaning assigned to such term in Section&#160;4(a). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t) &#8220;Dividend Period&#8221; has the meaning assigned to such term in Section&#160;4(a). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u) &#8220;Dividend Record Date&#8221; has the meaning assigned to such term in Section&#160;4(a). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) &#8220;Fixed Rate&#8221; means an amount equal to 5.95%. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(w) &#8220;Fixed Rate Period&#8221; means the period from, and including, the Issue Date to, but excluding, July&#160;1, 2023. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x) &#8220;Floating Rate&#8221; means an amount equal to 3-Month LIBOR plus 4.06%&#59; provided that the Floating Rate will in no event exceed the maximum rate permitted by law. The Floating Rate shall be reset on the applicable LIBOR Reset Date for each Dividend Period during the Floating Rate Period pursuant to Section&#160;4(b).</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y) &#8220;Floating Rate Period&#8221; means the period from, and including, July&#160;1, 2023 to the date no Preference Shares are outstanding. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(z) &#8220;Global Preference Shares&#8221; has the meaning assigned to such term in Section&#160;14(a). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(aa) &#8220;Insurance Act&#8221; means the Insurance Act 1978 of Bermuda. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bb) &#8220;Issue Date&#8221; means May&#160;2, 2013, the original date of issuance of the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cc) &#8220;Junior Stock&#8221; means any class or series of capital stock of the Company, including the Company&#8217;s Ordinary Shares, that ranks junior to the Preference Shares either as to the payment of dividends or as to the distribution of assets upon any liquidation, dissolution or winding-up of the Company. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 3 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dd) &#8220;LIBOR Determination Date&#8221; means the second London Banking Day immediately preceding the applicable LIBOR Reset Date. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ee) &#8220;LIBOR Reset Date&#8221; has the meaning assigned to such term in Section&#160;4(b). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ff) &#8220;Liquidation Distribution&#8221; has the meaning assigned to such term in Section&#160;6(a). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(gg) &#8220;Liquidation Preference&#8221; has the meaning assigned to such term in Section&#160;1. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(hh) &#8220;London Banking Day&#8221; means a day on which commercial banks are open for business, including dealings in deposits in U.S. dollars, in London. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) &#8220;Memorandum of Association&#8221; means the memorandum of association of the Company, as they may be amended from time to time. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(jj) &#8220;Nonpayment&#8221; has the meaning assigned to such term in Section&#160;10(b). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(kk) &#8220;Ordinary Shares&#8221; means the Ordinary Shares, par value $0.0015144558 per share, of the Company, or any other class of shares resulting from successive changes or reclassifications of such Ordinary Shares consisting solely of changes in par value, or from par value to no par value, or as a result of a subdivision, combination, merger, consolidation or similar transaction in which the Company is a constituent corporation. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ll) &#8220;Parity Stock&#8221; means any class or series of capital stock of the Company that ranks equally with the Preference Shares as to payment of dividends and the distribution of assets on any liquidation, dissolution or winding-up of the Company, including the 7.250% Perpetual Preference Shares, 7.401% Perpetual Preference Shares, Perpetual PIERS, if any and the Perpetual Preference Shares issuable upon conversion of the Perpetual PIERS. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(mm) &#8220;Paying Agent&#8221; initially means Computershare Shareowner Services LLC. The Company may, in its sole discretion, remove the Paying Agent within ten (10)&#160;calendar days prior notice to the Paying Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company shall appoint a successor Paying Agent who shall accept such appointment prior to the effectiveness of such removal. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nn) &#8220;Perpetual PIERS&#8221; means the series of preference shares, par value 0.15144558&#162;&#160;per share, of the Company designated as the 5.625% Perpetual Preferred Income Equity Replacement Securities (Perpetual PIERS). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(oo) &#8220;Perpetual Preference Shares&#8221; means the series of preference shares, par value 0.15144558&#162;&#160;per share, of the Company designated as the Perpetual Preference Shares, issuable upon the conversion of the Perpetual PIERS. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pp) &#8220;Preference Share Director&#8221; has the meaning assigned to such term in Section&#160;10(b). </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(qq) &#8220;Preference Shares&#8221; has the meaning assigned to such term in the recitals. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(rr) &#8220;Redemption Date&#8221; means, in the case of an optional redemption, the day specified in the Company&#8217;s notice of redemption. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ss) &#8220;Reference Treasury Dealer&#8221; means each of three primary U.S. government securities dealers (each a &#8220;Primary Treasury Dealer&#8221;), as specified by the Company&#59; provided that if any Primary Treasury Dealer as specified by the Company ceases to be a Primary Treasury Dealer, the Company shall substitute for such Primary Treasury Dealer another Primary Treasury Dealer and if the Company fails to select a substitute within a reasonable period of time, then the substitute shall be a Primary Treasury Dealer selected by the Calculation Agent after consultation with the Company. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(tt) &#8220;Reference Treasury Dealer Quotations&#8221; means, with respect to the Reference Treasury Dealer and any Redemption Date, the average, as determined by the Calculation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed, in each case, as a percentage of its principal amount) quoted in writing to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 4 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Calculation Agent by such Reference Treasury Dealer at 5&#58;00 p.m. (New York City time) on the third Business Day preceding such Redemption Date.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(uu) &#8220;Register of Members&#8221; means the Register of Members of the Company. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vv) &#8220;Registrar&#8221; initially means Computershare Shareowner Services LLC. The Company may, in its sole discretion, remove the Registrar within ten (10)&#160;calendar days prior notice to the Registrar&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company shall appoint a successor Registrar who shall accept such appointment prior to the effectiveness of such removal. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ww) &#8220;Relevant Date&#8221; means, in respect of any payment, the date on which such payment first becomes due and payable, but if the full amount of the moneys payable has not been received by the dividend disbursing agent on or prior to such due date, it means the first date on which the full amount of such moneys has been so received and is available for payment to holders, and notice to that effect shall have been duly given to the holders of the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xx) &#8220;Relevant Taxing Jurisdiction&#8221; means (a)&#160;Bermuda or any political subdivision or governmental authority of or in Bermuda with the power to tax, (b)&#160;any jurisdiction from or through which the Company or its dividend disbursing agent are making payments on the Preference Shares or any political subdivision or governmental authority of or in that jurisdiction with the power to tax or (c)&#160;any other jurisdiction in which the Company or a Successor Corporation is organized or generally subject to taxation on a net income basis or any political subdivision or governmental authority of or in that jurisdiction with the power to tax. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(yy) &#8220;Reuters Page LIBOR01&#8221; means the display so designated on Reuters 3000 Xtra (or any successor service) (or any other page as may replace such page on such service) or such other service as may be nominated by the Company as the information vendor for the purpose of displaying the London interbank offer rates of major banks for U.S. dollars deposits. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(zz) &#8220;Senior Shares&#8221; means any class of share capital or series of preference shares established after the Issue Date by the Board of Directors, the terms of which expressly provide that such class or series will rank senior to the Preference Shares as to dividend rights or rights upon liquidation, winding-up or dissolution of the Company. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(aaa) &#8220;set aside for payment&#8221; means, without any action other than the following, the recording by the Company in its accounting ledgers of any accounting or bookkeeping entry which indicates, pursuant to a declaration of a dividend or other distribution by the Board of Directors, the allocation of the funds to be so paid on any class or series of the Company&#8217;s shares&#59; provided, that if any funds for any class or series of Junior Stock or any class or series of Parity Stock are placed in a separate account of the Company or delivered to a disbursing, paying or other similar agent, then &#8220;set aside for payment&#8221; with respect to the Preference Shares shall mean placing such funds in a separate account or delivering such funds to a disbursing, paying or other similar agent. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bbb) &#8220;Succession Date&#8221; means the date on which the Company consolidates, merges or amalgamates with a Successor Corporation or conveys, transfers or leases substantially all its properties and assets to a Successor Corporation. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ccc) &#8220;Successor Corporation&#8221; has the meaning assigned to such term in the definition of Tax Event. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ddd) &#8220;Tax Event&#8221; means a Change in Tax Law that, in the Company&#8217;s reasonable determination, results in a substantial probability that the Company or any entity formed by a consolidation, merger or amalgamation involving the Company or the entity to which the Company conveys, transfers or leases substantially all its properties and assets (a &#8220;Successor Corporation&#8221;) would be required to pay any Additional Amounts with respect to the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(eee) &#8220;Treasury Rate&#8221; means the rate per year equal to the quarterly equivalent yield to maturity of the Comparable Treasury Issue, calculated using a price for the Comparable Treasury Issue (expressed as a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 5 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">percentage of its principal amount) equal to the Comparable Treasury Price for such Redemption Date. The Treasury Rate will be calculated on the third Business Day preceding the Redemption Date. </font></div><div style="margin-bottom:9pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ranking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Preference Shares shall, with respect to dividend rights or rights upon the liquidation, winding-up or dissolution of the Company, rank (a)&#160;senior to all Junior Shares, including, without limitation, the Ordinary Shares, (b)&#160;on a parity with all Parity Shares, including, without limitation, 7.250% Perpetual Preference Shares, 7.401% Perpetual Preference Shares, Perpetual PIERS and the Perpetual Preference Shares issuable upon conversion of the Perpetual PIERS, if any, (c)&#160;junior to any Senior Shares and (d)&#160;junior to all of the Company&#8217;s existing and future debt obligations. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rate and Payment of Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of Preference Shares shall be entitled to receive, only when, as and if declared by the Board of Directors, subject to compliance with Bermuda law, non-cumulative cash dividends from, and including, the Issue Date, quarterly in arrears, on January&#160;1,&#160;April&#160;1,&#160;July&#160;1 and October&#160;1 of each year (each, a &#8220;Dividend Payment Date&#8221;), commencing on July&#160;1, 2013, without accumulation of any undeclared dividends. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent declared, during the Fixed Rate Period, dividends shall accumulate, with respect to each Dividend Period, in an amount per share equal to the Fixed Rate of the Liquidation Preference per Preference Share per annum. During the Fixed Rate Period, dividends payable on the Preference Shares shall be computed on the basis of a 360-day year consisting of twelve 30-day months with respect to a full Dividend Period, and on the basis of the actual number of days elapsed during such Dividend Period with respect to a Dividend Period other than a full Dividend Period. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent declared, during the Floating Rate Period, dividends shall accumulate, with respect to each Dividend Period, in an amount per share equal to the Floating Rate of the Liquidation Preference per Preference Share per annum, as described in the immediately following sentence. During the Floating Rate Period, dividends payable per Preference Share shall be computed by multiplying the Floating Rate for that Dividend Period by a fraction, the numerator of which shall be the actual number of days elapsed during that Dividend Period (determined by including the first day of the Dividend Period and excluding the last day, which is the Dividend Payment Date), and the denominator of which shall be 360, and by multiplying the result by the Liquidation Preference per Preference Share. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends that are payable on Preference Shares on any Dividend Payment Date shall be payable to holders of record of Preference Shares as they appear on the Register of Members at 5&#58;00 p.m. (New York City time) on the immediately preceding December&#160;15,&#160;March&#160;15,&#160;June&#160;15 and September&#160;15 (each, a &#8220;Dividend Record Date&#8221;). The Dividend Record Dates shall apply regardless of whether a particular Dividend Record Date is a Business Day. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A dividend period (each, a &#8220;Dividend Period&#8221;) is the period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial Dividend Period shall commence on, and include, the Issue Date and shall end on, and exclude, the July&#160;1, 2013 Dividend Payment Date. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Fixed Rate Period, if any date on which dividends would otherwise be payable is not a Business Day, then the Dividend Payment Date shall be the next succeeding Business Day after the original Dividend Payment Date, and no additional dividends shall accumulate on the amount so payable as a result of the delay. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Floating Rate Period, if any Dividend Payment Date other than a Redemption Date, falls on a day that is not a Business Day, the Dividend Payment Date shall be postponed to the next day that is a Business Day. If a Redemption Date falls on a day that is not a Business Day, the payment of dividends and redemption price shall be made on the first Business Day following such Redemption Date, without accrual to the actual payment date. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on the Preference Shares are non-cumulative. Consequently, if the Board of Directors does not authorize and declare a dividend for any Dividend Period, holders of the Preference Shares will not be entitled to receive a dividend for such Dividend Period, and such undeclared dividend will not accumulate and will not be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 6 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payable. The Company will have no obligation to pay dividends for a Dividend Period after the Dividend Payment Date for such Dividend Period if the Board of Directors has not declared such dividend before the related Dividend Payment Date, whether or not dividends are declared for any subsequent Dividend Period with respect to the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Preference Shares shall not be entitled to any dividends, whether payable in cash, securities or other property, other than dividends, if any, declared and payable on the Preference Shares as specified in this Section&#160;4. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the Company issues additional Preference Shares after the Issue Date, to the extent declared, dividends on such additional Preference Shares may accumulate from, and including, their Issue Date or any other date the Company specifies at the time such additional Preference Shares are issued. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Determination of Floating Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Floating Rate shall be reset quarterly on the first day of each Dividend Period during the Floating Rate Period (each, a &#8220;LIBOR Reset Date&#8221;). During the Floating Rate Period, if any LIBOR Reset Date falls on a day that is not a Business Day, the LIBOR Reset Date will be postponed to the next day that is a Business Day, which shall also be the Dividend Payment Date for the preceding Dividend Period. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Priority of Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. So long as any Preference Shares remain outstanding for any Dividend Period, unless the full dividends for the latest completed Dividend Period on all outstanding Preference Shares and Parity Stock have been declared and paid or declared and a sum sufficient for the payment thereof has been set aside&#58; </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) no dividend shall be paid or declared on the Ordinary Shares or any other shares of Junior Stock or Parity Stock (except in the case of the Parity Stock on a pro rata basis with the Preference Shares as described below), other than a dividend payable solely in Ordinary Shares, other Junior Stock or Parity Stock, as applicable, and </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) no Ordinary Shares, other Junior Stock or Parity Stock shall be purchased, redeemed or otherwise acquired for consideration by the Company, directly or indirectly (other than (a)&#160;as a result of a reclassification of Junior Stock for or into other Junior Stock, or a reclassification of Parity Stock for or into other Parity Stock, as applicable, or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock, or the exchange or conversion of one share of Parity Stock for or into another share of Parity Stock, as applicable, (b)&#160;through the use of the proceeds of a substantially contemporaneous sale of Junior Stock or Parity Stock, as applicable, or (c)&#160;as required by or necessary to fulfill the terms of any employment contract, benefit plan or similar arrangement with or for the benefit of one or more employees, directors or consultants). </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When dividends are not paid or duly provided for in full on any Dividend Payment Date upon the Preference Shares and any shares of Parity Stock, all dividends declared upon the Preference Shares and all such Parity Stock and payable on such Dividend Payment Date shall be declared on a pro rata basis so that the respective amounts of such dividends shall bear the same ratio to each other as the full amount of dividends payable on the outstanding Preference Shares for such Dividend Period and the accumulated and unpaid dividends, or the full amount of dividends payable for such Dividend Period in the case of non-cumulative preferred stock, on all such Parity Stock bear to each other. In the case of any Parity Stock having dividend payment dates different from the Dividend Payment Dates pertaining to the Preference Shares, the measurement date for such Parity Stock shall be the Dividend Payment Date falling within the related Dividend Period for the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Additional Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company shall make all payments on the Preference Shares free and clear of and without withholding or deduction at source for, or on account of, any present or future taxes, fees, duties, assessments or governmental charges of whatever nature imposed or levied by or on behalf of any Relevant Taxing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 7 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jurisdiction, unless such taxes, fees, duties, assessments or governmental charges are required to be withheld or deducted by (x)&#160;the laws (or any regulations or rulings promulgated thereunder) of any Relevant Taxing Jurisdiction or (y)&#160;an official position regarding the application, administration, interpretation or enforcement of any such laws, regulations or rulings (including, without limitation, a holding by a court of competent jurisdiction or by a taxing authority in any Relevant Taxing Jurisdiction). If a withholding or deduction at source is required, the Company shall, subject to certain limitations and exceptions described below, pay to the holders of the Preference Shares such additional amounts (the &#8220;Additional Amounts&#8221;) as may be necessary so that every net payment made to such holders, after the withholding or deduction, shall not be less than the amount provided for in this Certificate of Designation to be then due and payable. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The Company shall not be required to pay any Additional Amounts for or on account of&#58; </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) any tax, fee, duty, assessment or governmental charge of whatever nature that would not have been imposed but for the fact that such holder (i)&#160;was a resident, citizen, domiciliary or national of, or engaged in business or maintained a permanent establishment or was physically present in, the Relevant Taxing Jurisdiction or otherwise had some connection with the Relevant Taxing Jurisdiction other than by reason of the mere ownership of, or receipt of payment under, such Preference Shares or (ii)&#160;presented, where presentation is required, such Preference Shares for payment more than 30 days after the Relevant Date, except to the extent that the holder would have been entitled to such Additional Amounts if it had presented such Preference Shares for payment on any day within that 30-day period&#59; </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) any estate, inheritance, gift, sale, transfer, personal property or similar tax, fee, duty, assessment or other governmental charge&#59; </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) any tax, fee, duty, assessment or other governmental charge that is payable otherwise than by withholding or deduction from payment of the Liquidation Preference of or any dividends on the Preference Shares&#59; </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) any tax, fee, duty, assessment or other governmental charge that is imposed or withheld by reason of the failure by the holder of such Preference Shares to comply with any reasonable request by the Company addressed to the holder within ninety (90)&#160;days of such request (a)&#160;to provide information concerning the nationality, citizenship, residence or identity of the holder or (b)&#160;to make any declaration or other similar claim or satisfy any information or reporting requirement, which is required or imposed by statute, treaty, regulation or administrative practice of the Relevant Taxing Jurisdiction or any political subdivision thereof as a precondition to exemption from all or part of such tax, fee, duty, assessment or other governmental charge&#59; </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) any withholding or deduction required to be made pursuant to any European Union Directive on the taxation of savings implementing the conclusions of the ECOFIN Council meetings of 26-27&#160;November 2000 and 3&#160;June 2003 or any law implementing or complying with, or introduced in order to conform to, such European Union Directive&#59; or </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) any taxes, duties, assessments or governmental charges required to be withheld or deducted under sections 1471 through 1474 of the United States Internal Revenue Code of 1986, as amended (or any United States Treasury Regulations or other administrative guidance thereunder)&#59; or </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7) any combination of items (1), (2), (3), (4), (5)&#160;and (6). </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Company shall not pay Additional Amounts with respect to any payment on any such Preference Shares to any holder who is a fiduciary, partnership, limited liability company or other pass-through entity or a person other than the sole beneficial owner of such Preference Shares if such payment would be required by the laws of the Relevant Taxing Jurisdiction to be included in the income for tax purposes of a beneficiary or settlor with respect to such fiduciary or a member of such partnership, limited liability company or other pass-through entity or a beneficial owner to the extent such beneficiary, settlor, member or beneficial owner would not have been entitled to such Additional Amounts had it been the holder of the Preference Shares. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 8 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) The requirement to pay Additional Amounts shall apply to any Successor Corporation. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voluntary or Involuntary Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of the Preference Shares shall be entitled to receive out of the Company&#8217;s assets legally available for distribution to shareholders, after satisfaction of indebtedness and other liabilities of the Company, if any, the Liquidation Preference plus declared and unpaid dividends thereon, if any, to, but excluding, the date fixed for distribution, without accumulation of any undeclared dividends (the &#8220;Liquidation Distribution&#8221;), before any distribution of assets is made to holders of Ordinary Shares, or any of the Company&#8217;s other shares of stock ranking junior to the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the payment to the holders of the Preference Shares of the Liquidation Distribution to which such holders are entitled as provided in this Section&#160;6, the holders of the Preference Shares shall have no right or claim to any of the remaining assets of the Company. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event the Company&#8217;s assets are not sufficient to pay the Liquidation Preference in full to all holders of the Preference Shares and the liquidation preference of any Parity Stock to all holders of such Parity Stock, the amounts paid to the holders of Preference Shares and to the holders of any Parity Stock shall be paid </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in accordance with the respective aggregate liquidation preferences of those holders. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Residual Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event the Liquidation Preference has been paid in full to all holders of the Preference Shares and any holders of any Parity Stock, the holders of the Company&#8217;s other capital stock shall be entitled to receive all of the Company&#8217;s remaining assets according to their respective rights and preferences. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger, Consolidation and Sale of Assets Not Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For purposes of this Section&#160;6, neither a consolidation, amalgamation, merger, arrangement or reconstruction involving the Company or the sale or transfer of all or substantially all of the shares of capital stock or the property or business of the Company shall be deemed to constitute a liquidation, dissolution or winding-up of the Company. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Optional Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Company may not redeem Preference Shares prior to July&#160;1, 2023, except as provided in Sections 7(a)(2), 7(a)(3) and 7(a)(4). On July&#160;1, 2023 and any Dividend Payment Date thereafter, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or in part, upon notice given as provided in Section&#160;7(c), at a cash redemption price equal to $25 per Preference Share, plus declared and unpaid dividends, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) On any Dividend Payment Date following the occurrence of a Tax Event, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or in part, upon notice given as provided in Section&#160;7(c), at a cash redemption price equal to $25 per Preference Share, plus declared and unpaid dividends, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) On the Dividend Payment Date after the Company has reasonably determined that, as a result of (i)&#160;any amendment to, or change in, the laws or regulations of Bermuda that is enacted or becomes effective after the Issue Date&#59; (ii)&#160;any proposed amendment to, or change in, those laws or regulations that is announced or becomes effective after the Issue Date&#59; or (iii)&#160;any official administrative decision or judicial decision or administrative action or other official pronouncement interpreting or applying those laws or regulations that is announced after the Issue Date, a Capital Disqualification Redemption Event has occurred, the Preference Shares </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 9 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or in part, upon notice given as provided in Section&#160;7(c), at a cash redemption price equal to $25 per Preference Share, plus declared and unpaid dividends, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends&#59; provided that any such redemption in part may only be made if (x)&#160;the Company has reasonably determined that the portion of the Preference Shares to be redeemed are the subject of the Capital Disqualification Redemption Event and (y)&#160;after giving effect to such redemption, the Company has reasonably determined that a Capital Disqualification Redemption Event will not exist with respect to the then-outstanding Preference Shares and such redemption will not result in the suspension or removal of the Preference Shares from listing on the New York Stock Exchange. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) At any time prior to July&#160;1, 2023, if (i)&#160;the Company submits to the holders of Ordinary Shares a proposal for an amalgamation or merger, or (ii)&#160;if the Company submits any proposal for any other matter that requires, as a result of any change in Bermuda law after April&#160;25, 2013, for its validation or effectuation an affirmative vote of the holders of the Preference Shares at the time outstanding, whether voting as a separate series or together with any other series or class of preference shares as a single class, the Company shall have the option, subject to compliance with Bermuda law, by not less than 30 nor more than 60 days prior written notice to the relevant holders, in such form and given in such manner as to be in accordance with Section&#160;7(c), to redeem all of the outstanding Preference Shares for cash at a redemption price per Preference Share equal to the greater of&#58; </font></div><div style="margin-bottom:9pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) $25 per Preference Share&#59; and </font></div><div style="margin-bottom:9pt;padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the sum of the present value of $25 per Preference Share and the present value of all undeclared dividends for the Dividend Periods from the Redemption Date to, and including, the July&#160;1, 2023 Dividend Payment Date, in each case, discounted to the Redemption Date on a quarterly basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate, as calculated by the Calculation Agent, plus 50 basis points, and in the case of both (i)&#160;and (ii)&#160;plus declared and unpaid dividends. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Mandatory Redemption&#59; No Sinking Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Preference Shares shall not be subject to any mandatory redemption, sinking fund, retirement fund or purchase fund or other similar provisions. Holders of Preference Shares shall have no right to require redemption or repurchase of any Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notice of each redemption of Preference Shares shall be given by first class mail, to the holders of record of the Preference Shares to be redeemed, not less than 30 nor more than 60 days prior to the Redemption Date. Notwithstanding the foregoing, if the Preference Shares or any depositary shares representing interests in the Preference Shares are held in book-entry form through The Depository Trust Company, notice of redemption may be given to the holders of Preference Shares in any manner permitted by The Depository Trust Company. Each such notice given to a holder shall state&#58; (1)&#160;the Redemption Date&#59; (2)&#160;the number of Preference Shares to be redeemed and, if less than all of the Preference Shares held by such holder are to be redeemed, the number of such Preference Shares to be redeemed from such holder&#59; (3)&#160;the redemption price or the methodology for determining the redemption price&#59; and (4)&#160;the place or places where certificates for such Preference Shares are to be surrendered for payment of the redemption price. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> Partial Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In case of any redemption of only part of the Preference Shares at the time outstanding, the Preference Shares to be redeemed shall be selected either </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or in such other manner as the Company may determine to be fair and equitable. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effectiveness of Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a notice of redemption has been duly given and if all funds necessary for the redemption have been set aside for payment by the Company for the benefit of the holders of any Preference Shares called for redemption, then, from and after the Redemption Date, dividends shall cease to accumulate on all Preference Shares so called for redemption, all Preference Shares so called for redemption shall no longer be deemed outstanding and all rights of holders of such Preference Shares shall forthwith on such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 10 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption Date cease and terminate, except the right of the holders thereof to transfer the Preference Shares prior to the Redemption Date and the right to receive the redemption price pursuant to Section&#160;7(a). </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Redemption Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On or prior to the Redemption Date, the Company shall deposit with the Paying Agent an amount in immediately available funds sufficient to pay the aggregate redemption price plus any declared and unpaid dividends&#59; provided that if such payment is deposited on the Redemption Date, it must be received by the Paying Agent by 10&#58;00 a.m. (New York City time) on the Redemption Date. An amount equal to the redemption price plus any declared and unpaid dividends shall be paid to the holders promptly following the later of (i)&#160;the Redemption Date and (ii)&#160;the time of book-entry transfer or surrender of the certificate(s) evidencing such Preference Shares to the Paying Agent, as applicable. Any declared but unpaid dividends payable on a Redemption Date that occurs subsequent to the Dividend Record Date for such Dividend Period shall not be paid to the holder entitled to receive the redemption price on the Redemption Date, but rather shall be paid to the holder of record of the redeemed Preference Shares on such Dividend Record Date relating to the Dividend Payment Date. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Preference Shares have no stated maturity. The Preference Shares shall remain outstanding perpetually, unless and until the Company elects to redeem the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variation or Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) At any time following a Tax Event or at any time following a Capital Disqualification Change Event, the Company may, without the consent of any holders of the Preference Shares, vary the terms of the Preference Shares or exchange the Preference Shares for new securities, which (i)&#160;in the case of a Tax Event, would eliminate the substantial probability that the Company or any Successor Corporation would be required to pay any Additional Amounts with respect to the Preference Shares as a result of a Change in Tax Law or (ii)&#160;in the case of Capital Disqualification Change Event, would cause the Preference Shares to become securities that qualify as Tier 1 capital (where capital is subdivided into tiers) or its equivalent under then-applicable Capital Adequacy Regulations imposed upon the Company by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority), including under the Bermuda Monetary Authority&#8217;s enhanced capital requirements, for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or levels of the Company or any subsidiary thereof. The terms of the varied securities or new securities considered in the aggregate shall not be less favorable, including from a financial perspective, to holders than the terms of the Preference Shares prior to being varied or exchanged (as reasonably determined by the Company)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no such variation of terms or securities received in exchange shall change the specified denominations, or any payment of dividend on, the redemption dates (other than any extension of the period during which an optional redemption may not be exercised by the Company) or currency of, the Preference Shares, reduce the Liquidation Preference thereof or the dividend payable thereon, lower the ranking of the securities, reduce the voting threshold for the issuance of Senior Shares or change the foregoing list of items that may not be so amended as part of such variation or exchange. No such variation of terms or securities received in exchange shall impair the right of a holder of the securities to institute suit for the payment of any amounts due (as provided under this Certificate of Designation), but unpaid with respect to such holder&#8217;s securities. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Prior to any variation or exchange, the Company shall be required to (i)&#160;receive an opinion of independent legal advisers of recognized standing to the effect that holders and beneficial owners of the Preference Shares (including as holders and beneficial owners of the varied or exchanged securities) shall not recognize income, gain or loss for United States federal income tax purposes as a result of such variation or exchange and shall be subject to United States federal income tax on the same amounts, in the same manner and at the same times as would have been the case had such variation or exchange not occurred, and (ii)&#160;deliver a certificate signed by two executive officers of the Company to the transfer agent for the Preference Shares confirming that (x)&#160;a Capital Disqualification Change Event or a Tax Event has occurred and is continuing (as reasonably determined by the Company) and (y)&#160;that the terms of the varied or new securities, considered in the aggregate, are not less favorable, including from a financial perspective, to holders than the terms of the Preference Shares prior to being varied or exchanged (as reasonably determined by the Company). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 11 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Any variation or exchange of the Preference Shares described above shall be made after notice is given to the holders of the Preference Shares not less than 30 nor more than 60 days prior to the date fixed for variation or exchange, as applicable. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as provided in this Section&#160;10 or otherwise required by Bermuda law from time to time, the holders of the Preference Shares shall not have any voting rights. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> Right to Elect Two Directors upon Nonpayment Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Whenever full dividends payable on any Preference Shares shall have not been declared and paid for the equivalent of any six (6)&#160;Dividend Periods, whether or not consecutive (a &#8220;Nonpayment&#8221;), the holders of the Preference Shares, acting together as a single class with holders of any and all other series of Appointing Preference Shares then outstanding, shall be entitled to the appointment (the &#8220;Appointing Rights&#8221;) of a total of two additional members to the Board of Directors (each, a &#8220;Preference Share Director&#8221;), provided that the appointment of any such directors shall not cause the Company to violate the corporate governance requirements of the New York Stock Exchange as applied to U.S. issuers (or any other securities exchange or automated quotation system on which the Company&#8217;s securities may be then listed or quoted) that listed companies must have a majority of independent directors. In the case of a Nonpayment, the number of directors on the Board of Directors shall automatically increase by two (to the extent such increase does not exceed the maximum number of directors permitted under the Company&#8217;s Bye-Laws, and the new directors shall be selected by at least a majority of the aggregate Liquidation Preference of the Preference Shares and any other Appointing Preference Shares at a special meeting called at the request of the record holders of at least 20% of the aggregate Liquidation Preference of the Preference Shares or of any other series of Appointing Preference Shares then outstanding. The Board of Directors shall duly appoint the Preference Share Directors selected by the holders of the Preference Shares and any other Appointing Preference Shares then outstanding, and shall, subject to the Company&#8217;s Bye-Laws, determine which classes of directors the Preference Share Directors shall be a part of and shall allocate such Preference Share Directors to the classes having the longest term of office remaining at the time of such appointment. Each Preference Share Director shall be entitled to one vote per director on any matter. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Appointing Rights shall continue until dividends on the Preference Shares and any such series of Appointing Preference Shares following the nonpayment shall have been fully declared and paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for payment) for at least four (4)&#160;consecutive Dividend Periods. When the term of a class of directors of which any Preference Share Director is a part of is expiring, the Board of Directors shall set the size of such class of directors to be elected by the Company&#8217;s ordinary shareholders at a level to include such Preference Share Director duly appointed by the Board of Directors upon the exercise of the Appointing Rights. The Company shall use its best efforts to increase the number of directors constituting the Board of Directors to the extent necessary to effect these Appointing Rights. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">So long as a Nonpayment shall continue, any vacancy in the office of a Preference Share Director (other than prior to the initial appointment after a Nonpayment) may be filled by the Board of Directors pursuant to an exercise of the Appointing Rights by the holders of Preference Shares and any other Appointing Preference Shares then outstanding. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If and when dividends for four (4)&#160;consecutive Dividend Periods following a Nonpayment have been paid in full (or declared and a sum sufficient for the payment of such dividends shall have been set aside), the holders of the Preference Shares shall be divested of the Appointing Rights (subject to revesting in the event of each subsequent Nonpayment, as described above) and, if such Appointing Rights for all other holders of Appointing Preference Shares have terminated, the office of each Preference Share Director so appointed shall, notwithstanding the class of directors such Preference Share Director shall be a part of, automatically be vacated and the number of directors on the Board of Directors shall automatically decrease by two (2). In determining whether dividends have been fully paid for four (4)&#160;consecutive Dividend Periods following a Nonpayment, the Company may take into account any dividend the Company elects to pay for a Dividend Period after the regular Dividend Payment Date for that period has passed. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 12 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting on Variations of Rights and Senior Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Notwithstanding the Company&#8217;s Bye-Laws, the affirmative vote or consent of the holders of at least 66&#160;2&#47;3% of the aggregate Liquidation Preference of the outstanding Preference Shares and any series of Appointing Preference Shares, voting together as a single class, shall be required for the authorization or issuance of any class or series of Senior Shares (or any security convertible into or exchangeable for Senior Shares) ranking senior to the Preference Shares as to dividend rights or rights upon the Company&#8217;s liquidation. The authorization of, the increase in the authorized amount of, or the issuance of any shares of any class or series of parity shares or junior shares shall not require the consent of any holder of the Preference Shares, and shall not be deemed to materially adversely affect the rights of the holders of the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The affirmative vote or consent of the holders of at least 66&#160;2&#47;3% of the aggregate Liquidation Preference of the Company&#8217;s outstanding Preference Shares shall be required for amendments to the Company&#8217;s Memorandum of Association or Bye-Laws that would materially adversely affect the rights of holders of the Preference Shares. If all preference shares of the Company are not equally affected by any such proposed amendment and if the </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preference Shares would have diminished status compared to other preference shares as a result, the approval of holders of at least 662&#47;3% of the outstanding Preference Shares, voting together as a single class, shall be required. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) The foregoing voting provisions of this Section&#160;10 will not apply if, at or prior to the time when the act with respect to which such vote would otherwise be required shall be effected, all outstanding Preference Shares shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have been set aside for payment by the Company for the benefit of the holders of Preference Shares to effect such redemption as set forth in Section&#160;7. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> Record Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the fullest extent permitted by applicable law, the Company and the transfer agent for the Preference Shares may deem and treat the record holder of any share of Preference Shares as the true and lawful owner thereof for all purposes, and neither the Company nor such transfer agent shall be affected by any notice to the contrary. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments or Modifications&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) To the extent permitted by applicable law, the Board of Directors may modify the terms of this Certificate of Designation without the consent of any holder of Preference Shares for any of the following purposes&#58; </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) to evidence the succession of another person to the Company&#8217;s obligations&#59; </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) to add to the covenants for the benefit of the holders of the Preference Shares or to surrender any of the Company&#8217;s rights or powers under the Preference Shares&#59; </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) to cure any ambiguity to correct or supplement any provisions that may be inconsistent, provided that such action shall not adversely affect the interest of the holders of the Preference Shares in any material respect&#59; or </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) to make any other provision with respect to such matters or questions arising under this Certificate of Designation which the Company may deem desirable and which shall adversely affect the interests of the holders of the Preference Shares in any material respect. </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Except as provided below in this Section&#160;12(b), this Certificate of Designation may be amended, modified or supplemented, and noncompliance in any particular instance with any provision of this Certificate of Designation or the Preference Shares may be waived, in each case with the affirmative vote or written consent of the holders of at least a majority of the aggregate liquidation preference of the Preference Shares then outstanding, including any modification occurring in connection with any merger or consolidation of the Company or otherwise. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 13 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Board of Directors may, subject to the prior written consent or the affirmative vote of the holders of at least a majority of the aggregate liquidation preference of the Preference Shares, amend the terms of this Certificate of Designation or the rights, powers, preferences and privileges of the holders of the Preference Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no such amendment shall, without the consent of the holder of each outstanding Preference Share affected by the amendment&#58; </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) change any Dividend Payment Date&#59; </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) reduce the rate of dividends payable on the Preference Shares when, as and if declared by the Board of Directors&#59; </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) reduce the redemption price or alter the July&#160;1, 2023 optional redemption date&#59; </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) change the place or currency of payment&#59; </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) impair the right to institute suit for the enforcement of the Preference Shares&#59; or </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) change the percentage of aggregate Liquidation Preference of the Preference Shares whose holders must approve any amendment. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger, Amalgamation, Consolidation and Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company covenants that it will not merge or amalgamate with or into, consolidate with or convert into any other person or entity or sell, assign, transfer, lease or convey all or substantially all of the Company&#8217;s properties and assets into any person or entity, unless </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) either the Company is the continuing corporation or the successor corporation is a corporation organized under the laws of the United States, a state thereof, the District of Columbia, Bermuda or any country which is, on the date hereof, a member of the Organization for Economic Cooperation and Development and the Preference Shares shall be exchanged for or converted into and shall become Preference Shares of the successor corporation with substantially the same rights, powers, preferences and privileges, and </font></div><div style="margin-bottom:9pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) the Company or the successor corporation is not, immediately after such merger, amalgamation, consolidation, conversion, sale, assignment, transfer, lease or conveyance, in default of any obligation under the Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Preference Shares shall be issued initially in the form of one or more fully registered global certificates with the global securities legend set forth in Exhibit A hereto (&#8220;Global Preference Shares&#8221;), each as set forth on the form of Preference Shares certificate attached hereto as Exhibit A which is hereby incorporated in and expressly made a part of this Certificate of Designation. The Global Preference Shares certificate may have notations, legends or endorsements required by law, stock exchange rules, agreements to which the Company is subject, if any, or usage (provided that any such notation, legend or endorsement is in a form acceptable to the Company). The Global Preference Shares shall be deposited on behalf of the holders of the Preference Shares represented thereby with the Registrar, as custodian for DTC (or with such other custodian as DTC may direct), and registered in the name of DTC or a nominee of DTC, duly executed by the Company and countersigned by the Registrar as hereinafter provided, The aggregate number of Preference Shares represented by Global Preference Shares may from time to time be increased or decreased by adjustments made on the records of the Registrar and DTC or its nominee as hereinafter provided. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event Global Preference Shares are deposited with or on behalf of DTC, the Company shall execute, and the Registrar shall countersign and deliver, initially one or more Global Preference Shares certificates that (a)&#160;shall be registered in the name of Cede&#160;&#38; Co. or other nominee of the Depositary and (b)&#160;shall be delivered by the Registrar to DTC or pursuant to DTC&#8217;s instructions or held by the Registrar as custodian for DTC. Members of, or participants in, DTC (&#8220;Agent Members&#8221;) shall have no rights under this Certificate of Designation with respect to any Global Preference Shares held on their behalf by DTC or by the Registrar as the custodian of DTC or under such Global Preference Shares, and DTC may be treated by the Company, the Registrar and any agent of the Company or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 14 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Registrar as the absolute owner of such Global Preference Shares for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Registrar or any agent of the Company or the Registrar from giving effect to any written certification, proxy or other authorization furnished by DTC or impair, as between DTC and its Agent Members, the operation of customary practices of DTC governing the exercise of the rights of a holder of a beneficial interest in any Global Preference Shares. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Owners of beneficial interests in Global Preference Shares shall not be entitled to receive physical delivery of certificated Preference Shares, unless&#58; </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) DTC is unwilling or unable to continue as Depositary for the Global Preference Shares and the Company does not appoint a qualified replacement for DTC within 90 calendar days&#59; </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) DTC ceases to be a &#8220;clearing agency&#8221; registered under the Exchange Act and the Company does not appoint a qualified replacement for DTC within 90 calendar days&#59; or </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) the Company decides to discontinue the use of book-entry transfer through DTC (or any successor Depositary). </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any such case, the Global Preference Shares shall be exchanged in whole for certificated Preference Shares in registered form, with the same terms and of an equal aggregate liquidation preference (unless the Company determines otherwise in accordance with applicable law). Certificated Preference Shares shall be registered in the name or names of the Person or Person specified by DTC in a written instrument to the Registrar. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) An Officer shall sign the Preference Shares certificate for the Company by manual or facsimile signature. If the Officer whose signature is on a Preference Shares certificate no longer holds that office at the time the Registrar countersigns the Preference Shares certificate, the Preference Shares certificate shall be valid nevertheless. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Preference Shares certificate shall not be valid until an authorized signatory of the Registrar signs the Preference Shares certificate by manual or facsimile signature. The signature shall be conclusive evidence that the Preference Shares certificate has been countersigned under this Certificate of Designation. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;15. Notices. All notices or communications in respect of Preference Shares shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designation, the Memorandum of Association, the Bye-Laws or by applicable law. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;16. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Preemptive Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Holders of the Preference Shares shall not have any rights of preemption whatsoever as to any securities of the Company, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;17. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations on Transfer and Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The holders of Preference Shares shall be subject to the limitations on transfer and ownership contained in the Bye-laws. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;18. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Preference Shares shall not be convertible into or exchangeable for any other securities or property of the Company. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;19. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Preference Shares shall not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, limitations or restrictions other than as set forth in this Certificate of Designation, the Memorandum of Association, the Bye-laws or applicable law. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;20. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation in Respect of Preference Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company will be responsible for making all calculations called for in respect of the Preference Shares, including, but not limited to, the determination of the dividends payable on the Preference Shares. Any calculations made in good faith and without manifest error will be final and binding on holders of the Preference Shares. The Company or its agents will be required to deliver to the Paying Agent a schedule of its calculations and the Paying Agent will be entitled to rely upon the accuracy of such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 15 -</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">calculations without independent verification. The Paying Agent will forward such calculations to any holder of the Preference Shares upon the request of such holder. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;21. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event any provision of this Certificate of Designation shall be invalid, unenforceable or illegal, then, to the fullest extent permitted by applicable law, the validity, enforceability and legality of the remaining provisions shall not in any way be affected or impaired thereby. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- 16 -</font></div></div></div></div><div id="i9c0fdd92909e40c89f1b11a0560cac61_62"></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, ASPEN INSURANCE HOLDINGS LIMITED has caused this Certificate of Designation to be signed this 2nd day of May, 2013.</font></div><div style="margin-bottom:9pt;padding-left:280.8pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.384%"><tr><td style="width:1.0%"></td><td style="width:9.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.782%"><tr><td style="width:1.0%"></td><td style="width:15.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.372%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attest&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></div><div id="i9c0fdd92909e40c89f1b11a0560cac61_78"></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT A </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form of Preference Shares Certificate </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.95% FIXED-TO-FLOATING RATE PERPETUAL NON-CUMULATIVE PREFERENCE SHARES </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FACE OF SECURITY </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&#160;&#38; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&#160;&#38; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE&#160;&#38; CO. HAS AN INTEREST HEREIN. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE CERTIFICATE OF DESIGNATION REFERRED TO BELOW. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. </font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Preference Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000,000</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CUSIP NO.&#58; G05384154</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISIN NO.&#58; BMG053841547</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liquidation preference U.S.$25 per Preference Share) </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), hereby certifies that Cede&#160;&#38; Co. or its registered assigns (the &#8220;Holder&#8221;) is the registered owner of 11,000,000, or such number as is indicated in the records of the Registrar and the Depository, fully paid and non-assessable preference shares of the Company designated the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, with a liquidation preference of U.S.$25 per share (the &#8220;Preference Shares&#8221;). The Preference Shares are transferable on the books and records of the Registrar, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper form for transfer. The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Preference Shares represented hereby are issued and shall in all respects be subject to the provisions of the Certificate of Designation dated May&#160;2, 2013, as the same may be amended from time to time (the &#8220;Certificate of Designation&#8221;). Capitalized terms used herein but not defined shall have the meaning given them in the Certificate of Designation. The Company will provide a copy of the Certificate of Designation to a holder without charge upon written request to the Company at its principal place of business. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to select provisions of the Preference Shares set forth on the reverse hereof, and to the Certificate of Designation, which select provisions and the Certificate of Designation shall for all purposes have the same effect as if set forth at this place. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of this certificate, the holder is bound by the Certificate of Designation and is entitled to the benefits thereunder. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the Registrar has properly countersigned, these Preference Shares shall not be entitled to any benefit under the Certificate of Designation or be valid or obligatory for any purpose. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></div><div id="i9c0fdd92909e40c89f1b11a0560cac61_93"></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has executed this certificate this 2nd day of May, 2013.</font></div><div style="margin-bottom:9pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.628%"><tr><td style="width:1.0%"></td><td style="width:19.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGISTRAR&#8217;S COUNTERSIGNATURE </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These are Preference Shares referred to in the within-mentioned Certificate of Designation. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; May&#160;2, 2013 </font></div><div style="margin-bottom:9pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.794%"><tr><td style="width:1.0%"></td><td style="width:10.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPUTERSHARE SHAREOWNER SERVICES LLC, as Registrar</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVERSE OF SECURITY </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on each Preference Share shall be payable at the rate provided in the Certificate of Designation. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Preference Shares shall be redeemable at the Company&#8217;s option in the manner and accordance with the terms set forth in the Certificate of Designation. </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall furnish without charge to each holder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class or series of share capital and the qualifications, limitations or restrictions of such preferences and&#47;or rights. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASSIGNMENT </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned assigns and transfers the Preference Shares evidenced hereby to&#58; </font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Insert assignee&#8217;s social security or tax identification number) &#160;</font></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Insert address and zip code of assignee) </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and irrevocably appoints&#58; </font></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">agent to transfer the Preference Shares evidenced hereby on the books of the Transfer Agent. The agent may substitute another to act for him or her.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.173%"><tr><td style="width:1.0%"></td><td style="width:16.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Sign exactly as your name appears on the other side of this Preference Shares Certificate) &#160;</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.391%"><tr><td style="width:1.0%"></td><td style="width:26.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#160;Guarantee&#58;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Signature must be guaranteed by an &#8220;eligible guarantor institution&#8221; that is a bank, stockbroker, savings and loan association or credit union meeting the requirements of the Transfer Agent, which requirements include membership or participation in the Securities Transfer Agents Medallion Program (&#8220;STAMP&#8221;) or such other &#8220;signature guarantee program&#8221; as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.5
<SEQUENCE>7
<FILENAME>exhibit35-fx1.htm
<DESCRIPTION>EX-3.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4cf03a3887f2478081bc5dd7b27e2d49_79"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 3.5 </font></div></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.95% FIXED-TO-FLOATING RATE PERPETUAL NON-CUMULATIVE PREFERENCE SHARES </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FACE OF SECURITY </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&#160;&#38; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&#160;&#38; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE&#160;&#38; CO. HAS AN INTEREST HEREIN. </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE CERTIFICATE OF DESIGNATION REFERRED TO BELOW. </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.866%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Preference Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000,000</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CUSIP NO.&#58; G05384154</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISIN NO.&#58; BMG053841547</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liquidation preference U.S.$25 per Preference Share) </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), hereby certifies that Cede&#160;&#38; Co. or its registered assigns (the &#8220;Holder&#8221;) is the registered owner of 11,000,000, or such number as is indicated in the records of the Registrar and the Depository, fully paid and non-assessable preference shares of the Company designated the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, with a liquidation preference of U.S.$25 per share (the &#8220;Preference Shares&#8221;). The Preference Shares are transferable on the books and records of the Registrar, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper form for transfer. The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Preference Shares represented hereby are issued and shall in all respects be subject to the provisions of the Certificate of Designation dated May&#160;2, 2013, as the same may be amended from time to time (the &#8220;Certificate of Designation&#8221;). Capitalized terms used herein but not defined shall have the meaning given them in the Certificate of Designation. The Company will provide a copy of the Certificate of Designation to a holder without charge upon written request to the Company at its principal place of business. </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to select provisions of the Preference Shares set forth on the reverse hereof, and to the Certificate of Designation, which select provisions and the Certificate of Designation shall for all purposes have the same effect as if set forth at this place. </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of this certificate, the holder is bound by the Certificate of Designation and is entitled to the benefits thereunder. </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the Registrar has properly countersigned, these Preference Shares shall not be entitled to any benefit under the Certificate of Designation or be valid or obligatory for any purpose.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has executed this certificate this 2nd day of May, 2013. </font></div><div style="padding-left:280.8pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.185%"><tr><td style="width:1.0%"></td><td style="width:14.464%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John Worth</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Worth</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGISTRAR&#8217;S COUNTERSIGNATURE </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These are Preference Shares referred to in the within-mentioned Certificate of Designation. </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; May&#160;2, 2013 </font></div><div style="margin-top:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.185%"><tr><td style="width:1.0%"></td><td style="width:14.464%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPUTERSHARE SHAREOWNER SERVICES LLC, as Registrar</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carole Nilsen</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVERSE OF SECURITY </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on each Preference Share shall be payable at the rate provided in the Certificate of Designation. </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Preference Shares shall be redeemable at the Company&#8217;s option in the manner and accordance with the terms set forth in the Certificate of Designation. </font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall furnish without charge to each holder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class or series of share capital and the qualifications, limitations or restrictions of such preferences and&#47;or rights.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASSIGNMENT </font></div><div style="margin-bottom:18pt;margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned assigns and transfers the Preference Shares evidenced hereby to&#58; </font></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert assignee&#8217;s social security or tax identification number) </font></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert address and zip code of assignee) </font></div><div style="margin-bottom:18pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and irrevocably appoints&#58; </font></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt 0 3.77pt"></td></tr></table></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agent to transfer the Preference Shares evidenced hereby on the books of the Transfer Agent. The agent may substitute another to act for him or her. </font></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.326%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.606%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Sign exactly as your name appears on the other side of this Preference Shares Certificate)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#160;Guarantee&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Signature must be guaranteed by an &#8220;eligible guarantor institution&#8221; that is a bank, stockbroker, savings and loan association or credit union meeting the requirements of the Transfer Agent, which requirements include membership or participation in the Securities Transfer Agents Medallion Program (&#8220;STAMP&#8221;) or such other &#8220;signature guarantee program&#8221; as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.6
<SEQUENCE>8
<FILENAME>exhibit36-fx1.htm
<DESCRIPTION>EX-3.6
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i47401896b28d4c07923d444477ebd2ef_59"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 3.6</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATE OF DESIGNATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.625% PERPETUAL NON-CUMULATIVE PREFERENCE SHARES</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), HEREBY CERTIFIES that pursuant to resolutions of duly authorized Directors adopted on September 12, 2016, the creation of the 5.625% Perpetual Non-Cumulative Preference Shares, with a liquidation preference of $25 per share (the &#8220;Preference Shares&#8221;) were authorized and the designations, preferences and privileges, voting rights, relative, participating, optional and other special rights, and qualifications, limitations and restrictions of the Preference Shares, in addition to those set forth in the Memorandum of Association and Bye-Laws of the Company, were fixed as follows&#58; </font></div><div style="margin-bottom:18pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Designation&#59; Amount of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The designation of this series of Preference Shares shall be &#8220;5.625% Perpetual Non-Cumulative Preference Shares&#8221;, and the number of shares constituting this series shall be 10,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, if the Company elects to issue additional Preference Shares after the date of this Certificate of Designation, any such additional shares are not treated as &#8220;disqualified preferred stock&#8221; within the meaning of Section 1059(f)(2) of the United States Internal Revenue Code of 1986, as amended, and such additional shares are otherwise treated as fungible with the Preference Shares for United States federal income tax purposes. The additional shares would form a single series with the Preference Shares. The Preference Shares shall have a liquidation preference of $25 per Preference Share (the &#8220;Liquidation Preference&#8221;). Each Preference Share shall be identical in all respects to every other Preference Share, except for the issue price, date of issuance and, in some cases, the initial Dividend Payment Date (as defined in Section 4(a)). Any Preference Shares retired by purchase or redemption, or otherwise acquired by the Company, will have the status of authorized but unissued Preference Shares and may be reissued as part of the same class or series or may be reclassified and reissued by the Board of Directors in the same manner as any other authorized and unissued shares. The number of authorized Preference Shares may be reduced (but not below the number of Preference Shares then issued and outstanding) by further resolution duly adopted by the Board of Directors. No such reduction shall affect the due authorization of any issued and outstanding Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As used herein with respect to the Preference Shares&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#8220;5.95% Perpetual Preference Shares&#8221; means the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162; per share, of the Company designated as the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#8220;7.250% Perpetual Preference Shares&#8221; means the 7.250% Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162; per share, of the Company designated as the 7.250% Perpetual Non-Cumulative Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;&#8220;7.401% Perpetual Preference Shares&#8221; means the 7.401% Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162; per share, of the Company designated as the 7.401% Perpetual Non-Cumulative Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#8220;Additional Amounts&#8221; has the meaning assigned to such term in Section 5(a).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#8220;Agent Members&#8221; has the meaning assigned to such term in Section 14(a). </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;&#8220;Appointing Preference Shares&#8221; means any other class or series of preference shares of the Company, including the 5.95% Perpetual Preference Shares, the 7.250% Perpetual Preference Shares and the 7.401% Perpetual Preference Shares, ranking equally with the Preference Shares either as to dividend rights or rights upon liquidation, winding-up or dissolution and upon which like Appointing Rights have been conferred and are exercisable. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;&#8220;Appointing Rights&#8221; has the meaning assigned to such term in Section 10(b). </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;&#8220;Board of Directors&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#8220;Business Day&#8221; means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City generally are authorized or obligated by law or executive order to close.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;&#8220;Bye-Laws&#8221; means the amended and restated bye-laws of the Company, as they may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;&#8220;Capital Adequacy Regulations&#8221; means the solvency margins, capital adequacy regulations or any other regulatory capital rules applicable to the Company from time to time on an individual or group basis pursuant to Bermuda law and&#47;or the laws of any other relevant jurisdiction and which set out the requirements to be satisfied by financial instruments to qualify as solvency margin or additional solvency margin or regulatory capital (or any equivalent terminology employed by the then-applicable capital adequacy regulations).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;&#8220;Capital Disqualification Change Event&#8221; means that the Preference Shares do not qualify, in whole or in part (including as a result of any transitional or grandfathering provisions or otherwise), for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level, of the Company or any subsidiary thereof, where capital is subdivided into tiers, as Tier 1 capital securities under then-applicable Capital Adequacy Regulations imposed upon the Company by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority), which would include, without limitation, the Company&#8217;s individual and group enhanced capital requirements under Bermuda Monetary Authority capital regulations, except as a result of any applicable limitation on the amount of such capital.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;&#8220;Capital Disqualification Redemption Event&#8221; means that the Preference Shares qualify, in whole or in part (including as a result of any transitional or grandfathering provisions or otherwise), for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level, of the Company or any subsidiary thereof, where capital is subdivided into tiers, as neither Tier 1 nor Tier 2 capital securities under then-applicable Capital Adequacy Regulations imposed upon the Company by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority), which would include, without limitation, the Company&#8217;s individual and group enhanced capital requirements under Bermuda Monetary Authority capital regulations, except as a result of any applicable limitation on the amount of such capital.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;&#8220;Certificate of Designation&#8221; means this Certificate of Designation relating to the Preference Shares, as it may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;&#8220;Change in Tax Law&#8221; means (a) a change in or amendment to laws, regulations or rulings of any Relevant Taxing Jurisdiction, (b) a change in the official application or interpretation of those laws, regulations or rulings, (c) any execution of or amendment to any treaty affecting taxation to which any Relevant Taxing Jurisdiction is party after September 13, 2016, or (d) a decision rendered by a court of competent jurisdiction in any Relevant Taxing Jurisdiction, whether or not such decision was rendered with respect to the Company, in each case, described in (a)-(d) above occurring after September 13, 2016&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the case of a Relevant Taxing Jurisdiction other than Bermuda in which a Successor Corporation is organized, such Change in Tax Law must occur after the Succession Date. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;&#8220;Dividend Payment Date&#8221; has the meaning assigned to such term in Section&#160;4(a).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;&#8220;Dividend Period&#8221; has the meaning assigned to such term in Section 4(a).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;&#8220;Dividend Record Date&#8221; has the meaning assigned to such term in Section&#160;4(a).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;&#8220;Global Preference Shares&#8221; has the meaning assigned to such term in Section 14(a). </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;&#8220;Insurance Act&#8221; means the Insurance Act 1978 of Bermuda.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;&#8220;Issue Date&#8221; means September 20, 2016, the original date of issuance of the Preference Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;&#8220;Junior Stock&#8221; means any class or series of capital stock of the Company, including the Company&#8217;s Ordinary Shares, that ranks junior to the Preference Shares either as to the payment of dividends or as to the distribution of assets upon any liquidation, dissolution or winding-up of the Company.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;&#8220;Liquidation Distribution&#8221; has the meaning assigned to such term in Section 6(a).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;&#8220;Liquidation Preference&#8221; has the meaning assigned to such term in Section 1.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(y)&#160;&#160;&#160;&#160;&#8220;Memorandum of Association&#8221; means the memorandum of association of the Company, as it may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(z)&#160;&#160;&#160;&#160;&#8220;Nonpayment&#8221; has the meaning assigned to such term in Section 10(b). </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(aa)&#160;&#160;&#160;&#160;&#8220;Ordinary Shares&#8221; means the Ordinary Shares, par value $0.0015144558 per share, of the Company, or any other class of shares resulting from successive changes or reclassifications of such Ordinary Shares consisting solely of changes in par value, or from par value to no par value, or as a result of a subdivision, combination, merger, consolidation or similar transaction in which the Company is a constituent corporation.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;&#8220;Parity Stock&#8221; means any class or series of capital stock of the Company that ranks equally with the Preference Shares as to payment of dividends and the distribution of assets on any liquidation, dissolution or winding-up of the Company, including the 5.95% Perpetual Preference Shares, the 7.250% Perpetual Preference Shares and the 7.401% Perpetual Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;&#8220;Paying Agent&#8221; initially means Computershare Trust Company, N.A. The Company may, in its sole discretion, remove the Paying Agent within ten (10) calendar days prior notice to the Paying Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Company shall appoint a successor Paying Agent who shall accept such appointment prior to the effectiveness of such removal.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;&#8220;Preference Share Director&#8221; has the meaning assigned to such term in Section&#160;10(b).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;&#8220;Preference Shares&#8221; has the meaning assigned to such term in the recitals.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ff)&#160;&#160;&#160;&#160;&#8220;Redemption Date&#8221; means, in the case of an optional redemption, the day specified in the Company&#8217;s notice of redemption. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(gg)&#160;&#160;&#160;&#160;&#8220;Register of Members&#8221; means the Register of Members of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(hh)&#160;&#160;&#160;&#160;&#8220;Registrar&#8221; initially means Computershare Trust Company, N.A. The Company may, in its sole discretion, remove the Registrar within ten (10) calendar days prior notice to the Registrar&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Company shall appoint a successor Registrar who shall accept such appointment prior to the effectiveness of such removal.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#8220;Relevant Date&#8221; means, in respect of any payment, the date on which such payment first becomes due and payable, but if the full amount of the moneys payable has not been received by the dividend disbursing agent on or prior to such due date, it means the first date on which the full amount of such moneys has been so received and is available for payment to holders, and notice to that effect shall have been duly given to the holders of the Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(jj)&#160;&#160;&#160;&#160;&#8220;Relevant Taxing Jurisdiction&#8221; means (a) Bermuda or any political subdivision or governmental authority of or in Bermuda with the power to tax, (b) any jurisdiction from or through which the Company or its dividend disbursing agent are making payments on the Preference Shares or any political subdivision or governmental authority of or in that jurisdiction with the power to tax or (c) any other jurisdiction in which the Company or a Successor Corporation is organized or generally subject to taxation on a net income basis or any political subdivision or governmental authority of or in that jurisdiction with the power to tax.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(kk)&#160;&#160;&#160;&#160;&#8220;Senior Shares&#8221; means any class of share capital or series of preference shares established after the Issue Date by the Board of Directors, the terms of which expressly provide that such class or series will rank senior to the Preference Shares as to dividend rights or rights upon liquidation, winding-up or dissolution of the Company.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ll)&#160;&#160;&#160;&#160;&#8220;set aside for payment&#8221; means, without any action other than the following, the recording by the Company in its accounting ledgers of any accounting or bookkeeping entry which indicates, pursuant to a declaration of a dividend or other distribution by the Board of Directors, the allocation of the funds to be so paid on any class or series of the Company&#8217;s shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if any funds for any class or series of Junior Stock or any class or series of Parity Stock are placed in a separate account of the Company or delivered to a disbursing, paying or other similar agent, then &#8220;set aside for payment&#8221; with respect to the Preference Shares shall mean placing such funds in a separate account or delivering such funds to a disbursing, paying or other similar agent.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(mm)&#160;&#160;&#160;&#160;&#8220;Succession Date&#8221; means the date on which the Company consolidates, merges or amalgamates with a Successor Corporation or conveys, transfers or leases substantially all its properties and assets to a Successor Corporation. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(nn)&#160;&#160;&#160;&#160;&#8220;Successor Corporation&#8221; has the meaning assigned to such term in the definition of Tax Event.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(oo)&#160;&#160;&#160;&#160;&#8220;Tax Event&#8221; means a Change in Tax Law that, in the Company&#8217;s reasonable determination, results in a substantial probability that the Company or any entity formed by a consolidation, merger or amalgamation involving the Company or the entity to which the Company conveys, transfers or leases substantially all its properties and assets (a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Successor Corporation&#8221;) would be required to pay any Additional Amounts with respect to the Preference Shares, which obligation cannot be avoided by the Company through reasonable measures.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ranking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall, with respect to dividend rights or rights upon the liquidation, winding-up or dissolution of the Company, rank (a) senior to all Junior Shares, including, without limitation, the Ordinary Shares, (b) on a parity with all Parity Shares, including, without limitation, the 5.95% Perpetual Preference Shares, the 7.250% Perpetual Preference Shares and the 7.401% Perpetual Preference Shares, (c) junior to any Senior Shares and (d) junior to all of the Company&#8217;s existing and future debt obligations.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Rate and Payment of Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The holders of Preference Shares shall be entitled to receive, only when, as and if declared by the Board of Directors, subject to compliance with Bermuda law, non-cumulative cash dividends from, and including, the Issue Date, quarterly in arrears, on January 1, April 1, July 1 and October 1 of each year (each, a &#8220;Dividend Payment Date&#8221;), commencing on January 1, 2017, without accumulation of any undeclared dividends. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent declared, dividends shall accumulate, with respect to each Dividend Period, in an amount per share equal to 5.625% of the Liquidation Preference per Preference Share per annum. Dividends payable on the Preference Shares shall be computed on the basis of a 360-day year consisting of twelve 30-day months with respect to a full Dividend Period, and on the basis of the actual number of days elapsed during such Dividend Period with respect to a Dividend Period other than a full Dividend Period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dividends that are payable on Preference Shares on any Dividend Payment Date shall be payable to holders of record of Preference Shares as they appear on the Register of Members at 5&#58;00 p.m. (New York City time) on the immediately preceding December 15, March 15, June 15 and September 15 (each, a &#8220;Dividend Record Date&#8221;). The Dividend Record Dates shall apply regardless of whether a particular Dividend Record Date is a Business Day. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A dividend period (each, a &#8220;Dividend Period&#8221;) is the period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial Dividend Period shall commence on, and include, the Issue Date and shall end on, and exclude, the January 1, 2017 Dividend Payment Date. If any date on which dividends would otherwise be payable is not a Business Day, then the Dividend Payment Date shall be the next succeeding Business Day after the original Dividend Payment Date, and no additional dividends shall accumulate on the amount so payable as a result of the delay. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Redemption Date falls on a day that is not a Business Day, the payment of dividends and redemption price shall be made on the first Business Day following such Redemption Date, without accrual to the actual payment date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dividends on the Preference Shares are non-cumulative. Consequently, if the Board of Directors does not authorize and declare a dividend for any Dividend Period, holders of the Preference Shares will not be entitled to receive a dividend for such Dividend Period, and such undeclared dividend will not accumulate and will not be payable. The Company will have no obligation to pay dividends for a Dividend Period after the Dividend Payment Date for such Dividend Period if the Board of Directors has not declared such dividend before the related Dividend Payment Date, whether or not dividends are declared for any subsequent Dividend Period with respect to the Preference Shares. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Holders of Preference Shares shall not be entitled to any dividends, whether payable in cash, securities or other property, other than dividends, if any, declared and payable on the Preference Shares as specified in this Section 4. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event that the Company issues additional Preference Shares after the Issue Date, to the extent declared, dividends on such additional Preference Shares may accumulate from, and including, their Issue Date or any other date the Company specifies at the time such additional Preference Shares are issued.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Priority of Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. So long as any Preference Shares remain outstanding for any Dividend Period, unless the full dividends for the latest completed Dividend Period on all outstanding Preference Shares and Parity Stock have been declared and paid or declared and a sum sufficient for the payment thereof has been set aside&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;no dividend shall be paid or declared on the Ordinary Shares or any other shares of Junior Stock or Parity Stock (except in the case of the Parity Stock on a pro rata basis with the Preference Shares as described below), other than a dividend payable solely in Ordinary Shares, other Junior Stock or Parity Stock, as applicable, and </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;no Ordinary Shares, other Junior Stock or Parity Stock shall be purchased, redeemed or otherwise acquired for consideration by the Company, directly or indirectly (other than (a) as a result of a reclassification of Junior Stock for or into other Junior Stock, or a reclassification of Parity Stock for or into other Parity Stock, as applicable, or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock, or the exchange or conversion of one share of Parity Stock for or into another share of Parity Stock, as applicable, (b) through the use of the proceeds of a substantially contemporaneous sale of Junior Stock or Parity Stock, as applicable, or (c) as required by or necessary to fulfill the terms of any employment contract, benefit plan or similar arrangement with or for the benefit of one or more employees, directors or consultants). </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When dividends are not paid or duly provided for in full on any Dividend Payment Date upon the Preference Shares and any shares of Parity Stock, all dividends declared upon the Preference Shares and all such Parity Stock and payable on such Dividend Payment Date shall be declared on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> basis so that the respective amounts of such dividends shall bear the same ratio to each other as the full amount of dividends payable on the outstanding </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Preference Shares for such Dividend Period and the accumulated and unpaid dividends, or the full amount of dividends payable for such Dividend Period in the case of non-cumulative preferred stock, on all such Parity Stock bear to each other. In the case of any Parity Stock having dividend payment dates different from the Dividend Payment Dates pertaining to the Preference Shares, the measurement date for such Parity Stock shall be the Dividend Payment Date falling within the related Dividend Period for the Preference Shares. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Additional Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company shall make all payments on the Preference Shares free and clear of and without withholding or deduction at source for, or on account of, any present or future taxes, fees, duties, assessments or governmental charges of whatever nature imposed or levied by or on behalf of any Relevant Taxing Jurisdiction, unless such taxes, fees, duties, assessments or governmental charges are required to be withheld or deducted by (x) the laws (or any regulations or rulings promulgated thereunder) of any Relevant Taxing Jurisdiction or (y) an official position regarding the application, administration, interpretation or enforcement of any such laws, regulations or rulings (including, without limitation, a holding by a court of competent jurisdiction or by a taxing authority in any Relevant Taxing Jurisdiction). If a withholding or deduction at source is required, the Company shall, subject to certain limitations and exceptions described below, pay to the holders or beneficial owners of the Preference Shares such additional amounts (the &#8220;Additional Amounts&#8221;) as may be necessary so that every net payment made to such holders or beneficial owners, after the withholding or deduction, shall not be less than the amount provided for in this Certificate of Designation to be then due and payable.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall not be required to pay any Additional Amounts for or on account of&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or governmental charge of whatever nature that would not have been imposed but for the fact that such holder or beneficial owner (i) was a resident, citizen, domiciliary or national of, or engaged in business or maintained a permanent establishment or was physically present in, the Relevant Taxing Jurisdiction or otherwise had some connection with the Relevant Taxing Jurisdiction other than by reason of the mere ownership of, or receipt of payment under, such Preference Shares or (ii) presented, where presentation is required, such Preference Shares for payment more than 30 days after the Relevant Date, except to the extent that the holder or beneficial owner would have been entitled to such Additional Amounts if it had presented such Preference Shares for payment on any day within that 30-day period&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;any estate, inheritance, gift, sale, transfer, personal property or similar tax, fee, duty, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or other governmental charge that is payable otherwise than by withholding or deduction from payment of the Liquidation Preference of or any dividends on the Preference Shares&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or other governmental charge that is imposed or withheld by reason of the failure by the holder or beneficial owner of such Preference Shares to comply with any reasonable request by the Company addressed to the holder within ninety (90) days of such request (a) to provide information concerning the nationality, citizenship, residence or identity of the holder or beneficial owner or (b) to make any declaration or other similar claim or satisfy any information or reporting requirement, which is required or imposed by statute, treaty, regulation or administrative practice of the Relevant Taxing Jurisdiction or any political subdivision thereof as a precondition to exemption from all or part of such tax, fee, duty, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;any taxes, duties, assessments or governmental charges required to be withheld or deducted under sections 1471 through 1474 of the United States Internal Revenue Code of 1986, as amended (or any United States Treasury Regulations or other administrative guidance thereunder)&#59; or</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;any combination of items (1), (2), (3), (4) and (5).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Company shall not pay Additional Amounts with respect to any payment on any such Preference Shares to any holder or beneficial owner who is a fiduciary, partnership, limited liability company or other pass-through entity or a person other than the sole beneficial owner of such Preference Shares if such payment would be required by the laws of the Relevant Taxing Jurisdiction to be included in the income for tax purposes of a beneficiary or settlor with respect to such fiduciary or a member of such partnership, limited liability company or other pass-through entity or a beneficial owner to the extent such beneficiary, settlor, member or beneficial owner would not have been entitled to such Additional Amounts had it been the holder or beneficial owner of the Preference Shares. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;If a payment on the Preference Shares is subject to withholding or deduction for, or on account of, any taxes or other governmental charges imposed or levied by or on behalf of any Relevant Taxing Jurisdiction, the Company shall pay the taxes or other governmental charges to the Relevant Taxing Jurisdiction in accordance with applicable law and furnish to the dividend disbursing agent certified copies of tax receipts (or other evidence of payment reasonably satisfactory to the dividend disbursing agent) evidencing payment of the taxes or other governmental charges. Copies of such documentation will be made available by the dividend disbursing agent to holders of the Preference Shares upon written request.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The requirement to pay Additional Amounts shall apply to any Successor Corporation. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voluntary or Involuntary Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event of any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of the Preference Shares shall be entitled to receive out of the Company&#8217;s assets legally available for distribution to shareholders, after satisfaction of indebtedness and other liabilities of the Company, if any, the Liquidation Preference plus declared and unpaid dividends thereon, if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any, to, but excluding, the date fixed for distribution, without accumulation of any undeclared dividends (the &#8220;Liquidation Distribution&#8221;), before any distribution of assets is made to holders of Ordinary Shares, or any of the Company&#8217;s other shares of stock ranking junior to the Preference Shares. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">After the payment to the holders of the Preference Shares of the Liquidation Distribution to which such holders are entitled as provided in this Section 6, the holders of the Preference Shares shall have no right or claim to any of the remaining assets of the Company. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event the Company&#8217;s assets are not sufficient to pay the Liquidation Preference in full to all holders of the Preference Shares and the liquidation preference of any Parity Stock to all holders of such Parity Stock, the amounts paid to the holders of Preference Shares and to the holders of any Parity Stock shall be paid </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in accordance with the respective aggregate liquidation preferences of those holders.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Residual Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event the Liquidation Preference has been paid in full to all holders of the Preference Shares and any holders of any Parity Stock, the holders of the Company&#8217;s other capital stock shall be entitled to receive all of the Company&#8217;s remaining assets according to their respective rights and preferences.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Merger, Consolidation and Sale of Assets Not Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. For purposes of this Section 6, neither a consolidation, amalgamation, merger, arrangement or reconstruction involving the Company or the sale or transfer of all or substantially all of the shares of capital stock or the property or business of the Company shall be deemed to constitute a liquidation, dissolution or winding-up of the Company.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Optional Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company may not redeem Preference Shares prior to January 1, 2027, except as provided in Sections 7(a)(2), 7(a)(3) and 7(a)(4). On January 1, 2027 and any Dividend Payment Date thereafter, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25 per Preference Share, plus declared and unpaid dividends, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;On any Dividend Payment Date following the occurrence of a Tax Event, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25 per Preference Share, plus declared and unpaid dividends, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;On the Dividend Payment Date after the Company has reasonably determined that, as a result of (i) any amendment to, or change in, the laws or regulations of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bermuda that is enacted or becomes effective after the Issue Date&#59; (ii) any proposed amendment to, or change in, those laws or regulations that is announced or becomes effective after the Issue Date&#59; or (iii) any official administrative decision or judicial decision or administrative action or other official pronouncement interpreting or applying those laws or regulations that is announced after the Issue Date, a Capital Disqualification Redemption Event has occurred, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25 per Preference Share, plus declared and unpaid dividends, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends&#59; provided that any such redemption in part may only be made if (x) the Company has reasonably determined that the portion of the Preference Shares to be redeemed are the subject of the Capital Disqualification Redemption Event and (y) after giving effect to such redemption, the Company has reasonably determined that a Capital Disqualification Redemption Event will not exist with respect to the then-outstanding Preference Shares and such redemption will not result in the suspension or removal of the Preference Shares from listing on the New York Stock Exchange.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;At any time prior to January 1, 2027, if (i) the Company submits to the holders of Ordinary Shares a proposal for an amalgamation or merger, or (ii) if the Company submits any proposal for any other matter that requires, as a result of any change in Bermuda law after September 13, 2016, for its validation or effectuation an affirmative vote of the holders of the Preference Shares at the time outstanding, whether voting as a separate series or together with any other series or class of preference shares as a single class, the Company shall have the option, subject to compliance with Bermuda law, by not less than 30 nor more than 60 days prior written notice to the relevant holders, in such form and given in such manner as to be in accordance with Section 7(c), to redeem all of the outstanding Preference Shares for cash at a redemption price of $26 per Preference Share, plus declared and unpaid dividends, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Mandatory Redemption&#59; No Sinking Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not be subject to any mandatory redemption, sinking fund, retirement fund or purchase fund or other similar provisions. Holders of Preference Shares shall have no right to require redemption or repurchase of any Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notice of each redemption of Preference Shares shall be given by first class mail, to the holders of record of the Preference Shares to be redeemed, not less than 30 nor more than 60 days prior to the Redemption Date. Notwithstanding the foregoing, if the Preference Shares or any depositary shares representing interests in the Preference Shares are held in book-entry form through The Depository Trust Company, notice of redemption may be given to the holders of Preference Shares in any manner permitted by The Depository Trust Company. Each such notice given to a holder shall state&#58; (1) the Redemption Date&#59; (2) the number of Preference Shares to be redeemed and, if less than all of the Preference Shares held by such holder are to be redeemed, the number of such Preference Shares to be redeemed from such holder&#59; (3) the redemption price or the methodology for determining the redemption price&#59; and (4) the place or places where certificates for such Preference Shares are to be surrendered for payment of the redemption price.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In case of any redemption of only part of the Preference Shares at the time outstanding, the Preference Shares to be redeemed shall be selected either </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or in such other manner as the Company may determine to be fair and equitable.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effectiveness of Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If a notice of redemption has been duly given and if all funds necessary for the redemption have been set aside for payment by the Company for the benefit of the holders of any Preference Shares called for redemption, then, from and after the Redemption Date, dividends shall cease to accumulate on all Preference Shares so called for redemption, all Preference Shares so called for redemption shall no longer be deemed outstanding and all rights of holders of such Preference Shares shall forthwith on such Redemption Date cease and terminate, except the right of the holders thereof to transfer the Preference Shares prior to the Redemption Date and the right to receive the redemption price pursuant to Section 7(a).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Redemption Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. On or prior to the Redemption Date, the Company shall deposit with the Paying Agent an amount in immediately available funds sufficient to pay the aggregate redemption price plus any declared and unpaid dividends&#59; provided that if such payment is deposited on the Redemption Date, it must be received by the Paying Agent by 10&#58;00 a.m. (New York City time) on the Redemption Date. An amount equal to the redemption price plus any declared and unpaid dividends shall be paid to the holders promptly following the later of (i) the Redemption Date and (ii) the time of book-entry transfer or surrender of the certificate(s) evidencing such Preference Shares to the Paying Agent, as applicable. Any declared but unpaid dividends payable on a Redemption Date that occurs subsequent to the Dividend Record Date for such Dividend Period shall not be paid to the holder entitled to receive the redemption price on the Redemption Date, but rather shall be paid to the holder of record of the redeemed Preference Shares on such Dividend Record Date relating to the Dividend Payment Date. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares have no stated maturity. The Preference Shares shall remain outstanding perpetually, unless and until the Company elects to redeem the Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Variation or Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;At any time following a Tax Event or at any time following a Capital Disqualification Change Event, the Company may, without the consent of any holders of the Preference Shares, vary the terms of the Preference Shares or exchange the Preference Shares for new securities, which (i) in the case of a Tax Event, would eliminate the substantial probability that the Company or any Successor Corporation would be required to pay any Additional Amounts with respect to the Preference Shares as a result of a Change in Tax Law or (ii) in the case of Capital Disqualification Change Event, would cause the Preference Shares to become securities that qualify as Tier 1 capital (where capital is subdivided into tiers) or its equivalent under then-applicable Capital Adequacy Regulations imposed upon the Company by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority), including under the Bermuda Monetary Authority&#8217;s enhanced capital requirements, for purposes of determining the solvency margin, capital adequacy ratios or any other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">comparable ratios, regulatory capital resource or levels of the Company or any subsidiary thereof. The terms of the varied securities or new securities considered in the aggregate shall not be less favorable, including from a financial perspective, to holders than the terms of the Preference Shares prior to being varied or exchanged (as reasonably determined by the Company)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such variation of terms or securities received in exchange shall change the specified denominations, or any payment of dividend on, the redemption dates (other than any extension of the period during which an optional redemption may not be exercised by the Company) or currency of, the Preference Shares, reduce the Liquidation Preference thereof or the dividend payable thereon, lower the ranking of the securities, reduce the voting threshold for the issuance of Senior Shares or change the foregoing list of items that may not be so amended as part of such variation or exchange. No such variation of terms or securities received in exchange shall impair the right of a holder of the securities to institute suit for the payment of any amounts due (as provided under this Certificate of Designation), but unpaid with respect to such holder&#8217;s securities. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Prior to any variation or exchange, the Company shall be required to (i) receive an opinion of independent legal advisers of recognized standing to the effect that holders and beneficial owners of the Preference Shares (including as holders and beneficial owners of the varied or exchanged securities) shall not recognize income, gain or loss for United States federal income tax purposes as a result of such variation or exchange and shall be subject to United States federal income tax on the same amounts, in the same manner and at the same times as would have been the case had such variation or exchange not occurred, and (ii) deliver a certificate signed by two executive officers of the Company to the transfer agent for the Preference Shares confirming that (x) a Capital Disqualification Change Event or a Tax Event has occurred and is continuing (as reasonably determined by the Company) and (y) that the terms of the varied or new securities, considered in the aggregate, are not less favorable, including from a financial perspective, to holders than the terms of the Preference Shares prior to being varied or exchanged (as reasonably determined by the Company). </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Any variation or exchange of the Preference Shares described above shall be made after notice is given to the holders of the Preference Shares not less than 30 nor more than 60 days prior to the date fixed for variation or exchange, as applicable.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as provided in this Section 10 or otherwise required by Bermuda law from time to time, the holders of the Preference Shares shall not have any voting rights.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Right to Elect Two Directors upon Nonpayment Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Whenever full dividends payable on any Preference Shares shall have not been declared and paid for the equivalent of any six (6) Dividend Periods, whether or not consecutive (a &#8220;Nonpayment&#8221;), the holders of the Preference Shares, acting together as a single class with holders of any and all other series of Appointing Preference Shares then outstanding, shall be entitled to the appointment (the &#8220;Appointing Rights&#8221;) of a total of two additional members to the Board of Directors (each, a &#8220;Preference Share Director&#8221;), provided that the appointment of any such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">directors shall not cause the Company to violate the corporate governance requirements of the New York Stock Exchange as applied to U.S. issuers (or any other securities exchange or automated quotation system on which the Company&#8217;s securities may be then listed or quoted) that listed companies must have a majority of independent directors. In the case of a Nonpayment, the number of directors on the Board of Directors shall automatically increase by two (to the extent such increase does not exceed the maximum number of directors permitted under the Company&#8217;s Bye-Laws, and the new directors shall be selected by at least a majority of the aggregate Liquidation Preference of the Preference Shares and any other Appointing Preference Shares at a special meeting called at the request of the record holders of at least 20% of the aggregate Liquidation Preference of the Preference Shares or of any other series of Appointing Preference Shares then outstanding. The Board of Directors shall duly appoint the Preference Share Directors selected by the holders of the Preference Shares and any other Appointing Preference Shares then outstanding, and shall, subject to the Company&#8217;s Bye-Laws, determine which classes of directors the Preference Share Directors shall be a part of and shall allocate such Preference Share Directors to the classes having the longest term of office remaining at the time of such appointment. Each Preference Share Director shall be entitled to one vote per director on any matter. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Appointing Rights shall continue until dividends on the Preference Shares and any such series of Appointing Preference Shares following the nonpayment shall have been fully declared and paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for payment) for at least four (4) consecutive Dividend Periods. When the term of a class of directors of which any Preference Share Director is a part of is expiring, the Board of Directors shall set the size of such class of directors to be elected by the Company&#8217;s ordinary shareholders at a level to include such Preference Share Director duly appointed by the Board of Directors upon the exercise of the Appointing Rights. The Company shall use its best efforts to increase the number of directors constituting the Board of Directors to the extent necessary to effect these Appointing Rights.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">So long as a Nonpayment shall continue, any vacancy in the office of a Preference Share Director (other than prior to the initial appointment after a Nonpayment) may be filled by the Board of Directors pursuant to an exercise of the Appointing Rights by the holders of Preference Shares and any other Appointing Preference Shares then outstanding.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If and when dividends for four (4) consecutive Dividend Periods following a Nonpayment have been paid in full (or declared and a sum sufficient for the payment of such dividends shall have been set aside), the holders of the Preference Shares shall be divested of the Appointing Rights (subject to revesting in the event of each subsequent Nonpayment, as described above) and, if such Appointing Rights for all other holders of Appointing Preference Shares have terminated, the office of each Preference Share Director so appointed shall, notwithstanding the class of directors such Preference Share Director shall be a part of, automatically be vacated and the number of directors on the Board of Directors shall automatically decrease by two (2). In determining whether dividends have been fully paid for four (4) consecutive Dividend Periods following a Nonpayment, the Company may take into </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">account any dividend the Company elects to pay for a Dividend Period after the regular Dividend Payment Date for that period has passed.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting on Variations of Rights and Senior Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Notwithstanding the Company&#8217;s Bye-Laws, the affirmative vote or consent of the holders of at least 66&#8532;% of the aggregate Liquidation Preference of the outstanding Preference Shares and any series of Appointing Preference Shares, voting together as a single class, shall be required for the authorization or issuance of any class or series of Senior Shares (or any security convertible into or exchangeable for Senior Shares) ranking senior to the Preference Shares as to dividend rights or rights upon the Company&#8217;s liquidation. The authorization of, the increase in the authorized amount of, or the issuance of any shares of any class or series of parity shares or junior shares shall not require the consent of any holder of the Preference Shares, and shall not be deemed to materially adversely affect the rights of the holders of the Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The affirmative vote or consent of the holders of at least 66&#8532;% of the aggregate Liquidation Preference of the Company&#8217;s outstanding Preference Shares shall be required for amendments to the Company&#8217;s Memorandum of Association or Bye-Laws that would materially adversely affect the rights of holders of the Preference Shares. If all preference shares of the Company are not equally affected by any such proposed amendment and if the Preference Shares would have diminished status compared to other preference shares as a result, the approval of holders of at least 66</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:1.69pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">% of the outstanding Preference Shares, voting together as a single class, shall be required.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The foregoing voting provisions of this Section 10 will not apply if, at or prior to the time when the act with respect to which such vote would otherwise be required shall be effected, all outstanding Preference Shares shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have been set aside for payment by the Company for the benefit of the holders of Preference Shares to effect such redemption as set forth in Section 7.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Record Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the fullest extent permitted by applicable law, the Company and the transfer agent for the Preference Shares may deem and treat the record holder of any share of Preference Shares as the true and lawful owner thereof for all purposes, and neither the Company nor such transfer agent shall be affected by any notice to the contrary.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments or Modifications&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;To the extent permitted by applicable law, the Board of Directors may modify the terms of this Certificate of Designation without the consent of any holder of Preference Shares for any of the following purposes&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;to evidence the succession of another person to the Company&#8217;s obligations&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;to add to the covenants for the benefit of the holders of the Preference Shares or to surrender any of the Company&#8217;s rights or powers under the Preference Shares&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;to cure any ambiguity to correct or supplement any provisions that may be inconsistent, provided that such action shall not adversely affect the interest of the holders of the Preference Shares in any material respect&#59; or</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;to make any other provision with respect to such matters or questions arising under this Certificate of Designation which the Company may deem desirable and which shall adversely affect the interests of the holders of the Preference Shares in any material respect.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Except as provided below in this Section 12(b), this Certificate of Designation may be amended, modified or supplemented, and noncompliance in any particular instance with any provision of this Certificate of Designation or the Preference Shares may be waived, in each case with the affirmative vote or written consent of the holders of at least a majority of the aggregate liquidation preference of the Preference Shares then outstanding, including any modification occurring in connection with any merger or consolidation of the Company or otherwise.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Board of Directors may, subject to the prior written consent or the affirmative vote of the holders of at least a majority of the aggregate liquidation preference of the Preference Shares, amend the terms of this Certificate of Designation or the rights, powers, preferences and privileges of the holders of the Preference Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no such amendment shall, without the consent of the holder of each outstanding Preference Share affected by the amendment&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;change any Dividend Payment Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;reduce the rate of dividends payable on the Preference Shares when, as and if declared by the Board of Directors&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;reduce the redemption price or alter the January 1, 2027 optional redemption date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;change the place or currency of payment&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;impair the right to institute suit for the enforcement of the Preference Shares&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;change the percentage of aggregate Liquidation Preference of the Preference Shares whose holders must approve any amendment.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Merger, Amalgamation, Consolidation and Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company covenants that it will not merge or amalgamate with or into, consolidate with or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">convert into any other person or entity or sell, assign, transfer, lease or convey all or substantially all of the Company&#8217;s properties and assets into any person or entity, unless </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;either the Company is the continuing corporation or the successor corporation is a corporation organized under the laws of the United States, a state thereof, the District of Columbia, Bermuda or any country which is, on the date hereof, a member of the Organization for Economic Cooperation and Development and the Preference Shares shall be exchanged for or converted into and shall become Preference Shares of the successor corporation with substantially the same rights, powers, preferences and privileges, and </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Company or the successor corporation is not, immediately after such merger, amalgamation, consolidation, conversion, sale, assignment, transfer, lease or conveyance, in default of any obligation under the Preference Shares.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Preference Shares shall be issued initially in the form of one or more fully registered global certificates with the global securities legend set forth in Exhibit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto (&#8220;Global Preference Shares&#8221;), each as set forth on the form of Preference Shares certificate attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> which is hereby incorporated in and expressly made a part of this Certificate of Designation. The Global Preference Shares certificate may have notations, legends or endorsements required by law, stock exchange rules, agreements to which the Company is subject, if any, or usage (provided that any such notation, legend or endorsement is in a form acceptable to the Company). The Global Preference Shares shall be deposited on behalf of the holders of the Preference Shares represented thereby with the Registrar, as custodian for DTC (or with such other custodian as DTC may direct), and registered in the name of DTC or a nominee of DTC, duly executed by the Company and countersigned by the Registrar as hereinafter provided, The aggregate number of Preference Shares represented by Global Preference Shares may from time to time be increased or decreased by adjustments made on the records of the Registrar and DTC or its nominee as hereinafter provided.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event Global Preference Shares are deposited with or on behalf of DTC, the Company shall execute, and the Registrar shall countersign and deliver, initially one or more Global Preference Shares certificates that (a) shall be registered in the name of Cede &#38; Co. or other nominee of the Depositary and (b) shall be delivered by the Registrar to DTC or pursuant to DTC's instructions or held by the Registrar as custodian for DTC. Members of, or participants in, DTC (&#8220;Agent Members&#8221;) shall have no rights under this Certificate of Designation with respect to any Global Preference Shares held on their behalf by DTC or by the Registrar as the custodian of DTC or under such Global Preference Shares, and DTC may be treated by the Company, the Registrar and any agent of the Company or the Registrar as the absolute owner of such Global Preference Shares for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Registrar or any agent of the Company or the Registrar from giving effect to any written certification, proxy or other authorization furnished by DTC or impair, as between DTC and its Agent Members, the operation of customary practices of DTC governing the exercise of the rights of a holder of a beneficial interest in any Global Preference Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Owners of beneficial interests in Global Preference Shares shall not be entitled to receive physical delivery of certificated Preference Shares, unless&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;DTC is unwilling or unable to continue as Depositary for the Global Preference Shares and the Company does not appoint a qualified replacement for DTC within 90 calendar days&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;DTC ceases to be a &#8220;clearing agency&#8221; registered under the Exchange Act and the Company does not appoint a qualified replacement for DTC within 90 calendar days&#59; or</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the Company decides to discontinue the use of book-entry transfer through DTC (or any successor Depositary).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In any such case, the Global Preference Shares shall be exchanged in whole for certificated Preference Shares in registered form, with the same terms and of an equal aggregate liquidation preference (unless the Company determines otherwise in accordance with applicable law). Certificated Preference Shares shall be registered in the name or names of the Person or Person specified by DTC in a written instrument to the Registrar.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;An Officer shall sign the Preference Shares certificate for the Company by manual or facsimile signature. If the Officer whose signature is on a Preference Shares certificate no longer holds that office at the time the Registrar countersigns the Preference Shares certificate, the Preference Shares certificate shall be valid nevertheless.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A Preference Shares certificate shall not be valid until an authorized signatory of the Registrar signs the Preference Shares certificate by manual or facsimile signature. The signature shall be conclusive evidence that the Preference Shares certificate has been countersigned under this Certificate of Designation.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All notices or communications in respect of Preference Shares shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designation, the Memorandum of Association, the Bye-Laws or by applicable law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Preemptive Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Holders of the Preference Shares shall not have any rights of preemption whatsoever as to any securities of the Company, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations on Transfer and Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The holders of Preference Shares shall be subject to the limitations on transfer and ownership contained in the Bye-laws.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not be convertible into or exchangeable for any other securities or property of the Company.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Other Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">limitations or restrictions other than as set forth in this Certificate of Designation, the Memorandum of Association, the Bye-laws or applicable law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation in Respect of Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company will be responsible for making all calculations called for in respect of the Preference Shares, including, but not limited to, the determination of the dividends payable on the Preference Shares. Any calculations made in good faith and without manifest error will be final and binding on holders of the Preference Shares. The Company or its agents will be required to deliver to the Paying Agent a schedule of its calculations and the Paying Agent will be entitled to rely upon the accuracy of such calculations without independent verification. The Paying Agent will forward such calculations to any holder of the Preference Shares upon the request of such holder.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event any provision of this Certificate of Designation shall be invalid, unenforceable or illegal, then, to the fullest extent permitted by applicable law, the validity, enforceability and legality of the remaining provisions shall not in any way be affected or impaired thereby.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><div id="i47401896b28d4c07923d444477ebd2ef_80"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, ASPEN INSURANCE HOLDINGS LIMITED has caused this Certificate of Designation to be signed this 20th day of September, 2016.</font></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:217.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:91.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:55.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Scott Kirk</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Scott Kirk</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:69.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:78.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:276.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attest&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Mike Cain</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Mike Cain</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Group General Counsel and Company Secretary</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i47401896b28d4c07923d444477ebd2ef_100"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXHIBIT A</font></div><div style="margin-bottom:48pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Form of Preference Shares Certificate</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% PERPETUAL NON-CUMULATIVE PREFERENCE SHARES </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FACE OF SECURITY </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &#38; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &#38; CO. HAS AN INTEREST HEREIN. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE CERTIFICATE OF DESIGNATION REFERRED TO BELOW. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Preference Shares</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CUSIP NO.&#58; G05384 162</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISIN NO.&#58; BMG053841620</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% Perpetual Non-Cumulative Preference Shares </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liquidation preference U.S.$25 per Preference Share) </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), hereby certifies that Cede &#38; Co. or its registered assigns (the &#8220;Holder&#8221;) is the registered owner of 10,000,000, or such number as is indicated in the records of the Registrar and the Depository, fully paid and non-assessable preference shares of the Company designated the 5.625% Perpetual Non-Cumulative Preference Shares, with a liquidation preference of U.S.$25 per share (the &#8220;Preference Shares&#8221;). The Preference Shares are transferable on the books and records of the Registrar, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper form for transfer. The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Preference Shares represented hereby are issued and shall in all respects be subject to the provisions of the Certificate of Designation dated September 20, 2016, as the same may be amended from time to time (the &#8220;Certificate of Designation&#8221;). Capitalized terms used herein but not defined shall have the meaning given them in the Certificate of Designation. The Company will provide a copy of the Certificate of Designation to a holder without charge upon written request to the Company at its principal place of business. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to select provisions of the Preference Shares set forth on the reverse hereof, and to the Certificate of Designation, which select provisions and the Certificate of Designation shall for all purposes have the same effect as if set forth at this place. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of this certificate, the holder is bound by the Certificate of Designation and is entitled to the benefits thereunder. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the Registrar has properly countersigned, these Preference Shares shall not be entitled to any benefit under the Certificate of Designation or be valid or obligatory for any purpose. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i47401896b28d4c07923d444477ebd2ef_135"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has executed this certificate this 20th day of September, 2016. </font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:264.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:165.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGISTRAR&#8217;S COUNTERSIGNATURE </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These are Preference Shares referred to in the within-mentioned Certificate of Designation. </font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; September 20, 2016</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:91.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:115.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:91.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:127.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPUTERSHARE TRUST COMPANY, N.A., as Registrar</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Signatory</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVERSE OF SECURITY </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on each Preference Share shall be payable at the rate provided in the Certificate of Designation. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Preference Shares shall be redeemable at the Company&#8217;s option in the manner and accordance with the terms set forth in the Certificate of Designation. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall furnish without charge to each holder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class or series of share capital and the qualifications, limitations or restrictions of such preferences and&#47;or rights. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASSIGNMENT </font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned assigns and transfers the Preference Shares evidenced hereby to&#58; </font></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert assignee&#8217;s social security or tax identification number) </font></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert address and zip code of assignee) </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and irrevocably appoints&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agent to transfer the Preference Shares evidenced hereby on the books of the Transfer Agent. The agent may substitute another to act for him or her. </font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; ____________________________________________________________</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature&#58;________________________________________________________</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Sign exactly as your name appears on the other side of this Preference Shares Certificate)</font></div><div style="margin-bottom:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature Guarantee&#58; _______________________________________________</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Signature must be guaranteed by an &#8220;eligible guarantor institution&#8221; that is a bank, stockbroker, savings and loan association or credit union meeting the requirements of the Transfer Agent, which requirements include membership or participation in the Securities Transfer Agents Medallion Program (&#8220;STAMP&#8221;) or such other &#8220;signature guarantee program&#8221; as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.7
<SEQUENCE>9
<FILENAME>exhibit37-fx1.htm
<DESCRIPTION>EX-3.7
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib438374c3594487982d8b79c718003cf_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.7</font></div></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form of Preference Shares Certificate</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% PERPETUAL NON-CUMULATIVE PREFERENCE SHARES </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FACE OF SECURITY </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &#38; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &#38; CO. HAS AN INTEREST HEREIN. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE CERTIFICATE OF DESIGNATION REFERRED TO BELOW. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:50.939%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.861%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Preference Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CUSIP NO.&#58; G05384 162</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISIN NO.&#58; BMG053841620</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% Perpetual Non-Cumulative Preference Shares </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liquidation preference U.S.$25 per Preference Share) </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), hereby certifies that Cede &#38; Co. or its registered assigns (the &#8220;Holder&#8221;) is the registered owner of 10,000,000, or such number as is indicated in the records of the Registrar and the Depository, fully paid and non-assessable preference shares of the Company designated the 5.625% Perpetual Non-Cumulative Preference Shares, with a liquidation preference of U.S.$25 per share (the &#8220;Preference Shares&#8221;). The Preference Shares are transferable on the books and records of the Registrar, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper form for transfer. The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Preference Shares represented hereby are issued and shall in all respects be subject to the provisions of the Certificate of Designation dated September 20, 2016, as the same may be amended from time to time (the &#8220;Certificate of Designation&#8221;). Capitalized terms used herein but not defined shall have the meaning given them in the Certificate of Designation. The Company will provide a copy of the Certificate of Designation to a holder without charge upon written request to the Company at its principal place of business. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to select provisions of the Preference Shares set forth on the reverse hereof, and to the Certificate of Designation, which select provisions and the Certificate of Designation shall for all purposes have the same effect as if set forth at this place. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of this certificate, the holder is bound by the Certificate of Designation and is entitled to the benefits thereunder. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the Registrar has properly countersigned, these Preference Shares shall not be entitled to any benefit under the Certificate of Designation or be valid or obligatory for any purpose. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has executed this certificate this 20th day of September, 2016. </font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.307%"><tr><td style="width:1.0%"></td><td style="width:9.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Scott Kirk</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Scott Kirk</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Chief Financial Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGISTRAR&#8217;S COUNTERSIGNATURE </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These are Preference Shares referred to in the within-mentioned Certificate of Designation. </font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; September 20, 2016</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.608%"><tr><td style="width:1.0%"></td><td style="width:6.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPUTERSHARE TRUST COMPANY, N.A., as Registrar</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Constance Adams</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVERSE OF SECURITY </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on each Preference Share shall be payable at the rate provided in the Certificate of Designation. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Preference Shares shall be redeemable at the Company&#8217;s option in the manner and accordance with the terms set forth in the Certificate of Designation. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall furnish without charge to each holder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class or series of share capital and the qualifications, limitations or restrictions of such preferences and&#47;or rights. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASSIGNMENT </font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned assigns and transfers the Preference Shares evidenced hereby to&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert assignee&#8217;s social security or tax identification number) </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert address and zip code of assignee) </font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and irrevocably appoints&#58; </font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.788%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agent to transfer the Preference Shares evidenced hereby on the books of the Transfer Agent. The agent may substitute another to act for him or her. </font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.634%"><tr><td style="width:1.0%"></td><td style="width:6.953%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.115%"><tr><td style="width:1.0%"></td><td style="width:12.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Sign exactly as your name appears on the other side of this Preference Shares Certificate)</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.435%"><tr><td style="width:1.0%"></td><td style="width:25.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature Guarantee&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Signature must be guaranteed by an &#8220;eligible guarantor institution&#8221; that is a bank, stockbroker, savings and loan association or credit union meeting the requirements of the Transfer Agent, which requirements include membership or participation in the Securities Transfer Agents Medallion Program (&#8220;STAMP&#8221;) or such other &#8220;signature guarantee program&#8221; as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.8
<SEQUENCE>10
<FILENAME>exhibit38-fx1.htm
<DESCRIPTION>EX-3.8
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i35fca176eb7347de8d863256c219ad63_59"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 3.8</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATE OF DESIGNATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.625% PERPETUAL NON-CUMULATIVE PREFERENCE SHARES</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), HEREBY CERTIFIES that pursuant to resolutions of duly authorized Directors adopted on May 29, 2019, the creation of the 5.625% Perpetual Non-Cumulative Preference Shares, with a liquidation preference of $25,000 per share (the &#8220;Preference Shares&#8221;) were authorized and the designations, preferences and privileges, voting rights, relative, participating, optional and other special rights, and qualifications, limitations and restrictions of the Preference Shares, in addition to those set forth in the Memorandum of Association and Bye-Laws of the Company, were fixed as follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Designation&#59; Amount of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The designation of this series of Preference Shares shall be &#8220;5.625% Perpetual Non-Cumulative Preference Shares,&#8221; and the number of shares constituting this series shall be 10,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, if the Company elects to issue additional Preference Shares after the date of this Certificate of Designation, any such additional shares are not treated as &#8220;disqualified preferred stock&#8221; within the meaning of Section 1059(f)(2) of the United States Internal Revenue Code of 1986, as amended, and such additional shares are otherwise treated as fungible with the Preference Shares for United States federal income tax purposes. The additional shares would form a single series with the Preference Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Preference Shares shall have a liquidation preference of $25,000 per Preference Share (the &#8220;Liquidation Preference&#8221;). Each Preference Share shall be identical in all respects to every other Preference Share, except for the issue price, date of issuance and, in some cases, the initial Dividend Payment Date (as defined in Section 4(a)). Any Preference Shares retired by purchase or redemption, or otherwise acquired by the Company, will have the status of authorized but unissued Preference Shares and may be reissued as part of the same class or series or may be reclassified and reissued by the Board of Directors in the same manner as any other authorized and unissued shares. The number of authorized Preference Shares may be reduced (but not below the number of Preference Shares then in issue) by further resolution duly adopted by the Board of Directors. No such reduction shall affect the due authorization of any Preference Shares in issue.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As used herein with respect to the Preference Shares&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#8220;5.625% Perpetual Preference Shares&#8221; means the 5.625% Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162; per share, of the Company designated as the 5.625% Perpetual Non-Cumulative Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#8220;5.95% Perpetual Preference Shares&#8221; means the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162; per share, of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company designated as the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;&#8220;Additional Amounts&#8221; has the meaning assigned to such term in Section 5(a).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#8220;Agent Members&#8221; has the meaning assigned to such term in Section 14(a).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#8220;Applicable Supervisory Regulations&#8221; means such insurance supervisory laws, rules and regulations relating to group supervision or the supervision of single insurance entities, as applicable, which are applicable to the Company or the Insurance Group, and which shall initially mean the Group Rules until such time when the BMA no longer has jurisdiction or responsibility to regulate the Company or the Insurance Group.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;&#8220;Appointing Preference Shares&#8221; means any other class or series of preference shares of the Company, including the 5.625% Perpetual Preference Shares and the 5.95% Perpetual Preference Shares, ranking equally with the Preference Shares either as to dividend rights or rights upon liquidation, winding-up or dissolution and upon which like Appointing Rights have been conferred and are exercisable.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;&#8220;Appointing Rights&#8221; has the meaning assigned to such term in Section 10(b).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;&#8220;BMA&#8221; means the Bermuda Monetary Authority, or, should the Bermuda Monetary Authority no longer have jurisdiction or responsibility to regulate the Company or the Insurance Group, as the context requires, a regulator which is otherwise subject to Applicable Supervisory Regulations.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#8220;Board of Directors&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;&#8220;Business Day&#8221; means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City generally are authorized or obligated by law or executive order to close.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;&#8220;Bye-Laws&#8221; means the amended and restated bye-laws of the Company, as they may be amended from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;&#8220;Capital Adequacy Regulations&#8221; means the solvency margins, capital adequacy regulations or any other regulatory capital rules applicable to the Company from time to time on an individual or group basis pursuant to Bermuda law and&#47;or the laws of any other relevant jurisdiction and which set out the requirements to be satisfied by financial instruments to qualify as solvency margin or additional solvency margin or regulatory capital (or any equivalent terminology employed by the then-applicable capital adequacy regulations).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;&#8220;Capital Disqualification Change Event&#8221; means that the Preference Shares do not qualify, in whole or in part (including as a result of any transitional or grandfathering provisions or otherwise), for purposes of determining the solvency </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level, of the Company or any subsidiary thereof, where capital is subdivided into tiers, as Tier 2 capital securities under then-applicable Capital Adequacy Regulations imposed upon the Company by the BMA, which would include, without limitation, the Company&#8217;s Enhanced Capital Requirement, except as a result of any applicable limitation on the amount of such capital.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;&#8220;Capital Disqualification Redemption Event&#8221; means that the Preference Shares qualify, in whole or in part (including as a result of any transitional or grandfathering provisions or otherwise), for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level, of the Company or any subsidiary thereof, where capital is subdivided into tiers, as neither Tier 1 nor Tier 2 capital securities under then-applicable Capital Adequacy Regulations imposed upon the Company by the BMA, which would include, without limitation, the Company&#8217;s Enhanced Capital Requirement, except as a result of any applicable limitation on the amount of such capital.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;&#8220;Certificate of Designation&#8221; means this Certificate of Designation relating to the Preference Shares, as it may be amended from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;&#8220;Change in Tax Law&#8221; means (a) a change in or amendment to laws, regulations or rulings of any Relevant Taxing Jurisdiction, (b) a change in the official application or interpretation of those laws, regulations or rulings, (c) any execution of or amendment to any treaty affecting taxation to which any Relevant Taxing Jurisdiction is party after August 6, 2019, or (d) a decision rendered by a court of competent jurisdiction in any Relevant Taxing Jurisdiction, whether or not such decision was rendered with respect to the Company, in each case, described in (a)-(d) above occurring after August 6, 2019&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the case of a Relevant Taxing Jurisdiction other than Bermuda in which a Successor Corporation is organized, such Change in Tax Law must occur after the Succession Date.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;&#8220;Dividend Payment Date&#8221; has the meaning assigned to such term in Section 4(a).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;&#8220;Dividend Period&#8221; has the meaning assigned to such term in Section 4(a).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;&#8220;Dividend Record Date&#8221; has the meaning assigned to such term in Section 4(a).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;&#8220;Enhanced Capital Requirement&#8221; means the enhanced capital and surplus requirement applicable to the Insurance Group and as defined in the Insurance Act or, should the Insurance Act or the Group Rules no longer apply to the Insurance Group, any and all other solvency capital requirements or any other requirement to maintain assets applicable to the Company or in respect of the Insurance Group, as applicable, pursuant to the Applicable Supervisory Regulations.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;&#8220;Exchange Act&#8221; means the U.S. Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;&#8220;Global Preference Shares&#8221; has the meaning assigned to such term in Section 14(a).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;&#8220;Group Rules&#8221; means the Group Solvency Standards, together with the Group Supervision Rules.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;&#8220;Group Solvency Standards&#8221; means the Bermuda Insurance (Prudential Standards) (Insurance Group Solvency Requirement) Rules 2011, as those rules and regulations may be amended or replaced from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(y)&#160;&#160;&#160;&#160;&#8220;Group Supervision Rules&#8221; means the Bermuda Insurance (Group Supervision) Rules 2011, as those rules and regulations may be amended or replaced from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(z)&#160;&#160;&#160;&#160;&#8220;Insurance Act&#8221; means the Insurance Act 1978 of Bermuda, as amended from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(aa)&#160;&#160;&#160;&#160;&#8220;Insurance Group&#8221; means all subsidiaries of the Company that are regulated insurance or reinsurance companies (or part of such regulatory group) pursuant to the Applicable Supervisory Regulations.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;&#8220;Issue Date&#8221; means August 13, 2019, the original date of issuance of the Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;&#8220;Junior Stock&#8221; means any class or series of capital stock of the Company, including the Company&#8217;s Ordinary Shares, that ranks junior to the Preference Shares either as to the payment of dividends or as to the distribution of assets upon any liquidation, dissolution or winding-up of the Company.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;&#8220;Liquidation Distribution&#8221; has the meaning assigned to such term in Section 6(a).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;&#8220;Liquidation Preference&#8221; has the meaning assigned to such term in Section 1.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ff)&#160;&#160;&#160;&#160;&#8220;Memorandum of Association&#8221; means the memorandum of association of the Company, as it may be amended from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(gg)&#160;&#160;&#160;&#160;&#8220;Nonpayment&#8221; has the meaning assigned to such term in Section 10(b).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(hh)&#160;&#160;&#160;&#160;&#8220;Ordinary Shares&#8221; means the Ordinary Shares, par value $0.01 per share, of the Company, or any other class of shares resulting from successive changes or reclassifications of such Ordinary Shares consisting solely of changes in par value, or from par value to no par value, or as a result of a subdivision, combination, merger, consolidation or similar transaction in which the Company is a constituent corporation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#8220;Parity Stock&#8221; means any class or series of capital stock of the Company that ranks equally with the Preference Shares as to payment of dividends and the distribution of assets on any liquidation, dissolution or winding-up of the Company, including the 5.625% Perpetual Preference Shares and the 5.95% Perpetual Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(jj)&#160;&#160;&#160;&#160;&#8220;Paying Agent&#8221; initially means Computershare Trust Company, N.A. The Company may, in its sole discretion, remove the Paying Agent within ten (10) calendar days prior notice to the Paying Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Company shall appoint a successor Paying Agent who shall accept such appointment prior to the effectiveness of such removal.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(kk)&#160;&#160;&#160;&#160;&#8220;Preference Share Director&#8221; has the meaning assigned to such term in Section 10(b).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ll)&#160;&#160;&#160;&#160;&#8220;Preference Shares&#8221; has the meaning assigned to such term in the recitals.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(mm)&#160;&#160;&#160;&#160;&#8220;Rating Agency Event&#8221; means any nationally recognized statistical rating organization, as defined in Section 3(a)(62) of the Exchange Act, that then publishes a rating for the Company (a &#8220;Rating Agency&#8221;) amends, clarifies or changes the criteria it uses to assign equity credit to securities such as the Preference Shares, which amendment, clarification or change results in (1) the shortening of the length of time the Preference Shares are assigned a particular level of equity credit by that Rating Agency as compared to the length of time they would have been assigned that level of equity credit by that Rating Agency or its predecessor on the initial issuance of the Preference Shares&#59; or (2) the lowering of the equity credit (including up to a lesser amount) assigned to the Preference Shares by that Rating Agency as compared to the equity credit assigned by that Rating Agency or its predecessor on the initial issuance of the Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(nn)&#160;&#160;&#160;&#160;&#8220;Redemption Date&#8221; means, in the case of an optional redemption, the day specified in the Company&#8217;s notice of redemption.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(oo)&#160;&#160;&#160;&#160;&#8220;Redemption Requirements has the meaning assigned to such term in Section 7(a)(1).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(pp)&#160;&#160;&#160;&#160;&#8220;Register of Members&#8221; means the Register of Members of the Company.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(qq)&#160;&#160;&#160;&#160;&#8220;Registrar&#8221; initially means Computershare Trust Company, N.A. The Company may, in its sole discretion, remove the Registrar within ten (10) calendar days prior notice to the Registrar&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Company shall appoint a successor Registrar who shall accept such appointment prior to the effectiveness of such removal.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(rr)&#160;&#160;&#160;&#160;&#8220;Relevant Date&#8221; means, in respect of any payment, the date on which such payment first becomes due and payable, but if the full amount of the moneys payable has not been received by the dividend disbursing agent on or prior to such due date, it means the first date on which the full amount of such moneys has been so received and is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">available for payment to holders, and notice to that effect shall have been duly given to the holders of the Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ss)&#160;&#160;&#160;&#160;&#8220;Relevant Taxing Jurisdiction&#8221; means (a) Bermuda or any political subdivision or governmental authority of or in Bermuda with the power to tax, (b) any jurisdiction from or through which the Company or its dividend disbursing agent are making payments on the Preference Shares or any political subdivision or governmental authority of or in that jurisdiction with the power to tax or (c) any other jurisdiction in which the Company or a Successor Corporation is organized or generally subject to taxation on a net income basis or any political subdivision or governmental authority of or in that jurisdiction with the power to tax.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(tt)&#160;&#160;&#160;&#160;&#8220;Senior Stock&#8221; means any class of share capital or series of capital stock of the Company established after the Issue Date by the Board of Directors, that ranks senior to the Preference Shares as to payment of dividends and the distribution of assets on any liquidation, dissolution or winding-up of the Company.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(uu)&#160;&#160;&#160;&#160;&#8220;set aside for payment&#8221; means, without any action other than the following, the recording by the Company in its accounting ledgers of any accounting or bookkeeping entry which indicates, pursuant to a declaration of a dividend or other distribution by the Board of Directors, the allocation of the funds to be so paid on any class or series of the Company&#8217;s shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if any funds for any class or series of Junior Stock or any class or series of Parity Stock are placed in a separate account of the Company or delivered to a disbursing, paying or other similar agent, then &#8220;set aside for payment&#8221; with respect to the Preference Shares shall mean placing such funds in a separate account or delivering such funds to a disbursing, paying or other similar agent.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vv)&#160;&#160;&#160;&#160;&#8220;Succession Date&#8221; means the date on which the Company consolidates, merges or amalgamates with a Successor Corporation or conveys, transfers or leases substantially all its properties and assets to a Successor Corporation.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ww)&#160;&#160;&#160;&#160;&#8220;Successor Corporation&#8221; has the meaning assigned to such term in the definition of Tax Event.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xx)&#160;&#160;&#160;&#160;&#8220;Tax Event&#8221; means a Change in Tax Law that, in the Company&#8217;s reasonable determination, results in a substantial probability that the Company or any entity formed by a consolidation, merger or amalgamation involving the Company or the entity to which the Company conveys, transfers or leases substantially all its properties and assets (a &#8220;Successor Corporation&#8221;) would be required to pay any Additional Amounts with respect to the Preference Shares, which obligation cannot be avoided by the Company through reasonable measures.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ranking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall, with respect to dividend rights or rights upon the liquidation, winding-up or dissolution of the Company, rank (a) senior to all Junior Stock, including, without limitation, the Ordinary Shares, (b) on parity with all Parity Stock, including, without limitation, the 5.625% Perpetual Preference Shares and the 5.95% Perpetual Preference Shares, (c) junior to any Senior Stock and (d) junior to all of the Company&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">existing and future debt obligations. The Preference Shares shall also be subordinated in right of payment to all obligations of the Company&#8217;s subsidiaries, including all existing and future policyholders&#8217; obligations of such subsidiaries.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Rate and Payment of Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The holders of Preference Shares shall be entitled to receive, only when, as and if declared by the Board of Directors, subject to compliance with Bermuda law, non-cumulative cash dividends from, and including, the Issue Date, quarterly in arrears, on January 1, April 1, July 1 and October 1 of each year (each, a &#8220;Dividend Payment Date&#8221;), commencing on October 1, 2019, without accumulation of any undeclared dividends.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent declared, dividends shall accumulate, with respect to each Dividend Period, in an amount per share equal to 5.625% of the Liquidation Preference per Preference Share per annum. Dividends payable on the Preference Shares shall be computed on the basis of a 360-day year consisting of twelve 30-day months with respect to a full Dividend Period, and on the basis of the actual number of days elapsed during such Dividend Period with respect to a Dividend Period other than a full Dividend Period.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dividends that are payable on Preference Shares on any Dividend Payment Date shall be payable to holders of record of Preference Shares as they appear on the Register of Members at 5&#58;00 p.m. (New York City time) on the immediately preceding December 15, March 15, June 15 and September 15 (each, a &#8220;Dividend Record Date&#8221;). The Dividend Record Dates shall apply regardless of whether a particular Dividend Record Date is a Business Day.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A dividend period (each, a &#8220;Dividend Period&#8221;) is the period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial Dividend Period shall commence on, and include, the Issue Date and shall end on, and exclude, the October 1, 2019 Dividend Payment Date. If any date on which dividends would otherwise be payable is not a Business Day, then the Dividend Payment Date shall be the next succeeding Business Day after the original Dividend Payment Date, and no additional dividends shall accumulate on the amount so payable as a result of the delay.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Redemption Date falls on a day that is not a Business Day, the payment of dividends and redemption price shall be made on the first Business Day following such Redemption Date, without accrual to the actual payment date.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dividends on the Preference Shares are non-cumulative. Consequently, if the Board of Directors does not authorize and declare a dividend for any Dividend Period, holders of the Preference Shares will not be entitled to receive a dividend for such Dividend Period, and such undeclared dividend will not accumulate and will not be payable. The Company will have no obligation to pay dividends for a Dividend Period </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">after the Dividend Payment Date for such Dividend Period if the Board of Directors has not declared such dividend before the related Dividend Payment Date, whether or not dividends are declared for any subsequent Dividend Period with respect to the Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Holders of Preference Shares shall not be entitled to any dividends, whether payable in cash, securities or other property, other than dividends, if any, declared and payable on the Preference Shares as specified in this Section 4.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Priority of Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. So long as any Preference Shares remain in issue for any Dividend Period, unless the full dividends for the latest completed Dividend Period on all issued Preference Shares and the latest completed dividend period on all issued Parity Stock have been declared and paid or declared and a sum sufficient for the payment thereof has been set aside&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;no dividend shall be paid or declared on the Ordinary Shares or any other shares of Junior Stock or Parity Stock (except in the case of the Parity Stock on a pro rata basis with the Preference Shares as described below), other than a dividend payable solely in Ordinary Shares, other Junior Stock or Parity Stock, as applicable, and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;no Ordinary Shares, other Junior Stock or Parity Stock shall be purchased, redeemed or otherwise acquired for consideration by the Company, directly or indirectly (other than (a) as a result of a reclassification of Junior Stock for or into other Junior Stock, or a reclassification of Parity Stock for or into other Parity Stock, as applicable, or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock, or the exchange or conversion of one share of Parity Stock for or into another share of Parity Stock, as applicable, (b) through the use of the proceeds of a substantially contemporaneous sale of Junior Stock or Parity Stock, as applicable, (c) as required by or necessary to fulfill the terms of any employment contract, benefit plan or similar arrangement with or for the benefit of one or more employees, directors or consultants of (d) in the case of Parity Stock, in accordance with the provisions of Section 7(a)(6)). </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When dividends are not paid or duly provided for in full on any Dividend Payment Date upon the Preference Shares and any shares of Parity Stock, all dividends declared upon the Preference Shares and all such Parity Stock and payable on such Dividend Payment Date shall be declared on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> basis so that the respective amounts of such dividends shall bear the same ratio to each other as the full amount of dividends payable on the issued Preference Shares for such Dividend Period and the accumulated and unpaid dividends, or the full amount of dividends payable for such Dividend Period in the case of non-cumulative preferred stock, on all such Parity Stock bear to each other. In the case of any Parity Stock having dividend payment dates different from the Dividend Payment Dates pertaining to the Preference Shares, the measurement date for such Parity Stock shall be the Dividend Payment Date falling within the related Dividend Period for the Preference Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Additional Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company shall make all payments on the Preference Shares free and clear of and without withholding or deduction at source for, or on account of, any present or future taxes, fees, duties, assessments or governmental charges of whatever nature imposed or levied by or on behalf of any Relevant Taxing Jurisdiction, unless such taxes, fees, duties, assessments or governmental charges are required to be withheld or deducted by (x) the laws (or any regulations or rulings promulgated thereunder) of any Relevant Taxing Jurisdiction or (y) an official position regarding the application, administration, interpretation or enforcement of any such laws, regulations or rulings (including, without limitation, a holding by a court of competent jurisdiction or by a taxing authority in any Relevant Taxing Jurisdiction). If a withholding or deduction at source is required, the Company shall, subject to certain limitations and exceptions described below, pay to the holders or beneficial owners of the Preference Shares such additional amounts (the &#8220;Additional Amounts&#8221;) as may be necessary so that every net payment made to such holders or beneficial owners, after the withholding or deduction, shall not be less than the amount provided for in this Certificate of Designation to be then due and payable.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall not be required to pay any Additional Amounts for or on account of&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or governmental charge of whatever nature that would not have been imposed but for the fact that such holder or beneficial owner (i) was a resident, citizen, domiciliary or national of, or engaged in business or maintained a permanent establishment or was physically present in, the Relevant Taxing Jurisdiction or otherwise had some connection with the Relevant Taxing Jurisdiction other than by reason of the mere ownership of, or receipt of payment under, such Preference Shares or (ii) presented, where presentation is required, such Preference Shares for payment more than 30 days after the Relevant Date, except to the extent that the holder or beneficial owner would have been entitled to such Additional Amounts if it had presented such Preference Shares for payment on any day within that 30-day period&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;any estate, inheritance, gift, sale, transfer, personal property or similar tax, fee, duty, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or other governmental charge that is payable otherwise than by withholding or deduction from payment on the Preference Shares&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or other governmental charge that is imposed or withheld by reason of the failure by the holder or beneficial owner of such Preference Shares to comply with any reasonable request by the Company addressed to the holder within ninety (90) days of such request (a) to provide information concerning the nationality, citizenship, residence or identity of the holder or beneficial owner or (b) to make any declaration or other similar claim or satisfy any information or reporting requirement, which is required or imposed by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">statute, treaty, regulation or administrative practice of the Relevant Taxing Jurisdiction or any political subdivision thereof as a precondition to exemption from all or part of such tax, fee, duty, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;any taxes, duties, assessments or governmental charges required to be withheld or deducted under Sections 1471 through 1474 of the United States Internal Revenue Code of 1986, as amended (or any United States Treasury Regulations or other administrative guidance thereunder)&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;any combination of items (1), (2), (3), (4) and (5).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Company shall not pay Additional Amounts with respect to any payment on any such Preference Shares to any holder or beneficial owner who is a fiduciary, partnership, limited liability company or other pass-through entity or a person other than the sole beneficial owner of such Preference Shares if such payment would be required by the laws of the Relevant Taxing Jurisdiction to be included in the income for tax purposes of a beneficiary or settlor with respect to such fiduciary or a member of such partnership, limited liability company or other pass-through entity or a beneficial owner to the extent such beneficiary, settlor, member or beneficial owner would not have been entitled to such Additional Amounts had it been the holder or beneficial owner of the Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;If a payment on the Preference Shares is subject to withholding or deduction for, or on account of, any taxes or other governmental charges imposed or levied by or on behalf of any Relevant Taxing Jurisdiction, the Company shall pay the taxes or other governmental charges to the Relevant Taxing Jurisdiction in accordance with applicable law and furnish to the dividend disbursing agent certified copies of tax receipts (or other evidence of payment reasonably satisfactory to the dividend disbursing agent) evidencing payment of the taxes or other governmental charges. Copies of such documentation will be made available by the dividend disbursing agent to holders of the Preference Shares upon written request.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The requirement to pay Additional Amounts shall apply to any Successor Corporation.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voluntary or Involuntary Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event of any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of the Preference Shares shall be entitled to receive out of the Company&#8217;s assets legally available for distribution to shareholders, after satisfaction of indebtedness and other liabilities of the Company (including policyholder obligations of its subsidiaries), if any, the Liquidation Preference, plus declared and unpaid dividends thereon, if any, to, but excluding, the date fixed for distribution, without accumulation of any undeclared dividends (the &#8220;Liquidation Distribution&#8221;), before any distribution of assets is made to holders of Ordinary Shares, or any of the Company&#8217;s other Junior Stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">After the payment to the holders of the Preference Shares of the Liquidation Distribution to which such holders are entitled as provided in this Section 6, the holders of the Preference Shares shall have no right or claim to any of the remaining assets of the Company.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event the Company&#8217;s assets are not sufficient to pay the Liquidation Preference in full to all holders of the Preference Shares and the liquidation preference of any Parity Stock to all holders of such Parity Stock, the amounts paid to the holders of Preference Shares and to the holders of any Parity Stock shall be paid </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in accordance with the respective aggregate liquidation preferences of those holders.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Residual Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event the Liquidation Preference has been paid in full to all holders of the Preference Shares and any holders of any Parity Stock, the holders of the Company&#8217;s other capital stock shall be entitled to receive all of the Company&#8217;s remaining assets according to their respective rights and preferences.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Merger, Consolidation and Sale of Assets Not Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. For purposes of this Section 6, neither a consolidation, amalgamation, merger, arrangement or reconstruction involving the Company or the sale or transfer of all or substantially all of the shares of capital stock or the property or business of the Company shall be deemed to constitute a liquidation, dissolution or winding-up of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Optional Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company may not redeem Preference Shares prior to October 1, 2024, except as provided in Sections 7(a)(2), 7(a)(3), 7(a)(4) and 7(a)(5). On October 1, 2024 and at any time thereafter, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or from time to time in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25,000 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;At any time prior to October 1, 2024, if (i) the Company submits to the holders of its Ordinary Shares a proposal for an amalgamation or merger, or (ii) if the Company submits any proposal for any other matter that requires, as a result of any change in Bermuda law after August 6, 2019, for its validation or effectuation an affirmative vote of the holders of the Preference Shares at the time in issue, whether voting as a separate series or together with any other series or class of preference shares as a single class, the Company shall have the option, subject to compliance with Bermuda law, upon notice given as provided in Section 7(c), to redeem all of the issued Preference Shares at a cash redemption price of $26,000 per Preference Share, plus an amount equal to the portion of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such redemption shall occur prior to October 1, 2024 unless (1) the Company has sufficient funds in order to meet the Enhanced Capital Requirement and the BMA approves of the redemption or (2) the Company replaces the capital represented by Preference Shares to be redeemed with capital having equal or better capital treatment as the Preference Shares under the Enhanced Capital Requirement (the conditions described in clauses (1) and (2), the &#8220;Redemption Requirements&#8221;).</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;At any time prior to October 1, 2024, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or from time to time in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25,000 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends, at any time within 90 days of the date on which the Company has reasonably determined that, as a result of (i) any amendment to, or change in, the laws or regulations of Bermuda that is enacted or becomes effective after the Issue Date&#59; (ii) any proposed amendment to, or change in, those laws or regulations that is announced or becomes effective after the Issue Date&#59; or (iii) any official administrative decision or judicial decision or administrative action or other official pronouncement interpreting or applying those laws or regulations that is announced after the Issue Date, a Capital Disqualification Redemption Event has occurred&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that any such redemption in part may only be made if (x) the Company has reasonably determined that the portion of the Preference Shares to be redeemed are the subject of the Capital Disqualification Redemption Event and (y) after giving effect to such redemption, the Company has reasonably determined that a Capital Disqualification Redemption Event will not exist with respect to the then-issued Preference Shares and such redemption will not result in the suspension or removal of the Preference Shares from listing on the New York Stock Exchange&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such redemption may occur prior to October 1, 2024 unless one of the Redemption Requirements is satisfied.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;At any time prior to October 1, 2024, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or from time to time in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25,000 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends, at any time following the occurrence of a Tax Event&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such redemption may occur prior to October 1, 2024 unless one of the Redemption Requirements is satisfied.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;At any time prior to October 1, 2024, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole, upon notice given as provided in Section 7(c), at a cash redemption price of $25,500 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends, within 90 days after the occurrence of a Rating Agency Event&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such redemption may occur prior to October 1, 2024 unless one of the Redemption Requirements is satisfied.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;Unless dividends on all issued Preference Shares and all Parity Stock shall have been declared and paid (or declared and a sum sufficient for the payment thereof set apart for payment) for the latest completed Dividend Period on all issued Preference Shares and the latest completed dividend period on all issued Parity Stock, no Preference Shares or any Parity Stock shall be redeemed, purchased or otherwise acquired by the Company unless all issued Preference Shares and any Parity Stock are redeemed (or purchased or otherwise acquired)&#59; provided, that the Company may acquire fewer than all of the issued Preference Shares or Parity Stock pursuant to a written purchase or exchange offer made to all holders of issued Preference Shares and Parity Stock upon such terms as the Board of Directors in its sole discretion, after consideration of the respective annual dividend rate and other relative rights and preferences of the respective classes or series, shall determine (which determination shall be final and conclusive) will result in fair and equitable treatment among the respective classes or series.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Mandatory Redemption&#59; No Sinking Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not be subject to any mandatory redemption, sinking fund, retirement fund or purchase fund or other similar provisions. Holders of Preference Shares shall have no right to require redemption or repurchase of any Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notice of each redemption of Preference Shares shall be given by first class mail, to the holders of record of the Preference Shares to be redeemed, not less than 30 nor more than 60 days prior to the Redemption Date. Notwithstanding the foregoing, if the Preference Shares or any depositary shares representing interests in the Preference Shares are held in book-entry form through The Depository Trust Company, notice of redemption may be given to the holders of Preference Shares in any manner permitted by The Depository Trust Company. Each such notice given to a holder shall state&#58; (1) the Redemption Date&#59; (1) the number of Preference Shares to be redeemed and, if less than all of the Preference Shares held by such holder are to be redeemed, the number of such Preference Shares to be redeemed from such holder&#59; (1) the redemption price or the methodology for determining the redemption price&#59; and (1) the place or places where certificates for such Preference Shares are to be surrendered for payment of the redemption price.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In case of any redemption of only part of the Preference Shares at the time in issue, the Preference Shares to be redeemed shall be selected either </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or in such other manner as the Company may determine to be fair and equitable.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effectiveness of Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If a notice of redemption has been duly given and if all funds necessary for the redemption have been set aside for payment by the Company for the benefit of the holders of any Preference Shares called for redemption, then, from and after the Redemption Date, dividends shall cease to accumulate on all Preference Shares so called for redemption, all Preference Shares so called for redemption shall no longer be deemed in issue and all rights of holders of such Preference Shares shall forthwith on such Redemption Date cease and terminate, except the right of the holders thereof to transfer the Preference Shares prior to the Redemption Date and the right to receive the redemption price pursuant to Section 7(a).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Redemption Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. On or prior to the Redemption Date, the Company shall deposit with the Paying Agent an amount in immediately available funds sufficient to pay the aggregate redemption price plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that if such payment is deposited on the Redemption Date, it must be received by the Paying Agent by 10&#58;00 a.m. (New York City time) on the Redemption Date. An amount equal to the redemption price plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, shall be paid to the holders promptly following the later of (i) the Redemption Date and (ii) the time of book-entry transfer or surrender of the certificate(s) evidencing such Preference Shares to the Paying Agent, as applicable. Any declared but unpaid dividends payable on a Redemption Date that occurs subsequent to the Dividend Record Date for such Dividend Period shall not be paid to the holder entitled to receive the redemption price on the Redemption Date, but rather shall be paid to the holder of record of the redeemed Preference Shares on such Dividend Record Date relating to the Dividend Payment Date.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares have no stated maturity. The Preference Shares shall remain in issue perpetually, unless and until the Company elects to redeem the Preference Shares.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Variation or Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;At any time following a Tax Event or at any time following a Capital Disqualification Change Event, the Company may, without the consent of any holders of the Preference Shares, vary the terms of the Preference Shares or exchange the Preference Shares for new securities, which (i) in the case of a Tax Event, would eliminate the substantial probability that the Company or any Successor Corporation would be required to pay any Additional Amounts with respect to the Preference Shares as a result of a Change in Tax Law or (ii) in the case of Capital Disqualification Change Event, would cause the Preference Shares to become securities that qualify as at least Tier 2 capital (where capital is subdivided into tiers) or its equivalent under then-applicable Capital Adequacy Regulations imposed upon the Company by the BMA, including the Enhanced </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Capital Requirement, for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or levels of the Company or any subsidiary thereof. In either case, the terms of the varied securities or new securities considered in the aggregate shall not be less favorable, including from a financial perspective, to holders and beneficial owners of the Preference Shares than the terms of the Preference Shares prior to being varied or exchanged (as reasonably determined by the Company)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such variation of terms or securities received in exchange shall change the specified denominations, or any payment of dividend on, the redemption dates (other than any extension of the period during which an optional redemption may not be exercised by the Company) or currency of, the Preference Shares, reduce the Liquidation Preference thereof or the dividend payable thereon, lower the ranking of the securities, reduce the voting threshold for the issuance of Senior Stock or change the foregoing list of items that may not be so amended as part of such variation or exchange. No such variation of terms or securities received in exchange shall impair the right of a holder of the securities to institute suit for the payment of any amounts due (as provided under this Certificate of Designation), but unpaid with respect to such holder&#8217;s securities.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Prior to any variation or exchange, the Company shall be required to (i) receive an opinion of independent legal advisers of recognized standing to the effect that holders and beneficial owners of the Preference Shares (including as holders and beneficial owners of the varied or exchanged securities) shall not recognize income, gain or loss for United States federal income tax purposes as a result of such variation or exchange and shall be subject to United States federal income tax on the same amounts, in the same manner and at the same times as would have been the case had such variation or exchange not occurred, and (ii) deliver a certificate signed by two executive officers of the Company to the transfer agent for the Preference Shares confirming that (x) a Capital Disqualification Change Event or a Tax Event has occurred and is continuing (as reasonably determined by the Company) and (y) the terms of the varied or new securities, considered in the aggregate, are not less favorable, including from a financial perspective, to holders and beneficial owners of the Preference Shares than the terms of the Preference Shares prior to being varied or exchanged (as reasonably determined by the Company).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Any variation or exchange of the Preference Shares described above shall be made after notice is given to the holders of the Preference Shares not less than 30 nor more than 60 days prior to the date fixed for variation or exchange, as applicable.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as provided in this Section 10 or otherwise required by Bermuda law from time to time, the holders of the Preference Shares shall not have any voting rights.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Right to Elect Two Directors upon Nonpayment Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Whenever dividends payable on any Preference Shares shall have not been declared and paid for the equivalent of any six (6) Dividend Periods, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">whether or not consecutive (a &#8220;Nonpayment&#8221;), the holders of the Preference Shares, acting together as a single class with holders of any and all other series of Appointing Preference Shares then issued, shall be entitled to the appointment (the &#8220;Appointing Rights&#8221;) of a total of two additional members to the Board of Directors (each, a &#8220;Preference Share Director&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the appointment of any such directors shall not cause the Company to violate the corporate governance requirements of the New York Stock Exchange as applied to U.S. issuers (or any other securities exchange or automated quotation system on which the Company&#8217;s securities may be then listed or quoted) that listed companies must have a majority of independent directors. In the case of a Nonpayment, the number of directors on the Board of Directors shall automatically increase by two (to the extent such increase does not exceed the maximum number of directors permitted under the Company&#8217;s Bye-Laws), and the new directors shall be selected by at least a majority of the aggregate liquidation preference of the Preference Shares and any other Appointing Preference Shares at a special meeting called at the request of the record holders of at least 20% of the aggregate liquidation preference of the Preference Shares or of any other series of Appointing Preference Shares then in issue. The Board of Directors shall duly appoint the Preference Share Directors selected by the holders of the Preference Shares and any other Appointing Preference Shares then issued, and shall, subject to the Company&#8217;s Bye-Laws, determine which classes of directors the Preference Share Directors shall be a part of and shall allocate such Preference Share Directors to the classes having the longest term of office remaining at the time of such appointment. Each Preference Share Director shall be entitled to one vote per director on any matter.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The Appointing Rights shall continue until dividends on the Preference Shares and any such other series of Appointing Preference Shares following the Nonpayment shall have been fully declared and paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for payment) for at least four (4) consecutive Dividend Periods. When the term of a class of directors of which any Preference Share Director is a part of is expiring, the Board of Directors shall set the size of such class of directors to be elected by the Company&#8217;s ordinary shareholders at a level to include such Preference Share Director duly appointed by the Board of Directors upon the exercise of the Appointing Rights. The Company shall use its best efforts to increase the number of directors constituting the Board of Directors to the extent necessary to effect these Appointing Rights.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;So long as a Nonpayment shall continue, any vacancy in the office of a Preference Share Director (other than prior to the initial appointment after a Nonpayment) may be filled by the Board of Directors pursuant to an exercise of the Appointing Rights by the holders of Preference Shares and any other Appointing Preference Shares then in issue.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;If and when dividends for four (4) consecutive Dividend Periods following a Nonpayment have been paid in full (or declared and a sum sufficient for the payment of such dividends shall have been set aside), the holders of the Preference Shares shall be divested of the Appointing Rights (subject to revesting in the event of each subsequent Nonpayment, as described above) and, if such Appointing Rights for all other holders of Appointing Preference Shares have terminated, the office of each Preference Share Director so appointed shall, notwithstanding the class of directors such Preference Share Director shall be a part of, automatically be vacated and the number of directors on the Board of Directors shall automatically decrease by two (2). In determining whether dividends have been fully paid for four (4) consecutive Dividend Periods following a Nonpayment, the Company may take into account any dividend the Company elects to pay for a Dividend Period after the regular Dividend Payment Date for that period has passed.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting on Variations of Rights and Senior Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Notwithstanding the Company&#8217;s Bye-Laws, the affirmative vote or consent of the holders of at least 66&#8532;% of the aggregate Liquidation Preference of the issued Preference Shares and any series of Appointing Preference Shares, voting together as a single class, shall be required for the authorization or issuance of any class or series of Senior Stock (or any security convertible into or exchangeable for Senior Stock) ranking senior to the Preference Shares as to dividend rights or rights upon the Company&#8217;s liquidation.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The affirmative vote or consent of the holders of at least 66&#8532;% of the aggregate Liquidation Preference of the Company&#8217;s issued Preference Shares shall be required for amendments to the Company&#8217;s Memorandum of Association or Bye-Laws that would materially adversely affect the rights of holders of the Preference Shares. The authorization of, the increase in the authorized amount of, or the issuance of any shares of any class or series of Parity Stock or Junior Stock shall not require the consent of any holder of the Preference Shares, and shall not be deemed to materially adversely affect the rights of the holders of the Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;If all preference shares of the Company are not equally affected by any such proposed amendment and if the Preference Shares would have diminished status compared to other preference shares as a result, the approval of holders of at least 66</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">% of the issued Preference Shares, voting together as a single class, shall be required.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The foregoing voting provisions of this Section 10 will not apply if, at or prior to the time when the act with respect to which such vote would otherwise be required shall be effected, all issued Preference Shares shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have been set aside </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for payment by the Company for the benefit of the holders of Preference Shares to effect such redemption as set forth in Section 7.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Record Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the fullest extent permitted by applicable law, the Company and the transfer agent for the Preference Shares may deem and treat the record holder of any share of Preference Shares as the true and lawful owner thereof for all purposes, and neither the Company nor such transfer agent shall be affected by any notice to the contrary.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments or Modifications&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;To the extent permitted by applicable law, the Board of Directors may modify the terms of this Certificate of Designation without the consent of any holder of Preference Shares for any of the following purposes&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;to evidence the succession of another person to the Company&#8217;s obligations&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;to add to the covenants for the benefit of the holders of the Preference Shares or to surrender any of the Company&#8217;s rights or powers under the Preference Shares&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;to cure any ambiguity to correct or supplement any provisions that may be inconsistent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such action shall not adversely affect the interest of the holders of the Preference Shares in any material respect&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;to make any other provision with respect to such matters or questions arising under this Certificate of Designation which the Company may deem desirable and which shall not adversely affect the interests of the holders of the Preference Shares in any material respect.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Except as provided below in Section 12(c), this Certificate of Designation may be amended, modified or supplemented, and noncompliance in any particular instance with any provision of this Certificate of Designation or the Preference Shares may be waived, in each case with the affirmative vote or written consent of the holders of at least a majority of the aggregate Liquidation Preference of the Preference Shares then issued, including any modification occurring in connection with any merger or consolidation of the Company or otherwise.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Board of Directors may, subject to the prior written consent or the affirmative vote of the holders of at least a majority of the aggregate Liquidation Preference of the Preference Shares in issue at the time, amend the terms of this Certificate of Designation or the rights, powers, preferences and privileges of the holders of the Preference Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no such amendment shall, without the consent of the holder of each issued Preference Share affected by the amendment&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;change any Dividend Payment Date&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;reduce the rate of dividends payable on the Preference Shares when, as and if declared by the Board of Directors&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;reduce the redemption price or alter the October 1, 2024 optional redemption date&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;change the place or currency of payment&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;impair the right to institute suit for the enforcement of the Preference Shares&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;change the percentage of aggregate Liquidation Preference of the Preference Shares whose holders must approve any amendment.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Merger, Amalgamation, Consolidation and Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company covenants that it will not merge or amalgamate with or into, consolidate with or convert into any other person or entity or sell, assign, transfer, lease or convey all or substantially all of the Company&#8217;s properties and assets into any person or entity, unless&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;either the Company is the continuing corporation or the successor corporation is a corporation organized under the laws of the United States, a state thereof, the District of Columbia, Bermuda or any country which is, on the date hereof, a member of the Organisation for Economic Cooperation and Development and the Preference Shares shall be exchanged for or converted into and shall become Preference Shares of the successor corporation with substantially the same rights, powers, preferences and privileges&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Company or the successor corporation is not, immediately after such merger, amalgamation, consolidation, conversion, sale, assignment, transfer, lease or conveyance, in default of any obligation under the Preference Shares.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Preference Shares shall be issued initially in the form of one or more fully registered global certificates with the global securities legend set forth in Exhibit A hereto (&#8220;Global Preference Shares&#8221;), each as set forth on the form of Preference Shares certificate attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> which is hereby incorporated in and expressly made a part of this Certificate of Designation. The Global Preference Shares certificate may have notations, legends or endorsements required by law, stock exchange rules, agreements to which the Company is subject, if any, or usage (provided that any such notation, legend or endorsement is in a form acceptable to the Company). The Global Preference Shares shall be deposited on behalf of the holders of the Preference Shares represented thereby with the Registrar, as custodian for DTC (or with such other custodian as DTC may direct), and registered in the name of DTC or a nominee of DTC, duly executed by the Company and countersigned by the Registrar as hereinafter provided, The aggregate number of Preference Shares represented by Global Preference </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares may from time to time be increased or decreased by adjustments made on the records of the Registrar and DTC or its nominee as hereinafter provided.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event Global Preference Shares are deposited with or on behalf of DTC, the Company shall execute, and the Registrar shall countersign and deliver, initially one or more Global Preference Shares certificates that (a) shall be registered in the name of Cede &#38; Co. or other nominee of the Depositary and (b) shall be delivered by the Registrar to DTC or pursuant to DTC's instructions or held by the Registrar as custodian for DTC. Members of, or participants in, DTC (&#8220;Agent Members&#8221;) shall have no rights under this Certificate of Designation with respect to any Global Preference Shares held on their behalf by DTC or by the Registrar as the custodian of DTC or under such Global Preference Shares, and DTC may be treated by the Company, the Registrar and any agent of the Company or the Registrar as the absolute owner of such Global Preference Shares for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Registrar or any agent of the Company or the Registrar from giving effect to any written certification, proxy or other authorization furnished by DTC or impair, as between DTC and its Agent Members, the operation of customary practices of DTC governing the exercise of the rights of a holder of a beneficial interest in any Global Preference Shares.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Owners of beneficial interests in Global Preference Shares shall not be entitled to receive physical delivery of certificated Preference Shares, unless&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;DTC is unwilling or unable to continue as Depositary for the Global Preference Shares and the Company does not appoint a qualified replacement for DTC within 90 calendar days&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;DTC ceases to be a &#8220;clearing agency&#8221; registered under the Exchange Act and the Company does not appoint a qualified replacement for DTC within 90 calendar days&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the Company decides to discontinue the use of book-entry transfer through DTC (or any successor Depositary).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In any such case, the Global Preference Shares shall be exchanged in whole for certificated Preference Shares in registered form, with the same terms and of an equal aggregate liquidation preference (unless the Company determines otherwise in accordance with applicable law). Certificated Preference Shares shall be registered in the name or names of the Person or Person specified by DTC in a written instrument to the Registrar.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;An Officer shall sign the Preference Shares certificate for the Company by manual or facsimile signature. If the Officer whose signature is on a Preference Shares certificate no longer holds that office at the time the Registrar countersigns the Preference Shares certificate, the Preference Shares certificate shall be valid nevertheless.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A Preference Shares certificate shall not be valid until an authorized signatory of the Registrar signs the Preference Shares certificate by manual or facsimile signature. The signature shall be conclusive evidence that the Preference Shares certificate has been countersigned under this Certificate of Designation.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All notices or communications in respect of Preference Shares shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designation, the Memorandum of Association, the Bye-Laws or by applicable law.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Preemptive Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Holders of the Preference Shares shall not have any rights of preemption or subscription whatsoever as to any securities of the Company, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations on Transfer and Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The holders of Preference Shares shall be subject to the limitations on transfer and ownership contained in the Bye-laws.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not be convertible into or exchangeable for any other securities or property of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Other Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, limitations or restrictions other than as set forth in this Certificate of Designation, the Memorandum of Association, the Bye-laws or applicable law.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation in Respect of Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall be responsible for making all calculations called for in respect of the Preference Shares, including, but not limited to, the determination of the dividends payable on the Preference Shares. The Company or its agents shall make all of these calculations in good faith and, absent manifest error, such calculations shall be final and binding on holders of the Preference Shares. The Company or its agents shall deliver to the Paying Agent a schedule of its calculations and the Paying Agent shall be entitled to rely upon the accuracy of such calculations without independent verification. The Paying Agent shall forward such calculations to any holder of the Preference Shares upon the request of such holder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event any provision of this Certificate of Designation shall be invalid, unenforceable or illegal, then, to the fullest extent permitted by applicable law, the validity, enforceability and legality of the remaining provisions shall not in any way be affected or impaired thereby.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i35fca176eb7347de8d863256c219ad63_83"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, ASPEN INSURANCE HOLDINGS LIMITED has caused this Certificate of Designation to be signed this 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of August, 2019.</font></div><div style="margin-bottom:40pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Scott Kirk</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Scott Kirk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Group Chief Finance Officer </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attest&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Mark Cloutier</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Mark Cloutier</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Group Chief Executive Officer &#38; Chairman</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">AIHL &#8211; Signature Page to Certificate of Designation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="i35fca176eb7347de8d863256c219ad63_104"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXHIBIT A</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Form of Preference Shares Certificate</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% PERPETUAL NON-CUMULATIVE PREFERENCE SHARES</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FACE OF SECURITY</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &#38; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &#38; CO. HAS AN INTEREST HEREIN.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE CERTIFICATE OF DESIGNATION REFERRED TO BELOW.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Preference Shares</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10,000</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CUSIP NO.&#58; G05384303</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISIN NO.&#58; BMG053843030</font></td></tr></table></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% Perpetual Non-Cumulative Preference Shares</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liquidation preference U.S.$25,000 per Preference Share)</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), hereby certifies that Cede &#38; Co. or its registered assigns (the &#8220;Holder&#8221;) is the registered owner of 10,000, or such number as is indicated in the records of the Registrar and the Depository, fully paid and non-assessable preference shares of the Company designated the 5.625% Perpetual Non-Cumulative Preference Shares, with a liquidation preference of U.S.$25,000 per share (the &#8220;Preference Shares&#8221;). The Preference Shares are transferable on the books and records of the Registrar, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper form for transfer. The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Preference Shares represented hereby are issued and shall in all respects be subject to the provisions of the Certificate of Designation dated August 13, 2019, as the same may be amended from time to time (the &#8220;Certificate of Designation&#8221;). Capitalized terms used herein but not defined shall have the meaning given them in the Certificate of Designation. The Company will provide a copy of the Certificate of Designation to a holder without charge upon written request to the Company at its principal place of business.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to select provisions of the Preference Shares set forth on the reverse hereof, and to the Certificate of Designation, which select provisions and the Certificate of Designation shall for all purposes have the same effect as if set forth at this place.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of this certificate, the holder is bound by the Certificate of Designation and is entitled to the benefits thereunder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the Registrar has properly countersigned, these Preference Shares shall not be entitled to any benefit under the Certificate of Designation or be valid or obligatory for any purpose.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has executed this certificate this 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> day of August 13, 2019.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGISTRAR&#8217;S COUNTERSIGNATURE</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These are Preference Shares referred to in the within-mentioned Certificate of Designation.</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; August 13, 2019</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.760%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPUTERSHARE TRUST COMPANY, N.A., as Registrar</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Signatory</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVERSE OF SECURITY</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on each Preference Share shall be payable at the rate provided in the Certificate of Designation.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Preference Shares shall be redeemable at the Company&#8217;s option in the manner and accordance with the terms set forth in the Certificate of Designation.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall furnish without charge to each holder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class or series of share capital and the qualifications, limitations or restrictions of such preferences and&#47;or rights.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASSIGNMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned assigns and transfers the Preference Shares evidenced hereby to&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert assignee&#8217;s social security or tax identification number)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert address and zip code of assignee)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and irrevocably appoints&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.920%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agent to transfer the Preference Shares evidenced hereby on the books of the Transfer Agent. The agent may substitute another to act for him or her.</font></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:4.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.247%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Sign exactly as your name appears on the other side of this Preference Shares Certificate)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature Guarantee&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Signature must be guaranteed by an &#8220;eligible guarantor institution&#8221; that is a bank, stockbroker, savings and loan association or credit union meeting the requirements of the Transfer Agent, which requirements include membership or participation in the Securities Transfer Agents Medallion Program (&#8220;STAMP&#8221;) or such other &#8220;signature guarantee program&#8221; as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the U.S. Securities Exchange Act of 1934, as amended.)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.9
<SEQUENCE>11
<FILENAME>exhibit39-fx1.htm
<DESCRIPTION>EX-3.9
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i91a0f072cc044bc49d61de4e500b4445_50"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 3.9</font></div></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Preference Shares Certificate</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% PERPETUAL NON-CUMULATIVE PREFERENCE SHARES</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FACE OF SECURITY</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &#38; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &#38; CO. HAS AN INTEREST HEREIN.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE CERTIFICATE OF DESIGNATION REFERRED TO BELOW.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS.</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Preference Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CUSIP NO.&#58; G05384303</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISIN NO.&#58; BMG053843030</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% Perpetual Non-Cumulative Preference Shares</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liquidation preference U.S.$25,000 per Preference Share)</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), hereby certifies that Cede &#38; Co. or its registered assigns (the &#8220;Holder&#8221;) is the registered owner of 10,000, or such number as is indicated in the records of the Registrar and the Depository, fully paid and non-assessable preference shares of the Company designated the 5.625% Perpetual Non-Cumulative Preference Shares, with a liquidation preference of U.S.$25,000 per share (the &#8220;Preference Shares&#8221;). The Preference Shares are transferable on the books and records of the Registrar, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper form for transfer. The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Preference Shares represented hereby are issued and shall in all respects be subject to the provisions of the Certificate of Designation dated August 13, 2019, as the same may be amended from time to time (the &#8220;Certificate of Designation&#8221;). Capitalized terms used herein but not defined shall have the meaning given them in the Certificate of Designation. The Company will provide a copy of the Certificate of Designation to a holder without charge upon written request to the Company at its principal place of business.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to select provisions of the Preference Shares set forth on the reverse hereof, and to the Certificate of Designation, which select provisions and the Certificate of Designation shall for all purposes have the same effect as if set forth at this place.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of this certificate, the holder is bound by the Certificate of Designation and is entitled to the benefits thereunder.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the Registrar has properly countersigned, these Preference Shares shall not be entitled to any benefit under the Certificate of Designation or be valid or obligatory for any purpose.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><div id="i91a0f072cc044bc49d61de4e500b4445_73"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has executed this certificate this 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> day of August, 2019.</font></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.506%"><tr><td style="width:1.0%"></td><td style="width:9.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#47;s&#47; Scott Kirk</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; Scott Kirk</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Group Chief Finance Officer</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGISTRAR&#8217;S COUNTERSIGNATURE</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These are Preference Shares referred to in the within-mentioned Certificate of Designation.</font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; August 13, 2019</font></div><div style="margin-bottom:396pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.608%"><tr><td style="width:1.0%"></td><td style="width:13.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPUTERSHARE TRUST COMPANY, N.A., as Registrar</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#47;s&#47; Constance Adams </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Signatory</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page &#8211; Preference Share Certificate&#93;</font></div></div></div><div id="i91a0f072cc044bc49d61de4e500b4445_91"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVERSE OF SECURITY</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on each Preference Share shall be payable at the rate provided in the Certificate of Designation.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Preference Shares shall be redeemable at the Company&#8217;s option in the manner and accordance with the terms set forth in the Certificate of Designation.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall furnish without charge to each holder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class or series of share capital and the qualifications, limitations or restrictions of such preferences and&#47;or rights.</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASSIGNMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned assigns and transfers the Preference Shares evidenced hereby to&#58;</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.029%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert assignee&#8217;s social security or tax identification number)</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.029%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Insert address and zip code of assignee)</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and irrevocably appoints&#58;</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.788%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agent to transfer the Preference Shares evidenced hereby on the books of the Transfer Agent. The agent may substitute another to act for him or her.</font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; ____________________________________________________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature&#58;________________________________________________________</font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Sign exactly as your name appears on the other side of this Preference Shares Certificate)</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature Guarantee&#58; _______________________________________________</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Signature must be guaranteed by an &#8220;eligible guarantor institution&#8221; that is a bank, stockbroker, savings and loan association or credit union meeting the requirements of the Transfer Agent, which requirements include </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">membership or participation in the Securities Transfer Agents Medallion Program (&#8220;STAMP&#8221;) or such other &#8220;signature guarantee program&#8221; as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the U.S. Securities Exchange Act of 1934, as amended.)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>12
<FILENAME>exhibit101-fx1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8397e381e0744e94b2ebcd2ab14478b4_59"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:150pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEPOSIT AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated </font></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">August 13, 2019 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AS ISSUER, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COMPUTERSHARE INC. AND COMPUTERSHARE TRUST COMPANY, N.A.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AS DEPOSITARY, </font></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- and - </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Holders from Time to Time of </font></div><div style="margin-bottom:30pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary Receipts Described Herein </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RELATING TO THE RECEIPTS, DEPOSITARY SHARES AND RELATED 5.625% PERPETUAL NON-CUMULATIVE PREFERENCE SHARES OF THE ISSUER</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i8397e381e0744e94b2ebcd2ab14478b4_83"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 1 <br>DEFINITIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 2 <br>FORM OF RECEIPTS, DEPOSIT OF PREFERENCE SHARES, EXECUTION AND DELIVERY, TRANSFER, SURRENDER AND REDEMPTION OF RECEIPTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.01 Form and Transferability of Receipts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.02 Deposit of Preference Shares&#59; Execution and Delivery of Receipts in Respect Thereof</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.03 Optional Redemption of Preference Shares for Cash</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.04 Registration of Transfers of Receipts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.05 Combinations and Split-ups of Receipts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.06 Surrender of Receipts and Withdrawal of Preference Shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.07 Limitations on Execution and Delivery, Transfer, Split-up</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.08 Lost Receipts, etc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.09 Cancellation and Destruction of Surrendered Receipts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.10 No Pre-Release</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 3 <br>CERTAIN OBLIGATIONS OF HOLDERS OF RECEIPTS AND THE COMPANY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">11</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.01 Filing Proofs, Certificates and Other Information</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.02 Payment of Fees and Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.03 Representations and Warranties as to Preference Shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.04 Representation and Warranty as to Receipts and Depositary Shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.05 Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 4 <br>THE PREFERENCE SHARES&#59; NOTICES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">12</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.01 Cash Distributions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.02 Distributions Other Than Cash</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.03 Subscription Rights, Preferences or Privileges</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.04 Notice of Dividends&#59; Fixing of Record Date for Holders of Receipts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.05 Voting Right</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- i -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.06 Changes Affecting Preference Shares and Reclassifications, Recapitalizations, Etc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.07 Inspection of Reports</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.08 Lists of Receipt Holders</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.09 Withholding</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 5 <br>THE DEPOSITARY, THE DEPOSITARY&#8217;S AGENTS, THE REGISTRAR AND THE COMPANY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">17</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.01 Maintenance of Offices, Agencies and Transfer Books by the Depositary and the Registrar</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.02 Prevention or Delay in Performance by the Depositary, the Depositary&#8217;s Agents, the Registrar or the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.03 Obligations of the Depositary, the Depositary&#8217;s Agents, the Registrar and the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.04 Resignation and Removal of the Depositary&#59; Appointment of Successor Depositary</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.05 Notices, Reports and Documents</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.06 Indemnification by the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.07 Fees, Charges and Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.08 Tax Compliance</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 6 <br>AMENDMENT AND TERMINATION</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">24</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.01 Amendment</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.02 Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 7 <br>MISCELLANEOUS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">25</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.01 Counterparts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.02 Exclusive Benefits of Parties</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.03 Invalidity of Provisions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.04 Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.05 Depositary&#8217;s Agents</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.06 Holders of Receipts Are Parties</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.07 Governing Law</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- ii -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.08 Inspection of Deposit Agreement and Certificate of Designation</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.09 Headings</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.10 Confidentiality</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.11 Further Assurances</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT A </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Form of Face of Receipt&#59; Form of Reverse of Receipt</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT B </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certificate of Designation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- iii -</font></div></div></div><div id="i8397e381e0744e94b2ebcd2ab14478b4_104"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEPOSIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DEPOSIT AGREEMENT, dated August 13, 2019 among </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Bermuda exempted company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COMPUTERSHARE INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Computershare</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and its wholly-owned subsidiary, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COMPUTERSHARE TRUST COMPANY, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a federally chartered trust company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trust Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), jointly as Depositary (as hereinafter defined), and the holders from time to time of Receipts (as hereinafter defined) issued hereunder.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WITNESSETH&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, it is desired to provide, as hereinafter set forth in this Deposit Agreement, for the deposit of the Company&#8217;s Preference Shares (as hereinafter defined) with the Depositary for the purposes set forth in this Deposit Agreement and for the issuance hereunder of Depositary Shares representing a fractional interest in the Preference Shares deposited and for the execution and delivery of Receipts evidencing Depositary Shares&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Receipts are to be substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> annexed to this Deposit Agreement, with appropriate insertions, modifications and omissions, as hereinafter provided in this Deposit Agreement&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the terms and conditions of the Preference Shares are substantially set forth in the Certificate of Designation attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the premises contained herein, it is agreed by and among the parties hereto as follows&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following definitions shall apply to the respective terms (in the singular and plural forms of such terms) used in this Deposit Agreement and the Receipts&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Certificate of Designation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the certificate of designation, adopted by the Board of Directors of the Company or a duly authorized committee thereof, establishing and setting forth the rights, preferences and privileges of the Preference Shares attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and as such certificate may be amended or restated from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Deposit Agreement&#8221; or &#8220;Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean this agreement, as the same may be amended, modified or supplemented from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Depositary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean Computershare and the Trust Company, acting jointly, and any successor as Depositary hereunder. The Depositary, along with its affiliates, shall maintain combined capital and surplus of at least $50,000,000, and so shall any successor depositary hereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 1 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Depositary Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the principal office of the Depositary at which at any particular time its business in respect of matters governed by this Deposit Agreement shall be administered, which at the date of this Deposit Agreement is located at 150 Royall Street, Canton, Massachusetts 02010.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Depositary Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the security representing a 1&#47;1,000th fractional interest in a Preference Share deposited with the Depositary hereunder and the same proportionate interest in any and all other property received by the Depositary in respect of such Preference Share and held under this Deposit Agreement, all as evidenced by the Receipts issued hereunder. Subject to the terms of this Deposit Agreement, each owner of a Depositary Share is entitled, proportionately, to all the rights, preferences and privileges of the Preference Shares represented by such Depositary Share (including the dividend, voting, redemption and liquidation rights contained in the Certificate of Designation).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Depositary&#8217;s Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an agent appointed by the Depositary as provided, and for the purposes specified, in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Disbursing Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean Computershare or any bank or trust company appointed to receive dividends on the deposited Preference Shares and disburse the same to the holders of the Receipts, as herein provided.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the Certificate of Designation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DTC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means The Depository Trust Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DTC Receipt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Company&#8217;s 5.625% Perpetual Non-Cumulative Preference Shares with a par value of $.0015144558 per share, heretofore validly issued, fully paid and non-assessable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Receipt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a receipt issued hereunder to evidence one or more Depositary Shares, whether in definitive or temporary form, substantially in the form set forth as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">record date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the date fixed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">record holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; as applied to a Receipt shall mean the individual, entity or person in whose name a Receipt is registered on the books maintained by the Depositary for such purpose.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 2 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Redemption Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean Computershare and the Trust Company or any bank or trust company appointed to receive redemption proceeds on the deposited Preference Shares and to disburse the same to the holders of the Receipts, as herein provided.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">redemption date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">redemption price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Registrar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Trust Company or any bank or trust company appointed to register ownership and transfers of Receipts and the deposited Preference Shares, as herein provided.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Trust Company or any bank or trust company appointed to transfer the Receipts and the deposited Preference Shares, as herein provided.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE&#160;2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM OF RECEIPTS, DEPOSIT OF PREFERENCE SHARES, EXECUTION AND DELIVERY, TRANSFER, SURRENDER AND REDEMPTION OF RECEIPTS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Form and Transferability of Receipts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Definitive Receipts shall be printed and shall be substantially in the form set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> annexed to this Deposit Agreement, in each case with appropriate insertions, modifications and omissions, as hereinafter provided. Pending the preparation of definitive Receipts, the Depositary, upon and pursuant to the written order of the Company delivered in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, shall be authorized and instructed to, and shall, execute and deliver temporary Receipts which shall be substantially of the tenor of the definitive Receipts in lieu of which they are issued and in each case with such appropriate insertions, omissions, substitutions and other variations as the persons executing such Receipts may determine (but which do not affect the rights or duties of the Depositary), as evidenced by their execution of such Receipts. If temporary Receipts are issued, the Company and the Depositary will cause definitive Receipts to be prepared without unreasonable delay. After the preparation of definitive Receipts, the temporary Receipts shall be exchangeable for definitive Receipts upon surrender of the temporary Receipts at the Depositary Office without charge to the holder. Upon surrender for cancellation of any one or more temporary Receipts, the Depositary is hereby authorized and instructed to, and shall, execute and deliver in exchange therefor definitive Receipts representing the same number of Depositary Shares as represented by the surrendered temporary Receipt or Receipts. Such exchange shall be made at the Company&#8217;s expense and without any charge therefor. Until so exchanged, the temporary Receipts shall in all respects be entitled to the same benefits under this Deposit Agreement, and with respect to the Preference Shares deposited, as definitive Receipts.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 3 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Receipts shall be executed by the Depositary by the manual or facsimile signature of a duly authorized signatory of the Depositary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if a Registrar for the Receipts (other than the Depositary) shall have been appointed then such Receipts shall also be countersigned by manual or facsimile signature of a duly authorized signatory of the Registrar. No Receipt shall be entitled to any benefits under this Deposit Agreement or be valid or obligatory for any purpose unless it shall have been executed as provided in the preceding sentence. The Depositary shall record on its books each Receipt executed as provided above and delivered as hereinafter provided. Receipts bearing the manual or facsimile signature of a duly authorized signatory of the Depositary who was at any time a proper signatory of the Depositary shall bind the Depositary, notwithstanding that such signatory ceased to hold such office prior to the execution and delivery of such Receipts by the Registrar or did not hold such office on the date of issuance of such Receipts.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Receipts shall be in denominations of any number of whole Depositary Shares. All Receipts shall be dated the date of their issuance.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Receipts may be endorsed with or have incorporated in the text thereof such legends or recitals or changes not inconsistent with the provisions of this Deposit Agreement as may be required by the Depositary and approved by the Company, or which the Company has determined are required to comply with any applicable law or regulation or with the rules and regulations of any securities exchange upon which the Depositary Shares may be listed for trading or to conform with any usage with respect thereto, or to indicate any special limitations or restrictions to which any particular Receipts are subject, in each case as directed by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title to any Receipt (and to the Depositary Shares evidenced by such Receipt) that is properly endorsed, or accompanied by a properly executed instrument of transfer or endorsement, shall be transferable by delivery with the same effect as in the case of a negotiable instrument&#59; provided, however, that until transfer of a Receipt shall be registered on the books of the Depositary as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Depositary may, notwithstanding any notice to the contrary, treat the record holder thereof at such time as the absolute owner thereof for the purpose of determining the person entitled to distributions of dividends or other distributions or payments with respect to the Preference Shares, to exercise any redemption or voting rights or to receive any notice provided for in this Deposit Agreement and for all other purposes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Depositary and the Company will make application to DTC for acceptance of all of the Receipts for its book-entry settlement system. In connection with such request, the Company hereby appoints the Depositary acting through any authorized officer thereof as its attorney-in-fact, with full power to delegate, for purposes of executing any agreements, certifications or other instruments or documents necessary or desirable in order to effect the acceptance of such Receipts for DTC eligibility. So long as the Receipts are eligible for book-entry settlement with DTC, unless otherwise required by law, all Depositary Shares to be traded on the New York Stock Exchange with book-entry settlement through DTC shall be represented by a single receipt (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DTC Receipt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which shall be deposited with DTC (or its custodian) evidencing all such Depositary Shares and registered in the name of the nominee of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 4 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DTC (initially expected to be Cede &#38; Co.). The Depositary or such other entity as is agreed to by DTC may hold the DTC Receipt as custodian for DTC. Ownership of beneficial interests in the DTC Receipt shall be shown on, and the transfer of such ownership shall be effected through, records maintained by (i) DTC or its nominee for such DTC Receipt or (ii) institutions that have accounts with DTC.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If issued, the DTC Receipt shall be exchangeable for definitive Receipts only if (i) DTC notifies the Company at any time that it is unwilling or unable to continue to make its book-entry settlement system available for the Receipts and a successor to DTC is not appointed by the Company within 90 days of the date the Company is so informed in writing, (ii) DTC notifies the Company at any time that it has ceased to be a clearing agency registered under applicable law and a successor to DTC is not appointed by the Company within 90 days of the date the Company is so informed in writing or (iii) the Company executes and delivers to DTC a notice to the effect that such DTC Receipt shall be so exchangeable. If the beneficial owners of interests in Depositary Shares are entitled to exchange such interests for definitive Receipts as the result of an event described in clause (i), (ii) or (iii) of the preceding sentence, then without unnecessary delay but in any event not later than the earliest date on which such beneficial interests may be so exchanged, the Depositary is hereby directed to and shall provide written instructions to DTC to deliver to the Depositary for cancellation the DTC Receipt, and the Company shall instruct the Depositary in writing to execute and deliver to the beneficial owners of the Depositary Shares previously evidenced by the DTC Receipt definitive Receipts in physical form evidencing such Depositary Shares. The DTC Receipt shall be in such form and shall bear such legend or legends as may be appropriate or required by DTC in order for it to accept the Depositary Shares for its book-entry settlement system. Notwithstanding any other provision herein to the contrary, if the Receipts are at any time eligible for book-entry settlement through DTC, delivery of Preference Shares and other property in connection with the withdrawal or redemption of Depositary Shares will be made through DTC and in accordance with its procedures, unless the holder of the relevant Receipt otherwise requests and such request is reasonably acceptable to the Depositary and the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Deposit of Preference Shares&#59; Execution and Delivery of Receipts in Respect Thereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Concurrently with the execution of this Deposit Agreement, the Company is delivering to the Depositary a certificate or certificates, registered in the name of the Depositary and evidencing 10,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Preference Shares, properly endorsed or accompanied, if required by the Depositary, by a duly executed instrument of transfer or endorsement, in form satisfactory to the Depositary, together with (i) all such certifications as may be required by the Depositary in accordance with the provisions of this Deposit Agreement and an executed officer&#8217;s certificate attaching the Certificate of Designation and all other information required to be set forth therein, (ii) an opinion of counsel to the Company addressed to the Depository containing opinions, or a letter of counsel to the Company authorizing reliance on such counsel&#8217;s opinions delivered to the underwriters named therein, relating to, (A) the existence and good standing of the Company, (B) the due authorization of the Depositary Shares and the status of the Depositary Shares as validly issued, fully paid and non-assessable, and (C) the effectiveness of any registration statement under the Securities Act relating to the Depositary Shares or whether exemption from such registration is applicable, and (iii) a written order of the Company directing the Depositary to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 5 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">execute and deliver to, or upon the written order of, the person or persons stated in such order a Receipt or Receipts for the Depositary Shares representing such deposited Preference Shares registered in such names specified in such written order. The Depositary acknowledges receipt of the aforementioned 10,000 Preference Shares and related documentation and agrees to hold such deposited Preference Shares in an account to be established by the Depositary at the Depositary Office or at such other office as the Depositary shall determine. The Company hereby appoints Computershare and the Trust Company as the Depositary, Registrar, Transfer Agent, Dividend Disbursing Agent and Redemption Agent for the Preference Shares deposited hereunder and the Trust Company and Computershare hereby accept such appointment and, as such, will reflect changes in the number of shares (including any fractional shares) of deposited Preference Shares held by it by notation, book-entry or other appropriate method.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If required by the Depositary, Preference Shares presented for deposit by the Company at any time, whether or not the register of shareholders of the Company is closed, shall also be accompanied by an agreement or assignment, or other instrument satisfactory to the Depositary, that will provide for the prompt transfer to the Depositary or its nominee of any dividend or right to subscribe for additional Preference Shares or to receive other property that any person in whose name the Preference Shares are or has been registered may thereafter receive upon or in respect of such deposited Preference Shares, or in lieu thereof such agreement of indemnity or other agreement as shall be satisfactory to the Depositary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon receipt by the Depositary of a certificate or certificates for Preference Shares deposited hereunder, together with the other documents specified above, and upon registering such Preference Shares in the name of the Depositary, the Depositary, subject to the terms and conditions of this Deposit Agreement, shall execute and deliver to, or upon the order of, the person or persons named in the written order delivered to the Depositary referred to in the first paragraph of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Receipt or Receipts for the number of whole Depositary Shares representing the Preference Shares so deposited and registered in such name or names as may be requested by such person or persons. The Depositary shall execute and deliver such Receipt or Receipts at the Depositary Office, except that, at the request, risk and expense of any person requesting such delivery, such delivery may be made at such other place as may be designated by such person. Other than in the case of splits, combinations or other reclassifications affecting the Preference Shares, or in the case of dividends or other distributions of Preference Shares, if any, there shall be deposited hereunder not more than the number of shares constituting the Preference Shares as set forth in the Certificate of Designation, as such may be amended. To the extent that the Company issues Preference Shares in excess of the amount set forth in the Certificate of Designation as of the date hereof (which shares have been duly authorized by the Company), the Company shall notify the Depositary of such issuance in writing.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary shall be permitted to rely on applicable opinions of counsel delivered to the underwriters pursuant to each of Sections 7(d) and 7(e) of the underwriting agreement dated August 6, 2019 among the Company and the underwriters named therein relating to the sale of the Depositary Shares to the public. In addition, Willkie Farr &#38; Gallagher LLP, U.S. counsel to the Company, shall deliver a letter to the Depositary, subject to the qualifications and assumptions set forth therein, that (i) the Company&#8217;s registration statement on Form S-3 (the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 6 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) relating to depositary shares, preference shares and other securities became effective upon filing with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and (ii) no stop order suspending the effectiveness of the Registration Statement has been instituted or is pending or threatened by the Commission.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall deliver to the Depositary from time to time such quantities of Receipts as the Depositary may request to enable the Depositary to perform its obligations under this Deposit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Optional Redemption of Preference Shares for Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Whenever the Company shall elect to redeem deposited Preference Shares for cash in accordance with the provisions of the Certificate of Designation, it shall (unless otherwise agreed in writing with the Depositary) give the Depositary not less than 35 nor more than 60 days&#8217; prior written notice of the date fixed for redemption of such Preference Shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">redemption date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and of the number of such Preference Shares held by the Depositary to be redeemed and the applicable redemption price (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">redemption price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), as set forth in the Certificate of Designation. The Depositary shall mail, first-class postage prepaid, or otherwise transmit by an authorized method, notice of the redemption of Preference Shares and the proposed simultaneous redemption of the Depositary Shares representing the Preference Shares to be redeemed, not less than 30 and not more than 60 days prior to the redemption date, to the holders of record on the record date fixed for such redemption pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Receipts evidencing the Depositary Shares to be so redeemed, at the addresses of such holders as the same appear on the records of the Depositary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the failure to mail any such notice to one or more such holders or any defect in any such notice shall not affect the sufficiency of the proceedings for redemption except as to the holder to whom notice was not given or defective.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall prepare and provide the Depositary with such notice, and each such notice shall state&#58; (i) the redemption date&#59; (ii) the redemption price&#59; (iii) the number of deposited Preference Shares and Depositary Shares to be redeemed&#59; (iv) if fewer than all Depositary Shares held by any holder are to be redeemed, the number of such Depositary Shares held by such holder to be so redeemed&#59; (v) the place or places where the Preference Shares and the Receipts evidencing Depositary Shares to be redeemed are to be surrendered for payment of the redemption price&#59; and (vi) that on the redemption date dividends in respect of the Preference Shares represented by the Depositary Shares to be redeemed will cease to accrue.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event that notice of redemption has been made as described in the immediately preceding paragraphs and the Company shall then have paid in full to the Depositary the redemption price (determined pursuant to the Certificate of Designation) of the Preference Shares deposited with the Depositary to be redeemed, the Depositary shall redeem the number of Depositary Shares representing such Preference Shares so called for redemption by the Company and on the redemption date (unless the Company shall have failed to pay for the Preference Shares to be redeemed by it as set forth in the Company&#8217;s notice provided for in the preceding paragraph), all dividends in respect of the Preference Shares called for redemption shall cease to accrue, the Depositary Shares called for redemption shall be deemed no longer to be outstanding and all rights of the holders of Receipts evidencing such Depositary Shares (except the right to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 7 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">receive the redemption price) shall, to the extent of such Depositary Shares, cease and terminate. Upon surrender in accordance with said notice of the Receipts evidencing such Depositary Shares (properly endorsed or assigned for transfer, if the Depositary shall so require), such Depositary Shares shall be redeemed at a cash redemption price per Depositary Share equal to 1&#47;1,000th of the redemption price per share paid in respect of the Preference Shares, plus an amount equal to the portion of the quarterly dividend attributable to the then-current Dividend Period, if any, to, but excluding, the redemption date, without accumulation of any undeclared dividends. The foregoing shall be further subject to the terms and conditions of the Certificate of Designation. In the event of any conflict between the provisions of the Deposit Agreement and the provisions of the Certificate of Designation, the provisions of the Certificate of Designation will govern and the Company will instruct the Depositary, as applicable, in writing accordingly of such governing terms&#59; provided, however, that under no circumstances will the Certificate of Designation be deemed to change or modify any of the rights, duties or immunities of the Depositary contained herein.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If fewer than all of the Depositary Shares evidenced by a Receipt are called for redemption, the Depositary will deliver to the holder of such Receipt upon its surrender to the Depositary, together with payment of the redemption price for and all other amounts payable in respect of the Depositary Shares called for redemption, a new Receipt evidencing the Depositary Shares evidenced by such prior Receipt and not called for redemption.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If less than all of the Preference Shares are redeemed pursuant to the Company&#8217;s exercise of its optional redemption right, the Depositary will select the Depositary Shares to be redeemed pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> on a pro rata basis, by lot or in such other manner as the Depositary may determine to be fair and equitable or as may be required by the principal national stock exchange on which the Depositary Shares are listed. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All funds received by Computershare under this Agreement that are to be distributed or applied by Computershare in the performance of services under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be held by Computershare as agent for the Company and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for the Company. Until paid pursuant to this Agreement, Computershare may hold or invest the Funds through such accounts in&#58; (i) obligations of, or guaranteed by, the United States of America, (ii) commercial paper obligations rated A-1 or P-1 or better by Standard &#38; Poor&#8217;s Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or Moody&#8217;s Investors Service, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), respectively, (iii) money market funds that comply with Rule 2a-7 of the Investment Company Act of 1940, or (iv) demand deposit accounts, short term certificates of deposit, bank repurchase agreements or bankers&#8217; acceptances, of commercial banks with Tier 1 capital exceeding $1 billion or with an average rating above investment grade by S&#38;P (LT Local Issuer Credit Rating), Moody&#8217;s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Company shall have no responsibility or liability for any diminution of the Funds that may result from any deposit or investment made by Computershare in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. Computershare shall have no responsibility or liability for any losses resulting from a default by any bank, financial institution or other third party. Computershare may from time to time receive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 8 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">interest, dividends or other earnings in connection with such deposits or investments. Computershare shall not be obligated to pay such interest, dividends or earnings to the Company, any holder or any other party.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Registration of Transfers of Receipts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company hereby appoints the Trust Company as the Registrar and Transfer Agent for the Receipts and the Trust Company hereby accepts such appointment and, as such, shall register on its books from time to time transfers of Receipts upon any surrender thereof by the holder in person or by a duly authorized attorney, agent or representative properly endorsed or accompanied by a properly executed instrument of transfer or endorsement and appropriate evidence of authority, which shall include a signature guarantee from an eligible guarantor institution participating in a signature guarantee program approved by the Securities Transfer Association, and any other reasonable evidence of authority that may be required by the Trust Company, together with evidence of the payment by the applicable party of any transfer taxes as may be required by law. Upon such surrender, the Trust Company shall execute a new Receipt or Receipts and deliver the same to or upon the order of the person entitled thereto evidencing the same aggregate number of Depositary Shares evidenced by the Receipt or Receipts surrendered.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Combinations and Split-ups of Receipts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Upon surrender of a Receipt or Receipts at the Depositary Office or such other office as the Depositary may designate for the purpose of effecting a split-up or combination of Receipts, subject to the terms and conditions of this Deposit Agreement, the Depositary shall execute and deliver a new Receipt or Receipts in the authorized denominations requested evidencing the same aggregate number of Depositary Shares evidenced by the Receipt or Receipts surrendered.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Surrender of Receipts and Withdrawal of Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any holder of a Receipt or Receipts may withdraw any number of whole shares of deposited Preference Shares represented by the Depositary Shares evidenced by such Receipt or Receipts and all money and other property, if any, represented by such Depositary Shares by surrendering such Receipt or Receipts to the Depositary Office or at such other office as the Depositary may designate for such withdrawals&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that a holder of a Receipt or Receipts may not withdraw such Preference Shares (or money and other property, if any, represented thereby) which has previously been called for redemption. Upon such surrender, upon payment of the fee of the Depositary for the surrender of Receipts to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and payment of all taxes and governmental charges in connection with such surrender and withdrawal of Preference Shares, and subject to the terms and conditions of this Deposit Agreement, without unreasonable delay, the Depositary shall deliver to such holder, or to the person or persons designated by such holder as hereinafter provided, the number of whole shares of such Preference Shares and all such money and other property, if any, represented by the Depositary Shares evidenced by the Receipt or Receipts so surrendered for withdrawal, but holders of such whole shares of Preference Shares will not thereafter be entitled to deposit such Preference Shares hereunder or to receive Depositary Shares therefor. If the Receipt or Receipts delivered by the holder to the Depositary in connection with such withdrawal shall evidence a number of Depositary Shares in excess of the number of Depositary Shares representing the number of whole shares of deposited Preference Shares to be withdrawn, the Depositary shall at </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 9 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the same time, in addition to such number of whole shares of Preference Shares and such money and other property, if any, to be withdrawn, deliver to such holder, or upon such holder&#8217;s order (subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), a new Receipt or Receipts evidencing such excess number of Depositary Shares. Delivery of such Preference Shares and such money and other property being withdrawn may be made by the delivery of such certificates, documents of title and other instruments as the Depositary may deem appropriate, which, if required by the Depositary, shall be properly endorsed or accompanied by proper instruments of transfer.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the deposited Preference Shares and the money and other property being withdrawn are to be delivered to a person or persons other than the record holder of the Receipt or Receipts being surrendered for withdrawal of Preference Shares, such holder shall execute and deliver to the Depositary a written order so directing the Depositary and the Depositary may require that the Receipt or Receipts surrendered by such holder for withdrawal of such Preference Shares be properly endorsed in blank or accompanied by a properly executed instrument of transfer or endorsement in blank.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary shall deliver the deposited Preference Shares and the money and other property, if any, represented by the Depositary Shares evidenced by Receipts surrendered for withdrawal at the Depositary Office, except that, at the request, risk and expense of the holder surrendering such Receipt or Receipts and for the account of the holder thereof, such delivery may be made at such other place as may be designated by such holder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Limitations on Execution and Delivery, Transfer, Split-up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As a condition precedent to the execution and delivery, transfer, split-up, combination, surrender or exchange of any Receipt, the Depositary, any of the Depositary&#8217;s Agents or the Company may require any or all of the following&#58; (i) payment to it of a sum sufficient for the payment (or, in the event that the Company shall have made such payment, the reimbursement to it) of any tax or other governmental charge and stock transfer or registration fee with respect thereto (including any such tax or charge with respect to the Preference Shares being deposited or withdrawn)&#59; (ii) the production of proof satisfactory to it as to the identity and genuineness of any signature (or the authority of any signature) including, as noted in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> above, a signature guarantee from an eligible guarantor institution participating in a signature guarantee program approved by the Securities Transfer Association, and any other reasonable evidence of authority that may be required by the Depositary&#59; and (iii) compliance with such regulations, if any, as the Depositary or the Company may establish consistent with the provisions of this Deposit Agreement as may be required by any securities exchange on which the deposited Preference Shares, the Depositary Shares or the Receipts may be included for quotation or listed.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The deposit of Preference Shares may be refused, the delivery of Receipts against Preference Shares may be suspended, the transfer of Receipts may be refused, and the transfer, split-up, combination, surrender, exchange or redemption of outstanding Receipts may be suspended (i) during any period when the register of shareholders of the Company is closed or (ii) if any such action is deemed reasonably necessary or advisable by the Depositary, any of the Depositary&#8217;s Agents or the Company at any time or from time to time because of any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 10 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">requirement of law or of any government or governmental body or commission, or under any other provision of this Deposit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Lost Receipts, etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> In case any Receipt shall be mutilated and surrendered to the Depositary or destroyed or lost or stolen, the Depositary shall execute and deliver a Receipt of like form and tenor in exchange and substitution for such mutilated Receipt or in lieu of and in substitution for such destroyed, lost or stolen Receipt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the holder thereof shall have (i) filed with the Depositary (a) a request for such execution and delivery before the Depositary has notice that the Receipt has been acquired by a protected purchaser and (b) an open penalty surety bond satisfactory to the Depositary, (ii) satisfied any other reasonable requirements imposed by the Depositary and (iii) complied with such other reasonable regulations and paid such other reasonable charges as the Depositary may prescribe and as required by Section 8-405 of the Uniform Commercial Code as in effect in the State of New York.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Cancellation and Destruction of Surrendered Receipts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All Receipts surrendered to the Depositary or any Depositary&#8217;s Agent shall be cancelled by the Depositary. Except as prohibited by applicable law or regulation, the Depositary is authorized, but not required, to destroy such Receipts so cancelled.</font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">No Pre-Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Depositary shall not deliver any deposited Preference Shares evidenced by Receipts prior to the receipt and cancellation of such Receipts or other similar method used with respect to Receipts held by DTC. The Depositary shall not issue any Receipts prior to the receipt by the Depositary of the corresponding Preference Shares evidenced by such Receipts. At no time will any Receipts be outstanding if such Receipts do not represent Preference Shares deposited with the Depositary.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE&#160;3</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTAIN OBLIGATIONS OF HOLDERS OF RECEIPTS AND THE COMPANY</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Filing Proofs, Certificates and Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any person presenting Preference Shares for deposit or any holder of a Receipt may be required from time to time to file with the Depositary such proof of residence, guarantee of signature or other information and to execute such certificates as the Depositary may reasonably deem necessary or proper or the Company may reasonably require by written request to the Depositary. The Depositary or the Company may withhold or delay the delivery of any Receipt, the transfer, redemption or exchange of any Receipt, the withdrawal of the deposited Preference Shares represented by the Depositary Shares evidenced by any Receipt, the distribution of any dividend or other distribution or the sale of any rights or of the proceeds thereof, until such proof or other information is filed, or such certificates are executed.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Payment of Fees and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Holders of Receipts shall be obligated to make payments to the Depositary of certain fees and expenses and taxes or other governmental charges to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, or provide evidence satisfactory to the Depositary that such fees and expenses and taxes or other governmental charges have been </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 11 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">paid. Until such payment is made, transfer of any Receipt or any withdrawal of the Preference Shares or money or other property, if any, represented by the Depositary Shares evidenced by such Receipt may be refused, any dividend or other distribution may be withheld, and any part or all of the Preference Shares or other property represented by the Depositary Shares evidenced by such Receipt may be sold for the account of the holder thereof (after attempting by reasonable means to notify such holder a reasonable number of days prior to such sale). Any dividend or other distribution so withheld and the proceeds of any such sale may be applied to any payment of such fees or expenses, the holder of such Receipt remaining liable for any deficiency.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;3.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties as to Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the case of the initial deposit of the Preference Shares hereunder, the Company represents and warrants that such Preference Shares and each certificate therefor are validly issued, fully paid and non-assessable. Such representations and warranties shall survive the deposit of the Preference Shares and the issuance of Receipts.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Representation and Warranty as to Receipts and Depositary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company hereby represents and warrants that the Receipts, when issued, will evidence legal and valid interests in the Depositary Shares and each Depositary Share will represent a legal and valid 1&#47;1,000th fractional interest in a deposited Preference Share represented by such Depositary Share. Such representation and warranty shall survive the deposit of the Preference Shares and the issuance of Receipts evidencing the Depositary Shares.</font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Taxes. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company will pay any and all stock transfer, documentary, stamp and similar taxes that may be payable in respect of any issuance or delivery of Depositary Shares or Preference Shares or other securities issued on account of Depositary Shares or certificates representing such shares or securities. The Company, however, will not be required to pay any such tax that may be payable in respect of any transfer involved in the issuance or delivery of Preference Shares, Depositary Shares or other securities in a name other than that in which the Depositary Shares with respect to which such shares or other securities are issued or delivered were registered, or in respect of any payment to any person other than a payment to the record holder thereof, and will not be required to make any such issuance, delivery or payment unless and until the person otherwise entitled to such issuance, delivery or payment has paid to the Company the amount of any such tax or has established, to the satisfaction of the Company, that such tax has been paid or is not payable.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE&#160;4</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THE PREFERENCE SHARES&#59; NOTICES</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Cash Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Whenever Computershare shall receive any cash dividend or other cash distribution on the deposited Preference Shares, including any cash received upon redemption of any Preference Shares pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Computershare shall, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, distribute to record holders of Receipts on the record date fixed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> such amounts of such sum as are, as nearly as practicable, in proportion to the respective numbers of Depositary Shares evidenced by the Receipts held by such holders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in case the Company or Computershare shall be required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 12 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by law to and shall withhold from any cash dividend or other cash distribution in respect of the Preference Shares represented by the Receipts held by any holder an amount on account of taxes or as otherwise required by law, regulation or court process, the amount made available for distribution or distributed in respect of Depositary Shares represented by such Receipts subject to such withholding shall be reduced accordingly. Computershare, however, shall distribute or make available for distribution, as the case may be, only such amount as can be distributed without attributing to any holder of Receipts a fraction of one cent. Any such fractional amounts shall be rounded down to the nearest whole cent and so distributed to record holders entitled thereto and any balance not so distributable shall be held by Computershare (without liability for interest thereon) and shall be added to and be treated as part of the next succeeding distribution to record holders of such Receipts. Each holder of a Receipt shall provide the Depositary with a properly completed Form W-8 (i.e., Form W-8BEN, Form W-8BEN-E, Form W-8EXP, Form W-8IMY, Form W-8ECI or another applicable Form W-8) or Form W-9 (which form shall set forth such holder&#8217;s certified taxpayer identification number if requested on such form), as may be applicable. Each holder of a Receipt acknowledges that in the event of non-compliance with the preceding sentence, the Internal Revenue Code of 1986, as amended, may require withholding by Computershare of a portion of any of the distribution to be made hereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Distributions Other Than Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Whenever the Depositary shall receive any distribution other than cash on the deposited Preference Shares, the Depositary shall, at the direction of the Company, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, distribute to record holders of Receipts on the record date fixed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> such amounts of the securities or property received by it as are, as nearly as practicable, in proportion to the respective numbers of Depositary Shares evidenced by the Receipts held by such holders, in any manner that the Depositary and the Company may deem equitable and practicable for accomplishing such distribution. If in the opinion of the Depositary such distribution cannot be made proportionately among such record holders, or if for any other reason (including any requirement that the Company or Computershare withhold an amount because of taxes) the Depositary deems, after consultation with the Company, such distribution not to be feasible, the Depositary may, with the approval of the Company, adopt such method as it deems equitable and practicable for the purpose of effecting such distribution, including the sale of the property thus received, or any part thereof, in a commercially reasonable manner. The net proceeds of any such sale shall, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> be distributed or made available for distribution, as the case may be, by Computershare to record holders of receipts as provided by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in the case of a distribution received by cash. The Depositary shall not make any distribution of securities to the holders of Receipts unless the Company shall have provided to the Depositary an opinion of counsel stating that such securities have been registered under the Securities Act or do not need to be registered.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Subscription Rights, Preferences or Privileges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Company shall at any time offer or cause to be offered to the persons in whose names deposited Preference Shares are registered on the books of the Company any rights, preferences or privileges to subscribe for or to purchase any securities or any rights, preferences or privileges of any other nature, such rights, preferences or privileges shall in each such instance be made available by the Depositary to the record holders of Receipts in such manner as the Company shall instruct (including by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 13 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">issue to such record holders of warrants representing such rights, preferences or privileges)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that (i) if at the time of issue or offer of any such rights, preferences or privileges the Company determines upon advice of its legal counsel that it is not lawful or feasible to make such rights, preferences or privileges available to the holders of Receipts (by the issue of warrants or otherwise) or (ii) if and to the extent instructed by holders of Receipts who do not desire to exercise such rights, preferences or privileges, the Depositary shall then, if so directed by the Company and provided with an opinion of counsel that if the Depositary undertakes such actions it will not be deemed an &#8220;issuer&#8221; under the Securities Act or an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended, and if applicable laws or the terms of such rights, preferences or privileges so permit, sell such rights, preferences or privileges of such holders at public or private sale, at such place or places and upon such terms as it may deem proper. The net proceeds of any such sale shall, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, be distributed by the Depositary to the record holders of Receipts entitled thereto as provided by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in the case of a distribution received in cash. The Depositary shall not make any distribution of such rights, preferences or privileges, unless the Company shall have provided to the Depositary an opinion of counsel stating that such rights, preferences or privileges have been registered under the Securities Act or do not need to be registered.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If registration under the Securities Act of the securities to which any rights, preferences or privileges relate is required in order for holders of Receipts to be offered or sold the securities to which such rights, preferences or privileges relate, the Company agrees that it will promptly notify the Depositary of such requirement, that it will promptly file a registration statement pursuant to the Securities Act with respect to such rights, preferences or privileges and securities and use its commercially reasonable efforts and take all steps available to it to cause such registration statement to become effective sufficiently in advance of the expiration of such rights, preferences or privileges to enable such holders to exercise such rights, preferences or privileges. In no event shall the Depositary make available to the holders of Receipts any right, preference or privilege to subscribe for or to purchase any securities unless and until such a registration statement shall have become effective or unless the offering and sale of such securities to such holders are exempt from registration under the provisions of the Securities Act and the Company shall have provided to the Depositary an opinion of counsel to such effect.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any other action under the law of any jurisdiction or any governmental or administrative authorization, consent or permit is required in order for such rights, preferences or privileges to be made available to holders of Receipts, the Company agrees that it will promptly notify the Depositary of such requirement and use its commercially reasonable efforts to take such action or obtain such authorization, consent or permit sufficiently in advance of the expiration of such rights, preferences or privileges to enable such holders to exercise such rights, preferences or privileges.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary will not be deemed to have any knowledge of any item for which it is supposed to receive notification under any section of this Deposit Agreement unless and until it has received such notification.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 14 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Notice of Dividends&#59; Fixing of Record Date for Holders of Receipts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Whenever any cash dividend or other cash distribution shall become payable, any distribution other than cash shall be made, or any rights, preferences or privileges shall at any time be offered, with respect to the deposited Preference Shares, or whenever the Depositary shall receive notice of (i) any meeting at which holders of such Preference Shares are entitled to vote or of which holders of such Preference Shares are entitled to notice or (ii) any election on the part of the Company to redeem any such Preference Shares, the Depositary shall in each such instance fix a record date (which shall be the same date as the record date fixed by the Company with respect to the Preference Shares) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">record date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) for the determination of the holders of Receipts who shall be entitled to receive such dividend, distribution, rights, preferences or privileges or the net proceeds of the sale thereof, to give instructions for the exercise of voting rights at any such meeting or to receive notice of such meeting or whose Depositary Shares are to be so redeemed.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Upon receipt of notice of any meeting at which the holders of deposited Preference Shares are entitled to vote, the Depositary shall, as soon as practicable thereafter, mail to the record holders of Receipts a notice, which shall be provided by the Company and which shall contain (i) such information as is contained in such notice of meeting, (ii) a statement that the holders of Receipts at the close of business on a specified record date fixed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> will be entitled, subject to any applicable provision of law, to instruct the Depositary as to the exercise of the voting rights pertaining to the amount of Preference Shares represented by their respective Depositary Shares and (iii) a brief statement as to the manner in which such instructions may be given. Upon the written request of a holder of a Receipt on such record date, the Depositary shall, insofar as practicable, vote or cause to be voted the amount of Preference Shares represented by the Depositary Shares evidenced by such Receipt in accordance with the instructions set forth in such request. To the extent any such instructions request the voting of a fractional interest of a deposited Preference Share, the Depositary shall aggregate such interest with all other fractional interests resulting from requests with the same voting instructions and shall vote the number of whole votes resulting from such aggregation in accordance with the instructions received in such requests. Each Preference Share is entitled to one vote and, accordingly, each Depositary Share is entitled to 1&#47;1,000th of a vote. The Company hereby agrees to take all reasonable action that may be deemed necessary by the Depositary in order to enable the Depositary to vote such Preference Shares or cause such Preference Shares to be voted. In the absence of specific instructions from the holder of a Receipt, the Depositary will refrain from voting any Preference Shares represented by the Depositary Shares evidenced by such Receipt.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Changes Affecting Preference Shares and Reclassifications, Recapitalizations, Etc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon any change in liquidation preference, par or stated value, split-up, combination or any other reclassification of the Preference Shares, or upon any recapitalization, reorganization, merger, amalgamation or consolidation to which the Company is a party or sale of all or substantially all of the Company&#8217;s assets, the Depositary shall, upon the written instructions of the Company setting forth any of the following adjustments, (i) reflect such adjustments in the Depositary&#8217;s books and records in (a) the fraction of an interest in a Preference Share represented by one Depositary Share and (b) the ratio of the redemption price </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 15 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">per Depositary Share to the redemption price of a Preference Share, as may be required by or as is consistent with the provisions of the Certificate of Designation to fully reflect the effects of such change in liquidation preference, par or stated value, split-up, combination or other reclassification of Preference Shares, of such recapitalization, reorganization, merger, amalgamation or consolidation or sale and (ii) treat any shares of stock or other securities or property (including cash) that shall be received by the Depositary in exchange for or in respect of the Preference Shares as new deposited property under this Deposit Agreement, and Receipts then outstanding shall thenceforth represent the proportionate interests of holders thereof in the new deposited property so received in exchange for or in respect of such Preference Shares. In any such case the Depositary may, upon the receipt of written request of the Company, execute and deliver additional Receipts, or may call for the surrender of all outstanding Receipts to be exchanged for new Receipts specifically describing such new deposited property.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Anything to the contrary herein notwithstanding, holders of Receipts shall have the right from and after the effective date of any such change in liquidation preference, par or stated value, split-up, combination or other reclassification of the Preference Shares for any such recapitalization, reorganization, merger, amalgamation or consolidation or sale to the extent that holders of Preference Shares had the right, prior to or as of the applicable effective date, to convert, exchange or surrender the Preference Share represented thereby only into or for, as the case may be, the kind and amount of shares of stock and other securities and property and cash into which such Preference Shares might have been exchanged or surrendered immediately prior to the effective date of such transaction.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Inspection of Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Depositary shall make available for inspection by holders of Receipts at the Depositary Office, and at such other places as it may from time to time deem advisable during normal business hours, any reports and communications received from the Company that are both received by the Depositary as the holder of deposited Preference Shares and made generally available to the holders of the Preference Shares. In addition, the Depositary shall transmit, upon written request by the Company, certain notices and reports to the holders of Receipts as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Lists of Receipt Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Promptly upon request from time to time by the Company, the Registrar shall furnish to the Company a list, as of a recent date specified by the Company, of the names, addresses and holdings of Depositary Shares of all persons in whose names Receipts are registered on the books of the Registrar.</font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;4.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of this Deposit Agreement, in the event that the Depositary determines that any distribution in property is subject to any tax or other governmental charge which the Depositary is obligated by law to withhold, the Depositary may dispose of, by public or private sale, all or a portion of such property in such amounts and in such manner as the Depositary deems necessary and practicable to pay such taxes, and the Depositary shall distribute the net proceeds of any such sale or the balance of any such property after deduction of such taxes to the holders of Receipts entitled thereto in proportion to the number of Depositary Shares held by them, respectively&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the event the Depositary determines that such distribution of property is subject </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 16 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to withholding tax only with respect to some but not all holders of Receipts, the Depositary will use its best efforts (i) to sell only that portion of such property distributable to such holders that is required to generate sufficient proceeds to pay such withholding tax and (ii) to effect any such sale in such a manner so as to avoid affecting the rights of any other holders of Receipts to receive such distribution in property.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE&#160;5</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THE DEPOSITARY, THE DEPOSITARY&#8217;S AGENTS, THE REGISTRAR AND THE COMPANY</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;5.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Maintenance of Offices, Agencies and Transfer Books by the Depositary and the Registrar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Depositary shall maintain at the Depositary Office facilities for the execution and delivery, transfer, surrender and exchange, split-up, combination and redemption of Receipts and deposit and withdrawal of Preference Shares and at the offices of the Depositary&#8217;s Agents, if any, facilities for the delivery, transfer, surrender and exchange, split-up, combination and redemption of Receipts and deposit and withdrawal of Preference Shares, all in accordance with the provisions of this Deposit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Registrar shall keep books at the Depositary Office for the registration and transfer of Receipts, which books at all reasonable times during normal business hours shall be open for inspection by the record holders of Receipts as provided by applicable law. The Company may cause the Registrar to close such books, at any time or from time to time, when deemed expedient by it in connection with the performance of its duties hereunder and the Registrar may close such books because of any requirement of law or any government, governmental body or commission, stock exchange or any applicable self-regulatory body.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Receipts or the Depositary Shares evidenced thereby or the Preference Shares represented by such Depositary Shares shall be listed on the New York Stock Exchange or any other stock exchange, the Depositary may, with the written approval of the Company, appoint a registrar (acceptable to the Company) for registration of such Receipts or Depositary Shares in accordance with the requirements of such exchange. Such registrar (which may be the Registrar if so permitted by the requirements of such exchange) may be removed and a substitute registrar appointed by the Registrar upon the request or with the written approval of the Company. If the Receipts, such Depositary Shares or such Preference Shares are listed on one or more other stock exchanges, the Registrar will, at the request and expense of the Company, arrange such facilities for the delivery, transfer, surrender, redemption and exchange of such Receipts, such Depositary Shares or such Preference Shares as may be required by law or applicable stock exchange regulations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;5.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Prevention or Delay in Performance by the Depositary, the Depositary&#8217;s Agents, the Registrar or the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. None of the Depositary, any Depositary&#8217;s Agent, any Registrar, any Transfer Agent, or the Company shall incur any liability to any holder of any Receipt, if by reason of any provision of any present or future law or regulation thereunder of the United States of America or of any other governmental authority or, in the case of the Depositary, the Depositary&#8217;s Agent or the Registrar or Transfer Agent, by reason of any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 17 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provision, present or future, of the Certificate of Designation or, in the case of the Company, the Depositary, the Depositary&#8217;s Agent, the Transfer Agent or the Registrar, by reason of any act of God or war or other circumstance beyond the control of the relevant party, the Depositary, any Depositary&#8217;s Agent, the Transfer Agent, the Registrar or the Company shall be prevented or forbidden from doing or performing any act or thing that the terms of this Deposit Agreement provide shall be done or performed&#59; nor shall the Depositary, any Depositary&#8217;s Agent, the Transfer Agent, any Registrar or the Company incur any liability to any holder of a Receipt (or any beneficial owner thereof) by reason of any non-performance or delay, caused as aforesaid, in the performance of any act or thing that the terms of this Deposit Agreement provide shall or may be done or performed, or by reason of any exercise of, or failure to exercise, any discretion provided for in this Deposit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Obligations of the Depositary, the Depositary&#8217;s Agents, the Registrar and the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company does not assume any obligation and shall not be subject to any liability under this Deposit Agreement or any Receipt to holders of Receipts other than from acts or omissions arising out of conduct constituting bad faith, gross negligence or willful misconduct in the performance of such duties as are specifically set forth in this Deposit Agreement (which bad faith, gross negligence or willful misconduct must be determined by a final, non-appealable order, judgment, decree or ruling of a court of competent jurisdiction). Neither the Depositary nor any Depositary&#8217;s Agent nor any Transfer Agent or Registrar assumes any obligation and shall not be subject to any liability under this Deposit Agreement to holders of Receipts, the Company or any other person or entity other than for its bad faith, gross negligence or willful misconduct (which bad faith, gross negligence or willful misconduct must be determined by a final, non-appealable order, judgment, decree or ruling of a court of competent jurisdiction). Notwithstanding anything to the contrary contained herein, neither the Depositary, nor any Depositary&#8217;s Agent nor any Transfer Agent or Registrar shall be liable for any special, indirect, incidental, consequential, punitive or exemplary damages, including but not limited to, lost profits, even if such person or entity alleged to be liable has knowledge of the possibility of such damages. Notwithstanding anything contained herein to the contrary, the Depositary&#8217;s aggregate liability during any term of this Agreement with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under this Agreement, whether in contract, or in tort, or otherwise, is limited to, and shall not exceed, the amounts paid hereunder by the Company to Depositary as fees and charges, but not including reimbursable expenses.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">None of the Depositary, any Depositary&#8217;s Agent, any Registrar or Transfer Agent or the Company shall be under any obligation to appear in, prosecute or defend any action, suit or other proceeding with respect to the deposited Preference Shares, Depositary Shares or Receipts that in its opinion may involve it in expense or liability, unless indemnity satisfactory to it against all expense and liability be furnished as often as may be required.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">None of the Depositary, any Depositary&#8217;s Agent, any Registrar or Transfer Agent or the Company shall be liable for any action or any failure to act by it in reliance upon the advice of legal counsel or accountants, or information provided by any person presenting Preference Shares for deposit or any holder of a Receipt. The Depositary, any Depositary&#8217;s Agent, any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 18 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Registrar, any Transfer Agent and the Company may each rely and shall each be protected in acting upon any written notice, request, direction or other document believed by it to be genuine and to have been signed or presented by the proper party or parties.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event the Depositary, any Depositary&#8217;s Agent, any Registrar or Transfer Agent shall receive conflicting claims, requests or instructions from any holders of Receipts, on the one hand, and the Company, on the other hand, the Depositary, any Depositary&#8217;s Agent, any Registrar or Transfer Agent, as applicable, shall be entitled to act on such claims, requests or instructions received from the Company, and shall incur no liability and shall be entitled to the full indemnification set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in connection with any action so taken.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary shall not be responsible for any failure to carry out any instruction to vote any of the deposited Preference Shares or for the manner or effect of any such vote made, as long as any such action or non-action does not result from bad faith, gross negligence or willful misconduct of the Depositary (which bad faith, gross negligence or willful misconduct must be determined by a final, non-appealable order, judgment, decree or ruling of a court of competent jurisdiction). The Depositary undertakes, and any Registrar or Transfer Agent shall be required to undertake, to perform such duties and only such duties as are specifically set forth in this Deposit Agreement, and no implied covenants or obligations shall be read into this Agreement against the Depositary or any Registrar or Transfer Agent.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary, its parent, affiliate, or subsidiaries, any Depositary&#8217;s Agent, and any Registrar or Transfer Agent may own, buy, sell or deal in any class of securities of the Company and its affiliates and in Receipts or Depositary Shares or become pecuniarily interested in any transaction in which the Company or its affiliates may be interested or contract with or lend money to or otherwise act as fully or as freely as if it were not the Depositary or the Depositary&#8217;s Agent hereunder. The Depositary may also act as transfer agent or registrar of any of the securities of the Company and its affiliates or act in any other capacity for the Company or its affiliates.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">It is intended that neither the Depositary nor any Depositary&#8217;s Agent shall be deemed to be an &#8220;issuer&#8221; of the securities under the federal securities laws or applicable state securities laws, it being expressly understood and agreed that the Depositary and any Depositary&#8217;s Agent are acting only in a ministerial capacity as Depositary for the deposited Preference Shares&#59; provided, however, that the Depositary agrees to comply with all information reporting and withholding requirements applicable to it under law or this Deposit Agreement in its capacity as Depositary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the Depositary (or its officers, directors, employees, agents or affiliates) nor any Depositary&#8217;s Agent makes any representation or has any responsibility as to the validity of the registration statement pursuant to which the Depositary Shares are registered under the Securities Act, the deposited Preference Shares, the Depositary Shares, the Receipts (except its countersignature thereon) or any instruments referred to therein or herein, or as to the correctness of any statement made therein or herein&#59; provided, however, that the Depositary is responsible for its representations in this Deposit Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 19 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company agrees that it will register the deposited Preference Shares and the Depositary Shares in accordance with the applicable securities laws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event the Depositary, the Depositary&#8217;s Agent or any Registrar or Transfer Agent believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request or other communication, paper or document received by it pursuant to this Deposit Agreement, the Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar shall promptly notify the Company of the details of such alleged ambiguity or uncertainty, and may, in its sole discretion, refrain from taking any action, and the Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar shall be fully protected and shall incur no liability to any person from refraining from taking such action, absent bad faith, gross negligence or willful misconduct (which bad faith, gross negligence or willful misconduct must be determined by a final, non-appealable order, judgment, decree or ruling of a court of competent jurisdiction), unless and until (i) the rights of all parties have been fully and finally adjudicated by a court of appropriate jurisdiction or (ii) the Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar receives written instructions with respect to such matter signed by the Company that eliminates such ambiguity or uncertainty to the satisfaction of the Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Whenever in the performance of its duties under this Deposit Agreement, the Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking, suffering or omitting to take any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively provided and established by a certificate signed by any one of the Chief Executive Officer, Chief Financial Officer, General Counsel, Chief Accounting Officer or Secretary of the Company and delivered to the Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar&#59; and such certificate shall be full and complete authorization and protection to the Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar and the Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar shall incur no liability for or in respect of any action taken, suffered or omitted by it under the provisions of this Deposit Agreement in reliance upon such certificate. The Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar shall not be liable for or by reason of any of the statements of fact or recitals contained in this Deposit Agreement or in the Receipts (except its countersignature thereof) or be required to verify the same, and all such statements and recitals are and shall be deemed to have been made by the Company only.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary, the Depositary&#8217;s Agent, Transfer Agent or Registrar will not be under any duty or responsibility to ensure compliance with any applicable federal or state securities laws in connection with the issuance, transfer or exchange of the Receipts, Preference Shares or Depositary Shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything herein to the contrary, no amendment to the Certificate of Designation shall affect the rights, duties, obligations or immunities of the Depositary, Transfer Agent, the Depositary&#8217;s Agent or Registrar hereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 20 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary, any Depositary&#8217;s Agent, Transfer Agent and any Registrar hereunder&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have no duties or obligations other than those specifically set forth herein (and no implied duties or obligations), or as may subsequently be agreed to in writing by the parties&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have no obligation to make payment hereunder unless the Company shall have provided the necessary federal or other immediately available funds or securities or property, as the case may be, to pay in full amounts due and payable with respect thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall not be obligated to take any legal or other action hereunder&#59; if, however, it determines to take any legal or other action hereunder, and, where the taking of such action might in its judgment subject or expose it to any expense or liability, it shall not be required to act unless it shall have been furnished with an indemnity satisfactory to it&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">may rely on and shall be authorized and protected in acting or failing to act upon any certificate, instrument, opinion, notice, letter, facsimile transmission or other document or security delivered to it and believed by it to be genuine and to have been signed by the proper party or parties, and shall have no responsibility for determining the accuracy thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">may rely on and shall be authorized and protected in acting or failing to act upon the written, telephonic, electronic and oral instructions given in accordance with this Deposit Agreement, with respect to any matter relating to its actions as Depositary, Transfer Agent or Registrar covered by this Deposit Agreement (or supplementing or qualifying any such actions) of officers of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">may consult counsel satisfactory to it, and the advice of such counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted to be taken by it hereunder in accordance with the advice of such counsel&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall not be called upon at any time to advise any person with respect to the Preference Shares, Depositary Shares or Receipts&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall not be liable or responsible for any recital or statement contained in any documents relating hereto or the Preference Shares, Depositary Shares or Receipts&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall not be liable in any respect on account of the identity, authority or rights of the parties (other than with respect to the Depositary) executing or delivering or purporting to execute or deliver this Deposit Agreement or any documents or papers deposited or called for under this Deposit Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 21 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The obligations of the Company and the rights of the Depositary, the Depositary&#8217;s Agent, Transfer Agent and Registrar set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall survive the replacement, removal or resignation of the Depositary, any Registrar, Transfer Agent or Depositary&#8217;s Agent or termination of this Deposit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;5.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Resignation and Removal of the Depositary&#59; Appointment of Successor Depositary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Depositary may at any time resign as Depositary hereunder by notice of its election to do so delivered to the Company, such resignation to take effect upon the appointment of a successor depositary and its acceptance of such appointment as hereinafter provided.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary may at any time be removed by the Company by notice of such removal delivered to the Depositary, such removal to take effect upon the appointment of a successor depositary and its acceptance of such appointment as hereinafter provided. Upon any such removal or appointment, the Company shall send notice thereof by first-class mail, postage prepaid, to the holders of Receipts.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In case at any time the Depositary acting hereunder shall resign or be removed, the Company shall, within 60 days after the delivery of the notice of resignation or removal, as the case may be, appoint a successor depositary, which shall be (i) a bank or trust company having its principal office in the United States of America and having a combined capital and surplus, together with its affiliates, of at least $50,000,000 or (ii) an affiliate of a person specified in clause (i). If a successor depositary shall not have been appointed and have accepted appointment in 60 days, the resigning Depositary may petition a court of competent jurisdiction to appoint a successor depositary. Every successor depositary shall execute and deliver to its predecessor and to the Company an instrument in writing accepting its appointment hereunder, and thereupon such successor depositary, without any further act or deed, shall become fully vested with all the rights, powers, duties and obligations of its predecessor and for all purposes shall be the Depositary under this Deposit Agreement, and such predecessor, upon payment of all sums due it and on the written request of the Company, shall promptly execute and deliver an instrument transferring to such successor all rights and powers of such predecessor hereunder, shall duly assign, transfer and deliver all rights, title and interest in the deposited Preference Shares and any moneys or property held hereunder to such successor and shall deliver to such successor a list of the record holders of all outstanding Receipts.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any corporation or other entity into or with which the Depositary may be merged, consolidated or converted, or any corporation or other entity to which all or a substantial part of the assets of the Depositary may be transferred, shall be the successor of such Depositary without the execution or filing of any document or any further act. Such successor depositary may execute the Receipts either in the name of the predecessor depositary or in the name of the successor depositary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as they apply to the Depositary apply to the Registrar and Transfer Agent, as if specifically enumerated herein.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;5.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Notices, Reports and Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company agrees that it will deliver to the Depositary, and the Depositary, if requested in writing by the Company, will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 22 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">promptly after receipt of such notice, transmit to the record holders of Receipts, in each case at the address recorded in the Depositary&#8217;s books, copies of all notices and reports generally made available by the Company to holders of the Preference Shares and not otherwise made publicly available. Such transmission will be at the Company&#8217;s expense and the Company will provide the Depositary with such number of copies of such documents as the Depositary may reasonably request. In addition, the Depositary will transmit to the record holders of Receipts at the Company&#8217;s expense such other documents as may be requested by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;5.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Indemnification by the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall indemnify the Depositary, any Depositary&#8217;s Agent and any Transfer Agent or Registrar against, and hold each of them harmless from, any loss, liability, damage, cost or expense (including the costs and expenses of defending itself) which may arise out of (i) acts performed, suffered or omitted to be taken in connection with this Deposit Agreement and the Receipts (a) by the Depositary, any Transfer Agent or Registrar or any of their respective agents (including any Depositary&#8217;s Agent), except for any liability arising out of bad faith, gross negligence or willful misconduct (which bad faith, gross negligence or willful misconduct must be determined by a final, non-appealable order, judgment, decree or ruling of a court of competent jurisdiction) on the respective parts of any such person or persons, or (b) by the Company or any of its agents, or (ii) the offer, sale or registration of the Receipts or Preference Shares pursuant to the provisions hereof. The obligations of the Company and the rights of the Depositary, Registrar, Transfer Agent and Depositary&#8217;s Agent set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall survive the replacement, removal or resignation of any Depositary, Registrar, Transfer Agent or Depositary&#8217;s Agent or termination of this Deposit Agreement. In no event shall the Depositary have any right of set off or counterclaim against the Depositary Shares or the Preference Shares.</font></div><div style="margin-bottom:30pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;5.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Fees, Charges and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No charges and expenses of the Depositary or any Depositary&#8217;s Agent hereunder shall be payable by any person, except as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall pay all transfer and other taxes, assessments and governmental charges arising solely from the existence of the depositary arrangements. The Company shall also pay all fees and expenses of the Depositary in connection with the initial deposit of the Preference Shares and the initial issuance of the Depositary Shares evidenced by the Receipts, any redemption of the Preference Shares at the option of the Company and all withdrawals of the Preference Shares by holders of Receipts. All other fees and expenses of the Depositary and any Depositary&#8217;s Agent hereunder and of any Registrar or Transfer Agent (including, in each case, fees and expenses of counsel) incurred in the preparation, delivery, amendment, administration and execution of this Deposit Agreement and incident to the performance of their respective obligations hereunder will be paid by the Company as previously agreed between the Depositary and the Company. The Depositary (and if applicable, the Transfer Agent and Registrar) shall present its statement for fees and expenses to the Company once every three months or at such other intervals as the Company and the Depositary may agree.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 23 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;5.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Tax Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary, on its own behalf and on behalf of the Company, will comply with all applicable certification, information reporting and withholding (including &#8220;backup&#8221; withholding) requirements imposed by applicable tax laws, regulations or administrative practice with respect to (i) any payments made with respect to the Depositary Shares or (ii) the issuance, delivery, holding, transfer, redemption or exercise of rights under the Receipts or the Depositary Shares. Such compliance shall include, without limitation, the preparation and timely filing of required returns and the timely payment of all amounts required to be withheld to the appropriate taxing authority or its designated agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary shall comply with any direction received from the Company with respect to the application of such requirements to particular payments or holders or in other particular circumstances, and may for purposes of this Deposit Agreement rely on any such direction in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof.</font></div><div style="margin-bottom:30pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Depositary shall maintain all appropriate records documenting compliance with such requirements and shall make such records available on request to the Company or to its authorized representatives.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE&#160;6</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDMENT AND TERMINATION</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;6.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The form of the Receipts and any provision of this Deposit Agreement may at any time and from time to time be amended by agreement between the Company and the Depositary without the consent of holders of Receipts in any respect that the Company and the Depositary may deem necessary or desirable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no such amendment (other than any change in the fees of any Depositary, Registrar or Transfer Agent that are payable by the Company) that (i) shall materially and adversely alter the rights of the holders of Receipts or (ii) would be materially and adversely inconsistent with the rights granted to the holders of the Preference Shares pursuant to the Certificate of Designation shall be effective unless such amendment has been approved by the record holders of at least the number of Depositary Shares then outstanding necessary to approve any amendment that would materially and adversely affect the rights of the holders of the Preference Shares. In no event shall any amendment impair the right, subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">2.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Article&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, of any holder of any Receipts evidencing such Depositary Shares to surrender any Receipt with instructions to the Depositary to deliver to the holder the deposited Preference Shares and all money and other property, if any, represented thereby, except in order to comply with mandatory provisions of applicable law. Every holder of an outstanding Receipt at the time any such amendment becomes effective shall be deemed, by continuing to hold such Receipt, to consent and agree to such amendment and to be bound by this Deposit Agreement as amended thereby. As a condition precedent to the Depositary&#8217;s execution of any amendment, the Company shall deliver to the Depositary a certificate from a duly authorized officer of the Company that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 24 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">states that the proposed amendment is in compliance with the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary contained herein, the Depositary may, but shall not be obligated to, enter into any amendment that adversely affects its own rights, duties, obligations, responsibilities, liabilities and indemnities hereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;6.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Deposit Agreement may be terminated by the Company upon not less than 30 days&#8217; prior written notice to the Depositary if the holders of Receipts evidencing a majority of the Depositary Shares then outstanding consent to such termination, whereupon the Depositary shall deliver or make available to each holder of a Receipt, upon surrender of the Receipt held by such holder, such number of whole or fractional shares of deposited Preference Shares as are represented by the Depositary Shares evidenced by such Receipt, together with any other property held by the Depositary in respect of such Receipt. This Deposit Agreement will automatically terminate if (i) all outstanding Depositary Shares shall have been redeemed in accordance with the provisions hereof or (ii) there shall have been made a final distribution in respect of the deposited Preference Shares in connection with any liquidation, dissolution or winding-up of the Company and such distribution shall have been distributed to the holders of Receipts entitled thereto.</font></div><div style="margin-bottom:30pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon the termination of this Deposit Agreement, the Company shall be discharged from all obligations under this Deposit Agreement except for its obligations to the Depositary, any Depositary&#8217;s Agent and any Transfer Agent or Registrar under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections&#160;5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE&#160;7</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Deposit Agreement may be executed in any number of counterparts, and by each of the parties hereto on separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed an original, but all such counterparts taken together shall constitute one and the same instrument. Delivery of an executed counterpart of a signature page to this Deposit Agreement by facsimile, PDF or other secure electronic means shall be effective as delivery of a manually executed counterpart of this Deposit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Exclusive Benefits of Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Deposit Agreement is for the exclusive benefit of the parties hereto, and their respective successors hereunder, and shall not be deemed to give any legal or equitable right, remedy or claim to any other person whatsoever.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Invalidity of Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In case any one or more of the provisions contained in this Deposit Agreement or in the Receipts should be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein or therein shall in no way be affected, prejudiced or disturbed thereby&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if such provision affects the rights, duties, liabilities or obligations of the Depositary, the Depositary shall be entitled to resign immediately.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 25 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any and all notices to be given to the Company hereunder or under the Receipts shall be in writing and shall be deemed to have been duly given if personally delivered or sent by mail, overnight delivery service or by facsimile transmission confirmed by letter, addressed to the Company at&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.634%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Aspen Insurance Holdings Limited </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">141 Front Street</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Hamilton HM 19</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Bermuda </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Silvia Martinez, General Counsel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Telephone&#58; (441) 295-8201</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facsimile&#58; (441) 295-1829 </font></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or at any other address of which the Company shall have notified the Depositary in writing.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any notices to be given to the Depositary, Transfer Agent or Registrar hereunder or under the Receipts shall be in writing and shall be deemed to have been duly given if personally delivered or sent by mail, overnight delivery service, or facsimile transmission confirmed by letter, addressed to the Depositary&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.634%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Computershare Trust Company, N.A.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Computershare Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">150 Royall Street</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Canton, Massachusetts 02021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; General Counsel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facsimile&#58; 781-575-4210</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any notices given to any record holder of a Receipt hereunder or under the Receipts shall be in writing and shall be deemed to have been duly given if transmitted through the facilities of DTC in accordance with DTC&#8217;s procedures or personally delivered or sent by mail, recognized next-day courier service or telecopier confirmed by letter, addressed to such record holder at the address of such record holder as it appears on the books of the Depositary&#59; provided, that any record holder may direct the Depositary to deliver notices to such record holder at an alternate address or in a specific manner that is reasonably requested by such record holder in a written request timely filed with the Depositary and that is reasonably acceptable to the Depositary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Delivery of a notice sent by mail shall be deemed to be effected at the time when a duly addressed letter containing the same (or a confirmation thereof in the case of a facsimile message) is deposited, postage prepaid, in a post office letter box, or in the case of a next-day courier service, when deposited with such courier, courier fees prepaid. The Depositary or the Company may, however, act upon any facsimile message received by it from the other or from any holder of a Receipt, notwithstanding that such facsimile message shall not subsequently be confirmed by letter as aforesaid.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 26 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Depositary&#8217;s Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Depositary may from time to time appoint Depositary&#8217;s Agents to act in any respect for the Depositary for the purposes of this Deposit Agreement and may at any time appoint additional Depositary&#8217;s Agents and vary or terminate the appointment of such Depositary&#8217;s Agents. The Depositary will notify the Company of any such action.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Holders of Receipts Are Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The holders of Receipts from time to time shall be deemed to be parties to this Deposit Agreement and shall be bound by all of the terms and conditions hereof and of the Receipts by acceptance of delivery thereof to the same extent as though such person executed this Deposit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Deposit Agreement and the Receipts and all rights hereunder and thereunder and provisions hereof and thereof shall be governed by, and construed in accordance with, the law of the State of New York applicable to agreements made and to be performed in said State, without regard to conflicts of laws principles that would result in the application of the law of any state other than the State of New York.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Inspection of Deposit Agreement and Certificate of Designation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Copies of this Deposit Agreement and the Certificate of Designation shall be filed with the Depositary and the Depositary&#8217;s Agents and shall be open to inspection during business hours at the Depositary Office by any holder of any Receipt.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The headings of articles and sections in this Deposit Agreement and in the form of the Receipt set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto have been inserted for convenience only and are not to be regarded as a part of this Deposit Agreement or to have any bearing upon the meaning or interpretation of any provision contained herein or in the Receipts.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Depositary and the Company agree that all books, records, information and data pertaining to the business of the other party, including, inter alia, personal, non-public holder information, which are exchanged or received pursuant to the negotiation or the carrying out of this Deposit Agreement, shall remain confidential, and shall not be voluntarily disclosed to any other person, except as may be required by law or legal process.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION&#160;7.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. From time-to-time and after the date hereof, the Company agrees that it will perform, acknowledge and deliver or cause to be performed, acknowledged and delivered all such further and other acts, documents, instruments and assurances as may be reasonably required by the Depositary for the carrying out or performing by the Depositary of the provisions of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 27 -</font></div></div></div><div id="i8397e381e0744e94b2ebcd2ab14478b4_185"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Aspen Insurance Holdings Limited and Computershare Inc. and Computershare Trust Company, N.A. have duly executed this Deposit Agreement as of the day and year first set forth above and all holders of Receipts shall become parties hereto by and upon acceptance by them of delivery of Receipts issued in accordance with the terms hereof.</font></div><div style="margin-bottom:24pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:251.25pt"><tr><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:4.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:112.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47;Scott Kirk</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Scott Kirk</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Group Chief Finance Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">COMPUTERSHARE TRUST COMPANY, N.A.,<br>and COMPUTERSHARE INC., as Depositary</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Constance Adams</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Constance Adams</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Relationship Manager</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Deposit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="i8397e381e0744e94b2ebcd2ab14478b4_158"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-bottom:15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Form of Face of Receipt&#59; Form of Reverse of Receipt</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:140%">UNLESS THIS RECEIPT IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), NEW YORK, NEW YORK, TO ASPEN INSURANCE HOLDINGS LIMITED OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY RECEIPT ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &#38; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &#38; CO., HAS AN INTEREST HEREIN.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:140%">TRANSFERS OF THIS GLOBAL RECEIPT SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL RECEIPT SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE DEPOSIT AGREEMENT REFERRED TO BELOW.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:140%">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS.</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificate Number&#58; 1 </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of Depositary Shares&#58; 10,000,000</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CUSIP NO.&#58; G05384204</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">RECEIPT FOR DEPOSITARY SHARES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Each Representing a 1&#47;1,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:174%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%"> Interest in a Share of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">5.625% Perpetual Non-Cumulative Preference Shares</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">(par value $0.0015144558 per share) </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">(liquidation preference $25,000 per share (equivalent to $25 per Depositary Share))</font></div><div style="margin-bottom:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Computershare Inc., a Delaware corporation (&#8220;Computershare&#8221;), and its wholly-owned subsidiary Computershare Trust Company, N.A., a federally chartered national association (the &#8220;Trust Company&#8221; and jointly with Computershare, the &#8220;Depositary&#8221;), hereby certify that CEDE &#38; CO. is the registered owner of ten million (10,000,000) depositary shares ($250,000,000 aggregate liquidation preference) (&#8220;Depositary Shares&#8221;), each Depositary Share representing a 1&#47;1,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%"> interest in a share of 5.625% Perpetual Non-Cumulative Preference Shares, $0.0015144558 par value per share and liquidation preference of $25,000 per share (equivalent to $25.00 per Depositary Share) of Aspen Insurance Holdings Limited, a Bermuda exempted company (the &#8220;Company&#8221;), on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">deposit with the Depositary, subject to the terms and entitled to the benefits of the Deposit Agreement, dated August 13, 2019 (the &#8220;Deposit Agreement&#8221;), among the Company, the Depositary, the Trust Company, as Registrar and Transfer Agent (each term as defined in the Deposit Agreement), and Computershare, as Dividend Disbursing Agent and Redemption Agent (each term as defined in the Deposit Agreement) and the holders from time to time of Receipts for Depositary Shares. By accepting this Receipt, the holder hereof becomes a party to and agrees to be bound by all the terms and conditions of the Deposit Agreement. This Receipt shall not be valid or obligatory for any purpose or entitled to any benefits under the Deposit Agreement unless it shall have been executed by the Depositary by the manual or facsimile signature of a duly authorized officer or, if a Registrar in respect of the Receipts (other than the Depositary) shall have been appointed, by the manual signature of a duly authorized officer of such Registrar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.</font></div><div style="margin-bottom:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; August 13, 2019</font></div><div style="margin-bottom:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.923%"><tr><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computershare Inc. and Computershare Trust Company, N.A., as Depositary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;FORM OF REVERSE OF RECEIPT&#93;</font></div><div style="margin-bottom:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following abbreviations when used in the instructions on the face of this receipt shall be construed as though they were written out in full according to applicable laws or regulations.</font></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:6.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:160.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:87.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:45.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEN COM - as tenant in common</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNIF GIFT MIN ACT - </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Custodian</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Cust) (Minor)</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEN ENT - as tenants by the entireties</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Uniform Gifts to Minors Act</font></td></tr><tr style="height:19pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JT TEN - as joint tenants with right of survivorship and not as tenants in common</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional abbreviations may also be used though not in the above list.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 29 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ASSIGNMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For value received, ________________________ hereby sell(s), assign(s) and transfer(s) unto</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PLEASE INSERT SOCIAL SECURITY OR </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OTHER IDENTIFYING NUMBER OF ASSIGNEE, AS APPLICABLE </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCLUDING POSTAL ZIP CODE OF ASSIGNEE</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________ Depositary Shares represented by the within Receipt, and do hereby irrevocably constitute and appoint</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________ Attorney to transfer the said Depositary Shares on the books of the within named Depositary with full power of substitution in the premises.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOTICE&#58; The signature to the assignment must correspond with the name as written upon the face of this Receipt in every particular, without alteration or enlargement or any change whatever.</font></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE GUARANTEED</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">NOTICE&#58; The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations, and credit unions with membership in an approved signature guarantee medallion program), pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 30 -</font></div></div></div><div id="i8397e381e0744e94b2ebcd2ab14478b4_137"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT&#160;B</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certificate of Designation</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATE OF DESIGNATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.625% PERPETUAL NON-CUMULATIVE PREFERENCE SHARES</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda company (the &#8220;Company&#8221;), HEREBY CERTIFIES that pursuant to resolutions of duly authorized Directors adopted on May 29, 2019, the creation of the 5.625% Perpetual Non-Cumulative Preference Shares, with a liquidation preference of $25,000 per share (the &#8220;Preference Shares&#8221;) were authorized and the designations, preferences and privileges, voting rights, relative, participating, optional and other special rights, and qualifications, limitations and restrictions of the Preference Shares, in addition to those set forth in the Memorandum of Association and Bye-Laws of the Company, were fixed as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Designation&#59; Amount of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The designation of this series of Preference Shares shall be &#8220;5.625% Perpetual Non-Cumulative Preference Shares,&#8221; and the number of shares constituting this series shall be 10,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, if the Company elects to issue additional Preference Shares after the date of this Certificate of Designation, any such additional shares are not treated as &#8220;disqualified preferred stock&#8221; within the meaning of Section 1059(f)(2) of the United States Internal Revenue Code of 1986, as amended, and such additional shares are otherwise treated as fungible with the Preference Shares for United States federal income tax purposes. The additional shares would form a single series with the Preference Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Preference Shares shall have a liquidation preference of $25,000 per Preference Share (the &#8220;Liquidation Preference&#8221;). Each Preference Share shall be identical in all respects to every other Preference Share, except for the issue price, date of issuance and, in some cases, the initial Dividend Payment Date (as defined in Section 4(a)). Any Preference Shares retired by purchase or redemption, or otherwise acquired by the Company, will have the status of authorized but unissued Preference Shares and may be reissued as part of the same class or series or may be reclassified and reissued by the Board of Directors in the same manner as any other authorized and unissued shares. The number of authorized Preference Shares may be reduced (but not below the number of Preference Shares then in issue) by further resolution duly adopted by the Board of Directors. No such reduction shall affect the due authorization of any Preference Shares in issue.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 31 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As used herein with respect to the Preference Shares&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#8220;5.625% Perpetual Preference Shares&#8221; means the 5.625% Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162; per share, of the Company designated as the 5.625% Perpetual Non-Cumulative Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#8220;5.95% Perpetual Preference Shares&#8221; means the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, par value 0.15144558&#162; per share, of the Company designated as the 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;&#8220;Additional Amounts&#8221; has the meaning assigned to such term in Section 5(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#8220;Agent Members&#8221; has the meaning assigned to such term in Section 14(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#8220;Applicable Supervisory Regulations&#8221; means such insurance supervisory laws, rules and regulations relating to group supervision or the supervision of single insurance entities, as applicable, which are applicable to the Company or the Insurance Group, and which shall initially mean the Group Rules until such time when the BMA no longer has jurisdiction or responsibility to regulate the Company or the Insurance Group.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;&#8220;Appointing Preference Shares&#8221; means any other class or series of preference shares of the Company, including the 5.625% Perpetual Preference Shares and the 5.95% Perpetual Preference Shares, ranking equally with the Preference Shares either as to dividend rights or rights upon liquidation, winding-up or dissolution and upon which like Appointing Rights have been conferred and are exercisable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;&#8220;Appointing Rights&#8221; has the meaning assigned to such term in Section 10(b).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;&#8220;BMA&#8221; means the Bermuda Monetary Authority, or, should the Bermuda Monetary Authority no longer have jurisdiction or responsibility to regulate the Company or the Insurance Group, as the context requires, a regulator which is otherwise subject to Applicable Supervisory Regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#8220;Board of Directors&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;&#8220;Business Day&#8221; means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City generally are authorized or obligated by law or executive order to close.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;&#8220;Bye-Laws&#8221; means the amended and restated bye-laws of the Company, as they may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;&#8220;Capital Adequacy Regulations&#8221; means the solvency margins, capital adequacy regulations or any other regulatory capital rules applicable to the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 32 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">from time to time on an individual or group basis pursuant to Bermuda law and&#47;or the laws of any other relevant jurisdiction and which set out the requirements to be satisfied by financial instruments to qualify as solvency margin or additional solvency margin or regulatory capital (or any equivalent terminology employed by the then-applicable capital adequacy regulations).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;&#8220;Capital Disqualification Change Event&#8221; means that the Preference Shares do not qualify, in whole or in part (including as a result of any transitional or grandfathering provisions or otherwise), for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level, of the Company or any subsidiary thereof, where capital is subdivided into tiers, as Tier 2 capital securities under then-applicable Capital Adequacy Regulations imposed upon the Company by the BMA, which would include, without limitation, the Company&#8217;s Enhanced Capital Requirement, except as a result of any applicable limitation on the amount of such capital.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;&#8220;Capital Disqualification Redemption Event&#8221; means that the Preference Shares qualify, in whole or in part (including as a result of any transitional or grandfathering provisions or otherwise), for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level, of the Company or any subsidiary thereof, where capital is subdivided into tiers, as neither Tier 1 nor Tier 2 capital securities under then-applicable Capital Adequacy Regulations imposed upon the Company by the BMA, which would include, without limitation, the Company&#8217;s Enhanced Capital Requirement, except as a result of any applicable limitation on the amount of such capital.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;&#8220;Certificate of Designation&#8221; means this Certificate of Designation relating to the Preference Shares, as it may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;&#8220;Change in Tax Law&#8221; means (a) a change in or amendment to laws, regulations or rulings of any Relevant Taxing Jurisdiction, (b) a change in the official application or interpretation of those laws, regulations or rulings, (c) any execution of or amendment to any treaty affecting taxation to which any Relevant Taxing Jurisdiction is party after August 6, 2019, or (d) a decision rendered by a court of competent jurisdiction in any Relevant Taxing Jurisdiction, whether or not such decision was rendered with respect to the Company, in each case, described in (a)-(d) above occurring after August 6, 2019&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the case of a Relevant Taxing Jurisdiction other than Bermuda in which a Successor Corporation is organized, such Change in Tax Law must occur after the Succession Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;&#8220;Dividend Payment Date&#8221; has the meaning assigned to such term in Section 4(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;&#8220;Dividend Period&#8221; has the meaning assigned to such term in Section 4(a).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 33 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;&#8220;Dividend Record Date&#8221; has the meaning assigned to such term in Section 4(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;&#8220;Enhanced Capital Requirement&#8221; means the enhanced capital and surplus requirement applicable to the Insurance Group and as defined in the Insurance Act or, should the Insurance Act or the Group Rules no longer apply to the Insurance Group, any and all other solvency capital requirements or any other requirement to maintain assets applicable to the Company or in respect of the Insurance Group, as applicable, pursuant to the Applicable Supervisory Regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;&#8220;Exchange Act&#8221; means the U.S. Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;&#8220;Global Preference Shares&#8221; has the meaning assigned to such term in Section 14(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;&#8220;Group Rules&#8221; means the Group Solvency Standards, together with the Group Supervision Rules.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;&#8220;Group Solvency Standards&#8221; means the Bermuda Insurance (Prudential Standards) (Insurance Group Solvency Requirement) Rules 2011, as those rules and regulations may be amended or replaced from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(y)&#160;&#160;&#160;&#160;&#8220;Group Supervision Rules&#8221; means the Bermuda Insurance (Group Supervision) Rules 2011, as those rules and regulations may be amended or replaced from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(z)&#160;&#160;&#160;&#160;&#8220;Insurance Act&#8221; means the Insurance Act 1978 of Bermuda, as amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(aa)&#160;&#160;&#160;&#160;&#8220;Insurance Group&#8221; means all subsidiaries of the Company that are regulated insurance or reinsurance companies (or part of such regulatory group) pursuant to the Applicable Supervisory Regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;&#8220;Issue Date&#8221; means August 13, 2019, the original date of issuance of the Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;&#8220;Junior Stock&#8221; means any class or series of capital stock of the Company, including the Company&#8217;s Ordinary Shares, that ranks junior to the Preference Shares either as to the payment of dividends or as to the distribution of assets upon any liquidation, dissolution or winding-up of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;&#8220;Liquidation Distribution&#8221; has the meaning assigned to such term in Section 6(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;&#8220;Liquidation Preference&#8221; has the meaning assigned to such term in Section&#160;1.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 34 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ff)&#160;&#160;&#160;&#160;&#8220;Memorandum of Association&#8221; means the memorandum of association of the Company, as it may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(gg)&#160;&#160;&#160;&#160;&#8220;Nonpayment&#8221; has the meaning assigned to such term in Section 10(b).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(hh)&#160;&#160;&#160;&#160;&#8220;Ordinary Shares&#8221; means the Ordinary Shares, par value $0.01 per share, of the Company, or any other class of shares resulting from successive changes or reclassifications of such Ordinary Shares consisting solely of changes in par value, or from par value to no par value, or as a result of a subdivision, combination, merger, consolidation or similar transaction in which the Company is a constituent corporation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#8220;Parity Stock&#8221; means any class or series of capital stock of the Company that ranks equally with the Preference Shares as to payment of dividends and the distribution of assets on any liquidation, dissolution or winding-up of the Company, including the 5.625% Perpetual Preference Shares and the 5.95% Perpetual Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(jj)&#160;&#160;&#160;&#160;&#8220;Paying Agent&#8221; initially means Computershare Trust Company, N.A. The Company may, in its sole discretion, remove the Paying Agent within ten (10) calendar days prior notice to the Paying Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Company shall appoint a successor Paying Agent who shall accept such appointment prior to the effectiveness of such removal.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(kk)&#160;&#160;&#160;&#160;&#8220;Preference Share Director&#8221; has the meaning assigned to such term in Section 10(b).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ll)&#160;&#160;&#160;&#160;&#8220;Preference Shares&#8221; has the meaning assigned to such term in the recitals.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(mm)&#160;&#160;&#160;&#160;&#8220;Rating Agency Event&#8221; means any nationally recognized statistical rating organization, as defined in Section 3(a)(62) of the Exchange Act, that then publishes a rating for the Company (a &#8220;Rating Agency&#8221;) amends, clarifies or changes the criteria it uses to assign equity credit to securities such as the Preference Shares, which amendment, clarification or change results in (1) the shortening of the length of time the Preference Shares are assigned a particular level of equity credit by that Rating Agency as compared to the length of time they would have been assigned that level of equity credit by that Rating Agency or its predecessor on the initial issuance of the Preference Shares&#59; or (2) the lowering of the equity credit (including up to a lesser amount) assigned to the Preference Shares by that Rating Agency as compared to the equity credit assigned by that Rating Agency or its predecessor on the initial issuance of the Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(nn)&#160;&#160;&#160;&#160;&#8220;Redemption Date&#8221; means, in the case of an optional redemption, the day specified in the Company&#8217;s notice of redemption.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(oo)&#160;&#160;&#160;&#160;&#8220;Redemption Requirements has the meaning assigned to such term in Section 7(a)(1).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 35 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(pp)&#160;&#160;&#160;&#160;&#8220;Register of Members&#8221; means the Register of Members of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(qq)&#160;&#160;&#160;&#160;&#8220;Registrar&#8221; initially means Computershare Trust Company, N.A. The Company may, in its sole discretion, remove the Registrar within ten (10) calendar days prior notice to the Registrar&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Company shall appoint a successor Registrar who shall accept such appointment prior to the effectiveness of such removal.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(rr)&#160;&#160;&#160;&#160;&#8220;Relevant Date&#8221; means, in respect of any payment, the date on which such payment first becomes due and payable, but if the full amount of the moneys payable has not been received by the dividend disbursing agent on or prior to such due date, it means the first date on which the full amount of such moneys has been so received and is available for payment to holders, and notice to that effect shall have been duly given to the holders of the Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ss)&#160;&#160;&#160;&#160;&#8220;Relevant Taxing Jurisdiction&#8221; means (a) Bermuda or any political subdivision or governmental authority of or in Bermuda with the power to tax, (b) any jurisdiction from or through which the Company or its dividend disbursing agent are making payments on the Preference Shares or any political subdivision or governmental authority of or in that jurisdiction with the power to tax or (c) any other jurisdiction in which the Company or a Successor Corporation is organized or generally subject to taxation on a net income basis or any political subdivision or governmental authority of or in that jurisdiction with the power to tax.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(tt)&#160;&#160;&#160;&#160;&#8220;Senior Stock&#8221; means any class of share capital or series of capital stock of the Company established after the Issue Date by the Board of Directors, that ranks senior to the Preference Shares as to payment of dividends and the distribution of assets on any liquidation, dissolution or winding-up of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(uu)&#160;&#160;&#160;&#160;&#8220;set aside for payment&#8221; means, without any action other than the following, the recording by the Company in its accounting ledgers of any accounting or bookkeeping entry which indicates, pursuant to a declaration of a dividend or other distribution by the Board of Directors, the allocation of the funds to be so paid on any class or series of the Company&#8217;s shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if any funds for any class or series of Junior Stock or any class or series of Parity Stock are placed in a separate account of the Company or delivered to a disbursing, paying or other similar agent, then &#8220;set aside for payment&#8221; with respect to the Preference Shares shall mean placing such funds in a separate account or delivering such funds to a disbursing, paying or other similar agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vv)&#160;&#160;&#160;&#160;&#8220;Succession Date&#8221; means the date on which the Company consolidates, merges or amalgamates with a Successor Corporation or conveys, transfers or leases substantially all its properties and assets to a Successor Corporation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ww)&#160;&#160;&#160;&#160;&#8220;Successor Corporation&#8221; has the meaning assigned to such term in the definition of Tax Event.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 36 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xx)&#160;&#160;&#160;&#160;&#8220;Tax Event&#8221; means a Change in Tax Law that, in the Company&#8217;s reasonable determination, results in a substantial probability that the Company or any entity formed by a consolidation, merger or amalgamation involving the Company or the entity to which the Company conveys, transfers or leases substantially all its properties and assets (a &#8220;Successor Corporation&#8221;) would be required to pay any Additional Amounts with respect to the Preference Shares, which obligation cannot be avoided by the Company through reasonable measures.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ranking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall, with respect to dividend rights or rights upon the liquidation, winding-up or dissolution of the Company, rank (a) senior to all Junior Stock, including, without limitation, the Ordinary Shares, (b) on parity with all Parity Stock, including, without limitation, the 5.625% Perpetual Preference Shares and the 5.95% Perpetual Preference Shares, (c) junior to any Senior Stock and (d) junior to all of the Company&#8217;s existing and future debt obligations. The Preference Shares shall also be subordinated in right of payment to all obligations of the Company&#8217;s subsidiaries, including all existing and future policyholders&#8217; obligations of such subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Rate and Payment of Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The holders of Preference Shares shall be entitled to receive, only when, as and if declared by the Board of Directors, subject to compliance with Bermuda law, non-cumulative cash dividends from, and including, the Issue Date, quarterly in arrears, on January 1, April 1, July 1 and October 1 of each year (each, a &#8220;Dividend Payment Date&#8221;), commencing on October 1, 2019, without accumulation of any undeclared dividends.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent declared, dividends shall accumulate, with respect to each Dividend Period, in an amount per share equal to 5.625% of the Liquidation Preference per Preference Share per annum. Dividends payable on the Preference Shares shall be computed on the basis of a 360-day year consisting of twelve 30-day months with respect to a full Dividend Period, and on the basis of the actual number of days elapsed during such Dividend Period with respect to a Dividend Period other than a full Dividend Period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dividends that are payable on Preference Shares on any Dividend Payment Date shall be payable to holders of record of Preference Shares as they appear on the Register of Members at 5&#58;00 p.m. (New York City time) on the immediately preceding December 15, March 15, June 15 and September 15 (each, a &#8220;Dividend Record Date&#8221;). The Dividend Record Dates shall apply regardless of whether a particular Dividend Record Date is a Business Day.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A dividend period (each, a &#8220;Dividend Period&#8221;) is the period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial Dividend Period shall commence on, and include, the Issue Date and shall end on, and exclude, the October 1, 2019 Dividend Payment Date. If any date on which </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 37 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">dividends would otherwise be payable is not a Business Day, then the Dividend Payment Date shall be the next succeeding Business Day after the original Dividend Payment Date, and no additional dividends shall accumulate on the amount so payable as a result of the delay.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Redemption Date falls on a day that is not a Business Day, the payment of dividends and redemption price shall be made on the first Business Day following such Redemption Date, without accrual to the actual payment date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dividends on the Preference Shares are non-cumulative. Consequently, if the Board of Directors does not authorize and declare a dividend for any Dividend Period, holders of the Preference Shares will not be entitled to receive a dividend for such Dividend Period, and such undeclared dividend will not accumulate and will not be payable. The Company will have no obligation to pay dividends for a Dividend Period after the Dividend Payment Date for such Dividend Period if the Board of Directors has not declared such dividend before the related Dividend Payment Date, whether or not dividends are declared for any subsequent Dividend Period with respect to the Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Holders of Preference Shares shall not be entitled to any dividends, whether payable in cash, securities or other property, other than dividends, if any, declared and payable on the Preference Shares as specified in this Section 4.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Priority of Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. So long as any Preference Shares remain in issue for any Dividend Period, unless the full dividends for the latest completed Dividend Period on all issued Preference Shares and the latest completed dividend period on all issued Parity Stock have been declared and paid or declared and a sum sufficient for the payment thereof has been set aside&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;no dividend shall be paid or declared on the Ordinary Shares or any other shares of Junior Stock or Parity Stock (except in the case of the Parity Stock on a pro rata basis with the Preference Shares as described below), other than a dividend payable solely in Ordinary Shares, other Junior Stock or Parity Stock, as applicable, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;no Ordinary Shares, other Junior Stock or Parity Stock shall be purchased, redeemed or otherwise acquired for consideration by the Company, directly or indirectly (other than (a) as a result of a reclassification of Junior Stock for or into other Junior Stock, or a reclassification of Parity Stock for or into other Parity Stock, as applicable, or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock, or the exchange or conversion of one share of Parity Stock for or into another share of Parity Stock, as applicable, (b) through the use of the proceeds of a substantially contemporaneous sale of Junior Stock or Parity Stock, as applicable, (c) as required by or necessary to fulfill the terms of any employment contract, benefit plan or similar arrangement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 38 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with or for the benefit of one or more employees, directors or consultants of (d) in the case of Parity Stock, in accordance with the provisions of Section 7(a)(6)). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When dividends are not paid or duly provided for in full on any Dividend Payment Date upon the Preference Shares and any shares of Parity Stock, all dividends declared upon the Preference Shares and all such Parity Stock and payable on such Dividend Payment Date shall be declared on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> basis so that the respective amounts of such dividends shall bear the same ratio to each other as the full amount of dividends payable on the issued Preference Shares for such Dividend Period and the accumulated and unpaid dividends, or the full amount of dividends payable for such Dividend Period in the case of non-cumulative preferred stock, on all such Parity Stock bear to each other. In the case of any Parity Stock having dividend payment dates different from the Dividend Payment Dates pertaining to the Preference Shares, the measurement date for such Parity Stock shall be the Dividend Payment Date falling within the related Dividend Period for the Preference Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Additional Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company shall make all payments on the Preference Shares free and clear of and without withholding or deduction at source for, or on account of, any present or future taxes, fees, duties, assessments or governmental charges of whatever nature imposed or levied by or on behalf of any Relevant Taxing Jurisdiction, unless such taxes, fees, duties, assessments or governmental charges are required to be withheld or deducted by (x) the laws (or any regulations or rulings promulgated thereunder) of any Relevant Taxing Jurisdiction or (y) an official position regarding the application, administration, interpretation or enforcement of any such laws, regulations or rulings (including, without limitation, a holding by a court of competent jurisdiction or by a taxing authority in any Relevant Taxing Jurisdiction). If a withholding or deduction at source is required, the Company shall, subject to certain limitations and exceptions described below, pay to the holders or beneficial owners of the Preference Shares such additional amounts (the &#8220;Additional Amounts&#8221;) as may be necessary so that every net payment made to such holders or beneficial owners, after the withholding or deduction, shall not be less than the amount provided for in this Certificate of Designation to be then due and payable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall not be required to pay any Additional Amounts for or on account of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or governmental charge of whatever nature that would not have been imposed but for the fact that such holder or beneficial owner (i) was a resident, citizen, domiciliary or national of, or engaged in business or maintained a permanent establishment or was physically present in, the Relevant Taxing Jurisdiction or otherwise had some connection with the Relevant Taxing Jurisdiction other than by reason of the mere ownership of, or receipt of payment under, such Preference Shares or (ii) presented, where presentation is required, such Preference Shares for payment more than 30 days after the Relevant Date, except to the extent that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 39 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the holder or beneficial owner would have been entitled to such Additional Amounts if it had presented such Preference Shares for payment on any day within that 30-day period&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;any estate, inheritance, gift, sale, transfer, personal property or similar tax, fee, duty, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or other governmental charge that is payable otherwise than by withholding or deduction from payment on the Preference Shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;any tax, fee, duty, assessment or other governmental charge that is imposed or withheld by reason of the failure by the holder or beneficial owner of such Preference Shares to comply with any reasonable request by the Company addressed to the holder within ninety (90) days of such request (a) to provide information concerning the nationality, citizenship, residence or identity of the holder or beneficial owner or (b) to make any declaration or other similar claim or satisfy any information or reporting requirement, which is required or imposed by statute, treaty, regulation or administrative practice of the Relevant Taxing Jurisdiction or any political subdivision thereof as a precondition to exemption from all or part of such tax, fee, duty, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;any taxes, duties, assessments or governmental charges required to be withheld or deducted under Sections 1471 through 1474 of the United States Internal Revenue Code of 1986, as amended (or any United States Treasury Regulations or other administrative guidance thereunder)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;any combination of items (1), (2), (3), (4) and (5).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Company shall not pay Additional Amounts with respect to any payment on any such Preference Shares to any holder or beneficial owner who is a fiduciary, partnership, limited liability company or other pass-through entity or a person other than the sole beneficial owner of such Preference Shares if such payment would be required by the laws of the Relevant Taxing Jurisdiction to be included in the income for tax purposes of a beneficiary or settlor with respect to such fiduciary or a member of such partnership, limited liability company or other pass-through entity or a beneficial owner to the extent such beneficiary, settlor, member or beneficial owner would not have been entitled to such Additional Amounts had it been the holder or beneficial owner of the Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;If a payment on the Preference Shares is subject to withholding or deduction for, or on account of, any taxes or other governmental charges imposed or levied by or on behalf of any Relevant Taxing Jurisdiction, the Company shall pay the taxes or other governmental charges to the Relevant Taxing Jurisdiction in accordance with applicable law and furnish to the dividend disbursing agent certified copies of tax receipts (or other evidence of payment reasonably satisfactory to the dividend disbursing agent) evidencing payment of the taxes or other governmental charges. Copies of such documentation will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 40 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be made available by the dividend disbursing agent to holders of the Preference Shares upon written request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The requirement to pay Additional Amounts shall apply to any Successor Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voluntary or Involuntary Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event of any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of the Preference Shares shall be entitled to receive out of the Company&#8217;s assets legally available for distribution to shareholders, after satisfaction of indebtedness and other liabilities of the Company (including policyholder obligations of its subsidiaries), if any, the Liquidation Preference, plus declared and unpaid dividends thereon, if any, to, but excluding, the date fixed for distribution, without accumulation of any undeclared dividends (the &#8220;Liquidation Distribution&#8221;), before any distribution of assets is made to holders of Ordinary Shares, or any of the Company&#8217;s other Junior Stock.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">After the payment to the holders of the Preference Shares of the Liquidation Distribution to which such holders are entitled as provided in this Section 6, the holders of the Preference Shares shall have no right or claim to any of the remaining assets of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event the Company&#8217;s assets are not sufficient to pay the Liquidation Preference in full to all holders of the Preference Shares and the liquidation preference of any Parity Stock to all holders of such Parity Stock, the amounts paid to the holders of Preference Shares and to the holders of any Parity Stock shall be paid </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in accordance with the respective aggregate liquidation preferences of those holders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Residual Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event the Liquidation Preference has been paid in full to all holders of the Preference Shares and any holders of any Parity Stock, the holders of the Company&#8217;s other capital stock shall be entitled to receive all of the Company&#8217;s remaining assets according to their respective rights and preferences.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Merger, Consolidation and Sale of Assets Not Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. For purposes of this Section 6, neither a consolidation, amalgamation, merger, arrangement or reconstruction involving the Company or the sale or transfer of all or substantially all of the shares of capital stock or the property or business of the Company shall be deemed to constitute a liquidation, dissolution or winding-up of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 41 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Optional Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company may not redeem Preference Shares prior to October 1, 2024, except as provided in Sections 7(a)(2), 7(a)(3), 7(a)(4) and 7(a)(5). On October 1, 2024 and at any time thereafter, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or from time to time in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25,000 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;At any time prior to October 1, 2024, if (i) the Company submits to the holders of its Ordinary Shares a proposal for an amalgamation or merger, or (ii) if the Company submits any proposal for any other matter that requires, as a result of any change in Bermuda law after August 6, 2019, for its validation or effectuation an affirmative vote of the holders of the Preference Shares at the time in issue, whether voting as a separate series or together with any other series or class of preference shares as a single class, the Company shall have the option, subject to compliance with Bermuda law, upon notice given as provided in Section 7(c), to redeem all of the issued Preference Shares at a cash redemption price of $26,000 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such redemption shall occur prior to October 1, 2024 unless (1) the Company has sufficient funds in order to meet the Enhanced Capital Requirement and the BMA approves of the redemption or (2) the Company replaces the capital represented by Preference Shares to be redeemed with capital having equal or better capital treatment as the Preference Shares under the Enhanced Capital Requirement (the conditions described in clauses (1) and (2), the &#8220;Redemption Requirements&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;At any time prior to October 1, 2024, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or from time to time in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25,000 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends, at any time within 90 days of the date on which the Company has reasonably determined that, as a result of (i) any amendment to, or change in, the laws or regulations of Bermuda that is enacted or becomes effective after the Issue Date&#59; (ii) any proposed amendment to, or change in, those laws or regulations that is announced or becomes effective after the Issue </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 42 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#59; or (iii) any official administrative decision or judicial decision or administrative action or other official pronouncement interpreting or applying those laws or regulations that is announced after the Issue Date, a Capital Disqualification Redemption Event has occurred&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that any such redemption in part may only be made if (x) the Company has reasonably determined that the portion of the Preference Shares to be redeemed are the subject of the Capital Disqualification Redemption Event and (y) after giving effect to such redemption, the Company has reasonably determined that a Capital Disqualification Redemption Event will not exist with respect to the then-issued Preference Shares and such redemption will not result in the suspension or removal of the Preference Shares from listing on the New York Stock Exchange&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such redemption may occur prior to October 1, 2024 unless one of the Redemption Requirements is satisfied.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;At any time prior to October 1, 2024, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole or from time to time in part, upon notice given as provided in Section 7(c), at a cash redemption price equal to $25,000 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends, at any time following the occurrence of a Tax Event&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such redemption may occur prior to October 1, 2024 unless one of the Redemption Requirements is satisfied.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;At any time prior to October 1, 2024, the Preference Shares shall be redeemable at the Company&#8217;s option, subject to compliance with Bermuda law, in whole, upon notice given as provided in Section 7(c), at a cash redemption price of $25,500 per Preference Share, plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any, to, but excluding, the Redemption Date, without accumulation of any undeclared dividends, within 90 days after the occurrence of a Rating Agency Event&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such redemption may occur prior to October 1, 2024 unless one of the Redemption Requirements is satisfied.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;Unless dividends on all issued Preference Shares and all Parity Stock shall have been declared and paid (or declared and a sum sufficient for the payment thereof set apart for payment) for the latest completed Dividend Period on all issued Preference Shares and the latest completed dividend period on all issued Parity Stock, no Preference Shares or any Parity Stock shall be redeemed, purchased or otherwise acquired by the Company unless all issued Preference Shares and any Parity Stock are redeemed (or purchased or otherwise acquired)&#59; provided, that the Company may acquire fewer than all of the issued Preference Shares or Parity Stock pursuant to a written purchase or exchange offer made to all holders of issued Preference Shares and Parity Stock upon such terms as the Board of Directors in its sole discretion, after consideration of the respective </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 43 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">annual dividend rate and other relative rights and preferences of the respective classes or series, shall determine (which determination shall be final and conclusive) will result in fair and equitable treatment among the respective classes or series.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Mandatory Redemption&#59; No Sinking Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not be subject to any mandatory redemption, sinking fund, retirement fund or purchase fund or other similar provisions. Holders of Preference Shares shall have no right to require redemption or repurchase of any Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notice of each redemption of Preference Shares shall be given by first class mail, to the holders of record of the Preference Shares to be redeemed, not less than 30 nor more than 60 days prior to the Redemption Date. Notwithstanding the foregoing, if the Preference Shares or any depositary shares representing interests in the Preference Shares are held in book-entry form through The Depository Trust Company, notice of redemption may be given to the holders of Preference Shares in any manner permitted by The Depository Trust Company. Each such notice given to a holder shall state&#58; (1) the Redemption Date&#59; (1) the number of Preference Shares to be redeemed and, if less than all of the Preference Shares held by such holder are to be redeemed, the number of such Preference Shares to be redeemed from such holder&#59; (1) the redemption price or the methodology for determining the redemption price&#59; and (1) the place or places where certificates for such Preference Shares are to be surrendered for payment of the redemption price.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In case of any redemption of only part of the Preference Shares at the time in issue, the Preference Shares to be redeemed shall be selected either </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or in such other manner as the Company may determine to be fair and equitable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effectiveness of Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If a notice of redemption has been duly given and if all funds necessary for the redemption have been set aside for payment by the Company for the benefit of the holders of any Preference Shares called for redemption, then, from and after the Redemption Date, dividends shall cease to accumulate on all Preference Shares so called for redemption, all Preference Shares so called for redemption shall no longer be deemed in issue and all rights of holders of such Preference Shares shall forthwith on such Redemption Date cease and terminate, except the right of the holders thereof to transfer the Preference Shares prior to the Redemption Date and the right to receive the redemption price pursuant to Section 7(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Redemption Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. On or prior to the Redemption Date, the Company shall deposit with the Paying Agent an amount in immediately available funds sufficient to pay the aggregate redemption price plus an amount equal to the portion of the quarterly dividend attributable to the then-current dividend period, if any&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that if such payment is deposited on the Redemption Date, it must be received by the Paying Agent by 10&#58;00 a.m. (New York City time) on the Redemption Date. An amount equal to the redemption price plus an amount equal to the portion of the quarterly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 44 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">dividend attributable to the then-current dividend period, if any, shall be paid to the holders promptly following the later of (i) the Redemption Date and (ii) the time of book-entry transfer or surrender of the certificate(s) evidencing such Preference Shares to the Paying Agent, as applicable. Any declared but unpaid dividends payable on a Redemption Date that occurs subsequent to the Dividend Record Date for such Dividend Period shall not be paid to the holder entitled to receive the redemption price on the Redemption Date, but rather shall be paid to the holder of record of the redeemed Preference Shares on such Dividend Record Date relating to the Dividend Payment Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares have no stated maturity. The Preference Shares shall remain in issue perpetually, unless and until the Company elects to redeem the Preference Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Variation or Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;At any time following a Tax Event or at any time following a Capital Disqualification Change Event, the Company may, without the consent of any holders of the Preference Shares, vary the terms of the Preference Shares or exchange the Preference Shares for new securities, which (i) in the case of a Tax Event, would eliminate the substantial probability that the Company or any Successor Corporation would be required to pay any Additional Amounts with respect to the Preference Shares as a result of a Change in Tax Law or (ii) in the case of Capital Disqualification Change Event, would cause the Preference Shares to become securities that qualify as at least Tier 2 capital (where capital is subdivided into tiers) or its equivalent under then-applicable Capital Adequacy Regulations imposed upon the Company by the BMA, including the Enhanced Capital Requirement, for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or levels of the Company or any subsidiary thereof. In either case, the terms of the varied securities or new securities considered in the aggregate shall not be less favorable, including from a financial perspective, to holders and beneficial owners of the Preference Shares than the terms of the Preference Shares prior to being varied or exchanged (as reasonably determined by the Company)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such variation of terms or securities received in exchange shall change the specified denominations, or any payment of dividend on, the redemption dates (other than any extension of the period during which an optional redemption may not be exercised by the Company) or currency of, the Preference Shares, reduce the Liquidation Preference thereof or the dividend payable thereon, lower the ranking of the securities, reduce the voting threshold for the issuance of Senior Stock or change the foregoing list of items that may not be so amended as part of such variation or exchange. No such variation of terms or securities received in exchange shall impair the right of a holder of the securities to institute suit for the payment of any amounts due (as provided under this Certificate of Designation), but unpaid with respect to such holder&#8217;s securities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Prior to any variation or exchange, the Company shall be required to (i) receive an opinion of independent legal advisers of recognized standing to the effect that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 45 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">holders and beneficial owners of the Preference Shares (including as holders and beneficial owners of the varied or exchanged securities) shall not recognize income, gain or loss for United States federal income tax purposes as a result of such variation or exchange and shall be subject to United States federal income tax on the same amounts, in the same manner and at the same times as would have been the case had such variation or exchange not occurred, and (ii) deliver a certificate signed by two executive officers of the Company to the transfer agent for the Preference Shares confirming that (x) a Capital Disqualification Change Event or a Tax Event has occurred and is continuing (as reasonably determined by the Company) and (y) the terms of the varied or new securities, considered in the aggregate, are not less favorable, including from a financial perspective, to holders and beneficial owners of the Preference Shares than the terms of the Preference Shares prior to being varied or exchanged (as reasonably determined by the Company).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Any variation or exchange of the Preference Shares described above shall be made after notice is given to the holders of the Preference Shares not less than 30 nor more than 60 days prior to the date fixed for variation or exchange, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as provided in this Section 10 or otherwise required by Bermuda law from time to time, the holders of the Preference Shares shall not have any voting rights.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Right to Elect Two Directors upon Nonpayment Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Whenever dividends payable on any Preference Shares shall have not been declared and paid for the equivalent of any six (6) Dividend Periods, whether or not consecutive (a &#8220;Nonpayment&#8221;), the holders of the Preference Shares, acting together as a single class with holders of any and all other series of Appointing Preference Shares then issued, shall be entitled to the appointment (the &#8220;Appointing Rights&#8221;) of a total of two additional members to the Board of Directors (each, a &#8220;Preference Share Director&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the appointment of any such directors shall not cause the Company to violate the corporate governance requirements of the New York Stock Exchange as applied to U.S. issuers (or any other securities exchange or automated quotation system on which the Company&#8217;s securities may be then listed or quoted) that listed companies must have a majority of independent directors. In the case of a Nonpayment, the number of directors on the Board of Directors shall automatically increase by two (to the extent such increase does not exceed the maximum number of directors permitted under the Company&#8217;s Bye-Laws), and the new directors shall be selected by at least a majority of the aggregate liquidation preference of the Preference Shares and any other Appointing Preference Shares at a special meeting called at the request of the record holders of at least 20% of the aggregate liquidation preference of the Preference Shares or of any other series of Appointing Preference Shares then in issue. The Board of Directors shall duly appoint the Preference Share Directors selected by the holders of the Preference </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 46 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Shares and any other Appointing Preference Shares then issued, and shall, subject to the Company&#8217;s Bye-Laws, determine which classes of directors the Preference Share Directors shall be a part of and shall allocate such Preference Share Directors to the classes having the longest term of office remaining at the time of such appointment. Each Preference Share Director shall be entitled to one vote per director on any matter.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The Appointing Rights shall continue until dividends on the Preference Shares and any such other series of Appointing Preference Shares following the Nonpayment shall have been fully declared and paid (or declared and a sum sufficient for the payment of such dividends shall have been set aside for payment) for at least four (4) consecutive Dividend Periods. When the term of a class of directors of which any Preference Share Director is a part of is expiring, the Board of Directors shall set the size of such class of directors to be elected by the Company&#8217;s ordinary shareholders at a level to include such Preference Share Director duly appointed by the Board of Directors upon the exercise of the Appointing Rights. The Company shall use its best efforts to increase the number of directors constituting the Board of Directors to the extent necessary to effect these Appointing Rights.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;So long as a Nonpayment shall continue, any vacancy in the office of a Preference Share Director (other than prior to the initial appointment after a Nonpayment) may be filled by the Board of Directors pursuant to an exercise of the Appointing Rights by the holders of Preference Shares and any other Appointing Preference Shares then in issue.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;If and when dividends for four (4) consecutive Dividend Periods following a Nonpayment have been paid in full (or declared and a sum sufficient for the payment of such dividends shall have been set aside), the holders of the Preference Shares shall be divested of the Appointing Rights (subject to revesting in the event of each subsequent Nonpayment, as described above) and, if such Appointing Rights for all other holders of Appointing Preference Shares have terminated, the office of each Preference Share Director so appointed shall, notwithstanding the class of directors such Preference Share Director shall be a part of, automatically be vacated and the number of directors on the Board of Directors shall automatically decrease by two (2). In determining whether dividends have been fully paid for four (4) consecutive Dividend Periods following a Nonpayment, the Company may take into account any dividend the Company elects to pay for a Dividend Period after the regular Dividend Payment Date for that period has passed.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting on Variations of Rights and Senior Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Notwithstanding the Company&#8217;s Bye-Laws, the affirmative vote or consent of the holders of at least 66&#8532;% of the aggregate Liquidation Preference of the issued Preference Shares and any series of Appointing Preference Shares, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 47 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">voting together as a single class, shall be required for the authorization or issuance of any class or series of Senior Stock (or any security convertible into or exchangeable for Senior Stock) ranking senior to the Preference Shares as to dividend rights or rights upon the Company&#8217;s liquidation.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The affirmative vote or consent of the holders of at least 66&#8532;% of the aggregate Liquidation Preference of the Company&#8217;s issued Preference Shares shall be required for amendments to the Company&#8217;s Memorandum of Association or Bye-Laws that would materially adversely affect the rights of holders of the Preference Shares. The authorization of, the increase in the authorized amount of, or the issuance of any shares of any class or series of Parity Stock or Junior Stock shall not require the consent of any holder of the Preference Shares, and shall not be deemed to materially adversely affect the rights of the holders of the Preference Shares.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;If all preference shares of the Company are not equally affected by any such proposed amendment and if the Preference Shares would have diminished status compared to other preference shares as a result, the approval of holders of at least 66</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">% of the issued Preference Shares, voting together as a single class, shall be required.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The foregoing voting provisions of this Section 10 will not apply if, at or prior to the time when the act with respect to which such vote would otherwise be required shall be effected, all issued Preference Shares shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have been set aside for payment by the Company for the benefit of the holders of Preference Shares to effect such redemption as set forth in Section 7.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Record Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the fullest extent permitted by applicable law, the Company and the transfer agent for the Preference Shares may deem and treat the record holder of any share of Preference Shares as the true and lawful owner thereof for all purposes, and neither the Company nor such transfer agent shall be affected by any notice to the contrary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments or Modifications&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;To the extent permitted by applicable law, the Board of Directors may modify the terms of this Certificate of Designation without the consent of any holder of Preference Shares for any of the following purposes&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;to evidence the succession of another person to the Company&#8217;s obligations&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;to add to the covenants for the benefit of the holders of the Preference Shares or to surrender any of the Company&#8217;s rights or powers under the Preference Shares&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 48 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;to cure any ambiguity to correct or supplement any provisions that may be inconsistent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such action shall not adversely affect the interest of the holders of the Preference Shares in any material respect&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;to make any other provision with respect to such matters or questions arising under this Certificate of Designation which the Company may deem desirable and which shall not adversely affect the interests of the holders of the Preference Shares in any material respect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Except as provided below in Section 12(c), this Certificate of Designation may be amended, modified or supplemented, and noncompliance in any particular instance with any provision of this Certificate of Designation or the Preference Shares may be waived, in each case with the affirmative vote or written consent of the holders of at least a majority of the aggregate Liquidation Preference of the Preference Shares then issued, including any modification occurring in connection with any merger or consolidation of the Company or otherwise.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Board of Directors may, subject to the prior written consent or the affirmative vote of the holders of at least a majority of the aggregate Liquidation Preference of the Preference Shares in issue at the time, amend the terms of this Certificate of Designation or the rights, powers, preferences and privileges of the holders of the Preference Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no such amendment shall, without the consent of the holder of each issued Preference Share affected by the amendment&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;change any Dividend Payment Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;reduce the rate of dividends payable on the Preference Shares when, as and if declared by the Board of Directors&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;reduce the redemption price or alter the October 1, 2024 optional redemption date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;change the place or currency of payment&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;impair the right to institute suit for the enforcement of the Preference Shares&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;change the percentage of aggregate Liquidation Preference of the Preference Shares whose holders must approve any amendment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Merger, Amalgamation, Consolidation and Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company covenants that it will not merge or amalgamate with or into, consolidate with or convert into any other person or entity or sell, assign, transfer, lease or convey all or substantially all of the Company&#8217;s properties and assets into any person or entity, unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;either the Company is the continuing corporation or the successor corporation is a corporation organized under the laws of the United States, a state thereof, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 49 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the District of Columbia, Bermuda or any country which is, on the date hereof, a member of the Organisation for Economic Cooperation and Development and the Preference Shares shall be exchanged for or converted into and shall become Preference Shares of the successor corporation with substantially the same rights, powers, preferences and privileges&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Company or the successor corporation is not, immediately after such merger, amalgamation, consolidation, conversion, sale, assignment, transfer, lease or conveyance, in default of any obligation under the Preference Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Preference Shares shall be issued initially in the form of one or more fully registered global certificates with the global securities legend set forth in Exhibit A hereto (&#8220;Global Preference Shares&#8221;), each as set forth on the form of Preference Shares certificate attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> which is hereby incorporated in and expressly made a part of this Certificate of Designation. The Global Preference Shares certificate may have notations, legends or endorsements required by law, stock exchange rules, agreements to which the Company is subject, if any, or usage (provided that any such notation, legend or endorsement is in a form acceptable to the Company). The Global Preference Shares shall be deposited on behalf of the holders of the Preference Shares represented thereby with the Registrar, as custodian for DTC (or with such other custodian as DTC may direct), and registered in the name of DTC or a nominee of DTC, duly executed by the Company and countersigned by the Registrar as hereinafter provided, The aggregate number of Preference Shares represented by Global Preference Shares may from time to time be increased or decreased by adjustments made on the records of the Registrar and DTC or its nominee as hereinafter provided.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event Global Preference Shares are deposited with or on behalf of DTC, the Company shall execute, and the Registrar shall countersign and deliver, initially one or more Global Preference Shares certificates that (a) shall be registered in the name of Cede &#38; Co. or other nominee of the Depositary and (b) shall be delivered by the Registrar to DTC or pursuant to DTC's instructions or held by the Registrar as custodian for DTC. Members of, or participants in, DTC (&#8220;Agent Members&#8221;) shall have no rights under this Certificate of Designation with respect to any Global Preference Shares held on their behalf by DTC or by the Registrar as the custodian of DTC or under such Global Preference Shares, and DTC may be treated by the Company, the Registrar and any agent of the Company or the Registrar as the absolute owner of such Global Preference Shares for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Registrar or any agent of the Company or the Registrar from giving effect to any written certification, proxy or other authorization furnished by DTC or impair, as between DTC and its Agent Members, the operation of customary practices of DTC governing the exercise of the rights of a holder of a beneficial interest in any Global Preference Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 50 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Owners of beneficial interests in Global Preference Shares shall not be entitled to receive physical delivery of certificated Preference Shares, unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;DTC is unwilling or unable to continue as Depositary for the Global Preference Shares and the Company does not appoint a qualified replacement for DTC within 90 calendar days&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;DTC ceases to be a &#8220;clearing agency&#8221; registered under the Exchange Act and the Company does not appoint a qualified replacement for DTC within 90 calendar days&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the Company decides to discontinue the use of book-entry transfer through DTC (or any successor Depositary).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In any such case, the Global Preference Shares shall be exchanged in whole for certificated Preference Shares in registered form, with the same terms and of an equal aggregate liquidation preference (unless the Company determines otherwise in accordance with applicable law). Certificated Preference Shares shall be registered in the name or names of the Person or Person specified by DTC in a written instrument to the Registrar.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;An Officer shall sign the Preference Shares certificate for the Company by manual or facsimile signature. If the Officer whose signature is on a Preference Shares certificate no longer holds that office at the time the Registrar countersigns the Preference Shares certificate, the Preference Shares certificate shall be valid nevertheless.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A Preference Shares certificate shall not be valid until an authorized signatory of the Registrar signs the Preference Shares certificate by manual or facsimile signature. The signature shall be conclusive evidence that the Preference Shares certificate has been countersigned under this Certificate of Designation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All notices or communications in respect of Preference Shares shall be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Certificate of Designation, the Memorandum of Association, the Bye-Laws or by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Preemptive Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Holders of the Preference Shares shall not have any rights of preemption or subscription whatsoever as to any securities of the Company, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations on Transfer and Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The holders of Preference Shares shall be subject to the limitations on transfer and ownership contained in the Bye-laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not be convertible into or exchangeable for any other securities or property of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 51 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Other Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Preference Shares shall not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, limitations or restrictions other than as set forth in this Certificate of Designation, the Memorandum of Association, the Bye-laws or applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation in Respect of Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall be responsible for making all calculations called for in respect of the Preference Shares, including, but not limited to, the determination of the dividends payable on the Preference Shares. The Company or its agents shall make all of these calculations in good faith and, absent manifest error, such calculations shall be final and binding on holders of the Preference Shares. The Company or its agents shall deliver to the Paying Agent a schedule of its calculations and the Paying Agent shall be entitled to rely upon the accuracy of such calculations without independent verification. The Paying Agent shall forward such calculations to any holder of the Preference Shares upon the request of such holder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event any provision of this Certificate of Designation shall be invalid, unenforceable or illegal, then, to the fullest extent permitted by applicable law, the validity, enforceability and legality of the remaining provisions shall not in any way be affected or impaired thereby.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 52 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, ASPEN INSURANCE HOLDINGS LIMITED has caused this Certificate of Designation to be signed this 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of August, 2019.</font></div><div style="margin-bottom:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:252.00pt"><tr><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:9.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:215.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attest&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 53 -</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>13
<FILENAME>exhibit102-fx1.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia0c02b89e2d646a9b0ab58e4f143340b_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNLESS THIS RECEIPT IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), NEW YORK, NEW YORK, TO ASPEN INSURANCE HOLDINGS LIMITED OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY RECEIPT ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &#38; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &#38; CO., HAS AN INTEREST HEREIN.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSFERS OF THIS GLOBAL RECEIPT SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL RECEIPT SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE DEPOSIT AGREEMENT REFERRED TO BELOW.</font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificate Number&#58; 1</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of Depositary Shares&#58; 10,000,000</font></div><div style="margin-bottom:3pt;text-align:center;text-indent:31.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CUSIP NO.&#58; G05384204</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RECEIPT FOR DEPOSITARY SHARES</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Representing a 1&#47;1,000</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Interest in a Share of</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.625% Perpetual Non-Cumulative Preference Shares</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(par value $0.0015144558 per share)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(liquidation preference $25,000 per share (equivalent to $25 per Depositary Share))</font></div><div style="margin-bottom:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computershare Inc., a Delaware corporation (&#8220;Computershare&#8221;), and its wholly-owned subsidiary Computershare Trust Company, N.A., a federally chartered national association (the &#8220;Trust Company&#8221; and jointly with Computershare, the &#8220;Depositary&#8221;), hereby certify that CEDE &#38; CO. is the registered owner of ten million (10,000,000) depositary shares ($250,000,000 aggregate liquidation preference) (&#8220;Depositary Shares&#8221;), each Depositary Share representing a 1&#47;1,000</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> interest in a share of 5.625% Perpetual Non-Cumulative Preference Shares, $0.0015144558 par value per share and liquidation preference of $25,000 per share (equivalent to $25.00 per Depositary Share) of Aspen Insurance Holdings Limited, a Bermuda exempted company (the &#8220;Company&#8221;), on deposit with the Depositary, subject to the terms and entitled to the benefits of the Deposit Agreement, dated August 13, 2019 (the &#8220;Deposit Agreement&#8221;), among the Company, the Depositary, the Trust Company, as Registrar and Transfer Agent (each term as defined in the Deposit Agreement), and Computershare, as Dividend Disbursing Agent and Redemption Agent (each term as defined in the Deposit Agreement) and the holders from time to time of Receipts for Depositary Shares. By accepting this Receipt, the holder hereof becomes a party to and agrees to be bound by all the terms and conditions of the Deposit Agreement. This Receipt shall not be valid or obligatory for any purpose or entitled to any benefits under the Deposit Agreement unless it shall have been executed by the Depositary by the manual or facsimile signature of a duly authorized officer or, if a Registrar in respect of the Receipts (other than the Depositary) shall have been appointed, by the manual signature of a duly authorized officer of such Registrar</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; August 13, 2019</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.589%"><tr><td style="width:1.0%"></td><td style="width:9.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computershare Inc. and Computershare Trust </font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company, N.A., as Depositary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Constance Adams</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;FORM OF REVERSE OF RECEIPT&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following abbreviations when used in the instructions on the face of this receipt shall be construed as though they were written out in full according to applicable laws or regulations.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.724%"><tr><td style="width:1.0%"></td><td style="width:51.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.013%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEN COM - as tenant in common</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNIF GIFT MIN ACT - </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Custodian </font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Cust) (Minor)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEN ENT - as tenants by the entireties</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Uniform Gifts to Minors Act</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JT TEN - as joint tenants with right of </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">survivorship and not as tenants in common</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional abbreviations may also be used though not in the above list.</font></td></tr></table></div><div style="margin-bottom:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASSIGNMENT</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For value received, </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hereby sell(s), assign(s) and transfer(s) unto</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PLEASE INSERT SOCIAL SECURITY OR</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OTHER IDENTIFYING NUMBER OF ASSIGNEE, AS APPLICABLE</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="15" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCLUDING POSTAL ZIP CODE OF ASSIGNEE</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Depositary Shares represented by the within Receipt, and do hereby irrevocably </font></div></td></tr><tr><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">constitute and appoint</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attorney to transfer the said Depositary Shares on the books of the within named </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOTICE&#58; The signature to the assignment must correspond with the name as written upon the face of this Receipt in every particular, without alteration or enlargement or any change whatever.</font></td></tr></table></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE GUARANTEED</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTICE&#58; The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations, and credit unions with membership in an approved signature guarantee medallion program), pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>14
<FILENAME>exhibit103-fx1.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i945374149a3b4d4197343f4a046e5f5b_59"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="margin-bottom:150pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEUTSCHE BANK TRUST COMPANY AMERICAS,</font></div><div style="margin-bottom:55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trustee</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INDENTURE</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated as of August 16, 2004</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEBT SECURITIES</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i945374149a3b4d4197343f4a046e5f5b_85"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table Of Contents</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 1 DEFINITIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTAIN TERMS DEFINED</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 2 SECURITY FORMS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORMS GENERALLY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF LEGEND FOR RESTRICTED SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF TRUSTEE'S CERTIFICATE OF AUTHENTICATION</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF TRUSTEE'S CERTIFICATE OF AUTHENTICATION BY AN AUTHENTICATING AGENT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECURITIES ISSUABLE IN THE FORM OF GLOBAL SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 3 THE SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMOUNT UNLIMITED&#59; ISSUABLE IN SERIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM AND DENOMINATIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AUTHENTICATION, DATING AND DELIVERY OF SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXECUTION OF SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATE OF AUTHENTICATION</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGISTRATION, REGISTRATION OF TRANSFER AND EXCHANGE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADDITIONAL PROVISIONS RELATED TO TRANSFER AND EXCHANGE OF RESTRICTED SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MUTILATED, DESTROYED, LOST AND STOLEN SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAYMENT OF INTEREST AND CERTAIN ADDITIONAL AMOUNTS&#59; INTEREST RIGHTS AND CERTAIN ADDITIONAL AMOUNTS PRESERVED</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADDITIONAL OR SPECIAL INTEREST UNDER REGISTRATION RIGHTS AGREEMENTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CANCELLATION OF SECURITIES&#59; DESTRUCTION THEREOF</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TEMPORARY SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPUTATION OF INTEREST</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CUSIP NUMBERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 4 COVENANTS OF THE COMPANY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAYMENT OF SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OFFICES OR AGENCY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MONEY FOR SECURITIES PAYMENTS TO BE HELD IN TRUST</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADDITIONAL AMOUNTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REDEMPTION FOR TAX PURPOSES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIMITATION ON LIENS ON STOCK OF DESIGNATED SUBSIDIARIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table Of Contents</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(continued)</font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIMITATION ON DISPOSITION OF STOCK OF DESIGNATED SUBSIDIARIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CORPORATE EXISTENCE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WAIVER OF CERTAIN COVENANTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATES TO TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CALCULATION OF ORIGINAL ISSUE DISCOUNT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 5 SECURITYHOLDER LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPANY TO FURNISH TRUSTEE INFORMATION AS TO NAMES AND ADDRESSES OF SECURITYHOLDERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRESERVATION AND DISCLOSURE OF SECURITYHOLDER LISTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPORTS BY THE COMPANY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPORTS BY THE TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 6 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EVENT OF DEFAULT DEFINED&#59; ACCELERATION OF MATURITY&#59; WAIVER OF DEFAULT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COLLECTION OF INDEBTEDNESS BY TRUSTEE&#59; TRUSTEE MAY PROVE DEBT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APPLICATION OF PROCEEDS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUITS FOR ENFORCEMENT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RESTORATION OF RIGHTS ON ABANDONMENT OF PROCEEDINGS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIMITATIONS ON SUITS BY SECURITYHOLDERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNCONDITIONAL RIGHT OF SECURITYHOLDERS TO INSTITUTE CERTAIN SUITS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">POWERS AND REMEDIES CUMULATIVE&#59; DELAY OR OMISSION NOT WAIVER OF DEFAULT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONTROL BY HOLDERS OF SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WAIVER OF PAST DEFAULTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRUSTEE TO GIVE NOTICE OF DEFAULT, BUT MAY WITHHOLD IN CERTAIN CIRCUMSTANCES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RIGHT OF COURT TO REQUIRE FILING OF UNDERTAKING TO PAY COSTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WAIVER OF USURY, STAY OR EXTENSION LAWS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DELAY OR OMISSION NOT WAIVER</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 7 CONCERNING THE TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DUTIES AND RESPONSIBILITIES OF THE TRUSTEE&#59; DURING DEFAULT&#59; PRIOR TO DEFAULT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTAIN RIGHTS OF THE TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRUSTEE NOT RESPONSIBLE FOR RECITALS, DISPOSITION OF SECURITIES OR APPLICATION OF PROCEEDS THEREOF</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table Of Contents</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(continued)</font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRUSTEE AND AGENTS MAY HOLD SECURITIES&#59; COLLECTIONS, ETC</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MONEYS HELD BY TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPENSATION AND INDEMNIFICATION OF TRUSTEE AND ITS PRIOR CLAIM</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RIGHT OF TRUSTEE TO RELY ON OFFICER'S CERTIFICATE, ETC</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">QUALIFICATION OF TRUSTEE&#59; CONFLICTING INTERESTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PERSONS ELIGIBLE FOR APPOINTMENT AS TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RESIGNATION AND REMOVAL&#59; APPOINTMENT OF SUCCESSOR TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCEPTANCE OF APPOINTMENT BY SUCCESSOR TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MERGER, CONVERSION, CONSOLIDATION OR SUCCESSION TO BUSINESS OF TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PREFERENTIAL COLLECTION OF CLAIMS AGAINST THE COMPANY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AUTHENTICATING AGENT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 8 CONCERNING THE HOLDERS OF SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACTION BY HOLDERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROOF OF EXECUTION OF INSTRUMENTS BY HOLDERS OF SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 8.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HOLDERS TO BE TREATED AS OWNERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECURITIES OWNED BY COMPANY DEEMED NOT OUTSTANDING</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RIGHT OF REVOCATION OF ACTION TAKEN</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 9 HOLDERS' MEETINGS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURPOSES OF MEETINGS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CALL OF MEETINGS BY TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 9.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CALL OF MEETINGS BY COMPANY OR HOLDERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 9.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">QUALIFICATIONS FOR VOTING</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 9.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGULATIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 9.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VOTING</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 9.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NO DELAY OF RIGHTS BY REASON OF MEETING</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 10 SUPPLEMENTAL INDENTURES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 10.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUPPLEMENTAL INDENTURES WITHOUT CONSENT OF SECURITYHOLDERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 10.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUPPLEMENTAL INDENTURES WITH CONSENT OF SECURITYHOLDERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 10.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTICE OF SUPPLEMENTAL INDENTURE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 10.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EFFECT OF SUPPLEMENTAL INDENTURE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table Of Contents</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(continued)</font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 10.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOCUMENTS TO BE GIVEN TO TRUSTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 10.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTATION ON SECURITIES IN RESPECT OF SUPPLEMENTAL INDENTURES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 11 CONSOLIDATION, AMALGAMATION, MERGER OR SALE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 11.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPANY MAY CONSOLIDATE, ETC., ONLY ON CERTAIN TERMS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 11.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OPINION OF COUNSEL</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 11.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUCCESSOR PERSON SUBSTITUTED</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 12 SATISFACTION AND DISCHARGE OF INDENTURE, UNCLAIMED MONEYS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 12.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SATISFACTION AND DISCHARGE OF SECURITIES OF ANY SERIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 12.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFEASANCE AND COVENANT DEFEASANCE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 12.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APPLICATION OF TRUST MONEY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 12.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPAYMENT OF MONEYS HELD BY PAYING AGENT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 12.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RETURN OF UNCLAIMED MONEYS HELD BY TRUSTEE AND PAYING AGENT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 13 MISCELLANEOUS PROVISIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS OF COMPANY EXEMPT FROM INDIVIDUAL LIABILITY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROVISIONS OF INDENTURE FOR THE SOLE BENEFIT OF PARTIES AND SECURITYHOLDERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUCCESSORS AND ASSIGNS OF COMPANY BOUND BY INDENTURE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTICES TO HOLDERS&#59; WAIVER</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADDRESSES FOR NOTICES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OFFICER'S CERTIFICATES AND OPINIONS OF COUNSEL&#59; STATEMENTS TO BE CONTAINED THEREIN</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEPARABILITY CLAUSE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEGAL HOLIDAYS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONFLICT OF ANY PROVISION OF INDENTURE WITH TRUST INDENTURE ACT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOVERNING LAW</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUDGMENT CURRENCY</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NO SECURITY INTEREST CREATED</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUBMISSION TO JURISDICTION</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COUNTERPARTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 13.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EFFECT OF HEADINGS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 14 REDEMPTION OF SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 14.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APPLICABILITY OF ARTICLE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table Of Contents</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(continued)</font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 14.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTICE OF REDEMPTION&#59; SELECTION OF SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 14.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAYMENT OF SECURITIES CALLED FOR REDEMPTION</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 15 SINKING FUNDS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 15.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APPLICABILITY OF ARTICLE</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 15.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SATISFACTION OF MANDATORY SINKING FUND PAYMENT WITH SECURITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 15.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REDEMPTION OF SECURITIES FOR SINKING FUND</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</font></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBITS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.587%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT A </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CERTIFICATE FOR TRANSFER FROM RULE 144A GLOBAL SECURITY TO REGULATION S GLOBAL SECURITY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CERTIFICATE FOR TRANSFER FROM REGULATION S GLOBAL SECURITY TO RULE 144A GLOBAL SECURITY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CERTIFICATE FOR TRANSFERS FROM RESTRICTED GLOBAL SECURITY TO UNRESTRICTED GLOBAL SECURITY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT D</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CERTIFICATE FOR TRANSFERS PURSUANT TO RULE 144</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v</font></div></div></div><div id="i945374149a3b4d4197343f4a046e5f5b_223"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">---------</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Reconciliation and tie between Trust Indenture Act of 1939, as amended by the Trust Reform Act of 1990, and Indenture, dated as of August 16, 2004.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section of the <br>Trust Indenture Act of 1939</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt dashed #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section of Indenture</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="18" style="border-top:1pt dashed #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310(a)(1), (2) and (5)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310(a)(3) and (4)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inapplicable</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 and 7.10(a)and(b)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.13(a) and (c)(i) and (iii)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.13(b)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 and 5.2(a)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2(b)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312(c)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2(b)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4(a)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313(b)(1)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inapplicable</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313(b)(2)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4(b)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313(c)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4(c)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313(d)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4(d)</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10 and 5.3</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inapplicable</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314(c)(1) and (2)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314(c)(3)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inapplicable</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314(d)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inapplicable</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314(e)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315(a), (c) and (d)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.11</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315(e)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.12</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316(a)(1)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316(a)(2)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inapplicable</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316(a) (last sentence)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316(c)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317(b)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 and 4.3</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318(a)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;This reconciliation and tie shall not, for any purpose, be deemed to be part of the Indenture or to have any bearing upon the interpretation of any of its terms or provisions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i945374149a3b4d4197343f4a046e5f5b_102"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INDENTURE, dated as of August 16, 2004, between ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda limited company (herein, subject to Article 11, sometimes called the &#34;Company&#34;), having its principal office at Victoria Hall, 11 Victoria Street, Hamilton HM 11, Bermuda, and DEUTSCHE BANK TRUST COMPANY AMERICAS, a New York banking corporation duly organized and existing under the laws of the State of New York, as Trustee (hereinafter, subject to Article 12, called the &#34;Trustee&#34;), having its principal corporate trust office at 60 Wall Street, New York, NY, 10005. Attention&#58; Trust and Securities Services.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recitals of the Company</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has duly authorized the execution and delivery of this Indenture to provide for the issuance from time to time of its notes, debentures or other evidences of its unsecured indebtedness (herein called the &#34;Securities&#34;), to be issued in one or more series, authenticated and delivered, as in this Indenture provided.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All things necessary have been done to make this Indenture a valid and legally binding agreement of the Company, in accordance with its terms. </font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, THIS INDENTURE WITNESSETH&#58;</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For and in consideration of the premises and the purchase of the Securities by the Persons acquiring the same, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders of the Securities or of the Securities of any series, without giving any priority of any one Security or series over any other, except as otherwise expressly provided herein, as follows&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 1</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFINITIONS</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 1.1&#160;&#160;&#160;&#160;Certain Terms Defined.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms (except as otherwise expressly provided or unless the context otherwise clearly requires) for all purposes of this Indenture, including any indenture supplemental hereto, have the respective meanings specified in this Section. All other terms used in this Indenture that are defined in the Trust Indenture Act or the definitions of which in the Securities Act of 1933 are referred to in the Trust Indenture Act or that are defined by rule of the Commission under the Trust Indenture Act (except as herein otherwise expressly provided or unless the context otherwise clearly requires) have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act or in said Commission rule under the Trust Indenture Act as in force at the date on which this Indenture was originally executed (subject to Section 10.1 and Section 10.2). The words &#34;herein&#34;, &#34;hereof&#34; and &#34;hereunder&#34; and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision. All references herein to &#34;Articles&#34; or other subdivisions are to the corresponding Articles or other subdivisions of this Indenture. The terms defined in this Article have the meanings assigned to them in this Article and include the plural as well as the singular.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Additional Amounts&#34; means any additional amounts which are required hereby or by any Security, under circumstances specified herein or therein, to be paid by the Company in respect of certain taxes, assessments or other governmental charges imposed on Holders specified therein and which are owing to such Holders.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Affiliate&#34; of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, &#34;control&#34; when used with respect to any specified Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise&#59; and the terms &#34;controlling&#34; and &#34;controlled&#34; have meanings correlative to the foregoing.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Authenticating Agent&#34; means, with respect to any series of Securities, any authenticating agent appointed by the Trustee, with respect to that series of Securities, pursuant to Section 7.14.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Authorized Newspaper&#34; means a newspaper or financial journal printed in the English language, customarily published at least once a day, and customarily published for at least five days in each calendar week, whether or not published on days that are legal holidays and of general circulation&#59; or, in the alternative, shall mean such form of communication as may have come into general use for the dissemination of information of import similar to that of the information specified to be published by the provisions hereof. Whenever successive publications are required or authorized to be made in Authorized Newspapers, the successive publications may be made (unless otherwise expressly provided herein) in the same or different newspapers meeting the foregoing requirements and in each case on any Business Day and at the expense of the Company. In case, by reason of the suspension of publication of any Authorized Newspaper, or for any other cause, it shall be impractical without unreasonable expense to make publication of any notice in an Authorized Newspaper as required by this Indenture, then such method of publication or notification as shall be made with the approval of the Trustee shall be deemed the equivalent of the required publication of such notice in an Authorized Newspaper.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Board of Directors&#34; means either the board of directors of the Company or any committee of such Board of Directors or Officer duly authorized to act with respect to a particular matter on behalf of the Board of Directors.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Board Resolution&#34; means a copy of a resolution certified by the Secretary or any Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification, and delivered to the Trustee.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Broker-Dealer&#34; has the meaning set forth in any applicable Registration Rights Agreement.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Business Day&#34;, when used with respect to any Place of Payment or any other location specified in the Securities or this Indenture, means each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in that Place of Payment or location are generally authorized or obligated by law, regulation or executive order to close, except as may be otherwise specified as contemplated by Section 3.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Capitalized Lease Obligation&#34; means an obligation under a lease that is required to be capitalized for financial reporting purposes in accordance with generally accepted accounting principles, and the amount of Indebtedness represented by such obligation shall be the capitalized amount of such obligation determined in accordance with such principles.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Commission&#34; means the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act, or if at any time after the date on which this Indenture was originally executed such Commission is not existing and performing the duties assigned to it under the Trust Indenture Act on such date of original execution, then the body performing such duties at such time.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Common Shares&#34; in respect of any Corporation means Share Capital of any class or classes (however designated) which has no preference as to the payment of dividends, or as to the distribution of assets upon any voluntary or involuntary liquidation or dissolution of such Corporation, and which is not subject to redemption by such Corporation.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Company&#34; means Aspen Insurance Holdings Limited, a Bermuda company, and, subject to ARTICLE 11, its successors and assigns.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Company Order&#34; and &#34;Company Request&#34; mean a written order or request signed in the name of the Company by the chairman, any vice chairman, the president, any vice president, the chief executive officer, the chief financial officer, treasurer or controller and by the chief financial officer, chief operating officer, any assistant treasurer, any assistant controller, the secretary or any assistant secretary of the Company, and delivered to the Trustee.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Consolidated Book Value&#34; in respect of any Person means the total of the amounts shown on the balance sheet of such Person and its consolidated Subsidiaries, determined on a consolidated basis in accordance with GAAP, as of the end of the most recent fiscal quarter of such Person ending at least 45 days prior to the taking </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of any action for the purpose of which the determination is being made, as (i) the par or stated value of all outstanding Share Capital of such Person plus (ii) paid-in capital, share premium or capital surplus relating to such Share Capital plus (iii) any retained earnings or earned surplus plus (iv) any accumulated other comprehensive income, less any accumulated deficit.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Conversion Event&#34; means the cessation of use of (i) a Foreign Currency both by the government of the country or the confederation which issued such Foreign Currency and for the settlement of transactions by a central bank or other public institutions of or within the international banking community or (ii) any currency unit or composite currency for the purposes for which it was established.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Corporate Trust Office&#34; means the principal office of the Trustee at which at any particular time its corporate trust business shall be administered, which office, on the date of original execution of this Indenture, is located at 60 Wall Street, New York, NY, 10005, Attention&#58; Trust and Securities Services or at any other time at such other address as the Trustee may designate from time to time by notice to the parties hereto, or at the principal corporate trust office of any successor trustee as to which such successor trustee may notify the parties hereto in writing.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Corporation&#34; includes corporations, limited liability companies, incorporated associations, companies and business trusts.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Depository&#34; means, with respect to the Securities of any series or any Tranche thereof, which, in accordance with the determination of the Company, will be issued in whole or in part in the form of one or more Global Securities, The Depository Trust Company, New York, New York, another clearing agency or any successor registered under the Exchange Act, or other applicable statute or regulation, which, in each case, shall be designated by the Company pursuant to either Section 2.5 or Section 3.1. If at any time there is more than one such Person, &#34;Depository&#34; as used with respect to the Securities of any such series or Tranche thereof means the Depository with respect to the Securities of that series or Tranche.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#34;Designated Subsidiary&#34; means any present or future consolidated Subsidiary of the Company, the Consolidated Book Value of which constitutes at least 20% of the Consolidated Book Value of the Company.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Dollar&#34; (&#34;$&#34;) means the coin or currency of the United States of America as at the time of payment is legal tender for the payment of public and private debts.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Exchange Act&#34; means the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, in each case as amended from time to time.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Exchange Securities&#34; means the Securities issued in a Registered Exchange Offer.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Event of Default&#34; means any event or condition specified as such in Section 6.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Foreign Currency&#34; means any currency, currency unit or composite currency, including, without limitation, the euro, issued by the government of one or more countries other than the United States of America or by any recognized confederation or association of such governments.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;GAAP&#34; means generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Standards Accounting Board, and as are applicable to the financial statements of the Company, in each case as of the date of any computation required hereunder.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Global Security&#34; means, with respect to all or any part of any series of Securities, a Security executed by the Company and authenticated and delivered by the Trustee to the Depository or pursuant to the Depository's instruction, all in accordance with this Indenture and pursuant to a Company Order, which shall be registered in the name of the Depository or its nominee and the ownership of which will be registered in a &#34;book-entry&#34; or other system maintained by the Depository.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Government Obligations&#34; means securities which are (i) direct obligations of the United States of America or the other government or governments or confederation or association of governments which issued the Foreign Currency in which the principal of or any premium or interest on such Security or any Additional Amounts in respect thereof shall be payable, in each case where the payment or payments thereunder are supported by the full faith and credit of such government or governments or confederation or association of governments&#59; or (ii) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America or such other government or governments or confederation or association of governments, in each case where the timely payment or payments thereunder are unconditionally guaranteed as a full faith and credit obligation by the United States of America or such other government or governments or confederation or association of governments, and which, in the case of (i) or (ii), are not callable or redeemable at the option of the issuer or issuers thereof, and shall also include a depository receipt issued by a bank or trust company as custodian with respect to any such Government Obligation or a specific payment of interest on or principal of or other amount with respect to any such Government Obligation held by such custodian for the account of the holder of a depository receipt, provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depository receipt from any amount received by the custodian in respect of the Government Obligation or the specific payment of interest on or principal of or other amount with respect to the Government Obligation evidenced by such depository receipt.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Holder&#34;, &#34;Registered Holder&#34; and &#34;Securityholder&#34; mean, with respect to a Security, the Person in whose name such Security is registered in the Securities Register (which terms, in the case of a Global Security, mean the Depository, notwithstanding that the Depository maintains a &#34;book-entry&#34; or other system for identification of ownership in respect of such Global Security). </font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#34;include&#34; (and other forms of such term) means &#34;include, without limitation&#34;. </font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Indebtedness&#34; means, with respect to any Person, (i) the principal of and any premium and interest on (a) indebtedness of such Person for money borrowed or (b) indebtedness evidenced by notes, debentures, bonds or other similar instruments for the payment of which such Person is responsible or liable&#59; (ii) all Capitalized Lease Obligations of such Person&#59; (iii) all obligations of such Person issued or assumed as the deferred purchase price of property, all conditional sale obligations and all obligations under any title retention agreement (but excluding trade accounts payable arising in the ordinary course of business)&#59; (iv) all obligations of such Person for the reimbursement of any obligor on any letter of credit, banker's acceptance or similar credit transaction (other than obligations with respect to letters of credit securing obligations (other than obligations described in (i) through (iii) above) entered into in the ordinary course of business of such Person to the extent such letters of credit are not drawn upon or, if and to the extent drawn upon, such drawing is reimbursed no later than the third Business Day following receipt by such Person of a demand for reimbursement following payment on the letter of credit)&#59; (v) all obligations of the type referred to in clauses (i) through (iv) of other Persons and all dividends of other Persons for the payment of which, in either case, such Person is responsible or liable as obligor, guarantor or otherwise, the amount thereof being deemed to be the lesser of the stated recourse, if limited, and the amount of the obligations or dividends of the other Person&#59; (vi) all obligations of the type referred to in clauses (i) through (v) of other Persons secured by any Lien on any property or asset of such Person (whether or not such obligation is assumed by such Person), the amount of such obligation being deemed to be the lesser of the value of such property or assets or the amount of the obligation so secured&#59; and (vii) any amendments, modifications, refundings, renewals or extensions of any indebtedness or obligation described as Indebtedness in clauses (i) through (vi) above.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Indenture&#34; means this instrument as originally executed and delivered or, if amended or supplemented as herein provided, as so amended or supplemented, and includes the forms and terms of particular series of Securities established as contemplated hereunder.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#34;interest&#34; means, with respect to any Original Issue Discount Security which by its terms bears interest only after Maturity, means interest payable after Maturity and, when used with respect to a Security which provides for the payment of Additional Amounts pursuant to Section 4.4, includes such Additional Amounts.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Interest Payment Date&#34; means, with respect to any Security, the Stated Maturity of an installment of interest on such Security.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Judgment Currency&#34; has the meaning specified in Section 13.11.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Lien&#34; has the meaning specified in Section 4.6.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Maturity&#34; means, with respect to any Security, the date on which the principal of such Security becomes due and payable as therein or herein provided, whether at the Stated Maturity or by acceleration, call for redemption or otherwise.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;New York Banking Day&#34; has the meaning specified in Section 13.11.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Non-U.S. Person&#34; means a Person who is not a U.S. person as defined in Regulation S.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Officer&#34; means the Chairman of the Board, the Vice Chairman of the Board, the President, any Vice President, the Treasurer, any Assistant Treasurer, the Controller, the Secretary, any Assistant Controller, any Assistant Secretary, the principal executive officer, the principal financial officer, the principal accounting officer or the chief operating officer of the Company.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Officer's Certificate&#34; means a certificate signed by one or more Officers (as applicable) and delivered to the Trustee, except as otherwise specifically set forth herein.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Opinion of Counsel&#34; means an opinion in writing signed by legal counsel who may be an employee of or counsel to the Company.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Original Issue Discount Security&#34; means any Security that provides for an amount less than the principal amount thereof to be due and payable upon a declaration of acceleration with respect thereto pursuant to Section 6.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Outstanding&#34; (subject to Section 8.4) means, with reference to Securities as of the date of determination, all Securities authenticated and delivered under this Indenture, except&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Securities theretofore cancelled by the Trustee or delivered to the Trustee for cancellation&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Securities, or portions thereof, for the payment or redemption of which moneys in the necessary amount shall have been irrevocably deposited in trust with the Trustee or with any Paying Agent (other than the Company) or shall have been set aside, segregated and held in trust by the Company for the Holders of such Securities (if the Company shall act as its own Paying Agent) or for the payment of which Government Obligations shall have been irrevocably deposited in trust with the Trustee in accordance with ARTICLE 12&#59; provided that, if such Securities, or portions thereof, are to be redeemed prior to the Stated Maturity thereof, notice of such redemption shall have been given as herein provided, or provision satisfactory to the Trustee shall have been made for giving such notice&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) any such Security with respect to which the Company has effected defeasance pursuant to the terms hereof, except to the extent provided in Section 12.2&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Securities in substitution for which other Securities shall have been authenticated and delivered, or which shall have been paid, pursuant to the terms of Section 3.8 (except with respect to any such Security as to which proof satisfactory to the Trustee and the Company is presented that such Security is held by a Person in whose hands such Security is a legal, valid and binding obligation of the Company)&#59; and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) any such Security converted or exchanged as contemplated by this Indenture into Common Shares of the Company or other securities, if the terms of such Security provide for such conversion or exchange pursuant to Section 3.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether Holders of the requisite principal amount of Outstanding Securities of any or all series have made or given any request, demand, authorization, direction, notice, consent or waiver hereunder, or are present to constitute a quorum at a meeting of Holders of Securities, (i) the principal amount of an Original Issue Discount Security that shall be deemed to be Outstanding for such purposes shall be the amount of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">principal thereof that would be due and payable as of the date of such determination upon a declaration of acceleration with respect thereto pursuant to Section 6.1 and (ii) Securities owned by the Company or any other obligor upon the Securities or any Affiliate of the Company or such other obligor, shall be disregarded and deemed not to be Outstanding, except that, in determining whether the Trustee shall be protected in making such a determination or relying upon any such quorum, consent or vote, only Securities which a Responsible Officer of the Trustee actually knows to be so owned shall be so disregarded.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Overdue Rate&#34; means, with respect to any Security of Securities, the rate designated as such in or pursuant to the resolution of the Board of Directors or the supplemental indenture, as the case may be, relating to such Security as contemplated by Section 3.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Paying Agent&#34; means any Person authorized by the Company to pay the principal of, or premium, if any, or interest, if any, on, any Securities on behalf of the Company.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Periodic Offering&#34; means an offering of Securities of a series from time to time, any or all of the specific terms of which Securities, which may be in one or more Tranches, including the rate or rates of interest, if any, thereon, the Stated Maturity or Maturities thereof and the redemption provisions, if any, with respect thereto, are to be determined by the Company or its agents from time to time subsequent to the initial request for authentication and delivery of such Securities by the Trustee, all as contemplated in Section 3.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Person&#34; means any individual, corporation, limited liability company, partnership, limited liability partnership, joint venture, association, joint stock company, trust, unincorporated organization or government or any agency or political subdivision thereof.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Place of Payment&#34; means, with respect to any Security, the place or places where the principal of, and premium, if any, and interest, if any, on, such Security are payable as specified pursuant to Section 3.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Predecessor Security&#34; of any particular Security means every previous Security evidencing all or a portion of the same Indebtedness as that evidenced by such particular Security&#59; and, for the purposes of this definition, any Security authenticated and delivered under Section 3.8 in lieu of a lost, destroyed, mutilated or stolen Security shall be deemed to evidence the same debt as the lost, destroyed or stolen Security.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Private Placement Legend&#34; has the meaning specified in Section 2.2.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;QIB&#34; means a &#34;qualified institutional buyer&#34;, as defined in Rule 144A.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Redemption Date&#34; means, with respect to any Security to be redeemed, the date fixed for such redemption by or pursuant to this Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Redemption Price&#34; means, with respect to any Security or portion thereof to be redeemed, the price at which it is to be redeemed pursuant to this Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Registered Holder&#34;&#58;  See &#34;Holder&#34;.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Regular Record Date&#34; for the interest payable on any Interest Payment Date on a Security means the date specified for that purpose pursuant to Section 3.1 or as specified in Section 3.9.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Registered Exchange Offer&#34; means an exchange offer by the Company registered under the Securities Act pursuant to which Restricted Securities are exchanged for Securities of like principal amount not bearing the Private Placement Legend.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Registration Rights Agreement&#34; means any registration rights agreement between the Company and one or more initial purchasers in connection with the issuance of Restricted Securities of any series under this Indenture.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Regulation S&#34; means Regulation S under the Securities Act (including any successor regulation thereto) as may be amended from time to time.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Regulation S Global Security&#34; means each Global Security that represents Securities sold in reliance on Regulation S and as specified in Section 2.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Required Currency&#34; has the meaning specified in Section 13.11.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Responsible Officer&#34; means, with respect to the Trustee, any officer assigned to the Corporate Trust Office, including any managing director, vice president, assistant vice president, assistant treasurer, assistant secretary or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers, and also, with respect to a particular matter, any other officer, to whom such matter is referred because of such officer's knowledge of and familiarity with the particular subject.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Restricted Global Security&#34; means a Global Security that bears the Private Placement Legend.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Restricted Security&#34; means any Security (or beneficial interest therein) not originally issued and sold in a transaction registered under the Securities Act, until such time as&#58; (i) such Security (or beneficial interest therein) has been transferred in a transaction registered under the Securities Act&#59; (ii) the Restriction Termination Date therefor has passed&#59; or (iii) the Private Placement Legend therefor has otherwise been removed pursuant to Section 3.7(e) hereof or, in the case of a beneficial interest in a Global Security, such beneficial interest has been exchanged for an interest in a Global Security not bearing a Private Placement Legend.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Restriction Termination Date&#34; means, with respect to any Restricted Security (or beneficial interest therein) resold in reliance on Rule 144A, two years (or such other period specified in Rule 144(k)) or, with respect to any Restricted Security (or beneficial interest therein) resold in reliance on Regulation S, the last day of the distribution compliance period specified in Rule 903 of Regulation S (if applicable), in each case from the original issue date of such Restricted Security or, if any additional Restricted Securities within the same series have been issued and sold prior to the Restriction Termination Date for such Restricted Security, from the latest original issue date of such additional Securities.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Rule 144&#34; means Rule 144 under the Securities Act (including any successor regulation thereto) as may be amended from time to time.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Rule 144A&#34; means Rule 144A under the Securities Act (including any successor regulation thereto) as may be amended from time to time.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Rule 144A Global Security&#34; means each Global Security that represents Securities resold in reliance on Rule 144A, and as specified in Section 2.1.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Securities Act&#34; means the Securities Act of 1933 and any statute successor thereto, in each case as amended from time to time.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Securities Register&#34; and &#34;Securities Registrar&#34;&#58; See Section 3.6.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Security&#34; or &#34;Securities&#34; has the meaning stated in the recitals of this Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Share Capital&#34; of any Person means any and all share capital, interests, rights to purchase, warrants, options, participations or other equivalents of or interests in (however designated) equity of such Person, including preferred stock, but excluding any debt securities convertible into such equity.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Special Record Date&#34; for the payment of any defaulted interest means a date fixed pursuant to Section 3.9.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Stated Maturity&#34; means, with respect to any Security or any installment of principal thereof or interest thereon or any Additional Amounts with respect thereto, the date specified in such Security as the fixed date </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on which the principal of such Security or such installment of principal or interest is, or such Additional Amounts are, due and payable (without regard to any provisions for redemption, prepayment, acceleration, purchase or extension).</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Subsidiary&#34; means, in respect of any Person, any Corporation, limited or general partnership or other business entity of which at the time of determination more than 50% of the voting power of the shares of its Share Capital or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is owned or controlled, directly or indirectly, by (i) such Person, (ii) such Person and one or more Subsidiaries of such Person or (iii) one or more Subsidiaries of such Person.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Tranche&#34; means a group of Securities which (a) are of the same series and (b) are identical except as to principal amount and&#47;or date of issuance.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Trust Indenture Act&#34; means the Trust Indenture Act of 1939, as amended, as in force at the date as of which this Indenture was executed&#59; provided, however, that in the event that such Act is amended after such date, &#34;Trust Indenture Act&#34; means, to the extent required by such amendment, the Trust Indenture Act of 1939 as so amended.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Trustee&#34; means the Person identified as &#34;Trustee&#34; in the first paragraph hereof and, subject to the provisions of ARTICLE 7, shall also include any successor trustee.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;United States,&#34; except as otherwise provided in or pursuant to this Indenture or any Board Resolution, Company Order and Company Request or both, means the United States of America (including the states thereof and the District of Columbia), its territories and possessions and other areas subject to its jurisdiction.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Vice President&#34; means any vice president, whether or not designated by a number or a word or words added before or after the title &#34;vice president&#34;.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 2</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECURITY FORMS</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 2.1 Forms Generally.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities of each series shall be in substantially such form as shall be established pursuant to Section 3.1, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture or any indenture supplemental hereto, and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as the Company may deem appropriate and as are not contrary to the provisions of this Indenture, or as may be required to comply with any law or with any rules made pursuant thereto or with any rules of any securities exchange or of any automated quotation system, or to conform to usage, all as determined by the officers executing such Securities, as conclusively evidenced by their execution of the Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Securities originally offered and sold to QIBs in reliance on Rule 144A will be issued in the form of one or more permanent Global Securities (each, a &#34;Rule 144A Global Security&#34;). Any Securities originally offered and sold outside the United States in reliance on Regulation S will be issued in the form of one or more permanent Global Securities (each, a &#34;Regulation S Global Security&#34;).</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definitive Securities shall be prepared by the Company and shall be printed, lithographed or engraved on steel-engraved borders, or may be produced in any other manner, all as determined by the officers executing such Securities, as conclusively evidenced by their execution of such Securities, subject to the rules of any securities exchange or automated quotation system on which such Securities are listed or quoted and (with respect to Global Securities) to the rules of the Depository.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 2.2 Form of Legend for Restricted Securities.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Restricted Security shall bear the following legend (the &#34;Private Placement Legend&#34;) on the face thereof&#59; provided, however, that the Private Placement Legend on any Security shall be removed at the request of the Holder on or after the date when such Security ceases to be a Restricted Security&#58;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &#34;SECURITIES ACT&#34;) AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) (1) TO A PERSON WHO THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENT OF RULE 144A, (2) IN AN OFFSHORE TRANSACTION COMPLYING WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, OR (3) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE), OR (4) TO AN INSTITUTIONAL ACCREDITED INVESTOR IN A TRANSACTION EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, OR (5) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND (B) IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 2.3&#160;&#160;&#160;&#160;Form of Trustee's Certificate of Authentication.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee's Certificate of Authentication on all Securities shall be in substantially the following form&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.337%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutsche Bank Trust Company Americas, as Trustee</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Signatory</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 2.4 Form of Trustee's Certificate of Authentication by an Authenticating Agent.</font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If at any time there shall be an Authenticating Agent appointed with respect to any series of Securities, then the Trustee's Certificate of Authentication by such Authenticating Agent on all Securities of each such series shall be in substantially the following form&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.337%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutsche Bank Trust Company Americas, as Trustee</font></div></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.255%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;NAME OF AUTHENTICATING AGENT&#93;,</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authenticating Agent</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Signatory</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 2.5 Securities Issuable in the Form of Global Securities.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) If the Company shall establish pursuant to Section 3.1 that the Securities of a particular series are to be issued in whole or in part as one or more Global Securities, then the Company shall execute, and the Trustee shall, in accordance with Section 3.3 and the Company Order deliver to the Trustee thereunder, authenticate and make available for delivery, one or more Global Securities, each of which (i) shall represent an aggregate principal amount equal to the aggregate principal amount of the Outstanding Securities of such series to be represented by such Global Security and may also provide that the aggregate amount of Outstanding Securities represented thereby may from time to time be increased or reduced to reflect exchanges, (ii) shall be registered in the name of the Depository or its nominee, (iii) shall be delivered by the Trustee to the Depository or pursuant to the Depository's instruction and (iv) if required by the Depository, shall bear a legend reflecting the Depository's interest in such Global Security.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Notwithstanding any provision of Section 3.6, any Global Security thereof may be transferred, in whole but not in part, and in the manner provided in Section 3.6, only to another nominee of the Depository for such series or Tranche, or to a successor Depository for such series selected or approved by the Company or to a nominee of such successor Depository.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) If at any time (A) (i) the Depository for Securities of a series or Tranche thereof notifies the Company that it is unwilling or unable to continue as Depository for Securities of such series or Tranche, or (ii) the Depository shall no longer be registered or in good standing under the Exchange Act, or other applicable statute or regulation, and a successor Depository is not appointed by the Company within 90 days after the Company receives such notice or becomes aware of such condition, as the case may be, or (B) there shall have occurred and be continuing an Event of Default with respect to such Global Security, this Section shall no longer be applicable to the Securities of such series or Tranche and the Company will execute, and the Trustee, upon receipt of a Company Order for the authentication and delivery of individual Securities of such series or Tranche, will authenticate and make available for delivery, Securities of such series or Tranche, in authorized denominations, and in an aggregate principal amount equal to the aggregate principal amount of the Global Security or Global Securities of such series or Tranche in exchange for such Global Security or Global Securities.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may at any time determine that Securities of any series or Tranche thereof shall no longer be represented by one or more Global Securities and that the provisions of this Section shall no longer apply to the Securities of such series or Tranche. In such event the Company will execute and the Trustee, upon receipt of a Company Order for the authentication and delivery of individual Securities of such series or Tranche, will authenticate and make available for delivery Securities of such series or Tranche, in authorized denominations, and in an aggregate principal amount equal to the aggregate principal amount of the Global Security or Global Securities of such series or Tranche in exchange for such Global Security.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If specified by the Company pursuant to Section 3.1 with respect to a series of Securities or Tranche thereof, the Depository for such series or Tranche may surrender a Global Security for such series or Tranche in exchange in whole or in part for individual Securities of such series or Tranche on such terms as are acceptable to the Company and such Depository. Thereupon, the Company shall execute, and the Trustee shall authenticate and make available for delivery, without service charge,</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) to each Person specified by such Depository a new  individual Security or Securities of the same series or Tranche, of any  authorized denomination as requested by such Person in aggregate  principal amount equal to and in exchange for such Persons' beneficial  interest in the Global Security&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) to such Depository a new Global Security in a denomination equal to the difference, if any, between the principal amount of the surrendered Global Security and the aggregate principal amount of individual Securities delivered to Holders thereof.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any exchange provided for in any of the preceding paragraphs of this Section, the Company will execute and the Trustee will authenticate and make available for delivery individual Securities in registered form in authorized denominations.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the exchange of a Global Security for individual Securities, such Global Security shall be cancelled by the Trustee. Individual Securities issued in exchange for a Global Security pursuant to this Section shall be registered in such names and in such authorized denominations as the Depository for such Global Security shall instruct the Trustee. The Trustee shall make such Securities available for delivery to the Persons in whose names such Securities are so registered.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 3</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE SECURITIES</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.1 Amount Unlimited&#59; Issuable in Series.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate principal amount of Securities which may be authenticated and delivered under this Indenture is unlimited.</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities may be issued from time to time in one or more series. With respect to the Securities of any particular series, there shall be established in, or pursuant to the authority granted in, a resolution of the Board of Directors, and set forth in an Officer's Certificate, or established in one or more indentures supplemental hereto prior to the issuance of Securities of a series&#58;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) the form of the Securities of the series&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) the title of the Securities of the series (which shall distinguish the Securities of the series from all other Securities)&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) any limit upon the aggregate principal amount of the Securities of the series that may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the series pursuant to Section 2.5, Section 3.6, Section 3.8, Section 3.12 or Section 14.3)&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) the date or dates on which the Securities of the series may be issued&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) the date or dates, which may be serial, on which the principal of, and premium, if any, on, the Securities of the series are payable&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) the rate or rates, or the method of determination thereof, at which the Securities of the series shall bear interest, if any, any Overdue Rate (including the rate or rates at which overdue principal shall bear interest, if different from the rate or rates at which such Securities shall bear interest prior to Maturity, and, if applicable, the rate or rates at which overdue premium or interest shall bear interest, if any)&#59; any formulary or other method or other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means by which any such rate or rates shall be determined, by reference to an index or other fact or event ascertainable outside this Indenture or otherwise&#59; the date or dates from which such interest shall accrue and the method or methods, if any, by which such date or dates are to be determined, the Interest Payment Dates on which such interest shall be payable and the Regular Record Date, if other than as set forth in Section 3.9, for the determination of Holders to whom interest is payable, whether and under what circumstances Additional Amounts (in addition to those set forth in Section 4.4) on such Securities or any of them shall be payable, the notice, if  any, to Holders regarding the determination of interest on a floating rate Security, and the manner of giving such notice, and the basis upon which interest shall be calculated if other than that of a 360-day year of twelve 30-day months&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) the place or places where the principal of, and premium, if any, and interest on or any Additional Amounts, if any, with respect to such Securities of the series shall be payable (if other than as provided in Section 4.2)&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) the provisions, if any, establishing the price or prices at which, the date or dates on which, the period or periods within which and the terms and conditions upon which Securities of the series may be redeemed, in whole or in part, at the option of the Company, pursuant to any sinking fund or otherwise&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the obligation, if any, of the Company to redeem, purchase or repay Securities of the series pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof and the price or prices at which, the date or dates on which, and the period or periods within which, and the terms and conditions upon which, Securities of the series shall be redeemed, purchased or repaid, in whole or in part, pursuant to such obligation and any provisions for the remarketing of such Securities so redeemed or purchased&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j) if other than denominations of $1,000, and any integral multiple thereof, the denominations in which Securities of the series shall be issuable&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k) whether the Securities of the series will be convertible into shares of Common Shares of the Company and&#47;or exchangeable for other securities, whether or not issued by the Company, and, if so, the terms and conditions upon which such Securities will be so convertible or exchangeable, and any deletions from or modifications or additions to this Indenture to permit or to facilitate the issuance of such convertible or exchangeable Securities or the administration thereof&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l) whether the Securities of the series are to be issued as Original Issue Discount Securities and, if so, the amount of the discount with respect thereto&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m) if other than the principal amount thereof, the portion of the principal amount of the Securities of the series which shall be payable upon declaration of acceleration with respect thereto pursuant to Section 6.1 or payable in bankruptcy pursuant to Section 6.2&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n) any Events of Default or restrictive covenants provided for with respect to the Securities of the series, if other than as set forth in Section 6.1, ARTICLE 4 and ARTICLE 11&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o) in case the Securities of the series do not bear interest, the applicable dates for the purpose of Section 5.1&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p) whether the Securities of the series will bear any other form of special interest&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q) whether either or both of Section 12.2(b) relating to defeasance or Section 12.2(c) relating to covenant defeasance shall not be applicable to the Securities of such series, or any covenants in addition to those specified in Section 12.2(c) relating to the Securities of such series which shall be subject to covenant defeasance, and any deletions from, or modifications or additions to, the provisions of ARTICLE 12 in respect of the Securities of such series&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r) any trustees, paying agents, transfer agents or registrars with respect to the Securities of the series&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s) whether the Securities of the series are issuable in whole or in part as one or more Global Securities and, in such case, the identity of the Depository for such Global Security or Global Securities&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t) any restrictions on transfer with respect to the Securities of the series and any legend reflecting such restrictions to be placed on such Securities&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u) if the amount of payment of principal of, and premium, if any, or interest on or Additional Amounts, if any, with respect to such Securities of the series may be determined with reference to an index, formula or other method, and, if so, the terms and conditions upon which and the manner in which such amounts shall be determined&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) any exceptions to Section 13.8 or in the definition of &#34;Business Day&#34; with respect to the Securities of the series&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(w) if other than U.S. dollars, the Foreign Currency in which the Securities of such series shall be denominated and in which payments or principal of, and any premium or interest on or Additional Amounts with respect to, such Securities shall or may be payable&#59;</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x) if the principal of, any premium or interest on or any Additional Amounts with respect to any of such Securities are to be payable, at the election of the Company or a Holder thereof or otherwise, in Dollars or in a Foreign Currency other than that in which such Securities are stated to be payable, the date or dates on which, the period or periods within which, and the other terms and conditions upon which, such election may be made, and the time and manner of determining the exchange rate between the Currency in which such Securities are stated to be payable and the Currency in which such Securities or any of them are to be paid pursuant to such election, and any deletions from or modifications of or additions to the terms of this Indenture to provide for or to facilitate the issuance of Securities denominated or payable, at the election of the Company or a Holder thereof or otherwise, in a Foreign Currency&#59; and</font></div><div style="margin-bottom:10pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y) any other terms of the series and any other modifications or additions to this Indenture in respect of such Securities (which terms shall not be contrary to the provisions of this Indenture).</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Securities of a series subject to a Periodic Offering, such resolution of the Board of Directors or indenture supplemental hereto may provide general terms or parameters and may provide that the specific terms of particular Securities, and the Persons authorized to determine such terms or parameters, may be determined in accordance with or pursuant to the Company Order referred to in Section 3.3.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Securities of any one series shall be substantially identical except as to denomination and except as may otherwise be provided in, or pursuant to the authority granted in, such resolution of the Board of Directors or in any such indenture supplemental hereto.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anything herein to the contrary notwithstanding, the Trustee shall be under no obligation to authenticate and deliver Securities of any series the terms of which, established as contemplated by this Section, would affect the rights, duties, obligations, liabilities or immunities of the Trustee under this Indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.2 Form and Denominations.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the absence of any specification pursuant to Section 3.1 with respect to the Securities of any series, the Securities of such series shall be issuable in fully registered form, without coupons, in denominations of $1,000 and any integral multiple thereof.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.3 Authentication, Dating and Delivery of Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time and from time to time after the original execution and delivery of this Indenture, the Company may deliver Securities of any series, executed by the Company, to the Trustee for authentication. Except as otherwise provided in this Article, the Trustee shall thereupon authenticate and make available for delivery, or cause to be authenticated and delivered, said Securities to or upon a Company Order, without any further action by the Company&#59; provided, however, that the Trustee shall authenticate and make available for delivery Securities of such series for original issue from time to time in the aggregate principal amount established for such series pursuant to such procedures, acceptable to the Trustee and to such recipients, as may be specified from time to time by a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company Order. The maturity dates, original issue dates, interest rates and any other terms of the Securities of such series shall be determined by or pursuant to such Company Order and procedures.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In authenticating such Securities and accepting the responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive, prior to the initial authentication of such Securities, and (subject to Section 7.1) shall be fully protected in relying upon&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) a Board Resolution relating thereto&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) an Officer's Certificate or an executed supplemental indenture setting forth the terms of such Securities as provided in Section 3.1&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) an Officer's Certificate which shall state that all conditions precedent provided for in this Indenture relating to the issuance of such Securities have been complied with, that no Event of Default with respect to any series of Securities has occurred and is continuing and that the issuance of such Securities does not constitute and will not result in (i) any Event of Default or any event or condition, which, upon the giving of notice or the lapse of time or both, would become an Event of Default or (ii) any default under the provisions of any other instrument or agreement by which the Company is bound&#59; and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) an Opinion of Counsel, which shall state&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) that the form and the terms of such Securities have been duly authorized by the Company and have been established in conformity with the provisions of this Indenture&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) that such Securities, when authenticated and delivered by the Trustee and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute valid and binding obligations of the Company enforceable in accordance with their terms, except to the extent enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, arrangement, fraudulent conveyance, fraudulent transfer and other similar laws affecting the enforcement of creditors' rights generally and by general principles of equity (regardless of whether enforceability is considered in a proceeding in equity or at law)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) that no consent, approval, authorization, order, registration or qualification of or with any court or any governmental agency or body having jurisdiction over the Company is required for the execution and delivery of such Securities by the Company, except such as have been obtained (and except that no opinion need be expressed as to state securities or &#34;blue sky&#34; laws)&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) all applicable laws and requirements in respect of the execution and delivery by the Company of such Securities have been complied with&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the provisions of Section 3.1 and of the immediately preceding paragraph, with respect to Securities of a series subject to a Periodic Offering, the Trustee shall be entitled to receive the Officer's Certificate otherwise required pursuant to Section 3.3(c) and the Opinion of Counsel required by this Section 3.3(d) only once at or prior to the time of the first authentication and delivery of such Securities (provided that such Opinion of Counsel addresses the authentication and delivery of all such Securities) and that, in lieu of the opinions described in clause (ii) above, Counsel may opine that&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x) when the terms of such Securities shall have been established pursuant to a Company Order or Orders or pursuant to such procedures as may be specified from time to time by a Company Order or Orders, all as contemplated by and in accordance with the instrument or instruments delivered pursuant to clause (i) above, such terms will have been duly authorized by the Company and will have been established in conformity with the provisions of this Indenture&#59; and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y) when such Securities shall have been authenticated and delivered by the Trustee in accordance with this Indenture and the Company Order or Orders or the specified procedures referred to in paragraph (x) above and issued and delivered by the Company in the manner and subject to any conditions specified in such Opinion of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Counsel, such Securities will constitute valid obligations of the Company enforceable in accordance with their terms except to the extent enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting the enforcement of creditors rights generally and by the effect of general principles of equity (regardless of whether enforceability is considered in a proceeding in equity or at law).</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Securities of a series subject to a Periodic Offering, the Trustee may conclusively rely, as to the authorization by the Company of any of such Securities, the forms and terms thereof, the validity thereof and the compliance of the authentication and delivery thereof with the terms and conditions of this Indenture, upon the Opinion or Opinions of Counsel, the Officer's Certificate and the certificates and other documents delivered pursuant to this Section 3.3 at or prior to the time of the first authentication and delivery of Securities of such series until any of such opinions, certificates or other documents have been superseded or revoked or expire by their terms&#59; provided, however, that any request by the Company to the Trustee to authenticate and deliver Securities of such series shall constitute a representation and warranty by the Company that as of the date of such request the statements made in the most recent Officer's Certificate delivered pursuant to Section 3.3(c) are true and correct as if made on and as of the date thereof.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee shall have the right to decline to authenticate and make available for delivery any Securities under this Section if the Trustee, being advised by counsel reasonably acceptable to the Trustee and the Company, determines that such action would be contrary to the provisions hereof or would expose the Trustee to personal liability.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Security shall be dated the date of its authentication, except as otherwise provided pursuant to Section 3.1 with respect to the series of which such Security is a part and except that any substitute Security under Section 3.8 shall be dated so that neither gain nor loss in interest shall result from any mutilation, destruction, loss or theft of the relevant Predecessor Security.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.4 Execution of Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities shall be signed in the name of and on behalf of the Company by both (a) its chairman, vice chairman, president, any vice president, chief executive officer or chief financial officer and (b) its chief financial officer, chief operating officer, treasurer, any assistant treasurer, its secretary or any assistant secretary, under its corporate seal which may, but need not, be attested. Such signatures may be the manual or facsimile signatures of such officers. The seal of the Company may be in the form of a facsimile thereof and may be impressed, affixed, imprinted or otherwise reproduced thereon. Typographical and other minor errors or defects in any such reproduction of the seal or any such signature shall not affect the validity or enforceability of any Security that has been duly authenticated and delivered by the Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case any officer of the Company who shall have signed any of the Securities shall cease to be such officer before the Security so signed shall be authenticated and delivered by or on behalf of the Trustee or disposed of by the Company, such Securities nevertheless may be authenticated and delivered or disposed of as though the Person who signed such Securities had not ceased to be such officer of the Company&#59; and any Security may be signed on behalf of the Company by such Persons as, at the actual date of the original execution of such Security, shall be the proper officers of the Company, although at the date of the original execution and delivery of this Indenture, or at the date of such Security, any such Person was not such an officer.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.5 Certificate of Authentication.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No Security shall be entitled to the benefits of this Indenture or be valid or obligatory for any purpose, unless there appears on such Security a certificate of authentication substantially in the form hereinbefore recited, executed by or on behalf of the Trustee by manual signature. Such certificate by or on behalf of the Trustee upon any Security executed by the Company shall be conclusive evidence that the Security so authenticated has been duly authenticated and delivered hereunder and that the Holder is entitled to the benefits of this Indenture.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.6 Registration, Registration of Transfer and Exchange.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the conditions set forth below (and subject, with respect to Global Securities, to Section 2.5), Securities of any series may be exchanged for a like aggregate principal amount of Securities of the same series and having the same terms but in other authorized denominations. Securities to be exchanged shall be surrendered at the offices or agencies to be maintained for such purposes as provided in Section 4.2, and the Company shall execute and the Trustee or any Authenticating Agent shall authenticate and make available for delivery in exchange therefor the Security or Securities which the Holder making the exchange shall be entitled to receive.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall keep or cause to be kept, at one of said offices or agencies maintained pursuant to Section 4.2, a register for each series of Securities issued hereunder (hereinafter collectively referred to as the &#34;Securities Register&#34;) in which, subject to such reasonable regulations as it may prescribe, the Company shall, subject to the provisions of Section 2.5, provide for the registration of Securities of such series and shall register the transfer of Securities of such series as in this Article provided. The Securities Register shall be in written form or in any other form capable of being converted into written form within a reasonable time. The Trustee is hereby appointed as the initial &#34;Securities Registrar&#34; for the purpose of registering Securities and registering transfers of Securities as herein provided.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions of Section 2.5, upon surrender for registration of transfer of any Security of any series at any such office or agency, the Company shall execute and the Trustee or any Authenticating Agent shall authenticate and make available for delivery in the name of transferee or transferees a new Security or Securities of the same series for an equal aggregate principal amount.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall have the right to remove and replace from time to time the Security Registrar for any series of Securities&#59; provided that no such removal or replacement shall be effective until a successor Security Registrar with respect to such series of Securities shall have been appointed by the Company and shall have accepted such appointment by the Company. In the event that the Trustee shall not be or shall cease to be Security Registrar with respect to a series of Securities, it shall have the right to examine the Security Register for such series at all reasonable times. There shall be only one Security Register for each series of Securities.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Securities presented for registration of transfer or for exchange, redemption or payment shall (if so required by the Company or the Securities Registrar) be duly endorsed by, or be accompanied by a written instrument or instruments of transfer in form satisfactory to the Company and the Securities Registrar duly executed by, the Holder thereof or his attorney duly authorized in writing.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Security issued upon registration of transfer or exchange of Securities pursuant to this Section shall be the valid obligation of the Company, evidencing the same indebtedness and entitled to the same benefits under this Indenture as the Security or Securities surrendered upon registration of such transfer or exchange.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No service charge shall be made for any registration of transfer or exchange of Securities, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in connection with any registration of transfer or exchange of Securities, other than exchanges pursuant to Section 3.12, Section 10.6 or Section 14.3 not involving any transfer.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither the Company nor the Security Registrar shall be required (a) to issue, exchange or register the transfer of any Securities of any series during a period beginning at the opening of business 15 days before the day of the mailing of a notice of redemption of Securities of such series and ending at the close of business on the day of such mailing, or (b) to exchange or register the transfer of any Securities selected, called or being called for redemption except, in the case of any Security to be redeemed in part, the portion thereof not to be redeemed.</font></div><div style="margin-bottom:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.7 Additional Provisions Related to Transfer and Exchange of Restricted Securities.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) If the owner of a beneficial interest in a Rule 144A Global Security that is a Restricted Security wishes to transfer such interest (or a portion thereof) to a Non-U.S. Person pursuant to Regulations S, then upon receipt by the Trustee of (i) instructions from the Holder of the Rule 144A Global Security directing the Trustee to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">credit or cause to be credited a beneficial interest in the Regulation S Global Security equal to the principal amount of the beneficial interest in the Rule 144A Global Security to be transferred and (ii) a certificate from the transferor in the form of Exhibit A, the Trustee shall, subject to the rules and procedures of the Depository, instruct the Depository to increase the Regulation S Global Security and decrease the Rule 144A Global Security by the amount so transferred.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) If the owner of a beneficial interest in a Regulation S Global Security that is a Restricted Security wishes to transfer such interest (or a portion thereof) to a QIB pursuant to Rule 144A, then upon receipt by the Trustee of (i) instructions from the Holder of the Regulation S Global Security directing the Trustee to credit or cause to be credited a beneficial interest in the Rule 144A Global Security equal to the principal amount of the beneficial interest in the Regular S Global Note to be transferred and (ii) a certificate from the transferor in the form of Exhibit B, the Trustee shall, subject to the rules and procedures of the Depository, instruct the Depository to increase the Rule 144A Global Security and decrease the Regulation S Global Security by the amount so transferred.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) If the owner of a beneficial interest in a Restricted Global Security wishes to transfer such interest in a Global Security that is unrestricted pursuant to a Registered Exchange Offer, then upon receipt by the Trustee of (i) instructions from the Holder of the Restricted Global Security directing the Trustee to cause the transfer and exchange in the beneficial interest in the Restricted Global Security to a beneficial interest in a Global Security that is unrestricted, equal to the principal amount of the beneficial interest in the Restricted Global Security to be transferred, and (ii) a certificate from the owner in the form of Exhibit C, the Trustee shall, subject to the rules and procedures of the Depository, instruct the Depository to cause such transfer and exchange.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to and in accordance with the provisions of this Section 3.7, upon the close of the Registered Exchange Offer in accordance with the terms of the Registration Rights Agreement, the Company shall execute and, upon receipt of a Company Order, the Trustee shall authenticate and deliver one or more unrestricted Global Securities representing an aggregate principal amount of Securities equal to the principal amount of Securities tendered for acceptance by Persons that certify in the applicable letters of transmittal that (x) they are not Broker-Dealers, (y) they are not participating in a distribution of the Exchange Securities and (z) they are not affiliates (as defined in Rule 144) of the Company, and accepted for exchange in the Exchange Offer.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Any transfer of Restricted Securities not described above (other than transfers of beneficial interests within the same Global Security, which must be effected in accordance with applicable law and the rules and procedures of the Depository) shall be made only upon receipt by the Trustee of such opinions of counsel, certificates and&#47;or other information reasonably required by and satisfactory to it in order to ensure compliance with the Securities Act or in accordance with subsection (e) below.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Upon the transfer, exchange or replacement of any Security (or a beneficial interest in a Global Security) bearing a Private Placement Legend, the Trustee shall deliver only a Security (or a beneficial interest in a Global Security) that bears a Private Placement Legend unless&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) such Security (or beneficial interest) is exchanged in a Registered Exchange Offer&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) such Security (or beneficial interest) is transferred pursuant to an effective registration statement&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) such Security (or beneficial interest) is transferred pursuant to Rule 144 upon delivery to the Trustee of a certificate from the transferor in the form of Exhibit D and an opinion of counsel reasonably satisfactory to the Trustee&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) such Security (or beneficial interest) is transferred, replaced or exchanged after the Restriction Termination Date therefor&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) in connection with such transfer, exchange or replacement, the Trustee shall have received an opinion of counsel and other evidence reasonably satisfactory to it to the effect that neither such Private </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Placement Legend nor the related restrictions on transfer are required in order to maintain compliance with the Securities Act.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.8 Mutilated, Destroyed, Lost and Stolen Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case any temporary or definitive Security shall become mutilated (whether by defacement or otherwise) or be destroyed, lost or stolen, and in the absence of notice to the Company or the Trustee that such Security has been acquired by a bona fide purchaser, the Company shall, except as otherwise provided in this Section, execute, and upon a Company Request, the Trustee shall authenticate and make available for delivery, a new Security of the same series, tenor and principal amount, bearing a number, letter or other distinguishing symbol not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu of and in substitution for the Security so destroyed, lost or stolen. In every case the applicant for a substituted Security shall furnish to the Company and to the Trustee and any agent of the Company or the Trustee such security or indemnity as may be required by them to save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee and any agent of the Company or the Trustee evidence to their satisfaction of the destruction, loss or theft of such Security and of the ownership thereof.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the issuance of any substitute Security under this Section, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee or any Authenticating Agent) connected therewith.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case any Security which has matured or is about to mature or has been called for redemption in full shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security, pay or authorize the payment of the same (without surrender thereof except in the case of a mutilated Security). In every case, the applicant for such payment shall furnish to the Company and to the Trustee and any agent of the Company or the Trustee such security or indemnity as any of them may require to save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee and any agent of the Company or the Trustee evidence to their satisfaction of the destruction, loss or theft of such Security and of the ownership thereof.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Every substitute Security of any series issued pursuant to the provisions of this Section by virtue of the fact that any such Security is destroyed, lost or stolen shall constitute an additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone and shall be entitled to all the benefits of (but shall be subject to all the limitations of rights set forth in) this Indenture equally and proportionately with any and all other Securities of such series duly authenticated and delivered hereunder. All Securities shall be held and owned upon the express condition that, to the extent permitted by law, the foregoing provisions of this Section are exclusive with respect to the replacement or payment of mutilated (whether by defacement or otherwise) or destroyed, lost or stolen Securities and shall preclude any and all other rights or remedies notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment of negotiable instruments or other securities without their surrender.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.9 Payment of Interest and Certain Additional Amounts&#59; Interest Rights and Certain Additional Amounts Preserved.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Holder of any Securities at the close of business on the Regular Record Date with respect to any Interest Payment Date shall be entitled to receive the interest, if any, and any Additional Amounts payable on such Interest Payment Date notwithstanding the cancellation of such Securities upon any registration of transfer or exchange subsequent to the Regular Record Date and prior to such Interest Payment Date, and, if provided for in the Board Resolution or supplemental indenture pursuant to Section 3.1, in the case of a Security issued between a Regular Record Date and the initial Interest Payment Date relating to such Regular Record Date, interest for the period beginning on the date of issue and ending on such initial Interest Payment Date shall be paid to the Person to whom such Security shall have been originally issued. Except as otherwise specified as contemplated by Section 3.1, for Securities of a particular series the term &#34;Regular Record Date&#34; as used in this Section with respect to any Interest Payment Date shall mean the close of business on the last day of the calendar month preceding such Interest </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment Date if such Interest Payment Date is the fifteenth day of a calendar month and shall mean the close of business on the fifteenth day of the calendar month preceding such Interest Payment Date if such Interest Payment Date is the first day of a calendar month, whether or not such day shall be a Business Day. At the option of the Company, payment of interest on any Security may be made by check mailed to the address of the Person entitled thereto (which shall be the Depository in the case of Global Securities) as such address shall appear in the Securities Register.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If and to the extent the Company shall default in the payment of the interest due or any Additional Amounts on such Interest Payment Date in respect of any Securities, such defaulted interest shall be paid by the Company at its election in each case, as provided in clause (a) or (b) below&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company may make payment of any defaulted interest to the Holder of Securities at the close of business on a &#34;Special Record Date&#34; established by notice given by mail, by or on behalf of the Company, to such Holder not less than 15 days preceding such Special Record Date, such Special Record Date to be not less than 10 days preceding the date for payment of such defaulted interest.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The Company may make payment of any defaulted interest on the Securities of any series in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of such series may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the foregoing provisions of this Section, each Security delivered under this Indenture upon registration of transfer of, or in exchange for, or in lieu of, any other Security shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.10 Additional or Special Interest Under Registration Rights Agreements.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under certain circumstances, the Company may be obligated to pay additional or special interest as liquidated damages to Holders of Outstanding Securities of any series, all as and to the extent set forth in the Registration Rights Agreement (if any) applicable to such series. In any such event, such additional or special interest the Company may be obligated to pay as liquidated damages will be deemed to be interest for purposes of this Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee shall have no duty or responsibility for determining if any additional or special interest or liquidated damages are payable with respect to Securities of any series or, if any such additional or special interest or liquidated damages are payable thereon, when such additional or special interest or liquidated damages are payable and the amount thereof. The Company shall notify the Trustee and Paying Agent in writing at least five Business Days prior to each Interest Payment Date with respect to Securities of such series whether additional or special interest or liquidated damages are payable and, to the extent such additional or special interest or liquidated damages are payable, shall certify in such notice the date such additional or special interest or liquidated damages commenced to accrue, the applicable per annum interest rate or rates applicable thereto and the periods such additional or special interest or liquidated damages accrued at each such rate and the aggregate amount of such additional or special interest or liquidated damages payable on such Interest Payment Date.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.11 Cancellation of Securities&#59; Destruction Thereof.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Securities surrendered for payment, redemption, registration of transfer or exchange, or for credit against any payment in respect of a sinking or analogous fund, shall, if surrendered to the Company or any Paying Agent or any Securities Registrar, be delivered to the Trustee for cancellation or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be issued in lieu thereof except as expressly permitted by any of the provisions of this Indenture. The Trustee shall, unless instructed to deliver the Securities to the Company in a company order, destroy such cancelled Securities and deliver certification of their destruction to the Company. If the Company shall acquire any of the Securities, such acquisition shall not operate as a redemption or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered to the Trustee for cancellation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.12 Temporary Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pending the preparation by the Company of definitive Securities of any series, the Company may execute and the Trustee shall authenticate and make available for delivery in the manner provided in Section 3.3, temporary Securities for such series (printed, lithographed, typewritten or otherwise reproduced, in each case in form satisfactory to the Trustee). Temporary Securities of any series shall be issuable in any authorized denomination, and substantially in the form of the definitive Securities of such series in lieu of which they are issued but with such omissions, insertions and variations as may be appropriate for temporary securities, all as may be determined by the Company with the concurrence of the Trustee. Temporary Securities may contain such reference to any provisions of this Indenture as may be appropriate. Every temporary Security shall be executed by the Company and be authenticated by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as the definitive Securities. Without unreasonable delay the Company shall execute and shall furnish definitive Securities of such series and thereupon temporary Securities of such series may be surrendered in exchange therefor without charge at the Corporate Trust Office of the Trustee, and the Trustee shall authenticate and make available for delivery in exchange for such temporary Securities an equal aggregate principal amount of definitive Securities of the same series. Such exchange shall be made by the Company at its own expense and without any charge therefor except that in case of any such exchange involving any registration of transfer the Company may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto. Until so exchanged, the temporary Securities of any series shall in all respects be entitled to the same benefits under this Indenture as definitive Securities of such series authenticated and delivered hereunder.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.13 Computation of Interest.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise specified as contemplated by Section 3.1 for Securities of any series, interest on the Securities of each series shall be computed on the basis of a 360-day year of twelve 30-day months.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 3.14 CUSIP Numbers.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company in issuing the Securities may use &#34;CUSIP&#34; numbers (if then generally in use), and, if so, the Trustee shall use &#34;CUSIP&#34; numbers in notices of redemption as a convenience to Holders as set-forth in Section 14.2.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 4</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVENANTS OF THE COMPANY</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company covenants and agrees for the benefit of each series of Securities (except to the extent that any series of Securities is excluded from the benefits of any of such covenants pursuant to Section 3.1(n)) that on and after the date of original execution of this Indenture and so long as any of the Securities of such series remain Outstanding&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.1 Payment of Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will duly and punctually pay or cause to be paid the principal of any premium and interest on, and any Additional Amounts with respect to the Securities of such series at the place or places, at the respective times and in the manner provided in such Securities and in the Indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.2 Offices or Agency.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">So long as any of the Securities remain Outstanding, the Company will maintain in the Borough of Manhattan, The City of New York, New York, an office or agency where such Securities may be presented or surrendered for payment, where such Securities may be surrendered for registration of transfer or exchange and where notices and demands to or upon the Company in respect of such Securities and this Indenture may be served, which office or agency shall initially be the Corporate Trust Office of the Trustee or, if the Corporate Trust Office of the Trustee is not located in the Borough of Manhattan, The City of New York, such office or agency shall be the principal corporate trust office of the Authenticating Agent designated pursuant to Section 7.14 hereof. The Company will give prompt written notice to the Trustee of any change in the location of any such office or agency. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If at any time the Company shall fail to maintain such required office or agency or shall fail to furnish the Trustee with the required information with respect thereto, presentations, surrenders, notices and demands in respect of Securities may be made or served at the Corporate Trust Office of the Trustee and the corporate trust office of any Authenticating Agent appointed hereunder&#59; and the Company hereby appoints the Trustee and any Authenticating Agent appointed hereunder its agents to receive all such presentations, surrenders, notices and demands.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also from time to time designate one or more other offices or agencies (in or outside The City of New York) where the Securities of one or more series, or any Tranche thereof may be presented or surrendered for any or all of such purposes, and may from time to time rescind such designation&#59; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain for such purposes an office or agency in the Borough of Manhattan, The City of New York. The Company will promptly notify the Trustee of any such designation or rescission thereof.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise specified with respect to any Securities pursuant to Section 3.1, if and so long as the Securities of any series (i) are denominated in a Foreign Currency or (ii) may be payable in a Foreign Currency, or so long as it is required under any other provision of this Indenture, then the Company will maintain with respect to each such series of Securities, or as so required, at least one exchange rate agent.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.3 Money for Securities Payments to Be Held in Trust.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company shall at any time act as its own Paying Agent with respect to any series of Securities, it shall, on or before each due date of the principal of, any premium or interest on or Additional Amounts with respect to any of the Securities of such series, segregate and hold in trust for the benefit of the Persons entitled thereto a sum in the currency or currencies, currency unit or units or composite currency or currencies in which the Securities of such series are payable (except as otherwise specified pursuant to Section 3.1 for the Securities of such series) sufficient to pay the principal or any premium, interest or Additional Amounts so becoming due until such sums shall be paid to such Persons or otherwise disposed of as herein provided, and shall promptly notify the Trustee in writing of its action or failure so to act.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever the Company shall have one or more Paying Agents for any series of Securities, it shall, on or prior to each due date of the principal of, any premium or interest on or any Additional Amounts with respect to any Securities of such series, deposit with any Paying Agent a sum (in the currency or currencies, currency unit or units or composite currency or currencies described in the preceding paragraph) sufficient to pay the principal and any premium, interest or Additional Amounts so becoming due, such sum to be held in trust for the benefit of the Persons entitled thereto, and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee in writing of its action or failure so to act.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall cause each Paying Agent for any series of Securities other than the Trustee to execute and deliver to the Trustee an instrument in which such Paying Agent shall agree with the Trustee, subject to the provisions of this Section, that such Paying Agent shall&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) hold all sums held by it for the payment of the principal of, any premium or interest on or any Additional Amounts with respect to Securities of such series or Tranche in trust for the benefit of the Persons entitled thereto until such sums shall be paid to such Persons or otherwise disposed of as provided in or pursuant to this Indenture&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) give the Trustee notice of any default by the Company (or any other obligor upon the Securities of such series) in the making of any payment of principal of, any premium or interest on or any Additional Amounts with respect to the Securities of such series&#59; and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) At any time during the continuance of any such default, upon the written request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such Paying Agent.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or by Company Order direct any Paying Agent to pay, to the Trustee all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sums held in trust by the Company or such Paying Agent, such sums to be held by the Trustee upon the same terms as those upon which such sums were held by the Company or such Paying Agent&#59; and, upon such payment by any Paying Agent to the Trustee, such Paying Agent shall be released from all further liability with respect to such sums.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anything in this Section to the contrary notwithstanding, the agreement to hold sums in trust as provided in this Section is subject to the provisions of Section 12.3, Section 12.4 and Section 12.5.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.4 Additional Amounts.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All payments of principal of and premium, if any, interest and any other amounts on, or in respect of, the Securities of any series shall be made without withholding or deduction at source for, or on account of, any present or future taxes, fees, duties, assessments or governmental charges of whatever nature imposed or levied by or on behalf of Bermuda or any other jurisdiction in which the Company is organized or otherwise considered to be a resident for tax purposes, or any other jurisdiction from which or through which a payment on the Securities is made by the Company (each, a &#34;Taxing Jurisdiction&#34;) or any political subdivision or taxing authority thereof or therein, unless such taxes, fees, duties, assessments or governmental charges are required to be withheld or deducted by (i) the laws (or any regulations or ruling promulgated thereunder) of a Taxing Jurisdiction or any political subdivision or taxing authority thereof or therein or (ii) an official position regarding the application, administration, interpretation or enforcement of any such laws, regulations or rulings (including, without limitation, a holding by a court of competent jurisdiction or by a taxing authority in a Taxing Jurisdiction or any political subdivision thereof).</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a withholding or deduction at source is required, the Company shall, subject to certain limitations and exceptions set forth below, pay to the Holder of any such Security such Additional Amounts as may be necessary so that every net payment of principal, premium, if any, interest or any other amount made to such Holder, after such withholding or deduction (including any such withholding or deduction from such additional amounts), shall not be less than the amount provided for in such Security and this Indenture to be then due and payable&#59; provided, however, that the Company shall not be required to make payment of such Additional Amounts for or on account of&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) any tax, fee, duty, assessment or governmental charge of whatever nature which would not have been imposed but for the fact that such Holder&#58; (A) was a resident, domiciliary or national of, or engaged in business or maintained a permanent establishment or was physically present in, the relevant Taxing Jurisdiction or any political subdivision thereof or otherwise had some connection with the relevant Taxing Jurisdiction other than by reason of the mere ownership of, or receipt of payment under, or enforcement of rights with respect to, such Security&#59; (B) presented such Security, where presentation is required, for payment in the relevant Taxing Jurisdiction or any political subdivision thereof, unless such Security could not have been presented for payment elsewhere&#59; or (C) presented such Security, where presentation is required, more than thirty (30) days after the date on which the payment in respect of such Security first became due and payable or provided for, whichever is later, except to the extent that the Holder would have been entitled to such Additional Amounts if it had presented such Security for payment on any day within such period of thirty (30) days&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) any estate, inheritance, gift, sale, transfer, personal property or similar tax, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) any tax, assessment or other governmental charge that is imposed or withheld by reason of the failure by the Holder or the beneficial owner of such Security to comply with any reasonable request by the Company addressed to the Holder within 90 days of such request (A) to provide information concerning the nationality, residence or identity of the Holder or such beneficial owner or (B) to make any declaration or other similar claim or satisfy any information or reporting requirement, which, in the case of (A) or (B), is required or imposed by statute, treaty, regulation or administrative practice of the relevant Taxing Jurisdiction or any political subdivision thereof as a precondition to exemption from all or part of such tax, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) any withholding or deduction required to be made pursuant to any EU Directive on the taxation of savings implementing the conclusions of the ECOFIN Council meetings of 26-27 November 2000, 3 June 2003 or any law implementing or complying with, or introduced in order to confirm to, such EU Directive&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) any combination of items (a), (b), (c) and (d)&#59;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nor shall Additional Amounts be paid with respect to any payment of the principal of, or premium, if any, interest or any other amounts on, any such Security to any Holder who is a fiduciary or partnership or other than the sole beneficial owner of such Security to the extent such payment would be required by the laws of the relevant Taxing Jurisdiction (or any political subdivision or relevant taxing authority thereof or therein) to be included in the income for tax purposes of a beneficiary or partner or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner who would not have been entitled to such Additional Amounts had it been the Holder of the Security.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever in this Indenture there is mentioned, in any context, the payment of the principal of or any premium, interest or any other amounts on, or in respect of, any Security of any series or the net proceeds received on the sale or exchange of any Security of any series, such mention shall be deemed to include mention of the payment of Additional Amounts provided by the terms of such series established hereby or pursuant hereto to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to such terms, and express mention of the payment of Additional Amounts (if applicable) in any provision hereof shall not be construed as excluding the payment of Additional Amounts in those provisions hereof where such express mention is not made.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise provided in or pursuant to this Indenture or the related Board Resolution of the applicable series, at least 10 days prior to the first Interest Payment Date with respect to a series of Securities (or if the Securities of such series shall not bear interest prior to Maturity, the first day on which a payment of principal is made), and at least 10 days prior to each date of payment of principal or interest if there has been any change with respect to the matters set forth in the below-mentioned Officer's Certificate, the Company shall furnish to the Trustee and the principal Paying Agent or Paying Agents, if other than the Trustee, an Officer's Certificate instructing the Trustee and such Paying Agent or Paying Agents whether such payment of principal of and premium, if any, interest or any other amounts on the Securities of such series shall be made to Holders of Securities of such series without withholding for or on account of any tax, fee, duty, assessment or other governmental charge described in this Section 4.4. If any such withholding shall be required, then such Officer's Certificate shall specify by Taxing Jurisdiction the amount, if any, required to be withheld on such payments to such Holders of Securities and the Company agrees to pay to the Trustee or such Paying Agent the Additional Amounts required by this Section 4.4. The Company covenants to indemnify the Trustee and any Paying Agent for, and to hold them harmless against, any loss, liability or expense reasonably incurred without negligence or bad faith on their part arising out of or in connection with actions taken or omitted by any of them in reliance on any Officer's Certificate furnished pursuant to this Section 4.4.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will make any required withholding or deduction and remit the full amount deducted or withheld to the relevant Taxing Jurisdiction in accordance with applicable law. The Company will furnish to the Holders, within 60 days after the date the payment of any taxes so deducted or withheld is due pursuant to applicable law, either certified copies of tax receipts evidencing such payment by the Company or, if such receipts are not obtainable, other evidence of such payments by the Company reasonably satisfactory to the Holders.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall promptly pay when due any present or future stamp, court or documentary taxes or any other excise or property taxes, charges or similar levies that arise in any Taxing Jurisdiction from the execution, delivery, or registration of any Security or any other document or instrument relating to the issuance thereof or the receipt of any payments with respect to the Securities. The Company shall indemnify and make whole the Holders of Securities for any present or future stamp, court or documentary taxes or any other excise or property taxes, charges or similar levies payable by the Company as provided in this Section 4.4 that are paid by such Holders.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing obligations will survive any termination, defeasance or discharge of the Indenture and will apply mutatis mutandis to any jurisdiction in which any successor to the Company is organized or any political subdivision or taxing authority or agency thereof or therein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.5 Redemption for Tax Purposes.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the Securities at its option, in whole but not in part, at a Redemption Price equal to 100% of the principal amount, together with accrued and unpaid interest and Additional Amounts, if any, to the date fixed for redemption, if at any time it determines in good faith that as a result of (i) any change in or amendment to the laws or treaties (or any regulations or rulings promulgated under these laws or treaties) of any Taxing Jurisdiction (or of any political subdivision or taxation authority thereof affecting taxation) or any change in the position regarding the application or official interpretation of such laws, treaties, regulations or rulings (including a holding, judgment or order by a court of competent jurisdiction) which change in position becomes effective after the issuance of the Securities, or (ii) any action taken by any Taxing Jurisdiction (or any political subdivision or taxing authority thereof affecting taxation) which action is generally applied or is taken with respect to the Company, the Company would be required as of the next Interest Payment Date to pay Additional Amounts with respect to the Securities as provided in Section 4.4 and such requirements cannot be avoided by the use of reasonable measures (consistent with practices and interpretations generally followed or in effect at the time such measures could be taken) then available. If the Company elects to redeem the Securities under this provision it will give written notice of such election to the Trustee. If the Company elects to redeem the Securities under this provision it will also mail a notice of redemption at least 30 days but no more than 60 days before the Redemption Date to each Holder of the Securities to be redeemed. Unless the Company defaults in the payment of the Redemption Price, on and after the Redemption Date, interest will cease to accrue on the Securities or portions thereof called for redemption. Any such redemption will be subject to ARTICLE 14 hereof.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, no such notice of redemption will be given earlier than 90 days prior to the earliest date on which the Company would be obliged to make such payment of Additional Amounts or withholding if a payment in respect of the Securities were then due. In any event, prior to the publication or mailing or any notice of redemption of the Securities pursuant to the foregoing, the Company will deliver to the Trustee an opinion of independent tax counsel of recognized standing reasonably satisfactory to the Trustee to the effect that the circumstances referred to above exist. The Trustee will accept such opinion as sufficient evidence of the satisfaction of the conditions precedent described above, in which event it will be conclusive and binding on the Holders of the Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.6 Limitation on Liens on Stock of Designated Subsidiaries.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">So long as any Securities are Outstanding, the Company will not, nor will it permit any Subsidiary to, create, assume, incur, guarantee or otherwise permit to exist any Indebtedness secured by any mortgage, pledge, lien, security interest or other encumbrance (a &#34;Lien&#34;) upon any shares of Share Capital of any Designated Subsidiary (whether such shares of stock are now owned or hereafter acquired) without effectively providing concurrently that the Securities (and, if the Company so elects, any other Indebtedness of the Company that is not subordinate to the Securities and with respect to which the governing instruments require, or pursuant to which the Company is otherwise obligated, to provide such security) shall be secured equally and ratably with such Indebtedness for at least the time period such other Indebtedness is so secured.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.7 Limitation on Disposition of Stock of Designated Subsidiaries.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) So long as any Securities are outstanding and except in a transaction otherwise governed by this Indenture, the Company (i) will not, nor will it permit any subsidiary to (other than to the Company or another Designated Subsidiary) issue, sell, assign, transfer or otherwise dispose of any shares of, securities convertible into, or warrants, rights or options to subscribe for or purchase shares of, Share Capital (other than preferred stock having no voting rights of any kind) of any Designated Subsidiary, and (ii) will not permit any Designated Subsidiary to issue (other than to the Company or another Designated Subsidiary) any shares (other than the director's qualifying shares) of, or securities convertible into, or warrants, rights or options to subscribe for or purchase shares of, Share Capital (other than preferred stock having no voting rights of any kind) of any Designated Subsidiary, if, in any transaction contemplated by (i) and (ii) above, after giving effect to any such transaction and the issuance of the maximum number of shares issuable upon the conversion or exercise of all such convertible securities, warrants, rights or options, the Designated Subsidiary would remain a Subsidiary of the Company and the Company would own, directly or indirectly, less than 80% of the shares of Share Capital of such Designated Subsidiary (other than </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preferred stock having no voting rights of any kind)&#59; provided, however, that the foregoing will not prohibit (i) any issuance, sale, assignment, transfer or other disposition made for at least a fair market value consideration as determined by the Board of Directors pursuant to a Board Resolution adopted in good faith and (ii) any such issuance or disposition of securities if required by any law or any regulation or order of any governmental or insurance regulatory authority.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Notwithstanding the foregoing, (i) the Company may merge, amalgamate or consolidate any Designated Subsidiary into or with another direct or indirect Subsidiary of the Company the shares of Share Capital of which the Company owns at least 80% and (ii) the Company may, subject to the provisions of ARTICLE 11, sell, assign, transfer or otherwise dispose of the entire Share Capital of any Designated Subsidiary at one time for at least a fair market value consideration as determined by the Board of Directors pursuant to a Board Resolution adopted in good faith.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.8 Corporate Existence.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to ARTICLE 11 and Section 4.6, the Company shall do or cause to be done all things necessary to preserve and keep in full force and effect its legal existence and rights (charter and statutory) and franchises&#59; provided, however, that the foregoing shall not obligate the Company to preserve any such right or franchise if the Company shall determine that the preservation thereof is no longer desirable in the conduct of its business and that the loss thereof is not disadvantageous in any material respect to any Holder.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.9 Waiver of Certain Covenants.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may omit in any particular instance to comply with any term, provision or condition set forth in Sections 4.6, 4.7 or 4.8 with respect to the Securities of any series if before the time for such compliance the Holders of at least a majority in principal amount of the Outstanding Securities of such series, by Act of such Holders, either shall waive such compliance in such instance or generally shall have waived compliance with such term, provision or condition, but no such waiver shall extend to or affect such term, provision or condition except to the extent so expressly waived, and, until such waiver shall become effective, the obligations of the Company and the duties of the Trustee in respect of any such term, provision or condition shall remain in full force and effect.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.10 Certificates to Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will, within 120 days after the end of each fiscal year, file with the Trustee an Officer's Certificate complying with the provisions of the second paragraph of Section 13.6, covering the period from the date of original execution of this Indenture to December 31, 2004 in the case of the first such certificate, and covering the preceding calendar year in the case of each subsequent certificate, and stating whether or not, to the knowledge of each of the signers, one of whom shall be the principal executive officer, the principal financial officer or the principal accounting officer, the Company has complied with the conditions and covenants on its part contained in this Indenture, and, if the signers, to the best of their knowledge, know of any event which is, or after notice or lapse of time or both would become, a default by the Company in the performance, observance or fulfillment of any such condition or covenant, specifying each such default and the nature thereof. For the purpose of this Section, compliance shall be determined without regard to any grace period or requirement of notice provided pursuant to the terms of this Indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall deliver to the Trustee, within five days after the occurrence thereof, written notice of any Event of Default or any event which after notice or lapse of time or both would become an Event of Default pursuant to clause (c) of Section 6.1.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.11 Calculation of Original Issue Discount.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall file with the Trustee promptly at the end of each calendar year (i) a written notice specifying the amount of original issue discount (including daily rates and accrual periods) accrued on any Outstanding Original Issue Discount Securities as of the end of such year and (ii) such other specific information </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relating to such original issue discount as may then be relevant under the Internal Revenue Code of 1986, as amended from time to time.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 5</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECURITYHOLDER LISTS AND REPORTS BY THE</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPANY AND THE TRUSTEE</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 5.1 Company to Furnish Trustee Information as to Names and Addresses of Securityholders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company covenants and agrees that it will furnish or cause to be furnished to the Trustee a list in such form as the Trustee may reasonably require of the names and addresses of the Holders of the Securities of each series semiannually and not later than June 30 and December 31 in each year, and at such other times as the Trustee may request in writing, as of a date no more than 15 days prior to the date such information is so furnished&#59; provided that, if and so long as the Trustee shall be the Securities Registrar for such series, such list shall not be required to be furnished.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 5.2 Preservation and Disclosure of Securityholder Lists.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Trustee shall preserve, in as current a form as is reasonably practicable, all information received by it pursuant to Section 5.1 and similar information received by it in any other capacity under this Indenture and afford Holders access to the information preserved by it, all to such extent, if any, and in such manner as shall be required by the Trust Indenture Act.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Each and every Holder of Securities, by receiving and holding the same, agrees with the Company and the Trustee that neither the Company nor the Trustee nor any Paying Agent shall be held accountable by reason of the disclosure of any such information as to the names and addresses of the Holders of Securities in accordance with the provisions of Section 5.2(a), regardless of the source from which such information was derived, and that the Trustee shall not be held accountable by reason of mailing any material pursuant to a request made under Section 5.2(a). In case three or more Holders of Securities of any series (for purposes of this Section, &#34;applicants&#34;) apply in writing to the Trustee and furnish to the Trustee reasonable proof that each such applicant has owned a Security for a period of at least six months preceding the date of such application, and such application states that the applicants desire to communicate with other Holders of Securities of a particular series (in which case the applicants must all hold Securities of such series) or with Holders of all Securities with respect to their rights under this Indenture or under such Securities and such application is accompanied by a copy of the form of proxy or other communication which such applicants propose to transmit, then the Trustee shall, within five business days after the receipt of such application, at its election, either&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) afford to such applicants access to the information preserved at the time by the Trustee in accordance with the provision of subsection (a) of this Section 5.2, or</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) inform such applicant as to the approximate number of Holders of Securities of such series or all Securities, as the case may be, whose names and addresses appear in the information preserved at the time by the Trustee, in accordance with the provisions of subsection (a) of this Section 5.2, and as to the approximate cost of mailing to such Securityholders the form of proxy or other communication, if any, specified in such application. If the Trustee shall elect not to afford to such applicants access to such information, the Trustee shall, upon the written request of such applicants, mail to each Securityholder of such series or all Securities, as the case may be, whose name and address appear in the information preserved at the time by the Trustee in accordance with the provisions of subsection (a) of this Section 5.2, a copy of the form of proxy or other communication which is specified in such request, with reasonable promptness after a tender to the Trustee of the material to be mailed and of payment, or provision for the payment, of the reasonable expenses of a mailing, unless within five days after such tender, the Trustee shall mail to such applicants and file with the Commission together with a copy of the material to be mailed, a written statement to the effect that, in the opinion of the Trustee, such mailing would be contrary to the best interest of the Holders of Securities of such series or all Securities, as the case may be, or could be in violation of applicable law. Such written statement shall specify the basis of such opinion. If the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission, after opportunity for a hearing upon the objections specified in the written statement so filed, shall enter an order refusing to sustain any of such objections or if, after the entry of such order sustaining one or more of such objections, the Commission shall find, after notice and opportunity for hearing, that all the objections so sustained have been met, and shall enter an order so declaring, the Trustee shall mail copies of such material to all such Securityholders with reasonable promptness after the entry of such order and the renewal of such tender&#59; otherwise the Trustee shall be relieved of any obligation or duty to such applicants respecting their application.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 5.3 Reports by the Company.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company covenants&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) to file with the Trustee, within 15 days after the Company is required to file the same with the Commission, copies of the annual reports and of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time to time by rules and regulations prescribe) which the Company may be required to file with the Commission pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934&#59; or, if the Company is not required to file information, documents or reports pursuant to either of such Sections, then to file with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to time by the Commission, such of the supplementary and periodic information, documents and reports which may be required pursuant to Section 13 of the Securities Exchange Act of 1934 in respect of a security listed and registered on a national securities exchange as may be prescribed from time to time in such rules and regulations&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) to file with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to time by the Commission, such additional information, documents and reports with respect to compliance by the Company with the conditions and covenants provided for in this Indenture as may be required from time to time by such rules and regulations&#59; and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) to transmit by mail to the Holders of Securities in the manner and to the extent provided in Section 5.4 within 30 days after the filing thereof with the Trustee, such summaries of any information, documents and reports required to be filed by the Company pursuant to subsections (a) and (b) of this Section as may be required to be transmitted to such Holders by rules and regulations prescribed from time to time by the Commission.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The delivery of such reports, information and documents to the Trustee pursuant to this Section 5.3 is for informational purposes only and the Trustee's receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company's compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officer's Certificates) other than with respect to Section 7.2.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 5.4 Reports by the Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Within 60 days after May 15 in each year following the date of original execution of this Indenture, so long as any Securities are Outstanding hereunder, the Trustee shall transmit by mail (with a copy to the Company) to the Securityholders of such series in the manner and to extent provided in Trust Indenture Act Section 313(c), a brief report, as provided by the Trust Indenture Act Sections 313(a) and (b).</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) A copy of each such report shall, at the time of such transmission to the Securityholders of any series, be furnished to the Company and be filed by the Trustee with each stock exchange upon which the Securities of such series are listed and also with the Commission. The Company agrees to notify the Trustee promptly when and as the Securities of any series become admitted to trading on any national securities exchange.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ON EVENT OF DEFAULT</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.1 Event of Default Defined&#59; Acceleration of Maturity&#59; Waiver of Default.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Event of Default&#34;, with respect to the Securities of any series, wherever used herein, means each one of the following events which shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body), unless it is either inapplicable to a particular series or it is specifically deleted or modified in the applicable resolution of the Board of Directors or in the supplemental indenture under which such series of Securities is issued, as the case may be, as contemplated by Section 3.1&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) default in the payment of any interest on any of the Securities of such series, or any Additional Amounts payable with respect thereto, as and when the same shall become due and payable, and continuance of such default for a period of 30 days and the time for payment of such interest or Additional Amounts has not been extended&#59; provided, however that if the Company is permitted by the terms of the Securities of the applicable series to defer the payment in question, the date on which such payment is due and payable shall be the date on which the Company is required to make payment following such deferral, if such deferral has been elected pursuant to the terms of the Securities of that series&#59; or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) default in the payment of the principal of or premium, if any, on any of the Securities of such series as, or any Additional Amounts payable with respect thereto, and when the same shall become due and payable at Maturity, and the time for payment of such principal (or premium, if any), or any Additional Amounts payable with respect thereto, has not been extended&#59; provided, however, that if the Company is permitted by the terms of the Securities of the applicable series to defer the payment in question, the date on which such payment is due and payable shall be the date on which the Company is required to make payment following such deferral, if such deferral has been elected pursuant to the terms of the Securities of that series&#59; or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) default in the performance or breach of any other covenant or warranty of the Company in respect of the Securities of such series (other than a covenant or warranty in respect of the Securities of such series a default in whose performance or observance is elsewhere in this Section specifically dealt with), and continuance of such default for a period of 60 days after there has been given, by registered or certified mail, to the Company by the Trustee, or to the Company and the Trustee by the Holders of at least 25% in principal amount of the Outstanding Securities of all series affected thereby, a written notice specifying such default and requiring it to be remedied and stating that such notice is a &#34;Notice of Default&#34; hereunder&#59; or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) default in the payment at Maturity of Indebtedness of the Company in excess of $50,000,000 or if any event of default as defined in any mortgage, indenture or instrument under which there may be issued, or by which there may be secured or evidenced, any Indebtedness of the Company (other than Indebtedness which is non-recourse to the Company) shall happen and shall result in the acceleration of more than $50,000,000 in principal amount of such Indebtedness (after giving effect to any applicable grace period) and such default shall not be cured or waived or such acceleration shall not be rescinded or annulled within a period of 60 days after there shall have been given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal amount of the Outstanding Securities of such series, a written notice specifying such default or event of default and requiring the Company to cause such default to be cured or waived or to cause such acceleration to be rescinded or annulled or to cause such Indebtedness to be discharged and stating that such notice is a &#34;Notice of Default&#34; hereunder&#59; or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) the Company shall fail within 60 days to pay, bond or otherwise discharge any uninsured judgment or court order for the payment of money in excess of $50,000,000, which is not stayed on appeal or is not otherwise being appropriately contested in good faith&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) a court having jurisdiction in the premises shall enter a decree or order for relief in respect of the Company in an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or, under any such law, (i) appointing a receiver, liquidator, assignee, custodian, trustee or sequestrator (or similar official) of the Company or for any substantial part of its property or (ii) ordering the winding up or liquidation of its affairs, and such decree or order shall remain unstayed and in effect for a period of 60 consecutive days&#59; or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) the Company shall commence a voluntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or, under any such law, (i) consent to the entry of an order for relief in an involuntary case under any such law, (ii) consent to the appointment or taking possession by a receiver, liquidator, assignee, custodian, trustee or sequestrator (or similar official) of the Company or for any substantial part of its property, or (iii) make any general assignment for the benefit of creditors&#59; or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) default in the performance or breach of the conditions of Section 11.1 and Section 11.2, and the continuation of such violation for 60 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal amount of the Outstanding Securities of such series, a written notice specifying such failure to comply and requiring it to be remedied and stating that such notice is a &#34;Notice of Default&#34;&#59; or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) any other Event of Default established by or pursuant to a resolution of the Board of Directors or one or more indentures supplemental hereto as applicable to the Securities of such series.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an Event of Default described in clause (a), (b), (c), (d), (e), (h) or (i) above occurs and is continuing with respect to Securities of any series at the time Outstanding, the Trustee or the Holders of not less than 25% in aggregate principal amount of the Securities of such series then Outstanding, by notice in writing to the Company (and to the Trustee if given by Securityholders), may declare the entire principal (or, if the Securities of such series are Original Issue Discount Securities, such portion of the principal as may be specified in the terms of such series) of all Securities of such series and the interest accrued thereon, if any, to be due and payable immediately, and upon any such declaration the same shall become immediately due and payable.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any Event of Default described in clause (f) or (g) above occurs and is continuing, all unpaid principal of the Securities then Outstanding of that series and the interest accrued thereon, if any, shall ipso facto become and be immediately due and payable without declaration, presentment, demand or notice of any kind by the Trustee or any Holder of Securities of that series.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing provisions, however, are subject to the condition that if, at any time after a declaration of acceleration with respect to the Securities of any series has been made and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the Company shall pay or shall deposit with the Trustee a sum sufficient to pay all matured installments of interest, if any, and any Additional Amounts with respect to all the Securities of such series (or upon all the Securities, as the case may be) and the principal of (and premium, if any, on) any and all Securities of such series (or of all the Securities, as the case may be) which shall have become due otherwise than by acceleration (with interest upon such principal and premium, if any, and, to the extent that payment of such interest is enforceable under applicable law, on overdue installments of interest or Additional Amounts, at the Overdue Rate applicable to such series to the date of such payment or deposit) and all amounts payable to the Trustee pursuant to the provisions of Section 7.6, and such amount as shall be sufficient to cover reasonable compensation to the Trustee, its agents, attorneys and counsel, and all other expenses and liabilities incurred, and all advances made, by the Trustee except as a result of its negligence or bad faith, and if any and all Events of Default under the Indenture, other than the nonpayment of the principal of and accrued interest on and any Additional Amounts with respect to Securities of such series which shall have become due by acceleration, shall have been cured, waived or otherwise remedied as provided herein - then and in every such case the Holders of a majority in aggregate principal amount of the Securities of such series (each series voting as a separate class), or of all the Securities (voting as a single class), as the case may be, then Outstanding, by written notice to the Company and to the Trustee, may waive all defaults with respect to that series (or with respect to all the Securities, as the case may be) and rescind and annul such acceleration and its consequences, but no such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">waiver or rescission and annulment shall extend to or shall affect any subsequent default or shall impair any right consequent thereon.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all purposes under this Indenture, if a portion of the principal of any Original Issue Discount Security shall have been accelerated and declared or become due and payable pursuant to the provisions hereof, then, from and after such acceleration, unless such acceleration has been rescinded and annulled, the principal amount of such Original Issue Discount Security shall be deemed, for all purposes hereunder, to be such portion of the principal thereof as shall be due and payable as a result of such acceleration, and payment of such portion of the principal thereof as shall be due and payable as a result of such acceleration, together with interest, if any, thereon and all other amounts owing thereunder, shall constitute payment in full of such Original Issue Discount Security.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.2 Collection of Indebtedness by Trustee&#59; Trustee May Prove Debt.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company covenants that (a) in case default shall be made in the payment of any installment of interest on or any Additional Amounts with respect to any of the Securities of any series when such interest shall have become due and payable, and such default shall have continued for a period of 30 days or (b) in case default shall be made in the payment of all or any part of the principal of or any premium, if any, on any Securities of any series or any Additional Amounts with respect thereto when the same shall have become due and payable, whether upon Stated Maturity of the Securities of such series or upon any redemption or by acceleration or otherwise, then upon demand of the Trustee for such series, the Company will pay to the Trustee for the benefit of the Holder of any such Security the whole amount that then shall have become due and payable on any such Security for the principal, premium, if any, and interest, if any, with interest upon the overdue principal and premium, if any, and, so far as payment of the same is enforceable under applicable law, on overdue installments of interest and Additional Amounts, at the Overdue Rate applicable to any such Security&#59; and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, and any further amounts payable to the Trustee, its agents and counsel pursuant to the provisions of Section 7.6.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case the Company shall fail forthwith to pay such amounts upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and empowered to institute any action or proceedings at law or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or proceedings to judgment or final decree, and may enforce any such judgment or final decree against the Company or other obligor upon such Securities and collect in the manner provided by law out of the property of the Company or other obligor upon such Securities, wherever situated, the moneys adjudged or decreed to be payable.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee shall be entitled and empowered, either in its own name as trustee of an express trust, or as attorney-in-fact for the Holders of any of the Securities, or in both such capacities, to file such proof of debt, amendment of proof of debt, claim, petition or other document as may be necessary or advisable in order to have the claims of the Trustee and of the Holders of Securities allowed in any equity receivership, insolvency, bankruptcy, liquidation, readjustment, reorganization or other similar proceedings, or any judicial proceedings, relative to the Company or any other obligor on the Securities or its creditors or its property. The Trustee is hereby irrevocably appointed (and the successive respective Holders of the Securities, by taking and holding the same, shall be conclusively deemed to have so appointed the Trustee) the true and lawful attorney-in-fact of the respective Holders of the Securities, with authority to make or file in the respective names of the Holders of the Securities any proof of debt, amendment of proof of debt, claim, petition or other document in any such proceedings and to receive payment of any sums becoming distributable on account thereof, and to execute any other papers and documents and do and perform any and all acts and things for and on behalf of such Holders of the Securities as may be necessary or advisable in the opinion of the Trustee in order to have the respective claims of the Holders of the Securities against the Company or any other obligor on the Securities and&#47;or its property allowed in any such proceedings, and to receive payment of or on account of such claims&#59; provided, however, that nothing herein contained shall be deemed to authorize or empower the Trustee to consent to or accept or adopt, on behalf of any Holder of Securities, any plan of reorganization or readjustment of the Company or any other obligor on the Securities or, by other action of any character in any such proceeding, to waive or change in any way any right of any Holder of any Security, even though it may otherwise be entitled so to do under any present or future law, all such power or authorization being hereby expressly denied.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All rights of action and of asserting claims under this Indenture or under any of the Securities may be enforced by the Trustee without the possession of any of the Securities or the production thereof in any trial or other proceedings relative thereto, and any such action or proceedings instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment, subject to the payment of the expenses, disbursements and compensation of the Trustee, each predecessor Trustee and their respective agents and attorneys, shall be for the ratable benefit of the holders of the Securities in respect of which such action was taken.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any proceedings brought by the Trustee (and also any proceedings involving the interpretation of any provision of this Indenture to which the Trustee shall be a party), the Trustee shall be held to represent all the Holders of the Securities in respect of which such action was taken, and it shall not be necessary to make any Holders of such Securities parties to any such proceedings.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.3 Application of Proceeds.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any moneys collected by the Trustee pursuant to this Article in respect of any series of the Securities, together with any other sums held by the Trustee (as such) hereunder (other than sums held in trust for the benefit of the Holders of particular Securities), shall be applied in the following order at the date or dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal, or any premium, interest or Additional Amounts, upon presentation (except in respect of Subdivision First below) of the several Securities in respect of which moneys have been collected and stamping (or otherwise noting) thereon the payment, or issuing Securities of such series in reduced principal amounts in exchange for the presented Securities of like series if only partially paid, or upon surrender thereof if fully paid&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIRST&#58; To the payment of costs and expenses applicable to such series in respect of which moneys have been collected, including reasonable compensation to the Trustee and each predecessor Trustee and their respective agents and attorneys and of all expenses and liabilities incurred, and all advances made, by the Trustee and each predecessor Trustee except as a result of its negligence or bad faith, and all other amounts due to the Trustee or any predecessor Trustee pursuant to Section 7.6&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECOND&#58; In case the principal of the Securities of such series in respect of which moneys have been collected shall not have become and be then due and payable, to the payment of interest and any Additional Amounts on the Securities of such series in default in the order of the maturity of the installments of such interest, with interest (to the extent that such interest has been collected by the Trustee), so far as it may be enforceable under applicable law, upon the overdue installments of interest and any Additional Amounts at the Overdue Rate applicable to such series, such payments to be made ratably to the Persons entitled thereto, without discrimination or preference&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIRD&#58; In case the principal of the Securities of such series in respect of which moneys have been collected shall have become and shall be then due and payable, to the payment of the whole amount then owing and unpaid upon all the Securities of such series for principal and premium, if any, and interest, if any, and any Additional Amounts, with interest upon the overdue principal and premium, if any, and (to the extent that such interest has been collected by the Trustee), so far as payment of the same is enforceable under applicable law, upon overdue installments of interest and any Additional Amounts, if any, at the Overdue Rate applicable to such series&#59; and in case such moneys shall be insufficient to pay in full the whole amount so due and unpaid upon the Securities of such series, then to the payment of such principal, premium, if any, and interest, if any, and any Additional Amounts, without preference or priority of principal and premium, if any, over interest or any Additional Amounts, or of interest or any Additional Amounts, if any, over principal and premium, if any, or of any installment of interest over any other installment of interest, or of any Security of such series over any other Security of such series, ratably to the aggregate of such principal, premium, if any, and accrued and unpaid interest, if any&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOURTH&#58; To the payment of the remainder, if any, to the Company or as a court of competent jurisdiction may direct in writing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.4 Suits for Enforcement.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case an Event of Default with respect to Securities of any series has occurred, has not been waived and is continuing, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in this Indenture or in aid of the exercise of any power granted in this Indenture or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.5 Restoration of Rights on Abandonment of Proceedings.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case the Trustee or any Holder shall have proceeded to enforce any right under this Indenture and such proceedings shall have been discontinued or abandoned for any reason, or shall have been determined adversely to the Trustee or such Holder, then and in every such case (subject to the binding effect of any determination made in such proceedings) the Company and the Trustee and each of the Holders shall be restored severally and respectively to their former positions and rights hereunder, and (subject as aforesaid) all rights, remedies and powers of the Company, the Trustee and the Holders shall continue as though no such proceedings had been instituted.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.6 Limitations on Suits by Securityholders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No Holder of any Security of any series shall have any right by virtue or by availing of any provision of this Indenture to institute an action or proceeding at law or in equity or in bankruptcy or otherwise upon or under or with respect to this Indenture, or for the appointment of a trustee, receiver, liquidator, custodian or other similar official or for any other remedy hereunder, unless such Holder previously shall have given to the Trustee written notice of an Event of Default and of the continuance thereof, as hereinbefore provided, and unless also the Holders of not less than 25% in aggregate principal amount of the Securities of such series then Outstanding shall have made written request upon the Trustee to institute such action or proceeding in its own name as Trustee hereunder and shall have offered to the Trustee such reasonable indemnity as it may require against the costs, expenses and liabilities to be incurred therein or thereby and the Trustee for 60 days after its receipt of such notice, request and offer of indemnity shall have failed to institute any such action or proceeding and no direction inconsistent with such written request shall have been given to the Trustee pursuant to Section 6.9&#59; it being understood and intended, and being expressly covenanted by the taker and Holder of every Security with every other taker and Holder of any Security and with the Trustee, that no one or more Holders of Securities of any series shall have any right in any manner whatever by virtue or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of any other Holder of Securities, or to obtain or seek to obtain priority over or preference to any other such Holder or to enforce any right under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of all Holders of Securities of such series. For the protection and enforcement of the provisions of this Section, each and every Holder of Securities of any series and the Trustee shall be entitled to such relief as can be given either at law or in equity.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.7 Unconditional Right of Securityholders to Institute Certain Suits.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nothing contained in this Indenture or in the Securities of any series shall affect or impair the obligation of the Company, which is unconditional and absolute, to pay the principal of, and premium, if any, and interest, if any, on, and any Additional Amounts with respect to, the Securities of such series at the respective places, at the respective times, at the respective rates, in the respective amounts and in the coin or currency therein and herein prescribed, or affect or impair the right of action, which is also absolute and unconditional, of any Holder of any Security to institute suit to enforce such payment at the respective due dates expressed in such Security, or upon redemption, by declaration, repayment or otherwise as herein provided without reference to, or the consent of, the Trustee or the Holder of any other Security, unless such Holder consents thereto or unless and to the extent that the institution or prosecution.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.8 Powers and Remedies Cumulative&#59; Delay or Omission Not Waiver of Default.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as provided in Section 6.6, no right or remedy herein conferred upon or reserved to the Trustee or to the Holder of any Security is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No delay or omission of the Trustee or of any Holder of any Security of any series to exercise any right or power accruing upon any Event of Default occurring and continuing as aforesaid shall impair any such right or power or shall be construed to be a waiver of any such Event of Default or an acquiescence therein&#59; and, subject to Section 6.6, every power and remedy given by this Indenture or by law to the Trustee or to the Holder of any Security may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Holder of such Security.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.9 Control by Holders of Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Holders of a majority in aggregate principal amount of the Securities of each series affected (with each series voting as a separate class) at the time Outstanding shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee with respect to the Securities of such series by this Indenture&#59; provided that such direction shall not be otherwise than in accordance with law and the provisions of this Indenture, and provided, further, that (subject to the provisions of Section 7.1) the Trustee shall have the right to decline to follow any such direction if the Trustee, being advised by counsel, shall determine that the action or proceeding so directed may not lawfully be taken or if the Trustee shall determine that the action or proceedings so directed would expose the Trustee to personal liability or would be contrary to the provisions hereof, being advised by counsel reasonably acceptable to the Trustee and the Company, or if the Trustee in good faith shall so determine that the actions or forebearances specified in or pursuant to such direction would be unduly prejudicial to the interests of Holders of the Securities of all series so affected not joining in the giving of said direction, it being understood that (subject to Section 7.1) the Trustee shall have no duty to ascertain whether or not such actions or forebearances are unduly prejudicial to such Holders.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As between the Trustee and the Holders of the Securities, nothing in this Indenture shall impair the right of the Trustee in its discretion to take any action deemed proper by the Trustee and which is not inconsistent with such direction or directions by Securityholders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.10 Waiver of Past Defaults.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Holders of not less than a majority in principal amount of the Outstanding Securities of any series on behalf of the Holders of all the Securities of such series may waive any past default hereunder with respect to such series and its consequences, except a default&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) in the payment of the principal of, any premium or interest on, or any Additional Amounts with respect to, any Security of such series, or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) in respect of a covenant or provision hereof which under ARTICLE 10 cannot be modified or amended without the consent of the Holder of each Outstanding Security of such series affected.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon any such waiver, such default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured, for every purpose of this Indenture&#59; but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.11 Trustee to Give Notice of Default, But May Withhold in Certain Circumstances.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee shall transmit to the Securityholders of any series, as the names and addresses of such Holders appear on the Security Register, notice by mail of all defaults known to a Responsible Officer of the Trustee which </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have occurred with respect to such series, such notice to be transmitted within 60 days after the Trustee shall have knowledge thereof, as provided in section 7.1(i), unless such defaults shall have been cured before the giving of such notice (the term &#34;default&#34; or &#34;defaults&#34; for the purposes of this Section being hereby defined to mean any event or condition which is, or with notice or lapse of time or both would become, an Event of Default)&#59; provided that, except in the case of default in the payment of the principal of, or premium, if any, or interest, if any, on, or any Additional Amounts with respect to, any of the Securities of such series, the Trustee shall be protected in withholding such notice if and so long as the board of directors, the executive committee or a trust committee of directors or Responsible Officers of the Trustee in good faith determines that the withholding of such notice is in the interests of the Securityholders of such series.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.12 Right of Court to Require Filing of Undertaking to Pay Costs.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties to this Indenture agree, and each Holder of any Security by his acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken, suffered or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys' fees, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant&#59; but the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder or group of Securityholders of any series holding in the aggregate more than 10% in aggregate principal amount of the Securities of such series Outstanding, or, in the case of any suit relating to or arising under Section 6.1(c) or Section 6.1(i) (if the suit relates to Securities of more than one but fewer than all series), 10% in aggregate principal amount of Securities Outstanding affected thereby, or, in the case of any suit relating to or arising under Section 6.1(c) or Section 6.1(i) (if the suit under clause (d) or (g) relates to all the Securities then Outstanding), Section 6.1(f) or Section 6.1(g), 10% in aggregate principal amount of all Securities Outstanding, or to any suit instituted by any Holder of Securities for the enforcement of the payment of the principal of, or premium, if any, or interest, if any, on, any Security on or after the due date expressed in such Security.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.13 Waiver of Usury, Stay or Extension Laws.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company covenants that (to the extent that it may lawfully do so) it will not at any time insist upon, or plead, or in any manner whatsoever claim or take the benefit or advantage of, any usury, stay or extension law wherever enacted, now or at any time hereafter in force, which may affect the covenants or the performance of this Indenture&#59; and the Company expressly waives (to the extent that it may lawfully do so) all benefit or advantage of any such law and covenants that it will not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 6.14 Delay or Omission Not Waiver.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No delay or omission of the Trustee or of any Holder of any Security to exercise any right or remedy accruing upon any Event of Default shall impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article or by law to the Trustee or to any Holder of a Security may be exercised from time to time, and as often as may be deemed expedient, by the Trustee or by such Holder, as the case may be.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 7</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONCERNING THE TRUSTEE</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.1 Duties and Responsibilities of the Trustee&#59; During Default&#59; Prior to Default.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the Holders of any series of Securities issued hereunder, the Trustee, prior to the occurrence of an Event of Default with respect to the Securities of that series and after the curing or waiving of all Events of Default which may have occurred with respect to such series, undertakes to perform such duties and only such duties as are specifically set forth in this Indenture. In case an Event of Default with respect to the Securities of a series has occurred (which has not been cured or waived), the Trustee shall exercise such of the rights and powers vested in it </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by this Indenture, and use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his own affairs.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to act, or its own willful misconduct, except that&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) prior to the occurrence of an Event of Default with respect to the Securities of such series and after the curing or waiving of all such Events of Default with respect to such series which may have occurred&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the duties and obligations of the Trustee shall be determined solely by the express provisions of this Indenture, and the Trustee shall not be liable except for the performance of such duties and obligations as are specifically set forth in this Indenture, and no implied covenants or obligations shall be read into this Indenture against the Trustee&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) in the absence of bad faith on the part of the Trustee, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any statements, certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture&#59; but in the case of any such statements, certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer or Responsible Officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts&#59; and </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders of Securities pursuant to Section 6.9 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur personal financial liability in the performance of any of its duties or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that the repayment of such funds or adequate indemnity against such liability is not reasonably assured to it.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.2 Certain Rights of the Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to Section 7.1&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) the Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, Officer's Certificate or any other certificate, statement, instrument, opinion, report, notice, request, consent, order, bond, debenture, note, coupon, security or other paper or document (whether in original or facsimile form) believed by it to be genuine and to have been signed or presented by the proper party or parties&#59; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by an Officer's Certificate (unless other evidence in respect thereof be herein specifically prescribed)&#59; and any resolution of the Board of Directors may be evidenced to the Trustee by a copy thereof certified by the secretary or any assistant secretary of the Company&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the Trustee may consult with counsel and any advice or Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted to be taken by it hereunder in good faith and in accordance with such advice or Opinion of Counsel&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) the Trustee shall be under no obligation to exercise any of the trusts or powers vested in it by this Indenture at the request, order or direction of any of the Securityholders pursuant to the provisions of this Indenture, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unless such Securityholders shall have offered to the Trustee reasonable security or indemnity satisfactory to it against the costs, expenses and liabilities which might be incurred therein or thereby&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) the Trustee shall not be liable for any action taken or omitted by it in good faith and believed by it to be authorized or within the discretion, rights or powers conferred upon it by this Indenture&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) prior to the occurrence of an Event of Default hereunder and after the curing or waiving of all Events of Default, the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, approval, appraisal, bond, debenture, note, coupon, security or other paper or document unless requested in writing so to do by the Holders of not less than a majority in aggregate principal amount of the Securities of all series affected then Outstanding&#59; provided that, if the payment within a reasonable time to the Trustee of the costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in the opinion of the Trustee, not reasonably assured to the Trustee by the security afforded to it by the terms of this Indenture, the Trustee may require reasonable indemnity against such expenses or liabilities as a condition to proceeding&#59; the reasonable expenses of every such investigation shall be paid by the Company or, if paid by the Trustee or any predecessor Trustee, shall be repaid by the Company upon demand&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) the Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys not regularly in its employ, and the Trustee shall not be responsible for any misconduct or negligence on the part of any such agent or attorney appointed with due care by it hereunder&#59; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine during reasonable hours and upon reasonable notice the books, records and premises of the Company, personally or by agent or attorney&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the Trustee shall not be deemed to have notice of any Default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">written notice of any event which is in fact such a default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the Securities and this Indenture&#59; and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j) the rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person authorized to act hereunder.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.3 Trustee Not Responsible for Recitals, Disposition of Securities or Application of Proceeds Thereof.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recitals contained herein and in the Securities, except the certificates of authentication, shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness of the same, except that the Trustee represents that it is duly authorized to execute and deliver this Indenture, authenticate the Securities and perform its obligations hereunder and that the statements made by it in a Statement of Eligibility on Form T-1 supplied to the Company are true and accurate, subject to the qualifications set forth therein. The Trustee makes no representation as to the validity or sufficiency of this Indenture or of the Securities. The Trustee shall not be accountable for the use or application by the Company of any of the Securities or of the proceeds thereof.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.4 Trustee and Agents May Hold Securities&#59; Collections, etc.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee, any Paying Agent, Securities Registrar, Authenticating Agent or any agent of the Company or the Trustee, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not the Trustee or such agent, and, subject to Section 7.8 and Section 7.13, if operative, may otherwise deal with the Company and receive, collect, hold and retain collections from the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with the same rights it would have if it were not the Trustee, Paying Agent, Securities Registrar, Authenticating Agent or such agent.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.5 Moneys Held by Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions of Section 12.3, all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they were received, but need not be segregated from other funds except to the extent required by mandatory provisions of law. The Trustee shall have no liability for interest on money it receives and holds in trust except as specifically provided herein.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.6 Compensation and Indemnification of Trustee and Its Prior Claim.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company covenants and agrees to pay the Trustee from time to time, and the Trustee shall be entitled to such compensation as the Company and the Trustee may from time to time agree in writing for all services rendered by the Trustee hereunder (which compensation shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust) and the Company covenants and agrees to pay or reimburse the Trustee and each predecessor trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by or on behalf of it in accordance with any of the provisions of this Indenture (including the reasonable compensation and the expenses and disbursements of its counsel and of all agents and other Persons not regularly in its employ) except any such expense, disbursement or advance as shall be attributable to its negligence or bad faith. The Company also covenants to indemnify the Trustee and each predecessor trustee for, and hold it harmless against, any loss, liability, damage, claims or expense, including taxes (other than taxes measured by the income of the Trustee or otherwise applicable to the Trustee for operations outside the scope of this Indenture) incurred without negligence or bad faith on its part, arising out of or in connection with the acceptance or administration of this Indenture or the trusts hereunder and the performance of its duties hereunder, including the costs and expenses of defending itself against or investigating any claim of liability in connection with the exercise or performance of any of its powers or duties hereunder except to the extent that any such loss, liability, damage, claims or expense shall be attributable to the Trustee's negligence or bad faith. The obligations of the Company under this Section to compensate and indemnify the Trustee and each predecessor trustee and to pay or reimburse the Trustee and each predecessor trustee for expenses, disbursements and advances shall constitute additional indebtedness hereunder and shall survive the satisfaction and discharge of this Indenture and resignation or removal of the Trustee. Such additional indebtedness shall be a lien prior to that of the Securities upon all property and funds held or collected by the Trustee as such, except funds held in trust for the benefit of the Holders of particular Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.7 Right of Trustee to Rely on Officer's Certificate, etc.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to Section 7.1 and Section 7.2, whenever in the administration of the trusts of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or suffering or omitting any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be deemed to be conclusively proved and established by an Officer's Certificate delivered to the Trustee, and such certificate, in the absence of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted by it under the provisions of this Indenture upon the good faith thereof.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.8 Qualification of Trustee&#59; Conflicting Interests.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee for the Securities of any series issued hereunder shall be subject to the provisions of Section 310(b) of the Trust Indenture Act during the period of time provided for therein. In determining whether the Trustee has a conflicting interest as defined in Section 310(b) of the Trust Indenture Act with respect to the Securities of any series, there shall be excluded this Indenture with respect to Securities of any particular series of Securities other than that series. Nothing herein shall prevent the Trustee from filing with the Commission the application referred to in the penultimate paragraph of Section 310(b) of the Trust Indenture Act.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.9 Persons Eligible for Appointment as Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There shall at all times be a Trustee hereunder for each series of Securities, which shall be at all times either&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) a corporation organized and doing business under the laws of the United States of America or of any State or territory or the District of Columbia, authorized under such laws to exercise corporate trust powers and subject to supervision or examination by Federal, State, territory or District of Columbia authority&#59; or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) a corporation or other Person organized and doing business under the laws of a foreign government that is permitted to act as Trustee pursuant to a rule, regulation or order of the Commission, authorized under such laws to exercise corporate trust powers, and subject to supervision or examination by authority of such foreign government or a political subdivision thereof substantially equivalent to supervision or examination applicable to United States institutional trustees, in either case having a combined capital and surplus of at least $50,000,000. If such corporation publishes reports of condition at least annually, pursuant to law or to requirements of the aforesaid supervising or examining authority, then for the purposes of this Section 7.9, the combined capital and surplus of such corporation shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. If at any time the Trustee for the Securities of any series shall cease to be eligible in accordance with the provisions of this Section 7.9, it shall resign immediately in the manner and with the effect hereinafter specified in this Article. Neither the Company nor any Person directly or indirectly controlling, controlled by, or under common control with the Company shall serve as Trustee for the Securities of any series issued hereunder.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.10 Resignation and Removal&#59; Appointment of Successor Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Trustee, or any trustee or trustees hereafter appointed, may at any time resign by giving written notice of resignation to the Company and by mailing notice thereof by first-class mail to Holders of the Securities at their last addresses as they shall appear on the Security Register. Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee or trustees by written instrument in duplicate, executed by authority of the Board of Directors, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee or trustees. If no successor trustee shall have been so appointed and have accepted appointment within 30 days after the mailing of such notice of resignation, the resigning Trustee may petition at the expense of the Company any court of competent jurisdiction for the appointment of a successor trustee, or any Securityholder who has been a bona fide Holder of a Security or Securities for at least six months may, subject to the provisions of Section 6.12, on behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) In case at any time any of the following shall occur&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the Trustee shall fail to comply with the provisions of Section 310(b) of the Trust Indenture Act after written request therefor by the Company or by any Securityholder who has been a bona fide Holder of a Security or Securities for at least six months unless the Trustee's duty to resign is stayed in accordance with the provisions of Section 310(b) of the Trust Indenture Act&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the Trustee shall cease to be eligible in accordance with the provisions of Section 7.9 and shall fail to resign after written request therefor by the Company or by any Securityholder&#59; or the Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent&#59; or a receiver or liquidator of the Trustee or of  its property shall be appointed, or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation&#59; then, in any case, the Company may remove the Trustee and appoint a successor trustee by written instrument, in duplicate, executed by order of the Board of Directors of the Company, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or, subject to the provisions of Section 6.12, any Securityholder who has been a bona fide Holder of a Security or Securities for at least six months may, on behalf of himself and all others similarly situated, petition any court of competent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">jurisdiction for the removal of the Trustee and the appointment of a successor trustee. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, remove the Trustee and appoint a successor trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Holders of a majority in aggregate principal amount of the Securities at the time Outstanding may at any time remove the Trustee and appoint a successor trustee by delivering to the Trustee so removed, to the successor trustee so appointed and to the Company the evidence provided for in Section 8.1 of the action in that regard taken by the Securityholders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) No resignation or removal of the Trustee and no appointment of a successor trustee pursuant to any of the provisions of this Section 7.10 shall become effective until acceptance of appointment by the successor trustee as provided in Section 7.11.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.11 Acceptance of Appointment by Successor Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any successor trustee appointed as provided in Section 7.10 shall execute, acknowledge and deliver to the Company and to its predecessor trustee an instrument accepting such appointment hereunder, and thereupon the resignation or removal of the predecessor trustee shall become effective and such successor trustee, without any further act, deed or conveyance, shall become vested with all rights, powers, duties and obligations of its predecessor hereunder, with like effect as if originally named as trustee hereunder&#59; but nevertheless, on the written request of the Company or of the successor trustee, upon payment of all amounts due to the Trustee under Section 7.6, the Trustee ceasing to act shall, subject to Section 4.4, pay over to the successor trustee all moneys at the time held by it hereunder and shall execute and deliver an instrument transferring to such successor trustee all such rights, powers, duties and obligations. Upon request of any successor trustee, the Company shall execute any and all instruments in writing for more fully and certainly vesting in and confirming to such successor trustee all such rights and powers. Any Trustee ceasing to act, shall, nevertheless, retain a prior lien upon all property or funds held or collected by such trustee to secure any amounts then due it pursuant to the provisions of Section 7.6.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No successor trustee shall accept appointment as provided in this Section 7.11 unless at the time of such acceptance such successor trustee shall be qualified under the provisions of Section 7.8 and eligible under the provisions of Section 7.9.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon acceptance of appointment by any successor trustee as provided in this Section 7.11, the Company shall mail notice thereof by first-class mail to the Holders of Securities at their last addresses as they shall appear on the Security Register. If the acceptance of appointment is substantially contemporaneous with the resignation, then the notice called for by the preceding sentence may be combined with the notice called for by Section 7.10. If the Company fails to mail such notice within 10 days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be mailed at the expense of the Company.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.12 Merger, Conversion, Consolidation or Succession to Business of Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any corporation in which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation succeeding to substantially all of the corporate trust business of the Trustee, shall be the successor of the trustee hereunder, provided that such corporation shall be qualified under the provisions of Section 7.8 and eligible under the provisions of Section 7.9, without the execution or filing of any paper or any further act (including the giving of any notice to Securityholders) on the part of any of the parties hereto, anything herein to the contrary notwithstanding.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case at the time such successor to the Trustee shall succeed to the trusts created by this Indenture any of the Securities shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee and deliver such Securities so authenticated&#59; and, in case at that time any of the Securities shall not have been authenticated, any successor to the Trustee may authenticate such Securities either in the name of any predecessor hereunder or in the name of the successor trustee&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and in all such cases such certificate shall have the full force which it is anywhere in the Securities or in this Indenture provided for the certificate of authentication of the Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.13 Preferential Collection of Claims Against the Company.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Subject to the provisions of this Section, if the Trustee shall be or shall become a creditor, directly or indirectly, secured or unsecured, of the Company or any other obligor of the Securities within three months prior to a default, as defined in Section 7.13(c), or subsequent to such a default, then, unless and until such default shall be cured, the Trustee shall set apart and hold in a special account for the benefit of the Trustee individually, the Holders of the Securities and the holders of other indenture securities (as defined in this Section)&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) an amount equal to any and all reductions in the amount due and owing upon any claim as such creditor in respect of principal or interest, effected after the beginning of such three months' period and valid as against the Company and its other creditors, except any such reduction resulting from the receipt or disposition of any property described in Section 7.13(a)(ii), or from the exercise of any right of set-off which the Trustee could have exercised if a petition in bankruptcy had been filed by or against the Company upon the date of such default&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) all property received by the Trustee in respect of any claim as such creditor, either as security therefor, or in satisfaction or composition thereof, or otherwise, after the beginning of such three months' period, or an amount equal to the proceeds of any such property, if disposed of, subject, however, to the rights, if any, of the Company and its other creditors in such property or such proceeds.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nothing herein contained, however, shall affect the right of the Trustee&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A) to retain for its own account (i) payments made on account of any such claim by any Person (other than the Company) who is liable thereon, (ii) the proceeds of a bona fide sale of any such claim by the Trustee to a third Person, and (iii) distributions made in cash, securities or other property in respect of claims filed against the Company in bankruptcy or receivership or in the proceedings for reorganization pursuant to the Federal Bankruptcy Code or applicable state law&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B) to realize, for its own account, upon any property held by it as security for any such claim, if such property was so held prior to the beginning of such three months' period&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C) to realize, for its own account, but only to the extent of the claim hereinafter mentioned, upon any property held by it as security for any such claim, if such claim was created after the beginning of such three months' period and such property was received as security therefor simultaneously with the creation thereof, and if the Trustee shall sustain the burden of proving that at the time such property was so received the Trustee has no reasonable cause to believe that a default as defined by Section 7.13(c) would occur within three months&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D) to receive payment on any claim referred to in paragraph (B) or (C) above, against the release of any property held as security for such claim as provided in such paragraph (B) or (C), as the case may be, to the extent of the fair value of such property.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of paragraphs (B), (C) and (D), property substituted after the beginning of such three months' period for property held as security at the time of such substitution shall, to the extent of the fair value of the property released, have the same status as the property released, and, to the extent that any claim referred to in any of such paragraphs is created in renewal of or in substitution for or for the purpose of repaying or refunding any pre-existing claim of the Trustee as such creditor, such claim shall have the same status as such pre-existing claim. </font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Trustee shall be required to account, the funds and property held in such special account and the proceeds thereof shall be apportioned between the Trustee, the Holders of the Securities and the holders of other indenture securities in such manner that the Trustee, such Holders and the holders of other indenture securities realize, as a result of payments from such special account and payments of dividends on claims filed against the Company in bankruptcy or receivership or in proceedings for reorganization pursuant to the Federal Bankruptcy </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Code or applicable state law, the same percentage of their respective claims, figured before crediting to the claim of the Trustee anything on account of the receipt by it from the Company of the funds and property in such special account and before crediting to the respective claims of the Trustee, Holders of the Securities and the holders of other indenture securities dividends on claims filed against the Company in bankruptcy or receivership or in proceedings for reorganization pursuant to the Federal Bankruptcy Code or applicable state law, but after crediting thereon receipts on account of the indebtedness represented by their respective claims from all sources other than from such dividends and from the funds and property so held in such special account. As used in this paragraph, with respect to any claim, the term &#34;dividends&#34; shall include any distribution with respect to such claim, in bankruptcy or receivership or in proceedings for reorganization pursuant to the Federal Bankruptcy Code or applicable state law, whether such distribution is made in cash, securities or other property, but shall not include any such distribution with respect to the secured portion, if any, of such claim. The court in which such bankruptcy, receivership or proceeding for reorganization is pending shall have jurisdiction (i) to apportion between the Trustee, the Holders of Securities and the holders of other indenture securities, in accordance with the provisions of this paragraph, the funds and property held in such special account and the proceeds thereof&#59; or (ii) in lieu of such apportionment, in whole or in part, to give to the provisions of this paragraph due consideration in determining the fairness of the distributions to be made to the Trustee, the Holders of Securities and the holders of other indenture securities with respect to their respective claims, in which event it shall not be necessary to liquidate or to appraise the value of any securities or other property held in such special account or as security for any such claim, or to make a specific allocation of such distribution as between the secured and unsecured portions of such claims, or otherwise to apply the provisions of this paragraph as a mathematical formula.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Trustee who has resigned or been removed after the beginning of such three months' period shall be subject to the provisions of this Section 7.13(a) as though such resignation or removal had not occurred. If any Trustee has resigned or been removed prior to the beginning of such three months' period, it shall be subject to the provisions of this Section 7.13(a) if and only if the following conditions exist&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E) the receipt of property or reduction of claim which would have given rise to the obligation to account, if such Trustee had continued as trustee, occurred after the beginning of such three months' period&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F) such receipt of property or reduction of claim occurred within three months after such resignation or removal.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) There shall be excluded from the operation of this Section a creditor relationship arising from&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the ownership or acquisition of securities issued under any indenture, or any security or securities having a maturity of one year or more at the time of acquisition by the Trustee&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) advances authorized by a receivership or bankruptcy court of competent jurisdiction or by this Indenture for the purpose of preserving any property which shall at any time be subject to the lien of this Indenture or of discharging tax liens or other prior liens or encumbrances thereon, if notice of such advance and of the circumstances surrounding the making thereof is given to the Holders of the applicable series of Securities at the time and in the manner provided in this Indenture&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) disbursements made in the ordinary course of business in the capacity of trustee under an indenture, transfer agent, registrar, custodian, paying agent, fiscal agent or depositary, or other similar capacity&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) an indebtedness created as a result of services rendered or premises rented or an indebtedness created as a result of goods or securities sold in a cash transaction as defined in Section 7.13(c)(iii)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) the ownership of stock or of some other securities of a corporation organized under the provisions of Section 25(a) of the Federal Reserve Act, as amended, which is directly or indirectly a creditor of the Company&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) the acquisition, ownership, acceptance or negotiation of any drafts, bills of exchange, acceptances or obligations which fall within the classification of self-liquidating paper as defined in Section 7.13(c)(iv).</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) As used in this Section&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the term &#34;default&#34; shall mean any failure to make payment in full of the principal of or interest upon any of the Securities of the applicable series or upon the other indenture securities when and as such principal or interest becomes due and payable&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the term &#34;other indenture securities&#34; shall mean securities upon which the Company is an obligor (as defined in the Trust Indenture Act) outstanding under any other indenture (i) under which the Trustee is also trustee, (ii) which contains provisions substantially similar to the provisions of Section 7.13(a), and (iii) under which a default exists at the time of the apportionment of the funds and property held in said special account&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) the term &#34;cash transaction&#34; shall mean any transaction in which full payment for goods or securities sold is made within seven days after delivery of the goods or securities in currency or in checks or other orders drawn upon banks or bankers and payable upon demand&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) the term &#34;self-liquidating paper&#34; shall mean any draft, bill of exchange, acceptance or obligation which is made, drawn, negotiated or incurred by the Company for the purpose of financing the purchase, processing, manufacture, shipment, storage or sale of goods, wares or merchandise and which is secured by documents evidencing title to, possession of, or a lien upon the goods, wares or merchandise or the receivables or proceeds arising from the sale of goods, wares or merchandise previously constituting the security, provided that the security is received by the Trustee simultaneously with the creation of the creditor relationship with the Company arising from the making, drawing, negotiating or incurring of the draft, bill of exchange, acceptance or obligation&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) the term &#34;Company&#34; shall mean any obligor upon the Securities. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 7.14 Authenticating Agent.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">So long as any Securities remain Outstanding, if the Corporate Trust Office of the Trustee is not located in the Borough of Manhattan, The City of New York, or otherwise upon a Company Request, there shall be an authenticating agent (the &#34;Authenticating Agent&#34;) appointed, for such period as the Company shall elect, by the Trustee to act as its agent on its behalf and subject to its direction in connection with the authentication and delivery of Securities. Securities authenticated by such Authenticating Agent shall be entitled to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by such Trustee. Wherever reference is made in this Indenture to the authentication and delivery of Securities by the Trustee or to the Trustee's Certificate of Authentication, such reference shall be deemed to include authentication and delivery on behalf of the Trustee by an Authenticating Agent and a Certificate of Authentication executed on behalf of such Trustee by such Authenticating Agent. Such Authenticating Agent shall at all times be a corporation organized and doing business under the laws of the United States of America or of any State or of the District of Columbia, authorized under such laws to exercise corporate trust powers, having a combined capital and surplus of at least $50,000,000 and subject to supervision or examination by Federal, State or District of Columbia authority. If the Corporate Trust Office of the Trustee is not located in the Borough of Manhattan, The City of New York, the Authenticating Agent shall have its principal office and place of business in the Borough of Manhattan, The City of New York.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any corporation into which any Authenticating Agent may be merged or converted, or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which any Authenticating Agent shall be a party, or any corporation succeeding to the corporate agency business of any Authenticating Agent, shall continue to be the Authenticating Agent without the execution or filing of any paper or any further act on the part of the Trustee or such Authenticating Agent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Authenticating Agent may at any time, and if it shall cease to be eligible shall, resign by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating Agent and to the Company. Upon receiving such a notice of resignation or upon such a termination, or in case at any time any Authenticating Agent shall cease to be eligible in accordance with the provisions of this Section 7.14, the Trustee shall upon Company Request appoint a successor Authenticating Agent, and the Company shall provide notice of such appointment to all Holders of Securities in the manner and to the extent provided in Section 13.4. Any successor Authenticating Agent upon acceptance of its appointment hereunder shall become vested with all rights, powers, duties and responsibilities of its predecessor hereunder, with like effect as if originally named as Authenticating Agent herein. The Company agrees to pay or to cause to be paid to the Authenticating Agent from time to time reasonable compensation for its services. The Authenticating Agent shall have no responsibility or liability for any action taken by it as such in good faith at the direction of the Trustee.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 8</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONCERNING THE HOLDERS OF SECURITIES</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 8.1 Action by Holders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever in this Indenture it is provided that the Holders of a specified percentage in aggregate principal amount of the Securities of any series may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action) the fact that at the time of taking any such action the Holders of such specified percentage have joined therein may be evidenced (a) by any instrument or any number of instruments of similar tenor executed by Holders in Person or by agent or proxy appointed in writing, or (b) by the record of Holders voting in favor thereof at any meeting of such Holders duly called and held in accordance with the provisions of ARTICLE 9, or (c) by a combination of such instrument or instruments and any such record of such a meeting of Holders. The Company may (but shall not be required to) set a record date for purposes of determining the identity of Securityholders entitled to vote or consent to any action by vote or consent authorized or permitted under this Indenture, which record date shall be the later of 10 days prior to the first solicitation of such consent or the date of the most recent list of Holders furnished to the Trustee pursuant to Section 5.1 of this Indenture prior to such solicitation. If a record date is fixed, those Persons who were Securityholders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to take such action by vote or consent or to revoke any vote or consent previously given, whether or not such Persons continue to be Holders after such record date.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 8.2 Proof of Execution of Instruments by Holders of Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to Section 7.1, Section 7.2 and Section 9.5, the execution of any instrument by a Holder of a Security or his agent or proxy may be proved in any reasonable manner that the Trustee deems sufficient, including, without limitation, in the following manner&#58;</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fact and date of the execution by any such Person of any instrument may be proved by the certificate of any notary public or other officer authorized to take acknowledgments of deeds, that the Person executing such instrument acknowledged to him the execution thereof, or by an affidavit or written statement of a witness to such execution. Where such execution is by an officer of a corporation or association or a member of a partnership on behalf of such corporation, association or partnership, as the case may be, or by any other Person acting in a representative capacity, such certificate, affidavit or written statement shall also constitute sufficient proof of his authority.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ownership of Securities shall be proved by the Securities Register or by a certificate of the Securities Registrar.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The record of any Holders' meeting shall be proved in the manner provided in Section 9.6.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 8.3 Holders to be Treated as Owners.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, the Trustee and any agent of the Company or the Trustee may deem and treat the Person in whose name any Security shall be registered upon the Security Register as the absolute owner of such Security (notwithstanding any notation of ownership or other writing thereon) for the purpose of receiving payment of principal of, and premium, if any, and (subject to Section 3.6 and Section 3.9) interest, if any, on, such Security, and for all other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary. All such payments so made to any Holder for the time being, shall be valid, and, to the extent of the sum or sums so paid, effectual to satisfy and discharge the liability for moneys payable upon such Security.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the Company, the Trustee or any agent of the Company or the Trustee shall have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interest of a Global Security, or for maintaining, supervising or reviewing any records relating to such beneficial ownership interest. Notwithstanding the foregoing, with respect to any Global Security, nothing herein shall prevent the Company or the Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by any Depository (or its nominee), as a Holder, with respect to such Global Security or impair, as between such Depository and owners of beneficial interests in such Global Security, the operation of customary practices governing the exercise of the right of such Depository (or its nominee) as holder of such Global Security.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 8.4 Securities Owned by Company Deemed Not Outstanding.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether the Holders of the requisite aggregate principal amount of Securities of any or all series have concurred in any direction, consent or waiver under this Indenture, Securities which are owned by the Company or any other obligor on the Securities with respect to which such determination is being made or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any other obligor on the Securities with respect to which such determination is being made shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or waiver only Securities which the Trustee knows are so owned shall be so disregarded. Securities so owned which have been pledged in good faith may be regarded as Outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee's right so to act with respect to such Securities and that the pledgee is not the Company or any other obligor upon the Securities or any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any other obligor on the Securities. In case of a dispute as to such right, the advice of counsel shall be full protection in respect of any decision made by the Trustee in accordance with such advice. Upon request of the Trustee, the Company shall furnish to the Trustee promptly an Officer's Certificate listing and identifying all Securities, if any, known by the Company to be owned or held by or for the account of any of the above-described Persons&#59; and, subject to Section 7.1 and Section 7.2, the Trustee shall be entitled to accept such Officer's Certificate as conclusive evidence of the facts therein set forth and of the fact that all Securities not listed therein are Outstanding for the purpose of any such determination.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 8.5 Right of Revocation of Action Taken.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time prior to (but not after) the evidencing to the Trustee, as provided in Section 8.1, of the taking of any action by the Holders of the percentage in aggregate principal amount of the Securities of any or all series, as the case may be, specified in this Indenture in connection with such action, any Holder of a Security, the number, letter or other distinguishing symbol of which is shown by the evidence to be included in the Securities the Holders of which have consented to such action, may, by filing written notice at the Corporate Trust Office and upon proof of holding as provided in this Article, revoke such action so far as concerns such Security. Except as aforesaid, any such action taken by the Holder of any Security shall be conclusive and binding upon such Holder and upon all future Holders and owners of such Security and of any Securities issued in exchange or substitution therefor, irrespective of whether or not any notation in regard thereto is made upon any such Security or such other Security. Any action taken by the Holders of the percentage in aggregate principal amount of the Securities of any or all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">series, as the case may be, specified in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the Holders of all the Securities affected by such action.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 9</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HOLDERS' MEETINGS</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 9.1 Purposes of Meetings.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A meeting of Holders of Securities of any or all series may be called at any time and from time to time pursuant to the provisions of this Article for any of the following purposes&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) to give any notice to the Company or to the Trustee for the Securities of such series, or to give any directions to the Trustee, or to consent to the waiving of any default hereunder and its consequences, or to take any other action authorized to be taken by Holders pursuant to any of the provisions of ARTICLE 6&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) to remove the Trustee and nominate a successor Trustee pursuant to the provisions of ARTICLE 7&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) to consent to the execution of an indenture or indentures supplemental hereto pursuant to the provisions of Section 10.2&#59; or </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) to take any other action authorized to be taken by or on behalf of the Holders of any specified aggregate principal amount of the Securities of any one or more or all series, as the case may be, under any other provision of this Indenture or under applicable law.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 9.2 Call of Meetings by Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee may at any time call a meeting of Holders of Securities to take any action specified in Section 9.1, to be held at such time and at such place in the Borough of Manhattan, The City of New York, or such other Place of Payment, as the Trustee shall determine. Notice of every meeting of the Holders of Securities, setting forth the time and the place of such meeting, and in general terms the action proposed to be taken at such meeting, shall be given to Holders of Securities of the particular series in the manner and to the extent provided in Section 13.4. Such notice shall be given not less than 20 nor more than 90 days prior to the date fixed for the meeting.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 9.3 Call of Meetings by Company or Holders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case at any time the Company, pursuant to a resolution of its Board of Directors, or the Holders of at least 10% in aggregate principal amount of the Outstanding Securities of any or all series, as the case may be, shall have requested the Trustee to call a meeting of Holders of Securities of any or all series, as the case may be, by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee for such series shall not have given the notice of such meeting within 20 days after receipt of such request, then the Company or such Holders may determine the time and the place in the Borough of Manhattan or other Place of Payment for such meeting and may call such meeting to take any action authorized in Section 9.1, by giving notice thereof as provided in Section 9.2.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 9.4 Qualifications for Voting.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be entitled to vote at any meeting of Holders a Person shall be (a) a Holder of one or more outstanding Securities with respect to which such meeting is being held or (b) a Person appointed by an instrument in writing as proxy by such Holder. The only Persons who shall be entitled to be present or to speak at any meeting of Holders shall be the Persons entitled to vote at such meeting and their counsel and any representatives of the Trustee and its counsel and any representatives of the Company and its counsel.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 9.5 Regulations.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any meeting of Holders of the Securities in regard to proof of the holding of Securities </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and of the appointment of proxies, and in regard to the appointment and duties of inspectors of votes, the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall think fit.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee shall, by an instrument in writing, appoint a temporary chairman of the meeting, unless the meeting shall have been called by the Company or by Holders of Securities as provided in Section 9.3, in which case the Company or the Holders calling the meeting, as the case may be, shall in like manner appoint a temporary chairman. A permanent chairman and a permanent secretary of the meeting shall be elected by majority vote of the meeting.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to Section 8.4, at any meeting each Holder of Securities with respect to which such meeting is being held or proxy therefor shall be entitled to one vote for each $1,000 principal amount (in the case of Original Issue Discount Securities, such principal amount to be determined as provided in the definition of &#34;Outstanding&#34;) of Securities held or represented by him&#59; provided, however, that no vote shall be cast or counted at any meeting in respect of any such Security challenged as not Outstanding and ruled by the chairman of the meeting to be not Outstanding. The chairman of the meeting shall have no right to vote other than by virtue of Securities held by him or instruments in writing aforesaid duly designating him as the Person to vote on behalf of other Holders. At any meeting of Holders, the presence of Persons holding or representing Securities with respect to which such meeting is being held in an aggregate principal amount sufficient to take action on the business for the transaction of which such meeting was called shall constitute a quorum, but, if less than a quorum is present, the Persons holding or representing a majority in aggregate principal amount of such Securities represented at the meeting may adjourn such meeting with the same effect, for all intents and purposes, as though a quorum had been present. Any meeting of Holders of Securities with respect to which a meeting was duly called pursuant to the provisions of Section 9.2 or Section 9.3 may be adjourned from time to time by Persons holding or representing a majority in aggregate principal amount of such Securities represented at the meeting, present, whether or not constituting a quorum, and the meeting may be held as so adjourned without further notice.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 9.6 Voting.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vote upon any resolution submitted to any meeting of Holders of Securities with respect to which such meeting is being held shall be by written ballots on which shall be subscribed the signatures of such Holders or of their representatives by proxy and the serial number or numbers of the Securities held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record in duplicate of the proceedings of each meeting of holders shall be prepared by the secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that said notice was mailed as provided in Section 9.2. The record shall show the serial numbers of the Securities voting in favor of or against any resolution. The record shall be signed and verified by the affidavits of the permanent chairman and secretary of the meeting and one of the duplicates shall be delivered to the Company and the other to the Trustee to be preserved by the Trustee.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any record so signed and verified shall be conclusive evidence of the matters therein stated.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 9.7 No Delay of Rights by Reason of Meeting.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nothing in this Article contained shall be deemed or construed to authorize or permit, by reason of any call of a meeting of Holders or any rights expressly or impliedly conferred hereunder to make such call, any hindrance or delay in the exercise of any right or rights conferred upon or reserved to the Trustee or to the Holders under any of the provisions of this Indenture or of the Securities of any series.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 10</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUPPLEMENTAL INDENTURES</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 10.1 Supplemental Indentures Without Consent of Securityholders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without the consent of any Holders of Securities, the Company, when authorized by a resolution of its Board of Directors, and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as in force at the date of the execution thereof) for one or more of the following purposes&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) to convey, transfer, assign, mortgage or pledge to the Trustee as security for the Securities any property or assets&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) to evidence the succession of another Person to the Company, or successive successions, and the assumption by the successor Person of the covenants, agreements and obligations of the Company under this Indenture and the Securities, in each case in compliance with the Indenture&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) to add to the covenants of the Company such further covenants, restrictions, conditions or provisions as its Board of Directors shall consider to be for the protection of the Holders of any series of Securities or Tranche thereof, or to surrender any right or power herein conferred upon the Company and to make the occurrence and continuance of a default in any such additional covenants, restrictions, conditions or provisions an Event of Default permitting the enforcement of all or any of the several remedies provided in this Indenture as herein set forth&#59; provided that in respect of any such additional covenant, restriction, condition or provision such supplemental indenture may provide for a particular period of grace after default (which period may be shorter or longer than that allowed in the case of other defaults) or may provide for an immediate enforcement upon such an Event of Default or may limit the remedies available to the Trustee upon such an Event of Default or may limit the right of the Holders of a majority in aggregate principal amount of the Securities of such series to waive such an Event of Default&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) to cure any ambiguity or to correct or supplement any provision contained herein or in any supplemental indenture which may be defective or inconsistent with any other provision contained herein or in any supplemental indenture&#59; or to make such other provisions in regard to matters or questions arising under this Indenture or under any supplemental indenture as the Board of Directors may deem necessary or desirable and which shall not materially adversely affect the interests of the Holders of any Securities&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) to establish the form or terms of Securities of any series as permitted by Section 3.1&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) to provide for the issuance under this Indenture of Securities in coupon form (including Securities registrable as to principal only), to provide for interchangeability thereof with Securities in registered form of the same series and to make all appropriate changes for such purpose, or to permit or facilitate the issuance of Securities of any series in uncertificated form provided any such action shall not adversely affect the interests of the Holders of Outstanding Securities of any series in any material respect&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) to add to, delete from or revise the conditions, limitations and restrictions on the authorized amount, terms or purposes of issue, authentication and delivery of Securities, as herein set forth&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) to add any additional Events of Default with respect to all or any series of Securities (as shall be specified in such supplemental indenture)&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) to supplement any of the provisions of this Indenture to such extent as shall be necessary to permit or facilitate the defeasance and discharge of any series of Securities pursuant to ARTICLE 12, provided that any such action shall not adversely affect the interests of any Holder of an Outstanding Security of such series or any other Outstanding Security in any material respect&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j) to make provisions with respect to conversion or exchange rights of Holders of Securities of any series&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k) to provide for the issuance under this Indenture of Securities denominated or payable in currency other than Dollars and to make all appropriate changes for such purpose&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l) to evidence and provide for the acceptance of appointment hereunder by a successor trustee with respect to the Securities, pursuant to Section 7.11, or to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m) to modify any restrictions on and procedures for resales of Securities of any series that is not registered pursuant to the Securities Act to reflect any change in applicable law or regulation (or the interpretation thereof) or in practices relating to the resale or transfer of restricted securities generally and to modify any legends placed on such Securities to reflect such restrictions and procedures&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n) to add to or change or eliminate any provision of this Indenture as shall be necessary or desirable to conform to provisions of the Trust Indenture Act as at the time in effect, provided that such action shall not materially adversely affect the interests of the Holders of the Securities of any series&#59;and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o) otherwise to amend or supplement any of the provisions of this Indenture or in any supplemental indenture&#59; provided, however, that no such amendment or supplement shall materially adversely affect the interests of the Holders of any Securities then Outstanding.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture, to make any further appropriate agreements and stipulations, which may be therein contained and to accept the conveyance, transfer, assignment, mortgage or pledge of any property thereunder, but the Trustee shall not be obligated to enter into any such supplemental indenture which affects the Trustee's own rights, duties or immunities under this Indenture or otherwise.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any supplemental indenture authorized by the provisions of this Section may be executed without the consent of the Holders of any of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 10.2.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 10.2 Supplemental Indentures With Consent of Securityholders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the consent (evidenced as provided in Article VIII) of the Holders of not less than a majority in aggregate principal amount of the Securities at the time Outstanding of all series affected by such supplemental indenture (voting as one class), the Company, when authorized by a resolution of its Board of Directors, and the Trustee may, from time to time and at any time, enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as in force at the date of execution thereof) for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner the rights of the Holders of the Securities of each such series&#59; provided that no such supplemental indenture shall (a) change the Stated Maturity of the principal of, or any premium or installment of interest on or any Additional Amounts with respect to, any Security of such series, or reduce the principal amount thereof (or modify the calculation of such principal amount) or rate of interest thereon or any Additional Amounts with respect thereto (or modify the calculation of such rate), or any premium payable on redemption thereof or otherwise, or reduce the amount of the principal of an Original Issue Discount Security that would be due and payable upon an acceleration with respect thereto pursuant to Section 6.1 or the amount thereof provable in bankruptcy pursuant to Section 6.2, or change the obligation of the Company to pay Additional Amounts pursuant to Section 4.4 (except as contemplated by Section 11.1 and permitted by Section 10.1), or change the redemption provisions, or change the Place of Payment, currency in which the principal of, any premium or interest on, or any Additional Amounts with respect to any security is payable, or impair or adversely affect the right of any Securityholder to institute suit for the payment thereof or, if the Securities provide therefor, any right of repayment at the option of the Securityholder, without the consent of the Holder of each Security of such series so affected&#59; or (b) reduce the aforesaid percentage of the principal amount of Securities Outstanding of such series, the consent of the Holders of which is required for any such supplemental indenture or any waiver of any obligations of the Company under this Indenture, without the consent of the Holders of each Security of such series so affected, or reduce the requirements for quorum on voting&#59; or (c) modify any of the provisions this Section, Section 6.10 or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 4.9, except to increase any such percentage or to provide that certain other provisions of this Indenture cannot be modified without the consent of the Holder of each Outstanding Security thereby.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the request of the Company, accompanied by a Board Resolution authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of evidence of the consent of Securityholders as aforesaid and other documents, if any, required by Section 8.1, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee's own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It shall not be necessary for the consent of the Securityholders under this Section to approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A supplemental indenture which changes or eliminates any covenant or other provision of this Indenture which has expressly been included solely for the benefit of one or more particular series of Securities, or which modifies the rights of the Holders of Securities of such series with respect to such covenant or other provision, shall be deemed not to affect the rights under this Indenture of the Holders of Securities of any other series.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 10.3 Notice of Supplemental Indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of Section 10.2, the Company shall mail a notice thereof by first-class mail to the Holders of Securities of each series affected thereby at their addresses as they shall appear on the Security Register, setting forth in general terms the substance of such supplemental indenture. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 10.4 Effect of Supplemental Indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the execution of any supplemental indenture pursuant to the provisions of this Article, this Indenture shall be and be deemed to be modified and amended in accordance therewith, but only with regard to the Securities of each series affected by such supplemental indenture, and the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the Holders of any Securities of such series affected thereby shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes with regard to the Securities of such series.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 10.5 Documents To Be Given to Trustee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee, subject to the provisions of Section 7.1 and Section 7.2, shall be provided with an Officer's Certificate and an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article complies with the applicable provisions of this Indenture and is authorized or permitted by this Indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 10.6 Notation on Securities in Respect of Supplemental Indentures.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities of any series affected by any supplemental indenture which are authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions of this Article may bear a notation in form approved by the Company and the Trustee as to any matter provided for in such supplemental indenture. If the Company shall so determine, new Securities of any series so modified as to conform, in the opinion of the Company, to any modification of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee and delivered in exchange for the Securities of such series then Outstanding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 11</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATION, AMALGAMATION, MERGER OR SALE</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 11.1 Company May Consolidate, Etc., Only on Certain Terms.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall not consolidate or amalgamate with or merge into any other Person (whether or not affiliated with the Company), or convey, transfer, sell or lease its properties and assets as an entirety or substantially as an entirety to any other Person (whether or not affiliated with the Company), and the Company shall not permit any other Person (whether or not affiliated with the Company) to consolidate or amalgamate with or merge into the Company or convey, transfer or lease its properties and assets as an entirety or substantially as an entirety to the Company, unless&#58;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) in case the Company shall consolidate or amalgamate with or merge into another Person or convey, transfer or lease its properties and assets as an entirety or substantially as an entirety to any Person, the Person formed by such consolidation or amalgamation or into which the Company is merged or the Person which acquires by conveyance or transfer, or which leases, the properties and assets of the Company as an entirety or substantially as an entirety shall be a Corporation or limited liability company organized and existing under the laws of the United States of America, any state thereof or the District of Columbia, Bermuda, or any other country (including under the laws of any state, province or other political subdivision thereof) which is on the date of this Indenture a member of the Organization for Economic Cooperation and Development, and shall expressly assume, by an indenture (or indentures, if at such time there is more than one Trustee) supplemental hereto, executed by the successor Person and delivered to the Trustee the due and punctual payment of the principal of, any premium and interest on and any Additional Amounts with respect to all the Securities and the performance of every obligation in this Indenture and the Outstanding Securities on the part of the Company to be performed or observed and shall provide for conversion or exchange rights in accordance with the provisions of the Securities of any series that are convertible or exchangeable into Common Shares or other securities&#59; and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) immediately after giving effect to such transaction and treating any indebtedness which becomes an obligation of the Company or a Designated Subsidiary as a result of such transaction as having been incurred by the Company or a Designated Subsidiary at the time of such transaction, no Event of Default or event which, after notice or lapse of time, or both, would become an Event of Default, shall have occurred and be continuing.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 11.2 Opinion of Counsel.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Either the Company or the successor Person shall deliver to the Trustee prior to the proposed transaction(s) covered by Section 11.1 an Officer's Certificate and an Opinion of Counsel stating that the transaction(s) and such supplemental indenture are authorized and permitted by this Indenture and that all conditions precedent to the consummation of the transaction(s) under this Indenture have been met.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 11.3 Successor Person Substituted.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon any consolidation or amalgamation by the Company with or merger of the Company into any other Person or any lease, sale, assignment, or transfer of all or substantially all of the property and assets of the Company in accordance with Section 11.1, the successor Person formed by such consolidation or amalgamation or into which the Company is merged or the successor Person or affiliated group of Persons to which such lease, sale, assignment, or transfer is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor Person or Persons had been named as the Company herein, and thereafter, except in the case of a lease, the predecessor Person or Persons shall be relieved of all obligations and covenants under this Indenture and the Securities and in the event of such conveyance or transfer, except in the case of a lease, any such predecessor Person may be dissolved and liquidated.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 12</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SATISFACTION AND DISCHARGE OF INDENTURE,</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNCLAIMED MONEYS</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 12.1 Satisfaction and Discharge of Securities of Any Series.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall be deemed to have satisfied and discharged this Indenture with respect to the entire indebtedness on all the Outstanding Securities of any particular series, and the Trustee, at the expense of the Company and upon Company Request, shall execute proper instruments acknowledging such satisfaction and discharge, when</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) either&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) all Outstanding Securities of such series theretofore authenticated and delivered (other than (i) any Securities of such series which have been destroyed, lost or stolen and which have been replaced or paid as provided in Section 3.8 and (ii) Outstanding Securities of such series for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company or discharged from such trust, as provided in Section 12.3) have been delivered to the Trustee for cancellation&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) all Outstanding Securities of such series described in sub-clause (i) above (other than the Securities referred to in the parenthetical phrase thereof) not theretofore delivered to the Trustee for cancellation&#58;</font></div><div style="margin-bottom:10pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;have become due and payable&#59;</font></div><div style="margin-bottom:10pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y)&#160;&#160;&#160;&#160;will become due and payable at their Stated Maturity within one year&#59; or</font></div><div style="margin-bottom:10pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(z)&#160;&#160;&#160;&#160;if redeemable at the option of the Company or pursuant to the operation of a sinking fund, are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A) the Company has irrevocably deposited or caused to be irrevocably deposited with the Trustee as trust funds in trust an amount (except as otherwise specified pursuant to Section 3.1 for the Securities of such series) sufficient to pay and discharge the entire indebtedness on all such Outstanding Securities of such series, not therefore delivered to the Trustee for cancellation, including the principal of, any premium and interest on, and any Additional Amounts with respect to such Securities (based upon applicable law as in effect on the date of such deposit), to the date of such deposit (in the case of Securities which have become due and payable) or to the Maturity thereof, as the case may be&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B) the Company has irrevocably deposited or caused to be irrevocably deposited with the Trustee as obligations in trust such amount of Government Obligations as will, in a written opinion of independent public accountants delivered to the Trustee, together with the predetermined and certain income to accrue thereon (without consideration of any reinvestment thereof), be sufficient to pay and discharge when due the entire indebtedness on all such Outstanding Securities of such series for unpaid principal (and premium, if any), interest on, and any Additional Amounts to the date of such deposit (in the case of Securities which have become due and payable) or Maturity thereof, as the case may be&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) the Company has paid or caused to be paid all other sums payable with respect to the Outstanding Securities of such series including all fees due to the Trustee under Section 7.6&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the Company has delivered to the Trustee an Officer's Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to the due satisfaction and discharge of this Indenture with respect to the entire indebtedness on all Outstanding Securities of any such series have been complied with&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) if the Securities of such series are not to become due and payable at their Stated Maturity within one year of the date of such deposit or are not to be called for redemption within one year of the date of such deposit under arrangements satisfactory to the Trustee as of the date of such deposit, then the Company shall have given, not later than the date of such deposit, notice of such deposit to the Holders of the Securities of such series.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the satisfaction of the conditions set forth in this Section 12.1 with respect to all the Outstanding Securities of any series, the terms and conditions with respect thereto set forth in this Indenture shall no longer be binding upon, or applicable to, the Company&#59; provided, however, that the Company shall not be discharged from (a) any obligations under Section 7.6 and Section 7.10 and (b) any obligations under Section 3.6, Section 3.9, Section 5.1 and Section 12.3 and (c) any obligations under Section 4.4, with respect to the payment of any Additional Amounts, if any, (but only to the extent that the Additional Amounts payable with respect to any Outstanding Securities of such series exceed the amount deposited in respect of such Additional Amounts pursuant to Section 12.1(a)(ii))&#59; and provided, further, that in the event a petition for relief under the Federal Bankruptcy Code or a successor statute is filed with respect to the Company within 91 days after the deposit, this Indenture with respect to the entire indebtedness on all Securities of such series shall not be discharged, and in such event the Trustee shall return such deposited funds or obligations as it is then holding to the Company upon Company Request.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 12.2 Defeasance and Covenant Defeasance.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Unless pursuant to Section 3.1, either or both of (i) defeasance of the Securities of or within a series under clause (b) of this Section 12.2 shall not be applicable with respect to the Securities of such series or (ii) covenant defeasance of the Securities of or within a series under clause (c) of this Section 12.2 shall not be applicable with respect to the Securities of such series, then such provisions, together with the other provisions of this Section 12.2 (with such modifications thereto as may be specified pursuant to Section 3.1 with respect to any Securities), shall be applicable to such Securities and the Company may at its option by Board Resolution, at any time, with respect to such Securities, elect to have Section 12.2(b) or Section 12.2(c) be applied to such Outstanding Securities upon compliance with the conditions set forth below in this Section 12.2.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Upon the Company's exercise of the above option applicable to this Section 12.2(b) with respect to any Securities of or within a series, the Company shall be deemed to have been discharged from its obligations with respect to such Outstanding Securities on the date the conditions set forth in clause (d) of this Section 12.2 are satisfied (hereinafter, &#34;defeasance&#34;). For this purpose, such defeasance means that the Company shall be deemed to have paid and discharged the entire Indebtedness represented by such Outstanding Securities which shall thereafter be deemed to be &#34;Outstanding&#34; only for the purposes of clause (c) of this Section 12.2 and the other Sections of this Indenture referred to in clauses (i) and (ii) below, and to have satisfied all of its other obligations under such Securities and this Indenture insofar as such Securities are concerned (and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging the same), except for the following which shall survive until otherwise terminated or discharged hereunder&#58; (i) the rights of Holders of such Outstanding Securities, solely from the trust fund described in clause (d) of this Section 12.2 and as more fully set forth in such clause, payments in respect of the principal of (and premium, if any) and interest, if any, on, and Additional Amounts, if any, with respect to, such Securities when such payments are due, and any rights of such Holder to convert such Securities into Common Shares of the Company or exchange such Securities for other securities&#59; (ii) the obligations of the Company and the Trustee with respect to such Securities under Sections 3.6, 3.9, 4.2, 4.3 and 12.3 and with respect to the payment of Additional Amounts, if any, on such Securities as contemplated by Section 4.4 (but only to the extent that the Additional Amounts payable with respect to such Securities exceed the amount deposited in respect of such Additional Amounts pursuant to Section 12.2(d)(i) below), and with respect to any rights to convert such Securities into Common Shares of the Company or exchange such Securities for other securities&#59; (iii) the rights, powers, trusts, duties and immunities of the Trustee hereunder including, without limitation, the compensation, reimbursement and indemnities provided in Section 7.6 herein&#59; and (iv) this Section 12.2. The Company may exercise its option under this Section 12.2(b) notwithstanding the prior exercise of its option under clause (c) of this Section 12.2 with respect to such Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Upon the Company's exercise of the option to have this Section 12.2(c) apply with respect to any Securities of or within a series, the Company shall be released from its obligations in respect of any other covenant applicable to such Securities, with respect to such Outstanding Securities on and after the date the conditions set </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forth in clause (d) of this Section 12.2 are satisfied (hereinafter, &#34;covenant defeasance&#34;), and such Securities shall thereafter be deemed to be not &#34;Outstanding&#34; for the purposes of any direction, waiver, consent or declaration or Act of Holders (and the consequences of any thereof) in connection with any such covenant or obligation, but shall continue to be deemed &#34;Outstanding&#34; for all other purposes hereunder. For this purpose, such covenant defeasance means that, with respect to such Outstanding Securities, the Company may omit to comply with, and shall have no liability in respect of, any term, condition or limitation set forth in any such Section or such other covenant or obligation, whether directly or indirectly, by reason of any reference elsewhere herein to any such Section or such other covenant or obligation or by reason of reference in any such Section or such other covenant to any other provision herein or in any other document and such omission to comply shall not constitute a default or an Event of Default under Section 6.1 but, except as specified above, the remainder of this Indenture and such Securities shall be unaffected thereby.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) The following shall be the conditions to application of clause (b) or (c) of this Section 12.2 to any Outstanding Securities of or within a series&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) The Company shall irrevocably have deposited or caused to be deposited with the Trustee (or another trustee satisfying the requirements of Section 7.8 who shall agree to comply with the provisions of this Section 12.2 applicable to it) as trust funds in trust for the purpose of making the following payments, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of such Securities, (1) an amount in Dollars or in such Foreign Currency in which such Securities are then specified as payable at Stated Maturity, or (2) Government Obligations applicable to such Securities (determined on the basis of the Currency in which such Securities are then specified as payable at Stated Maturity) which through the scheduled payment of principal and interest in respect thereof in accordance with their terms will provide, not later than one day before the due date of any payment with respect to such Securities, money in an amount, or (3) a combination thereof, in any case, in an amount, sufficient, without consideration of any reinvestment of such principal and interest, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge, and which shall be applied by the Trustee (or other qualifying trustee) to pay and discharge, (y) the principal of (and premium, if any) and interest, if any, on, and any Additional Amounts with respect to such Securities (based upon applicable law as in effect on the date of such deposit), such Outstanding Securities at the Stated Maturity or Redemption Date of such principal or installment of principal or premium or interest and (z) any mandatory sinking fund payments or analogous payments applicable to such Outstanding Securities on the days on which such payments are due and payable in accordance with the terms of this Indenture and of such Securities and, if applicable, shall have made irrevocable arrangements satisfactory to the Trustee for the redemption of any Securities to be redeemed at the option of the Company in connection with such deposit.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) No Event of Default or event which with notice or lapse of time or both would become an Event of Default with respect to such Securities shall have occurred and be continuing on the date of such deposit (after giving effect thereto) and, with respect to defeasance only, no event described in Section 6.1(f) or (g) at any time during the period ending on the 91st day after the date of such deposit (it being understood that this condition shall not be deemed satisfied until the expiration of such period).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) Such defeasance or covenant defeasance shall not result in a breach or violation of, or constitute a default under, any material agreement or instrument (other than this Indenture) to which the Company is a party or by which it is bound.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) In the case of an election under clause (b) of this Section 12.2 for which the Place of Payment is within the United States, the Company shall have delivered to the Trustee an Opinion of Counsel stating that (i) the Company has received from the Internal Revenue Service a letter ruling, or there has been published by the Internal Revenue Service a Revenue Ruling, or (ii) since the date of execution of this Indenture, there has been a change in the applicable Federal income tax law, in either case to the effect that, and based thereon such opinion shall confirm that, the Holders of such Outstanding Securities will not recognize income, gain or loss for Federal income tax purposes as a result of such defeasance and will be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to Federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such defeasance had not occurred.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) In the case of an election under clause (c) of this Section 12.2 with respect to Requested Securities and for which the Place of Payment is within the United States, the Company shall have delivered to the Trustee an Opinion of Counsel to the effect that the Holders of such Outstanding Securities will not recognize income, gain or loss for Federal income tax purposes as a result of such covenant defeasance and will be subject to Federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such covenant defeasance had not occurred.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) With respect to defeasance only, the Company shall have delivered to the Trustee an Opinion of Counsel to the effect that, after the 91st day after the date of deposit, all money and Government Obligations (or other property as may be provided pursuant to Section 3.1) (including the proceeds thereof) deposited or caused to be deposited with the Trustee (or other qualifying trustee) pursuant to this clause (d) to be held in trust will not be subject to recapture or avoidance as a preference in any case or proceeding (whether voluntary or involuntary) in respect of the Company under any Federal or State bankruptcy, insolvency, reorganization or other similar law, or any decree or order for relief in respect of the Company issued in connection therewith (for which purpose such Opinion of Counsel may assume that no Holder is an &#34;insider&#34;).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii) With respect to defeasance only, the Company shall have delivered to the Trustee an Officer's Certificate as to solvency and the absence of any intent of preferring the Holders over any other creditors of the Company.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii) The Company shall have delivered to the Trustee an Officer's Certificate and an Opinion of Counsel, each stating that all conditions precedent to the defeasance or covenant defeasance under  clause (b) or (c) of this Section 12.2 (as the case may be) have been complied with.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix) Notwithstanding any other provisions of this Section 12.2(d), such defeasance or covenant defeasance shall be effected in compliance with any additional or substitute terms, conditions or limitations which may be imposed on the Company in connection therewith pursuant to Section 3.1.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Unless otherwise specified in or pursuant to this Indenture, if, after a deposit referred to in Section 12.2(d)(i) has been made, (i) the Holder of a Security in respect of which such deposit was made is entitled to, and does, elect pursuant to Section 3.1 or the terms of such Security to receive payment in a Currency other than that in which the deposit pursuant to Section 12.2(d)(i) has been made in respect of such Security, or (ii) a Conversion Event occurs in respect of the Foreign Currency in which the deposit pursuant to Section 12.2(d)(i) has been made, the indebtedness represented by such Security shall be deemed to have been, and will be, fully discharged and satisfied through the payment of the principal of (and premium, if any), and interest, if any, on, and Additional Amounts, if any, with respect to, such Security as the same becomes due out of the proceeds yielded by converting (from time to time as specified below in the case of any such election) the amount or other property deposited in respect of such Security into the Currency in which such Security becomes payable as a result of such election or Conversion Event based on (x) in the case of payments made pursuant to clause (i) above, the applicable market exchange rate for such Currency in effect on the second Business Day prior to each payment date, or (y) with respect to a Conversion Event, the applicable market exchange rate for such Foreign Currency in effect (as nearly as feasible) at the time of the Conversion Event.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall pay and indemnify the Trustee (or other qualifying trustee, collectively for purposes of this Section 12.2(d) and Section 12.3, the &#34;Trustee&#34;) against any tax, fee or other charge, imposed on or assessed against the Government Obligations deposited pursuant to this Section 12.2 or the principal or interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of such Outstanding Securities.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anything in this Section 12.2 to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from time to time upon Company Request any money or Government Obligations (or other property </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and any proceeds therefrom) held by it as provided in clause (d) of this Section 12.2 which, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, are in excess of the amount thereof which would then be required to be deposited to effect a defeasance or covenant defeasance, as applicable, in accordance with this Section 12.2.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 12.3 Application of Trust Money.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All money and obligations deposited with the Trustee pursuant to Section 12.1 or 12.2 shall be held irrevocably in trust and shall be made under the terms of an escrow trust agreement in form and substance satisfactory to the Company and the Trustee. Such money and obligations shall be applied by the Trustee, in accordance with the provisions of the Securities, this Indenture and such escrow trust agreement, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the Persons entitled thereto, of the principal of (and premium, if any) and interest, if any, on the Securities for the payment of which such money and obligations have been deposited with the Trustee. If Securities of any series are to be redeemed prior to their Stated Maturity, whether pursuant to any optional redemption provisions or in accordance with any mandatory or optional sinking fund requirement, the Company shall give the required notice of redemption or shall make such arrangements as are satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 12.4 Repayment of Moneys Held by Paying Agent.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the satisfaction and discharge of this Indenture with respect to Securities of any series, all moneys with respect to such series then held by any Paying Agent (and not required for such satisfaction and discharge) shall, upon demand of the Company, be repaid to it or paid to the Trustee and thereupon such Paying Agent shall be released from all further liability with respect to such moneys.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 12.5 Return of Unclaimed Moneys Held by Trustee and Paying Agent. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any moneys deposited with or paid to the Trustee or any Paying Agent for the payment of the principal of, or premium, if any, or interest, if any, on, Securities of any series and which shall not be applied but shall remain unclaimed by the Holders of Securities of such series for two years after the date upon which such payment shall have become due and payable, shall be repaid to the Company by the Trustee on demand&#59; and the Holder of any of such Securities entitled to receive such payment shall thereafter look only to the Company for the payment thereof&#59; provided, however, that the Company or the Trustee, before making any such repayment, shall at the expense of the Company cause to be published once a week for two successive weeks (in each case on any day of the week) in an Authorized Newspaper, or mail to each Holder, or both, a notice that said moneys have not been so applied and that after a date named therein any unclaimed balance of said moneys then remaining will be returned to the Company.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Trustee or Paying Agent is unable to apply any money in accordance with Section 12.3 by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company's obligations under this Indenture and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to Section 12.1 or Section 12.2 until such time as the Trustee or Paying Agent is permitted to apply all such money in accordance with Section 12.3&#59; provided, however, that if the Company makes any payment of interest on or principal of, or any Additional Amounts, with respect to any Security following the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money held by the Trustee or Paying Agent.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 13</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MISCELLANEOUS PROVISIONS</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.1 Incorporators, Stockholders, Officers and Directors of Company Exempt from Individual Liability.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No recourse under or upon any obligation, covenant or agreement contained in this Indenture, or in any Security, or for any claim based thereon or otherwise in respect thereof, or because of any indebtedness evidenced </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">thereby, shall be had against any incorporator, as such, or against any past, present or future stockholder, officer or director, as such, of the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise it being expressly understood that this Indenture and the obligations issued hereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, shareholders, officers or directors, as such, of the Company, or any of them, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any Security or implied therefrom&#59; and that any and all such personal liability of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, shareholder, officer or director, as such, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any Security or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issuance of such Security.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.2 Provisions of Indenture for the Sole Benefit of Parties and Securityholders.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nothing in this Indenture or in the Securities, expressed or implied, shall give or be construed to give to any Person, other than the parties hereto and their successors and the Holders of the Securities, any legal or equitable right, remedy or claim under this Indenture or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the parties hereto and their successors and the Holders of the Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.3 Successors and Assigns of Company Bound by Indenture.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All the covenants, stipulations, promises and agreements in this Indenture contained by or on behalf of the Company shall bind its successors and assigns, whether so expressed or not.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.4 Notices to Holders&#59; Waiver.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where this Indenture provides for notice to Holders of any event, such notice shall be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed by first-class mail, postage prepaid, to such Holders as their names and addresses appear on the Securities Register within the time prescribed.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where this Indenture provides for notice in any manner, such notice may be waived in writing by the Person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the validity of any action taken in reliance on such waiver. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed to any particular Holder, shall affect the sufficiency of such notice with respect to other Holders, and any notice which is mailed in the manner herein provided shall be conclusively presumed to have been duly given. In the case by reason of the suspension of regular mail service or by reason of any other cause it shall be impracticable to give such notice by mail, then such notification as shall be made with the approval of the Trustee shall constitute a sufficient notification for every purpose hereunder. In case by reason of the suspension of publication of any Authorized Newspapers or by reason of any other cause it shall be impracticable to publish any notice to Holders otherwise required or permitted under this Indenture, then such notification as shall be given with the approval of the Trustee shall constitute sufficient notice to such Holders for every purpose hereunder.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.5 Addresses for Notices.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any notice or demand which by any provision of this Indenture is required or permitted to be given or served by the Trustee or by the Holders of Securities of any series on the Company may be given or served by registered mail addressed (until another address is filed by the Company with the Trustee) as follows&#58; Aspen Insurance Holdings Limited, Victoria Hall, 11 Victoria Street, Hamilton HM 11, Bermuda, Attention&#58; Chief Financial Officer. Any notice, direction, request or demand by the Company or any Holders of Securities of any series to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if received at the Corporate Trust Office of such Trustee.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.6 Officer's Certificates and Opinions of Counsel&#59; Statements to Be Contained Therein.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall furnish to the Trustee an Officer's Certificate stating that all conditions precedent (including any covenants compliance with which constitutes a condition precedent), if any, provided for in this Indenture relating to the proposed action have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent (including any covenants compliance with which constitutes a condition precedent) have been complied with, except that in the case of any such application or demand as to which the furnishing of such documents is specifically required by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each certificate or opinion provided for in this Indenture (other than annual certificates provided pursuant to Section 4.10) and delivered to the Trustee with respect to compliance with a condition or covenant provided for in this Indenture shall include (a) a statement that the Person making such certificate or opinion has read such covenant or condition, (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based, (c) a statement that, in the opinion of such Person, he has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with and (d) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been complied with.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any certificate, statement or opinion of an officer of the Company may be based, insofar as it relates to legal matters, upon a certificate or opinion of or representations by counsel, unless such officer knows that the certificate or opinion or representations with respect to the matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are erroneous. Any certificate, statement or opinion of counsel may be based, insofar as it relates to factual matters, information with respect to which is in the possession of the Company, upon the certificate, statement or opinion of or representations by an officer or officers of the Company, unless such counsel knows that the certificate, statement or opinion or representations with respect to the matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are erroneous.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any certificate, statement or opinion of an officer of the Company or of counsel may be based, insofar as it relates to accounting matters, upon a certificate or opinion of or representations by an accountant or firm of accountants in the employ of the Company, unless such officer or counsel, as the case may be, knows that the certificate or opinion or representations with respect to the accounting matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are erroneous.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any certificate or opinion of any independent firm of public accountants filed with the Trustee shall contain a statement that such firm is independent.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.7 Separability Clause.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case any provision of this Indenture or of the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.8 Legal Holidays.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any case where any Interest Payment Date, Redemption Date or Stated Maturity of any Security shall not be a Business Day in any Place of Payment, then (notwithstanding any other provision of this Indenture or of the Securities, other than a provision in Securities of any series, or any Tranche thereof, or in the indenture supplemental hereto, Board Resolution or Officer's Certificate that establishes the terms of the Securities of such series or Tranche, which specifically states that such provision shall apply in lieu of this Section) payment of interest or principal and premium, if any, need not be made at such Place of Payment on such date, but may be made on the next succeeding Business Day at such Place of Payment with the same force and effect as if made on the Interest Payment Date or Redemption Date, or at the Stated Maturity, and, if such payment is made or duly provided for on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such Business Day, no interest shall accrue on the amount so payable for the period from and after such Interest Payment Date, Redemption Date or Stated Maturity, as the case may be, to such Business Day.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.9 Conflict of Any Provision of Indenture with Trust Indenture Act.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If and to the extent that any provision of this Indenture limits, qualifies or conflicts with a provision of the Trust Indenture Act that is required under such Act to be a part of and govern this Indenture, the latter provision shall control. If any provision of this Indenture modifies or excludes any provision of the Trust Indenture Act that may be so modified or excluded, the former provision shall control.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.10 Governing Law.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Indenture and each Security shall be deemed to be a contract governed by and construed in accordance with the laws of the State of New York applicable to agreements made or instruments entered into and, in each case, performed in said state.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.11 Judgment Currency.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company agrees, to the fullest extent that it may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court it is necessary to convert the sum due in respect of the principal of, or premium or interest, if any, or Additional Amounts on the Securities of any series (the &#34;Required Currency&#34;) into a currency in which a judgment will be rendered (the &#34;Judgment Currency&#34;), the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in the City of New York the requisite amount of the Required Currency with the Judgment Currency on the New York Banking Day preceding the day on which a final unappealable judgment is given and (b) its obligations under this Indenture to make payments in the Required Currency (i) shall not be discharged or satisfied by any tender, or any recovery pursuant to any judgment (whether or not entered in accordance with clause (a)), in any currency other than the Required Currency, except to the extent that such tender or recovery shall result in the actual receipt, by the payee, of the full amount of the Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as an alternative or additional cause of action for the purpose of recovering in the Required Currency the amount, if any, by which such actual receipt shall fall short of the full amount of the Required Currency so expressed to be payable and (iii) shall not be affected by judgment being obtained for any other sum due under this Indenture. For purposes of the foregoing, &#34;New York Banking Day&#34; means any day except a Saturday, Sunday or a legal holiday in The City of New York or a day on which banking institutions in The City of New York are authorized or obligated by law, regulation or executive order to be closed.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.12 No Security Interest Created.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions of Section 4.6, nothing in this Indenture or in any Securities, express or implied, shall be construed to constitute a security interest under the Uniform Commercial Code or similar legislation, as now or hereafter enacted and in effect in any jurisdiction where property of the Company or its Subsidiaries is or may be located.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.13 Submission to Jurisdiction.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company agrees that any legal suit, action or proceeding instituted against the Company in relation to any matter arising under this Indenture or the Securities appertaining thereto may be brought in any United States Federal or New York State court sitting in the Borough of Manhattan, The City of New York, New York to the extent that such court has subject matter jurisdiction over the controversy, and, by execution and delivery of this Indenture, the Company hereby irrevocably submits to, generally and unconditionally, the personal jurisdiction of the aforesaid courts, acknowledges their competence and irrevocably agrees to be bound by any judgment rendered in such proceeding. The Company also irrevocably and unconditionally waives for the benefit of the Trustee and the Holders of the Securities any objection to the venue of a proceeding in any such court and any immunity from legal process (whether through service or notice, attachment prior to judgment, attachment in the aid of execution, execution or otherwise) in respect of this Indenture. The Company hereby irrevocably designates and appoints for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the benefit of the Trustee and the Holders of the Securities for the term of this Indenture CT Corporation System, 111 Eighth Avenue, New York, New York 10011, as its agent to receive on its behalf service of all process (with a copy of all such service of process to be delivered to Aspen Insurance UK Limited, 100 Leadenhall Street, London EC3A 3DD, Attention&#58; General Counsel) brought against it with respect to any such proceeding in any such court in The City of New York, such service being hereby acknowledged by the Company to be effective and binding service on it in every respect whether or not the Company shall then be doing or shall have at any time done business in New York. Such appointment shall be irrevocable so long as any of the Securities or the obligations of the Company hereunder remain outstanding until the appointment of a successor by the Company and such successor's acceptance of such appointment. Upon such acceptance, the Company shall notify the Trustee in writing of the name and address of such successor. The Company further agrees for the benefit of the Trustee and the Holders of the Securities to take any and all action, including the execution and filing of any and all such documents and instruments, as its agent in full force and effect so long as any of the Securities or the obligations of the Company hereunder shall be outstanding. The Trustee shall not be obligated and shall have no responsibility with respect to any failure by the Company to take any such action. Nothing herein shall affect the right to serve process in any other manner permitted by any law or limit the right of the Trustee or any Holder to institute proceedings against the Company in the courts of any other jurisdiction or jurisdictions.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.14 Counterparts.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Indenture may be executed in any number of counterparts, and on separate counterparts, each of which shall be an original&#59; but such counterparts shall together constitute but one and the same instrument.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 13.15 Effect of Headings.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Article and Section headings herein and the Table of Contents are for convenience only and shall not affect the interpretation hereof.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 14</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REDEMPTION OF SECURITIES</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 14.1 Applicability of Article.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of this Article shall be applicable to the Securities of any series which are redeemable before their Stated Maturity except as otherwise specified as contemplated by Section 3.1 for Securities of such series.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 14.2 Notice of Redemption&#59; Selection of Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case the Company shall desire to exercise the right to redeem all or, as the case may be, any part of the Securities of any series in accordance with their terms, it shall fix a Redemption Date and shall provide notice of such redemption at least 45 days prior to such Redemption Date to the Trustee and at least 30 days but no more than 60 days prior to such Redemption Date to the Holders of Securities of such series so to be redeemed as a whole or in part in the manner provided in Section 13.4, unless a different period is specified in the Securities to be redeemed. The notice provided in the manner herein specified shall be conclusively presumed to have been duly given, whether or not the Holder receives such notice. In any case, failure to give such notice or any defect in the notice to the Holder of any Security of a series designated for redemption as a whole or in part shall not affect the validity of the proceedings for the redemption of any other Security of such series.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each such notice of redemption shall specify the Redemption Date, the Redemption Price, the CUSIP or other comparable number, the Place or Places of Payment, that the Securities of such series are being redeemed at the option of the Company pursuant to provisions contained in the terms of the Securities of such series or in a supplemental indenture establishing such series, if such be the case, together with a brief statement of the facts permitting such redemption, that payment will be made upon presentation and surrender of the applicable Securities at the Place or Places of Payment, that the Redemption Price together with any interest accrued and Additional Amounts to the Redemption Date will be paid as specified in said notice, and that on and after said </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption Date any interest thereon or on the portions thereof to be redeemed will cease to accrue, and any information that is required to be included therein by the Depository.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If fewer than all the Securities of any series are to be redeemed the notice of redemption shall specify the numbers of the Securities of such series to be redeemed. In case any Security of any series is to be redeemed in part only, the notice of redemption shall state the portion of the principal amount thereof to be redeemed and shall state that on and after the Redemption Date, upon surrender of such Security, a new Security or Securities of such series in principal amount equal to the unredeemed portion thereof will be issued, or, in the case of Securities providing appropriate space for such notation, at the option of the Holders the Trustee, in lieu of delivering a new Security or Securities as aforesaid, may make a notation on such Security of the payment of the redeemed portion thereof.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or before the Redemption Date with respect to the Securities of any series stated in the notice of redemption given as provided in this Section 14.2, the Company will deposit with the Trustee or with one or more Paying Agents an amount of money (except as otherwise specified as contemplated by Section 3.1 for the Securities of such series or if the Company is acting as its own Paying Agent, segregate and hold in trust as provided in Section 4.3) sufficient to redeem on such Redemption Date all the Securities or portions thereof so called for redemption at the applicable Redemption Price, together with accrued interest on and Additional Amounts with respect thereto, to such Redemption Date.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If fewer than all the Securities of any series, or any Tranche thereof, are to be redeemed, the Company shall give notice of redemption to the Trustee not less than 60 days prior to the Redemption Date as to the aggregate principal amount of Securities to be redeemed.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a Holders' Redemption Agreement, as hereinafter defined, is not on file with the Trustee and in effect, the particular Securities to be redeemed shall be selected by the Trustee, from the Outstanding Securities of such series or Tranche not previously called for redemption, substantially pro rata, by lot or by any other method the Trustee considers fair and appropriate and that complies with the requirements of the principal national securities exchange, if any, on which such Securities are listed, and which may provide for the selection for redemption of portions (equal to the minimum authorized denomination for Securities of that series or Tranche or any integral multiple thereof) of the principal amount of Securities of such series or Tranche of a denomination larger than the minimum authorized denomination for Securities of that series or Tranche&#59; provided that in case the Securities of such series or Tranche have different terms and maturities, the Securities to be redeemed shall be selected by the Company and the Company shall give notice thereof to the Trustee&#59; provided, however, that if, as indicated in an Officer's Certificate, the Company shall have offered to purchase all or any principal amount of the Securities then Outstanding of any series, or any Tranche thereof, and fewer than all of such Securities as to which such offer was made shall have been tendered to the Company for such purchase, the Trustee, if so directed by Company Order, shall select for redemption all or any principal amount of such Securities which have not been so tendered.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Trustee shall use &#34;CUSIP&#34; numbers in notices as a convenience to Holders, then any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee in writing of any change in the &#34;CUSIP&#34; numbers.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If at the time the Company shall have given notice of redemption to the Trustee in accordance with Section 14.2, there shall be on file with the Trustee and in effect a Holders' Redemption Agreement, as hereinafter defined, then the Trustee shall select, in accordance with the provisions of said Holders' Redemption Agreement, the Securities or parts thereof to be redeemed.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this Indenture, the term &#34;Holders' Redemption Agreement&#34; shall mean an agreement, reasonably satisfactory to the Trustee, executed as provided in this Section, which provides for the method to be followed by the Trustee in selecting Securities or parts of Securities for redemption out of any funds held by the Trustee to be applied to such redemption. A Holders' Redemption Agreement may be made with respect </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to a single series of Securities, or Tranche thereof, in which case it shall be executed by or on behalf of the Holders of all Outstanding Securities of such series or Tranche, or it may be made with respect to all Outstanding Securities in which case it shall be executed by or on behalf of the Holders of all Securities Outstanding hereunder.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee shall promptly notify the Company in writing of the Securities selected for redemption and, in the case of any Securities selected for partial redemption, the principal amount thereof to be redeemed.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 14.3 Payment of Securities Called for Redemption.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If notice of redemption has been given as above provided and the Company has deposited, on or before the Redemption Date, with the Trustee (and&#47;or having irrevocably directed the Trustee to apply, from money held by it available to be used for the redemption of Securities) an amount in cash sufficient to redeem all of the Securities to be redeemed, the Securities or portions of Securities of the series specified in such notice shall become due and payable on the Redemption Date, and at the place or places stated in such notice at the applicable Redemption Price, together with any interest accrued to such Redemption Date, and on and after said Redemption Date any interest on the Securities or portion of Securities of any series so called for redemption shall cease to accrue. On presentation and surrender of such Securities at a Place of Payment in such notice specified, such Securities or the specified portions thereof shall be paid and redeemed by the Company at the applicable Redemption Price, together with any interest accrued and Additional Amounts to the Redemption Date, except that if such Redemption Date is an Interest Payment Date, interest shall be paid as provided in Section 3.9.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon presentation of any Security redeemed in part only, the Company shall execute and the Trustee shall authenticate and make available for delivery to or on the order of the Holder thereof, at the expense of the Company, a new Security or Securities of such series, of authorized denominations, in principal amount equal to the unredeemed portion of the Security so presented.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a Security in global form is so surrendered, the Company shall execute, and the Trustee shall authenticate and deliver to the U.S. Depository or other Depository for such Security in global form as shall be specified in the Company Order with respect thereto to the Trustee, without service charge, a new Security in global form in a denomination equal to and in exchange for the unredeemed portion of the principal of the Security in global form so surrendered.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any Security called for redemption shall not be so paid upon surrender thereof for redemption, the principal and any premium, until paid, shall bear interest from the Redemption Date at the rate prescribed therefor in the Security.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE 15</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SINKING FUNDS</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 15.1 Applicability of Article.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of this Article shall be applicable to any sinking fund for the retirement of Securities of a series except as otherwise specified as contemplated by Section 3.1 for Securities of such series.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a &#34;mandatory sinking fund payment&#34;, and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an &#34;optional sinking fund payment&#34;.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 15.2 Satisfaction of Mandatory Sinking Fund Payment with Securities.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In lieu of making all or any part of any mandatory sinking fund payment with respect to any Securities of a series in cash, the Company may at its option, at any time but not less than 45 days prior to the date on which such sinking fund payment is due, deliver to the Trustee Securities of such series theretofore purchased or otherwise acquired by the Company, except Securities of such series which have been redeemed through the application of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mandatory sinking fund payments pursuant to the terms of the Securities of such series, accompanied by a company order instructing the Trustee to credit such obligations and stating that the Securities of such series were originally issued by the Company by way of bona fide sale or other negotiation for value&#59; provided that such Securities have not been previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the Redemption Price specified in such Securities for redemption through operation of the mandatory sinking fund and the amount of such mandatory sinking fund payment shall be reduced accordingly.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 15.3 Redemption of Securities for Sinking Fund.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not less than 60 days prior to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee a certificate signed by the chief executive officer, the chief financial officer, the chief operating officer, a Vice President, the Treasurer or any Assistant Treasurer of the Company specifying the amount of the next ensuing sinking fund payment for such series pursuant to the terms of such series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting Securities of such series pursuant to Section 15.2 and whether the Company intends to exercise its rights to make a permitted optional sinking fund payment with respect to such series. Such certificate shall be irrevocable and upon its delivery the Company shall be obligated to make the cash payment or payments therein referred to, if any, on or before the next succeeding sinking fund payment date. In the case of the failure of the Company to deliver such certificate (or to deliver the Securities, if any, specified in such certificate within the time period specified in Section 15.2), unless otherwise agreed by the Trustee, the sinking fund payment due on the next succeeding sinking fund payment date for such series shall be paid entirely in cash and shall be sufficient to redeem the principal amount of the Securities of such series subject to a mandatory sinking fund payment without the right to deliver or credit Securities as provided in Section 15.2 and without the right to make any optional sinking fund payment, if any, with respect to such series.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any sinking fund payment or payments (mandatory or optional) made in cash plus any unused balance of any preceding sinking fund payments made with respect to the Securities of any particular series shall be applied by the Trustee (or by the Company if the Company is acting as its own Paying Agent) on the sinking fund payment date on which such payment is made (or, if such payment is made before a sinking fund payment date, on the sinking fund payment date following the date of such payment) to the redemption of Securities of such series at the Redemption Price specified in such Securities with respect to the sinking fund together with accrued interest, if any, to the applicable Redemption Date. Any sinking fund moneys not so applied or allocated by the Trustee (or by the Company if the Company is acting as its own Paying Agent) to the redemption of Securities shall be added to the next sinking fund payment received by the Trustee (or if the Company is acting as its own Paying Agent, segregated and held in trust as provided in Section 4.3) for such series and, together with such payment (or such amount so segregated) shall be applied in accordance with the provisions of this Section 15.3. Any and all sinking fund moneys with respect to the Securities of any particular series held by the Trustee (or if the Company is acting as its own Paying Agent, segregated and held in trust as provided in Section 4.3) on the last sinking fund payment date with respect to Securities of such series and not held for the payment or redemption of particular Securities of such series shall be applied by the Trustee (or by the Company if the Company is acting as its own Paying Agent), together with other moneys, if necessary, to be deposited (or segregated) sufficient for the purpose, to the payment of the principal of the Securities of such series at Maturity.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee shall select or cause to be selected the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 14.2 and the Company shall cause notice of the redemption thereof to be given in the manner provided in Section 14.2 except that the notice of redemption shall also state that the Securities are being redeemed by operation of the sinking fund and whether the sinking fund payment is mandatory or optional, or both, as the case may be. Such notice having been duly given, the redemption of the Securities shall be made upon the terms and in the manner stated in Section 14.3.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or before each sinking fund payment date, the Company shall pay to the Trustee (or, if the Company is acting as its own Paying Agent, will segregate and hold in trust as provided in Section 4.3) in cash a sum equal to the principal and any interest accrued to the Redemption Date for Securities or portions thereof to be redeemed on such sinking fund payment date pursuant to this Section.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither the Trustee nor the Company shall redeem any Securities of a series with sinking fund moneys or mail any notice of redemption of Securities of such series by operation of the sinking fund for such series during the continuance of a default in payment of interest, if any, on any Securities of such series or of any Event of Default (other than an Event of Default occurring as a consequence of this paragraph) with respect to the Securities of such series, except that if the notice of redemption shall have been provided in accordance with the provisions hereof, the Trustee (or the Company if the Company is acting as its own Paying Agent) shall redeem such Securities if cash sufficient for that purpose shall be deposited with the Trustee (or segregated by the Company) for that purpose in accordance with the terms of this Article. Except as aforesaid, any moneys in the sinking fund for such series at the time when any such default or Event of Default shall occur and any moneys thereafter paid into such sinking fund shall, during the continuance of such default or Event of Default, be held as security for the payment of the Securities of such series&#59; provided, however, that in case such Event of Default or default shall have been cured or waived as provided herein, such moneys shall thereafter be applied on the next sinking fund payment date for the Securities of such series on which such moneys may be applied pursuant to the provisions of this Section.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</font></div></div></div><div id="i945374149a3b4d4197343f4a046e5f5b_118"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:100pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Aspen Insurance Holdings Limited has caused this Indenture to be duly executed as a deed as of the date above written.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></div></td></tr></table></div><div style="margin-bottom:30pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned, being duly authorized, has executed this Indenture as of the date first above written.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.157%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEUTSCHE BANK TRUST COMPANY AMERICAS, AS TRUSTEE</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i945374149a3b4d4197343f4a046e5f5b_1099511628106"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CERTIFICATE FOR TRANSFER FROM</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RULE 144A GLOBAL SECURITY TO REGULATION S GLOBAL SECURITY</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(transfers pursuant to Section 3.7(a) of the Indenture)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Date&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutsche Bank Trust Company Americas</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Debt Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trust and Securities Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60 Wall Street</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, New York 10005</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Victoria Hall</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 Victoria Street</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton HM 11</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re&#58;&#160;&#160;&#160;&#160;&#91;Note&#93;&#91;Debenture&#93;&#91;Zero Coupon&#93; Due _______ (the &#34;Securities&#34;) of Aspen Insurance Holdings Limited (the &#34;Company&#34;)</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to the Indenture, dated as of &#91; &#93;, 2004 (as amended and supplemented from time to time, the &#34;Indenture&#34;), between the Company, as issuer and Deutsche Bank Trust Company Americas (the &#34;Trustee&#34;). Capitalized terms used but not defined herein shall have the meanings given them in the Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This letter relates to $_________ principal amount of Securities which are held by the undersigned (the &#34;Transferor&#34;) as a beneficial interest in the Rule 144A Global Security (CUSIP No. ______________) deposited with &#91;Name of Depository&#93; (the &#34;Depository&#34;). The Transferor has requested a transfer of such beneficial interest for an interest in the Regulation S Global Security (CUSIP No. ______________) deposited with the Depository.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with such request and in respect of such   Securities, the Transferor hereby certifies that such transfer has been   effected pursuant to and in accordance with Regulation S and accordingly further certifies that&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the offer of the Securities was not made to a person in the United States&#59;</font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;either (i) at the time the buy order was originated, the transferee was outside the United States or the Transferor and any person acting on its behalf reasonably believed that the transferee was outside the United States or (ii) the transaction was executed in, on or through the facilities of a  designated off-shore securities market and neither the Transferor nor any person acting on its behalf knows that the transaction has been pre-arranged with a buyer in the United States&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;no directed selling efforts have been made in the United States in contravention of the requirements of Rule 903(b) or Rule 904(b) of Regulation S, as applicable&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the transaction is not part of a plan or scheme to evade the registration requirements of the Securities Act&#59; and</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;the Transferor is the beneficial owner of the Securities being transferred.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if the transfer is made during the distribution compliance period specified in Rule 903 of Regulation S and the provisions of Rule 904(b)(1) or Rule 904(b)(2) of Regulation S are applicable thereto, the Transferor confirms that such transfer has been made in accordance with the applicable provisions of Rule 904(b)(1) or Rule 904(b)(2), as the case may be.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You and the Company are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Very truly yours,</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Name of Transferor&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized signature</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-2</font></div></div></div><div id="i945374149a3b4d4197343f4a046e5f5b_1099511628127"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CERTIFICATE FOR TRANSFER FROM</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGULATION S GLOBAL SECURITY TO RULE 144A GLOBAL SECURITY</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(transfers pursuant to Section 3.7(b) of the Indenture)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Date&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutsche Bank Trust Company Americas</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Debt Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trust and Securities Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60 Wall Street</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, New York 10005</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Victoria Hall</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 Victoria Street</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton HM 11</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re&#58;&#160;&#160;&#160;&#160;&#91;Note&#93;&#91;Debenture&#93;&#91;Zero Coupon&#93; Due _______ (the &#34;Securities&#34;) of Aspen Insurance Holdings Limited (the &#34;Company&#34;)</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to the Indenture, dated as of &#91; &#93;, 2004 (as amended and supplemented from time to time, the &#34;Indenture&#34;), between the Company, as issuer, and Deutsche Bank Trust Company Americas, as trustee (the &#34;Trustee&#34;). Capitalized terms used but not defined herein shall have the meanings given them in the Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This letter relates to $_________ principal amount of Securities which are held by the undersigned (the &#34;Transferor&#34;) as a beneficial interest in the Regulation S Global Security (CUSIP No. ______________) deposited with &#91;Name of Depository&#93; (the &#34;Depository&#34;). The Transferor has requested a transfer of such beneficial interest for an interest in the Rule 144A Global Security (CUSIP No. ______________) deposited with the Depository.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with such request and in respect of such Securities, the Transferor hereby certifies that such Securities are being transferred to a transferee that the Transferor reasonably believes is purchasing the Securities for its own account or an account with respect to which the transferee exercises sole investment discretion, and the transferee, as well as any such account, is a &#34;qualified institutional buyer&#34; within the meaning of Rule 144A, in a transaction meeting the requirements of Rule 144A and in accordance with applicable securities laws of any state of the United States or any other jurisdiction.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You and the Company are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Very truly yours,</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Name of Transferor&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized signature</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B-1</font></div></div></div><div id="i945374149a3b4d4197343f4a046e5f5b_166"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT C</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CERTIFICATE FOR TRANSFERS FROM RESTRICTED GLOBAL SECURITY TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNRESTRICTED GLOBAL SECURITY</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Transfers pursuant to section 3.7(c) of the Indenture)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Date&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutsche Bank Trust Company Americas</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Debt Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trust and Securities Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60 Wall Street</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, New York 10005</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Victoria Hall</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 Victoria Street</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton HM 11</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda</font></div><div style="margin-bottom:10pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re&#58;&#160;&#160;&#160;&#160;&#91;Note&#93;&#91;Debenture&#93;&#91;Zero Coupon&#93; Due _______ (the &#34;Securities&#34;) of Aspen Insurance Holdings Limited (the &#34;Company&#34;)</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to the Indenture, dated as of &#91;&#160;&#160;&#93;, 2004 (as amended and supplemented from time to time, the &#34;Indenture&#34;), between the Company, as issuer, and Deutsche Bank Trust Company Americas, as Trustee. Capitalized terms used but not defined herein shall have the meanings given them in the Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This letter relates to $_________ principal amount of Securities which are held by the undersigned (the &#34;Owner&#34;) as a beneficial interest in the Regulation S Global Security (CUSIP No. ______________)&#47;Rule 144A Global Security (CUSIP No. ______________) deposited with &#91;Name of Depository&#93; (the &#34;Depository&#34;). The Owner owns and proposes to exchange the interest in the Regulation S Global Security (CUSIP No. ______________)&#47;Rule 144A Global Security (CUSIP No. ______________) for an interest in the unrestricted Global Security (CUSIP No. ______________) deposited with the Depository (the &#34;Exchange&#34;).</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with such request and in respect of such Securities, the Owner hereby certifies that (i) the beneficial interest is being acquired for the Owner's own account without transfer, (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Global Securities and pursuant to and in accordance with the United States Securities Act of 1933, as amended (the &#34;SECURITIES ACT&#34;), (iii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act and (iv) the beneficial interest in an unrestricted Security is being acquired in compliance with any applicable blue sky securities laws of any state of the United States.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You and the Company are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Very truly yours,</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Name of Transferor&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized signature</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-1</font></div></div></div><div id="i945374149a3b4d4197343f4a046e5f5b_182"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT D</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CERTIFICATE FOR TRANSFERS PURSUANT TO RULE 144</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(transfers pursuant to section 3.7(e) of the Indenture)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Date&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutsche Bank Trust Company Americas</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Debt Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trust and Securities Services</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60 Wall Street</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, New York 10005</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Victoria Hall</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 Victoria Street</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton HM 11</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda</font></div><div style="margin-bottom:10pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re&#58;&#160;&#160;&#160;&#160;&#91;Note&#93;&#91;Debenture&#93;&#91;Zero Coupon&#93; Due _______ (the &#34;Securities&#34;) of Aspen Insurance Holdings Limited (the &#34;Company&#34;)</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is hereby made to the Indenture, dated as of &#91; &#93;, 2004 (as amended and supplemented from time to time, the &#34;Indenture&#34;), between the Company, as issuer, and Deutsche Bank Trust Company Americas, as Trustee. Capitalized terms used but not defined herein shall have the meanings given them in the Indenture.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our proposed sale of $___________ principal amount of the Securities, which represent an interest in a Rule 144A Global Note beneficially owned by the undersigned (the &#34;Transferor&#34;), we confirm that such sale has been effected pursuant to and in accordance with Rule 144.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You and the Company are entitled to rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; Very truly yours,</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Name of Transferor&#93;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized signature</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>15
<FILENAME>exhibit104-fx1.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if7428ff6868a4dd48513253d52f0706f_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="margin-bottom:126pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THIRD SUPPLEMENTAL INDENTURE BY AND BETWEEN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, AS ISSUER</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEUTSCHE BANK TRUST COMPANY AMERICAS, AS TRUSTEE</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dated as of November 13, 2013</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">$300,000,000</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.650% SENIOR NOTES DUE 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THIRD SUPPLEMENTAL INDENTURE</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Third Supplemental Indenture, dated as of November 13, 2013 (the &#8220;Third Supplemental Indenture&#8221;), to the Indenture, dated as of August 16, 2004 (the &#8220;Original Indenture&#8221;) by and between Aspen Insurance Holdings Limited, a limited company duly organized and existing under the laws of Bermuda, having its principal executive office located at 141 Front Street, Hamilton HM 19, Bermuda (the &#8220;Company&#8221;), as issuer, and Deutsche Bank Trust Company Americas, a New York banking corporation duly organized and existing under the laws of the State of New York, having its corporate trust office located at 60 Wall Street, New York, NY 10005 (the &#8220;Trustee&#8221;), as trustee, is effective upon the execution hereof by the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company has heretofore executed and delivered to the Trustee the Original Indenture providing for the issuance from time to time of its notes, debentures or other evidences of its unsecured indebtedness (the &#8220;Securities&#8221;), unlimited as to principal amount&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Original Indenture is incorporated herein by reference and the Original Indenture, as supplemented by this Third Supplemental Indenture, is herein called the &#8220;Indenture&#8221;&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Section 3.1 of the Original Indenture provides that, with respect to any series of Securities to be authenticated and delivered under the Indenture, the terms of such series of Securities shall be established by (i) a resolution of the Board of Directors and set forth in an Officer&#8217;s Certificate or (ii) one or more indentures supplemental to the Original Indenture&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company desires to create, under the Indenture, a series of Securities to be known as its 4.650% Senior Notes due 2023 (the &#8220;Senior Notes&#8221;), the form and substance of such notes and the terms, provisions and conditions thereof to be set forth as provided in the Original Indenture and this Third Supplemental Indenture&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, all conditions necessary to authorize the execution and delivery of this Supplemental Indenture and to make it a valid and binding obligation of the Company have been done or performed&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company and the Trustee mutually covenant and agree as follows&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Article I</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.1.&#160;&#160; Definitions. The following defined terms used herein shall have the meanings specified below. Capitalized terms used herein without definition shall have the respective meanings assigned such terms in the Original Indenture.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Interest Payment Date&#8221; means, with respect to the Senior Notes only, May 15 and November 15 of each year.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Regular Record Date&#8221; means, with respect to the Senior Notes only, 5&#58;00 p.m., New York City time, on May 1 or November 1, as the case may be, immediately preceding each Interest Payment Date.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:-90pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GENERAL TERMS AND CONDITIONS OF THE SENIOR NOTES</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There is hereby established a new series of Securities under the Indenture with the following terms&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.1.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Title.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The title of the series is &#8220;4.650% Senior Notes due 2023&#8221;.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.2.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Principal Amount.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> There are to be issued by the Company, and authenticated and delivered by the Trustee on the date hereof, $300,000,000 principal amount of Senior Notes, and such principal amount of Senior Notes may be increased from time to time pursuant to Section 3.1 of the Original Indenture. All Senior Notes need not be issued on the same date and such series may be reopened at any time, without the consent of any Holder, for issuances of additional Senior Notes, unlimited in principal amount, upon delivery by the Company to the Trustee of either a resolution of the Board of Directors and set forth in an Officer&#8217;s Certificate or an indenture supplemental to the Original Indenture, setting forth the original issuance date of such additional Senior Notes. The terms of any such additional Senior Notes will be identical (except as to denomination, and the date from which interest shall accrue, the issue price and the first Interest Payment Date) to the terms of the Senior Notes initially issued, authenticated and delivered on the date hereof. Any such additional Senior Notes will, together with the previously issued Senior Notes, constitute a single series of Securities under the Indenture.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.3.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Principal and Interest.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The principal of the Senior Notes shall be due on November 15, 2023 which date shall be the Stated Maturity, subject to the provisions of the Indenture relating to acceleration of maturity. The Senior Notes will bear interest from November 13, 2013 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, at a rate of 4.650% per annum, payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014, and at the Stated Maturity. The Company will pay interest to the Persons in whose names the Senior Notes are registered on the Regular Record Date for such Interest Payment Date. Interest will be computed on the basis of a 360-day year of twelve 30-day months.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If any Interest Payment Date falls on a day that is not a Business Day, the interest payment will be postponed to the next day that is a Business Day, and no interest on such payment will accrue for the period from and after such Interest Payment Date. If the maturity date of the Senior Notes falls on a day that is not a Business Day, the payment of interest and principal may be made on the next succeeding Business Day, and no interest on such payment will accrue for the period from and after the maturity date. Interest payments for the Senior Notes will include accrued interest from and including the date of issue or from and including the last date in respect of which interest has been paid, as the case may be, to, but excluding, the Interest Payment Date or the date of maturity, as the case may be. Interest on the Senior Notes which have a Redemption Date after a Regular Record Date, and on or before the following Interest Payment Date, will also be payable to the Persons in whose names the Senior Notes are registered on such Regular Record Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Payment of the principal and interest due at maturity of the Senior Notes shall be made upon surrender of the Senior Notes at the Corporate Trust Office of the Trustee. The principal of and interest on the Senior Notes shall be paid in Dollars. Payments of principal of or interest on the Senior Notes will be made, subject to such surrender where applicable, at the option of the Company, (i) by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (ii) by wire transfer to an account maintained by the payee with a bank located in the United States.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.4.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Optional Redemption.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Senior Notes will be redeemable as a whole at any time or in part from time to time, at the option of the Company, at a &#8220;make-whole&#8221; redemption price equal to the greater of (i) 100% of the principal amount of the Senior Notes being redeemed or (ii) the sum of the present values of the remaining scheduled payments of principal and interest (other than accrued interest) on the Senior Notes being redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 30 basis points, plus, in either case, any accrued and unpaid interest to, but excluding, the date of redemption. Notice of any redemption will be mailed at least 30 days but no more than 60 days before the redemption date to each Holder of the Senior Notes to be redeemed. Unless the Company defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Senior Notes or portions thereof called for redemption.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For the purposes of this Section 2.4,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Treasury Issue&#8221; means the United States Treasury security selected by a Quotation Agent (as defined below) as having a maturity comparable to the remaining term of the Senior Notes being redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Senior Notes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Treasury Price&#8221; means, with respect to any redemption date for the Senior Notes, (1) the average of the Reference Treasury Dealer Quotations (as defined below) for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (2) if the Company obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (3) if only one Reference Treasury Dealer Quotation is received, such Reference Treasury Dealer Quotation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Quotation Agent&#8221; means one of the Reference Treasury Dealers appointed by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Reference Treasury Dealer&#8221; means (1) each of Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and HSBC Securities (USA) Inc. (or their respective affiliates that are Primary Treasury Dealers) and their respective successors&#59; provided, however, that if any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a &#8220;Primary Treasury Dealer&#8221;), the Company shall appoint therefor another Primary Treasury Dealer as a substitute and (2) any other Primary Treasury Dealer selected by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Reference Treasury Dealer Quotations&#8221; means, for each Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Quotation Agent by such Reference Treasury Dealer at 5&#58;00 p.m., New York City time, on the third business day preceding the redemption date for the Senior Notes being redeemed.&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Treasury Rate&#8221; means, with respect to any redemption date for the Senior Notes, the rate per year equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for the redemption date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.5.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The provisos in Section 6.1(a) and Section 6.l(b) of the Original Indenture shall not be applicable with respect to the Senior Notes.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.6.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Form, Currency and Denominations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Senior Notes shall be issued in fully registered form, without coupons, in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. The Senior Notes will be issued in substantially the form set forth in Exhibit A hereto. The Depository with respect to the Senior Notes shall be The Depository Trust Company, New York, New York.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ection 2.7.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Global Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Senior Notes will be issued in the form of one or more Global Securities registered in the name of the Depository or its nominee. Except under the circumstances set forth in Section 3.6 of the Original Indenture, the Global Securities will not be exchangeable for, and will not otherwise be issuable as, Senior Notes in definitive form. Owners of beneficial interests in such a Global Security will not be considered the registered owners or Holders of Senior Notes for any purpose.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;No Security representing a Senior Note shall be exchangeable, except for another Global Security of like denomination and tenor to be registered in the name of the Depository or its nominee or to a successor Depository or its nominee. Payment of principal of, any premium or interest on, and any Additional Amounts, if applicable, in respect of, any Senior Note in global form shall be made to the registered Holder thereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.8.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ranking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Senior Notes will represent the Company&#8217;s direct, unsecured obligations and will rank equally in right of payment with all the Company&#8217;s current and future unsecured and unsubordinated indebtedness.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.9.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company is not obligated to redeem or purchase any Senior Notes pursuant to any sinking fund or analogous provision. The Senior Notes will not be convertible into shares of Common Stock of the Company and&#47;or exchangeable for other securities. The amount of payments of principal with respect to the Senior Notes shall not be determined with reference to an index, formula or other method or methods. No Senior Notes are issuable upon the exercise of warrants. Each of Section 12.2(b) of the Original Indenture relating to defeasance and Section 12.2(c) of the Original Indenture relating to covenant defeasance shall be applicable to the Senior Notes. Except as set forth in Section 4.4 of the Original Indenture, there will be no Additional Amounts payable on the Senior Notes. The Company may exercise its option to redeem the Senior Notes for tax purposes pursuant to Section 4.5 of the Original Indenture.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.10.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Section 10.1 of the Original Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Pursuant to Sections 3.l(y) and 10.1(o) of the Original Indenture and only with respect to the Senior Notes issued hereunder&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 10.1(j) of the Original Indenture shall be deleted in its entirety&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in place of the deleted Section 10.l(j) described in (a) above, the following clause shall be inserted as a new Section 10.1(j)&#58; &#8220;to provide collateral security for the Securities&#59;&#8221;.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MISCELLANEOUS PROVISIONS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.1.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ratification and Incorporation of the Original Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As amended and supplemented hereby, the Original Indenture is in all respects ratified and confirmed, and the Original Indenture, as amended and supplemented by this Third Supplemental Indenture, shall be read, taken and construed as one and the same instrument.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.2.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Third Supplemental Indenture may be executed in several counterparts, each of which shall be an original and all of which shall constitute but one and the same instrument.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.3.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Third Supplemental Indenture shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and performed in said state.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.4.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Article and Section headings herein are for convenience only and shall not affect the construction hereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.5.&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Trustee makes no representations as to the validity or sufficiency of this Third Supplemental Indenture. The recitals and statements herein are deemed to be those of the Company and not of the Trustee.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;The remainder of this page is intentionally left blank.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><div id="if7428ff6868a4dd48513253d52f0706f_60"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:90pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Aspen Insurance Holdings Limited has caused this Third Supplemental Indenture to be duly executed as of the date first above written.</font></div><div style="margin-bottom:24pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:8.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher O&#8217;Kane</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Christopher O&#8217;Kane</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JohnWorth</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">John Worth</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned, being duly authorized, has executed this Third Supplemental Indenture as of the date first above written.</font></div><div style="margin-bottom:24pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:8.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DEUTSCHE BANK TRUST COMPANY AMERICAS, AS TRUSTEE</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; Deutsche Bank National Trust Company</font></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Chris Niesz</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chris Niesz</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Associate</font></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kelvin Vargas</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kelvin Vargas</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Associate</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="if7428ff6868a4dd48513253d52f0706f_76"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM OF SECURITY CERTIFICATE REPRESENTING SENIOR NOTES </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.650% SENIOR NOTES DUE 2023</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), TO ASPEN INSURANCE HOLDINGS LIMITED OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND SUCH</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">PAYMENT IS MADE TO CEDE &#38; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER, CEDE &#38; CO., HAS AN INTEREST HEREIN.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">UNLESS AND UNTIL THIS CERTIFICATE IS EXCHANGED IN WHOLE OR IN PART FOR SENIOR NOTES IN CERTIFICATED FORM, THIS CERTIFICATE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE THEREOF OR BY A NOMINEE THEREOF TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR OF DTC OR A NOMINEE OF SUCH SUCCESSOR.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.650% SENIOR NOTES DUE 2023</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No. R1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CUSIP No.&#58; 04530D AD4&#59; ISIN No.&#58; US04530D AD49</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Amount&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$300,000,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regular Record Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1 or November 1, as the case may be, immediately preceding each Interest Payment Date</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original Issue Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 13, 2013</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturity Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 15, 2023</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Payment Dates&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 15 and November 15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.650% per annum</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized Denomination&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000, or any integral multiple of $1,000 in excess thereof</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited, a company duly existing and organized under the laws of Bermuda (the &#8220;Company,&#8221; which term includes any successor corporation under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay to CEDE &#38; CO., or registered assigns, the Principal Amount shown above on the Maturity Date shown above, and to pay interest thereon from the Original Issuance Date shown above, or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi annually in arrears on each Interest Payment Date as specified above (including the Maturity Date), commencing on May 15, 2014, at the rate of 4.650% per annum until the principal hereof is paid or duly provided for. Interest not timely paid or provided for shall, to the extent permitted by applicable laws, bear simple interest at the rate of 4.650% per annum. As provided in the Indenture, the Company under certain circumstances would be required to pay Additional Amounts to the Holders of the Senior Notes.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date (including the Maturity Date) will, as provided in the Indenture, be paid to the Person in whose name this Senior Note is registered at the close of business on the Regular Record Date as specified above next preceding each Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Senior Note is registered at the close of business on a Special Record Date for the payment of such defaulted interest established by notice given by or on behalf of the Company to the Holders of Senior Notes not less than 15 days prior to such Special Record Date, such Special Record Date to be not less than 10 days prior to the date for payment of such defaulted interest, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange, if any, on which the Senior Notes shall be listed, and upon such notice as may be required by any such exchange, all as more fully provided in the Indenture.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments of interest on this Senior Note will include interest accrued to but excluding the respective Interest Payment Dates. Interest payments for this Senior Note shall be computed and paid on the basis of a 360-day year of twelve 30-day months. In the event that any date on which interest is payable on this Senior Note is not a Business Day, then payment of the interest payable on such date will be made on the next succeeding day that is a Business Day, with the same force and effect as if made on the date the payment was originally payable. A &#8220;Business Day&#8221; shall mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in New York City are generally authorized or obligated, by law, regulation or executive order to close.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of the principal of and interest due on the Maturity Date of this Senior Note shall be made upon surrender of this Senior Note at the Corporate Trust Office of the Trustee. The principal of and interest on this Senior Note shall be paid in Dollars. Payments of principal of or interest will be made, subject to such surrender where applicable, at the option of the Company, (i) by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (ii) by wire transfer to an account maintained by the payee with a bank located in the United States.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REFERENCE IS HEREBY MADE TO THE FURTHER PROVISIONS OF THIS SENIOR NOTE SET FORTH ON THE REVERSE HEREOF, WHICH FURTHER PROVISIONS SHALL FOR ALL PURPOSES HAVE THE SAME EFFECT AS IF SET FORTH AT THIS PLACE.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the certificate of authentication hereon has been executed by the Trustee by manual signature, this Senior Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed.</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58;</font></div><div style="margin-bottom:36pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:8.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="margin-bottom:72pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.250%"><tr><td style="width:1.0%"></td><td style="width:7.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATE OF AUTHENTICATION</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This is one of the 4.650% Senior Notes due 2023 referred to in the withinmentioned Indenture. </font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58; </font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58; Deutsche Bank National Trust Company</font></div><div style="margin-bottom:12pt;padding-left:8.64pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.814%"><tr><td style="width:1.0%"></td><td style="width:7.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.400%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(reverse side of security)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This security is one of a duly authorized issue of debt securities of the Company (hereinafter called the &#8220;Securities&#8221;), all issued or to be issued under and pursuant to an Indenture, dated as of August 16, 2004 (the &#8220;Original Indenture&#8221;), between the Company and Deutsche Bank Trust Company Americas, as trustee (the &#8220;Trustee,&#8221; which term includes any successor trustee under the Indenture), as supplemented by the Third Supplemental Indenture dated as of November 13, 2013 (the &#8220;Third Supplemental Indenture,&#8221; and together with the Original Indenture, the &#8220;Indenture&#8217;&#8217;), to which Indenture and all indentures supplemental thereto relating to this security (including, without limitation, the Third Supplemental Indenture, dated as of November 13, 2013, between the Company and the Trustee) reference is hereby made for a statement of the respective rights, limitation of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities issued thereunder and of the terms upon which said Securities are, and are to be, authenticated and delivered. The Securities may be issued in one or more series, which different series may be issued in various aggregate principal amounts, may mature at different times, may bear interest at different rates and may otherwise vary as provided in the Indenture or any indenture supplemental thereto. This security is one of a series designated on the face as 4.650% Senior Notes due 2023 (the &#8220;Senior Notes&#8221;), initially limited in aggregate principal amount to $300,000,000, subject to increase as provided in Section 3.1 of the Indenture. Capitalized terms used herein for which no definition is provided herein shall have the meanings set forth in the Indenture.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">While this Senior Note is represented by one or more global notes registered in the name of DTC or its nominee, the Company will cause payments of principal of, premium, if any, and interest on this Senior Note to be made to DTC or its nominee, as the case may be, by wire transfer to the extent, in the funds and in the manner required by agreements with, or regulations or procedures prescribed from time to time by, DTC or its nominee, and otherwise in accordance with such agreements, regulations and procedures.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Senior Notes will not have a sinking fund.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Senior Notes will be redeemable as a whole at any time or in part from time to time, at the option of the Company, at a &#8220;make-whole&#8221; redemption price equal to the greater of (i) 100% of the principal amount of the Senior Notes being redeemed or (ii) the sum of the present values of the remaining scheduled payments of principal and interest (other than accrued interest) on the Senior Notes being redeemed, discounted to the redemption date on a semi annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 30 basis points, plus, in either case, any interest accrued but not paid to the date of redemption. Notice of any redemption will be mailed at least 30 days but no more than 60 days before the redemption date to each Holder of the Senior Notes to be redeemed. Unless the Company defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Senior Notes or portions thereof called for redemption.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Treasury Issue&#8221; means the United States Treasury security selected by a Quotation Agent (as defined below) as having a maturity comparable to the remaining term of the Senior Notes being redeemed that would be utilized, at the time of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Senior Notes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable Treasury Price&#8221; means, with respect to any redemption date for the Senior Notes, (1) the average of the Reference Treasury Dealer Quotations (as defined below) for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (2) if the Company obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (3) if only one Reference Treasury Dealer Quotation is received, such Reference Treasury Dealer Quotation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Quotation Agent&#8221; means one of the Reference Treasury Dealers appointed by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Reference Treasury Dealer&#8221; means (1) each of Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and HSBC Securities (USA) Inc. (or their respective affiliates that are Primary Treasury Dealers) and their respective successors&#59; provided, however, that if any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a &#8220;Primary Treasury Dealer&#8221;), the Company shall appoint therefor another Primary Treasury Dealer as a substitute and (2) any other Primary Treasury Dealer selected by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Reference Treasury Dealer Quotations&#8221; means, for each Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Quotation Agent by such Reference Treasury Dealer at 5&#58;00 p.m., New York City time, on the third business day preceding the redemption date for the Senior Notes being redeemed.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Treasury Rate&#8221; means, with respect to any redemption date for the Senior Notes, the rate per year equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for the redemption date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company will mail a notice of redemption at least 30 days but no more than 60 days before the redemption date to each Holder of the Securities to be redeemed. If less than all of the Securities are to be redeemed, the Trustee will select, by such method as it will deem fair and appropriate, including pro rata or by lot, the Securities to be redeemed in whole or in part.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains provisions for redemption of the Senior Notes for tax purposes in whole but not in part at the option of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture also contains provisions for defeasance at any time of the entire indebtedness of the Senior Notes or of certain restrictive covenants with respect to the Senior Notes, in each case upon compliance with certain conditions set forth in the Indenture.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default with respect to the Senior Notes shall occur and be continuing, the principal of the Senior Notes may be declared due and payable in the manner, with the effect and subject to the conditions provided in the Indenture.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Senior Notes to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of not less than a majority in principal amount of the Senior Notes at the time Outstanding affected thereby. The Indenture also contains provisions permitting the Holders of not less than a majority in principal amount of the Senior Notes at the time Outstanding, on behalf of the Holders of all Senior Notes, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Senior Note shall be conclusive and binding upon such Holder and upon all future Holders of this Senior Note and of any Senior Note issued upon the registration of transfer hereof or in exchange hereof or in lieu hereof, whether or not notation of such consent or waiver is made upon this Senior Note.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No reference herein to the Indenture and no provision of this Senior Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest on this Senior Note at the times, place and rate, and in the coin or currency, herein prescribed.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Senior Note is registrable in the Security Register, upon surrender of this Senior Note for registration of transfer at the office or agency of the Company for such purpose, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar and duly executed by, the Holder hereof or his attorney duly </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">authorized in writing, and thereupon one or more new Senior Notes, of authorized denominations and of like tenor and for the same aggregate principal amount, will be issued to the designated transferee or transferees. No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge or certain other expenses payable in connection therewith.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to due presentment of this Senior Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Senior Note is registered as the owner hereof for all purposes, whether or not this Senior Note be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Senior Notes are issuable only in registered form without coupons in minimum denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in the Indenture and subject to certain limitations therein set forth, Senior Notes are exchangeable for a like aggregate principal amount of Senior Notes of a different authorized denomination, as requested by the Holder surrendering the same upon surrender of the Senior Note or Notes to be exchanged at the office or agency of the Company.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Senior Note shall be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements made and performed in said state.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ABBREVIATIONS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full according to applicable laws or regulations&#58;</font></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:160.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:95.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:45.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEN COM - as tenant in common</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UNIF GIFT MIN ACT - </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Custodian</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Cust) (Minor)</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEN ENT - as tenants by the entireties</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Uniform Gifts to Minors Act</font></td></tr><tr style="height:19pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JT TEN - as joint tenants with right of survivorship and not as tenants in common</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additional abbreviations may also be used though not on the above list</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned hereby sell(s) and transfer(s) unto</font></div><div style="margin-bottom:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(please insert Social Security or other identifying number of assignee)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE OF ASSIGNEE</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the within Senior Note and all rights thereunder, hereby irrevocably constituting and appointing agent to transfer said Senior Note on the books of the Company with full power of substitution in</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the premises.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOTICE&#58; The signature to the assignment must correspond with the name as written upon the face of this Receipt in every particular, without alteration or enlargement or any change whatever.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>16
<FILENAME>exhibit105-fx1.htm
<DESCRIPTION>EX-10.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib11c2c453ea447e3ab444cede4e6758b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FOURTH SUPPLEMENTAL INDENTURE, dated June 27, 2019 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fourth Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), between Aspen Insurance Holdings Limited, an exempted company formed under the laws of Bermuda, having its principal executive office located at 141 Front Street, Hamilton HM 19, Bermuda (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and Deutsche Bank Trust Company Americas, a New York banking corporation duly organized and existing under the laws of the State of New York, having its corporate trust office located at 60 Wall Street, New York, NY 10005 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RECITALS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and the Trustee entered into an Indenture, dated as of August 16, 2004 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Original Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), pursuant to which senior debt securities of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) may be issued in one or more series from time to time&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and the Trustee entered into a Third Supplemental Indenture, dated as of November 13, 2013 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), pursuant to which the Company issued its 4.650% Senior Notes due 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Senior Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Section 10.1 of the Original Indenture provides that the Company, when authorized by a resolution of its Board of Directors, and the Trustee, at any time and from time to time, may enter into an indenture or indentures supplemental to the Original Indenture without the consent of the Holders to, among other things, amend or supplement the provisions of the Indenture or in any supplemental indenture&#59; provided, that no such amendment or supplement shall materially adversely affect the interests of the Holders of any Securities then Outstanding&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company has determined that the changes to the Third Supplemental Indenture proposed to be made pursuant to this Fourth Supplemental Indenture do not materially adversely affect the interests of the Holders of the Senior Notes&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Board of Directors of the Company, pursuant to the resolutions duly adopted on June 20, 2019, has duly authorized the Company to enter into this Fourth Supplemental Indenture&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company has requested that the Trustee execute and deliver this Fourth Supplemental Indenture&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, all acts and things necessary to make this Fourth Supplemental Indenture a valid agreement according to its terms have been done and performed, and the execution of this Fourth Supplemental Indenture has been duly authorized in all respects.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, the Company and the Trustee mutually covenant and agree, for the equal and proportionate benefit of the respective Holders from time to time of the Senior Notes, as follows&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Article 1</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Original Indenture together with the Third Supplemental Indenture and this Fourth Supplemental Indenture are hereinafter sometimes collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#8221; For the avoidance of doubt, references to any &#8220;Section&#8221; of the &#8220;Indenture&#8221; refer to such Section of the Original Indenture as supplemented and amended by the Third Supplemental Indenture and as further supplemented and amended by this Fourth Supplemental Indenture. All capitalized terms which are used herein and not otherwise defined herein are defined in the Original Indenture and are used herein with the same meanings as in the Original Indenture. If a capitalized term is defined in the Original Indenture or in the Third Supplemental Indenture and in this Fourth Supplemental Indenture, the definition in this Fourth Supplemental Indenture shall apply to the Senior Notes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For all purposes of this Fourth Supplemental Indenture, except as otherwise expressly provided or unless the context otherwise requires&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;words in the singular include the plural, and in the plural include the singular&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the words &#8220;herein,&#8221; &#8220;hereof&#8221; and &#8220;hereunder&#8221; and other words of similar import refer to this Indenture as a whole and not to any particular article, section or other subdivision.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 2</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AMENDMENTS</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Optional Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Section 2.4 of the Third Supplemental Indenture is hereby amended by adding Sections 2.4(c), 2.4(d) and 2.4(e) as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in Section 2.4(a) or Section 2.4(b) hereof or Section 4.5 of the Original Indenture, the Company may only redeem the Senior Notes pursuant to this Section 2.4 or Section 4.5 of the Original Indenture if the Conditions to Redemption have been satisfied at the time of such redemption.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For purposes of this Section 2.4, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Applicable Supervisory Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means such insurance supervisory laws, rules and regulations relating to group supervision or the supervision of single insurance entities, as applicable, which are applicable to the Insurance Group, and which shall initially mean the Group Rules until such time when the BMA no longer has jurisdiction or responsibility to regulate the Company or the Insurance Group.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Bermuda Monetary Authority, or, should the Bermuda Monetary Authority no longer have jurisdiction or responsibility to regulate the Insurance Group, as the context requires, a regulator which is otherwise subject to Applicable Supervisory Regulations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conditions to Redemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; are satisfied on any day with respect to a scheduled redemption or a planned purchase by the Company of Senior Notes, if&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;such redemption or purchase of Senior Notes would not result in, or accelerate the occurrence of, an Insolvency Event&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;either (A) the Solvency Capital Requirement is complied with immediately after such redemption or purchase of Senior Notes or (B) substantially concurrently with such redemption or purchase, the Company replaces the capital represented by the Senior Notes being redeemed with capital having equal or better capital treatment as the Senior Notes under the Group Rules&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the BMA has given, and not withdrawn by such day, its prior consent to such redemption or purchase of Senior Notes&#59; provided, however, that if under the Applicable Supervisory Regulations no such consent is required on such day in order for the Senior Notes to qualify or continue to qualify, as applicable, as Tier 3 Capital of the Company or the Insurance Group, this clause (iii) shall not apply.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ECR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the enhanced capital and surplus requirement applicable to the Insurance Group and as defined in the Insurance Act or, should the Insurance Act or the Group Rules no longer apply to the Insurance Group, any and all other solvency capital requirements defined in the Applicable Supervisory Regulations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Group Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Group Solvency Standards, together with the Group Supervision Rules, as those rules and regulations may be amended or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Group Solvency Standards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Bermuda Insurance (Prudential Standards) (Insurance Group Solvency Requirement) Rules 2011, as those rules and regulations may be amended or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Group Supervision Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Bermuda Insurance (Group Supervision) Rules 2011, as those rules and regulations may be amended or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Insolvency Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of the relevant date, the Company is not, or, after making an applicable payment with respect to Senior Notes, would not be, solvent.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Insurance Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Bermuda Insurance Act 1978, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Insurance Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all subsidiaries of the Company that are regulated insurance or reinsurance companies (or part of such regulatory group) pursuant to the Applicable Supervisory Regulations.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Solvency Capital Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the ECR or any other requirement to maintain assets applicable to the Company or in respect of the Insurance Group, as applicable, pursuant to the Applicable Supervisory Regulations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Tier 3 Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means &#8220;Tier 3 Ancillary Capital&#8221; as set out in the Group Supervision Rules (or, if the Group Supervision Rules are amended so as to no longer refer to Tier 3 Ancillary Capital in this respect, the nearest corresponding concept (if any) under the Group Supervision Rules, as amended).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;An Officers&#8217; Certificate in connection with any redemption of Senior Notes contemplated by this Section 2.4 certifying that, as of the date notice of such redemption is given and assuming payment of the redemption price had been made on such date, the applicable Conditions to Redemption are satisfied shall, in the absence of manifest error, be treated and accepted by the Trustee, the Holders of Senior Notes and all other interested parties as correct and sufficient evidence thereof, shall be final and binding on such parties, and the Trustee shall be entitled to rely conclusively on such Officers&#8217; Certificate with respect to the satisfaction of the applicable Conditions to Redemption without liability to any Person.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Security</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The terms of the Senior Notes are hereby amended by adding new Section 2.11 to the Third Supplemental Indenture as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.11. No Security. Notwithstanding anything to the contrary in the Senior Notes or the Indenture (as defined in Section 1.1. of the Fourth Supplemental Indenture) (in particular Section 4.6 (Limitations on Liens on Stock of Designated Subsidiaries) and Section 10.1 (Supplemental Indentures Without Consent of Securityholders) of the Indenture), for the avoidance of doubt, no security or encumbrance of any kind is provided by the Company or any of its affiliates to secure the rights of Holders of the Senior Notes.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ARTICLE 3</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MISCELLANEOUS</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of this Fourth Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;This Fourth Supplemental Indenture is a supplemental indenture within the meaning of Article 10 of the Original Indenture, and the Original Indenture shall be read together with the Third Supplemental Indenture and this Fourth Supplemental Indenture and shall have the same effect over Senior Notes, in the same manner as if the provisions of the Original Indenture, the Third Supplemental Indenture and this Fourth Supplemental Indenture were contained in the same instrument.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In all other respects, the Original Indenture and the Third Supplemental Indenture are confirmed by the parties hereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Article and Section headings herein are for convenience only and shall not affect the construction hereof.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All covenants and agreements in this Fourth Supplemental Indenture by the Company, the Trustee and the Holders shall bind their successors and assigns, whether so expressed or not.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Separability Claus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any provision of this Fourth Supplemental Indenture or of Senior Notes, or the application of any such provision to any Person or circumstance, shall be held to be invalid, illegal or unenforceable, the remainder of this Fourth Supplemental Indenture or of Senior Notes, or the application of such provision to Persons or circumstances other than those as to whom or which it is invalid, illegal or unenforceable, shall not in any way be affected or impaired thereby.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conflict</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event that there is a conflict or inconsistency between the Original Indenture, the Third Supplemental Indenture and this Fourth Supplemental Indenture, the provisions of this Fourth Supplemental Indenture shall control&#59; provided, however, if any provision hereof limits, qualifies or conflicts with another provision herein or in the Original Indenture, in either case, which is required or deemed to be included in this Indenture by any of the provisions of the Trust Indenture Act, such required or deemed provision shall control.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law&#59; Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;This Fourth Supplemental Indenture shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and performed in said state..</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;EACH OF THE COMPANY, THE TRUSTEE AND THE HOLDERS BY THEIR ACCEPTANCE OF ANY NOTE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS FOURTH SUPPLEMENTAL INDENTURE OR THE SENIOR NOTES.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Fourth Supplemental Indenture may be executed in several counterparts, each of which shall be an original and all of which shall constitute but one and the same instrument.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trustee&#8217;s Disclaimer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Trustee accepts the amendments of the Indenture effected by this Fourth Supplemental Indenture, but on the terms and conditions set forth in the Indenture, including the terms and provisions defining and limiting the liabilities and responsibilities of the Trustee. Without limiting the generality of the foregoing, the Trustee shall not be responsible in any manner whatsoever for or with respect to any of the recitals or statements contained herein, all of which recitals or statements are made solely by the Company, or for or with respect to (i) the validity or sufficiency of this Fourth Supplemental Indenture or any of the terms or provisions hereof, (ii) the proper authorization hereof by the Company by action or otherwise, (iii) the due execution hereof by the Company or (iv) the consequences of any amendment herein provided for, and the Trustee makes no representation with respect to any such matters. The Trustee represents that it is duly authorized to execute and deliver this Fourth Supplemental Indenture and perform its obligations hereunder and that it has duly executed this Fourth Supplemental Indenture. Nothing contained in this Section 3.8 shall be deemed to limit such authorization and execution, nor shall this Section 3.8 be interpreted to in any way limit the Trustee&#8217;s authentication of the Senior Notes.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><div id="ib11c2c453ea447e3ab444cede4e6758b_87"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed on the date and year first written above.</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.564%"><tr><td style="width:1.0%"></td><td style="width:13.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED, as the company</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Scott Kirk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott Kirk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.564%"><tr><td style="width:1.0%"></td><td style="width:13.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DEUTSCHE BANK TRUST COMPANY AMERICAS,</font></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Trustee</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Irina Golovashchuk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Irina Golovashchuk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Chris Niesz</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chris Niesz</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to Aspen Insurance Holdings Limited Fourth Supplemental Indenture</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>17
<FILENAME>exhibit106-fx1.htm
<DESCRIPTION>EX-10.6
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i39f9c8dd703240c09b25cddf6e2a32fc_59"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.6</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGREEMENT AND PLAN OF MERGER </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by and among </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIGHLANDS HOLDINGS, LTD. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIGHLANDS MERGER SUB, LTD. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated as of August&#160;27, 2018 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_82"></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE I.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEFINITIONS AND TERMS</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interpretations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE II.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THE MERGER</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger Effective Time</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.03</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of Merger</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.04</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorandum of Association and Bye-Laws of the Surviving Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.05</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board of Directors and Officers of Surviving Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.06</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.07</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe Events</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE III.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EFFECT ON THE SHARE CAPITAL OF THE CONSTITUENT ENTITIES&#59; PAYMENT OF CONSIDERATION</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Merger on the Share Capital of Merger Sub and the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Fund</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.03</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Equity Awards</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.04</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments with Respect to Company Equity Awards</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.05</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of Dissenting Holders</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.06</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE IV.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organization&#59; Standing</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.03</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authority&#59; Noncontravention&#59; Voting Requirements</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.04</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental Approvals</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.05</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company SEC Documents&#59; Undisclosed Liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.06</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Absence of Certain Changes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.07</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal Proceedings</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.08</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compliance with Laws&#59; Permits</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.09</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Benefits</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Labor Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.13</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual Property</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.14</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-Takeover Provisions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.15</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Property&#59; Environmental Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.16</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contracts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.17</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Subsidiaries&#59; Insurance Business</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.18</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory Statements&#59; Examinations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.19</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreements with Insurance Regulators</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.20</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance, Reinsurance and Retrocession</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.21</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.22</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Policies</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.23</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opinion of Financial Advisor</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.24</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brokers and Other Advisors</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.25</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT Systems&#59; Data Security and Privacy</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.26</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment Management</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.27</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Other Representations or Warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE V.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organization&#59; Standing</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authority&#59; Noncontravention</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.03</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental Approvals</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.04</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership and Operations of Merger Sub</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.05</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sufficiency of Funds</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.06</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain Arrangements</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.07</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Supplied</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.08</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal Proceedings</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.09</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership of Company Shares, 5.95% Preference Shares or 5.625% Preference Shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brokers and Other Advisors</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Other Representations or Warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE VI.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDITIONAL COVENANTS AND AGREEMENTS</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conduct of Business</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Solicitation by the Company&#59; Change in Recommendation</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.03</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preparation of the Proxy Statement&#59; Shareholders Meeting</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.04</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reasonable Best Efforts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.05</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.06</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Announcements</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.07</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Access to Information</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.08</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification and Insurance</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.09</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rule 16b-3</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notification of Certain Matters&#59; Shareholder Litigation</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger Sub Shareholder Approval</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.13</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Consents</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.14</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing Cooperation</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.15</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing Indebtedness</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.16</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Financing</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.17</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratings</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.18</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net CAT Losses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE VII.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CONDITIONS PRECEDENT</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 7.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions to Each Party&#8217;s Obligation To Effect the Merger</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 7.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions to Obligations of Parent and Merger Sub</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 7.03</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions to Obligations of the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE VIII.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TERMINATION</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 8.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 8.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 8.03</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Termination Fee and Parent Termination Fee</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARTICLE IX.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MISCELLANEOUS</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.01</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Survival of Representations and Warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.02</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment or Supplement</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.03</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extension of Time, Waiver, Etc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.04</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assignment</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.05</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Counterparts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.06</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Entire Agreement&#59; No Third-Party Beneficiaries</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.07</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governing Law&#59; Jurisdiction</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.08</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specific Enforcement</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.09</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WAIVER OF JURY TRIAL</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severability</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees and Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.13</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Recourse</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</font></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory Merger Agreement</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit B</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Bye-Law Amendment</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SCHEDULES</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule I</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Required Regulatory Approvals</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule II</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Insurance Subsidiaries Ratings</font></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv</font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_104"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGREEMENT AND PLAN OF MERGER </font></div><div style="margin-bottom:24pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This AGREEMENT AND PLAN OF MERGER (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) dated as of August&#160;27, 2018, among Aspen Insurance Holdings Limited, a Bermuda exempted company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), Highlands Holdings, Ltd., a Bermuda exempted company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and Highlands Merger Sub, Ltd., a Bermuda exempted company and a wholly owned Subsidiary of Parent (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">W I T N E S S E T H&#58; </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS the Board of Directors of each of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), Parent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and Merger Sub (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have, by a unanimous vote of all directors present, (i)&#160;approved the business combination transaction provided for herein in which Merger Sub will, subject to the terms and conditions set forth herein and in the Statutory Merger Agreement, merge with and into the Company, with the Company surviving such merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), so that, immediately following the Merger, the Company will be a wholly owned Subsidiary of Parent, (ii)&#160;determined that the terms of this Agreement and the Statutory Merger Agreement are in the best interests of and fair to the Company, Parent, or Merger Sub, as applicable and (iii)&#160;declared the advisability of this Agreement, the Statutory Merger Agreement, and the Merger&#59; </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS the Company Board has, by a unanimous vote of all directors present, (i)&#160;determined that the Merger Consideration constitutes fair value for each Company Share in accordance with the Bermuda Companies Act, (ii)&#160;determined that the preferred shares of the Surviving Company as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> constitute fair value for each 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Share in accordance with the Bermuda Companies Act, (iii)&#160;determined that the preferred shares of the Surviving Company as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> constitute fair value for each 5.625% Perpetual Non-Cumulative Preference Share in accordance with the Bermuda Companies Act,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;determined that the Merger, on the terms and subject to the conditions set forth herein, is fair to, and in the best interests of, the Company, (v)&#160;approved the Merger, this Agreement and the Statutory Merger Agreement and (vi)&#160;resolved, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to recommend approval of the Merger, this Agreement and the Statutory Merger Agreement to the Company&#8217;s shareholders&#59; </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Company Board has (i)&#160;authorized and approved the Bye-Law Amendment (as hereinafter defined), and deems it advisable and in the best interests of the Company and (ii)&#160;resolved to recommend approval of the Bye-Law Amendment to the Company&#8217;s shareholders&#59; </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition to the willingness of the Company to enter into this Agreement, (a)&#160;Apollo Investment Fund IX, L.P., Apollo Overseas Partners (Delaware 892) IX, L.P., Apollo Overseas Partners (Delaware) IX, L.P., Apollo Overseas Partners (Lux) IX, SCSp and Apollo Overseas Partners IX, L.P. (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) are entering into a limited guarantee pursuant to which Guarantors are guaranteeing certain of Parent&#8217;s and Merger Sub&#8217;s obligations under this Agreement, subject to the terms and conditions set forth therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and (b)&#160;Parent has delivered the Commitment Letters (as hereinafter defined) to the Company&#59; and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS the Company, Parent and Merger Sub desire to make certain representations, warranties, covenants and agreements in connection with the Merger and also to prescribe various conditions to the Merger. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the foregoing, the parties agree as follows&#58; </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE I. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEFINITIONS AND TERMS </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;1.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following terms shall have the respective meanings set forth below throughout this Agreement&#58; </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5.625% Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s 5.625% Perpetual Non-Cumulative Preference Shares. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5.95% Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">A.M. Best</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means A.M. Best Company, Inc. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acceptable Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any confidentiality agreement entered into by the Company from and after the date of this Agreement that contains provisions relating to confidentiality that are not less restrictive on the other party than those contained in the Confidentiality Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no such confidentiality agreement (a)&#160;need prohibit the making, or amendment, of any Takeover Proposal to the Company or (b)&#160;shall prohibit or prevent the Company from disclosing to Parent the terms and conditions of any Takeover Proposal or the identity of the Person or group of Persons making such Takeover Proposal or otherwise keeping Parent reasonably informed of the developments with respect to any Takeover Proposal (including any changes thereto) or otherwise complying with its obligations hereunder. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any legal or administrative proceeding, suit, investigation, arbitration or action. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Actuary Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18(b)(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adverse Recommendation Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advisers Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Investment Advisers Act of 1940. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advisory Client Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advisory Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any written agreement pursuant to which the IA Subsidiary provides investment advisory, investment management, commodity trading or collateral management services (including subadvisory services) to a Client. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is under common control with, such Person. For this purpose, &#8220;control&#8221; (including, with its correlative meanings, &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests, by Contract or otherwise. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreed Standard</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any determination regarding CAT Events made by any Person at any time, that such Person made such determination reasonably and in good faith and after taking into account all relevant information reasonably available, including available industry loss estimates from reliable sources, the Company&#8217;s own estimates and modeling with respect to losses arising out of such CAT Events (or the Company&#8217;s representations regarding such estimates and modeling, as applicable), the amount of time that has passed since the occurrence of such CAT Events and relevant historical experience regarding events that were similar to such CAT Events. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the preamble. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ALAE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means allocated loss adjustment expenses. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.08(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Anti-Money Laundering Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means laws, regulations, and orders regarding anti-money laundering to the extent applicable to any of the Company or any Subsidiary, including the U.S. Bank Secrecy Act, the USA PATRIOT Act, and Bermuda&#8217;s Proceeds of Crime Act 1997, Anti-Terrorism (Financial and Other Measures) Act 2004, Proceeds (Anti-Money Laundering and Anti-Terrorist Financing Supervision and Enforcement) Act 2008, and the Proceeds of Crime (Anti-Money Laundering and Anti-Terrorist Financing) Regulations 2008, including the Company&#8217;s know-your-customer obligations. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Antitrust Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Sherman Act, the Clayton Act, the HSR Act, the Federal Trade Commission Act, all applicable non-U.S. antitrust Laws and all other applicable Laws issued by a Governmental Authority that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening of competition through merger or acquisition. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable SAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Company Insurance Subsidiary, the applicable statutory accounting principles (or local equivalents in the applicable jurisdiction) prescribed or permitted by the applicable Insurance Regulator under the Insurance Law of such Company Insurance Subsidiary&#8217;s domiciliary jurisdiction. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appraisal Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.05(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appraised Fair Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.05(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bankruptcy and Equity Exception</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bermuda Companies Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Book-Entry Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">business day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any day, except a Saturday, a Sunday or other day on which the SEC or banks in the City of New York or Bermuda are authorized or required by Law to be closed. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bye-Law Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the amendment to the Company&#8217;s Bye-Laws set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capitalization Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CAT Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following events that first occurs during the Measurement Period&#58; (i)&#160;any hurricane, windstorm, tropical storm, typhoon, cyclone, earthquake, seaquake, wildfire, severe thunderstorm, winter storm, flood, volcanic eruption, meteorite impact, weather event or any other naturally occurring peril that is identified by PCS as a &#8220;catastrophe&#8221; (or equivalent designation)&#59; (ii) any natural catastrophe event that is identified by PERILS&#59; (iii)&#160;any tsunami that makes landfall in the country of Japan&#59; (iv)&#160;any weather system that makes landfall in the country of Japan and is named by the Japan Meteorological Agency to be a tropical cyclone&#59; (v)&#160;any event which is allocated a Catastrophe Code by Lloyd&#8217;s of London&#59; (vi)&#160;any other natural catastrophe event of similar type and size as those identified in clauses (i)&#160;through (v) above and that occurs in a location that is not covered by PCS or PERILS&#59; (vii)&#160;any act of terrorism or Human-Made Catastrophe&#59; or (viii)&#160;any Life-Related Catastrophe. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ceded Reinsurance Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any reinsurance or retrocession treaty or agreement, slip, binder, cover note, or other similar arrangement pursuant to which any Company Insurance Subsidiary is the cedent that, as of December&#160;31, 2017, had at least $10,000,000 in gross ceded reserves or involved an annual premium of at least $2,500,000. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certificate of Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Recommendation Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Client</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Private Fund or other client to which the IA Subsidiary provides investment advisory (including any subadvisory), investment management or commodity trading advisory or collateral management services. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.10(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the U.S. Internal Revenue Code of 1986. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the Equity Commitment Letter and the Debt Commitment Letter. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the preamble. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Acquisition Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Company Performance Unit, Company Phantom Share or Company RSU Award, as applicable. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the recitals. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Board Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Bye-Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s Amended and Restated Bye-Laws, as amended up to and including the date of this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Charter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s Memorandum of Association, as amended up to and including the date of this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Disclosure Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.05(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Insurance Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Insurance Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Subsidiary of the Company that conducts the business of insurance or reinsurance or is licensed as a Lloyd&#8217;s corporate member or Lloyd&#8217;s managing agent. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any lease, sublease, license or other agreement under which the Company or any of its Subsidiaries leases, subleases, licenses, uses or occupies (in each case, whether as landlord, tenant, sublandlord, subtenant or by other occupancy arrangement) or has the right to use or occupy, now or in the future, any real property. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Organizational Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company Charter and the Company Bye-Laws. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Pension Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any employee pension benefit plan within the meaning of Section&#160;3(2) of ERISA (whether or not subject to ERISA) that is sponsored or maintained by the Company or any of its Subsidiaries, to which the Company or any of its Subsidiaries contributes or is obligated to contribute to or with respect to which the Company or any of its Subsidiaries has any liability, other than any such employee pension benefit plan sponsored by a Governmental Authority. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Performance Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Phantom Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each plan, program, policy, agreement or other arrangement, that is (a)&#160;an employee welfare plan within the meaning of Section&#160;3(1) of ERISA (whether or not subject to ERISA), (b) a Company Pension Plan, (c)&#160;a share option, share purchase, share appreciation right, restricted share, restricted share unit or other share- or equity-based compensation agreement, program or plan, (d)&#160;an individual employment, consulting, severance, change of control, retention or other similar agreement to which the Company or any of its Subsidiaries is a party or (e)&#160;a bonus, incentive, deferred compensation, profit-sharing, retirement, post-retirement, paid time off, severance or termination pay, benefit, fringe-benefit or similar plan, program, policy, agreement or other arrangement, in each case that is sponsored or maintained by the Company or any of its Subsidiaries, to which the Company or any of its Subsidiaries contributes or is obligated to contribute to or with respect to which the Company or any of its Subsidiaries is a party or has any liability, other than, in each case, any such plan, program, policy, agreement or other arrangement sponsored by a Governmental Authority. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Related Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each of the Company, its Subsidiaries and any of its or their respective former, current or future general or limited partners, stockholders, controlling Persons, managers, members, directors, officers, employees, Affiliates, representatives, agents or any their respective assignees or successors or any former, current or future general or limited partner, stockholder, controlling Person, manager, member, director, officer, employee, Affiliate, representative, agent, assignee or successor of any of the foregoing. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03(a)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company SEC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.05(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Share Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, (i)&#160;the 2003 Share Incentive Plan, (ii)&#160;the 2013 Share Incentive Plan, and (iii)&#160;the 2016 Stock Incentive Plan for Non-Employee Directors, in each case, as amended from time to time. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Share Purchase Plan Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Shareholders Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Statutory Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.18(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a cash amount equal to $82,935,000. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the confidentiality agreement, dated April&#160;3, 2018, by and between the Company and Parent. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any consent, waiver, approval, license, Permit, order, non-objection, or authorization. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuation Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Person, any loan or credit agreement, debenture, note, bond, mortgage, indenture, deed, lease, sublease, license, contract, or other agreement, instrument, obligation or authorization, to which such Person is a party or by which such Person&#8217;s assets or properties are bound. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Council</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Council of Lloyd&#8217;s as constituted by the Lloyd&#8217;s Act 1982, including its delegates and persons by whom it acts. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Debt Commitment Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any executed debt commitment letter, dated on or after the date hereof, by and among Parent and the Debt Financing Sources, pursuant to which the Debt Financing Sources agree to provide, subject to the terms and conditions set forth therein, the Debt Financing. For purposes of this Agreement, references to the &#8220;Debt Commitment Letter&#8221; shall include the financing contemplated by the Debt Commitment Letter as permitted to be amended, modified or replaced. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Debt Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the debt financing in the amount(s) set forth in the Debt Commitment Letter. For purposes of this Agreement, references to the &#8220;Debt Financing&#8221; shall include the financing contemplated by the Debt Commitment Letter as permitted to be amended, modified or replaced. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Debt Financing Sources</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the lenders, arrangers, bookrunners and agents party to the Debt Commitment Letter. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Debt Financing Sources Related Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Debt Financing Sources, together with their respective Affiliates, and the respective directors, officers, employees, partners, members, managers, agents, advisors, controlling persons, and the other representatives, successors and assigns of each of the foregoing. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Designated Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Determination Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18(b)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dissenting Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Company Shares held by a holder of Company Shares, 5.95% Preference Shares or 5.625% Preference Shares who (a)&#160;did not vote in favor of the Merger, (b)&#160;complied with all of the provisions of the Bermuda Companies Act concerning the right of holders of Company Shares, 5.95% Preference Shares or 5.625% Preference Shares to require appraisal of their Company Shares, 5.95% Preference Shares or 5.625% Preference Shares pursuant to the Bermuda Companies Act, (c)&#160;perfected such right to appraisal, and (d)&#160;did not deliver an Appraisal Withdrawal. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Engagement Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Commitment Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the letter agreement, dated as of the date hereof, by and among Parent and the Investors, pursuant to which the Investors committed, subject to the terms and conditions set forth therein, to invest in Parent, directly or indirectly, the Equity Financing on the date on which the Closing should occur pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and which provides that the Company is a third-party beneficiary thereof in accordance with the terms set forth therein. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an amount in cash equal to the amount set forth in the Equity Commitment Letter. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Employee Retirement Income Security Act of 1974. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any trade or business, whether or not incorporated, that together with the Company or any of its Subsidiaries would be, or, to the extent that the Company or any of its Subsidiaries could have liability with respect to such trade or business, was, deemed to be a single employer within the meaning of Section&#160;4001(b) of ERISA or Sections&#160;414(b), (c), (m) or (o)&#160;of the Code. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Existing Debt Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Existing Revolving Credit Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means that certain Second Amended and Restated Credit Agreement, dated as of March&#160;27, 2017, among the Company, certain Subsidiaries of the Company party thereto, Barclays Bank plc, as administrative agent, and the lenders party thereto from time to time. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FASB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Financial Accounting Standards Board. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Filed SEC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the Debt Financing and the Equity Financing. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financing Uses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.05(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Franchise Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Franchise Board established by the Council or any subcommittee or officer or employee of Lloyd&#8217;s authorised by the Council or Franchise Board to discharge the duties and functions or to exercise the powers and discretions specified in such authorization. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means generally accepted accounting principles in the United States. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any government, legislature, political subdivision, court, board, regulatory or administrative agency, self-regulatory agency, commission, or authority or other legislative, executive, or judicial governmental entity, whether federal, national, provincial, state, local, foreign, or multinational, including Lloyd&#8217;s. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the recitals. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the recitals. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">HSR Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Human-Made Catastrophe</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a disastrous event that is caused by identifiable human action (whether intentional, deliberate, negligent, reckless or otherwise) that results in large-scale losses comprising environmental damage, physical property damage, loss of services or business, loss of life or other damages that are insured or reinsured by the global insurance or reinsurance industry and that the global insurance and reinsurance industry generally considers (or is reasonably likely with the passage of time generally to consider) to be a &#8220;human-made disaster&#8221; or &#8220;human-made catastrophe.&#8221; For illustrative purposes only, the parties agree that examples of human-made catastrophes could include spills, fires, contamination, aviation, rail and maritime disasters, industrial and mining accidents, building and bridge collapses, power plant failures and release of dangerous substances. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IA Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.26(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IA Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Aspen Capital Advisors Inc. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(a)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Independent Actuary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18(b)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any insurance policy or Contract, in each case, together with all policies, binders, slips, certificates, applications, supplements, endorsements, riders and ancillary agreements in connection therewith that are issued by the Company Insurance Subsidiaries. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all Laws applicable to the business of insurance or reinsurance or the regulation of insurance or reinsurance companies, whether federal, national, provincial, state, local, foreign, or multinational, and all applicable orders, directives of, and market conduct recommendations resulting from market conduct examinations of, Insurance Regulators (including, for the avoidance of doubt, Lloyd&#8217;s Regulations and the handbooks of the UK Financial Conduct Authority and the UK Prudential Regulation Authority, respectively). </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Regulators</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all Governmental Authorities regulating the business of insurance or reinsurance, or regulating insurance or reinsurance companies, under Insurance Laws. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all intellectual property and other similar rights in any jurisdiction, whether registered or unregistered, including such rights in and to&#58; any patent (including all reissues, divisions, continuations, continuations-in-part and extensions thereof) and patent application&#59; any trademark, service mark, trade name, logo, business name, brand name, Internet domain name, social media identifier, design right and other similar designations of source or origin, including any and all goodwill associated therewith&#59; any copyright, or database rights (including rights in Software)&#59; all registrations and application to register or renew the registration of any of the foregoing, and any Trade Secret. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intervening Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a material effect, change, event, circumstance, state of facts, development, or occurrence relating to the Company and its Subsidiaries, taken as a whole, (a)&#160;that was not known to the Company Board prior to the execution of this Agreement, (b)&#160;is not reasonably foreseeable as of the date of this Agreement, and (c)&#160;first arises or occurs or, if such effect, change, event, circumstance, state of facts, development, or occurrence existed as of the date of this Agreement, becomes known to the Company Board, after the execution of this Agreement and on or prior to the date of the Company Shareholder Approval&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such effect, change, event, circumstance, state of facts, development, or occurrence is not specifically related to the receipt, existence of, or terms of a Takeover Proposal or any inquiry relating thereto. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Investment Company Act of 1940. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the Equity Commitment Letter. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the U.S. Internal Revenue Service. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IT Systems</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the hardware, Software, data, databases, data communication lines, network and telecommunications equipment, Internet-related information technology infrastructure, wide area network, and other information technology equipment, owned, leased, or licensed by the Company or any of its Subsidiaries. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Knowledge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, (a)&#160;with respect to the Company, the knowledge, after reasonable inquiry of direct reports, of the individuals listed on Section&#160;1.01 of the Company Disclosure Letter and (b)&#160;with respect to Parent, the knowledge, after reasonable inquiry of direct reports, of the individuals listed on Section&#160;1.01 of the Parent Disclosure Letter. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means federal, national, provincial, state, local, or multinational laws, statutes, common law, ordinances, codes, rules, and regulations. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any pledges, liens, charges, mortgages, encumbrances, leases, licenses, hypothecations, or security interests of any kind or nature. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Life-Related Catastrophe</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a catastrophe that is not a natural catastrophe event or Human-Made Catastrophe (such as pandemics or an epidemic of infectious disease, whether viral, bacterial or otherwise) that causes mortality rates in a relevant geographic region to increase significantly from historical or generally expected experience. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lloyd&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Council and Society and Corporation of Lloyd&#8217;s created and governed by the Lloyd&#8217;s Act 1871 to 1982 of England and Wales, including for the avoidance of doubt the Franchise Board. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lloyd&#8217;s Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.17(a)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loss Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Malware</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any virus, Trojan horse, time bomb, key-lock, spyware, worm, malicious code, or other software program designed to or able to, without the knowledge and authorization of the Company or any of its Subsidiaries, disrupt, disable, harm, interfere with the operation of, or install itself within or on any Software, computer data, network memory, or hardware. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any effect, change, event, circumstance, state of facts, development, or occurrence that, individually or in the aggregate, has had, or is reasonably expected to have, a material adverse effect on the business, operations, results of operations, assets and liabilities (considered together), or financial condition of the Company and its Subsidiaries, taken as a whole&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that in no event shall any of the following, alone or in combination, be deemed to constitute, nor be taken into account in determining whether there has been or would reasonably be expected to be, a Material Adverse Effect&#58; (a)&#160;changes, events, or conditions generally affecting the insurance, reinsurance, risk management, or investment management industries in the geographic regions or product markets in which the Company and its Subsidiaries operate or underwrite insurance or reinsurance or manage risk&#59; (b)&#160;general economic or regulatory, legislative, or political conditions or securities, credit, financial, or other capital markets conditions in any jurisdiction (including changes in the value of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment Assets, to the extent arising from any of the foregoing)&#59; (c) any failure, in and of itself, by the Company to meet any internal or published projections, forecasts, estimates, or predictions in respect of revenues, earnings, or other financial or operating metrics for any period&#59; (d)&#160;geopolitical conditions, the outbreak or escalation of hostilities, any acts of war (whether or not declared), sabotage, terrorism (including cyber-terrorism), or man-made disaster, or any escalation or worsening of any such hostilities, acts of war (whether or not declared), sabotage, terrorism, or man-made disaster&#59; (e)&#160;the occurrence or continuation of any volcanic eruption, tsunami, pandemic, hurricane, tornado, windstorm, flood, earthquake, wildfire, or other natural disaster or any conditions resulting from such natural disasters (including increases in liabilities under or in connection with insurance or reinsurance Contracts to which the Company or any of its Subsidiaries is a party arising from such a natural disaster)&#59; (f) the negotiation, execution, and delivery of this Agreement or the public announcement or performance of the Transactions, including the impact thereof on the relationships of the Company or any of its Subsidiaries with employees, customers, insureds, cedants, policyholders, brokers, agents, financing sources, business partners, service providers, Governmental Authorities, or reinsurance providers, and including any Action arising out of any of the foregoing&#59; (g)&#160;any change or announcement of a potential change, in and of itself, in the Company&#8217;s or any of its Subsidiaries&#8217; credit, financial strength, or claims paying ratings or the ratings of any of the Company&#8217;s or its Subsidiaries&#8217; businesses&#59; (h)&#160;any change, in and of itself, in the market price, ratings, or trading volume of the Company&#8217;s or any of its Subsidiaries&#8217; securities&#59; (i)&#160;any change in applicable Law, GAAP (or authoritative interpretation or enforcement thereof), or in Applicable SAP, including accounting and financial reporting pronouncements by the SEC, the National Association of Insurance Commissioners, any Insurance Regulator, and the FASB&#59; (j)&#160;any action required to be taken by the Company, or that the Company is required to cause one of its Subsidiaries to take, pursuant to the terms of this Agreement&#59; (k)&#160;any failure of the Company or any of its Subsidiaries to take an action prohibited by the terms of this Agreement (but only if the Company has requested and Parent has refused to provide a waiver of the applicable prohibition in this Agreement in a reasonably timely manner)&#59; (l) the effects of any breach or violation of any provision of this Agreement by Parent or any of its Affiliates&#59; or (m)&#160;the potential departure of the United Kingdom (or any part thereof) from the European Union, negotiations with respect to passporting rights (as defined in the UK Financial Conduct Authority handbook) and any resultant effects thereof (it being understood that (A)&#160;the exceptions in clauses (c), (g), and (h)&#160;shall not prevent or otherwise affect a determination that the underlying cause of any such failure or change referred to therein (if not otherwise falling within any of the other exceptions provided by clauses (a)&#160;through (m) hereof) constitutes, or contributed to, a Material Adverse Effect and (B)&#160;the exceptions in clause (i)&#160;shall not prevent or otherwise affect a determination that the actual consequences of an action taken or an omission by the Company or any of its Subsidiaries that resulted in a failure by the Company or any of its Subsidiaries to comply with applicable Law constitutes, or contributed to, a Material Adverse Effect)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that any effect, change, event, circumstance, state of facts, development, or occurrence referred to in clauses (a), (b), (d), (e) or (i)&#160;may be taken into account in determining whether or not there has been a Material Adverse Effect, to the extent such effect, change, event, circumstance, state of facts, development, or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other participants engaged primarily in the industries and in the geographic regions or product markets in which the Company and its Subsidiaries operate (in which case only the disproportionate adverse effect or effects may be taken into account in determining whether or not a Material Adverse Effect has occurred). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Material Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Material Insurance Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each of Aspen Insurance UK Limited, Aspen Underwriting Limited (United Kingdom), Aspen Bermuda Limited (Bermuda), Aspen Specialty Insurance Company, and Aspen American Insurance Company. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Maximum Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Measurement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period that begins on July&#160;1, 2018 and ends on the earlier of January&#160;31, 2019 and the Closing Date. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the recitals. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Application</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the preamble. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the recitals. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MGA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.17(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MGA Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.17(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net CAT Losses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to CAT Events (and without duplication), the aggregate amount of all (i)&#160;losses and ALAE incurred and reinstatement premiums paid or payable with respect to ceded reinsurance or retrocessional treaties plus (ii)&#160;loss and ALAE reserves established (based on the Company&#8217;s historical reserving methodologies and information available as of the applicable date of determination) less (iii)&#160;reinsurance and other recoverables that are not doubtful or reasonably likely to be uncollectible less (iv)&#160;reinstatement premiums due (and not doubtful or reasonably likely to be uncollectible) or received with respect to assumed reinsurance or retrocessional treaties. For the avoidance of doubt, (i)&#160;attritional losses and (ii)&#160;other losses and expenses, regardless of size, that, in each case, are not proximately caused by or do not arise out of CAT Events will not be considered Net CAT Losses hereunder. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Open Source Software</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.13(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Organizational Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the articles of incorporation, certificate of incorporation, charter, bye-laws, articles of formation, certificate of formation, regulations, operating agreement, certificate of limited partnership, partnership agreement, limited liability company agreement, and all other similar documents, instruments, or certificates executed, adopted, or filed in connection with the creation, formation, or organization of a Person, including any amendments thereto. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Owned Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all Intellectual Property owned or purported to be owned by the Company or any of its Subsidiaries. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the preamble. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the recitals. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Burdensome Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.04(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Disclosure Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Insurance Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any effect, change, event, circumstance, state of facts, development, or occurrence that would, or would reasonably be expected to, individually or in the aggregate, prevent or delay, interfere with, hinder, or impair, in each case, in any material respect, (x)&#160;the consummation by Parent or Merger Sub of any of the Transactions on a timely basis or (y)&#160;the compliance by Parent or Merger Sub with its obligations under this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Related Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each of Parent, Merger Sub, any of their respective former, current or future equityholders, controlling Persons, limited or general partners, managers, members, Affiliates, directors, officers, employees, agents, attorneys, stockholders, assignees or Representatives. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a cash amount equal to $165,870,000. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paying Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PCS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Property Claim Services division of ISO Services, Inc. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Per Share Accrued Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Company RSU Award, an amount in cash equal to the value of any dividends accrued pursuant to the applicable award agreement governing such Company RSU Award, which dividends remain unpaid as of immediately prior to the Effective Time. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PERILS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means PERILS AG. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.08(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (a)&#160;statutory Liens for Taxes, assessments, or other charges by Governmental Authorities not yet due and payable or the amount or validity of which is being contested in good faith and by appropriate proceedings and, in either case, for which adequate reserves are being maintained on the most recent Company Financial Statements in accordance with GAAP and Applicable SAP, (b)&#160;mechanics&#8217;, materialmen&#8217;s, carriers&#8217;, workmen&#8217;s, warehouseman&#8217;s, repairmen&#8217;s, landlords&#8217;, and similar Liens granted or which arise in the ordinary course of business, (c)&#160;Liens securing payment, or any obligation, of the Company or its Subsidiaries with respect to outstanding Indebtedness reflected on the most recent Company Financial Statements (the existence of which Liens is referred to in the notes to such Company Financial Statements), so long as there is no default under such Indebtedness, (d)&#160;Liens granted in the ordinary course of business in connection with the insurance or reinsurance business of the Company or its Subsidiaries on cash and cash equivalent instruments or other investments, including Liens granted (i)&#160;in connection with (A)&#160;pledges of such instruments or investments to collateralize letters of credit delivered by the Company or its Subsidiaries, (B)&#160;the creation of trust funds for the benefit of ceding companies, (C)&#160;underwriting activities of the Company or its Subsidiaries, (D)&#160;deposit liabilities, (E)&#160;statutory deposits, (F)&#160;ordinary-course securities lending, repurchase, reverse repurchase, and short-sale transactions and (G)&#160;premium trust funds and other funds held under trust in connection with conducting business at Lloyd&#8217;s and (ii)&#160;with respect to investment securities held in the name of a nominee, custodian, depository, clearinghouse, or other record owner, (e)&#160;pledges or deposits by the Company or any of its Subsidiaries under workmen&#8217;s compensation Laws, unemployment insurance Laws, or similar legislation, or good faith deposits in connection with bids, tenders, Contracts (other than for the payment of Indebtedness), or leases to which such entity is a party, or deposits to secure public or statutory obligations of such entity or to secure surety or appeal bonds to which such entity is a party, or deposits as security for contested Taxes, in each case incurred or made in the ordinary course of business, (f)&#160;zoning, building codes, entitlement, and other land use and environmental regulations by any Governmental Authority, (g)&#160;licenses (including nonexclusive licenses of Intellectual Property) granted to third parties in the ordinary course of business by the Company or its Subsidiaries, (h)&#160;Liens created by or through the actions of Parent or any of its Affiliates, (i)&#160;transfer restrictions imposed by Law, and (j)&#160;such other Liens or imperfections that are not material in amount or do not materially detract from the value of or materially impair the existing use of the property or asset affected by such Lien or imperfection. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual, corporation, limited liability company, partnership, joint venture, association, trust, unincorporated organization, or any other entity, including a Governmental Authority. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Personal Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any information that alone or in combination with other information identifies or can be used to identify individuals. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Private Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any pooled investment vehicle that would be an &#8220;investment company&#8221; under the Investment Company Act but for Section&#160;3(c)(1) or 3(c)(7) of the Investment Company Act for which the IA Subsidiary acts as investment adviser, general partner, managing member, manager or sponsor. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Producers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the agents, general agents, sub-agents, brokers, wholesale brokers, independent contractors, consultants, insurance solicitors, producers or other Persons who solicit, negotiate or sell the Insurance Contracts. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proxy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Registrar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Person, its directors, officers, employees, agents, financial advisors, investment bankers, attorneys, accountants, consultants, and other advisors and representatives and their respective successors and assigns. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Required Regulatory Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.01(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restraints</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Review Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, Standard&#160;&#38; Poor&#8217;s Financial Services LLC or any of its Affiliates. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means at any time any Person&#58; (a)&#160;listed on any Sanctions-related list of designated or blocked Persons&#59; (b)&#160;resident in or organized under the laws of a country or territory that is the subject of comprehensive restrictive Sanctions from time to time (as of the date of this Agreement Cuba, Iran, North Korea, Syria, and the Crimea region)&#59; or (c)&#160;majority-owned or controlled by any of the foregoing. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those trade, economic and financial sanctions laws, regulations, embargoes, and restrictive measures of a Governmental Authority that has jurisdiction over the Company or any of its Subsidiaries with respect to the action (including those restrictive measures imposed, administered, or enforced from time to time by the United States (including the U.S. Office of Foreign Assets Control, the U.S. Department of Treasury, the U.S. Department of Commerce, and the U.S. Department of State), the United Nations Security Council, the European Union, or the United Kingdom (including Her Majesty&#8217;s Treasury and the UK Office of Financial Sanctions Implementation)). </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Sarbanes-Oxley Act of 2002. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities and Exchange Commission. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Act of 1933. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(a)(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Software</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all software, including, but not limited to, application software (including mobile digital applications), system software, firmware, middleware, assemblers, applets, compilers, and binary libraries, including all source code and object code versions of any and all of the foregoing, in any and all forms and media, and all related documentation. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means $350,000,000. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Statutory Merger Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Statutory Merger Agreement, in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to be executed and delivered by the Company, Parent and Merger Sub as contemplated by the terms hereof. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; when used with respect to any party, means any corporation, limited liability company, partnership, association, trust, or other entity of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power (or, in the case of a partnership, more than 50% of the general partnership interests) are, as of such date, owned by such party or one or more Subsidiaries of such party or by such party and one or more Subsidiaries of such party. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Summary Business Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the summary of the material terms of Parent&#8217;s business plan for the Company, which was sent by Parent to the Company on the date hereof immediately prior to the execution and delivery of this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Superior Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any bona fide written Takeover Proposal received after the execution of this Agreement that, if consummated, would result in any Person or group (other than Parent and its Subsidiaries) (or the shareholders of any such Person or group) owning, directly or indirectly, (a) 50% or more of the outstanding voting equity securities of the Company or of the surviving entity in a merger or the resulting direct or indirect parent of the Company or such surviving entity, (b) 50% or more of the consolidated assets of the Company and its Subsidiaries, taken as a whole, or (c) 50% or more of the net exposure to insured liabilities of the Company and its Subsidiaries, taken as a whole, in either case, which Takeover Proposal did not result from any material breach of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, solely for purposes of determining whether a breach of the first sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has occurred for purposes of this definition as it relates to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(d)(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(but not, for the avoidance of doubt, for the purpose of determining whether a breach has occurred for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(a)(i))</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company&#8217;s obligation to use its reasonable best efforts to cause its Representatives to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be a covenant (without qualification of reasonable best efforts)) that the Company Board has determined, in its good faith judgment, after consultation with its financial advisors and outside legal counsel, considering legal, financial, regulatory and other aspects of the Takeover Proposal (including any break-up fee, expense reimbursement provisions, conditions to consummation and financing terms), the Person or group making the Takeover Proposal, and such other factors as the Company Board considers to be appropriate, (i)&#160;is reasonably likely to be consummated in accordance with its terms, taking into account all legal, financial, and regulatory aspects of the proposal and the identity of the Person making the proposal, and (ii)&#160;to be more favorable to the holders of Company Shares than the Merger. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Surviving Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Takeover Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any inquiry, proposal or offer from any Person or group (other than Parent and its Subsidiaries) relating to, in a single transaction or series of related transactions, any direct or indirect (a)&#160;acquisition, including by means of reinsurance or retrocession, outside the ordinary course of business in a single transaction or a series of related transactions that, if consummated, would result in any Person or group owning or having the economic benefit of 10% or more of the consolidated assets, revenues or net income of the Company and its Subsidiaries or net exposure to insured liabilities, (b)&#160;acquisition of Company Shares representing 10% or more of the issued and outstanding Company Shares, (c)&#160;any transaction that, if consummated, would result in any Person (or the shareholders of such Person) (other than the Company or any of its Subsidiaries as of the date hereof) being the direct or indirect beneficial owner of 10% or more of the voting power of, or economic interest in, any &#8220;significant subsidiary&#8221; of the Company within the meaning of Rule 1-02(w) of Regulation S-X of the SEC, (d)&#160;tender offer or exchange offer that, if consummated, would result in any Person or group having beneficial ownership of Company Shares representing 10% or more of the issued and outstanding Company Shares, (e)&#160;merger, amalgamation, consolidation, share exchange, scheme of arrangement, business combination, reorganization, recapitalization, liquidation, dissolution, or similar transaction involving the Company pursuant to which such Person or group (or the shareholders of any Person) would acquire, directly or indirectly, 10% or more of the aggregate voting power (without taking into account the voting cutback provisions in the Company Bye-Laws) or economic interest in the Company or in the surviving entity in such transaction or the resulting direct or indirect parent of the Company or such surviving entity, or (f)&#160;combination of the foregoing, in each case, other than the Transactions. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all U.S. and non-U.S. federal, national, provincial, state or local taxes, charges, fees, levies or other similar assessments or liabilities in the nature of taxes, including income, corporation, gross receipts, premium, capital, ad valorem, value-added, excise, real property, personal property, sales, use, severance, transfer, stamp, withholding, employment, payroll, occupation, social security, unemployment, capital stock, license, estimated and franchise taxes, imposed by a Governmental Authority, together with any interest, penalties, assessments or additions to tax imposed with respect to such amounts. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all reports, returns, declarations, claims for refunds, declarations, statements or other information required to be supplied to a Governmental Authority relating to Taxes or any schedule or attachment thereto, or any amendment thereof. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade Secrets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any trade secret, know-how, invention, process, formula, algorithm, model, data and other information of a confidential nature. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transaction Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, this Agreement, the Statutory Merger Agreement, the Confidentiality Agreement, the Commitment Letters, the Guarantee and any other document or instrument contemplated hereby or thereby or any document or instrument delivered in connection herein or therein. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the transactions contemplated by this Agreement and the Statutory Merger Agreement, including the Merger. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Triggering Event Notice Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-Away Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Willful Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a material breach of this Agreement that is a consequence of a deliberate act or omission undertaken by the breaching party with the Knowledge that the taking of or the omission of taking such act would, or would reasonably be expected to, cause or constitute a material breach of this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Year of Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an underwriting year of account as defined in Lloyd&#8217;s Regulations. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;1.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interpretations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As used in this Agreement, references to the following terms have the meanings indicated&#58; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) to the Preamble or to the Recitals, Sections, Articles, Exhibits, or Schedules are to the Preamble or a Recital, Section, or Article of, or an Exhibit or Schedule to, this Agreement, unless otherwise clearly indicated to the contrary&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) to any Law are to such Law, as amended, modified, supplemented, or replaced from time to time and any rules or regulations promulgated thereunder and to any section of any Law including any successor to such section&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) to any Governmental Authority include any successor to the Governmental Authority and to any Affiliate include any successor to the Affiliate&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) to any &#8220;copy&#8221; of any Contract or other document or instrument are to a true and complete copy thereof&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) to &#8220;hereof&#8221;, &#8220;herein&#8221;, &#8220;hereunder&#8221;, &#8220;hereby&#8221;, &#8220;herewith&#8221;, and words of similar import refer to this Agreement as a whole and not to any particular Article, Section, or clause of this Agreement, unless otherwise clearly indicated to the contrary&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) to the &#8220;date of this Agreement&#8221;, &#8220;the date hereof&#8221;, and words of similar import refer to August&#160;27, 2018&#59; and </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii) to &#8220;this Agreement&#8221; includes the Exhibits and Schedules (including the Company Disclosure Letter and the Parent Disclosure Letter) to this Agreement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Whenever the words &#8220;include&#8221;, &#8220;includes&#8221;, or &#8220;including&#8221; are used in this Agreement, they will be deemed to be followed by the words &#8220;without limitation&#8221;. The word &#8220;or&#8221; shall not be exclusive. Any singular term in this Agreement will be deemed to include the plural, and any plural term the singular. All pronouns and variations of pronouns will be deemed to refer to the feminine, masculine, or neuter, singular or plural, as the identity of the Person referred to may require. Where a word or phrase is defined herein, each of its other grammatical forms shall have a corresponding meaning. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Whenever the last day for the exercise of any right or the discharge of any duty under this Agreement falls on a day other than a business day, the party having such right or duty shall have until the next business day to exercise such right or discharge such duty. Unless otherwise indicated, the word &#8220;day&#8221; shall be interpreted as a calendar day. With respect to any determination of any period of time, unless otherwise set forth herein, the word &#8220;from&#8221; means &#8220;from and including&#8221; and the word &#8220;to&#8221; means &#8220;to but excluding&#8221;. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) The table of contents and headings contained in this Agreement are for reference purposes only and will not affect in any way the meaning or interpretation of this Agreement. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) References to a &#8220;party&#8221; hereto means Parent, Merger Sub, or the Company and references to &#8220;parties&#8221; hereto means Parent, Merger Sub, and the Company, unless the context otherwise requires. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) References to &#8220;dollars&#8221; or &#8220;$&#8221; mean United States dollars, unless otherwise clearly indicated to the contrary. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) The parties have participated jointly in the negotiation and drafting of this Agreement&#59; consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) No summary of this Agreement prepared by or on behalf of any party shall affect the meaning or interpretation of this Agreement. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) Any documents and agreements referred to herein (other than the Company Disclosure Letter and the Engagement Letters) shall be deemed to have been &#8220;delivered&#8221;, &#8220;provided&#8221;, or &#8220;made available&#8221; (or any phrase of similar import) prior to the date hereof to Parent by the Company for purposes of this Agreement if they have been posted to the virtual data room maintained by the Company for &#8220;Project Highlands&#8221; on the Venue platform by Donnelley Financial Solutions prior to the date of this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j) All capitalized terms used without definition in the Exhibits and Schedules (including the Company Disclosure Letter and the Parent Disclosure Letter) to this Agreement shall have the meanings ascribed to such terms in this Agreement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE II. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE MERGER </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;2.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On the terms and subject to the conditions set forth in this Agreement and the Statutory Merger Agreement, and pursuant to Section&#160;104H of the Companies Act 1981 of Bermuda (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bermuda Companies Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), at the Effective Time, Merger Sub shall be merged with and into the Company, the separate corporate existence of Merger Sub shall thereupon cease, and the Company shall be the surviving company in the Merger (such surviving company, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Surviving Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;2.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On the terms and subject to the conditions set forth in this Agreement and the Statutory Merger Agreement, the Company, Parent and Merger Sub will (a)&#160;on the Closing Date, execute and deliver the Statutory Merger Agreement, (b)&#160;on or prior to the Closing Date, cause an application for registration of the Surviving Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Application</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to be executed and delivered to the Registrar of Companies in Bermuda (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Registrar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as provided under Section&#160;108 of the Bermuda Companies Act and to be accompanied by the documents required by Section&#160;108(2) of the Bermuda Companies Act, and (c)&#160;cause to be included in the Merger Application a request that the Registrar issue the certificate of merger with respect to the Merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certificate of Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on the Closing Date at the time of day mutually agreed upon by the Company and Parent and set forth in the Merger Application. The Merger shall become effective upon the issuance of the Certificate of Merger by the Registrar at the time and date shown on the Certificate of Merger. The Company, Parent, and Merger Sub agree that they will request that the Registrar provide in the Certificate of Merger that the effective time of the Merger shall be 10&#58;00 a.m., Bermuda time (or such other time mutually agreed upon by the Company and Parent), on the Closing Date (such time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;2.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effects of Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. From and after the Effective Time, the Merger shall have the effects set forth in this Agreement and Section&#160;109(2) of the Bermuda Companies Act. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;2.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Memorandum of Association and Bye-Laws of the Surviving Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the Effective Time, the memorandum of association and bye-laws of the Surviving Company shall be in the form of the memorandum of association and bye-laws of Merger Sub immediately prior to the Effective Time until thereafter changed or amended as provided therein or pursuant to applicable Law (in each case, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;2.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board of Directors and Officers of Surviving Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The directors of Merger Sub in office immediately prior to the Effective Time shall be the directors of the Surviving Company until the earlier of their death, resignation, or removal or until their respective successors are duly elected or appointed and qualified, as the case may be in accordance with the Bermuda Companies Act and the bye-laws of the Surviving Company. The officers of the Company in office immediately prior to the Effective Time shall be the officers of the Surviving Company until the earlier of their death, resignation, or removal or until their respective successors are duly elected or appointed and qualified, as the case may be. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;2.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the closing (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of the Merger shall take place at the offices of Appleby, Canon&#8217;s Court, 22 Victoria Street, PO Box HM 1179, Hamilton HM EX, Bermuda at 10&#58;00 a.m., Bermuda time, on the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) business day following the satisfaction or (to the extent permitted herein and by applicable Law) waiver by the party or parties entitled to the benefits thereof of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or (to the extent permitted herein and by applicable Law) waiver of those conditions at such time), or at such other place, time and date as shall be agreed to in writing by the Company and Parent. The date on which the Closing occurs is referred to in this Agreement as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;2.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Catastrophe Events.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If, as of the date on which the Closing would otherwise occur pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above, one or more CAT Events has occurred during the Measurement Period and Parent, acting in accordance with the Agreed Standard, believes that Net CAT Losses arising from such CAT Events may reasonably be likely to exceed the Specified Amount but that more time is needed to determine more accurately the amount of such Net CAT Losses, then Parent may delay the Closing for up to 30 days by delivering a written notice to such effect to the Company. If Parent validly exercises its right to delay the Closing pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, then, unless the parties otherwise agree, the Closing will not occur prior to the date that is 30 days after the date of such notice. Parent may not exercise its right to delay the Closing pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> more than once. If, at or after the end of such 30-day period, all conditions to the Closing have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at such time), then, unless the parties otherwise agree in writing or Parent has validly exercised its Determination Right pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Closing will occur on the first business day after the end of such 30-day period. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE III. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EFFECT ON THE SHARE CAPITAL OF THE CONSTITUENT ENTITIES&#59; </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PAYMENT OF CONSIDERATION </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;3.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Merger on the Share Capital of Merger Sub and the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the Effective Time, by virtue of the occurrence of the Merger, and without any action on the part of the Company, Parent, Merger Sub or any holder of any common shares, par value $0.015144558 per common share, of the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or any common shares, par value $0.01 per common share, of Merger Sub (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#58; </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share Capital of Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Merger Sub Share issued and outstanding immediately prior to the Effective Time shall automatically be canceled and converted into and become one duly authorized, validly issued, fully paid and nonassessable common share, par value $0.01 per common share, of the Surviving Company. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cancelation of Treasury Shares and Parent-Owned Shares&#59; Treatment of Shares Held by Company Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Company Share that is (i)&#160;owned by the Company as treasury shares or owned by any Subsidiary of the Company or (ii)&#160;owned by Parent, Merger Sub, or any other direct or indirect wholly owned Subsidiary of Parent issued and outstanding immediately prior to the Effective Time shall by virtue of the Merger and without any action on the part of the holder thereof be canceled automatically and shall cease to exist and be outstanding and no consideration shall be delivered in exchange therefor nor any repayment of capital made in respect thereof. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion of Company Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each Company Share issued and outstanding immediately prior to the Effective Time, other than any Company Share that is subject to any Company Award, shall automatically be canceled and converted into and shall thereafter represent the right to receive an amount in cash equal to $42.75, without interest (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as of the Effective Time, all such Company Shares shall no longer be issued and outstanding and shall automatically be canceled and shall cease to exist, and each holder of a certificate that immediately prior to the Effective Time evidenced any Company Shares (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or uncertificated Company Shares represented by book-entry immediately prior to the Effective Time (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Book-Entry Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration pertaining to the Company Shares represented by such Certificate or Book-Entry Share, as applicable, to be paid in consideration therefor, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> without interest. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5.95% Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each 5.95% Preference Share issued and outstanding immediately prior to the Effective Time shall remain issued and outstanding as a preference share of the Surviving Company and shall be entitled to the same dividend and all other preferences and privileges, voting rights, relative, participating, optional and other special rights, and qualifications, limitations and restrictions set forth in the certificate of designations applicable to the 5.95% Preference Shares, which certificate of designations shall remain at and following the Effective Time in full force and effect as an obligation of the Surviving Company in accordance with Section&#160;109(2) of the Bermuda Companies Act. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5.625% Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each 5.625% Preference Share issued and outstanding immediately prior to the Effective Time shall remain issued and outstanding as a preference share of the Surviving Company and shall be entitled to the same dividend and all other preferences and privileges, voting rights, relative, participating, optional and other special rights, and qualifications, limitations and restrictions set forth in the certificate of designations applicable to the 5.625% Preference Shares, which certificate of designations shall remain at and following the Effective Time in full force and effect as an obligation of the Surviving Company in accordance with Section&#160;109(2) of the Bermuda Companies Act. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;3.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paying Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Not less than ten (10)&#160;business days prior to the anticipated Closing Date, Parent shall designate a bank or trust company reasonably acceptable to the Company to act as agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paying Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for the payment and delivery of the aggregate Merger Consideration payable to holders of Company Shares in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and, in connection therewith, shall enter into an agreement with the Paying Agent prior to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Closing Date in a form reasonably acceptable to the Company. At or prior to the Closing, Parent shall deposit or cause to be deposited with the Paying Agent an amount in cash sufficient to pay the aggregate Merger Consideration payable to holders of Company Shares (such cash, and the cash referred to in the immediately following sentence, being hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Pending its disbursement in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Exchange Fund shall be invested by the Paying Agent as directed by Parent in (i)&#160;short-term direct obligations of the United States of America, (ii)&#160;short-term obligations for which the full faith and credit of the United States of America is pledged to provide for the payment of principal and interest, (iii)&#160;short-term commercial paper rated the highest quality by either Moody&#8217;s Investors Service, Inc. or Standard and Poor&#8217;s Ratings Services, or (iv)&#160;certificates of deposit, bank repurchase agreements or banker&#8217;s acceptances of commercial banks with capital exceeding $5,000,000,000. No investment losses resulting from investment of the funds deposited with the Paying Agent shall diminish the rights of any former holder of Company Shares to receive the Merger Consideration as provided herein. The Exchange Fund shall not be used for any purpose, other than the payment to holders of Company Shares of the Merger Consideration or payment to the Surviving Company as contemplated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Transmittal&#59; Exchange of Company Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As soon as practicable after the Effective Time (but in no event later than three (3)&#160;business days after the Effective Time), the Surviving Company or Parent shall cause the Paying Agent to mail to each holder of record of a Certificate a form of letter of transmittal (which shall be in such form and have such other customary provisions as the Surviving Company may specify, subject to the Company&#8217;s reasonable approval (to be obtained prior to the Effective Time)), together with instructions thereto, setting forth, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter alia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the procedures by which holders of Certificates may receive the Merger Consideration. Upon the completion of such applicable procedures by a holder and the surrender of such holder&#8217;s Certificates, and without any action by any holder of record of Book-Entry Shares, the Paying Agent shall deliver to such holder (other than any holder of Company Shares representing Dissenting Shares), (A) in the case of Book-Entry Shares, a notice of the effectiveness of the Merger and (B)&#160;cash in an amount equal to the number of Company Shares represented by such Certificate or Book-Entry Shares immediately prior to the Effective Time </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Merger Consideration, and such Certificates or Book-Entry Shares shall forthwith be canceled. If payment of the Merger Consideration is to be made to a Person, other than the Person in whose name a Certificate surrendered is registered, it shall be a condition of payment that (x)&#160;the Certificate so surrendered shall be properly endorsed or shall otherwise be in proper form for transfer and (y)&#160;the Person requesting such payment shall have established to the reasonable satisfaction of the Surviving Company that any transfer and other Taxes required by reason of the payment of the Merger Consideration to a Person other than the registered holder either has been paid or is not applicable. Until satisfaction of the applicable procedures contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each Certificate or Book-Entry Share shall be deemed at any time after the Effective Time to represent only the right to receive the Merger Consideration. No interest shall be paid or shall accrue on the cash payable with respect to Company Shares pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lost, Stolen or Destroyed Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by the Surviving Company, the posting by such Person of a bond, in such reasonable amount as Parent may direct, as indemnity against any claim that may be made against it with respect to such Certificate, the Surviving Company shall cause the Paying Agent to pay, in exchange for such lost, stolen or destroyed Certificate, the applicable Merger Consideration. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Exchange Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At any time following the first anniversary of the Closing Date, the Surviving Company shall be entitled to require the Paying Agent to deliver to it any portion of the Exchange Fund (including any interest received with respect thereto) that had been delivered to the Paying Agent and which has not been disbursed to former holders of Company Shares, and thereafter such former holders shall be entitled to look only to Parent and the Surviving Company for, and Parent and the Surviving Company shall remain liable for, payment of their claims of the Merger Consideration. Any amounts remaining unclaimed by such holders at such time at which such amounts would otherwise escheat to or become property of any Governmental Authority shall become, to the extent permitted by applicable Law, the property of Parent or its designee, free and clear of all claims or interest of any Person previously entitled thereto. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary contained in this Agreement, none of the parties, the Surviving Company, or the Paying Agent shall be liable in any way whatsoever to any Person for Merger Consideration delivered to a public official or Governmental Authority pursuant to any applicable state, federal, or other abandoned property, escheat, or similar Law. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer Books&#59; No Further Ownership Rights in Company Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Merger Consideration paid in respect of each Company Share in accordance with the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be deemed to have been paid in full satisfaction of all rights pertaining to such Company Shares previously represented by such Certificates or Book-Entry Shares, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the Effective Time, the share transfer books of the Company shall be closed and thereafter there shall be no further registration of transfers on the share transfer books of the Surviving Company of Company Shares that were issued and outstanding immediately prior to the Effective Time. From and after the Effective Time, the holders of Company Shares formerly represented by Certificates or Book-Entry Shares immediately prior to the Effective Time shall cease to have any rights with respect to such underlying Company Shares, except as otherwise provided for herein or by applicable Law. Subject to the last sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if, at any time after the Effective Time, Certificates or Book-Entry Shares are presented to the Surviving Company for any reason, they shall be canceled and exchanged as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Parent, the Surviving Company and the Paying Agent (without duplication) shall be entitled to deduct and withhold from the amounts otherwise payable pursuant to this Agreement (including in respect of Company Plans, Company Awards, or Company Share Purchase Plan Awards) such amounts as are required to be deducted and withheld with respect to the making of such payment under (i)&#160;the Code, or under any provision of other applicable Tax Law&#59; or (ii)&#160;pursuant to the terms of any Company Plan, Company Award, or Company Share Purchase Plan Award. Any amounts that are deducted and withheld from the amounts otherwise payable pursuant to this Agreement pursuant to the preceding sentence shall be timely paid over to the appropriate Governmental Authority. To the extent amounts are so withheld and paid over to the appropriate Governmental Authority, the withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding were made. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;3.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Prior to the Effective Time, the Company Board (or, if appropriate, any duly-authorized committee thereof administering the Company Share Plans) shall adopt such resolutions and take all such other actions as may be required to provide the following, effective upon the Effective Time, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) each restricted share unit granted under a Company Share Plan that is subject to performance-based vesting requirements (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Performance Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that is outstanding immediately prior to the Effective Time shall, to the extent not vested, become fully vested, and shall be canceled and converted into the right to receive a lump-sum amount in cash, without interest, equal to the Merger Consideration&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, for purposes of determining the number of Company Performance Units outstanding immediately prior to the Effective Time, (1)&#160;with respect to any portion of a Company Performance Unit award with a performance period that has been completed, the number of shares shall be determined based on the actual level of performance achieved, and (2)&#160;with respect to any portion of a Company Performance Unit award with a performance period that has not been completed, any applicable performance-based vesting requirements shall be deemed to be achieved immediately prior to the Effective Time at target payout levels&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) each phantom Company Share granted under a Company Share Plan that is subject to performance-based vesting requirements (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Phantom Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that is outstanding immediately prior to the Effective Time shall, to the extent not vested, become fully vested, and shall be canceled and converted into the right to receive a lump-sum amount in cash, without interest, equal to the Merger Consideration&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, for purposes of determining the number of Company Phantom Shares outstanding immediately prior to the Effective Time, (1)&#160;with respect to any portion of a Company Phantom Share award with a performance period that has been completed, the number of shares shall be determined based on the actual level of performance achieved, and (2)&#160;with respect to any portion of a Company Phantom Share award with a performance period that has not been completed, any applicable performance-based vesting requirements shall be deemed to be achieved immediately prior to the Effective Time at target payout levels&#59; and </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) each restricted share unit award granted under a Company Share Plan (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that is outstanding immediately prior to the Effective Time shall, to the extent not vested, become fully vested, and shall be canceled and converted into the right to receive a lump-sum amount in cash, without interest, equal to the product of (x)&#160;the sum of (1)&#160;the Merger Consideration and (2)&#160;any Per Share Accrued Dividend Equivalents in respect of such Company RSU Award times (y)&#160;the number of Company Shares subject to such Company RSU Award, which had not previously been settled. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Treatment of Company ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) The Company shall take all actions necessary to (A)&#160;cause the Company&#8217;s Employee Share Purchase Plan, the 2008 Sharesave Scheme, as amended, and the International Employee Share Purchase Plan (collectively, the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) not to (1)&#160;commence an offering period to purchase Company Shares that would otherwise begin after the end of any offering period in effect as of the date hereof, (2)&#160;accept payroll deductions to be used to purchase Company Shares under the Company ESPP after the end of any offering period in effect as of the date hereof or (3)&#160;ensure that no new participants be permitted to participate in the Company ESPP and that the existing participants thereunder may not increase their elections with respect to any offering period in effect as of the date hereof, and (B)&#160;cause the Company ESPP to terminate immediately after the purchases set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if any, and immediately prior to the Effective Time. </font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) In the case of any outstanding purchase rights (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Share Purchase Plan Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Company ESPP, (A)&#160;immediately prior to the Effective Time (1)&#160;any offering period under the Company&#8217;s Employee Share Purchase Plan and the International Employee Share Purchase Plan shall end and each participant&#8217;s accumulated payroll deduction shall be used to purchase newly issued Company Shares in accordance with the terms of the Company&#8217;s Employee Share Purchase Plan or the International Employee Share Purchase Plan (as applicable) and (2)&#160;such Company Shares shall be treated the same as all other Company Shares in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (B)&#160;prior to the Effective Time (1)&#160;the Company shall promptly take all actions necessary to enable and require participants in the 2008 Sharesave Scheme, as amended, to utilize their accumulated payroll deduction to purchase newly issued Company Shares in accordance with the terms of the 2008 Sharesave Scheme, as amended, such that there are no outstanding purchase rights thereunder as at the Effective Time and (2)&#160;such Company Shares shall be treated the same as all other Company Shares in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;3.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payments with Respect to Company Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Promptly after the Effective Time (but in any event, no later than second regular payroll date of the Surviving Company following the Effective Time), the Surviving Company shall pay to the holders of Company Awards, through its payroll systems, any amounts due pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in respect of any then-vested Company Awards&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, to the extent any such payment would cause an impermissible acceleration event under Section&#160;409A of the Code (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), such amounts will be paid at the earliest time such payment would not cause an impermissible acceleration event under Section&#160;409A. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;3.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Shares of Dissenting Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) At the Effective Time, all Dissenting Shares shall automatically be canceled and, unless otherwise required by applicable Law, converted into the right to receive the Merger Consideration pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with respect to Company Shares, the preferred shares of the Surviving Company as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with respect to 5.95% Preference Shares or the preferred shares of the Surviving Company as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with respect to 5.625% Preference Shares, and any holder of Dissenting Shares shall, in the event that the fair value of a Dissenting Share as appraised by the Supreme Court of Bermuda under Section&#160;106(6) of the Bermuda Companies Act (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appraised Fair Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is greater than, the Merger Consideration with respect to Company Shares, the value of the preferred shares of the Surviving Company as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with respect to 5.95% Preference Shares or the value of the preferred shares of the Surviving Company, as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with respect to 5.625% Preference Shares, be entitled to receive such difference from the Surviving Company by payment made within thirty (30)&#160;days after such Appraised Fair Value is finally determined pursuant to such appraisal procedure. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) In the event that a holder fails to exercise, effectively withdraws or otherwise waives any right to appraisal (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appraisal Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), such holder shall have no other rights with respect to such Dissenting Shares, other than as contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Company shall give Parent (i)&#160;written notice of (A)&#160;any demands for appraisal of Dissenting Shares or Appraisal Withdrawals and any other written instruments, notices, petitions, or other communication received by the Company in connection with the foregoing and (B)&#160;to the extent that the Company has Knowledge thereof, any applications to the Supreme Court of Bermuda for appraisal of the fair value of the Dissenting Shares and (ii)&#160;to the extent permitted by applicable Law, the opportunity to participate with the Company in any settlement negotiations and proceedings with respect to any demands for appraisal under the Bermuda Companies Act. The Company shall not, without the prior written consent of Parent, voluntarily make any payment with respect to, offer to settle, or settle any such demands or applications, or waive any failure to timely deliver a written demand for appraisal or to timely take any other action to exercise appraisal rights in accordance with the Bermuda Companies Act. Payment of any amount payable to holders of Dissenting Shares shall be the obligation of the Surviving Company. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;3.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the contrary, if, between the date of this Agreement and the Effective Time, the issued and outstanding Company Shares shall have been changed into a different number of shares or a different class by reason of the occurrence or record date of any share dividend, subdivision, reclassification, recapitalization, split, combination, exchange of shares, or similar transaction, the Merger Consideration shall be appropriately adjusted to reflect such share dividend, subdivision, reclassification, recapitalization, split, combination, exchange of shares, or similar transaction.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE IV. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPRESENTATIONS AND WARRANTIES OF THE COMPANY </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company hereby represents and warrants to Parent and Merger Sub that, as of the date hereof and as of the Closing Date, except as (A)&#160;set forth in the disclosure letter delivered by the Company to Parent and Merger Sub on the date of this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Disclosure Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) (it being understood that any information set forth on one section or subsection of the Company Disclosure Letter shall be deemed to apply to and qualify the section or subsection of this Agreement to which it corresponds in number and each other section or subsection of this Agreement or the Company Disclosure Letter to the extent that it is reasonably apparent that such information is relevant to such other section or subsection) or (B)&#160;disclosed in any report, schedule, form, statement or other document (including exhibits) filed with, or furnished to, the SEC since January&#160;1, 2018 by the Company and publicly available at least one (1)&#160;business day prior to the date of this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Filed SEC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), other than disclosure contained in the &#8220;Risk Factors&#8221; or &#8220;Forward-Looking Statements&#8221; sections of such Filed SEC Documents or that otherwise constitute risk factors or forward-looking statements, to the extent it is reasonably apparent on its face that such disclosure would be applicable to the applicable representation and warranty&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the disclosures therein shall not be deemed to qualify any representations and warranties made in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Organization&#59; Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company is an exempted company duly incorporated, validly existing, and in good standing under the Laws of Bermuda. The Company has all requisite power and authority necessary to carry on its business as it is now being conducted, and to own, lease, and operate its assets and properties in all material respects. The Company is duly licensed or qualified to do business and is in good standing (where such concept is recognized under applicable Law) in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified, or in good standing would not constitute a Material Adverse Effect or reasonably be expected to prevent or materially delay, interfere with, hinder, or impair (x)&#160;the consummation by the Company of any of the Transactions on a timely basis or (y)&#160;the compliance by the Company with its obligations under this Agreement. A copy of each of the Company Organizational Documents is included in the Filed SEC Documents. The Company is not in violation of the Company Organizational Documents, and no Subsidiary of the Company is in violation of any of its Organizational Documents, except, in each case, as would not be material to the Company and its Subsidiaries, taken as a whole. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Each of the Company&#8217;s Subsidiaries is duly incorporated or organized, validly existing and in good standing (where such concept is recognized under applicable Law) under the Laws of the jurisdiction of its incorporation or organization, except where the failure to be so incorporated or organized, existing and in good standing would not constitute a Material Adverse Effect. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capitalization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The authorized share capital of the Company consists of $1,630,185.83 divided into 1,076,416,910 shares of par value $0.015144558 each. At the close of business on August&#160;24, 2018 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capitalization Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), (i) 59,692,594 Company Shares were issued and outstanding, (ii) 11,000,000 5.95% Preference Shares were issued and outstanding, (iii) 10,000,000 5.625% Preference Shares were issued and outstanding, (iv)&#160;no Company Shares were held by the Company as treasury shares or held by its Subsidiaries, (v) 847,153 Company Shares were issuable in respect of outstanding Company RSU Awards and Company Performance Units, measured at the target level of performance and (vi) 286,919 Company Shares were subject to Company Phantom Share awards measured at target level of performance (which Company Phantom Share awards are, by their terms, settled solely in cash). The number of Company Shares that could be acquired with accumulated payroll deductions under the Company ESPP at the close of business on the purchase date for any offering period in effect as of the date of this Agreement (assuming (A)&#160;the market price of a Company Share as of the close of business on the business day immediately preceding such date is equal to the Merger Consideration, (B)&#160;such date represents the last day of the current offering period, and (C)&#160;payroll deductions continue at the current rate) does not exceed 75,858 Company Shares. Since the Capitalization Date through the date of this Agreement, other than in connection with the vesting, settlement, or exercise of Company Awards outstanding on the Capitalization Date and included in the second sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the issuance of Company Share Purchase Plan Awards included in the immediately preceding sentence, neither the Company nor any of its Subsidiaries has issued any Company Securities. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as of the date of this Agreement, there were (i)&#160;no issued and outstanding Company Shares or other equity or voting interests in the Company, (ii)&#160;no outstanding securities of the Company convertible into or exchangeable for Company Shares or other equity or voting interests in the Company, (iii)&#160;no outstanding options, warrants, rights, or other commitments or agreements to acquire from the Company, or that obligate the Company to issue, any Company Shares or other equity or voting interests in, or any securities convertible into or exchangeable for Company Shares or other equity or voting interests in the Company, (iv)&#160;no obligations of the Company to grant, extend, or enter into any subscription, warrant, right, convertible or exchangeable security, or other similar agreement or commitment relating to any Company Shares, or other equity or voting interests in, the Company (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and the items in clauses (i), (ii), (iii) and (iv)&#160;being referred to, collectively, as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and (v)&#160;no other obligations by the Company or any of its Subsidiaries to make any payments based on the price or value of any Company Securities or dividends paid thereon. Other than in connection with the Company Awards outstanding on the Capitalization Date and included in the second sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or Company Share Purchase Plan Awards included in the third sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there are no outstanding agreements or instruments of any kind that obligate the Company or any of its Subsidiaries to repurchase, redeem, or otherwise acquire any Company Securities (or obligate the Company to grant, extend, or enter into any such agreements relating to any Company Securities) or that grant from the Company or any of its Subsidiaries any preemptive rights, subscription rights, anti-dilutive rights, rights of first refusal, or similar rights with respect to any Company Securities. With respect to each Company Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company Disclosure </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letter sets forth (i)&#160;the name of the holder of such Company Award, (ii)&#160;the type of award, (iii)&#160;the number of Company Shares subject to such Company Award, (iv)&#160;the grant date of such Company Award, (v)&#160;the vesting schedule applicable to such Company Award, and (vi)&#160;the Company Share Plan under which such Company Award was granted. Except as described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, no direct or indirect Subsidiary of the Company owns any Company Securities. None of the Company or any Subsidiary of the Company is a party to any shareholders&#8217; agreement, voting trust agreement, registration rights agreement, or other similar agreement or understanding relating to any Company Securities or any other agreement relating to the disposition, voting, or dividends with respect to any Company Securities. All issued and outstanding Company Shares have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights. There are no accrued or unpaid dividends or dividend equivalent rights with respect to any Company Shares, Company Performance Units, or Company RSU Awards, except for the Per Share Accrued Dividend Equivalents. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Company Shares, the 5.95% Preference Shares, and the 5.625% Preference Shares constitute the only issued and outstanding classes of equity securities of the Company and its Subsidiaries registered under the Exchange Act. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Section 4.02(d) of the Company Disclosure Letter sets forth a true and complete list, as of the date of this Agreement, of the name and jurisdiction of incorporation or organization of each Subsidiary of the Company. All of the issued and outstanding shares, share capital or shares of capital stock of, or other equity or voting interests in, each Subsidiary of the Company (except for directors&#8217; qualifying shares or the like) are owned, directly or indirectly, beneficially and of record, by the Company, free and clear of all Liens and material transfer restrictions, except for such Liens and transfer restrictions of general applicability as may be provided under the Securities Act, other applicable securities Laws, or Insurance Laws (including any restriction on the right to vote, sell, or otherwise dispose of such shares, share capital, shares of capital stock, or other equity or voting interests). Each issued and outstanding share, share capital, or share of capital stock of each Subsidiary of the Company that is held, directly or indirectly, by the Company is duly authorized, validly issued, fully paid, nonassessable, and free of preemptive rights, and there are no subscriptions, options, warrants, rights, calls, contracts, or other commitments, understandings, restrictions, or arrangements relating to the issuance, acquisition, redemption, repurchase, or sale of any shares, share capital, or shares of capital stock or other equity or voting interests of any Subsidiary of the Company, including any right of conversion or exchange under any outstanding security, instrument or agreement, and agreement granting any preemptive rights, subscription rights, anti-dilutive rights, rights of first refusal, or similar rights (to Persons other than the Company or any Subsidiary of the Company) with respect to any securities of any Subsidiary of the Company. None of the Subsidiaries of the Company has any outstanding equity compensation plans relating to the share capital of, or other equity or voting interests in, any Subsidiary of the Company. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Authority&#59; Noncontravention&#59; Voting Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company has all necessary power and authority to execute and deliver this Agreement and the Statutory Merger Agreement and, subject to obtaining the Company Shareholder Approval, to perform its obligations hereunder and to consummate the Transactions. The execution, delivery and performance by the Company of this Agreement and the Statutory Merger Agreement, and the consummation by the Company of the Transactions, have been duly authorized and approved by the Company Board, and, except for obtaining the Company Shareholder Approval, executing and delivering the Statutory Merger Agreement and filing the Merger Application with the Registrar pursuant to the Bermuda Companies Act, no other action on the part of the Company is necessary to authorize the execution, delivery, and performance by the Company of this Agreement and the Statutory Merger Agreement and the consummation by the Company of the Transactions. This Agreement has been duly executed and delivered by the Company and, assuming due authorization, execution, and delivery hereof by the other parties, constitutes a legal, valid, and binding obligation of the Company, enforceable against the Company in accordance with its terms, except that such enforceability (i)&#160;may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium, rehabilitation, conservatorship, liquidation, receivership, and other similar Laws of general application affecting or relating to the enforcement of creditors&#8217; rights generally, and (ii)&#160;is subject to general principles of equity, whether considered in a proceeding at law or in equity (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bankruptcy and Equity Exception</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) As of the date of this Agreement, the Company Board has unanimously, by all directors present at a duly called meeting, adopted resolutions whereby it has (i)&#160;determined that the Merger Consideration constitutes fair value for each Company Share in accordance with the Bermuda Companies Act, (ii)&#160;determined that the preferred shares of the Surviving Company as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> constitutes fair value for each 5.95% Preference Share in accordance with the Bermuda Companies Act, (iii)&#160;determined that the preferred shares of the Surviving Company as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> constitutes fair value for each 5.625% Preference Share in accordance with the Bermuda Companies Act, (iv)&#160;determined that the Merger, on the terms and subject to the conditions set forth herein, is fair to, and in the best interests of, the Company, (v)&#160;approved the Merger, this Agreement, and the Statutory Merger Agreement, (vi)&#160;determined that the Bye-Law Amendment is advisable to and in the best interests of the Company, and authorized and approved the Bye-Law Amendment, and (vii)&#160;resolved, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to recommend, and submit to the Company&#8217;s shareholders for, approval of the Merger, this Agreement, the Statutory Merger Agreement, and the Bye-Law Amendment to the Company&#8217;s shareholders (such recommendation, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Board Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Neither the execution and delivery of this Agreement or the Statutory Merger Agreement by the Company, nor the consummation by the Company of the Transactions, nor performance or compliance by the Company with any of the terms or provisions hereof, will (i)&#160;contravene, conflict with or violate any provision of (A)&#160;the Company Organizational Documents (as they may be amended pursuant to the Bye-Law Amendment) or (B)&#160;the similar Organizational Documents of any of the Company&#8217;s Subsidiaries or (ii)&#160;assuming (A) compliance with the matters set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.02(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (other than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.02(c)(ii)(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (and assuming the accuracy of the representations and warranties made in such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.02(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (B) that the actions described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> have been completed, (C)&#160;that the Consents referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the Company Shareholder Approval are obtained, and (D)&#160;that the filings referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are made and any waiting periods thereunder have terminated or expired, in the case of each of the foregoing clauses (A)&#160;through (D), prior to the Effective Time, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x) violate any Law, writ, injunction, directive, judgment, decree, or order applicable to the Company or any of its Subsidiaries, (y)&#160;violate or constitute a breach of or default (with or without notice or lapse of time or both) under any of the terms, conditions, or provisions of, or give rise to a right of termination, modification, acceleration or cancellation under, any Material Contract or Ceded Reinsurance Contract or accelerate the Company&#8217;s or, if applicable, any of its Subsidiaries&#8217; rights or obligations under any such Material Contract or Ceded Reinsurance Contract, or (z)&#160;result in the creation of any Lien (other than any Permitted Lien) on any properties or assets of the Company or any of its Subsidiaries, except, in the case of clauses (i)(B) and (ii), as would not constitute a Material Adverse Effect or reasonably be expected to prevent or materially delay, interfere with, hinder, or impair (x)&#160;the consummation by the Company of any of the Transactions on a timely basis or (y)&#160;the compliance by the Company with its obligations under this Agreement. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Subject to bye-law 50 of the Company Bye-Laws, the affirmative vote in favor of the approval of the Bye-Law Amendment of at least 66% of the voting power of shares entitled to vote, at a duly convened meeting of the Company shareholders at which a quorum is present in accordance with the Company&#8217;s Bye-Laws, is the only vote or approval of the holders of any class or series of shares of the Company or any of its Subsidiaries that is necessary to approve Bye-Law Amendment. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Subject to bye-law 50 of the Company Bye-Laws, (i)&#160;if the Bye-Law Amendment is approved, the affirmative vote in favor of the approval of this Agreement, the Statutory Merger Agreement, and the Merger of at least a majority of the voting power of votes cast, at a duly convened meeting of the Company shareholders at which a quorum is present in accordance with the Company&#8217;s Bye-Laws, or (ii)&#160;if the Bye-Law Amendment is not approved, the affirmative vote in favor of the approval of this Agreement, the Statutory Merger Agreement, and the Merger of at least 66% of the voting power of shares entitled to vote, at a duly convened meeting of the Company shareholders at which a quorum is present in accordance with the Company&#8217;s Bye-Laws ((i) or (ii)&#160;as applicable, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), is the only vote or approval of the holders of any class or series of shares of the Company or any of its Subsidiaries that is necessary to approve this Agreement and the other transactions contemplated hereby, the Statutory Merger Agreement and the Merger. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except for (a)&#160;compliance with the applicable requirements of the Exchange Act, including the filing with the SEC of a proxy statement relating to the Company Shareholders Meeting (as amended or supplemented from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proxy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), (b) compliance with the rules and regulations of the New York Stock Exchange, (c)&#160;the filing of the Merger Application with the Registrar pursuant to the Bermuda Companies Act, (d)&#160;the approval of the Bermuda Monetary Authority pursuant to the Exchange Control Act 1972 regarding the change of ownership of the Company, (e)&#160;filings required under, and compliance with other applicable requirements of, the HSR Act and such other Consents, filings, declarations, or registrations as are required to be made or obtained under any other Antitrust Laws, (f)&#160;compliance with any applicable state securities or blue sky Laws, (g)&#160;approvals, filings, and notices under all applicable Insurance Laws as set forth in Section&#160;4.04 of the Company Disclosure Letter (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Insurance Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and (h)&#160;the Parent Insurance Approvals (assuming the accuracy of the representations and warranties made in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.03(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the completeness of Section&#160;5.03 of the Parent Disclosure Letter), no Consent of, or filing, declaration, or registration with, or notification to, or waiver from, any Governmental Authority is necessary for the execution and delivery of this Agreement by the Company, the performance by the Company of its obligations hereunder, and the consummation by the Company of the Transactions, other than such other Consents, filings, declarations, or registrations that, if not obtained, made, or given, would not constitute a Material Adverse Effect or reasonably be expected to prevent or materially delay, interfere with, hinder, or impair (x)&#160;the consummation by the Company of any of the Transactions on a timely basis or (y)&#160;the compliance by the Company with its obligations under this Agreement. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company SEC Documents&#59; Undisclosed Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company has timely filed with or furnished to (as applicable) the SEC all reports, schedules, forms, statements, and other documents required to be filed or furnished by the Company with the SEC pursuant to the Securities Act or the Exchange Act since January 1, 2017 (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company SEC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). As of their respective effective dates (in the case of Company SEC Documents that are registration statements filed pursuant to the requirements of the Securities Act) or their respective SEC filing dates (in the case of all other Company SEC Documents), the Company SEC Documents complied as to form in all material respects with the requirements of the Securities Act or the Exchange Act, as the case may be, applicable to such Company SEC Documents, and none of the Company SEC Documents as of such respective dates (or, if amended prior to the date of this Agreement, the date of the filing of such amendment, with respect to the disclosures that are amended) contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no unresolved written comments from the SEC with respect to the Company SEC Documents. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The consolidated financial statements of the Company (including all related notes or schedules) included or incorporated by reference in the Company SEC Documents (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) complied as to form, as of their respective dates of filing with the SEC, in all material respects with the published rules and regulations of the SEC with respect thereto, have been prepared in accordance with GAAP, consistently applied for the applicable period (except, in the case of unaudited quarterly statements, as permitted by Form 10-Q of the SEC or other rules and regulations of the SEC) applied on a consistent basis during the periods involved (except (i)&#160;as may be indicated in the notes thereto or (ii)&#160;as permitted by Regulation S-X) and fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of their operations, changes in shareholders&#8217; equity, and cash flows for the periods shown (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Neither the Company nor any of its Subsidiaries has any liabilities of any nature (whether accrued, absolute, contingent, or otherwise) that would be required under GAAP as in effect on the date of this Agreement to be reflected on a consolidated balance sheet of the Company (including the notes thereto), except liabilities (i)&#160;reflected or reserved against in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balance sheet (or the notes thereto) of the Company and its Subsidiaries as of December&#160;31, 2017, included in the Filed SEC Documents, (ii)&#160;incurred after December&#160;31, 2017, in the ordinary course of business, (iii)&#160;as contemplated by this Agreement or otherwise incurred in connection with the Transactions, (iv)&#160;as related to Taxes, or (v)&#160;that would not constitute a Material Adverse Effect. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) The Company is in compliance in all material respects with the provisions of the Sarbanes-Oxley Act and the rules and regulations of the New York Stock Exchange, in each case, that are applicable to the Company. With respect to each Company SEC Document on Form 10-K or 10-Q, each of the principal executive officers and the principal financial officer of the Company has made all certifications required by Rule 13a, 14 or 15(d) of the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act with respect to such Company SEC Documents. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) The Proxy Statement will comply as to form in all material respects with the requirements of the Exchange Act and will not, at the date it is first mailed to holders of Company Shares, at the time of any amendment thereof or supplement thereto, and at the time of the Company Shareholders Meeting, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no representation or warranty with respect to statements made or incorporated by reference therein based on information supplied by or on behalf of Parent or Merger Sub or any Affiliates thereof for inclusion or incorporation by reference in the Proxy Statement. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) No material weaknesses exist with respect to the internal control over financial reporting of the Company that would be required to be disclosed by the Company pursuant to Item 308(a)(3) of Regulation S-K promulgated by the SEC that has not been disclosed in the Company SEC Documents as filed with or furnished to the SEC prior to the date hereof. The Company has established and maintains &#8220;disclosure controls and procedures&#8221; and &#8220;internal control over financial reporting&#8221; (as such terms are defined in paragraphs (e)&#160;and (f), respectively, of Rule 13a-15 under the Exchange Act) as required by Rule 13a-15 under the Exchange Act, designed to ensure that information required to be disclosed by the Company in the reports that it files and submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, including that information required to be disclosed by the Company in the reports that it files and submits under the Exchange Act is accumulated and communicated to management of the Company, as appropriate, to allow timely decisions regarding required disclosure. The Company has disclosed, based on its most recent evaluation, to the Company&#8217;s outside auditors and the audit committee of the Company Board, (i)&#160;all significant deficiencies and material weaknesses in the design and operation of internal control over financial reporting that are reasonably likely to adversely affect in any material respect the Company&#8217;s ability to record, process, summarize, and report financial data and (ii)&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal control over financial reporting. The Company has provided or made available to Parent correct and complete copies of any such disclosure contemplated by clauses (i)&#160;and (ii) of the immediately preceding sentence made by management to the Company&#8217;s independent auditors and the audit committee of the Company Board since December&#160;31, 2017 through the date of this Agreement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) Since December&#160;31, 2017, (i) neither the Company nor any of its Subsidiaries has received any written complaint, allegation, assertion, or claim, in each case material to the Company and its Subsidiaries, taken as a whole, regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or any of its Subsidiaries or their respective internal accounting controls, including any credible complaint, allegation, assertion, or claim that the Company or any of its Subsidiaries has engaged in questionable accounting or auditing practices, and (ii)&#160;no attorney representing the Company or any of its Subsidiaries, whether or not employed by the Company or any of its Subsidiaries, has reported evidence of a material violation of securities Laws, breach of fiduciary duty, or similar violation by the Company or any of its Subsidiaries or their respective officers, directors, employees, or agents to the Company Board or any committee thereof or to any director or officer of the Company pursuant to the rules of the SEC adopted under Section&#160;307 of the Sarbanes-Oxley Act. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) There are no &#8220;off balance sheet arrangements,&#8221; as defined in Item 303 of Regulation S-K under the Securities Act, to which the Company or any of its Subsidiaries is a party. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Absence of Certain Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a)&#160;From December&#160;31, 2017 through the date of this Agreement, except for the execution, delivery, and performance of this Agreement and the discussions, negotiations, and transactions related thereto, the business of the Company and its Subsidiaries has been conducted in all material respects in the ordinary course of business and (b)&#160;since December&#160;31, 2017, there has not been any Material Adverse Effect. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as would not constitute a Material Adverse Effect, as of the date of this Agreement, there is no (a)&#160;pending or, to the Knowledge of the Company, threatened legal or administrative proceeding, suit, arbitration, action, claim, controversy, dispute, hearing, charge, complaint, examination, indictment, litigation, or, to the Knowledge of the Company, investigation against the Company or any of its Subsidiaries (other than ordinary course claims made under or in connection with Contracts of insurance or reinsurance issued by the Company or any of its Subsidiaries) or (b)&#160;outstanding injunction, order, judgment, ruling, decree, or writ imposed upon the Company or any of its Subsidiaries or, to the Knowledge of the Company, any director or officer of the Company or any of its Subsidiaries, in each case, by or before any Governmental Authority. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.08 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance with Laws&#59; Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company and each of its Subsidiaries are, and, since January&#160;1, 2017, have been, in compliance with all applicable Laws, judgments, decrees, and orders of Governmental Authorities and Permits, except as would not constitute a Material Adverse Effect. Since January&#160;1, 2017 through the date hereof, neither the Company nor any of its Subsidiaries has received any written notification or, to the Knowledge of the Company, oral notification from any Governmental Authority of any violation of Law applicable to the Company or any of its Subsidiaries or by which any of their respective businesses, operations, properties or assets are bound, except as would not constitute a Material Adverse Effect. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The Company and each of its Subsidiaries hold, and, since January&#160;1, 2017, have held, all licenses, franchises, permits, certificates, approvals, authorizations, and registrations from Governmental Authorities necessary for the lawful conduct of their respective businesses (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and all such Permits are in full force and effect in all material respects, except where the failure to hold the same or the failure of the same to be in full force and effect would not constitute a Material Adverse Effect. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Company and each of its Subsidiaries is in compliance in all material respects with (i)&#160;the Foreign Corrupt Practices Act of 1977, as amended (including without limitation its provisions relating to the accuracy of books and records and maintenance of internal controls sufficient to prevent bribery), (ii) the Organization for Economic Cooperation and Development Convention Against Bribery of Foreign Public Officials in International Business Transactions and legislation implementing such convention, (iii)&#160;the United Kingdom Bribery Act of 2010, (iv) the Bermuda Bribery Act 2016, and (v)&#160;all other similar Laws, writs, injunctions, directives, judgments, decrees, or orders to which the Company or its Subsidiaries are subject relating to anti-corruption compliance (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Except as would not constitute a Material Adverse Effect&#58; (i)&#160;the Company has complied at all times with all applicable Laws pertaining to privacy and data security and the collection, use, and transfer of Nonpublic Personal Information (as defined as 15 U.S.C. &#167;6809), including the Gramm-Leach-Bliley Act, the Telephone Consumer Protection Act and the NY Department of Financial Services Cybersecurity Regulation, 23 NYCRR 500&#59; (ii) the Company does not use, collect, or receive any Nonpublic Personal Information and does not become aware of the identity or location of, or identify or locate, any person as a result of any receipt of such Nonpublic Personal Information in violation of applicable Laws&#59; (iii)&#160;any website owned or operated by the Company since January&#160;1, 2017 has maintained a publicly posted privacy policy that accurately describes the practices of Company with respect to the collection, use and disclosure of Nonpublic Personal Information collected by such websites&#59; (iv)&#160;the Company has established and is in compliance with a written information security program that (x)&#160;includes administrative, technical, and physical safeguards reasonably designed to safeguard the security, confidentiality, and integrity of transactions involving Nonpublic Personal Information and (y)&#160;is reasonably designed to protect against unauthorized access to Nonpublic Personal Information and the systems of any third-party service providers that have access to Nonpublic Personal Information&#59; (v)&#160;the Company is currently and since January&#160;1, 2017 has been certified to be in compliance with Payment Card Industry Data Security Standard&#59; and (vi)&#160;the Company has neither provided, nor been required to provide, notice to an individual, business entity, or state or federal governmental entity relating to a cybersecurity incident or the unauthorized access to or acquisition of Nonpublic Personal Information. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Since January&#160;1, 2015, none of the Company and its Subsidiaries nor, to the Knowledge of the Company, any director, officer, agent, or employee of the Company or any of its Subsidiaries has for the benefit of the Company or any of its Subsidiaries engaged in any financial transaction or other business conduct, including the sale, import, or export of goods or services, or facilitated such financial transaction or business conduct, or otherwise engaged in any business or financial arrangement with a Sanctioned Person or otherwise in violation of Sanctions. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) The Company and its Subsidiaries have in place and have adhered to policies, procedures, and internal controls reasonably designed to prevent their respective directors, officers, employees, agents, and representatives from undertaking any activity, practice, or conduct relating to the business of the Company or any Subsidiary that would constitute an offense under any Anti-Money Laundering Laws, and none of the Company or its Subsidiaries has violated any applicable Anti-Money Laundering Laws in any material respect. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) None of the Company nor any of its Subsidiaries has (i)&#160;received any written correspondence, (ii)&#160;conducted an internal investigation, (iii)&#160;provided any voluntary disclosure, or (iv)&#160;been the subject of any investigation, inquiry, or enforcement proceedings (to which they have received notification of such investigation, inquiry, or enforcement proceedings) by any Governmental Authority, in each case, relating to an offense under or alleged violation of any of the Anti-Money Laundering Laws, Anti-Corruption Laws, or Sanctions. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.09 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as would not constitute a Material Adverse Effect&#58; </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company and each of its Subsidiaries have timely filed, or had timely filed on their behalf (taking into account any extension of time within which to file), all Tax Returns required to be filed by any of them with the appropriate Governmental Authority in all jurisdictions in which Tax Returns are required to be filed. All such filed Tax Returns (taking into account all amendments thereto) are true, correct and complete, and all Taxes owed by the Company and each of its Subsidiaries that are due (whether or not shown as due on any Tax Return) and payable have been timely paid or have been adequately reserved against in accordance with GAAP and Applicable SAP. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The Company and each of its Subsidiaries have complied in all respects with all applicable Laws relating to the withholding of Taxes and have duly withheld and paid over to the appropriate Governmental Authority all Taxes required to be so withheld and paid over. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) There are no Liens for Taxes on any of the assets of the Company or any of its Subsidiaries other than Permitted Liens. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) As of the date of this Agreement, the Company has not received written notice of any pending or threatened audits, examinations, investigations, claims, actions, suits or other proceedings in respect of any Taxes of the Company or any of its Subsidiaries. No deficiency for any Tax has been asserted or assessed by any Governmental Authority in writing against the Company or any of its Subsidiaries, except for deficiencies that have been satisfied by payment in full, settled or withdrawn, or that have been adequately reserved for in accordance with GAAP and Applicable SAP. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Neither the Company nor any of its Subsidiaries has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to an assessment or deficiency for Taxes, which waiver or agreement, as applicable, remains in effect (other than pursuant to extensions of time to file Tax Returns obtained in the ordinary course of business). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) Neither the Company nor any of its Subsidiaries has entered into a closing agreement or other similar agreement with a Governmental Authority relating to Taxes of the Company or any of its Subsidiaries nor has been issued any private letter ruling, technical advice memorandum or similar agreement or ruling by any taxing authority, in each case which could affect the Company&#8217;s or any of its Subsidiaries&#8217; liability for Taxes after the Closing. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) Neither the Company nor any of its Subsidiaries has received written notice from any Governmental Authority in a jurisdiction in which the Company or any of its Subsidiaries does not file a particular Tax Return that the Company or any of its Subsidiaries is or may be subject to particular Tax by or required to file or be included in a particular Tax Return in that jurisdiction that has not been resolved. Neither the Company nor any of its Subsidiaries is or has been treated as being resident for Tax purposes in a country other than the country in which it is organized and neither the Company nor any of its Subsidiaries has or has had any branch, agency, or permanent establishment, as defined in any applicable Tax treaty or convention, or otherwise has or has had an office or fixed place of business in a country, other than the country in which it is organized, in each case whether for domestic law purposes or pursuant to the application of any applicable Tax Treaty or convention (and no Governmental Authority has ever sought to assert the same). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) Neither the Company nor any of its Subsidiaries has any liability for Taxes of another Person (other than the Company or any of its current or former Subsidiaries) under U.S. Treasury Regulations Section&#160;1.1502-6 (or any similar provision of applicable Law), as a transferee or successor or by Contract (other than any ordinary course Contract that does not relate principally to Taxes). Neither the Company nor any of its Subsidiaries has been a member of an affiliated, consolidated, combined, unitary, or similar Tax group, other than such a group of which it is presently a member. None of the Company or any of its Subsidiaries is a party to, or is bound by, any Tax sharing, allocation, or indemnification Contract or arrangement that remains in effect (other than a Contract or arrangement exclusively between or among the Company and one or more of Subsidiaries or customary gross-up or indemnity provisions in any credit agreement, employment agreement or similar commercial Contract, the primary purpose of which does not relate to Taxes). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) Neither the Company nor any of its Subsidiaries has been a &#8220;controlled corporation&#8221; or a &#8220;distributing corporation&#8221; in any distribution occurring during the two-year period ending on the date of this Agreement that was purported or intended to be governed by Section&#160;355 of the Code (or any similar provision of applicable Tax Law). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j) Neither the Company nor any of its Subsidiaries has participated in any &#8220;listed transaction&#8221; within the meaning of U.S. Treasury Regulation Section&#160;1.6011-4(b)(2). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k) Neither the Company nor any of its Subsidiaries is required to include any amount in income, or exclude any item of deduction, after the Closing Date as a result of any (i)&#160;adjustment pursuant to Section&#160;481(a) of the Code with respect to a change in accounting method that occurred before the Closing Date, (ii)&#160;installment sale or open transaction disposition made on or before the Closing Date, (iii)&#160;prepaid amount received outside the ordinary course of business before the Closing Date, (iv)&#160;election under Section&#160;108(i) of the Code. Neither the Company nor any of its Subsidiaries have made an election under Section&#160;965(h) of the Code. Section&#160;4.09(k) of the Company Disclosure Letter sets forth a schedule of amounts the Company or a Subsidiary will be required to include in income after the Closing Date under Section&#160;13517(c) of the Tax Cuts and Jobs Act, Public Law No&#58; 115-97. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l) All transactions or arrangements involving the Company and&#47;or any Subsidiary and any related person (including any transactions or arrangements between the Company and any Subsidiary) have been undertaken on arm&#8217;s length terms, and the Company and each Subsidiary has in its possession or under its control evidence and records sufficient to demonstrate (to the extent required by law) that all transactions or arrangements entered into by the Company and each Subsidiary with any person connected for Tax purposes were entered into or are on arm&#8217;s length terms. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Section 4.10(a) of the Company Disclosure Letter sets forth a list, as of the date of this Agreement, of each material Company Plan. With respect to each material Company Plan, the Company has made available to Parent copies (to the extent applicable) of (i)&#160;the plan document, including any amendments thereto, other than any document that the Company or any of its Subsidiaries is prohibited from making available to Parent as the result of applicable Law relating to the safeguarding of data privacy, (ii)&#160;the most recent summary plan description for each material Company Plan for which such summary plan description is required by applicable Law and all summaries of material modifications thereto, (iii)&#160;each trust, insurance or group annuity contract or other funding vehicle, (iv)&#160;the three most recent annual reports on Form 5500 and all schedules and attachments thereto (if any), (v) the most recent IRS opinion or determination letter and (vi)&#160;all non-routine correspondence received from or provided to the Department of Labor, the Pension Benefit Guaranty Corporation, the IRS or any other Governmental Authority, in each case, during the three (3)&#160;year period ending on the Closing Date. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Except as would not constitute a Material Adverse Effect, (A)&#160;each Company Plan (including any related trust) has been established, operated and administered in material compliance with its terms and applicable Laws and (B)&#160;there are no existing circumstances or any events that have occurred (or failed to occur) that would reasonably be likely to result in any default under or violation of any Company Plan. Each Company Pension Plan that is intended to be &#8220;qualified&#8221; within the meaning of Section&#160;401(a) of the Code is so qualified, has received a currently effective favorable determination letter from the IRS or is entitled to rely upon a favorable opinion issued by the IRS, and to the Knowledge of the Company, no circumstances or any events have occurred that would reasonably be likely to cause the loss of any such qualification status of any such Company Pension Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) None of the Company, any of its Subsidiaries or any of their respective ERISA Affiliates maintains or contributes to or has any liability with respect to any plan subject to Title IV or Section&#160;302 of ERISA or Section&#160;412 of the Code, including any &#8220;single employer&#8221; defined benefit plan, any &#8220;multiemployer plan&#8221; (each, as defined in Section&#160;4001 of ERISA) or any &#8220;multiple employer plan&#8221; (as defined in Section&#160;413 of the Code). None of the Company or any of its Subsidiaries maintains or contributes to or has any material liability with respect to any &#8220;multiple employer welfare arrangement&#8221; (as defined in Section&#160;3(40) of ERISA). During the last six (6)&#160;years, no material liability under (A)&#160;Title IV or Section&#160;302 of ERISA or Sections 412 and 4971 of the Code or (B)&#160;Section&#160;4980B of the Code, Part 6 of Subtitle B of Title I of ERISA or any similar state or local Law (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as a result of a failure to comply with the continuation coverage requirements of such Laws, has, in either case, been incurred by the Company, any of its Subsidiaries or any of their respective ERISA Affiliates that has not been satisfied in full, and no condition exists that presents a material risk to the Company, any of its Subsidiaries or any ERISA Affiliate of incurring any such liability. There has been no prohibited transaction (within the meaning of Section&#160;406 of ERISA or Section&#160;4975 of the Code) with respect to any Company Plan which would reasonably be expected to result in material liability to the Company or any of its Subsidiaries. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) No Company Plan nor the Company or any of its Subsidiaries provides, or has an obligation to provide, health, medical, dental, life insurance or welfare benefits following retirement or other termination of employment to any current or former employee or other service provider or any of their respective dependents, in each case, except as required under COBRA. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) There are no pending or, to the Knowledge of the Company, threatened material claims, suits, investigations, audits involving any Company Plan (other than routine claims for benefits). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) None of the execution and delivery of this Agreement, shareholder or other approval of the Transactions nor the consummation of the Transactions, will, either alone or in combination with another event, (i)&#160;trigger any payment, benefit or funding (through a grantor trust or otherwise), accelerate the time of payment or vesting, or increase the amount of compensation or benefits due or payable to any current or former director, officer, employee or other individual service provider of the Company or any of its Subsidiaries (whether by virtue of any termination, severance, change of control or similar benefit or otherwise), (ii) cause the Company to transfer or set aside any assets to fund any benefits under any Company Plan or (iii)&#160;limit or restrict the right to amend, terminate or transfer the assets of any Company Plan on or following the Effective Time. The consummation of the Transactions (either alone or in combination with another event) will not result in any payments (or acceleration of vesting) or benefits constituting an &#8220;excess parachute payment&#8221; within the meaning of Section&#160;280G of the Code. The Company and its Subsidiaries are not a party to, and are not otherwise obligated under, any contract, agreement, plan or arrangement that provides for the gross-up of a Tax, interest or penalties imposed by Section&#160;409A, 457A or 4999 of the Code (or any corresponding or similar provision of state, local or non-U.S. Law). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) (i) Each Company Plan that is or forms part of a &#8220;nonqualified deferred compensation plan&#8221; within the meaning of Section&#160;409A is in material documentary compliance with the requirements of Section&#160;409A, and the Company and its Subsidiaries have complied, in all material respects, in practice and operation with all applicable requirements of Section&#160;409A and (ii)&#160;neither the Company nor its Subsidiaries have maintained, sponsored, been a party to, participated in, or contributed to any plan, agreement or arrangement subject to the provisions of Section&#160;457A of the Code. As of the date of this Agreement, the Company&#8217;s federal income tax return is not under examination by the IRS with respect to nonqualified deferred compensation. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) Except as would not constitute a Material Adverse Effect, each Company Plan that primarily covers current or former directors, officers or employees of the Company or any of its Subsidiaries based outside of the United States and&#47;or that is subject to any Law other than United States federal, state or local Law (i)&#160;that is intended to qualify for special Tax treatment meets all requirements for such treatment, (ii)&#160;if required to be book reserved, funded or insured, is so reserved, funded or insured in compliance with applicable Laws and (iii)&#160;if required to be registered or approved by a non-U.S. Governmental Authority, has been registered or approved and has been maintained in good standing with the applicable regulatory authorities, and, to the Knowledge of the Company, there are no existing circumstances or any events that have occurred since the date of the most recent approval or application therefor relating to any such plan that would reasonably be likely to adversely affect any such approval or good standing. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Labor Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Section 4.11(a) of the Company Disclosure Letter sets forth the following information for each Company Employee&#58; (i)&#160;name (or ID number, with name to be provided at Closing)&#59; (ii) current job title&#59; (iii)&#160;exempt&#47;non-exempt status for U.S. wage and hour purposes if work location is the United States&#59; (iv)&#160;date of hire (and, if different from date of hire, service date)&#59; (v) work location&#59; (vi)&#160;employing entity&#59; (vii)&#160;annual base rate of compensation&#59; (viii) 2018 target for any bonus or incentive compensation&#59; (ix)&#160;if the employee is currently on leave, the nature of the leave and anticipated return date, if known&#59; (x)&#160;if the employee is a union employee, identity of his or her collective bargaining representative&#59; and (xi)&#160;if the employee is not a U.S. citizen, visa or work permit status if work location is the United States. Except as would not reasonably be expected to result in material liability to the Company or any of its Subsidiaries, all Company Employees are legally authorized to work in the country where they are located or assigned and, except as set forth in Section&#160;4.11(a) of the Company Disclosure Letter, all Senior Employees that are resident in the United States are &#8220;employees at will,&#8221; and their employment may be terminated at any time, without notice and without penalty. Section&#160;4.11(a) of the Company Disclosure Letter shall be updated and delivered to Parent no later than the Closing Date and no earlier than two (2)&#160;business days prior to the Closing Date. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Neither the Company nor any of its Subsidiaries is a party to, or bound by, any collective bargaining agreement or other agreement with a labor union, labor organization, trades council, works council or similar organization. Since June&#160;30, 2015, (i) to the Knowledge of the Company there have been no activities or proceedings of any labor organization to organize any employees of the Company or any of its Subsidiaries and no demand for recognition or certification as the exclusive bargaining representative of any employees has been made by or on behalf of any labor or similar organization, and (ii)&#160;there have been no pending or, to the Knowledge of the Company, threatened strikes, lockouts, slowdowns, work stoppages, or other labor disputes, by or with respect to the employees of the Company or any of its Subsidiaries. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Since June&#160;30, 2015, (i) the Company and its Subsidiaries have been in compliance in all material respects with all applicable Laws respecting labor, employment, discrimination in employment, terms and conditions of employment, payroll, worker classification (including the proper classification of workers as contingent workers, independent contractors and consultants, and also as exempt or nonexempt for purposes of the Fair Labor Standards Act), wages, mandatory social security schemes, hours and occupational safety and health, immigration, terms and conditions of employment and employment practices, and (ii)&#160;there is and has been no material charge or complaint of discrimination in employment or employment practices, including with respect to age, gender, race, religion or other legally protected category, or any other Action concerning employment-related matters, pending or, to the Knowledge of the Company, threatened in court or before the United States Equal Employment Opportunity Commission, the United States Department of Labor, OSHA, or any other Governmental Authority responsible for the prevention of unlawful employment practices in any jurisdiction in which the Company or any Subsidiary has employed or currently employs any person. Neither the Company nor any of its Subsidiaries has taken any action during the past three (3)&#160;years that has resulted in any unsatisfied material liability under the Worker Adjustment and Retraining Notification Act of 1988 and any other similar applicable foreign, state, or local statutes or regulations of any jurisdiction relating to any plant closing or mass layoff or similar triggering event. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company has made available to Parent a list of all bonds, stocks, mortgage loans, and other investments that were carried on the books and records of the Company and its Subsidiaries as of December&#160;31, 2017, other than in respect of any Company Pension Plan (such bonds, stocks, mortgage loans and other investments, together with all bonds, stocks, mortgage loans and other investments acquired by the Company and its Subsidiaries between such date and the date of this Agreement, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Except for Investment Assets that matured or were sold, redeemed or otherwise disposed of after December&#160;31, 2017, each of the Company and its Subsidiaries, as applicable, has good and marketable title to all of the Investment Assets it purports to own, free and clear of all Liens, except Permitted Liens. The Company has made available to Parent a copy, as of the date of this Agreement, of the Company&#8217;s policies with respect to the investment of the Investment Assets (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and the composition of the Investment Assets complies in all material respects with the Investment Guidelines. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) To the Knowledge of the Company, as of the date hereof, none of the Investment Assets are subject, save pursuant to Permitted Liens, to any capital calls or similar liabilities, or any restrictions or suspensions on redemptions, &#8220;lock-ups&#8221;, &#8220;gates&#8221;, &#8220;side pockets&#8221;, stepped-up fee provisions, or other penalties or restrictions relating to withdrawals or redemptions, except as would not constitute a Material Adverse Effect. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Except as would not constitute a Material Adverse Effect, (i)&#160;neither the Company nor any of its Subsidiaries has any funding obligations of any kind, or obligation to make any additional advances or investments (including any obligation relating to any currency or interest rate swap, hedge or similar arrangement), in respect of any of the Investment Assets and (ii)&#160;there are no outstanding commitments, options, put agreements, or other arrangements relating to the Investment Assets to which the Company or any of its Subsidiaries may be subject upon or after the Closing. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.13 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Section 4.13(a) of the Company Disclosure Letter sets forth a true and complete list, as of the date hereof, of all patents and patent applications, trademark registrations and applications, copyright registrations and applications and domain name registrations, in each case which are owned by the Company or a Subsidiary of the Company as of the date hereof. Except as would not constitute a Material Adverse Effect, (i)&#160;the Company and its Subsidiaries have sufficient rights to use all Intellectual Property used in the conduct of the business of the Company and its Subsidiaries as currently conducted, (ii)&#160;the Company and its Subsidiaries are the exclusive owners of the Owned Intellectual Property, free and clear of any Liens, other than Permitted Liens, (iii)&#160;any registrations or pending applications for Owned Intellectual Property are subsisting, (iv)&#160;the Owned Intellectual Property is valid and enforceable, and (v)&#160;the Company and each of its Subsidiaries have taken commercially reasonable measures to maintain the secrecy of all Trade Secrets used in the businesses of the Company and its Subsidiaries. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Except as would not constitute a Material Adverse Effect, no claims are pending or, to the Knowledge of the Company, threatened in writing (i)&#160;challenging the ownership, enforceability, scope, validity, or use by the Company or any of its Subsidiaries of any Owned Intellectual Property or (ii)&#160;alleging that the Company or any of its Subsidiaries is violating, misappropriating, or infringing the Intellectual Property rights of any Person. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Except as would not constitute a Material Adverse Effect, to the Knowledge of the Company, (i)&#160;no Person is misappropriating, violating, or infringing the rights of the Company or any of its Subsidiaries with respect to any Owned Intellectual Property and (ii)&#160;the operation of the business of the Company and its Subsidiaries as currently conducted does not violate, misappropriate, or infringe the Intellectual Property rights of any other Person. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Except as would not constitute a Material Adverse Effect, (i)&#160;neither the Company nor any of its Subsidiaries uses or distributes, or has used or distributed, any Software licensed, provided, or distributed under any open source license, including any license meeting the Open Source Definition (as promulgated by the Open Source Initiative) or the Free Software Definition (as promulgated by the Free Software Foundation) or any Software that contains or is derived from any such Software (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Open Source Software</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in any manner that would require any source code of the Software included in Owned Intellectual Property to be disclosed, licensed for free, publicly distributed, attributed to any person, or dedicated to the public and (ii)&#160;the Company and its Subsidiaries are in compliance with all terms and conditions of all relevant licenses (including all requirements relating to notices and making source code available to third parties) for all Open Source Software used in their businesses. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.14 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Anti-Takeover Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No &#8220;fair price&#8221;, &#8220;moratorium&#8221;, &#8220;control share acquisition&#8221;, or other similar anti-takeover statute or similar statute or regulation applies to the Company with respect to this Agreement or the Merger. The Company is not party to a shareholder rights plan, &#8220;poison pill&#8221; or similar anti-takeover arrangement or plan. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.15 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Real Property&#59; Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Section&#160;4.15 of the Company Disclosure Letter sets forth a true and complete list, as of the date hereof, of each Company Lease. Except as would not constitute a Material Adverse Effect, (a)&#160;the Company or one of its Subsidiaries has a good and valid leasehold interest in each Company Lease, free and clear of all Liens (other than Permitted Liens), and (b)&#160;none of the Company or any of its Subsidiaries has received written notice of any default under any Company Lease. Except for the Company Leases set forth in Section&#160;4.15 of the Company Disclosure Letter and the Investment Assets held in the ordinary course of business, neither the Company nor any of its Subsidiaries owns or holds any interest in any real property. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.16 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contracts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Except for this Agreement and each Contract filed as an exhibit to the Filed SEC Documents, Section&#160;4.16(a) of the Company Disclosure Letter sets forth a list, as of the date of this Agreement, of all Material Contracts. For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Material Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all Contracts to which the Company or any of its Subsidiaries is a party or by which the Company, any of its Subsidiaries, or any of their respective properties or assets is bound (other than Company Plans and insurance, reinsurance, or retrocession treaties or agreements, slips, binders, cover notes, or other similar arrangements) that&#58; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) are or would be required to be filed by the Company as a &#8220;material contract&#8221; pursuant to Item 601(b)(10) of Regulation S-K under the Securities Act&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) relate to the formation or management of any joint venture, partnership, or other similar agreement that is material to the business of the Company and its Subsidiaries, taken as a whole&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) provide for Indebtedness of the Company or any of its Subsidiaries having an outstanding or committed amount equal to or in excess of $10,000,000, other than any Indebtedness between or among any of the Company and any of its Subsidiaries&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) are any keepwell or similar agreement under which the Company or any of its Subsidiaries has directly guaranteed any liabilities or obligations of another Person or under which another Person has directly guaranteed any liabilities or obligations of the Company or any of its Subsidiaries, in each case involving liabilities or obligations in excess of $10,000,000 (other than any contracts under which the Company or a Subsidiary has guaranteed the liabilities or obligations of a wholly owned Subsidiary of the Company)&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) have been entered into since January&#160;1, 2017, and involve the acquisition from another Person or disposition to another Person of capital stock or other equity interests of another Person or of a business, in each case, for aggregate consideration under such Contract in excess of $10,000,000 (excluding, for the avoidance of doubt, acquisitions or dispositions of investments made pursuant to the Investment Guidelines, or of supplies, products, properties, or other assets in the ordinary course of business or of supplies, products, properties, or other assets that are obsolete, worn out, surplus, or no longer used or useful in the conduct of business of the Company or any of its Subsidiaries)&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) prohibit the payment of dividends or distributions in respect of the shares or capital stock of the Company or any of its Subsidiaries, prohibit the pledging of the shares or capital stock of the Company or any Subsidiary of the Company or prohibit the issuance of any guarantee by the Company or any Subsidiary of the Company&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii) restrict or grant rights to use or practice rights under material Intellectual Property, including agreements providing for the creation or development of material Intellectual Property or access and use of hosted Software and licenses to use or practice material Intellectual Property granted by (x)&#160;the Company or any of its Subsidiaries to a third Person or (y)&#160;a third Person to the Company or any of its Subsidiaries, in each case, for aggregate annual or one-time fees in excess of $2,000,000, other than commercially available &#8220;off-the-shelf&#8221; software licenses under which software is licensed to the Company or any of its Subsidiaries&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii) involve or could reasonably be expected to involve aggregate payments or receipts by or to it and&#47;or its Subsidiaries in excess of $10,000,000 in any twelve month period, other (x)&#160;than those terminable on less than ninety (90)&#160;days&#8217; notice without payment by the Company or any Subsidiary of the Company of any material penalty, (y)&#160;any Company Lease, or (z)&#160;any Contract with financial advisors, investment bankers, attorneys, accountants, consultants, or other advisors in connection with the Transactions&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix) would reasonably be expected to, individually or in the aggregate, prevent, materially delay, or materially impede the Company&#8217;s ability to consummate the Transactions or Parent&#8217;s ability to own and&#47;or conduct the business of the Company or any of its Subsidiaries after the Effective Time&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x) contain provisions that prohibit the Company or any of its Affiliates from competing in any material line of business or grant a right of exclusivity to any Person that prevents the Company or any Affiliate of the Company from entering any material territory, market, or field or freely engaging in business anywhere in the world, other than Contracts that can be terminated (including such restrictive provisions) by the Company or any of its Subsidiaries on less than ninety (90)&#160;days&#8217; notice without payment by the Company or any Subsidiary of the Company of any material penalty&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xi) involve the retention of any independent contractor, consultant, or agency for the provision of services to the Company with annualized fees in excess of $300,000&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xii) constitute collective bargaining agreements&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiii) involve the provision of material third-party administration or other policy or claims administration services with respect to any Insurance Contracts, or investment management services to the Company or any of its Subsidiaries&#59; or </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiv) provide for the outsourcing of any material function or part of the business of the Company or any of its Subsidiaries that is necessary for the conduct of the business of the Company and its Subsidiaries as currently conducted, other than managing agency agreements or managing general underwriting agreements. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) As of the date of this Agreement, (i)&#160;each Material Contract is valid and binding on the Company or any of its Subsidiaries, to the extent such Person is a party thereto, as applicable, and, to the Knowledge of the Company, each other party thereto, and is in full force and effect, except where the failure to be valid, binding, or in full force and effect would not constitute a Material Adverse Effect, (ii)&#160;the Company and each of its Subsidiaries, and, to the Knowledge of the Company, any other party thereto, has performed all obligations required to be performed by it under each Material Contract, except where such noncompliance would not constitute a Material Adverse Effect, (iii)&#160;neither the Company nor any of its Subsidiaries has received notice of the existence of any event or condition that constitutes, or, after notice or lapse of time or both, will constitute, a default on the part of the Company or any of its Subsidiaries under any Material Contract, except where such default would not constitute a Material Adverse Effect, and (iv)&#160;there are no events or conditions that constitute, or, after notice or lapse of time or both, will constitute a default on the part of any counterparty under such Material Contract, except as would not constitute a Material Adverse Effect. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.17 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Subsidiaries&#59; Insurance Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Except as would not constitute a Material Adverse Effect&#58; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) Each Company Insurance Subsidiary is (A)&#160;duly licensed or authorized as an insurance company and&#47;or, where applicable, reinsurance company, Lloyd&#8217;s corporate member, or Lloyd&#8217;s managing agent in its jurisdiction of incorporation or organization and (B)&#160;duly licensed, authorized, or otherwise eligible to transact the business of insurance or reinsurance or participate in Lloyd&#8217;s, as applicable, in each other jurisdiction where it is required to be so licensed, authorized, or otherwise eligible in order to conduct its business as currently conducted. No Company Insurance Subsidiary is or would be considered by any Governmental Authority to be commercially domiciled in any jurisdiction. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) Since January&#160;1, 2017, each Subsidiary of the Company that participates in Lloyd&#8217;s (A)&#160;has not participated as a member of any Lloyd&#8217;s syndicate, other than Syndicate 4711, (B) has not agreed to sell or transfer any of its rights to participate as a member of a Lloyd&#8217;s syndicate or offered to acquire rights to participate in any Lloyd&#8217;s syndicate, and (C)&#160;has complied with the franchise standards (including principles and minimum standards) issued by Lloyd&#8217;s and any and all undertakings given to Lloyd&#8217;s in respect of its participation. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) No Person is, or has the right to participate as, a member of Syndicate 4711, other than a Subsidiary of the Company. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) Since January&#160;1, 2017, (A) all funds held on behalf of Lloyd&#8217;s Syndicate 4711 have been held in accordance with all applicable fiduciary obligations and with the terms of the relevant premiums trust deed or other deposit arrangement, as required by the bye-laws, regulations, codes of practice, and mandatory directions and requirements governing the conduct and management of underwriting business at Lloyd&#8217;s from time to time (whether by the Council, the Franchise Board or otherwise) and the provisions of any deed, agreement, or undertaking executed, made, or given for compliance with Lloyd&#8217;s requirements from time to time (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lloyd&#8217;s Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and (B)&#160;the Company or any of its Subsidiaries required to do so have complied in all material respects with all relevant regulations, directions, notices, and requirements in relation to the maintenance of Funds at Lloyd&#8217;s (as defined in the Lloyd&#8217;s Membership Byelaw (No. 5 of 2005)) in accordance with Lloyd&#8217;s Regulations and any directions imposed on the Company or any of its Subsidiaries by Lloyd&#8217;s and such Funds at Lloyd&#8217;s remain at the level required by Lloyd&#8217;s for the continued underwriting by Lloyd&#8217;s Syndicate 4711 in accordance with the current syndicate business plan for Lloyd&#8217;s Syndicate 4711. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) each Subsidiary of the Company that is a Lloyd&#8217;s managing agent has (A)&#160;only entered into or become party by novation or otherwise to any underwriting agency agreement with a member of Lloyd&#8217;s in the form of the managing agent&#8217;s agreement in the form prescribed by Lloyd&#8217;s and only where such member of Lloyd&#8217;s is also a Subsidiary of the Company&#59; and (B)&#160;only managed Lloyd&#8217;s Syndicate 4711. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) All Funds at Lloyd&#8217;s provided for or on behalf of each Subsidiary of the Company that participates in Lloyd&#8217;s has been provided by a Subsidiary of the Company or by way of a banking facility entered into by a Subsidiary of the Company. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii) The only Years of Account of Lloyd&#8217;s Syndicate 4711 that remain open Years of Account are the 2016, 2017 and 2018 Years of Account. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) All Company Insurance Contracts and any and all marketing materials related thereto are, to the extent required under applicable Insurance Laws, on forms and at rates approved by the applicable insurance regulatory authority or, to the extent required by applicable Insurance Laws, have been filed with and not objected to by such authority within the period provided for objection, except as would not constitute a Material Adverse Effect. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Except as would not constitute a Material Adverse Effect, since December&#160;31, 2015, to the Knowledge of the Company, (i)&#160;each Producer, at the time such Producer sold or produced any Insurance Contract, was duly and appropriately appointed by a Company Insurance Subsidiary, in compliance with applicable Law, to act as a Producer for a Company Insurance Subsidiary and was duly and appropriately licensed as a Producer (for the type of business sold or produced by such Producer on behalf of a Company Insurance Subsidiary), in each jurisdiction in which such Producer was required to be so licensed, and no such Producer violated any term or provision of applicable Law relating to the sale or production of any Insurance Contract, (ii)&#160;no Producer has breached the terms of any agency or broker contract with a Company Insurance Subsidiary or violated any Law or policy of a Company Insurance Subsidiary in the solicitation, negotiation, writing, sale, or production of business for any Company Insurance Subsidiary, (iii)&#160;no Producer has been enjoined, indicted, convicted, or made the subject of any consent decree or judgment on account of any violation of applicable Law in connection with such Producer&#8217;s actions in his, her or its capacity as a Producer for a Company Insurance Subsidiary or any enforcement or disciplinary proceeding alleging any such violation and (iv)&#160;neither the Company nor any Subsidiary of the Company has received any written notice from any Governmental Authority that any Producer is under investigation for any of the matters described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as set forth in Section&#160;4.17(c) of the Company Disclosure Letter, as of the date hereof, there are no outstanding (x)&#160;disputes with Producers concerning material amounts of commissions or other incentive compensation, (y)&#160;to the Company&#8217;s Knowledge, material errors and omissions claims against any Producer in regard to any Insurance Contract, or (z)&#160;material amounts owed by any Producer to the Company or any of its Subsidiaries. The manner in which the Company and each of its Subsidiaries compensates Producers involved in the sale or servicing of Insurance Contracts is in compliance with applicable Law in all material respects and the terms of any applicable agreement with such Producers in all material respects. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Section 4.17(d) of the Company Disclosure Letter contains a list of programs and delegated authorities under which any Producer has binding underwriting authority on behalf of any Company Insurance Subsidiary. The Company and the Company Insurance Subsidiaries, and, to the Company&#8217;s Knowledge, all MGAs, are in compliance with all Insurance Laws relating to managing general agents and fronting. All Contracts between the Company or any Company Insurance Subsidiary, on the one hand, and any Producer, on the other hand (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MGA Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), under which the Producer has binding underwriting authority on behalf of any Company Insurance Subsidiary (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MGA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) are in compliance in all material respects with applicable Insurance Laws and reflect the current underwriting authority of each such Producer. Since December&#160;31, 2017, (i) to the Knowledge of the Company, no Producer with binding underwriting authority on behalf of any Company Insurance Subsidiary has issued any Insurance Contract in contravention of such Producer&#8217;s underwriting authority and (ii)&#160;neither the Company nor any Company Insurance Subsidiary has temporarily or permanently suspended the underwriting authority of any such Producer. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Since December&#160;31, 2015, all claims made by any Person under any Insurance Contract issued by any Company Insurance Subsidiary have in all material respects been paid (or provision for payment thereof has been made) or are being assessed in accordance with the terms of such Insurance Contract and the Laws under which they arose, and such payments were paid (or any such payments now owing shall be paid) without fines or penalties, except for any such claims made for which the applicable Company Insurance Subsidiary is in the process of assessing such claim in accordance with the terms of such Insurance Contract or reasonably believes or believed that there is a reasonable basis to contest payment and is taking such action. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) The Insurance Contracts have been marketed, sold and issued in material compliance with all applicable Laws. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.18 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Statutory Statements&#59; Examinations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Except for any failure to file or submit the same that has been cured or resolved to the satisfaction of the applicable Insurance Regulator, since January&#160;1, 2017, each of the Company Insurance Subsidiaries has filed or submitted all material annual and quarterly statutory financial statements, together with all exhibits, interrogatories, notes, schedules, actuarial opinions, affirmations, and certifications, in each case, required by applicable Insurance Law to be filed with or submitted to the appropriate Insurance Regulator of each jurisdiction in which it is licensed, authorized, or otherwise eligible with respect to the conduct of the business of insurance or reinsurance, as applicable (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Statutory Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The Company has made available to Parent, to the extent permitted by applicable Law and to the extent required to be filed with the applicable Insurance Regulator on or prior to the date of this Agreement, copies of all material Company Statutory Statements of each of the Material Insurance Subsidiaries as of December&#160;31, 2016 and December&#160;31, 2017, and for the annual periods then ended, each in the form filed with the applicable Insurance Regulator. The financial statements included in the Company Statutory Statements of the Company Insurance Subsidiaries as of December&#160;31, 2016 and December&#160;31, 2017, and for the annual periods then ended, were prepared in accordance with Applicable SAP applied on a consistent basis for the applicable period, except as may have been noted therein, during the periods involved, and fairly present in all material respects, the statutory financial position of the relevant Company Insurance Subsidiary as of the respective dates thereof and the results of operations and changes in capital and surplus and cash flow (or shareholders&#8217; equity, as applicable) of such Company Insurance Subsidiary for the respective periods then ended. Such Company Statutory Statements complied in all material respects with all applicable Insurance Laws when filed or submitted and no material violation or deficiency has been asserted in writing by any Insurance Regulator with respect to any of such Company Statutory Statements that has not been cured or otherwise resolved to the satisfaction of such Insurance Regulator. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Company has made available to Parent, to the extent permitted by applicable Law, copies of all material examination reports (and has notified Parent of any pending material examinations) of any Insurance Regulators received by it on or after January&#160;1, 2017, through the date of this Agreement, relating to the Material Insurance Subsidiaries. All material deficiencies or violations noted in any material examination reports received since January&#160;1, 2017 through the date of this Agreement by any of the Company Insurance Subsidiaries have been substantially cured or resolved to the satisfaction of the applicable Insurance Regulator. Without limiting the generality of the foregoing, as of the date of this Agreement, there are no unpaid claims or assessments made in writing or, to the Knowledge of the Company, as of the date of this Agreement, threatened against the Company or any of its Subsidiaries by any insurance guaranty associations or similar organizations in connection with such association&#8217;s or other organization&#8217;s insurance guaranty fund, other than unpaid claims or assessments (i)&#160;disclosed, provided for, reflected in, reserved against, or otherwise described in the Company Statutory Statements provided or made available to Parent, or (ii)&#160;that are not material to the Company and its Subsidiaries, taken together as a whole. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Since January&#160;1, 2017 through the date of this Agreement, no material fine or penalty has been imposed on any Company Insurance Subsidiary by any Insurance Regulator. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Since January&#160;1, 2017 through the date of this Agreement, each of the Company&#8217;s Subsidiaries that are a Lloyd&#8217;s managing agent has prepared audited accounts for each syndicate managed by it for all applicable years ended December&#160;31 in all material respects in accordance with the requirements of the Insurance Accounts Directive (Lloyd&#8217;s Syndicate and Aggregate Accounts) Regulations 2008 and the Syndicate Accounting Byelaw (No. 8 of 2005) and such accounts give a true and fair view of such syndicate&#8217;s affairs as at 31&#160;December for the applicable year. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.19 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreements with Insurance Regulators</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a)&#160;Except as required by applicable Insurance Laws and the insurance and reinsurance Permits maintained by the Company Insurance Subsidiaries, there is no (x)&#160;written agreement, memorandum of understanding, commitment letter, or similar undertaking with any Insurance Regulator that is binding on the Company or any Company Insurance Subsidiary or (y)&#160;order or directive by, or supervisory letter (other than those provided on an industry or sector wide basis) or cease-and-desist order from, any Insurance Regulator that is binding on the Company or any Company Insurance Subsidiary and (b)&#160;neither the Company nor any of the Company Insurance Subsidiaries have adopted any board resolution at the request of any Insurance Regulator, in the case of each of clauses (a)&#160;and (b), that (i)&#160;limits in any material respect the ability of any Company Insurance Subsidiary to issue or enter into any reinsurance or retrocession treaties or agreements, slips, binders, cover notes, or other similar arrangements, (ii)&#160;requires the divestiture of any material investment of any Company Insurance Subsidiary, (iii)&#160;limits in any material respect the ability of any Company Insurance Subsidiary to pay dividends, or (iv)&#160;requires any material investment of any Company Insurance Subsidiary to be treated as a non-admitted asset (or the local equivalent). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.20 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance, Reinsurance and Retrocession</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of the date of this Agreement, (a)&#160;each Ceded Reinsurance Contract is valid and binding on the Company and each Company Insurance Subsidiary to the extent party thereto, as applicable, and, to the Knowledge of the Company, each other party thereto, and is in full force and effect, except where the failure to be valid, binding, or in full force and effect would not constitute a Material Adverse Effect, (b)&#160;the Company Insurance Subsidiary party thereto and, to the Knowledge of the Company, any other party thereto has performed all obligations required to be performed by it under each Ceded Reinsurance Contract, except where such noncompliance would not constitute a Material Adverse Effect, (c)&#160;none of the Company or any Company Insurance Subsidiary party thereto has received notice of the existence of any event or condition that constitutes, or, after notice or lapse of time or both, will constitute, a default on the part of the Company or any such Company Insurance Subsidiary under any Ceded Reinsurance Contract, except where such default would not constitute a Material Adverse Effect, (d)&#160;to the Knowledge of the Company, there are no events or conditions that constitute, or, after notice or lapse of time or both, will constitute, a default on the part of any counterparty under any Ceded Reinsurance Contract, except as would not constitute a Material Adverse Effect, (e)&#160;none of the Company Insurance Subsidiaries and, to the Knowledge of the Company, no party to a Ceded Reinsurance Contract is insolvent or the subject of a rehabilitation, liquidation, conservatorship, receivership, bankruptcy, or similar proceeding, and (f)&#160;there are no disputes under any Ceded Reinsurance Contract, except as would not constitute a Material Adverse Effect. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.21 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reserves</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The insurance policy reserves for claims, losses (including incurred but not reported losses), loss adjustment expenses (whether allocated or unallocated), and unearned premiums of each Company Insurance Subsidiary contained in its Company Statutory Statements (a)&#160;were, except as otherwise noted in the applicable Company Statutory Statement, determined in all material respects in accordance with generally accepted actuarial standards and (b)&#160;satisfied the requirements of all applicable Insurance Laws in all material respects. Notwithstanding anything to the contrary in this Agreement or any other agreement, document, or instrument delivered or to be delivered in connection herewith, each of Parent and Merger Sub acknowledges and agrees that the Company and its Subsidiaries make no representation or warranty with respect to, and nothing contained in this Agreement or in any other agreement, document, or instrument to be delivered in connection herewith is intended or shall be construed to be a representation or warranty, express or implied, for any purposes of this Agreement or any other agreement, document, or instrument to be delivered in connection herewith or therewith, in respect of the adequacy or sufficiency of reserves or the effect of the adequacy or sufficiency of reserves on any line item, asset, liability or equity amount on any financial or other document. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.22 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as would not constitute a Material Adverse Effect, (a)&#160;all insurance policies maintained by the Company and its Subsidiaries of which the Company or any of its Subsidiaries is the beneficiary are in full force and effect and all premiums due and payable thereon have been paid and (b)&#160;neither the Company nor any of its Subsidiaries is in breach or default of any of the insurance policies or has taken any action or failed to take any action that, with notice or lapse of time, would constitute such a breach or default or permit termination or modification of any of the insurance policies. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.23 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Opinion of Financial Advisor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company Board has received the opinion of each of Goldman, Sachs&#160;&#38; Co. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goldman</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and J.P. Morgan Securities LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">JPM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), dated the date of this Agreement, to the effect that, as of the date of such opinion, and based upon and subject to the various assumptions, qualifications, and limitations set forth therein, the Merger Consideration to be received by the holders of Company Shares pursuant to this Agreement is fair, from a financial point of view, to such holders of Company Shares. It is agreed and understood that such opinion is for the benefit of the Company Board and may not be relied on by Parent or Merger Sub for any purpose. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.24 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Brokers and Other Advisors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except for Goldman and JPM, the fees and expenses of which will be paid by the Company, no broker, investment banker, financial advisor, or other Person is entitled to any broker&#8217;s, finder&#8217;s, financial advisor&#8217;s, or other similar fee or commission or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries. A true and complete copy of each of (i)&#160;the engagement letter between the Company and Goldman and (ii)&#160;the engagement letter between the Company and JPM has been provided to Parent prior to the date hereof (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Engagement Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.25 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IT Systems&#59; Data Security and Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Except as would not constitute a Material Adverse Effect, (i)&#160;since January&#160;1, 2017, a failure or lack of capacity of the IT Systems has not prevented the Company or any of its Affiliates from conducting their respective businesses in the ordinary course, and (ii)&#160;to the Knowledge of the Company, the IT Systems do not contain any Malware that would reasonably be expected to disrupt the ability of the Company and its Subsidiaries to conduct their businesses or present a risk of unauthorized access, disclosure, use, corruption, destruction, or loss of any Personal Information or other non-public information. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Except as would not constitute a Material Adverse Effect, the Company, and its Subsidiaries have implemented, maintain, and comply with written information security (including cybersecurity), business continuity, and backup and disaster recovery plans and procedures that are consistent with generally accepted industry standards and applicable Laws, writs, injunctions, directives, judgments, decrees, and orders. Except as would not constitute a Material Adverse Effect, since January&#160;1, 2017, to the Knowledge of the Company, there has been no unauthorized disclosure, use of or access to (i)&#160;any Personal Information or other non-public information held by or on behalf of the Company or its Affiliates or (ii)&#160;the IT Systems. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Except as would not constitute a Material Adverse Effect, since January&#160;1, 2017, the Company and its Subsidiaries have implemented, maintain and comply with internal privacy policies and procedures and comply with any and all applicable regulatory guidelines, contractual requirements, terms of use, and industry standards applicable to the collection, retention, storage, protection, security, use, disclosure, distribution, transmission, maintenance, and disposal of Personal Information. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.26 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Management</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Investment Advisers. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Registration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The IA Subsidiary is, and at all times required by applicable Law since January&#160;1, 2017 has been, registered as an investment adviser under the Advisers Act and the rules and regulations thereunder. Neither the Company nor any Subsidiary, other than the IA Subsidiary is registered or required to be registered as an investment adviser with the SEC. Neither the Company nor any Subsidiary is, or at any time since January&#160;1, 2017 has been, required to be registered as an investment adviser with any Governmental Authority, other than the SEC, except where the failure so to register would not reasonably be expected to constitute a Material Adverse Effect. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The IA Subsidiary has filed each Form ADV and all amendments thereto required to be filed with the SEC since January&#160;1, 2017 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IA Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Since January&#160;1, 2017, the IA Filings did not at the time they were filed contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, except as would not reasonably be expected to constitute a Material Adverse Effect. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disqualification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A) To the Knowledge of the Company, neither the IA Subsidiary nor any director, officer or employee of, or any other &#8220;person associated with&#8221; (as defined under the Advisers Act), the IA Subsidiary has, since January&#160;30, 2017 through the date hereof, been ineligible to serve as an investment adviser or &#8220;person associated with an investment adviser&#8221; (as defined under the Advisers Act) under Section&#160;203(e) or Section&#160;203(f) of the Advisers Act or ineligible under Rule 206(4)-3(a)(1)(ii) under the Advisers Act to receive a cash fee with respect to solicitation activities, unless the IA Subsidiary or such associated person has received no-action or exemptive relief from the SEC with respect to any such disqualification. </font></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B) Neither the IA Subsidiary nor, to the Knowledge of the Company, any executive officer or director of the IA Subsidiary or any other officer of the IA Subsidiary (to the extent such other officer would be reasonably expected to participate in an offering of securities in reliance on Rule 506 of Regulation D under the Securities Act in connection with his or her duties to the IA Subsidiary), is ineligible pursuant to Rule 506(d) of Regulation D under the Securities Act to serve as an investment manager, solicitor, promoter, or in any other capacity with respect to an offering of securities in reliance on Rule 506 of Regulation D under the Securities Act, nor is there any Action pending that would result in the ineligibility of the IA Subsidiary or any such Person to serve as an investment manager, solicitor, promoter, or in any other capacity with respect an offering of securities in reliance on Rule 506 of Regulation D under the Securities Act. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C) The IA Subsidiary does not provide investment advisory services for compensation to any &#8220;government entity&#8221; either directly or through a &#8220;covered investment pool&#8221; (as such terms are defined in Rule 206(4)-5 under the Advisers Act). </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Private Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Registration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Private Fund is, or at any time since January&#160;1, 2017 was, required to register with the SEC as an investment company under the Investment Company Act. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Offerings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The shares, units, securities, or other interests in each Private Fund (A)&#160;have been issued and sold in compliance with applicable Law, except as would not reasonably be expected to constitute a Material Adverse Effect, and (B)&#160;are registered or qualified for public offering and sale or exempt from such registration or qualification under applicable Law in each jurisdiction where offers of such interests were made, except where the failure to be so registered or qualified would not constitute a Material Adverse Effect. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Private Fund is, and at all times since January&#160;1, 2017 has been, in compliance with all applicable Law, except such events of non-compliance as would not, individually or in the aggregate, reasonably be expected to constitute a Material Adverse Effect. </font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disqualification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Private Fund, any executive officer or director of any such Private Fund, or any other officer of any such Private Fund (to the extent such other officer would be reasonably expected to participate in an offering of securities in reliance on Rule 506 of Regulation D under the Securities Act in connection with his or her duties to a Private Fund) is ineligible pursuant to Rule 506(d) of Regulation D under the Securities Act with respect to an offering of securities in reliance on Rule 506 of Regulation D under the Securities Act, nor is there any Action pending that would result in the ineligibility of any such Private Fund or any such Person to participate in an offering of securities of the Private Funds in reliance on Rule 506 of Regulation D under the Securities Act, except as would not constitute a Material Adverse Effect. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;4.27 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Other Representations or Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except for the representations and warranties made by the Company in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, neither the Company nor any other Person makes any other express or implied representation or warranty with respect to the Company or any of its Subsidiaries or their respective businesses, operations, assets, liabilities, condition (financial or otherwise), or prospects, notwithstanding the delivery or disclosure to Parent, Merger Sub, or any of their respective Representatives or Affiliates of any documentation, forecasts or other information with respect to any one or more of the foregoing, and each of Parent and Merger Sub acknowledge the foregoing. In particular, and without limiting the generality of the foregoing, neither the Company nor any other Person makes or has made any express or implied representation or warranty to Parent, Merger Sub, or any of their </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respective Representatives or Affiliates with respect to (a)&#160;any financial projection, forecast, estimate, budget, or prospective information relating to the Company, any of its Subsidiaries, or their respective businesses, (b)&#160;any judgment based on actuarial principles, practices, or analyses by any Person or as to the future satisfaction or outcome of any assumption, (c)&#160;whether (i) reserves for losses (including incurred but not reported losses, loss adjustment expenses whether allocated or unallocated, unearned premium, or uncollectible reinsurance)&#160;(A) will be sufficient or adequate for the purposes for which they were established or (B)&#160;may not develop adversely or (ii)&#160;the reinsurance or other recoverables taken into account in determining the amount of such reserves for losses will be collectible, or (d)&#160;except for the representations and warranties made by the Company in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, any oral or written information presented to Parent, Merger Sub, or any of their respective Representatives or Affiliates in the course of their due diligence investigation of the Company, the negotiation of this Agreement, or the course of the Transactions. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE V.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parent and Merger Sub hereby jointly and severally represent and warrant to the Company that, as of the date hereof and as of the Closing Date, except as set forth in the disclosure letter delivered by Parent and Merger Sub to the Company on the date of this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Disclosure Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) (it being understood that any information set forth on one section or subsection of the Parent Disclosure Letter shall be deemed to apply to and qualify the section or subsection of this Agreement to which it corresponds in number and each other section or subsection of this Agreement or the Parent Disclosure Letter to the extent that it is reasonably apparent on the face of such disclosure that such information is relevant to such other section or subsection)&#58; </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Organization&#59; Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each of Parent and Merger Sub is an exempted company duly organized, validly existing, and in good standing under the Laws of Bermuda. Each of Parent and Merger Sub has all requisite power and authority necessary to carry on its business as it is now being conducted and to own, lease, and operate its assets and properties in all material respects. Each of Parent and Merger Sub is duly licensed or qualified to do business and is in good standing (where such concept is recognized under applicable Law) in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified or in good standing would not constitute a Parent Material Adverse Effect. Parent has made available to the Company copies of Parent&#8217;s and Merger Sub&#8217;s Organizational Documents, each as amended to the date of this Agreement. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Authority&#59; Noncontravention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Each of Parent and Merger Sub has all necessary power and authority to execute and deliver this Agreement and the Statutory Merger Agreement and, subject to obtaining the Merger Sub Shareholder Approval, to perform its obligations hereunder and to consummate the Transactions. The execution, delivery, and performance by Parent and Merger </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sub of this Agreement and the Statutory Merger Agreement, and the consummation by Parent and Merger Sub of the Transactions, have been duly authorized and approved by the Parent Board and the Merger Sub Board, as applicable, and, except for executing and delivering the Statutory Merger Agreement, filing the Merger Application with the Registrar pursuant to the Bermuda Companies Act and obtaining the Merger Sub Shareholder Approval (which approval shall be provided by the written consent of Parent immediately following the execution of this Agreement), no other action (including any shareholder vote or other action) on the part of Parent or Merger Sub is necessary to authorize the execution, delivery, and performance by Parent and Merger Sub of this Agreement and the Statutory Merger Agreement and the consummation by Parent and Merger Sub of the Transactions. This Agreement has been duly executed and delivered by Parent and Merger Sub and, assuming due authorization, execution, and delivery hereof by the Company, constitutes a legal, valid, and binding obligation of each of Parent and Merger Sub, enforceable against each of them in accordance with its terms, except that such enforceability may be limited by and is subject to the Bankruptcy and Equity Exception. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Each of the Parent Board and the Merger Sub Board have adopted resolutions that have approved the Merger, this Agreement and the Statutory Merger Agreement. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Neither the execution and delivery of this Agreement or the Statutory Merger Agreement by Parent and Merger Sub, nor the consummation by Parent or Merger Sub of the Transactions, nor performance or compliance by Parent or Merger Sub with any of the terms or provisions hereof, will (i)&#160;contravene, conflict with, or violate any provision of Organizational Documents of (A)&#160;Parent or Merger Sub or (B)&#160;any of Parent&#8217;s other Subsidiaries or (ii)&#160;assuming (A) compliance with the matters set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (other than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(c)(ii)(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (and assuming the accuracy of the representations and warranties made in such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (B) that the actions described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> have been completed, (C)&#160;that the Consents referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are, and, in the case of Merger Sub, the Merger Sub Shareholder Approval is, obtained, and (D)&#160;that the filings referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are made and any waiting periods thereunder have terminated or expired, in the case of each of the foregoing clauses (A)&#160;through (D), prior to the Effective Time, (x)&#160;violate any Law, writ, injunction, directive, judgment, decree, or order applicable to Parent or any of its Subsidiaries, (y)&#160;violate or constitute a breach of or default (with or without notice or lapse of time or both) under any of the terms, conditions, or provisions of, or give rise to a right of termination, modification, acceleration, or cancellation under, any material Contract to which Parent or any of its Subsidiaries is a party or accelerate Parent&#8217;s or, if applicable, any of its Subsidiaries&#8217; rights or obligations under any such material Contract, or (z)&#160;result in the creation of any Lien on any properties or assets of Parent or any of its Subsidiaries, except, in the case of clauses (i)(B) and (ii), as would not constitute a Parent Material Adverse Effect. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) The Merger Sub Shareholder Approval (which approval shall be provided by the written consent of Parent as contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is the only vote or approval of the holders of any class or series of shares of Parent, Merger Sub, or any of its other Subsidiaries that is necessary to approve this Agreement, the Statutory Merger Agreement, and the Merger. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except for (a)&#160;compliance with the applicable requirements of the Exchange Act, including the filing with the SEC of the Proxy Statement, (b)&#160;compliance with the rules and regulations of the New York Stock Exchange, (c)&#160;the filing of the Merger Application with the Registrar pursuant to the Bermuda Companies Act, (d)&#160;the approval of the Bermuda Monetary Authority pursuant to the Exchange Control Act 1972 regarding the change of ownership of the Company, (e)&#160;filings required under, and compliance with other applicable requirements of, the HSR Act, and such other Consents, filings, declarations, or registrations as are required to be made or obtained under any other Antitrust Laws, (f)&#160;compliance with any applicable state securities or blue sky Laws, (g)&#160;approvals, filings, and notices under all applicable Insurance Laws as set forth in Section&#160;5.03 of the Parent Disclosure Letter (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Insurance Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and (h)&#160;the Company Insurance Approvals (assuming the accuracy of the representations and warranties made in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.04(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the completeness of Section&#160;4.04 of the Company Disclosure Letter), no Consent of, or filing, declaration, or registration with, or notification to, or waiver from, any Governmental Authority is necessary for the execution and delivery of this Agreement by Parent and Merger Sub, the performance by Parent and Merger Sub of their obligations hereunder, and the consummation by Parent and Merger Sub of the Transactions, other than such other Consents, filings, declarations, or registrations that, if not obtained, made, or given, would not constitute a Parent Material Adverse Effect. As of the date of this Agreement, Parent has a reasonable basis to believe that the Parent Insurance Approvals set forth on Section&#160;5.03 of the Parent Disclosure Letter will be obtained prior to the Walk-Away Date. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ownership and Operations of Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Parent owns beneficially and of record all of the issued and outstanding shares of Merger Sub, free and clear of all Liens. Merger Sub was formed solely for the purpose of engaging in the Transactions, has no assets, liabilities or obligations of any nature, other than those incident to its formation and pursuant to the Transactions, and, prior to the Effective Time, will not have engaged in any business activities other than those relating to the Transactions. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sufficiency of Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Parent has delivered to the Company a true and complete copy of the executed Equity Commitment Letter. Assuming the Equity Financing is funded in accordance with the Equity Commitment Letter, at the Closing, Parent will have sufficient funds to pay the Merger Consideration and all other amounts required to be paid by Parent at Closing under this Agreement, and all related fees and expenses required to be paid at the Closing by Parent in connection with the Transactions (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financing Uses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). As of the date hereof, there are no side letters or other Contracts relating to the funding of the Equity Financing, other than as expressly set forth in the Equity Commitment Letter. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) As of the date hereof, the Equity Commitment Letter is in full force and effect and has not been withdrawn, terminated, or rescinded or otherwise amended, supplemented, or modified in any respect and no such amendment, supplement, or modification is contemplated by Parent or, to the Knowledge of Parent, by the other parties thereto. As of the date hereof, the Equity Commitment Letter, in the form delivered to the Company, is a legal, valid, and binding obligation of each of Parent and, to the Knowledge of Parent, the other parties </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">thereto, enforceable against Parent and, to the Knowledge of Parent, such other parties thereto in accordance with its terms and conditions, subject to the Bankruptcy and Equity Exception. As of the date hereof, to the Knowledge of Parent, no event has occurred which, with or without notice, lapse of time, or both, would, or would reasonably be expected to, constitute a material default or breach on the part of Parent or any Investor under any term, or a failure to satisfy a condition, of the Equity Commitment Letter or otherwise result in any portion of the Equity Financing necessary to satisfy the Financing Uses contemplated thereby being unavailable on the date on which the Closing should occur pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of the date hereof, assuming the satisfaction of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Parent has no reason to believe that it or any Investor would be unable to satisfy on a timely basis any term or condition of the Equity Commitment Letter required to be satisfied by it or that the full amount of the Equity Financing will not be available to it at the Closing. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certain Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of the date of this Agreement, there are no Contracts or commitments to enter into Contracts (a)&#160;between Parent, Merger Sub, or any of their Affiliates, on the one hand, and any member of the Company&#8217;s management or the Company Board, on the other hand, that relate in any way to the Company or any of its Subsidiaries or the Transactions, (b)&#160;pursuant to which any shareholder of the Company would be entitled to receive consideration of a different amount or nature than the Merger Consideration or pursuant to which any shareholder of the Company agrees to vote to approve the Merger and this Agreement or agrees to vote against any Superior Proposal, or (c)&#160;between Parent, Merger Sub, or any of their Affiliates, on the one hand, and any holder of Company Awards, on the other hand, pursuant to which such holder would be entitled to receive consideration of a different amount or nature than the consideration payable pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Information Supplied</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. None of the information supplied or to be supplied by or on behalf of Parent or Merger Sub for inclusion or incorporation by reference in the Proxy Statement to be sent to the holders of Company Shares in connection with the Company Shareholders Meeting (including any amendment or supplement thereto or document incorporated by reference therein) shall, on the date the Proxy Statement is first mailed to the holders of Company Shares, at the time of any amendment thereof or supplement thereto, and at the time of the Company Shareholders Meeting, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading or omit to state a material fact necessary to correct any statement in any earlier communication with respect to the solicitation of proxies for the Company Shareholders Meeting which has become false or misleading. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.08 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as would not constitute a Parent Material Adverse Effect, as of the date of this Agreement, there is no (a)&#160;pending or, to the Knowledge of Parent, threatened legal or administrative proceeding, suit, arbitration, action, claim, controversy, dispute, hearing, charge, complaint, examination, indictment, litigation, or, to the Knowledge of Parent, investigation against Parent or any of its Subsidiaries (other than ordinary course claims made under or in connection with Contracts of insurance issued by Parent or any of its Subsidiaries) or (b)&#160;outstanding injunction, order, judgment, ruling, decree, or writ imposed upon Parent or any of its Subsidiaries, in each case, by or before any Governmental Authority. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.09 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ownership of Company Shares, 5.95% Preference Shares or 5.625% Preference Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. None of Parent, Merger Sub or any of their Affiliates beneficially own (within the meaning of Section&#160;13 of the Exchange Act), or will prior to the Closing Date beneficially own, any Company Shares, 5.95% Preference Shares, or 5.625% Preference Shares, or is a party, or will prior to the Closing Date become a party, to any Contract (other than this Agreement) for the purpose of acquiring, holding, voting, or disposing of any Company Shares, 5.95% Preference Shares or 5.625% Preference Shares. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Brokers and Other Advisors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except for Willis Towers Watson and Libero Ventures, the fees and expenses of which will be paid by Parent, no broker, investment banker, financial advisor, or other Person is entitled to any broker&#8217;s, finder&#8217;s, financial advisor&#8217;s, or other similar fee or commission or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of Parent or any of its Subsidiaries. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Concurrently with the execution of this Agreement, Parent and Merger Sub have caused Guarantors to deliver the Guarantee, dated as of the date hereof, to the Company. The Guarantee is in full force and effect (assuming the due authorization, execution, and delivery thereof by the other parties thereto). The Guarantee constitutes the valid and binding obligation of the Guarantors and is enforceable against the Guarantors, subject to the Bankruptcy and Equity Exception. There is no default under the Guarantee by the Guarantors, and no event has occurred that with the lapse of time or the giving of notice or both would constitute a default thereunder by Guarantors. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;5.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Other Representations or Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Except for the representations and warranties made by Parent and Merger Sub in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and in the Equity Commitment Letter and the Guarantee, neither Parent, Merger Sub, nor any other Person makes any other express or implied representation or warranty with respect to Parent or Merger Sub or any of their Subsidiaries or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise), or prospects, notwithstanding the delivery or disclosure to the Company or any of its Representatives or Affiliates of any documentation, forecasts, or other information with respect to any one or more of the foregoing, and the Company acknowledges the foregoing. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Except for the representations and warranties expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article&#160;IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Parent and Merger Sub hereby agree and acknowledge that neither the Company nor any of its Subsidiaries, nor any other Person, has made or is making, and Parent and Merger Sub are not relying on, any other express or implied representation or warranty with respect to the Company or any of its Subsidiaries or their respective businesses, operations, assets, liabilities, condition (financial or otherwise), or prospects, including with respect to any information made available to Parent, Merger Sub, or any of their respective Representatives or Affiliates (including with respect to any judgment based on actuarial principles, practices, or analyses by any Person or as to the future satisfaction or outcome of any assumption) or any information developed by Parent, Merger Sub or any of their respective Representatives or Affiliates. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE VI. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADDITIONAL COVENANTS AND AGREEMENTS </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conduct of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) During the period from the date of this Agreement through the earlier of the Closing and the termination of this Agreement, except as required by applicable Law, as required or contemplated by the terms of this Agreement (including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company Disclosure Letter, unless Parent otherwise consents in writing (such consent not to be unreasonably withheld, conditioned, or delayed), (w) the Company shall, and shall cause each of its Subsidiaries to, use reasonable best efforts to carry on its business in all material respects in the ordinary course of business consistent with past practice, (x)&#160;to the extent consistent with the prohibitions set forth in clauses (i)&#160;through (xxxiii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company shall, and shall cause each of its Subsidiaries to, use reasonable best efforts to preserve its and each of its Subsidiaries&#8217; business organizations and material assets substantially intact, keep available in all material respects the services of its current officers, employees and consultants and preserve its goodwill and existing relationships with material customers, brokers, reinsurance providers, regulators, officers, employees, and other Persons with whom the Company or any of its Subsidiaries have significant business relationships and (y)&#160;the Company shall not, and shall not permit any of its Subsidiaries to&#58; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) issue, sell, or grant any of its shares or other equity or voting interests of the Company, or any securities or rights convertible into, exchangeable or exercisable for, or evidencing the right to subscribe for any shares or other equity or voting interests of the Company or any of its Subsidiaries, or any options, rights, warrants, or other commitments or agreements to acquire from the Company or any of its Subsidiaries, or that obligate the Company or any of its Subsidiaries to issue, any share capital of, or other equity or voting interests in, or any securities convertible into or exchangeable for shares of, or other equity or voting interests in, the Company or any of its Subsidiaries or any Company Awards&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company may issue Company Shares or other securities as required pursuant to the vesting, settlement, or exercise of Company Awards, Company Share Purchase Plan Awards, or Company Rights outstanding on the date of this Agreement in accordance with the terms of the applicable Company Award, Company Share Purchase Plan Award, or Company Right in effect on the date of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Subsidiaries of the Company may make any such issuances, sales, or grants to the Company or a direct or indirect wholly owned Subsidiary of the Company&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) redeem, purchase, or otherwise acquire any outstanding shares or other equity or voting interests of the Company or any of its Subsidiaries or any rights, warrants, or options to acquire any shares of the Company or any of its Subsidiaries or other equity or voting interests of the Company or any of its Subsidiaries, except (A)&#160;pursuant to the Company Plans, the Company Awards, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company Share Purchase Plan Awards (including, for the avoidance of doubt, in connection with the forfeiture of any Company Awards or the satisfaction of any per share exercise price related to any Company Awards) or (B)&#160;in connection with the satisfaction of Tax withholding obligations with respect to any Company Awards or Company Share Purchase Plan Awards&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) establish a record date for, declare, set aside for payment, or pay any dividend on, or make any other distribution in respect of, any shares or other equity or voting interests of the Company or any of its Subsidiaries, in each case, other than (A)&#160;periodic cash dividends paid by the Company on 5.95% Preference Shares and 5.625% Preference Shares not in excess of the amounts contemplated by the applicable certificates of designations for such shares with record dates and payments dates generally consistent with the timing of record and payment dates in the most recent comparable prior fiscal quarter prior to the date of this Agreement, (B)&#160;periodic cash dividends paid by the applicable Subsidiary of the Company on preferred shares issued and outstanding on the date hereof in an amount not in excess of the amounts required by the applicable bye-laws, certificate of designation, or authorizing resolutions for such preferred shares, with record and payment dates generally consistent with the timing of record and payment dates in the most recent comparable prior year fiscal quarter prior to the date of this Agreement and (C)&#160;dividends paid by a Subsidiary of the Company to the Company or any direct or indirect wholly owned Subsidiary of the Company&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) split, combine, subdivide, or reclassify any shares or other equity or voting interests of the Company or any of its Subsidiaries&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) incur any indebtedness for borrowed money, issue or sell any bonds, debentures, or other debt securities or warrants or other rights to acquire any bonds, debentures, or other debt securities of the Company or any of its Subsidiaries, guarantee any such indebtedness or any debt securities of another Person, or enter into any &#8220;keep well&#8221; or other agreement to maintain any financial statement condition of another Person (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), except for (A)&#160;Indebtedness incurred solely between the Company and any of its Subsidiaries or solely between its Subsidiaries, (B)&#160;letters of credit issued in the ordinary course of business in the insurance or reinsurance business of the Company or any of its Subsidiaries, (C)&#160;borrowings under the Company&#8217;s existing credit facilities having an aggregate principal amount outstanding that is not in excess of $20,000,000, (D) any other Indebtedness in an aggregate principal amount not in excess of $20,000,000, and (E)&#160;Indebtedness incurred in connection with the refinancing of any Indebtedness existing on the date of this Agreement or permitted to be incurred, assumed, or otherwise entered into hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, in the case of this clause (E), the amount of Indebtedness incurred in connection with such refinancing does not exceed the principal amount of the Indebtedness so refinanced (other than with respect to increased amounts attributable to unpaid accrued interest, fees and premiums (including tender premiums), defeasance costs, and underwriting discounts, fees, commissions and expenses associated therewith)&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) enter into any swap or hedging transaction or other derivative agreement, except for in the ordinary course of business and in compliance with the Investment Guidelines&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii) sell or lease to any Person, in a single transaction or series of related transactions, any of its owned properties or assets whose value or purchase price exceeds $10,000,000 individually or $20,000,000 in the aggregate, except (A)&#160;dispositions of obsolete, surplus, or worn out assets or assets that are no longer used or useful in the conduct of the business of the Company or any of its Subsidiaries, (B)&#160;transfers among the Company and its Subsidiaries, (C)&#160;leases and subleases of real property owned or leased by the Company or its Subsidiaries, or (D)&#160;sales of Investment Assets in the ordinary course of business (including in connection with cash management or investment portfolio activities) and in compliance with the Investment Guidelines&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii) make or authorize any capital expenditures outside the ordinary course of business or make loans or advances to, or, except as permitted by the Investment Guidelines, any investments in, any other Person, other than a Subsidiary of the Company&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix) make any acquisition (including by merger or amalgamation) of the share capital or other equity or voting interests of any other Person (except the acquisition of Investment Assets in the ordinary course of business and in compliance with the Investment Guidelines) or of the assets of any other Person, in each case, for consideration in excess of $10,000,000 individually or $20,000,000 in the aggregate&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x) make any material changes in financial accounting methods, principles, or practices materially affecting the consolidated assets, liabilities, or results of operations of the Company and its Subsidiaries, except insofar as may be required by (or, in the reasonable good faith judgment of the Company, advisable under)&#160;(A) GAAP (or any interpretation thereof), including pursuant to standards, guidelines and interpretations of the FASB or any similar organization, or (B)&#160;Applicable SAP (or any interpretation thereof), including pursuant to standards, guidelines, and interpretations of the National Association of Insurance Commissioners or any similar organization&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xi) materially alter or materially amend any existing (x)&#160;insurance or reinsurance underwriting, reserving, claim handling, loss control, policy retention or conservation, (y)&#160;ceded reinsurance diversification, counterparty criteria, business line or quota share percentage, or (z)&#160;actuarial practice guideline or policy of the Company or any Company Insurance Subsidiary or any material assumption underlying any reserves or actuarial practice or policy, except as may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be required by (or, in the reasonable good faith judgment of the Company, advisable under)&#160;(A) GAAP (or any interpretation thereof), including pursuant to standards, guidelines and interpretations of the FASB or any similar organization, or (B)&#160;Applicable SAP (or any interpretation thereof), including pursuant to standards, guidelines, and interpretations of the National Association of Insurance Commissioners or any similar organization&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xii) reduce or strengthen any reserves, provisions for losses, or other liability amounts in respect of Insurance Contracts and assumed reinsurance Contracts, except (A)&#160;as may be required by (or, in the reasonable good faith judgment of the Company, advisable under) Applicable SAP or GAAP, as applicable, (B)&#160;as a result of loss or exposure payments to other parties in accordance with the terms of Insurance Contracts and assumed reinsurance Contracts, or (C)&#160;in the ordinary course of business&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiii) adopt or implement any shareholder rights plan or similar arrangement&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiv) (A) amend the Company Organizational Documents (other than pursuant to the Bye-Law Amendment) or (B)&#160;amend in any material respect the comparable Organizational Documents of any of the Subsidiaries of the Company in a manner that would reasonably be likely to prevent or to impede, interfere with, hinder, or delay in any material respect the consummation of the Transactions&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xv) adopt any plan or agreement of complete or partial liquidation or dissolution, merger, amalgamation, consolidation, restructuring, recapitalization, or other reorganization of the Company or any of its Subsidiaries, continue or agree to continue the Company or any of its Subsidiaries into any other jurisdiction, or convert or agree to convert the Company or any of its Subsidiaries into any other form of legal entity (in each case, other than dormant Subsidiaries or, with respect to any merger, amalgamation, or consolidation, other than among wholly owned Subsidiaries)&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xvi) grant any Lien (other than Permitted Liens) in any of its material properties or assets, except to secure Indebtedness permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(a)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xvii) settle, discharge or compromise any pending or threatened Action against the Company or any of its Subsidiaries, or any of their officers or directors in their capacities as such, other than the settlement or discharge of Actions (A)&#160;solely for monetary damages for an amount not to exceed $1,500,000 for any such settlement individually or $5,000,000 in the aggregate (with such aggregate amount calculated taking into account the amount of any settled Tax proceedings permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(a)(xxiv)(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or (B)&#160;for claims under Contracts of insurance or reinsurance issued by the Company or any of its Subsidiaries in accordance with applicable policy or contractual limits in the ordinary course of business&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xviii) cancel any material Indebtedness or waive any material claims or rights under any Material Contract, other than in the ordinary course of business&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xix) except as required by Law or the terms of a Company Plan as of the date hereof, (A)&#160;terminate, establish, adopt, enter into, or amend any Company Plan (or any other arrangement that would be a Company Plan, if in effect on the date hereof), (B) accelerate the payment, funding, right to payment, or vesting of, compensation or benefits of, any current or former director, officer, employee or individual service provider, (C)&#160;modify the compensation or benefits of any Senior Employee, current or former director or individual service provider or, except for annual base salary increases given in the ordinary course of business consistent with past practice, materially increase the compensation or benefits of any other employee, (D)&#160;loan or advance any money or other property to any director, officer, employee or individual service provider, or (E)&#160;grant any equity or equity-based awards to any director, officer, employee or individual service provider&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xx) (A)&#160;terminate the employment of any employee whose base salary exceeds $300,000 (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), other than for &#8220;cause&#8221;, or (B)&#160;hire or promote any Senior Employee (or any employee who would be a Senior Employee, if employed on the date hereof)&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxi) amend, modify, or terminate any Material Contract or Ceded Reinsurance Contract in such a way as to materially reduce the expected business or economic benefits thereof or enter into any Contract that would constitute a Material Contract if in effect as of the date hereof, in each case, except in the ordinary course of business&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxii) voluntarily abandon, dispose of, or permit to lapse any right to Owned Intellectual Property material to the Company and its Subsidiaries, taken as a whole, other than in the ordinary course of business&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxiii) voluntarily abandon, dispose of or permit to lapse any Permit material to the business of the Company or any of its Subsidiaries&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxiv) (A) make any material Tax election, except for in the ordinary course of business, (B)&#160;settle or compromise any audit or other proceeding relating to a material amount of Tax (other than in an amount not to exceed $10,000,000 for any such settlement or compromise individually or $50,000,000 in the aggregate (with such aggregate amount calculated taking into account the amount of any settled Actions permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(a)(xvii)(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)), (C) file any material amended Tax Return, (D)&#160;extend or waive the application of any statute of limitations regarding the assessment or collection of any material Tax, other than in the ordinary course of business, (E)&#160;enter into any Tax </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indemnification, sharing, allocation, reimbursement or similar agreement, arrangement or understanding (other than any Contract entered into in the ordinary course of business that does not relate principally to Taxes), (F) surrender any right to claim any material Tax refund, (G)&#160;make any material change to any Tax accounting method, except for in the ordinary course of business, (H)&#160;change its residence for Tax purposes&#59; or (I)&#160;establish any office, branch or permanent establishment in any country other than the country in which it is organized&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxv) acquire or dispose of any material Investment Assets in any manner inconsistent with the Investment Guidelines&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxvi) materially amend, materially modify, or otherwise materially change the Investment Guidelines or manage the investment portfolios of the Company Insurance Subsidiaries in a manner that is inconsistent with the Investment Guidelines in any material respect&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxvii) enter into any new lines of business or withdraw from, or put into &#8220;run off&#8221;, any existing material lines of business&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxviii) change in any material respect any material products or any material operating or enterprise risk management policies, in each case, except as required by Law or by policies imposed, or requests made, by a Governmental Authority&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxix) recognize any labor union or negotiate, enter into, or amend any collective bargaining agreement&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxx) enter into any Contract or commitment with any insurance regulatory authority other than in the ordinary course of business consistent with past practice&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxxi) enter into (A)&#160;any material funding obligation of any kind, or material obligation to make any additional advances or investments (including any obligation relating to any currency or interest rate swap, hedge, or similar arrangement), in respect of any of the Investment Assets or (B)&#160;any material outstanding commitments, options, put agreements or other arrangements relating to the Investment Assets to which the Company or any of its Subsidiaries may be subject upon or after the Closing, in each case, other than in the ordinary course of business consistent with past practice&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxxii) enter into, or amend or modify in any significant manner, any Contract or commitment with any former or present director or officer of the Company or any of its Subsidiaries or with any Affiliate of any of the foregoing Persons or any other Person covered under Item&#160;404(a) of Regulation S-K under the Securities Act, other than as would not be adverse to the Company and its Subsidiaries&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxxiii) enter into, amend, or modify any agreement with any broker, investment banker, financial advisor, or other Person entitling such Person to any broker&#8217;s, finder&#8217;s, financial advisor&#8217;s, or other similar fee or commission or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries, including any amendment or modification of any Engagement Letter&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxxiv) enter into, amend, modify, or exercise any right to renew any Company Lease that provides for or involves rent payments of $2&#160;million in any twelve (12)&#160;month period or more or has a term of more than three (3)&#160;years&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxxv) (A) enter into, renew, or modify any Ceded Reinsurance Contract that would, or would reasonably be expected to, result in the Company and its Subsidiaries, taken together, ceding to third parties in excess of twenty five percent (25%) of the total gross written premiums of the Company and its Subsidiaries, taken together, in 2019 or (B)&#160;enter into, renew or modify any loss portfolio transfer or adverse development cover or similar transaction&#59; or </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xxxvi) authorize any of, or commit or agree, in writing or otherwise, to take any of, the foregoing actions. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Nothing in this Agreement is intended to give Parent, directly or indirectly, the right to control or direct the Company&#8217;s or its Subsidiaries&#8217; operations prior to the Effective Time, and nothing in this Agreement is intended to give the Company, directly or indirectly, the right to control or direct Parent&#8217;s or its Subsidiaries&#8217; operations. Prior to the Effective Time, each of Parent and the Company shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries&#8217; respective operations. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) (A) If, between the date hereof and the Closing Date, the Company or any of its Representatives receives a clear indication from A.M. Best or S&#38;P after a discussion with such rating agency that such rating agency intends to downgrade the financial strength rating of any Company Insurance Subsidiary in the near-term, the Company will as promptly as reasonably practicable notify Parent of the receipt of such indication and disclose any reasoning given by such rating agency for the potential downgrade. Parent and the Company shall thereafter cooperate and work together in good faith to develop and implement in a timely manner a plan for addressing any matters raised by such rating agency so as to avoid such downgrade. If Parent and the Company mutually agree on the actions to be taken to avoid such ratings downgrade and that the Company should take such actions, the Company may take such actions and the taking of such actions will not constitute a breach of this Agreement by the Company (notwithstanding anything to the contrary in this Agreement). (B) If Parent and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company do not mutually agree on the actions to be taken to avoid such ratings downgrade or that the Company should take any particular actions, then the Company may, notwithstanding anything to the contrary in this Agreement (including the restrictions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hereunder), take any commercially reasonable actions that the Company Board reasonably determines are reasonably necessary to avoid such a ratings downgrade&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company notifies Parent no later than 1 business day after such determination and notifies Parent no later than 1 business day after it has taken such action (which notices shall describe the action taken or to be taken and the rationale therefor). </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) Notwithstanding anything to the contrary in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if (x)&#160;the Company takes any action pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(c)(i)(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the taking of such action causes, or would reasonably be expected to cause, a significant adverse economic consequence for the Company and its Subsidiaries, taken as a whole, or increases, in any respect, the aggregate Merger Consideration payable to the holders of Company Shares in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or (y)&#160;without the express prior written consent of Parent, the Company takes, or refrains from taking, any action pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(c)(i)(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and such action, or failure to act, would otherwise violate the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 6.01(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xxiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xxvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xxviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xxx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(xxxv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in any material respect (any such action, or failure to act, under clause (x)&#160;or clause (y), a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), then in either case Parent shall be entitled to terminate this Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on or prior to the 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business day after the later of (A)&#160;the date on which the Company causes (by action or failure to act) a Triggering Event and (B)&#160;the date on which the Company notifies Parent that it has caused (by action or failure to act) a Triggering Event. For the avoidance of doubt, notwithstanding anything to the contrary in this Agreement, the taking of any such action, or failure to act, under clause (x)&#160;or clause (y)&#160;in the circumstances contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> will not constitute a breach or violation of this Agreement by the Company for any other purpose and will not result in a right of termination, other than pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) During the period from the date of this Agreement through the earlier of the Closing and the termination of this Agreement, the Company shall not, and shall cause its Subsidiaries not to, capitalize or agree to any capital plan with respect to Aspen Insurance Ireland Designated Activity Company in any manner that is inconsistent with the capital plan set forth in the application to the Central Bank of Ireland for authorization of Aspen Insurance Ireland Designated Activity Company as an insurance carrier, which was submitted by the Company to the Central Bank of Ireland prior to the date hereof, in any case, without the prior written consent of Parent. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Solicitation by the Company&#59; Change in Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Except as permitted by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company shall and shall cause each of its Subsidiaries to, and its and their respective directors, officers, and employees to, and shall use its reasonable best efforts to cause its other Representatives (including by providing written direction to its financial advisor informing it of the obligations set forth in clauses (i)&#160;and (ii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), as applicable, to, (i)&#160;immediately cease any solicitation, knowing encouragement, discussions or negotiations of or with any Persons that may be ongoing with respect to a Takeover Proposal and (ii)&#160;during the period from the date of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">this Agreement through the earlier of the Closing and the termination of this Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, not, directly or indirectly, (A)&#160;solicit, knowingly encourage, initiate, or take any action to facilitate the submission of any inquiry or the making of any proposal or offer, in each case that constitutes, or would reasonably be expected to lead to, a Takeover Proposal, (B)&#160;engage in or otherwise participate in any discussions or negotiations regarding any submission, proposal, announcement, offer, or inquiry that constitutes or would reasonably be expected to lead to a Takeover Proposal or furnish to any other Person any non-public information in connection with a Takeover Proposal or any such submission, proposal, announcement, offer, or inquiry, (C)&#160;enter into any Company Acquisition Agreement, (D)&#160;terminate, waive, amend, release or modify any provision of any confidentiality agreement to which the Company or any Subsidiary of the Company is a party in connection with any Takeover Proposal or any submission, proposal, offer, or inquiry that would reasonably be expected to lead to any Takeover Proposal (unless the Company Board determines in good faith (after consultation with its outside counsel) that failure to do so would be inconsistent with the fiduciary duties of directors under applicable Law), (E) reimburse or agree to reimburse the expenses of any Person (other than the Company&#8217;s Representatives) in connection with any Takeover Proposal, or (F)&#160;publicly propose or agree to do any of the foregoing. Promptly following the execution of this Agreement, the Company shall, to the extent it had not previously done so prior to the date of this Agreement, deliver a request to each Person that has executed a confidentiality agreement with the Company during the eighteen (18)&#160;months prior to the date of this Agreement or has received non-public information from or on behalf of the Company during such period, in either case, in connection with considering or making a Takeover Proposal to promptly return or destroy any non-public information previously furnished or made available to such Person or any of its Representatives on behalf of the Company or its Representatives. Notwithstanding the foregoing or anything else in this Agreement to the contrary, the Company may waive, and may choose not to enforce, any provision of any standstill or confidentiality agreement with any Person that would prohibit such Person from communicating confidentially a Takeover Proposal to the Company Board, if and only to the extent that the Company Board determines in good faith, after consultation with its financial advisors and outside legal counsel, that the failure to do so would be inconsistent with its fiduciary duties under applicable Law. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Notwithstanding anything contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or any other provision of this Agreement to the contrary, if, at any time after the execution of this Agreement and prior to obtaining the Company Shareholder Approval, the Company receives a bona fide Takeover Proposal, which Takeover Proposal did not result from any material breach of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, solely for purposes of determining whether a breach of the first sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has occurred for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(d)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, but not, for the avoidance of doubt, for the purpose of determining whether a breach has occurred for purposes of Section&#160;8.02 or Section&#160;8.03(a)(i), the Company&#8217;s obligation to use its reasonable best efforts to cause its Representatives to comply with the first sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be a covenant (without qualification of reasonable best efforts) to cause its Representatives to comply with clauses (i)&#160;and (ii) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), then (i)&#160;the Company and its Representatives may contact such Person or group of Persons making the Takeover Proposal solely to clarify the terms and conditions thereof or to request that any Takeover Proposal made orally be made in writing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company shall promptly provide to Parent any material written correspondence with any such Person or its Representatives and communicate to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parent any material terms and conditions of such Takeover Proposal that were orally communicated to the Company or its Representatives by such Person and (ii)&#160;if the Company Board determines in good faith after consultation with its financial advisors and outside legal counsel that such Takeover Proposal constitutes or would reasonably be expected to lead to a Superior Proposal, then the Company and its Representatives may (x)&#160;enter into an Acceptable Confidentiality Agreement with the Person or group of Persons making the Takeover Proposal and furnish pursuant thereto information (including non-public information) with respect to the Company and its Subsidiaries to the Person or group of Persons who has made such Takeover Proposal&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company (1)&#160;shall promptly provide to Parent a copy of such Acceptable Confidentiality Agreement&#59; and (2)&#160;has previously provided, or substantially concurrently with the time such information is provided to such Person or group of Persons, provides, all such information concerning the Company or any of its Subsidiaries to Parent or its Representatives, and (y)&#160;engage in or otherwise participate in discussions or negotiations with the Person or group of Persons making such Takeover Proposal after entering into an Acceptable Confidentiality Agreement with such Person. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Company shall promptly notify Parent in the event that the Company or any of its Subsidiaries or its or their Representatives receives a Takeover Proposal (and in any event within twenty-four (24)&#160;hours after receipt thereof) and shall disclose to Parent the material terms and conditions of any such Takeover Proposal and the identity of the Person or group of Persons making such Takeover Proposal and unredacted copies of all proposals, offers, indications of interest, term sheets, or other material agreements and documents with respect thereto or that contain proposed terms of such Takeover Proposal and communicate to Parent any material terms and conditions orally communicated to the Company or its Representatives in connection with such Takeover Proposal, in each case, as promptly as practicable (and in no event later than twenty-four (24)&#160;hours) after receipt or delivery thereof. The Company shall keep Parent reasonably informed of any material developments with respect to any such Takeover Proposal (including any material changes thereto and provide copies of proposals, offers, indications of interest, term sheets, or other material agreements, as contemplated above) on a prompt basis. For the avoidance of doubt, all information provided to Parent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> will be subject to the terms of the Confidentiality Agreement. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Neither the Company Board nor any committee thereof shall (x)&#160;(A) withhold or withdraw or publicly propose to withdraw or withhold the Company Board Recommendation, (B)&#160;modify, qualify, or amend or publicly propose to modify, qualify or amend the Company Board Recommendation in a manner adverse to Parent, (C)&#160;fail to include the Company Board Recommendation in the Proxy Statement, (D)&#160;approve, publicly endorse, or recommend or propose to approve, publicly endorse, or recommend any Takeover Proposal, (E)&#160;make any recommendation in connection with a tender offer or exchange offer, other than a recommendation against such offer, or fail to recommend against acceptance of such a tender or exchange offer, including by taking no position with respect to acceptance of such tender or exchange offer, by the close of business on the earlier of (i)&#160;the tenth (10th) business day after the commencement of such tender offer or exchange offer pursuant to Rule 14d-2 under the Exchange Act and (ii)&#160;the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) business day prior to the date of the Company Shareholders Meeting (if such tender or exchange offer is commenced prior to the fourth (4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) business day prior to the Company Shareholders Meeting) or the date and time of the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders Meeting (if such tender or exchange offer is commenced on or after the fourth (4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) business day prior to the Company Shareholders Meeting), or (F)&#160;fail to publicly reaffirm the Company Board Recommendation within five (5)&#160;business days after receipt of a written request by Parent to make such public reaffirmation following the receipt by the Company of a public Takeover Proposal (other than in the case of a Takeover Proposal in the form of a tender offer or exchange offer, which shall be governed by clause (E)) that has not been withdrawn&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that Parent may make any such request only once in any ten (10)&#160;business day period and only once for each such public Takeover Proposal and once for each public material amendment to such Takeover Proposal (any prohibited action described in this clause (x)&#160;being referred to as an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adverse Recommendation Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or (y)&#160;authorize, cause, or permit or publicly propose to authorize, cause or permit the Company or any of its Subsidiaries to execute or enter into any letter of intent, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement, stock purchase agreement, asset purchase agreement, option agreement, amalgamation agreement, or other agreement related to any Takeover Proposal (other than any Acceptable Confidentiality Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Acquisition Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or requiring, directly or indirectly, the Company to abandon, terminate, or fail to consummate the transactions contemplated hereby. Notwithstanding the foregoing or any other provision of this Agreement to the contrary, prior to the time the Company Shareholder Approval is obtained, the Company Board may&#58; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) in response to an Intervening Event, if the Company Board has determined in good faith, after consultation with the Company&#8217;s outside legal counsel, that failure to take such action would be inconsistent with the directors&#8217; fiduciary duties under applicable Law, make an Adverse Recommendation Change&#59; and </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) in response to a Superior Proposal that has not been withdrawn, if the Company Board has determined in good faith, after consultation with the Company&#8217;s financial advisors and outside legal counsel, that failure to take such action would be inconsistent with the directors&#8217; fiduciary duties under applicable Law, (A)&#160;make an Adverse Recommendation Change or (B)&#160;cause the Company to terminate this Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(d)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, pay the Company Termination Fee, and enter into a definitive agreement to implement such Superior Proposal&#59; </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company has complied in all material respects with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and has given Parent at least four (4)&#160;business days&#8217; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Recommendation Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) written notice (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) prior to taking any such action, which notice shall include a statement that the Company Board intends to take such action and specifying the reasons therefor and (I)&#160;in the case of an Intervening Event, specifies the material changes, developments, effects, circumstances, states of facts, or events comprising such Intervening Event, and (II)&#160;in the case of a Superior Proposal, discloses (1)&#160;the material terms and conditions of such Superior Proposal and the identity of the Person or group of Persons making such Superior Proposal and its or their financing sources, if applicable, and (2)&#160;a copy of the most current version of the Company Acquisition Agreement (if any) with respect to such Superior Proposal and any agreement in the Company&#8217;s possession relating to the financing of such Superior Proposal&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(X) during such Change of Recommendation Notice Period (it being understood and agreed that any change to the financial or other material terms and conditions of a Superior Proposal shall require an additional Company Notice to Parent and an additional two (2)&#160;business day period prior to taking any specified action), the Company shall have, and shall have caused its Subsidiaries and its and their respective Representatives to, negotiate with Parent in good faith (to the extent Parent desires to negotiate) to make such commercially reasonable adjustments to the terms and conditions of this Agreement as would enable the Company Board to no longer make an Adverse Recommendation Change or a determination that a Takeover Proposal constitutes a Superior Proposal and (Y)&#160;the Company Board shall have determined in good faith following the end of such Change of Recommendation Notice Period (as it may be extended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), after considering the results of such negotiations and the revised proposals made by Parent, if any, after consultation with the Company&#8217;s financial advisors and outside legal counsel, (i)&#160;that the Superior Proposal giving rise to such Company Notice continues to be a Superior Proposal or (ii)&#160;that failure to make an Adverse Recommendation Change in respect of the applicable Intervening Event would be inconsistent with the directors&#8217; fiduciary duties under applicable Law. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or elsewhere in this Agreement shall prohibit the Company or the Company Board or any committee thereof from (i)&#160;taking and disclosing to shareholders of the Company a position or communication contemplated by Rule 14e-2(a), Rule 14d-9, or Item 1012(a) of Regulation M-A promulgated under the Exchange Act, (ii)&#160;making any disclosure or communication to shareholders of the Company that the Company Board determines in good faith, after consultation with the Company&#8217;s financial advisors and outside legal counsel, is required by the directors&#8217; fiduciary duties under applicable Law or otherwise by applicable Law, it being understood, however, that this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not be deemed to permit the Company Board to make an Adverse Recommendation Change or take any of the actions referred to in clause (y)&#160;of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, except, in each case, to the extent permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or (iii)&#160;informing any Person of the existence of the provisions contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) As used in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, &#8220;group&#8221; has the meaning ascribed to it in Rule 13d-5 promulgated under the Exchange Act. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Preparation of the Proxy Statement&#59; Shareholders Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As promptly as reasonably practicable after the execution of this Agreement, the Company (with the assistance and cooperation of Parent as reasonably requested by the Company) shall prepare the Proxy Statement and file it with the SEC. Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company Board shall make the Company Board Recommendation to the holders of Company Shares and shall include such recommendation in the Proxy Statement. Parent shall provide to the Company all information concerning Parent and Merger Sub as may be reasonably requested by the Company in connection with the Proxy Statement and shall otherwise assist and cooperate with the Company in the preparation of the Proxy Statement and the resolution of any comments thereto received from the SEC. Each of the Company, Parent, and Merger Sub shall promptly correct any information provided by it for use in the Proxy Statement, if and to the extent such information shall have become false or misleading in any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">material respect. Each of the Company and Parent shall notify the other promptly in writing after the receipt of any comments from the SEC and of any request by the SEC for amendments or supplements to the Proxy Statement or for additional information and shall supply the other with copies of all written correspondence between such party or any of its Representatives, on the one hand, and the SEC, on the other hand, with respect to the Proxy Statement. Each of the Company and Parent shall use their respective reasonable best efforts to respond as promptly as reasonably practicable to any comments received from the SEC concerning the Proxy Statement and to resolve such comments with the SEC, and the Company shall use its reasonable best efforts to cause the Proxy Statement to be disseminated to its shareholders as promptly as reasonably practicable after the resolution of any such comments. Prior to the filing of the Proxy Statement (or any amendment or supplement thereto) or any dissemination thereof to the holders of Company Shares, or responding to any comments from the SEC with respect thereto, the Company shall provide Parent with a reasonable opportunity to review and to propose comments on such document or response, which the Company shall consider in good faith. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company shall take all necessary actions, including in accordance with applicable Law, the Company Organizational Documents, and the rules of the New York Stock Exchange, to duly call, give notice of, convene, and hold a meeting of its shareholders (including any adjournment, recess, reconvening, or postponement thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Shareholders Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for the purpose of obtaining approval of the Bye-Law Amendment and Company Shareholder Approval, as soon as reasonably practicable after the SEC confirms that it has no further comments on the Proxy Statement. Without limiting the generality of the foregoing, the Company agrees that its obligations pursuant to the first sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not be affected by (i)&#160;the commencement, public proposal, public disclosure or communication to the Company of any Takeover Proposal or (ii)&#160;the Company Board of Directors making an Adverse Recommendation Change. The Bye-Law Amendment proposal shall appear first on the proxy card in the Proxy Statement ahead of the proposals to obtain the Company Shareholder Approval. The Company shall not include in the Proxy Statement any proposal to vote upon or consider any Takeover Proposal. Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company shall use its reasonable best efforts to obtain approval of the Bye-Law Amendment and the Company Shareholder Approval. Notwithstanding anything to the contrary contained in this Agreement, the Company shall not, without Parent&#8217;s consent, adjourn, recess, reconvene, or postpone the Company Shareholders Meeting, if after reasonable consultation with Parent, the Company reasonably believes that (i)&#160;such adjournment, recess, reconvening, or postponement is necessary to ensure that any required supplement or amendment to the Proxy Statement is provided to the holders of Company Shares within a reasonable amount of time in advance of the Company Shareholders Meeting, (ii)&#160;as of the time for which the Company Shareholders Meeting is originally scheduled (as set forth in the Proxy Statement), (A) there will be an insufficient number of Company Shares present (either in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Shareholders Meeting or (B)&#160;there will be an insufficient number of proxies to obtain approval of the Bye-Law Amendment or the Company Shareholder Approval or (iii)&#160;such adjournment, recess, reconvening or postponement is required by Law or a court or other Governmental Authority of competent jurisdiction in connection with any Actions in connection with this Agreement or the Transactions or has been requested by the SEC or its staff. The Company shall adjourn or postpone the Company Shareholders Meeting once, for a period of up to fourteen (14)&#160;days, if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requested by Parent (in Parent&#8217;s sole discretion) to permit additional time to solicit the Company Shareholder Approval, if sufficient proxies constituting the Company Shareholder Approval have not been received by the Company. If requested by Parent, the Company shall advise Parent at least on a daily basis on each of the last seven (7)&#160;days prior to the date of the Company Shareholders Meeting (and any reconvening thereof) as to the aggregate tally of proxies received by the Company with respect to the Company Shareholder Approval and whether such proxies have been voted affirmatively or negatively with respect to each of the proposals to be presented at the Company Shareholders Meeting. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reasonable Best Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Upon the terms and subject to the conditions set forth in this Agreement, each of Parent, Merger Sub, and the Company shall, and shall cause their respective Subsidiaries to, and Parent shall use its reasonable best efforts to cause its control persons under applicable Law to, if applicable, use its reasonable best efforts to fulfill all conditions to Closing applicable to such party pursuant to this Agreement and to consummate and make effective, in the most expeditious manner reasonably practicable, the Merger and the other Transactions, including (i)&#160;using reasonable best efforts to obtain all necessary, proper, or advisable Consents from Governmental Authorities and making all necessary, proper, or advisable registrations, filings, and notices and using reasonable best efforts to take all steps as may be necessary to obtain such Consents from any Governmental Authority (including under Insurance Laws and the HSR Act and any other applicable Antitrust Laws) and (ii)&#160;executing and delivering any additional agreements, documents, or instruments necessary, proper, or advisable to consummate the Transactions, and to fully carry out the purposes of, this Agreement. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Without limiting the foregoing and subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.04(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.04(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each party hereto shall, and shall cause its Subsidiaries to, and Parent shall use its reasonable best efforts to cause its control persons under applicable Law to, if applicable, use reasonable best efforts to avoid each and every impediment under any applicable Law that may be asserted by, or judgment, decree, and order that may be entered with, any Governmental Authority with respect to this Agreement, the Merger, or any other Transaction, so as to enable the Closing to occur in the most expeditious manner reasonably practicable, including using reasonable best efforts to (i)&#160;obtain all Consents of Governmental Authorities necessary, proper, or advisable to consummate the Transactions and secure the expiration or termination of any applicable waiting period under the HSR Act and any other applicable Antitrust Laws, (ii)&#160;resolve any objections that may be asserted by any Governmental Authority with respect to the Merger or any other transaction contemplated hereby, and (iii)&#160;prevent the entry of, and have vacated, lifted, reversed, or overturned, any judgment, decree, or order of Governmental Authorities that would prevent, prohibit, restrict, or delay the consummation of the Merger or any other Transaction contemplated hereby. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) In furtherance of and without limiting the foregoing, (i)&#160;Parent shall, and shall use its reasonable best efforts to cause each of its control persons under applicable Law, if applicable, to, file a &#8220;Form A&#8221; Acquisition of Control with the Insurance Commissioner of the States of Texas and North Dakota, within twenty (20)&#160;business days after the date hereof, which filings shall include a business plan that is consistent in all material respects with the Summary </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business Plan, (ii)&#160;Parent shall file any pre-acquisition notifications on &#8220;Form E&#8221; or similar market share notifications to be filed in each jurisdiction where required by applicable Insurance Laws within twenty (20)&#160;business days after the date hereof&#59; (iii)&#160;each of Parent and the Company shall file a notification and report form pursuant to the HSR Act with the Federal Trade Commission and the Antitrust Division of the United States Department of Justice with respect to the Transactions and requesting early termination of the waiting period under the HSR Act, within twenty (20)&#160;business days after the date hereof, (iv)&#160;Parent shall file an application with the Bermuda Monetary Authority within twenty (20)&#160;business days after the date hereof, (v)&#160;Parent shall, and shall use its reasonable best efforts to cause each of its control persons under applicable Law, if applicable, to, file a notification under section 178 of the Financial Services and Markets Act 2000 to the Prudential Regulation Authority and the Financial Conduct Authority within twenty (20)&#160;business days after the date hereof, (vi)&#160;Parent or, where appropriate, the Company Subsidiary that is a Lloyd&#8217;s managing agent, shall, following the provision of a draft approved by Parent, file a notification requesting the written consent of the Franchise Board as required by paragraph 43 of the Lloyd&#8217;s Underwriting Bye-Law within twenty (20)&#160;business days after the date hereof, (vii)&#160;Parent shall, and shall use its reasonable best efforts to cause each of its control persons under applicable Law, if applicable, to, file a notification requesting the written consent of the Council as required by paragraph 12 of the Lloyd&#8217;s Membership Bye-law to Lloyd&#8217;s within twenty (20)&#160;business days after the date hereof, (viii)&#160;Parent or the Company, as applicable, shall, and shall use its reasonable best efforts to cause each of their control persons under applicable Law, if applicable, to, make any other necessary, proper, or advisable registrations, filings, and notices under non-U.S. Insurance Laws within twenty (20)&#160;business days after the date hereof, (ix)&#160;Parent or the Company, as applicable, shall make any necessary, proper, or advisable registrations, draft filings and notices under non-U.S. Antitrust Laws within twenty (20)&#160;business days after the Company provides the information necessary to determine what filings are required under any applicable Antitrust Laws, and (x)&#160;Parent or the Company, as applicable, shall, and shall use its reasonable best efforts to cause each of their control persons under applicable Law, if applicable, to, make any other necessary, proper, or advisable registrations, filings, and notices within twenty (20)&#160;business days after the date hereof. All filings, presentations or communications to the public or to third parties that are made by or on behalf of Parent or any of its control persons under applicable Law in connection with the transactions contemplated by this Agreement that include or require a description of, or an attachment of, any plans for the business, operations or management of the Company or any of its Subsidiaries after the Closing shall include a description or plan that is consistent in all material respects with the Summary Business Plan, and neither Parent nor any of its control persons under applicable Law or Representatives shall make any statements or representations to any Governmental Authority, rating agency or any other Person in connection with the transactions contemplated by this Agreement that are inconsistent with the Summary Business Plan. All filing fees payable in connection with the foregoing shall be borne by Parent. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Each of the Company, Parent, and Merger Sub shall consult with one another with respect to the obtaining of all Consents of Governmental Authorities necessary, proper, or advisable to consummate the Transactions and each of the Company, Parent, and Merger Sub shall keep the others reasonably apprised on a prompt basis of the status of matters relating to such Consents. The Company shall supply all information reasonably requested by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parent to prepare any necessary filings and to make a determination of what filings under the Antitrust Laws are necessary. Parent and the Company shall have the right to review in advance and, to the extent practicable, and subject to any restrictions under applicable Law, each shall consult the other with respect to, any filing made with, or written materials submitted to, any Governmental Authority or any third party in connection with the Transactions and each party agrees to in good faith consider comments of the other parties thereon. Parent and the Company shall promptly furnish to each other copies of all such filings and written materials after their filing or submission, in each case subject to applicable Laws. Parent and the Company shall promptly advise each other upon receiving any communication from any Governmental Authority whose Consent is required to consummate the Transactions, including promptly furnishing each other copies of any written or electronic communication (redacted or on an outside counsel basis as necessary), and shall promptly advise each other when any such communication causes such party to believe that there is a reasonable likelihood that any such Consent will not be obtained or that the receipt of any such Consent will be materially delayed or conditioned. Parent, Merger Sub, and the Company shall not, and shall cause their respective Affiliates not to, permit any of their respective Representatives to participate in any live or telephonic meeting with any Governmental Authority (other than routine or ministerial matters) in respect of any filing, investigation, or other inquiry relating to the Transactions, unless, to the extent practicable, (i)&#160;it consults with the other party in advance and, (ii)&#160;to the extent permitted by applicable Law and by such Governmental Authority, gives the other party the opportunity to attend and participate in such meeting. Notwithstanding the foregoing or anything else contained in this Agreement, no party shall be obligated to provide information to another party, if such party determines, in its reasonable judgment, that (i)&#160;doing so would violate applicable Law or a Contract, agreement, privilege or obligation of confidentiality owing to a third party, jeopardize the protection of an attorney-client privilege, or expose such party to risk of liability for disclosure of sensitive or personal information (it being understood that the parties shall, and shall cause their respective Affiliates to, use commercially reasonable efforts to enable such information to be furnished or made available to the requesting party or its Representatives without so jeopardizing privilege or protection, incurring liability, or contravening applicable Law or Contract, agreement, or obligation, including by entering into a customary joint defense agreement or common interest agreement with the requesting party, to the extent such an agreement would preserve the applicable privilege or protection) or (ii)&#160;such information is not directly related to the Transactions. For the avoidance of doubt, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.04(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (except for the immediately preceding sentence) shall not apply with respect to Tax matters. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Notwithstanding anything to the contrary contained in this Agreement, in no event shall a party or any of its Affiliates be required by a Governmental Authority to agree to take, or enter into any action, which action is not conditioned upon the Closing. </font></div><div style="margin-bottom:9pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) Notwithstanding anything to the contrary contained in this Agreement, in no event shall Parent or any of its Affiliates be required to (and in no event shall the Company or any Subsidiary of the Company without the prior written consent of Parent agree to) take or refrain from taking, or agree to take or refrain from taking, any action, including entering into any consent decree, hold separate order, or other arrangement, or permit or suffer to exist any condition, limitation, restriction or requirement (i)&#160;that would, or would reasonably be expected to, have a material adverse effect on the business, results of operations, or financial condition of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A) the Company and its Subsidiaries, taken as a whole, or (B)&#160;Parent or any of its Affiliates (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, for this purpose, that the business and the financial condition, results of operations and other financial metrics of Parent or any of its Affiliates that is of a smaller scale than the Company and its Subsidiaries, taken as a whole, shall be deemed to be of the same scale as those of the Company and its Subsidiaries, taken as a whole), (ii) relating to the contribution of capital, or any guaranty, keep-well, capital maintenance or similar arrangement, by Parent or any of its Affiliates (other than the Company and its Subsidiaries) to or of the Company or any of its Subsidiaries or any restrictions on dividends or distributions that, in any case, has or would reasonably be expected to have a non-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adverse economic impact on Parent or any of its Affiliates or (iii)&#160;that requires or involves any adverse deviation in any material respect from any key term of the Summary Business Plan with respect to the Company and the Company Insurance Subsidiaries in connection with the Merger identified in Section&#160;6.04(f) of the Parent Disclosure Letter (any such requirement, individually or together with all other such requirements, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Burdensome Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Except as approved by Parent, the Company shall not, and shall not permit any of its Subsidiaries to, make or agree to any concessions with a Governmental Authority in order to obtain the approvals set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to Parent being entitled to invoke a Parent Burdensome Condition, the parties and their respective Representatives shall promptly confer in good faith in order to (i)&#160;exchange and review their respective views and positions as to any Parent Burdensome Condition or potential Parent Burdensome Condition and (ii)&#160;discuss and present to, and engage with, the applicable Governmental Authority regarding any approaches or actions that would avoid the imposition of a Parent Burdensome Condition or mitigate its impact so that it is no longer a Parent Burdensome Condition. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) If requested by Parent, (i)&#160;the Company shall reasonably cooperate with Parent in preparing and implementing a communications strategy with respect to Producers, reinsurers and other Persons with material relationships with the Company and (ii)&#160;the parties shall, and shall cause their respective Subsidiaries to, use reasonable best efforts to obtain all consents and approvals under any Contracts to which the Company or any of its Subsidiaries is a party in order to avoid any breach or loss of any right thereunder by the Company or any of its Subsidiaries or any right of termination by any counterparty thereto arising solely as a result of the entry into this Agreement or the consummation of the transactions contemplated hereby&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that (A)&#160;without the prior written consent of Parent, the Company shall not (and shall cause its Subsidiaries not to) make any concessions to any such Persons in connection with their efforts to obtain such consents and approvals, (B)&#160;the Company and its Subsidiaries shall not be required to make any concessions to the counterparty to such Contracts that would result in any of them incurring any cost or making any payment in connection with obtaining any such consent (unless Parent agrees to make such payment or incur such cost on behalf of the Company or to indemnify the Company therefore, or such payment or cost is not required to be paid or incurred until after the Effective Time), (C) the Company and its Subsidiaries shall not be required to agree to take or enter into any action that is not conditioned upon the Closing, and (D)&#160;Parent shall not be required to agree to make any concessions to the counterparty to any such Contract (unless Parent agrees to make any payments in connection with such concessions on behalf of the Company or to indemnify the Company therefore, or such concessions would not be effective until after the Effective Time). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, all share transfer, real estate transfer, documentary, stamp, recording and other similar Taxes (including interest, penalties, and additions to any such Taxes) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) incurred in connection with the Transactions shall be paid by Parent or the Surviving Company, and, prior to the Effective Time, the Company shall cooperate with Parent in preparing, executing, and filing any applicable Tax Returns with respect to such Transfer Taxes. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Public Announcements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Parent and Merger Sub, on the one hand, and the Company, on the other hand, shall consult with each other before issuing, and give each other reasonable opportunity to review and comment upon, any press release or other public statement with respect to the Transactions, and shall not (and shall not cause or permit their respective Subsidiaries or Representatives to) issue any such press release or make any such public statement prior to such consultation, except (i)&#160;as may be required by applicable Law, court process, or the rules and regulations of any national securities exchange or national securities quotation system, (ii)&#160;as otherwise explicitly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or (iii)&#160;to enforce its rights and remedies under this Agreement. The parties agree that the initial press release to be issued with respect to the Transactions following execution of this Agreement shall be in the form heretofore agreed to by the parties. The Company shall not make any internal announcements or other communications to its employees, customers, brokers or reinsurance providers with respect to this Agreement or the Transactions without Parent&#8217;s prior written consent, such consent not to be unreasonably withheld, conditioned or delayed. Notwithstanding the foregoing, Parent and the Company may make any oral or written public or internal announcements, releases or statements without complying with the foregoing requirements, if the substance of such announcements, releases or statements, was publicly or internally disclosed and previously subject to the foregoing requirements. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Access to Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to applicable Law, upon reasonable notice, the Company shall afford to Parent and Parent&#8217;s Representatives reasonable access during normal business hours to the Company&#8217;s officers, employees, agents, properties, books, Contracts, and records and the Company shall furnish promptly to Parent and Parent&#8217;s Representatives such information concerning its business, personnel, assets, liabilities, and properties as Parent may reasonably request&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that Parent and its Representatives shall conduct any such activities in such a manner as not to interfere unreasonably with the business or operations of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, notwithstanding the foregoing, the Company shall not be obligated to provide such access or information, if the Company determines, in its reasonable judgment, that doing so could violate applicable Law or a Contract or obligation of confidentiality owing to a third party, waive the protection of an attorney-client privilege or other legal privilege, or expose the Company to risk of liability for disclosure of sensitive or personal information. Without limiting the foregoing, in the event that the Company does not provide access or information in reliance on the immediately preceding sentence, it shall provide notice to Parent that it is withholding such access or information and the basis for such withholding and shall use its commercially reasonable efforts to enable such information to be furnished or made available to the requesting party or its Representatives without so jeopardizing privilege or protection, incurring liability, or contravening applicable Law or Contract or obligation, including by entering into a customary joint defense agreement or common interest agreement with the requesting party, to the extent such an agreement would </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preserve the applicable privilege or protection. All requests for information made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be directed to the Person designated by the Company. In furtherance and not in limitation of the foregoing, during the period from the date of this Agreement through the earlier of the Closing and the termination of this Agreement, except as required by applicable Law, the Company shall cause its applicable officers and employees, including its Chief Financial Officer and Head of Reinsurance, to meet (which may be by electronic means) on a regular basis, and in any event no less than weekly, unless otherwise agreed by the Company and the Designated Representative, with representatives of Parent and its Affiliates designated by Parent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Designated Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to discuss the Company&#8217;s ceded reinsurance plan for 2019 and future periods. Among other things, the Company and the Designated Representatives will cooperate and consider in good faith modifications to the Company&#8217;s 2019 reinsurance program that may result in a different overall mix of reinsurance protection than in past periods, with a focus on downside protection with greater emphasis on excess of loss and catastrophe coverage and less overall emphasis on quota-share reinsurance. The Company shall consult with, and consider in good faith any recommendations of, the Designated Representatives in regard to the development of the overall reinsurance plan for the Company and its Subsidiaries, as well as on any determination to enter into, renew and modify any Ceded Reinsurance Contract. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.08 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification and Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) From and after the Effective Time, the Surviving Company shall, and Parent shall cause the Surviving Company to, (i)&#160;indemnify and hold harmless each individual who at the Effective Time is, or at any time prior to the Effective Time was, a director or officer of the Company, a Subsidiary of the Company, or any other Person in which the Company or any of its Subsidiaries owns any equity interests at the request of the Company (each, together with such Person&#8217;s heirs, executors and administrators, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnitees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) with respect to all claims, liabilities, losses, damages, judgments, fines, penalties, costs (including amounts paid in settlement or compromise), and expenses (including fees and expenses of legal counsel) in connection with any Action (whether civil, criminal, administrative, or investigative), whenever asserted, based on or arising out of, in whole or in part, (A)&#160;the fact that an Indemnitee is or was a director or officer of the Company or such Subsidiary or (B)&#160;acts or omissions by an Indemnitee in the Indemnitee&#8217;s capacity as a director, officer, employee, or agent of the Company or such Subsidiary or taken at the request of the Company or such Subsidiary (including in connection with serving at the request of the Company or such Subsidiary as a director, officer, employee, agent, trustee, or fiduciary of another Person (including any employee benefit plan)), in each case under clause (A)&#160;or (B), at, or at any time prior to, the Effective Time (including any Action relating in whole or in part to the Transactions or relating to the enforcement of this provision or any other indemnification or advancement right of any Indemnitee), to the fullest extent permitted under applicable Law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no Indemnitee shall be indemnified against any liability that by virtue of any rule of law attaches to such Indemnitee in respect of any fraud or dishonesty of which such Indemnitee is guilty in relation to the Company, as finally determined by the Supreme Court of Bermuda&#59; and (ii)&#160;assume all obligations of the Company and such Subsidiaries to the Indemnitees in respect of indemnification and exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time (and rights for advancement of expenses) as provided </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Company Organizational Documents and the Organizational Documents of such Subsidiaries as in effect on the date of this Agreement or in any agreement in existence as of the date of this Agreement providing for indemnification between the Company and any Indemnitee. Without limiting the foregoing, Parent, from and after the Effective Time, shall cause, to the fullest extent permitted under applicable Law, the memorandum of association and bye-laws of the Surviving Company to contain provisions no less favorable to the Indemnitees with respect to limitation of liabilities of directors and officers, advancement of expenses and indemnification than are set forth as of the date of this Agreement in the Company Organizational Documents, which provisions shall not be amended, repealed, or otherwise modified for a period of six (6)&#160;years from the Effective Time in a manner that would adversely affect the rights thereunder of the Indemnitees, except as amendments may be required by applicable Law during such period. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) For the six-year period commencing immediately after the Effective Time, the Surviving Company shall maintain in effect directors&#8217; and officers&#8217; liability insurance from an insurance carrier with the same or better financial strength of the Company&#8217;s current carrier with respect to directors&#8217; and officers&#8217; liability insurance covering acts or omissions occurring at or prior to the Effective Time with respect to Indemnitees on terms and scope with respect to such coverage, and in amount, no less favorable to such individuals than those of such policies in effect on the date of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, if the annual premium for such insurance shall exceed 300% of the current annual premium (such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">300% threshold, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Maximum Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which Maximum Premium is set forth in Section&#160;6.08(b) of the Company Disclosure Letter, then Parent shall provide or cause to be provided a policy for the applicable individuals with the best coverage as shall then be available at an annual premium not in excess of the Maximum Premium. The Company may prior to the Effective Time purchase, for an aggregate amount not to exceed the aggregate Maximum Premium for six (6)&#160;years, a six-year prepaid &#8220;tail&#8221; policy on terms and conditions providing at least substantially equivalent benefits as the current policies of directors&#8217; and officers&#8217; liability insurance maintained by the Company and its Subsidiaries with respect to matters existing or occurring prior to the Effective Time, including the Transactions. If such prepaid &#8220;tail&#8221; policy has been obtained by the Company, it shall be deemed to satisfy all obligations to obtain insurance pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the Surviving Company shall use its reasonable best efforts to cause such policy to be maintained in full force and effect, for its full term, and to honor all of its obligations thereunder. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are (i)&#160;intended to be for the benefit of, and shall be enforceable by, each Indemnitee, his or her heirs, and his or her Representatives and (ii)&#160;in addition to, and not in substitution for, any other rights to indemnification or contribution that any such individual may have under the Company Organizational Documents, by Contract, or otherwise. The obligations of Parent and the Surviving Company under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not be terminated or modified in such a manner as to adversely affect the rights of any Indemnitee to whom this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applies, unless (x)&#160;such termination or modification is required by applicable Law or (y)&#160;the affected Indemnitee shall have consented in writing to such termination or modification (it being expressly agreed that the Indemnitees to whom this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applies shall be third party beneficiaries of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) In the event that Parent, the Surviving Company, or any of their respective successors or assigns (i)&#160;consolidates or amalgamates with or merges into any other Person and is not the continuing or surviving company or entity of such consolidation, amalgamation, or merger or (ii)&#160;transfers or conveys all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Parent or the Surviving Company shall assume all of the obligations thereof set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Nothing in this Agreement is intended to, shall be construed to, or shall release, waive, or impair any rights to directors&#8217; and officers&#8217; insurance claims under any policy that is or has been in existence with respect to the Company or any of its Subsidiaries for any of their respective directors, officers, or other employees, it being understood and agreed that the indemnification provided for in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is not prior to or in substitution for any such claims under such policies. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.09 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to the Effective Time, the Company and Parent shall take such steps as may be reasonably necessary or advisable to cause dispositions of Company equity securities (including derivative securities) and acquisitions of Parent equity securities (including derivative securities) pursuant to the Transactions by each individual who is a director or officer of the Company subject to Section&#160;16 of the Exchange Act to be exempt under Rule 16b-3 promulgated under the Exchange Act. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) From and after the Effective Time through the end of the calendar year following the year in which the Effective Time occurs (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuation Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), Parent shall provide, or shall cause the Surviving Company to provide, each individual who is employed by the Company or any of its Subsidiaries immediately prior to the Effective Time (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) with a base salary or wage rate, target annual incentive compensation opportunity and other compensation and employee benefits (excluding special, one-time or transaction-based compensation and benefits, defined benefit plan benefits, retiree welfare and long-term incentive compensation opportunities) that are not materially less favorable, in the aggregate, than those provided to such Company Employee by the Company and any of its Subsidiaries immediately prior to the Effective Time. Without limiting the generality of the foregoing, Parent shall provide, or shall cause the Surviving Company to provide, each Company Employee whose employment is terminated by Parent, the Surviving Company or any of their respective Affiliates during the Continuation Period (other than for cause)with severance benefits that are no less favorable, in the aggregate, than those set forth on Section&#160;6.10(a) of the Company Disclosure Letter. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Without limiting the generality of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, from and after the Effective Time, Parent shall, or shall cause the Surviving Company to, honor and continue all of the Company&#8217;s employment, severance, retention, termination and change-in-control plans, policies, programs, agreements and arrangements maintained by the Company or any of its Subsidiaries as set forth in Section&#160;6.10(b) of the Company Disclosure Letter, in each case, as in effect at the Effective Time, including with respect to any payments, benefits or rights arising as a result of the Transactions (either alone or in combination with any other event), subject, in each case, to the terms and conditions of such arrangements including any provisions related to amendment, modification, termination and discontinuance. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) With respect to all employee benefit plans of Parent, the Surviving Company and its Subsidiaries, including any &#8220;employee benefit plan&#8221; (as defined in Section&#160;3(3) of ERISA) (including any paid time off and severance plans) in which Company Employees are first eligible to participate following the Effective Time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), for purposes of determining eligibility to participate, level of benefits and vesting, each Company Employee&#8217;s service with the Company or any of its Subsidiaries (as well as service with any predecessor employer of the Company or any such Subsidiary, to the extent service with the predecessor employer was recognized by the Company or such Subsidiary) shall be treated as service with Parent, the Surviving Company or any of its Subsidiaries (or in the case of a transfer of all or substantially all the assets and business of the Surviving Company, its successors and assigns)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that for the avoidance of doubt such service need not be recognized for purposes of any retiree health or welfare arrangements, any frozen benefit plan, benefit accrual under any defined benefit pension plan or to the extent that such recognition would result in any duplication of benefits for the same period of service. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Without limiting the generality of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Parent shall, or shall cause the Surviving Company to, use commercially reasonable efforts to waive, or cause to be waived, any pre-existing condition limitations, exclusions, actively-at-work requirements and waiting periods under any New Benefit Plan that is a welfare benefit plan in which Company Employees (and their eligible dependents) will be eligible to participate from and after the Effective Time, except to the extent that such pre-existing condition limitations, exclusions, actively-at-work requirements and waiting periods would not have been satisfied or waived under the comparable Company Plan immediately prior to the Effective Time. With respect to such New Benefit Plans, Parent shall, or shall cause the Surviving Company to, use commercially reasonable efforts to recognize the dollar amount of all co-payments, deductibles and similar expenses incurred by each Company Employee (and his or her eligible dependents) prior to the Effective Time during the calendar year in which the Effective Time occurs for purposes of satisfying such year&#8217;s deductible and co-payment limitations under the relevant welfare benefit plans in which they will be eligible to participate from and after the Effective Time. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) For the avoidance of doubt, for purposes of any Company Plan containing a definition of &#8220;change in control&#8221; or &#8220;change of control&#8221; (or term of similar import) that relates to the Company, the occurrence of the Closing shall be deemed to constitute a &#8220;change in control&#8221; or &#8220;change of control&#8221; (or such term of similar import) of the Company under such Company Plan. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f) With respect to any Company Employee whose principal place of employment is outside of the United States, Parent&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be modified to the extent necessary to comply with applicable Law of the foreign countries and political subdivisions thereof in which such Company Employee primarily performs his duties. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g) Company shall provide an accurate and complete list upon the Closing of each Company Employee whose employment with the Company terminated within the ninety (90)&#160;days prior to the Closing Date, stating for each such employee the date of termination, the employee&#8217;s position and work location, and whether such termination was voluntary or involuntary, and if involuntary, whether it was for cause. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h) The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are solely for the benefit of the parties to this Agreement, and no provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is intended to, or shall, constitute the establishment or adoption of or an amendment to any employee benefit plan for purposes of ERISA or otherwise and, except as otherwise explicitly provided for in this Agreement, no current or former employee or any other individual associated therewith shall be regarded for any purpose as a third-party beneficiary of this Agreement or have the right to enforce the provisions hereof. Nothing contained in this Agreement is intended to prevent Parent, the Surviving Company or any of their Affiliates from, after the Effective Time, (i)&#160;amending or terminating any of their benefit plans in accordance with their terms or (ii)&#160;terminating the employment of any Company Employee. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notification of Certain Matters&#59; Shareholder Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the period from the date of this Agreement through the earlier of the Closing and the termination of this Agreement, Parent shall give prompt notice to the Company, and the Company shall give prompt notice to Parent, of any Actions commenced or, to such party&#8217;s Knowledge, threatened against such party which relates to this Agreement, the Statutory Merger Agreement, or the Transactions and such party shall keep the other party reasonably informed regarding any such Action. Subject to applicable Law, the Company shall give due consideration to Parent&#8217;s advice with respect to such Action and shall give Parent the opportunity to participate, at Parent&#8217;s sole cost and expense, in the defense and settlement of any such Action, and no such settlement shall be agreed to without Parent&#8217;s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed). </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Immediately following the execution of this Agreement, Parent shall execute and deliver, in accordance with Section&#160;106 of the Bermuda Companies Act and in its capacity as the sole shareholder of Merger Sub, a written consent approving this Agreement, the Statutory Merger Agreement, and the Merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Sub Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.13 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Client Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company shall, or shall cause the IA Subsidiary to, use commercially reasonable efforts to obtain the consent (which consent may take the form of negative consent, to the extent written consent is not required by such Client&#8217;s Advisory Contract or, if the Client is a Private Fund, the Private Fund&#8217;s Organizational Documents) of each Client to the deemed assignment of such Client&#8217;s Advisory Contract in connection with the transactions contemplated hereby (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advisory Client Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). In connection with obtaining the Advisory Client Consents, (a)&#160;the Company shall take reasonable steps to keep Parent reasonably informed of the status of obtaining such Advisory Client Consents and such other actions and, upon Parent&#8217;s request, make available to Parent copies of all such executed Advisory Client Consents and other records relating to the Advisory Client Consent process and (b)&#160;Parent shall have the right to review in advance of distribution the general forms of any notices or other materials to be distributed by the IA Subsidiary to Clients (or, if the Client is a Private Fund, any limited partner, member or beneficial owner of the Private Fund) and shall have the right to have its reasonable comments considered by the Company in a commercially reasonable manner prior to distribution. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.14 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financing Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The Company shall use its reasonable best efforts to provide, and to cause each of its Subsidiaries and their respective advisors, legal counsel, accountants, and representatives to use reasonable best efforts to provide, such reasonable cooperation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, in each case, the requested cooperation does not unreasonably interfere with the ongoing operations of the Company and&#47;or any of its Subsidiaries) that is customary in connection with the arrangement of the Debt Financing contemplated by the Debt Commitment Letter, including using reasonable best efforts to&#58; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) assist in preparation for and participate in marketing efforts and lender presentations in connection with the Debt Financing at reasonable times and locations mutually agreed&#59; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) assist Parent with the preparation by Parent and the Debt Financing Sources of bank information memoranda and similar marketing documents required in connection with the Debt Financing, including the execution and delivery of customary representation letters in connection with bank information memoranda&#59; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) cooperate reasonably with the Debt Financing Sources&#8217; due diligence, to the extent customary and reasonable&#59; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) execute and deliver as of (but not prior to) the Closing any pledge and security documents, account control agreements, mortgages, other definitive financing documents, currency or interest hedging arrangements, or other certificates or documents as may be reasonably requested by Parent (including a certificate of the chief financial officer (or other comparable officer) of the Company with respect to solvency matters after giving effect to the transactions contemplated hereby) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, other than with respect to any customary representation letters referred to in clause (ii)&#160;above, (A) none of the documents or certificates shall be executed or delivered, except in connection with the Closing, and (B)&#160;the effectiveness thereof shall be conditioned upon, or become operative after, the occurrence of the Closing) and otherwise reasonably facilitate the pledging of collateral and the granting of security interests in respect of the Debt Financing&#59; and </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) provide all documentation and other information about the Company and its Subsidiaries as is reasonably required under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations including the USA PATRIOT Act, to the extent required by the Debt Commitment Letter. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) In connection with such cooperation, neither the Company nor any of its Subsidiaries shall be required to (i)&#160;pay any commitment or similar fee in connection with the Debt Financing prior to the Closing Date or bear or reimburse any costs or expenses or make any payment to obtain consent or to incur any other actual or potential liability or cause or permit any Lien to be placed on any of its assets in connection with the Debt Financing prior to Closing, in each case, for which it has not received prior reimbursement or is not otherwise fully indemnified by or on behalf of Parent, (ii)&#160;become an issuer or other obligor with respect to the Debt Financing, unless and until the Closing occurs, or (iii)&#160;execute or deliver, or take any corporate or other action to adopt or approve, any document, agreement, certificate or instrument with respect to the Financing that will be effective before the Closing Date. Parent shall, promptly, upon written request by the Company, reimburse the Company or any of its Subsidiaries, as applicable, for all reasonable and documented out-of-pocket fees, costs, and expenses incurred by any the Company and its Subsidiaries or any of their respective representatives (including those of their accounting firms engaged to assist in connection with the Debt Financing and legal counsel) in connection with the cooperation required by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and shall indemnify and hold harmless the Company and its Subsidiaries and each of their respective representatives from and against all losses, damages, claims, costs, or expenses (including reasonable attorneys&#8217; fees) suffered or incurred by any of them directly or indirectly in connection with such Person complying with their obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and any information used in connection therewith. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The Company hereby consents to the use of its logos solely in connection with the Financing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that Parent and Merger Sub shall ensure that such logos are used solely in a manner that would not harm or disparage the Company or the Company&#8217;s reputation, goodwill or marks and will comply with the Company&#8217;s reasonable usage requirements. </font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall require such cooperation to the extent it would (i)&#160;cause any condition to Closing set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to fail to be satisfied or otherwise cause any breach of this Agreement (unless, in each case, waived by Parent), (ii) require the Company or any of its Subsidiaries to waive or amend any terms of this Agreement or take any action that would reasonably be expected to conflict with, or result in any violation or breach of, or default (with or without notice or lapse of time, or both) under any of their respective Organizational Documents, any applicable Laws or the Existing Debt Documents or (iii)&#160;result in any officer, director employee, agent or other representative of the Company or any of its Subsidiaries incurring any personal liability (as opposed to liability in his or her capacity as officer) with respect to any matters relating to the Debt Financing. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.15 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Existing Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If requested by Parent, the Company shall use reasonable best efforts to cooperate with Parent and Merger Sub in taking such actions as are necessary under (x)&#160;the indentures listed in item (iii)&#160;of Section&#160;4.16 of the Company Disclosure Letter and (y)&#160;the credit agreements listed in Section&#160;4.03(c) of the Company Disclosure Letter (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Existing Debt Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in respect of the Transactions, including delivering or causing a Subsidiary to deliver any such notices, agreements, documents, or instruments necessary, proper, or advisable to comply with the terms thereof, including the delivery of any officer certificates and opinions of counsel required to be delivered thereunder in connection with the Transactions. If and to the extent reasonably requested by Parent in writing, the Company shall use reasonable best efforts to cooperate with Parent and Merger Sub in either (a)&#160;arranging for the termination of Existing Debt Documents (or redemption of the relevant notes or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debentures) at the Closing (or such other date thereafter as agreed to by Parent and the Company), which redemption shall be the sole responsibility of Parent, and the procurement of customary payoff letters and other customary release documentation in connection therewith (including with respect to the Existing Revolving Credit Facility) or (b)&#160;obtaining any consents required under any Existing Debt Documents to permit the consummation of the Transactions thereunder and obtaining any amendments to or other consents under the Existing Debt Documents as may be reasonably requested by Parent, and in each case, if reasonably requested by Parent, the Company shall, and shall cause its Subsidiaries to, execute and deliver such customary notices, agreements, documents, or instruments necessary in connection therewith. Notwithstanding anything in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the contrary, in no event shall the Company be required in connection with its obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to (i)&#160;incur or agree to incur any out-of-pocket expenses, unless they are promptly reimbursed by Parent, (ii)&#160;incur or agree to incur any commitment, tender, consent, amendment fee or any fee similar to any of the foregoing, unless Parent provides the funding to the Company therefor, (iii)&#160;amend or agree to amend any Existing Debt Document, which amendment is not conditioned on the Closing, (iv)&#160;incur any liability in connection therewith prior to the Closing Date, unless contingent upon the occurrence of the Closing, (v)&#160;take any action that would unreasonably interfere with or unreasonably disrupt the normal operations and management of the Company and its Subsidiaries, (vi)&#160;take any action that the Company reasonably believes could (A)&#160;violate its or its Subsidiaries&#8217; certificate of incorporation or bye-laws (or comparable documents), (B) violate any applicable Law, (C)&#160;constitute a default or violation under, or give rise to any right of termination, cancellation, or acceleration of any right or obligation of the Company or its Subsidiaries or to a loss of any benefit to which the Company or its Subsidiaries is entitled under any provision of any Contract, or (D)&#160;result in the creation or imposition of any Lien on any asset of the Company or its Subsidiaries, (vii)&#160;waive or amend any terms of this Agreement, (viii)&#160;take any action that could reasonably be expected to cause any representation or warranty or covenant contained in this Agreement to be breached or to cause any condition to the Closing set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to fail to be satisfied or otherwise cause any breach of this Agreement, (ix)&#160;provide access to or disclose information that the Company determines would jeopardize any attorney-client privilege of the Company or any of its Subsidiaries, (x)&#160;fund any repayment, redemption, cash collateralization, or provide any &#8220;backstop&#8221; letters of credit prior to the Closing, or (xi)&#160;result in any of the Company&#8217;s or any of its Subsidiaries&#8217; Representatives incurring any personal liability with respect to any matters relating to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Parent shall defend, indemnify, and hold harmless the Company, any of its Subsidiaries, and any of their respective Representatives from, against, and in respect of any and all claims, liabilities, losses, damages, judgments, fines, penalties, costs, and expenses (including fees of legal counsel) resulting from or incurred in connection with the cooperation hereunder or any information utilized in connection therewith. Notwithstanding this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or anything in this Agreement to the contrary, each of the parties hereto agrees that it is not a condition to the Closing that the Debt Financing, payoff letters, consents, amendments, or other similar actions described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> be obtained. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.16 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Subject to the terms and conditions set forth herein, prior to the Closing, Parent shall use its reasonable best efforts to consummate and obtain the Equity Financing on the terms and conditions set forth in the Equity Commitment Letter no later than the date that the Closing is required to occur in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including using reasonable best efforts to&#58;&#160;(i) maintain in full force and effect the Equity Commitment Letter&#59; (ii)&#160;satisfy all conditions to the funding of the Equity Commitment Letter that are within its control&#59; (iii)&#160;comply on a timely basis with its obligations under the Equity Commitment Letter&#59; (iv)&#160;consummate the Equity Financing at or prior to the date that the Closing is required to occur in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and (v)&#160;enforce its rights under the Equity Commitment Letter. Nothing in this Agreement shall require, and in no event shall the reasonable best efforts of Parent or Merger Sub be deemed or construed to require, either Parent or Merger Sub to seek the Equity Financing from any source other than the Investors counterparty to, or in any amount in excess of that contemplated by, the Equity Commitment Letter.</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Parent shall not, without the prior written consent of the Company (which consent shall not be unreasonably withheld, conditioned or delayed), permit any amendment or modification to be made to or waiver of any rights under the Equity Commitment Letter. For the avoidance of doubt, (i)&#160;nothing herein shall prohibit or prevent Parent from exercising any of its rights under the Equity Commitment Letter without the consent of the Company, including the right to assign any of its rights or obligations thereunder in accordance with the terms thereof, and (ii)&#160;nothing in this Agreement shall prohibit the assignment by any Investor of any of its rights or obligations under the Equity Commitment Letter in accordance with its terms. Notwithstanding anything to the contrary in this Agreement or the Confidentiality Agreement, Parent and Merger Sub may enter discussions regarding, and may enter into arrangements and agreements relating to the Equity Financing to add other equity providers, so long as in respect of any such arrangements and agreements, the following conditions are met&#58; (i)&#160;the aggregate amount of the Equity Financing is not reduced&#59; (ii)&#160;the arrangements and agreements, individually or in the aggregate, would not be reasonably likely to delay or prevent the Closing&#59; (iii)&#160;the arrangements and agreements would not diminish or release the pre-Closing obligations of the parties to the Equity Commitment Letter, adversely affect the rights of Parent or Merger Sub to enforce its rights against the other parties to the Equity Commitment Letter, or otherwise constitute a waiver or reduction of Parent&#8217;s or Merger Sub&#8217;s rights under the Equity Commitment Letter&#59; and (iv)&#160;no such additional equity provider would (A)&#160;acquire ten percent (10%) or more of the equity securities of Parent or any of its Subsidiaries or (B)&#160;be granted a right to designate any member of the board of directors or other governing body of Parent or any of its Subsidiaries. Upon the consummation of the Equity Financing to Parent, in accordance with the Equity Commitment Letter, Parent shall draw down at Closing such amount of such Equity Financing as is required to make the full amount of payments it is required to make pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.17 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ratings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the other rights and terms of this Agreement, Parent shall not, and shall use its reasonable efforts to cause its control persons under applicable Law not to, knowingly take any action or knowingly fail to take any action with respect to the Transactions or the Company or any of its Subsidiaries that Parent, acting reasonably and assuming due consideration of the matter, believes is reasonably likely to result in a downgrade by A.M. Best or S&#38;P of the financial strength ratings of the Company Insurance Subsidiaries. Parent shall ensure that all of the actions taken by it or any of its control persons under applicable Law, or on behalf of any of them, with respect to the Company or any of its Subsidiaries or the Transactions, will be consistent with the Summary Business Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;6.18 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net CAT Losses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) If, as of any time on or prior to March&#160;3, 2019, one or more CAT Events has occurred during the Measurement Period and Parent, acting in accordance with the Agreed Standard, believes that Net CAT Losses arising from such CAT Events exceed the Specified Amount, then Parent may initiate the procedures contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to determine the amount of Net CAT Losses by delivering a written notice to such effect to the Company. If Parent validly exercises its right to initiate such procedures pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Determination Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), then the parties shall comply with the procedures set forth in clause (b)&#160;of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. Parent may not exercise the Determination Right more than once, and may not exercise the Determination Right after March&#160;3, 2019. If the Determination Right has been exercised, then the Closing will not occur until the Loss Report (as defined below) has been finally determined pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;If, after the Loss Report (as defined below) has been finally determined pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, all conditions to the Closing have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at such time), then, unless the parties otherwise agree in writing, the Closing will occur on the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business day after the date on which the Loss Report is finally determined pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) If Parent exercises the Determination Right in accordance with Section&#160;6.18(a) above, then the Company, acting in accordance with the Agreed Standard, shall within five Business Days after the Determination Right has been exercised deliver to Parent a written report (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loss Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) setting forth the Company&#8217;s reasonable and good faith estimated calculation of Net CAT Losses as of the end of the month immediately preceding the month in which the Determination Right was exercised.&#160;In all cases, the amounts set forth on the Loss Report shall be determined, and the calculation of Net CAT Losses as reflected therein shall be made, in accordance with Applicable SAP and the Company&#8217;s historical practice for setting reserves and determining similar amounts. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) Parent shall have ten business days to review the Loss Report and the calculations set forth therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Review Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).&#160;In furtherance of such review, the Company shall provide Parent and its Representatives with such reasonable access to the employees and Representatives of the Company, and to such documentation, records and other information of the Company relating to the information set forth on the Loss Report, as Parent may reasonably request. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) If Parent, acting in accordance with the Agreed Standard (and based on then available information), disagrees with the Company&#8217;s Loss Report (including any amount or computation set forth therein) on the basis that the Loss Report is inaccurate and that, if the Loss Report were accurate, Net CAT Losses as reflected on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such Loss Report would be greater than the Specified Amount, Parent may, on or prior to the last day of the Review Period, deliver a notice to the Company setting forth, in reasonable detail, each disputed item or amount and the basis for Parent&#8217;s disagreement therewith (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).&#160;The Dispute Notice shall set forth, with respect to each disputed item, Parent&#8217;s position as to the correct amount or computation that should have been included in the Loss Report. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) If no Dispute Notice is received by the Company with respect to any item in the Loss Report on or prior to the last day of the Review Period, the amount or computation with respect to such items as set forth in the Loss Report shall be deemed accepted by Parent, whereupon the amount or computation of such item or items shall be final and binding on the parties. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) For a period of ten business days beginning on the date that the Company receives a Dispute Notice, if any, the Company and the Parent, each acting in accordance with the Agreed Standard, shall endeavor in good faith to resolve by mutual agreement all matters identified in the Dispute Notice.&#160;In the event that the parties are unable to resolve by mutual agreement any matter in the Dispute Notice within such two business-day period, the Company and Parent shall jointly engage a mutually agreeable independent nationally recognized third party actuarial or accounting firm (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Independent Actuary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to resolve the dispute. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi) Parent and the Company will direct the Independent Actuary to render a determination within fifteen business days after its retention, and Parent, the Company and their respective employees and Representatives will cooperate with the Independent Actuary, as applicable, during its engagement.&#160;the Company, on the one hand, and Parent, on the other hand, shall promptly (and in any event within three business days) after the Independent Actuary&#8217;s engagement, as applicable, each submit to the&#160;Independent Actuary their respective computations of the disputed items identified in the Dispute Notice and information, arguments and support for their respective positions, and shall concurrently deliver a copy of such materials to the other party.&#160;Each party shall then be given an opportunity to supplement the information, arguments and support included in its initial submission with one additional submission to respond to any arguments or positions taken by the other party in such other party&#8217;s initial submission, which supplemental information shall be submitted to&#160;the Independent Actuary (with a copy thereof to the other party) within five business days after the first date on which both parties have submitted their respective initial submissions to the Independent Actuary.&#160;The Independent Actuary, as applicable, shall thereafter be permitted to request additional or clarifying information from the parties, and each of the parties shall cooperate and shall cause their Representatives to cooperate with such requests of the Independent Actuary.&#160;The Independent Actuary, as applicable, shall determine, based solely on the materials so presented by the parties and upon information received in response to such requests for additional or clarifying information and not by independent review, only those issues in dispute specifically set forth in the Dispute Notice and shall render a written report to Parent and the Company (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Actuary Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in which the Independent Actuary, as applicable shall, after considering all matters set forth in the Dispute Notice, determine what adjustments, if any, should be made to the amounts and computations set forth in the Loss Report. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii) The Actuary Report shall set forth, in reasonable detail, the Independent Actuary&#8217;s determination with respect to each of the disputed items or amounts specified in the Dispute Notice, and the revisions, if any, to be made to the Loss Report, together with supporting calculations.&#160;In resolving any disputed item, the Independent Actuary (i)&#160;shall be bound to the principles of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the terms of this Agreement (including that the amounts set forth in the Loss Report shall be determined in accordance with the Agreed Standard, Applicable SAP and the Company&#8217;s historical practice for setting reserves and similar amounts&#59; provided that the Independent Actuary may also review whether the amounts set forth on the Loss Report are reasonable based on industry practice and the nature of and circumstances surrounding any particular CAT Event or CAT Events), but (ii)&#160;shall limit its review to matters specifically set forth in the Dispute Notice and (iii)&#160;shall not assign a value to any item higher than the highest value for such item claimed by either party or less than the lowest value for such item claimed by either party.</font></div><div style="margin-bottom:24pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii) All fees and expenses relating to the work of the Independent Actuary shall be paid by the party (that is, the Company or Parent) whose position with respect to the matter in dispute is furthest from the Independent Actuary&#8217;s final determination.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE VII. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDITIONS PRECEDENT </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;7.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Each Party&#8217;s Obligation To Effect the Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The respective obligations of the Company, Parent, and Merger Sub to effect the Merger shall be subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing Date of the following conditions&#58; </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company Shareholder Approval shall have been obtained and either (i)&#160;the Bye-Law Amendment shall have been approved at the Company Shareholders Meeting or (ii)&#160;the affirmative vote in favor of the approval of this Agreement, the Statutory Merger Agreement, and the Merger of at least 66% of the voting power of the Company Shares entitled to vote, at a duly convened meeting of the Company shareholders at which a quorum is present in accordance with the Company&#8217;s Bye-Laws shall have been obtained. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (i)&#160;Any waiting period (or extension thereof) applicable to the Transactions under the HSR Act shall have been terminated or shall have expired and (ii)&#160;the Consents of, or declarations, notifications, or filings with, and the other terminations or expirations of waiting periods required from, the Governmental Authorities set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall have been filed, have occurred, or been obtained and, if applicable, shall be in full force and effect (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Required Regulatory Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Injunctions or Restraints</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No injunction, judgment, or ruling enacted, promulgated, issued, entered, amended, or enforced by any Governmental Authority (in each case, if with respect to any Antitrust Laws or Insurance Laws, solely with respect to the Required Regulatory Approvals) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restraints</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall be in effect enjoining, restraining, or otherwise making illegal or prohibiting consummation of the Merger. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;7.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Obligations of Parent and Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The obligations of Parent and Merger Sub to effect the Merger are further subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing Date of the following conditions&#58; </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The representations and warranties of the Company (i)&#160;set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be true and correct in all respects, except for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inaccuracies, as of the Closing Date, with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), (ii) set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.03(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be true and correct in all material respects as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such date), (iii) set forth in clause (b)&#160;of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be true and correct in all respects as of the Closing Date as if made on such date and (iv)&#160;set forth in this Agreement, other than those Sections specifically identified in clauses (i)&#160;or (iii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, shall be true and correct (disregarding all qualifications or limitations as to &#8220;materiality&#8221;, &#8220;Material Adverse Effect&#8221;, and words of similar import set forth therein) as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such date), except, in the case of this clause (iv), where the failure to be true and correct has not had and would not, individually or in the aggregate, constitute a Material Adverse Effect. Parent shall have received a certificate dated as of the Closing Date signed on behalf of the Company by an executive officer of the Company to such effect. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Obligations and Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company shall have performed or complied in all material respects with the obligations and agreements required to be performed or complied with by it under this Agreement at or prior to the Effective Time, and Parent shall have received a certificate dated as of the Closing Date signed on behalf of the Company by an executive officer of the Company to such effect. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Parent Burdensome Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. None of the consents, approvals, or authorizations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall contain, require, or result in a Parent Burdensome Condition. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ratings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of the Closing, the applicable financial strength ratings of the Company Insurance Subsidiaries identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that are&#58; (i)&#160;issued by A.M. Best shall be &#8220;A (Excellent)&#8221; or a higher rating (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the placement of such ratings under review, including &#8220;under review with negative implications&#8221; or &#8220;under review with developing implications,&#8221; shall not constitute a failure of this condition)&#59; and (ii)&#160;that are issued by S&#38;P shall be &#8220;A (Strong)&#8221; or a higher rating (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the placement of such ratings under review, including any &#8220;CreditWatch&#8221; action, or the attachment of any outlook to such ratings or &#8220;CreditWatch&#8221; action, including any &#8220;negative,&#8221; or &#8220;developing&#8221; outlook, shall not constitute a failure of this condition). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Triggering Event Notice Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There shall not have been any Triggering Event Notice Date within the twenty (20)&#160;business day period immediately prior to the Closing Date or Parent shall have waived its right to terminate this Agreement in response to a Triggering Event pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;7.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Obligations of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The obligations of the Company to effect the Merger are further subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing Date of the following conditions&#58; </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The representations and warranties of Parent and Merger Sub (i)&#160;set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be true and correct in all material respects as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such date) and (ii)&#160;set forth in this Agreement, other than those Sections specifically identified in clause (i)&#160;of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, shall be true and correct (disregarding all qualifications or limitations as to &#8220;materiality&#8221;, &#8220;Parent Material Adverse Effect&#8221;, and words of similar import set forth therein) as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which case as of such date), except, in the case of this clause (ii), where the failure to be true and correct has not had and would not, individually or in the aggregate, constitute a Parent Material Adverse Effect. The Company shall have received a certificate dated as of the Closing Date signed on behalf of Parent and Merger Sub by an executive officer of Parent to such effect. </font></div><div style="margin-bottom:24pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Obligations and Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Parent and Merger Sub shall have performed or complied in all material respects with the obligations and agreements required to be performed or complied with by them under this Agreement at or prior to the Effective Time, and the Company shall have received a certificate dated as of the Closing Date signed on behalf of Parent and Merger Sub by an executive officer of Parent to such effect. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE VIII. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TERMINATION </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;8.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement may be terminated and the Transactions abandoned at any time prior to the Effective Time, whether before or after receipt of the Company Shareholder Approval (except as otherwise expressly noted)&#58; </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) by the mutual written consent of the Company and Parent, duly authorized by each of the Company Board and the Parent Board&#59; </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) by either of the Company or Parent&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) if the Merger shall not have been consummated on or prior to May&#160;31, 2019 (as such date may be extended pursuant to the first proviso to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or, if applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-Away Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, if on such date the condition precedent to the consummation of the Merger and the other Transactions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.01(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not have been satisfied, but all other conditions precedent to the consummation of the Merger and the other Transactions have been satisfied (or, in the case of conditions that by their terms are to be satisfied at the Closing, are capable of being satisfied on that date), then the Walk-Away Date shall automatically be extended to July&#160;31, 2019&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the right to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not be available to any party, if the breach by such party of its representations and warranties set forth in this Agreement or the failure of such party to perform any of its obligations under this Agreement, including its failure to use its reasonable best efforts to consummate the Transactions as required by and subject to the terms and conditions of this Agreement, has been a principal cause of or resulted in the failure of the Merger to be consummated on or prior to such date (it being understood that Parent and Merger Sub shall be deemed a single party for purposes of the foregoing proviso)&#59; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) if any Restraint having the effect set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be in effect and shall have become final and nonappealable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the party seeking to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall have performed in all material respects its obligations under this Agreement, including to use its reasonable best efforts to prevent the entry of and to remove such Restraint in accordance with its obligations under this Agreement (it being understood that Parent and Merger Sub shall be deemed a single party for purposes of the foregoing proviso)&#59; or </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) if the Company Shareholder Approval shall not have been obtained at the Company Shareholders Meeting duly convened therefor or at any adjournment or postponement thereof at which a vote on the matter has been taken. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) by Parent&#58; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) if the Company shall have breached any of its representations or warranties or failed to perform any of its obligations or agreements set forth in this Agreement, which breach or failure to perform (A)&#160;would give rise to the failure of a condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and (B)&#160;is not reasonably capable of being cured prior to the Walk-Away Date or, if reasonably capable of being cured, shall not have been cured within thirty (30)&#160;days following receipt by the Company of written notice of such breach or failure to perform from Parent stating Parent&#8217;s intention to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the basis for such termination (or in any event has not been cured by the Walk-Away Date)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that Parent shall not have the right to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if Parent or Merger Sub is then in material breach of any of its representations, warranties, covenants, or agreements hereunder&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) prior to receipt of the Company Shareholder Approval, if the Company Board shall have effected an Adverse Recommendation Change&#59; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) if the Company has caused (by action or failure to act) a Triggering Event pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.01(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, with respect to any particular Triggering Event, Parent may only terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on or prior to the 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business day after the later of (A)&#160;the date on which the Company caused (by action or failure to act) such Triggering Event and (B)&#160;the date on which the Company notifies Parent that it caused (by action or failure to act) such Triggering Event (such later date, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Triggering Event Notice Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), after which date this Agreement may not be terminated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a result of such Triggering Event&#59; or </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) (iv) if (A)&#160;Parent has validly and timely exercised the Determination Right pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (B) the Loss Report has been finally determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and (C)&#160;Net CAT Losses as reflected on such finally determined Loss Report are greater than the Specified Amount&#59; provided that, if this termination right becomes effective in accordance with its terms, then Parent may only terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on or prior to the 10th business day after the Loss Report has been finally determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) by the Company&#58; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) if Parent or Merger Sub shall have breached any of its representations or warranties or failed to perform any of its obligations or agreements set forth in this Agreement, which breach or failure to perform (A)&#160;would give rise to the failure of a condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and (B)&#160;is not reasonably capable of being cured prior to the Walk-Away Date or, if reasonably capable of being cured, shall not have been cured within thirty (30)&#160;days following receipt by Parent or Merger Sub of written notice of such breach or failure to perform from the Company stating the Company&#8217;s intention to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the basis for such termination (or in any event has not been cured by the Walk-Away Date)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company shall not have the right to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if the Company is then in material breach of any of its representations, warranties, covenants, or agreements hereunder&#59; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) prior to receipt of the Company Shareholder Approval, concurrently with entering into a definitive agreement to implement a Superior Proposal in accordance with clause (ii)&#160;of the second sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, prior to or concurrently with such termination, the Company pays the amounts due under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in accordance with the terms thereof&#59; or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:27pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) if (A)&#160;all of the conditions in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (other than those conditions that by their nature are to be satisfied at the Closing and that would be satisfied if there were a Closing at such time) have been satisfied or waived, (B)&#160;the Company has notified Parent in writing at least three (3)&#160;business days prior to such termination that the Company is irrevocably ready, willing, and able to consummate the Closing, and (C)&#160;Parent and Merger Sub have failed to consummate the Closing within three (3)&#160;business days after the date by which the Closing is required to have occurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;8.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of the valid termination of this Agreement as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, written notice thereof shall be given to the other party or parties, specifying the provision hereof pursuant to which such termination is made, and this Agreement shall forthwith become null and void (other than this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the last sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.02(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, all of which shall survive termination of this Agreement), and there shall be no liability on the part of Parent, Merger Sub, the Company, or their respective directors, officers, and Affiliates or the Debt Financing Sources Related Parties, except, subject in all respects to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (a) as liability may exist pursuant to the provisions specified in the immediately preceding parenthetical that survive such termination and (b)&#160;no such termination shall relieve any party from liability for any Willful Breach by such party of any provision of this Agreement or actual, knowing fraud by such party with the intent to deceive or mislead any other party, regarding such first party&#8217;s representations and warranties herein (which shall not include constructive fraud or similar claims)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that in no event will the Parent Related Parties have any liability for monetary damages (including damages for fraud, monetary damages in lieu of specific performance or otherwise) in the aggregate in excess of the Parent Termination Fee and subject in all respects to the limitations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the parties acknowledge and agree that the immediately preceding proviso shall not apply to claims, if any, against any Person that is party to, and solely pursuant to the terms and conditions of, the Confidentiality Agreement. </font></div><div style="margin-bottom:6pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;8.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Termination Fee and Parent Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) In the event that&#58; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) (A) this Agreement is terminated by Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a result of a material breach of by the Company of its obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article VI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (and not as a result of any other breach)&#160;(B) at any time after the date hereof and prior to the breach giving rise to Parent&#8217;s right to terminate under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a Takeover Proposal shall have been made known to the Company Board or publicly announced or publicly made known to the holders of Company Shares and not withdrawn prior to such breach, and (C)&#160;within twelve (12)&#160;months after such termination, the Company either consummates any Takeover Proposal or enters into a definitive written agreement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to consummate any Takeover Proposal and the Company thereafter consummates such Takeover Proposal (whether or not within such twelve (12)&#160;month period), the Company shall pay to Parent or its designee the Company Termination Fee by wire transfer of same-day funds upon the earlier of the consummation of the Takeover Proposal or the entry into a definitive agreement with respect thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the references to &#8220;10%&#8221; in the definition of Takeover Proposal shall be deemed to be references to &#8220;50%&#8221;&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) (A) this Agreement is terminated by either Parent or the Company pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(b)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (B) at any time after the date hereof and prior to the Company Shareholders Meeting, a Takeover Proposal shall have been publicly announced or publicly made known to the holders of Company Shares and not publicly withdrawn prior to the Company Shareholders Meeting, and (C)&#160;within twelve (12)&#160;months after such termination, the Company either consummates any Takeover Proposal or enters into a definitive written agreement to consummate any Takeover Proposal and the Company thereafter consummates such Takeover Proposal (whether or not within such twelve (12)&#160;month period), the Company shall pay to Parent or its designee the Company Termination Fee by wire transfer of same-day funds upon the earlier of the consummation of the Takeover Proposal or the entry into a definitive agreement with respect thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the references to &#8220;10%&#8221; in the definition of Takeover Proposal shall be deemed to be references to &#8220;50%&#8221;&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) this Agreement is terminated by the Company pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(d)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company shall pay the Company Termination Fee to Parent or its designee by wire transfer of same-day funds simultaneously with such termination&#59; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) this Agreement is terminated by Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company shall pay the Company Termination Fee to Parent or its designee by wire transfer of same-day funds within two (2)&#160;business days after such termination&#59; or </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v) this Agreement is terminated by the Company pursuant to (A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;Section&#160;8.01(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a result of a material breach by Parent or Merger Sub of their respective obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and at the time of such termination the conditions to the Closing set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 7.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">7.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">7.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">7.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and, other than with respect to the Required Regulatory Approvals required to be obtained by Parent or Merger Sub, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 7.01(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">7.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, have been satisfied or would have been satisfied if the Closing had occurred on such date of termination or (B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;Section&#160;8.01(d)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Parent shall pay the Parent Termination Fee to the Company or its designee by wire transfer of same-day funds within two (2)&#160;business days after such termination. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In no event shall the Company be required to pay the Company Termination Fee more than once. In no event shall Parent be required to pay the Parent Termination Fee more than once. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Each of the parties acknowledges and hereby agrees that the agreements contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are an integral part of the Transactions, and that, without these agreements, the other parties would not enter into this Agreement&#59; accordingly, if the Company or Parent fails to timely pay any amount due pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and, in order to obtain the payment, the other party commences an Action that results in a judgment against the non-paying party for the payment set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the non-paying party shall pay the other party for its reasonable and documented costs and expenses (including reasonable and documented attorneys&#8217; fees) in connection with such Action, together with interest on such amount at the prime rate as published in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in effect on the date such payment was required to be made through the date such payment was actually received, subject in all respects to the limitations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each of the parties acknowledge and hereby agrees that each of the Parent Termination Fee and the Company Termination Fee, as applicable, if, as, and when required pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, shall not constitute a penalty but will be liquidated damages, in a reasonable amount that will compensate the party receiving such amount in the circumstances in which it is payable for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation of the Merger, which amount would otherwise be impossible to calculate with precision. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Notwithstanding anything to the contrary in this Agreement, any other Transaction Document or any other agreement referenced herein or therein or otherwise, but subject in all respects to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (including, in each case, the limitations set forth therein), if Parent or Merger Sub fails to effect the Closing when required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for any or no reason or otherwise breaches this Agreement or any Transaction Document (whether such breach is intentional, unintentional, willful (including a Willful Breach) or otherwise) or fails to perform hereunder or thereunder or fails to perform any obligation under Law (in each case, whether such failure is intentional, unintentional, willful (including a Willful Breach) or otherwise), then the Company&#8217;s right to seek (but never receive more than one of)&#160;(i) a decree or order of specific performance or any injunction or injunctions or other equitable relief if and to the extent permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to cause the Merger Consideration to be paid and the Closing to occur, (ii)&#160;terminate the Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and seek monetary damages solely on the basis of actual, knowing fraud by Parent or Merger Sub with the intent to deceive or mislead the Company, regarding Parent&#8217;s or Merger Sub&#8217;s representations and warranties (subject in all respects to the limitations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and (iii)&#160;terminate the Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(d)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and if, as, and when required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(a)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, receive payment of the Parent Termination Fee, and, subject to the limitation set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">clause (B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the costs and expenses of the Company pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the reimbursement obligations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.15 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the obligations to pay fees and expenses of the Independent Actuary pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, be the sole and exclusive remedies (whether at Law, in equity, in Contract, in tort or otherwise) of the Company Related Parties, Representatives of the Company and any other person against the Parent Related Parties for any breach, liability, cost, expense, obligation, loss or damage suffered as a result thereof or in connection therewith or related thereto. Notwithstanding anything to the contrary, under no circumstances can the Company receive more than one of the three remedies set forth in clauses (i), (ii) or (iii)&#160;of the previous sentence. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Except (i)&#160;as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or (ii)&#160;claims, if any, against any Person that is party to, and solely pursuant to the terms and conditions of, the Confidentiality Agreement, no Parent Related Party will have any liability or obligation to the Company Related Parties, the Representatives of the Company, or any other Person, including any multiple, consequential, indirect, special, statutory, exemplary, or punitive damages, relating to or arising out of this Agreement or any other Transaction Document or any documents or certificates referenced herein or the transactions contemplated hereby or thereby or any breach of any representation, warranty, or covenant contained herein or therein, or the failure of such transactions to be consummated, or, in respect of any other Contract, document, or theory of Law or equity or in respect of any representations made or alleged to be made in connection herewith or therewith, whether in equity or at Law, in Contract, in tort, or otherwise. The Company acknowledges and agrees that none of the Debt Financing Sources Related Parties nor any of their former, current, and future equity holders, controlling persons, directors, officers, employees, agents, attorneys, affiliates, members, managers, general or limited partners, stockholders, or assignees shall have any liability or obligation to the Company Related Parties, the Representatives of the Company, or any other Person arising out of their breach or failure to perform (whether willfully, intentionally, unintentionally, or otherwise) any of their obligations under the Debt Commitment Letters. Without limiting the foregoing, upon payment of the Parent Termination Fee, if, as, and when required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(a)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the amounts, if any, as and when due pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, no Parent Related Party shall have any further liability or obligation to the Company Related Parties, the Representatives of the Company, or any other Person, including any multiple, consequential, indirect, special, statutory, exemplary, or punitive damages, relating to or arising out of this Agreement, any other Transaction Document, or any other documents referenced herein or therein or the transactions contemplated hereby or thereby or in respect of any representation, warranty, or covenant contained herein or therein, or the failure of such transactions to be consummated, or in respect of any other Contract, document, or theory of Law or equity or in respect of any representations made or alleged to be made in connection herewith or therewith, whether in equity or at Law, in Contract, in tort, or otherwise. </font></div><div style="margin-bottom:9pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Notwithstanding anything to the contrary in this Agreement, any other Transaction Document, or any other agreement referenced herein or therein or otherwise, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the maximum aggregate liability of the Parent Related Parties under the Transaction Documents or otherwise, collectively (including monetary damages for breach, whether willful, intentional, unintentional, or otherwise, or monetary damages in lieu of specific performance), or in connection with the failure of the transactions contemplated hereby or thereby (including the Financing) to be consummated, or in respect of any representation made or alleged to have been made in connection herewith or therewith, whether in equity or at Law, in Contract, in tort or otherwise, together with any payment of the Parent Termination Fee and any other payment in connection with any Transaction Document or otherwise, shall not exceed under any circumstances an amount equal to the sum of (i)&#160;the Parent Termination Fee, if any, due and owing to the Company pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(a)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, plus (ii)&#160;the amounts, if any, due </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and owing to the Company pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and as a result of the reimbursement obligations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the obligations to pay fees and expenses of the Independent Actuary pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (A)&#160;in no event shall the aggregate amount of Parent&#8217;s obligations described in clause (i)&#160;of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> together with the aggregate amount of Parent&#8217;s obligations described in clause (b)&#160;of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exceed the amount of the Parent Termination Fee and (B)&#160;in no event shall the aggregate amount of Parent&#8217;s obligations described in clause (ii)&#160;of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exceed $1,500,000, and in no event shall the Company Related Parties and the Representatives of the Company seek, directly or indirectly, to recover against the Parent Related Parties, or compel payment by the Parent Related Parties of, any damages or other payments whatsoever (including multiple, consequential, indirect, special, statutory, exemplary or punitive damages) in excess of the Parent Termination Fee or any of the foregoing limitations (as applicable)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the parties acknowledge and agree that the foregoing shall not apply to claims, if any, against any Person that is party to, and solely pursuant to the terms and conditions of, the Confidentiality Agreement. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE IX. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MISCELLANEOUS </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the agreements of the Company, Parent, and Merger Sub contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall survive the Effective Time. No other representations, warranties, obligations or agreements in this Agreement shall survive the Effective Time. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.02 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment or Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At any time prior to the Effective Time, this Agreement may be amended or supplemented in any and all respects, whether before or after receipt of the Company Shareholder Approval, by written agreement of the parties, by action taken by the Parent Board and the Company Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, (a)&#160;following receipt of the Company Shareholder Approval, there shall be no amendment or change to the provisions hereof which by applicable Law would require further approval by the shareholders of the Company without such approval and (b)&#160;any modification or amendment of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (solely to the extent that it relates to the Debt Financing Sources Related Parties), clause (b)&#160;of this proviso of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, clause (iv)&#160;of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.07(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (solely to the extent that it relates to the Debt Financing Sources Related Parties), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (solely to the extent that it relates to the Debt Financing Sources Related Parties) and the definitions of Debt Commitment Letter, Debt Financing, Debt Financing Sources, and Debt Financing Sources Related Parties that is adverse to the interests of the Debt Financing Sources Related Parties will not be effective against the Debt Financing Sources Related Parties without the prior written consent of the Debt Financing Sources. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Extension of Time, Waiver, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At any time prior to the Effective Time, Parent and the Company may, subject to applicable Law, (a)&#160;waive any inaccuracies in the representations and warranties of the other party, (b)&#160;extend the time for the performance of any of the obligations or acts of the other party, or (c)&#160;subject to the requirements of applicable Law, waive compliance by the other party with any of the agreements contained herein or, except as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">otherwise provided herein, waive any of such party&#8217;s conditions (it being understood that Parent and Merger Sub shall be deemed a single party for purposes of the foregoing). Notwithstanding the foregoing, no failure or delay by the Company, Parent, or Merger Sub in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right hereunder. Any agreement on the part of a party to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.04 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither this Agreement nor any of the rights, interests, or obligations hereunder shall be assigned, in whole or in part, by operation of Law or otherwise, by any of the parties without the prior written consent of the other parties. No assignment by any party shall relieve such party of any of its obligations hereunder. Subject to the immediately preceding two sentences, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by the parties and their respective successors and permitted assigns. Any purported assignment not permitted under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be null and void. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.05 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement may be executed in one or more counterparts (including by facsimile or electronic mail), each of which shall be deemed to be an original but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.06 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement&#59; No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement, the Equity Commitment Letter, the Guarantee and the Confidentiality Agreement constitute the entire agreement, and supersede all other prior agreements and understandings, both written and oral, among the parties and their Affiliates, or any of them, with respect to the subject matter hereof. This Agreement is not intended to and shall not confer upon any Person, other than the parties, any rights or remedies hereunder, except for (i)&#160;if the Effective Time occurs, the right of the holders of Company Shares to receive the Merger Consideration payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article III,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ii)&#160;the provisions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Agreement, (iii)&#160;from and after the Effective Time, the rights of the holders of Company Awards to receive the payments contemplated by the applicable provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in accordance with the terms and conditions of this Agreement and (iv)&#160;each Debt Financing Sources Related Party shall be a third-party beneficiary of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (solely to the extent that it relates to the Debt Financing Sources Related Parties), clause (b)&#160;of the proviso of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, this clause (iv)&#160;of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.07(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (solely to the extent that it relates to the Debt Financing Sources Related Parties), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (solely to the extent that it relates to the Debt Financing Sources Related Parties). Notwithstanding the foregoing, the Company shall have the right to recover, following termination by the Company of this Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, through an Action brought by the Company, damages from Parent to the extent arising out of a Willful Breach of this Agreement by Parent subject in all respects to the limitations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in which event the damages recoverable by the Company for itself and on behalf of the holders of Company Shares shall be determined by reference to the total amount that would have been recoverable under the circumstances of such breach by such holders if all such holders brought an action against Parent and were recognized as third-party beneficiaries hereunder. The representations, warranties, covenants, and agreements in this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement are the product of negotiations among the parties and are for the sole benefit of the parties and may, in certain instances, be qualified, limited or changed by confidential disclosure letters. Any inaccuracies in such representations or warranties or failure to perform or breach of such covenants or agreements are subject to waiver by the parties in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> without notice or liability to any other Person. In some instances, the representations, warranties, covenants, and agreements in this Agreement may represent an allocation among the parties of risk associated with particular matters, regardless of the knowledge of any of the parties. Consequently, Persons, other than the parties, may not rely upon the representations, warranties, covenants, and agreements in this Agreement as characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date. </font></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.07 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware applicable to contracts executed in and to be performed entirely within that state, regardless of the laws that might otherwise govern under any applicable conflict of laws principles, except to the extent the provisions of the laws of Bermuda are mandatorily applicable to the Merger. </font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) All Actions arising out of or relating to the interpretation and enforcement of the provisions of this Agreement and in respect of the Transactions (except to the extent any such proceeding mandatorily must be brought in Bermuda) shall be heard and determined in the Delaware Court of Chancery, or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal court within the State of Delaware, or, if both the Delaware Court of Chancery and the federal courts within the State of Delaware decline to accept jurisdiction over a particular matter, any other state court within the State of Delaware, and, in each case, any appellate court therefrom. The parties hereby irrevocably submit to the exclusive jurisdiction and venue of such courts in any such Actions and irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such Action. The consents to jurisdiction and venue set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.07(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose, except as provided in this paragraph and shall not be deemed to confer rights on any Person other than the parties. Each party agrees that service of process upon such party in any Action arising out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Agreement. The parties agree that a final judgment in any such Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that nothing contained in the foregoing shall restrict any party&#8217;s rights to seek any post-judgment relief regarding, or any appeal from, a final trial court judgment. </font></div><div style="margin-bottom:9pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each party to this Agreement acknowledges and irrevocably agrees (i)&#160;that any legal action, whether at law or in equity, whether in contract or in tort or otherwise, against any Debt Financing Sources Related Party arising out of or relating to this Agreement or the Debt Commitment Letter or the performance thereunder shall be subject to the exclusive jurisdiction of the Supreme Court of the State of New York, County of New York, or, if under applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Law exclusive jurisdiction is vested in Federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof), (ii) that, except to the extent relating to the interpretation of any provisions in this Agreement and&#47;or the Equity Commitment Letter, any legal action, whether at law or in equity, whether in contract or in tort or otherwise, against any Debt Financing Sources Related Party shall be governed by, and construed in accordance with, the Laws of the State of New York, (iii)&#160;not to bring or permit any of their Affiliates to bring any such legal action in any other court, and (iv)&#160;that the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.07(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall apply to any such legal action. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.08 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specific Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The parties agree that irreparable damage for which monetary relief, even if available, would not be an adequate remedy, would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached, including if the parties fail to take any action required of them hereunder to consummate this Agreement, subject to the terms and conditions of this Agreement. The parties acknowledge and agree that (a)&#160;the parties shall be entitled to an injunction or injunctions, specific performance, or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof (including, for the avoidance of doubt, the right of the Company to cause the Merger to be consummated on the terms and subject to the conditions set forth in this Agreement) in the courts described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.07(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement, and (b)&#160;the right of specific enforcement is an integral part of the Transactions and without that right, neither the Company nor Parent would have entered into this Agreement. The parties agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable for any reason, and not to assert that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at law. The parties acknowledge and agree that any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall not be required to provide any bond or other security in connection with any such order or injunction. If, prior to the Walk-Away Date (or following the Walk-Away Date if, (i)&#160;in the case of the Company, the termination right in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is unavailable to Parent or (ii)&#160;in the case of Parent, the termination right in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.01(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is unavailable to the Company), any party brings any action, in each case, in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to enforce specifically the performance of the terms and provisions hereof by any other party, or any party brings any action (whether in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or otherwise) with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or initiates any procedure to resolve disputes with respect to the Loss Report as contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Walk-Away Date shall automatically be extended (x)&#160;for the period during which such action is pending, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ten (10)&#160;business days or (y)&#160;by such other time period established by the court presiding over such action, as the case may be. Except as otherwise provided in this Agreement, and for the avoidance of doubt, subject in all respects to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (and, in each case, the limitations set forth herein or therein), any and all remedies expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred by this Agreement or by applicable Law on such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy. Notwithstanding anything else to the contrary in any Transaction Document or otherwise, for the avoidance of doubt, while the Company may, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject in all respects to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, concurrently seek (A)&#160;specific performance or other equitable relief, subject in all respects to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (B)&#160;payment of monetary damages pursuant to clause (b)&#160;of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the Parent Termination Fee, if, as, and when required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.03(a)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under no circumstances shall the Company, directly or indirectly, be permitted or entitled to receive (1)&#160;both a grant of specific performance to cause the Equity Financing to be funded (whether under this Agreement or the Equity Commitment Letter) or other equitable relief to cause the Merger Consideration to be paid and the Closing to occur, on the one hand, and payment of any monetary damages whatsoever and&#47;or the payment of the Parent Termination Fee, on the other hand, or (2)&#160;both payment of any monetary damages whatsoever, on the one hand, and payment of any of the Parent Termination Fee, on the other hand. Notwithstanding anything to the contrary in this Agreement or any other agreement referenced herein or otherwise to the contrary, it is acknowledged and agreed that Parent has an obligation hereunder to cause the Equity Financing to be funded, including by exercising its rights under the Equity Commitment Letter, and such obligation of Parent, and the right of the Company to specific performance in connection with enforcing such obligation of Parent (whether under this Agreement or the Equity Commitment Letter), and the obligation of Parent to consummate the Merger, will be subject to the requirements that (I)&#160;all of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> have been and continue to be satisfied or waived (other than those conditions that by their nature are to be satisfied at the Closing and that would be satisfied if there were a Closing at such time)&#59; (II) Parent and Merger Sub fail to consummate the Closing on the date required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and (III)&#160;the Company has irrevocably confirmed in a written notice to Parent that, if specific performance is granted and the Equity Financing is funded, then the Company would take such actions that are required of it by this Agreement to cause the Closing to occur (and the Company has not revoked, withdrawn, modified, or conditioned such irrevocable confirmation), and Parent and Merger Sub fail to complete the Closing within three (3)&#160;business days after delivery of the Company&#8217;s irrevocable written confirmation. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.09 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (INCLUDING THE FINANCING). EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A)&#160;NO REPRESENTATIVE, AGENT, OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B)&#160;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C)&#160;IT MAKES SUCH WAIVER VOLUNTARILY, AND (D)&#160;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SECTION 9.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All notices, requests and other communications to any party hereunder shall be in writing and shall be deemed given if delivered personally, facsimiled (which is confirmed), emailed (which is confirmed) or sent by overnight courier (providing proof of delivery) to the parties at the following addresses&#58; </font></div><div style="margin-bottom:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to Parent or Merger Sub, to it at&#58; </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Highlands Holdings, Ltd. </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c&#47;o Apollo Management IX, L.P. </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 West 57th Street, 43rd Floor </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, NY </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ahumphreys&#64;apollolp.com&#59; lmedley&#64;apollolp.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Alex Humphreys&#59; Laurie Medley </font></div><div style="margin-bottom:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with copies (which shall not constitute notice) to&#58; </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sidley Austin LLP </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One South Dearborn </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chicago, Illinois 60603 </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facsimile&#58; 312-853-7036 </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; pshwachman&#64;sidley.com </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Perry J. Shwachman </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; scarney&#64;sidley.com </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Sean M. Carney </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; asnyder&#64;sidley.com </font></div><div style="margin-bottom:6pt;padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Adam M. Snyder </font></div><div style="margin-bottom:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to the Company, to&#58; </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141 Front Street </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton, Bermuda HM19 </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facsimile&#58; 441-295-1829 </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; Mike.Cain&#64;aspen.co </font></div><div style="margin-bottom:6pt;padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Michael Cain </font></div><div style="margin-bottom:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with copies (which shall not constitute notice) to&#58; </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Willkie Farr&#160;&#38; Gallagher LLP </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">787 Seventh Avenue </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, New York 10019 </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facsimile&#58; 212-728-9616 </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">mgroll&#64;willkie.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Michael Groll </font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">rabbassi&#64;willkie.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Rajab S. Abbassi </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or such other address, facsimile number, or email address as such party may hereafter specify by like notice to the other parties. All such notices, requests and other communications shall be deemed received on the date of actual receipt by the recipient thereof, if received prior to 5&#58;00 p.m., Bermuda time, and such day is a business day in Bermuda. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding business day in the place of receipt. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any term, condition, or other provision of this Agreement is finally determined by a court of competent jurisdiction to be invalid, illegal, or incapable of being enforced by any applicable Law or public policy, all other terms, provisions and conditions of this Agreement shall nevertheless remain in full force and effect, so long as the economic or legal substance of the Transactions is not affected in any manner materially adverse to any party or such party waives its rights under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with respect thereto. Upon such determination that any term, condition, or other provision is invalid, illegal, or incapable of being enforced, the parties shall negotiate to attempt to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable Law in an acceptable manner to the end that the Transactions are fulfilled to the extent possible. </font></div><div style="margin-bottom:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fees and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Whether or not the Merger is consummated, all fees and expenses incurred in connection with the Merger, this Agreement, and the other Transactions shall be paid by the party incurring or required to incur such fees or expenses, except as otherwise set forth in this Agreement. </font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;9.13 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recourse</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each party agrees, on behalf of itself and its Affiliates (and, in the case of the Company, the Company Related Parties, and, in the case of Parent, the Parent Related Parties), that all Actions, claims, obligations, liabilities, or causes of action (whether in contract or in tort, in Law, or in equity or otherwise, or granted by statute or otherwise, whether by or through attempted piercing of the corporate, limited partnership, or limited liability company veil or any other theory or doctrine, including alter ego or otherwise) that may be based upon, in respect of, arise under, out or by reason of, be connected with, or relate to&#58; (A)&#160;this Agreement, any other Transaction Document or any other agreement referenced herein or therein or the transactions contemplated hereunder or thereunder (including the Financing), (B) the negotiation, execution or performance this Agreement, any other Transaction Document or any other agreement referenced herein or therein (including any representation or warranty made in, in connection with, or as an inducement to this Agreement, any other Transaction Document or such other agreement), (C) any breach or violation of this Agreement, any other Transaction Document or any other agreement referenced herein or therein, and (D)&#160;any failure of the transactions contemplated hereunder or under any Transaction Document or any other agreement referenced herein or therein (including the Financing) to be consummated, in each case, may be made only against (and are those solely of) the Persons that are expressly identified as parties to this Agreement in accordance with, and subject to the terms and conditions of, this Agreement (but subject to the exceptions set forth in the next sentence). Notwithstanding anything contained in this Agreement, any other Transaction Document or any other agreement referenced herein or therein or otherwise to the contrary, each party hereto covenants, agrees, and acknowledges, on behalf of itself and its respective Affiliates (and, in the case of the Company, the Company Related Parties, and, in the case of Parent, the Parent Related </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parties), that no recourse under this Agreement, any other Transaction Document, or any other agreement referenced herein or therein or in connection with any transactions contemplated hereby or thereby (including the Financing) shall be sought or had against any other Person, including any Company Related Party, any Parent Related Party, and any Debt Financing Sources Related Party, and no other Person, including any Company Related Party, any Parent Related Party, and any Debt Financing Sources Related Party, shall have any liabilities or obligations (whether in contract or in tort, in Law, or in equity or otherwise, or granted by statute or otherwise, whether by or through attempted piercing of the corporate, limited partnership, or limited liability company veil or any other theory or doctrine, including alter ego or otherwise) for any claims, causes of action, obligations, or liabilities arising under, out of, in connection with, or related to the items in the immediately preceding clauses (A)&#160;through (D), it being expressly agreed and acknowledged that no personal liability or losses whatsoever shall attach to, be imposed on, or otherwise be incurred by any of the aforementioned, as such, arising under, out of, in connection with, or related to the items in the immediately preceding clauses (A)&#160;through (D), in each case, except for claims that (1)&#160;the Company, Parent, or Merger Sub, as applicable, may assert (subject with respect to the following clauses (ii)&#160;and (iii), in all respects to the limitations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#58; (i) against any Person that is party to, and solely pursuant to the terms and conditions of, the Confidentiality Agreement&#59; (ii)&#160;against each Guarantor under, if, as, and when required pursuant to the terms and conditions of, the Guarantee&#59; (iii)&#160;against the equity providers for specific performance of their obligation to fund their committed portions of the Equity Financing, solely in accordance with, and pursuant to the terms and conditions of, the Equity Commitment Letter&#59; or (iv)&#160;against the Company, Parent, and Merger Sub, solely in accordance with, and pursuant to the terms and conditions of, this Agreement and (2)&#160;Parent and its Affiliates may assert, including by bringing an Action, against the Debt Financing Sources pursuant to the terms and conditions of the Commitment Letters. Notwithstanding anything to the contrary herein or otherwise, no Company Related Party, Parent Related Party, or Debt Financing Sources Related Party shall be responsible or liable for any multiple, consequential, indirect, special, statutory, exemplary, or punitive damages that may be alleged as a result of this Agreement, the other Transaction Documents, or any other agreement referenced herein or therein or the transactions contemplated hereunder or thereunder (including the Financing), or the termination or abandonment of any of the foregoing. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The remainder of this page is intentionally left blank.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_136"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered as of the date first above written. </font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:260.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:183.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HIGHLANDS HOLDINGS, LTD.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; William B. Kuesel</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; William B. Kuesel</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HIGHLANDS MERGER SUB, LTD.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; William B. Kuesel</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; William B. Kuesel</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page to Agreement and Plan of Merger&#93; </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:260.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:183.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher O&#8217;Kane</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Christopher O&#8217;Kane</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Director and Chief Executive Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page to Agreement and Plan of Merger&#93; </font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_159"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT A </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATUTORY MERGER AGREEMENT </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_221"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT A </font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DATED &#91;&#8226;&#93;, 2018 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) HIGHLANDS HOLDINGS, LTD. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) HIGHLANDS MERGER SUB, LTD. and </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) ASPEN INSURANCE HOLDINGS LIMITED </font></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.75pt"><tr><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATUTORY MERGER AGREEMENT</font></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.75pt"><tr><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_243"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THIS STATUTORY MERGER AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is dated as of &#91;&#8226;&#93;, 2018 </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BETWEEN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIGHLANDS HOLDINGS, LTD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an exempted company incorporated under the laws of Bermuda having its registered office at &#91;&#8226;&#93; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#59; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIGHLANDS MERGER SUB, LTD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an exempted company incorporated under the laws of Bermuda having its registered office at &#91;&#8226;&#93; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#59; and </font></div><div style="margin-bottom:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an exempted company incorporated under the laws of Bermuda having its registered office at 141 Front Street, Hamilton, Bermuda HM19 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Merger Sub is a wholly-owned subsidiary of Parent&#59;</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Pursuant to the Agreement and Plan of Merger by and among Parent, Merger Sub and the Company dated August&#160;27, 2018 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan of Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and subject to the terms and conditions set forth therein, Parent, Merger Sub and the Company have agreed that Merger Sub will merge with and into the Company (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), with the Company continuing as the Surviving Company, in accordance with the provisions of the Companies Act 1981 of Bermuda, as amended (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Companies Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#59; and </font></div><div style="margin-bottom:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;This Agreement is the Statutory Merger Agreement referred to in the Plan of Merger.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOW THEREFORE THE PARTIES HAVE AGREED AS FOLLOWS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEFINITIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:24pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, capitalized terms have the same meaning as used and defined in the Plan of Merger. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EFFECTIVENESS OF MERGER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties to this Agreement agree that, on the terms and subject to the conditions of this Agreement and the Plan of Merger and in accordance with the Companies Act, at the Effective Time, Merger Sub shall be merged with and into the Company with the Company surviving such Merger and continuing as the Surviving Company and the Merger Sub shall cease to exist and shall be struck off the register of companies in Bermuda. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Surviving Company will continue to be a Bermuda exempted company under the conditions of this Agreement and the Plan of Merger. </font></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger shall be conditional on the satisfaction or waiver on or before the Effective Time of each of the conditions to Merger identified in Article VII of the Plan of Merger and the issuance of a Certificate of Merger by the Registrar of Companies in Bermuda. </font></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger shall become effective at the time and date shown on the Certificate of Merger issued by the Registrar of Companies in Bermuda. </font></div><div style="margin-bottom:18pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;2.02 of the Plan of Merger, the parties to this Agreement have agreed to request that the Registrar of Companies in Bermuda provides in the Certificate of Merger that the Effective Time will be 10&#58;00 a.m. Bermuda time (or such other time mutually agreed upon by the Company and Parent). </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NAME OF SURVIVING COMPANY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:18pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Surviving Company shall continue to be named &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aspen Insurance Holdings Limited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEMORANDUM OF ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:18pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The memorandum of association of the Surviving Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be substantially in the form of the memorandum of association of the Merger Sub immediately prior to the Effective Time, until thereafter changed or amended as provided therein or pursuant to applicable law. </font></div><div style="padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">BYE-LAWS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%"> </font></div><div style="margin-bottom:18pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The bye-laws of the Surviving Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be in the form of the bye-laws of Merger Sub in effect immediately prior to the Effective Time, until thereafter changed or amended as provided therein or pursuant to applicable law. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The persons whose names and addresses are set out below being the directors of the Merger Sub immediate prior to the Effective Time, shall be the Board of Directors of the Surviving Company until their respective successors are duly elected or appointed or until the earlier of their death, resignation or removal in accordance with the bye-laws of the Surviving Company and applicable Laws&#58; </font></div><div style="margin-bottom:18pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;TBC&#93; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EFFECT OF MERGER ON SHARE CAPITAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1&#160;&#160;&#160;&#160;At the Effective Time, by virtue of the occurrence of the Merger, and without any action on the part of the Company, Parent, Merger Sub or any holder of any common shares, par value $0.015144558 per common share, of the Company (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or any common shares, par value $0.01 per common share, of Merger Sub (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger Sub Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#58; </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Merger Sub Share issued and outstanding immediately prior to the Effective Time shall automatically be canceled and converted into and become one duly authorized, validly issued, fully paid and non-assessable common share, par value $0.01 per common share, of the Surviving Company.</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each Company Share that is (i)&#160;owned by the Company as treasury shares or owned by any Subsidiary of the Company or (ii)&#160;owned by Parent, Merger Sub, or any other direct or indirect wholly owned Subsidiary of Parent issued and outstanding immediately prior to the Effective Time shall by virtue of the Merger and without any action on the part of the holder thereof be canceled automatically and shall cease to exist and be outstanding and no consideration shall be delivered in exchange therefor nor any repayment of capital made in respect thereof.</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Subject to Section&#160;7.1(b) and Sections 7.3-7.5, each Company Share issued and outstanding immediately prior to the Effective Time, other than any Company Share that is subject to any Company Award, shall automatically be canceled and converted into and shall thereafter represent the right to receive an amount in cash equal to $42.75, without interest (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Subject to Sections 7.3-7.5, as of the Effective Time, all such Company Shares shall no longer be issued and outstanding and shall automatically be canceled and shall cease to exist, and each holder of a certificate that immediately prior to the Effective Time evidenced any Company Shares (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or uncertificated Company Shares represented by book-entry immediately prior to the Effective Time (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Book-Entry Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration pertaining to the Company Shares represented by such Certificate or Book-Entry Share, as applicable, to be paid in consideration therefor, in accordance with Section&#160;3.02(b) of the Plan of Merger without interest. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Subject to Sections 7.3-7.5, each 5.95% Preference Share issued and outstanding immediately prior to the Effective Time shall remain issued and outstanding as a preference share of the Surviving Company and shall be entitled to the same dividend and all other preferences and privileges, voting rights, relative, participating, optional and other special rights, and qualifications, limitations and restrictions set forth in the certificate of designations applicable to the 5.95% Preference Shares, which certificate of designations shall remain at and following the Effective Time in full force and effect as an obligation of the Surviving Company in accordance with Section&#160;109(2) of the Bermuda Companies Act.</font></div><div style="margin-bottom:18pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Subject to Sections 7.3-7.5, each 5.625% Preference Share issued and outstanding immediately prior to the Effective Time shall remain issued and outstanding as a preference share of the Surviving Company and shall be entitled to the same dividend and all other preferences and privileges, voting rights, relative, participating, optional and other special rights, and qualifications, limitations and restrictions set forth in the certificate of designations applicable to the 5.625% Preference Shares, which certificate of designations shall remain at and following the Effective Time in full force and effect as an obligation of the Surviving Company in accordance with Section&#160;109(2) of the Bermuda Companies Act.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;&#160;&#160;&#160;Company Equity Awards.</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Prior to the Effective Time, the Company Board (or, if appropriate, any duly-authorized committee thereof administering the Company Share Plans) shall adopt such resolutions and take all such other actions as may be required to provide the following, effective upon the Effective Time, subject to Section&#160;3.02(g) of the Plan of Merger&#58;</font></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;each restricted share unit granted under a Company Share Plan that is subject to performance-based vesting requirements (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Performance Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that is outstanding immediately prior to the Effective Time shall, to the extent not vested, become fully vested, and shall be canceled and converted into the right to receive a lump-sum amount in cash, without interest, equal to the Merger Consideration&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, for purposes of determining the number of Company Performance Units outstanding immediately prior to the Effective Time, (1)&#160;with respect to any portion of a Company Performance Unit award with a performance period that has been completed, the number of shares shall be determined based on the actual level of performance achieved, and (2)&#160;with respect to any portion of a Company Performance Unit award with a performance period that has not been completed, any applicable performance-based vesting requirements shall be deemed to be achieved immediately prior to the Effective Time at target payout levels&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;each phantom Company Share granted under a Company Share Plan that is subject to performance-based vesting requirements (a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;Company Phantom Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that is outstanding immediately prior to the Effective Time shall, to the extent not vested, become fully vested, and shall be canceled and converted into the right to receive a lump-sum amount in cash, without interest, equal to the Merger Consideration&#59; provided that, for purposes of determining the number of Company Phantom Shares outstanding immediately prior to the Effective Time, (1)&#160;with respect to any portion of a Company Phantom Share award with a performance period that has been completed, the number of shares shall be determined based on the actual level of performance achieved, and (2)&#160;with respect to any portion of a Company Phantom Share award with a performance period that has not been completed, any applicable performance-based vesting requirements shall be deemed to be achieved immediately prior to the Effective Time at target payout levels&#59; and </font></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;each restricted share unit award granted under a Company Share Plan (a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;Company RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that is outstanding immediately prior to the Effective Time shall, to the extent not vested, become fully vested, and shall be canceled and converted into the right to receive a lump-sum amount in cash, without interest, equal to the product of (x)&#160;the sum of (1)&#160;the Merger Consideration and (2)&#160;any Per Share Accrued Dividend Equivalents in respect of such Company RSU Award times (y)&#160;the number of Company Shares subject to such Company RSU Award, which had not previously been settled. </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Treatment of Company ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;The Company shall take all actions necessary to (A)&#160;cause the Company&#8217;s Employee Share Purchase Plan, the 2008 Sharesave Scheme, as amended, and the International Employee Share Purchase Plan (collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;Company ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) not to (1)&#160;commence an offering period to purchase Company Shares that would otherwise begin after the end of any offering period in effect as of the date hereof, (2)&#160;accept payroll deductions to be used to purchase Company Shares under the Company ESPP after the end of any offering period in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effect as of the date hereof or (3)&#160;ensure that no new participants be permitted to participate in the Company ESPP and that the existing participants thereunder may not increase their elections with respect to any offering period in effect as of the date hereof, and (B)&#160;cause the Company ESPP to terminate immediately after the purchases set forth in Section&#160;7.2(b)(ii), if any, and immediately prior to the Effective Time.</font></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;In the case of any outstanding purchase rights (the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;Company Share Purchase Plan Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the Company ESPP, (A)&#160;immediately prior to the Effective Time (1)&#160;any offering period under the Company&#8217;s Employee Share Purchase Plan and the International Employee Share Purchase Plan shall end and each participant&#8217;s accumulated payroll deduction shall be used to purchase newly issued Company Shares in accordance with the terms of the Company&#8217;s Employee Share Purchase Plan or the International Employee Share Purchase Plan (as applicable) and (2)&#160;such Company Shares shall be treated the same as all other Company Shares in accordance with Section&#160;7.1(c), and (B)&#160;prior to the Effective Time (1)&#160;the Company shall promptly take all actions necessary to enable and require participants in the 2008 Sharesave Scheme, as amended, to utilize their accumulated payroll deduction to purchase newly issued Company Shares in accordance with the terms of the 2008 Sharesave Scheme, as amended, such that there are no outstanding purchase rights thereunder as at the Effective Time and (2)&#160;such Company Shares shall be treated the same as all other Company Shares in accordance with Section&#160;7.1(c). </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;&#160;&#160;&#160;At the Effective Time, all Dissenting Shares shall automatically be cancelled and, unless otherwise required by applicable Law, converted into the right to receive the Merger Consideration pursuant to Section&#160;7.1(c) with respect to Company Shares, the preferred shares of the Surviving Company as described in Section&#160;7.1(d) with respect to 5.95% Preference Shares or the preferred shares of the Surviving Company as described in Section&#160;7.1(e) with respect to 5.625% Preference Shares, and any holder of Dissenting Shares shall, in the event that the fair value of a Dissenting Share as appraised by the Supreme Court of Bermuda under Section&#160;106(6) of the Bermuda Companies Act (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Appraised Fair Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) is greater than, the Merger Consideration with respect to Company Shares, the value of the preferred shares of the Surviving Company as described in Section&#160;7.1(d) with respect to 5.95% Preference Shares or the value of the preferred shares of the Surviving Company, as described in Section&#160;7.1(e) with respect to 5.625% Preference Shares, be entitled to receive such difference from the Surviving Company by payment made within thirty (30)&#160;days after such Appraised Fair Value is finally determined pursuant to such appraisal procedure. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;&#160;&#160;&#160;In the event that a holder fails to exercise, effectively withdraws or otherwise waives any right to appraisal (each, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Appraisal Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), such holder shall have no other rights with respect to such Dissenting Shares, other than as contemplated by Section&#160;7.1. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;&#160;&#160;&#160;The Company shall give Parent (i)&#160;written notice of (A)&#160;any demands for appraisal of Dissenting Shares or Appraisal Withdrawals and any other written instruments, notices, petitions, or other communication received by the Company in connection with the foregoing and (B)&#160;to the extent that the Company has Knowledge thereof, any applications to the Supreme Court of Bermuda for appraisal of the fair value of the Dissenting Shares and (ii)&#160;to the extent permitted by applicable Law, the opportunity to participate with the Company in any settlement negotiations and proceedings with respect to any demands for appraisal under the Bermuda Companies Act. The Company shall not, without the prior written consent of Parent, voluntarily make any payment with respect to, offer to settle, or settle any such demands or applications, or waive any failure to timely deliver a written demand for appraisal or to timely take any other action to exercise appraisal rights in accordance with the Bermuda Companies Act. Payment of any amount payable to holders of Dissenting Shares shall be the obligation of the Surviving Company.</font></div><div style="margin-bottom:18pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;&#160;&#160;&#160;Notwithstanding any provision of Article III of the Plan of Merger to the contrary, if, between the date of this Agreement and the Effective Time, the issued and outstanding Company Shares shall have been changed into a different number of shares or a different class by reason of the occurrence or record date of any share dividend, subdivision, reclassification, recapitalization, split, combination, exchange of shares, or similar transaction, the Merger Consideration shall be appropriately adjusted to reflect such share dividend, subdivision, reclassification, recapitalization, split, combination, exchange of shares, or similar transaction.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SETTLEMENT OF MERGER CONSIDERATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:18pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Promptly after the Effective Time the exchange procedures identified in Section&#160;3.02 of the Plan of Merger shall be implemented.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MISCELLANEOUS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;&#160;&#160;&#160;Termination, Amendment and Waiver</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;This Agreement shall terminate upon the earliest to occur of&#58; (i)&#160;agreement in writing between Parent, Merger Sub and the Company at any time prior to the Effective Time&#59; and (ii)&#160;automatically upon termination of the Plan of Merger in accordance with its terms. Without prejudice to any liability of any party in respect of any antecedent breach hereof or to any accrued rights of any party hereto (including those which have accrued under the Plan of Merger), if this Agreement is terminated pursuant to this Section then this Agreement shall terminate and there shall be no other liability between Parent and Merger Sub, on the one hand, or the Company, on the other hand.</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The amendment and extension&#59; waiver provisions set out in Sections 9.02 and 9.03 of the Plan of Merger shall apply to this Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.2&#160;&#160;&#160;&#160;Entire Agreement</font></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set out in the Plan of Merger, this Agreement and any documents referred to in this Agreement, constitute the entire agreement between the parties with respect to the subject matter of and the transactions referred to herein and supersede any previous arrangements, understandings and agreements between them relating to such subject matter and transactions. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;&#160;&#160;&#160;Execution in Counterparts</font></div><div style="margin-bottom:18pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement may be executed in counterparts each of which when executed and delivered shall constitute an original but all such counterparts together shall constitute one and the same instrument. </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any notice, request, instruction or other communication under this Agreement shall be in writing and delivered by hand, overnight courier service, facsimile or other electronic transmission&#58; </font></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to Parent or to Merger Sub, to&#58; </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Highlands Holdings, Ltd. </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c&#47;o Apollo Management IX, L.P. </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 West 57th Street, 43rd Floor </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, NY </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Alex Humphreys&#59; Laurie Medley </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ahumphreys&#64;apollolp.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">lmedley&#64;apollolp.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with a copy (which shall not constitute notice) to&#58; </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sidley Austin LLP </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One South Dearborn </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chicago, Illinois 60603 </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Perry J. Shwachman </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facsimile&#58; 312-853-7036 </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pshwachman&#64;sidley.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to the Company, to&#58; </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141 Front Street </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton, Bermuda, HM19 </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Michael Cain </font></div><div style="padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facsimile&#58; 441-295-1829 </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Mike.Cain&#64;aspen.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:24.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with a copy (which shall not constitute notice) to&#58; </font></div><div style="padding-left:24.45pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Willkie Farr&#160;&#38; Gallagher LLP </font></div><div style="padding-left:24.45pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">787 Seventh Avenue </font></div><div style="padding-left:24.45pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, New York 10019 </font></div><div style="padding-left:24.45pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Michael Groll&#59; Rajab S Abbassi </font></div><div style="padding-left:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facsimile&#58; 212-728-9616 </font></div><div style="margin-bottom:18pt;padding-left:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">mgroll&#64;willkie.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">rabbassi&#64;willkie.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNING LAW</font></div><div style="margin-bottom:12pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and conditions of this agreement and the rights of the parties hereunder shall be governed by and construed in all respects in accordance with the laws of Bermuda. The parties to this agreement hereby irrevocably agree that the courts of Bermuda shall have non-exclusive jurisdiction in respect of any dispute, suite, action arbitration or proceedings (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) which may arise out of or in connection with this agreement and waive any objection to Proceedings in courts of Bermuda on the grounds of venue or on the basis that the Proceedings have been brought in an inconvenient forum. </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature Page Follows </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the parties hereto have executed this Agreement the day and year first written above.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:178.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:250.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:26pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNED for and on behalf of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PARENT</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNED for and on behalf of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MERGER SUB</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNED for and on behalf of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPANY</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_270"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPANY BYE-LAW AMENDMENT </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B-1</font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_292"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPANY BYE-LAW AMENDMENT</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company bye-laws will be amended by the replacement of bye-law 50 with the following&#58; </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;50. Notwithstanding the provisions of Bye-Laws 48-49 (in addition to any approval requirements set out in the Companies Act), (i) the following action shall be approved by the affirmative vote of at least a majority of the voting power of votes cast at a meeting of Shareholders (taking into account the provisions of Bye-Laws 63-67), in substitution for any higher voting requirement that would otherwise apply under the Companies Act&#58; a merger or amalgamation with, or a sale, lease or transfer of all or substantially all of the assets of the Company to, a third party&#59; and (ii)&#160;the following action shall be approved by the affirmative vote of at least sixty-six percent (66%) of the voting power of shares entitled to vote at a meeting of Shareholders (taking into account the provisions of Bye-Laws 63-67)&#58; discontinuance of the Company out of Bermuda to another jurisdiction. Any amendment to clause (i)&#160;of this Bye-law 50 shall be approved by the affirmative vote of at least a majority of the voting power of votes cast a meeting of Shareholders (taking into account the provisions of Bye-Laws 63-67). Any amendment to clause (ii)&#160;of this Bye-law 50 shall be approved by the affirmative vote of at least sixty-six percent (66%) of the voting power of shares entitled to vote at a meeting of Shareholders (taking into account the provisions of Bye-Laws 63-67).&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_315"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REQUIRED REGULATORY APPROVALS </font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">1.&#160;&#160;&#160;&#160;Approval&#47;expiration of waiting periods pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">2.&#160;&#160;&#160;&#160;Any necessary approvals or filings required under non-U.S. Antitrust Laws in jurisdictions in which parties typically would make such approvals or filings a condition to consummation of a transaction.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">3.&#160;&#160;&#160;&#160;Form A Statement Regarding the Acquisition of Control of or Merger with a Domestic Insurer filing with, and approval (or non-disapproval) from, each of the North Dakota Insurance Department and Texas Department of Insurance with respect to the acquisition of Aspen Specialty Insurance Company and Aspen American Insurance Company, respectively.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">4.&#160;&#160;&#160;&#160;Letter of Notification to the Texas Department of Insurance by the Company pursuant to Section 823.161 of the Texas Insurance Code.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">5.&#160;&#160;&#160;&#160;Section 30E and 30J notification filings with, and approvals (or non-disapprovals) from, the Bermuda Monetary Authority with respect to Aspen Bermuda Limited, Peregrine Reinsurance Ltd. and Silverton Re Ltd.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">6.&#160;&#160;&#160;&#160;Section 30EA notification filing with, and approval (or non-disapproval) from, the Bermuda Monetary Authority with respect to Aspen Bermuda Limited.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">7.&#160;&#160;&#160;&#160;Section 30CA notification filing with, and approval (or non-disapproval) from, the Bermuda Monetary Authority with respect to Aspen Capital Management, Ltd.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">8.&#160;&#160;&#160;&#160;Written confirmation from the Bermuda Monetary Authority that it has no objection to Parent becoming a 50 percent shareholder controller of each Company Subsidiary registered under the Bermuda Insurance Act.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">9.&#160;&#160;&#160;&#160;Section 178 change of control applications to, and approval or consent from, the UK Prudential Regulatory Authority and the Financial Conduct Authority in respect of the acquisition of Aspen Insurance UK Limited and Aspen Managing Agency Limited.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">10.&#160;&#160;&#160;&#160;Section 178 change of control applications to, and approval or consent from, the UK Financial Conduct Authority in respect of the acquisition of Aspen Risk Management Limited and Aspen UK Syndicate Services Limited.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">11.&#160;&#160;&#160;&#160;Such pre-acquisition change of control notifications to, and approval or consent from, Lloyd&#8217;s as are required in respect of the acquisition of Aspen Managing Agency Limited, Aspen UK Syndicate Services Limited, and Aspen Underwriting Limited.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">12.&#160;&#160;&#160;&#160;Such voluntary clearance statement to the Pensions Regulator as may be required in respect of a corporate transaction that is regarded as a &#8220;Type A event&#8221; that would be materially detrimental to the ability of the scheme to meet its liabilities in connection with AIUK Trustees Limited.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">13.&#160;&#160;&#160;&#160;Such pre-acquisition filing to, and (where required by applicable Law) approval (or non-disapproval) from, the Australian Prudential Regulation Authority (and any other applicable Governmental Authorities in Australia) as may be required in connection with a change of control of Aspen Insurance UK Limited (Australia branch).</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">14.&#160;&#160;&#160;&#160;Such pre-acquisition notice to and filings with, and (where required by applicable Law) approval (or non-disapproval) from, the Jersey Financial Services Commission as may be required in connection with the change of control of APJ Asset Protection Jersey Limited.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">15.&#160;&#160;&#160;&#160;Such pre-acquisition notice to and filings with, and (where required by applicable Law) approval (or non-disapproval) from, the Dubai Financial Services Authority as may be required in connection with the change of control of Aspen UK Syndicate Services Limited (Dubai Branch).</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">16.&#160;&#160;&#160;&#160;Such change of control application to, and (where required by applicable Law) approval (or non-disapproval) from, the Bank of Ireland as may be required in connection with the acquisition of Aspen Insurance Ireland Designated Activity Company.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">17.&#160;&#160;&#160;&#160;Any necessary approvals or filings required under the Insurance Laws of Italy with respect to the indirect acquisition by Parent of the Company&#8217;s minority stake in Bene Assicurazioni.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">18.&#160;&#160;&#160;&#160;Such pre-acquisition notices to the Monetary Authority of Singapore as may be required in connection with the change of control of Aspen Insurance UK Limited (Singapore Branch) and Aspen Singapore Pte. Ltd.</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">19.&#160;&#160;&#160;&#160;Such pre-acquisition notice to and filings with the Office of the Superintendent of Financial Institutions of Canada as may be required in connection with the change of control of Aspen Insurance UK Limited (Canada Branch).</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i39f9c8dd703240c09b25cddf6e2a32fc_337"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RATINGS </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">A.M. BEST</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance UK Limited </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda Limited </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Specialty Insurance Company </font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen American Insurance Company </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance UK Limited </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda Limited </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>18
<FILENAME>exhibit107-fx1.htm
<DESCRIPTION>EX-10.7
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3dd5f36d41c743bf81da0d5a65a56f59_59"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.7</font></div></div><div style="margin-bottom:30pt;text-align:center"><font><br></font></div><div style="margin-bottom:150pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DATED February 19, 2019</font></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and</font></div><div style="margin-bottom:35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MARK CLOUTIER</font></div><div style="margin-bottom:65pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SERVICE AGREEMENT</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i3dd5f36d41c743bf81da0d5a65a56f59_82"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONTENTS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.273%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Clause</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Page</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">1.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DEFINITIONS AND INTERPRETATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">2.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APPOINTMENT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">3.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TERM</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">4.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DUTIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">5.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">INSIDE INFORMATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">6.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">REMUNERATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">7.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TRAVEL AND EXPENSES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">8.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PENSION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">9.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BENEFITS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">10.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HOLIDAYS AND HOLIDAY PAY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">11.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SICKNESS, ABSENCE, DISABILITY OR DEATH</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">12.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CONFIDENTIAL INFORMATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">13.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PROTECTION OF THE COMPANY&#8217;S BUSINESS INTERESTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">14.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">INTELLECTUAL PROPERTY RIGHTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">15.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TERMINATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">16.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GARDEN LEAVE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">17.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CHANGE IN CONTROL</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">18.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EFFECT OF TERMINATION OF THIS AGREEMENT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">19.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APPOINTMENT OF ATTORNEY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">20.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AMALGAMATION, RECONSTRUCTION AND CHANGE OF DIRECTOR</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">21.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DISCIPLINARY AND GRIEVANCE PROCEDURES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.273%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">22.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DATA PROTECTION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">23.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MISCELLANEOUS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">24.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ENTIRE AGREEMENT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">25.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SEVERABILITY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">26.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">COOPERATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">27.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SUCCESSORS AND BINDING AGREEMENT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">28.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CONTRACTS (RIGHTS OF THIRD PARTIES) ACT 2016</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">29.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">COUNTERPARTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">30.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GOVERNING LAW</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">31.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JURISDICTION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i3dd5f36d41c743bf81da0d5a65a56f59_103"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THIS SERVICE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is made on February 19, 2019.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMONG&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">ASPEN INSURANCE HOLDINGS LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> incorporated in the Islands of Bermuda whose registered office is at Cedar Avenue, Hamilton, Bermuda (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Aspen Holdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">ASPEN BERMUDA LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> a subsidiary of Aspen Holdings incorporated in the Islands of Bermuda whose registered office is at Cedar Avenue, Hamilton, Bermuda (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">MARK CLOUTIER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of 141 Front Street, Hamilton, Bermuda HM19 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BACKGROUND AND CONDITION OF AGREEMENT</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Highlands Holdings, Ltd., a Bermuda exempted company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), has acquired Aspen Holdings and its Group Companies by way of a merger agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">This Agreement is effective as of the completion of the Merger.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IT IS AGREED&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">DEFINITIONS AND INTERPRETATION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">In this Agreement where it is appropriate in context singular words shall include the plural and vice versa. Words defined below shall have the following respective meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appointment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the employment of the Executive under the terms of this Agreement and the schedule&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of Aspen Holdings from time to time or its duly authorised representative&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the business of the Group or any Group Company at the date of termination of the Executive&#8217;s employment with which the Executive has been concerned to a material extent at any time in the Relevant Period&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the earliest date on which the Merger has completed and where such employment with the Company would not, as reasonably determined by Parent, amount to a breach by the Executive of the non-competition provision at clause 22.2 of the Executive's employment contract with Brit Group Services Limited&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Intellectual Property Rights created by the Executive (whether jointly or alone) in the course of the Executive&#8217;s employment with the Company or serving as the Chief Executive Officer of Aspen Holdings, whether or not during working hours or using Company or Aspen Holdings premises or resources and whether or not recorded in material form&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall the meaning set out in section 995 of the Income Tax Act 2007&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Garden Leave</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any period in respect of which Aspen Holdings or the Company has exercised its rights under clause 16.1&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Aspen Holdings, the Company, and all companies which are for the time being a Holding Company or Subsidiary of Aspen Holdings&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Group Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any company within the Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Incapacitated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means prevented by illness, injury, accident or other incapacity or circumstances beyond the Executive&#8217;s control from properly fulfilling his duties under this Agreement (and &#8220;Incapacity&#8221; shall be construed accordingly)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means patents, Inventions, copyright and related rights, trademarks, trade names, service marks and domain names, rights in get-up, goodwill, rights to sue for passing off, design rights, semi-conductor topography rights, database rights, confidential information, moral rights, proprietary rights and any other intellectual property rights in each case whether registered or unregistered and including all applications or rights to apply for, and renewals or extensions of such rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Invention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any invention, idea, discovery, development, improvement or innovation, processes, formulae, models or prototypes, whether or not patentable or capable of registration, and whether or not recorded in any medium&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Market Abuse Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Market Abuse Regulation (EU) 596&#47;2014&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recognised Investment Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a recognised investment exchange as defined by section 285 of the UK&#8217;s Financial Services and Markets Act 2000&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Relevant Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the period of 24 months immediately preceding the date of termination of the Executive&#8217;s employment or, in the event that Aspen Holdings or the Company exercises all or any of its rights under Clause 16, the period of 24 months immediately preceding the date on which it exercises such rights&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the basic salary payable to the Executive under this Agreement from time to time and does not include any benefits (or the value of benefits, including pension benefits), bonus, commission or other remuneration payable to the Executive&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Holding Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meanings ascribed to them by section 86 of the Companies Act 1981 or any statutory modification or re-enactment thereof&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any tax, levy, impost, duty, charge, employer social security contribution or other governmental charge (national or local) or withholding of a similar nature </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(including any penalty or interest payable in connection with any failure to pay or any delay in paying any of the same).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The headings in this Agreement are included for convenience only and shall not affect its interpretation or construction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">This Agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation including non-contractual disputes or claims shall be construed and governed in accordance with the laws of Bermuda and the parties submit to the exclusive jurisdiction of the Supreme Court of Bermuda over any claim or matter arising under or in connection with this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">References to any legislation shall be construed as references to legislation as from time to time amended, re-enacted or consolidated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">References to clauses and the parties are respectively to clauses of and the parties to this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Each of Aspen Holdings and the Company accepts the benefits in this Agreement on its own behalf and on behalf of all Group Companies. Each of the Company and Aspen Holdings shall be entitled to assign its rights and those of other Group Companies in connection with this Agreement to any other Group Company at any time with immediate effect on giving written notice to the Executive.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">APPOINTMENT</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company shall employ the Executive, and the Executive shall be appointed and shall serve in the capacity of Chief Executive Officer of Aspen Holdings. The Executive shall also hold the title of Chairman of the Board, until such time as Apollo Management IX, L.P, a Delaware limited partnership, reasonably determines otherwise ahead of an Initial Public Offering. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Executive warrants that by entering into this Agreement he will not be in breach of any express or implied terms of any contract or of any other obligation binding upon him.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">TERM</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Appointment is effective as of the Commencement Date and can be terminated at any time by either Aspen Holdings or the Company giving 6 months&#8217; notice in writing to the Executive, or the Executive giving 6 months&#8217; notice in writing to Aspen Holdings and the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">No employment with a previous employer counts towards the Executive&#8217;s period of continuous employment with the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">DUTIES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">During the Appointment the Executive shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">be responsible directly to the Board&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">perform the duties and exercise the powers and functions which from time to time may reasonably be assigned to or vested in him by the Board in relation to the Company, Aspen Holdings and any other Group Company to the extent consistent with his job title (without being entitled to any additional remuneration in respect of such duties for any Group Company)&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">except as agreed in writing in advance by the Company or Aspen Holdings, devote his business time, energy and skill to the performance of duties for the Company, Aspen Holdings and the wider Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">unless prevented by ill health, devote the whole of his time and attention, endeavours and abilities to promoting the interests of the Company, Aspen Holdings and of the Group and shall not engage in any activity which it is reasonably foreseeable may be or may become harmful to or contrary to the interests of the Company, Aspen Holdings or of the Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">observe and comply with the Market Abuse Regulation and all lawful and reasonable requests, instructions, resolutions and regulations of the Board and give to them such explanations information and assistance as they may reasonably require&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">observe and comply with all policies and procedures of the Company, Aspen Holdings and&#47;or the Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">carry out his duties in a proper, loyal and efficient manner to the best of his ability and use his best endeavours to maintain, develop and extend the business of the Company, Aspen Holdings and of the Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">comply with all legal duties imposed on him including those contained in the Companies Act 1981&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">report to the Board in writing any matter relating to the Company, Aspen Holdings or any Group Company or any of its or their officers or employees which he becomes aware of and which could be the subject of a protected disclosure as defined by section 29A of the Employment Act 2000&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">be based at the Company&#8217;s or Aspen Holdings&#8217; offices in Bermuda, London, and the United States and perform such duties at such place or places as required&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">work such hours and travel within and outside Bermuda as may reasonably be required for the proper performance of his duties&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">accept (if offered) appointment as a director of the Company, Aspen Holdings or any Group Company with or without such executive powers as the Board shall decide in its absolute discretion and resign any such appointment if requested by the Board without any claim for damages or compensation. If the Executive fails to resign any such appointment each of the Company and Aspen Holdings is hereby irrevocably authorised to appoint some person in his name and on his behalf to sign and execute all documents and do all things necessary to constitute and give effect to such resignation. The Executive also agrees that any resignation of any directorship or other office held by the Executive shall not terminate the Executive&#8217;s employment or amount to a breach of the terms of this Agreement by the Company or Aspen Holdings.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">During the Appointment the Executive shall not without the written consent of the Board (such consent not to be unreasonably withheld)&#58;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">be engaged or interested either directly or indirectly (through any member of his family) in any capacity in any trade, business or occupation whatsoever other than the Business of the Company, Aspen Holdings or the Group provided that the Executive shall not be prohibited from holding (whether directly or indirectly), for investment purposes only, up to five per cent of the shares or stock of any class of any public company quoted or dealt in on a Recognised Investment Exchange&#59; and</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">pledge the credit of the Company, Aspen Holdings or any Group Company other than in accordance with the applicable Group policy.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">INSIDE INFORMATION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">During the Appointment the Executive shall comply with the provisions of the Market Abuse Regulation relating to insider dealing and the use of inside information relating to Aspen Holdings and any other applicable law or regulations applying to dealings in securities of Aspen Holdings or of any Group Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Executive shall not and shall procure that none of his closely associated persons (as defined in the Market Abuse Regulation) (including his spouse or civil partner and any children or step-children under the age of 18) shall deal in any way in any securities of Aspen Holdings or of any Group Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">REMUNERATION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company shall pay to the Executive a Salary at a rate of US $1,500,000 per annum or at such other rate as may from time to time be agreed between the Company and the Executive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Salary shall be deemed to accrue evenly from day to day and shall be payable in arrears by equal monthly instalments in accordance with the Company&#8217;s normal pay policy into a bank account nominated by the Executive. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Executive shall be eligible to be considered for an annual variable performance-based Bonus, which is payable in cash (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Executive shall be entitled to a guaranteed minimum bonus of 100% of the Salary for the first bonus year of the Appointment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Year 1 Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), pro-rated to reflect the portion of the bonus year actually worked. The Year 1 Bonus shall be calculated by multiplying the Salary with a fraction, the numerator of which is the number of days that the Executive was employed or engaged during the applicable bonus year and the denominator of which is 365. Thereafter, the Executive's Bonus will be based upon a target of 150% of Salary, with a maximum bonus potential of up to 200% of Salary. Any applicable performance metrics shall be determined by the Board from time to time at its sole discretion and will be communicated to the Executive. All Bonus targets and payments may be subject to such conditions as the Compensation Committee of the Board may in its absolute discretion decide. Save for the Year 1 Bonus, the Executive shall not be entitled to receive any Bonus if he is not employed or is under notice, whether issued by the Executive or the Company, on 31 December of the relevant bonus year. All Bonus payments are subject to the terms of Aspen Holdings&#8217; or the Company's Malus and Clawback Policies that are in place from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company may deduct from the Salary, Bonus, or any other payments to or terms owed to the Executive, any&#58; </font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">money owed to the Company, Aspen Holdings or any Group Company by the Executive&#59; and</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">deductions or withholdings for or on account of Tax as may be required by law</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company shall review the Salary for increase at least once each year, and any change in the Salary resulting from such review will take effect from 1 April. The Company's review shall take into consideration, among other factors, the base salary paid to Chief Executive Officers at comparable companies based in Bermuda, the United Kingdom and the United States, as well as other relevant local or global talent pool comparables, it being expressly understood that while it is intended that the Company shall consider these factors, it shall have no obligation to take any specific action based on such factors.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company shall pay to the Executive a one-time sign-on bonus of US $650,000 in cash in the first payroll cycle following the Commencement Date. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">TRAVEL AND EXPENSES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Company shall reimburse the Executive for all reasonable and authorised out of pocket expenses (including hotel and travelling expenses) wholly, necessarily and exclusively incurred by the Executive in the discharge of his duties subject to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">production of appropriate VAT receipts or such other evidence as the Company may reasonably require as proof of such expenses and in accordance with the Group&#8217;s rules and policies relating to expenses as may be in force from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">The Executive is permitted to travel first class for international flights required for the proper performance of his duties. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">PENSION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company will comply with the employer pension duties in accordance with National Pension Scheme (Occupational Pensions) Act 1998.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">BENEFITS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">During the Employment Period, the Executive shall be entitled to&#58;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Such private medical, life assurance and disability insurance coverage at a level that is competitive with similar benefits provided to individuals at CEO level in insurance companies comparable in structure, headcount, and turnover to Aspen Holdings, and as set forth from time to time in the applicable plan documents&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Benefits under any plan or arrangement available generally for the employees of Aspen Holdings at the level of seniority of the Executive, including Aspen Holding&#8217;s pension plan, subject to and consistent with the terms and conditions and overall administration of such plans as set forth from time to time in the applicable plan documents&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">HOLIDAYS AND HOLIDAY PAY</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24pt">The Company&#8217;s holiday year runs between 1 January and 31 December. In addition to the normal bank and public holidays applicable in Berumda the Executive shall be entitled to 30 working days&#8217; paid holiday during each holiday year to be taken at such time as the Board may from time to time approve and paid at the rate of basic Salary (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Holiday Entitlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24pt">Untaken Holiday Entitlement in any holiday year may not be carried forward to any following holiday year and such Holiday Entitlement will be forfeited without any right to payment in lieu.</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24pt">Holiday entitlement will accrue at the rate of 2.5 days per complete month of service. Holiday entitlement in the holiday year in which the Employment commences and the holiday year in which the Employment terminates will be proportionate to your period of service during that holiday year (rounded up to the nearest full day).Upon termination of the Appointment the Executive shall, subject to clause 15.2 if appropriate, either be entitled to Salary in lieu of any outstanding Holiday Entitlement or be required to repay to the Company any Salary received in respect of Holiday Entitlement taken in excess of his </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">proportionate Holiday Entitlement and any sums repayable by the Executive may be deducted from any outstanding Salary or other payments due to the Executive.</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24pt">The Company reserves the right to require the Executive to take any accrued but unused Holiday Entitlement during any period of notice given to terminate the Appointment or at any other time, or, if applicable, any such holiday shall be deemed to be taken during any period of Garden Leave.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">SICKNESS, ABSENCE, DISABILITY OR DEATH</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If the Executive is Incapacitated he shall immediately notify a member of the Board and inform him or her of the reason for his absence.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Each time the Executive is absent from work he shall provide evidence to the Company of the reason for such absence. This evidence shall be provided by way of a self-certification form obtainable from the Board which shall be completed by the Executive on the first day of his resumption of duty. In addition, in the case of illness or injury lasting for more than seven consecutive days, the Executive shall provide a doctor&#8217;s certificate on the fifth day of illness or injury and weekly thereafter.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive agrees that at any time during the Appointment he will consent, if required by the Company or Aspen Holdings, to a medical examination by a medical practitioner appointed by the Company or Aspen Holdings at its expense and shall authorise such medical practitioner to disclose to and discuss with the Board the results of any such medical examination.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If the Executive is Incapacitated by the action of a third party in respect of which damages are or may be recoverable the Executive shall notify the Board of that fact and of any claim, compromise, settlement or judgment awarded as soon as is reasonably practicable. The Executive shall include in any claim for damages against such third party a claim in respect of monies paid by the Company or Aspen Holdings under this clause 11.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If the Executive is absent from his duties hereunder owing to illness, accident or other incapacity duly certified in accordance with the provisions of clause 11.2 he shall be paid his full remuneration for any period of absence of up to a maximum of 26 weeks in aggregate in any period of 52 consecutive weeks and thereafter, subject to the provisions of clause 15, to such remuneration (if any) as the Board shall in its absolute discretion allow.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If the Executive shall be, on the basis of a medical report supplied to the Company or Aspen Holdings following his having undergone a medical examination pursuant to clause 11.3, in the opinion of the Board unfit ever to return to his duties (but in such circumstances and prior to any action being taken under this clause, the Executive shall have the right to have a second medical report from a duly qualified doctor or medical </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">adviser selected by the Executive and approved by the Board, which approval shall not be unreasonably withheld) the Company and Aspen Holdings shall be entitled to place the Executive on permanent sick leave without pay or benefits (other than permanent health insurance benefits) with effect from any time on or after the commencement of payments under the permanent health insurance arrangements referred to in clause 9.1.1.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">CONFIDENTIAL INFORMATION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall not at any time during the Appointment nor at any time after its termination except for a purpose of the Company, Aspen Holdings or the Group directly or indirectly use or disclose trade secrets or confidential information relating to the Company, Aspen Holdings or any Group Company or the Company&#8217;s, Aspen Holdings&#8217; or any Group Company&#8217;s agents, customers, prospective customers or suppliers.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">For the purposes of clause 12.1 confidential information shall include any information relating to the Business and&#47;or the financial affairs of the Company, Aspen Holdings and&#47;or the Group and the Company&#8217;s, Aspen Holdings&#8217; and&#47;or any Group Company&#8217;s agents, customers, prospective customers or suppliers and in particular shall include&#58;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the business methods and information of the Company, Aspen Holdings and any Group Company (including prices charged, discounts given to customers or obtained from suppliers, product development, marketing and advertising programmes, costings, budgets, turnover, sales targets or other financial information)&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">lists and particulars of the Company&#8217;s, Aspen Holdings&#8217; and any Group Company&#8217;s suppliers and customers and the individual contacts at such suppliers and customers&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">details and terms of the Company&#8217;s, Aspen Holdings&#8217; and any Group Company&#8217;s agreements with suppliers and customers&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">secret manufacturing or production processes and know-how employed by the Company, Aspen Holdings and any Group Company or its&#47;their suppliers&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">confidential details as to the design of the Company&#8217;s, Aspen Holdings&#8217; and any Group Company&#8217;s and its and&#47;or their suppliers&#8217; products and inventions or developments relating to future products&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">details of any promotions or future promotions or marketing or publicity exercises planned by the Company, Aspen Holdings and any Group Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">details of any budgets or business plans of the Company, Aspen Holdings and any Group Company&#59; and</font></div><div style="padding-left:85.5pt;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">any information which may affect the value of the Business or the shares of the Company, Aspen Holdings or any Group Company,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">whether or not in the case of documents or other written materials or any materials in electronic format they are or were marked as confidential and whether or not, in the case of other information, such information is identified or treated by the Company, Aspen Holdings or any Group Company as being confidential.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall not be restrained from using or disclosing any confidential information which&#58;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">he is authorised to use or disclose by the Board&#59; or</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">has entered the public domain unless it enters the public domain as a result of an unauthorised disclosure by the Executive or anyone else employed or engaged by the Company, Aspen Holdings or any Group Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">he is required to disclose by law&#59; or</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">he is entitled to disclose under section 29A of the Employment Act 2000 provided that the disclosure is made in an appropriate way to an appropriate person having regard to the provisions of that Act and clause 5.1.9,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provided that, in the case of any disclosure under sub-clauses 12.3.3 or 12.3.4 above, the Executive shall (to the extent permitted by the applicable laws) notify the Company and Aspen Holdings in advance of the disclosure</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall not make copies of any document, memoranda, correspondence (including emails), computer disk, CD-ROM, memory stick, video tape or any similar matter (including for the avoidance of doubt in any electronic format) or remove any such items from the premises of the Company, Aspen Holdings or of any Group Company other than in the proper performance of his duties under this Agreement except with the written authority of the Board, which authority will apply in that instance only.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall not make any public statement (whether written or oral) to the media or otherwise relating to the affairs of the Company, Aspen Holdings or any Group Company and shall not write any article for publication on any matter concerned with the Business or other affairs of the Company, Aspen Holdings or the Group without the prior written consent of the Board.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">PROTECTION OF THE COMPANY&#8217;S AND ASPEN HOLDINGS&#8217; BUSINESS INTERESTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive acknowledges that following termination of the Appointment he will be in a position to compete unfairly with the Company and Aspen Holdings as a result of the confidential information, trade secrets and knowledge about the business, operations, customers, Executives and trade connections of the Company, Aspen Holdings and the Group he has acquired or will acquire and through the connections that he has developed and will develop during the Appointment. The Executive therefore agrees to enter into </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the restrictions in this clause 13 for the purpose of protecting the Company&#8217;s and Aspen Holdings&#8217; legitimate business interests and in particular the confidential information, goodwill and the stable trained workforce of the Company, Aspen Holdings and the Group.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive covenants with the Company, Aspen Holdings and each other Group Company that he shall not without the prior written consent of the Board (such consent not to be unreasonably withheld), directly or indirectly, on his own behalf, or on behalf of any person, firm, or company in connection with any business which is or is intended or about to be competitive with the Restricted Business (as defined below) or in relation to the provision of any goods or services similar to or competitive with those sold or provided by the Company, Aspen Holdings or any Group Company in connection with the Restricted Business&#58;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">for a period of 12 months after the termination of the Appointment solicit or canvass the custom of any Customer (as defined below)&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">for a period of 12 months after the termination of the Appointment solicit or canvass the custom of any Potential Customer (as defined below)&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">for a period of 12 months after the termination of the Appointment deal with any Customer&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">for a period of 12 months after the termination of the Appointment deal with any Potential Customer&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">for a period of 12 months after the termination of the Appointment solicit or entice away, or attempt to entice away from the Company, Aspen Holdings or any Group Company any Restricted Employee (as defined below)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">for a period of 12 months after the termination of the Appointment employ, offer to employ or enter into partnership with any Restricted Employee with a view to using the knowledge or skills of such person in connection with any business or activity which is or is intended to be competitive with the Restricted Business.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall not without the prior written consent of the Board (such consent not to be unreasonably withheld) for a period of 12 months after the termination of the Appointment, directly or indirectly, on his own behalf, or on behalf of any person, firm or company&#58;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">within the Restricted Territory (as defined below) set up, carry on, be employed in, provide relevant services to, be associated with, or be engaged or interested in, whether as director, employee, principal, shareholder, partner or other owner, agent or otherwise, any business which is or is intended or about to be competitive with the Restricted Business save as a shareholder of not more than </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">five per cent of any public company whose shares or stocks are quoted or dealt in on any Recognised Investment Exchange&#59; and</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">endeavor to cause any person, firm or company who is at the date of termination of the Appointment or at any time during the 12 months immediately prior to such termination was a Restricted Supplier (as defined below) to the Company, Aspen Holdings and&#47;or any Group Company, to either cease to supply the Company, Aspen Holdings or any Group Company or materially alter the terms of such supply in a manner detrimental to the Company, Aspen Holdings or any Group Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">In clause 13 the following words and phrases shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any person, firm or company who at the date of termination of the Appointment or at any time during the 12 months immediately prior to such termination was a customer of the Company, Aspen Holdings or any Group Company and from whom the Executive had obtained business on behalf of the Company, Aspen Holdings or any Group Company or to whom the Executive had provided or arranged the provision of goods or services on behalf of the Company, Aspen Holdings or any Group Company or for whom the Executive had management responsibility, at any time during the 12 months immediately prior to such termination&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Networking Site</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean Facebook, LinkedIn, Twitter, Google+ or any similar social or professional networking online sites or applications&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Potential Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any person, firm or company with whom either the Executive or any other employee of the Company, Aspen Holdings or any Group Company for whom the Executive had, at the date of the negotiations, management responsibility carried out negotiations on behalf of the Company, Aspen Holdings or any Group Company at any time during the period of 6 months immediately prior either to the start of a period of Garden Leave or to the date of termination of the Appointment where there is no period of Garden Leave with a view to such person, firm or company becoming a customer of the Company, Aspen Holdings or of any Group Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Business or any part of the Business which in either case&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">is carried on by the Company, Aspen Holdings or any Group Company at the date of termination of the Appointment&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">was carried on by the Company, Aspen Holdings or by any Group Company at any time during the period of 12 months immediately prior either to the start of a period of Garden Leave or to the date of termination of the Appointment where there is no period of Garden Leave&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">is to the knowledge of the Executive to be carried out by the Company, Aspen Holdings or by any Group Company at any time during the period of 12 months immediately following the date of termination of the Appointment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and which the Executive was materially concerned with or had management responsibility for (or had substantial confidential information (as defined in clause 12.2) regarding in either case at any time during the period of 12 months immediately prior to the date of termination of the Appointment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any senior employee of the Company, Aspen Holdings or any Group Company employed at the date of termination of the Appointment in the capacity of director or in any research, technical, IT, financial, marketing, operational, actuarial, risk, or sales function or other managerial role whom the Executive has managed or with whom he has worked at any time during the period of 12 months immediately prior to the termination of the Appointment, and shall not include any employee employed in an administrative, clerical, manual or secretarial capacity&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Supplier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any supplier to the Company, Aspen Holdings or to any Group Company with whom the Executive has had material personal contact or for whom the Executive has had managerial responsibility during the period of 12 months immediately prior to the termination of the Appointment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Territory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean United Kingdom and Bermuda together with any other country in which the Company, Aspen Holdings or any other Group Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">carried on any Restricted Business or provided any goods or services in connection with any Restricted Business at the date of termination of the Appointment&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">carried on any Restricted Business or provided any goods or services in connection with any Restricted Business at any time during the period of 12 months immediately prior to the date of termination of the Appointment&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">is to the knowledge of the Executive to carry out any Restricted Business at any time during the period of 12 months immediately following the date of termination of the Appointment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and regarding which country at any time during the period of 12 months immediately prior to the date of termination of the Appointment the Executive&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">was materially concerned or worked in&#59; and&#47;or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">had management responsibility for&#59; and&#47;or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">obtained confidential information (as defined in clause 12.2).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive may be required to amend or remove any information posted on a Networking Site which is deemed to constitute a breach of this clause 13.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive may disclose the restrictions set out in this clause 13 to a prospective employer. In the event that the Executive accepts an offer of employment or request to provide services either during the Appointment or during the currency of the restrictive periods set out in clauses 13.2 and 13.3, the Executive shall notify the Company and Aspen Holdings, and the Executive hereby agrees that the Company or Aspen Holdings may provide to such person, company or other entity making such an offer or request a full and accurate copy of this clause 13.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The restrictions contained in this clause are considered by the parties to be reasonable in all the circumstances. Each sub-clause constitutes an entirely separate and independent restriction and the duration, extent and application of each of the restrictions are no greater than is necessary for the protection of the interests of the Company, Aspen Holdings and any Group Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">INTELLECTUAL PROPERTY RIGHTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The parties acknowledge that the Executive may create Inventions (alone or jointly) in the course of his employment with the Company and his service as the Chief Executive Officer of Aspen Holdings and that the Executive has a special obligation to further the interests of the Company and Aspen Holdings in relation to such Inventions. The Executive shall, promptly following creation, disclose to the Company and Aspen Holdings all such Inventions and works embodying Company Intellectual Property.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive acknowledges that (except to the extent prohibited by or ineffective in law) all Company Intellectual Property and materials embodying them shall automatically belong to Aspen Holdings as from creation for the full term of those rights and (except to the extent prohibited by or ineffective in law), the Executive hereby assigns, by way of present and future assignment, any and all rights, title and interests therein to Aspen Holdings.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">To the extent that any Company Intellectual Property does not vest in Aspen Holdings automatically pursuant to clause 14.2 (and except to the extent prohibited by or ineffective in law), the Executive holds such property on trust for Aspen Holdings and hereby grants to Aspen Holdings an exclusive, royalty free licence to use such property in its discretion until such Company Intellectual Property fully vests in Aspen Holdings.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">To the extent that any Inventions created by the Executive (whether alone or jointly) at any time during the course of his employment are prohibited by or prevented in law from automatically vesting with Aspen Holdings pursuant to clause 14.2, the Executive shall, immediately upon creation of such rights, grant Aspen Holdings a right of first refusal, in writing, to acquire them on arm&#8217;s length terms to be agreed between the parties. If the parties cannot agree on such terms within 30 days of Aspen Holdings receiving the offer, Aspen Holdings shall refer the dispute to an arbitrator who shall be appointed by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">President of the Institute of Chartered Accountants in England and Wales. The arbitrator&#8217;s decision shall be final and binding on the parties and the costs of arbitration shall be borne equally by the parties</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive agrees&#58;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">to use best endeavours to execute all such documents, both during and after the Appointment, as Aspen Holdings may reasonably require to vest in Aspen Holdings all rights, title and interests pursuant to this Agreement at the reasonable expense of Aspen Holdings&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">to use best endeavours to provide all such information and assistance and do all such further things as Aspen Holdings may reasonably require to enable it to protect, maintain and exploit the Company Intellectual Property to the best advantage, at the reasonable expense of Aspen Holdings, including (without limitation), at Aspen Holdings&#8217; request, applying for the protection of Inventions throughout the world&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">to use best endeavours to assist Aspen Holdings in applying for the registration of any registrable Company Intellectual Property, to enable it to enforce the Company Intellectual Property against third parties and to defend claims for infringement of third party Intellectual Property Rights at the reasonable expense of Aspen Holdings&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">not to apply for the registration of any Company Intellectual Property in the United Kingdom or Bermuda or any other part of the world without the prior written consent of Aspen Holdings&#59; and</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">to keep confidential all Company Intellectual Property unless Aspen Holdings has consented in writing to its disclosure by the Executive.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">As against the Company, Aspen Holdings, their respective successors and assigns and any licensee of any of the foregoing, the Executive hereby waives all of his present and future moral rights which arise under the Copyright and Designs Act 2004 and all similar rights in other jurisdictions relating to the Company Intellectual Property.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive acknowledges that, except as provided by law, no further remuneration or compensation, other than that provided for in this Agreement, is or may become due to the Executive in respect of his compliance with this clause.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive irrevocably appoints Aspen Holdings as the Executive&#8217;s attorney in the Executive&#8217;s name to sign, execute, do or deliver on the Executive&#8217;s behalf any deed, document or other instrument and to use the Executive&#8217;s name for the purpose of giving full effect to this clause.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Rights and obligations under this Agreement shall continue in force after termination of this Agreement in respect of any Company Intellectual Property.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">TERMINATION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Appointment may be terminated without notice or pay in lieu of notice with immediate effect by the Company or Aspen Holdings if at any time&#58;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">it is found that the Executive did not comply with any lawful order or direction given to him by the Board&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the Board reasonably believes that the Executive has committed any serious breach or repeated after warning any breach or is guilty of a continuing breach of any of the terms of this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the Board reasonably believes that the Executive is guilty of any gross or serious misconduct or (after warning) willful neglect in the discharge of his duties under this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the Board reasonably believes that the Executive is guilty of any bribery, corruption, fraud, dishonesty or conduct tending to bring himself, the Company, Aspen Holdings or any Group Company into disrepute including for the avoidance of doubt any criminal offence (except a road traffic offence not involving a custodial sentence)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the Board reasonably believes that the Executive has committed a breach of any legislation in force which may affect or relate to the business of the Company, Aspen Holdings or any Group Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the Executive is declared bankrupt or has a receiving order made against him or makes any general composition with his creditors or takes advantage of any statute affording relief for insolvent debtors&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the Executive becomes prohibited by law from being or acting as a director of the Company, Aspen Holdings and any other Group Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the Executive fails to maintain or becomes disqualified from maintaining registration with any regulatory body, membership of which is reasonably required by the Company, Aspen Holdings and any other Group Company for the Executive to carry out his duties&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">the Executive refuses or fails to agree to accept employment on the terms and in the circumstances specified in clause 20.1 of this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.5pt">the Executive resigns as a director of Aspen Holdings or any other Group Company other than at the request of the Board&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.5pt">the Executive is guilty of a breach of the rules or regulations as amended from time to time of the UK Listing Authority, the London Stock Exchange, New York Stock Exchange, Euronext or any regulatory authorities relevant to the Company, Aspen Holdings or any Group Company or any code of practice issued by the Company or Aspen Holdings (as amended from time to time).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">In the event of termination under clause 15.1 above neither the Company nor Aspen Holdings shall be obliged to make any further payment to the Executive except for payments by the Company of such Salary as shall have accrued at the date of termination and in respect of accrued but untaken Holiday Entitlement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Upon notice of termination of the Appointment being given, or upon termination of the Appointment, or, at the start of a period of Garden Leave, or at any time upon request by the Company or Aspen Holdings in writing, the Executive shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">at the request of the Company or Aspen Holdings resign from all (if any) offices held by him in the Company, Aspen Holdings or any Group Company and all (if any) trusteeships held by him of any pension scheme or any trust established or subscribed to&#47;by the Company, Aspen Holdings and any Group Company and in the event of his failure to do so each of the Company and Aspen Holdings is hereby irrevocably authorised to appoint some person in his name and on his behalf to sign and execute all documents and do all things necessary to constitute and give effect to such resignation&#59;</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">immediately return to Aspen Holdings all correspondence (including emails), documents, papers, memoranda, notes, records such as may be contained in magnetic media or other forms of computer storage, videos, tapes (whether or not prepared or produced by him) and any copies thereof charge and credit cards and all other property (including any car) belonging to the Company or Aspen Holdings which may be in the Executive&#8217;s possession or under his control provided that the Executive shall not be obliged to return during any period of Garden Leave any property provided to him as a contractual benefit&#59; and</font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">if requested send to the Board a signed statement confirming that he has complied with sub-clause 15.3.2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall not at any time after the termination of the Appointment represent himself as being in any way connected with or interested in the Business of the Company, Aspen Holdings or the Group.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">At its absolute discretion the Company or Aspen Holdings may at any time (including without limitation after notice of termination shall have been given by either party) lawfully terminate this Agreement with immediate effect by notifying the Executive in writing that the Company or Aspen Holdings is exercising its right under this clause 15.5 and that it will make within 28 days a payment in lieu of notice of the Executive&#8217;s Salary only (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment in Lieu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and any Payment in Lieu paid pursuant to this clause 15 will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be paid less any deductions or withholdings for or on account of Tax as may be required by law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall have no right to receive a Payment in Lieu unless the Company or Aspen Holdings has exercised its discretion in clause 15.5. Nothing in this clause 15 shall prevent the Company or Aspen Holdings from terminating the Appointment in breach.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Notwithstanding clause 15.5 the Executive shall not be entitled to any Payment in Lieu if the Company or Aspen Holdings would otherwise have been entitled to terminate the Appointment without notice in accordance with clause 15.1 and in that case the Company and Aspen Holdings shall also be entitled to recover from the Executive any Payment in Lieu (or instalment thereof) already made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">On lawful termination of the Appointment howsoever arising the Executive shall not have any claim for breach of contract in respect of the loss of any rights or benefits under any share option, bonus, long-term incentive plan or other profit sharing scheme operated by the Company, Aspen Holdings or by any Group Company in which he may participate which would otherwise have accrued during the period of notice to which the Executive is entitled under this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive expressly agrees that the Company may make such deductions from Salary or other payments due on the termination of or during the Appointment as may be necessary to reimburse the Company for sums paid out by the Company to or on behalf of the Executive but which are recoverable by it including but not limited to loans, advances, relocation expenses, and excess holiday payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">GARDEN LEAVE</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Following notice to terminate the Appointment being given by the Company, Aspen Holdings or the Executive or if the Executive purports to terminate the Appointment in breach of contract, the Company or Aspen Holdings may by written notice require the Executive not to perform any services (or to perform only specified services) for the Company, Aspen Holdings or for any Group Company for all or part of the applicable notice period required under clause 3.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">During any period of Garden Leave the Executive shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">continue to receive the Salary and other contractual benefits under this Agreement in the usual way and subject to the terms of any benefit arrangements&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">remain an employee of the Company and remain bound by his duties and obligations, whether under this Agreement or otherwise, which shall continue in full force and effect&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">not contact or deal with (or attempt to contact or deal with) any customer, client, supplier, agent, distributor, shareholder, employee, officer or other business contact of the Company, Aspen Holdings or any Group Company without the prior written consent of Aspen Holdings&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">not (unless otherwise requested) enter onto the premises of the Company, Aspen Holdings or any Group Company without the prior written consent of the Company</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">not commence any other employment or engagement (including taking up any directorships or consultancy services)&#59;</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">provide such assistance as the Company, Aspen Holdings or any Group Company may require to effect an orderly handover of his responsibilities to any individual or individuals appointed by the Company, Aspen Holdings or any Group Company to take over his role or responsibilities&#59; and</font></div><div style="margin-bottom:12pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.5pt">make himself available to deal with requests for information, to provide assistance, to attend meetings and to advise on matters relating to the Business.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">In the event that the Company or Aspen Holdings exercises its rights under clause 16.1 of this Agreement then any Garden Leave shall be set off against and therefore reduce the periods for which the restrictions in clauses 13.2 and 13.3 of this Agreement apply.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">CHANGE IN CONTROL</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If a company or other entity acquires or agrees to acquire the whole or substantially the whole of the undertaking and assets of Aspen Holdings or acquires or agrees to acquire Control of Aspen Holdings, and within the period of 24 months from the date on which the acquisition takes place, or the agreement to make the acquisition is completed, the Company or Aspen Holdings dismisses you in breach of the terms of this Agreement, or you resign from the Employment in circumstances where you are entitled to treat yourself as dismissed due to the conduct of the Company or Aspen Holdings, then you will be entitled to the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Lump Sum Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34; in full and final settlement of all your claims against the Company, Aspen Holdings and any Group Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">For the purposes of Clause 17.1, the Lump Sum Payment is a payment equivalent to your Salary and the value of contractual benefits for the period of notice the Company or Aspen Holdings is required to give to terminate your employment under Clause 3.1, multiplied by two, less any sums already actually paid to you in respect of a period of notice under Clause 3.1 or as pay in lieu of notice under Clause 15.5.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">EFFECT OF TERMINATION OF THIS AGREEMENT</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The expiry or termination of this Agreement however arising shall not operate to affect any of the provisions hereof which are expressed to operate or have effect thereafter and shall not prejudice the exercise of any right or remedy of either party accrued beforehand.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">APPOINTMENT OF ATTORNEY</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Executive irrevocably and by way of security appoints each of the Company and Aspen Holdings to be his attorney with authority to do all such things and to execute all such documents in the Executive's name and on his behalf, as may be necessary to secure that the full benefit and advantage of the rights arising under Clauses 15 (Intellectual Property Rights) and 16 (Termination) are obtained by the Company and Aspen Holdings (or, where appropriate, any Group Company) and a letter signed by any director or secretary of the Company or Aspen Holdings certifying that any thing or any document has been done or executed within the authority conferred by this clause will be conclusive evidence of it.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">AMALGAMATION, RECONSTRUCTION AND CHANGE OF DIRECTOR</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If Aspen Holdings or the Company is wound up for the purposes of reconstruction or amalgamation the Executive shall not as a result or by reason of any termination of the Appointment have any claim against the Company, Aspen Holdings or any other Group Company for damages for termination of the Appointment or otherwise so long as he shall be offered employment with any concern or undertaking resulting from such reconstruction or amalgamation on terms and conditions no less favourable to the Executive than the terms contained in this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The appointment of the Executive as a director of the Company, Aspen Holdings or any Group Company does not amount to a term of employment and each of the Company and Aspen Holdings reserves the right to remove the Executive from any such directorship at any time for any reason, provided that it exercises its right reasonably. Where the Company or Aspen Holdings exercises this right reasonably, this shall not amount to a breach of this Agreement and shall not give rise to a claim for damages or compensation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">DISCIPLINARY AND GRIEVANCE PROCEDURES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall refer any grievance he may have about his employment or an appeal in connection with any disciplinary decision relating to him to a member of the Board in writing in the first instance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Board shall have the right to suspend the Executive from his duties on such terms and conditions as the Board shall determine for the purpose of carrying out an investigation into any allegation of misconduct or negligence or an allegation of bullying harassment or discrimination against the Executive and pending any disciplinary hearing. The Company shall be required to continue to pay such Salary and provide all such other contractual benefits to the Executive during any period of suspension as the Executive would have been entitled to if not suspended. Neither the Company nor Aspen Holdings shall be required to give any reason for exercising its right under this clause.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">DATA PROTECTION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Company and Aspen Holdings will collect and process information relating to the Executive in accordance with the privacy notice which is in place from time to time. The Executive is required to sign and date the privacy notice, and return to HR.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">The Executive shall comply with Aspen Holdings&#8217; data protection policy when handling personal data in the course of employment including personal data relating to any employee, worker, contractor, customer, client, supplier or agent of the Company, Aspen Holdings or any Group Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Failure to comply with Aspen Holdings&#8217; data protection policy or any other privacy related policy or practice may be dealt with under Aspen Holdings&#8217; disciplinary procedure and, in serious cases, may be treated as gross misconduct leading to summary dismissal.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">During the Appointment and for six years following its termination the Executive shall be entitled to be covered by a policy of directors&#8217; and officers&#8217; liability insurance on terms no less favourable than those in place from time to time for other members of the Board. Aspen Holdings shall grant you a deed of indemnity against certain liabilities that may be incurred as a result of your office to the extent permitted by section 98 of the Companies Act 1981.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Notices may be given by any party by personal delivery or by letter or email or fax message addressed to the other parties at (in the case of the Company or Aspen Holdings) its registered office for the time being and (in the case of the Executive) his last known address. Any such notice given by letter shall be deemed to have been given 48 hours after posting and any such notice given by fax shall be deemed to have been given at the time on the confirmation report. Any notice given to the Company or Aspen Holdings by email may be sent to the normal business email address of a member of the Board and any notice given to the Executive by email may be sent to the Executive&#8217;s usual email address or such other email address as may be agreed between the Executive and the Company or Aspen Holdings from time to time and any notice given by email shall be deemed to have been given one hour after it was sent and a hard copy shall be sent by post or fax by way of confirmation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">There are no collective agreements in force which affect the terms and conditions of the Appointment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">If any provision of this Agreement (including without limitation the provisions contained in clause 12 and clause 13) shall be found by any court or administrative body of competent jurisdiction to be invalid or unenforceable, such invalidity or unenforceability shall not affect the other provisions of this Agreement which shall remain in full force and effect. If any provision of this Agreement (including without limitation the provisions </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">contained in clause 12 and clause 13) is so found to be invalid or unenforceable but would be valid or enforceable if some part of the provision were deleted, the provision in question shall apply with such modifications as may be necessary to make it valid.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">ENTIRE AGREEMENT</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">This Agreement, together with the documents referred to in it constitutes the entire agreement and understanding between the parties in respect of the terms of your employment and supersedes, cancels and nullifies any and all previous or contemporaneous statements, agreements and understandings, oral or written, with respect to the terms of your employment, including, without limitation any statements made to you during the recruitment process, notwithstanding the terms of any previous agreement or arrangement expressed to survive termination.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Each of the parties acknowledges and agrees that in entering into this Agreement, and the documents referred to in it, it does not rely on, and shall have no remedy in respect of, any statement, representation, warranty or understanding (whether negligently or innocently made) other than as expressly set out in this Agreement. The only remedy available to either party in respect of any such statement, representation, warranty or understanding shall be for breach of contract under the terms of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt">Nothing in this clause 24 shall operate to exclude any liability for fraud.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">SEVERABILITY</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">COOPERATION</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During employment by the Company or service as Aspen Holdings&#8217; Chief Executive Officer and thereafter, the Executive shall provide his reasonable cooperation in connection with any action or proceeding ( or any appeal from any action or proceeding) that relates to events occurring during the Executive&#8217;s employment&#59; provided, however, that after the Executive&#8217;s employment by the Company or service as Aspen Holdings&#8217; Chief Executive Officer has ended, (i) any request for such cooperation shall accommodate the demands of the Executive&#8217;s then existing schedule and (ii) if any such request will involve more than a de minimis amount of the Executive&#8217;s time, the Executive shall be entitled to reasonable compensation therefor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">SUCCESSORS AND BINDING AGREEMENT</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall inure to the benefit of and be binding upon personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees of the parties hereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">28.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">CONTRACTS (RIGHTS OF THIRD PARTIES) ACT 2016</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A person who is not party to this Agreement shall have no right under the Contracts (Rights of Third Parties) Act 2016 to enforce any term of this Agreement. This clause does not affect any right or remedy of any person which exists or is available otherwise than pursuant to that Act.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">COUNTERPARTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be executed in any number of counterparts each of which when executed by one or more of the parties hereto shall constitute an original but all of which shall constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">GOVERNING LAW</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the law of Bermuda.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">31.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">JURISDICTION</font></div><div style="margin-bottom:24pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each party irrevocably agrees that the courts of Bermuda shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this Agreement or its subject matter or formation (including non-contractual disputes or claims). </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Signature page to follow</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23</font></div></div></div><div id="i3dd5f36d41c743bf81da0d5a65a56f59_123"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> whereof the parties have executed this Agreement as a deed on the date of this Agreement.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executed as a deed by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;)</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in the presence of a witness &#160;&#160;&#160;&#160;)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Cain</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name (block capitals)&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MICHAEL CAIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group General Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> for</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Witness signature</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Scott Kirk</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Witness name&#58; &#160;&#160;&#160;&#160;SCOTT KIRK </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(block capitals)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Witness address&#58; &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Address intentionally omitted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executed as a deed by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN BERMUDA LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;)</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in the presence of a witness &#160;&#160;&#160;&#160;)</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Marcus Foley</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name (block capitals)&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MARCUS FOLEY </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Chief Risk Officer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASPEN BERMUDA LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Witness signature</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Mark Pickering</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Witness name&#58; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MARK PICKERING </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(block capitals)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Witness address&#58; &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Address intentionally omitted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signed as a deed by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> MARK CLOUTIER &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)</font></div><div style="margin-bottom:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in the presence of a witness &#160;&#160;&#160;&#160;)</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Mark Cloutier</font></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Witness signature</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Scott Kirk</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Witness name&#58; &#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SCOTT KIRK</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(block capitals)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Witness address&#58; &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Address intentionally omitted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-indent:261pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>19
<FILENAME>exhibit108-fx1.htm
<DESCRIPTION>EX-10.8
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0c4c4a0bda3c4ec694ef1c532c84cdbf_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.8</font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">MANAGEMENT CONSULTING AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MANAGEMENT CONSULTING AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">dated March 28, 2019 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), by and between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Bermuda exempted company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APOLLO MANAGEMENT HOLDINGS, L.P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Delaware limited partnership (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Service Provider has expertise in the areas of finance, strategy, investment, acquisitions and other matters relating to the Company, its direct and indirect divisions and subsidiaries, and, where applicable, parent entities and controlled affiliates (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and their businesses&#59; </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Company desires to avail itself of the Service Provider&#8217;s expertise and consequently has requested that the Service Provider make such expertise available from time to time to render certain management consulting and advisory services related to the business and affairs of the Company Group and the review and analysis of certain financial and other transactions&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Service Provider and the Company agree that it is in their respective best interests to enter into this Agreement whereby, for the consideration specified herein, the Service Provider shall provide the services identified herein to the Company Group on the terms and subject to the conditions set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOW, THEREFORE,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in consideration of the foregoing, and the mutual agreements and covenants set forth herein and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows&#58; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 1.&#160;&#160;&#160;&#160;Retention of the Service Provider.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company retains the Service Provider to provide the services hereunder, and the Service Provider accepts such retention, upon the terms and subject to the conditions set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 2.&#160;&#160;&#160;&#160;Term.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall commence on, and shall be effective from, the Commencement Date, and shall terminate upon the earliest to occur of (i) the Termination Date (as defined below), (ii) a Termination Event (as defined below) and (iii) the written agreement by each of the Service Provider and the Company to such effect.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date that is the eight (8) year anniversary of the Commencement Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, on each of the eight (8) year and nine (9) year anniversaries of the Commencement Date, the Termination Date shall be automatically extended by one successive twelve (12) month period absent contrary notice by either party given not less than thirty (30) days prior to such anniversary date. For the avoidance of doubt, in no event shall the Termination Date occur later than the ten (10) year anniversary of the Commencement Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the consummation of any transaction or series of transactions (including any merger, consolidation, disposition, recapitalization or issuance or sale of assets or equity interests, whether pursuant to one or more Underwritten Offerings (as defined below), private sales or otherwise), whether or not related, as a result of which New Holders (as defined below) become the beneficial owner, directly or indirectly, of more than ninety percent (90%) of the ordinary shares or other common equity and voting securities of the Company Group. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">New Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means one or more Persons that are not Initial Holders&#59; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Initial Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (A) holders of equity interests of Highlands Holdings, Ltd. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Parent Holdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) as of the Commencement Date, (B) any Persons who acquire equity interests of Parent Holdings during the six (6) month period following the Commencement Date, (C) any directors, officers, employees and&#47;or other members of management of Parent Holdings and&#47;or its subsidiaries who acquire or receive equity interests of Parent Holdings at any time in their capacities as such and&#47;or (D) any Affiliates (as defined below) of any of the foregoing Persons described in clauses (A) or (B) of this definition.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means February 15, 2019, which is the Closing Date, as defined in the Agreement and Plan of Merger, dated as of August 27, 2018 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Transaction Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), by and among the Company, Highlands Holdings, Ltd. and Highlands Merger Sub, Ltd.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the (i) obligations of the Company Group pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (ii) provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall survive any termination of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 3.&#160;&#160;&#160;&#160;Management Consulting Services.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Service Provider shall advise the Company Group concerning such management matters that relate to proposed financial transactions, acquisitions and other senior management matters related to the business, administration and policies of the members of the Company Group (including the analysis of the return on investment of capital and other expenditures and deployment projects), in each case as the Company shall reasonably and specifically request by way of written notice to the Service Provider, which notice shall specify the services required of the Service Provider and shall include all background materials and information necessary for the Service Provider to complete such services. If requested by the Company to provide such services, the Service Provider shall devote such time to any such written request as the Service Provider shall deem, in its good faith discretion, necessary. Such consulting services, in the Service Provider&#8217;s good faith discretion, shall be rendered in person or by telephone or other communication. The Service Provider shall have no obligation to any member of the Company Group as to the manner and time of rendering its services hereunder, and no member of the Company Group shall have any right to dictate or direct the details of the services rendered hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall promptly provide any materials or information that the Service Provider may reasonably request in connection with the provision of services by the Service Provider pursuant to the terms and conditions of this Agreement or to comply with Securities and Exchange Commission or other legal or regulatory requirements (any such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">materials or information so furnished, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Company recognizes and confirms that the Service Provider (i)&#160;shall use and rely primarily on the Information and on information available from generally recognized public sources in performing the services contemplated by this Agreement without having independently verified the same, (ii)&#160;does not assume any responsibility or liability whatsoever for the accuracy or completeness of the Information and such other information and (iii)&#160;is entitled to rely upon the Information without independent verification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Service Provider shall perform all services to be provided hereunder (i) in support of the members of management and boards of directors (or equivalent governing body) of the Company Group but (ii) as an independent contractor to the Company Group and not as an employee, agent, partner of, member of a joint venture with, equity holder or representative of any member of the Company Group. The Service Provider shall not have any authority to act for or to bind any member of the Company Group while acting in its capacity as an advisor to the Company Group under this Agreement without the Company&#8217;s prior written consent. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall in no way prohibit the Service Provider, its Affiliates, or any of its or its Affiliates&#8217; current or former limited partners, general partners, directors, members, officers, managers, employees, agents, independent contractors, equity holders, affiliates, advisors or representatives (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) from engaging in other activities or performing services for its or their own account or for the account of others, including for any Person that may be in direct or indirect competition with any business of any member of the Company Group, and the Company, on behalf of each member of the Company Group, disclaims to the fullest extent permitted by law any such prohibition thereon.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Service Provider shall not have, by reason of this Agreement, a fiduciary relationship in respect of the Company Group, and nothing in this Agreement is intended to or shall be so construed as to impose upon the Service Provider, its Affiliates or any of the Service Provider&#8217;s or its Affiliates&#8217; Representatives, any obligation, except as expressly set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any advice or opinions provided by the Service Provider may not be referred to publicly or disclosed to any third party (other than the Company&#8217;s or any of its affiliates&#8217; legal, tax, financial or other advisors, each of which agrees to keep such advice or opinions confidential), except in accordance with the Service Provider&#8217;s prior written consent.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 4.&#160;&#160;&#160;&#160;Compensation.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As consideration for the Service Provider&#8217;s agreement to provide the services set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and to waiver or deferral as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> below, the Company shall pay, or cause to be paid, to the Service Provider a nonrefundable annual management consulting fee equal to the greater of (i) one percent (1%) of the consolidated net income of the Company and its subsidiaries for the applicable fiscal year and </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) $5 million (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Consulting Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Such Consulting Fee shall be payable as follows&#58; (x) $1.25 million shall be payable on the first business day following the end of each fiscal quarter of such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">fiscal year and (y) following the completion of the Company&#8217;s annual audit in respect of such fiscal year, the remaining unpaid amount of the Consulting Fee, if any (after taking into account the payments made in accordance with clause (x)), shall be payable on the first business day following the completion of such annual audit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Consulting Fee applicable to the 2019 fiscal year shall be prorated to cover only the time period commencing on the Commencement Date and ending on December 31, 2019. The Consulting Fee will be payable to the Service Provider at the same time by wire transfer in same-day funds to the bank account or accounts designated by the Service Provider.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties acknowledge and agree that the Company Group&#8217;s maximization of value for its equity holders may also include consummating (or participating in the consummation of) one or more underwritten public offerings of any class of equity or debt securities of the Company or any other member of the Company Group or a direct or indirect parent company thereof pursuant to an effective registration statement (other than on Form S-8 or a successor thereto) under the Securities Act of 1933, as amended, or similar law in other jurisdictions (each such offering, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Underwritten Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The services provided to the Company Group by the Service Provider pursuant to this Agreement will help to facilitate the consummation of an Underwritten Offering, if any member of the Company Group decides to pursue such a transaction. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon presentation by the Service Provider to the Company of such documentation as may be reasonably requested by the Company, the Company shall reimburse (or cause to be reimbursed) the Service Provider for all reasonable out-of-pocket expenses, including legal fees and expenses, and other disbursements incurred by the Service Provider, its Affiliates and all of its and its Affiliates&#8217; Representatives in the performance of the Service Provider&#8217;s obligations hereunder, whether incurred before, on or after the Commencement Date, including reasonable out-of-pocket expenses incurred in connection with (1) the Transaction Agreement and (2) any (a) Underwritten Offering or (b) transaction (including a merger, consolidation, recapitalization or sale of assets or equity interests) as a result of which any Person other than any Affiliate of the Service Provider becomes the beneficial owner, directly or indirectly, of more than 50% of the ordinary shares or other common equity and voting securities, or all or substantially all of the assets, of the Company Group. The parties acknowledge that such amounts shall be in addition to the fees payable to the Service Provider pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement. Notwithstanding the foregoing, the Service Provider may instruct the Company to pay, or cause one or more of its subsidiaries to pay, directly to any third party any amount that would otherwise be required to be paid to the Service Provider pursuant to the first sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Nothing in this Agreement shall prohibit the Service Provider, its Affiliates or any of its or its Affiliates&#8217; Representatives from receiving any other fees from the Company or any other member of the Company Group pursuant to any other agreement or arrangement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any portion of the fees payable to the Service Provider under this Agreement that the Company is prohibited from paying or causing to be paid to the Service Provider under any debt facility or credit support arrangement (including any earn-out obligation) that the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company or any of its subsidiaries may from time to time incur (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Financing Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be deferred and shall be payable at the earliest time permitted under the Financing Agreements or upon the payment in full of all obligations under the Financing Agreements. The Company shall notify the Service Provider if the Company shall be unable to pay any fees pursuant to this Agreement on each date on which the Company would otherwise make a payment of fees under this Agreement to the Service Provider. Any portion of any fees not paid on the scheduled due date shall bear interest at an annual rate equal to the yield to maturity on such scheduled due date of the class of outstanding U.S. government bonds having a final maturity closest to the eight-year anniversary of the Commencement Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All amounts payable to the Service Provider hereunder shall be paid to the Service Provider in U.S. dollars by wire transfer in same-day funds to the bank account or accounts designated by the Service Provider.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Service Provider may, at its sole discretion, waive or defer, in full or in part, payment of the Consulting Fee by providing written notice to such effect to the Company. The Company shall not claim a deduction on any tax return (i) for any such fee waived by the Service Provider and (ii) for any such fee deferred by the Service Provider until actually paid to the Service Provider, if at all. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 5.&#160;&#160;&#160;&#160;Indemnification&#59; Limitation on Damages</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall indemnify and hold harmless the Service Provider, its Affiliates, and all of the Representatives of Service Provider and its Affiliates (other than the Company and its subsidiaries) (each such Person being an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) from and against any and all losses, awards, claims, demands, actions, causes of action, judgments, obligations, contracts, agreements, debts, costs, expenses, disbursements, damages and liabilities, whether known or unknown, contingent or otherwise, at common law, civil law and in equity, including in connection with seeking indemnification and, whether joint or several (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), related to, arising out of or in connection with, the services rendered by the Service Provider, the engagement of the Service Provider pursuant to, and&#47;or the performance by the Service Provider (or any other Person permitted hereunder) of the services contemplated by this Agreement, whether or not pending or threatened, whether or not an Indemnified Party is a party, whether or not resulting in any liability and whether or not such action, claim, demand, suit, investigation or proceeding is initiated or brought by or on behalf of any member of the Company Group. The Company shall reimburse any Indemnified Party for all costs, fees, disbursements and expenses (including attorneys&#8217; fees and expenses and fees and expenses of any investigator or consultant) as they are incurred in connection with investigating, preparing, pursuing, defending or assisting in the defense of any action, claim, demand, suit, investigation or proceeding for which the Indemnified Party would be entitled to indemnification under the terms of the previous sentence, or any action or proceeding arising therefrom, whether or not such Indemnified Party is a party thereto. The Company shall not be liable under the foregoing indemnification provisions to the extent any Liability of an Indemnified Party is determined by a court of competent jurisdiction, in a final judgment from which no further appeal may be taken, to have resulted primarily from the willful misconduct of such Indemnified Party. The fees, expenses, costs and disbursements of an Indemnified Party (including attorneys&#8217; fees and fees and expenses of any investigator or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consultant) shall be paid by the Company as they are incurred upon receipt, in each case, of an undertaking by or on behalf of the Indemnified Party to repay such amounts if it is finally judicially determined that the Liabilities in question resulted primarily from the willful misconduct of such Indemnified Party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company Group&#8217;s sole and exclusive remedy against the Service Provider and any other Indemnified Party for breach of this Agreement or otherwise arising from, in connection with or related to the performance of the services to be rendered hereunder, shall be to offset any fees otherwise payable to the Service Provider by the amount of any Liabilities arising out of or relating to this Agreement or the services to be rendered hereunder, it being understood that any recovery shall be limited to recovery of actual damages, and no special, consequential, indirect, or punitive damages shall be allowed. No Indemnified Party shall be liable to the Company Group (i) for any breach hereunder by another Indemnified Party or (ii) for any breach by it, unless, with respect to this clause (ii) only, such breach constitutes willful misconduct as determined in a final judgment of a court of competent jurisdiction from which no appeal can be made.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.&#160;&#160;&#160;&#160;Notices.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All notices, requests, consents and other communications hereunder shall be in writing and shall be deemed sufficient if personally delivered, sent by internationally-recognized overnight courier, by facsimile or email, or by registered or certified mail, return receipt requested and postage prepaid, addressed as follows&#58; </font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.044%"><tr><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.399%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">if to the Service Provider, to&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Apollo Management Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9 West 57th Street</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">New York, New York 10019</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; William B. Kuesel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facsimile&#58; 646-607-0528</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with a copy to (which shall not constitute notice)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sidley Austin LLP </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">One South Dearborn </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chicago, Illinois 60603</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facsimile&#58; 312-853-7036 </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; pshwachman&#64;sidley.com </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Perry J. Shwachman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; scarney&#64;sidley.com</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Sean M. Carney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; asnyder&#64;sidley.com</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.564%"><tr><td style="width:1.0%"></td><td style="width:12.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Adam M. Snyder</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">if to the Company, to&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Aspen Insurance Holdings Limited </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">141 Front Street </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Hamilton, Bermuda HM19</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facsimile&#58; 441-295-1829 </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; Mike.Cain&#64;aspen.co </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Michael Cain</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with a copy to (which shall not constitute notice)&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sidley Austin LLP</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">One South Dearborn</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chicago, Illinois 60603</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facsimile&#58; 312-853-7036</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; pshwachman&#64;sidley.com</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Perry J. Shwachman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; scarney&#64;sidley.com</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Sean M. Carney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; asnyder&#64;sidley.com</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Adam M. Snyder</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or to such other address as the party to whom notice is to be given may have furnished to each other party in writing in accordance herewith. Any such notice or communication shall be deemed to have been received (a) in the case of personal delivery, on the date of such delivery, (b) in the case of nationally-recognized overnight courier, on the next business day after the date when sent, (c) in the case of facsimile or email transmission, upon confirmation of receipt, and (d) in the case of mailing, on the third business day following that on which the piece of mail containing such communication is posted.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.&#160;&#160;&#160;&#160;Benefits of Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall bind and inure to the benefit of the Service Provider, the Company, the Indemnified Parties and any successors to or assigns of the Service Provider, the Company and the Indemnified Parties&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">this Agreement may not be assigned by either party hereto without the prior written consent of the other party, which consent will not be unreasonably withheld in the case of any assignment by the Service Provider and&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no consent of any party shall be required for any assignment by the Service Provider to an Affiliate of the Service Provider. Upon the Service Provider&#8217;s request, the Company shall cause the other members of the Company Group to become direct parties hereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 8.&#160;&#160;&#160;&#160;Governing Law&#59; Jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall be governed by, and construed, enforced and interpreted in accordance with, the laws of the State of New York, without giving effect to any law that would cause the laws of any jurisdiction other than the State of New York to be applied. Each of the parties hereto hereby (i)&#160;submits to the exclusive jurisdiction of any state court sitting in New York City or any federal court sitting in the Southern District of New York for the purpose of any action arising out of or relating to this letter agreement brought by any party hereto, (ii) agrees that all claims in respect of such action or proceeding shall be heard and determined only in any such court, (iii) agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, (iv) agrees not to bring any action or proceeding arising out of or relating to this letter agreement or any of the transactions contemplated by this letter agreement in any other court and (v)&#160;irrevocably waives, in any such action, any claim of improper venue or any claim that such courts are an inconvenient forum. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.&#160;&#160;&#160;&#160;Headings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section headings are used for convenience only and shall in no way affect the construction of this Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 10.&#160;&#160;&#160;&#160;Entire Agreement&#59; Amendments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement contains the entire understanding of the parties hereto with respect to its subject matter and supersedes any and all prior or contemporaneous agreements or understandings, and neither it nor any part of it may in any way be altered, amended, extended, waived, discharged, modified or terminated except by a written agreement signed by each of the parties hereto.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.&#160;&#160;&#160;&#160;Counterparts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be executed in counterparts, including via facsimile transmission or PDF copies sent by e-mail, and each such counterpart shall be deemed to be an original instrument, but all such counterparts together shall constitute one and the same document. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 12.&#160;&#160;&#160;&#160;Waivers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any party to this Agreement may, by written notice to the other party, waive any provision of this Agreement. The waiver by any party of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent obligation or breach.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.&#160;&#160;&#160;&#160;Severability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction will, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or unenforceability in any jurisdiction will not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 14.&#160;&#160;&#160;&#160;Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Agreement, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; with respect to the Service Provider, shall include, without limitation, Apollo Investment Fund IX, L.P., Apollo Overseas Partners IX, L.P., Apollo Overseas Partners (Delaware) IX, L.P., Apollo Overseas Partners (Delaware 892) IX, L.P., Apollo Overseas Partners (Lux) IX, SCSp, Apollo Advisors IX, L.P. and each of their respective affiliates (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the general partner of each of the Funds and each Person controlling, controlled by or under common control with any of the foregoing Persons. Furthermore, for purposes of this Agreement, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an individual, partnership, limited liability partnership, corporation, limited liability company, association, joint stock company, trust, estate, joint venture, unincorporated organization or governmental authority (or any department, agency or political subdivision thereof). The words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; mean include, includes and including &#8220;without limitation&#8221;. Each and every decision, election, instruction or direction to be made or given by, or any act to be performed (or omitted) by, the Service Provider hereunder shall be made, given, taken or omitted by the Service Provider in its sole and non-reviewable discretion.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UK Carbon Reduction Commitment (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">CRC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8221;) Paying Agent Authorization</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company acknowledges that the Service Provider, and certain companies in which investment funds Affiliated with the Service Provider have control (collectively with the Service Provider, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">CRC Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), are subject to the U.K&#8217;s Carbon Reduction Commitment Energy Efficiency Scheme. If certain of the Company&#8217;s U.K. energy use falls within the scope of CRC, the Company will be required under U.K. law to purchase CRC Allowances for CRC Emissions (each as defined in the CRC Energy Efficiency Scheme Order 2013) associated with that energy use for each annual reporting year. In addition, the Company would be required to participate in CRC with the Service Provider&#8217;s CRC Group. In such case, the Company acknowledges and agrees that the Service Provider may from time to time, in its discretion, make payments to, or receive monies from, the UK Environment Agency pursuant to CRC on the Company&#8217;s behalf. Any such action shall be for the administrative convenience of the Company as a member of the CRC Group, and the Company hereby authorizes, ratifies and confirms the Service Provider&#8217;s ability to so act on the Company&#8217;s behalf as paying agent solely for the limited purpose set forth above. The Company shall indemnify the Service Provider in respect of any such actions on the Company&#8217;s behalf. The Service Provider shall provide the Company with reasonable supporting documentation for any payment made to the UK Environment Agency on the Company&#8217;s behalf.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page Follows.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div></div><div id="i0c4c4a0bda3c4ec694ef1c532c84cdbf_59"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the parties have duly executed this Agreement as of the date first above written. </font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"></td><td style="width:6.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.483%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">&#47;s&#47; Mark Cloutier </font></div><div style="text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Name&#58; Mark Cloutier</font></div><div style="text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Title&#58; Group Chief Executive Officer and Chairman</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page to Management Consulting Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">SERVICE PROVIDER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APOLLO MANAGEMENT HOLDINGS, L.P.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.852%"><tr><td style="width:1.0%"></td><td style="width:22.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Apollo Management Holdings GP, LLC,</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">its general partner</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.807%"><tr><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">&#47;s&#47; William Kuesel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; William Kuesel </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Vice President</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page to Management Consulting Agreement&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>20
<FILENAME>exhibit109-fx1.htm
<DESCRIPTION>EX-10.9
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3ef566daa72b4c149f727bbba4fefd6f_59"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.9</font></div></div><div style="margin-bottom:150pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE U.S. SERVICES INC.</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NONQUALIFIED DEFERRED COMPENSATION PLAN</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This document is drafted with the intent that it comply with Internal Revenue Code Section 409A and regulations promulgated thereunder. NFP Executive Benefits has provided you this specimen document strictly in its capacity as an employee benefits consulting firm and plan record keeper. NFP Executive Benefits does NOT provide legal, tax or accounting consultation or advice. It is NFP Executive Benefits&#8217; recommendation that you seek appropriately specialized professional consultation regarding the information and&#47;or material contained herein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i3ef566daa72b4c149f727bbba4fefd6f_81"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE U.S. SERVICES INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nonqualified Deferred Compensation Plan</font></div></div><div style="margin-bottom:10pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="margin-bottom:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bonus</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change-in-Control</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.8</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferrals</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferral Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.10</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Employee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Discretionary Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Matching Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.17</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.18</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Fund</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.19</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.20</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Year</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.21</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.22</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Salary</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.23</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.24</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Service Recipient</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.25</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.26</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trust</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.27</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trustee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.28</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Years of Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement of Participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loss of Eligible Employee Status</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferral Elections - General</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Time of Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution Elections</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Requirements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cancellation of Deferral Election due to Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Matching Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Discretionary Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Deferrals</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Matching Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Employer Discretionary Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting due to Certain Events</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amounts Not Vested</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Forfeitures</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investments, Gains and Losses</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions upon an In-Service Account Triggering Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions upon Retirement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Substantially Equal Annual Installments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions due to other Separation from Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions due to Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions upon Death</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.8</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Changes to Distribution Elections</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acceleration or Delay in Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.10</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unforeseeable Emergency</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.11</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions to Specified Employee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.12</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Minimum Distribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.13</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form of Payment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.14</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions upon a Change-in-Control</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiaries</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">7.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiaries</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">7.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lost Beneficiary</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 8</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Funding</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">8.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prohibition against Funding</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">8.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deposits in Trust</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">8.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding of Employee Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Administration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Procedure</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Right of Appeal</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Review of Appeal</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Designation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 10</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General Provisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Assignment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Employment Rights</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incompetence</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Identity</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Benefits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expenses</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.8</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insolvency</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment or Modification</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.10</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Suspension</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.11</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Termination</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.12</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Termination due to a Change-in-Control</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.13</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Construction</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.14</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.15</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.16</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Headings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.17</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Terms</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.18</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 409A Fail Safe Provision</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i3ef566daa72b4c149f727bbba4fefd6f_102"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE U.S. SERVICES INC.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nonqualified Deferred Compensation Plan</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Aspen Insurance U.S. Services Inc., and its affiliates and subsidiaries (the &#8220;Employer&#8221;), adopted the Aspen Insurance U. S. Services, Inc. Deferred Compensation Plan (&#8220;Prior Plan&#8221;) on January 8, 2013 with an effective date of January 1, 2012&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Employer desires to change certain provisions of the Prior Plan effective July 1, 2014&#59; and </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Section 9.1 of the Prior Plan provides Employer with the authority to amend and modify the Plan, subject to non-applicable restrictions&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW THEREFORE, the Employer hereby amends and restates the Prior Plan as the Aspen Insurance U.S. Services Inc. Nonqualified Deferred Compensation Plan (&#8220;Plan&#8221;). This Plan is an unfunded arrangement and is intended to be exempt from the participation, vesting, funding, and fiduciary requirements set forth in Title I of the Employee Retirement Income Security Act of 1974, as amended. It is intended to comply with Internal Revenue Code Section 409A. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 1&#160;&#160;&#160;&#160;Definitions</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.1&#160;&#160;&#160;&#160;Account</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sum of all the bookkeeping sub-accounts as may be established for each Participant as provided in Section 5.1 hereof. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.2&#160;&#160;&#160;&#160;Administrator</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer or individuals or an administrative committee appointed by the Board shall serve as the Administrator of the Plan. The Administrator shall serve as the agent for the Employer with respect to the Trust. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.3&#160;&#160;&#160;&#160;Board</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors of the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.4&#160;&#160;&#160;&#160;Bonus</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation which is designated as such by the Employer and which relates to services performed during an incentive period by an Eligible Employee in addition to his or her Salary, including any pretax elective deferrals from said Bonus to any Employer sponsored plan that includes amounts deferred under a Deferral Election or any elective deferral as defined in Code Section 402(g)(3) or any amount contributed or deferred at the election of the Eligible Employee in accordance with Code Section 125 or 132(f)(4).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.5&#160;&#160;&#160;&#160;Change-in-Control</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, a &#8220;Change-in-Control&#8221; of the Employer (which, for purpose of this Section 1.5 shall mean ABC Company but not any of its affiliates or subsidiaries) shall mean the first to occur of any of the following&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date that any one person or persons acting as a group acquires ownership of Employer stock constituting more than fifty percent (50%) of the total fair market value or total voting power of the Employer&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date that any one person or persons acting as a group acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) ownership of the stock of the Employer possessing thirty percent (30%) or more of the total voting power of the stock of the Employer&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date that any one person or persons acting as a group acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) assets from the Employer that have a total gross fair market value equal to or more than forty percent (40%) of the total gross fair market value of all of the assets of the Employer immediately prior to such acquisition&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date that a majority of members of the Employer&#8217;s Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or elections.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.6&#160;&#160;&#160;&#160;Code</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Internal Revenue Code of 1986, as amended.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.7&#160;&#160;&#160;&#160;Compensation</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Participant&#8217;s earned income, consisting of Salary and Bonus. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.8&#160;&#160;&#160;&#160;Deferrals</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of Compensation that a Participant elects to defer in accordance with Section 3.1 hereof.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.9&#160;&#160;&#160;&#160;Deferral Election</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The separate agreement, submitted to the Administrator, by which an Eligible Employee agrees to participate in the Plan and make Deferrals thereto.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.10&#160;&#160;&#160;&#160;Disability</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, a Participant shall be considered to have incurred a Disability if&#58; (i) the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months&#59; (ii) the Participant is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than 3 months under an accident and health plan covering employees of the Participant&#8217;s Employer&#59; or (iii) determined to be totally disabled by the Social Security Administration.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.11&#160;&#160;&#160;&#160;Effective Date</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 1, 2014.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.12&#160;&#160;&#160;&#160;Eligible Employee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Employee shall be considered an Eligible Employee if such Employee is a member of a &#8220;select group of management or highly compensated employees,&#8221; within the meaning of Sections 201, 301 and 401 of ERISA, and is designated as an Eligible Employee by the Administrator. The Administrator may at any time, in its sole discretion, change the eligible criteria for an Eligible Employee or determine that one or more Participants will cease to be an Eligible Employee. The designation of an Employee as an Eligible Employee in any year shall not confer upon such Employee any right to be designated as an Eligible Employee in any future Plan Year.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.13&#160;&#160;&#160;&#160;Employee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person employed by the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.14&#160;&#160;&#160;&#160;Employer</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance U.S. Services Inc. and its subsidiaries and affiliates.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.15&#160;&#160;&#160;&#160;Employer Discretionary Contribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A discretionary contribution made by the Employer that is credited to one or more Participant&#8217;s Accounts in accordance with the terms of Section 3.7 hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.16&#160;&#160;&#160;&#160;Employer Matching Contribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contribution made by the Employer that is credited to one or more Participant&#8217;s Accounts in accordance with the terms of Section 3.6 hereof.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.17&#160;&#160;&#160;&#160;ERISA</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.18&#160;&#160;&#160;&#160;Investment Fund</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each investment(s) which serves as a means to measure value, increases or decreases with respect to a Participant&#8217;s Accounts.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.19&#160;&#160;&#160;&#160;Participant</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Eligible Employee who is a Participant as provided in Article 2.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.20&#160;&#160;&#160;&#160;Plan Year</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the initial Plan Year, Effective Date through December 31, 2014. For each year thereafter, January 1 through December 31.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.21&#160;&#160;&#160;&#160;Retirement</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement shall mean a Participant&#8217;s Separation from Service from the Employer for reasons other than death or Disability, on or after the earlier of the Participant&#8217;s attainment of sixty-five (65) years of age or the attainment of age fifty-five (55) with at least ten (10) Years of Service with the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.22&#160;&#160;&#160;&#160;Salary</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Eligible Employee&#8217;s base salary earned during a Plan Year, including any pretax elective deferrals from said Salary to any Employer sponsored plan that includes amounts deferred under a Deferral Election or any elective deferral as defined in Code Section 402(g)(3) or any amount contributed or deferred at the election of the Eligible Employee in accordance with Code Section 125 or 132(f)(4).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.23&#160;&#160;&#160;&#160;Separation from Service</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, a Participant shall incur a Separation from Service with the Service Recipient due to death, retirement or other termination of employment with the Service Recipient unless the employment relationship is treated as continuing intact while the individual is on military leave, sick leave, or other bona fide leave of absence if the period of such leave does not exceed six months, or if longer, so long as the individual retains a right to reemployment with the Service Recipient under an applicable statute or by contract. Upon a sale or other disposition of the assets of the Employer to an unrelated purchaser, the Administrator reserves the right, to the extent permitted by Code section 409A to determine whether Participants providing services to the purchaser after and in connection with the purchase transaction have experienced a Separation from Service.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.24&#160;&#160;&#160;&#160;Service Recipient</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, Service Recipient shall mean the Employer or person for whom the services are performed and with respect to whom the legally binding right to compensation arises, and all persons with whom such person would be considered a single employer under Code Section 414(b) (employees of controlled group of corporations), and all persons with whom such person would be considered a single employer under Code Section 414(c) (employees of partnerships, proprietorships, etc., under common control).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.25&#160;&#160;&#160;&#160;Specified Employee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, a &#8220;Specified Employee&#8221; shall mean a participant who is considered a key employee on the Identification Date, as defined in Code Section 416(i) without regard to section 416(i)(5) and such other requirements imposed under Code Section 409A(a)(2)(B)(i) and regulations thereunder for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period beginning April 1 of the year subsequent to the Identification Date and ending March 31 of the following year. The Identification Date for this Plan is December 31 of each year. Notwithstanding anything to the contrary, a Participant is not a Specified Employee unless any stock of the Service Recipient is publicly traded on an established securities market or otherwise. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.26&#160;&#160;&#160;&#160;Trust</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement between the Employer and the Trustee under which the assets of the Plan are held, administered and managed, which shall conform to the terms of Rev. Proc. 92-64.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.27&#160;&#160;&#160;&#160;Trustee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The person or entity appointed as trustee under the terms of the Trust or such other successor that shall become trustee pursuant to the terms of the Plan.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.28&#160;&#160;&#160;&#160;Years of Service</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant&#8217;s &#8220;Years of Service&#8221; shall be measured by employment during a twelve (12) month period commencing with the Participant&#8217;s date of hire and anniversaries thereof. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 2&#160;&#160;&#160;&#160;Participation</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.1&#160;&#160;&#160;&#160;Commencement of Participation</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Eligible Employee shall become a Participant at the earlier of the date on which his or her Deferral Election first becomes effective or the date on which an Employer Discretionary Contribution is first credited to his or her Account.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.2&#160;&#160;&#160;&#160;Loss of Eligible Employee Status</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant who is no longer an Eligible Employee shall not be permitted to submit a Deferral Election and all Deferrals for such Participant shall cease as of the end of the Plan Year in which such Participant is determined to no longer be an Eligible Employee. Amounts credited to the Account of a Participant who is no longer an Eligible Employee shall continue to be held pursuant to the terms of the Plan and shall be distributed as provided in Article 6. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 3&#160;&#160;&#160;&#160;Contributions</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.1&#160;&#160;&#160;&#160;Deferral Elections - General</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant&#8217;s Deferral Election for a Plan Year is irrevocable for that applicable Plan Year&#59; provided, however that a cessation of Deferrals shall be allowed if required by the terms of the Employer&#8217;s qualified 401(k) plan in order for the Participant to obtain a hardship withdrawal from the 401(k) plan, or if required under Section 6.10 (Unforeseeable Emergency) of this Plan. Such amounts deferred under the Plan shall not be made available to such Participant, except as provided in Article 6, and shall reduce such Participant&#8217;s Compensation from the Employer in accordance with the provisions of the applicable Deferral Election&#59; provided, however, that all such amounts shall be subject to the rights of the general creditors of the Employer as provided in Article 8. The Deferral Election, in addition to the requirements set forth below, must designate&#58; (i) the amount of Compensation to be deferred, (ii) the time of the distribution, and (iii) the form of the distribution.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.2&#160;&#160;&#160;&#160;Time of Election</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Deferral Election shall be void if it is not made in a timely manner as follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Deferral Election with respect to any Compensation must be submitted to the Administrator before the beginning of the calendar year during which the amount to be deferred will be earned. As of December 31 of each calendar year, said Deferral Election is irrevocable for the calendar year.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding the foregoing and in the discretion of the Employer, in a year in which an Employee is first eligible to participate, and provided that such Employee is not eligible to participate in any other similar account balance arrangement subject to Code Section 409A, such Deferral Election </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be submitted within thirty (30) days after the date on which an Employee is first eligible to participate, and such Deferral Election shall apply to Compensation to be earned during the remainder of the calendar year after such election is made. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.3&#160;&#160;&#160;&#160;Distribution Elections</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time a Participant makes a Deferral Election, he or she must also elect the time and form of the distribution by establishing one or more In-Service Account or Separation Account(s) as provided in Sections 5.1 and 6.1. If the Participant fails to properly designate the time and form of a distribution, the Participant&#8217;s Account shall be designated as a Separation Account and shall be paid in a lump sum.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.4&#160;&#160;&#160;&#160;Additional Requirements</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Deferral Election, subject to the limitations set forth in Sections 3.1 and 3.2 hereof, shall comply with the following additional requirements, or as otherwise required by the Administrator in its sole discretion&#58; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferrals may be made in whole percentages or stated dollar amounts as determined by the Administrator.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum amount that may be deferred each Plan Year is fifty percent (50%) of the Participant&#8217;s Salary and Commissions, and one-hundred percent (100%) of the Participant&#8217;s Bonus and Performance-based Compensation, net of applicable taxes. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution year for an In-Service Account must be at least three (3) Plan Years after the Plan Year in which such Deferral is credited to an In-Service subaccount. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.5&#160;&#160;&#160;&#160;Cancellation of Deferral Election due to Disability</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary, if a Participant incurs a disability as defined in this Section 3.5, said Participant may file an election to stop Deferrals as of the date the election is received by the Administrator, provided that such cancellation occurs by the later of the end of the calendar year or the 15th day of the third month following the date the Participant incurs a disability. Disability for purposes of this Section 3.5 only means that a Participant incurs a medically determinable physical or mental impairment resulting in the Participant&#8217;s inability to perform the duties of his or her position or any substantially similar position, where such impairment can be expected to result in death or can be expected to last for a continuous period of not less than six months, as determined by the Administrator in its sole discretion.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.6&#160;&#160;&#160;&#160;Matching Contribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may also credit to the Account of each Participant who makes Deferrals a Matching Contribution in an amount equal to a percentage of the Deferrals contributed by the Participant, with such percentage determined annually by the Employer, in its sole discretion. Such Matching Contribution shall be credited to such sub-account as may be elected by the Participant for his or her Salary Deferrals, or if no Salary Deferrals, then for Bonus Deferrals in accordance with Section 5.1 and procedures established by the Plan Administrator. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.7&#160;&#160;&#160;&#160;Employer Discretionary Contribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may make discretionary contributions to some or all Participants&#8217; Accounts in such amount and in such manner as may be determined by the Employer. Such Employer Discretionary Contribution, at the option of the Employer, shall be credited to such sub-account as may be elected by the Participant in accordance with Sections 3.1 and 5.1 and procedures established by the Administrator. In the event no such election is made by the Participant or if Employer desires to direct Employer Discretionary Contributions to a particular Participant sub-account, the Employer, in its sole discretion, may determine which sub-account will be credited with such Employer Discretionary Contribution. In the event the Employer does not designate which Participant sub-account shall be credited, such Employer Discretionary Contribution shall be credited to a lump-sum Separation&#47;Retirement sub-account.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4&#160;&#160;&#160;&#160;Vesting</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.1&#160;&#160;&#160;&#160;Vesting of Deferrals</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant shall be one-hundred percent (100%) vested in his or her Account attributable to Deferrals and any earning or losses on the investment of such Deferrals. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.2&#160;&#160;&#160;&#160;Vesting of Matching Contributions</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise provided herein, a Participant shall have a vested right to the portion of his or her Account attributable to Matching Contribution(s) and any earnings or losses on the investment of such Matching Contribution(s) according to such vesting schedule as the Employer shall determine at the time an Matching Contribution is made. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.3&#160;&#160;&#160;&#160;Vesting of Employer Discretionary Contributions</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant shall have a vested right to the portion of his or her Account attributable to Employer Discretionary Contribution(s) and any earnings or losses on the investment of such Employer Discretionary Contribution(s) according to such vesting schedule as the Employer shall determine at the time an Employer Discretionary Contribution is made. </font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.4&#160;&#160;&#160;&#160;Vesting due to Certain Events</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant who incurs a Disability shall be fully vested in the amounts credited to his or her Account as of the date of Disability.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a Participant&#8217;s death, the Participant shall be fully vested in the amounts credited to his or her Account.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant who incurs a Separation from Service due to Retirement shall be fully vested in the amounts credited to his or her Account as of the date of Retirement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a Change-in-Control, all Participants shall be fully vested in the amounts credited to their Accounts as of the date of the Change-in-Control.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.5&#160;&#160;&#160;&#160;Amounts Not Vested</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts credited to a Participant&#8217;s Account that are not vested at the time of a distribution event shall be forfeited.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.6&#160;&#160;&#160;&#160;Forfeitures</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the discretion of the Employer, any forfeitures from a Participant&#8217;s Account (i) may continue to be held in the Trust, may be separately invested, and may be used to reduce succeeding Deferrals and any Employer Contributions, or (ii) may be returned to the Employer as soon as administratively feasible.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alt&#58; Any forfeitures from a Participant&#8217;s Account shall continue to be held in the Trust, shall be separately invested and shall be used to reduce succeeding Deferrals, Employer Matching Contributions, or Employer Discretionary Contributions until such forfeitures have been entirely so applied. If no further Contributions will be made, then such forfeitures shall be returned to the Employer.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 5&#160;&#160;&#160;&#160;Accounts</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.1&#160;&#160;&#160;&#160;Accounts</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall establish and maintain a bookkeeping account in the name of each Participant. The Administrator shall also establish sub-accounts as provided in subsection (a) and (b), below, as elected by the Participant pursuant to Article 3. A Participant may have a maximum of ten (10) sub-accounts at any time.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant may establish one or more Retirement Account (&#8220;Retirement sub-account&#8221;) by designating as such on the Participant&#8217;s Deferral Election. Each Participant&#8217;s Retirement sub-account </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be credited with Deferrals (as specified in the Participant&#8217;s Deferral Election), any Employer Matching Contributions allocable thereto, any Employer Discretionary Contributions, and the Participant&#8217;s allocable share of any earnings or losses on the foregoing. Each Participant&#8217;s Retirement sub-account shall be reduced by any distributions made plus any federal and state tax withholding, and any social security withholding tax as may be required by law. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant may elect to establish one or more In-Service Account (&#8220;In-Service sub-account&#8221;) by designating as such in the Participant&#8217;s Deferral Election the year in which payment shall be made. Each Participant&#8217;s In-Service sub-account shall be credited with Deferrals (as specified in the Participant&#8217;s Deferral Election), any Employer Matching Contributions allocable thereto, any Employer Discretionary Contributions and the Participant&#8217;s allocable share of any earnings or losses on the foregoing. Each Participant&#8217;s In-Service sub-account shall be reduced by any distributions made plus any federal and state tax withholding and any social security withholding tax as may be required by law.</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.2&#160;&#160;&#160;&#160;Investments, Gains and Losses</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant may direct that his or her Retirement sub-accounts and or In-Service sub-accounts established pursuant to Section 5.1 may be valued as if they were invested in one or more Investment Funds as selected by the Employer in multiples of one percent (1%). The Employer may from time to time, at the discretion of the Administrator, change the Investment Funds for purposes of this Plan. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall adjust the amounts credited to each Participant&#8217;s Account to reflect Deferrals, Employer Matching Contributions, any Employer Discretionary Contributions, investment experience, distributions and any other appropriate adjustments. Such adjustments shall be made as frequently as is administratively feasible.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant may change his or her selection of Investment Funds no more than six (6) times each Plan Year with respect to his or her Account or sub-accounts by filing a new election in accordance with procedures established by the Administrator. An election shall be effective as soon as administratively feasible following the date the change is submitted on a form prescribed by the Administrator.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the Participant&#8217;s ability to designate the Investment Fund in which his or her deferred Compensation shall be deemed invested, the Employer shall have no obligation to invest any funds in accordance with the Participant&#8217;s election. Participants&#8217; Accounts shall merely be bookkeeping entries on the Employer&#8217;s books, and no Participant shall obtain any property right or interest in any Investment Fund.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 6&#160;&#160;&#160;&#160;Distributions</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.1&#160;&#160;&#160;&#160;Distribution Election</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Participant shall designate in his or her Deferral Election the form and timing of his or her distribution by indicating the type of sub-account as described under Section 5.1, and by designating the form in which payments shall be made from the choices available under Section 6.2 and 6.3 hereof. Notwithstanding anything to the contrary contained herein provided, no acceleration of the time or schedule of payments under the Plan shall occur except as permitted under both this Plan and Code Section 409A.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.2&#160;&#160;&#160;&#160;Distributions upon an In-Service Account Triggering Date</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-Service sub-account distributions shall occur as soon as administratively feasible but no later than ninety (90) days following June 1 of the calendar year designated by the Participant on a properly submitted Deferral Election and is payable in a lump-sum payment. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.3&#160;&#160;&#160;&#160;Distributions upon Retirement</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Participant has a Separation from Service due to Retirement, the Participant&#8217;s Retirement sub-account(s) shall be distributed as soon as administratively feasible but no later than ninety (90) days following the Participant&#8217;s Retirement, subject to Section 6.11 (Distributions to Specified Employees). Distribution shall be made either in a lump-sum payment or in substantially equal annual installments, as defined in Section 6.4 below, over a period of up to ten (10) years as elected by the Participant. If the Participant fails to designate the form of the distribution, the sub-account shall be paid in a lump-sum payment. If a Participant has any In-Service sub-accounts at the time of his or her Retirement, said sub-accounts shall be distributed in a lump sum as soon as administratively feasible but no later than ninety (90) days following Participant&#8217;s Retirement, subject to Section 6.11 (Distributions to Specified Employees). </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alt&#58; If a Participant has any In-Service sub-accounts at the time of his or her Retirement, said sub-accounts shall be distributed in a lump sum as soon as administratively feasible but no earlier than six months and no later than eight months following Participant&#8217;s Retirement. </font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.4&#160;&#160;&#160;&#160;Substantially Equal Annual Installments</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The amount of the substantially equal payments shall be determined by multiplying the Participant&#8217;s Account or sub-account by a fraction, the denominator of which in the first year of payment equals the number of years over which benefits are to be paid, and the numerator of which is one (1). The amounts of the payments for each succeeding year shall be determined by multiplying the Participant&#8217;s Account or sub-account as of the applicable anniversary of the payout by a fraction, the denominator of which equals the number of remaining years over which benefits are to be paid, and the numerator of which is one (1). Installment payments made pursuant to this Section 6.4 shall be made as soon as administratively feasible but no later than ninety (90) days following the anniversary of the distribution event, subject to Section 6.11 (Distributions to Specified Employees). </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For purposes of the Plan pursuant to Code Section 409A and regulations thereunder, a series of annual installments from a particular subaccount shall be considered a single payment. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions due to other Separation from Service</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a Participant&#8217;s Separation from Service for any reason other than Retirement, death or Disability, all vested amounts credited to his or her Account shall be paid to the Participant in a lump-sum, as soon as administratively feasible, but no later than ninety (90) days, following the date of Separation from Service, subject to Section 6.11 (Distributions to Specified Employees).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.6&#160;&#160;&#160;&#160;Distributions due to Disability</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a Participant&#8217;s Disability, all amounts credited to his or her Account shall be paid to the Participant in a lump sum as soon as administratively feasible but no later than ninety (90) days following the date of Disability.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.7&#160;&#160;&#160;&#160;Distributions upon Death</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the death of a Participant, all amounts credited to his or her Account shall be paid, as soon as administratively feasible but no later than ninety (90) days following Participant&#8217;s date of death, to his or her beneficiary or beneficiaries, as determined under Article 7 hereof, in a lump sum.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes to Distribution Elections</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant will be permitted to elect to change the form or timing of the distribution of the balance of his or her one or more sub-accounts within his or her Account to the extent permitted and in accordance with the requirements of Code Section 409A(a)(4)(C), including the requirement that (i) a redeferral election may not take effect until at least twelve (12) months after such election is filed with the Employer, (ii) an election to further defer a distribution (other than a distribution upon death, Disability or an unforeseeable emergency) must result in the first distribution subject to the election being made at least five (5) years after the previously elected date of distribution, and (iii) any redeferral election </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affecting a distribution at a fixed date must be filed with the Employer at least twelve (12) months before the first scheduled payment under the previous fixed date distribution election. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.9&#160;&#160;&#160;&#160;Acceleration or Delay in Payments</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent permitted by Code Section 409A, and notwithstanding any provision of the Plan to the contrary, the Administrator, in its sole discretion, may elect to (i) accelerate the time or form of payment of a benefit owed to a Participant hereunder in accordance with the terms and subject to the conditions of Treasury Regulations Section 1.409A-3(j)(4), or (ii) delay the time of payment of a benefit owed to a Participant hereunder in accordance with the terms and subject to the conditions of Treasury Regulations Section 1.409A-2(b)(7). By way of example, and at the sole discretion of the Administrator, if a Participant&#8217;s entire Account balance is less than the applicable Code Section 402(g) annual limit, the Employer may distribute the Participant&#8217;s Account in a lump sum provided that the distribution results in the termination of the participant&#8217;s entire interest in the Plan, subject to the plan aggregation rules of Code Section 409A and regulations thereunder. By way of example, the Administrator may permit such acceleration of the time or schedule of a payment under the arrangement to an individual other than a Participant as may be necessary to fulfill a domestic relations order (as defined in Code Section 414(p)(1)(B)).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unforeseeable Emergency</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator may permit an early distribution of part or all of any deferred amounts&#59; provided, however, that such distribution shall be made only if the Administrator, in its sole discretion, determines that the Participant, or the Participant&#8217;s beneficiary, has experienced an Unforeseeable Emergency. An Unforeseeable Emergency is defined as a severe financial hardship resulting from an illness or accident of the Participant, the Participant&#8217;s spouse, the Participant&#8217;s beneficiary, or a dependent (as defined in Code Section 152(a)) of the Participant, loss of the Participant&#8217;s property due to casualty or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant. If an Unforeseeable Emergency is determined to exist, a distribution may not exceed the amounts necessary to satisfy such emergency plus amounts necessary to pay taxes reasonably anticipated as a result of the distribution, after taking into account the extent to which such hardship is or may be relieved through reimbursement or compensation by insurance or otherwise or by liquidation of the Participant&#8217;s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship). Upon a distribution to a Participant under this Section 6.10, the Participant&#8217;s Deferrals shall cease and no further Deferrals shall be made for such Participant for the remainder of the Plan Year and one (1) subsequent Plan Year. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions to Specified Employee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding anything herein to the contrary, if any Participant is a Specified Employee upon a Separation from Service for any reason other than death, distributions to such Participant shall commence no earlier than six months following Separation from Service (or, if earlier, the date of death of the Participant) and no later than eight months following Separation from Service. If distributions are to be made in annual installments, the second installment and all those thereafter will be made on the applicable anniversaries of the date on which the Participant&#8217;s initial installment was payable.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Minimum Distribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision to the contrary, if the balance of a Participant&#8217;s Account or sub-account at the time of a distribution event is $25,000 or less, then the Participant shall be paid his or her Account or sub-account as a single lump sum.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form of Payment</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All distributions shall be made in the form of cash.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions upon a Change-in-Control</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any distribution election to the contrary, if a Change-in-Control occurs and a Participant incurs a Separation from Service during the period beginning on the date of the Change-in-Control and ending on the second anniversary of the Change-in-Control, then the remaining amount of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Participant&#8217;s vested Account shall be paid to the Participant or his or her beneficiary in a single lump-sum payment as soon as administratively possible, but no later than ninety (90) days, following such Change-in-Control.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 7&#160;&#160;&#160;&#160;Beneficiaries</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.1&#160;&#160;&#160;&#160;Beneficiaries</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Participant may from time to time designate one or more persons (who may be any one or more members of such person&#8217;s family or other persons, administrators, trusts, foundations or other entities) as his or her beneficiary under the Plan. Such designation shall be made in a form prescribed by the Administrator. Each Participant may at any time and from time to time, change any previous beneficiary designation, without notice to or consent of any previously designated beneficiary, by amending his or her previous designation in a form prescribed by the Administrator. If the beneficiary does not survive the Participant (or is otherwise unavailable to receive payment), or if no beneficiary is validly designated then the amounts payable under this Plan shall be paid to the Participant&#8217;s estate. If more than one person is the beneficiary of a deceased Participant, each such person shall receive a pro rata share of any death benefit payable unless otherwise designated in the applicable form. If a beneficiary who is receiving benefits dies, all benefits that were payable to such beneficiary shall then be payable to the estate of that beneficiary.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.2&#160;&#160;&#160;&#160;Lost Beneficiary</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Participants and beneficiaries shall have the obligation to keep the Administrator informed of their current address until such time as all benefits due have been paid. If a Participant or beneficiary cannot be located by the Administrator exercising due diligence, then, in its sole discretion, the Administrator may presume that the Participant or beneficiary is deceased for purposes of the Plan and all unpaid amounts (net of due diligence expenses) owed to the Participant or beneficiary shall be paid accordingly or, if a beneficiary cannot be so located, then such amounts may be forfeited. Any such presumption of death shall be final, conclusive and binding on all parties.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 8&#160;&#160;&#160;&#160;Funding</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.1&#160;&#160;&#160;&#160;Prohibition against Funding</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should any investment be acquired in connection with the liabilities assumed under this Plan, it is expressly understood and agreed that the Participants and beneficiaries shall not have any right with respect to, or claim against, such assets nor shall any such purchase be construed to create a trust of any kind or a fiduciary relationship between the Employer and the Participants, their beneficiaries or any other person. Any such assets shall be and remain a part of the general, unpledged, unrestricted assets of the Employer, subject to the claims of its general creditors. It is the express intention of the parties hereto that this arrangement shall be unfunded for tax purposes and for purposes of Title I of the ERISA. Each Participant and beneficiary shall be required to look to the provisions of this Plan and to the Employer itself for enforcement of any and all benefits due under this Plan, and to the extent any such person acquires a right to receive payment under this Plan, such right shall be no greater than the right of any unsecured general creditor of the Employer. The Employer or the Trust shall be designated the owner and beneficiary of any investment acquired in connection with its obligation under this Plan.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.2&#160;&#160;&#160;&#160;Deposits in Trust</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding Section 8.1, or any other provision of this Plan to the contrary, the Employer may deposit into the Trust any amounts it deems appropriate to pay the benefits under this Plan. The amounts so deposited may include all contributions made pursuant to a Deferral Election by a Participant, all Employer Matching Contributions and any Employer Discretionary Contributions.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.3&#160;&#160;&#160;&#160;Withholding of Employee Contributions</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator is authorized to make any and all necessary arrangements with the Employer in order to withhold the Participant&#8217;s Deferrals under Section 3.1 hereof from his or her Compensation. The Administrator shall determine the amount and timing of such withholding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 9&#160;&#160;&#160;&#160;Claims Administration</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.1&#160;&#160;&#160;&#160;General</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a Participant, beneficiary or his or her representative is denied all or a portion of an expected Plan benefit for any reason and the Participant, beneficiary or his or her representative desires to dispute the decision of the Administrator, he or she must file a written notification of his or her claim with the Administrator. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.2&#160;&#160;&#160;&#160;Claims Procedure</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of any written claim for benefits, the Administrator shall be notified and shall give due consideration to the claim presented. If any Participant or beneficiary claims to be entitled to benefits under the Plan and the Administrator determines that the claim should be denied in whole or in part, the Administrator shall, in writing, notify such claimant within ninety (90) days (forty-five (45) days if the claim is on account of Disability) of receipt of the claim that the claim has been denied. The Administrator may extend the period of time for making a determination with respect to any claim for a period of up to ninety (90) days (thirty (30) days if claim is on account of Disability), provided that the Administrator determines that such an extension is necessary because of special circumstances and notifies the claimant, prior to the expiration of the initial ninety (90) day (or forty-five (45) day) period, of the circumstances requiring the extension of time and the date by which the Plan expects to render a decision. If the claim is denied to any extent by the Administrator, the Administrator shall furnish the claimant with a written notice setting forth&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the specific reason or reasons for denial of the claim&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a specific reference to the Plan provisions on which the denial is based&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a description of any additional material or information necessary for the claimant to perfect the claim and an explanation of why such material or information is necessary&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an explanation of the provisions of this Article.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under no circumstances shall any failure by the Administrator to comply with the provisions of this Section 9.2 be considered to constitute an allowance of the claimant&#8217;s claim.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.3&#160;&#160;&#160;&#160;Right of Appeal</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A claimant who has a claim denied wholly or partially under Section 9.2 may appeal to the Administrator for reconsideration of that claim. A request for reconsideration under this Section must be filed by written notice within sixty (60) days (one-hundred and eighty (180) days if the claim is on account of Disability) after receipt by the claimant of the notice of denial under Section 9.2.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.4&#160;&#160;&#160;&#160;Review of Appeal</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of an appeal the Administrator shall promptly take action to give due consideration to the appeal. Such consideration may include a hearing of the parties involved, if the Administrator feels such a hearing is necessary. In preparing for this appeal, the claimant shall be given the right to review pertinent documents and the right to submit in writing a statement of issues and comments. After consideration of the merits of the appeal, the Administrator shall issue a written decision, which shall be binding on all parties. The decision shall specifically state its reasons and pertinent Plan provisions on which it relies. The Administrator&#8217;s decision shall be issued within sixty (60) days (forty-five (45) days if the claim is on account of Disability) after the appeal is filed, except that the Administrator may extend the period of time for making a determination with respect to any claim for a period of up one-hundred and twenty (120) days (ninety (90) days if the claim is on account of Disability), provided that the Administrator determines that such an extension is necessary because of special circumstances and notifies the claimant, prior to the expiration of the initial one-hundred and twenty (120) day (or, if the claim is on account of Disability, initial ninety (90) day) period, of the circumstances requiring the extension of time and the date by which the Plan expects to render a decision. Under no circumstances shall any failure by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Administrator to comply with the provisions of this Section 9.4 be considered to constitute an allowance of the claimant&#8217;s claim. In the case of a claim on account of Disability&#58; (i) the review of the denied claim shall be conducted by an employee who is neither the individual who made the initial determination or a subordinate of such person&#59; and (ii) no deference shall be given to the initial determination. For issues involving medical judgment, the employee must consult with an independent health care professional who may not be the health care professional who rendered the initial claim. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.5&#160;&#160;&#160;&#160;Designation</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator may designate any other person of its choosing to make any determination otherwise required under this Article. Any person so designated shall have the same authority and discretion granted to the Administrator hereunder.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 10&#160;&#160;&#160;&#160;General Provisions</font></div><div style="margin-bottom:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.1&#160;&#160;&#160;&#160;Administrator</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator is expressly empowered to limit the amount of Compensation that may be deferred&#59; to deposit amounts into the Trust in accordance with Section 8.2 hereof&#59; to interpret the Plan, and to determine all questions arising in the administration, interpretation and application of the Plan&#59; to employ actuaries, accountants, counsel, and other persons it deems necessary in connection with the administration of the Plan&#59; to request any information from the Employer it deems necessary to determine whether the Employer would be considered insolvent or subject to a proceeding in bankruptcy&#59; and to take all other necessary and proper actions to fulfill its duties as Administrator.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall not be liable for any actions by it hereunder, unless due to its own negligence, willful misconduct or lack of good faith.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be indemnified and saved harmless by the Employer from and against all personal liability to which it may be subject by reason of any act done or omitted to be done in its official capacity as Administrator in good faith in the administration of the Plan and Trust, including all expenses reasonably incurred in its defense in the event the Employer fails to provide such defense upon the request of the Administrator. The Administrator is relieved of all responsibility in connection with its duties hereunder to the fullest extent permitted by law, short of breach of duty to the beneficiaries.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.2&#160;&#160;&#160;&#160;No Assignment</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits or payments under this Plan shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, or garnishment by creditors of the Participant or the Participant&#8217;s beneficiary, whether voluntary or involuntary, and any attempt to so anticipate, alienate, sell, transfer, assign, pledge, encumber, attach or garnish the same shall not be valid, nor shall any such benefit or payment be in any way liable for or subject to the debts, contracts, liabilities, engagement or torts of any Participant or beneficiary, or any other person entitled to such benefit or payment pursuant to the terms of this Plan, except to such extent as may be required by law. If any Participant or beneficiary or any other person entitled to a benefit or payment pursuant to the terms of this Plan becomes bankrupt or attempts to anticipate, alienate, sell, transfer, assign, pledge, encumber, attach or garnish any benefit or payment under this Plan, in whole or in part, or if any attempt is made to subject any such benefit or payment, in whole or in part, to the debts, contracts, liabilities, engagements or torts of the Participant or beneficiary or any other person entitled to any such benefit or payment pursuant to the terms of this Plan, then such benefit or payment, in the discretion of the Administrator, shall cease and terminate with respect to such Participant or beneficiary, or any other such person.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.3&#160;&#160;&#160;&#160;No Employment Rights</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participation in this Plan shall not be construed to confer upon any Participant the legal right to be retained in the employ of the Employer, or give a Participant or beneficiary, or any other person, any right to any payment whatsoever, except to the extent of the benefits provided for hereunder. Each Participant shall remain subject to discharge to the same extent as if this Plan had never been adopted.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.4&#160;&#160;&#160;&#160;Incompetence</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Administrator determines that any person to whom a benefit is payable under this Plan is incompetent by reason of physical or mental disability, the Administrator shall have the power to cause the payments becoming due to such person to be made to another for his or her benefit without responsibility of the Administrator or the Employer to see to the application of such payments. Any payment made pursuant to such power shall, as to such payment, operate as a complete discharge of the Employer, the Administrator and the Trustee.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.5&#160;&#160;&#160;&#160;Identity</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, at any time, any doubt exists as to the identity of any person entitled to any payment hereunder or the amount or time of such payment, the Administrator shall be entitled to hold such sum until such identity or amount or time is determined or until an order of a court of competent jurisdiction is obtained. The Administrator shall also be entitled to pay such sum into court in accordance with the appropriate rules of law. Any expenses incurred by the Employer, Administrator, and Trust incident to such proceeding or litigation shall be charged against the Account of the affected Participant.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.6&#160;&#160;&#160;&#160;Other Benefits</font></div><div style="margin-bottom:20pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefits of each Participant or beneficiary hereunder shall be in addition to any benefits paid or payable to or on account of the Participant or beneficiary under any other pension, disability, annuity or retirement plan or policy whatsoever.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.7&#160;&#160;&#160;&#160;Expenses</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All expenses incurred in the administration of the Plan, whether incurred by the Employer or the Plan, shall be paid by the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.8&#160;&#160;&#160;&#160;Insolvency</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should the Employer be considered insolvent (as defined by the Trust), the Employer, through its Board and chief executive officer, shall give immediate written notice of such to the Administrator of the Plan and the Trustee. Upon receipt of such notice, the Administrator or Trustee shall cease to make any payments to Participants who were Employees of the Employer or their beneficiaries and shall hold any and all assets attributable to the Employer for the benefit of the general creditors of the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.9&#160;&#160;&#160;&#160;Amendment or Modification</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may, at any time, in its sole discretion, amend or modify the Plan in whole or in part, except that no such amendment or modification shall have any retroactive effect to reduce any amounts allocated to a Participant&#8217;s Accounts, and provided that such amendment or modification complies with Code Section 409A and related regulations thereunder. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.10&#160;&#160;&#160;&#160;Plan Suspension</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer further reserves the right to suspend the Plan in whole or in part, except that no such suspension shall have any retroactive effect to reduce any amounts allocated to a Participant&#8217;s Accounts, and provided that the distribution of the vested Participant Accounts shall not be accelerated but shall be paid at such time and in such manner as determined under the terms of the Plan immediately prior to suspension as if the Plan had not been suspended. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.11&#160;&#160;&#160;&#160;Plan Termination</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer further reserves the right to terminate the Plan in whole or in part, in the following manner, except that no such termination shall have any retroactive effect to reduce any amounts allocated to a Participant&#8217;s Accounts, and provided that such termination complies with Code Section 409A and related regulations thereunder&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer, in its sole discretion, may terminate the Plan and distribute all vested Participants&#8217; Accounts no earlier than twelve (12) calendar months from the date of the Plan termination and no later than twenty-four (24) calendar months from the date of the Plan termination, provided </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">however that all other similar arrangements are also terminated by the Employer for any affected Participant and no other similar arrangements are adopted by the Employer for any affected Participant within a three (3) year period from the date of termination&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may decide, in its sole discretion, to terminate the Plan in the event of a corporate dissolution taxed under Code Section 331, or with the approval of a bankruptcy court, provided that the Participants vested Account balances are distributed to Participants and are included in the Participants&#8217; gross income in the latest of&#58; (i) the calendar year in which the termination occurs&#59; (ii) the calendar year in which the amounts deferred are no longer subject to a substantial risk of forfeiture&#59; or (iii) the first calendar year in which payment is administratively practicable. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.12&#160;&#160;&#160;&#160;Plan Termination due to a Change-in-Control</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may decide, in its discretion, to terminate the Plan in the event of a Change-in-Control and distribute all vested Participants Account balances no earlier than thirty (30) days prior to the Change-in-Control and no later than twelve (12) months after the effective date of the Change-in-Control, provided however that the Employer terminates all other similar arrangements for any affected Participant. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.13&#160;&#160;&#160;&#160;Construction</font></div><div style="margin-bottom:20pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All questions of interpretation, construction or application arising under or concerning the terms of this Plan shall be decided by the Administrator, in its sole and final discretion, whose decision shall be final, binding and conclusive upon all persons.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.14&#160;&#160;&#160;&#160;Governing Law</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Plan shall be governed by, construed and administered in accordance with the applicable provisions of ERISA, Code Section 409A, and any other applicable federal law, provided, however, that to the extent not preempted by federal law this Plan shall be governed by, construed and administered under the laws of the State of Delaware, other than its laws respecting choice of law.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.15&#160;&#160;&#160;&#160;Severability</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any provision of this Plan is held invalid or unenforceable, its invalidity or unenforceability shall not affect any other provision of this Plan and this Plan shall be construed and enforced as if such provision had not been included therein. If the inclusion of any Employee (or Employees) as a Participant under this Plan would cause the Plan to fail to comply with the requirements of sections 201(2), 301(a)(3) and 401(a)(1) of ERISA, then the Plan shall be severed with respect to such Employee or Employees, who shall be considered to be participating in a separate arrangement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.16&#160;&#160;&#160;&#160;Headings</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Article headings contained herein are inserted only as a matter of convenience and for reference and in no way define, limit, enlarge or describe the scope or intent of this Plan nor in any way shall they affect this Plan or the construction of any provision thereof.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.17&#160;&#160;&#160;&#160;Terms</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized terms shall have meanings as defined herein. Singular nouns shall be read as plural, masculine pronouns shall be read as feminine, and vice versa, as appropriate.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.18&#160;&#160;&#160;&#160;Code Section 409A Fail Safe Provision</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any provision of this Plan violates Code Section 409A, the regulations promulgated thereunder, regulatory interpretations, announcements or mandatory judicial precedent construing Code Section 409A (collectively &#8220;Applicable Law&#8221;), then such provision shall be void and have no effect. At all times, this Plan shall be interpreted in such manner that it complies with Applicable Law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</font></div></div></div><div id="i3ef566daa72b4c149f727bbba4fefd6f_157"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Aspen Insurance U.S. Services Inc. has caused this instrument to be executed by its duly authorized officer, effective as of this 28th day of April, 2014.</font></div><div style="margin-bottom:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:279.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance U.S. Services Inc.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Mark Jones</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer &#8211; U.S.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>21
<FILENAME>exhibit1010-fx1.htm
<DESCRIPTION>EX-10.10
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i472ec9636c7a411793d00a01b5ab3d56_59"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.10</font></div></div><div style="margin-bottom:150pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE U.S. SERVICES INC.</font></div><div style="margin-bottom:15pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NONQUALIFIED DEFERRED COMPENSATION PLAN</font></div><div style="margin-bottom:15pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED EFFECTIVE AUGUST 1, 2014</font></div><div style="margin-bottom:15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This document is drafted with the intent that it comply with Internal Revenue Code Section 409A and regulations promulgated thereunder. NFP Executive Benefits has provided you this specimen document strictly in its capacity as an employee benefits consulting firm and plan record keeper. NFP Executive Benefits does NOT provide legal, tax or accounting consultation or advice. It is NFP Executive Benefits&#8217; recommendation that you seek appropriately specialized professional consultation regarding the information and&#47;or material contained herein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i472ec9636c7a411793d00a01b5ab3d56_80"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE U.S. SERVICES INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nonqualified Deferred Compensation Plan</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Account</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bonus</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change-in-Control</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.8</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferrals</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferral Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.10</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.11</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Employee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Discretionary Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Matching Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.17</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.18</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Fund</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.19</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.20</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Year</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.21</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.22</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Salary</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.23</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.24</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Service Recipient</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.25</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trust</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.26</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trustee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1.27</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Years of Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement of Participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loss of Eligible Employee Status</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferral Elections - General</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Time of Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution Elections</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Requirements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right;text-indent:36pt"><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cancellation of Deferral Election due to Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Matching Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3.7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Discretionary Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Deferrals</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Matching Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Employer Discretionary Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting due to Certain Events</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amounts Not Vested</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Forfeitures</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investments, Gains and Losses</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distribution Election</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions upon an In-Service Account Triggering Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions upon Retirement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Substantially Equal Annual Installments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions due to other Separation from Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions due to Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions upon Death</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.8</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Changes to Distribution Elections</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acceleration or Delay in Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.10</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unforeseeable Emergency</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.11</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Minimum Distribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.12</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form of Payment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6.13</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributions upon a Change-in-Control</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiaries</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">7.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiaries</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">7.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lost Beneficiary</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 8</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Funding</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">8.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prohibition against Funding</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">8.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deposits in Trust</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">8.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding of Employee Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Administration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Procedure</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Right of Appeal</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right;text-indent:36pt"><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Review of Appeal</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Designation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Article 10</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General Provisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.1</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.2</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Assignment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.3</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Employment Rights</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.4</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incompetence</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.5</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Identity</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.6</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Benefits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.7</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expenses</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.8</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insolvency</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.9</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment or Modification</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.10</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Suspension</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.11</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Termination</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.12</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Termination due to a Change-in-Control</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.13</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Construction</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.14</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.15</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.16</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Headings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.17</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Terms</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10.18</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 409A Fail Safe Provision</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i472ec9636c7a411793d00a01b5ab3d56_104"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">ASPEN INSURANCE U.S. SERVICES INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Nonqualified Deferred Compensation Plan</font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Aspen Insurance U.S. Services Inc., and its affiliates and subsidiaries (the &#8220;Employer&#8221;), adopted the Aspen Insurance U. S. Services, Inc. Deferred Compensation Plan (&#8220;Prior Plan&#8221;) on January 8, 2013 with an effective date of January 1, 2012&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Employer desires to change certain provisions of the Prior Plan effective July 1, 2014 as amended and restated effective August 1, 2014&#59; and </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Section 9.1 of the Prior Plan provides Employer with the authority to amend and modify the Plan, subject to non-applicable restrictions&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW THEREFORE, the Employer hereby amends and restates the Prior Plan as the Aspen Insurance U.S. Services Inc. Nonqualified Deferred Compensation Plan (&#8220;Plan&#8221;). This Plan is an unfunded arrangement and is intended to be exempt from the participation, vesting, funding, and fiduciary requirements set forth in Title I of the Employee Retirement Income Security Act of 1974, as amended. It is intended to comply with Internal Revenue Code Section 409A. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 1&#160;&#160;&#160;&#160;Definitions</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.1&#160;&#160;&#160;&#160;Account </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sum of all the bookkeeping sub-accounts as may be established for each Participant as provided in Section 5.1 hereof. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.2&#160;&#160;&#160;&#160;Administrator</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer or individuals or an administrative committee appointed by the Board shall serve as the Administrator of the Plan. The Administrator shall serve as the agent for the Employer with respect to the Trust. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.3&#160;&#160;&#160;&#160;Board</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors of the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.4&#160;&#160;&#160;&#160;Bonus</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation which is designated as such by the Employer and which relates to services performed during an incentive period by an Eligible Employee in addition to his or her Salary, including any pretax elective deferrals from said Bonus to any Employer sponsored plan that includes amounts deferred under a Deferral Election or any elective deferral as defined in Code Section 402(g)(3) or any amount contributed or deferred at the election of the Eligible Employee in accordance with Code Section 125 or 132(f)(4).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.5&#160;&#160;&#160;&#160;Change-in-Control</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, a &#8220;Change-in-Control&#8221; of the Employer (which, for purpose of this Section 1.5 shall mean ABC Company but not any of its affiliates or subsidiaries) shall mean the first to occur of any of the following&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date that any one person or persons acting as a group acquires ownership of Employer stock constituting more than fifty percent (50%) of the total fair market value or total voting power of the Employer&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date that any one person or persons acting as a group acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) ownership of the stock of the Employer possessing thirty percent (30%) or more of the total voting power of the stock of the Employer&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date that any one person or persons acting as a group acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) assets from the Employer that have a total gross fair market value equal to or more than forty percent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40%) of the total gross fair market value of all of the assets of the Employer immediately prior to such acquisition&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date that a majority of members of the Employer&#8217;s Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or elections.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.6&#160;&#160;&#160;&#160;Code</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Internal Revenue Code of 1986, as amended.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.7&#160;&#160;&#160;&#160;Compensation</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Participant&#8217;s earned income, consisting of Salary and Bonus. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.8&#160;&#160;&#160;&#160;Deferrals</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of Compensation that a Participant elects to defer in accordance with Section 3.1 hereof.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.9&#160;&#160;&#160;&#160;Deferral Election</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The separate agreement, submitted to the Administrator, by which an Eligible Employee agrees to participate in the Plan and make Deferrals thereto.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disability</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, a Participant shall be considered to have incurred a Disability if&#58; (i) the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months&#59; (ii) the Participant is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than 3 months under an accident and health plan covering employees of the Participant&#8217;s Employer&#59; or (iii) determined to be totally disabled by the Social Security Administration.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Date</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 1, 2014.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Eligible Employee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Employee shall be considered an Eligible Employee if such Employee is a member of a &#8220;select group of management or highly compensated employees,&#8221; within the meaning of Sections 201, 301 and 401 of ERISA, and is designated as an Eligible Employee by the Administrator. The Administrator may at any time, in its sole discretion, change the eligible criteria for an Eligible Employee or determine that one or more Participants will cease to be an Eligible Employee. The designation of an Employee as an Eligible Employee in any year shall not confer upon such Employee any right to be designated as an Eligible Employee in any future Plan Year.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person employed by the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employer</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance U.S. Services Inc. and its subsidiaries and affiliates.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employer Discretionary Contribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A discretionary contribution made by the Employer that is credited to one or more Participant&#8217;s Accounts in accordance with the terms of Section 3.7 hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employer Matching Contribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contribution made by the Employer that is credited to one or more Participant&#8217;s Accounts in accordance with the terms of Section 3.6 hereof.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ERISA</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.18</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Fund</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each investment(s) which serves as a means to measure value, increases or decreases with respect to a Participant&#8217;s Accounts.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Eligible Employee who is a Participant as provided in Article 2.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Year</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the initial Plan Year, Effective Date through December 31, 2014. For each year thereafter, January 1 through December 31.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.21</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement shall mean a Participant&#8217;s Separation from Service from the Employer for reasons other than death or Disability, on or after the earlier of the Participant&#8217;s attainment of sixty-five (65) years of age or the attainment of age fifty-five (55) with at least ten (10) Years of Service with the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Salary</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Eligible Employee&#8217;s base salary earned during a Plan Year, including any pretax elective deferrals from said Salary to any Employer sponsored plan that includes amounts deferred under a Deferral Election or any elective deferral as defined in Code Section 402(g)(3) or any amount contributed or deferred at the election of the Eligible Employee in accordance with Code Section 125 or 132(f)(4).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Separation from Service</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, a Participant shall incur a Separation from Service with the Service Recipient due to death, retirement or other termination of employment with the Service Recipient unless the employment relationship is treated as continuing intact while the individual is on military leave, sick leave, or other bona fide leave of absence if the period of such leave does not exceed six months, or if longer, so long as the individual retains a right to reemployment with the Service Recipient under an applicable statute or by contract. Upon a sale or other disposition of the assets of the Employer to an unrelated purchaser, the Administrator reserves the right, to the extent permitted by Code section 409A to determine whether Participants providing services to the purchaser after and in connection with the purchase transaction have experienced a Separation from Service.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.24</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Recipient</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that such term shall be interpreted within the meaning of regulations promulgated under Code Section 409A, Service Recipient shall mean the Employer or person for whom the services are performed and with respect to whom the legally binding right to compensation arises, and all persons with whom such person would be considered a single employer under Code Section 414(b) (employees of controlled group of corporations), and all persons with whom such person would be considered a single employer under Code Section 414(c) (employees of partnerships, proprietorships, etc., under common control).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.25</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement between the Employer and the Trustee under which the assets of the Plan are held, administered and managed, which shall conform to the terms of Rev. Proc. 92-64.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.26</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trustee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The person or entity appointed as trustee under the terms of the Trust or such other successor that shall become trustee pursuant to the terms of the Plan.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.27</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years of Service</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant&#8217;s &#8220;Years of Service&#8221; shall be measured by employment during a twelve (12) month period commencing with the Participant&#8217;s date of hire and anniversaries thereof. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 2&#160;&#160;&#160;&#160;Participation</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commencement of Participation</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Eligible Employee shall become a Participant at the earlier of the date on which his or her Deferral Election first becomes effective or the date on which an Employer Discretionary Contribution is first credited to his or her Account.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss of Eligible Employee Status</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant who is no longer an Eligible Employee shall not be permitted to submit a Deferral Election and all Deferrals for such Participant shall cease as of the end of the Plan Year in which such Participant is determined to no longer be an Eligible Employee. Amounts credited to the Account of a Participant who is no longer an Eligible Employee shall continue to be held pursuant to the terms of the Plan and shall be distributed as provided in Article 6. </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contributions</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferral Elections - General</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant&#8217;s Deferral Election for a Plan Year is irrevocable for that applicable Plan Year&#59; provided, however that a cessation of Deferrals shall be allowed if required by the terms of the Employer&#8217;s qualified 401(k) plan in order for the Participant to obtain a hardship withdrawal from the 401(k) plan, or if required under Section 6.10 (Unforeseeable Emergency) of this Plan. Such amounts deferred under the Plan shall not be made available to such Participant, except as provided in Article 6, and shall reduce such Participant&#8217;s Compensation from the Employer in accordance with the provisions of the applicable Deferral Election&#59; provided, however, that all such amounts shall be subject to the rights of the general creditors of the Employer as provided in Article 8. The Deferral Election, in addition to the requirements set forth below, must designate&#58; (i) the amount of Compensation to be deferred, (ii) the time of the distribution, and (iii) the form of the distribution.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Time of Election</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Deferral Election shall be void if it is not made in a timely manner as follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;A Deferral Election with respect to any Compensation must be submitted to the Administrator before the beginning of the calendar year during which the amount to be deferred will be earned. As of December 31 of each calendar year, said Deferral Election is irrevocable for the calendar year.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding the foregoing and in the discretion of the Employer, in a year in which an Employee is first eligible to participate, and provided that such Employee is not eligible to participate in any other similar account balance arrangement subject to Code Section 409A, such Deferral Election shall be submitted within thirty (30) days after the date on which an Employee is first eligible to participate, and such Deferral Election shall apply to Compensation to be earned during the remainder of the calendar year after such election is made. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution Elections</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time a Participant makes a Deferral Election, he or she must also elect the time and form of the distribution by establishing one or more In-Service Account or Separation Account(s) as provided in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sections 5.1 and 6.1. If the Participant fails to properly designate the time and form of a distribution, the Participant&#8217;s Account shall be designated as a Separation Account and shall be paid in a lump sum.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Requirements</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Deferral Election, subject to the limitations set forth in Sections 3.1 and 3.2 hereof, shall comply with the following additional requirements, or as otherwise required by the Administrator in its sole discretion&#58; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Deferrals may be made in whole percentages or stated dollar amounts as determined by the Administrator.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The maximum amount that may be deferred each Plan Year is fifty percent (50%) of the Participant&#8217;s Salary and Commissions, and one-hundred percent (100%) of the Participant&#8217;s Bonus and Performance-based Compensation, net of applicable taxes. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The distribution year for an In-Service Account must be at least three (3) Plan Years after the Plan Year in which such Deferral is credited to an In-Service subaccount. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cancellation of Deferral Election due to Disability</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary, if a Participant incurs a disability as defined in this Section 3.5, said Participant may file an election to stop Deferrals as of the date the election is received by the Administrator, provided that such cancellation occurs by the later of the end of the calendar year or the 15th day of the third month following the date the Participant incurs a disability. Disability for purposes of this Section 3.5 only means that a Participant incurs a medically determinable physical or mental impairment resulting in the Participant&#8217;s inability to perform the duties of his or her position or any substantially similar position, where such impairment can be expected to result in death or can be expected to last for a continuous period of not less than six months, as determined by the Administrator in its sole discretion.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matching Contribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may also credit to the Account of each Participant who makes Deferrals a Matching Contribution in an amount equal to a percentage of the Deferrals contributed by the Participant, with such percentage determined annually by the Employer, in its sole discretion. Such Matching Contribution shall be credited to such sub-account as may be elected by the Participant for his or her Salary Deferrals, or if no Salary Deferrals, then for Bonus Deferrals in accordance with Section 5.1 and procedures established by the Plan Administrator. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employer Discretionary Contribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may make discretionary contributions to some or all Participants&#8217; Accounts in such amount and in such manner as may be determined by the Employer. Such Employer Discretionary Contribution, at the option of the Employer, shall be credited to such sub-account as may be elected by the Participant in accordance with Sections 3.1 and 5.1 and procedures established by the Administrator. In the event no such election is made by the Participant or if Employer desires to direct Employer Discretionary Contributions to a particular Participant sub-account, the Employer, in its sole discretion, may determine which sub-account will be credited with such Employer Discretionary Contribution. In the event the Employer does not designate which Participant sub-account shall be credited, such Employer Discretionary Contribution shall be credited to a lump-sum Separation&#47;Retirement sub-account.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting of Deferrals</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant shall be one-hundred percent (100%) vested in his or her Account attributable to Deferrals and any earning or losses on the investment of such Deferrals. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting of Matching Contributions</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise provided herein, a Participant shall have a vested right to the portion of his or her Account attributable to Matching Contribution(s) and any earnings or losses on the investment of such Matching Contribution(s) according to such vesting schedule as the Employer shall determine at the time an Matching Contribution is made. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting of Employer Discretionary Contributions</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant shall have a vested right to the portion of his or her Account attributable to Employer Discretionary Contribution(s) and any earnings or losses on the investment of such Employer Discretionary Contribution(s) according to such vesting schedule as the Employer shall determine at the time an Employer Discretionary Contribution is made. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting due to Certain Events</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;A Participant who incurs a Disability shall be fully vested in the amounts credited to his or her Account as of the date of Disability.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Upon a Participant&#8217;s death, the Participant shall be fully vested in the amounts credited to his or her Account.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;A Participant who incurs a Separation from Service due to Retirement shall be fully vested in the amounts credited to his or her Account as of the date of Retirement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Upon a Change-in-Control, all Participants shall be fully vested in the amounts credited to their Accounts as of the date of the Change-in-Control.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amounts Not Vested</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts credited to a Participant&#8217;s Account that are not vested at the time of a distribution event shall be forfeited.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forfeitures</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the discretion of the Employer, any forfeitures from a Participant&#8217;s Account (i) may continue to be held in the Trust, may be separately invested, and may be used to reduce succeeding Deferrals and any Employer Contributions, or (ii) may be returned to the Employer as soon as administratively feasible.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alt&#58; Any forfeitures from a Participant&#8217;s Account shall continue to be held in the Trust, shall be separately invested and shall be used to reduce succeeding Deferrals, Employer Matching Contributions, or Employer Discretionary Contributions until such forfeitures have been entirely so applied. If no further Contributions will be made, then such forfeitures shall be returned to the Employer.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall establish and maintain a bookkeeping account in the name of each Participant. The Administrator shall also establish sub-accounts as provided in subsection (a) and (b), below, as elected by the Participant pursuant to Article 3. A Participant may have a maximum of ten (10) sub-accounts at any time.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;A Participant may establish one or more Retirement Account (&#8220;Retirement sub-account&#8221;) by designating as such on the Participant&#8217;s Deferral Election. Each Participant&#8217;s Retirement sub-account shall be credited with Deferrals (as specified in the Participant&#8217;s Deferral Election), any Employer Matching Contributions allocable thereto, any Employer Discretionary Contributions, and the Participant&#8217;s allocable share of any earnings or losses on the foregoing. Each Participant&#8217;s Retirement sub-account shall be reduced by any distributions made plus any federal and state tax withholding, and any social security withholding tax as may be required by law. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:20pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;A Participant may elect to establish one or more In-Service Account (&#8220;In-Service sub-account&#8221;) by designating as such in the Participant&#8217;s Deferral Election the year in which payment shall be made. Each Participant&#8217;s In-Service sub-account shall be credited with Deferrals (as specified in the Participant&#8217;s Deferral Election), any Employer Matching Contributions allocable thereto, any Employer Discretionary Contributions and the Participant&#8217;s allocable share of any earnings or losses on the foregoing. Each Participant&#8217;s In-Service sub-account shall be reduced by any distributions made plus any federal and state tax withholding and any social security withholding tax as may be required by law.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments, Gains and Losses</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;A Participant may direct that his or her Retirement sub-accounts and or In-Service sub-accounts established pursuant to Section 5.1 may be valued as if they were invested in one or more Investment Funds as selected by the Employer in multiples of one percent (1%). The Employer may from time to time, at the discretion of the Administrator, change the Investment Funds for purposes of this Plan. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Administrator shall adjust the amounts credited to each Participant&#8217;s Account to reflect Deferrals, Employer Matching Contributions, any Employer Discretionary Contributions, investment experience, distributions and any other appropriate adjustments. Such adjustments shall be made as frequently as is administratively feasible.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;A Participant may change his or her selection of Investment Funds no more than six (6) times each Plan Year with respect to his or her Account or sub-accounts by filing a new election in accordance with procedures established by the Administrator. An election shall be effective as soon as administratively feasible following the date the change is submitted on a form prescribed by the Administrator.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Notwithstanding the Participant&#8217;s ability to designate the Investment Fund in which his or her deferred Compensation shall be deemed invested, the Employer shall have no obligation to invest any funds in accordance with the Participant&#8217;s election. Participants&#8217; Accounts shall merely be bookkeeping entries on the Employer&#8217;s books, and no Participant shall obtain any property right or interest in any Investment Fund.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution Election</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Participant shall designate in his or her Deferral Election the form and timing of his or her distribution by indicating the type of sub-account as described under Section 5.1, and by designating the form in which payments shall be made from the choices available under Section 6.2 and 6.3 hereof. Notwithstanding anything to the contrary contained herein provided, no acceleration of the time or schedule of payments under the Plan shall occur except as permitted under both this Plan and Code Section 409A.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions upon an In-Service Account Triggering Date</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-Service sub-account distributions shall occur as soon as administratively feasible but no later than ninety (90) days following June 1 of the calendar year designated by the Participant on a properly submitted Deferral Election and is payable in a lump-sum payment. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions upon Retirement</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Participant has a Separation from Service due to Retirement, the Participant&#8217;s Retirement sub-account(s) shall be distributed as soon as administratively feasible, but no earlier than six (6) months and no later than eight (8) months following Participant&#8217;s Retirement. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distribution shall be made either in a lump-sum payment or in substantially equal annual installments, as defined in Section 6.4 below, over a period of up to ten (10) years as elected by the Participant. If the Participant fails to designate the form of the distribution, the sub-account shall be paid in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a lump-sum payment. If distributions are to be made in annual installments, the second installment and all those thereafter will be made on the applicable anniversaries of the date on which the Participant&#8217;s initial installment was payable.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a Participant has any In-Service sub-accounts at the time of his or her Retirement, said sub-accounts shall be distributed in a lump sum as soon as administratively feasible but no earlier than six (6) months and no later than eight (8) months following Participant&#8217;s Retirement. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Substantially Equal Annual Installments</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The amount of the substantially equal payments shall be determined by multiplying the Participant&#8217;s Account or sub-account by a fraction, the denominator of which in the first year of payment equals the number of years over which benefits are to be paid, and the numerator of which is one (1). The amounts of the payments for each succeeding year shall be determined by multiplying the Participant&#8217;s Account or sub-account as of the applicable anniversary of the payout by a fraction, the denominator of which equals the number of remaining years over which benefits are to be paid, and the numerator of which is one (1). Installment payments made pursuant to this Section 6.4 shall be made as soon as administratively feasible but no later than ninety (90) days following the anniversary of the distribution event, subject to Section 6.11 (Distributions to Specified Employees). </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For purposes of the Plan pursuant to Code Section 409A and regulations thereunder, a series of annual installments from a particular subaccount shall be considered a single payment. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions due to other Separation from Service</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a Participant&#8217;s Separation from Service for any reason other than Retirement, death or Disability, all vested amounts credited to his or her Account shall be paid to the Participant in a lump-sum no earlier six (6) months following the Participant&#8217;s Separation from Service and no later than eight&#47;nine months after such date. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions due to Disability</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a Participant&#8217;s Disability, all amounts credited to his or her Account shall be paid to the Participant in a lump sum as soon as administratively feasible but no later than ninety (90) days following the date of Disability.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions upon Death</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the death of a Participant, all amounts credited to his or her Account shall be paid, as soon as administratively feasible but no later than ninety (90) days following Participant&#8217;s date of death, to his or her beneficiary or beneficiaries, as determined under Article 7 hereof, in a lump sum.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes to Distribution Elections</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant will be permitted to elect to change the form or timing of the distribution of the balance of his or her one or more sub-accounts within his or her Account to the extent permitted and in accordance with the requirements of Code Section 409A(a)(4)(C), including the requirement that (i) a redeferral election may not take effect until at least twelve (12) months after such election is filed with the Employer, (ii) an election to further defer a distribution (other than a distribution upon death, Disability or an unforeseeable emergency) must result in the first distribution subject to the election being made at least five (5) years after the previously elected date of distribution, and (iii) any redeferral election affecting a distribution at a fixed date must be filed with the Employer at least twelve (12) months before the first scheduled payment under the previous fixed date distribution election. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acceleration or Delay in Payments</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent permitted by Code Section 409A, and notwithstanding any provision of the Plan to the contrary, the Administrator, in its sole discretion, may elect to (i) accelerate the time or form of payment of a benefit owed to a Participant hereunder in accordance with the terms and subject to the conditions of Treasury Regulations Section 1.409A-3(j)(4), or (ii) delay the time of payment of a benefit owed to a Participant hereunder in accordance with the terms and subject to the conditions of Treasury Regulations Section 1.409A-2(b)(7). By way of example, and at the sole discretion of the Administrator, if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a Participant&#8217;s entire Account balance is less than the applicable Code Section 402(g) annual limit, the Employer may distribute the Participant&#8217;s Account in a lump sum provided that the distribution results in the termination of the participant&#8217;s entire interest in the Plan, subject to the plan aggregation rules of Code Section 409A and regulations thereunder. By way of example, the Administrator may permit such acceleration of the time or schedule of a payment under the arrangement to an individual other than a Participant as may be necessary to fulfill a domestic relations order (as defined in Code Section 414(p)(1)(B)).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unforeseeable Emergency</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator may permit an early distribution of part or all of any deferred amounts&#59; provided, however, that such distribution shall be made only if the Administrator, in its sole discretion, determines that the Participant, or the Participant&#8217;s beneficiary, has experienced an Unforeseeable Emergency. An Unforeseeable Emergency is defined as a severe financial hardship resulting from an illness or accident of the Participant, the Participant&#8217;s spouse, the Participant&#8217;s beneficiary, or a dependent (as defined in Code Section 152(a)) of the Participant, loss of the Participant&#8217;s property due to casualty or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant. If an Unforeseeable Emergency is determined to exist, a distribution may not exceed the amounts necessary to satisfy such emergency plus amounts necessary to pay taxes reasonably anticipated as a result of the distribution, after taking into account the extent to which such hardship is or may be relieved through reimbursement or compensation by insurance or otherwise or by liquidation of the Participant&#8217;s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship). Upon a distribution to a Participant under this Section 6.10, the Participant&#8217;s Deferrals shall cease and no further Deferrals shall be made for such Participant for the remainder of the Plan Year and one (1) subsequent Plan Year. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Minimum Distribution</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision to the contrary, if the balance of a Participant&#8217;s Account or sub-account at the time of a distribution event is $25,000 or less, then the Participant shall be paid his or her Account or sub-account as a single lump sum.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form of Payment</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All distributions shall be made in the form of cash.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions upon a Change-in-Control</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any distribution election to the contrary, if a Change-in-Control occurs and a Participant incurs a Separation from Service during the period beginning on the date of the Change-in-Control and ending on the second anniversary of the Change-in-Control, then the remaining amount of the Participant&#8217;s vested Account shall be paid to the Participant or his or her beneficiary in a single lump-sum payment as soon as administratively possible, but no later than ninety (90) days, following such Change-in-Control.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beneficiaries</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beneficiaries</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Participant may from time to time designate one or more persons (who may be any one or more members of such person&#8217;s family or other persons, administrators, trusts, foundations or other entities) as his or her beneficiary under the Plan. Such designation shall be made in a form prescribed by the Administrator. Each Participant may at any time and from time to time, change any previous beneficiary designation, without notice to or consent of any previously designated beneficiary, by amending his or her previous designation in a form prescribed by the Administrator. If the beneficiary does not survive the Participant (or is otherwise unavailable to receive payment), or if no beneficiary is validly designated then the amounts payable under this Plan shall be paid to the Participant&#8217;s estate. If more than one person is the beneficiary of a deceased Participant, each such person shall receive a pro rata share of any death benefit payable unless otherwise designated in the applicable form. If a beneficiary </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">who is receiving benefits dies, all benefits that were payable to such beneficiary shall then be payable to the estate of that beneficiary.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lost Beneficiary</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Participants and beneficiaries shall have the obligation to keep the Administrator informed of their current address until such time as all benefits due have been paid. If a Participant or beneficiary cannot be located by the Administrator exercising due diligence, then, in its sole discretion, the Administrator may presume that the Participant or beneficiary is deceased for purposes of the Plan and all unpaid amounts (net of due diligence expenses) owed to the Participant or beneficiary shall be paid accordingly or, if a beneficiary cannot be so located, then such amounts may be forfeited. Any such presumption of death shall be final, conclusive and binding on all parties.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Funding</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prohibition against Funding</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should any investment be acquired in connection with the liabilities assumed under this Plan, it is expressly understood and agreed that the Participants and beneficiaries shall not have any right with respect to, or claim against, such assets nor shall any such purchase be construed to create a trust of any kind or a fiduciary relationship between the Employer and the Participants, their beneficiaries or any other person. Any such assets shall be and remain a part of the general, unpledged, unrestricted assets of the Employer, subject to the claims of its general creditors. It is the express intention of the parties hereto that this arrangement shall be unfunded for tax purposes and for purposes of Title I of the ERISA. Each Participant and beneficiary shall be required to look to the provisions of this Plan and to the Employer itself for enforcement of any and all benefits due under this Plan, and to the extent any such person acquires a right to receive payment under this Plan, such right shall be no greater than the right of any unsecured general creditor of the Employer. The Employer or the Trust shall be designated the owner and beneficiary of any investment acquired in connection with its obligation under this Plan.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposits in Trust</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding Section 8.1, or any other provision of this Plan to the contrary, the Employer may deposit into the Trust any amounts it deems appropriate to pay the benefits under this Plan. The amounts so deposited may include all contributions made pursuant to a Deferral Election by a Participant, all Employer Matching Contributions and any Employer Discretionary Contributions.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Withholding of Employee Contributions</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator is authorized to make any and all necessary arrangements with the Employer in order to withhold the Participant&#8217;s Deferrals under Section 3.1 hereof from his or her Compensation. The Administrator shall determine the amount and timing of such withholding.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Claims Administration</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a Participant, beneficiary or his or her representative is denied all or a portion of an expected Plan benefit for any reason and the Participant, beneficiary or his or her representative desires to dispute the decision of the Administrator, he or she must file a written notification of his or her claim with the Administrator. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Claims Procedure</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of any written claim for benefits, the Administrator shall be notified and shall give due consideration to the claim presented. If any Participant or beneficiary claims to be entitled to benefits under the Plan and the Administrator determines that the claim should be denied in whole or in part, the Administrator shall, in writing, notify such claimant within ninety (90) days (forty-five (45) days if the claim is on account of Disability) of receipt of the claim that the claim has been denied. The Administrator may extend the period of time for making a determination with respect to any claim for a period of up to ninety (90) days (thirty (30) days if claim is on account of Disability), provided that the Administrator determines </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that such an extension is necessary because of special circumstances and notifies the claimant, prior to the expiration of the initial ninety (90) day (or forty-five (45) day) period, of the circumstances requiring the extension of time and the date by which the Plan expects to render a decision. If the claim is denied to any extent by the Administrator, the Administrator shall furnish the claimant with a written notice setting forth&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the specific reason or reasons for denial of the claim&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;a specific reference to the Plan provisions on which the denial is based&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;a description of any additional material or information necessary for the claimant to perfect the claim and an explanation of why such material or information is necessary&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;an explanation of the provisions of this Article.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under no circumstances shall any failure by the Administrator to comply with the provisions of this Section 9.2 be considered to constitute an allowance of the claimant&#8217;s claim.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Right of Appeal</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A claimant who has a claim denied wholly or partially under Section 9.2 may appeal to the Administrator for reconsideration of that claim. A request for reconsideration under this Section must be filed by written notice within sixty (60) days (one-hundred and eighty (180) days if the claim is on account of Disability) after receipt by the claimant of the notice of denial under Section 9.2.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Review of Appeal</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of an appeal the Administrator shall promptly take action to give due consideration to the appeal. Such consideration may include a hearing of the parties involved, if the Administrator feels such a hearing is necessary. In preparing for this appeal, the claimant shall be given the right to review pertinent documents and the right to submit in writing a statement of issues and comments. After consideration of the merits of the appeal, the Administrator shall issue a written decision, which shall be binding on all parties. The decision shall specifically state its reasons and pertinent Plan provisions on which it relies. The Administrator&#8217;s decision shall be issued within sixty (60) days (forty-five (45) days if the claim is on account of Disability) after the appeal is filed, except that the Administrator may extend the period of time for making a determination with respect to any claim for a period of up one-hundred and twenty (120) days (ninety (90) days if the claim is on account of Disability), provided that the Administrator determines that such an extension is necessary because of special circumstances and notifies the claimant, prior to the expiration of the initial one-hundred and twenty (120) day (or, if the claim is on account of Disability, initial ninety (90) day) period, of the circumstances requiring the extension of time and the date by which the Plan expects to render a decision. Under no circumstances shall any failure by the Administrator to comply with the provisions of this Section 9.4 be considered to constitute an allowance of the claimant&#8217;s claim. In the case of a claim on account of Disability&#58; (i) the review of the denied claim shall be conducted by an employee who is neither the individual who made the initial determination or a subordinate of such person&#59; and (ii) no deference shall be given to the initial determination. For issues involving medical judgment, the employee must consult with an independent health care professional who may not be the health care professional who rendered the initial claim. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Designation</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator may designate any other person of its choosing to make any determination otherwise required under this Article. Any person so designated shall have the same authority and discretion granted to the Administrator hereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Provisions</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Administrator</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Administrator is expressly empowered to limit the amount of Compensation that may be deferred&#59; to deposit amounts into the Trust in accordance with Section 8.2 hereof&#59; to interpret the Plan, and to determine all questions arising in the administration, interpretation and application of the Plan&#59; to employ actuaries, accountants, counsel, and other persons it deems necessary in connection with the administration of the Plan&#59; to request any information from the Employer it deems necessary to determine whether the Employer would be considered insolvent or subject to a proceeding in bankruptcy&#59; and to take all other necessary and proper actions to fulfill its duties as Administrator.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Administrator shall not be liable for any actions by it hereunder, unless due to its own negligence, willful misconduct or lack of good faith.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Administrator shall be indemnified and saved harmless by the Employer from and against all personal liability to which it may be subject by reason of any act done or omitted to be done in its official capacity as Administrator in good faith in the administration of the Plan and Trust, including all expenses reasonably incurred in its defense in the event the Employer fails to provide such defense upon the request of the Administrator. The Administrator is relieved of all responsibility in connection with its duties hereunder to the fullest extent permitted by law, short of breach of duty to the beneficiaries.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Assignment</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits or payments under this Plan shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, or garnishment by creditors of the Participant or the Participant&#8217;s beneficiary, whether voluntary or involuntary, and any attempt to so anticipate, alienate, sell, transfer, assign, pledge, encumber, attach or garnish the same shall not be valid, nor shall any such benefit or payment be in any way liable for or subject to the debts, contracts, liabilities, engagement or torts of any Participant or beneficiary, or any other person entitled to such benefit or payment pursuant to the terms of this Plan, except to such extent as may be required by law. If any Participant or beneficiary or any other person entitled to a benefit or payment pursuant to the terms of this Plan becomes bankrupt or attempts to anticipate, alienate, sell, transfer, assign, pledge, encumber, attach or garnish any benefit or payment under this Plan, in whole or in part, or if any attempt is made to subject any such benefit or payment, in whole or in part, to the debts, contracts, liabilities, engagements or torts of the Participant or beneficiary or any other person entitled to any such benefit or payment pursuant to the terms of this Plan, then such benefit or payment, in the discretion of the Administrator, shall cease and terminate with respect to such Participant or beneficiary, or any other such person.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Employment Rights</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participation in this Plan shall not be construed to confer upon any Participant the legal right to be retained in the employ of the Employer, or give a Participant or beneficiary, or any other person, any right to any payment whatsoever, except to the extent of the benefits provided for hereunder. Each Participant shall remain subject to discharge to the same extent as if this Plan had never been adopted.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Incompetence</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Administrator determines that any person to whom a benefit is payable under this Plan is incompetent by reason of physical or mental disability, the Administrator shall have the power to cause the payments becoming due to such person to be made to another for his or her benefit without responsibility of the Administrator or the Employer to see to the application of such payments. Any payment made pursuant to such power shall, as to such payment, operate as a complete discharge of the Employer, the Administrator and the Trustee.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Identity</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, at any time, any doubt exists as to the identity of any person entitled to any payment hereunder or the amount or time of such payment, the Administrator shall be entitled to hold such sum until such identity or amount or time is determined or until an order of a court of competent jurisdiction is obtained. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall also be entitled to pay such sum into court in accordance with the appropriate rules of law. Any expenses incurred by the Employer, Administrator, and Trust incident to such proceeding or litigation shall be charged against the Account of the affected Participant.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Benefits</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefits of each Participant or beneficiary hereunder shall be in addition to any benefits paid or payable to or on account of the Participant or beneficiary under any other pension, disability, annuity or retirement plan or policy whatsoever.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expenses</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All expenses incurred in the administration of the Plan, whether incurred by the Employer or the Plan, shall be paid by the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insolvency</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should the Employer be considered insolvent (as defined by the Trust), the Employer, through its Board and chief executive officer, shall give immediate written notice of such to the Administrator of the Plan and the Trustee. Upon receipt of such notice, the Administrator or Trustee shall cease to make any payments to Participants who were Employees of the Employer or their beneficiaries and shall hold any and all assets attributable to the Employer for the benefit of the general creditors of the Employer.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendment or Modification</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may, at any time, in its sole discretion, amend or modify the Plan in whole or in part, except that no such amendment or modification shall have any retroactive effect to reduce any amounts allocated to a Participant&#8217;s Accounts, and provided that such amendment or modification complies with Code Section 409A and related regulations thereunder. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Suspension</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer further reserves the right to suspend the Plan in whole or in part, except that no such suspension shall have any retroactive effect to reduce any amounts allocated to a Participant&#8217;s Accounts, and provided that the distribution of the vested Participant Accounts shall not be accelerated but shall be paid at such time and in such manner as determined under the terms of the Plan immediately prior to suspension as if the Plan had not been suspended. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Termination</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer further reserves the right to terminate the Plan in whole or in part, in the following manner, except that no such termination shall have any retroactive effect to reduce any amounts allocated to a Participant&#8217;s Accounts, and provided that such termination complies with Code Section 409A and related regulations thereunder&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Employer, in its sole discretion, may terminate the Plan and distribute all vested Participants&#8217; Accounts no earlier than twelve (12) calendar months from the date of the Plan termination and no later than twenty-four (24) calendar months from the date of the Plan termination, provided however that all other similar arrangements are also terminated by the Employer for any affected Participant and no other similar arrangements are adopted by the Employer for any affected Participant within a three (3) year period from the date of termination&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Employer may decide, in its sole discretion, to terminate the Plan in the event of a corporate dissolution taxed under Code Section 331, or with the approval of a bankruptcy court, provided that the Participants vested Account balances are distributed to Participants and are included in the Participants&#8217; gross income in the latest of&#58; (i) the calendar year in which the termination occurs&#59; (ii) the calendar year in which the amounts deferred are no longer subject to a substantial risk of forfeiture&#59; or (iii) the first calendar year in which payment is administratively practicable. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Termination due to a Change-in-Control</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employer may decide, in its discretion, to terminate the Plan in the event of a Change-in-Control and distribute all vested Participants Account balances no earlier than thirty (30) days prior to the Change-in-Control and no later than twelve (12) months after the effective date of the Change-in-Control, provided however that the Employer terminates all other similar arrangements for any affected Participant. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Construction</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All questions of interpretation, construction or application arising under or concerning the terms of this Plan shall be decided by the Administrator, in its sole and final discretion, whose decision shall be final, binding and conclusive upon all persons.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governing Law</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Plan shall be governed by, construed and administered in accordance with the applicable provisions of ERISA, Code Section 409A, and any other applicable federal law, provided, however, that to the extent not preempted by federal law this Plan shall be governed by, construed and administered under the laws of the State of Delaware, other than its laws respecting choice of law.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Severability</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any provision of this Plan is held invalid or unenforceable, its invalidity or unenforceability shall not affect any other provision of this Plan and this Plan shall be construed and enforced as if such provision had not been included therein. If the inclusion of any Employee (or Employees) as a Participant under this Plan would cause the Plan to fail to comply with the requirements of sections 201(2), 301(a)(3) and 401(a)(1) of ERISA, then the Plan shall be severed with respect to such Employee or Employees, who shall be considered to be participating in a separate arrangement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Headings</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Article headings contained herein are inserted only as a matter of convenience and for reference and in no way define, limit, enlarge or describe the scope or intent of this Plan nor in any way shall they affect this Plan or the construction of any provision thereof.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Terms</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized terms shall have meanings as defined herein. Singular nouns shall be read as plural, masculine pronouns shall be read as feminine, and vice versa, as appropriate.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.18</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code Section 409A Fail Safe Provision</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any provision of this Plan violates Code Section 409A, the regulations promulgated thereunder, regulatory interpretations, announcements or mandatory judicial precedent construing Code Section 409A (collectively &#8220;Applicable Law&#8221;), then such provision shall be void and have no effect. At all times, this Plan shall be interpreted in such manner that it complies with Applicable Law.</font></div><div id="i472ec9636c7a411793d00a01b5ab3d56_161"></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Aspen Insurance U.S. Services Inc. has caused this instrument to be executed by its duly authorized officer, effective as of this 1st day of August, 2014.</font></div><div style="margin-bottom:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:316.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance U.S. Services Inc.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Mark Jones</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark Jones</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>22
<FILENAME>exhibit1011-fx1.htm
<DESCRIPTION>EX-10.11
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if4603bd17ae849c2bd6fca6756d96339_59"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.11</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECOND AMENDED AND RESTATED </font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CREDIT AGREEMENT</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">among</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Subsidiary Borrowers</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from Time to Time Parties Hereto,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Several Lenders from Time to Time Parties Hereto,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON,</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Collateral Agent,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CITIBANK, N.A.,</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Syndication Agent,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">DEUTSCHE BANK SECURITIES INC.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">THE BANK OF NEW YORK MELLON and</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">LLOYDS SECURITIES INC.,</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">As Co-Documentation Agents,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC,</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Administrative Agent</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dated as of March 27, 2017</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC and CITIGROUP GLOBAL MARKETS INC.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Joint Lead Arrangers and Joint Bookrunners</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_86"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Table of Contents</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFINITIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined Terms</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Definitional Provisions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Rates</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in GAAP</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMOUNT AND TERMS OF COMMITMENTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Commitments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Procedure for Borrowing</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination or Reduction of Commitments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optional and Mandatory Prepayments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion and Continuation Options</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limitations on Eurodollar Tranches</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rates and Payment Dates</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of Interest and Fees</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inability to Determine Interest Rate</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro Rata Treatment and Payments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requirements of Law&#59; Eurocurrency Liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnity</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change of Lending Office</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Replacement of Lenders</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defaulting Lenders</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LETTERS OF CREDIT</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L&#47;C Commitment</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Procedure for Issuance of Letter of Credit</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees and Other Charges</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L&#47;C Participations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursement Obligation of the Borrowers</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligations Absolute</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter of Credit Payments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Several Letters of Credit</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applications</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.10</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Issuing Lenders</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reporting</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-NAIC Approved Banks</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">REPRESENTATIONS AND WARRANTIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Conditions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existence&#59; Compliance with Law</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power&#59; Authorization&#59; Enforceable Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Legal Bar</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Default</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership of Property&#59; Liens</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal Regulations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERISA</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment Company Act</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of Proceeds</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accuracy of Information, etc</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.17</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PATRIOT Act&#59; OFAC</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CONDITIONS PRECEDENT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions to Initial Extensions of Credit</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions to Each Extension of Credit</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions for Additional Subsidiary Borrowers</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AFFIRMATIVE COVENANTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.312%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates&#59; Other Information</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintenance of Existence&#59; Compliance</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintenance of Property&#59; Insurance</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inspection of Property&#59; Books and Records&#59; Discussions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental Laws</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NEGATIVE COVENANTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Condition Covenants</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indebtedness</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposition of Property</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Payments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liens</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clauses Restricting Subsidiary Distributions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rating</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidations, Amalgamations, Mergers and Liquidations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.11</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactions with Affiliates</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EVENTS OF DEFAULT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE AGENTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appointment</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delegation of Duties</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exculpatory Provisions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reliance</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notice of Default</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Reliance on Agents and Other Lenders</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agent in Its Individual Capacity</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Successor Administrative Agent and Collateral Agent</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.10</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Security Document Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.11</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Agents</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">GUARANTEE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Subrogation</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments, etc. with respect to the Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee Absolute and Unconditional</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinstatement</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MISCELLANEOUS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments and Waivers</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Waiver&#59; Cumulative Remedies</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Survival of Representations and Warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of Expenses and Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Successors and Assigns&#59; Participations and Assignments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Set-off</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Counterparts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.10</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severability</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.11</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.12</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GOVERNING LAW</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.13</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Submission To Jurisdiction&#59; Waivers</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.14</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Process Agent</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.15</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency of Payment</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.16</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Releases of Liens</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.17</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidentiality</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.18</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Several Obligations of Borrowers&#59; Company as Agent of Borrowers</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.19</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Reserved&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iv</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.20</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WAIVERS OF JURY TRIAL</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.21</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Advisory or Fiduciary Duty</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.22</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USA Patriot Act</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.23</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Restatement</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE BORROWER REPRESENTATIVE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appointment&#59; Nature of Relationship</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Powers</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment of Agents</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Successor Borrower Representative</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of Loan Documents&#59; Borrowing Base Certificate</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">v</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ANNEX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A&#160;&#160;&#160;&#160;Pricing Grid</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SCHEDULES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;Commitments</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.13&#160;&#160;&#160;&#160;Subsidiaries</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.2(b)(iv)&#160;&#160;&#160;&#160;Existing Indebtedness</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.5&#160;&#160;&#160;&#160;Investments</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.6&#160;&#160;&#160;&#160;Existing Liens</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">EXHIBITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A&#160;&#160;&#160;&#160;Form of Compliance Certificate</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">B-1&#160;&#160;&#160;&#160;Form of Closing Certificate of the Company</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">B-2&#160;&#160;&#160;&#160;Form of Closing Certificate of each Subsidiary Borrower</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">C&#160;&#160;&#160;&#160;Form of Assignment and Assumption</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">D-1&#160;&#160;&#160;&#160;Form of Legal Opinion of Mayer Brown LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">D-2&#160;&#160;&#160;&#160;Form of Legal Opinion of Appleby (Bermuda) Limited</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E-1&#160;&#160;&#160;&#160;Form of Exemption Certificate (Non-Partnerships)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E-2&#160;&#160;&#160;&#160;Form of Exemption Certificate (Partnerships)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">F&#160;&#160;&#160;&#160;Form of Company Note</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">G&#160;&#160;&#160;&#160;Form of Subsidiary Borrower Note</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">H&#160;&#160;&#160;&#160;Form of Notice of Conversion&#47;Continuation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I&#160;&#160;&#160;&#160;Form of Subsidiary Borrower Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">J&#160;&#160;&#160;&#160;Form of Commitment Increase Supplement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">K&#160;&#160;&#160;&#160;Form of New Lender Supplement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">L&#160;&#160;&#160;&#160;Form of Several Letter of Credit</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">M&#160;&#160;&#160;&#160;Form of Borrowing Request</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">N&#160;&#160;&#160;&#160;Form of Prepayment Notice</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">vi</font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_103"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), dated as of March 27, 2017, among ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined below&#59; together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the several banks and other financial institutions or entities from time to time parties to this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), CITIBANK, N.A., as syndication agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Syndication Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), DEUTSCHE BANK SECURITIES INC., THE BANK OF NEW YORK MELLON and LLOYDS SECURITIES INC., as co-documentation agents (in such capacities, each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Co-Documentation Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), THE BANK OF NEW YORK MELLON, as collateral agent, and BARCLAYS BANK PLC, as administrative agent.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:24pt;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As used in this Agreement, the terms listed in this Section 1.1 shall have the respective meanings set forth in this Section 1.1.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ABR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; for any day, a rate per annum (rounded upwards, if necessary, to the next 1&#47;100 of 1%) equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day plus &#189; of 1% and (c) the one-month Eurodollar Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 1.0%. Any change in the ABR due to a change in the Prime Rate, the Federal Funds Effective Rate or the Eurodollar Rate shall be effective as of the opening of business on the effective day of such change in the applicable rate. If for any reason any rate described in clause (a), (b) or (c) above is not available, then the ABR shall be determined based upon one of the other rates set forth above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ABR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Loans that bear interest based upon the ABR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the Security Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Barclays Bank PLC, as the administrative agent for the Lenders under this Agreement and the other Loan Documents, together with any of its successors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Advance Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; for any category of cash or obligation or investment specified below in the column entitled &#8220;Cash and Eligible Securities&#8221; (other than cash, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the percentage set forth opposite such category of cash or Eligible Securities below in the column entitled &#8220;Advance Rate&#8221; and, in each case, subject to the original term to maturity criteria set forth therein&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cash and Eligible Securities&#160;&#160;&#160;&#160;Advance Rate</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash Denominated in Dollars&#160;&#160;&#160;&#160;100%</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investments in Permitted Funds (as defined below)&#160;&#160;&#160;&#160;95%</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. Government Bills, Notes and U.S. Government Guaranteed or Sponsored Agency Securities (including FNMA and FHLMC)</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#60;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2 years&#160;&#160;&#160;&#160;95%</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#60;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 10 years, but &#62; 2 years&#160;&#160;&#160;&#160;90%</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity &#62; 10 years&#160;&#160;&#160;&#160;85%</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-U.S. Government and Supranational Organization Obligations (Rating AA- or better or Aa3 or better)</font></div><div style="margin-bottom:3pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#60;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 5 years&#160;&#160;&#160;&#160;90%</font></div><div style="margin-bottom:3pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#60;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 10 years, but &#62; 5 years&#160;&#160;&#160;&#160;85%</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity &#62; 10 years&#160;&#160;&#160;&#160;80%</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. Corporate Bonds (Rating A1 or better or A+ or better, Non-convertible)</font></div><div style="margin-bottom:3pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity &#8804; 5 years&#160;&#160;&#160;&#160;90%</font></div><div style="margin-bottom:3pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity &#8804; 10 years, but &#62; 5 years&#160;&#160;&#160;&#160;85%</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity &#62; 10 years&#160;&#160;&#160;&#160;80%</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. Corporate Bonds (Rating A3 or better or A- or better but lower than A1 or A+, Non-convertible)</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maturity </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#60;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 10 years&#160;&#160;&#160;&#160;80%</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All other securities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, (a) the advance rate on securities issued by the Federal Home Loan Mortgage Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">FHLMC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; also known as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Freddie Mac</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Federal National Mortgage Association (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">FNMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; also known as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Fannie Mae</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) shall be decreased by an additional 7.5% to the extent that either FHLMC or FNMA shall no longer be under the conservatorship of the Federal Housing Finance Agency and (b) the value of the amount included in the Borrowing Base for the marketable securities set forth above shall be decreased by an additional 10.0% to the extent that such marketable securities are held in a currency other than the currency of the applicable Secured Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, any other Person that, directly or indirectly, is in control of, is controlled by, or is under common control with, such Person. For purposes of this definition, &#8220;control&#8221; of a Person means the power, directly or indirectly, either to (a) vote 20% or more of the securities having ordinary voting power for the election of directors (or persons performing similar functions) of such Person or (b) direct or cause the direction of the management and policies of such Person, whether by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to the Syndication Agent, the Administrative Agent, the Co-Documentation Agents and the Collateral Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Aggregate Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any Lender at any time, an amount equal to the amount of such Lender&#8217;s Commitment then in effect or, if the Commitments have been terminated, the amount of such Lender&#8217;s Extensions of Credit then outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Aggregate Exposure Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any Lender at any time, the ratio (expressed as a percentage) of such Lender&#8217;s Aggregate Exposure at such time to the Aggregate Exposure of all Lenders at such time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that when a Defaulting Lender shall exist, any such Defaulting Lender&#8217;s Commitment shall be disregarded in the calculation of Aggregate Exposure Percentage.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; all laws, rules and regulations of any jurisdiction applicable to the Company or any of its Subsidiaries from time to time concerning or relating to bribery or corruption, including the United States Foreign Corruption Practices Act of 1977 and the rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Issuing Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) in the case of Fronted Letters of Credit, the Issuing Lender and (b) in the case of Several Letters of Credit, the L&#47;C Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the rate per annum set forth under the relevant column heading in Annex A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Application</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; an application, in such form as the applicable Issuing Lender may specify from time to time, requesting such Issuing Lender to issue a Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; an Assignment and Assumption, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Available Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Lender at any time, an amount equal to the excess, if any, of (a) such Lender&#8217;s Commitment then in effect </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (b) such Lender&#8217;s Extensions of Credit then outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Bail-In Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the exercise of any Write-down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of an EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Bail-In Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any EEA Member Country implementing Article 55 of the Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefitted Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.7.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Bermuda Companies Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; The Bermuda Companies Act of 1981, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Bermuda Insurance Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; The Bermuda Insurance Act of 1978, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Board of Governors of the Federal Reserve System of the United States (or any successor).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Company, in its capacity as contractual representative of the Borrowers pursuant to Section 12.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowing Base</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, and in respect of each Borrower, the aggregate amount of cash and Eligible Securities held in the Accounts applicable to such Borrower under the applicable Collateral Account Control Agreement at such time multiplied in each case by the respective Advance Rates for cash and such Eligible Securities&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no Eligible Securities or cash shall be included in the calculation of a Borrowing Base unless (i) the Collateral Agent has a first priority perfected Lien on and security interest in such collateral pursuant to the Loan Documents and (ii) there shall exist no other Liens on such Eligible Securities and cash&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (1) no Eligible Security shall be included in the calculation of a Borrowing Base unless (A) either transactions with respect to such Eligible Security are settled through the Depositary Trust &#38; Clearing Corporation or such Eligible Security is listed on a generally recognized national securities exchange or is freely traded at readily established prices in over-the-counter transactions and (B) price quotations for such Eligible Security are available to the Custodian in the ordinary course of business, (2) other than cash, U.S. Government Bills, Notes, U.S. Government Guaranteed or Sponsored Agency Securities and investments in Permitted Funds, no single issue or issuer shall comprise more than 10% of a Borrowing Base for any Borrower, (3) U.S. Corporate Bonds shall be restricted to bonds with issue size of $250,000,000 or higher, (4) Non-U.S. Government and Supranational Organization Obligations shall be excluded from the calculation of a Borrowing Base unless such marketable securities are from the OECD country member states of United Kingdom, France, Germany or Japan, (5) no more than $100,000,000 of investments in Permitted Funds shall be included in the calculation of the Borrowing Bases for all Borrowers as of any date, (6) all maturities are calculated from the relevant date of determination of a Borrowing Base and (7) the total value included in the Borrowing Base of U.S. Corporate Bonds (Rating A3 or better or A- or better, Non-convertible) with a maturity of 10 years or shorter shall not exceed 25% of the total Borrowing Base&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that (i) the Borrowing Base in respect of any Borrower at any time shall be the amount thereof as set forth in the Borrowing Base Report (as defined in the applicable Collateral Account Control Agreement) then most recently delivered by the Collateral Agent to the Administrative Agent pursuant to Section 2 of Article III of the applicable Collateral Account Control Agreement and (ii) for the avoidance of doubt, each Borrower will take all such actions as shall be necessary to cause such Borrower to be in compliance with Article III of the applicable Collateral Account Control Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Business Day specified by the Borrower Representative as a date on which the Borrower Representative requests the relevant Lenders to make Loans hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a day other than a Saturday, Sunday or other day on which commercial banks in New York City or London or, for purposes of Section 2.5(b) only, Bermuda, are authorized or required by law to close&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that with respect to notices and determinations in connection with, and payments of principal and interest on, Eurodollar Loans, such day is also a day for trading by and between banks in Dollar deposits in the interbank eurodollar market.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Lease Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP and, for the purposes of this Agreement, the amount of such obligations at any time shall be the capitalized amount thereof at such time determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any and all shares, interests, participations or other equivalents (however designated) of capital stock (including Hybrid Capital) of a corporation, any and all equivalent ownership interests in a Person (other than a corporation) and any and all warrants, rights or options to purchase any of the foregoing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) marketable direct obligations issued by, or unconditionally guaranteed by, the United States federal government or issued by any agency thereof and backed by the full faith and credit of the United States, in each case maturing within one year from the date of acquisition&#59; (b) certificates of deposit, time deposits, eurodollar time deposits or overnight bank deposits having maturities of six months or less from the date of acquisition issued by any Lender or by any commercial bank organized under the laws of the United States or any state thereof having combined capital and surplus of not less than $500,000,000&#59; (c) commercial paper of an issuer rated at least &#8216;A-1&#8217; by S&#38;P or &#8216;P-1&#8217; by Moody&#8217;s, or carrying an equivalent rating by a nationally recognized rating agency, if both of the two named rating agencies cease publishing ratings of commercial paper issuers generally, and maturing within six months from the date of acquisition&#59; (d) repurchase obligations of any Lender or of any commercial bank satisfying the requirements of clause (b) of this definition, having a term of not more than 30 days, with respect to securities issued or fully guaranteed or insured by the United States federal government&#59; (e) securities with maturities of one year or less from the date of acquisition issued or fully guaranteed by any state, commonwealth or territory of the United States, by any political subdivision or taxing authority of any such state, commonwealth or territory or by any foreign government, the securities of which state, commonwealth, territory, political subdivision, taxing authority or foreign government (as the case may be) are rated at least &#8216;A&#8217; by S&#38;P or &#8216;A&#8217; by Moody&#8217;s&#59; (f) securities with maturities of six months or less from the date of acquisition backed by standby letters of credit issued by any Lender or any commercial bank satisfying the requirements of clause (b) of this definition&#59; (g) money market mutual or similar funds that invest exclusively in assets satisfying the requirements of clauses (a) through (f) of this definition&#59; or (h) money market funds that (i) comply with the criteria set forth in SEC Rule 2a-7 under the Investment Company Act of 1940, (ii) are rated &#8216;AAA&#8217; by S&#38;P and &#8216;Aaa&#8217; by Moody&#8217;s and (iii) have portfolio assets of at least $5,000,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any of the following&#58; (i) &#160;any &#8220;person&#8221; or &#8220;group&#8221; (as such terms are used in Sections&#160;13(d) and 14(d) of the Securities Exchange Act of 1934 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) other than the Company or any Subsidiary), shall become, or obtain rights (whether by means of warrants, options or otherwise (other than any such warrants, options or other rights which are not exercisable prior to the Termination Date)) to become, the &#8220;beneficial owner&#8221; (as defined in Rules 13(d)-3 and 13(d)-5 under the Exchange Act), directly or indirectly, of shares of Capital Stock representing more than 50% of the total voting power of any Borrower&#59; or (ii) the occupation of a majority of the seats (other than vacant seats) of the board of directors of the Company by Persons who are neither (x) the directors of the Company on the Closing Date nor (y) nominated by the board of directors of the Company nor (z) appointed by directors so nominated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the date on which the conditions precedent set forth in Section 5.1 shall have been satisfied, which date is March 27, 2017.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Internal Revenue Code of 1986, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Co-Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the Security Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral Account Control Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; each Collateral Account Control Agreement, among a Borrower, The Bank of New York Mellon, as securities intermediary, and the Collateral Agent, in form and substance reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the Security Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Lender, the obligation of such Lender to make Loans and issue or participate in Letters of Credit during the Commitment Period in an aggregate principal and&#47;or face amount not to exceed, at any one time outstanding, the amount set forth under the heading &#8220;Commitment&#8221; opposite such Lender&#8217;s name on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or in the Assignment and Assumption pursuant to which such Lender became a party hereto, as the same may be changed from time to time pursuant to the terms hereof. The original aggregate amount of the Commitments is $200,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 2.3(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Fee Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the rate per annum set forth under the relevant column heading in Annex&#160;A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Increase Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a supplement to this Agreement substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Lender at any time, the percentage which such Lender&#8217;s Commitment then constitutes of the Total Commitments or, at any time after the Commitments shall have expired or terminated, the percentage which the aggregate principal amount of such Lender&#8217;s Loans then outstanding constitutes of the aggregate principal amount of the Loans then outstanding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that in the event that the Loans are paid in full prior to the reduction to zero of the Total Extensions of Credit, the Commitment Percentages shall be determined in a manner designed to ensure that the other outstanding Extensions of Credit shall be held by the Lenders on a comparable basis.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the period from and including the Closing Date to but excluding the Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 3.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commonly Controlled Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; an entity, whether or not incorporated, that is under common control with the Company or any Subsidiary within the meaning of Section 4001 of ERISA or is part of a group that includes the Company or any Subsidiary and that is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Sections 302 and 303 of ERISA and Sections 412 and 4971 of the Code, is treated as a single employer under Section 414(b), (c), (m) or (o) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a certificate duly executed by a Responsible Officer of the Company substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information Memorandum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Confidential Information Memorandum dated February 2017 and furnished to certain Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Connection Income Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as of the last day of any fiscal quarter (expressed as a percentage), Consolidated Total Debt, divided by the sum of (i) Consolidated Total Debt and (ii) Consolidated Tangible Net Worth.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; for any period, the consolidated net income (or loss) of the Company and its Subsidiaries, determined on a consolidated basis in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Tangible Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; of the Company at any date, the consolidated stockholders&#8217; equity (including Hybrid Capital) of the Company and its Subsidiaries less their consolidated intangible assets, all determined on a consolidated basis as of such date in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Total Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any date, the aggregate principal amount of all Indebtedness of the Company and its Subsidiaries at such date, determined on a consolidated basis in accordance with GAAP&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that there shall be excluded from Consolidated Total Debt the then aggregate undrawn face amount of all then outstanding letters of credit issued on behalf of the Company and&#47;or any of its Subsidiaries (but the aggregate amount of drawings under such letters of credit that have not then been reimbursed shall not be so excluded). For the avoidance of doubt, Consolidated Total Debt shall not include Hybrid Capital.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Contractual Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, any provision of any security issued by such Person or of any agreement, instrument or other undertaking to which such Person is a party or by which it or any of its property is bound.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.15.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Custodian</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the Security Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any of the events specified in Section&#160;8, whether or not any requirement for the giving of notice, the lapse of time, or both, has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Lender, as reasonably determined by the Administrative Agent, that has (a) failed to fund any portion of its Loans, Several Letters of Credit or participations in Fronted Letters of Credit within three Business Days of the date required to be funded by it hereunder (unless, in the case of any Loan, such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#8217;s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied), (b) notified the Borrower, the Administrative Agent, any Issuing Lender or any Lender in writing that it does not intend to comply with any of its funding obligations under this Agreement or has made a public statement to the effect that it does not intend to comply with its funding obligations under this Agreement or under other agreements generally in which it commits to extend credit (unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) failed, within three Business Days after request by the Administrative Agent, to confirm that it will comply with the terms of this Agreement relating to its obligations to fund prospective Loans, Several Letters of Credit and participations in then outstanding Fronted Letters of Credit, (d) otherwise failed to pay over to the Administrative Agent or any other Lender any other amount required to be paid by it hereunder within three Business Days of the date when due, unless the subject of a reasonable good faith dispute, (e) (i) become or is insolvent or has a parent company that has become or is insolvent or (ii) become the subject of a bankruptcy or insolvency proceeding, or (iii) has had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">business or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such a capacity or (f) become the subject of a Bail-in Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any equity interest in such Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any property, any sale, lease, sale and leaseback, assignment, conveyance, transfer or other disposition thereof. The terms &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Dispose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Disposed of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall have correlative meanings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Dollar Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time (a) as to any amount in Dollars, such amount and (b) as to any amount in Pounds Sterling, the then Dollar Equivalent thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any amount of Pounds Sterling on any date, the equivalent amount in Dollars of such amount of Pounds Sterling as determined by the Administrative Agent in accordance with Section 1.3 using the applicable Exchange Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; dollars in lawful currency of the United States.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Domestic Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Subsidiary organized under the laws of any jurisdiction within the United States.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">EEA Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) any institution established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">EEA Member Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any of the member states of the United Kingdom, European Union, Iceland, Liechtenstein and Norway.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">EEA Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as provided in the definition of the term Advance Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any and all applicable foreign, Federal, state, local or municipal laws, requirements of any Governmental Authority or other Requirements of Law (including common law) regulating, relating to or imposing liability relating to (a) pollution or protection of the environment, (b) exposure of any Person to hazardous emissions or releases of Hazardous Materials, (c) protection of the public health or welfare from the effects of products&#59; by-products, emissions or releases of Hazardous Materials and (d) regulation of the manufacture, use or introduction into commerce of Hazardous Materials.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Employee Retirement Income Security Act of 1974.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Eurodollar Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Loans that bear interest based upon the Eurodollar Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor Person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Eurodollar Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; for any Interest Period as to any Eurodollar Loan, (i) the rate per annum determined by the Administrative Agent to be the offered rate which appears on the page of the Reuters Screen which displays the London interbank offered rate administered by ICE Benchmark Administration Limited (such page currently being the LIBOR01 page) (the &#8220;LIBO Rate&#8221;) for deposits (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period in Dollars, determined as of approximately 11&#58;00 a.m. (London, England time), two Business Days prior to the commencement of such Interest Period or (ii) in the event the rate referenced in the preceding clause (i) does not appear on such page or service or if such page or service shall cease to be available, the rate determined by the Administrative Agent to be the offered rate on such other page or other service which displays an average LIBO Rate for deposits (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period in Dollars, determined as of approximately 11&#58;00 a.m. (London, England time) two Business Days prior to the commencement of such Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if LIBO Rates are quoted under either of the preceding clauses (i) or (ii), but there is no such quotation for the Interest Period elected, the LIBO Rate shall be equal to the Interpolated Rate&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if any such rate determined pursuant to the preceding clauses (i) or (ii) is below zero, the Eurodollar Rate shall be deemed to be zero.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Eurodollar Tranche</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to Eurodollar Loans the then current Interest Periods with respect to all of which begin on the same date and end on the same later date (whether or not such Loans shall originally have been made on the same day).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any of the events specified in Section 8&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any requirement for the giving of notice, the lapse of time, or both, has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; on any day, with respect to Pounds Sterling, the rate at which such currency may be exchanged into Dollars, as set forth at approximately 11&#58;00 A.M., New York time, on such date on the Reuters World Currency Page for Pounds Sterling. In the event that such rate does not appear on any Reuters World Currency Page, the Exchange Rate shall be determined by reference to such other publicly available service for displaying exchange rates as may be selected by the Administrative Agent, or, in the event no such service is selected, such Exchange Rate shall instead be the arithmetic average of the spot rates of exchange of the Administrative Agent in the market where its foreign currency exchange operations in respect of Pounds Sterling are then being conducted, at or about 10&#58;00 A.M., local time, on such date for the purchase of the relevant currency for delivery two Business Days later&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent, after consultation with the Company, may use any reasonable method it deems appropriate to determine such rate, and such determination shall be presumed correct absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; means, with respect to the Administrative Agent, the Collateral Agent, any Lender or any other recipient (each of the foregoing, a &#8220;Recipient&#8221;) of any payment to be made by or on account of any obligation of any Borrower hereunder (or under any other Loan Documents), (a) franchise Taxes or Taxes imposed on (or measured by) the net income of such Recipient (i) by the United States of America, or by the jurisdiction under the laws of which such Recipient is organized or in which its principal office is located or, in the case of any Lender, in which its applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">lending office is located or (ii) that are Other Connection Taxes&#59; (b) any branch profits Taxes (i) imposed on such Recipient by the United States of America or any other jurisdiction in which such Recipient is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located or (ii) that are Other Connection Taxes&#59; (c) any U.S. federal withholding Tax (with respect to payments made by any U.S. Borrower) or United Kingdom withholding tax (with respect to payments made by any Borrower organized in the United Kingdom) that is in effect and would apply to amounts payable to (i) a Lender (other than a Lender on the Closing Date) at the time such Lender becomes a party to this Agreement or (ii) any Lender at the time such Lender designates a new lending office, except to the extent, in (i) or (ii), as applicable, such Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from any Borrower with respect to withholding tax pursuant to Section 2.13(a) subject to the Borrower&#8217;s rights under Section 2.15 and Section 2.16)&#59; (d) Taxes attributable to such Recipient&#8217;s failure to comply with Section 2.13(e)&#59; and (e) any U.S. federal withholding Tax imposed under FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Amended and Restated Credit Agreement, dated as of June 12, 2013, among the Company, the Subsidiary Borrowers (as defined therein) party thereto, the several banks and other financial institutions or entities from time to time parties thereto, The Bank of New York Mellon, as collateral agent, Barclays Bank PLC, as administrative agent, and the other agents party thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Lender at any time, an amount equal to the sum of (a) the aggregate principal amount of all Loans held by such Lender then outstanding and (b) such Lender&#8217;s Commitment Percentage of the L&#47;C Obligations then outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Sections 1471 through 1474 of the Code, as of the date of this Agreement (or amended or successor version that is substantially comparable and not materially more onerous to comply with), any current or future Treasury regulations promulgated thereunder or official administrative interpretations thereof and any agreements entered into pursuant to Section 1471(b)(1) of the Code, any intergovernmental agreement entered into in connection with the implementation of such Sections of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to such intergovernmental agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; for any day, the rate per annum equal to the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New&#160;York, or, if such rate is not so published for any day that is a Business Day, the average of the quotations for the day of such transactions received by the Administrative Agent from three federal funds brokers of recognized standing selected by it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Fee Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) the last Business Day of each March, June, September and December after the Closing Date and (b) the last day of the Commitment Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Company and any Subsidiary Borrower that is not a Domestic Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Fronted L&#47;C Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Issuing Lender, the obligation of such Issuing Lender to issue Fronted Letters of Credit during the Commitment Period in an aggregate face amount not to exceed an amount to be separately agreed between such Issuing Lender and the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Fronted Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a Letter of Credit issued by an Issuing Lender in which the Lenders purchase risk participations pursuant to Section 3.4(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Funding Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the office of the Administrative Agent specified in Section 11.2 or such other office as may be specified from time to time by the Administrative Agent as its funding office by written notice to the Borrower Representative and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; generally accepted accounting principles in the United States as in effect from time to time and set forth in any rule, regulation, opinion or pronouncement of the Accounting Principles Board and the American Institute of Certified Public Accountants and any rule, regulation, opinion or pronouncement of the Financial Accounting Standards Board (or agencies with similar functions of comparable stature and authority within the U.S. accounting profession), which are applicable to the circumstances as of the date of determination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government (including any supra-national body such as the European Union or the European Central Bank), any securities exchange, any self-regulatory organization (including the National Association of Insurance Commissioners, the U.K. Financial Services Authority and the Bermuda Monetary Authority).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Group Members</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to the Company and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), means any obligation, including a reimbursement, counterindemnity or similar obligation, of the guarantor that guarantees or in effect guarantees, or which is given to induce the creation of a separate obligation by another Person (including any bank under any letter of credit) that guarantees or in effect guarantees, any Indebtedness of any other third Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in any manner, whether directly or indirectly, including any obligation of the guarantor, whether or not contingent, (i) to purchase any such Indebtedness or any property constituting direct or indirect security therefor, (ii) to advance or supply funds (1) for the purchase or payment of any such Indebtedness or (2) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor so as to enable the primary obligor to pay Indebtedness or other obligation, (iii) to purchase property, securities or services primarily for the purpose of assuring the owner of any such Indebtedness of the ability of the primary obligor to make payment of such Indebtedness or (iv) otherwise to assure or hold harmless the owner of any such Indebtedness against loss in respect thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that the term Guarantee Obligation shall not include (a) endorsements of instruments for deposit or collection in the ordinary course of business or (b) obligations of any Insurance Subsidiary under any Primary Policy, Reinsurance Agreement, Retrocession Agreement or Other Insurance Product that is entered into in the ordinary course of business. The amount of any Guarantee Obligation of any guarantor shall be deemed to be the lower of (a) an amount equal to the stated or determinable amount of the Indebtedness in respect of which such Guarantee Obligation is made as such amount may be reduced from time to time and (b) the maximum amount for which such guarantor may be liable pursuant to the terms of the instrument embodying such Guarantee Obligation, as such amount may be reduced from time to time unless such Indebtedness and the maximum amount for which such guarantor may be liable are not stated or determinable, in which case the amount of such Guarantee Obligation shall be such guarantor&#8217;s maximum reasonably anticipated liability in respect thereof as determined by the Company in good faith. The term &#8220;Guarantee&#8221; as a verb has a corresponding meaning.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any substance, material or waste that is classified, regulated or otherwise characterized under any Environmental Law as hazardous, toxic, a contaminant or a pollutant or by other words of similar meaning or regulatory effect, including petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls, radioactive substances, and infectious or medical wastes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Hybrid Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, all subordinated securities, instruments or other obligations issued by the Company to the extent that such securities, instruments or other obligations (i) are accorded equity treatment by S&#38;P at issuance and (ii) mature no earlier than the date which is six months after the Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ILS Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#8221; means Silverton Re Ltd. and any other entity formed or sponsored by a Group Member in connection with the establishment and&#47;or management of insurance-linked securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; of any Person at any date, without duplication, (a) all indebtedness of such Person for borrowed money, (b) all obligations of such Person for the deferred purchase price of property or services (other than current trade payables incurred in the ordinary course of such Person&#8217;s business), (c) all obligations of such Person evidenced by notes, bonds, debentures, loan agreements or other similar debt instruments, (d) all indebtedness created or arising under any conditional sale or other title retention agreement with respect to property acquired by such Person (even though the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property), (e) all Capital Lease Obligations of such Person, (f) all obligations of such Person, contingent or otherwise, as an account party or applicant under or in respect of acceptances, letters of credit, surety bonds or similar arrangements, (g) the liquidation value of all mandatorily redeemable preferred Capital Stock of such Person, (h) net obligations of such Person under any Swap Contract, (i) any other instruments or obligations of such Person to the extent that such instruments or obligations are then classified as indebtedness by S&#38;P, (j) all Guarantee Obligations of such Person in respect of obligations of the kind referred to in clauses (a) through (i) above, (k) all obligations of the kind referred to in clauses (a) through (j) above secured by any Lien on property (including accounts and contract rights) owned by such Person, whether or not such Person has assumed or become liable for the payment of such obligation and (l) Indebtedness of any partnership in which such Person is a general partner to the extent that applicable law requires that such Person is liable for such Indebtedness unless the terms of such Indebtedness expressly provide that such Person is not so liable. The amount of any net obligation under any Swap Contract on any date shall be deemed to be the Swap Termination Value as of such date. For the avoidance of doubt, Indebtedness shall not include the obligations of any Insurance Subsidiary under any Primary Policy, Reinsurance Agreement, Retrocession Agreement or Other Insurance Product which is entered into in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Insolvency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any Multiemployer Plan, the condition that such Plan is insolvent within the meaning of Section 4245 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Insolvent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; pertaining to a condition of Insolvency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a Subsidiary of the Company engaged in the insurance and&#47;or reinsurance underwriting business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) as to any ABR Loan, the last Business Day of each March, June, September and December to occur while such Loan is outstanding and the Termination Date, (b) as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to any Eurodollar Loan having an Interest Period of three months or less, the last day of such Interest Period, (c) as to any Eurodollar Loan having an Interest Period longer than three months, each day that is three months, or a whole multiple thereof, after the first day of such Interest Period and the last day of such Interest Period and (d) as to any Loan (other than any Loan that is an ABR Loan), the date of any repayment or prepayment made in respect thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Eurodollar Loan, (a) initially, the period commencing on the borrowing or conversion date, as the case may be, with respect to such Eurodollar Loan and ending one, two, three or six months thereafter, as selected by the Borrower Representative in its notice of borrowing or notice of conversion, as the case may be, given with respect thereto&#59; and (b) thereafter, each period commencing on the last day of the next preceding Interest Period applicable to such Eurodollar Loan and ending one, two, three or six months thereafter, as selected by the Borrower Representative by irrevocable notice to the Administrative Agent not later than 11&#58;00 A.M., New York City time, on the date that is three Business Days prior to the last day of the then current Interest Period with respect thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, all of the foregoing provisions relating to Interest Periods are subject to the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;if any Interest Period would otherwise end on a day that is not a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless the result of such extension would be to carry such Interest Period into another calendar month in which event such Interest Period shall end on the immediately preceding Business Day&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the Borrower Representative may not select an Interest Period that would extend beyond the Termination Date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;any Interest Period that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of a calendar month.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Interpolated Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; in relation to the LIBO Rate, the rate which results from interpolating on a linear basis between&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the applicable LIBO Rate for the longest period (for which that LIBO Rate is available) which is less than the Interest Period of that Loan&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the applicable LIBO Rate for the shortest period (for which that LIBO Rate is available) which exceeds the Interest Period of that Loan,</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">each as of approximately 11&#58;00 a.m. (London, England time) two Business Days prior to the commencement of such Interest Period of that Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Issuing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Lender (or any Affiliate thereof) that becomes an Issuing Lender pursuant to Section 3.10, with respect to Letters of Credit issued by it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Barclays Bank PLC, as letter of credit administrator for the Lenders, together with any replacement L&#47;C Administrator arising under Section 9.9(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) with respect to a Fronted Letter of Credit, the Issuing Lender and (b) with respect to a Several Letter of Credit, each Lender.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, an amount equal to the sum of (a) the then aggregate Secured L&#47;C Obligations of all Borrowers and (b) the then aggregate Unsecured L&#47;C Obligations of all Borrowers. For purposes of determining the L&#47;C Obligations held by any Lender, a Lender shall be deemed to hold an amount equal to the sum of (i) the aggregate amount of such Lender&#8217;s direct obligation in all outstanding Several Letters of Credit and all Reimbursement Obligations owed to such Lender in respect thereof, (ii) such Lender&#8217;s risk participation in all outstanding Fronted Letters of Credit and in all Reimbursement Obligations with respect thereto and (iii) such Lender&#8217;s risk participation in all outstanding Several Letters of Credit, if any, with respect to which another Lender has acted as Limited Fronting Lender on such Lender&#8217;s behalf pursuant to a Limited Fronting Lender Agreement in accordance with Section 3.8(c) and in all Reimbursement Obligations with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to all the Lenders other than the applicable Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 3.1(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any mortgage, pledge, hypothecation, assignment, encumbrance, lien (statutory or other), charge or other security interest or any other security agreement (including the interest of a vendor or lessor in any conditional sale or other title retention agreement and any capital lease having substantially the same economic effect as any of the foregoing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limited Fronting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as provided in Section 3.8(c), any Lender which is a NAIC Approved Bank that agrees that it shall be an issuer with respect to any Non-NAIC Approved Bank&#8217;s Commitment Percentage of Several Letters of Credit outstanding and&#47;or issued during the period that such Non-NAIC Approved Bank is a Non-NAIC Approved Bank, in each case pursuant to a Limited Fronting Lender Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limited Fronting Lender Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 3.8(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any loan made by any Lender pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; this Agreement, the Security Documents, the Notes, any fee letter executed or delivered in connection herewith or therewith, any other document or instrument signed by any Borrower that expressly provides that it is a Loan Document as defined herein and any amendment, waiver, supplement or other modification to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any event, development or circumstance that has had or would reasonably be expected to have a material adverse effect on (a) the business, assets, liabilities, property or condition (financial or otherwise) of the Company and its Subsidiaries taken as a whole or (b) the validity or enforceability of this Agreement or any of the other Loan Documents or the rights or remedies of the Administrative Agent or the Lenders hereunder or thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Material Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, (i) any Subsidiary (x) the total consolidated assets or total consolidated revenues of which exceed 10% of the total consolidated assets or total consolidated revenues, respectively, of the Company and its Subsidiaries on a consolidated basis at the end of or for, respectively, the then most recently completed fiscal quarter of the Company for which financial statements shall have been made available to the Lenders as described in Section 4.1 or pursuant to Section 6.1 and&#47;or (y) the net assets of which exceed $100,000,000 at the end of the then most recently </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">completed fiscal quarter of the Company for which financial statements shall have been made available to the Lenders as described in Section 4.1 or pursuant to Section 6.1, (ii) Aspen Specialty Insurance Company, (iii) Aspen U.S. Holdings, Inc. and (iv) Aspen Underwriting Limited.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Moody&#8217;s Investors Service, Inc. and its successors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a Plan that is a multiemployer plan as defined in Section 4001(a)(3) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">NAIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the National Association of Insurance Commissioners or any successor thereto, or in the absence of the National Association of Insurance Commissioners or such successor, any other association, agency or other organization performing advisory, coordination or other like functions among insurance departments, insurance commissioners and similar Governmental Authorities of the various states of the United States toward the promotion of uniformity in the practices of such Governmental Authorities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">NAIC Approved Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Lender that is listed on the most current &#8220;Bank List&#8221; of banks approved by the NAIC&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such Lender is a Non-U.S. Lender, such Lender is acting through the United States branch of such Lender listed on such &#8220;Bank List&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Net Cash Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; in connection with any issuance or sale of Capital Stock by the Company, the cash proceeds received from such issuance or sale, net of attorneys&#8217; fees and disbursements, investment banking fees and disbursements, accountants&#8217; fees and disbursements, underwriting fees, discounts and commissions, printing expenses, any governmental or exchange fees incurred (or reasonably expected to be incurred) and other customary fees and expenses actually incurred in connection therewith&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that Net Cash Proceeds shall not include the proceeds of any issuance or sale of Capital Stock to the extent such proceeds are used, within twelve months of such issuance or sale, to redeem shares of Capital Stock of the Company then outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any bank, financial institution or other entity that becomes a &#8220;Lender&#8221; hereunder pursuant to Section 2.1(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">New Lender Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a supplement to this Agreement substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 2.13(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-NAIC Approved Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, any Lender that is not a NAIC Approved Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 2.13(e).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to any promissory note evidencing Loans, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the unpaid principal of and interest on (including interest accruing after the maturity of the Loans and Reimbursement Obligations and interest accruing after the filing of any petition in bankruptcy, or the commencement of any insolvency, reorganization or like proceeding, relating to any Borrower, whether or not a claim for post-filing or post-petition interest is allowed in such proceeding) the Loans and all other obligations and liabilities of any Borrower to the Administrative </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agent, the Syndication Agent and the Collateral Agent or to any Lender, whether direct or indirect, absolute or contingent, due or to become due, or now existing or hereafter incurred, which may arise under, out of, or in connection with, this Agreement (including the obligations of the Company pursuant to Section 10), any other Loan Document, the Letters of Credit or any other document made, delivered or given in connection herewith or therewith, whether on account of principal, interest, fees, reimbursement obligations, indemnities, costs, expenses or otherwise (including all reasonable fees, charges and disbursements of counsel to the Administrative Agent, the Syndication Agent, the Collateral Agent or to any Lender that are required to be paid by the Borrowers pursuant hereto).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 4.17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Other Insurance Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any specialty insurance or reinsurance product such as contingency reinsurance and structured risks.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the jurisdiction imposing such tax (other than connections arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any and all present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies arising from any payment made hereunder or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document, including any interest, additions to tax or penalties applicable thereto, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to Section 2.16).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA (or any successor).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Permitted Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any money market fund that qualifies as an investment company under the Investment Company Act of 1940 and (i) invests solely in securities issued or guaranteed as to principal and interest by the U.S. government and (ii) continues to be rated AAAm by S&#38;P and Aaa-mf by Moody's.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture, Governmental Authority or other entity of whatever nature.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at a particular time, any employee benefit plan that is subject to ERISA and in respect of which a Borrower, a Subsidiary or (with respect to an employee benefit plan subject to Title IV of ERISA) a Commonly Controlled Entity is (or, if such plan were terminated at such time, would under </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Section 4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in Section 3(5) of ERISA responsible for contributing to or under or having any liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Pounds Sterling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#163;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the lawful money of the United Kingdom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Pricing Grid</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the table set forth on Annex A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Primary Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any insurance policy issued by an Insurance Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; &#58; the rate of interest last quoted by The Wall Street Journal as the &#8220;Prime Rate&#8221; in the United States or, if The Wall Street Journal ceases to quote such rate, the highest per annum interest rate published by the Federal Reserve Board in Federal Reserve Statistical Release H.15 (519) (Selected Interest Rates) as the &#8220;bank prime loan&#8221; rate or, if such rate is no longer quoted therein, any similar rate quoted therein (as determined by the Administrative Agent) or any similar release by the Federal Reserve Board (as determined by the Administrative Agent).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Private Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; separate legislation enacted in Bermuda with the intention that such legislation applies specifically to a Borrower or a Subsidiary in whole or in part.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Projections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 4.16.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Properties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 4.15(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Process Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Regulation U</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Regulation U of the Board as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reimbursement Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the obligation of the applicable Borrower to reimburse the L&#47;C Issuers pursuant to Section 3.5 for amounts drawn under Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any agreement, contract, treaty, certificate or other arrangement whereby any Insurance Subsidiary agrees to assume from or reinsure an insurer or reinsurer for all or part of the liability of such insurer or reinsurer under a policy or policies of insurance issued by such insurer or reinsurer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reportable Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any of the events set forth in Section 4043(c) of ERISA, other than those events as to which the thirty day notice period is waived under PBGC Reg. &#167; 4043.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, the holders of more than 50% of the Total Commitments then in effect or, if the Commitments have been terminated, the Total Extensions of Credit then outstanding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Commitment of, and the Extensions of Credit held or deemed held by, any Defaulting Lender shall be excluded for purposes of making a determination of Required Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Requirement of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, the Memorandum of Association or the Certificate of Incorporation and By-laws or other organizational or governing documents of such Person, and any law, treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Responsible Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the chief executive officer, chief financial officer, chief investment officer, chief risk officer, president or treasurer of a Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 7.4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Retrocession Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any agreement, treaty, certificate or other arrangement whereby any Insurance Subsidiary cedes to another insurer all or part of such Insurance Subsidiary&#8217;s liability under a policy or policies of insurance reinsured by such Insurance Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Standard &#38; Poor&#8217;s Ratings Services and its successors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Securities and Exchange Commission, any successor thereto and any analogous Governmental Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Secured L&#47;C Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; of any Borrower at any time, an amount equal to the sum of (a) the then Dollar Amount of the aggregate then undrawn and unexpired amount of the then outstanding Secured Letters of Credit issued on behalf of such Borrower and (b) the then Dollar Amount of the aggregate amount of drawings under Secured Letters of Credit issued on behalf of such Borrower that have not then been reimbursed pursuant to Section 3.5.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Secured Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Letter of Credit designated as a &#8220;Secured Letter of Credit&#8221; by a Borrower in the Application therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Security Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Security Agreement, dated as of October 20, 2010, among the Borrowers and the Collateral Agent, as amended by the First Amendment to Security Agreement, dated as of June 12, 2013, among the Borrowers and the Collateral Agent and the Second Amendment to Security Agreement dated as of March 27, 2017 among the Borrowers and the Collateral Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Security Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (i) the Security Agreement, (ii) each Collateral Account Control Agreement, and (iii) each other document, agreement, certificate and&#47;or financing statement, executed, delivered, made or filed pursuant to the terms of the documents specified in foregoing clauses (i) and (ii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Several Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a Letter of Credit issued severally by or on behalf of the Lenders pursuant to which the Lenders are severally liable to the beneficiary which shall be substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit L</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or in such other form as may be agreed by the Company and the L&#47;C Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Single Employer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Plan that is subject to Title IV of ERISA, Section 412 of the Code or Section 302 of ERISA but that is not a Multiemployer Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Spot Selling Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; on any date, as determined by the Administrative Agent, the spot selling rate posted by Reuters on its website for the sale of the applicable currency for dollars at approximately 11&#58;00 a.m., New York City time, two Business Days prior to such date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Quotation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if, for any reason, no such spot rate is being quoted, the spot selling rate shall be determined by reference to such publicly available service for displaying exchange rates as may be reasonably selected by the Administrative Agent, or, in the event no such service is selected, such spot selling rate shall instead be the rate determined by the Administrative Agent as the spot rate of exchange in the market where its foreign currency exchange operations in respect of the applicable currency are then being conducted, at or about 11.00 a.m., New York City time, on the Applicable Quotation Date for the purchase of the relevant currency for delivery two Business Days later.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned by such Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that for purposes of this Agreement, no ILS Entity shall be considered a Subsidiary of the Company or any other Group Member. Unless otherwise qualified, all references to a &#8220;Subsidiary&#8221; or to &#8220;Subsidiaries&#8221; in this Agreement shall refer to a Subsidiary or Subsidiaries of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; each Material Subsidiary of the Company whose name is set out in the signature pages hereto and each Material Subsidiary of the Company that shall become a Borrower under this Agreement upon satisfaction of the conditions precedent set forth in Section 5.3&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if at any time the Company shall, in accordance with Section 11.1, be released from its obligations under Section 10 with respect to any Subsidiary which is, prior to such release, a Subsidiary Borrower, such Subsidiary, after such release, shall cease to be a Subsidiary Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Swap Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) any and all rate swap transactions, basis swaps, credit derivative transactions, forward rate transactions, commodity swaps, commodity options, forward commodity contracts, equity or equity index swaps or options, bond or bond price or bond index swaps or options or forward bond or forward bond price or forward bond index transactions, interest rate options, forward foreign exchange transactions, cap transactions, floor transactions, collar transactions, currency swap transactions, cross-currency rate swap transactions, currency options, spot contracts, or any other similar transactions or any combination of any of the foregoing (including any options to enter into any of the foregoing), whether or not any such transaction is governed by or subject to any master agreement, and (b) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules, a &#8220;Master Agreement&#8221;), including any such obligations or liabilities under any Master Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Swap Termination Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; in respect of any one or more Swap Contracts, after taking into account the effect of any legally enforceable netting agreement relating to such Swap Contracts, (a) for any date on or after the date such Swap Contracts have been closed out and termination value(s) determined in accordance therewith, such termination value(s), and (b) for any date prior to the date referenced in clause (a), the amount(s) determined as the mark-to-market value(s) for such Swap Contracts, as determined based upon one or more mid-market or other readily available quotations provided by any recognized dealer in such Swap Contracts (which may include a Lender or any Affiliate of a Lender).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Syndication Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; March 27, 2022.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Total Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, the aggregate amount of the Commitments then in effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Total Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, the aggregate amount of the Extensions of Credit of the Lenders outstanding at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Transferee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Assignee or Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Type</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Loan, its nature as an ABR Loan or a Eurodollar Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Unsecured L&#47;C Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; of any Borrower at any time, an amount equal to the sum of (a) the then Dollar Amount of the aggregate then undrawn and unexpired amount of the then outstanding Unsecured Letters of Credit issued on behalf of such Borrower and (b) the then Dollar Amount of the aggregate amount of drawings under Unsecured Letters of Credit issued on behalf of such Borrower that have not then been reimbursed pursuant to Section 3.5.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Unsecured Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Letter of Credit that is not a Secured Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Wholly Owned Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; of any Person, any Subsidiary of such Person to the extent all of the Capital Stock of such Subsidiary, other than directors&#8217; or nominees&#8217; qualifying shares, is owned directly or indirectly by such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any Borrower and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Other Definitional Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Unless otherwise specified therein, all terms defined in this Agreement shall have the defined meanings when used in the other Loan Documents or any certificate or other document made or delivered pursuant hereto or thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;As used herein and in the other Loan Documents, and any certificate or other document made or delivered pursuant hereto or thereto, (i) accounting terms relating to any Group Member not defined in Section 1.1 and accounting terms partly defined in Section 1.1, to the extent not defined, shall have the respective meanings given to them under GAAP (provided that all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to (A) any election under Accounting Standards Codification 825-10-25 (previously referred to as Statement of Financial Accounting Standards 159) (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of the Company or any Subsidiary at &#8220;fair value&#8221;, as defined therein, (B) any treatment of Indebtedness in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any such Indebtedness in a reduced or bifurcated manner as described therein, and such Indebtedness shall at all times be valued at the full stated principal amount thereof) and (C) any change to lease accounting rules from those in effect on the date hereof pursuant to Accounting Standards Codification 840 and other lease accounting guidance in effect on the date hereof, (ii) the words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the phrase &#8220;without limitation&#8221;, (iii) the word &#8220;incur&#8221; shall be construed to mean incur, create, issue, assume or become liable in respect of (and the words &#8220;incurred&#8221; and &#8220;incurrence&#8221; shall have correlative meanings), (iv) &#8220;consolidated&#8221; means, when used with reference to financial statements or financial statement items of a Person, such statements or items on a consolidated basis in accordance with applicable principles of consolidation under GAAP, (v) the words &#8220;asset&#8221; and &#8220;property&#8221; shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, Capital Stock, securities, revenues, accounts, leasehold interests and contract rights, (vi) references to agreements or other Contractual Obligations shall, unless otherwise specified, be deemed to refer to such agreements or Contractual Obligations as amended, supplemented, restated or otherwise modified from time to time and (vii) references to statutes or regulations shall, unless otherwise specified, be deemed to include all statutory and regulatory provisions amending, replacing, supplementing or interpreting such statutes or regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The words &#8220;hereof&#8221;, &#8220;herein&#8221; and &#8220;hereunder&#8221; and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and Section, Schedule and Exhibit references are to this Agreement unless otherwise specified.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The meanings given to terms defined herein shall be equally applicable to both the singular and plural forms of such terms.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. For purposes of calculating (a) the aggregate Dollar Equivalent of Letters of Credit denominated in Pounds Sterling and of unreimbursed drawings under Letters of Credit denominated in Pounds Sterling outstanding at any time during any period and (b) the Dollar Equivalent of any Letters of Credit denominated in Pounds Sterling at the time of the issuance of such Letter of Credit pursuant to Section 3.1, the Administrative Agent will on the first Business Day of each calendar quarter and at such other times as it in its sole discretion determines to be appropriate to do so (including on or prior to the date of any borrowing or issuance of a Letter of Credit), determine the respective rate of exchange into Dollars of Pounds Sterling (which rate of exchange shall be based upon the Exchange Rate in effect on the date of such determination). Such rates of exchange so determined on each such determination date shall, for purposes of the calculations described in the preceding sentence, be deemed to remain unchanged and in effect until the next such determination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Changes in GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If at any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in any Loan Document, and either the Company or the Required Lenders shall so request, the Administrative Agent, the Lenders and the Company shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP (subject to such approvals required under Section 11.1)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, until so amended, (a) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (b)&#160;the Company shall provide to the Administrative Agent and each Lender financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP.</font></div><div style="margin-bottom:24pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AMOUNT AND TERMS OF COMMITMENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to the terms and conditions hereof, each Lender severally agrees to make Loans to the Borrowers from time to time during the Commitment Period in an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">aggregate principal amount at any one time outstanding, when added to such Lender&#8217;s Commitment Percentage of the L&#47;C Obligations then outstanding, which does not exceed the amount of such Lender&#8217;s Commitment. During the Commitment Period, the Borrowers may use the Commitments by borrowing, prepaying the Loans in whole or in part and reborrowing, all in accordance with the terms and conditions hereof. The Loans may from time to time be Eurodollar Loans or ABR Loans, as determined by the Borrowers and notified to the Administrative Agent in accordance with Sections 2.2 and 2.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;From time to time during the Commitment Period, upon written notice by the Borrower Representative to the Administrative Agent, with the prior written consents of the Administrative Agent (which consent shall be in its sole discretion and shall not be unreasonably withheld or delayed) and the then Issuing Lenders (which consents shall not be unreasonably withheld or delayed), (i) any one or more existing Lenders may agree that such existing Lender or Lenders shall increase the amount of their Commitment or Commitments by executing and delivering to the Borrower Representative and the Administrative Agent a Commitment Increase Supplement or Commitment Increase Supplements, as the case may be, and&#47;or (ii) any one or more New Lenders may from time to time during the Commitment Period agree that such New Lender or New Lenders shall establish a new Commitment or Commitments by executing and delivering to the Borrower Representative and the Administrative Agent a New Lender Supplement or New Lender Supplements, as the case may be, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that each New Lender shall (A) be a NAIC Approved Bank or (B) shall have in effect a Limited Fronting Lender Agreement with a Lender which is a NAIC Approved Bank. From and after the effective date specified in each New Lender Supplement, the New Lender thereunder shall become a Lender with a Commitment in the amount set forth in such New Lender Supplement and shall have the rights and obligations of a Lender under this Agreement for all purposes and to the same extent as if originally a party hereto. Each New Lender shall deliver to the Administrative Agent an administrative questionnaire. Notwithstanding anything contained in this paragraph to the contrary, without the consent of (x) the Required Lenders, the aggregate amount of incremental Commitments established or increased after the Closing Date pursuant to this paragraph shall not exceed $100,000,000 and (y) the Administrative Agent, each increase in the Total Commitments effected pursuant to this paragraph shall be in a minimum aggregate amount of $10,000,000. No existing Lender shall have any obligation under this Agreement to enter into a Commitment Increase Supplement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Upon its receipt of (i) a duly executed Commitment Increase Supplement or a New Lender Supplement, (ii) a certificate of each Borrower attaching the resolutions of the board of directors of such Borrower authorizing the increase in the Commitments in an amount equal to or greater than the amount of such increase in the Commitments effected thereby (except to the extent resolutions authorizing the increased amount have previously been delivered by such Borrower), and (iii) each written consent thereto required by paragraph (b) of this Section, the Administrative Agent shall accept such Commitment Increase or New Lender Supplement, as the case may be, and record the information contained therein in the Register.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless otherwise agreed to by the Administrative Agent and the Company (which agreement may include (i) a phase-in of the applicable increase and&#47;or (ii) if agreed to by each Lender, Interest Periods having terms other than as set forth herein ), on each date upon which the Total Commitments shall be increased pursuant to this Section, to the extent necessary to rebalance the outstanding Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> among the Lenders (including any New Lenders) pursuant to their modified Aggregate Exposure Percentages, the Borrowers (i) shall prepay outstanding Loans, if any, which prepayment shall be accompanied by payment of all accrued interest on the amount prepaid and any amounts payable pursuant to Section 2.14 in connection therewith, and (ii) to the extent they determine to do so, reborrow such Loans from the Lenders (including any New Lenders) after giving effect to the new </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and&#47;or increased Commitments becoming effective on such date, in the case of each of clauses (i) and (ii) above such that, after giving effect thereto, the Loans (including the Types thereof and Interest Periods with respect thereto) shall be held by the Lenders (including for such purposes the New Lenders) pro rata according to their respective Aggregate Exposure Percentages. Any prepayment and reborrowing pursuant to the preceding sentence shall be effected, to the maximum extent practicable, through the netting of amounts payable between the Borrowers and the respective Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On the Termination Date, each Borrower shall repay all then outstanding Loans made by the Lenders to such Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Procedure for Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Borrower may borrow during the Commitment Period on any Business Day, provided that the Borrower Representative shall give the Administrative Agent irrevocable notice (which notice must be received by the Administrative Agent prior to 11&#58;00 A.M., New York City time, (a) three Business Days prior to the requested Borrowing Date, in the case of Eurodollar Loans, or (b) on the requested Borrowing Date, in the case of ABR Loans) substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, specifying (i) the amount and Type of Loans to be borrowed, (ii) the requested Borrowing Date, (iii) in the case of Eurodollar Loans, the respective length of the initial Interest Period therefor and (iv) the name of the applicable Borrower. Any Loans made on the Closing Date shall initially be ABR Loans. Each borrowing shall be in an amount equal to (x) in the case of ABR Loans, $5,000,000 or a whole multiple of $1,000,000 in excess thereof (or, if the then aggregate Available Commitments are less than $5,000,000, such lesser amount) and (y) in the case of Eurodollar Loans, $5,000,000 or a whole multiple of $1,000,000 in excess thereof. Upon receipt of any such notice from the Borrower Representative, the Administrative Agent shall promptly notify each Lender thereof. Each Lender will make the amount of its pro rata share of each borrowing available to the Administrative Agent for the account of the applicable Borrower at the Funding Office prior to 2&#58;00 P.M., New York City time, on the Borrowing Date requested by the Borrower Representative in funds immediately available to the Administrative Agent. Such borrowing will then be made available to the Borrower Representative by the Administrative Agent crediting the account of the Borrower Representative on the books of such office with the aggregate of the amounts made available to the Administrative Agent by the Lenders and in like funds as received by the Administrative Agent. Each Lender may, at its option, make any Loan available to any Foreign Borrower by causing any foreign or domestic branch or Affiliate of such Lender to make such Loan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any exercise of such option shall not affect the obligation of such Foreign Borrower to repay such Loan in accordance with the terms of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company agrees to pay to the Administrative Agent for the account of each Lender which has a then effective Commitment a commitment fee (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) for the period from and including the date hereof to the last day upon which such Lender&#8217;s Commitment shall have terminated, computed at the Commitment Fee Rate on the average daily amount of the Available Commitment of such Lender during the period for which payment is made, payable quarterly in arrears on each Fee Payment Date, commencing on the first such date to occur after the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company agrees to pay to the Administrative Agent and the Syndication Agent the fees in the amounts and on the dates as set forth in any fee agreements with the Administrative Agent and&#47;or the Syndication Agent and to perform any other obligations contained therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company agrees to pay or reimburse the Collateral Agent for such normal and customary costs and expenses as are incurred or charged by the Collateral Agent in maintaining and administering the Collateral and otherwise performing its obligations under the Loan Documents.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination or Reduction of Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Borrower Representative shall have the right, upon not less than five Business Days&#8217; notice to the Administrative Agent, to terminate the Commitments or, from time to time, to reduce the amount of the Commitments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no such termination or reduction of Commitments shall be permitted if, after giving effect thereto and to any prepayments of the Loans made on the effective date thereof, the Total Extensions of Credit would exceed the Total Commitments. Any such reduction shall be in an amount equal to $5,000,000, or a whole multiple thereof, and shall reduce permanently the Commitments then in effect (it being understood that any partial reduction of the Commitments shall not affect the Borrower Representative&#8217;s ability to exercise the unutilized portion of the increase option set forth in Section 2.1(b)).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Optional and Mandatory Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Borrower may at any time and from time to time prepay the Loans made by the Lenders to such Borrower, in whole or in part, without premium or penalty, upon irrevocable notice substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> delivered by the Borrower Representative to the Administrative Agent no later than 11&#58;00 A.M., New York City time, three Business Days prior thereto, in the case of Eurodollar Loans, and no later than 11&#58;00 A.M., New York City time, on the requested prepayment date, in the case of ABR Loans, which notice shall specify the date and amount of prepayment, the name of the applicable Borrower and whether the prepayment is of Eurodollar Loans or ABR Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if a Eurodollar Loan is prepaid on any day other than the last day of the Interest Period applicable thereto, such Borrower shall also pay any amounts owing pursuant to Section 2.14. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. If any such notice is given, the amount specified in such notice shall be due and payable on the date specified therein, together with (except in the case of Loans that are ABR Loans) accrued interest to such date on the amount prepaid. Partial prepayments of ABR Loans and Eurodollar Loans for all Borrowers shall be in an aggregate principal amount of $5,000,000 or a whole multiple of $1,000,000 in excess thereof (or, in the case of ABR Loans, the entire principal amount thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If, on any date, the aggregate Secured L&#47;C Obligations of any Borrower exceed the Borrowing Base of such Borrower on such date, such Borrower (or the Borrower Representative) shall within five Business Days of such date pay or deliver to the Custodian, to be held in accordance with the Security Agreement and the applicable Collateral Account Control Agreement, an amount of cash and&#47;or Eligible Securities sufficient to cause the Borrowing Base of such Borrower to be at least equal to the aggregate Secured L&#47;C Obligations of such Borrower. If such payment or delivery is not made, the applicable Borrower shall pay the fee applicable to Unsecured Letters of Credit, rather than the fee applicable to Secured Letters of Credit, pursuant to Section 3.3(a) with respect to the portion of such Secured L&#47;C Obligations that is more than the Borrowing Base until such time as the Borrowing Base of such Borrower is at least equal to the aggregate Secured L&#47;C Obligations of such Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if a portion, but not all, of the Secured L&#47;C Obligations with respect to a Secured Letter of Credit would be subject to the fee applicable to Unsecured Letters of Credit pursuant to the preceding clause of this sentence, such Secured Letter of Credit will be subject to the fee applicable to Unsecured Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If, on any date, the Total Extensions of Credit outstanding on such date exceed 102% of the Total Commitments in effect on such date, the Borrowers shall, upon demand by the Administrative Agent, promptly (but in any event, within three Business Days of the date of the Company&#8217;s receipt of such demand from the Administrative Agent) prepay any then outstanding Loans and&#47;or cash collateralize to the satisfaction of the Administrative Agent any then outstanding Letters of Credit in an aggregate principal and&#47;or face amount such that, after giving effect thereto and treating such cash collateralized Letters of Credit as being not then outstanding, the Total Extensions of Credit do not exceed the Total Commitments. Any prepayment of a Eurodollar Loan pursuant to this Section 2.5(c) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall be accompanied by interest accrued and unpaid to the date of such prepayment on the principal so prepaid and, if such prepayment is made on a day other than the last day of an Interest Period applicable to such Eurodollar Loan, the applicable Borrower shall also pay any amounts owing pursuant to Section 2.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion and Continuation Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower Representative may elect from time to time to convert Eurodollar Loans to ABR Loans by giving the Administrative Agent prior irrevocable notice of such election substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> no later than 10&#58;00 A.M., New York City time three Business Days prior to the proposed conversion date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such conversion of Eurodollar Loans may only be made on the last day of an Interest Period with respect thereto. The Borrower Representative may elect from time to time to convert ABR Loans to Eurodollar Loans by giving the Administrative Agent prior irrevocable notice of such election no later than 11&#58;00 A.M., New York City time, on the third Business Day preceding the proposed conversion date (which notice shall specify the length of the initial Interest Period therefor)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no ABR Loan may be converted into a Eurodollar Loan when any Event of Default or Default has occurred and is continuing and the Administrative Agent or the Required Lenders have determined in its or their sole discretion not to permit such conversions. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any Eurodollar Loan may be continued as such upon the expiration of the then current Interest Period with respect thereto by the Borrower Representative giving irrevocable notice to the Administrative Agent, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereto in accordance with the applicable provisions of the term &#8220;Interest Period&#8221; set forth in Section 1.1, of the length of the next Interest Period to be applicable to such Loan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no Eurodollar Loan may be continued as such when any Event of Default or Default has occurred and is continuing and the Administrative Agent has or the Required Lenders have determined in its or their sole discretion not to permit such continuations, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if the Borrower Representative shall fail to give any required notice as described above in this Section 2.6 or if such continuation is not permitted pursuant to the preceding proviso, such Loan shall be automatically converted to an ABR Loan on the last day of such then expiring Interest Period. Upon receipt of any such notice, the Administrative Agent shall promptly notify each relevant Lender thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations on Eurodollar Tranches</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in this Agreement, all borrowings, conversions and continuations of Eurodollar Loans and all selections of Interest Periods shall be in such amounts and be made pursuant to such elections so that, (a) after giving effect thereto, the aggregate principal amount of the Eurodollar Loans comprising each Eurodollar Tranche shall be equal to $5,000,000 or a whole multiple of $1,000,000 in excess thereof and (b) no more than twenty Eurodollar Tranches shall be outstanding at any one time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rates and Payment Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#160;&#160;&#160;&#160; Each Eurodollar Loan shall bear interest for each day during each Interest Period with respect thereto at a rate per annum equal to the Eurodollar Rate determined for such day plus the Applicable Margin.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each ABR Loan shall bear interest at a rate per annum equal to the ABR plus the Applicable Margin.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;(i) If an Event of Default under Section 8(a) or Section 8(f) shall have occurred and be continuing or upon the request of the Required Lenders if any other Event of Default shall have occurred and be continuing, the principal amount of all Loans shall bear interest at a rate per annum equal to the rate that would otherwise be applicable thereto pursuant to the foregoing provisions of this Section </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% and (ii) if all or a portion of any interest payable on any Loan or any Commitment Fee or other amount payable hereunder shall not be paid when due (whether at the stated maturity, by acceleration or otherwise), such overdue amount shall bear interest at a rate per annum equal to the rate then applicable to ABR Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, in each case as described in this clause (ii), from the date of such non-payment until such amount is paid in full (as well after as before judgment).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest shall be payable in arrears on each Interest Payment Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that interest accruing pursuant to paragraph (c)(ii) of this Section shall be payable from time to time on demand.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Computation of Interest and Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Interest and fees payable pursuant hereto shall be calculated on the basis of a 360-day year for the actual days elapsed, except that, with respect to ABR Loans the rate of interest on which is calculated on the basis of the Prime Rate, the interest thereon shall be calculated on the basis of a 365- (or 366, as the case may be) day year for the actual days elapsed. The Administrative Agent shall as soon as practicable notify the Company and the relevant Lenders of each determination of a Eurodollar Rate. Any change in the interest rate on a Loan resulting from a change in the ABR or the Eurodollar Rate (pursuant to Section 2.12) shall become effective as of the opening of business on the day on which such change becomes effective. The Administrative Agent shall as soon as practicable notify the Company and the relevant Lenders of the effective date and the amount of each such change in interest rate. Each determination of an interest rate by the Administrative Agent pursuant to any provision of this Agreement shall be conclusive and binding on each Borrower and the Lenders in the absence of manifest error. The Administrative Agent shall deliver to the Company a statement showing the quotations used by the Administrative Agent in determining any interest rate pursuant to Section 2.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Inability to Determine Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If prior to the first day of any Interest Period&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Administrative Agent shall have determined (which determination shall be conclusive and binding upon each Borrower absent manifest error) that, by reason of circumstances affecting the relevant market, adequate and reasonable means do not exist for ascertaining the Eurodollar Rate for such Interest Period, or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Administrative Agent shall have received notice from the Required Lenders that the Eurodollar Rate determined or to be determined for such Interest Period will not adequately and fairly reflect the cost to such Lenders (as conclusively certified by such Lenders) of making or maintaining their affected Loans during such Interest Period,</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Administrative Agent shall give electronic or telephonic notice thereof to the Company and the relevant Lenders as soon as practicable thereafter. Upon receipt of such notice, the Borrower Representative may revoke any notice of borrowing, conversion or continuation then submitted by it. If the Borrower Representative does not revoke such notice, then (x) any Eurodollar Loans requested to be made on the first day of such Interest Period shall be made as ABR Loans, (y)&#160;any Loans that were to have been converted on the first day of such Interest Period to Eurodollar Loans shall be continued as ABR Loans and (z) any outstanding Eurodollar Loans shall be converted, on the last day of the then-current Interest Period, to ABR Loans. Until such notice has been withdrawn by the Administrative Agent, no further Eurodollar Loans shall be made or continued as such, nor shall the Borrower Representative have the right to convert ABR Loans to Eurodollar Loans.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Pro Rata Treatment and Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#160;&#160;&#160;&#160; Each borrowing by any Borrower from the Lenders hereunder and any reduction of the Commitments of the Lenders shall be made pro rata according to the Lenders&#8217; respective Commitments, and each payment by any Borrower on account of any Commitment Fee shall be distributed by the Administrative Agent pro rata to each Lender according to the respective amounts thereof owing pursuant to Section 2.3(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each payment (including each prepayment) by any Borrower on account of principal of and interest on the Loans made to it shall be made </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> according to the respective outstanding principal amounts of such Loans then held by the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;All payments (including prepayments) to be made by any Borrower hereunder, whether on account of principal, interest, fees or otherwise, shall be made without setoff or counterclaim and shall be made prior to 12&#58;00 Noon, New York City time, on the due date thereof to the Administrative Agent, for the account of the Lenders, at the Funding Office, in the currency required hereunder and in immediately available funds. The Administrative Agent shall distribute such payments to the Lenders promptly upon receipt in like funds as received. If any payment hereunder (other than payments on the Eurodollar Loans) becomes due and payable on a day other than a Business Day, such payment shall be extended to the next succeeding Business Day. If any payment on a Eurodollar Loan becomes due and payable on a day other than a Business Day, the maturity thereof shall be extended to the next succeeding Business Day unless the result of such extension would be to extend such payment into another calendar month, in which event such payment shall be made on the immediately preceding Business Day. In the case of any extension of any payment of principal pursuant to the preceding two sentences, interest thereon shall be payable at the then applicable rate during such extension.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless the Administrative Agent shall have been notified in writing by any Lender prior to a borrowing that such Lender will not make the amount that would constitute its share of such borrowing available to the Administrative Agent, the Administrative Agent may assume that such Lender is making such amount available to the Administrative Agent, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrowers a corresponding amount. If such amount is not made available to the Administrative Agent by the required time on the Borrowing Date therefor, such Lender shall pay to the Administrative Agent, on demand, such amount with interest thereon, at a rate equal to the greater of (i) the Federal Funds Effective Rate and (ii) a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation, for the period until such Lender makes such amount immediately available to the Administrative Agent. A certificate of the Administrative Agent submitted to any Lender with respect to any amounts owing under this paragraph shall be conclusive in the absence of manifest error. If such Lender&#8217;s share of such borrowing is not made available to the Administrative Agent by such Lender within three Business Days after such Borrowing Date, the Administrative Agent shall also be entitled to recover such amount with interest thereon at the rate per annum applicable to ABR Loans, on demand, from the Borrowers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless the Administrative Agent shall have been notified in writing by the Borrower Representative prior to the date of any payment due to be made by any Borrower hereunder that such Borrower will not make such payment to the Administrative Agent, the Administrative Agent may assume that such Borrower is making such payment, and the Administrative Agent may, but shall not be required to, in reliance upon such assumption, make available to the Lenders their respective </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shares of a corresponding amount. If such payment is not made to the Administrative Agent by such Borrower within three Business Days after such due date, the Administrative Agent shall be entitled to recover, on demand, from each Lender to which any amount which was made available pursuant to the preceding sentence, such amount with interest thereon at the rate per annum equal to the daily average </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Federal Funds Effective Rate. Nothing herein shall be deemed to limit the rights of the Administrative Agent or any Lender against such Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Requirements of Law&#59; Eurocurrency Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If the adoption of or any change in any Requirement of Law or in the interpretation or application thereof or compliance by any Lender with any request or directive (whether or not having the force of law) from any central bank or other Governmental Authority, in each case made subsequent to the date hereof&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall subject any Lender, any Issuing Lender or the Administrative Agent to any tax of any kind whatsoever with respect to this Agreement, any Letter of Credit, any Application or any Eurodollar Loan made by it, or change the basis of taxation of payments to such Lender or Issuing Lender in respect thereof (except for (i) taxes described in clauses (c) through (e) of the definition of Excluded Taxes, (ii) Non-Excluded Taxes and (iii) Connection Income Taxes)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall impose, modify or hold applicable any reserve, special deposit, compulsory loan or similar requirement against assets held by, deposits or other liabilities in or for the account of, advances, loans or other extensions of credit by, or any other acquisition of funds by, any office of such Lender that is not otherwise included in the determination of the Eurodollar Rate&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall impose on such Lender or the London interbank market any other condition affecting this Agreement or such Lender&#8217;s Loan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and the result of any of the foregoing is to increase the cost to such Lender (or, in the case of clause (i) above, to such Lender, Issuing Lender or the Administrative Agent), by an amount that such Lender (or, in the case of clause (i) above, such Lender, Issuing Lender or the Administrative Agent) deems to be material, of making, converting into, continuing or maintaining Eurodollar Loans (or of its obligation to make any such Eurodollar Loan or to participate in any Letter of Credit), or to reduce any amount receivable hereunder in respect thereof, then, in any such case, the Borrower to which such Loans were made shall pay such Lender (or, in the case of clause (i) above, such Lender, Issuing Lender or the Administrative Agent) any additional amounts necessary to compensate such Lender (or, in the case of clause (i) above, such Lender, Issuing Lender or the Administrative Agent) for such increased cost or reduced amount receivable. If any Lender, any Issuing Lender or the Administrative Agent becomes entitled to claim any additional amounts pursuant to this paragraph, it shall promptly notify the Company (with a copy to the Administrative Agent) of the event by reason of which it has become so entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If any Lender shall have determined that the adoption of or any change in any Requirement of Law regarding capital adequacy or liquidity requirements or in the interpretation or application thereof or compliance by such Lender or any corporation controlling such Lender with any request or directive regarding capital adequacy or liquidity requirements (whether or not having the force of law) from any Governmental Authority, in each case made subsequent to the date hereof shall have the effect of reducing the rate of return on such Lender&#8217;s or such corporation&#8217;s capital as a consequence of its obligations hereunder or under or in respect of any Letter of Credit to a level below that which such Lender or such corporation could have achieved but for such adoption, change or compliance (taking into consideration such Lender&#8217;s or such corporation&#8217;s policies with respect to capital adequacy or liquidity requirements) by an amount deemed by such Lender to be material, then from time to time, after submission by such Lender to the Company (with a copy to the Administrative Agent) of a written request therefor, the Company shall pay to such Lender such additional amount or amounts as will compensate such Lender or such corporation for such reduction.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything herein to the contrary, (i) all requests, rules, guidelines, requirements and directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or by United States or foreign regulatory authorities, in each case pursuant to Basel III, and (ii) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines, requirements and directives thereunder or issued in connection therewith or in implementation thereof, shall in each case be deemed to be a change in law, regardless of the date enacted, adopted, issued or implemented.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company agrees to pay to each Lender, for any period that such Lender is required by applicable law, rule or regulation, or any guideline, request or directive of any Governmental Authority (whether or not having the force of law), to maintain reserves with respect to liabilities or assets consisting of or including Eurocurrency funds or deposits (currently known as &#8220;Eurocurrency liabilities&#8221;), additional interest on the unpaid principal amount of each Eurodollar Loan (and, for any period during which ABR is determined by reference to the Eurodollar Rate, each ABR Loan) equal to the costs of such reserves allocated to such Loan by such Lender (as determined by such Lender in good faith, which determination shall be conclusive absent manifest error), which shall be due and payable on each date on which interest is payable on such Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A certificate setting forth in reasonable detail a calculation of the amount of and the basis for any additional amount payable pursuant to this Section submitted by any Lender to the Company (with a copy to the Administrative Agent) shall be conclusive in the absence of manifest error. The Borrower shall pay such Lender the amount shown as due on such certificate within 10 Business Days after receipt by the Borrower. Notwithstanding anything to the contrary in this Section, the Company shall not be required to compensate a Lender pursuant to clause (a) or (b) of this Section for any amounts incurred more than six months prior to the date that such Lender notifies the Company of such Lender&#8217;s intention to claim compensation therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if the circumstances giving rise to such claim have a retroactive effect, then such six-month period shall be extended to include the period of such retroactive effect. The obligations of the Company pursuant to this Section shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. All payments made by (or on behalf of) any Borrower under this Agreement or any other Loan Document shall be made free and clear of, and without deduction or withholding for or on account of, any present or future income, stamp or other taxes, levies, imposts, duties, charges, fees, deductions or withholdings, now or hereafter imposed, levied, collected, withheld or assessed by any Governmental Authority, excluding Excluded Taxes. If any such non-excluded taxes, levies, imposts, duties, charges, fees, deductions or withholdings imposed on such payments (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or Other Taxes are required to be deducted or withheld from any amounts payable to the Administrative Agent or any Lender hereunder or under any other Loan Document, (i) the amounts so payable by the applicable Borrower to the Administrative Agent or such Lender shall be increased to the extent necessary to yield to the Administrative Agent or such Lender (after payment of all Non-Excluded Taxes and Other Taxes) interest or any such other amounts payable hereunder or under any other Loan Document at the rates or in the amounts specified in this Agreement or in the applicable Loan Document as if such withholding or deduction had not been made, (ii) the Borrower or applicable Withholding Agent shall deduct or withhold such amounts and (iii) the Borrower or applicable Withholding Agent shall pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that no Borrower shall be required to increase any such amounts </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">payable to any Lender with respect to any Non-Excluded Taxes that are attributable to such Lender&#8217;s failure to comply with the requirements of paragraph (e) of this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, each Borrower shall pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law or, at the option of the Administrative Agent, timely reimburse it for the payment of such Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Borrower shall indemnify the Administrative Agent and each Lender, within 10 Business Days after written demand therefor, for the full amount of any Non-Excluded Taxes or Other Taxes paid by the Administrative Agent or such Lender, as the case may be, on or with respect to any payment by or on account of any obligation of such Borrower hereunder or under any other Loan Document (including Non-Excluded Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this Section 2.13) and any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Non-Excluded Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to such Borrower by a Lender (with a copy to the Administrative Agent) or by the Administrative Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Whenever any Non-Excluded Taxes or Other Taxes are payable by a Borrower, as promptly as possible thereafter such Borrower shall send to the Administrative Agent for its own account or for the account of the relevant Lender, as the case may be, a certified copy of an original official receipt received by such Borrower showing payment thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A Lender that is entitled to an exemption from or reduction of withholding tax under the law of the jurisdiction in which a Borrower is located, or any treaty to which such jurisdiction is a party, with respect to payments under this Agreement shall deliver to such Borrower (with a copy to the Administrative Agent), at the time or times prescribed by applicable law or reasonably requested by such Borrower or the Administrative Agent, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without withholding or at a reduced rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Lender is legally entitled to complete, execute and deliver such documentation and in such Lender&#8217;s judgment such completion, execution or submission would not materially prejudice the legal or commercial position of such Lender. In addition, any Lender, if reasonably requested by a Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by such Borrower or the Administrative Agent as will enable such Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements and to allow such Borrower and the Administrative Agent to comply with any information reporting requirements to which they are subject&#59; provided that such Lender is legally entitled to complete, execute and deliver such documentation and in such Lender&#8217;s judgment such completion, execution or submission would not materially prejudice the legal or commercial position of such Lender. Each Lender that is a United States person, as defined in section 7701(a)(30) of the Code (a &#8220;United States Person&#8221;), shall deliver to the Company and the Administrative Agent on or before the date on which it becomes a party to this Agreement two properly completed and duly signed copies of U.S. Internal Revenue Service Form W-9 (or any successor form) certifying that such Lender is exempt from U.S. federal withholding tax. To the extent the Borrower is a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">United States Person (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">U.S. Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), each Lender (or Transferee) that is not a United States Person (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">U.S. Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) shall deliver to such U.S. Borrower and the Administrative Agent (or, in the case of a Participant, to the Lender from which the related participation shall have been purchased) (i) two copies of U.S. Internal Revenue Service Form W-8BEN or W-8BEN-E, Form W-8ECI or Form W-8IMY, or, (ii) in the case of a Non</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. Lender </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">claiming exemption from U.S. federal withholding tax under Section 871(h) or 881(c) of the Code with respect to payments of &#8220;portfolio interest&#8221;, a statement substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (except for Non-U.S. Lenders that are partnerships for U.S. Federal Income Tax purposes, which shall deliver a statement substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and a Form W-8BEN or W-8BEN-E or Form W-8IMY, or any subsequent versions thereof or successor thereto, properly completed and duly executed by such Non-U.S. Lender claiming complete exemption from, or a reduced rate of, U.S. federal withholding tax on all payments under this Agreement and the other Loan Documents. Such forms shall be delivered by each Non-U.S. Lender on or before the date it becomes a Non-U.S. Lender with respect to any U.S. Borrower under this Agreement (or, in the case of any Participant, on or before the date such Participant purchases the related participation) or within 10 Business Days of the request by such U.S. Borrower or the Administrative Agent. Each Non-U.S. Lender shall promptly notify each U.S. Borrower and the Administrative Agent at any time it determines that it is no longer in a position to provide any previously delivered certificate to such U.S. Borrower (or any other form of certification adopted by the U.S. taxing authorities for such purpose). If any Non-U.S. Lender provides a Form W-8IMY, such Non-U.S. Lender must also attach the additional documentation that must be transmitted with the Form W-8IMY, including the appropriate forms described in this Section 2.13(e).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender shall indemnify the Administrative Agent for the full amount of any taxes, levies, imposts, duties, charges, fees, deductions, withholdings or similar charges imposed by any Governmental Authority that are attributable to such Lender and that are payable or paid by the Administrative Agent, together with all interest, penalties, reasonable costs and expenses arising therefrom or with respect thereto, as determined by the Administrative Agent in good faith. A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Administrative Agent or a Lender determines, in its sole discretion, that it has received a refund of or credit for any Non-Excluded Taxes or Other Taxes as to which it has been indemnified by a Borrower or with respect to which a Borrower has paid any additional amount pursuant to this Section, it shall pay over such refund or the amount of such credit to such Borrower (but only to the extent of indemnity payments made, or additional amounts paid, by such Borrower under this Section with respect to the Non-Excluded Taxes or Other Taxes giving rise to such refund or credit), net of all reasonable out-of-pocket expenses incurred by the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund or credit)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Borrower, upon the request of the Administrative Agent or such Lender, agrees to repay the amount paid over to such Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender if the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority or loses the benefit of such credit. Notwithstanding anything to the contrary in this paragraph (g), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this paragraph (g) the payment of which would place the indemnified party in a less favorable net after-tax position than the indemnified party would have been in if the tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such tax had never been paid. This Section shall not be construed to require the Administrative Agent or any Lender to make available its tax returns (or any other information relating to its taxes that it deems confidential) to any Borrower or any other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Solely for purposes of determining withholding Taxes imposed under FATCA, from and after the effective date of this Agreement, the Borrower and the Administrative Agent shall treat </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(and the Lenders hereby authorize the Administrative Agent to treat) the Loan as not qualifying as a &#8220;grandfathered obligation&#8221; within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The agreements in this Section shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Borrower (and the Borrower Representative) agrees to indemnify each Lender for, and to hold each Lender harmless from, any loss or expense that such Lender may sustain or incur as a consequence of (a)&#160;any failure of such Borrower to make a borrowing of, conversion into or continuation of Eurodollar Loans after the Borrower Representative has given a notice requesting the same in accordance with the provisions of this Agreement, (b) any failure of such Borrower to make any prepayment of Eurodollar Loans after the Borrower Representative has given a notice thereof in accordance with the provisions of this Agreement or (c) the making of a prepayment of Eurodollar Loans on a day that is not the last day of an Interest Period with respect thereto. Absent any change in circumstances after the date hereof, the amount of such indemnification is intended to be equal to the excess, if any, of (i) the amount of interest that would have accrued on the amount so prepaid, or not so borrowed, converted or continued, for the period from the date of such prepayment or of such failure to borrow, convert or continue to the last day of such Interest Period (or, in the case of a failure to borrow, convert or continue, the Interest Period that would have commenced on the date of such failure) in each case at the applicable rate of interest for such Loans provided for herein (excluding, however, the Applicable Margin included therein) over (ii) the amount of interest (as reasonably determined by such Lender) that would have accrued to such Lender on such amount by placing such amount on deposit for a comparable period with leading banks in the interbank eurodollar market. A certificate as to any amounts payable pursuant to this Section submitted to the applicable Borrower (or the Borrower Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by any Lender shall be conclusive in the absence of manifest error. This covenant shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Lender agrees that, upon the occurrence of any event giving rise to the operation of Section 2.12(a), 2.12(b) or 2.13(a) with respect to such Lender, it will, if requested by the Borrower Representative, use reasonable efforts (subject to overall policy considerations of such Lender) to designate another lending office for any Loans affected by such event or assign its rights and obligations hereunder to an Affiliate with the object of avoiding the consequences of such event&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that such designation or assignment is made on terms that, in the sole judgment of such Lender, cause such Lender and its lending office(s) or such Affiliate, as the case may be, to suffer no economic, legal or regulatory disadvantage, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that nothing in this Section shall affect or postpone any of the obligations of any Borrower or the rights of any Lender pursuant to Section 2.12 or 2.13(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall be permitted to replace any Lender that (a) requests reimbursement for amounts owing pursuant to Section 2.12(a), 2.12(b) or 2.13(a), (b) refuses to consent to any waiver or amendment with respect to any Loan Document that requires the approval of each Lender and that has been consented to by the Required Lenders or (c) becomes a Defaulting Lender, with a replacement financial institution&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) such replacement does not conflict with any Requirement of Law, (ii) no Event of Default or Default shall have occurred and be continuing at the time of such replacement, (iii) prior to any such replacement, such Lender shall, within 30 days of the Company&#8217;s request have taken no action under Section 2.15 that eliminates the continued need for payment of amounts owing pursuant to Section 2.12 or 2.13(a), (iv) the replacement financial institution shall purchase, at par, all Loans and other amounts (including accrued interest) owing to such replaced Lender on or prior to the date of replacement, (v) the Borrowers shall be liable to such replaced </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender under Section 2.14 if any Eurodollar Loan owing to such replaced Lender shall be purchased other than on the last day of the Interest Period relating thereto as if it were prepaid on the date of such purchase (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the case of a replacement pursuant to clause (c) above, the Borrowers shall only be liable for the positive difference, if any, between (A) any amounts owing by the Borrowers under Section 2.14 and (B) any obligations owing by such Defaulting Lender to the Borrowers under the Loan Documents as a result of such Defaulting Lender becoming a Defaulting Lender), (vi) the replacement financial institution shall be reasonably satisfactory to each Issuing Lender and the Administrative Agent, (vii) the replaced Lender shall be obligated to make such replacement in accordance with the provisions of Section 11.6 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Company shall be obligated to pay the portion of the registration and processing fee referred to therein), (viii) until such time as such replacement shall be consummated, the Borrowers shall pay all additional amounts (if any) required pursuant to Section 2.12 or 2.13(a), as the case may be, and (ix)&#160;any such replacement shall not be deemed to be a waiver of any rights that the Borrower, the Administrative Agent or any other Lender shall have against the replaced Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Commitment Fee set forth in Section 2.3(a) shall cease to accrue for such Defaulting Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Commitment and Extensions of Credit of such Defaulting Lender shall not be included in determining whether all Lenders or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to Section 11.1), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any waiver, amendment or modification (i) requiring the consent of all Lenders or each affected Lender which affects such Defaulting Lender disproportionately with respect to the other affected Lenders or (ii) that would increase or extend the term of the Commitment of such Defaulting Lender shall require the consent of such Defaulting Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if any L&#47;C Obligations exist at the time a Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all or any part of such L&#47;C Obligations shall be reallocated among the non-Defaulting Lenders in accordance with their respective Commitment Percentages but only to the extent the sum of all non-Defaulting Lenders&#8217; Extensions of Credit does not exceed the total of all non-Defaulting Lenders&#8217; Commitments&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if the reallocation described in clause (i) above cannot, or can only partially, be effected, the applicable Borrower shall within one Business Day following notice by the Administrative Agent, (A) in the case of Unsecured Letters of Credit, cash collateralize such Defaulting Lender&#8217;s L&#47;C Obligations (after giving effect to any partial reallocation pursuant to clause (i) above) in accordance with the procedures set forth in Section 8 for so long as such L&#47;C Obligations are outstanding or (B) in the case of Secured Letters of Credit, ensure that the Borrowing Base includes an amount of cash equal to or greater than the Defaulting Lender&#8217;s L&#47;C Obligations (after giving effect to any partial reallocation pursuant to clause (i) above) for so long as such L&#47;C Obligations are outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s L&#47;C Obligations pursuant to this Section 2.18(c), the Borrower shall not be required to pay any fees to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">such Defaulting Lender pursuant to Section 3.3(a) with respect to such Defaulting Lender&#8217;s L&#47;C Obligations during the period such Defaulting Lender&#8217;s L&#47;C Obligations are cash collateralized&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if the L&#47;C Obligations of the non-Defaulting Lenders are reallocated pursuant to this Section 2.18(c) then the fees payable to the Lenders pursuant to Section 2.3(a) and Section 3.3(a) shall be adjusted in accordance with such non-Defaulting Lenders&#8217; Commitment Percentages&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if any Defaulting Lender&#8217;s L&#47;C Obligations are neither cash collateralized nor reallocated pursuant to this Section 2.18(c), then, without prejudice to any rights or remedies of any Issuing Lender or any Lender hereunder, all letter of credit fees payable under Section 3.3 with respect to such Defaulting Lender&#8217;s L&#47;C Obligations shall be payable to the applicable Issuing Lender until such L&#47;C Obligations are cash collateralized and&#47;or reallocated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">so long as any Lender is a Defaulting Lender, no Applicable Issuing Party shall be required to issue, amend or increase any Letter of Credit, unless it is satisfied that the related exposure will be 100% covered by the Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrower in accordance with Section 2.18(c), and participating interests or Commitment Shares in any such newly issued or increased Letter of Credit shall be allocated among non-Defaulting Lenders in a manner consistent with Section 2.18(c)(i) (and Defaulting Lenders shall not participate therein).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;any amount payable to such Defaulting Lender hereunder (whether on account of principal, interest, fees or otherwise and including any amount that would otherwise be payable to such Defaulting Lender pursuant to Section 11.7 but excluding Section 2.16) shall, in lieu of being distributed to such Defaulting Lender, be retained by the Administrative Agent in a segregated account and, subject to any applicable requirements of law, be applied at such time or times as may be determined by the Administrative Agent (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder, (ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata, to the payment of any amounts owing by such Defaulting Lender to the Applicable Issuing Parties hereunder, (iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent or requested by an Applicable Issuing Party, to be held in such account as cash collateral for future funding obligations of the Defaulting Lender of any participating interest or Commitment Share in any Letter of Credit, (iv) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the funding of any Loan in respect of which such Defaulting Lender has failed to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent, (v) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower, held in such account as cash collateral for future funding obligations of the Defaulting Lender of any Loans under this Agreement, (vi) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Lenders or an Issuing Lender as a result of any judgment of a court of competent jurisdiction obtained by any Lender or such Issuing Lender against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, (vii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">seventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Borrower as a result of any judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, and (viii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">eighth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such payment is (x) a prepayment of the principal amount of any Loans or reimbursement obligations in respect of a payment made by an Issuing Lender pursuant to a Letter of Credit for which a Defaulting Lender has funded its participation obligations and (y) made at a time when the conditions set forth in Section 5.2 are satisfied, such payment shall be applied solely to prepay the Loans of, and reimbursement obligations owed to, all non-Defaulting Lenders pro rata prior to being applied to the prepayment of any Loans, or reimbursement obligations owed to, any Defaulting Lender.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event that the Administrative Agent, the Borrower and each Issuing Lender agree that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then the L&#47;C Obligations of the Lenders shall be readjusted to reflect the inclusion of such Lender&#8217;s Commitment and on such date such Lender shall purchase at par such of the Loans of the other Lenders as the Administrative shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Commitment Percentage.</font></div><div style="margin-bottom:24pt;text-align:center;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LETTERS OF CREDIT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;&#160;Subject to the terms and conditions hereof, the Applicable Issuing Party, in reliance on the agreements of the other Lenders set forth in Sections 3.4(a) and 3.8(b), agrees to issue letters of credit (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) for the account of the Borrowers on any Business Day during the Commitment Period (i) in the case of Fronted Letters of Credit, in such form as may be approved from time to time by such Issuing Lender in an aggregate face amount not to exceed at any one time outstanding such Issuing Lender&#8217;s Fronted L&#47;C Commitment and (ii) in the case of Several Letters of Credit, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit L</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Applicable Issuing Party shall have no obligation to issue any Letter of Credit if, after giving effect to such issuance, the aggregate amount of the Available Commitments would be less than zero and, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that, if any Issuing Lender shall issue any Fronted Letter of Credit that results in the aggregate amount of the Available Commitments being less than zero without having received prior written confirmation from the Administrative Agent that the issuance of such Fronted Letter of Credit would not result in the aggregate amount of the Available Commitments being less than zero, the provisions of Section 3.4 shall be applicable to such Fronted Letter of Credit only to the extent of the portion thereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Participated Portion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) that, if such Fronted Letter of Credit had been issued in an amount equal to the Participated Portion, would not have resulted in the aggregate amount of the Available Commitment being less than zero and the portion of such Fronted Letter of Credit (and any related Reimbursement Obligations) that does not constitute the Participated Portion shall be subject and subordinate in right of payment and as to priority of the security provided by the Collateral to all other Obligations. Each Letter of Credit shall (i) be denominated in Dollars or Pounds Sterling and (ii) expire no later than the earlier of (x) the first anniversary of its date of issuance and (y) the date that is five Business Days prior to the Termination Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Letter of Credit with a one-year term may provide for the renewal thereof at the option of the applicable Borrower for additional one-year periods (which shall in no event extend beyond the date referred to in clause (y) above), so long as the Issuing Lender of such Letter of Credit has the right to refuse to extend such Letter of Credit if at the time of such refusal the applicable Borrower would be unable to satisfy the conditions set forth in Section 5.2&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Secured Letter of Credit may have an expiration date up to 364 days after the Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;No Applicable Issuing Party shall at any time issue (i) any Letter of Credit if such issuance would conflict with, or cause such Applicable Issuing Party, any L&#47;C Participant or any Lender to exceed any limits imposed by, any applicable Requirement of Law or (ii) any Secured Letter of Credit on behalf of any Borrower if (x) the then Borrowing Base of such Borrower would be less than such Borrower&#8217;s aggregate Secured L&#47;C Obligations after giving effect to the issuance of such Secured Letter of Credit or (y) all cash and Eligible Securities constituting such Borrowing Base are not then held in an Account of such Borrower established pursuant to Section 1 of Article II of the applicable Collateral Account Control Agreement. Prior to issuing any Secured Letter of Credit, the Applicable Issuing Party shall obtain confirmation from the Administrative Agent that the requirements imposed by clause (ii) of the preceding sentence shall be satisfied.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Procedure for Issuance of Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Borrower may from time to time request that an Applicable Issuing Party issue a Letter of Credit by delivering to such Applicable Issuing Party at its address for notices specified herein (with a copy to the Administrative Agent at its address for notices specified herein) an Application therefor, indicating (i) whether such Letter of Credit is to be a Secured Letter of Credit or an Unsecured Letter of Credit and (ii) whether such Letter of Credit is to be a Fronted Letter of Credit or a Several Letter of Credit and otherwise completed to the satisfaction of such Applicable Issuing Party, and such other certificates, documents and other papers and information as such Applicable Issuing Party may request&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in no event shall any Applicable Issuing Party other than Barclays Bank PLC or Citibank, N.A. and, with the consent of the Administrative Agent, one other Issuing Lender (and any of their respective Affiliates) issue any Letter of Credit denominated in Pounds Sterling. Upon receipt of any Application, the Applicable Issuing Party will process such Application and the certificates, documents and other papers and information delivered to it in connection therewith in accordance with its customary procedures and shall promptly issue the Letter of Credit requested thereby (but in no event shall any Applicable Issuing Party be required to issue any Letter of Credit earlier than five Business Days after its receipt of the Application therefor and all such other certificates, documents and other papers and information relating thereto) by issuing the original of such Letter of Credit to the beneficiary thereof or as otherwise may be agreed to by such Applicable Issuing Party and such Borrower. Such Applicable Issuing Party shall furnish a copy of such Letter of Credit (i) to such Borrower promptly following the issuance thereof and (ii) in the case of a Several Letter of Credit, to each Lender. Each Applicable Issuing Party shall promptly furnish to the Administrative Agent, which shall in turn promptly furnish to the Lenders, notice of the issuance of each Letter of Credit (including the amount thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Fees and Other Charges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;&#160;The applicable Borrower will pay to the Administrative Agent, for the account of the Lenders, a fee on the undrawn and unexpired face amount (calculated, in the case of any Letter of Credit denominated in Pounds Sterling, on the basis of the Exchange Rate in effect on the date payment of such fee is due) of each Letter of Credit issued on its behalf at a per annum rate equal to (i) in the case of an Unsecured Letter of Credit, the Applicable Margin then in effect with respect to Eurodollar Loans and (ii) in the case of a Secured Letter of Credit, 0.40%. Such fees shall be payable quarterly in arrears on each Fee Payment Date after the issuance date. The Administrative Agent will promptly pay to the Lenders their pro rata shares of any amounts received from the Borrowers in respect of any such fees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The applicable Borrower shall pay to each Issuing Lender for its own account a fronting fee at a rate per annum as agreed between such Borrower and such Issuing Lender on the undrawn and unexpired amount of each Fronted Letter of Credit issued on its behalf, payable quarterly in arrears on each Fee Payment Date after the issuance date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the foregoing fees, the applicable Borrower shall pay or reimburse (i) each Applicable Issuing Party for such normal and customary costs and expenses as are incurred or charged by such Applicable Issuing Party in issuing, negotiating, effecting payment under, amending or otherwise administering any Letter of Credit and (ii) each Lender for such normal and customary costs and expenses as are incurred or charged by such Lender in connection with any Several Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#160;&#160;&#160;&#160; Each Issuing Lender irrevocably agrees to grant and hereby grants to each L&#47;C Participant, and, to induce such Issuing Lender to issue Fronted Letters of Credit, each L&#47;C Participant irrevocably agrees to accept and purchase and hereby accepts and purchases from such Issuing Lender, on the terms and conditions set forth below, for such L&#47;C Participant&#8217;s own account and risk an undivided interest equal to such L&#47;C Participant&#8217;s Commitment Percentage in such Issuing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender&#8217;s obligations and rights under and in respect of each Fronted Letter of Credit and the amount of each draft paid by such Issuing Lender thereunder. Each L&#47;C Participant agrees with each Issuing Lender that, if a draft is paid under any Fronted Letter of Credit for which such Issuing Lender is not reimbursed in full by the applicable Borrower in accordance with the terms of this Agreement, such L&#47;C Participant shall pay to such Issuing Lender upon demand at such Issuing Lender&#8217;s address for notices specified herein an amount in Dollars equal to such L&#47;C Participant&#8217;s Commitment Percentage of (i) the amount of such draft, or any part thereof, that is paid in Dollars and is not so reimbursed or (ii) the Dollar Equivalent, using the Exchange Rate at the time such draft is paid, of the amount of such draft, or any part thereof, that is paid in Pounds Sterling and is not so reimbursed. Each L&#47;C Participant&#8217;s obligation to pay such amount shall be absolute and unconditional and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such L&#47;C Participant may have against the applicable Issuing Lender, any Borrower or any other Person for any reason whatsoever, (ii) the occurrence or continuance of a Default or an Event of Default or the failure to satisfy any of the other conditions specified in Section 5, (iii) any adverse change in the condition (financial or otherwise) of any Borrower, (iv) any breach of this Agreement or any other Loan Document by any Borrower or any other L&#47;C Participant or (v) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If any amount required to be paid by any L&#47;C Participant to an Issuing Lender pursuant to Section 3.4(a) in respect of any unreimbursed portion of any payment made by such Issuing Lender under any Fronted Letter of Credit is paid to such Issuing Lender within three Business Days after the date such payment is due, such L&#47;C Participant shall pay to such Issuing Lender on demand an amount equal to the product of (i) such amount, times (ii) the daily average Federal Funds Effective Rate during the period from and including the date such payment is required to the date on which such payment is immediately available to such Issuing Lender, times (iii) a fraction the numerator of which is the number of days that elapse during such period and the denominator of which is 360. If any such amount required to be paid by any L&#47;C Participant pursuant to Section 3.4(a) is not made available to the applicable Issuing Lender by such L&#47;C Participant within three Business Days after the date such payment is due, such Issuing Lender shall be entitled to recover from such L&#47;C Participant, on demand, such amount with interest thereon calculated from such due date at the rate per annum applicable to ABR Loans. A certificate of an Issuing Lender submitted to any L&#47;C Participant with respect to any amounts owing under this Section shall be conclusive in the absence of manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Whenever, at any time after the applicable Issuing Lender has made payment under any Fronted Letter of Credit and has received from any L&#47;C Participant its </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> share of such payment in accordance with Section 3.4(a), such Issuing Lender receives any payment related to such Fronted Letter of Credit (whether directly from the applicable Borrower or otherwise, including proceeds of collateral applied thereto by such Issuing Lender), or any payment of interest on account thereof, such Issuing Lender will distribute to such L&#47;C Participant its </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> share thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that in the event that any such payment received by such Issuing Lender shall be required to be returned by such Issuing Lender, such L&#47;C Participant shall return to such Issuing Lender the portion thereof previously distributed by such Issuing Lender to it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Section 3.4 shall be subject to the provisions of the second proviso to the first sentence of Section 3.1(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reimbursement Obligation of the Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any draft is paid under any Letter of Credit, the applicable Borrower shall reimburse the Applicable Issuing Party for the amount of (a) the draft so paid and (b) any taxes, fees, charges or other costs or expenses incurred by such Applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Issuing Party in connection with such payment, not later than 12&#58;00 Noon, New York City time, on (i) the Business Day that such Borrower receives notice of such draft, if such notice is received on such day prior to 10&#58;00 A.M., New York City time, or (ii) if clause (i) above does not apply, the Business Day immediately following the day that such Borrower receives such notice. Each such payment under a Letter of Credit denominated in Dollars shall be made to the Applicable Issuing Party at its address for notices specified herein (or as otherwise specified) in Dollars in immediately available funds. Each such payment under a Letter of Credit denominated in Pounds Sterling shall be made to the Applicable Issuing Party at its address for notices specified herein (or as otherwise specified) in Pounds Sterling in immediately available funds. Interest shall be payable on any such amounts from the date on which the relevant draft is paid until payment in full at the rate set forth in (x) until the Business Day next succeeding the date of the relevant notice, Section 2.8(b) and (y) thereafter, Section 2.8(c). In the case of payments made under this Section 3.5 in respect of Several Letters of Credit, the L&#47;C Administrator shall distribute such payments to the applicable Lenders promptly upon receipt in like funds as received.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Obligations Absolute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrowers&#8217; obligations under this Section 3 shall be absolute and unconditional under any and all circumstances and irrespective of any setoff, counterclaim or defense to payment that any Borrower may have or have had against any L&#47;C Issuer, any beneficiary of a Letter of Credit or any other Person. The Borrowers also agree with each L&#47;C Issuer that such L&#47;C Issuer shall not be responsible for, and the Borrowers&#8217; Reimbursement Obligations under Section 3.5 shall not be affected by, among other things, (i) the validity or genuineness of documents or of any endorsements thereon, even though such documents shall in fact prove to be invalid, fraudulent or forged, (ii) any dispute between or among any Borrower and any beneficiary of any Letter of Credit or any other party to which such Letter of Credit may be transferred or any claims whatsoever of any Borrower against any beneficiary of such Letter of Credit or any such transferee, (iii) payment by any L&#47;C Issuer under any Letter of Credit against presentation of a draft or other document that does not comply with the terms of such Letter of Credit or (iv) any other event or circumstances which might constitute a legal or equitable discharge or provide a right of setoff against the Borrowers&#8217; reimbursement obligation. No L&#47;C Issuer shall be liable for any error, omission, interruption or delay in transmission, dispatch or delivery of any message or advice, however transmitted, in connection with any Letter of Credit, except for errors or omissions found by a final and nonappealable decision of a court of competent jurisdiction of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by a Borrower to the extent permitted by applicable law) suffered by such Borrower to have resulted from the gross negligence or willful misconduct of such L&#47;C Issuer. The Borrowers agree that any action taken or omitted by any L&#47;C Issuer under or in connection with any Letter of Credit or the related drafts or documents, if done in the absence of gross negligence or willful misconduct, shall be binding on the Borrower and shall not result in any liability of such L&#47;C Issuer to any Borrower and that with respect to documents presented which appear on their face to be in substantial compliance with the terms of a Letter of Credit, the applicable L&#47;C Issuer may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Credit Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any draft shall be presented for payment under any Letter of Credit, the Applicable Issuing Party shall promptly notify the applicable Borrower of the date and amount thereof. The responsibility of the Applicable Issuing Party to the applicable Borrower in connection with any draft presented for payment under any Letter of Credit shall, in addition to any payment obligation expressly provided for in such Letter of Credit, be limited to determining that the documents (including each draft) delivered under such Letter of Credit in connection with such presentment are substantially in conformity with such Letter of Credit.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Several Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The L&#47;C Administrator is hereby authorized to execute and deliver each Several Letter of Credit and each amendment to a Several Letter of Credit on behalf of each Lender provided that, upon request of the Borrower, such Several Letter of Credit or amendment will be executed by each Lender. The L&#47;C Administrator shall use the Commitment Percentage of each Lender as its &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; under each Several Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that each Limited Fronting Lender (if any), in its capacity as such, shall, in addition to its own &#8220;Commitment Share&#8221; as a Lender, have a &#8220;Commitment Share&#8221; (or equivalent term) equal to the Commitment Percentage (or portion thereof, if applicable) of each Non-NAIC Approved Bank for which such Limited Fronting Lender acts in such capacity under such Several Letter of Credit. The L&#47;C Administrator shall not amend any Several Letter of Credit to change the &#8220;Commitment Shares&#8221; of any Lender or add or delete a Lender liable thereunder unless such amendment is done in connection with a Limited Fronting Lender Agreement in accordance with Section 3.8(c), an assignment in accordance with Section 11.6, a change in the Lenders and&#47;or the Commitment Percentages as a result of any increase in the Commitments pursuant to Section 2.1 or any other addition or replacement of a Lender in accordance with the terms of this Agreement. Each Lender (including, for the avoidance of doubt, each Limited Fronting Lender) hereby irrevocably constitutes and appoints the L&#47;C Administrator its true and lawful attorney-in-fact for and on behalf of such Lender with full power of substitution and revocation in its own name or in the name of the L&#47;C Administrator to issue, execute and deliver, as the case may be, each Several Letter of Credit and each amendment to a Several Letter of Credit and to carry out the purposes of this Agreement with respect to Several Letters of Credit. Upon request, each Lender shall execute such powers of attorney or other documents as any beneficiary of any Several Letter of Credit may reasonably request to evidence the authority of the L&#47;C Administrator to execute and deliver such Several Letter of Credit and any amendment or other modification thereto on behalf of the Lenders. To the extent that the L&#47;C Administrator has not received funds from a Lender with respect to a Several Letter of Credit, the L&#47;C Administrator shall only forward the funds actually received to the beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender (including, for the avoidance of doubt, each Limited Fronting Lender) agrees with the L&#47;C Administrator that, if a draft is paid under any Several Letter of Credit for which such L&#47;C Administrator is not reimbursed in full by the applicable Borrower in accordance with the terms of this Agreement, each Lender shall pay to the L&#47;C Administrator upon demand at the L&#47;C Administrator&#8217;s address for notices specified herein an amount in Dollars (in the case of a Several Letter of Credit denominated in Dollars) or Pounds Sterling (in the case of a Several Letter of Credit denominated in Pounds Sterling) equal to such Lender&#8217;s Commitment Share (and, in the case of each Limited Fronting Lender, the Commitment Share (or the portion thereof for which it has agreed to be a Limited Fronting Lender) of each applicable Non-NAIC Approved Bank). In the event that a Limited Fronting Lender pays the Commitment Share of a Non-NAIC Approved Bank, such Non-NAIC Approved Bank shall pay such Commitment Share (or the relevant portion thereof, if applicable) to such Limited Fronting Lender in purchase of its participation in such payment. Each Lender&#8217;s (including, for the avoidance of doubt, each Limited Fronting Lender&#8217;s and each Non-NAIC Approved Bank&#8217;s) obligation to pay such amount shall be absolute and unconditional and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such Lender may have against the L&#47;C Administrator, any Borrower or any other Person for any reason whatsoever, (ii) the occurrence or continuance of a Default or an Event of Default or the failure to satisfy any of the other conditions specified in Section 5, (iii) any adverse change in the condition (financial or otherwise) of any Borrower, (iv) any breach of this Agreement or any other Loan Document by any Borrower or any other Lender or (v) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event that any Lender agrees (in its sole discretion) to act as a Limited Fronting Lender for any Non-NAIC Approved Bank upon such terms and conditions as such parties may agree (including fees payable by such Non-NAIC Approved Bank to such Limited Fronting Lender) (such agreement, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limited Fronting Lender Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the following provisions shall apply (in addition to any other provisions hereof relating to Limited Fronting Lenders)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upon the issuance of any Several Letter of Credit pursuant hereto, with respect to any Non-NAIC Approved Bank, each applicable Limited Fronting Lender, in reliance upon the agreements of such Non-NAIC Approved Bank, agrees (A) to issue through the L&#47;C Administrator, in addition to its own obligations as a Lender under such Several Letter of Credit, severally, such Several Letter of Credit in an amount equal to such Non-NAIC Approved Bank&#8217;s Commitment Share of the stated amount of such Several Letter of Credit (or the portion thereof for which such Limited Fronting Lender has agreed to be a Limited Fronting Lender), and (B) to amend or extend each Several Letter of Credit previously issued by it as a Limited Fronting Lender for such Non-NAIC Approved Bank&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with respect to any Several Letter of Credit issued by a Limited Fronting Lender pursuant to clause (i) above for a Non-NAIC Approved Bank, such Non-NAIC Approved Bank agrees to purchase participations in the obligations of such Limited Fronting Lender under such Several Letter of Credit in the amount attributable to such Non-NAIC Approved Bank. Without any further action on the part of any party, each Limited Fronting Lender hereby grants to each applicable Non-NAIC Approved Bank for which it is acting as a Limited Fronting Lender hereunder, and each such Non-NAIC Approved Bank hereby acquires from such Limited Fronting Lender, a participation in such Limited Fronting Lender&#8217;s Commitment Share of each Several Letter of Credit for which such Limited Fronting Lender is acting as a Limited Fronting Lender on behalf of such Non-NAIC Approved Bank hereunder in the amount attributable to such Non-NAIC Approved Bank. Each such Non-NAIC Approved Bank purchasing a participation hereunder acknowledges and agrees that its obligation to acquire such participations in respect of Several Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment or extension of any Letter of Credit or the occurrence and continuance of a Default or Event of Default or reduction or termination of the Commitments. In consideration and in furtherance of the foregoing, each such Non-NAIC Approved Bank hereby absolutely and unconditionally agrees to pay to the L&#47;C Administrator, for account of the applicable Limited Fronting Lender, an amount equal to the amount of each payment made by such Limited Fronting Lender in respect of the portion of each such Several Letter of Credit in which such Non-NAIC Approved Bank holds a participation, promptly upon the request of such Limited Fronting Lender, at any time from the time such payment is made until such payment is reimbursed by the applicable Borrower or at any time after any reimbursement payment is required to be refunded to the applicable Borrower for any reason. Such payment by such Non-NAIC Approved Bank shall be made for the account of the applicable Limited Fronting Lender without any offset, abatement, withholding or reduction whatsoever. To the extent that any Non-NAIC Approved Bank has made payments pursuant to this paragraph to reimburse a Limited Fronting Lender in respect of any participation interests purchased hereunder in respect of any Several Letter of Credit, promptly following receipt by the L&#47;C Administrator of any payment from the applicable Borrower pursuant to Section 3.5 in respect of such Several Letter of Credit, the L&#47;C Administrator shall distribute such payment to such Limited Fronting Lender and such Non-NAIC Approved Bank as their interests may appear. Any payment made by a Non-NAIC Approved Bank in respect of its participation pursuant to this paragraph to reimburse the applicable Limited Fronting Lender for any payment made in respect </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of any drawing under a Several Letter of Credit shall not relieve the Borrowers of their obligation to reimburse the amount of such drawing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Borrowers&#8217; failure to reimburse the amount of such drawing shall not affect the obligation of any Non-NAIC Approved Bank to indemnify the Limited Fronting Letter for such amount pursuant to Section 3.8(b).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender that agrees to act as a Limited Fronting Lender for any Non-NAIC Approved Bank shall promptly notify the Administrative Agent (which shall promptly notify the L&#47;C Administrator) of such agreement and of any termination or expiration of such agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event that, pursuant to this Section 3.8(c), any Lender agrees to act as a Limited Fronting Lender for any other Lender that becomes a Non-NAIC Approved Bank, such Lender shall receive such compensation therefor as such Non-NAIC Approved Bank and such Lender may agree. Notwithstanding anything herein to the contrary, no Lender shall have any obligation to agree to act hereunder as a Limited Fronting Lender for any other Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The obligations of each Lender under and in respect of each Several Letter of Credit are several, and the failure by any Lender to perform its obligations hereunder or under any Several Letter of Credit shall not affect the obligations of the Borrowers toward any other party hereto nor shall any other such party (other than Limited Fronting Lenders with respect to Several Letters of Credit they have issued on behalf of Non-NAIC Approved Banks) be liable for the failure by such Lender to perform its obligations hereunder or under any Several Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Applications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent that any provision of any Application related to any Letter of Credit is inconsistent with the provisions of this Section 3, the provisions of this Section 3 shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Issuing Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, at any time and from time to time with the consent of the Administrative Agent (which consent shall not be unreasonably withheld or delayed) and such Lender, designate one or more Lenders to act as an issuing lender under the terms of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the total number of Issuing Lenders at any time shall not exceed four. Any Lender designated as an Issuing Lender pursuant to this Section 3.10 shall be deemed to be an &#8220;Issuing Lender&#8221; for the purposes of this Agreement (in addition to being a Lender) with respect to Letters of Credit issued by such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Unless the Administrative Agent otherwise agrees, each Applicable Issuing Party will report in writing to the Administrative Agent (i) on the first Business Day of each week and on the second Business Day to occur after the last day of each March, June, September and December, and on such other dates as the Administrative Agent may reasonably request, the daily activity during the preceding week, calendar quarter or other period, as the case may be, with respect to Letters of Credit issued by it, including the aggregate outstanding L&#47;C Obligations with respect to such Letters of Credit on each day during such week, quarter or other period, in such form and detail as shall be satisfactory to the Administrative Agent, (ii) on any Business Day on which the Borrower fails to pay any Reimbursement Obligation required to be reimbursed to such Applicable Issuing Party on such day, the date of such failure and the amount of such Reimbursement Obligation and (iii) such other information with respect to Letters of Credit issued by such Applicable Issuing Party as the Administrative Agent may reasonably request.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-NAIC Approved Banks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If, at any time from and after the Closing Date, any Lender is not or ceases to be a NAIC Approved Bank, such Lender shall promptly notify the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and the Administrative Agent thereof. Each Lender agrees to use commercially reasonable efforts, at all times from and after the Closing Date, (a) to be a NAIC Approved Bank or (b) if such Lender is not or ceases to be a NAIC Approved Bank, to agree with another Lender which is a NAIC Approved Bank, as provided in Section 3.8(c), that such NAIC Approved Bank shall (in its sole discretion) act as the Limited Fronting Lender for such Non-NAIC Approved Bank with respect to any Several Letters of Credit which are outstanding at the time such Lender becomes a Non-NAIC Approved Bank and&#47;or are issued during the period that such Lender is a Non-NAIC Approved Bank.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To induce the Administrative Agent and the Lenders to enter into this Agreement and to make the Extensions of Credit, the Company hereby represents and warrants to the Administrative Agent and each Lender that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The audited consolidated balance sheet of the Company and its Subsidiaries as at December 31, 2016, and the related consolidated statement of comprehensive income and of cash flows for the fiscal year ended on such date, reported on by and accompanied by an unqualified report from KPMG Audit Plc, present fairly the consolidated financial condition of the Company and its Subsidiaries as at such date, and the consolidated results of its operations and its consolidated cash flows for the fiscal year then ended. All such financial statements, including the related schedules and notes thereto, have been prepared in accordance with GAAP applied consistently throughout the periods involved (except as approved by the aforementioned firm of accountants and disclosed therein). As of the date of this Agreement, no Group Member has any material Guarantee Obligations, contingent liabilities and liabilities for taxes, or any material long-term leases or material unusual forward or long-term commitments, including any Swap Contracts, that are not reflected in the most recent financial statements referred to in this paragraph. During the period from December 31, 2016 to and including the date of this Agreement there has been no Disposition by any Group Member of any material part of its business or property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Since December 31, 2016, there has been no development or event that has had or could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Existence&#59; Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Group Member (a) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (b) has the power and authority, and the legal right, to own and operate its property, to lease the property it operates as lessee and to conduct the business in which it is currently engaged, (c) is duly qualified as a foreign corporation or other organization and in good standing under the laws of each jurisdiction where its ownership, lease or operation of property or the conduct of its business requires such qualification except where the failure to so qualify or be in good standing would not have a Material Adverse Effect and (d) is in compliance with all Requirements of Law (including the Bermuda Companies Law and Bermuda Insurance Law as applicable to the Company and each Subsidiary organized under the laws of Bermuda) except to the extent that the failure to comply therewith could not, in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary is subject to any Private Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Power&#59; Authorization&#59; Enforceable Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. (a) Each Borrower has or will have the power and authority, and the legal right, to make, deliver and perform the Loan Documents to which it is a party and to obtain Loans and Letters of Credit hereunder, and each Borrower has or will have taken </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all necessary organizational action to authorize the execution, delivery and performance of the Loan Documents to which it is a party and to authorize the borrowings, and the issuance of Letters of Credit on its behalf, on the terms and conditions of this Agreement. No consent or authorization of, filing with, notice to or other act by or in respect of, any Governmental Authority or any other Person is required in connection with the Loans or Letters of Credit or with the execution, delivery, performance, validity or enforceability of this Agreement or any other Loan Document, except (i) consents, authorizations, filings and notices that have been obtained or made and are in full force and effect and (ii) filings necessary to perfect Liens in favor of the Collateral Agent. Each Loan Document has been duly executed and delivered on behalf of each Borrower which is a party thereto. This Agreement constitutes, and each other Loan Document upon execution will constitute, a legal, valid and binding obligation of each Borrower which is a party thereto, enforceable against each Borrower in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Under the laws of the jurisdiction of its incorporation in force at the date hereof, no Borrower will be required to make any deduction or withholding from any payment it may make hereunder or under the Notes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The claims of the Collateral Agent and the Lenders against each Borrower under this Agreement and the Notes will rank at least </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">pari</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with the claims of all its other unsecured creditors under the laws of (i) the jurisdiction of such Borrower&#8217;s incorporation and (ii) New York, except creditors whose claims are preferred solely by any bankruptcy, insolvency or other similar law of general application governing the enforcement of creditors&#8217; rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In any proceedings taken in Bermuda in relation to this Agreement, the choice of New York law as the governing law of this Agreement, and any judgment obtained in the United States, will be recognized and enforced (other than a judgment for a sum payable in respect of taxes or other charges of a like nature in respect of a fine or other penalty, or in respect of multiple damages as defined in The Protection of Trading Interests Act 1981 of Bermuda), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) the court which rendered the judgment was competent to hear the action in accordance with private international law principles as applied in Bermuda and (ii) the judgment is not contrary to public policy (and the Company is not aware of anything contrary to public policy) in Bermuda, has not been obtained by fraud or in proceedings contrary to natural justice and is not based on an error in Bermuda law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Under the laws of Bermuda it is not necessary that this Agreement, the Notes or any other Loan Document be filed, recorded or enrolled with any court or other authority in such jurisdiction or that any stamp, registration or similar tax be paid on or in relation with this Agreement, the Notes or such other Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Legal Bar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The execution, delivery and performance of this Agreement and the other Loan Documents, the borrowings hereunder and the use of the proceeds thereof will not violate any Requirement of Law or any Contractual Obligation of any Group Member and will not result in, or require, the creation or imposition of any Lien on any of their respective properties or revenues pursuant to any Requirement of Law or any such Contractual Obligation (other than the Liens created by the Security Documents and except, in the case of Contractual Obligations, to the extent that the failure of any of the statements in this Section 4.5 to be accurate could not reasonably be expected to have a Material Adverse Effect).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No litigation, investigation or proceeding of or before any arbitrator or Governmental Authority is pending, or, to the knowledge of any Borrower, threatened, by or against any Group Member or against any of their respective properties or revenues (a) with respect to any of the Loan Documents or any of the transactions contemplated hereby or thereby, or (b) that could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No Group Member is in default under or with respect to any of its Contractual Obligations in any respect that could reasonably be expected to have a Material Adverse Effect. No Default or Event of Default has occurred and is continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Ownership of Property&#59; Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the Company and each Material Subsidiary has good title to, or a valid leasehold interest in all its real and personal property material to its business except for minor defects in title that could not reasonably be expected to have a Material Adverse Effect, and none of such property is subject to any Lien not permitted by Section 7.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Group Member has filed or caused to be filed all Federal, state and other material tax returns that are required to be filed and has paid all taxes shown to be due and payable on said returns (other than any taxes the amount or validity of which are currently being contested in good faith by appropriate proceedings and with respect to which reserves in conformity with GAAP have been provided on the books of the relevant Group Member) except to the extent that failure to do so could not reasonably be expected to have a Material Adverse Effect&#59; no material tax Lien has been filed against any Group Member&#59; and, to the knowledge of any Borrower, no claim is being asserted with respect to any tax return or for any unpaid taxes that, individually or in the aggregate for all such claims, would reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Federal Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No Borrower is engaged in the business of extending credit for the purpose of purchasing or carrying margin stock (within the meaning of Regulation U), and no proceeds of any Loan will be used to purchase or carry any such margin stock or to extend credit to others for the purpose of purchasing or carrying any such margin stock in contravention of Regulation T, U or X of the Board. If requested by any Lender or the Administrative Agent, the Company will furnish to the Administrative Agent and each Lender a statement to the foregoing effect in conformity with the requirements of FR Form G-3 or FR Form U-1, as applicable, referred to in Regulation U.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except as would not reasonably be expected to result in a Material Adverse Effect, (i) neither a Reportable Event nor a failure to satisfy the minimum funding standards (within the meaning of Sections 412 or 430 of the Code or Section 303 of ERISA), whether or not waived, has occurred during the five-year period prior to the date on which this representation is made or deemed made with respect to any Single Employer Plan, and each Single Employer Plan has complied in all material respects with the applicable provisions of ERISA and the Code&#59; (ii) no termination of a Single Employer Plan has occurred (other than a standard termination within the meaning of Section 4041(b) of ERISA), and no Lien in favor of the PBGC or a Plan has arisen, during such five-year period&#59; (iii) there has been no determination that any Single Employer Plan is, or is expected to be, in &#8220;at risk&#8221; status (within the meaning of Section 430 of the Code or Section 303 of ERISA and (iv) none of the Borrowers or any Commonly Controlled Entity has failed to make by its due date a required installment under Section 430(j) of the Code with respect to any Single Employer Plan nor failed to make by its due date a required contribution with respect to a Multiemployer Plan. Except as would not reasonably be expected to result in a Material Adverse Effect, none of the Borrowers nor any Commonly Controlled Entity has had a complete or partial withdrawal from any Multiemployer Plan that has resulted or could reasonably be expected to result in a material liability under ERISA, and none of the Borrowers nor any Commonly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Controlled Entity would become subject to any material liability under ERISA if such Borrower or any such Commonly Controlled Entity were to withdraw completely from all Multiemployer Plans as of the valuation date most closely preceding the date on which this representation is made or deemed made. Except as would not reasonably be expected to result in a Material Adverse Effect, no such Multiemployer Plan is Insolvent, or in &#8220;endangered&#8221; or &#8220;critical&#8221; status (within the meaning of Section 432 of the Code or Section 305 of ERISA).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No Borrower is an &#8220;investment company&#8221;, or a company &#8220;controlled&#8221; by, or an &#8220;affiliated person&#8221; of, or &#8220;principal underwriter&#8221; for, an &#8220;investment company&#8221;, within the meaning of the Investment Company Act of 1940.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> sets forth, as of the date of this Agreement, the name and jurisdiction of incorporation of each Subsidiary and, as to each such Subsidiary, the percentage of each class of Capital Stock owned by the Company or any other Subsidiary, and such Schedule indicates each Subsidiary Borrower as of such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The proceeds of the Extensions of Credit shall be used (a) to finance the working capital needs of the Company and its Subsidiaries and (b) for general corporate purposes of the Company and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except as, in the aggregate, could not reasonably be expected to have a Material Adverse Effect&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;none of the Group Members has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;none of the Group Members has become subject to liability under any Environmental Law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;none of the Group Members has received notice of any claim with respect to any liability under any Environmental Law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the facilities and properties owned, leased or operated by any Group Member (the &#8220;Properties&#8221;) do not contain any Hazardous Materials in amounts or concentrations or under circumstances that could reasonably be expected to give rise to liability under any Environmental Law&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Hazardous Materials have not been transported or disposed by any Group Member in a manner or to a location that could reasonably be expected to give rise to liability under any Environmental Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Accuracy of Information, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the best of the Company&#8217;s knowledge, the Confidential Information Memorandum, taken as a whole, is correct in all material respects as of the date thereof and does not, as of the date thereof, contain any untrue statement of a material fact or omit any material fact necessary to make the statements therein (taken as a whole) not misleading as of such date in light of the circumstances under which they were made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, however, that this representation does not extend to (i) any projections and other forward looking statements contained in the Confidential Information Memorandum (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Projections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and (ii) information in the Confidential Information Memorandum which is referenced to a specific source or derived from public or other sources. The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Projections contained in the Confidential Information Memorandum have been prepared in good faith based upon assumptions reasonably believed by the Company to be reasonable at the time of preparation, it being understood, and the Administrative Agent and each Lender understands that the Projections are subject to significant uncertainties and contingencies many of which are beyond the control of the Company and there can be no assurances that such Projections will be realized.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No written statement or information delivered by any Borrower to the Administrative Agent, the Syndication Agent, the Collateral Agent or the Lenders contained in this Agreement or any other Loan Document, taken as a whole, contains any untrue statement of a material fact or omits any material fact necessary to make the statements therein (taken as a whole) not misleading as of the date of such statement or information in light of the circumstances under which they were provided.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PATRIOT Act&#59; OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent applicable, each of the Company and its Subsidiaries is in compliance in all material respects with (i) the Trading with the Enemy Act (12 U.S.C. &#167;&#167; 95a&#8211;95b and 50 U.S.C. App. &#167;&#167; 1&#8211;44), and each of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V), and any other enabling legislation or executive order relating thereto&#59; (ii) the PATRIOT Act and (iii) Anti-Corruption Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sanctioned Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. None of the Company, any Subsidiary nor, to the knowledge of the Company, any director or officer of the Company or any Subsidiary is subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), U.S. Department of State, United Nations Security Council, European Union or Her Majesty&#8217;s Treasury (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and any other enabling legislation or executive order relating thereto, and no Borrower will directly or indirectly use the proceeds of the Loans, the Letters of Credit or otherwise make available such proceeds to any Person for the purpose of funding or financing the activities of or business of any Person, in any country or territory, that at the time of such funding or financing is restricted under Sanctions or in violation of any Anti-Corruption Laws.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company has implemented and maintains in effect for itself and its Subsidiaries policies and procedures to ensure compliance by the Company, its Subsidiaries and their respective officers, employees, directors and agents with the PATRIOT Act, Anti-Corruption Laws and applicable Sanctions.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CONDITIONS PRECEDENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Initial Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The agreement of each Lender to make the initial extension of credit requested to be made by it is subject to the satisfaction, prior to or concurrently with the making of such extension of credit, of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received this Agreement, executed and delivered by the Administrative Agent, the Syndication Agent, the Collateral Agent, each Borrower and each Person listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Lenders, the Administrative Agent, the Syndication Agent and the Collateral Agent shall have received all fees required to be paid, and all expenses for which invoices have </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">been presented (including the reasonable fees and expenses of legal counsel), on or before the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Certificate&#59; Certified Certificate of Incorporation&#59; Good Standing Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received (i) a certificate of the Company, dated the Closing Date, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and a certificate of each other Borrower, dated the Closing Date, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in each case, with appropriate insertions and attachments, including the Memorandum of Association, Articles of Incorporation or other organizational documents for each Borrower certified by the appropriate Governmental Authority of Bermuda, in the case of the Company, and by the appropriate Governmental Authority of the relevant jurisdiction of organization, in the case of each other Borrower, and By-laws (or equivalent) for each Borrower and (ii) a certificate of compliance&#47;good standing for each Borrower from its jurisdiction of organization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Opinions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received the executed&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;legal opinion of Mayer Brown LLP, counsel to the Company and its Subsidiaries, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;legal opinion of Appleby (Bermuda) Limited, counsel to the Company, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each such legal opinion shall cover such other matters incident to the transactions contemplated by this Agreement as the Administrative Agent may reasonably require.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral Documentation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received amendments to and reaffirmations of the Security Agreement and the existing Collateral Account Control Agreements in form and substance reasonably satisfactory to the Administrative Agent. The Lenders party hereto (constituting the Required Lenders as defined in the Existing Credit Agreement) hereby authorize and direct the Collateral Agent to enter into the amendments to the Security Agreement and the existing Collateral Account Control Agreements contemplated by the foregoing sentence on the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Uniform Commercial Code Financing Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received satisfactory evidence that Uniform Commercial Code financing statements covering the securities held under each Collateral Account Control Agreement and naming the Collateral Agent as secured party are currently on file and effective, or are in proper form for filing, (i) in New York, (ii) in the jurisdiction of organization of each Borrower organized under the laws of any state of the United States, (iii) in the District of Columbia for each Borrower not organized under the laws of a state of the United States and (iv) in the state of the United States in which a Borrower not organized under the laws of a state of the United States maintains its chief executive office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consents, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Borrower shall have received, on reasonably satisfactory terms, all consents and authorizations required pursuant to any Contractual Obligation with any other Person and shall have obtained all permits of, and effected all notices to and filings with, any Governmental Authority, in each case, as may be necessary to allow each Borrower lawfully to execute, deliver and perform, in all material respects, its obligations hereunder and under the other Loan Documents to which it is, or shall be, a party and each other agreement or instrument to be executed and delivered by it pursuant thereto or in connection therewith.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exiting Bank Acknowledgements and Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received (i) from each Person that is a &#8220;Lender&#8221; under and as defined in the Existing Credit Agreement but not a Lender hereunder (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exiting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), an acknowledgement that the Existing Credit Agreement is being amended and restated hereby and that such Person will not be a party hereto and (ii) from the Borrowers, for the account of each Exiting Lender, payment of all amounts then owed to each such Exiting Lender under the Existing Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent and each Lender shall have received such information as it shall have reasonably requested to comply with all applicable &#8220;know-your-customer&#8221; and anti-money laundering rules and regulations, including the Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Each Extension of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The agreement of each Lender to make any Extension of Credit requested to be made by it on any date (including its initial Extension of Credit) is subject to the satisfaction of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the representations and warranties made by any Borrower in the Loan Documents shall be true and correct in all material respects on and as of such date as if made on and as of such date (except where such representation and warranty speaks of a specific date in which case such representation and warranty shall be true and correct as of such date and except for Section 4.6), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the issuance of any Secured Letter of Credit, this clause (a) shall not be applicable to the representation and warranty set forth in Section 4.2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No Default or Event of Default shall have occurred and be continuing on such date or after giving effect to the Extensions of Credit requested to be made on such date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The obligations of the Company under Section 10 in respect of the Obligations of any other Borrower to or on behalf of which such Extension of Credit is to be made shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each borrowing by and issuance of a Letter of Credit on behalf of any Borrower hereunder shall constitute a representation and warranty by such Borrower as of the date of such Extension of Credit that the conditions contained in this Section 5.2 have been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions for Additional Subsidiary Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Material Subsidiary set forth in a written notification thereof delivered by the Company to the Administrative Agent shall become a Subsidiary Borrower on the date that the following conditions precedent shall have been satisfied&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received a Subsidiary Borrower Agreement duly executed by such Subsidiary Borrower substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Certificate&#59; Certified Certificate of Incorporation&#59; Good Standing Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received (i) a certificate of such Subsidiary Borrower substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, with appropriate insertions and attachments, including the Memorandum of Association, Articles of Incorporation or other organizational documents for such Subsidiary Borrower certified by the appropriate Governmental Authority of such Subsidiary Borrower&#8217;s relevant jurisdiction of organization and the By-laws (or equivalent) for such Subsidiary Borrower and (ii) a certificate of compliance&#47;good standing for such Subsidiary Borrower from its jurisdiction of organization.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Opinions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received an executed legal opinion of counsel to each Subsidiary Borrower in each jurisdiction reasonably requested by the Administrative Agent. Each such legal opinion shall cover such other matters incident to the transactions contemplated by this Agreement as the Administrative Agent may reasonably require.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. For purposes of compliance with the Patriot Act, the Administrative Agent and each Lender shall have received from the Company the following information with respect to such Material Subsidiary at least five Business Days prior to its becoming a Subsidiary Borrower, in the case of any Material Subsidiary that is both a Wholly Owned Subsidiary and a Domestic Subsidiary, and at least ten Business Days prior to its becoming a Subsidiary Borrower, in the case of any other Subsidiary&#58; (i) its full legal name&#59; (ii) the address of its principal place of business&#59; and (iii) if such Material Subsidiary is a Domestic Subsidiary, its United States tax identification number.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Objection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent shall not have received, within ten Business Days after providing notice to the Lenders of any such proposed Subsidiary Borrower, a written objection to the designation of such proposed Subsidiary Borrower from any Lender on the grounds that (i) lending to such proposed Subsidiary Borrower would be illegal for such Lender, (ii) such Lender does not have any applicable license, authority or other governmental approval to conduct business in the applicable jurisdiction or (iii) lending to such proposed Subsidiary Borrower would result in material costs to such Lender that would not otherwise be reimbursed under this Agreement.</font></div><div style="margin-bottom:24pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent and each Lender shall have received such other information as it shall have reasonably requested to comply with all applicable &#8220;know-your-customer&#8221; and anti-money laundering rules and regulations, including the Patriot Act.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company hereby agrees that, so long as the Commitments remain in effect, any Letter of Credit remains outstanding or any Loan or other amount is owing to any Lender or the Administrative Agent hereunder, the Company shall and shall cause each of its Subsidiaries to&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Furnish to the Administrative Agent&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;as soon as available, but in any event within 90&#160;days after the end of each fiscal year of the Company, a copy of the audited consolidated balance sheet of the Company and its consolidated Subsidiaries as at the end of such year and the related audited consolidated statements of comprehensive income and of cash flows for such year, setting forth in each case in comparative form the figures for the previous year certified by KPMG Audit Plc or other independent certified public accountants of nationally recognized standing&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;as soon as available, but in any event not later than 45 days after the end of each of the first three quarterly periods of each fiscal year of the Company, the unaudited consolidated balance sheet of the Company and its consolidated Subsidiaries as at the end of such quarter and the related unaudited consolidated statements of comprehensive income and of cash flows for such quarter and the portion of the fiscal year through the end of such quarter, setting forth in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">each case in comparative form the figures for the previous year, certified by a Responsible Officer of the Company as being fairly stated in all material respects (subject to normal year-end audit adjustments and the absence of footnotes).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All such financial statements shall be complete and correct in all material respects and shall be prepared in reasonable detail and in accordance with GAAP. Documents required to be delivered pursuant to Section 6.1(a) or (b) or Section 6.2(c) (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and, if so delivered, shall be deemed to have been delivered on the date (i) on which the Company posts such documents, or provides a link thereto on the Company&#8217;s website on the Internet&#59; or (ii) on which such documents are posted on the Company&#8217;s behalf on an Internet or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a third-party website (such as http&#58;&#47;&#47;sec.gov) or whether sponsored by the Administrative Agent)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Company shall (x) except to the extent that an option to automatically receive an e-mail alert with respect to any applicable document is available at <a href="https://www.sec.gov/Archives/edgar/data/1267395/000126739517000038/exhibit101aspensearcredita.htm" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:none">http&#58;&#47;&#47;investo</a>r.aspen.co&#47;EmailNotification(or another readily accessible page on the Company&#8217;s website), notify the Administrative Agent and each Lender (by telecopier or electronic mail) of the posting of any such document and (y) upon written request, provide to the Administrative Agent by electronic mail electronic versions (i.e., soft copies) of such documents. Notwithstanding anything contained herein, in every instance the Company shall be required to provide paper copies of the Compliance Certificates required by Section 6.2(a) to the Administrative Agent. Except for such Compliance Certificates, the Administrative Agent shall have no obligation to request the delivery or to maintain copies of the documents referred to above, and each Lender shall be solely responsible for maintaining its copies of such documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Certificates&#59; Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Furnish to the Administrative Agent (or, in the case of clause (d), to the relevant Lender)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;concurrently with the delivery of any financial statements pursuant to Section 6.1, a certificate of a Responsible Officer of the Company stating that, to the best of such Responsible Officer&#8217;s knowledge, each Borrower during such period has observed or performed all of its covenants and other agreements, and satisfied every condition contained in this Agreement and the other Loan Documents to which it is a party to be observed, performed or satisfied by it, and that such Responsible Officer has obtained no knowledge of any Default or Event of Default except as specified in such certificate and a Compliance Certificate containing all information and calculations necessary for determining compliance by the Company with the provisions of Section 7.1 and Section 7.9 of this Agreement as of the last day of the fiscal quarter or fiscal year of the Company, as the case may be&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;within 45 days after the end of each of the first three quarterly periods of each fiscal year of the Company, a narrative discussion and analysis of the consolidated financial condition and results of operations of the Company and its Subsidiaries for such fiscal quarter and for the period from the beginning of the then current fiscal year to the end of such fiscal quarter, as compared to the portion of the projections covering such periods and to the comparable periods of the previous year (it being understood that the delivery of the management&#8217;s discussion and analysis of the Form 10-Q containing the financial statements delivered pursuant to Section 6.1 shall satisfy the requirement of this Section 6.2(b))&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;within five days after the same are sent, copies of all financial statements and reports that the Company sends to the holders of any class of its debt securities or public equity </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">securities and, within five days after the same are filed, copies of all financial statements and reports that the Company files with the SEC&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;promptly, such additional financial and other information regarding the business, operations and financial conditions of the Company or any of its Subsidiaries as any Lender may from time to time reasonably request&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;promptly following receipt thereof, copies of any documents described in Sections 101(f), 101(k) or 101(l) of ERISA that any Borrower or any Commonly Controlled Entity may request with respect to any Multiemployer Plan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if any Borrower or any Commonly Controlled Entity has not requested such documents or notices from the administrator or sponsor of the applicable Multiemployer Plan, then, upon reasonable request of the Administrative Agent, any Borrower and&#47;or any Commonly Controlled Entity shall promptly make a request for such documents or notices from such administrator or sponsor and the Company shall provide copies of such documents and notices to the Administrative Agent (on behalf of each relevant Lender) promptly after receipt thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Pay, discharge or otherwise satisfy at or before maturity or before they become delinquent, as the case may be, all its material obligations (including taxes) of whatever nature, except where the amount or validity thereof is currently being contested in good faith by appropriate proceedings and reserves in conformity with GAAP with respect thereto have been provided on the books of the relevant Group Member or where the failure to pay, discharge or satisfy would not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Maintenance of Existence&#59; Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. (a)(i) Preserve, renew and keep in full force and effect the organizational existence of the Company, each Material Subsidiary and each Insurance Subsidiary and (ii) take all reasonable action to maintain all rights, privileges and franchises necessary or desirable in the normal conduct of its business, including all required insurance licenses of each Material Subsidiary, except, in each case, as otherwise permitted by Section 7.3 and except, in the case of each of clauses (i) and (ii) above, to the extent that failure to do so could not reasonably be expected to have a Material Adverse Effect&#59; and (b) comply with all Requirements of Law except to the extent that failure to comply therewith would not, in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Maintenance of Property&#59; Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (a)&#160; Keep all property useful and necessary in the business of the Company, each Material Subsidiary and each Insurance Subsidiary in good working order and condition, ordinary wear and tear excepted and (b)&#160;maintain with financially sound and reputable insurance companies insurance on all the property of the Company, each Material Subsidiary and each Insurance Subsidiary in at least such amounts and against at least such risks as are usually insured against in the same general area by companies engaged in the same or a similar business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Inspection of Property&#59; Books and Records&#59; Discussions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. (a) Keep such books of records and account as are necessary to permit the Company and its Subsidiaries to prepare financial statements that are in conformity with GAAP and that are in compliance with all Requirements of Law relating to the maintenance of financial records (except, in the case of such Requirements of Law, to the extent that the failure to comply therewith could not reasonably be expected to have a Material Adverse Effect) and (b) permit representatives of the Administrative Agent to visit and inspect any of its properties and examine and make abstracts from any of its books and records at any reasonable time and as often as may reasonably be desired and to discuss the business, operations, properties and financial and other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">condition of the Group Members with officers and employees of the Group Members and with their independent certified public accountants&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Company shall have an opportunity to participate in any discussions with any public accountants.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Promptly give notice to the Administrative Agent and each Lender of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the occurrence of any Default or Event of Default&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;any (i) default or event of default under any Contractual Obligation of any Group Member or (ii) litigation, investigation or proceeding that may exist at any time between any Group Member and any Governmental Authority, that in either case, if not cured or if adversely determined, as the case may be, could reasonably be expected to have a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;any other development or event that has had or could reasonably be expected to have a Material Adverse Effect&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;if a Borrower has knowledge that the aggregate Secured L&#47;C Obligations of such Borrower exceed the Borrowing Base of such Borrower and the Borrower has not paid or delivered to the Custodian such cash and&#47;or Eligible Securities sufficient to cause the Borrowing Base of such Borrower to be at least equal to the Secured L&#47;C Obligations of such Borrower in accordance with Section 2.5(b).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each notice pursuant to this Section 6.7 shall be accompanied by a statement of a Responsible Officer setting forth details of the occurrence referred to therein and stating what action the relevant Group Member proposes to take with respect thereto.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except as would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect, comply with all applicable Environmental Laws.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company hereby agrees that, so long as the Commitments remain in effect, any Letter of Credit remains outstanding or any Loan or other amount is owing to any Lender or the Administrative Agent hereunder, the Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Condition Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Permit the Consolidated Leverage Ratio as at the last day of any fiscal quarter of the Company to exceed 35%.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Tangible Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Permit Consolidated Tangible Net Worth as at any date to be less than the sum of (i) $2,323,100,000, (ii) 25% of Consolidated Net Income during the period from January 1, 2017 to and including such date (if positive) and (iii) 25% of the aggregate Net Cash Proceeds of all issuances by the Company of shares of its Capital Stock during the period from January 1, 2017 to and including such date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. With respect to the Company, create, incur, assume or permit to exist any Indebtedness, except for (i) the Obligations and (ii) other Indebtedness that is either </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">pari</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in right of payment with, or subordinated in right of payment to, the Obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, at the time of incurrence of such other Indebtedness, no Default or Event of Default shall have occurred and be continuing or would result therefrom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;With respect to any Subsidiary of the Company, create, incur, assume or permit to exist any Indebtedness, except for&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Indebtedness of any Borrower pursuant to any Loan Document&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Indebtedness of any Group Member to any other Group Member&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Guarantee Obligations by any Group Member of obligations of any other Group Member&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;Indebtedness outstanding on the date hereof and listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.2(b)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and any refinancings, refundings, renewals or extensions thereof (without increasing, or shortening the maturity of, the principal amount thereof, except by an amount equal to any existing commitments or increase options unutilized thereunder)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Indebtedness (including Capital Lease Obligations) incurred in the ordinary course of business and secured by Liens permitted by Section 7.6(h) in an aggregate principal amount not to exceed $25,000,000 at any one time outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;obligations (contingent or otherwise) existing or arising under any Swap Contract&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such obligations are (or were) entered into by such Subsidiary for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets or property held or reasonably anticipated by such Subsidiary, or changes in the value of securities issued by such Subsidiary, and not for purposes of speculation or taking a &#8220;market view&#8221;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;Indebtedness for letters of credit which have been issued on behalf of any Insurance Subsidiary to or for the benefit of reinsurance cedents or insurance clients in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(viii)&#160;&#160;&#160;&#160;Indebtedness of any Subsidiary incurred under securities lending arrangements entered into in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ix)&#160;&#160;&#160;&#160;Indebtedness incurred in the ordinary course of business in connection with workers&#8217; compensation claims, self-insurance obligations, unemployment insurance or other forms of governmental insurance or benefits pursuant to letters of credit or other security arrangements entered into in connection with such insurance or benefit&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;Indebtedness with respect to any Lien described in Section 7.6(p)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Indebtedness existed at the time the relevant Investment was made and such Indebtedness was not incurred with, as a result of or in contemplation of such Investment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(xi)&#160;&#160;&#160;&#160;to the extent constituting Indebtedness, any Indebtedness pursuant to overdraft facilities in the ordinary course of business and consistent with past practice&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(xii)&#160;&#160;&#160;&#160;so long as no Default or Event of Default shall have occurred and be continuing or would result therefrom, additional Indebtedness incurred in the ordinary course of business not otherwise permitted under this Section 7.2(b) in an aggregate principal amount (for all Subsidiaries) not to exceed 10% of Consolidated Tangible Net Worth at the time of creation, incurrence or assumption, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Disposition of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Dispose of any of its property, whether now owned or hereafter acquired, or, in the case of any Subsidiary, issue or sell any shares of such Subsidiary&#8217;s Capital Stock to any Person, except&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;transactions in the ordinary course of business involving current assets or other assets classified in the Company&#8217;s balance sheet as available for sale or trading (as defined in FAS 115), including the disposition in the ordinary course of business of any assets in its investment portfolio&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Disposition of obsolete, worn out or surplus property in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the sale of inventory in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the license (as licensor) of intellectual property so long as such license does not materially interfere with the business of the Company or any of its Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;the release, surrender or waiver of contract, tort or other claims of any kind as a result of the settlement of any litigation or threatened litigation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;the granting or existence of Liens (and foreclosure thereon) not prohibited by this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;the lease or sublease of real property so long as such lease or sublease does not materially interfere with the business of the Company or any of its Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;dividends not prohibited by Section 7.4&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;any ceding of insurance or reinsurance in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Dispositions permitted by Section 7.10(d)(i)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;the sale or issuance of any Subsidiary&#8217;s Capital Stock to any Borrower&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;Dispositions of the equity interests in a Subsidiary to a Wholly Owned Subsidiary of the Company&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;Dispositions of other property during any fiscal year of the Company having an aggregate fair market value not to exceed 10% of the consolidated assets of the Company and its Subsidiaries as of the last day of the prior fiscal year of the Company&#59;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Declare or pay any dividend (other than dividends payable solely in common stock of the Person making such dividend) on, or make any payment on account of, or set apart assets for a sinking or other analogous fund for, the purchase, redemption, defeasance, retirement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or other acquisition of, any Capital Stock of any Group Member (excluding (i) the 7.25% Perpetual Non-Cumulative Preference Shares issued by the Company in April 2012, (ii) the 5.95% Perpetual Non-Cumulative Preference Shares issued by the Company in May of 2013 and (iii) any other Hybrid Capital), whether now or hereafter outstanding, or make any other distribution in respect thereof, either directly or indirectly, whether in cash or property or in obligations of any Group Member (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), except that (a) any Subsidiary may make Restricted Payments to any Group Member and (b) so long as no Default or Event of Default shall have occurred and be continuing or would result therefrom, the Company may make Restricted Payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Make any advance, loan, extension of credit (by way of guaranty or otherwise) or capital contribution to, or purchase any Capital Stock, bonds, notes, debentures or other debt securities of, or any assets constituting a business unit of, or make any other investment in, any Person (all of the foregoing, &#8220;Investments&#8221;), except&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;extensions of trade credit in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;investments in Cash Equivalents&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;investments in securities lending arrangements entered into in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Guarantee Obligations permitted by Section 7.2&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;loans and advances to employees of any Group Member in the ordinary course of business (including for travel, entertainment and relocation expenses) in an aggregate amount for all Group Members not to exceed $5,000,000 at any one time outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;intercompany Investments by any Group Member in any other Group Member&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;acquisitions of all or substantially all of the Capital Stock or assets of another Person so long as at such time and immediately after giving effect thereto no Default or Event of Default exists or would result therefrom&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;(i) Investments by Insurance Subsidiaries in the ordinary course of business and (ii) Investments by the Company and its Subsidiaries that are not Insurance Subsidiaries in Investments that, if made by an Insurance Subsidiary, would be permitted by clause (i) immediately preceding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Investments of any Person at the time such Person becomes a Subsidiary and any modification, replacement, renewal or extension thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> such Investment was not made in connection with or anticipation of such Person becoming a Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Investments listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Investments in any ILS Entity&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;in addition to Investments otherwise expressly permitted by this Section, Investments by the Company or any of its Subsidiaries in an aggregate amount during the term of this Agreement (valued at cost, but giving effect to any distributions or returns therefrom) not to exceed 20 % of Consolidated Tangible Net Worth at the time any such Investment is made.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Create, incur, assume or suffer to exist any Lien upon any of its property, whether now owned or hereafter acquired, except&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Liens for taxes not yet due or that are being contested in good faith by appropriate proceedings, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that adequate reserves with respect thereto are maintained on the books of the Company or its Subsidiaries, as the case may be, in conformity with GAAP&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s or other like Liens arising in the ordinary course of business that are not overdue for a period of more than 30 days or that are being contested in good faith by appropriate proceedings&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;pledges or deposits in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;deposits to secure the performance of bids, trade contracts (other than for borrowed money), leases, statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Liens on assets of any Insurance Subsidiary pledged as collateral for Indebtedness of such Insurance Subsidiary incurred under Section 7.2(b)(vii)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Liens on assets of any Insurance Subsidiary created to secure obligations of such Insurance Subsidiary in connection with insurance and reinsurance arrangements&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;easements, rights-of-way, restrictions and other similar encumbrances incurred in the ordinary course of business that, in the aggregate, are not substantial in amount and that do not in any case materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of the Company or any of its Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Liens securing Indebtedness of the Company or any Subsidiary incurred pursuant to Section 7.2(a) or Section 7.2(b)(v) to finance the acquisition, construction or improvement of fixed or capital assets, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) such Liens shall be created substantially simultaneously with the acquisition, construction or improvement of such fixed or capital assets, (ii) such Liens do not at any time encumber any property other than the property financed by such Indebtedness, and (iii) the aggregate amount of all such Indebtedness of all Subsidiaries does not exceed the limit set forth in Section 7.2(b)(v)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Liens created pursuant to the Security Documents&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;any interest or title of a lessor under any lease entered into by the Company or any other Subsidiary in the ordinary course of its business and covering only the assets so leased&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Liens (including Liens in favor of the Custodian with respect to the Accounts) on cash and securities of any Group Member incurred as part of the management of its investment portfolio in accordance with customary portfolio management practice and not in violation of its investment policy as in effect on the date of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that, with respect to the Accounts, such Liens shall be permitted only to the extent that the Custodian has agreed to subordinate such Liens as provided in the applicable Collateral Account Control Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;Liens existing on the date hereof and listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;Liens arising in the ordinary course of business on operating accounts maintained by any Group Member in the ordinary course of business securing obligations (other than Indebtedness) arising in the ordinary course of business in favor of the banks in which such operating accounts are maintained&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;attachments, judgments and similar Liens for sums not exceeding $50,000,000 in the aggregate (excluding any portion thereof covered by insurance as to which the relevant insurance company has acknowledged coverage)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;attachments, judgments and similar Liens for sums of $50,000,000 or more (excluding any portion thereof which is covered by insurance as to which the relevant insurance company has acknowledged coverage), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the execution or other enforcement of such Liens is stayed and fully bonded pending appeal&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;any Lien existing on property acquired in connection with an Investment made in connection with Section 7.5, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Lien shall extend solely to the item or items of property so acquired and, if required by the terms of the instrument originally creating such Lien, other property which is an improvement to or is acquired for specific use in connection with such acquired property&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;restrictions and similar encumbrances created pursuant to Requirements of Law upon the sale or transferability of the Capital Stock of any Insurance Subsidiary and the exercise of any right to control any such Insurance Subsidiary</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;Liens securing Swap Contracts of any Subsidiary of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;Liens securing obligations of the Borrowers under any secured letter of credit facility existing on the Closing Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;any extension, renewal or replacement of any Lien permitted by the preceding subparagraphs of this Section 7.6, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no additional property (other than a substitution of like property) shall be encumbered thereby and no additional Indebtedness shall be secured thereby unless such additional Indebtedness on such property would have been permitted in connection with the original creation, incurrence or assumption of such Lien&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;other Liens securing obligations not at any time exceeding 10% of Consolidated Tangible Net Worth in the aggregate for the Company and all Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the avoidance of doubt, Liens made pursuant to Section 430(k) of the Code or Section 303(k) of ERISA shall not be permitted Liens.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Clauses Restricting Subsidiary Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Enter into or suffer to exist or become effective any consensual encumbrance or restriction on the ability of any Subsidiary of the Company to (a) make Restricted Payments in respect of any Capital Stock of such Subsidiary held by, or pay any Indebtedness owed to, the Company or any other Subsidiary of the Company, (b) make loans or advances to, or other Investments in, the Company or any other Subsidiary of the Company or (c) transfer any of its assets to the Company or any other Subsidiary of the Company, except for such encumbrances or restrictions existing under or by reason of (i) any restrictions existing under the Loan Documents and (ii) any restrictions with respect to a Subsidiary imposed pursuant to an agreement that has been entered into </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in connection with the Disposition of all or substantially all of the Capital Stock or assets of such Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Enter into any business, either directly or through any Subsidiary, except for insurance, reinsurance or insurance-related businesses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Rating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Permit at any time the rating of any Relevant Subsidiary that is rated by AM Best to have a rating below AM Best financial strength rating B++. For purposes herein, a &#8220;Relevant Subsidiary&#8221; is any Insurance Subsidiary the total consolidated assets or total consolidated revenues of which exceed 10% of the total consolidated assets or total consolidated revenues, respectively, of the Company and its Subsidiaries at the end of or for, respectively, the then most recently completed fiscal quarter of the Company for which financial statements shall have been made available to the Lenders as required herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidations, Amalgamations, Mergers and Liquidations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Enter into any merger, consolidation or amalgamation, or liquidate, wind up or dissolve itself (or suffer any liquidation or dissolution), or Dispose of all or substantially all of its property or business, except for (a) the merger or consolidation of any Subsidiary of the Company with or into the Company (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Company shall be the continuing or surviving corporation)&#59; (b) the merger or consolidation by any Borrower with or into any other Borrower&#59; (c) the merger or consolidation of any Subsidiary of the Company which is not a Borrower with or into any other Subsidiary of the Company which is not a Borrower or with or into any Borrower (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Borrower is the surviving corporation)&#59; (d) the Disposition by any Subsidiary of the Company of any or all of its assets (i) to any Borrower (upon voluntary liquidation or otherwise) or (ii) pursuant to a Disposition permitted by Section 7.3&#59; and (e) the merger or consolidation by any Person (other than as set forth above) with or into the Company or any other Borrower (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Company or such Borrower is the continuing or surviving corporation) so long as at the time of such merger or consolidation and immediately after giving effect thereto no Default or Event of Default exists or would result therefrom.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Sell, lease or otherwise transfer any property or assets to, or purchase, lease or otherwise acquire any property or assets from, or otherwise engage in any other transactions with, any of its Affiliates, except (a) transactions that (i)&#160;are in the ordinary course of business and (ii)&#160;are at prices and on terms and conditions not less favorable to the applicable Borrower or such Subsidiary than could be obtained on an arm&#8217;s-length basis from unrelated third parties, (b)&#160;transactions between or among any Borrower and any other Borrower not involving any other Affiliate and (c) transactions with any ILS Entity.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EVENTS OF DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If any of the following events shall occur and be continuing&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;any Borrower shall fail to pay any principal of any Loan or any Reimbursement Obligation when due in accordance with the terms hereof&#59; or any Borrower shall fail to pay any interest on any Loan or any other amount payable hereunder or under any other Loan Document, within five Business Days after any such interest or other amount becomes due in accordance with the terms hereof&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;any representation or warranty made or deemed made by any Borrower herein or in any other Loan Document or that is contained in any certificate, document or financial or other statement furnished by it at any time under or in connection with this Agreement or any such other Loan Document shall prove to have been inaccurate in any material respect on or as of the date made or deemed made&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;any Borrower shall default in the observance or performance of any agreement contained in Section 6.4(a) (with respect to the Borrowers only), Section 6.7(a) or Section 7 of this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;any Borrower shall default in the observance or performance of any other agreement contained in this Agreement or any other Loan Document (other than as provided in paragraphs (a) through (c) of this Section), and such default shall continue unremedied for a period of 30 days after notice to the Company from the Administrative Agent or the Required Lenders&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;any Group Member shall (i) default in making any payment of any principal of any Indebtedness (including any Guarantee Obligation, but excluding the Loans) on the scheduled or original due date with respect thereto&#59; or (ii) default in making any payment of any interest on any such Indebtedness beyond the period of grace, if any, provided in the instrument or agreement under which such Indebtedness was created&#59; or (iii) default in the observance or performance of any other agreement or condition relating to any such Indebtedness or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default or other event or condition is to cause, or to permit the holder or beneficiary of such Indebtedness (or a trustee or agent on behalf of such holder or beneficiary) to cause, with the giving of notice if required, such Indebtedness to become due prior to its stated maturity&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that a default, event or condition described in clause (i), (ii) or (iii) of this paragraph (e) shall not at any time constitute an Event of Default unless, at such time, one or more defaults, events or conditions of the type described in clauses (i), (ii) and (iii) of this paragraph (e) shall have occurred and be continuing with respect to Indebtedness the outstanding principal amount of which exceeds in the aggregate $50,000,000&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;(i) the Company or any Material Subsidiary shall commence any case, proceeding or other action (A) under any existing or future law of any jurisdiction, domestic or foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition or other relief with respect to it or its debts, or (B) seeking appointment of a receiver, trustee, custodian, conservator or other similar official for it or for all or any substantial part of its assets, or the Company or any Material Subsidiary shall make a general assignment for the benefit of its creditors&#59; or (ii) there shall be commenced against the Company or any Material Subsidiary any case, proceeding or other action of a nature referred to in clause (i) above that (A) results in the entry of an order for relief or any such adjudication or appointment or (B) remains undismissed, undischarged or unbonded for a period of 60 days&#59; or (iii) there shall be commenced against the Company or any Material Subsidiary any case, proceeding or other action seeking issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its assets that results in the entry of an order for any such relief that shall not have been vacated, discharged, or stayed or bonded pending appeal within 60 days from the entry thereof&#59; or (iv) the Company or any Material Subsidiary shall take any action in furtherance of, or indicating its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">consent to, approval of, or acquiescence in, any of the acts set forth in clause (i), (ii), or (iii) above&#59; or (v) the Company or any Material Subsidiary shall generally not, or shall be unable to, or shall admit in writing its inability to, pay its debts as they become due&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;one or more judgments or decrees shall be entered against any Group Member, and either (x) shall not have been vacated, discharged, stayed or bonded pending appeal within 60 days from the entry thereof or (y) enforcement proceedings are commenced by any creditor upon such judgment or decree, involving in the aggregate a liability (not paid or fully covered by insurance as to which the relevant insurance company has not denied coverage) of $50,000,000 or more&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;any Loan Document shall cease, for any reason, to be in full force and effect or any Borrower shall so assert&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;a Change of Control shall occur&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;(i) any Single Employer Plan shall fail to meet the minimum funding standards (within the meaning of Sections 412 or 430 of the Code or Section 302 of ERISA), whether or not waived, or any Lien in favor of the PBGC or a Single Employer Plan shall arise on the assets of any Group Member or any Commonly Controlled Entity, (ii) a Reportable Event shall occur with respect to, or proceedings shall commence to have a trustee appointed, or a trustee shall be appointed, to administer or to terminate, any Single Employer Plan, which Reportable Event or commencement of proceedings or appointment of a trustee is, in the reasonable opinion of the Required Lenders, likely to result in the termination of such Single Employer Plan for purposes of Title IV of ERISA, (iii) any Single Employer Plan shall terminate for purposes of Title IV of ERISA (other than a standard termination within the meaning of Section 4041(b) of ERISA), (iv) there shall be a determination that any Single Employer Plan is, or is expected to be, in &#8220;at risk&#8221; status (within the meaning of Section 430 of the Code or Section 303 of ERISA)&#59; (v) any Group Member or any Commonly Controlled Entity shall, or in the reasonable opinion of the Required Lenders is likely to, incur any liability in connection with a withdrawal from, or the Insolvency of, a Multiemployer Plan or a determination that any such Multiemployer Plan is in &#8220;endangered&#8221; or &#8220;critical&#8221; status (within the meaning of Section 432 of the Code or Section 305 of ERISA), or (vi) any other event or condition shall occur or exist with respect to a Plan&#59; and in each case in clauses (i) through (vi) above, such event or condition, together with all other such events or conditions, if any, could, in the sole judgment of the Required Lenders, reasonably be expected to have a Material Adverse Effect&#59;</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then, and in any such event, (A) if such event is an Event of Default specified in clause (i) or (ii) of paragraph (f) above with respect to any Borrower, automatically the Commitments shall immediately terminate and the Loans (with accrued interest thereon) and all other amounts owing under this Agreement and the other Loan Documents (including all amounts of L&#47;C Obligations, whether or not the beneficiaries of the then outstanding Letters of Credit shall have presented the documents required thereunder) shall immediately become due and payable, and (B) if such event is any other Event of Default, any or all of the following actions may be taken&#58; (i) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall, by notice to the Company declare the Commitments to be terminated forthwith, whereupon the Commitments shall immediately terminate&#59; (ii) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall, by notice to the Company, declare the Loans (with accrued interest thereon) and all other amounts owing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under this Agreement and the other Loan Documents (including all amounts of L&#47;C Obligations, whether or not the beneficiaries of the then outstanding Letters of Credit shall have presented the documents required thereunder) to be due and payable forthwith, whereupon the same shall immediately become due and payable and (iii) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall direct the Collateral Agent to exercise in respect of the Collateral, the rights and remedies under the Security Documents, subject to the provisions of Section 9.5(b) below. With respect to each Letter of Credit issued on behalf of any Borrower with respect to which presentment for honor shall not have occurred at the time of an acceleration pursuant to this paragraph, such Borrower shall at such time deposit in a cash collateral account opened by the Administrative Agent an amount in the currency in which such Letter of Credit is denominated equal to the aggregate then undrawn and unexpired amount of such Letter of Credit. Amounts held in each such cash collateral account shall be applied by the Administrative Agent to the payment of drafts drawn under such Letter of Credit in accordance with the terms and conditions set forth in Section 3, and the unused portion thereof after all Letters of Credit issued on behalf of such Borrower shall have expired or been fully drawn upon, if any, shall be applied to repay other obligations of such Borrower hereunder and under the other Loan Documents. After all Letters of Credit of such Borrower shall have expired or been fully drawn upon, all Reimbursement Obligations shall have been satisfied and all other obligations of such Borrower hereunder and under the other Loan Documents shall have been paid in full, the balance, if any, in such cash collateral account shall be returned to such Borrower (or such other Person as may be lawfully entitled thereto). Except as expressly provided above in this Section, presentment, demand, protest and all other notices of any kind are hereby expressly waived by the Borrowers.</font></div><div style="margin-bottom:24pt;text-align:center;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE AGENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Appointment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Lender hereby irrevocably designates and appoints the Administrative Agent as the agent of such Lender under this Agreement and the other Loan Documents and the Collateral Agent as the agent of such Lender and the Administrative Agent under the Security Agreement, and each such Lender irrevocably authorizes the Administrative Agent and the Collateral Agent, as the case may be, in such capacities, to take such action on its behalf under the provisions of this Agreement and the other Loan Documents, as applicable, and to exercise such powers and perform such duties as are expressly delegated to the Administrative Agent and the Collateral Agent, as the case may be, by the terms of this Agreement and the other Loan Documents, as applicable, together with such other powers as are reasonably incidental thereto. Notwithstanding any provision to the contrary elsewhere in this Agreement, neither the Administrative Agent nor the Collateral Agent shall have any duties or responsibilities, except those expressly set forth herein, or any fiduciary relationship with any Lender, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or any other Loan Document or otherwise exist against the Administrative Agent or the Collateral Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent and each Lender understand and agree that all Liens created by the Security Agreement on the Collateral have been created in favor of the Collateral Agent, for the benefit of the Administrative Agent and the Lenders, that all rights to take remedial action with respect to the Collateral under the Security Agreement have been granted to the Collateral Agent and that neither the Administrative Agent nor any Lender has the right to take any such remedial action with respect to the Collateral other than through the Collateral Agent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Delegation of Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent and the Collateral Agent may each execute any of its duties under this Agreement and the other Loan Documents by or through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties. Neither the Administrative Agent nor the Collateral Agent shall be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exculpatory Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither any Agent nor any of their respective officers, directors, employees, agents, attorneys-in-fact or affiliates shall be (i) liable for any action lawfully taken or omitted to be taken by it or such Person under or in connection with this Agreement or any other Loan Document (except to the extent the action or omission was performed with gross negligence or willful misconduct as determined by a final and nonappealable decision of a court of competent jurisdiction) or (ii) responsible in any manner to any of the Lenders for any recitals, statements, representations or warranties made by any Borrower or any officer thereof contained in this Agreement or any other Loan Document or in any certificate, report, statement or other document referred to or provided for in, or received by the Agents under or in connection with, this Agreement or any other Loan Document or for the value, validity, effectiveness, genuineness, enforceability or sufficiency of this Agreement or any other Loan Document or for any failure of any Borrower party thereto to perform its obligations hereunder or thereunder. The Collateral Agent shall not be liable for any action taken or omitted (i) at the express direction of the Administrative Agent or (ii) with the consent of the Required Lenders, in each case, except to the extent the action or omission directed or consented to was performed with gross negligence or willful misconduct as determined by a final and nonappealable decision of a court of competent jurisdiction. The Agents shall not be under any obligation to any Lender to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this Agreement or any other Loan Document, or to inspect the properties, books or records of any Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#160;&#160;&#160;&#160; The Administrative Agent shall be entitled to rely, and shall be fully protected in relying, upon any instrument, writing, resolution, notice, consent, certificate, affidavit, letter, telecopy, telex or teletype message, statement, order or other document or conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including counsel to the Borrowers), independent accountants and other experts selected by the Administrative Agent. The Administrative Agent may deem and treat the payee of any Note as the owner thereof for all purposes unless a written notice of assignment, negotiation or transfer thereof shall have been filed with the Administrative Agent. The Administrative Agent shall be fully justified in failing or refusing to take any action under this Agreement or any other Loan Document unless it shall first receive such advice or concurrence of the Required Lenders (or, if so specified by this Agreement, all Lenders) as it deems appropriate or it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense that may be incurred by it by reason of taking or continuing to take any such action. The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting under this Agreement and the other Loan Documents in accordance with a request of the Required Lenders (or, if so specified by this Agreement, all Lenders) and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and all future holders of the Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Collateral Agent shall be entitled to rely, and shall be fully protected in relying, upon any instrument, writing, resolution, notice, consent, certificate, affidavit, letter, telecopy, telex or teletype message, statement, order or other document or conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including counsel to the Borrowers), independent accountants and other experts selected by the Collateral Agent. The Collateral Agent may deem and treat the payee of any Note </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as the owner thereof for all purposes unless a written notice of assignment, negotiation or transfer thereof shall have been filed with the Administrative Agent. The Collateral Agent shall be fully justified in failing or refusing to take any action under any Security Document unless it shall first receive the direction of the Administrative Agent under Section 8 or such advice or concurrence of the Required Lenders (or, if so specified by this Agreement, all Lenders) as it deems appropriate or it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense that may be incurred by it by reason of taking or continuing to take any such action. The Collateral Agent shall in all cases be fully protected in acting, or in refraining from acting, under the Security Agreement at the direction of the Administrative Agent under Section 8 or in accordance with a request of the Required Lenders (or, if so specified by this Agreement, all Lenders), and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and all future holders of the Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#160;&#160;&#160;&#160; The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default unless it has received notice from a Lender or the Company referring to this Agreement, describing such Default or Event of Default and stating that such notice is a &#8220;notice of default&#8221;. In the event that the Administrative Agent receives such a notice, the Administrative Agent shall give notice thereof to the Lenders. The Administrative Agent shall take action with respect to such Default or Event of Default as shall be directed by the Required Lenders (or, if so specified by this Agreement, all Lenders)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that unless and until the Administrative Agent shall have received such directions, the Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable in the best interests of the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Collateral Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default unless it has received notice from the Administrative Agent, a Lender or the Company referring to this Agreement, describing such Default or Event of Default and stating that such notice is a &#8220;notice of default&#8221;. The Collateral Agent shall take action with respect to such Default or Event of Default as shall be directed by the Administrative Agent under Section 8, or by the Required Lenders (or, if so specified by this Agreement, all Lenders)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that unless and until the Collateral Agent shall have received such directions, the Collateral Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable in the best interests of the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Reliance on Agents and Other Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Lender expressly acknowledges that neither the Agents nor any of their respective officers, directors, employees, agents, attorneys-in-fact or affiliates have made any representations or warranties to it and that no act by any Agent hereafter taken, including any review of the affairs of a Borrower or any affiliate of a Borrower, shall be deemed to constitute any representation or warranty by any Agent to any Lender. Each Lender represents to the Agents that it has, independently and without reliance upon any Agent or any other Lender, and based on such documents and information as it has deemed appropriate, made its own appraisal of and investigation into the business, operations, property, financial and other condition and creditworthiness of the Borrowers and their affiliates and made its own decision to make its Loans hereunder and enter into this Agreement. Each Lender also represents that it will, independently and without reliance upon any Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Loan Documents, and to make such investigation as it deems necessary to inform itself as to the business, operations, property, financial and other condition and creditworthiness of the Borrowers and their affiliates. Except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative Agent hereunder, neither the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Administrative Agent nor the Collateral Agent shall have any duty or responsibility to provide any Lender with any credit or other information concerning the business, operations, property, condition (financial or otherwise), prospects or creditworthiness of any Borrower or any affiliate of a Borrower that may come into the possession of the Administrative Agent or the Collateral Agent or any of its respective officers, directors, employees, agents, attorneys-in-fact or affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#160;&#160;&#160;&#160; The Lenders agree to indemnify each Agent (other than the Collateral Agent) in its capacity as such (to the extent not reimbursed by the Borrowers and without limiting the obligation of each Borrower to do so), ratably according to their respective Aggregate Exposure Percentages in effect on the date on which indemnification is sought under this Section (or, if indemnification is sought after the date upon which the Commitments shall have terminated and the Loans shall have been paid in full, ratably in accordance with such Aggregate Exposure Percentages immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind whatsoever that may at any time (whether before or after the payment of the Loans) be imposed on, incurred by or asserted against such Agent in any way relating to or arising out of, the Commitments, this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by such Agent under or in connection with any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no Lender shall be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements that are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from such Agent&#8217;s gross negligence or willful misconduct. The agreements in this Section shall survive the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Lenders agree to indemnify the Collateral Agent in its capacity as such (to the extent not reimbursed by the Borrowers and without limiting the obligation of each Borrower to do so), ratably according to the respective percentages which (i) the Aggregate Exposure of each Lender constitutes of (ii) the Aggregate Exposure of all Lenders in effect on the date on which indemnification is sought under this Section (or, if indemnification is sought after the date upon which the Commitments shall have terminated and the Loans shall have been paid in full, ratably in accordance with such percentages immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind whatsoever that may at any time (whether before or after the payment of the Loans) be imposed on, incurred by or asserted against the Collateral Agent in any way relating to or arising out of, the Commitments, this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by the Collateral Agent under or in connection with any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no Lender shall be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements that are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from the Collateral Agent&#8217;s gross negligence or willful misconduct. The agreements in this Section shall survive the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agent in Its Individual Capacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Agent and its affiliates may make loans to, accept deposits from and generally engage in any kind of business with any Borrower as though such Agent were not an Agent. With respect to its Loans made or renewed by it and with respect to any Letter of Credit issued or participated in by it, each Agent shall have the same rights and powers under this Agreement and the other Loan Documents as any Lender and may exercise the same as though it were not an Agent, and the terms &#8220;Lender&#8221; and &#8220;Lenders&#8221; shall include each Agent in its individual capacity.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Administrative Agent and Collateral Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Administrative Agent may resign as Administrative Agent upon 30 days&#8217; notice to the Lenders and the Company. If the Administrative Agent shall resign as Administrative Agent under this Agreement and the other Loan Documents, then the Required Lenders shall appoint from among the Lenders a successor agent for the Lenders, which successor agent shall (unless an Event of Default under Section 8(a) or Section 8(f) with respect to any Borrower shall have occurred and be continuing) be subject to approval by the Company (which approval shall not be unreasonably withheld or delayed), whereupon such successor agent shall succeed to the rights, powers and duties of the Administrative Agent and the term &#8220;Administrative Agent&#8221; shall mean such successor agent effective upon such appointment and approval, and the former Administrative Agent&#8217;s rights, powers and duties as Administrative Agent shall be terminated, without any other or further act or deed on the part of such former Administrative Agent or any of the parties to this Agreement or any holders of the Loans. If no successor agent has accepted appointment as Administrative Agent by the date that is 30 days following a retiring Administrative Agent&#8217;s notice of resignation, the retiring Administrative Agent&#8217;s resignation shall nevertheless thereupon become effective, and the Lenders shall assume and perform all of the duties of the Administrative Agent hereunder until such time, if any, as the Required Lenders under this Agreement appoint a successor agent as provided for above. After any retiring Administrative Agent&#8217;s resignation as Administrative Agent, the provisions of this Section 9 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Administrative Agent under this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Collateral Agent may resign as Collateral Agent upon 30 days&#8217; notice to the Lenders and the Company. In addition, the Company shall have the right (unless a Default or Event of Default shall have occurred and be continuing) to remove the Collateral Agent upon 30 days&#8217; prior written notice to the Administrative Agent. If the Collateral Agent shall resign or be removed as Collateral Agent under this Agreement, then the Required Lenders shall appoint from among the Lenders a successor collateral agent, which successor collateral agent shall (unless an Event of Default under Section 8(a) or Section 8(f) with respect to any Borrower shall have occurred and be continuing) be subject to approval by the Company (which approval shall not be unreasonably withheld or delayed), whereupon such successor collateral agent shall succeed to the rights, powers and duties of the Collateral Agent and the term &#8220;Collateral Agent&#8221; shall mean such successor collateral agent effective upon such appointment and approval, and the former Collateral Agent&#8217;s rights, powers and duties as Collateral Agent shall be terminated, without any other or further act or deed on the part of such former Collateral Agent or any of the parties to this Agreement or any holders of the Loans. If no successor collateral agent has accepted appointment as Collateral Agent by the date that is 30 days following a retiring Collateral Agent&#8217;s notice of resignation or the Administrative Agent&#8217;s receipt of a notice of removal, the retiring Collateral Agent (after consultation with the Company) may appoint a financial institution rated at least &#8216;A&#8217; by S&#38;P or &#8216;A&#8217; by Moody&#8217;s, as a successor collateral agent, whereupon such successor collateral agent shall succeed to the rights, powers and duties of the Collateral Agent and the term &#8220;Collateral Agent&#8221; shall mean such successor collateral agent effective upon such appointment, and the former Collateral Agent&#8217;s rights, powers and duties as Collateral Agent shall be terminated, without any other or further act or deed on the part of such former Collateral Agent or any of the parties to this Agreement or any holders of the Loans. After any retiring Collateral Agent&#8217;s resignation or removal as Collateral Agent, the provisions of this Section 9 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Collateral Agent under this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Any resignation by Barclays Bank PLC as Administrative Agent pursuant to this Section 9.9 shall also constitute its resignation as the L&#47;C Administrator. Upon the acceptance of a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">successor&#8217;s appointment as Administrative Agent hereunder, (a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the L&#47;C Administrator, (b) the retiring L&#47;C Administrator shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents, and (c) the successor L&#47;C Administrator shall issue letters of credit in substitution for the Several Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to the retiring L&#47;C Administrator to effectively assume the obligations of the retiring L&#47;C Administrator with respect to such Several Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Security Document Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Agents, the Lenders, the Issuing Lenders and the Custodian expressly acknowledge and agree that the Security Documents may be enforced only by the action of the Collateral Agent acting upon the instructions of the Required Lenders or the Administrative Agent and that no other such Person shall have any right individually to seek to enforce or to enforce the Security Documents or to realize upon the security to be granted thereby, it being understood and agreed that such rights and remedies may be exercised by the Collateral Agent for the benefit of such Persons upon the terms of the Security Documents.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Other Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Syndication Agent and the Co-Documentation Agents shall not have any duties or responsibilities hereunder in such capacity.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">GUARANTEE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#160;&#160;&#160;&#160; To induce the Lenders to execute and deliver this Agreement and to make the Loans and issue or participate in the Letters of Credit, and in consideration thereof, the Company hereby unconditionally and irrevocably guarantees to the Administrative Agent, for the ratable benefit of the Lenders and their respective successors, indorsees and assigns, the prompt and complete payment and performance when due (whether at the stated maturity, by acceleration or otherwise) of the Obligations of the Subsidiary Borrowers, and the Company further agrees to pay the expenses which may be paid or incurred by the Administrative Agent or the Lenders in collecting any or all of the Obligations and&#47;or enforcing any rights under this Section 10.1 or under the Obligations in accordance with this Section 10.1. The guarantee contained in this Section 10.1 shall remain in full force and effect and be binding in accordance with and to the extent of its terms upon the Company and the successors and assigns thereof, and shall inure to the benefit of the Lenders and their successors and permitted assigns, until the Obligations shall have been satisfied in full and the Loans shall be terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Anything herein to the contrary notwithstanding, the maximum liability of the Company hereunder shall in no event exceed the amount which can be guaranteed by the Company under applicable federal and state laws relating to the insolvency of debtors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company agrees to the extent permitted by applicable law that the Obligations may at any time and from time to time exceed the amount of the liability of the Company hereunder without impairing the guarantee contained in this Section 10 or affecting the rights and remedies of the Administrative Agent or any Lender hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The guarantee contained in this Section 10 shall remain in full force and effect until all the Obligations and the obligations of the Company under the guarantee contained in this Section 10 shall have been satisfied by payment in full, all Letters of Credit shall have expired or been terminated and the Commitments shall be terminated, notwithstanding that from time to time during the term of this Agreement the Borrowers may be free from any Obligations.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;No payment made by any Borrower, the Company or any other Person or received or collected by the Administrative Agent or any Lender from any Borrower, the Company or any other Person by virtue of any action or proceeding or any set-off or appropriation or application at any time or from time to time in reduction of or in payment of the Obligations shall be deemed to modify, reduce, release or otherwise affect the liability of the Company hereunder which shall, notwithstanding any such payment (other than any payment made by the Company in respect of the Obligations or any payment received or collected from the Company in respect of the Obligations), remain liable for the Obligations until the Obligations are paid in full and the Commitments are terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Subrogation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding any payment made by the Company hereunder or any set-off or application of funds of the Company by the Administrative Agent or any Lender, the Company shall not be entitled to be subrogated to any of the rights of the Administrative Agent or any Lender against any Borrower or any collateral security or guarantee or right of offset held by the Administrative Agent or any Lender for the payment of the Obligations, nor shall the Company seek or be entitled to seek any contribution or reimbursement from any Borrower in respect of payments made by the Company hereunder, until all amounts owing to the Administrative Agent and the Lenders by any Borrower on account of the Obligations are paid in full, and Letters of Credit shall have expired or been terminated and the Commitments are terminated. If any amount shall be paid to the Company on account of such subrogation rights at any time when all of the Obligations shall not have been paid in full, such amount shall be held by the Company in trust for the Administrative Agent and the Lenders, segregated from other funds of the Company, and shall, forthwith upon receipt by the Company, be turned over to the Administrative Agent in the exact form received by the Company (duly indorsed by the Company to the Administrative Agent, if required), to be applied against the Obligations, whether matured or unmatured, in such order as the Administrative Agent may determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments, etc. with respect to the Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall remain obligated hereunder notwithstanding that, without any reservation of rights against the Company and without notice to or further assent by the Company, any demand for payment of any of the Obligations made by the Administrative Agent or any Lender may be rescinded by the Administrative Agent or such Lender and any of the Obligations continued, and the Obligations, or the liability of any other Person upon or for any part thereof, or any collateral security or guarantee therefor or right of offset with respect thereto, may, from time to time, in whole or in part, be renewed, extended, amended, modified, accelerated, compromised, waived, surrendered or released by the Administrative Agent or any Lender, and this Agreement and the Notes and any other documents executed and delivered in connection therewith may be amended, modified, supplemented or terminated, in whole or in part, as the Administrative Agent (or the Required Lenders or all Lenders, as the case may be) may deem advisable from time to time, and any collateral security, guarantee or right of offset at any time held by the Administrative Agent or any Lender for the payment of the Obligations may be sold, exchanged, waived, surrendered or released. Neither the Administrative Agent nor any Lender shall have any obligation to protect, secure, perfect or insure any Lien at any time held by it as security for the Obligations or for the guarantee contained in this Section 10 or any property subject thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee Absolute and Unconditional</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company waives any and all notice of the creation, renewal, extension or accrual of any of the Obligations and notice of or proof of reliance by the Administrative Agent or any Lender upon the guarantee contained in this Section 10 or acceptance of the guarantee contained in this Section 10&#59; the Obligations, and any of them, shall conclusively be deemed to have been created, contracted or incurred, or renewed, extended, amended or waived, in reliance upon the guarantee contained in this Section 10&#59; and all dealings between the Borrowers and the Company, on the one hand, and the Administrative Agent and the Lenders, on the other hand, likewise </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall be conclusively presumed to have been had or consummated in reliance upon the guarantee contained in this Section 10. The Company waives diligence, presentment, protest, demand for payment and notice of default or nonpayment to or upon any Borrower or the Company with respect to the Obligations. The Company understands and agrees that the guarantee contained in this Section 10 shall be construed as a continuing, absolute and unconditional guarantee of payment without regard to (a) the validity or enforceability of this Agreement or any Note, any of the Obligations or any other collateral security therefor or guarantee or right of offset with respect thereto at any time or from time to time held by the Administrative Agent or any Lender, (b) any defense, set-off or counterclaim (other than a defense of payment or performance) which may at any time be available to or be asserted by any Borrower or any other Person against the Administrative Agent or any Lender, or (c) any other circumstance whatsoever (with or without notice to or knowledge of the Borrowers or the Company) which constitutes, or might be construed to constitute, an equitable or legal discharge of the Borrowers for the Obligations, or of the Company under the guarantee contained in this Section 10, in bankruptcy or in any other instance. When making any demand hereunder or otherwise pursuing its rights and remedies hereunder against the Company, the Administrative Agent or any Lender may, but shall be under no obligation to, make a similar demand on or otherwise pursue such rights and remedies as it may have against any Borrower, or any other Person or against any collateral security or guarantee for the Obligations or any right of offset with respect thereto, and any failure by the Administrative Agent or any Lender to make any such demand, to pursue such other rights or remedies or to collect any payments from the Borrowers, or any other Person or to realize upon any such collateral security or guarantee or to exercise any such right of offset, or any release of any Borrower, or any other Person or any such collateral security, guarantee or right of offset, shall not relieve the Company of any obligation or liability hereunder, and shall not impair or affect the rights and remedies, whether express, implied or available as a matter of law, of the Administrative Agent or any Lender against the Company. For the purposes hereof &#8220;demand&#8221; shall include the commencement and continuance of any legal proceedings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reinstatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The guarantee contained in this Section 10 shall continue to be effective, or be reinstated, as the case may be, if at any time payment, or any part thereof, of any of the Obligations is rescinded or must otherwise be restored or returned by the Administrative Agent or any Lender upon the insolvency, bankruptcy, dissolution, liquidation or reorganization of any Borrower or the Company, or upon or as a result of the appointment of a receiver, intervenor or conservator of, or trustee or similar officer for, any Borrower or the Company or any substantial part of its property, or otherwise, all as though such payments had not been made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company hereby guarantees that payments hereunder will be paid to the Administrative Agent without set-off or counterclaim in the applicable currency at the Funding Office.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Independent Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The obligations of the Company under the guarantee contained in this Section 10 are independent of the obligations of the Borrowers, and a separate action or actions may be brought and prosecuted against the Company whether or not any Borrower is joined in any such action or actions. The Company waives, to the fullest extent permitted by law, the benefit of any statute of limitations affecting its liability hereunder or the enforcement thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments and Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. None of this Agreement, any other Loan Document, or any terms hereof or thereof may be amended, supplemented or modified except in accordance with the provisions of this Section 11.1. The Required Lenders and each Borrower which is a party to the relevant Loan Document may, or, with the written consent of the Required Lenders, the Administrative Agent or, as the case may be, the Collateral Agent, and each Borrower which is a party to the relevant Loan Document may, from time to time, (a) enter into written amendments, supplements or modifications hereto and to the other Loan Documents for the purpose of adding any provisions to this Agreement or the other Loan Documents or changing in any manner the rights of the Lenders or the Agents or of the Borrowers hereunder or thereunder or (b) waive, on such terms and conditions as the Required Lenders or the Administrative Agent or the Collateral Agent, as the case may be, may specify in such instrument, any of the requirements of this Agreement or the other Loan Documents or any Default or Event of Default and its consequences&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that no such waiver and no such amendment, supplement or modification shall (i) forgive the principal amount or extend the final scheduled date of maturity of any Loan, reduce the stated rate of any interest or fee payable hereunder (except (x) in connection with the waiver of applicability of any post-default increase in interest rates and (y) that any amendment or modification of defined terms used in the financial covenants in this Agreement shall not constitute a reduction in the rate of interest or fees for purposes of this clause (i)) or extend the scheduled date of any payment thereof, or increase the amount or extend the expiration date of any Lender&#8217;s Commitment, in each case without the written consent of each Lender directly affected thereby&#59; (ii) eliminate or reduce the voting rights of any Lender under this Section 11.1 without the written consent of such Lender&#59; (iii) reduce any percentage specified in the definition of Required Lenders, consent to the assignment or transfer by the Company of any of its rights and obligations under this Agreement and the other Loan Documents, release the Company from any of its obligations under Section 10 with respect to any Borrower which has any then outstanding Obligations, amend, modify or waive any provision of Section 5.2(c), or release all or substantially all of the Collateral (other than when permitted under the Loan Documents) or release all or substantially all of the Borrowers from their obligations under the Security Documents, in each case without the written consent of all Lenders&#59; (iv) amend, modify or waive any provision of Section 11.7 without the written consent of all Lenders&#59; (v) amend, modify or waive any provision of Section 2.11(a) or (b) without the written consent of all Lenders&#59; (vi) amend, modify or waive any provision of Section 9 without the written consent of the Administrative Agent and the Collateral Agent&#59; (vii) amend, modify or waive any provision of Section 3 in any manner that is adverse to the interests of any Issuing Lender or the L&#47;C Administrator without the written consent of such Issuing Lender and&#47;or LC Administrator&#59; (viii) amend, modify or waive any provision of Section 2.17, without the consent of each of the Administrative Agent, each Issuing Lender and the L&#47;C Administrator&#59; or (ix) amend or modify (1) the definition of &#8220;Borrowing Base&#8221; or any defined terms used in such definition or (2) the provisions of any Loan Document with respect to minimum Collateral requirements, in each case, without the written consent of all Lenders. Any such waiver and any such amendment, supplement or modification shall apply equally to each of the Lenders and shall be binding upon the Loan Parties, the Lenders, the Administrative Agent, the Collateral Agent and all future holders of the Loans. In the case of any waiver, the Loan Parties, the Lenders, the Administrative Agent and the Collateral Agent shall be restored to their former position and rights hereunder and under the other Loan Documents, and any Default or Event of Default waived shall be deemed to be cured and not continuing&#59; but no such waiver shall extend to any subsequent or other Default or Event of Default, or impair any right consequent thereon. Notwithstanding anything herein to the contrary, the Collateral Agent (solely in such capacity) shall agree to any amendments, supplements, modifications or waivers as expressly directed by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Administrative Agent, provided that the Collateral Agent need not agree to any such amendment, supplement, modification or waiver that shall affect its rights or duties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. All notices, requests and demands to or upon the respective parties hereto to be effective shall be in writing (including by telecopy), and, unless otherwise expressly provided herein, shall be deemed to have been duly given or made when delivered, or three Business Days after being deposited in the mail, postage prepaid, or, in the case of telecopy notice, when received, addressed as follows in the case of the Borrowers, the Administrative Agent and the Collateral Agent, and as set forth in an administrative questionnaire delivered to the Administrative Agent in the case of the Issuing Lenders and the Lenders, or to such other address as may be hereafter notified by the respective parties hereto&#58;</font></div><div style="margin-bottom:12pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:46.612%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company, the Borrower Representative or any Borrower&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Insurance Holdings Limited</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">141 Front Street </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Hamilton HM 19 Bermuda</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58; Mark Pickering</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Telecopy&#58; 441.297.9235</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Telephone&#58;441.295.8201</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Administrative Agent&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Christopher M. Aitkin <br>745 Seventh Avenue, 25th Floor</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">New York, NY 10019</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Telecopy&#58; 212.526.5115</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Telephone&#58; 212.320.6564</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with a copy to&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Christina Hill</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">700 Prides Crossing, 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Floor</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Newark, DE 19713</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Telephone&#58; 302.286.1984</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WSO Address&#58; 12145455230&#64;TLS.LDSPROD.com</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Collateral Agent&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Bank of New York Mellon</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">101 Barclay Street, 8W </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, New York 10286</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58; Nichole Leo</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Telecopy&#58; 732.667.9536</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Telephone&#58;&#160; 412.234.2475</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any notice, request or demand to or upon the Company, the Administrative Agent, the Collateral Agent or the Lenders shall not be effective until received.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices and other communications to the Lenders hereunder may be delivered or furnished by electronic communications pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to notices pursuant to Section 2 unless otherwise agreed by the Administrative Agent and the applicable Lender. The Administrative Agent or any Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Waiver&#59; Cumulative Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No failure to exercise and no delay in exercising, on the part of the Administrative Agent, the Collateral Agent or any Lender, any right, remedy, power or privilege hereunder or under the other Loan Documents shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. All representations and warranties made hereunder, in the other Loan Documents and in any document, certificate or statement delivered pursuant hereto or in connection herewith shall survive the execution and delivery of this Agreement and the making of the Loans and other extensions of credit hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Expenses and Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company agrees (a) to pay or reimburse the Administrative Agent, the Syndication Agent and the Collateral Agent for all its reasonable and documented or invoiced out-of-pocket costs and expenses incurred in connection with the development, preparation and execution of, and any amendment, supplement or modification to, this Agreement and the other Loan Documents and any other documents prepared in connection herewith or therewith, and the consummation and administration of the transactions contemplated hereby and thereby, including the reasonable and documented or invoiced fees and disbursements of a single counsel to each of (i) the Administrative Agent and the Syndication Agent and (ii) the Collateral Agent, and such other special or local counsel as the Administrative Agent may deem reasonably necessary (and any additional counsel in the case of a conflict) and filing and recording fees and expenses, with statements with respect to the foregoing to be submitted to the Company prior to the Closing Date (in the case of amounts to be paid on the Closing Date) and from time to time thereafter on a quarterly basis or such other periodic basis as the Administrative Agent, the Syndication Agent and the Collateral Agent shall deem appropriate, (b) to pay or reimburse each Lender, the Administrative Agent, the Syndication Agent and the Collateral Agent for all its reasonable and documented or invoiced costs and expenses incurred in connection with the enforcement or preservation of any rights under this Agreement, the other Loan Documents and any such other documents, including the fees and disbursements of a single counsel to each of (i) the Administrative Agent and the Lenders and (ii) the Collateral Agent, and such other special or local counsel as the Administrative Agent may deem reasonably necessary (and any additional counsel in the case of a conflict), (c) to pay, indemnify, and hold each Lender, the Administrative Agent and the Collateral Agent harmless from, any and all recording and filing fees and any and all liabilities with respect to, or resulting from any delay in paying stamp, excise and other taxes, if any, that may be payable or determined to be payable in connection with the execution and delivery of, or consummation or administration of any of the transactions contemplated by, or any amendment, supplement or modification of, or any waiver or consent under or in respect of, this Agreement, the other Loan Documents and any such other documents, and (d) to pay, indemnify, and hold each Lender, any L&#47;C Issuer, the Administrative Agent and the Collateral Agent and their respective officers, directors, employees, advisors, affiliates and agents (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) harmless from and against any and all other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever (whether brought by a Borrower or any other Person) with respect to the execution, delivery, enforcement, performance and administration of this Agreement, the other Loan Documents or Letters of Credit and any such other documents, including any of the foregoing relating to the use of proceeds of the Loans or Letters of Credit (including any refusal by any Issuing Bank to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit) or the violation of, noncompliance with or liability under, any Environmental Law applicable to the operations of any Group Member or any of the Properties (provided that such liability was incurred during such time as a Group Member controlled such Properties) and the reasonable documented or invoiced fees and expenses of legal counsel in connection with claims, actions or proceedings by any Indemnitee against any Borrower under any Loan Document or Letter of Credit or any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by the Company, and regardless of whether any Indemnitee is a party thereto (all the foregoing in this clause (d), collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnified Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that the Company shall have no obligation hereunder to any Indemnitee with respect to Indemnified Liabilities to the extent such Indemnified Liabilities are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from the gross negligence or willful misconduct of such Indemnitee or its affiliates. Without limiting the foregoing, and to the extent permitted by applicable law, the Company agrees not to assert and to cause its Subsidiaries not to assert, and hereby waives and agrees to cause its Subsidiaries to waive, all rights for contribution from any Indemnitee or any other rights of recovery from any Indemnitee with respect to all claims, demands, penalties, fines, liabilities, settlements, damages, costs and expenses of whatever kind or nature, under or related to Environmental Laws, that any of them might have by statute or otherwise against any Indemnitee. All amounts due under this Section 11.5 shall be payable not later than 10 Business Days after written demand therefor and shall be accompanied by a statement setting forth in reasonable detail the source of such Indemnified Liability and the amount claimed thereunder. Statements payable by the Company pursuant to this Section 11.5 shall be submitted to the Company, at the address of the Company set forth in Section 11.2, or to such other Person or address as may be hereafter designated by the Company in a written notice to the Administrative Agent. The agreements in this Section 11.5 shall survive repayment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns&#59; Participations and Assignments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. (a) The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby (including any affiliate of any Issuing Lender that issues any Letter of Credit), except that (i) no Borrower may assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender (and any attempted assignment or transfer by any Borrower without such consent shall be null and void) and (ii) no Lender may assign or otherwise transfer its rights or obligations hereunder except in accordance with this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i) Subject to the conditions set forth in paragraph (b)(ii) below, any Lender may assign to one or more assignees (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans at the time owing to it) with the prior written consent (such consent not to be unreasonably withheld or delayed) of&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:31.5pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Company, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no consent of the Company shall be required for an assignment (1) to a Lender, an Affiliate of a Lender or an Approved Fund (as defined below) or (2) if an Event of Default has occurred and is continuing&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:31.5pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Administrative Agent&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:31.5pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Issuing Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Assignments shall be subject to the following additional conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:31.5pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">except in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund or an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitments or Loans, the amount of the Commitments or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than $5,000,000 unless each of the Company and the Administrative Agent otherwise consent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such amounts shall be aggregated in respect of each Lender and its Affiliates or Approved Funds, if any&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:31.5pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $3,500&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:31.5pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an administrative questionnaire&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:31.5pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">no such assignment shall be made to (I) a Borrower or an Affiliate or Subsidiary of a Borrower, (II) any Defaulting Lender or any of its Subsidiaries, or any Person who, upon becoming a Lender hereunder, would constitute any of the foregoing Persons described in this subclause (II), (III) a natural person or (IV) any Person which is a Non-NAIC Approved Bank (unless such Non-NAIC Approved Bank shall have in effect a Limited Fronting Lender Agreement with a Lender which is a NAIC Approved Bank).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the purposes of this Section 11.6, the term &#8220;Approved Fund&#8221; has the following meaning&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any Person (other than a natural person) that is engaged in making, purchasing, holding or investing in bank loans and similar extensions of credit in the ordinary course of its business and that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to acceptance and recording thereof pursuant to paragraph&#160;(b)(iv) below, from and after the effective date specified in each Assignment and Assumption the Assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections&#160;2.12, 2.13, 2.14 and 11.5). Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this Section 11.6 shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (c) of this Section.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent, acting for this purpose as an agent of the Borrowers, shall maintain at one of its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amount (and stated interest) of the Loans and L&#47;C Obligations owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The entries in the Register shall be conclusive, and the Borrowers, the Administrative Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the Borrowers and any Lender, at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an Assignee, the Assignee&#8217;s completed administrative questionnaire (unless the Assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph&#160;(b) of this Section and each written consent to such assignment required by paragraph (b) of this Section, the Administrative Agent shall accept such Assignment and Assumption and record the information contained therein in the Register. No assignment shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i) Any Lender may, without the consent of any Borrower, the Company, any Issuing Lender or the Administrative Agent, sell participations to one or more banks or other entities (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in all or a portion of such Lender&#8217;s rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (A)&#160;such Lender&#8217;s obligations under this Agreement shall remain unchanged, (B)&#160;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (C)&#160;the Borrowers, the Administrative Agent and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement. Any agreement pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such agreement may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver that (1) requires the consent of each Lender directly affected thereby pursuant to the proviso to the second sentence of Section 11.1 and (2) directly affects such Participant. Subject to paragraph (c)(ii) of this Section, each Borrower agrees that each Participant shall be entitled to the benefits of, and subject to the limitations of, Sections&#160;2.12, 2.13, 2.14 to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of this Section. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section&#160;11.8 as though it were a Lender, provided such Participant shall be subject to Section 11.7 as though it were a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A Participant shall not be entitled to receive any greater payment under Section 2.12 or 2.13 than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Company&#8217;s prior written consent. Any Participant that is a Non-U.S. Lender shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not be entitled to the benefits of Section&#160;2.13 unless such Participant complies with Section 2.13(e).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender that sells a participation, acting solely for this purpose as a non-fiduciary agent (solely for tax purposes) of the Borrowers, shall maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#8217;s interest in the Loans and other obligations under this Agreement (the &#8220;Participant Register&#8221;). The entries in the Participant Register shall be conclusive, and such Lender, each Borrower and the Administrative Agent shall treat each person whose name is recorded in the Participant Register pursuant to the terms hereof as the owner of such participation for all purposes of this Agreement, notwithstanding notice to the contrary.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything else provided herein or otherwise, no Lender shall have any obligation to disclose all or any portion of the Participant Register to any Borrower or any other Person (including the identity of any Participant or any information relating to a Participant's interest in the Loans or other obligations under this Agreement or any other Loan Document) except to the extent such disclosure is necessary to establish that the Loans or such other obligations are in registered form under Section 5f.103-1(c) of the United States Treasury Regulations, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Participant shall only be entitled to the benefits of this Section 11.6(c) if the identity of such Participant has been disclosed to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Lender may at any time pledge or grant a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or grant to secure obligations to a Federal Reserve Bank, and this Section shall not apply to any such pledge or grant of a security interest&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no such pledge or grant of a security interest shall release such Lender from any of its obligations hereunder or substitute any such pledgee or grantee for such Lender as a party hereto and, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that nothing in this paragraph (d) shall be deemed to limit in any way the application of Section 11.6(b) to any assignment of the rights or obligations of such Lender under this Agreement resulting from a foreclosure of any such pledge or security interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Borrower, upon receipt of written notice from the relevant Lender, agrees to issue Notes to any Lender requiring Notes to facilitate transactions of the type described in paragraph (d) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except to the extent that this Agreement expressly provides for payments to be allocated to a particular Lender or to the Lenders, if any Lender (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefitted Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) shall receive any payment of all or part of the Obligations owing to it (whether directly from the Borrower, indirectly as a result of payment under the guarantee provided for in Section 10 or from the proceeds of the exercise of any remedies with respect to the Collateral pursuant to the Security Documents or otherwise), or receive any collateral in respect thereof (whether voluntarily or involuntarily, by set-off, pursuant to events or proceedings of the nature referred to in Section 8(f), or otherwise), in a greater proportion than any such payment to or collateral received by any other Lender, if any, in respect of the Obligations owing to such other Lender, such Benefitted Lender shall purchase for cash from the other Lenders a participating interest in such portion of the Obligations owing to each such other Lender, or shall provide such other Lenders with the benefits of any such collateral, as shall be necessary to cause such Benefitted Lender to share the excess payment or benefits of such collateral ratably with each of the Lenders&#59; provided, however, that if all or any portion of such excess payment or benefits is thereafter recovered from such Benefitted Lender, such purchase shall be rescinded, and the purchase price and benefits returned, to the extent of such recovery, but without interest.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Set-off</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Upon the occurrence and continuation of an Event of Default, in addition to any rights and remedies of the Lenders provided by law, each Lender shall have the right, without prior notice to any Borrower, any such notice being expressly waived by each Borrower to the extent permitted by applicable law, upon any amount becoming due and payable by any Borrower hereunder (whether at the stated maturity, by acceleration or otherwise), to set off and appropriate and apply against such amount any and all deposits (general or special, time or demand, provisional or final), in any currency, and any other credits, indebtedness or claims, in any currency, in each case whether direct or indirect, absolute or contingent, matured or unmatured, at any time held or owing by such Lender or any branch or agency thereof to or for the credit or the account of such Borrower, as the case may be, or of the Company. Each Lender agrees promptly to notify the Company and the Administrative Agent after any such setoff and application made by such Lender, provided that the failure to give such notice shall not affect the validity of such setoff and application.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement may be executed by one or more of the parties to this Agreement on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Agreement by facsimile or other electronic transmission shall be effective as delivery of a manually executed counterpart hereof. A set of the copies of this Agreement signed by all the parties shall be lodged with the Company and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Integration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement and the other Loan Documents represent the entire agreement of the Borrowers, the Administrative Agent, the Collateral Agent and the Lenders with respect to the subject matter hereof and thereof, and there are no promises, undertakings, representations or warranties by the Administrative Agent, the Collateral Agent or any Lender relative to the subject matter hereof not expressly set forth or referred to herein or in the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. THE CHOICE OF GOVERNING LAW HAS BEEN MADE PURSUANT TO SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Submission To Jurisdiction&#59; Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company, each other Borrower, the Administrative Agent, the Collateral Agent and each Lender hereby irrevocably and unconditionally&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">submits for itself and its property in any legal action or proceeding relating to this Agreement and the other Loan Documents to which it is a party, or for recognition and enforcement of any judgment in respect thereof, to the exclusive general jurisdiction of the courts of the State of New York sitting in New York County, the courts of the United States for the Southern District of New&#160;York, and appellate courts from any thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that nothing in this Agreement shall affect any right that the Administrative Agent, any Lender or any L&#47;C Issuer may otherwise have to bring any action or proceeding relating to this Agreement or any other Loan Document against the Borrowers or their properties in the courts of any jurisdiction&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">consents that any such action or proceeding may be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to the Borrowers, as the case may be at its address set forth in Section 11.2 or at such other address of which the Administrative Agent shall have been notified pursuant thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">waives, to the maximum extent not prohibited by law, any right it may have to claim or recover in any legal action or proceeding referred to in this Section any special, exemplary, punitive or consequential damages&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, however, that nothing contained in this Section 11.13(e) shall limit the Company&#8217;s, the other Borrowers&#8217; or the Lenders&#8217; indemnity and reimbursement obligations to the extent set forth in any Loan Document in respect of any third-party claims alleging such special, exemplary, punitive or consequential damages.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Process Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company and each other Borrower hereby irrevocably designates, appoints, authorizes and empowers Aspen American Insurance Company, with offices currently located at 590 Madison Avenue, 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Floor, New York, NY 10022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Process Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), as its agent to receive on behalf of itself and its property, service of copies of the summons and complaint and any other process which may be served in any suit, action or proceeding brought in the United States District Court for the Southern District of New York or the New York Supreme Court, New York County, and any appellate court thereof. Such service may be made by delivering a copy of such process to the Company and the other relevant Borrowers in care of the Process Agent at its address specified above, with a copy delivered to the Company and the other relevant Borrowers in accordance with Section&#160;11.2, and the Company and each other Borrower hereby authorizes and directs the Process Agent to accept such service on its behalf. The appointment of the Process Agent shall be irrevocable until the appointment of a successor Process Agent. The Company and each other Borrower further agrees to promptly appoint a successor Process Agent in New York City (which shall accept such appointment in form and substance satisfactory to the Administrative Agent) prior to the termination for any reason of the appointment of the initial Process Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each payment owing by the Company or any other Borrower hereunder shall be made in the relevant currency specified herein or, if not specified herein, specified in any other Loan Document executed by the Administrative Agent or the Collateral Agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) at the place specified herein (such requirements are of the essence of this Agreement). If, for the purpose of obtaining judgment in any court, it is necessary to convert a sum due hereunder in a Currency of Payment into another currency, the parties hereto agree that the rate of exchange used shall be that at which in accordance with normal banking procedures the Administrative Agent could purchase such Currency of Payment with such other currency at the Spot Selling Rate on the Business Day preceding that on which final judgment is given. The obligations in respect of any sum due hereunder to any Lender or any L&#47;C Issuer shall, notwithstanding any adjudication expressed in a currency other than the Currency of Payment, be discharged only to the extent that, on the Business Day following receipt by such Lender or L&#47;C Issuer of any sum adjudged to be so due in such other currency, such Lender or L&#47;C Issuer may, in accordance with normal banking procedures, purchase the Currency of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Payment with such other currency. The parties hereto agree that (a) if the amount of the Currency of Payment so purchased is less than the sum originally due to such Lender or L&#47;C Issuer in the Currency of Payment, as a separate obligation and notwithstanding the result of any such adjudication, the Company or such other Borrower, as applicable, shall immediately pay the shortfall (in the Currency of Payment) to such Lender or L&#47;C Issuer and (b) if the amount of the Currency of Payment so purchased exceeds the sum originally due to such Lender or L&#47;C Issuer, such Lender or L&#47;C Issuer shall promptly pay the excess over to the Company or such other Borrower, as applicable, in the currency and to the extent actually received.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Releases of Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. (a) Notwithstanding anything to the contrary contained herein or in any other Loan Document, the Collateral Agent is hereby irrevocably authorized by each Lender (without requirement of notice to or consent of any Lender except as expressly required by Section 11.1) to take any action requested by the Company having the effect of releasing any Collateral (i) to the extent permitted by the Security Agreement and the applicable Collateral Account Control Agreement or that has been consented to in accordance with Section 11.1 or (ii) under the circumstances described in paragraph (b) below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At such time as all Letters of Credit shall have expired, been terminated or been fully cash collateralized pursuant to Section 8 and the Commitments have been terminated and no Default or Event of Default has occurred and is continuing, the Collateral (other than any such cash collateral) shall cease to secure the Obligations, the Collateral (other than any such cash collateral) shall be released from the Liens created by the Security Agreement, and the Security Agreement and each Collateral Account Control Agreement and all obligations (other than those expressly stated to survive such termination) of the Administrative Agent, the Collateral Agent and each Borrower under the Security Agreement and each Collateral Account Control Agreement shall terminate, all without delivery of any instrument or performance of any act by any Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the Administrative Agent, the Collateral Agent and each Lender agrees to keep confidential all non-public information provided to it by any Group Member, the Administrative Agent, the Collateral Agent or any Lender pursuant to or in connection with this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that nothing herein shall prevent the Administrative Agent, the Collateral Agent or any Lender from disclosing any such Information (a) to the Administrative Agent, the Collateral Agent, any other Lender or any affiliate thereof, (b) subject to an agreement to comply with the provisions of this Section, to any actual or prospective Transferee or any actual or prospective counterparty (or its related parties) to any swap, derivative or other transaction under which payments are to be made by reference to any Borrower and its obligations, this Agreement or payments hereunder, (c) to its employees, directors, agents, attorneys, accountants, auditors and other professional advisors or those of any of its affiliates, provided that such parties agree to comply with the provisions of this Section, (d) upon the request or demand of any Governmental Authority (including any stock exchange or other similar organization or self-regulatory body), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Administrative Agent, the Collateral Agent or any Lender, as the case may be, requests confidential treatment of such Information to the extent permitted by law, (e) in response to any order of any court or other Governmental Authority or as may otherwise be required pursuant to any Requirement of Law, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Administrative Agent, the Collateral Agent or any Lender, as the case may be, requests confidential treatment of such Information to the extent permitted by law, (f) if requested or required to do so in connection with any litigation or similar proceeding, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (1) the Administrative Agent, the Collateral Agent or any Lender, as the case may be, provides the Company with notice of such event promptly upon obtaining knowledge thereof (provided that the Administrative Agent, the Collateral Agent or any Lender, as the case may be, is not legally prohibited by law from giving such notice) so that the Company may seek a protective order </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or other appropriate remedy and (2) in the event that such protective order or other remedy is not obtained, the Administrative Agent, the Collateral Agent or any Lender, as the case may be, shall furnish only that portion of the Information that is legally required and shall disclose the Information in a manner reasonably designed to preserve its confidential nature, (g) that has been publicly disclosed other than as a result of (1) disclosure by the Administrative Agent, the Collateral Agent or any Lender in violation of this Agreement or (2) becoming available from a third party which to the knowledge of the Administrative Agent, the Collateral Agent or any Lender, as the case may be, is prohibited from disclosing such information pursuant to a contractual, legal or fiduciary obligation to the Company or a third party, (h) to the National Association of Insurance Commissioners or any similar organization or any nationally recognized rating agency that requires access to information about a Lender&#8217;s investment portfolio in connection with ratings issued with respect to such Lender, or (i) in connection with the exercise of any remedy hereunder or under any other Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Several Obligations of Borrowers&#59; Company as Agent of Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. (a) The Obligations of each Borrower shall be several in nature.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) Each Borrower irrevocably appoints the Company as its agent for all purposes relevant to this Agreement and each of the other Loan Documents, including (i) the giving and receipt of notices and (ii) the execution and delivery of all documents, instruments and certificates contemplated herein and all modifications hereto. Any acknowledgement, consent, direction, certification or other action which might otherwise be valid or effective only if given or taken by all Borrowers, or by each Borrower acting singly, shall be valid and effective if given or taken only by the Company, whether or not any such other Borrower joins therein. Any notice, demand, consent, acknowledgement, direction, certification or other communication delivered to the Company in accordance with the terms of this Agreement shall be deemed to have been delivered to each other Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#91;Reserved.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">WAIVERS OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. THE COMPANY, EACH OTHER BORROWER, THE ADMINISTRATIVE AGENT, THE COLLATERAL AGENT AND THE LENDERS HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVE TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Advisory or Fiduciary Duty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), the Borrowers acknowledge and agree, and acknowledge their Affiliates&#8217; understanding, that&#58; (a) (i) no fiduciary, advisory or agency relationship between the Borrowers and their respective Subsidiaries and any Agent, any L&#47;C Issuer or any Lender is intended to be or has been created in respect of the transactions contemplated hereby or by the other Loan Documents, irrespective of whether any Agent, any L&#47;C Issuer or any Lender has advised or is advising the Borrower or any Subsidiary on other matters, (ii) the arranging and other services regarding this Agreement provided by the Agents, the L&#47;C Issuers and the Lenders are arm&#8217;s-length commercial transactions between the Borrowers and their Affiliates, on the one hand, and the Agents, the L&#47;C Issuers and the Lenders, on the other hand, (iii) the Borrowers have consulted their own legal, accounting, regulatory and tax advisors to the extent that they have deemed appropriate and (iv) the Borrowers are capable of evaluating, and understand and accept, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents&#59; and (b) (i) the Agents, the L&#47;C Issuers and the Lenders each is and has been acting solely as a principal and, except as expressly agreed in writing by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for the Borrowers or any of their Affiliates, or any other Person&#59; (ii) none of the Agents, the L&#47;C Issuers and the Lenders has any obligation to the Borrowers or any of their Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents&#59; and (iii) the Agents, the L&#47;C Issuers and the Lenders and their respective Affiliates may be engaged, for their own accounts or the accounts of customers, in a broad range of transactions that involve interests that differ from those of the Borrowers and their Affiliates, and none of the Agents, the L&#47;C Issuers and the Lenders has any obligation to disclose any of such interests to the Borrowers or their Affiliates.&#160; To the fullest extent permitted by law, each Borrower hereby waives and releases any claims that it may have against the Agents, the L&#47;C Issuers and the Lenders with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Lender hereby notifies each Borrower that pursuant to the requirements of the Patriot Act, it is required to obtain, verify and record information that identifies each Borrower, which information includes the name and address of each such Borrower and other information that will allow such Lender to identify each such Borrower in accordance with the Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement amends and restates and supersedes and replaces the Existing Credit Agreement. The parties hereto acknowledge and agree that (a) this Agreement and the other Loan Documents executed and delivered in connection herewith do not constitute a novation, payment and reborrowing, or termination of the obligations under the Existing Credit Agreement as in effect prior to the date hereof&#59; (b) such obligations are in all respects continuing (as amended and restated and superseded and replaced hereby) with only the terms being modified as provided in this Agreement and in the Loan Documents&#59; (c) the Security Agreement and each Collateral Account Control Agreement, as amended as of the date hereof, remain in full force and effect and are hereby ratified and confirmed&#59; (d) all Liens arising under any Loan Document are continuing and in full force and effect and secure the payment of the Secured Letters of Credit&#59; and (e) upon the effectiveness of this Agreement, all letters of credit outstanding under the Existing Credit Agreement will be deemed to be Letters of Credit hereunder and subject to the terms hereof. The Lenders party hereto (constituting the Required Lenders as defined in the Existing Credit Agreement) hereby authorize and direct the Collateral Agent to enter into this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Acknowledgement and Consent to Bail-In of EEA Financial Institutions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an EEA Financial Institution&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the effects of any Bail-In Action or any such liability, including, if applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial Institution, its parent entity, or a bridge institution that may be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-bottom:24pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;t</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">he variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of any EEA Resolution Authority.</font></div><div style="margin-bottom:36pt;text-indent:180pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 12</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE BORROWER REPRESENTATIVE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Appointment&#59; Nature of Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company is hereby appointed by each of the Borrowers as its contractual representative (herein referred to as the &#8220;Borrower Representative&#8221;) hereunder and under each other Loan Document, and each of the Borrowers irrevocably authorizes the Borrower Representative to act as the contractual representative of such Borrower with the rights and duties expressly set forth herein and in the other Loan Documents. The Borrower Representative agrees to act as such contractual representative upon the express conditions contained in this Section 12. Additionally, each Borrower hereby appoints, to the extent the Borrower Representative requests any Loan on behalf of such Borrower, the Borrower Representative as its agent to receive all of the proceeds of such Loan, at which time the Borrower Representative shall promptly disburse such Loan to such Borrower. Neither the Agents, the Lenders or the Applicable Issuing Parties and their respective officers, directors, agents or employees, shall be liable to the Borrower Representative or any Borrower for any action taken or omitted to be taken by the Borrower Representative or the Borrowers pursuant to this Section 12.1.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower Representative shall have and may exercise such powers under the Loan Documents as are specifically delegated to the Borrower Representative by the terms of each thereof, together with such powers as are reasonably incidental thereto. The Borrower Representative shall have no implied duties to the Borrowers, or any obligation to the Lenders to take any action thereunder except any action specifically provided by the Loan Documents to be taken by the Borrower Representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Employment of Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower Representative may execute any of its duties as the Borrower Representative hereunder and under any other Loan Document by or through authorized officers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any notice provided to the Borrower Representative hereunder shall constitute notice to each Borrower on the date received by the Borrower Representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Borrower Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Upon the prior written consent of the Administrative Agent, the Borrower Representative may resign at any time, such resignation to be effective upon the appointment of a successor Borrower Representative acceptable to the Administrative Agent. The Administrative Agent shall give notice of such resignation to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Execution of Loan Documents&#59; Borrowing Base Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrowers hereby empower and authorize the Borrower Representative, on behalf of the Borrowers, to execute and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">deliver to the Agents, the Applicable Issuing Parties and the Lenders the Loan Documents and all related agreements, certificates, documents, or instruments as shall be necessary or appropriate to effect the purposes of the Loan Documents. Each Borrower agrees that any action taken by the Borrower Representative or the Borrowers in accordance with the terms of this Agreement or the other Loan Documents, and the exercise by the Borrower Representative of its powers set forth therein or herein, together with such other powers that are reasonably incidental thereto, shall be binding upon all of the Borrowers.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_119"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered by their proper and duly authorized officers as of the day and year first above written.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED,<br>as a Borrower</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher O&#8217;Kane</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Christopher O&#8217;Kane</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Chief Executive Officer</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Scott Kirk</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Scott Kirk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Chief Financial Officer</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN BERMUDA LIMITED,<br>as a Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Cain</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Michael Cain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Chief Executive Officer</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN INSURANCE UK LIMITED,<br>as a Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Karen Green</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Karen Green </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN (UK) HOLDINGS LIMITED,<br>as a Borrower</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Scott Kirk </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Scott Kirk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN SPECIALTY INSURANCE COMPANY,<br>as a Borrower</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; CFO</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN U.S. HOLDINGS, INC.,<br>as a Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; CFO </font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN UNDERWRITING LIMITED,<br>as a Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Karen Green</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Karen Green </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN AMERICAN INSURANCE COMPANY,<br>as a Borrower</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; CFO</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.273%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC,<br>as Administrative Agent and a Lender</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Karla K. Maloof </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Karla K. Maloof</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Head of Insurance, FIG Corporate Banking-NA</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Executed in New York</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:41.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.482%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CITIBANK, N.A.,<br>as Syndication Agent and a Lender</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; John M. Mcdin</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; John M. Mcdin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Managing Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"><tr><td style="width:1.0%"></td><td style="width:42.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON,<br>as Collateral Agent</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Jose Alcantara </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Jose Alcantara</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Vice President</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DEUTSCHE BANK AG NEW YORK BRANCH,<br>as a Lender</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Ming K. Chu</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Ming K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DEUTSCHE BANK AG NEW YORK BRANCH,<br>as a Lender</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; John S. McGill</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; John S. McGill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"></td><td style="width:26.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON,<br>as a Lender</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Pensari</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Michael Pensari</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Managing Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.288%"><tr><td style="width:1.0%"></td><td style="width:29.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LLOYDS BANK PLC,<br>as a Lender</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Daven Popat</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Daven Popat &#8211; P003</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Senior Vice President</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Erin Walsh</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Erin Walsh &#8211; W004</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Assistant Vice President</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.455%"><tr><td style="width:1.0%"></td><td style="width:27.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.516%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. BANK NATIONAL ASSOCIATION,<br>as a Lender</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Tenzin Subhar</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Tenzin Subhar</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Vice President</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HSBC BANK USA, NATIONAL ASSOCIATION,<br>as a Lender</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Richard Herder</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Richard Herder</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Managing Director, Head of North America Insurance Coverage</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_135"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ANNEX A</font></div><div style="margin-bottom:48pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PRICING GRID</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Debt Rating</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Commitment Fee Rate (bps)</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Eurodollar Loan Applicable Margin (bps)</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABR Loan Applicable Margin (bps)</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8805;A&#47;A2</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.0</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">112.5</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.5</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#61;A-&#47;A3</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.5</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">125.0</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25.0</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#61;BBB+&#47;Baa1</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.5</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">137.5</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37.5</font></td></tr><tr style="height:8pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#61;BBB&#47;Baa2</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.5</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">150.0</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">50.0</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any less favorable rating or no rating</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">27.5</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">175.0</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">75.0</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of the Pricing Grid, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Debt Rating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, as of any date of determination, the long term unsecured senior, non-credit enhanced debt rating of the Company as determined by S&#38;P or Moody&#8217;s, as the case may be, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if a Debt Rating is issued by each of S&#38;P and Moody&#8217;s, then the higher of such Debt Ratings shall apply, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">unless</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> there is a split in Debt Ratings of more than one level, in which case the level that is one level lower than the higher Debt Rating shall apply. The Debt Ratings shall be determined from the most recent public announcement of any changes in the Debt Ratings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the purposes of the Pricing Grid, changes in the Applicable Margin resulting from changes in the Debt Rating shall become effective on the date that is three Business Days after the date on which new ratings are issued by S&#38;P or Moody&#8217;s and shall remain in effect until the next change to be effected pursuant to this paragraph.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.1</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMMITMENTS</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Lender</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Commitment</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Barclays Bank PLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$37,500,000</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Citibank, N.A.</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$37,500,000</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deutsche Bank AG New York Branch</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$27,000,000</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Bank of New York Mellon</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$27,000,000</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lloyds Bank plc</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$27,000,000</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Bank National Association</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$22,000,000</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">HSBC Bank USA, National Association</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$22,000,000</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Total</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$200,000,000</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 4.13</font></div><div style="margin-bottom:32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUBSIDIARIES</font></div><div style="margin-bottom:70pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Jurisdiction of Incorporation</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Percentage of Capital Stock&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Owned by any Borrower</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acorn Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Blue Waters Insurers, Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Puerto Rico</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Acorn Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Bermuda Limited*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:70pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Capital Management, Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Peregrine Reinsurance Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Capital Management, Ltd</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Cat Fund Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Capital Management Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen (UK) Holdings Limited*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen (US) Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Capital Advisors Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Delaware</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen (US) Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Managing Agency Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Managing Agency Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Underwriting Limited*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen European Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Insurance UK Limited*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen European Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Silverton Re Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Insurance UK Services Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen (UK) Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AIUK Trustees Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen Insurance UK Services Limited</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:70pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">APJ Continuation Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen (UK) Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen UK Syndicate Services Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by APJ Continuation Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">APJ Asset Protection Jersey Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jersey</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by APJ Continuation Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Risk Management Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">80% owned by Aspen (UK) Holdings Limited</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20% owned by employees of Aspen Risk Management Limited</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Recoveries Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen (UK) Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen U.S. Holdings, Inc.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Delaware</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen (UK) Holdings Limited</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Insurance U.S. Services Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Delaware</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen U.S. Holdings, Inc.</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Specialty Insurance Company*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; North Dakota</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen American Insurance Company</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Re America, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Delaware</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen U.S. Holdings, Inc.</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Specialty Insurance Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; California</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen U.S. Holdings, Inc.</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen Specialty Insurance Management, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Massachusetts</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen U.S. Holdings, Inc.</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspen American Insurance Company*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Texas</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen U.S. Holdings, Inc.</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AG Logic Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Texas</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by Aspen U.S. Holdings, Inc.</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:70pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AgriLogic Insurance Services, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Texas</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by AG Logic Holdings, LLC</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AgriLogic Consulting, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Texas</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by AG Logic Holdings, LLC</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AG Logic Acquisition, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; North Carolina</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% owned by AG Logic Holdings, LLC</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Golden State Crop and Insurance Services, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; California</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% AG Logic Acquisition, LLC</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Crop Insurance Services, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. &#8211; Oregon</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100% AG Logic Acquisition, LLC</font></td></tr></table></div><div style="margin-bottom:48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">* Subsidiary Borrower</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.2(b)(iv)</font></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXISTING INDEBTEDNESS</font></div><div style="margin-bottom:72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">None.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.5</font></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">INVESTMENTS</font></div><div style="margin-bottom:72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">None.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.6</font></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXISTING LIENS</font></div><div style="margin-bottom:72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">None.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_152"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT A</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF COMPLIANCE CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Compliance Certificate is delivered pursuant to Section 6.2(a) of the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A. as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The undersigned hereby certifies to the Administrative Agent and the Lenders as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I am the duly elected, qualified and acting &#91;_______________&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;I have reviewed and am familiar with the contents of this Certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;I have reviewed the terms of the Credit Agreement and the Loan Documents and have made, or caused to be made under my supervision, a review in reasonable detail of the transactions and condition of the Company during the accounting period covered by the financial statements attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Attachment 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Attachment 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are the computations showing compliance with the covenants set forth in Sections 7.1 and 7.9 of the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;To the best of my knowledge, during the accounting period covered by the Financial Statements attached hereto, each Borrower has observed or performed all of its covenants and other agreements, and satisfied every condition contained in the Credit Agreement and the other Loan Documents to which it is a party to be observed, performed or satisfied by it&#91;, except as set forth below&#93;.</font></div><div style="margin-bottom:133pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;I have no knowledge of the existence, as of the date of this Certificate, of any condition or event which constitutes a Default or Event of Default&#91;, except as set forth below&#93;.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Insert title of Responsible Officer of the Company signing the certificate.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:48pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this Compliance Certificate as of the date set forth below.</font></div><div style="margin-bottom:32pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.448%"><tr><td style="width:1.0%"></td><td style="width:46.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;______, 20__</font></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attachment 1</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Exhibit A</font></div><div style="margin-bottom:48pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Attach Financial Statements&#93;</font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attachment 2</font></div><div style="margin-bottom:48pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Exhibit A</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information described herein is as of ______, 20__, </font></div><div style="margin-bottom:52pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and pertains to the period from _________, 20__ to ________________ __, 20__.</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Set forth Covenant Calculations&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_250"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT B-1</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF CLOSING CERTIFICATE</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Closing Certificate is delivered pursuant to Section 5.1(c)(i) of the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein), Barclays Bank PLC, as Administrative Agent, various other agents and various lenders. Unless otherwise defined herein, terms defined in the Credit Agreement shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The undersigned &#91;insert title&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Company hereby certifies to the Administrative Agent and the Lenders as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The representations and warranties of the Company set forth in each of the Loan Documents to which it is a party or which are contained in any certificate furnished by or on behalf of the Company pursuant to any of the Loan Documents are true and correct in all material respects (or, in the case of any representation and warranty qualified by materiality, in all respects) on and as of the date hereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Default or Event of Default has occurred and is continuing as of the date hereof or after giving effect to the Loans or other extensions of credit to be made on the date hereof and the use of proceeds thereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The conditions precedent set forth in Section 5.1(g) of the Credit Agreement were satisfied as of the Closing Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no liquidation or dissolution proceedings pending or to my knowledge threatened against the Company as of the date hereof, nor has any other event occurred adversely affecting or threatening the continued existence of the Company.</font></div><div style="margin-bottom:132pt;text-align:center;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature follows&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be signed by a Responsible Officer.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this Closing Certificate as of the date first written above.</font></div><div style="margin-bottom:48pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_341"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT B-2</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF CLOSING CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Closing Certificate is delivered pursuant to Section 5.1(c)(i) of the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company, the Subsidiary Borrowers (as defined therein), Barclays Bank PLC, as Administrative Agent, various other agents and various lenders. Unless otherwise defined herein, terms defined in the Credit Agreement shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The undersigned Corporate Secretary of &#91;Borrower&#93; (the &#8220;Company&#8221;) certifies as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annex 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is a true, correct and complete copy of certain resolutions duly adopted by the Board of Directors of the Company on ____________, 2017 authorizing the execution, delivery and performance of the Loan Documents to which the Company is a party and the transactions contemplated thereby&#59; such resolutions have not in any way been amended, modified, revoked or rescinded, have been in full force and effect since their adoption to and including the date hereof and are now in full force and effect and are the only corporate proceedings of the Company now in force relating to or affecting the matters referred to therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annex 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is a true, correct and complete copy of the &#91;Memorandum of Association&#93; &#91;Articles of Incorporation&#93; of the Company as in effect on the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annex 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is a true and complete copy of the By-Laws of the Company as in effect on the date hereof.</font></div><div style="margin-bottom:60pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The persons whose names, titles and signatures appear on the Incumbency Schedule attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annex 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> are authorized representatives of the Company, holding the positions indicated next to their respective names, and the signatures appearing opposite their respective names are the true and genuine signatures of such persons, and each such person is duly authorized to execute and deliver on behalf of the Company each Loan Document to which the Company is a party and any certificate or other document to be delivered by the Company pursuant thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:60pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed the Closing Certificate as of the date first written above.</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate Secretary</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:-206.25pt"><font><br></font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I, _____________________, the duly elected ___________________ of the Company, hereby certify as of the date first written above that _________________ is the duly elected Corporate Secretary of the Company and, as such, is authorized to execute this Certificate on behalf of the Company and that the signature appearing above is such person&#8217;s true and genuine signature.</font></div><div style="margin-bottom:48pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:467.25pt"><tr><td style="width:1.0pt"></td><td style="width:172.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:115.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:172.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_356"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ANNEX 1</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Resolutions</font></div><div id="if4603bd17ae849c2bd6fca6756d96339_370"></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ANNEX 2</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Memorandum of Association&#93; &#91;Articles of Incorporation&#93;</font></div><div id="if4603bd17ae849c2bd6fca6756d96339_384"></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ANNEX 3</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By-Laws</font></div><div id="if4603bd17ae849c2bd6fca6756d96339_401"></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ANNEX 4</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Incumbency Schedule</font></div><div style="margin-bottom:60pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 50.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Office</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Signature</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_419"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT C</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF ASSIGNMENT AND ASSUMPTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reference is made to the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Assignor identified on Schedule l hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the Assignee identified on Schedule l hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Assignor hereby irrevocably sells and assigns to the Assignee without recourse to the Assignor, and the Assignee hereby irrevocably purchases and assumes from the Assignor without recourse to the Assignor, as of the Effective Date (as defined below), the interest described in Schedule 1 hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assigned Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in and to the Assignor's rights and obligations under the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Assignor (a) makes no representation or warranty and assumes no responsibility with respect to any statements, warranties or representations made in or in connection with the Credit Agreement or with respect to the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement, any other Loan Document or any other instrument or document furnished pursuant thereto, other than that the Assignor has not created any adverse claim upon the interest being assigned by it hereunder and that such interest is free and clear of any such adverse claim&#59; (b) makes no representation or warranty and assumes no responsibility with respect to the financial condition of the Company, any of its Subsidiaries or any other obligor or the performance or observance by the Company, any of its Subsidiaries or any other obligor of any of their respective obligations under the Credit Agreement or any other Loan Document or any other instrument or document furnished pursuant hereto or thereto&#59; and (c) attaches any Notes held by it evidencing the Assigned Interest and (i) requests that the Administrative Agent, upon request by the Assignee, exchange the attached Notes for a new Note or Notes payable to the Assignee and (ii)&#160;if the Assignor has retained any interest in the Credit Agreement, requests that the Administrative Agent exchange the attached Notes for a new Note or Notes payable to the Assignor, in each case in amounts which reflect the assignment being made hereby (and after giving effect to any other assignments which have become effective on the Effective Date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The Assignee (a) represents and warrants that it is legally authorized to enter into this Assignment and Assumption&#59; (b) confirms that it has received a copy of the Credit Agreement, together with copies of the financial statements delivered pursuant to Section 6.1 thereof and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment and Assumption&#59; (c) agrees that it will, independently and without reliance upon the Assignor, the Administrative Agent or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement, the other Loan Documents or any other instrument or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">document furnished pursuant hereto or thereto&#59; (d) appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise such powers and discretion under the Credit Agreement, the other Loan Documents or any other instrument or document furnished pursuant hereto or thereto as are delegated to the Administrative Agent by the terms thereof, together with such powers as are incidental thereto&#59; and (e) agrees that it will be bound by the provisions of the Credit Agreement and will perform in accordance with its terms all the obligations which by the terms of the Credit Agreement are required to be performed by it as a Lender including its obligation pursuant to Section 2.13(e) of the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The effective date of this Assignment and Assumption shall be the Effective Date of Assignment described in Schedule 1 hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). Following the execution of this Assignment and Assumption, it will be delivered to the Administrative Agent for acceptance by it and recording by the Administrative Agent pursuant to the Credit Agreement, effective as of the Effective Date (which shall not, unless otherwise agreed to by the Administrative Agent, be earlier than five Business Days after the date of such acceptance and recording by the Administrative Agent).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Upon such acceptance and recording, from and after the Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including payments of principal, interest, fees and other amounts) &#91;to the Assignor for amounts which have accrued prior to the Effective Date and to the Assignee for amounts which accrue subsequent to the Effective Date&#93; &#91;to the Assignee whether such amounts have accrued prior to the Effective Date or accrue subsequent to the Effective Date. The Assignor and the Assignee shall make all appropriate adjustments in payments by the Agent for periods prior to the Effective Date or with respect to the making of this assignment directly between themselves.&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;From and after the Effective Date, (a) the Assignee shall be a party to the Credit Agreement and, to the extent provided in this Assignment and Assumption, have the rights and obligations of a Lender thereunder and under the other Loan Documents and shall be bound by the provisions thereof and (b) the Assignor shall, to the extent provided in this Assignment and Assumption, relinquish its rights and be released from its obligations under the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;This Assignment and Assumption shall be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Assignment and Assumption to be executed as of the date first above written by their respective duly authorized officers on Schedule 1 hereto.</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Schedule 1 </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Assignment and Assumption</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name of Assignor&#58; _______________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name of Assignee&#58; _______________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Effective Date of Assignment&#58; _________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount Assigned&#58;&#160;&#160;&#160;&#160;$____________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Loans Assigned&#58; $____________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">L&#47;C Obligations Assigned&#58; $____________</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.853%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Name of Assignee&#93;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Name of Assignor&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accepted&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consented To&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">*</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC, as<br>Administrative Agent</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN HOLDINGS INSURANCE LIMITED</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Executed in New York</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC, as <br>Administrative Agent</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Executed in New York</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;NAME OF ISSUING LENDER&#93;, as <br>Issuing Lender</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td></tr></table></div><div style="margin-bottom:60pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Please refer to Section 11.6(b) of the Credit Agreement to determine if Borrower&#8217;s, Administrative Agent&#8217;s and&#47;or the Issuing Lenders&#8217; consent is required.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_434"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT D-1</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF LEGAL OPINION OF MAYER BROWN LLP</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Intentionally Omitted&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_449"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT D-2</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF LEGAL OPINION OF APPLEBY (BERMUDA) LIMITED</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Intentionally Omitted&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_463"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:48pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT E-1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF EXEMPTION CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(For Non-U.S. Lenders That Are Not Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reference is made to the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">______________________ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is providing this certificate pursuant to Section 2.13(e) of the Credit Agreement. The Non-U.S. Lender hereby represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Non-U.S. Lender is the sole record and beneficial owner of the Loans or the obligations evidenced by Note(s) in respect of which it is providing this certificate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Non-U.S. Lender is not a &#8220;bank&#8221; for purposes of Section 881(c)(3)(A) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). In this regard, the Non-U.S. Lender further represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Non-U.S. Lender is not subject to regulatory or other legal requirements as a bank in any jurisdiction&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Non-U.S. Lender has not been treated as a bank for purposes of any tax, securities law or other filing or submission made to any Governmental Authority, any application made to a rating agency or qualification for any exemption from tax, securities law or other legal requirements&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The Non-U.S. Lender is not a 10-percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The Non-U.S. Lender is not a controlled foreign corporation receiving interest from a related person within the meaning of Section 881(c)(3)(C) of the Code&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The income from the Loans held by the Non-U.S. Lender is not effectively connected with the conduct of a trade or business within the United States.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Non-U.S. Lender has furnished the Administrative Agent and the Borrower with a certificate of its non-U.S. person status on Internal Revenue Service Form W-8BEN or W-8BEN-E, as applicable. By executing this certificate, the Non-U.S. Lender agrees that (1) if the information provided on this certificate changes, the Non-U.S. Lender shall promptly so inform the Borrower and the Administrative Agent and (2) the Non-U.S. Lender shall have at all times furnished the Borrower and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Administrative Agent with a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the Non-U.S. Lender, or in either of the two calendar years preceding such payments.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this certificate as of the date set forth below.</font></div><div style="margin-bottom:48pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;NAME OF NON-U.S. LENDER&#93;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_480"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT E-2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF EXEMPTION CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(For Non-U.S. Lenders That Are Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reference is made to the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">______________________ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is providing this certificate pursuant to Section 2.13(e) of the Credit Agreement. The Non-U.S. Lender hereby represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Non-U.S. Lender is the sole record owner of the Loans or the obligations evidenced by Note(s) in respect of which it is providing this certificate and its partners&#47;members are the sole beneficial owners of such Loans or the obligations evidenced by Note(s).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Neither the Non-U.S. Lender nor any of its partners&#47;members is a &#8220;bank&#8221; for purposes of Section 881(c)(3)(A) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). In this regard, the Non-U.S. Lender further represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;neither the Non-U.S. Lender nor its partners&#47;members is subject to regulatory or other legal requirements as a bank in any jurisdiction&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;neither the Non-U.S. Lender nor its partners&#47;members has been treated as a bank for purposes of any tax, securities law or other filing or submission made to any Governmental Authority, any application made to a rating agency or qualification for any exemption from tax, securities law or other legal requirements&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Neither the Non-U.S. Lender nor any of its partners&#47;members is a 10-percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Neither the Non-U.S. Lender nor any of its partners&#47;members is a controlled foreign corporation receiving interest from a related person within the meaning of Section 881(c)(3)(C) of the Code&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The income from the Loans held by the Non-U.S. Lender is not effectively connected with the conduct of a trade or business within the United States by the Non-U.S. Lender or its partners&#47;members.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Non-U.S. Lender has furnished the Administrative Agent and the Borrower with Internal Revenue Service Form W-8IMY accompanied by an Internal Revenue Service Form W-8BEN or W-8BEN-E, as applicable, from each of its partners&#47;members claiming the portfolio interest exemption. By executing this certificate, the Non-U.S. Lender agrees that (1) if the information provided on this certificate changes, the Non-U.S. Lender shall promptly so inform the Borrower and the Administrative Agent and (2) the Non-U.S. Lender shall have at all times furnished the Borrower and the Administrative </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agent with a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the Non-U.S. Lender, or in either of the two calendar years preceding such payments.</font></div><div style="margin-bottom:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this certificate as of the date set forth below.</font></div><div style="margin-bottom:48pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;NAME OF NON-U.S. LENDER&#93;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_497"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT F</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF COMPANY NOTE</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THIS NOTE AND THE OBLIGATIONS REPRESENTED HEREBY MAY NOT BE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE TERMS AND PROVISIONS OF THE CREDIT AGREEMENT REFERRED TO BELOW. TRANSFERS OF THIS NOTE AND THE OBLIGATIONS REPRESENTED HEREBY MUST BE RECORDED IN THE REGISTER MAINTAINED BY THE ADMINISTRATIVE AGENT PURSUANT TO THE TERMS OF SUCH CREDIT AGREEMENT.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$____________&#160;&#160;&#160;&#160;New York, New York</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">________ __, 20___</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned, ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), hereby unconditionally promises to pay to the order of ____________________ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or its registered assigns at the Funding Office specified in the Credit Agreement (as hereinafter defined) in lawful money of the United States and in immediately available funds, on the Termination Date as to the Loans evidenced hereby, the principal amount of (a) ________ DOLLARS ($_____), or, if less, (b) the aggregate unpaid principal amount of all Loans made by the Lender to the Company pursuant to Section 2.1 of the Credit Agreement. The Company further agrees to pay interest in like money at such Funding Office on the unpaid principal amount hereof from time to time outstanding at the rates and on the dates specified in Section 2.8 of the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The holder of this Note is authorized to indorse on the schedules annexed hereto and made a part hereof or on a continuation thereof which shall be attached hereto and made a part hereof the date, Type, and amount of the Loan and the date and amount of each payment or prepayment of principal with respect thereto, each conversion of all or a portion thereof to another Type, each continuation of all or a portion thereof as the same Type and, in the case of Eurodollar Loans, the length of each Interest Period with respect thereto. The failure to make any such indorsement or any error in any such indorsement shall not affect the obligations of the Company in respect of the Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Note (a) is one of the Notes referred to in the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among the Company, the Subsidiary Borrowers (as defined in the Credit Agreement), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent, (b) is subject to the provisions of the Credit Agreement and (c) is subject to optional prepayment in whole or in part as provided in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon the occurrence of any one or more Events of Default, all principal and all accrued interest then remaining unpaid on this Note may be declared to be or may otherwise become, immediately due and payable, all as provided in the Credit Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All parties now and hereafter liable with respect to this Note, whether maker, principal, surety, guarantor, indorser or otherwise, hereby waive presentment, demand, protest and all other notices of any kind.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED HEREIN OR IN THE CREDIT AGREEMENT, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AND IN ACCORDANCE WITH THE REGISTRATION AND OTHER PROVISIONS OF SECTION 11.6 OF THE CREDIT AGREEMENT.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.</font></div><div style="margin-bottom:24pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.856%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_512"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Schedule A</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Company Note</font></div><div style="margin-bottom:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LOANS, CONVERSIONS AND REPAYMENTS OF ABR LOANS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount <br>Converted to <br>ABR Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Principal of <br>ABR Loans Repaid</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR <br>Loans Converted to <br>Eurodollar Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal Balance <br>of ABR Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation Made By</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:3pt double #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_528"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Schedule B</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Company Note</font></div><div style="margin-bottom:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LOANS, CONTINUATIONS, CONVERSIONS AND REPAYMENTS OF EURODOLLAR LOANS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.157%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Eurodollar <br>Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount Converted to <br>Eurodollar Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Period and <br>Eurodollar Rate with <br>Respect Thereto</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Principal of <br>Eurodollar Loans Repaid</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Eurodollar <br>Loans Converted to <br>ABR Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal <br>Balance of Eurodollar <br>Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation <br>Made By</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:3pt double #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_551"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT G</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF SUBSIDIARY BORROWER NOTE</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THIS NOTE AND THE OBLIGATIONS REPRESENTED HEREBY MAY NOT BE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE TERMS AND PROVISIONS OF THE CREDIT AGREEMENT REFERRED TO BELOW. TRANSFERS OF THIS NOTE AND THE OBLIGATIONS REPRESENTED HEREBY MUST BE RECORDED IN THE REGISTER MAINTAINED BY THE ADMINISTRATIVE AGENT PURSUANT TO THE TERMS OF SUCH CREDIT AGREEMENT.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$____________&#160;&#160;&#160;&#160;New York, New York</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">________ __, 20___</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned, &#91;NAME OF SUBSIDIARY BORROWER&#93;, a __________ &#91;corporation&#93; &#91;limited liability company&#93; &#91;limited partnership&#93; &#91;exempt limited liability corporation&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), hereby unconditionally promises to pay to the order of ____________________ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or its registered assigns at the Funding Office specified in the Credit Agreement (as hereinafter defined) in lawful money of the United States and in immediately available funds, on the Termination Date as to the Loans evidenced hereby, the principal amount of (a) ________ DOLLARS ($_____), or, if less, (b) the aggregate unpaid principal amount of all Loans made by the Lender to the Borrower pursuant to Section 2.1 of the Credit Agreement. The Borrower further agrees to pay interest in like money at such Funding Office on the unpaid principal amount hereof from time to time outstanding at the rates and on the dates specified in Section 2.8 of the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The holder of this Note is authorized to indorse on the schedules annexed hereto and made a part hereof or on a continuation thereof which shall be attached hereto and made a part hereof the date, Type, and amount of the Loan and the date and amount of each payment or prepayment of principal with respect thereto, each conversion of all or a portion thereof to another Type, each continuation of all or a portion thereof as the same Type and, in the case of Eurodollar Loans, the length of each Interest Period with respect thereto. The failure to make any such indorsement or any error in any such indorsement shall not affect the obligations of the Borrower in respect of the Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Note (a) is one of the Notes referred to in the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among the Company, the Subsidiary Borrowers (as defined in the Credit Agreement), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent, (b) is subject to the provisions of the Credit Agreement and (c) is subject to optional prepayment in whole or in part as provided in the Credit Agreement. This Note is guaranteed as provided in the Loan Documents. Reference is hereby made to the Loan Documents for the nature and extent of the guarantees, the terms and conditions upon which each guarantee was granted and the rights of the holder of this Note in respect thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon the occurrence of any one or more Events of Default, all principal and all accrued interest then remaining unpaid on this Note may be declared to be or may otherwise become, immediately due and payable, all as provided in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All parties now and hereafter liable with respect to this Note, whether maker, principal, surety, guarantor, indorser or otherwise, hereby waive presentment, demand, protest and all other notices of any kind.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED HEREIN OR IN THE CREDIT AGREEMENT, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AND IN ACCORDANCE WITH THE REGISTRATION AND OTHER PROVISIONS OF SECTION 11.6 OF THE CREDIT AGREEMENT.</font></div><div style="margin-bottom:38pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.</font></div><div style="margin-bottom:32pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#91;NAME OF SUBSIDIARY BORROWER&#93;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_567"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Schedule A</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Subsidiary Borrower Note</font></div><div style="margin-bottom:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LOANS, CONVERSIONS AND REPAYMENTS OF ABR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LOANS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount <br>Converted to <br>ABR Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Principal of <br>ABR Loans Repaid</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR <br>Loans Converted to <br>Eurodollar Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal Balance <br>of ABR Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation Made By</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:16pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:3pt double #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_583"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Schedule B</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Subsidiary Borrower Note</font></div><div style="margin-bottom:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LOANS, CONTINUATIONS, CONVERSIONS AND REPAYMENTS OF EURODOLLAR LOANS</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.512%"><tr><td style="width:1.0%"></td><td style="width:10.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Eurodollar <br>Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount Converted to <br>Eurodollar Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Period and <br>Eurodollar Rate with <br>Respect Thereto</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Principal of <br>Eurodollar Loans Repaid</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Eurodollar <br>Loans Converted to <br>ABR Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal <br>Balance of Eurodollar <br>Loans</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation <br>Made By</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:3pt double #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_294"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">FORM OF NOTICE OF CONVERSION&#47;CONTINUATION</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Barclays Bank PLC, as Administrative Agent for the Lenders parties to the Second Amended and Restated Credit Agreement dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The undersigned, Aspen Insurance Holdings Limited, refers to the Credit Agreement, the terms defined therein being used herein as therein defined, and hereby gives you notice irrevocably, pursuant to Section 2.6 of the Credit Agreement, of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">continuation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Loans specified herein, that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The conversion&#47;continuation date is , 20__ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion&#47;Continuation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The aggregate amount of the Loans to be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">converted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">continued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> is $_________.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The Loans are to be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">converted into</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">continued as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93; &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Eurodollar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;ABR&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If applicable&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The duration of the Interest Period for the Loans included in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">continuation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">______________ days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;_________ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">months</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;The undersigned hereby certifies that the following statement is true on the date hereof, and will be true on the proposed Conversion&#47;Continuation Date&#58; no Default or Event of Default has occurred and is continuing.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:96pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To be included for conversions of ABR Loans into Eurodollar Loans.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_598"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT I</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF SUBSIDIARY BORROWER AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUBSIDIARY BORROWER AGREEMENT, dated as of ____________, __ 20__, made by ______________________________, a ______________ &#91;corporation&#93; &#91;limited liability company&#93; &#91;limited partnership&#93; &#91;exempt limited liability corporation&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Subsidiary Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), in favor of Barclays Bank PLC, as administrative agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) for the Lenders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) parties to the Second Amended and Restated Credit Agreement referred to below. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Aspen Insurance Holdings Limited (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers, the Lenders, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent, have entered into a Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Credit Agreement permits the Additional Subsidiary Borrower to become a Subsidiary Borrower pursuant to the terms and conditions of the Credit Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Additional Subsidiary Borrower has agreed to execute and deliver this Subsidiary Borrower Agreement in order to become a Subsidiary Borrower under the Credit Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, IT IS AGREED&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to the satisfaction of each of the conditions set forth in subsection 5.3 of the Credit Agreement, by executing and delivering this Subsidiary Borrower Agreement, the Additional Subsidiary Borrower hereby becomes a Subsidiary Borrower under the Credit Agreement with the same force and effect as if originally named therein as a Subsidiary Borrower and, without limiting the generality of the foregoing, hereby expressly assumes all obligations and liabilities of a Subsidiary Borrower thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company hereby represents and warrants that each of the representations and warranties contained in Section 4 of the Credit Agreement is true and correct on and as of the date hereof (after giving effect to this Subsidiary Borrower Agreement) as if made on and as of such date (except where such representation and warranty speaks of a specific date in which case such representation and warranty shall be true and correct as of such date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. THIS SUBSIDIARY BORROWER AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned have caused this Subsidiary Borrower Agreement to be duly executed and delivered as of the date first above written.</font></div><div style="margin-bottom:110pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;ADDITIONAL SUBSIDIARY BORROWER&#93;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_613"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT J</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF </font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMMITMENT INCREASE SUPPLEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMMITMENT INCREASE SUPPLEMENT, dated _________________ (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), to the Second Amended and Restated Credit Agreement dated as of March 27, 2017 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">W I T N E S S E T H&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, pursuant to Section 2.1(b) of the Credit Agreement, the Borrowers have the right, subject to the terms and conditions thereof, to effectuate from time to time an increase in the aggregate Commitments under the Credit Agreement by requesting one or more Lenders to increase the amount of its Commitment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Borrowers have given notice to the Administrative Agent and the Issuing Lenders of their intention to increase the Total Commitments pursuant to Sections 2.1(b) and (c) of the Credit Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, pursuant to Sections 2.1(b) and (c) of the Credit Agreement, the undersigned Lender now desires to increase the amount of its Commitment under the Credit Agreement by executing and delivering to the Borrowers, the Administrative Agent and the Issuing Lenders a supplement to the Credit Agreement in substantially the form of this Supplement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW THEREFORE, each of the parties hereto hereby agrees as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The undersigned Lender agrees, subject to the terms and conditions of the Credit Agreement, that on the date of this Supplement it shall have its Commitment increased by $________, thereby making the aggregate amount of its Commitment equal to $_______________.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;This Supplement shall be governed by, and construed in accordance with, the laws of the State of New York.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;This Supplement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same document.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, each of the undersigned has caused this Supplement to be executed and delivered by a duly authorized officer on the date first above written.</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#91;INSERT NAME OF INCREASING LENDER&#93;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accepted and agreed to, for the Borrowers, as of the date first written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Acknowledged and agreed to as of the date first written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC, as </font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Administrative Agent</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Executed in New York</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Acknowledged and agreed to as of the date first written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;INSERT NAMES OF ISSUING LENDERS&#93;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_628"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT K</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NEW LENDER SUPPLEMENT</font></div><div style="margin-bottom:16pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NEW LENDER SUPPLEMENT, dated as of _______ ___, _____ (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), to the Second Amended and Restated Credit Agreement, dated as of March 27, 2017, as amended, supplemented or otherwise modified from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:16pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">W I T N E S S E T H&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Credit Agreement provides in Section 2.1(b) thereof that with the consent of the Administrative Agent and the Issuing Lenders (which consents shall not be unreasonably withheld or delayed), the Borrowers and any New Lender may agree that such New Lender shall establish a new Commitment and become a party to the Credit Agreement by executing and delivering to the Borrowers, the Administrative Agent and the Issuing Lenders a supplement to the Credit Agreement in substantially the form attached as Exhibit K thereto&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the undersigned desires to establish a new Commitment in the amount set forth herein and become a party to the Credit Agreement upon the terms and conditions set forth therein and herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, each of the parties hereto hereby agrees as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;From and after the Effective Date (as defined in paragraph 3 below) the undersigned shall be a party to and be bound by the provisions of the Credit Agreement as a Lender thereunder with an incremental Commitment of $_________, and shall perform in accordance with its terms all the obligations which by the terms of the Credit Agreement are required to be performed by it as a Lender (including, without limitation, its obligations pursuant to Section 2.13(e) of the Credit Agreement) to the same extent as if originally a party thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The undersigned (a) represents and warrants that it is legally authorized to enter into this Supplement&#59; (b) confirms that it has received a copy of the Credit Agreement, together with copies of the most recent financial statements referred to in Section 6.1 thereof and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Supplement&#59; (c) agrees that it has made and will, independently and without reliance upon the Administrative Agent or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement or any instrument or document furnished pursuant hereto or thereto&#59; and (d) appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise such powers and discretion under the Credit Agreement or any instrument or document furnished pursuant hereto </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or thereto as are delegated to the Administrative Agent by the terms thereof, together with such powers as are incidental thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;This Supplement shall be effective as of ____________ __, ____ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The undersigned has delivered to the Administrative Agent an administrative questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;This Supplement shall be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;This Supplement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same document.</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Remainder of page left blank intentionally.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has caused this Supplement to be executed and delivered by a duly authorized officer on the date first above written.</font></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.351%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#91;INSERT NAME OF NEW LENDER&#93;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td></tr></table></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accepted and agreed to, for the Borrowers, as of the first date written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Acknowledged and agreed to as of the first date written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC, as Administrative Agent</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Executed in New York</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Acknowledged and agreed to as of the date first written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;INSERT NAMES OF ISSUING LENDERS&#93;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT L</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;FORM OF&#93; SEVERAL LETTER OF CREDIT</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR INTERNAL IDENTIFICATION PURPOSES ONLY</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Does not affect terms of Letter of Credit or Bank&#8217;s obligations thereunder)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Issue Date&#58; __________, 20__ </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Expiry Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__________, 20__ </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">L&#47;C No. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amount&#58; $______________ (_____________________________________________)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accountholder&#47;Applicant&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">5</font></div><div style="padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58;_______________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IRREVOCABLE CLEAN &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ISSUE DATE _________________ </font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LETTER OF CREDIT NO. _________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BENEFICIARY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_____________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_____________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;padding-left:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_____________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We, the issuing banks listed below (hereinafter referred to individually as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Credit Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Credit Banks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), hereby establish this clean, irrevocable and unconditional Letter of Credit in your favor as Beneficiary for drawing up to an aggregate amount of $__________ ( the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Credit Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) effective immediately. This Letter of Credit shall expire with the close of business of the L&#47;C Administrator (defined below) on ___________. Except when the Letter of Credit Commitment is increased or amended to reflect a change in Commitment Share or Letter of Credit Bank as set forth in the last paragraph hereof, this Letter of Credit cannot be modified or revoked without the consent of the Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;The term &#8220;Beneficiary&#8221; includes any successor by operation of law of the named Beneficiary including, without limitation, any such liquidator, rehabilitator, receiver or conservator. Drawings by any liquidator, rehabilitator, receiver or conservator shall be for the benefit of all the Beneficiary's policyholders.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">7</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Insert initial amount of the Letter of Credit</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Insert name of party for whom Letter of Credit will be issued.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Insert full name and address of the Beneficiary.</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Insert if Letter of Credit is being issued to back a reinsurance policy and such language is required by the applicable insurance regulator. Additional changes to the letter of credit to reflect regulatory requirements will be inserted if necessary.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The maximum liability of each Letter of Credit Bank with respect to any demand for payment made hereunder shall be its Commitment Share of the amount of such demand for payment, as follows&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.196%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LETTER OF CREDIT BANK</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">COMMITMENT SHARE</font></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MAXIMUM SHARE OF LETTER OF CREDIT COMMITMENT</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Lender&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________%</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Lender&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________%</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Lender&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________%</font></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-right:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TOTAL &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;100%&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; $</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The obligations of the Letter of Credit Banks hereunder are several and not joint, and no Letter of Credit Bank shall be responsible or otherwise liable for the failure of any other Letter of Credit Bank to perform its obligations hereunder, nor shall the failure of any Letter of Credit Bank to perform its obligations under this Letter of Credit relieve any other Letter of Credit Bank of its obligations hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the further provisions of this Letter of Credit, demands for payment may be made by the Beneficiary by presentation to Barclays Bank PLC, as agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) of a sight draft drawn on the L&#47;C Administrator indicating the Letter of Credit No. ______, for all or any part of this Letter of Credit at the L&#47;C Administrator's office located at Barclays Bank PLC,&#160;New York Branch, 745 Seventh Avenue, New York, NY 10019, Attn&#58; Letters of Credit Dept &#47; Dawn Townsend, xraletterofcredit&#64;barclays.com, on or before the expiration date hereof &#91;or any automatically extended expiry date&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We the Letter of Credit Banks listed herein hereby undertake to promptly honor all of a Beneficiary&#8217;s demands for payment hereunder upon delivery of the sight draft as specified to the L&#47;C Administrator&#8217;s aforesaid office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as expressly stated herein, this undertaking is not subject to any agreement, requirement or qualification. The obligations of each Letter of Credit Bank under this Letter of Credit is the individual obligation of such Letter of Credit Bank and is in no way contingent upon reimbursement with respect thereto, or upon its ability to perfect any lien, security interest or any other reimbursement.</font></div><div style="margin-bottom:88pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon payment to you by the Letter of Credit Bank of its Commitment Share of the drawing amount specified in a demand presented hereunder, a Letter of Credit Bank shall be fully discharged of its obligation under this Letter of Credit to the extent of its Commitment Share of such demand and such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:88pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Letter of Credit Bank shall not thereafter be obligated to make any further payments under this Letter of Credit in respect of such demand.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Delete if not inserting automatic extension provision.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;This Letter of Credit shall be deemed automatically extended without amendment for one year from the expiration date hereof or any future expiration date unless at least &#91;__&#93; days prior to such expiration date, the L&#47;C Administrator notifies you by Registered Mail or overnight courier service that this Letter of Credit will not be extended for any such additional period.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;This Letter of Credit is subject to and governed by the Laws of the State of New York and the &#91;1993&#93; &#91;2007&#93; revision of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Uniform Customs and Practice for Documentary Credits of the International Chamber of Commerce</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (Publication &#91;500&#93;&#91;600&#93;), and in the event of any conflict, the Laws of the State of New York will control. If this Letter of Credit expires during an interruption of business as described in &#91;Article&#160;17 of said Publication 500&#93;&#91;Article 36 of said Publication 600&#93;, the bank hereby specifically agrees to effect payment if this Letter of Credit is drawn against within 30 days after the resumption of business.&#93; &#91;This Letter of Credit is subject to and governed by the law(s) of the State of New York, and the International Standby Practices 98 (ISP98) (International Chamber of Commerce Publication No. 590). In the event of any conflict, the laws of the State of New York will control.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Letter of Credit may be amended to delete a Letter of Credit Bank or add a Letter of Credit Bank, or change Commitment Shares, provided that such amendment does not decrease the Letter of Credit Commitment, and need only be signed by the L&#47;C Administrator (and, for the avoidance of doubt, without the consent of the Beneficiary) so long as any Letter of Credit Bank added shall be approved by the Securities Valuation Office of the National Association of Insurance Commissioners and shall have a rating of &#8220;A3&#8221; or better from Moody&#8217;s and&#47;or &#8220;A&#8221; or better from Standard and Poor's.</font></div><div style="margin-bottom:157pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:125.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:19.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:189.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:125.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Very truly yours,</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;BARCLAYS BANK PLC&#93;, as L&#47;C Administrator</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Executed in New York</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Insert if auto-extension is applicable</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Insert UCP 500 or UCP 600 if required by an insurance regulator, otherwise ISP 98 should be used.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if4603bd17ae849c2bd6fca6756d96339_644"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT M</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF REVOLVING LOAN BORROWING REQUEST</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58; ________, ____</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To&#58; Barclays Bank PLC, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Administrative Agent </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">745 Seventh Avenue, 25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Floor</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY 10019</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58; Christopher M. Aitkin</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58; 212.320.6564</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reference is made to that certain Second Amended and Restated Credit Agreement dated as of March 27, 2017 (as may be amended, restated, amended and restated, extended, supplemented or otherwise modified in writing from time to time in accordance with its terms, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the terms defined therein being used herein as therein defined), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, Barclays Bank PLC, as Administrative Agent, and the other parties thereto.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The undersigned Borrower hereby requests a borrowing of Loans, as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;In the aggregate amount of $________.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;On ________,&#160;20__ (a Business Day).</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Comprised of &#91;ABR&#93; &#91;Eurodollar&#93; Loans.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;4.&#160;&#160;&#160;&#160;With an Interest Period of ___&#160;months.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;4&#93;&#91;5&#93;.&#160;&#160;&#160;&#160;The Borrower&#8217;s account to which funds are to be disbursed is&#58;</font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account Number&#58; __________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:94.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Location&#58;_________________</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Borrowing Request and the borrowing requested herein comply with the (x) first three sentences of Section&#160;2.2 and (y) Section 5.2 of the Agreement.</font></div><div style="margin-bottom:509pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:145.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:19.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:150.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:145.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;NAME OF BORROWER&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Insert if a Eurodollar Rate Borrowing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT N</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FORM OF PREPAYMENT NOTICE</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58; _______, ____</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To&#58; Barclays Bank PLC, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Administrative Agent </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">745 Seventh Avenue, 25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Floor</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY 10019</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58; Christopher M. Aitkin</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58; 212.320.6564</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reference is made to that certain Second Amended and Restated Credit Agreement dated as of March 27, 2017 (as may be amended, restated, amended and restated, extended, supplemented or otherwise modified in writing from time to time in accordance with its terms, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the terms defined therein being used herein as therein defined), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, Barclays Bank PLC, as Administrative Agent, and the other parties thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Prepayment Notice is delivered to you pursuant to Section 2.5 of the Agreement. The undersigned Borrower hereby gives notice of a prepayment of Loans as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;(select Type(s) of Loans)</font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABR Loans in the aggregate principal amount of $________.</font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Eurodollar Loans with an Interest Period ending ______, 20__ in the aggregate principal amount of $________.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;On __________, 20__ (a Business Day).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Prepayment Notice complies with the first and fourth sentences of Section 2.5(a) of the Agreement.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:358.50pt"><tr><td style="width:1.0pt"></td><td style="width:183.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:146.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;NAME OF BORROWER&#93;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>23
<FILENAME>exhibit1012-fx1.htm
<DESCRIPTION>EX-10.12
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i190da568f4624c21b77474485e86d1ae_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.12</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FIRST AMENDMENT TO SECOND AMENDED AND RESTATED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), dated as of March 11, 2020,&#160;is among Aspen Insurance Holdings Limited (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the undersigned Subsidiary Borrowers (together with Aspen, each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the several banks that are parties hereto, and Barclays Bank PLC, as administrative agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Capitalized terms used but not defined herein have the respective meanings set forth in the Credit Agreement (as defined below).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Borrowers, various banks, the Collateral Agent and Barclays Bank PLC, as administrative agent, entered into a Second Amended and Restated Credit Agreement dated as of March 27, 2017 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the parties hereto wish to amend the Credit Agreement as set forth herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to Section 2 below, the Credit Agreement is hereby amended as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Section 6.1(a), Financial Statements, of the Credit Agreement is amended by replacing &#8220;90 days&#8221; with &#8220;120 days&#8221;&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Section 6.2(b) Certificates&#59; Other Information, of the Credit Agreement is amended by inserting the following to the beginning of the paragraph&#58; &#8220;If required to be filed by the Company with the SEC pursuant to SEC rules and regulations applicable to the Company&#58;&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Amendment shall become effective as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) when, and only when, each of the following conditions precedent shall have been satisfied&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Administrative Agent shall have received a counterpart of this Amendment executed by the Borrowers, the Administrative Agent and the Required Lenders.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The representations and warranties of the Borrowers contained in Section 4 of the Credit Agreement and in the other Loan Documents are true and correct in all material respects as of the Amendment Effective Date, with the same effect as though made on such date (unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;No Default has occurred and is continuing or will result from the effectiveness of this Amendment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower Representations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Each Borrower hereby represents and warrants, on and as of the Amendment Effective Date, that (i) the representations and warranties applicable to such Borrower contained in Section 4 of the Credit Agreement and in the other Loan Documents are true and correct in all material respects as of the Amendment Effective Date, with the same effect as though made on such date (unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date), (ii) this Amendment has been duly authorized, executed and delivered by such Borrower and constitutes the legal, valid and binding obligation of such Borrower, enforceable against such Borrower in accordance with its terms, subject to general principles of equity (regardless of whether considered in a proceeding in equity or at law) and to applicable bankruptcy, insolvency, and similar laws affecting the enforcement of creditors&#8217; rights generally and (iii) no Default shall have occurred and be continuing, both immediately before and after giving effect to the applicable provisions of this Amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reaffirmation of Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Borrower agrees that each Loan Document to which it is a party remains in full force and effect and is hereby ratified and confirmed. The amendments provided for herein are limited to the specific sections of the Credit Agreement specified herein and shall not constitute a consent, waiver or amendment of, or an indication of the Administrative Agent&#8217;s or any Lender&#8217;s willingness to consent to any action requiring consent under any other provision of the Credit Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The provisions of Sections 11.5, 11.9, 11.12, 11.13 and 11.20 of the Credit Agreement are incorporated herein by reference as if set forth in full herein,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div></div></div><div id="i190da568f4624c21b77474485e86d1ae_56"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their proper and duly authorized officers as of the day and year first above written.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Mark Pickering </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Mark Pickering </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Group Treasurer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Scott Kirk</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Scott Kirk </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Chief Financial Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN BERMUDA LIMITED, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Christian Dunleavy </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Christian Dunleavy</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Chief Executive Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN INSURANCE UK LIMITED, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Cain </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Michael Cain </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN (UK) HOLDINGS LIMITED, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Scott Kirk </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Scott Kirk </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to First Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN SPECIALTY INSURANCE COMPANY, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; CFO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN U.S. HOLDINGS, INC., </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; CFO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN UNDERWRITING LIMITED, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Stuart Riley </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Stuart Riley </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN AMERICAN INSURANCE COMPANY, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; CFO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BARCLAYS BANK PLC, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Administrative Agent and a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Karla K. Maloof</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Karla K. Maloof</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Head of Insurance, FIG Corporate Banking-NA</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executed in New York</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to First Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CITIBANK, N.A.,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Syndication Agent and a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; John M. Modin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; John M. Modin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Managing Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE BANK OF NEW YORK MELLON,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Collateral Agent</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Pensari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Michael Pensari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DEUTSCHE BANK AG NEW YORK BRANCH,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Annie Chung</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Annie Chung</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Min K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Ming K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DEUTSCHE BANK AG NEW YORK BRANCH,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; John S. McGill </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; John S. McGill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE BANK OF NEW YORK MELLON,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Pensari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Michael Pensari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to First Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LLOYDS BANK PLC,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kamala Basdeo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kamala Basdeo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Assistant Vice President<br>Transaction Execution</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#47;s&#47; Tina Wong</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Tina Wong </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Assistant Vice President<br>Transaction Execution</font></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.397%"><tr><td style="width:1.0%"></td><td style="width:45.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">U.S. BANK NATIONAL ASSOCIATION,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Mona Tavss</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Mona Tavss</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Vice President</font></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HSBC BANK USA, NATIONAL ASSOCIATION,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Teresa Pereyra</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Teresa Pereyra</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">VP, Global Relationship Manager<br>FIG, Insurance</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to First Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>24
<FILENAME>exhibit1013-fx1.htm
<DESCRIPTION>EX-10.13
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1afae93de43b441b9890e5455de2557c_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.13</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Execution Version</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECOND AMENDMENT TO SECOND AMENDED AND RESTATED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This SECOND AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), dated as of April 28, 2020,&#160;is among Aspen Insurance Holdings Limited (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the undersigned Subsidiary Borrowers (together with Aspen, each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the several banks that are parties hereto, and Barclays Bank PLC, as administrative agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Capitalized terms used but not defined herein have the respective meanings set forth in the Credit Agreement (as defined below).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Borrowers, various banks, the Collateral Agent and Barclays Bank PLC, as administrative agent, entered into a Second Amended and Restated Credit Agreement dated as of March 27, 2017, as amended by the First Amendment to Second Amended and Restated Credit Agreement dated as of March 11, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the parties hereto wish to amend the Credit Agreement as set forth herein&#59;</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to Section 2 below, the Credit Agreement is hereby amended as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt">Paragraph (b) of Section 7.1, Financial Condition Covenants, of the Credit Agreement is amended to read in its entirety as follows&#58;</font></div><div style="margin-bottom:24pt;padding-left:63pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt;text-decoration:underline">Consolidated Tangible Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Permit Consolidated Tangible Net Worth as at any date to be less than the sum of (i) $1,891,100,000, (ii) 25% of Consolidated Net Income during the period from January 1, 2020 to and including such date (if positive) and (iii) 25% of the aggregate Net Cash Proceeds of all issuances by the Company of shares of its Capital Stock during the period from January 1, 2020 to and including such date.</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Amendment shall become effective as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) when, and only when, each of the following conditions precedent shall have been satisfied&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Administrative Agent shall have received a counterpart of this Amendment executed by the Borrowers, the Administrative Agent and the Required Lenders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6.34pt">The representations and warranties of the Borrowers contained in Section 4 of the Credit Agreement and in the other Loan Documents are true and correct in all material respects as of the Amendment Effective Date, with the same effect as though made on such date (unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date).</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6.91pt">No Default has occurred and is continuing or will result from the effectiveness of this Amendment.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Borrower hereby represents and warrants, on and as of the Amendment Effective Date, that (i) the representations and warranties applicable to such Borrower contained in Section 4 of the Credit Agreement and in the other Loan Documents are true and correct in all material respects as of the Amendment Effective Date, with the same effect as though made on such date (unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date), (ii) this Amendment has been duly authorized, executed and delivered by such Borrower and constitutes the legal, valid and binding obligation of such Borrower, enforceable against such Borrower in accordance with its terms, subject to general principles of equity (regardless of whether considered in a proceeding in equity or at law) and to applicable bankruptcy, insolvency, and similar laws affecting the enforcement of creditors&#8217; rights generally and (iii) no Default shall have occurred and be continuing, both immediately before and after giving effect to the applicable provisions of this Amendment.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reaffirmation of Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Borrower agrees that each Loan Document to which it is a party remains in full force and effect and is hereby ratified and confirmed. The amendments provided for herein are limited to the specific sections of the Credit Agreement specified herein and shall not constitute a consent, waiver or amendment of, or an indication of the Administrative Agent&#8217;s or any Lender&#8217;s willingness to consent to any action requiring consent under any other provision of the Credit Agreement.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The provisions of Sections 11.5, 11.9, 11.12, 11.13 and 11.20 of the Credit Agreement are incorporated herein by reference as if set forth in full herein,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1afae93de43b441b9890e5455de2557c_63"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their proper and duly authorized officers as of the day and year first above written.</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:9.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.913%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDING LIMITED,</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Mark Pickering</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Mark Pickering</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Group Treasurer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASPEN BERMUDA LIMITED,</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Borrower</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Christian Dunleavy</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Christian Dunleavy</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Chief Executive Officer</font></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN INSURANCE UK LIMITED,</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Cain</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Michael Cain </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN (UK) HOLDINGS LIMITED,</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Borrower</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47;Michael Cain</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Michael Cain</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to Second Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:9.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN SPECIALTY INSURANCE COMPANY,</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; CFO</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASPEN U.S. HOLDINGS, INC.,</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Borrower</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; CFO</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN UNDERWRITING LIMITED,</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Borrower </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Stuart Riley</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Stuart Riley</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASPEN AMERICAN INSURANCE COMPANY,</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Borrower</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Kenneth Cadematori</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; CFO</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:100pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to Second Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:200pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.647%"><tr><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC, </font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Administrative Agent and a Lender</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Karla Maloof</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Karla Maloof</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Managing Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Executed in New York</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Executed in New York</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:8.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CITIBANK, N.A.,</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Syndication Agent and a Lender</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; John Modin</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; John Modin</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Managing Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to Second Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:100pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:8.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE BANK OF NEW YORK MELLON, </font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Pensari</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Michael Pensari</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:8.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DEUTSCHE BANK AG NEW YORK BRANCH,</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Annie Chung</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Annie Chung</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Ming K Chu</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Ming K Chu</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to Second Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:100pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.664%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LLOYDS BANK CORPORATE MARKETS PLC,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kamala Basdeo </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Kamala Basdeo</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Assistant Vice President</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Tina Wong</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Tina Wong</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Assistant Vice President</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HSBC BANK USA, NATIONAL ASSOCIATION, </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Maria Teresa Pereyra Lopez</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Maria Teresa Pereyra Lopez</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; VP, Global Relationship Banker,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FIG Insurance</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">U.S. BANK NATIONAL ASSOCIATION, </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to Second Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.038%"><tr><td style="width:1.0%"></td><td style="width:59.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Glenn Schuermann</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Glenn Schuermann</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Vice President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#91;Signature Page to Second Amendment to Second Amended and Restated Credit Agreement&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>25
<FILENAME>exhibit1014-fx1.htm
<DESCRIPTION>EX-10.14
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i18b286b8d4714811aa44a1654f3360f7_59"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.14</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Execution Version</font></div></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THIRD AMENDED AND RESTATED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CREDIT AGREEMENT</font></div><div style="margin-bottom:15pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">among</font></div><div style="margin-bottom:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED,</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Subsidiary Borrowers</font></div><div style="margin-bottom:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from Time to Time Parties Hereto,</font></div><div style="margin-bottom:25pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Several Lenders from Time to Time Parties Hereto,</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON,</font></div><div style="margin-bottom:25pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Collateral Agent,</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CITIBANK, N.A.,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Syndication Agent,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HSBC BANK USA, N.A., LLOYDS BANK CORPORATE MARKETS PLC AND WELLS FARGO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Co-Documentation Agents,</font></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC,</font></div><div style="margin-bottom:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Administrative Agent</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated as of December 1, 2021</font></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC and CITIGROUP GLOBAL MARKETS INC.,</font></div><div style="margin-bottom:15pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Joint Bookrunners</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC, CITIGROUP GLOBAL MARKETS INC., HSBC BANK USA, N.A.,</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LLOYDS BANK CORPORATE MARKETS PLC AND WELLS FARGO SECURITIES, LLC</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Joint Lead Arrangers</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_252"></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</font></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEFINITIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined Terms</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Definitional Provisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Rates</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in GAAP</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMOUNT AND TERMS OF COMMITMENTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Commitments</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Procedure for Borrowing</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination or Reduction of Commitments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optional and Mandatory Prepayments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion and Continuation Options</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limitations on Eurodollar Tranches</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rates and Payment Dates</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of Interest and Fees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inability to Determine Interest Rate</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro Rata Treatment and Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requirements of Law&#59; Eurocurrency Liabilities</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnity</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change of Lending Office</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Replacement of Lenders</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defaulting Lenders</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LETTERS OF CREDIT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L&#47;C Commitment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Procedure for Issuance of Letter of Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fees and Other Charges</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L&#47;C Participations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursement Obligation of the Borrowers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligations Absolute</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter of Credit Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Several Letters of Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Applications</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuing Lenders</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reporting</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-NAIC Approved Banks</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Conditions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Change</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existence&#59; Compliance with Law</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power&#59; Authorization&#59; Enforceable Obligations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Legal Bar</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Default</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership of Property&#59; Liens</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal Regulations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERISA</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment Company Act</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of Proceeds</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental Matters</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accuracy of Information, etc</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.17</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PATRIOT Act&#59; OFAC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.18</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Margin Regulations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CONDITIONS PRECEDENT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions to Initial Extensions of Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions to Each Extension of Credit</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conditions for Additional Subsidiary Borrowers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 6</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AFFIRMATIVE COVENANTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates&#59; Other Information</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of Obligations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintenance of Existence&#59; Compliance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintenance of Property&#59; Insurance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inspection of Property&#59; Books and Records&#59; Discussions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental Laws</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 7</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NEGATIVE COVENANTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Condition Covenants</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indebtedness</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposition of Property</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liens</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clauses Restricting Subsidiary Distributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rating</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidations, Amalgamations, Mergers and Liquidations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactions with Affiliates</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 8</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EVENTS OF DEFAULT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 9</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THE AGENTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appointment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delegation of Duties</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exculpatory Provisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reliance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notice of Default</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Reliance on Agents and Other Lenders</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agent in Its Individual Capacity</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Successor Administrative Agent and Collateral Agent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Security Document Matters</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Agents</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Erroneous Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.13</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain ERISA Matters</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 10</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GUARANTEE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Subrogation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments, etc. with respect to the Obligations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee Absolute and Unconditional</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinstatement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Obligations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 11</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MISCELLANEOUS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments and Waivers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Waiver&#59; Cumulative Remedies</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Survival of Representations and Warranties</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of Expenses and Taxes&#59; Indemnification&#59; Limitation of Liability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Successors and Assigns&#59; Participations and Assignments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Set-off</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Counterparts&#59; Electronic Execution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GOVERNING LAW</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.13</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Submission To Jurisdiction&#59; Waivers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.14</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Process Agent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.15</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency of Payment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.16</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Releases of Liens</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.17</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidentiality</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.18</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Several Obligations of Borrowers&#59; Company as Agent of Borrowers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.19</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Reserved.&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.20</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WAIVERS OF JURY TRIAL</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.21</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No Advisory or Fiduciary Duty</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.22</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USA Patriot Act</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.23</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Restatement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.24</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 12</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THE BORROWER REPRESENTATIVE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appointment&#59; Nature of Relationship</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Powers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment of Agents</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Successor Borrower Representative</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of Loan Documents&#59; Borrowing Base Certificate</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90</font></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv</font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ANNEX</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A&#160;&#160;&#160;&#160;Pricing Grid</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SCHEDULES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2(b)(iv)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing Indebtedness</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing Liens</font></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EXHIBITS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Compliance Certificate</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Closing Certificate of the Company</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Closing Certificate of each Subsidiary Borrower</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Assignment and Assumption</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D-1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Legal Opinion of WilIkie Farr &#38; Gallagher LLP</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D-2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Legal Opinion of Carey Olsen Bermuda Limited</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D-3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Legal Opinion of US General Counsel</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Exemption Certificate (Non-Partnerships)</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Exemption Certificate (Partnerships)</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Exemption Certificate (Non-U.S. Non-Partnerships)</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Exemption Certificate ((Non-U.S. Partnerships)</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company Note</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Subsidiary Borrower Note</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Notice of Conversion&#47;Continuation</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Subsidiary Borrower Agreement</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Commitment Increase Supplement</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of New Lender Supplement</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Several Letter of Credit</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Borrowing Request</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Prepayment Notice</font></div></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v</font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_287"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIRD AMENDED AND RESTATED CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), dated as of December 1, 2021, among ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;&#8217;), the Subsidiary Borrowers (as defined below&#59; together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the several banks and other financial institutions or entities from time to time parties to this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), THE BANK OF NEW YORK MELLON, as collateral agent, and BARCLAYS BANK PLC, as administrative agent.</font></div><div style="margin-bottom:18pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 1&#160;&#160;DEFINITIONS</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As used in this Agreement, the terms listed in this Section 1.1 shall have the respective meanings set forth in this Section 1.1.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ABR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; for any day, a rate per annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day plus 0.50% and (c) the sum of 1.0% plus the Eurodollar Rate for U.S. Dollars for an Interest Period of one month on such day (or if such day is not a Business Day, on the immediately preceding Business Day)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that if such Eurodollar Rate shall be less than the Floor, such rate shall be deemed to be the Floor for purposes of this clause (c)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that for the purpose of this definition, the Eurodollar Rate for any day shall be based on the LIBO Screen Rate (or if the LIBO Screen Rate is not available for such one month Interest Period, the Interpolated Rate) at approximately 11&#58;00 a.m. London time on such day. Any change in ABR due to a change in the Prime Rate or the Federal Funds Effective Rate shall be effective from and including the effective date of such change in the Prime Rate or the Federal Funds Effective Rate, respectively. If ABR is being used as an alternate rate of interest pursuant to Section 2.10, then ABR shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ABR Loans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Loans that bear interest based upon the ABR.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as defined in the Security Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; Barclays Bank PLC, as the administrative agent for the Lenders under this Agreement and the other Loan Documents, together with any of its successors.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advance Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; for any category of cash or obligation or investment specified below in the column entitled &#8220;Cash and Eligible Securities&#34; (including cash, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Collateral</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and other than cash, the &#8220; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Securities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the percentage set forth opposite such category of cash or Eligible Securities below in the column entitled &#8220;Advance Rate&#8221; and, in each case, subject to the original term to maturity criteria set forth therein&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and Eligible Securities</font></td><td colspan="3" style="background-color:#d9d9d9;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Advance Rate</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time deposits, certificates of deposit and money market deposits, denominated in Dollars, of any commercial bank incorporated in the United States with a rating of at least (i) AA- from S&#38;P, (ii) Aa3 from Moody&#8217;s or (iii) AA- from Fitch and maturing within two years from the date of determination. Money market mutual funds with same-day liquidity and with a rating of (i) AAA from S&#38;P, (ii) Aaa from Moody&#8217;s or (iii) AAA from Fitch</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper issued by any entity organized in the United States with maturities of one year or less (rated at least A-1 or the equivalent thereof by S&#38;P and&#47;or P-1 by Moody's)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Debt</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 5 years, but &#62; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 10 years, but &#62; 5 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#62; 10 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency Securities (GNMA, FNMA, FHLMC) rated by at least two of</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moody&#8217;s, S&#38;P, and&#47;or Fitch Ratings Aa3 &#47; AA- &#47; AA- or better</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WAL &#8804; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WAL &#8804; 5 years, but &#62; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WAL &#8804; 10 years, but &#62; 5 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WAL &#62; 10 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supranational Debt rated at least AA- by S&#38;P and&#47;or Aa3 by Moody&#8217;s</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 2 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 10 years, but &#62; 2 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#62; 10 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Securities (rated by at least two of Moody&#8217;s, S&#38;P, and&#47;or Fitch Aa3&#47;AA-&#47;AA- or better)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 5 years, but &#62; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 10 years, but &#62; 5 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#62; 10 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Securities (rated by at least two of Moody&#8217;s, S&#38;P, and&#47;or Fitch A3&#47;A-&#47;A- or better), Non-convertible</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 5 years, but &#62; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 10 years, but &#62; 5 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#62; 10 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Securities (rated by at least two of Moody&#8217;s, S&#38;P, and&#47;or Fitch Baa2&#47;BBB&#47;BBB or better), Non-convertible</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 5 years, but &#62; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 10 years, but &#62; 5 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#62; 10 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Backed Securities (rated by at least two of Moody&#8217;s, S&#38;P, and&#47;or Fitch Aa3&#47;AA-&#47;AA- or better)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 5 years, but &#62; 1 year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity &#8804; 10 years, but &#62; 5 years</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other securities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</font></td></tr></table></div><div style="text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the value of the amount included in the Borrowing Base for the Eligible Collateral set forth above shall be decreased by an additional 10.0% to the extent that such marketable securities are held in a currency other than the currency of the applicable Secured Letter of</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, any other Person that, directly or indirectly, is in control of, is controlled by, or is under common control with, such Person. For purposes of this definition, &#8220;control&#8221; of a Person means the power, directly or indirectly, either to (a) vote 20% or more of the securities having ordinary voting power for the election of directors (or persons performing similar functions) of such Person or (b) direct or cause the direction of the management and policies of such Person, whether by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to the Syndication Agent, the Administrative Agent, the Co-Documentation Agents and the Collateral Agent.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Aggregate Exposure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; with respect to any Lender at any time, an amount equal to the amount of such Lender&#8217;s Commitment then in effect or, if the Commitments have been terminated, the amount of such Lender&#8217;s Extensions of Credit then outstanding.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Aggregate Exposure Percentage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any Lender at any time, the ratio (expressed as a percentage) of such Lender&#8217;s Aggregate Exposure at such time to the Aggregate Exposure of all Lenders at such time&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that when a Defaulting Lender shall exist, any such Defaulting Lender&#8217;s Commitment shall be disregarded in the calculation of Aggregate Exposure Percentage.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; all laws, rules and regulations of any jurisdiction applicable to the Company or any of its Subsidiaries from time to time concerning or relating to bribery or corruption, including the United States Foreign Corruption Practices Act of 1977 and the rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Issuing Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; (a) in the case of Fronted Letters of Credit, the Issuing Lender and (b) in the case of Several Letters of Credit, the L&#47;C Administrator.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Margin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the rate per annum set forth under the relevant column heading in Annex A.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Application</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; an application, in such form as the applicable Issuing Lender may specify from time to time, requesting such Issuing Lender to issue a Letter of Credit.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6(b).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6(b).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; an Assignment and Assumption, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Available Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as to any Lender at any time, an amount equal to the excess, if any, of (a) such Lender&#8217;s Commitment then in effect </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (b) such Lender&#8217;s Extensions of Credit then outstanding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Available Tenor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if the then-current Benchmark is a term rate, any tenor for such Benchmark that is or may be used for determining the length of an Interest Period or (y) otherwise, any payment period for interest calculated with reference to such Benchmark, as applicable, pursuant to this Agreement as of such date.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bail-In Action</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bail-In Legislation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, regulation rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Benchmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; initially, USD LIBOR&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that if a replacement of the Benchmark has occurred pursuant to Section 2.10, then &#8220;Benchmark&#34; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate. Any reference to &#8220;Benchmark&#8221; shall include, as applicable, the published component used in the calculation thereof.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Benchmark Replacement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; for any Available Tenor&#58;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) For purposes of Section 2.10(b)(i), the first alternative set forth below that can be determined by the Administrative Agent&#58;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) the sum of&#58; (i) Term SOFR and (ii) 0.11448% (11.448 basis points) for an Available Tenor of one-month&#8217;s duration, 0.26161% (26.161 basis points) for an Available Tenor of three-months&#8217; duration, and 0.42826% (42.826 basis points) for an Available Tenor of six-months&#8217; duration, or</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) the sum of&#58; (i) Daily Simple SOFR and (ii) the spread adjustment selected or recommended by the Relevant Governmental Body for the replacement of the tenor of USD LIBOR with a SOFR-based rate having approximately the same length as the interest payment period specified in clause (a) of this Section&#59; and</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) For purposes of Section 2.10(b)(ii), the sum of (a) the alternate benchmark rate and (b) an adjustment (which may be a positive or negative value or zero), in each case, that has been selected by the Administrative Agent and the Borrower as the replacement for such Available Tenor of such Benchmark giving due consideration to any evolving or then-prevailing market convention, including any applicable recommendations made by the Relevant Governmental Body, for U.S. dollar-denominated syndicated credit facilities at such time&#59;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, if the Benchmark Replacement as determined pursuant to clause (1) or (2) above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Agreement and the other Loan Documents.</font></div><div style="text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;ABR,&#8221; the definition of &#8220;Business Day,&#8221; the definition of &#8220;Interest Period,&#8221; timing and frequency of</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent decides may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Benchmark Transition Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any then-current Benchmark other than USD LIBOR, the occurrence of a public statement or publication of information by or on behalf of the administrator of the then-current Benchmark, the regulatory supervisor for the administrator of such Benchmark, the Board of Governors of the Federal Reserve System, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark, a resolution authority with jurisdiction over the administrator for such Benchmark or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark, announcing or stating that (a) such administrator has ceased or will cease on a specified date to provide all Available Tenors of such Benchmark, permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark or (b) all Available Tenors of such Benchmark are or will no longer be representative of the underlying market and economic reality that such Benchmark is intended to measure and that representativeness will not be restored.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; a certification regarding beneficial ownership or control as required by the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; 31 C.F.R. &#167; 1010.230.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any of (a) an &#8220;employee benefit plan&#8221; (as defined in Section 3(3) of ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in Section 4975 of the Code to which Section 4975 of the Code applies, or (c) any Person whose assets include (for purposes of Section 3(42) of ERISA or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Benefitted Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as defined in Section 11.7.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bermuda Companies Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; The Bermuda Companies Act of 1981, as amended.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bermuda Insurance Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; The Bermuda Insurance Act of 1978, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Board of Governors of the Federal Reserve System of the United States (or any successor).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower Representative</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; the Company, in its capacity as contractual representative of the Borrowers pursuant to Section 12.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowing Base</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, and in respect of each Borrower, the aggregate amount of cash and Eligible Securities held in the Accounts applicable to such Borrower under the applicable Collateral Account Control Agreement at such time multiplied in each case by the respective Advance Rates for cash and such Eligible Securities&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no Eligible Securities or cash shall be included in the calculation of a Borrowing Base unless (i) the Collateral Agent has a first priority perfected Lien on and security interest in such collateral pursuant to the Loan Documents and (ii) there shall exist no other Liens on such Eligible Securities and cash&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (1) no Eligible Security shall be included in the calculation of a Borrowing Base unless (A) either transactions with respect to such Eligible Security are settled through the Depositary Trust &#38; Clearing Corporation or such Eligible Security is listed on a generally recognized national securities exchange or is freely traded at readily established prices in over-the-counter transactions and (B) price quotations for such Eligible Security are available to the Custodian in the ordinary course of business on a daily basis, (2) other than Government Debt and Agency Securities or, FHLMC and the FNMA (so long as such Person is under the conservatorship of the Federal Housing Finance Agency), no single issue or issuer shall constitute more than 10% of the fair market value of the Borrowing Base, (3) securities issued by reinsurers and insurers in relation to the Agreement shall not be included in the Borrowing Base, (4) no covered bonds shall be included in the Borrowing Base (5) all maturities are calculated from the relevant date of determination of a Borrowing Base and (6) the total value included in the Borrowing Base of U.S. Corporate Bonds (Rating BBB or worse) and asset-backed securities shall not exceed 30% of the total Borrowing Base&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that (i) the Borrowing Base in respect of any Borrower at any time shall be the amount thereof as set forth in the Borrowing Base Report (as defined in the applicable Collateral Account Control Agreement) then most recently delivered by the Collateral Agent to the Administrative Agent pursuant to Section 2 of Article III of the applicable Collateral Account Control Agreement, (ii) for the avoidance of doubt, each Borrower will take all such actions as shall be necessary to cause such Borrower to be in compliance with Article III of the applicable Collateral Account Control Agreement and (iii) all Eligible Collateral will be subject to monthly valuations.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowing Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Business Day specified by the Borrower Representative as a date on which the Borrower Representative requests the relevant Lenders to make Loans hereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; a day other than a Saturday, Sunday or other day on which commercial banks in New York City or London or, for purposes of Section 2.5(b) only, Bermuda, are authorized or required by law to close&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that with respect to notices and determinations in connection with, and payments of principal and interest on, Eurodollar Loans, such day is also a day for trading by and between banks in Dollar deposits in the interbank eurodollar market.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Lease Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP and, for the purposes of this Agreement, the amount of such obligations at any time shall be the capitalized amount thereof at such time determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any and all shares, interests, participations or other equivalents (however designated) of capital stock (including Hybrid Capital) of a corporation, any and all equivalent ownership interests in a Person (other than a corporation) and any and all warrants, rights or options to purchase any of the foregoing.</font></div><div style="text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Equivalents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) marketable direct obligations issued by, or unconditionally guaranteed by, the United States federal government or issued by any agency thereof and backed by the full faith and credit of the United States, in each case maturing within one year from the date of</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquisition&#59; (b) certificates of deposit, time deposits, eurodollar time deposits or overnight bank deposits having maturities of six months or less from the date of acquisition issued by any Lender or by any commercial bank organized under the laws of the United States or any state thereof having combined capital and surplus of not less than $500,000,000&#59; (c) commercial paper of an issuer rated at least *A-1&#8217; by S&#38;P or &#8216;P-1&#8217; by Moody&#8217;s, or carrying an equivalent rating by a nationally recognized rating agency, if both of the two named rating agencies cease publishing ratings of commercial paper issuers generally, and maturing within six months from the date of acquisition&#59; (d) repurchase obligations of any Lender or of any commercial bank satisfying the requirements of clause (b) of this definition, having a term of not more than 30 days, with respect to securities issued or fully guaranteed or insured by the United States federal government&#59; (e) securities with maturities of one year or less from the date of acquisition issued or fully guaranteed by any state, commonwealth or territory of the United States, by any political subdivision or taxing authority of any such state, commonwealth or territory or by any foreign government, the securities of which state, commonwealth, territory, political subdivision, taxing authority or foreign government (as the case may be) are rated at least &#8216;A&#8217; by S&#38;P or &#8216;A&#8217; by Moody&#8217;s&#59; (f) securities with maturities of six months or less from the date of acquisition backed by standby letters of credit issued by any Lender or any commercial bank satisfying the requirements of clause (b) of this definition&#59; (g) money market mutual or similar funds that invest exclusively in assets satisfying the requirements of clauses (a) through (f) of this definition&#59; or (h) money market funds that (i) comply with the criteria set forth in SEC Rule 2a-7 under the Investment Company Act of 1940, (ii) are rated &#8216;AAA&#8217; by S&#38;P and &#8216;Aaa&#8217; by Moody&#8217;s and (iii) have portfolio assets of at least $5,000,000,000.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any of the following&#58; (i) any &#8220;person&#8221; or &#8220;group&#8221; (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) other than the Company or any Subsidiary), shall become, or obtain rights (whether by means of warrants, options or otherwise (other than any such warrants, options or other rights which are not exercisable prior to the Termination Date)) to become, the &#8220;beneficial owner&#8221; (as defined in Rules 13(d)-3 and 13(d)-5 under the Exchange Act), directly or indirectly, of shares of Capital Stock representing more than 50% of the total voting power of any Borrower&#59; or (ii) the occupation of a majority of the seats (other than vacant seats) of the board of directors of the Company by Persons who are neither (x) the directors of the Company on the Closing Date nor (y) nominated by the board of directors of the Company nor (z) appointed by directors so nominated.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the date on which the conditions precedent set forth in Section 5.1 shall have been satisfied, which date is December 1, 2021.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Co-Documentation Agents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; HSBC Bank USA, N.A., Lloyds Bank Corporate Markets plc and Wells Fargo Bank, National Association, in their capacities as co-documentation agents.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Internal Revenue Code of 1986, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as defined in the Security Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral Account Control Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; each Collateral Account Control Agreement, among a Borrower, The Bank of New York Mellon, as securities intermediary, and the Collateral Agent, in form and substance reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the Security Agreement.</font></div><div style="text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Lender, the obligation of such Lender to make Loans and issue or participate in Letters of Credit during the Commitment Period in an aggregate principal and&#47;or face amount not to exceed, at any one time outstanding, the amount set forth under the heading &#8220;Commitment&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opposite such Lender&#8217;s name on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or in the Assignment and Assumption pursuant to which such Lender became a party hereto, as the same may be changed from time to time pursuant to the terms hereof. The original aggregate amount of the Commitments is $300,000,000.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Fee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as defined in Section 2.3(a).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Fee Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the rate per annum set forth under the relevant column heading in Annex A.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Increase Supplement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; a supplement to this Agreement substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit J</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Percentage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as to any Lender at any time, the percentage which such Lender&#8217;s Commitment then constitutes of the Total Commitments or, at any time after the Commitments shall have expired or terminated, the percentage which the aggregate principal amount of such Lender&#8217;s Loans then outstanding constitutes of the aggregate principal amount of the Loans then outstanding&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that in the event that the Loans are paid in full prior to the reduction to zero of the Total Extensions of Credit, the Commitment Percentages shall be determined in a manner designed to ensure that the other outstanding Extensions of Credit shall be held by the Lenders on a comparable basis.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the period from and including the Closing Date to but excluding the Termination Date.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Share</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 3.8(a).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commonly Controlled Entity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; an entity, whether or not incorporated, that is under common control with the Company or any Subsidiary within the meaning of Section 4001(a)(14) of ERISA or is part of a group that includes the Company or any Subsidiary and that is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Sections 302 and 303 of ERISA and Sections 412, 430 and 4971 of the Code, is treated as a single employer under Section 414(b), (c), (m) or (o) of the Code.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as defined in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance Certificate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; a certificate duly executed by a Responsible Officer of the Company substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information Memorandum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Confidential Information Memorandum dated October 2021 and furnished to certain Lenders.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Connection Income Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Leverage Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as of the last day of any fiscal quarter (expressed as a percentage), Consolidated Total Debt, divided by the sum of (i) Consolidated Total Debt and (ii) Consolidated Tangible Net Worth.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Net Income</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; for any period, the consolidated net income (or loss) of the Company and its Subsidiaries, determined on a consolidated basis in accordance with GAAP.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Tangible Net Worth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;&#8217;&#58; of the Company at any date, the consolidated stockholders&#8217; equity (including Hybrid Capital) of the Company and its Subsidiaries less their consolidated intangible assets, all determined on a consolidated basis as of such date in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Total Debt</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; at any date, the aggregate principal amount of all Indebtedness of the Company and its Subsidiaries at such date, determined on a consolidated basis in accordance with GAAP&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that there shall be excluded from Consolidated Total Debt (i) the then aggregate undrawn face amount of all then outstanding letters of credit issued on behalf of, or for the account or benefit of, the Company and&#47;or any of its Subsidiaries, (but the aggregate amount of drawings under such letters of credit that have not then been reimbursed shall not be so excluded), and (ii) the principal amount of any capital instrument entered into in connection with Funds at Lloyd&#8217;s. For the avoidance of doubt, Consolidated Total Debt shall not include Hybrid Capital.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contractual Obligation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as to any Person, any provision of any security issued by such Person or of any agreement, instrument or other undertaking to which such Person is a party or by which it or any of its property is bound.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency of Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as defined in Section 11.15.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Custodian</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; as defined in the Security Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Daily Simple SOFR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; for any day, SOFR, with the conventions for this rate (which will include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate recommended by the Relevant Governmental Body for determining &#8220;Daily Simple SOFR&#8221; for syndicated business loans&#59; provided, that if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; any of the events specified in Section 8, whether or not any requirement for the giving of notice, the lapse of time, or both, has been satisfied.</font></div><div style="text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Lender, as reasonably determined by the Administrative Agent, that has (a) failed to fund any portion of its Loans, Several Letters of Credit or participations in Fronted Letters of Credit within three Business Days of the date required to be funded by it hereunder (unless, in the case of any Loan, such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#8217;s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied), (b) notified the Borrower, the Administrative Agent, any Issuing Lender or any Lender in writing that it does not intend to comply with any of its funding obligations under this Agreement or has made a public statement to the effect that it does not intend to comply with its funding obligations under this Agreement or under other agreements generally in which it commits to extend credit (unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) failed, within three Business Days after request by the Administrative Agent, to confirm that it will comply with the terms of this Agreement relating to its obligations to fund prospective Loans, Several Letters of Credit and participations in then outstanding Fronted Letters of Credit, (d) otherwise failed to pay over to the Administrative Agent or any other Lender any other amount required to be paid by it hereunder within three Business Days of the date when due, unless the subject of a reasonable good faith</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dispute, (e) (i) become or is insolvent or has a parent company that has become or is insolvent or (ii) become the subject of a bankruptcy or insolvency proceeding, or (iii) has had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such a capacity or (f) become the subject of a Bail-in Action&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any equity interest in such Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disposition</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any property, any sale, lease, sale and leaseback, assignment, conveyance, transfer or other disposition thereof. The terms &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dispose</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disposed of</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have correlative meanings.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dollar Amount</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time (a) as to any amount in Dollars, such amount and (b) as to any amount in Pounds Sterling, the then Dollar Equivalent thereof.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dollar Equivalent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any amount of Pounds Sterling on any date, the equivalent amount in Dollars of such amount of Pounds Sterling as determined by the Administrative Agent in accordance with Section 1.3 using the applicable Exchange Rate.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58;dollars in lawful currency of the United States.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Domestic Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Subsidiary organized under the laws of any jurisdiction within the United States.</font></div><div style="margin-bottom:6pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Early Opt-in Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Early Opt-in Election, the sixth (6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, so long as the Administrative Agent has not received, by 5&#58;00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, written notice of objection to such Early Opt-in Election from Lenders comprising the Required Lenders.</font></div><div style="margin-bottom:6pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Early Opt-in Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;a notification by the Administrative Agent to (or the request by the Borrower to the Administrative Agent to notify) each of the other parties hereto that at least five currently outstanding U.S. dollar-denominated syndicated credit facilities at such time contain (as a result of amendment or as originally executed) a SOFR-based rate (including SOFR, a term SOFR or any other rate based upon SOFR) as a benchmark rate (and such syndicated credit facilities are identified in such notice and are publicly available for review), and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;the joint election by the Administrative Agent and the Borrower to trigger a fallback from USD LIBOR and the provision by the Administrative Agent of written notice of such election to the Lenders.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EEA Financial Institution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EEA Member Country</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EEA Resolution Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Signature</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; an electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Collateral</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as provided in the definition of the term Advance Rate.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Securities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as provided in the definition of the term Advance Rate.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any and all applicable foreign, Federal, state, local or municipal laws, requirements of any Governmental Authority or other Requirements of Law (including common law) regulating, relating to or imposing liability relating to (a) pollution or protection of the environment, (b) exposure of any Person to hazardous emissions or releases of Hazardous Materials, (c) protection of the public health or welfare from the effects of products&#59; by-products, emissions or releases of Hazardous Materials and (d) regulation of the manufacture, use or introduction into commerce of Hazardous Materials.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Employee Retirement Income Security Act of 1974, as amended from time to time, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor Person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eurodollar Loans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Loans that bear interest based upon the Eurodollar Rate.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eurodollar Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any Eurodollar Borrowing for any Interest Period, the LIBO Screen Rate at approximately 11&#58;00 a.m., London time, two Business Days prior to the commencement of such Interest Period, with tenor equal to such Interest Period&#59; provided that if the LIBO Screen Rate shall not be available at such time for such Interest Period (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Impacted Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) then the &#8220;Eurodollar Rate&#8221; with respect to such Eurodollar Borrowing for such Interest Period shall be the Interpolated Rate. Notwithstanding the foregoing, if the applicable rate described above is less than the Floor, such rate shall be deemed to be the Floor for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eurodollar Tranche</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to Eurodollar Loans the then current Interest Periods with respect to all of which begin on the same date and end on the same later date (whether or not such Loans shall originally have been made on the same day).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any of the events specified in Section 8&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that any requirement for the giving of notice, the lapse of time, or both, has been satisfied.</font></div><div style="margin-bottom:9pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; on any day, with respect to Pounds Sterling, the rate at which such currency may be exchanged into Dollars, as set forth at approximately 11&#58;00 A.M., New York time, on</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such date on the Reuters World Currency Page for Pounds Sterling. In the event that such rate does not appear on any Reuters World Currency Page, the Exchange Rate shall be determined by reference to such other publicly available service for displaying exchange rates as may be selected by the Administrative Agent, or, in the event no such service is selected, such Exchange Rate shall instead be the arithmetic average of the spot rates of exchange of the Administrative Agent in the market where its foreign currency exchange operations in respect of Pounds Sterling are then being conducted, at or about 10&#58;00 A.M., local time, on such date for the purchase of the relevant currency for delivery two Business Days later&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent, after consultation with the Company, may use any reasonable method it deems appropriate to determine such rate, and such determination shall be presumed correct absent manifest error.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Excluded Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; means, with respect to the Administrative Agent, the Collateral Agent, any Lender or any other recipient (each of the foregoing, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recipient</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of any payment to be made by or on account of any obligation of any Borrower hereunder (or under any other Loan Documents), (a) franchise Taxes or Taxes imposed on (or measured by) the net income of such Recipient (i) by the United States of America, or by the jurisdiction under the laws of which such Recipient is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located or (ii) that are Other Connection Taxes&#59; (b) any branch profits Taxes (i) imposed on such Recipient by the United States of America or any other jurisdiction in which such Recipient is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located or (ii) that are Other Connection Taxes&#59; (c) any U.S. federal withholding Tax (with respect to payments made by any U.S. Borrower) or United Kingdom withholding tax (with respect to payments made by any Borrower organized in the United Kingdom) that is in effect and would apply to amounts payable to (i) a Lender at the time such Lender becomes a party to this Agreement or (ii) any Lender at the time such Lender designates a new lending office, except to the extent, in (i) or (ii), as applicable, such Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from any Borrower with respect to withholding tax pursuant to Section 2.13(a) subject to the Borrower&#8217;s rights under Section 2.15 and Section 2.16)&#59; (d) Taxes attributable to such Recipient&#8217;s failure to comply with Section 2.13(e)&#59; and (e) any U.S. federal withholding Tax imposed under FATCA.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Existing Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Second Amended and Restated Credit Agreement, dated as of March 27, 2017 (as amended by the First Amendment, dated as of March 11, 2020, and the Second Amendment, dated as of April 28, 2020), among the Company, the Subsidiary Borrowers (as defined therein) party thereto, the several banks and other financial institutions or entities from time to time parties thereto, The Bank of New York Mellon, as collateral agent, Barclays Bank PLC, as administrative agent, and the other agents party thereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Extensions of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Lender at any time, an amount equal to the sum of (a) the aggregate principal amount of all Loans held by such Lender then outstanding and (b) such Lender&#8217;s Commitment Percentage of the L&#47;C Obligations then outstanding.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Sections 1471 through 1474 of the Code, as of the date of this Agreement (or amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future Treasury regulations promulgated thereunder or official administrative interpretations thereof and any agreements entered into pursuant to Section 1471(b)(1) of the Code, any intergovernmental agreement entered into in connection with the implementation of such Sections of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to such intergovernmental agreement treaty, or convention among Governmental Authorities and implementing such Sections of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FCA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 2.10(b)(i).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; for any day, the rate calculated by the Federal Reserve Bank of New York based on such day&#8217;s federal funds transactions by depository institutions (as determined in such manner as the Federal Reserve Bank of New York shall set forth on its public website from time to time) and published on the next succeeding Business Day by the Federal Reserve Bank of New York as the federal funds effective rate&#59; provided that if the applicable rate described above shall be less than the Floor, it shall be deemed to be the Floor for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fee Payment Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) the last Business Day of each March, June, September and December after the Closing Date and (b) the last day of the Commitment Period.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FHLMC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Federal Home Loan Mortgage Corporation.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Floor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a rate of interest equal to 0.0%.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FNMA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Federal National Mortgage Association.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Benefit Arrangement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any employee benefit arrangement mandated by non-US law that is maintained or contributed to by any Group Member, or any other entity related to a Group Member on a controlled group basis.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Company and any Subsidiary Borrower that is not a Domestic Subsidiary.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; each &#8220;employee benefit plan&#8221; (within the meaning of Section 3(3) of ERISA, whether or not subject to ERISA) that is not subject to US law and is maintained or contributed to by any Group Member, or any other entity related to a Group Member on a controlled group basis.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Plan Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any Foreign Benefit Arrangement or Foreign Plan, (a) the failure to make or, if applicable, accrue in accordance with normal accounting practices, any employer or employee contributions required by applicable law or by the terms of such Foreign Benefit Arrangement or Foreign Plan&#59; (b) the failure to register or loss of good standing with applicable regulatory authorities of any such Foreign Benefit Arrangement or Foreign Plan required to be registered&#59; or (c) the failure of any Foreign Benefit Arrangement or Foreign Plan to comply with any material provisions of applicable law and regulations or with the material terms of such Foreign Benefit Arrangement or Foreign Plan, save that, in the case of (a) or (b) or (c), such circumstance shall not be deemed to be a Foreign Plan Event to the extent such circumstance is capable of being remedied and has been so remedied within 10 Business Days after a Responsible Officer of the Borrowers becomes aware of such circumstance.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fronted L&#47;C Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Issuing Lender, the obligation of such Issuing Lender to issue Fronted Letters of Credit during the Commitment Period in an aggregate face amount not to exceed an amount to be separately agreed between such Issuing Lender and the Company.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fronted Letter of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; a Letter of Credit issued by an Issuing Lender in which the Lenders purchase risk participations pursuant to Section 3.4(a).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Funding Office</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the office of the Administrative Agent specified in Section 11.2 or such other office as may be specified from time to time by the Administrative Agent as its funding office by written notice to the Borrower Representative and the Lenders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Funds at Lloyd&#8217;s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those funds which must be lodged with Lloyd&#8217;s by, on behalf of, or for the account or benefit of, a Group Member that is a corporate member of Lloyd&#8217;s as security to support their underwriting business at Lloyd&#8217;s in respect of a given underwriting year, in accordance with paragraph 16 of the Membership Bye-Law (No. 5 of 2005).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; generally accepted accounting principles in the United States as in effect from time to time and set forth in any rule, regulation, opinion or pronouncement of the Accounting Principles Board and the American Institute of Certified Public Accountants and any rule, regulation, opinion or pronouncement of the Financial Accounting Standards Board (or agencies with similar functions of comparable stature and authority within the U.S. accounting profession), which are applicable to the circumstances as of the date of determination.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government (including any supra-national body such as the European Union or the European Central Bank), any securities exchange, any self-regulatory organization (including the National Association of Insurance Commissioners, the U.K. Financial Services Authority and the Bermuda Monetary Authority).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Group Members</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to the Company and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee Obligation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">guarantor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), means any obligation, including a reimbursement, counterindemnity or similar obligation, of the guarantor that guarantees or in effect guarantees, or which is given to induce the creation of a separate obligation by another Person (including any bank under any letter of credit) that guarantees or in effect guarantees, any Indebtedness of any other third Person (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">primary obligor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in any manner, whether directly or indirectly, including any obligation of the guarantor, whether or not contingent, (i) to purchase any such Indebtedness or any property constituting direct or indirect security therefor, (ii) to advance or supply funds (1) for the purchase or payment of any such Indebtedness or (2) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor so as to enable the primary obligor to pay Indebtedness or other obligation, (iii) to purchase property, securities or services primarily for the purpose of assuring the owner of any such Indebtedness of the ability of the primary obligor to make payment of such Indebtedness or (iv) otherwise to assure or hold harmless the owner of any such Indebtedness against loss in respect thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the term Guarantee Obligation shall not include (a) endorsements of instruments for deposit or collection in the ordinary course of business or (b) obligations of any Insurance Subsidiary under any Primary Policy, Reinsurance Agreement, Retrocession Agreement or Other Insurance Product that is entered into in the ordinary course of business. The amount of any Guarantee Obligation of any guarantor shall be deemed to be the lower of (a) an amount equal to the stated or determinable amount of the Indebtedness in respect of which such Guarantee Obligation is made as such amount may be reduced from time to time and (b) the maximum amount for which such guarantor may be liable pursuant to the terms of the instrument embodying such Guarantee Obligation, as such amount may be reduced from time to time unless such Indebtedness and the maximum amount for which such guarantor may be liable are not stated or determinable, in which case the amount of such Guarantee Obligation shall be such guarantor&#8217;s maximum reasonably anticipated liability in respect thereof as determined by the Company in good faith. The term &#8220;Guarantee&#8221; as a verb has a corresponding meaning.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any substance, material or waste that is classified, regulated or otherwise characterized under any Environmental Law as hazardous, toxic, a contaminant or a pollutant or by other words of similar meaning or regulatory effect, including petroleum or petroleum distillates,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asbestos or asbestos containing materials, polychlorinated biphenyls, radioactive substances, and infectious or medical wastes.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hybrid Capital</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, all subordinated securities, instruments or other obligations issued by the Company to the extent that such securities, instruments or other obligations (i) are accorded equity treatment by S&#38;P at issuance and (ii) mature no earlier than the date which is six months after the Termination Date.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;IBA&#8221;&#58; as defined in Section 2.10(a).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ILS Entity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#8221;&#58; Silverton Re Ltd., Peregrine Reinsurance Ltd. and any other entity formed or sponsored by a Group Member in connection with the establishment and&#47;or management of insurance- linked securities.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; of any Person at any date, without duplication, (a) all indebtedness of such Person for borrowed money, (b) all obligations of such Person for the deferred purchase price of property or services (other than current trade payables incurred in the ordinary course of such Person&#8217;s business), (c) all obligations of such Person evidenced by notes, bonds, debentures, loan agreements or other similar debt instruments, (d) all indebtedness created or arising under any conditional sale or other title retention agreement with respect to property acquired by such Person (even though the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property), (e) all Capital Lease Obligations of such Person, (f) all obligations of such Person, contingent or otherwise, as an account party or applicant under or in respect of acceptances, letters of credit, surety bonds or similar arrangements, (g) the liquidation value of all mandatorily redeemable preferred Capital Stock of such Person, (h) net obligations of such Person under any Swap Contract, (i) any other instruments or obligations of such Person to the extent that such instruments or obligations are then classified as indebtedness by S&#38;P, (j) all Guarantee Obligations of such Person in respect of obligations of the kind referred to in clauses (a) through (i) above, (k) all obligations of the kind referred to in clauses (a) through (j) above secured by any Lien on property (including accounts and contract rights) owned by such Person, whether or not such Person has assumed or become liable for the payment of such obligation and (I) Indebtedness of any partnership in which such Person is a general partner to the extent that applicable law requires that such Person is liable for such Indebtedness unless the terms of such Indebtedness expressly provide that such Person is not so liable. The amount of any net obligation under any Swap Contract on any date shall be deemed to be the Swap Termination Value as of such date. For the avoidance of doubt, Indebtedness shall not include the obligations of any Insurance Subsidiary under any Primary Policy, Reinsurance Agreement, Retrocession Agreement or Other Insurance Product which is entered into in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.17.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insolvency</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to any Multiemployer Plan, the condition that such Plan is insolvent within the meaning of Section 4245(b)(1) of ERISA.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insolvent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; pertaining to a condition of Insolvency.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; a Subsidiary of the Company engaged in the insurance and&#47;or reinsurance underwriting business.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Payment Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) as to any ABR Loan, the last Business Day of each March, June, September and December to occur while such Loan is outstanding and the Termination Date, (b) as to any Eurodollar Loan having an Interest Period of three months or less, the last day of such Interest</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Period, (c) as to any Eurodollar Loan having an Interest Period longer than three months, each day that is three months, or a whole multiple thereof, after the first day of such Interest Period and the last day of such Interest Period and (d) as to any Loan (other than any Loan that is an ABR Loan), the date of any repayment or prepayment made in respect thereof.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Eurodollar Loan, (a) initially, the period commencing on the borrowing or conversion date, as the case may be, with respect to such Eurodollar Loan and ending one, three, six months or twelve months (subject to availability and if agreed by all Lenders), thereafter as selected by the Borrower Representative in its notice of borrowing or notice of conversion, as the case may be, given with respect thereto&#59; and (b) thereafter, each period commencing on the last day of the next preceding Interest Period applicable to such Eurodollar Loan and ending one, three, six months or twelve months (if agreed by all Lenders) thereafter, as selected by the Borrower Representative by irrevocable notice to the Administrative Agent not later than 11&#58;00 A.M., New York City time, on the date that is three Business Days prior to the last day of the then current Interest Period with respect thereto&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that, all of the foregoing provisions relating to Interest Periods are subject to the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;if any Interest Period would otherwise end on a day that is not a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless the result of such extension would be to carry such Interest Period into another calendar month in which event such Interest Period shall end on the immediately preceding Business Day&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the Borrower Representative may not select an Interest Period that would extend beyond the Termination Date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;any Interest Period that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of a calendar month.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interpolated Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, for any Interest Period, the rate per annum (rounded to the same number of decimal places as the LIBO Screen Rate) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between&#58; (a) the LIBO Screen Rate for the longest period for which the LIBO Screen Rate is available that is shorter than the Impacted Interest Period&#59; and (b) the LIBO Screen Rate for the shortest period for which that LIBO Screen Rate is available for the applicable currency that exceeds the Impacted Interest Period, in each case, at such time each as of approximately 11&#58;00 a.m. (London, England time) two Business Days prior to the commencement of such Interest Period of that Loan. Notwithstanding the foregoing, if the Interpolated Rate, determined as set forth above, shall be less than the Floor, such rate shall be deemed to be the Floor for all purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issuing Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Lender (or any Affiliate thereof) that becomes an Issuing Lender pursuant to Section 3.10, with respect to Letters of Credit issued by it.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Administrator</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Barclays Bank PLC, as letter of credit administrator for the Lenders, together with any replacement L&#47;C Administrator arising under Section 9.9(c).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Issuer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) with respect to a Fronted Letter of Credit, the Issuing Lender and (b) with respect to a Several Letter of Credit, each Lender.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, an amount equal to the sum of (a) the then aggregate Secured L&#47;C Obligations of all Borrowers and (b) the then aggregate Unsecured L&#47;C Obligations of all</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowers. For purposes of determining the L&#47;C Obligations held by any Lender, a Lender shall be deemed to hold an amount equal to the sum of (i) the aggregate amount of such Lender&#8217;s direct obligation in all outstanding Several Letters of Credit and all Reimbursement Obligations owed to such Lender in respect thereof, (ii) such Lender&#8217;s risk participation in all outstanding Fronted Letters of Credit and in all Reimbursement Obligations with respect thereto and (iii) such Lender&#8217;s risk participation in all outstanding Several Letters of Credit, if any, with respect to which another Lender has acted as Limited Fronting Lender on such Lender&#8217;s behalf pursuant to a Limited Fronting Lender Agreement in accordance with Section 3.8(c) and in all Reimbursement Obligations with respect thereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Participants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;&#8217;&#58; the collective reference to all the Lenders other than the applicable Issuing Lender.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in the preamble hereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lender-Related Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.5(c).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 3.1(a).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LIBO Screen Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, for any day and time, with respect to any Eurodollar Borrowing for any Interest Period, the London interbank offered rate as administered by ICE Benchmark Administration (or any other Person that takes over the administration of such rate) for U.S. Dollars for a period equal in length to such Interest Period as displayed on such day and time on page LIBOR01 of the Thomson Reuters screen (or, in the event such rate does not appear on a Thomson Reuters page or screen, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion)&#59; provided that if the LI BO Screen Rate as so determined would be less than the Floor, such rate shall be deemed to the Floor for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lien</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any mortgage, pledge, hypothecation, assignment, encumbrance, lien (statutory or other), charge or other security interest or any other security agreement (including the interest of a vendor or lessor in any conditional sale or other title retention agreement and any capital lease having substantially the same economic effect as any of the foregoing).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limited Fronting Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as provided in Section 3.8(c), any Lender which is a NAIC Approved Bank that agrees that it shall be an issuer with respect to any Non-NAIC Approved Bank&#8217;s Commitment Percentage of Several Letters of Credit outstanding and&#47;or issued during the period that such Non-NAIC Approved Bank is a Non-NAIC Approved Bank, in each case pursuant to a Limited Fronting Lender Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limited Fronting Lender Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 3.8(c).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any loan made by any Lender pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; this Agreement, the Security Documents, the Notes, any fee letter executed or delivered in connection herewith or therewith, any other document or instrument signed by any Borrower that expressly provides that it is a Loan Document as defined herein and any amendment, waiver, supplement or other modification to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any event, development or circumstance that has had or would reasonably be expected to have a material adverse effect on (a) the business, assets, liabilities,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">property, financial condition or results of operations of the Company and its Subsidiaries taken as a whole or (b) the validity or enforceability of this Agreement or any of the other Loan Documents or the rights or remedies of the Administrative Agent or the Lenders hereunder or thereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Material Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, each Subsidiary Borrower and any Subsidiary (x) the total consolidated assets or total consolidated revenues of which exceed 10% of the total consolidated assets or total consolidated revenues, respectively, of the Company and its Subsidiaries on a consolidated basis at the end of or for, respectively, the then most recently completed fiscal quarter of the Company for which financial statements shall have been made available to the Lenders as described in Section 4.1 or pursuant to Section 6.1 and&#47;or (y) the net assets of which exceed $100,000,000 at the end of the then most recently completed fiscal quarter of the Company for which financial statements shall have been made available to the Lenders as described in Section 4.1 or pursuant to Section 6.1.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Moody&#8217;s Investors Service, Inc. and its successors.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; a Plan that is a multiemployer plan as defined in Section 4001(a)(3) of ERISA in respect of which a Group Member or a Commonly Controlled Entity has an obligation to contribute or has any direct or indirect liability.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NAIC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the National Association of Insurance Commissioners or any successor thereto, or in the absence of the National Association of Insurance Commissioners or such successor, any other association, agency or other organization performing advisory, coordination or other like functions among insurance departments, insurance commissioners and similar Governmental Authorities of the various states of the United States toward the promotion of uniformity in the practices of such Governmental Authorities.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NAIC Approved Bank</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Lender that is listed on the most current &#8220;Bank List&#8221; of banks approved by the NAIC&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that if such Lender is a Non-U.S. Lender, such Lender is acting through the United States branch of such Lender listed on such &#8220;Bank List&#8221;.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Cash Proceeds</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; in connection with any issuance or sale of Capital Stock by the Company, the cash proceeds received from such issuance or sale, net of attorneys&#8217; fees and disbursements, investment banking fees and disbursements, accountants&#8217; fees and disbursements, underwriting fees, discounts and commissions, printing expenses, any governmental or exchange fees incurred (or reasonably expected to be incurred) and other customary fees and expenses actually incurred in connection therewith&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that Net Cash Proceeds shall not include the proceeds of any issuance or sale of Capital Stock to the extent such proceeds are used, within twelve months of such issuance or sale, to redeem shares of Capital Stock of the Company then outstanding.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any bank, financial institution or other entity that becomes a &#8220;Lender&#8221; hereunder pursuant to Section 2.1(b).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New Lender Supplement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; a supplement to this Agreement substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit K</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Excluded Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of the Borrower under any Loan Document and, (b) to the extent not otherwise described in (a), Other Taxes.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-NAIC Approved Bank</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, any Lender that is not a NAIC Approved Bank.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 2.13(e).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the collective reference to any promissory note evidencing Loans, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as the case may be.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the unpaid principal of and interest on (including interest accruing after the maturity of the Loans and Reimbursement Obligations and interest accruing after the filing of any petition in bankruptcy, or the commencement of any insolvency, reorganization or like proceeding, relating to any Borrower, whether or not a claim for post-filing or post-petition interest is allowed in such proceeding) the Loans and all other obligations and liabilities of any Borrower to the Administrative Agent, the Syndication Agent and the Collateral Agent or to any Lender, whether direct or indirect, absolute or contingent, due or to become due, or now existing or hereafter incurred, which may arise under, out of, or in connection with, this Agreement (including the obligations of the Company pursuant to Section 10), any other Loan Document, the Letters of Credit or any other document made, delivered or given in connection herewith or therewith, whether on account of principal, interest, fees, reimbursement obligations, indemnities, costs, expenses or otherwise (including all reasonable fees, charges and disbursements of counsel to the Administrative Agent, the Syndication Agent, the Collateral Agent or to any Lender that are required to be paid by the Borrowers pursuant hereto).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 4.17(b).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Connection Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the jurisdiction imposing such tax (other than connections arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Insurance Product</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any specialty insurance or reinsurance product such as contingency reinsurance and structured risks.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any and all present or future stamp, or court or documentary, intangible, recording, filing or similar Taxes that arise from any payment made hereunder or from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, this Agreement or any other Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to Section 2.16).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6(c).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6(c).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Patriot Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 9.12(a).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 9.12(b).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Recipient</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 9.12(a).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;&#8217;&#58; the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA (or any successor).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture, Governmental Authority or other entity of whatever nature.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at a particular time, any &#8220;employee benefit plan&#8221; (within the meaning of Section 3(3) of ERISA) and in respect of which a Group Member or (with respect to an employee benefit plan subject to Title IV of ERISA) a Commonly Controlled Entity is (or, if such plan were terminated at such time, would under Section 4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in Section 3(5) of ERISA responsible for contributing to or under or having any liability.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pounds Sterling</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#163;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the lawful money of the United Kingdom.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pricing Grid</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the table set forth on Annex A.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Primary Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any insurance policy issued by an Insurance Subsidiary.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prime Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; &#58; the rate of interest last quoted by The Wall Street Journal as the &#8220;Prime Rate&#8221; in the U.S. or, if The Wall Street Journal ceases to quote such rate, the highest per annum interest rate published by the Federal Reserve Board in Federal Reserve Statistical Release H.15 (519) (Selected Interest Rates) as the &#8220;bank prime loan&#8221; rate or, if such rate is no longer quoted therein, any similar rate quoted therein (as determined by the Administrative Agent) or any similar release by the Federal Reserve Board (as determined by the Administrative Agent).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Private Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; separate legislation enacted in Bermuda with the intention that such legislation applies specifically to a Borrower or a Subsidiary in whole or in part.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Process Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.14.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Projections</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 4.16.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Properties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 4.15(d).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 11.6.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Regulation U</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Regulation U of the Board as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reimbursement Obligation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the obligation of the applicable Borrower to reimburse the L&#47;C Issuers pursuant to Section 3.5 for amounts drawn under Letters of Credit.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any agreement, contract, treaty, certificate or other arrangement whereby any Insurance Subsidiary agrees to assume from or reinsure an insurer or reinsurer for all or part of the liability of such insurer or reinsurer under a policy or policies of insurance issued by such insurer or reinsurer.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Relevant Governmental Body</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reportable Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any of the events set forth in Section 4043(c) of ERISA, other than those events as to which the thirty day notice period is waived under PBGC Reg. &#167; 4043.4.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Required Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, the holders of more than 50% of the Total Commitments then in effect or, if the Commitments have been terminated, the Total Extensions of Credit then outstanding&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Commitment of, and the Extensions of Credit held or deemed held by, any Defaulting Lender shall be excluded for purposes of making a determination of Required Lenders.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Requirement of Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, the Memorandum of Association or the Certificate of Incorporation and By-laws or other organizational or governing documents of such Person, and any law, treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Resolution Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Responsible Officer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the chief executive officer, chief financial officer, chief investment officer, chief risk officer, chief capital management officer, president or treasurer of a Borrower.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in Section 7.4.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retrocession Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any agreement, treaty, certificate or other arrangement whereby any Insurance Subsidiary cedes to another insurer all or part of such Insurance Subsidiary&#8217;s liability under a policy or policies of insurance reinsured by such Insurance Subsidiary.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Standard &#38; Poor&#8217;s Ratings Services and its successors.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Securities and Exchange Commission, any successor thereto and any analogous Governmental Authority.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Secured L&#47;C Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; of any Borrower at any time, an amount equal to the sum of (a) the then Dollar Amount of the aggregate then undrawn and unexpired amount of the then outstanding Secured Letters of Credit issued on behalf of such Borrower and (b) the then Dollar Amount of the aggregate amount of drawings under Secured Letters of Credit issued on behalf of such Borrower that have not then been reimbursed pursuant to Section 3.5.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Secured Letter of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Letter of Credit designated as a &#8220;Secured Letter of Credit&#8221; by a Borrower in the Application therefor.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Security Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Security Agreement, dated as of October 20, 2010, among the Borrowers and the Collateral Agent, as amended by the First Amendment to Security Agreement, dated as of June 12, 2013, among the Borrowers and the Collateral Agent, the Second Amendment to Security Agreement dated as of March 27, 2017 among the Borrowers and the Collateral Agent and the Third Amendment to Security Agreement dated as of December 1, 2021 among the Borrowers and the Collateral Agent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Security Documents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;&#8217;&#58; (i) the Security Agreement, (ii) each Collateral Account Control Agreement, and (iii) each other document, agreement, certificate and&#47;or financing statement, executed, delivered, made or filed pursuant to the terms of the documents specified in foregoing clauses (i) and (ii).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Several Letter of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; a Letter of Credit issued severally by or on behalf of the Lenders pursuant to which the Lenders are severally liable to the beneficiary which shall be substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit L</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or in such other form as may be agreed by the Company and the L&#47;C Administrator.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Single Employer Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Plan that is subject to Title IV of ERISA, Section 412 of the Code or Section 302 of ERISA but that is not a Multiemployer Plan.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a rate per annum equal to the secured overnight financing rate for such Business Day published by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate) on the website of the Federal Reserve Bank of New York, currently at http&#58;&#47;&#47;www.newyorkfed.org (or any successor source for the secured overnight financing rate identified as such by the administrator of the secured overnight financing rate from time to time).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Spot Selling Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; on any date, as determined by the Administrative Agent, the spot selling rate posted by Reuters on its website for the sale of the applicable currency for dollars at approximately 11&#58;00 a.m&#8222; New York City time, two Business Days prior to such date (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Quotation Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that if, for any reason, no such spot rate is being quoted, the spot selling rate shall be determined by reference to such publicly available service for displaying exchange rates as may be reasonably selected by the Administrative Agent, or, in the event no such service is selected, such spot selling rate shall instead be the rate determined by the Administrative Agent as the spot rate of exchange in the market where its foreign currency exchange operations in respect of the applicable currency are then being conducted, at or about 11.00 a.m., New York City time, on the Applicable Quotation Date for the purchase of the relevant currency for delivery two Business Days later.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned by such Person&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that for purposes of this Agreement, no ILS Entity shall be considered a Subsidiary of the Company or any other Group Member. Unless otherwise qualified, all references to a &#8220;Subsidiary&#8221; or to &#8220;Subsidiaries&#8221; in this Agreement shall refer to a Subsidiary or Subsidiaries of the Company.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; each Material Subsidiary of the Company whose name is set out in the signature pages hereto and each Material Subsidiary of the Company that shall become a Borrower under this Agreement upon satisfaction of the conditions precedent set forth in Section 5.3&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that if at any time the Company shall, in accordance with Section 11.1, be released from its obligations under Section 10 with respect to any Subsidiary which is, prior to such release, a Subsidiary Borrower, such Subsidiary, after such release, shall cease to be a Subsidiary Borrower.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Swap Contract</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) any and all rate swap transactions, basis swaps, credit derivative transactions, forward rate transactions, commodity swaps, commodity options, forward commodity contracts, equity or equity index swaps or options, bond or bond price or bond index swaps or options or forward bond or forward bond price or forward bond index transactions, interest rate options, forward foreign exchange transactions, cap transactions, floor transactions, collar transactions, currency swap transactions, cross-currency rate swap transactions, currency options, spot contracts, or any other similar</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transactions or any combination of any of the foregoing (including any options to enter into any of the foregoing), whether or not any such transaction is governed by or subject to any master agreement, and (b) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Master Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), including any such obligations or liabilities under any Master Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Swap Termination Value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; in respect of any one or more Swap Contracts, after taking into account the effect of any legally enforceable netting agreement relating to such Swap Contracts, (a) for any date on or after the date such Swap Contracts have been closed out and termination value(s) determined in accordance therewith, such termination value(s), and (b) for any date prior to the date referenced in clause (a), the amount(s) determined as the mark-to-market value(s) for such Swap Contracts, as determined based upon one or more mid-market or other readily available quotations provided by any recognized dealer in such Swap Contracts (which may include a Lender or any Affiliate of a Lender).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Syndication Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; Citibank, N.A., in its capacity as syndication agent.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; December 1, 2026.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, for the applicable corresponding tenor, the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant Governmental Body.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Total Commitments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, the aggregate amount of the Commitments then in effect.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Total Extensions of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; at any time, the aggregate amount of the Extensions of Credit of the Lenders outstanding at such time.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transferee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Assignee or Participant.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Type</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; as to any Loan, its nature as an ABR Loan or a Eurodollar Loan.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">UK Financial Institutions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended from time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">UK Resolution Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">United States</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; the United States of America.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unsecured L&#47;C Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; of any Borrower at any time, an amount equal to the sum of (a) the then Dollar Amount of the aggregate then undrawn and unexpired amount of the then outstanding Unsecured Letters of Credit issued on behalf of such Borrower and (b) the then Dollar Amount of the aggregate amount of drawings under Unsecured Letters of Credit issued on behalf of such Borrower that have not then been reimbursed pursuant to Section 3.5.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unsecured Letter of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Letter of Credit that is not a Secured Letter of Credit.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">USD LIBOR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the London interbank offered rate for U.S. dollars.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Wholly Owned Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; of any Person, any Subsidiary of such Person to the extent all of the Capital Stock of such Subsidiary, other than directors&#8217; or nominees&#8217; qualifying shares, is owned directly or indirectly by such Person.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; any Borrower and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#58; (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Definitional Provisions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Unless otherwise specified therein, all terms defined in this Agreement shall have the defined meanings when used in the other Loan Documents or any certificate or other document made or delivered pursuant hereto or thereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;As used herein and in the other Loan Documents, and any certificate or other document made or delivered pursuant hereto or thereto, (i) accounting terms relating to any Group Member not defined in Section 1.1 and accounting terms partly defined in Section 1.1, to the extent not defined, shall have the respective meanings given to them under GAAP (provided that all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to (A) any election under Accounting Standards Codification 825-10-25 (previously referred to as Statement of Financial Accounting Standards 159) (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of the Company or any Subsidiary at &#8220;fair value&#8221;, as defined therein, (B) any treatment of Indebtedness in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any such Indebtedness in a reduced or bifurcated manner as described therein, and such Indebtedness shall at all times be valued at the full stated principal amount thereof) and (C) any change to lease accounting rules from those in effect on March 27, 2017 pursuant to Accounting Standards Codification 840 and other lease accounting guidance in effect on such date, (ii) the words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by the phrase &#8220;without limitation&#8221;, (iii) the word &#8220;incur&#8221; shall be construed to mean incur, create, issue, assume or become liable in respect of (and the words &#8220;incurred&#8221; and &#8220;incurrence&#8221; shall have correlative</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">meanings), (iv) &#8220;consolidated&#8221; means, when used with reference to financial statements or financial statement items of a Person, such statements or items on a consolidated basis in accordance with applicable principles of consolidation under GAAP, (v) the words &#8220;asset&#8221; and &#8220;property&#8221; shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, Capital Stock, securities, revenues, accounts, leasehold interests and contract rights, (vi) references to agreements or other Contractual Obligations shall, unless otherwise specified, be deemed to refer to such agreements or Contractual Obligations as amended, supplemented, restated or otherwise modified from time to time and (vii) references to statutes or regulations shall, unless otherwise specified, be deemed to include all statutory and regulatory provisions amending, replacing, supplementing or interpreting such statutes or regulations.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The words &#8220;hereof&#8221;, &#8220;herein&#8221; and &#8220;hereunder&#8221; and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and Section, Schedule and Exhibit references are to this Agreement unless otherwise specified.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The meanings given to terms defined herein shall be equally applicable to both the singular and plural forms of such terms.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Rates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For purposes of calculating (a) the aggregate Dollar Equivalent of Letters of Credit denominated in Pounds Sterling and of unreimbursed drawings under Letters of Credit denominated in Pounds Sterling outstanding at any time during any period and (b) the Dollar Equivalent of any Letters of Credit denominated in Pounds Sterling at the time of the issuance of such Letter of Credit pursuant to Section 3.1, the Administrative Agent will on the first Business Day of each calendar quarter and at such other times as it in its sole discretion determines to be appropriate to do so (including on or prior to the date of any borrowing or issuance of a Letter of Credit), determine the respective rate of exchange into Dollars of Pounds Sterling (which rate of exchange shall be based upon the Exchange Rate in effect on the date of such determination). Such rates of exchange so determined on each such determination date shall, for purposes of the calculations described in the preceding sentence, be deemed to remain unchanged and in effect until the next such determination date.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Changes in GAAP</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If at any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in any Loan Document, and either the Company or the Required Lenders shall so request, the Administrative Agent, the Lenders and the Company shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP (subject to such approvals required under Section 11.1)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, until so amended, (a) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (b) the Company shall provide to the Administrative Agent and each Lender financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Divisions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction&#8217;s laws)&#58; (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized and acquired on the first date of its existence by the holders of its equity interests at such time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 2&#160;&#160;AMOUNT AND TERMS OF COMMITMENTS</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Commitments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Subject to the terms and conditions hereof, each Lender severally agrees to make Loans to the Borrowers from time to time during the Commitment Period in an aggregate principal amount at any one time outstanding, when added to such Lender&#8217;s Commitment Percentage of the L&#47;C Obligations then outstanding, which does not exceed the amount of such Lender&#8217;s Commitment. During the Commitment Period, the Borrowers may use the Commitments by borrowing, prepaying the Loans in whole or in part and reborrowing, all in accordance with the terms and conditions hereof. The Loans may from time to time be Eurodollar Loans or ABR Loans, as determined by the Borrowers and notified to the Administrative Agent in accordance with Sections 2.2 and 2.6.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;From time to time during the Commitment Period, upon written notice by the Borrower Representative to the Administrative Agent, with the prior written consents of the Administrative Agent (which consent shall be in its sole discretion and shall not be unreasonably withheld or delayed) and the then Issuing Lenders (which consents shall not be unreasonably withheld or delayed), (i) any one or more existing Lenders may agree that such existing Lender or Lenders shall increase the amount of their Commitment or Commitments by executing and delivering to the Borrower Representative and the Administrative Agent a Commitment Increase Supplement or Commitment Increase Supplements, as the case may be, and&#47;or (ii) any one or more New Lenders may from time to time during the Commitment Period agree that such New Lender or New Lenders shall establish a new Commitment or Commitments by executing and delivering to the Borrower Representative and the Administrative Agent a New Lender Supplement or New Lender Supplements, as the case may be, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that each New Lender shall (A) be a NAIC Approved Bank or (B) shall have in effect a Limited Fronting Lender Agreement with a Lender which is a NAIC Approved Bank. From and after the effective date specified in each New Lender Supplement, the New Lender thereunder shall become a Lender with a Commitment in the amount set forth in such New Lender Supplement and shall have the rights and obligations of a Lender under this Agreement for all purposes and to the same extent as if originally a party hereto. Each New Lender shall deliver to the Administrative Agent an administrative questionnaire. Notwithstanding anything contained in this paragraph to the contrary, without the consent of (x) the Required Lenders, the aggregate amount of incremental Commitments established or increased after the Closing Date pursuant to this paragraph shall not exceed $100,000,000 and (y) the Administrative Agent, each increase in the Total Commitments effected pursuant to this paragraph shall be in a minimum aggregate amount of $10,000,000, it being understood that in the case of clause (y), the Administrative Agent&#8217;s consent shall not be unreasonably withheld or delayed. No existing Lender shall have any obligation under this Agreement to enter into a Commitment Increase Supplement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Upon its receipt of (i) a duly executed Commitment Increase Supplement or a New Lender Supplement, (ii) a certificate of each Borrower attaching the resolutions of the board of directors of such Borrower authorizing the increase in the Commitments in an amount equal to or greater than the amount of such increase in the Commitments effected thereby (except to the extent resolutions authorizing the increased amount have previously been delivered by such Borrower), and (iii) each written consent thereto required by paragraph (b) of this Section, the Administrative Agent shall accept such Commitment Increase Supplement or New Lender Supplement, as the case may be, and record the information contained therein in the Register.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Unless otherwise agreed to by the Administrative Agent and the Company (which agreement may include (i) a phase-in of the applicable increase and&#47;or (ii) if agreed to by each Lender, Interest Periods having terms other than as set forth herein), on each date upon which the Total Commitments shall be increased pursuant to this Section, to the extent necessary to rebalance the outstanding Loans </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> among the Lenders (including any New Lenders) pursuant to their modified</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate Exposure Percentages, the Borrowers (i) shall prepay outstanding Loans, if any, which prepayment shall be accompanied by payment of all accrued interest on the amount prepaid and any amounts payable pursuant to Section 2.14 in connection therewith, and (ii) to the extent they determine to do so, reborrow such Loans from the Lenders (including any New Lenders) after giving effect to the new and&#47;or increased Commitments becoming effective on such date, in the case of each of clauses (i) and (ii) above such that, after giving effect thereto, the Loans (including the Types thereof and Interest Periods with respect thereto) shall be held by the Lenders (including for such purposes the New Lenders) pro rata according to their respective Aggregate Exposure Percentages. Any prepayment and reborrowing pursuant to the preceding sentence shall be effected, to the maximum extent practicable, through the netting of amounts payable between the Borrowers and the respective Lenders.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;On the Termination Date, each Borrower shall repay all then outstanding Loans made by the Lenders to such Borrower.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Procedure for Borrowing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any Borrower may borrow during the Commitment Period on any Business Day, provided that the Borrower Representative shall give the Administrative Agent irrevocable notice (which notice must be received by the Administrative Agent prior to 11&#58;00 A.M., New York City time, (a) three Business Days prior to the requested Borrowing Date, in the case of Eurodollar Loans, or (b) on the requested Borrowing Date, in the case of ABR Loans) substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit M</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, specifying (i) the amount and Type of Loans to be borrowed, (ii) the requested Borrowing Date, (iii) in the case of Eurodollar Loans, the respective length of the initial Interest Period therefor and (iv) the name of the applicable Borrower. Any Loans made on the Closing Date shall initially be ABR Loans. Each borrowing shall be in an amount equal to (x) in the case of ABR Loans, $5,000,000 or a whole multiple of $1,000,000 in excess thereof (or, if the then aggregate Available Commitments are less than $5,000,000, such lesser amount) and (y) in the case of Eurodollar Loans, $5,000,000 or a whole multiple of $1,000,000 in excess thereof. Upon receipt of any such notice from the Borrower Representative, the Administrative Agent shall promptly notify each Lender thereof. Each Lender will make the amount of its pro rata share of each borrowing available to the Administrative Agent for the account of the applicable Borrower at the Funding Office prior to 2&#58;00 P.M., New York City time, on the Borrowing Date requested by the Borrower Representative in funds immediately available to the Administrative Agent. Such borrowing will then be made available to the Borrower Representative by the Administrative Agent crediting the account of the Borrower Representative on the books of such office with the aggregate of the amounts made available to the Administrative Agent by the Lenders and in like funds as received by the Administrative Agent. Each Lender may, at its option, make any Loan available to any Foreign Borrower by causing any foreign or domestic branch or Affiliate of such Lender to make such Loan&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that any exercise of such option shall not affect the obligation of such Foreign Borrower to repay such Loan in accordance with the terms of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) The Company agrees to pay to the Administrative Agent for the account of each Lender which has a then effective Commitment a commitment fee (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment Fee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for the period from and including the date hereof to the last day upon which such Lender&#8217;s Commitment shall have terminated, computed at the Commitment Fee Rate on the average daily amount of the Available Commitment of such Lender during the period for which payment is made, payable quarterly in arrears on each Fee Payment Date, commencing on the first such date to occur after the date hereof.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company agrees to pay to the Administrative Agent and the Syndication Agent the fees in the amounts and on the dates as set forth in any fee agreements with the Administrative Agent and&#47;or the Syndication Agent and to perform any other obligations contained therein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Company agrees to pay or reimburse the Collateral Agent for such normal and customary costs and expenses as are incurred or charged by the Collateral Agent in maintaining and administering the Collateral and otherwise performing its obligations under the Loan Documents.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination or Reduction of Commitments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Borrower Representative shall have the right, upon not less than five Business Days&#8217; notice to the Administrative Agent, to terminate the Commitments or, from time to time, to reduce the amount of the Commitments&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no such termination or reduction of Commitments shall be permitted if, after giving effect thereto and to any prepayments of the Loans made on the effective date thereof, the Total Extensions of Credit would exceed the Total Commitments. Any such reduction shall be in an amount equal to $5,000,000, or a whole multiple thereof, and shall reduce permanently the Commitments then in effect (it being understood that any partial reduction of the Commitments shall not affect the Borrower Representative&#8217;s ability to exercise the unutilized portion of the increase option set forth in Section 2.1(b)).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Optional and Mandatory Prepayments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Each Borrower may at any time and from time to time prepay the Loans made by the Lenders to such Borrower, in whole or in part, without premium or penalty, upon irrevocable notice substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit N</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> delivered by the Borrower Representative to the Administrative Agent no later than 11&#58;00 A.M., New York City time, three Business Days prior thereto, in the case of Eurodollar Loans, and no later than 11&#58;00 A.M., New York City time, on the requested prepayment date, in the case of ABR Loans, which notice shall specify the date and amount of prepayment, the name of the applicable Borrower and whether the prepayment is of Eurodollar Loans or ABR Loans&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that if a Eurodollar Loan is prepaid on any day other than the last day of the Interest Period applicable thereto, such Borrower shall also pay any amounts owing pursuant to Section 2.14. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. If any such notice is given, the amount specified in such notice shall be due and payable on the date specified therein, together with (except in the case of Loans that are ABR Loans) accrued interest to such date on the amount prepaid. Partial prepayments of ABR Loans and Eurodollar Loans for all Borrowers shall be in an aggregate principal amount of $5,000,000 or a whole multiple of $1,000,000 in excess thereof (or, in the case of ABR Loans, the entire principal amount thereof).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If, on any date, the aggregate Secured L&#47;C Obligations of any Borrower exceed the Borrowing Base of such Borrower on such date, such Borrower (or the Borrower Representative) shall within five Business Days of such date pay or deliver to the Custodian, to be held in accordance with the Security Agreement and the applicable Collateral Account Control Agreement, an amount of cash and&#47;or Eligible Securities sufficient to cause the Borrowing Base of such Borrower to be at least equal to the aggregate Secured L&#47;C Obligations of such Borrower. If such payment or delivery is not made, the applicable Borrower shall pay the fee applicable to Unsecured Letters of Credit, rather than the fee applicable to Secured Letters of Credit, pursuant to Section 3.3(a) with respect to the portion of such Secured L&#47;C Obligations that is more than the Borrowing Base until such time as the Borrowing Base of such Borrower is at least equal to the aggregate Secured L&#47;C Obligations of such Borrower&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, if a portion, but not all, of the Secured L&#47;C Obligations with respect to a Secured Letter of Credit would be subject to the fee applicable to Unsecured Letters of Credit pursuant to the preceding clause of this sentence, such Secured Letter of Credit will be subject to the fee applicable to Unsecured Letters of Credit.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;If, on any date, the Total Extensions of Credit outstanding on such date exceed 102% of the Total Commitments in effect on such date, the Borrowers shall, upon demand by the Administrative Agent, promptly (but in any event, within three Business Days of the date of the Company&#8217;s receipt of such demand from the Administrative Agent) prepay any then outstanding Loans and&#47;or cash collateralize to the satisfaction of the Administrative Agent any then outstanding Letters of Credit in an aggregate principal and&#47;or face amount such that, after giving effect thereto and treating such</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash collateralized Letters of Credit as being not then outstanding, the Total Extensions of Credit do not exceed the Total Commitments. Any prepayment of a Eurodollar Loan pursuant to this Section 2.5(c) shall be accompanied by interest accrued and unpaid to the date of such prepayment on the principal so prepaid and, if such prepayment is made on a day other than the last day of an Interest Period applicable to such Eurodollar Loan, the applicable Borrower shall also pay any amounts owing pursuant to Section 2.14.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion and Continuation Options</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) The Borrower Representative may elect from time to time to convert Eurodollar Loans to ABR Loans by giving the Administrative Agent prior irrevocable notice of such election substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> no later than 10&#58;00 A.M., New York City time three Business Days prior to the proposed conversion date&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that any such conversion of Eurodollar Loans may only be made on the last day of an Interest Period with respect thereto. The Borrower Representative may elect from time to time to convert ABR Loans to Eurodollar Loans by giving the Administrative Agent prior irrevocable notice of such election no later than 11&#58;00 A.M., New York City time, on the third Business Day preceding the proposed conversion date (which notice shall specify the length of the initial Interest Period therefor)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no ABR Loan may be converted into a Eurodollar Loan when any Event of Default or Default has occurred and is continuing and the Administrative Agent or the Required Lenders have determined in its or their sole discretion not to permit such conversions. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any Eurodollar Loan may be continued as such upon the expiration of the then current Interest Period with respect thereto by the Borrower Representative giving irrevocable notice to the Administrative Agent, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hereto in accordance with the applicable provisions of the term &#8220;Interest Period&#8221; set forth in Section 1.1, of the length of the next Interest Period to be applicable to such Loan&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no Eurodollar Loan may be continued as such when any Event of Default or Default has occurred and is continuing and the Administrative Agent has or the Required Lenders have determined in its or their sole discretion not to permit such continuations, and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that if the Borrower Representative shall fail to give any required notice as described above in this Section 2.6 or if such continuation is not permitted pursuant to the preceding proviso, such Loan shall be automatically converted to an ABR Loan on the last day of such then expiring Interest Period. Upon receipt of any such notice, the Administrative Agent shall promptly notify each relevant Lender thereof.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations on Eurodollar Tranches</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in this Agreement, all borrowings, conversions and continuations of Eurodollar Loans and all selections of Interest Periods shall be in such amounts and be made pursuant to such elections so that, (a) after giving effect thereto, the aggregate principal amount of the Eurodollar Loans comprising each Eurodollar Tranche shall be equal to $5,000,000 or a whole multiple of $1,000,000 in excess thereof and (b) no more than twenty Eurodollar Tranches shall be outstanding at any one time.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rates and Payment Dates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Each Eurodollar Loan shall bear interest for each day during each Interest Period with respect thereto at a rate per annum equal to the Eurodollar Rate determined for such day plus the Applicable Margin.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each ABR Loan shall bear interest at a rate per annum equal to the ABR plus the Applicable Margin.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;(i) If an Event of Default under Section 8(a) or Section 8(f) shall have occurred and be continuing or upon the request of the Required Lenders if any other Event of Default shall have occurred and be continuing, the principal amount of all Loans shall bear interest at a rate per annum equal to the rate that would otherwise be applicable thereto pursuant to the foregoing provisions of this Section</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2% and (ii) if all or a portion of any interest payable on any Loan or any Commitment Fee or other amount payable hereunder shall not be paid when due (whether at the stated maturity, by acceleration or otherwise), such overdue amount shall bear interest at a rate per annum equal to the rate then applicable to ABR Loans </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2%, in each case as described in this clause (ii), from the date of such non-payment until such amount is paid in full (as well after as before judgment).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Interest shall be payable in arrears on each Interest Payment Date&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that interest accruing pursuant to paragraph (c) of this Section shall be payable from time to time on demand.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Computation of Interest and Fees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest and fees payable pursuant hereto shall be calculated on the basis of a 360-day year for the actual days elapsed, except that, with respect to ABR Loans the rate of interest on which is calculated on the basis of the Prime Rate, the interest thereon shall be calculated on the basis of a 365- (or 366, as the case may be) day year for the actual days elapsed. The Administrative Agent shall as soon as practicable notify the Company and the relevant Lenders of each determination of a Eurodollar Rate. Any change in the interest rate on a Loan resulting from a change in the ABR or the Eurodollar Rate (pursuant to Section 2.12) shall become effective as of the opening of business on the day on which such change becomes effective. The Administrative Agent shall as soon as practicable notify the Company and the relevant Lenders of the effective date and the amount of each such change in interest rate. Each determination of an interest rate by the Administrative Agent pursuant to any provision of this Agreement shall be conclusive and binding on each Borrower and the Lenders in the absence of manifest error. The Administrative Agent shall deliver to the Company a statement showing the quotations used by the Administrative Agent in determining any interest rate pursuant to Section 2.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inability to Determine Interest Rate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Subject to Section 2.10(b), if prior to the first day of any Interest Period&#58;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the Administrative Agent shall have determined (which determination shall be conclusive and binding upon each Borrower absent manifest error) that, by reason of circumstances affecting the relevant market, adequate and reasonable means do not exist for ascertaining the Eurodollar Rate for such Interest Period, or</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the Administrative Agent shall have received notice from the Required Lenders that the Eurodollar Rate determined or to be determined for such Interest Period will not adequately and fairly reflect the cost to such Lenders (as conclusively certified by such Lenders) of making or maintaining their affected Loans during such Interest Period,</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Administrative Agent shall give electronic or telephonic notice thereof to the Company and the relevant Lenders as soon as practicable thereafter. Upon receipt of such notice, the Borrower Representative may revoke any notice of borrowing, conversion or continuation then submitted by it. If the Borrower Representative does not revoke such notice, then (x) any Eurodollar Loans requested to be made on the first day of such Interest Period shall be made as ABR Loans, (y) any Loans that were to have been converted on the first day of such Interest Period to Eurodollar Loans shall be continued as ABR Loans and (z) any outstanding Eurodollar Loans shall be converted, on the last day of the then- current Interest Period, to ABR Loans. Until such notice has been withdrawn by the Administrative Agent, no further Eurodollar Loans shall be made or continued as such, nor shall the Borrower Representative have the right to convert ABR Loans to Eurodollar Loans.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein or in any other Loan Document&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Replacing USD LIBOR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On March 5, 2021 the Financial Conduct Authority (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FCA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the regulatory supervisor of USD LIBOR&#8217;s administrator (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IBA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), announced in a public statement the future cessation or loss of representativeness of overnight&#47;Spot Next, 1-month, 3-month, 6- month and 12-month USD LIBOR tenor settings. On the earlier of (i) the date that all Available Tenors of USD LIBOR have either permanently or indefinitely ceased to be provided by IBA or have been announced by the FCA pursuant to public statement or publication of information to be no longer representative and (ii) the Early Opt-in Effective Date, if the then-current Benchmark is USD LIBOR, the Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any setting of such Benchmark on such day and all subsequent settings without any amendment to, or further action or consent of any other party to this Agreement or any other Loan Document. If the Benchmark Replacement is Daily Simple SOFR, all interest payments will be payable on each date that is on the numerically corresponding day in each calendar month that is three months after the date of the Borrowing of which such Loan is a part&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (x) if any such date would be a day other than a Business Day, such date shall be extended to the next succeeding Business Day unless such next succeeding Business Day would fall in the next calendar month, in which case such date shall be the next preceding Business Day and (y) the Interest Payment Date with respect to any Borrowing that occurs on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in any applicable calendar month) shall be the last Business Day of any such succeeding applicable calendar month&#59; provided that the Administrative Agent may elect, in its sole discretion, an alternative interest payment schedule with respect to Daily Simple SOFR&#59; provided that such alternative interest payment schedule shall provide for interest payments no less frequently than quarterly.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Replacing Future Benchmarks</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the occurrence of a Benchmark Transition Event, the Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5&#58;00 p.m. on the fifth (5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders. At any time that the administrator of the then-current Benchmark has permanently or indefinitely ceased to provide such Benchmark or such Benchmark has been announced by the regulatory supervisor for the administrator of such Benchmark pursuant to public statement or publication of information to be no longer representative of the underlying market and economic reality that such Benchmark is intended to measure and that representativeness will not be restored, the Borrower may revoke any request for a borrowing of, conversion to or continuation of Loans to be made, converted or continued that would bear interest by reference to such Benchmark until the Borrower&#8217;s receipt of notice from the Administrative Agent that a Benchmark Replacement has replaced such Benchmark, and, failing that, the Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to ABR Loans. During the period referenced in the foregoing sentence, the component of ABR based upon the Benchmark will not be used in any determination of ABR.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with the implementation and administration of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notices&#59; Standards for Decisions and Determinations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent will promptly notify the Borrower and the Lenders of (i) the implementation of any Benchmark Replacement</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (ii) the effectiveness of any Benchmark Replacement Conforming Changes. Any determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this Section, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unavailability of Tenor of Benchmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a term rate (including Term SOFR or USD LIBOR), then the Administrative Agent may remove any tenor of such Benchmark that is unavailable or non-representative for Benchmark (including Benchmark Replacement) settings and (ii) the Administrative Agent may reinstate any such previously removed tenor for Benchmark (including Benchmark Replacement) settings.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pro Rata Treatment and Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Each borrowing by any Borrower from the Lenders hereunder and any reduction of the Commitments of the Lenders shall be made pro rata according to the Lenders&#8217; respective Commitments, and each payment by any Borrower on account of any Commitment Fee shall be distributed by the Administrative Agent pro rata to each Lender according to the respective amounts thereof owing pursuant to Section 2.3(a).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each payment (including each prepayment) by any Borrower on account of principal of and interest on the Loans made to it shall be made </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> according to the respective outstanding principal amounts of such Loans then held by the Lenders.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;All payments (including prepayments) to be made by any Borrower hereunder, whether on account of principal, interest, fees or otherwise, shall be made without setoff or counterclaim and shall be made prior to 12&#58;00 Noon, New York City time, on the due date thereof to the Administrative Agent, for the account of the Lenders, at the Funding Office, in the currency required hereunder and in immediately available funds. The Administrative Agent shall distribute such payments to the Lenders promptly upon receipt in like funds as received. If any payment hereunder (other than payments on the Eurodollar Loans) becomes due and payable on a day other than a Business Day, such payment shall be extended to the next succeeding Business Day. If any payment on a Eurodollar Loan becomes due and payable on a day other than a Business Day, the maturity thereof shall be extended to the next succeeding Business Day unless the result of such extension would be to extend such payment into another calendar month, in which event such payment shall be made on the immediately preceding Business Day. In the case of any extension of any payment of principal pursuant to the preceding two sentences, interest thereon shall be payable at the then applicable rate during such extension.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Unless the Administrative Agent shall have been notified in writing by any Lender prior to a borrowing that such Lender will not make the amount that would constitute its share of such borrowing available to the Administrative Agent, the Administrative Agent may assume that such Lender is making such amount available to the Administrative Agent, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrowers a corresponding amount. If such amount is not made available to the Administrative Agent by the required time on the Borrowing Date therefor, such Lender shall pay to the Administrative Agent, on demand, such amount with interest thereon, at a rate equal to the greater of (i) the Federal Funds Effective Rate and (ii) a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation, for the period until such Lender makes such amount immediately available to the Administrative Agent. A certificate of the Administrative Agent submitted to any Lender with respect to any amounts owing under this paragraph shall be conclusive in the absence of manifest error. If such Lender&#8217;s share of such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">borrowing is not made available to the Administrative Agent by such Lender within three Business Days after such Borrowing Date, the Administrative Agent shall also be entitled to recover such amount with interest thereon at the rate per annum applicable to ABR Loans, on demand, from the Borrowers.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Unless the Administrative Agent shall have been notified in writing by the Borrower Representative prior to the date of any payment due to be made by any Borrower hereunder that such Borrower will not make such payment to the Administrative Agent, the Administrative Agent may assume that such Borrower is making such payment, and the Administrative Agent may, but shall not be required to, in reliance upon such assumption, make available to the Lenders their respective </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of a corresponding amount. If such payment is not made to the Administrative Agent by such Borrower within three Business Days after such due date, the Administrative Agent shall be entitled to recover, on demand, from each Lender to which any amount which was made available pursuant to the preceding sentence, such amount with interest thereon at the rate per annum equal to the daily average Federal Funds Effective Rate. Nothing herein shall be deemed to limit the rights of the Administrative Agent or any Lender against such Borrower.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Requirements of Law&#59; Eurocurrency Liabilities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) If the adoption of or any change in any Requirement of Law or in the interpretation or application thereof or compliance by any Lender with any request or directive (whether or not having the force of law) from any central bank or other Governmental Authority, in each case made subsequent to the date hereof&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;shall subject any Lender, any Issuing Lender or the Administrative Agent to any tax of any kind whatsoever with respect to this Agreement, any Letter of Credit, any Application or any Eurodollar Loan made by it, or change the basis of taxation of payments to such Lender or Issuing Lender in respect thereof (except for (i) taxes described in clauses (c) through (e) of the definition of Excluded Taxes, (ii) Non-Excluded Taxes and (iii) Connection Income Taxes)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;shall impose, modify or hold applicable any reserve, special deposit, compulsory loan or similar requirement against assets held by, deposits or other liabilities in or for the account of, advances, loans or other extensions of credit by, or any other acquisition of funds by, any office of such Lender that is not otherwise included in the determination of the Eurodollar Rate&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;shall impose on such Lender or the London interbank market any other condition (not to include Taxes) affecting this Agreement or such Lender&#8217;s Loan&#59;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the result of any of the foregoing is to increase the cost to such Lender (or, in the case of clause (i) above, to such Lender, Issuing Lender or the Administrative Agent), by an amount that such Lender (or, in the case of clause (i) above, such Lender, Issuing Lender or the Administrative Agent) deems to be material, of making, converting into, continuing or maintaining Eurodollar Loans (or of its obligation to make any such Eurodollar Loan or to participate in any Letter of Credit), or to reduce any amount receivable hereunder in respect thereof, then, in any such case, the Borrower to which such Loans were made shall pay such Lender (or, in the case of clause (i) above, such Lender, Issuing Lender or the Administrative Agent) any additional amounts necessary to compensate such Lender (or, in the case of clause (i) above, such Lender, Issuing Lender or the Administrative Agent) for such increased cost or reduced amount receivable. If any Lender, any Issuing Lender or the Administrative Agent becomes entitled to claim any additional amounts pursuant to this paragraph, it shall promptly notify the Company (with a copy to the Administrative Agent) of the event by reason of which it has become so entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If any Lender shall have determined that the adoption of or any change in any Requirement of Law regarding capital adequacy or liquidity requirements or in the interpretation or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application thereof or compliance by such Lender or any corporation controlling such Lender with any request or directive regarding capital adequacy or liquidity requirements (whether or not having the force of law) from any Governmental Authority, in each case made subsequent to the date hereof shall have the effect of reducing the rate of return on such Lender&#8217;s or such corporation&#8217;s capital as a consequence of its obligations hereunder or under or in respect of any Letter of Credit to a level below that which such Lender or such corporation could have achieved but for such adoption, change or compliance (taking into consideration such Lender&#8217;s or such corporation&#8217;s policies with respect to capital adequacy or liquidity requirements) by an amount deemed by such Lender to be material, then from time to time, after submission by such Lender to the Company (with a copy to the Administrative Agent) of a written request therefor, the Company shall pay to such Lender such additional amount or amounts as will compensate such Lender or such corporation for such reduction.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Notwithstanding anything herein to the contrary, (i) all requests, rules, guidelines, requirements and directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or by United States or foreign regulatory authorities, in each case pursuant to Basel III, and (ii) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines, requirements and directives thereunder or issued in connection therewith or in implementation thereof, shall in each case be deemed to be a change in law, regardless of the date enacted, adopted, issued or implemented.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Company agrees to pay to each Lender, for any period that such Lender is required by applicable law, rule or regulation, or any guideline, request or directive of any Governmental Authority (whether or not having the force of law), to maintain reserves with respect to liabilities or assets consisting of or including Eurocurrency funds or deposits (currently known as &#8220;Eurocurrency liabilities&#8221;), additional interest on the unpaid principal amount of each Eurodollar Loan (and, for any period during which ABR is determined by reference to the Eurodollar Rate, each ABR Loan) equal to the costs of such reserves allocated to such Loan by such Lender (as determined by such Lender in good faith, which determination shall be conclusive absent manifest error), which shall be due and payable on each date on which interest is payable on such Loan.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;A certificate setting forth in reasonable detail a calculation of the amount of and the basis for any additional amount payable pursuant to this Section submitted by any Lender to the Company (with a copy to the Administrative Agent) shall be conclusive in the absence of manifest error. The Borrower shall pay such Lender the amount shown as due on such certificate within 10 Business Days after receipt by the Borrower. Notwithstanding anything to the contrary in this Section, the Company shall not be required to compensate a Lender pursuant to clause (a) or (b) of this Section for any amounts incurred more than six months prior to the date that such Lender notifies the Company of such Lender&#8217;s intention to claim compensation therefor&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, if the circumstances giving rise to such claim have a retroactive effect, then such six-month period shall be extended to include the period of such retroactive effect. The obligations of the Company pursuant to this Section shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Except as required by applicable law, all payments made by (or on behalf of) any Borrower under this Agreement or any other Loan Document shall be made free and clear of, and without deduction or withholding for or on account of, any Taxes. If any Non-Excluded Taxes are required to be deducted or withheld from any amounts payable to the Administrative Agent or any Lender hereunder or under any other Loan Document, (i) the amounts so payable by the applicable Borrower to the Administrative Agent or such Lender shall be increased to the extent necessary to yield to the Administrative Agent or such Lender (after payment of all Non-Excluded Taxes and Other Taxes) interest or any such other amounts payable hereunder or under any other Loan Document at the rates or in the amounts specified in this Agreement or in the applicable Loan Document as if such withholding or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deduction had not been made, (ii) the Borrower or applicable Withholding Agent shall deduct or withhold such amounts and (iii) the Borrower or applicable Withholding Agent shall pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable law&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no Borrower shall be required to increase any such amounts payable to any Lender with respect to any Non-Excluded Taxes that are attributable to such Lender&#8217;s failure to comply with the requirements of paragraph (e) of this Section.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In addition, each Borrower shall pay any Other Taxes and any Excluded Taxes in respect of which it has been by law required to make any deduction or withholding to the relevant Governmental Authority in accordance with applicable law or, in the case of Other Taxes, at the option of the Administrative Agent, timely reimburse it for the payment of such Other Taxes.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Each Borrower shall indemnify the Administrative Agent and each Lender, within 10 Business Days after written demand therefor, for the full amount of any Non-Excluded Taxes or Other Taxes paid by the Administrative Agent or such Lender, as the case may be, on or with respect to any payment by or on account of any obligation of such Borrower hereunder or under any other Loan Document (including Non-Excluded Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this Section 2.13), whether or not such Non-Excluded Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to such Borrower by a Lender (with a copy to the Administrative Agent) or by the Administrative Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Whenever any Non-Excluded Taxes or Other Taxes are payable by a Borrower, as promptly as possible thereafter such Borrower shall send to the Administrative Agent for its own account or for the account of the relevant Lender, as the case may be, a certified copy of an original official receipt received by such Borrower showing payment thereof.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;A Lender that is entitled to an exemption from or reduction of withholding tax with respect to payments made under any Loan Document shall deliver to such Borrower (with a copy to the Administrative Agent), at the time or times prescribed by applicable law or reasonably requested by such Borrower or the Administrative Agent, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without withholding or at a reduced rate&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such Lender is legally entitled to complete, execute and deliver such documentation and in such Lender&#8217;s judgment such completion, execution or submission would not materially prejudice the legal or commercial position of such Lender. In addition, any Lender, if reasonably requested by a Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by such Borrower or the Administrative Agent as will enable such Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements and to allow such Borrower and the Administrative Agent to comply with any information reporting requirements to which they are subject&#59; provided that such Lender is legally entitled to complete, execute and deliver such documentation and in such Lender&#8217;s judgment such completion, execution or submission would not materially prejudice the legal or commercial position of such Lender. Each Lender that is a United States person, as defined in section 7701(a)(30) of the Code (a &#8220;United States Person&#8221;), shall deliver to the Company and the Administrative Agent on or before the date on which it becomes a party to this Agreement two properly completed and duly signed copies of U.S. Internal Revenue Service Form W-9 (or any successor form) certifying that such Lender is exempt from U.S. federal withholding tax. To the extent the Borrower is a United States Person (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">U.S.&#160;Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), each Lender (or Transferee) that is not a United States Person (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall deliver to such U.S. Borrower and the Administrative Agent (or, in the case of a Participant, to the Lender from which the related participation shall have been purchased) (i) two </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">copies of U.S. Internal Revenue Service Form W-8BEN or W-8BEN-E, Form W-8ECI or Form W- 8IMY, or, (ii) in the case of a Non-U.S. Lender claiming exemption from U.S. federal withholding tax under Section 871(h) or 881(c) of the Code with respect to payments of &#8220;portfolio interest&#8221;, a statement substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E-1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (except for Non-U.S. Lenders that are partnerships for U.S. Federal Income Tax purposes, which shall deliver a statement substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E-2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and a Form W-8BEN or W-8BEN-E or Form W-8IMY, or any subsequent versions thereof or successor thereto, properly completed and duly executed by such Non-U.S. Lender claiming complete exemption from, or a reduced rate of, U.S. federal withholding tax on all payments under this Agreement and the other Loan Documents, or (iii) in the case of a Non-U.S. Lender that is not the beneficial owner of the Loan, two copies of Form W-8IMY, accompanied by Form W-8ECI, Form W-8BEN, Form W 8BEN-E, a statement substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E-2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E-3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Form W-9, and&#47;or other certification documents from each beneficial owner, as applicable&#59; provided that if the Non-U.S. Lender is a partnership and one or more direct or indirect partners of such Non-U.S. Lender are claiming the portfolio interest exemption, such Non-U.S. Lender may provide a statement substantially in the form of Exhibit E- 4 on behalf of each such direct and indirect partner. Such forms shall be delivered by each Non-U.S. Lender on or before the date it becomes a Non-U.S. Lender with respect to any U.S. Borrower under this Agreement (or, in the case of any Participant, on or before the date such Participant purchases the related participation) or within 10 Business Days of the request by such U.S. Borrower or the Administrative Agent. If a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Company and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Company or the Administrative Agent such documentation prescribed by applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Company or the Administrative Agent as may be necessary for the Company (or any Borrower, as applicable) and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender&#8217;s obligations under FATCA or to determine the amount, if any, to deduct and withhold from such payment. Any non-U.S. Lender shall, to the extent it is legally entitled to do so, deliver to the Company and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or about the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Company, the Borrower or the Administrative Agent), executed copies of any other form prescribed by Applicable Law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to permit the Company, Borrower or the Administrative Agent to determine the withholding or deduction required to be made. Each Non-U.S. Lender shall promptly notify each U.S. Borrower and the Administrative Agent at any time it determines that it is no longer in a position to provide any previously delivered certificate to such U.S. Borrower (or any other form of certification adopted by the U.S. taxing authorities for such purpose). If any Non-U.S. Lender provides a Form W-8IMY, such Non-U.S. Lender must also attach the additional documentation that must be transmitted with the Form W-8IMY, including the appropriate forms described in this Section 2.13(e).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Each Lender shall indemnify the Administrative Agent for the full amount of any Non-Excluded Taxes that are attributable to such Lender and that are payable or paid by the Administrative Agent, (but only to the extent that a Borrower has not already indemnified the Administrative Agent for such non-Excluded Taxes and without limiting the obligation of the Borrowers to do so). A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;If the Administrative Agent or a Lender determines, in its sole discretion, that it has received a refund of or credit for any Non-Excluded Taxes or Other Taxes as to which it has been indemnified by a Borrower or with respect to which a Borrower has paid any additional amount pursuant to this Section, it shall pay over such refund or the amount of such credit to such Borrower (but only to the extent of indemnity payments made, or additional amounts paid, by such Borrower under this Section with respect to the Non-Excluded Taxes or Other Taxes giving rise to such refund or credit), net of all reasonable out-of-pocket expenses incurred by the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund or credit)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such Borrower, upon the request of the Administrative Agent or such Lender, agrees to repay the amount paid over to such Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender if the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority or loses the benefit of such credit. Notwithstanding anything to the contrary in this paragraph (g), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this paragraph (g) the payment of which would place the indemnified party in a less favorable net after-tax position than the indemnified party would have been in if the tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such tax had never been paid. This Section shall not be construed to require the Administrative Agent or any Lender to make available its tax returns (or any other information relating to its taxes that it deems confidential) to any Borrower or any other Person.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Solely for purposes of determining withholding Taxes imposed under FATCA, from and after the effective date of this Agreement, the Borrower and the Administrative Agent shall treat (and the Lenders hereby authorize the Administrative Agent to treat) the Loan as not qualifying as a &#8220;grandfathered obligation&#8221; within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;The agreements in this Section shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Borrower (and the Borrower Representative) agrees to indemnify each Lender for, and to hold each Lender harmless from, any loss or expense that such Lender may sustain or incur as a consequence of (a) any failure of such Borrower to make a borrowing of, conversion into or continuation of Eurodollar Loans after the Borrower Representative has given a notice requesting the same in accordance with the provisions of this Agreement, (b) any failure of such Borrower to make any prepayment of Eurodollar Loans after the Borrower Representative has given a notice thereof in accordance with the provisions of this Agreement or (c) the making of a prepayment of Eurodollar Loans on a day that is not the last day of an Interest Period with respect thereto. Absent any change in circumstances after the date hereof, the amount of such indemnification is intended to be equal to the excess, if any, of (i) the amount of interest that would have accrued on the amount so prepaid, or not so borrowed, converted or continued, for the period from the date of such prepayment or of such failure to borrow, convert or continue to the last day of such Interest Period (or, in the case of a failure to borrow, convert or continue, the Interest Period that would have commenced on the date of such failure) in each case at the applicable rate of interest for such Loans provided for herein (excluding, however, the Applicable Margin included therein) over (ii) the amount of interest (as reasonably determined by such Lender) that would have accrued to such Lender on such amount by placing such amount on deposit for a comparable period with leading banks in the interbank eurodollar market. A certificate as to any amounts payable pursuant to this Section submitted to the applicable Borrower (or the Borrower Representative) by any Lender shall be conclusive in the absence of manifest error. This covenant shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Lending Office</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Lender agrees that, upon the occurrence of any event giving rise to the operation of Section 2.12(a), 2.12(b) or 2.13(a) with respect to such Lender, it will, if requested by the Borrower Representative, use reasonable efforts (subject to overall policy considerations of such Lender) to designate another lending office for any Loans affected by such event or assign its rights and obligations hereunder to an Affiliate with the object of avoiding the consequences of such event&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that such designation or assignment is made on terms that, in the sole judgment of such Lender, cause such Lender and its lending office(s) or such Affiliate, as the case may be, to suffer no unreimbursed economic, legal or regulatory disadvantage.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Replacement of Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company shall be permitted to replace any Lender that (a) requests reimbursement for amounts owing pursuant to Section 2.12(a), 2.12(b) or 2.13(a), (b) refuses to consent to any waiver or amendment with respect to any Loan Document that requires the approval of each Lender or all affected Lenders and that has been consented to by the Required Lenders or (c) becomes a Defaulting Lender, with a replacement financial institution&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (i) such replacement does not conflict with any Requirement of Law, (ii) no Event of Default or Default shall have occurred and be continuing at the time of such replacement, (iii) prior to any such replacement, such Lender shall, within 30 days of the Company&#8217;s request have taken no action under Section 2.15 that eliminates the continued need for payment of amounts owing pursuant to Section 2.12 or 2.13(a), (iv) the replacement financial institution shall purchase, at par, all Loans and other amounts (including accrued interest) owing to such replaced Lender on or prior to the date of replacement, (v) the Borrowers shall be liable to such replaced Lender under Section 2.14 if any Eurodollar Loan owing to such replaced Lender shall be purchased other than on the last day of the Interest Period relating thereto as if it were prepaid on the date of such purchase (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that in the case of a replacement pursuant to clause (c) above, the Borrowers shall only be liable for the positive difference, if any, between (A) any amounts owing by the Borrowers under Section 2.14 and (B) any obligations owing by such Defaulting Lender to the Borrowers under the Loan Documents as a result of such Defaulting Lender becoming a Defaulting Lender), (vi) the replacement financial institution shall be reasonably satisfactory to each Issuing Lender and the Administrative Agent, (vii) the replaced Lender shall be obligated to make such replacement in accordance with the provisions of Section 11.6 (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company shall be obligated to pay the portion of the registration and processing fee referred to therein), (viii) until such time as such replacement shall be consummated, the Borrowers shall pay all additional amounts (if any) required pursuant to Section 2.12 or 2.13(a), as the case may be, and (ix) any such replacement shall not be deemed to be a waiver of any rights that the Borrower, the Administrative Agent or any other Lender shall have against the replaced Lender.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Commitment Fee set forth in Section 2.3(a) shall cease to accrue for such Defaulting Lender.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Commitment and Extensions of Credit of such Defaulting Lender shall not be included in determining whether all Lenders or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to Section 11.1), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that any waiver, amendment or modification (i) requiring the consent of all Lenders or each affected Lender which affects such Defaulting Lender disproportionately with respect to the other affected Lenders or (ii) that would increase or extend the term of the Commitment of such Defaulting Lender shall require the consent of such Defaulting Lender.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;if any L&#47;C Obligations exist at the time a Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;all or any part of such L&#47;C Obligations shall be reallocated among the non-Defaulting Lenders in accordance with their respective Commitment Percentages but only to the extent the sum of all non-Defaulting Lenders&#8217; Extensions of Credit does not exceed the total of all non-Defaulting Lenders&#8217; Commitments&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;if the reallocation described in clause (i) above cannot, or can only partially, be effected, the applicable Borrower shall within one Business Day following notice by the Administrative Agent, (A) in the case of Unsecured Letters of Credit, cash collateralize such Defaulting Lender&#8217;s L&#47;C Obligations (after giving effect to any partial reallocation pursuant to clause (i) above) in accordance with the procedures set forth in Section 8 for so long as such L&#47;C Obligations are outstanding or (B) in the case of Secured Letters of Credit, ensure that the Borrowing Base includes an amount of cash equal to or greater than the Defaulting Lender&#8217;s L&#47;C Obligations (after giving effect to any partial reallocation pursuant to clause (i) above) for so long as such L&#47;C Obligations are outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s L&#47;C Obligations pursuant to this Section 2.17(c), the Borrower shall not be required to pay any fees to such Defaulting Lender pursuant to Section 3.3(a) with respect to such Defaulting Lender&#8217;s L&#47;C Obligations during the period such Defaulting Lender&#8217;s L&#47;C Obligations are cash collateralized&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;if the L&#47;C Obligations of the non-Defaulting Lenders are reallocated pursuant to this Section 2.17(c) then the fees payable to the Lenders pursuant to Section 2.3(a) and Section 3.3(a) shall be adjusted in accordance with such non-Defaulting Lenders&#8217; Commitment Percentages&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;if any Defaulting Lender&#8217;s L&#47;C Obligations are neither cash collateralized nor reallocated pursuant to this Section 2.17(c), then, without prejudice to any rights or remedies of any Issuing Lender or any Lender hereunder, all letter of credit fees payable under Section 3.3 with respect to such Defaulting Lender&#8217;s L&#47;C Obligations shall be payable to the applicable Issuing Lender until such L&#47;C Obligations are cash collateralized and&#47;or reallocated.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;so long as any Lender is a Defaulting Lender, no Applicable Issuing Party shall be required to issue, amend or increase any Letter of Credit, unless it is satisfied that the related exposure will be 100% covered by the Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrower in accordance with Section 2.17(c), and participating interests or Commitment Shares in any such newly issued or increased Letter of Credit shall be allocated among non-Defaulting Lenders in a manner consistent with Section 2.17(c)(i) (and Defaulting Lenders shall not participate therein).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;any amount payable to such Defaulting Lender hereunder (whether on account of principal, interest, fees or otherwise and including any amount that would otherwise be payable to such Defaulting Lender pursuant to Section 11.7 but excluding Section 2.16) shall, in lieu of being distributed to such Defaulting Lender, be retained by the Administrative Agent in a segregated account and, subject to any applicable requirements of law, be applied at such time or times as may be determined by the Administrative Agent (i) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder, (ii) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, pro rata, to the payment of any amounts owing by such Defaulting Lender to the Applicable Issuing Parties hereunder, (iii) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent or requested by an Applicable Issuing Party, to be held in such account as cash </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collateral for future funding obligations of the Defaulting Lender of any participating interest or Commitment Share in any Letter of Credit, (iv) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the funding of any Loan in respect of which such Defaulting Lender has failed to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent, (v) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower, held in such account as cash collateral for future funding obligations of the Defaulting Lender of any Loans under this Agreement, (vi) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Lenders or an Issuing Lender as a result of any judgment of a court of competent jurisdiction obtained by any Lender or such Issuing Lender against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, (vii) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">seventh</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Borrower as a result of any judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, and (viii) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">eighth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that if such payment is (x) a prepayment of the principal amount of any Loans or reimbursement obligations in respect of a payment made by an Issuing Lender pursuant to a Letter of Credit for which a Defaulting Lender has funded its participation obligations and (y) made at a time when the conditions set forth in Section 5.2 are satisfied, such payment shall be applied solely to prepay the Loans of, and reimbursement obligations owed to, all non-Defaulting Lenders pro rata prior to being applied to the prepayment of any Loans, or reimbursement obligations owed to, any Defaulting Lender.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the Administrative Agent, the Borrower and each Issuing Lender agree that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then the L&#47;C Obligations of the Lenders shall be readjusted to reflect the inclusion of such Lender&#8217;s Commitment and on such date such Lender shall purchase at par such of the Loans of the other Lenders as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Commitment Percentage.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3&#160;&#160;LETTERS OF CREDIT</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Subject to the terms and conditions hereof, the Applicable Issuing Party, in reliance on the agreements of the other Lenders set forth in Sections 3.4(a) and 3.8(b), agrees to issue letters of credit (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for the account of the applicable Borrower on any Business Day during the Commitment Period (i) in the case of Fronted Letters of Credit, in such form as may be approved from time to time by such Issuing Lender in an aggregate face amount not to exceed at any one time outstanding such Issuing Lender&#8217;s Fronted L&#47;C Commitment and (ii) in the case of Several Letters of Credit, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit L</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such Applicable Issuing Party shall have no obligation to issue any Letter of Credit if, after giving effect to such issuance, the aggregate amount of the Available Commitments would be less than zero and, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, if any Issuing Lender shall issue any Fronted Letter of Credit that results in the aggregate amount of the Available Commitments being less than zero without having received prior written confirmation from the Administrative Agent that the issuance of such Fronted Letter of Credit would not result in the aggregate amount of the Available Commitments being less than zero, the provisions of Section 3.4 shall be applicable to such Fronted Letter of Credit only to the extent of the portion thereof (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participated</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Portion</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that, if such Fronted Letter of Credit had been issued in an amount equal to the Participated Portion, would not have resulted in the aggregate amount of the Available Commitment being less than zero and the portion of such Fronted Letter of Credit (and any related Reimbursement Obligations) that does not constitute the Participated Portion shall be subject and subordinate in right of payment and as to priority of the security provided by the Collateral to all other Obligations. Each Letter of Credit shall (i) be denominated in Dollars or Pounds Sterling and (ii) expire no later than the earlier of (x) the first anniversary of its date of issuance and (y) the date that is five Business Days prior to the Termination Date&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that any Letter of Credit with a one-year term may provide for the renewal thereof at the option of the applicable Borrower for additional one-year periods (which shall in no event extend beyond </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date referred to in clause (y) above), so long as the Issuing Lender of such Letter of Credit has the right to refuse to extend such Letter of Credit if at the time of such refusal the applicable Borrower would be unable to satisfy the conditions set forth in Section 5.2&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that any Secured Letter of Credit may have an expiration date up to 364 days after the Termination Date.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;No Applicable Issuing Party shall at any time issue (i) any Letter of Credit if such issuance would conflict with, or cause such Applicable Issuing Party, any L&#47;C Participant or any Lender to exceed any limits imposed by, any applicable Requirement of Law or (ii) any Secured Letter of Credit on behalf of any Borrower if (x) the then Borrowing Base of such Borrower would be less than such Borrower&#8217;s aggregate Secured L&#47;C Obligations after giving effect to the issuance of such Secured Letter of Credit or (y) all cash and Eligible Securities constituting such Borrowing Base are not then held in an Account of such Borrower established pursuant to Section 1 of Article II of the applicable Collateral Account Control Agreement. Prior to issuing any Secured Letter of Credit, the Applicable Issuing Party shall obtain confirmation from the Administrative Agent that the requirements imposed by clause (ii) of the preceding sentence shall be satisfied.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Procedure for Issuance of Letter of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any Borrower may from time to time request that an Applicable Issuing Party issue a Letter of Credit by delivering to such Applicable Issuing Party at its address for notices specified herein (with a copy to the Administrative Agent at its address for notices specified herein) an Application therefor, indicating (i) whether such Letter of Credit is to be a Secured Letter of Credit or an Unsecured Letter of Credit and (ii) whether such Letter of Credit is to be a Fronted Letter of Credit or a Several Letter of Credit and otherwise completed to the satisfaction of such Applicable Issuing Party, and such other certificates, documents and other papers and information as such Applicable Issuing Party may request&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that in no event shall any Applicable Issuing Party other than Barclays Bank PLC or Citibank, N.A. and, with the consent of the Administrative Agent, one other Issuing Lender (and any of their respective Affiliates) issue any Letter of Credit denominated in Pounds Sterling. Upon receipt of any Application, the Applicable Issuing Party will process such Application and the certificates, documents and other papers and information delivered to it in connection therewith in accordance with its customary procedures and shall promptly issue the Letter of Credit requested thereby (but in no event shall any Applicable Issuing Party be required to issue any Letter of Credit earlier than five Business Days after its receipt of the Application therefor and all such other certificates, documents and other papers and information relating thereto) by issuing the original of such Letter of Credit to the beneficiary thereof or as otherwise may be agreed to by such Applicable Issuing Party and such Borrower. Such Applicable Issuing Party shall furnish a copy of such Letter of Credit (i) to such Borrower promptly following the issuance thereof and (ii) in the case of a Several Letter of Credit, to each Lender. Each Applicable Issuing Party shall promptly furnish to the Administrative Agent, which shall in turn promptly furnish to the Lenders, notice of the issuance of each Letter of Credit (including the amount thereof).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fees and Other Charges</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) The applicable Borrower will pay to the Administrative Agent, for the account of the Lenders, a fee on the undrawn and unexpired face amount (calculated, in the case of any Letter of Credit denominated in Pounds Sterling, on the basis of the Exchange Rate in effect on the date payment of such fee is due) of each Letter of Credit issued on its behalf at a per annum rate equal to (i) in the case of an Unsecured Letter of Credit, the Applicable Margin then in effect with respect to Eurodollar Loans and (ii) in the case of a Secured Letter of Credit, 0.40%. Such fees shall be payable quarterly in arrears on each Fee Payment Date after the issuance date. The Administrative Agent will promptly pay to the Lenders their pro rata shares of any amounts received from the Borrowers in respect of any such fees.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The applicable Borrower shall pay to each Issuing Lender for its own account a fronting fee at a rate per annum as agreed between such Borrower and such Issuing Lender on the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">undrawn and unexpired amount of each Fronted Letter of Credit issued on its behalf, payable quarterly in arrears on each Fee Payment Date after the issuance date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In addition to the foregoing fees, the applicable Borrower shall pay or reimburse (i) each Applicable Issuing Party for such normal and customary costs and expenses as are incurred or charged by such Applicable Issuing Party in issuing, negotiating, effecting payment under, amending or otherwise administering any Letter of Credit and (ii) each Lender for such normal and customary costs and expenses as are incurred or charged by such Lender in connection with any Several Letter of Credit.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">L&#47;C Participations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Each Issuing Lender irrevocably agrees to grant and hereby grants to each L&#47;C Participant, and, to induce such Issuing Lender to issue Fronted Letters of Credit, each L&#47;C Participant irrevocably agrees to accept and purchase and hereby accepts and purchases from such Issuing Lender, on the terms and conditions set forth below, for such L&#47;C Participant&#8217;s own account and risk an undivided interest equal to such L&#47;C Participant&#8217;s Commitment Percentage in such Issuing Lender&#8217;s obligations and rights under and in respect of each Fronted Letter of Credit and the amount of each draft paid by such Issuing Lender thereunder. Each L&#47;C Participant agrees with each Issuing Lender that, if a draft is paid under any Fronted Letter of Credit for which such Issuing Lender is not reimbursed in full by the applicable Borrower in accordance with the terms of this Agreement, such L&#47;C Participant shall pay to such Issuing Lender upon demand at such Issuing Lender&#8217;s address for notices specified herein an amount in Dollars equal to such L&#47;C Participant&#8217;s Commitment Percentage of (i) the amount of such draft, or any part thereof, that is paid in Dollars and is not so reimbursed or (ii) the Dollar Equivalent, using the Exchange Rate at the time such draft is paid, of the amount of such draft, or any part thereof, that is paid in Pounds Sterling and is not so reimbursed. Each L&#47;C Participant&#8217;s obligation to pay such amount shall be absolute and unconditional and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such L&#47;C Participant may have against the applicable Issuing Lender, any Borrower or any other Person for any reason whatsoever, (ii) the occurrence or continuance of a Default or an Event of Default or the failure to satisfy any of the other conditions specified in Section 5, (iii) any adverse change in the condition (financial or otherwise) of any Borrower, (iv) any breach of this Agreement or any other Loan Document by any Borrower or any other L&#47;C Participant or (v) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If any amount required to be paid by any L&#47;C Participant to an Issuing Lender pursuant to Section 3.4(a) in respect of any unreimbursed portion of any payment made by such Issuing Lender under any Fronted Letter of Credit is paid to such Issuing Lender within three Business Days after the date such payment is due, such L&#47;C Participant shall pay to such Issuing Lender on demand an amount equal to the product of (i) such amount, times (ii) the daily average Federal Funds Effective Rate during the period from and including the date such payment is required to the date on which such payment is immediately available to such Issuing Lender, times (iii) a fraction the numerator of which is the number of days that elapse during such period and the denominator of which is 360. If any such amount required to be paid by any L&#47;C Participant pursuant to Section 3.4(a) is not made available to the applicable Issuing Lender by such L&#47;C Participant within three Business Days after the date such payment is due, such Issuing Lender shall be entitled to recover from such L&#47;C Participant, on demand, such amount with interest thereon calculated from such due date at the rate per annum applicable to ABR Loans. A certificate of an Issuing Lender submitted to any L&#47;C Participant with respect to any amounts owing under this Section shall be conclusive in the absence of manifest error.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Whenever, at any time after the applicable Issuing Lender has made payment under any Fronted Letter of Credit and has received from any L&#47;C Participant its </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share of such payment in accordance with Section 3.4(a), such Issuing Lender receives any payment related to such Fronted Letter of Credit (whether directly from the applicable Borrower or otherwise, including proceeds </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of collateral applied thereto by such Issuing Lender), or any payment of interest on account thereof, such Issuing Lender will distribute to such L&#47;C Participant its </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that in the event that any such payment received by such Issuing Lender shall be required to be returned by such Issuing Lender, such L&#47;C Participant shall return to such Issuing Lender the portion thereof previously distributed by such Issuing Lender to it.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;This Section 3.4 shall be subject to the provisions of the second proviso to the first sentence of Section 3.1(a).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reimbursement Obligation of the Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any draft is paid under any Letter of Credit, the applicable Borrower shall reimburse the Applicable Issuing Party for the amount of (a) the draft so paid and (b) any fees, charges or other costs or expenses incurred by such Applicable Issuing Party in connection with such payment, not later than 12&#58;00 Noon, New York City time, on the date that is two Business Days following which such Borrower receives notice of such draft, it being understood that, if such notice is not received on such day prior to 10&#58;00 A.M., New York City time, such payment shall be due no later than two Business Days starting the Business Day immediately following the day that such Borrower receives such notice. Each such payment under a Letter of Credit denominated in Dollars shall be made to the Applicable Issuing Party at its address for notices specified herein (or as otherwise specified) in Dollars in immediately available funds. Each such payment under a Letter of Credit denominated in Pounds Sterling shall be made to the Applicable Issuing Party at its address for notices specified herein (or as otherwise specified) in Pounds Sterling in immediately available funds. Interest shall be payable on any such amounts from the date on which the relevant draft is paid until payment in full at the rate set forth in (x) until the Business Day next succeeding the date of the relevant notice, Section 2.8(b) and (y) thereafter, Section 2.8(c). In the case of payments made under this Section 3.5 in respect of Several Letters of Credit, the L&#47;C Administrator shall distribute such payments to the applicable Lenders promptly upon receipt in like funds as received.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Obligations Absolute</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Borrowers&#8217; obligations under this Section 3 shall be absolute and unconditional under any and all circumstances and irrespective of any setoff, counterclaim or defense to payment that any Borrower may have or have had against any L&#47;C Issuer, any beneficiary of a Letter of Credit or any other Person. The Borrowers also agree with each L&#47;C Issuer that such L&#47;C Issuer shall not be responsible for, and the Borrowers&#8217; Reimbursement Obligations under Section 3.5 shall not be affected by, among other things, (i) the validity or genuineness of documents or of any endorsements thereon, even though such documents shall in fact prove to be invalid, fraudulent or forged, (ii) any dispute between or among any Borrower and any beneficiary of any Letter of Credit or any other party to which such Letter of Credit may be transferred or any claims whatsoever of any Borrower against any beneficiary of such Letter of Credit or any such transferee, (iii) payment by any L&#47;C Issuer under any Letter of Credit against presentation of a draft or other document that does not comply with the terms of such Letter of Credit or (iv) any other event or circumstances which might constitute a legal or equitable discharge or provide a right of setoff against the Borrowers&#8217; reimbursement obligation. No L&#47;C Issuer shall be liable for any error, omission, interruption or delay in transmission, dispatch or delivery of any message or advice, however transmitted, in connection with any Letter of Credit, except for errors or omissions found by a final and nonappealable decision of a court of competent jurisdiction of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by a Borrower to the extent permitted by applicable law) suffered by such Borrower to have resulted from the gross negligence or willful misconduct of such L&#47;C Issuer. The Borrowers agree that any action taken or omitted by any L&#47;C Issuer under or in connection with any Letter of Credit or the related drafts or documents, if done in the absence of gross negligence or willful misconduct, shall be binding on the Borrower and shall not result in any liability of such L&#47;C Issuer to any Borrower and that with respect to documents presented which appear on their face to be in substantial compliance with the terms of a Letter of Credit, the applicable L&#47;C Issuer may, in its sole discretion, either accept and make payment upon such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Credit Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any draft shall be presented for payment under any Letter of Credit, the Applicable Issuing Party shall promptly notify the applicable Borrower of the date and amount thereof. The responsibility of the Applicable Issuing Party to the applicable Borrower in connection with any draft presented for payment under any Letter of Credit shall, in addition to any payment obligation expressly provided for in such Letter of Credit, be limited to determining that the documents (including each draft) delivered under such Letter of Credit in connection with such presentment are substantially in conformity with such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Several Letters of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The L&#47;C Administrator is hereby authorized to execute and deliver each Several Letter of Credit and each amendment to a Several Letter of Credit on behalf of each Lender provided that, upon request of the Borrower, such Several Letter of Credit or amendment will be executed by each Lender. The L&#47;C Administrator shall use the Commitment Percentage of each Lender as its &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitment&#160;Share</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; under each Several Letter of Credit&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that each Limited Fronting Lender (if any), in its capacity as such, shall, in addition to its own &#8220;Commitment Share&#8221; as a Lender, have a &#8220;Commitment Share&#8221; (or equivalent term) equal to the Commitment Percentage (or portion thereof, if applicable) of each Non-NAIC Approved Bank for which such Limited Fronting Lender acts in such capacity under such Several Letter of Credit. The L&#47;C Administrator shall not amend any Several Letter of Credit to change the &#8220;Commitment Shares&#8221; of any Lender or add or delete a Lender liable thereunder unless such amendment is done in connection with a Limited Fronting Lender Agreement in accordance with Section 3.8(c), an assignment in accordance with Section 11.6, a change in the Lenders and&#47;or the Commitment Percentages as a result of any increase in the Commitments pursuant to Section 2.1 or any other addition or replacement of a Lender in accordance with the terms of this Agreement. Each Lender (including, for the avoidance of doubt, each Limited Fronting Lender) hereby irrevocably constitutes and appoints the L&#47;C Administrator its true and lawful attorney-in-fact for and on behalf of such Lender with full power of substitution and revocation in its own name or in the name of the L&#47;C Administrator to issue, execute and deliver, as the case may be, each Several Letter of Credit and each amendment to a Several Letter of Credit and to carry out the purposes of this Agreement with respect to Several Letters of Credit. Upon request, each Lender shall execute such powers of attorney or other documents as any beneficiary of any Several Letter of Credit may reasonably request to evidence the authority of the L&#47;C Administrator to execute and deliver such Several Letter of Credit and any amendment or other modification thereto on behalf of the Lenders. To the extent that the L&#47;C Administrator has not received funds from a Lender with respect to a Several Letter of Credit, the L&#47;C Administrator shall only forward the funds actually received to the beneficiary.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each Lender (including, for the avoidance of doubt, each Limited Fronting Lender) agrees with the L&#47;C Administrator that, if a draft is paid under any Several Letter of Credit for which such L&#47;C Administrator is not reimbursed in full by the applicable Borrower in accordance with the terms of this Agreement, each Lender shall pay to the L&#47;C Administrator upon demand at the L&#47;C Administrator&#8217;s address for notices specified herein an amount in Dollars (in the case of a Several Letter of Credit denominated in Dollars) or Pounds Sterling (in the case of a Several Letter of Credit denominated in Pounds Sterling) equal to such Lender&#8217;s Commitment Share (and, in the case of each Limited Fronting Lender, the Commitment Share (or the portion thereof for which it has agreed to be a Limited Fronting Lender) of each applicable Non-NAIC Approved Bank). In the event that a Limited Fronting Lender pays the Commitment Share of a Non-NAIC Approved Bank, such Non-NAIC Approved Bank shall pay such Commitment Share (or the relevant portion thereof, if applicable) to such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Limited Fronting Lender in purchase of its participation in such payment. Each Lender&#8217;s (including, for the avoidance of doubt, each Limited Fronting Lender&#8217;s and each Non-NAIC Approved Bank&#8217;s) obligation to pay such amount shall be absolute and unconditional and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such Lender may have against the L&#47;C Administrator, any Borrower or any other Person for any reason whatsoever, (ii) the occurrence or continuance of a Default or an Event of Default or the failure to satisfy any of the other conditions specified in Section 5, (iii) any adverse change in the condition (financial or otherwise) of any Borrower, (iv) any breach of this Agreement or any other Loan Document by any Borrower or any other Lender or (v) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the event that any Lender agrees (in its sole discretion) to act as a Limited Fronting Lender for any Non-NAIC Approved Bank upon such terms and conditions as such parties may agree (including fees payable by such Non-NAIC Approved Bank to such Limited Fronting Lender) (such agreement, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limited Fronting Lender Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the following provisions shall apply (in addition to any other provisions hereof relating to Limited Fronting Lenders)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;upon the issuance of any Several Letter of Credit pursuant hereto, with respect to any Non-NAIC Approved Bank, each applicable Limited Fronting Lender, in reliance upon the agreements of such Non-NAIC Approved Bank, agrees (A) to issue through the L&#47;C Administrator, in addition to its own obligations as a Lender under such Several Letter of Credit, severally, such Several Letter of Credit in an amount equal to such Non-NAIC Approved Bank&#8217;s Commitment Share of the stated amount of such Several Letter of Credit (or the portion thereof for which such Limited Fronting Lender has agreed to be a Limited Fronting Lender), and (B) to amend or extend each Several Letter of Credit previously issued by it as a Limited Fronting Lender for such Non-NAIC Approved Bank&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;with respect to any Several Letter of Credit issued by a Limited Fronting Lender pursuant to clause (i) above for a Non-NAIC Approved Bank, such Non-NAIC Approved Bank agrees to purchase participations in the obligations of such Limited Fronting Lender under such Several Letter of Credit in the amount attributable to such Non-NAIC Approved Bank. Without any further action on the part of any party, each Limited Fronting Lender hereby grants to each applicable Non-NAIC Approved Bank for which it is acting as a Limited Fronting Lender hereunder, and each such Non-NAIC Approved Bank hereby acquires from such Limited Fronting Lender, a participation in such Limited Fronting Lender&#8217;s Commitment Share of each Several Letter of Credit for which such Limited Fronting Lender is acting as a Limited Fronting Lender on behalf of such Non-NAIC Approved Bank hereunder in the amount attributable to such Non-NAIC Approved Bank. Each such Non-NAIC Approved Bank purchasing a participation hereunder acknowledges and agrees that its obligation to acquire such participations in respect of Several Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment or extension of any Letter of Credit or the occurrence and continuance of a Default or Event of Default or reduction or termination of the Commitments. In consideration and in furtherance of the foregoing, each such Non-NAIC Approved Bank hereby absolutely and unconditionally agrees to pay to the L&#47;C Administrator, for account of the applicable Limited Fronting Lender, an amount equal to the amount of each payment made by such Limited Fronting Lender in respect of the portion of each such Several Letter of Credit in which such Non-NAIC Approved Bank holds a participation, promptly upon the request of such Limited Fronting Lender, at any time from the time such payment is made until such payment is reimbursed by the applicable Borrower or at any time after any reimbursement payment is required to be refunded to the applicable Borrower for any reason. Such payment by such Non-NAIC Approved Bank shall be made for the account of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicable Limited Fronting Lender without any offset, abatement, withholding or reduction whatsoever. To the extent that any Non-NAIC Approved Bank has made payments pursuant to this paragraph to reimburse a Limited Fronting Lender in respect of any participation interests purchased hereunder in respect of any Several Letter of Credit, promptly following receipt by the L&#47;C Administrator of any payment from the applicable Borrower pursuant to Section 3.5 in respect of such Several Letter of Credit, the L&#47;C Administrator shall distribute such payment to such Limited Fronting Lender and such Non-NAIC Approved Bank as their interests may appear. Any payment made by a Non-NAIC Approved Bank in respect of its participation pursuant to this paragraph to reimburse the applicable Limited Fronting Lender for any payment made in respect of any drawing under a Several Letter of Credit shall not relieve the Borrowers of their obligation to reimburse the amount of such drawing&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided, however,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Borrowers&#8217; failure to reimburse the amount of such drawing shall not affect the obligation of any Non-NAIC Approved Bank to indemnify the Limited Fronting Lender for such amount pursuant to Section 3.8(b).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Lender that agrees to act as a Limited Fronting Lender for any Non-NAIC Approved Bank shall promptly notify the Administrative Agent (which shall promptly notify the L&#47;C Administrator) of such agreement and of any termination or expiration of such agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that, pursuant to this Section 3.8(c), any Lender agrees to act as a Limited Fronting Lender for any other Lender that becomes a Non-NAIC Approved Bank, such Lender shall receive such compensation therefor as such Non-NAIC Approved Bank and such Lender may agree. Notwithstanding anything herein to the contrary, no Lender shall have any obligation to agree to act hereunder as a Limited Fronting Lender for any other Lender.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The obligations of each Lender under and in respect of each Several Letter of Credit are several, and the failure by any Lender to perform its obligations hereunder or under any Several Letter of Credit shall not affect the obligations of the Borrowers toward any other party hereto nor shall any other such party (other than Limited Fronting Lenders with respect to Several Letters of Credit they have issued on behalf of Non-NAIC Approved Banks) be liable for the failure by such Lender to perform its obligations hereunder or under any Several Letter of Credit.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Applications</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent that any provision of any Application related to any Letter of Credit is inconsistent with the provisions of this Section 3, the provisions of this Section 3 shall apply.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issuing Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Borrower may, at any time and from time to time with the consent of the Administrative Agent (which consent shall not be unreasonably withheld or delayed) and such Lender, designate one or more Lenders to act as an issuing lender under the terms of this Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the total number of Issuing Lenders at any time shall not exceed four. Any Lender designated as an Issuing Lender pursuant to this Section 3.10 shall be deemed to be an &#8220;Issuing Lender&#8221; for the purposes of this Agreement (in addition to being a Lender) with respect to Letters of Credit issued by such Lender.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reporting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless the Administrative Agent otherwise agrees, each Applicable Issuing Party will report in writing to the Administrative Agent (i) on the first Business Day of each week and on the second Business Day to occur after the last day of each March, June, September and December, and on such other dates as the Administrative Agent may reasonably request, the daily activity during the preceding week, calendar quarter or other period, as the case may be, with respect to Letters of Credit issued by it, including the aggregate outstanding L&#47;C Obligations with respect to such Letters of Credit on each day during such week, quarter or other period, in such form and detail as shall be satisfactory to the Administrative Agent, (ii) on any Business Day on which the Borrower fails to pay any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursement Obligation required to be reimbursed to such Applicable Issuing Party on such day, the date of such failure and the amount of such Reimbursement Obligation and (iii) such other information with respect to Letters of Credit issued by such Applicable Issuing Party as the Administrative Agent may reasonably request.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-NAIC Approved Banks</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If, at any time from and after the Closing Date, any Lender is not or ceases to be a NAIC Approved Bank, such Lender shall promptly notify the Company and the Administrative Agent thereof. Each Lender agrees to use commercially reasonable efforts, at all times from and after the Closing Date, (a) to be a NAIC Approved Bank or (b) if such Lender is not or ceases to be a NAIC Approved Bank, to agree with another Lender which is a NAIC Approved Bank, as provided in Section 3.8(c), that such NAIC Approved Bank shall (in its sole discretion) act as the Limited Fronting Lender for such Non-NAIC Approved Bank with respect to any Several Letters of Credit which are outstanding at the time such Lender becomes a Non-NAIC Approved Bank and&#47;or are issued during the period that such Lender is a Non-NAIC Approved Bank.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 4&#160;&#160;REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To induce the Administrative Agent and the Lenders to enter into this Agreement and to make the Extensions of Credit, the Company hereby represents and warrants to the Administrative Agent and each Lender that&#58;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Conditions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as set forth in the Company&#8217;s Form 6-K, dated July 30, 2021 and filed with the United States Securities and Exchange Commission, the audited consolidated balance sheet of the Company and its Subsidiaries as at December 31, 2020, and the related consolidated statement of comprehensive income and of cash flows for the fiscal year ended on such date, reported on by and accompanied by an unqualified report from KPMG Audit Plc, present fairly the consolidated financial condition of the Company and its Subsidiaries as at such date, and the consolidated results of its operations and its consolidated cash flows for the fiscal year then ended. All such financial statements, including the related schedules and notes thereto, have been prepared in accordance with GAAP applied consistently throughout the periods involved (except as approved by the aforementioned firm of accountants and disclosed therein). Except as set forth in the Company&#8217;s Form 6-K, dated July 30, 2021 and filed with the United States Securities and Exchange Commission, as of the date of this Agreement, no Group Member has any material Guarantee Obligations, contingent liabilities and liabilities for material taxes, or any material long-term leases or material unusual forward or long-term commitments, including any Swap Contracts, that are not reflected in the most recent financial statements referred to in this paragraph. During the period from December 31, 2020 to and including the date of this Agreement there has been no Disposition by any Group Member of any material part of its business or property.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Change</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as set forth in the Company&#8217;s Form 6-K, dated July 30, 2021 and filed with the United States Securities and Exchange Commission, since December 31, 2020, there has been no development or event that has had or could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Existence&#59; Compliance with Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Group Member (a) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (b) has the power and authority, and the legal right, to own and operate its property, to lease the property it operates as lessee and to conduct the business in which it is currently engaged, (c) is duly qualified as a foreign corporation or other organization and in good standing under the laws of each jurisdiction where its ownership, lease or operation of property or the conduct of its business requires such qualification except where the failure to so qualify or be in good standing would not have a Material Adverse Effect and (d) is in compliance with all Requirements of Law (including the Bermuda Companies Law and Bermuda </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance Law as applicable to the Company and each Subsidiary organized under the laws of Bermuda) except to the extent that the failure to comply therewith could not, in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary is subject to any Private Act.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Power&#59; Authorization&#59; Enforceable Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Each Borrower has or will have the power and authority, and the legal right, to make, deliver and perform the Loan Documents to which it is a party and to obtain Loans and Letters of Credit hereunder, and each Borrower has or will have taken all necessary organizational action to authorize the execution, delivery and performance of the Loan Documents to which it is a party and to authorize the borrowings, and the issuance of Letters of Credit on its behalf, on the terms and conditions of this Agreement. No consent or authorization of, filing with, notice to or other act by or in respect of, any Governmental Authority or any other Person is required in connection with the Loans or Letters of Credit or with the execution, delivery, performance, validity or enforceability of this Agreement or any other Loan Document, except (i) consents, authorizations, filings and notices that have been obtained or made and are in full force and effect and (ii) filings necessary to perfect Liens in favor of the Collateral Agent. Each Loan Document has been duly executed and delivered on behalf of each Borrower which is a party thereto. This Agreement constitutes, and each other Loan Document upon execution will constitute, a legal, valid and binding obligation of each Borrower which is a party thereto, enforceable against each Borrower in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Under the laws of the jurisdiction of its incorporation in force at the date hereof, no Borrower will be required to make any deduction or withholding from any payment it may make hereunder or under the Notes.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The claims of the Collateral Agent and the Lenders against each Borrower under this Agreement and the Notes will rank at least </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pari</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">passu</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with the claims of all its other unsecured creditors under the laws of (i) the jurisdiction of such Borrower&#8217;s incorporation and (ii) New York, except creditors whose claims are preferred solely by any bankruptcy, insolvency or other similar law of general application governing the enforcement of creditors&#8217; rights.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In any proceedings taken in Bermuda in relation to this Agreement, the choice of New York law as the governing law of this Agreement, and any judgment obtained in the United States, will be recognized and enforced (other than a judgment for a sum payable in respect of taxes or other charges of a like nature in respect of a fine or other penalty, or in respect of multiple damages as defined in The Protection of Trading Interests Act 1981 of Bermuda), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (i) the court which rendered the judgment was competent to hear the action in accordance with private international law principles as applied in Bermuda and (ii) the judgment is not contrary to public policy (and the Company is not aware of anything contrary to public policy) in Bermuda, has not been obtained by fraud or in proceedings contrary to natural justice and is not based on an error in Bermuda law.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Under the laws of Bermuda it is not necessary that this Agreement, the Notes or any other Loan Document be filed, recorded or enrolled with any court or other authority in such jurisdiction or that any stamp, registration or similar tax be paid on or in relation with this Agreement, the Notes or such other Loan Document.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Legal Bar</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The execution, delivery and performance of this Agreement and the other Loan Documents, the borrowings hereunder and the use of the proceeds thereof will not violate any Requirement of Law or any Contractual Obligation of any Group Member and will not result in, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">require, the creation or imposition of any Lien on any of their respective properties or revenues pursuant to any Requirement of Law or any such Contractual Obligation (other than the Liens created by the Security Documents and except, in the case of Contractual Obligations, to the extent that the failure of any of the statements in this Section 4.5 to be accurate could not reasonably be expected to have a Material Adverse Effect).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No litigation, investigation or proceeding of or before any arbitrator or Governmental Authority is pending, or, to the knowledge of any Borrower, threatened, by or against any Group Member or against any of their respective properties or revenues (a) with respect to any of the Loan Documents or any of the transactions contemplated hereby or thereby, or (b) that could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Group Member is in default under or with respect to any of its Contractual Obligations in any respect that could reasonably be expected to have a Material Adverse Effect. No Default or Event of Default has occurred and is continuing.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ownership of Property&#59; Liens</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each of the Company and each Material Subsidiary has good title to, or a valid leasehold interest in all its real and personal property material to its business except for minor defects in title that could not reasonably be expected to have a Material Adverse Effect, and none of such property is subject to any Lien not permitted by Section 7.6.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Group Member has filed or caused to be filed all Federal, state and other material tax returns that are required to be filed and has paid all taxes shown to be due and payable on said returns (other than any taxes the amount or validity of which are currently being contested in good faith by appropriate proceedings and with respect to which reserves in conformity with GAAP have been provided on the books of the relevant Group Member) except to the extent that failure to do so could not reasonably be expected to have a Material Adverse Effect&#59; no material tax Lien has been filed against any Group Member&#59; and, to the knowledge of any Borrower, no claim is being asserted with respect to any tax return or for any unpaid taxes that, individually or in the aggregate for all such claims, would reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Federal Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Borrower is engaged in the business of extending credit for the purpose of purchasing or carrying margin stock (within the meaning of Regulation U), and no proceeds of any Loan will be used to purchase or carry any such margin stock or to extend credit to others for the purpose of purchasing or carrying any such margin stock in contravention of Regulation T, U or X of the Board. If requested by any Lender or the Administrative Agent, the Company will furnish to the Administrative Agent and each Lender a statement to the foregoing effect in conformity with the requirements of FR Form G-3 or FR Form U-1, as applicable, referred to in Regulation U.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as would not reasonably be expected to result in a Material Adverse Effect, (i) neither a Reportable Event nor a failure to satisfy the minimum funding standards (within the meaning of Sections 412 or 430 of the Code or Section 303 of ERISA), whether or not waived, has occurred during the five-year period prior to the date on which this representation is made or deemed made with respect to any Single Employer Plan, and each Single Employer Plan has complied in all material respects with the applicable provisions of ERISA and the Code&#59; (ii) no termination of a Single Employer Plan has occurred (other than a standard termination within the meaning of Section 4041(b) of ERISA), and no Lien on the assets or property of any Group Member or any Commonly Controlled Entity in favor of the PBGC or a Plan has arisen, during such five-year period&#59; (iii) there has been no determination that any Single Employer Plan is, or is expected to be, in &#8220;at risk&#8221; status (within the meaning of Section 430(i)(4) of the Code or Section 303(i)(4) of ERISA, (iv) there has been no failure to make, by its due date, a required installment payment under Section 430(j) of the Code with respect to</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any Single Employer Plan nor any failure to make by its due date a required contribution to a Multiemployer Plan and (v) no Foreign Plan Event has occurred or is reasonably expected to occur. Except as would not reasonably be expected to result in a Material Adverse Effect, none of the Borrowers, Subsidiaries nor any Commonly Controlled Entity has had a complete or partial withdrawal from any Multiemployer Plan, and none of the Borrowers, Subsidiaries nor any Commonly Controlled Entity would become subject to any liability under ERISA if such entity were to withdraw completely from all Multiemployer Plans as of the valuation date most closely preceding the date on which this representation is made or deemed made. Except as would not reasonably be expected to result in a Material Adverse Effect, no Multiemployer Plan is Insolvent, or in &#8220;endangered&#8221; or &#8220;critical&#8221; status (within the meaning of Section 432(b) of the Code or Section 305(b) of ERISA).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Borrower is an &#8220;investment company&#8221;, or a company &#8220;controlled&#8221; by, or an &#8220;affiliated person&#8221; of, or &#8220;principal underwriter&#8221; for, an &#8220;investment company&#8221;, within the meaning of the Investment Company Act of 1940.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 4.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sets forth, as of the date of this Agreement, the name and jurisdiction of incorporation of each Subsidiary and, as to each such Subsidiary, the percentage of each class of Capital Stock owned by the Company or any other Subsidiary, and such Schedule indicates each Subsidiary Borrower as of such date.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The proceeds of the Extensions of Credit shall be used (a) to finance the working capital needs of the Company and its Subsidiaries and (b) for general corporate purposes of the Company and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as, in the aggregate, could not reasonably be expected to have a Material Adverse Effect&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;none of the Group Members has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;none of the Group Members has become subject to liability under any Environmental Law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;none of the Group Members has received notice of any claim with respect to any liability under any Environmental Law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the facilities and properties owned, leased or operated by any Group Member (the &#8220;Properties&#8221;) do not contain any Hazardous Materials in amounts or concentrations or under circumstances that could reasonably be expected to give rise to liability under any Environmental Law&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Hazardous Materials have not been transported or disposed by any Group Member in a manner or to a location that could reasonably be expected to give rise to liability under any Environmental Law.</font></div><div style="margin-bottom:12pt;padding-left:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accuracy of Information, etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;To the best of the Company&#8217;s knowledge, the Confidential Information Memorandum, taken as a whole, is correct in all material respects as of the date thereof and does not, as of the date thereof, contain any untrue statement of a material fact or omit any material</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fact necessary to make the statements therein (taken as a whole) not misleading as of such date in light of the circumstances under which they were made&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, however, that this representation does not extend to (i) any projections and other forward looking statements contained in the Confidential Information Memorandum (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Projections</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;&#8217;) and (ii) information in the Confidential Information Memorandum which is referenced to a specific source or derived from public or other sources. The Projections contained in the Confidential Information Memorandum have been prepared in good faith based upon assumptions reasonably believed by the Company to be reasonable at the time of preparation, it being understood, and the Administrative Agent and each Lender understands that the Projections are subject to significant uncertainties and contingencies many of which are beyond the control of the Company and there can be no assurances that such Projections will be realized.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;No written statement or information delivered by any Borrower to the Administrative Agent, the Syndication Agent, the Collateral Agent or the Lenders contained in this Agreement or any other Loan Document, taken as a whole, contains any untrue statement of a material fact or omits any material fact necessary to make the statements therein (taken as a whole) not misleading as of the date of such statement or information in light of the circumstances under which they were provided.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;As of the Closing Date, to the best knowledge of each Borrower, the information included in such Borrower&#8217;s Beneficial Ownership Certification provided on or prior to the Closing Date to any Lender in connection with this Agreement is true and correct in all respects.</font></div><div style="margin-bottom:12pt;padding-left:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PATRIOT Act&#59; OFAC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PATRIOT Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent applicable, each of the Company and its Subsidiaries is in compliance in all material respects with (i) the Trading with the Enemy Act (12 U.S.C. &#167;&#167; 95a-95b and 50 U.S.C. App. &#167;&#167; 1-44), and each of the foreign assets control regulations of the United States Treasury Department (31CFR, Subtitle B, Chapter V), and any other enabling legislation or executive order relating thereto&#59; (ii) the PATRIOT Act&#59; (iii) Sanctions and (iv) Anti-Corruption Laws.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sanctioned Persons</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. None of the Company, any Subsidiary nor, to the knowledge of the Company, any director or officer of the Company or any Subsidiary is the subject or target of (or is owned or controlled by a Person that is the subject or target of) any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), U.S. Department of State, United Nations Security Council, European Union or Her Majesty&#8217;s Treasury or other relevant sanctions authority (collectively, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and any other enabling legislation or executive order relating thereto, and no Borrower will directly or indirectly use the proceeds of the Loans, the Letters of Credit or otherwise make available such proceeds to any Person (i) for the purpose of funding or financing the activities of or business of any Person that at the time of such funding or financing is the subject or target of any Sanctions, (ii) for the purpose of funding or financing activities in or business in any country or territory, that at the time of such funding or financing is the subject or target of any Sanctions, or (iii) in violation of any Sanctions Laws or Anti-Corruption Laws.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company has implemented and maintains in effect for itself and its Subsidiaries policies and procedures designed to ensure compliance by the Company, its Subsidiaries and their respective officers, employees, directors and agents with the PATRIOT Act, Anti-Corruption Lawsand applicable Sanctions.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Margin Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No part of the proceeds of any Loan will be used, whether directly or indirectly, for any purpose that entails a violation of, or that is inconsistent with, the provisions</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Regulations of the Board of Governors of the Federal Reserve System of the United States of America, including Regulations T, U or X.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 5&#160;&#160;CONDITIONS PRECEDENT</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Initial Extensions of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The agreement of each Lender to make the initial extension of credit requested to be made by it is subject to the satisfaction, prior to or concurrently with the making of such extension of credit, of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received this Agreement, executed and delivered by the Administrative Agent, the Collateral Agent, each Borrower and each Person listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (i) The Lenders, the Administrative Agent, the Syndication Agent and the Collateral Agent shall have received all fees required to be paid, and all expenses for which invoices have been presented (including the reasonable fees and expenses of legal counsel), on or before the Closing Date. The Administrative Agent shall have received evidence that any outstanding interest and fees payable under the Existing Credit Agreement has been or concurrently with the Closing Date have been paid in full, subject to receipt of appropriate invoicing documentation in advance of the Closing Date.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Certificate&#59; Certified Certificate of Incorporation&#59; Good Standing Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received from a Responsible Officer or the secretary or assistant secretary of a Borrower (i) a certificate of the Company, dated the Closing Date, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a certificate of each other Borrower, dated the Closing Date, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in each case, with appropriate insertions and attachments, including the Memorandum of Association, Articles of Incorporation or other organizational documents for each Borrower issued (and to the extent available in such jurisdiction, certified) by the appropriate Governmental Authority of Bermuda, in the case of the Company, and by the appropriate Governmental Authority of the relevant jurisdiction of organization, in the case of each other Borrower, and By-laws (or equivalent) for each Borrower and (ii) a certificate of compliance&#47;good standing for each Borrower from its jurisdiction of organization (to the extent available in such jurisdiction).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Opinions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received the executed&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;legal opinion of Willkie Farr &#38; Gallagher LLP, counsel to the Company and its Subsidiaries, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;legal opinion of Carey Olsen Bermuda Limited, counsel to the Company, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;legal opinion of US general counsel of the Company, substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each such legal opinion shall cover such other matters incident to the transactions contemplated by this Agreement as the Administrative Agent may reasonably require.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral Documentation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received amendments to and reaffirmations of the Security Agreement and the existing Collateral Account Control Agreements in form and substance reasonably satisfactory to the Administrative Agent. The Lenders</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">52</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">party hereto (constituting the Required Lenders as defined in the Existing Credit Agreement) hereby authorize and direct the Collateral Agent to enter into the amendments to the Security Agreement and the existing Collateral Account Control Agreements contemplated by the foregoing sentence on the Closing Date.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Uniform Commercial Code Financing Statements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received satisfactory evidence that Uniform Commercial Code financing statements covering the securities held under each Collateral Account Control Agreement and naming the Collateral Agent as secured party are currently on file and effective, or are in proper form for filing, (i) in the jurisdiction of organization of each Borrower organized under the laws of any state of the United States or (ii) (x) in the District of Columbia for each Borrower not organized under the laws of a state of the United States and (y) in the state of the United States in which a Borrower not organized under the laws of a state of the United States maintains its chief executive office.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consents, Etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Borrower shall have received, on reasonably satisfactory terms, all consents and authorizations required pursuant to any Contractual Obligation with any other Person and shall have obtained all permits of, and effected all notices to and filings with, any Governmental Authority, in each case, as may be necessary to allow each Borrower lawfully to execute, deliver and perform, in all material respects, its obligations hereunder and under the other Loan Documents to which it is, or shall be, a party and each other agreement or instrument to be executed and delivered by it pursuant thereto or in connection therewith.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exiting Bank Acknowledgements and Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received (i) from each Person that is a &#8220;Lender&#8221; under and as defined in the Existing Credit Agreement but not a Lender hereunder, if any (each, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exiting Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), an acknowledgement that the Existing Credit Agreement is being amended and restated hereby and that such Person will not be a party hereto and (ii) from the Borrowers, for the account of each Exiting Lender, payment of all amounts then owed to each such Exiting Lender under the Existing Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (i) The Administrative Agent and each Lender shall have received such information as it shall have reasonably requested to comply with all applicable &#8220;know-your-customer&#8221; and anti-money laundering rules and regulations, including the Patriot Act and (ii) to the extent a Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, at least five days prior to the Closing Date, any Lender that has requested, in a written notice to the Company at least 10 days prior to the Closing Date, a Beneficial Ownership Certification in relation to such Borrower shall have received such Beneficial Ownership Certification (provided that, upon the execution and delivery by such Lender of its signature page to this Agreement, the condition set forth in this clause (ii) shall be deemed to be satisfied).</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lender Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Evidence that the Lenders under the Existing Credit Agreement other than any Exiting Lenders (if any) have approved this Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that each Lender&#8217;s signature page to this Agreement shall be evidence of such consent.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Each Extension of Credit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The agreement of each Lender to make any Extension of Credit requested to be made by it on any date (including its initial Extension of Credit) is subject to the satisfaction of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each of the representations and warranties made by any Borrower in the Loan Documents shall be true and correct in all material respects on and as of such date as if made on and as of such date (except where such representation and warranty speaks of a specific date in which case such representation and warranty shall be true</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and correct as of such date and except for Section 4.6), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with respect to the issuance of any Secured Letter of Credit, this clause (a) shall not be applicable to the representation and warranty set forth in Section 4.2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Default or Event of Default shall have occurred and be continuing on such date or after giving effect to the Extensions of Credit requested to be made on such date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Guarantee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The obligations of the Company under Section 10 in respect of the Obligations of any other Borrower to or on behalf of which such Extension of Credit is to be made shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Borrowing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received from the applicable Borrower a notice of borrowing in accordance with Section 2.2.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each borrowing by and issuance of a Letter of Credit on behalf of any Borrower hereunder shall constitute a representation and warranty by such Borrower as of the date of such Extension of Credit that the conditions contained in this Section 5.2 have been satisfied.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions for Additional Subsidiary Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any Material Subsidiary set forth in a written notification thereof delivered by the Company to the Administrative Agent shall become a Subsidiary Borrower on the date that the following conditions precedent shall have been satisfied&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received a Subsidiary Borrower Agreement duly executed by such Subsidiary Borrower substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Certificate&#58; Certified Certificate of Incorporation&#59; Good Standing Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received (i) a certificate of such Subsidiary Borrower substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B-2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, with appropriate insertions and attachments, including the Memorandum of Association, Articles of Incorporation or other organizational documents for such Subsidiary Borrower certified by the appropriate Governmental Authority of such Subsidiary Borrower&#8217;s relevant jurisdiction of organization and the By-laws (or equivalent) for such Subsidiary Borrower and (ii) a certificate of compliance&#47;good standing for such Subsidiary Borrower from its jurisdiction of organization.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Opinions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall have received an executed legal opinion of counsel to each Subsidiary Borrower in each jurisdiction reasonably requested by the Administrative Agent. Each such legal opinion shall cover such other matters incident to the transactions contemplated by this Agreement as the Administrative Agent may reasonably require.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">USA Patriot Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For purposes of compliance with the Patriot Act, the Administrative Agent and each Lender shall have received from the Company the following information with respect to such Material Subsidiary at least five Business Days prior to its becoming a Subsidiary Borrower, in the case of any Material Subsidiary that is both a Wholly Owned Subsidiary and a Domestic Subsidiary, and at least ten Business Days prior to its becoming a Subsidiary Borrower, in the case of any other Subsidiary&#58; (i) its full legal name&#59; (ii) the address of its principal place of business&#59; and (iii) if such Material Subsidiary is a Domestic Subsidiary, its United States tax identification number.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Objection</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent shall not have received, within ten Business Days after providing notice to the Lenders of any such proposed Subsidiary Borrower, a written objection to the designation of such proposed Subsidiary Borrower from any Lender on the grounds that (i) lending to such proposed Subsidiary Borrower would be illegal for such Lender, (ii) such Lender does not have any applicable license, authority or other governmental approval to conduct business in the applicable jurisdiction or (iii) lending to such proposed Subsidiary Borrower would result in material costs to such Lender that would not otherwise be reimbursed under this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent and each Lender shall have received such other information as it shall have reasonably requested to comply with all applicable &#8220;know-your-customer&#8221; and anti-money laundering rules and regulations, including the Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 6&#160;&#160;AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company hereby agrees that, so long as the Commitments remain in effect, any Letter of Credit remains outstanding or any Loan or other amount is owing to any Lender or the Administrative Agent hereunder, the Company shall and shall cause each of its Subsidiaries to&#58;</font></div><div style="margin-bottom:12pt;padding-left:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Furnish to the Administrative Agent&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;as soon as available, but in any event within 120 days after the end of each fiscal year of the Company, a copy of the audited consolidated balance sheet of the Company and its consolidated Subsidiaries as at the end of such year and the related audited consolidated statements of comprehensive income and of cash flows for such year, setting forth in each case in comparative form the figures for the previous year certified by KPMG Audit Plc or other independent certified public accountants of nationally recognized standing&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;as soon as available, but in any event not later than 45 days after the end of each of the first three quarterly periods of each fiscal year of the Company, the unaudited consolidated balance sheet of the Company and its consolidated Subsidiaries as at the end of such quarter and the related unaudited consolidated statements of comprehensive income and of cash flows for such quarter and the portion of the fiscal year through the end of such quarter, setting forth in each case in comparative form the figures for the previous year, certified by a Responsible Officer of the Company as being fairly stated in all material respects (subject to normal year-end audit adjustments and the absence of footnotes).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All such financial statements shall be complete and correct in all material respects and shall be prepared in reasonable detail and in accordance with GAAP. Documents required to be delivered pursuant to Section 6.1(a) or (b) or Section 6.2(c) (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and, if so delivered, shall be deemed to have been delivered on the date (i) on which the Company posts such documents, or provides a link thereto on the Company&#8217;s website on the Internet&#59; or (ii) on which such documents are posted on the Company&#8217;s behalf on an Internet or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a third-party website (such as http&#58;&#47;&#47;sec.gov) or whether sponsored by the Administrative Agent)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company shall (x) except to the extent that an option to automatically receive an e-mail alert with respect to any applicable document is available at http&#58;&#47;&#47;investor.aspen.co&#47;EmailNotification(or another readily accessible page on the Company&#8217;s website), notify the Administrative Agent and each Lender (by telecopier or electronic mail) of the posting of any such document and (y) upon written request, provide to the Administrative Agent by electronic mail</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic versions (i.e., soft copies) of such documents. Notwithstanding anything contained herein, in every instance the Company shall be required to provide paper copies of the Compliance Certificates required by Section 6.2(a) to the Administrative Agent. Except for such Compliance Certificates, the Administrative Agent shall have no obligation to request the delivery or to maintain copies of the documents referred to above, and each Lender shall be solely responsible for maintaining its copies of such documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certificates&#59; Other Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Furnish to the Administrative Agent (or, in the case of clause (d), to the relevant Lender)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;concurrently with the delivery of any financial statements pursuant to Section 6.1, a certificate of a Responsible Officer of the Company stating that, to the best of such Responsible Officer&#8217;s knowledge, each Borrower during such period has observed or performed all of its covenants and other agreements, and satisfied every condition contained in this Agreement and the other Loan Documents to which it is a party to be observed, performed or satisfied by it, and that such Responsible Officer has obtained no knowledge of any Default or Event of Default except as specified in such certificate and a Compliance Certificate containing all information and calculations necessary for determining compliance by the Company with the provisions of Section 7.1 and Section 7.9 of this Agreement as of the last day of the fiscal quarter or fiscal year of the Company, as the case may be&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;if required to be filed by the Company with the SEC pursuant to SEC rules and regulations applicable to the Company&#58; within 45 days after the end of each of the first three quarterly periods of each fiscal year of the Company, a narrative discussion and analysis of the consolidated financial condition and results of operations of the Company and its Subsidiaries for such fiscal quarter and for the period from the beginning of the then current fiscal year to the end of such fiscal quarter, as compared to the portion of the projections covering such periods and to the comparable periods of the previous year (it being understood that the delivery of the management&#8217;s discussion and analysis of the applicable Form 10-Q containing the financial statements delivered pursuant to Section 6.1 shall satisfy the requirement of this Section 6.2(b))&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;within five days after the same are sent, copies of all financial statements and reports that the Company sends to the holders of any class of its debt securities or public equity securities and, within five days after the same are filed, copies of all financial statements and reports that the Company files with the SEC&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;promptly, such additional financial and other information regarding the business, operations and financial conditions of the Company or any of its Subsidiaries as any Lender may from time to time reasonably request&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;promptly following receipt thereof, copies of any documents described in Sections 101(f), 101(k) or 101(I) of ERISA that any Borrower, Subsidiary or any Commonly Controlled Entity may request with respect to any Multiemployer Plan&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that if any Borrower, Subsidiary or any Commonly Controlled Entity has not requested such documents or notices from the administrator or sponsor of the applicable Multiemployer Plan, then, upon reasonable request of the Administrative Agent, any Borrower, Subsidiary and&#47;or any Commonly Controlled Entity shall promptly make a request for such documents or notices from such administrator or sponsor and the Company shall provide copies of such documents and notices to the Administrative Agent (on behalf of each relevant Lender) promptly after receipt thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Pay, discharge or otherwise satisfy at or before maturity or before they become delinquent, as the case may be, all its material obligations (including taxes) of whatever nature, except where the amount or validity thereof is currently being contested in good faith by appropriate proceedings and reserves in conformity with GAAP with respect thereto have been provided on the books of the relevant Group Member or where the failure to pay, discharge or satisfy would not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Maintenance of Existence&#59; Compliance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a)(i) Preserve, renew and keep in full force and effect the organizational existence of the Company, each Material Subsidiary and each Insurance Subsidiary and (ii) take all reasonable action to maintain all rights, privileges and franchises necessary or desirable in the normal conduct of its business, including all required insurance licenses of each Material Subsidiary, except, in each case, as otherwise permitted by Section 7.3 and except, in the case of each of clauses (i) and (ii) above, to the extent that failure to do so could not reasonably be expected to have a Material Adverse Effect&#59; and (b) comply with all Requirements of Law except to the extent that failure to comply therewith would not, in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Maintenance of Property&#59; Insurance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (a) Keep all property useful and necessary in the business of the Company, each Material Subsidiary and each Insurance Subsidiary in good working order and condition, ordinary wear and tear excepted and (b) maintain with financially sound and reputable insurance companies insurance on all the property of the Company, each Material Subsidiary and each Insurance Subsidiary in at least such amounts and against at least such risks as are usually insured against in the same general area by companies engaged in the same or a similar business.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inspection of Property&#59; Books and Records&#59; Discussions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Keep such books of records and account as are necessary to permit the Company and its Subsidiaries to prepare financial statements that are in conformity with GAAP and that are in compliance with all Requirements of Law relating to the maintenance of financial records (except, in the case of such Requirements of Law, to the extent that the failure to comply therewith could not reasonably be expected to have a Material Adverse Effect) and (b) permit representatives of the Administrative Agent to visit and inspect any of its properties and examine and make abstracts from any of its books and records at any reasonable time and as often as may reasonably be desired and to discuss the business, operations, properties and financial and other condition of the Group Members with officers and employees of the Group Members and with their independent certified public accountants&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company shall have an opportunity to participate in any discussions with any public accountants.</font></div><div style="margin-bottom:12pt;padding-left:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Promptly give notice to the Administrative Agent and each Lender of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the occurrence of any Default or Event of Default&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;any (i) default or event of default under any Contractual Obligation of any Group Member or (ii) litigation, investigation or proceeding that may exist at any time between any Group Member and any Governmental Authority, that in either case, if not cured or if adversely determined, as the case may be, could reasonably be expected to have a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;any other development or event that has had or could reasonably be expected to have a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;any change in the information provided in the Beneficial Ownership Certification delivered to such Lender that would result in a change to the list of beneficial owners identified in such certification&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;if a Borrower has knowledge that the aggregate Secured L&#47;C Obligations of such Borrower exceed the Borrowing Base of such Borrower and the Borrower has not paid or delivered to the Custodian such cash and&#47;or Eligible Securities sufficient to cause the Borrowing Base of such Borrower to be at least equal to the Secured L&#47;C Obligations of such Borrower in accordance with Section 2.5(b).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each notice pursuant to this Section 6.7 shall be accompanied by a statement of a Responsible Officer setting forth details of the occurrence referred to therein and stating what action the relevant Group Member proposes to take with respect thereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect, comply with all applicable Environmental Laws.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 7&#160;&#160;NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company hereby agrees that, so long as the Commitments remain in effect, any Letter of Credit remains outstanding or any Loan or other amount is owing to any Lender or the Administrative Agent hereunder, the Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly&#58;</font></div><div style="margin-bottom:12pt;padding-left:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Condition Covenants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Leverage Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Permit the Consolidated Leverage Ratio as at the last day of any fiscal quarter of the Company to exceed 35%.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Tangible Net Worth</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Permit Consolidated Tangible Net Worth as at the last day of each fiscal quarter of the Company to be less than the sum of (i) $2,019,600,000, (ii) 25% of Consolidated Net Income during the period from January 1, 2021 to and including such last day of such fiscal quarter (if positive) and (iii) 25% of the aggregate Net Cash Proceeds of all issuances by the Company of shares of its Capital Stock during the period from January 1, 2021 to and including such last day of such fiscal quarter.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (a) With respect to the Company, create, incur, assume or permit to exist any Indebtedness, except for (i) the Obligations, (ii) Indebtedness in connection with the 4.65% 2023 senior notes issued on November 13, 2013, (iii) Indebtedness under any capital instrument entered into in connection with Funds at Lloyd&#8217;s, and (iv) other Indebtedness that is either </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pari passu</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in right of payment with, or subordinated in right of payment to, the Obligations&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, at the time of incurrence of such other Indebtedness, no Default or Event of Default shall have occurred and be continuing or would result therefrom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) With respect to any Subsidiary of the Company, create, incur, assume or permit to exist any Indebtedness, except for&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Indebtedness of any Borrower pursuant to any Loan Document&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Indebtedness of any Group Member to any other Group Member&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Guarantee Obligations by any Group Member of obligations of any other Group Member&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;Indebtedness outstanding on the date hereof and listed on Schedule 7.2(b)(iv) and any refinancings, refundings, renewals or extensions thereof (without increasing, or shortening the maturity of, the principal amount thereof, except by an amount equal to any existing commitments or increase options unutilized thereunder)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Indebtedness (including Capital Lease Obligations) incurred in the ordinary course of business and secured by Liens permitted by Section 7.6(h) in an aggregate principal amount not to exceed $25,000,000 at any one time outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;obligations (contingent or otherwise) existing or arising under any Swap Contract&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such obligations are (or were) entered into by such Subsidiary for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets or property held or reasonably anticipated by such Subsidiary, or changes in the value of securities issued by such Subsidiary, and not for purposes of speculation or taking a &#8220;market view&#8221;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;Indebtedness for letters of credit which have been issued on behalf of any Insurance Subsidiary to or for the benefit of reinsurance cedents or insurance clients in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii)&#160;&#160;&#160;&#160;Indebtedness under any capital instrument entered into in connection with Funds at Lloyd&#8217;s&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix)&#160;&#160;&#160;&#160;Indebtedness of any Subsidiary incurred under securities lending arrangements entered into in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;Indebtedness incurred in the ordinary course of business in connection with workers&#8217; compensation claims, self-insurance obligations, unemployment insurance or other forms of governmental insurance or benefits pursuant to letters of credit or other security arrangements entered into in connection with such insurance or benefit&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xi)&#160;&#160;&#160;&#160;Indebtedness incurred by an Insurance Subsidiary in the ordinary course of day-to-day insurance or reinsurance activities and which is substantially consistent with past practice for such Subsidiary prior to the Closing Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xii)&#160;&#160;&#160;&#160;Indebtedness with respect to any Lien described in Section 7.6(p)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such Indebtedness existed at the time the relevant Investment was made and such Indebtedness was not incurred with, as a result of or in contemplation of such Investment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiii)&#160;&#160;&#160;&#160;to the extent constituting Indebtedness, any Indebtedness pursuant to overdraft facilities in the ordinary course of business and consistent with past practice&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiv)&#160;&#160;&#160;&#160;so long as no Default or Event of Default shall have occurred and be continuing or would result therefrom, additional Indebtedness incurred in the ordinary course of business not otherwise permitted under this Section 7.2(b) in an aggregate principal amount (for all Subsidiaries) not to exceed 10% of Consolidated Tangible Net Worth at the time of creation, incurrence or assumption, as the case may be.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disposition of Property</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Dispose of any of its property, whether now owned or hereafter acquired, or, in the case of any Subsidiary, issue or sell any shares of such Subsidiary&#8217;s Capital Stock to any Person, except&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;transactions in the ordinary course of business involving current assets or other assets classified in the Company&#8217;s balance sheet as available for sale or trading (as defined in FAS 115), including the disposition in the ordinary course of business of any assets in its investment portfolio and intra-Group Member capital contributions in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Disposition of obsolete, worn out or surplus property in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the sale of inventory in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the transfer by any Subsidiary of the Company of its assets to any other Subsidiary of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;the license (as licensor) of intellectual property so long as such license does not materially interfere with the business of the Company or any of its Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;the release, surrender or waiver of contract, tort or other claims of any kind as a result of the settlement of any litigation or threatened litigation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;the granting or existence of Liens (and foreclosure thereon) not prohibited by this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;the lease or sublease of real property so long as such lease or sublease does not materially interfere with the business of the Company or any of its Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;dividends not prohibited by Section 7.4&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;any ceding of insurance or reinsurance in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Dispositions permitted by Section 7.10(d)(i)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;the sale or issuance of any Subsidiary&#8217;s Capital Stock to any Borrower&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;Dispositions of the equity interests in a Subsidiary to a Wholly Owned Subsidiary of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;Any Disposition as to which the proceeds are applied to the Obligations of any Borrower under this Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (i) the Company or such Subsidiary receives consideration at the time of such Disposition at least equal to the fair market value (as determined at the time of contractually agreeing to such Disposition) of the assets sold or otherwise disposed of and (ii) such consideration is in the form of cash or Cash Equivalents&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;Dispositions of other property during any fiscal year of the Company having an aggregate fair market value not to exceed 10% of the consolidated assets of the Company and its Subsidiaries as of the last day of the prior fiscal year of the Company&#59;.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Declare or pay any dividend (other than dividends payable solely in common stock of the Person making such dividend) on, or make any payment on account of, or set apart assets for a sinking or other analogous fund for, the purchase, redemption, defeasance, retirement or other acquisition of, any Capital Stock of any Group Member (excluding (i) the 5.625% Perpetual Non</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">60</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative Preference Shares issued by the Company on September 20, 2016, (ii) the 5.95% Perpetual Non-Cumulative Preference Shares issued by the Company on May 2, 2013 , (iii) the depository shares of the Company issued on August 13, 2019, and (iv) any other Hybrid Capital), whether now or hereafter outstanding, or make any other distribution in respect thereof, either directly or indirectly, whether in cash or property or in obligations of any Group Member (collectively, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), except that (a) any Subsidiary may make Restricted Payments to any Group Member and (b) so long as no Default or Event of Default shall have occurred and be continuing or would result therefrom, the Company may make Restricted Payments.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Make any advance, loan, extension of credit (by way of guaranty or otherwise) or capital contribution to, or purchase any Capital Stock, bonds, notes, debentures or other debt securities of, or any assets constituting a business unit of, or make any other investment in, any Person (all of the foregoing, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), except&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;extensions of trade credit in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;investments in Cash Equivalents&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;investments in securities lending arrangements entered into in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Guarantee Obligations permitted by Section 7.2&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;loans and advances to employees of any Group Member in the ordinary course of business (including for travel, entertainment and relocation expenses) in an aggregate amount for all Group Members not to exceed $5,000,000 at any one time outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;intercompany Investments by any Group Member in any other Group Member, including, without limitation, intercompany loans issued by any Group Member to any other Group Member)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;acquisitions of all or substantially all of the Capital Stock or assets of another Person so long as at such time and immediately after giving effect thereto no Default or Event of Default exists or would result therefrom&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;(i) Investments by Insurance Subsidiaries in the ordinary course of business and (ii) Investments by the Company and its Subsidiaries that are not Insurance Subsidiaries in Investments that, if made by an Insurance Subsidiary, would be permitted by clause (i) immediately preceding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Investments of any Person at the time such Person becomes a Subsidiary and any modification, replacement, renewal or extension thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> such Investment was not made in connection with or anticipation of such Person becoming a Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Investments listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Investments in any ILS Entity&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;Participation as a corporate member of Lloyd&#8217;s Syndicate 4711 and Carbon Syndicate 4747&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">61</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;in addition to Investments otherwise expressly permitted by this Section, Investments by the Company or any of its Subsidiaries in an aggregate amount during the term of this Agreement (valued at cost, but giving effect to any distributions or returns therefrom) not to exceed 20 % of Consolidated Tangible Net Worth at the time any such Investment is made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Create, incur, assume or suffer to exist any Lien upon any of its property, whether now owned or hereafter acquired, except&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Liens for taxes not yet due or that are being contested in good faith by appropriate proceedings, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that adequate reserves with respect thereto are maintained on the books of the Company or its Subsidiaries, as the case may be, in conformity with GAAP&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s or other like Liens arising in the ordinary course of business that are not overdue for a period of more than 30 days or that are being contested in good faith by appropriate proceedings&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;pledges or deposits in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;deposits to secure the performance of bids, trade contracts (other than for borrowed money), leases, statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Liens on assets of any Subsidiary pledged as collateral for Indebtedness of such Insurance Subsidiary incurred under Section 7.2(b)(vii)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Liens on assets of any Subsidiary created to secure obligations of such Insurance Subsidiary in connection with insurance and reinsurance arrangements&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;easements, rights-of-way, restrictions and other similar encumbrances incurred in the ordinary course of business that, in the aggregate, are not substantial in amount and that do not in any case materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of the Company or any of its Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Liens securing Indebtedness of the Company or any Subsidiary incurred pursuant to Section 7.2(a) or Section 7.2(b)(v) to finance the acquisition, construction or improvement of fixed or capital assets, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (i) such Liens shall be created substantially simultaneously with the acquisition, construction or improvement of such fixed or capital assets, (ii) such Liens do not at any time encumber any property other than the property financed by such Indebtedness, and (iii) the aggregate amount of all such Indebtedness of all Subsidiaries does not exceed the limit set forth in Section 7.2(b)(v)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Liens created pursuant to the Security Documents&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;any interest or title of a lessor under any lease entered into by the Company or any other Subsidiary in the ordinary course of its business and covering only the assets so leased&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Liens (including Liens in favor of the Custodian with respect to the Accounts) on cash and securities of any Group Member incurred as part of the management of its investment portfolio in accordance with customary portfolio management practice and not in violation of its investment policy as in effect on the date of this Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, with respect</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">62</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Accounts, such Liens shall be permitted only to the extent that the Custodian has agreed to subordinate such Liens as provided in the applicable Collateral Account Control Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;Liens existing on the date hereof and listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;Liens arising in the ordinary course of business on operating accounts maintained by any Group Member in the ordinary course of business securing obligations (other than Indebtedness) arising in the ordinary course of business in favor of the banks in which such operating accounts are maintained&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;attachments, judgments and similar Liens for sums not exceeding $50,000,000 in the aggregate (excluding any portion thereof covered by insurance as to which the relevant insurance company has acknowledged coverage)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;attachments, judgments and similar Liens for sums of $50,000,000 or more (excluding any portion thereof which is covered by insurance as to which the relevant insurance company has acknowledged coverage), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the execution or other enforcement of such Liens is stayed and fully bonded pending appeal&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;any Lien existing on property acquired in connection with an Investment made in connection with Section 7.5, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such Lien shall extend solely to the item or items of property so acquired and, if required by the terms of the instrument originally creating such Lien, other property which is an improvement to or is acquired for specific use in connection with such acquired property&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;restrictions and similar encumbrances created pursuant to Requirements of Law upon the sale or transferability of the Capital Stock of any Insurance Subsidiary and the exercise of any right to control any such Insurance Subsidiary</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;Liens securing Swap Contracts of any Subsidiary of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;Liens securing obligations of the Borrowers under any letter of credit facility entered into in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;Liens securing obligations of the Borrowers under any capital instrument entered into in connection with Funds at Lloyd&#8217;s&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;any extension, renewal or replacement of any Lien permitted by the preceding subparagraphs of this Section 7.6, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no additional property (other than a substitution of like property) shall be encumbered thereby and no additional Indebtedness shall be secured thereby unless such additional Indebtedness on such property would have been permitted in connection with the original creation, incurrence or assumption of such Lien&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;other Liens securing obligations not at any time exceeding 10% of Consolidated Tangible Net Worth in the aggregate for the Company and all Subsidiaries.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the avoidance of doubt, Liens made pursuant to Section 430(k) of the Code or Section 303(k) of ERISA shall not be permitted Liens.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Clauses Restricting Subsidiary Distributions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Enter into or suffer to exist or become effective any consensual encumbrance or restriction on the ability of any Subsidiary of the</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">63</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company to (a) make Restricted Payments in respect of any Capital Stock of such Subsidiary held by, or pay any Indebtedness owed to, the Company or any other Subsidiary of the Company, (b) make loans or advances to, or other Investments in, the Company or any other Subsidiary of the Company or (c) transfer any of its assets to the Company or any other Subsidiary of the Company, except for such encumbrances or restrictions existing under or by reason of (i) any restrictions existing under the Loan Documents and (ii) any restrictions with respect to a Subsidiary imposed pursuant to an agreement that has been entered into in connection with the Disposition of all or substantially all of the Capital Stock or assets of such Subsidiary.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Enter into any business, either directly or through any Subsidiary, except for insurance, reinsurance or insurance-related businesses.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rating</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Permit at any time the rating of any Relevant Subsidiary that is rated by AM Best to have a rating below AM Best financial strength rating B++. For purposes herein, a &#8220;Relevant Subsidiary&#8221; is any Insurance Subsidiary the total consolidated assets or total consolidated revenues of which exceed 10% of the total consolidated assets or total consolidated revenues, respectively, of the Company and its Subsidiaries at the end of or for, respectively, the then most recently completed fiscal quarter of the Company for which financial statements shall have been made available to the Lenders as required herein.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidations, Amalgamations, Mergers and Liquidations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Enter into any merger, consolidation or amalgamation, or liquidate, wind up or dissolve itself (or suffer any liquidation or dissolution), or Dispose of all or substantially all of its property or business, except for (a) the merger or consolidation of any Subsidiary of the Company with or into the Company </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company shall be the continuing or surviving corporation)&#59; (b) the merger or consolidation by any Borrower with or into any other Borrower&#59; (c) the merger or consolidation of any Subsidiary of the Company which is not a Borrower with or into any other Subsidiary of the Company which is not a Borrower or with or into any Borrower </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Borrower is the surviving corporation)&#59; (d) the Disposition by any Subsidiary of the Company of any or all of its assets (i) to any Borrower (upon voluntary liquidation or otherwise) or (ii) pursuant to a Disposition permitted by Section 7.3&#59; and (e) the merger or consolidation by any Person (other than as set forth above) with or into the Company or any other Borrower </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Company or such Borrower is the continuing or surviving corporation) so long as at the time of such merger or consolidation and immediately after giving effect thereto no Default or Event of Default exists or would result therefrom.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Sell, lease or otherwise transfer any property or assets to, or purchase, lease or otherwise acquire any property or assets from, or otherwise engage in any other transactions with, any of its Affiliates, except (a) transactions that (i) are in the ordinary course of business and (ii) are at prices and on terms and conditions not less favorable to the applicable Borrower or such Subsidiary than could be obtained on an arm&#8217;s-length basis from unrelated third parties, (b) transactions between or among any Borrower and any other Borrower not involving any other Affiliate, (c) transactions with any ILS Entity, (d) employment and severance arrangements (including equity incentive plans and employee benefit plans and arrangements) with their respective officers and employees in the ordinary course of business and (e) payment of customary fees and reasonable out-of pocket expenses to, and indemnities for the benefit of, directors, officers and employees of any Group Member, in all cases, arising in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 8&#160;&#160;EVENTS OF DEFAULT</font></div><div style="margin-bottom:12pt;padding-left:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the following events shall occur and be continuing&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">64</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;any Borrower shall fail to pay any principal of any Loan or any Reimbursement Obligation when due in accordance with the terms hereof&#59; or any Borrower shall fail to pay any interest on any Loan or any other amount payable hereunder or under any other Loan Document, within five Business Days after any such interest or other amount becomes due in accordance with the terms hereof&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;any representation or warranty made or deemed made by any Borrower herein or in any other Loan Document or that is contained in any certificate, document or financial or other statement furnished by it at any time under or in connection with this Agreement or any such other Loan Document shall prove to have been inaccurate in any material respect on or as of the date made or deemed made&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;any Borrower shall default in the observance or performance of any agreement contained in Section 6.4(a) (with respect to the Borrowers only), Section 6.7(a) or Section 7 of this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;any Borrower shall default in the observance or performance of any other agreement contained in this Agreement or any other Loan Document (other than as provided in paragraphs (a) through (c) of this Section), and such default shall continue unremedied for a period of 30 days after notice to the Company from the Administrative Agent or the Required Lenders&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;any Group Member shall (i) default in making any payment of any principal of any Indebtedness (including any Guarantee Obligation, but excluding the Loans) on the scheduled or original due date with respect thereto&#59; or (ii) default in making any payment of any interest on any such Indebtedness beyond the period of grace, if any, provided in the instrument or agreement under which such Indebtedness was created&#59; or (iii) default in the observance or performance of any other agreement or condition relating to any such Indebtedness or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default or other event or condition is to cause, or to permit the holder or beneficiary of such Indebtedness (or a trustee or agent on behalf of such holder or beneficiary) to cause, with the giving of notice if required, such Indebtedness to become due prior to its stated maturity&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that a default, event or condition described in clause (i), (ii) or (iii) of this paragraph (e) shall not at any time constitute an Event of Default unless, at such time, one or more defaults, events or conditions of the type described in clauses (i), (ii) and (iii) of this paragraph (e) shall have occurred and be continuing with respect to Indebtedness the outstanding principal amount of which exceeds in the aggregate $50,000,000&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;(i) the Company or any Material Subsidiary shall commence any case, proceeding or other action (A) under any existing or future law of any jurisdiction, domestic or foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition or other relief with respect to it or its debts, or (B) seeking appointment of a receiver, trustee, custodian, conservator or other similar official for it or for all or any substantial part of its assets, or the Company or any Material Subsidiary shall make a general assignment for the benefit of its creditors&#59; or (ii) there shall be commenced against the Company or any Material Subsidiary any case, proceeding or other action of a nature referred to in clause (i) above that (A) results in the entry of an order for relief or any such adjudication or appointment or (B) remains undismissed, undischarged or unbonded for a period of 60 days&#59; or (iii) there shall be commenced against the Company or any Material Subsidiary any case, proceeding or other action seeking</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">65</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its assets that results in the entry of an order for any such relief that shall not have been vacated, discharged, or stayed or bonded pending appeal within 60 days from the entry thereof&#59; or (iv) the Company or any Material Subsidiary shall take any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in clause (i), (ii), or (iii) above&#59; or (v) the Company or any Material Subsidiary shall generally not, or shall be unable to, or shall admit in writing its inability to, pay its debts as they become due&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;one or more judgments or decrees shall be entered against any Group Member, and either (x) shall not have been vacated, discharged, stayed or bonded pending appeal within 60 days from the entry thereof or (y) enforcement proceedings are commenced by any creditor upon such judgment or decree, involving in the aggregate a liability (not paid or fully covered by insurance as to which the relevant insurance company has not denied coverage) of $50,000,000 or more&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;any Loan Document shall cease, for any reason, to be in full force and effect or any Borrower shall so assert&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;a Change of Control shall occur&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;(i) any Single Employer Plan shall fail to meet the minimum funding standards (within the meaning of Sections 412 or 430 of the Code or Sections 302 or 303 of ERISA), whether or not waived, or any Lien in favor of the PBGC or a Single Employer Plan shall arise on the assets of any Group Member or any Commonly Controlled Entity, (ii) a Reportable Event shall occur with respect to, or proceedings shall commence to have a trustee appointed, or a trustee shall be appointed, to administer or to terminate, any Single Employer Plan, which Reportable Event or commencement of proceedings or appointment of a trustee is, in the reasonable opinion of the Required Lenders, likely to result in the termination of such Single Employer Plan for purposes of Title IV of ERISA, (iii) any Single Employer Plan shall terminate for purposes of Title IV of ERISA (other than a standard termination within the meaning of Section 4041(b) of ERISA), (iv) there shall be a determination that any Single Employer Plan is, or is expected to be, in &#8220;at risk&#8221; status (within the meaning of Section 430(i)(4) of the Code or Section 303(i)(4) of ERISA)&#59; (v) any Group Member or any Commonly Controlled Entity shall, or in the reasonable opinion of the Required Lenders is likely to, incur any liability in connection with a withdrawal from, or the Insolvency of, a Multiemployer Plan or a determination that any such Multiemployer Plan is in &#8220;endangered&#8221; or &#8220;critical&#34; status (within the meaning of Section 432 of the Code or Section 305 of ERISA), (vi) a Foreign Plan Event shall occur or (vii) any other event or condition shall occur or exist with respect to a Plan&#59; and in each case in clauses (i) through (vii) above, such event or condition, together with all other such events or conditions, if any, could, in the sole judgment of the Required Lenders, reasonably be expected to have a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">then, and in any such event, (A) if such event is an Event of Default specified in clause (i) or (ii) of paragraph (f) above with respect to any Borrower, automatically the Commitments shall immediately terminate and the Loans (with accrued interest thereon) and all other amounts owing under this Agreement and the other Loan Documents (including all amounts of L&#47;C Obligations, whether or not the beneficiaries of the then outstanding Letters of Credit shall have presented the documents required thereunder) shall immediately become due and payable, and (B) if such event is any other Event of Default, any or all of the following actions may be taken&#58; (i) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall, by notice to the Company declare the Commitments to be terminated forthwith, whereupon the</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">66</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments shall immediately terminate&#59; (ii) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall, by notice to the Company, declare the Loans (with accrued interest thereon) and all other amounts owing under this Agreement and the other Loan Documents (including all amounts of L&#47;C Obligations, whether or not the beneficiaries of the then outstanding Letters of Credit shall have presented the documents required thereunder) to be due and payable forthwith, whereupon the same shall immediately become due and payable and (iii) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall direct the Collateral Agent to exercise in respect of the Collateral, the rights and remedies under the Security Documents, subject to the provisions of Section 9.5(b) below. With respect to each Letter of Credit issued on behalf of any Borrower with respect to which presentment for honor shall not have occurred at the time of an acceleration pursuant to this paragraph, such Borrower shall at such time deposit in a cash collateral account opened by the Administrative Agent an amount in the currency in which such Letter of Credit is denominated equal to the aggregate then undrawn and unexpired amount of such Letter of Credit. Amounts held in each such cash collateral account shall be applied by the Administrative Agent to the payment of drafts drawn under such Letter of Credit in accordance with the terms and conditions set forth in Section 3, and the unused portion thereof after all Letters of Credit issued on behalf of such Borrower shall have expired or been fully drawn upon, if any, shall be applied to repay other obligations of such Borrower hereunder and under the other Loan Documents. After all Letters of Credit of such Borrower shall have expired or been fully drawn upon, all Reimbursement Obligations shall have been satisfied and all other obligations of such Borrower hereunder and under the other Loan Documents shall have been paid in full, the balance, if any, in such cash collateral account shall be returned to such Borrower (or such other Person as may be lawfully entitled thereto). Except as expressly provided above in this Section, presentment, demand, protest and all other notices of any kind are hereby expressly waived by the Borrowers.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 9&#160;&#160;THE AGENTS</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appointment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Lender hereby irrevocably designates and appoints the Administrative Agent as the agent of such Lender under this Agreement and the other Loan Documents and the Collateral Agent as the agent of such Lender and the Administrative Agent under the Security Agreement, and each such Lender irrevocably authorizes the Administrative Agent and the Collateral Agent, as the case may be, in such capacities, to take such action on its behalf under the provisions of this Agreement and the other Loan Documents, as applicable, and to exercise such powers and perform such duties as are expressly delegated to the Administrative Agent and the Collateral Agent, as the case may be, by the terms of this Agreement and the other Loan Documents, as applicable, together with such other powers as are reasonably incidental thereto. Notwithstanding any provision to the contrary elsewhere in this Agreement, neither the Administrative Agent nor the Collateral Agent shall have any duties or responsibilities, except those expressly set forth herein, or any fiduciary relationship with any Lender, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or any other Loan Document or otherwise exist against the Administrative Agent or the Collateral Agent.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrative Agent and each Lender understand and agree that all Liens created by the Security Agreement on the Collateral have been created in favor of the Collateral Agent, for the benefit of the Administrative Agent and the Lenders, that all rights to take remedial action with respect to the Collateral under the Security Agreement have been granted to the Collateral Agent and that neither the Administrative Agent nor any Lender has the right to take any such remedial action with respect to the Collateral other than through the Collateral Agent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">67</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Delegation of Duties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrative Agent and the Collateral Agent may each execute any of its duties under this Agreement and the other Loan Documents by or through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties. Neither the Administrative Agent nor the Collateral Agent shall be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exculpatory Provisions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither any Agent nor any of their respective officers, directors, employees, agents, attorneys-in-fact or affiliates shall be (i) liable for any action lawfully taken or omitted to be taken by it or such Person under or in connection with this Agreement or any other Loan Document (except to the extent the action or omission was performed with gross negligence or willful misconduct as determined by a final and nonappealable decision of a court of competent jurisdiction) or (ii) responsible in any manner to any of the Lenders for any recitals, statements, representations or warranties made by any Borrower or any officer thereof contained in this Agreement or any other Loan Document or in any certificate, report, statement or other document referred to or provided for in, or received by the Agents under or in connection with, this Agreement or any other Loan Document or for the value, validity, effectiveness, genuineness, enforceability or sufficiency of this Agreement or any other Loan Document or for any failure of any Borrower party thereto to perform its obligations hereunder or thereunder. The Collateral Agent shall not be liable for any action taken or omitted (i) at the express direction of the Administrative Agent or (ii) with the consent of the Required Lenders, in each case, except to the extent the action or omission directed or consented to was performed with gross negligence or willful misconduct as determined by a final and nonappealable decision of a court of competent jurisdiction. The Agents shall not be under any obligation to any Lender to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this Agreement or any other Loan Document, or to inspect the properties, books or records of any Borrower.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reliance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (a) The Administrative Agent shall be entitled to rely, and shall be fully protected in relying, upon any instrument, writing, resolution, notice, consent, certificate, affidavit, letter, telecopy, telex or teletype message, statement, order or other document or conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including counsel to the Borrowers), independent accountants and other experts selected by the Administrative Agent. The Administrative Agent may deem and treat the payee of any Note as the owner thereof for all purposes unless a written notice of assignment, negotiation or transfer thereof shall have been filed with the Administrative Agent. The Administrative Agent shall be fully justified in failing or refusing to take any action under this Agreement or any other Loan Document unless it shall first receive such advice or concurrence of the Required Lenders (or, if so specified by this Agreement, all Lenders) as it deems appropriate or it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense that may be incurred by it by reason of taking or continuing to take any such action. The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting under this Agreement and the other Loan Documents in accordance with a request of the Required Lenders (or, if so specified by this Agreement, all Lenders) and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and all future holders of the Loans.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Collateral Agent shall be entitled to rely, and shall be fully protected in relying, upon any instrument, writing, resolution, notice, consent, certificate, affidavit, letter, telecopy, telex or teletype message, statement, order or other document or conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including counsel to the Borrowers), independent accountants and other experts selected by the Collateral Agent. The Collateral Agent may deem and treat the payee of any Note as the owner thereof for all purposes unless a written notice of assignment, negotiation or transfer thereof shall have been filed with the Administrative Agent. The Collateral Agent shall be fully justified in</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">68</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">failing or refusing to take any action under any Security Document unless it shall first receive the direction of the Administrative Agent under Section 8 or such advice or concurrence of the Required Lenders (or, if so specified by this Agreement, all Lenders) as it deems appropriate or it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense that may be incurred by it by reason of taking or continuing to take any such action. The Collateral Agent shall in all cases be fully protected in acting, or in refraining from acting, under the Security Agreement at the direction of the Administrative Agent under Section 8 or in accordance with a request of the Required Lenders (or, if so specified by this Agreement, all Lenders), and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and all future holders of the Loans.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (a) The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default unless it has received notice from a Lender or the Company referring to this Agreement, describing such Default or Event of Default and stating that such notice is a &#8220;notice of default&#8221;. In the event that the Administrative Agent receives such a notice, the Administrative Agent shall give notice thereof to the Lenders. The Administrative Agent shall take action with respect to such Default or Event of Default as shall be directed by the Required Lenders (or, if so specified by this Agreement, all Lenders)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that unless and until the Administrative Agent shall have received such directions, the Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable in the best interests of the Lenders.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Collateral Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default unless it has received notice from the Administrative Agent, a Lender or the Company referring to this Agreement, describing such Default or Event of Default and stating that such notice is a &#8220;notice of default&#8221;. The Collateral Agent shall take action with respect to such Default or Event of Default as shall be directed by the Administrative Agent under Section 8, or by the Required Lenders (or, if so specified by this Agreement, all Lenders)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that unless and until the Collateral Agent shall have received such directions, the Collateral Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable in the best interests of the Lenders.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Reliance on Agents and Other Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Lender expressly acknowledges that neither the Agents nor any of their respective officers, directors, employees, agents, attorneys-in-fact or affiliates have made any representations or warranties to it and that no act by any Agent hereafter taken, including any review of the affairs of a Borrower or any affiliate of a Borrower, shall be deemed to constitute any representation or warranty by any Agent to any Lender. Each Lender represents to the Agents that it has, independently and without reliance upon any Agent or any other Lender, and based on such documents and information as it has deemed appropriate, made its own appraisal of and investigation into the business, operations, property, financial and other condition and creditworthiness of the Borrowers and their affiliates and made its own decision to make its Loans hereunder and enter into this Agreement. Each Lender also represents that it will, independently and without reliance upon any Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Loan Documents, and to make such investigation as it deems necessary to inform itself as to the business, operations, property, financial and other condition and creditworthiness of the Borrowers and their affiliates. Except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative Agent hereunder, neither the Administrative Agent nor the Collateral Agent shall have any duty or responsibility to provide any Lender with any credit or other information concerning the business, operations, property, condition (financial or otherwise), prospects or creditworthiness of any Borrower or any affiliate of a</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">69</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrower that may come into the possession of the Administrative Agent or the Collateral Agent or any of its respective officers, directors, employees, agents, attorneys-in-fact or affiliates.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) The Lenders agree to indemnify each Agent (other than the Collateral Agent) in its capacity as such (to the extent not reimbursed by the Borrowers and without limiting the obligation of each Borrower to do so), ratably according to their respective Aggregate Exposure Percentages in effect on the date on which indemnification is sought under this Section (or, if indemnification is sought after the date upon which the Commitments shall have terminated and the Loans shall have been paid in full, ratably in accordance with such Aggregate Exposure Percentages immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever that may at any time (whether before or after the payment of the Loans) be imposed on, incurred by or asserted against such Agent in any way relating to or arising out of, the Commitments, this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by such Agent under or in connection with any of the foregoing&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no Lender shall be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements that are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from such Agent&#8217;s gross negligence or willful misconduct. The agreements in this Section shall survive the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Lenders agree to indemnify the Collateral Agent in its capacity as such (to the extent not reimbursed by the Borrowers and without limiting the obligation of each Borrower to do so), ratably according to the respective percentages which (i) the Aggregate Exposure of each Lender constitutes of (ii) the Aggregate Exposure of all Lenders in effect on the date on which indemnification is sought under this Section (or, if indemnification is sought after the date upon which the Commitments shall have terminated and the Loans shall have been paid in full, ratably in accordance with such percentages immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever that may at any time (whether before or after the payment of the Loans) be imposed on, incurred by or asserted against the Collateral Agent in any way relating to or arising out of, the Commitments, this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by the Collateral Agent under or in connection with any of the foregoing&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no Lender shall be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements that are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from the Collateral Agent&#8217;s gross negligence or willful misconduct. The agreements in this Section shall survive the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agent in Its Individual Capacity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Agent and its affiliates may make loans to, accept deposits from and generally engage in any kind of business with any Borrower as though such Agent were not an Agent. With respect to its Loans made or renewed by it and with respect to any Letter of Credit issued or participated in by it, each Agent shall have the same rights and powers under this Agreement and the other Loan Documents as any Lender and may exercise the same as though it were not an Agent, and the terms &#8220;Lender&#34; and &#8220;Lenders&#8221; shall include each Agent in its individual capacity.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Administrative Agent and Collateral Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Administrative Agent may resign as Administrative Agent upon 30 days&#8217; notice to the Lenders and the Company. If the Administrative Agent shall resign as Administrative Agent</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">70</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under this Agreement and the other Loan Documents, then the Required Lenders shall appoint from among the Lenders a successor agent for the Lenders, which successor agent shall (unless an Event of Default under Section 8(a) or Section 8(f) with respect to any Borrower shall have occurred and be continuing) be subject to approval by the Company (which approval shall not be unreasonably withheld or delayed), whereupon such successor agent shall succeed to the rights, powers and duties of the Administrative Agent and the term &#8220;Administrative Agent&#8221; shall mean such successor agent effective upon such appointment and approval, and the former Administrative Agent&#8217;s rights, powers and duties as Administrative Agent shall be terminated, without any other or further act or deed on the part of such former Administrative Agent or any of the parties to this Agreement or any holders of the Loans. If no successor agent has accepted appointment as Administrative Agent by the date that is 30 days following a retiring Administrative Agent&#8217;s notice of resignation, the retiring Administrative Agent&#8217;s resignation shall nevertheless thereupon become effective, and the Lenders shall assume and perform all of the duties of the Administrative Agent hereunder until such time, if any, as the Required Lenders under this Agreement appoint a successor agent as provided for above. After any retiring Administrative Agent&#8217;s resignation as Administrative Agent, the provisions of this Section 9 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Administrative Agent under this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Collateral Agent may resign as Collateral Agent upon 30 days&#8217; notice to the Lenders and the Company. In addition, the Company shall have the right (unless a Default or Event of Default shall have occurred and be continuing) to remove the Collateral Agent upon 30 days&#8217; prior written notice to the Administrative Agent. If the Collateral Agent shall resign or be removed as Collateral Agent under this Agreement, then the Required Lenders shall appoint from among the Lenders a successor collateral agent, which successor collateral agent shall (unless an Event of Default under Section 8(a) or Section 8(f) with respect to any Borrower shall have occurred and be continuing) be subject to approval by the Company (which approval shall not be unreasonably withheld or delayed), whereupon such successor collateral agent shall succeed to the rights, powers and duties of the Collateral Agent and the term &#8220;Collateral Agent&#8221; shall mean such successor collateral agent effective upon such appointment and approval, and the former Collateral Agent&#8217;s rights, powers and duties as Collateral Agent shall be terminated, without any other or further act or deed on the part of such former Collateral Agent or any of the parties to this Agreement or any holders of the Loans. If no successor collateral agent has accepted appointment as Collateral Agent by the date that is 30 days following a retiring Collateral Agent&#8217;s notice of resignation or the Administrative Agent&#8217;s receipt of a notice of removal, the retiring Collateral Agent (after consultation with the Company) may appoint a financial institution rated at least &#8216;A&#8217; by S&#38;P or &#8216;A&#8217; by Moody&#8217;s, as a successor collateral agent, whereupon such successor collateral agent shall succeed to the rights, powers and duties of the Collateral Agent and the term &#8220;Collateral Agent&#8221; shall mean such successor collateral agent effective upon such appointment, and the former Collateral Agent&#8217;s rights, powers and duties as Collateral Agent shall be terminated, without any other or further act or deed on the part of such former Collateral Agent or any of the parties to this Agreement or any holders of the Loans. After any retiring Collateral Agent&#8217;s resignation or removal as Collateral Agent, the provisions of this Section 9 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Collateral Agent under this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Any resignation by Barclays Bank PLC as Administrative Agent pursuant to this Section 9.9 shall also constitute its resignation as the L&#47;C Administrator. Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, (a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the L&#47;C Administrator, (b) the retiring L&#47;C Administrator shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents, and (c) the successor L&#47;C Administrator shall issue letters of credit in substitution for the Several Letters of Credit, if any, outstanding at the time of such succession or make</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">71</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other arrangements satisfactory to the retiring L&#47;C Administrator to effectively assume the obligations of the retiring L&#47;C Administrator with respect to such Several Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Security Document Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Agents, the Lenders, the Issuing Lenders and the Custodian expressly acknowledge and agree that the Security Documents may be enforced only by the action of the Collateral Agent acting upon the instructions of the Required Lenders or the Administrative Agent and that no other such Person shall have any right individually to seek to enforce or to enforce the Security Documents or to realize upon the security to be granted thereby, it being understood and agreed that such rights and remedies may be exercised by the Collateral Agent for the benefit of such Persons upon the terms of the Security Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Agents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Syndication Agent and the Co-Documentation Agents shall not have any duties or responsibilities hereunder in such capacity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Lender and each L&#47;C Issuer (and each Participant of any of the foregoing, by its acceptance of a Participation) hereby acknowledges and agrees that if the Administrative Agent notifies such Lender or L&#47;C Issuer that the Administrative Agent has determined in its sole discretion that any funds (or any portion thereof) received by such Lender or L&#47;C Issuer (any of the foregoing, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Recipient</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) from the Administrative Agent (or any of its Affiliates) were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Payment Recipient (whether or not known to such Payment Recipient) (whether as a payment, prepayment or repayment of principal, interest, fees or otherwise&#59; individually and collectively, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) and demands the return of such Payment, such Payment Recipient shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Payment as to which such a demand was made. A notice of the Administrative Agent to any Payment Recipient under this Section shall be conclusive, absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Without limitation of clause (a) above, each Payment Recipient further acknowledges and agrees that if such Payment Recipient receives a Payment from the Administrative Agent (or any of its Affiliates) (x) that is in an amount, or on a date different from the amount and&#47;or date specified in a notice of payment sent by the Administrative Agent (or any of its Affiliates) with respect to such Payment (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), (y) that was not preceded or accompanied by a Payment Notice, or (z) that such Payment Recipient otherwise becomes aware was transmitted, or received, in error or by mistake (in whole or in part), in each case, it understands and agrees at the time of receipt of such Payment that an error has been made (and that it is deemed to have knowledge of such error) with respect to such Payment. Each Payment Recipient agrees that, in each such case, it shall promptly notify the Administrative Agent of such occurrence and, upon demand from the Administrative Agent, it shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Payment (or portion thereof) as to which such a demand was made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Any Payment required to be returned by a Payment Recipient under this Section shall be made in same day funds in the currency so received, together with interest thereon in respect of each day from and including the date such Payment (or portion thereof) was received by such Payment Recipient to the date such amount is repaid to the Administrative Agent at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect. Each Payment Recipient hereby agrees that it shall not assert and, to the fullest extent permitted by applicable law, hereby waives, any right to retain such Payment, and any claim, counterclaim, defense or right of set-off or recoupment or similar right to any demand by</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">72</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Administrative Agent for the return of any Payment received, including without limitation any defense based on &#8220;discharge for value&#8221; or any similar doctrine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Borrowers hereby agree that (x) in the event an erroneous Payment (or portion thereof) is not recovered from any Lender that has received such Payment (or portion thereof) for any reason, the Administrative Agent shall be subrogated to all the rights of such Lender with respect to such amount and (y) an erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by any Borrower except, in each case, to the extent such erroneous Payment is, and with respect to the amount of such erroneous Payment that is, comprised of funds of any Borrower.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certain ERISA Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and each Joint Lead Arranger and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrowers, that at least one of the following is and will be true&#58;</font></div><div style="margin-bottom:12pt;text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;such Lender is not using &#8220;plan assets&#8221; (within the meaning of Section 3(42) of ERISA, or otherwise) of one or more Benefit Plans in connection with the Loans, the Letters of Credit or the Commitments&#59;</font></div><div style="margin-bottom:12pt;text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In addition, unless sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or such Lender has provided another representation, warranty and covenant as provided in sub-clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent, and each Joint Lead Arranger and their respective</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">73</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrowers, that none of the Administrative Agent, or any Joint Lead Arranger or any of their respective Affiliates is a fiduciary with respect to the Collateral or the assets of such Lender (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related to hereto or thereto).</font></div><div style="margin-bottom:24pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Administrative Agent, and each Joint Lead Arranger hereby informs the Lenders that each such Person is not undertaking to provide investment advice or to give advice in a fiduciary capacity, in connection with the transactions contemplated hereby, and that such Person has a financial interest in the transactions contemplated hereby in that such Person or an Affiliate thereof (i) may receive interest or other payments with respect to the Loans, the Letters of Credit, the Commitments, this Agreement and any other Loan Document (ii) may recognize a gain if it extended the Loans, the Letters of Credit or the Commitments for an amount less than the amount being paid for an interest in the Loans, the Letters of Credit or the Commitments by such Lender or (iii) may receive fees or other payments in connection with the transactions contemplated hereby, the Loan Documents or otherwise, including structuring fees, commitment fees, arrangement fees, facility fees, upfront fees, underwriting fees, ticking fees, agency fees, administrative agent or collateral agent fees, utilization fees, minimum usage fees, letter of credit fees, fronting fees, deal-away or alternate transaction fees, amendment fees, processing fees, term out premiums, banker&#8217;s acceptance fees, breakage or other early termination fees or fees similar to the foregoing.</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 10&#160;&#160;GUARANTEE</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) To induce the Lenders to execute and deliver this Agreement and to make the Loans and issue or participate in the Letters of Credit, and in consideration thereof, the Company hereby unconditionally and irrevocably guarantees to the Administrative Agent, for the ratable benefit of the Lenders and their respective successors, indorsees and assigns, the prompt and complete payment and performance when due (whether at the stated maturity, by acceleration or otherwise) of the Obligations of the Subsidiary Borrowers, and the Company further agrees to pay the expenses which may be paid or incurred by the Administrative Agent or the Lenders in collecting any or all of the Obligations and&#47;or enforcing any rights under this Section 10.1 or under the Obligations in accordance with this Section 10.1. The guarantee contained in this Section 10.1 shall remain in full force and effect and be binding in accordance with and to the extent of its terms upon the Company and the successors and assigns thereof, and shall inure to the benefit of the Lenders and their successors and permitted assigns, until the Obligations shall have been satisfied in full and the Loans shall be terminated.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Anything herein to the contrary notwithstanding, the maximum liability of the Company hereunder shall in no event exceed the amount which can be guaranteed by the Company under applicable federal and state laws relating to the insolvency of debtors.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Company agrees to the extent permitted by applicable law that the Obligations may at any time and from time to time exceed the amount of the liability of the Company hereunder without impairing the guarantee contained in this Section 10 or affecting the rights and remedies of the Administrative Agent or any Lender hereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The guarantee contained in this Section 10 shall remain in full force and effect until all the Obligations and the obligations of the Company under the guarantee contained in this Section 10 shall have been satisfied by payment in full, all Letters of Credit shall have expired or been terminated and the Commitments shall be terminated, notwithstanding that from time to time during the term of this Agreement the Borrowers may be free from any Obligations.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">74</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;No payment made by any Borrower, the Company or any other Person or received or collected by the Administrative Agent or any Lender from any Borrower, the Company or any other Person by virtue of any action or proceeding or any set-off or appropriation or application at any time or from time to time in reduction of or in payment of the Obligations shall be deemed to modify, reduce, release or otherwise affect the liability of the Company hereunder which shall, notwithstanding any such payment (other than any payment made by the Company in respect of the Obligations or any payment received or collected from the Company in respect of the Obligations), remain liable for the Obligations until the Obligations are paid in full and the Commitments are terminated.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Subrogation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any payment made by the Company hereunder or any set-off or application of funds of the Company by the Administrative Agent or any Lender, the Company shall not be entitled to be subrogated to any of the rights of the Administrative Agent or any Lender against any Borrower or any collateral security or guarantee or right of offset held by the Administrative Agent or any Lender for the payment of the Obligations, nor shall the Company seek or be entitled to seek any contribution or reimbursement from any Borrower in respect of payments made by the Company hereunder, until all amounts owing to the Administrative Agent and the Lenders by any Borrower on account of the Obligations are paid in full, and Letters of Credit shall have expired or been terminated and the Commitments are terminated. If any amount shall be paid to the Company on account of such subrogation rights at any time when all of the Obligations shall not have been paid in full, such amount shall be held by the Company in trust for the Administrative Agent and the Lenders, segregated from other funds of the Company, and shall, forthwith upon receipt by the Company, be turned over to the Administrative Agent in the exact form received by the Company (duly indorsed by the Company to the Administrative Agent, if required), to be applied against the Obligations, whether matured or unmatured, in such order as the Administrative Agent may determine.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments, etc, with respect to the Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company shall remain obligated hereunder notwithstanding that, without any reservation of rights against the Company and without notice to or further assent by the Company, any demand for payment of any of the Obligations made by the Administrative Agent or any Lender may be rescinded by the Administrative Agent or such Lender and any of the Obligations continued, and the Obligations, or the liability of any other Person upon or for any part thereof, or any collateral security or guarantee therefor or right of offset with respect thereto, may, from time to time, in whole or in part, be renewed, extended, amended, modified, accelerated, compromised, waived, surrendered or released by the Administrative Agent or any Lender, and this Agreement and the Notes and any other documents executed and delivered in connection therewith may be amended, modified, supplemented or terminated, in whole or in part, as the Administrative Agent (or the Required Lenders or all Lenders, as the case may be) may deem advisable from time to time, and any collateral security, guarantee or right of offset at any time held by the Administrative Agent or any Lender for the payment of the Obligations may be sold, exchanged, waived, surrendered or released. Neither the Administrative Agent nor any Lender shall have any obligation to protect, secure, perfect or insure any Lien at any time held by it as security for the Obligations or for the guarantee contained in this Section 10 or any property subject thereto.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantee Absolute and Unconditional</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company waives any and all notice of the creation, renewal, extension or accrual of any of the Obligations and notice of or proof of reliance by the Administrative Agent or any Lender upon the guarantee contained in this Section 10 or acceptance of the guarantee contained in this Section 10&#59; the Obligations, and any of them, shall conclusively be deemed to have been created, contracted or incurred, or renewed, extended, amended or waived, in reliance upon the guarantee contained in this Section 10&#59; and all dealings between the Borrowers and the Company, on the one hand, and the Administrative Agent and the Lenders, on the other hand, likewise shall be conclusively presumed to have been had or consummated in reliance upon the guarantee contained in this Section 10. The Company waives diligence, presentment, protest, demand for payment</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">75</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and notice of default or nonpayment to or upon any Borrower or the Company with respect to the Obligations. The Company understands and agrees that the guarantee contained in this Section 10 shall be construed as a continuing, absolute and unconditional guarantee of payment without regard to (a) the validity or enforceability of this Agreement or any Note, any of the Obligations or any other collateral security therefor or guarantee or right of offset with respect thereto at any time or from time to time held by the Administrative Agent or any Lender, (b) any defense, set-off or counterclaim (other than a defense of payment or performance) which may at any time be available to or be asserted by any Borrower or any other Person against the Administrative Agent or any Lender (including but not limited to any defense relating to any law, regulation, decree or order of any jurisdiction, or any other event, affecting any term of any Obligation), or (c) any other circumstance whatsoever (with or without notice to or knowledge of the Borrowers or the Company) which constitutes, or might be construed to constitute, an equitable or legal discharge of the Borrowers for the Obligations, or of the Company under the guarantee contained in this Section 10, in bankruptcy or in any other instance. When making any demand hereunder or otherwise pursuing its rights and remedies hereunder against the Company, the Administrative Agent or any Lender may, but shall be under no obligation to, make a similar demand on or otherwise pursue such rights and remedies as it may have against any Borrower, or any other Person or against any collateral security or guarantee for the Obligations or any right of offset with respect thereto, and any failure by the Administrative Agent or any Lender to make any such demand, to pursue such other rights or remedies or to collect any payments from the Borrowers, or any other Person or to realize upon any such collateral security or guarantee or to exercise any such right of offset, or any release of any Borrower, or any other Person or any such collateral security, guarantee or right of offset, shall not relieve the Company of any obligation or liability hereunder, and shall not impair or affect the rights and remedies, whether express, implied or available as a matter of law, of the Administrative Agent or any Lender against the Company. For the purposes hereof &#8220;demand&#8221; shall include the commencement and continuance of any legal proceedings.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reinstatement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guarantee contained in this Section 10 shall continue to be effective, or be reinstated, as the case may be, if at any time payment, or any part thereof, of any of the Obligations is rescinded or must otherwise be restored or returned by the Administrative Agent or any Lender upon the insolvency, bankruptcy, dissolution, liquidation or reorganization of any Borrower or the Company, or upon or as a result of the appointment of a receiver, intervenor or conservator of, or trustee or similar officer for, any Borrower or the Company or any substantial part of its property, or otherwise, all as though such payments had not been made.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company hereby guarantees that payments hereunder will be paid to the Administrative Agent without set-off or counterclaim in the applicable currency at the Funding Office.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Independent Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The obligations of the Company under the guarantee contained in this Section 10 are independent of the obligations of the Borrowers, and a separate action or actions may be brought and prosecuted against the Company whether or not any Borrower is joined in any such action or actions. The Company waives, to the fullest extent permitted by law, the benefit of any statute of limitations affecting its liability hereunder or the enforcement thereof.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 11&#160;&#160;MISCELLANEOUS</font></div><div style="margin-bottom:9pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments and Waivers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. None of this Agreement, any other Loan Document, or any terms hereof or thereof may be amended, supplemented or modified except in accordance with the provisions of this Section 11.1. The Required Lenders and each Borrower which is a party to the relevant Loan Document may, or, with the written consent of the Required Lenders, the Administrative Agent or, as the case may be, the Collateral Agent, and each Borrower which is a party to the relevant Loan</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">76</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Document may, from time to time, (a) enter into written amendments, supplements or modifications hereto and to the other Loan Documents for the purpose of adding any provisions to this Agreement or the other Loan Documents or changing in any manner the rights of the Lenders or the Agents or of the Borrowers hereunder or thereunder or (b) waive, on such terms and conditions as the Required Lenders or the Administrative Agent or the Collateral Agent, as the case may be, may specify in such instrument, any of the requirements of this Agreement or the other Loan Documents or any Default or Event of Default and its consequences&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no such waiver and no such amendment, supplement or modification shall (i) forgive the principal amount or extend the final scheduled date of maturity of any Loan, reduce the stated rate of any interest or fee payable hereunder (except (x) in connection with the waiver of applicability of any post-default increase in interest rates and (y) that any amendment or modification of defined terms used in the financial covenants in this Agreement shall not constitute a reduction in the rate of interest or fees for purposes of this clause (i)) or extend the scheduled date of any payment thereof, or increase the amount or extend the expiration date of any Lender&#8217;s Commitment, in each case without the written consent of each Lender directly affected thereby&#59; (ii) eliminate or reduce the voting rights of any Lender under this Section 11.1 without the written consent of such Lender&#59; (iii) reduce any percentage specified in the definition of Required Lenders, consent to the assignment or transfer by the Company of any of its rights and obligations under this Agreement and the other Loan Documents, release the Company from any of its obligations under Section 10 with respect to any Borrower which has any then outstanding Obligations, amend, modify or waive any provision of Section 5.2(c), or release all or substantially all of the Collateral (other than when permitted under the Loan Documents) or release all or substantially all of the Borrowers from their obligations under the Security Documents, in each case without the written consent of all Lenders&#59; (iv) amend, modify or waive any provision of Section 11.7 without the written consent of all Lenders&#59; (v) amend, modify or waive any provision of Section 2.11(a) or (b) without the written consent of all Lenders&#59; (vi) amend, modify or waive any provision of Section 9 without the written consent of the Administrative Agent and the Collateral Agent&#59; (vii) amend, modify or waive any provision of Section 3 in any manner that is adverse to the interests of any Issuing Lender or the L&#47;C Administrator without the written consent of such Issuing Lender and&#47;or L&#47;C Administrator&#59; (viii) amend, modify or waive any provision of Section 2.17, without the consent of each of the Administrative Agent, each Issuing Lender and the L&#47;C Administrator&#59; or (ix) amend or modify (1) the definition of &#8220;Borrowing Base&#8221; or any defined terms used in such definition or (2) the provisions of any Loan Document with respect to minimum Collateral requirements, in each case, without the written consent of all Lenders. Any such waiver and any such amendment, supplement or modification shall apply equally to each of the Lenders and shall be binding upon the Borrowers, the Lenders, the Administrative Agent, the Collateral Agent and all future holders of the Loans. In the case of any waiver, the Borrowers, the Lenders, the Administrative Agent and the Collateral Agent shall be restored to their former position and rights hereunder and under the other Loan Documents, and any Default or Event of Default waived shall be deemed to be cured and not continuing&#59; but no such waiver shall extend to any subsequent or other Default or Event of Default, or impair any right consequent thereon. Notwithstanding anything herein to the contrary, the Collateral Agent (solely in such capacity) shall agree to any amendments, supplements, modifications or waivers as expressly directed by the Administrative Agent, provided that the Collateral Agent need not agree to any such amendment, supplement, modification or waiver that shall affect its rights or duties.</font></div><div style="text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All notices, requests and demands to or upon the respective parties hereto to be effective shall be in writing (including by telecopy), and, unless otherwise expressly provided herein, shall be deemed to have been duly given or made when delivered, or three Business Days after being deposited in the mail, postage prepaid, or, in the case of telecopy notice, when received, addressed as follows in the case of the Borrowers, the Administrative Agent and the Collateral Agent, and as set forth in an administrative questionnaire delivered to the Administrative Agent in the case of the Issuing Lenders and the Lenders, or to such other address as may be hereafter notified by the respective parties hereto&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">77</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.230%"><tr><td style="width:1.0%"></td><td style="width:5.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, the Borrower <br>Representative or any <br>Borrower&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited 141 Front Street</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton HM 19 Bermuda</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Mark Pickering</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telecopy&#58; 441.297.9235</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telephone&#58; 441.295.8201</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative Agent&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nick Sibayan</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">745 Seventh Avenue, 8th Floor New York, NY 10019</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telecopy&#58; 212.526.5115</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telephone&#58; 212.526.9531</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with a copy to&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matt Santangelo</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">400 Jefferson Park</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whippany, NJ 07981</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telephone&#58; 201.499.2903</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WSO Address&#58; </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">12145455230&#64;tls.ldsprod.com</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collateral Agent&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Bank of New York Mellon 500 Ross Street, 12th Floor Pittsburgh, PA 15262</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Daniel Rhoades Telecopy&#58; 732.667.9536 Telephone&#58; 412.236.8468</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that any notice, request or demand to or upon the Company, the Administrative Agent, the Collateral Agent or the Lenders shall not be effective until received.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notices and other communications to the Lenders hereunder may be delivered or furnished by electronic communications pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to notices pursuant to Section 2 unless otherwise agreed by the Administrative Agent and the applicable Lender. The Administrative Agent or any Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Waiver&#59; Cumulative Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No failure to exercise and no delay in exercising, on the part of the Administrative Agent, the Collateral Agent or any Lender, any right, remedy, power or privilege hereunder or under the other Loan Documents shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All representations and warranties made hereunder, in the other Loan Documents and in any document, certificate or statement delivered</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">78</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pursuant hereto or in connection herewith shall survive the execution and delivery of this Agreement and the making of the Loans and other extensions of credit hereunder.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Expenses and Taxes&#59; Indemnification&#59; Limitation of Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Payment of Expenses and Taxes&#58; The Company agrees (i) to pay or reimburse the Administrative Agent, the Syndication Agent and the Collateral Agent for all its reasonable and documented or invoiced out-of-pocket costs and expenses incurred in connection with the development, preparation and execution of, and any amendment, supplement or modification to, this Agreement and the other Loan Documents and any other documents prepared in connection herewith or therewith, and the consummation and administration of the transactions contemplated hereby and thereby, including the reasonable and documented or invoiced fees and disbursements of a single counsel to each of (x) the Administrative Agent and the Syndication Agent and (y) the Collateral Agent, and such other special or local counsel as the Administrative Agent may deem reasonably necessary (and any additional counsel in the case of a conflict) and filing and recording fees and expenses, with statements with respect to the foregoing to be submitted to the Company prior to the Closing Date (in the case of amounts to be paid on the Closing Date) and from time to time thereafter on a quarterly basis or such other periodic basis as the Administrative Agent, the Syndication Agent and the Collateral Agent shall deem appropriate, (ii) to pay or reimburse each Lender, the Administrative Agent, the Syndication Agent and the Collateral Agent for all its reasonable and documented or invoiced costs and expenses incurred in connection with the enforcement or preservation of any rights under this Agreement, the other Loan Documents and any such other documents, including the fees and disbursements of a single counsel to each of (x) the Administrative Agent and the Lenders and (y) the Collateral Agent, and such other special or local counsel as the Administrative Agent may deem reasonably necessary (and any additional counsel in the case of a conflict), (iii) to pay, indemnify, and hold each Lender, the Administrative Agent and the Collateral Agent harmless from, any and all recording and filing fees and any and all liabilities with respect to, or resulting from any delay in paying stamp, excise and other similar taxes, if any, that may be payable or determined to be payable in connection with the execution and delivery of, or consummation or administration of any of the transactions contemplated by, or any amendment, supplement or modification of, or any waiver or consent under or in respect of, this Agreement, the other Loan Documents and any such other documents,</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Indemnity&#58; The Company agrees to pay, indemnify, and hold each Lender, any L&#47;C Issuer, the Administrative Agent and the Collateral Agent and their respective officers, directors, employees, advisors, affiliates and agents (each, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) harmless from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever (whether brought by a Borrower or any other Person) with respect to the execution, delivery, enforcement, performance and administration of this Agreement, the other Loan Documents or Letters of Credit and any such other documents, including any of the foregoing relating to the use of proceeds of the Loans or Letters of Credit (including any refusal by any L&#47;C Issuer to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit) or the violation of, noncompliance with or liability under, any Environmental Law applicable to the operations of any Group Member or any of the Properties (provided that such liability was incurred during such time as a Group Member controlled such Properties) and the reasonable documented or invoiced fees and expenses of legal counsel in connection with claims, actions or proceedings by any Indemnitee against any Borrower under any Loan Document or Letter of Credit or any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by the Company, and regardless of whether any Indemnitee is a party thereto (all the foregoing in this clause (b), collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnified Liabilities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Company shall have no obligation hereunder to any Indemnitee with respect to Indemnified</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities to the extent such Indemnified Liabilities are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from the gross negligence or willful misconduct of such Indemnitee or its affiliates. Without limiting the foregoing, and to the extent permitted by applicable law, the Company agrees not to assert and to cause its Subsidiaries not to assert, and hereby waives and agrees to cause its Subsidiaries to waive, all rights for contribution from any Indemnitee or any other rights of recovery from any Indemnitee with respect to all claims, demands, penalties, fines, liabilities, settlements, damages, costs and expenses of whatever kind or nature, under or related to Environmental Laws, that any of them might have by statute or otherwise against any Indemnitee. All amounts due under this Section 11.5 shall be payable not later than 10 Business Days after written demand therefor and shall be accompanied by a statement setting forth in reasonable detail the source of such Indemnified Liability and the amount claimed thereunder. Statements payable by the Company pursuant to this Section 11.5 shall be submitted to the Company, at the address of the Company set forth in Section 11.2, or to such other Person or address as may be hereafter designated by the Company in a written notice to the Administrative Agent. The agreements in this Section 11.5 shall survive repayment of the Loans and all other amounts payable hereunder. Paragraph (b) of this Section shall not apply with respect to Taxes other than any Taxes that represent losses, claims, damages, etc. arising from any non-Tax claim.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Limitation of Liability&#58; The Borrowers agree, to the extent permitted by applicable law, that they shall not assert, and hereby waive, any claim against any Lender, any L&#47;C Issuer, the Administrative Agent and the Collateral Agent and their respective officers, directors, employees, advisors, affiliates and agents (each, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lender-Related Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for any losses, claims (including intraparty claims), demands, damages or liabilities of any kind arising from the use by others of information or other materials (including, without limitation, any personal data) obtained through telecommunications, electronic or other information transmission systems (including the Internet). The Borrowers agree they shall not assert, and each such party hereby waives, any losses, claims (including intraparty claims), demands, damages or liabilities of any kind against any other party hereto, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any other Loan Document, or any agreement or instrument contemplated hereby or thereby, any Loan or Letter of Credit or the use of the proceeds thereof&#59; provided that, nothing in this Section 11.5(c) shall relieve the Borrowers of any obligation it may have to indemnify an Indemnitee, as provided in Section 11.5(b), against any special, indirect, consequential or punitive damages asserted against such Indemnitee by a third party</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns&#59; Participations and Assignments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (a) The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby (including any affiliate of any Issuing Lender that issues any Letter of Credit), except that (i) no Borrower may assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender (and any attempted assignment or transfer by any Borrower without such consent shall be null and void) and (ii) no Lender may assign or otherwise transfer its rights or obligations hereunder except in accordance with this Section.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;(i) Subject to the conditions set forth in paragraph (b)(ii) below, any Lender may assign to one or more assignees (each, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans at the time owing to it) with the prior written consent (such consent not to be unreasonably withheld or delayed) of&#58;</font></div><div style="margin-bottom:12pt;padding-left:63pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the Company, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no consent of the Company shall be required for an assignment (1) to a Lender, an Affiliate of a Lender or an Approved Fund (as defined below) or (2) if an Event of Default has occurred and is continuing&#59;</font></div><div style="margin-bottom:12pt;padding-left:63pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the Administrative Agent&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">80</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:63pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;the Issuing Lenders.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Assignments shall be subject to the following additional conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:63pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;except in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund or an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitments or Loans, the amount of the Commitments or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than $5,000,000 unless each of the Company and the Administrative Agent otherwise consent, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such amounts shall be aggregated in respect of each Lender and its Affiliates or Approved Funds, if any&#59;</font></div><div style="margin-bottom:12pt;padding-left:63pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $3,500&#59;</font></div><div style="margin-bottom:12pt;padding-left:63pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;the Assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an administrative questionnaire&#59; and</font></div><div style="margin-bottom:12pt;padding-left:63pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;no such assignment shall be made to (I) a Borrower or an Affiliate or Subsidiary of a Borrower, (II) any Defaulting Lender or any of its Subsidiaries, or any Person who, upon becoming a Lender hereunder, would constitute any of the foregoing Persons described in this subclause (II), (III) a natural person, (IV) any Person which is a Non-NAIC Approved Bank (unless such Non-NAIC Approved Bank shall have in effect a Limited Fronting Lender Agreement with a Lender which is a NAIC Approved Bank) or (V) any business that competes directly with the Company in providing insurance or reinsurance products and is identified in writing by the Company to the Administrative Agent from time to time or any of such direct competitor&#8217;s Affiliates that are clearly identifiable on the basis of such Affiliate&#8217;s name.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this Section 11.6, the term &#8220;Approved Fund&#8221; has the following meaning&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means any Person (other than a natural person) that is engaged in making, purchasing, holding or investing in bank loans and similar extensions of credit in the ordinary course of its business and that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Subject to acceptance and recording thereof pursuant to paragraph (b)(iv) below, from and after the effective date specified in each Assignment and Assumption the Assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.12, 2.13, 2.14 and 11.5). Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this Section 11.6 shall be</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">81</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (c) of this Section.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;The Administrative Agent, acting for this purpose as an agent of the Borrowers, shall maintain at one of its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amount (and stated interest) of the Loans and L&#47;C Obligations owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The entries in the Register shall be conclusive, and the Borrowers, the Administrative Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the Borrowers and any Lender, at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an Assignee, the Assignee&#8217;s completed administrative questionnaire (unless the Assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b) of this Section and each written consent to such assignment required by paragraph (b) of this Section, the Administrative Agent shall accept such Assignment and Assumption and record the information contained therein in the Register. No assignment shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;(i) Any Lender may, without the consent of any Borrower, the Company, any Issuing Lender or the Administrative Agent, sell participations to one or more banks or other entities (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in all or a portion of such Lender&#8217;s rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans owing to it)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (A) such Lender&#8217;s obligations under this Agreement shall remain unchanged, (B) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, (C) the Borrowers, the Administrative Agent and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement and (D) no such participation shall be made to (I) a Borrower or an Affiliate or Subsidiary of a Borrower, (II) a natural person or (III) any business that competes directly with the Company in providing insurance or reinsurance products and is identified in writing by the Company to the Administrative Agent from time to time or any of such direct competitor&#8217;s Affiliates that are clearly identifiable on the basis of such Affiliate&#8217;s name. Any agreement pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that such agreement may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver that (1) requires the consent of each Lender directly affected thereby pursuant to the proviso to the second sentence of Section 11.1 and (2) directly affects such Participant. Subject to paragraph (c)(ii) of this Section, each Borrower agrees that each Participant shall be entitled to the benefits of, and subject to the limitations of, Sections 2.12, 2.13, 2.14 to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of this Section (it being understood that the documentation required under Section 2.13 shall be delivered to the participating Lender). To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 11.8 as though it were a Lender, provided such Participant shall be subject to Section 11.7 as though it were a Lender.</font></div><div style="padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;A Participant shall not be entitled to receive any greater payment under Section 2.12 or 2.13 than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">82</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made with the Company&#8217;s prior written consent. Any Participant that is a Non-U.S. Lender shall not be entitled to the benefits of Section 2.13 unless such Participant complies with Section 2.13(e).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Each Lender that sells a participation, acting solely for this purpose as a non-fiduciary agent (solely for tax purposes) of the Borrowers, shall maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant's interest in the Loans and other obligations under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The entries in the Participant Register shall be conclusive, and such Lender, each Borrower and the Administrative Agent shall treat each person whose name is recorded in the Participant Register pursuant to the terms hereof as the owner of such participation for all purposes of this Agreement, notwithstanding notice to the contrary.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding anything else provided herein or otherwise, no Lender shall have any obligation to disclose all or any portion of the Participant Register to any Borrower or any other Person (including the identity of any Participant or any information relating to a Participant's interest in the Loans or other obligations under this Agreement or any other Loan Document) except to the extent such disclosure is necessary to establish that the Loans or such other obligations are in registered form under Section 5f.103-1(c) of the United States Treasury Regulations, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that any Participant shall only be entitled to the benefits of this Section 11.6(c) if the identity of such Participant has been disclosed to the Company.</font></div><div style="margin-bottom:12pt;text-indent:62.86pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Any Lender may at any time pledge or grant a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or grant to secure obligations to a Federal Reserve Bank, and this Section shall not apply to any such pledge or grant of a security interest&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no such pledge or grant of a security interest shall release such Lender from any of its obligations hereunder or substitute any such pledgee or grantee for such Lender as a party hereto and, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that nothing in this paragraph (d) shall be deemed to limit in any way the application of Section 11.6(b) to any assignment of the rights or obligations of such Lender under this Agreement resulting from a foreclosure of any such pledge or security interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.86pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Each Borrower, upon receipt of written notice from the relevant Lender, agrees to issue Notes to any Lender requiring Notes to facilitate transactions of the type described in paragraph (d) above.</font></div><div style="margin-bottom:10pt;text-indent:62.86pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except to the extent that this Agreement expressly provides for payments to be allocated to a particular Lender or to the Lenders, if any Lender (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Benefitted Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall receive any payment of all or part of the Obligations owing to it (whether directly from the Borrower, indirectly as a result of payment under the guarantee provided for in Section 10 or from the proceeds of the exercise of any remedies with respect to the Collateral pursuant to the Security Documents or otherwise), or receive any collateral in respect thereof (whether voluntarily or involuntarily, by set-off, pursuant to events or proceedings of the nature referred to in Section 8(f), or otherwise), in a greater proportion than any such payment to or collateral received by any other Lender, if any, in respect of the Obligations owing to such other Lender, such Benefitted Lender shall purchase for cash from the other Lenders a participating interest in such portion of the Obligations owing to each such other Lender, or shall provide such other Lenders with the benefits of any such collateral, as shall be necessary to cause such Benefitted Lender to share the excess payment or benefits of such collateral ratably with each of the Lenders&#59; provided, however, that if all or any portion of such excess payment or benefits is thereafter recovered from such Benefitted Lender, such purchase shall be rescinded, and the purchase price and benefits returned, to the extent of such recovery, but without interest.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">83</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Set-off</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the occurrence and continuation of an Event of Default, in addition to any rights and remedies of the Lenders provided by law, each Lender shall have the right, without prior notice to any Borrower, any such notice being expressly waived by each Borrower to the extent permitted by applicable law, upon any amount becoming due and payable by any Borrower hereunder (whether at the stated maturity, by acceleration or otherwise), to set off and appropriate and apply against such amount any and all deposits (general or special, time or demand, provisional or final), in any currency, and any other credits, indebtedness or claims, in any currency, in each case whether direct or indirect, absolute or contingent, matured or unmatured, at any time held or owing by such Lender or any branch or agency thereof to or for the credit or the account of such Borrower, as the case may be, or of the Company. Each Lender agrees promptly to notify the Company and the Administrative Agent after any such setoff and application made by such Lender, provided that the failure to give such notice shall not affect the validity of such setoff and application.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts&#59; Electronic Execution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;This Agreement may be executed by one or more of the parties to this Agreement on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Agreement by facsimile or other electronic transmission shall be effective as delivery of a manually executed counterpart hereof. A set of the copies of this Agreement signed by all the parties shall be lodged with the Company and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Delivery of an executed counterpart of a signature page of (x) this Agreement, (y) any other Loan Document and&#47;or (z) any other document related to this Agreement, any other Loan Document and&#47;or the transactions contemplated hereby and&#47;or thereby that is an Electronic Signature transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page shall be effective as delivery of a manually executed counterpart of this Agreement, such other Loan Document or such other related document, as applicable. The words &#8220;execution,&#34; &#8220;signed,&#8221; &#8220;signature,&#8221; &#8220;delivery,&#8221; and words of like import in or relating to this Agreement, any other Loan Document and&#47;or any other related document shall be deemed to include Electronic Signatures, deliveries or the keeping of records in any electronic form (including deliveries by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page), each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Integration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement and the other Loan Documents represent the entire agreement of the Borrowers, the Administrative Agent, the Collateral Agent and the Lenders with respect to the subject matter hereof and thereof, and there are no promises, undertakings, representations or warranties by the Administrative Agent, the Collateral Agent or any Lender relative to the subject matter hereof not expressly set forth or referred to herein or in the other Loan Documents.</font></div><div style="text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">84</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEW YORK. THE CHOICE OF GOVERNING LAW HAS BEEN MADE PURSUANT TO SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Submission To Jurisdiction&#59; Waivers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company, each other Borrower, the Administrative Agent, the Collateral Agent and each Lender hereby irrevocably and unconditionally&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;submits for itself and its property in any legal action or proceeding relating to this Agreement and the other Loan Documents to which it is a party, or for recognition and enforcement of any judgment in respect thereof, to the exclusive general jurisdiction of the courts of the State of New York sitting in New York County, the courts of the United States for the Southern District of New York, and appellate courts from any thereof&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that nothing in this Agreement shall affect any right that the Administrative Agent, any Lender or any L&#47;C Issuer may otherwise have to bring any action or proceeding relating to this Agreement or any other Loan Document against the Borrowers or their properties in the courts of any jurisdiction&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;consents that any such action or proceeding may be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to the Borrowers, as the case may be at its address set forth in Section 11.2 or at such other address of which the Administrative Agent shall have been notified pursuant thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;waives, to the maximum extent not prohibited by law, any right it may have to claim or recover in any legal action or proceeding referred to in this Section any special, exemplary, punitive or consequential damages&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, however, that nothing contained in this Section 11.13(e) shall limit the Company&#8217;s, the other Borrowers&#8217; or the Lenders&#8217; indemnity and reimbursement obligations to the extent set forth in any Loan Document in respect of any third- party claims alleging such special, exemplary, punitive or consequential damages.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Process Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company and each other Borrower hereby irrevocably designates, appoints, authorizes and empowers Aspen Insurance U.S. Services Inc. with offices currently located at 400 Capital Boulevard, Suite 200, Rocky Hill, Connecticut, 06067, USA (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Process Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), as its agent to receive on behalf of itself and its property, service of copies of the summons and complaint and any other process which may be served in any suit, action or proceeding brought in the United States District Court for the Southern District of New York or the New York Supreme Court, New York County, and any appellate court thereof. Such service may be made by delivering a copy of such process to the Company and the other relevant Borrowers in care of the Process Agent at its address specified above, with a copy delivered to the Company and the other relevant Borrowers in accordance with Section 11.2, and the Company and each other Borrower hereby authorizes and directs the Process Agent to accept such service on its behalf. The appointment of the Process Agent shall be irrevocable until the appointment of a successor Process Agent. The Company and each other Borrower further agrees to promptly appoint a successor Process Agent in New York City (which shall accept such appointment in form and substance satisfactory to the Administrative Agent) prior to the termination for any reason of the appointment of the initial Process Agent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">85</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency of Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each payment owing by the Company or any other Borrower hereunder shall be made in the relevant currency specified herein or, if not specified herein, specified in any other Loan Document executed by the Administrative Agent or the Collateral Agent (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency of Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) at the place specified herein (such requirements are of the essence of this Agreement). If, for the purpose of obtaining judgment in any court, it is necessary to convert a sum due hereunder in a Currency of Payment into another currency, the parties hereto agree that the rate of exchange used shall be that at which in accordance with normal banking procedures the Administrative Agent could purchase such Currency of Payment with such other currency at the Spot Selling Rate on the Business Day preceding that on which final judgment is given. The obligations in respect of any sum due hereunder to any Lender or any L&#47;C Issuer shall, notwithstanding any adjudication expressed in a currency other than the Currency of Payment, be discharged only to the extent that, on the Business Day following receipt by such Lender or L&#47;C Issuer of any sum adjudged to be so due in such other currency, such Lender or L&#47;C Issuer may, in accordance with normal banking procedures, purchase the Currency of Payment with such other currency. The parties hereto agree that (a) if the amount of the Currency of Payment so purchased is less than the sum originally due to such Lender or L&#47;C Issuer in the Currency of Payment, as a separate obligation and notwithstanding the result of any such adjudication, the Company or such other Borrower, as applicable, shall immediately pay the shortfall (in the Currency of Payment) to such Lender or L&#47;C Issuer and (b) if the amount of the Currency of Payment so purchased exceeds the sum originally due to such Lender or L&#47;C Issuer, such Lender or L&#47;C Issuer shall promptly pay the excess over to the Company or such other Borrower, as applicable, in the currency and to the extent actually received.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Releases of Liens</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) Notwithstanding anything to the contrary contained herein or in any other Loan Document, the Collateral Agent is hereby irrevocably authorized by each Lender (without requirement of notice to or consent of any Lender except as expressly required by Section 11.1) to take any action requested by the Company having the effect of releasing any Collateral (i) to the extent permitted by the Security Agreement and the applicable Collateral Account Control Agreement or that has been consented to in accordance with Section 11.1 or (ii) under the circumstances described in paragraph (b) below.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;At such time as all Letters of Credit shall have expired, been terminated or been fully cash collateralized pursuant to Section 8 and the Commitments have been terminated and no Default or Event of Default has occurred and is continuing, the Collateral (other than any such cash collateral) shall cease to secure the Obligations, the Collateral (other than any such cash collateral) shall be released from the Liens created by the Security Agreement, and the Security Agreement and each Collateral Account Control Agreement and all obligations (other than those expressly stated to survive such termination) of the Administrative Agent, the Collateral Agent and each Borrower under the Security Agreement and each Collateral Account Control Agreement shall terminate, all without delivery of any instrument or performance of any act by any Person.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each of the Administrative Agent, the Collateral Agent and each Lender agrees to keep confidential all non-public information provided to it by any Group Member, the Administrative Agent, the Collateral Agent or any Lender pursuant to or in connection with this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that nothing herein shall prevent the Administrative Agent, the Collateral Agent or any Lender from disclosing any such Information (a) to the Administrative Agent, the Collateral Agent, any other Lender or any affiliate thereof, (b) subject to an agreement to comply with the provisions of this Section, to any actual or prospective Transferee or any actual or prospective counterparty (or its related parties) to any swap, derivative or other transaction under which payments are to be made by reference to any Borrower and its obligations, this Agreement or payments hereunder, (c) to its employees, directors, agents, attorneys, accountants, auditors and other professional advisors or those of any of its affiliates (it being understood that the Persons to whom such disclosure is made will be</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">86</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">informed of the confidential nature of such Information and instructed to keep such Information confidential), (d) upon the request or demand of any Governmental Authority (including any stock exchange or other similar organization or self-regulatory body), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Administrative Agent, the Collateral Agent or any Lender, as the case may be, requests confidential treatment of such Information to the extent practicable and permitted by law, (e) in response to any order of any court or other Governmental Authority or as may otherwise be required pursuant to any Requirement of Law, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Administrative Agent, the Collateral Agent or any Lender, as the case may be, requests confidential treatment of such Information to the extent permitted by law, (f) if requested or required to do so in connection with any litigation or similar proceeding, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (1) the Administrative Agent, the Collateral Agent or any Lender, as the case may be, provides the Company with notice of such event promptly upon obtaining knowledge thereof (provided that the Administrative Agent, the Collateral Agent or any Lender, as the case may be, is not legally prohibited by law from giving such notice) so that the Company may seek a protective order or other appropriate remedy and (2) in the event that such protective order or other remedy is not obtained, the Administrative Agent, the Collateral Agent or any Lender, as the case may be, shall furnish only that portion of the Information that is legally required and shall disclose the Information in a manner reasonably designed to preserve its confidential nature, (g) that has been publicly disclosed other than as a result of (1) disclosure by the Administrative Agent, the Collateral Agent or any Lender in violation of this Agreement or (2) becoming available from a third party which to the knowledge of the Administrative Agent, the Collateral Agent or any Lender, as the case may be, is prohibited from disclosing such information pursuant to a contractual, legal or fiduciary obligation to the Company or a third party, (h) to the National Association of Insurance Commissioners or any similar organization or any nationally recognized rating agency that requires access to information about a Lender&#8217;s investment portfolio in connection with ratings issued with respect to such Lender, or (i) in connection with the exercise of any remedy hereunder or under any other Loan Document.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Several Obligations of Borrowers&#58; Company as Agent of Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. (a) The Obligations of each Borrower shall be several in nature.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Each Borrower irrevocably appoints the Company as its agent for all purposes relevant to this Agreement and each of the other Loan Documents, including (i) the giving and receipt of notices and (ii) the execution and delivery of all documents, instruments and certificates contemplated herein and all modifications hereto. Any acknowledgement, consent, direction, certification or other action which might otherwise be valid or effective only if given or taken by all Borrowers, or by each Borrower acting singly, shall be valid and effective if given or taken only by the Company, whether or not any such other Borrower joins therein. Any notice, demand, consent, acknowledgement, direction, certification or other communication delivered to the Company in accordance with the terms of this Agreement shall be deemed to have been delivered to each other Borrower.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.19&#160;&#160;&#160;&#160;&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reserved.&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">WAIVERS OF JURY TRIAL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. THE COMPANY, EACH OTHER BORROWER, THE ADMINISTRATIVE AGENT, THE COLLATERAL AGENT AND THE LENDERS HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVE TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Advisory or Fiduciary Duty</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), the Borrowers acknowledge and agree, and acknowledge their Affiliates&#8217; understanding, that&#58; (a) (i) no fiduciary, advisory or agency relationship between the Borrowers and their respective Subsidiaries and any Agent, any L&#47;C Issuer or any Lender is</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">87</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intended to be or has been created in respect of the transactions contemplated hereby or by the other Loan Documents, irrespective of whether any Agent, any L&#47;C Issuer or any Lender has advised or is advising the Borrower or any Subsidiary on other matters, (ii) the arranging and other services regarding this Agreement provided by the Agents, the L&#47;C Issuers and the Lenders are arm&#8217;s-length commercial transactions between the Borrowers and their Affiliates, on the one hand, and the Agents, the L&#47;C Issuers and the Lenders, on the other hand, (iii) the Borrowers have consulted their own legal, accounting, regulatory and tax advisors to the extent that they have deemed appropriate and (iv) the Borrowers are capable of evaluating, and understand and accept, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents&#59; and (b) (i) the Agents, the L&#47;C Issuers and the Lenders each is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for the Borrowers or any of their Affiliates, or any other Person&#59; (ii) none of the Agents, the L&#47;C Issuers and the Lenders has any obligation to the Borrowers or any of their Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents&#59; and (iii) the Agents, the L&#47;C Issuers and the Lenders and their respective Affiliates may be engaged, for their own accounts or the accounts of customers, in a broad range of transactions that involve interests that differ from those of the Borrowers and their Affiliates, and none of the Agents, the L&#47;C Issuers and the Lenders has any obligation to disclose any of such interests to the Borrowers or their Affiliates. To the fullest extent permitted by law, each Borrower hereby waives and releases any claims that it may have against the Agents, the L&#47;C Issuers and the Lenders with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.22&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">USA Patriot Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Lender hereby notifies each Borrower that pursuant to the requirements of the Patriot Act, it is required to obtain, verify and record information that identifies each Borrower, which information includes the name and address of each such Borrower and other information that will allow such Lender to identify each such Borrower in accordance with the Patriot Act.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.23&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Restatement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement amends and restates and supersedes and replaces the Existing Credit Agreement. The parties hereto acknowledge and agree that (a) this Agreement and the other Loan Documents executed and delivered in connection herewith do not constitute a novation, payment and reborrowing, or termination of the obligations under the Existing Credit Agreement as in effect prior to the date hereof&#59; (b) such obligations are in all respects continuing (as amended and restated and superseded and replaced hereby) with only the terms being modified as provided in this Agreement and in the Loan Documents&#59; (c) the Security Agreement and each Collateral Account Control Agreement, as amended as of the date hereof, remain in full force and effect and are hereby ratified and confirmed&#59; (d) all Liens arising under any Loan Document are continuing and in full force and effect and secure the payment of the Secured Letters of Credit&#59; and (e) upon the effectiveness of this Agreement, all letters of credit outstanding under the Existing Credit Agreement will be deemed to be Letters of Credit hereunder and subject to the terms hereof. The Lenders party hereto (constituting the Required Lenders as defined in the Existing Credit Agreement) hereby authorize and direct the Collateral Agent to enter into this Agreement. On the Closing Date, (i) any new Lender, and any existing Lender whose Commitment Percentage has increased, shall pay to the Administrative Agent such amounts as are necessary to fund its new or increased Commitment Percentage of all existing Loans, and (ii) the Administrative Agent will use the proceeds thereof to pay all existing Lenders whose Commitment Percentage is decreasing such amounts as are necessary so that each Lender&#8217;s share of all Loans will be equal to its adjusted Commitment Percentage.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.24&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">88</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Affected Financial Institution arising under any Loan Document may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the application of any Write-Down and Conversion Powers by an the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution&#59; and</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the effects of any Bail-In Action or any such liability, including, if applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent entity, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 12</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE BORROWER REPRESENTATIVE</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appointment&#58; Nature of Relationship</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is hereby appointed by each of the Borrowers as its contractual representative (herein referred to as the &#8220;Borrower Representative&#8221;) hereunder and under each other Loan Document, and each of the Borrowers irrevocably authorizes the Borrower Representative to act as the contractual representative of such Borrower with the rights and duties expressly set forth herein and in the other Loan Documents. The Borrower Representative agrees to act as such contractual representative upon the express conditions contained in this Section 12. Additionally, each Borrower hereby appoints, to the extent the Borrower Representative requests any Loan on behalf of such Borrower, the Borrower Representative as its agent to receive all of the proceeds of such Loan, at which time the Borrower Representative shall promptly disburse such Loan to such Borrower. Neither the Agents, the Lenders or the Applicable Issuing Parties and their respective officers, directors, agents or employees, shall be liable to the Borrower Representative or any Borrower for any action taken or omitted to be taken by the Borrower Representative or the Borrowers pursuant to this Section 12.1.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Powers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Borrower Representative shall have and may exercise such powers under the Loan Documents as are specifically delegated to the Borrower Representative by the terms of each thereof, together with such powers as are reasonably incidental thereto. The Borrower Representative shall have no implied duties to the Borrowers, or any obligation to the Lenders to take any action thereunder except any action specifically provided by the Loan Documents to be taken by the Borrower Representative.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employment of Agents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Borrower Representative may execute any of its duties as the Borrower Representative hereunder and under any other Loan Document by or through authorized officers.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">89</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any notice provided to the Borrower Representative hereunder shall constitute notice to each Borrower on the date received by the Borrower Representative.</font></div><div style="margin-bottom:12pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Borrower Representative</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the prior written consent of the Administrative Agent, the Borrower Representative may resign at any time, such resignation to be effective upon the appointment of a successor Borrower Representative acceptable to the Administrative Agent. The Administrative Agent shall give notice of such resignation to the Lenders.</font></div><div style="margin-bottom:24pt;text-indent:63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Execution of Loan Documents&#59; Borrowing Base Certificate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Borrowers hereby empower and authorize the Borrower Representative, on behalf of the Borrowers, to execute and deliver to the Agents, the Applicable Issuing Parties and the Lenders the Loan Documents and all related agreements, certificates, documents, or instruments as shall be necessary or appropriate to effect the purposes of the Loan Documents. Each Borrower agrees that any action taken by the Borrower Representative or the Borrowers in accordance with the terms of this Agreement or the other Loan Documents, and the exercise by the Borrower Representative of its powers set forth therein or herein, together with such other powers that are reasonably incidental thereto, shall be binding upon all of the Borrowers.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Pages Follow&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">90</font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_323"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered by their proper and duly authorized officers as of the day and year first above written.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:208.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:167.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED, </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Borrower</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark Pickering</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Mark Pickering</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Group Chief Capital Management Officer &#38; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasurer</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN BERMUDA LIMITED, </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Borrower</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christian Dunleavy</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Christian Dunleavy</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:32pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN INSURANCE UK LIMITED, </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Borrower</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; Chris Jones</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:32pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Name&#58; Chris Jones</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:32pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Title&#58; Director</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN (UK) HOLDINGS LIMITED,</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Borrower</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; Chris Jones</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:32pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Name&#58; Chris Jones</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:32pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Title&#58; Director</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:208.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:167.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN SPECIALTY INSURANCE COMPANY, </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Borrower</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Timothy P. Kenefick</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Name&#58; Timothy P. Kenefick</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Title&#58; Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN U.S. HOLDINGS, INC., </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Borrower</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Timothy P. Kenefick</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Name&#58; Timothy P. Kenefick</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Title&#58; Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN UNDERWRITING LIMITED, </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Borrower</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; Helen Rose</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:32pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Name&#58; Helen Rose</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:32pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Title&#58; Director</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASPEN AMERICAN INSURANCE COMPANY,</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Borrower</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; Timothy P. Kenefick</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Name&#58; Timothy P. Kenefick</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Title&#58; Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC, </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Administrative Agent and a Lender</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; Karla K. Maloof</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Karla K. Maloof</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:137%">Title&#58; Authorized Signatory</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CITIBANK, N.A., </font></div><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Lender</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Maureen Maroney</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Name&#58; Maureen Maroney</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Title&#58; Vice President</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON, </font></div><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Collateral Agent</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#47;s&#47; Glenn G. McKeever</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Name&#58; Glenn G. McKeever</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:20pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Title&#58; Vice President</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HSBC BANK USA, N.A., </font></div><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Lender</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#47;s&#47; Teresa Pereyra</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Name&#58; Teresa Pereyra</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Vice President, Financial Institutions Group, </font></div><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LLOYDS BANK CORPORATE MARKETS PLC, </font></div><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#47;s&#47; Kamala Basdeo</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Name&#58; Kamala Basdeo</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Title&#58; Assistant Vice President</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#47;s&#47; Tina Wong</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:21pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Name&#58; Tina Wong</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:31pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Title&#58; Assistant Vice President</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION, </font></div><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Hanh Huynh</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Hanh Huynh</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:20pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:137%">Title&#58; Vice President</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BANK OF MONTREAL, </font></div><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a Lender</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brij Grewal</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Brij Grewal</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Managing Director</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:208.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:168.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:65.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEUTSCHE BANK AG NEW YORK BRANCH,<br>as a Lender</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; Ming K. Chu</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Ming K. Chu</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:137%">Title&#58; Director</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:137%">&#47;s&#47; Annie Chung</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:137%">Name&#58; Annie Chung</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:137%">Title&#58; Director</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:208.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:168.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:65.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON,<br>as a Lender</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; Kenneth P. Sneider Jr.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Kenneth P. Sneider Jr.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:137%">Title&#58; Director</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-11</font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_352"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ANNEX A</font></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRICING GRID</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:115.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:115.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:115.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:115.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:38pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt Rating</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitment Fee<br>Rate (bps)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eurodollar Loan<br>Applicable Margin<br>(bps)</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ABR Loan Applicable<br>Margin (bps)</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#62;</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-&#47;A3</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#61;BBB+&#47;Baa1</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.0</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#61;BBB&#47;Baa2</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.5</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#61;BBB-&#47;Baa3</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any less favorable rating<br>or no rating</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.0</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;text-indent:63pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the Pricing Grid, &#8220;</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Debt Rating</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as of any date of determination, the long term unsecured senior, non-credit enhanced debt rating of the Company as determined by S&#38;P or Moody&#8217;s, as the case may be, </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that if a Debt Rating is issued by each of S&#38;P and Moody&#8217;s, then the higher of such Debt Ratings shall apply, </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">unless</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> there is a split in Debt Ratings of more than one level, in which case the level that is one level lower than the higher Debt Rating shall apply. The Debt Ratings shall be determined from the most recent public announcement of any changes in the Debt Ratings.</font></div><div style="text-indent:63pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of the Pricing Grid, changes in the Applicable Margin resulting from changes in the Debt Rating shall become effective on the date that is three Business Days after the date on which new ratings are issued by S&#38;P or Moody&#8217;s and shall remain in effect until the next change to be effected pursuant to this paragraph.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_379"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.1</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:232.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:232.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Lender</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays Bank PLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40,500,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank, N.A.</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40,500,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HSBC Bank USA, N.A.</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40,500,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lloyds Bank Corporate Markets plc</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40,500,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wells Fargo Bank, National Association</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40,500,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank of Montreal</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32,500,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deutsche Bank AG New York Branch</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32,500,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Bank of New York Mellon</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32,500,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Total</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$300,000,000</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_406"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 4.13</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUBSIDIARIES</font></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jurisdiction of<br>Incorporation</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ownership</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acorn Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Waters Insurers, Corp.</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Acorn<br>Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Bermuda Limited *</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Capital Management Ltd</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peregrine Reinsurance Ltd</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Capital Management, Ltd</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Cat Fund Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Capital Management, Ltd</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen (UK) Holdings Limited *</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen (US) Holdings Limited</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Capital Advisors Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. - Delaware</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen (US)<br>Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Managing Agency<br>Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Singapore Pte. Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Managing Agency Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Underwriting Limited *</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen European Holdings<br>Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Insurance UK Limited *</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>European Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silverton Re Ltd</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance UK Services<br>Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen (UK)<br>Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AIUK Trustees Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance UK Services<br>Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen UK Syndicate Services<br>Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by 100% owned<br>by Aspen (UK) Holdings<br>Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APJ Asset Protection Jersey<br>Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jersey</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen (UK)<br>Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Risk Management<br>Limited</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen (UK)<br>Holdings Limited</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Recoveries Limited</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen (UK)<br>Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Australia Service<br>Company Pty Limited</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen (UK)<br>Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen U.S. Holdings, Inc. *</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. - Delaware</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen (UK)<br>Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance U.S. Services<br>Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. - Delaware</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen U.S.<br>Holdings, Inc.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Specialty Insurance<br>Company *</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. - North Dakota</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>American Insurance<br>Company</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Re America, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. - Delaware</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen U.S.<br>Holdings, Inc.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Specialty Insurance<br>Solutions, LLC</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. - California</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen U.S.<br>Holdings, Inc.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Specialty Insurance<br>Management, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. - Massachusetts</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen U.S.<br>Holdings, Inc.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen American Insurance<br>Company *</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. - Texas</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen U.S.<br>Holdings, Inc.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Ireland<br>Holdings Limited</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% owned by Aspen<br>Insurance Holdings Limited</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsidiary Borrower</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_62"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.2(b)(iv)</font></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXISTING INDEBTEDNESS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_437"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.5</font></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENTS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_461"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 7.6</font></div><div style="margin-bottom:40pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXISTING LIENS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_486"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPLIANCE CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Compliance Certificate is delivered pursuant to Section 6.2(a) of the Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (as amended, supplemented or modified from time to time), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the Subsidiary Borrowers (as defined therein) (together with the Company, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Several Lenders party thereto, Citibank, N.A., as syndication agent, Barclays Bank PLC, as administrative agent, and the other financial institutions party thereto (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;). Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned hereby certifies to the Administrative Agent and the Lenders as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I am the duly elected, qualified and acting &#91;insert title of Responsible Officer signing the certificate&#93; of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;I have reviewed and am familiar with the contents of this Certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;I have reviewed the terms of the Credit Agreement and the Loan Documents and have made, or caused to be made under my supervision, a review in reasonable detail of the transactions and condition of the Company during the accounting period covered by the financial statements attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Attachment 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Attachment 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are the computations showing compliance with the covenants set forth in Section 7.1 and 7.9 of the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;To the best of my knowledge, during the accounting period covered by the Financial Statements attached hereto, each Borrower has observed or performed all of its covenants and other agreements, and satisfied every condition contained in the Credit Agreement and the other Loan Documents to which it is a party to be observed, performed or satisfied by it &#91;, except as set forth below&#93;.</font></div><div style="margin-bottom:40pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;I have no knowledge of the existence, as of the date of this Certificate, of any condition or event which constitutes a Default or Event of Default &#91;, except as set forth below&#93;.</font></div><div style="margin-bottom:40pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this Compliance Certificate as of the date set forth below&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_1316"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment 1 to Exhibit A</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Attach Financial Statements&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_1295"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment 2 to Exhibit A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Covenant Calculations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth herein is as of __________, 20__ and pertains to the period from _________,</font></div><div style="margin-bottom:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20__ to __________, 20__.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">I.&#160;&#160;Consolidated Leverage Ratio (Section 7.1(a))</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.090%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" rowspan="2" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.&#160;Consolidated Total Debt</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate principal amount of all Indebtedness of the Company and its Subsidiaries at such date, determined on a consolidated basis in accordance with GAAP<font style="font-size:6.5pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font></font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$______</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" rowspan="2" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.&#160;Consolidated Tangible Net Worth&#58;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated stockholders&#8217; equity (including Hybrid Capital) of the Company and its Subsidiaries determined on a consolidated basis as of such date in accordance with GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$______</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated intangible assets of the Company and its Subsidiaries, determined on a consolidated basis as of such date in accordance with GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$______</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Tangible Net Worth&#58; B(a) - B(b)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$______</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Leverage Ratio (clause A(a) divided by the sum of (clause A(a) and clause B(c))</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Leverage Ratio less than or equal to 35%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Yes&#93;&#91;No&#93;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#525252;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#525252;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a conflict between the provisions of this Attachment 2 and the Credit Agreement, the provisions of the Credit Agreement shall control.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excludes&#58; (i) the then aggregate undrawn face amount of all then outstanding letters of credit issued on behalf of, or for the account or benefit of, the Company and&#47;or any of its Subsidiaries, (but the aggregate amount of drawings under such letters of credit that have not then been reimbursed shall not be so excluded), and (ii) the principal amount of any capital instrument entered into in connection with Funds at Lloyd&#8217;s. For the avoidance of doubt, Consolidated Total Debt shall not include Hybrid Capital</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">II.&#160;&#160;Consolidated Tangible Net Worth (Section 7.1(b))</font></div><div style="margin-bottom:60pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" rowspan="2" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.&#160;Consolidated Tangible Net Worth</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See Section l(B)(c) above</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$______</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="18" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.&#160;Minimum Consolidated Tangible Net Worth Base Value</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,019,600,000</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.&#160;Additional Amounts</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25% of Consolidated Net Income during the period from January 1, 2021 to and including such last day of such fiscal quarter (if positive)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$______</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25% of the aggregate Net Cash Proceeds of all issuances by the Company of shares of its Capital Stock during the period from January 1, 2021 to and including such last day of such fiscal quarter</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$______</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Tangible Net Worth Test&#58; Is clause A(a) greater than the sum of (clauses B + C(a) + C(b))&#63;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Yes&#93;&#91;No&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">III.&#160;&#160;Rating (Section 7.9)</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rating of any Relevant Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> may not fall below A.M. Best financial strength rating B++.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiary Borrowers (rated)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">A.M. Best</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Aspen Bermuda Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Insurance UK Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen American Insurance Company</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Specialty Insurance Company&#93;<font style="font-size:6.5pt;position:relative;top:-3.5pt;vertical-align:baseline">4</font></font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#525252;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3</font><font style="color:#525252;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes herein, a &#8220;Relevant Subsidiary&#8221; is any Insurance Subsidiary the total consolidated assets or total consolidated revenues of which exceed 10% of the total consolidated assets or total consolidated revenues, respectively, of the Company and its Subsidiaries at the end of or for, respectively, the then most recently completed fiscal quarter of the Company for which financial statements shall have been made available to the Lenders as required under the Credit Agreement.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be updated as necessary.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_513"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT B-1</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CLOSING CERTIFICATE</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Closing Certificate is delivered pursuant to Section 5.1(c)(i) of the Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein), Barclays Bank PLC, as Administrative Agent, various other agents and various lenders. Unless otherwise defined herein, terms defined in the Credit Agreement shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned &#91;insert title&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company hereby certifies to the Administrative Agent and the Lenders as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The representations and warranties of the Company set forth in each of the Loan Documents to which it is a party or which are contained in any certificate furnished by or on behalf of the Company pursuant to any of the Loan Documents are true and correct in all material respects (or, in the case of any representation and warranty qualified by materiality, in all respects) on and as of the date hereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;No Default or Event of Default has occurred and is continuing as of the date hereof or after giving effect to the Loans or other extensions of credit to be made on the date hereof and the use of proceeds thereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The conditions precedent set forth in Section 5.1(g) of the Credit Agreement were satisfied as of the Closing Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;There are no liquidation or dissolution proceedings pending or to my knowledge threatened against the Company as of the date hereof, nor has any other event occurred adversely affecting or threatening the continued existence of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature follows&#93;</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be signed by a Responsible Officer</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this Closing Certificate as of the date first written above.</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT B-2</font></div><div style="margin-bottom:21pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF CLOSING CERTIFICATE</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Closing Certificate is delivered pursuant to Section 5.1(c)(i) of the Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company, the Subsidiary Borrowers (as defined therein), Barclays Bank PLC, as Administrative Agent, various other agents and various lenders. Unless otherwise defined herein, terms defined in the Credit Agreement shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned Corporate Secretary of &#91;Borrower&#93; (the &#8220;Company&#8221;) certifies as follows&#58;</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annex 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a true, correct and complete copy of certain resolutions duly adopted by the Board of Directors of the Company on ___________, 2021 authorizing the execution, delivery and performance of the Loan Documents to which the Company is a party and the transactions contemplated thereby&#59; such resolutions have not in any way been amended, modified, revoked or rescinded, have been in full force and effect since their adoption to and including the date hereof and are now in full force and effect and are the only corporate proceedings of the Company now in force relating to or affecting the matters referred to therein.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annex 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a true, correct and complete copy of the &#91;Memorandum of Association&#93; &#91;Articles of Incorporation&#93; of the Company as in effect on the date hereof.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annex 3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a true and complete copy of the By-Laws of the Company as in effect on the date hereof.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The persons whose names, titles and signatures appear on the Incumbency Schedule attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annex 4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are authorized representatives of the Company, holding the positions indicated next to their respective names, and the signatures appearing opposite their respective names are the true and genuine signatures of such persons, and each such person is duly authorized to execute and deliver on behalf of the Company each Loan Document to which the Company is a party and any certificate or other document to be delivered by the Company pursuant thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:61pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed the Closing Certificate as of the date first written above.</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.036%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Secretary</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, ___________________, the duly elected _________________ of the Company, hereby certify as of the date first written above that________________is the duly elected Corporate Secretary of the Company and, as such, is authorized to execute this Certificate on behalf of the Company and that the signature appearing above is such person&#8217;s true and genuine signature.</font></div><div style="margin-bottom:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.677%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_541"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ANNEX 1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resolutions</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_568"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ANNEX 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Memorandum of Association&#93; &#91;Articles of Incorporation&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_593"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ANNEX 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By-Laws</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_618"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:45.15pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ANNEX 4</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:26.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incumbency Schedule</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_65"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT C</font></div><div style="margin-bottom:21pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF ASSIGNMENT AND ASSUMPTION</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Assignor identified on Schedule I hereto (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and the Assignee identified on Schedule I hereto (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assignee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) agree as follows&#58;</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Assignor hereby irrevocably sells and assigns to the Assignee without recourse to the Assignor, and the Assignee hereby irrevocably purchases and assumes from the Assignor without recourse to the Assignor, as of the Effective Date (as defined below), the interest described in Schedule 1 hereto (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assigned Interest</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in and to the Assignor's rights and obligations under the Credit Agreement.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Assignor (a) makes no representation or warranty and assumes no responsibility with respect to any statements, warranties or representations made in or in connection with the Credit Agreement or with respect to the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement, any other Loan Document or any other instrument or document furnished pursuant thereto, other than that the Assignor has not created any adverse claim upon the interest being assigned by it hereunder and that such interest is free and clear of any such adverse claim&#59; (b) makes no representation or warranty and assumes no responsibility with respect to the financial condition of the Company, any of its Subsidiaries or any other obligor or the performance or observance by the Company, any of its Subsidiaries or any other obligor of any of their respective obligations under the Credit Agreement or any other Loan Document or any other instrument or document furnished pursuant hereto or thereto&#59; and (c) attaches any Notes held by it evidencing the Assigned Interest and (i) requests that the Administrative Agent, upon request by the Assignee, exchange the attached Notes for a new Note or Notes payable to the Assignee and (ii) if the Assignor has retained any interest in the Credit Agreement, requests that the Administrative Agent exchange the attached Notes for a new Note or Notes payable to the Assignor, in each case in amounts which reflect the assignment being made hereby (and after giving effect to any other assignments which have become effective on the Effective Date).</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The Assignee (a) represents and warrants that it is legally authorized to enter into this Assignment and Assumption&#59; (b) confirms that it has received a copy of the Credit Agreement, together with copies of the financial statements delivered pursuant to Section 6.1 thereof and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment and Assumption&#59; (c) agrees that it will, independently and without reliance upon the Assignor, the Administrative Agent or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement, the other Loan Documents or any other instrument or document furnished pursuant hereto or thereto&#59; (d) appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise such powers and discretion under the Credit Agreement, the</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other Loan Documents or any other instrument or document furnished pursuant hereto or thereto as are delegated to the Administrative Agent by the terms thereof, together with such powers as are incidental thereto&#59; and (e) agrees that it will be bound by the provisions of the Credit Agreement and will perform in accordance with its terms all the obligations which by the terms of the Credit Agreement are required to be performed by it as a Lender including its obligation pursuant to Section 2.13(e) of the Credit Agreement.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The effective date of this Assignment and Assumption shall be the Effective Date of Assignment described in Schedule 1 hereto (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Following the execution of this Assignment and Assumption, it will be delivered to the Administrative Agent for acceptance by it and recording by the Administrative Agent pursuant to the Credit Agreement, effective as of the Effective Date (which shall not, unless otherwise agreed to by the Administrative Agent, be earlier than five Business Days after the date of such acceptance and recording by the Administrative Agent).</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Upon such acceptance and recording, from and after the Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including payments of principal, interest, fees and other amounts) &#91;to the Assignor for amounts which have accrued prior to the Effective Date and to the Assignee for amounts which accrue subsequent to the Effective Date&#93; &#91;to the Assignee whether such amounts have accrued prior to the Effective Date or accrue subsequent to the Effective Date. The Assignor and the Assignee shall make all appropriate adjustments in payments by the Agent for periods prior to the Effective Date or with respect to the making of this assignment directly between themselves.&#93;</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;From and after the Effective Date, (a) the Assignee shall be a party to the Credit Agreement and, to the extent provided in this Assignment and Assumption, have the rights and obligations of a Lender thereunder and under the other Loan Documents and shall be bound by the provisions thereof and (b) the Assignor shall, to the extent provided in this Assignment and Assumption, relinquish its rights and be released from its obligations under the Credit Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;This Assignment and Assumption shall be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Assignment and Assumption to be executed as of the date first above written by their respective duly authorized officers on Schedule 1 hereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 1</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Assignment and Assumption</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of Assignor&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of Assignee&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date of Assignment&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment Amount Assigned&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans Assigned&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L&#47;C Obligations Assigned&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Name of Assignee&#93;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Name of Assignor&#93;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accepted&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consented To&#58;*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARCLAYS BANK PLC, as</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN HOLDINGS INSURANCE LIMITED</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative Agent</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARCLAYS BANK PLC, as</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative Agent</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;NAME OF ISSUING LENDER&#93;, as </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuing Lender</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">____________________</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Please refer to Section 11.6(b) of the Credit Agreement to determine if Borrower&#8217;s, Administrative Agent&#8217;s and&#47;or the Issuing Lenders&#8217; consent is required.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_681"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT D-1</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF LEGAL OPINION OF WILLKIE FARR &#38; GALLAGHER LLP</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Intentionally Omitted&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT D-2</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF LEGAL OPINION OF CAREY OLSEN BERMUDA LIMITED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Intentionally Omitted&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT D-3</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF LEGAL OPINION OF US GENERAL COUNSEL</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Intentionally Omitted&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_706"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT E-1</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF EXEMPTION CERTIFICATE</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(For Non-U.S. Lenders That Are Not Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________ (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is providing this certificate pursuant to Section 2.13(e) of the Credit Agreement. The Non-U.S. Lender hereby represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Non-U.S. Lender is the sole record and beneficial owner of the Loans or the obligations evidenced by Note(s) in respect of which it is providing this certificate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Non-U.S. Lender is not a &#8220;bank&#8221; for purposes of Section 881(c)(3)(A) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). In this regard, the Non-U.S. Lender further represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Non-U.S. Lender is not subject to regulatory or other legal requirements as a bank in any jurisdiction&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Non-U.S. Lender has not been treated as a bank for purposes of any tax, securities law or other filing or submission made to any Governmental Authority, any application made to a rating agency or qualification for any exemption from tax, securities law or other legal requirements&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The Non-U.S. Lender is not a 10-percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The Non-U.S. Lender is not a controlled foreign corporation receiving interest from a related person within the meaning of Section 881(c)(3)(C) of the Code&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The income from the Loans held by the Non-U.S. Lender is not effectively connected with the conduct of a trade or business within the United States.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Non-U.S. Lender has furnished the Administrative Agent and the Borrower with a certificate of its non-U.S. person status on Internal Revenue Service Form W-8BEN or W-8BEN-E, as applicable. By executing this certificate, the Non-U.S. Lender agrees that (1) if the information provided on this certificate changes, the Non-U.S. Lender shall promptly so inform the Borrower and the Administrative Agent and (2) the Non-U.S. Lender shall have at all times furnished the Borrower and the Administrative Agent with a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the Non-U.S. Lender, or in either of the two calendar years preceding such payments.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this certificate as of the date set forth below.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;NAME OF NON-U.S. LENDER&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT E-2</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF EXEMPTION CERTIFICATE</font></div><div style="margin-bottom:26pt;text-align:justify;text-indent:38pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(For Non-U.S. Lenders That Are Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the Third Amended and Restated Credit Agreement, dated as of December 1,2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________ (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is providing this certificate pursuant to Section 2.13(e) of the Credit Agreement. The Non-U.S. Lender hereby represents and warrants that&#58;</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Non-U.S. Lender is the sole record owner of the Loans or the obligations evidenced by Note(s) in respect of which it is providing this certificate and its partners&#47;members are the sole beneficial owners of such Loans or the obligations evidenced by Note(s).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Neither the Non-U.S. Lender nor any of its partners&#47;members is a &#8220;bank&#8221; for purposes of Section 881(c)(3)(A) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). In this regard, the Non-U.S. Lender further represents and warrants that&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;neither the Non-U.S. Lender nor its partners&#47;members is subject to regulatory or other legal requirements as a bank in any jurisdiction&#59; and</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;neither the Non-U.S. Lender nor its partners&#47;members has been treated as a bank for purposes of any tax, securities law or other filing or submission made to any Governmental Authority, any application made to a rating agency or qualification for any exemption from tax, securities law or other legal requirements&#59;</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Neither the Non-U.S. Lender nor any of its partners&#47;members is a 10-percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code&#59;</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Neither the Non-U.S. Lender nor any of its partners&#47;members is a controlled foreign corporation receiving interest from a related person within the meaning of Section 881(c)(3)(C) of the Code&#59; and</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The income from the Loans held by the Non-U.S. Lender is not effectively connected with the conduct of a trade or business within the United States by the Non-U.S. Lender or its partners&#47;members.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Non-U.S. Lender has furnished the Administrative Agent and the Borrower with Internal Revenue Service Form W-8IMY accompanied by an Internal Revenue Service Form W-8BEN or W-8BEN-E, as applicable, from each of its partners&#47;members claiming the portfolio interest exemption. By executing this certificate, the Non-U.S. Lender agrees that (1) if the information provided on this certificate changes, the Non-U.S. Lender shall promptly so inform the Borrower and the Administrative Agent and (2) the Non-U.S. Lender shall have at all times furnished the Borrower and the Administrative Agent with a properly completed and currently effective certificate in either the calendar year in which </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each payment is to be made to the Non-U.S. Lender, or in either of the two calendar years preceding such payments.</font></div><div style="margin-bottom:24pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this certificate as of the date set forth below.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;NAME OF NON-U.S. LENDER&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:60pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT E-3</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF EXEMPTION CERTIFICATE</font></div><div style="margin-bottom:24pt;text-indent:23pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(For Non-U.S. Participants That Are Not Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S. Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is providing this certificate pursuant to Section 2.13(e) of the Credit Agreement. The Non-U.S. Participant hereby represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Non-U.S. Participant is the sole record and beneficial owner of the participation in respect of which it is providing this certificate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Non-U.S. Participant is not a &#8220;bank&#8221; for purposes of Section 881(c)(3)(A) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). In this regard, the Non-U.S. Participant further represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Non-U.S. Participant is not subject to regulatory or other legal requirements as a bank in any jurisdiction&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Non-U.S. Participant has not been treated as a bank for purposes of any tax, securities law or other filing or submission made to any Governmental Authority, any application made to a rating agency or qualification for any exemption from tax, securities law or other legal requirements&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The Non-U.S. Participant is not a 10-percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The Non-U.S. Participant is not a controlled foreign corporation receiving interest from a related person within the meaning of Section 881(c)(3)(C) of the Code&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The income from the participation held by the Non-U.S. Participant is not effectively connected with the conduct of a trade or business within the United States.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Non-U.S. Participant has furnished its participating Lender and the Administrative Agent with a certificate of its non-U.S. person status on Internal Revenue Service Form W-8BEN or W- 8BEN-E, as applicable. By executing this certificate, the Non-U.S. Participant agrees that (1) if the information provided on this certificate changes, the Non-U.S. Participant shall promptly so inform such Lender and the Administrative Agent and (2) the Non-U.S. Participant shall have at all times furnished such Lender and the Administrative Agent with a properly completed and currently effective certificate in</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">either the calendar year in which each payment is to be made to the Non-U.S. Participant, or in either of the two calendar years preceding such payments.</font></div><div style="margin-bottom:24pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this certificate as of the date set forth below.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;NAME OF NON-U.S. PARTICIPANT&#93;</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT E-4</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF EXEMPTION CERTIFICATE</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(For Non-U.S. Participants That Are Partnerships for U.S. Federal Income Tax Purposes)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the Third Amended and Restated Credit Agreement, dated as of December 1,2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-U.S.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Participant&#8221;) is providing this certificate pursuant to Section 2.13(e) of the Credit Agreement. The Non-U.S. Participant hereby represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Non-U.S. Participant is the sole record owner of the participation in respect of which it is providing this certificate and its partners&#47;members are the sole beneficial owners of such participation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Neither the Non-U.S. Participant nor any of its partners&#47;members is a &#8220;bank&#8221; for purposes of Section 881(c)(3)(A) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;). In this regard, the Non-U.S. Participant further represents and warrants that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;neither the Non-U.S. Participant nor its partners&#47;members is subject to regulatory or other legal requirements as a bank in any jurisdiction&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;neither the Non-U.S. Participant nor its partners&#47;members has been treated as a bank for purposes of any tax, securities law or other filing or submission made to any Governmental Authority, any application made to a rating agency or qualification for any exemption from tax, securities law or other legal requirements&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Neither the Non-U.S. Participant nor any of its partners&#47;members is a 10-percent shareholder of the Borrower within the meaning of Section 871(h)(3)(B) of the Code&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Neither the Non-U.S. Participant nor any of its partners&#47;members is a controlled foreign corporation receiving interest from a related person within the meaning of Section 881(c)(3)(C) of the Code&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The income from the participation held by the Non-U.S. Participant is not effectively connected with the conduct of a trade or business within the United States by the Non-U.S. Participant or its partners&#47;members.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Non-U.S. Participant has furnished its participating Lender and the Administrative Agent with Internal Revenue Service Form W-8IMY accompanied by an Internal Revenue Service Form W-8BEN or W-8BEN-E, as applicable, from each of its partners&#47;members claiming the portfolio interest exemption. By executing this certificate, the Non-U.S. Participant agrees that (1) if the information provided on this certificate changes, the Non-U.S. Participant shall promptly so inform such Lender and the Administrative Agent and (2) the Non-U.S. Participant shall have at all times furnished such Lender</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the Administrative Agent with a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the Non-U.S. Participant, or in either of the two calendar years preceding such payments.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this certificate as of the date set forth below.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;NAME OF NON-U.S. PARTICIPANT&#93;</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_739"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT F</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF COMPANY NOTE</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIS NOTE AND THE OBLIGATIONS REPRESENTED HEREBY MAY NOT BE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE TERMS AND PROVISIONS OF THE CREDIT AGREEMENT REFERRED TO BELOW. TRANSFERS OF THIS NOTE AND THE OBLIGATIONS REPRESENTED HEREBY MUST BE RECORDED IN THE REGISTER MAINTAINED BY THE ADMINISTRATIVE AGENT PURSUANT TO THE TERMS OF SUCH CREDIT AGREEMENT.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$___________</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York, New York</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">________ __, 20__</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned, ASPEN INSURANCE HOLDINGS LIMITED, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), hereby unconditionally promises to pay to the order of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or its registered assigns at the Funding Office specified in the Credit Agreement (as hereinafter defined) in lawful money of the United States and in immediately available funds, on the Termination Date as to the Loans evidenced hereby, the principal amount of (a) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> DOLLARS ($ </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), or, if less, (b) the aggregate unpaid principal amount of all Loans made by the Lender to the Company pursuant to Section 2.1 of the Credit Agreement. The Company further agrees to pay interest in like money at such Funding Office on the unpaid principal amount hereof from time to time outstanding at the rates and on the dates specified in Section 2.8 of the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holder of this Note is authorized to indorse on the schedules annexed hereto and made a part hereof or on a continuation thereof which shall be attached hereto and made a part hereof the date, Type, and amount of the Loan and the date and amount of each payment or prepayment of principal with respect thereto, each conversion of all or a portion thereof to another Type, each continuation of all or a portion thereof as the same Type and, in the case of Eurodollar Loans, the length of each Interest Period with respect thereto. The failure to make any such indorsement or any error in any such indorsement shall not affect the obligations of the Company in respect of the Loan.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Note (a) is one of the Notes referred to in the Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among the Company, the Subsidiary Borrowers (as defined in the Credit Agreement), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent, (b) is subject to the provisions of the Credit Agreement and (c) is subject to optional prepayment in whole or in part as provided in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the occurrence of any one or more Events of Default, all principal and all accrued interest then remaining unpaid on this Note may be declared to be or may otherwise become, immediately due and payable, all as provided in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All parties now and hereafter liable with respect to this Note, whether maker, principal, surety, guarantor, indorser or otherwise, hereby waive presentment, demand, protest and all other notices of any kind.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED HEREIN OR IN THE CREDIT AGREEMENT, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AND IN ACCORDANCE WITH THE REGISTRATION AND OTHER PROVISIONS OF SECTION 11.6 OF THE CREDIT AGREEMENT.</font></div><div style="margin-bottom:24pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_764"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule A</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Company Note</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LOANS, CONVERSIONS AND REPAYMENTS OF ABR LOANS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR Loans</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Principal</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR Loans Repaid</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR<br>Loans Converted to<br>Eurodollar Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal<br>Balance<br>of ABR Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Made By</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR Loans</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Principal</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR Loans Repaid</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR<br>Loans Converted to<br>Eurodollar Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal<br>Balance<br>of ABR Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Made By</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_790"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule B</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Company Note</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LOANS, CONTINUATIONS, CONVERSIONS AND REPAYMENTS OF EURODOLLAR LOANS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount<br>Converted to<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Period<br>and<br>Eurodollar Rate<br>with<br>Respect Thereto</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eurodollar Loans</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repaid</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of<br>Eurodollar<br>Loans Converted<br>to<br>ABR Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal<br>Balance of<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Made By</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:22pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:22pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:22pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount<br>Converted to<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Period<br>and<br>Eurodollar Rate<br>with<br>Respect Thereto</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eurodollar Loans</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repaid</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of<br>Eurodollar<br>Loans Converted<br>to<br>ABR Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal<br>Balance of<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Made By</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_74"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT G</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF SUBSIDIARY BORROWER NOTE</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIS NOTE AND THE OBLIGATIONS REPRESENTED HEREBY MAY NOT BE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE TERMS AND PROVISIONS OF THE CREDIT AGREEMENT REFERRED TO BELOW. TRANSFERS OF THIS NOTE AND THE OBLIGATIONS REPRESENTED HEREBY MUST BE RECORDED IN THE REGISTER MAINTAINED BY THE ADMINISTRATIVE AGENT PURSUANT TO THE TERMS OF SUCH CREDIT AGREEMENT.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$___________</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York, New York</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">________ __, 20__</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, the undersigned, &#91;NAME OF SUBSIDIARY BORROWER&#93;, a</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#91;corporation&#93; &#91;limited liability company&#93; &#91;limited partnership&#93; &#91;exempt limited liability corporation&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), hereby unconditionally promises to pay to the order of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lender</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or its registered assigns at the Funding Office specified in the Credit Agreement (as hereinafter defined) in lawful money of the United States and in immediately available funds, on the Termination Date as to the Loans evidenced hereby, the principal amount of (a) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> DOLLARS ($ </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), or, if less, (b) the aggregate unpaid principal amount of all Loans made by the Lender to the Borrower pursuant to Section 2.1 of the Credit Agreement. The Borrower further agrees to pay interest in like money at such Funding Office on the unpaid principal amount hereof from time to time outstanding at the rates and on the dates specified in Section 2.8 of the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holder of this Note is authorized to indorse on the schedules annexed hereto and made a part hereof or on a continuation thereof which shall be attached hereto and made a part hereof the date, Type, and amount of the Loan and the date and amount of each payment or prepayment of principal with respect thereto, each conversion of all or a portion thereof to another Type, each continuation of all or a portion thereof as the same Type and, in the case of Eurodollar Loans, the length of each Interest Period with respect thereto. The failure to make any such indorsement or any error in any such indorsement shall not affect the obligations of the Borrower in respect of the Loan.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Note (a) is one of the Notes referred to in the Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among the Company, the Subsidiary Borrowers (as defined in the Credit Agreement), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent, (b) is subject to the provisions of the Credit Agreement and (c) is subject to optional prepayment in whole or in part as provided in the Credit Agreement. This Note is guaranteed as provided in the Loan Documents. Reference is hereby made to the Loan Documents for the nature and extent of the guarantees, the terms and conditions upon which each guarantee was granted and the rights of the holder of this Note in respect thereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the occurrence of any one or more Events of Default, all principal and all accrued interest then remaining unpaid on this Note may be declared to be or may otherwise become, immediately due and payable, all as provided in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All parties now and hereafter liable with respect to this Note, whether maker, principal, surety, guarantor, indorser or otherwise, hereby waive presentment, demand, protest and all other notices of any kind.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED HEREIN OR IN THE CREDIT AGREEMENT, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AND IN ACCORDANCE WITH THE REGISTRATION AND OTHER PROVISIONS OF SECTION 11.6 OF THE CREDIT AGREEMENT.</font></div><div style="margin-bottom:24pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;NAME OF SUBSIDIARY BORROWER&#93;</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_821"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule A</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Subsidiary Borrower Note</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LOANS, CONVERSIONS AND REPAYMENTS OF ABR LOANS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR Loans</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Principal</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR Loans Repaid</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR<br>Loans Converted to<br>Eurodollar Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal<br>Balance<br>of ABR Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Made By</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR Loans</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Principal</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABR Loans Repaid</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of ABR<br>Loans Converted to<br>Eurodollar Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal<br>Balance<br>of ABR Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Made By</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_77"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule B</font></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Subsidiary Borrower Note</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LOANS, CONTINUATIONS, CONVERSIONS AND REPAYMENTS OF EURODOLLAR LOANS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount<br>Converted to<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Period<br>and<br>Eurodollar Rate<br>with<br>Respect Thereto</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eurodollar Loans</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repaid</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of<br>Eurodollar<br>Loans Converted<br>to<br>ABR Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid Principal<br>Balance of<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Made By</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount<br>Converted to<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest Period<br>and<br>Eurodollar Rate<br>with<br>Respect Thereto</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eurodollar Loans</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repaid</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of<br>Eurodollar<br>Loans Converted<br>to<br>ABR Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid Principal<br>Balance of<br>Eurodollar<br>Loans</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Made By</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_853"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT H</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF NOTICE OF CONVERSION&#47;CONTINUATION</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#58;&#160;&#160;&#160;&#160;Barclays Bank PLC, as Administrative Agent for the Lenders parties to the Third Amended and Restated Credit Agreement dated as of December 1, 2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;'), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Aspen Insurance Holdings Limited, refers to the Credit Agreement, the terms defined therein being used herein as therein defined, and hereby gives you notice irrevocably, pursuant to Section 2.6 of the Credit Agreement, of the &#91;conversion&#93; &#91;continuation&#93; of the Loans specified herein, that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The conversion&#47;continuation date is </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion&#47;Continuation Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The aggregate amount of the Loans to be &#91;converted&#93; &#91;continued&#93; is $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The Loans are to be &#91;converted into&#93; &#91;continued as&#93; &#91;Eurodollar&#93; &#91;ABR&#93; Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#91;If applicable&#58;&#93; The duration of the Interest Period for the Loans included in the &#91;conversion&#93; &#91;continuation&#93; shall be &#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> days&#93; &#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months&#93;.</font></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;The undersigned hereby certifies that the following statement is true on the date hereof, and will be true on the proposed Conversion&#47;continuation Date&#58; no Default or Event of Default has occurred and is continuing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:206.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:133.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:101.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To be included for conversions of ABR Loans into Eurodollar Loans.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_882"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT I</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF SUBSIDIARY BORROWER AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUBSIDIARY BORROWER AGREEMENT, dated as of  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, made by  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#91;corporation&#93; &#91;limited liability company&#93; &#91;limited partnership&#93; &#91;exempt limited liability corporation&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Subsidiary Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), in favor of Barclays Bank PLC, as administrative agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for the Lenders (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) parties to the Third Amended and Restated Credit Agreement referred to below. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">W</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">I</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">T</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">N</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">S</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">S</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">T</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">H</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Aspen Insurance Holdings Limited (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the Subsidiary Borrowers, the Lenders, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent, have entered into a Third Amended and Restated Credit Agreement, dated as of December 1, 2021 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;)&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Credit Agreement permits the Additional Subsidiary Borrower to become a Subsidiary Borrower pursuant to the terms and conditions of the Credit Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Additional Subsidiary Borrower has agreed to execute and deliver this Subsidiary Borrower Agreement in order to become a Subsidiary Borrower under the Credit Agreement&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, IT IS AGREED&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the satisfaction of each of the conditions set forth in subsection 5.3 of the Credit Agreement, by executing and delivering this Subsidiary Borrower Agreement, the Additional Subsidiary Borrower hereby becomes a Subsidiary Borrower under the Credit Agreement with the same force and effect as if originally named therein as a Subsidiary Borrower and, without limiting the generality of the foregoing, hereby expressly assumes all obligations and liabilities of a Subsidiary Borrower thereunder.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company hereby represents and warrants that each of the representations and warranties contained in Section 4 of the Credit Agreement is true and correct on and as of the date hereof (after giving effect to this Subsidiary Borrower Agreement) as if made on and as of such date (except where such representation and warranty speaks of a specific date in which case such representation and warranty shall be true and correct as of such date).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. THIS SUBSIDIARY BORROWER AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned have caused this Subsidiary Borrower Agreement to be duly executed and delivered as of the date first above written.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:213.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:138.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:90.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;ADDITIONAL SUBSIDIARY BORROWER&#93;</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_906"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT J</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENT INCREASE SUPPLEMENT</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENT INCREASE SUPPLEMENT, dated  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Supplement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), to the Third Amended and Restated Credit Agreement dated as of December 1, 2021(as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">W I T N E S S E T H&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, pursuant to Section 2.1(b) of the Credit Agreement, the Borrowers have the right, subject to the terms and conditions thereof, to effectuate from time to time an increase in the aggregate Commitments under the Credit Agreement by requesting one or more Lenders to increase the amount of its Commitment&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Borrowers have given notice to the Administrative Agent and the Issuing Lenders of their intention to increase the Total Commitments pursuant to Sections 2.1(b) and (c) of the Credit Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, pursuant to Sections 2.1(b) and (c) of the Credit Agreement, the undersigned Lender now desires to increase the amount of its Commitment under the Credit Agreement by executing and delivering to the Borrowers, the Administrative Agent and the Issuing Lenders a supplement to the Credit Agreement in substantially the form of this Supplement&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW THEREFORE, each of the parties hereto hereby agrees as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The undersigned Lender agrees, subject to the terms and conditions of the Credit Agreement, that on the date of this Supplement it shall have its Commitment increased by $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, thereby making the aggregate amount of its Commitment equal to $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;This Supplement shall be governed by, and construed in accordance with, the laws of the State of New York.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;This Supplement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same document.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, each of the undersigned has caused this Supplement to be executed and delivered by a duly authorized officer on the date first above written.</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:178.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:232.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;INSERT NAME OF INCREASING LENDER&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:139.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:102.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:200.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accepted and agreed to, for the Borrowers, as of the date first written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:139.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:102.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:200.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledged and agreed to as of the date first written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BARCLAYS BANK PLC, as</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administrative Agent</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:139.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:102.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:200.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledged and agreed to as of the date first written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;INSERT NAMES OF ISSUING LENDERS&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_930"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT K</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEW LENDER SUPPLEMENT</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEW LENDER SUPPLEMENT, dated as of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Supplement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), to the Third Amended and Restated Credit Agreement, dated as of December 1, 2021, as amended, supplemented or otherwise modified from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, The Bank of New York Mellon, as Collateral Agent, Citibank, N.A., as Syndication Agent, and Barclays Bank PLC, as Administrative Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">W I T N E S S E T H&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Credit Agreement provides in Section 2.1(b) thereof that with the consent of the Administrative Agent and the Issuing Lenders (which consents shall not be unreasonably withheld or delayed), the Borrowers and any New Lender may agree that such New Lender shall establish a new Commitment and become a party to the Credit Agreement by executing and delivering to the Borrowers, the Administrative Agent and the Issuing Lenders a supplement to the Credit Agreement in substantially the form attached as Exhibit K thereto&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the undersigned desires to establish a new Commitment in the amount set forth herein and become a party to the Credit Agreement upon the terms and conditions set forth therein and herein&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, each of the parties hereto hereby agrees as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;From and after the Effective Date (as defined in paragraph 3 below) the undersigned shall be a party to and be bound by the provisions of the Credit Agreement as a Lender thereunder with an incremental Commitment of $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and shall perform in accordance with its terms all the obligations which by the terms of the Credit Agreement are required to be performed by it as a Lender (including, without limitation, its obligations pursuant to Section 2.13(e) of the Credit Agreement) to the same extent as if originally a party thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The undersigned (a) represents and warrants that it is legally authorized to enter into this Supplement&#59; (b) confirms that it has received a copy of the Credit Agreement, together with copies of the most recent financial statements referred to in Section 6.1 thereof and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Supplement&#59; (c) agrees that it has made and will, independently and without reliance upon the Administrative Agent or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement or any instrument or document furnished pursuant hereto or thereto&#59; and (d) appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise such powers and discretion under the Credit Agreement or any instrument or document furnished pursuant hereto or thereto as are delegated to the Administrative Agent by the terms thereof, together with such powers as are incidental thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;This Supplement shall be effective as of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The undersigned has delivered to the Administrative Agent an administrative questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;This Supplement shall be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;This Supplement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same document.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Remainder of page left blank intentionally.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has caused this Supplement to be executed and delivered by a duly authorized officer on the date first above written.</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;INSERT NAME OF NEW LENDER&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accepted and agreed to, for the Borrowers, as of the first date written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledged and agreed to as of the first date written above&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARCLAYS BANK PLC, as Administrative Agent</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledged and agreed to as of the date first written above&#58;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;INSERT NAMES OF ISSUING LENDERS&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_954"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT L</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;FORM OF&#93; SEVERAL LETTER OF CREDIT</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR INTERNAL IDENTIFICATION PURPOSES ONLY</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Does not affect terms of Letter of Credit or Bank&#8217;s obligations thereunder)</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issue Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiry Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">L&#47;C No. &#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount&#58; $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">7</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accountholder&#47;Applicant&#58; &#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</font></div><div style="text-indent:126pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;text-indent:126pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="margin-bottom:36pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRREVOCABLE CLEAN</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISSUE DATE </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LETTER OF CREDIT NO. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#58;&#160;&#160;&#160;&#160;&#91;BENEFICIARY&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the issuing banks listed below (hereinafter referred to individually as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Credit Bank</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8217;&#8217; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Credit Banks</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), hereby establish this clean, irrevocable and unconditional Letter of Credit in your favor as Beneficiary for drawing up to an aggregate amount of $(the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Letter of Credit Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) effective immediately. This Letter of Credit shall expire with the close of business of the L&#47;C Administrator (defined below) on. Except when the Letter of Credit Commitment is increased or amended to reflect a change in Commitment Share or Letter of Credit Bank as set forth in the last paragraph hereof, this Letter of Credit cannot be modified or revoked without the consent of the Beneficiary.</font></div><div style="margin-bottom:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;The term &#8220;Beneficiary&#8221; includes any successor by operation of law of the named Beneficiary including, without limitation, any such liquidator, rehabilitator, receiver or conservator. Drawings by any</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insert initial amount of the Letter of Credit.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insert name of party for whom Letter of Credit will be issued.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insert full name and address of the Beneficiary.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liquidator, rehabilitator, receiver or conservator shall be for the benefit of all the Beneficiary's policyholders.&#93;</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</font></div><div style="margin-bottom:24pt;text-indent:72pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum liability of each Letter of Credit Bank with respect to any demand for payment made hereunder shall be its Commitment Share of the amount of such demand for payment, as follows&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.671%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LETTER OF CREDIT BANK</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMMITMENT</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHARE</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MAXIMUM SHARE OF<br>LETTER OF CREDIT<br>COMMITMENT</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Lender&#93;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Lender&#93;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Lender&#93;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of the Letter of Credit Banks hereunder are several and not joint, and no Letter of Credit Bank shall be responsible or otherwise liable for the failure of any other Letter of Credit Bank to perform its obligations hereunder, nor shall the failure of any Letter of Credit Bank to perform its obligations under this Letter of Credit relieve any other Letter of Credit Bank of its obligations hereunder.</font></div><div style="text-indent:72pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the further provisions of this Letter of Credit, demands for payment may be made by the Beneficiary by presentation to Barclays Bank PLC, as agent (in such capacity, the &#8220;L&#47;C </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) of a sight draft drawn on the L&#47;C Administrator indicating the Letter of Credit No. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for all or any part of this Letter of Credit at the L&#47;C Administrator's office located at Barclays Bank PLC, New York Branch, 745 Seventh Avenue, New York, NY 10019, Attn&#58; BDM LC Support &#47; Letters of Credit Department, </font><font style="color:#3623bf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">xraBDMLCSUPPQRT&#64;barclf.ys.com</font><font style="color:#3623bf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </font></div><div style="margin-bottom:12pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">xraletterofcredit&#64;barclays.com, on or before the expiration date hereof &#91;or any automatically extended expiry date&#93;</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We the Letter of Credit Banks listed herein hereby undertake to promptly honor </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of a Beneficiary&#8217;s demands for payment hereunder upon delivery of the sight draft as specified to the L&#47;C Administrator&#8217;s aforesaid office.</font></div><div style="margin-bottom:48pt;text-indent:72pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as expressly stated herein, this undertaking is not subject to any agreement, requirement or qualification. The obligations of each Letter of Credit Bank under this Letter of Credit is the individual obligation of such Letter of Credit Bank and is in no way contingent upon reimbursement with respect thereto, or upon its ability to perfect any lien, security interest or any other reimbursement.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________________</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insert if Letter of Credit is being issued to back a reinsurance policy and such language is required by the applicable insurance regulator. Additional changes to the letter of credit to reflect regulatory requirements will be inserted if necessary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delete if not inserting automatic extension provision.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon payment to you by the Letter of Credit Bank of its Commitment Share of the drawing amount specified in a demand presented hereunder, a Letter of Credit Bank shall be fully discharged of its obligation under this Letter of Credit to the extent of its Commitment Share of such demand and such Letter of Credit Bank shall not thereafter be obligated to make any further payments under this Letter of Credit in respect of such demand.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;This Letter of Credit shall be deemed automatically extended without amendment for one year from the expiration date hereof or any future expiration date unless at least &#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93; days prior to such expiration date, the L&#47;C Administrator notifies you by Registered Mail or overnight courier service that this Letter of Credit will not be extended for any such additional period.&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">12</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;This Letter of Credit is subject to and governed by the Laws of the State of New York and the 2007 revision of the Uniform Customs and Practice for Documentary Credits of the International Chamber of Commerce (Publication &#91;500&#93;&#91;600&#93;), and in the event of any conflict, the Laws of the State of New York will control. If this Letter of Credit expires during an interruption of business as described in &#91;Article 17 of said Publication 500&#93;&#91;Article 36 of said Publication 600&#93;, the bank hereby specifically agrees to effect payment if this Letter of Credit is drawn against within 30 days after the resumption of business.&#93; &#91;This Letter of Credit is subject to and governed by the law(s) of the State of New York, and the International Standby Practices 98 (ISP98) (International Chamber of Commerce Publication No. 590). In the event of any conflict, the laws of the State of New York will control.&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Letter of Credit may be amended to delete a Letter of Credit Bank or add a Letter of Credit Bank, or change Commitment Shares, provided that such amendment does not decrease the Letter of Credit Commitment, and need only be signed by the L&#47;C Administrator (and, for the avoidance of doubt, without the consent of the Beneficiary) so long as any Letter of Credit Bank added shall be approved by the Securities Valuation Office of the National Association of Insurance Commissioners and shall have a rating of &#8220;A3&#8221; or better from Moody&#8217;s and&#47;or &#8220;A&#8221; or better from Standard and Poor's.</font></div><div style="margin-bottom:100pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:206.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:175.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Very truly yours,</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;BARCLAYS BANK PLC&#93;, as L&#47;C Administrator</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insert if auto-extension is applicable.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insert UCP 500 or UCP 600 if required by an insurance regulator, otherwise ISP 98 should be used.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_978"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT M</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF REVOLVING LOAN BORROWING REQUEST</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#58; Barclays Bank PLC,</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Administrative Agent</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">745 Seventh Avenue,</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, NY 10019</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Matt Santangelo</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">400 Jefferson Park</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whippany, NJ 07981</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telephone&#58; (201) 499-2903</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WSO Address&#58; 12145455230&#64;tls.ldsprod.com</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to that certain Third Amended and Restated Credit Agreement dated as of December 1, 2021 (as may be amended, restated, amended and restated, extended, supplemented or otherwise modified in writing from time to time in accordance with its terms, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; the terms defined therein being used herein as therein defined), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, Barclays Bank PLC, as Administrative Agent, and the other parties thereto.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned Borrower hereby requests a borrowing of Loans, as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;In the aggregate amount of $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;On </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (a Business Day).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Comprised of &#91;ABR&#93; &#91;Eurodollar&#93; Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;4.&#160;&#160;&#160;&#160;With an Interest Period of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months.&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;4&#93;&#91;5&#93;.&#160;&#160;&#160;&#160;The Borrower&#8217;s account to which funds are to be disbursed is&#58;</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Account Number&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Location&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Borrowing Request and the borrowing requested herein comply with the (x) first three sentences of Section 2.2 and (y) Section 5.2 of the Agreement.</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Insert if a Eurodollar Rate Borrowing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:100pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;NAME OF BORROWER&#93;</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i18b286b8d4714811aa44a1654f3360f7_1002"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT N</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM OF PREPAYMENT NOTICE</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#58; Barclays Bank PLC,</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as Administrative Agent</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">745 Seventh Avenue,</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, NY 10019</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Matt Santangelo</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">400 Jefferson Park</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whippany, NJ 07981Telephone&#58; (201) 499-2903</font></div><div style="margin-bottom:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WSO Address&#58; 12145455230&#64;tls.ldsprod.com</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to that certain Third Amended and Restated Credit Agreement dated as of December 1, 2021 (as may be amended, restated, amended and restated, extended, supplemented or otherwise modified in writing from time to time in accordance with its terms, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;&#58; the terms defined therein being used herein as therein defined), among Aspen Insurance Holdings Limited, a Bermuda exempted limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Subsidiary Borrowers (as defined therein) (together with the Company, collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Lenders parties thereto, Barclays Bank PLC, as Administrative Agent, and the other parties thereto.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Prepayment Notice is delivered to you pursuant to Section 2.5 of the Agreement. The undersigned Borrower hereby gives notice of a prepayment of Loans as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;(select Type(s) of Loans)</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;ABR Loans in the aggregate principal amount of $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Eurodollar Loans with an Interest Period ending </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the aggregate principal amount of $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;On </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a Business Day).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Prepayment Notice complies with the first and fourth sentences of Section 2.5(a) of the Agreement.</font></div><div style="margin-bottom:100pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.466%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;NAME OF BORROWER&#93;</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>26
<FILENAME>exhibit1015-fx1.htm
<DESCRIPTION>EX-10.15
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7edd74ef39f84e158f3809c93661619f_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.15</font></div><div style="margin-bottom:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Execution Version</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance Letters of Credit &#8722; Master Agreement</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:20pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 3&#47;CIFS</font></div></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.865%"><tr><td style="width:1.0%"></td><td style="width:14.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.214%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To&#58;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank Ireland Financial Services plc</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Letter of Credit Department</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Floor</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 North Wall Quay</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin 1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Republic of Ireland</font></div></td></tr></table></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Sirs,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance Letters of Credit &#8722; Master Agreement</font></div><div style="margin-bottom:10pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance&#47;Reinsurance Companies or Brokers</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of this letter is to record our agreement (the &#8216;&#8216;Agreement&#8217;&#8217;) to the following method of establishing letters of credit or similar or equivalent instruments acceptable to you (each a &#8216;&#8216;Credit&#8217;&#8217; and collectively the &#8216;&#8216;Credits&#8217;&#8217;) on our behalf in favour of beneficiaries located in the United States of America or elsewhere (the &#8216;&#8216;Beneficiary&#8217;&#8217; or &#8216;&#8216;Beneficiaries&#8217;&#8217; as the context may require). In connection with this Agreement, we have also separately agreed with you the contractual or security arrangements that will apply in respect of our obligations under or pursuant to this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">It is agreed between us in relation to each Credit that&#58;-</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;you will, upon receipt of an application form for the establishment of a Credit in such form as you may be willing to accept for this purpose and which may, without limitation, be received by you via any electronic system(s) or transmission arrangement(s) acceptable to you (referred to in this Agreement in relation to any Credit as an &#8216;&#8216;application form&#8217;&#8217;) completed by us or on our behalf in accordance with the terms of our banking mandate(s) or other authorities lodged with you or arrangement(s) made with you from time to time and indicating therein the name of the Beneficiary and the amount and term of the Credit required, establish on our behalf an irrevocable clean sight Credit (or such other form of Credit as may be required by the application form relating thereto) available, in whole or in part, by the Beneficiary&#8217;s sight draft on Citibank Ireland Financial Services plc or otherwise as may be required by the terms of the Credit&#59; provided, however, that&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the opening of any Credit hereunder shall, in every instance, be at your option and nothing herein shall be construed as obliging you to open any Credit&#59;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;prior to the establishment of any Credit or in order to maintain a Credit we undertake as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;forthwith at your request to deposit at a bank approved by you or with Citibank, N.A. at their branch at Citigroup Centre, Canada Square, Canary Wharf, London E14 5LB or, if notified by you, at such other branch as you may designate or at another bank approved by you, in an account or accounts in our name either cash or securities or a combination of cash and securities of such amount and combination as you may require (a &#8216;&#8216;Deposit&#8217;&#8217;)&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;should a Deposit have been requested, to execute the Bank&#8217;s standard form charge documentation in relation to any accounts opened pursuant to (ii)(a) above&#59; and</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;without prejudice to the generality of (i) above, the opening of any Credit hereunder shall be dependent upon you being satisfied, in your absolute discretion, that the a Deposit has been carried out and that the documentation required to be executed under (ii)(b) above has been validly executed&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i7edd74ef39f84e158f3809c93661619f_100"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(b)&#160;&#160;&#160;&#160;we undertake to reimburse you, on demand, the amount of any and all drawings under each Credit&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(c)&#160;&#160;&#160;&#160;we undertake to indemnify you, on demand, for and against all actions, proceedings, losses, damages, charges, costs, expenses, claims and demands which you may incur, pay or sustain by reason of or arising in any way whatsoever (apart from your own gross negligence or wilful misconduct) in connection with each Credit and&#47;or this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(d)&#160;&#160;&#160;&#160;we undertake to pay to you, on demand, such fees and&#47;or commissions of such amount(s) and&#47;or at such rate(s) as shall have been or as may be advised by you to us as payable in connection with each Credit&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(e)&#160;&#160;&#160;&#160;we hereby irrevocably authorise you to make any payments and comply with any demands which may be claimed from or made upon you in connection with each Credit without any reference to or further authority from us and we hereby agree that it shall not be incumbent upon you to enquire or to take notice whether or not any such payments or demands claimed from or made upon you in connection with each Credit are properly made or to enquire or to take notice whether or not any dispute exists between ourselves and the Beneficiary thereof and we further agree that any payment which you shall make in accordance with the terms and conditions of each Credit shall be binding upon us and shall be accepted by us as conclusive evidence that you were liable to make such payment or comply with such demand&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(f)&#160;&#160;&#160;&#160;we represent and warrant to you and undertake that&#58;-</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(i)&#160;&#160;&#160;&#160;we have and will at all times have the necessary power to enable us to enter into and perform the obligations expressed to be assumed by us under this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(ii)&#160;&#160;&#160;&#160;this Agreement constitutes our legal, valid, binding and enforceable obligation effective in accordance with its terms&#59; and</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(iii)&#160;&#160;&#160;&#160;all necessary authorisations to enable or entitle us to enter into this Agreement have been obtained and are in full force and effect and will remain in such force and effect at all times during the subsistence of this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(g)&#160;&#160;&#160;&#160;we represent and warrant to you that&#58;-</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(i)&#160;&#160;&#160;&#160;we are not unable to pay our debts as they fall due&#59;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(ii)&#160;&#160;&#160;&#160;we have not been deemed or declared to be unable to pay our debts under applicable law&#59;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(iii)&#160;&#160;&#160;&#160;we have not suspended making payments on any of our debts&#59;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(iv)&#160;&#160;&#160;&#160;we have not by reason of actual or anticipated financial difficulties commenced negotiations with any of our creditors with a view to rescheduling any of our indebtedness&#59;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(v)&#160;&#160;&#160;&#160;the value of our assets is not less than our liabilities (taking into account contingent and prospective liabilities)&#59;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(vi)&#160;&#160;&#160;&#160;no moratorium has been declared in respect of any of our indebtedness&#59; and</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(vii)&#160;&#160;&#160;&#160;no analogous or similar event or concept to those set out in Clauses 1(g)(i) to 1(g)(vi) above has occurred or is the case under the laws of any jurisdiction.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:10.5pt">Where an application form has been completed by or on behalf of any other applicant(s) with whom you have entered into an agreement similar or equivalent in effect to this Agreement, and a separate application form has been completed by us or on our behalf which corresponds, in your opinion with such other application form (or any other combination of circumstances exist which, in your opinion, are reasonably equivalent to the foregoing) then you shall be at liberty to open a single Credit on behalf of ourselves and such other applicant(s) jointly and in that event the following provisions shall apply&#58;-</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;our obligations pursuant to Clause 1(b) above shall be in respect of our due proportion of each drawing under any such Credit&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;in establishing our due proportion of each drawing under any such Credit you are hereby irrevocably authorised to make apportionments between ourselves and such other applicant(s) (i) on a pro rata basis by reference to the amounts set forth in the application forms originally completed by us and them in respect of such Credit (and after taking into account any subsequent increases or decreases in such Credit effected by you for our or their respective accounts) or, if you should so choose (ii) in reliance on the instructions and advice of and information provided by the relevant Insurance Broker (construed in accordance with paragraph 3 below)&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;for the purposes of paragraph 1(c) above, you may make any required apportionments in such manner as you, in your sole discretion, consider to be fair and reasonable.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">You may refer any query or problem arising in connection with this Agreement or any transaction hereby contemplated to the relevant Insurance Broker or respond to any question relating to the status of any Credit made by the relevant Insurance Broker (and, in such response, if you consider that it is material to make reference to the subject matter of any other agreement(s) now or hereafter entered into between us in connection with this Agreement, you may disclose such information relating thereto as you in your sole discretion consider to be appropriate). For the purposes of this Agreement, references to the relevant Insurance Broker shall be construed so as to mean the insurance broker or other intermediary (a) through whom you originally received the application form relating to the Credit in question (or the person(s) who purport to have succeeded to the business thereof) or (b) which, in your opinion, acts in connection with such Credit.</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any Credit established hereunder may, if requested by us on the application form relating thereto and subject to your consent, bear a clause to the effect that it will automatically be extended for successive periods of one year (or such other period as may be stated in the relevant application form) unless the Beneficiary has received from the bank or institution issuing the Credit (the &#8216;&#8216;Issuing Bank&#8217;&#8217;) by registered mail (or other appropriate receipted delivery) notification of intention not to renew such Credit at least 30 days (or such other period as may be stated in the relevant application form) (the &#8216;&#8216;Notice Period&#8217;&#8217;) prior to the end of the original term or, as the case may be, of a period of extension. The Issuing Bank shall be under no obligation to us to send the Beneficiary such notification (and without such notification to the Beneficiary the Credit will be automatically extended as provided above) unless you shall have received by registered mail or other means acceptable to you notification from us (or from any one or more of the other parties (if any) for whose account(s) such Credit may also have been established as contemplated by paragraph 2 above) of our or its election not to renew such Credit at least 30 days prior to the commencement of the Notice Period relating to the original term or, as the case may be, a period of extension&#59; provided however that you will, as soon as is reasonably possible, give us advice of the receipt by you of any such notice from any other such parties. We understand that receipt by you of any such notice may result in the whole of such Credit being cancelled (and not just the portion attributable to us in the case of a joint credit as referred to in paragraph 2 above) and, save as is provided above, you reserve the right, at your sole option and discretion, to give or procure the giving at any time to the Beneficiary of notification of intention not to renew any Credit and that if you exercise such said right you will give us notice in writing thereof as soon as is reasonably possible.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If, in either of the circumstances referred to in sub-paragraph (a) above, the Issuing Bank has given notification not to renew such Credit, then you may (but shall not be obliged to) without further authority from us (or from any of the other persons as aforesaid) arrange for the Beneficiary to accept (1) a substitute Credit (the &#8216;&#8216;Substitute Credit&#8217;&#8217;) from the Issuing Bank on terms identical to such Credit except that (i) the amount of the Substitute Credit will be equal to the then undrawn face value of such Credit less the portion thereof (determined by you) to be attributable to the person(s) (the &#8216;&#8216;excluded Person(s)&#8217;&#8217;) who gave a notice of non-renewal to</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">you or, as the case may be, for whom you do not wish to arrange the issuance of the Substitute Credit and (ii) the original term of the Substitute Credit will, subject to renewal as mentioned in sub-paragraph (a) above, be up to one year in duration (or such longer duration as may be required by any regulatory or other authority having jurisdiction as to the acceptability of the Substitute Credit) OR (2) such other arrangement, compromise, release or waiver as, in your sole opinion, will result in the same effect being achieved as in (1) above. You will, as soon as reasonably possible, advise us (unless we are the or one of the Excluded Person(s)) of the matter(s) effected by you pursuant to the foregoing provisions.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">You may, at your sole option, arrange for the issuance of any Credit as being subject to either (i) the Uniform Customs and Practice for Documentary Credits (1993 Revision) ICC Publication No. 500 or (ii) the International Chamber of Commerce Publication No. 590 &#8212; the International Standby Practices 1998, (or any subsequent version of either)&#59; provided however that you may agree such modifications thereof as may be required by any regulatory or other authority having jurisdiction as to the acceptability of the Credit in question.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Unless otherwise agreed between us in writing, the previous agreement(s) (if any) entered into between us governing Credits (other than those at any time governed by a &#8216;&#8216;Master Agreement &#8212; London Market Letter of Credit Scheme&#8217;&#8217; or substantially equivalent agreement) established by Citibank Ireland Financial Services plc on our behalf in favour of Beneficiaries shall, on acceptance by you of this letter duly executed by us, cease to apply to all such Credits established by Citibank Ireland Financial Services plc prior to the date of our signature of this Agreement and all such Credits shall, from the date of such acceptance be governed by this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">For the avoidance of doubt any letter or letters of credit or similar or equivalent instrument or instruments (the &#8216;&#8216;Existing Credit(s)&#8217;&#8217;) which has or have been established or opened pursuant to the terms of any previous agreement(s) entered into between us and Citibank, N.A. governing the Existing Credits (including any security arrangements that apply in respect of any obligation under or pursuant to such previous agreement(s)) (the &#8216;&#8216;Existing Agreement(s)&#8217;&#8217;) shall continue in force until cancelled. The Existing Agreement(s) shall continue to apply to the Existing Credit(s) until all the Existing Credit(s) have been cancelled. If requested to do so by you, we undertake to take all reasonable steps to procure that any cancelled Existing Credit(s) are destroyed or returned to you.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">If, at our request, a Credit expressly chooses a state or country law other than New York, U.S.A. or English law, or is silent with respect to the International Chamber of Commerce Publication No. 500 &#8212; Uniform Customs and Practice for Documentary Credits (the &#8216;&#8216;UCP&#8217;&#8217;), the International Chamber of Commerce Publication No. 590 &#8212; International Standby Practices 1998 (the &#8216;&#8216;ISP&#8217;&#8217;) or a governing law, Citibank Ireland Financial Services plc shall not be liable for any payment, cost, expense or loss resulting from any action or inaction taken by Citibank Ireland Financial Services plc if such action or inaction is justified under UCP, ISP, New York law or English law or the law governing the Credit.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">We understand that Citibank Ireland Financial Services plc may carry out any of its obligations under this Agreement through any offices or branches of Citibank Ireland Financial Services plc wheresoever situated and may wish to exercise any of its rights under this Agreement through offices or branches of Citibank Ireland Financial Services plc wheresoever situated.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We further understand that Citibank Ireland Financial Services plc also reserves the right to issue any Credit through any third party correspondent of its choice and&#47;or to have any Credit confirmed by Citibank, N.A. and, in such circumstances, Citibank Ireland Financial Services plc will be required to guarantee reimbursement to such correspondent (and&#47;or to Citibank, N.A., as the case may be) of any payments which such correspondent (and&#47;or Citibank, N.A., as the case may be) may make under the Credit in question and such guarantee (howsoever described) shall also be treated mutatis mutandis as a Credit for the purpose of this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The provisions of the foregoing paragraphs shall be equally applicable to any increase, extension, renewal, partial renewal, modification or amendment of or substitute instrument for any Credit to</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">which they apply. If for any reason any amount paid under any Credit is repaid, in whole or in part, by the Beneficiary thereof, you may, in your sole discretion, treat (or procure the treatment of) such repayment as a reinstatement of an amount (equal to such repayment) under such Credit. The value date applied by you to any such reinstatement shall not be earlier than the date of such repayment and you shall not be liable for any loss of any nature which we may suffer or incur and which may arise from any inadvertent or erroneous drawing.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:5.5pt">Any notice or demand to be served on us by you hereunder may be served&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;on any of our officers personally&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;by letter addressed to us or to any of our officers and left at our registered office or at any one of our principal places of business&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;by posting the same by letter addressed in any such manner as aforesaid to such registered office or any such principal place of business&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;by telex or facsimile addressed in any such manner as aforesaid to any then published telex or facsimile number of ourselves.</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unless otherwise stated, any notice or demand to be served on you by us hereunder must be served on you either at your address stated at the beginning of this Agreement (or such other address as you may notify us of from time to time) or by facsimile to such number as you may notify us of from time to time.</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any notice or demand&#58;-</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;sent by post to any address in the Republic of Ireland or the United Kingdom shall be deemed to have been served on us at 10am. (London time) on the first Business Day after the date of posting (in the case of an address in the Republic of Ireland) and on the second Business Day after posting (in the case of an address in the United Kingdom) or, in the case of an address outside the Republic of Ireland or the United Kingdom (or a notice or demand to you), shall be deemed to have been served on the relevant party at 10am. (London time) on the third Business Day after and exclusive of the date of posting&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(f)&#160;&#160;&#160;&#160;sent by telex or facsimile shall be deemed to have been served on the relevant party when dispatched.</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In proving such service by post it shall be sufficient to show that the letter containing the notice or demand was properly addressed and posted and such proof of service shall be effective notwithstanding that the letter was in fact not delivered or was returned undelivered.</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In this Clause &#8216;&#8216;Business Day&#8217;&#8217; shall be construed as a reference to a day (other than a Saturday or a Sunday) on which banks are generally open in London.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:5.5pt">You shall have a full and unfettered right to (a) assign the whole or any part of the rights under or the benefit of this Agreement or (b) (subject to Clause 14 below) novate your rights and obligations under this Agreement. The words &#8216;&#8216;you&#8217;&#8217; and &#8216;&#8216;your&#8217;&#8217; wherever used herein shall be deemed to include your assignees and novatees and other successors, whether immediate or derivative, who shall be entitled to enforce and proceed upon this Agreement in the same manner as if named herein. You shall be entitled to impart any information concerning us to any such assignee, novatee or other successor or any participant or proposed assignee, novatee, successor or participant.</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.1&#160;&#160;&#160;&#160;The person who is for the time being liable to perform your obligations under this Agreement (a &#8216;&#8216;Transferring Bank&#8217;&#8217;) shall be entitled to novate at any time, upon service of a notice in the form attached as Schedule One to this Agreement (a &#8216;&#8216;Novation Notice&#8217;&#8217;) on us, any or all of its rights and obligations under, and the benefit of, this Agreement to any Permitted Transferee. With effect from the date on which a Novation Notice is executed by the Transferring Bank and the Permitted Transferee and served on us (the &#8216;&#8216;Novation Date&#8217;&#8217;), the provisions of Clause 14.2 shall have effect (but not otherwise).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">For the purposes of this Clause 14 a &#8216;&#8216;Permitted Transferee&#8217;&#8217; shall mean any holding company, subsidiary or affiliate of Citigroup.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">14.2&#160;&#160;&#160;&#160;With effect from (and subject to the occurrence of) the Novation Date&#58;</font></div><div style="margin-bottom:10pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(a)&#160;&#160;&#160;&#160;the Permitted Transferee shall be bound by the terms of this Agreement (as novated) in every way as if the Permitted Transferee were and had been a party hereto in place of the Transferring Bank and the Permitted Transferee shall undertake and perform and discharge all your obligations and liabilities under this Agreement (as novated) whether the same fell or fall to be performed or arose or arise on, before or after the Novation Date&#59;</font></div><div style="margin-bottom:10pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(b)&#160;&#160;&#160;&#160;we shall release and discharge the Transferring Bank from further performance of its obligations arising in favour of us on and after the Novation Date under this Agreement and all claims and demands whatsoever in respect thereof against the Transferring Bank and we shall accept the liability of the Permitted Transferee in respect of such obligations in place of the liability of the Transferring Bank&#59;</font></div><div style="margin-bottom:10pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(c)&#160;&#160;&#160;&#160;the Transferring Bank shall release and discharge us from further performance of our obligations arising in favour of the Transferring Bank on and after the Novation Date under this Agreement and all claims and demands whatsoever in respect thereof by the Transferring Bank&#59;</font></div><div style="margin-bottom:10pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(d)&#160;&#160;&#160;&#160;we shall be bound by the terms of this Agreement (as novated) in every way, and we shall undertake and perform and discharge in favour of the Permitted Transferee each of our obligations whether the same fell or fall to be performed or arose or arise on, before or after the Novation Date and expressed to be owed to you.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">14.3&#160;&#160;&#160;&#160;Without prejudice to the automatic novation of the Transferring Bank&#8217;s rights and obligations pursuant to Clause 14.2 we undertake to sign and return promptly each acknowledgement of the Novation Notice from time to time delivered to us promptly following receipt of the same from the Transferring Bank.</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">15.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">15.1&#160;&#160;&#160;&#160;We hereby irrevocably authorise you to debit and credit, on our behalf, any account or accounts which are held in our name with Citibank, N.A.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">15.2&#160;&#160;&#160;&#160;We hereby agree that Citibank N.A. shall be entitled to rely on and action any credit or debit made by you in accordance with Clause 15.1.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:5.5pt">This Agreement shall be governed by English law and for your benefit we hereby irrevocably submit to the jurisdiction of the English Courts in respect of any dispute which may arise from or in connection with this Agreement. The terms of this Agreement may not be waived, modified or amended unless such waiver, modification or amendment is in writing and signed by you nor may we assign any of our rights here under without your prior written consent.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">17.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">17.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Subject to this Clause and to Clause 15.2 a person who is not a party to this Agreement has no rights under the Contracts (Rights of Third Parties) Act 1999 (the &#8216;&#8216;Third Parties Act&#8217;&#8217;) to enforce any terms of this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">17.2&#160;&#160;&#160;&#160;Citibank, N.A. may enforce the terms of Clause 15.2 subject to and in accordance with this Clause and Clause 16 and the provisions of the Third Parties Act.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">17.3&#160;&#160;&#160;&#160;The parties to this Agreement do not require the consent of Citibank, N.A. to rescind or vary this Agreement at any time.</font></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">17.4&#160;&#160;&#160;&#160;If Citibank, N.A. brings proceedings to enforce the terms of Clause 15.2 we shall only have available to us by way of defence, set-off or counterclaim a matter that would have been available by way of defence, set-off or counterclaim if Citibank, N.A. had been party to this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.5&#160;&#160;&#160;&#160;Citibank, N.A. may not take proceedings to enforce Clause 15.2 unless and until it gives notice in writing to us in any manner as is permitted by Clause 12, agreeing irrevocably to the provisions of Clause 16.</font></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.051%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yours faithfully,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For and on behalf of</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASPEN INSURANCE LIMITED </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*(Full name of Company &#47; Firm)</font></td></tr><tr style="height:65pt"><td colspan="3" style="padding:0 1pt"><div><img alt="exhibit1015signaturea.jpg" src="exhibit1015signaturea.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div></td></tr></table></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.051%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:75pt"><td colspan="3" style="padding:0 1pt"><div><img alt="exhibit1015signature2a.jpg" src="exhibit1015signature2a.jpg" style="height:87px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i7edd74ef39f84e158f3809c93661619f_85"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXECUTION COPY</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE ONE</font></div><div style="margin-bottom:10pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form of Novation Notice for Clause 14</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></div><div style="margin-bottom:10pt;text-align:right;text-indent:20pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Sirs</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance Letters of Credit &#8722; Master Agreement (Form 3&#47;CIFS) dated &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; and made between Citibank Ireland Financial Services plc and &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; (the &#8216;&#8216;Agreement&#8217;&#8217;)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer to Clause 14 of the Agreement. We hereby notify you that we wish to exercise our option to novate under Clause 14 thereof so that with effect from today&#8217;s date the rights, liabilities and obligations of &#91;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">name of Transferring Bank</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93; shall be novated to &#91;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">name of Permitted Transferee</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93; in the manner set out in Clause 14 thereof.</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The relevant address for the purposes of Clause 4(a) and Clause 12 is as follows&#58;</font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">insert new address</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.891%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yours faithfully</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:142%">for and on behalf of</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;TRANSFERRING BANK&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:142%">for and on behalf of</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;PERMITTED TRANSFEREE&#93;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;NAME OF COUNTERPARTY&#93;&#58;</font></td></tr></table></div><div style="margin-bottom:10pt;padding-left:22.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">acknowledges receipt of the Novation Notice&#59; and</font></div><div style="margin-bottom:10pt;padding-left:22.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">agrees that with effect from the date of the Novation Notice the rights, liabilities and obligations of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; are novated to &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; in the manner set out in Clause 14 of the Agreement.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.250%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:142%">for and on behalf of</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;NAME OF COUNTERPARTY&#93;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>27
<FILENAME>exhibit1016-fx1.htm
<DESCRIPTION>EX-10.16
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie9d5e4696c76452ba3246e4e163f48c3_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.16</font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASSIGNMENT AGREEMENT (THIS &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">AGREEMENT&#8221;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:9pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">October 11, 2006</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the following documents (collectively referred to as the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Original Agreements&#8221;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15.34pt">INSURANCE LETTERS OF CREDIT MASTER AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, dated December 15, 2003 and attached hereto as Exhibit I (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Master Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) among Citibank Ireland Financial Services plc (whose name has since been changed to Citibank Europe Plc) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CEP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and Aspen Insurance Ltd (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), as Applicant&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15.34pt">PLEDGE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, dated January 17, 2006, attached hereto as Exhibit II (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pledge Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) executed by Aspen in favor of Citibank N.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Citibank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) whereby Aspen has agreed that certain of its assets are pledged in favor of Citibank as security for the payment of all obligations under the Master Agreement&#59; and</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15.34pt">COLLATERAL ACCOUNT CONTROL AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, dated January 17, 2006, attached hereto as Exhibit III (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Control Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) among Aspen, Citibank Ireland Financial Services plc (whose name has since been changed to Citibank Europe Plc) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CEP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and The Bank of New York (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">BONY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as the Securities Intermediary.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Pledge Agreement incorrectly lists Citibank as the Pledgee and as the issuer of letters of credit under the Master Agreement&#59;</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the issuer of letters of credit under the Master Agreement is actually CEP, and not Citibank&#59;</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the parties to this Agreement wish to replace Citibank with CEP as the Pledgee under the Pledge Agreement, but maintain the Control Agreement and the Master Agreement as currently in effect&#59;</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW THEREFORE, in consideration of the mutual promises set forth hereafter, Aspen, Citibank, CEP and BONY hereby acknowledge, accept and confirm as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">In accordance with Section 18 of the Pledge Agreement, Citibank hereby assigns, transfers and conveys to CEP, and CEP hereby accepts and assumes from Citibank and Aspen, that interest in and to all of Citibank&#8217;s rights, duties, liabilities and obligations as Pledgee under and in respect of the Pledge Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assigned Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as security for all Obligations of Aspen to CIFS now or hereafter existing under the Master Agreement&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">BONY, as Securities Intermediary under the Control Agreement, and Aspen, as Pledgor under the Pledge Agreement and Control Agreement and as account party and applicant under the Master Agreement, each hereby consents to the foregoing assignment&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">CEP, Aspen and BONY shall acquire the same rights and benefits and assume the same obligations between themselves pursuant to the Original Agreements as they would have acquired and assumed had the Pledge Agreement been issued originally in favor of CEP, and not Citibank, as Pledgee and had the Account been pledged originally by Aspen in favor of CEP, and not Citibank, specifically as security for all obligations of Aspen under the Master Agreement and the Pledge Agreement&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Aspen hereby represents and warrants that each of the representations and warranties it originally made in the Original Agreements are true and correct as made once again on this date&#59; and</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Except as set forth herein, nothing in this Agreement will be construed to affect any of the other rights and obligations of the parties hereto pursuant to the Original Agreements.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized terms not defined herein shall have the meaning ascribed thereto in the Original Agreements, as applicable.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement is being delivered in, and shall be governed by and construed and interpreted in accordance with the laws of, the State of New York. Each party submits to the non-exclusive jurisdiction of the federal and state courts </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">located in the Borough of Manhattan, New York, New York for the purposes of resolving any disputes under this Agreement.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">This Agreement shall be binding upon the parties and their respective successors and permitted assigns. No failure or delay on the part of either party in exercising any right hereunder shall operate as a waiver of such right&#59; nor shall any single or partial exercise of any such right preclude any other or further exercise thereof or the exercise of any other rights. No waiver of any such right shall be effective unless given in a signed writing or other authenticated record. No waiver of any such right shall be deemed a waiver of any other right hereunder.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">This Agreement may be executed by the parties to this Agreement on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTED</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of the date set forth above by</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.173%"><tr><td style="width:1.0%"></td><td style="width:19.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.128%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASPEN INSURANCE LTD</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David Skinner</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Skinner</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 11, 2006</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CITIBANK N.A.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Phil Arch</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phil Arch</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 11, 2006</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CITIBANK EUROPE PLC</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1 North Wall Quay<br>Dublin 1<br>Ireland</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Phil Arch</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phil Arch</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 11, 2006</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">THE BANK OF NEW YORK</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Dimitra Petroutsas</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dimitra Petroutsas</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assistant Vice President</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 12, 2006</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>28
<FILENAME>exhibit1017-fx1.htm
<DESCRIPTION>EX-10.17
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i34885986815e4a29adc212f0800eaedb_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.17</font></div></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 October, 2006</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Limited</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attn Bryan Astwood</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maxwell Roberts Building</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 Church Street</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HM 11</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda</font></div><div style="margin-bottom:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Sirs</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) Reinsurance Deposit Agreement (Charge Form &#8211; Citibank, N.A. as Custodian) (Form 12) registered against Aspen Insurance Limited by and in favour of Citibank Ireland Financial Services plc (whose name has since been changed to Citibank Europe plc) dated 15 December 2003&#59; and (2) Pledge Agreement dated 17 January 2006, registered against Aspen Insurance Limited by and in favour of Citibank Ireland Financial Services plc (now Citibank Europe plc) (by way of Assignment Agreement dated October 11, 2006), (respectively the &#8216;&#8216;Reinsurance Deposit Agreement&#8217;&#8217; and the &#8216;&#8216;Pledge Agreement&#8217;&#8217;) and each as may be from time to time amended, varied, supplemented, novated or assigned as the case may be.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With reference to the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Deposit Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we write to record that you and we have agreed that Schedule Two thereto shall be replaced by the form set out in Annex One to this letter.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With reference to the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pledge Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, without prejudice to the provisions of Section 2, Section 6(k) shall be deleted in its entirety and replaced by the following&#58;-</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8216;&#8216;The Pledgor shall cause Securities of the type specified in Schedule I to be pledged as Collateral so that at all times the fair market value of such Securities shall equal or exceed (i) an amount equal to 111.111111% of the aggregate amount of the then outstanding Credits where the Collateral provided in respect of such Credits comprises Tranche 1 Financial Assets (ii) an amount equal to 117.647% of the aggregate amount of the then outstanding Credits where the Collateral provided in respect of such Credits comprises Tranche 2 Financial Assets and without limiting the foregoing, if at any time the Pledgor is not in compliance with the requirements of this subsection (k), the Pledgor shall forthwith cause additional Securities of the type specified in Schedule I (whether Tranche 1 and&#47;or Tranche 2 Financial Assets as required) to be held as Collateral pursuant to Section 2 to the extent required to cause the Pledgor to be in compliance with this subsection (k).&#8217;&#8217;</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With reference to the above </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pledge Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, without prejudice to the provisions of Sections 2 and 6(k) (the latter as amended herein), Schedule 1 thereto shall be replaced by the form set out in Annex Two to this letter.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Save as expressly provided in this letter, the provisions of the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Deposit Agreement </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pledge Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall remain in full force and effect.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please counter-sign and return the enclosed copy of this letter.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yours faithfully</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.147%"><tr><td style="width:1.0%"></td><td style="width:15.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Phil Arch</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for Citibank Europe plc</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We hereby confirm our agreement to the above.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 11, 2006</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signed&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David Skinner</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for and on behalf of</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASPEN INSURANCE LIMITED</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i34885986815e4a29adc212f0800eaedb_81"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNEX ONE</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REINSURANCE DEPOSIT AGREEMENT (CHARGE FORM &#8211; CITIBANK, N.A. AS CUSTODIAN) (FORM 12)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE TWO</font></div><div style="margin-bottom:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of Clause 3(a)(i)&#58;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The figure of &#8216;&#8216;100%&#8217;&#8217; specified in Clause 3(a)(i)(1) shall be replaced by the figure of not less than 0% (zero percent) such that there shall be no minimum percentage requirement&#59; provided that there shall be for the time being be in full force and effect the Pledge Agreement of 17 January 2006 made by the Chargor in favour of the Bank (by way of Assignment Agreement dated Ocotber 11, 2006).</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">A Reinsurance Deposit may be in any currency which is acceptable to the Bank and which is freely transferable and convertible into U.S. dollars. Where, after a Reinsurance Deposit has been established, the currency of all or a portion thereof ceases to be acceptable to the Bank, the Bank may require that such Reinsurance Deposit or such portion thereof be converted into or re-established in another currency acceptable to the Bank and may instruct the Custodian to so convert or re-establish such deposit. The Bank is irrevocably authorised (without reference to us) to so instruct the Custodian.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">Where a Reinsurance Deposit or a portion thereof is denominated in the same currency as a Credit (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8216;&#8216;Credit Currency&#8217;&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), the Reinsurance Deposit or such portion thereof shall have a value of 100% of its value in the relative Credit Currency&#59; and for this purpose the Bank (and the Custodian) shall notionally match each Credit with a Reinsurance Deposit or a portion thereof denominated in the relative Credit Currency.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">Where a Reinsurance Deposit or a portion thereof is denominated in a currency other than the relative Credit Currency, both the proportion specified above of the face value of the Credit (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8216;&#8216;Required Value&#8217;&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) (or, where only a portion of the Reinsurance Deposit is in the relative Credit currency, the balance of the Required Value remaining unmatched) and the Reinsurance Deposit or such portion thereof shall be notionally converted into a common base currency (as the Bank may in its discretion determine)&#59; and following such notional conversion the Reinsurance Deposit or such portion thereof shall suffer a deduction of the Relevant Percentage, to cover exchange movements that may from time to time affect the value of the underlying unmatched Reinsurance Deposit or a portion thereof and the contingent obligations to which it relates.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">The </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8216;&#8216;Relevant Percentage&#8217;&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> means&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">where a Reinsurance Deposit or a portion thereof is denominated in U.S. dollars, Canadian dollars or Sterling, 10%&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">where a Reinsurance Deposit or a portion thereof is denominated in Euro, Swiss francs or Japanese yen, 15%&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">where a Reinsurance Deposit or a portion thereof is denominated in any other currency, 25%.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">For the purposes of each notional conversion to be effected hereunder the provisions of Clause 14(a) shall apply mutatis mutandis.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i34885986815e4a29adc212f0800eaedb_101"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNEX TWO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEDGE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE 1</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities or Other Assets Acceptable as Financial Assets can comprise Securities as set out in, and subject to the limitations of, Tranche 1 and&#47;or Tranche 2 below, it being understood that different margins apply to each Tranche as set out in Section 6(k) of this Agreement.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tranche 1</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Up to a maximum of USD 300,000,000 (Three Hundred Million United States Dollars) can be secured by&#58;-</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities issued by the US government or its agencies (whose debt obligations are fully and explicitly guaranteed as to the timely payment of principal and interest by the full faith and credit of the US government) or the central government of an OECD (Organisation for Economic Co-operation and Development) country, in each case rated AA or AA equivalent or better.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tranche 2</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Up to a maximum of USD 150,000,000 (One Hundred and Fifty Million United States Dollars) can be secured by&#58;-</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities issued by Corporations, each rated A- or A- equivalent or better (and not more than 10% by value of the Charged Portfolio shall be represented by Securities issued by any one issuer and each bond within the Charged Portfolio shall mature not more than 10 years after the date on which it comes within the Charged Portfolio) provided that at all times the average rating of such Securities held within the Charged Portfolio is rated at least AA- or AA- equivalent or better.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Required Value is USD 58, 391,000 (Fifty Eight Million and Three Hundred and Ninety One Thousand United States Dollars)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>29
<FILENAME>exhibit1018-fx1.htm
<DESCRIPTION>EX-10.18
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie3beb0cbe1f747c4b3b0cf615b08b727_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.18</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 North Wall Quay</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin 1</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="citilogo.jpg" src="citilogo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Niall Tuckey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ILOC Product</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank Europe plc<br>1 North Wall Quay<br>Dublin 1, Ireland</font></td></tr></table></div></div><div style="margin-bottom:30pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date 30&#160;July 2012 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda Limited </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141 Front Street </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton HM19 </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Bryan Astwood </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Bryan </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Committed letter of credit facility</font></div><div style="margin-bottom:9pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further to recent discussions, Citibank Europe plc (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is pleased to confirm its committed letter of credit issuance facility (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) subject to the terms and conditions set out in this Letter. </font></div><div style="margin-bottom:9pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Facility is intended to replace the committed letter of credit facility established pursuant to a facility letter between Aspen Insurance Limited and Citibank Europe plc dated 12&#160;August 2011 (&#8220;the Old Facility&#8221;). The Old Facility is hereby terminated with immediate effect and the parties fully released from all rights, obligations and liabilities arising there from. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Amount</font></div><div style="margin-bottom:9pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Facility shall be in a maximum aggregate amount of USD 950,000,000 (Nine hundred and fifty million United States Dollars) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate Facility Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) comprising two maturity tranches&#58; Tranche 1 having a sub limit of USD 650,000,000 (six hundred and fifty million United States Dollars)&#59; and Tranche II having a sub limit of USD 300,000,000 (three hundred million United States Dollars). Should the Company (as defined below) wish to reduce the Aggregate Facility Limit or any Tranche sub limit, it may do so upon written notification to the Bank. The notification (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) must (i)&#160;specifically reference this Letter and (ii)&#160;clearly state the new facility limit that is to apply (&#8220;the New Limit&#8221;). The New Limit will take effect five Business Days following receipt, by the Bank, of the Notification. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Facility Documents</font></div><div style="margin-bottom:9pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Limited, now Aspen Bermuda Limited (&#8220;the Company&#8221;) has entered into the following documents in relation to the Facility (each as amended, varied, supplemented, novated or assigned as the case may be)&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Insurance Letters of Credit - Master Agreement (Form 3&#47;CIFS) dated 15&#160;December&#160;2003 (the &#8220;Master Agreement&#8221;)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Reinsurance Deposit Agreement (Charge Form - Citibank N.A. as Custodian) dated 15&#160;December&#160;2003(&#8220;Form 12&#8221;)&#59;</font></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Citibank Europe plc </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors&#58; Aidan M Brady, Mark Fitzgerald, Jim Farrell, Bo J. Hammerich (Sweden), Brian Hayes, Mary Lambkin, Frank McCabe, William J. Mills (USA), Terence O&#8217;Leary (U.K.), Cecilia Ronan, Patrick Scally, Christopher Teano (U.S.A.), Francesco Vanni d&#8217;Archirafi (Italy), Tony Woods. </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registered in Ireland&#58; Registration Number 132781. Registered Office&#58; 1 North Wall Quay, Dublin 1. </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultimately owned by Citigroup Inc., New York, U.S.A. </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Citibank Europe plc is regulated by the Central Bank of Ireland </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="citilogo.jpg" src="citilogo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Pledge Agreement dated 17&#160;January 2006 (&#8220;the Pledge Agreement&#8221;)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Collateral Account Control Agreement dated 17&#160;January 2006 (&#8220;the Collateral Account Control Agreement&#8221;)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Corporate Mandate dated 29&#160;April 2009&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">General Communications Indemnity dated 29&#160;April 2009.</font></div><div style="margin-bottom:9pt;padding-left:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of any inconsistency between the terms of this letter and the terms of any Facility Document, the terms of this letter shall prevail.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Conditions precedent</font></div><div style="margin-bottom:9pt;padding-left:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall not request the issue of any Credit until the Bank has received the documents and other evidence specified below in a form and substance satisfactory to the Bank (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condition Precedent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">the enclosed duplicate of this Letter, duly executed on behalf of the Company before 31 July 2012&#59; and </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">such other documents and other evidence as the Bank may reasonably require. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Utilisation requests</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Whenever the Company wishes the Bank (which, for purposes of this paragraph 5 shall include any branch or affiliate of the Bank that issues a Credit pursuant hereto) to issue a Credit under the Facility, it shall provide a duly completed application form in accordance with the provisions of the Master Agreement. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Bank shall be entitled to examine each request to issue a Credit on a case-by-case basis and, notwithstanding clause 1(a)(i) of the Master Agreement during the continuance of this Letter, shall only be entitled to decline any such request without liability where&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">such request would cause the Bank to be in breach of any law of any jurisdiction (including non-exclusively any breach of sanctions imposed by the law of the United States of America)&#59; or </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Credit requested is in a currency other than US dollars, GB pounds sterling, Canadian dollars or Euros&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">the tenor of a Tranche I Credit is longer than 12 months or the tenor of a Tranche II Credit is longer than 60 months, as applicable&#59; and&#47;or </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any deposit(s) as may have been requested by the Bank to be placed in the accounts established pursuant to the terms of the Form 12 and&#47;or Pledge and Collateral Account Control Agreements have not been carried out to the Bank&#8217;s satisfaction. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Interest </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company shall pay interest on the amount drawn by a Beneficiary under a Credit at a rate per annum of LIBOR plus 1% (plus Reserve Asset Costs, if any) from the date of drawing until the date of reimbursement by the Company. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Any interest accruing under this paragraph 6 shall be immediately payable by the Company on demand by the Bank. Overdue interest shall be compounded in accordance with the usual practice of the Bank in respect of unauthorised overdrafts.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Interest due from the Company under this Letter shall&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">be calculated and accrue from day to day&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">be calculated on the basis of the actual number of days elapsed and a 360 day year (or such other day count convention as is market practice for the relevant currency)&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="citilogo.jpg" src="citilogo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">be payable both before and after judgment. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Fees </font></div><div style="margin-bottom:9pt;padding-left:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees that the Company is obliged to pay to the Bank in connection with the Facility are as set out in the Fee Letter. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Repayment and expiry </font></div><div style="margin-bottom:9pt;padding-left:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Facility shall only apply in respect of Credits issued under Tranche 1 on or prior to 30 June 2014 (&#8220;the Tranche1 Facility Period&#8221;), and in the case of Tranche II on or prior to 30 June 2013 (&#8220;the Tranche 2 Facility Period&#8221;). Each tranche of the Facility shall expire on the earlier of (1) the date that is one year from the end of the relevant Tranche Facility Period&#59; or (2) the stated expiry date on the last remaining Credit issued within the relevant Tranche Facility Period (&#8220;the Expiry Date&#8221;). The Bank and the Company shall commence negotiations, without being under any obligation, regarding the renewal of the Facility at least 60 days before the end of the Tranche II Facility Period. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Representations and warranties </font></div><div style="margin-bottom:9pt;padding-left:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company represents and warrants to the Bank, on the date of its acceptance of this Letter and with reference to (f)(ii) below only on each day (by reference to the facts and circumstances then existing) until this Letter has expired or terminated, that&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">the Company (i) is duly organised, validly existing and (to the extent applicable) in good standing under the laws of its jurisdiction of incorporation or organisation, (ii) is duly qualified to do business and (to the extent applicable) in good standing in each jurisdiction where, because of the nature of its activities or properties, such qualification is required, (iii) has the requisite corporate power and authority and the right to own and operate its properties, to lease the property it operates under lease, and to conduct its business as now and proposed to be conducted, and (iv) has obtained all material licenses, permits, consents or approvals from or by, and has made all filings with, and given all notices to, all governmental authorities having jurisdictions, to the extent required for such ownership, operation and conduct (including, without limitation, the consummation of transactions contemplated by this Letter) as to each of the foregoing, except, in each case in clauses (ii), (iii) and (iv), where the failure to do so would not have a material adverse effect on the financial condition or prospects of the Group. </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The execution, delivery and performance by the Company of this Letter and the consummation of the transactions contemplated hereby are within the Company&#8217;s corporate powers, have been duly authorised by all necessary corporate action, and do not contravene (i) the Company&#8217;s constitutional documents or (ii) law or any contractual restriction binding on or affecting the Company. </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">No authorisation or approval or other action by, and no notice to or filing with, any governmental authority or regulatory body or any third party is required for the due execution, delivery and performance by the Company of this Letter or in respect of any Credit, except for those authorisations, approvals, actions, notices and filings that have been duly obtained, taken, given or made and are in full force and effect. </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This Letter has been duly executed and delivered by the Company and constitutes the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, subject to (i) the effect of any applicable bankruptcy, insolvency, reorganisation, moratorium or similar law affecting creditors&#8217; rights generally, (ii) the effect of general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or law). </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The consolidated financial statements included in the most recent 10Q filing of the Group, copies of which have been furnished to the Bank, fairly present the consolidated financial condition of the Group in accordance with generally accepted accounting principles consistently applied. Since the date of such filing there has been no material adverse change to the financial condition or property of the Company or the Group. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="citilogo.jpg" src="citilogo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">There is no pending or, to the knowledge of the Company, threatened action, suit, investigation, litigation or proceeding affecting any member of the Group before any court, governmental agency or arbitrator that (i) could be reasonably likely to have a material adverse effect on the financial position or prospects of the Group or (ii) purports to affect the legality, validity or enforceability of this Letter or any Facility Document or the consummation of the transactions contemplated hereby. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Undertakings </font></div><div style="margin-bottom:9pt;padding-left:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company undertakes to the Bank that it shall&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">ensure that the Bank receives each annual report on Form 10-K filed by Aspen Insurance Holdings Limited with the SEC as soon as it is available and in any event within 90 days of its financial year end&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">ensure that the Bank receives each quarterly report on Form 10-Q filed by Aspen Insurance Holdings Limited with the SEC as soon as it is available and in any event within 45 days of the end of the relevant quarter&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">promptly upon it becoming aware of the event, provide the Bank with notice of any change in the Company&#8217;s ownership structure such that its ultimate parent (as at the date of this Letter) ceases to own, directly or indirectly, a majority of the equity of the Company or upon any announcement of such a restructuring by the parent. Any such event shall entitle the Bank, at its sole discretion, to terminate the Facility. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Costs and expenses </font></div><div style="margin-bottom:9pt;padding-left:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company undertakes to indemnify the Bank, on demand, for and against all actions, proceedings, losses, damages, charges, costs, expenses, claims and demands which the Bank may incur, pay or sustain (apart from the Bank&#8217;s own gross negligence or wilful misconduct) in connection with this Letter (including non-exclusively the cost of all registrations and any other legal fees that the Bank incurs in relation to the Facility). </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Certificates </font></div><div style="margin-bottom:9pt;padding-left:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any demand, notification or certificate issued by the Bank specifying any amount due under this Letter or any Facility Document or any determination of any ratio shall, in the absence of manifest error, be conclusive and binding on the Company. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Miscellaneous</font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">The rights of the Bank under this Letter and the Facility Documents may be exercised as often as necessary&#59; are cumulative and not exclusive of its rights under the general law&#59; and may be waived only in writing and specifically. Delay in exercising or non-exercise of any such right is not a waiver of that right.</font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">If any provision of this Letter or any Facility Document is or becomes illegal, invalid or unenforceable in any jurisdiction, that shall not affect (i) the legality, validity or enforceability in that jurisdiction of any other provision of that document&#59; or (ii) the legality, validity or enforceability in any other jurisdiction of that or any other provision of that document. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">In no event shall the Bank be liable on any theory of liability for any special, indirect, consequential or punitive damages and the Company hereby waives, releases and agrees (for itself and on behalf of the other members of the Group) not to sue upon any such claim for any such damages, whether or not accrued and whether or not known or suspected to exist in its or their favour. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">The Bank may set off any obligation of the Company under the Facility Documents or in respect of any Credit (whether present or future, actual or contingent) against any obligation owed by the Bank to the Company or Citibank N.A., regardless of the place of payment, booking branch or currency of either obligation. If the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="citilogo.jpg" src="citilogo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"></div></div><div style="margin-bottom:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obligations are in different currencies, the Bank may convert either obligation at a market rate of exchange in its usual course of business for the purpose of the set-off. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">Clauses 13 and 14 &#91;Assignment&#47;Novation&#93; of the Master Agreement shall apply in respect of this Letter, with necessary changes. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">The terms of this Letter may not be waived, modified or amended unless such waiver, modification or amendment is in writing and signed by you nor may the Company assign any of its rights hereunder without the prior written consent of the Bank.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Definitions and interpretation </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">Terms defined in any Facility Document shall have the same meanings when used in this Letter. Additionally, the following terms have the following meanings. </font></div><div style="margin-bottom:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means a day (other than a Saturday or a Sunday) on which banks are generally open in Dublin and London. </font></div><div style="margin-bottom:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means the documents specified in paragraphs 3(a) through 3(e) and any other document pursuant to which a security interest, guarantee or other form of credit support is created or exists in favour of the Bank in respect of the obligations of the Company under this Letter. </font></div><div style="margin-bottom:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means the Company and each other person from time to time included in the consolidated financial statements of Aspen Insurance Holdings Limited filed with the Securities and Exchange Commission. </font></div><div style="margin-bottom:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means the overnight rate for US Dollars which appears on the screen display designated &#8220;Reuters Screen LIBOR01&#8221; on the Reuters Service (or such other screen display or service as may replace it for the purpose of displaying the relevant British Bankers&#8217; Association Interest Settlement Rates for deposits in US Dollars in the London interbank market) at or about 11.00 a.m. on the relevant day. </font></div><div style="margin-bottom:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarter Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means 1 January, 1 April, 1 July and 1 October. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">In this Letter (unless otherwise provided)&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">words importing the singular shall include the plural and vice versa&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">references to&#58; </font></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">paragraphs are to be construed as references to the paragraphs of this Letter&#59; </font></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">any document shall be construed as references to that document, as amended, varied, novated or supplemented&#59; </font></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">any statute or statutory provision shall include any statute or statutory provision which amends, extends, consolidates or replaces the same&#59;</font></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">any document or person being </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">acceptable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">approved</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">satisfactory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be construed as meaning acceptable to or approved by or satisfactory to the Bank in its sole discretion&#59; </font></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall be construed so as to include that person&#8217;s assignors, transferees or successors in title and shall be construed as including references to an individual, firm, partnership, joint venture, company, corporation, body corporate, unincorporated body of persons or any state or any agency of a state&#59; and </font></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">time are to London time. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">The headings in this Letter are for convenience only and shall be ignored in construing this Letter. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="citilogo.jpg" src="citilogo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Communications </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">Any notice or demand to be served on the Company by the Bank hereunder may be served&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Personally on any officers listed in the Company&#8217;s General Communications Indemnity dated 29 April 2009 as amended from time to time (such shall be referred to as &#8220;Authorized Officer(s)&#8221;)&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">by letter addressed to the Company or to any of its officers at the Company&#8217;s registered office or at any one of its principal places of business&#59; or </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">by telex or facsimile addressed in any such manner as aforesaid to any then published telex or facsimile number of the Company. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">Unless otherwise stated, any notice or demand to be served on the Bank by the Company hereunder must be served on the Bank either at its address stated at the beginning of this Letter (or such other address as the Bank may notify the Company of from time to time) or by facsimile to such number as the Bank may notify the Company of from time to time. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">Any notice or demand&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">sent by post shall be deemed to have been served on the relevant party on the third Business Day after and exclusive of the day of posting&#59; or </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">sent by telex or facsimile shall be deemed to have been served on the relevant party when confirmation is received. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In proving such service by post it shall be sufficient to show that the letter containing the notice or demand was properly addressed and posted and such proof of service shall be effective notwithstanding that the letter was in fact not delivered or was returned undelivered. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Governing law </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">This Letter shall be governed by English law and for the benefit of the Bank the Company irrevocably submits to the jurisdiction of the English Courts in respect of any dispute which may arise from or in connection with this Letter or any Credit. </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">A person who is not a party to this Letter has no rights under the Contracts (Rights of Third Parties) Act 1999 to enforce any terms of this Letter. </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Anti-Tying </font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5pt">Citigroup&#8217;s Corporate and Investment Bank&#8217;s anti-tying policies are incorporated herein by reference.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yours faithfully,</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.224%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Niall Tuckey</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For and on behalf of Citibank Europe plc</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accepted and agreed on</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David Skinner</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For and on behalf of Aspen Bermuda Limited</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accepted and agreed on</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Fred Lemoine</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For and on behalf of Aspen Bermuda Limited</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.19
<SEQUENCE>30
<FILENAME>exhibit1019-fx1.htm
<DESCRIPTION>EX-10.19
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib894651256594a5f9fd9e88423b5523d_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.19</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1 North Wall Quay</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">T +353 1 622 2000</font></div></td><td colspan="3" rowspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="exhibit10191a.jpg" src="exhibit10191a.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:69px"></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dublin 1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">F +353 1 622 2222</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Ireland</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:20pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.121%"><tr><td style="width:1.0%"></td><td style="width:53.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Niall Tuckey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Director</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">ILOC Product</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Citibank Europe plc</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1 North Wall Quay</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Dublin 1, Ireland</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Tel+353 (1) 622 7430</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fax+353 (1) 622 2741</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Niall.Tuckey&#64;Citi.com</font></div></td></tr></table></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.326%"><tr><td style="width:1.0%"></td><td style="width:22.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FROM&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Citibank Europe plc (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Bank&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TO&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Bermuda Limited (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Company&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141 Front Street</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton HM19</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Jazmin Da Ponte</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DATE&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30th June 2014</font></div></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Jazmin,</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committed Facility Letter dated 30 July 2012 between the Bank and the Company regarding a committed letter of credit facility in a maximum aggregate amount of USD 950,000,000, as amended, varied, supplemented, novated or assigned as the case may be (the &#8220;Committed Facility Letter&#8221;).</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;We refer to the Committed Facility Letter. Defined terms used in this letter shall have the meanings given to them in the Committed Facility Letter (including where defined in the Committed Facility Letter by reference to another document).</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Bank and the Company agree, for good and valuable consideration, the receipt and legal sufficiency of which are hereby acknowledged, that as effective from the date of this letter&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Clause 2 of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The Facility shall be in a maximum aggregate amount of USD 575,000,000 (five hundred and seventy five million United States Dollars) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility Limit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Should the Company (as defined below) wish to reduce the Facility Limit, it may do so upon written notification to the Bank. The notification (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) must (i) specifically reference this Letter and (ii) clearly state the new facility limit that is to apply (&#8220;the New Limit&#8221;). The New Limit will take effect five Business Days following receipt, by the Bank, of the Notification.&#8221;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Clause 5.2 (c) of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;the tenor of a Credit is longer than 12 months&#59; and&#47;or&#8217; </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Clause 8 of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The facility shall only apply in respect of Credits issued on or prior to 30 June 2016 (the &#8220;Facility Period&#8221;). The Facility shall expire on the earlier of (1) the date that is one year from the end of the Facility Period&#59; or (2) the stated expiry date on the last remaining Credit issued within the Facility Period (the &#8220;Expiry Date&#8221;). The Bank and the Company shall commence </font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Citibank Europe plc</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Directors&#58; Aidan M Brady, Mark Fitzgerald, Jim Farrell, Bo J. Hammerich (Sweden), Brian Hayes, Mary Lambkin, Frank McCabe, William J. Mills (USA), </font></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Terence O&#8217;Leary (U.K.), Cecilia Ronan, Patrick Scally, Christopher Teano (U.S.A.), Francesco Vanni d&#8217;Archirafi (Italy), Tony Woods.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Registered in Ireland&#58; Registration Number 132781. Registered Office&#58; 1 North Wall Quay, Dublin 1.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Ultimately owned by Citigroup Inc., New York, U.S.A.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Citibank Europe plc is regulated by the Central Bank of Ireland</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.333%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:48pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="exhibit10191a.jpg" src="exhibit10191a.jpg" style="height:45px;margin-bottom:5pt;vertical-align:text-bottom;width:72px"></div></td></tr></table></div></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">negotiations, without being under any obligation, regarding the renewal of the Facility at least 60 days before the end of the Facility Period.&#8221;</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Except as expressly amended by this letter, the Committed Facility Letter remains unmodified and in full force and effect. In the event of a conflict or inconsistency between the terms of this letter and the terms of the Committed Facility Letter, the terms of this letter shall prevail.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;This letter may be executed in counterparts, each of which shall be deemed to be an original, and all such counterparts taken together shall constitute one and the same agreement.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;This letter and any non-contractual obligations arising in connection with it shall be governed by English law and for the benefit of the Bank the Company irrevocably submits to the jurisdiction of the English courts in respect of any dispute which may arise from or in connection with this letter.</font></div><div style="margin-bottom:20pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Please indicate your agreement to the foregoing by countersigning the attached copy of this letter and returning the same to us.</font></div><div style="margin-bottom:50pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.121%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For and on behalf of</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Citibank Europe plc</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Niall Tuckey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;Niall Tuckey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;Director</font></td></tr></table></div><div style="margin-bottom:25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We agree to the terms set out in this letter.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.974%"><tr><td style="width:1.0%"></td><td style="width:37.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For and on behalf of</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aspen Bermuda Limited</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Bryan Astwood</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Fred Lemoine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;Bryan Astwood</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;Fred Lemoine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;Chief Investment Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;Chief Financial Officer</font></td></tr></table></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Citibank Europe plc</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Directors&#58; Aidan M Brady, Mark Fitzgerald, Jim Farrell, Bo J. Hammerich (Sweden), Brian Hayes, Mary Lambkin, Frank McCabe, William J. Mills (USA), </font></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Terence O&#8217;Leary (U.K.), Cecilia Ronan, Patrick Scally, Christopher Teano (U.S.A.), Francesco Vanni d&#8217;Archirafi (Italy), Tony Woods.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Registered in Ireland&#58; Registration Number 132781. Registered Office&#58; 1 North Wall Quay, Dublin 1.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Ultimately owned by Citigroup Inc., New York, U.S.A.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Citibank Europe plc is regulated by the Central Bank of Ireland</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>31
<FILENAME>exhibit1020-fx1.htm
<DESCRIPTION>EX-10.20
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ief89b01a18f34d9591a8203719109973_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.20</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.615%"><tr><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1 North Wall Quay</font></div><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dublin 1</font></div><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">T +353 1 622 2000</font></div><div><font style="color:#a1a3a7;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">F +353 1 622 2222</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:44pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><img alt="citilogo2.jpg" src="citilogo2.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:72px"></div></td></tr></table></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.352%"><tr><td style="width:1.0%"></td><td style="width:41.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.498%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Niall Tuckey</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Citibank Europe plc</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 North Wall Quay</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">ILOC Product</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dublin 1, Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tel+353 (1) 622 7430</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fax+353 (1) 622 2741</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Niall.Tuckey&#64;Citi.com</font></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FROM&#58;&#160;&#160;&#160;&#160;Citibank Europe plc (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Bank&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO&#58;&#160;&#160;&#160;&#160;Aspen Bermuda Limited (the &#8220;Company&#8221;)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141 Front Street</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hamilton HM19</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Mark Pickering</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DATE&#58; &#160;&#160;&#160;&#160;30 June 2016</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Sir&#47;Madam,</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committed Facility Letter dated 30 July 2012 between the Bank and the Company regarding a committed letter of credit facility in a maximum aggregate amount of USD 575,000,000, as amended, varied, supplemented, novated or assigned as the case may be (the &#8220;Committed Facility Letter&#8221;).</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">We refer to the Committed Facility Letter. Defined terms used in this letter shall have the meanings given to them in the Committed Facility Letter (including where defined in the Committed Facility Letter by reference to another document).</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Bank and the Company agree, for good and valuable consideration, the receipt and legal sufficiency of which are hereby acknowledged, that as effective from the date of this letter&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Clause 2 of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The Facility shall be in a maximum aggregate amount of USD 550,000,000 (five hundred and fifty million United States Dollars) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility Limit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Should the Company (as defined below) wish to reduce the Facility Limit, it may do so upon written notification to the Bank. The notification (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) must (i) specifically reference this Letter and (ii) clearly state the new facility limit that is to apply (&#8220;the New Limit&#8221;). The New Limit will take effect five Business Days following receipt, by the Bank, of the Notification.&#8221;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">Clause 5.2 (c) of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;the tenor of a Credit is no longer than 24 months&#59; and&#47;or&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Directors&#58; Breffni Byrne, Susan H. Dean (U.K.), Jim Farrell, Bo J. Hammerich (Sweden), Deepak Jain (U.K.), Mary Lambkin, Marc Luet (France), Rajesh Mehta (India), </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Cecilia Ronan, Patrick Scally, Christopher Teano (U.S.A.), Zdenek Turek (Czech Republic) Francesco Vanni d&#8217;Archirafi (Italy), Tony Woods</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Registered in Ireland&#58; Registration Number 132781. Registered Office&#58; 1 North Wall Quay, Dublin 1.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Ultimately owned by Citigroup Inc., New York, U.S.A.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Citibank Europe plc is regulated by the Central Bank of Ireland</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">Clause 8 of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The facility shall only apply in respect of Credits issued on or prior to 30 June 2018 (the &#8220;Facility Period&#8221;). The Facility shall expire on the earlier of (1) the date that is one year from the end of the Facility Period&#59; or (2) the stated expiry date on the last remaining Credit issued within the Facility Period (the &#8220;Expiry Date&#8221;). The Bank and the Company shall commence negotiations, without being under any obligation, regarding the renewal of the Facility at least 60 days before the end of the Facility Period.&#8221;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Except as expressly amended by this letter, the Committed Facility Letter remains unmodified and in full force and effect.  In the event of a conflict or inconsistency between the terms of this letter and the terms of the Committed Facility Letter, the terms of this letter shall prevail.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">This letter may be executed in counterparts, each of which shall be deemed to be an original, and all such counterparts taken together shall constitute one and the same agreement.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">This letter and any non-contractual obligations arising in connection with it shall be governed by English law and for the benefit of the Bank the Company irrevocably submits to the jurisdiction of the English courts in respect of any dispute which may arise from or in connection with this letter.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Please indicate your agreement to the foregoing by countersigning the attached copy of this letter and returning the same to us.</font></div><div style="margin-bottom:18pt;padding-left:27pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.788%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For and on behalf of</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Citibank Europe plc</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Niall Tuckey<br></font></td></tr><tr><td colspan="3" style="border-top:1pt dotted #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Niall Tuckey Title&#58;Director</font></td></tr></table></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We agree to the terms set out in this letter.</font></div><div style="padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.230%"><tr><td style="width:1.0%"></td><td style="width:45.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For and on behalf of</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aspen Bermuda Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Fred Lemoine<br></font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark Pickering<br></font></td></tr><tr><td colspan="3" style="border-top:1pt dotted #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;Fred Lemoine</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dotted #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;Mark Pickering</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;CFO, Aspen Bermuda Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;Group Treasurer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>32
<FILENAME>exhibit1021-fx1.htm
<DESCRIPTION>EX-10.21
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i86c953a38a354376a0140cc7e1c0759a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.21</font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DEED OF AMENDMENT</font></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date&#58; 29 June 2018</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Between&#58;</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(1) Citibank Europe plc (&#8220;Citibank&#8221;)&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(2) Aspen Bermuda Limited (the &#8220;Company&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1. Background</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1 On 30 July 2012 a Committed Facility Letter for Issuance of Payment Instruments was signed between Citibank and the Company, as amended by a Letter of Amendment dated 30 June 2014 and a Letter of Amendment dated 30 June 2016 (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;Committed Facility Letter&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">). </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.2 The Parties have agreed certain amendments to the Committed Facility Letter as detailed in this deed. </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.3 Terms and expressions defined in the Committed Facility Letter shall have the same meanings when used in this deed unless the context otherwise requires or the contrary is otherwise indicated. </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.4 The parties to this deed hereby agree that from the Effective Date (as defined below) the rights and obligations of the parties under the Committed Facility Letter and the terms of the Committed Facility Letter shall be amended as specifically set out below. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2. Effective Date</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following amendments shall take effect on and from 30 June 2018 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3. Amendments</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With effect from the Effective Date, the the following amendments shall be made to the Committed Facility Letter&#58;</font></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Clause 5.2 (c) of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;the tenor of a Credit is no longer than 24 months&#59; and&#47;or&#8221;</font></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Clause 8 of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;The facility shall only apply in respect of Credits issued on or prior to 30 June 2020 (the &#8220;Facility Period&#8221;). The Facility shall expire on the earlier of (1) the date that is one year from the end of the Facility Period&#59; or (2) the stated expiry date on the last remaining Credit issued within the Facility Period (the &#8220;Expiry Date&#8221;). The Bank and the Company shall commence negotiations, without being under any obligation, regarding the renewal of the Facility at least 60 days before the end of the Facility Period.&#8221;</font></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;A new Clause 18 (Data Protection) to be inserted to the Committed Facility Letter as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;18. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Data Protection</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:30pt">Definitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The terms </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8216;personal data&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8216;processing&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8216;data subject&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8216;supervisory authority&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall have the respective meanings set forth in the General Data Protection Regulation (EU) 2016&#47;679, as amended or superseded from time-to-time.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:32pt">Compliance with law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Each party will comply with applicable data protection and privacy laws in processing personal data in connection with its activities under this Fee Letter. Without limiting the foregoing, the Company warrants that&#58; (i) any personal data that it provides to the Bank has been processed fairly and lawfully, is accurate and is relevant for the purposes for which it is provided to the Bank&#59; (ii) it shall provide notice to, and shall seek consent from (and promptly upon the Bank&#8217;s request shall provide evidence to the Bank of having provided such notices and&#47;or obtained such consents), data subjects regarding the Bank&#8217;s processing of their personal data in accordance with any instructions of the Bank from time to time&#59; and (iii) pursuant to clause (ii) it will provide data subjects with a copy of the relevant TTS EEA Privacy Statement accessible at https&#58;&#47;&#47;www.citibank.com&#47;tts&#47;sa&#47;tts-privacy-statements&#47;index.html (or such other URL or statement as the Bank may notify to the Company from time to time). </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:32pt">Mutual cooperation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In respect of the personal data a Party processes under or in connection with this Agreement, the Party&#58;</font></div><div style="margin-bottom:9pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;will promptly notify, and reasonably cooperate with and provide information to, the other party in respect of any data subject requests, communications from supervisory authorities, or material security incidents relating to the processing of personal data under this Committed Facility Letter, in each case to the extent reasonably necessary to enable the other party to meet its obligations to data subjects and&#47;or supervisory authorities.</font></div><div style="margin-bottom:9pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;will implement and maintain reasonable and appropriate technical and organisational security measures to protect the personal data that is within its custody or control against unauthorised or unlawful processing and against accidental loss or destruction of, or damage to the personal data&#59; and</font></div><div style="margin-bottom:9pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;will ensure that employees who have access to the personal data have undergone training in the care and handling of personal data.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4. Costs and expenses</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each party to this deed shall bear its own costs and expenses in relation to the amendments agreed pursuant to the terms of this deed. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5. Affirmation and acceptance</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.1 With effect from the Effective Date, the terms and conditions of the Committed Facility Letter shall be read and construed by reference to this deed and all references to the Committed Facility Letter shall be deemed to incorporate the relevant amendments contained within this deed and all references in the Committed Facility Letter to &#8220;this Committed Facility Letter&#8221; shall with effect from the Effective Date be references to the Committed Facility Letter as amended by this deed.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.2 In the event of any conflict between the terms of this deed and the Committed Facility Letter, the terms of this deed shall prevail. </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.3 For the avoidance of doubt, except as amended by the terms of this deed, all of the terms and conditions of the Committed Facility Letter shall continue to apply and remain in full force and effect. </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.5 The Company shall, at the request of Citibank, do all such acts necessary or desirable to give effect to the amendments effected or to be effected pursuant to the terms of this deed. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6. Continuation of Security</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company confirms that, on and after the Effective Date&#58;</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) notwithstanding the amendments made to the Committed Facility Letter pursuant to this deed, the Amended and Restated Pledge Agreement dated 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> December 2014 between the Company and Ciitbank (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pledge Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and any security granted under it continues in full force and effect&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b) such Pledge Agreement and security extends to the Committed Facility Letter, as amended pursuant to this deed.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7. Counterparts</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This deed may be executed in counterparts, each of which shall be deemed to be an original, and all such counterparts taken together shall constitute one and the same agreement.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8. Third party rights</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No person shall have any right to enforce any provision of this deed under the Contracts (Rights of Third Parties) Act 1999. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9. Governing law</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This deed (and any non-contractual obligation, dispute, controversy, proceedings or claim of whatever nature arising out of it or in any way relating to this deed or its formation) shall be governed by and construed in accordance with English law. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Signatories to the deed of amendment</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:20pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">EXECUTED AS A DEED BY OR ON BEHALF OF THE COMPANY </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and signed by the persons specified on the right </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">acting in accordance with the laws of Bermuda,</font><font style="color:#c0c0c0;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:50pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">under the authority of the Company pursuant to a unanimous decision by the Board of Directors of Aspen Bermuda Limited at a board meting dated 2 May 2018 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">GIVEN UNDER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">the Common Seal of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;CITIBANK EUROPE PLC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and delivered as a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DEED&#58;</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Signed &#47;s&#47; Bryan Astwood</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Name Bryan Astwood</font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Title Director</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Signed &#47;s&#47; Marcus Foley</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Name Marcus Foley</font></div><div style="margin-bottom:60pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Title Director</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Director&#58; &#47;s&#47; Cecilia Ronan Secretary&#58; &#47;s&#47; Fiona Mahon</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>33
<FILENAME>exhibit1022-fx1.htm
<DESCRIPTION>EX-10.22
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iba460b7c315c4bda913bc90fe9a35af9_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.22</font></div></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DEED OF AMENDMENT</font></div><div style="margin-bottom:11pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date&#58; 20 September 2019</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Between&#58;</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(1) Citibank Europe plc (&#8220;Citibank&#8221;)&#59; and</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(2) Aspen Bermuda Limited (the &#8220;Company&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;Background</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;On 30 July 2012 a Committed Facility Letter for Issuance of Payment Instruments was signed between Citibank and the Company, as amended by a Letter of Amendment dated 30 June 2014 and a Letter of Amendment dated 30 June 2016 and a Deed of Amendment dated 21 June 2018 (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;Committed Facility Letter&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;The Parties have agreed certain amendments to the Committed Facility Letter as detailed in this deed. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.3&#160;&#160;&#160;&#160;Terms and expressions defined in the Committed Facility Letter shall have the same meanings when used in this deed unless the context otherwise requires or the contrary is otherwise indicated. </font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;The parties to this deed hereby agree that from the Effective Date (as defined below) the rights and obligations of the parties under the Committed Facility Letter and the terms of the Committed Facility Letter shall be amended as specifically set out below. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Effective Date</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following amendments shall take effect on and from 20 September 2019 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;Amendments</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With effect from the Effective Date, the the following amendments shall be made to the Committed Facility Letter&#58;</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:7.63pt">Clause 2 of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:11pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">&#8220;The Facility shall be in a maximum aggregate amount of USD 500,000,000 (five hundred million United States Dollars) (the &#8220;Facility Limit&#8221;). Should the Company (as defined below) wish to reduce the Facility Limit, it may do so upon written notification to the Bank. The notification (the &#8220;Notification&#8221;) must (i) specifically reference this Letter and (ii) clearly state the new facility limit that is to apply (&#8220;the New Limit&#8221;). The New Limit will take effect five Business Days following receipt, by the Bank, of the Notification.&#8221;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;Costs and expenses</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each party to this deed shall bear its own costs and expenses in relation to the amendments agreed pursuant to the terms of this deed. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;Affirmation and acceptance</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.1&#160;&#160;&#160;&#160;With effect from the Effective Date, the terms and conditions of the Committed Facility Letter shall be read and construed by reference to this deed and all references to the Committed Facility Letter shall be deemed to incorporate the relevant amendments contained within this deed and all references in the Committed Facility Letter to &#8220;this Committed Facility Letter&#8221; shall with effect from the Effective Date be references to the Committed Facility Letter as amended by this deed.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.2&#160;&#160;&#160;&#160;In the event of any conflict between the terms of this deed and the Committed Facility Letter, the terms of this deed shall prevail. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.3&#160;&#160;&#160;&#160;For the avoidance of doubt, except as amended by the terms of this deed, all of the terms and conditions of the Committed Facility Letter shall continue to apply and remain in full force and effect. </font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.5&#160;&#160;&#160;&#160;The Company shall, at the request of Citibank, do all such acts necessary or desirable to give effect to the amendments effected or to be effected pursuant to the terms of this deed. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;Continuation of Security</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company confirms that, on and after the Effective Date&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) notwithstanding the amendments made to the Committed Facility Letter pursuant to this deed, the Amended and Restated Pledge Agreement dated 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> December 2014 between the Company and Citibank (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pledge Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and any security granted under it continues in full force and effect&#59; and</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b) such Pledge Agreement and security extends to the Committed Facility Letter, as amended pursuant to this deed.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;Counterparts</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This deed may be executed in counterparts, each of which shall be deemed to be an original, and all such counterparts taken together shall constitute one and the same agreement. This amendment shall take effect as a deed notwithstanding it is signed under hand by Citibank.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;Third party rights</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No person shall have any right to enforce any provision of this deed under the Contracts (Rights of Third Parties) Act 1999. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;Governing law</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This deed (and any non-contractual obligation, dispute, controversy, proceedings or claim of whatever nature arising out of it or in any way relating to this deed or its formation) shall be governed by and construed in accordance with English law. </font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;signature pages to follow&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="iba460b7c315c4bda913bc90fe9a35af9_54"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Signatories to the deed of amendment</font></div><div style="margin-bottom:30pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.216%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">EXECUTED AS A DEED BY OR ON BEHALF OF THE COMPANY</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Signed &#47;s&#47; Mark Pickering</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Name Mark Pickering</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and signed by the persons specified on the right acting in accordance with the laws of Bermuda, under the authority of the Company pursuant to a resolution of Aspen Bermuda Limited dated July 31, 2019&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Title Director</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Signed &#47;s&#47; Bryan Astwood</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name Bryan Astwood</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title Director</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WE HEREBY CONFIRM OUR ACCEPTANCE ON BEHALF OF CITIBANK&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:30.128%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Niall Tuckey</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Niall Tuckey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.23
<SEQUENCE>34
<FILENAME>exhibit1023-fx1.htm
<DESCRIPTION>EX-10.23
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6296afa7e90d4f2aa19d7b3a9906d914_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.23</font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DEED OF AMENDMENT</font></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date&#58; June 26, 2020 </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Between&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(1) Citibank Europe plc (&#8220;Citibank&#8221;)&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(2) Aspen Bermuda Limited (the &#8220;Company&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1. Background</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1 On 30 July 2012 a Committed Facility Letter for Issuance of Payment Instruments was signed between Citibank and the Company, as amended by Letters of Amendment dated 30 June 2014 and 30 June 2016, and Deeds of Amendment dated 21 June 2018 and 20 September 2019 (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;Committed Facility Letter&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.2 The Parties have agreed certain amendments to the Committed Facility Letter as detailed in this deed. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.3 Terms and expressions defined in the Committed Facility Letter shall have the same meanings when used in this deed unless the context otherwise requires or the contrary is otherwise indicated. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.4 The parties to this deed hereby agree that from the Effective Date (as defined below) the rights and obligations of the parties under the Committed Facility Letter and the terms of the Committed Facility Letter shall be amended as specifically set out below. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2. Effective Date</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following amendments shall take effect on and from 30 June 2020 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3. Amendments</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With effect from the Effective Date, the the following amendments shall be made to the Committed Facility Letter&#58;</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.Clause 8 of the Committed Facility Letter shall be amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;The facility shall only apply in respect of Credits issued on or prior to 30 June 2022 (the &#8220;Facility Period&#8221;). The Facility shall expire on the earlier of (1) the date that is one year from the end of the Facility Period&#59; or (2) the stated expiry date on the last remaining Credit issued within the Facility Period (the &#8220;Expiry Date&#8221;). The Bank and the Company shall commence negotiations, without being under any obligation, regarding the renewal of the Facility at least 60 days before the end of the Facility Period.&#8221;</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4. Costs and expenses</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each party to this deed shall bear its own costs and expenses in relation to the amendments agreed pursuant to the terms of this deed. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5. Affirmation and acceptance</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.1 With effect from the Effective Date, the terms and conditions of the Committed Facility Letter shall be read and construed by reference to this deed and all references to the Committed Facility Letter shall be deemed to incorporate the relevant amendments contained within this deed and all references in the Committed Facility Letter to &#8220;this Committed Facility Letter&#8221; shall with effect from the Effective Date be references to the Committed Facility Letter as amended by this deed.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.2 In the event of any conflict between the terms of this deed and the Committed Facility Letter, the terms of this deed shall prevail. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.3 For the avoidance of doubt, except as amended by the terms of this deed, all of the terms and conditions of the Committed Facility Letter shall continue to apply and remain in full force and effect. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.4 The Company shall, at the request of Citibank, do all such acts necessary or desirable to give effect to the amendments effected or to be effected pursuant to the terms of this deed. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6. Continuation of Security</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company confirms that, on and after the Effective Date&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) notwithstanding the amendments made to the Committed Facility Letter pursuant to this deed, the Amended and Restated Pledge Agreement dated 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> December 2014, between the Company and Citibank, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pledge Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and any security granted under it continues in full force and effect&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b) such Pledge Agreement and security extends to the Committed Facility Letter, as amended pursuant to this deed.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7. Counterparts</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This deed may be executed in counterparts, each of which shall be deemed to be an original, and all such counterparts taken together shall constitute one and the same agreement. This amendment shall take effect as a deed notwithstanding it is signed under hand by Citibank.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8. Third party rights</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No person shall have any right to enforce any provision of this deed under the Contracts (Rights of Third Parties) Act 1999. </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9. Governing law</font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This deed (and any non-contractual obligation, dispute, controversy, proceedings or claim of whatever nature arising out of it or in any way relating to this deed or its formation) shall be governed by and construed in accordance with English law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Signatories to the deed of amendment</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:63.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EXECUTED AS A DEED BY OR ON BEHALF OF THE COMPANY</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Signed</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Mark Pickering</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Pickering</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">and signed by the persons specified on the right</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">acting in accordance with the laws of Bermuda,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">under the authority of the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">pursuant to a resolution of Aspen Bermuda Limited dated&#58; </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Signed</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Bryan Astwood</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bryan Astwood</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Investment Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">I&#47;WE HEREBY CONFIRM OUR ACCEPTANCE ON BEHALF OF CITIBANK</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.243%"><tr><td style="width:1.0%"></td><td style="width:38.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.489%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Niall Tuckey</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Niall Tuckey</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>35
<FILENAME>exhibit1024-fx1.htm
<DESCRIPTION>EX-10.24
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i934f5a4554ae4a8aad7499d702260dde_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.24</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ff0000;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AMENDED AND RESTATED PLEDGE AGREEMENT</font></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED PLEDGE AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, dated as of December 18, 2014 (as may be amended, restated or otherwise modified from time to time, this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), made among </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN BERMUDA LIMITED</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a company organized and existing under the laws of Bermuda whose address of its registered or principal office is at 141 Front Street, Hamilton, HM19 Bermuda (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pledgor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CITIBANK EUROPE plc </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(as successor by assignment to Citibank, N.A.&#59; referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pledgee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRELIMINARY STATEMENTS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:59.78pt">The Pledgor and the Pledgee have entered into a master agreement, dated as of December 15, 2003 (as form time to time amended, the &#8220;Master Agreement&#8221;) pursuant to which the Pledgee may, from time to time in its sole discretion, issue for the account of the Pledgor letters of credit or similar or equivalent instruments (each a &#8220;Credit&#8221; and, collectively, the &#8220;Credits&#8221;).</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:59.78pt">The Pledgor has agreed to collateralize its obligations to the Pledgee that result from time to time under the Master Agreement and in respect of the Credits issued thereunder, whether now existing or from time to time hereafter incurred or arising, as such obligations are more fully defined in Section 3 of this Agreement as the Secured Obligations (as such term is defined in Section 3 below).</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:59.78pt">The Pledgor and the Pledgee desire to execute and deliver this Agreement for the purpose of securing the Secured Obligations and subjecting the property hereinafter, described to the Lien of this Agreement as security for the performance of the Secured Obligations.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:59.78pt">The Pledgor has opened the accounts as set forth in the Amended and Restated Account Control Agreement, dated as of December 18, 2014 (as amended from time to time, the &#8220;Control Agreement&#8221;) among Pledgor, Pledgee and The Bank of New York Mellon, including the Deposit Account defined in the Control Agreement (the &#8220;Deposit Account&#8221;), the Securities Account defined in the Control Agreement (the &#8220;Securities Account&#8221;) and the Money Market Funds Account defined in the Control Agreement (the &#8220;Money Market Funds Account&#8221; and together with the Deposit Account and the Securities Account, the &#8220;Account&#8221;) with The Bank of New York Mellon at its office at 101 Barclay Street, New York, NY 10286 U.S.A. (&#8220;Financial Institution&#8221;).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NOW, THEREFORE, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in consideration of the premises and in order to induce the Pledgee to enter into transactions with and to provide services to the Pledgor and its subsidiaries pursuant to separate agreements or arrangements between such persons and the Pledgee, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except as otherwise expressly provided herein, capitalized terms used herein shall have the meaning assigned to such terms in Appendix A.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 2. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Grant of Security</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Subject to and in accordance with the provisions of this Agreement, the Pledgor hereby assigns, pledges and grants to the Pledgee a first priority security interest in and a Lien on all of the Pledgor's right, title and interest, whether now owned or hereafter acquired, in all of the following (collectively, the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Collateral&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the Account&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the Securities and any Instruments or other Financial Assets credited to the Account or otherwise acquired by the Pledgee in any manner and under its control as Collateral (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pledged Securities&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) including, without limitation Securities of the type and in the aggregate amounts specified in Schedule I hereto and any Securities Account and Security Entitlement in respect of the Account, the Pledged Securities or any of them&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;all additional Investment Property (including without limitation) Securities, Security Entitlements, Financial Assets, or other property and all funds, cash or cash equivalents (together with any applicable Account or Securities Account) from time to time (A) received, receivable or otherwise distributed in respect of or in exchange or substitution for any other Collateral (all such funds, cash or cash equivalents to be Financial Assets for the purposes of this Agreement) or (B) otherwise acquired by the Pledgor in any manner and delivered to Pledgee or under the control of Pledgee as Collateral&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;All proceeds (including, without limitation, cash proceeds) of any or all of the foregoing, including without limitation, proceeds that constitute property of the types described in clauses (i), (ii) and (iii) above.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 3. Security of Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement (and the Collateral pledged hereunder) secures the payment of all obligations of the Pledgor now or hereafter existing under each Master Agreement (including all contingent obligations with respect to credit(s) issued or procured for issuance by the Pledgee for the Pledgor&#8217;s account) and this Agreement, whether direct or indirect, absolute or contingent, and whether for principal, interest, fees, expenses or otherwise and the payment of any and all reasonable expenses (including reasonable counsel fees and expenses) incurred by the Pledgee in enforcing any rights under this Agreement (all such obligations being the &#8220;Secured Obligations&#8221;). Subject to the provisions set forth in the Control Agreement, this Agreement is intended to convey to the Pledgee, and hereby grants to the Pledgee, the right and power to exercise exclusive control over the Account and all Security Entitlements relating thereto, and the sold right and power to direct dispositions of all cash deposits in the Account for the purposes of sections 9-106(c) and 9-104(b) of the NYUCC. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 4. Delivery of Security Collateral</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">On or prior to the date hereof, the Pledgor shall transfer or credit, or cause to be transferred or credited, all of the Pledged Securities to the Pledgee or to the Account under arrangements acceptable to the Pledgee in its sole discretion. Pledgor shall deliver all other Collateral to the Pledgee or to a Securities Intermediary subject to the control of the Pledgee under arrangements acceptable to the Pledgee in its sole discretion. Upon the occurrence and during the continuance of an Event of Default (and until such time as such Event of Default is cured to the satisfaction of Pledgee), the Pledgee shall have the right, at any time it reasonably determines is necessary or desirable to enable the Pledgee to better perfect or protect the security interests granted hereunder, upon notice to the Pledgor, to transfer to or to register in the name of the Pledgee or any of its nominees any or all of the Collateral.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">At any time and upon thirty (30) days notice, the Pledgee may require the Pledgor to transfer the Collateral from the Account to an account at Citibank, N.A. (London, England branch) (&#8220;CBNA-UK&#8221;) and to execute a replacement deposit agreement (in substantially the customary form used by CBNA-UK, a copy of which deposit agreement has been provided to Pledgor) in substitution for this Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 5. Use of Proceeds</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Proceeds that are received in respect of any Collateral shall be held as cash as Collateral as provided in Section 2 of this Agreement and shall be deposited and maintained in the Account.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 6. Representations and Warranties.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Pledgor represents and warrants as follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Pledgor is a corporation duly organized and, validly existing under the laws of its incorporation and has all requisite corporate power and authority (including, without limitation, all governmental licenses, permits and other approvals except where such failure would not have a material adverse effect on the Pledgor's business), to own or lease and operate its properties and to carry on its business as now conducted and as proposed to be conducted. All of the outstanding capital stock of the Pledgor has been validly issued, is fully paid and non-assessable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The execution, delivery and performance by the Pledgor of this Agreement, and the consummation of the transactions contemplated hereby, are within the Pledgor's corporate powers and have been duly authorized by all necessary corporate action.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The execution, delivery and performance by the Pledgor of this Agreement and the consummation of the transactions contemplated hereby do not and will not (i) violate any provision of law, rule or regulation applicable to the Pledgor&#59; (ii) conflict with the charter or bylaws or substantively similar constitutive documents of the Pledgor&#59; or (iii) conflict with or result in a breach of, or constitute a default under, or result in the creation or imposition of, any Lien upon any of the property or assets of the Pledgor or any of its subsidiaries, under any indenture, loan agreement, mortgage, deed of trust or other instrument or agreement to which the Pledgor or any of its subsidiaries may be or become a party or by which it may be or become bound or to which the property or assets of the Pledgor of any of its subsidiaries may be or become subject.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;No consent of any other Person and no authorization, approval or other action by, and no notice to or filing with, any governmental authority or regulatory body or other third party is required either (i) for the grant by the Pledgor of the assignment and security interest granted hereby, for the pledge by the Pledgor of the Collateral pursuant hereto or for the execution, delivery or performance of this Agreement by the Pledgor, (ii) for the perfection or maintenance of the pledge, assignment and security interest created hereby (including the first priority nature of such pledge, assignment or security interest) or (iii) for the exercise by the Pledgee of its rights provided for in this Agreement or the remedies in respect of the Collateral pursuant to this Agreement, except as may be required in connection with the disposition of any portion of the Collateral by laws affecting the offering and sale of securities generally or as may be applicable to the Pledgee.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;This Agreement has been duly executed and delivered by the Pledgor. This Agreement constitutes, or when executed and delivered will constitute, the legal, valid and binding obligation of the Pledgor enforceable against the Pledgor in accordance with its terms, subject as to enforceability to applicable bankruptcy, insolvency, and similar laws affecting creditors' rights generally.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;The Pledgor is the legal and beneficial owner of the Collateral and Pledgor has and shall at all times have rights in, and good and valid title to, the Collateral, free and clear of all Liens and &#8220;adverse claims&#8221; (as such term is defined in Section 8-102(a)(1) of the NYUCC).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;To the best of the Pledgor's knowledge, no default has occurred under or with respect to any Collateral as of the date hereof.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;(i) This agreement and the pledge and assignment of the Collateral pursuant hereto create a valid security in the Collateral, securing the payment of the Secured Obligations, (ii) this Agreement and the Control Agreement are sufficient to perfect such security interests, and (iii) assuming the Pledgee has no notice of any Liens or &#8220;adverse claims&#8221; (as such term is defined in Section 8-102(a)(1) of the NYUCC) with respect to the Collateral, the Pledgee will take the Collateral free and clear of all Liens and adverse claims. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;The Pledgor is subject to civil and commercial law with respect to its obligations hereunder, and the execution, delivery and performance by the Pledgor of its obligations under this Agreement constitute private and commercial acts rather than public or governmental acts. Neither the Pledgor or any of its properties has any immunity from jurisdiction of any court or from set-off or any legal process (whether through service or notice, attachment prior to judgment, attachment in aid of execution, execution or otherwise) under the laws of Bermuda.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;(A) This Agreement is in proper legal form under all applicable laws of Bermuda for the enforcement thereof against the Pledgor in accordance with its terms. To ensure the legality, validity, enforceability or admissibility into evidence of this Agreement it is not necessary that this Agreement or any other document be filed or recorded with any governmental authority of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bermuda or that any stamp or similar tax be paid on or in respect of this Agreement or any other document delivered pursuant hereto.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B) It is not necessary (X) in order for the Pledgee to enforce any rights or remedies under this Agreement or (Y) solely by reason of the execution delivery and performance of this Agreement by the Pledgee, that the Pledgee be licensed or qualified with a Bermudian governmental authority or be entitled to carry on business in Bermuda.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;The Pledgor shall cause Securities of the type specified in Schedule 1 attached hereto (collectively, &#8220;Qualifying Collateral&#8221;) to be pledged as Collateral so that at all times the Letter of Credit Value of such Securities shall equal or exceed the aggregate amount of the then outstanding Credits (&#8220;Required Account Value&#8221;) and, without limiting the foregoing, if at any time the Pledgor is not in compliance with the requirements of this sub-section (k), the Pledgor shall forthwith cause additional Qualifying Collateral to be held as Collateral pursuant to Section 2 to the extent required to cause the Pledgor to be in compliance with this sub-section (k). Final determination as to whether a security shall be treated as Qualifying Collateral for the purposes of this section 6(k) shall be at the sole discretion of the Pledgee. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 7. Further Assurances.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Pledgor agrees that from time to time, at the expense of the Pledgor, the Pledgor will promptly execute and deliver all further Instruments and documents, and take all further action, that may be necessary or desirable, or that the Pledgee may reasonably request, in order to continue, perfect and protect any pledge, assignment or security interest granted or purported to be granted hereby or to enable the Pledgee to exercise and enforce its rights and remedies hereunder with respect to any Collateral. Without limiting the generality of the foregoing, the Pledgor will execute and file such financing or continuation statements, or amendments thereto, and such other Instruments or notices, as may be necessary or desirable, or as the Pledgee may request, in order to perfect and preserve the pledge, assignment and security interest granted or purported to be granted hereby.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Pledgor hereby authorizes the Pledgee to file one or more financing or continuation statements, and amendments thereto, relating to all or any part of the Collateral without the signature of the Pledgor where permitted by law. A photocopy or other reproduction of this Agreement or any financing statement covering the Collateral or any part thereof shall be sufficient as a financing statement where permitted by law.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 8. Distributions.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other than upon the occurrence and during the continuance of an Event of Default, the Pledgor shall be entitled to receive and retain any and all distributions paid in respect of the Pledged Securities&#59; provided however, that any and all </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.12pt">distributions paid or payable other than cash in respect of, and Instruments, Financial Assets and other property received, receivable or otherwise distributed in respect of, or in exchange for, any Collateral and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.9pt">cash paid, payable or otherwise distributed in respect of principal of, or in redemption of, or in exchange for, any Collateral,</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be forthwith pledged to the Pledgee and deposited or credited to the Account to hold as Collateral and shall, if received by the Pledgor, be received in trust for the benefit of the Pledgee, be segregated from the other property or funds of the Pledgor and be forthwith pledged to the Pledgee and deposited or credited to the Account to hold as Collateral in the same form as so received (with any necessary endorsement). Upon the written consent of the Pledgee (which consent shall not be unreasonably </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">withheld absent an Event of Default), such distributions may be retained by the Pledgor, as further described in the Control Agreement. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For the purpose of this section 8 and sections 4, 9 and 14 hereof, the term &#8220;Events of Default&#8221; shall mean a failure of the Pledgor to perform in any material respect any of its obligations under the Master Agreement or this Agreement, which failure shall continue unremedied for five (5) business days after written notice thereof shall have been given by the Pledgee to the Pledgor.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Pledgee shall execute and deliver (or cause to be executed and delivered) to the Pledgor all such proxies and other instruments as the Pledgor may reasonably request for the purpose of enabling the Pledgor to receive the interest payments that it is authorized to receive and retain pursuant to paragraph (a) above.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 9. Transfer and Other Liens.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Pledgor shall not (i) sell, assign or otherwise dispose of, or grant any option with respect to, any of the Collateral, or (ii) create or suffer to exist any Lien upon or with respect to any of the Collateral, including any right to give any entitlement order with respect to the Collateral, except for the pledge, assignment and security interest created by this Agreement, provided that the Pledgor may give directions or entitlement orders, as applicable, to the Financial Institution to make Permitted Entitlement Orders (as defined in the Control Agreement) so long as no Event of Default exists and after giving effect to the proposed Permitted Entitlement Order, the Letter of Credit Value of the Collateral shall equal or exceed the Required Account Value.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 10. Pledgee Appointed Attorney-in-Fact.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Pledgor hereby irrevocably appoints the Pledgee as the Pledgor's attorney-in-fact, with full authority upon failure of the Pledgor to perform any of the obligations under the Master Agreement or this Agreement in the place and stead of the Pledgor and in the name of the Pledgor or otherwise, from time to time to take any action and to execute any instrument that the Pledgee may deem necessary or advisable to accomplish the purposes of this Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 11. Pledgee May Perform</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Pledgor fails to perform any agreement contained herein after receipt of a written request from the Pledgee to do so, the Pledgee may (but shall have no obligation to) itself perform, or cause performance of, such obligation, and the reasonable expenses of the Pledgee incurred in connection therewith shall be payable by the Pledgor under Section 15(b) hereof.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 12. Pledgee's Duties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The powers conferred on the Pledgee hereunder are solely to protect its interest in the Collateral and shall not impose any duty upon it to exercise any such powers. Except for the safe custody of any Collateral in its possession and the accounting for moneys actually received by it hereunder, the Pledgee shall have no duty as to any Collateral, as to ascertaining or taking action with respect to calls, conversions, exchanges, maturities, tenders or other matters relative to any Collateral, whether or not the Pledgee has or is deemed to have knowledge of such matters, or as to the taking of any necessary steps to preserve rights against any parties or any other rights pertaining to any Collateral. The Pledgee shall be deemed to have exercised reasonable care in the custody and preservation of any Collateral in its possession if such Collateral is accorded treatment substantially equal to that which the Pledgee accords its own property.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 13. Security Interest Absolute</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The obligations of the Pledgor under this Agreement are independent of the Secured Obligations and any agreement with respect to the Secured Obligations, and a separate action or actions may be brought and prosecuted against the Pledgor to enforce this Agreement, irrespective of whether any action is brought against the Pledgor or whether the Pledgor is joined in any such action or actions. All rights of the Pledgee and the pledge, assignment and security interest hereunder, and all obligations of the Pledgor hereunder, shall be absolute and unconditional, irrespective of&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any lack of validity or enforceability of the Master Agreement or any other agreement or instrument relating thereto&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any change in time, manner or place of payment of, or in any other term of, all or any of Secured Obligations or any other amendment or waiver of or any consent to any departure from this Agreement or the Master Agreement, including, without limitation, any increase in the Secured Obligations&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">any taking, exchange, release or non-perfection of any other collateral, or any taking, release or amendment or waiver of or consent to departure from any guaranty for all or any of the Secured Obligations&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any manner of application of the Collateral, or proceeds thereof, to all or any of the Secured Obligations, or any manner of sale or other disposition of any Collateral for all or any of the Secured Obligations or any other assets of the Pledgor or any of its subsidiaries&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any change, restructuring or termination of the corporate structure or existence of the Pledgor or any of its subsidiaries&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Pledgor or a third party grantor of a security interest.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 14. Remedies.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If an Event of Default shall occur and be continuing&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Pledgee may exercise in respect of the Collateral, in addition to other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of a secured party upon default under the NYUCC and also may without notice, except as specified below, sell the Collateral or any part thereof in one or more parcels at any public or private sale, at any of the Pledgee's offices or elsewhere, for cash, on credit or for future delivery, and upon such other terms as the Pledgee may deem commercially reasonable. The Pledgor agrees that, to the extent notice of sale shall be required by law, at least ten (10) days' notice to the Pledgor of the time and place of any public sale shall constitute reasonable notification. The Pledgee shall not be obligated to make any sale of Collateral regardless of notice of sale having been given. The Pledgee may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;All cash proceeds received by the Pledgee in respect of any sale of, collection from, or other realization upon all or any part of the Collateral may, in the discretion of the Pledgee, be held by the Pledgee as collateral for, and&#47;or then or at any time thereafter applied (after payment of any amounts payable to the Pledgee pursuant to Section 15) in whole or in part by the Pledgee against, all or any part of the Secured Obligations in such order as the Pledgee shall elect. Any surplus of such cash or cash proceeds held by the Pledgee and remaining after payment in full of all the Secured Obligations shall be paid to the Pledgor or to whomsoever may be lawfully entitled to receive such surplus.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Pledgee may, without notice to the Pledgor except as required by law and at any time or from time to time, charge, set-off and otherwise apply all or any part of the Secured Obligations against the Collateral or any part thereof.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 15. Indemnity and Expenses.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Pledgor agrees to indemnify the Pledgee and their affiliates and their officers, directors, employees, agents, attorneys and advisors from and against any and all claims, damages, losses and liabilities growing out of or resulting from this Agreement (including, without limitation, enforcement of this Agreement), except claims, damages, losses or liabilities resulting from the Pledgee's fraud, gross negligence or willful misconduct.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Pledgor will upon demand pay to the Pledgee the amount of any and all reasonable expenses, including the reasonable fees and expenses of its counsel and of any experts and agents, that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Pledgee may incur in connection with (i) the administration of this Agreement, (ii) the custody, preservation, use or operation of, or the sale of, collection from or other realization upon, any of the Collateral, (iii) the exercise or enforcement (whether through negotiations, legal proceedings or otherwise) of any of the rights of the Pledgee hereunder or (iv) the failure by the Pledgor to perform or observe any of the provisions hereof.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 16. Amendments&#59; Waivers.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No amendment or waiver of any provision of this Agreement, and no consent to any departure by the Pledgor herefor, shall in any event be effective unless the same shall be in writing and signed by the Pledgee, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given. No failure on the part of the Pledgee to exercise, and no delay in exercising any right hereunder, shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any such right preclude any other or further exercise thereof or the exercise of any other right.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 17. Addresses for Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All notices and other communications provided for hereunder shall be in writing (including telecopier, telegraphic, telex or cable communication) and, mailed telegraphed, telecopied, telexed, cabled or delivered if to the Pledgor at Aspen Bermuda Limited, 141 Front Street, Hamilton HM 19 Bermuda, as to either party, at such other address as shall be designated by such party in a written notice to each other party complying as to delivery with the terms of this section 17. All such notices and communications shall, when mailed, telecopied, telegraphed or telexed, be effective five (5) business days after deposit in the mail, or when telecopied, delivered to the telegraph company or confirmed by telex answerback, respectively, except that notices and communications to the Pledgee shall not be effective until received by the Pledgee. Delivery by telecopier of an executed counterpart of any amendment or waiver of any provision of this Agreement or of any exhibit hereto to be executed and delivered hereunder shall be effective as delivery of a manually executed counterpart thereof.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 18. Continuing Security Interest&#59; Assignments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement shall create a continuing security interest in the Collateral and shall (a) remain in full force and effect until the payment in full in cash of the Secured Obligations, (b) be binding upon the Pledgor and the Pledgee and their respective successors and assigns and (c) inure, together with the rights and remedies of the Pledgee and its respective successors, transferees and assigns. Without limiting the generality of the foregoing clause (c), the Pledgee may assign or otherwise transfer to any other Person all or any portion of its rights and obligations under this Agreement to any other Person, and such other Person shall thereupon become vested with all the benefits in respect thereof granted to the Pledgee herein or otherwise. The Pledgor will, at its own expense, make, execute, endorse, acknowledge, fileand&#47;or deliver to the Pledgee such confirmatory assignments, conveyances, financing statements, transfer endorsements, powers of attorney, certificates, reports and other assurances or instruments and take such further steps related to the Collateral and other property or rights covered by the security interest hereby granted, which the Pledgee deems reasonably advisable to perfect, preserve or protect its security interest in the Collateral, including any actions which may be required or advisable as a result of any amendment or supplement to applicable laws, including the NYUCC.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 19. Release and Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the later of the payment in full in cash of the Secured Obligations or any termination as provided in Master Agreement, the pledge, assignment and security interest granted hereby shall terminate and all rights to the Collateral shall revert to the Pledgor with immediate effect. Upon any such termination, the Pledgee will, at the Pledgor's expense, execute and deliver to the Pledgor such documents as the Pledgor shall reasonably request to evidence such termination.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SECTION 20. GOVERNING LAW&#59; TERMS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, EXCEPT TO THE EXTENT THAT THE VALIDITY OR PERFECTION OF THE SECURITY INTEREST HEREUNDER IN RESPECT OF ANY PARTICULAR COLLATERAL IS MANDATORILY GOVERNED BY THE LAWS OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK, IN WHICH CASE THE LAWS OF SUCH OTHER JURISDICTION SHALL GOVERN SUCH MATTERS.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 21. Jurisdiction, Venue.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Pledgor hereby irrevocably and unconditionally submits, for itself and its property, to the nonexclusive jurisdiction of any New York State or Federal court (to the extent such court has subject matter jurisdiction) sitting in New York City and any appellate court from any thereof in any action or proceeding arising out of or relating to this Agreement or for the recognition and enforcement of any judgment, and the Pledgor hereby irrevocably and unconditionally agrees that all claims in respect of such action or proceeding may be heard and determined in such New York State court or in such Federal court. The Pledgor hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. The Pledgor hereto irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement in any New York State or federal court. The Pledgor hereby irrevocably waives, to the fullest extent it may effectively do so, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. The Pledgor irrevocably consents to the service of any and all process in any such action or proceeding by the mailing of copies of such process to such Pledgor at its address specified in Section 17. The Pledgor agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable law.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Nothing in this Section 21 shall affect the right of the Pledgee to serve legal process in any other manner permitted by applicable law or affect any right which the Pledge would otherwise have to bring any action or proceeding against the Pledgor or its property in the courts of any other jurisdiction.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;To the extent that the Pledgor has or hereafter may acquire any immunity from jurisdiction of any court or from any legal process (whether through service or notice, attachment prior to judgment, attachment in aid of execution, execution or otherwise) with respect to itself or its property, the Pledgor to the extent permitted by law hereby irrevocably waives such immunity in respect of its obligations under this Agreement and, without limiting the generality of the foregoing, agrees that the waivers set forth in this subsection (c) shall have the fullest scope permitted under the United States Foreign Sovereign Immunities Act of 1976, as amended, and are intended to be irrevocable for purposes of such act.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SECTION 22. WAIVER OF JURY TRAIL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. EACH OF THE PLEDGOR AND THE PLEDGEE HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF THE PLEDGEE IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 23. Execution in Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by telecopier shall be effective as delivery of a manually executed counterpart of this Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 24. Severability.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If any term or provision of this Agreement is or shall become illegal, invalid or unenforceable in any jurisdiction, all other terms and provisions of this Agreement shall remain legal, valid and enforceable in such jurisdiction and such illegal, invalid or unenforceable provision shall be legal, valid and enforceable in any other jurisdiction.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section 25. Termination of Prior Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The parties agree that any prior pledge agreement with respect to the Collateral is terminated as of the effective date of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parties hereto have caused this Agreement to be duly executed and delivered by its officer thereunto duly authorized as of the date first above written.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;signature page follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i934f5a4554ae4a8aad7499d702260dde_57"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:30pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.583%"><tr><td style="width:1.0%"></td><td style="width:17.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Citibank Europe Plc</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Akos Nemeth</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Akos Nemeth</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President </font></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:6.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aspen Bermuda Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Fred Lemoine</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Bryan Astwood</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fred Lemoine </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bryan Astwood</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Chief Investment Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i934f5a4554ae4a8aad7499d702260dde_73"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">SCHEDULE 1</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter of Credit Value and Pledgee's Requirements</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.292%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="6" rowspan="2" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Qualifying Collateral</font></td><td colspan="9" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Pledgee's Requirements</font></td><td colspan="3" rowspan="2" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Letter of Credit Value</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuer</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rating</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tenor</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Ai)</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash Deposits held at Citibank, N.A. London Branch.</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Aii)</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash Deposits held in the Account solely to the extent that such account is proceeds of investment property held in the Account</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Aiii)</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Money Market Funds</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(i) BNY Mellon US Dollar Liquidity Fund, ISIN 0004514828. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(ii) Any other money market fund that is acceptable to the Pledgee in its sole discretion. </font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AAA or equivalent</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(B i)</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Government &#38; Agency Securities</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities issued by the US or another OECD (the &#8220;Organisation for Economic Co-operation and Development&#8221;) Government rated AA or AA equivalent, or issued by agencies whose debt obligations are fully and explicitly guaranteed as to the timely payment of principal and interest by the full faith and credit of the US government, and including securities issued by the FHLMC or FNMA to the extent the same shall be under the conservatorship of the Federal Housing Finance Agency. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities issued by GNMA whose debt obligations are fully and explicitly guaranteed as to the timely payment of principal and interest by the full faith and credit of the US Government. </font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:120pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">AA or AA equivalent</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AA or AA equivalent</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:130pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20 years</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30 years</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:90pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">89% of the fair market value of such Government &#38; Agency Securities</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89% of the fair market value of such Government &#38; Agency Securities</font></div></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(B ii)</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US Agency MBS Securities&#58; FHLMC &#38; FNMA</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities issued by the FHLMC or FNMA to the extent the same shall be under the conservatorship of the Federal Housing Finance Agency.</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">AA or AA equivalent</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30 years</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">86.5% of the fair market value of such US Agency MBS Securities</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(C)</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Multilateral Lending Institution Securities</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities issued by multilateral lending institutions or regional development banks in which the US government is a shareholder or contributing member, including International Bank for Reconstruction and Development (the World Bank), the International Finance Corporation, the Inter-American Development Bank, the Asian Development Bank, the African Development Bank, the European Investment Bank, the European Bank for Reconstruction and Development and the Nordic Investment Bank.</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">AA or AA equivalent or better</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20 years</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">88.5% of the fair market value of such Multilateral Lending Institution Securities.</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(D)</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US or OECD Government Agency Securities</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities issued by US or other OECD government agencies whose debt is implicitly guaranteed by the US government or an OECD government.</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">AA or AA equivalent or better</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20 years</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">88.5% of the fair market value of such US or OECD Government Agency Securities</font></td></tr><tr style="height:54pt"><td colspan="3" rowspan="2" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(E)</font></td><td colspan="3" rowspan="2" style="border-bottom:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Corporate Bonds</font></td><td colspan="3" rowspan="2" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-convertible publicly traded securities, excluding warrants and perpetual instruments, issued by corporate entities domiciled in the US or other OECD countries. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The Pledgor shall not deliver Corporate Bonds such that 10% or more of the Pledged Securities is constituted by Corporate Bonds of a single issuer.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Corporate Bonds shall not exceed 35% of the aggregate Letter of Credit outstandings at any time. </font></div></td><td colspan="3" rowspan="2" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">A or A equivalent or better</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10 years</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">85% of the fair market value of such Corporate Bonds</font></td></tr><tr style="height:32pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15 years</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">80% of the fair market value of such Corporate Bonds</font></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No Citigroup Inc., Convertibles, Perpetuals or Warrants shall constitute Qualifying Collateral.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should an eligible pledged asset be assigned a rating by an agency which is divergent from the rating assigned by any other agency, the Pledgee shall utilise the lowest rating in determining collateral eligibility.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Securities that do not comply with the requirements set out above shall not be considered part of the Qualifying Collateral solely for the purposes of calculating the Required Account Value.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pledged assets constituting &#8220;Qualifying Collateral&#8221; shall exclude any Financial Assets issued by Pledgor, its corporate parent, its affiliates and its subsidiaries or any other financial instrument as determined by Pledgee.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i934f5a4554ae4a8aad7499d702260dde_87"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">SCHEDULE 2</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Margins</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Where the Qualifying Collateral or a portion thereof is denominated in the same currency as a Credit (the &#8220;Credit Currency&#8221;), the Qualifying Collateral or such portion thereof shall have a value of 100% of its value in the relative Credit Currency&#59; and for this purpose the Pledgee shall notionally match each Credit with the Collateral or a portion thereof denominated in the relative Credit Currency.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Where the Qualifying Collateral or a portion thereof is denominated in a currency other than the Credit Currency, both the Letter of Credit Value (or, where only a portion of the Qualifying Collateral is in the Credit Currency, the balance of the Letter of Credit Value remaining unmatched) and the Qualifying Collateral or such portion thereof shall be notionally converted into a common base currency (as the Pledgee may in its discretion determine)&#59; and following such notional conversion the Qualifying Collateral or such portion thereof shall suffer a deduction of the Relevant Percentage (as defined below), to cover exchange movements that may from time to time affect the value of the underlying unmatched Qualifying Collateral or a portion thereof and the contingent obligations to which it relates.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The &#8220;Relevant Percentage&#8221; means&#58;</font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">where the Qualifying Collateral or a portion is denominated in U.S. dollars, Euro, Canadian dollars, or English Pounds Sterling, 5%&#59;</font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">where the Qualifying Collateral or a portion thereof is denominated in New Zealand dollars or Australian dollars, 7.5%&#59; and</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">where the Qualifying Collateral or a portion thereof is denominated in any other currency, 25%.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i934f5a4554ae4a8aad7499d702260dde_101"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNEX A</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN DEFINED TERMS</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized terms used herein shall have the respective meanings ascribed to them below&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Collateral&#8221; has the meaning specified therefor in Section 2 hereof.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Entitlement Holder&#8221; means a Person that (i) is an &#8220;entitlement holder&#8221; as defined in Section 8-102(a)(7) of the NYUCC (except in respect of a Book-entry Security)&#59; and (ii) in respect of any book-entry Security, is an &#8220;entitlement holder&#8221; as defined in 31 C.F.R. &#10065;357.2 (or, as applicable to such book-entry Security, the corresponding Federal Book-Entry Regulations governing such book-entry Security) which, to the extent required or permitted by the Federal Book-Entry Regulations, is also an &#8220;entitlement holder&#8221; as defined in Section 8-102(a)(7) of the NYUCC.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Entitlement Order&#8221; shall have the meaning set forth in Section 8-102(a)(8) of the NYUCC and shall include, without limitation, any notice or related instructions from the Pledgee directing the transfer or redemption of the Collateral or any part thereof.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Federal Book-Entry Regulations&#8221; means the federal regulations contained in Subpart B (&#8220;Treasury&#47;Reserve Automated Debt Entry System (TRADES)&#8221; governing book-entry securities consisting of United States Treasury securities, U.S. Treasury bonds, notes and bills) and Subpart D (&#8220;Additional Provisions&#8221;) of 31 C.F.R. Part 357, 31 C.F.R. &#10065; 357.10 through &#10065;357.14 and &#10065;357.41 through &#10065;357.44 (including related defined terms in 31 C.F.R. 357.2), as amended by regulations published at 61 Fed. Reg. 43626 (August 23, 1996) and as amended by an subsequent regulations.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Insurance Letter of Credit Master Agreement&#8221; means the Insurance Letter of Credit Master Agreement delivered by the Pledgor to the Pledgee.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Letter of Credit Value&#8221; means, in respect of each component of the Qualifying Collateral, (x) the market value of the Security or (y) the cash value, in each case&#58; (i) subject to the provisions of Schedules 1 and 2&#59; (ii) multiplied by the percentage specified in the table set out in Schedule 1 under the column headed &#8220;Letter of Credit Value&#8221; for that type of Security or for cash&#59; and if at any time there is more than one component part to the Qualifying Collateral, the Letter of Credit Value for the Qualifying Collateral shall be the sum of the Letter of Credit Values for each component part of the Qualifying Collateral&#59; and (iii) such other amount calculated in such other manner as mutually agreed upon from time to time by the Pledgee and Pledgor. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Lien&#8221; means any mortgage, pledge, attachment, lien, charge, claim, encumbrance, lease or security interest, easement, right of first or last refusal, right of first offer or other option or contingent purchase right.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;NYUCC&#8221; means the Uniform Commercial Code from time to time in effect in the State of New York.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NYUCC Terms. Terms defined or referenced in the NYUCC and not otherwise defined or referenced herein are used herein as therein defined or referenced. In particular, the following terms are used herein as defined or referenced in the respective NYUCC sections indicated below&#58; &#8220;Account&#8221;&#58; Section 9-106&#59; &#8220;Entitlement Order&#58; Section 8-102(a)(8)&#59; &#8220;Financial Asset&#8221;&#58; Section 8-102(a)(9)&#59; &#8220;Instrument&#8221;&#58; Section 9-105(I)(i)&#59; &#8220;Investment Property&#8221;&#58; Section 9-115(1)(f)&#59; &#8220;Person&#8221;&#58; Section 1-201(30)&#59; &#8220;Securities Account&#8221;&#58; Section 8-501(a)&#59; &#8220;Security&#8221;&#58; Section 8-102(a)(15).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Person&#8221; means any individual, corporation, partnership, joint venture, foundation, association, joint-stock company, trust, unincorporated organization, government or any political subdivision thereof or any agency or instrumentality of any thereof.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Secured Obligations&#8221; has the meaning specified therefor in Section 3 hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Secured Intermediary&#8221; means a Person that (i) is a &#8220;securities intermediary&#8221; as defined in Section 8-102(a)(14) of the NYUCC and (ii) in respect of any U.S. Government Obligations, is also a &#8220;securities intermediary&#8221; as defined in 31 C.F.R. &#10065;357.2.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Security Control&#8221; means &#8220;control&#8221; as defined in Section 9-115(1)(e) of the NYUCC.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Security Entitlement&#8221; means (i) &#8220;security entitlement&#34; as defined in Section 8-102(a)(17) of the NYUCC (except in respect of a U.S. Government Obligation)&#59; and (ii) in respect of any U.S. Government Obligation, a &#8220;security entitlement&#8221; as defined in 31 C.F.R. &#10065;357.2 which, to the extent required or permitted by the Federal Book-Entry Regulations, is also a &#8220;security entitlement&#8221; as defined in Section 8-102(a)(17) of the NYUCC.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;STRIPS&#8221; shall have the meaning thereof set forth in Section 357.2 of the Federal Book-Entry Regulations.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;U.S. Government Obligations&#8221; means all of the United States Treasury securities (including STRIPS) maintained in the commercial book-entry system entitled Treasury&#47;Reserve Automated Debt Entry System (&#8220;TRADES&#8221;) pursuant to the Federal Book-Entry Regulations or pursuant to a successor system.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>36
<FILENAME>exhibit1027-fx1.htm
<DESCRIPTION>EX-10.27
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1daf1e1ec32d4c559b664f09399cccc9_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.27</font></div></div><div style="margin-bottom:50pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECAUSE IT IS BOTH NOT MATERIAL AND&#160;IS THE TYPE THAT THE REGISTRANT</font></div><div style="margin-bottom:24pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TREATS AS PRIVATE OR CONFIDENTIAL</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REINSURANCE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">by and among</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE UK LIMITED,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN MANAGING AGENCY LIMITED for and on behalf of the UNDERWRITING MEMBER(S) OF LLOYD&#8217;S SYNDICATE 4711,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN BERMUDA LIMITED,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN AMERICAN INSURANCE COMPANY,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN SPECIALTY INSURANCE COMPANY,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(solely for the purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Sections 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">13.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">14.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">16.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">16.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">16.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">16.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">16.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">and</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CAVELLO BAY REINSURANCE LIMITED</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dated as of January 10, 2022</font></div><div style="margin-bottom:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_57"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Page</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE I DEFINITIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">2</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">1.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Definitions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">2</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE II REINSURANCE CEDED</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">12</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">2.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Reinsurance Coverage</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">12</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">2.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Follow the Fortunes</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">12</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">2.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Contract Changes</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">12</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">2.4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Territory</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">13</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">2.5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Exclusions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">13</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">2.6</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Sanctions Exclusions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">13</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE III REINSURANCE CONSIDERATION</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">13</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">3.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Reinsurance Premium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">13</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">3.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Closing and Effectiveness</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">15</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">3.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Post-Closing Adjustment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">15</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">3.4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Funds Withheld Account Interest and Release</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">17</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">3.5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Reinsurance Premium Currency Allocation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">17</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE IV ADMINISTRATION and REPORTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">18</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">4.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Administration</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">18</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">4.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Reports</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">19</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">4.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Quarterly Report</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">20</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">4.4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Remittances</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">20</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE V BOOKS AND RECORDS</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">21</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">5.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Access to Books and Records</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">21</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE VI DURATION AND TERMINATION</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">22</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">6.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Duration and Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">22</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">6.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Effect of Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">23</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">6.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Outside Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">23</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE VII INSOLVENCY</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">23</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">7.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Insolvency of Aspen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">23</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE VIII SECURITY</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">24</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">8.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Security</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">24</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">8.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Collateral Arrangements&#59; Reinsurer&#8217;s Collateral Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">25</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">8.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Ongoing Collateral Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">26</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">8.4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Substitution of Trust Assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">27</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">8.5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Settlements</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">27</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">8.6</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Withdrawal of Assets by Aspen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">27</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">8.7</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Withdrawal of Assets by the Reinsurer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">28</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">8.8</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Collateral Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">28</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE IX SALVAGE, SUBROGATION AND THIRD PARTY REINSURANCE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">28</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">9.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Salvage and Subrogation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">28</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">9.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">29</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">9.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Third Party Reinsurance</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">29</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 86.5pt;text-align:left;text-indent:-85.5pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE X ERRORS AND OMISSIONS&#59; REGULATORY MATTERS&#59; COVENANTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">29</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">10.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Errors and Omissions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">29</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">10.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Cooperation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">29</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">10.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Regulatory Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">30</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">10.4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Existing Agreements</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">31</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">10.5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Reinsurance of Reinsured Policies</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">31</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">10.6</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Commercially Reasonable Efforts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">31</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE XI Representations and warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">31</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">11.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Aspen Representations and Warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">31</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">11.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Reinsurer Representations and Warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">35</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE XII Closing conditions</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">37</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">12.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Conditions to Reinsurer&#8217;s Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">37</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">12.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Conditions to Aspen&#8217;s Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">37</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">12.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Alternative Closing Structure</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">38</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE XIII INDEMNIFICATION</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">39</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">13.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">The Reinsurer&#8217;s Obligation to Indemnify</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">39</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">13.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Aspen Parent&#8217;s Obligation to Indemnify</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">39</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE XIV UTMOST GOOD FAITH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">39</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">14.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Utmost Good Faith and Fair Dealing</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">39</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE XV TAXES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">40</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">15.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Federal Excise Tax</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">40</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">15.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">FATCA and Withholding</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">40</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">ARTICLE XVI MISCELLANEOUS PROVISIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">40</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">40</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Confidentiality&#59; Public Announcements</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">41</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Agent</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">44</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Entire Agreement</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">44</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Waiver and Amendment</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">44</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.6</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Successors and Assigns</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">44</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.7</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Headings</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">44</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.8</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Governing Law&#59; Specific Performance</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">45</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.9</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Service of Suit</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">45</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.10</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">No Third Party Beneficiaries</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">46</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.11</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Counterparts</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">46</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.12</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Severability</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">46</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.13</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Offset</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">46</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.14</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Currency</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">47</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.15</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Interpretation</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">47</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">16.16</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Execution</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">48</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_73"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED REINSURANCE AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This AMENDED AND RESTATED REINSURANCE AGREEMENT, dated as of January 10, 2022 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), is made by and among Aspen Insurance UK Limited, a company incorporated in England and Wales, Aspen Managing Agency Limited, a company incorporated in England and Wales, for and on behalf of the underwriting members(s) of Lloyd&#8217;s Syndicate 4711, Aspen Bermuda Limited, a company incorporated in Bermuda, Aspen American Insurance Company, a Texas-domiciled insurance company, Aspen Specialty Insurance Company, a North Dakota-domiciled insurance company (individually or collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Aspen Insurance Holdings Limited, a company incorporated in Bermuda (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) (solely for the purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">13.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">14.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and Cavello Bay Reinsurance Limited, a Bermuda insurance company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Capitalized terms used but not otherwise defined herein have the respective meanings set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Aspen has issued the Reinsured Policies constituting the Subject Business&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, pursuant to that certain Adverse Development Cover Agreement, dated as of March 2, 2020 and amended as of April 15, 2020 (as so amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Original Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), by and among the parties hereto, Aspen ceded, and the Reinsurer assumed, one hundred percent (100%) of the liability of Aspen for covered losses specified therein in excess of the agreed retention and up to the aggregate limit specified therein, subject to the agreed loss corridor and the other terms and conditions thereof&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, this Agreement shall, subject to the terms and conditions hereof (including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), amend and restate the Original Agreement in its entirety in order for Aspen to cede, and the Reinsurer to assume, one hundred percent (100%) of the liability of Aspen for all Covered Losses from and after the Effective Date, subject to the terms and conditions hereof&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Parties desire that the terms of the Original Agreement remain in force and to continue to apply in their entirety, until the Closing in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> below.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the representations, warranties, covenants and agreements contained in this Agreement, Aspen, Aspen Parent (solely for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">13.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">14.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and the Reinsurer (each individually, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE I</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, the following terms shall have the respective meanings set forth below&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Services Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an administrative services agreement to be entered into by and between certain Affiliates of Reinsurer (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Aspen and certain Affiliates of Aspen with respect to the  administration of the Subject Business, which shall be based on the outline of terms attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and in a form reasonably acceptable to the Reinsurer and Aspen.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Rights Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Person, another Person that, directly or indirectly, controls, is controlled by, or is under common control with, such first Person, where &#8220;control,&#8221; including the terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control,&#8221; means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Aspen Parent.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Preamble</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreed Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (a) those internal presentations and reports in form and substance consistent with those provided by Aspen to the Reinsurer pursuant to the Original Agreement and (b) the additional reports described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as to be provided by Aspen to the Reinsurer or the Reinsurer to Aspen, as applicable, in each case, as may be modified from time to time following the Closing by mutual written consent of Aspen and the Reinsurer.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Allocated Loss Adjustment Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all reasonable costs and expenses incurred by or on behalf of Aspen paid or payable on or after the Effective Date in connection with any investigation, appraisal, adjustment, audit, negotiation, settlement, litigation, defense or appeal that is allocable to an occurrence or claim made under or in connection with a Reinsured Policy, which shall include (a) outside retained adjusters&#8217; fees, (b) attorneys&#8217;, experts&#8217; and consultants&#8217; fees in connection with coverage investigation or analysis and&#47;or actual, anticipated or threatened actions, suits or proceedings, whether declaratory, coercive or otherwise, (c) costs levied in any claim, suit or proceeding (including court costs), (d) costs of supersedeas and appeal bonds, (e) subrogation, salvage and recovery expenses (incurred with respect to Recoverables), (f) to the extent incurred consistent with Aspen&#8217;s customary past practice prior to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Effective Date, interinsurer expense-related obligations arising from equitable contribution or similar claims, (g) to the extent incurred consistent with Aspen&#8217;s customary past practice prior to the Effective Date, fees (at cost) of staff counsel expressly charged with performing functions generally performed by outside counsel, (h) pre-judgment interest and (i) interest accruing after entry of judgment.  Except as otherwise provided in this definition, Allocated Loss Adjustment Expenses shall not include salaries, benefits and expenses of Aspen&#8217;s (or any of its Affiliates&#8217;) employees and other overhead and office expenses of Aspen (or any of its Affiliates), and, for the avoidance of doubt, such costs shall be included in the definition of &#8220;ULAE.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Aspen Annual Investment Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any date of determination, a percentage equal to (a) 50%, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Aspen Annual Investment Return for the applicable Crediting Interest Rate Period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) 1.75%&#59; provided that if the foregoing would result in the Applicable Aspen Annual Investment Margin being less than zero (0), then the Applicable Aspen Annual Investment Margin shall be equal to zero (0).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any domestic or foreign, federal, state or local statute, law, ordinance or code, or any written rules or regulations, in each case applicable to any Party, and any Order applicable to any Party.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Reserves</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any date, all reserves (including case reserves and incurred-but-not-reported reserves, or provisions for losses, claims, benefits, and Allocated Loss Adjustment Expenses) of Aspen on a net basis allocable to the Subject Business as of such date, calculated in accordance with GAAP and consistent with Aspen&#8217;s practice since the closing under the Original Agreement.  &#8220;Net basis&#8221; means gross reserves allocable to the Subject Business, excluding any reserves for ULAE and any reserves for Extra Contractual Obligations (other than Reinsured Extra Contractual Obligations), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Third Party Reinsurance Recoverables, in each case as of the date of the determination.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Preamble</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen Annual Investment Return</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to each Crediting Interest Rate Period, the total return on the total investments and cash and cash equivalents of Aspen Parent and all of its subsidiaries during such Crediting Interest Rate Period, in each case, as set forth on the books and records of Aspen Parent.  For the avoidance of doubt, such return shall include all net investment income and realized and unrealized gains and losses during each such respective period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Preamble</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Crediting Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a rate of 1.75% per annum, compounded daily.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Crediting Interest Rate Accrued Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any period, the amount of interest accrued on the applicable Prior Funds Withheld Account Balance Average if interest accrued on such amount at the Base Crediting Interest Rate. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Books and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means originals or copies of all records and all other data and information (in whatever form maintained) in the possession or control of Aspen or its Affiliates to the extent relating to the Subject Business or the Reinsured Policies, including (a) administrative records, (b) claim records, (c) policy files, (d) sales records, (e) files and records relating to Applicable Law, (f) underwriting records and (g) accounting records, but excluding (i) Tax Returns and Tax records and all other information and data with respect to Tax, (ii) files, records, data and information with respect to employees, (iii) records, data and information with respect to any employee benefit plan, (iv) any materials or other information the disclosure or transfer of which would violate Applicable Law, (v) any materials prepared for the board of directors of Aspen and (vi) any internal drafts, opinions, valuations, correspondence or other materials prepared in connection with the negotiation, valuation and consummation of the transactions contemplated by this Agreement&#59; provided, that the files, records, data and information referenced in clause (ii) or (iii) to the extent related to Transferring Employees shall be included in the definition of &#8220;Books and Records&#8221; following the mutual agreement of Aspen and the Reinsurer as to which employees of Aspen will become Transferring Employees and entry into the Administrative Services Agreement containing data processing and data sharing provisions reasonably acceptable to Aspen and the Reinsurer.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any day other than a Saturday, Sunday or a day on which commercial banks in New York, New York or Hamilton, Bermuda are required or authorized by law to be closed.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any monetary demand, obligation, suit, occurrence (as defined in the applicable Reinsured Policy), loss (as defined in the applicable Reinsured Policy) or settlement, actual or alleged, arising out or in connection with the Reinsured Policies (including, for the avoidance of doubt, any extra contractual obligations for which Aspen is liable to an underlying reinsured under the terms of any Reinsured Policy assumed by Aspen from such underlying reinsured).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Covered Losses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means those Claims payable by Aspen on or after the Effective Date with respect to the Subject Business, including all amounts payable in respect of Allocated Loss Adjustment Expenses, Reinsured Extra Contractual Obligations, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ex gratia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> payments for which the Reinsurer has provided its prior written consent or which are made by or at the express written direction of the Administrator&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that &#8220;Covered Losses&#8221; shall not include any Excluded Liabilities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Crediting Interest Rate Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 13.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disclosing Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disputed Item</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means October 1, 2021.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date Reserve Currency Split</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means 12&#58;01 a.m. Eastern time on the Effective Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means cash (United States legal tender), certificates of deposit (issued by a United States bank and payable in United States legal tender) or investments that comply with the Investment Guidelines.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Enforceability Exceptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Estimated Initial Required Collateral Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Estimated New Reinsurance Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to (a) $3,160,000,000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the Original Cash Premium, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c) the Estimated Roll-forward Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (d) the Estimated New Reinsurance Premium Accrued Interest,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (e) the Estimated ULAE Reimbursement Amount.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Estimated New Reinsurance Premium Accrued Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to the interest that would accrue on an amount equal to (a) $3,160,000,000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the Original Cash Premium, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c) 50% of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Estimated Roll-forward Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (d) 50% of the Estimated ULAE Reimbursement Amount for the period beginning on the Effective Date and ending on the Closing Date if interest on such amount accrued at the Full Crediting Interest Rate.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Estimated Roll-forward Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Estimated ULAE Reimbursement Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Excluded Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Existing Trust Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Trust Accounts (as defined in the Original Agreement). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Extra Contractual Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all liabilities and any other related expenses (including attorneys&#8217; fees) arising out of or relating to the Reinsured Policies other than those arising under or relating to the express terms of and within the express limits of the Reinsured Policies, whether to principals, obligees, Governmental Authorities or any other Person, which liabilities and expenses shall include losses in excess of policy limits, consequential, compensatory, punitive, exemplary, special, statutory or regulatory damages (or fines, penalties, forfeitures or similar charges of a penal or disciplinary nature), in each case, not within the express terms and limits of the Reinsured Policies, or any other form of extra contractual damages or liabilities arising out of or relating to the Reinsured Policies, including those that arise from any alleged or actual act, error or omission, whether or not intentional, in bad faith or otherwise, including any act, error or omission relating to (a) the marketing, underwriting, production, sale, issuance, cancellation, termination, novation or administration of the Reinsured Policies, (b) the investigation, defense, trial, settlement or handling of Claims, benefits, or payments arising out of or relating to the Reinsured Policies or (c) the failure to pay, or the delay in payment of, Claims, benefits or any other payments due or alleged to be due under the Reinsured Policies.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 15.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Final Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Full Crediting Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (a) for the period from and after October 1, 2021 until (and including) September 30, 2022, a rate of 1.75% per annum, compounded daily and (b) for any period beginning from and after October 1, 2022, a rate equal to 1.75% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Applicable Aspen Annual Investment Margin per annum, compounded daily.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Full Crediting Interest Rate Accrued Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any period, the amount of interest accrued on the applicable Prior Funds Withheld Account Balance Average if interest accrued on such amount at the Full Crediting Interest Rate. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Funds Withheld Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Funds Withheld Account Balance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any date of determination, the balance of the Funds Withheld Account after giving effect to the crediting of the Full Crediting Interest Rate pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Funds Withheld Release Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date on which the Parties agree in writing the Funds Withheld Account Balance shall be released to the Reinsurer, which shall (a) not occur later than September 30, 2025 and (b) be subject to the approval of the Reinsurer and 90 days&#8217; advance written notice in the event that Aspen intends to release the Funds Withheld Account Balance earlier than September 30, 2025.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means U.S. generally accepted accounting principles, consistently applied.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GDPR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means means the EU General Data Protection Regulation 2016&#47;679 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">EU GDPR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) as implemented by countries within the EEA and the EU GDPR as retained as law in England and Wales by the European Union (Withdrawal) Act 2018 (as applicable to the processing).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any government, political subdivision, court, arbitrator, arbitration panel, mediator, mediation panel, board, commission, regulatory or administrative agency or other instrumentality thereof, whether federal, state, provincial, local or foreign and including any regulatory authority which may be partly or wholly autonomous and including Lloyd&#8217;s.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Incident</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Independent Actuary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Initial Required Collateral Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to (a) (i) $3,120,000,000 (representing the Applicable Reserves relating to the Covered Losses reinsured hereunder as of September 30, 2021), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) the Roll-forward Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) 102%.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the investments specified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> attached hereto.  For the avoidance of doubt but subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Investment Guidelines shall apply across the assets held in the Trust Accounts in total, rather than at the individual Trust Account level.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means letters of credit posted by the Reinsurer for the benefit of Aspen to secure the Reinsurer&#8217;s obligations hereunder in a form and type, and from an institution, reasonably acceptable to Aspen and that satisfies in full all applicable requirements in order to allow the reinsured included in the definition of &#8220;Aspen&#8221; that is the beneficiary of such letter of credit to take full financial statement and regulatory credit for the reinsurance provided hereunder in all applicable jurisdictions.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Lloyd&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any time and with respect to any asset, the fair market value thereof as of such time, as determined in accordance with the terms of the applicable Trust Agreement. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Material Third Party Reinsurance Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, collectively, all Third Party Reinsurance Agreements as to which there were claim reserves, case-specific reserves for incurred but not reported claims, unearned premiums, refunds or policy reserves, in the aggregate, equal to or exceeding $10,000,000 as of September 30, 2021. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Negative Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">New Reinsurance Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to (a) $3,160,000,000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) the Original Cash Premium, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c) the Roll-forward Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (d) the New Reinsurance Premium Accrued Interest, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (e) the ULAE Reimbursement Amount.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">New Reinsurance Premium Accrued Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to the interest that would accrue on an amount equal to (a) $3,160,000,000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the Original Cash Premium, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c) 50% of the Roll-forward Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (d) 50% of the ULAE Reimbursement Amount for the period beginning on the Effective Date and ending on the Closing Date if interest on such amount accrued at the Full Crediting Interest Rate.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Original Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Recitals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Original Cash Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means $770,000,000.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.3.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Recitals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an individual, corporation, partnership, joint venture, limited liability company, association, trust, unincorporated organization, Governmental Authority or other entity.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Personal Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (a) any information which relates to an identified or identifiable individual, or (b) &#8220;personal data,&#8221; &#8220;personal information,&#8221; &#8220;nonpublic personal information,&#8221; or other similar terms as defined by Privacy Laws.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Positive Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">PRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Premiums</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all premiums, retrospective premiums, considerations, deposits and other similar amounts paid or payable by policyholders, other insureds or reinsureds in respect of the Reinsured Policies&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, &#8220;Premiums&#8221; shall not include any Third Party Reinsurance Recoverables or Recoverables.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Funds Withheld Balance Account Average</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any date of determination, an amount equal to (a)(i) the Funds Withheld Account Balance as of the first day of the prior calendar quarter, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) the Funds Withheld Account Balance as of the last day of the prior calendar quarter, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by (b) two (2).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Privacy Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any applicable data protection or privacy laws. It shall include, but not be limited to, as applicable&#58; (a) the EU e-Privacy Directive 2002&#47;58&#47;EC (as amended) as implemented by countries within the European Economic Area (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">EEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; (b) the GDPR&#59; (c) the UK Data Protection Act 2018 and the UK Privacy and Electronic </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Communications (EC Directive) Regulations 2003&#59; (d) U.S. state and federal privacy, data protection, and data breach notification laws and regulations (including, but not limited to, the California Consumer Privacy Act, Cal. Civ. Code &#167; 1798.100, et seq., Federal Trade Commission Act, 15 U.S.C. &#167; 45, et seq., New York Department of Financial Services Cybersecurity Regulation, 23 N.Y.C.R.R. &#167; 500, et seq., and the Gramm-Leach-Bliley Act, 15 U.S.C. &#167; 6801, et seq.)&#59; and&#47;or (e) other laws that are similar to, equivalent to, successors to, or that are intended to or implement the laws that are identified in (a) through (d) above.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Quarterly Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a report meeting the specifications set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Receiving Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Recoverables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsured Extra Contractual Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means those Extra Contractual Obligations (a) that arise from or are related to the handling of any Claim with respect to the Subject Business by the Reinsurer or its Affiliates from and after the Closing Date, (b) with respect to which Aspen has consulted with the Reinsurer after disclosing all relevant material information to the Reinsurer and prior to Aspen taking the course of conduct that gives rise to such Extra Contractual Obligations and with respect to which the Reinsurer has consented in writing to the course of conduct taken by Aspen, or Aspen has followed the express written direction of the Reinsurer, in each case, giving rise to such Extra Contractual Obligations or (c) any other Extra Contractual Obligation resulting from actions taken by the Reinsurer or its Affiliates.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsured Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, collectively, each binder, certificate, policy, contract of insurance, treaty, reinsurance agreement or other written evidence of insurance written or assumed by Aspen on or prior to December 31, 2019.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Preamble</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurer&#8217;s Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to (a) $3,570,000,000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) an amount equal to the aggregate amount of Reinsured Extra Contractual Obligations described under clause (a) or (c) of the definition of &#8220;Reinsured Extra Contractual Obligations,&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c) the Roll-forward Amount.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurer&#8217;s Posted Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurer&#8217;s Remaining Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any date of determination, an amount equal to (a) the Reinsurer&#8217;s Limit, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the aggregate Ultimate Net Loss paid by the Reinsurer under this Agreement as of such date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Replacement Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Person, a director, officer, employee, attorney or consultant of such Person or one of its Affiliates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Required Collateral Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the Applicable Reserves relating to the Covered Losses reinsured hereunder multiplied by 102%&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that &#8220;Required Collateral Amount&#8221; shall not be deemed to require the Reinsurer to post collateral to the extent such posted collateral would exceed 102% of the Reinsurer&#8217;s Remaining Limit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Roll-forward Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to Ultimate Net Loss paid by or on behalf of Aspen during the period from (and including) October 1, 2021 to (and including) the Closing Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as to any Person, the accounting principles prescribed by the Governmental Authority(ies) responsible for the regulation and&#47;or supervision of insurance companies and&#47;or Lloyd&#8217;s syndicates in the jurisdiction in which such Person is domiciled.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Shared Personal Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any Personal Information that Aspen discloses, provides or otherwise makes available to the Reinsurer (either directly or indirectly) under or in connection with this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Subject Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Reinsured Policies&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that &#8220;Subject Business&#8221; shall not include Claims arising out of the Reinsured Policies with dates of loss on or after January 1, 2020 (it being agreed and understood in the case of any continuous trigger losses, the date of loss shall be the inception date of the Reinsured Policy&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that with respect to any Reinsured Policy in force on January 1, 2020, such continuous trigger losses shall be shared proportionately between Aspen and the Reinsurer based on their respective time at risk).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any and all federal, state, foreign or local income, gross receipts, premium, capital stock, franchise, guaranty fund assessment, retaliatory, profits, withholding, social security, unemployment, disability, real property, ad valorem&#47;personal property, stamp, excise, occupation, sales, use, transfer, value added, alternative minimum, estimated or other tax, fee, duty, levy, custom, tariff, impost, assessment, obligation or charge of the same or of a similar nature to any of the foregoing, including any interest, penalty or addition thereto. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Return</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any report, estimate, extension request, information statement, claim for refund, or return relating to, or required to be filed in connection with, any Tax, including any schedule or attachment thereto, and any amendment thereof. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Third Party Reinsurance Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means ceded reinsurance related to the Subject Business other than (a) this Agreement and (b) for the avoidance of doubt, the Original Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Third Party Reinsurance Recoverables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means recoverables under Third Party Reinsurance Agreements, when and as calculated in accordance with the terms of the applicable Third Party Reinsurance Agreement, with respect to the Subject Business, whether or not billed or collected, by or on behalf of Aspen, less any reinstatement premiums or other loss-triggered additional premiums paid under Third Party Reinsurance Agreements to the extent applicable to Covered Losses, and excluding any recoverables under Third Party Reinsurance Agreements to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the extent attributable to Claims paid by Aspen prior to the Effective Date or other amounts paid by Aspen prior to the Closing Date and excluded pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For the avoidance of doubt, any reinstatement premiums or other loss-triggered additional premiums paid under Third Party Reinsurance Agreements to the extent applicable to Covered Losses are for the account of the Reinsurer and may result in the value of the Third Party Reinsurance Recoverables determined in respect of a period being equal to or less than zero (0).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Transferring Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Transaction Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means this Agreement and the other agreements to be entered into in connection with the transactions contemplated by this Agreement as described herein, including each Trust Agreement and the Administrative Services Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">True-up Dispute Cooling-Off Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">True-Up Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trust Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any account established pursuant to a Trust Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trust Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any trust agreement (or other relevant security and custody agreements) to be entered into by and among the Reinsurer, as grantor, a reinsured included in the definition of &#8220;Aspen&#8221;, as beneficiary, and the Trustee for purposes of providing security for the Reinsurer&#8217;s obligations under this Agreement with respect to such reinsured, which shall be substantially in the forms referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such form shall be amended to the extent reasonably required and reasonably acceptable to the Reinsurer and Aspen to take account of relevant applicable rules and guidance of Governmental Authorities and to ensure that it satisfies in full all applicable requirements in order to allow the reinsured included in the definition of &#8220;Aspen&#8221; that is the beneficiary of such trust account (or secured party under or in connection with such relevant security and custody agreements) to take full financial statement and regulatory credit for the reinsurance provided hereunder in all applicable jurisdictions (including, without limitation, the jurisdictions in which the relevant reinsured has a branch office that may require localization of assets).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means The Bank of New York Mellon or another trustee and&#47;or custodian reasonably acceptable to the Reinsurer and Aspen.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ULAE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means unallocated loss adjustment expenses and similar unallocated expenses, including the salaries, benefits and expenses of Aspen&#8217;s (or any of its Affiliates&#8217;) employees and other overhead and office expenses (except for fees of staff counsel expressly included in the definition of &#8220;Allocated Loss Adjustment Expenses&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ULAE Reimbursement Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ultimate Net Loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the sum of (a) Covered Losses actually paid by or on behalf of Aspen, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) Recoverables collected by or on behalf of Aspen, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c) Third Party </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Reinsurance Recoverables, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (d) Premiums collected by or on behalf of Aspen on or after the Effective Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The terms &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">controller</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">data subject</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">personal data breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">processing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;, and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">supervisory authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the same meanings ascribed to them under the GDPR.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE II</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REINSURANCE CEDED</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions of this Agreement, from and after the Closing, the Reinsurer shall pay, on the terms and subject to the conditions and limitations set forth in this Agreement, Aspen for all Ultimate Net Loss up to the Reinsurer&#8217;s Limit.  For avoidance of doubt, in no event shall the Reinsurer be required (i) to make aggregate payments under this Agreement in respect of Ultimate Net Loss in excess of the Reinsurer&#8217;s Limit or (ii) to make aggregate payments (including, for this purpose, by posting collateral) under this Agreement in respect of Ultimate Net Loss in excess of 102% of the Reinsurer&#8217;s Limit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Follow the Fortunes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Reinsurer&#8217;s liability under this Agreement for Covered Losses shall attach simultaneously with that of Aspen and the attachment of the Reinsurer&#8217;s liability thereto, and all reinsurance with respect to which the Reinsurer shall be liable shall be subject in all respects to the same risks, terms, rates, conditions, interpretations and waivers, and, subject to the terms of this Agreement, to the same good faith modifications, alterations, and cancellations, as are the Reinsured Polices to which liability under this Agreement attaches.  The true intent of this Agreement being that the Reinsurer shall, in each and every case to which liability under this Agreement attaches, follow the fortunes and settlements of Aspen, and the Reinsurer shall be bound, without limitation, by all payments and settlements entered into by or on behalf of Aspen, subject to the terms, conditions and provisions set forth herein.  All of Aspen&#8217;s liability as determined by a court or arbitration panel or arising from a judgment, settlement, compromise, adjustment, or commutation of claims or losses under the Subject Business, including payments involving coverage issues involving the Reinsured Policies included within the Subject Business, and&#47;or the resolution of whether such claims or losses are required by Applicable Law or Governmental Authority to be covered (or not to be excluded), shall, subject to the terms of this Agreement, be binding on the Reinsurer regardless of whether such court or arbitrational determination, judgment, settlement, compromise, adjustment or commutation is in respect of a liability recognized by or contrary to the governing law of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Pursuant to the terms and conditions set forth in this Agreement, the Reinsurer shall reinsure any Covered Losses resulting from any changes in the terms or conditions of any Reinsured Policy that are required by Applicable Law or any Governmental Authority or that are made in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in each case, on or after the Effective Time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Territory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The reinsurance provided under this Agreement shall be coextensive with the territory of the Reinsured Policies.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exclusions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision of this Agreement to the contrary, Covered Losses and the reinsurance under this Agreement shall not include&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any sum paid prior to the Closing Date in settlement or payment of any liability or obligation arising from any of the Reinsured Policies (provided, however, that the foregoing exclusion shall not operate to limit the Roll-forward Amount)&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For the avoidance of doubt, insurance liabilities acquired or assumed by Aspen following the Effective Date&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;ULAE (provided, however, that the foregoing exclusion shall not operate to limit the ULAE Reimbursement Amount)&#59; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Any Taxes imposed on or payable by or on behalf of Aspen (except liabilities of Aspen pursuant to the express terms of the Reinsured Policies)&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Any amounts payable under Third Party Reinsurance Agreements (for the avoidance of doubt, certain amounts payable under Third Party Reinsurance Agreements are, to the extent set forth in the definition of &#8220;Third Party Reinsurance Recoverables,&#8221; for the Reinsurer&#8217;s account)&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ex gratia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> payments made by or on behalf of Aspen on or after the Effective Date, unless (i) the Reinsurer has given its prior written consent to such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ex gratia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> payments or (ii) such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ex gratia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> payment is made by or at the express written direction of the Administrator under the Administrative Services Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Any Extra Contractual Obligations other than Reinsured Extra Contractual Obligations (collectively, (a)-(g), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Excluded Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sanctions Exclusions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer will not be liable to provide any coverage or make any payment hereunder if to do so would be in violation of any sanctions Applicable Law that would expose the Reinsurer or any of its Affiliates to any sanctions, prohibition, restriction or penalty under such sanctions Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE III</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REINSURANCE CONSIDERATION</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;No later than five (5) Business Days prior to the anticipated Closing Date, Aspen shall deliver to the Reinsurer a statement in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) hereto setting forth its good faith estimate of (i) the Estimated New Reinsurance Premium (including the Estimated New Reinsurance Premium Accrued Interest, the Roll-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">forward Amount and the ULAE Reimbursement Amount used to calculate the Estimated New Reinsurance Premium (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Estimated Roll-forward Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Estimated ULAE Reimbursement Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; respectively)) and (ii) the Initial Required Collateral Amount (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Estimated Initial Required Collateral Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), in each case, as of the Closing Date. On the Closing Date, Aspen shall pay the Reinsurer the Estimated New Reinsurance Premium by establishing a funds withheld account on its books and records, which shall be clearly designated as a notional account on the books and records of Aspen for the benefit of the Reinsurer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Funds Withheld Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) with an initial balance equal to the Estimated New Reinsurance Premium. Aspen shall, in its sole discretion, determine how to allocate the initial Funds Withheld Account Balance among the reinsureds included in the definition of &#8220;Aspen.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;All amounts held in the Existing Trust Accounts to secure the Reinsurer&#8217;s obligations under the Original Agreement shall remain in such Existing Trust Accounts or be deposited into the new Trust Accounts as of the Closing Date, in either case, to secure the Reinsurer&#8217;s obligations under this Agreement.  For the avoidance of doubt, the Parties acknowledge that such funds originated from the premium paid under the Original Agreement pursuant to which the Reinsurer assumed a portion of the liabilities being ceded pursuant to this Agreement and, as such, remain premium paid to the Reinsurer (including for U.S. federal tax purposes, except to the extent otherwise required by Applicable Law).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Reinsurer shall be permitted to instruct any bank issuing a Letter of Credit in support of its obligations under the Original Agreement to redesignate such Letter of Credit as of the Closing Date as being issued in support of the Reinsurer&#8217;s obligations under this Agreement and Aspen shall provide any consent or other cooperation reasonably required to effect such redesignation.  For the avoidance of doubt, the Parties acknowledge that as of the Closing Date, Aspen shall have no right to, and shall not, draw on any Letter of Credit issued in respect of the Original Agreement and not redesignated as being issued in support of the Reinsurer&#8217;s obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;On the Closing Date, the Reinsurer shall, to the extent necessary, deposit into the Trust Accounts (in accordance with any allocation provided by Aspen), or provide a Letter of Credit with a face amount equal to, an amount such that, following such deposit or Letter of Credit being provided and after giving effect to the transactions contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Reinsurer&#8217;s Posted Collateral equals the Estimated Initial Required Collateral Amount.  In the event the Reinsurer&#8217;s Posted Collateral would exceed the Estimated Initial Required Collateral Amount on the Closing Date, Aspen shall reduce the Funds Withheld Account by the amount of such excess and pay such amount to Reinsurer by wire transfer of immediately available funds.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;As additional consideration for the reinsurance provided herein, Aspen shall apply for the benefit of the Reinsurer one hundred percent (100%) of any Recoverables actually received or collected with respect to Covered Losses by or on behalf of Aspen on or after the Effective Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Closing and Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Unless otherwise agreed by Aspen and the Reinsurer, the closing of the transactions contemplated by this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall take place on the Business Day after all of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 12.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">12.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> are satisfied or waived by the Party or Parties entitled to waive the same (other than those conditions that by their nature are to be satisfied at Closing, but subject to the satisfaction or waiver of those conditions at Closing) at the offices of Sidley Austin LLP, 787 Seventh Avenue, New York, New York 10019, unless another date, time or place is agreed by the Parties.  If and when the Closing is effected, the Parties&#8217; rights and obligations under this Agreement shall commence on the Closing Date but shall be effective as of the Effective Date, as set forth herein.  Notwithstanding the foregoing, the Closing may occur at such other place, at such other time or on such other date as Aspen and the Reinsurer may mutually agree.  Aspen and the Reinsurer agree that the Closing may take place by conference call and electronic or facsimile delivery of signature pages.  The date on which the Closing takes place is referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#8221; The Closing shall be deemed to have occurred at 12&#58;01 a.m., Eastern Time, on the Closing Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary set forth herein&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the terms of the Original Agreement shall continue to apply until the Closing, at which time the terms of the Original Agreement shall no longer apply&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the terms of this Agreement shall not apply until the Closing&#59; provided, however, that the terms of the following shall apply from and after the date hereof&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (to the extent necessary to give effect to the following Sections and Articles), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4.1(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 10.2, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE XII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE XIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE XIV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE XV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE XVI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Post-Closing Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;No later than forty-five (45) days following the Closing Date, Aspen shall deliver to the Reinsurer a detailed statement in the same form as the Closing Statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Final Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) setting forth Aspen&#8217;s good faith calculation of (i) the New Reinsurance Premium (including the New Reinsurance Premium Accrued Interest, the Roll-forward Amount and the ULAE Reimbursement Amount) and (ii) the Initial Required Collateral Amount, in each case, as of the Closing Date, together with all accounting, actuarial and other data and documentation reasonably necessary for the Reinsurer to review Aspen&#8217;s proposed final calculations of such amounts.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Upon receipt of the Final Closing Statement, the Reinsurer and its authorized Representatives will be given reasonable access to all accounting, actuarial and other data and documentation related to the preparation of the Final Closing Statement for the purpose of, and to the extent reasonably necessary for, verifying the Final Closing Statement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no independent accountants or independent actuaries of Aspen shall be required to make any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">work papers available to the Reinsurer unless the Reinsurer has signed a customary agreement relating to such access to work papers in form and substance reasonably acceptable to such independent accountants or independent actuaries, as applicable.  Within forty-five (45) days of the Reinsurer&#8217;s receipt of the Final Closing Statement, the Reinsurer may deliver written notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">True-Up Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to Aspen of any objections, specifying in reasonable detail any contested amounts and the basis therefor, which the Reinsurer may have to the Final Closing Statement.  The failure of the Reinsurer to deliver such True-Up Dispute Notice within the prescribed time period will constitute the Reinsurer&#8217;s acceptance as final of the Final Closing Statement as determined by Aspen.  Any amounts not disputed in the True-Up Dispute Notice (if one is delivered) shall be deemed to be accepted by the Reinsurer as final, except to the extent that such amounts are affected by any disputed amounts.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;If Aspen and the Reinsurer are unable to resolve all disagreements with respect to the Final Closing Statement within thirty (30) days following Aspen&#8217;s receipt of a True-Up Dispute Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">True-up Dispute Cooling-Off Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the items and amounts in dispute shall be submitted for review to the Independent Actuary for final determination within forty-five (45) days after such submission. The Independent Actuary shall decide all matters relating to the procedures to be followed for resolution of the dispute, including those relating to the submission and receipt of information and documents&#59; provided, however, that at the request of either Aspen or the Reinsurer, a meeting shall be held at which the Parties may present their views, that both Aspen and the Reinsurer shall have equal access to the Independent Actuary, and that all information and documents which either Party delivers or makes available to the Independent Actuary shall be furnished to the other Party as well.  The review by the Independent Actuary shall be limited solely to the disputed items (and any items affected thereby) and amounts in the True-Up Dispute Notice that remain unresolved.  Any determination by the Independent Actuary shall not be outside the range defined by the respective amounts in the Final Closing Statement and the True-Up Dispute Notice, and such determination shall be final and binding upon, and non-appealable by, the Parties and their respective successors and assigns for all purposes of this Agreement, and not subject to collateral attack for any reason absent manifest error or fraud.  The fees and expenses of the Independent Actuary arising from such arbitration shall be paid by the Parties pro rata based on where the Independent Actuary&#8217;s determination of the New Reinsurance Premium falls in comparison to the amount claimed by Aspen in the Final Closing Statement and the amount claimed by the Reinsurer in the True-Up Dispute Notice. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;If the New Reinsurance Premium as finally determined pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is (i) greater than the Estimated New Reinsurance Premium (such difference, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Positive Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then Aspen shall pay to the Reinsurer (or to the applicable Trust Accounts, to the extent that the Reinsurer&#8217;s Posted Collateral is less than the Initial Required Collateral Amount), by wire transfer of immediately available funds to one or more accounts designated in writing by the Reinsurer, the Positive Adjustment Amount within five (5) Business Days following final determination of the New Reinsurance Premium pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or (ii) less than the Estimated New Reinsurance Premium (the absolute value of such difference, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Negative Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then Aspen shall reduce the Funds Withheld Account Balance by the Negative Adjustment Amount.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Funds Withheld Account Interest and Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;During the period from the Closing Date to the Funds Withheld Release Date, interest shall accrue daily on the Funds Withheld Account Balance at the Full Crediting Interest Rate, calculated for each calendar quarter using the applicable Prior Funds Withheld Account Balance Average.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Beginning with the period beginning on the Closing Date and ending on September 30 following the Closing Date and continuing for each twelve- (12) month period ending on September 30 thereafter (each such period, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Crediting Interest Rate Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;within five (5) Business Days of the end of any calendar quarter ending within such Crediting Interest Rate Period, the Base Crediting Interest Rate Accrued Amount with respect to such calendar quarter (or shorter, if applicable) shall be paid from the Funds Withheld Account to the Reinsurer&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;within forty-five (45) calendar days of the end of such Crediting Interest Rate Period, the amount (if any) by which the (A) the Full Crediting Interest Rate Accrued Amount for such Crediting Interest Rate Period exceeds (B) the Base Crediting Interest Rate Accrued Amount for such Crediting Interest Rate Period shall be paid from the Funds Withheld Account to the Reinsurer.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;On the Funds Withheld Release Date, Aspen shall pay to the Reinsurer (or, at the direction of the Reinsurer, deposit into one or more Trust Accounts) an amount equal to the Funds Withheld Account Balance as of such date (with such amount denominated in currencies in accordance with the breakdown of currencies of the Applicable Reserves underlying the most recently determined Required Collateral Amount) and, following such payment, Aspen shall have no further obligation to maintain the Funds Withheld Account.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance Premium Currency Allocation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Aspen represents and warrants to the Reinsurer that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto sets forth a breakdown of the currencies in which the Applicable Reserves relating to the Covered Losses reinsured hereunder as of September 30, 2021 were held by Aspen (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date Reserve Currency Split</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary set forth herein&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the Estimated New Reinsurance Premium allocated to the Funds Withheld Account pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be denominated in currencies in accordance with the Effective Date Reserve Currency Split as adjusted to account for the Ultimate Net Loss paid by or on behalf of Aspen during the period from (and including) October 1, 2021 to (and including) the Closing Date (including accounting for the currencies in which such Ultimate Net Loss was paid)&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;for so long as the Funds Withheld Account is maintained, promptly following the final determination of the Required Collateral Amount in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> each calendar quarter, Aspen shall cause, after giving effect to the currencies in which the Ultimate Net Loss incurred in such calendar quarter was paid (and any reduction in the assets held in the Funds Withheld Account in connection therewith pursuant to this Agreement, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), the Funds Withheld Account to be denominated in currencies in accordance with the breakdown of currencies of the Applicable Reserves underlying such Required Collateral Amount.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE IV</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ADMINISTRATION AND REPORTS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;At the Closing Date or as soon as reasonably practicable thereafter, the Reinsurer and Aspen will, or will cause their respective Affiliates to, enter into the Administrative Services Agreement pursuant to which the Administrator, on the one hand, and Aspen or its Affiliates, on the other hand, will each provide certain administrative services with respect to the Subject Business as described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Without limiting the provisions of the Administrative Services Agreement, in the event the Administrator reasonably requests a power of attorney to administer the Subject Business, Aspen shall, to the extent not precluded by Applicable Law, execute and deliver to the Administrator a limited power of attorney solely for the purposes of the administration of the Subject Business pursuant to the Administrative Services Agreement, in customary form.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Until the Administrative Services Agreement has been entered into by the parties thereto, Aspen shall cause the Subject Business to be administered in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 4.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Between the date hereof and the date on which the Administrative Services Agreement has been entered into by the parties thereto, (i) Aspen and the Reinsurer shall negotiate the terms of the Administrative Services Agreement in good faith and consistent with the terms set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and (ii) Aspen or the Reinsurer, as applicable, shall provide the Agreed Reports and Aspen shall provide the transition related services to the Reinsurer and the Administrator set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;If, as of the end of any calendar quarter, (i) the Ultimate Net Loss paid by or on behalf of Aspen plus the Roll-forward Amount is an amount equal to or greater than $3,000,000,000, and (ii) as of the end of such calendar quarter and each of the two (2) prior calendar quarters, the Ultimate Net Loss paid by or on behalf of Aspen plus the Roll-forward Amount plus the Applicable Reserves is an amount equal to or greater than $3,650,000,000 (together, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Rights Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Aspen shall be entitled to, at Aspen&#8217;s election, assume the administrative services required to be performed by the Administrator under the Administrative Services Agreement or hire a third-party administrator to assume such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">services.  Following any such election by Aspen following an Administrative Rights Triggering Event, the Administrator and the Reinsurer shall cooperate and work in good faith to transition such services to Aspen or such third-party administrator, including transitioning any data and documents in the Administrator&#8217;s possession or under its control that are reasonably necessary to perform such services and shall, if requested by Aspen, negotiate in good faith a transition services agreement between the Administrator and Aspen or such third-party administrator in order for the Administrator to provide reasonable services for a reasonable period of time in order to transition administration of the Subject Business to Aspen or such third-party administrator.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Each Party shall use its commercially reasonable efforts to cooperate with the other Party as reasonably requested by such other Party in connection with the administration of the Subject Business as contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and take such further actions and execute such further documents and agreements as may be necessary to carry out the purpose and intent of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Within thirty (30) days of the end of each calendar quarter, Aspen shall provide the Reinsurer with a report in respect of the Subject Business in substantially the same form as the quarterly reports delivered by Aspen under the Original Agreement (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Quarterly Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and which shall include the following quarterly information with respect to the Subject Business (which information shall include a breakdown by currency, as applicable)&#58;  (i) gross and net paid Covered Losses, (ii) gross and net outstanding case reserves for Covered Losses and gross and net outstanding IBNR reserves for Covered Losses, (iii) applicable reinsurance, subrogation, salvage or other recoveries, (iv) Aspen&#8217;s cumulative net paid Covered Losses since the Effective Time, (v) any amounts withdrawn by Aspen from the Funds Withheld Account, any Trust Account or drawn on any Letters of Credit or other form of collateral posted by the Reinsurer, if applicable, (vi) the investment analysis report in connection with the total investments and cash and cash equivalents of Aspen Parent and all of its subsidiaries, and (vii) any amounts due from the Reinsurer pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Actuaries from the Parties shall meet at least quarterly to discuss the data quality provided by Aspen and the Reinsurer, as applicable, any modifications to the data segmentation or reporting systems, any changes in claims practices and such other information as they mutually agree during the term of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Within forty-five (45) calendar days of the end of each Crediting Interest Rate Period, Aspen shall provide to the Reinsurer a statement of the Aspen Annual Investment Return as of the end of such Crediting Interest Rate Period certified by the chief financial officer, chief investment officer, capital management officer or chief executive officer of Aspen Parent as being determined in accordance with the definition of &#8220;Aspen Annual Investment Return&#8221; set forth herein.  Such statement shall include a summary of the portfolio underlying the Aspen Annual Investment Return.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Without limiting the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Aspen shall provide to Reinsurer such periodic accounting and other reports with respect to the Subject Business and the liabilities reinsured hereunder as the Reinsurer may reasonably request.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Quarterly Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any balance due by the Reinsurer as set forth in a Quarterly Report shall be remitted by the Reinsurer (including by the Reinsurer directing Aspen to reduce the Funds Withheld Account Balance by such balance) within forty-five (45) days of its receipt of such Quarterly Report.  For the avoidance of doubt, any disputes with respect to a Quarterly Report shall be subject to the dispute resolution provisions of the Administrative Services Agreement and the other applicable provisions of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In addition to the payments set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, upon the mutual written agreement of Aspen and the Reinsurer, an interim payment amount may be calculated by Aspen and provided to the Reinsurer.  The net amount due with respect to any such interim payment amount shall be paid by the Reinsurer to Aspen, and shall be reflected in the applicable Quarterly Report for the applicable calendar quarter.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Remittances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary set forth herein, any amounts owed by the Reinsurer hereunder may be satisfied by draws by Aspen from the Funds Withheld Account, the Trust Accounts or the Letters of Credit or any other collateral provided by the Reinsurer pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and the Reinsurer shall have no obligation to pay settlements hereunder to the extent of amounts so drawn&#59; provided, however, that (i) Aspen shall draw upon the amount held in the Funds Withheld Account (if any) in order to satisfy any amounts owed by the Reinsurer hereunder prior to drawing upon the Trust Accounts, the Letters of Credit or any other collateral provided by the Reinsurer pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (ii) subject to the foregoing clause (i), to satisfy any amounts owed by the Reinsurer hereunder, Aspen shall draw upon assets denominated in the currency in which such amount is owed (to the extent such assets are available) prior to drawing upon assets denominated in a currency other than the currency in which such amount is owed.  Without limiting the obligation of the Reinsurer to provide collateral as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in no event shall the Reinsurer be obligated to settle balances due hereunder directly with Aspen until such collateral has been fully depleted.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Except as otherwise set forth herein or in the Administrative Services Agreement, settlement with respect to amounts owed hereunder by the Reinsurer to Aspen in respect of Covered Losses and by Aspen to the Reinsurer in respect of Recoverables may be performed through the direct payment by the Reinsurer (or its Affiliates) of Covered Losses and direct receipt by the Reinsurer (or its Affiliates) of Recoverables on an ongoing basis as may be provided in the Administrative Services Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE V</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BOOKS AND RECORDS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Access to Books and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;From time to time Aspen shall&#58;  (i) allow the Reinsurer and its designees, upon reasonable notice and during normal business hours and subject to the rules applicable to visitors at Aspen&#8217;s offices, generally, the right to examine and make copies, at the Reinsurer&#8217;s expense, of any Books and Records of Aspen and (ii) allow the Reinsurer and its designees to interview Representatives of Aspen, in each case, for any reasonable purpose relating to this Agreement, including the Reinsured Policies and Covered Losses, including in connection with the Reinsurer&#8217;s preparation of regulatory and statutory filings and financial statements and, in each case, subject to the confidentiality provisions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Access to Aspen&#8217;s Representatives and Books and Records and other information shall not unreasonably interfere with the business operations of Aspen or its Affiliates, and shall otherwise be effectuated in a reasonable manner, giving effect to the size and scope of this transaction.  The Parties acknowledge that they share a common interest with respect to any privileged matters set forth in the Books and Records of Aspen.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding any other provision of this Agreement to the contrary, Aspen shall not be obligated to provide such access to any Books and Records, Representatives or other information if Aspen determines, in its reasonable judgment, that doing so would violate Applicable Law or a contract, agreement or obligation of confidentiality owing to a third-party, jeopardize the protection of any attorney-client privilege, or expose Aspen to liability for disclosure of sensitive or personal information.  The Parties will work in good faith to develop protocols for providing access to Aspen&#8217;s Books and Records in such circumstances.  In addition, the preparation of actuarial reports and analyses involves consultation with internal and external counsel, such that determinations of individual reserve levels including incurred-but-not reported reserves may disclose Aspen&#8217;s privileged determinations about the strengths of legal coverage defenses in individual matters.  To protect such privilege, information on reserves and incurred-but-not reported reserves shall be provided in aggregate and rolled up views.  The Parties will cooperate fully to protect such legal privilege to the greatest extent possible while providing reporting and substantiation for the reinsurance provided hereunder.  Notwithstanding the foregoing, the Parties acknowledge and agree that they may share a common interest with respect to certain Books and Records and that, accordingly, to the extent they share such common interest, the Parties will cooperate to provide the Reinsurer with access to such Books and Records where such access would, if not for such common interest, jeopardize attorney-client privilege.  Further, the Parties acknowledge and agree that the disclosure of Claims-related information to the Reinsurer in the ordinary course of a reinsurer-insured relationship shall not, absent legal advice to the contrary, be deemed to jeopardize the protection of any attorney-client privilege or expose Aspen to liability for disclosure of sensitive or personal information for purposes of this paragraph.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE VI</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DURATION AND TERMINATION</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Duration and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;This Agreement shall commence as of the Closing Date (provided that those provisions that, by their nature, are intended to commence as of the date hereof shall commence as of the date hereof) and continue in force until the earlier of the date on which (i) Reinsurer has paid aggregate Covered Losses equal to the Reinsurer&#8217;s Limit&#59; (ii) Aspen&#8217;s liability under all of the Reinsured Policies has terminated or extinguished and all amounts due to Aspen under this Agreement with respect to such Reinsured Policies have been paid and (iii) this Agreement is terminated upon a commutation by the mutual written agreement of the Parties.  In the event this Agreement is terminated in accordance with the preceding sentence or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, unless otherwise agreed by the Parties, subject to the payment to Aspen by the Reinsurer of an agreed settlement amount in the event this Agreement is terminated pursuant to clause (iii) of the prior sentence or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Reinsurer shall be entitled to (A) terminate any and all Letters of Credit, (B) the Funds Withheld Account Balance and all assets held in any Trust Account, which shall be released to the Reinsurer, and (C) 100% of all Recoverables owed to the Reinsurer pursuant to the terms hereof that remain outstanding as of the termination date of this Agreement.  All provisions hereof relating to collection or application of such Recoverables shall survive termination.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Aspen may terminate this Agreement if (i) the Reinsurer fails to pay any undisputed amounts due and owing under this Agreement where such failure to pay has not been cured within fifteen (15) days following Aspen&#8217;s notification to the Reinsurer of such failure (and Aspen does not have access to sufficient collateral provided hereunder to pay or recover for such amount owing) or the Reinsurer fails to provide additional collateral as and when required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (and Reinsurer has not remedied such failure within thirty (30) days of receiving written notice of such failure from Aspen), and&#47;or (ii) the Reinsurer should at any time (whether voluntarily or otherwise) become insolvent or the subject of any liquidation, administration, rehabilitation, receivership, supervision, conservation or bankruptcy action or proceeding (whether judicial or otherwise) or the Reinsurer ceasing to meet its &#8220;Enhanced Capital Requirement&#8221; as stipulated by the framework of the applicable Governmental Authority of Bermuda (or, where amended or replaced, its equivalent)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that this Agreement shall terminate automatically in the event that the Reinsurer becomes subject to an order of liquidation, administration or rehabilitation or similar order of a non-United States jurisdiction (in the event of such an order, termination of this Agreement shall be on a clean-cut basis, with the Reinsurer liable on and as of the termination date for all of the Reinsurer&#8217;s obligations under this Agreement for (i) losses and expenses due from but not recovered from the Reinsurer, (ii) the reserves for losses and expenses reported and outstanding (case reserves) and (iii) the reserves for losses and expenses incurred but not reported (IBNR)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, for the avoidance of doubt, Aspen shall offset any balances payable by it to the Reinsurer from such forgoing obligations under this Agreement).  The Reinsurer may terminate this Agreement if Aspen fails to pay any undisputed amounts due and owing under this Agreement (including, but </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">not limited to, failing to pay the Funds Withheld Account Balance on the Funds Withheld Release Date pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) where such failure to pay has not been cured within fifteen (15) days following the Reinsurer&#8217;s notification to Aspen of such failure and in the event of such a termination, termination of this Agreement shall be on a clean-cut basis, with the Reinsurer liable on and as of the termination date for all of the Reinsurer&#8217;s obligations under this Agreement for (i) losses and expenses due from but not paid by the Reinsurer, (ii) the reserves for losses and expenses reported and outstanding (case reserves) and (iii) the reserves for losses and expenses incurred but not reported (IBNR)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, for the avoidance of doubt, the Reinsurer shall offset any ceded balances payable by Aspen to the Reinsurer from such forgoing obligations under this Agreement.  For purposes of determining the payment to be made in connection with a termination of this Agreement in respect of reserves, the reserves shall be determined using Aspen&#8217;s historical practice for preparing such reserves and consistent with the definition of &#8220;Applicable Reserves&#8221;.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding the other provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the terms and conditions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VI, ARTICLE XIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 16.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.9,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall remain in full force and effect after the termination of this Agreement.  Any Letter of Credit posted by the Reinsurer pursuant to this Agreement shall terminate upon the termination of this Agreement.  In the event that this Agreement is terminated prior to the occurrence of the Closing, the Original Agreement shall continue in full force and effect in accordance with its terms. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Closing has not occurred on or before the date that is nine (9) months following the date hereof  (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then either Party may terminate this Agreement by written notice to the other Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if the sole cause of the Closing not occurring by the Outside Date is the failure to receive all consents, approvals and authorizations of Governmental Authorities required to consummate the transactions contemplated hereby by the Outside Date, the Outside Date shall be automatically extended for an additional thirty (30) days&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such right to terminate this Agreement shall not be available to a Party if the failure of the Closing to occur before the Outside Date was primarily due to the failure of such Party to perform any of its obligations under this Agreement. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE VII</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INSOLVENCY</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Insolvency of Aspen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Reinsurer hereby agrees that in the event of the insolvency, liquidation or rehabilitation of Aspen or the appointment of a conservator, liquidator, receiver or statutory successor of Aspen, all amounts due to Aspen under this Agreement shall be payable by the Reinsurer to Aspen or any conservator, liquidator, receiver or statutory successor of Aspen on the basis of the claims allowed against Aspen by any court of competent jurisdiction or by any conservator, liquidator, receiver or statutory successor of Aspen having authority to allow such claims, without diminution because of that insolvency, liquidation, rehabilitation or appointment, or because the conservator, liquidator, receiver or statutory successor has failed to pay all or a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">portion of any claims.  Payments by the Reinsurer as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be made directly to Aspen or to its conservator, liquidator, receiver, or statutory successor, provided that such payment may be effected by draw on the amounts held in the Funds Withheld Account or other collateral and the Reinsurer shall be entitled to recoup amounts held by Aspen in the Funds Withheld Account or other collateral against the Reinsurer&#8217;s obligations to make any such payment, except (i) where this Agreement specifically provides another payee of such reinsurance in the event of the insolvency of Aspen, (ii) if applicable, as provided by Section 4118(a)(1)(A) and 1114(c) of the New York Insurance Law, (iii) where the Reinsurer, with consent of the direct insured(s), has voluntarily assumed such Reinsured Policy obligations of Aspen as direct obligations of the Reinsurer to payees under such Reinsured Policies in substitution for obligations of Aspen to the payees, or (iv) where provided otherwise under Applicable Law.  Unless otherwise required by Applicable Law, under no circumstances shall the Reinsurer&#8217;s liability hereunder be accelerated or enlarged by the insolvency of Aspen.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;It is agreed and understood, however, that in the event of the insolvency of Aspen, the liquidator, receiver, conservator or statutory successor of Aspen shall give written notice to the Reinsurer of the pendency of a claim against Aspen for a Covered Loss within a reasonable period of time after such claim is filed in the insolvency, liquidation or rehabilitation proceedings and that during the pendency of such claim the Reinsurer may investigate such claim and interpose, at its own expense, in the proceeding where such claim is to be adjudicated, any defense or defenses which it may deem available to Aspen or its liquidator, receiver, conservator or statutory successor.  It is further understood that the expense thus incurred by the Reinsurer shall be chargeable, subject to court approval, against Aspen as part of the expense of administration or liquidation to the extent of a proportionate share of the benefit that may accrue to Aspen solely as a result of the defense undertaken by the Reinsurer.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall apply severally to each reinsured included in the definition of &#8220;Aspen.&#8221; </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE VIII</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITY</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Security</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Reinsurer shall take all steps necessary to permit each reinsured included in the definition of &#8220;Aspen&#8221; to obtain full financial statement and regulatory credit for the reinsurance provided hereunder in all jurisdictions applicable to such reinsured.  In the event any of the provisions of this Agreement conflict with or otherwise fail to satisfy the requirements of the appropriate credit for reinsurance Applicable Laws and&#47;or regulatory guidance or directives of any applicable jurisdiction, this Agreement shall be deemed amended to conform to the appropriate Applicable Laws and&#47;or regulatory guidance or directives of such applicable jurisdiction&#59; the intent of this Agreement being that each reinsured included in the definition of &#8220;Aspen&#8221; shall be permitted to realize full financial statement and regulatory credit for the reinsurance ceded to the Reinsurer under this Agreement at all times, and such collateral held shall be in an amount and form, shall be issued by or held by an acceptable entity, and shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">otherwise comply, at all times, with the appropriate Applicable Laws and&#47;or regulatory guidance or directives concerning credit for reinsurance and collateral required to be held for the benefit of each reinsured included in the definition of &#8220;Aspen&#8221;.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary set forth in this Agreement, the Reinsurer shall not, as of any date of determination, be required to provide an aggregate amount of collateral hereunder, whether through the Funds Withheld Account, the deposit of assets into the Trust Account, the posting of Letters of Credit or otherwise, in excess of the Required Collateral Amount as of such date of determination.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Reinsurer&#8217;s obligations under this Agreement may be secured, in whole or in part, by any form of collateral reasonably acceptable to Aspen that satisfies all applicable credit for reinsurance Applicable Laws and&#47;or regulatory guidance or directives of all jurisdictions applicable to the relevant reinsured included in the definition of &#8220;Aspen&#8221; in order for such reinsured to receive full financial statement and regulatory credit for the reinsurance provided hereunder, which (subject to the foregoing) may include Letters of Credit, the Funds Withheld Account, or assets held in one or more Trust Accounts.  As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurer&#8217;s Posted Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any date of determination, the aggregate amount of (i) the balance of all Letters of Credit provided by the Reinsurer pursuant to this Agreement, (ii) the aggregate Market Value of the assets held in all Trust Accounts, (iii) the Funds Withheld Account Balance, and (iv) the aggregate amount of any other collateral provided by the Reinsurer for the benefit of a reinsured included in the definition of &#8220;Aspen&#8221; that satisfies the requirements set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral Arrangements&#59; Reinsurer&#8217;s Collateral Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Parties shall work together in good faith and use commercially reasonable efforts to put into place, as promptly as practicable following the Closing Date and no later than the Funds Withheld Release Date, collateral arrangements that satisfy the requirements set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> with respect to each reinsured included in the definition of &#8220;Aspen&#8221;, which may include entering into one or more Trust Agreements establishing one of more Trust Accounts for the sole benefit of one or more reinsureds included in the definition of &#8220;Aspen&#8221;. The Funds Withheld Account Balance shall initially be equal to the Estimated New Reinsurance Premium and the Reinsurer acknowledges that the Estimated New Reinsurance Premium will be held by Aspen on a funds withheld basis as collateral for the performance of the Reinsurer&#8217;s obligations hereunder.  The Funds Withheld Account shall serve as a source of payment of the Reinsurer&#8217;s obligations to Aspen hereunder.  Aspen shall not, and shall cause its Affiliates not to, (i) grant or cause to be created in favor of any Person any security interest whatsoever in the Funds Withheld Account or any assets therein and (ii) use any of the assets in the Funds Withheld Account to provide other security in respect of the Reinsured Policies or otherwise.  Five (5) days prior to the Closing Date, Aspen will provide to the Reinsurer a breakdown prepared in good faith of the Applicable Reserves attributable to each reinsured included in the definition of &#8220;Aspen&#8221; as of the calendar quarter immediately preceding the Closing Date.  The Reinsurer will fund its collateral obligations to each such reinsured hereunder in proportion to the breakdown of Applicable Reserves attributable to such reinsured, subject in all events to the additional terms and conditions set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In accordance with the terms set forth herein and in any Trust Agreement, and subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Reinsurer shall ensure that the Reinsurer&#8217;s Posted Collateral is greater than or equal to the Required Collateral Amount, if any, as of a date of determination.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Reinsurer, prior to depositing assets with any Trustee, shall execute assignments or endorsements in blank, or transfer legal title to such Trustee of all shares, obligations or other assets requiring assignments so that such Trustee, upon the direction of the applicable reinsured included in the definition of &#8220;Aspen&#8221;, may negotiate such assets without consent or signature from the Reinsurer or any other Person.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Ongoing Collateral Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Within thirty (30) calendar days following the end of each calendar quarter, beginning with the calendar quarter in which the Closing Date occurs, Aspen shall deliver to the Reinsurer a quarterly funding report calculating the Required Collateral Amount as of the end of such calendar quarter (the last day of each calendar quarter, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Calculation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), together with a breakdown prepared in good faith of the Applicable Reserves attributable to each reinsured included in the definition of &#8220;Aspen&#8221;, prepared by Aspen.  The funding reports shall contain sufficient detail for the Reinsurer to confirm the calculation of the Applicable Reserves, the Required Collateral Amount and the breakdown of the Applicable Reserves attributable to each reinsured included in the definition of &#8220;Aspen.&#8221;  In the event the Reinsurer disagrees with any matters set forth in the funding report, within fifteen (15) days following receipt of the funding report, the Reinsurer shall deliver to Aspen a notice of disagreement specifying in reasonable detail each item it disputes (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disputed Item</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  If the Reinsurer does not deliver a notice of disagreement within such fifteen (15) day period, then the Required Collateral Amount set forth in the funding report shall be final and binding.  If the Reinsurer timely submits a notice of disagreement, the Parties shall negotiate in good faith to resolve the Disputed Items for five (5) days following receipt by Aspen of such notice of disagreement.  If the Parties cannot resolve the Disputed Items within such five (5) day period, the Parties shall submit the Disputed Items to a mutually acceptable, independent actuarial firm (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Independent Actuary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), with an international reputation, to resolve the Disputed Items.  Each Party shall furnish to the Independent Actuary such work papers, books, records and documents and other information pertaining to the Disputed Items as the Independent Actuary may request.  The Independent Actuary shall issue its written determination with respect to each of the Disputed Items within ten (10) days after such matters are submitted to the Independent Actuary for review.  The costs and expenses of the Independent Actuary shall be split evenly between Aspen and the Reinsurer.  The determination by the Independent Actuary shall be binding on the Parties with respect to the Disputed Items solely for the purposes of establishing the applicable Required Collateral Amount.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If the Required Collateral Amount, as determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, for any calendar quarter exceeds the Reinsurer&#8217;s Posted Collateral (determined as of the applicable Calculation Date), the Reinsurer shall, within five (5) calendar days after determination of the Required Collateral Amount pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3(a),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (i) pay an amount in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">cash to Aspen for deposit into the Funds Withheld Account or (ii) provide additional collateral in a form reasonably acceptable to Aspen that satisfies the requirements set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in either case such that the Reinsurer&#8217;s Posted Collateral equals or exceeds the Required Collateral Amount.  For the avoidance of doubt, the Reinsurer shall not be required to post collateral that, in the aggregate, exceeds the Required Collateral Amount and in no event shall the Reinsurer be required to post collateral to the extent such posted collateral plus the aggregate Ultimate Net Loss paid by the Reinsurer under this Agreement would exceed 102% of the Reinsurer&#8217;s Limit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Substitution of Trust Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer may substitute or exchange assets in any Trust Account, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (i) any assets to be so substituted or exchanged (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Replacement Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) are Eligible Assets, (ii) the Replacement Assets are deposited in such Trust Account on the day of the substitution or exchange and (iii) the aggregate Market Value of the Replacement Assets is at least equal to the aggregate Market Value of the assets being removed from such Trust Account.  The Reinsurer shall also be permitted to withdraw assets from any Trust Account immediately following the posting of a Letter of Credit securing the Reinsurer&#8217;s obligations hereunder in a face amount equal to the Market Value of the assets to be so withdrawn.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Settlements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, all settlements of account between the Reinsurer and Aspen shall be made in United States dollars in cash or its equivalent&#59; provided, however, that Ultimate Net Loss shall be settled in the applicable currency in which the amounts underlying such Ultimate Net Loss were paid.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Withdrawal of Assets by Aspen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Assets in the Funds Withheld Account, any Trust Account, Letters of Credit and any other collateral provided by the Reinsurer may be drawn upon by Aspen (or any successor by operation of law of Aspen, including any liquidator, rehabilitator, receiver or conservator of Aspen) at any time, and shall be utilized and applied by Aspen (or any successor by operation of law of Aspen, including any liquidator, rehabilitator, receiver or conservator of Aspen), without diminution because of insolvency on the part of Aspen or the Reinsurer, only for one or more of the following purposes&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;to pay or reimburse Aspen for the Reinsurer&#8217;s share of Covered Losses not otherwise paid by the Reinsurer when due&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;to make payment to the Reinsurer of any excess collateral amounts in the event and to the extent that the Reinsurer&#8217;s Posted Collateral exceeds the Required Collateral Amount, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;in the case of assets in any Trust Account or Letters of Credit (1) when Aspen has received notification of the termination of the Trust Account or the termination or non-renewal of the Letter of Credit (as applicable) or (2) in the event of any insolvency, bankruptcy or other similar credit event in respect of the Reinsurer or the Trustee, and when any of the Reinsurer&#8217;s obligations under this Agreement remain unliquidated and undischarged ten (10) calendar days prior to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the date of such termination or non-renewal or at the time of such insolvency, bankruptcy or other credit event, to fund a segregated account in the name of Aspen in an amount at least equal to such obligations for reinsurance ceded under this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Aspen shall deposit in any Trust Account (in the event of a withdrawal from a Trust Account or a draw against a Letter of Credit) or the Funds Withheld Account (in the event of a withdrawal from the Funds Withheld Account), within five (5) Business Days, assets withdrawn from such Trust Account, amounts drawn against any Letters of Credit or amounts drawn from the Funds Withheld Account in excess of all amounts due under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 8.6(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or, in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.6(a)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, assets that are subsequently determined not to be due.  Any such excess amount shall at all times be held by Aspen (or any successor by operation of law of Aspen, including any liquidator, rehabilitator, receiver or conservator of Aspen) in trust for the sole and exclusive benefit of the Reinsurer and be maintained in a segregated account, separate and apart from any assets of Aspen for the sole purpose of funding the payments and reimbursements described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen shall pay interest in cash to the Reinsurer on the amount withdrawn, equal to the actual amount of interest, dividends, and other income earned on the assets in such segregated account.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Withdrawal of Assets by the Reinsurer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen shall (if requested in writing by the Reinsurer) promptly pay to the Reinsurer from the Funds Withheld Account, or the Reinsurer may withdraw assets from any Trust Account or cause any Letters of Credit or other forms of collateral provided by the Reinsurer to be amended or terminated, if, but only to the extent that, the Reinsurer&#8217;s Posted Collateral exceeds the Required Collateral Amount as of any date of determination, as determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and Aspen shall take such action as is necessary to make such payment to the Reinsurer or to allow the Reinsurer to so withdraw assets or cause any such Letters of Credit or other forms of collateral to be so amended or terminated.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Collateral Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Promptly following termination of this Agreement and provided that the Reinsurer has paid any and all amounts due to Aspen, Aspen and the Reinsurer shall take all actions necessary to terminate each Trust Account, each Trust Agreement and any Letters of Credit or other form of collateral provided by the Reinsurer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Further, Aspen shall no longer be obligated to maintain the Funds Withheld Account and any balance therein shall be promptly paid to the Reinsurer.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE IX</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SALVAGE, SUBROGATION AND THIRD PARTY REINSURANCE</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Salvage and Subrogation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer shall be subrogated to all rights of Aspen against any Person who may be legally responsible in damages constituting Covered Losses for which the Reinsurer shall actually pay on or after the Effective Date (but only to the extent of the amount of payment by the Reinsurer).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In determining the amount of salvage or subrogation, there shall not be deducted from any amount recovered the out-of-pocket expenses incurred by Aspen in effecting the recovery (which the Parties acknowledge shall be included in Allocated Loss Adjustment Expenses).  All amounts recovered in connection with salvage and subrogation pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, excluding any amounts recovered that are attributable to Claims paid by Aspen prior to the Effective Date or other amounts paid by Aspen prior to the Closing Date and excluded pursuant to Section 2.5(a), shall be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Recoverables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Third Party Reinsurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For so long as the Administrative Services Agreement remains in effect, the Reinsurer (or the Administrator) shall have the right in accordance with the terms thereof to collect all Third Party Reinsurance Recoverables on behalf of Aspen and to make any payments due or owing by Aspen to any counterparty pursuant to any Third Party Reinsurance Agreement to the extent applicable to Covered Losses.  Notwithstanding the foregoing, with respect to any Third Party Reinsurance Agreements and Third Party Reinsurance Recoverables applicable to both the Subject Business and other business of Aspen (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Shared Outward Reinsurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall apply.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE X</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ERRORS AND OMISSIONS&#59; REGULATORY MATTERS&#59; COVENANTS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Errors and Omissions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Inadvertent delays, errors or omissions made in connection with this Agreement or any transaction hereunder shall not relieve any Party from any liability which would have attached had such delay, error or omission not occurred, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such error or omission is promptly rectified after discovery by an officer of such Party, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Party making such error or omission or responsible for such delay shall be responsible for any additional liability which attaches as a result.  If (a) the failure of any Party to comply with any provision of this Agreement is unintentional or the result of a misunderstanding or oversight and (b) such failure to comply is promptly rectified after discovery, the Parties shall be restored as closely as possible to the positions they would have occupied if no error or oversight had occurred.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen and the Reinsurer shall cooperate with each other in order to accomplish the objectives of this Agreement by furnishing any additional information and executing and delivering any additional documents and taking such other actions as may be reasonably requested by the other to further perfect or evidence the consummation of, or otherwise implement, any transaction contemplated by this Agreement or any other Transaction Agreement, or to aid in the preparation of any regulatory filing or financial statement or original or amended Tax Return&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any such additional documents must be reasonably satisfactory to each of the Parties and not impose upon any Party any material liability, risk, obligation, loss, cost or expense not contemplated by this Agreement or the other Transaction Agreements to which it is a party.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Regulatory Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If Aspen or the Reinsurer receives notice of, or otherwise becomes aware of, any written inquiry, investigation, examination, audit, proceeding or action by Governmental Authorities relating to the Subject Business, the Reinsured Policies or the reinsurance provided hereunder, Aspen and the Reinsurer, as applicable, shall promptly notify the other Party thereof to the extent permitted under Applicable Law, whereupon the Parties shall cooperate in good faith to resolve such matter in a mutually satisfactory manner and shall act reasonably in light of the Parties&#8217; respective interests in the matter at issue.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding any other provision in this Agreement or any other Transaction Agreement to the contrary, Aspen shall retain ultimate authority with respect to the handling of all regulatory matters in respect of the Subject Business.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;At all times during the term of this Agreement, each of Aspen and the Reinsurer, respectively, agrees that it shall hold and maintain all licenses and authorizations required under Applicable Law to perform its respective obligations under the Transaction Agreements and shall comply in all material respects with all Applicable Law in connection with its performance of such obligations and the Reinsurer shall not (and shall procure that its Affiliates shall not) cause Aspen to breach Applicable Law through the performance of its (or their) obligations under the Administration Services Agreement. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Parties agree to work together in good faith to amend the terms of the Transaction Agreements to the extent necessary to comply with Applicable Law or other accounting or regulatory requirements applicable to the Parties&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, subject and without prejudice to the each Party&#8217;s obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that neither Party shall be required to materially alter the terms of the transactions (including the amount of collateral to be provided and the delivery of any guarantee, keep-well or similar agreement) contemplated by this Agreement or the other Transaction Agreements in connection with the foregoing.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Prior to the Closing, the Parties agree to cooperate and amend this Agreement and the form of Administration Services Agreement with respect to the approach to&#58; (i) the administration of Claims&#59; and&#47;or (ii) the type or form of collateral and security, in each case, to reflect any requirements of applicable Governmental Authorities (including, without limitation, with respect to step-in rights, termination rights and&#47;or retaining certain assets in the Funds Withheld Account after the Funds Withheld Release Date to comply with localization of assets and&#47;or retention of title requirements of Applicable Law).  In connection with any required amendment described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.3(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Parties shall also make any further amendment to this Agreement or any other Transaction Agreement that would be necessary to achieve the original intent and economic effect of the transactions contemplated hereby and thereby to the greatest extent practicable as if such required amendment was not made (including, for example and without limitation, by amending the interest rate credited to any assets retained in the Funds Withheld Account after the Funds Withheld Release Date to reflect the profit or loss that would have been earned on such retained amounts had they been released on the Funds Withheld Release Date and invested in the Trust Accounts). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Existing Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen shall not amend, waive or terminate the terms of any Reinsured Policy, without the prior written consent of the Reinsurer (such consent not to be unreasonably withheld, delayed or conditioned), except (a) as required by Applicable Law or (b) as would not reasonably be expected to increase the exposure of Aspen under such Reinsured Policy in any material respect or otherwise adversely affect the Reinsurer or the coverage provided hereunder in any material respect.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance of Reinsured Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Other than existing reinsurance under the Third Party Reinsurance Agreements or any existing reinsurance between two or more of the Aspen entities, Aspen shall not reinsure any Covered Loss or enter into any agreement that would constitute a Third Party Reinsurance Agreement.  Aspen will provide the Reinsurer or a designated Affiliate thereof a right of first offer with respect to any reinsurance Aspen seeks to acquire for all or any portion of its risk above the Reinsurer&#8217;s Limit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commercially Reasonable Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the terms and subject to the conditions set forth in this Agreement, between the date of this Agreement and the Closing Date, Aspen and the Reinsurer shall each use their commercially reasonable efforts to promptly obtain from any Governmental Authority any actions, non-actions, clearances, waivers, consents, approvals, permits or orders required to be obtained by such Party or any of its Affiliates in connection with the authorization, execution, delivery and performance of this Agreement and the other Transaction Agreements and the consummation of the transactions contemplated hereby and thereby, including, as promptly as practicable after the date hereof, making any necessary filings with, or notifications to, such Governmental Authorities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, subject and without prejudice to each Party&#8217;s obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no Party shall be required to materially alter the terms of such transactions (including the amount of collateral to be provided and the delivery of any guarantee, keep-well or similar agreement) contemplated by this Agreement or the other Transaction Agreements in connection with the foregoing.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XI</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as set forth in the disclosure letter delivered by Aspen to the Reinsurer on the date hereof, Aspen Parent represents and warrants to the Reinsurer, as of the date hereof and as of the Closing Date (except for representations and warranties which address matters only as of a specific date, which representations and warranties shall be true and correct as of such specific date) and each of the reinsureds included in the definition of &#8220;Aspen&#8221; represents and warrants to the Reinsurer, separately and not jointly, and only with respect to such reinsured and not to the other reinsureds that comprise the definition of &#8220;Aspen&#8221; or the Aspen Parent, as of the date such reinsured executes this Agreement and as of the Closing Date (except for representations and warranties which address matters only as of a specific date, which representations and warranties shall be true and correct as of such specific date) as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Organization, Standing and Corporate Power</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen and Aspen Parent are each duly organized, validly existing and in good standing under the laws of their respective </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">jurisdictions of formation, and have all requisite corporate power and authority to carry on the operations of their respective businesses as they are now being conducted.  As of the Closing Date, Aspen and Aspen Parent will have obtained all authorizations and approvals required under Applicable Law to perform their respective obligations under the Transaction Agreements.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen and Aspen Parent have the requisite corporate (or other organizational) power and authority to enter into the Transaction Agreements to which they are a party and to consummate the respective transactions contemplated thereby.  The execution and delivery by Aspen and Aspen Parent of the Transaction Agreements to which they are a party and the consummation by Aspen and Aspen Parent of the respective transactions contemplated thereby have been and, with respect to the Transaction Agreements to which they are a party to be executed and delivered at or after Closing, will be, duly authorized by all necessary corporate or other organizational action on the part of Aspen and Aspen Parent.  Each of the Transaction Agreements have been or, with respect to the Transaction Agreements to be executed and delivered at or after the Closing, will be, duly executed and delivered by Aspen and Aspen Parent and, assuming the Transaction Agreements constitute valid and binding agreements of the other parties thereto (other than Aspen and Aspen Parent), constitute valid and binding obligations of Aspen and Aspen Parent, enforceable against Aspen and Aspen Parent in accordance with their terms, except that (i) such enforcement may be subject to applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws, now or hereafter in effect, affecting creditors&#8217; rights generally and (ii) the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought (clauses (i) and (ii) shall be referred to as, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Enforceability Exceptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Conflict or Violation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The execution, delivery and performance by Aspen and Aspen Parent of the Transaction Agreements to which they are a party and the consummation of the respective transactions contemplated thereby in accordance with the respective terms and conditions thereof will not (i) violate any provision of the organizational documents of Aspen and Aspen Parent or (ii) violate any material contract, Applicable Law, Order, license or permit to which Aspen or Aspen Parent is a party or otherwise subject in any material respect.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the matters referred to in the next sentence, the execution, delivery and performance by Aspen and Aspen Parent of the Transaction Agreements to which they are a party and the consummation of the respective transactions contemplated thereby in accordance with the respective terms and conditions thereof will not contravene any Applicable Law in any material respect.  No consent, approval or authorization of, or declaration or filing with, or notice to, any Governmental Authority, other than (a) filing of a Form 20-F, Form 6-K or other applicable form with the U.S. Securities and Exchange Commission&#59; (b) Form D filings with applicable U.S. insurance regulators&#59; (c) consent or non-objection from the UK Prudential Regulation Authority (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">PRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Lloyd&#8217;s of London (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Lloyd&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and (d) consents, approvals or non-objections as may be required from the Governmental Authorities in Australia, Bermuda, Canada, Singapore and Switzerland, arising out of or in connection with the transaction contemplated by this Agreement, where such approval(s) are required to be obtained </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by any applicable reinsured included within the definition of &#8220;Aspen&#8221;, or any other Person is required by or with respect to Aspen or Aspen Parent in connection with the execution and delivery of any Transaction Agreements by Aspen or Aspen Parent, or the consummation by Aspen or Aspen Parent of the transactions contemplated thereby.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen and Aspen Parent are in material compliance with each of the following&#58; (i) their respective organizational documents&#59; (ii) all Applicable Law to the extent related to the Reinsured Policies or the Subject Business and (iii) all material permits and licenses issued to them by any Governmental Authority in connection with the Reinsured Policies or the Subject Business.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Brokers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No broker or finder, other than Evercore Partners International LLP (whose fee shall be paid by Aspen), has acted directly or indirectly for Aspen or its Affiliates, and neither Aspen nor any of its Affiliates has incurred any obligation in respect of any broker or finder, which might be entitled to any fee or commission from the Reinsurer or its Affiliates in connection with the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the knowledge of Aspen Parent, the historical claims data made available to the Reinsurer by Aspen Parent and its subsidiaries as regards the Reinsured Policies is accurate in all material respects as of the date indicated.  The reserves and other provisions made for claims, benefits and any other liabilities with respect to the Reinsured Policies, whether reported or incurred but not reported, as established or reflected on Aspen&#8217;s most recent statutory annual statement and statutory quarterly statement were calculated in all material respects in accordance with (i) statutory accounting principles and generally accepted actuarial principles, in each case consistently applied, (ii) Applicable Law and (iii) otherwise in accordance with the terms of the Reinsured Policies.  Aspen Parent has made available to the Reinsurer all information material to the liabilities reinsured hereunder. For the avoidance of doubt, no representation or warranty is made as to the adequacy or sufficiency of reserves as of any date.  For the avoidance of doubt, only Aspen Parent is making the representations and warranties set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and no reinsured that comprises the definition of &#8220;Aspen&#8221; is making, or shall be deemed to be making, the representations and warranties set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Absence of Certain Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Since the Effective Date, (i) the Subject Business has been conducted in all material respects in the ordinary course consistent with past practices and (ii) there has not been any adverse event, change or circumstance that, individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the Subject Business or the liabilities reinsured hereunder.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Orders and Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  As of the date hereof, there are no (i) material outstanding Orders relating to the Reinsured Policies or the Subject Business against or involving Aspen, Aspen Parent or any of their assets related to the Reinsured Policies or the Subject Business or (ii) material consent agreements, commitment agreements, capital maintenance or similar written agreements entered into between any Governmental Authority and Aspen or any of its Affiliates that expressly relate to the Reinsured Policies or the Subject Business under which Aspen or any of its Affiliates has any continuing obligations.  As of the date hereof, there </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">is no material claim, action, suit, litigation, legal, administrative or arbitration proceeding, regulatory inquiry, investigation or examination relating to the Reinsured Policies or the Subject Business which is pending or threatened against or involving Aspen, Aspen Parent or any of their assets, properties, rights or privileges relating to the Reinsured Policies or the Subject Business that, in each case, challenges or may reasonably be expected to have the effect of preventing or delaying or making unlawful the consummation of the transactions contemplated by the Transaction Agreements. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsured Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  With respect to each Reinsured Policy, to the knowledge of Aspen and Aspen Parent, (i) the applicable issuing insurance company or entity is not in default under such Reinsured Policy in any material respect and no event has occurred which would create such a default by such company or entity under such Reinsured Policy (it being understood that claims under the Reinsured Policies that are the subject of a good faith dispute shall not constitute defaults under the Reinsured Policies for the purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and (ii) such Reinsured Policy was issued in compliance in all material respects with Applicable Law.  To the knowledge of Aspen and Aspen Parent, there are no material pending or threatened disputes with respect to the validity of any Reinsured Policy.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Third Party Reinsurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;As of September&#160;30, 2021, the aggregate value of all Third Party Reinsurance Recoverables was &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;, which (A) consisted of &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;for case reserves and &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;for incurred but not reported losses and (B) was calculated in all material respects in accordance with (1) statutory accounting principles and generally accepted actuarial principles, in each case consistently applied, (2) Applicable Law and (3) otherwise in accordance with the terms of the applicable Third Party Reinsurance Agreements.  Notwithstanding the foregoing, the Reinsurer acknowledges that none of Aspen or Aspen Parent has made or is making any representation or warranty, express or implied, that &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;of Third Party Reinsurance Recoverables will actually be collected.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;To the knowledge of Aspen and Aspen Parent, other than in regard to net retained line clauses and similar provisions&#58;  (A) no Material Third Party Reinsurance Agreement contains any provision under which the reinsurer may terminate such agreement by reason of the transactions contemplated by this Agreement or the agreements contemplated hereby and (B) there has been no separate contract between the applicable ceding company (or its Affiliates) and any other party to such Material Third Party Reinsurance Agreement that would under any circumstances reduce, limit, mitigate or otherwise affect any actual or potential loss to the parties under any such Material Third Party Reinsurance Agreement, other than inuring contracts that are explicitly defined in any such Material Third Party Reinsurance Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;With respect to each Material Third Party Reinsurance Agreement, to the knowledge of Aspen and Aspen Parent, (A) neither the applicable ceding company (or its Affiliates), on the one hand, nor the reinsurer, on the other, is in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">default under such Material Third Party Reinsurance Agreement, and no event has occurred which would create a material default or breach by the applicable ceding company (or its Affiliates) under such Material Third Party Reinsurance Agreement, (B) such Material Third Party Reinsurance Agreement is in full force and effect and is valid and enforceable in accordance with its terms subject to the Enforceability Exceptions, and (C) such Material Third Party Reinsurance Agreement complies in all material respects with Applicable Law.  To the knowledge of Aspen and Aspen Parent, there are no material pending or threatened disputes with respect to the validity of any Material Third Party Reinsurance Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;&#91;***&#93;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No other Representations or Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything contained in this Agreement or the other Transaction Agreements to the contrary, neither Aspen nor any other Person acting on behalf of Aspen has made or is making any other representation or warranty whatsoever, expressly or implied, beyond those expressly made in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Without limiting the generality of the foregoing, the Reinsurer acknowledges that no representations or warranties are made with respect to any projections, forecasts, or estimates, except to the extent expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that has or may have been made available to the Reinsurer, its Affiliates or any of their respective Representatives.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The exclusive remedy for misrepresentation or breach of representations and warranties with respect to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is a claim for indemnification pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE XIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any claim for indemnification for a breach of representations or warranties shall be made no later than three (3) years following the Closing Date. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurer Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer represents and warrants to Aspen as of the date hereof and as of the Closing Date (except for representations and warranties which address matters only as of a specific date, which representations and warranties shall be true and correct as of such specific date) as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Organization, Standing and Corporate Power</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer is duly organized, validly existing and in good standing under the laws of Bermuda, and has all requisite corporate power and authority to carry on the operations of its business as it is now being conducted.  As of the Closing Date, the Reinsurer will have obtained all authorizations and approvals required under Applicable Law to perform its obligations under the Transaction Agreements.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer has the requisite corporate power and authority to enter into the Transaction Agreements to which it is a party and to consummate the transactions contemplated thereby.  The execution and delivery by the Reinsurer of the respective Transaction Agreements to which it is a party and the consummation by it of the respective transactions contemplated thereby have been and, with respect to the Transaction Agreements to which it is a party to be executed and delivered at or after the Closing, will be, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">duly authorized by all necessary corporate or other organizational action on the part of the Reinsurer.  Each of the Transaction Agreements has been or, with respect to the Transaction Agreements to be executed and delivered at or after the Closing, will be, duly executed and delivered by the Reinsurer and, assuming the Transaction Agreements constitute valid and binding agreements of the other parties thereto (other than the Reinsurer), constitute valid and binding obligations of the Reinsurer, enforceable against the Reinsurer in accordance with their terms, subject to the Enforceability Exceptions.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Conflict or Violation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The execution, delivery and performance by the Reinsurer of the Transaction Agreements to which it is a party and the consummation of the transactions contemplated thereby in accordance with the respective terms and conditions thereof will not (i) violate any provision of the organizational documents of the Reinsurer, or (ii) violate any material contract, Applicable Law, Order, license or permit to which the Reinsurer is a party or otherwise subject in any material respect.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the matters referred to in the next sentence, the execution, delivery and performance by the Reinsurer of the Transaction Agreements to which it is a party and the consummation of the transactions contemplated thereby in accordance with the respective terms and conditions thereof will not contravene any Applicable Law in any material respect.  No consent, approval or authorization of, or declaration or filing with, or notice to, any Governmental Authority, other than the Bermuda Monetary Authority, or any other Person is required by or with respect to the Reinsurer in connection with the execution and delivery of the Transaction Agreements by the Reinsurer, or the consummation by the Reinsurer of the transactions contemplated thereby.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer is in material compliance with each of the following&#58;  (i) its organizational documents, (ii) all Applicable Law and (iii) all material permits and licenses issued to it by any Governmental Authority, except for any non-compliance which would not, individually or in the aggregate, reasonably be expected to impair the ability of the Reinsurer to consummate the transactions contemplated by the Transaction Agreements or perform its obligations thereunder.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No broker or finder has acted directly or indirectly for the Reinsurer or its Affiliates and the Reinsurer has not incurred any obligation in respect of any broker or finder, which might be entitled to any fee or commission from Aspen or its Affiliates in connection with the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No other Representations or Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything contained in this Agreement or the other Transaction Agreements to the contrary, neither the Reinsurer nor any other Person acting on behalf of the Reinsurer has made or is making any other representation or warranty whatsoever, expressly or implied, beyond those expressly made in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The exclusive remedy for misrepresentation or breach of representations and warranties with respect to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is a claim for indemnification </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE XIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any claim for indemnification for a breach of representations or warranties shall be made no later than three (3) years following the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XII</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CLOSING CONDITIONS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Reinsurer&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer&#8217;s obligation to consummate the transactions contemplated by the Transaction Agreements is subject to the satisfaction (or waiver, if permissible under Applicable Law) on or prior to the Closing Date of the following conditions&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The representations and warranties of Aspen contained in this Agreement shall be true and correct on the Closing Date (except to the extent that any such representations and warranties are given as of a particular date or relate solely to a particular date or period, in which case such representations and warranties shall be true and correct as of such date or for such period) except as would not have a material adverse effect on the liabilities reinsured hereunder or the ability of Aspen to perform its obligations under this Agreement or the other Transaction Agreements.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Aspen shall have performed and complied in all material respects with all covenants and agreements required by this Agreement to be performed or complied with by Aspen at or prior to the Closing.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Reinsurer shall have received a certificate, dated as of the Closing Date and signed by a duly authorized officer of Aspen Parent, that each of the conditions set forth in the foregoing clauses (a) and (b) have been satisfied.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;There shall be no Order or mandatory requirement of any Governmental Authority restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated by this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The Reinsurer shall have received the approval of the Bermuda Monetary Authority and any other applicable Governmental Authorities (approval from which is required by Applicable Law) to consummate the transactions contemplated hereby.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;The Reinsurer shall have received executed copies of each of the Transaction Agreements to be executed and delivered by Aspen or any Affiliate thereof and such other agreements, documents or instruments as the Reinsurer shall reasonably request from Aspen in connection with the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Aspen&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen&#8217;s obligation to consummate the transactions contemplated by the Transaction Agreements is subject to the satisfaction (or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">waiver, if permissible under Applicable Law) on or prior to the Closing Date of the following conditions&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The representations and warranties of the Reinsurer contained in this Agreement shall be true and correct on the Closing Date (except to the extent that any such representations and warranties are given as of a particular date or relate solely to a particular date or period, in which case such representations and warranties shall be true and correct as of such date or for such period) except as would not have a material adverse effect on the ability of the Reinsurer to perform its obligations under this Agreement or the other Transaction Agreements.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Reinsurer shall have performed and complied in all material respects with all covenants and agreements required by this Agreement to be performed or complied with by the Reinsurer at or prior to the Closing.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Aspen shall have received a certificate, dated as of the Closing Date and signed by a duly authorized officer of the Reinsurer, that each of the conditions set forth in the foregoing clauses (a) and (b) have been satisfied.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;There shall be no Order or mandatory requirement of any Governmental Authority restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated by this Agreement. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Aspen (or the applicable reinsured within the definition of &#8220;Aspen&#8221;) shall have received such consents, approvals and&#47;or non-objections from all of the applicable Governmental Authorities referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to consummate the transactions contemplated hereby.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Aspen shall have received executed copies of each of the Transaction Agreements to be executed and delivered by the Reinsurer or any Affiliate thereof and such other agreements, documents or instruments as Aspen shall reasonably request from the Reinsurer in connection with the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Alternative Closing Structure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If at any time following the 90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day after the date hereof (a) the Parties have not yet received any required consents, approvals or non-objections with respect to the transactions contemplated by this Agreement from the applicable insurance regulatory authorities in Australia, Canada, Singapore or Switzerland, and (b) the other conditions to Closing have been satisfied or are capable of being satisfied at the Closing, the Parties shall discuss in good faith proceeding with the Closing with respect to the portion of the Subject Business that is not subject to the regulation of the insurance regulatory authority in any such jurisdiction that has not yet provided its consent, approval or non-objection, with such adjustments to the terms of this Agreement to take into account the exclusion of a portion of the Subject Business.  If the Parties agree to effect the Closing with respect to a portion of the Subject Business, they shall remain obligated, pursuant to the terms of this Agreement, to pursue </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">one or more additional closings with respect to the excluded portion of the Subject Business on or prior to the Outside Closing Date.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XIII</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INDEMNIFICATION</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">The Reinsurer&#8217;s Obligation to Indemnify</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer shall indemnify, defend and hold harmless Aspen and its Affiliates and each of their respective directors, officers, employees, agents, successors and permitted assigns from and against any and all losses, liabilities, claims, expenses (including reasonable attorneys&#8217; fees and expenses) and damages (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) actually incurred by Aspen to the extent arising from (a) any breach of the representations, warranties, covenants or obligations of the Reinsurer contained in this Agreement and (b) any successful enforcement of this indemnity.  Nothing herein shall be construed to require the Reinsurer to indemnify Aspen to the extent any Damages are attributable to any acts or omissions of a Person who is a director, officer, employee, agent, successor or permitted assign of Aspen or any of its Affiliates, Representatives or agents, unless such Person is acting at the express written direction or written request of the Reinsurer (or any of its Affiliates, Representatives or agents).  Damages shall not include punitive, exemplary and consequential damages.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Aspen Parent&#8217;s Obligation to Indemnify</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen Parent shall indemnify, defend and hold harmless the Reinsurer and its Affiliates and each of their respective directors, officers, employees, agents, successors and permitted assigns from and against any and all Damages actually incurred by the Reinsurer to the extent arising from (a) any breach of the representations, warranties, covenants or obligations of Aspen contained in this Agreement, (b) the Excluded Liabilities, and (c) any successful enforcement of this indemnity.  Nothing herein shall be construed to require Aspen Parent to indemnify the Reinsurer to the extent any Damages are attributable to any acts or omissions of a Person who is a director, officer, employee, agent, successor or permitted assign of the Reinsurer or any of its Affiliates, Representatives or agents, unless such Person is acting at the express written direction or written request of Aspen Parent (or any of its Affiliates, Representatives or agents).  Damages shall not include punitive, exemplary and consequential damages.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XIV</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UTMOST GOOD FAITH</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Utmost Good Faith and Fair Dealing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The relationship of the Parties with respect to the matters covered by this Agreement shall be in accordance with the principles of utmost good faith and fair dealing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, notwithstanding anything contained herein or in any other Transaction Agreement to the contrary, each of the Reinsurer, Aspen Parent and Aspen absolutely and irrevocably waives resort to the duty of &#8220;utmost good faith&#8221; or any similar principle in connection with the negotiation or execution of this Agreement. For the avoidance of doubt, this waiver shall not apply to any such duty as may exist with respect to matters arising, and actions taken, on or after the date hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XV</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TAXES</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Federal Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen will pay all Federal excise tax applicable to the New Reinsurance Premium (including, for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 15.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, any interest credited to the Funds Withheld Account Balance in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), to the extent the New Reinsurance Premium is subject to such excise tax&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that notwithstanding anything herein to the contrary, Aspen shall be entitled to deduct from such New Reinsurance Premium an amount equal to fifty percent (50%) of the Federal excise tax applicable to such New Reinsurance Premium up to an amount not to exceed &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;. The parties hereto acknowledge and agree that the amount of the New Reinsurance Premium that is subject to such excise tax shall be determined in accordance with the allocation referenced in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FATCA and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer shall provide or otherwise make available to Aspen, on or before the Closing Date, documentation on forms approved by the United States Internal Revenue Service establishing an exemption from withholding of premium or other amounts payable hereunder in accordance with the United States Internal Revenue Code, including the Foreign Account Tax Compliance Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and the Reinsurer shall provide or otherwise make available updated documentation to Aspen upon request therefor.  In the event that the Reinsurer fails to do so or ceases to be exempt from withholding in accordance with FATCA, or if withholding is otherwise required by Applicable Law, Aspen shall withhold the applicable percentage of premium or other amount payable hereunder, and the Reinsurer shall allow such withholding.  Interest shall not be payable on any amounts withheld in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 15.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, nor shall any such amounts be subject to offset.  The Reinsurer agrees to indemnify Aspen for any liability, incurred in whatever form, on account of the Reinsurer&#8217;s failure to properly comply with its obligations under FATCA, any other withholding Tax requirement or the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 15.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XVI</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MISCELLANEOUS PROVISIONS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any notice, request, demand, waiver, consent, approval or other communication required or permitted to be given by any Party hereunder shall be in writing and shall be delivered personally, sent by registered or certified mail, postage prepaid, sent by a standard overnight courier of national reputation with written confirmation of delivery or sent by e-mail.  Any such notice shall be deemed given when so delivered personally, or if mailed, on the date shown on the receipt therefor, or if sent by overnight courier, on the date shown on the written confirmation of delivery, or if sent by e-mail, at the time of completion of the transmission by the sender and, where transmitted other than on a Business Day or outside of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">normal hours of the recipient, on the next Business Day of the recipient.  Such notices shall be given to the following address&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to Aspen&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">141 Front Street</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hamilton, HM19</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bermuda</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attn&#58;  David Amaro&#59; Group Head of Legal</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58; David.Amaro&#64;Aspen.co</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with copies (which shall not constitute notice) to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Sidley Austin LLP</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">One South Dearborn Street</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chicago, IL 60603</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Sean Carney&#59; Jennifer Norris</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58;  scarney&#64;sidley.com&#59; jnorris&#64;sidley.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Reinsurer&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cavello Bay Reinsurance Limited</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Windsor Place, 3rd Floor</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22 Queen Street</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hamilton, HM11</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bermuda</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Paul J. O&#8217;Shea</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58;  Paul.OShea&#64;enstargroup.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with copies (which shall not constitute notice) to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hogan Lovells US LLP </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1735 Market Street, Suite 2300</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Philadelphia, PA 19103-6996</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58;  Robert C. Juelke</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Telephone&#58;  267-675-4615</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Email&#58;  bob.juelke&#64;hoganlovells.com</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Party may change its notice provisions on fifteen (15) calendar days&#8217; advance notice in writing to the other Party.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Confidentiality&#59; Public Announcements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The confidentiality agreement entered into by the Parties (or their Affiliates), dated September 10, 2021, shall survive the execution and delivery of this Agreement in accordance with its terms.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Parties (each, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Receiving Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) hereby covenant and agree, each on behalf of itself and on behalf of its Affiliates, that from and after the date hereof, the Receiving Party and its Affiliates will not disclose, give, sell, process, use or otherwise divulge any Confidential Information (as defined below) of the other Party (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disclosing Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or permit their respective Representatives to do the same, except that each Receiving Party may disclose such Confidential Information or portions thereof (i) if legally compelled to do so or as required in connection with an examination by an insurance regulatory authority, (ii) to the extent necessary for the performance of such Receiving Party&#8217;s and its Affiliates&#8217; obligations under this Agreement or under any other Transaction Agreement, (iii) to enforce the rights of such Receiving Party or its Affiliates under this Agreement or under any other Transaction Agreement, (iv) to those of such Receiving Party&#8217;s Affiliates, and to their respective Representatives, in each case, who need to know such information for the foregoing purposes, (v) as required under any Applicable Law, (vi) as required by a tax authority to support a position taken on any tax return or (vii) as required by the rules of any stock exchange on which the stock of a Receiving Party&#8217;s Affiliate is traded, as applicable.  If the Receiving Party or its Affiliates, or any of their respective Representatives, become legally compelled to disclose any Confidential Information (other than as required in connection with an examination by an insurance regulatory authority or as required to a tax authority to support a position taken on any tax return), the Receiving Party shall provide the Disclosing Party with prompt written notice of such requirement (if permitted by Applicable Law) so that the Disclosing Party may seek a protective order or other remedy or waive compliance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that such protective order or other remedy is not obtained, or the Disclosing Party waives compliance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Receiving Party or its Affiliates, as applicable, shall furnish only that portion of Confidential Information which is legally required to be provided and exercise its commercially reasonable efforts to obtain assurances that appropriate confidential treatment will be accorded to the Confidential Information.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Receiving Party, on behalf of itself and on behalf of its Affiliates and their respective Representatives, acknowledges that a breach of its obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> may result in irreparable injury to the Disclosing Party.  In the event of the breach by the Receiving Party or any of its Affiliates or their respective Representatives of any of the terms and conditions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Disclosing Party shall be entitled to seek equitable relief, including injunctive relief and specific performance, in addition to any other remedies available under this Agreement or otherwise available in equity or at law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;For the purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all confidential information (irrespective of the form of such information) of any kind, including any analyses, compilations, data, studies, notes, translations, memoranda or other documents, concerning the Disclosing Party or any of its Affiliates obtained directly or indirectly from the Disclosing Party or any of its Affiliates or Representatives in connection with the transactions contemplated by this Agreement and the other Transaction Agreements, including any information regarding the Subject Business or provisions or terms of this Agreement or the other Transaction Agreements (provided that, notwithstanding the foregoing, each Party may make such disclosures in its filings with the U.S. Securities and Exchange Commission as it believes are required), except information (i) which, at the time of the disclosure, was ascertainable or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">available to the public (other than as a result of a disclosure directly or indirectly by the Receiving Party or any of its Affiliates or Representatives in breach hereof), (ii) that is or becomes available to the Receiving Party on a non-confidential basis from a source other than the Disclosing Party or any of its Affiliates or Representatives&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, to the knowledge of such Receiving Party, such source was not prohibited from disclosing such information to the Receiving Party by a legal, contractual or fiduciary obligation owed to another Person, (iii) that the Receiving Party can establish is already in its possession or the possession of any of its Affiliates or Representatives (other than information furnished by or on behalf of the Disclosing Party) or (iv) that is independently developed by the Receiving Party or its Affiliates without the use or benefit of any information that would otherwise be Confidential Information.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Each Party acknowledges that where it processes Shared Personal Information under this Agreement it alone determines the purposes and means of such processing as a controller.  The Reinsurer hereby acknowledges and agrees that it shall process Shared Personal Information only in connection with the objectives and purposes for which Aspen and the Reinsurer have entered into this Agreement and&#47;or to comply with Applicable Law.  The Reinsurer confirms that it shall process the Shared Personal Information at all times in compliance with Privacy Laws and that it has in place written and up-to-date administrative, organizational, technical and physical safeguards to protect the security, availability, integrity and confidentiality of Shared Personal Information in accordance with Privacy Laws to the extent relevant to this Agreement. Should the Reinsurer learn or have reason to believe that Shared Personal Information has been processed in a manner contrary to Privacy Laws and&#47;or the subject of a personal data breach (collectively, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Incident</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Reinsurer, upon learning of such Incident, shall give Aspen immediate written notice of such Incident, and the Reinsurer, at its own expense, shall take immediate action to remedy any such Incident to the extent reasonably required and fully cooperate with Aspen regarding any investigation of the Incident.  The Reinsurer shall notify Aspen immediately of any communication or request received by the Reinsurer from a data subject and&#47;or supervisory authority and shall provide such assistance to Aspen as is reasonably required to enable Aspen to respond to such communication or request within the time limits imposed by Privacy Laws.  The Reinsurer shall not, by act or omission, cause Aspen to violate any Privacy Laws, notices provided to, or any consents obtained from, data subjects, in each case, in connection with processing Shared Personal Information under this Agreement.  The Parties agree that Aspen will not transfer and&#47;or otherwise make available any Personal Information to the Reinsurer until such time as the Parties have entered into standard contractual clauses (or equivalent) to legitimize such international transfers of Personal Information.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Each Party and its respective Affiliates shall consult with each other before issuing, and provide each other the opportunity to review and comment upon, any press release or other public statement with respect to the transactions contemplated by the Transaction Agreements and shall not issue any such press release or make any such public statement with respect to such matters without the advance approval of the other Parties following such consultation (such approval not to be unreasonably withheld, delayed or conditioned), except as may be required by Applicable Law or by the requirements of any securities exchange&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that, in the event that any Party is required by Applicable Law or the requirements of any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">securities exchange to issue any such press release or make any public statement and it is not feasible to obtain the advance approval of the other Parties as required by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.2(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Party that issues such press release or makes such public statement shall provide the other Parties with notice and a copy of such press release or public statement as soon as reasonably practicable thereafter.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Agent shall be deemed the agent of each entity that constitutes &#8220;Aspen&#8221; for purposes of this Agreement and the transactions contemplated hereby, including for purposes of sending or receiving notices required by the terms and conditions of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement (including the exhibits and schedules hereto), the other Transaction Agreements and any other documents delivered pursuant hereto and thereto constitute the entire agreement among the Parties and their respective Affiliates with respect to the subject matter hereof and thereof and supersede all prior negotiations, discussions, writings, agreements and understandings, oral and written, among the Parties with respect to the subject matter hereof and thereof. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Waiver and Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be amended, superseded, canceled, renewed or extended, and the terms hereof may be waived, only by an instrument in writing signed by the Parties, or, in the case of a waiver, by the Party waiving compliance.  No delay on the part of any Party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other such right, power or privilege.  The failure of any Party to insist on compliance with any obligation contained in this Agreement or to exercise any right or remedy hereunder shall not constitute a waiver of any right or remedy contained herein nor stop any Party from thereafter demanding full and complete compliance nor prevent any Party from exercising such right or remedy in the future.  No waiver of any breach of this Agreement shall be held to constitute a waiver of any other or subsequent breach.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The rights and obligations of the Parties under this Agreement shall not be subject to assignment without the prior written consent of the other Parties, and any attempted assignment without the prior written consent of the other Parties shall be invalid </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ab initio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The terms of this Agreement shall be binding upon, inure to the benefit of and be enforceable by and against the successors and permitted assigns of the Parties.  Notwithstanding the foregoing, the Reinsurer shall have the right to reinsure or otherwise share the losses reinsured hereunder, solely with the consent of Aspen (other than with respect to reinsurance to or sharing with affiliates of the Reinsurer), which consent shall not be unreasonably withheld, conditioned or delayed and provided that in no way shall such reinsurance or other sharing of losses lessen or in any way diminish the Reinsurer&#8217;s obligations to Aspen hereunder.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The headings and table of contents of this Agreement are for convenience of reference only and shall not define or limit any of the terms or provisions hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law&#59; Specific Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to such state&#8217;s principles of conflict of laws that could compel the application of the laws of another jurisdiction.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding any other provision to the contrary herein, each Party acknowledges that the breach of certain obligations may cause irreparable injury and damages, which may be difficult to ascertain.  Without regard to paragraph (a) above, each Party immediately shall be entitled to seek injunctive relief with respect to such breaches by the other Parties and without the requirement of posting a bond.  This provision shall not in any way limit such other remedies as may be available to any Party at law or in equity.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Service of Suit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In the event of the failure of Aspen or Aspen Parent to perform their respective obligations hereunder, they, at the request of the Reinsurer, shall submit to the jurisdiction of a court of competent jurisdiction within the United States.  Nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> constitutes or should be understood to constitute a waiver of Aspen&#8217;s or Aspen Parent&#8217;s rights to commence an action in any court of competent jurisdiction in the United States, to remove an action to a United States District Court, or to seek a transfer of a case to another court as permitted by the laws of the United States or any state in the United States.  Aspen and Aspen Parent, once the appropriate court is selected, whether such court is the one originally chosen by the Reinsurer and accepted by Aspen or Aspen Parent, as applicable, or is determined by removal, transfer, or otherwise, as provided for above, shall comply with all requirements necessary to give said court jurisdiction and, in any suit instituted against Aspen or Aspen Parent, as applicable, under this Agreement, shall abide by the final decision of such court or of any appellate court in the event of an appeal.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Unless Aspen or Aspen Parent designates a different party in writing, service of process in such suit may be made upon Aspen Parent at Aspen Specialty Insurance Company, 400 Capital Boulevard, Rocky Hill, CT 06067, United States of America, which is hereby authorized and directed to accept service of process on behalf of Aspen and Aspen Parent in any such suit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the event of the failure of the Reinsurer to perform its obligations hereunder, the Reinsurer, at the request of Aspen, shall submit to the jurisdiction of a court of competent jurisdiction within the United States.  Nothing in this Article constitutes or should be understood to constitute a waiver of the Reinsurer&#8217;s rights to commence an action in any court of competent jurisdiction in the United States, to remove an action to a United States District Court, or to seek a transfer of a case to another court as permitted by the laws of the United States or any state in the United States.  The Reinsurer, once the appropriate court is selected, whether such court is the one originally chosen by Aspen and accepted by the Reinsurer or is determined by removal, transfer, or otherwise, as provided for above, shall comply with all requirements necessary to give said court jurisdiction and, in any suit instituted against the Reinsurer under </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">this Agreement, shall abide by the final decision of such court or of any appellate court in the event of an appeal.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Unless the Reinsurer designates a different party in writing, service of process in such suit may be made upon Enstar (US) Inc., 411 Fifth Avenue, Fl. 5, New York, NY 10016, Attention&#58; Senior Vice President, Legal Director US, which is hereby authorized and directed to accept service of process on behalf of the Reinsurer in any such suit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Further, pursuant to any statute of any State, Territory or District of the United States which makes provision therefor, the Reinsurer hereby designates the Superintendent, Commissioner or the Director of Insurance or other officer specified for that purpose in the statute, or his successor or successors in office, as its true and lawful attorney upon whom may be served any lawful process in any action, suit or proceeding instituted by or on behalf of Aspen or any beneficiary hereunder arising out of this Agreement and hereby designates the above-named entity as the entity to whom the said officer is authorized to mail such process or a true copy thereof&#59; provided that process is concurrently served upon the Reinsurer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Third Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Nothing in this Agreement is intended or shall be construed to give any Person, other than the Parties, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed by the Parties in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument binding upon all of the Parties notwithstanding the fact that all Parties are not signatory to the original or the same counterpart.  Each counterpart may consist of a number of copies hereof each signed by less than all, but together signed by all, of the Parties.  Each counterpart may be delivered by facsimile or electronic transmission, which transmission shall be deemed delivery of an originally executed document.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction, so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any Party.  If any provision of this Agreement is so broad as to be unenforceable, that provision shall be interpreted to be only so broad as is enforceable.  In the event of such invalidity or unenforceability of any term or provision of this Agreement, the Parties shall use their commercially reasonable efforts to reform such terms or provisions to carry out the commercial intent of the Parties as reflected herein, while curing the circumstance giving rise to the invalidity or unenforceability of such term or provision.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Offset</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Reinsurer may offset any amount due to the Aspen Parent and any reinsured included in the definition of &#8220;Aspen&#8221; under this Agreement against any amounts </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">owed or alleged to be owed from the Aspen Parent or such reinsured included in the definition of &#8220;Aspen&#8221; under this Agreement, but only against amounts owed or allegedly owed from such specific entity.  For the avoidance of doubt, the Reinsurer shall not be permitted to offset an amount due to one reinsured included in the definition of &#8220;Aspen&#8221; under this Agreement against any amounts owed or allegedly to be owed from a different reinsured included in the definition of &#8220;Aspen&#8221; or the Aspen Parent.  Each of the Aspen Parent and each reinsured included in the definition of &#8220;Aspen&#8221; may offset any amount due to the Reinsurer under this Agreement against any amounts owed or alleged to be owed from the Reinsurer under this Agreement, but only against amounts owed or allegedly owed to such specific entity.  To the maximum extent permitted by Applicable Law, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall apply notwithstanding the insolvency, liquidation, rehabilitation, conservation, supervision or similar proceeding by or against any Party or any Party&#8217;s Affiliates.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and except as otherwise required hereby, all financial data required to be provided pursuant to the terms of this Agreement shall be expressed in United States dollars.  Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and except as otherwise required hereby, all payments and all settlements of account between the Parties shall be in United States currency unless otherwise agreed by the Parties.  For purposes of determining the erosion of the Reinsurer&#8217;s Limit and the Reinsurer&#8217;s Remaining Limit hereunder, Ultimate Net Loss paid by the Reinsurer under this Agreement in currencies other than United States dollars shall be converted into United States dollars using the applicable exchange rate used on the books and records of Aspen in the ordinary course of business at the time of such payment.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Interpretation of this Agreement shall be governed by the following rules of construction&#58; (a) words in the singular shall be held to include the plural and vice versa, and words of one gender shall be held to include the other gender as the context requires&#59; (b) references to the terms Article, Section, paragraph, exhibits and schedules are references to the Articles, Sections, paragraphs, exhibits and schedules of or to this Agreement, unless otherwise specified&#59; (c) the terms &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereby,&#8221; &#8220;hereto,&#8221; and derivative or similar words refer to this entire Agreement, including the exhibits and schedules hereto&#59; (d) references to &#8220;$&#8221; shall mean United States dollars&#59; (e) the word &#8220;including&#8221; and words of similar import when used in this Agreement shall mean &#8220;including without limitation,&#8221; unless otherwise specified&#59; (f) the word &#8220;or&#8221; shall not be exclusive&#59; (g) except as otherwise provided herein, references to &#8220;written&#8221; or &#8220;in writing&#8221; include in electronic form&#59; (h) the headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement&#59; (i) a reference to any Person includes such Person&#8217;s successors and permitted assigns&#59; (j) a reference to an agreement or other document includes amendments to or restatements of such agreement or other document&#59; (k) any reference to &#8220;days&#8221; means calendar days unless Business Days are expressly specified&#59; and (l) when calculating the period of time before which, within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded, if the last day of such period is not a Business Day, the period shall end on the next succeeding Business Day.  This Agreement shall take precedence over any exhibits or schedules hereto, to the extent of any conflict.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Aspen Parent shall hereby execute this Agreement on behalf of itself and on behalf of Aspen, it being understood that each reinsured included in the definition of &#8220;Aspen&#8221; will be, and is, party to this Agreement and shall execute this Agreement promptly after the date hereof.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(remainder of page intentionally left blank)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_581"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their respective duly authorized representatives, all as of the date first written above.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE HOLDINGS LIMITED</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#47;s&#47; Mark Cloutier</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Mark Cloutier</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Group Chief Executive Officer</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Amended and Restated Reinsurance Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN INSURANCE UK LIMITED</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Richard Milner</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Richard Milner</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;&#160;&#160; Chief Executive Officer</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Amended and Restated Reinsurance Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN MANAGING AGENCY LIMITED for and on behalf of the UNDERWRITING MEMBER(S) OF LLOYD'S SYNDICATE 4711</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Richard Milner</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Richard Milner</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;&#160;&#160; Chief Executive Officer</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Amended and Restated Reinsurance Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN BERMUDA LIMITED</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Mark Pickering</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Mark Pickering</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;&#160;&#160; Chief Executive Officer</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Amended and Restated Reinsurance Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN AMERICAN INSURANCE COMPANY</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Tim Kenefick</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Tim Kenefick</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;&#160;&#160; Chief Financial Officer</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Amended and Restated Reinsurance Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASPEN SPECIALTY INSURANCE COMPANY</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Tim Kenefick</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Tim Kenefick</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Chief Financial Officer</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Amended and Restated Reinsurance Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CAVELLO BAY REINSURANCE LIMITED</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Paul C. Bohus</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Paul C. Bohus</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Chief Executive Officer</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Amended and Restated Reinsurance Agreement&#93;</font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_598"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Schedule 1.1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Guidelines</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_614"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Schedule 1.2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_630"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Schedule 3.1(a)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Form of Closing Statement</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_646"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Schedule 3.5</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reinsurance Premium Currency Allocation</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_662"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Schedule 4.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Interim Administration</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_678"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Schedule 9.3</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Shared Outward Reinsurance</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_694"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Administration and Transition Principles</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><div id="i1daf1e1ec32d4c559b664f09399cccc9_711"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Form of Trust Agreement</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.28
<SEQUENCE>37
<FILENAME>exhibit1028-fx1.htm
<DESCRIPTION>EX-10.28
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i40225d583f4044f2961e6f90cadc8d7c_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.28</font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECAUSE IT IS BOTH NOT MATERIAL AND&#160;IS THE TYPE THAT THE REGISTRANT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TREATS AS PRIVATE OR CONFIDENTIAL</font></div><div style="margin-bottom:80pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATED </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) ASPEN INSURANCE UK SERVICES LIMITED</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- and -</font></div><div style="margin-bottom:89pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) MINDTREE LIMITED</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.788%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MASTER SERVICES AGREEMENT&#58; </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITO SERVICES</font></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.788%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i40225d583f4044f2961e6f90cadc8d7c_39"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INTERPRETATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CALL OFF OF SERVICES</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SERVICE PROVIDER'S RESPONSIBILITIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TRANSITION AND TRANSFORMATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WARRANTIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PERFORMANCE METRICS AND SERVICE CREDITS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">STEP IN</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ENHANCED COOPERATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN DEPENDENCIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASPEN'S OBLIGATIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GOVERNANCE AND REPORTING</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ACCEPTANCE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PRICE AND PAYMENT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TAX</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHANGE CONTROL</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PREMISES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASSETS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TERM AND TERMINATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TERMINATION ASSISTANCE&#47;EXIT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INTELLECTUAL PROPERTY RIGHTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INDEMNITY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LIMITATION OF LIABILITY AND INSURANCE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONFIDENTIALITY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">FORCE MAJEURE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASSIGNMENT AND SUBCONTRACTING&#59; DIVESTMENT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ANTI-BRIBERY AND CORRUPTION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DATA PROTECTION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THIRD PARTY RIGHTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REGULATORY MATTERS AND AUDIT RIGHTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DISPUTE RESOLUTION PROCEDURE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PUBLICITY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CORPORATE SOCIAL RESPONSIBILITY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">HEALTH AND SAFETY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RELATIONSHIP OF THE PARTIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NON-SOLICITATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GENERAL</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</font></div></div></div><div id="i40225d583f4044f2961e6f90cadc8d7c_78"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedules, Exhibits and Attachments&#58; </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 1 - Data Processing Terms </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 2 - Service Delivery Contract </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit A &#8211; Service Descriptions </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment A-1 (Cross Tower Services)</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment A-2 (Data Center and Cloud Services) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment A-3 (Network Services)</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment A-4 (Database Services) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment A-5 (IT Security Services) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit B - Fees</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment B-1 (Resource Rates) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment B-2 (T&#38;M Rate Card) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment B-3 (RU and Role Definitions) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment B-4 (Transition Charges) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment B-5 (Transformation Charges) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment B-6 (Termination Charges)</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment B-7 (Financial Responsibility Matrix) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit C - Service Level Methodology </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment C-1 (Service Level Matrix) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment C-2 (Severity and Priority Levels) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit D - Transition</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment D-1 (In Flight Projects) </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit E - Transformation</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit F &#8211; Reporting</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit G &#8211; Provider Delivery Locations </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit H &#8211; Key Personnel</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit I &#8211; Supported Environments </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit J &#8211; Provider and Customer Tools </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit K - Approved Subcontractors </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 3 - Governance</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 4 - Contract Change Control Procedure </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 5 - Standards and Policies</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 6 - Security &#8211; IT &#38; Physical </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 7 - Form of Local Agreement</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 8 - SOW and Work Request Pro formas </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 9 - Benchmarking</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 10 - Exit Plan and Service Transfer Arrangements </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 11 - Business Continuity and Disaster Recovery </font></div><div style="margin-bottom:35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule 12 - Site Licence</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;SCHEDULES, EXHIBITS AND ATTACHMENTS INTENTIONALLY OMITTED&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iv)</font></div></div></div><div id="i40225d583f4044f2961e6f90cadc8d7c_97"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THIS AGREEMENT </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is made on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BETWEEN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASPEN INSURANCE UK SERVICES LIMITED </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(registered number 04270446) whose registered office is at 30 Fenchurch Street, London, EC3M 3BD (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aspen</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MINDTREE LIMITED </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(registered number L72200KA1999PLC025564 ) whose registered office is at Global Village, RVCE Post, Mysore Road, Bangalore, 560059, Karnataka, India (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Provider</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(each a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and together the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;).</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider has agreed to supply and Aspen has agreed to accept the Services on the terms and conditions of this Agreement&#59;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IT IS AGREED </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;INTERPRETATION</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;In this Agreement&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Acceptance&#8221; or &#8220;Acceptance Testing&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the process of testing Materials or Services as further described in clause 12&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Acceptance Certificate&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a written notice, issued by Aspen in accordance with clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">12.4,</a> certifying that an Acceptance Item has passed (in full, or conditionally) the relevant acceptance tests&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acceptance Criteria</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the mutually agreed objective criteria which an Acceptance Item must satisfy during the acceptance tests as set out in this Agreement before Aspen is required to issue an Acceptance Certificate for that Acceptance Item&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acceptance Item</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Deliverable or Service or any other item expressed to be subject to acceptance testing under this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Active Directory&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means Microsoft's proprietary directory service and runs on Windows Server and enables administrators to manage user permissions and access to network resources&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Affiliate&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any direct or indirect subsidiary of a Party or any direct or indirect subsidiary of any direct or indirect parent or holding company of Party&#59; and an </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Aspen Affiliate&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any such subsidiary related by the same means to Aspen. Subsidiary and holding company shall each have the respective meanings given to them in section 1159 of the Companies Act 2006&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Agreed Form NDA&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the form of non-disclosure agreement set out in Schedule 10 (Exit Plan and Service Transfer Arrangements)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Agreement&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means this Master Services Agreement including all Statements of Work and work requests (WARs) plus the Schedules, Exhibits and Attachments&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Allocation&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Review&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the meeting to take place annually as the same is further described in Schedule 3 (Governance)&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Approved Sub-contractor&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those Service Provider Subcontractors listed in Schedule 2, Exhibit K (as the same may be updated from time to time by agreement in writing between the Parties)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aspen Applicable Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means (i) Relevant Laws which are in force from time to time during the Term, including any amendments to any or all of them, and which apply to Aspen and Aspen Affiliates and&#47;or their use of or receipt of the Services but which in each case are not Service Provider Applicable Regulations&#59; and (ii) those things deemed to be Aspen Applicable Regulations pursuant to the definition of Service Provider Applicable Regulations&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Aspen Contract Manager&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the person nominated by Aspen as its manager for the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Aspen Dependencies&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the obligations of Aspen which are specifically identified as being Aspen Dependencies in this Agreement including those identified as such in the Financial Responsibility Matrix&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Aspen Equipment&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">17.1&#59;</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Aspen IPR&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any IPR owned by or licensed to Aspen or its Affiliates and licensed (or sub-licensed) by Aspen to Service Provider in relation to its provision of the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Asset&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any Customer item being managed as part of the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Asset Management&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the management of Assets in accordance with the requirements of this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;At Risk Amount</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;At Risk Percentage&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Authorized User</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Customer Personnel notified to the Service Provider as being entitled to give directions to the Service Provider</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Backup&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a copy of computer data taken and stored elsewhere so that it may be used to restore the original as&#47;if needed&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Baseline Period&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Benchmarked Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Benchmarker&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Benchmark Information&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Benchmarking Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to it in Schedule 9&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Benchmark Notice&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning set out in paragraph 1.2 of Schedule 9 (Benchmarking)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Benchmark Parameter&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Benchmark Report&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Business Continuity Plan&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 11&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means a day other than a Saturday, Sunday or public holiday in England&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Calendar Year</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period of 365 (or 366 as applicable) days starting from the first (1st) day of January and ending on the thirty first (31st) day of December&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Calendar Quarter&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any one of the following four periods of three months that make up a Calendar Year&#58; 1st January to 31st March (quarter 1)&#59; 1st April to 30th June (quarter 2)&#59; 1st July to 30th September (quarter 3) and 1st October to 31st December (quarter 4)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Change&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any change to this Agreement and&#47;or provision of the Deliverables and&#47;or Services agreed between the Parties in accordance with Schedule 4 (Contract Change Control Procedure)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Change Control Note&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be a document agreed between the Parties in the form set out in Appendix 1 to Schedule 4 (Contract Change Control Procedure) that records a Change&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Change Management Process&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the process and procedures used to manage changes to a Customer&#8217;s IT environment&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Change Request&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a written request from either party to vary the terms of this Agreement pursuant to the procedure set out in Schedule 4 (Contract Change Control Procedure)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Charges&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those prices to be charged by the Service Provider as detailed in Schedule 2, Exhibit B, or such other charges as agreed in writing between the Parties from time to time&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Commercially Reasonable Efforts&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means that the Party obliged to perform shall take all such steps and perform in such a manner as if it were acting in a determined, prudent and reasonable manner in order to achieve the desired result for its own benefit&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Comparative Charges&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Comparator&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Confidential Information&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means all confidential, proprietary and secret information concerning a Party's or an Affiliate's businesses, research, know-how and technical activities, which is disclosed, whether in writing or orally or in electronic or magnetic media, by or with the authority of such Party (&#34;the Disclosing Party&#34;) to the other Party (&#34;the Receiving Party&#34;) and which is, or by its nature would reasonably be presumed to be, confidential. In particular, this shall include but not be limited to all information concerning a Party's customers, clients, brokers, premiums, discounts, proprietary wordings and renewal dates, and the existence and contents of this Agreement and any Statements of Work hereunder&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Configuration Management&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the tracking of supported Customer assets in the Customer provided CMDB&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Consultants&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.2&#59;</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Continuation Services&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Services (other than Termination Assistance) which Aspen may continue to require the Service Provider to provide during the Termination Assistance Period&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continuous Service Improvement&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the same as the ITIL term &#8220;Continual Improvement&#8221; as at the Effective Date&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Contract Change Control Procedure or &#8216;CCP&#8217;&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the process for modifying the provision of the Services or the Agreement as set out in Schedule 4 (Contract Change Control Procedure)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Contract Manager&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Aspen Contract Manager or the Service Provider Contract Manager&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Control&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the direct or indirect power to direct or cause the direction of the management and policies of a company or other business entity, whether through ownership of 50% or more of the voting interest, by contract, or otherwise&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;COTS Materials&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mean any materials or software owned by the Service Provider or a third party and specifically identified in this Agreement or an SOW as being items that are to be separately licensed to Aspen by the Service Provider on standalone terms&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Critical Event&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a threat to Customer&#8217;s IT operation, safety or reputation of an organisation with an element of surprise and unpredictability, necessitating rapid and effective decision-making&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Critical Service Levels&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those Service Levels identified as such in the attachments to Schedule 2, Exhibit C or as otherwise agreed between the Parties from time to time&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Critical Service Level Credit&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Service Level Default</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Cross-Functional Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit A, Attachment A-1&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Customer Applicable Regulations&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the same meaning as Aspen Applicable Regulations&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Customer Data&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means information regarding or relating to Aspen or Aspen Affiliates that is provided to the Service Provider pursuant to this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Customer Device&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a hardware asset owned or operated by the Customer&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Customer Group&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means Aspen and its Affiliates from time to time&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Customer Locations or Customer Sites&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the locations and sites from which Aspen operates and to which the Service Provider will require access in order to provide the Services from time to time, as set out in the Procedures Manual, any applicable Exhibit to Schedule 2 and&#47;or Schedule 12 (Site Licence)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Customer Material&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any Material owned by or licensed to Aspen or its Affiliates (and any modifications to that Material)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Customer Personnel&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the directors, officers, employees, agents, agency workers, contractors and sub-contractors of Aspen and its sub-contractors (other than the Service Provider and its Affiliates)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Customer Representative&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Customer Individual (as identified in Schedule 3) or their appointed alternative contact&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Cybersecurity Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit A, Attachment A-5&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Database&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means an organized collection of structured information, or data, typically stored electronically&#8221; in a computer system&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Database Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit A, Attachment A-4&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Data Network Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit A, Attachment A- 3&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Data Protection Legislation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means all applicable national, international and local laws, rules, regulations or directives concerning data protection, information security, cyber security, data </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">privacy and data breach notification including, without limitation and where applicable, the Data Protection Act 2018 and the General Data Protection Regulation (Regulation (EU) 2016&#47;679) (&#34;GDPR&#34;), each as amended from time to time and any successor laws, rules, legislation, regulation or directives&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Dedicated Licences&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are licences which the Service Provider has purchased specifically for the Aspen to use to receive the Services and excludes licences for Service Provider Tools and COTS Vendor software or services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Dedicated Third Party Contracts&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a third party contract designated as such in Schedule 10 (Exit Plan and Service Transfer Arrangement)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Deliverable&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any tangible item or output required to be provided by the Service Provider to Aspen under this Agreement or a SOW&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Designated Areas&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those areas designated as such in accordance with the Procedures Manual, any applicable Exhibit to Schedule 2 and&#47;or Schedule 12 (Site Licence)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Detailed Transformation Plan&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit E&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Developed IPR&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any IPR created by Supplier in connection with this Agreement apart from any such IPRs identified as Enhancements&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Disaster&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any disruption to the performance or receipt of the Services (whether caused by a natural or a man-made phenomenon or occurrence) that requires the implementation of the Disaster Recovery Plan and which is acknowledged to be a Disaster by Aspen&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Dispute Resolution Procedure&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the procedure set out in clause 30 (Dispute Resolution Procedure)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Divested Affiliate&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any entity which has been, during the term, an Affiliate of Aspen, and which subsequently ceases to be an Affiliate of Aspen&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Documentation&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means all documentation including user manuals or other operating manuals relating to a Deliverable or the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Earnback&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Effective Date&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the date of the last signature written below&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Employment Costs&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means&#58; all taxes, national insurance and other costs, compensation and benefits of any personnel of the Service Provider or any of its subcontractors, including salary, health, accident and workers' compensation benefits, pensions and contributions that an employer is required to pay with respect to the employment of such personnel&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;End User&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means an individual authorised by the Customer to use and access the Customer&#8217;s systems and who is enabled on the Customer&#8217;s active directory.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Enhancements&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any enhancements or additions to the Service Provider&#8217;s Pre- existing IPR or any Third Party IPR (including any created arising in respect of the COTS Materials (if any)) developed by or on behalf of the Service Provider including those commissioned by or developed with the involvement of Aspen pursuant to this Agreement (including an SOW) but which are agreed in writing to be of general application rather than of use only for Aspen and its Affiliates. All Enhancements shall be owned by the Service Provider or its licensors&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Equality Legislation&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any and all legislation, applicable guidance and statutory codes of practice relating to equality, diversity, non-discrimination and human rights as may be in force in the jurisdictions in which Aspen operates from time to time&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Equipment&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means all components, materials, plant, tools, test equipment, hardware, firmware, computing and data communications equipment and any related documentation used in the provision of the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Equivalent Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Exit Information&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 10&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exit Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; the plan to be developed pursuant to Schedule 10 that shall set out in such detail as is reasonably required by Aspen a plan by which the Services shall be transferred to Aspen or a Successor Service Provider following the termination or expiry of this Agreement in whole or in part&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; where used shall be deemed to mean Charges&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Responsibility Matrix</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the document defining the Parties&#8217; respective legal and financial responsibility for the equipment, hardware, software, staffing and facilities set out in Schedule 2, Exhibit B-7&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Equipment&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">17.3&#59;</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Good Industry Practice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means that degree of skill, care, prudence, foresight and practice which would ordinarily be expected of a skilled, experienced and leading supplier of services of the same or a similar nature to the Services and which, for the avoidance of doubt, includes compliance with standards akin to applicable British Standards Institute and International Organization for Standardization (ISO)standards&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governance Process</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the processes described in Schedule 3 (Governance)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Hardware&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the physical material parts of a computer or other system&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Incident&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means an unplanned interruption to a supported IT service or reduction in the quality of an IT service. Failure of a configuration item that has not yet affected service is also an incident&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;In-flight Projects&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those projects identified as such in the Annex D-1 to Schedule 2, Exhibit D&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Information Security Requirements&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the cybersecurity and compliance standard defined by Customer&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Infrastructure Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means Cross Tower Services, Data Center and Cloud Services, Network Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Infrastructure System&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means server running an operating system supported by Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Initial Term&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning set out in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">18.1&#59;</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Intellectual Property Rights&#34; or &#8220;IPR&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean all patents and patent-related rights, trademarks, trade names, domain names, design rights, utility models, copyright, rights in respect of confidential information, rights in databases, know-how and other intellectual property rights, in each case whether registered or unregistered and including applications for the grant of any such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rights and the right to apply for such rights, and all current or future rights having equivalent or similar effect anywhere in the world&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;IT Security Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit A, Attachment A-5&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Key Measurements&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the service measures identified as such in the attachments to Schedule 2, Exhibit C (Service Levels)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Key Milestone&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any Milestone identified as such by the Parties in accordance with Schedule 2, Exhibit D (Transition) and Exhibit E (Transformation) and&#47;or in relation to any Project&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Key Personnel&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means members of the Service Provider&#8217;s Team identified as such in Schedule 2, Exhibit H (Key Personnel)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Knowledge Exchange&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a method of acquiring and exchanging knowledge about Customer IT environment&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Knowledge Repository&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a system or tool that is used to store and access organizational knowledge, artifacts, and other content&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Known Problems Database&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning as given in ITIL as at the Effective Date&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Local Agreement&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means an agreement substantially in the form set out in Schedule 7 entered into between an Aspen Affiliate and the Service Provider or its Affiliates to cover the provision of the Services to such Affiliate in a specified jurisdiction&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Market Competitive&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Material&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means methodology or process, documentation, data or other material in whatever form, including without limitation any reports, specifications, business rules or requirements, user manuals, user guides, operations manuals, training materials and instructions, but excluding Software&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Material Adverse Change&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any of the following occurring in relation to Service Provider or, where applicable, any Affiliate that Controls it (its &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;there being an investigation into improper financial accounting and reporting, suspected fraud or any other financial impropriety of Service Provider or its parent&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Service Provider or its parent committing a material breach of covenants to its lenders&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Service Provider ceasing to actively seek to provide services akin to the Services to other potential customers&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Service Provider's chief executive or that of its parent failing respond promptly and in a substantive manner to queries raised by Aspen as to Service Provider's or its parent's(i) financial wellbeing&#59; or (ii) priorities for and intentions regarding Service Provider and&#47;or its activities over the next twelve (12) months following the query&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Monthly Board Meeting&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the meeting to take place monthly as the same is further described in Schedule 3 (Governance)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Network Devices&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any hardware that links to any network</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;New Service&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a service additional to the Services&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Milestone&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a milestone identified and agreed between the Parties for the performance of any element of the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Milestone Date&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means, in relation to an agreed Milestone, the date by which such Milestone is to be achieved&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Minimum Service Level</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Non-Dedicated Licences&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are licences which the Service Provider has not purchased specifically for Aspen to use to receive the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Operating Fees&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Operating System&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a software that acts as an interface between computer hardware components and the user, manages allocation of resources to program. (e.g., Windows, Linux)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Operating Systems Software&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a software that acts as an interface between computer hardware components and the user, manages allocation of resources to program. (e.g., Windows, Linux)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Operational Risk&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.15</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Other Sites&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any other Customer Site which is not subject to a Site Licence under Schedule 12 (Locations and Site Licence) which Aspen may procure access pursuant to Schedule 12 (Locations and Site Licence)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Performance Metrics&#34; or &#8220;Performance Standards&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the quality and performance measures including the Service Levels, Critical Service Levels and Key Measurements that the Service Provider is required to meet in performing the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Performance Metric Report&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Permitted Region&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">27.5.1&#59;</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Pool Percentage Available for Allocation&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Pre-existing IPR&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any IPR owned by or licensed to a Party prior to the Effective Date or applicable Service Commencement Date used in the provision of the Deliverables or Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Premises&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any premises owned or occupied by an Aspen Affiliate&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Pricebook&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be deemed to mean a reference to the applicable element of Schedule 2, Exhibit B and its attachments&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Problem&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the underlying cause of one or more Incidents&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Problem Management&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the process of managing the lifecycle of the underlying cause of a Problem&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Procedures Manual&#8221; or &#8220;SOP&#8221; or &#8220;Standard Operating Procedures&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in clause 11.2&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Project&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a scope of work which will require additional Fees&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Project Steering Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to it in Schedule 3&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;QA Report&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;QA Review&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the quality assurance review to be performed pursuant to section 9 of Schedule 9.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Quality Gate&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">refers to a predefined and mutually agreed criteria to be met before the project can proceed to the next phase&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Quarterly Business Review&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the meeting to take place each quarter as the same is further described in Schedule 3 (Governance)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Rate Card&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the rate cards set out in in Schedule 2, Attachment B-2 used to calculate certain Charges payable under this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Raw Data&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Service Delivery Contract&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refined Data</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to it in Schedule 2, Service Delivery Contract&#59; </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Reference Group&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 9&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Regulatory Change&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any change to any Customer Applicable Regulations or Service Provider Applicable Regulations&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Related Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any goods or services provided to Aspen by a third party that rely on or enable the Services or are otherwise relevant to the performance, receipt of use of the Services by Aspen&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Release Unit&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any services that Service Provider must perform to enable third-party and&#47;or Service Provider Product utilisation by Customer&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Relevant Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;any statute, regulation, by-law, ordinance or subordinate legislation in force from time to time to which a Party is subject including Data Protection Legislation and Equality Legislation&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the common law as applicable to the Parties from time to time&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;any binding court order, judgment or decree&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;any applicable industry code, policy or standard, in each case enforceable by law&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;all applicable statutory and all other rules, guidance regulations, instruments and provisions in force from time to time including the rules, codes of conduct, codes of practice, practice requirements guidance and accreditation terms, in each case of mandatory effect and stipulated by any regulatory authority to which a Party or its Affiliates is subject from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Relevant Person&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any officer, employee or contractor of either Aspen or the Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Request</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; also refers to Service Request, means a request from a user for information, advice, a standard change, or access to a service&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Replacement Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means the provision of services by an entity other than the Service Provider or Service Provider Affiliate in substitution of the Service Provider following the expiry or termination of all or part of the Services&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Resource Unit&#8221; has the meaning given to it in Schedule 2, Exhibit B&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Root Cause Report&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security Control Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set out in para 3.1.1 of Schedule 6&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Delivery Model&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">refers to the way Service Provider manages the information technology systems, process and people that deliver services to the Customer&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Description&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the terms of Schedule 2&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Desk&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the service desk operated by a Third-Party Supplier on behalf of the Customer&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Incident&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit C </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Service Level Default&#8221; means any failure to meet a Service Level&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Security Event Management&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">refers to computer security disciplines that use data inspection tools to centralize the storage and interpretation of logs or events generated by other software running on a network&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Security Incident&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any actual or suspected unauthorised access or disclosure, accidental or unlawful destruction or accidental loss or alteration of Customer Data&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Security Management&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means well defined tasks executed by the security servers, defined by Customer and transitioned to Service Providers security operations center (SOC)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Server&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a Customer computer, device or a program that manages IT network resources, be it physical, virtual or cloud hosted&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Service(s) Commencement Date&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the date agreed between the parties during Transition on which Transition is successfully completed and the business as usual Services start to be performed &#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Services&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those services (and any associated goods) to be provided by the Service Provider as set out in this Agreement, or such other services as agreed in writing between the Parties from time to time. The Services include all Transition, Transformation and Termination Assistance related activities performed by the Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Service Levels&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those levels of standards or service levels which the Service Provider is required to achieve, if any, in the provision of the Services, as set out in the attachments to Schedule 2, Exhibit C or as otherwise agreed between the Parties in writing from time to time&#59;</font></div><div style="margin-bottom:20pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Management&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means IT Service Management is a strategic approach for designing, delivering, managing, and improving the way information technology (IT) is used within an organization&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Service Credits&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the credits (if any) which become payable to Aspen in accordance with clause 6&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Provider Applicable Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means all Relevant Laws which are in force from time to time during the Term, including any amendments to any or all of them, and which apply to&#58; (a) the Service Provider in its business specifically as a provider of information technology services, or (b) the Service Provider or any of its sub-contractors or Affiliates in relation to the Service Provider's delivery of the Services under this Agreement and, in each case, save to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">extent that Aspen or its regulators require a specific approach to be taken as regards the delivery of the Services in which case, pursuant to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.1</a> , such specific approach shall not be a Service Provider Applicable Regulation and be designated an Aspen Applicable Regulation&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Provider BC Representative&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 11&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Service Provider's Equipment&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any equipment, including tools, systems, cabling or facilities, provided by the Service Provider or its sub-contractors and used directly or indirectly in the supply of the Services which are not the subject of a separate agreement between the Parties under which title passes to Aspen&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Provider Service Locations&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those locations, site or facilities from which Services shall be provided that from time to time are owned, leased or under the control of the Service Provider, its Affiliates, or their sub-contractors&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Service Provider Contract Manager&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the manager nominated by the Service Provider as its dedicated manager for the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Service Provider's Team&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Service Provider Contract Manager and all employees, consultants, agents and sub-contractors which the Service Provider engages in any way in relation to the supply of the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Service Provider Subcontractors&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a person engaged by Service Provider in accordance with the terms of this Agreement, as an independent contractor to perform, or to assist from time to time in performing, one or more of the Services to be arranged or performed by Service Provider under the Agreement, together with its agents, officers and employees&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Request&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">together with Request for Service or RFC means an Authorized User request for information or advice, or for a standard change (a pre-approved change that is low risk, relatively common and follows a procedure) or for access to an IT service. Activities include individual installation, move, add, change or deletion of an individual item from the Supported Environment, defined in Exhibit I, will either be funded through Dispatch ARC or, if applicable, Project Pool hours. Service Requests requiring more dollars than available in the Project Pool will be treated as a Project&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Service Tower&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means each of the Cross Tower Services, Data Center and Cloud Services, Network Services, Database Services and IT Security Services as set out in Attachments A-1 to A-5.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Site Licence&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 12&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Software&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any computer program (in object code or Source Code form), program interfaces and any tools or object libraries embedded in that Software&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Standards and Policies&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means those standard and policies set out in Schedule 5 (Standards and Policies)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Statement of Work&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;SOW&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a document substantially in the form set out in Schedule 8 agreed by both Parties in accordance with clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">2.2</a> detailing the scope and cost of specific or one off project type Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Steady State Service&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the successful completion of Transition and the beginning of production support&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Storage&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means enterprise storage array used by Customer to keep the production data and applications operational&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Subsystem&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a virtual server within the larger physical server&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Successor Service Provider</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means the third party or Aspen, or an Aspen Affiliate appointed by Aspen to provide the Replacement Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning set out in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">26.2.</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;System&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means an interconnected grouping or electronic processes, including Equipment, Software and associated attachments, features, accessories, peripherals and cabling, and all additions, modifications, substitutions, upgrades or enhancements to such System, to the extent a party has financial or operational responsibility for such System or System components hereunder. System shall include all Systems in use or required to be used as of the applicable Service Commencement Date, all additions, modifications, substitutions, upgrades or enhancements to such Systems and all Systems installed or developed by or for Aspen or Service Provider following the applicable Service Commencement Date&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Target Operating Model&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the service delivery model to be implemented once Transition has been successfully completed&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Term&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Initial Term together with any extension of the Initial Term&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Termination Assistance&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Services to be provided by the Service Provider in the event of and&#47;or in the lead in to the termination (in whole or in part) or expiry of the Agreement as further described in clause 19 (Termination Assistance) and Schedule 10 (Exit Plan and Transfer Arrangements)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Termination Assistance Period&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the period of time during which Termination Assistance is to be provided to Aspen by the Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Third Country&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a country outside the Permitted Region that does not benefit from an adequacy decision pursuant to Article 45 of the GDPR (or the equivalent UK adequacy regulations, as applicable)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Third Party IPR&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any IPR which is not owned by Aspen or its Affiliates or the Service Provider and its Affiliates&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Third Party Provider or TPP</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a third party entity that provides goods or services to Aspen in relation to or otherwise connected to Aspen&#8217;s receipt or use of the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Tool&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any program used for software development, testing, data search, analysis, project management, measurement and monitoring or system maintenance, including related know-how&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transformation&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the processes undertaken by the Service Provider to change the approach to the provision of the Services as the same may be agreed from time to time pursuant to Schedule 2, Exhibit E (Transformation)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transformation Charges&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Charges agreed from time to time by the Parties (if any) in relation to the delivery of Transformation related Projects&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transformation Manager&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit E&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transformation Manager Meetings&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to it in Schedule 2, Exhibit E&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transformation Plan&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means (the detailed plan of activities and associated timescales for the implementation of the Transformation activities that may be agreed by the Parties pursuant to Schedule 2, Exhibit E&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transformation Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the services agreed between the Parties pursuant to Schedule 2, Exhibit E (Transformation)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transition&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means implementation of those services to be provided by the Service Provider to Aspen after the Effective Date in accordance with the terms of this Agreement and as more particularly described in Schedule 2, Exhibit D (Transition)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transition Charges&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Charges which may be payable for Transition as set out in Schedule 2, Exhibit B, Attachment B-6 (Transition Charges)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transition Manager&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a role refers to Service Provider personnel responsible to plan, manage and govern IT support transition towards steady state production support&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transition Plan&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the detailed plan of activities and associated timescales for the implementation of the Services set out in or to be developed pursuant to Schedule 2, Exhibit D (Transition)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transition PMO&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">refers a management structure that standardizes the project transition- related governance processes and facilitates the sharing of resources, methodologies, tools, and techniques&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Transition Services&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the Services provided to deliver Transition&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#34;Vendor&#34; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a person engaged by Service Provider as an independent contractor to provide a product, as opposed to a service (which may include supplying a product), needed for Service Provider to perform the Services, together with its agents, officers and employees&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Wilful Abandonment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means Service Provider deliberately ceasing the provision of all or a substantial part of the Services in breach of this Agreement.</font></div><div style="margin-bottom:20pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Work Request&#8221; or &#8220;WAR&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means any statement agreed between the Parties for a Change Project in accordance with the template(s) set out in Schedule 8 (SOW and Work Request Pro formas) to this Agreement provided always that references to SOWs in this Agreement shall include Work Requests unless otherwise stated in the relevant provision (including, in particular, for the purposes of calculation of liability under clause 22)&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;Headings in this Agreement (including any headings shown in bold at the start of sub-clauses) shall not affect the interpretation of this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;&#160;&#160;&#160;A reference to a statute or statutory provision is a reference to it as it is in force for the time being, including any amendment, extension, or re-enactment and includes any subordinate legislation for the time being in force under it.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;Any words following the terms </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">including</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">include</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">in particular</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">for example </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or any similar expression shall be construed as illustrative and shall not limit the sense of the words, description, definition, phrase or term preceding those terms.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;CALL OFF OF SERVICES</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#160;&#160;&#160;&#160;Aspen may require that Local Agreements are put in place between Aspen or its Affiliates and the Service Provider or, exceptionally, its Affiliates (it being agreed that wherever possible such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arrangements shall be made with the Service Provider only) pursuant to which the provision of local delivery of certain of the Services may be managed or provided. The Service Provider agrees that subject always to agreement on the appropriate invoicing and taxation arrangements it shall not unreasonably withhold its consent to the agreement of such Local Agreements and further agrees that any such Local Agreements shall incorporate all of the terms of this Agreement save as specified and agreed by the executing parties in such Local Agreement and approved in writing by Aspen and the Service Provider themselves as well as any Affiliate(s) that is party to such Local Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;During the Term of this Agreement, in addition to providing the Services described herein Aspen may order and the Service Provider may provide Services by entering into a Statement of Work. Each Statement of Work, upon execution by both Parties, shall form a part of and be governed by the terms of this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3&#160;&#160;&#160;&#160;In the event of conflict or ambiguity the provisions of this Agreement and any SOW that may be agreed pursuant to its terms are to be read in the following order of precedence in relation to that conflict&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3.1&#160;&#160;&#160;&#160;this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3.2&#160;&#160;&#160;&#160;its Schedules&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3.3&#160;&#160;&#160;&#160;any exhibits to its Schedules&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3.4&#160;&#160;&#160;&#160;any attachments or annexures to the Exhibits or Schedules&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3.5&#160;&#160;&#160;&#160;the Statement of Work,</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">except that a provision in a Statement of Work may override a provision in this Agreement if it expressly refers to and states that the relevant provision(s) of the Statement of Work shall override the conflicting provision(s) of this Agreement and the Statement of Work is signed by both Parties.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;SERVICE PROVIDER'S RESPONSIBILITIES</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision of services. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider shall provide to Aspen&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1.1&#160;&#160;&#160;&#160;the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1.2&#160;&#160;&#160;&#160;any ancillary services, functions or responsibilities to enable the Services, performed within the twelve (12) month period immediately preceding the Effective Date by Aspen&#8217;s employees, agents and&#47;or contractors whose functions were displaced as a result of this Agreement, even if the service, function or responsibility is not specifically described in this Agreement unless such function or responsibility is specifically identified in this Agreement as either no longer being required or as being the responsibility of Aspen whether in the Financial Responsibility Matrix or agreed elsewhere in this Agreement&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1.3&#160;&#160;&#160;&#160;any services, functions and responsibilities (including any incidental services, functions and responsibilities) not expressly specified or described in this Agreement but which are reasonably and necessarily required for, or related to, the proper performance and provision of the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standard of services. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider shall perform its obligations under this Agreement with reasonable skill and care and in accordance with all applicable laws and with the terms of this Agreement, including the Performance Metrics, and shall allocate sufficient resources </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(including Service Provider's Equipment of a sufficient quality and standard) to the Services to enable it to comply with this obligation.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delivery timeframe. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider shall meet any performance dates under this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notification of delay. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Service Provider becomes aware that the provision of the Services or any other activity under this Agreement is being, or in its reasonable estimation is likely to be, delayed or interrupted (for whatever reason), such that it shall not meet any of its obligations under this Agreement, then the Service Provider shall give written notice immediately to Aspen of the relevant circumstances. The giving of such notice shall not prejudice Aspen's rights under this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Independence. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider warrants that it is not in breach of any other contract by providing the Services and shall provide independent and unbiased advice to Aspen in connection with the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Provider Locations. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider shall provide Services solely from the locations set forth in Schedule 2, Exhibit G (Service Provider Delivery Locations). Notwithstanding the foregoing, Aspen agrees and acknowledges that Service Provider has implemented a Flexi-Office-Remote working model&#47;policy for its employees (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR Model</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Under the FOR Model, Service Provider personnel are permitted to work in flexi (hybrid) mode or fully in office mode or fully remote mode. Accordingly, the Parties may mutually discuss and agree on the percentage of Service Provider personnel working in FOR Model for the provision of the Services. The foregoing will not affect Service Provider personnel&#8217;s obligation to comply with the terms and conditions under this Agreement, including performance obligations, and adherence to applicable Aspen policies and procedures.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Provider's Team. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider shall ensure that all members of the Service Provider's Team will have the necessary skills and experience required and will perform the Services with the standard of skill, care, knowledge and foresight which would reasonably and ordinarily be expected from an experienced person engaged in providing services of the same kind as the relevant Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Provider Contract Manager. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider shall appoint the Service Provider Contract Manager in relation to the Services, who shall have the authority to represent the Service Provider on day-to-day matters relating to the Agreement. Additionally the Service Provider shall appoint dedicated project managers to manage individual projects who shall report to the Service Provider Contract Manager. If reasonably requested by Aspen, the Service Provider shall replace the Service Provider Contract Manager, or any other member of the Service Provider's Team, within a reasonable timeframe not to exceed five (5) Business Days, such replacement to be approved by Aspen.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Personnel. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term, Service Provider shall only remove or change the Key Personnel with the written consent of Aspen except where removal or change results from resignation, death, maternity or other parental leave, long-term sickness or termination of employment of the Key Personnel in question in which case Service Provider shall promptly notify Aspen of such removal and the proposed replacement. Service Provider may only assign or replace any Key Personnel with Aspen's prior written consent (which in the circumstances set out above shall be deemed to have been given) and only after Service Provider has provided Aspen with the relevant curriculum vitae of the proposed replacement and a reasonable opportunity to interview such individual. At no additional cost to Aspen, where possible, Service Provider shall provide for an appropriate transition (including overlap) period for the new individual so that there is no disruption to the performance of Service Provider's obligations or Aspen's receipt of the Services under this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.10&#160;&#160;&#160;&#160;not used.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aspen policies. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider shall ensure that the Service Provider's Team maintains appropriate standards of behaviour and complies with Aspen's IT policies, Health and Safety rules, security arrangements and any other relevant Aspen policy which has been made known to the Service Provider in the performance of the Services on the Premises or any third parties' premises including those set out in Schedules 5 and 6.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Training. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service Provider shall provide ongoing training, at no additional cost, for all Service Provider personnel employed or engaged in the provision of the Services in compliance with the standards and policies in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">3.11.</a> Without limiting clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">3.11,</a> Service Provider shall comply and shall ensure that all Service Provider subcontractors comply with vetting procedures and policies in respect of all Service Provider personnel and that those procedures comply with Good Industry Practice</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No employee transfers.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.13.1&#160;&#160;&#160;&#160;the Service Provider acknowledges and agrees that it is intended that all employees of the Service Provider shall remain employees of the Service Provider and that termination of this Agreement (or any part of it) shall not operate to transfer the contracts of employment of any of the Service Provider's employees to Aspen or any third party, whether the Services subsequently cease to be provided, are provided by a third party, or by Aspen in-house&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.13.2&#160;&#160;&#160;&#160;the Service Provider shall use all reasonable endeavours to ensure that none of its employees are deployed in the delivery of the Services to the extent that the Transfer of Undertakings (Protection of Employment) Regulations 2006, as amended by the Collective Redundancies and Transfer of Undertakings (Protection of Employment) (Amendment) Regulations 2014 (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TUPE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) or any equivalent legislation anywhere in the world, may operate to transfer the employment of such employee to Aspen or any successor service provider upon termination of this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.13.3&#160;&#160;&#160;&#160;on termination of this Agreement the Service Provider will indemnify Aspen, any relevant Aspen Affiliate and any Successor Service Provider in respect of all liabilities, claims, damages, costs (including reasonable legal fees), Employment Costs, loss and expense arising from the operation of the TUPE and its application to any or all of the Service Provider's Team or any other Service Provider employees deployed in the delivery of the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.13.4&#160;&#160;&#160;&#160;on entry into this Agreement the parties shall use their reasonable endeavours to ensure that no Customer Personnel, employees of Aspen Affiliates or any of Aspen&#8217;s pre-existing vendors (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Displaced Employees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) are subject to transfer pursuant to TUPE&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.13.5&#160;&#160;&#160;&#160;on entry into this Agreement Aspen will indemnify the Service Provider in respect of all liabilities, claims, damages, costs (including reasonable legal fees), Employment Costs, loss and expense arising from the operation of the TUPE and its application to any or all of the Displaced Employees deployed in the delivery of services displaced by the entry into this Agreement and the performance of the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business continuity plan. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without prejudice to any Services relating to disaster recovery or business continuity the Parties may agree, the Service Provider shall manage and maintain internal disaster recovery and business continuity policies and procedures consistent with Good Industry Practice and the requirements of Schedule 11 (Business Continuity and Disaster Recovery Plan) throughout the Term at no additional cost to Aspen.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-exclusive. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider accepts that Aspen does not guarantee the volume or value of work under this Agreement and that Aspen has the right to procure services from the Service Provider or any other provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remedying defects. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If at any time within one hundred and eighty (180) days (or such other period as may be agreed between the Parties in the applicable Schedule, Exhibit or other attachment to this Agreement or any individual SOW or WAR) following the date of provision of any Deliverable any element of the Deliverable is found to be defective or otherwise not in accordance with requirements of this Agreement, the Service Provider shall promptly on request and without charge remedy the deficiency by re-performing the Deliverable (or, where applicable, the relevant element of the Deliverable). A variation to the warranty period made in any Schedule, Exhibit or other attachment to this Agreement or any individual SOW or WAR shall take precedence over this clause notwithstanding the terms of clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">2.3.</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Co-operation. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Provider acknowledges that it will be delivering the Services to Aspen in a multi-vendor environment. Accordingly, and without prejudice to the specific obligations agreed pursuant to Schedule 3 (Governance) or set out in OLAs, the Service Provider shall cooperate in good faith with Aspen, to the extent relevant to obtain the benefit of the Services, and with Aspen's other suppliers, its Affiliates and end-customers to facilitate the integrated and efficient carrying out of Aspen's operations and the provision of the Services. Such co-operation shall include providing advice, assistance, data and information as reasonably required by Aspen and (subject to reasonable confidentiality provisions being in place) its suppliers and end-customers.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.18&#160;&#160;&#160;&#160;The parties acknowledge that Schedule 2, Exhibit I (Supported Environments) remains to be completed during Transition and they undertake to work together in good faith to complete it on or before the Service Commencement Date.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Security</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.19&#160;&#160;&#160;&#160;The Service Provider shall provide ongoing training for all the Service Provider Personnel employed or engaged in the provision of the Services in compliance with Aspen&#8217;s standards and policies listed in Schedule 5 (as the same may be updated from time to time).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.20&#160;&#160;&#160;&#160;Without limiting clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">3.19,</a> the Service Provider shall comply and shall ensure that all Sub- contractors comply with vetting procedures and policies in respect of all Service Provider personnel that comply with Good Industry Practice.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.21&#160;&#160;&#160;&#160;The Service Provider shall ensure that principles aligned to ISO 27001 and, to the extent applicable, PCI DSS, are reflected in its performance of the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.22&#160;&#160;&#160;&#160;Aspen shall retain exclusive rights and ownership of all of Customer Data and the Customer Data shall not be&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.22.1&#160;&#160;&#160;&#160;used by the Service Provider for any purpose other than as required under the Agreement in connection with providing the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.22.2&#160;&#160;&#160;&#160;disclosed, sold, assigned, leased or otherwise provided to third parties by the Service Provider&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.22.3&#160;&#160;&#160;&#160;commercially exploited or otherwise used by or on behalf of the Service Provider, its affiliates, officers, directors, employees, or agents, other than in accordance with the Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.23&#160;&#160;&#160;&#160;Upon request by Aspen and at its election and at no additional charge, the Service Provider shall promptly return to Aspen the Customer Data in the format and on the media as reasonably </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requested by Aspen, or erase or destroy Customer Data in the Service Provider&#8217;s possession, power or control (except that the Service Provide may retain one copy for legal records) and, if requested by Aspen to do so, shall provide Aspen with confirmation in writing signed by a corporate officer of the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.24&#160;&#160;&#160;&#160;The Service Provider shall protect the Customer Data in its possession, power or control so as to not lose, damage, destroy or corrupt the Customer Data.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.25&#160;&#160;&#160;&#160;Pursuant to the requirements of Schedule 6 (Security &#8211; IT and Physical) the Service Provider shall establish and maintain all appropriate technical and organisational controls to safeguard against the destruction, loss or alteration of Customer Data in its possession, power or control and that are no less rigorous than those maintained by the Service Provider for the Service Provider&#8217;s own information of a similar nature or that otherwise comply with Good Industry Practice. This obligation is additional to and separate from the Service Provider&#8217;s duty to provide the Security Services and applies in relation to its provision of all Services under this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.26&#160;&#160;&#160;&#160;Service Provider personnel must not attempt to access, or allow access to, Customer Data to which they are not entitled or that is not required for the performance of the Services by Service Provider personnel. In relation to its provision of the Services described in Exhibits A-1 to A-5 and Exhibits D and E of Schedule 2, under no circumstances shall the Service Provider or the Service Provider&#8217;s Team request access any personal data processed on the Customer&#8217;s systems and it shall put in place appropriate controls and safeguards to ensure that no such access is requested or otherwise obtained without Aspen&#8217;s knowledge and consent, by any member of Service Provider&#8217;s Team.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.27&#160;&#160;&#160;&#160;The Service Provider acknowledges that Aspen is subject to the New York Department of Financial Services Cybersecurity Regulation (23 NYCRR Part 500) (&#8220;NYDFS&#8221;) and that the Service Provider&#8217;s compliance with clauses 18.8 and 18.9 in relation to Customer Confidential Information is required for Aspen to comply with NYDFS. The Service Provider will also reasonably assist Aspen to comply with any additional requirements of NYDFS (at Aspen&#8217;s reasonable and demonstrable cost) provided that the Parties agree in writing the scope of any such additional requirements via the Contract Change Control Procedure.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;TRANSITION AND TRANSFORMATION</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;The parties shall comply with the provisions of Schedule 2, Exhibit D (Transition) to manage the adoption by the Service Provider of additional or substantially amended Services. The parties have agreed that in relation to the Run Services the obligations in Schedule 2, Exhibit D shall apply.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;&#160;&#160;&#160;To the extent that in future the parties agree that a Transformation related project should be undertaken, they agree the provisions of Schedule 2, Exhibit E (Transformation) shall apply to the same.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;WARRANTIES</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;&#160;&#160;&#160;Each Party represents, warrants and undertakes to the other, as at the date of this Agreement&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1.1&#160;&#160;&#160;&#160;that it has the power and authority to enter into and perform its obligations under this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1.2&#160;&#160;&#160;&#160;that it has all necessary rights, licences, permissions and consents to provide (in the case of Service Provider) or receive (in the case of Aspen) the Services&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1.3&#160;&#160;&#160;&#160;that the signing of this Agreement does not violate any law or constitute a default under any other agreement that Party has entered into.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2&#160;&#160;&#160;&#160;Service Provider represents, warrants and undertakes to Aspen on a continuing basis throughout the Term that&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2.1&#160;&#160;&#160;&#160;it shall not conduct itself in a way so as to adversely affect Aspen's public image or reputation (except that this clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">5.2.1</a> shall not preclude Service Provider from enforcing its rights under this Agreement)&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2.2&#160;&#160;&#160;&#160;it is not insolvent or unable to pay its debts within the meaning of the insolvency legislation applicable to it&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2.3&#160;&#160;&#160;&#160;it shall ensure that principles aligned to the ISO standards applicable to the Services are reflected in its performance of the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2.4&#160;&#160;&#160;&#160;it shall not knowingly and&#47;or negligently insert or include, or permit or cause any Service Provider personnel to insert or include, any known virus into any items provided to Aspen or Aspen's IT systems&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2.5&#160;&#160;&#160;&#160;it has undertaken all diligence it requires (including in relation to Aspen's existing services) in order to plan and perform the Services and that accordingly its prices and estimates may be relied upon by Aspen and will not be subject to unexpected changes&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2.6&#160;&#160;&#160;&#160;all information it provides to Aspen during the Term shall, at the time it is supplied, be true and accurate in all material respects&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2.7&#160;&#160;&#160;&#160;the Services will be performed in accordance with all&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;applicable laws&#59; and</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;ISO standards applicable to its Services and products&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2.8&#160;&#160;&#160;&#160;it shall comply with any reasonable Aspen request or instruction that enables Aspen to comply with its regulatory requirements (if any) in respect of the Services at mutually agreed terms. Any Aspen requests or instructions which fall outside of the scope of the Services shall be agreed through the change control procedure in clause 15.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3&#160;&#160;&#160;&#160;Except as expressly set forth herein and to the extent permitted by law, both parties hereby disclaim all other warranties, conditions or statements, whether express, implied, or statutory.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;PERFORMANCE METRICS AND SERVICE CREDITS</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;&#160;&#160;&#160;Service Provider acknowledges that any failure to provide a Service in accordance with the Performance Metrics or any of them may have a material adverse impact on the business and operations of Aspen and that, accordingly, the Service Provider shall&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1.1&#160;&#160;&#160;&#160;at all times meet the Performance Metrics&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1.2&#160;&#160;&#160;&#160;perform the Services with accuracy, quality, timeliness, responsiveness and efficiency in accordance with Good Industry Practice.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;&#160;&#160;&#160;Each Party acknowledges and agrees that any Service Credits that may become payable to Aspen are an adjustment to the Charges and that the payment and receipt of Service Credits is without prejudice to any other right or remedy available to Aspen as a result of Service Provider's failure to meet the relevant Performance Metrics.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;STEP IN</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1&#160;&#160;&#160;&#160;If&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1.1&#160;&#160;&#160;&#160;any default or non-performance by the Service Provider occurs and as a result, the performance of any business critical service is prevented, hindered, degraded or delayed for more than two (2) consecutive days&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1.2&#160;&#160;&#160;&#160;the Service Provider is excused from the performance of the Services pursuant to a Force Majeure event&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1.3&#160;&#160;&#160;&#160;a regulator requires Aspen to do so&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1.4&#160;&#160;&#160;&#160;the circumstances in paragraph 13.1 of Schedule 10 (Exit Plan and Service Transfer Arrangements) occur, </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">then, without limiting any other rights it may have, Aspen may take control of the part of the Services (including the entirety of an impacted Service Tower) affected by the Service Provider default or non-performance, or the Force Majeure event and in the case of clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">7.1.3</a>, Aspen shall take control of the part of the Services affected by the regulatory direction (in each case, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Step In</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for a maximum period of two (2) months after which Aspen shall either terminate this Agreement pursuant to any rights to do so hereunder it may have or allow the Service Provider to resume performance of the relevant Service.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;&#160;&#160;&#160;In exercising its rights of Step In Aspen may perform any act that Aspen deems reasonably necessary in order to restore the Services (including by engaging a third party service provider) or may direct the Service Provider to procure those Services from a third party supplier provided that Aspen&#58; (i) complies with the Service Provider&#8217;s reasonable security and confidentiality policies as notified to Aspen&#59; (ii) procures that any third party that it engages signs an Agreed Form NDA, with an obligation to erect &#8220;ethical walls&#8221; within its own organisation to protect the Service Provider&#8217;s confidentiality, if the third party stepping in is a competitor of the Service Provider&#59; (iii) does not have unsupervised access to the Service Provider&#8217;s facilities and shared computing environment&#59; and (iv) does not require the Service Provider to disclose its commercially sensitive information to any third party.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;&#160;&#160;&#160;Where a third party supplier is engaged in connection with a Step In, the Service Provider shall be liable for the payment of the difference between the sums that would have been paid to the Service Provider for the provision of those Services and the sums payable to the third party supplier for performing the same, for as long as the failure to perform continues (save for where the Step In is a result of a Force Majeure event or consequent to a regulatory direction unless such direction arises due to acts or omissions of the Service Provider), and Aspen shall not be charged for Services that are not provided to Aspen as a result of a Force Majeure event or the Service Provider&#8217;s default or non-performance. In the event that the incremental cost of replacement services exceeds &#91;***&#93;, Service Provider shall have the right, but not the obligation, to propose an alternate third party supplier and Aspen shall consider such proposal in good faith. The Service Provider shall either pay directly or reimburse Aspen for any such third party costs incurred. Such payments made by the Service Provider may be credited against the Charges or paid by way of cheque or direct debit to Aspen, at Aspen&#8217;s option.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;&#160;&#160;&#160;In the event of Aspen exercising its right of Step In, the Service Provider shall co-operate with Aspen (and its agents or representatives, including any applicable third party supplier) and provide reasonable assistance at no charge to Aspen to restore such Aspen function or the Services or any part of them as soon as reasonably possible, including giving Aspen (and its agents or representatives, including any applicable third party services provider) reasonable access to the Service Provider&#8217;s premises, Equipment, material and software, to the extent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reasonably necessary for the purpose of restoring such Aspen function or the Services or any part of them to the level required under this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;&#160;&#160;&#160;As soon as reasonably practicable following the restoration of the affected Aspen function or the affected part of the Services (meaning that its performance is no longer substantially prevented, hindered, degraded or delayed) to Aspen&#8217;s reasonable satisfaction or a Regulator lifting its Step In requirement, the Service Provider shall resume the performance of the relevant Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;&#160;&#160;&#160;Without prejudice to the caps set out in clause 22, nothing in this clause 7 limits the Service Provider&#8217;s liability to Aspen with respect to any default or non-performance by the Service Provider under this Agreement provided always that the Service Provider shall be relieved of its obligations to deliver the Services affected by any Step In during the period Aspen or any third party supplier has taken over delivery of such Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;ENHANCED COOPERATION</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1&#160;&#160;&#160;&#160;The parties acknowledge and agree that Aspen shall be entitled to exercise its rights under this clause 8 only if the parties fail to resolve a matter or issue through the issue escalation process in clauses 11.5 and 11.6.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.2&#160;&#160;&#160;&#160;Where Aspen requires the right to do so in order to obtain an improved understanding of the Services or to assist Service Provider to improve its performance (including in particular in the circumstances set out in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.3</a>), the parties agree that Aspen may nominate a certain number of its employees, agents or contractors (subject to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.4</a>) to be seconded to Service Provider or any of its subcontractors (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consultants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) provided that the Parties agree the role and responsibilities of such Consultants and the desired outcomes of involvement. The number of Consultants shall be the minimum reasonably necessary (as determined by Aspen acting reasonably) for the limited purposes described in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.3</a> and Aspen agrees to appoint Consultants with a level of seniority appropriate to the tasks they shall be engaged in and to provide Service Provider with at least five (5) working days' notice of its intention to exercise its rights under this clause 8 8.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;&#160;&#160;&#160;The circumstances that the parties agree shall entitle Aspen to invoke its rights under clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.2</a> include where&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.1&#160;&#160;&#160;&#160;Aspen has the right, or has reasonable grounds for believing that it has the right, to terminate the Agreement in whole or in part for cause&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.2&#160;&#160;&#160;&#160;Service Provider is not performing any of the Services in accordance with the Performance Metrics&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.3&#160;&#160;&#160;&#160;Service Provider is or Aspen has reasonable grounds for believing that Service Provider is reasonably likely to be in material breach of its obligations under the Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.4&#160;&#160;&#160;&#160;Aspen has reasonable grounds to suspect acts of fraud are being committed by Service Provider, any Service Provider subcontractor or any Service Provider personnel&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.5&#160;&#160;&#160;&#160;Service Provider causes Aspen to breach its legal or regulatory obligations&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.6&#160;&#160;&#160;&#160;Service Provider fails to provide the Services in accordance with the Agreement (whether such failure amounts to a material breach of contract or not) and that failure causes, or is in Aspen's opinion likely to cause&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;delay in delivery of the Services that means that Service Provider will not be able to meet a Key Milestone date&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the degradation or unavailability of the Services which, in Aspen's opinion, is unlikely to be resolved within a reasonable period of time&#59; or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Aspen to incur a material loss, liability or cost whether direct or indirect or to suffer any adverse publicity.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4&#160;&#160;&#160;&#160;No Consultant shall become an employee of Service Provider, or have a legal entitlement to any benefits conferred by Service Provider on its employees, as a result of his or her secondment under this clause 8.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;&#160;&#160;&#160;A Consultant may not be an employee of any entity who competes with Service Provider unless they are an employee of Aspen.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.6&#160;&#160;&#160;&#160;The Consultants shall be given full access to all information (other than commercially sensitive information or information related to the Charges) that is available to all relevant Service Provider personnel and that is related to the performance of the Services for the purposes described in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.2</a> and shall be able to make suggestions related to any element of the performance of the Services provided that the Consultant&#58; (i) complies with Service Provider's reasonable security and confidentiality policies as notified to the Consultant&#59; (ii) signs a non- disclosure agreement&#59; and (iii) does not have unsupervised access to Service Provider's facilities and shared computing environment.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.7&#160;&#160;&#160;&#160;Service Provider shall not be obliged to follow any suggestions given by the Consultants.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;&#160;&#160;&#160;If Service Provider does follow a suggestion of a Consultant, then Service Provider shall be fully responsible for all consequences that flow from the suggestion as if it were Service Provider's own suggestion.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.9&#160;&#160;&#160;&#160;By exercising its right under this clause 8, Aspen shall not, and shall not be deemed to, assume any obligation to resolve any issue or problem with the Services or relieve Service Provider of any obligation or liability in relation to that event. Without limiting the foregoing, nothing in this clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.9</a> shall be construed to limit Service Provider's obligation to continue to perform the Services in accordance with all applicable Performance Metrics and Milestone dates.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.10&#160;&#160;&#160;&#160;If Aspen exercises its rights under this clause 8, the parties shall carry out a monthly review to agree on whether the secondment shall continue. In any case, a secondment under this section may be terminated by Aspen at any time by giving written notice to Service Provider, but shall in any event cease when the secondment has been effective for a continuous period of ninety (90) days (or such longer period as may be agreed between the parties, such agreement may not be withheld by Service Provider where clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.12</a> applies), when both of the following conditions are satisfied&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.10.1&#160;&#160;&#160;&#160;the event giving rise to the appointment of the Consultants under this clause 7 has ceased and&#47;or has been resolved or remedied&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.10.2&#160;&#160;&#160;&#160;Service Provider has demonstrated to Aspen's reasonable satisfaction that Service Provider has taken all reasonable measures to ensure that the event giving rise to the appointment of the Consultants shall not reoccur.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.11&#160;&#160;&#160;&#160;Subject to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">8.12,</a> Aspen shall be responsible for paying the Consultants' reasonable and demonstrable fees for the duration of the secondment, plus any reasonable, actual and demonstrable travel and subsistence costs incurred by the Consultants in relation to their secondment under this clause 8 provided that the salaries of the Consultants are reasonable given their level of seniority and experience and Good Industry Practice (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consultant Costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.12&#160;&#160;&#160;&#160;The parties agree that to the extent that Aspen exercises its rights due to an alleged Service Provider default and it transpires that Service Provider was in default, then Service Provider shall be responsible for &#91;***&#93;.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.13&#160;&#160;&#160;&#160;The exercise by Aspen of its rights in this clause 8 shall be without prejudice to any other rights or remedies of Aspen.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;ASPEN DEPENDENCIES</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;&#160;&#160;&#160;Service Provider shall be excused from failures to perform its obligations under this Agreement if Aspen delays or fails to provide Aspen Dependencies but only&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1.1&#160;&#160;&#160;&#160;to the extent that such failure causes or materially contributes to Service Provider's failure to perform&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1.2&#160;&#160;&#160;&#160;provided that such acts or omissions are not undertaken by Aspen at Service Provider's direction or with Service Provider's written consent&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1.3&#160;&#160;&#160;&#160;provided that Service Provider gives Aspen reasonable written notice of Aspen's failure to perform Aspen Dependencies&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1.4&#160;&#160;&#160;&#160;provided Service Provider uses Commercially Reasonable Efforts to mitigate the adverse consequences of Aspen's failure and continues to provide the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.2&#160;&#160;&#160;&#160;Provided Service Provider has complied with the obligations set out in Section <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">9.1</a> above and has notified Aspen, Service Provider will be entitled to receive a reasonable adjustment in the timeframes to deliver or perform its obligations and reimbursement of its reasonable, demonstrable, unavoidable costs incurred directly as a result of Aspen's failure to perform the relevant Aspen Dependency.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;&#160;&#160;&#160;Service Provider shall only be entitled to relief under this Section 9 from the date on which it notifies Aspen in accordance with Section <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">9.1.3.</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;ASPEN'S OBLIGATIONS</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1&#160;&#160;&#160;&#160;Aspen shall&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1.1&#160;&#160;&#160;&#160;co-operate with the Service Provider in all matters relating to the Services and appoint the Aspen Contract Manager in relation to the Services, who shall have the authority to represent Aspen on day-to-day matters relating to this Agreement&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1.2&#160;&#160;&#160;&#160;inform the Service Provider of all policies relevant to the provision of the Services, including without limitation any reasonable security requirements at the Premises.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;GOVERNANCE AND REPORTING</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.1&#160;&#160;&#160;&#160;The Service Provider shall comply with Aspen's governance and reporting requirements as set out in Schedule 3 and the operational reporting requirements set out in Schedule 2.</font></div><div style="margin-bottom:10pt;padding-left:41pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Procedures Manual</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2&#160;&#160;&#160;&#160;Service Provider shall develop on or before the date agreed in the Transition Plan and in any event within 90 working days following the Effective Date and maintain (subject always to approval by Aspen) a policy and procedures manual (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Procedures Manual</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) that describes, at a minimum&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.1&#160;&#160;&#160;&#160;how the Services are to be performed and delivered&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.2&#160;&#160;&#160;&#160;the equipment and software to be used&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.3&#160;&#160;&#160;&#160;the relevant documentation including operations manuals and user guides&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.4&#160;&#160;&#160;&#160;the quality assurance procedures approved by Aspen&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.5&#160;&#160;&#160;&#160;the supervision, monitoring, staffing, reporting, planning and oversight activities to be undertaken by Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.6&#160;&#160;&#160;&#160;Service Provider's problem management escalation procedures&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.7&#160;&#160;&#160;&#160;other pertinent Service Provider standards and procedures&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.8&#160;&#160;&#160;&#160;Aspen's standards and policies notified to Service Provider pursuant to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">3.11.</a></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.3&#160;&#160;&#160;&#160;Service Provider shall update and maintain the Procedures Manual at least annually and Aspen and Service Provider shall agree on any policies and procedures to be included within the same.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.4&#160;&#160;&#160;&#160;Until the Procedures Manual is approved, Service Provider shall perform the Services consistent with existing Aspen standards and policies.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Escalation and Incentives</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5&#160;&#160;&#160;&#160;Service Provider agrees that if an agreed trigger event occurs (it being agreed that this shall include if&#58; (i) there are repeated delivery or service failures&#59; (ii) there is a major one-off failure such as a failure to achieve a Key Milestone Date&#59; and&#47;or (iii) Service Provider fails to comply with its rectification obligations) then, without prejudice to its ongoing duty to address the underlying issue in accordance with the terms of this Agreement, it will commit to executive escalation as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5.1&#160;&#160;&#160;&#160;as a first level of executive escalation (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Escalation (a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) Service Provider has agreed that should Executive Escalation (a) be triggered then the Service Provider&#8217;s insurance business head (as at the Effective Date Jim Davidson) shall relocate to Aspen's offices for four (4) full working days per week to lead Service Provider's team and to explain progress&#59; and Service Provider's CEO or his or her nominee who shall be a member of Service Provider&#8217;s senior leadership team shall telephone Aspen's CEO or CIO (at Aspen&#8217;s election) once each week to report progress. Without prejudice to its other rights and remedies Aspen may in its sole and absolute discretion elect to waive or defer Executive Escalation (a)&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5.2&#160;&#160;&#160;&#160;not used.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.6&#160;&#160;&#160;&#160;Service Provider shall request that Aspen act as a reference source in relation to at least two (2) bids each year. Such bids shall be for services broadly similar to the Services for clients of a similar size to Aspen. Failure to do this shall require Service Provider's Chief Business Officer to provide detailed reasons for such failure to Aspen's CIO.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;ACCEPTANCE</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1&#160;&#160;&#160;&#160;The Parties shall agree and set out in writing the Acceptance Criteria for each Acceptance Item.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2&#160;&#160;&#160;&#160;The Service Provider must undertake its own internal testing of any Acceptance Item before submitting it to Aspen for acceptance testing.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.3&#160;&#160;&#160;&#160;Unless otherwise agreed, the Service Provider must provide Aspen with at least ten (10) Business Days' notice prior to submitting any item for acceptance testing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.4&#160;&#160;&#160;&#160;Unless otherwise agreed between the Parties, Aspen shall conduct the acceptance testing promptly after receiving the Acceptance Item and promptly (but in any event no later than ten (10) Business Days from receipt or such other period that is agreed in a SOW) notify the Service Provider whether it accepts, rejects or conditionally accepts the Acceptance Item. Aspen shall promptly issue an Acceptance Certificate if it accepts or conditionally accepts the Acceptance Item. To be binding the Acceptance Certificate must be issued by (or otherwise authorised by) the Customer Individual appointed pursuant to Schedule 3.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.5&#160;&#160;&#160;&#160;The Service Provider shall provide all reasonable support to Aspen in relation to conducting the acceptance testing at no additional charge.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;&#160;&#160;&#160;If the Service Provider conducts the acceptance testing, Aspen shall be entitled to observe the acceptance testing and shall provide reasonable support to the Service Provider in relation to the conduct of the acceptance testing.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.7&#160;&#160;&#160;&#160;If an Acceptance Item is rejected, Aspen shall provide reasons for such rejection, and the Service Provider shall remedy the relevant defects at no additional charge and re-submit the Acceptance Item to Aspen as soon as reasonably practicable but in all cases within seven (7) Business Days.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;&#160;&#160;&#160;If an Acceptance Item is rejected a second time, without prejudice to any other rights Aspen may have, Aspen shall have the option to&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8.1&#160;&#160;&#160;&#160;require the Service Provider to rectify any defects and re-submit the Acceptance Item for acceptance&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8.2&#160;&#160;&#160;&#160;accept the Acceptance Item subject to an equitable reduction in the Charges for such Acceptance Item and, in this scenario, such Acceptance Item shall be treated as if it were fully accepted&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8.3&#160;&#160;&#160;&#160;immediately terminate the Service related to the Acceptance Item and any other affected Services for material breach and be refunded all Charges paid under this Agreement in connection with the Acceptance Item and the affected Services provided that all Acceptance Items related to such termination are returned to the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.9&#160;&#160;&#160;&#160;In no circumstances shall Aspen be deemed to have accepted an Acceptance Item, other than where it is unconditionally accepted and an Acceptance Certificate is issued.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.10&#160;&#160;&#160;&#160;If Aspen conditionally accepts an Acceptance Item, it shall notify the Service Provider of the conditions to which the acceptance is subject and the Acceptance Item shall not be fully accepted until such conditions have been met. The Charges related to the relevant Acceptance Item shall be subject to an equitable reduction, with the balance paid when the defects or backlog of issues have been completed.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;PRICE AND PAYMENT</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;&#160;&#160;&#160;The Charges shall be incurred and become payable in accordance with the terms of Schedule 2, Exhibit B.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.2&#160;&#160;&#160;&#160;The Service Provider's pricing shall not be subject to or contingent upon any due diligence to be performed after the Effective Date. The foregoing shall not preclude the application of the True-up Period process in relation to quantities described in Schedule 2, Exhibit B (Fees).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.3&#160;&#160;&#160;&#160;Unless stated otherwise in an SOW with reference to this clause, the Supplier shall invoice for the Charges monthly in arrears and all such invoices shall be accompanied by a statement setting out the Services supplied in the relevant month in sufficient detail to justify the Charges charged. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where any Charges are in respect of Services provided to one or more Aspen Affiliate, the Supplier's invoices shall detail which Charges apply to each Aspen Affiliate.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.4&#160;&#160;&#160;&#160;Service Provider shall only be entitled to invoice Aspen for its expenses if such expenses have been agreed upon in advance in writing. In the event of any travel made by Service Provider personnel at Aspen&#8217;s request, provided the same have been agreed pursuant to the foregoing 13.4 such travel shall be charged to Aspen at actuals together with such evidence as Aspen may reasonably request.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.5&#160;&#160;&#160;&#160;Service Provider shall maintain complete and accurate records of, and supporting documentation for, the amounts billable to and payments made by Aspen under this Agreement, and Service Provider shall provide Aspen with documentation and other information with respect to each invoice as may be reasonably requested by Aspen to verify accuracy and compliance with the provisions of the Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6&#160;&#160;&#160;&#160;In the event the Parties agree that a particular pass through expense is to be paid directly by Aspen, such pass through expense shall not be subject to any mark up, unless agreed otherwise by the parties in writing and Service Provider shall provide Aspen with the original third party invoice together with a statement that the Charges are proper and valid and should be paid by Aspen.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.7&#160;&#160;&#160;&#160;Within 30 days following receipt of the Service Provider's invoice, Aspen will pay the undisputed Charges to the Service Provider. In the event that a payment is not made within the payment period specified herein, Service Provider reserves the right to levy a delayed payment charge of &#91;***&#93; until the date Aspen remits payment in full.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.8&#160;&#160;&#160;&#160;Aspen may withhold payment of particular charges that Aspen reasonably and in good faith disputes on notice to Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.9&#160;&#160;&#160;&#160;If Aspen disputes a part of an invoice, Service Provider shall re-issue an invoice (with the original invoice date) for the undisputed Charges and Aspen shall pay such undisputed Charges in accordance with this clause 13 of the Agreement. Service Provider shall also re-issue a separate invoice for the disputed Charges (with the original invoice date). The Parties shall diligently pursue an expedited resolution of such dispute in accordance with the issue escalation process in Schedule 3 (Governance).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.10&#160;&#160;&#160;&#160;To the extent Service Credits become payable these shall be credited against the next invoice that falls due after they arise. If no invoices remain to be raised then they shall be paid to Aspen by the Supplier.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.11&#160;&#160;&#160;&#160;Aspen may on reasonable notice (not less than thirty (30) days) to the Service Provider set-off part or all of the payments due to the Service Provider under this Agreement against undisputed amounts due from the Service Provider to Aspen under this Agreement or any other agreements.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.12&#160;&#160;&#160;&#160;All invoices shall be sent by email to AspenInvoiceCapture&#64;Concursolutions.com or to such address, or by other such means, as Aspen may notify to the Service Provider in writing from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.13&#160;&#160;&#160;&#160;The Service Provider agrees that Aspen may invoke its rights to assess the value for money represented by the Services and Charges pursuant to Schedule 9 at such times and in accordance with such procedures as set out in Schedule 9.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.14&#160;&#160;&#160;&#160;With effect from the anniversary date of this Agreement, the professional rates under the Rate Card attached to Schedule 2, Attachment B-3 will be adjusted based on the applicable official index&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;issued&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;by&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;World&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Bank&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;at http&#58;&#47;&#47;data.worldbank.org&#47;indicator&#47;FP.CPI.TOTL.ZG&#63;_sm_au_&#61;iVHRPMZqWB3SpJLM for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respective countries from which the Services are delivered or by a maximum of (i) &#91;***&#93; for onsite resources and (ii) &#91;***&#93;, in each case whichever is lower.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;TAX</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.1&#160;&#160;&#160;&#160;All prices are exclusive of value added tax or any other locally applicable equivalent sales taxes (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VAT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which is payable at the rate and as prescribed by law.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.2&#160;&#160;&#160;&#160;Unless otherwise agreed between the Parties, the Service Provider will be responsible for all other taxes which are incurred as a result of its provision of the Services under this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3&#160;&#160;&#160;&#160;Aspen shall be entitled to deduct the sums required to pay any withholding taxes, demanded by any taxation authority, from payment to the Service Provider. Upon becoming aware that it must make a tax deduction, Aspen must notify the Service Provider accordingly.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;&#160;&#160;&#160;If Aspen does deduct any amounts pursuant to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">14.3,</a> it shall pay such sums to the relevant taxation authority within the period for payment permitted by law, and furnish the Service Provider with evidence of payment of the relevant amount from the relevant tax authority. Aspen shall upon request reasonably assist the Service Provider with obtaining relevant basic information about such tax obligations and shall use reasonable efforts to assist the Service Provider with reclaiming such withholding tax, where any double-tax treaties or similar rules in the jurisdiction allow for tax reclaims to reduce the Service Provider&#8217;s tax burden, or with claiming a foreign tax credit.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.5&#160;&#160;&#160;&#160;If VAT or other taxes are payable on damages payable or paid under this Agreement, then the Party liable for payment of such damages must pay any such VAT or other taxes in addition to the relevant amount of damages upon production of a valid VAT or other appropriate tax invoice by the other Party.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;CHANGE CONTROL</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.1&#160;&#160;&#160;&#160;If either Party wishes to change the scope of provision of the Services it shall submit details of the requested change to the other Party's authorised representative in writing in accordance with Schedule 4 (Contract Change Control Procedure).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;PREMISES</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1&#160;&#160;&#160;&#160;The Service Provider shall be entitled to use such parts of the Premises as Aspen may from time to time designate as necessary for the performance of the Services provided that use of this space is solely for the purpose of providing the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.2&#160;&#160;&#160;&#160;Aspen may refuse to admit to, or order the removal from, the Premises any member of the Service Provider's Team or person otherwise acting on behalf of the Service Provider who, in the reasonable opinion of Aspen, is not behaving in accordance with the requirements of this Agreement or whose behaviour, conduct or dress renders such person unfit or unsuitable to be on the Premises. Costs associated with any such refusal of admittance or removal and with the provision of a suitable replacement shall be met by the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;ASSETS</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equipment</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.1&#160;&#160;&#160;&#160;In the event Aspen deems it necessary to require Service Provider to use equipment owned or operated by Aspen (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aspen Equipment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), Service Provider shall be responsible for transfer, but not transportation, of Aspen equipment to Service Provider's sites&#47;environments. As at the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service Commencement Date, the Parties do not envisage any Aspen Equipment being installed on Service Provider's sites&#47;environments.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.2&#160;&#160;&#160;&#160;Service Provider shall be fully responsible for monitoring the operation of and maintenance of Aspen Equipment (if any) and shall promptly notify Aspen of any issues with the same that may impact the provision of the Services or achievement of the Performance Metrics.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.3&#160;&#160;&#160;&#160;Service Provider may, where directed to do so by Aspen, acquire future equipment (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Equipment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), including modifications, upgrades, enhancements, additions and replacements of Aspen Equipment, as necessary or appropriate to provide the Services. Such Future Equipment shall be acquired in the name of Aspen and title shall vest in Aspen and, unless agreed to the contrary pursuant to the change control procedure in clause 15, Aspen shall pay the vendor directly for such Future Equipment.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.4&#160;&#160;&#160;&#160;Aspen shall have the right to approve any software or Service Provider tools used by Service Provider in relation to the Services and installed on Aspen IT systems prior to Service Provider's use of the same in order to provide the Services, such approval shall not be unreasonably withheld or delayed. Service Provider shall be responsible for&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.4.1&#160;&#160;&#160;&#160;installing, operating and maintaining Service Provider software and Service Provider tools&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.4.2&#160;&#160;&#160;&#160;managing and using any other software, systems or materials (including Aspen software, Aspen systems and Aspen materials) required to provide the Services&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.4.3&#160;&#160;&#160;&#160;modifying such other software, systems or materials (including Aspen software, Aspen systems and Aspen materials) where the same is agreed by the Parties.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.5&#160;&#160;&#160;&#160;During the first 120 days after the Service Commencement Date, Service Provider shall conduct an asset 'Verification and Condition' based survey along with a verification of the Services. Any differences found between this information, the tender information, Service Provider's price and pricing model shall be discussed and, based on the resulting cost&#47;benefit analysis, the Parties may agree through the change control procedure in clause 15 whether and to what extent Service Provider shall provide a repricing of the Charges for the Services in line with these changes.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk of Loss</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.6&#160;&#160;&#160;&#160;Each Party shall be responsible for risk of loss of, and damage to, equipment, software or other material in its possession or under its control.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.7&#160;&#160;&#160;&#160;Service Provider shall be responsible for the risk of loss of, and damage to, any property, systems or material used by it to provide the Services, except to the extent that any loss of, or damage to, any such property, systems or materials is caused by the negligence or an intentional wrongful act or omission of Aspen or Aspen personnel.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;TERM AND TERMINATION</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.1&#160;&#160;&#160;&#160;This Agreement shall commence on the Effective Date and 31 December 2025 unless terminated earlier in accordance with its terms (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.2&#160;&#160;&#160;&#160;Aspen may, in its sole discretion, extend the Initial Term by up to two further periods of one (1) year from the expiry of the Initial Term, by giving written notice to the Service Provider at least ninety (90) days prior to the expiry of the Initial Term or an extension period, as applicable.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.3&#160;&#160;&#160;&#160;Not used.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.4&#160;&#160;&#160;&#160;Aspen shall be entitled to terminate this Agreement without cause by giving the Service Provider not less than three (3) months' written notice of termination (and any SOW by giving not less than thirty (30) days' written notice of termination), in which event the Service Provider will comply with Aspen's reasonable instructions with regard to termination and Aspen will only be liable to pay the Service Provider (i) in respect of the Services satisfactorily performed and accepted by Aspen up to the effective date of such termination&#59; and (ii) any other pre-agreed termination charges as specified in Schedule 2, Exhibit B, Attachment B-4 (Termination Charges). Termination of this Agreement pursuant to this clause shall, unless stated otherwise, terminate all SOWs then in force.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.5&#160;&#160;&#160;&#160;Either Party shall be entitled to terminate this Agreement or any SOW immediately if the other Party&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.5.1&#160;&#160;&#160;&#160;has committed a material breach of any of its obligations thereunder which is not capable of remedy and in this regard it is agreed that the Service Provider shall be deemed to have committed a material breach that is incapable of remedy entitling Aspen to terminate immediately if&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the termination rights described in Section 4.6 of Schedule 2, Exhibit C arise&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;a Material Adverse Change occurs in relation to Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;a Change of Control of Service Provider (other than an internal re-organisation within the Service Provider Group)&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;any breach by Service Provider which causes Aspen or any Aspen Affiliate to be in breach of its obligations pursuant to Relevant Law&#59; or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;any breach by Service Provider which has a material adverse impact on Aspen's reputation (or that of any Aspen Affiliate) or leads to material adverse publicity&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.5.2&#160;&#160;&#160;&#160;has committed a material breach of any of its obligations thereunder which is capable of remedy but which has not been remedied within 30 days of receipt of written notice to do so&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.5.3&#160;&#160;&#160;&#160;becomes insolvent, has a receiver or administrator appointed over the whole or any part of its assets, enters into any compromise with its creditors, has an order made or resolution passed for it to be wound up (unless for the purposes of amalgamation or reconstruction) or undergoes any similar process in any jurisdiction to which such Party is subject.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.6&#160;&#160;&#160;&#160;Upon the termination or expiry of this Agreement or an SOW the Service Provider will immediately deliver up to Aspen all items, equipment, and documentation which is the property of Aspen or an Aspen Affiliate, together with notes, memoranda, correspondence, documents, specifications, and other records (however stored) which contain or reflect Confidential Information related to Aspen or an Aspen Affiliate which have been made or obtained by the Service Provider or the Service Provider's Team in the course of providing the terminated Services or are otherwise in its possession or control.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.7&#160;&#160;&#160;&#160;Termination or expiry of this Agreement or any SOW shall not affect any rights, remedies, obligations or liabilities of the Parties that have accrued up to the date of termination or expiry, including the right to claim damages in respect of any breach of this Agreement or the applicable SOW(s) which existed at or before the date of termination or expiry.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.8&#160;&#160;&#160;&#160;Following the expiry or termination (for whatever reason) of this Agreement or any SOW, the Service Provider shall co-operate with Aspen and other suppliers to Aspen to ensure a smooth handover of the terminated Services carried out by the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.9&#160;&#160;&#160;&#160;Any provision of this Agreement that expressly or by implication is intended to come into or continue in force on or after termination or expiry of this Agreement including clauses 20 (Intellectual Property Rights), 21 (Indemnity), 22 (Limitation of Liability), 23 (Confidentiality), 27 (Data Protection) and 33 (Health and Safety) shall survive termination of this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;TERMINATION ASSISTANCE&#47;EXIT</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.1&#160;&#160;&#160;&#160;Subject to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">19.5,</a> for up to a maximum period of nine (9) months following the effective date of termination or expiration of the Agreement or following the date of any notice of termination, at Aspen's election and request the Service Provider shall co-operate with Aspen and other suppliers to Aspen to ensure a smooth handover of the work carried out by the Service Provider at the agreed day rates and in accordance with Schedule 10.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.2&#160;&#160;&#160;&#160;Actions by the Service Provider under this clause 19 shall be subject to the provisions of the Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.3&#160;&#160;&#160;&#160;Charges for termination assistance activities by the Service Provider shall be at the services rates set out in Schedule 2, Exhibit B or such lower rates (if any) as specified in an Exit Plan.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4&#160;&#160;&#160;&#160;The Service Provider represents and warrants that the termination assistance services shall be provided to facilitate Aspen to readily continue the provision of the services in-house or by a replacement supplier (working in accordance with Good Industry Practice) and eliminate or minimise any disruption or deterioration of the Services, including, but not limited to, the following&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4.1&#160;&#160;&#160;&#160;efficient and comprehensive transition&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4.2&#160;&#160;&#160;&#160;assistance in providing information required to prepare and execute any request for proposal process&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4.3&#160;&#160;&#160;&#160;knowledge transfer&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4.4&#160;&#160;&#160;&#160;enabling data migration&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4.5&#160;&#160;&#160;&#160;executing any document required for assignment of rights.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.5&#160;&#160;&#160;&#160;Aspen shall procure that any Successor Service Provider shall enter into a confidentiality agreement with the Service Provider on terms consistent with clause 23 (Confidentiality).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;INTELLECTUAL PROPERTY RIGHTS</font></div><div style="margin-bottom:10pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-existing IPR</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;&#160;&#160;&#160;Each Party shall retain its rights in its own Pre-existing IPR. Except as expressly provided in this clause 20 (Intellectual Property Rights), neither Party shall gain by virtue of this Agreement any rights of ownership in any Intellectual Property Rights owned by the other Party or any third party.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Developed IPR</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.2&#160;&#160;&#160;&#160;The Service Provider shall procure that all members of the Service Provider&#8217;s Team waive all Moral Rights (as defined in has the meaning set out in Chapter IV of the UK Copyright, Designs and Patents Act 1988) that such individuals may have in any deliverable or item provided to, or used by, Aspen in connection with this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.3&#160;&#160;&#160;&#160;Developed IPR shall be solely owned by Aspen and shall vest in Aspen on creation. The Service Provider may use the Developed IPR solely to provide the Services to Aspen during the Term. To the extent that title and&#47;or ownership rights may not automatically vest in Aspen as contemplated by this clause, the Service Provider agrees to irrevocably assign, transfer and convey to Aspen all rights, title and ownership in the Developed IPR. The Service Provider shall and shall procure that all Service Provider personnel shall give Aspen or its designees, all reasonable assistance and execute all documents necessary to assist or enable Aspen to perfect, preserve, register or record its rights in the Developed IPR.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.4&#160;&#160;&#160;&#160;The Service Provider shall ensure that where Developed IPR is comprised of software, it shall deliver the same in source code and object code form, with appropriate documentation and that both versions shall be able to be used by a reasonably skilled programmer familiar with the relevant software language.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licences granted by the Service Provider</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.5&#160;&#160;&#160;&#160;Save for the rights in the Pre-existing IPR and any Enhancements arising in relation to COTS Materials (it being acknowledged that as at the Effective Date no such COTS Materials have been identified), the Service Provider grants to Aspen and its Affiliates a royalty free, world- wide, non-exclusive transferable licence (at no additional charge and including the right to sub- licence) to use, copy, modify, and prepare derivative works of&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.5.1&#160;&#160;&#160;&#160;the Service Provider&#8217;s Pre-existing IPR&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.5.2&#160;&#160;&#160;&#160;the Enhancements&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.5.3&#160;&#160;&#160;&#160;any Third Party IPR used or provided by it in connection with the delivery of the Services, </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in each case&#58; (i) in connection with Aspen&#8217;s and its Affiliates use and receipt of the Deliverables, Services or any Replacement Services provided in-house or by a Successor Service Provider, or any Related Services&#59; and (ii) on a perpetual and irrevocable basis to the extent the same are embedded in or form part of any Developed IPR and in all other cases during the Term and during any Termination Assistance Period. For the purposes of clarity, unless specifically agreed to the contrary in an SOW, no right is granted to Aspen or its Affiliates to extract, separate, use or commercially exploit any Pre-existing IPR or Enhancements on a stand-alone basis, or as a separate development tool.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licence granted by Aspen</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;&#160;&#160;&#160;Aspen grants to the Service Provider a non-exclusive, non-transferable, revocable licence (including the right to sub-licence, but only to subcontractors approved by Aspen in accordance with this Agreement) to use, copy, modify, and prepare derivative works of Aspen IPR for the sole purpose of providing the Services to Aspen during the Term.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;INDEMNITY</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.1&#160;&#160;&#160;&#160;The Service Provider shall indemnify, defend and hold harmless Aspen and its Affiliates and their respective officials, employees, agents and assigns (each, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnified Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) against any claims, losses, damages, costs (including reasonable legal fees), expenses and liabilities incurred or suffered by an Indemnified Party in connection with any infringement (or claim of infringement) of any IPR or other proprietary rights of a third party, alleged to have occurred because of materials or Services provided by or on behalf of the Service Provider to Aspen or any of its Affiliates, or based upon Service Provider&#8217;s performance or Aspen&#8217;s or its Affiliate&#8217;s receipt or use of such materials or Services.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.2&#160;&#160;&#160;&#160;Without prejudice to its obligations pursuant to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">21.1,</a> if any Service or other item or material provided by the Service Provider or the provision of the Services by the Service Provider is, or in the Service Provider&#8217;s reasonable judgment is likely to become, the subject of a claim (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Infringing Item</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Service Provider, at its expense and in addition to the indemnity and defending the claim, will procure for Aspen the right to use and continue using the Infringing Item or replace it with a non-infringing equivalent or modify it to make its use non- infringing, provided that such replacement or modification does not result in a degradation of the performance or quality of the Infringing Item.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.3&#160;&#160;&#160;&#160;The Service Provider&#8217;s indemnification obligations under clause 21.1 above shall be excluded to the extent the infringement arises from&#58; (i) any modification to the Services, Deliverables or materials by persons other than Service Provider personnel or otherwise made with the permission or in accordance with instructions of the Service Provider&#59; (ii) any information or materials supplied by or instructions given by Aspen, an Aspen Affiliate or a Third Party Provider and used in the Services, Deliverable(s) or other infringing item unless, acting in accordance with Good Industry Practice, Service Provider should have identified that such infringement may arise&#59; or (iii) use of the Deliverables or Services or portions thereof in combination with any other services&#47; deliverables not envisaged by this Agreement or the applicable SOW or otherwise not recommended, approved or provided by the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.4&#160;&#160;&#160;&#160;The following procedures will apply with respect to indemnification for third party claims arising in connection with this Agreement save that Aspen shall only give the Service Provider the right to control third party litigation relating to a third party claim that is subject to indemnification by Service Provider where the claim relates to IPR&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.4.1&#160;&#160;&#160;&#160;as soon as reasonably practicable after receipt by an Indemnified Party of written notice of the assertion or the commencement of any claim, demand, action, cause of action or other proceeding by a third party, whether by legal process or otherwise (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Claim</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), but no later than fourteen (14) days following receipt of written notice from the Indemnified Party relating to any Claim, the indemnifying Party will notify the Indemnified Party in writing whether it wishes to assume control of the defence and settlement of such Claim (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.4.2&#160;&#160;&#160;&#160;if the indemnifying Party delivers the Notice relating to any claim within the required notice period, the indemnifying Party will be entitled to have control over the defence and settlement of such Claim&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.4.3&#160;&#160;&#160;&#160;if the indemnifying Party fails to assume the defence of any such Claim within the prescribed period of time, then the Indemnified Party may assume the defence of any such Claim at the cost and expense of the indemnifying Party&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.4.4&#160;&#160;&#160;&#160;subject to the payment of its reasonable costs, the Indemnified Party shall provide reasonable assistance to the indemnifying Party, including reasonable assistance to the indemnifying Party&#8217;s employees, agents, independent contractors and Affiliates, as applicable. Notwithstanding any provision of this clause 21 to the contrary, the indemnifying Party will not consent to the entry of any judgment or enter into any settlement that provides for injunctive or other non-monetary relief affecting the Indemnified Party without the prior written consent of the Indemnified Party, such consent not to be unreasonably withheld or delayed.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.5&#160;&#160;&#160;&#160;Service Provider shall additionally procure that Aspen receives the full benefit and protection of any IPR indemnity that Service Provider has in relation to IPR which is not owned by Service Provider (whether Third Party IPR or otherwise) but is supplied to Aspen pursuant to this Agreement and&#47;or any SOW.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.&#160;&#160;&#160;&#160;LIMITATION OF LIABILITY AND INSURANCE</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.1&#160;&#160;&#160;&#160;Nothing in this Agreement shall exclude or restrict the liability of either Party to the other for death or personal injury arising from negligence or for fraudulent misrepresentation, in relation to the indemnities granted under clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">3.13,</a> or in any other circumstances where liability may not be so limited under any applicable law.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.2&#160;&#160;&#160;&#160;Nothing in this clause 22 shall exclude or restrict the liability of the Service Provider to Aspen&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.2.1&#160;&#160;&#160;&#160;under the indemnities given in clause 21&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.2.2&#160;&#160;&#160;&#160;for any breach by the Service Provider of clause 23 (Confidentiality)&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.2.3&#160;&#160;&#160;&#160;for any liability arising from its Wilful Abandonment.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.3&#160;&#160;&#160;&#160;Subject to clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">22.1</a> and <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">22.2,</a> neither Party shall be liable to the other whether in contract, tort, negligence, breach of statutory duty or otherwise for any indirect loss or damage, costs or expenses arising under or in connection with this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4&#160;&#160;&#160;&#160;The exclusions in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">22.3</a> shall not exclude liability for the following heads of losses which the Parties agree shall be deemed to be direct losses or damages suffered by Aspen but subject to the other limitations of liability contained in this clause 22&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4.1&#160;&#160;&#160;&#160;the costs of procuring and implementing an alternative to the Services provided (or not provided) by the Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4.2&#160;&#160;&#160;&#160;the cost of restoring lost or damaged data caused or contributed to by the Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4.3&#160;&#160;&#160;&#160;the cost of restoring damage to physical property caused or contributed to by the Service Provider&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4.4&#160;&#160;&#160;&#160;additional wages, overtime and expenses incurred by Aspen or its subcontractors or agents in performing or rectifying defective Services and&#47;or managing a third party&#8217;s performance of the same&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4.5&#160;&#160;&#160;&#160;fines or penalties imposed on Aspen as result of the Service Provider&#8217;s breach of its data protection obligations contained in this Agreement or any SOW (whether by act, omission or otherwise)&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4.6&#160;&#160;&#160;&#160;in the event that a default (whether by act, omission or otherwise) of the Service Provider prevents Aspen from running its business in the normal way, the costs of the remedial action necessary so as to re-enable such normal running together with the costs of implementing any temporary work-around.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.5&#160;&#160;&#160;&#160;Subject to clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">22.1</a> and <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">22.2,</a> the total liability of the Service Provider to Aspen whether in contract, tort, negligence, breach of statutory duty or otherwise for any direct loss or damage, costs or expenses arising under or in connection with this Agreement shall not exceed&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.5.1&#160;&#160;&#160;&#160;for any breach by the Service Provider of clause 27 (Data Protection) and&#47;or Schedule 1 the greater of (i) &#91;***&#93;&#59; or (ii) &#91;***&#93;&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.5.2&#160;&#160;&#160;&#160;for any other breach occurring during any twelve month period commencing on the Effective Date and each anniversary thereof contract year in the aggregate the greater of &#91;***&#93; or &#91;***&#93;. For the avoidance of doubt, the limitation of liability specified herein for each </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such 12-month period, including any unclaimed portion thereof, shall not be carried forward to the subsequent 12-month period.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.6&#160;&#160;&#160;&#160;Subject to clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">22.1</a> and <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">22.2,</a> Aspen's liability whether in contract, tort, negligence, breach of statutory duty or otherwise under or in connection with this Agreement shall be limited to a sum equal to the Charges paid in the 12 months preceding the relevant claim.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7&#160;&#160;&#160;&#160;The Service Provider shall maintain at its own cost (and on request provide evidence to Aspen in the form of a broker&#8217;s letter) the following insurance policies with an insurer of good standing (subject to clause 35.2) for the Term Agreement and six (6) years thereafter&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7.1&#160;&#160;&#160;&#160;professional liability insurance for a minimum amount of &#91;***&#93;&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7.2&#160;&#160;&#160;&#160;public and product liability insurance for a minimum amount of &#91;***&#93;&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7.3&#160;&#160;&#160;&#160;employer&#8217;s liability insurance for a minimum amount of &#91;***&#93;.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.8&#160;&#160;&#160;&#160;The Service Provider shall not take out or hold any of the insurance coverage described in clause 0 with Aspen or any member of Aspen Group without Aspen&#8217;s prior written consent.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.9&#160;&#160;&#160;&#160;The Service Provider shall not during the Term and for a period of six (6) years thereafter act or refrain from acting in such a way as would entitle the underwriter(s) of the policies required by clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">0</a> above to avoid or negate their liability to deal with any claim(s) which would otherwise be covered.</font></div><div style="margin-bottom:30pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.10&#160;&#160;&#160;&#160;The Service Provider shall, whenever reasonably requested by Aspen, provide evidence of such insurance and of its currency.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.&#160;&#160;&#160;&#160;CONFIDENTIALITY</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1&#160;&#160;&#160;&#160;Each Party shall, and will ensure that its respective Affiliates, directors, officers, employees and contractors shall&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1.1&#160;&#160;&#160;&#160;treat Confidential Information as secret and confidential&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1.2&#160;&#160;&#160;&#160;use Confidential Information only as is necessary for the performance or receipt of the Services and in particular will not make commercial use of it or otherwise use it to the detriment of the Disclosing Party without such Party's prior written agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1.3&#160;&#160;&#160;&#160;restrict Confidential Information to such of the Receiving Party's Affiliates, directors, officers, employees or contractors who require access to it for the delivery or receipt of the Services and who have undertaken or are subject to confidentiality obligations to the Receiving Party no less stringent than those undertaken herein&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1.4&#160;&#160;&#160;&#160;not copy or reproduce Confidential Information except where this is reasonably necessary for the delivery or receipt of the Services. The Parties agree that all copies or reproductions of Confidential Information, in any form, shall be the property of the Disclosing Party&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1.5&#160;&#160;&#160;&#160;refrain from directly or indirectly disclosing Confidential Information to any third party.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.2&#160;&#160;&#160;&#160;Clause 23.1 will not apply to&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.2.1&#160;&#160;&#160;&#160;information which the Receiving Party can prove with documentary evidence was already known to it prior to disclosure, other than that disclosed in any other agreement with Disclosing Party, and free of any confidentiality obligations to the Disclosing Party&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.2.2&#160;&#160;&#160;&#160;information which is disclosed to the Receiving Party by a third party with a legal right to do so and free of any obligations of confidence to the Disclosing Party&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.2.3&#160;&#160;&#160;&#160;disclosure to any court or government or regulatory authority, where this is required by law or judicial decree, provided that the Receiving Party (i) promptly notifies the Disclosing Party in advance if legally permitted to do so, (ii) exercises reasonable efforts to obtain assurance that confidential treatment will be applied to that portion of the Confidential Information that is being disclosed and (iii) takes all reasonable steps at the expense of the Disclosing Party to assist in the protection of it.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.3&#160;&#160;&#160;&#160;For the avoidance of doubt, the Disclosing Party may not disclose Confidential Information made up of a combination of items of Confidential Information merely because one or more of the items falls within the exceptions in Clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">23.2</a> above, if the combination as a whole does not.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.4&#160;&#160;&#160;&#160;On termination or expiry of this Agreement the obligations in Clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">23.1</a> to <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">23.4</a> shall remain in force for three years from the date of termination or expiry.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.5&#160;&#160;&#160;&#160;On expiry or termination of this Agreement (or earlier if the Disclosing Party so requests in writing), the Receiving Party shall, on request, return, delete or destroy all copies of any Confidential Information it has received from the Disclosing Party.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.6&#160;&#160;&#160;&#160;The Receiving Party agrees that breach of the obligations contained in this clause 23 may result in substantial harm to the Disclosing Party or an affiliate thereof&#59; and that the Disclosing Party is accordingly entitled to seek injunctive or other equitable relief without first exhausting any or all of its available legal remedies&#59; and that the Receiving Party will reimburse the Disclosing Party for all loss and expense, including legal costs, arising from the Receiving Party's breach of the terms of this clause 23 and the Disclosing Party enforcing its rights hereunder.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">24.&#160;&#160;&#160;&#160;FORCE MAJEURE</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1&#160;&#160;&#160;&#160;In this Agreement, &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Force Majeure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means circumstances outside the Affected Party's reasonable control which prevent or delay it from performing its obligations under this Agreement, including acts of God, flood, earthquake or other natural disaster&#59; war&#59; riot or civil commotion&#59; or strike, lockout or other labour disturbance (not including those involving the Service Provider's Team). Any failure or delay by the Service Provider in performing its obligations under this Agreement which results from a failure or delay by an agent, sub- contractor or supplier shall be regarded as due to a Force Majeure event only if that agent, sub- contractor or supplier is itself impeded by a Force Majeure event from complying with an obligation to the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.2&#160;&#160;&#160;&#160;If Aspen or the Service Provider (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Affected Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) is prevented or delayed from performing any of its obligations under this Agreement (whether in whole or in part) by reason of a Force Majeure event it shall as promptly as practicable given the nature of the event notify the other Party (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaffected Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) in writing of the circumstances constituting the Force Majeure event and shall keep the Unaffected Party regularly informed of its progress in resuming full performance of its obligations.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.3&#160;&#160;&#160;&#160;The Affected Party shall take all reasonable steps to minimise the adverse effects of the event of Force Majeure on the performance of its obligations under this Agreement and, in the case of the Service Provider, shall, to the extent feasible and practical, provide workarounds which in Aspen's reasonable opinion are satisfactory.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.4&#160;&#160;&#160;&#160;Subject to the Affected Party's compliance with its obligations under clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">24.2</a> and <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">24.3</a> above, the Affected Party shall not be treated as being in breach of this Agreement if and to the extent that its failure to perform this Agreement results from a Force Majeure event.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.5&#160;&#160;&#160;&#160;If the event of Force Majeure prevents the Affected Party from complying with this Agreement for a period of two months or more then the Unaffected Party may at the expiry of such period give notice in writing to the Affected Party to immediately terminate this Agreement. If the Service Provider is the Affected Party, it shall be under a continuing obligation to co-operate with Aspen in transferring the work to another supplier or otherwise ensuring that Aspen's business needs continue to be met despite the event of Force Majeure at Aspen's reasonable cost, to the extent applicable and only at the rates set forth for the Services herein.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.6&#160;&#160;&#160;&#160;Where following an event of Force Majeure to which this clause applies the Affected Party is able to resume performance of its obligations it shall notify the Unaffected Party accordingly and promptly resume performance of the affected obligations.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25.&#160;&#160;&#160;&#160;ASSIGNMENT AND SUBCONTRACTING&#59; DIVESTMENT</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.1&#160;&#160;&#160;&#160;The Service Provider shall not, without the prior written consent of Aspen, assign, transfer, charge, create a trust in, or deal in any other manner with all or any of its rights or obligations under this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.2&#160;&#160;&#160;&#160;The Service Provider may not sub-contract the provision of any material part of the Services without the prior written consent of Aspen, such consent not to be unreasonably withheld or delayed which as at the Effective Date shall be deemed to include all the Approved Sub- contractors. The Service Provider agrees that its subcontracts with Service Provider Subcontractors shall include robust terms broadly equivalent to those set out in this Agreement. For the avoidance of doubt, the engagement of individual subcontractors as members of theService Provider&#8217;s Team shall not be restricted by this clause and such individuals shall not be deemed to be sub-processors for the purposes of the Data Protection Legislation.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.3&#160;&#160;&#160;&#160;Notwithstanding any sub-contracting permitted under clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">25.2,</a> the Service Provider shall remain wholly liable and responsible for all acts and omissions (howsoever arising) of its sub- contractors in the performance of the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.4&#160;&#160;&#160;&#160;Aspen may assign or novate this Agreement to an Aspen Affiliate or any provider of outsourcing or third party services that is employed under a service contract to provide services to Aspen or an Aspen Affiliate.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.5&#160;&#160;&#160;&#160;At Aspen's discretion and upon notice to Service Provider of the divestment, any Divested Affiliate shall be entitled (at no additional charge to it or Aspen other than in respect of any separation costs identified and agreed pursuant to the change control procedure in clause 15) to continue to receive the Services, which it has been receiving pursuant to this Agreement (including the governance regime in Schedule 3 (Governance), for a period of up to two (2) years from the date of completion of such divestment or the date of notice whichever is later, such period to co-terminate with the Term and provided that&#58; (i) the overall liability of Service Provider under this Agreement or any Statement of Work to Aspen, the Divested Affiliate and any of the beneficiaries does not increase&#59; and (ii) the Divested Affiliate passes Service Provider's reasonable ethics and compliance checks. The Divested Affiliate shall enjoy the same Charges for the Services. Any separation costs will be agreed pursuant to the change control procedure in clause 15. Any changes to the relevant Services or additional requirements (for example, separate invoices for Aspen and Divested Affiliate) or other commercial impact (including to the Charges) resulting from the activities contemplated in this Section shall be agreed in accordance with the change control procedure in clause 15.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">26.&#160;&#160;&#160;&#160;ANTI-BRIBERY AND CORRUPTION</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Bribery</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.1&#160;&#160;&#160;&#160;Each Party shall comply with all Relevant Laws relating to anti-bribery and anti-corruption including (but not limited to) the UK Bribery Act 2010 and all relevant US requirements.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Modern Slavery</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.2&#160;&#160;&#160;&#160;Without prejudice to any other provisions in this Agreement, the Service Provider shall, and shall procure that all persons who will or may be used in performing or to support the performance of this Agreement in any part of the world (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall, at all relevant times&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.2.1&#160;&#160;&#160;&#160;comply with the provisions of the Modern Slavery Act 2015 and all Relevant Laws made under it or relating to it (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MSA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and ensure that all relevant Service Provider personnel have received appropriate training on the same&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.2.2&#160;&#160;&#160;&#160;comply with any Aspen policy relating to modern slavery and&#47;or human trafficking as is notified to the Service Provider by Aspen from time to time&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.2.3&#160;&#160;&#160;&#160;immediately notify Aspen&#8217;s Head of Procurement in writing if it has reason to believe that it or any member of its Supply Chain is in breach or is likely to breach any of the MSA or any provisions of these clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">26.2</a> to <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">26.4</a> (or would do so if it were a party to this Agreement), or if it receives a communication from any person alleging breach of any of the MSA.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.3&#160;&#160;&#160;&#160;The Service Provider shall maintain detailed, accurate and up-to-date records setting out&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.3.1&#160;&#160;&#160;&#160;its staff hiring procedures&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.3.2&#160;&#160;&#160;&#160;its supplier selection processes&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.3.3&#160;&#160;&#160;&#160;the steps it takes to ensure that it and each member of its Supply Chain is not engaged in the activities prohibited by the MSA, and shall promptly provide copies of such records to Aspen on Aspen&#8217;s request.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.4&#160;&#160;&#160;&#160;On Aspen&#8217;s reasonable request, the Service Provider shall make, and shall require any relevant member of its Supply Chain to make, such adjustments to its processes that relate to staff hiring and supplier selection as Aspen reasonably considers to be desirable to address any risk of non-compliance with the MSA.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environment</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.5&#160;&#160;&#160;&#160;The Service Provider shall ensure that its performance of the Services shall comply with all applicable environmental laws, statutes, regulations and relevant government issued guidance.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health &#38; Safety</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.6&#160;&#160;&#160;&#160;The Service Provider shall at times throughout the Term comply with all Relevant Laws relating to health and safety including (but not limited to) the Health and Safety at Work etc. Act 1974 and shall maintain a written health &#38; safety policy.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equal Opportunities</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.7&#160;&#160;&#160;&#160;The Service Provider shall at all times throughout the Term comply with all Relevant Law relating to equal opportunities, including, (but not limited to) the Equality Act 2010.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compliance with Competition Laws</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.8&#160;&#160;&#160;&#160;The Service Provider confirms that it has not colluded with any third parties in relation to the Charges and that it shall comply with all Relevant Laws relating to competition and anti-trust including (but not limited to) the UK Competition Act 1998 and all relevant US requirements.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compliance with Import&#47;Export Laws</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.9&#160;&#160;&#160;&#160;Aspen agrees to notify Service Provider of (1) any requirements for Deliverables or (2) any other technology, technical data or information to which the Service Provider will have access as a result of the Services that, in either case, will subject the Deliverables or the other technology, technical data or information to control under applicable export regulations under any classification other than EAR99 (or its non-U.S. equivalent) and, in such event, will (i) identify to the Service Provider the applicable regulations (e.g. EAR or ITAR) and classifications (e.g. ECCN) and (ii) follow such guidelines as the Service Provider may communicate to Aspen that reasonably are required to avoid violations. Subject to and except for the foregoing, the Service Provider agrees to notify Aspen of any technology, technical data or information that it will provide to Aspen pursuant to this Agreement that is subject to control under applicable export regulations under any classification other than EAR99 (or its non-U.S. equivalent) and, in such event, will (i) identify to Aspen the applicable regulations (e.g. EAR or ITAR) and classifications (e.g. ECCN) and (ii) follow such guidelines as Aspen may communicate to the Service Provider that reasonably are required to avoid violations. Subject to the foregoing the Service Provider shall comply with all Relevant Laws with respect to the Service Provider&#8217;s export and&#47;or import of systems, dual-use items, materials, data, information and technologies necessary for the provision of the Services to each Aspen Site (including those comprising the Deliverables) and with applicable embargoes, sanctions, and similar restrictions in force from time to time (including by determining and obtaining all relevant import and&#47;or export authorisations). Notwithstanding the foregoing, Aspen agrees that it will not provide the Service Provider with any technology, technical data or information that is subject to control under the International Traffic in Arms Regulations (ITAR). In the event that Aspen wishes to provide the Service Provider with ITAR-controlled technology, technical data or information, Aspen will notify the Service Provider in writing of such intent, and the Parties agree to cooperate to determine the appropriate agreements and controls, if any, required before Aspen makes such disclosure.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lloyd&#8217;s Centre of Excellence</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.10&#160;&#160;&#160;&#160;Aspen expects the Service Provider to demonstrate a commitment to developing its knowledge of the London insurance market during the Term. Accordingly, the Service Provider shall commit to&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.10.1&#160;&#160;&#160;&#160;engaging with external consultants to develop training materials and to obtain a deeper understanding of Lloyd&#8217;s of London performance standards and requirements&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.10.2&#160;&#160;&#160;&#160;developing and delivering training and certification programmes for Service Provider personnel delivering the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.10.3&#160;&#160;&#160;&#160;increasing the general pool of Service Provider staff who are familiar with Lloyd&#8217;s of London operations&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.10.4&#160;&#160;&#160;&#160;promoting the sharing of experience across the Service Provider&#8217;s and its Affiliate&#8217;s clients in the Lloyd&#8217;s of London market including by promoting opportunities for such clients to network and share experiences&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.10.5&#160;&#160;&#160;&#160;inviting Lloyd&#8217;s of London staff to participate as guest teachers &#47; lecturers&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.10.6&#160;&#160;&#160;&#160;identifying best practices across all the clients of the Service Provider and its Affiliates in the insurance sector and applying such best practice to services in areas regulated by Lloyd&#8217;s of London including by recommending enhancements to processes.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">27.&#160;&#160;&#160;&#160;DATA PROTECTION</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.1&#160;&#160;&#160;&#160;Both Parties will comply with all applicable requirements of the Data Protection Legislation. This clause 27 is in addition to, and does not relieve, remove or replace, a Party's obligations under the Data Protection Legislation.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.2&#160;&#160;&#160;&#160;The terms 'Data Controller', 'Data Processor', 'Data Subject', 'Personal Data', 'processing' and 'Sensitive Personal Data' shall have the meanings as defined in the relevant Data Protection Legislation.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.3&#160;&#160;&#160;&#160;The Parties acknowledge that for the purposes of the Data Protection Legislation, Aspen is the Data Controller and the Service Provider is the Data Processor. Schedule 1 sets out the scope, nature and purpose of processing by the Service Provider, the duration of the processing and the types of Personal Data and categories of Data Subject.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.4&#160;&#160;&#160;&#160;Without prejudice to the generality of clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">27.1,</a> Aspen will ensure that it has all necessary appropriate consents and notices in place to enable lawful transfer of the Personal Data to the Service Provider for the duration and purposes of this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5&#160;&#160;&#160;&#160;Without prejudice to the generality of clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">27.1,</a> the Service Provider shall, in relation to any Personal Data processed in connection with the performance by the Service Provider of its obligations under this Agreement&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.1&#160;&#160;&#160;&#160;process Personal Data only on the prior written instructions of Aspen including, but not limited to, with regard to transfers of Personal Data outside the region comprising the UK and the European Economic Area Member States (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Region</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), or between countries that are outside the Permitted Region, unless required by the laws of a country in the Permitted Region or of the European Union applicable to the Service Provider (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Applicable Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;). Where the Service Provider is relying on Applicable Law as the basis for processing Personal Data, the Service Provider shall notify Aspen of this as soon as such reliance is known and, in any event, before performing the processing required unless the Applicable Law prohibits the Service Provider from so notifying Aspen&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.2&#160;&#160;&#160;&#160;put in place appropriate technical and organisational measures to protect Personal Data against unauthorised or unlawful processing and against accidental loss, alteration, unauthorised disclosure or access, in particular where any processing involves the transmission of Personal Data over a network, and against all other unlawful access, disclosure, use or processing. Such measures shall include, where appropriate, pseudonymising and encrypting Personal Data in transit and at rest, implementing effective access controls such as multi-factor authentication, ensuring confidentiality, integrity, availability and resilience of systems and services, ensuring that availability of and access to Personal Data can be restored in a timely manner after an incident (i.e. back-up and disaster recovery processes), and regularly assessing and evaluating the effectiveness of the technical and organisational measures adopted&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.3&#160;&#160;&#160;&#160;ensure that access is strictly limited to those individuals who need to know &#47; access the relevant Personal Data, as strictly necessary for the purposes of this Agreement, ensuring that all such individuals are subject to confidentiality undertakings or professional or statutory obligations of confidentiality&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.4&#160;&#160;&#160;&#160;assist Aspen, in responding to any request from a Data Subject and in ensuring compliance with Aspen's obligations under the Data Protection Legislation with respect to security, breach notifications, impact assessments and consultations with supervisory authorities or regulators. The Service Provider shall not respond to any request from a Data Subject except on the written instructions of Aspen or as required by Data Protection Legislation, in which case the Service Provider shall inform Aspen of that legal requirement before it responds to any such request&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.5&#160;&#160;&#160;&#160;notify Aspen immediately (and in any event within one day) of becoming aware of any security breach and cooperate fully with Aspen in the event of any security breach to limit the unauthorised disclosure or use of data, seek the return of any Personal Data and assist in providing notice of the data breach to affected individuals if requested by Aspen. For the avoidance of doubt, data security breaches shall include, but not be limited to, data which has been accessed, disclosed, acquired, released or used without proper authorisation and contrary to the terms of this Agreement&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.6&#160;&#160;&#160;&#160;take such reasonable commercial steps as are directed by Aspen to assist in the investigation, mitigation and remediation of any such security breaches, including preserving all evidence regarding the breach and providing Aspen or its agents with access to such evidence as well as any facilities, equipment, or operations that may have been affected, together with access to all staff or contractors with knowledge of the matter and all relevant records, logs, files, data or other materials&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.7&#160;&#160;&#160;&#160;at the written direction of Aspen, delete or return Personal Data and copies thereof to Aspen on termination of this Agreement unless required by Applicable Law to store the Personal Data&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.8&#160;&#160;&#160;&#160;maintain complete and accurate records and information to demonstrate its compliance with this Agreement and allow for audits by Aspen or Aspen's designated auditor&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.9&#160;&#160;&#160;&#160;inform Aspen immediately if it thinks it has been given an instruction which doesn't comply with applicable Data Protection Legislation&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5.10&#160;&#160;&#160;&#160;not process any Personal Data outside the Permitted Region unless (1) Aspen has provided its prior written consent to this, and (2) in addition to obtaining Aspen's prior written consent, the Service Provider ensures that the transfer out of the Permitted Region is effected by way of a legally enforceable safeguarding mechanism that is permitted under the Data Protection Legislation at the time of the relevant transfer.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.6&#160;&#160;&#160;&#160;Without limiting the foregoing, Service Provider acknowledges that the Service Provider's obligations with respect to Personal Data set out in Clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">27.5.2,</a> <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">27.5.3</a> and <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">27.5.5</a> &#8211; (i) shall also apply to the same extent to any confidential, financial, material or proprietary non-public information regarding Aspen or its business received by Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.7&#160;&#160;&#160;&#160;For the purposes of the Data Protection Legislation, the Service Provider agrees, and will procure that the Service Provider's Team agrees, to Aspen holding and processing (both electronically and manually) Personal Data provided by the Service Provider or the Service Provider's Team to Aspen for purposes relating to the Service Provider's engagement and the operation, management, security and administration of Aspen's businesses.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.8&#160;&#160;&#160;&#160;The Service Provider shall indemnify Aspen and its Affiliates in respect of any of the Service Provider's failures to comply with any Data Protection Legislation provisions, any other breach of the data protection obligations contained in this Agreement or where it has acted without Aspen's lawful instructions, or against Aspen's instructions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.9&#160;&#160;&#160;&#160;The Service Provider shall not appoint a third-party processor of Personal Data without Aspen's prior written consent. In the case of Aspen's written authorisation, the Service Provider shall&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.9.1&#160;&#160;&#160;&#160;inform Aspen of any intended changes concerning the addition or replacement of third party processors, thereby giving Aspen the opportunity to object to such changes&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.9.2&#160;&#160;&#160;&#160;confirm that it has entered or (as the case may be) will enter into a written agreement with the third-party processor incorporating terms which are substantially similar to those set out in this clause 27&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.9.3&#160;&#160;&#160;&#160;indemnify Aspen and its Affiliates, and remain fully liable for all acts or omissions of any third-party processor(s) appointed by it.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.&#160;&#160;&#160;&#160;THIRD PARTY RIGHTS</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.1&#160;&#160;&#160;&#160;This Agreement does not create any rights or benefits enforceable by any person not a Party to it except that an Aspen Affiliate or a person who under clause 25 is a permitted successor or assignee, novatee or transferee of the rights or benefits of a Party, may enforce such rights or benefits.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">29.&#160;&#160;&#160;&#160;REGULATORY MATTERS AND AUDIT RIGHTS</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;&#160;&#160;&#160;Without prejudice to the generality of clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">3.2&#58;</a></font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1.1&#160;&#160;&#160;&#160;the Service Provider shall comply with all Service Provider Applicable Regulations&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1.2&#160;&#160;&#160;&#160;Aspen may notify the Service Provider&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;of any Aspen Applicable Regulations it specifically requires the Service Provider to comply with (including any requirements set out in the Performance Metrics to either comply with Aspen Applicable Regulations referenced there or to ensure compliance with Aspen Applicable Regulations by following certain policies or procedures)&#59; and&#47;or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;if it requires compliance with what would otherwise be a Service Provider Applicable Regulation in a Aspen specific way (such specific compliance becoming compliance with a Aspen Applicable Regulation for the purposes of this Agreement and the definition of Service Provider Applicable Regulation).</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once any such Aspen Applicable Regulations are identified the Parties will agree how they are to be complied with. For the avoidance of doubt, such notifications under clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.1.2</a> may relate to compliance with Aspen Applicable Regulations in any jurisdictions worldwide in which Aspen or Aspen Affiliates operate or do business from time to time.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2&#160;&#160;&#160;&#160;The Service Provider recognises that Aspen and Aspen Affiliates are subject to regulation by (or have regulatory responsibilities in respect of) the regulatory authorities in the jurisdictions in which it operates and that, in particular, Aspen has regulatory responsibilities in respect of&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.1&#160;&#160;&#160;&#160;the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.2&#160;&#160;&#160;&#160;the Financial Conduct Authority, the Prudential Regulation Authority and Lloyd&#8217;s of London&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.3&#160;&#160;&#160;&#160;the Bermuda Monetary Authority&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.4&#160;&#160;&#160;&#160;North Dakota Department of Insurance and the Texas Department of Insurance&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.5&#160;&#160;&#160;&#160;the Jersey Financial Services Commission&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.6&#160;&#160;&#160;&#160;the Swiss Financial Market Supervisory Authority&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.7&#160;&#160;&#160;&#160;the Monetary Authority of Singapore&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.8&#160;&#160;&#160;&#160;The Australian Prudential Regulation Authority&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.9&#160;&#160;&#160;&#160;the Central Bank of Ireland&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.10&#160;&#160;&#160;&#160;the Office of the Superintendent of Financial Institutions&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.11&#160;&#160;&#160;&#160;the successor organisations&#47;regulators of each entity listed in clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.2.1</a> to <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.2.9</a> from time to time&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2.12&#160;&#160;&#160;&#160;various other relevant governmental agencies or bodies around the world.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.3&#160;&#160;&#160;&#160;The Service Provider shall make any modifications to the Services as reasonably necessary as a result of changes to Service Provider Applicable Regulations at no extra cost to Aspen. Where the relevant modification is required to address a change in Aspen Applicable Regulations or a change in the applicable regulatory authorities in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.2</a> the effect on cost and delivery shall be assessed and agreed via the change control procedure set out in clause 15 of this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.4&#160;&#160;&#160;&#160;Subject to clause 23 (Confidentiality) and the applicable terms in clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.5</a> to <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.14</a> (External Audits), the Service Provider shall provide such cooperation with all applicable regulatory authorities as may reasonably be requested by Aspen or otherwise required by such authorities and in any event shall cooperate with both Aspen and any regulatory authorities in responding to any enquiries made by such authorities. Such cooperation shall be provided at Aspen's reasonable cost. The Service Provider's obligations under this clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.4</a> shall include&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.4.1&#160;&#160;&#160;&#160;providing, on request, such assistance as Aspen may reasonably require to prove its compliance with its regulatory requirements in the context of the Services&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.4.2&#160;&#160;&#160;&#160;providing to Aspen such information and&#47;or documentation as a regulatory authority may request in its supervision of the performance of the Services and it consents to such information and documentation being passed on to the relevant regulatory authority&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.4.3&#160;&#160;&#160;&#160;in addition to Aspen's own audit rights hereunder, permitting a regulator to carry out audits of Service Provider where such regulator requires the right to do so.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">External Audits</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.5&#160;&#160;&#160;&#160;Aspen (or its nominee) shall be entitled to audit the Service Provider's conformance with its obligations under the Agreement (including to verify the Charges) and the relevant Service Provider's facilities in each case in respect of the Services provided to Aspen and its Affiliates, during business hours up to a maximum of two (2) times per year in aggregate for all audits under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">this clause </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(at no charge) on reasonable written notice (which shall, other than in the case of an emergency or regulatory audit, be no less than one (1) month), provided that the audit is carried out subject to clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.6,</a> <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.7</a> and <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.12&#59;</a> the auditor is not a direct competitor of the Service Provider&#59; and the auditor enters into a confidentiality agreement with Aspen on terms no less onerous than those set out in clause 23 (Confidentiality). For the avoidance of doubt, the audit departments of the &#34;Big 4&#34; accountancy firms are not direct competitors of the Service Provider, provided that they sign a confidentiality agreement with the Service Provider, including the obligation to put in place appropriate ethical walls between their audit departments and those </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">parts of their business which provide business and technology consulting and services, to ensure that all information obtained by their audit department is not disclosed to parts of their business which may compete with the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.6&#160;&#160;&#160;&#160;The Service Provider shall provide all reasonable co-operation with any audits conducted pursuant to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.5</a> and Aspen shall use its reasonable endeavours to seek to&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.6.1&#160;&#160;&#160;&#160;minimise any disruption to the Services&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.6.2&#160;&#160;&#160;&#160;consolidate such audits for each aspect of the Services and the Premises, where possible.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.7&#160;&#160;&#160;&#160;In conducting an audit, Aspen (or its nominee) shall comply with the Service Provider's reasonable security and confidentiality procedures and shall not be permitted to have unsupervised access to the Service Provider's shared facilities and systems. The Service Provider shall be entitled to reasonable relief if there is any disruption to the Services as a direct result of Aspen carrying out an audit.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.8&#160;&#160;&#160;&#160;Subject to the restrictions in clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.5,</a> <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.6</a> and <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.7</a> (other than in relation to the frequency of audits), Aspen (or its nominee) shall be entitled to undertake no more than one (1) further audit in that same year across the Agreement as a whole, (with the Service Provider providing all reasonable co-operation) at its own cost (at the Service Provider's relevant day rate), unless such audits reveal fraud or a breach (other than a minor or cosmetic breach) of the Agreement (including all instances of overcharging), in which case the cost of the audit shall be borne by the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.9&#160;&#160;&#160;&#160;If, as a result of an audit, it is determined that the Service Provider has overcharged Aspen, Aspen shall notify the Service Provider of the amount of such overcharge and the Service Provider shall promptly, and in any event no later than thirty (30) days from the date of receipt of notice of overcharge, pay to Aspen the amount of the overcharge interest at a rate of &#91;***&#93; until the date of payment to Aspen.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.10&#160;&#160;&#160;&#160;In the event any such audit by Aspen or its agents reveals an overcharge to Aspen by the Service Provider of &#91;***&#93;, the Service Provider shall reimburse Aspen for the cost of such audit in addition to the repayment of the sum plus interest at the rate set out above.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.11&#160;&#160;&#160;&#160;The Service Provider agrees that the restrictions on the number of audits and the notice period for such audits set out in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.5</a> will not apply to audits required for legal or regulatory reasons. Such audits shall be conducted at Aspen's cost where the number set out in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.5</a> has been exceeded.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.12&#160;&#160;&#160;&#160;If any audit by an auditor designated by Aspen or a regulatory authority having jurisdiction over Aspen results in Aspen being notified that it is not in compliance with any generally accepted accounting principle or audit requirement relating to the Services, then provided that the non- compliance resulted from the Service Provider's default, the Service Provider shall, at its own expense and within the period of time specified by such auditor or regulatory authority, bring the Services into compliance. If the Service Provider fails to bring the Services into compliance within a reasonable time Aspen shall be entitled to terminate this Agreement under clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">18.5.1</a> on the grounds of the Service Provider's irremediable material breach of contract on the provision of written notice.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.13&#160;&#160;&#160;&#160;The Service Provider shall maintain and retain in a manner that complies with Good Industry Practice accurate records (including complete financial records of its operations and activities specifically related to the Services) in relation to the provision of the Services provided to Aspen </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the Term for seven (7) years after the termination or expiry of the Agreement and make the same available to Aspen and its auditors.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.14&#160;&#160;&#160;&#160;The Service Provider shall provide all reasonable assistance and information in relation to the conduct of the audit at its own cost. For the avoidance of doubt such information shall not include the provision of any background cost or overhead information or any of the Service Provider internal reports relating to the Services (although the Service Provider shall act reasonably in this regard).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.15&#160;&#160;&#160;&#160;Operational Risk&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.15.1&#160;&#160;&#160;&#160;Service Provider must notify Aspen immediately when Service Provider becomes aware of the potential for or a material deficiency in the provision of the Services or this Agreement, including in relation to conformity to the Performance Metrics and compliance with applicable laws and regulatory requirements (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operational Risk</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;).</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.15.2&#160;&#160;&#160;&#160;Aspen will inform Service Provider immediately when Aspen becomes aware of an Operational Risk in the provision of the Services or this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.15.3&#160;&#160;&#160;&#160;Service Provider will register and maintain a risk register of all Operational Risks raised by either Service Provider or Aspen.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.15.4&#160;&#160;&#160;&#160;Within five (5) working days of the Operational Risk being registered in the risk register Service Provider will provide, for agreement with Aspen, a mitigation plan to mitigate the Operational Risk.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internal Audit</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.16&#160;&#160;&#160;&#160;The Service Provider shall establish and maintain a system of internal audits to provide management with assurance that a quality assurance system is being utilised, is effective, meets customer and business needs and continues to improve (&#34;Internal Audits&#34;).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.17&#160;&#160;&#160;&#160;The Service Provider shall maintain internal controls lists in a manner consistent with Good Industry Practice and provide confirmation of the same at least once per year.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.18&#160;&#160;&#160;&#160;Where specifically requested by Aspen, the Service Provider shall also provide a copy of its&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.18.1&#160;&#160;&#160;&#160;internal independent audit reports concerning (i) International Standard on Assurance Engagements No. 3402 (ISAE 3402) Assurance Reports on Controls at a Service Organisation, (ii) HIPAA and (iii) PCI DSS&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.18.2&#160;&#160;&#160;&#160;Statement on Standards for Attestation Engagements No. 18 (SSAE 18)&#59; and&#47;or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.18.3&#160;&#160;&#160;&#160;SOC 2 Type 2 Report prepared in accordance with AT-C320 issued by the AICPA, to Aspen within a reasonable time after any such reports are completed (provided the Service Provider is not required to provide copies of reports which cover or refer to other clients of the Service Provider) and shall make all documents regarding such audits available to any applicable Regulator, to Aspen within a reasonable time after any such reports are completed. If Service Provider does not undertake such internal audits then Aspen acknowledges it shall have no right to require the same pursuant to this clause.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.19&#160;&#160;&#160;&#160;Should any Internal Audit identify an overcharge, the provisions of clauses <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.9</a> and <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">29.10</a> shall apply.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">30.&#160;&#160;&#160;&#160;DISPUTE RESOLUTION PROCEDURE</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.1&#160;&#160;&#160;&#160;Disputes relating to this Agreement will be escalated in accordance with paragraph 9 of Schedule 3 (Governance).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.2&#160;&#160;&#160;&#160;If the matter in dispute has not been resolved within 30 days of the commencement of the discussions and negotiations described in clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">30.1,</a> either Party shall be entitled to refer the dispute to a mediator to be agreed by both Parties or, in default of such agreement, to be appointed by the Centre for Effective Dispute Resolution, to attempt resolution by way of mediation.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.3&#160;&#160;&#160;&#160;Subject always to clause <a href="#i40225d583f4044f2961e6f90cadc8d7c_1" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">30.5,</a> in the event that the Parties are unable to resolve a dispute within 60 days of the commencement of the mediation, either Party may (but shall not be obliged to) issue legal proceedings.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.4&#160;&#160;&#160;&#160;The Service Provider shall continue to supply the Services and Aspen shall continue to pay undisputed invoices in accordance with the terms of this Agreement until a dispute has been resolved.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.5&#160;&#160;&#160;&#160;Nothing in this clause 30 shall prevent either Party from applying at any time for injunctive or other equitable relief on the grounds of breach, or threatened breach, of the other Party's obligations of confidentiality contained in clause 23 of this Agreement or on the grounds of infringement, or threatened infringement, of the applicant's Intellectual Property Rights.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">31.&#160;&#160;&#160;&#160;PUBLICITY</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1&#160;&#160;&#160;&#160;The Service Provider shall not publicise the terms or existence of this Agreement or use the name of Aspen or an Aspen Affiliate or any trade name or trade mark used by Aspen, or refer to Aspen in any other way in any promotional literature, publications or advertising material without the prior written consent of Aspen.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">32.&#160;&#160;&#160;&#160;CORPORATE SOCIAL RESPONSIBILITY</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1&#160;&#160;&#160;&#160;The Service Provider shall&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1.1&#160;&#160;&#160;&#160;ensure that it complies, and its sub-contractors comply, with the provisions of the International Labour Organisation's core standards&#59; the provisions of the United Nations Universal Declaration of Human Rights&#59; and the provisions of the Modern Slavery Act 2015 in respect of both its direct employees and its suppliers and ensure that neither it nor its supply chain makes use of slavery, forced or bonded labour or human trafficking&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1.2&#160;&#160;&#160;&#160;ensure that it and its suppliers demonstrate a set of environmental standards with a commitment to environmentally sustainable working practices and materials&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1.3&#160;&#160;&#160;&#160;ensure that its staff and any agents and contractors employed by it in respect of this Agreement will comply with appropriate ethical standards&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1.4&#160;&#160;&#160;&#160;ensure that it does not, whether as an employer or supplier of the Services, engage in any act or omission that would contravene the Equality Legislation and takes all reasonable endeavours to ensure that the Service Provider's Team does not unlawfully discriminate within the meaning of the Equality Legislation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">33.&#160;&#160;&#160;&#160;HEALTH AND SAFETY</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.1&#160;&#160;&#160;&#160;The Service Provider shall ensure that it and the Service Provider's Team at all times comply strictly with the provisions of all statutory and regulatory provisions applicable to the Services. The Service Provider shall ensure that it does nothing to cause Aspen to be in breach of same.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.2&#160;&#160;&#160;&#160;The Service Provider shall supply to Aspen written evidence that any necessary assessments for works and activities comprising or relating to the Services under statute or regulation have been carried out and that appropriate actions necessary as a result of such assessments have been taken before the commencement of the Services.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.3&#160;&#160;&#160;&#160;The Service Provider will do nothing which might reasonably be expected to place Aspen or an Aspen Affiliate in breach of its obligations owed to a landlord or owner of the Premises.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.4&#160;&#160;&#160;&#160;Each Party shall supply to the other any appropriate information to enable the other to meet its obligations under all applicable statutory and regulatory provisions and all leases and property rental agreements.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">34.&#160;&#160;&#160;&#160;RELATIONSHIP OF THE PARTIES</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.1&#160;&#160;&#160;&#160;Nothing in this Agreement shall create, or be deemed to create, a partnership or joint venture between the Parties, or make a Party the agent or representative of the other Party except as expressly stated.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.2&#160;&#160;&#160;&#160;It is understood and agreed that in the performance of the Service Provider's duties under this Agreement each member of the Service Provider&#8217;s Team will be an employee or contractor of the Service Provider and that nothing in this Agreement shall be construed as creating any contract of employment pursuant to the Employment Rights Act 1996 (including any amending or replacement legislation in the field of employee's rights from time to time) or the relationship of principal and agent between Aspen and any member of the Service Provider's Team or the Service Provider. In particular but without prejudice to the generality of the foregoing, no member of the Service Provider's Team will be covered by, nor will any member of the Service Provider's Team seek, any personal accident, medical or other insurance policies or any other benefits which Aspen provides or may provide for its employees.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.3&#160;&#160;&#160;&#160;Unless specifically authorised in writing by Aspen, neither the Service Provider nor Service Provider's Team will make any purchase or incur any liability on behalf of Aspen or pledge the credit of Aspen or in any way bind Aspen or do anything likely to cause third parties to consider the Service Provider or Service Provider's Team as acting as an agent of Aspen.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">35.&#160;&#160;&#160;&#160;NON-SOLICITATION</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35.1&#160;&#160;&#160;&#160;During the course of this agreement and until the expiry of six months from the earlier of the date of termination of this Agreement or the date on which a Relevant Person ceases to be a Party's employee or contractor, neither Aspen nor the Service Provider shall directly or indirectly (either alone or jointly or in partnership with any other person, firm or company) induce or seek to induce any such Relevant Person to leave the other's employment or to cease to be a contractor to such Party.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35.2&#160;&#160;&#160;&#160;Nothing in this clause shall prevent either Party from placing job advertisements in the general press or from making offers of employment to any Relevant Person in response to unsolicited enquiries.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">36.&#160;&#160;&#160;&#160;GENERAL</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.1&#160;&#160;&#160;&#160;Any waiver of a breach of any provision of this Agreement shall not be considered as a waiver of any subsequent breach of the same of any other provision.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.2&#160;&#160;&#160;&#160;Any variation to this Agreement must be in writing and signed on behalf of both Aspen and the Service Provider.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.3&#160;&#160;&#160;&#160;Notice given under this Agreement shall be in writing (including by email), sent for the attention of the other Party's nominated representative (Aspen's Contract Manager or the Service Provider Contract Manager, as the case may be), and shall be delivered in person or sent by email or by registered post or recorded delivery.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.4&#160;&#160;&#160;&#160;This Agreement shall be governed by and construed in accordance with English law and the Parties submit to the exclusive jurisdiction of the English courts.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.5&#160;&#160;&#160;&#160;This Agreement sets out the entire agreement and understanding between the Parties relating to the Services to be provided and replaces any prior correspondence or representations.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47</font></div></div></div><div id="i40225d583f4044f2961e6f90cadc8d7c_116"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.314%"><tr><td style="width:1.0%"></td><td style="width:5.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNED </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for and on behalf of</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aspen Insurance UK Services Limited</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Rob Houghton </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Signature) </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; Rob Houghton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Group COO</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; June 1, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNED </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for and on behalf of</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mindtree Limited</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Amit Shinde</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Signature) </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; Amit Shinde </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Associate </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General Counsel</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 27, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>38
<FILENAME>exhibit211-fx1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4c6b5e695955431e8d071ca0c4107731_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Exhibit 21.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARIES OF THE COMPANY</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">NAME OF SUBSIDIARY</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">JURISDICTION OF INCORPORATION</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Acorn Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bermuda</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">APJ Asset Protection Jersey Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Jersey</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen (UK) Holdings Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen (US) Holdings Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen American Insurance Company</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Texas</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Australia Service Company Pty Ltd</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Australia</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Bermuda Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bermuda</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Capital Management, Ltd</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bermuda</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Cat Fund Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bermuda</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen European Holdings Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Insurance U.S. Services Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Insurance UK Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Insurance UK Services Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Managing Agency Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Re America, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Risk Management Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Singapore Pte. Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Specialty Insurance Company</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">North Dakota</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Specialty Insurance Management, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Specialty Insurance Solutions LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">California</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen U.S. Holdings, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen UK Syndicate Services Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aspen Underwriting Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Blue Waters Insurers, Corp.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Puerto Rico</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Peregrine Reinsurance Ltd</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bermuda</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Silverton Re Ltd.</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.62pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bermuda</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>39
<FILENAME>exhibit231-fx1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6d474ddeb5b9480993a572bcf72f625a_34"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the use of our report dated May 16, 2022, with respect to the consolidated financial statements of Aspen Insurance Holdings Limited, included herein</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and to the reference to our firm under the heading &#8220;Experts&#8221; in the prospectus.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; KPMG LLP</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">London, United Kingdom</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 20, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>40
<FILENAME>exhibit232-fx1.htm
<DESCRIPTION>EX-23.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i81579700e9e34cd5810701beada2e655_34"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.2</font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#333333;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:24pt;text-indent:18pt"><font style="color:#333333;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">We consent to the reference to our firm under the caption &#34;Experts&#34; in the Registration Statement (Form F-1) and related Prospectus of Aspen Insurance Holdings Limited for the registration of ordinary shares, and to the inclusion therein of our report dated April 20, 2023, with respect to the consolidated financial statements of Aspen Insurance Holdings Limited, included in the Registration Statement and related Prospectus.</font></div><div style="margin-bottom:24pt"><font style="color:#333333;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font style="color:#333333;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">London, United Kingdom</font></div><div style="margin-bottom:12pt"><font style="color:#333333;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">December 20, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>41
<FILENAME>ahl-20231220.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:c8bdf706-6073-4046-a439-e42c560d7bb0,g:8520f5b6-a319-4843-ab2c-4a3e439c5aeb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ahl="http://www.aspen.co/20231220" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.aspen.co/20231220">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ahl-20231220_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ahl-20231220_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ahl-20231220_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ahl-20231220_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.aspen.co/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical" roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME" roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME">
        <link:definition>0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS_1" roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS_1">
        <link:definition>0000007 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1" roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1">
        <link:definition>0000008 - Statement - CONSOLIDATED BALANCE SHEETS Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1" roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY_1" roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY_1">
        <link:definition>0000010 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1" roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1">
        <link:definition>0000011 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HistoryandOrganization" roleURI="http://www.aspen.co/role/HistoryandOrganization">
        <link:definition>0000012 - Disclosure - History and Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPreparationandSignificantAccountingPolicies" roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPolicies">
        <link:definition>0000013 - Disclosure - Basis of Preparation and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.aspen.co/role/SegmentReporting">
        <link:definition>0000014 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.aspen.co/role/Investments">
        <link:definition>0000015 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://www.aspen.co/role/VariableInterestEntities">
        <link:definition>0000016 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.aspen.co/role/FairValueMeasurements">
        <link:definition>0000017 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Reinsurance" roleURI="http://www.aspen.co/role/Reinsurance">
        <link:definition>0000018 - Disclosure - Reinsurance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContracts" roleURI="http://www.aspen.co/role/DerivativeContracts">
        <link:definition>0000019 - Disclosure - Derivative Contracts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredPolicyAcquisitionCosts" roleURI="http://www.aspen.co/role/DeferredPolicyAcquisitionCosts">
        <link:definition>0000020 - Disclosure - Deferred Policy Acquisition Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpenses" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpenses">
        <link:definition>0000021 - Disclosure - Reserves for Losses and Adjustment Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.aspen.co/role/IncomeTaxes">
        <link:definition>0000022 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructure" roleURI="http://www.aspen.co/role/CapitalStructure">
        <link:definition>0000023 - Disclosure - Capital Structure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatutoryRequirementsandDividendsRestrictions" roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictions">
        <link:definition>0000024 - Disclosure - Statutory Requirements and Dividends Restrictions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Dividends" roleURI="http://www.aspen.co/role/Dividends">
        <link:definition>0000025 - Disclosure - Dividends</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlans" roleURI="http://www.aspen.co/role/RetirementPlans">
        <link:definition>0000026 - Disclosure - Retirement Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsandLongTermIncentivePlan" roleURI="http://www.aspen.co/role/ShareBasedPaymentsandLongTermIncentivePlan">
        <link:definition>0000027 - Disclosure - Share-Based Payments and Long-Term Incentive Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://www.aspen.co/role/IntangibleAssetsandGoodwill">
        <link:definition>0000028 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesNotes" roleURI="http://www.aspen.co/role/OperatingLeasesNotes">
        <link:definition>0000029 - Disclosure - Operating Leases (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.aspen.co/role/RelatedPartyTransactions">
        <link:definition>0000030 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.aspen.co/role/CommitmentsandContingencies">
        <link:definition>0000031 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationofCreditRisk" roleURI="http://www.aspen.co/role/ConcentrationofCreditRisk">
        <link:definition>0000032 - Disclosure - Concentration of Credit Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReclassificationsfromAccumulatedOtherComprehensiveIncome" roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncome">
        <link:definition>0000033 - Disclosure - Reclassifications from Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilitiesandShorttermDebt" roleURI="http://www.aspen.co/role/CreditFacilitiesandShorttermDebt">
        <link:definition>0000034 - Disclosure - Credit Facilities and Short-term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditLosses" roleURI="http://www.aspen.co/role/CreditLosses">
        <link:definition>0000035 - Disclosure - Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.aspen.co/role/SubsequentEvents">
        <link:definition>0000036 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIInvestments" roleURI="http://www.aspen.co/role/ScheduleIInvestments">
        <link:definition>0000037 - Disclosure - Schedule I - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIICondensedFinancialInformationofRegistrant" roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrant">
        <link:definition>0000038 - Disclosure - Schedule II - Condensed Financial Information of Registrant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIISupplementaryInsuranceInformation" roleURI="http://www.aspen.co/role/ScheduleIIISupplementaryInsuranceInformation">
        <link:definition>0000039 - Disclosure - Schedule III - Supplementary Insurance Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIVReinsurance" roleURI="http://www.aspen.co/role/ScheduleIVReinsurance">
        <link:definition>0000040 - Disclosure - Schedule IV - Reinsurance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleVValuationandQualifyingAccounts" roleURI="http://www.aspen.co/role/ScheduleVValuationandQualifyingAccounts">
        <link:definition>0000041 - Disclosure - Schedule V - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HistoryandOrganization_1" roleURI="http://www.aspen.co/role/HistoryandOrganization_1">
        <link:definition>0000042 - Disclosure - History and Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPreparationandSignificantAccountingPolicies_1" roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPolicies_1">
        <link:definition>0000043 - Disclosure - Basis of Preparation and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting_1" roleURI="http://www.aspen.co/role/SegmentReporting_1">
        <link:definition>0000044 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments_1" roleURI="http://www.aspen.co/role/Investments_1">
        <link:definition>0000045 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements_1" roleURI="http://www.aspen.co/role/FairValueMeasurements_1">
        <link:definition>0000046 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Reinsurance_1" roleURI="http://www.aspen.co/role/Reinsurance_1">
        <link:definition>0000047 - Disclosure - Reinsurance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContracts_1" roleURI="http://www.aspen.co/role/DerivativeContracts_1">
        <link:definition>0000048 - Disclosure - Derivative Contracts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpenses_1" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpenses_1">
        <link:definition>0000049 - Disclosure - Reserves for Losses and Adjustment Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructure_1" roleURI="http://www.aspen.co/role/CapitalStructure_1">
        <link:definition>0000050 - Disclosure - Capital Structure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Dividends_1" roleURI="http://www.aspen.co/role/Dividends_1">
        <link:definition>0000051 - Disclosure - Dividends</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions_1" roleURI="http://www.aspen.co/role/RelatedPartyTransactions_1">
        <link:definition>0000052 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies_1" roleURI="http://www.aspen.co/role/CommitmentsandContingencies_1">
        <link:definition>0000053 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationofCreditRisk_1" roleURI="http://www.aspen.co/role/ConcentrationofCreditRisk_1">
        <link:definition>0000054 - Disclosure - Concentration of Credit Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReclassificationsfromAccumulatedOtherComprehensiveIncome_1" roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncome_1">
        <link:definition>0000055 - Disclosure - Reclassifications from Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents_1" roleURI="http://www.aspen.co/role/SubsequentEvents_1">
        <link:definition>0000056 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies" roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies">
        <link:definition>0000057 - Disclosure - Basis of Preparation and Significant Accounting Policies Basis of Preparation and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies_1" roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies_1">
        <link:definition>0000058 - Disclosure - Basis of Preparation and Significant Accounting Policies Basis of Preparation and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.aspen.co/role/SegmentReportingTables">
        <link:definition>0000059 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.aspen.co/role/InvestmentsTables">
        <link:definition>0000060 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.aspen.co/role/FairValueMeasurementsTables">
        <link:definition>0000061 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceTables" roleURI="http://www.aspen.co/role/ReinsuranceTables">
        <link:definition>0000062 - Disclosure - Reinsurance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsTables" roleURI="http://www.aspen.co/role/DerivativeContractsTables">
        <link:definition>0000063 - Disclosure - Derivative Contracts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredPolicyAcquisitionCostsTables" roleURI="http://www.aspen.co/role/DeferredPolicyAcquisitionCostsTables">
        <link:definition>0000064 - Disclosure - Deferred Policy Acquisition Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesTables" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesTables">
        <link:definition>0000065 - Disclosure - Reserves for Losses and Adjustment Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.aspen.co/role/IncomeTaxesTables">
        <link:definition>0000066 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureTables" roleURI="http://www.aspen.co/role/CapitalStructureTables">
        <link:definition>0000067 - Disclosure - Capital Structure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatutoryRequirementsandDividendsRestrictionsTables" roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsTables">
        <link:definition>0000068 - Disclosure - Statutory Requirements and Dividends Restrictions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DividendsTables" roleURI="http://www.aspen.co/role/DividendsTables">
        <link:definition>0000069 - Disclosure - Dividends (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://www.aspen.co/role/IntangibleAssetsandGoodwillTables">
        <link:definition>0000070 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.aspen.co/role/OperatingLeasesTables">
        <link:definition>0000071 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.aspen.co/role/CommitmentsandContingenciesTables">
        <link:definition>0000072 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationofCreditRiskTables" roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskTables">
        <link:definition>0000073 - Disclosure - Concentration of Credit Risk (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables">
        <link:definition>0000074 - Disclosure - Reclassifications from Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityandShorttermDebtTables" roleURI="http://www.aspen.co/role/CreditFacilityandShorttermDebtTables">
        <link:definition>0000075 - Disclosure - Credit Facility and Short-term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditLossesTables" roleURI="http://www.aspen.co/role/CreditLossesTables">
        <link:definition>0000076 - Disclosure - Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables_1" roleURI="http://www.aspen.co/role/SegmentReportingTables_1">
        <link:definition>0000077 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables_1" roleURI="http://www.aspen.co/role/InvestmentsTables_1">
        <link:definition>0000078 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables_1" roleURI="http://www.aspen.co/role/FairValueMeasurementsTables_1">
        <link:definition>0000079 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceTables_1" roleURI="http://www.aspen.co/role/ReinsuranceTables_1">
        <link:definition>0000080 - Disclosure - Reinsurance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsTables_1" roleURI="http://www.aspen.co/role/DerivativeContractsTables_1">
        <link:definition>0000081 - Disclosure - Derivative Contracts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesTables_1" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesTables_1">
        <link:definition>0000082 - Disclosure - Reserves for Losses and Adjustment Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureTables_1" roleURI="http://www.aspen.co/role/CapitalStructureTables_1">
        <link:definition>0000083 - Disclosure - Capital Structure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DividendsTables_1" roleURI="http://www.aspen.co/role/DividendsTables_1">
        <link:definition>0000084 - Disclosure - Dividends (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables_1" roleURI="http://www.aspen.co/role/CommitmentsandContingenciesTables_1">
        <link:definition>0000085 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationofCreditRiskTables_1" roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskTables_1">
        <link:definition>0000086 - Disclosure - Concentration of Credit Risk (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables_1" roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables_1">
        <link:definition>0000087 - Disclosure - Reclassifications from Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPreparationandSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>0000088 - Disclosure - Basis of Preparation and Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingAdditionalInformationNarrativeDetails" roleURI="http://www.aspen.co/role/SegmentReportingAdditionalInformationNarrativeDetails">
        <link:definition>0000089 - Disclosure - Segment Reporting - Additional Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails" roleURI="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails">
        <link:definition>0000090 - Disclosure - Segment Reporting - Summary of Gross and Net Written and Earned Premiums, Underwriting Results, Ratios and Reserves for Each of Company's Business Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryoftheScheduleoftheCompanysgrosswrittenpremiumsbasedonthelocationoftheinsuredriskDetails" roleURI="http://www.aspen.co/role/SegmentReportingSummaryoftheScheduleoftheCompanysgrosswrittenpremiumsbasedonthelocationoftheinsuredriskDetails">
        <link:definition>0000091 - Disclosure - Segment Reporting - Summary of the Schedule of the Company's gross written premiums based on the location of the insured risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryofInvestmentIncomeDetails" roleURI="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails">
        <link:definition>0000092 - Disclosure - Investments - Summary of Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails" roleURI="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails">
        <link:definition>0000093 - Disclosure - Investments - Net Realized and Unrealized Investment Gains and Losses and Change in Unrealized Gains and Losses on Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails" roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails">
        <link:definition>0000094 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Estimated Fair Value of Available for Sale Investments in Fixed Income Maturities and Short-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails" roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails">
        <link:definition>0000095 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Estimated Fair Value of Trading Investments in Fixed Income Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails" roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails">
        <link:definition>0000096 - Disclosure - Investments Investments - Distribution of Commercial Mortgage and Middle Market Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsLoantoValueRatiosDetails" roleURI="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails">
        <link:definition>0000097 - Disclosure - Investments Investments - Loan-to-Value Ratios (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails" roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails">
        <link:definition>0000098 - Disclosure - Investments Investments - Debt Service and Fixed Charge Coverage Ratios (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsOtherInvestmentsDetails" roleURI="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails">
        <link:definition>0000099 - Disclosure - Investments - Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryofFixedMaturitiesDetails" roleURI="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails">
        <link:definition>0000100 - Disclosure - Investments - Summary of Fixed Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails" roleURI="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails">
        <link:definition>0000101 - Disclosure - Investments - Aggregate Fair Value and Gross Unrealized Loss by Type of Security (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAdditionalInformationNarrativeDetails" roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails">
        <link:definition>0000102 - Disclosure - Investments - Additional Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAdditionalInformationNarrativeDetails_1" roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_1">
        <link:definition>0000102 - Disclosure - Investments - Additional Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesNarrativeDetails" roleURI="http://www.aspen.co/role/VariableInterestEntitiesNarrativeDetails">
        <link:definition>0000103 - Disclosure - Variable Interest Entities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails" roleURI="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails">
        <link:definition>0000104 - Disclosure - Fair Value Measurements - Financial Assets Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3InputsDetails" roleURI="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails">
        <link:definition>0000105 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails" roleURI="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails">
        <link:definition>0000106 - Disclosure - Fair Value Measurements Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsInputsUsedDetails" roleURI="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails">
        <link:definition>0000107 - Disclosure - Fair Value Measurements - Inputs Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationNarrativeDetails" roleURI="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails">
        <link:definition>0000108 - Disclosure - Fair Value Measurements - Additional Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails" roleURI="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails">
        <link:definition>0000109 - Disclosure - Reinsurance - Summary of Assumed and Ceded Reinsurance on Premiums Written, Premiums Earned and Insurance Losses and Loss Adjustment Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceAdditionalInformationDetails" roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails">
        <link:definition>0000110 - Disclosure - Reinsurance - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceAdditionalInformationDetails_1" roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_1">
        <link:definition>0000110 - Disclosure - Reinsurance - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsFairValueofDerivativeInstrumentsDetails" roleURI="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails">
        <link:definition>0000111 - Disclosure - Derivative Contracts - Fair Value of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails" roleURI="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails">
        <link:definition>0000112 - Disclosure - Derivative Contracts - Gain/(Loss) Recognized in Income on Derivative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsAdditionalInformationDetails" roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails">
        <link:definition>0000113 - Disclosure - Derivative Contracts - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredPolicyAcquisitionCostsDetails" roleURI="http://www.aspen.co/role/DeferredPolicyAcquisitionCostsDetails">
        <link:definition>0000114 - Disclosure - Deferred Policy Acquisition Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails">
        <link:definition>0000115 - Disclosure - Reserves for Losses and Adjustment Expenses - Reconciliation of Beginning and Ending Consolidated Loss and Loss Adjustment Expenses (LAE) Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_1" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_1">
        <link:definition>0000115 - Disclosure - Reserves for Losses and Adjustment Expenses - Reconciliation of Beginning and Ending Consolidated Loss and Loss Adjustment Expenses (LAE) Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails">
        <link:definition>0000116 - Disclosure - Reserves for Losses and Adjustment Expenses - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails">
        <link:definition>0000117 - Disclosure - Reserves for Losses and Adjustment Expenses - Reconciliation of Reinsurance Recoverables on Unpaid Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_1" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_1">
        <link:definition>0000117 - Disclosure - Reserves for Losses and Adjustment Expenses - Reconciliation of Reinsurance Recoverables on Unpaid Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails">
        <link:definition>0000118 - Disclosure - Reserves for Losses and Adjustment Expenses Short-duration Insurance Contracts, Claims by Accident Year (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesShortdurationinsurancecontractsReconciliationofClaimsDevelopmentDetails" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationinsurancecontractsReconciliationofClaimsDevelopmentDetails">
        <link:definition>0000119 - Disclosure - Reserves for Losses and Adjustment Expenses Short-duration insurance contracts - Reconciliation of Claims Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesShortdurationContractsHistoricalClaimsDurationDetails" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationContractsHistoricalClaimsDurationDetails">
        <link:definition>0000120 - Disclosure - Reserves for Losses and Adjustment Expenses Short-duration Contracts - Historical Claims Duration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofTotalIncomeTaxDetails" roleURI="http://www.aspen.co/role/IncomeTaxesSummaryofTotalIncomeTaxDetails">
        <link:definition>0000121 - Disclosure - Income Taxes - Summary of Total Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails" roleURI="http://www.aspen.co/role/IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails">
        <link:definition>0000122 - Disclosure - Income Taxes - Income/(Loss) Before Tax and Income Tax Expense/(Benefit) Attributable to that Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxReconciliationDetails" roleURI="http://www.aspen.co/role/IncomeTaxesIncomeTaxReconciliationDetails">
        <link:definition>0000123 - Disclosure - Income Taxes - Income Tax Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxEffectsofDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" roleURI="http://www.aspen.co/role/IncomeTaxesTaxEffectsofDeferredTaxAssetsandDeferredTaxLiabilitiesDetails">
        <link:definition>0000124 - Disclosure - Income Taxes - Tax Effects of Deferred Tax Assets and Deferred Tax Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.aspen.co/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>0000125 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails" roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails">
        <link:definition>0000126 - Disclosure - Capital Structure - Summary of Authorized and Issued Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom" roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom">
        <link:definition>0000127 - Disclosure - Capital Structure - Summary of Authorized and Issued Share Capital (Details)(Phantom)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureSummaryofOrdinarySharesDetails" roleURI="http://www.aspen.co/role/CapitalStructureSummaryofOrdinarySharesDetails">
        <link:definition>0000128 - Disclosure - Capital Structure - Summary of Ordinary Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureAdditionalInformationDetails" roleURI="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails">
        <link:definition>0000129 - Disclosure - Capital Structure - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatutoryRequirementsandDividendsRestrictionsSummaryofStatutoryRequirementsandDividendsRestrictionsDetails" roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsSummaryofStatutoryRequirementsandDividendsRestrictionsDetails">
        <link:definition>0000130 - Disclosure - Statutory Requirements and Dividends Restrictions - Summary of Statutory Requirements and Dividends Restrictions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatutoryRequirementsandDividendsRestrictionsAdditionalInformationDetails" roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsAdditionalInformationDetails">
        <link:definition>0000131 - Disclosure - Statutory Requirements and Dividends Restrictions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DividendsSummaryofDeclaredDividendsDetails" roleURI="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails">
        <link:definition>0000132 - Disclosure - Dividends - Summary of Declared Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansDetails" roleURI="http://www.aspen.co/role/RetirementPlansDetails">
        <link:definition>0000133 - Disclosure - Retirement Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsandLongtermIncentivePlanNarrativeDetails" roleURI="http://www.aspen.co/role/ShareBasedPaymentsandLongtermIncentivePlanNarrativeDetails">
        <link:definition>0000134 - Disclosure - Share-Based Payments and Long-term Incentive Plan - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsSummaryofChangesinIntangibleAssetsDetails" roleURI="http://www.aspen.co/role/IntangibleAssetsSummaryofChangesinIntangibleAssetsDetails">
        <link:definition>0000135 - Disclosure - Intangible Assets - Summary of Changes in Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAdditionalInformationDetails" roleURI="http://www.aspen.co/role/IntangibleAssetsAdditionalInformationDetails">
        <link:definition>0000136 - Disclosure - Intangible Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesScheduleofOperatingLeaseCostsDetails" roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseCostsDetails">
        <link:definition>0000137 - Disclosure - Operating Leases - Schedule of Operating Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails" roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails">
        <link:definition>0000138 - Disclosure - Operating Leases - Schedule of Operating Lease Liability, Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails_1" roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails_1">
        <link:definition>0000138 - Disclosure - Operating Leases - Schedule of Operating Lease Liability, Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesScheduleofOperatingLeasesCashFlowsDetails" roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeasesCashFlowsDetails">
        <link:definition>0000139 - Disclosure - Operating Leases - Schedule of Operating Leases Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesAdditionalInformationDetails" roleURI="http://www.aspen.co/role/OperatingLeasesAdditionalInformationDetails">
        <link:definition>0000140 - Disclosure - Operating Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsNarrativeDetails" roleURI="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails">
        <link:definition>0000141 - Disclosure - Related Party Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails" roleURI="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails">
        <link:definition>0000142 - Disclosure - Commitments and Contingencies - Schedule of Company's Restricted Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetails" roleURI="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails">
        <link:definition>0000143 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationofCreditRiskScheduleOfGrossWrittenPremiumFromMajorBrokersDetails" roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskScheduleOfGrossWrittenPremiumFromMajorBrokersDetails">
        <link:definition>0000144 - Disclosure - Concentration of Credit Risk - Schedule Of Gross Written Premium From Major Brokers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationofCreditRiskAdditionalInformationDetails" roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails">
        <link:definition>0000145 - Disclosure - Concentration of Credit Risk - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails" roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails">
        <link:definition>0000146 - Disclosure - Reclassifications from Accumulated Other Comprehensive Income - Schedule of Accumulated Other Comprehensive Income Reclassification (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilitiesandShortTermDebtSummaryofContractualObligationsUnderShorttermDebtsDetails" roleURI="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtSummaryofContractualObligationsUnderShorttermDebtsDetails">
        <link:definition>0000147 - Disclosure - Credit Facilities and Short-Term Debt - Summary of Contractual Obligations Under Short-term Debts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilitiesandShortTermDebtAdditionalInformationDetails" roleURI="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtAdditionalInformationDetails">
        <link:definition>0000148 - Disclosure - Credit Facilities and Short-Term Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditLossesDetails" roleURI="http://www.aspen.co/role/CreditLossesDetails">
        <link:definition>0000149 - Disclosure - Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsNarrativeDetails" roleURI="http://www.aspen.co/role/SubsequentEventsNarrativeDetails">
        <link:definition>0000150 - Disclosure - Subsequent Events - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails" roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails">
        <link:definition>0000151 - Disclosure - Schedule II - Condensed Financial Information of Registrant Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails" roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails">
        <link:definition>0000152 - Disclosure - Schedule II - Condensed Financial Information of Registrant Statements of Operations and Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails" roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails">
        <link:definition>0000153 - Disclosure - Schedule II - Condensed Financial Information of Registrant Statements of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIISupplementaryInsuranceInformationDetails" roleURI="http://www.aspen.co/role/ScheduleIIISupplementaryInsuranceInformationDetails">
        <link:definition>0000154 - Disclosure - Schedule III - Supplementary Insurance Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIVReinsurancePremiumsWrittenandPremiumsEarnedDetails" roleURI="http://www.aspen.co/role/ScheduleIVReinsurancePremiumsWrittenandPremiumsEarnedDetails">
        <link:definition>0000155 - Disclosure - Schedule IV - Reinsurance Premiums Written and Premiums Earned (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleVValuationandQualifyingAccountsDetails" roleURI="http://www.aspen.co/role/ScheduleVValuationandQualifyingAccountsDetails">
        <link:definition>0000156 - Disclosure - Schedule V - Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingAdditionalInformationNarrativeDetails_1" roleURI="http://www.aspen.co/role/SegmentReportingAdditionalInformationNarrativeDetails_1">
        <link:definition>0000157 - Disclosure - Segment Reporting - Additional Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails_1" roleURI="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails_1">
        <link:definition>0000158 - Disclosure - Segment Reporting - Summary of Gross and Net Written and Earned Premiums, Underwriting Results, Ratios and Reserves for Each of Company's Business Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryofInvestmentIncomeDetails_1" roleURI="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails_1">
        <link:definition>0000159 - Disclosure - Investments - Summary of Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails_1" roleURI="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails_1">
        <link:definition>0000160 - Disclosure - Investments - Net Realized and Unrealized Investment Gains and Losses and Change in Unrealized Gains and Losses on Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails_1" roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails_1">
        <link:definition>0000161 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Estimated Fair Value of Available for Sale Investments in Fixed Income Maturities and Short-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails_1" roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails_1">
        <link:definition>0000162 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Estimated Fair Value of Trading Investments in Fixed Income Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails_1" roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails_1">
        <link:definition>0000163 - Disclosure - Investments Investments - Distribution of Commercial Mortgage and Middle Market Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsLoantoValueRatiosDetails_1" roleURI="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails_1">
        <link:definition>0000164 - Disclosure - Investments Investments - Loan-to-Value Ratios (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails_1" roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails_1">
        <link:definition>0000165 - Disclosure - Investments Investments - Debt Service and Fixed Charge Coverage Ratios (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsOtherInvestmentsDetails_1" roleURI="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails_1">
        <link:definition>0000166 - Disclosure - Investments - Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryofFixedMaturitiesDetails_1" roleURI="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails_1">
        <link:definition>0000167 - Disclosure - Investments - Summary of Fixed Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails_1" roleURI="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails_1">
        <link:definition>0000168 - Disclosure - Investments - Aggregate Fair Value and Gross Unrealized Loss by Type of Security (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAdditionalInformationNarrativeDetails_2" roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_2">
        <link:definition>0000169 - Disclosure - Investments - Additional Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAdditionalInformationNarrativeDetails_3" roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_3">
        <link:definition>0000169 - Disclosure - Investments - Additional Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails_1" roleURI="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails_1">
        <link:definition>0000170 - Disclosure - Fair Value Measurements - Financial Assets Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3InputsDetails_1" roleURI="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails_1">
        <link:definition>0000171 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails_1" roleURI="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails_1">
        <link:definition>0000172 - Disclosure - Fair Value Measurements Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsInputsUsedDetails_1" roleURI="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails_1">
        <link:definition>0000173 - Disclosure - Fair Value Measurements - Inputs Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationNarrativeDetails_1" roleURI="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails_1">
        <link:definition>0000174 - Disclosure - Fair Value Measurements - Additional Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails_1" roleURI="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails_1">
        <link:definition>0000175 - Disclosure - Reinsurance - Summary of Assumed and Ceded Reinsurance on Premiums Written, Premiums Earned and Insurance Losses and Loss Adjustment Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceAdditionalInformationDetails_2" roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_2">
        <link:definition>0000176 - Disclosure - Reinsurance - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceAdditionalInformationDetails_3" roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_3">
        <link:definition>0000176 - Disclosure - Reinsurance - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsFairValueofDerivativeInstrumentsDetails_1" roleURI="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails_1">
        <link:definition>0000177 - Disclosure - Derivative Contracts - Fair Value of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails_1" roleURI="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails_1">
        <link:definition>0000178 - Disclosure - Derivative Contracts - Gain/(Loss) Recognized in Income on Derivative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsAdditionalInformationDetails_1" roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_1">
        <link:definition>0000179 - Disclosure - Derivative Contracts - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeContractsAdditionalInformationDetails_2" roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_2">
        <link:definition>0000179 - Disclosure - Derivative Contracts - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_2" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_2">
        <link:definition>0000180 - Disclosure - Reserves for Losses and Adjustment Expenses - Reconciliation of Beginning and Ending Consolidated Loss and Loss Adjustment Expenses (LAE) Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_3" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_3">
        <link:definition>0000180 - Disclosure - Reserves for Losses and Adjustment Expenses - Reconciliation of Beginning and Ending Consolidated Loss and Loss Adjustment Expenses (LAE) Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_1" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_1">
        <link:definition>0000181 - Disclosure - Reserves for Losses and Adjustment Expenses - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_2" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_2">
        <link:definition>0000181 - Disclosure - Reserves for Losses and Adjustment Expenses - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_2" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_2">
        <link:definition>0000182 - Disclosure - Reserves for Losses and Adjustment Expenses - Reconciliation of Reinsurance Recoverables on Unpaid Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_3" roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_3">
        <link:definition>0000182 - Disclosure - Reserves for Losses and Adjustment Expenses - Reconciliation of Reinsurance Recoverables on Unpaid Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails_1" roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails_1">
        <link:definition>0000183 - Disclosure - Capital Structure - Summary of Authorized and Issued Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom_1" roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom_1">
        <link:definition>0000184 - Disclosure - Capital Structure - Summary of Authorized and Issued Share Capital (Details)(Phantom)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureSummaryofOrdinarySharesDetails_1" roleURI="http://www.aspen.co/role/CapitalStructureSummaryofOrdinarySharesDetails_1">
        <link:definition>0000185 - Disclosure - Capital Structure - Summary of Ordinary Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureAdditionalInformationDetails_1" roleURI="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails_1">
        <link:definition>0000186 - Disclosure - Capital Structure - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DividendsSummaryofDeclaredDividendsDetails_1" roleURI="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails_1">
        <link:definition>0000187 - Disclosure - Dividends - Summary of Declared Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsNarrativeDetails_1" roleURI="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails_1">
        <link:definition>0000188 - Disclosure - Related Party Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails_1" roleURI="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails_1">
        <link:definition>0000189 - Disclosure - Commitments and Contingencies - Schedule of Company's Restricted Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetails_1" roleURI="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails_1">
        <link:definition>0000190 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationofCreditRiskAdditionalInformationDetails_1" roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails_1">
        <link:definition>0000191 - Disclosure - Concentration of Credit Risk - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails_1" roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails_1">
        <link:definition>0000192 - Disclosure - Reclassifications from Accumulated Other Comprehensive Income - Schedule of Accumulated Other Comprehensive Income Reclassification (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsNarrativeDetails_1" roleURI="http://www.aspen.co/role/SubsequentEventsNarrativeDetails_1">
        <link:definition>0000193 - Disclosure - Subsequent Events - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ahl_AustralianTrustFundMember" abstract="true" name="AustralianTrustFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate" abstract="false" name="PreferredStockLiquidationPreferenceValueFixedForFloatingRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_ApolloRealEstateFundMember" abstract="true" name="ApolloRealEstateFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_GlobalCorporateSecuritiesMember" abstract="true" name="GlobalCorporateSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DebttoValueRatio50to60PercentMember" abstract="true" name="DebttoValueRatio50to60PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ValuationTechniqueLiquidationMethodMember" abstract="true" name="ValuationTechniqueLiquidationMethodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_RestrictedCashAndCollateralTable" abstract="true" name="RestrictedCashAndCollateralTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" abstract="false" name="LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_CatastropheBondsMember" abstract="true" name="CatastropheBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_GainsLossesOnInvestmentAndForeignExchange" abstract="false" name="GainsLossesOnInvestmentAndForeignExchange" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" abstract="false" name="DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" abstract="false" name="CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" abstract="false" name="NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" abstract="false" name="DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_DeferredTaxAssetsUnearnedPremiums" abstract="false" name="DeferredTaxAssetsUnearnedPremiums" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember" abstract="true" name="AdditionalPaidInCapitalExcludingPreferenceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ShortTermInvestmentsTradingAtFairValueMember" abstract="true" name="ShortTermInvestmentsTradingAtFairValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_LIBOR1Member" abstract="true" name="LIBOR1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AspenTrademarkMember" abstract="true" name="AspenTrademarkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ReservesForLossAndAdjustmentExpensesTextBlock" abstract="false" name="ReservesForLossAndAdjustmentExpensesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ahl_AssumedSpecialtyCommercialInsuranceProductLineMember" abstract="true" name="AssumedSpecialtyCommercialInsuranceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_RestrictedAssets" abstract="false" name="RestrictedAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" abstract="false" name="AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_NetRealizedAndUnrealizedGainsLosses" abstract="false" name="NetRealizedAndUnrealizedGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_FinitelivedIntangibleAssetsAcquiredDisposed" abstract="false" name="FinitelivedIntangibleAssetsAcquiredDisposed" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_IssuedShareCapital" abstract="false" name="IssuedShareCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DepositaryShareDividendRateFractionalInterest" abstract="false" name="DepositaryShareDividendRateFractionalInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_UnitedStatesAndCanadaMember" abstract="true" name="UnitedStatesAndCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_LossPortfolioTransferMember" abstract="true" name="LossPortfolioTransferMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AssumedCasualtyCommercialInsuranceProductLineMember" abstract="true" name="AssumedCasualtyCommercialInsuranceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DepositWithStates" abstract="false" name="DepositWithStates" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_LiabilitiesUnderDerivativeContractsMember" abstract="true" name="LiabilitiesUnderDerivativeContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" abstract="false" name="LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable" abstract="true" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ahl_OtherComprehensiveIncomeLossAbstract" abstract="true" name="OtherComprehensiveIncomeLossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_EquityMethodInvestmentAggregateCostRollForward" abstract="true" name="EquityMethodInvestmentAggregateCostRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_BlueWatersMember" abstract="true" name="BlueWatersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_MVIMember" abstract="true" name="MVIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PrivatelyHeldInvestmentLossesIncurred" abstract="false" name="PrivatelyHeldInvestmentLossesIncurred" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_HighYieldLoansMember" abstract="true" name="HighYieldLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AspenBermudaMember" abstract="true" name="AspenBermudaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" abstract="false" name="ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ahl_DebtServiceCoverageRatioGreaterThan1.2xMember" abstract="true" name="DebtServiceCoverageRatioGreaterThan1.2xMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PercentageOfConsolidatedLeverageRatioPermitted" abstract="false" name="PercentageOfConsolidatedLeverageRatioPermitted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_ReinsuranceRecoverablesTotalRecoverable" abstract="false" name="ReinsuranceRecoverablesTotalRecoverable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ahl_FundsAtLloydsFacilityAgreement" abstract="false" name="FundsAtLloydsFacilityAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_RelatedPartyInvestmentIncomeMember" abstract="true" name="RelatedPartyInvestmentIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ApolloOriginatingPartnershipMember" abstract="true" name="ApolloOriginatingPartnershipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_Expense" abstract="false" name="Expense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" abstract="false" name="DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_EverestReMember" abstract="true" name="EverestReMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PrivatelyheldinvestmentsMember" abstract="true" name="PrivatelyheldinvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_GlobalSecuritiesCorporateMember" abstract="true" name="GlobalSecuritiesCorporateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" abstract="false" name="TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CitibankEuropeMember" abstract="true" name="CitibankEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_SwissTrustFundMember" abstract="true" name="SwissTrustFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_InsuranceReserveAbstract" abstract="true" name="InsuranceReserveAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" abstract="false" name="DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DeutscheMember" abstract="true" name="DeutscheMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" abstract="false" name="DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" abstract="false" name="NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_NetchangefromcurrentperiodhedgedtransactionsMember" abstract="true" name="NetchangefromcurrentperiodhedgedtransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_CorporateExpenses" abstract="false" name="CorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_NonagencycommercialmortgagebackedsecuritiesMember" abstract="true" name="NonagencycommercialmortgagebackedsecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_MinimumTrustFund" abstract="false" name="MinimumTrustFund" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" abstract="false" name="AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash" abstract="false" name="PaymentsforProceedsfromInvestingActivitiesNetofCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CMLLessNonPerformingOrFutureConstruction" abstract="false" name="CMLLessNonPerformingOrFutureConstruction" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ReinsuranceLiabilities" abstract="false" name="ReinsuranceLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_Shortterminvestmentsavailableforsaleamortizedcost" abstract="false" name="Shortterminvestmentsavailableforsaleamortizedcost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract" abstract="true" name="DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" abstract="false" name="NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_SingaporeTrustFundMember" abstract="true" name="SingaporeTrustFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AggregateLiquidationPreferences" abstract="false" name="AggregateLiquidationPreferences" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AAICMember" abstract="true" name="AAICMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_InvestmentInMultilineReinsurer" abstract="false" name="InvestmentInMultilineReinsurer" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_RealEstateFundSept2021Member" abstract="true" name="RealEstateFundSept2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_NumberOfInvestmentsInVariableInterestEntities" abstract="false" name="NumberOfInvestmentsInVariableInterestEntities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ahl_CapitalReserves" abstract="false" name="CapitalReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DebttoValueRatio71to80PercentMember" abstract="true" name="DebttoValueRatio71to80PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_CashAndCashEquivalentsIncludesRestrictedCash" abstract="false" name="CashAndCashEquivalentsIncludesRestrictedCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_FairValueOfDerivativesMember" abstract="true" name="FairValueOfDerivativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" abstract="false" name="ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ahl_OtherMiscellaneousAssets" abstract="false" name="OtherMiscellaneousAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DebttoValueRatioLessthan50PercentMember" abstract="true" name="DebttoValueRatioLessthan50PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PrivatelyheldInvestments" abstract="false" name="PrivatelyheldInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PaymentsforAvailableforsaleSecuritiesShortterm" abstract="false" name="PaymentsforAvailableforsaleSecuritiesShortterm" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" abstract="false" name="CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_UsMultiBeneficiaryTrustFundMember" abstract="true" name="UsMultiBeneficiaryTrustFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DebtDefaultMinimum" abstract="false" name="DebtDefaultMinimum" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CorporateTaxRate" abstract="false" name="CorporateTaxRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" abstract="false" name="ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DebtServiceCoverageRatioLessThan1.00xMember" abstract="true" name="DebtServiceCoverageRatioLessThan1.00xMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ChangeInOtherAssets" abstract="false" name="ChangeInOtherAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PaymentsForProceedsFromOtherInvestments" abstract="false" name="PaymentsForProceedsFromOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CatastropheBond" abstract="false" name="CatastropheBond" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_EquityInNetEarningsOfSubsidiaries" abstract="false" name="EquityInNetEarningsOfSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember" abstract="true" name="AssumedPropertyandCasualtyCommercialInsuranceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PremiumsReceivableNonCurrent" abstract="false" name="PremiumsReceivableNonCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue" abstract="false" name="Privatelyheldinvestmentsamortizedcosttradingatfairvalue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AspenUKMember" abstract="true" name="AspenUKMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" abstract="false" name="TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PrivatelyheldInvestmentsatfairvalue" abstract="false" name="PrivatelyheldInvestmentsatfairvalue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PremiumsWrittenGrossPercentage" abstract="false" name="PremiumsWrittenGrossPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_DeferredPolicyAcquisitionCostOtherExpenses" abstract="false" name="DeferredPolicyAcquisitionCostOtherExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PurchasesOfProceedsFromCatastropheBonds" abstract="false" name="PurchasesOfProceedsFromCatastropheBonds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_MajorRatingAgenciesDomain" abstract="true" name="MajorRatingAgenciesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_USOperatingSubsidiariesMember" abstract="true" name="USOperatingSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_RestrictedCashAndCollateralLineItems" abstract="true" name="RestrictedCashAndCollateralLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_LetterOfCreditToSupportFundsAtLloyds" abstract="false" name="LetterOfCreditToSupportFundsAtLloyds" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" abstract="false" name="DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_InsuranceMember" abstract="true" name="InsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_UsSurplusLinesTrustFundMember" abstract="true" name="UsSurplusLinesTrustFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_InsuranceReserves" abstract="false" name="InsuranceReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AAOrHigherMember" abstract="true" name="AAOrHigherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval" abstract="false" name="StatutoryCapitalandSurplusPercentReductionRequiringApproval" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" abstract="false" name="ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" abstract="false" name="NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CropReMember" abstract="true" name="CropReMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_Interestonoperatingleaseliabilities" abstract="false" name="Interestonoperatingleaseliabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ProceedsfromAvailableforsaleSecuritiesShortterm" abstract="false" name="ProceedsfromAvailableforsaleSecuritiesShortterm" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_Operatinglosscarryforwardsdateofexpiration" abstract="false" name="Operatinglosscarryforwardsdateofexpiration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:gYearItemType"/>
  <xs:element id="ahl_RelatedPartyTransactionMaximumRateIncrease" abstract="false" name="RelatedPartyTransactionMaximumRateIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ahl_TotalRestrictedAssets" abstract="false" name="TotalRestrictedAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ReinsuranceRecoverablesCollateralizedPercent" abstract="false" name="ReinsuranceRecoverablesCollateralizedPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ahl_AonCorporationMember" abstract="true" name="AonCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets" abstract="false" name="DeferredTaxAssetsTimingDifferencesOnFixedAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ConsumerStaplesServiceMember" abstract="true" name="ConsumerStaplesServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_MultiLineReinsurerMember" abstract="true" name="MultiLineReinsurerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_RealEstateFundDec2017Member" abstract="true" name="RealEstateFundDec2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" abstract="false" name="NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AspenEuropeanMember" abstract="true" name="AspenEuropeanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" abstract="false" name="UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AspenUnderwritingLimitedMember" abstract="true" name="AspenUnderwritingLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DebtServiceCoverageRatio1.00to1.20xMember" abstract="true" name="DebtServiceCoverageRatio1.00to1.20xMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_CanadianTrustFundMember" abstract="true" name="CanadianTrustFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_SupplementalDisclosureOfCashFlowsInformationAbstract" abstract="true" name="SupplementalDisclosureOfCashFlowsInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_TotalAllowanceForCreditLoss" abstract="false" name="TotalAllowanceForCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_TotalTradingMember" abstract="true" name="TotalTradingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" abstract="false" name="PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_FundsMaintainedAtSyndicate" abstract="false" name="FundsMaintainedAtSyndicate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ReinsuranceRecoverablesAdjustment" abstract="false" name="ReinsuranceRecoverablesAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_ConcentrationRiskThresholdPercentage" abstract="false" name="ConcentrationRiskThresholdPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ahl_TradingFixedMaturityInvestmentsMember" abstract="true" name="TradingFixedMaturityInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_NetAdditionsdisposalsOfLeaseLiabilities" abstract="false" name="NetAdditionsdisposalsOfLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_LossesAndLossAdjustmentExpenses" abstract="false" name="LossesAndLossAdjustmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ReinsuranceMember" abstract="true" name="ReinsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DebtServiceCoverageRatioAxis" abstract="true" name="DebtServiceCoverageRatioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ahl_NonPaymentOfDividendsNumberOfPeriods" abstract="false" name="NonPaymentOfDividendsNumberOfPeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ahl_IntangibleAssetsandGoodwillAcquiredDisposed" abstract="false" name="IntangibleAssetsandGoodwillAcquiredDisposed" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DepositaryShareDividend" abstract="false" name="DepositaryShareDividend" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="ahl_SecuritiesassetbackedMember" abstract="true" name="SecuritiesassetbackedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DebtServiceCoverageRatioDomain" abstract="true" name="DebtServiceCoverageRatioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_LloydsMember" abstract="true" name="LloydsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_OtherJuridictionsMember" abstract="true" name="OtherJuridictionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" abstract="false" name="Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_HSBCBankUSANationalAssociationMember" abstract="true" name="HSBCBankUSANationalAssociationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_MiddlemarketloansMember" abstract="true" name="MiddlemarketloansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract" abstract="true" name="DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" abstract="false" name="TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AAOrLowerMember" abstract="true" name="AAOrLowerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" abstract="false" name="ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DigitalRiskMember" abstract="true" name="DigitalRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_IndustrialServiceMember" abstract="true" name="IndustrialServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AuthorizedShareCapitalAbstract" abstract="true" name="AuthorizedShareCapitalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_InvestmentFunds" abstract="false" name="InvestmentFunds" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_WillisGroupHoldingsLtdMember" abstract="true" name="WillisGroupHoldingsLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_InvestmentsExcludingDerivativeAssets" abstract="false" name="InvestmentsExcludingDerivativeAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" abstract="false" name="ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" abstract="false" name="ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_WorldwideIncludingUnitedStatesMember" abstract="true" name="WorldwideIncludingUnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_OthersMember" abstract="true" name="OthersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ApolloClassBNotesMember" abstract="true" name="ApolloClassBNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ShorttermInvestmentTradingMember" abstract="true" name="ShorttermInvestmentTradingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ConsumerDiscretionaryServiceMember" abstract="true" name="ConsumerDiscretionaryServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" abstract="false" name="GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CasualtyCommercialInsuranceProductLineMember" abstract="true" name="CasualtyCommercialInsuranceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment" abstract="false" name="FairValueInputsOfferedQuotesPerFixedIncomeInvestment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DebttoValueRatio61to70PercentMember" abstract="true" name="DebttoValueRatio61to70PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_SharebasedpaymentandLTIPexpense" abstract="false" name="SharebasedpaymentandLTIPexpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DerivativeAtFairValueMember" abstract="true" name="DerivativeAtFairValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ShortTermInvestmentsTradingAmortizedCost" abstract="false" name="ShortTermInvestmentsTradingAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ManagementConsultingAgreementMember" abstract="true" name="ManagementConsultingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ThirdPartyMember" abstract="true" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_CommonStockValueAuthorized" abstract="false" name="CommonStockValueAuthorized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds" abstract="false" name="SecuritiesLendingTransactionToSupportFundsAtLloyds" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_DebtToValueRatioGreaterThan100Member" abstract="true" name="DebtToValueRatioGreaterThan100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AspenSpecialtyMember" abstract="true" name="AspenSpecialtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AccruedExpensesMember" abstract="true" name="AccruedExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_NatixisMember" abstract="true" name="NatixisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" abstract="false" name="ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" abstract="false" name="LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_RestrictedAssetsExcludingIlliquidAssets" abstract="false" name="RestrictedAssetsExcludingIlliquidAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_TradingSecuritiesCatastropheBondsGainLoss" abstract="false" name="TradingSecuritiesCatastropheBondsGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_InfrastructureFundMember" abstract="true" name="InfrastructureFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_SubsidiariesOneMember" abstract="true" name="SubsidiariesOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_CitibankEuropeplcMember" abstract="true" name="CitibankEuropeplcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PreferredStockValueAuthorized" abstract="false" name="PreferredStockValueAuthorized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_MunichReMember" abstract="true" name="MunichReMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember" abstract="true" name="AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_DeferredTaxLossesOperatingLossCarryforward" abstract="false" name="DeferredTaxLossesOperatingLossCarryforward" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_RegulatoryDeposits" abstract="false" name="RegulatoryDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_NetRealizedAndUnrealizedInvestmentGainsLosses" abstract="false" name="NetRealizedAndUnrealizedInvestmentGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" abstract="false" name="AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ahl_ShortTermInvestmentsAvailableForSale" abstract="false" name="ShortTermInvestmentsAvailableForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DeferredTaxLiabilitiesGAAPDifferences" abstract="false" name="DeferredTaxLiabilitiesGAAPDifferences" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PreferredStockIssuanceCost" abstract="false" name="PreferredStockIssuanceCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_IssuedShareCapitalAbstract" abstract="true" name="IssuedShareCapitalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember" abstract="true" name="ShortTermInvestmentsPrivatelyHeldInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ReinsuranceRecoverablesUncollateralized" abstract="false" name="ReinsuranceRecoverablesUncollateralized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_EnstarMember" abstract="true" name="EnstarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_ApolloClassANotesMember" abstract="true" name="ApolloClassANotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" abstract="false" name="PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_BeneAssicurazioniMember" abstract="true" name="BeneAssicurazioniMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution" abstract="false" name="AdjustmentToAdditionalPaidInCapitalCapitalContribution" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_NonoperatingexpensesrelatedtoMergerAgreement" abstract="false" name="NonoperatingexpensesrelatedtoMergerAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract" abstract="true" name="AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_RelatedPartyTransactionRateofInterest" abstract="false" name="RelatedPartyTransactionRateofInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ahl_PaymentstoAcquirePrivatelyheldInvestments" abstract="false" name="PaymentstoAcquirePrivatelyheldInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CatastropheBondsFairValueDisclosure" abstract="false" name="CatastropheBondsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" abstract="false" name="CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ProceedsfromSaleofPrivatelyheldInvestments" abstract="false" name="ProceedsfromSaleofPrivatelyheldInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PreferenceSharesPolicyTextBlock" abstract="false" name="PreferenceSharesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ahl_DeferredTaxLiabilitiesOperatingLeaseAssets" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DelayedDrawTermLoanFacility" abstract="false" name="DelayedDrawTermLoanFacility" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" abstract="false" name="PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" abstract="false" name="DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AdditionalPaidInCapitalExcludingPreferenceShares" abstract="false" name="AdditionalPaidInCapitalExcludingPreferenceShares" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_FinancialandProfessionalCommercialInsuranceProductLineMember" abstract="true" name="FinancialandProfessionalCommercialInsuranceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_IncreaseDecreaseInIntercompanyActivities" abstract="false" name="IncreaseDecreaseInIntercompanyActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" abstract="false" name="DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" abstract="false" name="PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" abstract="false" name="FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ClassABNotesMember" abstract="true" name="ClassABNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_MarshAndMcLennanCompaniesIncMember" abstract="true" name="MarshAndMcLennanCompaniesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward" abstract="true" name="FiniteandIndefiniteLivedIntangibleAssetsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_MajorRatingAgenciesAxis" abstract="true" name="MajorRatingAgenciesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff" abstract="false" name="NonOperatingExpensesRelatedToFixedIncomeWriteoff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AuthorizedShareCapital" abstract="false" name="AuthorizedShareCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_PercentageOfReinsuranceLiabilities" abstract="false" name="PercentageOfReinsuranceLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_LineOfCreditFacilityIncreasableCapacity" abstract="false" name="LineOfCreditFacilityIncreasableCapacity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_ShortTermInvestmentsTradingAtFairValue" abstract="false" name="ShortTermInvestmentsTradingAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_SummaryofOtherLeaseInformationTableTextBlock" abstract="false" name="SummaryofOtherLeaseInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" abstract="false" name="AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ahl_PremiumsEarnedGross" abstract="false" name="PremiumsEarnedGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_IncreaseDecreaseInLongTermDebt" abstract="false" name="IncreaseDecreaseInLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_UnpaidLosses" abstract="false" name="UnpaidLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity" abstract="false" name="AvailableForSaleSecuritiesAverageRatingsByMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ahl_InvestmentNetCarryingValueMember" abstract="true" name="InvestmentNetCarryingValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember" abstract="true" name="MarineAviationandEnergyCommercialInsuranceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" abstract="false" name="LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>42
<FILENAME>ahl-20231220_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:c8bdf706-6073-4046-a439-e42c560d7bb0,g:8520f5b6-a319-4843-ab2c-4a3e439c5aeb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:href="ahl-20231220.xsd#ahl_InvestmentsExcludingDerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_31bca1f0-548e-4071-a7a0-9d07cf707288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_31bca1f0-548e-4071-a7a0-9d07cf707288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_86bf9b8c-858b-46d2-ab3f-e79029b7b111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:to="loc_us-gaap_TradingSecuritiesDebt_86bf9b8c-858b-46d2-ab3f-e79029b7b111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsAvailableForSale_de0d4810-fc81-4b60-816d-89fe0c0c9afa" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsAvailableForSale"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:to="loc_ahl_ShortTermInvestmentsAvailableForSale_de0d4810-fc81-4b60-816d-89fe0c0c9afa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValue_1bf988bf-69d1-44f6-8823-5e0a9e51e0bb" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValue_1bf988bf-69d1-44f6-8823-5e0a9e51e0bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_329c274a-43d1-4315-a4db-2ee44569728b" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:to="loc_ahl_CatastropheBond_329c274a-43d1-4315-a4db-2ee44569728b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_c00b3351-6d3f-4978-8a6c-1e08352804dc" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:to="loc_ahl_PrivatelyheldInvestments_c00b3351-6d3f-4978-8a6c-1e08352804dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f03d9de6-a1d1-42cd-b1e8-c8b225fdc74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:to="loc_us-gaap_EquityMethodInvestments_f03d9de6-a1d1-42cd-b1e8-c8b225fdc74e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_782fc2dd-a076-473e-ae8e-4b2886044be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets_c0bbe842-02d9-4271-a6ad-a0c13a64d118" xlink:to="loc_us-gaap_OtherInvestments_782fc2dd-a076-473e-ae8e-4b2886044be8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_447f7e52-3f41-4b6d-8b79-6af31b3ae9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11aeac5b-90e5-4ea5-9677-26fe5f9dde83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_447f7e52-3f41-4b6d-8b79-6af31b3ae9a0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11aeac5b-90e5-4ea5-9677-26fe5f9dde83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0b59fa5c-0f61-4874-abd9-c77869c6c822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_447f7e52-3f41-4b6d-8b79-6af31b3ae9a0" xlink:to="loc_us-gaap_Liabilities_0b59fa5c-0f61-4874-abd9-c77869c6c822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_ee786156-fa53-431e-b9c8-f9f28b46665c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_ee786156-fa53-431e-b9c8-f9f28b46665c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_02e4a519-51f8-4212-9c17-2882843ce09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_OperatingLeaseLiability_02e4a519-51f8-4212-9c17-2882843ce09b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_cd664f67-d444-45c9-95cf-539007a614cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_DerivativeLiabilities_cd664f67-d444-45c9-95cf-539007a614cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserves_c8aab46f-793c-4269-ab34-95287782f8f6" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_ahl_InsuranceReserves_c8aab46f-793c-4269-ab34-95287782f8f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_f9d737ff-7051-491a-a329-a4d317a080ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_f9d737ff-7051-491a-a329-a4d317a080ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_35d4a450-0d78-4349-8237-b81b53ab0be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_35d4a450-0d78-4349-8237-b81b53ab0be5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_88334de0-f75d-4ba3-b2b5-54941ff7e47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_88334de0-f75d-4ba3-b2b5-54941ff7e47b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6f87f6b3-f483-45b3-a041-3eb60e0af057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_LongTermDebt_6f87f6b3-f483-45b3-a041-3eb60e0af057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePayable_66fa3eb7-d61f-4cea-8a2c-f186a41998ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_ReinsurancePayable_66fa3eb7-d61f-4cea-8a2c-f186a41998ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_0c91c45c-f16b-4504-92b0-f6392c3a770c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_06e95cc9-a980-410e-b619-bf0a56edbc84" xlink:to="loc_us-gaap_ShortTermBorrowings_0c91c45c-f16b-4504-92b0-f6392c3a770c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694f5bb9-d49d-4ea2-abe2-5f2e9ccc67a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_158a7711-f7be-4f77-81c3-2696789edc28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694f5bb9-d49d-4ea2-abe2-5f2e9ccc67a9" xlink:to="loc_us-gaap_AdditionalPaidInCapital_158a7711-f7be-4f77-81c3-2696789edc28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_55b17310-ea85-4ae8-bcda-5831f69a4d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694f5bb9-d49d-4ea2-abe2-5f2e9ccc67a9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_55b17310-ea85-4ae8-bcda-5831f69a4d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a0bc14a7-838d-4229-95f7-6e44791bcc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694f5bb9-d49d-4ea2-abe2-5f2e9ccc67a9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a0bc14a7-838d-4229-95f7-6e44791bcc3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b716b8aa-aeee-4b72-8264-e8c88a5245b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694f5bb9-d49d-4ea2-abe2-5f2e9ccc67a9" xlink:to="loc_us-gaap_CommonStockValue_b716b8aa-aeee-4b72-8264-e8c88a5245b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserves_edfc7db6-a0f4-44b7-b074-db5b60234952" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserves"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_4667fb87-6f76-4d3d-a4ea-d41935a1ffd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InsuranceReserves_edfc7db6-a0f4-44b7-b074-db5b60234952" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_4667fb87-6f76-4d3d-a4ea-d41935a1ffd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_ccfc5890-cde5-44fd-b9d3-ef6871f55342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_InsuranceReserves_edfc7db6-a0f4-44b7-b074-db5b60234952" xlink:to="loc_us-gaap_UnearnedPremiums_ccfc5890-cde5-44fd-b9d3-ef6871f55342" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentsExcludingDerivativeAssets_aabb604f-0421-4311-88b5-f72567702874" xlink:href="ahl-20231220.xsd#ahl_InvestmentsExcludingDerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_ahl_InvestmentsExcludingDerivativeAssets_aabb604f-0421-4311-88b5-f72567702874" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b33287f2-df47-4111-b3eb-917ed81cf99c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b33287f2-df47-4111-b3eb-917ed81cf99c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_f7ead670-a1a0-42fc-bcc7-0269610372a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_f7ead670-a1a0-42fc-bcc7-0269610372a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums_144893bf-8df3-452a-a42f-fb94c3ead37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_PrepaidReinsurancePremiums_144893bf-8df3-452a-a42f-fb94c3ead37f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_f3a0d9b0-bb70-40ac-a9fc-361b194ce264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_f3a0d9b0-bb70-40ac-a9fc-361b194ce264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_ce8b699a-9e4a-401e-9f08-8d074a893e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_OtherReceivables_ce8b699a-9e4a-401e-9f08-8d074a893e2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_e1b535af-a221-4d4c-aa41-d9c594c71b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldUnderReinsuranceAgreementsAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_e1b535af-a221-4d4c-aa41-d9c594c71b1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_9cd9e257-77bd-4a2c-9b09-79c9af5552ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_9cd9e257-77bd-4a2c-9b09-79c9af5552ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f210d273-e524-4817-ab0f-8c59b3bc5af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_DerivativeAssets_f210d273-e524-4817-ab0f-8c59b3bc5af7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_553ab50b-9a1e-4a7b-aeca-a0bb25e294df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_553ab50b-9a1e-4a7b-aeca-a0bb25e294df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c2627ae7-9ef4-4ffd-b846-f08117d72f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c2627ae7-9ef4-4ffd-b846-f08117d72f42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2cebeea9-f4bf-4abb-a1db-b1bbbf131485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2cebeea9-f4bf-4abb-a1db-b1bbbf131485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_3690c46d-8169-40eb-b4e3-ff2408666180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_IncomeTaxReceivable_3690c46d-8169-40eb-b4e3-ff2408666180" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_5fafb19a-1480-4962-9a40-94e00fa243ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_OtherAssets_5fafb19a-1480-4962-9a40-94e00fa243ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_86e2a106-db3e-4ffe-900e-59067f075147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_86e2a106-db3e-4ffe-900e-59067f075147" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_164a1aff-34dd-45e1-9242-d573a9aa82fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_444edc69-b88e-4c80-bf1a-0872aeb5039c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_164a1aff-34dd-45e1-9242-d573a9aa82fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dd7ab65c-560a-4c66-8c2a-f4a3eec661af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_aae040bc-d27f-404f-9fda-7b9d7774c4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dd7ab65c-560a-4c66-8c2a-f4a3eec661af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_aae040bc-d27f-404f-9fda-7b9d7774c4e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_36d51dd5-2063-4508-8f45-754090b5d769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dd7ab65c-560a-4c66-8c2a-f4a3eec661af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_36d51dd5-2063-4508-8f45-754090b5d769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_90995e9d-b72d-4d61-a8e3-e286fa200177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b126c93b-a048-40fa-ba10-63a0ff58c5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_90995e9d-b72d-4d61-a8e3-e286fa200177" xlink:to="loc_us-gaap_ProfitLoss_b126c93b-a048-40fa-ba10-63a0ff58c5b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_be70785f-51b2-4f65-9641-3bb14c68c546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_90995e9d-b72d-4d61-a8e3-e286fa200177" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_be70785f-51b2-4f65-9641-3bb14c68c546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_97cbb148-b34d-47db-a9c1-0d7f0d1f997a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_9989868d-5563-4f24-b98e-5d2bddb1a5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_97cbb148-b34d-47db-a9c1-0d7f0d1f997a" xlink:to="loc_us-gaap_PremiumsEarnedNet_9989868d-5563-4f24-b98e-5d2bddb1a5ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_46dad319-15b9-4830-9cf6-23d6b19a3786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_97cbb148-b34d-47db-a9c1-0d7f0d1f997a" xlink:to="loc_us-gaap_NetInvestmentIncome_46dad319-15b9-4830-9cf6-23d6b19a3786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_ef4886ec-fedb-4c3a-a59d-cec7a9a871be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_97cbb148-b34d-47db-a9c1-0d7f0d1f997a" xlink:to="loc_us-gaap_GainLossOnInvestments_ef4886ec-fedb-4c3a-a59d-cec7a9a871be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_6f9e3ff6-6ca5-4d12-b1ca-440f2d43d81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_97cbb148-b34d-47db-a9c1-0d7f0d1f997a" xlink:to="loc_us-gaap_OtherIncome_6f9e3ff6-6ca5-4d12-b1ca-440f2d43d81f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:href="ahl-20231220.xsd#ahl_Expense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_160788b7-b0d4-42c4-adcf-cdf2993edfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_160788b7-b0d4-42c4-adcf-cdf2993edfa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_73a13fe1-d0ac-46da-b681-760621fa0288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_73a13fe1-d0ac-46da-b681-760621fa0288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_031a4dc1-f9bc-47b7-b0db-1ae1c693daae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_031a4dc1-f9bc-47b7-b0db-1ae1c693daae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d548d363-fea9-45b3-aeef-80a6c856a7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:to="loc_us-gaap_InterestExpenseDebt_d548d363-fea9-45b3-aeef-80a6c856a7ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2dd72b8e-0156-4c81-abb8-fe6dbf17bace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2dd72b8e-0156-4c81-abb8-fe6dbf17bace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_dc2a29fd-30ee-430e-98b3-69ba1f2cfe7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_dc2a29fd-30ee-430e-98b3-69ba1f2cfe7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2d8391c5-35cf-427e-bac4-3ac6fc0a0b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2d8391c5-35cf-427e-bac4-3ac6fc0a0b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_37a7f37b-2f20-4dd5-9830-8397dce3b288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_Expense_072da57c-c4ef-4412-83e1-30d6682b4b58" xlink:to="loc_us-gaap_OtherExpenses_37a7f37b-2f20-4dd5-9830-8397dce3b288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0c2ada22-4a9c-4f8d-8b49-f159645d35c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b9fc6b99-08b5-438f-8bba-bfccd8db695e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_0c2ada22-4a9c-4f8d-8b49-f159645d35c9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b9fc6b99-08b5-438f-8bba-bfccd8db695e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bbfcbdbf-db92-4d66-87e0-2b11741860cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_0c2ada22-4a9c-4f8d-8b49-f159645d35c9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bbfcbdbf-db92-4d66-87e0-2b11741860cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7d42527e-6152-4cdd-8fe7-ff2fc1c8824e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9448600c-9e0a-4f3b-ae10-d55d1cf17060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7d42527e-6152-4cdd-8fe7-ff2fc1c8824e" xlink:to="loc_us-gaap_NetIncomeLoss_9448600c-9e0a-4f3b-ae10-d55d1cf17060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a28679ea-6593-4bfc-ba06-802b8d2fe521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7d42527e-6152-4cdd-8fe7-ff2fc1c8824e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a28679ea-6593-4bfc-ba06-802b8d2fe521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1774c649-a15d-47ec-9d4a-5470a3b1b425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b80b3a84-4136-4a07-9387-5fa7f0c33a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1774c649-a15d-47ec-9d4a-5470a3b1b425" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b80b3a84-4136-4a07-9387-5fa7f0c33a8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_4efa56b1-79d7-4d0d-a840-c19fb80bf57b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1774c649-a15d-47ec-9d4a-5470a3b1b425" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_4efa56b1-79d7-4d0d-a840-c19fb80bf57b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_7689dd1d-3a18-4bbb-8df7-b782fc622f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1774c649-a15d-47ec-9d4a-5470a3b1b425" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_7689dd1d-3a18-4bbb-8df7-b782fc622f0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_4c9b17ca-0165-4ff4-8a40-c2de0bc850b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1774c649-a15d-47ec-9d4a-5470a3b1b425" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_4c9b17ca-0165-4ff4-8a40-c2de0bc850b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6d28330a-28df-41d4-9458-6cc5fc584aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cf4500b8-e257-46c2-8afa-6fe93c1dee7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6d28330a-28df-41d4-9458-6cc5fc584aa0" xlink:to="loc_us-gaap_Revenues_cf4500b8-e257-46c2-8afa-6fe93c1dee7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Expense_d3320b42-50c5-4ba2-af72-80ff6531d491" xlink:href="ahl-20231220.xsd#ahl_Expense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6d28330a-28df-41d4-9458-6cc5fc584aa0" xlink:to="loc_ahl_Expense_d3320b42-50c5-4ba2-af72-80ff6531d491" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_41786469-71f4-47f6-9a09-6be3673b0134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_41786469-71f4-47f6-9a09-6be3673b0134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_7e5dba44-b1c3-4b9a-b366-0fc83556101d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_7e5dba44-b1c3-4b9a-b366-0fc83556101d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_62598f6d-5a9d-4036-a017-c8855f5fad61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_62598f6d-5a9d-4036-a017-c8855f5fad61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c2dff917-9d5c-45ab-8289-d8c6b256a625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c2dff917-9d5c-45ab-8289-d8c6b256a625" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Interestonoperatingleaseliabilities_0bf23337-e9d3-4633-a98f-ee5729232ad4" xlink:href="ahl-20231220.xsd#ahl_Interestonoperatingleaseliabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_ahl_Interestonoperatingleaseliabilities_0bf23337-e9d3-4633-a98f-ee5729232ad4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_fc925d0b-f298-4265-a835-b68f587626c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_GainLossOnInvestments_fc925d0b-f298-4265-a835-b68f587626c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_91943cfb-a9ca-4593-9c83-68965d61ffa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_91943cfb-a9ca-4593-9c83-68965d61ffa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_aeef4f1c-fc72-40d7-8cc6-00f821085b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_aeef4f1c-fc72-40d7-8cc6-00f821085b63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GainsLossesOnInvestmentAndForeignExchange_35118cc4-caed-4297-ba45-8a69b11a43e2" xlink:href="ahl-20231220.xsd#ahl_GainsLossesOnInvestmentAndForeignExchange"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_ahl_GainsLossesOnInvestmentAndForeignExchange_35118cc4-caed-4297-ba45-8a69b11a43e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_d5429909-25f9-4f86-9f63-2ea7e3d6ba57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_d5429909-25f9-4f86-9f63-2ea7e3d6ba57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_0b0d19d0-0bfc-4886-a3b2-32b310091c3a" xlink:href="ahl-20231220.xsd#ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_0b0d19d0-0bfc-4886-a3b2-32b310091c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_114daf29-9b37-4cb4-bd45-cdc4aaee27a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_114daf29-9b37-4cb4-bd45-cdc4aaee27a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_cc8afe92-fdb5-4f3c-a050-21871c15dea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_cc8afe92-fdb5-4f3c-a050-21871c15dea8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnpaidLosses_394120fb-dfc9-4ebc-b3b0-35117ae86a43" xlink:href="ahl-20231220.xsd#ahl_UnpaidLosses"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_ahl_UnpaidLosses_394120fb-dfc9-4ebc-b3b0-35117ae86a43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_6a95df76-02fe-4949-a619-0dc818538676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_6a95df76-02fe-4949-a619-0dc818538676" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_7aa8ecb7-f5dd-404e-9438-8c925fada5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_7aa8ecb7-f5dd-404e-9438-8c925fada5e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_d8627104-cf7f-47f0-b760-5c7842cf7b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_d8627104-cf7f-47f0-b760-5c7842cf7b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReinsurancePayables_947b404e-8056-497f-9b26-986bb694a4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReinsurancePayables"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInReinsurancePayables_947b404e-8056-497f-9b26-986bb694a4c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_cd52a1d8-3fad-4869-8a72-41155d1a934d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_cd52a1d8-3fad-4869-8a72-41155d1a934d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_38f6da66-c536-496c-96bb-62b5156eaf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_38f6da66-c536-496c-96bb-62b5156eaf0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_49d31fdc-f538-4aee-bf6d-df3f7070e3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_49d31fdc-f538-4aee-bf6d-df3f7070e3be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c260f17f-6280-4485-a34f-1c482e0b64f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c260f17f-6280-4485-a34f-1c482e0b64f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_67ca40b2-5986-475a-9e09-91e7605cb7c9" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives"/>
    <link:calculationArc order="23" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_67ca40b2-5986-475a-9e09-91e7605cb7c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncreaseDecreaseInLongTermDebt_cd360309-2892-4d5a-9165-fc293511d81c" xlink:href="ahl-20231220.xsd#ahl_IncreaseDecreaseInLongTermDebt"/>
    <link:calculationArc order="24" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_ahl_IncreaseDecreaseInLongTermDebt_cd360309-2892-4d5a-9165-fc293511d81c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_8f64f86d-43e5-4b04-9506-3d116c0f7f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:calculationArc order="25" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_OperatingLeasePayments_8f64f86d-43e5-4b04-9506-3d116c0f7f90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aacec607-0bb6-47eb-9211-71419237ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="26" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26b6c4fb-f808-4c6c-92ff-f43bbfd3fb6f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aacec607-0bb6-47eb-9211-71419237ed9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2db9c240-b4b9-4ae4-b5ed-59b13c7562c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1eb2e490-8d91-4a7f-9892-d55f0015ac8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2db9c240-b4b9-4ae4-b5ed-59b13c7562c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1eb2e490-8d91-4a7f-9892-d55f0015ac8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_02a6b409-d1c6-4e12-8154-ec893406e35d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2db9c240-b4b9-4ae4-b5ed-59b13c7562c4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_02a6b409-d1c6-4e12-8154-ec893406e35d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa379f11-d7be-4c54-a87b-0f0e3007ea4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2db9c240-b4b9-4ae4-b5ed-59b13c7562c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa379f11-d7be-4c54-a87b-0f0e3007ea4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3247d4f2-f293-472c-bac1-008d044099f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2db9c240-b4b9-4ae4-b5ed-59b13c7562c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3247d4f2-f293-472c-bac1-008d044099f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c790c06c-103d-4ef1-8256-9b97fa1d231d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_3433945b-4229-48b7-af90-d3e2eae10f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c790c06c-103d-4ef1-8256-9b97fa1d231d" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_3433945b-4229-48b7-af90-d3e2eae10f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_86357b14-1998-4255-82d7-98f1a6be4441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c790c06c-103d-4ef1-8256-9b97fa1d231d" xlink:to="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_86357b14-1998-4255-82d7-98f1a6be4441" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_603230ba-ef20-41a8-ab0e-20548960612e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c790c06c-103d-4ef1-8256-9b97fa1d231d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_603230ba-ef20-41a8-ab0e-20548960612e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_729daf3b-3209-4235-8fec-95cd7864be9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_729daf3b-3209-4235-8fec-95cd7864be9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsForProceedsFromOtherInvestments_2c47eaa5-0008-4c28-8de8-f9c120afbaff" xlink:href="ahl-20231220.xsd#ahl_PaymentsForProceedsFromOtherInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_PaymentsForProceedsFromOtherInvestments_2c47eaa5-0008-4c28-8de8-f9c120afbaff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ProceedsfromSaleofPrivatelyheldInvestments_51a83e57-622e-49ea-bed4-8a6acab62851" xlink:href="ahl-20231220.xsd#ahl_ProceedsfromSaleofPrivatelyheldInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_ProceedsfromSaleofPrivatelyheldInvestments_51a83e57-622e-49ea-bed4-8a6acab62851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_ef233e7d-a2ed-445d-b30a-fb069671e131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_ef233e7d-a2ed-445d-b30a-fb069671e131" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_8f8a893e-6381-44ba-8891-6dde241a029d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_8f8a893e-6381-44ba-8891-6dde241a029d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_dec36d57-4957-4aef-ad27-46ff3ceaab25" xlink:href="ahl-20231220.xsd#ahl_ProceedsfromAvailableforsaleSecuritiesShortterm"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_dec36d57-4957-4aef-ad27-46ff3ceaab25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_7fd5835d-fd6b-4f26-9ce9-a34a447cb7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_7fd5835d-fd6b-4f26-9ce9-a34a447cb7ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentInMultilineReinsurer_9115a97c-de1d-4974-bcae-35e1095004e9" xlink:href="ahl-20231220.xsd#ahl_InvestmentInMultilineReinsurer"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_InvestmentInMultilineReinsurer_9115a97c-de1d-4974-bcae-35e1095004e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PurchasesOfProceedsFromCatastropheBonds_a1013f89-0ca0-4ddd-a582-b438d390553a" xlink:href="ahl-20231220.xsd#ahl_PurchasesOfProceedsFromCatastropheBonds"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_PurchasesOfProceedsFromCatastropheBonds_a1013f89-0ca0-4ddd-a582-b438d390553a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_1c40af99-d268-4683-a77e-0c3dc2970c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_1c40af99-d268-4683-a77e-0c3dc2970c06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2392145c-94da-4067-9379-191672a27771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2392145c-94da-4067-9379-191672a27771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_44b40c4d-60d0-440c-95d9-3ccf8b33b5ec" xlink:href="ahl-20231220.xsd#ahl_PaymentstoAcquirePrivatelyheldInvestments"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_44b40c4d-60d0-440c-95d9-3ccf8b33b5ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_0ff1660d-c819-4332-8a7b-2c8a4f53f288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_0ff1660d-c819-4332-8a7b-2c8a4f53f288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_b6843e25-c9db-42f4-83fe-b263592a7a65" xlink:href="ahl-20231220.xsd#ahl_PaymentsforAvailableforsaleSecuritiesShortterm"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_b6843e25-c9db-42f4-83fe-b263592a7a65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_6f36ee3e-a1e1-4361-94f3-a075478b7767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_6f36ee3e-a1e1-4361-94f3-a075478b7767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_e8ade94e-78a8-476f-b3db-cec64ba79fe0" xlink:href="ahl-20231220.xsd#ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_e8ade94e-78a8-476f-b3db-cec64ba79fe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_66ba26b2-1627-4bfe-86e2-9c3565bd10f2" xlink:href="ahl-20231220.xsd#ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7365244d-4165-4c4f-a5dd-62bc36b99c8f" xlink:to="loc_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_66ba26b2-1627-4bfe-86e2-9c3565bd10f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETS_1"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_472f558d-c766-412f-96d7-b5de3dccc888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9342931e-e6a5-4d5d-8306-9fe2ed6cd885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_472f558d-c766-412f-96d7-b5de3dccc888" xlink:to="loc_us-gaap_PreferredStockValue_9342931e-e6a5-4d5d-8306-9fe2ed6cd885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_536b653c-bbf0-44ff-9aa3-d790a0f272ab" xlink:href="ahl-20231220.xsd#ahl_AdditionalPaidInCapitalExcludingPreferenceShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_472f558d-c766-412f-96d7-b5de3dccc888" xlink:to="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_536b653c-bbf0-44ff-9aa3-d790a0f272ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ef0facfc-3f77-4a04-ba75-354ab88b1c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_472f558d-c766-412f-96d7-b5de3dccc888" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ef0facfc-3f77-4a04-ba75-354ab88b1c3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_75af2854-7a4b-45ae-b407-05635688d70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_472f558d-c766-412f-96d7-b5de3dccc888" xlink:to="loc_us-gaap_CommonStockValue_75af2854-7a4b-45ae-b407-05635688d70b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0fa05e10-af1d-4d17-b47e-2a110dcad0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_472f558d-c766-412f-96d7-b5de3dccc888" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0fa05e10-af1d-4d17-b47e-2a110dcad0e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_2a6c766a-0390-499e-91a9-55819fae0d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:to="loc_us-gaap_DerivativeLiabilities_2a6c766a-0390-499e-91a9-55819fae0d9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_df4258fe-236e-402d-b988-4ce287c69e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:to="loc_us-gaap_ShortTermBorrowings_df4258fe-236e-402d-b988-4ce287c69e6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_619e61ef-45f1-47ff-b624-892f5676b5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_619e61ef-45f1-47ff-b624-892f5676b5a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserves_8812c6eb-e606-41e0-b41d-66c768522476" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:to="loc_ahl_InsuranceReserves_8812c6eb-e606-41e0-b41d-66c768522476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_463178dc-7021-4c51-aed2-4700626e4e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_463178dc-7021-4c51-aed2-4700626e4e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_203e65cb-3a9f-4321-8651-6bc886d52396" xlink:href="ahl-20231220.xsd#ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:to="loc_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_203e65cb-3a9f-4321-8651-6bc886d52396" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7e5ed6c1-4ffc-4dd4-a022-7d4df403059c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:to="loc_us-gaap_OperatingLeaseLiability_7e5ed6c1-4ffc-4dd4-a022-7d4df403059c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePayable_7cedc367-3946-4cc9-abec-fd8cd6efc928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a6628af-1c65-4f95-883c-69eb29df3d4f" xlink:to="loc_us-gaap_ReinsurancePayable_7cedc367-3946-4cc9-abec-fd8cd6efc928" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_90442676-e38e-40ba-9e9b-451a1fe6e884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_90442676-e38e-40ba-9e9b-451a1fe6e884" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentsExcludingDerivativeAssets_fb9db38d-ac42-42bf-af2f-21a09154a052" xlink:href="ahl-20231220.xsd#ahl_InvestmentsExcludingDerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_ahl_InvestmentsExcludingDerivativeAssets_fb9db38d-ac42-42bf-af2f-21a09154a052" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f9b5879-3d75-451b-be2e-b4009a9abcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f9b5879-3d75-451b-be2e-b4009a9abcd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_3ad4b930-ea0c-4b1b-a7f3-1afb833864c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldUnderReinsuranceAgreementsAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_3ad4b930-ea0c-4b1b-a7f3-1afb833864c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_822ab5b2-765b-4c64-9e6f-76556163cb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_822ab5b2-765b-4c64-9e6f-76556163cb3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_741a9e00-e219-4302-8382-8ade24077499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_OtherReceivables_741a9e00-e219-4302-8382-8ade24077499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_ff02b091-5a08-4b14-b414-f0cc4cf927e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_ff02b091-5a08-4b14-b414-f0cc4cf927e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums_11619357-cc14-4bf9-a737-8d9bf2a7fe80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_PrepaidReinsurancePremiums_11619357-cc14-4bf9-a737-8d9bf2a7fe80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_c8d8b743-c246-4585-a559-cc8504b05315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_c8d8b743-c246-4585-a559-cc8504b05315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_3fd008cc-39e9-45ac-972e-b1d0306ae439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_DerivativeAssets_3fd008cc-39e9-45ac-972e-b1d0306ae439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherMiscellaneousAssets_dfbb32c6-3851-41c3-9de0-ec7d43e582bf" xlink:href="ahl-20231220.xsd#ahl_OtherMiscellaneousAssets"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_ahl_OtherMiscellaneousAssets_dfbb32c6-3851-41c3-9de0-ec7d43e582bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_5f7a8724-43e7-4500-a084-1ca6a71c6705" xlink:href="ahl-20231220.xsd#ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_5f7a8724-43e7-4500-a084-1ca6a71c6705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_a56939c3-91fb-43b6-858e-2a87f4128517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2b228270-4088-4499-b846-9e21a7b31dfc" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_a56939c3-91fb-43b6-858e-2a87f4128517" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_a4c752ce-3f88-470c-899c-719ac01288d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_ccabc277-a8a3-4f04-8710-0dc9ca04a389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_a4c752ce-3f88-470c-899c-719ac01288d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_ccabc277-a8a3-4f04-8710-0dc9ca04a389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fbd3e7c5-e8bb-49bf-a367-a899c8c7c7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_a4c752ce-3f88-470c-899c-719ac01288d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fbd3e7c5-e8bb-49bf-a367-a899c8c7c7d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6f1128e6-7c3f-4906-8616-6b986bb70c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6f1128e6-7c3f-4906-8616-6b986bb70c25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_e9fcf07f-79e6-451d-87bc-0680ed4acc29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_e9fcf07f-79e6-451d-87bc-0680ed4acc29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_b1978247-2400-40ec-ac9e-06f7baf0e22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_b1978247-2400-40ec-ac9e-06f7baf0e22a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets_419f87bc-ddad-426b-9f27-f3a696080a12" xlink:href="ahl-20231220.xsd#ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets_419f87bc-ddad-426b-9f27-f3a696080a12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_eee22f2a-e646-4dc9-a91a-f285aa3988eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_eee22f2a-e646-4dc9-a91a-f285aa3988eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_7369295b-0a41-42e0-8aae-f5f9e9d84073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_7369295b-0a41-42e0-8aae-f5f9e9d84073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_fac09d92-5068-4e28-9899-0146a57b1200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_fac09d92-5068-4e28-9899-0146a57b1200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_d8a48295-9395-4f1c-b3b1-9280dc054ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_d8a48295-9395-4f1c-b3b1-9280dc054ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_32fd04b0-3a0e-41c1-804a-58585cfcb90b" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_32fd04b0-3a0e-41c1-804a-58585cfcb90b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1360c6a0-2490-4dbe-bbe5-e9058c066256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1360c6a0-2490-4dbe-bbe5-e9058c066256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Interestonoperatingleaseliabilities_61e261cd-1042-4161-aed6-47a476e4abc2" xlink:href="ahl-20231220.xsd#ahl_Interestonoperatingleaseliabilities"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_ahl_Interestonoperatingleaseliabilities_61e261cd-1042-4161-aed6-47a476e4abc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReinsurancePayables_ee3c6462-9b10-4248-8869-05b66594d62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReinsurancePayables"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInReinsurancePayables_ee3c6462-9b10-4248-8869-05b66594d62a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_a64ac01b-78cc-4d1e-b484-e9f9b2758bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_a64ac01b-78cc-4d1e-b484-e9f9b2758bbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_f1a0ac75-2fcf-4eda-8117-664193689c46" xlink:href="ahl-20231220.xsd#ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_f1a0ac75-2fcf-4eda-8117-664193689c46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetAdditionsdisposalsOfLeaseLiabilities_8af9cec2-e94c-4198-bbf0-45f268af6631" xlink:href="ahl-20231220.xsd#ahl_NetAdditionsdisposalsOfLeaseLiabilities"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_ahl_NetAdditionsdisposalsOfLeaseLiabilities_8af9cec2-e94c-4198-bbf0-45f268af6631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b8eddf44-4652-4d96-b4e0-d1922f4b5e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b8eddf44-4652-4d96-b4e0-d1922f4b5e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_229959c2-0458-4c32-9367-35e065c51722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_229959c2-0458-4c32-9367-35e065c51722" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_3b43ee3f-9a2a-4fa6-9690-f2a3ac60881b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_3b43ee3f-9a2a-4fa6-9690-f2a3ac60881b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GainsLossesOnInvestmentAndForeignExchange_5b38f8ea-128c-4145-8183-b156725077c3" xlink:href="ahl-20231220.xsd#ahl_GainsLossesOnInvestmentAndForeignExchange"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_ahl_GainsLossesOnInvestmentAndForeignExchange_5b38f8ea-128c-4145-8183-b156725077c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_09666f47-2727-4f6a-a66b-2d0a46b625de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_09666f47-2727-4f6a-a66b-2d0a46b625de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_236f8f32-e615-48e8-9dd4-7ab749e6d122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_236f8f32-e615-48e8-9dd4-7ab749e6d122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_a7ef16ab-67de-46b1-96b8-35fba30a7027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:calculationArc order="22" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_a7ef16ab-67de-46b1-96b8-35fba30a7027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_ed9b510b-a5b0-41ab-a409-e9ca73b67f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="23" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_ed9b510b-a5b0-41ab-a409-e9ca73b67f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnpaidLosses_a0fa1036-d965-49c3-b494-7b791bb3aaa7" xlink:href="ahl-20231220.xsd#ahl_UnpaidLosses"/>
    <link:calculationArc order="24" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_ahl_UnpaidLosses_a0fa1036-d965-49c3-b494-7b791bb3aaa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a590bd29-3bd9-4fbb-b825-fc0e16130a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="25" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a590bd29-3bd9-4fbb-b825-fc0e16130a3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_4fe64548-6fcc-444d-a4b0-373ec429dd89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="26" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aaee0b37-77cf-49bd-9f7a-6831e3e02030" xlink:to="loc_us-gaap_GainLossOnInvestments_4fe64548-6fcc-444d-a4b0-373ec429dd89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingExpenseRatio_673c35c9-5848-44cd-8aa8-430efe27781c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCostRatio_97617514-de02-4954-8818-4f12ba6293cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCostRatio"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnderwritingExpenseRatio_673c35c9-5848-44cd-8aa8-430efe27781c" xlink:to="loc_us-gaap_AcquisitionCostRatio_97617514-de02-4954-8818-4f12ba6293cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_6336703b-5b19-4fc6-b3da-8fd6fc24c0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnderwritingExpenseRatio_673c35c9-5848-44cd-8aa8-430efe27781c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_6336703b-5b19-4fc6-b3da-8fd6fc24c0dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CombinedRatio_79fcd864-889b-4e28-8947-7b079ea3a09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CombinedRatio"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossRatio_affc92d8-bea2-4a44-b95f-2617128dd738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossRatio"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CombinedRatio_79fcd864-889b-4e28-8947-7b079ea3a09b" xlink:to="loc_us-gaap_LossRatio_affc92d8-bea2-4a44-b95f-2617128dd738" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingExpenseRatio_9b32eb70-8c56-424d-bf23-6c8871a6aad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CombinedRatio_79fcd864-889b-4e28-8947-7b079ea3a09b" xlink:to="loc_us-gaap_UnderwritingExpenseRatio_9b32eb70-8c56-424d-bf23-6c8871a6aad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingIncomeLoss_cddb304f-1149-449c-aa90-7198cf8f350d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_6d5fe6a7-8467-4ecb-9c32-302e4e533f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnderwritingIncomeLoss_cddb304f-1149-449c-aa90-7198cf8f350d" xlink:to="loc_us-gaap_PremiumsEarnedNet_6d5fe6a7-8467-4ecb-9c32-302e4e533f9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_9561f3c7-88ae-4d71-9725-1e4f6787726b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnderwritingIncomeLoss_cddb304f-1149-449c-aa90-7198cf8f350d" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_9561f3c7-88ae-4d71-9725-1e4f6787726b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_e480b93d-f5ac-4e20-8bc0-f26bb37fc2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnderwritingIncomeLoss_cddb304f-1149-449c-aa90-7198cf8f350d" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_e480b93d-f5ac-4e20-8bc0-f26bb37fc2b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9954147d-0887-4324-93a9-4673ea1af344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnderwritingIncomeLoss_cddb304f-1149-449c-aa90-7198cf8f350d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9954147d-0887-4324-93a9-4673ea1af344" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_c7ccb97a-73f3-4f8b-a05b-fbf3bd073c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_a1b2dad3-88d2-4c95-b451-fc3a0a7717e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetInvestmentIncome_c7ccb97a-73f3-4f8b-a05b-fbf3bd073c4b" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_a1b2dad3-88d2-4c95-b451-fc3a0a7717e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_7afddf88-ec59-446a-bed7-2412fc171b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetInvestmentIncome_c7ccb97a-73f3-4f8b-a05b-fbf3bd073c4b" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_7afddf88-ec59-446a-bed7-2412fc171b18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_bcb5cdc7-fade-4485-be31-f0fbb14488a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_1e6dd0b8-c020-4ce4-aa5d-81ec55389214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_bcb5cdc7-fade-4485-be31-f0fbb14488a1" xlink:to="loc_us-gaap_TradingSecurities_1e6dd0b8-c020-4ce4-aa5d-81ec55389214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_9c21e2a2-5372-43b6-9185-f9a5d1b9b494" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_bcb5cdc7-fade-4485-be31-f0fbb14488a1" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_9c21e2a2-5372-43b6-9185-f9a5d1b9b494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_3fc82617-554e-4b01-b066-a8e0bc448482" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_bcb5cdc7-fade-4485-be31-f0fbb14488a1" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_3fc82617-554e-4b01-b066-a8e0bc448482" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedInvestmentGainsLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_659f6d45-2a01-49fe-8c16-8dd00feb35ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedLoss"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_659f6d45-2a01-49fe-8c16-8dd00feb35ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGain_0d54a101-0e88-4ef6-a759-3468ac52feef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGain"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedGain_0d54a101-0e88-4ef6-a759-3468ac52feef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_b4654947-6dff-4d8e-91e9-43c3e843d8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_b4654947-6dff-4d8e-91e9-43c3e843d8ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_8dbfd9a4-d743-4ce7-8973-cc01226a07ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_8dbfd9a4-d743-4ce7-8973-cc01226a07ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_00a32b0d-8ea1-4e55-8ffd-7dcf659f520f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_00a32b0d-8ea1-4e55-8ffd-7dcf659f520f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_6598d816-464c-463e-a41c-033c1c296cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_6598d816-464c-463e-a41c-033c1c296cc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_81015c34-f3db-49cc-8a75-85ae05962d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_81015c34-f3db-49cc-8a75-85ae05962d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_4ae4e3e7-d6bf-435d-9d63-2145f960a159" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesCatastropheBondsGainLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_4ae4e3e7-d6bf-435d-9d63-2145f960a159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_3b130776-b161-454b-8c02-3956e5762e0b" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_f4941262-c07d-4cf9-b271-554a20efdd45" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_3b130776-b161-454b-8c02-3956e5762e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c3a0612c-82e5-46c0-a153-c493e46cf1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_0ba00966-ec3f-44d6-a144-a345168d66a4" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c3a0612c-82e5-46c0-a153-c493e46cf1c5" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_0ba00966-ec3f-44d6-a144-a345168d66a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_f87f56aa-be9d-468b-a384-3cc9cc1e6168" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c3a0612c-82e5-46c0-a153-c493e46cf1c5" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_f87f56aa-be9d-468b-a384-3cc9cc1e6168" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofFixedMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_acdba84b-fa85-4264-9014-7440ad159fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_3b4396e9-0dbf-437d-95d3-494dda4e9477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_acdba84b-fa85-4264-9014-7440ad159fc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_3b4396e9-0dbf-437d-95d3-494dda4e9477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_61e2d95b-0081-4fa8-89f3-ad32e26c5faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_acdba84b-fa85-4264-9014-7440ad159fc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_61e2d95b-0081-4fa8-89f3-ad32e26c5faf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_4d081fab-355b-4dfc-8673-08f27a9a0cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_acdba84b-fa85-4264-9014-7440ad159fc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_4d081fab-355b-4dfc-8673-08f27a9a0cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_36551984-34df-48b1-93de-ada0bdb8b1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_acdba84b-fa85-4264-9014-7440ad159fc9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_36551984-34df-48b1-93de-ada0bdb8b1ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c3f12dd-5a0e-4741-bd58-d39df8543a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_e77d41e8-75ad-469e-99cb-c4c461255069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c3f12dd-5a0e-4741-bd58-d39df8543a58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_e77d41e8-75ad-469e-99cb-c4c461255069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_a628fe2c-a2dc-4f10-8142-c152c1ff2c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c3f12dd-5a0e-4741-bd58-d39df8543a58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_a628fe2c-a2dc-4f10-8142-c152c1ff2c4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_b7facae6-e847-4297-b643-ab11f8cd9a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c3f12dd-5a0e-4741-bd58-d39df8543a58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_b7facae6-e847-4297-b643-ab11f8cd9a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_46b0aea1-5780-4f8d-b20f-fe3974f16a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c3f12dd-5a0e-4741-bd58-d39df8543a58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_46b0aea1-5780-4f8d-b20f-fe3974f16a3b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_54b68c68-8a03-44db-95e6-055a68c95121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_31f2839c-129a-4448-ba1d-f2ea8db593e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_54b68c68-8a03-44db-95e6-055a68c95121" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_31f2839c-129a-4448-ba1d-f2ea8db593e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1ea131d6-3215-40a9-b321-1a8128380f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_54b68c68-8a03-44db-95e6-055a68c95121" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1ea131d6-3215-40a9-b321-1a8128380f76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_17a09a02-ab0e-4682-ad1b-aa7511c0323f" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_83b989e2-18dc-4df5-bd13-e0f2faf5ce99" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_17a09a02-ab0e-4682-ad1b-aa7511c0323f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_83b989e2-18dc-4df5-bd13-e0f2faf5ce99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_7271e751-bd83-4111-a6a4-e4501b857d57" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_17a09a02-ab0e-4682-ad1b-aa7511c0323f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_7271e751-bd83-4111-a6a4-e4501b857d57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_f12d4d92-ab10-454f-9275-2d95cd3bfb77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_e83529ae-00eb-4a58-b7dc-b54f656b50e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_f12d4d92-ab10-454f-9275-2d95cd3bfb77" xlink:to="loc_us-gaap_DirectPremiumsEarned_e83529ae-00eb-4a58-b7dc-b54f656b50e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_e7c6b404-0ef7-420b-acc3-45328daa508f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_f12d4d92-ab10-454f-9275-2d95cd3bfb77" xlink:to="loc_us-gaap_AssumedPremiumsEarned_e7c6b404-0ef7-420b-acc3-45328daa508f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_fbf96a3e-ce91-46dd-b724-a2e1cc615b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsEarned"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_f12d4d92-ab10-454f-9275-2d95cd3bfb77" xlink:to="loc_us-gaap_CededPremiumsEarned_fbf96a3e-ce91-46dd-b724-a2e1cc615b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_26d4271d-7ebf-447a-98b9-6fc219837d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsWritten_60450ea3-365d-4713-8748-788480aab96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsWritten"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsWrittenNet_26d4271d-7ebf-447a-98b9-6fc219837d7d" xlink:to="loc_us-gaap_DirectPremiumsWritten_60450ea3-365d-4713-8748-788480aab96d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsWritten_83a0e9e5-906f-43eb-9ce1-11c59210bb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsWritten"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsWrittenNet_26d4271d-7ebf-447a-98b9-6fc219837d7d" xlink:to="loc_us-gaap_AssumedPremiumsWritten_83a0e9e5-906f-43eb-9ce1-11c59210bb78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsWritten_a6f76cca-e8c1-4948-8c9c-d1e3a021e14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsWritten"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsWrittenNet_26d4271d-7ebf-447a-98b9-6fc219837d7d" xlink:to="loc_us-gaap_CededPremiumsWritten_a6f76cca-e8c1-4948-8c9c-d1e3a021e14f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_9b486e4f-a941-4148-8374-687d0b26821d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_aa50305d-aa1b-40bd-8e6f-2e2f629c92c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_9b486e4f-a941-4148-8374-687d0b26821d" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_aa50305d-aa1b-40bd-8e6f-2e2f629c92c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_61c9af84-1780-439f-97dd-94ee17a8b908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_9b486e4f-a941-4148-8374-687d0b26821d" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_61c9af84-1780-439f-97dd-94ee17a8b908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_7dc4f0f5-35ac-4596-a1d6-9497adbcf658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_9b486e4f-a941-4148-8374-687d0b26821d" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_7dc4f0f5-35ac-4596-a1d6-9497adbcf658" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_1b907c84-e384-4831-8f4a-e047ae263275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_33de9de1-5a18-4777-bee6-13d2da1cb834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_1b907c84-e384-4831-8f4a-e047ae263275" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_33de9de1-5a18-4777-bee6-13d2da1cb834" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_3bd9854e-4b87-4ee7-bcbf-24cce2754395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_1b907c84-e384-4831-8f4a-e047ae263275" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_3bd9854e-4b87-4ee7-bcbf-24cce2754395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_6ddc156e-c4ab-4f0a-b68f-a6362b1ca1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_2e23d380-89bf-47a8-9bca-e958ede3c0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_6ddc156e-c4ab-4f0a-b68f-a6362b1ca1dd" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_2e23d380-89bf-47a8-9bca-e958ede3c0b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_60794d03-45c2-43ee-9cf0-ed00407977a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_6ddc156e-c4ab-4f0a-b68f-a6362b1ca1dd" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_60794d03-45c2-43ee-9cf0-ed00407977a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_bbd4faf9-7c6a-4009-8881-ba1ca79ec39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5aef63a2-da8e-4aba-86ab-35780304c107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_bbd4faf9-7c6a-4009-8881-ba1ca79ec39f" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5aef63a2-da8e-4aba-86ab-35780304c107" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesAdjustment_8b3b6390-0cc2-4cd0-8a30-5e03d52aab17" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesAdjustment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_bbd4faf9-7c6a-4009-8881-ba1ca79ec39f" xlink:to="loc_ahl_ReinsuranceRecoverablesAdjustment_8b3b6390-0cc2-4cd0-8a30-5e03d52aab17" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f186f309-fa7e-45e4-8743-74667f2b1e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_faab9055-c869-4b4f-be1f-f1e94e43f577" xlink:href="ahl-20231220.xsd#ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f186f309-fa7e-45e4-8743-74667f2b1e79" xlink:to="loc_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_faab9055-c869-4b4f-be1f-f1e94e43f577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_9ef837c4-aa98-4183-8678-b24ccf09ae1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f186f309-fa7e-45e4-8743-74667f2b1e79" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_9ef837c4-aa98-4183-8678-b24ccf09ae1b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesSummaryofTotalIncomeTaxDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesSummaryofTotalIncomeTaxDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/IncomeTaxesSummaryofTotalIncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_df34108d-5248-4ac7-abbc-7dd71644091e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a9cae4a5-14a8-4b88-ad0d-a55b0d03ee5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_df34108d-5248-4ac7-abbc-7dd71644091e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a9cae4a5-14a8-4b88-ad0d-a55b0d03ee5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_76a5ae43-89c8-40c1-aeda-1973402e649d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_df34108d-5248-4ac7-abbc-7dd71644091e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_76a5ae43-89c8-40c1-aeda-1973402e649d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa052799-6a3d-4b06-8d76-5a3d3cc799b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ea2f0580-8855-436c-847b-677084e9b0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa052799-6a3d-4b06-8d76-5a3d3cc799b9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ea2f0580-8855-436c-847b-677084e9b0a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_27cdd02a-4f05-438d-8c81-ae557363daa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa052799-6a3d-4b06-8d76-5a3d3cc799b9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_27cdd02a-4f05-438d-8c81-ae557363daa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_92906134-51d0-4c73-8db6-b4d7d66af586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_30a4c830-19c2-4978-95c1-cd7f792e0c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_92906134-51d0-4c73-8db6-b4d7d66af586" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_30a4c830-19c2-4978-95c1-cd7f792e0c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_3130bd5c-b1e2-401c-bb80-d8b1fd2a92cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_92906134-51d0-4c73-8db6-b4d7d66af586" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_3130bd5c-b1e2-401c-bb80-d8b1fd2a92cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9192683e-53e5-4f8e-b202-6a36a668e260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_0dedb1cf-d2db-46ba-8a5b-12b252e1a8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_9192683e-53e5-4f8e-b202-6a36a668e260" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_0dedb1cf-d2db-46ba-8a5b-12b252e1a8bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9c02c690-4c28-4b9d-81eb-4f9dbaba24e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_9192683e-53e5-4f8e-b202-6a36a668e260" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9c02c690-4c28-4b9d-81eb-4f9dbaba24e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_70e10ef8-dcf1-433e-b809-49725b128181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6c79cf41-3273-4761-bc46-79847d7b1c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_70e10ef8-dcf1-433e-b809-49725b128181" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6c79cf41-3273-4761-bc46-79847d7b1c58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2a745b26-fdf0-409e-b386-ff849da97955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_70e10ef8-dcf1-433e-b809-49725b128181" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2a745b26-fdf0-409e-b386-ff849da97955" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesIncomeTaxReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_a51177a4-8372-491b-94f9-73c0a720f3f5" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_a51177a4-8372-491b-94f9-73c0a720f3f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_10916607-884b-4270-bf66-8050b94a6632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_10916607-884b-4270-bf66-8050b94a6632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6fd19e1b-318f-450a-94d3-1a03dcc346e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6fd19e1b-318f-450a-94d3-1a03dcc346e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_d78f5bc9-64e7-4566-b3dd-7c54d7ff055f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_d78f5bc9-64e7-4566-b3dd-7c54d7ff055f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_2f640f83-a6b4-419f-b04f-9b10ba85bcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_2f640f83-a6b4-419f-b04f-9b10ba85bcc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_50569f62-33e8-49e2-bdfd-b18f3f1af840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesForeign"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_50569f62-33e8-49e2-bdfd-b18f3f1af840" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_8c8d2a23-c37c-4cba-98ef-c90554546004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_8c8d2a23-c37c-4cba-98ef-c90554546004" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_e7ebbe2a-61b3-4b6b-b518-23208eb0ff59" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_e7ebbe2a-61b3-4b6b-b518-23208eb0ff59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_d8d73573-fd0d-44ec-b9ff-bc7cd9092321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_d8d73573-fd0d-44ec-b9ff-bc7cd9092321" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c6ce18f4-28cb-4a63-9adb-978f8c046ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c6ce18f4-28cb-4a63-9adb-978f8c046ea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1841730b-e360-47a4-a593-f0c492307fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d3bf74b-3e61-4971-950d-b8b5691920ab" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1841730b-e360-47a4-a593-f0c492307fa0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesTaxEffectsofDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesTaxEffectsofDeferredTaxAssetsandDeferredTaxLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/IncomeTaxesTaxEffectsofDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_a3db6eee-a35b-4d08-869d-1eeddd2170ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_092e6ca0-2151-43fb-9c10-af86b741c8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_a3db6eee-a35b-4d08-869d-1eeddd2170ba" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_092e6ca0-2151-43fb-9c10-af86b741c8e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f2608abf-f3b2-4c6f-9543-e9cc79216d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_a3db6eee-a35b-4d08-869d-1eeddd2170ba" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f2608abf-f3b2-4c6f-9543-e9cc79216d8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e0f7e8d4-8a45-4485-936f-ce86220f8087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e0f7e8d4-8a45-4485-936f-ce86220f8087" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_b61ea453-c65d-47e0-9573-ac69f2dbb11f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_b61ea453-c65d-47e0-9573-ac69f2dbb11f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_472b0b6e-e21c-4545-8582-5d7582cd9b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_472b0b6e-e21c-4545-8582-5d7582cd9b66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_1100d224-e340-4464-9150-eaa91a98c283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_1100d224-e340-4464-9150-eaa91a98c283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_c68d7870-fabd-4d80-bd18-4707a7ecfa10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_c68d7870-fabd-4d80-bd18-4707a7ecfa10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_cfe9ff56-0a05-47ce-90cf-e8a7b4b71fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_cfe9ff56-0a05-47ce-90cf-e8a7b4b71fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsUnearnedPremiums_0383b6a5-8a87-46b9-a72e-744a898248f2" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsUnearnedPremiums"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_ahl_DeferredTaxAssetsUnearnedPremiums_0383b6a5-8a87-46b9-a72e-744a898248f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_f773ff6e-ae1e-48d0-9438-42ecdc09b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_f773ff6e-ae1e-48d0-9438-42ecdc09b40b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets_785662c1-790e-446e-88cf-2358d7af30c9" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets_785662c1-790e-446e-88cf-2358d7af30c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLeaseLiability_439a6cbc-b2ba-4a0b-9c64-bb1ca1d643f9" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_ahl_DeferredTaxAssetsOperatingLeaseLiability_439a6cbc-b2ba-4a0b-9c64-bb1ca1d643f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2cc17447-28d6-4334-ad3e-be788ec974d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_46956bd0-9171-48d6-b9bf-38e9d97a0493" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_2cc17447-28d6-4334-ad3e-be788ec974d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_8d6282a7-7d47-43d0-a279-01d92cc6b33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_2c849fdb-5c89-4e2b-89e2-e6db16a2e060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_8d6282a7-7d47-43d0-a279-01d92cc6b33d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_2c849fdb-5c89-4e2b-89e2-e6db16a2e060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_f35526d4-e308-410c-9952-7de2b7c83e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_8d6282a7-7d47-43d0-a279-01d92cc6b33d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_f35526d4-e308-410c-9952-7de2b7c83e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_e109da57-6a98-4f63-9d53-8fb18b20a608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_8d6282a7-7d47-43d0-a279-01d92cc6b33d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_e109da57-6a98-4f63-9d53-8fb18b20a608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets_43513d7f-4d25-4103-8758-9a425ff3ca9c" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_8d6282a7-7d47-43d0-a279-01d92cc6b33d" xlink:to="loc_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets_43513d7f-4d25-4103-8758-9a425ff3ca9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_94202f1b-10ae-4b66-a92a-3db51179c76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_8d6282a7-7d47-43d0-a279-01d92cc6b33d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_94202f1b-10ae-4b66-a92a-3db51179c76e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLiabilitiesGAAPDifferences_7a7e1742-dfa4-4a15-8710-67acf0646a2c" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLiabilitiesGAAPDifferences"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_8d6282a7-7d47-43d0-a279-01d92cc6b33d" xlink:to="loc_ahl_DeferredTaxLiabilitiesGAAPDifferences_7a7e1742-dfa4-4a15-8710-67acf0646a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_56c5fa8e-7eee-47fb-890e-2112d2c8de1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_64a7fdf1-5a38-412e-bc1d-edf5691a816a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_56c5fa8e-7eee-47fb-890e-2112d2c8de1e" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_64a7fdf1-5a38-412e-bc1d-edf5691a816a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_d5f3eda3-7daf-4b99-8e02-b2ff9eceeb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_56c5fa8e-7eee-47fb-890e-2112d2c8de1e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_d5f3eda3-7daf-4b99-8e02-b2ff9eceeb42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_d43dcb68-4b3a-4801-822d-1086a3881252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_68f57d75-fde1-408b-a0d5-c112e685489f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_d43dcb68-4b3a-4801-822d-1086a3881252" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_68f57d75-fde1-408b-a0d5-c112e685489f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_4c192a42-01bd-473d-ab78-6a70092dd86d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_d43dcb68-4b3a-4801-822d-1086a3881252" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_4c192a42-01bd-473d-ab78-6a70092dd86d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_43bff58a-6ddd-43b6-a9ac-138109a2ee03" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CommonStockValueAuthorized_a4a2bfcc-7a2c-4472-bbe5-a81fe3c10bb5" xlink:href="ahl-20231220.xsd#ahl_CommonStockValueAuthorized"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_AuthorizedShareCapital_43bff58a-6ddd-43b6-a9ac-138109a2ee03" xlink:to="loc_ahl_CommonStockValueAuthorized_a4a2bfcc-7a2c-4472-bbe5-a81fe3c10bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockValueAuthorized_29d8b800-7d15-42b3-b365-4c147e004953" xlink:href="ahl-20231220.xsd#ahl_PreferredStockValueAuthorized"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_AuthorizedShareCapital_43bff58a-6ddd-43b6-a9ac-138109a2ee03" xlink:to="loc_ahl_PreferredStockValueAuthorized_29d8b800-7d15-42b3-b365-4c147e004953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapital_44d3296f-b72c-42d3-b45e-56ce78be39a2" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_664abf4c-a58b-478a-9e1c-146071be0f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_IssuedShareCapital_44d3296f-b72c-42d3-b45e-56ce78be39a2" xlink:to="loc_us-gaap_CommonStockValue_664abf4c-a58b-478a-9e1c-146071be0f78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_882b8efb-7c1a-4612-b1eb-94070f2a243a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesSubscribedButUnissuedValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ahl_IssuedShareCapital_44d3296f-b72c-42d3-b45e-56ce78be39a2" xlink:to="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_882b8efb-7c1a-4612-b1eb-94070f2a243a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53256dee-f25f-4823-9899-71eed2709dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a1e4fa37-f2b7-40ac-976f-2c0542123893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53256dee-f25f-4823-9899-71eed2709dbd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a1e4fa37-f2b7-40ac-976f-2c0542123893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5431d2ac-9530-4d64-9419-f626e5ccdc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53256dee-f25f-4823-9899-71eed2709dbd" xlink:to="loc_us-gaap_OperatingLeaseLiability_5431d2ac-9530-4d64-9419-f626e5ccdc4c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b2c48b7-d174-4038-8d76-15ae70023364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d000553c-e442-4fd7-b0c5-9e192035b47f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b2c48b7-d174-4038-8d76-15ae70023364" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d000553c-e442-4fd7-b0c5-9e192035b47f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ae083a8-85dd-45bf-8a53-e86afc172816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b2c48b7-d174-4038-8d76-15ae70023364" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ae083a8-85dd-45bf-8a53-e86afc172816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d5dd63dc-090a-4944-8e88-4f7b8261550b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b2c48b7-d174-4038-8d76-15ae70023364" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d5dd63dc-090a-4944-8e88-4f7b8261550b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear_1b92763a-8ebc-497b-8166-26b61d335dea" xlink:href="ahl-20231220.xsd#ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b2c48b7-d174-4038-8d76-15ae70023364" xlink:to="loc_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear_1b92763a-8ebc-497b-8166-26b61d335dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_eb2b3570-88ff-434b-a060-a72b665392c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b2c48b7-d174-4038-8d76-15ae70023364" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_eb2b3570-88ff-434b-a060-a72b665392c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8fe6c490-10af-425a-b99c-b1e734cf3f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b2c48b7-d174-4038-8d76-15ae70023364" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8fe6c490-10af-425a-b99c-b1e734cf3f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_885c4334-2bd8-4775-8210-139f2e433f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b2c48b7-d174-4038-8d76-15ae70023364" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_885c4334-2bd8-4775-8210-139f2e433f55" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa0b5c7e-4f8b-43b7-9aea-3619ebdc5038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_9f31e10b-20d7-4057-b96c-b66d478c9289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa0b5c7e-4f8b-43b7-9aea-3619ebdc5038" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_9f31e10b-20d7-4057-b96c-b66d478c9289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_8156108e-5ca2-4469-99cb-0ccbbb55cd68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa0b5c7e-4f8b-43b7-9aea-3619ebdc5038" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_8156108e-5ca2-4469-99cb-0ccbbb55cd68" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1fa37725-f166-4315-babe-8540b64bdfc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_8d87aece-3869-4f56-b0c5-6b56a1e7a956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1fa37725-f166-4315-babe-8540b64bdfc8" xlink:to="loc_us-gaap_TradingSecurities_8d87aece-3869-4f56-b0c5-6b56a1e7a956" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_21d2b6a7-4412-4929-9239-fd2a55d2fbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1fa37725-f166-4315-babe-8540b64bdfc8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_21d2b6a7-4412-4929-9239-fd2a55d2fbd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_21d4e912-c349-4adb-81a0-614057ab40f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1fa37725-f166-4315-babe-8540b64bdfc8" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_21d4e912-c349-4adb-81a0-614057ab40f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_c26db910-f408-459f-b550-3e853b38f01a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1fa37725-f166-4315-babe-8540b64bdfc8" xlink:to="loc_us-gaap_OtherInvestments_c26db910-f408-459f-b550-3e853b38f01a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_e9f48b36-0b29-40b1-b7d1-a73913aa1443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromAffiliates"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1fa37725-f166-4315-babe-8540b64bdfc8" xlink:to="loc_us-gaap_DueFromAffiliates_e9f48b36-0b29-40b1-b7d1-a73913aa1443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_20507f85-c5c4-462e-81e7-2e2195f64e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1fa37725-f166-4315-babe-8540b64bdfc8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_20507f85-c5c4-462e-81e7-2e2195f64e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_7bd9d4ab-2bb1-418c-9d8c-65f3079e3d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1fa37725-f166-4315-babe-8540b64bdfc8" xlink:to="loc_us-gaap_OtherAssets_7bd9d4ab-2bb1-418c-9d8c-65f3079e3d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_670d5c2b-3175-4cd7-ad57-dce05c574ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_aee29323-cd42-4e02-8dd4-ade28668474f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_670d5c2b-3175-4cd7-ad57-dce05c574ef7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_aee29323-cd42-4e02-8dd4-ade28668474f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_7876c8f1-2f88-45f7-adb9-cd7013133a40" xlink:href="ahl-20231220.xsd#ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_670d5c2b-3175-4cd7-ad57-dce05c574ef7" xlink:to="loc_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_7876c8f1-2f88-45f7-adb9-cd7013133a40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_52e7934e-0295-44b6-9925-f414e8457889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_670d5c2b-3175-4cd7-ad57-dce05c574ef7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_52e7934e-0295-44b6-9925-f414e8457889" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a497f93c-7c92-4a50-80c9-a73aac1d21c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e859694b-ba10-4951-affa-9388be5b9b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a497f93c-7c92-4a50-80c9-a73aac1d21c2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e859694b-ba10-4951-affa-9388be5b9b43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a0adb75f-141d-4c1e-89ea-927923c5e794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a497f93c-7c92-4a50-80c9-a73aac1d21c2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a0adb75f-141d-4c1e-89ea-927923c5e794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_25f706d9-1f16-4251-baaf-766567bcff56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a497f93c-7c92-4a50-80c9-a73aac1d21c2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_25f706d9-1f16-4251-baaf-766567bcff56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19b39fe0-9351-4940-a056-fd877bfa5d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_692dae28-035f-4996-9c28-6082e19b08b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19b39fe0-9351-4940-a056-fd877bfa5d09" xlink:to="loc_us-gaap_Revenues_692dae28-035f-4996-9c28-6082e19b08b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_44539ee1-917d-41ee-8e63-8e12430fee85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19b39fe0-9351-4940-a056-fd877bfa5d09" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_44539ee1-917d-41ee-8e63-8e12430fee85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7cc5f835-8440-487d-80e2-3452fe652c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19b39fe0-9351-4940-a056-fd877bfa5d09" xlink:to="loc_us-gaap_InterestExpense_7cc5f835-8440-487d-80e2-3452fe652c83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_05753f5e-1b20-4b61-ac32-eb417a3ae476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19b39fe0-9351-4940-a056-fd877bfa5d09" xlink:to="loc_us-gaap_OtherExpenses_05753f5e-1b20-4b61-ac32-eb417a3ae476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dffa41a3-ebdd-4fb8-9d80-1d9b0c408318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityInNetEarningsOfSubsidiaries_79275587-aad0-488b-b67f-001a28c81630" xlink:href="ahl-20231220.xsd#ahl_EquityInNetEarningsOfSubsidiaries"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_dffa41a3-ebdd-4fb8-9d80-1d9b0c408318" xlink:to="loc_ahl_EquityInNetEarningsOfSubsidiaries_79275587-aad0-488b-b67f-001a28c81630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_f22378d1-2dbc-4545-a99b-a0d034a27bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_dffa41a3-ebdd-4fb8-9d80-1d9b0c408318" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_f22378d1-2dbc-4545-a99b-a0d034a27bf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_1a59db47-bd8a-45b8-a2fc-e38f7c5ffd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_dffa41a3-ebdd-4fb8-9d80-1d9b0c408318" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_1a59db47-bd8a-45b8-a2fc-e38f7c5ffd9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_1395e5cf-c1bd-4e0c-a001-98aaf9042d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_dffa41a3-ebdd-4fb8-9d80-1d9b0c408318" xlink:to="loc_us-gaap_OtherIncome_1395e5cf-c1bd-4e0c-a001-98aaf9042d06" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails"/>
  <link:calculationLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2cc813c5-7194-4922-ac4d-3b90e54d90d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_1abac7ad-b133-4eac-b366-c93d5ba6f8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2cc813c5-7194-4922-ac4d-3b90e54d90d6" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_1abac7ad-b133-4eac-b366-c93d5ba6f8c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_9e95da23-89a3-4e58-8f32-00bc15b15f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2cc813c5-7194-4922-ac4d-3b90e54d90d6" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_9e95da23-89a3-4e58-8f32-00bc15b15f1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_cb8c6daf-072f-4440-8e36-bdb84d268f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2cc813c5-7194-4922-ac4d-3b90e54d90d6" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_cb8c6daf-072f-4440-8e36-bdb84d268f60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_56fde9f0-7210-4e1d-9d40-d7cc9d6f2378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2cc813c5-7194-4922-ac4d-3b90e54d90d6" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_56fde9f0-7210-4e1d-9d40-d7cc9d6f2378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2e0bb21e-e22c-4529-b211-2ea0b548bf88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2e0bb21e-e22c-4529-b211-2ea0b548bf88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_06af1d0b-2136-4177-bc3e-28fd0b01544f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_06af1d0b-2136-4177-bc3e-28fd0b01544f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedGainsLosses_1dd7b720-b9c1-465b-9579-a51e3bf0f5ab" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedGainsLosses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_ahl_NetRealizedAndUnrealizedGainsLosses_1dd7b720-b9c1-465b-9579-a51e3bf0f5ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLossOnDerivative_0a68a1c1-38c7-4735-bf0f-bbf159a029a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLossOnDerivative"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_us-gaap_DerivativeLossOnDerivative_0a68a1c1-38c7-4735-bf0f-bbf159a029a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_edd027a6-bed7-43eb-89f7-50848aa5a52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_edd027a6-bed7-43eb-89f7-50848aa5a52c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_ec50f2d2-b2e8-4e05-99c6-8072db3b269f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_ec50f2d2-b2e8-4e05-99c6-8072db3b269f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_c25b38f7-b241-4c4b-8190-14b1953a72fc" xlink:href="ahl-20231220.xsd#ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_c25b38f7-b241-4c4b-8190-14b1953a72fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_bc33ab34-a3d6-4de5-a332-b994ef3263e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_us-gaap_OperatingLeasePayments_bc33ab34-a3d6-4de5-a332-b994ef3263e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncreaseDecreaseInIntercompanyActivities_ac0ba631-311b-40b8-8f20-2c898c38b8bf" xlink:href="ahl-20231220.xsd#ahl_IncreaseDecreaseInIntercompanyActivities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_ahl_IncreaseDecreaseInIntercompanyActivities_ac0ba631-311b-40b8-8f20-2c898c38b8bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ChangeInOtherAssets_93069d83-726c-49f3-9eeb-dd50a3397fff" xlink:href="ahl-20231220.xsd#ahl_ChangeInOtherAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57df1d10-43a2-4cad-8a7d-cf5783bec71d" xlink:to="loc_ahl_ChangeInOtherAssets_93069d83-726c-49f3-9eeb-dd50a3397fff" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>43
<FILENAME>ahl-20231220_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:c8bdf706-6073-4046-a439-e42c560d7bb0,g:8520f5b6-a319-4843-ab2c-4a3e439c5aeb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8053a56a-fd5b-40d8-9e86-7c749021e878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8053a56a-fd5b-40d8-9e86-7c749021e878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_d0335a64-4ff8-46f1-a8a0-29ae497cc65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_us-gaap_TradingSecuritiesDebt_d0335a64-4ff8-46f1-a8a0-29ae497cc65b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsAvailableForSale_5e1a617f-f004-43ff-8310-4c934e4fccaa" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsAvailableForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_ShortTermInvestmentsAvailableForSale_5e1a617f-f004-43ff-8310-4c934e4fccaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValue_384ed158-6380-4cf8-9db2-4133a53dce47" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValue_384ed158-6380-4cf8-9db2-4133a53dce47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_043c16de-616d-4d5b-af19-4fea1dcb8ef6" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_CatastropheBond_043c16de-616d-4d5b-af19-4fea1dcb8ef6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_2d1a6c34-8d61-4a9c-9dc4-6cb85c635d89" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_PrivatelyheldInvestments_2d1a6c34-8d61-4a9c-9dc4-6cb85c635d89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_6dee1330-0e63-44f2-927b-187627c55a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_us-gaap_EquityMethodInvestments_6dee1330-0e63-44f2-927b-187627c55a92" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_020834c8-9952-4164-adf3-f8876361f40f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_us-gaap_OtherInvestments_020834c8-9952-4164-adf3-f8876361f40f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentsExcludingDerivativeAssets_efb29daa-c29e-4865-8462-ec4c8be4dc02" xlink:href="ahl-20231220.xsd#ahl_InvestmentsExcludingDerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_InvestmentsExcludingDerivativeAssets_efb29daa-c29e-4865-8462-ec4c8be4dc02" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0ba41b1e-aaf3-4768-acb2-96ac48de2c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0ba41b1e-aaf3-4768-acb2-96ac48de2c61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_4739aa93-8ccc-41b4-b5f0-d5eb5dbcb1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_4739aa93-8ccc-41b4-b5f0-d5eb5dbcb1f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_d5ea8867-b79d-400a-bc9a-3e8ab4302e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_4739aa93-8ccc-41b4-b5f0-d5eb5dbcb1f7" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_d5ea8867-b79d-400a-bc9a-3e8ab4302e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums_bd7b4f38-a867-47ec-a670-fa460ff1316c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_4739aa93-8ccc-41b4-b5f0-d5eb5dbcb1f7" xlink:to="loc_us-gaap_PrepaidReinsurancePremiums_bd7b4f38-a867-47ec-a670-fa460ff1316c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_ac3779ea-a611-4ac7-8554-70039b69d199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_ReceivablesAbstract_ac3779ea-a611-4ac7-8554-70039b69d199" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_63d3962f-329b-4274-b422-9df4c0d2e670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesAbstract_ac3779ea-a611-4ac7-8554-70039b69d199" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_63d3962f-329b-4274-b422-9df4c0d2e670" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_1151ac75-7bff-44f5-a036-fc67632bd38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesAbstract_ac3779ea-a611-4ac7-8554-70039b69d199" xlink:to="loc_us-gaap_OtherReceivables_1151ac75-7bff-44f5-a036-fc67632bd38e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_d3779c3d-f1dc-4cd1-931b-e549cb063e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldUnderReinsuranceAgreementsAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_d3779c3d-f1dc-4cd1-931b-e549cb063e08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_2c7b31e7-2456-4941-a387-1fe0688e0de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_2c7b31e7-2456-4941-a387-1fe0688e0de6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_3089f0aa-e68c-4717-9be9-9bca963c3907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_DerivativeAssets_3089f0aa-e68c-4717-9be9-9bca963c3907" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_606f9cc6-7ec3-4243-92e3-500019c7c502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_606f9cc6-7ec3-4243-92e3-500019c7c502" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5d4540ae-47f6-4cdf-9577-b2a1736b2140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5d4540ae-47f6-4cdf-9577-b2a1736b2140" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_53acb7b0-37ed-435e-8463-30554e3da97b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_53acb7b0-37ed-435e-8463-30554e3da97b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_3038a8c7-21af-4bb4-9d9d-6765d506780a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_IncomeTaxReceivable_3038a8c7-21af-4bb4-9d9d-6765d506780a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_373f0be7-0eb9-4600-9c34-d3bc78f802db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_373f0be7-0eb9-4600-9c34-d3bc78f802db" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_af1c06b1-064f-4473-a8b3-40e467bf340f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_OtherAssets_af1c06b1-064f-4473-a8b3-40e467bf340f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_eed20739-a6d7-41ba-92a9-d52b9d5ef738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_eed20739-a6d7-41ba-92a9-d52b9d5ef738" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_37b16828-0955-4c81-94ff-ff53d1b1a949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_Assets_37b16828-0955-4c81-94ff-ff53d1b1a949" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserveAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:to="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b1a1310e-5e0a-49ee-b5cc-03d68a04bef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b1a1310e-5e0a-49ee-b5cc-03d68a04bef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_231330c4-3e6b-4be4-a1c6-8d4674aa2125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:to="loc_us-gaap_UnearnedPremiums_231330c4-3e6b-4be4-a1c6-8d4674aa2125" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserves_4c55fec3-a756-44f4-ac32-c2d68d750966" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:to="loc_ahl_InsuranceReserves_4c55fec3-a756-44f4-ac32-c2d68d750966" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePayable_91c4b36a-6af2-4a18-9f8a-9a6a2b26e9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:to="loc_us-gaap_ReinsurancePayable_91c4b36a-6af2-4a18-9f8a-9a6a2b26e9aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_4ca094d7-00d8-4480-85fb-3f498abd5df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_4ca094d7-00d8-4480-85fb-3f498abd5df0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b88e1ac0-3f8a-4e5e-9b6e-aed4506ca38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b88e1ac0-3f8a-4e5e-9b6e-aed4506ca38e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_0b18f1c4-a25b-482c-88f1-abebb1932834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_0b18f1c4-a25b-482c-88f1-abebb1932834" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_a98a70bd-ea1d-4c12-a649-0675872dedda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_a98a70bd-ea1d-4c12-a649-0675872dedda" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_09c3bed5-c04b-4070-a197-0e8ba8a79d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_OperatingLeaseLiability_09c3bed5-c04b-4070-a197-0e8ba8a79d46" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_77e5d146-0399-417f-81d4-045b023a4447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_DerivativeLiabilities_77e5d146-0399-417f-81d4-045b023a4447" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_c1432923-8f07-4012-a24a-b2a30b4df83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_ShortTermBorrowings_c1432923-8f07-4012-a24a-b2a30b4df83d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_37ba1e66-8cfd-4c30-b045-2bfdcbce2183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_LongTermDebt_37ba1e66-8cfd-4c30-b045-2bfdcbce2183" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5d2436eb-f646-4647-bc36-69f0cb91cd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:to="loc_us-gaap_Liabilities_5d2436eb-f646-4647-bc36-69f0cb91cd29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7056acee-99e5-4893-a2e4-f30ed04b8276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7056acee-99e5-4893-a2e4-f30ed04b8276" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6fdf1e4b-9067-43cd-b17c-a983359e3ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6fdf1e4b-9067-43cd-b17c-a983359e3ad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b63ec093-16fc-45a6-816d-70cd00088299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6fdf1e4b-9067-43cd-b17c-a983359e3ad1" xlink:to="loc_us-gaap_CommonStockValue_b63ec093-16fc-45a6-816d-70cd00088299" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b5f58106-fbf5-4d8c-ab8e-8fd0263f839c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b5f58106-fbf5-4d8c-ab8e-8fd0263f839c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3f691b45-64b2-4acf-ac48-80e4a2213d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3f691b45-64b2-4acf-ac48-80e4a2213d23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1d7814f3-0abc-4cd2-80c2-5883ee1f777b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1d7814f3-0abc-4cd2-80c2-5883ee1f777b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d744b68e-e59a-4bfb-bb68-4a4489116e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d744b68e-e59a-4bfb-bb68-4a4489116e11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_787a5780-37df-4c9c-a2b6-3a33b8ee9393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_787a5780-37df-4c9c-a2b6-3a33b8ee9393" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4c19a58d-f20d-4f89-aac9-30ffd42a6511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_InvestmentTypeAxis_4c19a58d-f20d-4f89-aac9-30ffd42a6511" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4c19a58d-f20d-4f89-aac9-30ffd42a6511_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_4c19a58d-f20d-4f89-aac9-30ffd42a6511" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4c19a58d-f20d-4f89-aac9-30ffd42a6511_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_579beea5-1274-4b10-b276-741bcc319bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_4c19a58d-f20d-4f89-aac9-30ffd42a6511" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_579beea5-1274-4b10-b276-741bcc319bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_2d5e1ca3-ed91-4b01-9c81-e40f39e89b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_579beea5-1274-4b10-b276-741bcc319bde" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_2d5e1ca3-ed91-4b01-9c81-e40f39e89b6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_9a5f8bdc-8a0f-4406-8e3b-74670bec5bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_579beea5-1274-4b10-b276-741bcc319bde" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_9a5f8bdc-8a0f-4406-8e3b-74670bec5bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b96ca9bf-4c23-46ee-9911-2eec17c11d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b96ca9bf-4c23-46ee-9911-2eec17c11d45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b96ca9bf-4c23-46ee-9911-2eec17c11d45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b96ca9bf-4c23-46ee-9911-2eec17c11d45" xlink:to="loc_us-gaap_RelatedPartyDomain_b96ca9bf-4c23-46ee-9911-2eec17c11d45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d049dc7f-ac45-4ee6-8a2b-913be1bd5e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b96ca9bf-4c23-46ee-9911-2eec17c11d45" xlink:to="loc_us-gaap_RelatedPartyDomain_d049dc7f-ac45-4ee6-8a2b-913be1bd5e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_7d4b535b-f446-42ad-9409-4e7709776fb1" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d049dc7f-ac45-4ee6-8a2b-913be1bd5e89" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_7d4b535b-f446-42ad-9409-4e7709776fb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_eec95944-b7fc-4447-bb9f-c0a6261105cf" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d049dc7f-ac45-4ee6-8a2b-913be1bd5e89" xlink:to="loc_ahl_ApolloRealEstateFundMember_eec95944-b7fc-4447-bb9f-c0a6261105cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_384eb52a-3de4-4504-ac77-15b500355ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_384eb52a-3de4-4504-ac77-15b500355ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember_d6d8e1ae-d0d9-4976-bf7e-ce746a20a48b" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_384eb52a-3de4-4504-ac77-15b500355ce0" xlink:to="loc_ahl_AccruedExpensesMember_d6d8e1ae-d0d9-4976-bf7e-ce746a20a48b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_85ab917a-e088-45ab-aea4-31db6f11d506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_85ab917a-e088-45ab-aea4-31db6f11d506" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_85ab917a-e088-45ab-aea4-31db6f11d506_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85ab917a-e088-45ab-aea4-31db6f11d506" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_85ab917a-e088-45ab-aea4-31db6f11d506_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_24d465d1-d7d1-437f-b58a-cdaa9c1376ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85ab917a-e088-45ab-aea4-31db6f11d506" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_24d465d1-d7d1-437f-b58a-cdaa9c1376ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_5a710ee7-a258-4e51-b14b-70be9a7acdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_24d465d1-d7d1-437f-b58a-cdaa9c1376ae" xlink:to="loc_us-gaap_AssetManagementArrangementMember_5a710ee7-a258-4e51-b14b-70be9a7acdfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_72703b70-dc2f-4e99-a6b5-bece651387c1" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_24d465d1-d7d1-437f-b58a-cdaa9c1376ae" xlink:to="loc_ahl_ManagementConsultingAgreementMember_72703b70-dc2f-4e99-a6b5-bece651387c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5ee63684-e6d3-412e-b241-e0c17ee4011b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5ee63684-e6d3-412e-b241-e0c17ee4011b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5ee63684-e6d3-412e-b241-e0c17ee4011b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5ee63684-e6d3-412e-b241-e0c17ee4011b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5ee63684-e6d3-412e-b241-e0c17ee4011b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0a8af491-9ca9-423e-97eb-01e29eba861c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5ee63684-e6d3-412e-b241-e0c17ee4011b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0a8af491-9ca9-423e-97eb-01e29eba861c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_84146e8b-69bf-4b1b-8fb4-c4a1fae00421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0a8af491-9ca9-423e-97eb-01e29eba861c" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_84146e8b-69bf-4b1b-8fb4-c4a1fae00421" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a06263c-9768-4a96-9419-31651170eea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a06263c-9768-4a96-9419-31651170eea7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_4d508b63-a4af-43c8-a74a-8a13327efb28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_4d508b63-a4af-43c8-a74a-8a13327efb28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_1066d29e-357b-48f3-9cea-99f9d5c8638d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_1066d29e-357b-48f3-9cea-99f9d5c8638d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost_ecff2017-606b-46cf-9940-eaeebdce36a0" xlink:href="ahl-20231220.xsd#ahl_Shortterminvestmentsavailableforsaleamortizedcost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost_ecff2017-606b-46cf-9940-eaeebdce36a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAmortizedCost_974e074e-61fd-45b5-bc6b-6086c2377ba4" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_ShortTermInvestmentsTradingAmortizedCost_974e074e-61fd-45b5-bc6b-6086c2377ba4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure_026024bf-609c-43ca-a48e-4e86c90b830d" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_CatastropheBondsFairValueDisclosure_026024bf-609c-43ca-a48e-4e86c90b830d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_667d5df0-65d4-47b2-b689-c10d55b70226" xlink:href="ahl-20231220.xsd#ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_667d5df0-65d4-47b2-b689-c10d55b70226" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_b665b727-c9d7-4a7d-acc9-f0453cf55517" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_b665b727-c9d7-4a7d-acc9-f0453cf55517" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_ec762f6e-61f5-4e93-9281-aa6687280b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_ec762f6e-61f5-4e93-9281-aa6687280b49" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_36054677-6cd1-4f06-b0fc-1944520462b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_CommonStockSharesIssued_36054677-6cd1-4f06-b0fc-1944520462b6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c77e9300-40b6-41cb-bfc0-c8b1660d2747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c77e9300-40b6-41cb-bfc0-c8b1660d2747" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_59381745-6492-4cbb-948b-008a4a6998b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_59381745-6492-4cbb-948b-008a4a6998b2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_82942705-163a-4501-8597-7ef34021ec25" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludesRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_82942705-163a-4501-8597-7ef34021ec25" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_79b3f756-9f5d-4bf7-a7ec-f7110e90b0ce" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_PrivatelyheldInvestments_79b3f756-9f5d-4bf7-a7ec-f7110e90b0ce" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_a9108e3e-5fcb-4c3f-96fb-2827b47885ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_OtherInvestments_a9108e3e-5fcb-4c3f-96fb-2827b47885ff" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_176dc8bd-ecf4-4283-ab20-3d063c8c95c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_176dc8bd-ecf4-4283-ab20-3d063c8c95c4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_da2cada9-6d38-4958-9486-6c562ffb1a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_InvestmentTypeAxis_da2cada9-6d38-4958-9486-6c562ffb1a98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_da2cada9-6d38-4958-9486-6c562ffb1a98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_da2cada9-6d38-4958-9486-6c562ffb1a98" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_da2cada9-6d38-4958-9486-6c562ffb1a98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_da2cada9-6d38-4958-9486-6c562ffb1a98" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_e620623e-cb55-4916-9503-7088d51d1dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:to="loc_us-gaap_FixedMaturitiesMember_e620623e-cb55-4916-9503-7088d51d1dc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_dd94de4c-1e27-46c7-9509-61562b73acf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_dd94de4c-1e27-46c7-9509-61562b73acf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_53d6900d-16b1-4741-9e9a-21ec8979a4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_53d6900d-16b1-4741-9e9a-21ec8979a4cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5da92468-cd6c-479e-b3ac-997c6eb69158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5da92468-cd6c-479e-b3ac-997c6eb69158" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5da92468-cd6c-479e-b3ac-997c6eb69158_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5da92468-cd6c-479e-b3ac-997c6eb69158" xlink:to="loc_us-gaap_ClassOfStockDomain_5da92468-cd6c-479e-b3ac-997c6eb69158_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5da92468-cd6c-479e-b3ac-997c6eb69158" xlink:to="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_48bf2249-be65-4ce2-bbcc-301e4d702fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_48bf2249-be65-4ce2-bbcc-301e4d702fb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_3029ec44-a0a3-48d4-b7a6-ca097926dea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_3029ec44-a0a3-48d4-b7a6-ca097926dea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_61815265-6680-465e-8c44-3ce40f452712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_61815265-6680-465e-8c44-3ce40f452712" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b52c834b-d51a-426c-a807-201c2c132630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b52c834b-d51a-426c-a807-201c2c132630" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b52c834b-d51a-426c-a807-201c2c132630_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b52c834b-d51a-426c-a807-201c2c132630" xlink:to="loc_us-gaap_RelatedPartyDomain_b52c834b-d51a-426c-a807-201c2c132630_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_28c889aa-4689-4ce2-8e9a-d28e43ce7218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b52c834b-d51a-426c-a807-201c2c132630" xlink:to="loc_us-gaap_RelatedPartyDomain_28c889aa-4689-4ce2-8e9a-d28e43ce7218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_f50e39f1-d835-45b9-9770-4e7c229cd6d3" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_28c889aa-4689-4ce2-8e9a-d28e43ce7218" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_f50e39f1-d835-45b9-9770-4e7c229cd6d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_77f9f3cc-3691-46a0-ac65-dfdbc54cf281" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_28c889aa-4689-4ce2-8e9a-d28e43ce7218" xlink:to="loc_ahl_ApolloRealEstateFundMember_77f9f3cc-3691-46a0-ac65-dfdbc54cf281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968e1b82-ee91-48bc-bae6-a156695cd97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968e1b82-ee91-48bc-bae6-a156695cd97f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_968e1b82-ee91-48bc-bae6-a156695cd97f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968e1b82-ee91-48bc-bae6-a156695cd97f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_968e1b82-ee91-48bc-bae6-a156695cd97f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_54990d62-7ed0-47bb-a23f-0c91ca306df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968e1b82-ee91-48bc-bae6-a156695cd97f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_54990d62-7ed0-47bb-a23f-0c91ca306df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ea741f47-f85c-4ec6-922d-d33fb9869bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_54990d62-7ed0-47bb-a23f-0c91ca306df2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ea741f47-f85c-4ec6-922d-d33fb9869bc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d3e7091d-ee4f-4b28-b601-3da831d0de66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d3e7091d-ee4f-4b28-b601-3da831d0de66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember_d2533c76-8ae3-48ee-a664-c2008660f262" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d3e7091d-ee4f-4b28-b601-3da831d0de66" xlink:to="loc_ahl_AccruedExpensesMember_d2533c76-8ae3-48ee-a664-c2008660f262" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_85ae6f95-95a2-4cff-a794-bd8d16c7847b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_85ae6f95-95a2-4cff-a794-bd8d16c7847b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_85ae6f95-95a2-4cff-a794-bd8d16c7847b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85ae6f95-95a2-4cff-a794-bd8d16c7847b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_85ae6f95-95a2-4cff-a794-bd8d16c7847b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d96676a8-10ab-4424-a390-376487e00dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85ae6f95-95a2-4cff-a794-bd8d16c7847b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d96676a8-10ab-4424-a390-376487e00dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_d83f10d6-b2fc-4820-b273-3ebfbc200274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d96676a8-10ab-4424-a390-376487e00dd3" xlink:to="loc_us-gaap_AssetManagementArrangementMember_d83f10d6-b2fc-4820-b273-3ebfbc200274" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_66c8a51c-6fc3-4815-bd22-ee9a3f79bea0" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d96676a8-10ab-4424-a390-376487e00dd3" xlink:to="loc_ahl_ManagementConsultingAgreementMember_66c8a51c-6fc3-4815-bd22-ee9a3f79bea0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_4f4799b3-203e-42eb-a3d8-49c8644ad352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_PremiumsEarnedNet_4f4799b3-203e-42eb-a3d8-49c8644ad352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_e174ec02-d05c-4d14-9a43-e29cea606879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_NetInvestmentIncome_e174ec02-d05c-4d14-9a43-e29cea606879" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_5215d361-c4b9-443a-bd9a-805c003ce869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_GainLossOnInvestments_5215d361-c4b9-443a-bd9a-805c003ce869" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_c89726bc-2979-4862-ab54-dc803a9d7b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_OtherIncome_c89726bc-2979-4862-ab54-dc803a9d7b87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_927ddcd4-ca8e-4443-b648-976177cdf829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_Revenues_927ddcd4-ca8e-4443-b648-976177cdf829" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_c250a9d1-cf61-4ccf-9867-2acb67c3a4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_c250a9d1-cf61-4ccf-9867-2acb67c3a4cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_cad39391-8247-46dc-a771-f448b2d856d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_cad39391-8247-46dc-a771-f448b2d856d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5530d754-efde-4098-8459-e380d4d82301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5530d754-efde-4098-8459-e380d4d82301" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_204789be-80ad-4206-9ec1-e2054932b0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_InterestExpenseDebt_204789be-80ad-4206-9ec1-e2054932b0a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6bd46709-aac8-4cba-8276-a83cdc520cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6bd46709-aac8-4cba-8276-a83cdc520cd7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_9b68c2e2-47d2-435e-8c6f-245435359ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_9b68c2e2-47d2-435e-8c6f-245435359ed2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_956df62b-99f5-47e9-89b1-3de4094fd32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_956df62b-99f5-47e9-89b1-3de4094fd32d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_e2f6dc6e-b224-4d06-ab56-13c8077ac75a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_OtherExpenses_e2f6dc6e-b224-4d06-ab56-13c8077ac75a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Expense_88c2f8c0-40dd-4edb-90bc-32442a4cfbec" xlink:href="ahl-20231220.xsd#ahl_Expense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_ahl_Expense_88c2f8c0-40dd-4edb-90bc-32442a4cfbec" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0909d318-fbac-4f1f-949e-91bdffbdff7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0909d318-fbac-4f1f-949e-91bdffbdff7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cc35d6cc-ad69-45ad-bcc9-b14eed881c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cc35d6cc-ad69-45ad-bcc9-b14eed881c0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2db32bc6-43cb-458a-a9ef-787a0bbdf3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_ProfitLoss_2db32bc6-43cb-458a-a9ef-787a0bbdf3fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7814a5e4-9dcd-446b-9e01-fe0b9212cf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_NetIncomeLoss_7814a5e4-9dcd-446b-9e01-fe0b9212cf77" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_910c3b9e-1caa-49d9-83fe-82d269117d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_910c3b9e-1caa-49d9-83fe-82d269117d04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_e65634d1-c392-4914-aaef-2e65581a00db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_e65634d1-c392-4914-aaef-2e65581a00db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_926cd34e-aa4f-42e3-8d05-2f6ac07880db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_926cd34e-aa4f-42e3-8d05-2f6ac07880db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_9137911c-db72-4914-a78f-1a051a1ccd66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_9137911c-db72-4914-a78f-1a051a1ccd66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e868cd55-88a7-4e65-bf4d-f0f52f83d0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e868cd55-88a7-4e65-bf4d-f0f52f83d0d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_64dcbb81-4bc6-4cc1-a813-5b60b675fd81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_64dcbb81-4bc6-4cc1-a813-5b60b675fd81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_f3501a16-1e22-47be-8999-be66335c8aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_64dcbb81-4bc6-4cc1-a813-5b60b675fd81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_f3501a16-1e22-47be-8999-be66335c8aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_32e9180a-86c6-47f9-82cc-5473ea308349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_64dcbb81-4bc6-4cc1-a813-5b60b675fd81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_32e9180a-86c6-47f9-82cc-5473ea308349" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_48f73243-d851-4b7f-b56f-49d2b267d61e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_48f73243-d851-4b7f-b56f-49d2b267d61e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_89c83b46-12b7-46f9-94d2-71142df000c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_89c83b46-12b7-46f9-94d2-71142df000c9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_d8b5610f-306c-4f3b-86cc-3c464a107b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_DueToAffiliateCurrent_d8b5610f-306c-4f3b-86cc-3c464a107b48" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:to="loc_srt_ProductOrServiceAxis_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b" xlink:to="loc_srt_ProductsAndServicesDomain_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_830c11fa-ad8d-4f4b-96d0-cf46f7cf3917" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b" xlink:to="loc_srt_ProductsAndServicesDomain_830c11fa-ad8d-4f4b-96d0-cf46f7cf3917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretySegmentMember_13a8688a-adb6-4421-a200-e5d7efcc990f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretySegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_830c11fa-ad8d-4f4b-96d0-cf46f7cf3917" xlink:to="loc_us-gaap_SuretySegmentMember_13a8688a-adb6-4421-a200-e5d7efcc990f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_5185166d-fad1-4830-8f09-a87c9a2e97d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_5185166d-fad1-4830-8f09-a87c9a2e97d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_5185166d-fad1-4830-8f09-a87c9a2e97d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5185166d-fad1-4830-8f09-a87c9a2e97d5" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_5185166d-fad1-4830-8f09-a87c9a2e97d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5185166d-fad1-4830-8f09-a87c9a2e97d5" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_d4f99997-6fb2-495f-9794-01ea5fc96e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_us-gaap_RealEstateFundsMember_d4f99997-6fb2-495f-9794-01ea5fc96e1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_dfd216b7-aab6-49d4-b572-65e6aa63c7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_us-gaap_AssetManagementArrangementMember_dfd216b7-aab6-49d4-b572-65e6aa63c7ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_dca1b3ea-728d-4a5f-8075-4089e1d6cd64" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_ahl_ManagementConsultingAgreementMember_dca1b3ea-728d-4a5f-8075-4089e1d6cd64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyInvestmentIncomeMember_3585aa6b-8d97-465c-bd24-603b08b8ba78" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyInvestmentIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_ahl_RelatedPartyInvestmentIncomeMember_3585aa6b-8d97-465c-bd24-603b08b8ba78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember_84eda0a6-3c55-40fa-906c-7ffe478bd628" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_ahl_ClassABNotesMember_84eda0a6-3c55-40fa-906c-7ffe478bd628" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9dc0422f-d777-4fbe-9db1-99ff4e8db50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9dc0422f-d777-4fbe-9db1-99ff4e8db50e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9dc0422f-d777-4fbe-9db1-99ff4e8db50e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9dc0422f-d777-4fbe-9db1-99ff4e8db50e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9dc0422f-d777-4fbe-9db1-99ff4e8db50e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9dc0422f-d777-4fbe-9db1-99ff4e8db50e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_fdbff9b9-9129-4732-9db2-e8d6d67297d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:to="loc_us-gaap_InvestmentIncomeMember_fdbff9b9-9129-4732-9db2-e8d6d67297d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5d435f59-693d-44a1-9528-b267c94b7aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5d435f59-693d-44a1-9528-b267c94b7aa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1_1dbf4085-7393-4f42-8e1d-58944ac22c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:to="loc_us-gaap_GainLossOnInvestmentsMember1_1dbf4085-7393-4f42-8e1d-58944ac22c74" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1eac0bb8-bee8-4f99-96ba-b2b2f572c290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1eac0bb8-bee8-4f99-96ba-b2b2f572c290" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_79cb888b-ef93-489a-acf0-28271a86ed93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_79cb888b-ef93-489a-acf0-28271a86ed93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_4bcafb08-c330-46e2-b159-39499328afc8" xlink:href="ahl-20231220.xsd#ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_4bcafb08-c330-46e2-b159-39499328afc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_851a8978-f089-47f9-b010-645ad1c017a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_ProfitLoss_851a8978-f089-47f9-b010-645ad1c017a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_b7985208-8af3-407e-b86f-15134f6bdc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_Dividends_b7985208-8af3-407e-b86f-15134f6bdc4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_05208fb4-508b-4a1e-a3d3-754680eb2b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_05208fb4-508b-4a1e-a3d3-754680eb2b27" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_a6c11355-e97d-4e9d-89fa-96f608aa3c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_a6c11355-e97d-4e9d-89fa-96f608aa3c64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_afdbe849-beee-4ed7-9e6d-0ad8d61c96ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_afdbe849-beee-4ed7-9e6d-0ad8d61c96ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1eac0bb8-bee8-4f99-96ba-b2b2f572c290" xlink:to="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d18377d8-b34b-4319-812a-393a9a911045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d18377d8-b34b-4319-812a-393a9a911045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_d18377d8-b34b-4319-812a-393a9a911045_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d18377d8-b34b-4319-812a-393a9a911045" xlink:to="loc_us-gaap_TypeOfAdoptionMember_d18377d8-b34b-4319-812a-393a9a911045_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7f7e3bee-9893-407e-a1cb-5562c826db05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d18377d8-b34b-4319-812a-393a9a911045" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7f7e3bee-9893-407e-a1cb-5562c826db05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_504d6546-b3ae-4336-8bc0-18728fcefed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_7f7e3bee-9893-407e-a1cb-5562c826db05" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_504d6546-b3ae-4336-8bc0-18728fcefed3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_43b0305f-da44-4729-aee1-1143dbdca533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_43b0305f-da44-4729-aee1-1143dbdca533" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_43b0305f-da44-4729-aee1-1143dbdca533_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_43b0305f-da44-4729-aee1-1143dbdca533" xlink:to="loc_us-gaap_EquityComponentDomain_43b0305f-da44-4729-aee1-1143dbdca533_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_43b0305f-da44-4729-aee1-1143dbdca533" xlink:to="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bf7246c7-9e0c-465e-8fa2-fe9830c1bc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_CommonStockMember_bf7246c7-9e0c-465e-8fa2-fe9830c1bc5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_f7d94d15-c632-4f05-941d-403401961aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_PreferredStockMember_f7d94d15-c632-4f05-941d-403401961aec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_feb1f364-d328-4d14-bb18-44730067857d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_feb1f364-d328-4d14-bb18-44730067857d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ec720e68-e771-414f-ad56-754224998b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_RetainedEarningsMember_ec720e68-e771-414f-ad56-754224998b51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3c0f95cc-55c5-433a-a2eb-ad9f8d29c9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3c0f95cc-55c5-433a-a2eb-ad9f8d29c9fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c7e1aec1-998c-4c84-bfb4-fd6a05d14bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c7e1aec1-998c-4c84-bfb4-fd6a05d14bea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1d8606a2-fed9-4bd8-b5b0-ac56a6d382c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1d8606a2-fed9-4bd8-b5b0-ac56a6d382c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b67d2989-6941-4446-aa60-a7401bbad4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b67d2989-6941-4446-aa60-a7401bbad4e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b67d2989-6941-4446-aa60-a7401bbad4e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b67d2989-6941-4446-aa60-a7401bbad4e0" xlink:to="loc_us-gaap_ClassOfStockDomain_b67d2989-6941-4446-aa60-a7401bbad4e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_226a67a9-6a41-48f2-be0a-128981f02b94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b67d2989-6941-4446-aa60-a7401bbad4e0" xlink:to="loc_us-gaap_ClassOfStockDomain_226a67a9-6a41-48f2-be0a-128981f02b94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5a2cbc5d-9617-48ec-9064-58e683d2038d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_226a67a9-6a41-48f2-be0a-128981f02b94" xlink:to="loc_us-gaap_CommonStockMember_5a2cbc5d-9617-48ec-9064-58e683d2038d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_dd7a167b-48e0-4da6-b0aa-6ea5c1dc2232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_226a67a9-6a41-48f2-be0a-128981f02b94" xlink:to="loc_us-gaap_PreferredStockMember_dd7a167b-48e0-4da6-b0aa-6ea5c1dc2232" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETS_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0cc0cbce-78c7-43d6-9b71-73d133394e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0cc0cbce-78c7-43d6-9b71-73d133394e92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_a7da9044-6b3f-4739-b98a-c994ba3c0aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_us-gaap_TradingSecuritiesDebt_a7da9044-6b3f-4739-b98a-c994ba3c0aa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsAvailableForSale_3df0be7e-b0b1-4960-b3c7-7942c04f6d5f" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsAvailableForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_ShortTermInvestmentsAvailableForSale_3df0be7e-b0b1-4960-b3c7-7942c04f6d5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValue_e0737975-1b26-450f-92bb-8f7727c95057" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValue_e0737975-1b26-450f-92bb-8f7727c95057" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_6b6e4f2c-e51c-43e0-a5b1-a3e0b0a6fa05" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_CatastropheBond_6b6e4f2c-e51c-43e0-a5b1-a3e0b0a6fa05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_7e62d50f-ce65-419c-b88e-4381c093f4e6" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_PrivatelyheldInvestments_7e62d50f-ce65-419c-b88e-4381c093f4e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ca1c6c04-c8cf-4c23-92dc-ee42b8822aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_us-gaap_EquityMethodInvestments_ca1c6c04-c8cf-4c23-92dc-ee42b8822aff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_e8603806-aac1-4a30-b38c-a1c83d0d87be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_us-gaap_OtherInvestments_e8603806-aac1-4a30-b38c-a1c83d0d87be" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentsExcludingDerivativeAssets_d64ff128-c543-46f4-bc7e-d509e11039bc" xlink:href="ahl-20231220.xsd#ahl_InvestmentsExcludingDerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_InvestmentsExcludingDerivativeAssets_d64ff128-c543-46f4-bc7e-d509e11039bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_301e779c-f577-40e6-90c1-86a7e45999a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_301e779c-f577-40e6-90c1-86a7e45999a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_23c9005d-0c1b-4c51-806e-18d87348dca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_23c9005d-0c1b-4c51-806e-18d87348dca2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_35b92fc6-dde2-44fb-a703-c3ee5cd2a1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_23c9005d-0c1b-4c51-806e-18d87348dca2" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_35b92fc6-dde2-44fb-a703-c3ee5cd2a1c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums_4d8f7608-bce2-4210-a54e-cddbcf88a6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_23c9005d-0c1b-4c51-806e-18d87348dca2" xlink:to="loc_us-gaap_PrepaidReinsurancePremiums_4d8f7608-bce2-4210-a54e-cddbcf88a6e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_e57f5a4b-26b9-4406-9285-930c8856c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_ReceivablesAbstract_e57f5a4b-26b9-4406-9285-930c8856c4cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_6359ff6e-2dec-4923-b45e-808184d00f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesAbstract_e57f5a4b-26b9-4406-9285-930c8856c4cb" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_6359ff6e-2dec-4923-b45e-808184d00f0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_7e7e7ed2-1ea2-4be5-b7fe-8f926e9620df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesAbstract_e57f5a4b-26b9-4406-9285-930c8856c4cb" xlink:to="loc_us-gaap_OtherReceivables_7e7e7ed2-1ea2-4be5-b7fe-8f926e9620df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_f7485a24-54f3-4a76-9500-7c5e32a52057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldUnderReinsuranceAgreementsAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_f7485a24-54f3-4a76-9500-7c5e32a52057" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_41051f33-89ac-41b4-bfb8-c7911e8e6911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_41051f33-89ac-41b4-bfb8-c7911e8e6911" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_93b8cdf4-789f-4793-ae09-d07eec378d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_DerivativeAssets_93b8cdf4-789f-4793-ae09-d07eec378d83" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_9289bdec-f248-4c0d-9672-7b827336f3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_9289bdec-f248-4c0d-9672-7b827336f3e8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_9a0ab27e-fbf8-4b2e-854a-3af2d2ee1f41" xlink:href="ahl-20231220.xsd#ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_9a0ab27e-fbf8-4b2e-854a-3af2d2ee1f41" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherMiscellaneousAssets_503eab02-6f53-4c8c-8fb8-9682d9891b4e" xlink:href="ahl-20231220.xsd#ahl_OtherMiscellaneousAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_ahl_OtherMiscellaneousAssets_503eab02-6f53-4c8c-8fb8-9682d9891b4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_57549256-bc42-4d46-8538-04dbbcc11022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_57549256-bc42-4d46-8538-04dbbcc11022" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_820ac82c-0420-402e-842a-98fbfceb5d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_Assets_820ac82c-0420-402e-842a-98fbfceb5d31" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserveAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:to="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e35a1b18-d549-4f7d-9d34-a3ed75f34fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e35a1b18-d549-4f7d-9d34-a3ed75f34fd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_95524af1-fe94-4093-afe0-6e6f0a94c049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:to="loc_us-gaap_UnearnedPremiums_95524af1-fe94-4093-afe0-6e6f0a94c049" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserves_4b890eec-4c69-42de-8e23-28e67df1c59e" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:to="loc_ahl_InsuranceReserves_4b890eec-4c69-42de-8e23-28e67df1c59e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePayable_0dc9d887-df7b-4d25-b54e-31b2ffc515dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:to="loc_us-gaap_ReinsurancePayable_0dc9d887-df7b-4d25-b54e-31b2ffc515dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_80b4e1da-816e-437a-ad57-0da996d221bc" xlink:href="ahl-20231220.xsd#ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_80b4e1da-816e-437a-ad57-0da996d221bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_5106c2b9-e5bb-419d-a9da-a51ba0f5058e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_5106c2b9-e5bb-419d-a9da-a51ba0f5058e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_32b5e2a4-62fc-4948-bbc0-a644b6520eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_32b5e2a4-62fc-4948-bbc0-a644b6520eea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_70ff72b6-babe-4121-9bb9-f5b83e377368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_OperatingLeaseLiability_70ff72b6-babe-4121-9bb9-f5b83e377368" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_86c35f2c-7cc4-4b86-981e-6acb46986100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_DerivativeLiabilities_86c35f2c-7cc4-4b86-981e-6acb46986100" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_31085a67-138f-425b-ba03-4081357e82e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_ShortTermBorrowings_31085a67-138f-425b-ba03-4081357e82e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e925c19e-4b37-4615-b8c7-d0ef765ea4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:to="loc_us-gaap_Liabilities_e925c19e-4b37-4615-b8c7-d0ef765ea4c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_15f43c94-dcca-4c78-9d63-0631425731c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_CommitmentsAndContingencies_15f43c94-dcca-4c78-9d63-0631425731c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_f96ab058-e45e-4467-92d5-291bafd87681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_f96ab058-e45e-4467-92d5-291bafd87681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4d432a39-ce2f-4ed4-937a-beb7e1e756ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_f96ab058-e45e-4467-92d5-291bafd87681" xlink:to="loc_us-gaap_CommonStockValue_4d432a39-ce2f-4ed4-937a-beb7e1e756ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_88dcfbea-2a9f-4a12-97f0-a7539a668966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_f96ab058-e45e-4467-92d5-291bafd87681" xlink:to="loc_us-gaap_PreferredStockValue_88dcfbea-2a9f-4a12-97f0-a7539a668966" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_9b8a19ce-70b4-44a6-afa5-ca5bbb360df7" xlink:href="ahl-20231220.xsd#ahl_AdditionalPaidInCapitalExcludingPreferenceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_9b8a19ce-70b4-44a6-afa5-ca5bbb360df7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_06ba4746-a3f9-40d9-9370-570175bc1e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_06ba4746-a3f9-40d9-9370-570175bc1e06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ab930732-8276-4a96-9da7-df64c509bd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ab930732-8276-4a96-9da7-df64c509bd53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c222391b-c76c-4675-91aa-bf3461b0bbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c222391b-c76c-4675-91aa-bf3461b0bbba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_73fa4a83-eec5-4643-8016-c1be31985b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_73fa4a83-eec5-4643-8016-c1be31985b22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_51340b1f-a4c6-446a-a04a-518d43ace960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_InvestmentTypeAxis_51340b1f-a4c6-446a-a04a-518d43ace960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_51340b1f-a4c6-446a-a04a-518d43ace960_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_51340b1f-a4c6-446a-a04a-518d43ace960" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_51340b1f-a4c6-446a-a04a-518d43ace960_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a4a6b5e7-0c43-4b44-9b22-b9ddc2d94e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_51340b1f-a4c6-446a-a04a-518d43ace960" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a4a6b5e7-0c43-4b44-9b22-b9ddc2d94e93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_98997dc1-6f38-4aa3-b83a-0775c6659b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a4a6b5e7-0c43-4b44-9b22-b9ddc2d94e93" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_98997dc1-6f38-4aa3-b83a-0775c6659b6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_9e574cc6-fe73-4184-b809-1a8a13daed06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a4a6b5e7-0c43-4b44-9b22-b9ddc2d94e93" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_9e574cc6-fe73-4184-b809-1a8a13daed06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_14f8f467-39d3-4b4f-ab37-49e95b8266ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_14f8f467-39d3-4b4f-ab37-49e95b8266ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_14f8f467-39d3-4b4f-ab37-49e95b8266ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_14f8f467-39d3-4b4f-ab37-49e95b8266ac" xlink:to="loc_us-gaap_RelatedPartyDomain_14f8f467-39d3-4b4f-ab37-49e95b8266ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ef4cb071-6a79-4363-9724-baa757bd48d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_14f8f467-39d3-4b4f-ab37-49e95b8266ac" xlink:to="loc_us-gaap_RelatedPartyDomain_ef4cb071-6a79-4363-9724-baa757bd48d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_7a43a411-beeb-4825-91a3-6c45e5200686" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ef4cb071-6a79-4363-9724-baa757bd48d8" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_7a43a411-beeb-4825-91a3-6c45e5200686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_5bc22617-6691-4905-a414-140c5e13debb" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ef4cb071-6a79-4363-9724-baa757bd48d8" xlink:to="loc_ahl_ApolloRealEstateFundMember_5bc22617-6691-4905-a414-140c5e13debb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_40dc2c14-8414-4fdf-8e81-30616eafaff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_40dc2c14-8414-4fdf-8e81-30616eafaff1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_40dc2c14-8414-4fdf-8e81-30616eafaff1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_40dc2c14-8414-4fdf-8e81-30616eafaff1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_40dc2c14-8414-4fdf-8e81-30616eafaff1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f0edf00a-eeee-4b05-9859-b814fc2a1eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_40dc2c14-8414-4fdf-8e81-30616eafaff1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f0edf00a-eeee-4b05-9859-b814fc2a1eb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember_b75ef390-bdbe-4044-b64a-269270b73302" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f0edf00a-eeee-4b05-9859-b814fc2a1eb7" xlink:to="loc_ahl_AccruedExpensesMember_b75ef390-bdbe-4044-b64a-269270b73302" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_698c25a7-fdcc-4d3e-97aa-caba34b4cf95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_698c25a7-fdcc-4d3e-97aa-caba34b4cf95" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_698c25a7-fdcc-4d3e-97aa-caba34b4cf95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_698c25a7-fdcc-4d3e-97aa-caba34b4cf95" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_698c25a7-fdcc-4d3e-97aa-caba34b4cf95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_6a891009-82a9-4aca-a546-c047d10a42c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_698c25a7-fdcc-4d3e-97aa-caba34b4cf95" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_6a891009-82a9-4aca-a546-c047d10a42c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_8c5ffc16-8a46-4a31-9b30-a58ca6083534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6a891009-82a9-4aca-a546-c047d10a42c0" xlink:to="loc_us-gaap_AssetManagementArrangementMember_8c5ffc16-8a46-4a31-9b30-a58ca6083534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_f3ddc770-1b0b-4713-8c6b-cc9e233af569" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6a891009-82a9-4aca-a546-c047d10a42c0" xlink:to="loc_ahl_ManagementConsultingAgreementMember_f3ddc770-1b0b-4713-8c6b-cc9e233af569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4466c8fd-6de4-451b-8105-cf6cf8ae40f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4466c8fd-6de4-451b-8105-cf6cf8ae40f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4466c8fd-6de4-451b-8105-cf6cf8ae40f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4466c8fd-6de4-451b-8105-cf6cf8ae40f8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4466c8fd-6de4-451b-8105-cf6cf8ae40f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7dce5f3b-7240-49e7-9b20-c5477784fb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4466c8fd-6de4-451b-8105-cf6cf8ae40f8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7dce5f3b-7240-49e7-9b20-c5477784fb3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_8f1c3ad4-f363-44ef-b048-06a7a5418bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7dce5f3b-7240-49e7-9b20-c5477784fb3d" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_8f1c3ad4-f363-44ef-b048-06a7a5418bfc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_84e48702-af51-4d44-81e4-e133962f8a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_84e48702-af51-4d44-81e4-e133962f8a78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_164b3440-97c6-436b-b404-06b41e7d9a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_164b3440-97c6-436b-b404-06b41e7d9a20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_4d736462-1332-4a52-831a-80c56c14e272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_2f26a784-65fb-4c1e-a543-384a09af02c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_2f26a784-65fb-4c1e-a543-384a09af02c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost_6ded1c0a-b133-44e3-8133-6c3db3c12dd6" xlink:href="ahl-20231220.xsd#ahl_Shortterminvestmentsavailableforsaleamortizedcost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost_6ded1c0a-b133-44e3-8133-6c3db3c12dd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAmortizedCost_c961950b-249d-419f-989e-c0e8948d33f1" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_ShortTermInvestmentsTradingAmortizedCost_c961950b-249d-419f-989e-c0e8948d33f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure_a93f290d-213d-420a-a7c6-513c9fa545e5" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_CatastropheBondsFairValueDisclosure_a93f290d-213d-420a-a7c6-513c9fa545e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_d2a8eac1-6ea2-40c8-bdd7-0550419cc980" xlink:href="ahl-20231220.xsd#ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_d2a8eac1-6ea2-40c8-bdd7-0550419cc980" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_edae39ce-df1d-4cba-a47d-8aa3b9e0d4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_edae39ce-df1d-4cba-a47d-8aa3b9e0d4e0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2d372892-2119-4e29-94f3-2037e6b7e320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_CommonStockSharesIssued_2d372892-2119-4e29-94f3-2037e6b7e320" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f9a2898e-5e17-4767-bb2f-2c53c62079a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f9a2898e-5e17-4767-bb2f-2c53c62079a4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_eab00b72-1914-4147-b9c7-318439a4708f" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_eab00b72-1914-4147-b9c7-318439a4708f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_04d3f6b1-82a5-40a0-8580-9dbe625c3cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_04d3f6b1-82a5-40a0-8580-9dbe625c3cfe" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_aa35368e-252b-4891-8de3-13519207e8af" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludesRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_aa35368e-252b-4891-8de3-13519207e8af" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_d29bc09d-d9d9-4538-8adc-edff83648a9d" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_PrivatelyheldInvestments_d29bc09d-d9d9-4538-8adc-edff83648a9d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_a54cf164-52d6-4a3f-b5fc-4f2803c58a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_OtherInvestments_a54cf164-52d6-4a3f-b5fc-4f2803c58a87" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_ea23b170-6995-4a30-b890-d4b4366b79de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_ea23b170-6995-4a30-b890-d4b4366b79de" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_InvestmentTypeAxis_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_b51f90e0-7d1a-4f9a-9c0e-5b76b19ed24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:to="loc_us-gaap_FixedMaturitiesMember_b51f90e0-7d1a-4f9a-9c0e-5b76b19ed24f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_d5511c15-0bf3-4916-9560-4868824c5a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_d5511c15-0bf3-4916-9560-4868824c5a5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_a0d72aac-6021-496e-a9a9-b83fd77bd24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_a0d72aac-6021-496e-a9a9-b83fd77bd24a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f6a174a8-6217-44cd-a68c-a45a6a1761f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f6a174a8-6217-44cd-a68c-a45a6a1761f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f6a174a8-6217-44cd-a68c-a45a6a1761f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f6a174a8-6217-44cd-a68c-a45a6a1761f7" xlink:to="loc_us-gaap_ClassOfStockDomain_f6a174a8-6217-44cd-a68c-a45a6a1761f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f6a174a8-6217-44cd-a68c-a45a6a1761f7" xlink:to="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_b7138376-57ba-4764-a74b-a45b8f2d5833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_b7138376-57ba-4764-a74b-a45b8f2d5833" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_bcf390f9-099b-45fa-8f57-dbd7ba5cad7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_bcf390f9-099b-45fa-8f57-dbd7ba5cad7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_3c4e6f53-2ed0-4c85-8afe-5b18d62f1b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_3c4e6f53-2ed0-4c85-8afe-5b18d62f1b76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9c7e1311-b626-467e-a593-6944f85b0fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9c7e1311-b626-467e-a593-6944f85b0fe5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9c7e1311-b626-467e-a593-6944f85b0fe5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9c7e1311-b626-467e-a593-6944f85b0fe5" xlink:to="loc_us-gaap_RelatedPartyDomain_9c7e1311-b626-467e-a593-6944f85b0fe5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_43160a80-12c9-48ba-9b9f-c47d5744fbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9c7e1311-b626-467e-a593-6944f85b0fe5" xlink:to="loc_us-gaap_RelatedPartyDomain_43160a80-12c9-48ba-9b9f-c47d5744fbf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_e315fe32-936f-485e-87bc-17f13bee47b4" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_43160a80-12c9-48ba-9b9f-c47d5744fbf3" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_e315fe32-936f-485e-87bc-17f13bee47b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_282b2bec-a6ce-478b-b7a9-456630ab6a2c" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_43160a80-12c9-48ba-9b9f-c47d5744fbf3" xlink:to="loc_ahl_ApolloRealEstateFundMember_282b2bec-a6ce-478b-b7a9-456630ab6a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f30dc5a-4fa8-41be-89f7-3584839533a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f30dc5a-4fa8-41be-89f7-3584839533a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7f30dc5a-4fa8-41be-89f7-3584839533a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f30dc5a-4fa8-41be-89f7-3584839533a9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7f30dc5a-4fa8-41be-89f7-3584839533a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_102fba8c-4029-48da-a150-7f8c168155d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f30dc5a-4fa8-41be-89f7-3584839533a9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_102fba8c-4029-48da-a150-7f8c168155d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1d064f38-6257-4945-a298-e30e58e8ebc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_102fba8c-4029-48da-a150-7f8c168155d9" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1d064f38-6257-4945-a298-e30e58e8ebc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8663a6d5-caf3-415b-b5c1-e49fd47b5119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8663a6d5-caf3-415b-b5c1-e49fd47b5119" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8663a6d5-caf3-415b-b5c1-e49fd47b5119_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8663a6d5-caf3-415b-b5c1-e49fd47b5119" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8663a6d5-caf3-415b-b5c1-e49fd47b5119_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a0a3a3ad-f61a-4f65-ae50-f1f2042674c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8663a6d5-caf3-415b-b5c1-e49fd47b5119" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a0a3a3ad-f61a-4f65-ae50-f1f2042674c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember_41f96264-5c43-40da-bd0f-c144fb32872e" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a0a3a3ad-f61a-4f65-ae50-f1f2042674c6" xlink:to="loc_ahl_AccruedExpensesMember_41f96264-5c43-40da-bd0f-c144fb32872e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_ba26a138-c981-467f-8b00-cc0d0cce4f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_ba26a138-c981-467f-8b00-cc0d0cce4f4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ba26a138-c981-467f-8b00-cc0d0cce4f4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ba26a138-c981-467f-8b00-cc0d0cce4f4e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ba26a138-c981-467f-8b00-cc0d0cce4f4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a74bd0cf-b6ed-42f7-899a-49f3481ccc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ba26a138-c981-467f-8b00-cc0d0cce4f4e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a74bd0cf-b6ed-42f7-899a-49f3481ccc8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_8d918191-f34b-4d9a-b65f-8d0e675801da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_a74bd0cf-b6ed-42f7-899a-49f3481ccc8e" xlink:to="loc_us-gaap_AssetManagementArrangementMember_8d918191-f34b-4d9a-b65f-8d0e675801da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_4eeb1694-0530-4cbe-a79d-d9980994e0ae" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_a74bd0cf-b6ed-42f7-899a-49f3481ccc8e" xlink:to="loc_ahl_ManagementConsultingAgreementMember_4eeb1694-0530-4cbe-a79d-d9980994e0ae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_300db7ca-c95b-44e3-abbc-3e1db8e87559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:to="loc_us-gaap_PremiumsEarnedNet_300db7ca-c95b-44e3-abbc-3e1db8e87559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_cd18474f-6105-424a-b135-aa14db924831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:to="loc_us-gaap_NetInvestmentIncome_cd18474f-6105-424a-b135-aa14db924831" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_3f40ac77-e0a2-434d-83b7-e54b9a61f954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:to="loc_us-gaap_GainLossOnInvestments_3f40ac77-e0a2-434d-83b7-e54b9a61f954" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b3a63784-f342-4918-9737-8747477f8738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:to="loc_us-gaap_Revenues_b3a63784-f342-4918-9737-8747477f8738" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_ee59e16c-a55d-403a-9b04-5d33467fb3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_ee59e16c-a55d-403a-9b04-5d33467fb3be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_c8e93508-240a-4201-8f90-6a898e1279ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_c8e93508-240a-4201-8f90-6a898e1279ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_10956a29-cc98-40e8-b788-497ec4a8c35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_10956a29-cc98-40e8-b788-497ec4a8c35e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_31e64cca-3cda-46fa-a66d-7c97ba32c45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_InterestExpenseDebt_31e64cca-3cda-46fa-a66d-7c97ba32c45f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9bdbe00f-baca-49ea-baa8-b1e670e344e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9bdbe00f-baca-49ea-baa8-b1e670e344e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_02e2976c-4b22-4da5-9d0b-d1a2dc6206e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_02e2976c-4b22-4da5-9d0b-d1a2dc6206e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7668df42-b237-4398-9d91-26a5ef405911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7668df42-b237-4398-9d91-26a5ef405911" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Expense_88392dbb-e358-4c18-9c9b-b33cd02191f1" xlink:href="ahl-20231220.xsd#ahl_Expense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_ahl_Expense_88392dbb-e358-4c18-9c9b-b33cd02191f1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4899bdf2-fb17-4af9-9f7c-084070a383b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4899bdf2-fb17-4af9-9f7c-084070a383b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6d074525-bf36-4556-93d2-bbb7c5c478e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6d074525-bf36-4556-93d2-bbb7c5c478e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6925c9df-fbe4-470e-bed7-bf6364d6f2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_ProfitLoss_6925c9df-fbe4-470e-bed7-bf6364d6f2ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_11aac6b7-079d-417f-b781-4cee6c1890fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_Dividends_11aac6b7-079d-417f-b781-4cee6c1890fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cf6b9a2e-f92d-4706-a2a8-ee4bf0d7a0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_NetIncomeLoss_cf6b9a2e-f92d-4706-a2a8-ee4bf0d7a0c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7606f786-8d5e-4bc7-82bc-b089fd5c05ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7606f786-8d5e-4bc7-82bc-b089fd5c05ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_65ea89cc-3601-4f94-9b97-26d5e689e3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_65ea89cc-3601-4f94-9b97-26d5e689e3f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_be9898ce-43e1-45e4-a139-d5a6a41e645f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_be9898ce-43e1-45e4-a139-d5a6a41e645f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_83a8ec25-9fc5-4354-b762-3b4ccd247e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_83a8ec25-9fc5-4354-b762-3b4ccd247e31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_24008d93-d0ec-4bb9-b8e5-5441dce28e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_24008d93-d0ec-4bb9-b8e5-5441dce28e9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_18a1d89a-1098-4cfb-87f8-c32bec838466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_18a1d89a-1098-4cfb-87f8-c32bec838466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a43e67b1-5f20-458c-ae87-2920043a1dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a43e67b1-5f20-458c-ae87-2920043a1dc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_68d754cf-d4c4-4aa3-b876-9ee23480b73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_68d754cf-d4c4-4aa3-b876-9ee23480b73c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_25939e53-f00a-4b22-8c5e-427c534b7fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_25939e53-f00a-4b22-8c5e-427c534b7fde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e439cc13-00de-451e-a0a8-56bd8110632a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e439cc13-00de-451e-a0a8-56bd8110632a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_da051cbd-76d1-4a50-9f21-876ad1be1632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_DueToAffiliateCurrent_da051cbd-76d1-4a50-9f21-876ad1be1632" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_303665ec-02c4-4701-808c-c1dead40e2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_us-gaap_RealEstateFundsMember_303665ec-02c4-4701-808c-c1dead40e2c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_01187214-f1b3-47cf-991d-bea631fe2578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_us-gaap_AssetManagementArrangementMember_01187214-f1b3-47cf-991d-bea631fe2578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_ffbc8ead-4b10-4b7d-ac20-54fa2b41a3b0" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_ahl_ManagementConsultingAgreementMember_ffbc8ead-4b10-4b7d-ac20-54fa2b41a3b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyInvestmentIncomeMember_17652cda-2d28-45bc-b93e-cd0a1976f7b0" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyInvestmentIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_ahl_RelatedPartyInvestmentIncomeMember_17652cda-2d28-45bc-b93e-cd0a1976f7b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember_60d456c7-0e0d-4b24-9ece-094b791a2f57" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_ahl_ClassABNotesMember_60d456c7-0e0d-4b24-9ece-094b791a2f57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_787392ed-721e-4ad9-809e-83c04aa540e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_787392ed-721e-4ad9-809e-83c04aa540e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_787392ed-721e-4ad9-809e-83c04aa540e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_787392ed-721e-4ad9-809e-83c04aa540e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_787392ed-721e-4ad9-809e-83c04aa540e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_787392ed-721e-4ad9-809e-83c04aa540e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_361ed68c-cfbf-4358-a946-b66fe428089f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:to="loc_us-gaap_InvestmentIncomeMember_361ed68c-cfbf-4358-a946-b66fe428089f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f2eda6f0-a894-4d6b-acb4-a9c03f4a453e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f2eda6f0-a894-4d6b-acb4-a9c03f4a453e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1_728bd143-3d39-4563-af56-007d20a374ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:to="loc_us-gaap_GainLossOnInvestmentsMember1_728bd143-3d39-4563-af56-007d20a374ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8" xlink:to="loc_us-gaap_ClassOfStockDomain_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_747557f8-b93c-4ee9-a49e-7e3341f14735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8" xlink:to="loc_us-gaap_ClassOfStockDomain_747557f8-b93c-4ee9-a49e-7e3341f14735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_cb420eab-364d-4d48-81b2-fc86bd99800a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_747557f8-b93c-4ee9-a49e-7e3341f14735" xlink:to="loc_us-gaap_PreferredStockMember_cb420eab-364d-4d48-81b2-fc86bd99800a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf6b2cc3-1e88-49ed-9bf8-6d9759c5015b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf6b2cc3-1e88-49ed-9bf8-6d9759c5015b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d66bd3d1-624f-4bc6-a6ff-17573d488892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_ProfitLoss_d66bd3d1-624f-4bc6-a6ff-17573d488892" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_3f0e439e-b9c4-429f-bdb3-fe0e69cf5a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_Dividends_3f0e439e-b9c4-429f-bdb3-fe0e69cf5a79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6b935fc9-01c7-4ffc-a3ce-d31bcb017b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6b935fc9-01c7-4ffc-a3ce-d31bcb017b7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_6570102a-c053-4033-a1c0-3335c0b546d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_6570102a-c053-4033-a1c0-3335c0b546d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66a339f6-df5c-4589-bf26-70617dae8e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66a339f6-df5c-4589-bf26-70617dae8e0e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AggregateLiquidationPreferences_a4e12140-9e8e-4b5b-96a3-94b31196244a" xlink:href="ahl-20231220.xsd#ahl_AggregateLiquidationPreferences"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:to="loc_ahl_AggregateLiquidationPreferences_a4e12140-9e8e-4b5b-96a3-94b31196244a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockIssuanceCost_d5bb3511-30b5-4fd3-9927-b2336a7b2882" xlink:href="ahl-20231220.xsd#ahl_PreferredStockIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:to="loc_ahl_PreferredStockIssuanceCost_d5bb3511-30b5-4fd3-9927-b2336a7b2882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:to="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_09c54742-b1a7-476f-b2f7-461fa1300364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_09c54742-b1a7-476f-b2f7-461fa1300364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_09c54742-b1a7-476f-b2f7-461fa1300364_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_09c54742-b1a7-476f-b2f7-461fa1300364" xlink:to="loc_us-gaap_TypeOfAdoptionMember_09c54742-b1a7-476f-b2f7-461fa1300364_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9351cb75-a585-42b1-bf1a-4b057949f7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_09c54742-b1a7-476f-b2f7-461fa1300364" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9351cb75-a585-42b1-bf1a-4b057949f7a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_12f6e18e-e65e-4301-9935-272a1530868e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_12f6e18e-e65e-4301-9935-272a1530868e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_12f6e18e-e65e-4301-9935-272a1530868e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12f6e18e-e65e-4301-9935-272a1530868e" xlink:to="loc_us-gaap_EquityComponentDomain_12f6e18e-e65e-4301-9935-272a1530868e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12f6e18e-e65e-4301-9935-272a1530868e" xlink:to="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a37f3c45-4689-4f57-84c6-e6489f1db5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_CommonStockMember_a37f3c45-4689-4f57-84c6-e6489f1db5b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_eff62ffb-ea9b-4b7b-8fff-59139875a488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_PreferredStockMember_eff62ffb-ea9b-4b7b-8fff-59139875a488" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember_177981c3-789d-4581-adcf-02c89debf597" xlink:href="ahl-20231220.xsd#ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember_177981c3-789d-4581-adcf-02c89debf597" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c24a90a4-4668-49ad-80c4-0fc0e1ff49d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_RetainedEarningsMember_c24a90a4-4668-49ad-80c4-0fc0e1ff49d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6c901162-41d8-4fae-8b3e-262b997d5147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6c901162-41d8-4fae-8b3e-262b997d5147" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_11f9675c-42f8-428e-adab-f50b47a5d000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_11f9675c-42f8-428e-adab-f50b47a5d000" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_aec5f5ab-f220-4aa3-bd37-3f6347344d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_aec5f5ab-f220-4aa3-bd37-3f6347344d5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a166795c-0e90-44c6-8f5a-2619f62fde1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a166795c-0e90-44c6-8f5a-2619f62fde1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a166795c-0e90-44c6-8f5a-2619f62fde1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a166795c-0e90-44c6-8f5a-2619f62fde1b" xlink:to="loc_us-gaap_ClassOfStockDomain_a166795c-0e90-44c6-8f5a-2619f62fde1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_08f32e55-2efe-4b68-bd23-c98bb7c85610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a166795c-0e90-44c6-8f5a-2619f62fde1b" xlink:to="loc_us-gaap_ClassOfStockDomain_08f32e55-2efe-4b68-bd23-c98bb7c85610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_77ca6ebd-fb70-4b66-8f11-5714ad95282e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_08f32e55-2efe-4b68-bd23-c98bb7c85610" xlink:to="loc_us-gaap_CommonStockMember_77ca6ebd-fb70-4b66-8f11-5714ad95282e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_8a60236e-5393-4ae1-b78b-54214d3c96fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_08f32e55-2efe-4b68-bd23-c98bb7c85610" xlink:to="loc_us-gaap_PreferredStockMember_8a60236e-5393-4ae1-b78b-54214d3c96fb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#BasisofPreparationandSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_769bc9ed-89a9-4a67-9928-7cee4faf46c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3eb27bac-0fe2-4d48-b63e-100788775c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_769bc9ed-89a9-4a67-9928-7cee4faf46c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3eb27bac-0fe2-4d48-b63e-100788775c8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonPaymentOfDividendsNumberOfPeriods_fc17205c-ec89-442c-b448-10ecc9c4259f" xlink:href="ahl-20231220.xsd#ahl_NonPaymentOfDividendsNumberOfPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_769bc9ed-89a9-4a67-9928-7cee4faf46c2" xlink:to="loc_ahl_NonPaymentOfDividendsNumberOfPeriods_fc17205c-ec89-442c-b448-10ecc9c4259f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_769bc9ed-89a9-4a67-9928-7cee4faf46c2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_adc11984-3460-42b7-9c41-6cd4ca3b2af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:to="loc_us-gaap_InvestmentTypeAxis_adc11984-3460-42b7-9c41-6cd4ca3b2af1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_adc11984-3460-42b7-9c41-6cd4ca3b2af1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_adc11984-3460-42b7-9c41-6cd4ca3b2af1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_adc11984-3460-42b7-9c41-6cd4ca3b2af1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_5560ed1e-7cf5-4824-b94c-604f7b372bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_adc11984-3460-42b7-9c41-6cd4ca3b2af1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_5560ed1e-7cf5-4824-b94c-604f7b372bbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_998a2682-e1a3-4505-8257-e5113746de30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5560ed1e-7cf5-4824-b94c-604f7b372bbb" xlink:to="loc_us-gaap_FixedMaturitiesMember_998a2682-e1a3-4505-8257-e5113746de30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6fc4389-f4c8-4178-82d2-fd8eda9fb654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6fc4389-f4c8-4178-82d2-fd8eda9fb654" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a6fc4389-f4c8-4178-82d2-fd8eda9fb654_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6fc4389-f4c8-4178-82d2-fd8eda9fb654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a6fc4389-f4c8-4178-82d2-fd8eda9fb654_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6fc4389-f4c8-4178-82d2-fd8eda9fb654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_1358c4dd-bdbf-4b75-a418-1591182f5eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:to="loc_us-gaap_ComputerEquipmentMember_1358c4dd-bdbf-4b75-a418-1591182f5eae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_6b8b2466-fde0-4797-9e9d-06a1bfff04ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_6b8b2466-fde0-4797-9e9d-06a1bfff04ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_974fa846-2d96-4c28-b00f-7bd3aaca2ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_974fa846-2d96-4c28-b00f-7bd3aaca2ff6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d726a073-6eca-4421-9e5d-6abd2f714590" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:to="loc_srt_RangeAxis_d726a073-6eca-4421-9e5d-6abd2f714590" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d726a073-6eca-4421-9e5d-6abd2f714590_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d726a073-6eca-4421-9e5d-6abd2f714590" xlink:to="loc_srt_RangeMember_d726a073-6eca-4421-9e5d-6abd2f714590_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2d570882-167c-47ff-a083-1b37bb6fd009" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d726a073-6eca-4421-9e5d-6abd2f714590" xlink:to="loc_srt_RangeMember_2d570882-167c-47ff-a083-1b37bb6fd009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d9d1d779-806a-40ac-b453-fca3e3331d51" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2d570882-167c-47ff-a083-1b37bb6fd009" xlink:to="loc_srt_MinimumMember_d9d1d779-806a-40ac-b453-fca3e3331d51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_412288ba-03f8-4a3c-a538-d9f03cf88c89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2d570882-167c-47ff-a083-1b37bb6fd009" xlink:to="loc_srt_MaximumMember_412288ba-03f8-4a3c-a538-d9f03cf88c89" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_75e74628-138a-4630-b258-a8b17335acaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_PremiumsWrittenGross_75e74628-138a-4630-b258-a8b17335acaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_97d19371-eadd-4796-91d4-0c7b01deb198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_PremiumsWrittenNet_97d19371-eadd-4796-91d4-0c7b01deb198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsEarnedGross_4113b3cb-a9b4-409e-ad23-45b2d2c092cd" xlink:href="ahl-20231220.xsd#ahl_PremiumsEarnedGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_PremiumsEarnedGross_4113b3cb-a9b4-409e-ad23-45b2d2c092cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_8e68d133-a56b-4a66-8a38-432de286b55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_PremiumsEarnedNet_8e68d133-a56b-4a66-8a38-432de286b55b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e07bb421-5202-4350-9a97-dc0e44d1ecaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e07bb421-5202-4350-9a97-dc0e44d1ecaa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_6bb464c1-5138-4b65-b4df-d2b692cec1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_6bb464c1-5138-4b65-b4df-d2b692cec1e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_65ebee8f-db39-4448-861b-da4fffe079b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_65ebee8f-db39-4448-861b-da4fffe079b0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingIncomeLoss_e79a561e-371d-49b4-b79a-95594eb0ef78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_UnderwritingIncomeLoss_e79a561e-371d-49b4-b79a-95594eb0ef78" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateExpenses_dfac1856-784f-4901-9a84-673118cdb3b7" xlink:href="ahl-20231220.xsd#ahl_CorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_CorporateExpenses_dfac1856-784f-4901-9a84-673118cdb3b7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a2de2951-2d35-4895-9cb9-f2c488ddf033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a2de2951-2d35-4895-9cb9-f2c488ddf033" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_293e4134-dbac-4cc9-808f-6b9cfe541773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_NetInvestmentIncome_293e4134-dbac-4cc9-808f-6b9cfe541773" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_e58c8458-515f-4e5f-ac04-2e782c1d45c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_GainLossOnInvestments_e58c8458-515f-4e5f-ac04-2e782c1d45c8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_b040ec0b-9646-49cb-a19b-c9b4ae4f9d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_b040ec0b-9646-49cb-a19b-c9b4ae4f9d16" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0af60362-70ec-4024-ae20-743000d6da7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0af60362-70ec-4024-ae20-743000d6da7a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8af49c72-3303-40ab-8f40-53cd5a50dba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_InterestExpenseDebt_8af49c72-3303-40ab-8f40-53cd5a50dba3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_acf6833f-bc52-4d75-a65a-df09051b643d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_acf6833f-bc52-4d75-a65a-df09051b643d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_5f68b27a-39e1-42b1-b84f-92bf3d0b31b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_OtherIncome_5f68b27a-39e1-42b1-b84f-92bf3d0b31b0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_09b0bef8-1ee6-4823-a4a8-14ab64910bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_OtherExpenses_09b0bef8-1ee6-4823-a4a8-14ab64910bbc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c32718cb-00e6-48a3-843d-64845a626228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c32718cb-00e6-48a3-843d-64845a626228" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_199971ee-c354-4ac1-91cd-787dc49a7311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_199971ee-c354-4ac1-91cd-787dc49a7311" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aaf9f426-b0a0-4b49-a23f-4371e4e87c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_ProfitLoss_aaf9f426-b0a0-4b49-a23f-4371e4e87c13" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a6959e1b-413f-4d51-a1e0-455457bbb4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a6959e1b-413f-4d51-a1e0-455457bbb4ae" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_f8b8f09d-0764-4f03-94e9-5a3742ba1bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_f8b8f09d-0764-4f03-94e9-5a3742ba1bab" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceRatiosAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossRatio_f8a94dba-6a7f-4474-883e-af6e8a017c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_LossRatio_f8a94dba-6a7f-4474-883e-af6e8a017c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCostRatio_6e793f94-8d29-471f-9f23-a7318ba56445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCostRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_AcquisitionCostRatio_6e793f94-8d29-471f-9f23-a7318ba56445" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_f25c995a-5616-41af-965d-9dc5cf2d2a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_f25c995a-5616-41af-965d-9dc5cf2d2a60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingExpenseRatio_bd2fe5b9-5efe-440e-adc2-abf04f0c1e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_UnderwritingExpenseRatio_bd2fe5b9-5efe-440e-adc2-abf04f0c1e06" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CombinedRatio_afd85968-13e8-4ab1-be76-bfe93d81e67c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CombinedRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_CombinedRatio_afd85968-13e8-4ab1-be76-bfe93d81e67c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff_e0d589a5-a458-4bed-bf7a-df1b1de69843" xlink:href="ahl-20231220.xsd#ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff_e0d589a5-a458-4bed-bf7a-df1b1de69843" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts_49681a6f-c588-49e2-9ca4-b7307fb72a69" xlink:href="ahl-20231220.xsd#ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts_49681a6f-c588-49e2-9ca4-b7307fb72a69" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_de07e718-ee58-4467-b720-85775cda2289" xlink:href="ahl-20231220.xsd#ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_de07e718-ee58-4467-b720-85775cda2289" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonoperatingexpensesrelatedtoMergerAgreement_b1a32991-ab0a-498f-8497-c94c715e287f" xlink:href="ahl-20231220.xsd#ahl_NonoperatingexpensesrelatedtoMergerAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_NonoperatingexpensesrelatedtoMergerAgreement_b1a32991-ab0a-498f-8497-c94c715e287f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram_77bdf836-e3b5-4c4d-a086-7f8f0ef39f2e" xlink:href="ahl-20231220.xsd#ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram_77bdf836-e3b5-4c4d-a086-7f8f0ef39f2e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4e080dba-f82d-4be6-bec6-21c88faf0d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4e080dba-f82d-4be6-bec6-21c88faf0d8f" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_04585f6f-cef6-4df9-b378-ed2240ef402b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:to="loc_srt_ConsolidationItemsAxis_04585f6f-cef6-4df9-b378-ed2240ef402b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_04585f6f-cef6-4df9-b378-ed2240ef402b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_04585f6f-cef6-4df9-b378-ed2240ef402b" xlink:to="loc_srt_ConsolidationItemsDomain_04585f6f-cef6-4df9-b378-ed2240ef402b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3fce300d-b209-40e8-a89f-d782d3f606ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_04585f6f-cef6-4df9-b378-ed2240ef402b" xlink:to="loc_srt_ConsolidationItemsDomain_3fce300d-b209-40e8-a89f-d782d3f606ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_18a6a622-5978-4ac0-8c55-a953e6dce628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3fce300d-b209-40e8-a89f-d782d3f606ba" xlink:to="loc_us-gaap_OperatingSegmentsMember_18a6a622-5978-4ac0-8c55-a953e6dce628" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3dcd1f61-d10e-419b-b8fb-74dea21a62f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3dcd1f61-d10e-419b-b8fb-74dea21a62f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3dcd1f61-d10e-419b-b8fb-74dea21a62f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3dcd1f61-d10e-419b-b8fb-74dea21a62f0" xlink:to="loc_us-gaap_SegmentDomain_3dcd1f61-d10e-419b-b8fb-74dea21a62f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fed8343b-8d4a-434f-8eff-a3636d27a637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3dcd1f61-d10e-419b-b8fb-74dea21a62f0" xlink:to="loc_us-gaap_SegmentDomain_fed8343b-8d4a-434f-8eff-a3636d27a637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_b25f7755-b3f7-427b-88d6-f389897223df" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fed8343b-8d4a-434f-8eff-a3636d27a637" xlink:to="loc_ahl_ReinsuranceMember_b25f7755-b3f7-427b-88d6-f389897223df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_994bf419-6b07-455d-9c7a-a592b58ae0d4" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fed8343b-8d4a-434f-8eff-a3636d27a637" xlink:to="loc_ahl_InsuranceMember_994bf419-6b07-455d-9c7a-a592b58ae0d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingSummaryoftheScheduleoftheCompanysgrosswrittenpremiumsbasedonthelocationoftheinsuredriskDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingSummaryoftheScheduleoftheCompanysgrosswrittenpremiumsbasedonthelocationoftheinsuredriskDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/SegmentReportingSummaryoftheScheduleoftheCompanysgrosswrittenpremiumsbasedonthelocationoftheinsuredriskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5fabc71b-5a72-4918-8519-7fbe2743c411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_7d21117a-fa58-49a8-9c4e-aeddf683f42d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fabc71b-5a72-4918-8519-7fbe2743c411" xlink:to="loc_us-gaap_PremiumsWrittenGross_7d21117a-fa58-49a8-9c4e-aeddf683f42d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b291e21-5778-4f6a-90ef-a03b8531b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fabc71b-5a72-4918-8519-7fbe2743c411" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b291e21-5778-4f6a-90ef-a03b8531b79a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2fa2d145-d7ba-4788-8674-929a7f2b8c01" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b291e21-5778-4f6a-90ef-a03b8531b79a" xlink:to="loc_srt_StatementGeographicalAxis_2fa2d145-d7ba-4788-8674-929a7f2b8c01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2fa2d145-d7ba-4788-8674-929a7f2b8c01_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2fa2d145-d7ba-4788-8674-929a7f2b8c01" xlink:to="loc_srt_SegmentGeographicalDomain_2fa2d145-d7ba-4788-8674-929a7f2b8c01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2fa2d145-d7ba-4788-8674-929a7f2b8c01" xlink:to="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_f74cc9be-6805-40c5-ad9f-944c9d72d945" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_srt_AsiaPacificMember_f74cc9be-6805-40c5-ad9f-944c9d72d945" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b1ab1488-c091-4e4b-956b-2e3c44f4f58a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_srt_EuropeMember_b1ab1488-c091-4e4b-956b-2e3c44f4f58a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_bb030038-25c7-49a8-a775-f73f6f14631d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_country_GB_bb030038-25c7-49a8-a775-f73f6f14631d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnitedStatesAndCanadaMember_d3ec3dab-1e04-49c3-8bf2-5f0e2833ed95" xlink:href="ahl-20231220.xsd#ahl_UnitedStatesAndCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_ahl_UnitedStatesAndCanadaMember_d3ec3dab-1e04-49c3-8bf2-5f0e2833ed95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_47c41fc7-bad2-4e48-a2c1-a77ee6cd3c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_us-gaap_NonUsMember_47c41fc7-bad2-4e48-a2c1-a77ee6cd3c3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_WorldwideIncludingUnitedStatesMember_9fa62357-40cc-491e-97e1-d22ee0c6b6a7" xlink:href="ahl-20231220.xsd#ahl_WorldwideIncludingUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_ahl_WorldwideIncludingUnitedStatesMember_9fa62357-40cc-491e-97e1-d22ee0c6b6a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherCountriesMember_548b57cc-05e0-48c1-aa90-75c01f0dfc49" xlink:href="ahl-20231220.xsd#ahl_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_ahl_OtherCountriesMember_548b57cc-05e0-48c1-aa90-75c01f0dfc49" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_cd132043-c9f9-41c3-84fe-ccb0bff3a462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_cd132043-c9f9-41c3-84fe-ccb0bff3a462" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_f5a612c8-3e08-455c-9c36-1b1dcff71750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_f5a612c8-3e08-455c-9c36-1b1dcff71750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_2fb6fa20-6b1b-4408-9b00-8a138e7334e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:to="loc_us-gaap_NetInvestmentIncome_2fb6fa20-6b1b-4408-9b00-8a138e7334e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca907328-857b-4281-b8f2-27e2fd56b059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca907328-857b-4281-b8f2-27e2fd56b059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca907328-857b-4281-b8f2-27e2fd56b059_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca907328-857b-4281-b8f2-27e2fd56b059" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca907328-857b-4281-b8f2-27e2fd56b059_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd013a9f-78ba-408b-a170-ef36c530ada1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca907328-857b-4281-b8f2-27e2fd56b059" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd013a9f-78ba-408b-a170-ef36c530ada1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_e7673f6e-4e9a-4aab-ac43-f33a4be722ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd013a9f-78ba-408b-a170-ef36c530ada1" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_e7673f6e-4e9a-4aab-ac43-f33a4be722ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_6ddcaca4-ca08-4136-9ba0-dc86f0614f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:to="loc_us-gaap_InvestmentTypeAxis_6ddcaca4-ca08-4136-9ba0-dc86f0614f19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6ddcaca4-ca08-4136-9ba0-dc86f0614f19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_6ddcaca4-ca08-4136-9ba0-dc86f0614f19" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6ddcaca4-ca08-4136-9ba0-dc86f0614f19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_6ddcaca4-ca08-4136-9ba0-dc86f0614f19" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b5b7cc6e-7117-4881-9ce7-19dfeb8b03cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_DebtSecuritiesMember_b5b7cc6e-7117-4881-9ce7-19dfeb8b03cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_fb6cde45-52b5-4bc9-8a39-13d200d2bafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_fb6cde45-52b5-4bc9-8a39-13d200d2bafe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShorttermInvestmentTradingMember_54c09f48-342a-4a91-afdb-5e78b6a7b6d7" xlink:href="ahl-20231220.xsd#ahl_ShorttermInvestmentTradingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_ahl_ShorttermInvestmentTradingMember_54c09f48-342a-4a91-afdb-5e78b6a7b6d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_e1942466-1b56-4214-8d11-485f22f7c750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_e1942466-1b56-4214-8d11-485f22f7c750" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_04d9d0d3-77ac-43a7-b4a2-000212ed6836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_EquitySecuritiesMember_04d9d0d3-77ac-43a7-b4a2-000212ed6836" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember_392b4785-f430-4d78-96b3-2d2f8cda8c7f" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_ahl_CatastropheBondsMember_392b4785-f430-4d78-96b3-2d2f8cda8c7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_b112dbcc-9c9c-47c9-8426-694a11e8320f" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_b112dbcc-9c9c-47c9-8426-694a11e8320f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_5a948e71-d1da-4126-931c-a10efaf18fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_5a948e71-d1da-4126-931c-a10efaf18fc5" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_de42df49-6db6-422e-ae4b-f504e893edff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_de42df49-6db6-422e-ae4b-f504e893edff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_daf17198-4de6-4dae-811c-86696a116844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_daf17198-4de6-4dae-811c-86696a116844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_3e7c4dc0-0620-46db-aaf0-d77f40a6c3e9" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_3e7c4dc0-0620-46db-aaf0-d77f40a6c3e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGain_72ddf534-1872-4325-8b47-c1f04fab595b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedGain_72ddf534-1872-4325-8b47-c1f04fab595b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_75d22d7c-34a6-4f2c-97ab-28044c9671fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_75d22d7c-34a6-4f2c-97ab-28044c9671fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_c233b0b4-0b66-4d20-9cb9-7b66c808a458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_c233b0b4-0b66-4d20-9cb9-7b66c808a458" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_6dc585ef-ee32-4638-9d91-4678f5c0d94d" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesCatastropheBondsGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_6dc585ef-ee32-4638-9d91-4678f5c0d94d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c44f96ff-6939-4ec1-876b-d81b53918db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c44f96ff-6939-4ec1-876b-d81b53918db4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_a7669f1b-90c3-44ed-b5ad-6b109caa3e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_a7669f1b-90c3-44ed-b5ad-6b109caa3e2b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_27c26864-ef91-454e-8c2b-8f710df0bed5" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_27c26864-ef91-454e-8c2b-8f710df0bed5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_4838e474-34a4-4932-95df-b514720d825d" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_4838e474-34a4-4932-95df-b514720d825d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_85c579ba-9415-4c7f-a48d-8c4984bd6adf" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_85c579ba-9415-4c7f-a48d-8c4984bd6adf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e0360301-8ffc-41a6-b7d6-e401bca04a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e0360301-8ffc-41a6-b7d6-e401bca04a5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_bcd93373-ba70-4603-8526-2dc94220b698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_bcd93373-ba70-4603-8526-2dc94220b698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bcd93373-ba70-4603-8526-2dc94220b698_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_bcd93373-ba70-4603-8526-2dc94220b698" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bcd93373-ba70-4603-8526-2dc94220b698_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0c6d58c8-5d6a-4357-a395-63582ad9efdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_bcd93373-ba70-4603-8526-2dc94220b698" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0c6d58c8-5d6a-4357-a395-63582ad9efdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_95542a09-f775-447c-8634-d698184e50b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0c6d58c8-5d6a-4357-a395-63582ad9efdf" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_95542a09-f775-447c-8634-d698184e50b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_27470751-7fc3-448d-b841-04a47f7807eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_27470751-7fc3-448d-b841-04a47f7807eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_27470751-7fc3-448d-b841-04a47f7807eb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_27470751-7fc3-448d-b841-04a47f7807eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_27470751-7fc3-448d-b841-04a47f7807eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_27470751-7fc3-448d-b841-04a47f7807eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_ba0f0da0-5f3b-4c6c-9364-4cf0ecf27507" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:to="loc_ahl_MVIMember_ba0f0da0-5f3b-4c6c-9364-4cf0ecf27507" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_0940e403-56f1-41fe-972c-cd6f1e6955c3" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:to="loc_ahl_MultiLineReinsurerMember_0940e403-56f1-41fe-972c-cd6f1e6955c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_02046ead-37f1-4bb2-b2d0-47aa3da6abb6" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:to="loc_ahl_DigitalRiskMember_02046ead-37f1-4bb2-b2d0-47aa3da6abb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_55c0a0dd-7987-4e78-9d29-cfc72f281295" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:to="loc_ahl_BeneAssicurazioniMember_55c0a0dd-7987-4e78-9d29-cfc72f281295" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_041f4872-0bd5-46f6-949c-f63c4b67f40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_us-gaap_InvestmentTypeAxis_041f4872-0bd5-46f6-949c-f63c4b67f40b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_041f4872-0bd5-46f6-949c-f63c4b67f40b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_041f4872-0bd5-46f6-949c-f63c4b67f40b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_041f4872-0bd5-46f6-949c-f63c4b67f40b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_cbbb269c-5474-46e6-a0cd-35175e8066ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_041f4872-0bd5-46f6-949c-f63c4b67f40b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_cbbb269c-5474-46e6-a0cd-35175e8066ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a6bc292e-2f47-4b3e-ad64-289899a708fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cbbb269c-5474-46e6-a0cd-35175e8066ae" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a6bc292e-2f47-4b3e-ad64-289899a708fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_a7989d5f-4029-4be2-bd68-20d8a9b0eef7" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cbbb269c-5474-46e6-a0cd-35175e8066ae" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_a7989d5f-4029-4be2-bd68-20d8a9b0eef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d92696d4-efb7-4979-b1bb-ec0601721c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d92696d4-efb7-4979-b1bb-ec0601721c15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d92696d4-efb7-4979-b1bb-ec0601721c15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d92696d4-efb7-4979-b1bb-ec0601721c15" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d92696d4-efb7-4979-b1bb-ec0601721c15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6aa626b5-b3fd-4ed8-bfce-3e71adb3543e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d92696d4-efb7-4979-b1bb-ec0601721c15" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6aa626b5-b3fd-4ed8-bfce-3e71adb3543e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_07bed637-7600-4679-b05a-ae483491e3a4" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6aa626b5-b3fd-4ed8-bfce-3e71adb3543e" xlink:to="loc_ahl_BeneAssicurazioniMember_07bed637-7600-4679-b05a-ae483491e3a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CropReMember_1b104594-e7a8-4f13-8add-c9200b8d1837" xlink:href="ahl-20231220.xsd#ahl_CropReMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6aa626b5-b3fd-4ed8-bfce-3e71adb3543e" xlink:to="loc_ahl_CropReMember_1b104594-e7a8-4f13-8add-c9200b8d1837" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9f5b2eaf-4439-473e-890c-f0c71593f503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9f5b2eaf-4439-473e-890c-f0c71593f503" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e4a8863c-338d-4904-8571-4b5d23111bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e4a8863c-338d-4904-8571-4b5d23111bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ee1856a6-8eed-49a2-897c-1fec983412d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ee1856a6-8eed-49a2-897c-1fec983412d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_3d265c7f-e91b-49e0-8e8b-456a0d5c4e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_3d265c7f-e91b-49e0-8e8b-456a0d5c4e28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ba18cf80-8461-42e1-ba35-0a2e93b9c28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ba18cf80-8461-42e1-ba35-0a2e93b9c28d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_dba5a275-010c-4f37-8661-a6b5db615615" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_dba5a275-010c-4f37-8661-a6b5db615615" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a652f755-d673-4b84-ad79-7e044f0b3d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a652f755-d673-4b84-ad79-7e044f0b3d2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_4e049117-7a5b-48ba-bde1-fd22b5b8df6c" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_4e049117-7a5b-48ba-bde1-fd22b5b8df6c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_3aa999f1-c2b6-418d-9c70-2aa351cc2e23" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_3aa999f1-c2b6-418d-9c70-2aa351cc2e23" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fe9aca1f-cb36-4521-8e13-a6cccd9657c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fe9aca1f-cb36-4521-8e13-a6cccd9657c1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_73f7fe3f-bd9c-4cc7-a885-bcc111ce6494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_73f7fe3f-bd9c-4cc7-a885-bcc111ce6494" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_db2c37a7-8162-4957-9726-0a1b1404b374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_db2c37a7-8162-4957-9726-0a1b1404b374" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c91c9ebc-f964-440d-b2e0-ccc68d54c513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c91c9ebc-f964-440d-b2e0-ccc68d54c513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c91c9ebc-f964-440d-b2e0-ccc68d54c513_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c91c9ebc-f964-440d-b2e0-ccc68d54c513" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c91c9ebc-f964-440d-b2e0-ccc68d54c513_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c91c9ebc-f964-440d-b2e0-ccc68d54c513" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0ef72b65-a0f3-4f41-a250-9550df87d115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0ef72b65-a0f3-4f41-a250-9550df87d115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9f450c6c-d814-4ba4-9607-dafa3dcfb07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9f450c6c-d814-4ba4-9607-dafa3dcfb07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_98d1248e-ca54-42fc-b50f-709caf3c0c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_MunicipalBondsMember_98d1248e-ca54-42fc-b50f-709caf3c0c70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_948559c4-f342-4eb4-b1af-67aa3768fdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_948559c4-f342-4eb4-b1af-67aa3768fdad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_5a33181d-e481-4b82-8dbc-5ab90fcc8bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_5a33181d-e481-4b82-8dbc-5ab90fcc8bcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_391593d6-8a0f-4a82-90e3-fae74eed973d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_391593d6-8a0f-4a82-90e3-fae74eed973d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_61afb27e-e5f1-43d0-ba79-02b109adf00a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_61afb27e-e5f1-43d0-ba79-02b109adf00a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_da488c4c-0c51-4d51-afba-9bf939e877c7" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_da488c4c-0c51-4d51-afba-9bf939e877c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_d8261ce1-870d-49ae-b064-cb286315b9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_d8261ce1-870d-49ae-b064-cb286315b9ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_8a4f143a-ef04-4de6-9ab2-a6d65e3b694f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_DebtSecuritiesMember_8a4f143a-ef04-4de6-9ab2-a6d65e3b694f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_02a065b2-ce0e-4107-a040-a0479ad0f59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:to="loc_us-gaap_InvestmentTypeAxis_02a065b2-ce0e-4107-a040-a0479ad0f59f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_02a065b2-ce0e-4107-a040-a0479ad0f59f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_02a065b2-ce0e-4107-a040-a0479ad0f59f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_02a065b2-ce0e-4107-a040-a0479ad0f59f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_02a065b2-ce0e-4107-a040-a0479ad0f59f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b6378d40-282c-4f8e-8865-102196a5c922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_DebtSecuritiesMember_b6378d40-282c-4f8e-8865-102196a5c922" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_c808dc7e-2296-4284-8949-5d3d2e5dc774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_FixedMaturitiesMember_c808dc7e-2296-4284-8949-5d3d2e5dc774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_abf37fec-ab3c-47b3-93e4-9834ae456b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_EquitySecuritiesMember_abf37fec-ab3c-47b3-93e4-9834ae456b58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_1a92ebcc-d06f-4a8f-96d2-bdb152b08235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_1a92ebcc-d06f-4a8f-96d2-bdb152b08235" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_ef1a7af0-fd9b-4675-848e-6cdde5a39a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_ef1a7af0-fd9b-4675-848e-6cdde5a39a1a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_b2413339-2e3d-44ef-819f-10e435977b79" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_b2413339-2e3d-44ef-819f-10e435977b79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_9ffe66f9-4b6b-49eb-9153-5275bd8bc960" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_9ffe66f9-4b6b-49eb-9153-5275bd8bc960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_b47e1137-c872-4b5f-8fa1-9fb8a3a87aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_us-gaap_TradingSecurities_b47e1137-c872-4b5f-8fa1-9fb8a3a87aba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_05b9bf6a-e009-4074-a11e-03acfc65aafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_05b9bf6a-e009-4074-a11e-03acfc65aafb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_39f06843-f622-45ed-b311-ec11017d1a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:to="loc_us-gaap_FinancialInstrumentAxis_39f06843-f622-45ed-b311-ec11017d1a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_39f06843-f622-45ed-b311-ec11017d1a10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_39f06843-f622-45ed-b311-ec11017d1a10" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_39f06843-f622-45ed-b311-ec11017d1a10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_39f06843-f622-45ed-b311-ec11017d1a10" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_7d293149-c343-4bd9-a9bf-2efb466a363d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_7d293149-c343-4bd9-a9bf-2efb466a363d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_87ce9ed3-09ab-4757-96f8-9a373646b4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_MunicipalBondsMember_87ce9ed3-09ab-4757-96f8-9a373646b4da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_896e3971-511e-43fa-ad00-14885f618483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_896e3971-511e-43fa-ad00-14885f618483" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_67ac4d4d-7f90-4a82-b83f-9d30769f1c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_67ac4d4d-7f90-4a82-b83f-9d30769f1c32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_59993775-9edf-4107-b2c2-c593f1b65b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_59993775-9edf-4107-b2c2-c593f1b65b97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_f4137895-c923-4c8d-b506-987ac6f0391f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_f4137895-c923-4c8d-b506-987ac6f0391f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_0d4917b0-4204-4bbb-bf93-2203e692b64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_0d4917b0-4204-4bbb-bf93-2203e692b64b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_9b756657-9350-47fc-b960-409e2e73c366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:to="loc_us-gaap_InvestmentTypeAxis_9b756657-9350-47fc-b960-409e2e73c366" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_9b756657-9350-47fc-b960-409e2e73c366_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_9b756657-9350-47fc-b960-409e2e73c366" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_9b756657-9350-47fc-b960-409e2e73c366_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_9b756657-9350-47fc-b960-409e2e73c366" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember_06a07b61-159e-4a1a-9c55-c64c759b2c5e" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_HighYieldLoansMember_06a07b61-159e-4a1a-9c55-c64c759b2c5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingFixedMaturityInvestmentsMember_c1b038f3-7a05-4699-8365-125ee7021a2a" xlink:href="ahl-20231220.xsd#ahl_TradingFixedMaturityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_TradingFixedMaturityInvestmentsMember_c1b038f3-7a05-4699-8365-125ee7021a2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_de41e6a5-6400-4f62-bfda-3bb3149ff269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_de41e6a5-6400-4f62-bfda-3bb3149ff269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember_77fae2bf-d394-4a84-8b7f-9d765fd5739c" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_CatastropheBondsMember_77fae2bf-d394-4a84-8b7f-9d765fd5739c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_1c29a5cc-1fdd-429c-b1f8-afd8c6d0c674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_1c29a5cc-1fdd-429c-b1f8-afd8c6d0c674" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_1593a752-a9e4-4a57-a751-f33ccd4668b8" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_MiddlemarketloansMember_1593a752-a9e4-4a57-a751-f33ccd4668b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SecuritiesassetbackedMember_6a7cc6f9-b4d1-46e9-b095-38a45ae0d752" xlink:href="ahl-20231220.xsd#ahl_SecuritiesassetbackedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_SecuritiesassetbackedMember_6a7cc6f9-b4d1-46e9-b095-38a45ae0d752" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalSecuritiesCorporateMember_b5497b70-9873-4d29-9612-74e10542ac0f" xlink:href="ahl-20231220.xsd#ahl_GlobalSecuritiesCorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_GlobalSecuritiesCorporateMember_b5497b70-9873-4d29-9612-74e10542ac0f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_3927078c-1a99-4e8f-93d7-5856e5f9ae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_us-gaap_EquitySecuritiesMember_3927078c-1a99-4e8f-93d7-5856e5f9ae6f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_7367ef54-bf7e-4d8a-be5c-6edb4cfdaea1" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_7367ef54-bf7e-4d8a-be5c-6edb4cfdaea1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_437f5fd3-1fc9-4cd3-b7cd-ddccddeb3461" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_437f5fd3-1fc9-4cd3-b7cd-ddccddeb3461" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalTradingMember_598a51c9-16f8-4c50-85aa-e4dd2ad1eb93" xlink:href="ahl-20231220.xsd#ahl_TotalTradingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_TotalTradingMember_598a51c9-16f8-4c50-85aa-e4dd2ad1eb93" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_2dbaef10-ceca-4086-9da9-6e7c4625cd24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_dce7b9ca-669c-424d-964a-e2e8c2d68c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_2dbaef10-ceca-4086-9da9-6e7c4625cd24" xlink:to="loc_us-gaap_TradingSecurities_dce7b9ca-669c-424d-964a-e2e8c2d68c42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_80975aea-0dec-4c9a-902a-0b99b9c89755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_2dbaef10-ceca-4086-9da9-6e7c4625cd24" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_80975aea-0dec-4c9a-902a-0b99b9c89755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationByPropertyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_2dbaef10-ceca-4086-9da9-6e7c4625cd24" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_e69217f9-e86b-4efd-930c-75cf87469270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_us-gaap_GeographicDistributionAxis_e69217f9-e86b-4efd-930c-75cf87469270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_e69217f9-e86b-4efd-930c-75cf87469270_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_e69217f9-e86b-4efd-930c-75cf87469270" xlink:to="loc_us-gaap_GeographicDistributionDomain_e69217f9-e86b-4efd-930c-75cf87469270_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_45fe8858-2de5-475d-9352-1c41cf716ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_e69217f9-e86b-4efd-930c-75cf87469270" xlink:to="loc_us-gaap_GeographicDistributionDomain_45fe8858-2de5-475d-9352-1c41cf716ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_bb8fa13f-0de2-4b7c-9b8f-d5fefe932e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_45fe8858-2de5-475d-9352-1c41cf716ab7" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_bb8fa13f-0de2-4b7c-9b8f-d5fefe932e54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_f29dafa9-1fa0-4bef-845c-98b0e0090295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_45fe8858-2de5-475d-9352-1c41cf716ab7" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_f29dafa9-1fa0-4bef-845c-98b0e0090295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d65861da-147e-4aca-90e6-f626f06b14f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d65861da-147e-4aca-90e6-f626f06b14f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d65861da-147e-4aca-90e6-f626f06b14f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d65861da-147e-4aca-90e6-f626f06b14f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d65861da-147e-4aca-90e6-f626f06b14f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f200703a-4f31-4220-8a91-67e0162dc196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d65861da-147e-4aca-90e6-f626f06b14f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f200703a-4f31-4220-8a91-67e0162dc196" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentNetCarryingValueMember_5e32613b-27b8-42a0-a5f1-204a8f131167" xlink:href="ahl-20231220.xsd#ahl_InvestmentNetCarryingValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f200703a-4f31-4220-8a91-67e0162dc196" xlink:to="loc_ahl_InvestmentNetCarryingValueMember_5e32613b-27b8-42a0-a5f1-204a8f131167" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_us-gaap_InvestmentTypeAxis_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4483e89b-4c5b-4340-a0c5-7d2cb1d8964f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4483e89b-4c5b-4340-a0c5-7d2cb1d8964f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_cf6a7835-c5dd-4454-b028-f0380c38f424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_4483e89b-4c5b-4340-a0c5-7d2cb1d8964f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_cf6a7835-c5dd-4454-b028-f0380c38f424" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_bee83b6f-03ce-4f3c-b403-237f4a99b0d4" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_4483e89b-4c5b-4340-a0c5-7d2cb1d8964f" xlink:to="loc_ahl_MiddlemarketloansMember_bee83b6f-03ce-4f3c-b403-237f4a99b0d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c415e432-b127-4ede-8986-2d9aed1326a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c415e432-b127-4ede-8986-2d9aed1326a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c415e432-b127-4ede-8986-2d9aed1326a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c415e432-b127-4ede-8986-2d9aed1326a6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c415e432-b127-4ede-8986-2d9aed1326a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fceafa23-a3fc-4aac-8685-3547320e130d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c415e432-b127-4ede-8986-2d9aed1326a6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fceafa23-a3fc-4aac-8685-3547320e130d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_93a46fd1-5ad1-4bc7-8260-dec4c3696f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fceafa23-a3fc-4aac-8685-3547320e130d" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_93a46fd1-5ad1-4bc7-8260-dec4c3696f64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_ff0c1044-4ea9-4206-b9cf-bf754b6e9b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fceafa23-a3fc-4aac-8685-3547320e130d" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_ff0c1044-4ea9-4206-b9cf-bf754b6e9b5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0261fc87-3d5d-4b44-b90a-8370afa2fdc5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_srt_ProductOrServiceAxis_0261fc87-3d5d-4b44-b90a-8370afa2fdc5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0261fc87-3d5d-4b44-b90a-8370afa2fdc5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0261fc87-3d5d-4b44-b90a-8370afa2fdc5" xlink:to="loc_srt_ProductsAndServicesDomain_0261fc87-3d5d-4b44-b90a-8370afa2fdc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0261fc87-3d5d-4b44-b90a-8370afa2fdc5" xlink:to="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_a4be49af-26ca-4d81-804c-3cbced90f15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_ProductMember_a4be49af-26ca-4d81-804c-3cbced90f15a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServiceMember_85f65031-2291-47fd-a548-6b49083d462d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_FinancialServiceMember_85f65031-2291-47fd-a548-6b49083d462d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IndustrialServiceMember_b525d5dd-e472-4b5e-b4ad-930a8aedd29a" xlink:href="ahl-20231220.xsd#ahl_IndustrialServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_ahl_IndustrialServiceMember_b525d5dd-e472-4b5e-b4ad-930a8aedd29a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConsumerDiscretionaryServiceMember_eeb4167e-b4b1-4d10-b469-31c202d31e99" xlink:href="ahl-20231220.xsd#ahl_ConsumerDiscretionaryServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_ahl_ConsumerDiscretionaryServiceMember_eeb4167e-b4b1-4d10-b469-31c202d31e99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_9c9faf5d-8be0-4560-934f-a2048d86e3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_HealthCareMember_9c9faf5d-8be0-4560-934f-a2048d86e3ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergyCommoditiesAndServiceMember_da8e8a94-7ab2-4e89-ad74-e731cf104cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnergyCommoditiesAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_EnergyCommoditiesAndServiceMember_da8e8a94-7ab2-4e89-ad74-e731cf104cf2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConsumerStaplesServiceMember_40223893-878f-433a-9083-56c2dcff8fee" xlink:href="ahl-20231220.xsd#ahl_ConsumerStaplesServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_ahl_ConsumerStaplesServiceMember_40223893-878f-433a-9083-56c2dcff8fee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember_b7daef11-fd7a-46df-91f1-19918c1b6646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_TechnologyServiceMember_b7daef11-fd7a-46df-91f1-19918c1b6646" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_55936a97-2414-498b-8d96-6c154330be26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_55936a97-2414-498b-8d96-6c154330be26" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_55936a97-2414-498b-8d96-6c154330be26_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_55936a97-2414-498b-8d96-6c154330be26" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_55936a97-2414-498b-8d96-6c154330be26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_55936a97-2414-498b-8d96-6c154330be26" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ApartmentBuildingMember_453522a6-d5a1-46f7-b6de-29e5f4cec54d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ApartmentBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_ApartmentBuildingMember_453522a6-d5a1-46f7-b6de-29e5f4cec54d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_HotelMember_b1b9b49e-e25f-4a0c-ae36-815fe3282bd9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_HotelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_HotelMember_b1b9b49e-e25f-4a0c-ae36-815fe3282bd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_8501ca4b-31f0-4506-bebd-0e57ed8db64f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OfficeBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_OfficeBuildingMember_8501ca4b-31f0-4506-bebd-0e57ed8db64f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_9ee9dbab-e18c-4d39-a1d8-926ce4f6d6dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_OtherPropertyMember_9ee9dbab-e18c-4d39-a1d8-926ce4f6d6dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailMember_3bbbd827-3daa-4c96-9007-df5042e48259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_us-gaap_RetailMember_3bbbd827-3daa-4c96-9007-df5042e48259" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_IndustrialPropertyMember_bafc05fd-465d-4905-aafd-4986157dfbf9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_IndustrialPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_IndustrialPropertyMember_bafc05fd-465d-4905-aafd-4986157dfbf9" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsLoantoValueRatiosDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_7e9d5d9a-6eea-49e0-b96e-e079902d54ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_3093668c-7854-489c-af48-56abae71dc54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_7e9d5d9a-6eea-49e0-b96e-e079902d54ab" xlink:to="loc_us-gaap_TradingSecurities_3093668c-7854-489c-af48-56abae71dc54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_7e9d5d9a-6eea-49e0-b96e-e079902d54ab" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_abeeae5b-9e4e-4578-9859-4820e5c513fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:to="loc_us-gaap_InvestmentTypeAxis_abeeae5b-9e4e-4578-9859-4820e5c513fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_abeeae5b-9e4e-4578-9859-4820e5c513fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_abeeae5b-9e4e-4578-9859-4820e5c513fc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_abeeae5b-9e4e-4578-9859-4820e5c513fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0f4c9aef-59dd-46c1-9984-d3bc14fb5708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_abeeae5b-9e4e-4578-9859-4820e5c513fc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0f4c9aef-59dd-46c1-9984-d3bc14fb5708" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_7de82d2e-3010-4f88-b577-2eb2cb13adce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0f4c9aef-59dd-46c1-9984-d3bc14fb5708" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_7de82d2e-3010-4f88-b577-2eb2cb13adce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_48705eb4-9c19-41ed-95aa-031f9503ba4d" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0f4c9aef-59dd-46c1-9984-d3bc14fb5708" xlink:to="loc_ahl_MiddlemarketloansMember_48705eb4-9c19-41ed-95aa-031f9503ba4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_1af57dca-6c6a-4df3-9f18-82520ce41e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:to="loc_us-gaap_LoanToValueAxis_1af57dca-6c6a-4df3-9f18-82520ce41e04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_1af57dca-6c6a-4df3-9f18-82520ce41e04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LoanToValueAxis_1af57dca-6c6a-4df3-9f18-82520ce41e04" xlink:to="loc_us-gaap_LoanToValueDomain_1af57dca-6c6a-4df3-9f18-82520ce41e04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LoanToValueAxis_1af57dca-6c6a-4df3-9f18-82520ce41e04" xlink:to="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember_c747ecef-7fd8-41bd-9922-b0c378726e6c" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebttoValueRatioLessthan50PercentMember_c747ecef-7fd8-41bd-9922-b0c378726e6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember_35a0df2e-686d-48b7-8ec5-07e9fde902cc" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebttoValueRatio50to60PercentMember_35a0df2e-686d-48b7-8ec5-07e9fde902cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember_ae12685b-c3e5-4d69-af94-24a0bc8b82b1" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebttoValueRatio61to70PercentMember_ae12685b-c3e5-4d69-af94-24a0bc8b82b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio71to80PercentMember_c3ad45b2-b958-4d8d-b559-2649fc889007" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio71to80PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebttoValueRatio71to80PercentMember_c3ad45b2-b958-4d8d-b559-2649fc889007" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Ltv80To100PercentMember_dceba94d-d29c-4a87-8671-a3a350786b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Ltv80To100PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_us-gaap_Ltv80To100PercentMember_dceba94d-d29c-4a87-8671-a3a350786b64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtToValueRatioGreaterThan100Member_34bf6ec9-7865-48c2-953d-fb9ad08b0ae5" xlink:href="ahl-20231220.xsd#ahl_DebtToValueRatioGreaterThan100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebtToValueRatioGreaterThan100Member_34bf6ec9-7865-48c2-953d-fb9ad08b0ae5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_8a14e538-0964-4fc7-9068-0d175d9db432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:to="loc_us-gaap_TradingSecurities_8a14e538-0964-4fc7-9068-0d175d9db432" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CMLLessNonPerformingOrFutureConstruction_af316ca8-a2d8-474c-ba03-3f5f67f78202" xlink:href="ahl-20231220.xsd#ahl_CMLLessNonPerformingOrFutureConstruction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:to="loc_ahl_CMLLessNonPerformingOrFutureConstruction_af316ca8-a2d8-474c-ba03-3f5f67f78202" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_175d263e-b1a9-4add-994c-b57850e1d3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:to="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_175d263e-b1a9-4add-994c-b57850e1d3f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:to="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioAxis_f91b3a88-66a3-43f4-8d96-852b473cb814" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_ahl_DebtServiceCoverageRatioAxis_f91b3a88-66a3-43f4-8d96-852b473cb814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioDomain_f91b3a88-66a3-43f4-8d96-852b473cb814_default" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ahl_DebtServiceCoverageRatioAxis_f91b3a88-66a3-43f4-8d96-852b473cb814" xlink:to="loc_ahl_DebtServiceCoverageRatioDomain_f91b3a88-66a3-43f4-8d96-852b473cb814_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ahl_DebtServiceCoverageRatioAxis_f91b3a88-66a3-43f4-8d96-852b473cb814" xlink:to="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_402d7148-e2f7-4e7b-9e13-a1009b550c51" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioGreaterThan1.2xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:to="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_402d7148-e2f7-4e7b-9e13-a1009b550c51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember_de7d7283-ec7f-41b8-a58d-85181aaf9407" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatio1.00to1.20xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:to="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember_de7d7283-ec7f-41b8-a58d-85181aaf9407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember_11acf364-25c6-4258-a8b1-046658fd3d29" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioLessThan1.00xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:to="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember_11acf364-25c6-4258-a8b1-046658fd3d29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_us-gaap_InvestmentTypeAxis_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8e46b427-e17c-48ed-a388-c6b226077e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8e46b427-e17c-48ed-a388-c6b226077e27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c423df4e-e6a8-4920-991d-29e1a4e0457d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8e46b427-e17c-48ed-a388-c6b226077e27" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c423df4e-e6a8-4920-991d-29e1a4e0457d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_ca1aa0b7-f072-4211-bda2-ee15f62d083e" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8e46b427-e17c-48ed-a388-c6b226077e27" xlink:to="loc_ahl_MiddlemarketloansMember_ca1aa0b7-f072-4211-bda2-ee15f62d083e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_us-gaap_LoanToValueAxis_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LoanToValueAxis_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f" xlink:to="loc_us-gaap_LoanToValueDomain_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LoanToValueAxis_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f" xlink:to="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember_3af2e1d3-e057-4094-b0fc-cf90bfc10b66" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_ahl_DebttoValueRatioLessthan50PercentMember_3af2e1d3-e057-4094-b0fc-cf90bfc10b66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember_005f9ed9-8dc5-4d9c-b76a-5b4f3c7dac79" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_ahl_DebttoValueRatio50to60PercentMember_005f9ed9-8dc5-4d9c-b76a-5b4f3c7dac79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember_146e572b-861a-4586-ad15-4c8d376f6b16" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_ahl_DebttoValueRatio61to70PercentMember_146e572b-861a-4586-ad15-4c8d376f6b16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio71to80PercentMember_a4175db2-de79-43e8-bd65-a711077cfaa9" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio71to80PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_ahl_DebttoValueRatio71to80PercentMember_a4175db2-de79-43e8-bd65-a711077cfaa9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Ltv80To100PercentMember_491613cc-eb33-4c1e-8e0f-f8987b521e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Ltv80To100PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_us-gaap_Ltv80To100PercentMember_491613cc-eb33-4c1e-8e0f-f8987b521e82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_49c24f72-fb45-4b70-894d-4208080a7992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_49c24f72-fb45-4b70-894d-4208080a7992" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_49c24f72-fb45-4b70-894d-4208080a7992_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_49c24f72-fb45-4b70-894d-4208080a7992" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_49c24f72-fb45-4b70-894d-4208080a7992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_5d329c7b-4b83-475d-81ae-26879a6ec7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_49c24f72-fb45-4b70-894d-4208080a7992" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_5d329c7b-4b83-475d-81ae-26879a6ec7ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonperformingFinancingReceivableMember_636281ae-79cc-4d9a-97d8-0b9da2d25d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonperformingFinancingReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_5d329c7b-4b83-475d-81ae-26879a6ec7ce" xlink:to="loc_us-gaap_NonperformingFinancingReceivableMember_636281ae-79cc-4d9a-97d8-0b9da2d25d5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3f89233c-ae00-4898-a3f5-e0222aa513e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:href="ahl-20231220.xsd#ahl_EquityMethodInvestmentAggregateCostRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3f89233c-ae00-4898-a3f5-e0222aa513e3" xlink:to="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_6e159455-76e6-474f-848a-db063b8a1396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_6e159455-76e6-474f-848a-db063b8a1396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_1ad8beb4-af1d-4296-91c9-5ce2006b8e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_1ad8beb4-af1d-4296-91c9-5ce2006b8e7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_55902580-f650-4c11-b0aa-8d9940345e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_55902580-f650-4c11-b0aa-8d9940345e80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_bd113899-6d8b-4ada-8e4f-44ae8301cb88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_bd113899-6d8b-4ada-8e4f-44ae8301cb88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_21c8581b-f82d-41ab-b8c0-c64eaaa49b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_b5f35669-329a-43fa-b7b9-15fed012153a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3f89233c-ae00-4898-a3f5-e0222aa513e3" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_b5f35669-329a-43fa-b7b9-15fed012153a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3f89233c-ae00-4898-a3f5-e0222aa513e3" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a12a8dd4-2678-42e0-a704-c867b9d68e50" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a12a8dd4-2678-42e0-a704-c867b9d68e50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a12a8dd4-2678-42e0-a704-c867b9d68e50_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a12a8dd4-2678-42e0-a704-c867b9d68e50" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a12a8dd4-2678-42e0-a704-c867b9d68e50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a12a8dd4-2678-42e0-a704-c867b9d68e50" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_daf2c07b-1def-4f67-b713-649603189529" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:to="loc_ahl_MVIMember_daf2c07b-1def-4f67-b713-649603189529" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_1cf9ad29-0c32-4011-b2fa-43cf09361822" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:to="loc_ahl_DigitalRiskMember_1cf9ad29-0c32-4011-b2fa-43cf09361822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_85238744-1d61-4c5a-a4c8-97b3aecab738" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:to="loc_ahl_MultiLineReinsurerMember_85238744-1d61-4c5a-a4c8-97b3aecab738" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ce8712cf-ce26-4a12-aa57-e74ebb94fe37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ce8712cf-ce26-4a12-aa57-e74ebb94fe37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_ce8712cf-ce26-4a12-aa57-e74ebb94fe37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ce8712cf-ce26-4a12-aa57-e74ebb94fe37" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_ce8712cf-ce26-4a12-aa57-e74ebb94fe37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_29af313b-8ce2-45fb-9b55-c513d5ea69fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ce8712cf-ce26-4a12-aa57-e74ebb94fe37" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_29af313b-8ce2-45fb-9b55-c513d5ea69fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_79397fba-95b4-4e87-ac91-d9c85a74e90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_29af313b-8ce2-45fb-9b55-c513d5ea69fc" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_79397fba-95b4-4e87-ac91-d9c85a74e90a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59708f47-2c10-483d-8572-21a1e9908344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59708f47-2c10-483d-8572-21a1e9908344" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_59708f47-2c10-483d-8572-21a1e9908344_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59708f47-2c10-483d-8572-21a1e9908344" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_59708f47-2c10-483d-8572-21a1e9908344_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6aadd7c7-efd9-48c4-b18d-2e1de5c6dafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59708f47-2c10-483d-8572-21a1e9908344" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6aadd7c7-efd9-48c4-b18d-2e1de5c6dafe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c2c76b26-33d8-416d-b8fe-e7be0d7d17f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6aadd7c7-efd9-48c4-b18d-2e1de5c6dafe" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c2c76b26-33d8-416d-b8fe-e7be0d7d17f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_482bd760-b4fb-478a-9f12-03168441ccfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_us-gaap_InvestmentTypeAxis_482bd760-b4fb-478a-9f12-03168441ccfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_482bd760-b4fb-478a-9f12-03168441ccfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_482bd760-b4fb-478a-9f12-03168441ccfe" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_482bd760-b4fb-478a-9f12-03168441ccfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_69f01c85-57ab-44b2-8b13-99082adedb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_482bd760-b4fb-478a-9f12-03168441ccfe" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_69f01c85-57ab-44b2-8b13-99082adedb4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_fc00eff3-65cf-4a34-83d6-049fe74845c4" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_69f01c85-57ab-44b2-8b13-99082adedb4d" xlink:to="loc_ahl_RealEstateFundDec2017Member_fc00eff3-65cf-4a34-83d6-049fe74845c4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofFixedMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_6c3dff6b-f720-4d8d-8605-401bbf9a4eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_6c3dff6b-f720-4d8d-8605-401bbf9a4eab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_441e82bb-e19e-4467-860c-2b981bfc99b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_441e82bb-e19e-4467-860c-2b981bfc99b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_1c1cb083-8486-4c87-9ac4-54567dfa5909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_1c1cb083-8486-4c87-9ac4-54567dfa5909" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_6f625ae1-ba85-4a56-ad9c-cb68fbb028a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_6f625ae1-ba85-4a56-ad9c-cb68fbb028a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a7ca918e-31c5-4546-8b4d-650f82d30bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a7ca918e-31c5-4546-8b4d-650f82d30bc9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_e2ea74d4-7d88-44c9-872c-5afcd555aef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_e2ea74d4-7d88-44c9-872c-5afcd555aef7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_a68527a5-2263-4a18-9324-7d2ae2dd07a5" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_a68527a5-2263-4a18-9324-7d2ae2dd07a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cb08cdcc-0c72-47a7-b473-889c3f6bf75f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cb08cdcc-0c72-47a7-b473-889c3f6bf75f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_3b4189d5-026c-4a6b-b51f-ab515fcbe6be" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_3b4189d5-026c-4a6b-b51f-ab515fcbe6be" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_3dd95f25-675c-4e81-be0e-227795c43907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_3dd95f25-675c-4e81-be0e-227795c43907" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_f82d9a08-acba-4873-97dc-229037f49cc6" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_f82d9a08-acba-4873-97dc-229037f49cc6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_443109b3-8d25-4f6b-9811-3de3732029be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_443109b3-8d25-4f6b-9811-3de3732029be" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_1a02c646-f96e-4053-8f49-287cebedb6dd" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_1a02c646-f96e-4053-8f49-287cebedb6dd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eea4f08f-b224-449e-85cc-65293917261e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eea4f08f-b224-449e-85cc-65293917261e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_bf553b42-c300-4a61-b970-1d9483031a94" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_bf553b42-c300-4a61-b970-1d9483031a94" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_0a796ebd-8393-4b1b-a1d5-1fbc340f470a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_0a796ebd-8393-4b1b-a1d5-1fbc340f470a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6de3a236-37a1-46a6-8a4d-e5cef0eb644d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_0a796ebd-8393-4b1b-a1d5-1fbc340f470a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6de3a236-37a1-46a6-8a4d-e5cef0eb644d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6de3a236-37a1-46a6-8a4d-e5cef0eb644d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6de3a236-37a1-46a6-8a4d-e5cef0eb644d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6de3a236-37a1-46a6-8a4d-e5cef0eb644d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6de3a236-37a1-46a6-8a4d-e5cef0eb644d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_bd23390f-bce2-4780-b5a7-f744993ae665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_bd23390f-bce2-4780-b5a7-f744993ae665" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_9279e4fe-6214-452b-a1f6-43fffa83ee40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_9279e4fe-6214-452b-a1f6-43fffa83ee40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_10aba096-09e6-41fe-b8c8-d73fd088e369" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_10aba096-09e6-41fe-b8c8-d73fd088e369" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_1e282862-84fa-44b7-9e63-345bc099c575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:to="loc_us-gaap_FixedMaturitiesMember_1e282862-84fa-44b7-9e63-345bc099c575" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_a75fd6ca-f895-4449-95c4-f11be4c853c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FixedMaturitiesMember_1e282862-84fa-44b7-9e63-345bc099c575" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_a75fd6ca-f895-4449-95c4-f11be4c853c2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_707624cd-5883-42b4-928f-98a3869fa8e6" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_707624cd-5883-42b4-928f-98a3869fa8e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_39093442-35c4-4e80-9e2a-6084dc61c23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_39093442-35c4-4e80-9e2a-6084dc61c23d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_6ac8199f-dc1d-4fe0-a0bd-20fa1b3f29a8" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_6ac8199f-dc1d-4fe0-a0bd-20fa1b3f29a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_653bd36e-6f5b-4b60-8b78-b2ae614aa64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_653bd36e-6f5b-4b60-8b78-b2ae614aa64e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_e1795de5-369b-460a-bc78-d3950c6fc4f5" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_e1795de5-369b-460a-bc78-d3950c6fc4f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3202b948-5174-4f3a-ac19-9e838fe04744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3202b948-5174-4f3a-ac19-9e838fe04744" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_9835d007-1fe9-4aa6-baf3-e13c3913ecb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_9835d007-1fe9-4aa6-baf3-e13c3913ecb1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5725cd37-fa37-492d-81a5-bdc27cc9ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5725cd37-fa37-492d-81a5-bdc27cc9ed2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5725cd37-fa37-492d-81a5-bdc27cc9ed2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5725cd37-fa37-492d-81a5-bdc27cc9ed2b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5725cd37-fa37-492d-81a5-bdc27cc9ed2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5725cd37-fa37-492d-81a5-bdc27cc9ed2b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_671a88da-fb16-48cb-b54c-6fe32f7f0124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_671a88da-fb16-48cb-b54c-6fe32f7f0124" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8d93f2e2-057a-46db-aec7-73c32ae5f13d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8d93f2e2-057a-46db-aec7-73c32ae5f13d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_b8dde3e2-db96-4864-be3c-0f6f28397824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_MunicipalBondsMember_b8dde3e2-db96-4864-be3c-0f6f28397824" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_1e98e2f3-e4cf-4d43-9440-8d6a2d099c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_1e98e2f3-e4cf-4d43-9440-8d6a2d099c0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_25e14a72-a6e1-4bd6-b39b-f9058f18377d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_25e14a72-a6e1-4bd6-b39b-f9058f18377d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_27864030-78cf-4c58-bd30-c89d1fe902bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_27864030-78cf-4c58-bd30-c89d1fe902bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_357a67e8-8d8e-4d1e-a756-abb38cd4afc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_357a67e8-8d8e-4d1e-a756-abb38cd4afc4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_03098b1d-b6f1-4e8f-992f-88bb67348956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:to="loc_us-gaap_InvestmentTypeAxis_03098b1d-b6f1-4e8f-992f-88bb67348956" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_03098b1d-b6f1-4e8f-992f-88bb67348956_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_03098b1d-b6f1-4e8f-992f-88bb67348956" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_03098b1d-b6f1-4e8f-992f-88bb67348956_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3d3eca9b-431c-403c-a986-c3a9a939e8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_03098b1d-b6f1-4e8f-992f-88bb67348956" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3d3eca9b-431c-403c-a986-c3a9a939e8b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_c3ce11b8-01ce-4003-9604-9e622a5d7f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3d3eca9b-431c-403c-a986-c3a9a939e8b8" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_c3ce11b8-01ce-4003-9604-9e622a5d7f4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_5a6ffe80-83cd-4621-961f-c83afc632385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3d3eca9b-431c-403c-a986-c3a9a939e8b8" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_5a6ffe80-83cd-4621-961f-c83afc632385" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAdditionalInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_ce4abec0-b161-4d17-a17f-f5b323250c03" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_CatastropheBond_ce4abec0-b161-4d17-a17f-f5b323250c03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_a8edebac-2c2c-4d9a-89d3-f7f162f2be48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_TradingSecurities_a8edebac-2c2c-4d9a-89d3-f7f162f2be48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_99e33abb-35cf-4bbf-a8a9-c007994f6977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_99e33abb-35cf-4bbf-a8a9-c007994f6977" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_472919c6-f02c-44e3-92ad-f461b7e877a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_472919c6-f02c-44e3-92ad-f461b7e877a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_9efb554d-df34-4084-b30a-9ee9cf1abf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_9efb554d-df34-4084-b30a-9ee9cf1abf8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_b7a9d437-c2bd-4dcd-b8e6-33d5af47218e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_OtherInvestments_b7a9d437-c2bd-4dcd-b8e6-33d5af47218e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fc5bcabc-3229-4450-a4ca-579c4cbdd886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fc5bcabc-3229-4450-a4ca-579c4cbdd886" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_b3c57c79-0bc9-4280-8fea-59bd68aa9efb" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_RestrictedAssets_b3c57c79-0bc9-4280-8fea-59bd68aa9efb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_b8ba35b0-7785-489b-9c0a-5e44cdd5b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_b8ba35b0-7785-489b-9c0a-5e44cdd5b0d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentFunds_e359fee4-f681-4fd1-829e-e787eff02cbb" xlink:href="ahl-20231220.xsd#ahl_InvestmentFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_InvestmentFunds_e359fee4-f681-4fd1-829e-e787eff02cbb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_2e95beb4-2e21-45dc-b640-c030e3a5019c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_2e95beb4-2e21-45dc-b640-c030e3a5019c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5ba9e4fa-f09f-439c-8613-3de61659395e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5ba9e4fa-f09f-439c-8613-3de61659395e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_4c507f97-bca8-42f4-9479-9e6c73d14838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_OtherCommitment_4c507f97-bca8-42f4-9479-9e6c73d14838" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4ae8ea31-9e52-487c-92cd-6d8a1cddb49d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4ae8ea31-9e52-487c-92cd-6d8a1cddb49d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_e8d55574-f1a0-4d00-bcf5-2706192a9008_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_e8d55574-f1a0-4d00-bcf5-2706192a9008_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_6a122b9a-ae26-4649-bc06-23b96c1e21cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:to="loc_us-gaap_LimitedPartnerMember_6a122b9a-ae26-4649-bc06-23b96c1e21cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5944ffb6-7f94-40fd-8884-d00d2135acf0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5944ffb6-7f94-40fd-8884-d00d2135acf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_df703e6a-4826-4fab-a48c-eb7ec483c2e9" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_BeneAssicurazioniMember_df703e6a-4826-4fab-a48c-eb7ec483c2e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_e1d8251b-19c9-4a2a-a86d-3040272b3180" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_MVIMember_e1d8251b-19c9-4a2a-a86d-3040272b3180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_71f48fe1-6c1e-4446-a152-cd41975491a2" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_DigitalRiskMember_71f48fe1-6c1e-4446-a152-cd41975491a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CropReMember_e013a845-3c27-46ee-8044-1652bf036bf4" xlink:href="ahl-20231220.xsd#ahl_CropReMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_CropReMember_e013a845-3c27-46ee-8044-1652bf036bf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_545f8e9d-ac45-479c-89f2-4e80561a401a" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_MultiLineReinsurerMember_545f8e9d-ac45-479c-89f2-4e80561a401a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_adf1608a-fe80-4071-a442-212d5148f491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_adf1608a-fe80-4071-a442-212d5148f491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_9c8bce75-b558-4c63-be4f-254533e5a0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_us-gaap_RealEstateFundsMember_9c8bce75-b558-4c63-be4f-254533e5a0a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8f4fbc38-d3e9-417f-bec6-ac619e4e8bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8f4fbc38-d3e9-417f-bec6-ac619e4e8bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_bb16a51f-e85b-4c24-a504-f346de65c435" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_MiddlemarketloansMember_bb16a51f-e85b-4c24-a504-f346de65c435" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_26c46f38-9484-42e6-bc53-4406e128682f" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_26c46f38-9484-42e6-bc53-4406e128682f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_89e88869-ba78-4f40-9285-c648943b0c49" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_RealEstateFundDec2017Member_89e88869-ba78-4f40-9285-c648943b0c49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundSept2021Member_71fe7e05-8741-4d0c-9736-d36e5394ce1c" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundSept2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_RealEstateFundSept2021Member_71fe7e05-8741-4d0c-9736-d36e5394ce1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InfrastructureFundMember_53c70637-b601-4260-88fa-d18f78b009bb" xlink:href="ahl-20231220.xsd#ahl_InfrastructureFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_InfrastructureFundMember_53c70637-b601-4260-88fa-d18f78b009bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_b12c14e7-dbba-44e5-a709-6b31c1d93740" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_ApolloRealEstateFundMember_b12c14e7-dbba-44e5-a709-6b31c1d93740" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e60eed7c-a573-41ed-80a8-bf165557f7de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e60eed7c-a573-41ed-80a8-bf165557f7de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c9fc0eb9-4e84-4d9d-8fed-d63b97dba217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c9fc0eb9-4e84-4d9d-8fed-d63b97dba217" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_04be63d7-08e3-47a8-b449-e707e776ad8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_04be63d7-08e3-47a8-b449-e707e776ad8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_8598c24d-07c2-4903-8cdb-8085af126df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_8598c24d-07c2-4903-8cdb-8085af126df9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:to="loc_us-gaap_RelatedPartyDomain_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:to="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_882e2477-8c00-42a2-86ba-409ec2f49c9b" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:to="loc_ahl_ApolloRealEstateFundMember_882e2477-8c00-42a2-86ba-409ec2f49c9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_InvestmentIdentifierAxis_0a039304-9c1b-4021-a308-297062bd6faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap-supplement_InvestmentIdentifierAxis_0a039304-9c1b-4021-a308-297062bd6faa" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAdditionalInformationNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_ce4abec0-b161-4d17-a17f-f5b323250c03" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_CatastropheBond_ce4abec0-b161-4d17-a17f-f5b323250c03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_a8edebac-2c2c-4d9a-89d3-f7f162f2be48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_TradingSecurities_a8edebac-2c2c-4d9a-89d3-f7f162f2be48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_99e33abb-35cf-4bbf-a8a9-c007994f6977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_99e33abb-35cf-4bbf-a8a9-c007994f6977" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_472919c6-f02c-44e3-92ad-f461b7e877a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_472919c6-f02c-44e3-92ad-f461b7e877a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_9efb554d-df34-4084-b30a-9ee9cf1abf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_9efb554d-df34-4084-b30a-9ee9cf1abf8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_b7a9d437-c2bd-4dcd-b8e6-33d5af47218e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_OtherInvestments_b7a9d437-c2bd-4dcd-b8e6-33d5af47218e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fc5bcabc-3229-4450-a4ca-579c4cbdd886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fc5bcabc-3229-4450-a4ca-579c4cbdd886" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_b3c57c79-0bc9-4280-8fea-59bd68aa9efb" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_RestrictedAssets_b3c57c79-0bc9-4280-8fea-59bd68aa9efb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_b8ba35b0-7785-489b-9c0a-5e44cdd5b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_b8ba35b0-7785-489b-9c0a-5e44cdd5b0d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentFunds_e359fee4-f681-4fd1-829e-e787eff02cbb" xlink:href="ahl-20231220.xsd#ahl_InvestmentFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_InvestmentFunds_e359fee4-f681-4fd1-829e-e787eff02cbb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_2e95beb4-2e21-45dc-b640-c030e3a5019c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_2e95beb4-2e21-45dc-b640-c030e3a5019c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5ba9e4fa-f09f-439c-8613-3de61659395e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5ba9e4fa-f09f-439c-8613-3de61659395e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_4c507f97-bca8-42f4-9479-9e6c73d14838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_OtherCommitment_4c507f97-bca8-42f4-9479-9e6c73d14838" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4ae8ea31-9e52-487c-92cd-6d8a1cddb49d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4ae8ea31-9e52-487c-92cd-6d8a1cddb49d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_e8d55574-f1a0-4d00-bcf5-2706192a9008_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_e8d55574-f1a0-4d00-bcf5-2706192a9008_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_6a122b9a-ae26-4649-bc06-23b96c1e21cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:to="loc_us-gaap_LimitedPartnerMember_6a122b9a-ae26-4649-bc06-23b96c1e21cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5944ffb6-7f94-40fd-8884-d00d2135acf0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5944ffb6-7f94-40fd-8884-d00d2135acf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_df703e6a-4826-4fab-a48c-eb7ec483c2e9" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_BeneAssicurazioniMember_df703e6a-4826-4fab-a48c-eb7ec483c2e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_e1d8251b-19c9-4a2a-a86d-3040272b3180" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_MVIMember_e1d8251b-19c9-4a2a-a86d-3040272b3180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_71f48fe1-6c1e-4446-a152-cd41975491a2" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_DigitalRiskMember_71f48fe1-6c1e-4446-a152-cd41975491a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CropReMember_e013a845-3c27-46ee-8044-1652bf036bf4" xlink:href="ahl-20231220.xsd#ahl_CropReMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_CropReMember_e013a845-3c27-46ee-8044-1652bf036bf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_545f8e9d-ac45-479c-89f2-4e80561a401a" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_MultiLineReinsurerMember_545f8e9d-ac45-479c-89f2-4e80561a401a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_adf1608a-fe80-4071-a442-212d5148f491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_adf1608a-fe80-4071-a442-212d5148f491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_9c8bce75-b558-4c63-be4f-254533e5a0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_us-gaap_RealEstateFundsMember_9c8bce75-b558-4c63-be4f-254533e5a0a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8f4fbc38-d3e9-417f-bec6-ac619e4e8bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8f4fbc38-d3e9-417f-bec6-ac619e4e8bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_bb16a51f-e85b-4c24-a504-f346de65c435" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_MiddlemarketloansMember_bb16a51f-e85b-4c24-a504-f346de65c435" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_26c46f38-9484-42e6-bc53-4406e128682f" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_26c46f38-9484-42e6-bc53-4406e128682f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_89e88869-ba78-4f40-9285-c648943b0c49" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_RealEstateFundDec2017Member_89e88869-ba78-4f40-9285-c648943b0c49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundSept2021Member_71fe7e05-8741-4d0c-9736-d36e5394ce1c" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundSept2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_RealEstateFundSept2021Member_71fe7e05-8741-4d0c-9736-d36e5394ce1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InfrastructureFundMember_53c70637-b601-4260-88fa-d18f78b009bb" xlink:href="ahl-20231220.xsd#ahl_InfrastructureFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_InfrastructureFundMember_53c70637-b601-4260-88fa-d18f78b009bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_b12c14e7-dbba-44e5-a709-6b31c1d93740" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_ApolloRealEstateFundMember_b12c14e7-dbba-44e5-a709-6b31c1d93740" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e60eed7c-a573-41ed-80a8-bf165557f7de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e60eed7c-a573-41ed-80a8-bf165557f7de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c9fc0eb9-4e84-4d9d-8fed-d63b97dba217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c9fc0eb9-4e84-4d9d-8fed-d63b97dba217" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_04be63d7-08e3-47a8-b449-e707e776ad8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_04be63d7-08e3-47a8-b449-e707e776ad8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_8598c24d-07c2-4903-8cdb-8085af126df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_8598c24d-07c2-4903-8cdb-8085af126df9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:to="loc_us-gaap_RelatedPartyDomain_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:to="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_882e2477-8c00-42a2-86ba-409ec2f49c9b" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:to="loc_ahl_ApolloRealEstateFundMember_882e2477-8c00-42a2-86ba-409ec2f49c9b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_dcc76616-a4e7-41b6-886b-4698ac18918f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_dcc76616-a4e7-41b6-886b-4698ac18918f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_c0d150a5-5c15-4025-91ef-14c840e286ac" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_c0d150a5-5c15-4025-91ef-14c840e286ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure_25d0a651-0640-476e-ba8f-48ebf2b012d5" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_ahl_CatastropheBondsFairValueDisclosure_25d0a651-0640-476e-ba8f-48ebf2b012d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_7db0793a-3cd5-4024-9f18-adf01de69a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_DerivativeAssets_7db0793a-3cd5-4024-9f18-adf01de69a79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e6a380ec-9338-4b6c-85cf-b652ba10823e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e6a380ec-9338-4b6c-85cf-b652ba10823e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_65e180f0-c55c-4c84-8f4b-a9db70cdee90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_65e180f0-c55c-4c84-8f4b-a9db70cdee90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e4ecf994-7a9b-4a64-ac4b-401c2fc85840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e4ecf994-7a9b-4a64-ac4b-401c2fc85840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4ecf994-7a9b-4a64-ac4b-401c2fc85840_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4ecf994-7a9b-4a64-ac4b-401c2fc85840" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4ecf994-7a9b-4a64-ac4b-401c2fc85840_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4ecf994-7a9b-4a64-ac4b-401c2fc85840" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_3fdc53c0-81b0-4c57-97bc-4f28c85dfb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_3fdc53c0-81b0-4c57-97bc-4f28c85dfb78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3b0874bc-2365-43d7-8086-d49eed874521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3b0874bc-2365-43d7-8086-d49eed874521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_ab159475-92e5-43d0-beed-a53da3209471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_MunicipalBondsMember_ab159475-92e5-43d0-beed-a53da3209471" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d90b5a06-2da3-4fe6-8097-a72d81d0e179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d90b5a06-2da3-4fe6-8097-a72d81d0e179" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_0fd19dd3-6521-4b8b-9b78-24d93007655f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_0fd19dd3-6521-4b8b-9b78-24d93007655f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_de05c6b9-6c8a-4910-9863-2b9c189cebee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_de05c6b9-6c8a-4910-9863-2b9c189cebee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_a71ed345-8e03-4e97-8461-319e1350b363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_a71ed345-8e03-4e97-8461-319e1350b363" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_b7b37b2a-9d64-4409-9af7-ea93c8fc8733" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_b7b37b2a-9d64-4409-9af7-ea93c8fc8733" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_69f9fb94-6747-4f68-b2fc-d68ec8e01455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_69f9fb94-6747-4f68-b2fc-d68ec8e01455" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember_55cb5e57-a294-4f64-a71e-38ba191ab780" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_ahl_HighYieldLoansMember_55cb5e57-a294-4f64-a71e-38ba191ab780" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136a3f86-aad1-4b54-b0b1-505618b915df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136a3f86-aad1-4b54-b0b1-505618b915df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_136a3f86-aad1-4b54-b0b1-505618b915df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136a3f86-aad1-4b54-b0b1-505618b915df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_136a3f86-aad1-4b54-b0b1-505618b915df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_47d76c55-f133-4a7d-921d-6bbabf1169da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136a3f86-aad1-4b54-b0b1-505618b915df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_47d76c55-f133-4a7d-921d-6bbabf1169da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d6f8022a-7dd7-4bd5-a1c1-4ffdaf8740a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_47d76c55-f133-4a7d-921d-6bbabf1169da" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d6f8022a-7dd7-4bd5-a1c1-4ffdaf8740a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_05c80483-cee8-4a60-8f03-7c4b87c29a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_05c80483-cee8-4a60-8f03-7c4b87c29a53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05c80483-cee8-4a60-8f03-7c4b87c29a53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_05c80483-cee8-4a60-8f03-7c4b87c29a53" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05c80483-cee8-4a60-8f03-7c4b87c29a53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_05c80483-cee8-4a60-8f03-7c4b87c29a53" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1a8ae1b2-c6f8-4d1f-b5e3-323f3587baa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1a8ae1b2-c6f8-4d1f-b5e3-323f3587baa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f8dc9fb8-9168-4648-bffd-e97e9fd4ec16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f8dc9fb8-9168-4648-bffd-e97e9fd4ec16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_77319f69-5284-4f55-9c2c-5bd2c5f9229b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_77319f69-5284-4f55-9c2c-5bd2c5f9229b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_322b5240-5d63-4231-8439-e7e806872d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_InvestmentTypeAxis_322b5240-5d63-4231-8439-e7e806872d2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_322b5240-5d63-4231-8439-e7e806872d2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_322b5240-5d63-4231-8439-e7e806872d2a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_322b5240-5d63-4231-8439-e7e806872d2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_322b5240-5d63-4231-8439-e7e806872d2a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_e57fbefa-c53b-4295-83f7-a92603073884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_e57fbefa-c53b-4295-83f7-a92603073884" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_1124e3c5-3351-4ad1-9caa-18613d905daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_1124e3c5-3351-4ad1-9caa-18613d905daa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_463b60bf-3320-4291-b571-3e26459700a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_463b60bf-3320-4291-b571-3e26459700a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_391ca725-8467-4f5e-a60d-399d86906200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_391ca725-8467-4f5e-a60d-399d86906200" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember_1c14f1be-e4d9-45fc-b1bf-c10a1a0644fa" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember_1c14f1be-e4d9-45fc-b1bf-c10a1a0644fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_e63442bd-d8e7-42ef-bb47-0e10361b8776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_RealEstateFundsMember_e63442bd-d8e7-42ef-bb47-0e10361b8776" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_8ee81bf2-1e67-45a2-8c80-524f73405863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_8ee81bf2-1e67-45a2-8c80-524f73405863" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_8ee81bf2-1e67-45a2-8c80-524f73405863_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_8ee81bf2-1e67-45a2-8c80-524f73405863" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_8ee81bf2-1e67-45a2-8c80-524f73405863_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_8ee81bf2-1e67-45a2-8c80-524f73405863" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_da427ee7-5781-4e28-a263-8b19f25acc14" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_da427ee7-5781-4e28-a263-8b19f25acc14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_45e6b7af-af10-406b-a64e-3e8aac750d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_45e6b7af-af10-406b-a64e-3e8aac750d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_2c60c08c-79c2-4c33-ba3e-5645e63eb3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_2c60c08c-79c2-4c33-ba3e-5645e63eb3fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_68033674-b1c5-4b99-881c-3ff522f824ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_68033674-b1c5-4b99-881c-3ff522f824ce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_68033674-b1c5-4b99-881c-3ff522f824ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_68033674-b1c5-4b99-881c-3ff522f824ce" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_68033674-b1c5-4b99-881c-3ff522f824ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_52c839b3-8064-4b3e-90c3-fb441386756e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_68033674-b1c5-4b99-881c-3ff522f824ce" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_52c839b3-8064-4b3e-90c3-fb441386756e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_fe652d38-f703-484e-b904-8bea3d51f455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_52c839b3-8064-4b3e-90c3-fb441386756e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_fe652d38-f703-484e-b904-8bea3d51f455" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_351ee8bf-4248-4bc0-bb81-4807f1c3cd9f" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_52c839b3-8064-4b3e-90c3-fb441386756e" xlink:to="loc_ahl_LossPortfolioTransferMember_351ee8bf-4248-4bc0-bb81-4807f1c3cd9f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsReconciliationofLevel3InputsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_af1457ba-3871-427e-a5df-689981998da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_af1457ba-3871-427e-a5df-689981998da6" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347a76fa-2f95-4650-b291-4ce6da165547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347a76fa-2f95-4650-b291-4ce6da165547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_347a76fa-2f95-4650-b291-4ce6da165547_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347a76fa-2f95-4650-b291-4ce6da165547" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_347a76fa-2f95-4650-b291-4ce6da165547_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c78e4755-3593-40d5-b4cc-32b5b8e0d71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347a76fa-2f95-4650-b291-4ce6da165547" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c78e4755-3593-40d5-b4cc-32b5b8e0d71b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e0827bfe-496c-4947-a690-d9ede71bb23c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c78e4755-3593-40d5-b4cc-32b5b8e0d71b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e0827bfe-496c-4947-a690-d9ede71bb23c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f6b6ec3-31e5-4029-b155-ae091a5f23d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f6b6ec3-31e5-4029-b155-ae091a5f23d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_38bf93ab-b21e-4b75-9619-2cb3f105997f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f6b6ec3-31e5-4029-b155-ae091a5f23d3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_38bf93ab-b21e-4b75-9619-2cb3f105997f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_a1dab840-591a-471e-ae1b-cf22d2f07d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_a1dab840-591a-471e-ae1b-cf22d2f07d8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ba959cf9-91ad-478c-93fa-ba9a8429e3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ba959cf9-91ad-478c-93fa-ba9a8429e3f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_af42bbec-c4da-45fe-a5f4-da689711d17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_TradingSecurities_af42bbec-c4da-45fe-a5f4-da689711d17d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_56b401e9-6a62-42c1-b387-61913d6130db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_56b401e9-6a62-42c1-b387-61913d6130db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_d152274a-aa09-4f9c-b7a2-14a1cd8eca3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_d152274a-aa09-4f9c-b7a2-14a1cd8eca3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_ffa4440b-d59a-406b-a91e-47a4e9fe2d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_ffa4440b-d59a-406b-a91e-47a4e9fe2d82" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_2989ab97-7927-4f55-82c6-5d2270c7c666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_f972108e-188f-46c9-bc1a-13f08071e1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_f972108e-188f-46c9-bc1a-13f08071e1bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_85221fff-a7f7-4963-b47a-8c6d13f49434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_85221fff-a7f7-4963-b47a-8c6d13f49434" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_74f1b439-e6c7-41a9-b7a4-f7cc876912d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_74f1b439-e6c7-41a9-b7a4-f7cc876912d9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_eecb2f64-6737-4670-a9b1-e2cae54f4ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_eecb2f64-6737-4670-a9b1-e2cae54f4ca4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_f505a3b0-1fd6-44c4-a7e6-3f0c1235fcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_f505a3b0-1fd6-44c4-a7e6-3f0c1235fcf2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_994bf2c7-88ce-4367-a770-1eaf04dcae9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_994bf2c7-88ce-4367-a770-1eaf04dcae9d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_46a48cd2-1946-4842-b612-ef7ffbfa8d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_d002e2fa-fab0-4c8e-bdf9-7fb472c968f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_d002e2fa-fab0-4c8e-bdf9-7fb472c968f7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_12eb2cad-7a39-4695-b391-9905913346b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_12eb2cad-7a39-4695-b391-9905913346b4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_423193c8-d73c-4bd0-ab8b-3c2148b32e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_423193c8-d73c-4bd0-ab8b-3c2148b32e3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_423193c8-d73c-4bd0-ab8b-3c2148b32e3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_423193c8-d73c-4bd0-ab8b-3c2148b32e3c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_423193c8-d73c-4bd0-ab8b-3c2148b32e3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c29ebc8b-5c69-4940-89eb-78115ac0d245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_423193c8-d73c-4bd0-ab8b-3c2148b32e3c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c29ebc8b-5c69-4940-89eb-78115ac0d245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_68266f3b-5b03-41de-a252-a2d2e952d461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c29ebc8b-5c69-4940-89eb-78115ac0d245" xlink:to="loc_us-gaap_AssetsMember_68266f3b-5b03-41de-a252-a2d2e952d461" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2d7a3f1c-38ac-4f5e-a114-bd49945a8add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2d7a3f1c-38ac-4f5e-a114-bd49945a8add" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2d7a3f1c-38ac-4f5e-a114-bd49945a8add_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2d7a3f1c-38ac-4f5e-a114-bd49945a8add" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2d7a3f1c-38ac-4f5e-a114-bd49945a8add_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d2eccd7a-42c3-447f-8b71-ca930113258f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2d7a3f1c-38ac-4f5e-a114-bd49945a8add" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d2eccd7a-42c3-447f-8b71-ca930113258f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_dc784877-9dba-4717-8ce3-8d89069ee8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d2eccd7a-42c3-447f-8b71-ca930113258f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_dc784877-9dba-4717-8ce3-8d89069ee8cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ce8a181b-b392-47af-902d-acfc5b52f979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_InvestmentTypeAxis_ce8a181b-b392-47af-902d-acfc5b52f979" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ce8a181b-b392-47af-902d-acfc5b52f979_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ce8a181b-b392-47af-902d-acfc5b52f979" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ce8a181b-b392-47af-902d-acfc5b52f979_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ce8a181b-b392-47af-902d-acfc5b52f979" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_056c49de-23ba-41ef-977d-0e5def9f6450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_056c49de-23ba-41ef-977d-0e5def9f6450" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_7a636f65-244b-48cc-bc61-e82fe0010bfa" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_ahl_MiddlemarketloansMember_7a636f65-244b-48cc-bc61-e82fe0010bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_39aad42a-eade-42f5-9b5c-646d37839437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_39aad42a-eade-42f5-9b5c-646d37839437" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember_d17e469f-20e8-4ceb-add6-e502a14bdfc9" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_ahl_GlobalCorporateSecuritiesMember_d17e469f-20e8-4ceb-add6-e502a14bdfc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_be5e56e3-23dd-4864-b0e5-324b43bcb72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_us-gaap_EquitySecuritiesMember_be5e56e3-23dd-4864-b0e5-324b43bcb72b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_a108f39f-34e1-4dd8-b41b-1869f8798698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_us-gaap_PreferredStockMember_a108f39f-34e1-4dd8-b41b-1869f8798698" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_249e270d-e075-4024-8699-695d6671e1a6" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_249e270d-e075-4024-8699-695d6671e1a6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e43264e5-43aa-493c-a93e-86c920c34716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e43264e5-43aa-493c-a93e-86c920c34716" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e43264e5-43aa-493c-a93e-86c920c34716_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e43264e5-43aa-493c-a93e-86c920c34716" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e43264e5-43aa-493c-a93e-86c920c34716_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_768f65fa-d5e0-44a1-a0c8-5b937448c298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e43264e5-43aa-493c-a93e-86c920c34716" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_768f65fa-d5e0-44a1-a0c8-5b937448c298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_93f550ac-ec78-41f7-bb8e-6dbc70d40c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_768f65fa-d5e0-44a1-a0c8-5b937448c298" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_93f550ac-ec78-41f7-bb8e-6dbc70d40c85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_86a39e25-6608-4dde-bdbf-548c079e340a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_86a39e25-6608-4dde-bdbf-548c079e340a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_86a39e25-6608-4dde-bdbf-548c079e340a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_86a39e25-6608-4dde-bdbf-548c079e340a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_86a39e25-6608-4dde-bdbf-548c079e340a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c371351e-4392-40cb-a4d0-edbbc5a4fe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_86a39e25-6608-4dde-bdbf-548c079e340a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c371351e-4392-40cb-a4d0-edbbc5a4fe4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_b182d6c1-6051-4f70-9899-50c25a44fbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c371351e-4392-40cb-a4d0-edbbc5a4fe4e" xlink:to="loc_us-gaap_LiabilityMember_b182d6c1-6051-4f70-9899-50c25a44fbdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f7fe9b74-729c-42a7-834b-4dcf7bf4923d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f7fe9b74-729c-42a7-834b-4dcf7bf4923d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f7fe9b74-729c-42a7-834b-4dcf7bf4923d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f7fe9b74-729c-42a7-834b-4dcf7bf4923d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f7fe9b74-729c-42a7-834b-4dcf7bf4923d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_41b1b9b8-4da7-495f-9329-3b0351c434f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f7fe9b74-729c-42a7-834b-4dcf7bf4923d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_41b1b9b8-4da7-495f-9329-3b0351c434f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_68f9b831-7de3-4170-b14d-9d656bdda13d" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_41b1b9b8-4da7-495f-9329-3b0351c434f7" xlink:to="loc_ahl_LossPortfolioTransferMember_68f9b831-7de3-4170-b14d-9d656bdda13d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsInputsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_d9bbbbf3-3bfc-498c-9056-e007a4c900c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:to="loc_us-gaap_PremiumsWrittenGross_d9bbbbf3-3bfc-498c-9056-e007a4c900c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_155c293c-16ca-4889-a096-bbe0cc815a47" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_155c293c-16ca-4889-a096-bbe0cc815a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingMeasurementInput_783bea43-6faa-4cf5-8a6f-4a80f80ca3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:to="loc_us-gaap_DebtSecuritiesTradingMeasurementInput_783bea43-6faa-4cf5-8a6f-4a80f80ca3f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_a3c5f05d-bed1-45a6-9260-8ea704e16811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_ValuationTechniqueAxis_a3c5f05d-bed1-45a6-9260-8ea704e16811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_a3c5f05d-bed1-45a6-9260-8ea704e16811_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_a3c5f05d-bed1-45a6-9260-8ea704e16811" xlink:to="loc_us-gaap_ValuationTechniqueDomain_a3c5f05d-bed1-45a6-9260-8ea704e16811_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_a3c5f05d-bed1-45a6-9260-8ea704e16811" xlink:to="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_0dd1501e-3501-4dc7-b977-5193f3044215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_0dd1501e-3501-4dc7-b977-5193f3044215" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_4f418253-b321-4531-9da5-a1b47cf822f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_4f418253-b321-4531-9da5-a1b47cf822f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ValuationTechniqueLiquidationMethodMember_9d6df232-38eb-41bc-bfc7-3439ba494d19" xlink:href="ahl-20231220.xsd#ahl_ValuationTechniqueLiquidationMethodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:to="loc_ahl_ValuationTechniqueLiquidationMethodMember_9d6df232-38eb-41bc-bfc7-3439ba494d19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostApproachValuationTechniqueMember_3b5f0e96-948c-4ebc-930f-be637bd8b6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostApproachValuationTechniqueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:to="loc_us-gaap_CostApproachValuationTechniqueMember_3b5f0e96-948c-4ebc-930f-be637bd8b6db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_0cde03dd-4962-4b21-bc06-bba303df6f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_InvestmentTypeAxis_0cde03dd-4962-4b21-bc06-bba303df6f98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0cde03dd-4962-4b21-bc06-bba303df6f98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_0cde03dd-4962-4b21-bc06-bba303df6f98" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0cde03dd-4962-4b21-bc06-bba303df6f98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_0cde03dd-4962-4b21-bc06-bba303df6f98" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_02d1c9ad-5170-46e4-9e09-f2b7a8afe86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_02d1c9ad-5170-46e4-9e09-f2b7a8afe86c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_abcaa6c7-5661-4fe3-bbed-7f8f53ba47ba" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_ahl_MiddlemarketloansMember_abcaa6c7-5661-4fe3-bbed-7f8f53ba47ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_7640a8b7-9052-40af-8978-afea894813b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_7640a8b7-9052-40af-8978-afea894813b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember_1c4ae2a6-2fc3-451f-b6b1-9a4dcad6b8b6" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_ahl_GlobalCorporateSecuritiesMember_1c4ae2a6-2fc3-451f-b6b1-9a4dcad6b8b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_8ee2de56-4a6e-48f3-a58d-370e3a130d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_EquitySecuritiesMember_8ee2de56-4a6e-48f3-a58d-370e3a130d29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_8aff42f1-8e94-413d-9c83-c9bf0639848d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_8aff42f1-8e94-413d-9c83-c9bf0639848d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_27fa264b-9d51-4db8-83f0-36a9e00ad4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_27fa264b-9d51-4db8-83f0-36a9e00ad4d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e014d05-cee9-4a6d-a191-d027244644e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e014d05-cee9-4a6d-a191-d027244644e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6e014d05-cee9-4a6d-a191-d027244644e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e014d05-cee9-4a6d-a191-d027244644e8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6e014d05-cee9-4a6d-a191-d027244644e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_59998f43-d2ea-4e42-b622-ded3bfb743e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e014d05-cee9-4a6d-a191-d027244644e8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_59998f43-d2ea-4e42-b622-ded3bfb743e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_86ecdec5-e621-4b16-9da5-f02d9a64fad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_59998f43-d2ea-4e42-b622-ded3bfb743e6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_86ecdec5-e621-4b16-9da5-f02d9a64fad3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_srt_RangeAxis_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d" xlink:to="loc_srt_RangeMember_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d" xlink:to="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_35d4d9ce-85fe-4599-b204-3a178e560eb2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:to="loc_srt_MinimumMember_35d4d9ce-85fe-4599-b204-3a178e560eb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_492fe927-a3a1-4481-a9fd-f1c08e503625" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:to="loc_srt_MaximumMember_492fe927-a3a1-4481-a9fd-f1c08e503625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_e4704aa5-941d-4907-9c5f-5ef847b8a6a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:to="loc_srt_WeightedAverageMember_e4704aa5-941d-4907-9c5f-5ef847b8a6a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f2ea5b08-b046-4796-82b1-cb89625d9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f2ea5b08-b046-4796-82b1-cb89625d9ab0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2ea5b08-b046-4796-82b1-cb89625d9ab0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f2ea5b08-b046-4796-82b1-cb89625d9ab0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2ea5b08-b046-4796-82b1-cb89625d9ab0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3a8dab3-e1f2-47e4-a57f-cbd9be339c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f2ea5b08-b046-4796-82b1-cb89625d9ab0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3a8dab3-e1f2-47e4-a57f-cbd9be339c08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6ed8d9a3-395d-4425-a17d-83031cd95f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3a8dab3-e1f2-47e4-a57f-cbd9be339c08" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6ed8d9a3-395d-4425-a17d-83031cd95f78" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsAdditionalInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_f4c4bb8d-5282-4e5e-8937-728a645c2037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_f4c4bb8d-5282-4e5e-8937-728a645c2037" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_ba323e7d-74ca-475e-9af4-c5a2589d1b96" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_ba323e7d-74ca-475e-9af4-c5a2589d1b96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7ac1c331-7cf7-4e10-b6f1-4a677561d0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7ac1c331-7cf7-4e10-b6f1-4a677561d0c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_28375ae7-b008-4a1c-9042-5c067d9412db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_28375ae7-b008-4a1c-9042-5c067d9412db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_73651fc5-f70d-4963-bfb0-628775078be4" xlink:href="ahl-20231220.xsd#ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_73651fc5-f70d-4963-bfb0-628775078be4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_fa82334c-b517-4e6e-b535-4012f5761089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_InvestmentTypeAxis_fa82334c-b517-4e6e-b535-4012f5761089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_fa82334c-b517-4e6e-b535-4012f5761089_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_fa82334c-b517-4e6e-b535-4012f5761089" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_fa82334c-b517-4e6e-b535-4012f5761089_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_edd5950c-afef-462e-ac8c-fb900a2f1eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_fa82334c-b517-4e6e-b535-4012f5761089" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_edd5950c-afef-462e-ac8c-fb900a2f1eaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_5a413896-a95a-4878-a36e-c19dd4c39881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_edd5950c-afef-462e-ac8c-fb900a2f1eaf" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_5a413896-a95a-4878-a36e-c19dd4c39881" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_60acfde3-fede-4b46-b858-cf23201d02a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_60acfde3-fede-4b46-b858-cf23201d02a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_60acfde3-fede-4b46-b858-cf23201d02a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_60acfde3-fede-4b46-b858-cf23201d02a8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_60acfde3-fede-4b46-b858-cf23201d02a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_527d0e74-c153-4705-81e7-ec6f8fa45db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_60acfde3-fede-4b46-b858-cf23201d02a8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_527d0e74-c153-4705-81e7-ec6f8fa45db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_6755691f-e1e8-49a2-8093-2364c0490819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_527d0e74-c153-4705-81e7-ec6f8fa45db6" xlink:to="loc_us-gaap_AssetsMember_6755691f-e1e8-49a2-8093-2364c0490819" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_6cec4154-c371-4d58-8498-6e25346f3b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_527d0e74-c153-4705-81e7-ec6f8fa45db6" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_6cec4154-c371-4d58-8498-6e25346f3b39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ebe2d49-96d6-4e61-9056-cfa29b62a43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ebe2d49-96d6-4e61-9056-cfa29b62a43d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2ebe2d49-96d6-4e61-9056-cfa29b62a43d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ebe2d49-96d6-4e61-9056-cfa29b62a43d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2ebe2d49-96d6-4e61-9056-cfa29b62a43d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b2592f84-5cc9-4862-81fb-1a700829d22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ebe2d49-96d6-4e61-9056-cfa29b62a43d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b2592f84-5cc9-4862-81fb-1a700829d22a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_422275f6-772a-484b-8955-fa7e66920ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b2592f84-5cc9-4862-81fb-1a700829d22a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_422275f6-772a-484b-8955-fa7e66920ef3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d001a002-b6ce-4657-b8bf-32632ece0ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d001a002-b6ce-4657-b8bf-32632ece0ac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7eaf9d48-185d-47b6-9da1-65c4a34901f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d001a002-b6ce-4657-b8bf-32632ece0ac2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7eaf9d48-185d-47b6-9da1-65c4a34901f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_319b3396-54a5-4547-8256-b494a930536f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_319b3396-54a5-4547-8256-b494a930536f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_a65dd105-7827-45a7-94d5-5c41def057b5" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_319b3396-54a5-4547-8256-b494a930536f" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_a65dd105-7827-45a7-94d5-5c41def057b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_546f9631-555d-46d1-992b-77a4ef089592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_546f9631-555d-46d1-992b-77a4ef089592" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_546f9631-555d-46d1-992b-77a4ef089592_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_546f9631-555d-46d1-992b-77a4ef089592" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_546f9631-555d-46d1-992b-77a4ef089592_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_55f595c9-dddb-4ccc-98fd-7ea3d7e3b184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_546f9631-555d-46d1-992b-77a4ef089592" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_55f595c9-dddb-4ccc-98fd-7ea3d7e3b184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_HedgingDesignationAxis_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde" xlink:to="loc_us-gaap_HedgingDesignationDomain_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8e880c28-c1e6-457c-a6ed-0be264b7046f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde" xlink:to="loc_us-gaap_HedgingDesignationDomain_8e880c28-c1e6-457c-a6ed-0be264b7046f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_0b11c90b-106a-413b-886b-5ad5e1860d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8e880c28-c1e6-457c-a6ed-0be264b7046f" xlink:to="loc_us-gaap_NondesignatedMember_0b11c90b-106a-413b-886b-5ad5e1860d61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_a92e07c6-a700-4b5b-9efe-6ba74d6f8329" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_696ca0e8-5de5-4944-a9f0-97e22cd65429" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_a92e07c6-a700-4b5b-9efe-6ba74d6f8329" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_696ca0e8-5de5-4944-a9f0-97e22cd65429" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f14f9563-8481-4190-82ac-4012770fce71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_696ca0e8-5de5-4944-a9f0-97e22cd65429" xlink:to="loc_srt_ProductOrServiceAxis_f14f9563-8481-4190-82ac-4012770fce71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f14f9563-8481-4190-82ac-4012770fce71_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f14f9563-8481-4190-82ac-4012770fce71" xlink:to="loc_srt_ProductsAndServicesDomain_f14f9563-8481-4190-82ac-4012770fce71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_45ee6d31-a4ec-435e-bed6-d15c8c3dc157" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f14f9563-8481-4190-82ac-4012770fce71" xlink:to="loc_srt_ProductsAndServicesDomain_45ee6d31-a4ec-435e-bed6-d15c8c3dc157" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_13d32720-9238-4742-b990-c390d1bc28ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverables_13d32720-9238-4742-b990-c390d1bc28ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_92964880-7f32-4c5b-947b-c36f36e96b2f" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_92964880-7f32-4c5b-947b-c36f36e96b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_eb386714-cac3-4a35-86e1-6da208eebf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_eb386714-cac3-4a35-86e1-6da208eebf1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_2ae73f50-8a9d-4b62-a1f1-70143ac1bd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_2ae73f50-8a9d-4b62-a1f1-70143ac1bd73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_3767aa54-6828-4864-9124-966954bd40e4" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_3767aa54-6828-4864-9124-966954bd40e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent_3526bd39-398f-4921-9f45-af4bc89ae969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionAmountRetainedPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent_3526bd39-398f-4921-9f45-af4bc89ae969" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_c56bd85d-0e13-4813-853b-11a93bf3971b" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_c56bd85d-0e13-4813-853b-11a93bf3971b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_a76bfb3d-b5cc-4114-adf6-2164f9bfdb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_a76bfb3d-b5cc-4114-adf6-2164f9bfdb9f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4295a777-4e6c-4f7d-a929-6b0f71982fc8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:to="loc_srt_RangeMember_4295a777-4e6c-4f7d-a929-6b0f71982fc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:to="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f12aa369-0480-436d-9504-2ec7bed68ee4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:to="loc_srt_MaximumMember_f12aa369-0480-436d-9504-2ec7bed68ee4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25daf461-c4e1-434b-a1ec-7002fbe6fae2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:to="loc_srt_MinimumMember_25daf461-c4e1-434b-a1ec-7002fbe6fae2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce49bf84-a993-4dd2-a623-a8fb54ca663e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce49bf84-a993-4dd2-a623-a8fb54ca663e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_f357b9fd-b4b2-4b9c-b965-cbe306bf3368" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:to="loc_ahl_EnstarMember_f357b9fd-b4b2-4b9c-b965-cbe306bf3368" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_2d9282a9-1b7c-431d-b07d-c580fc0c4747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_us-gaap_ReinsuranceContractAxis_2d9282a9-1b7c-431d-b07d-c580fc0c4747" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_13d32720-9238-4742-b990-c390d1bc28ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverables_13d32720-9238-4742-b990-c390d1bc28ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_92964880-7f32-4c5b-947b-c36f36e96b2f" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_92964880-7f32-4c5b-947b-c36f36e96b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_eb386714-cac3-4a35-86e1-6da208eebf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_eb386714-cac3-4a35-86e1-6da208eebf1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_2ae73f50-8a9d-4b62-a1f1-70143ac1bd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_2ae73f50-8a9d-4b62-a1f1-70143ac1bd73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_3767aa54-6828-4864-9124-966954bd40e4" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_3767aa54-6828-4864-9124-966954bd40e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent_3526bd39-398f-4921-9f45-af4bc89ae969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionAmountRetainedPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent_3526bd39-398f-4921-9f45-af4bc89ae969" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_c56bd85d-0e13-4813-853b-11a93bf3971b" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_c56bd85d-0e13-4813-853b-11a93bf3971b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_a76bfb3d-b5cc-4114-adf6-2164f9bfdb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_a76bfb3d-b5cc-4114-adf6-2164f9bfdb9f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4295a777-4e6c-4f7d-a929-6b0f71982fc8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:to="loc_srt_RangeMember_4295a777-4e6c-4f7d-a929-6b0f71982fc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:to="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f12aa369-0480-436d-9504-2ec7bed68ee4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:to="loc_srt_MaximumMember_f12aa369-0480-436d-9504-2ec7bed68ee4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25daf461-c4e1-434b-a1ec-7002fbe6fae2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:to="loc_srt_MinimumMember_25daf461-c4e1-434b-a1ec-7002fbe6fae2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce49bf84-a993-4dd2-a623-a8fb54ca663e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce49bf84-a993-4dd2-a623-a8fb54ca663e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_f357b9fd-b4b2-4b9c-b965-cbe306bf3368" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:to="loc_ahl_EnstarMember_f357b9fd-b4b2-4b9c-b965-cbe306bf3368" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsFairValueofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5354a953-0637-4d26-89cf-63ef78795099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5354a953-0637-4d26-89cf-63ef78795099" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_feb7eb5f-80a0-47cc-adec-78a6404e7c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_feb7eb5f-80a0-47cc-adec-78a6404e7c9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_1be0c688-a7bd-4861-902e-987f145e5892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_1be0c688-a7bd-4861-902e-987f145e5892" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0c61dc3f-148a-426b-b514-ef2499ff66fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:to="loc_us-gaap_HedgingDesignationAxis_0c61dc3f-148a-426b-b514-ef2499ff66fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0c61dc3f-148a-426b-b514-ef2499ff66fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0c61dc3f-148a-426b-b514-ef2499ff66fd" xlink:to="loc_us-gaap_HedgingDesignationDomain_0c61dc3f-148a-426b-b514-ef2499ff66fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5e77125c-3e9a-4466-bbab-82a042695fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0c61dc3f-148a-426b-b514-ef2499ff66fd" xlink:to="loc_us-gaap_HedgingDesignationDomain_5e77125c-3e9a-4466-bbab-82a042695fcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_003395d3-7bfd-4014-a3b9-d57803c8be6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5e77125c-3e9a-4466-bbab-82a042695fcf" xlink:to="loc_us-gaap_NondesignatedMember_003395d3-7bfd-4014-a3b9-d57803c8be6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_91811203-e56c-425e-a0d2-41a46d112a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5e77125c-3e9a-4466-bbab-82a042695fcf" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_91811203-e56c-425e-a0d2-41a46d112a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c956cd2e-be90-41b1-b740-113a546d0844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c956cd2e-be90-41b1-b740-113a546d0844" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c956cd2e-be90-41b1-b740-113a546d0844_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c956cd2e-be90-41b1-b740-113a546d0844" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c956cd2e-be90-41b1-b740-113a546d0844_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5c950326-8a19-4ca7-9c53-a7964d5bdf48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c956cd2e-be90-41b1-b740-113a546d0844" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5c950326-8a19-4ca7-9c53-a7964d5bdf48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_5fc80a0d-276e-4d14-b64e-98bf15927f7e" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5c950326-8a19-4ca7-9c53-a7964d5bdf48" xlink:to="loc_ahl_DerivativeAtFairValueMember_5fc80a0d-276e-4d14-b64e-98bf15927f7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_903ba977-9392-4b06-8ed7-e01666dcbee6" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5c950326-8a19-4ca7-9c53-a7964d5bdf48" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_903ba977-9392-4b06-8ed7-e01666dcbee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bb78628c-3a61-4b30-b2b9-d69b98d65e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bb78628c-3a61-4b30-b2b9-d69b98d65e68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bb78628c-3a61-4b30-b2b9-d69b98d65e68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bb78628c-3a61-4b30-b2b9-d69b98d65e68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bb78628c-3a61-4b30-b2b9-d69b98d65e68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e938c61f-079f-4ed1-867d-31cd2a1a9c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bb78628c-3a61-4b30-b2b9-d69b98d65e68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e938c61f-079f-4ed1-867d-31cd2a1a9c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a9194076-1711-4017-be5b-b82ffd563287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e938c61f-079f-4ed1-867d-31cd2a1a9c1c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a9194076-1711-4017-be5b-b82ffd563287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_6e23101c-600c-4dc1-801d-99f946b38d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e938c61f-079f-4ed1-867d-31cd2a1a9c1c" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_6e23101c-600c-4dc1-801d-99f946b38d88" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_36492086-8072-4be0-8dda-11afea805ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a31a1175-3325-44ce-853e-80841d2c5875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_36492086-8072-4be0-8dda-11afea805ddd" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a31a1175-3325-44ce-853e-80841d2c5875" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_e28230d6-1297-42f9-8d79-29237f8ffcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_36492086-8072-4be0-8dda-11afea805ddd" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_e28230d6-1297-42f9-8d79-29237f8ffcfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_36492086-8072-4be0-8dda-11afea805ddd" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e7ca7e67-2fd3-4f99-8a83-4bec796b542f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:to="loc_us-gaap_HedgingDesignationAxis_e7ca7e67-2fd3-4f99-8a83-4bec796b542f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e7ca7e67-2fd3-4f99-8a83-4bec796b542f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e7ca7e67-2fd3-4f99-8a83-4bec796b542f" xlink:to="loc_us-gaap_HedgingDesignationDomain_e7ca7e67-2fd3-4f99-8a83-4bec796b542f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b283bec8-23f1-42e9-9ae7-7d3598524c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e7ca7e67-2fd3-4f99-8a83-4bec796b542f" xlink:to="loc_us-gaap_HedgingDesignationDomain_b283bec8-23f1-42e9-9ae7-7d3598524c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c7a9ab42-2678-46f0-8fa5-dd9db4224b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b283bec8-23f1-42e9-9ae7-7d3598524c26" xlink:to="loc_us-gaap_NondesignatedMember_c7a9ab42-2678-46f0-8fa5-dd9db4224b5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_910545fc-4caf-4dff-acf2-d50642e1e530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b283bec8-23f1-42e9-9ae7-7d3598524c26" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_910545fc-4caf-4dff-acf2-d50642e1e530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_156883c8-34c3-4ee0-898d-1d1125ca70ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_156883c8-34c3-4ee0-898d-1d1125ca70ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_156883c8-34c3-4ee0-898d-1d1125ca70ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_156883c8-34c3-4ee0-898d-1d1125ca70ae" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_156883c8-34c3-4ee0-898d-1d1125ca70ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5fb5d5ce-980f-4346-abe6-8d38d5833e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_156883c8-34c3-4ee0-898d-1d1125ca70ae" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5fb5d5ce-980f-4346-abe6-8d38d5833e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_fdf2d5d2-1119-4b9b-8d00-0feb3d8edba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5fb5d5ce-980f-4346-abe6-8d38d5833e06" xlink:to="loc_us-gaap_ForeignExchangeContractMember_fdf2d5d2-1119-4b9b-8d00-0feb3d8edba6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e94d187b-3553-4a32-8566-a7762850664a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e94d187b-3553-4a32-8566-a7762850664a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e94d187b-3553-4a32-8566-a7762850664a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e94d187b-3553-4a32-8566-a7762850664a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e94d187b-3553-4a32-8566-a7762850664a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e94d187b-3553-4a32-8566-a7762850664a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_734f303f-522e-4d60-b0b0-f76e515dc710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_734f303f-522e-4d60-b0b0-f76e515dc710" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_ade5e9ef-040e-4303-a7b6-4f1bf7207004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_ade5e9ef-040e-4303-a7b6-4f1bf7207004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_031be7f6-8fc4-4fab-b4f3-b86b74bec06e" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_031be7f6-8fc4-4fab-b4f3-b86b74bec06e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a4376d7d-0980-4f2d-ba69-d5a74ac4b18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a4376d7d-0980-4f2d-ba69-d5a74ac4b18d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_db8889bb-20db-41e8-b103-cd9badfb4c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_db8889bb-20db-41e8-b103-cd9badfb4c1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_306bf376-4f58-497e-ac6b-15b8626f9dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_306bf376-4f58-497e-ac6b-15b8626f9dd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a5d001d1-476d-47d4-8f02-6b75e2389b40" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a5d001d1-476d-47d4-8f02-6b75e2389b40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_89c36013-aa20-4963-9d5a-8c50aa0d2e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_89c36013-aa20-4963-9d5a-8c50aa0d2e65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_72c71b8c-3260-41e1-8c9c-339853acb8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_72c71b8c-3260-41e1-8c9c-339853acb8b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72c71b8c-3260-41e1-8c9c-339853acb8b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72c71b8c-3260-41e1-8c9c-339853acb8b0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72c71b8c-3260-41e1-8c9c-339853acb8b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6f3ac009-4032-44d1-8971-2e870d0cf307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72c71b8c-3260-41e1-8c9c-339853acb8b0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6f3ac009-4032-44d1-8971-2e870d0cf307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_bc41342c-9f09-4137-a0f9-eadbcfdbbcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6f3ac009-4032-44d1-8971-2e870d0cf307" xlink:to="loc_us-gaap_ForeignExchangeContractMember_bc41342c-9f09-4137-a0f9-eadbcfdbbcc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_7352c059-5745-4841-a478-e75e099d5850" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6f3ac009-4032-44d1-8971-2e870d0cf307" xlink:to="loc_ahl_LossPortfolioTransferMember_7352c059-5745-4841-a478-e75e099d5850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6d95812e-d4e8-47e8-a654-68221e59fe37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6d95812e-d4e8-47e8-a654-68221e59fe37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6d95812e-d4e8-47e8-a654-68221e59fe37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6d95812e-d4e8-47e8-a654-68221e59fe37" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6d95812e-d4e8-47e8-a654-68221e59fe37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6d95812e-d4e8-47e8-a654-68221e59fe37" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_79e521dc-d2db-4152-803c-f5473f71c429" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_79e521dc-d2db-4152-803c-f5473f71c429" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2762383a-5072-416a-b4ac-574cfe787f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2762383a-5072-416a-b4ac-574cfe787f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_988e0c57-f2b4-4bb9-9227-94e3f2a3ee51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_988e0c57-f2b4-4bb9-9227-94e3f2a3ee51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5d7923d0-cafc-4439-bd85-aae30dd368cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_HedgingDesignationAxis_5d7923d0-cafc-4439-bd85-aae30dd368cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d7923d0-cafc-4439-bd85-aae30dd368cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d7923d0-cafc-4439-bd85-aae30dd368cd" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d7923d0-cafc-4439-bd85-aae30dd368cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_78d20ea5-b898-4b07-868a-59b8f9ba175e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d7923d0-cafc-4439-bd85-aae30dd368cd" xlink:to="loc_us-gaap_HedgingDesignationDomain_78d20ea5-b898-4b07-868a-59b8f9ba175e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_17f047dd-8b73-4fa2-a7fa-3a508b51235f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_78d20ea5-b898-4b07-868a-59b8f9ba175e" xlink:to="loc_us-gaap_NondesignatedMember_17f047dd-8b73-4fa2-a7fa-3a508b51235f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_326067d6-4118-4a3b-a950-696741e20cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_78d20ea5-b898-4b07-868a-59b8f9ba175e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_326067d6-4118-4a3b-a950-696741e20cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7d927fd1-1f72-4630-baa9-f68a3e91a57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7d927fd1-1f72-4630-baa9-f68a3e91a57a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7d927fd1-1f72-4630-baa9-f68a3e91a57a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7d927fd1-1f72-4630-baa9-f68a3e91a57a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7d927fd1-1f72-4630-baa9-f68a3e91a57a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4902b6a9-9970-428f-8a72-b94581ec5e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7d927fd1-1f72-4630-baa9-f68a3e91a57a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4902b6a9-9970-428f-8a72-b94581ec5e16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_1cd8fca8-c8ee-447e-ac98-db8ba161ba6d" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4902b6a9-9970-428f-8a72-b94581ec5e16" xlink:to="loc_ahl_DerivativeAtFairValueMember_1cd8fca8-c8ee-447e-ac98-db8ba161ba6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_242f6c0e-012d-4f52-a383-4d0ea74badf6" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4902b6a9-9970-428f-8a72-b94581ec5e16" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_242f6c0e-012d-4f52-a383-4d0ea74badf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e23fb037-6b09-4f70-b289-c678c047637f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e23fb037-6b09-4f70-b289-c678c047637f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e23fb037-6b09-4f70-b289-c678c047637f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e23fb037-6b09-4f70-b289-c678c047637f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e23fb037-6b09-4f70-b289-c678c047637f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ede1cd6-9f67-47aa-b4f0-bbafb76d2b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e23fb037-6b09-4f70-b289-c678c047637f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ede1cd6-9f67-47aa-b4f0-bbafb76d2b5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1ffcbaab-7518-4940-bc04-8811f2064572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ede1cd6-9f67-47aa-b4f0-bbafb76d2b5a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1ffcbaab-7518-4940-bc04-8811f2064572" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_21cb16c0-3047-4ea9-8ada-ac9cb205223f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_21cb16c0-3047-4ea9-8ada-ac9cb205223f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_21cb16c0-3047-4ea9-8ada-ac9cb205223f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_21cb16c0-3047-4ea9-8ada-ac9cb205223f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_21cb16c0-3047-4ea9-8ada-ac9cb205223f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_55b13e59-6d6a-45b7-a639-154ac42aaeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_21cb16c0-3047-4ea9-8ada-ac9cb205223f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_55b13e59-6d6a-45b7-a639-154ac42aaeb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_9551536a-dec7-419c-b0bc-0ccd7d45398a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_55b13e59-6d6a-45b7-a639-154ac42aaeb0" xlink:to="loc_us-gaap_LiabilityMember_9551536a-dec7-419c-b0bc-0ccd7d45398a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bb188956-5b70-4b93-95c3-3b74e3b32191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bb188956-5b70-4b93-95c3-3b74e3b32191" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bb188956-5b70-4b93-95c3-3b74e3b32191_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bb188956-5b70-4b93-95c3-3b74e3b32191" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bb188956-5b70-4b93-95c3-3b74e3b32191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c6b825d8-bed5-4b56-8bb2-79e9c90f444f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bb188956-5b70-4b93-95c3-3b74e3b32191" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c6b825d8-bed5-4b56-8bb2-79e9c90f444f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_636eb739-082d-4924-b6b6-5cda0dc670c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c6b825d8-bed5-4b56-8bb2-79e9c90f444f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_636eb739-082d-4924-b6b6-5cda0dc670c7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_34783f5b-9a2d-4b9d-8a40-cd51e18c7773" xlink:href="ahl-20231220.xsd#ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_34783f5b-9a2d-4b9d-8a40-cd51e18c7773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_ddca87dd-2827-496f-a420-eac79ac606cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_ddca87dd-2827-496f-a420-eac79ac606cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_e796322a-7293-4948-81ac-1b3d2558a8b2" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesTotalRecoverable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_e796322a-7293-4948-81ac-1b3d2558a8b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_af7fe4b9-c886-45e3-8c43-a047c6e38596_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_af7fe4b9-c886-45e3-8c43-a047c6e38596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_9338742f-09c5-4a4d-a3bb-d9a774d062f4" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:to="loc_ahl_EnstarMember_9338742f-09c5-4a4d-a3bb-d9a774d062f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:to="loc_srt_ProductsAndServicesDomain_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:to="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretySegmentMember_2cec9869-7df4-4e29-b9b8-4d2cbd759f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretySegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:to="loc_us-gaap_SuretySegmentMember_2cec9869-7df4-4e29-b9b8-4d2cbd759f9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccidentAndHealthInsuranceSegmentMember_479feca6-31b7-4aa0-bee1-24f54cc6e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccidentAndHealthInsuranceSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:to="loc_us-gaap_AccidentAndHealthInsuranceSegmentMember_479feca6-31b7-4aa0-bee1-24f54cc6e2cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4308cab1-2476-4517-b9d5-77aee35f438e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:to="loc_us-gaap_SegmentDomain_4308cab1-2476-4517-b9d5-77aee35f438e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:to="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_05cccc20-e2b6-4568-9633-e28bca7ee866" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:to="loc_ahl_InsuranceMember_05cccc20-e2b6-4568-9633-e28bca7ee866" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_b9562cb6-9a30-46dd-9723-605afaacfdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_us-gaap_ReinsuranceContractAxis_b9562cb6-9a30-46dd-9723-605afaacfdd2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_34783f5b-9a2d-4b9d-8a40-cd51e18c7773" xlink:href="ahl-20231220.xsd#ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_34783f5b-9a2d-4b9d-8a40-cd51e18c7773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_ddca87dd-2827-496f-a420-eac79ac606cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_ddca87dd-2827-496f-a420-eac79ac606cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_e796322a-7293-4948-81ac-1b3d2558a8b2" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesTotalRecoverable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_e796322a-7293-4948-81ac-1b3d2558a8b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_af7fe4b9-c886-45e3-8c43-a047c6e38596_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_af7fe4b9-c886-45e3-8c43-a047c6e38596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_9338742f-09c5-4a4d-a3bb-d9a774d062f4" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:to="loc_ahl_EnstarMember_9338742f-09c5-4a4d-a3bb-d9a774d062f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:to="loc_srt_ProductsAndServicesDomain_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:to="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretySegmentMember_2cec9869-7df4-4e29-b9b8-4d2cbd759f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretySegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:to="loc_us-gaap_SuretySegmentMember_2cec9869-7df4-4e29-b9b8-4d2cbd759f9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccidentAndHealthInsuranceSegmentMember_479feca6-31b7-4aa0-bee1-24f54cc6e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccidentAndHealthInsuranceSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:to="loc_us-gaap_AccidentAndHealthInsuranceSegmentMember_479feca6-31b7-4aa0-bee1-24f54cc6e2cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4308cab1-2476-4517-b9d5-77aee35f438e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:to="loc_us-gaap_SegmentDomain_4308cab1-2476-4517-b9d5-77aee35f438e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:to="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_05cccc20-e2b6-4568-9633-e28bca7ee866" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:to="loc_ahl_InsuranceMember_05cccc20-e2b6-4568-9633-e28bca7ee866" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_d053fca3-5d3b-43fc-b2de-bad7cf367ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_f19fd8ef-a837-4126-89b8-0826c09513ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_d053fca3-5d3b-43fc-b2de-bad7cf367ccf" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_f19fd8ef-a837-4126-89b8-0826c09513ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_d053fca3-5d3b-43fc-b2de-bad7cf367ccf" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_26a52d73-49ee-4a97-948b-406a7fd50f60" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_26a52d73-49ee-4a97-948b-406a7fd50f60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f14a1c8d-f948-470e-8630-a6b969815efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f14a1c8d-f948-470e-8630-a6b969815efb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f14a1c8d-f948-470e-8630-a6b969815efb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f14a1c8d-f948-470e-8630-a6b969815efb" xlink:to="loc_us-gaap_SegmentDomain_f14a1c8d-f948-470e-8630-a6b969815efb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2629bcb9-373c-49cb-9f5a-023c2d855af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f14a1c8d-f948-470e-8630-a6b969815efb" xlink:to="loc_us-gaap_SegmentDomain_2629bcb9-373c-49cb-9f5a-023c2d855af6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_b74aea3e-6e0f-4623-9db7-f4a3edac97ae" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2629bcb9-373c-49cb-9f5a-023c2d855af6" xlink:to="loc_ahl_ReinsuranceMember_b74aea3e-6e0f-4623-9db7-f4a3edac97ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_95f989e2-9afa-484a-b3fb-17c2208d422c" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2629bcb9-373c-49cb-9f5a-023c2d855af6" xlink:to="loc_ahl_InsuranceMember_95f989e2-9afa-484a-b3fb-17c2208d422c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f3a70710-7118-4655-a3b1-814378dd5b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f3a70710-7118-4655-a3b1-814378dd5b47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_55af0b98-1baa-4324-8327-9f630a8f23da" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_55af0b98-1baa-4324-8327-9f630a8f23da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1d579d7b-0006-4023-9cc1-2d64729e6e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_193f1545-6f83-4966-bbc7-44f74cf78f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_193f1545-6f83-4966-bbc7-44f74cf78f51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_b807ad86-3ddd-4353-8039-79865a015362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_b807ad86-3ddd-4353-8039-79865a015362" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_9a19ab2b-3fdd-4a42-8b41-0a23689560f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:to="loc_us-gaap_ReinsuranceContractAxis_9a19ab2b-3fdd-4a42-8b41-0a23689560f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f3a70710-7118-4655-a3b1-814378dd5b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f3a70710-7118-4655-a3b1-814378dd5b47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_55af0b98-1baa-4324-8327-9f630a8f23da" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_55af0b98-1baa-4324-8327-9f630a8f23da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1d579d7b-0006-4023-9cc1-2d64729e6e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_193f1545-6f83-4966-bbc7-44f74cf78f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_193f1545-6f83-4966-bbc7-44f74cf78f51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_b807ad86-3ddd-4353-8039-79865a015362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_b807ad86-3ddd-4353-8039-79865a015362" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_fc9c7706-bd15-488c-a7b3-617d2177de6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_fc9c7706-bd15-488c-a7b3-617d2177de6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e135ad1e-d669-4dd1-a7e1-19c515c150f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e135ad1e-d669-4dd1-a7e1-19c515c150f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_31796eb0-bb38-4283-9a17-19e67f159bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_31796eb0-bb38-4283-9a17-19e67f159bec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_b11f629b-af7e-4323-a852-88d06cd093be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_b11f629b-af7e-4323-a852-88d06cd093be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_ba65b2a9-4a2e-46df-87e1-e1e6f1cde73d" xlink:href="ahl-20231220.xsd#ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_ba65b2a9-4a2e-46df-87e1-e1e6f1cde73d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_2864ce3e-b6ab-4053-bfb6-71230f965873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_2864ce3e-b6ab-4053-bfb6-71230f965873" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_8373f83e-d725-4df2-a890-e5a65c9392b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_8373f83e-d725-4df2-a890-e5a65c9392b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f1791ee3-5ca7-445b-8878-59d7cbd1b383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f1791ee3-5ca7-445b-8878-59d7cbd1b383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f1791ee3-5ca7-445b-8878-59d7cbd1b383_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f1791ee3-5ca7-445b-8878-59d7cbd1b383" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f1791ee3-5ca7-445b-8878-59d7cbd1b383_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f1791ee3-5ca7-445b-8878-59d7cbd1b383" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member_daaf1b09-4e80-45e6-b581-5d4a47826334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member_daaf1b09-4e80-45e6-b581-5d4a47826334" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member_2ac82dd6-34fc-426b-a7e2-514a60e20a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member_2ac82dd6-34fc-426b-a7e2-514a60e20a00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_17fd663c-1c3d-4266-9787-38627c276a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_17fd663c-1c3d-4266-9787-38627c276a46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_b4bcd4fb-345c-4585-b8e7-715b7cd55a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_b4bcd4fb-345c-4585-b8e7-715b7cd55a48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_51ddf5b5-c692-47f8-9bfe-bdf79ed04f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_51ddf5b5-c692-47f8-9bfe-bdf79ed04f67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_12cfdbaa-3695-48c8-b693-24805e664965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_12cfdbaa-3695-48c8-b693-24805e664965" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_8a5152a6-0a6f-401a-96da-45ae3aca1536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_8a5152a6-0a6f-401a-96da-45ae3aca1536" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1f9e44af-484a-409f-9afc-4f2b9d3bf5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1f9e44af-484a-409f-9afc-4f2b9d3bf5fc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_fbb7c490-084b-46ca-b681-bcd0a98398a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_fbb7c490-084b-46ca-b681-bcd0a98398a4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_f6acdae6-44e6-4a70-b369-6254afe4ef7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_f6acdae6-44e6-4a70-b369-6254afe4ef7a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2e919b66-81fa-45b5-ac39-f026e95e6728" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:to="loc_srt_ProductOrServiceAxis_2e919b66-81fa-45b5-ac39-f026e95e6728" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2e919b66-81fa-45b5-ac39-f026e95e6728_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2e919b66-81fa-45b5-ac39-f026e95e6728" xlink:to="loc_srt_ProductsAndServicesDomain_2e919b66-81fa-45b5-ac39-f026e95e6728_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2e919b66-81fa-45b5-ac39-f026e95e6728" xlink:to="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyInsuranceProductLineMember_f9ecd320-a43a-47c7-a82e-0a15b40d0e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_us-gaap_PropertyInsuranceProductLineMember_f9ecd320-a43a-47c7-a82e-0a15b40d0e70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CasualtyCommercialInsuranceProductLineMember_d2afed95-f2e5-4051-a070-0cde8ea6333b" xlink:href="ahl-20231220.xsd#ahl_CasualtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_CasualtyCommercialInsuranceProductLineMember_d2afed95-f2e5-4051-a070-0cde8ea6333b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_a9b90007-e0a5-42c2-92d6-74fbf3954c26" xlink:href="ahl-20231220.xsd#ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_a9b90007-e0a5-42c2-92d6-74fbf3954c26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_f2714087-62fb-4e55-acf0-0529fb4d9be0" xlink:href="ahl-20231220.xsd#ahl_FinancialandProfessionalCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_f2714087-62fb-4e55-acf0-0529fb4d9be0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_29c06d75-52b2-4f8b-9ec0-5a9925664a51" xlink:href="ahl-20231220.xsd#ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_29c06d75-52b2-4f8b-9ec0-5a9925664a51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_49a85e7e-e39b-4fb7-8026-053dd57dccdf" xlink:href="ahl-20231220.xsd#ahl_AssumedCasualtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_49a85e7e-e39b-4fb7-8026-053dd57dccdf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_70f2e354-203d-4a45-a46f-ed40942174b6" xlink:href="ahl-20231220.xsd#ahl_AssumedSpecialtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_70f2e354-203d-4a45-a46f-ed40942174b6" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationinsurancecontractsReconciliationofClaimsDevelopmentDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesShortdurationinsurancecontractsReconciliationofClaimsDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationinsurancecontractsReconciliationofClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_a295e6dd-7d59-4344-8e7a-19d8b05b2f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_a295e6dd-7d59-4344-8e7a-19d8b05b2f14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_17beb83f-7067-4985-8179-73fa5855f6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_17beb83f-7067-4985-8179-73fa5855f6bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense_b26e993b-0306-4c83-97c9-7643b6469d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense_b26e993b-0306-4c83-97c9-7643b6469d0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable_3a42ee76-e7ee-4f99-a52b-d71857b455dd" xlink:href="ahl-20231220.xsd#ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable_3a42ee76-e7ee-4f99-a52b-d71857b455dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves_6c8d30b7-1c1b-491e-81c8-78d80970aba1" xlink:href="ahl-20231220.xsd#ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves_6c8d30b7-1c1b-491e-81c8-78d80970aba1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_d4f62bfa-37ac-4d18-9733-84d18bf1a775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_d4f62bfa-37ac-4d18-9733-84d18bf1a775" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_3c50a07d-f910-4350-b054-16241a80558f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_3c50a07d-f910-4350-b054-16241a80558f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d62f7f09-368c-4188-bc51-bb707a58c2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d62f7f09-368c-4188-bc51-bb707a58c2e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_6898cd2a-5a61-4ecb-8ef4-76b0e4e8abad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_6898cd2a-5a61-4ecb-8ef4-76b0e4e8abad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_939b991e-dee9-4528-8de2-d95d9591e014" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_6898cd2a-5a61-4ecb-8ef4-76b0e4e8abad" xlink:to="loc_srt_ProductOrServiceAxis_939b991e-dee9-4528-8de2-d95d9591e014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_939b991e-dee9-4528-8de2-d95d9591e014_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_939b991e-dee9-4528-8de2-d95d9591e014" xlink:to="loc_srt_ProductsAndServicesDomain_939b991e-dee9-4528-8de2-d95d9591e014_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_939b991e-dee9-4528-8de2-d95d9591e014" xlink:to="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyInsuranceProductLineMember_7412875c-fdf0-449c-b408-13a4d149b172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_us-gaap_PropertyInsuranceProductLineMember_7412875c-fdf0-449c-b408-13a4d149b172" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CasualtyCommercialInsuranceProductLineMember_4b4ad8d1-a01e-4f94-b90a-37d17f5d72d5" xlink:href="ahl-20231220.xsd#ahl_CasualtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_CasualtyCommercialInsuranceProductLineMember_4b4ad8d1-a01e-4f94-b90a-37d17f5d72d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_9267479d-c973-4a1c-8452-13e7bbcd353f" xlink:href="ahl-20231220.xsd#ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_9267479d-c973-4a1c-8452-13e7bbcd353f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_6cee78b1-043f-4e2f-bdbb-3fa10154fa4c" xlink:href="ahl-20231220.xsd#ahl_FinancialandProfessionalCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_6cee78b1-043f-4e2f-bdbb-3fa10154fa4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_bb70a6e9-4d81-4fb5-b82c-43bfcd16ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_bb70a6e9-4d81-4fb5-b82c-43bfcd16ebc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_45939b94-1714-4153-9646-c7b3b5e48ff4" xlink:href="ahl-20231220.xsd#ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_45939b94-1714-4153-9646-c7b3b5e48ff4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_7b850a54-5d42-4785-9944-b93f694d1ecf" xlink:href="ahl-20231220.xsd#ahl_AssumedCasualtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_7b850a54-5d42-4785-9944-b93f694d1ecf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_2f9c8f53-f620-4e94-baa0-111384ef5b3c" xlink:href="ahl-20231220.xsd#ahl_AssumedSpecialtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_2f9c8f53-f620-4e94-baa0-111384ef5b3c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortdurationInsuranceProductLineMember_ce14592f-1419-4a89-9662-19256c2f248b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortdurationInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_us-gaap_OtherShortdurationInsuranceProductLineMember_ce14592f-1419-4a89-9662-19256c2f248b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongdurationInsuranceProductLineMember_281a35f3-b95a-42d4-9d25-8ef0ab32f01e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongdurationInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_us-gaap_OtherLongdurationInsuranceProductLineMember_281a35f3-b95a-42d4-9d25-8ef0ab32f01e" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationContractsHistoricalClaimsDurationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesShortdurationContractsHistoricalClaimsDurationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationContractsHistoricalClaimsDurationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne_a7e9f59b-e840-4e5a-925c-e42c372eeeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne_a7e9f59b-e840-4e5a-925c-e42c372eeeb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo_28e6d2a7-a425-4727-87a3-b37c97ac993d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo_28e6d2a7-a425-4727-87a3-b37c97ac993d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree_7d1f871e-e166-49d1-ac94-5a8debe384c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree_7d1f871e-e166-49d1-ac94-5a8debe384c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour_d9a81f06-9bf5-41cb-aa29-c2a5e97fde10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour_d9a81f06-9bf5-41cb-aa29-c2a5e97fde10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive_25fd782d-9b90-4ba1-900f-0e4ac6d47d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive_25fd782d-9b90-4ba1-900f-0e4ac6d47d9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix_ec7492ac-de45-42dc-817a-9a80a3a50045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix_ec7492ac-de45-42dc-817a-9a80a3a50045" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven_e5e2b738-90d9-4c4f-963a-1d15f0075f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven_e5e2b738-90d9-4c4f-963a-1d15f0075f0e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight_437f1801-3b2b-4a00-bf67-879180ff5788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight_437f1801-3b2b-4a00-bf67-879180ff5788" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine_829f3c8e-c557-44a0-85ab-2eddbdda524a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine_829f3c8e-c557-44a0-85ab-2eddbdda524a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen_4c3183fd-6db9-4f4d-85a3-2aecfc64dae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen_4c3183fd-6db9-4f4d-85a3-2aecfc64dae1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_111dfce0-da83-4127-8ff7-db45ee7adb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_111dfce0-da83-4127-8ff7-db45ee7adb1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_59deb0c0-cbe6-4245-bdba-59e78a2a05f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_111dfce0-da83-4127-8ff7-db45ee7adb1e" xlink:to="loc_srt_ProductOrServiceAxis_59deb0c0-cbe6-4245-bdba-59e78a2a05f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_59deb0c0-cbe6-4245-bdba-59e78a2a05f0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_59deb0c0-cbe6-4245-bdba-59e78a2a05f0" xlink:to="loc_srt_ProductsAndServicesDomain_59deb0c0-cbe6-4245-bdba-59e78a2a05f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c36316c5-73f1-4091-8dab-e82b2ddd91bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_59deb0c0-cbe6-4245-bdba-59e78a2a05f0" xlink:to="loc_srt_ProductsAndServicesDomain_c36316c5-73f1-4091-8dab-e82b2ddd91bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_6fccd9ef-c738-408f-b4a6-1f70345e1c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c36316c5-73f1-4091-8dab-e82b2ddd91bc" xlink:to="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_6fccd9ef-c738-408f-b4a6-1f70345e1c0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember_0679789a-8527-4765-9d21-047793f75540" xlink:href="ahl-20231220.xsd#ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c36316c5-73f1-4091-8dab-e82b2ddd91bc" xlink:to="loc_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember_0679789a-8527-4765-9d21-047793f75540" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_983486bf-3a3a-4cd2-bfe1-942fbe24e008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_983486bf-3a3a-4cd2-bfe1-942fbe24e008" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6b1c5593-6013-404b-8595-55e09df5cb92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6b1c5593-6013-404b-8595-55e09df5cb92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5fc6f075-6889-4842-b70b-6b6b66c934a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5fc6f075-6889-4842-b70b-6b6b66c934a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d2ebdf21-4df6-40cd-bbdb-7084b66e411e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d2ebdf21-4df6-40cd-bbdb-7084b66e411e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0f8600bb-0296-4722-b507-0f1bfdcf0aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0f8600bb-0296-4722-b507-0f1bfdcf0aed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3c31a10-0821-45f5-a77f-0af728a470fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3c31a10-0821-45f5-a77f-0af728a470fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_eb602a2a-6de7-48b2-aa62-5c3aaa13e494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_eb602a2a-6de7-48b2-aa62-5c3aaa13e494" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a906fffe-2bb1-46c2-9f72-e66e3c09ce99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a906fffe-2bb1-46c2-9f72-e66e3c09ce99" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9fb9d425-3d1a-4434-8ed5-96311ddd0c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9fb9d425-3d1a-4434-8ed5-96311ddd0c8c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_e4f39ae9-30f0-4f38-83b7-7a3d7b1200ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_e4f39ae9-30f0-4f38-83b7-7a3d7b1200ff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_bc7ba419-7109-4475-bdd6-133be9b740ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_bc7ba419-7109-4475-bdd6-133be9b740ea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e626c774-6549-4a17-9581-c9fb114ba6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e626c774-6549-4a17-9581-c9fb114ba6a3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear_2b13d45c-2e9f-4aae-8e39-8295ebfdea61" xlink:href="ahl-20231220.xsd#ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear_2b13d45c-2e9f-4aae-8e39-8295ebfdea61" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_a069a833-7267-4f37-b4ea-ac3f62d7ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_a069a833-7267-4f37-b4ea-ac3f62d7ab90" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_68952a91-5f7c-4ff9-afba-b240e4279ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_68952a91-5f7c-4ff9-afba-b240e4279ba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_68952a91-5f7c-4ff9-afba-b240e4279ba2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_68952a91-5f7c-4ff9-afba-b240e4279ba2" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_68952a91-5f7c-4ff9-afba-b240e4279ba2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_8ef6c36c-b7db-421e-8ac7-6b54b16f1cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_68952a91-5f7c-4ff9-afba-b240e4279ba2" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_8ef6c36c-b7db-421e-8ac7-6b54b16f1cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_11de547a-202f-4938-b4e3-9cb40c868fe2" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_8ef6c36c-b7db-421e-8ac7-6b54b16f1cac" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_11de547a-202f-4938-b4e3-9cb40c868fe2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_0c76f313-c972-44e3-98d9-654c52a0adea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_0c76f313-c972-44e3-98d9-654c52a0adea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_0c76f313-c972-44e3-98d9-654c52a0adea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_0c76f313-c972-44e3-98d9-654c52a0adea" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_0c76f313-c972-44e3-98d9-654c52a0adea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_5423fad0-00cc-44d0-8f75-bb8cc70475c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_0c76f313-c972-44e3-98d9-654c52a0adea" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_5423fad0-00cc-44d0-8f75-bb8cc70475c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_2c4c727e-9cb6-4749-8df4-eadcca417e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeOfTheTaxCommissionerBermudaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_5423fad0-00cc-44d0-8f75-bb8cc70475c7" xlink:to="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_2c4c727e-9cb6-4749-8df4-eadcca417e62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_5ac14aef-76ca-4bd1-8881-7ac9f6f9877b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_5423fad0-00cc-44d0-8f75-bb8cc70475c7" xlink:to="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_5ac14aef-76ca-4bd1-8881-7ac9f6f9877b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_127b4318-324b-4b95-84b4-c72b8569a857" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:to="loc_dei_LegalEntityAxis_127b4318-324b-4b95-84b4-c72b8569a857" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_127b4318-324b-4b95-84b4-c72b8569a857_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_127b4318-324b-4b95-84b4-c72b8569a857" xlink:to="loc_dei_EntityDomain_127b4318-324b-4b95-84b4-c72b8569a857_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_581be4eb-8f6e-49b3-9184-3c34d41a9e04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_127b4318-324b-4b95-84b4-c72b8569a857" xlink:to="loc_dei_EntityDomain_581be4eb-8f6e-49b3-9184-3c34d41a9e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_USOperatingSubsidiariesMember_f930c758-f86c-45cc-8cfd-5d8391c0ec5e" xlink:href="ahl-20231220.xsd#ahl_USOperatingSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_581be4eb-8f6e-49b3-9184-3c34d41a9e04" xlink:to="loc_ahl_USOperatingSubsidiariesMember_f930c758-f86c-45cc-8cfd-5d8391c0ec5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_65b173f5-d73b-4b02-accc-9d272a7ca684" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_581be4eb-8f6e-49b3-9184-3c34d41a9e04" xlink:to="loc_ahl_AspenUKMember_65b173f5-d73b-4b02-accc-9d272a7ca684" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesIncomeTaxReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7bb1678b-7f17-4e3a-a9dd-6982388a65e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7bb1678b-7f17-4e3a-a9dd-6982388a65e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_33088228-f865-4cfb-9603-dcc75852c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_33088228-f865-4cfb-9603-dcc75852c14a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_4b0adaac-9c55-44ee-be9b-449cf147d4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_4b0adaac-9c55-44ee-be9b-449cf147d4f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_a4f7f878-66d4-4c41-9875-835358f41aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_a4f7f878-66d4-4c41-9875-835358f41aba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2c273f84-3125-4b80-8b6b-c0c4a3c311df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2c273f84-3125-4b80-8b6b-c0c4a3c311df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_4d9ce31b-86f7-45ef-843b-34e9dc61732f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_4d9ce31b-86f7-45ef-843b-34e9dc61732f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_548b6d54-4270-45fb-b061-c3ba4bce2367" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_548b6d54-4270-45fb-b061-c3ba4bce2367" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_77fa8dbd-8749-42b4-99e8-cae10f173b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_77fa8dbd-8749-42b4-99e8-cae10f173b52" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_689a2090-cfbf-4223-bc67-ff53be0b5401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_689a2090-cfbf-4223-bc67-ff53be0b5401" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_a0140d99-862c-41cb-97c0-e62c95c01d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_a0140d99-862c-41cb-97c0-e62c95c01d1c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_a682cc69-0fca-485b-a3f4-9b1444daaf08" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_a682cc69-0fca-485b-a3f4-9b1444daaf08" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f9116121-ce16-4a2c-a8ff-6e304662c227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f9116121-ce16-4a2c-a8ff-6e304662c227" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_f1354942-5e8b-47ce-be24-32c73c9e61b1" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_f1354942-5e8b-47ce-be24-32c73c9e61b1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateTaxRate_35f675ec-5068-4d29-a0cc-c4c1074e09c9" xlink:href="ahl-20231220.xsd#ahl_CorporateTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_ahl_CorporateTaxRate_35f675ec-5068-4d29-a0cc-c4c1074e09c9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_5622b88f-9b67-4208-9a05-cc073a59c48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_5622b88f-9b67-4208-9a05-cc073a59c48b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_5622b88f-9b67-4208-9a05-cc073a59c48b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_5622b88f-9b67-4208-9a05-cc073a59c48b" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_5622b88f-9b67-4208-9a05-cc073a59c48b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_82012c3e-e794-4e00-818a-283ff6c2687a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_5622b88f-9b67-4208-9a05-cc073a59c48b" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_82012c3e-e794-4e00-818a-283ff6c2687a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_b8568781-4e74-4976-8fc4-d2547f63fdef" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_82012c3e-e794-4e00-818a-283ff6c2687a" xlink:to="loc_ahl_LloydsMember_b8568781-4e74-4976-8fc4-d2547f63fdef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_7b456027-95e9-428c-a9ea-960188b33147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_7b456027-95e9-428c-a9ea-960188b33147" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_7b456027-95e9-428c-a9ea-960188b33147_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7b456027-95e9-428c-a9ea-960188b33147" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_7b456027-95e9-428c-a9ea-960188b33147_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_c644cb54-54f6-4bb1-8380-a1fdb15f3a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7b456027-95e9-428c-a9ea-960188b33147" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_c644cb54-54f6-4bb1-8380-a1fdb15f3a60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_f1b3d7a7-0fcd-46db-bc97-9bc4d160a450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_c644cb54-54f6-4bb1-8380-a1fdb15f3a60" xlink:to="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_f1b3d7a7-0fcd-46db-bc97-9bc4d160a450" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f107e801-0c28-4e83-b450-2a8babd56f2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_srt_StatementScenarioAxis_f107e801-0c28-4e83-b450-2a8babd56f2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f107e801-0c28-4e83-b450-2a8babd56f2f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f107e801-0c28-4e83-b450-2a8babd56f2f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f107e801-0c28-4e83-b450-2a8babd56f2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5c3fbe89-df7b-48e6-b07a-9c070ed5913c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f107e801-0c28-4e83-b450-2a8babd56f2f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5c3fbe89-df7b-48e6-b07a-9c070ed5913c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c0ed5b3d-dec9-405e-af15-49d77f60683c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5c3fbe89-df7b-48e6-b07a-9c070ed5913c" xlink:to="loc_srt_ScenarioForecastMember_c0ed5b3d-dec9-405e-af15-49d77f60683c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_dei_LegalEntityAxis_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e" xlink:to="loc_dei_EntityDomain_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_24f69ca8-8602-4e80-9990-2c8cd5459865" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e" xlink:to="loc_dei_EntityDomain_24f69ca8-8602-4e80-9990-2c8cd5459865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_USOperatingSubsidiariesMember_fbfec5a3-b667-4bbc-a7e5-06cdd06aa96b" xlink:href="ahl-20231220.xsd#ahl_USOperatingSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_24f69ca8-8602-4e80-9990-2c8cd5459865" xlink:to="loc_ahl_USOperatingSubsidiariesMember_fbfec5a3-b667-4bbc-a7e5-06cdd06aa96b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_1397b9c1-fc8c-482e-8ae2-57944cf20bfe" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_24f69ca8-8602-4e80-9990-2c8cd5459865" xlink:to="loc_ahl_AspenUKMember_1397b9c1-fc8c-482e-8ae2-57944cf20bfe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:href="ahl-20231220.xsd#ahl_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6a404fbb-07a7-43dd-8074-63b6a9483cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6a404fbb-07a7-43dd-8074-63b6a9483cc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateTaxRate_e688b0f8-54b6-47b5-ae78-0fafa67f0d05" xlink:href="ahl-20231220.xsd#ahl_CorporateTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_CorporateTaxRate_e688b0f8-54b6-47b5-ae78-0fafa67f0d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebf585d3-6e1e-43be-a779-9a6900b38dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebf585d3-6e1e-43be-a779-9a6900b38dfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_e400fb29-49c6-4900-a304-0b1615901ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_OperatingLossCarryforwards_e400fb29-49c6-4900-a304-0b1615901ca7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset_61d65d09-56fa-4dbc-a99a-a78dd37e4cc0" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset_61d65d09-56fa-4dbc-a99a-a78dd37e4cc0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Operatinglosscarryforwardsdateofexpiration_21f76327-9cce-4bad-b3f8-c24ce2320f0f" xlink:href="ahl-20231220.xsd#ahl_Operatinglosscarryforwardsdateofexpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_Operatinglosscarryforwardsdateofexpiration_21f76327-9cce-4bad-b3f8-c24ce2320f0f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_a8d3e67f-93e9-41f3-a462-26ba34618c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_a8d3e67f-93e9-41f3-a462-26ba34618c37" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLossesOperatingLossCarryforward_1355b53e-8c95-4b58-b714-250001ae7926" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLossesOperatingLossCarryforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_DeferredTaxLossesOperatingLossCarryforward_1355b53e-8c95-4b58-b714-250001ae7926" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_7a8c1e51-bd36-43d1-a4c7-22d547089111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_7a8c1e51-bd36-43d1-a4c7-22d547089111" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership_59c98a9f-f772-4aa5-9996-a88c99627d87" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership_59c98a9f-f772-4aa5-9996-a88c99627d87" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0e0abde6-49c2-450e-a943-cbca11453b94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0e0abde6-49c2-450e-a943-cbca11453b94" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f9ddeacc-7313-406b-8321-215bf2bcce51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxLiabilities_f9ddeacc-7313-406b-8321-215bf2bcce51" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0852805b-c8e0-46da-a78c-bfdfe7b5902b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_0852805b-c8e0-46da-a78c-bfdfe7b5902b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:href="ahl-20231220.xsd#ahl_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_42693609-9364-4b15-af72-12660e7fd20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_42693609-9364-4b15-af72-12660e7fd20b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_3dc93c56-422f-4468-9174-e703b5d3a27d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:to="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_3dc93c56-422f-4468-9174-e703b5d3a27d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_1a5a01f8-be18-4efe-9ee1-153ec79f4bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeOfTheTaxCommissionerBermudaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:to="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_1a5a01f8-be18-4efe-9ee1-153ec79f4bc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0329cb34-d76d-4107-a1b6-f4488cdd6725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0329cb34-d76d-4107-a1b6-f4488cdd6725" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_0329cb34-d76d-4107-a1b6-f4488cdd6725_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0329cb34-d76d-4107-a1b6-f4488cdd6725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_0329cb34-d76d-4107-a1b6-f4488cdd6725_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_26a144c2-53fa-47de-811b-c827c029ed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0329cb34-d76d-4107-a1b6-f4488cdd6725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_26a144c2-53fa-47de-811b-c827c029ed7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5eb5cfc1-3335-4f5f-8901-ee420361a0bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_srt_RangeAxis_5eb5cfc1-3335-4f5f-8901-ee420361a0bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5eb5cfc1-3335-4f5f-8901-ee420361a0bf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5eb5cfc1-3335-4f5f-8901-ee420361a0bf" xlink:to="loc_srt_RangeMember_5eb5cfc1-3335-4f5f-8901-ee420361a0bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_60727d73-8867-4f4e-a712-b65b25dfd345" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5eb5cfc1-3335-4f5f-8901-ee420361a0bf" xlink:to="loc_srt_RangeMember_60727d73-8867-4f4e-a712-b65b25dfd345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d771b832-b8e5-491a-81a4-fd3582f02ff2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_60727d73-8867-4f4e-a712-b65b25dfd345" xlink:to="loc_srt_MinimumMember_d771b832-b8e5-491a-81a4-fd3582f02ff2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2155d689-7e22-4823-a05d-2684f8585bda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_60727d73-8867-4f4e-a712-b65b25dfd345" xlink:to="loc_srt_MaximumMember_2155d689-7e22-4823-a05d-2684f8585bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ea9807f9-88bd-4ad2-ab2e-720bb9948525" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_dei_LegalEntityAxis_ea9807f9-88bd-4ad2-ab2e-720bb9948525" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ea9807f9-88bd-4ad2-ab2e-720bb9948525_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ea9807f9-88bd-4ad2-ab2e-720bb9948525" xlink:to="loc_dei_EntityDomain_ea9807f9-88bd-4ad2-ab2e-720bb9948525_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ea9807f9-88bd-4ad2-ab2e-720bb9948525" xlink:to="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_cc5b0516-b5bb-4b9b-87fc-607ecfa7d457" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:to="loc_ahl_AspenUKMember_cc5b0516-b5bb-4b9b-87fc-607ecfa7d457" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_USOperatingSubsidiariesMember_421fa8fb-61eb-44f9-ba98-56cbddfeff94" xlink:href="ahl-20231220.xsd#ahl_USOperatingSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:to="loc_ahl_USOperatingSubsidiariesMember_421fa8fb-61eb-44f9-ba98-56cbddfeff94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_024edcb3-cc09-4c56-9790-3026eb402cd3" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:to="loc_ahl_LloydsMember_024edcb3-cc09-4c56-9790-3026eb402cd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherJuridictionsMember_972af698-4151-405a-b169-5b98e7ac90f3" xlink:href="ahl-20231220.xsd#ahl_OtherJuridictionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:to="loc_ahl_OtherJuridictionsMember_972af698-4151-405a-b169-5b98e7ac90f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_0ca4b10b-f3cc-48ac-b913-d768144465c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_0ca4b10b-f3cc-48ac-b913-d768144465c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0ca4b10b-f3cc-48ac-b913-d768144465c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0ca4b10b-f3cc-48ac-b913-d768144465c5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0ca4b10b-f3cc-48ac-b913-d768144465c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d6d9a6c7-2150-4ab0-8aa9-a139368ad0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0ca4b10b-f3cc-48ac-b913-d768144465c5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d6d9a6c7-2150-4ab0-8aa9-a139368ad0cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_997d3cf9-af77-4471-890c-18d8d0450565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d6d9a6c7-2150-4ab0-8aa9-a139368ad0cc" xlink:to="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_997d3cf9-af77-4471-890c-18d8d0450565" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_1e225e92-0384-4c8d-a8cd-3c355c6f4b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d6d9a6c7-2150-4ab0-8aa9-a139368ad0cc" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_1e225e92-0384-4c8d-a8cd-3c355c6f4b84" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_085dceaa-892b-4485-a0e7-a7881d3f46ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_085dceaa-892b-4485-a0e7-a7881d3f46ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e050dbac-12d6-45dc-9bff-1c912368d826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e050dbac-12d6-45dc-9bff-1c912368d826" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CommonStockValueAuthorized_dc1eeaf8-6212-4b9c-9fcf-805ac8d27d58" xlink:href="ahl-20231220.xsd#ahl_CommonStockValueAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_ahl_CommonStockValueAuthorized_dc1eeaf8-6212-4b9c-9fcf-805ac8d27d58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockValueAuthorized_3b9c04e2-c73a-4a18-8bc8-c4a658a767be" xlink:href="ahl-20231220.xsd#ahl_PreferredStockValueAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_ahl_PreferredStockValueAuthorized_3b9c04e2-c73a-4a18-8bc8-c4a658a767be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_19a33253-17f7-42ef-aea7-5a3043cc1607" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_ahl_AuthorizedShareCapital_19a33253-17f7-42ef-aea7-5a3043cc1607" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8b88642d-0fe0-451c-ac17-550e7e1d2552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_us-gaap_CommonStockSharesIssued_8b88642d-0fe0-451c-ac17-550e7e1d2552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_007558e7-e6c6-42c4-adf5-14078c93e83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_us-gaap_PreferredStockSharesIssued_007558e7-e6c6-42c4-adf5-14078c93e83c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2e18d7cf-7a31-4887-932c-8d97a1462339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_us-gaap_CommonStockValue_2e18d7cf-7a31-4887-932c-8d97a1462339" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_9872db04-1779-41be-a206-f2c5045e33d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesSubscribedButUnissuedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_9872db04-1779-41be-a206-f2c5045e33d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapital_95f92331-3142-4fa9-af9c-3499aad9f329" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_ahl_IssuedShareCapital_95f92331-3142-4fa9-af9c-3499aad9f329" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_02f773da-5d8b-4f3f-908d-1eb00b55e1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_02f773da-5d8b-4f3f-908d-1eb00b55e1c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_90d9b5c6-a271-488f-bbca-48b477841c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_90d9b5c6-a271-488f-bbca-48b477841c39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f4821e17-5006-4e46-b8ca-0625ce555ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f4821e17-5006-4e46-b8ca-0625ce555ca1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_53cc32a6-cf77-402b-a9cb-6379a856859e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_53cc32a6-cf77-402b-a9cb-6379a856859e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_cad53d45-0fcc-4eb2-941e-175710a3af02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_cad53d45-0fcc-4eb2-941e-175710a3af02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_857deaf3-9722-42b8-8d76-91e6d5904103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cad53d45-0fcc-4eb2-941e-175710a3af02" xlink:to="loc_us-gaap_StatementClassOfStockAxis_857deaf3-9722-42b8-8d76-91e6d5904103" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_857deaf3-9722-42b8-8d76-91e6d5904103_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_857deaf3-9722-42b8-8d76-91e6d5904103" xlink:to="loc_us-gaap_ClassOfStockDomain_857deaf3-9722-42b8-8d76-91e6d5904103_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_857deaf3-9722-42b8-8d76-91e6d5904103" xlink:to="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_99fd04c0-ae79-41fe-a3fb-eb7584eeac27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_99fd04c0-ae79-41fe-a3fb-eb7584eeac27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_3ece50fd-39b0-47f5-acb5-dd237f2570e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_3ece50fd-39b0-47f5-acb5-dd237f2570e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_08825879-a068-4ec6-a089-eb522eb79ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_08825879-a068-4ec6-a089-eb522eb79ee3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a63b9376-6fe2-4bd0-8c9c-db07733e18ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a63b9376-6fe2-4bd0-8c9c-db07733e18ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9e9299ef-6318-4137-8b60-495a13a99568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9e9299ef-6318-4137-8b60-495a13a99568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_ef2f5641-798c-4f2e-b9d9-2c1a6452dd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_ef2f5641-798c-4f2e-b9d9-2c1a6452dd1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_2d37a3b2-9c2b-43cd-864f-1fea6d6667be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_2d37a3b2-9c2b-43cd-864f-1fea6d6667be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fd5802de-7326-4314-b37d-9bc4bd35bff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2d37a3b2-9c2b-43cd-864f-1fea6d6667be" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fd5802de-7326-4314-b37d-9bc4bd35bff4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fd5802de-7326-4314-b37d-9bc4bd35bff4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fd5802de-7326-4314-b37d-9bc4bd35bff4" xlink:to="loc_us-gaap_ClassOfStockDomain_fd5802de-7326-4314-b37d-9bc4bd35bff4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fd5802de-7326-4314-b37d-9bc4bd35bff4" xlink:to="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_d3d0aa94-5afb-4735-b553-deaa5a97bab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_d3d0aa94-5afb-4735-b553-deaa5a97bab1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_9f19a9fc-2281-4188-a69b-9fa022c41c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_9f19a9fc-2281-4188-a69b-9fa022c41c35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_525bcf3f-3156-40d9-9abb-545fd7c87214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_525bcf3f-3156-40d9-9abb-545fd7c87214" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_fd2c87c1-ec83-473c-b7d6-8f0b9beee0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_AdditionalPaidInCapital_fd2c87c1-ec83-473c-b7d6-8f0b9beee0f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AggregateLiquidationPreferences_e7d01445-416d-4ec3-a422-080ab646fe04" xlink:href="ahl-20231220.xsd#ahl_AggregateLiquidationPreferences"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_ahl_AggregateLiquidationPreferences_e7d01445-416d-4ec3-a422-080ab646fe04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockIssuanceCost_0f796245-c74d-4c05-9fc0-e46fb13d5028" xlink:href="ahl-20231220.xsd#ahl_PreferredStockIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_ahl_PreferredStockIssuanceCost_0f796245-c74d-4c05-9fc0-e46fb13d5028" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_6ac8715c-ad04-459f-ae94-7840c65265b3" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_ahl_AuthorizedShareCapital_6ac8715c-ad04-459f-ae94-7840c65265b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_22e80cc8-8f61-4ee4-8be7-37fca1dbae6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_22e80cc8-8f61-4ee4-8be7-37fca1dbae6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_111c076f-3fa4-4ec9-872c-315c918acf71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_111c076f-3fa4-4ec9-872c-315c918acf71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f01e4023-20e5-4b05-89bc-af5c0eae507d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f01e4023-20e5-4b05-89bc-af5c0eae507d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_362bef5b-4daa-4350-a469-07265e75f626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_362bef5b-4daa-4350-a469-07265e75f626" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_00390089-5679-4013-9bc0-0d922b7ad328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_CommonStockSharesIssued_00390089-5679-4013-9bc0-0d922b7ad328" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_15f495de-2d2b-4074-8c20-c745a1364a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockSharesIssued_15f495de-2d2b-4074-8c20-c745a1364a5f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_b7934bee-8408-42da-bb52-5a7e39f099d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_b7934bee-8408-42da-bb52-5a7e39f099d7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_2756ceed-0d88-463c-b639-5bae29ca4789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_2756ceed-0d88-463c-b639-5bae29ca4789" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_db67880c-0571-4b43-96ce-c7954e2a21e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_db67880c-0571-4b43-96ce-c7954e2a21e7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_79200560-4933-4a60-bd06-f718d0775714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_79200560-4933-4a60-bd06-f718d0775714" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_950f5589-bd33-4d06-a0bf-ae39620c1c10" xlink:href="ahl-20231220.xsd#ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_950f5589-bd33-4d06-a0bf-ae39620c1c10" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f499c57f-7c64-41a0-95a8-12461344736b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f499c57f-7c64-41a0-95a8-12461344736b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f499c57f-7c64-41a0-95a8-12461344736b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f499c57f-7c64-41a0-95a8-12461344736b" xlink:to="loc_us-gaap_EquityComponentDomain_f499c57f-7c64-41a0-95a8-12461344736b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2355f425-ecb9-439a-8621-feeff9981d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f499c57f-7c64-41a0-95a8-12461344736b" xlink:to="loc_us-gaap_EquityComponentDomain_2355f425-ecb9-439a-8621-feeff9981d33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_721f4530-28f5-4ced-9d2a-3ea98302986c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2355f425-ecb9-439a-8621-feeff9981d33" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_721f4530-28f5-4ced-9d2a-3ea98302986c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7cd047f8-dea6-4f9c-8417-0507cbd35373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7cd047f8-dea6-4f9c-8417-0507cbd35373" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7cd047f8-dea6-4f9c-8417-0507cbd35373_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7cd047f8-dea6-4f9c-8417-0507cbd35373" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7cd047f8-dea6-4f9c-8417-0507cbd35373_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1611d49c-b301-419d-9480-04b2c1dc13ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7cd047f8-dea6-4f9c-8417-0507cbd35373" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1611d49c-b301-419d-9480-04b2c1dc13ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8a6f6996-e13f-43ce-a231-0d54e0fb05e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8a6f6996-e13f-43ce-a231-0d54e0fb05e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8a6f6996-e13f-43ce-a231-0d54e0fb05e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8a6f6996-e13f-43ce-a231-0d54e0fb05e7" xlink:to="loc_us-gaap_ClassOfStockDomain_8a6f6996-e13f-43ce-a231-0d54e0fb05e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8a6f6996-e13f-43ce-a231-0d54e0fb05e7" xlink:to="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_6da8ecc4-5077-4fca-8050-91efb5d4a907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:to="loc_us-gaap_PreferredStockMember_6da8ecc4-5077-4fca-8050-91efb5d4a907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_f1f36485-d03b-4f9b-b881-1048bee1463d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_f1f36485-d03b-4f9b-b881-1048bee1463d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_ebc21a8f-f87a-471c-9707-11835a3fc6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_ebc21a8f-f87a-471c-9707-11835a3fc6c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_81785e3f-5567-495d-9a9d-c8bc73515c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_81785e3f-5567-495d-9a9d-c8bc73515c27" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsSummaryofStatutoryRequirementsandDividendsRestrictionsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#StatutoryRequirementsandDividendsRestrictionsSummaryofStatutoryRequirementsandDividendsRestrictionsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsSummaryofStatutoryRequirementsandDividendsRestrictionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f2dc21c1-68a7-4550-85a4-b925134cb05c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus_3f96b901-e962-41fd-85e7-b547b9f5582f" xlink:href="ahl-20231220.xsd#ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f2dc21c1-68a7-4550-85a4-b925134cb05c" xlink:to="loc_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus_3f96b901-e962-41fd-85e7-b547b9f5582f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1_0515b455-91a3-4329-b704-dd9a17013513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f2dc21c1-68a7-4550-85a4-b925134cb05c" xlink:to="loc_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1_0515b455-91a3-4329-b704-dd9a17013513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e19d52ee-ea04-420f-8cba-fdd4e71dbaca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f2dc21c1-68a7-4550-85a4-b925134cb05c" xlink:to="loc_us-gaap_StatementTable_e19d52ee-ea04-420f-8cba-fdd4e71dbaca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_ab39c066-5766-4fcb-8ae6-0ed19f72737c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesByJurisdictionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e19d52ee-ea04-420f-8cba-fdd4e71dbaca" xlink:to="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_ab39c066-5766-4fcb-8ae6-0ed19f72737c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_ab39c066-5766-4fcb-8ae6-0ed19f72737c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesJurisdictionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_ab39c066-5766-4fcb-8ae6-0ed19f72737c" xlink:to="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_ab39c066-5766-4fcb-8ae6-0ed19f72737c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesJurisdictionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_ab39c066-5766-4fcb-8ae6-0ed19f72737c" xlink:to="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eef584d0-3df6-42db-b5fc-1950659ab0fb" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:to="loc_country_US_eef584d0-3df6-42db-b5fc-1950659ab0fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BM_07c56933-378c-46f5-bd85-064d26270502" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_BM"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:to="loc_country_BM_07c56933-378c-46f5-bd85-064d26270502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_4ec43ef5-1805-4c7a-8c61-e9a915a84531" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:to="loc_country_GB_4ec43ef5-1805-4c7a-8c61-e9a915a84531" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#StatutoryRequirementsandDividendsRestrictionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_c275a90b-1b26-4cba-a8ae-32445573b149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_c275a90b-1b26-4cba-a8ae-32445573b149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CapitalReserves_82fe1b75-9b41-455c-9d28-61cd84320b2d" xlink:href="ahl-20231220.xsd#ahl_CapitalReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_CapitalReserves_82fe1b75-9b41-455c-9d28-61cd84320b2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent_8c6e3fbb-68e2-4a37-b98b-e07eca1b3572" xlink:href="ahl-20231220.xsd#ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent_8c6e3fbb-68e2-4a37-b98b-e07eca1b3572" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval_b78e23d2-506a-4f66-a7e5-8f5c9759d515" xlink:href="ahl-20231220.xsd#ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval_b78e23d2-506a-4f66-a7e5-8f5c9759d515" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FundsMaintainedAtSyndicate_fadf9645-8dc1-4782-b461-4fa40e3e8fe7" xlink:href="ahl-20231220.xsd#ahl_FundsMaintainedAtSyndicate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_FundsMaintainedAtSyndicate_fadf9645-8dc1-4782-b461-4fa40e3e8fe7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldForClients_6cbc4deb-5f35-4aa7-b298-8534be3fe1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldForClients"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_us-gaap_FundsHeldForClients_6cbc4deb-5f35-4aa7-b298-8534be3fe1f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus_5056fc6c-71a9-493e-b64b-33c989c3ba15" xlink:href="ahl-20231220.xsd#ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus_5056fc6c-71a9-493e-b64b-33c989c3ba15" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_409759ba-3138-40f1-8191-8213564b5458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesByJurisdictionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:to="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_409759ba-3138-40f1-8191-8213564b5458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_409759ba-3138-40f1-8191-8213564b5458_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesJurisdictionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_409759ba-3138-40f1-8191-8213564b5458" xlink:to="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_409759ba-3138-40f1-8191-8213564b5458_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_23b87fbd-550b-4801-abee-f3297a2af6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesJurisdictionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_409759ba-3138-40f1-8191-8213564b5458" xlink:to="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_23b87fbd-550b-4801-abee-f3297a2af6a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_8a851e06-eae5-4e06-adbc-ed34de6333c9" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_23b87fbd-550b-4801-abee-f3297a2af6a6" xlink:to="loc_country_GB_8a851e06-eae5-4e06-adbc-ed34de6333c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BM_ca131ef2-440c-4040-8865-da77d352581c" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_BM"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_23b87fbd-550b-4801-abee-f3297a2af6a6" xlink:to="loc_country_BM_ca131ef2-440c-4040-8865-da77d352581c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6440e417-6865-479e-a47f-68f6e6a0deba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:to="loc_dei_LegalEntityAxis_6440e417-6865-479e-a47f-68f6e6a0deba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6440e417-6865-479e-a47f-68f6e6a0deba_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6440e417-6865-479e-a47f-68f6e6a0deba" xlink:to="loc_dei_EntityDomain_6440e417-6865-479e-a47f-68f6e6a0deba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0139cbd2-1aed-4906-ba53-ef9a92737625" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6440e417-6865-479e-a47f-68f6e6a0deba" xlink:to="loc_dei_EntityDomain_0139cbd2-1aed-4906-ba53-ef9a92737625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SubsidiariesOneMember_603fef6a-85b5-437a-bffe-17f750d9f4a3" xlink:href="ahl-20231220.xsd#ahl_SubsidiariesOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0139cbd2-1aed-4906-ba53-ef9a92737625" xlink:to="loc_ahl_SubsidiariesOneMember_603fef6a-85b5-437a-bffe-17f750d9f4a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DividendsSummaryofDeclaredDividendsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_0f0989f2-5d51-4769-9e3f-441e97158c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_0f0989f2-5d51-4769-9e3f-441e97158c09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_e7fd2408-cb38-426f-b1fd-794a405ec5da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_e7fd2408-cb38-426f-b1fd-794a405ec5da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_7b2b51d2-0182-489c-89bc-bdf76cbaedeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_7b2b51d2-0182-489c-89bc-bdf76cbaedeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositaryShareDividend_991f3af9-b51f-4dfa-85c6-30401b833838" xlink:href="ahl-20231220.xsd#ahl_DepositaryShareDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_ahl_DepositaryShareDividend_991f3af9-b51f-4dfa-85c6-30401b833838" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_5aeb3a18-89e5-4b57-a4c0-e6364d4633fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_5aeb3a18-89e5-4b57-a4c0-e6364d4633fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_36a44b5c-988f-4515-b207-1b88749db1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_36a44b5c-988f-4515-b207-1b88749db1d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3e11fd38-e490-4da8-8711-b0bd3b0972f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3e11fd38-e490-4da8-8711-b0bd3b0972f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3e11fd38-e490-4da8-8711-b0bd3b0972f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3e11fd38-e490-4da8-8711-b0bd3b0972f8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3e11fd38-e490-4da8-8711-b0bd3b0972f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9ae6e39d-db2f-44c5-8634-455fd12b149e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3e11fd38-e490-4da8-8711-b0bd3b0972f8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9ae6e39d-db2f-44c5-8634-455fd12b149e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_baf017f7-54d1-4bb2-8f65-4d3c3a40ed54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9ae6e39d-db2f-44c5-8634-455fd12b149e" xlink:to="loc_us-gaap_SubsequentEventMember_baf017f7-54d1-4bb2-8f65-4d3c3a40ed54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c51f321c-85fe-4fea-b79b-d000f735ccaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c51f321c-85fe-4fea-b79b-d000f735ccaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c51f321c-85fe-4fea-b79b-d000f735ccaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c51f321c-85fe-4fea-b79b-d000f735ccaf" xlink:to="loc_us-gaap_ClassOfStockDomain_c51f321c-85fe-4fea-b79b-d000f735ccaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c51f321c-85fe-4fea-b79b-d000f735ccaf" xlink:to="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_bf05e70e-0a7a-4c2f-8b4b-aa184ccfaef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_bf05e70e-0a7a-4c2f-8b4b-aa184ccfaef2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_a2e4ad18-d908-4ca8-bd95-4117ab8bfc09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_a2e4ad18-d908-4ca8-bd95-4117ab8bfc09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_a3d70bcd-6254-4e3b-a234-8764a4cb6622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_a3d70bcd-6254-4e3b-a234-8764a4cb6622" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ShareBasedPaymentsandLongtermIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ShareBasedPaymentsandLongtermIncentivePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ShareBasedPaymentsandLongtermIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80353e0a-9c94-46b5-a494-6fa2bd7e8ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SharebasedpaymentandLTIPexpense_b47dccd7-4022-430b-b697-2e843af905c3" xlink:href="ahl-20231220.xsd#ahl_SharebasedpaymentandLTIPexpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80353e0a-9c94-46b5-a494-6fa2bd7e8ab7" xlink:to="loc_ahl_SharebasedpaymentandLTIPexpense_b47dccd7-4022-430b-b697-2e843af905c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f12013a5-619e-4bcb-930d-3b0af171cf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80353e0a-9c94-46b5-a494-6fa2bd7e8ab7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f12013a5-619e-4bcb-930d-3b0af171cf8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_054c4510-bd8e-4ed2-8043-53d92c7b1934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80353e0a-9c94-46b5-a494-6fa2bd7e8ab7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_054c4510-bd8e-4ed2-8043-53d92c7b1934" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_96661faa-64b0-444f-8c2f-4cb09581fde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_054c4510-bd8e-4ed2-8043-53d92c7b1934" xlink:to="loc_us-gaap_AwardTypeAxis_96661faa-64b0-444f-8c2f-4cb09581fde6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96661faa-64b0-444f-8c2f-4cb09581fde6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_96661faa-64b0-444f-8c2f-4cb09581fde6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96661faa-64b0-444f-8c2f-4cb09581fde6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a7b0225-67cb-43b9-a37d-a60aa4abd601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_96661faa-64b0-444f-8c2f-4cb09581fde6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a7b0225-67cb-43b9-a37d-a60aa4abd601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_cd40fc0a-41c6-4c3a-a599-93a67e81099d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a7b0225-67cb-43b9-a37d-a60aa4abd601" xlink:to="loc_us-gaap_PerformanceSharesMember_cd40fc0a-41c6-4c3a-a599-93a67e81099d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IntangibleAssetsSummaryofChangesinIntangibleAssetsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IntangibleAssetsSummaryofChangesinIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/IntangibleAssetsSummaryofChangesinIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:href="ahl-20231220.xsd#ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9a8d86a6-7e1f-4125-b199-37697ac46c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9a8d86a6-7e1f-4125-b199-37697ac46c0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FinitelivedIntangibleAssetsAcquiredDisposed_d152f564-5593-4136-adfc-211832cba644" xlink:href="ahl-20231220.xsd#ahl_FinitelivedIntangibleAssetsAcquiredDisposed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_ahl_FinitelivedIntangibleAssetsAcquiredDisposed_d152f564-5593-4136-adfc-211832cba644" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3092b6d5-786c-40b0-be97-93d40a9fd3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3092b6d5-786c-40b0-be97-93d40a9fd3ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_7c1b6f70-bf91-455f-9430-ba38aa343f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_7c1b6f70-bf91-455f-9430-ba38aa343f75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58c90769-6294-4b02-8a5d-ad880fc585a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7b511b2a-4cff-40f9-985b-e6784ccfada4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:to="loc_us-gaap_Goodwill_7b511b2a-4cff-40f9-985b-e6784ccfada4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_5938c76d-627e-4f03-8eb9-f43518c5c5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_5938c76d-627e-4f03-8eb9-f43518c5c5a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7b93ac10-0ad4-42f2-819c-c843257f4b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7b93ac10-0ad4-42f2-819c-c843257f4b5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d3d3d6c0-fc1b-4653-bb2d-a193340bfdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_db00b634-6f40-4742-a808-a42fc33b8ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_db00b634-6f40-4742-a808-a42fc33b8ab0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IntangibleAssetsandGoodwillAcquiredDisposed_8837eb31-6491-4d0c-b41e-0bb6e61904bb" xlink:href="ahl-20231220.xsd#ahl_IntangibleAssetsandGoodwillAcquiredDisposed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_ahl_IntangibleAssetsandGoodwillAcquiredDisposed_8837eb31-6491-4d0c-b41e-0bb6e61904bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_99c3b9d2-ebec-48a8-8925-e5fcf813a8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_99c3b9d2-ebec-48a8-8925-e5fcf813a8ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_db8e2da7-cb66-4b72-9207-59c498a53bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_202879a1-2c69-4bf8-ba1b-8bf45b854ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_202879a1-2c69-4bf8-ba1b-8bf45b854ce9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad1f772b-4549-445e-a686-fc5c980552f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_202879a1-2c69-4bf8-ba1b-8bf45b854ce9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad1f772b-4549-445e-a686-fc5c980552f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad1f772b-4549-445e-a686-fc5c980552f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad1f772b-4549-445e-a686-fc5c980552f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad1f772b-4549-445e-a686-fc5c980552f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad1f772b-4549-445e-a686-fc5c980552f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_779c45f7-7955-411b-8772-a60c12a01dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:to="loc_us-gaap_TrademarksMember_779c45f7-7955-411b-8772-a60c12a01dc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember_22a7bdcc-5c09-47b1-a06e-0ad6074906a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:to="loc_us-gaap_CustomerListsMember_22a7bdcc-5c09-47b1-a06e-0ad6074906a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_be848a71-de10-460f-b889-5ef9f8e06548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:to="loc_us-gaap_LicensingAgreementsMember_be848a71-de10-460f-b889-5ef9f8e06548" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IntangibleAssetsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:href="ahl-20231220.xsd#ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6ba0fe9b-7480-4af9-9df8-7d3dd70f7206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6ba0fe9b-7480-4af9-9df8-7d3dd70f7206" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_46b25f26-1837-47a9-babc-3aa6759c60ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_46b25f26-1837-47a9-babc-3aa6759c60ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1118e404-a333-43d4-a0c5-fb3b00492acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1118e404-a333-43d4-a0c5-fb3b00492acf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:href="ahl-20231220.xsd#ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:to="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_31134be8-89e0-4261-b6cb-6ef00e3e8ca1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_31134be8-89e0-4261-b6cb-6ef00e3e8ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_31134be8-89e0-4261-b6cb-6ef00e3e8ca1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_31134be8-89e0-4261-b6cb-6ef00e3e8ca1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_31134be8-89e0-4261-b6cb-6ef00e3e8ca1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c3ab9f6e-99be-437d-8138-3dbb71fabeab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_31134be8-89e0-4261-b6cb-6ef00e3e8ca1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c3ab9f6e-99be-437d-8138-3dbb71fabeab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_ca6069a3-2bca-4c97-a22e-2f3c8a5f40a9" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c3ab9f6e-99be-437d-8138-3dbb71fabeab" xlink:to="loc_ahl_DigitalRiskMember_ca6069a3-2bca-4c97-a22e-2f3c8a5f40a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f998b765-6ac7-4efa-87b5-ebb77999c97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f998b765-6ac7-4efa-87b5-ebb77999c97a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f998b765-6ac7-4efa-87b5-ebb77999c97a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f998b765-6ac7-4efa-87b5-ebb77999c97a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f998b765-6ac7-4efa-87b5-ebb77999c97a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b322ecb-3f02-437b-a0f6-a54a553f0e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f998b765-6ac7-4efa-87b5-ebb77999c97a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b322ecb-3f02-437b-a0f6-a54a553f0e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_8bfd3b72-9752-49d2-899d-3ee633124f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b322ecb-3f02-437b-a0f6-a54a553f0e9a" xlink:to="loc_us-gaap_TrademarksMember_8bfd3b72-9752-49d2-899d-3ee633124f1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenTrademarkMember_6af5623d-3d2a-4789-972e-584ece4b9da3" xlink:href="ahl-20231220.xsd#ahl_AspenTrademarkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TrademarksMember_8bfd3b72-9752-49d2-899d-3ee633124f1c" xlink:to="loc_ahl_AspenTrademarkMember_6af5623d-3d2a-4789-972e-584ece4b9da3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BlueWatersMember_b720c7a9-3c9c-4e4e-af12-fe6d9de23b16" xlink:href="ahl-20231220.xsd#ahl_BlueWatersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TrademarksMember_8bfd3b72-9752-49d2-899d-3ee633124f1c" xlink:to="loc_ahl_BlueWatersMember_b720c7a9-3c9c-4e4e-af12-fe6d9de23b16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_b6c810f1-f04d-44d6-8e22-a55e77690e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b322ecb-3f02-437b-a0f6-a54a553f0e9a" xlink:to="loc_us-gaap_LicensingAgreementsMember_b6c810f1-f04d-44d6-8e22-a55e77690e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c5e6c907-943f-4756-93dd-ca2a218642db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c5e6c907-943f-4756-93dd-ca2a218642db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5e6c907-943f-4756-93dd-ca2a218642db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c5e6c907-943f-4756-93dd-ca2a218642db" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5e6c907-943f-4756-93dd-ca2a218642db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8a2732e1-8dca-4368-85e3-7634a786d0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c5e6c907-943f-4756-93dd-ca2a218642db" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8a2732e1-8dca-4368-85e3-7634a786d0d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BlueWatersMember_e6023ed6-d910-4417-8966-9b057f995962" xlink:href="ahl-20231220.xsd#ahl_BlueWatersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8a2732e1-8dca-4368-85e3-7634a786d0d7" xlink:to="loc_ahl_BlueWatersMember_e6023ed6-d910-4417-8966-9b057f995962" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_14338aed-791f-43a3-bbe1-af8893af9107" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_dei_LegalEntityAxis_14338aed-791f-43a3-bbe1-af8893af9107" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_14338aed-791f-43a3-bbe1-af8893af9107_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_14338aed-791f-43a3-bbe1-af8893af9107" xlink:to="loc_dei_EntityDomain_14338aed-791f-43a3-bbe1-af8893af9107_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_986fe12f-9cb9-44f4-8322-6e24184d676d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_14338aed-791f-43a3-bbe1-af8893af9107" xlink:to="loc_dei_EntityDomain_986fe12f-9cb9-44f4-8322-6e24184d676d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenSpecialtyMember_9f6ee4cc-9065-4d71-be74-54f316f9e0c4" xlink:href="ahl-20231220.xsd#ahl_AspenSpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_986fe12f-9cb9-44f4-8322-6e24184d676d" xlink:to="loc_ahl_AspenSpecialtyMember_9f6ee4cc-9065-4d71-be74-54f316f9e0c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_101ab1ce-c1d1-4bf0-8459-27647474844b" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_986fe12f-9cb9-44f4-8322-6e24184d676d" xlink:to="loc_ahl_AspenUKMember_101ab1ce-c1d1-4bf0-8459-27647474844b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionRateofInterest_8167ca13-edef-488f-b69f-608f99d520ea" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionRateofInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_ahl_RelatedPartyTransactionRateofInterest_8167ca13-edef-488f-b69f-608f99d520ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionMaximumRateIncrease_4f7dcf75-9013-4808-9d0c-e9968a7e3e55" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionMaximumRateIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_ahl_RelatedPartyTransactionMaximumRateIncrease_4f7dcf75-9013-4808-9d0c-e9968a7e3e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_6babf19d-aca3-4154-9a65-c7de4370230e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_6babf19d-aca3-4154-9a65-c7de4370230e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromOfficersOrStockholdersCurrent_bcd82636-d8cb-453c-ae4e-1078eea12898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_DueFromOfficersOrStockholdersCurrent_bcd82636-d8cb-453c-ae4e-1078eea12898" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_99e7c119-877a-4e0c-b14c-8b131a3dd16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_DueToAffiliateCurrent_99e7c119-877a-4e0c-b14c-8b131a3dd16c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_26a75344-6d5b-4bd5-8632-1ba012a745de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_26a75344-6d5b-4bd5-8632-1ba012a745de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_6577e804-8d37-4127-83bf-278080267860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_6577e804-8d37-4127-83bf-278080267860" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_c9163406-6532-4e90-9a19-96928a132581" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_ahl_PrivatelyheldInvestments_c9163406-6532-4e90-9a19-96928a132581" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_8b9663d8-7a8a-4e7e-8fbc-851bd5149183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_OtherInvestments_8b9663d8-7a8a-4e7e-8fbc-851bd5149183" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyHeldInvestmentLossesIncurred_de85df20-dc26-446c-a2f5-10bb7f04df3a" xlink:href="ahl-20231220.xsd#ahl_PrivatelyHeldInvestmentLossesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_ahl_PrivatelyHeldInvestmentLossesIncurred_de85df20-dc26-446c-a2f5-10bb7f04df3a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0330ded1-a830-43b7-9122-130d57c1ca0f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_srt_RangeAxis_0330ded1-a830-43b7-9122-130d57c1ca0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0330ded1-a830-43b7-9122-130d57c1ca0f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0330ded1-a830-43b7-9122-130d57c1ca0f" xlink:to="loc_srt_RangeMember_0330ded1-a830-43b7-9122-130d57c1ca0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f2dcde55-c602-4228-a1d8-b5a69e8a22af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0330ded1-a830-43b7-9122-130d57c1ca0f" xlink:to="loc_srt_RangeMember_f2dcde55-c602-4228-a1d8-b5a69e8a22af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1eff8955-baed-42c2-b95b-e1c6b2a661ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f2dcde55-c602-4228-a1d8-b5a69e8a22af" xlink:to="loc_srt_MaximumMember_1eff8955-baed-42c2-b95b-e1c6b2a661ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c" xlink:to="loc_us-gaap_RelatedPartyDomain_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c" xlink:to="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_db399a97-b3f3-4d6b-8e4c-b3065110c502" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_srt_AffiliatedEntityMember_db399a97-b3f3-4d6b-8e4c-b3065110c502" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BeneficialOwnerMember_f512d126-46c0-481d-82c2-971f255608b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BeneficialOwnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_us-gaap_BeneficialOwnerMember_f512d126-46c0-481d-82c2-971f255608b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_0424b5ce-ace9-43fa-aaad-ca1db0131e09" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ApolloRealEstateFundMember_0424b5ce-ace9-43fa-aaad-ca1db0131e09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_4b00ea6b-b2a8-4606-a313-1bcf24b2c869" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_4b00ea6b-b2a8-4606-a313-1bcf24b2c869" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassANotesMember_a3f17871-49af-4ebb-a595-3d02e0b7f686" xlink:href="ahl-20231220.xsd#ahl_ApolloClassANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ApolloClassANotesMember_a3f17871-49af-4ebb-a595-3d02e0b7f686" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassBNotesMember_050c7669-ad5e-49a5-8b7a-7c9c1420a3cf" xlink:href="ahl-20231220.xsd#ahl_ApolloClassBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ApolloClassBNotesMember_050c7669-ad5e-49a5-8b7a-7c9c1420a3cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember_aa2290bf-7093-494a-97cd-a08fbef2bebc" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ClassABNotesMember_aa2290bf-7093-494a-97cd-a08fbef2bebc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b8b86c79-623f-4caf-81d7-888026e6de4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b8b86c79-623f-4caf-81d7-888026e6de4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b8b86c79-623f-4caf-81d7-888026e6de4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b8b86c79-623f-4caf-81d7-888026e6de4b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b8b86c79-623f-4caf-81d7-888026e6de4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b8b86c79-623f-4caf-81d7-888026e6de4b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_a154ad54-0bba-4736-a816-0a2eb206d1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:to="loc_us-gaap_AssetManagementArrangementMember_a154ad54-0bba-4736-a816-0a2eb206d1b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_221a5036-d127-4749-ba76-960101d76855" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:to="loc_ahl_ManagementConsultingAgreementMember_221a5036-d127-4749-ba76-960101d76855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_7f6bbc4e-97f3-416f-8359-7464e324d355" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_7f6bbc4e-97f3-416f-8359-7464e324d355" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c6061068-e0ac-4e55-bf29-24ffd5629888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c6061068-e0ac-4e55-bf29-24ffd5629888" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c6061068-e0ac-4e55-bf29-24ffd5629888_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c6061068-e0ac-4e55-bf29-24ffd5629888" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c6061068-e0ac-4e55-bf29-24ffd5629888_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c6061068-e0ac-4e55-bf29-24ffd5629888" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_cd4b7a29-9137-486a-b719-c2355671ca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:to="loc_us-gaap_InvestmentIncomeMember_cd4b7a29-9137-486a-b719-c2355671ca4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_78155891-6b00-4e5c-9882-dc122163382a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_78155891-6b00-4e5c-9882-dc122163382a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1_18028797-c196-40dc-b709-a4d534f15029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:to="loc_us-gaap_GainLossOnInvestmentsMember1_18028797-c196-40dc-b709-a4d534f15029" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cedc30a8-391f-4b9d-8e24-c6e7a425f326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cedc30a8-391f-4b9d-8e24-c6e7a425f326" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cedc30a8-391f-4b9d-8e24-c6e7a425f326_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cedc30a8-391f-4b9d-8e24-c6e7a425f326" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cedc30a8-391f-4b9d-8e24-c6e7a425f326_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4fca8866-dadb-4540-bf31-690e3d57a302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cedc30a8-391f-4b9d-8e24-c6e7a425f326" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4fca8866-dadb-4540-bf31-690e3d57a302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_dddcefe7-a609-49dd-b1da-08af3056de5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4fca8866-dadb-4540-bf31-690e3d57a302" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_dddcefe7-a609-49dd-b1da-08af3056de5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c263e128-2828-460c-8de9-8eef85d9ef5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c263e128-2828-460c-8de9-8eef85d9ef5a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c263e128-2828-460c-8de9-8eef85d9ef5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c263e128-2828-460c-8de9-8eef85d9ef5a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c263e128-2828-460c-8de9-8eef85d9ef5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0d9115d6-836c-42d1-9425-f99aaa0cb056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c263e128-2828-460c-8de9-8eef85d9ef5a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0d9115d6-836c-42d1-9425-f99aaa0cb056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_edb85bbc-fb76-4e12-a29f-2bc2a465657c" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0d9115d6-836c-42d1-9425-f99aaa0cb056" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_edb85bbc-fb76-4e12-a29f-2bc2a465657c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_fc050ddc-efdb-4117-bc7d-5cf4016dd76b" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_RestrictedAssets_fc050ddc-efdb-4117-bc7d-5cf4016dd76b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssetsExcludingIlliquidAssets_533aa1e5-17fe-4ca5-b5f7-ebec15f7c22a" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssetsExcludingIlliquidAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_RestrictedAssetsExcludingIlliquidAssets_533aa1e5-17fe-4ca5-b5f7-ebec15f7c22a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_05899135-927b-40c7-97ab-22d0b72c22ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_us-gaap_OtherInvestments_05899135-927b-40c7-97ab-22d0b72c22ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalRestrictedAssets_fd59d3c3-7cb9-4d4c-9631-9da6a7740c57" xlink:href="ahl-20231220.xsd#ahl_TotalRestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_TotalRestrictedAssets_fd59d3c3-7cb9-4d4c-9631-9da6a7740c57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_b765feb2-f306-4aa4-a8b3-4df661741441" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_b765feb2-f306-4aa4-a8b3-4df661741441" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_0961a79d-2ba8-4afc-a338-2f7dd73deb63" xlink:href="ahl-20231220.xsd#ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_0961a79d-2ba8-4afc-a338-2f7dd73deb63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_3cac694f-f4aa-4301-a964-44c70c938d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_3cac694f-f4aa-4301-a964-44c70c938d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_3cac694f-f4aa-4301-a964-44c70c938d38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_3cac694f-f4aa-4301-a964-44c70c938d38" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_3cac694f-f4aa-4301-a964-44c70c938d38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_83c15153-7474-4538-938e-fa94aeae51a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_3cac694f-f4aa-4301-a964-44c70c938d38" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_83c15153-7474-4538-938e-fa94aeae51a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_4c23a304-0187-4bda-84bc-032fb8c20d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_83c15153-7474-4538-938e-fa94aeae51a2" xlink:to="loc_us-gaap_LimitedPartnerMember_4c23a304-0187-4bda-84bc-032fb8c20d21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_6ea335c5-945c-48d2-a951-af8b5adbafe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:to="loc_us-gaap_InvestmentTypeAxis_6ea335c5-945c-48d2-a951-af8b5adbafe8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6ea335c5-945c-48d2-a951-af8b5adbafe8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_6ea335c5-945c-48d2-a951-af8b5adbafe8" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6ea335c5-945c-48d2-a951-af8b5adbafe8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_73b6caf9-aa63-4c98-9b1e-b24eb92bde4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_6ea335c5-945c-48d2-a951-af8b5adbafe8" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_73b6caf9-aa63-4c98-9b1e-b24eb92bde4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_1fb2c6a8-dd3b-4b05-abd2-6714e9be5536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73b6caf9-aa63-4c98-9b1e-b24eb92bde4a" xlink:to="loc_us-gaap_RealEstateFundsMember_1fb2c6a8-dd3b-4b05-abd2-6714e9be5536" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4eb08f2-b6b5-4342-8016-cddbce4bed69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4eb08f2-b6b5-4342-8016-cddbce4bed69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e4eb08f2-b6b5-4342-8016-cddbce4bed69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4eb08f2-b6b5-4342-8016-cddbce4bed69" xlink:to="loc_us-gaap_RelatedPartyDomain_e4eb08f2-b6b5-4342-8016-cddbce4bed69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_55bbd1ac-f7d1-4071-9f81-257df6e770d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4eb08f2-b6b5-4342-8016-cddbce4bed69" xlink:to="loc_us-gaap_RelatedPartyDomain_55bbd1ac-f7d1-4071-9f81-257df6e770d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_beabd95d-29ac-4a34-be53-6dd4d5c28d59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_55bbd1ac-f7d1-4071-9f81-257df6e770d4" xlink:to="loc_srt_AffiliatedEntityMember_beabd95d-29ac-4a34-be53-6dd4d5c28d59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ThirdPartyMember_ead00c88-c218-49dd-acec-d79d43daa9ff" xlink:href="ahl-20231220.xsd#ahl_ThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_55bbd1ac-f7d1-4071-9f81-257df6e770d4" xlink:to="loc_ahl_ThirdPartyMember_ead00c88-c218-49dd-acec-d79d43daa9ff" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_5b5c1d94-ad27-43cd-8025-071da1269af3" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_RestrictedAssets_5b5c1d94-ad27-43cd-8025-071da1269af3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_7e2a7898-4772-4bb2-b3d9-bc19805ab13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_OtherInvestments_7e2a7898-4772-4bb2-b3d9-bc19805ab13c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_42164d73-18bb-4cf2-8b73-4037e9b9e4c2" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_42164d73-18bb-4cf2-8b73-4037e9b9e4c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8a81ffc9-09c5-44d1-8498-93794571747e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8a81ffc9-09c5-44d1-8498-93794571747e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_7b1dfc90-a8da-4a3a-9ac0-92a16e677fdc" xlink:href="ahl-20231220.xsd#ahl_PaymentstoAcquirePrivatelyheldInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_7b1dfc90-a8da-4a3a-9ac0-92a16e677fdc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_65c36889-ad0b-4e6b-9b86-2d8b0bf3034d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_65c36889-ad0b-4e6b-9b86-2d8b0bf3034d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_3139a465-b149-46bf-af1e-998cd18d476e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_3139a465-b149-46bf-af1e-998cd18d476e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumNetCapitalRequired1_a5d6dde3-3f0c-4701-a32e-292e04607c39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumNetCapitalRequired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_srt_MinimumNetCapitalRequired1_a5d6dde3-3f0c-4701-a32e-292e04607c39" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MinimumTrustFund_a57dba44-6637-41b9-8730-8a8ca70507f2" xlink:href="ahl-20231220.xsd#ahl_MinimumTrustFund"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_MinimumTrustFund_a57dba44-6637-41b9-8730-8a8ca70507f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfReinsuranceLiabilities_cfb02c93-9310-4c73-9b9f-8a37aa40d5bd" xlink:href="ahl-20231220.xsd#ahl_PercentageOfReinsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_PercentageOfReinsuranceLiabilities_cfb02c93-9310-4c73-9b9f-8a37aa40d5bd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceLiabilities_23da8b23-441d-48df-bfba-fdaf107ed4ad" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_ReinsuranceLiabilities_23da8b23-441d-48df-bfba-fdaf107ed4ad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_14084f09-985f-4f4c-bf4e-d45073bbf21e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_AssetsHeldInTrust_14084f09-985f-4f4c-bf4e-d45073bbf21e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RegulatoryDeposits_954fa772-be88-4641-8cdb-d224012aa53c" xlink:href="ahl-20231220.xsd#ahl_RegulatoryDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_RegulatoryDeposits_954fa772-be88-4641-8cdb-d224012aa53c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositWithStates_a6e39ec4-08e6-49c5-a90c-181af3b63709" xlink:href="ahl-20231220.xsd#ahl_DepositWithStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_DepositWithStates_a6e39ec4-08e6-49c5-a90c-181af3b63709" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NumberOfInvestmentsInVariableInterestEntities_431cb651-1aa6-4341-8ee5-adadd733c261" xlink:href="ahl-20231220.xsd#ahl_NumberOfInvestmentsInVariableInterestEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_NumberOfInvestmentsInVariableInterestEntities_431cb651-1aa6-4341-8ee5-adadd733c261" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_cbcb74c0-550e-473c-a509-2d3351b5b878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_cbcb74c0-550e-473c-a509-2d3351b5b878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_cbcb74c0-550e-473c-a509-2d3351b5b878_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_cbcb74c0-550e-473c-a509-2d3351b5b878" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_cbcb74c0-550e-473c-a509-2d3351b5b878_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4a789cb3-2395-4492-933a-14b9ee2a78ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_cbcb74c0-550e-473c-a509-2d3351b5b878" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4a789cb3-2395-4492-933a-14b9ee2a78ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_16269e13-039b-4bc0-9c27-c54265e6d143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4a789cb3-2395-4492-933a-14b9ee2a78ff" xlink:to="loc_us-gaap_LimitedPartnerMember_16269e13-039b-4bc0-9c27-c54265e6d143" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ce65e11f-4322-4ef0-afca-7bc147ef9d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_InvestmentTypeAxis_ce65e11f-4322-4ef0-afca-7bc147ef9d5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ce65e11f-4322-4ef0-afca-7bc147ef9d5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ce65e11f-4322-4ef0-afca-7bc147ef9d5c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ce65e11f-4322-4ef0-afca-7bc147ef9d5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d65fba6c-504f-48de-b1f0-34bed9d62ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ce65e11f-4322-4ef0-afca-7bc147ef9d5c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d65fba6c-504f-48de-b1f0-34bed9d62ea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_8453bb2f-ceca-4bbb-8464-4bdc36f7e7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_d65fba6c-504f-48de-b1f0-34bed9d62ea4" xlink:to="loc_us-gaap_RealEstateFundsMember_8453bb2f-ceca-4bbb-8464-4bdc36f7e7f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_85469c27-98b8-41b5-b126-a9d4c26a796d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_HedgingDesignationAxis_85469c27-98b8-41b5-b126-a9d4c26a796d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_85469c27-98b8-41b5-b126-a9d4c26a796d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_85469c27-98b8-41b5-b126-a9d4c26a796d" xlink:to="loc_us-gaap_HedgingDesignationDomain_85469c27-98b8-41b5-b126-a9d4c26a796d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_23f60191-b2fa-4afb-b5d7-862430ea578c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_85469c27-98b8-41b5-b126-a9d4c26a796d" xlink:to="loc_us-gaap_HedgingDesignationDomain_23f60191-b2fa-4afb-b5d7-862430ea578c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_449f226e-91c1-4753-af13-e877145bedf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_23f60191-b2fa-4afb-b5d7-862430ea578c" xlink:to="loc_us-gaap_NondesignatedMember_449f226e-91c1-4753-af13-e877145bedf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fb0842ab-d967-48cf-9186-c54dcde4068a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_dei_LegalEntityAxis_fb0842ab-d967-48cf-9186-c54dcde4068a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fb0842ab-d967-48cf-9186-c54dcde4068a_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_fb0842ab-d967-48cf-9186-c54dcde4068a" xlink:to="loc_dei_EntityDomain_fb0842ab-d967-48cf-9186-c54dcde4068a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5fe3d059-4e74-424a-80ea-257daaff8d04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_fb0842ab-d967-48cf-9186-c54dcde4068a" xlink:to="loc_dei_EntityDomain_5fe3d059-4e74-424a-80ea-257daaff8d04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenBermudaMember_a2a4763c-9273-4b5a-911e-4cfcda875006" xlink:href="ahl-20231220.xsd#ahl_AspenBermudaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5fe3d059-4e74-424a-80ea-257daaff8d04" xlink:to="loc_ahl_AspenBermudaMember_a2a4763c-9273-4b5a-911e-4cfcda875006" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8370ad2-2503-4c27-b690-37339fd0cd10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8370ad2-2503-4c27-b690-37339fd0cd10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8370ad2-2503-4c27-b690-37339fd0cd10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8370ad2-2503-4c27-b690-37339fd0cd10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8370ad2-2503-4c27-b690-37339fd0cd10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8370ad2-2503-4c27-b690-37339fd0cd10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsMultiBeneficiaryTrustFundMember_a7ef2fdc-5446-4024-8b75-f6260a2f67c9" xlink:href="ahl-20231220.xsd#ahl_UsMultiBeneficiaryTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_UsMultiBeneficiaryTrustFundMember_a7ef2fdc-5446-4024-8b75-f6260a2f67c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsSurplusLinesTrustFundMember_485a56a5-e074-4247-9948-f970f1ac976e" xlink:href="ahl-20231220.xsd#ahl_UsSurplusLinesTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_UsSurplusLinesTrustFundMember_485a56a5-e074-4247-9948-f970f1ac976e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CanadianTrustFundMember_3fd32d17-b303-4702-a6f1-892b69d85941" xlink:href="ahl-20231220.xsd#ahl_CanadianTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_CanadianTrustFundMember_3fd32d17-b303-4702-a6f1-892b69d85941" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AustralianTrustFundMember_d76be418-2e13-4b45-9594-4abf0e2f5b9b" xlink:href="ahl-20231220.xsd#ahl_AustralianTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_AustralianTrustFundMember_d76be418-2e13-4b45-9594-4abf0e2f5b9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SwissTrustFundMember_05a3127b-bf15-4a97-94b3-aa49973d76d2" xlink:href="ahl-20231220.xsd#ahl_SwissTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_SwissTrustFundMember_05a3127b-bf15-4a97-94b3-aa49973d76d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SingaporeTrustFundMember_98de2916-aece-4342-869d-0cc6660ec231" xlink:href="ahl-20231220.xsd#ahl_SingaporeTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_SingaporeTrustFundMember_98de2916-aece-4342-869d-0cc6660ec231" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f0d2243-8943-447a-9315-bc8f4cd69110" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f0d2243-8943-447a-9315-bc8f4cd69110" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1f0d2243-8943-447a-9315-bc8f4cd69110_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f0d2243-8943-447a-9315-bc8f4cd69110" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1f0d2243-8943-447a-9315-bc8f4cd69110_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9f9a8424-be87-4712-9cfa-09d9b234f965" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f0d2243-8943-447a-9315-bc8f4cd69110" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9f9a8424-be87-4712-9cfa-09d9b234f965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_2f5ce13a-4a0a-40aa-82c5-95b7c22eb141" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9f9a8424-be87-4712-9cfa-09d9b234f965" xlink:to="loc_ahl_MVIMember_2f5ce13a-4a0a-40aa-82c5-95b7c22eb141" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_d36759ed-deab-441c-8ce7-907f8d87d5a6" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9f9a8424-be87-4712-9cfa-09d9b234f965" xlink:to="loc_ahl_MultiLineReinsurerMember_d36759ed-deab-441c-8ce7-907f8d87d5a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3a303f62-fcd4-4458-823d-44f99d125036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3a303f62-fcd4-4458-823d-44f99d125036" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3a303f62-fcd4-4458-823d-44f99d125036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3a303f62-fcd4-4458-823d-44f99d125036" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3a303f62-fcd4-4458-823d-44f99d125036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_21c06bf1-8ec0-4025-b449-edf09b3a39b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3a303f62-fcd4-4458-823d-44f99d125036" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_21c06bf1-8ec0-4025-b449-edf09b3a39b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_74ae1178-d254-4744-a9f1-4455ebed04d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_21c06bf1-8ec0-4025-b449-edf09b3a39b3" xlink:to="loc_us-gaap_SubsequentEventMember_74ae1178-d254-4744-a9f1-4455ebed04d5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskScheduleOfGrossWrittenPremiumFromMajorBrokersDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRiskScheduleOfGrossWrittenPremiumFromMajorBrokersDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRiskScheduleOfGrossWrittenPremiumFromMajorBrokersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsWrittenGrossPercentage_0cf0a0f3-9d90-4426-a03c-b0f2b709ff04" xlink:href="ahl-20231220.xsd#ahl_PremiumsWrittenGrossPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:to="loc_ahl_PremiumsWrittenGrossPercentage_0cf0a0f3-9d90-4426-a03c-b0f2b709ff04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_8ebcbce3-7267-4633-af47-8965228800af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:to="loc_us-gaap_PremiumsWrittenGross_8ebcbce3-7267-4633-af47-8965228800af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_557bc00a-8b0a-4771-96ba-830be490c2a8" xlink:href="ahl-20231220.xsd#ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:to="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_557bc00a-8b0a-4771-96ba-830be490c2a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_45c4a7c1-635a-498b-aedb-505e64c873f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:to="loc_us-gaap_InvestmentHoldingsTable_45c4a7c1-635a-498b-aedb-505e64c873f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ff72f0cb-a235-4c0c-9b31-7b9383081057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_45c4a7c1-635a-498b-aedb-505e64c873f2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ff72f0cb-a235-4c0c-9b31-7b9383081057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ff72f0cb-a235-4c0c-9b31-7b9383081057_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ff72f0cb-a235-4c0c-9b31-7b9383081057" xlink:to="loc_us-gaap_RelatedPartyDomain_ff72f0cb-a235-4c0c-9b31-7b9383081057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ff72f0cb-a235-4c0c-9b31-7b9383081057" xlink:to="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AonCorporationMember_9087011a-ca81-4e0b-b466-d7d15c49dfbe" xlink:href="ahl-20231220.xsd#ahl_AonCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:to="loc_ahl_AonCorporationMember_9087011a-ca81-4e0b-b466-d7d15c49dfbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MarshAndMcLennanCompaniesIncMember_54de1f39-5631-48ab-9387-ff030509e0a7" xlink:href="ahl-20231220.xsd#ahl_MarshAndMcLennanCompaniesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:to="loc_ahl_MarshAndMcLennanCompaniesIncMember_54de1f39-5631-48ab-9387-ff030509e0a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_WillisGroupHoldingsLtdMember_55bdcf15-5818-4a29-968e-11ff1454acd7" xlink:href="ahl-20231220.xsd#ahl_WillisGroupHoldingsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:to="loc_ahl_WillisGroupHoldingsLtdMember_55bdcf15-5818-4a29-968e-11ff1454acd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OthersMember_448e6396-3015-46be-b07d-192edb390acd" xlink:href="ahl-20231220.xsd#ahl_OthersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:to="loc_ahl_OthersMember_448e6396-3015-46be-b07d-192edb390acd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRiskAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_d143e11e-edd2-40f7-829c-419f3365ec7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_ReinsuranceRecoverables_d143e11e-edd2-40f7-829c-419f3365ec7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesUncollateralized_ee03ab82-9f84-42c7-a248-16d549be4ba1" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesUncollateralized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_ReinsuranceRecoverablesUncollateralized_ee03ab82-9f84-42c7-a248-16d549be4ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConcentrationRiskThresholdPercentage_a57c670c-d0a4-4049-99dd-b5ca882f26be" xlink:href="ahl-20231220.xsd#ahl_ConcentrationRiskThresholdPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_ConcentrationRiskThresholdPercentage_a57c670c-d0a4-4049-99dd-b5ca882f26be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_e0956bdd-1cdb-4508-94f8-c44da03effb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_e0956bdd-1cdb-4508-94f8-c44da03effb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsReceivableNonCurrent_6196482a-5352-4c34-948e-cbc065957e84" xlink:href="ahl-20231220.xsd#ahl_PremiumsReceivableNonCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_PremiumsReceivableNonCurrent_6196482a-5352-4c34-948e-cbc065957e84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_65f12c08-114e-45e7-b2b8-f7e0c1b3e103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_65f12c08-114e-45e7-b2b8-f7e0c1b3e103" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_a81262cf-852e-466d-859c-98e9d1bc97fa" xlink:href="ahl-20231220.xsd#ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_a81262cf-852e-466d-859c-98e9d1bc97fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_18dd138b-57ce-4d46-938a-33edd958f4bb" xlink:href="ahl-20231220.xsd#ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_18dd138b-57ce-4d46-938a-33edd958f4bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_9fd07580-2614-4947-b8ed-344dd9b78010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_9fd07580-2614-4947-b8ed-344dd9b78010" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingAMBestAxis_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingAMBestAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_srt_CreditRatingAMBestAxis_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingAMBestDomain_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingAMBestDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CreditRatingAMBestAxis_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a" xlink:to="loc_srt_CreditRatingAMBestDomain_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingAMBestDomain_4cb10b34-31e3-4289-8d75-80dad397a417" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingAMBestDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CreditRatingAMBestAxis_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a" xlink:to="loc_srt_CreditRatingAMBestDomain_4cb10b34-31e3-4289-8d75-80dad397a417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AMBestAPlusRatingMember_aa168eac-e7bf-41d6-b798-2535c55cb9d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AMBestAPlusRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CreditRatingAMBestDomain_4cb10b34-31e3-4289-8d75-80dad397a417" xlink:to="loc_srt_AMBestAPlusRatingMember_aa168eac-e7bf-41d6-b798-2535c55cb9d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AMBestARatingMember_d2657a59-c567-41f6-a09f-2e1eb5feb79c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AMBestARatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CreditRatingAMBestDomain_4cb10b34-31e3-4289-8d75-80dad397a417" xlink:to="loc_srt_AMBestARatingMember_d2657a59-c567-41f6-a09f-2e1eb5feb79c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis_7b7e2e56-1e12-49d0-ab45-84998976f070" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_srt_CreditRatingStandardPoorsAxis_7b7e2e56-1e12-49d0-ab45-84998976f070" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_7b7e2e56-1e12-49d0-ab45-84998976f070_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_7b7e2e56-1e12-49d0-ab45-84998976f070" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_7b7e2e56-1e12-49d0-ab45-84998976f070_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_04002c1d-7857-448e-bc4e-2d27615c1bab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_7b7e2e56-1e12-49d0-ab45-84998976f070" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_04002c1d-7857-448e-bc4e-2d27615c1bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAPlusRatingMember_432babf4-df24-4962-8ce1-f721013f5662" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAPlusRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_04002c1d-7857-448e-bc4e-2d27615c1bab" xlink:to="loc_srt_StandardPoorsAPlusRatingMember_432babf4-df24-4962-8ce1-f721013f5662" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAAMinusRatingMember_f0d14ebe-6ff3-4fa3-b098-f1f100e29c34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAAMinusRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_04002c1d-7857-448e-bc4e-2d27615c1bab" xlink:to="loc_srt_StandardPoorsAAMinusRatingMember_f0d14ebe-6ff3-4fa3-b098-f1f100e29c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b85ba15-ef89-4606-9a08-fdfb8bd3e573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b85ba15-ef89-4606-9a08-fdfb8bd3e573" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2b85ba15-ef89-4606-9a08-fdfb8bd3e573_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b85ba15-ef89-4606-9a08-fdfb8bd3e573" xlink:to="loc_us-gaap_RelatedPartyDomain_2b85ba15-ef89-4606-9a08-fdfb8bd3e573_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b85ba15-ef89-4606-9a08-fdfb8bd3e573" xlink:to="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MunichReMember_b23dddd9-297b-4ce3-95e3-670b946d594a" xlink:href="ahl-20231220.xsd#ahl_MunichReMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:to="loc_ahl_MunichReMember_b23dddd9-297b-4ce3-95e3-670b946d594a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EverestReMember_5d79f7f3-0961-4cb3-8a05-e810a29a69d4" xlink:href="ahl-20231220.xsd#ahl_EverestReMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:to="loc_ahl_EverestReMember_5d79f7f3-0961-4cb3-8a05-e810a29a69d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_5e062f10-2b19-4821-8647-4e684e6b8644" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:to="loc_ahl_LloydsMember_5e062f10-2b19-4821-8647-4e684e6b8644" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ed01bc1f-e52c-4224-8785-5de496d8017f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ed01bc1f-e52c-4224-8785-5de496d8017f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ed01bc1f-e52c-4224-8785-5de496d8017f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ed01bc1f-e52c-4224-8785-5de496d8017f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ed01bc1f-e52c-4224-8785-5de496d8017f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_45cd7bdf-8c2c-4747-ade1-4961557d9c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ed01bc1f-e52c-4224-8785-5de496d8017f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_45cd7bdf-8c2c-4747-ade1-4961557d9c50" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_1d190fd3-20be-4cfc-9285-4424e64fdb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_1d190fd3-20be-4cfc-9285-4424e64fdb9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_834947bd-32d0-4fa6-b796-4fb3a59fa1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_834947bd-32d0-4fa6-b796-4fb3a59fa1e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2c277421-7d95-4ad9-a645-7b8c8eeacb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2c277421-7d95-4ad9-a645-7b8c8eeacb50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4af56f52-74b3-4165-9745-f2452d3969f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4af56f52-74b3-4165-9745-f2452d3969f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4653af2a-84d8-4eb6-b635-7f0a5442b9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4653af2a-84d8-4eb6-b635-7f0a5442b9dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_93eee6f3-3702-4a4d-a0f2-c86a3b7e1051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_93eee6f3-3702-4a4d-a0f2-c86a3b7e1051" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d38ff921-177c-4dac-bf50-b34b3c35e415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_ProfitLoss_d38ff921-177c-4dac-bf50-b34b3c35e415" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a00661e7-108d-4b8d-a20c-50ce7205155a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a00661e7-108d-4b8d-a20c-50ce7205155a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a00661e7-108d-4b8d-a20c-50ce7205155a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a00661e7-108d-4b8d-a20c-50ce7205155a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a00661e7-108d-4b8d-a20c-50ce7205155a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_952be1ad-d458-4956-80a8-55e00077047d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a00661e7-108d-4b8d-a20c-50ce7205155a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_952be1ad-d458-4956-80a8-55e00077047d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f1a411d7-1eed-4853-8aed-079482e7aff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_952be1ad-d458-4956-80a8-55e00077047d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f1a411d7-1eed-4853-8aed-079482e7aff3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_27e51a92-faef-4d4d-a728-fde251748270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_27e51a92-faef-4d4d-a728-fde251748270" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_27e51a92-faef-4d4d-a728-fde251748270_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_27e51a92-faef-4d4d-a728-fde251748270" xlink:to="loc_us-gaap_EquityComponentDomain_27e51a92-faef-4d4d-a728-fde251748270_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c1a33dcb-8f75-4e3c-b73a-9668194ad8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_27e51a92-faef-4d4d-a728-fde251748270" xlink:to="loc_us-gaap_EquityComponentDomain_c1a33dcb-8f75-4e3c-b73a-9668194ad8df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2acb8baa-776c-4221-9ee7-fdcb39db78da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c1a33dcb-8f75-4e3c-b73a-9668194ad8df" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2acb8baa-776c-4221-9ee7-fdcb39db78da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_56b78e63-e6be-4f8c-a8a7-ef1b58c553ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c1a33dcb-8f75-4e3c-b73a-9668194ad8df" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_56b78e63-e6be-4f8c-a8a7-ef1b58c553ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_ced543a6-cf06-48e9-8b94-8acacc85628a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_ced543a6-cf06-48e9-8b94-8acacc85628a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_ced543a6-cf06-48e9-8b94-8acacc85628a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_ced543a6-cf06-48e9-8b94-8acacc85628a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_ced543a6-cf06-48e9-8b94-8acacc85628a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6738e5e0-d4d1-473e-a604-dfc764480fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_ced543a6-cf06-48e9-8b94-8acacc85628a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6738e5e0-d4d1-473e-a604-dfc764480fb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8cff26ce-9c4a-418a-ae7f-cbe55c1e3a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6738e5e0-d4d1-473e-a604-dfc764480fb3" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8cff26ce-9c4a-418a-ae7f-cbe55c1e3a21" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtSummaryofContractualObligationsUnderShorttermDebtsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditFacilitiesandShortTermDebtSummaryofContractualObligationsUnderShorttermDebtsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtSummaryofContractualObligationsUnderShorttermDebtsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_313a71eb-61f0-4472-b628-a78356a18ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_81c689e7-5472-4e5f-8e22-9fe1e13c7af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_313a71eb-61f0-4472-b628-a78356a18ba0" xlink:to="loc_us-gaap_ShortTermBorrowings_81c689e7-5472-4e5f-8e22-9fe1e13c7af8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_7af6b6df-3568-40d5-be6e-ae47ffc7d06d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_313a71eb-61f0-4472-b628-a78356a18ba0" xlink:to="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_7af6b6df-3568-40d5-be6e-ae47ffc7d06d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_1c454917-11fc-4109-89ea-a9d5ccdd7557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_313a71eb-61f0-4472-b628-a78356a18ba0" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_1c454917-11fc-4109-89ea-a9d5ccdd7557" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_da3daab7-2a97-4c09-8911-c1d8775a3483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_1c454917-11fc-4109-89ea-a9d5ccdd7557" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_da3daab7-2a97-4c09-8911-c1d8775a3483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_da3daab7-2a97-4c09-8911-c1d8775a3483_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_da3daab7-2a97-4c09-8911-c1d8775a3483" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_da3daab7-2a97-4c09-8911-c1d8775a3483_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_59b1ef08-1cb0-4146-a6b6-c73130b1479b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_da3daab7-2a97-4c09-8911-c1d8775a3483" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_59b1ef08-1cb0-4146-a6b6-c73130b1479b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtMember_86d16739-4d9e-4ef5-880e-4a189077332c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_59b1ef08-1cb0-4146-a6b6-c73130b1479b" xlink:to="loc_us-gaap_ShortTermDebtMember_86d16739-4d9e-4ef5-880e-4a189077332c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditFacilitiesandShortTermDebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d453927d-caad-4806-b853-1774a40fabad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d453927d-caad-4806-b853-1774a40fabad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityIncreasableCapacity_1ceba018-67df-464f-a9c8-3c5b79ebeb71" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityIncreasableCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityIncreasableCapacity_1ceba018-67df-464f-a9c8-3c5b79ebeb71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum_2d52f3fd-5a2f-4d03-a056-3dc9f340e301" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum_2d52f3fd-5a2f-4d03-a056-3dc9f340e301" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations_0bb148eb-e9be-42cb-b68b-e426d22443ef" xlink:href="ahl-20231220.xsd#ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations_0bb148eb-e9be-42cb-b68b-e426d22443ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction_1e8e3fec-c0e9-45d0-84b9-7036487e09d2" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction_1e8e3fec-c0e9-45d0-84b9-7036487e09d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction_bf0425f2-562b-4bcc-84bb-702451393d06" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction_bf0425f2-562b-4bcc-84bb-702451393d06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfConsolidatedLeverageRatioPermitted_dab71bc2-2fcb-4a1e-90ac-617b5fb4858c" xlink:href="ahl-20231220.xsd#ahl_PercentageOfConsolidatedLeverageRatioPermitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_PercentageOfConsolidatedLeverageRatioPermitted_dab71bc2-2fcb-4a1e-90ac-617b5fb4858c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity_c110bbad-1308-4e53-b5fe-1e269129f66f" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity_c110bbad-1308-4e53-b5fe-1e269129f66f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ee0d67d7-82e7-4072-8d5c-868d5f3d1e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ee0d67d7-82e7-4072-8d5c-868d5f3d1e35" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2d32c6e-2148-4aec-ad40-56e763db582a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2d32c6e-2148-4aec-ad40-56e763db582a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_381f267c-a98f-4860-8764-b96b0c949016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_381f267c-a98f-4860-8764-b96b0c949016" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtDefaultMinimum_987dafb3-faba-4a27-a40f-e5c68d050c40" xlink:href="ahl-20231220.xsd#ahl_DebtDefaultMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_DebtDefaultMinimum_987dafb3-faba-4a27-a40f-e5c68d050c40" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_51546fda-847c-47b5-b64c-f4bc544b0251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_51546fda-847c-47b5-b64c-f4bc544b0251" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LetterOfCreditToSupportFundsAtLloyds_ab6fdf17-542e-4b65-a9c6-067118b9f139" xlink:href="ahl-20231220.xsd#ahl_LetterOfCreditToSupportFundsAtLloyds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LetterOfCreditToSupportFundsAtLloyds_ab6fdf17-542e-4b65-a9c6-067118b9f139" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FundsAtLloydsFacilityAgreement_23053c98-2742-4dc5-82e3-ee1f7da2c00b" xlink:href="ahl-20231220.xsd#ahl_FundsAtLloydsFacilityAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_FundsAtLloydsFacilityAgreement_23053c98-2742-4dc5-82e3-ee1f7da2c00b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_1d83249e-1b3b-412b-bdac-c1d505f08673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_1d83249e-1b3b-412b-bdac-c1d505f08673" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds_f9b3d300-2c1e-4c1a-bff5-f59835bc7f95" xlink:href="ahl-20231220.xsd#ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds_f9b3d300-2c1e-4c1a-bff5-f59835bc7f95" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_56d71c08-cd19-4c40-b8ee-074c56de09de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_56d71c08-cd19-4c40-b8ee-074c56de09de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_56d71c08-cd19-4c40-b8ee-074c56de09de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_56d71c08-cd19-4c40-b8ee-074c56de09de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_56d71c08-cd19-4c40-b8ee-074c56de09de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a2723c86-3a19-4231-a6d9-6d8c3a43f2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_56d71c08-cd19-4c40-b8ee-074c56de09de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a2723c86-3a19-4231-a6d9-6d8c3a43f2ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CitibankEuropeplcMember_ff9239ff-f1ca-493e-8436-a220baf948df" xlink:href="ahl-20231220.xsd#ahl_CitibankEuropeplcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a2723c86-3a19-4231-a6d9-6d8c3a43f2ed" xlink:to="loc_ahl_CitibankEuropeplcMember_ff9239ff-f1ca-493e-8436-a220baf948df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_a4a14990-ce77-43de-afe8-a810c9c686d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a2723c86-3a19-4231-a6d9-6d8c3a43f2ed" xlink:to="loc_us-gaap_SeniorNotesMember_a4a14990-ce77-43de-afe8-a810c9c686d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_CreditFacilityAxis_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f" xlink:to="loc_us-gaap_CreditFacilityDomain_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f" xlink:to="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CitibankEuropeMember_f8a1e3ef-343f-409f-91d5-f56ca2e64391" xlink:href="ahl-20231220.xsd#ahl_CitibankEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:to="loc_ahl_CitibankEuropeMember_f8a1e3ef-343f-409f-91d5-f56ca2e64391" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_5694e715-9831-4adb-a7c8-b441faee4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:to="loc_us-gaap_LetterOfCreditMember_5694e715-9831-4adb-a7c8-b441faee4f36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_9cecb555-79be-4eef-8c6c-bc8d9617cc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_9cecb555-79be-4eef-8c6c-bc8d9617cc3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_94175853-ffa9-409d-b33a-287fc4c49393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_94175853-ffa9-409d-b33a-287fc4c49393" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94175853-ffa9-409d-b33a-287fc4c49393_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_94175853-ffa9-409d-b33a-287fc4c49393" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94175853-ffa9-409d-b33a-287fc4c49393_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_93b694be-5817-42bc-b136-7d894596ea95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_94175853-ffa9-409d-b33a-287fc4c49393" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_93b694be-5817-42bc-b136-7d894596ea95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_095fcfa1-fd90-404a-8c4f-b4a521a26391" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_dei_LegalEntityAxis_095fcfa1-fd90-404a-8c4f-b4a521a26391" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_095fcfa1-fd90-404a-8c4f-b4a521a26391_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_095fcfa1-fd90-404a-8c4f-b4a521a26391" xlink:to="loc_dei_EntityDomain_095fcfa1-fd90-404a-8c4f-b4a521a26391_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_095fcfa1-fd90-404a-8c4f-b4a521a26391" xlink:to="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_33902623-b933-4087-bb9c-7acdbce79dad" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AspenUKMember_33902623-b933-4087-bb9c-7acdbce79dad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUnderwritingLimitedMember_6da251f1-6352-4e02-ae01-50b21e2f3155" xlink:href="ahl-20231220.xsd#ahl_AspenUnderwritingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AspenUnderwritingLimitedMember_6da251f1-6352-4e02-ae01-50b21e2f3155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenBermudaMember_852e4d35-54bb-4850-bb80-f6cca1f3b67b" xlink:href="ahl-20231220.xsd#ahl_AspenBermudaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AspenBermudaMember_852e4d35-54bb-4850-bb80-f6cca1f3b67b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenSpecialtyMember_92d02991-87ae-48ce-831c-05df9aad1656" xlink:href="ahl-20231220.xsd#ahl_AspenSpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AspenSpecialtyMember_92d02991-87ae-48ce-831c-05df9aad1656" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAICMember_9cf17421-ccbd-4e0e-a486-88ee784ab727" xlink:href="ahl-20231220.xsd#ahl_AAICMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AAICMember_9cf17421-ccbd-4e0e-a486-88ee784ab727" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_23168879-d627-4595-99ad-4540ae66b9b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_srt_CounterpartyNameAxis_23168879-d627-4595-99ad-4540ae66b9b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23168879-d627-4595-99ad-4540ae66b9b5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_23168879-d627-4595-99ad-4540ae66b9b5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23168879-d627-4595-99ad-4540ae66b9b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_23168879-d627-4595-99ad-4540ae66b9b5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenEuropeanMember_2d40ce90-de68-4fe4-aa17-e65d3a03fcfa" xlink:href="ahl-20231220.xsd#ahl_AspenEuropeanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_AspenEuropeanMember_2d40ce90-de68-4fe4-aa17-e65d3a03fcfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_47358c3b-5bdb-4ef2-bd22-d719a9813502" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_LloydsMember_47358c3b-5bdb-4ef2-bd22-d719a9813502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NatixisMember_2165b334-2adf-4088-9643-3aaf13542360" xlink:href="ahl-20231220.xsd#ahl_NatixisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_NatixisMember_2165b334-2adf-4088-9643-3aaf13542360" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HSBCBankUSANationalAssociationMember_a7a10443-58a0-4b9e-a240-8f0d41e797cc" xlink:href="ahl-20231220.xsd#ahl_HSBCBankUSANationalAssociationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_HSBCBankUSANationalAssociationMember_a7a10443-58a0-4b9e-a240-8f0d41e797cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeutscheMember_3a6054b8-0df6-444e-8b85-1721a4a9d226" xlink:href="ahl-20231220.xsd#ahl_DeutscheMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_DeutscheMember_3a6054b8-0df6-444e-8b85-1721a4a9d226" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CitibankEuropeMember_99733884-2e0f-4ec6-a83f-6711bd9eb29f" xlink:href="ahl-20231220.xsd#ahl_CitibankEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_CitibankEuropeMember_99733884-2e0f-4ec6-a83f-6711bd9eb29f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_d21c7462-1019-47cb-a532-ba24d33b2e0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_d21c7462-1019-47cb-a532-ba24d33b2e0c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_d21c7462-1019-47cb-a532-ba24d33b2e0c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_d21c7462-1019-47cb-a532-ba24d33b2e0c" xlink:to="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_d21c7462-1019-47cb-a532-ba24d33b2e0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_51fd9489-1a52-400d-8e7a-1983252e5e4f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_d21c7462-1019-47cb-a532-ba24d33b2e0c" xlink:to="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_51fd9489-1a52-400d-8e7a-1983252e5e4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankOfBostonMember_fe9fcbe0-c903-4995-affe-3ed30f90f9c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankOfBostonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_51fd9489-1a52-400d-8e7a-1983252e5e4f" xlink:to="loc_srt_FederalHomeLoanBankOfBostonMember_fe9fcbe0-c903-4995-affe-3ed30f90f9c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d5ec692c-4da6-40d0-a381-0c29cfa23ec2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_srt_RangeAxis_d5ec692c-4da6-40d0-a381-0c29cfa23ec2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d5ec692c-4da6-40d0-a381-0c29cfa23ec2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d5ec692c-4da6-40d0-a381-0c29cfa23ec2" xlink:to="loc_srt_RangeMember_d5ec692c-4da6-40d0-a381-0c29cfa23ec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_edecd7b9-521f-4be1-9f52-7cc5d63ced50" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d5ec692c-4da6-40d0-a381-0c29cfa23ec2" xlink:to="loc_srt_RangeMember_edecd7b9-521f-4be1-9f52-7cc5d63ced50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cd9e3a45-b36a-4b10-838d-8f75f033b3ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_edecd7b9-521f-4be1-9f52-7cc5d63ced50" xlink:to="loc_srt_MaximumMember_cd9e3a45-b36a-4b10-838d-8f75f033b3ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6ab566c6-0403-4b59-8b29-c3da09396362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6ab566c6-0403-4b59-8b29-c3da09396362" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6ab566c6-0403-4b59-8b29-c3da09396362_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6ab566c6-0403-4b59-8b29-c3da09396362" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6ab566c6-0403-4b59-8b29-c3da09396362_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3ad4ef38-920c-498e-b279-27ccd693c3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6ab566c6-0403-4b59-8b29-c3da09396362" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3ad4ef38-920c-498e-b279-27ccd693c3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a5b38b38-afc3-4b3d-9747-7fa110a28ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3ad4ef38-920c-498e-b279-27ccd693c3ae" xlink:to="loc_us-gaap_SubsequentEventMember_a5b38b38-afc3-4b3d-9747-7fa110a28ca2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#SubsequentEventsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/SubsequentEventsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_5d316f66-84fe-43c7-b582-9c8eb751c264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_58f8add9-20ac-4563-96b9-228dd04c4b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5d316f66-84fe-43c7-b582-9c8eb751c264" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_58f8add9-20ac-4563-96b9-228dd04c4b9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2aeb167f-8f25-4c83-b5cc-163d3e81f735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_5d316f66-84fe-43c7-b582-9c8eb751c264" xlink:to="loc_us-gaap_SubsequentEventTable_2aeb167f-8f25-4c83-b5cc-163d3e81f735" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1114a3f4-a056-483c-943e-3489eece8650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2aeb167f-8f25-4c83-b5cc-163d3e81f735" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1114a3f4-a056-483c-943e-3489eece8650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1114a3f4-a056-483c-943e-3489eece8650_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1114a3f4-a056-483c-943e-3489eece8650" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1114a3f4-a056-483c-943e-3489eece8650_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1b53b2a6-5ea4-4e15-8894-cada4fb46816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1114a3f4-a056-483c-943e-3489eece8650" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1b53b2a6-5ea4-4e15-8894-cada4fb46816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c55db997-7043-46be-9f4e-0ab87756064a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1b53b2a6-5ea4-4e15-8894-cada4fb46816" xlink:to="loc_us-gaap_SubsequentEventMember_c55db997-7043-46be-9f4e-0ab87756064a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_b366b154-2638-4257-86d5-dfa14b8ef107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_TradingSecurities_b366b154-2638-4257-86d5-dfa14b8ef107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6188e025-0272-4f00-af52-bf3e95985dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6188e025-0272-4f00-af52-bf3e95985dcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4b8eca07-fb0f-4963-bb70-79ad6ce416db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4b8eca07-fb0f-4963-bb70-79ad6ce416db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_a90397ea-a603-4b7d-8e73-03024f2e5401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_OtherInvestments_a90397ea-a603-4b7d-8e73-03024f2e5401" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_f80bb997-65dd-4d7e-a25b-547bc10e9dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_DueFromAffiliates_f80bb997-65dd-4d7e-a25b-547bc10e9dec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e4bd7e8-70c4-4ff8-b084-670b699018cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e4bd7e8-70c4-4ff8-b084-670b699018cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_e5355ccf-249f-4906-98b1-2ed3d35bebf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_OtherAssets_e5355ccf-249f-4906-98b1-2ed3d35bebf9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bb964346-d729-482b-86d0-6b61c99c28c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_Assets_bb964346-d729-482b-86d0-6b61c99c28c3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_d7d46440-a87f-4529-afba-53ab813eb73e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_d7d46440-a87f-4529-afba-53ab813eb73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_a86682df-b30e-4774-b077-9541b8f09719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_a86682df-b30e-4774-b077-9541b8f09719" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_55d8a93a-0a5b-4c52-a8e1-973a11da279c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_ShortTermBorrowings_55d8a93a-0a5b-4c52-a8e1-973a11da279c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6dfd7a50-9256-4851-9c3d-ad2b2567ca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_LongTermDebt_6dfd7a50-9256-4851-9c3d-ad2b2567ca3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cbf5297a-6e22-43d5-bf55-eaea6934e9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_OperatingLeaseLiability_cbf5297a-6e22-43d5-bf55-eaea6934e9db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_58ab5845-8934-49b8-aadf-8baa55a66cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_Liabilities_58ab5845-8934-49b8-aadf-8baa55a66cd4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7f834b0e-8ba2-4070-9393-1ac861e09379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_CommonStockValue_7f834b0e-8ba2-4070-9393-1ac861e09379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_056207df-309a-4579-9b7a-b8eeeaf0d2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AdditionalPaidInCapital_056207df-309a-4579-9b7a-b8eeeaf0d2dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d2a20824-c884-480b-8864-e00bcb2dbb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d2a20824-c884-480b-8864-e00bcb2dbb74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cece1ed2-e486-451e-b30b-8786497d0bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cece1ed2-e486-451e-b30b-8786497d0bc8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_57f8b152-40d2-4cd7-8306-54bf0a07323a" xlink:href="ahl-20231220.xsd#ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_57f8b152-40d2-4cd7-8306-54bf0a07323a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_815298fe-5c51-46f8-a13b-a5a7e5a7b5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_815298fe-5c51-46f8-a13b-a5a7e5a7b5c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_576c5f7b-ec6c-4fa0-b362-c84111b4a563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6a077bf-a77a-43a9-8cc9-4f115d42b485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6a077bf-a77a-43a9-8cc9-4f115d42b485" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6c0ce7bf-3873-4f27-98f9-030f721ddc76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_StockholdersEquity_6c0ce7bf-3873-4f27-98f9-030f721ddc76" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2d324ac9-6c71-49e4-88f9-f8580f6bd964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2d324ac9-6c71-49e4-88f9-f8580f6bd964" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3d0fc04e-90ab-4778-877c-e9fc14d99022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_CommonStockSharesIssued_3d0fc04e-90ab-4778-877c-e9fc14d99022" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_db0df465-cad0-4e21-85bb-c33bf562f7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_db0df465-cad0-4e21-85bb-c33bf562f7db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d38ed8e2-66c6-49e0-a01f-2400e118bbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d38ed8e2-66c6-49e0-a01f-2400e118bbf7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_1953729f-c6b6-476c-9293-3a14e3223c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_1953729f-c6b6-476c-9293-3a14e3223c90" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2b53595e-dff3-4d8d-bab9-7d9330230f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2b53595e-dff3-4d8d-bab9-7d9330230f89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_58f32f87-0e9d-4797-9bca-a628bba1eee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_58f32f87-0e9d-4797-9bca-a628bba1eee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_58f32f87-0e9d-4797-9bca-a628bba1eee5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_58f32f87-0e9d-4797-9bca-a628bba1eee5" xlink:to="loc_us-gaap_EquityComponentDomain_58f32f87-0e9d-4797-9bca-a628bba1eee5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ac3d292-7ddb-49f5-b7a0-fb8968bbffad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_58f32f87-0e9d-4797-9bca-a628bba1eee5" xlink:to="loc_us-gaap_EquityComponentDomain_5ac3d292-7ddb-49f5-b7a0-fb8968bbffad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e9cdedce-ab3e-46ce-b4b9-6d962e85df71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5ac3d292-7ddb-49f5-b7a0-fb8968bbffad" xlink:to="loc_us-gaap_RetainedEarningsMember_e9cdedce-ab3e-46ce-b4b9-6d962e85df71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2f1ec75d-37a1-4153-9c03-90132b317547" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2f1ec75d-37a1-4153-9c03-90132b317547" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2f1ec75d-37a1-4153-9c03-90132b317547_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2f1ec75d-37a1-4153-9c03-90132b317547" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2f1ec75d-37a1-4153-9c03-90132b317547_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_164e6c72-97da-4a02-adfc-2adca6b556ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2f1ec75d-37a1-4153-9c03-90132b317547" xlink:to="loc_srt_ConsolidatedEntitiesDomain_164e6c72-97da-4a02-adfc-2adca6b556ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_09dd76aa-dbbe-4e9e-be70-d942c7d1913e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_164e6c72-97da-4a02-adfc-2adca6b556ec" xlink:to="loc_srt_ParentCompanyMember_09dd76aa-dbbe-4e9e-be70-d942c7d1913e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ba821f33-fa3a-4e10-88a4-a9a401f79d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ba821f33-fa3a-4e10-88a4-a9a401f79d35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ba821f33-fa3a-4e10-88a4-a9a401f79d35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ba821f33-fa3a-4e10-88a4-a9a401f79d35" xlink:to="loc_us-gaap_ClassOfStockDomain_ba821f33-fa3a-4e10-88a4-a9a401f79d35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ba821f33-fa3a-4e10-88a4-a9a401f79d35" xlink:to="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_6595ee03-98ba-4af4-9a91-4f21cbca0c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_6595ee03-98ba-4af4-9a91-4f21cbca0c18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_f6f03c29-278b-46fc-971c-28f7c6505e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_f6f03c29-278b-46fc-971c-28f7c6505e23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_db583a14-783e-4efc-801c-282477e927ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_db583a14-783e-4efc-801c-282477e927ef" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityInNetEarningsOfSubsidiaries_fd9984fc-047c-4ee4-a68e-5674d1b79e6a" xlink:href="ahl-20231220.xsd#ahl_EquityInNetEarningsOfSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_ahl_EquityInNetEarningsOfSubsidiaries_fd9984fc-047c-4ee4-a68e-5674d1b79e6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_cda3ed28-6183-4a43-8faa-da57019c2850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_cda3ed28-6183-4a43-8faa-da57019c2850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_beac0ae3-f2c7-43db-83f5-4f287b6a0d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_beac0ae3-f2c7-43db-83f5-4f287b6a0d13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_8f2467bd-1f69-4b8b-8447-74e3f2597ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_OtherIncome_8f2467bd-1f69-4b8b-8447-74e3f2597ffb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d455a4d7-7e93-4943-bd6b-79cdda33e2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_Revenues_d455a4d7-7e93-4943-bd6b-79cdda33e2de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eee50332-7080-45c8-ad25-0fe583ca7459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eee50332-7080-45c8-ad25-0fe583ca7459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c09da2de-7b0d-449a-8c24-4bafb1ab69b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_InterestExpense_c09da2de-7b0d-449a-8c24-4bafb1ab69b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_bf59e193-4869-4656-968b-93524d30dbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_OtherExpenses_bf59e193-4869-4656-968b-93524d30dbc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2d9a6711-8ac1-4563-9e94-69b2c182b016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2d9a6711-8ac1-4563-9e94-69b2c182b016" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c529840d-00eb-4d98-b678-05dfb92b1736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c529840d-00eb-4d98-b678-05dfb92b1736" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_25d18556-3bf3-4760-bc4f-288762f62ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_ProfitLoss_25d18556-3bf3-4760-bc4f-288762f62ecc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5dc35b49-d33c-4a5c-b4c4-30d3e3e44126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5dc35b49-d33c-4a5c-b4c4-30d3e3e44126" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c74003cd-0652-4c0b-a785-ec2ac1d8bf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_NetIncomeLoss_c74003cd-0652-4c0b-a785-ec2ac1d8bf1f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:href="ahl-20231220.xsd#ahl_OtherComprehensiveIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8983cd8f-c3df-44a5-b80d-3d5e99fa259d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8983cd8f-c3df-44a5-b80d-3d5e99fa259d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_544b4167-2add-4e0a-b448-fc14bf5541fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_544b4167-2add-4e0a-b448-fc14bf5541fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5c7cac31-6243-452c-95fc-844f6bc9def4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5c7cac31-6243-452c-95fc-844f6bc9def4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dffb672e-3df4-41bb-95c3-83478ff381b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dffb672e-3df4-41bb-95c3-83478ff381b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b7a7f1fb-9900-4116-88d3-6498795b7618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b7a7f1fb-9900-4116-88d3-6498795b7618" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_6e1fc8a5-78c9-4450-a2f7-a7d566353f5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_6e1fc8a5-78c9-4450-a2f7-a7d566353f5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5138f244-df86-4380-9c29-6d6a76dcc860" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_6e1fc8a5-78c9-4450-a2f7-a7d566353f5c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5138f244-df86-4380-9c29-6d6a76dcc860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5138f244-df86-4380-9c29-6d6a76dcc860_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5138f244-df86-4380-9c29-6d6a76dcc860" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5138f244-df86-4380-9c29-6d6a76dcc860_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_93e3332b-d81a-49a4-a373-c0e17a06fa7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5138f244-df86-4380-9c29-6d6a76dcc860" xlink:to="loc_srt_ConsolidatedEntitiesDomain_93e3332b-d81a-49a4-a373-c0e17a06fa7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d3c19914-1ccf-44cf-9239-034ff46c24fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_93e3332b-d81a-49a4-a373-c0e17a06fa7f" xlink:to="loc_srt_ParentCompanyMember_d3c19914-1ccf-44cf-9239-034ff46c24fc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_99553927-8385-42eb-b3fd-50127715a846" xlink:href="ahl-20231220.xsd#ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_99553927-8385-42eb-b3fd-50127715a846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedGainsLosses_f3008373-feac-45b9-92c2-c5c0c86f9c0b" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_ahl_NetRealizedAndUnrealizedGainsLosses_f3008373-feac-45b9-92c2-c5c0c86f9c0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLossOnDerivative_0aca37bb-722c-443c-ad0e-b40fa4d0693f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLossOnDerivative"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_DerivativeLossOnDerivative_0aca37bb-722c-443c-ad0e-b40fa4d0693f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_17e87287-d8d7-4663-9be3-64d2cc7c7fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_17e87287-d8d7-4663-9be3-64d2cc7c7fb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_dd7f3027-b654-4b5f-9de8-012e78a81ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_dd7f3027-b654-4b5f-9de8-012e78a81ab2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ChangeInOtherAssets_b051b64b-8cae-4a46-a396-c20f5986d5ef" xlink:href="ahl-20231220.xsd#ahl_ChangeInOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_ahl_ChangeInOtherAssets_b051b64b-8cae-4a46-a396-c20f5986d5ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_abb38acf-a243-4bfa-88ad-e7ac33dbb363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_abb38acf-a243-4bfa-88ad-e7ac33dbb363" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_9e3ff7e1-ada9-48fd-92a8-c6f32246f109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_9e3ff7e1-ada9-48fd-92a8-c6f32246f109" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncreaseDecreaseInIntercompanyActivities_3c19ab89-d4c5-4004-8d93-175f27b46c23" xlink:href="ahl-20231220.xsd#ahl_IncreaseDecreaseInIntercompanyActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_ahl_IncreaseDecreaseInIntercompanyActivities_3c19ab89-d4c5-4004-8d93-175f27b46c23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ab14b306-ac04-4b02-bfa3-00e81b7ad2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_OperatingLeasePayments_ab14b306-ac04-4b02-bfa3-00e81b7ad2e7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_760ff4fc-0da8-4939-8d66-4905c28105ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_760ff4fc-0da8-4939-8d66-4905c28105ab" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_14fbc874-ec68-4920-9fa2-00d086501235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_14fbc874-ec68-4920-9fa2-00d086501235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_82d947b2-8e54-4dae-ba93-f80e2dada261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_82d947b2-8e54-4dae-ba93-f80e2dada261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_8f931277-0efe-46f4-898c-6a899e4ff38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_8f931277-0efe-46f4-898c-6a899e4ff38e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_ea586b1f-d5bf-4108-bf55-eaacc26d48d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_ea586b1f-d5bf-4108-bf55-eaacc26d48d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1d894bda-0c94-400c-b2ca-b79468d3634c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1d894bda-0c94-400c-b2ca-b79468d3634c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da2a6ab5-27a9-4950-98fa-f6193028270f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da2a6ab5-27a9-4950-98fa-f6193028270f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c58625ec-2b69-446b-b3c1-b41988e261c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c58625ec-2b69-446b-b3c1-b41988e261c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a6e74165-869b-4a71-bd0f-6b04d7dd7a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a6e74165-869b-4a71-bd0f-6b04d7dd7a99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5bca2e9a-056b-440f-828f-109e35ac9efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_368862c6-48d8-4529-a20a-5b5bc8c18de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_368862c6-48d8-4529-a20a-5b5bc8c18de8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_f49571d3-1603-41e9-9e62-a453fa2e7efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_f49571d3-1603-41e9-9e62-a453fa2e7efc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_49e36986-86bc-4309-9985-bfd5e8c11b2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_49e36986-86bc-4309-9985-bfd5e8c11b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_c2f8e7ba-1189-4aa9-806b-53bd9d6a0d1b" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_49e36986-86bc-4309-9985-bfd5e8c11b2b" xlink:to="loc_ahl_MVIMember_c2f8e7ba-1189-4aa9-806b-53bd9d6a0d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_69eb2e60-95f3-418e-94c7-cd2d23d5cde0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:to="loc_srt_ConsolidatedEntitiesAxis_69eb2e60-95f3-418e-94c7-cd2d23d5cde0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_69eb2e60-95f3-418e-94c7-cd2d23d5cde0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69eb2e60-95f3-418e-94c7-cd2d23d5cde0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_69eb2e60-95f3-418e-94c7-cd2d23d5cde0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a19ea9f4-5eae-409e-9a4c-5bcf52ab557d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69eb2e60-95f3-418e-94c7-cd2d23d5cde0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a19ea9f4-5eae-409e-9a4c-5bcf52ab557d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_21b76251-808c-4152-9fe7-8159a271a905" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_a19ea9f4-5eae-409e-9a4c-5bcf52ab557d" xlink:to="loc_srt_ParentCompanyMember_21b76251-808c-4152-9fe7-8159a271a905" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIIISupplementaryInsuranceInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIIISupplementaryInsuranceInformationDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ScheduleIIISupplementaryInsuranceInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts_0d4b7670-8229-426d-9b9f-74b520b2c07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts_0d4b7670-8229-426d-9b9f-74b520b2c07f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_7520a39c-36c2-4654-bf4f-24f0d534fedd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_7520a39c-36c2-4654-bf4f-24f0d534fedd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums_6ad52d83-52f0-484c-a16e-68e0ea796669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationUnearnedPremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums_6ad52d83-52f0-484c-a16e-68e0ea796669" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_486314f4-ea4a-4514-a7dc-c38d5b43f2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_PremiumsEarnedNet_486314f4-ea4a-4514-a7dc-c38d5b43f2b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome_6e1cbf8f-6091-449e-97a4-6ac391d82186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome_6e1cbf8f-6091-449e-97a4-6ac391d82186" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossesAndLossAdjustmentExpenses_91af0eca-ef43-4bd7-a648-dc708bcd31ed" xlink:href="ahl-20231220.xsd#ahl_LossesAndLossAdjustmentExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_ahl_LossesAndLossAdjustmentExpenses_91af0eca-ef43-4bd7-a648-dc708bcd31ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredPolicyAcquisitionCostOtherExpenses_7f050063-e858-4c79-a737-38815b828643" xlink:href="ahl-20231220.xsd#ahl_DeferredPolicyAcquisitionCostOtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_ahl_DeferredPolicyAcquisitionCostOtherExpenses_7f050063-e858-4c79-a737-38815b828643" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_0bdcae17-21a9-4ffa-a826-76544b633eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_PremiumsWrittenNet_0bdcae17-21a9-4ffa-a826-76544b633eae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_c6aba619-303a-4bb3-98d3-fdb598851414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_c6aba619-303a-4bb3-98d3-fdb598851414" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bfa44b07-f24e-4bef-8b7c-2c6ef79ab2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_StatementTable_bfa44b07-f24e-4bef-8b7c-2c6ef79ab2fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ed738e08-3aca-4eef-810e-685d937eb56a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bfa44b07-f24e-4bef-8b7c-2c6ef79ab2fa" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ed738e08-3aca-4eef-810e-685d937eb56a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed738e08-3aca-4eef-810e-685d937eb56a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed738e08-3aca-4eef-810e-685d937eb56a" xlink:to="loc_us-gaap_SegmentDomain_ed738e08-3aca-4eef-810e-685d937eb56a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c4540cd4-8bee-4431-9cb8-7375ff1ea342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed738e08-3aca-4eef-810e-685d937eb56a" xlink:to="loc_us-gaap_SegmentDomain_c4540cd4-8bee-4431-9cb8-7375ff1ea342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_b9ebf64e-7afc-400c-9b9c-d80026098ce1" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c4540cd4-8bee-4431-9cb8-7375ff1ea342" xlink:to="loc_ahl_ReinsuranceMember_b9ebf64e-7afc-400c-9b9c-d80026098ce1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_6b82469e-36ba-4b40-b0e9-8ab83459e956" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c4540cd4-8bee-4431-9cb8-7375ff1ea342" xlink:to="loc_ahl_InsuranceMember_6b82469e-36ba-4b40-b0e9-8ab83459e956" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleVValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleVValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ScheduleVValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ed45b921-0c5a-4dc5-8abd-05b71636a2d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ed45b921-0c5a-4dc5-8abd-05b71636a2d3" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_e0b0a28c-cb9c-4cc3-9ddf-96266817dc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_e0b0a28c-cb9c-4cc3-9ddf-96266817dc79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_22365d78-15d2-46a6-b54a-21fb8536148a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_22365d78-15d2-46a6-b54a-21fb8536148a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_97cdcc5b-3db6-4517-946b-11825ec1d1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_97cdcc5b-3db6-4517-946b-11825ec1d1a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_30675cd3-43d6-4bff-a5de-02c6a0a2d087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_30675cd3-43d6-4bff-a5de-02c6a0a2d087" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_9e29d952-403d-4e8d-89c4-e33459d11269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f42501d7-4274-4a15-9210-869150d3b78c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ed45b921-0c5a-4dc5-8abd-05b71636a2d3" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f42501d7-4274-4a15-9210-869150d3b78c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4b255243-9d52-43fd-b4a6-2c9d6cbb7525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f42501d7-4274-4a15-9210-869150d3b78c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4b255243-9d52-43fd-b4a6-2c9d6cbb7525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b255243-9d52-43fd-b4a6-2c9d6cbb7525_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4b255243-9d52-43fd-b4a6-2c9d6cbb7525" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b255243-9d52-43fd-b4a6-2c9d6cbb7525_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b140cf57-a6d9-4aff-8385-36e0418e5ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4b255243-9d52-43fd-b4a6-2c9d6cbb7525" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b140cf57-a6d9-4aff-8385-36e0418e5ec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableMember_52a5b80b-35f3-42db-bfca-7ba6d8fe8a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b140cf57-a6d9-4aff-8385-36e0418e5ec9" xlink:to="loc_us-gaap_PremiumsReceivableMember_52a5b80b-35f3-42db-bfca-7ba6d8fe8a6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_77c5b301-fae6-44f9-99ce-b0f45be68d68" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b140cf57-a6d9-4aff-8385-36e0418e5ec9" xlink:to="loc_ahl_ReinsuranceMember_77c5b301-fae6-44f9-99ce-b0f45be68d68" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_fbf92ae7-af90-4b44-82da-926c93007135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_PremiumsWrittenGross_fbf92ae7-af90-4b44-82da-926c93007135" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_ec98e9d4-b603-46ed-8d66-99e24622dd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_PremiumsWrittenNet_ec98e9d4-b603-46ed-8d66-99e24622dd52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsEarnedGross_d0abac97-1b04-4346-8463-9f506983111d" xlink:href="ahl-20231220.xsd#ahl_PremiumsEarnedGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_ahl_PremiumsEarnedGross_d0abac97-1b04-4346-8463-9f506983111d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_4d26dc5b-6132-4938-9b33-e323350c349e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_PremiumsEarnedNet_4d26dc5b-6132-4938-9b33-e323350c349e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_f294f318-c03d-411f-8382-d90f384e410b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_f294f318-c03d-411f-8382-d90f384e410b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_a4c7911e-d235-40c3-a0a8-badcee55abff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_a4c7911e-d235-40c3-a0a8-badcee55abff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5afef925-e5c6-4826-a044-943356cfee46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5afef925-e5c6-4826-a044-943356cfee46" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingIncomeLoss_7b2a25d3-5b64-4020-ac6b-655fd8abc769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_UnderwritingIncomeLoss_7b2a25d3-5b64-4020-ac6b-655fd8abc769" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateExpenses_50d18e61-e733-4703-8f9a-439858a5266b" xlink:href="ahl-20231220.xsd#ahl_CorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_ahl_CorporateExpenses_50d18e61-e733-4703-8f9a-439858a5266b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4b129a6d-130b-4ace-80ec-256c4351e05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4b129a6d-130b-4ace-80ec-256c4351e05a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_3bf1c3b8-9244-49e4-8d54-2037f540f588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_NetInvestmentIncome_3bf1c3b8-9244-49e4-8d54-2037f540f588" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_7eb834a1-5eb7-4cda-b9db-3ed2114b78ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_GainLossOnInvestments_7eb834a1-5eb7-4cda-b9db-3ed2114b78ef" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_250f04ad-495b-4053-bfcf-1d5ad7e35e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_250f04ad-495b-4053-bfcf-1d5ad7e35e48" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_50b32056-49d6-4dfb-a82f-3160fe98578a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_50b32056-49d6-4dfb-a82f-3160fe98578a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_e892607a-4c24-4ea3-abd2-3c803621b336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_e892607a-4c24-4ea3-abd2-3c803621b336" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_7dc4afb2-f191-47cb-99e6-5d0047c314ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_InterestExpenseDebt_7dc4afb2-f191-47cb-99e6-5d0047c314ff" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e61d80e4-c531-4da8-97fb-bbe8b6ec6efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e61d80e4-c531-4da8-97fb-bbe8b6ec6efd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_bf8d5f48-ea8f-45a0-9da0-bec7dbd59f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_OtherNonoperatingIncome_bf8d5f48-ea8f-45a0-9da0-bec7dbd59f06" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_21be3089-586d-4556-a6bb-1a0238fbcb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_OtherNonoperatingExpense_21be3089-586d-4556-a6bb-1a0238fbcb7f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5918740f-350b-47f2-9592-44c335454041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5918740f-350b-47f2-9592-44c335454041" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c359338c-cf8d-4eb8-a196-2d3a68b46bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c359338c-cf8d-4eb8-a196-2d3a68b46bca" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_579010ab-9c84-47f9-a558-5c2929ad85bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_ProfitLoss_579010ab-9c84-47f9-a558-5c2929ad85bb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9d2d7fd9-0eed-4637-a4e7-8307fab17e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9d2d7fd9-0eed-4637-a4e7-8307fab17e74" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_702baaea-71f1-4331-8071-7c65ac4e5304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_702baaea-71f1-4331-8071-7c65ac4e5304" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceRatiosAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossRatio_10116974-7525-4b39-aa4f-4a3c84aac266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_LossRatio_10116974-7525-4b39-aa4f-4a3c84aac266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCostRatio_8606d6f2-b3ba-4406-b91c-0d73e6b7a5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCostRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_AcquisitionCostRatio_8606d6f2-b3ba-4406-b91c-0d73e6b7a5dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_ffb53ce4-6400-42fb-9977-810da4062c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_ffb53ce4-6400-42fb-9977-810da4062c8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingExpenseRatio_eee6bcf8-1e30-4e6c-a172-679ce5d5c692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_UnderwritingExpenseRatio_eee6bcf8-1e30-4e6c-a172-679ce5d5c692" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CombinedRatio_d2bf7f47-71bc-410a-9c49-c377701181d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CombinedRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_CombinedRatio_d2bf7f47-71bc-410a-9c49-c377701181d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity_c9431ab1-c3fb-425f-9a59-0ee63edc30c4" xlink:href="ahl-20231220.xsd#ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity_c9431ab1-c3fb-425f-9a59-0ee63edc30c4" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c67c2159-e4f7-43dc-b433-2c1b08d1304d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:to="loc_srt_ConsolidationItemsAxis_c67c2159-e4f7-43dc-b433-2c1b08d1304d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c67c2159-e4f7-43dc-b433-2c1b08d1304d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c67c2159-e4f7-43dc-b433-2c1b08d1304d" xlink:to="loc_srt_ConsolidationItemsDomain_c67c2159-e4f7-43dc-b433-2c1b08d1304d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4c392330-3196-4bae-b051-f1a2bd2859f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c67c2159-e4f7-43dc-b433-2c1b08d1304d" xlink:to="loc_srt_ConsolidationItemsDomain_4c392330-3196-4bae-b051-f1a2bd2859f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fbfb35a6-680d-4b2f-b3a0-458025fa1c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4c392330-3196-4bae-b051-f1a2bd2859f0" xlink:to="loc_us-gaap_OperatingSegmentsMember_fbfb35a6-680d-4b2f-b3a0-458025fa1c4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_26d04f20-c394-43da-8b89-de622093b757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_26d04f20-c394-43da-8b89-de622093b757" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_26d04f20-c394-43da-8b89-de622093b757_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26d04f20-c394-43da-8b89-de622093b757" xlink:to="loc_us-gaap_SegmentDomain_26d04f20-c394-43da-8b89-de622093b757_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_90c86530-355f-46a3-a34d-55f4b1811969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26d04f20-c394-43da-8b89-de622093b757" xlink:to="loc_us-gaap_SegmentDomain_90c86530-355f-46a3-a34d-55f4b1811969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_3f93244a-48c5-4364-8ca1-b8d3e1cc0540" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_90c86530-355f-46a3-a34d-55f4b1811969" xlink:to="loc_ahl_ReinsuranceMember_3f93244a-48c5-4364-8ca1-b8d3e1cc0540" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_2a34c90f-cfa0-47c2-b29f-756169b74034" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_90c86530-355f-46a3-a34d-55f4b1811969" xlink:to="loc_ahl_InsuranceMember_2a34c90f-cfa0-47c2-b29f-756169b74034" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofInvestmentIncomeDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_87ce18d4-d8c7-49bb-9d39-cb40f3cc99dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_87ce18d4-d8c7-49bb-9d39-cb40f3cc99dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_cf4bf30d-719c-45e4-8711-6e4a53982d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_cf4bf30d-719c-45e4-8711-6e4a53982d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_22502f0d-426f-40a4-b729-162f8b8675b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:to="loc_us-gaap_NetInvestmentIncome_22502f0d-426f-40a4-b729-162f8b8675b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b550a9df-10c1-4e66-8e40-46096055e5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b550a9df-10c1-4e66-8e40-46096055e5cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_6d65ad5f-48ae-4040-af4c-094b75bd1d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b550a9df-10c1-4e66-8e40-46096055e5cf" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_6d65ad5f-48ae-4040-af4c-094b75bd1d2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_41acb646-0b6e-418d-b4d3-7cf93758e18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:to="loc_us-gaap_InvestmentTypeAxis_41acb646-0b6e-418d-b4d3-7cf93758e18f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_41acb646-0b6e-418d-b4d3-7cf93758e18f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_41acb646-0b6e-418d-b4d3-7cf93758e18f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_41acb646-0b6e-418d-b4d3-7cf93758e18f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_41acb646-0b6e-418d-b4d3-7cf93758e18f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_6ecb8b8e-798d-4b23-8222-4e15654f5082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_DebtSecuritiesMember_6ecb8b8e-798d-4b23-8222-4e15654f5082" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_c592e580-7fbc-447d-a4d3-dee315c0e783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_c592e580-7fbc-447d-a4d3-dee315c0e783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShorttermInvestmentTradingMember_a97dad1c-fb5b-4021-b51c-7fec2806dbc6" xlink:href="ahl-20231220.xsd#ahl_ShorttermInvestmentTradingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_ahl_ShorttermInvestmentTradingMember_a97dad1c-fb5b-4021-b51c-7fec2806dbc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_9a119d96-0cef-4d41-84db-5c3cfb1e09c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_9a119d96-0cef-4d41-84db-5c3cfb1e09c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_e49a6bbf-9cc1-4377-95d2-803f3b256eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_EquitySecuritiesMember_e49a6bbf-9cc1-4377-95d2-803f3b256eba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember_acf74f32-b42c-4848-9780-66476d4a866a" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_ahl_CatastropheBondsMember_acf74f32-b42c-4848-9780-66476d4a866a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_2fca9db2-b726-4662-ba58-759a1858d3f4" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_2fca9db2-b726-4662-ba58-759a1858d3f4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_70906a86-12f0-4c91-8ce6-9d924f924fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_70906a86-12f0-4c91-8ce6-9d924f924fa7" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_9860c376-e171-4f78-9c56-7215b61368c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_9860c376-e171-4f78-9c56-7215b61368c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_f6e8529d-b7ac-4dbf-ab35-bc7ca2887b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_f6e8529d-b7ac-4dbf-ab35-bc7ca2887b00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_9b8fb839-2b74-4446-8250-f5f0aad15cbe" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_9b8fb839-2b74-4446-8250-f5f0aad15cbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGain_cdb60d3f-c0a0-4dce-a6ab-010f1c1fbfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedGain_cdb60d3f-c0a0-4dce-a6ab-010f1c1fbfbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_b8f568f2-8e18-48f9-b4c3-471005d96870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_b8f568f2-8e18-48f9-b4c3-471005d96870" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_c5ba18c4-467c-4532-b36e-0d7a03a50c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_c5ba18c4-467c-4532-b36e-0d7a03a50c85" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_7f4d3358-7690-4331-b750-81c9eba55290" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesCatastropheBondsGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_7f4d3358-7690-4331-b750-81c9eba55290" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c683ff8c-4beb-48c5-85c6-97f9fd1c7f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c683ff8c-4beb-48c5-85c6-97f9fd1c7f72" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_ebfba64c-7d70-4d98-a404-30d2dad5384a" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_ebfba64c-7d70-4d98-a404-30d2dad5384a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_e3f79460-0b5b-4dd5-bc6f-ecf52412736e" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_e3f79460-0b5b-4dd5-bc6f-ecf52412736e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_9d4d032d-01ba-4aba-9bf4-b9fff06df2b8" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_9d4d032d-01ba-4aba-9bf4-b9fff06df2b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9131b7ad-d54b-486f-a73e-c2664269ab5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9131b7ad-d54b-486f-a73e-c2664269ab5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d8b9b5be-118d-46fa-a311-20ff8b3fcfff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d8b9b5be-118d-46fa-a311-20ff8b3fcfff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d8b9b5be-118d-46fa-a311-20ff8b3fcfff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d8b9b5be-118d-46fa-a311-20ff8b3fcfff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d8b9b5be-118d-46fa-a311-20ff8b3fcfff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fb17828b-c773-4580-b68a-30cfb3a628aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d8b9b5be-118d-46fa-a311-20ff8b3fcfff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fb17828b-c773-4580-b68a-30cfb3a628aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_66b702bc-a57d-4479-aef3-a491d4c1ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fb17828b-c773-4580-b68a-30cfb3a628aa" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_66b702bc-a57d-4479-aef3-a491d4c1ee84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a987022-b15b-4920-9691-ce3255ae6fbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a987022-b15b-4920-9691-ce3255ae6fbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2a987022-b15b-4920-9691-ce3255ae6fbf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a987022-b15b-4920-9691-ce3255ae6fbf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2a987022-b15b-4920-9691-ce3255ae6fbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a987022-b15b-4920-9691-ce3255ae6fbf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_0c80a025-c3c2-4478-924c-2f3108ba2fff" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:to="loc_ahl_MVIMember_0c80a025-c3c2-4478-924c-2f3108ba2fff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_0886e624-bf77-4fcd-8f67-236f14afa38d" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:to="loc_ahl_MultiLineReinsurerMember_0886e624-bf77-4fcd-8f67-236f14afa38d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_97cd4760-7025-47c0-b98a-fc5de347980b" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:to="loc_ahl_DigitalRiskMember_97cd4760-7025-47c0-b98a-fc5de347980b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_cc0c47b2-82c8-4200-a71d-8cdc7fcc06b1" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:to="loc_ahl_BeneAssicurazioniMember_cc0c47b2-82c8-4200-a71d-8cdc7fcc06b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_642391bd-7d67-4ef3-b9e6-417bfc240105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_us-gaap_InvestmentTypeAxis_642391bd-7d67-4ef3-b9e6-417bfc240105" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_642391bd-7d67-4ef3-b9e6-417bfc240105_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_642391bd-7d67-4ef3-b9e6-417bfc240105" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_642391bd-7d67-4ef3-b9e6-417bfc240105_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_642391bd-7d67-4ef3-b9e6-417bfc240105" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_4bbc635a-7d9a-4439-ac23-a1b2586650a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_4bbc635a-7d9a-4439-ac23-a1b2586650a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_ee08d993-fab6-41ee-a2d4-4ffbd51453a5" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_ee08d993-fab6-41ee-a2d4-4ffbd51453a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e5e41fc8-45c0-47b6-a227-f76059d06a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e5e41fc8-45c0-47b6-a227-f76059d06a1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f76d07b7-ea44-48fd-9113-c3738b1a04f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f76d07b7-ea44-48fd-9113-c3738b1a04f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f76d07b7-ea44-48fd-9113-c3738b1a04f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f76d07b7-ea44-48fd-9113-c3738b1a04f3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f76d07b7-ea44-48fd-9113-c3738b1a04f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2f8e3d80-f5ed-4af6-9bd8-a62d37791022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f76d07b7-ea44-48fd-9113-c3738b1a04f3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2f8e3d80-f5ed-4af6-9bd8-a62d37791022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_0b63a6f7-87d6-4348-94bf-d4e860b81dfe" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2f8e3d80-f5ed-4af6-9bd8-a62d37791022" xlink:to="loc_ahl_BeneAssicurazioniMember_0b63a6f7-87d6-4348-94bf-d4e860b81dfe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1ffa98c7-bbf4-4e6d-bd2d-9d5d47b96b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1ffa98c7-bbf4-4e6d-bd2d-9d5d47b96b1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00568082-d97f-4808-9aa4-4e00522ebb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00568082-d97f-4808-9aa4-4e00522ebb2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fa10237d-ae59-4152-b0a8-8ff216dc21f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fa10237d-ae59-4152-b0a8-8ff216dc21f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_43568901-1da2-4868-a222-79f8adbb3713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_43568901-1da2-4868-a222-79f8adbb3713" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ce1ac608-3204-4dea-b587-f5a99d8d9b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ce1ac608-3204-4dea-b587-f5a99d8d9b4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_b013e28d-ce82-40fc-8e0e-4636fc2306b3" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_b013e28d-ce82-40fc-8e0e-4636fc2306b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_fcff597d-7427-41c3-81f7-47c32fd43b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_fcff597d-7427-41c3-81f7-47c32fd43b92" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_511c2a90-d01e-419a-9991-bd8e82590a57" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_511c2a90-d01e-419a-9991-bd8e82590a57" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_d1a10a28-26eb-41fe-8c32-ec40b9294fdc" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_d1a10a28-26eb-41fe-8c32-ec40b9294fdc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4f90f5db-0502-4b24-bf61-6f48030d3890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4f90f5db-0502-4b24-bf61-6f48030d3890" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_3a8e1a2b-4ce2-4b93-bf1c-851e13d7e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_3a8e1a2b-4ce2-4b93-bf1c-851e13d7e70e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a1ab8770-fe05-4fe6-b82d-95bd82889d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a1ab8770-fe05-4fe6-b82d-95bd82889d67" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c214c997-efbf-4a55-8290-d83daad2969d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c214c997-efbf-4a55-8290-d83daad2969d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c214c997-efbf-4a55-8290-d83daad2969d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c214c997-efbf-4a55-8290-d83daad2969d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c214c997-efbf-4a55-8290-d83daad2969d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c214c997-efbf-4a55-8290-d83daad2969d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_bb4f8ea7-64d8-4a44-bdfb-04b33edaf33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_bb4f8ea7-64d8-4a44-bdfb-04b33edaf33e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f4732536-417d-4c4a-8823-99c5cf827319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f4732536-417d-4c4a-8823-99c5cf827319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_5d30a9af-ab80-41b6-9677-e9db5387d853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_MunicipalBondsMember_5d30a9af-ab80-41b6-9677-e9db5387d853" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_16088061-3145-466a-b313-78bbb826a9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_16088061-3145-466a-b313-78bbb826a9e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_6c1f62f5-ff0f-42c2-967c-b6bc81a59111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_6c1f62f5-ff0f-42c2-967c-b6bc81a59111" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b7d250a9-c4e8-417d-a3af-3621954b0448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b7d250a9-c4e8-417d-a3af-3621954b0448" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_ad6e8e51-afad-4d75-98e6-24c8f27f158f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_ad6e8e51-afad-4d75-98e6-24c8f27f158f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_a27d0dcd-0a97-4b60-8fd5-222db0fc1acf" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_a27d0dcd-0a97-4b60-8fd5-222db0fc1acf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_17a6b0b3-f0a5-471c-b36f-feeae01f5831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_17a6b0b3-f0a5-471c-b36f-feeae01f5831" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_654fb8f7-f1ca-4b34-9d24-d9e447d73168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_DebtSecuritiesMember_654fb8f7-f1ca-4b34-9d24-d9e447d73168" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_357af6d7-f9ec-4b84-87a5-778e4a3b913f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:to="loc_us-gaap_InvestmentTypeAxis_357af6d7-f9ec-4b84-87a5-778e4a3b913f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_357af6d7-f9ec-4b84-87a5-778e4a3b913f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_357af6d7-f9ec-4b84-87a5-778e4a3b913f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_357af6d7-f9ec-4b84-87a5-778e4a3b913f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_357af6d7-f9ec-4b84-87a5-778e4a3b913f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_bae7e81b-0931-416d-9571-6b4ed9e79a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_DebtSecuritiesMember_bae7e81b-0931-416d-9571-6b4ed9e79a2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_f648eeff-98f3-4229-b973-434fc8226907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_FixedMaturitiesMember_f648eeff-98f3-4229-b973-434fc8226907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_94871160-cc2d-4972-ba03-afd7f70cde60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_EquitySecuritiesMember_94871160-cc2d-4972-ba03-afd7f70cde60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_4752badf-2df3-4008-b19d-b9c8cc972465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_4752badf-2df3-4008-b19d-b9c8cc972465" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_8c70b5df-4a8d-4c47-8ced-e78d559b8baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_8c70b5df-4a8d-4c47-8ced-e78d559b8baf" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_b2ba3868-01c2-4a7b-b1b1-ded4468007ea" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_b2ba3868-01c2-4a7b-b1b1-ded4468007ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_298219c6-6350-4dd5-a83a-942e6e725a6b" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_298219c6-6350-4dd5-a83a-942e6e725a6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_8d69b75f-d990-42be-a4a4-d9ea40a1113c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_us-gaap_TradingSecurities_8d69b75f-d990-42be-a4a4-d9ea40a1113c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_1971073c-c218-4ee9-b639-d011ba4ebfce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_1971073c-c218-4ee9-b639-d011ba4ebfce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f567c1ae-8d81-4559-9978-e521f15d8024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f567c1ae-8d81-4559-9978-e521f15d8024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f567c1ae-8d81-4559-9978-e521f15d8024_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f567c1ae-8d81-4559-9978-e521f15d8024" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f567c1ae-8d81-4559-9978-e521f15d8024_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f567c1ae-8d81-4559-9978-e521f15d8024" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_24cf4657-3cc5-4d50-a31d-1ad8a19db799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_24cf4657-3cc5-4d50-a31d-1ad8a19db799" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_79e16fc4-e2cd-4a9d-ae1e-4c61c7bf606f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_MunicipalBondsMember_79e16fc4-e2cd-4a9d-ae1e-4c61c7bf606f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3dcccf74-eb27-4707-971d-123dc0307615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3dcccf74-eb27-4707-971d-123dc0307615" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_6bad651d-f490-411a-93bb-1e989afa81d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_6bad651d-f490-411a-93bb-1e989afa81d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_87c84359-d75d-4e14-851a-f97cf0a07750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_87c84359-d75d-4e14-851a-f97cf0a07750" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_0d0a6c75-b0c6-4599-b99d-e87c54c58733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_0d0a6c75-b0c6-4599-b99d-e87c54c58733" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_474a1a03-c653-4cfd-a55a-a01ab6f306c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_474a1a03-c653-4cfd-a55a-a01ab6f306c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d2e23c8a-cd02-4391-8d8e-86d02aa5006f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:to="loc_us-gaap_InvestmentTypeAxis_d2e23c8a-cd02-4391-8d8e-86d02aa5006f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d2e23c8a-cd02-4391-8d8e-86d02aa5006f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_d2e23c8a-cd02-4391-8d8e-86d02aa5006f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d2e23c8a-cd02-4391-8d8e-86d02aa5006f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_d2e23c8a-cd02-4391-8d8e-86d02aa5006f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember_8769be48-2811-4ba6-9f23-0e0c6ff37095" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_HighYieldLoansMember_8769be48-2811-4ba6-9f23-0e0c6ff37095" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingFixedMaturityInvestmentsMember_4c2791b8-40f3-471f-b7d2-88c96fc6e562" xlink:href="ahl-20231220.xsd#ahl_TradingFixedMaturityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_TradingFixedMaturityInvestmentsMember_4c2791b8-40f3-471f-b7d2-88c96fc6e562" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_8bb18cf7-aa85-4144-80ce-14abbaa6e8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_8bb18cf7-aa85-4144-80ce-14abbaa6e8dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember_4ece086a-6a43-448c-ad13-408afb066a50" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_CatastropheBondsMember_4ece086a-6a43-448c-ad13-408afb066a50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_cd91f670-b660-4036-8c8a-3f289d2dfe22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_cd91f670-b660-4036-8c8a-3f289d2dfe22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_afafcefd-14e5-4a45-b147-79515f9ad890" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_MiddlemarketloansMember_afafcefd-14e5-4a45-b147-79515f9ad890" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SecuritiesassetbackedMember_9c889a65-9d4a-42b3-97ef-b54ae46654f6" xlink:href="ahl-20231220.xsd#ahl_SecuritiesassetbackedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_SecuritiesassetbackedMember_9c889a65-9d4a-42b3-97ef-b54ae46654f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalSecuritiesCorporateMember_460398c1-a547-4c16-9bb8-f3fcb8d06072" xlink:href="ahl-20231220.xsd#ahl_GlobalSecuritiesCorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_GlobalSecuritiesCorporateMember_460398c1-a547-4c16-9bb8-f3fcb8d06072" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_34152bd1-f4c8-464f-ab60-599813744af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_us-gaap_EquitySecuritiesMember_34152bd1-f4c8-464f-ab60-599813744af7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_af3ff28f-bede-4bf2-915a-3db267e4de66" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_af3ff28f-bede-4bf2-915a-3db267e4de66" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_97c9d5e2-c583-4590-a6ae-2cb31ae12419" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_97c9d5e2-c583-4590-a6ae-2cb31ae12419" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalTradingMember_7312927a-16b8-4cd7-8f0f-291102579c38" xlink:href="ahl-20231220.xsd#ahl_TotalTradingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_TotalTradingMember_7312927a-16b8-4cd7-8f0f-291102579c38" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_94ef9b1a-1135-4c28-875b-d190e1d8c65d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_2d3a396b-66aa-4cd7-af16-90b02971135b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_94ef9b1a-1135-4c28-875b-d190e1d8c65d" xlink:to="loc_us-gaap_TradingSecurities_2d3a396b-66aa-4cd7-af16-90b02971135b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f7caf14a-9282-4d44-b022-4ceacbef22e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_94ef9b1a-1135-4c28-875b-d190e1d8c65d" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f7caf14a-9282-4d44-b022-4ceacbef22e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationByPropertyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_94ef9b1a-1135-4c28-875b-d190e1d8c65d" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_42ef6ed6-5256-4ea8-b658-16a28c473fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_us-gaap_GeographicDistributionAxis_42ef6ed6-5256-4ea8-b658-16a28c473fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_42ef6ed6-5256-4ea8-b658-16a28c473fed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_42ef6ed6-5256-4ea8-b658-16a28c473fed" xlink:to="loc_us-gaap_GeographicDistributionDomain_42ef6ed6-5256-4ea8-b658-16a28c473fed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_d759d0b1-d09e-4338-9bac-76055ed8f3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_42ef6ed6-5256-4ea8-b658-16a28c473fed" xlink:to="loc_us-gaap_GeographicDistributionDomain_d759d0b1-d09e-4338-9bac-76055ed8f3d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_3dd478af-94b3-47e3-9d9e-f3e32a6a7664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_d759d0b1-d09e-4338-9bac-76055ed8f3d3" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_3dd478af-94b3-47e3-9d9e-f3e32a6a7664" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_094c780d-6b04-44ab-8650-61b2fced125a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_d759d0b1-d09e-4338-9bac-76055ed8f3d3" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_094c780d-6b04-44ab-8650-61b2fced125a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_dde03cb7-2f67-4354-8100-254902d60981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_dde03cb7-2f67-4354-8100-254902d60981" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_dde03cb7-2f67-4354-8100-254902d60981_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_dde03cb7-2f67-4354-8100-254902d60981" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_dde03cb7-2f67-4354-8100-254902d60981_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_21c82132-be74-4abc-ac5f-6ba771c0407f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_dde03cb7-2f67-4354-8100-254902d60981" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_21c82132-be74-4abc-ac5f-6ba771c0407f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentNetCarryingValueMember_839c030d-ff97-440a-86cc-2a534f9e0486" xlink:href="ahl-20231220.xsd#ahl_InvestmentNetCarryingValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_21c82132-be74-4abc-ac5f-6ba771c0407f" xlink:to="loc_ahl_InvestmentNetCarryingValueMember_839c030d-ff97-440a-86cc-2a534f9e0486" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_us-gaap_InvestmentTypeAxis_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_17229f4b-9fff-4399-b4aa-993e9b0ce407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_17229f4b-9fff-4399-b4aa-993e9b0ce407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b78b9d02-f29f-4858-a12f-542676fec179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_17229f4b-9fff-4399-b4aa-993e9b0ce407" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b78b9d02-f29f-4858-a12f-542676fec179" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_18026fa6-a15f-4c26-bb87-e7f5b3744cd1" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_17229f4b-9fff-4399-b4aa-993e9b0ce407" xlink:to="loc_ahl_MiddlemarketloansMember_18026fa6-a15f-4c26-bb87-e7f5b3744cd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c2e42908-3404-4a23-8a2b-97f4dc514aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c2e42908-3404-4a23-8a2b-97f4dc514aad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c2e42908-3404-4a23-8a2b-97f4dc514aad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c2e42908-3404-4a23-8a2b-97f4dc514aad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c2e42908-3404-4a23-8a2b-97f4dc514aad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8e748157-34f1-4005-a411-893d919674b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c2e42908-3404-4a23-8a2b-97f4dc514aad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8e748157-34f1-4005-a411-893d919674b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_1aeb7fd0-e7cc-4ecc-b589-c20dae5b6d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8e748157-34f1-4005-a411-893d919674b1" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_1aeb7fd0-e7cc-4ecc-b589-c20dae5b6d5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_498457c4-5ea9-4983-b89c-453b95d1427d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8e748157-34f1-4005-a411-893d919674b1" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_498457c4-5ea9-4983-b89c-453b95d1427d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4bb0c45e-7e70-467c-afb9-2ac5850ea988" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_srt_ProductOrServiceAxis_4bb0c45e-7e70-467c-afb9-2ac5850ea988" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4bb0c45e-7e70-467c-afb9-2ac5850ea988_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4bb0c45e-7e70-467c-afb9-2ac5850ea988" xlink:to="loc_srt_ProductsAndServicesDomain_4bb0c45e-7e70-467c-afb9-2ac5850ea988_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4bb0c45e-7e70-467c-afb9-2ac5850ea988" xlink:to="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_ac7e062d-6d9f-4df1-a7c9-7ad2a03c79b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_us-gaap_ProductMember_ac7e062d-6d9f-4df1-a7c9-7ad2a03c79b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServiceMember_919640b0-81ec-418c-921f-90052d255f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_us-gaap_FinancialServiceMember_919640b0-81ec-418c-921f-90052d255f2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IndustrialServiceMember_37be4ff3-e594-4fd0-bda1-4fa51f5d6b57" xlink:href="ahl-20231220.xsd#ahl_IndustrialServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_ahl_IndustrialServiceMember_37be4ff3-e594-4fd0-bda1-4fa51f5d6b57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConsumerDiscretionaryServiceMember_c36873f8-8d9d-4ff1-991d-760639796c80" xlink:href="ahl-20231220.xsd#ahl_ConsumerDiscretionaryServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_ahl_ConsumerDiscretionaryServiceMember_c36873f8-8d9d-4ff1-991d-760639796c80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergyCommoditiesAndServiceMember_0e4e95df-8910-457c-b7de-a94f25a3fabb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnergyCommoditiesAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_us-gaap_EnergyCommoditiesAndServiceMember_0e4e95df-8910-457c-b7de-a94f25a3fabb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember_449a07f5-5987-47e9-83a5-aef6bf679e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_us-gaap_TechnologyServiceMember_449a07f5-5987-47e9-83a5-aef6bf679e18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b1439420-94e9-4a9e-a4b4-0eeb237263d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b1439420-94e9-4a9e-a4b4-0eeb237263d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b1439420-94e9-4a9e-a4b4-0eeb237263d4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b1439420-94e9-4a9e-a4b4-0eeb237263d4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b1439420-94e9-4a9e-a4b4-0eeb237263d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b1439420-94e9-4a9e-a4b4-0eeb237263d4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ApartmentBuildingMember_052828f3-8f9b-403a-8fd5-623a97915f71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ApartmentBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_ApartmentBuildingMember_052828f3-8f9b-403a-8fd5-623a97915f71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_HotelMember_2050d81e-57f9-48a1-9052-cd31d8ce0781" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_HotelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_HotelMember_2050d81e-57f9-48a1-9052-cd31d8ce0781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_2d0e6399-58e6-4a86-b9fc-887d87ce8186" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OfficeBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_OfficeBuildingMember_2d0e6399-58e6-4a86-b9fc-887d87ce8186" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_e9ba89c8-5a58-49e4-b95b-38a122defbdf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_OtherPropertyMember_e9ba89c8-5a58-49e4-b95b-38a122defbdf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailMember_dc4105f4-4abe-4169-897a-230fe483fc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_us-gaap_RetailMember_dc4105f4-4abe-4169-897a-230fe483fc67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_IndustrialPropertyMember_7ee1b8b1-7174-49bd-a667-f78670858d32" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_IndustrialPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_IndustrialPropertyMember_7ee1b8b1-7174-49bd-a667-f78670858d32" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsLoantoValueRatiosDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_6ae57723-9072-4cce-ab31-5df99ec8dd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_c390f71f-d56d-49ea-9bbf-2826a4b04165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_6ae57723-9072-4cce-ab31-5df99ec8dd8c" xlink:to="loc_us-gaap_TradingSecurities_c390f71f-d56d-49ea-9bbf-2826a4b04165" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_6ae57723-9072-4cce-ab31-5df99ec8dd8c" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_3c284c7f-0f23-4500-b245-5c13b7c4d887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:to="loc_us-gaap_InvestmentTypeAxis_3c284c7f-0f23-4500-b245-5c13b7c4d887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3c284c7f-0f23-4500-b245-5c13b7c4d887_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_3c284c7f-0f23-4500-b245-5c13b7c4d887" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3c284c7f-0f23-4500-b245-5c13b7c4d887_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0d92666c-3637-4155-932b-1d9c80ec336e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_3c284c7f-0f23-4500-b245-5c13b7c4d887" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0d92666c-3637-4155-932b-1d9c80ec336e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d2a1545b-6047-4cbd-b82b-01829cc99793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0d92666c-3637-4155-932b-1d9c80ec336e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d2a1545b-6047-4cbd-b82b-01829cc99793" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_1f3af596-8f57-409a-a84f-b7148e90dac1" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0d92666c-3637-4155-932b-1d9c80ec336e" xlink:to="loc_ahl_MiddlemarketloansMember_1f3af596-8f57-409a-a84f-b7148e90dac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:to="loc_us-gaap_LoanToValueAxis_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LoanToValueAxis_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98" xlink:to="loc_us-gaap_LoanToValueDomain_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LoanToValueAxis_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98" xlink:to="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember_5cd5de47-6a79-4f87-b1e5-a851a9755c15" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:to="loc_ahl_DebttoValueRatioLessthan50PercentMember_5cd5de47-6a79-4f87-b1e5-a851a9755c15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember_d2db72d1-9714-4e70-b3bb-249079e6d1f3" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:to="loc_ahl_DebttoValueRatio50to60PercentMember_d2db72d1-9714-4e70-b3bb-249079e6d1f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember_1b9de4be-ccc2-4fef-abb7-c17ab0ba4ecc" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:to="loc_ahl_DebttoValueRatio61to70PercentMember_1b9de4be-ccc2-4fef-abb7-c17ab0ba4ecc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_994df813-7f1a-4dee-8254-34d2d0bcdbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:to="loc_us-gaap_TradingSecurities_994df813-7f1a-4dee-8254-34d2d0bcdbdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CMLLessNonPerformingOrFutureConstruction_abf06b08-8563-4e9d-9fc2-403771596798" xlink:href="ahl-20231220.xsd#ahl_CMLLessNonPerformingOrFutureConstruction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:to="loc_ahl_CMLLessNonPerformingOrFutureConstruction_abf06b08-8563-4e9d-9fc2-403771596798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_526856fc-c32c-4dd5-b8e9-a0e42b672ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:to="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_526856fc-c32c-4dd5-b8e9-a0e42b672ce2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:to="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioAxis_9dabbd3d-077a-476a-b5d9-53b1b942a73d" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_ahl_DebtServiceCoverageRatioAxis_9dabbd3d-077a-476a-b5d9-53b1b942a73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioDomain_9dabbd3d-077a-476a-b5d9-53b1b942a73d_default" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ahl_DebtServiceCoverageRatioAxis_9dabbd3d-077a-476a-b5d9-53b1b942a73d" xlink:to="loc_ahl_DebtServiceCoverageRatioDomain_9dabbd3d-077a-476a-b5d9-53b1b942a73d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ahl_DebtServiceCoverageRatioAxis_9dabbd3d-077a-476a-b5d9-53b1b942a73d" xlink:to="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_c092fc71-fae0-4492-a040-3d1adbe5c24d" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioGreaterThan1.2xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:to="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_c092fc71-fae0-4492-a040-3d1adbe5c24d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember_92660fee-aa7b-41bf-9b63-48798895afef" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatio1.00to1.20xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:to="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember_92660fee-aa7b-41bf-9b63-48798895afef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember_83107bfa-a74c-41fa-a141-a2470fcd0434" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioLessThan1.00xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:to="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember_83107bfa-a74c-41fa-a141-a2470fcd0434" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7cd2dd2a-ca32-48ea-841b-5ec544164327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_us-gaap_InvestmentTypeAxis_7cd2dd2a-ca32-48ea-841b-5ec544164327" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7cd2dd2a-ca32-48ea-841b-5ec544164327_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_7cd2dd2a-ca32-48ea-841b-5ec544164327" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7cd2dd2a-ca32-48ea-841b-5ec544164327_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0b60044b-769a-4a8a-96d4-7cfecfa8ecab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_7cd2dd2a-ca32-48ea-841b-5ec544164327" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0b60044b-769a-4a8a-96d4-7cfecfa8ecab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b51554b2-d1e6-436d-8166-4a50142066a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0b60044b-769a-4a8a-96d4-7cfecfa8ecab" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b51554b2-d1e6-436d-8166-4a50142066a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_d02de8c9-a148-49ba-8c23-c01b712a5399" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0b60044b-769a-4a8a-96d4-7cfecfa8ecab" xlink:to="loc_ahl_MiddlemarketloansMember_d02de8c9-a148-49ba-8c23-c01b712a5399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_90c202a2-eb5d-4671-9e66-20407b2ef3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_us-gaap_LoanToValueAxis_90c202a2-eb5d-4671-9e66-20407b2ef3c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_90c202a2-eb5d-4671-9e66-20407b2ef3c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LoanToValueAxis_90c202a2-eb5d-4671-9e66-20407b2ef3c2" xlink:to="loc_us-gaap_LoanToValueDomain_90c202a2-eb5d-4671-9e66-20407b2ef3c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LoanToValueAxis_90c202a2-eb5d-4671-9e66-20407b2ef3c2" xlink:to="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember_79f81b3f-dfa4-4419-8ae8-0b06c8a261fa" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:to="loc_ahl_DebttoValueRatioLessthan50PercentMember_79f81b3f-dfa4-4419-8ae8-0b06c8a261fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember_fab8d308-deee-4fc8-8e2c-3d81cb091c69" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:to="loc_ahl_DebttoValueRatio50to60PercentMember_fab8d308-deee-4fc8-8e2c-3d81cb091c69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember_bb5ad5b6-ae27-43b6-8ea0-6b478ed23642" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:to="loc_ahl_DebttoValueRatio61to70PercentMember_bb5ad5b6-ae27-43b6-8ea0-6b478ed23642" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_03a2e57d-baac-48a9-92fc-e49ffa277db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_03a2e57d-baac-48a9-92fc-e49ffa277db4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_03a2e57d-baac-48a9-92fc-e49ffa277db4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_03a2e57d-baac-48a9-92fc-e49ffa277db4" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_03a2e57d-baac-48a9-92fc-e49ffa277db4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d1a05f2d-a56e-483d-b749-8a5c33380275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_03a2e57d-baac-48a9-92fc-e49ffa277db4" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d1a05f2d-a56e-483d-b749-8a5c33380275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonperformingFinancingReceivableMember_64d4d3f3-2e19-420c-8d3e-2e7fa2704a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonperformingFinancingReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d1a05f2d-a56e-483d-b749-8a5c33380275" xlink:to="loc_us-gaap_NonperformingFinancingReceivableMember_64d4d3f3-2e19-420c-8d3e-2e7fa2704a70" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsOtherInvestmentsDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1aeb7e91-c236-4ebc-ad09-6905af97d23c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:href="ahl-20231220.xsd#ahl_EquityMethodInvestmentAggregateCostRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1aeb7e91-c236-4ebc-ad09-6905af97d23c" xlink:to="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d2eab0-bf40-4493-a634-ab371a7e8400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d2eab0-bf40-4493-a634-ab371a7e8400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8e861edd-582a-47d8-823e-f0b40e44b379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8e861edd-582a-47d8-823e-f0b40e44b379" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_94309684-8ee8-49a9-a338-c4297d1f3304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_94309684-8ee8-49a9-a338-c4297d1f3304" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_449be330-0d53-4eb8-9904-85a4f5903aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_c4706ede-19ed-4b93-b0ba-f3959bb7f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1aeb7e91-c236-4ebc-ad09-6905af97d23c" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_c4706ede-19ed-4b93-b0ba-f3959bb7f0e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1aeb7e91-c236-4ebc-ad09-6905af97d23c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b52d255c-ff18-4e45-b2ff-48a030342bd0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b52d255c-ff18-4e45-b2ff-48a030342bd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b52d255c-ff18-4e45-b2ff-48a030342bd0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b52d255c-ff18-4e45-b2ff-48a030342bd0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b52d255c-ff18-4e45-b2ff-48a030342bd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b52d255c-ff18-4e45-b2ff-48a030342bd0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_56742b45-3105-4319-9fdb-2c63437eb77b" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:to="loc_ahl_MVIMember_56742b45-3105-4319-9fdb-2c63437eb77b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_32065b10-52bf-4276-8329-a98364bd0946" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:to="loc_ahl_DigitalRiskMember_32065b10-52bf-4276-8329-a98364bd0946" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_562ec5e6-bd7b-471e-a0ac-d20339cc9839" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:to="loc_ahl_MultiLineReinsurerMember_562ec5e6-bd7b-471e-a0ac-d20339cc9839" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0dee6d59-d8bb-4180-9438-51b1d49539d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0dee6d59-d8bb-4180-9438-51b1d49539d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0dee6d59-d8bb-4180-9438-51b1d49539d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0dee6d59-d8bb-4180-9438-51b1d49539d3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0dee6d59-d8bb-4180-9438-51b1d49539d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7a83e275-d289-42c0-ab7a-63dbee1fc0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0dee6d59-d8bb-4180-9438-51b1d49539d3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7a83e275-d289-42c0-ab7a-63dbee1fc0d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8b9e67f9-c641-4058-865d-3f9be1d5321d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7a83e275-d289-42c0-ab7a-63dbee1fc0d5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8b9e67f9-c641-4058-865d-3f9be1d5321d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_6268ee33-8f83-41ca-94a6-d6732b553ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_us-gaap_InvestmentTypeAxis_6268ee33-8f83-41ca-94a6-d6732b553ee7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6268ee33-8f83-41ca-94a6-d6732b553ee7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_6268ee33-8f83-41ca-94a6-d6732b553ee7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6268ee33-8f83-41ca-94a6-d6732b553ee7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d63dcfed-4763-4c0a-86dd-fc1b908569f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_6268ee33-8f83-41ca-94a6-d6732b553ee7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d63dcfed-4763-4c0a-86dd-fc1b908569f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_5a817bfd-ba55-4dab-89b4-ea0895887a15" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_d63dcfed-4763-4c0a-86dd-fc1b908569f5" xlink:to="loc_ahl_RealEstateFundDec2017Member_5a817bfd-ba55-4dab-89b4-ea0895887a15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3a2f24d4-eaee-44c3-8479-2c2860bbe5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3a2f24d4-eaee-44c3-8479-2c2860bbe5b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_1f4716fb-e120-48de-98f1-3b5bba1fa74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3a2f24d4-eaee-44c3-8479-2c2860bbe5b9" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_1f4716fb-e120-48de-98f1-3b5bba1fa74e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofFixedMaturitiesDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5daddae9-ce74-4571-8b3f-df27ba3d95db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5daddae9-ce74-4571-8b3f-df27ba3d95db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_9e531e48-9fab-429f-ad61-ba48b9e2d089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_9e531e48-9fab-429f-ad61-ba48b9e2d089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_3d5cf857-a555-4704-a831-1a2a549bec39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_3d5cf857-a555-4704-a831-1a2a549bec39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_94fda06e-3566-4d1c-9807-fbb2beaa6678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_94fda06e-3566-4d1c-9807-fbb2beaa6678" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4fad030d-f43e-4a42-b3cc-dc1f702635c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4fad030d-f43e-4a42-b3cc-dc1f702635c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9bf31a00-1d8c-4ee6-82a7-a54854477394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9bf31a00-1d8c-4ee6-82a7-a54854477394" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_835b31c7-1499-4f32-bb0f-e5f758b186fe" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_835b31c7-1499-4f32-bb0f-e5f758b186fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2b2b0ab7-22bd-4200-84d5-5844c7b0c3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2b2b0ab7-22bd-4200-84d5-5844c7b0c3fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_a19bf9e7-35ae-4c99-811e-63aab04e409b" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_a19bf9e7-35ae-4c99-811e-63aab04e409b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_ec13446a-1f13-4591-884a-d901d26b1a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_ec13446a-1f13-4591-884a-d901d26b1a66" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_b1e18931-ad94-4cb3-8842-5932daeb2463" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_b1e18931-ad94-4cb3-8842-5932daeb2463" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_a947992f-3833-461a-a58d-62d3a525b0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_a947992f-3833-461a-a58d-62d3a525b0db" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_0baaabde-a352-4abc-993d-5bb794634f83" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_0baaabde-a352-4abc-993d-5bb794634f83" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cec41d6c-c6ec-406d-bb72-462d59310af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cec41d6c-c6ec-406d-bb72-462d59310af5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_4ff19bdf-5355-4f31-98ed-5fdf260bdcde" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_4ff19bdf-5355-4f31-98ed-5fdf260bdcde" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bcfc1a5-0b88-4e2d-9ea2-e281720b5bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bcfc1a5-0b88-4e2d-9ea2-e281720b5bf2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d080ebf9-ee0a-4fab-a150-399945eeb16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bcfc1a5-0b88-4e2d-9ea2-e281720b5bf2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d080ebf9-ee0a-4fab-a150-399945eeb16f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d080ebf9-ee0a-4fab-a150-399945eeb16f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d080ebf9-ee0a-4fab-a150-399945eeb16f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d080ebf9-ee0a-4fab-a150-399945eeb16f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d080ebf9-ee0a-4fab-a150-399945eeb16f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_f071438d-d0f4-49ff-8666-484d5d3209a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_f071438d-d0f4-49ff-8666-484d5d3209a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_50ba7de5-fb3b-477e-85ef-684c51680431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_50ba7de5-fb3b-477e-85ef-684c51680431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_bc4851eb-beaf-459f-8206-af4288e78dea" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_bc4851eb-beaf-459f-8206-af4288e78dea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_683b7e1f-1f60-4e82-992d-437feb241dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:to="loc_us-gaap_FixedMaturitiesMember_683b7e1f-1f60-4e82-992d-437feb241dad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_0c10384e-10f4-417b-a03d-14178c31399c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FixedMaturitiesMember_683b7e1f-1f60-4e82-992d-437feb241dad" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_0c10384e-10f4-417b-a03d-14178c31399c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_a654a74f-4b26-4aa8-82cb-e04ceb3cc605" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_a654a74f-4b26-4aa8-82cb-e04ceb3cc605" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b1e35a7d-5c6c-4253-a11e-b98fb1769dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b1e35a7d-5c6c-4253-a11e-b98fb1769dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_50cafec6-7bc1-4246-85ae-bb52c20aad31" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_50cafec6-7bc1-4246-85ae-bb52c20aad31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4cbee3a4-b4b5-4806-98c3-5392050105d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4cbee3a4-b4b5-4806-98c3-5392050105d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_4b4a6f80-f732-4e6a-b85d-a8c4f74cdc9a" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_4b4a6f80-f732-4e6a-b85d-a8c4f74cdc9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_46087e9c-b9d9-46c2-b244-18e2f3385101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_46087e9c-b9d9-46c2-b244-18e2f3385101" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_67095a39-9554-4430-ab04-ca45b8057a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_67095a39-9554-4430-ab04-ca45b8057a99" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6ed0e13e-b017-492d-8c61-d4e92bbaea7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6ed0e13e-b017-492d-8c61-d4e92bbaea7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ed0e13e-b017-492d-8c61-d4e92bbaea7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6ed0e13e-b017-492d-8c61-d4e92bbaea7a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ed0e13e-b017-492d-8c61-d4e92bbaea7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6ed0e13e-b017-492d-8c61-d4e92bbaea7a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_4df3ab3d-5b6f-43a5-83fe-063c2d2ed692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_4df3ab3d-5b6f-43a5-83fe-063c2d2ed692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cd72b56e-0047-4e60-b97d-32225b4ec31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cd72b56e-0047-4e60-b97d-32225b4ec31e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_80d1795c-c9c4-4fa0-a20d-3da136fe8305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_MunicipalBondsMember_80d1795c-c9c4-4fa0-a20d-3da136fe8305" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b3bcb135-b4da-4dfc-a579-93bc394c434a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b3bcb135-b4da-4dfc-a579-93bc394c434a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_467fc898-c690-42b3-a0bb-f2e1075a4b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_467fc898-c690-42b3-a0bb-f2e1075a4b1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_2d6665bc-8a25-409d-8d3a-1f6ceaed4812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_2d6665bc-8a25-409d-8d3a-1f6ceaed4812" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_e9714ee7-a7f6-47a2-8112-0cee679b88bb" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_e9714ee7-a7f6-47a2-8112-0cee679b88bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_e2115f38-0cb8-4c86-a6dc-bbacab43039f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_e2115f38-0cb8-4c86-a6dc-bbacab43039f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7b113bed-9ebf-4d02-acf5-b165ef44dd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:to="loc_us-gaap_InvestmentTypeAxis_7b113bed-9ebf-4d02-acf5-b165ef44dd6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7b113bed-9ebf-4d02-acf5-b165ef44dd6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_7b113bed-9ebf-4d02-acf5-b165ef44dd6b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7b113bed-9ebf-4d02-acf5-b165ef44dd6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_46edf308-7832-40d2-95cd-0f94988a2b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_7b113bed-9ebf-4d02-acf5-b165ef44dd6b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_46edf308-7832-40d2-95cd-0f94988a2b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_1fd394fb-0f50-4b85-a45f-908a1a927761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46edf308-7832-40d2-95cd-0f94988a2b85" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_1fd394fb-0f50-4b85-a45f-908a1a927761" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_01b0ce6f-853f-412e-b465-f0e273bdf138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46edf308-7832-40d2-95cd-0f94988a2b85" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_01b0ce6f-853f-412e-b465-f0e273bdf138" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAdditionalInformationNarrativeDetails_2"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_db716038-a368-42ad-a25e-a8db3a52ac44" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_CatastropheBond_db716038-a368-42ad-a25e-a8db3a52ac44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_bda3b5df-064f-407b-bf2d-b9f942723f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_TradingSecurities_bda3b5df-064f-407b-bf2d-b9f942723f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_c8e50be8-2fa0-4235-b8ae-89cbd3b3048d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_c8e50be8-2fa0-4235-b8ae-89cbd3b3048d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5d27132-e2e9-43b6-be9a-3b052c033249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5d27132-e2e9-43b6-be9a-3b052c033249" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_bce1766f-0db5-4e84-a7fc-cbd2c12bc0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_bce1766f-0db5-4e84-a7fc-cbd2c12bc0a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_7730f2a0-fd73-4258-ae26-37fce3918e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_OtherInvestments_7730f2a0-fd73-4258-ae26-37fce3918e49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0495962e-8a8d-44af-9dbb-568822bc0787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0495962e-8a8d-44af-9dbb-568822bc0787" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_762af2e8-09a2-4276-b458-3c34a25f39d6" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_RestrictedAssets_762af2e8-09a2-4276-b458-3c34a25f39d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentFunds_2f0cb279-c8b1-4ec5-99df-103598ca9ed8" xlink:href="ahl-20231220.xsd#ahl_InvestmentFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_InvestmentFunds_2f0cb279-c8b1-4ec5-99df-103598ca9ed8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_31e6bf6a-1417-437c-811b-f944c6ffd26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_31e6bf6a-1417-437c-811b-f944c6ffd26f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f13b18d1-e268-4508-aecb-16d5b0f31e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f13b18d1-e268-4508-aecb-16d5b0f31e51" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_caf3ae11-1f69-4d16-8650-b199019a0b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_OtherCommitment_caf3ae11-1f69-4d16-8650-b199019a0b75" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2556c8b2-6a14-4272-b156-81715ed7c72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2556c8b2-6a14-4272-b156-81715ed7c72d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_8d5f3088-0d0c-4359-a6fc-dae154895c78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_8d5f3088-0d0c-4359-a6fc-dae154895c78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_2735f55b-08ef-4962-a4b8-c04ee15b9ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:to="loc_us-gaap_LimitedPartnerMember_2735f55b-08ef-4962-a4b8-c04ee15b9ffe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0820724c-efb7-4265-8f09-0ae3c102e3ae_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0820724c-efb7-4265-8f09-0ae3c102e3ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_c4ef4fa8-03ec-42b2-9eba-cda4ea8b5936" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_BeneAssicurazioniMember_c4ef4fa8-03ec-42b2-9eba-cda4ea8b5936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_c0b1ebc3-fde0-4215-b9bc-98163b20f5a7" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_MVIMember_c0b1ebc3-fde0-4215-b9bc-98163b20f5a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_afed5716-0b43-4bde-94d2-7fbab6ab5550" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_DigitalRiskMember_afed5716-0b43-4bde-94d2-7fbab6ab5550" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_b127523c-3d2f-46c0-9109-dfbfe648c82e" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_MultiLineReinsurerMember_b127523c-3d2f-46c0-9109-dfbfe648c82e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e2cae724-eecf-4984-8ecd-79f8bc0473d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e2cae724-eecf-4984-8ecd-79f8bc0473d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_72a15c43-0590-4dcd-8134-e94363ccdf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_us-gaap_RealEstateFundsMember_72a15c43-0590-4dcd-8134-e94363ccdf17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6db8fc34-03e8-4c57-89c8-852c7d028191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6db8fc34-03e8-4c57-89c8-852c7d028191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_34df10c0-7a60-49fb-8383-2c8472cbbc30" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_MiddlemarketloansMember_34df10c0-7a60-49fb-8383-2c8472cbbc30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_963c2227-5c28-411c-8d26-18b2aca90f31" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_963c2227-5c28-411c-8d26-18b2aca90f31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_7cd4db94-fde6-43e9-8a64-96acf682f475" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_RealEstateFundDec2017Member_7cd4db94-fde6-43e9-8a64-96acf682f475" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundSept2021Member_01220c72-c654-4ba3-ae61-22cc5ebbfaaf" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundSept2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_RealEstateFundSept2021Member_01220c72-c654-4ba3-ae61-22cc5ebbfaaf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InfrastructureFundMember_2f6a937e-87c1-4523-b191-98fe4f777523" xlink:href="ahl-20231220.xsd#ahl_InfrastructureFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_InfrastructureFundMember_2f6a937e-87c1-4523-b191-98fe4f777523" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_36166fd8-3846-41c6-8046-53956ab47646" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_ApolloRealEstateFundMember_36166fd8-3846-41c6-8046-53956ab47646" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c54ad8c0-2e4f-45fc-849f-6b6df213678a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c54ad8c0-2e4f-45fc-849f-6b6df213678a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4fe0779b-20f3-465e-99ab-e71ea9f16889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4fe0779b-20f3-465e-99ab-e71ea9f16889" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_06f150ff-a527-446c-a851-d2faa4197620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_06f150ff-a527-446c-a851-d2faa4197620" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8b9b8376-5369-400e-adc9-2dbbede3c144_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:to="loc_us-gaap_RelatedPartyDomain_8b9b8376-5369-400e-adc9-2dbbede3c144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:to="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_766c5df1-268e-4363-ba77-00d4bb59f270" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:to="loc_ahl_ApolloRealEstateFundMember_766c5df1-268e-4363-ba77-00d4bb59f270" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_InvestmentIdentifierAxis_6e4aaba7-9bd9-4b19-9f21-1439ecfd42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap-supplement_InvestmentIdentifierAxis_6e4aaba7-9bd9-4b19-9f21-1439ecfd42ee" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_3" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAdditionalInformationNarrativeDetails_3"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_3" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_db716038-a368-42ad-a25e-a8db3a52ac44" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_CatastropheBond_db716038-a368-42ad-a25e-a8db3a52ac44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_bda3b5df-064f-407b-bf2d-b9f942723f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_TradingSecurities_bda3b5df-064f-407b-bf2d-b9f942723f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_c8e50be8-2fa0-4235-b8ae-89cbd3b3048d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_c8e50be8-2fa0-4235-b8ae-89cbd3b3048d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5d27132-e2e9-43b6-be9a-3b052c033249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5d27132-e2e9-43b6-be9a-3b052c033249" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_bce1766f-0db5-4e84-a7fc-cbd2c12bc0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_bce1766f-0db5-4e84-a7fc-cbd2c12bc0a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_7730f2a0-fd73-4258-ae26-37fce3918e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_OtherInvestments_7730f2a0-fd73-4258-ae26-37fce3918e49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0495962e-8a8d-44af-9dbb-568822bc0787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0495962e-8a8d-44af-9dbb-568822bc0787" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_762af2e8-09a2-4276-b458-3c34a25f39d6" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_RestrictedAssets_762af2e8-09a2-4276-b458-3c34a25f39d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentFunds_2f0cb279-c8b1-4ec5-99df-103598ca9ed8" xlink:href="ahl-20231220.xsd#ahl_InvestmentFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_InvestmentFunds_2f0cb279-c8b1-4ec5-99df-103598ca9ed8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_31e6bf6a-1417-437c-811b-f944c6ffd26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_31e6bf6a-1417-437c-811b-f944c6ffd26f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f13b18d1-e268-4508-aecb-16d5b0f31e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f13b18d1-e268-4508-aecb-16d5b0f31e51" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_caf3ae11-1f69-4d16-8650-b199019a0b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_OtherCommitment_caf3ae11-1f69-4d16-8650-b199019a0b75" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2556c8b2-6a14-4272-b156-81715ed7c72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2556c8b2-6a14-4272-b156-81715ed7c72d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_8d5f3088-0d0c-4359-a6fc-dae154895c78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_8d5f3088-0d0c-4359-a6fc-dae154895c78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_2735f55b-08ef-4962-a4b8-c04ee15b9ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:to="loc_us-gaap_LimitedPartnerMember_2735f55b-08ef-4962-a4b8-c04ee15b9ffe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0820724c-efb7-4265-8f09-0ae3c102e3ae_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0820724c-efb7-4265-8f09-0ae3c102e3ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_c4ef4fa8-03ec-42b2-9eba-cda4ea8b5936" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_BeneAssicurazioniMember_c4ef4fa8-03ec-42b2-9eba-cda4ea8b5936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_c0b1ebc3-fde0-4215-b9bc-98163b20f5a7" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_MVIMember_c0b1ebc3-fde0-4215-b9bc-98163b20f5a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_afed5716-0b43-4bde-94d2-7fbab6ab5550" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_DigitalRiskMember_afed5716-0b43-4bde-94d2-7fbab6ab5550" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_b127523c-3d2f-46c0-9109-dfbfe648c82e" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_MultiLineReinsurerMember_b127523c-3d2f-46c0-9109-dfbfe648c82e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e2cae724-eecf-4984-8ecd-79f8bc0473d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e2cae724-eecf-4984-8ecd-79f8bc0473d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_72a15c43-0590-4dcd-8134-e94363ccdf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_us-gaap_RealEstateFundsMember_72a15c43-0590-4dcd-8134-e94363ccdf17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6db8fc34-03e8-4c57-89c8-852c7d028191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6db8fc34-03e8-4c57-89c8-852c7d028191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_34df10c0-7a60-49fb-8383-2c8472cbbc30" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_MiddlemarketloansMember_34df10c0-7a60-49fb-8383-2c8472cbbc30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_963c2227-5c28-411c-8d26-18b2aca90f31" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_963c2227-5c28-411c-8d26-18b2aca90f31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_7cd4db94-fde6-43e9-8a64-96acf682f475" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_RealEstateFundDec2017Member_7cd4db94-fde6-43e9-8a64-96acf682f475" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundSept2021Member_01220c72-c654-4ba3-ae61-22cc5ebbfaaf" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundSept2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_RealEstateFundSept2021Member_01220c72-c654-4ba3-ae61-22cc5ebbfaaf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InfrastructureFundMember_2f6a937e-87c1-4523-b191-98fe4f777523" xlink:href="ahl-20231220.xsd#ahl_InfrastructureFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_InfrastructureFundMember_2f6a937e-87c1-4523-b191-98fe4f777523" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_36166fd8-3846-41c6-8046-53956ab47646" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_ApolloRealEstateFundMember_36166fd8-3846-41c6-8046-53956ab47646" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c54ad8c0-2e4f-45fc-849f-6b6df213678a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c54ad8c0-2e4f-45fc-849f-6b6df213678a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4fe0779b-20f3-465e-99ab-e71ea9f16889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4fe0779b-20f3-465e-99ab-e71ea9f16889" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_06f150ff-a527-446c-a851-d2faa4197620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_06f150ff-a527-446c-a851-d2faa4197620" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8b9b8376-5369-400e-adc9-2dbbede3c144_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:to="loc_us-gaap_RelatedPartyDomain_8b9b8376-5369-400e-adc9-2dbbede3c144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:to="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_766c5df1-268e-4363-ba77-00d4bb59f270" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:to="loc_ahl_ApolloRealEstateFundMember_766c5df1-268e-4363-ba77-00d4bb59f270" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_30e7d026-ab21-4bfe-937d-a8b449209853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_30e7d026-ab21-4bfe-937d-a8b449209853" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_40c3d427-c377-4fff-af35-2321acc1fcbe" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_40c3d427-c377-4fff-af35-2321acc1fcbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure_4eb1fe3c-a0ef-4c5e-b404-a9d100150825" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_ahl_CatastropheBondsFairValueDisclosure_4eb1fe3c-a0ef-4c5e-b404-a9d100150825" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_7f52ac6c-671b-4519-aec3-37ba3a876997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_DerivativeAssets_7f52ac6c-671b-4519-aec3-37ba3a876997" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_19cc8420-d55c-477b-acca-da0fa1f094ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_19cc8420-d55c-477b-acca-da0fa1f094ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_675ade14-0dc8-4b23-a7c0-bc7c0e042060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_675ade14-0dc8-4b23-a7c0-bc7c0e042060" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2c98870c-a057-41a7-a417-7a716e8689a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2c98870c-a057-41a7-a417-7a716e8689a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2c98870c-a057-41a7-a417-7a716e8689a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2c98870c-a057-41a7-a417-7a716e8689a4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2c98870c-a057-41a7-a417-7a716e8689a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2c98870c-a057-41a7-a417-7a716e8689a4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ff4ebed6-ae71-47b0-989d-bbff57d3c00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ff4ebed6-ae71-47b0-989d-bbff57d3c00e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_27754b19-0648-4184-95ca-0c980f51c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_27754b19-0648-4184-95ca-0c980f51c0f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_1db90472-2d90-4431-8f97-084f7c7534ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_MunicipalBondsMember_1db90472-2d90-4431-8f97-084f7c7534ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f84f24ab-9489-4771-8177-06df6ff0746b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f84f24ab-9489-4771-8177-06df6ff0746b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3922b7ab-b6fa-4c3e-bfd7-1c50cbe7fdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3922b7ab-b6fa-4c3e-bfd7-1c50cbe7fdc9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_c70a43d7-aa37-4173-91d2-a40cc3c2186d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_c70a43d7-aa37-4173-91d2-a40cc3c2186d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_30ac7efb-3d55-4a4b-9bdb-4bccc5317d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_30ac7efb-3d55-4a4b-9bdb-4bccc5317d12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_4b4bfba6-da1a-4c18-86b5-340d17f091b9" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_4b4bfba6-da1a-4c18-86b5-340d17f091b9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_b5487e97-6772-4333-87a3-cf4d0c934a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_b5487e97-6772-4333-87a3-cf4d0c934a4c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember_0cec1d9d-ead3-4ba9-8211-96e642983304" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_ahl_HighYieldLoansMember_0cec1d9d-ead3-4ba9-8211-96e642983304" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_af0a9ca6-c13f-49e9-94bb-a02d0beb005b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_af0a9ca6-c13f-49e9-94bb-a02d0beb005b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_af0a9ca6-c13f-49e9-94bb-a02d0beb005b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_af0a9ca6-c13f-49e9-94bb-a02d0beb005b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_af0a9ca6-c13f-49e9-94bb-a02d0beb005b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_06caf033-cfc8-4d6c-8617-f26718216f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_af0a9ca6-c13f-49e9-94bb-a02d0beb005b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_06caf033-cfc8-4d6c-8617-f26718216f78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2ac3f24b-4421-4c29-beb8-180e384b9e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_06caf033-cfc8-4d6c-8617-f26718216f78" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2ac3f24b-4421-4c29-beb8-180e384b9e63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e02d07bd-69aa-46de-8c1f-508f025d89a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e02d07bd-69aa-46de-8c1f-508f025d89a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e02d07bd-69aa-46de-8c1f-508f025d89a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e02d07bd-69aa-46de-8c1f-508f025d89a5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e02d07bd-69aa-46de-8c1f-508f025d89a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e02d07bd-69aa-46de-8c1f-508f025d89a5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5cd09526-d32d-49c1-abdb-e31eec1a3737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5cd09526-d32d-49c1-abdb-e31eec1a3737" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_79871704-2597-4c3d-8bad-33fd53a12b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_79871704-2597-4c3d-8bad-33fd53a12b8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_16c536fe-3dc7-44fe-b26b-77a7693650e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_16c536fe-3dc7-44fe-b26b-77a7693650e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d0c048d2-f5ee-4a2d-920d-ade7484fa832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_InvestmentTypeAxis_d0c048d2-f5ee-4a2d-920d-ade7484fa832" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d0c048d2-f5ee-4a2d-920d-ade7484fa832_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_d0c048d2-f5ee-4a2d-920d-ade7484fa832" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d0c048d2-f5ee-4a2d-920d-ade7484fa832_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_d0c048d2-f5ee-4a2d-920d-ade7484fa832" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_14910f99-ff95-42ac-87e8-e0176ada2fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_14910f99-ff95-42ac-87e8-e0176ada2fe6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_12bcc206-05b2-494e-8e98-fa8a704d0468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_12bcc206-05b2-494e-8e98-fa8a704d0468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_ab5ab9fa-6284-41f2-91b1-ac4495ed6007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_ab5ab9fa-6284-41f2-91b1-ac4495ed6007" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_ac303352-99e4-4608-b24e-71c81a89ffe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_ac303352-99e4-4608-b24e-71c81a89ffe0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember_7c501171-aeb3-4551-8c23-82dab490c085" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember_7c501171-aeb3-4551-8c23-82dab490c085" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_f029595a-cd9c-411c-a478-e66a9c10a718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_RealEstateFundsMember_f029595a-cd9c-411c-a478-e66a9c10a718" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_64eaadb0-fa72-43c8-b4fa-66bffe0244b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_64eaadb0-fa72-43c8-b4fa-66bffe0244b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_64eaadb0-fa72-43c8-b4fa-66bffe0244b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_64eaadb0-fa72-43c8-b4fa-66bffe0244b4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_64eaadb0-fa72-43c8-b4fa-66bffe0244b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_64eaadb0-fa72-43c8-b4fa-66bffe0244b4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_c24b829a-fa0b-48d0-9d51-a1fccb08b30d" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_c24b829a-fa0b-48d0-9d51-a1fccb08b30d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_d6425442-9e42-47ee-bec4-7e08a40d4912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_d6425442-9e42-47ee-bec4-7e08a40d4912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_53b5fe76-2c3b-4985-ba01-614f9c846ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_53b5fe76-2c3b-4985-ba01-614f9c846ca0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae94bb1-a248-4c66-be7d-7125ba6fca68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae94bb1-a248-4c66-be7d-7125ba6fca68" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9ae94bb1-a248-4c66-be7d-7125ba6fca68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae94bb1-a248-4c66-be7d-7125ba6fca68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9ae94bb1-a248-4c66-be7d-7125ba6fca68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0516d9d9-06c3-4baa-ba8a-cccebd7379fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae94bb1-a248-4c66-be7d-7125ba6fca68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0516d9d9-06c3-4baa-ba8a-cccebd7379fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2ec49e90-8082-4152-9c9f-a81251997220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0516d9d9-06c3-4baa-ba8a-cccebd7379fb" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2ec49e90-8082-4152-9c9f-a81251997220" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_0d1a9589-2afc-40c3-80c6-25611ebe77ee" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0516d9d9-06c3-4baa-ba8a-cccebd7379fb" xlink:to="loc_ahl_LossPortfolioTransferMember_0d1a9589-2afc-40c3-80c6-25611ebe77ee" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsReconciliationofLevel3InputsDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1be08957-286f-424a-8e16-4d961f7a23ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1be08957-286f-424a-8e16-4d961f7a23ee" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40662945-f09e-4d1e-b9ab-b20b3bc51516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40662945-f09e-4d1e-b9ab-b20b3bc51516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_40662945-f09e-4d1e-b9ab-b20b3bc51516_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40662945-f09e-4d1e-b9ab-b20b3bc51516" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_40662945-f09e-4d1e-b9ab-b20b3bc51516_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0a6fb3ce-87a3-4d7b-a940-658d06e005f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40662945-f09e-4d1e-b9ab-b20b3bc51516" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0a6fb3ce-87a3-4d7b-a940-658d06e005f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_da919c63-42e3-41aa-a4ac-60654eb763da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0a6fb3ce-87a3-4d7b-a940-658d06e005f3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_da919c63-42e3-41aa-a4ac-60654eb763da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_249f5075-d31f-428b-a3be-bfe16e2e42b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_249f5075-d31f-428b-a3be-bfe16e2e42b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_249f5075-d31f-428b-a3be-bfe16e2e42b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_249f5075-d31f-428b-a3be-bfe16e2e42b3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_249f5075-d31f-428b-a3be-bfe16e2e42b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25ec8c25-c20b-4b8a-bbf4-027b9b6427c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_249f5075-d31f-428b-a3be-bfe16e2e42b3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25ec8c25-c20b-4b8a-bbf4-027b9b6427c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4a4d0db9-0a12-4bf7-a39f-6d6de80ebc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25ec8c25-c20b-4b8a-bbf4-027b9b6427c3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4a4d0db9-0a12-4bf7-a39f-6d6de80ebc2a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_aa182139-e2b9-44f9-b42c-cdc8cdef2d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_aa182139-e2b9-44f9-b42c-cdc8cdef2d13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_73218627-7db1-43cd-826d-c33e879a0f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_73218627-7db1-43cd-826d-c33e879a0f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e54419c2-35a9-484d-93af-7efaa7c05170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_TradingSecurities_e54419c2-35a9-484d-93af-7efaa7c05170" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_72d5f5cc-241a-48f4-b1e3-c0a71a79c892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_72d5f5cc-241a-48f4-b1e3-c0a71a79c892" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5c427db4-258d-4c42-9469-a3e9e253a90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5c427db4-258d-4c42-9469-a3e9e253a90e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_408fdff1-fc66-44f1-8bfc-f6830c0b3b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_408fdff1-fc66-44f1-8bfc-f6830c0b3b5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_dfa97a29-b144-4460-acda-e3b222a49828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_0f077b21-bfc8-40a4-b292-60fc206352f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_0f077b21-bfc8-40a4-b292-60fc206352f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bbadc0dd-6213-4f96-bfd6-aab686e0f4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bbadc0dd-6213-4f96-bfd6-aab686e0f4f4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0629b633-e35b-410d-8d98-10e9b3dfcf34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0629b633-e35b-410d-8d98-10e9b3dfcf34" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_ccc9ec3b-0004-47aa-890d-c0d0cafe42c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_ccc9ec3b-0004-47aa-890d-c0d0cafe42c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_323ca735-073b-42fc-8835-4afd3d749384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_323ca735-073b-42fc-8835-4afd3d749384" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d0198c24-7c13-49fc-b7c4-dec3be9a4554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d0198c24-7c13-49fc-b7c4-dec3be9a4554" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fab8b894-6a5f-4ff0-9f58-b2d45457c4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_b3915cb5-02f2-4d98-9712-5093c9b8b495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_b3915cb5-02f2-4d98-9712-5093c9b8b495" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_a69a84e3-8a0b-4fb0-8272-aed5c25768f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_a69a84e3-8a0b-4fb0-8272-aed5c25768f4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_eb7a2f5b-dc12-49c5-a05e-19e071a2b850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_eb7a2f5b-dc12-49c5-a05e-19e071a2b850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_eb7a2f5b-dc12-49c5-a05e-19e071a2b850_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_eb7a2f5b-dc12-49c5-a05e-19e071a2b850" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_eb7a2f5b-dc12-49c5-a05e-19e071a2b850_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e48482c8-10c3-43c9-8ad2-9f90ceafe2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_eb7a2f5b-dc12-49c5-a05e-19e071a2b850" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e48482c8-10c3-43c9-8ad2-9f90ceafe2aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_9a364fc3-8e6e-45ea-9f1a-09478e9f9c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e48482c8-10c3-43c9-8ad2-9f90ceafe2aa" xlink:to="loc_us-gaap_AssetsMember_9a364fc3-8e6e-45ea-9f1a-09478e9f9c29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fb8273e0-a773-41fb-9817-008121135c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fb8273e0-a773-41fb-9817-008121135c49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb8273e0-a773-41fb-9817-008121135c49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fb8273e0-a773-41fb-9817-008121135c49" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb8273e0-a773-41fb-9817-008121135c49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_03cb3708-8800-4e49-ab44-999325117fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fb8273e0-a773-41fb-9817-008121135c49" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_03cb3708-8800-4e49-ab44-999325117fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8ab98eaf-b227-4464-a12a-f071ef666690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_03cb3708-8800-4e49-ab44-999325117fd3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8ab98eaf-b227-4464-a12a-f071ef666690" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d32e4185-1631-40ad-9761-f770ab4b231a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_InvestmentTypeAxis_d32e4185-1631-40ad-9761-f770ab4b231a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d32e4185-1631-40ad-9761-f770ab4b231a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_d32e4185-1631-40ad-9761-f770ab4b231a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d32e4185-1631-40ad-9761-f770ab4b231a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_d32e4185-1631-40ad-9761-f770ab4b231a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_dcc57eb5-7fa9-4072-b4dc-32a5b38ac268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_dcc57eb5-7fa9-4072-b4dc-32a5b38ac268" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_8cf228a4-0ef5-4e2b-9125-833cd0e8bb3a" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_ahl_MiddlemarketloansMember_8cf228a4-0ef5-4e2b-9125-833cd0e8bb3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_a78e3224-4d20-4a96-b1ef-89fff73f9fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_a78e3224-4d20-4a96-b1ef-89fff73f9fa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember_56b7f8f7-a175-445e-984c-6df0134fd738" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_ahl_GlobalCorporateSecuritiesMember_56b7f8f7-a175-445e-984c-6df0134fd738" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_55bc5183-c7b2-434d-9e77-f1bc37eaac50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_us-gaap_EquitySecuritiesMember_55bc5183-c7b2-434d-9e77-f1bc37eaac50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_3fd75aa1-1d34-4bf0-a11c-ef514663df81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_us-gaap_PreferredStockMember_3fd75aa1-1d34-4bf0-a11c-ef514663df81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_85e94741-b7cc-4521-9db2-30c36630df4f" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_85e94741-b7cc-4521-9db2-30c36630df4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1b6e258-527e-4fe8-a5f1-a36f15dadda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1b6e258-527e-4fe8-a5f1-a36f15dadda6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1b6e258-527e-4fe8-a5f1-a36f15dadda6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1b6e258-527e-4fe8-a5f1-a36f15dadda6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1b6e258-527e-4fe8-a5f1-a36f15dadda6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c4f52fa-2ff8-40fc-a890-1925f31289c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1b6e258-527e-4fe8-a5f1-a36f15dadda6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c4f52fa-2ff8-40fc-a890-1925f31289c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c75a80b8-2caf-4cdf-9c45-4fa8e7dd4a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c4f52fa-2ff8-40fc-a890-1925f31289c3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c75a80b8-2caf-4cdf-9c45-4fa8e7dd4a04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_894c7d68-eaff-47f6-9a41-fb6902c8c4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_894c7d68-eaff-47f6-9a41-fb6902c8c4d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_894c7d68-eaff-47f6-9a41-fb6902c8c4d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_894c7d68-eaff-47f6-9a41-fb6902c8c4d4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_894c7d68-eaff-47f6-9a41-fb6902c8c4d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ba42810f-510c-4fcb-abe9-120ed8194583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_894c7d68-eaff-47f6-9a41-fb6902c8c4d4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ba42810f-510c-4fcb-abe9-120ed8194583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_25816dba-71eb-4fb8-bcd2-55039b567f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ba42810f-510c-4fcb-abe9-120ed8194583" xlink:to="loc_us-gaap_LiabilityMember_25816dba-71eb-4fb8-bcd2-55039b567f6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_22d65555-6b35-41c3-a615-8c011a720687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_22d65555-6b35-41c3-a615-8c011a720687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_9021ae56-d6e6-4695-8e8d-f1acca183351" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_22d65555-6b35-41c3-a615-8c011a720687" xlink:to="loc_ahl_LossPortfolioTransferMember_9021ae56-d6e6-4695-8e8d-f1acca183351" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsInputsUsedDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_f379b5f9-4d1d-42d3-958b-fa53923fc8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:to="loc_us-gaap_PremiumsWrittenGross_f379b5f9-4d1d-42d3-958b-fa53923fc8ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_24c36857-daa0-4248-9fe6-96f373d50edb" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_24c36857-daa0-4248-9fe6-96f373d50edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingMeasurementInput_1dac2436-cfd5-477c-9393-435e02eba36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:to="loc_us-gaap_DebtSecuritiesTradingMeasurementInput_1dac2436-cfd5-477c-9393-435e02eba36a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_223a2078-efde-4f6f-a3c2-08094f59f23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_ValuationTechniqueAxis_223a2078-efde-4f6f-a3c2-08094f59f23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_223a2078-efde-4f6f-a3c2-08094f59f23a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_223a2078-efde-4f6f-a3c2-08094f59f23a" xlink:to="loc_us-gaap_ValuationTechniqueDomain_223a2078-efde-4f6f-a3c2-08094f59f23a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_223a2078-efde-4f6f-a3c2-08094f59f23a" xlink:to="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_ab4e7a21-8b99-4065-ba54-07c1f9b01037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_ab4e7a21-8b99-4065-ba54-07c1f9b01037" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_848c9d91-c537-4edd-9530-bf3b586e6b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_848c9d91-c537-4edd-9530-bf3b586e6b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ValuationTechniqueLiquidationMethodMember_b80584fa-1a99-4134-85b9-3f1947e9c70a" xlink:href="ahl-20231220.xsd#ahl_ValuationTechniqueLiquidationMethodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:to="loc_ahl_ValuationTechniqueLiquidationMethodMember_b80584fa-1a99-4134-85b9-3f1947e9c70a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostApproachValuationTechniqueMember_6f8442d5-4a4c-4637-a71b-68ad1a098312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostApproachValuationTechniqueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:to="loc_us-gaap_CostApproachValuationTechniqueMember_6f8442d5-4a4c-4637-a71b-68ad1a098312" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_020e65fb-242e-4fa2-9ce0-e2c67ab3268e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_InvestmentTypeAxis_020e65fb-242e-4fa2-9ce0-e2c67ab3268e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_020e65fb-242e-4fa2-9ce0-e2c67ab3268e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_020e65fb-242e-4fa2-9ce0-e2c67ab3268e" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_020e65fb-242e-4fa2-9ce0-e2c67ab3268e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_020e65fb-242e-4fa2-9ce0-e2c67ab3268e" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d32ab9b9-f445-4490-9d6a-1a3ce9510ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d32ab9b9-f445-4490-9d6a-1a3ce9510ad4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_73258d16-eb02-4398-bc3b-314ddea79f5e" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_ahl_MiddlemarketloansMember_73258d16-eb02-4398-bc3b-314ddea79f5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_edff0880-d426-4d5f-b25f-d2723a7463ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_edff0880-d426-4d5f-b25f-d2723a7463ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember_744f0eb8-af57-44bf-a6c4-63c5abc0cb6a" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_ahl_GlobalCorporateSecuritiesMember_744f0eb8-af57-44bf-a6c4-63c5abc0cb6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_50a3dc87-d08d-417c-8f07-893076aad828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_50a3dc87-d08d-417c-8f07-893076aad828" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalSecuritiesCorporateMember_b82f9a0a-2c1d-4d97-acd1-a4d4145cb514" xlink:href="ahl-20231220.xsd#ahl_GlobalSecuritiesCorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_ahl_GlobalSecuritiesCorporateMember_b82f9a0a-2c1d-4d97-acd1-a4d4145cb514" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_62324c30-ad54-48b0-bc28-5e071b628f33" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_62324c30-ad54-48b0-bc28-5e071b628f33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_84391422-919c-45da-b1df-783572caddbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_84391422-919c-45da-b1df-783572caddbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_84391422-919c-45da-b1df-783572caddbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_84391422-919c-45da-b1df-783572caddbd" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_84391422-919c-45da-b1df-783572caddbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e26b5bf3-c08a-4c76-b4e4-e2bcbbd85804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_84391422-919c-45da-b1df-783572caddbd" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e26b5bf3-c08a-4c76-b4e4-e2bcbbd85804" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9ab71088-0dbc-4b29-be17-81b5096382a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e26b5bf3-c08a-4c76-b4e4-e2bcbbd85804" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9ab71088-0dbc-4b29-be17-81b5096382a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ccd5399-f74a-41bd-88bb-9e3807eda787" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_srt_RangeAxis_1ccd5399-f74a-41bd-88bb-9e3807eda787" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ccd5399-f74a-41bd-88bb-9e3807eda787_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1ccd5399-f74a-41bd-88bb-9e3807eda787" xlink:to="loc_srt_RangeMember_1ccd5399-f74a-41bd-88bb-9e3807eda787_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1ccd5399-f74a-41bd-88bb-9e3807eda787" xlink:to="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7d5a7daa-8e41-4c34-b99f-93475d4e0074" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:to="loc_srt_MinimumMember_7d5a7daa-8e41-4c34-b99f-93475d4e0074" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba163206-743a-41a3-b65b-2f9acb5951b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:to="loc_srt_MaximumMember_ba163206-743a-41a3-b65b-2f9acb5951b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_bdeca634-9a46-4145-be54-eb35fad9341b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:to="loc_srt_WeightedAverageMember_bdeca634-9a46-4145-be54-eb35fad9341b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb9827a1-7b23-41ea-ac04-b778ec7f17e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb9827a1-7b23-41ea-ac04-b778ec7f17e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb9827a1-7b23-41ea-ac04-b778ec7f17e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb9827a1-7b23-41ea-ac04-b778ec7f17e2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb9827a1-7b23-41ea-ac04-b778ec7f17e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_153dbc11-701d-43f0-9893-803d2b01bfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb9827a1-7b23-41ea-ac04-b778ec7f17e2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_153dbc11-701d-43f0-9893-803d2b01bfc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9e38ece6-30df-4177-8ca8-fdce37493948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_153dbc11-701d-43f0-9893-803d2b01bfc3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9e38ece6-30df-4177-8ca8-fdce37493948" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsAdditionalInformationNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_8bd98290-b9cd-4087-ae09-50cb2d763470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_8bd98290-b9cd-4087-ae09-50cb2d763470" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_26634188-5436-4629-823d-4caa25471467" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_26634188-5436-4629-823d-4caa25471467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_42423e78-f3a3-4906-9bd8-43015e85ff86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_42423e78-f3a3-4906-9bd8-43015e85ff86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_ded83efd-53fa-4396-83a4-e3e80b453cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_ded83efd-53fa-4396-83a4-e3e80b453cb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_38aeef28-a3ac-43fd-805a-376113fb5409" xlink:href="ahl-20231220.xsd#ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_38aeef28-a3ac-43fd-805a-376113fb5409" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_def2f811-594b-4cd3-8415-8a793d4f54a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_InvestmentTypeAxis_def2f811-594b-4cd3-8415-8a793d4f54a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_def2f811-594b-4cd3-8415-8a793d4f54a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_def2f811-594b-4cd3-8415-8a793d4f54a3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_def2f811-594b-4cd3-8415-8a793d4f54a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_61ab37a9-577d-4241-907d-8a8f114bb6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_def2f811-594b-4cd3-8415-8a793d4f54a3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_61ab37a9-577d-4241-907d-8a8f114bb6f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_db6804fe-4b7c-4aa4-a164-9c75c6512de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_61ab37a9-577d-4241-907d-8a8f114bb6f7" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_db6804fe-4b7c-4aa4-a164-9c75c6512de7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_53289b92-80d8-4efb-aa1b-aab347115fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_53289b92-80d8-4efb-aa1b-aab347115fb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_53289b92-80d8-4efb-aa1b-aab347115fb6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_53289b92-80d8-4efb-aa1b-aab347115fb6" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_53289b92-80d8-4efb-aa1b-aab347115fb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_63ca0590-55a8-4ee1-b1c4-2aab59c7d6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_53289b92-80d8-4efb-aa1b-aab347115fb6" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_63ca0590-55a8-4ee1-b1c4-2aab59c7d6ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_5045f5c8-cfe0-40b7-b081-bde67da6b3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_63ca0590-55a8-4ee1-b1c4-2aab59c7d6ce" xlink:to="loc_us-gaap_AssetsMember_5045f5c8-cfe0-40b7-b081-bde67da6b3d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_541d6ede-7069-47b3-961c-788658a3646d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_63ca0590-55a8-4ee1-b1c4-2aab59c7d6ce" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_541d6ede-7069-47b3-961c-788658a3646d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_956e0b12-d76d-4e07-ba56-d5ff77d49b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_956e0b12-d76d-4e07-ba56-d5ff77d49b5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_956e0b12-d76d-4e07-ba56-d5ff77d49b5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_956e0b12-d76d-4e07-ba56-d5ff77d49b5c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_956e0b12-d76d-4e07-ba56-d5ff77d49b5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_343c8449-151b-43e8-8880-7bc5fab0dd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_956e0b12-d76d-4e07-ba56-d5ff77d49b5c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_343c8449-151b-43e8-8880-7bc5fab0dd4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8cba925b-dc2f-48b2-aafa-d61b3a221fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_343c8449-151b-43e8-8880-7bc5fab0dd4e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8cba925b-dc2f-48b2-aafa-d61b3a221fa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f3a93ea-a227-4539-8b34-c12de9613c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f3a93ea-a227-4539-8b34-c12de9613c44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f3a93ea-a227-4539-8b34-c12de9613c44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f3a93ea-a227-4539-8b34-c12de9613c44" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f3a93ea-a227-4539-8b34-c12de9613c44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d94b418e-3b4c-4db0-a8e5-f64f2442e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f3a93ea-a227-4539-8b34-c12de9613c44" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d94b418e-3b4c-4db0-a8e5-f64f2442e98a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bbbd1602-fbf4-4adb-8a0e-a60e9daada47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d94b418e-3b4c-4db0-a8e5-f64f2442e98a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bbbd1602-fbf4-4adb-8a0e-a60e9daada47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_16114e6f-e858-4f29-b831-be384a8ad685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_16114e6f-e858-4f29-b831-be384a8ad685" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16114e6f-e858-4f29-b831-be384a8ad685_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_16114e6f-e858-4f29-b831-be384a8ad685" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16114e6f-e858-4f29-b831-be384a8ad685_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_517c0386-c6da-469f-a1f0-db64e1fc6f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_16114e6f-e858-4f29-b831-be384a8ad685" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_517c0386-c6da-469f-a1f0-db64e1fc6f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_2df8332a-bb68-48e5-9123-c56469f306e3" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_517c0386-c6da-469f-a1f0-db64e1fc6f69" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_2df8332a-bb68-48e5-9123-c56469f306e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b736b882-5e03-4862-ab5f-3f3348b2c6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b736b882-5e03-4862-ab5f-3f3348b2c6ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_27236cd7-1433-48bf-9daf-c8408f48c712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_HedgingDesignationAxis_27236cd7-1433-48bf-9daf-c8408f48c712" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_27236cd7-1433-48bf-9daf-c8408f48c712_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_27236cd7-1433-48bf-9daf-c8408f48c712" xlink:to="loc_us-gaap_HedgingDesignationDomain_27236cd7-1433-48bf-9daf-c8408f48c712_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3688a885-933d-49c1-b03e-4b52b2f19bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_27236cd7-1433-48bf-9daf-c8408f48c712" xlink:to="loc_us-gaap_HedgingDesignationDomain_3688a885-933d-49c1-b03e-4b52b2f19bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_bb948e7b-a693-4adb-abcf-428aed555ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3688a885-933d-49c1-b03e-4b52b2f19bfa" xlink:to="loc_us-gaap_NondesignatedMember_bb948e7b-a693-4adb-abcf-428aed555ecb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_6ce232fa-46b1-4b36-9699-95375d669f2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_c93a6dcd-65f3-4982-8781-bad990f5c662" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_6ce232fa-46b1-4b36-9699-95375d669f2a" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_c93a6dcd-65f3-4982-8781-bad990f5c662" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_22fd2557-fa7d-426f-b516-686ffea429fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_c93a6dcd-65f3-4982-8781-bad990f5c662" xlink:to="loc_srt_ProductOrServiceAxis_22fd2557-fa7d-426f-b516-686ffea429fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_22fd2557-fa7d-426f-b516-686ffea429fe_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_22fd2557-fa7d-426f-b516-686ffea429fe" xlink:to="loc_srt_ProductsAndServicesDomain_22fd2557-fa7d-426f-b516-686ffea429fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90c45c29-70e2-49e9-820e-e0a854f5f422" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_22fd2557-fa7d-426f-b516-686ffea429fe" xlink:to="loc_srt_ProductsAndServicesDomain_90c45c29-70e2-49e9-820e-e0a854f5f422" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceAdditionalInformationDetails_2"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_e3574f38-0764-41aa-b922-5325dcfbbef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverables_e3574f38-0764-41aa-b922-5325dcfbbef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_091081c0-8205-46fa-b42a-6bcda95396c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_091081c0-8205-46fa-b42a-6bcda95396c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_c6302968-a494-4261-9f95-c7ae906d6307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_c6302968-a494-4261-9f95-c7ae906d6307" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_4e33c6dd-ddd2-4b5b-b731-45204d6a63f5" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_4e33c6dd-ddd2-4b5b-b731-45204d6a63f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_40063a2c-0458-479b-97f2-649e425277f4" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_40063a2c-0458-479b-97f2-649e425277f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_66fe02d1-ffb1-4a00-989f-2dc294135aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_66fe02d1-ffb1-4a00-989f-2dc294135aea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5be3c921-923c-4728-a906-0f78812d24f4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:to="loc_srt_RangeMember_5be3c921-923c-4728-a906-0f78812d24f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:to="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a574fe7-7eb7-4d96-9ca6-08df108fcc78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:to="loc_srt_MaximumMember_8a574fe7-7eb7-4d96-9ca6-08df108fcc78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b69abd1b-45b4-4961-83f4-d839543d9221" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:to="loc_srt_MinimumMember_b69abd1b-45b4-4961-83f4-d839543d9221" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0eb6c159-7ea1-471f-9542-98645a54e1de_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0eb6c159-7ea1-471f-9542-98645a54e1de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_bdf6d8f0-a716-4042-af72-b4f4621780df" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:to="loc_ahl_EnstarMember_bdf6d8f0-a716-4042-af72-b4f4621780df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_f03278a2-ef75-4452-a7fd-1f49d07202ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_us-gaap_ReinsuranceContractAxis_f03278a2-ef75-4452-a7fd-1f49d07202ba" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_3" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceAdditionalInformationDetails_3"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_3" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_e3574f38-0764-41aa-b922-5325dcfbbef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverables_e3574f38-0764-41aa-b922-5325dcfbbef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_091081c0-8205-46fa-b42a-6bcda95396c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_091081c0-8205-46fa-b42a-6bcda95396c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_c6302968-a494-4261-9f95-c7ae906d6307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_c6302968-a494-4261-9f95-c7ae906d6307" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_4e33c6dd-ddd2-4b5b-b731-45204d6a63f5" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_4e33c6dd-ddd2-4b5b-b731-45204d6a63f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_40063a2c-0458-479b-97f2-649e425277f4" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_40063a2c-0458-479b-97f2-649e425277f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_66fe02d1-ffb1-4a00-989f-2dc294135aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_66fe02d1-ffb1-4a00-989f-2dc294135aea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5be3c921-923c-4728-a906-0f78812d24f4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:to="loc_srt_RangeMember_5be3c921-923c-4728-a906-0f78812d24f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:to="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a574fe7-7eb7-4d96-9ca6-08df108fcc78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:to="loc_srt_MaximumMember_8a574fe7-7eb7-4d96-9ca6-08df108fcc78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b69abd1b-45b4-4961-83f4-d839543d9221" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:to="loc_srt_MinimumMember_b69abd1b-45b4-4961-83f4-d839543d9221" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0eb6c159-7ea1-471f-9542-98645a54e1de_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0eb6c159-7ea1-471f-9542-98645a54e1de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_bdf6d8f0-a716-4042-af72-b4f4621780df" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:to="loc_ahl_EnstarMember_bdf6d8f0-a716-4042-af72-b4f4621780df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsFairValueofDerivativeInstrumentsDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_266f200a-6cdb-4666-be8b-2edfe4712856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_266f200a-6cdb-4666-be8b-2edfe4712856" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a906e673-d1eb-42b5-84c3-60d52409e871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a906e673-d1eb-42b5-84c3-60d52409e871" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_3909ca52-97e6-4745-a6d4-3c3f64d8f1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_3909ca52-97e6-4745-a6d4-3c3f64d8f1fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_14f5b0f7-2b55-400b-971f-6595a1b0f528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:to="loc_us-gaap_HedgingDesignationAxis_14f5b0f7-2b55-400b-971f-6595a1b0f528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_14f5b0f7-2b55-400b-971f-6595a1b0f528_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_14f5b0f7-2b55-400b-971f-6595a1b0f528" xlink:to="loc_us-gaap_HedgingDesignationDomain_14f5b0f7-2b55-400b-971f-6595a1b0f528_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_21b22352-56de-498d-9792-692d1cd6e965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_14f5b0f7-2b55-400b-971f-6595a1b0f528" xlink:to="loc_us-gaap_HedgingDesignationDomain_21b22352-56de-498d-9792-692d1cd6e965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_aef33dfe-6e6a-4a03-9f41-52cdfbcb7c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_21b22352-56de-498d-9792-692d1cd6e965" xlink:to="loc_us-gaap_NondesignatedMember_aef33dfe-6e6a-4a03-9f41-52cdfbcb7c19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6363814c-a6b1-499c-b333-f75e9dcb9a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_21b22352-56de-498d-9792-692d1cd6e965" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6363814c-a6b1-499c-b333-f75e9dcb9a54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8bfff456-f727-4864-9ec2-e1e0029ed882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8bfff456-f727-4864-9ec2-e1e0029ed882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8bfff456-f727-4864-9ec2-e1e0029ed882_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8bfff456-f727-4864-9ec2-e1e0029ed882" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8bfff456-f727-4864-9ec2-e1e0029ed882_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cdffd1c2-813e-4c5e-86ec-29d75c0cee2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8bfff456-f727-4864-9ec2-e1e0029ed882" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cdffd1c2-813e-4c5e-86ec-29d75c0cee2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_f34595b4-0fac-4a84-ab74-7114e808d883" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cdffd1c2-813e-4c5e-86ec-29d75c0cee2a" xlink:to="loc_ahl_DerivativeAtFairValueMember_f34595b4-0fac-4a84-ab74-7114e808d883" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_b4de4e33-f108-4548-8fa9-7ef4a9547662" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cdffd1c2-813e-4c5e-86ec-29d75c0cee2a" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_b4de4e33-f108-4548-8fa9-7ef4a9547662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_eb4e8386-4374-41ef-ba7c-d0712580e1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_eb4e8386-4374-41ef-ba7c-d0712580e1cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eb4e8386-4374-41ef-ba7c-d0712580e1cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eb4e8386-4374-41ef-ba7c-d0712580e1cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eb4e8386-4374-41ef-ba7c-d0712580e1cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cde1364b-c716-4fd4-8a29-9298f2a8f115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eb4e8386-4374-41ef-ba7c-d0712580e1cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cde1364b-c716-4fd4-8a29-9298f2a8f115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_56655462-f90c-4d7f-983b-bd1af0b63736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cde1364b-c716-4fd4-8a29-9298f2a8f115" xlink:to="loc_us-gaap_ForeignExchangeContractMember_56655462-f90c-4d7f-983b-bd1af0b63736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_c3c6e484-b987-4f65-b2b6-b6bd736a59b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cde1364b-c716-4fd4-8a29-9298f2a8f115" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_c3c6e484-b987-4f65-b2b6-b6bd736a59b9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b27434fa-63a5-43a1-b69d-5c30015fa9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_517cdd7f-bcf8-4f53-a663-16b3f64a9141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b27434fa-63a5-43a1-b69d-5c30015fa9b7" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_517cdd7f-bcf8-4f53-a663-16b3f64a9141" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_3f2cf0f6-6057-415b-8d4b-9bbbef24491f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b27434fa-63a5-43a1-b69d-5c30015fa9b7" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_3f2cf0f6-6057-415b-8d4b-9bbbef24491f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b27434fa-63a5-43a1-b69d-5c30015fa9b7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f1469439-31d1-4c2a-8baa-f66a01668b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:to="loc_us-gaap_HedgingDesignationAxis_f1469439-31d1-4c2a-8baa-f66a01668b7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f1469439-31d1-4c2a-8baa-f66a01668b7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f1469439-31d1-4c2a-8baa-f66a01668b7e" xlink:to="loc_us-gaap_HedgingDesignationDomain_f1469439-31d1-4c2a-8baa-f66a01668b7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_73ed4c4c-418b-40e9-ab6e-138b708ba3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f1469439-31d1-4c2a-8baa-f66a01668b7e" xlink:to="loc_us-gaap_HedgingDesignationDomain_73ed4c4c-418b-40e9-ab6e-138b708ba3fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_33bdbcff-6502-429d-af99-7f3aa9e548fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_73ed4c4c-418b-40e9-ab6e-138b708ba3fb" xlink:to="loc_us-gaap_NondesignatedMember_33bdbcff-6502-429d-af99-7f3aa9e548fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_35a756fd-6acf-4be9-9090-5b91894d2041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_73ed4c4c-418b-40e9-ab6e-138b708ba3fb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_35a756fd-6acf-4be9-9090-5b91894d2041" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_05f3cf2f-7c4f-40fa-8203-90ac783944cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_05f3cf2f-7c4f-40fa-8203-90ac783944cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_05f3cf2f-7c4f-40fa-8203-90ac783944cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05f3cf2f-7c4f-40fa-8203-90ac783944cd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_05f3cf2f-7c4f-40fa-8203-90ac783944cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7004855a-4e47-4eab-922e-82a17dc8844a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05f3cf2f-7c4f-40fa-8203-90ac783944cd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7004855a-4e47-4eab-922e-82a17dc8844a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_257c4bb8-6331-470e-a1ff-1a9d14950b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7004855a-4e47-4eab-922e-82a17dc8844a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_257c4bb8-6331-470e-a1ff-1a9d14950b18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a5ff49ca-969c-414f-87af-28937b7ea39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a5ff49ca-969c-414f-87af-28937b7ea39f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a5ff49ca-969c-414f-87af-28937b7ea39f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a5ff49ca-969c-414f-87af-28937b7ea39f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a5ff49ca-969c-414f-87af-28937b7ea39f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a5ff49ca-969c-414f-87af-28937b7ea39f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_428e3332-c3d4-4e05-b6b6-0e2392adc386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_428e3332-c3d4-4e05-b6b6-0e2392adc386" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_aa59459b-31b7-4930-8048-2d1a34522a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_aa59459b-31b7-4930-8048-2d1a34522a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_c715f6fb-3a97-4c73-9c55-6ebb824de95e" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_c715f6fb-3a97-4c73-9c55-6ebb824de95e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2e82955f-f9fb-463b-990f-84fc22d0ab2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2e82955f-f9fb-463b-990f-84fc22d0ab2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_340a14ef-1fce-497b-b8bf-44936e03dd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_340a14ef-1fce-497b-b8bf-44936e03dd7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_34f128e0-f27f-4827-a12b-a324c2b5bf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_34f128e0-f27f-4827-a12b-a324c2b5bf8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a2227237-3953-4712-ae18-7ffdd5ab0591" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a2227237-3953-4712-ae18-7ffdd5ab0591" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d66ab37c-93b9-4454-8521-28915d69d3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d66ab37c-93b9-4454-8521-28915d69d3a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ae0c28d9-f58e-4876-931f-26ba2d5aadf8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ae0c28d9-f58e-4876-931f-26ba2d5aadf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ae61c274-caa4-4058-8e8b-64aff2f60f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ae61c274-caa4-4058-8e8b-64aff2f60f02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_5e1304ea-a26b-458a-bd1f-0a6132116363" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:to="loc_ahl_LossPortfolioTransferMember_5e1304ea-a26b-458a-bd1f-0a6132116363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1d34214f-06bf-4d41-a950-839d9ec04e63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1d34214f-06bf-4d41-a950-839d9ec04e63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_4dc4283c-6892-48f3-99a7-0e95f2059755" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_4dc4283c-6892-48f3-99a7-0e95f2059755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a8ec5a38-bbc4-4def-b654-2ed1d336ddab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a8ec5a38-bbc4-4def-b654-2ed1d336ddab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_49f461d4-8230-4aae-aa92-cba969a15231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_49f461d4-8230-4aae-aa92-cba969a15231" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_29cf108f-7098-44c2-afb3-e88b490d6c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_29cf108f-7098-44c2-afb3-e88b490d6c5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesMember_2a38d952-d7c4-4d3e-9896-ed4b6b7ee568" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_ahl_FairValueOfDerivativesMember_2a38d952-d7c4-4d3e-9896-ed4b6b7ee568" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_76f14d75-6c45-4ddc-a0a5-230ac15d9736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:to="loc_us-gaap_HedgingDesignationDomain_76f14d75-6c45-4ddc-a0a5-230ac15d9736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:to="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e17955d0-84d5-4d6a-a329-ddd0c3c19740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:to="loc_us-gaap_NondesignatedMember_e17955d0-84d5-4d6a-a329-ddd0c3c19740" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6e007745-8e1c-4047-9547-9b90101d7e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6e007745-8e1c-4047-9547-9b90101d7e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_4439fc57-d165-4493-9696-4fcc8d44eead" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:to="loc_ahl_DerivativeAtFairValueMember_4439fc57-d165-4493-9696-4fcc8d44eead" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_9c69025d-0364-48f2-86d0-fe0a79d2866c" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_9c69025d-0364-48f2-86d0-fe0a79d2866c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52ffbb99-8b57-4698-8bc9-ab178a3384c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52ffbb99-8b57-4698-8bc9-ab178a3384c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dc1086df-5228-4462-8c2b-3888232aa02c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dc1086df-5228-4462-8c2b-3888232aa02c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8ff98888-85de-4147-b2d3-81b826b3124a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8ff98888-85de-4147-b2d3-81b826b3124a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_e6c38bd2-c508-4445-8212-c20489fe68cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:to="loc_us-gaap_LiabilityMember_e6c38bd2-c508-4445-8212-c20489fe68cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_12f5f944-588e-49c8-882c-d54d46bc2bb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_12f5f944-588e-49c8-882c-d54d46bc2bb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4f9ed9f4-15bd-4662-b141-b31085390dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4f9ed9f4-15bd-4662-b141-b31085390dfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_ef3b3b2c-63fe-48a5-83ec-b29faee9e92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_ReinsuranceContractAxis_ef3b3b2c-63fe-48a5-83ec-b29faee9e92d" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsAdditionalInformationDetails_2"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2e82955f-f9fb-463b-990f-84fc22d0ab2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2e82955f-f9fb-463b-990f-84fc22d0ab2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_340a14ef-1fce-497b-b8bf-44936e03dd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_340a14ef-1fce-497b-b8bf-44936e03dd7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_34f128e0-f27f-4827-a12b-a324c2b5bf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_34f128e0-f27f-4827-a12b-a324c2b5bf8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a2227237-3953-4712-ae18-7ffdd5ab0591" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a2227237-3953-4712-ae18-7ffdd5ab0591" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d66ab37c-93b9-4454-8521-28915d69d3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d66ab37c-93b9-4454-8521-28915d69d3a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ae0c28d9-f58e-4876-931f-26ba2d5aadf8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ae0c28d9-f58e-4876-931f-26ba2d5aadf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ae61c274-caa4-4058-8e8b-64aff2f60f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ae61c274-caa4-4058-8e8b-64aff2f60f02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_5e1304ea-a26b-458a-bd1f-0a6132116363" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:to="loc_ahl_LossPortfolioTransferMember_5e1304ea-a26b-458a-bd1f-0a6132116363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1d34214f-06bf-4d41-a950-839d9ec04e63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1d34214f-06bf-4d41-a950-839d9ec04e63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_4dc4283c-6892-48f3-99a7-0e95f2059755" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_4dc4283c-6892-48f3-99a7-0e95f2059755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a8ec5a38-bbc4-4def-b654-2ed1d336ddab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a8ec5a38-bbc4-4def-b654-2ed1d336ddab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_49f461d4-8230-4aae-aa92-cba969a15231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_49f461d4-8230-4aae-aa92-cba969a15231" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_29cf108f-7098-44c2-afb3-e88b490d6c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_29cf108f-7098-44c2-afb3-e88b490d6c5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesMember_2a38d952-d7c4-4d3e-9896-ed4b6b7ee568" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_ahl_FairValueOfDerivativesMember_2a38d952-d7c4-4d3e-9896-ed4b6b7ee568" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_76f14d75-6c45-4ddc-a0a5-230ac15d9736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:to="loc_us-gaap_HedgingDesignationDomain_76f14d75-6c45-4ddc-a0a5-230ac15d9736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:to="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e17955d0-84d5-4d6a-a329-ddd0c3c19740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:to="loc_us-gaap_NondesignatedMember_e17955d0-84d5-4d6a-a329-ddd0c3c19740" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6e007745-8e1c-4047-9547-9b90101d7e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6e007745-8e1c-4047-9547-9b90101d7e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_4439fc57-d165-4493-9696-4fcc8d44eead" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:to="loc_ahl_DerivativeAtFairValueMember_4439fc57-d165-4493-9696-4fcc8d44eead" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_9c69025d-0364-48f2-86d0-fe0a79d2866c" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_9c69025d-0364-48f2-86d0-fe0a79d2866c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52ffbb99-8b57-4698-8bc9-ab178a3384c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52ffbb99-8b57-4698-8bc9-ab178a3384c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dc1086df-5228-4462-8c2b-3888232aa02c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dc1086df-5228-4462-8c2b-3888232aa02c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8ff98888-85de-4147-b2d3-81b826b3124a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8ff98888-85de-4147-b2d3-81b826b3124a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_e6c38bd2-c508-4445-8212-c20489fe68cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:to="loc_us-gaap_LiabilityMember_e6c38bd2-c508-4445-8212-c20489fe68cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_12f5f944-588e-49c8-882c-d54d46bc2bb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_12f5f944-588e-49c8-882c-d54d46bc2bb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4f9ed9f4-15bd-4662-b141-b31085390dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4f9ed9f4-15bd-4662-b141-b31085390dfe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_2"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_3076c978-5397-4be5-9017-3452903ccb7d" xlink:href="ahl-20231220.xsd#ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_3076c978-5397-4be5-9017-3452903ccb7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_7ff77f69-8cc6-4bdf-84a7-8b38ea3ea6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_7ff77f69-8cc6-4bdf-84a7-8b38ea3ea6b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_2fadfc3f-5c29-48bb-bc2e-e65057a99c5b" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesTotalRecoverable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_2fadfc3f-5c29-48bb-bc2e-e65057a99c5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_cbff012d-95dd-450e-be26-7c3502aed526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_us-gaap_ReinsuranceRecoverables_cbff012d-95dd-450e-be26-7c3502aed526" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_e7c3f436-8928-4116-9f7b-1b6e40d600bb" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:to="loc_ahl_EnstarMember_e7c3f436-8928-4116-9f7b-1b6e40d600bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:to="loc_us-gaap_SegmentDomain_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:to="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_563b86bc-c9b1-45cc-a6a7-5e64487efa70" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:to="loc_ahl_InsuranceMember_563b86bc-c9b1-45cc-a6a7-5e64487efa70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_099e8df5-4f97-409e-8aae-e74af0fe67b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_us-gaap_ReinsuranceContractAxis_099e8df5-4f97-409e-8aae-e74af0fe67b5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_3" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_3"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_3" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_3076c978-5397-4be5-9017-3452903ccb7d" xlink:href="ahl-20231220.xsd#ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_3076c978-5397-4be5-9017-3452903ccb7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_7ff77f69-8cc6-4bdf-84a7-8b38ea3ea6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_7ff77f69-8cc6-4bdf-84a7-8b38ea3ea6b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_2fadfc3f-5c29-48bb-bc2e-e65057a99c5b" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesTotalRecoverable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_2fadfc3f-5c29-48bb-bc2e-e65057a99c5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_cbff012d-95dd-450e-be26-7c3502aed526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_us-gaap_ReinsuranceRecoverables_cbff012d-95dd-450e-be26-7c3502aed526" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_e7c3f436-8928-4116-9f7b-1b6e40d600bb" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:to="loc_ahl_EnstarMember_e7c3f436-8928-4116-9f7b-1b6e40d600bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:to="loc_us-gaap_SegmentDomain_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:to="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_563b86bc-c9b1-45cc-a6a7-5e64487efa70" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:to="loc_ahl_InsuranceMember_563b86bc-c9b1-45cc-a6a7-5e64487efa70" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_423ffe45-4844-4d69-b69b-5ab284b23520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_423ffe45-4844-4d69-b69b-5ab284b23520" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6c2418e8-10b2-4499-9c5b-25d8e924f837_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6c2418e8-10b2-4499-9c5b-25d8e924f837_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e39f7c88-a5bc-480d-96ea-4678c5c92840" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e39f7c88-a5bc-480d-96ea-4678c5c92840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_456dcf78-b027-440e-afd8-0611cb375311_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:to="loc_us-gaap_SegmentDomain_456dcf78-b027-440e-afd8-0611cb375311_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:to="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_21d22737-214c-4aef-805b-e18853d2572c" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:to="loc_ahl_ReinsuranceMember_21d22737-214c-4aef-805b-e18853d2572c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_a585fc6e-549d-41b2-9e06-7f86473c90b2" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:to="loc_ahl_InsuranceMember_a585fc6e-549d-41b2-9e06-7f86473c90b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_896c9777-dfdd-467b-bd77-5fbb23a7c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_us-gaap_ReinsuranceContractAxis_896c9777-dfdd-467b-bd77-5fbb23a7c726" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_2"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_423ffe45-4844-4d69-b69b-5ab284b23520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_423ffe45-4844-4d69-b69b-5ab284b23520" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6c2418e8-10b2-4499-9c5b-25d8e924f837_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6c2418e8-10b2-4499-9c5b-25d8e924f837_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e39f7c88-a5bc-480d-96ea-4678c5c92840" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e39f7c88-a5bc-480d-96ea-4678c5c92840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_456dcf78-b027-440e-afd8-0611cb375311_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:to="loc_us-gaap_SegmentDomain_456dcf78-b027-440e-afd8-0611cb375311_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:to="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_21d22737-214c-4aef-805b-e18853d2572c" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:to="loc_ahl_ReinsuranceMember_21d22737-214c-4aef-805b-e18853d2572c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_a585fc6e-549d-41b2-9e06-7f86473c90b2" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:to="loc_ahl_InsuranceMember_a585fc6e-549d-41b2-9e06-7f86473c90b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_2"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ecc8e52f-e0fa-408b-908a-f6ed4647b86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ecc8e52f-e0fa-408b-908a-f6ed4647b86e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_e489b6e1-dce9-4e72-b10d-4bbf84117336" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_e489b6e1-dce9-4e72-b10d-4bbf84117336" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1bd16450-15a2-4357-b618-9ac27ae66655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7d049db1-c566-4f54-8a52-cd3b48217a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7d049db1-c566-4f54-8a52-cd3b48217a21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_22e9ae9a-fea5-4eb2-95f9-c35068894047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_22e9ae9a-fea5-4eb2-95f9-c35068894047" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_bf69096f-d313-4be8-9f0a-55f4715fcc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:to="loc_us-gaap_ReinsuranceContractAxis_bf69096f-d313-4be8-9f0a-55f4715fcc3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_356324ed-eada-4d21-997e-9d72952b5f7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:to="loc_us-gaap_SegmentDomain_356324ed-eada-4d21-997e-9d72952b5f7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:to="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_a413b88b-ba6b-4f8e-86f9-a84c51ddf572" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:to="loc_ahl_ReinsuranceMember_a413b88b-ba6b-4f8e-86f9-a84c51ddf572" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_3" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_3"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_3" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ecc8e52f-e0fa-408b-908a-f6ed4647b86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ecc8e52f-e0fa-408b-908a-f6ed4647b86e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_e489b6e1-dce9-4e72-b10d-4bbf84117336" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_e489b6e1-dce9-4e72-b10d-4bbf84117336" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1bd16450-15a2-4357-b618-9ac27ae66655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7d049db1-c566-4f54-8a52-cd3b48217a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7d049db1-c566-4f54-8a52-cd3b48217a21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_22e9ae9a-fea5-4eb2-95f9-c35068894047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_22e9ae9a-fea5-4eb2-95f9-c35068894047" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_356324ed-eada-4d21-997e-9d72952b5f7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:to="loc_us-gaap_SegmentDomain_356324ed-eada-4d21-997e-9d72952b5f7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:to="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_a413b88b-ba6b-4f8e-86f9-a84c51ddf572" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:to="loc_ahl_ReinsuranceMember_a413b88b-ba6b-4f8e-86f9-a84c51ddf572" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8e025297-8aca-4cab-9a1f-38d98c266e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8e025297-8aca-4cab-9a1f-38d98c266e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_65afd4a4-5a40-406f-87a4-90201093a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_65afd4a4-5a40-406f-87a4-90201093a80a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CommonStockValueAuthorized_f2e39756-23de-4d50-8d78-a8b2b56d9df0" xlink:href="ahl-20231220.xsd#ahl_CommonStockValueAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_ahl_CommonStockValueAuthorized_f2e39756-23de-4d50-8d78-a8b2b56d9df0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockValueAuthorized_44f9a2f7-c8a1-49b7-a434-b4cde0421255" xlink:href="ahl-20231220.xsd#ahl_PreferredStockValueAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_ahl_PreferredStockValueAuthorized_44f9a2f7-c8a1-49b7-a434-b4cde0421255" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_acb12a45-edad-4526-b24b-facf2825c82f" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_ahl_AuthorizedShareCapital_acb12a45-edad-4526-b24b-facf2825c82f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a4a1b3b7-12a9-4324-a405-bcf56bb32242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_us-gaap_CommonStockSharesIssued_a4a1b3b7-12a9-4324-a405-bcf56bb32242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1db89144-9b1a-4078-b7d4-3680a810f9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1db89144-9b1a-4078-b7d4-3680a810f9c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_319657d3-8474-400e-b715-4d0773741bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_us-gaap_CommonStockValue_319657d3-8474-400e-b715-4d0773741bfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_14caebd0-0ee6-4a9e-8ce1-0dcae7a907dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesSubscribedButUnissuedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_14caebd0-0ee6-4a9e-8ce1-0dcae7a907dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapital_3d55729c-8283-418c-8df2-09b9111b35fe" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_ahl_IssuedShareCapital_3d55729c-8283-418c-8df2-09b9111b35fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b7b982fa-5f20-40ed-a3ea-1aae00e1fe93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b7b982fa-5f20-40ed-a3ea-1aae00e1fe93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_290055c8-994d-46bb-be23-2da0afb6ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_290055c8-994d-46bb-be23-2da0afb6ab0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_73932235-1464-4364-b61e-cb9b3b0a323f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_73932235-1464-4364-b61e-cb9b3b0a323f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_671d745c-737f-4100-805b-f1251718f96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_671d745c-737f-4100-805b-f1251718f96a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1940c175-1ffb-47ca-9c46-7bf132dd17f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1940c175-1ffb-47ca-9c46-7bf132dd17f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1940c175-1ffb-47ca-9c46-7bf132dd17f7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb" xlink:to="loc_us-gaap_ClassOfStockDomain_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb" xlink:to="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_e0f46c98-c1fc-45b2-9f96-ee9c5d7ac8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_e0f46c98-c1fc-45b2-9f96-ee9c5d7ac8af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_32d75d1f-7428-4f4b-b654-42723864a7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_32d75d1f-7428-4f4b-b654-42723864a7df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_031b72b1-4ad2-4c62-8124-7a4e8495d891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_031b72b1-4ad2-4c62-8124-7a4e8495d891" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a63c3125-d2df-4591-88c5-f476f16b5726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a63c3125-d2df-4591-88c5-f476f16b5726" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e2aa42e4-493f-41af-816b-1393ed7f8385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e2aa42e4-493f-41af-816b-1393ed7f8385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_612550dd-6cf1-43e5-9fa0-9020b38932d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_612550dd-6cf1-43e5-9fa0-9020b38932d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositaryShareDividendRateFractionalInterest_a3619bcd-c4c6-456f-9580-c809e6be2c16" xlink:href="ahl-20231220.xsd#ahl_DepositaryShareDividendRateFractionalInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_ahl_DepositaryShareDividendRateFractionalInterest_a3619bcd-c4c6-456f-9580-c809e6be2c16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_458d932c-6d78-4ce8-bb9b-15df833566e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_458d932c-6d78-4ce8-bb9b-15df833566e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_458d932c-6d78-4ce8-bb9b-15df833566e7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4" xlink:to="loc_us-gaap_ClassOfStockDomain_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4" xlink:to="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_039695c2-fa9e-41a4-a4ac-7428a3ce0d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_039695c2-fa9e-41a4-a4ac-7428a3ce0d32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_ebef80fa-060c-43e5-b157-771abebff69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_ebef80fa-060c-43e5-b157-771abebff69b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_b0037c6f-ce27-4a19-98e0-fac8372b2bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_b0037c6f-ce27-4a19-98e0-fac8372b2bc3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b861ef2c-8b2f-4587-b410-b8001e0c405b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b861ef2c-8b2f-4587-b410-b8001e0c405b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockIssuanceCost_96f167c5-2247-4c04-9a51-05f4a8d6cb80" xlink:href="ahl-20231220.xsd#ahl_PreferredStockIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_ahl_PreferredStockIssuanceCost_96f167c5-2247-4c04-9a51-05f4a8d6cb80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_fb474ace-2120-47bc-9baa-1e2531f14556" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_ahl_AuthorizedShareCapital_fb474ace-2120-47bc-9baa-1e2531f14556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e812a10c-77c5-401b-968c-e6f1a68a9536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e812a10c-77c5-401b-968c-e6f1a68a9536" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4ce56fd3-64d9-4a6b-beeb-b336d057cbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4ce56fd3-64d9-4a6b-beeb-b336d057cbeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9551f4c6-7809-47f8-8331-6e33516be8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9551f4c6-7809-47f8-8331-6e33516be8c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0a9fd46a-4fa2-4d0e-b02c-de495ed88658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0a9fd46a-4fa2-4d0e-b02c-de495ed88658" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_685567d8-d046-4552-988f-04e56b710d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_CommonStockSharesIssued_685567d8-d046-4552-988f-04e56b710d5a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_34453b44-292e-459b-97a0-7e7e331b55dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_34453b44-292e-459b-97a0-7e7e331b55dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_d8124217-1dd4-49bf-9f26-982052d9bd93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_d8124217-1dd4-49bf-9f26-982052d9bd93" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_f03f7110-92e5-4817-926a-9f62d986c68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_f03f7110-92e5-4817-926a-9f62d986c68d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_68a6ae5d-c039-4453-a58e-eca064684d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_68a6ae5d-c039-4453-a58e-eca064684d4b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_2595ad79-9e81-4135-b5a5-ffdcca72f179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_2595ad79-9e81-4135-b5a5-ffdcca72f179" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate_272d3728-7535-441a-9741-e347784a3995" xlink:href="ahl-20231220.xsd#ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate_272d3728-7535-441a-9741-e347784a3995" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8731345a-8b65-464c-963e-9e05f224852f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8731345a-8b65-464c-963e-9e05f224852f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8731345a-8b65-464c-963e-9e05f224852f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8731345a-8b65-464c-963e-9e05f224852f" xlink:to="loc_us-gaap_EquityComponentDomain_8731345a-8b65-464c-963e-9e05f224852f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f7f4ad85-a195-4f52-bbc5-6674d7242e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8731345a-8b65-464c-963e-9e05f224852f" xlink:to="loc_us-gaap_EquityComponentDomain_f7f4ad85-a195-4f52-bbc5-6674d7242e77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b75c6805-d3ee-42f5-a189-4138bb14466e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f7f4ad85-a195-4f52-bbc5-6674d7242e77" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b75c6805-d3ee-42f5-a189-4138bb14466e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_9dc33d75-e292-4b93-a413-65b50dd41e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_9dc33d75-e292-4b93-a413-65b50dd41e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_29476e93-20a8-4ee4-b01e-09fcfe50123b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_StatementClassOfStockAxis_29476e93-20a8-4ee4-b01e-09fcfe50123b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_29476e93-20a8-4ee4-b01e-09fcfe50123b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_29476e93-20a8-4ee4-b01e-09fcfe50123b" xlink:to="loc_us-gaap_ClassOfStockDomain_29476e93-20a8-4ee4-b01e-09fcfe50123b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_29476e93-20a8-4ee4-b01e-09fcfe50123b" xlink:to="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_14b64c7c-6df8-4af6-b018-649dc41b714b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:to="loc_us-gaap_PreferredStockMember_14b64c7c-6df8-4af6-b018-649dc41b714b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_ef581f38-e8e1-4497-8ca4-17a3fcd68aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_ef581f38-e8e1-4497-8ca4-17a3fcd68aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_bb01d498-500d-4776-9315-7a3e01735a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_bb01d498-500d-4776-9315-7a3e01735a9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_63931cbd-856a-4d0e-8b57-89ab6493b31d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_63931cbd-856a-4d0e-8b57-89ab6493b31d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_20657ef5-33cc-44b4-8966-edb82e902528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_VariableRateAxis_20657ef5-33cc-44b4-8966-edb82e902528" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_20657ef5-33cc-44b4-8966-edb82e902528_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_20657ef5-33cc-44b4-8966-edb82e902528" xlink:to="loc_us-gaap_VariableRateDomain_20657ef5-33cc-44b4-8966-edb82e902528_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_88fbb4d2-1cb5-4243-99ab-f1fd38116605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_20657ef5-33cc-44b4-8966-edb82e902528" xlink:to="loc_us-gaap_VariableRateDomain_88fbb4d2-1cb5-4243-99ab-f1fd38116605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LIBOR1Member_39a5a28e-f7ee-4d58-9937-fa8f7e9849c8" xlink:href="ahl-20231220.xsd#ahl_LIBOR1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_88fbb4d2-1cb5-4243-99ab-f1fd38116605" xlink:to="loc_ahl_LIBOR1Member_39a5a28e-f7ee-4d58-9937-fa8f7e9849c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2f08bf1c-3be6-41a3-836e-8161e4116d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2f08bf1c-3be6-41a3-836e-8161e4116d07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_01fdfe79-ac2e-4566-b248-8f6912bc5a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2f08bf1c-3be6-41a3-836e-8161e4116d07" xlink:to="loc_us-gaap_SubsequentEventMember_01fdfe79-ac2e-4566-b248-8f6912bc5a1c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DividendsSummaryofDeclaredDividendsDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_41bdd649-8180-41d5-8f30-f7822a54c2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_41bdd649-8180-41d5-8f30-f7822a54c2c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_777d89b7-c97a-49e1-b624-c93a53ab301c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_777d89b7-c97a-49e1-b624-c93a53ab301c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_90353aeb-94f8-4c04-80db-1825326511cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_90353aeb-94f8-4c04-80db-1825326511cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositaryShareDividend_090e877b-4b38-48fa-9f33-0f1d706e74bb" xlink:href="ahl-20231220.xsd#ahl_DepositaryShareDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_ahl_DepositaryShareDividend_090e877b-4b38-48fa-9f33-0f1d706e74bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_aa576d30-7253-4eac-ab03-18a99bf2c85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_aa576d30-7253-4eac-ab03-18a99bf2c85b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_d3244231-6206-4cad-9574-78e59e349c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_d3244231-6206-4cad-9574-78e59e349c43" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4afabd3d-6206-41d0-9de9-542b352956de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4afabd3d-6206-41d0-9de9-542b352956de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4afabd3d-6206-41d0-9de9-542b352956de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4afabd3d-6206-41d0-9de9-542b352956de" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4afabd3d-6206-41d0-9de9-542b352956de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0be0e5a3-528d-4723-95df-188fd2bdc686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4afabd3d-6206-41d0-9de9-542b352956de" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0be0e5a3-528d-4723-95df-188fd2bdc686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_42942570-f554-48bc-a25b-e0a80592f334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0be0e5a3-528d-4723-95df-188fd2bdc686" xlink:to="loc_us-gaap_SubsequentEventMember_42942570-f554-48bc-a25b-e0a80592f334" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c16bd290-bd89-4139-90da-f05e066840fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c16bd290-bd89-4139-90da-f05e066840fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c16bd290-bd89-4139-90da-f05e066840fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c16bd290-bd89-4139-90da-f05e066840fe" xlink:to="loc_us-gaap_ClassOfStockDomain_c16bd290-bd89-4139-90da-f05e066840fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c16bd290-bd89-4139-90da-f05e066840fe" xlink:to="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_490513da-4bc1-482e-b3c1-c7c562037bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_490513da-4bc1-482e-b3c1-c7c562037bc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_e44ca2be-7242-4827-81ab-e2c831c13e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_e44ca2be-7242-4827-81ab-e2c831c13e98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_ad3b2d03-ae7c-4bfd-ba9f-5eb531623948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_ad3b2d03-ae7c-4bfd-ba9f-5eb531623948" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#RelatedPartyTransactionsNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionRateofInterest_ae5cd544-a604-4e2e-abd6-8c4598ac7954" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionRateofInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_ahl_RelatedPartyTransactionRateofInterest_ae5cd544-a604-4e2e-abd6-8c4598ac7954" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionMaximumRateIncrease_bf90050f-7380-432f-ab2e-f57cd86e8737" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionMaximumRateIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_ahl_RelatedPartyTransactionMaximumRateIncrease_bf90050f-7380-432f-ab2e-f57cd86e8737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_d454212c-1585-4918-820d-7a248681ac29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_d454212c-1585-4918-820d-7a248681ac29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromOfficersOrStockholdersCurrent_476978cf-24de-4695-a6ee-78992916496c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_DueFromOfficersOrStockholdersCurrent_476978cf-24de-4695-a6ee-78992916496c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_ead0a22c-51d0-4433-9ea7-c1355e9c4ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_DueToAffiliateCurrent_ead0a22c-51d0-4433-9ea7-c1355e9c4ddc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_699b1dcb-1308-4d16-899e-d8c302355c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_699b1dcb-1308-4d16-899e-d8c302355c13" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_1d5f651d-a649-462f-9d1b-0335550aa95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_1d5f651d-a649-462f-9d1b-0335550aa95b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_d979abc1-5ffc-4cf0-818d-d0550812f63b" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_ahl_PrivatelyheldInvestments_d979abc1-5ffc-4cf0-818d-d0550812f63b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_2fd31bac-501d-448f-bcaa-fbaaea8d22e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_OtherInvestments_2fd31bac-501d-448f-bcaa-fbaaea8d22e7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyHeldInvestmentLossesIncurred_ef9b65c0-95dd-4964-abfe-e098ff9740bc" xlink:href="ahl-20231220.xsd#ahl_PrivatelyHeldInvestmentLossesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_ahl_PrivatelyHeldInvestmentLossesIncurred_ef9b65c0-95dd-4964-abfe-e098ff9740bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2cafd76d-fd1d-4988-b24d-0896f453330b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_srt_RangeAxis_2cafd76d-fd1d-4988-b24d-0896f453330b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2cafd76d-fd1d-4988-b24d-0896f453330b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2cafd76d-fd1d-4988-b24d-0896f453330b" xlink:to="loc_srt_RangeMember_2cafd76d-fd1d-4988-b24d-0896f453330b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_348433ae-e54d-4476-8cb6-b10537fec486" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2cafd76d-fd1d-4988-b24d-0896f453330b" xlink:to="loc_srt_RangeMember_348433ae-e54d-4476-8cb6-b10537fec486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5713b81d-92da-46bb-8c84-e9bc02d69304" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_348433ae-e54d-4476-8cb6-b10537fec486" xlink:to="loc_srt_MaximumMember_5713b81d-92da-46bb-8c84-e9bc02d69304" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0" xlink:to="loc_us-gaap_RelatedPartyDomain_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0" xlink:to="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_8ece1435-5099-4850-9c83-e93bce4e7f27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_srt_AffiliatedEntityMember_8ece1435-5099-4850-9c83-e93bce4e7f27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BeneficialOwnerMember_5e17d07a-3f98-45dd-9a72-5b9df93896a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BeneficialOwnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_us-gaap_BeneficialOwnerMember_5e17d07a-3f98-45dd-9a72-5b9df93896a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_5d8568a3-09ce-4cd4-8d3d-d64acf19646c" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ApolloRealEstateFundMember_5d8568a3-09ce-4cd4-8d3d-d64acf19646c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_61df3875-8084-4d36-b07c-11ade3acb49f" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_61df3875-8084-4d36-b07c-11ade3acb49f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassANotesMember_317885f5-92f0-4587-9968-18f2d33eb720" xlink:href="ahl-20231220.xsd#ahl_ApolloClassANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ApolloClassANotesMember_317885f5-92f0-4587-9968-18f2d33eb720" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassBNotesMember_249716ba-a9fe-46f0-8609-a9089cfe47a7" xlink:href="ahl-20231220.xsd#ahl_ApolloClassBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ApolloClassBNotesMember_249716ba-a9fe-46f0-8609-a9089cfe47a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember_e2ee0138-bf58-4b89-b9d6-ceea9ec57967" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ClassABNotesMember_e2ee0138-bf58-4b89-b9d6-ceea9ec57967" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_24fe7750-fdef-420d-8b20-5cb190e60aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_24fe7750-fdef-420d-8b20-5cb190e60aa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_24fe7750-fdef-420d-8b20-5cb190e60aa4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_24fe7750-fdef-420d-8b20-5cb190e60aa4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_24fe7750-fdef-420d-8b20-5cb190e60aa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_24fe7750-fdef-420d-8b20-5cb190e60aa4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_bdfa1f66-8ffc-4da7-a5a1-378477716af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:to="loc_us-gaap_AssetManagementArrangementMember_bdfa1f66-8ffc-4da7-a5a1-378477716af4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_fcf2c3af-17e3-42d8-89ca-848d99094f24" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:to="loc_ahl_ManagementConsultingAgreementMember_fcf2c3af-17e3-42d8-89ca-848d99094f24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_a4847e0f-84e2-4794-990d-278057b92b81" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_a4847e0f-84e2-4794-990d-278057b92b81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_61b61554-09e7-4a8d-83a7-661dfab8de3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_61b61554-09e7-4a8d-83a7-661dfab8de3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_61b61554-09e7-4a8d-83a7-661dfab8de3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_61b61554-09e7-4a8d-83a7-661dfab8de3a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_61b61554-09e7-4a8d-83a7-661dfab8de3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_61b61554-09e7-4a8d-83a7-661dfab8de3a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_144e25f9-7ed4-4229-b6a7-e7f376ac2939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:to="loc_us-gaap_InvestmentIncomeMember_144e25f9-7ed4-4229-b6a7-e7f376ac2939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9fb26665-259a-4ae4-b8d4-0a4924d58fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9fb26665-259a-4ae4-b8d4-0a4924d58fa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1_45858980-0831-4cb6-bce7-70080bcf4234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:to="loc_us-gaap_GainLossOnInvestmentsMember1_45858980-0831-4cb6-bce7-70080bcf4234" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca4e13d-e5ea-419d-99bb-310021d3fc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca4e13d-e5ea-419d-99bb-310021d3fc1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2ca4e13d-e5ea-419d-99bb-310021d3fc1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca4e13d-e5ea-419d-99bb-310021d3fc1d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2ca4e13d-e5ea-419d-99bb-310021d3fc1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_475f437c-6560-4da8-884c-98203220bf49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca4e13d-e5ea-419d-99bb-310021d3fc1d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_475f437c-6560-4da8-884c-98203220bf49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c0cf23f8-7fb3-4e18-ab19-4fc0572bebf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_475f437c-6560-4da8-884c-98203220bf49" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c0cf23f8-7fb3-4e18-ab19-4fc0572bebf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_52b79fb7-2437-41cb-99da-8f97a1fc605f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_52b79fb7-2437-41cb-99da-8f97a1fc605f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_52b79fb7-2437-41cb-99da-8f97a1fc605f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_52b79fb7-2437-41cb-99da-8f97a1fc605f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_52b79fb7-2437-41cb-99da-8f97a1fc605f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_987443e0-b500-47a2-ba9b-9c46f4a0c2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_52b79fb7-2437-41cb-99da-8f97a1fc605f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_987443e0-b500-47a2-ba9b-9c46f4a0c2ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_52520c9f-1aa7-472e-b68d-d21a1333c482" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987443e0-b500-47a2-ba9b-9c46f4a0c2ee" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_52520c9f-1aa7-472e-b68d-d21a1333c482" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_f77b0885-2ec3-4c05-ab39-c83f3c61ac62" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_RestrictedAssets_f77b0885-2ec3-4c05-ab39-c83f3c61ac62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssetsExcludingIlliquidAssets_82e3f11b-7429-4b28-84fc-c6c2138e8ac9" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssetsExcludingIlliquidAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_RestrictedAssetsExcludingIlliquidAssets_82e3f11b-7429-4b28-84fc-c6c2138e8ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_1b85b332-9878-42c0-b726-b57873c77dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_us-gaap_OtherInvestments_1b85b332-9878-42c0-b726-b57873c77dcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalRestrictedAssets_25be262a-bb6b-4dcc-9302-7e709f5cb272" xlink:href="ahl-20231220.xsd#ahl_TotalRestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_TotalRestrictedAssets_25be262a-bb6b-4dcc-9302-7e709f5cb272" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_bde37beb-8a23-442f-a2df-99063ed3483f" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_bde37beb-8a23-442f-a2df-99063ed3483f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_e5df5cbf-a85a-48ff-b72c-0d1f2fe4ca3f" xlink:href="ahl-20231220.xsd#ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_e5df5cbf-a85a-48ff-b72c-0d1f2fe4ca3f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_44148dbe-c415-4584-bbc0-7c4795608f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_44148dbe-c415-4584-bbc0-7c4795608f17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_44148dbe-c415-4584-bbc0-7c4795608f17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_44148dbe-c415-4584-bbc0-7c4795608f17" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_44148dbe-c415-4584-bbc0-7c4795608f17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6766accf-54d3-4bd2-9c90-f4c352a11e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_44148dbe-c415-4584-bbc0-7c4795608f17" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6766accf-54d3-4bd2-9c90-f4c352a11e42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_21e82344-d070-422d-9d2c-e527250430b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6766accf-54d3-4bd2-9c90-f4c352a11e42" xlink:to="loc_us-gaap_LimitedPartnerMember_21e82344-d070-422d-9d2c-e527250430b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_22b300f5-a39f-4dad-a3a4-8b00f19d1415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:to="loc_us-gaap_InvestmentTypeAxis_22b300f5-a39f-4dad-a3a4-8b00f19d1415" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_22b300f5-a39f-4dad-a3a4-8b00f19d1415_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_22b300f5-a39f-4dad-a3a4-8b00f19d1415" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_22b300f5-a39f-4dad-a3a4-8b00f19d1415_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b6bf0b51-a90e-4c4f-b038-7f1c4f23c5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_22b300f5-a39f-4dad-a3a4-8b00f19d1415" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b6bf0b51-a90e-4c4f-b038-7f1c4f23c5a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_6f136cb5-df17-4b60-b715-3777a609f502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6bf0b51-a90e-4c4f-b038-7f1c4f23c5a8" xlink:to="loc_us-gaap_RealEstateFundsMember_6f136cb5-df17-4b60-b715-3777a609f502" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_596c2e0d-914e-427c-8993-9804ca229780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_596c2e0d-914e-427c-8993-9804ca229780" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_596c2e0d-914e-427c-8993-9804ca229780_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_596c2e0d-914e-427c-8993-9804ca229780" xlink:to="loc_us-gaap_RelatedPartyDomain_596c2e0d-914e-427c-8993-9804ca229780_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e578cf4b-b4bd-46bc-9baa-a0803c609abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_596c2e0d-914e-427c-8993-9804ca229780" xlink:to="loc_us-gaap_RelatedPartyDomain_e578cf4b-b4bd-46bc-9baa-a0803c609abe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_f0b6d3f5-982f-4bdf-a014-63f857658e53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_e578cf4b-b4bd-46bc-9baa-a0803c609abe" xlink:to="loc_srt_AffiliatedEntityMember_f0b6d3f5-982f-4bdf-a014-63f857658e53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ThirdPartyMember_ef4b9254-3c53-47bf-a306-2621ec8c9b26" xlink:href="ahl-20231220.xsd#ahl_ThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_e578cf4b-b4bd-46bc-9baa-a0803c609abe" xlink:to="loc_ahl_ThirdPartyMember_ef4b9254-3c53-47bf-a306-2621ec8c9b26" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_0b794b5a-ee74-4a5a-a568-094332dc99ae" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_RestrictedAssets_0b794b5a-ee74-4a5a-a568-094332dc99ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_9adf4c00-66dc-4603-b9db-503219ebd62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_OtherInvestments_9adf4c00-66dc-4603-b9db-503219ebd62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_0835ec5f-8609-4b4a-8b03-8fbddec23b89" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_0835ec5f-8609-4b4a-8b03-8fbddec23b89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_eee14f53-7a7a-48f9-86e0-1adb33d86f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_eee14f53-7a7a-48f9-86e0-1adb33d86f98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_188b098a-9735-4b33-b501-c2ab887012f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_188b098a-9735-4b33-b501-c2ab887012f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_10bbc6f7-7592-47f8-acee-4740c96882d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_10bbc6f7-7592-47f8-acee-4740c96882d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumNetCapitalRequired1_ff72da18-0932-4053-b08c-6dabae8e5bb1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumNetCapitalRequired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_srt_MinimumNetCapitalRequired1_ff72da18-0932-4053-b08c-6dabae8e5bb1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MinimumTrustFund_69358f8a-2933-477f-9afa-e52a8608b835" xlink:href="ahl-20231220.xsd#ahl_MinimumTrustFund"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_MinimumTrustFund_69358f8a-2933-477f-9afa-e52a8608b835" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfReinsuranceLiabilities_dde19535-ccdb-44ee-9bc7-4452f6e3997a" xlink:href="ahl-20231220.xsd#ahl_PercentageOfReinsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_PercentageOfReinsuranceLiabilities_dde19535-ccdb-44ee-9bc7-4452f6e3997a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceLiabilities_e980416c-814c-4613-af33-f739a1bf09d6" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_ReinsuranceLiabilities_e980416c-814c-4613-af33-f739a1bf09d6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_c2ffde35-564c-47e1-bcb8-8b7786bd2a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_AssetsHeldInTrust_c2ffde35-564c-47e1-bcb8-8b7786bd2a02" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RegulatoryDeposits_41ba1e06-fcdb-4d56-9d29-528c722d9d16" xlink:href="ahl-20231220.xsd#ahl_RegulatoryDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_RegulatoryDeposits_41ba1e06-fcdb-4d56-9d29-528c722d9d16" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositWithStates_f8b4f695-2d22-4090-9c87-2d147465eab6" xlink:href="ahl-20231220.xsd#ahl_DepositWithStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_DepositWithStates_f8b4f695-2d22-4090-9c87-2d147465eab6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_7c4735c0-ba1e-485c-9cf9-222b2853192d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_7c4735c0-ba1e-485c-9cf9-222b2853192d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7c4735c0-ba1e-485c-9cf9-222b2853192d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_7c4735c0-ba1e-485c-9cf9-222b2853192d" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7c4735c0-ba1e-485c-9cf9-222b2853192d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4ce29760-54db-4ec2-a190-a6453a3202e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_7c4735c0-ba1e-485c-9cf9-222b2853192d" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4ce29760-54db-4ec2-a190-a6453a3202e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_1ec2622f-6fde-4160-9326-2f7cb93bf944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4ce29760-54db-4ec2-a190-a6453a3202e6" xlink:to="loc_us-gaap_LimitedPartnerMember_1ec2622f-6fde-4160-9326-2f7cb93bf944" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2a8e2476-3c89-4bb2-8313-eb34dae43049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_InvestmentTypeAxis_2a8e2476-3c89-4bb2-8313-eb34dae43049" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2a8e2476-3c89-4bb2-8313-eb34dae43049_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_2a8e2476-3c89-4bb2-8313-eb34dae43049" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2a8e2476-3c89-4bb2-8313-eb34dae43049_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ab20d9be-4b7e-457e-8efd-62d911cb18ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_2a8e2476-3c89-4bb2-8313-eb34dae43049" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ab20d9be-4b7e-457e-8efd-62d911cb18ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_642881ad-9a4f-43d3-985d-987433b5e4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ab20d9be-4b7e-457e-8efd-62d911cb18ed" xlink:to="loc_us-gaap_RealEstateFundsMember_642881ad-9a4f-43d3-985d-987433b5e4c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_90900981-290f-4554-bdd9-3fd37980ae18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_HedgingDesignationAxis_90900981-290f-4554-bdd9-3fd37980ae18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_90900981-290f-4554-bdd9-3fd37980ae18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_90900981-290f-4554-bdd9-3fd37980ae18" xlink:to="loc_us-gaap_HedgingDesignationDomain_90900981-290f-4554-bdd9-3fd37980ae18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f0de2e18-7744-4a46-9000-c61f7ab35b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_90900981-290f-4554-bdd9-3fd37980ae18" xlink:to="loc_us-gaap_HedgingDesignationDomain_f0de2e18-7744-4a46-9000-c61f7ab35b17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d0fd0c5e-970d-4fdc-abf0-ae101205dbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f0de2e18-7744-4a46-9000-c61f7ab35b17" xlink:to="loc_us-gaap_NondesignatedMember_d0fd0c5e-970d-4fdc-abf0-ae101205dbb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6361a4f5-570f-41f6-8c7c-a7c6e21b8834" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_dei_LegalEntityAxis_6361a4f5-570f-41f6-8c7c-a7c6e21b8834" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6361a4f5-570f-41f6-8c7c-a7c6e21b8834_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6361a4f5-570f-41f6-8c7c-a7c6e21b8834" xlink:to="loc_dei_EntityDomain_6361a4f5-570f-41f6-8c7c-a7c6e21b8834_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_919f6903-d769-405c-b300-efe6fd43ee1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6361a4f5-570f-41f6-8c7c-a7c6e21b8834" xlink:to="loc_dei_EntityDomain_919f6903-d769-405c-b300-efe6fd43ee1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenBermudaMember_3c42b31f-c816-44db-8afb-db88eb1579b6" xlink:href="ahl-20231220.xsd#ahl_AspenBermudaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_919f6903-d769-405c-b300-efe6fd43ee1a" xlink:to="loc_ahl_AspenBermudaMember_3c42b31f-c816-44db-8afb-db88eb1579b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c541037-6a61-4f8f-849e-2782e6f8f34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c541037-6a61-4f8f-849e-2782e6f8f34e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c541037-6a61-4f8f-849e-2782e6f8f34e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c541037-6a61-4f8f-849e-2782e6f8f34e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c541037-6a61-4f8f-849e-2782e6f8f34e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c541037-6a61-4f8f-849e-2782e6f8f34e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsMultiBeneficiaryTrustFundMember_47b4c6d1-2d14-4d4d-878a-ed3359515144" xlink:href="ahl-20231220.xsd#ahl_UsMultiBeneficiaryTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_UsMultiBeneficiaryTrustFundMember_47b4c6d1-2d14-4d4d-878a-ed3359515144" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsSurplusLinesTrustFundMember_dd322620-23f8-4b55-8734-218fbdde4863" xlink:href="ahl-20231220.xsd#ahl_UsSurplusLinesTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_UsSurplusLinesTrustFundMember_dd322620-23f8-4b55-8734-218fbdde4863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CanadianTrustFundMember_5f7fa2d2-622e-4a8b-8d32-b1536c0e2fa4" xlink:href="ahl-20231220.xsd#ahl_CanadianTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_CanadianTrustFundMember_5f7fa2d2-622e-4a8b-8d32-b1536c0e2fa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AustralianTrustFundMember_39d49b86-d2a6-4d35-8807-05657bb1129a" xlink:href="ahl-20231220.xsd#ahl_AustralianTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_AustralianTrustFundMember_39d49b86-d2a6-4d35-8807-05657bb1129a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SwissTrustFundMember_182567d3-41e3-429b-b64f-9b6d95319169" xlink:href="ahl-20231220.xsd#ahl_SwissTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_SwissTrustFundMember_182567d3-41e3-429b-b64f-9b6d95319169" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SingaporeTrustFundMember_8714a32a-5184-4ad2-80d9-0905a59b1b9b" xlink:href="ahl-20231220.xsd#ahl_SingaporeTrustFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_SingaporeTrustFundMember_8714a32a-5184-4ad2-80d9-0905a59b1b9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86de128f-10c8-45d4-9d09-f46dcb173e6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86de128f-10c8-45d4-9d09-f46dcb173e6f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_86de128f-10c8-45d4-9d09-f46dcb173e6f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86de128f-10c8-45d4-9d09-f46dcb173e6f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_86de128f-10c8-45d4-9d09-f46dcb173e6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_487571ce-17fa-40a8-90da-3d2d66f0173e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86de128f-10c8-45d4-9d09-f46dcb173e6f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_487571ce-17fa-40a8-90da-3d2d66f0173e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_ade065b9-f2d8-4325-ad6e-32a64c62aa22" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_487571ce-17fa-40a8-90da-3d2d66f0173e" xlink:to="loc_ahl_MVIMember_ade065b9-f2d8-4325-ad6e-32a64c62aa22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_7326c2c4-80a2-4ed4-b04c-98e9f5ab8b0b" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_487571ce-17fa-40a8-90da-3d2d66f0173e" xlink:to="loc_ahl_MultiLineReinsurerMember_7326c2c4-80a2-4ed4-b04c-98e9f5ab8b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bba7493e-23b1-46a1-8d8b-fb067872fa47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bba7493e-23b1-46a1-8d8b-fb067872fa47" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bba7493e-23b1-46a1-8d8b-fb067872fa47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bba7493e-23b1-46a1-8d8b-fb067872fa47" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bba7493e-23b1-46a1-8d8b-fb067872fa47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5982ecc1-3100-4304-ad6d-59790a1eb807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bba7493e-23b1-46a1-8d8b-fb067872fa47" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5982ecc1-3100-4304-ad6d-59790a1eb807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_141564b3-d93a-4dc3-a096-52297656877e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5982ecc1-3100-4304-ad6d-59790a1eb807" xlink:to="loc_us-gaap_SubsequentEventMember_141564b3-d93a-4dc3-a096-52297656877e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRiskAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_38f4d1c8-3af1-4d27-86ce-612d11108d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_ReinsuranceRecoverables_38f4d1c8-3af1-4d27-86ce-612d11108d25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesCollateralizedPercent_f9f6c341-2edf-4189-9bd8-80875d36a5f9" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesCollateralizedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_ahl_ReinsuranceRecoverablesCollateralizedPercent_f9f6c341-2edf-4189-9bd8-80875d36a5f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConcentrationRiskThresholdPercentage_0aceda21-7287-45ae-a4aa-5934dff0d70f" xlink:href="ahl-20231220.xsd#ahl_ConcentrationRiskThresholdPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_ahl_ConcentrationRiskThresholdPercentage_0aceda21-7287-45ae-a4aa-5934dff0d70f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_9198a43e-0a4d-4f29-b9bb-8dc9d1093c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_9198a43e-0a4d-4f29-b9bb-8dc9d1093c30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsReceivableNonCurrent_0abdd523-a7de-41b3-a6eb-685e99b292c3" xlink:href="ahl-20231220.xsd#ahl_PremiumsReceivableNonCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_ahl_PremiumsReceivableNonCurrent_0abdd523-a7de-41b3-a6eb-685e99b292c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_e767a989-4ce5-41dd-8c17-09375c1564ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_e767a989-4ce5-41dd-8c17-09375c1564ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_29e7724d-56c2-4c71-a9b1-e8f75ae49aab" xlink:href="ahl-20231220.xsd#ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_29e7724d-56c2-4c71-a9b1-e8f75ae49aab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_4a9508d2-bb72-4c7e-a0e8-65cc631aa1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_4a9508d2-bb72-4c7e-a0e8-65cc631aa1a6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MajorRatingAgenciesAxis_563d91b5-a5c1-48c9-a688-302c8aa3c38b" xlink:href="ahl-20231220.xsd#ahl_MajorRatingAgenciesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:to="loc_ahl_MajorRatingAgenciesAxis_563d91b5-a5c1-48c9-a688-302c8aa3c38b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MajorRatingAgenciesDomain_563d91b5-a5c1-48c9-a688-302c8aa3c38b_default" xlink:href="ahl-20231220.xsd#ahl_MajorRatingAgenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ahl_MajorRatingAgenciesAxis_563d91b5-a5c1-48c9-a688-302c8aa3c38b" xlink:to="loc_ahl_MajorRatingAgenciesDomain_563d91b5-a5c1-48c9-a688-302c8aa3c38b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MajorRatingAgenciesDomain_286cdbe0-3880-42f6-939d-7a58c8853c22" xlink:href="ahl-20231220.xsd#ahl_MajorRatingAgenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ahl_MajorRatingAgenciesAxis_563d91b5-a5c1-48c9-a688-302c8aa3c38b" xlink:to="loc_ahl_MajorRatingAgenciesDomain_286cdbe0-3880-42f6-939d-7a58c8853c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAOrHigherMember_3f2ce676-5b4d-4892-8dfb-38b56926ab99" xlink:href="ahl-20231220.xsd#ahl_AAOrHigherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_MajorRatingAgenciesDomain_286cdbe0-3880-42f6-939d-7a58c8853c22" xlink:to="loc_ahl_AAOrHigherMember_3f2ce676-5b4d-4892-8dfb-38b56926ab99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAOrLowerMember_5c556549-34ee-47c5-89d6-ce4afe2cd363" xlink:href="ahl-20231220.xsd#ahl_AAOrLowerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ahl_MajorRatingAgenciesDomain_286cdbe0-3880-42f6-939d-7a58c8853c22" xlink:to="loc_ahl_AAOrLowerMember_5c556549-34ee-47c5-89d6-ce4afe2cd363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d012b6c4-8dec-417a-9558-72a531f3444b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d012b6c4-8dec-417a-9558-72a531f3444b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d012b6c4-8dec-417a-9558-72a531f3444b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d012b6c4-8dec-417a-9558-72a531f3444b" xlink:to="loc_us-gaap_RelatedPartyDomain_d012b6c4-8dec-417a-9558-72a531f3444b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d012b6c4-8dec-417a-9558-72a531f3444b" xlink:to="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MunichReMember_cf10ddc7-727d-472a-87f5-887d8300b641" xlink:href="ahl-20231220.xsd#ahl_MunichReMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:to="loc_ahl_MunichReMember_cf10ddc7-727d-472a-87f5-887d8300b641" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EverestReMember_bb944c09-0e30-40fb-9d39-f6f782bb81f4" xlink:href="ahl-20231220.xsd#ahl_EverestReMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:to="loc_ahl_EverestReMember_bb944c09-0e30-40fb-9d39-f6f782bb81f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_9fd85e4c-86a1-443b-b2ac-b6024e9288c7" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:to="loc_ahl_LloydsMember_9fd85e4c-86a1-443b-b2ac-b6024e9288c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_40665516-bf56-419c-aa24-68e6057ee7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_40665516-bf56-419c-aa24-68e6057ee7dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_40665516-bf56-419c-aa24-68e6057ee7dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_40665516-bf56-419c-aa24-68e6057ee7dd" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_40665516-bf56-419c-aa24-68e6057ee7dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_748728fa-abad-4853-8957-dffd3ed9b5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_40665516-bf56-419c-aa24-68e6057ee7dd" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_748728fa-abad-4853-8957-dffd3ed9b5b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_c6774c12-b90f-477b-a0cc-397c9b9b3abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_c6774c12-b90f-477b-a0cc-397c9b9b3abd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_a1ca2b5a-22ea-41e6-963f-b33150ca7f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_a1ca2b5a-22ea-41e6-963f-b33150ca7f7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_03f1adb2-d4aa-48dd-a83e-18c20c56bc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_03f1adb2-d4aa-48dd-a83e-18c20c56bc87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9a3b66a8-6687-4229-9d24-a619f79bbf64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9a3b66a8-6687-4229-9d24-a619f79bbf64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_348c1eee-1f96-4d18-843c-abe25585f551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_348c1eee-1f96-4d18-843c-abe25585f551" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_f004c42f-c147-4648-a353-02151ab4ef30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_f004c42f-c147-4648-a353-02151ab4ef30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b55c0d8d-36d0-4b4d-a456-831bb8ae6f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_ProfitLoss_b55c0d8d-36d0-4b4d-a456-831bb8ae6f89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6b95931b-f5c1-40d4-b6a1-d68e691d8415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6b95931b-f5c1-40d4-b6a1-d68e691d8415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6b95931b-f5c1-40d4-b6a1-d68e691d8415_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6b95931b-f5c1-40d4-b6a1-d68e691d8415" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6b95931b-f5c1-40d4-b6a1-d68e691d8415_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_71483071-bd79-4114-aa15-3c06d736e793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6b95931b-f5c1-40d4-b6a1-d68e691d8415" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_71483071-bd79-4114-aa15-3c06d736e793" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_c30764d9-9dc1-4b51-b30b-298f81c3d1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71483071-bd79-4114-aa15-3c06d736e793" xlink:to="loc_us-gaap_ForeignExchangeContractMember_c30764d9-9dc1-4b51-b30b-298f81c3d1b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cf7407ce-7301-4d45-8e7c-13ffd0b60825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cf7407ce-7301-4d45-8e7c-13ffd0b60825" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cf7407ce-7301-4d45-8e7c-13ffd0b60825_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cf7407ce-7301-4d45-8e7c-13ffd0b60825" xlink:to="loc_us-gaap_EquityComponentDomain_cf7407ce-7301-4d45-8e7c-13ffd0b60825_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4748bc3f-a4d9-447b-87cd-e38484a0717d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cf7407ce-7301-4d45-8e7c-13ffd0b60825" xlink:to="loc_us-gaap_EquityComponentDomain_4748bc3f-a4d9-447b-87cd-e38484a0717d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8754bec4-a0df-4b53-a462-ee33e2a9ad6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4748bc3f-a4d9-447b-87cd-e38484a0717d" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8754bec4-a0df-4b53-a462-ee33e2a9ad6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_b1541a52-564b-47ac-8435-c042877d60d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4748bc3f-a4d9-447b-87cd-e38484a0717d" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_b1541a52-564b-47ac-8435-c042877d60d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_343b37a2-05e9-4d82-97be-b1ff8c30b92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_343b37a2-05e9-4d82-97be-b1ff8c30b92a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_343b37a2-05e9-4d82-97be-b1ff8c30b92a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_343b37a2-05e9-4d82-97be-b1ff8c30b92a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_343b37a2-05e9-4d82-97be-b1ff8c30b92a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5fcdba98-71d6-493e-9322-d23410bf8401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_343b37a2-05e9-4d82-97be-b1ff8c30b92a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5fcdba98-71d6-493e-9322-d23410bf8401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3179d266-44aa-45ce-8a01-c6fa82b24cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5fcdba98-71d6-493e-9322-d23410bf8401" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3179d266-44aa-45ce-8a01-c6fa82b24cf4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SubsequentEventsNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#SubsequentEventsNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.aspen.co/role/SubsequentEventsNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_7ad9358e-40b3-421b-a369-b88b6fef8075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DelayedDrawTermLoanFacility_f5b617ed-37b4-4d0d-bb98-660f82c8d9c3" xlink:href="ahl-20231220.xsd#ahl_DelayedDrawTermLoanFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_7ad9358e-40b3-421b-a369-b88b6fef8075" xlink:to="loc_ahl_DelayedDrawTermLoanFacility_f5b617ed-37b4-4d0d-bb98-660f82c8d9c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_4db43d5c-e0eb-4dbd-bfd7-38b757adffd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_7ad9358e-40b3-421b-a369-b88b6fef8075" xlink:to="loc_us-gaap_SubsequentEventTable_4db43d5c-e0eb-4dbd-bfd7-38b757adffd3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_4db43d5c-e0eb-4dbd-bfd7-38b757adffd3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_43275f49-f3fe-4421-8fd5-3480ab462cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_43275f49-f3fe-4421-8fd5-3480ab462cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6a569b33-87fb-4615-9db1-80d3d2117282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_43275f49-f3fe-4421-8fd5-3480ab462cc4" xlink:to="loc_us-gaap_SubsequentEventMember_6a569b33-87fb-4615-9db1-80d3d2117282" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>44
<FILENAME>ahl-20231220_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:c8bdf706-6073-4046-a439-e42c560d7bb0,g:8520f5b6-a319-4843-ab2c-4a3e439c5aeb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_e82cd8fb-8956-45d6-974d-22c1040921ed_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_TotalTradingMember_7c36f1a4-8fc3-4777-8990-e50e77923992_terseLabel_en-US" xlink:label="lab_ahl_TotalTradingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total - Trading</link:label>
    <link:label id="lab_ahl_TotalTradingMember_label_en-US" xlink:label="lab_ahl_TotalTradingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total - Trading [Member]</link:label>
    <link:label id="lab_ahl_TotalTradingMember_documentation_en-US" xlink:label="lab_ahl_TotalTradingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total - Trading [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalTradingMember" xlink:href="ahl-20231220.xsd#ahl_TotalTradingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_TotalTradingMember" xlink:to="lab_ahl_TotalTradingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_326faf87-4c61-4e77-aa09-7b8da2456634_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_TotalRestrictedAssets_dbd2f51f-b9a6-407f-92a1-2e61612dc889_terseLabel_en-US" xlink:label="lab_ahl_TotalRestrictedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restricted assets</link:label>
    <link:label id="lab_ahl_TotalRestrictedAssets_label_en-US" xlink:label="lab_ahl_TotalRestrictedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restricted assets</link:label>
    <link:label id="lab_ahl_TotalRestrictedAssets_documentation_en-US" xlink:label="lab_ahl_TotalRestrictedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restricted assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalRestrictedAssets" xlink:href="ahl-20231220.xsd#ahl_TotalRestrictedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_TotalRestrictedAssets" xlink:to="lab_ahl_TotalRestrictedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_070ef300-36e4-48d1-981a-bb2aee1abbb3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax (benefit)/expense, Non-U.S.</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_211480c8-3bfd-4e01-8072-95287c64f518_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Foreign Currencies Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MajorRatingAgenciesDomain_8fa9fd83-838b-4973-aa8b-e914b3835ab9_terseLabel_en-US" xlink:label="lab_ahl_MajorRatingAgenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major rating agencies [Domain]</link:label>
    <link:label id="lab_ahl_MajorRatingAgenciesDomain_label_en-US" xlink:label="lab_ahl_MajorRatingAgenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major rating agencies [Domain]</link:label>
    <link:label id="lab_ahl_MajorRatingAgenciesDomain_documentation_en-US" xlink:label="lab_ahl_MajorRatingAgenciesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major rating agencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MajorRatingAgenciesDomain" xlink:href="ahl-20231220.xsd#ahl_MajorRatingAgenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MajorRatingAgenciesDomain" xlink:to="lab_ahl_MajorRatingAgenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_4e822197-c0cb-4cfd-a392-f7a0c6c039de_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_ed9f5a49-084c-4ad7-836e-32ed17f77a1e_terseLabel_en-US" xlink:label="lab_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Catastrophe and Other Property Reinsurance</link:label>
    <link:label id="lab_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_label_en-US" xlink:label="lab_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Property Catastrophe and Other Property, Commercial Insurance Product Line [Member]</link:label>
    <link:label id="lab_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_documentation_en-US" xlink:label="lab_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Property Catastrophe and Other Property, Commercial Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember" xlink:href="ahl-20231220.xsd#ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember" xlink:to="lab_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_81b0b170-e7dc-47b7-a21b-cbde70a8be54_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses and loss adjustment expenses</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_41927f7e-8905-41c6-a91e-ec9e8642c3ab_totalLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net insurance losses and loss adjustment expenses</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_c4ab5ac9-84e7-4b62-8b5e-ac14595d4c9b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_4cbaf19c-8c08-41c0-8a34-d0dc76d82b7e_verboseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value, trading</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_0fc855c7-3b8c-4581-9130-24f2dd6c6274_periodStartLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the year</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_995863bc-02f3-40dd-87f3-0ed4a3787017_periodEndLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the year</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_d75de63e-b2c8-436b-b875-5b323cddb280_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income maturities, trading at fair value (amortized cost &#8212; $1,106.6 and $1,205.0)</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments_fbf6242a-92ee-4601-9925-0fa6e24c793f_negatedTerseLabel_en-US" xlink:label="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Purchases) of privately-held investments &#8212; Trading</link:label>
    <link:label id="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments_08bec89f-16f9-43eb-bae7-0576e4eb8bea_verboseLabel_en-US" xlink:label="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to invest in private assets</link:label>
    <link:label id="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments_label_en-US" xlink:label="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Privately-held Investments</link:label>
    <link:label id="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments_documentation_en-US" xlink:label="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Privately-held Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments" xlink:href="ahl-20231220.xsd#ahl_PaymentstoAcquirePrivatelyheldInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments" xlink:to="lab_ahl_PaymentstoAcquirePrivatelyheldInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_fcc9d102-30e0-4b50-b65b-2d97d430b95f_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted cash flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_6a4215d9-a60f-4c86-a954-a6ce759d007b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_e067a405-4d9e-4563-aa1d-dfd8f44a18bc_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized investment gains</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_856872d6-c096-40b7-964b-52bc2d13c841_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized investment gains</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_39aec4f1-b525-473f-adf5-d500f2bc09ac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_b8a1ffff-4d6f-4d85-b1a1-03769526b9dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_d80d5b5b-fe96-4f08-8e18-ff80ccd367b2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_60979274-3cda-44d5-9e66-dc019e37ebd6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract_eaaaca0c-0d60-48ad-aae2-21ea3e4f95e7_terseLabel_en-US" xlink:label="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Statutory Requirements And Dividends Restrictions Additional Information [Abstract]</link:label>
    <link:label id="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract_label_en-US" xlink:label="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Statutory Requirements And Dividends Restrictions Additional Information [Abstract]</link:label>
    <link:label id="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract_documentation_en-US" xlink:label="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure - Statutory Requirements and Dividends Restrictions - Additional Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract" xlink:href="ahl-20231220.xsd#ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract" xlink:to="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NonoperatingexpensesrelatedtoMergerAgreement_784dea4b-5010-4487-8322-912e8590ad9a_terseLabel_en-US" xlink:label="lab_ahl_NonoperatingexpensesrelatedtoMergerAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to Merger Agreement</link:label>
    <link:label id="lab_ahl_NonoperatingexpensesrelatedtoMergerAgreement_label_en-US" xlink:label="lab_ahl_NonoperatingexpensesrelatedtoMergerAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to Merger Agreement</link:label>
    <link:label id="lab_ahl_NonoperatingexpensesrelatedtoMergerAgreement_documentation_en-US" xlink:label="lab_ahl_NonoperatingexpensesrelatedtoMergerAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to Merger Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonoperatingexpensesrelatedtoMergerAgreement" xlink:href="ahl-20231220.xsd#ahl_NonoperatingexpensesrelatedtoMergerAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NonoperatingexpensesrelatedtoMergerAgreement" xlink:to="lab_ahl_NonoperatingexpensesrelatedtoMergerAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_1b97c69d-8a2d-42dc-96a4-ebb301296068_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_82d7456b-2392-489b-a946-d011d4294dba_terseLabel_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities After Ten Years Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_label_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities After Ten Years Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_documentation_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities debt maturities after ten years average ratings by maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" xlink:to="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f3087265-f29e-4a6d-81ef-8a5b018513c5_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_64a4ea88-c2fb-497c-9394-16097b462aa1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DigitalRiskMember_f70a8336-df00-4eda-ab77-9a6dd0bb636f_terseLabel_en-US" xlink:label="lab_ahl_DigitalRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digital Re</link:label>
    <link:label id="lab_ahl_DigitalRiskMember_label_en-US" xlink:label="lab_ahl_DigitalRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digital Risk [Member]</link:label>
    <link:label id="lab_ahl_DigitalRiskMember_documentation_en-US" xlink:label="lab_ahl_DigitalRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digital Risk Resources LLP[Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DigitalRiskMember" xlink:to="lab_ahl_DigitalRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ebac6515-c3e6-4b03-bfce-9953c851567a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses and loss adjustment expenses</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_486fce91-88a6-4a70-bce6-25db8bdc67ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for losses and LAE, beginning balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_34e2ec28-787e-4442-bac5-98285af149a3_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for losses and LAE at the end of the year</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_1c05dcd5-b6a1-4410-9caf-2969f9a15c36_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years, Fair Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDividendsPayableTextBlock_1aaf698c-5ed7-452f-b27c-7d71dd20645b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Declared Dividends</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDividendsPayableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Dividends Payable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDividendsPayableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_326ac2ad-99bf-4824-9728-cf7ce949d2c3_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_bcc10ffb-34a6-4275-9bb9-704b7cab08dc_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.950% Preference Shares (AHL PRC)</link:label>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesDPreferredStockMember" xlink:to="lab_us-gaap_SeriesDPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_fd0a4f64-f797-4350-a817-88436fea073f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear_12c5fb48-1cc3-4777-95d9-2b5fe4875371_terseLabel_en-US" xlink:label="lab_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allowance for credit losses increase (decrease)</link:label>
    <link:label id="lab_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear_label_en-US" xlink:label="lab_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total movement of the allowance for credit losses during the year</link:label>
    <link:label id="lab_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear_documentation_en-US" xlink:label="lab_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total movement of the allowance for credit losses during the year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" xlink:href="ahl-20231220.xsd#ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" xlink:to="lab_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_HotelMember_973382f8-0ab1-4ee1-8fa0-705807bde27f_terseLabel_en-US" xlink:label="lab_srt_HotelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hotel</link:label>
    <link:label id="lab_srt_HotelMember_label_en-US" xlink:label="lab_srt_HotelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hotel [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_HotelMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_HotelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_HotelMember" xlink:to="lab_srt_HotelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_339893d6-a46a-4e78-a3cf-a17e04d0e2bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ThirdPartyMember_cf0925d7-ecde-47e7-82f7-14bb545f9f38_verboseLabel_en-US" xlink:label="lab_ahl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party</link:label>
    <link:label id="lab_ahl_ThirdPartyMember_label_en-US" xlink:label="lab_ahl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party [Member]</link:label>
    <link:label id="lab_ahl_ThirdPartyMember_documentation_en-US" xlink:label="lab_ahl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ThirdPartyMember" xlink:href="ahl-20231220.xsd#ahl_ThirdPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ThirdPartyMember" xlink:to="lab_ahl_ThirdPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bdf3b9e5-9a20-4cfe-aa77-f3df7277a284_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average discount rate (percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_557772ab-86bf-4737-ae01-ee3e20231383_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of gross written premiums based on geographical areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_70cb779e-764a-4ee9-97cf-2d506bb0459e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_17b78fd2-ea99-4517-ae83-d5f8440a2b99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(Loss) Recognized in Income on Derivative</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_e0154d2e-ed35-4f80-88c7-7c836f98e86e_terseLabel_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in available for sale net unrealized (losses)/gains:</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_label_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Change In Unrealized Gains [Abstract]</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_documentation_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities change in unrealized gains.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract" xlink:to="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_0e2cf811-9f2f-4d89-877a-10cc0bc80185_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_InvestmentInMultilineReinsurer_6c61a8b0-74a8-4f31-be64-051487c5d5cf_negatedTerseLabel_en-US" xlink:label="lab_ahl_InvestmentInMultilineReinsurer" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in multiline reinsurer</link:label>
    <link:label id="lab_ahl_InvestmentInMultilineReinsurer_label_en-US" xlink:label="lab_ahl_InvestmentInMultilineReinsurer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in multiline reinsurer</link:label>
    <link:label id="lab_ahl_InvestmentInMultilineReinsurer_documentation_en-US" xlink:label="lab_ahl_InvestmentInMultilineReinsurer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in multiline reinsurer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentInMultilineReinsurer" xlink:href="ahl-20231220.xsd#ahl_InvestmentInMultilineReinsurer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_InvestmentInMultilineReinsurer" xlink:to="lab_ahl_InvestmentInMultilineReinsurer" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LossPortfolioTransferMember_4e4a3754-1c0f-42b4-ab97-18c3253fe378_terseLabel_en-US" xlink:label="lab_ahl_LossPortfolioTransferMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Portfolio Transfer</link:label>
    <link:label id="lab_ahl_LossPortfolioTransferMember_label_en-US" xlink:label="lab_ahl_LossPortfolioTransferMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Portfolio Transfer [Member]</link:label>
    <link:label id="lab_ahl_LossPortfolioTransferMember_documentation_en-US" xlink:label="lab_ahl_LossPortfolioTransferMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Portfolio Transfer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LossPortfolioTransferMember" xlink:to="lab_ahl_LossPortfolioTransferMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_67a96a0f-872e-4733-b5d3-5e3e08665cd9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2016</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract_2db65898-6070-4d11-ac25-eaabfa97ee4e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear_ab73fc7e-3479-431e-a9f7-be849b251bd6_terseLabel_en-US" xlink:label="lab_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Payments, Due prior year</link:label>
    <link:label id="lab_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear_label_en-US" xlink:label="lab_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Payments Due Prior Year</link:label>
    <link:label id="lab_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear_documentation_en-US" xlink:label="lab_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Payments Due Prior Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" xlink:href="ahl-20231220.xsd#ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" xlink:to="lab_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CatastropheBondsFairValueDisclosure_beb6455a-16dd-4c70-8ba3-1559ea0b4c29_verboseLabel_en-US" xlink:label="lab_ahl_CatastropheBondsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe Bonds, Fair Value Disclosure</link:label>
    <link:label id="lab_ahl_CatastropheBondsFairValueDisclosure_label_en-US" xlink:label="lab_ahl_CatastropheBondsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe Bonds, Fair Value Disclosure</link:label>
    <link:label id="lab_ahl_CatastropheBondsFairValueDisclosure_documentation_en-US" xlink:label="lab_ahl_CatastropheBondsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe Bonds, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CatastropheBondsFairValueDisclosure" xlink:to="lab_ahl_CatastropheBondsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AonCorporationMember_3cc368fb-bc3d-4788-92d3-4b103c28f965_terseLabel_en-US" xlink:label="lab_ahl_AonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aon Corporation</link:label>
    <link:label id="lab_ahl_AonCorporationMember_label_en-US" xlink:label="lab_ahl_AonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aon Corporation [Member]</link:label>
    <link:label id="lab_ahl_AonCorporationMember_documentation_en-US" xlink:label="lab_ahl_AonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AON Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AonCorporationMember" xlink:href="ahl-20231220.xsd#ahl_AonCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AonCorporationMember" xlink:to="lab_ahl_AonCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine_c146f51d-6629-4986-a0fa-09e4a9849e50_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year Nine</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year Nine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_c3bde810-5bda-42bd-ae32-bc41100a3b9d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, net of allowance for expected credit losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_3341f46e-f4e4-4718-8b50-b3eccdb04419_periodStartLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Investments, Allowance for Credit Loss, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_e6b81020-67ed-42f9-9920-5e97fdbb73ae_periodEndLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Investments, Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_c1feb555-4733-4c42-ac45-5a9e2a4d6f09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_505a6819-e0b3-47bd-9c48-ce5c65535964_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Payments, Due after year five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DepositaryShareDividend_0464418d-30b3-4e22-848c-020526598058_terseLabel_en-US" xlink:label="lab_ahl_DepositaryShareDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary share dividend</link:label>
    <link:label id="lab_ahl_DepositaryShareDividend_label_en-US" xlink:label="lab_ahl_DepositaryShareDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary Share Dividend</link:label>
    <link:label id="lab_ahl_DepositaryShareDividend_documentation_en-US" xlink:label="lab_ahl_DepositaryShareDividend" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary Share Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositaryShareDividend" xlink:href="ahl-20231220.xsd#ahl_DepositaryShareDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DepositaryShareDividend" xlink:to="lab_ahl_DepositaryShareDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_7cdb342c-9a8f-4ade-9300-679357387b08_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (1)</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_ee45c32a-62d8-4f1e-a638-2a17af59dc83_totalLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_4617c5d3-5278-4bef-9a40-00548f9e426d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a5b54d22-5e88-42c3-8cfe-a6d8a819edf6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1b23fd9b-8064-4f70-afe9-f9f1eb3bee5c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (loss)/gains on investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OtherPropertyMember_78dc08b7-57e8-4d43-a162-45d431a26eaf_terseLabel_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other commercial</link:label>
    <link:label id="lab_srt_OtherPropertyMember_label_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OtherPropertyMember" xlink:to="lab_srt_OtherPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_03ec391f-5e5a-4f19-bb6a-ae55ec347cec_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of consolidated group's net income due to Apollo Management</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionRate" xlink:to="lab_us-gaap_RelatedPartyTransactionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_17fb2594-c75d-42b7-9d16-ad270a355db9_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_4dbfae08-38ea-49a6-b2d7-2b8583d68559_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_128691e7-0c29-4b6e-9c81-de8826dc2cb6_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_1e1d163a-28ea-4013-ba61-66c13467ebf4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use operating lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_OtherMiscellaneousAssets_229c370b-0150-4adb-b921-6d3a28dca177_terseLabel_en-US" xlink:label="lab_ahl_OtherMiscellaneousAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_ahl_OtherMiscellaneousAssets_label_en-US" xlink:label="lab_ahl_OtherMiscellaneousAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Miscellaneous Assets</link:label>
    <link:label id="lab_ahl_OtherMiscellaneousAssets_documentation_en-US" xlink:label="lab_ahl_OtherMiscellaneousAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Miscellaneous Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherMiscellaneousAssets" xlink:href="ahl-20231220.xsd#ahl_OtherMiscellaneousAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_OtherMiscellaneousAssets" xlink:to="lab_ahl_OtherMiscellaneousAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven_741b2528-2517-4af2-bc9c-1b5d14dccc50_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year Seven</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year Seven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_55ae8587-c163-43e4-b9f8-721197fee1ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on foreign currency translation (start of period)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_8689ae09-68b2-43f2-9acf-0138f8031901_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on foreign currency translation (end of period)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_Expense_f5dc72db-393a-4ca3-aec3-988b7fdfbfa4_totalLabel_en-US" xlink:label="lab_ahl_Expense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_ahl_Expense_07e6c014-3769-460d-9a2e-7ed2a7169f15_terseLabel_en-US" xlink:label="lab_ahl_Expense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_ahl_Expense_label_en-US" xlink:label="lab_ahl_Expense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense</link:label>
    <link:label id="lab_ahl_Expense_documentation_en-US" xlink:label="lab_ahl_Expense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Expense" xlink:href="ahl-20231220.xsd#ahl_Expense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_Expense" xlink:to="lab_ahl_Expense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_3925ae57-1e1f-4b1a-a88e-ccb517ee4377_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_98109660-fe3b-49e0-b4ed-400aac10f632_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredTaxLossesOperatingLossCarryforward_b5650f25-8442-41ed-b870-4ce9e614dac0_negatedTerseLabel_en-US" xlink:label="lab_ahl_DeferredTaxLossesOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax losses, operating loss carryforward</link:label>
    <link:label id="lab_ahl_DeferredTaxLossesOperatingLossCarryforward_label_en-US" xlink:label="lab_ahl_DeferredTaxLossesOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Losses, Operating Loss Carryforward</link:label>
    <link:label id="lab_ahl_DeferredTaxLossesOperatingLossCarryforward_documentation_en-US" xlink:label="lab_ahl_DeferredTaxLossesOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Losses, Operating Loss Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLossesOperatingLossCarryforward" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLossesOperatingLossCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredTaxLossesOperatingLossCarryforward" xlink:to="lab_ahl_DeferredTaxLossesOperatingLossCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_25d1f02f-79f6-4f32-b892-ee65f5d687db_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c5d362e5-6bbe-4eb4-949e-62c508f905c1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9042feba-6d7f-4c96-bb05-47072e254b12_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments in fixed income maturities, Fair Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_4ee97e7a-b423-4c78-812f-d7232c6d89b5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_7437b47b-75ee-44f4-9858-2b72ce37f03c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities - gross realizes (losses)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss, Excluding Other-than-temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_a3f28ee5-ae2c-4f4b-bfd6-88c30093ee8d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_1d93060d-1abd-4cdd-abe0-c06ff0d89e0e_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums earned:</link:label>
    <link:label id="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:to="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ClassABNotesMember_d2306ef8-01f6-48cb-a15c-681c6b208283_terseLabel_en-US" xlink:label="lab_ahl_ClassABNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo, Class A &amp; B Notes</link:label>
    <link:label id="lab_ahl_ClassABNotesMember_label_en-US" xlink:label="lab_ahl_ClassABNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A &amp; B Notes [Member]</link:label>
    <link:label id="lab_ahl_ClassABNotesMember_documentation_en-US" xlink:label="lab_ahl_ClassABNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A &amp; B Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ClassABNotesMember" xlink:to="lab_ahl_ClassABNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NumberOfInvestmentsInVariableInterestEntities_cc34b2fd-b021-4ec7-84c0-cc0dfa59155f_terseLabel_en-US" xlink:label="lab_ahl_NumberOfInvestmentsInVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investments in VIEs</link:label>
    <link:label id="lab_ahl_NumberOfInvestmentsInVariableInterestEntities_00762b2e-2008-44e5-8adf-a85897bf8177_verboseLabel_en-US" xlink:label="lab_ahl_NumberOfInvestmentsInVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investments</link:label>
    <link:label id="lab_ahl_NumberOfInvestmentsInVariableInterestEntities_label_en-US" xlink:label="lab_ahl_NumberOfInvestmentsInVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Investments In Variable Interest Entities</link:label>
    <link:label id="lab_ahl_NumberOfInvestmentsInVariableInterestEntities_documentation_en-US" xlink:label="lab_ahl_NumberOfInvestmentsInVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Investments In Variable Interest Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NumberOfInvestmentsInVariableInterestEntities" xlink:href="ahl-20231220.xsd#ahl_NumberOfInvestmentsInVariableInterestEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NumberOfInvestmentsInVariableInterestEntities" xlink:to="lab_ahl_NumberOfInvestmentsInVariableInterestEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidReinsurancePremiums_f076a71a-ab63-4ffc-8be0-a35d97a83d1c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidReinsurancePremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded unearned premiums</link:label>
    <link:label id="lab_us-gaap_PrepaidReinsurancePremiums_label_en-US" xlink:label="lab_us-gaap_PrepaidReinsurancePremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Reinsurance Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidReinsurancePremiums" xlink:to="lab_us-gaap_PrepaidReinsurancePremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverables_f1587864-0370-4776-aa6a-6ebc7f9ebfc9_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus reinsurance recoverable on unpaid losses at the end of the year</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverables_9343f5a8-7575-48ef-9710-892488765c53_verboseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less foreign exchange (gains)/losses</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverables_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Including Reinsurance Premium Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverables" xlink:to="lab_us-gaap_ReinsuranceRecoverables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_d47a6660-397a-4eaf-97c5-48527e59c872_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_305957d8-7bf0-49db-8d56-83756c4fa81e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b6f4a5e3-6caa-4096-9356-45b7f9d16883_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LineOfCreditFacilityIncreasableCapacity_5f5e7c92-9c9c-4e24-a8e7-a5ae49369352_terseLabel_en-US" xlink:label="lab_ahl_LineOfCreditFacilityIncreasableCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility Increasable capacity</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityIncreasableCapacity_label_en-US" xlink:label="lab_ahl_LineOfCreditFacilityIncreasableCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Increasable Capacity</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityIncreasableCapacity_documentation_en-US" xlink:label="lab_ahl_LineOfCreditFacilityIncreasableCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility Increasable capacity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityIncreasableCapacity" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityIncreasableCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LineOfCreditFacilityIncreasableCapacity" xlink:to="lab_ahl_LineOfCreditFacilityIncreasableCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_2de7460e-a20c-470a-b378-433415218dba_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RelatedPartyTransactionRateofInterest_3c7128f1-fa55-4375-a48b-c9fbfacc2e6d_terseLabel_en-US" xlink:label="lab_ahl_RelatedPartyTransactionRateofInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus component of annual investment management fee</link:label>
    <link:label id="lab_ahl_RelatedPartyTransactionRateofInterest_label_en-US" xlink:label="lab_ahl_RelatedPartyTransactionRateofInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Rate of Interest</link:label>
    <link:label id="lab_ahl_RelatedPartyTransactionRateofInterest_documentation_en-US" xlink:label="lab_ahl_RelatedPartyTransactionRateofInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Rate of Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionRateofInterest" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionRateofInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RelatedPartyTransactionRateofInterest" xlink:to="lab_ahl_RelatedPartyTransactionRateofInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_b001a7cb-0424-400c-964e-c1aadf5c2c05_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7ac837d7-0240-43b3-b76a-7db2dd0793d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year adjustments</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_10878cb7-cdc1-4bdd-b1ac-72d15acc759b_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_16deba2b-ec29-4347-951e-d760322e8ddd_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_06bf80fc-70bd-40e8-9305-8396ea754a39_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums_22df2a41-258e-4ad4-b029-2fdc2f265b2d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:to="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b906982e-6011-4c0a-836e-b31906c6838c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average remaining lease term (years(</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense_3cecb2d8-dee4-46eb-86d2-6da8fbc40329_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated claims incurred</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expense, Accumulated Unallocated Claim Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_269e75f9-edd1-4a02-9c99-b448aa5719c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b2d7f87b-e706-42f2-9976-609a707c9831_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows (used in)/from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PremiumsReceivableNonCurrent_1c51b9cf-8944-4d36-b838-e60201cd9b86_terseLabel_en-US" xlink:label="lab_ahl_PremiumsReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due for settlement</link:label>
    <link:label id="lab_ahl_PremiumsReceivableNonCurrent_label_en-US" xlink:label="lab_ahl_PremiumsReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable Non Current</link:label>
    <link:label id="lab_ahl_PremiumsReceivableNonCurrent_documentation_en-US" xlink:label="lab_ahl_PremiumsReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums receivable non current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsReceivableNonCurrent" xlink:href="ahl-20231220.xsd#ahl_PremiumsReceivableNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PremiumsReceivableNonCurrent" xlink:to="lab_ahl_PremiumsReceivableNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_58359093-16f7-432a-ac3b-66c14c9a7016_totalLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for claims and claim adjustment expenses, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_cf855f22-bf39-47f7-a952-23ed313908ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for claims and claim adjustment expenses, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_9525ee8e-e53f-4298-9a6e-9d5d0e6cbedb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_763e34cf-80fa-4a58-8a96-d6dabadba720_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a070c63b-673f-459b-b29d-8152c3d0206d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_021219a7-adf3-47eb-922f-232a85e9fd50_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-supplement_InvestmentIdentifierAxis_1c66d57c-f809-4e75-8b91-84dbc6180897_terseLabel_en-US" xlink:label="lab_us-gaap-supplement_InvestmentIdentifierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Identifier [Axis]</link:label>
    <link:label id="lab_us-gaap-supplement_InvestmentIdentifierAxis_label_en-US" xlink:label="lab_us-gaap-supplement_InvestmentIdentifierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Identifier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_InvestmentIdentifierAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-supplement_InvestmentIdentifierAxis" xlink:to="lab_us-gaap-supplement_InvestmentIdentifierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0ac7ad3c-e8c0-4693-8d13-67c2c5b39ba4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized appreciation on available for sale investments:</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_891a292d-6d92-4ccc-93d5-bcfa4fe3e42d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_f9e153fb-09ff-4296-879e-3f8dc5e961bd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities &#8212; gross realized (losses)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_5a4e3537-95a0-4e82-a2b2-cbf6ebbf28c7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_0b234314-067c-4e32-a819-0e05464930fc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of beginning and ending deferred policy acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_TradingFixedMaturityInvestmentsMember_a709fca1-b64d-49de-b581-5206400b44a3_terseLabel_en-US" xlink:label="lab_ahl_TradingFixedMaturityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities - trading</link:label>
    <link:label id="lab_ahl_TradingFixedMaturityInvestmentsMember_label_en-US" xlink:label="lab_ahl_TradingFixedMaturityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Fixed Maturity Investments [Member]</link:label>
    <link:label id="lab_ahl_TradingFixedMaturityInvestmentsMember_documentation_en-US" xlink:label="lab_ahl_TradingFixedMaturityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading fixed maturity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingFixedMaturityInvestmentsMember" xlink:href="ahl-20231220.xsd#ahl_TradingFixedMaturityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_TradingFixedMaturityInvestmentsMember" xlink:to="lab_ahl_TradingFixedMaturityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dcdf6b98-24af-4923-b80c-1ab80b07a7a0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RegulatoryDeposits_f36a7805-044c-413c-8879-06db0b805313_terseLabel_en-US" xlink:label="lab_ahl_RegulatoryDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory deposits</link:label>
    <link:label id="lab_ahl_RegulatoryDeposits_label_en-US" xlink:label="lab_ahl_RegulatoryDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Deposits</link:label>
    <link:label id="lab_ahl_RegulatoryDeposits_documentation_en-US" xlink:label="lab_ahl_RegulatoryDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory deposits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RegulatoryDeposits" xlink:href="ahl-20231220.xsd#ahl_RegulatoryDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RegulatoryDeposits" xlink:to="lab_ahl_RegulatoryDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_05e42f07-2b3b-4f7f-a350-b6a81adfb11d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on derivatives, net of taxes</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_a0f56437-ec3e-46b6-91c3-a2e0e0eddf12_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_46dbe2bd-31d1-4983-92a2-56d9ba2d8245_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax, Total</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_cec92dde-8339-454c-97b2-60849f4f258b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments:</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FairValueOfDerivativesMember_b77f5c3d-58d0-4870-af5c-c4788458436a_terseLabel_en-US" xlink:label="lab_ahl_FairValueOfDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivatives</link:label>
    <link:label id="lab_ahl_FairValueOfDerivativesMember_label_en-US" xlink:label="lab_ahl_FairValueOfDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivatives [Member]</link:label>
    <link:label id="lab_ahl_FairValueOfDerivativesMember_documentation_en-US" xlink:label="lab_ahl_FairValueOfDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesMember" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FairValueOfDerivativesMember" xlink:to="lab_ahl_FairValueOfDerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_1cea077d-3b70-4f2c-b6de-7a91c197f6da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_632c7b8a-f603-4b48-969b-c0174c251008_terseLabel_en-US" xlink:label="lab_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities and cash as collateral secured letters of credit</link:label>
    <link:label id="lab_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_label_en-US" xlink:label="lab_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Securities And Cash As Collateral Secured Letters Of Credit</link:label>
    <link:label id="lab_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_documentation_en-US" xlink:label="lab_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit securities and cash as collateral secured letters of credit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" xlink:href="ahl-20231220.xsd#ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" xlink:to="lab_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_1e6295aa-448a-490e-a4bf-b5cd99c60a08_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in fair value included in net income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_968f76af-5692-4528-af1e-532af95411a9_terseLabel_en-US" xlink:label="lab_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quotes per fixed income investment</link:label>
    <link:label id="lab_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_label_en-US" xlink:label="lab_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs Offered Quotes Per Fixed Income Investment</link:label>
    <link:label id="lab_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_documentation_en-US" xlink:label="lab_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value inputs offered quotes per fixed income investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment" xlink:href="ahl-20231220.xsd#ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment" xlink:to="lab_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_2eaaead6-379b-49a8-9160-fb332c324c87_terseLabel_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Effect of OCI, Amount</link:label>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_label_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Effect of OCI, Amount</link:label>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_documentation_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Effect of OCI in income statement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" xlink:to="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_a3603dbe-6ca8-4493-8f26-ad3e21ce9386_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_HighYieldLoansMember_75e6aa99-30ec-4608-b2bd-efd7dea18e44_terseLabel_en-US" xlink:label="lab_ahl_HighYieldLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High yield loans</link:label>
    <link:label id="lab_ahl_HighYieldLoansMember_label_en-US" xlink:label="lab_ahl_HighYieldLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High yield loans [Member]</link:label>
    <link:label id="lab_ahl_HighYieldLoansMember_documentation_en-US" xlink:label="lab_ahl_HighYieldLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High yield loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_HighYieldLoansMember" xlink:to="lab_ahl_HighYieldLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_20c46fcc-1b2a-4eb9-9833-1b1406752e1a_terseLabel_en-US" xlink:label="lab_us-gaap_HerMajestysRevenueAndCustomsHMRCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K.</link:label>
    <link:label id="lab_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_label_en-US" xlink:label="lab_us-gaap_HerMajestysRevenueAndCustomsHMRCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Her Majesty's Revenue and Customs (HMRC) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember" xlink:to="lab_us-gaap_HerMajestysRevenueAndCustomsHMRCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CatastropheBondsMember_195af916-927d-4018-9dab-0fa79d29636a_verboseLabel_en-US" xlink:label="lab_ahl_CatastropheBondsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe bonds &#8212; Trading</link:label>
    <link:label id="lab_ahl_CatastropheBondsMember_c1cce610-a006-450d-8ef4-7027d36208d3_terseLabel_en-US" xlink:label="lab_ahl_CatastropheBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe Bonds</link:label>
    <link:label id="lab_ahl_CatastropheBondsMember_label_en-US" xlink:label="lab_ahl_CatastropheBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe Bonds [Member]</link:label>
    <link:label id="lab_ahl_CatastropheBondsMember_documentation_en-US" xlink:label="lab_ahl_CatastropheBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CatastropheBondsMember" xlink:to="lab_ahl_CatastropheBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_eed2bbb7-4c3b-47c1-ba41-4893d91799e7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_71b3521d-cf13-4483-bfbd-32bde37aa8f0_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_bbc17c56-aa70-4e67-8e9c-abc640681dc5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_d8d14a70-d9e2-4caa-a496-2136de5b5470_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceRecoverablesTotalRecoverable_7e589396-acb5-43f0-ac11-445a5ff5f6ce_terseLabel_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesTotalRecoverable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverable total</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesTotalRecoverable_label_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesTotalRecoverable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables, total recoverable</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesTotalRecoverable_documentation_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesTotalRecoverable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables, total recoverable from ADC plus closing date ceded reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesTotalRecoverable" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesTotalRecoverable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceRecoverablesTotalRecoverable" xlink:to="lab_ahl_ReinsuranceRecoverablesTotalRecoverable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_5cd02bd9-1667-4398-bd36-e48643bd41f6_verboseLabel_en-US" xlink:label="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_label_en-US" xlink:label="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid In Capital, Excluding Preference Shares</link:label>
    <link:label id="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_documentation_en-US" xlink:label="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid In Capital, Excluding Preference Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceShares" xlink:href="ahl-20231220.xsd#ahl_AdditionalPaidInCapitalExcludingPreferenceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceShares" xlink:to="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_20a6ca8b-fe42-4fe9-945c-9e79cb8b19e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_8cbcc543-ab3a-4250-944d-149c229efecd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net unrealized (losses)/gains on available for sale securities held</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_dd862e22-c08d-45be-9457-b3dd3d26cb9e_terseLabel_en-US" xlink:label="lab_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in (payable)/receivable for securities (purchased)/sold</link:label>
    <link:label id="lab_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_label_en-US" xlink:label="lab_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change in Receivable for Securities Sold or Payable for Securities Purchased</link:label>
    <link:label id="lab_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_documentation_en-US" xlink:label="lab_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change in Receivable for Securities Sold or Payable for Securities Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" xlink:href="ahl-20231220.xsd#ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" xlink:to="lab_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_2daa5b0d-0694-45b3-b657-a47a52592b60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit/(expense) allocated to other comprehensive (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_cc3d71fa-60be-41e8-b543-1e447a3d9a64_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit/(expense) allocated to other comprehensive (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis_6c2f6caa-8b92-4946-ae99-6d7f9c72ba4c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:to="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5734232d-7ad7-4fd3-9cbe-106d6b48bbaf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc7f5a31-79eb-4146-b5ab-97cf5dc4ef3c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_18c61270-ea0e-4d0d-8fc8-ce25ff7a575b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_38630cd6-0c09-4588-8b67-37cbe27ad844_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_f252f1a6-2a61-4ead-92a7-02a9002d4618_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DerivativeAtFairValueMember_79f8168d-d832-4903-9ffc-2a374a3130d9_terseLabel_en-US" xlink:label="lab_ahl_DerivativeAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives at Fair Value</link:label>
    <link:label id="lab_ahl_DerivativeAtFairValueMember_90450967-4a16-4dfd-9382-4959f9f7c1e8_verboseLabel_en-US" xlink:label="lab_ahl_DerivativeAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative At Fair Value</link:label>
    <link:label id="lab_ahl_DerivativeAtFairValueMember_label_en-US" xlink:label="lab_ahl_DerivativeAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative At Fair Value [Member]</link:label>
    <link:label id="lab_ahl_DerivativeAtFairValueMember_documentation_en-US" xlink:label="lab_ahl_DerivativeAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative at fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DerivativeAtFairValueMember" xlink:to="lab_ahl_DerivativeAtFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_d8d40094-c46a-46bb-9fd6-e0989d463513_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized gain on sale of equity method investment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_28ffb605-2024-4c04-b008-1730412cb3aa_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_fbb596bb-81eb-4c95-8dcb-f2c296d20dfb_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany funds due to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_71151be3-f252-4ce6-8914-7e73447438ad_verboseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party fees still due</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_6f9aaed9-c8af-4370-80b7-5c8c669c9863_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Cost or Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossRatio_d09d5862-3973-4d8c-8db4-baaf711afcd5_terseLabel_en-US" xlink:label="lab_us-gaap_LossRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss ratio</link:label>
    <link:label id="lab_us-gaap_LossRatio_label_en-US" xlink:label="lab_us-gaap_LossRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossRatio" xlink:to="lab_us-gaap_LossRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_8f92a1b6-7437-4cd0-9757-b98d73d4b856_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_dd8e2971-f542-4a73-8ba3-35bb9c77bee9_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net unrealized gains on available for sale securities held</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_bcf68af7-40c6-4874-8f88-1d6ae860e247_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_bc0d129f-bb7b-42d8-b444-ae2e4295978a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3d215c5a-9d88-4f29-929e-c1b754e8592d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_65922fd5-b2cd-42d1-b5d8-ad6b063f7873_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c716653a-a7e8-481a-8af0-aaeaa2128f90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_d0a46de8-734e-44a8-9375-fea9157ef735_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_47345dc1-8180-4f25-ab5d-514260bb6ae5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesDebt_61224a41-a4a9-4c3a-8239-4b8adaf7861a_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesDebt" xlink:to="lab_us-gaap_TradingSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_c403df99-68c8-4aa0-bcee-5b08b6b5e6d4_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Preparation and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3f6e1dac-8ec7-4275-bfe9-d9c7ec9d6599_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_1995880b-4a71-4652-91a6-75226c5865df_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. government-backed corporate</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_11c22735-2d18-4214-8812-c892f7993a12_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reported Claims</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Cumulative Number of Reported Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_903f9dd6-5d46-4bfd-89ba-f4687ffd761b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_ad28e399-090a-4b7b-9baa-1f8f81450b4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets_7fc3c5a5-c601-47f0-9b18-e4f471f11b6f_negatedTerseLabel_en-US" xlink:label="lab_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (additions)/disposals of right-to-use operating lease assets</link:label>
    <link:label id="lab_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets_label_en-US" xlink:label="lab_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (additions)/disposals of right-to-use operating lease assets</link:label>
    <link:label id="lab_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets_documentation_en-US" xlink:label="lab_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (additions)/disposals of right-to-use operating lease assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" xlink:href="ahl-20231220.xsd#ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" xlink:to="lab_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_InvestmentNetCarryingValueMember_6114fe0d-0bec-42e3-9688-e3366d278efb_terseLabel_en-US" xlink:label="lab_ahl_InvestmentNetCarryingValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Net Carrying Value</link:label>
    <link:label id="lab_ahl_InvestmentNetCarryingValueMember_label_en-US" xlink:label="lab_ahl_InvestmentNetCarryingValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Net Carrying Value [Member]</link:label>
    <link:label id="lab_ahl_InvestmentNetCarryingValueMember_documentation_en-US" xlink:label="lab_ahl_InvestmentNetCarryingValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Net Carrying Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentNetCarryingValueMember" xlink:href="ahl-20231220.xsd#ahl_InvestmentNetCarryingValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_InvestmentNetCarryingValueMember" xlink:to="lab_ahl_InvestmentNetCarryingValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_771ae9cb-87dc-421f-8253-5ac89d06b83f_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_1af66b9e-9ff0-46bb-be31-d2e067155621_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_172c5440-3d2a-428f-88d8-4179783e3fa1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_afd399f7-fbd5-401d-9c29-538d85bb2912_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_8d9753a9-494a-4707-b371-daadf0925160_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f61f6aed-a4d4-452c-82c8-2ee6872ab542_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7dc4e068-ecf5-4e3b-b8be-b901c2827507_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3902975c-2a63-4835-a4e7-51ed26a840f8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_bbf01b0a-b693-421d-a164-6eb0e307002d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_489062d8-efe1-48a8-b0e3-5892c103e1b7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due one year or less, Cost or Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3fda71c5-00cb-4b1c-b0ed-7039e513a146_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_db640949-3031-4123-b526-fd8622c34aec_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_5704a316-7fcf-4ae8-a13a-1f3e0bc12271_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_f58b8988-2ac2-45f1-9ff0-f215b5631ba0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6a8ff068-09f8-4005-9b68-c1a3d0c20dfe_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_fc0b8673-ef44-410d-9fc9-2bc130d639ad_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionForeignMember" xlink:to="lab_us-gaap_GeographicDistributionForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_35a9b911-d3a4-4589-adf7-2d92c7d07d7b_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_c79eaeeb-5a4b-4ffc-880f-3dc353d9bd1b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_bb67c715-9e24-4315-a50a-36501f518fe5_terseLabel_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems" xlink:to="lab_us-gaap_LoansAndLeasesReceivableDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_ae3b1ec5-d512-4971-8f5a-212b58365c14_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_IntangibleAssetsandGoodwillAcquiredDisposed_aed35ce0-f371-4a12-a08a-8be9e3b574a6_terseLabel_en-US" xlink:label="lab_ahl_IntangibleAssetsandGoodwillAcquiredDisposed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill, Additions (Disposals)</link:label>
    <link:label id="lab_ahl_IntangibleAssetsandGoodwillAcquiredDisposed_label_en-US" xlink:label="lab_ahl_IntangibleAssetsandGoodwillAcquiredDisposed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill, Acquired (Disposed)</link:label>
    <link:label id="lab_ahl_IntangibleAssetsandGoodwillAcquiredDisposed_documentation_en-US" xlink:label="lab_ahl_IntangibleAssetsandGoodwillAcquiredDisposed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill, Acquired (Disposed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IntangibleAssetsandGoodwillAcquiredDisposed" xlink:href="ahl-20231220.xsd#ahl_IntangibleAssetsandGoodwillAcquiredDisposed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_IntangibleAssetsandGoodwillAcquiredDisposed" xlink:to="lab_ahl_IntangibleAssetsandGoodwillAcquiredDisposed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_8c98e212-6525-487f-b5c7-2646bdc94107_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit), Non-U.S.</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dc6363fd-260f-44a1-a8b7-d1cd1eea8e46_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6fc61091-a572-4c0d-80c8-dbc6e0560520_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_419e103f-14ae-4278-80b5-941ea938379b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7bc0efbc-4794-4d67-a949-63a7eb7a1824_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bermuda tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_c732ffcb-d9a8-4938-9cbf-481baf36e4ba_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.625% Preference Shares (AHL PRD)</link:label>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesEPreferredStockMember" xlink:to="lab_us-gaap_SeriesEPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_d2458531-ce34-433f-9562-6842d62588eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_7f36dbbf-7d51-4187-8d7f-b29e6e59d6dc_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_b48ca4d7-74a6-4c5f-beed-407c59bc411e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CommonStockValueAuthorized_acae2350-df27-40d1-9af0-6f59771e3b16_terseLabel_en-US" xlink:label="lab_ahl_CommonStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, authorized</link:label>
    <link:label id="lab_ahl_CommonStockValueAuthorized_label_en-US" xlink:label="lab_ahl_CommonStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Value Authorized</link:label>
    <link:label id="lab_ahl_CommonStockValueAuthorized_documentation_en-US" xlink:label="lab_ahl_CommonStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock value authorized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CommonStockValueAuthorized" xlink:href="ahl-20231220.xsd#ahl_CommonStockValueAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CommonStockValueAuthorized" xlink:to="lab_ahl_CommonStockValueAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_92a54dc8-85e2-4274-a0c3-cc920089a1d3_terseLabel_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_2d2dd5f9-c959-4efb-a2cf-d71d422bd763_verboseLabel_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed&#160;From Other Companies</link:label>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssumedPremiumsEarned" xlink:to="lab_us-gaap_AssumedPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_71e004ff-c12d-4187-a4fa-16534c61afca_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative paid claims and allocated claim adjustment expense, Net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6656d7ca-962e-4c86-af10-71eb0a688309_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the year</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8fc3904d-efe5-409e-a28f-87f24300af6a_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_17f3df08-9d16-4a20-8eec-c2c41bdfa013_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtServiceCoverageRatioDomain_44007ff1-669e-41fe-9582-afeba142a892_terseLabel_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio [Domain]</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatioDomain_label_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio [Domain]</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatioDomain_documentation_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Service Coverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioDomain" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain" xlink:to="lab_ahl_DebtServiceCoverageRatioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebttoValueRatio71to80PercentMember_849b011f-d2c4-4b60-ba4f-e8ab377d6cb4_terseLabel_en-US" xlink:label="lab_ahl_DebttoValueRatio71to80PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">71 to 80 Percent</link:label>
    <link:label id="lab_ahl_DebttoValueRatio71to80PercentMember_label_en-US" xlink:label="lab_ahl_DebttoValueRatio71to80PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, 71 to 80 Percent [Member]</link:label>
    <link:label id="lab_ahl_DebttoValueRatio71to80PercentMember_documentation_en-US" xlink:label="lab_ahl_DebttoValueRatio71to80PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, 71 to 80 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio71to80PercentMember" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio71to80PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebttoValueRatio71to80PercentMember" xlink:to="lab_ahl_DebttoValueRatio71to80PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_2c66782c-0e00-4ef7-ad19-5fe676a48516_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Realized and Unrealized Investment Gains and Losses and Change in Unrealized Gains and Losses on Investments</link:label>
    <link:label id="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ad396771-aabb-42bc-b60a-f2782d2a26d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_2e02afb9-472b-4d44-85a9-b37cc16236c2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1a52d482-e73d-42ad-a513-c093a79c285e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Trading Securities and Other Trading Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RealEstateFundSept2021Member_2dec77ad-e834-4e2e-93d4-ec7b968bcb8d_terseLabel_en-US" xlink:label="lab_ahl_RealEstateFundSept2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate fund (Sept 2021)</link:label>
    <link:label id="lab_ahl_RealEstateFundSept2021Member_label_en-US" xlink:label="lab_ahl_RealEstateFundSept2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Fund (Sept 2021) [Member]</link:label>
    <link:label id="lab_ahl_RealEstateFundSept2021Member_documentation_en-US" xlink:label="lab_ahl_RealEstateFundSept2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Fund (Sept 2021)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundSept2021Member" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundSept2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RealEstateFundSept2021Member" xlink:to="lab_ahl_RealEstateFundSept2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen_70af8bc2-70eb-4c51-83a7-3143b3a30598_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year Ten</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram_84314b30-3c56-42cc-9dc4-9ad0e58d499c_terseLabel_en-US" xlink:label="lab_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to Effectiveness And Efficiency Program</link:label>
    <link:label id="lab_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram_label_en-US" xlink:label="lab_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Expenses Related To Effectiveness And Efficiency Program</link:label>
    <link:label id="lab_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram_documentation_en-US" xlink:label="lab_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Expenses Related To Effectiveness And Efficiency Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" xlink:href="ahl-20231220.xsd#ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" xlink:to="lab_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RestrictedCashAndCollateralLineItems_39aba3f9-fa92-429b-a4f2-cb07679bd057_terseLabel_en-US" xlink:label="lab_ahl_RestrictedCashAndCollateralLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Collateral [Line Items]</link:label>
    <link:label id="lab_ahl_RestrictedCashAndCollateralLineItems_label_en-US" xlink:label="lab_ahl_RestrictedCashAndCollateralLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Collateral [Line Items]</link:label>
    <link:label id="lab_ahl_RestrictedCashAndCollateralLineItems_documentation_en-US" xlink:label="lab_ahl_RestrictedCashAndCollateralLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Collateral [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralLineItems" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems" xlink:to="lab_ahl_RestrictedCashAndCollateralLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_6762f5c2-9997-4785-8724-bf4f64464daa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_0ba5197e-d451-4c5f-834a-b4d4cc22e611_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for net realized gains/(losses) on investments included in net income/(loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_USOperatingSubsidiariesMember_4ad911b8-2268-4cbb-a950-c50cf3cbcd50_terseLabel_en-US" xlink:label="lab_ahl_USOperatingSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operating subsidiaries</link:label>
    <link:label id="lab_ahl_USOperatingSubsidiariesMember_label_en-US" xlink:label="lab_ahl_USOperatingSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operating subsidiaries [Member]</link:label>
    <link:label id="lab_ahl_USOperatingSubsidiariesMember_documentation_en-US" xlink:label="lab_ahl_USOperatingSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operating subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_USOperatingSubsidiariesMember" xlink:href="ahl-20231220.xsd#ahl_USOperatingSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_USOperatingSubsidiariesMember" xlink:to="lab_ahl_USOperatingSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_f5af790f-b67a-4237-b214-72f0f5231847_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change from current period hedged transactions</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NonPaymentOfDividendsNumberOfPeriods_88e4a6f5-a73a-4d93-8fd1-7aae0acafd15_terseLabel_en-US" xlink:label="lab_ahl_NonPaymentOfDividendsNumberOfPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Payment Of Dividends, Number Of Periods</link:label>
    <link:label id="lab_ahl_NonPaymentOfDividendsNumberOfPeriods_label_en-US" xlink:label="lab_ahl_NonPaymentOfDividendsNumberOfPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Payment Of Dividends, Number Of Periods</link:label>
    <link:label id="lab_ahl_NonPaymentOfDividendsNumberOfPeriods_documentation_en-US" xlink:label="lab_ahl_NonPaymentOfDividendsNumberOfPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Payment Of Dividends, Number Of Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonPaymentOfDividendsNumberOfPeriods" xlink:href="ahl-20231220.xsd#ahl_NonPaymentOfDividendsNumberOfPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NonPaymentOfDividendsNumberOfPeriods" xlink:to="lab_ahl_NonPaymentOfDividendsNumberOfPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_SharebasedpaymentandLTIPexpense_d8747441-0e17-43e7-8fab-4746563bf1df_terseLabel_en-US" xlink:label="lab_ahl_SharebasedpaymentandLTIPexpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment and LTIP expense</link:label>
    <link:label id="lab_ahl_SharebasedpaymentandLTIPexpense_label_en-US" xlink:label="lab_ahl_SharebasedpaymentandLTIPexpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment and LTIP expense</link:label>
    <link:label id="lab_ahl_SharebasedpaymentandLTIPexpense_documentation_en-US" xlink:label="lab_ahl_SharebasedpaymentandLTIPexpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment and LTIP expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SharebasedpaymentandLTIPexpense" xlink:href="ahl-20231220.xsd#ahl_SharebasedpaymentandLTIPexpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_SharebasedpaymentandLTIPexpense" xlink:to="lab_ahl_SharebasedpaymentandLTIPexpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_71dbad9b-67d4-4414-8daf-5d40610afeb7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years, Cost or Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredPolicyAcquisitionCostOtherExpenses_c9349771-0e70-45d0-a173-1b3dc8878bba_terseLabel_en-US" xlink:label="lab_ahl_DeferredPolicyAcquisitionCostOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy Acquisition Expenses&#160;</link:label>
    <link:label id="lab_ahl_DeferredPolicyAcquisitionCostOtherExpenses_label_en-US" xlink:label="lab_ahl_DeferredPolicyAcquisitionCostOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost Other Expenses</link:label>
    <link:label id="lab_ahl_DeferredPolicyAcquisitionCostOtherExpenses_documentation_en-US" xlink:label="lab_ahl_DeferredPolicyAcquisitionCostOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredPolicyAcquisitionCostOtherExpenses" xlink:href="ahl-20231220.xsd#ahl_DeferredPolicyAcquisitionCostOtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredPolicyAcquisitionCostOtherExpenses" xlink:to="lab_ahl_DeferredPolicyAcquisitionCostOtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_7c8ed687-9d0d-4567-aef2-658108152cc2_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_88924c1a-78a6-40a5-ab1e-75b0822201a8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AAICMember_625b87b6-5ae0-409e-ad68-de56193c694f_terseLabel_en-US" xlink:label="lab_ahl_AAICMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAIC</link:label>
    <link:label id="lab_ahl_AAICMember_label_en-US" xlink:label="lab_ahl_AAICMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAIC [Member]</link:label>
    <link:label id="lab_ahl_AAICMember_documentation_en-US" xlink:label="lab_ahl_AAICMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAIC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAICMember" xlink:href="ahl-20231220.xsd#ahl_AAICMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AAICMember" xlink:to="lab_ahl_AAICMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededPremiumsEarned_989e8a20-271a-42db-ad96-8ae1d12994c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CededPremiumsEarned" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_CededPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_CededPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededPremiumsEarned" xlink:to="lab_us-gaap_CededPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_76744077-4c5b-43d4-8d34-eece90713b15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ea1f6dc1-153b-4eb9-99d0-1fc79db40651_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance reserves:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff_dd86c40e-857b-40e4-b287-8e0a3d8336e0_terseLabel_en-US" xlink:label="lab_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to fixed income writeoff</link:label>
    <link:label id="lab_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff_label_en-US" xlink:label="lab_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to fixed income writeoff</link:label>
    <link:label id="lab_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff_documentation_en-US" xlink:label="lab_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to fixed income writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff" xlink:href="ahl-20231220.xsd#ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff" xlink:to="lab_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_12748492-0997-454e-b75f-49025e3d267a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities&#160;&#8212; Available for sale</link:label>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:to="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_69b305a0-908e-4542-9d99-92a65f20cc80_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments &#8212; Trading</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonperformingFinancingReceivableMember_ff2b7d78-a33f-4d14-9bd0-a00edd63d5c2_terseLabel_en-US" xlink:label="lab_us-gaap_NonperformingFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonperforming loans</link:label>
    <link:label id="lab_us-gaap_NonperformingFinancingReceivableMember_label_en-US" xlink:label="lab_us-gaap_NonperformingFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonperforming Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonperformingFinancingReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonperformingFinancingReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonperformingFinancingReceivableMember" xlink:to="lab_us-gaap_NonperformingFinancingReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_92473814-7177-41bf-abd8-d3d9c9adefa1_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expenses&#160;</link:label>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_label_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:to="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ApolloRealEstateFundMember_c561d02a-56d2-4b46-9db7-58f92196a154_terseLabel_en-US" xlink:label="lab_ahl_ApolloRealEstateFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo real estate fund</link:label>
    <link:label id="lab_ahl_ApolloRealEstateFundMember_label_en-US" xlink:label="lab_ahl_ApolloRealEstateFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo Real Estate Fund [Member]</link:label>
    <link:label id="lab_ahl_ApolloRealEstateFundMember_documentation_en-US" xlink:label="lab_ahl_ApolloRealEstateFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo Real Estate Fund</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ApolloRealEstateFundMember" xlink:to="lab_ahl_ApolloRealEstateFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_a2e4f215-b08d-41e5-bf05-0e863517772f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_ebd9498d-1732-49cc-9651-2f1a9606b0a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_edda2896-1b25-4d83-a3c0-15cbbb4a5495_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CapitalReserves_ee89891f-5cb5-49e4-b19e-b9687958141a_terseLabel_en-US" xlink:label="lab_ahl_CapitalReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions reserves</link:label>
    <link:label id="lab_ahl_CapitalReserves_label_en-US" xlink:label="lab_ahl_CapitalReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Reserves</link:label>
    <link:label id="lab_ahl_CapitalReserves_documentation_en-US" xlink:label="lab_ahl_CapitalReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CapitalReserves" xlink:href="ahl-20231220.xsd#ahl_CapitalReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CapitalReserves" xlink:to="lab_ahl_CapitalReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_c6da490c-251c-4732-9f13-9e488950926e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PercentageOfReinsuranceLiabilities_1fb80dcf-723b-4c35-ae84-cf9a96cc79c9_terseLabel_en-US" xlink:label="lab_ahl_PercentageOfReinsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of reinsurance liabilities</link:label>
    <link:label id="lab_ahl_PercentageOfReinsuranceLiabilities_label_en-US" xlink:label="lab_ahl_PercentageOfReinsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Reinsurance Liabilities</link:label>
    <link:label id="lab_ahl_PercentageOfReinsuranceLiabilities_documentation_en-US" xlink:label="lab_ahl_PercentageOfReinsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of reinsurance liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfReinsuranceLiabilities" xlink:href="ahl-20231220.xsd#ahl_PercentageOfReinsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PercentageOfReinsuranceLiabilities" xlink:to="lab_ahl_PercentageOfReinsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_46ce3991-b333-461b-9f14-c6be8df3080d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_20d1f7ba-0b8e-4bc7-a2e4-02555fa0765c_terseLabel_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale, Continuous Loss Position, Fair Market Value</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_c5c80025-1bf2-464c-b528-92d6d62b645b_totalLabel_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Fair Market Value</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_label_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale, Continuous Loss Position, Fair Market Value</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_documentation_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale, Continuous Loss Position, Fair Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" xlink:to="lab_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_a0b614d5-80c3-4d96-ad57-1ad38e6272cf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers in/(out)</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_GlobalCorporateSecuritiesMember_1c254b0e-f792-4a9c-9eea-01273f8e2a8b_terseLabel_en-US" xlink:label="lab_ahl_GlobalCorporateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global corporate securities</link:label>
    <link:label id="lab_ahl_GlobalCorporateSecuritiesMember_label_en-US" xlink:label="lab_ahl_GlobalCorporateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global corporate securities [Member]</link:label>
    <link:label id="lab_ahl_GlobalCorporateSecuritiesMember_documentation_en-US" xlink:label="lab_ahl_GlobalCorporateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global corporates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_GlobalCorporateSecuritiesMember" xlink:to="lab_ahl_GlobalCorporateSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_5109a57b-0bb0-4949-b3e0-62910b33bfea_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years, Cost or Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1dcbf0a4-8fe6-4fed-9b99-d1e75366ab55_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_3e334511-c9ad-43bc-a5ce-ae6224b0aa8c_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_983a46bc-7663-4908-803b-25cbf581bf09_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_205e5574-fc92-4c94-8a55-6c32b57de9f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_48e4073e-1891-4754-9308-e71f22b1ba3a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_80d4de33-1ac4-4388-b1a4-1bf62de63271_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AuthorizedShareCapital_cd6e469e-206c-4ee6-ab2f-cca95e5ede06_totalLabel_en-US" xlink:label="lab_ahl_AuthorizedShareCapital" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total authorized share capital</link:label>
    <link:label id="lab_ahl_AuthorizedShareCapital_5cd3d360-0407-4128-a174-0ac7441275c5_terseLabel_en-US" xlink:label="lab_ahl_AuthorizedShareCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized share capital</link:label>
    <link:label id="lab_ahl_AuthorizedShareCapital_label_en-US" xlink:label="lab_ahl_AuthorizedShareCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized Share Capital</link:label>
    <link:label id="lab_ahl_AuthorizedShareCapital_documentation_en-US" xlink:label="lab_ahl_AuthorizedShareCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized Share Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AuthorizedShareCapital" xlink:to="lab_ahl_AuthorizedShareCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b3fa8fcf-169d-4fd1-a59c-fdc2034db61f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9e9af27f-967e-473c-bdd9-232161ba4d0a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses, less than twelve months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NatixisMember_49e672bc-d3fa-49f6-b5d8-445473dbab7b_terseLabel_en-US" xlink:label="lab_ahl_NatixisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natixis</link:label>
    <link:label id="lab_ahl_NatixisMember_label_en-US" xlink:label="lab_ahl_NatixisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natixis [Member]</link:label>
    <link:label id="lab_ahl_NatixisMember_documentation_en-US" xlink:label="lab_ahl_NatixisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natixis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NatixisMember" xlink:href="ahl-20231220.xsd#ahl_NatixisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NatixisMember" xlink:to="lab_ahl_NatixisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AspenEuropeanMember_91a7601d-bcf3-40ae-a87f-132642eeb668_terseLabel_en-US" xlink:label="lab_ahl_AspenEuropeanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen European</link:label>
    <link:label id="lab_ahl_AspenEuropeanMember_label_en-US" xlink:label="lab_ahl_AspenEuropeanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen European [Member]</link:label>
    <link:label id="lab_ahl_AspenEuropeanMember_documentation_en-US" xlink:label="lab_ahl_AspenEuropeanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen European</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenEuropeanMember" xlink:href="ahl-20231220.xsd#ahl_AspenEuropeanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AspenEuropeanMember" xlink:to="lab_ahl_AspenEuropeanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fd0fbd97-5a7a-4fcf-a5c2-6aa05010c88f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows (used in)/from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_9864e73e-502a-4b9c-9131-c3373c2d0baa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities under derivative contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtServiceCoverageRatio1.00to1.20xMember_ca158674-a7f4-42ff-87f0-e88ad755cf8a_terseLabel_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatio1.00to1.20xMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.00 - 1.20x</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatio1.00to1.20xMember_label_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatio1.00to1.20xMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio, 1.00 to 1.20x [Member]</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatio1.00to1.20xMember_documentation_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatio1.00to1.20xMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio, 1.00 to 1.20x [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatio1.00to1.20xMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember" xlink:to="lab_ahl_DebtServiceCoverageRatio1.00to1.20xMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_33125bbd-ad4a-41ce-832c-db5ff29474e6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses and loss adjustment expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:to="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAtFairValue_e43526f5-b348-4a1a-97e6-7e974e18e3ed_terseLabel_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, trading at fair value</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAtFairValue_label_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, trading at fair value</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAtFairValue_documentation_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAtFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, trading at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValue" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShortTermInvestmentsTradingAtFairValue" xlink:to="lab_ahl_ShortTermInvestmentsTradingAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1035d1af-a7d4-4c0c-9e3e-ac46ec6a43a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds_e3583d29-a020-4450-ac53-44be5dbcf8a8_terseLabel_en-US" xlink:label="lab_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities lending transaction</link:label>
    <link:label id="lab_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds_label_en-US" xlink:label="lab_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities lending transaction to support funds at Lloyd's</link:label>
    <link:label id="lab_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds_documentation_en-US" xlink:label="lab_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities lending transaction to support funds at Lloyd's</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds" xlink:href="ahl-20231220.xsd#ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds" xlink:to="lab_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_2d9a9e29-2af8-4801-b382-6141ed2ceeec_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax (benefit)/expense, Total</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_f8c7324a-9e44-43c2-b890-f95fba2eca10_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_6cd3075f-131c-479e-8d17-e244e5ccb1e2_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Quality Indicators of Commercial Mortgage and Middle Market Loans</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Credit Quality Indicators [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:to="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsMember1_17d415a1-f28a-4e35-bedc-09f08b255e6b_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsMember1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsMember1_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsMember1" xlink:to="lab_us-gaap_GainLossOnInvestmentsMember1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_7f2deaa0-dd95-4632-aa65-517c9dcd8a8a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MultiLineReinsurerMember_403b8313-2a2d-4318-826e-f4036fe65671_terseLabel_en-US" xlink:label="lab_ahl_MultiLineReinsurerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi-Line Insurer</link:label>
    <link:label id="lab_ahl_MultiLineReinsurerMember_label_en-US" xlink:label="lab_ahl_MultiLineReinsurerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi-Line Reinsurer [Member]</link:label>
    <link:label id="lab_ahl_MultiLineReinsurerMember_documentation_en-US" xlink:label="lab_ahl_MultiLineReinsurerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi-Line Reinsurer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MultiLineReinsurerMember" xlink:to="lab_ahl_MultiLineReinsurerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_4792026b-9792-4fc5-82bd-51c51d7505bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gains or losses</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_bd284533-74e4-4b52-8f22-7d0c038f6f76_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ef50fd59-ba35-42ba-a78b-6ff35043d3ce_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in subsidiaries (1)</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_190c598f-6d70-49cd-a136-0e9901038772_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_6b9b5472-6eec-4990-ac1c-601d8eb5cd7f_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, End of the Period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6c04d72f-c164-4bfe-8bdb-f0d24f328f4c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_bdc4ce4f-6f63-421d-9a2c-230ca3554789_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain_f5d8c147-60d0-4f2c-b63d-554810607464_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:to="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtServiceCoverageRatioAxis_66d3e4d3-9b1a-4942-b3e1-33141bbe3125_terseLabel_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio [Axis]</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatioAxis_label_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio [Axis]</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatioAxis_documentation_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioAxis" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtServiceCoverageRatioAxis" xlink:to="lab_ahl_DebtServiceCoverageRatioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_b82b5bf4-f660-476c-a419-77df38a4082b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes refundable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReceivable" xlink:to="lab_us-gaap_IncomeTaxReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1a33bd08-9b8f-4909-bc46-8284aa6b315d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit/(expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d8631c1e-cdda-442f-b92d-a6bc88666a93_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7c0289ae-b620-49de-a580-c1cbc2c21ff6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit)/expense allocated to net income</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_99ef1d90-2f01-49d3-800d-3e3fe48eaf3d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total tax expense/(benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_13358a1b-424c-4527-8ecf-3936cd1ea26f_negatedNetLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (expense)/benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5abfbb2c-e296-4d4a-9302-aa609746ae80_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7237de99-95b6-4d47-b876-bc3cf2f5a92d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0e71bd20-a2b1-4393-bbbc-3642bae42bd9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_13c82714-305a-4041-9ddd-87d2aeed8130_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_8631522d-dfa3-45e8-b3d9-af539453375f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_25f2c3bd-2be2-41a0-a7bf-ee1140944466_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Policy Acquisition Costs</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Policy Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AustralianTrustFundMember_77388e39-2a1c-43ef-aa7a-b8aad98a5ba5_terseLabel_en-US" xlink:label="lab_ahl_AustralianTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Trust Fund</link:label>
    <link:label id="lab_ahl_AustralianTrustFundMember_label_en-US" xlink:label="lab_ahl_AustralianTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Trust Fund [Member]</link:label>
    <link:label id="lab_ahl_AustralianTrustFundMember_documentation_en-US" xlink:label="lab_ahl_AustralianTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Trust Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AustralianTrustFundMember" xlink:href="ahl-20231220.xsd#ahl_AustralianTrustFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AustralianTrustFundMember" xlink:to="lab_ahl_AustralianTrustFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_73e5acea-74c2-4606-941e-8d92e3b9ec42_negatedTerseLabel_en-US" xlink:label="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_37e41d18-f57e-459e-b86d-07d12381350f_terseLabel_en-US" xlink:label="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_label_en-US" xlink:label="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_documentation_en-US" xlink:label="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" xlink:to="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_64cff5da-b03e-4cea-9521-78966227b93e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_89dacb1f-1140-4c00-98a2-17f910a231e2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_45b5635e-dcec-4293-ab64-97dddfc608f5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities under derivative contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7fd9ca85-25d7-4439-8613-dfa0a361b074_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities under derivative contracts, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_ea270541-fa3d-49a5-968c-99ebb92c5e9a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_82792d19-6079-4c50-b178-91b98c7a92e8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee, Other</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_380fd4de-f2d2-45b0-bc98-8b013b53394e_terseLabel_en-US" xlink:label="lab_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite and Indefinite Lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite and Indefinite Lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_documentation_en-US" xlink:label="lab_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite and Indefinite Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward" xlink:href="ahl-20231220.xsd#ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward" xlink:to="lab_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ApartmentBuildingMember_38c05811-5581-4f63-9fad-5cfb9ae7bab0_terseLabel_en-US" xlink:label="lab_srt_ApartmentBuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apartment</link:label>
    <link:label id="lab_srt_ApartmentBuildingMember_label_en-US" xlink:label="lab_srt_ApartmentBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apartment Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ApartmentBuildingMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ApartmentBuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ApartmentBuildingMember" xlink:to="lab_srt_ApartmentBuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_61b63193-ae34-4b56-bb3a-64e7ad2a25e4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contribution carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Charitable Contribution Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_OtherComprehensiveIncomeLossAbstract_ae9108d3-699d-44d5-ad41-179cb4911e91_terseLabel_en-US" xlink:label="lab_ahl_OtherComprehensiveIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income:</link:label>
    <link:label id="lab_ahl_OtherComprehensiveIncomeLossAbstract_label_en-US" xlink:label="lab_ahl_OtherComprehensiveIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Loss [Abstract]</link:label>
    <link:label id="lab_ahl_OtherComprehensiveIncomeLossAbstract_documentation_en-US" xlink:label="lab_ahl_OtherComprehensiveIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherComprehensiveIncomeLossAbstract" xlink:href="ahl-20231220.xsd#ahl_OtherComprehensiveIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract" xlink:to="lab_ahl_OtherComprehensiveIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_c349bbac-165c-4078-8cb5-e30ee6de4ebd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">60,395,839 ordinary shares of par value $0.01 each (December&#160;31, 2021 &#8212; 60,395,839 shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_96606dd3-5e7b-4223-bb35-e9e3112666a5_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, value</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_317466eb-50b4-4f51-9209-490d8e345c00_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_195ae9dd-4890-4a87-a702-6a6678539128_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_05f5c7a4-d3c9-4ff6-96fd-7d18862655a2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_d002b5bb-6131-4a28-bae0-c54108196018_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_14ebc484-54df-43e6-9d42-bbdcd1fe5616_negatedLabel_en-US" xlink:label="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivatives and settlement of liabilities under derivatives</link:label>
    <link:label id="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_dc0a6f6e-d2fd-4a13-a81e-953e7d65aa07_negatedTerseLabel_en-US" xlink:label="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Derivatives And Settlement Of Liabilities Under Derivatives</link:label>
    <link:label id="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_label_en-US" xlink:label="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Derivatives And Settlement Of Liabilities Under Derivatives</link:label>
    <link:label id="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_documentation_en-US" xlink:label="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivatives and settlement of liabilities under derivatives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" xlink:to="lab_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_fbba1af2-05f7-4ccc-9ac1-5ab9c45f345d_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_24826c4e-ffb1-44c4-a8be-5c5bae587502_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged&#160;to Other Accounts&#160;</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_e0e66615-3687-4712-897a-3df5d12bba92_terseLabel_en-US" xlink:label="lab_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Retention Policy, Retrocession Premium, Interest Rate</link:label>
    <link:label id="lab_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_label_en-US" xlink:label="lab_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Retention Policy, Retrocession Premium, Interest Rate</link:label>
    <link:label id="lab_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_documentation_en-US" xlink:label="lab_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Retention Policy, Retrocession Premium, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" xlink:to="lab_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_8ed17ab8-5795-4683-8d22-f365497b36fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded commitment</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_6691d9e7-4ddf-43de-ac0c-7444b0e79a2e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedLoss_215b4130-7b02-452d-bc75-4032bf95c89b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities, trading, gross realizes (losses)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesTradingRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_232902ef-4dae-4297-be12-6916ad819607_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e8ac64d1-3740-4a59-a490-793ef41a3aeb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) before tax, Non-U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_53f1775c-c477-4406-a8b2-77d5712e280f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assumed and Ceded Reinsurance on Premiums Written, Premiums Earned and Insurance Losses and Loss Adjustment Expenses</link:label>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_label_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Reinsurance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:to="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_85847a91-48d1-4bab-add2-cc2cc6b9c7a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_52006229-b2ad-4b5b-9efe-ddb521c6303b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of changes in statutory tax rates (4)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CitibankEuropeplcMember_626fc9cf-00de-4fb7-8a3e-b2b3c27fecf0_terseLabel_en-US" xlink:label="lab_ahl_CitibankEuropeplcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank Europe plc</link:label>
    <link:label id="lab_ahl_CitibankEuropeplcMember_label_en-US" xlink:label="lab_ahl_CitibankEuropeplcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank Europe plc [Member]</link:label>
    <link:label id="lab_ahl_CitibankEuropeplcMember_documentation_en-US" xlink:label="lab_ahl_CitibankEuropeplcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank Europe plc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CitibankEuropeplcMember" xlink:href="ahl-20231220.xsd#ahl_CitibankEuropeplcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CitibankEuropeplcMember" xlink:to="lab_ahl_CitibankEuropeplcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_0352d46f-0304-406e-859a-ec4868dcd1f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and issuances</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AccruedExpensesMember_1c0d5fcd-0d40-4e95-9216-05fa7a3680fb_terseLabel_en-US" xlink:label="lab_ahl_AccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_ahl_AccruedExpensesMember_label_en-US" xlink:label="lab_ahl_AccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses [Member]</link:label>
    <link:label id="lab_ahl_AccruedExpensesMember_documentation_en-US" xlink:label="lab_ahl_AccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AccruedExpensesMember" xlink:to="lab_ahl_AccruedExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_InvestmentsExcludingDerivativeAssets_43f4bb97-5b9e-4dac-9bfa-653dea5fef67_totalLabel_en-US" xlink:label="lab_ahl_InvestmentsExcludingDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Excluding Derivative Assets</link:label>
    <link:label id="lab_ahl_InvestmentsExcludingDerivativeAssets_eeb2149a-f142-4a07-bff6-f1cc285935d0_terseLabel_en-US" xlink:label="lab_ahl_InvestmentsExcludingDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Excluding Derivative Assets</link:label>
    <link:label id="lab_ahl_InvestmentsExcludingDerivativeAssets_label_en-US" xlink:label="lab_ahl_InvestmentsExcludingDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Excluding Derivative Assets</link:label>
    <link:label id="lab_ahl_InvestmentsExcludingDerivativeAssets_documentation_en-US" xlink:label="lab_ahl_InvestmentsExcludingDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Excluding Derivative Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentsExcludingDerivativeAssets" xlink:href="ahl-20231220.xsd#ahl_InvestmentsExcludingDerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_InvestmentsExcludingDerivativeAssets" xlink:to="lab_ahl_InvestmentsExcludingDerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_5d949db9-f34b-4d9c-be51-74f07c387ac7_terseLabel_en-US" xlink:label="lab_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:href="ahl-20231220.xsd#ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="lab_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ConsumerStaplesServiceMember_83f21b0e-2d1c-419f-bf1d-81d717532d15_terseLabel_en-US" xlink:label="lab_ahl_ConsumerStaplesServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer staples</link:label>
    <link:label id="lab_ahl_ConsumerStaplesServiceMember_label_en-US" xlink:label="lab_ahl_ConsumerStaplesServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Staples Service [Member]</link:label>
    <link:label id="lab_ahl_ConsumerStaplesServiceMember_documentation_en-US" xlink:label="lab_ahl_ConsumerStaplesServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Staples Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConsumerStaplesServiceMember" xlink:href="ahl-20231220.xsd#ahl_ConsumerStaplesServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ConsumerStaplesServiceMember" xlink:to="lab_ahl_ConsumerStaplesServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_cddfe90d-2252-465e-940d-87e3d1e8366d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_SingaporeTrustFundMember_1d554744-11d0-4c61-a26b-d5a56b6c528d_terseLabel_en-US" xlink:label="lab_ahl_SingaporeTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore Trust Fund</link:label>
    <link:label id="lab_ahl_SingaporeTrustFundMember_label_en-US" xlink:label="lab_ahl_SingaporeTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore Trust Fund [Member]</link:label>
    <link:label id="lab_ahl_SingaporeTrustFundMember_documentation_en-US" xlink:label="lab_ahl_SingaporeTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore trust fund</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SingaporeTrustFundMember" xlink:href="ahl-20231220.xsd#ahl_SingaporeTrustFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_SingaporeTrustFundMember" xlink:to="lab_ahl_SingaporeTrustFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_9f930630-cd18-47d8-b749-08b7592e5eee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MinimumTrustFund_cb6e79fb-1b35-43fe-8e85-093dc38de2d0_terseLabel_en-US" xlink:label="lab_ahl_MinimumTrustFund" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum trust fund</link:label>
    <link:label id="lab_ahl_MinimumTrustFund_label_en-US" xlink:label="lab_ahl_MinimumTrustFund" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Trust Fund</link:label>
    <link:label id="lab_ahl_MinimumTrustFund_documentation_en-US" xlink:label="lab_ahl_MinimumTrustFund" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum trust fund.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MinimumTrustFund" xlink:href="ahl-20231220.xsd#ahl_MinimumTrustFund"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MinimumTrustFund" xlink:to="lab_ahl_MinimumTrustFund" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_c60c6899-c471-4a2b-9457-96a501ccba63_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance reserves: Losses and loss adjustment expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_3163b426-f1b7-48a7-8f70-7de654d663c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_3f382eda-e967-42ae-ba80-e7754a8fc5ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other payables (4)</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0a5e719d-20d1-4d3b-9126-528502cfcbaa_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLeaseLiability_64c697a3-b870-4780-b87a-54235e97a2cb_terseLabel_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liability</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_ahl_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_3674d3c4-2b27-4d71-a340-6a27180d8ca0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsTable" xlink:to="lab_us-gaap_InvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_3f2480f9-b070-4323-9682-d3a07c3fa111_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_455a7daa-3a0b-4c97-a3dd-3fe8e51382ba_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc3883b5-c4c6-4524-9acd-f18448b63217_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss)/income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_590f23d2-dca2-4f4b-b156-ad0c4cb51fa1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss)/income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive_f6179331-1689-45ad-a5bd-fc86787dfe0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year Five</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_75a2241d-42f2-47f1-b5f9-22fb2aa5657a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesFPreferredStockMember_960f9fd8-9858-41f0-a8ab-0d7a4a1783ba_verboseLabel_en-US" xlink:label="lab_us-gaap_SeriesFPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.625% Preference Shares, rep by Dep Shares (AHL PRE)</link:label>
    <link:label id="lab_us-gaap_SeriesFPreferredStockMember_fee87ae9-72b4-435d-8b0f-22dbdc88a45d_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesFPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.625% Preference Shares (AHL PRE)</link:label>
    <link:label id="lab_us-gaap_SeriesFPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesFPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series F Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesFPreferredStockMember" xlink:to="lab_us-gaap_SeriesFPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetManagementArrangementMember_73171630-b668-4df8-b9ce-41a8d7d76683_terseLabel_en-US" xlink:label="lab_us-gaap_AssetManagementArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Management Arrangement</link:label>
    <link:label id="lab_us-gaap_AssetManagementArrangementMember_label_en-US" xlink:label="lab_us-gaap_AssetManagementArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Management Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetManagementArrangementMember" xlink:to="lab_us-gaap_AssetManagementArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DepositaryShareDividendRateFractionalInterest_889e40cc-74a6-4cf9-8bbe-e468311a36c9_terseLabel_en-US" xlink:label="lab_ahl_DepositaryShareDividendRateFractionalInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary share interest of 1/1000th in each 5.625%</link:label>
    <link:label id="lab_ahl_DepositaryShareDividendRateFractionalInterest_label_en-US" xlink:label="lab_ahl_DepositaryShareDividendRateFractionalInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DepositaryShareDividendRateFractionalInterest</link:label>
    <link:label id="lab_ahl_DepositaryShareDividendRateFractionalInterest_documentation_en-US" xlink:label="lab_ahl_DepositaryShareDividendRateFractionalInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Depositary Share Fractional Interest (1/1000th of 5.625% Preference Share)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositaryShareDividendRateFractionalInterest" xlink:href="ahl-20231220.xsd#ahl_DepositaryShareDividendRateFractionalInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DepositaryShareDividendRateFractionalInterest" xlink:to="lab_ahl_DepositaryShareDividendRateFractionalInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_OtherJuridictionsMember_df683f02-1a43-43bb-8517-08715735b7ba_terseLabel_en-US" xlink:label="lab_ahl_OtherJuridictionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other juridictions</link:label>
    <link:label id="lab_ahl_OtherJuridictionsMember_label_en-US" xlink:label="lab_ahl_OtherJuridictionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other juridictions [Member]</link:label>
    <link:label id="lab_ahl_OtherJuridictionsMember_documentation_en-US" xlink:label="lab_ahl_OtherJuridictionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other juridictions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherJuridictionsMember" xlink:href="ahl-20231220.xsd#ahl_OtherJuridictionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_OtherJuridictionsMember" xlink:to="lab_ahl_OtherJuridictionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_10084064-abdc-4dea-b7cf-ff98addc56a0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c251d21d-6211-4dac-bb49-934b6ac77096_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_0bac8629-90a1-41e1-b0a8-c0c6a624bfe5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Losses and LAE payments for claims incurred:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_6a5843ab-c4dc-40d7-9118-04c49a30a92e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_b96b5d0d-d690-4454-b1d3-3da679284fb0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2015</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year 2015 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_SwissTrustFundMember_6a9d1c41-fac3-4d9a-9fdc-08c5642aa68e_terseLabel_en-US" xlink:label="lab_ahl_SwissTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Trust Fund</link:label>
    <link:label id="lab_ahl_SwissTrustFundMember_label_en-US" xlink:label="lab_ahl_SwissTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Trust Fund [Member]</link:label>
    <link:label id="lab_ahl_SwissTrustFundMember_documentation_en-US" xlink:label="lab_ahl_SwissTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Trust Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SwissTrustFundMember" xlink:href="ahl-20231220.xsd#ahl_SwissTrustFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_SwissTrustFundMember" xlink:to="lab_ahl_SwissTrustFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_1bc104ec-9425-491f-ba68-aa32c0fc8697_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e4578e96-f3e7-47db-a096-268704a76951_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_bafc2b34-3619-43ef-8d2a-a263f37919e8_terseLabel_en-US" xlink:label="lab_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of written premium major broker accounted minimum</link:label>
    <link:label id="lab_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_label_en-US" xlink:label="lab_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Written Premium Major Broker Accounted Minimum</link:label>
    <link:label id="lab_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_documentation_en-US" xlink:label="lab_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of written premium major broker accounted minimum.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" xlink:href="ahl-20231220.xsd#ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" xlink:to="lab_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock_d0df8079-3013-44b2-9699-3abb7d1b446d_terseLabel_en-US" xlink:label="lab_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Total Income Tax</link:label>
    <link:label id="lab_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock_label_en-US" xlink:label="lab_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Income Tax Expense Benefit Intraperiod Tax Allocation [Table Text Block]</link:label>
    <link:label id="lab_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock_documentation_en-US" xlink:label="lab_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income tax expense benefit intraperiod tax allocation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" xlink:href="ahl-20231220.xsd#ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" xlink:to="lab_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_79276f52-5e9f-411c-b3f8-330f11a80993_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_9d7c91a4-ac8d-42cb-a0c0-a171bf8c2771_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_35221845-ff20-48e2-a70c-de008f55f4c3_periodStartLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and goodwill, Beginning of the period</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_e7824026-fc76-49b5-9ed7-14174736ddf5_periodEndLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and goodwill, End of the period</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_f35b6d1e-9e39-44ae-a347-750670d71a2a_negatedTerseLabel_en-US" xlink:label="lab_ahl_PaymentsforAvailableforsaleSecuritiesShortterm" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Purchases) of short-term investments &#8212; Available for sale</link:label>
    <link:label id="lab_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_label_en-US" xlink:label="lab_ahl_PaymentsforAvailableforsaleSecuritiesShortterm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Available-for-sale Securities, Short-term</link:label>
    <link:label id="lab_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_documentation_en-US" xlink:label="lab_ahl_PaymentsforAvailableforsaleSecuritiesShortterm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Available-for-sale Securities, Short-term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsforAvailableforsaleSecuritiesShortterm" xlink:href="ahl-20231220.xsd#ahl_PaymentsforAvailableforsaleSecuritiesShortterm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PaymentsforAvailableforsaleSecuritiesShortterm" xlink:to="lab_ahl_PaymentsforAvailableforsaleSecuritiesShortterm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_742a0db0-7e73-4ef9-b5f6-b7e5fb20d732_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_ece11a6c-2d48-4954-b31b-4c5b36a06f97_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease charge</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_660f5637-5d9a-473f-b696-7680882fac70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3b5e0799-f5e6-48ec-bec5-4d172442608e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change for the year, net of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f602bf6f-d640-4ded-a91f-7c446e15a618_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_88ad5ef4-a543-46c0-a5fa-39330c52e48d_terseLabel_en-US" xlink:label="lab_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments &#8212; Available for sale</link:label>
    <link:label id="lab_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_label_en-US" xlink:label="lab_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Available-for-sale Securities, Short-term</link:label>
    <link:label id="lab_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_documentation_en-US" xlink:label="lab_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Available-for-sale Securities, Short-term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm" xlink:href="ahl-20231220.xsd#ahl_ProceedsfromAvailableforsaleSecuritiesShortterm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm" xlink:to="lab_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_5490e528-bd5d-4765-b661-24441841bb91_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_EquityInNetEarningsOfSubsidiaries_2719c342-2ae4-4c4e-8170-124675c49308_terseLabel_en-US" xlink:label="lab_ahl_EquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net earnings/(losses) of subsidiaries and other investments, equity method</link:label>
    <link:label id="lab_ahl_EquityInNetEarningsOfSubsidiaries_label_en-US" xlink:label="lab_ahl_EquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity In Net Earnings Of Subsidiaries</link:label>
    <link:label id="lab_ahl_EquityInNetEarningsOfSubsidiaries_documentation_en-US" xlink:label="lab_ahl_EquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net earnings of subsidiaries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityInNetEarningsOfSubsidiaries" xlink:href="ahl-20231220.xsd#ahl_EquityInNetEarningsOfSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_EquityInNetEarningsOfSubsidiaries" xlink:to="lab_ahl_EquityInNetEarningsOfSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FundsMaintainedAtSyndicate_d1231e0b-9f26-436a-88b2-8ac17d263b43_terseLabel_en-US" xlink:label="lab_ahl_FundsMaintainedAtSyndicate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicate to maintain funds at Lloyd</link:label>
    <link:label id="lab_ahl_FundsMaintainedAtSyndicate_label_en-US" xlink:label="lab_ahl_FundsMaintainedAtSyndicate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds Maintained At Syndicate</link:label>
    <link:label id="lab_ahl_FundsMaintainedAtSyndicate_documentation_en-US" xlink:label="lab_ahl_FundsMaintainedAtSyndicate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds maintained at syndicate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FundsMaintainedAtSyndicate" xlink:href="ahl-20231220.xsd#ahl_FundsMaintainedAtSyndicate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FundsMaintainedAtSyndicate" xlink:to="lab_ahl_FundsMaintainedAtSyndicate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_134bdaa5-6e1a-41be-afce-dae817e80a48_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_c8346752-7264-47e5-9b9e-44a1e81d05c7_terseLabel_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II - Condensed Financial Information of Registrant</link:label>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:to="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_48f548a0-7781-43ea-b076-8e322b430477_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents (including cash within consolidated variable interest entities of &#8212; $65.7448377 and $75.15054353)</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_291c20b7-77e3-4bea-963a-5465e71aca1d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5561bdab-2c7d-4d9c-9e28-2bb0cb9c6339_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period (1)</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_c573e758-bcd5-441a-a8c5-661a795cb51f_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock_eecbdad5-4917-4f5f-809b-496149747edd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Statutory Requirements and Dividends Restrictions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Payment Restrictions [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_72ea5452-60df-4665-b158-a36ca1c35925_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_4bdd7ae5-3a15-4473-b73d-fe45291ceb51_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change from current period hedged transactions</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NetAdditionsdisposalsOfLeaseLiabilities_5ee4b3f4-b580-4098-ba6a-50e2df87cd1f_negatedTerseLabel_en-US" xlink:label="lab_ahl_NetAdditionsdisposalsOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (additions)/disposals of lease liabilities</link:label>
    <link:label id="lab_ahl_NetAdditionsdisposalsOfLeaseLiabilities_label_en-US" xlink:label="lab_ahl_NetAdditionsdisposalsOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (additions)/disposals of lease liabilities</link:label>
    <link:label id="lab_ahl_NetAdditionsdisposalsOfLeaseLiabilities_documentation_en-US" xlink:label="lab_ahl_NetAdditionsdisposalsOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (additions)/disposals of lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetAdditionsdisposalsOfLeaseLiabilities" xlink:href="ahl-20231220.xsd#ahl_NetAdditionsdisposalsOfLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NetAdditionsdisposalsOfLeaseLiabilities" xlink:to="lab_ahl_NetAdditionsdisposalsOfLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_170c867b-517d-498d-bd9b-c62bda021f41_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Structure</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_bb432363-cb52-4323-b426-2b88021cae21_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CasualtyCommercialInsuranceProductLineMember_a9b9ae57-b04a-4445-9ac2-d2762b57502d_terseLabel_en-US" xlink:label="lab_ahl_CasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casualty Insurance</link:label>
    <link:label id="lab_ahl_CasualtyCommercialInsuranceProductLineMember_label_en-US" xlink:label="lab_ahl_CasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casualty, Commercial Insurance Product Line [Member]</link:label>
    <link:label id="lab_ahl_CasualtyCommercialInsuranceProductLineMember_documentation_en-US" xlink:label="lab_ahl_CasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casualty, Commercial Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CasualtyCommercialInsuranceProductLineMember" xlink:href="ahl-20231220.xsd#ahl_CasualtyCommercialInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CasualtyCommercialInsuranceProductLineMember" xlink:to="lab_ahl_CasualtyCommercialInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_IncreaseDecreaseInIntercompanyActivities_b9063a15-b9ce-4b2c-95e3-e65d3c78afb4_negatedLabel_en-US" xlink:label="lab_ahl_IncreaseDecreaseInIntercompanyActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in intercompany activities</link:label>
    <link:label id="lab_ahl_IncreaseDecreaseInIntercompanyActivities_label_en-US" xlink:label="lab_ahl_IncreaseDecreaseInIntercompanyActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Intercompany Activities</link:label>
    <link:label id="lab_ahl_IncreaseDecreaseInIntercompanyActivities_documentation_en-US" xlink:label="lab_ahl_IncreaseDecreaseInIntercompanyActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in intercompany activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncreaseDecreaseInIntercompanyActivities" xlink:href="ahl-20231220.xsd#ahl_IncreaseDecreaseInIntercompanyActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_IncreaseDecreaseInIntercompanyActivities" xlink:to="lab_ahl_IncreaseDecreaseInIntercompanyActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_079bc2eb-7a4b-47ba-bc7d-3d801e522a00_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NonagencycommercialmortgagebackedsecuritiesMember_9ac8613c-87ae-4016-84e1-ae2bbd1ad2e0_terseLabel_en-US" xlink:label="lab_ahl_NonagencycommercialmortgagebackedsecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-agency commercial mortgage-backed securities</link:label>
    <link:label id="lab_ahl_NonagencycommercialmortgagebackedsecuritiesMember_label_en-US" xlink:label="lab_ahl_NonagencycommercialmortgagebackedsecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-agency commercial mortgage-backed securities [Member]</link:label>
    <link:label id="lab_ahl_NonagencycommercialmortgagebackedsecuritiesMember_documentation_en-US" xlink:label="lab_ahl_NonagencycommercialmortgagebackedsecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-agency commercial mortgage-backed securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember" xlink:to="lab_ahl_NonagencycommercialmortgagebackedsecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_9757da87-5b90-47cc-b60b-7b0e470011eb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d916cefa-f280-4875-a951-fd5578f1e78a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Purchases) of fixed income securities &#8212; Available for sale</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8c31c85c-ea76-427d-a900-ec0e2398b63d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AspenSpecialtyMember_5639dc96-c7f8-4989-866b-b3d02af2c4f9_terseLabel_en-US" xlink:label="lab_ahl_AspenSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Specialty</link:label>
    <link:label id="lab_ahl_AspenSpecialtyMember_label_en-US" xlink:label="lab_ahl_AspenSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Specialty [Member]</link:label>
    <link:label id="lab_ahl_AspenSpecialtyMember_documentation_en-US" xlink:label="lab_ahl_AspenSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Specialty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenSpecialtyMember" xlink:href="ahl-20231220.xsd#ahl_AspenSpecialtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AspenSpecialtyMember" xlink:to="lab_ahl_AspenSpecialtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_IndustrialPropertyMember_a98a346a-14aa-4aa9-b235-77a87625b1e7_terseLabel_en-US" xlink:label="lab_srt_IndustrialPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial</link:label>
    <link:label id="lab_srt_IndustrialPropertyMember_label_en-US" xlink:label="lab_srt_IndustrialPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_IndustrialPropertyMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_IndustrialPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_IndustrialPropertyMember" xlink:to="lab_srt_IndustrialPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_f14cfb70-7593-407b-a1fa-01923040f299_terseLabel_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0-12 months, Fair Market Value</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_label_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale, Continuous Unrealized Loss Position Less Than 12 Months, Fair Market Value</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_documentation_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale Continuous Unrealized Loss Position Less Than Twelve Months Fair Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" xlink:to="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeMember_e6739f71-80c8-4c64-8949-ba2aa6339975_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeMember_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeMember" xlink:to="lab_us-gaap_InvestmentIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_UnitedStatesAndCanadaMember_7f3888d1-7ff7-4ef3-8526-6f431f7bd881_terseLabel_en-US" xlink:label="lab_ahl_UnitedStatesAndCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States &amp; Canada</link:label>
    <link:label id="lab_ahl_UnitedStatesAndCanadaMember_label_en-US" xlink:label="lab_ahl_UnitedStatesAndCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States And Canada [Member]</link:label>
    <link:label id="lab_ahl_UnitedStatesAndCanadaMember_documentation_en-US" xlink:label="lab_ahl_UnitedStatesAndCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States &amp; Canada.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnitedStatesAndCanadaMember" xlink:href="ahl-20231220.xsd#ahl_UnitedStatesAndCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_UnitedStatesAndCanadaMember" xlink:to="lab_ahl_UnitedStatesAndCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_07ff4c6b-393f-4e2a-910b-ebb000a21d96_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance losses and loss adjustment expenses:</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ProceedsfromSaleofPrivatelyheldInvestments_6b762b55-ad34-4b7a-bf5c-65b7c306f644_terseLabel_en-US" xlink:label="lab_ahl_ProceedsfromSaleofPrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of privately-held investments &#8212; Trading</link:label>
    <link:label id="lab_ahl_ProceedsfromSaleofPrivatelyheldInvestments_label_en-US" xlink:label="lab_ahl_ProceedsfromSaleofPrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Privately-held Investments</link:label>
    <link:label id="lab_ahl_ProceedsfromSaleofPrivatelyheldInvestments_documentation_en-US" xlink:label="lab_ahl_ProceedsfromSaleofPrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Privately-held Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ProceedsfromSaleofPrivatelyheldInvestments" xlink:href="ahl-20231220.xsd#ahl_ProceedsfromSaleofPrivatelyheldInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ProceedsfromSaleofPrivatelyheldInvestments" xlink:to="lab_ahl_ProceedsfromSaleofPrivatelyheldInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum_a079832a-2699-4aa4-9044-477972e1a619_terseLabel_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum consolidated tangible net worth under credit facility</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum_label_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Tangible Net Worth Restrictions Minimum</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum_documentation_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility tangible net worth restrictions minimum.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" xlink:to="lab_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_84ce0dc0-899c-4c92-8683-f5a14e453fd6_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Maximum Amount Outstanding During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:to="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RestrictedAssets_59b01799-0926-4584-8b12-a0222ead6925_verboseLabel_en-US" xlink:label="lab_ahl_RestrictedAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted assets</link:label>
    <link:label id="lab_ahl_RestrictedAssets_333ba928-2218-4095-9c63-1a796daef1ee_terseLabel_en-US" xlink:label="lab_ahl_RestrictedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Assets</link:label>
    <link:label id="lab_ahl_RestrictedAssets_label_en-US" xlink:label="lab_ahl_RestrictedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Assets</link:label>
    <link:label id="lab_ahl_RestrictedAssets_documentation_en-US" xlink:label="lab_ahl_RestrictedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RestrictedAssets" xlink:to="lab_ahl_RestrictedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_FederalHomeLoanBankOfBostonMember_8932d0e8-4262-4102-9e5b-5b99bb94bdb4_terseLabel_en-US" xlink:label="lab_srt_FederalHomeLoanBankOfBostonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank of Boston</link:label>
    <link:label id="lab_srt_FederalHomeLoanBankOfBostonMember_label_en-US" xlink:label="lab_srt_FederalHomeLoanBankOfBostonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank of Boston [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankOfBostonMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankOfBostonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_FederalHomeLoanBankOfBostonMember" xlink:to="lab_srt_FederalHomeLoanBankOfBostonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ApolloOriginatingPartnershipMember_ff989e16-8cf2-470d-a4df-2e5bf2cc6ec6_terseLabel_en-US" xlink:label="lab_ahl_ApolloOriginatingPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo originating partnership</link:label>
    <link:label id="lab_ahl_ApolloOriginatingPartnershipMember_label_en-US" xlink:label="lab_ahl_ApolloOriginatingPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo Originating Partnership [Member]</link:label>
    <link:label id="lab_ahl_ApolloOriginatingPartnershipMember_documentation_en-US" xlink:label="lab_ahl_ApolloOriginatingPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo Originating Partnership Class A and Class B notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ApolloOriginatingPartnershipMember" xlink:to="lab_ahl_ApolloOriginatingPartnershipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_4ee1ef84-b0e2-47cc-b22c-face064733d1_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_bdf49ea7-916c-4e7d-ba33-5f4a364bbb0d_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">History and Organization</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_3352a2fb-fde1-41ac-9842-e5b76bbb0a08_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:to="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_6dd383c9-3911-49ac-bdfc-f50f40fef0c5_verboseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_1664210a-3f52-4cf4-a8b1-5be44f1df875_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fixed income securities &#8212; Available for sale</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_64fbef12-5ce0-4a34-8653-0ab8668dfcdb_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_5b238b0c-e87e-4371-9450-4dabfcbf7c1a_negatedTerseLabel_en-US" xlink:label="lab_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss and LAE expenses disposed (1)</link:label>
    <link:label id="lab_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_label_en-US" xlink:label="lab_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense Amount Disposed Of</link:label>
    <link:label id="lab_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_documentation_en-US" xlink:label="lab_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for unpaid claims and claims adjustment expense amount disposed of.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" xlink:href="ahl-20231220.xsd#ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" xlink:to="lab_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_10319951-8015-4202-89e5-e6e678130b9f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee Insurance Contracts, Premium Received over Contract Period [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee Insurance Contracts, Premium Received over Contract Period [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract" xlink:to="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_4ba9059b-4317-499c-94b8-b6416fbb8f85_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_dcdcf847-f6de-47ed-ba5e-5a232678f137_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Company's Restricted Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_3d1e2a71-881e-480c-a542-729cb7bd5531_terseLabel_en-US" xlink:label="lab_ahl_AssumedCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casualty Reinsurance</link:label>
    <link:label id="lab_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_label_en-US" xlink:label="lab_ahl_AssumedCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Casualty, Commercial Insurance Product Line [Member]</link:label>
    <link:label id="lab_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_documentation_en-US" xlink:label="lab_ahl_AssumedCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Casualty, Commercial Insurance Product Line</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember" xlink:href="ahl-20231220.xsd#ahl_AssumedCasualtyCommercialInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember" xlink:to="lab_ahl_AssumedCasualtyCommercialInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_250928fb-a9fb-40aa-a11d-be58e8811907_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncome_3921caec-41a5-4f1b-83b3-2cd5520fa010_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncome_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncome" xlink:to="lab_us-gaap_OtherNonoperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_f8e25e58-6ed9-4256-a92d-277c0a80c167_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_16dd1f5c-9f05-42e8-924f-fbc9423b1376_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_02d7d7c9-2203-4412-95e1-b08caf4f9102_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_85e14beb-0c17-4786-b339-c6170ba0b2d0_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over 12 months, Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_b3ee8fe5-3b3e-47ac-a3ef-734635ab38a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_18763ff8-7c7d-48a1-a3f6-175362cb2560_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_f5e0fe5d-dff1-466f-b250-ba99515b54af_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_8bf04a77-e2c3-49ce-91fe-ce5b2c69c19d_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance lines</link:label>
    <link:label id="lab_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_d9604d91-6833-4aa1-9000-f163236c21c1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Casualty, Commercial Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember" xlink:to="lab_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock_43706783-becb-4317-bcd8-726d8d15822d_terseLabel_en-US" xlink:label="lab_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Gross Written Premium From Major Brokers</link:label>
    <link:label id="lab_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock_label_en-US" xlink:label="lab_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Gross Written Premium From Major Brokers [Table Text Block]</link:label>
    <link:label id="lab_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock_documentation_en-US" xlink:label="lab_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of gross written premium from major brokers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" xlink:href="ahl-20231220.xsd#ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" xlink:to="lab_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_Operatinglosscarryforwardsdateofexpiration_2c4f037c-25d3-4717-bd7c-3c78ddd02294_terseLabel_en-US" xlink:label="lab_ahl_Operatinglosscarryforwardsdateofexpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, date of expiration</link:label>
    <link:label id="lab_ahl_Operatinglosscarryforwardsdateofexpiration_label_en-US" xlink:label="lab_ahl_Operatinglosscarryforwardsdateofexpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, date of expiration</link:label>
    <link:label id="lab_ahl_Operatinglosscarryforwardsdateofexpiration_documentation_en-US" xlink:label="lab_ahl_Operatinglosscarryforwardsdateofexpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, date of expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Operatinglosscarryforwardsdateofexpiration" xlink:href="ahl-20231220.xsd#ahl_Operatinglosscarryforwardsdateofexpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_Operatinglosscarryforwardsdateofexpiration" xlink:to="lab_ahl_Operatinglosscarryforwardsdateofexpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_c33132e7-ad83-4f52-a366-c1af652d668a_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_39d4d2f3-8956-417e-9dc4-71dccc469e7b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_7caf8df5-8359-4d4d-8ac2-b7b4e6a62aba_terseLabel_en-US" xlink:label="lab_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Reinsurance</link:label>
    <link:label id="lab_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_label_en-US" xlink:label="lab_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Specialty, Commercial Insurance Product Line [Member]</link:label>
    <link:label id="lab_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_documentation_en-US" xlink:label="lab_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Specialty, Commercial Insurance Product Line</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember" xlink:href="ahl-20231220.xsd#ahl_AssumedSpecialtyCommercialInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember" xlink:to="lab_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_101f836e-0d48-4f7b-be07-2ac117af9788_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_a5f6a0a6-9bf5-42c4-bb84-a12a8bcdf8d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CreditRatingStandardPoorsAxis_71b20e2c-91f3-4429-826e-30d1c0d6c964_terseLabel_en-US" xlink:label="lab_srt_CreditRatingStandardPoorsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Standard &amp; Poor's [Axis]</link:label>
    <link:label id="lab_srt_CreditRatingStandardPoorsAxis_label_en-US" xlink:label="lab_srt_CreditRatingStandardPoorsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Standard &amp; Poor's [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CreditRatingStandardPoorsAxis" xlink:to="lab_srt_CreditRatingStandardPoorsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock_b140cb82-3dec-4196-ae6a-bd2028e3e795_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial Mortgage and Middle Market Loans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Participating Mortgage Loans [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock" xlink:to="lab_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract_b75a955d-100d-459f-a43e-ebe64525e6a7_terseLabel_en-US" xlink:label="lab_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract_label_en-US" xlink:label="lab_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure Of Cash Flows Information [Abstract]</link:label>
    <link:label id="lab_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract_documentation_en-US" xlink:label="lab_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract" xlink:href="ahl-20231220.xsd#ahl_SupplementalDisclosureOfCashFlowsInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract" xlink:to="lab_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_13331e5c-a229-4f37-87ce-11f23707f83c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c5dd9874-d88a-4fb9-ba43-bacf15daba64_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_6d41dbd4-8a89-4488-adb8-6a0b2e9d042b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_69602c66-9d1b-4b73-ac05-60b3b799b12d_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for losses and LAE for claims incurred</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_5cbb5125-8527-4513-b8c9-924decc85d96_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumNetCapitalRequired1_ede942b6-d492-4399-a64f-0fe9e5643821_terseLabel_en-US" xlink:label="lab_srt_MinimumNetCapitalRequired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum capital required</link:label>
    <link:label id="lab_srt_MinimumNetCapitalRequired1_label_en-US" xlink:label="lab_srt_MinimumNetCapitalRequired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broker-Dealer, Minimum Net Capital Required, Aggregate Indebtedness Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumNetCapitalRequired1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumNetCapitalRequired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumNetCapitalRequired1" xlink:to="lab_srt_MinimumNetCapitalRequired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_569e0afa-2c1b-46f4-9b02-1da727f024b4_terseLabel_en-US" xlink:label="lab_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds withheld</link:label>
    <link:label id="lab_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_label_en-US" xlink:label="lab_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds Held under Reinsurance Agreements, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldUnderReinsuranceAgreementsAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset" xlink:to="lab_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_449bdeaf-dfce-483a-a871-68c0a95e96fb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_UsSurplusLinesTrustFundMember_e426ce0f-3642-4c6e-8c21-2e4f075f2594_terseLabel_en-US" xlink:label="lab_ahl_UsSurplusLinesTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Us Surplus Lines Trust Fund</link:label>
    <link:label id="lab_ahl_UsSurplusLinesTrustFundMember_label_en-US" xlink:label="lab_ahl_UsSurplusLinesTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Us Surplus Lines Trust Fund [Member]</link:label>
    <link:label id="lab_ahl_UsSurplusLinesTrustFundMember_documentation_en-US" xlink:label="lab_ahl_UsSurplusLinesTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US surplus lines trust fund.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsSurplusLinesTrustFundMember" xlink:href="ahl-20231220.xsd#ahl_UsSurplusLinesTrustFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_UsSurplusLinesTrustFundMember" xlink:to="lab_ahl_UsSurplusLinesTrustFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_3dcace98-e263-402b-8a13-7bfa95a05565_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_4ce969b0-3a2f-4c09-ae17-dbb7fe18df98_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of US and foreign exchange</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_4e5783cd-3edd-4755-b616-5c9e165149b9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares, value</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_6278dbac-c4d9-45d5-a836-806734527611_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_8b1f668f-a01b-477e-b31b-16ef8cc1a3d1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_0e0c9739-7543-4c51-b9f6-bd1519b1fd85_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_5a25b46c-d160-410f-a3f2-c094d12cc1ed_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General, administrative and corporate expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_2e3f9233-a33f-4216-a0cf-384b02f23758_terseLabel_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payable Date</link:label>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:to="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member_bd078a50-24cd-40cb-91f5-4eeaf519d919_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2013</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year 2013 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_63017fa5-b161-4325-a5c3-c4967040eebd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity_9c89b9a5-762b-47ac-8e28-ebec32898fa2_terseLabel_en-US" xlink:label="lab_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding collateralized letters of credit facility</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity_label_en-US" xlink:label="lab_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Increase Additional Borrowing Capacity</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity_documentation_en-US" xlink:label="lab_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility increase additional borrowing capacity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" xlink:to="lab_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_10830510-f1f2-4cc4-a252-9fe5c54dd0e2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measured on a Recurring Basis, Gain (Loss) Included in Earnings</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_63255a4b-494c-4602-b93f-bb50d7a884f6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Right-of-Use Operating Lease Assets</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_OthersMember_d0eadf1d-99c9-446a-9316-8a5af6c3dd2a_terseLabel_en-US" xlink:label="lab_ahl_OthersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_ahl_OthersMember_label_en-US" xlink:label="lab_ahl_OthersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others [Member]</link:label>
    <link:label id="lab_ahl_OthersMember_documentation_en-US" xlink:label="lab_ahl_OthersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OthersMember" xlink:href="ahl-20231220.xsd#ahl_OthersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_OthersMember" xlink:to="lab_ahl_OthersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_c09a5ee8-3c29-44f0-bbae-00c0269a259c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_13eab082-94c8-436b-b334-65fa35b8777a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1a0442f0-cc76-4bfe-8c78-9fe3a4a6cf15_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b3c5a483-61e7-4966-9227-9b33bc2296d7_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Payments and Long-term Incentive Plan</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_a4ec0ff4-bf5b-4284-9c21-93838479e36c_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_0eddd66f-212f-44d2-9ccf-ddd640d57bb6_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Ending Balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedMaturitiesMember_c9351675-a9df-40d6-9f3a-c43f3fe1637e_verboseLabel_en-US" xlink:label="lab_us-gaap_FixedMaturitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed maturities</link:label>
    <link:label id="lab_us-gaap_FixedMaturitiesMember_535be2a8-f635-4b8c-bce7-141103e9e8e0_terseLabel_en-US" xlink:label="lab_us-gaap_FixedMaturitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fixed income securities&#160;&#8212; Available for sale</link:label>
    <link:label id="lab_us-gaap_FixedMaturitiesMember_label_en-US" xlink:label="lab_us-gaap_FixedMaturitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Maturities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedMaturitiesMember" xlink:to="lab_us-gaap_FixedMaturitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5737e238-c51f-4668-9993-af485482305a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax expense/(benefit)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CanadianTrustFundMember_b3dca010-f2cc-4db2-ab6a-1b76c50ca1ab_terseLabel_en-US" xlink:label="lab_ahl_CanadianTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Trust Fund</link:label>
    <link:label id="lab_ahl_CanadianTrustFundMember_label_en-US" xlink:label="lab_ahl_CanadianTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Trust Fund [Member]</link:label>
    <link:label id="lab_ahl_CanadianTrustFundMember_documentation_en-US" xlink:label="lab_ahl_CanadianTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Trust Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CanadianTrustFundMember" xlink:href="ahl-20231220.xsd#ahl_CanadianTrustFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CanadianTrustFundMember" xlink:to="lab_ahl_CanadianTrustFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_f01bd8c0-aa82-4366-8038-b3d32b76707a_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesByJurisdictionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis" xlink:to="lab_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsWrittenNet_ac228fbf-8c6c-468b-8608-73c35ed92ca9_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsWrittenNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net written premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsWrittenNet_90ddc968-f655-4df9-8607-ecaabe583bfd_totalLabel_en-US" xlink:label="lab_us-gaap_PremiumsWrittenNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums written</link:label>
    <link:label id="lab_us-gaap_PremiumsWrittenNet_label_en-US" xlink:label="lab_us-gaap_PremiumsWrittenNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Written, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsWrittenNet" xlink:to="lab_us-gaap_PremiumsWrittenNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_InfrastructureFundMember_15c590f1-f291-445a-814a-edafc5ad8d66_terseLabel_en-US" xlink:label="lab_ahl_InfrastructureFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infrastructure fund</link:label>
    <link:label id="lab_ahl_InfrastructureFundMember_label_en-US" xlink:label="lab_ahl_InfrastructureFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infrastructure fund [Member]</link:label>
    <link:label id="lab_ahl_InfrastructureFundMember_documentation_en-US" xlink:label="lab_ahl_InfrastructureFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infrastructure fund, make investments in environmental services, transportation, communications and digital, energy/energy transition and other sectors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InfrastructureFundMember" xlink:href="ahl-20231220.xsd#ahl_InfrastructureFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_InfrastructureFundMember" xlink:to="lab_ahl_InfrastructureFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_372ca293-6b23-4687-9c02-beebd7217690_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Effects of Deferred Tax Assets and Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_e854f40c-bc62-4dad-b277-c4f529532ae9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c9d8a75f-1e36-4b21-b592-001352371cf9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_015aceef-d2f7-41e4-8d9a-d2d3ff1d201b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements and sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceRecoverablesUncollateralized_c2189915-fafd-4c45-90c5-f8f3ad6659d1_terseLabel_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesUncollateralized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Uncollateralized</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesUncollateralized_label_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesUncollateralized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Uncollateralized</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesUncollateralized_documentation_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesUncollateralized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Uncollateralized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesUncollateralized" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesUncollateralized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceRecoverablesUncollateralized" xlink:to="lab_ahl_ReinsuranceRecoverablesUncollateralized" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ApolloClassBNotesMember_02a4f95d-ef54-4a6f-b54b-21039c35c9df_terseLabel_en-US" xlink:label="lab_ahl_ApolloClassBNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo originating partnership, class B notes</link:label>
    <link:label id="lab_ahl_ApolloClassBNotesMember_label_en-US" xlink:label="lab_ahl_ApolloClassBNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo, Class B Notes [Member]</link:label>
    <link:label id="lab_ahl_ApolloClassBNotesMember_documentation_en-US" xlink:label="lab_ahl_ApolloClassBNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo Originating Partnership, Class B Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassBNotesMember" xlink:href="ahl-20231220.xsd#ahl_ApolloClassBNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ApolloClassBNotesMember" xlink:to="lab_ahl_ApolloClassBNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_694b449f-dd32-41ab-b41d-5df3aea75e87_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_318ababa-4901-48ea-a05f-de3ae8527b3c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_BeneAssicurazioniMember_eeadc7e1-0e69-4684-99b5-5bb5dc743d63_terseLabel_en-US" xlink:label="lab_ahl_BeneAssicurazioniMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bene</link:label>
    <link:label id="lab_ahl_BeneAssicurazioniMember_label_en-US" xlink:label="lab_ahl_BeneAssicurazioniMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bene Assicurazioni [Member]</link:label>
    <link:label id="lab_ahl_BeneAssicurazioniMember_documentation_en-US" xlink:label="lab_ahl_BeneAssicurazioniMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bene Assicurazioni [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_BeneAssicurazioniMember" xlink:to="lab_ahl_BeneAssicurazioniMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b94a78f9-b34a-4eb0-b054-82d66c293658_periodStartLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Beginning of the period</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_0c65d03b-e704-4a65-8b78-3114eb370372_periodEndLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, End of the period</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ce865c81-8e6e-4a56-bf2d-a65316638abc_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of the asset</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_00e393c2-163c-4de4-b117-21faf51e8e62_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_74b4469c-87ea-487d-a8bf-52e159182eef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_b3129c8f-1923-4209-98e5-6ed9546abea1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f5050b92-426f-4460-99cd-930e4f6b3c99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service and Fixed Charge Coverage Ratios</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_Shortterminvestmentsavailableforsaleamortizedcost_8442edd9-69ee-45bd-9063-6aef779bb92c_terseLabel_en-US" xlink:label="lab_ahl_Shortterminvestmentsavailableforsaleamortizedcost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments available for sale, amortized cost</link:label>
    <link:label id="lab_ahl_Shortterminvestmentsavailableforsaleamortizedcost_label_en-US" xlink:label="lab_ahl_Shortterminvestmentsavailableforsaleamortizedcost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments available for sale, amortized cost</link:label>
    <link:label id="lab_ahl_Shortterminvestmentsavailableforsaleamortizedcost_documentation_en-US" xlink:label="lab_ahl_Shortterminvestmentsavailableforsaleamortizedcost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments available for sale, amortized cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost" xlink:href="ahl-20231220.xsd#ahl_Shortterminvestmentsavailableforsaleamortizedcost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost" xlink:to="lab_ahl_Shortterminvestmentsavailableforsaleamortizedcost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_daf146c9-f3f0-4c18-90cb-86636a936338_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net, Total</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_15032b81-2c05-4986-b23f-5ba2cd163467_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net losses and LAE reserves, beginning balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_42f7b9aa-7905-4bc5-bc95-03688fbf3f35_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net losses and LAE reserves, ending balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_1b655c97-f9ee-450a-81a4-cd514fac3007_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Reserves for&#160;Losses and LAE&#160;</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsAPlusRatingMember_7bb10994-0575-4387-af53-f7ac7b7146bd_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsAPlusRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard &amp; Poor's, A plus Rating</link:label>
    <link:label id="lab_srt_StandardPoorsAPlusRatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsAPlusRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard &amp; Poor's, A+ Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAPlusRatingMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAPlusRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsAPlusRatingMember" xlink:to="lab_srt_StandardPoorsAPlusRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_a2ce854f-08e6-4359-83dc-f97dbd671713_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables for securities purchased</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction_17c81c35-e534-43bc-b43a-4d5e95f4365f_terseLabel_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of consolidated net income</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction_label_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Tangible Net Worth Net Income Restriction</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction_documentation_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility tangible net worth net income restriction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" xlink:to="lab_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PrivatelyHeldInvestmentLossesIncurred_efa8dae0-afa8-4522-8658-51bb63b4a7e8_negatedTerseLabel_en-US" xlink:label="lab_ahl_PrivatelyHeldInvestmentLossesIncurred" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investment, losses incurred</link:label>
    <link:label id="lab_ahl_PrivatelyHeldInvestmentLossesIncurred_da7888e1-e33a-4acc-8b6f-023ea48b0f3b_terseLabel_en-US" xlink:label="lab_ahl_PrivatelyHeldInvestmentLossesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investment, losses incurred</link:label>
    <link:label id="lab_ahl_PrivatelyHeldInvestmentLossesIncurred_label_en-US" xlink:label="lab_ahl_PrivatelyHeldInvestmentLossesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investment, losses incurred</link:label>
    <link:label id="lab_ahl_PrivatelyHeldInvestmentLossesIncurred_documentation_en-US" xlink:label="lab_ahl_PrivatelyHeldInvestmentLossesIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investment, losses incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyHeldInvestmentLossesIncurred" xlink:href="ahl-20231220.xsd#ahl_PrivatelyHeldInvestmentLossesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PrivatelyHeldInvestmentLossesIncurred" xlink:to="lab_ahl_PrivatelyHeldInvestmentLossesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_89206cf7-428e-4b56-8799-0ee9a058e381_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S government</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_7f780ecf-4570-4034-9976-61fd6d48fb6b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList" xlink:to="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_3b386b87-eb36-4924-94be-595cf873876e_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_label_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceTextBlock" xlink:to="lab_us-gaap_ReinsuranceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_f463570d-3f1e-4334-bacc-7cb315ac4f1e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue_e1d1018d-8c83-437b-9b2d-bb1bcda1e1ed_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash collateral</link:label>
    <link:label id="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue_label_en-US" xlink:label="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Already Posted, Aggregate Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:to="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment_b37a5084-4126-448a-bead-799940991a33_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales/(purchases) of fixed assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Machinery and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_c491e71e-e7cd-4cf5-a0b0-160b965bd0f1_terseLabel_en-US" xlink:label="lab_ahl_NetchangefromcurrentperiodhedgedtransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change from current period hedged transactions</link:label>
    <link:label id="lab_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_label_en-US" xlink:label="lab_ahl_NetchangefromcurrentperiodhedgedtransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change from current period hedged transactions [Member]</link:label>
    <link:label id="lab_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_documentation_en-US" xlink:label="lab_ahl_NetchangefromcurrentperiodhedgedtransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change from current period hedged transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember" xlink:to="lab_ahl_NetchangefromcurrentperiodhedgedtransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_a3dcedf4-ca98-4232-baae-b893568ee2e8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_92d45c10-a915-4fa7-8bc1-e37235ca157c_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a02dc438-0a5e-41bc-9cd6-133a18866efb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4153f557-fbe6-4329-9e33-d9db4e4c1e82_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_33821fce-3e98-483a-9cdb-2127d4a4215f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock_ea357e8b-066d-4164-8bda-3a3e1891d662_terseLabel_en-US" xlink:label="lab_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Insurance and Reinsurance Operations</link:label>
    <link:label id="lab_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock_label_en-US" xlink:label="lab_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting For Insurance And Reinsurance Operations [Policy Text Block]</link:label>
    <link:label id="lab_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock_documentation_en-US" xlink:label="lab_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for insurance and reinsurance operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" xlink:href="ahl-20231220.xsd#ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" xlink:to="lab_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7634c94-4c71-440c-8b83-fd7dd7d2ae3a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_3c2c882c-0ec1-479c-879c-9b99635fe76b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d65ee921-8af1-4838-b515-9872fe19b3cd_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total change in net unrealized (losses)/gains, net of taxes recorded in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7d956895-b7af-40d8-b353-0fa5f52fd5d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized (losses)/gains on investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1_83ed2701-2d60-40bd-aedd-4a50a386c8e9_terseLabel_en-US" xlink:label="lab_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual statutory capital and surplus</link:label>
    <link:label id="lab_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1_label_en-US" xlink:label="lab_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Payments Restrictions Schedule, Statutory Capital and Surplus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" xlink:to="lab_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_a9d78d89-48a6-459b-9c99-a74ca9b8c0ca_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_d72a76fd-2605-40e0-8038-c26d019efe3a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnderwritingExpenseRatio_ac9bc2f3-aafe-4442-be0c-cb38452c7696_totalLabel_en-US" xlink:label="lab_us-gaap_UnderwritingExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense ratio</link:label>
    <link:label id="lab_us-gaap_UnderwritingExpenseRatio_ebaac323-d412-450e-afbf-864bd3748208_terseLabel_en-US" xlink:label="lab_us-gaap_UnderwritingExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense ratio</link:label>
    <link:label id="lab_us-gaap_UnderwritingExpenseRatio_label_en-US" xlink:label="lab_us-gaap_UnderwritingExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting Expense Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingExpenseRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnderwritingExpenseRatio" xlink:to="lab_us-gaap_UnderwritingExpenseRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CashAndCashEquivalentsIncludesRestrictedCash_b5661a4a-3fcc-46be-8cea-0126dbf59125_terseLabel_en-US" xlink:label="lab_ahl_CashAndCashEquivalentsIncludesRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_ahl_CashAndCashEquivalentsIncludesRestrictedCash_label_en-US" xlink:label="lab_ahl_CashAndCashEquivalentsIncludesRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents includes restricted cash</link:label>
    <link:label id="lab_ahl_CashAndCashEquivalentsIncludesRestrictedCash_documentation_en-US" xlink:label="lab_ahl_CashAndCashEquivalentsIncludesRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents includes restricted cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludesRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash" xlink:to="lab_ahl_CashAndCashEquivalentsIncludesRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_58668e1a-5864-4809-8f4a-408317d5fefb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RestrictedCashAndCollateralTable_35d19d84-f2dc-4560-97bb-8cfa02887127_terseLabel_en-US" xlink:label="lab_ahl_RestrictedCashAndCollateralTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Collateral [Table]</link:label>
    <link:label id="lab_ahl_RestrictedCashAndCollateralTable_label_en-US" xlink:label="lab_ahl_RestrictedCashAndCollateralTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Collateral [Table]</link:label>
    <link:label id="lab_ahl_RestrictedCashAndCollateralTable_documentation_en-US" xlink:label="lab_ahl_RestrictedCashAndCollateralTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Collateral Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralTable" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RestrictedCashAndCollateralTable" xlink:to="lab_ahl_RestrictedCashAndCollateralTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerListsMember_df715b90-410d-4ac3-aa93-49810c602f76_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerListsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerListsMember_label_en-US" xlink:label="lab_us-gaap_CustomerListsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Lists [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerListsMember" xlink:to="lab_us-gaap_CustomerListsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortdurationInsuranceProductLineMember_dd26f65a-66cf-4dfc-beb4-5feb12404655_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortdurationInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance lines</link:label>
    <link:label id="lab_us-gaap_OtherShortdurationInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_OtherShortdurationInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortdurationInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortdurationInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortdurationInsuranceProductLineMember" xlink:to="lab_us-gaap_OtherShortdurationInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_7d5e3e3c-5372-4201-8e83-c2358a3ff1a1_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:to="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAggregatedInvestmentsMember_0f4062d5-f110-44a1-afcd-c696a941420c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAggregatedInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments, at fair value</link:label>
    <link:label id="lab_us-gaap_OtherAggregatedInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherAggregatedInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Security Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAggregatedInvestmentsMember" xlink:to="lab_us-gaap_OtherAggregatedInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_5b981537-1cb0-446d-b0fa-a71cf27f671a_terseLabel_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, associated losses</link:label>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_label_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation, Allowance, Associated Losses</link:label>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_documentation_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation, Allowance, Associated Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" xlink:to="lab_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums_6cdec44f-c328-466e-94cb-4887d1076eb6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Reserves for Unearned Premiums</link:label>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums_label_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Unearned Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationUnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums" xlink:to="lab_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_b0402f36-50a3-4c86-9fac-e6a8257eff84_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableMember_ca4b14b1-306a-4d20-a76b-9d7459378b6a_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums receivable from underwriting activities</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableMember_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableMember" xlink:to="lab_us-gaap_PremiumsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReinsurancePayables_3d72ec0a-0d6d-4eb7-8adc-e030ea1f3a06_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReinsurancePayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance premiums payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReinsurancePayables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReinsurancePayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Reinsurance Payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReinsurancePayables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReinsurancePayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReinsurancePayables" xlink:to="lab_us-gaap_IncreaseDecreaseInReinsurancePayables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceContractAxis_73597a31-7347-4347-9b5a-6425ba61137b_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceContractAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Contracts [Axis]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceContractAxis_label_en-US" xlink:label="lab_us-gaap_ReinsuranceContractAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Contract [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceContractAxis" xlink:to="lab_us-gaap_ReinsuranceContractAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d5b278c3-07e5-49fe-9a12-c973b3a391ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e63aa3d4-372c-4c2b-b30a-ea8b0382ec9c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease)/increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0d7369f2-10d1-49d8-af99-ab97182a5cc3_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_161b1787-d2a1-46b7-a8b5-3eb370365853_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CombinedRatio_c018f73f-3e62-4de4-b098-7bf398d62e2a_totalLabel_en-US" xlink:label="lab_us-gaap_CombinedRatio" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined ratio</link:label>
    <link:label id="lab_us-gaap_CombinedRatio_86e5b731-b606-4312-bf4e-4e56efe1a06d_terseLabel_en-US" xlink:label="lab_us-gaap_CombinedRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined ratio</link:label>
    <link:label id="lab_us-gaap_CombinedRatio_label_en-US" xlink:label="lab_us-gaap_CombinedRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CombinedRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CombinedRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CombinedRatio" xlink:to="lab_us-gaap_CombinedRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_4e7116d1-2f17-4b19-9ac0-5c8ffd249a98_terseLabel_en-US" xlink:label="lab_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_label_en-US" xlink:label="lab_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, privately-held investments [Member]</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_documentation_en-US" xlink:label="lab_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, privately-held investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember" xlink:to="lab_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne_f7582365-0bd6-430f-9b03-e09a9546a621_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year One</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RealEstateFundDec2017Member_d5e653f4-d8eb-41bc-906c-49fcc4102b2c_terseLabel_en-US" xlink:label="lab_ahl_RealEstateFundDec2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate fund (Dec 2017)</link:label>
    <link:label id="lab_ahl_RealEstateFundDec2017Member_label_en-US" xlink:label="lab_ahl_RealEstateFundDec2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Fund (Dec 2017) [Member]</link:label>
    <link:label id="lab_ahl_RealEstateFundDec2017Member_documentation_en-US" xlink:label="lab_ahl_RealEstateFundDec2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Fund (Dec 2017)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RealEstateFundDec2017Member" xlink:to="lab_ahl_RealEstateFundDec2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_9e8f63f3-0528-4b01-a0aa-b9c5523adff9_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesJurisdictionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesJurisdictionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesJurisdictionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain" xlink:to="lab_us-gaap_StatutoryAccountingPracticesJurisdictionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts_44e8a149-6254-4493-9346-ec2a9f02cc7a_terseLabel_en-US" xlink:label="lab_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to severance, retention awards and other non-recurring costs</link:label>
    <link:label id="lab_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts_label_en-US" xlink:label="lab_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to severance, retention awards and other non-recurring costs</link:label>
    <link:label id="lab_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts_documentation_en-US" xlink:label="lab_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to severance, retention awards and other non-recurring costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" xlink:href="ahl-20231220.xsd#ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" xlink:to="lab_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_50e08372-1016-43af-aa0a-3e9d274582c0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_54103648-5484-4f6c-bddc-3249333c14f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_36a44efe-6415-4696-9c9d-f397f056b82e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss)/Income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5ddced9e-cab8-4165-92b9-473121d0d065_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_9c71ce09-1c9e-4f73-a162-c589e0e5e474_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Historical Claims Duration [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_23bd5ca4-f937-4eb4-b07c-c3e162a80015_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on foreign currency fair value hedge derivatives</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6db4c5-dc27-4c1d-a86d-011653f695b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_a2b16d1f-66f5-4317-a962-5e10fc2e306d_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember_b5b203a8-57c8-404e-bcd1-1dfe0d55447b_terseLabel_en-US" xlink:label="lab_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember_label_en-US" xlink:label="lab_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Property and Casualty, Commercial Insurance Product Line [Member]</link:label>
    <link:label id="lab_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember_documentation_en-US" xlink:label="lab_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product line consisting of assumed insurance (ie reinsurance) provided to policyholders on commercial properties, which covers property-related losses including, but not limited to, damage, theft or legal liability for personal injury.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember" xlink:href="ahl-20231220.xsd#ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember" xlink:to="lab_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_dff8559f-3320-4292-badf-3ac0627db2f8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets_b8b0eaf9-bf70-479c-9f95-504a69f86932_terseLabel_en-US" xlink:label="lab_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office properties and equipment</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets_label_en-US" xlink:label="lab_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Timing Differences On Fixed Assets</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets_documentation_en-US" xlink:label="lab_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Timing Differences On Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets" xlink:to="lab_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LloydsMember_55d08249-70af-4e6c-8c4e-6638ba9ea314_verboseLabel_en-US" xlink:label="lab_ahl_LloydsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lloyd's syndicate</link:label>
    <link:label id="lab_ahl_LloydsMember_9575bb88-7bb4-42b9-aa0d-1d2a293d72d5_terseLabel_en-US" xlink:label="lab_ahl_LloydsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lloyd's</link:label>
    <link:label id="lab_ahl_LloydsMember_label_en-US" xlink:label="lab_ahl_LloydsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lloyds [Member]</link:label>
    <link:label id="lab_ahl_LloydsMember_documentation_en-US" xlink:label="lab_ahl_LloydsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lloyds syndicate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LloydsMember" xlink:to="lab_ahl_LloydsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_5b68563d-b88f-459e-9bf7-ff6b053d6fa3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Fair Value and Gross Unrealized Loss by Type of Security</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_2ac6d1c9-f5dc-448d-853a-ecedb1d160ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_IncomeTaxesLineItems_60a0193e-be04-434f-bf18-ce5a4f2cf74e_terseLabel_en-US" xlink:label="lab_ahl_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_ahl_IncomeTaxesLineItems_label_en-US" xlink:label="lab_ahl_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_ahl_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_ahl_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncomeTaxesLineItems" xlink:href="ahl-20231220.xsd#ahl_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_IncomeTaxesLineItems" xlink:to="lab_ahl_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LIBOR1Member_ca17e18a-3e7a-4fd8-b1b0-23681723e41a_terseLabel_en-US" xlink:label="lab_ahl_LIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_ahl_LIBOR1Member_label_en-US" xlink:label="lab_ahl_LIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR1 [Member]</link:label>
    <link:label id="lab_ahl_LIBOR1Member_documentation_en-US" xlink:label="lab_ahl_LIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LIBOR1Member" xlink:href="ahl-20231220.xsd#ahl_LIBOR1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LIBOR1Member" xlink:to="lab_ahl_LIBOR1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_6223b334-743c-4e68-bdba-a0aa5a66a1b5_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_602ba015-a94b-4a30-8e0a-da024b5579f3_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency mortgage-backed</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_82331eac-909f-468d-a5b2-1b10de771dac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_ca929cf7-0160-4e1c-967f-fbdb8dfc3c26_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_4ea8fd72-9eb3-4f6d-b108-8efcfd71d79c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares liquidation preference, value</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_2af1108d-5f17-41c6-a1e6-b5b335435a6c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_2c779456-05d1-4d79-a3a8-82f37fbcf498_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income/(loss) from equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_8573a739-64c2-48d2-8e38-734850d42b2a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized and unrealized gains (loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_Interestonoperatingleaseliabilities_dfbcf5cd-7081-4122-915c-0ba9c2d368aa_negatedTerseLabel_en-US" xlink:label="lab_ahl_Interestonoperatingleaseliabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on operating lease liabilities</link:label>
    <link:label id="lab_ahl_Interestonoperatingleaseliabilities_label_en-US" xlink:label="lab_ahl_Interestonoperatingleaseliabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on operating lease liabilities</link:label>
    <link:label id="lab_ahl_Interestonoperatingleaseliabilities_documentation_en-US" xlink:label="lab_ahl_Interestonoperatingleaseliabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on operating lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Interestonoperatingleaseliabilities" xlink:href="ahl-20231220.xsd#ahl_Interestonoperatingleaseliabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_Interestonoperatingleaseliabilities" xlink:to="lab_ahl_Interestonoperatingleaseliabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_e1ca6e68-cecb-49b9-9ad0-d039892a4185_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_e166864a-b98f-403b-a7d0-b9a459fd13d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized losses on sale of securities and cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e8acf21d-7d8a-42fd-8033-f06a585bd221_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset obtained in exchange for operating lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnearnedPremiums_04608ee8-aee3-471a-8483-aecf036a695a_terseLabel_en-US" xlink:label="lab_us-gaap_UnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums</link:label>
    <link:label id="lab_us-gaap_UnearnedPremiums_label_en-US" xlink:label="lab_us-gaap_UnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnearnedPremiums" xlink:to="lab_us-gaap_UnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesDebtAmortizedCost_38fbfc9b-0b6c-456d-bbdd-a51dc98e8359_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebtAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities, trading, amortized cost</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesDebtAmortizedCost_1b2a0bd0-fa1f-47e4-bae1-01e012717f15_totalLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebtAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesDebtAmortizedCost_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebtAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesDebtAmortizedCost" xlink:to="lab_us-gaap_TradingSecuritiesDebtAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_29d7c08d-a3d1-4f1a-ba6f-f02b7d1faed3_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9b42235e-bf7e-4baf-8a1c-f0cc4d2d40e8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due one year or less, Fair Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_c23d5524-dbe7-4d97-9d78-f9cb46053b7d_terseLabel_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type of Partners' Capital Account, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_label_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type of Partners' Capital Account, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:to="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_c54ae99d-2db5-44d3-a1c0-83a0ff504f6a_terseLabel_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities After One Through Five Years Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_label_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities After One Through Five Years Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_documentation_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities debt maturities after one through five years average ratings by maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" xlink:to="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aa37f8b7-d4e0-4589-9d54-bf5da72a41ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_38b1b81a-077f-4b55-a459-f0a0e3bacc7a_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_8def9735-d5b6-48b2-b3d7-e99c4fa7fd89_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income/(loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_7ab74309-286b-4abe-b1d2-5b10f6cb0762_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income/(loss) for the year</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_01fbab46-b316-4c7d-a125-3f22144976b0_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_e423a8dd-50f8-4b5e-8e07-03cb16598688_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_4b24f1e9-e83e-4268-b231-a68f175f39f3_terseLabel_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over 12 months, Fair Market Value</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_label_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Market Value</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_documentation_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" xlink:to="lab_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_d9bee265-eb9d-4c00-9568-a458c7077ded_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesSubscribedButUnissuedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares, value</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesSubscribedButUnissuedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Subscriptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesSubscribedButUnissuedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue" xlink:to="lab_us-gaap_PreferredStockSharesSubscribedButUnissuedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SuretySegmentMember_ba130157-cba7-491c-bfb0-0dbca1127497_terseLabel_en-US" xlink:label="lab_us-gaap_SuretySegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surety Product Line</link:label>
    <link:label id="lab_us-gaap_SuretySegmentMember_label_en-US" xlink:label="lab_us-gaap_SuretySegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surety Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretySegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretySegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SuretySegmentMember" xlink:to="lab_us-gaap_SuretySegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts_f5e73456-c3b0-4668-8611-08e757f55629_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs&#160;</link:label>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Deferred Policy Acquisition Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" xlink:to="lab_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredTaxAssetsUnearnedPremiums_3624a874-bcfd-466f-8e07-19f27fded468_terseLabel_en-US" xlink:label="lab_ahl_DeferredTaxAssetsUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsUnearnedPremiums_label_en-US" xlink:label="lab_ahl_DeferredTaxAssetsUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unearned Premiums</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsUnearnedPremiums_documentation_en-US" xlink:label="lab_ahl_DeferredTaxAssetsUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsUnearnedPremiums" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsUnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredTaxAssetsUnearnedPremiums" xlink:to="lab_ahl_DeferredTaxAssetsUnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_69046d15-d335-4773-a385-1d75350b8e02_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2017</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_ecfadb7c-e2c5-4c9f-a214-31f6d7134702_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_0a5baed9-e7e8-445f-8c9a-35a2570e81cf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_2b22abe0-0367-46d2-a6db-c2840ddfa2f4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_3c84902a-b512-48d7-a87b-de23ac961d62_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares, rate</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c49cffaa-529f-4fbf-80ba-6e26aeeead4e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, credit agreement maximum limit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ee337284-a37c-4ce3-b047-002b467b8e16_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtServiceCoverageRatioLessThan1.00xMember_9eb20de8-eaff-494e-b6cf-679f6b722be2_terseLabel_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioLessThan1.00xMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 1.00x</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatioLessThan1.00xMember_label_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioLessThan1.00xMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio, Less Than 1.00x [Member]</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatioLessThan1.00xMember_documentation_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioLessThan1.00xMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio, Less Than 1.00x [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioLessThan1.00xMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember" xlink:to="lab_ahl_DebtServiceCoverageRatioLessThan1.00xMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseRatio_e584d293-7161-4bd9-ab78-9ef35fe3dff0_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expense ratio</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseRatio_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock_cb255b3c-29fe-4785-84cc-9dc7f79c223f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Schedule of Historical Claims Duration</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Schedule of Historical Claims Duration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_eb6dea5c-971e-4292-87d5-271e548b9239_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebttoValueRatioLessthan50PercentMember_51642fda-beb5-4e10-a17f-b2ed66465439_terseLabel_en-US" xlink:label="lab_ahl_DebttoValueRatioLessthan50PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 50 Percent</link:label>
    <link:label id="lab_ahl_DebttoValueRatioLessthan50PercentMember_label_en-US" xlink:label="lab_ahl_DebttoValueRatioLessthan50PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, Less than 50 Percent [Member]</link:label>
    <link:label id="lab_ahl_DebttoValueRatioLessthan50PercentMember_documentation_en-US" xlink:label="lab_ahl_DebttoValueRatioLessthan50PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, Less than 50 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebttoValueRatioLessthan50PercentMember" xlink:to="lab_ahl_DebttoValueRatioLessthan50PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LetterOfCreditToSupportFundsAtLloyds_86c1a425-f8c9-4ba8-9cda-7f7d18893ccb_terseLabel_en-US" xlink:label="lab_ahl_LetterOfCreditToSupportFundsAtLloyds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit to Support Funds at Lloyd's</link:label>
    <link:label id="lab_ahl_LetterOfCreditToSupportFundsAtLloyds_label_en-US" xlink:label="lab_ahl_LetterOfCreditToSupportFundsAtLloyds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit to Support Funds at Lloyd's</link:label>
    <link:label id="lab_ahl_LetterOfCreditToSupportFundsAtLloyds_documentation_en-US" xlink:label="lab_ahl_LetterOfCreditToSupportFundsAtLloyds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit to Support Funds at Lloyd's</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LetterOfCreditToSupportFundsAtLloyds" xlink:href="ahl-20231220.xsd#ahl_LetterOfCreditToSupportFundsAtLloyds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LetterOfCreditToSupportFundsAtLloyds" xlink:to="lab_ahl_LetterOfCreditToSupportFundsAtLloyds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldByInsuranceRegulators_0b2e3a77-653f-42cd-867d-016d70522875_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investable assets held by insurance regulators</link:label>
    <link:label id="lab_us-gaap_AssetsHeldByInsuranceRegulators_label_en-US" xlink:label="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held by Insurance Regulators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldByInsuranceRegulators" xlink:to="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_d4fb72ba-a9a0-4a89-a93e-b8fb994e5526_terseLabel_en-US" xlink:label="lab_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for trading financial assets, at fair value</link:label>
    <link:label id="lab_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Assets, Excluding Debt and Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember" xlink:to="lab_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_8084e944-cac0-43fe-8fb5-7f828eff680e_terseLabel_en-US" xlink:label="lab_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total as percent of investable assets</link:label>
    <link:label id="lab_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_label_en-US" xlink:label="lab_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Funds Held As Percentage Of Cash And Short Term Investments</link:label>
    <link:label id="lab_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_documentation_en-US" xlink:label="lab_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral funds held as percentage of cash and short term investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" xlink:to="lab_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1dceae82-01ce-4631-bfb2-60df8f727666_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Purchases) of other investments</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8a769302-5167-4d83-8fef-d8c41b28e41a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_9554cae0-3a49-4732-ad03-a4261c0ba5c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix_3487b0a1-6311-4247-a098-dc2879fe0b7f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year Six</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_00a62700-0348-49ef-9a7e-48f78ade6822_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract_9430d600-9d0f-4c45-b4ec-789c71adaf23_terseLabel_en-US" xlink:label="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Statutory Requirements And Dividends Restrictions Summary Of Statutory Requirements And Dividends Restrictions [Abstract]</link:label>
    <link:label id="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract_label_en-US" xlink:label="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Statutory Requirements And Dividends Restrictions Summary Of Statutory Requirements And Dividends Restrictions [Abstract]</link:label>
    <link:label id="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract_documentation_en-US" xlink:label="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure - Statutory Requirements and Dividends Restrictions - Summary of Statutory Requirements and Dividends Restrictions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract" xlink:href="ahl-20231220.xsd#ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract" xlink:to="lab_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_SummaryofOtherLeaseInformationTableTextBlock_49cc7143-1a3f-46b5-af58-bd5aeff68206_terseLabel_en-US" xlink:label="lab_ahl_SummaryofOtherLeaseInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Lease Information</link:label>
    <link:label id="lab_ahl_SummaryofOtherLeaseInformationTableTextBlock_label_en-US" xlink:label="lab_ahl_SummaryofOtherLeaseInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Lease Information [Table Text Block]</link:label>
    <link:label id="lab_ahl_SummaryofOtherLeaseInformationTableTextBlock_documentation_en-US" xlink:label="lab_ahl_SummaryofOtherLeaseInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Lease Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SummaryofOtherLeaseInformationTableTextBlock" xlink:href="ahl-20231220.xsd#ahl_SummaryofOtherLeaseInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_SummaryofOtherLeaseInformationTableTextBlock" xlink:to="lab_ahl_SummaryofOtherLeaseInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_fb317efc-2db0-4565-82e6-23f90edbc3b6_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income/(loss) attributable to Aspen Insurance Holdings Limited&#8217;s ordinary shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f2d56748-973c-4931-b01e-5f2f3ba3e949_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss)/income attributable to Aspen Insurance Holdings Limited&#8217;s ordinary shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_1cb858d4-1af6-497d-bcc8-d96e29fc2f6a_terseLabel_en-US" xlink:label="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to impairment charges on lease assets</link:label>
    <link:label id="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_1c84781d-6aef-4fcf-aa1a-afaf3dfd14b2_negatedTerseLabel_en-US" xlink:label="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to impairment charges on lease assets</link:label>
    <link:label id="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_label_en-US" xlink:label="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to impairment charges on lease assets</link:label>
    <link:label id="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_documentation_en-US" xlink:label="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses related to impairment charges on lease assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" xlink:href="ahl-20231220.xsd#ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" xlink:to="lab_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_e62afb4f-880f-4e4f-8311-f1864af48480_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Fair Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_0fc47e13-bea7-4e0c-a90f-03c511e3c9ad_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_8f830f14-d486-40c0-9137-b2b17351a508_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term investments&#160;&#8212; Available for sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_50c8d8b6-bc90-4fd6-952d-b87937769920_terseLabel_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian non-resident withholding tax</link:label>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_label_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Non-Resident Withholding Tax, Amount</link:label>
    <link:label id="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_documentation_en-US" xlink:label="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Non-Resident Withholding Tax, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" xlink:to="lab_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CorporateExpenses_9ba8b681-e2cd-4f7f-bc0b-c0eb0875ba2a_negatedTerseLabel_en-US" xlink:label="lab_ahl_CorporateExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses</link:label>
    <link:label id="lab_ahl_CorporateExpenses_label_en-US" xlink:label="lab_ahl_CorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses</link:label>
    <link:label id="lab_ahl_CorporateExpenses_documentation_en-US" xlink:label="lab_ahl_CorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateExpenses" xlink:href="ahl-20231220.xsd#ahl_CorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CorporateExpenses" xlink:to="lab_ahl_CorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1ac419b3-3662-44a8-94e8-2d0952eb68b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contractual Obligations Under Short-term Debts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_4c870cd6-9318-4bb0-aa52-f5e194a53336_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_6abc2b76-6ab8-4140-9351-446a282f4a69_terseLabel_en-US" xlink:label="lab_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_label_en-US" xlink:label="lab_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net and Income Taxes Receivable</link:label>
    <link:label id="lab_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_documentation_en-US" xlink:label="lab_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net and Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" xlink:href="ahl-20231220.xsd#ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" xlink:to="lab_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesGainLoss_5dee1a67-9672-4bcb-9124-7570c7a7c1aa_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized investment losses (3)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesGainLoss_3007621c-6236-441b-b357-e28ad7f1530d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized investment losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesGainLoss_38831554-36e2-4856-a482-2ae89daa9aca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized investment losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_63550c0d-195a-49b0-961d-e296479b6a6f_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_91770a50-05f3-4eff-aa45-ccbd2a1ec8d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance (2)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_eb467483-29d9-4d74-90e4-4fb7d6925287_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Historical Claims Duration [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_dea5fe09-0e65-4621-b9b6-940dfee825b5_terseLabel_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities Within One Year Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_label_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities Within One Year Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_documentation_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities debt maturities within one year average ratings by maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" xlink:to="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_be5a4760-9a19-43d5-ac30-2f254e30ae4e_terseLabel_en-US" xlink:label="lab_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delinquent amount of loans at end of period</link:label>
    <link:label id="lab_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_label_en-US" xlink:label="lab_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delinquent Amount at End of Period on Loans Managed and Securitized or Asset-Backed Financing Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" xlink:to="lab_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_TradingSecuritiesCatastropheBondsGainLoss_97c07b21-a630-49d7-8c1f-2a9e1ccc982c_terseLabel_en-US" xlink:label="lab_ahl_TradingSecuritiesCatastropheBondsGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe bonds</link:label>
    <link:label id="lab_ahl_TradingSecuritiesCatastropheBondsGainLoss_label_en-US" xlink:label="lab_ahl_TradingSecuritiesCatastropheBondsGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities, Catastrophe Bonds Gain (Loss)</link:label>
    <link:label id="lab_ahl_TradingSecuritiesCatastropheBondsGainLoss_documentation_en-US" xlink:label="lab_ahl_TradingSecuritiesCatastropheBondsGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities, Catastrophe Bonds Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesCatastropheBondsGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss" xlink:to="lab_ahl_TradingSecuritiesCatastropheBondsGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_9501f189-8007-4bed-b7ae-2ba57dce3fdd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Trading Securities and Other Trading Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_3ed9deb7-e211-4f93-aa8b-c87ae346668e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_InsuranceReserveAbstract_5446f932-4a23-4fa5-a95f-9b549b81c9fc_terseLabel_en-US" xlink:label="lab_ahl_InsuranceReserveAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance reserves</link:label>
    <link:label id="lab_ahl_InsuranceReserveAbstract_label_en-US" xlink:label="lab_ahl_InsuranceReserveAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Reserve [Abstract]</link:label>
    <link:label id="lab_ahl_InsuranceReserveAbstract_documentation_en-US" xlink:label="lab_ahl_InsuranceReserveAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Reserve.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserveAbstract" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserveAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_InsuranceReserveAbstract" xlink:to="lab_ahl_InsuranceReserveAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_75a77e34-954c-4270-8165-4e327307d784_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems" xlink:to="lab_us-gaap_InvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_020fff6c-12db-4dc1-b1bc-253e95fc5c4f_verboseLabel_en-US" xlink:label="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_81b967c4-8561-4766-9797-89b077cbe7af_negatedLabel_en-US" xlink:label="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_label_en-US" xlink:label="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label id="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_documentation_en-US" xlink:label="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" xlink:to="lab_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_IncreaseDecreaseInLongTermDebt_ef4a0384-e7c3-4dce-83fd-445e23ff39e1_terseLabel_en-US" xlink:label="lab_ahl_IncreaseDecreaseInLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and loan notes issued by variable interest entities</link:label>
    <link:label id="lab_ahl_IncreaseDecreaseInLongTermDebt_label_en-US" xlink:label="lab_ahl_IncreaseDecreaseInLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Long Term Debt</link:label>
    <link:label id="lab_ahl_IncreaseDecreaseInLongTermDebt_documentation_en-US" xlink:label="lab_ahl_IncreaseDecreaseInLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the amounts payable on long-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncreaseDecreaseInLongTermDebt" xlink:href="ahl-20231220.xsd#ahl_IncreaseDecreaseInLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_IncreaseDecreaseInLongTermDebt" xlink:to="lab_ahl_IncreaseDecreaseInLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_51d51997-f96f-4e7d-b026-1e3513399afa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_64fb9d29-7202-40be-8efb-6f5499a4b392_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ChangeInOtherAssets_aa279546-57a2-4285-bcb3-4ad1c2aebb21_terseLabel_en-US" xlink:label="lab_ahl_ChangeInOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in other assets</link:label>
    <link:label id="lab_ahl_ChangeInOtherAssets_label_en-US" xlink:label="lab_ahl_ChangeInOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Other Assets</link:label>
    <link:label id="lab_ahl_ChangeInOtherAssets_documentation_en-US" xlink:label="lab_ahl_ChangeInOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ChangeInOtherAssets" xlink:href="ahl-20231220.xsd#ahl_ChangeInOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ChangeInOtherAssets" xlink:to="lab_ahl_ChangeInOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_af0597ef-f061-4642-a272-56ea5af094c3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c48c9cec-4146-42ae-9e29-efa7c90ece34_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval_96fa11e0-1164-4ef0-beae-71f858cc74d2_terseLabel_en-US" xlink:label="lab_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory capital and surplus, percent reduction requiring approval</link:label>
    <link:label id="lab_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval_label_en-US" xlink:label="lab_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Capital and Surplus, Percent Reduction Requiring Approval</link:label>
    <link:label id="lab_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval_documentation_en-US" xlink:label="lab_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Capital and Surplus, Percent Requiring Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval" xlink:href="ahl-20231220.xsd#ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval" xlink:to="lab_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent_246efcfb-7252-49ae-b399-5f828fafea7f_terseLabel_en-US" xlink:label="lab_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory capital and surplus, percent</link:label>
    <link:label id="lab_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent_label_en-US" xlink:label="lab_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Payments Restrictions Schedule, Statutory Capital and Surplus, Percent</link:label>
    <link:label id="lab_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent_documentation_en-US" xlink:label="lab_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Payments Restrictions Schedule, Statutory Capital and Surplus, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" xlink:href="ahl-20231220.xsd#ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" xlink:to="lab_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DelayedDrawTermLoanFacility_eba76b45-7a13-4635-886f-acd6d7747162_terseLabel_en-US" xlink:label="lab_ahl_DelayedDrawTermLoanFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed draw term loan facility</link:label>
    <link:label id="lab_ahl_DelayedDrawTermLoanFacility_label_en-US" xlink:label="lab_ahl_DelayedDrawTermLoanFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed draw term loan facility</link:label>
    <link:label id="lab_ahl_DelayedDrawTermLoanFacility_documentation_en-US" xlink:label="lab_ahl_DelayedDrawTermLoanFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed draw term loan facility, remains undrawn</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DelayedDrawTermLoanFacility" xlink:href="ahl-20231220.xsd#ahl_DelayedDrawTermLoanFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DelayedDrawTermLoanFacility" xlink:to="lab_ahl_DelayedDrawTermLoanFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member_c6c67c06-cba3-43a2-a8d6-0be9f50b9a47_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2014</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year 2014 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLossOnDerivative_52ebbd9c-7b21-441c-a8d8-93c218d477f3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLossOnDerivative" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain)/loss on derivative contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeLossOnDerivative_label_en-US" xlink:label="lab_us-gaap_DerivativeLossOnDerivative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Loss on Derivative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLossOnDerivative" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLossOnDerivative"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLossOnDerivative" xlink:to="lab_us-gaap_DerivativeLossOnDerivative" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_a82a8f0e-f1d9-4b0f-967b-0097e47ad8dd_terseLabel_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables, premium paid and recognized</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_label_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables, including premium paid and recognized</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_documentation_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables, including premium paid and recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" xlink:to="lab_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Ltv80To100PercentMember_a006173a-dbec-40cb-9376-871ebaec7476_terseLabel_en-US" xlink:label="lab_us-gaap_Ltv80To100PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">80 to 100 Percent</link:label>
    <link:label id="lab_us-gaap_Ltv80To100PercentMember_label_en-US" xlink:label="lab_us-gaap_Ltv80To100PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value Ratio, 80 to 100 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Ltv80To100PercentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Ltv80To100PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Ltv80To100PercentMember" xlink:to="lab_us-gaap_Ltv80To100PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_InsuranceMember_c5532a3a-c00b-456a-ba3d-c079b02e5fad_terseLabel_en-US" xlink:label="lab_ahl_InsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_ahl_InsuranceMember_label_en-US" xlink:label="lab_ahl_InsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Member]</link:label>
    <link:label id="lab_ahl_InsuranceMember_documentation_en-US" xlink:label="lab_ahl_InsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_InsuranceMember" xlink:to="lab_ahl_InsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_2198f0c4-12d9-4612-a4b2-fcbe30ed5964_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_40daa692-6304-4075-bdbd-130d2f30a430_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives at fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_0c2104cf-8ac2-4d39-9f6c-890f3b2b940f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost or Amortized Cost, Unrealized and Realized Gains and Losses and Estimated Fair Value of Available for Sale Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebttoValueRatio61to70PercentMember_73a2ae33-84ad-49a9-809a-7720109efd9d_terseLabel_en-US" xlink:label="lab_ahl_DebttoValueRatio61to70PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">61 to 70 Percent</link:label>
    <link:label id="lab_ahl_DebttoValueRatio61to70PercentMember_label_en-US" xlink:label="lab_ahl_DebttoValueRatio61to70PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, 61 to 70 Percent [Member]</link:label>
    <link:label id="lab_ahl_DebttoValueRatio61to70PercentMember_documentation_en-US" xlink:label="lab_ahl_DebttoValueRatio61to70PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, 61 to 70 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebttoValueRatio61to70PercentMember" xlink:to="lab_ahl_DebttoValueRatio61to70PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_791e02b4-ba54-46f8-a1a8-f80163703459_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_638de9ef-71cd-44b6-b705-4038df2a9995_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_e6c6725a-1262-45d5-81c0-f4a4463eb237_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtToValueRatioGreaterThan100Member_68718fd9-0930-4840-8816-c6ec759ca1ab_terseLabel_en-US" xlink:label="lab_ahl_DebtToValueRatioGreaterThan100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than 100%</link:label>
    <link:label id="lab_ahl_DebtToValueRatioGreaterThan100Member_label_en-US" xlink:label="lab_ahl_DebtToValueRatioGreaterThan100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, Greater than 100% [Member]</link:label>
    <link:label id="lab_ahl_DebtToValueRatioGreaterThan100Member_documentation_en-US" xlink:label="lab_ahl_DebtToValueRatioGreaterThan100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, Greater than 100%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtToValueRatioGreaterThan100Member" xlink:href="ahl-20231220.xsd#ahl_DebtToValueRatioGreaterThan100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtToValueRatioGreaterThan100Member" xlink:to="lab_ahl_DebtToValueRatioGreaterThan100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_db575007-8a08-4e2b-a18f-d43cb1659651_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e98808ac-5e61-4c40-90e7-f97d9bb3873a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember_79547da9-10a1-4a60-9bea-a26ed3a6f00f_terseLabel_en-US" xlink:label="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember_label_en-US" xlink:label="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid In Capital, Excluding Preference Shares [Member]</link:label>
    <link:label id="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember_documentation_en-US" xlink:label="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid In Capital, Excluding Preference Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember" xlink:href="ahl-20231220.xsd#ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember" xlink:to="lab_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_9669bb09-d5d5-4e97-8881-bccf6afe7243_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables:</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsMember_a65c4a05-eb33-4ac6-8042-3de4d62e7a6d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsMember_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsMember" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_a38f30a6-5652-4cb4-873b-3dde992098c9_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_29cbd7b7-a859-4838-8e9c-3e40e1b8c245_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RelatedPartyInvestmentIncomeMember_b613b7a5-4123-4364-81e1-7d5acd144235_terseLabel_en-US" xlink:label="lab_ahl_RelatedPartyInvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party investment income</link:label>
    <link:label id="lab_ahl_RelatedPartyInvestmentIncomeMember_label_en-US" xlink:label="lab_ahl_RelatedPartyInvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party investment income [Member]</link:label>
    <link:label id="lab_ahl_RelatedPartyInvestmentIncomeMember_documentation_en-US" xlink:label="lab_ahl_RelatedPartyInvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party investment income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyInvestmentIncomeMember" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyInvestmentIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RelatedPartyInvestmentIncomeMember" xlink:to="lab_ahl_RelatedPartyInvestmentIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationLineItems_408d4e67-deff-4520-9918-ab54e63537f9_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationLineItems_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_2c14a42e-694a-4ca8-b296-e5aa11f79ede_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AuthorizedShareCapitalAbstract_13e64b51-6427-472e-8053-2ca82e3b9929_terseLabel_en-US" xlink:label="lab_ahl_AuthorizedShareCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized share capital:</link:label>
    <link:label id="lab_ahl_AuthorizedShareCapitalAbstract_label_en-US" xlink:label="lab_ahl_AuthorizedShareCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized Share Capital [Abstract]</link:label>
    <link:label id="lab_ahl_AuthorizedShareCapitalAbstract_documentation_en-US" xlink:label="lab_ahl_AuthorizedShareCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized share capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapitalAbstract" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract" xlink:to="lab_ahl_AuthorizedShareCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent_e18b6dbd-231c-4af7-8c42-7265065eab59_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance, Amount Retained, Per Event</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance, Amount Retained, Per Event</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionAmountRetainedPerEvent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent" xlink:to="lab_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PremiumsWrittenGrossPercentage_2175efe1-c014-47ce-b0a9-65ceea655672_terseLabel_en-US" xlink:label="lab_ahl_PremiumsWrittenGrossPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross written premiums, percentage</link:label>
    <link:label id="lab_ahl_PremiumsWrittenGrossPercentage_label_en-US" xlink:label="lab_ahl_PremiumsWrittenGrossPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Written Gross Percentage</link:label>
    <link:label id="lab_ahl_PremiumsWrittenGrossPercentage_documentation_en-US" xlink:label="lab_ahl_PremiumsWrittenGrossPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums written gross percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsWrittenGrossPercentage" xlink:href="ahl-20231220.xsd#ahl_PremiumsWrittenGrossPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PremiumsWrittenGrossPercentage" xlink:to="lab_ahl_PremiumsWrittenGrossPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_fb1a55a6-ad33-4ba0-acbe-94f104d9255b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds or share issuance</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_098a9638-a3e6-4c93-9bd3-aaa1aa3434be_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accrued expenses and other payables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_53cedd96-43e6-4fe9-a95f-3f58f4a1999c_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromAffiliates_682fc4f5-98b3-4b6a-a0c4-60a36be57f98_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany funds due from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromAffiliates_label_en-US" xlink:label="lab_us-gaap_DueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromAffiliates" xlink:to="lab_us-gaap_DueFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d126ba11-9500-4a7e-93fd-4291c524170b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_347aaa68-12cf-4832-9531-7859adea3ecd_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares, issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate_5f6d330d-3ab4-432c-a400-23cf05c623a5_terseLabel_en-US" xlink:label="lab_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Liquidation Preference Value, Fixed for Floating Rate</link:label>
    <link:label id="lab_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate_label_en-US" xlink:label="lab_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Liquidation Preference Value, Fixed for Floating Rate</link:label>
    <link:label id="lab_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate_documentation_en-US" xlink:label="lab_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Liquidation Preference Value, Fixed for Floating Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate" xlink:href="ahl-20231220.xsd#ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate" xlink:to="lab_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_5d962456-5600-49ce-895c-ae90731bd335_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_e3dff778-6b3e-4c91-8ac0-f61fd6657706_terseLabel_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than 1.20x</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_label_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio, Greater Than 1.2x [Member]</link:label>
    <link:label id="lab_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_documentation_en-US" xlink:label="lab_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Service Coverage Ratio, Greater Than 1.2x [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioGreaterThan1.2xMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember" xlink:to="lab_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MiddlemarketloansMember_61ad53f3-8083-4ac1-8209-98a3e6827c91_verboseLabel_en-US" xlink:label="lab_ahl_MiddlemarketloansMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middle market loans</link:label>
    <link:label id="lab_ahl_MiddlemarketloansMember_label_en-US" xlink:label="lab_ahl_MiddlemarketloansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middle market loans [Member]</link:label>
    <link:label id="lab_ahl_MiddlemarketloansMember_documentation_en-US" xlink:label="lab_ahl_MiddlemarketloansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middle market loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MiddlemarketloansMember" xlink:to="lab_ahl_MiddlemarketloansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_0377861f-1475-4a29-aaeb-30e42ea0fc3f_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_099626c1-3d5f-466c-89dc-de140103b696_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_28d7b0e6-6919-47cf-86aa-e15591a3fb74_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities and Short-term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_8aef22cc-1c1e-4703-991d-28abd10c2a71_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plans</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_48f7aa1c-a6b9-4220-897d-2d86df13383b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_5430a6e8-f2ec-44af-8c0e-6d5d6a39237d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_96c637c6-a4e7-4183-bf50-e9c92f47911e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_08b5c895-7a2d-45b2-abc4-9e6586f5089e_terseLabel_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_a5f11d33-8518-462a-899a-11b6589d78e1_verboseLabel_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross&#160;Amount</link:label>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectPremiumsEarned" xlink:to="lab_us-gaap_DirectPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_2e310050-055a-49ad-b4d5-b02971910563_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_e7122785-9dce-4082-8f1b-7abce300e142_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:to="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeInvestmentsMember_bc30d658-94a1-4db9-a49e-83a92c9c7b72_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Investments</link:label>
    <link:label id="lab_us-gaap_FixedIncomeInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeInvestmentsMember" xlink:to="lab_us-gaap_FixedIncomeInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_c833f072-3783-4ef3-acf7-24e07af21ae9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShorttermInvestmentTradingMember_8ba8792c-7649-4ab4-a4b3-8cb9f8d2ea1b_terseLabel_en-US" xlink:label="lab_ahl_ShorttermInvestmentTradingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investment, Trading</link:label>
    <link:label id="lab_ahl_ShorttermInvestmentTradingMember_label_en-US" xlink:label="lab_ahl_ShorttermInvestmentTradingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investment, Trading [Member]</link:label>
    <link:label id="lab_ahl_ShorttermInvestmentTradingMember_documentation_en-US" xlink:label="lab_ahl_ShorttermInvestmentTradingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investment, Trading [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShorttermInvestmentTradingMember" xlink:href="ahl-20231220.xsd#ahl_ShorttermInvestmentTradingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShorttermInvestmentTradingMember" xlink:to="lab_ahl_ShorttermInvestmentTradingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_12dc7c49-68ca-4fea-bb8b-ed315e0a05fe_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Payments, Next twelve months</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_f4095a8f-2000-4e4c-bc1e-8b46d3e85dad_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total tax expense/(benefit), Non-U.S.</link:label>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_9ac84a5b-a60c-4d1e-b408-73b9dfaba3b1_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestments_c4c824cd-d0db-43a8-8a03-e4d2af1bd81c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments, at fair value (2)</link:label>
    <link:label id="lab_us-gaap_OtherInvestments_9b3d6b31-6808-4c7f-aeb6-6bac41c8977f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments (equity method)</link:label>
    <link:label id="lab_us-gaap_OtherInvestments_label_en-US" xlink:label="lab_us-gaap_OtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestments" xlink:to="lab_us-gaap_OtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_f56d2b73-5744-4a8d-92d6-d1be0e509f43_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated transactions</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyServiceMember_9e15ffe6-4ee2-47eb-b732-ef328b356cb3_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information technology</link:label>
    <link:label id="lab_us-gaap_TechnologyServiceMember_label_en-US" xlink:label="lab_us-gaap_TechnologyServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyServiceMember" xlink:to="lab_us-gaap_TechnologyServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_689a0a6f-aaf9-4832-beb1-7381224a9166_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit/(expense) thereon:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AAOrLowerMember_af8ec4d5-ecda-4f92-9722-f244d106634e_terseLabel_en-US" xlink:label="lab_ahl_AAOrLowerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AA- or lower</link:label>
    <link:label id="lab_ahl_AAOrLowerMember_label_en-US" xlink:label="lab_ahl_AAOrLowerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AA- or lower [Member]</link:label>
    <link:label id="lab_ahl_AAOrLowerMember_documentation_en-US" xlink:label="lab_ahl_AAOrLowerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AA- or lower</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAOrLowerMember" xlink:href="ahl-20231220.xsd#ahl_AAOrLowerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AAOrLowerMember" xlink:to="lab_ahl_AAOrLowerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_8572752b-df2f-4590-a738-532379172ffc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_52953970-00dd-4205-8190-e338064c03f0_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CitibankEuropeMember_0a1d7033-7780-446e-9803-2572a6dad783_terseLabel_en-US" xlink:label="lab_ahl_CitibankEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank Europe</link:label>
    <link:label id="lab_ahl_CitibankEuropeMember_label_en-US" xlink:label="lab_ahl_CitibankEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank Europe [Member]</link:label>
    <link:label id="lab_ahl_CitibankEuropeMember_documentation_en-US" xlink:label="lab_ahl_CitibankEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank Europe.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CitibankEuropeMember" xlink:href="ahl-20231220.xsd#ahl_CitibankEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CitibankEuropeMember" xlink:to="lab_ahl_CitibankEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cf17fd3c-1d1e-4617-b35d-9d5a89b509c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income Reclassification</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e855939b-5366-47e5-b019-6354a29b9b49_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_bac947e7-fd80-473a-aaf2-81ee80575be4_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour_b3e206cb-0bb6-48b9-9a92-916f45a3ae78_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year Four</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3a65f1d1-abff-4a17-bbd1-238e0b182343_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_TotalAllowanceForCreditLoss_a76459b8-135a-4629-8104-21a5ce7481fd_periodStartLabel_en-US" xlink:label="lab_ahl_TotalAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Allowance for Credit Loss, Beginning Balance</link:label>
    <link:label id="lab_ahl_TotalAllowanceForCreditLoss_defb79ac-a81b-46d6-819f-2f3d89486dd4_periodEndLabel_en-US" xlink:label="lab_ahl_TotalAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Allowance for Credit Loss, Ending Balance</link:label>
    <link:label id="lab_ahl_TotalAllowanceForCreditLoss_label_en-US" xlink:label="lab_ahl_TotalAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Allowance for Credit Loss</link:label>
    <link:label id="lab_ahl_TotalAllowanceForCreditLoss_documentation_en-US" xlink:label="lab_ahl_TotalAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalAllowanceForCreditLoss" xlink:href="ahl-20231220.xsd#ahl_TotalAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_TotalAllowanceForCreditLoss" xlink:to="lab_ahl_TotalAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_85ebd57f-cfc6-4e40-a959-0475e721b87b_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_a6b14cb1-d6eb-4f60-95a4-e4f135dee2ea_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price per share</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3092fbe1-8137-4d8d-985e-bb8f9b7f8bbd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Payments, Due year five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingMeasurementInput_65f97e20-9406-4405-8542-a8900d597551_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement inputs</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingMeasurementInput" xlink:to="lab_us-gaap_DebtSecuritiesTradingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_b09101a3-ed9f-4687-82ac-d7b43bb6e751_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomesticMember" xlink:to="lab_us-gaap_GeographicDistributionDomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_GainsLossesOnInvestmentAndForeignExchange_78e0564f-1494-463b-9fdc-ad4df86bdc82_negatedLabel_en-US" xlink:label="lab_ahl_GainsLossesOnInvestmentAndForeignExchange" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and unrealized investment foreign exchange (gains)/losses</link:label>
    <link:label id="lab_ahl_GainsLossesOnInvestmentAndForeignExchange_1b3bdca1-38b9-4ebe-ba86-34f2f3c32b51_negatedTerseLabel_en-US" xlink:label="lab_ahl_GainsLossesOnInvestmentAndForeignExchange" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) On Investment And Foreign Exchange</link:label>
    <link:label id="lab_ahl_GainsLossesOnInvestmentAndForeignExchange_label_en-US" xlink:label="lab_ahl_GainsLossesOnInvestmentAndForeignExchange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) On Investment And Foreign Exchange</link:label>
    <link:label id="lab_ahl_GainsLossesOnInvestmentAndForeignExchange_documentation_en-US" xlink:label="lab_ahl_GainsLossesOnInvestmentAndForeignExchange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on investment and foreign exchange.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GainsLossesOnInvestmentAndForeignExchange" xlink:href="ahl-20231220.xsd#ahl_GainsLossesOnInvestmentAndForeignExchange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_GainsLossesOnInvestmentAndForeignExchange" xlink:to="lab_ahl_GainsLossesOnInvestmentAndForeignExchange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_8658548a-6134-4a3d-8451-ff00845cc6af_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsWrittenGross_31bf79b5-7406-4608-aff6-e36ffc9cc004_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsWrittenGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross written premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsWrittenGross_label_en-US" xlink:label="lab_us-gaap_PremiumsWrittenGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Written, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsWrittenGross" xlink:to="lab_us-gaap_PremiumsWrittenGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_f8ac2641-66ab-4d39-a985-637b623141c7_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_871f6860-59d0-4ef5-a999-fda47bb16a0b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_eaa81b68-706f-421a-8042-95761ce81eb5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on preference shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_d97b1d70-f04c-4ac7-80c6-bdf693da2cbe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on preference shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Preferred Stock and Preference Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_3dd39b10-66e6-4c6b-9723-239eef710030_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_8da260cd-8c27-4368-9dc3-8be72a39def3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other temporary differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_67bb9da6-44e8-4136-95e4-19263264da84_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_57030108-8b91-477c-951f-f53fa08d4e46_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverable for unpaid claims under retroactive reinsurance, beginning balance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ae2104b5-474f-4ca3-806e-0401e6562e46_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverable for unpaid claims under retroactive reinsurance, beginning balance, Ending Balance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_04512893-5852-48a1-b1d1-762bd68b027b_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverable on unpaid losses</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FinitelivedIntangibleAssetsAcquiredDisposed_dc34134a-6b3a-4de3-a628-9d77fdd6ac2b_terseLabel_en-US" xlink:label="lab_ahl_FinitelivedIntangibleAssetsAcquiredDisposed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets acquired (disposed)</link:label>
    <link:label id="lab_ahl_FinitelivedIntangibleAssetsAcquiredDisposed_label_en-US" xlink:label="lab_ahl_FinitelivedIntangibleAssetsAcquiredDisposed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired (Disposed)</link:label>
    <link:label id="lab_ahl_FinitelivedIntangibleAssetsAcquiredDisposed_documentation_en-US" xlink:label="lab_ahl_FinitelivedIntangibleAssetsAcquiredDisposed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired (Disposed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FinitelivedIntangibleAssetsAcquiredDisposed" xlink:href="ahl-20231220.xsd#ahl_FinitelivedIntangibleAssetsAcquiredDisposed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FinitelivedIntangibleAssetsAcquiredDisposed" xlink:to="lab_ahl_FinitelivedIntangibleAssetsAcquiredDisposed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f78d1043-4b2f-475b-9985-24124baed1cf_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember_ba0bb834-16e4-4bab-af2d-dd94df80501d_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives at fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_bdcafcff-7f38-44a5-ac4a-1cb725c39adc_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b3b5601b-7d5f-4d83-aff3-62033a1da741_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_c9b72ac6-451e-4f41-a94b-71741f4ace65_terseLabel_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in expected credit gains (losses)</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_label_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities Available For Sale Gain Loss, Net Change Expected Credit Gains(Losses)</link:label>
    <link:label id="lab_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_documentation_en-US" xlink:label="lab_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities Available For Sale Gain Loss, Net Change Expected Credit Gains(Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" xlink:to="lab_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_afb49c19-cf8b-4cda-a925-702a96c288ad_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_bf68acae-377e-4550-bf43-0940bca84d0b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Ceded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_f70dfea5-1651-448c-a478-1ec035166c32_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_624f78f2-af6e-4363-8496-95927393563c_terseLabel_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables for Unpaid Claims and Claims Adjustment, Ceded Claims Gross</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_label_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables for Unpaid Claims and Claims Adjustment, Ceded Cumulative Losses</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_documentation_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables for Unpaid Claims and Claims Adjustments, Ceded Cumulative Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" xlink:to="lab_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_e0337eb4-6f06-4f8f-ba64-a7d2842c5650_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_921e3529-bee1-49bb-a2c2-c5818683c626_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2022</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_46a2f7b2-badf-4f53-aff7-3d1210b0e24d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative foreign currency translation adjustments:</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OfficeBuildingMember_12f535e1-2cd7-4183-8c1b-70ea1309fc67_terseLabel_en-US" xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office building</link:label>
    <link:label id="lab_srt_OfficeBuildingMember_label_en-US" xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OfficeBuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficeBuildingMember" xlink:to="lab_srt_OfficeBuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsAndOtherReceivablesNetAbstract_3d0e2fd8-fe9e-4f99-b4c5-d27a9394ee66_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsAndOtherReceivablesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables:</link:label>
    <link:label id="lab_us-gaap_PremiumsAndOtherReceivablesNetAbstract_label_en-US" xlink:label="lab_us-gaap_PremiumsAndOtherReceivablesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums and Other Receivables, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract" xlink:to="lab_us-gaap_PremiumsAndOtherReceivablesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions_7e7c1a56-2d95-4b40-a6c3-46ab0bf53e96_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs deferred</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost, Capitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_1680b4af-6783-45cc-b417-aa3f1d2c7dc1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_a03571e0-6ef7-4aba-b61d-704dee994a70_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeutscheMember_49cebe93-3010-44e5-8964-c7dbe44c8b23_terseLabel_en-US" xlink:label="lab_ahl_DeutscheMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deutsche</link:label>
    <link:label id="lab_ahl_DeutscheMember_label_en-US" xlink:label="lab_ahl_DeutscheMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deutsche [Member]</link:label>
    <link:label id="lab_ahl_DeutscheMember_documentation_en-US" xlink:label="lab_ahl_DeutscheMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deutsche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeutscheMember" xlink:href="ahl-20231220.xsd#ahl_DeutscheMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeutscheMember" xlink:to="lab_ahl_DeutscheMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear_0202d2f9-df01-48cb-8d3d-fee8eebef9a0_terseLabel_en-US" xlink:label="lab_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expenses (benefit) related to prior year</link:label>
    <link:label id="lab_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear_label_en-US" xlink:label="lab_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expenses (Benefit) Related to Prior Year</link:label>
    <link:label id="lab_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear_documentation_en-US" xlink:label="lab_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expenses (Benefit) Related to Prior Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" xlink:href="ahl-20231220.xsd#ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" xlink:to="lab_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b6bd9af9-0462-4d43-a09a-49fac874e26b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CreditRatingAMBestDomain_188c589c-af47-4983-a685-15ec073f122b_terseLabel_en-US" xlink:label="lab_srt_CreditRatingAMBestDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, AM Best [Domain]</link:label>
    <link:label id="lab_srt_CreditRatingAMBestDomain_label_en-US" xlink:label="lab_srt_CreditRatingAMBestDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, AM Best [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingAMBestDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingAMBestDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CreditRatingAMBestDomain" xlink:to="lab_srt_CreditRatingAMBestDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReservesForLossAndAdjustmentExpensesTextBlock_026bcf55-205f-49df-9afa-787ab1d78ee5_terseLabel_en-US" xlink:label="lab_ahl_ReservesForLossAndAdjustmentExpensesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for Losses and Adjustment Expenses</link:label>
    <link:label id="lab_ahl_ReservesForLossAndAdjustmentExpensesTextBlock_label_en-US" xlink:label="lab_ahl_ReservesForLossAndAdjustmentExpensesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves For Loss And Adjustment Expenses [Text Block]</link:label>
    <link:label id="lab_ahl_ReservesForLossAndAdjustmentExpensesTextBlock_documentation_en-US" xlink:label="lab_ahl_ReservesForLossAndAdjustmentExpensesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for Loss and Adjustment Expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReservesForLossAndAdjustmentExpensesTextBlock" xlink:href="ahl-20231220.xsd#ahl_ReservesForLossAndAdjustmentExpensesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReservesForLossAndAdjustmentExpensesTextBlock" xlink:to="lab_ahl_ReservesForLossAndAdjustmentExpensesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_BM_6c2c1892-00cc-4adf-aa84-86ffd888146f_terseLabel_en-US" xlink:label="lab_country_BM" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bermuda</link:label>
    <link:label id="lab_country_BM_label_en-US" xlink:label="lab_country_BM" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BERMUDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_BM" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_BM"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_BM" xlink:to="lab_country_BM" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_d9a23309-d1d6-4a3a-9b45-59ab0a7dcad6_terseLabel_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_label_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:to="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_60bd229e-affa-4158-84f5-450ee2270bb3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_89509f4a-ece3-4a2d-8daa-b5e592f844f7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_7ad0ba28-d2b4-4de8-ab63-6f9c03a693d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_0140d915-fcf0-4e21-b1de-c08359b3de71_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ac3fd90e-7d2a-426e-acee-b734b4f9e3ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e2238270-bf70-49e0-b10e-7f656b68ae44_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_b41192a6-19e8-4004-8520-be8761e80903_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_WorldwideIncludingUnitedStatesMember_15a48d88-2cff-4664-b5a7-b6ce897b8998_terseLabel_en-US" xlink:label="lab_ahl_WorldwideIncludingUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Worldwide including United States</link:label>
    <link:label id="lab_ahl_WorldwideIncludingUnitedStatesMember_label_en-US" xlink:label="lab_ahl_WorldwideIncludingUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Worldwide Including United States [Member]</link:label>
    <link:label id="lab_ahl_WorldwideIncludingUnitedStatesMember_documentation_en-US" xlink:label="lab_ahl_WorldwideIncludingUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Worldwide including United States.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_WorldwideIncludingUnitedStatesMember" xlink:href="ahl-20231220.xsd#ahl_WorldwideIncludingUnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_WorldwideIncludingUnitedStatesMember" xlink:to="lab_ahl_WorldwideIncludingUnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesTextBlock_9675197a-f505-44bc-ac09-32e559bdb41b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Expected Credit Losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_b7c81c08-a914-44a4-b1ad-27f75f8b2b13_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Purchases) of short-term investments &#8212; Trading</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_14b4c6ab-b906-4c31-a6bc-c0d92ea47b49_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds/(purchases) of short term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AAOrHigherMember_4607c7a4-134f-4c36-9b35-fd73a0127c54_terseLabel_en-US" xlink:label="lab_ahl_AAOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AA- or higher</link:label>
    <link:label id="lab_ahl_AAOrHigherMember_label_en-US" xlink:label="lab_ahl_AAOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AA- or higher [Member]</link:label>
    <link:label id="lab_ahl_AAOrHigherMember_documentation_en-US" xlink:label="lab_ahl_AAOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AA- or higher</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAOrHigherMember" xlink:href="ahl-20231220.xsd#ahl_AAOrHigherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AAOrHigherMember" xlink:to="lab_ahl_AAOrHigherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_4e801eeb-aee5-48b7-8eea-858fce6fd6ee_terseLabel_en-US" xlink:label="lab_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Professional Insurance</link:label>
    <link:label id="lab_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_label_en-US" xlink:label="lab_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Professional, Commercial Insurance Product Line [Member]</link:label>
    <link:label id="lab_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_documentation_en-US" xlink:label="lab_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Professional, Commercial Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember" xlink:href="ahl-20231220.xsd#ahl_FinancialandProfessionalCommercialInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember" xlink:to="lab_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_844eeef4-96e1-4cbe-8edc-e8ed373c214d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExternalCreditRatingStandardPoorsMember_62cf2192-d52d-40a4-9a2a-ffdcc02f0b5f_terseLabel_en-US" xlink:label="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Standard &amp; Poor's [Domain]</link:label>
    <link:label id="lab_srt_ExternalCreditRatingStandardPoorsMember_label_en-US" xlink:label="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Standard &amp; Poor's [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember" xlink:to="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PrivatelyheldInvestments_5355e2a7-8a45-4ade-b60c-ecfdc16459e4_terseLabel_en-US" xlink:label="lab_ahl_PrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held Investments</link:label>
    <link:label id="lab_ahl_PrivatelyheldInvestments_label_en-US" xlink:label="lab_ahl_PrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held Investments</link:label>
    <link:label id="lab_ahl_PrivatelyheldInvestments_documentation_en-US" xlink:label="lab_ahl_PrivatelyheldInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PrivatelyheldInvestments" xlink:to="lab_ahl_PrivatelyheldInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_582a1fee-3bef-44e3-9864-82b645b07706_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for unpaid claims and claim adjustment expense, aggregate reconciling items</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Aggregate Reconciling Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_b54d1042-a2e7-49ce-ad02-625747499da3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base erosion and anti-abuse (BEAT) expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, BEAT, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_d9bc3720-7579-4b1e-af53-36655490557d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax (benefit)/expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Intraperiod Tax Allocation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_e312b905-593d-43e8-a686-bec9615aa970_terseLabel_en-US" xlink:label="lab_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marine, Aviation and Energy Insurance</link:label>
    <link:label id="lab_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_label_en-US" xlink:label="lab_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marine, Aviation and Energy, Commercial Insurance Product Line [Member]</link:label>
    <link:label id="lab_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_documentation_en-US" xlink:label="lab_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marine, Aviation and Energy, Commercial Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember" xlink:href="ahl-20231220.xsd#ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember" xlink:to="lab_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_7f5c0a89-408d-4e8f-88cb-f59e0cb74fa0_verboseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributedCapital_4bbb03d6-77bb-4a00-9125-6d5b8e6f981f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contribution</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributedCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributed Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributedCapital" xlink:to="lab_us-gaap_ProceedsFromContributedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsAAMinusRatingMember_a250c45f-a210-419b-a105-00ee3d1cd50f_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsAAMinusRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard &amp; Poor's, AA- Rating</link:label>
    <link:label id="lab_srt_StandardPoorsAAMinusRatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsAAMinusRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard &amp; Poor's, AA- Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAAMinusRatingMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAAMinusRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsAAMinusRatingMember" xlink:to="lab_srt_StandardPoorsAAMinusRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_f9fc73ff-64a3-458a-bae1-4d361d8f3598_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_b068fe7b-b5d4-4593-961e-a02c4e1a8ce9_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_45b65b71-fff5-460c-bca5-9796886462d9_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AMBestAPlusRatingMember_eb205911-abdf-471f-bd33-d0e5da96760f_terseLabel_en-US" xlink:label="lab_srt_AMBestAPlusRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AM Best, A plus Rating</link:label>
    <link:label id="lab_srt_AMBestAPlusRatingMember_label_en-US" xlink:label="lab_srt_AMBestAPlusRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AM Best, A+ Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AMBestAPlusRatingMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AMBestAPlusRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AMBestAPlusRatingMember" xlink:to="lab_srt_AMBestAPlusRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PrivatelyheldInvestmentsatfairvalue_ed63026f-eb90-4f4c-919e-cc3100bd38fc_terseLabel_en-US" xlink:label="lab_ahl_PrivatelyheldInvestmentsatfairvalue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held Investments, at fair value</link:label>
    <link:label id="lab_ahl_PrivatelyheldInvestmentsatfairvalue_label_en-US" xlink:label="lab_ahl_PrivatelyheldInvestmentsatfairvalue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held Investments, at fair value</link:label>
    <link:label id="lab_ahl_PrivatelyheldInvestmentsatfairvalue_documentation_en-US" xlink:label="lab_ahl_PrivatelyheldInvestmentsatfairvalue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held Investments, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PrivatelyheldInvestmentsatfairvalue" xlink:to="lab_ahl_PrivatelyheldInvestmentsatfairvalue" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_EquityMethodInvestmentAggregateCostRollForward_385013ee-521c-4495-8d6a-fd17c03e9253_terseLabel_en-US" xlink:label="lab_ahl_EquityMethodInvestmentAggregateCostRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost [Roll Forward]</link:label>
    <link:label id="lab_ahl_EquityMethodInvestmentAggregateCostRollForward_label_en-US" xlink:label="lab_ahl_EquityMethodInvestmentAggregateCostRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost [Roll Forward]</link:label>
    <link:label id="lab_ahl_EquityMethodInvestmentAggregateCostRollForward_documentation_en-US" xlink:label="lab_ahl_EquityMethodInvestmentAggregateCostRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityMethodInvestmentAggregateCostRollForward" xlink:href="ahl-20231220.xsd#ahl_EquityMethodInvestmentAggregateCostRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward" xlink:to="lab_ahl_EquityMethodInvestmentAggregateCostRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_18507c10-5918-43e7-b1ed-919d499e5e91_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_EverestReMember_8c44bc8b-2bc9-4ada-8e07-bf3354328352_terseLabel_en-US" xlink:label="lab_ahl_EverestReMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Everest Re</link:label>
    <link:label id="lab_ahl_EverestReMember_label_en-US" xlink:label="lab_ahl_EverestReMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Everest Re [Member]</link:label>
    <link:label id="lab_ahl_EverestReMember_documentation_en-US" xlink:label="lab_ahl_EverestReMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Everest Re [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EverestReMember" xlink:href="ahl-20231220.xsd#ahl_EverestReMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_EverestReMember" xlink:to="lab_ahl_EverestReMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1c299f85-61da-4cf6-9804-a18c8ece8363_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit), U.S.</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareMember_26211507-228b-4fb3-985f-72db0a819779_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care</link:label>
    <link:label id="lab_us-gaap_HealthCareMember_label_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareMember" xlink:to="lab_us-gaap_HealthCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_02ac37c1-44e3-43b7-b4d6-77322f87e76d_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_75884270-1701-47aa-88d9-082145b44883_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Record Date</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock_3bac8f77-ee44-4e1d-8b53-b4fe81f260e8_terseLabel_en-US" xlink:label="lab_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Investments, Cash and Cash Equivalents</link:label>
    <link:label id="lab_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting For Investments Cash And Cash Equivalents [Policy Text Block]</link:label>
    <link:label id="lab_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock_documentation_en-US" xlink:label="lab_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Investments, cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" xlink:href="ahl-20231220.xsd#ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAtFairValueMember_136f0d28-5053-447e-8b7b-dfecca8c7429_terseLabel_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments trading at fair value</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAtFairValueMember_label_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Investments Trading At Fair Value [Member]</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAtFairValueMember_documentation_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments trading, at fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember" xlink:to="lab_ahl_ShortTermInvestmentsTradingAtFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_32d489c3-3cdb-40d0-86fc-a9aafd7b554e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Payments, Due year three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations_5edbc993-615e-4e91-98ad-d3fea8bdeb52_terseLabel_en-US" xlink:label="lab_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage limit of pledged assets permitted to secure debt obligations</link:label>
    <link:label id="lab_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations_label_en-US" xlink:label="lab_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage limit of reserve assets permitted to secure debt obligations</link:label>
    <link:label id="lab_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations_documentation_en-US" xlink:label="lab_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage limit of reserve assets permitted to secure debt obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" xlink:href="ahl-20231220.xsd#ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" xlink:to="lab_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_380f93a9-5f97-45cb-9448-38b07936d6cd_terseLabel_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]</link:label>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_label_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract" xlink:to="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_7f759e62-7872-459c-9b70-4f514f8034d1_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee Insurance Contracts, Premium Received over Contract Period [Table]</link:label>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_label_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee Insurance Contracts, Premium Received over Contract Period [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable" xlink:to="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyInsuranceProductLineMember_b190dc4c-404a-4ea9-8627-afb3c178fa68_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Insurance</link:label>
    <link:label id="lab_us-gaap_PropertyInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_PropertyInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyInsuranceProductLineMember" xlink:to="lab_us-gaap_PropertyInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_5f46996d-2a3e-43d5-a37a-652771ea42b3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves_3d3aaacc-82fd-42ce-b59d-12dbe8009086_terseLabel_en-US" xlink:label="lab_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carbon syndicate reserves</link:label>
    <link:label id="lab_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves_label_en-US" xlink:label="lab_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expenses, Other Reconciling Item, Carbon Syndicate Reserves</link:label>
    <link:label id="lab_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves_documentation_en-US" xlink:label="lab_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expenses, Other Reconciling Item, Carbon Syndicate Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" xlink:href="ahl-20231220.xsd#ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" xlink:to="lab_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_4bc0223c-00a5-424f-bd02-ebd1420375bb_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_91863cff-f4d6-43b9-a056-98224ab02a7c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5504a1cf-65d6-4a6a-bc16-d39457e4e313_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_b4bc848f-cef8-4a7a-ac0a-40157289847e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fc999437-f2b3-438b-a2cb-f94c38b81744_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period (1)</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ccc765c7-afc4-4f1c-934f-83eef541dcbc_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of right-of use assets resulting from reductions to lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_2f298e43-6d1c-4a34-bb8b-f5af73fa111b_terseLabel_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities After Five Through Ten Years Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_label_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities After Five Through Ten Years Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_documentation_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities debt maturities after five through ten years average ratings by maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" xlink:to="lab_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_8440d911-0b70-4b87-b038-a8e5825afae4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party fees</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_97407e4c-5d49-407c-b8ba-fae983bf0787_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party fees</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_b91ab21a-eb14-4b10-a6a5-367c9f2c0697_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FundsAtLloydsFacilityAgreement_7493781d-1699-45c7-bc04-517981dbad0b_terseLabel_en-US" xlink:label="lab_ahl_FundsAtLloydsFacilityAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds at Lloyd's Facility Agreement</link:label>
    <link:label id="lab_ahl_FundsAtLloydsFacilityAgreement_label_en-US" xlink:label="lab_ahl_FundsAtLloydsFacilityAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds at Lloyd's Facility Agreement</link:label>
    <link:label id="lab_ahl_FundsAtLloydsFacilityAgreement_documentation_en-US" xlink:label="lab_ahl_FundsAtLloydsFacilityAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds at Lloyd's Facility Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FundsAtLloydsFacilityAgreement" xlink:href="ahl-20231220.xsd#ahl_FundsAtLloydsFacilityAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FundsAtLloydsFacilityAgreement" xlink:to="lab_ahl_FundsAtLloydsFacilityAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_119cbc1a-914a-458f-aebc-e961be5b8f06_terseLabel_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_label_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Securities Change In Unrealized Gains</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_documentation_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gains (losses) for available for sale fixed-income maturities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" xlink:to="lab_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_fd08991a-dbb8-4133-a7d8-e594dd15ec78_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:to="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_36088529-9e12-42f1-985c-09c82d5cfb90_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other temporary differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_d832cbd1-2a46-4af5-867d-6a433d668dcb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability transfers</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_31d7f90d-f3c5-476b-9c3b-93032f4b48b9_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage loans</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AspenUnderwritingLimitedMember_abb3542e-1152-43c7-a3c5-5ad5694de1f0_terseLabel_en-US" xlink:label="lab_ahl_AspenUnderwritingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AUL</link:label>
    <link:label id="lab_ahl_AspenUnderwritingLimitedMember_label_en-US" xlink:label="lab_ahl_AspenUnderwritingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Underwriting Limited [Member]</link:label>
    <link:label id="lab_ahl_AspenUnderwritingLimitedMember_documentation_en-US" xlink:label="lab_ahl_AspenUnderwritingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Underwriting Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUnderwritingLimitedMember" xlink:href="ahl-20231220.xsd#ahl_AspenUnderwritingLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AspenUnderwritingLimitedMember" xlink:to="lab_ahl_AspenUnderwritingLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_dceb5e4e-3598-4c71-ba15-3e0b76603982_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_453da526-51e0-4c3a-bceb-aa233f987f17_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetDomain" xlink:to="lab_us-gaap_DeferredTaxAssetDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_BlueWatersMember_1693e83a-3472-4498-9071-8b7dd726ac96_terseLabel_en-US" xlink:label="lab_ahl_BlueWatersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Waters</link:label>
    <link:label id="lab_ahl_BlueWatersMember_label_en-US" xlink:label="lab_ahl_BlueWatersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Waters [Member]</link:label>
    <link:label id="lab_ahl_BlueWatersMember_documentation_en-US" xlink:label="lab_ahl_BlueWatersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Waters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BlueWatersMember" xlink:href="ahl-20231220.xsd#ahl_BlueWatersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_BlueWatersMember" xlink:to="lab_ahl_BlueWatersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AspenTrademarkMember_4ae56c71-a696-472f-8f54-43e740cd8bde_terseLabel_en-US" xlink:label="lab_ahl_AspenTrademarkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen trademark</link:label>
    <link:label id="lab_ahl_AspenTrademarkMember_label_en-US" xlink:label="lab_ahl_AspenTrademarkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Trademark [Member]</link:label>
    <link:label id="lab_ahl_AspenTrademarkMember_documentation_en-US" xlink:label="lab_ahl_AspenTrademarkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Trademark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenTrademarkMember" xlink:href="ahl-20231220.xsd#ahl_AspenTrademarkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AspenTrademarkMember" xlink:to="lab_ahl_AspenTrademarkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_6f62ccd5-04dc-42dc-af6a-276b643a4c31_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:to="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_df5f768d-1809-4dce-9f10-32886a02eb0d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2021</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_779116bb-9d59-4c05-a3de-3f8c042f07d3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of fixed income securities &#8212; Available for sale</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccidentAndHealthInsuranceSegmentMember_318138e7-e191-4e1f-8208-3dbe7464bfd5_terseLabel_en-US" xlink:label="lab_us-gaap_AccidentAndHealthInsuranceSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident and Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_AccidentAndHealthInsuranceSegmentMember_label_en-US" xlink:label="lab_us-gaap_AccidentAndHealthInsuranceSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident and Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccidentAndHealthInsuranceSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccidentAndHealthInsuranceSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccidentAndHealthInsuranceSegmentMember" xlink:to="lab_us-gaap_AccidentAndHealthInsuranceSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_fec49ac1-47fb-4970-bedb-ea11c421ad50_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_cf3d4e03-cf70-49ae-90ee-f863a7e122de_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_26014891-e9fb-424d-ba31-3c419cc7acd3_terseLabel_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule IV - Reinsurance</link:label>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_label_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:to="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_0ad14de0-e2f2-41f3-a54c-a73b3bd96ef9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_ff3b7b49-c5c5-46dc-b18c-4c0351bbe955_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting premiums receivables (net of allowance for expected credit losses of 2022: $25.0 &#8212; 2021: $30.2)</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_52c6aec5-3bbf-48d5-b7b2-729a1ba1d49e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_05ca1142-8602-490d-8d28-f1929742c0d6_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets_83bad715-8a95-4fce-892d-c412bd43229f_negatedTerseLabel_en-US" xlink:label="lab_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets_label_en-US" xlink:label="lab_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease Assets</link:label>
    <link:label id="lab_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets_documentation_en-US" xlink:label="lab_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:to="lab_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5813c5fb-4a14-4fca-be63-91d10163ae14_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_690c7248-22c5-4ce8-a2eb-41817ec0e689_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investable assets held by the Company</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems_a93b90e6-fd07-4236-a487-52d27442f4cb_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_0d8ef1b1-facc-4e69-853f-13061a365f6b_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit / guarantees</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_551b5419-41c1-42aa-9c2e-4b4f8f8afbef_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_0f297f5c-ffe6-46e7-8139-d80a371337ba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs, and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_b1f5215b-c13a-4519-ae5b-b875b5975e1e_terseLabel_en-US" xlink:label="lab_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (excluding equity in net earnings of subsidiaries)</link:label>
    <link:label id="lab_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_label_en-US" xlink:label="lab_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Before Equity In Net Earnings Of Subsidiaries</link:label>
    <link:label id="lab_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_documentation_en-US" xlink:label="lab_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Before Equity In Net Earnings Of Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:href="ahl-20231220.xsd#ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:to="lab_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_05fcc2a7-c657-4f70-a082-e71739c42264_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total contributions by the Company to the retirement plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_66090937-c205-4109-a92c-203c6141016d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus_d6898113-bbe1-40c2-b26b-9abe2aa697be_terseLabel_en-US" xlink:label="lab_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent warning level of amount of enhanced capital required from statutory capital and surplus</link:label>
    <link:label id="lab_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus_label_en-US" xlink:label="lab_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Warning Level of Amount of Enhanced Capital Required from Statutory Capital and Surplus</link:label>
    <link:label id="lab_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus_documentation_en-US" xlink:label="lab_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Warning Level of Amount of Enhanced Capital Required from Statutory Capital and Surplus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" xlink:href="ahl-20231220.xsd#ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" xlink:to="lab_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_6be879dd-1fe0-4910-b60b-365c7f425b8d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss)/income, before income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_82952188-8e30-41a1-a360-9b3c69ab8bc3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss)/income, before income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e2014b28-4011-4805-96a0-ea30d03c1bca_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_d150d9d8-368b-44c5-abaa-40205ad8cd12_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_5788b6c9-6d71-4b0a-ad55-9f7eefe08887_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_652fbaf6-8697-4e3b-ae38-4049618d452d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_06df4258-3c8b-4a84-876d-aa1701a13563_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Purchases) of fixed income securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_2fe201df-91c3-4712-8596-ce59cec1068a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f3cfee1c-6fa1-4397-bd78-dc9bb5973da1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7d0fc2df-1c12-44c0-a196-aeb916b53376_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_a805e8ef-d30b-4bd9-ae44-3d43ef891edd_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef582acf-e61f-4fac-8260-e89bcd1f716a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_fbaa8e46-c7fd-4a12-9f13-ff4ee4c59724_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MarshAndMcLennanCompaniesIncMember_b9627642-a6dd-4fce-832e-8c662cb3f5d1_terseLabel_en-US" xlink:label="lab_ahl_MarshAndMcLennanCompaniesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marsh&#160;&amp; McLennan Companies, Inc.</link:label>
    <link:label id="lab_ahl_MarshAndMcLennanCompaniesIncMember_label_en-US" xlink:label="lab_ahl_MarshAndMcLennanCompaniesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marsh And Mc Lennan Companies Inc [Member]</link:label>
    <link:label id="lab_ahl_MarshAndMcLennanCompaniesIncMember_documentation_en-US" xlink:label="lab_ahl_MarshAndMcLennanCompaniesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marsh &amp; McLennan Companies, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MarshAndMcLennanCompaniesIncMember" xlink:href="ahl-20231220.xsd#ahl_MarshAndMcLennanCompaniesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MarshAndMcLennanCompaniesIncMember" xlink:to="lab_ahl_MarshAndMcLennanCompaniesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_IssuedShareCapital_54efc2f9-2163-4179-960b-318a8431ab6e_totalLabel_en-US" xlink:label="lab_ahl_IssuedShareCapital" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total issued share capital</link:label>
    <link:label id="lab_ahl_IssuedShareCapital_e245fb0b-0ae7-4508-a443-bc9c18d83896_terseLabel_en-US" xlink:label="lab_ahl_IssuedShareCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total issued share capital</link:label>
    <link:label id="lab_ahl_IssuedShareCapital_label_en-US" xlink:label="lab_ahl_IssuedShareCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued Share Capital</link:label>
    <link:label id="lab_ahl_IssuedShareCapital_documentation_en-US" xlink:label="lab_ahl_IssuedShareCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued share capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapital" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_IssuedShareCapital" xlink:to="lab_ahl_IssuedShareCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_84eccc26-0291-44d4-b8be-3cca0690a92b_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom</link:label>
    <link:label id="lab_country_GB_426b04bd-b2b1-4233-97c8-31328ba097d3_verboseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K.</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_907a650c-fa3d-4aeb-8db6-8f2797f8bd11_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_55620953-8004-4f0e-a697-f19dfef5a268_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Direct</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_83f5e1e0-863e-4564-9a53-c58a4db9eb44_terseLabel_en-US" xlink:label="lab_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, including cash within variable interest entities</link:label>
    <link:label id="lab_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_label_en-US" xlink:label="lab_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, including cash within variable interest entities</link:label>
    <link:label id="lab_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_documentation_en-US" xlink:label="lab_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, including cash within variable interest entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" xlink:to="lab_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_b6ae4a38-94ab-4104-9a08-42dbd6a1dc5f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Additions (Disposals)</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5f3d86da-f4fb-4669-a211-57389af877bf_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses (1)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_2193e31e-c7e2-46df-91fe-631f135d5ea4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnderwritingIncomeLoss_aeda5e3d-dede-475f-ab7e-1d76feb3fcc2_totalLabel_en-US" xlink:label="lab_us-gaap_UnderwritingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting income (loss)</link:label>
    <link:label id="lab_us-gaap_UnderwritingIncomeLoss_63c2e916-0314-4747-b52b-ed6ed62c3355_terseLabel_en-US" xlink:label="lab_us-gaap_UnderwritingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting income (loss)</link:label>
    <link:label id="lab_us-gaap_UnderwritingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_UnderwritingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnderwritingIncomeLoss" xlink:to="lab_us-gaap_UnderwritingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ea6d73aa-79c7-4213-a4eb-a92cde7173a3_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General, administrative and corporate expenses (2)</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_9a5cfb13-52c5-4c1a-a809-3b6604c286ab_negatedLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General, administrative and corporate expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_6a79a0f3-8e5d-4213-b3f3-4e376ee07898_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General, administrative and corporate expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_74c38403-2700-4cbd-a98a-14d465f5481e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2019</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssumedPremiumsWritten_998da097-abc9-49ed-ac69-0784d59264a8_terseLabel_en-US" xlink:label="lab_us-gaap_AssumedPremiumsWritten" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_AssumedPremiumsWritten_label_en-US" xlink:label="lab_us-gaap_AssumedPremiumsWritten" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Premiums Written</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsWritten" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsWritten"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssumedPremiumsWritten" xlink:to="lab_us-gaap_AssumedPremiumsWritten" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsWrittenNetConsolidatedAbstract_af06e2c0-c49c-4d58-9939-44fd9064cbfd_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsWrittenNetConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums written:</link:label>
    <link:label id="lab_us-gaap_PremiumsWrittenNetConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_PremiumsWrittenNetConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Written, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNetConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract" xlink:to="lab_us-gaap_PremiumsWrittenNetConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PrivatelyheldinvestmentsMember_a0e7334f-66c6-4f71-ae50-a2761fbac8ec_verboseLabel_en-US" xlink:label="lab_ahl_PrivatelyheldinvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investments &#8212; Trading</link:label>
    <link:label id="lab_ahl_PrivatelyheldinvestmentsMember_7a1ff398-cbb4-4964-acb9-ebf47f51737f_terseLabel_en-US" xlink:label="lab_ahl_PrivatelyheldinvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investments</link:label>
    <link:label id="lab_ahl_PrivatelyheldinvestmentsMember_label_en-US" xlink:label="lab_ahl_PrivatelyheldinvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investments [Member]</link:label>
    <link:label id="lab_ahl_PrivatelyheldinvestmentsMember_documentation_en-US" xlink:label="lab_ahl_PrivatelyheldinvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PrivatelyheldinvestmentsMember" xlink:to="lab_ahl_PrivatelyheldinvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a866cce9-98d1-4cd9-9687-327585424f21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_99fe2a92-ce87-449b-95f5-8fcf4ab56cc0_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5035c5cc-4ae2-4464-920f-82b35ddad0f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock_9d3d7ffa-de30-46f7-a913-d42ecc6ee539_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_e3a1f22d-b8f4-4e1f-a750-ed88f4f3793e_terseLabel_en-US" xlink:label="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Branch [Domain]</link:label>
    <link:label id="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_label_en-US" xlink:label="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Branch [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain" xlink:to="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_ccb6b310-7ffa-4bb6-816c-1ea503e42195_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications from Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_aca4a8fb-915b-4985-9476-35193b395e73_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in the period</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8a21430d-128d-4728-9361-ee37df9176c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions and investments, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Businesses and Interest in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:to="lab_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_8306b541-ea8e-4f63-897c-e995097d4e34_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investments net unrealized gains/(losses)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostApproachValuationTechniqueMember_0dd86fe5-8169-4239-9fee-0c7c2533360e_terseLabel_en-US" xlink:label="lab_us-gaap_CostApproachValuationTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery approach</link:label>
    <link:label id="lab_us-gaap_CostApproachValuationTechniqueMember_label_en-US" xlink:label="lab_us-gaap_CostApproachValuationTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Cost Approach [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostApproachValuationTechniqueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostApproachValuationTechniqueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostApproachValuationTechniqueMember" xlink:to="lab_us-gaap_CostApproachValuationTechniqueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AspenUKMember_bd6a0e10-ba17-4132-96c7-02bae8ae8827_terseLabel_en-US" xlink:label="lab_ahl_AspenUKMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen U.K.</link:label>
    <link:label id="lab_ahl_AspenUKMember_label_en-US" xlink:label="lab_ahl_AspenUKMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen U.K. [Member]</link:label>
    <link:label id="lab_ahl_AspenUKMember_documentation_en-US" xlink:label="lab_ahl_AspenUKMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen U.K.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AspenUKMember" xlink:to="lab_ahl_AspenUKMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongdurationInsuranceProductLineMember_fac58a04-ea08-493d-9496-4727ed3fe430_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongdurationInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance lines other than short-duration</link:label>
    <link:label id="lab_us-gaap_OtherLongdurationInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_OtherLongdurationInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Duration Insurance, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongdurationInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongdurationInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongdurationInsuranceProductLineMember" xlink:to="lab_us-gaap_OtherLongdurationInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d9c1fb46-171b-492e-b03a-2064b0f138d1_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromOfficersOrStockholdersCurrent_00bcb09b-a485-496e-866e-17c5fb6799d6_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees due to Apollo Management</link:label>
    <link:label id="lab_us-gaap_DueFromOfficersOrStockholdersCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Officers or Stockholders, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:to="lab_us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebtDefaultMinimum_744a1749-461c-4c64-8e35-19154b55975f_terseLabel_en-US" xlink:label="lab_ahl_DebtDefaultMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of indebtedness subject to default in payment</link:label>
    <link:label id="lab_ahl_DebtDefaultMinimum_label_en-US" xlink:label="lab_ahl_DebtDefaultMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Default Minimum</link:label>
    <link:label id="lab_ahl_DebtDefaultMinimum_documentation_en-US" xlink:label="lab_ahl_DebtDefaultMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt default minimum.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtDefaultMinimum" xlink:href="ahl-20231220.xsd#ahl_DebtDefaultMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebtDefaultMinimum" xlink:to="lab_ahl_DebtDefaultMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsPercentageAssumedToNet_934dde61-1413-4092-8eb4-eaba36764281_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsPercentageAssumedToNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage&#160;of Amount Assumed to Net</link:label>
    <link:label id="lab_us-gaap_PremiumsPercentageAssumedToNet_label_en-US" xlink:label="lab_us-gaap_PremiumsPercentageAssumedToNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance, Premium, Percentage Assumed to Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsPercentageAssumedToNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsPercentageAssumedToNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsPercentageAssumedToNet" xlink:to="lab_us-gaap_PremiumsPercentageAssumedToNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_6b49ef8e-a463-4daa-9ea8-184f0c63fee2_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ValuationTechniqueLiquidationMethodMember_8206e331-3270-40e3-9a33-aa7f115921f4_terseLabel_en-US" xlink:label="lab_ahl_ValuationTechniqueLiquidationMethodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation method</link:label>
    <link:label id="lab_ahl_ValuationTechniqueLiquidationMethodMember_label_en-US" xlink:label="lab_ahl_ValuationTechniqueLiquidationMethodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Liquidation Method [Member]</link:label>
    <link:label id="lab_ahl_ValuationTechniqueLiquidationMethodMember_documentation_en-US" xlink:label="lab_ahl_ValuationTechniqueLiquidationMethodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Liquidation Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ValuationTechniqueLiquidationMethodMember" xlink:href="ahl-20231220.xsd#ahl_ValuationTechniqueLiquidationMethodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ValuationTechniqueLiquidationMethodMember" xlink:to="lab_ahl_ValuationTechniqueLiquidationMethodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity_ae0e8ba6-50aa-4ee2-889b-d762743b8ccf_terseLabel_en-US" xlink:label="lab_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value of Loan Notes, Issued by Variable Interest Entity</link:label>
    <link:label id="lab_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity_label_en-US" xlink:label="lab_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value of Loan Notes, Issued by Variable Interest Entity</link:label>
    <link:label id="lab_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity_documentation_en-US" xlink:label="lab_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value of Loan Notes, Issued by Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" xlink:href="ahl-20231220.xsd#ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" xlink:to="lab_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_6e9f81f5-0490-4e48-81f5-f9ffea394b10_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overseas statutory tax rates differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialServiceMember_0b065674-ebe8-4e61-87f8-420c9ab76618_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financials</link:label>
    <link:label id="lab_us-gaap_FinancialServiceMember_label_en-US" xlink:label="lab_us-gaap_FinancialServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialServiceMember" xlink:to="lab_us-gaap_FinancialServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e024a50-bbfe-46b9-b80b-d661b7150656_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income/(loss) to net cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_09cbf4a9-4e7c-413d-996a-6b01534b70a0_terseLabel_en-US" xlink:label="lab_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowable holdings of a single issue or issuer, percentage</link:label>
    <link:label id="lab_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_label_en-US" xlink:label="lab_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Allowable Holdings Of A Single Issuer Or Issuer, Minimum</link:label>
    <link:label id="lab_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_documentation_en-US" xlink:label="lab_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Allowable Holdings Of A Single Issuer Or Issuer, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" xlink:href="ahl-20231220.xsd#ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" xlink:to="lab_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2b253a99-0541-4dc4-9461-090d349e9f37_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Office Properties and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_4659c69a-3ab0-4634-bf4e-fa2de1b0ccd4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9a27453b-0615-41eb-8fb8-c9f4d7d7b3ba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Payments, Due year four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_c013d2d5-78a6-4f7c-b8c7-3a82e6ba147c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditLossAbstract_2f2c294c-4d46-40bb-9635-754fd3a18d19_terseLabel_en-US" xlink:label="lab_us-gaap_CreditLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_CreditLossAbstract_label_en-US" xlink:label="lab_us-gaap_CreditLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditLossAbstract" xlink:to="lab_us-gaap_CreditLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NetRealizedAndUnrealizedGainsLosses_7bc26be6-bc41-4a31-99d3-1b470f930df8_negatedTerseLabel_en-US" xlink:label="lab_ahl_NetRealizedAndUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized losses/(gains)</link:label>
    <link:label id="lab_ahl_NetRealizedAndUnrealizedGainsLosses_label_en-US" xlink:label="lab_ahl_NetRealizedAndUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Realized And Unrealized Gains Losses</link:label>
    <link:label id="lab_ahl_NetRealizedAndUnrealizedGainsLosses_documentation_en-US" xlink:label="lab_ahl_NetRealizedAndUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and unrealized (gains) losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedGainsLosses" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NetRealizedAndUnrealizedGainsLosses" xlink:to="lab_ahl_NetRealizedAndUnrealizedGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_89d36b6a-2f5d-4cf5-aa63-50b41dfe5bcd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_81ae4de8-74d8-4fb1-8ff9-61c2917d652c_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AMBestARatingMember_52da3721-71c1-4f28-a8b7-ed29820dd71f_terseLabel_en-US" xlink:label="lab_srt_AMBestARatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AM Best, A Rating</link:label>
    <link:label id="lab_srt_AMBestARatingMember_label_en-US" xlink:label="lab_srt_AMBestARatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AM Best, A Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AMBestARatingMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AMBestARatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AMBestARatingMember" xlink:to="lab_srt_AMBestARatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_ea221103-332e-4e1f-8c2c-51a84df1bb02_negatedLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_26dbf1ca-cdd7-4339-88b2-9e21a1ecee7a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Multiline reinsurer</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceMember_38f0b71a-c222-4722-9732-fe986bc30d3b_terseLabel_en-US" xlink:label="lab_ahl_ReinsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_ahl_ReinsuranceMember_label_en-US" xlink:label="lab_ahl_ReinsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Member]</link:label>
    <link:label id="lab_ahl_ReinsuranceMember_documentation_en-US" xlink:label="lab_ahl_ReinsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceMember" xlink:to="lab_ahl_ReinsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_5e84c11d-90ad-4ebd-8bca-e1aa21a7a9be_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnergyCommoditiesAndServiceMember_a33cc047-bf63-44e5-94f3-f6efe4e2e36b_terseLabel_en-US" xlink:label="lab_us-gaap_EnergyCommoditiesAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy</link:label>
    <link:label id="lab_us-gaap_EnergyCommoditiesAndServiceMember_label_en-US" xlink:label="lab_us-gaap_EnergyCommoditiesAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy Commodities and Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergyCommoditiesAndServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnergyCommoditiesAndServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnergyCommoditiesAndServiceMember" xlink:to="lab_us-gaap_EnergyCommoditiesAndServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_88d8f749-5f18-4b31-8fd2-3606fcf3a586_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change from current period hedged transactions</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_21a50262-bbb8-49d5-afee-acd6197dc645_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_c8d27ce1-7bdc-4103-92bc-fef581b63fec_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction_025dee92-db0f-4afc-bf43-68b01f414042_terseLabel_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of aggregate net cash proceeds from the issuance of capital stock</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction_label_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Tangible Net Worth Cash Proceeds From Issuance Of Capital Stock Restriction</link:label>
    <link:label id="lab_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction_documentation_en-US" xlink:label="lab_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility tangible net worth cash proceeds from the issuance of capital stock restriction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" xlink:to="lab_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_EnstarMember_b991090f-b8db-4644-8337-7c98fdfea227_terseLabel_en-US" xlink:label="lab_ahl_EnstarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enstar</link:label>
    <link:label id="lab_ahl_EnstarMember_label_en-US" xlink:label="lab_ahl_EnstarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enstar [Member]</link:label>
    <link:label id="lab_ahl_EnstarMember_documentation_en-US" xlink:label="lab_ahl_EnstarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enstar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_EnstarMember" xlink:to="lab_ahl_EnstarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_615e5c91-4e23-4886-8ca2-bc89e58601dd_terseLabel_en-US" xlink:label="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Branch [Axis]</link:label>
    <link:label id="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_label_en-US" xlink:label="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Branch [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis" xlink:to="lab_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CatastropheBond_e9c6adfe-19e2-4f6b-adde-4b25c1a94073_terseLabel_en-US" xlink:label="lab_ahl_CatastropheBond" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe bonds, trading at fair value (amortized cost &#8212; 2022: $5.1 and 2021: $5.3)</link:label>
    <link:label id="lab_ahl_CatastropheBond_2dbd1306-4f7a-4fa5-b18d-092d1e0700ec_verboseLabel_en-US" xlink:label="lab_ahl_CatastropheBond" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe bonds, trading, cost</link:label>
    <link:label id="lab_ahl_CatastropheBond_label_en-US" xlink:label="lab_ahl_CatastropheBond" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe Bond</link:label>
    <link:label id="lab_ahl_CatastropheBond_documentation_en-US" xlink:label="lab_ahl_CatastropheBond" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Catastrophe Bond</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CatastropheBond" xlink:to="lab_ahl_CatastropheBond" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c367bae8-2184-4fa7-8a9e-c199c7495d24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree_9dc4ccc2-3573-4952-90b3-0ced8ef7b841_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year Three</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ConsumerDiscretionaryServiceMember_95c44bb5-f0aa-4e68-bfb6-6236d38ae53d_terseLabel_en-US" xlink:label="lab_ahl_ConsumerDiscretionaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer discretionary</link:label>
    <link:label id="lab_ahl_ConsumerDiscretionaryServiceMember_label_en-US" xlink:label="lab_ahl_ConsumerDiscretionaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Discretionary Service [Member]</link:label>
    <link:label id="lab_ahl_ConsumerDiscretionaryServiceMember_documentation_en-US" xlink:label="lab_ahl_ConsumerDiscretionaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Discretionary Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConsumerDiscretionaryServiceMember" xlink:href="ahl-20231220.xsd#ahl_ConsumerDiscretionaryServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ConsumerDiscretionaryServiceMember" xlink:to="lab_ahl_ConsumerDiscretionaryServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome_8fd673e1-c6df-46a7-9428-4b2ea91cf3d0_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income&#160;</link:label>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome" xlink:to="lab_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_OtherCountriesMember_7b3fd174-65e1-4fae-b93a-732c3b5aa3a7_terseLabel_en-US" xlink:label="lab_ahl_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (4)</link:label>
    <link:label id="lab_ahl_OtherCountriesMember_label_en-US" xlink:label="lab_ahl_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_ahl_OtherCountriesMember_documentation_en-US" xlink:label="lab_ahl_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherCountriesMember" xlink:href="ahl-20231220.xsd#ahl_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_OtherCountriesMember" xlink:to="lab_ahl_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_ee487355-b34a-4aa1-94c6-62dd177286fa_verboseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia/Asia</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_23ef959e-df06-408c-9da8-1f6d49d492de_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and unrealized investment (losses)/gains</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss_45222d65-bcf6-4bdb-ba92-320cc7c14778_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gains)/losses</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_8f3c7881-0b97-411b-9f28-c30ffd7a4192_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_1d29b15b-f4a5-4f99-b4e6-475e78a6dbcb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Purchases) of fixed income securities &#8212; Trading</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_1b138adf-8a0c-4971-9346-cf0324840972_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Trading Securities Held-for-investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Trading Securities Held-for-investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:to="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedPartnerMember_42b37f21-ed93-4028-bd15-f566fc57997f_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedPartnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Partner</link:label>
    <link:label id="lab_us-gaap_LimitedPartnerMember_label_en-US" xlink:label="lab_us-gaap_LimitedPartnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Partner [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedPartnerMember" xlink:to="lab_us-gaap_LimitedPartnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ab84f538-483a-4773-b697-0ba8f2a93ae1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of preference shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_7023a6e5-0451-4050-807a-a78cf7aad670_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_623ea721-19ae-4518-b2cb-35c628a276c3_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eeed6f5b-f8c2-48b7-b686-bbc672440d88_negatedNetLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion due to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_161936fd-580c-41fb-975a-6a8968747e86_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus_0ed209db-e30c-4237-bfe2-761477d5a57b_terseLabel_en-US" xlink:label="lab_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required statutory capital and surplus</link:label>
    <link:label id="lab_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus_label_en-US" xlink:label="lab_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Payments Restrictions Schedule Required Statutory Capital And Surplus</link:label>
    <link:label id="lab_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus_documentation_en-US" xlink:label="lab_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payments restrictions schedule required statutory capital and surplus.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" xlink:href="ahl-20231220.xsd#ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" xlink:to="lab_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_403f5d67-46e9-4427-8158-ec06099a2898_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_625f8191-0636-4caf-a557-28258c23d57b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_3db614ae-61ab-46a7-bbad-78f4ae914759_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1_cb1f3916-63b4-4620-a623-b62c64f38150_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsTextBlock1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_a6c6d561-5323-4e01-859f-bcf9ce31e1b7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, equity method</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CMLLessNonPerformingOrFutureConstruction_dae740ea-39a7-4810-9fd2-e46b29ab4b92_terseLabel_en-US" xlink:label="lab_ahl_CMLLessNonPerformingOrFutureConstruction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage loans</link:label>
    <link:label id="lab_ahl_CMLLessNonPerformingOrFutureConstruction_label_en-US" xlink:label="lab_ahl_CMLLessNonPerformingOrFutureConstruction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CML less non-performing or future construction</link:label>
    <link:label id="lab_ahl_CMLLessNonPerformingOrFutureConstruction_documentation_en-US" xlink:label="lab_ahl_CMLLessNonPerformingOrFutureConstruction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CML less non-performing or future construction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CMLLessNonPerformingOrFutureConstruction" xlink:href="ahl-20231220.xsd#ahl_CMLLessNonPerformingOrFutureConstruction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CMLLessNonPerformingOrFutureConstruction" xlink:to="lab_ahl_CMLLessNonPerformingOrFutureConstruction" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AggregateLiquidationPreferences_b2e6590b-9e9c-4b46-b875-a262d3ed46bc_terseLabel_en-US" xlink:label="lab_ahl_AggregateLiquidationPreferences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate liquidation preferences</link:label>
    <link:label id="lab_ahl_AggregateLiquidationPreferences_label_en-US" xlink:label="lab_ahl_AggregateLiquidationPreferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Liquidation Preferences</link:label>
    <link:label id="lab_ahl_AggregateLiquidationPreferences_documentation_en-US" xlink:label="lab_ahl_AggregateLiquidationPreferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate liquidation preferences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AggregateLiquidationPreferences" xlink:href="ahl-20231220.xsd#ahl_AggregateLiquidationPreferences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AggregateLiquidationPreferences" xlink:to="lab_ahl_AggregateLiquidationPreferences" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_2c5637bf-de24-4c3a-8c9d-3f793836863e_terseLabel_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_label_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_48a6e508-c9fc-4528-b15c-91af1f9340f9_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and unrealized foreign exchange (gains)/losses</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_78084287-e402-40da-9e23-42295ee61188_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and unrealized foreign exchange gains</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_71ad0413-605b-46b8-9d75-4d26c12015fe_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Gross Unrealized Gains and Losses, and Estimated Fair Value of Trading Investments in Fixed Income Maturities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01182c28-1605-4fde-a4eb-c1f4e9d2406c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CropReMember_002c69f9-90cf-4f88-bcca-329e15d5d5a7_terseLabel_en-US" xlink:label="lab_ahl_CropReMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Crop Re</link:label>
    <link:label id="lab_ahl_CropReMember_label_en-US" xlink:label="lab_ahl_CropReMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Crop Re [Member]</link:label>
    <link:label id="lab_ahl_CropReMember_documentation_en-US" xlink:label="lab_ahl_CropReMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Crop Re Services LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CropReMember" xlink:href="ahl-20231220.xsd#ahl_CropReMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CropReMember" xlink:to="lab_ahl_CropReMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_39c1546c-e1c0-4092-a01b-4a153d4ad84a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_732fb3be-e1e2-468f-8bc3-c4cb0fb49ee4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_eaa61369-0f22-4f8c-8d01-2e9907d98fdf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans issued</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_b5128cac-5ed3-4f0b-8d39-94b732ac8ce7_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS)</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrent_53397f32-1524-4074-920b-3835fe03f6fd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany balance payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_3d172c22-0a95-46b6-8a0c-087788f73c49_terseLabel_en-US" xlink:label="lab_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_label_en-US" xlink:label="lab_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net and Income Taxes Payable</link:label>
    <link:label id="lab_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_documentation_en-US" xlink:label="lab_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net and Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" xlink:href="ahl-20231220.xsd#ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" xlink:to="lab_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2cf2ae69-2289-4d3d-a882-17c58fad7653_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive (loss)/income attributable to Aspen Insurance Holdings Limited's ordinary shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_b89670fd-8685-4400-83ff-c0205d61ceac_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive (loss)/income attributable to Aspen Insurance Holdings Limited's ordinary shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_365df8c4-eb78-4987-a201-6e5a6ab08cee_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2020</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SupplementaryInsuranceInformationAbstract_4e888f8a-12d4-4172-9115-2c421611237b_terseLabel_en-US" xlink:label="lab_srt_SupplementaryInsuranceInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]</link:label>
    <link:label id="lab_srt_SupplementaryInsuranceInformationAbstract_label_en-US" xlink:label="lab_srt_SupplementaryInsuranceInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementaryInsuranceInformationAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementaryInsuranceInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SupplementaryInsuranceInformationAbstract" xlink:to="lab_srt_SupplementaryInsuranceInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_2f08c1ce-cbe7-4707-bdcb-a5edf3b38000_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_b49f72ef-2e80-4dc7-bee2-93d20f3044f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock_d741b314-3c49-4117-be0c-fe3f1cfb9087_terseLabel_en-US" xlink:label="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I - Investments</link:label>
    <link:label id="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock_label_en-US" xlink:label="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock" xlink:to="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_da5a1c4b-11e8-436d-a290-fa585b0f17e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of gross and net written and earned premiums, underwriting results, ratios and reserves for each of Company's business segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableDisclosureTable_66350c61-96f7-42cd-a715-dc2681ec3a93_terseLabel_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable Disclosure [Table]</link:label>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableDisclosureTable_label_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable" xlink:to="lab_us-gaap_LoansAndLeasesReceivableDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_e4b9c9cc-a0d1-4a35-9799-0094f6dd0e52_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_0954acd7-c57f-4869-a86f-5a839807661b_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance, Excess Retention, Amount Reinsured, Per Event</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance, Excess Retention, Amount Reinsured, Per Event</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent" xlink:to="lab_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_51d89433-0d16-4fc7-bede-e62348c5160e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (gains) on investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Unrealized Gains on Trading Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_WillisGroupHoldingsLtdMember_c4c04694-0193-437b-b4da-0f755a73b409_terseLabel_en-US" xlink:label="lab_ahl_WillisGroupHoldingsLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Willis Group Holdings, Ltd.</link:label>
    <link:label id="lab_ahl_WillisGroupHoldingsLtdMember_label_en-US" xlink:label="lab_ahl_WillisGroupHoldingsLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Willis Group Holdings Ltd [Member]</link:label>
    <link:label id="lab_ahl_WillisGroupHoldingsLtdMember_documentation_en-US" xlink:label="lab_ahl_WillisGroupHoldingsLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Willis Group Holdings, Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_WillisGroupHoldingsLtdMember" xlink:href="ahl-20231220.xsd#ahl_WillisGroupHoldingsLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_WillisGroupHoldingsLtdMember" xlink:to="lab_ahl_WillisGroupHoldingsLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_aa5cac04-30d3-4777-9855-866de9334aae_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States corporate tax at a rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_dc17d578-7091-472a-bcfc-138c094e263e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_e3a013bd-609a-4ae6-9656-f30da44b1383_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in right of lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_0d70544f-f637-49f5-81c4-2ff742dd27bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_107ae6fa-6d8a-4fc7-90f5-e05e654b4918_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_774d1c90-4b81-48c6-91d9-de443ca3fdb4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income/(loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_086cac5d-e7a0-46a1-90a8-d182d2218461_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend, in usd per share</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1b97d6da-c204-4cef-a532-5f4d9acdcf8c_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged&#160;to Costs and Expenses&#160;</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredTaxLiabilitiesGAAPDifferences_24586cbd-d15f-4857-b42e-d1aac8615dda_terseLabel_en-US" xlink:label="lab_ahl_DeferredTaxLiabilitiesGAAPDifferences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, GAAP differences</link:label>
    <link:label id="lab_ahl_DeferredTaxLiabilitiesGAAPDifferences_label_en-US" xlink:label="lab_ahl_DeferredTaxLiabilitiesGAAPDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, GAAP differences</link:label>
    <link:label id="lab_ahl_DeferredTaxLiabilitiesGAAPDifferences_documentation_en-US" xlink:label="lab_ahl_DeferredTaxLiabilitiesGAAPDifferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, GAAP differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLiabilitiesGAAPDifferences" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLiabilitiesGAAPDifferences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredTaxLiabilitiesGAAPDifferences" xlink:to="lab_ahl_DeferredTaxLiabilitiesGAAPDifferences" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceRatiosAbstract_ddf8aa59-f7e9-4fb5-9476-7042fd38f5b7_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceRatiosAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratios</link:label>
    <link:label id="lab_us-gaap_InsuranceRatiosAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceRatiosAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Ratios [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRatiosAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceRatiosAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceRatiosAbstract" xlink:to="lab_us-gaap_InsuranceRatiosAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LossesAndLossAdjustmentExpenses_e7eb74c1-caca-4d6f-a750-5ce4216946f2_terseLabel_en-US" xlink:label="lab_ahl_LossesAndLossAdjustmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses&#160;and LAE Expenses&#160;</link:label>
    <link:label id="lab_ahl_LossesAndLossAdjustmentExpenses_label_en-US" xlink:label="lab_ahl_LossesAndLossAdjustmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses And Loss Adjustment Expenses</link:label>
    <link:label id="lab_ahl_LossesAndLossAdjustmentExpenses_documentation_en-US" xlink:label="lab_ahl_LossesAndLossAdjustmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses And Loss Adjustment Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossesAndLossAdjustmentExpenses" xlink:href="ahl-20231220.xsd#ahl_LossesAndLossAdjustmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LossesAndLossAdjustmentExpenses" xlink:to="lab_ahl_LossesAndLossAdjustmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PercentageOfConsolidatedLeverageRatioPermitted_cd48b93c-47b9-40b0-b53e-6557a81476f6_terseLabel_en-US" xlink:label="lab_ahl_PercentageOfConsolidatedLeverageRatioPermitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of consolidated leverage ratio permitted</link:label>
    <link:label id="lab_ahl_PercentageOfConsolidatedLeverageRatioPermitted_label_en-US" xlink:label="lab_ahl_PercentageOfConsolidatedLeverageRatioPermitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Consolidated Leverage Ratio Permitted</link:label>
    <link:label id="lab_ahl_PercentageOfConsolidatedLeverageRatioPermitted_documentation_en-US" xlink:label="lab_ahl_PercentageOfConsolidatedLeverageRatioPermitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of consolidated leverage ratio permitted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfConsolidatedLeverageRatioPermitted" xlink:href="ahl-20231220.xsd#ahl_PercentageOfConsolidatedLeverageRatioPermitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PercentageOfConsolidatedLeverageRatioPermitted" xlink:to="lab_ahl_PercentageOfConsolidatedLeverageRatioPermitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_3341e238-5307-4f8f-b268-420adb73267f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_8d8f7070-e14f-4540-99b3-b63445927f2d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds withheld</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_f87a7b01-9287-4a20-a5b2-3d5b214c325c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Funds Held under Reinsurance Agreements</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Funds Held under Reinsurance Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" xlink:to="lab_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PreferenceSharesPolicyTextBlock_418bd497-2d0d-4392-bc9e-c5483feff887_terseLabel_en-US" xlink:label="lab_ahl_PreferenceSharesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Preference Shares</link:label>
    <link:label id="lab_ahl_PreferenceSharesPolicyTextBlock_label_en-US" xlink:label="lab_ahl_PreferenceSharesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference Shares [Policy Text Block]</link:label>
    <link:label id="lab_ahl_PreferenceSharesPolicyTextBlock_documentation_en-US" xlink:label="lab_ahl_PreferenceSharesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferenceSharesPolicyTextBlock" xlink:href="ahl-20231220.xsd#ahl_PreferenceSharesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PreferenceSharesPolicyTextBlock" xlink:to="lab_ahl_PreferenceSharesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_c4fa4517-85ad-40f4-ac71-c3136294c287_terseLabel_en-US" xlink:label="lab_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss)/gain on derivatives</link:label>
    <link:label id="lab_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_label_en-US" xlink:label="lab_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) on Derivatives, Effect Net of Tax</link:label>
    <link:label id="lab_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_documentation_en-US" xlink:label="lab_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) on Derivatives, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" xlink:href="ahl-20231220.xsd#ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" xlink:to="lab_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_86bca6e0-216a-433b-be51-c6fe38aa645b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_92174439-89c6-49de-90b6-7694b345b328_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate movements on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_c047f854-c247-4457-9a4d-0a7f1f605e19_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8c1f3860-17da-4d43-bbfd-87283e4777d2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office properties and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_IndustrialServiceMember_1cfc1e83-b084-492c-9c66-83c868c08167_terseLabel_en-US" xlink:label="lab_ahl_IndustrialServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrials</link:label>
    <link:label id="lab_ahl_IndustrialServiceMember_label_en-US" xlink:label="lab_ahl_IndustrialServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Service [Member]</link:label>
    <link:label id="lab_ahl_IndustrialServiceMember_documentation_en-US" xlink:label="lab_ahl_IndustrialServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IndustrialServiceMember" xlink:href="ahl-20231220.xsd#ahl_IndustrialServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_IndustrialServiceMember" xlink:to="lab_ahl_IndustrialServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_966242c9-4b1d-4f20-961b-45047e53f7da_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_665674e1-2bcb-450f-8307-eb1e1d210fd9_negatedTerseLabel_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit/(expense)</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_label_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Change In Unrealized Gains Tax</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_documentation_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total change in taxes of unrealized gains (losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" xlink:to="lab_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CreditRatingAMBestAxis_b3ec9b31-257e-4ea2-ae0c-6a6a2d65d26d_terseLabel_en-US" xlink:label="lab_srt_CreditRatingAMBestAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, AM Best [Axis]</link:label>
    <link:label id="lab_srt_CreditRatingAMBestAxis_label_en-US" xlink:label="lab_srt_CreditRatingAMBestAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, AM Best [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingAMBestAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingAMBestAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CreditRatingAMBestAxis" xlink:to="lab_srt_CreditRatingAMBestAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d3d34709-93c6-4c68-bc22-fb64b919747a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, increase (decrease) in fv included in net income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_4b9117da-8093-401e-83bd-9b92a4793719_negatedLabel_en-US" xlink:label="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from sales of other investments</link:label>
    <link:label id="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_49bc8a8d-9486-4fee-ba2c-2805ae638056_negatedTerseLabel_en-US" xlink:label="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Investing Activities, Net of Cash</link:label>
    <link:label id="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_label_en-US" xlink:label="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Investing Activities, Net of Cash</link:label>
    <link:label id="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_documentation_en-US" xlink:label="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Investing Activities, Net of Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash" xlink:href="ahl-20231220.xsd#ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash" xlink:to="lab_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ConcentrationRiskThresholdPercentage_3f3425e4-20ba-403f-89db-814e85975389_terseLabel_en-US" xlink:label="lab_ahl_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_ahl_ConcentrationRiskThresholdPercentage_label_en-US" xlink:label="lab_ahl_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Threshold Percentage</link:label>
    <link:label id="lab_ahl_ConcentrationRiskThresholdPercentage_documentation_en-US" xlink:label="lab_ahl_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value represents the Concentration Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConcentrationRiskThresholdPercentage" xlink:href="ahl-20231220.xsd#ahl_ConcentrationRiskThresholdPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ConcentrationRiskThresholdPercentage" xlink:to="lab_ahl_ConcentrationRiskThresholdPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_6a50de6f-7e70-4b52-99ab-46c7b210c99b_negatedLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_b215ed29-b89b-475a-9ada-5f7bcd28cdfd_terseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on preference shares</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedGain_59ff2f9e-3a3d-46df-a394-483e89d496bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities, trading - gross realized gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesTradingRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_9a29c04a-38f1-4bea-91e0-71bc340c3751_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_bee2fdd2-0b0e-4cff-99f9-169b0ea50d22_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_a06f4a17-dc20-4285-a989-b65582c4aae9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accident Year 2018</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_501d1610-b15e-4e2e-88a5-e9613df4f17b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d8e8f0ed-4bac-4238-aaaa-d0d879e1b5a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) to net income from derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_42514a7c-3218-4821-a0c6-5709f6c17189_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6077deaf-57a8-449b-9d93-eea59bee1ea1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated other comprehensive (loss)/income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9b3e331a-191f-4af6-9b18-04c0a782c3d2_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated other comprehensive (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_9ac7626b-e2bd-4a00-ac12-9eebefa897f3_terseLabel_en-US" xlink:label="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_label_en-US" xlink:label="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:to="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DebttoValueRatio50to60PercentMember_029d557d-37ee-471e-affc-1ff330d60268_terseLabel_en-US" xlink:label="lab_ahl_DebttoValueRatio50to60PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">50 to 60 Percent</link:label>
    <link:label id="lab_ahl_DebttoValueRatio50to60PercentMember_label_en-US" xlink:label="lab_ahl_DebttoValueRatio50to60PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, 50 to 60 Percent [Member]</link:label>
    <link:label id="lab_ahl_DebttoValueRatio50to60PercentMember_documentation_en-US" xlink:label="lab_ahl_DebttoValueRatio50to60PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to Value Ratio, 50 to 60 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DebttoValueRatio50to60PercentMember" xlink:to="lab_ahl_DebttoValueRatio50to60PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset_988fa3a5-3a41-48c7-a57b-90d969681766_terseLabel_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, remaining</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset_label_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, available to offset</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset_documentation_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, available to offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" xlink:to="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_InsuranceReserves_3a7e03eb-97a8-433f-945e-198568530286_totalLabel_en-US" xlink:label="lab_ahl_InsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total insurance reserves</link:label>
    <link:label id="lab_ahl_InsuranceReserves_540cf671-3e1d-4b73-aa25-c56a066d0654_terseLabel_en-US" xlink:label="lab_ahl_InsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total insurance reserves</link:label>
    <link:label id="lab_ahl_InsuranceReserves_label_en-US" xlink:label="lab_ahl_InsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Reserves</link:label>
    <link:label id="lab_ahl_InsuranceReserves_documentation_en-US" xlink:label="lab_ahl_InsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserves" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_InsuranceReserves" xlink:to="lab_ahl_InsuranceReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_GlobalSecuritiesCorporateMember_2d33491f-cbd1-4e19-9819-5baa8099c543_terseLabel_en-US" xlink:label="lab_ahl_GlobalSecuritiesCorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global corporates securities</link:label>
    <link:label id="lab_ahl_GlobalSecuritiesCorporateMember_label_en-US" xlink:label="lab_ahl_GlobalSecuritiesCorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global securities, corporate [Member]</link:label>
    <link:label id="lab_ahl_GlobalSecuritiesCorporateMember_documentation_en-US" xlink:label="lab_ahl_GlobalSecuritiesCorporateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global corporates securities, privately held investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalSecuritiesCorporateMember" xlink:href="ahl-20231220.xsd#ahl_GlobalSecuritiesCorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_GlobalSecuritiesCorporateMember" xlink:to="lab_ahl_GlobalSecuritiesCorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_58185881-44a0-4895-961a-b34184b654ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b1ab5300-ac61-4d2c-b7ac-5d357210d3aa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueOptionPricingModelMember_a1fd88eb-aef6-47d6-bd1b-83d89d19f89d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction value</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueOptionPricingModelMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_105d859b-64a6-4e00-a7b2-09b1efbafecc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_2f405013-cd9d-4653-a55d-65711f940db0_verboseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earned premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_fab94a2f-c302-4ca6-97c5-d0e49af897f9_totalLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums earned</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_94a50498-1461-4547-91c7-7898ef5da5e0_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums earned</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_3ca12264-99db-45ef-9e7d-d43f3332b351_terseLabel_en-US" xlink:label="lab_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_documentation_en-US" xlink:label="lab_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets By Major Class [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="ahl-20231220.xsd#ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldInTrust_96d4d89d-eb44-450b-8f89-e3e60f3b4ca1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held-in-trust</link:label>
    <link:label id="lab_us-gaap_AssetsHeldInTrust_label_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-in-trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldInTrust" xlink:to="lab_us-gaap_AssetsHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_4ada2528-42cd-4a03-92a1-e9cf835e7308_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_b7ed1aac-8aa2-49cc-8b9d-253a5644a76c_terseLabel_en-US" xlink:label="lab_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investments, cost, trading at fair value</link:label>
    <link:label id="lab_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_label_en-US" xlink:label="lab_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investments, amortized cost, trading at fair value</link:label>
    <link:label id="lab_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_documentation_en-US" xlink:label="lab_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-held investments, amortized cost, trading at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue" xlink:href="ahl-20231220.xsd#ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue" xlink:to="lab_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_1b56599b-f0f6-4c69-a4dc-666f377a7cfd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All outstanding liabilities before 2013, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoanToValueAxis_50fe67fc-98d8-45c9-968f-c564f6cd032e_terseLabel_en-US" xlink:label="lab_us-gaap_LoanToValueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value [Axis]</link:label>
    <link:label id="lab_us-gaap_LoanToValueAxis_label_en-US" xlink:label="lab_us-gaap_LoanToValueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoanToValueAxis" xlink:to="lab_us-gaap_LoanToValueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_eed38868-fdf1-46ff-be33-4065954aa23d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_f0a961ab-90fb-426e-82c5-98575faeddbd_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change from current period hedged transactions</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_6673701e-e987-4470-a6f2-e8ba9ae4ca73_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Derivatives</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:to="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_eecf54a0-8770-4a27-9e4a-40949512ec44_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_c87438c7-0fe3-4521-ba29-4050cc6b421d_terseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total tax expense/(benefit), U.S.</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FundsHeldForClients_551bf4a2-547d-4177-b638-68e35ed81174_terseLabel_en-US" xlink:label="lab_us-gaap_FundsHeldForClients" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total funds held by AUL</link:label>
    <link:label id="lab_us-gaap_FundsHeldForClients_label_en-US" xlink:label="lab_us-gaap_FundsHeldForClients" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds Held for Clients</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldForClients" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldForClients"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FundsHeldForClients" xlink:to="lab_us-gaap_FundsHeldForClients" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_33c27ece-f2c6-49c8-8b9a-0064227fd9d4_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MajorRatingAgenciesAxis_0408ac52-dbe4-45a4-a963-469f2870cc6b_terseLabel_en-US" xlink:label="lab_ahl_MajorRatingAgenciesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major rating agencies [Axis]</link:label>
    <link:label id="lab_ahl_MajorRatingAgenciesAxis_label_en-US" xlink:label="lab_ahl_MajorRatingAgenciesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major rating agencies [Axis]</link:label>
    <link:label id="lab_ahl_MajorRatingAgenciesAxis_documentation_en-US" xlink:label="lab_ahl_MajorRatingAgenciesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major rating agencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MajorRatingAgenciesAxis" xlink:href="ahl-20231220.xsd#ahl_MajorRatingAgenciesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MajorRatingAgenciesAxis" xlink:to="lab_ahl_MajorRatingAgenciesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7e03149d-a668-4ae6-896d-d3f96535ab3d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares:</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_7a442600-b25f-4a1f-90ab-a60b1d04be88_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1b8ce80e-ff3c-4e38-a7c5-f82186b0524c_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. agency</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_fe974443-0bf5-4846-9338-b5d074052018_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_fa7bbdf7-5984-4b73-b19a-75ccae108c26_verboseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid losses recoverable from reinsurers (net of allowance for expected credit losses of 2022: $3.7 &#8212; 2021: $3.3)</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:to="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_022eaa11-324e-41d6-b727-d9b434b52a08_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160; of Year&#160;</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_b2810da6-2775-4341-9789-e8bfee93a751_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End&#160;of&#160; Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_bde67384-19a9-49d0-93d9-2eac7446caaf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Long-term Incentive Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_c88e143e-e8c5-400c-83df-03793371d383_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale investment, allowance for credit loss, increase (decrease)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d05a397c-e63d-411c-a96d-07acf7e3d4c3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_f0112127-42d0-45ff-bd0f-30d58a7a86e8_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_9557f25d-770b-414c-8664-daef1145cba1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_InvestmentFunds_24861619-d694-479c-9137-6144a112c887_terseLabel_en-US" xlink:label="lab_ahl_InvestmentFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment funded</link:label>
    <link:label id="lab_ahl_InvestmentFunds_label_en-US" xlink:label="lab_ahl_InvestmentFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Funds</link:label>
    <link:label id="lab_ahl_InvestmentFunds_documentation_en-US" xlink:label="lab_ahl_InvestmentFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentFunds" xlink:href="ahl-20231220.xsd#ahl_InvestmentFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_InvestmentFunds" xlink:to="lab_ahl_InvestmentFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ManagementConsultingAgreementMember_21d67b43-2f65-466a-a505-40b3a3df0616_terseLabel_en-US" xlink:label="lab_ahl_ManagementConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Consulting Agreement</link:label>
    <link:label id="lab_ahl_ManagementConsultingAgreementMember_label_en-US" xlink:label="lab_ahl_ManagementConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Consulting Agreement [Member]</link:label>
    <link:label id="lab_ahl_ManagementConsultingAgreementMember_documentation_en-US" xlink:label="lab_ahl_ManagementConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Consulting Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ManagementConsultingAgreementMember" xlink:to="lab_ahl_ManagementConsultingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ece4cde4-da32-4ebc-b60f-f3b3673ac246_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities, available for sale amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b89677b3-42fd-40fc-a079-c4ea634dea63_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities, available for sale amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_d3bf0bf8-9e2f-476d-9b44-03f2c9574737_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenses_21424184-fad3-4791-ae26-8202a9595578_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_OtherExpenses_97ce246b-a46a-45b7-943b-ab9add4f0338_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_OtherExpenses_label_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenses" xlink:to="lab_us-gaap_OtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract_be123b03-dff9-48ef-a294-e3802d2d3180_terseLabel_en-US" xlink:label="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]</link:label>
    <link:label id="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract_label_en-US" xlink:label="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract" xlink:to="lab_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShortTermInvestmentsAvailableForSale_670118d1-df62-44ca-8306-5636a0b8a4fd_terseLabel_en-US" xlink:label="lab_ahl_ShortTermInvestmentsAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, available for sale</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsAvailableForSale_label_en-US" xlink:label="lab_ahl_ShortTermInvestmentsAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, available for sale</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsAvailableForSale_documentation_en-US" xlink:label="lab_ahl_ShortTermInvestmentsAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, available for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsAvailableForSale" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsAvailableForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShortTermInvestmentsAvailableForSale" xlink:to="lab_ahl_ShortTermInvestmentsAvailableForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aed71c76-7145-4415-990e-c68f344c275c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_32a0d909-440d-4f92-a934-9cc7e18503f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ApolloClassANotesMember_697be354-43f7-4eac-843f-a1f19dcf7684_terseLabel_en-US" xlink:label="lab_ahl_ApolloClassANotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo originating partnership, class A notes</link:label>
    <link:label id="lab_ahl_ApolloClassANotesMember_label_en-US" xlink:label="lab_ahl_ApolloClassANotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo, Class A Notes [Member]</link:label>
    <link:label id="lab_ahl_ApolloClassANotesMember_documentation_en-US" xlink:label="lab_ahl_ApolloClassANotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo Originating Partnership, Class A Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassANotesMember" xlink:href="ahl-20231220.xsd#ahl_ApolloClassANotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ApolloClassANotesMember" xlink:to="lab_ahl_ApolloClassANotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_e6b0f5a2-0b33-46bf-a6d2-b1831fc9c37d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_9f34990d-f2d8-4c6e-9c09-fda73f810c6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_a6447811-1d8b-4c1d-87d5-d1d2ebb39c50_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fixed Maturities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_e64fb20d-e558-4006-b70e-cc8c7c0a3d41_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PurchasesOfProceedsFromCatastropheBonds_ffb6205f-1a69-4ff9-9135-4808ea321784_negatedTerseLabel_en-US" xlink:label="lab_ahl_PurchasesOfProceedsFromCatastropheBonds" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from catastrophe bonds &#8212; Trading</link:label>
    <link:label id="lab_ahl_PurchasesOfProceedsFromCatastropheBonds_label_en-US" xlink:label="lab_ahl_PurchasesOfProceedsFromCatastropheBonds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases Of (Proceeds From) Catastrophe Bonds</link:label>
    <link:label id="lab_ahl_PurchasesOfProceedsFromCatastropheBonds_documentation_en-US" xlink:label="lab_ahl_PurchasesOfProceedsFromCatastropheBonds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases Of (Proceeds From) Catastrophe Bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PurchasesOfProceedsFromCatastropheBonds" xlink:href="ahl-20231220.xsd#ahl_PurchasesOfProceedsFromCatastropheBonds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PurchasesOfProceedsFromCatastropheBonds" xlink:to="lab_ahl_PurchasesOfProceedsFromCatastropheBonds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_1c784760-e47c-4729-9b7c-9492ff67f1f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f6f0b4d4-501f-4b31-add5-35aac8383857_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePayable_1c42090d-b58f-475c-bb08-d76a2aa421d9_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance premiums</link:label>
    <link:label id="lab_us-gaap_ReinsurancePayable_label_en-US" xlink:label="lab_us-gaap_ReinsurancePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePayable" xlink:to="lab_us-gaap_ReinsurancePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_93af91f7-f33d-4b57-a4b2-a7c6a35818f0_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax (benefit)/expense, U.S.</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_e2305029-201b-486c-a436-35b545d56411_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable_942f2064-85b9-46d1-abb4-76200998a5d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership_2ef50786-24cf-4c5d-bfd1-72f411b44557_terseLabel_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to s382 limitation</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership_label_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carryforwards, s382 Limitation, Change of Ownership</link:label>
    <link:label id="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership_documentation_en-US" xlink:label="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carryforwards, s382 Limitation, Change of Ownership</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" xlink:to="lab_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MunichReMember_80212305-107a-4793-aeb6-cc6b9b728a01_terseLabel_en-US" xlink:label="lab_ahl_MunichReMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Munich Re</link:label>
    <link:label id="lab_ahl_MunichReMember_label_en-US" xlink:label="lab_ahl_MunichReMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Munich Re [Member]</link:label>
    <link:label id="lab_ahl_MunichReMember_documentation_en-US" xlink:label="lab_ahl_MunichReMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Munich Re [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MunichReMember" xlink:href="ahl-20231220.xsd#ahl_MunichReMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MunichReMember" xlink:to="lab_ahl_MunichReMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_404ceb19-a028-47a7-bdd2-035b8fb90dcb_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_fbcbd2e0-a2c2-4d70-b4fa-857f21fdfdfc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingent liabilities (see Note&#160;20)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_ac72098d-a5d7-482c-8687-a615d4d54219_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_1a26777b-cb90-4d57-9f72-82731775d5a2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_c9af315f-85bb-4692-8fc6-f41bbd953f08_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_5f5d2afc-6f10-431c-8a6e-005d6eebb385_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_IssuedShareCapitalAbstract_ce25f31f-1fe6-4cc1-832e-ecd5892d4a0d_terseLabel_en-US" xlink:label="lab_ahl_IssuedShareCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued share capital:</link:label>
    <link:label id="lab_ahl_IssuedShareCapitalAbstract_label_en-US" xlink:label="lab_ahl_IssuedShareCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued Share Capital [Abstract]</link:label>
    <link:label id="lab_ahl_IssuedShareCapitalAbstract_documentation_en-US" xlink:label="lab_ahl_IssuedShareCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued share capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapitalAbstract" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_IssuedShareCapitalAbstract" xlink:to="lab_ahl_IssuedShareCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_e85bdff6-8a91-454f-84cd-9da6f531cabf_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded unearned premiums</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_7ef438c3-0eb4-4a46-8d9b-678f827a2c1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Reinsurance Premiums</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Reinsurance Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_8ea69a0e-8654-4fcd-9022-d1be0adfeec3_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed term deposits (included in cash and cash equivalents)</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_19bf8df4-cc98-4298-a899-3215118b0696_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_c6a4640a-21cd-47fe-b7a5-9e4b13ce2f15_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceLiabilities_4c321053-9c5c-4acc-bab3-e6e80526436a_terseLabel_en-US" xlink:label="lab_ahl_ReinsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance liabilities</link:label>
    <link:label id="lab_ahl_ReinsuranceLiabilities_label_en-US" xlink:label="lab_ahl_ReinsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Liabilities</link:label>
    <link:label id="lab_ahl_ReinsuranceLiabilities_documentation_en-US" xlink:label="lab_ahl_ReinsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceLiabilities" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceLiabilities" xlink:to="lab_ahl_ReinsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_41c26b8b-ad01-465d-9fd0-7a9b594978ff_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_c617b5de-7abf-48de-9c3c-9b8ca482b773_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_UnpaidLosses_68ca895b-c34f-4381-8315-1d5e896c6c77_terseLabel_en-US" xlink:label="lab_ahl_UnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid losses</link:label>
    <link:label id="lab_ahl_UnpaidLosses_49be9da7-2340-4222-8d6f-345fd6f88168_negatedTerseLabel_en-US" xlink:label="lab_ahl_UnpaidLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid losses</link:label>
    <link:label id="lab_ahl_UnpaidLosses_label_en-US" xlink:label="lab_ahl_UnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid losses</link:label>
    <link:label id="lab_ahl_UnpaidLosses_documentation_en-US" xlink:label="lab_ahl_UnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnpaidLosses" xlink:href="ahl-20231220.xsd#ahl_UnpaidLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_UnpaidLosses" xlink:to="lab_ahl_UnpaidLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_5ed36dc9-3752-40f7-a989-5a01cfa77373_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_4d505687-6e4b-4f7b-99af-1a8684e21fc4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64248cc6-9066-459a-8c79-87652b61c84c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in net provision for losses and LAE for claims incurred:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo_2ba3d1b6-c519-4f1a-a2b9-f92a15a35880_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year Two</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_873de867-a69f-4175-aea6-09b2a5684fe6_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_07bbd1c8-931e-495d-9e2d-2b1c57f2a70e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_e064ce6f-16ae-4f4f-9821-313d542dc1e7_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_UsMultiBeneficiaryTrustFundMember_b6b47dc2-4f10-4000-a881-0c01671f429a_terseLabel_en-US" xlink:label="lab_ahl_UsMultiBeneficiaryTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Us Multi Beneficiary Trust Fund</link:label>
    <link:label id="lab_ahl_UsMultiBeneficiaryTrustFundMember_label_en-US" xlink:label="lab_ahl_UsMultiBeneficiaryTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Us Multi Beneficiary Trust Fund [Member]</link:label>
    <link:label id="lab_ahl_UsMultiBeneficiaryTrustFundMember_documentation_en-US" xlink:label="lab_ahl_UsMultiBeneficiaryTrustFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Multi-beneficiary Trust Fund.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsMultiBeneficiaryTrustFundMember" xlink:href="ahl-20231220.xsd#ahl_UsMultiBeneficiaryTrustFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_UsMultiBeneficiaryTrustFundMember" xlink:to="lab_ahl_UsMultiBeneficiaryTrustFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b0942c8f-b819-428f-8a2a-2e906b7dc54c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_9141494a-62f0-41d5-9ca5-15134f8cd2b9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_448d69a3-9d6d-479a-beda-f3f6376bb3f2_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_2e82986c-fbc5-4bbd-9977-681f9600cf2d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_eda215d7-9b66-4d0d-bb8b-3d1731e08129_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_b4935afc-215e-413f-a7db-b1d04c0527aa_terseLabel_en-US" xlink:label="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Table]</link:label>
    <link:label id="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_label_en-US" xlink:label="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable" xlink:to="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_06f1a986-93e6-4752-8e03-83fd016a38de_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Worldwide excluding United States</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_e75dd50b-1518-4022-8a27-742ff996c7a7_terseLabel_en-US" xlink:label="lab_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</link:label>
    <link:label id="lab_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_label_en-US" xlink:label="lab_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Duration Insurance Contracts, Liability for Unpaid Claim Adjustment Expense, Net, Not Separately Presented, Subtotal</link:label>
    <link:label id="lab_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_documentation_en-US" xlink:label="lab_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted subtotal amount, after reinsurance, of the liability for unpaid claim adjustment expense for short durations insurance contracts not separately presented in claim development information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" xlink:href="ahl-20231220.xsd#ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" xlink:to="lab_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_d06a574d-c1aa-411c-82be-7ab7edc6910c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_2fade40d-d05c-47fb-aff9-ebb202e07c7a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_d738e564-d990-4692-b0cc-535ac5931279_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_CorporateTaxRate_59ad0303-fd24-40d4-94d9-4752dd875e1c_terseLabel_en-US" xlink:label="lab_ahl_CorporateTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U. K. corporate tax rate</link:label>
    <link:label id="lab_ahl_CorporateTaxRate_label_en-US" xlink:label="lab_ahl_CorporateTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Tax Rate</link:label>
    <link:label id="lab_ahl_CorporateTaxRate_documentation_en-US" xlink:label="lab_ahl_CorporateTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate tax rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateTaxRate" xlink:href="ahl-20231220.xsd#ahl_CorporateTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_CorporateTaxRate" xlink:to="lab_ahl_CorporateTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_7c2b4917-f288-4adf-85eb-cb3da11a95d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax by Taxing Authority</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_b6f7339b-b986-4005-b93f-212f073df0de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities - gross realized gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a661a3ec-edc6-4588-9e1d-63c11d28687b_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_IncomeTaxesTable_c93a7e44-1221-4c97-9a32-ca6c36470036_terseLabel_en-US" xlink:label="lab_ahl_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_ahl_IncomeTaxesTable_label_en-US" xlink:label="lab_ahl_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_ahl_IncomeTaxesTable_documentation_en-US" xlink:label="lab_ahl_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncomeTaxesTable" xlink:href="ahl-20231220.xsd#ahl_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_IncomeTaxesTable" xlink:to="lab_ahl_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_85214585-48f6-4815-81c1-91b55c8eee09_terseLabel_en-US" xlink:label="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]</link:label>
    <link:label id="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_label_en-US" xlink:label="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems" xlink:to="lab_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_3a565dc8-a36e-496d-a51f-e9ae601d9a66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Authorized and Issued Share Capital</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_e99f1b21-d2de-4573-9568-2a22977146a0_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_449afbb8-d408-482c-ab94-4f9190bab0fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_3d7696e4-3da8-4e09-a21e-dc4337be51cd_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock_6577878d-18ae-4438-9669-0f1ea732bcd0_terseLabel_en-US" xlink:label="lab_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule III - Supplementary Insurance Information</link:label>
    <link:label id="lab_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock_label_en-US" xlink:label="lab_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock" xlink:to="lab_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_MVIMember_d55ba0d6-cb84-425b-a275-193c7a0c7aa3_terseLabel_en-US" xlink:label="lab_ahl_MVIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MVI</link:label>
    <link:label id="lab_ahl_MVIMember_label_en-US" xlink:label="lab_ahl_MVIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MVI [Member]</link:label>
    <link:label id="lab_ahl_MVIMember_documentation_en-US" xlink:label="lab_ahl_MVIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MVI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_MVIMember" xlink:to="lab_ahl_MVIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ba010cf5-6a4f-45ec-aed3-118eb0bff373_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Payments, Due year two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_5e388747-556d-44e6-a1cd-219717ffc78a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years, Fair Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9e1bc8b7-d687-48d4-b6f3-596dd4780387_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_cb9d5946-af1a-479e-8887-fa84fc7c6ae9_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e98bf5b3-75ae-4df8-9e11-d12dcfc738fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_61403b70-8230-48ef-a308-705ee1b88d0f_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeOfTheTaxCommissionerBermudaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bermuda</link:label>
    <link:label id="lab_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_label_en-US" xlink:label="lab_us-gaap_OfficeOfTheTaxCommissionerBermudaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office of the Tax Commissioner, Bermuda [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeOfTheTaxCommissionerBermudaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember" xlink:to="lab_us-gaap_OfficeOfTheTaxCommissionerBermudaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceRecoverablesAdjustment_55705668-4e10-4fa2-8eaf-75ff71e522b0_negatedTerseLabel_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less reinsurance recoverable</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesAdjustment_label_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables Adjustment</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesAdjustment_documentation_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables Adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesAdjustment" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceRecoverablesAdjustment" xlink:to="lab_ahl_ReinsuranceRecoverablesAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_9d35b0d9-0410-43bd-b7fa-9e528b7eedc1_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities &#8212; Trading</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_31bb336a-50dc-4242-b165-a79d0f04619c_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_0f9d321f-b1a8-4d6a-ad8e-79bd950d16c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b20bca8d-c511-4059-b1af-77cb44c71a3b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) before tax, U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_119e2bda-b5ad-4bb6-ab7f-c01a7b4cd02c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_d8b0f9a7-c166-4817-b2df-dbe81924c1e8_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_2456ed49-40c2-4d23-b1f6-d246323067fd_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_e3db9046-0883-421e-a899-93ad934a63ec_totalLabel_en-US" xlink:label="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net realized and unrealized investment (losses)/gains recorded in the consolidated statement of operations</link:label>
    <link:label id="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_028a4294-3b96-4925-8d2a-9b36b21363bc_terseLabel_en-US" xlink:label="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net realized and unrealized investment (losses)/gains recorded in the consolidated statement of operations</link:label>
    <link:label id="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Realized And Unrealized Investment Gains (Losses)</link:label>
    <link:label id="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_documentation_en-US" xlink:label="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Realized And Unrealized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses" xlink:to="lab_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionCostRatio_16761781-c783-43e3-bb03-043ae1a9917e_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionCostRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition cost ratio</link:label>
    <link:label id="lab_us-gaap_AcquisitionCostRatio_label_en-US" xlink:label="lab_us-gaap_AcquisitionCostRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Cost Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCostRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCostRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionCostRatio" xlink:to="lab_us-gaap_AcquisitionCostRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f0bcd74d-654b-4a61-9133-e69bf23d91b2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_351aae8e-2ee6-49e5-9cdf-4e029e50878f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit)/expense allocated to other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateFundsMember_e6590859-01cd-4424-8071-a5865d72c2fa_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate fund</link:label>
    <link:label id="lab_us-gaap_RealEstateFundsMember_label_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateFundsMember" xlink:to="lab_us-gaap_RealEstateFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_SubsidiariesOneMember_7658c7ef-046f-49dd-a17e-16214a36da9e_terseLabel_en-US" xlink:label="lab_ahl_SubsidiariesOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AUL</link:label>
    <link:label id="lab_ahl_SubsidiariesOneMember_label_en-US" xlink:label="lab_ahl_SubsidiariesOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries One [Member]</link:label>
    <link:label id="lab_ahl_SubsidiariesOneMember_documentation_en-US" xlink:label="lab_ahl_SubsidiariesOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SubsidiariesOneMember" xlink:href="ahl-20231220.xsd#ahl_SubsidiariesOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_SubsidiariesOneMember" xlink:to="lab_ahl_SubsidiariesOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetailMember_28a46533-0d3d-4711-ad50-29cf3e18d3d6_terseLabel_en-US" xlink:label="lab_us-gaap_RetailMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail</link:label>
    <link:label id="lab_us-gaap_RetailMember_label_en-US" xlink:label="lab_us-gaap_RetailMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetailMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetailMember" xlink:to="lab_us-gaap_RetailMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_c49ed71d-3c9f-497a-9231-c816faf6ddc0_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtMember_7864d932-b48d-41ef-8733-aafd7b5e39c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtMember_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtMember" xlink:to="lab_us-gaap_ShortTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_DepositWithStates_629a0b79-fcc1-4191-9f68-bc654884a4d1_terseLabel_en-US" xlink:label="lab_ahl_DepositWithStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit with states</link:label>
    <link:label id="lab_ahl_DepositWithStates_label_en-US" xlink:label="lab_ahl_DepositWithStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit With States</link:label>
    <link:label id="lab_ahl_DepositWithStates_documentation_en-US" xlink:label="lab_ahl_DepositWithStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit with states.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositWithStates" xlink:href="ahl-20231220.xsd#ahl_DepositWithStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_DepositWithStates" xlink:to="lab_ahl_DepositWithStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_4860367c-c6a5-4946-8f46-e6fca0d6c4cf_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededPremiumsWritten_a664867f-66c6-4f08-a36f-1544f6cd9a35_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CededPremiumsWritten" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_CededPremiumsWritten_label_en-US" xlink:label="lab_us-gaap_CededPremiumsWritten" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Premiums Written</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsWritten" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsWritten"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededPremiumsWritten" xlink:to="lab_us-gaap_CededPremiumsWritten" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3f71e402-8725-4d48-987f-a2d0360bc65f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_4565c1bf-64fe-4d26-9134-889d9e72759d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoanToValueDomain_f92e7648-808b-4abd-bdcb-e0453763024e_terseLabel_en-US" xlink:label="lab_us-gaap_LoanToValueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value [Domain]</link:label>
    <link:label id="lab_us-gaap_LoanToValueDomain_label_en-US" xlink:label="lab_us-gaap_LoanToValueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoanToValueDomain" xlink:to="lab_us-gaap_LoanToValueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_SecuritiesassetbackedMember_c6a7ba59-4e61-4c89-b783-68453de164f0_terseLabel_en-US" xlink:label="lab_ahl_SecuritiesassetbackedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, asset-backed</link:label>
    <link:label id="lab_ahl_SecuritiesassetbackedMember_label_en-US" xlink:label="lab_ahl_SecuritiesassetbackedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, asset-backed [Member]</link:label>
    <link:label id="lab_ahl_SecuritiesassetbackedMember_documentation_en-US" xlink:label="lab_ahl_SecuritiesassetbackedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, asset-backed [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SecuritiesassetbackedMember" xlink:href="ahl-20231220.xsd#ahl_SecuritiesassetbackedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_SecuritiesassetbackedMember" xlink:to="lab_ahl_SecuritiesassetbackedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_9d317ad3-6fa7-45a8-bc0a-67a054742404_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payment made without regulatory approval</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_e000298e-434f-4b4a-830f-c651b30f64fe_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_b20216d1-5cf2-4b3b-9ae9-e9bee3713834_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationByPropertyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, by Property [Table]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationByPropertyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, by Property [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationByPropertyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationByPropertyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable_23bc4e2f-33c4-444a-a0e0-b9ecf7f0bc28_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable_45cbc50b-8b9b-4ebb-8ed5-9f242c8004e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Premiums Receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Premiums Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_628a1146-e964-493b-914f-551ff157e689_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_LiabilitiesUnderDerivativeContractsMember_1cf88720-08ab-4d4c-98f4-5d2522540433_terseLabel_en-US" xlink:label="lab_ahl_LiabilitiesUnderDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Under Derivative Contracts</link:label>
    <link:label id="lab_ahl_LiabilitiesUnderDerivativeContractsMember_label_en-US" xlink:label="lab_ahl_LiabilitiesUnderDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Under Derivative Contracts [Member]</link:label>
    <link:label id="lab_ahl_LiabilitiesUnderDerivativeContractsMember_documentation_en-US" xlink:label="lab_ahl_LiabilitiesUnderDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities under derivative contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_LiabilitiesUnderDerivativeContractsMember" xlink:to="lab_ahl_LiabilitiesUnderDerivativeContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAmortizedCost_18329b58-8c00-4f9e-ad44-ea31237e20a2_terseLabel_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, trading, amortized cost</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAmortizedCost_label_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Investments Trading Amortized Cost</link:label>
    <link:label id="lab_ahl_ShortTermInvestmentsTradingAmortizedCost_documentation_en-US" xlink:label="lab_ahl_ShortTermInvestmentsTradingAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, trading, amortized cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAmortizedCost" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShortTermInvestmentsTradingAmortizedCost" xlink:to="lab_ahl_ShortTermInvestmentsTradingAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_a5dd65a9-b38a-4c81-b99a-dab67a731997_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RestrictedAssetsExcludingIlliquidAssets_3f4b7d78-e755-4b45-ba7d-02362dcc3627_terseLabel_en-US" xlink:label="lab_ahl_RestrictedAssetsExcludingIlliquidAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted assets, excluding illiquid assets</link:label>
    <link:label id="lab_ahl_RestrictedAssetsExcludingIlliquidAssets_label_en-US" xlink:label="lab_ahl_RestrictedAssetsExcludingIlliquidAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Assets, excluding illiquid assets</link:label>
    <link:label id="lab_ahl_RestrictedAssetsExcludingIlliquidAssets_documentation_en-US" xlink:label="lab_ahl_RestrictedAssetsExcludingIlliquidAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Assets, excluding illiquid assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssetsExcludingIlliquidAssets" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssetsExcludingIlliquidAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RestrictedAssetsExcludingIlliquidAssets" xlink:to="lab_ahl_RestrictedAssetsExcludingIlliquidAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_RelatedPartyTransactionMaximumRateIncrease_20513411-5af1-4e20-bb41-d8e91335b4ed_terseLabel_en-US" xlink:label="lab_ahl_RelatedPartyTransactionMaximumRateIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual fee cap</link:label>
    <link:label id="lab_ahl_RelatedPartyTransactionMaximumRateIncrease_label_en-US" xlink:label="lab_ahl_RelatedPartyTransactionMaximumRateIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Maximum Rate Increase</link:label>
    <link:label id="lab_ahl_RelatedPartyTransactionMaximumRateIncrease_documentation_en-US" xlink:label="lab_ahl_RelatedPartyTransactionMaximumRateIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Maximum Rate Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionMaximumRateIncrease" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionMaximumRateIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_RelatedPartyTransactionMaximumRateIncrease" xlink:to="lab_ahl_RelatedPartyTransactionMaximumRateIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight_4d7c5738-8731-4696-bdd3-e8d5a3fde80d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Annual Percentage Payout of Incurred Claims, Net of Reinsurance, Year Eight</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Historical Claims Duration, Year Eight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_5873a404-dca1-4d18-a01c-42c001564076_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on operating lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_4ec40f8e-a06d-49b3-a33d-cc8e0fe21d8a_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on operating lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PaymentsForProceedsFromOtherInvestments_804eb4cf-015f-49e1-8ec1-138f59d52302_negatedTerseLabel_en-US" xlink:label="lab_ahl_PaymentsForProceedsFromOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (purchases)/sales of investments, equity method</link:label>
    <link:label id="lab_ahl_PaymentsForProceedsFromOtherInvestments_label_en-US" xlink:label="lab_ahl_PaymentsForProceedsFromOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Proceeds From Other Investments</link:label>
    <link:label id="lab_ahl_PaymentsForProceedsFromOtherInvestments_documentation_en-US" xlink:label="lab_ahl_PaymentsForProceedsFromOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for proceeds from other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsForProceedsFromOtherInvestments" xlink:href="ahl-20231220.xsd#ahl_PaymentsForProceedsFromOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PaymentsForProceedsFromOtherInvestments" xlink:to="lab_ahl_PaymentsForProceedsFromOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_e4e657dd-d003-426b-9db3-f50816a97215_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule V - Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PremiumsEarnedGross_e6af8b11-969f-4762-9238-194935ddcc7e_terseLabel_en-US" xlink:label="lab_ahl_PremiumsEarnedGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross earned premiums</link:label>
    <link:label id="lab_ahl_PremiumsEarnedGross_label_en-US" xlink:label="lab_ahl_PremiumsEarnedGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Gross</link:label>
    <link:label id="lab_ahl_PremiumsEarnedGross_documentation_en-US" xlink:label="lab_ahl_PremiumsEarnedGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsEarnedGross" xlink:href="ahl-20231220.xsd#ahl_PremiumsEarnedGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PremiumsEarnedGross" xlink:to="lab_ahl_PremiumsEarnedGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BeneficialOwnerMember_170b5e5c-b017-48c1-968b-863f63c4e9ff_terseLabel_en-US" xlink:label="lab_us-gaap_BeneficialOwnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beneficial owner</link:label>
    <link:label id="lab_us-gaap_BeneficialOwnerMember_label_en-US" xlink:label="lab_us-gaap_BeneficialOwnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beneficial Owner [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BeneficialOwnerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BeneficialOwnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BeneficialOwnerMember" xlink:to="lab_us-gaap_BeneficialOwnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PreferredStockValueAuthorized_0929b227-9905-4069-91d2-a6ffb353872a_terseLabel_en-US" xlink:label="lab_ahl_PreferredStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preference Shares, authorized</link:label>
    <link:label id="lab_ahl_PreferredStockValueAuthorized_label_en-US" xlink:label="lab_ahl_PreferredStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Value Authorized</link:label>
    <link:label id="lab_ahl_PreferredStockValueAuthorized_documentation_en-US" xlink:label="lab_ahl_PreferredStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock shares authorized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockValueAuthorized" xlink:href="ahl-20231220.xsd#ahl_PreferredStockValueAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PreferredStockValueAuthorized" xlink:to="lab_ahl_PreferredStockValueAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_786aea4d-dca1-446f-8bf0-80c3a2ea49ad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_49260320-b538-4495-a2b2-dc9e61872b91_terseLabel_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_label_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Average Ratings By Maturity</link:label>
    <link:label id="lab_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_documentation_en-US" xlink:label="lab_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities average ratings by maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity" xlink:to="lab_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_b14612fc-8436-4551-a092-42b073f31565_terseLabel_en-US" xlink:label="lab_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contribution</link:label>
    <link:label id="lab_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_label_en-US" xlink:label="lab_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid In Capital, Capital Contribution</link:label>
    <link:label id="lab_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_documentation_en-US" xlink:label="lab_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid In Capital, Capital Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution" xlink:href="ahl-20231220.xsd#ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution" xlink:to="lab_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_HSBCBankUSANationalAssociationMember_536d548e-86bf-48f3-99ea-d254173b24ec_terseLabel_en-US" xlink:label="lab_ahl_HSBCBankUSANationalAssociationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSBC Bank USA, National Association</link:label>
    <link:label id="lab_ahl_HSBCBankUSANationalAssociationMember_label_en-US" xlink:label="lab_ahl_HSBCBankUSANationalAssociationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSBC Bank USA, National Association [Member]</link:label>
    <link:label id="lab_ahl_HSBCBankUSANationalAssociationMember_documentation_en-US" xlink:label="lab_ahl_HSBCBankUSANationalAssociationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSBC Bank USA, National Association</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HSBCBankUSANationalAssociationMember" xlink:href="ahl-20231220.xsd#ahl_HSBCBankUSANationalAssociationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_HSBCBankUSANationalAssociationMember" xlink:to="lab_ahl_HSBCBankUSANationalAssociationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_PreferredStockIssuanceCost_fd321e90-0702-42d6-a8da-996ccd5cf93b_terseLabel_en-US" xlink:label="lab_ahl_PreferredStockIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issuance cost</link:label>
    <link:label id="lab_ahl_PreferredStockIssuanceCost_label_en-US" xlink:label="lab_ahl_PreferredStockIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Issuance Cost</link:label>
    <link:label id="lab_ahl_PreferredStockIssuanceCost_documentation_en-US" xlink:label="lab_ahl_PreferredStockIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issuance cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockIssuanceCost" xlink:href="ahl-20231220.xsd#ahl_PreferredStockIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_PreferredStockIssuanceCost" xlink:to="lab_ahl_PreferredStockIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_ce00f0d9-fdb0-45c6-a0c4-c039a2bbdf26_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesAllowance_ba0b3236-f277-4cc0-9d76-96b1eee7dcdc_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid losses recoverable from reinsurers (net of allowance for expected credit losses of 2022: $3.7 &#8212; 2021: $3.3)</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesAllowance_cdf6e8b6-c853-4f60-8741-5054918ab18c_verboseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesAllowance_1b39f3eb-143c-4471-9120-8f4218ab5b8a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesAllowance_39c6aace-4d12-4ddb-a10a-6d75add3fb79_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss, Ending Balance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesAllowance_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverablesAllowance" xlink:to="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_016247b7-d394-497c-bc53-ea38e93a8850_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_e2de54ca-85cb-42f4-bc22-7d66f0ab7cae_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_b64322c3-64ee-4c51-b04f-d2cb2cb72344_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets (excluding goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_49c42cb1-f1aa-492f-b770-19e3138abb8a_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_4ec9c20d-6bbf-49ae-9ec7-b2fd41727e0f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual interest payable</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:to="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_f4678cdd-3afb-4f7d-b823-eaa08f885b8f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_0063f81f-dac3-44a6-a569-74befb04204f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:to="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_7c148a71-32b2-4b18-9a29-8bcc017024ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_20bd103f-2809-4bfc-8964-0b1468555397_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit at statutory tax rate of zero percent</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectPremiumsWritten_66a551b6-55fe-4d47-abf1-1c9a38fc9016_terseLabel_en-US" xlink:label="lab_us-gaap_DirectPremiumsWritten" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_DirectPremiumsWritten_label_en-US" xlink:label="lab_us-gaap_DirectPremiumsWritten" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Premiums Written</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsWritten" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsWritten"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectPremiumsWritten" xlink:to="lab_us-gaap_DirectPremiumsWritten" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_0b7b4def-955f-4daa-8bed-c487d9837a8c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of fixed income securities &#8212; Trading</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_a1e72e62-2333-48ca-9686-ffb4a2339404_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables for securities sold</link:label>
    <link:label id="lab_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_label_en-US" xlink:label="lab_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable from Broker-Dealer and Clearing Organization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations" xlink:to="lab_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60c58ca1-13c4-4910-b825-764ab05491cd_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used in/from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_1b625eda-22bd-4396-9474-1c886832e579_negatedTerseLabel_en-US" xlink:label="lab_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (gain)/loss on real estate fund in net investment income</link:label>
    <link:label id="lab_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_label_en-US" xlink:label="lab_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (gain)/loss on real estate fund in net investment income</link:label>
    <link:label id="lab_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_documentation_en-US" xlink:label="lab_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (gain)/loss on real estate fund in net investment income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" xlink:href="ahl-20231220.xsd#ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" xlink:to="lab_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable_0f76904e-70d8-4e5f-a5a6-94c28668a9d2_negatedTerseLabel_en-US" xlink:label="lab_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other reinsurance balances recoverable</link:label>
    <link:label id="lab_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable_label_en-US" xlink:label="lab_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expense, Other Reconciling Item, Other Reinsurance Balances Recoverable</link:label>
    <link:label id="lab_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable_documentation_en-US" xlink:label="lab_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expense, Other Reconciling Item, Other Reinsurance Balances Recoverable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" xlink:href="ahl-20231220.xsd#ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" xlink:to="lab_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_ReinsuranceRecoverablesCollateralizedPercent_5ebe94eb-6e29-44fe-a860-00bec4eb9a28_terseLabel_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesCollateralizedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Collateralized</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesCollateralizedPercent_label_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesCollateralizedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Collateralized, percent</link:label>
    <link:label id="lab_ahl_ReinsuranceRecoverablesCollateralizedPercent_documentation_en-US" xlink:label="lab_ahl_ReinsuranceRecoverablesCollateralizedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Collateralized, percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesCollateralizedPercent" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesCollateralizedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_ReinsuranceRecoverablesCollateralizedPercent" xlink:to="lab_ahl_ReinsuranceRecoverablesCollateralizedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_091bfec8-1d77-4993-b33c-5843bb29c8e2_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_2bc4520c-7768-4b86-becb-bb7cc22c9006_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ahl_AspenBermudaMember_b862ea44-7202-4a4e-9dbb-8c7a87709cf5_terseLabel_en-US" xlink:label="lab_ahl_AspenBermudaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bermuda</link:label>
    <link:label id="lab_ahl_AspenBermudaMember_label_en-US" xlink:label="lab_ahl_AspenBermudaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Bermuda [Member]</link:label>
    <link:label id="lab_ahl_AspenBermudaMember_documentation_en-US" xlink:label="lab_ahl_AspenBermudaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Bermuda [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenBermudaMember" xlink:href="ahl-20231220.xsd#ahl_AspenBermudaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ahl_AspenBermudaMember" xlink:to="lab_ahl_AspenBermudaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_b25e0768-0414-44d4-939e-c6d36e2d62f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening undistributed value of investment, beginning balance</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_b1aad5aa-fb3f-42f7-ad81-2c31c08f39f1_periodEndLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing value of investment, ending balance</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_b8a83a29-050f-48de-9098-55b8927e24fc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, aggregate cost</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>45
<FILENAME>ahl-20231220_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:c8bdf706-6073-4046-a439-e42c560d7bb0,g:8520f5b6-a319-4843-ab2c-4a3e439c5aeb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.aspen.co/role/CoverPage" xlink:type="simple" xlink:href="ahl-20231220.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5fd969b1-0eb6-414e-8dfa-7925ebcc1428" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_09b52c07-8ca6-43ef-b9b3-47a784d0caf1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5fd969b1-0eb6-414e-8dfa-7925ebcc1428" xlink:to="loc_dei_DocumentType_09b52c07-8ca6-43ef-b9b3-47a784d0caf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a7bad3f0-8ef8-46f7-bb5b-fa3fafc5469e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5fd969b1-0eb6-414e-8dfa-7925ebcc1428" xlink:to="loc_dei_EntityRegistrantName_a7bad3f0-8ef8-46f7-bb5b-fa3fafc5469e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_72af4cbd-791f-4628-95b1-e20c338e1be1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5fd969b1-0eb6-414e-8dfa-7925ebcc1428" xlink:to="loc_dei_EntityEmergingGrowthCompany_72af4cbd-791f-4628-95b1-e20c338e1be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b2db217c-f6c4-483c-b6d2-c2593d83229b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5fd969b1-0eb6-414e-8dfa-7925ebcc1428" xlink:to="loc_dei_AmendmentFlag_b2db217c-f6c4-483c-b6d2-c2593d83229b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f21aa609-3af6-4f89-abe1-4b7c2a1f20d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5fd969b1-0eb6-414e-8dfa-7925ebcc1428" xlink:to="loc_dei_EntityCentralIndexKey_f21aa609-3af6-4f89-abe1-4b7c2a1f20d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_88b4af01-c206-43c9-a142-6fd457c32276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_88b4af01-c206-43c9-a142-6fd457c32276" xlink:to="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4c19a58d-f20d-4f89-aac9-30ffd42a6511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_InvestmentTypeAxis_4c19a58d-f20d-4f89-aac9-30ffd42a6511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_579beea5-1274-4b10-b276-741bcc319bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_4c19a58d-f20d-4f89-aac9-30ffd42a6511" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_579beea5-1274-4b10-b276-741bcc319bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_2d5e1ca3-ed91-4b01-9c81-e40f39e89b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_579beea5-1274-4b10-b276-741bcc319bde" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_2d5e1ca3-ed91-4b01-9c81-e40f39e89b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_9a5f8bdc-8a0f-4406-8e3b-74670bec5bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_579beea5-1274-4b10-b276-741bcc319bde" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_9a5f8bdc-8a0f-4406-8e3b-74670bec5bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b96ca9bf-4c23-46ee-9911-2eec17c11d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b96ca9bf-4c23-46ee-9911-2eec17c11d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d049dc7f-ac45-4ee6-8a2b-913be1bd5e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b96ca9bf-4c23-46ee-9911-2eec17c11d45" xlink:to="loc_us-gaap_RelatedPartyDomain_d049dc7f-ac45-4ee6-8a2b-913be1bd5e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_7d4b535b-f446-42ad-9409-4e7709776fb1" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d049dc7f-ac45-4ee6-8a2b-913be1bd5e89" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_7d4b535b-f446-42ad-9409-4e7709776fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_eec95944-b7fc-4447-bb9f-c0a6261105cf" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d049dc7f-ac45-4ee6-8a2b-913be1bd5e89" xlink:to="loc_ahl_ApolloRealEstateFundMember_eec95944-b7fc-4447-bb9f-c0a6261105cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_384eb52a-3de4-4504-ac77-15b500355ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4ed3bdb4-ca50-4484-8fdc-9bf117906fa1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_384eb52a-3de4-4504-ac77-15b500355ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember_d6d8e1ae-d0d9-4976-bf7e-ce746a20a48b" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_384eb52a-3de4-4504-ac77-15b500355ce0" xlink:to="loc_ahl_AccruedExpensesMember_d6d8e1ae-d0d9-4976-bf7e-ce746a20a48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_85ab917a-e088-45ab-aea4-31db6f11d506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_85ab917a-e088-45ab-aea4-31db6f11d506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_24d465d1-d7d1-437f-b58a-cdaa9c1376ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85ab917a-e088-45ab-aea4-31db6f11d506" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_24d465d1-d7d1-437f-b58a-cdaa9c1376ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_5a710ee7-a258-4e51-b14b-70be9a7acdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_24d465d1-d7d1-437f-b58a-cdaa9c1376ae" xlink:to="loc_us-gaap_AssetManagementArrangementMember_5a710ee7-a258-4e51-b14b-70be9a7acdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_72703b70-dc2f-4e99-a6b5-bece651387c1" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_24d465d1-d7d1-437f-b58a-cdaa9c1376ae" xlink:to="loc_ahl_ManagementConsultingAgreementMember_72703b70-dc2f-4e99-a6b5-bece651387c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5ee63684-e6d3-412e-b241-e0c17ee4011b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5ee63684-e6d3-412e-b241-e0c17ee4011b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0a8af491-9ca9-423e-97eb-01e29eba861c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5ee63684-e6d3-412e-b241-e0c17ee4011b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0a8af491-9ca9-423e-97eb-01e29eba861c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_84146e8b-69bf-4b1b-8fb4-c4a1fae00421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0a8af491-9ca9-423e-97eb-01e29eba861c" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_84146e8b-69bf-4b1b-8fb4-c4a1fae00421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a911e51-75e4-4400-9d64-157985947ca5" xlink:to="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8053a56a-fd5b-40d8-9e86-7c749021e878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8053a56a-fd5b-40d8-9e86-7c749021e878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_d0335a64-4ff8-46f1-a8a0-29ae497cc65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_us-gaap_TradingSecuritiesDebt_d0335a64-4ff8-46f1-a8a0-29ae497cc65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsAvailableForSale_5e1a617f-f004-43ff-8310-4c934e4fccaa" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsAvailableForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_ShortTermInvestmentsAvailableForSale_5e1a617f-f004-43ff-8310-4c934e4fccaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValue_384ed158-6380-4cf8-9db2-4133a53dce47" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValue_384ed158-6380-4cf8-9db2-4133a53dce47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_043c16de-616d-4d5b-af19-4fea1dcb8ef6" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_CatastropheBond_043c16de-616d-4d5b-af19-4fea1dcb8ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_2d1a6c34-8d61-4a9c-9dc4-6cb85c635d89" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_PrivatelyheldInvestments_2d1a6c34-8d61-4a9c-9dc4-6cb85c635d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_6dee1330-0e63-44f2-927b-187627c55a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_us-gaap_EquityMethodInvestments_6dee1330-0e63-44f2-927b-187627c55a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_020834c8-9952-4164-adf3-f8876361f40f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_us-gaap_OtherInvestments_020834c8-9952-4164-adf3-f8876361f40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentsExcludingDerivativeAssets_efb29daa-c29e-4865-8462-ec4c8be4dc02" xlink:href="ahl-20231220.xsd#ahl_InvestmentsExcludingDerivativeAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_396e83b6-68aa-49c6-889f-b4fdf6baa717" xlink:to="loc_ahl_InvestmentsExcludingDerivativeAssets_efb29daa-c29e-4865-8462-ec4c8be4dc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0ba41b1e-aaf3-4768-acb2-96ac48de2c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0ba41b1e-aaf3-4768-acb2-96ac48de2c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_4739aa93-8ccc-41b4-b5f0-d5eb5dbcb1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_4739aa93-8ccc-41b4-b5f0-d5eb5dbcb1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_d5ea8867-b79d-400a-bc9a-3e8ab4302e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_4739aa93-8ccc-41b4-b5f0-d5eb5dbcb1f7" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_d5ea8867-b79d-400a-bc9a-3e8ab4302e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums_bd7b4f38-a867-47ec-a670-fa460ff1316c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_4739aa93-8ccc-41b4-b5f0-d5eb5dbcb1f7" xlink:to="loc_us-gaap_PrepaidReinsurancePremiums_bd7b4f38-a867-47ec-a670-fa460ff1316c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_ac3779ea-a611-4ac7-8554-70039b69d199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_ReceivablesAbstract_ac3779ea-a611-4ac7-8554-70039b69d199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_63d3962f-329b-4274-b422-9df4c0d2e670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_ac3779ea-a611-4ac7-8554-70039b69d199" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_63d3962f-329b-4274-b422-9df4c0d2e670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_1151ac75-7bff-44f5-a036-fc67632bd38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_ac3779ea-a611-4ac7-8554-70039b69d199" xlink:to="loc_us-gaap_OtherReceivables_1151ac75-7bff-44f5-a036-fc67632bd38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_d3779c3d-f1dc-4cd1-931b-e549cb063e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldUnderReinsuranceAgreementsAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_d3779c3d-f1dc-4cd1-931b-e549cb063e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_2c7b31e7-2456-4941-a387-1fe0688e0de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_2c7b31e7-2456-4941-a387-1fe0688e0de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_3089f0aa-e68c-4717-9be9-9bca963c3907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_DerivativeAssets_3089f0aa-e68c-4717-9be9-9bca963c3907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_606f9cc6-7ec3-4243-92e3-500019c7c502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_606f9cc6-7ec3-4243-92e3-500019c7c502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5d4540ae-47f6-4cdf-9577-b2a1736b2140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5d4540ae-47f6-4cdf-9577-b2a1736b2140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_53acb7b0-37ed-435e-8463-30554e3da97b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_53acb7b0-37ed-435e-8463-30554e3da97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_3038a8c7-21af-4bb4-9d9d-6765d506780a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_IncomeTaxReceivable_3038a8c7-21af-4bb4-9d9d-6765d506780a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_373f0be7-0eb9-4600-9c34-d3bc78f802db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_373f0be7-0eb9-4600-9c34-d3bc78f802db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_af1c06b1-064f-4473-a8b3-40e467bf340f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_OtherAssets_af1c06b1-064f-4473-a8b3-40e467bf340f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_eed20739-a6d7-41ba-92a9-d52b9d5ef738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_eed20739-a6d7-41ba-92a9-d52b9d5ef738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_37b16828-0955-4c81-94ff-ff53d1b1a949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1c0489d1-b13b-46a9-8927-732d4faf8cd2" xlink:to="loc_us-gaap_Assets_37b16828-0955-4c81-94ff-ff53d1b1a949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserveAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:to="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b1a1310e-5e0a-49ee-b5cc-03d68a04bef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b1a1310e-5e0a-49ee-b5cc-03d68a04bef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_231330c4-3e6b-4be4-a1c6-8d4674aa2125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:to="loc_us-gaap_UnearnedPremiums_231330c4-3e6b-4be4-a1c6-8d4674aa2125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserves_4c55fec3-a756-44f4-ac32-c2d68d750966" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_InsuranceReserveAbstract_4c65a99f-511c-4b1d-a81b-41f397ede811" xlink:to="loc_ahl_InsuranceReserves_4c55fec3-a756-44f4-ac32-c2d68d750966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePayable_91c4b36a-6af2-4a18-9f8a-9a6a2b26e9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:to="loc_us-gaap_ReinsurancePayable_91c4b36a-6af2-4a18-9f8a-9a6a2b26e9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_4ca094d7-00d8-4480-85fb-3f498abd5df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_4ca094d7-00d8-4480-85fb-3f498abd5df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b88e1ac0-3f8a-4e5e-9b6e-aed4506ca38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b88e1ac0-3f8a-4e5e-9b6e-aed4506ca38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_0b18f1c4-a25b-482c-88f1-abebb1932834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_0b18f1c4-a25b-482c-88f1-abebb1932834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_a98a70bd-ea1d-4c12-a649-0675872dedda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_a98a70bd-ea1d-4c12-a649-0675872dedda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_09c3bed5-c04b-4070-a197-0e8ba8a79d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_OperatingLeaseLiability_09c3bed5-c04b-4070-a197-0e8ba8a79d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_77e5d146-0399-417f-81d4-045b023a4447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_DerivativeLiabilities_77e5d146-0399-417f-81d4-045b023a4447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_c1432923-8f07-4012-a24a-b2a30b4df83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_ShortTermBorrowings_c1432923-8f07-4012-a24a-b2a30b4df83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_37ba1e66-8cfd-4c30-b045-2bfdcbce2183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f93fd775-da00-4300-8774-cd897e244e54" xlink:to="loc_us-gaap_LongTermDebt_37ba1e66-8cfd-4c30-b045-2bfdcbce2183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5d2436eb-f646-4647-bc36-69f0cb91cd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c0501f14-d0ed-48e7-879a-c2a9243a2313" xlink:to="loc_us-gaap_Liabilities_5d2436eb-f646-4647-bc36-69f0cb91cd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7056acee-99e5-4893-a2e4-f30ed04b8276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7056acee-99e5-4893-a2e4-f30ed04b8276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6fdf1e4b-9067-43cd-b17c-a983359e3ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6fdf1e4b-9067-43cd-b17c-a983359e3ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b63ec093-16fc-45a6-816d-70cd00088299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6fdf1e4b-9067-43cd-b17c-a983359e3ad1" xlink:to="loc_us-gaap_CommonStockValue_b63ec093-16fc-45a6-816d-70cd00088299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b5f58106-fbf5-4d8c-ab8e-8fd0263f839c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b5f58106-fbf5-4d8c-ab8e-8fd0263f839c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3f691b45-64b2-4acf-ac48-80e4a2213d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3f691b45-64b2-4acf-ac48-80e4a2213d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1d7814f3-0abc-4cd2-80c2-5883ee1f777b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1d7814f3-0abc-4cd2-80c2-5883ee1f777b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d744b68e-e59a-4bfb-bb68-4a4489116e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_98891b35-5928-480f-bc56-6f78862340eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d744b68e-e59a-4bfb-bb68-4a4489116e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_787a5780-37df-4c9c-a2b6-3a33b8ee9393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1c63ffbe-75c1-47cc-a547-483dca348eac" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_787a5780-37df-4c9c-a2b6-3a33b8ee9393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_19fbd143-8161-41eb-9014-cd5c5b1c2d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_19fbd143-8161-41eb-9014-cd5c5b1c2d95" xlink:to="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_da2cada9-6d38-4958-9486-6c562ffb1a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_InvestmentTypeAxis_da2cada9-6d38-4958-9486-6c562ffb1a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_da2cada9-6d38-4958-9486-6c562ffb1a98" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_e620623e-cb55-4916-9503-7088d51d1dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:to="loc_us-gaap_FixedMaturitiesMember_e620623e-cb55-4916-9503-7088d51d1dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_dd94de4c-1e27-46c7-9509-61562b73acf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_dd94de4c-1e27-46c7-9509-61562b73acf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_53d6900d-16b1-4741-9e9a-21ec8979a4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be9dd5b8-adba-4022-9857-8b11c7e75774" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_53d6900d-16b1-4741-9e9a-21ec8979a4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5da92468-cd6c-479e-b3ac-997c6eb69158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5da92468-cd6c-479e-b3ac-997c6eb69158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5da92468-cd6c-479e-b3ac-997c6eb69158" xlink:to="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_48bf2249-be65-4ce2-bbcc-301e4d702fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_48bf2249-be65-4ce2-bbcc-301e4d702fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_3029ec44-a0a3-48d4-b7a6-ca097926dea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_3029ec44-a0a3-48d4-b7a6-ca097926dea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_61815265-6680-465e-8c44-3ce40f452712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_77e39819-bccc-42d8-b5a0-f4da563278c0" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_61815265-6680-465e-8c44-3ce40f452712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b52c834b-d51a-426c-a807-201c2c132630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b52c834b-d51a-426c-a807-201c2c132630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_28c889aa-4689-4ce2-8e9a-d28e43ce7218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b52c834b-d51a-426c-a807-201c2c132630" xlink:to="loc_us-gaap_RelatedPartyDomain_28c889aa-4689-4ce2-8e9a-d28e43ce7218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_f50e39f1-d835-45b9-9770-4e7c229cd6d3" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_28c889aa-4689-4ce2-8e9a-d28e43ce7218" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_f50e39f1-d835-45b9-9770-4e7c229cd6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_77f9f3cc-3691-46a0-ac65-dfdbc54cf281" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_28c889aa-4689-4ce2-8e9a-d28e43ce7218" xlink:to="loc_ahl_ApolloRealEstateFundMember_77f9f3cc-3691-46a0-ac65-dfdbc54cf281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968e1b82-ee91-48bc-bae6-a156695cd97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968e1b82-ee91-48bc-bae6-a156695cd97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_54990d62-7ed0-47bb-a23f-0c91ca306df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968e1b82-ee91-48bc-bae6-a156695cd97f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_54990d62-7ed0-47bb-a23f-0c91ca306df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ea741f47-f85c-4ec6-922d-d33fb9869bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_54990d62-7ed0-47bb-a23f-0c91ca306df2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ea741f47-f85c-4ec6-922d-d33fb9869bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d3e7091d-ee4f-4b28-b601-3da831d0de66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3a5a160-62fa-4c59-ad9d-6ae1a740ec04" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d3e7091d-ee4f-4b28-b601-3da831d0de66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember_d2533c76-8ae3-48ee-a664-c2008660f262" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d3e7091d-ee4f-4b28-b601-3da831d0de66" xlink:to="loc_ahl_AccruedExpensesMember_d2533c76-8ae3-48ee-a664-c2008660f262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_85ae6f95-95a2-4cff-a794-bd8d16c7847b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_85ae6f95-95a2-4cff-a794-bd8d16c7847b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d96676a8-10ab-4424-a390-376487e00dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85ae6f95-95a2-4cff-a794-bd8d16c7847b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d96676a8-10ab-4424-a390-376487e00dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_d83f10d6-b2fc-4820-b273-3ebfbc200274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d96676a8-10ab-4424-a390-376487e00dd3" xlink:to="loc_us-gaap_AssetManagementArrangementMember_d83f10d6-b2fc-4820-b273-3ebfbc200274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_66c8a51c-6fc3-4815-bd22-ee9a3f79bea0" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d96676a8-10ab-4424-a390-376487e00dd3" xlink:to="loc_ahl_ManagementConsultingAgreementMember_66c8a51c-6fc3-4815-bd22-ee9a3f79bea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0bab4e82-d415-4d1a-938e-92187f00adfe" xlink:to="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a06263c-9768-4a96-9419-31651170eea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a06263c-9768-4a96-9419-31651170eea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_4d508b63-a4af-43c8-a74a-8a13327efb28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_4d508b63-a4af-43c8-a74a-8a13327efb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_1066d29e-357b-48f3-9cea-99f9d5c8638d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_1066d29e-357b-48f3-9cea-99f9d5c8638d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost_ecff2017-606b-46cf-9940-eaeebdce36a0" xlink:href="ahl-20231220.xsd#ahl_Shortterminvestmentsavailableforsaleamortizedcost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost_ecff2017-606b-46cf-9940-eaeebdce36a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAmortizedCost_974e074e-61fd-45b5-bc6b-6086c2377ba4" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_ShortTermInvestmentsTradingAmortizedCost_974e074e-61fd-45b5-bc6b-6086c2377ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure_026024bf-609c-43ca-a48e-4e86c90b830d" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_CatastropheBondsFairValueDisclosure_026024bf-609c-43ca-a48e-4e86c90b830d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_667d5df0-65d4-47b2-b689-c10d55b70226" xlink:href="ahl-20231220.xsd#ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_667d5df0-65d4-47b2-b689-c10d55b70226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_b665b727-c9d7-4a7d-acc9-f0453cf55517" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_b665b727-c9d7-4a7d-acc9-f0453cf55517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_ec762f6e-61f5-4e93-9281-aa6687280b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_ec762f6e-61f5-4e93-9281-aa6687280b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_36054677-6cd1-4f06-b0fc-1944520462b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_CommonStockSharesIssued_36054677-6cd1-4f06-b0fc-1944520462b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c77e9300-40b6-41cb-bfc0-c8b1660d2747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c77e9300-40b6-41cb-bfc0-c8b1660d2747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_59381745-6492-4cbb-948b-008a4a6998b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_59381745-6492-4cbb-948b-008a4a6998b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_82942705-163a-4501-8597-7ef34021ec25" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludesRestrictedCash"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_82942705-163a-4501-8597-7ef34021ec25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_79b3f756-9f5d-4bf7-a7ec-f7110e90b0ce" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_ahl_PrivatelyheldInvestments_79b3f756-9f5d-4bf7-a7ec-f7110e90b0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_a9108e3e-5fcb-4c3f-96fb-2827b47885ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_OtherInvestments_a9108e3e-5fcb-4c3f-96fb-2827b47885ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_176dc8bd-ecf4-4283-ab20-3d063c8c95c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e4e1be6-1a3f-4226-919c-44375c4e25b5" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_176dc8bd-ecf4-4283-ab20-3d063c8c95c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4086e2ce-823c-4e6e-9040-8885faf31020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4086e2ce-823c-4e6e-9040-8885faf31020" xlink:to="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:to="loc_srt_ProductOrServiceAxis_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_830c11fa-ad8d-4f4b-96d0-cf46f7cf3917" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e4e5d929-62eb-446d-a1c6-e8aa1d53e20b" xlink:to="loc_srt_ProductsAndServicesDomain_830c11fa-ad8d-4f4b-96d0-cf46f7cf3917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretySegmentMember_13a8688a-adb6-4421-a200-e5d7efcc990f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretySegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_830c11fa-ad8d-4f4b-96d0-cf46f7cf3917" xlink:to="loc_us-gaap_SuretySegmentMember_13a8688a-adb6-4421-a200-e5d7efcc990f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_5185166d-fad1-4830-8f09-a87c9a2e97d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_5185166d-fad1-4830-8f09-a87c9a2e97d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5185166d-fad1-4830-8f09-a87c9a2e97d5" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_d4f99997-6fb2-495f-9794-01ea5fc96e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_us-gaap_RealEstateFundsMember_d4f99997-6fb2-495f-9794-01ea5fc96e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_dfd216b7-aab6-49d4-b572-65e6aa63c7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_us-gaap_AssetManagementArrangementMember_dfd216b7-aab6-49d4-b572-65e6aa63c7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_dca1b3ea-728d-4a5f-8075-4089e1d6cd64" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_ahl_ManagementConsultingAgreementMember_dca1b3ea-728d-4a5f-8075-4089e1d6cd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyInvestmentIncomeMember_3585aa6b-8d97-465c-bd24-603b08b8ba78" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyInvestmentIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_ahl_RelatedPartyInvestmentIncomeMember_3585aa6b-8d97-465c-bd24-603b08b8ba78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember_84eda0a6-3c55-40fa-906c-7ffe478bd628" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_dc0cd81b-9a60-490d-9663-7e074a471f52" xlink:to="loc_ahl_ClassABNotesMember_84eda0a6-3c55-40fa-906c-7ffe478bd628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9dc0422f-d777-4fbe-9db1-99ff4e8db50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9dc0422f-d777-4fbe-9db1-99ff4e8db50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9dc0422f-d777-4fbe-9db1-99ff4e8db50e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_fdbff9b9-9129-4732-9db2-e8d6d67297d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:to="loc_us-gaap_InvestmentIncomeMember_fdbff9b9-9129-4732-9db2-e8d6d67297d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5d435f59-693d-44a1-9528-b267c94b7aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5d435f59-693d-44a1-9528-b267c94b7aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1_1dbf4085-7393-4f42-8e1d-58944ac22c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_443b0724-f46a-4810-a6fc-c6166dd03da7" xlink:to="loc_us-gaap_GainLossOnInvestmentsMember1_1dbf4085-7393-4f42-8e1d-58944ac22c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ffe143fb-0eec-4d6e-8c6a-e8587eb09f79" xlink:to="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_4f4799b3-203e-42eb-a3d8-49c8644ad352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_PremiumsEarnedNet_4f4799b3-203e-42eb-a3d8-49c8644ad352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_e174ec02-d05c-4d14-9a43-e29cea606879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_NetInvestmentIncome_e174ec02-d05c-4d14-9a43-e29cea606879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_5215d361-c4b9-443a-bd9a-805c003ce869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_GainLossOnInvestments_5215d361-c4b9-443a-bd9a-805c003ce869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_c89726bc-2979-4862-ab54-dc803a9d7b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_OtherIncome_c89726bc-2979-4862-ab54-dc803a9d7b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_927ddcd4-ca8e-4443-b648-976177cdf829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6e778e9c-ad9c-4fa1-acbc-c34c5a3e9933" xlink:to="loc_us-gaap_Revenues_927ddcd4-ca8e-4443-b648-976177cdf829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_c250a9d1-cf61-4ccf-9867-2acb67c3a4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_c250a9d1-cf61-4ccf-9867-2acb67c3a4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_cad39391-8247-46dc-a771-f448b2d856d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_cad39391-8247-46dc-a771-f448b2d856d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5530d754-efde-4098-8459-e380d4d82301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5530d754-efde-4098-8459-e380d4d82301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_204789be-80ad-4206-9ec1-e2054932b0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_InterestExpenseDebt_204789be-80ad-4206-9ec1-e2054932b0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6bd46709-aac8-4cba-8276-a83cdc520cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6bd46709-aac8-4cba-8276-a83cdc520cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_9b68c2e2-47d2-435e-8c6f-245435359ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_9b68c2e2-47d2-435e-8c6f-245435359ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_956df62b-99f5-47e9-89b1-3de4094fd32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_956df62b-99f5-47e9-89b1-3de4094fd32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_e2f6dc6e-b224-4d06-ab56-13c8077ac75a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_us-gaap_OtherExpenses_e2f6dc6e-b224-4d06-ab56-13c8077ac75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Expense_88c2f8c0-40dd-4edb-90bc-32442a4cfbec" xlink:href="ahl-20231220.xsd#ahl_Expense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc4ee6d8-ddac-4d55-aa7c-07d685a100cb" xlink:to="loc_ahl_Expense_88c2f8c0-40dd-4edb-90bc-32442a4cfbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0909d318-fbac-4f1f-949e-91bdffbdff7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0909d318-fbac-4f1f-949e-91bdffbdff7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cc35d6cc-ad69-45ad-bcc9-b14eed881c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cc35d6cc-ad69-45ad-bcc9-b14eed881c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2db32bc6-43cb-458a-a9ef-787a0bbdf3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_ProfitLoss_2db32bc6-43cb-458a-a9ef-787a0bbdf3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7814a5e4-9dcd-446b-9e01-fe0b9212cf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_NetIncomeLoss_7814a5e4-9dcd-446b-9e01-fe0b9212cf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_910c3b9e-1caa-49d9-83fe-82d269117d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_910c3b9e-1caa-49d9-83fe-82d269117d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_e65634d1-c392-4914-aaef-2e65581a00db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_e65634d1-c392-4914-aaef-2e65581a00db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_926cd34e-aa4f-42e3-8d05-2f6ac07880db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_926cd34e-aa4f-42e3-8d05-2f6ac07880db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_9137911c-db72-4914-a78f-1a051a1ccd66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_9137911c-db72-4914-a78f-1a051a1ccd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e868cd55-88a7-4e65-bf4d-f0f52f83d0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_ede7edc7-1dfa-4610-8345-998f587436dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e868cd55-88a7-4e65-bf4d-f0f52f83d0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_64dcbb81-4bc6-4cc1-a813-5b60b675fd81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_64dcbb81-4bc6-4cc1-a813-5b60b675fd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_f3501a16-1e22-47be-8999-be66335c8aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_64dcbb81-4bc6-4cc1-a813-5b60b675fd81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_f3501a16-1e22-47be-8999-be66335c8aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_32e9180a-86c6-47f9-82cc-5473ea308349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_64dcbb81-4bc6-4cc1-a813-5b60b675fd81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_32e9180a-86c6-47f9-82cc-5473ea308349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_48f73243-d851-4b7f-b56f-49d2b267d61e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a824faa2-cfba-4fff-ba3f-e99872f60c04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_48f73243-d851-4b7f-b56f-49d2b267d61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_89c83b46-12b7-46f9-94d2-71142df000c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_89c83b46-12b7-46f9-94d2-71142df000c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_d8b5610f-306c-4f3b-86cc-3c464a107b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7728764f-5ab2-49aa-849b-ba7f452dcb06" xlink:to="loc_us-gaap_DueToAffiliateCurrent_d8b5610f-306c-4f3b-86cc-3c464a107b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_cd3e452f-ca2b-48c9-a926-b251d1a6cd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_cd3e452f-ca2b-48c9-a926-b251d1a6cd29" xlink:to="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d18377d8-b34b-4319-812a-393a9a911045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d18377d8-b34b-4319-812a-393a9a911045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7f7e3bee-9893-407e-a1cb-5562c826db05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d18377d8-b34b-4319-812a-393a9a911045" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7f7e3bee-9893-407e-a1cb-5562c826db05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_504d6546-b3ae-4336-8bc0-18728fcefed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_7f7e3bee-9893-407e-a1cb-5562c826db05" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_504d6546-b3ae-4336-8bc0-18728fcefed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_43b0305f-da44-4729-aee1-1143dbdca533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_43b0305f-da44-4729-aee1-1143dbdca533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_43b0305f-da44-4729-aee1-1143dbdca533" xlink:to="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bf7246c7-9e0c-465e-8fa2-fe9830c1bc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_CommonStockMember_bf7246c7-9e0c-465e-8fa2-fe9830c1bc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_f7d94d15-c632-4f05-941d-403401961aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_PreferredStockMember_f7d94d15-c632-4f05-941d-403401961aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_feb1f364-d328-4d14-bb18-44730067857d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_feb1f364-d328-4d14-bb18-44730067857d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ec720e68-e771-414f-ad56-754224998b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_RetainedEarningsMember_ec720e68-e771-414f-ad56-754224998b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3c0f95cc-55c5-433a-a2eb-ad9f8d29c9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3c0f95cc-55c5-433a-a2eb-ad9f8d29c9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c7e1aec1-998c-4c84-bfb4-fd6a05d14bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c7e1aec1-998c-4c84-bfb4-fd6a05d14bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1d8606a2-fed9-4bd8-b5b0-ac56a6d382c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f772d1bd-7f5e-460b-aef7-538b20eeee1a" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1d8606a2-fed9-4bd8-b5b0-ac56a6d382c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b67d2989-6941-4446-aa60-a7401bbad4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b67d2989-6941-4446-aa60-a7401bbad4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_226a67a9-6a41-48f2-be0a-128981f02b94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b67d2989-6941-4446-aa60-a7401bbad4e0" xlink:to="loc_us-gaap_ClassOfStockDomain_226a67a9-6a41-48f2-be0a-128981f02b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5a2cbc5d-9617-48ec-9064-58e683d2038d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_226a67a9-6a41-48f2-be0a-128981f02b94" xlink:to="loc_us-gaap_CommonStockMember_5a2cbc5d-9617-48ec-9064-58e683d2038d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_dd7a167b-48e0-4da6-b0aa-6ea5c1dc2232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_226a67a9-6a41-48f2-be0a-128981f02b94" xlink:to="loc_us-gaap_PreferredStockMember_dd7a167b-48e0-4da6-b0aa-6ea5c1dc2232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1eac0bb8-bee8-4f99-96ba-b2b2f572c290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d44df31e-4f4c-4cb9-abe4-3c7bf6a1dd95" xlink:to="loc_us-gaap_StatementLineItems_1eac0bb8-bee8-4f99-96ba-b2b2f572c290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1eac0bb8-bee8-4f99-96ba-b2b2f572c290" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_79cb888b-ef93-489a-acf0-28271a86ed93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_79cb888b-ef93-489a-acf0-28271a86ed93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_4bcafb08-c330-46e2-b159-39499328afc8" xlink:href="ahl-20231220.xsd#ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_4bcafb08-c330-46e2-b159-39499328afc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_851a8978-f089-47f9-b010-645ad1c017a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_ProfitLoss_851a8978-f089-47f9-b010-645ad1c017a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_b7985208-8af3-407e-b86f-15134f6bdc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_Dividends_b7985208-8af3-407e-b86f-15134f6bdc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_05208fb4-508b-4a1e-a3d3-754680eb2b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_05208fb4-508b-4a1e-a3d3-754680eb2b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_a6c11355-e97d-4e9d-89fa-96f608aa3c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_a6c11355-e97d-4e9d-89fa-96f608aa3c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_afdbe849-beee-4ed7-9e6d-0ad8d61c96ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_11447c74-2a45-4f67-a301-ad393ef09329" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_afdbe849-beee-4ed7-9e6d-0ad8d61c96ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_534fa46d-c2d5-42de-8531-e7084b66be31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_534fa46d-c2d5-42de-8531-e7084b66be31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_cc286994-3012-4452-bc93-ada183b6fe29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_534fa46d-c2d5-42de-8531-e7084b66be31" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_cc286994-3012-4452-bc93-ada183b6fe29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_534fa46d-c2d5-42de-8531-e7084b66be31" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_e0694057-a694-4c9d-a30c-674df7036f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_e0694057-a694-4c9d-a30c-674df7036f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_cfbc62c8-fec0-4381-ae56-cd3fb225eb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_cfbc62c8-fec0-4381-ae56-cd3fb225eb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39fd8ea9-d896-4438-ba6a-b76f539f2d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39fd8ea9-d896-4438-ba6a-b76f539f2d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Interestonoperatingleaseliabilities_bcdda587-654a-4237-9a43-b58b97b277e8" xlink:href="ahl-20231220.xsd#ahl_Interestonoperatingleaseliabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_ahl_Interestonoperatingleaseliabilities_bcdda587-654a-4237-9a43-b58b97b277e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_0d7f649b-1160-4862-b09e-fac83e6fe2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_GainLossOnInvestments_0d7f649b-1160-4862-b09e-fac83e6fe2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_bc858f83-4d75-4e72-93c6-c3008a8aa374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_bc858f83-4d75-4e72-93c6-c3008a8aa374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a303f3dc-5e1f-4d8a-b369-f77dd5067d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a303f3dc-5e1f-4d8a-b369-f77dd5067d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GainsLossesOnInvestmentAndForeignExchange_3c163bed-d221-46df-be7d-7f967d3d98b3" xlink:href="ahl-20231220.xsd#ahl_GainsLossesOnInvestmentAndForeignExchange"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_ahl_GainsLossesOnInvestmentAndForeignExchange_3c163bed-d221-46df-be7d-7f967d3d98b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_729ec795-a114-4279-8447-a444aab16819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_729ec795-a114-4279-8447-a444aab16819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_5704687b-86ab-4218-877b-cc606d8c1d6d" xlink:href="ahl-20231220.xsd#ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_5704687b-86ab-4218-877b-cc606d8c1d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d4052c9-ca44-4150-b200-39c870bc13d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d4052c9-ca44-4150-b200-39c870bc13d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_bd5134a1-20d2-4169-8703-0c0b6839e1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d4052c9-ca44-4150-b200-39c870bc13d0" xlink:to="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_bd5134a1-20d2-4169-8703-0c0b6839e1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_e01eadb6-5048-4951-8779-e0d3022f9cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d4052c9-ca44-4150-b200-39c870bc13d0" xlink:to="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_e01eadb6-5048-4951-8779-e0d3022f9cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract_25190e22-fecf-464f-952e-8d1eeb357e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract_25190e22-fecf-464f-952e-8d1eeb357e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnpaidLosses_b56a92f1-f679-4c6e-80c2-c8b12e68b9cd" xlink:href="ahl-20231220.xsd#ahl_UnpaidLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract_25190e22-fecf-464f-952e-8d1eeb357e8c" xlink:to="loc_ahl_UnpaidLosses_b56a92f1-f679-4c6e-80c2-c8b12e68b9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_c4893d94-e0ff-4519-ad66-17688e1a5725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract_25190e22-fecf-464f-952e-8d1eeb357e8c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_c4893d94-e0ff-4519-ad66-17688e1a5725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_6acbab9c-d2c3-435b-bb59-041e7525827e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_6acbab9c-d2c3-435b-bb59-041e7525827e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_7fd64017-5baf-4ad3-b309-4cbb6513e217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_7fd64017-5baf-4ad3-b309-4cbb6513e217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReinsurancePayables_ca9bd6d0-c609-4661-b063-933b2b78ad09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReinsurancePayables"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInReinsurancePayables_ca9bd6d0-c609-4661-b063-933b2b78ad09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_dd6fd6ea-7d5a-4a0b-9cff-f452a15b9c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_dd6fd6ea-7d5a-4a0b-9cff-f452a15b9c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_0f80d6fd-3312-4a8b-8dae-3c28cfd32bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_0f80d6fd-3312-4a8b-8dae-3c28cfd32bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_346b2cc9-1783-4129-9071-b6a39edde201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_346b2cc9-1783-4129-9071-b6a39edde201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f879b466-5ca3-4ca9-b531-8893796a5c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f879b466-5ca3-4ca9-b531-8893796a5c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_3c810de1-6909-45b7-83f7-be53ddeef379" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_3c810de1-6909-45b7-83f7-be53ddeef379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncreaseDecreaseInLongTermDebt_51dca9fa-8043-43df-a7f0-6fe82603786f" xlink:href="ahl-20231220.xsd#ahl_IncreaseDecreaseInLongTermDebt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_ahl_IncreaseDecreaseInLongTermDebt_51dca9fa-8043-43df-a7f0-6fe82603786f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_47a15e99-2d46-4c71-83f8-96996656c41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_OperatingLeasePayments_47a15e99-2d46-4c71-83f8-96996656c41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5117f491-738e-47a2-bc6e-b113271444b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33207609-ab5b-4fce-ab31-7a64b5835191" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5117f491-738e-47a2-bc6e-b113271444b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e4358b3-c2ab-4f5b-825f-d97df524d0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_534fa46d-c2d5-42de-8531-e7084b66be31" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e4358b3-c2ab-4f5b-825f-d97df524d0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1b779112-344b-429d-a084-b3b6428e739a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1b779112-344b-429d-a084-b3b6428e739a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_3a159d58-e7f7-4eec-8c13-fc7fa4d60db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_3a159d58-e7f7-4eec-8c13-fc7fa4d60db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9165aa3e-aa1c-4b36-8a32-70dd4aa593d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9165aa3e-aa1c-4b36-8a32-70dd4aa593d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_e97d9a35-9f1c-49f8-bc65-b050fd454dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_e97d9a35-9f1c-49f8-bc65-b050fd454dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PurchasesOfProceedsFromCatastropheBonds_d1ae54cf-48b4-4abc-97d2-f0af92079e65" xlink:href="ahl-20231220.xsd#ahl_PurchasesOfProceedsFromCatastropheBonds"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_PurchasesOfProceedsFromCatastropheBonds_d1ae54cf-48b4-4abc-97d2-f0af92079e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_2679fdde-e24c-407c-9697-6d0ed68ed5d7" xlink:href="ahl-20231220.xsd#ahl_PaymentsforAvailableforsaleSecuritiesShortterm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_2679fdde-e24c-407c-9697-6d0ed68ed5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_873aa455-3b53-4419-9809-5418f64481ce" xlink:href="ahl-20231220.xsd#ahl_ProceedsfromAvailableforsaleSecuritiesShortterm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_873aa455-3b53-4419-9809-5418f64481ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_83c6b279-4fcc-4d6c-bbf1-688521d3d7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_83c6b279-4fcc-4d6c-bbf1-688521d3d7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_a58060fb-efbf-4e9d-8bf1-503b04dbec04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_a58060fb-efbf-4e9d-8bf1-503b04dbec04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_b1fb87fb-f95c-4499-a7a0-0e2f98f3b6bc" xlink:href="ahl-20231220.xsd#ahl_PaymentstoAcquirePrivatelyheldInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_b1fb87fb-f95c-4499-a7a0-0e2f98f3b6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ProceedsfromSaleofPrivatelyheldInvestments_09280588-5116-4c2c-b1df-0fd0a742e7c0" xlink:href="ahl-20231220.xsd#ahl_ProceedsfromSaleofPrivatelyheldInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_ProceedsfromSaleofPrivatelyheldInvestments_09280588-5116-4c2c-b1df-0fd0a742e7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_6a4bddcb-4fca-45bf-80b3-56eaad8828d9" xlink:href="ahl-20231220.xsd#ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_6a4bddcb-4fca-45bf-80b3-56eaad8828d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_47f5570d-103a-423d-94fa-9c80e1b29428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_47f5570d-103a-423d-94fa-9c80e1b29428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_9624ef2b-ac43-4d8c-8b7b-1cdc03f20e09" xlink:href="ahl-20231220.xsd#ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_9624ef2b-ac43-4d8c-8b7b-1cdc03f20e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_29e0e846-28ee-42e8-ad18-5327e808ddb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_29e0e846-28ee-42e8-ad18-5327e808ddb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentInMultilineReinsurer_b13a470a-2c7d-4439-bd8c-632cf72048ff" xlink:href="ahl-20231220.xsd#ahl_InvestmentInMultilineReinsurer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_InvestmentInMultilineReinsurer_b13a470a-2c7d-4439-bd8c-632cf72048ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsForProceedsFromOtherInvestments_d993d289-ea16-45f2-a9d0-74a5f4aa7a04" xlink:href="ahl-20231220.xsd#ahl_PaymentsForProceedsFromOtherInvestments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_ahl_PaymentsForProceedsFromOtherInvestments_d993d289-ea16-45f2-a9d0-74a5f4aa7a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_02f0b855-b885-4b07-8acd-a669f4dc689b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9448eeb-610e-4e61-8daf-defdfe4c6425" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_02f0b855-b885-4b07-8acd-a669f4dc689b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31f5657-fc26-4449-abfd-bd89fb3f688d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31f5657-fc26-4449-abfd-bd89fb3f688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_71949e63-da0e-40e2-aa2c-f476dd73fc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31f5657-fc26-4449-abfd-bd89fb3f688d" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_71949e63-da0e-40e2-aa2c-f476dd73fc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_e8fceb8b-7ec7-40fe-9213-3a934e613f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31f5657-fc26-4449-abfd-bd89fb3f688d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_e8fceb8b-7ec7-40fe-9213-3a934e613f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_50dc49d5-3319-4f17-86e4-6df68c8e40d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31f5657-fc26-4449-abfd-bd89fb3f688d" xlink:to="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_50dc49d5-3319-4f17-86e4-6df68c8e40d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b74d7f56-fe87-4f7c-a716-a4079d8ed350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31f5657-fc26-4449-abfd-bd89fb3f688d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b74d7f56-fe87-4f7c-a716-a4079d8ed350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_467ea06c-bbea-4c2e-b877-b122053ca57b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_467ea06c-bbea-4c2e-b877-b122053ca57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9be79b05-3c2c-47d7-a962-b33dc181fde1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9be79b05-3c2c-47d7-a962-b33dc181fde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_44fb4557-4640-4778-b15c-09f44a33aced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_44fb4557-4640-4778-b15c-09f44a33aced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_42fa6b7b-b53b-495b-9395-4c9702857116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_42fa6b7b-b53b-495b-9395-4c9702857116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_e7d964f5-6670-4a9e-b34b-3d70799ade77" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludesRestrictedCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_e7d964f5-6670-4a9e-b34b-3d70799ade77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract_faeddce2-c70f-44c3-b92c-430184549471" xlink:href="ahl-20231220.xsd#ahl_SupplementalDisclosureOfCashFlowsInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_59811de4-03ad-4c15-8077-cafd6c39755c" xlink:to="loc_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract_faeddce2-c70f-44c3-b92c-430184549471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_b1a1d88b-533e-4d9e-8185-ff3ea04272b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract_faeddce2-c70f-44c3-b92c-430184549471" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_b1a1d88b-533e-4d9e-8185-ff3ea04272b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_59c7a465-d5c9-4e9f-b84e-4d1206e3f4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract_faeddce2-c70f-44c3-b92c-430184549471" xlink:to="loc_us-gaap_InterestPaid_59c7a465-d5c9-4e9f-b84e-4d1206e3f4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETS_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETS_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_353c195c-0c49-4e48-96c4-c1d768085a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_353c195c-0c49-4e48-96c4-c1d768085a3c" xlink:to="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_51340b1f-a4c6-446a-a04a-518d43ace960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_InvestmentTypeAxis_51340b1f-a4c6-446a-a04a-518d43ace960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a4a6b5e7-0c43-4b44-9b22-b9ddc2d94e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_51340b1f-a4c6-446a-a04a-518d43ace960" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a4a6b5e7-0c43-4b44-9b22-b9ddc2d94e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_98997dc1-6f38-4aa3-b83a-0775c6659b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a4a6b5e7-0c43-4b44-9b22-b9ddc2d94e93" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_98997dc1-6f38-4aa3-b83a-0775c6659b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_9e574cc6-fe73-4184-b809-1a8a13daed06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a4a6b5e7-0c43-4b44-9b22-b9ddc2d94e93" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_9e574cc6-fe73-4184-b809-1a8a13daed06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_14f8f467-39d3-4b4f-ab37-49e95b8266ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_14f8f467-39d3-4b4f-ab37-49e95b8266ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ef4cb071-6a79-4363-9724-baa757bd48d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_14f8f467-39d3-4b4f-ab37-49e95b8266ac" xlink:to="loc_us-gaap_RelatedPartyDomain_ef4cb071-6a79-4363-9724-baa757bd48d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_7a43a411-beeb-4825-91a3-6c45e5200686" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ef4cb071-6a79-4363-9724-baa757bd48d8" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_7a43a411-beeb-4825-91a3-6c45e5200686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_5bc22617-6691-4905-a414-140c5e13debb" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ef4cb071-6a79-4363-9724-baa757bd48d8" xlink:to="loc_ahl_ApolloRealEstateFundMember_5bc22617-6691-4905-a414-140c5e13debb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_40dc2c14-8414-4fdf-8e81-30616eafaff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_40dc2c14-8414-4fdf-8e81-30616eafaff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f0edf00a-eeee-4b05-9859-b814fc2a1eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_40dc2c14-8414-4fdf-8e81-30616eafaff1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f0edf00a-eeee-4b05-9859-b814fc2a1eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember_b75ef390-bdbe-4044-b64a-269270b73302" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f0edf00a-eeee-4b05-9859-b814fc2a1eb7" xlink:to="loc_ahl_AccruedExpensesMember_b75ef390-bdbe-4044-b64a-269270b73302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_698c25a7-fdcc-4d3e-97aa-caba34b4cf95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_698c25a7-fdcc-4d3e-97aa-caba34b4cf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_6a891009-82a9-4aca-a546-c047d10a42c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_698c25a7-fdcc-4d3e-97aa-caba34b4cf95" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_6a891009-82a9-4aca-a546-c047d10a42c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_8c5ffc16-8a46-4a31-9b30-a58ca6083534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6a891009-82a9-4aca-a546-c047d10a42c0" xlink:to="loc_us-gaap_AssetManagementArrangementMember_8c5ffc16-8a46-4a31-9b30-a58ca6083534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_f3ddc770-1b0b-4713-8c6b-cc9e233af569" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6a891009-82a9-4aca-a546-c047d10a42c0" xlink:to="loc_ahl_ManagementConsultingAgreementMember_f3ddc770-1b0b-4713-8c6b-cc9e233af569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4466c8fd-6de4-451b-8105-cf6cf8ae40f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4466c8fd-6de4-451b-8105-cf6cf8ae40f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7dce5f3b-7240-49e7-9b20-c5477784fb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4466c8fd-6de4-451b-8105-cf6cf8ae40f8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7dce5f3b-7240-49e7-9b20-c5477784fb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_8f1c3ad4-f363-44ef-b048-06a7a5418bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7dce5f3b-7240-49e7-9b20-c5477784fb3d" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_8f1c3ad4-f363-44ef-b048-06a7a5418bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2fa7070e-c6eb-46d2-8c60-3457ab74bc26" xlink:to="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0cc0cbce-78c7-43d6-9b71-73d133394e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0cc0cbce-78c7-43d6-9b71-73d133394e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_a7da9044-6b3f-4739-b98a-c994ba3c0aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_us-gaap_TradingSecuritiesDebt_a7da9044-6b3f-4739-b98a-c994ba3c0aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsAvailableForSale_3df0be7e-b0b1-4960-b3c7-7942c04f6d5f" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsAvailableForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_ShortTermInvestmentsAvailableForSale_3df0be7e-b0b1-4960-b3c7-7942c04f6d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValue_e0737975-1b26-450f-92bb-8f7727c95057" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValue_e0737975-1b26-450f-92bb-8f7727c95057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_6b6e4f2c-e51c-43e0-a5b1-a3e0b0a6fa05" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_CatastropheBond_6b6e4f2c-e51c-43e0-a5b1-a3e0b0a6fa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_7e62d50f-ce65-419c-b88e-4381c093f4e6" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_PrivatelyheldInvestments_7e62d50f-ce65-419c-b88e-4381c093f4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ca1c6c04-c8cf-4c23-92dc-ee42b8822aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_us-gaap_EquityMethodInvestments_ca1c6c04-c8cf-4c23-92dc-ee42b8822aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_e8603806-aac1-4a30-b38c-a1c83d0d87be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_us-gaap_OtherInvestments_e8603806-aac1-4a30-b38c-a1c83d0d87be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentsExcludingDerivativeAssets_d64ff128-c543-46f4-bc7e-d509e11039bc" xlink:href="ahl-20231220.xsd#ahl_InvestmentsExcludingDerivativeAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_289701ee-3304-4a0f-aab4-d6611e872027" xlink:to="loc_ahl_InvestmentsExcludingDerivativeAssets_d64ff128-c543-46f4-bc7e-d509e11039bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_301e779c-f577-40e6-90c1-86a7e45999a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_301e779c-f577-40e6-90c1-86a7e45999a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_23c9005d-0c1b-4c51-806e-18d87348dca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_23c9005d-0c1b-4c51-806e-18d87348dca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_35b92fc6-dde2-44fb-a703-c3ee5cd2a1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_23c9005d-0c1b-4c51-806e-18d87348dca2" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_35b92fc6-dde2-44fb-a703-c3ee5cd2a1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidReinsurancePremiums_4d8f7608-bce2-4210-a54e-cddbcf88a6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidReinsurancePremiums"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNetAbstract_23c9005d-0c1b-4c51-806e-18d87348dca2" xlink:to="loc_us-gaap_PrepaidReinsurancePremiums_4d8f7608-bce2-4210-a54e-cddbcf88a6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_e57f5a4b-26b9-4406-9285-930c8856c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_ReceivablesAbstract_e57f5a4b-26b9-4406-9285-930c8856c4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_6359ff6e-2dec-4923-b45e-808184d00f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e57f5a4b-26b9-4406-9285-930c8856c4cb" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_6359ff6e-2dec-4923-b45e-808184d00f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_7e7e7ed2-1ea2-4be5-b7fe-8f926e9620df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e57f5a4b-26b9-4406-9285-930c8856c4cb" xlink:to="loc_us-gaap_OtherReceivables_7e7e7ed2-1ea2-4be5-b7fe-8f926e9620df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_f7485a24-54f3-4a76-9500-7c5e32a52057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldUnderReinsuranceAgreementsAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset_f7485a24-54f3-4a76-9500-7c5e32a52057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_41051f33-89ac-41b4-bfb8-c7911e8e6911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_41051f33-89ac-41b4-bfb8-c7911e8e6911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_93b8cdf4-789f-4793-ae09-d07eec378d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_DerivativeAssets_93b8cdf4-789f-4793-ae09-d07eec378d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_9289bdec-f248-4c0d-9672-7b827336f3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations_9289bdec-f248-4c0d-9672-7b827336f3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_9a0ab27e-fbf8-4b2e-854a-3af2d2ee1f41" xlink:href="ahl-20231220.xsd#ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable_9a0ab27e-fbf8-4b2e-854a-3af2d2ee1f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherMiscellaneousAssets_503eab02-6f53-4c8c-8fb8-9682d9891b4e" xlink:href="ahl-20231220.xsd#ahl_OtherMiscellaneousAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_ahl_OtherMiscellaneousAssets_503eab02-6f53-4c8c-8fb8-9682d9891b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_57549256-bc42-4d46-8538-04dbbcc11022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_57549256-bc42-4d46-8538-04dbbcc11022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_820ac82c-0420-402e-842a-98fbfceb5d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f4b3bec6-05c0-4436-8c49-1c6c8c9777c4" xlink:to="loc_us-gaap_Assets_820ac82c-0420-402e-842a-98fbfceb5d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserveAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:to="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e35a1b18-d549-4f7d-9d34-a3ed75f34fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e35a1b18-d549-4f7d-9d34-a3ed75f34fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_95524af1-fe94-4093-afe0-6e6f0a94c049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:to="loc_us-gaap_UnearnedPremiums_95524af1-fe94-4093-afe0-6e6f0a94c049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceReserves_4b890eec-4c69-42de-8e23-28e67df1c59e" xlink:href="ahl-20231220.xsd#ahl_InsuranceReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_InsuranceReserveAbstract_150e4476-5a57-416c-9415-e7a6e10fc3d6" xlink:to="loc_ahl_InsuranceReserves_4b890eec-4c69-42de-8e23-28e67df1c59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePayable_0dc9d887-df7b-4d25-b54e-31b2ffc515dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:to="loc_us-gaap_ReinsurancePayable_0dc9d887-df7b-4d25-b54e-31b2ffc515dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_80b4e1da-816e-437a-ad57-0da996d221bc" xlink:href="ahl-20231220.xsd#ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable_80b4e1da-816e-437a-ad57-0da996d221bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_5106c2b9-e5bb-419d-a9da-a51ba0f5058e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_5106c2b9-e5bb-419d-a9da-a51ba0f5058e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_32b5e2a4-62fc-4948-bbc0-a644b6520eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_32b5e2a4-62fc-4948-bbc0-a644b6520eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_70ff72b6-babe-4121-9bb9-f5b83e377368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_OperatingLeaseLiability_70ff72b6-babe-4121-9bb9-f5b83e377368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_86c35f2c-7cc4-4b86-981e-6acb46986100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_DerivativeLiabilities_86c35f2c-7cc4-4b86-981e-6acb46986100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_31085a67-138f-425b-ba03-4081357e82e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_f0be1c04-33d2-4718-8cd0-62b5832aa224" xlink:to="loc_us-gaap_ShortTermBorrowings_31085a67-138f-425b-ba03-4081357e82e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e925c19e-4b37-4615-b8c7-d0ef765ea4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f5942818-748c-4212-ad83-136e911c0ce0" xlink:to="loc_us-gaap_Liabilities_e925c19e-4b37-4615-b8c7-d0ef765ea4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_15f43c94-dcca-4c78-9d63-0631425731c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_CommitmentsAndContingencies_15f43c94-dcca-4c78-9d63-0631425731c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_f96ab058-e45e-4467-92d5-291bafd87681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_f96ab058-e45e-4467-92d5-291bafd87681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4d432a39-ce2f-4ed4-937a-beb7e1e756ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_f96ab058-e45e-4467-92d5-291bafd87681" xlink:to="loc_us-gaap_CommonStockValue_4d432a39-ce2f-4ed4-937a-beb7e1e756ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_88dcfbea-2a9f-4a12-97f0-a7539a668966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_f96ab058-e45e-4467-92d5-291bafd87681" xlink:to="loc_us-gaap_PreferredStockValue_88dcfbea-2a9f-4a12-97f0-a7539a668966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_9b8a19ce-70b4-44a6-afa5-ca5bbb360df7" xlink:href="ahl-20231220.xsd#ahl_AdditionalPaidInCapitalExcludingPreferenceShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceShares_9b8a19ce-70b4-44a6-afa5-ca5bbb360df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_06ba4746-a3f9-40d9-9370-570175bc1e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_06ba4746-a3f9-40d9-9370-570175bc1e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ab930732-8276-4a96-9da7-df64c509bd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ab930732-8276-4a96-9da7-df64c509bd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c222391b-c76c-4675-91aa-bf3461b0bbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1ef8dfb4-3b94-47ae-96c5-371683135b5c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c222391b-c76c-4675-91aa-bf3461b0bbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_73fa4a83-eec5-4643-8016-c1be31985b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcf24fb3-d21e-4da8-9411-bb4c29a9dc31" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_73fa4a83-eec5-4643-8016-c1be31985b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDBALANCESHEETSConsolidatedBalanceSheetsParenthetical_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f9c56879-1576-40d5-8e48-490bac80651e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f9c56879-1576-40d5-8e48-490bac80651e" xlink:to="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_InvestmentTypeAxis_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_0a9bf3cf-cbd3-4671-b7f4-adde30f2ff7c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_b51f90e0-7d1a-4f9a-9c0e-5b76b19ed24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:to="loc_us-gaap_FixedMaturitiesMember_b51f90e0-7d1a-4f9a-9c0e-5b76b19ed24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_d5511c15-0bf3-4916-9560-4868824c5a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_d5511c15-0bf3-4916-9560-4868824c5a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_a0d72aac-6021-496e-a9a9-b83fd77bd24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_843a84cb-9e15-4dd3-aae5-6bd6e4a1d7fc" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_a0d72aac-6021-496e-a9a9-b83fd77bd24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f6a174a8-6217-44cd-a68c-a45a6a1761f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f6a174a8-6217-44cd-a68c-a45a6a1761f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f6a174a8-6217-44cd-a68c-a45a6a1761f7" xlink:to="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_b7138376-57ba-4764-a74b-a45b8f2d5833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_b7138376-57ba-4764-a74b-a45b8f2d5833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_bcf390f9-099b-45fa-8f57-dbd7ba5cad7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_bcf390f9-099b-45fa-8f57-dbd7ba5cad7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_3c4e6f53-2ed0-4c85-8afe-5b18d62f1b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2fc9456e-9c32-42a4-8f8e-9d7d169ddc50" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_3c4e6f53-2ed0-4c85-8afe-5b18d62f1b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9c7e1311-b626-467e-a593-6944f85b0fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9c7e1311-b626-467e-a593-6944f85b0fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_43160a80-12c9-48ba-9b9f-c47d5744fbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9c7e1311-b626-467e-a593-6944f85b0fe5" xlink:to="loc_us-gaap_RelatedPartyDomain_43160a80-12c9-48ba-9b9f-c47d5744fbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_e315fe32-936f-485e-87bc-17f13bee47b4" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_43160a80-12c9-48ba-9b9f-c47d5744fbf3" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_e315fe32-936f-485e-87bc-17f13bee47b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_282b2bec-a6ce-478b-b7a9-456630ab6a2c" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_43160a80-12c9-48ba-9b9f-c47d5744fbf3" xlink:to="loc_ahl_ApolloRealEstateFundMember_282b2bec-a6ce-478b-b7a9-456630ab6a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f30dc5a-4fa8-41be-89f7-3584839533a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f30dc5a-4fa8-41be-89f7-3584839533a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_102fba8c-4029-48da-a150-7f8c168155d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f30dc5a-4fa8-41be-89f7-3584839533a9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_102fba8c-4029-48da-a150-7f8c168155d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1d064f38-6257-4945-a298-e30e58e8ebc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_102fba8c-4029-48da-a150-7f8c168155d9" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1d064f38-6257-4945-a298-e30e58e8ebc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8663a6d5-caf3-415b-b5c1-e49fd47b5119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8663a6d5-caf3-415b-b5c1-e49fd47b5119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a0a3a3ad-f61a-4f65-ae50-f1f2042674c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8663a6d5-caf3-415b-b5c1-e49fd47b5119" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a0a3a3ad-f61a-4f65-ae50-f1f2042674c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccruedExpensesMember_41f96264-5c43-40da-bd0f-c144fb32872e" xlink:href="ahl-20231220.xsd#ahl_AccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a0a3a3ad-f61a-4f65-ae50-f1f2042674c6" xlink:to="loc_ahl_AccruedExpensesMember_41f96264-5c43-40da-bd0f-c144fb32872e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_ba26a138-c981-467f-8b00-cc0d0cce4f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_ba26a138-c981-467f-8b00-cc0d0cce4f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a74bd0cf-b6ed-42f7-899a-49f3481ccc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ba26a138-c981-467f-8b00-cc0d0cce4f4e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a74bd0cf-b6ed-42f7-899a-49f3481ccc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_8d918191-f34b-4d9a-b65f-8d0e675801da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_a74bd0cf-b6ed-42f7-899a-49f3481ccc8e" xlink:to="loc_us-gaap_AssetManagementArrangementMember_8d918191-f34b-4d9a-b65f-8d0e675801da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_4eeb1694-0530-4cbe-a79d-d9980994e0ae" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_a74bd0cf-b6ed-42f7-899a-49f3481ccc8e" xlink:to="loc_ahl_ManagementConsultingAgreementMember_4eeb1694-0530-4cbe-a79d-d9980994e0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2de03f2b-7815-40b4-81bb-ffa73a644f80" xlink:to="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_84e48702-af51-4d44-81e4-e133962f8a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_84e48702-af51-4d44-81e4-e133962f8a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_164b3440-97c6-436b-b404-06b41e7d9a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_164b3440-97c6-436b-b404-06b41e7d9a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_4d736462-1332-4a52-831a-80c56c14e272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_2f26a784-65fb-4c1e-a543-384a09af02c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_2f26a784-65fb-4c1e-a543-384a09af02c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost_6ded1c0a-b133-44e3-8133-6c3db3c12dd6" xlink:href="ahl-20231220.xsd#ahl_Shortterminvestmentsavailableforsaleamortizedcost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_Shortterminvestmentsavailableforsaleamortizedcost_6ded1c0a-b133-44e3-8133-6c3db3c12dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAmortizedCost_c961950b-249d-419f-989e-c0e8948d33f1" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAmortizedCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_ShortTermInvestmentsTradingAmortizedCost_c961950b-249d-419f-989e-c0e8948d33f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure_a93f290d-213d-420a-a7c6-513c9fa545e5" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_CatastropheBondsFairValueDisclosure_a93f290d-213d-420a-a7c6-513c9fa545e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_d2a8eac1-6ea2-40c8-bdd7-0550419cc980" xlink:href="ahl-20231220.xsd#ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue_d2a8eac1-6ea2-40c8-bdd7-0550419cc980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_edae39ce-df1d-4cba-a47d-8aa3b9e0d4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_edae39ce-df1d-4cba-a47d-8aa3b9e0d4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2d372892-2119-4e29-94f3-2037e6b7e320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_CommonStockSharesIssued_2d372892-2119-4e29-94f3-2037e6b7e320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f9a2898e-5e17-4767-bb2f-2c53c62079a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f9a2898e-5e17-4767-bb2f-2c53c62079a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_eab00b72-1914-4147-b9c7-318439a4708f" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities_eab00b72-1914-4147-b9c7-318439a4708f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_04d3f6b1-82a5-40a0-8580-9dbe625c3cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_04d3f6b1-82a5-40a0-8580-9dbe625c3cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_aa35368e-252b-4891-8de3-13519207e8af" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludesRestrictedCash"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_aa35368e-252b-4891-8de3-13519207e8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_d29bc09d-d9d9-4538-8adc-edff83648a9d" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_ahl_PrivatelyheldInvestments_d29bc09d-d9d9-4538-8adc-edff83648a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_a54cf164-52d6-4a3f-b5fc-4f2803c58a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_OtherInvestments_a54cf164-52d6-4a3f-b5fc-4f2803c58a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_ea23b170-6995-4a30-b890-d4b4366b79de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cac1956-0369-4a83-9165-7b64deabd015" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_ea23b170-6995-4a30-b890-d4b4366b79de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDOTHERCOMPREHENSIVEINCOME_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5b944fed-fba7-4740-aaea-fa7de096d753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5b944fed-fba7-4740-aaea-fa7de096d753" xlink:to="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2b0c8856-6a1f-43e0-b1b7-a6abcf4be01b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_303665ec-02c4-4701-808c-c1dead40e2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_us-gaap_RealEstateFundsMember_303665ec-02c4-4701-808c-c1dead40e2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_01187214-f1b3-47cf-991d-bea631fe2578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_us-gaap_AssetManagementArrangementMember_01187214-f1b3-47cf-991d-bea631fe2578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_ffbc8ead-4b10-4b7d-ac20-54fa2b41a3b0" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_ahl_ManagementConsultingAgreementMember_ffbc8ead-4b10-4b7d-ac20-54fa2b41a3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyInvestmentIncomeMember_17652cda-2d28-45bc-b93e-cd0a1976f7b0" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyInvestmentIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_ahl_RelatedPartyInvestmentIncomeMember_17652cda-2d28-45bc-b93e-cd0a1976f7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember_60d456c7-0e0d-4b24-9ece-094b791a2f57" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5ae79f92-ec5c-4314-972e-7019a9c7793f" xlink:to="loc_ahl_ClassABNotesMember_60d456c7-0e0d-4b24-9ece-094b791a2f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_787392ed-721e-4ad9-809e-83c04aa540e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_787392ed-721e-4ad9-809e-83c04aa540e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_787392ed-721e-4ad9-809e-83c04aa540e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_361ed68c-cfbf-4358-a946-b66fe428089f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:to="loc_us-gaap_InvestmentIncomeMember_361ed68c-cfbf-4358-a946-b66fe428089f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f2eda6f0-a894-4d6b-acb4-a9c03f4a453e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f2eda6f0-a894-4d6b-acb4-a9c03f4a453e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1_728bd143-3d39-4563-af56-007d20a374ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c751ae3-16ae-4e46-a458-880969fb9d03" xlink:to="loc_us-gaap_GainLossOnInvestmentsMember1_728bd143-3d39-4563-af56-007d20a374ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_747557f8-b93c-4ee9-a49e-7e3341f14735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0aa35aa5-4e6f-4407-9c4c-70b4110b0dc8" xlink:to="loc_us-gaap_ClassOfStockDomain_747557f8-b93c-4ee9-a49e-7e3341f14735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_cb420eab-364d-4d48-81b2-fc86bd99800a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_747557f8-b93c-4ee9-a49e-7e3341f14735" xlink:to="loc_us-gaap_PreferredStockMember_cb420eab-364d-4d48-81b2-fc86bd99800a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9eb563a3-6ab0-4dd8-9762-6aff7ed6f4a7" xlink:to="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_300db7ca-c95b-44e3-abbc-3e1db8e87559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:to="loc_us-gaap_PremiumsEarnedNet_300db7ca-c95b-44e3-abbc-3e1db8e87559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_cd18474f-6105-424a-b135-aa14db924831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:to="loc_us-gaap_NetInvestmentIncome_cd18474f-6105-424a-b135-aa14db924831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_3f40ac77-e0a2-434d-83b7-e54b9a61f954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:to="loc_us-gaap_GainLossOnInvestments_3f40ac77-e0a2-434d-83b7-e54b9a61f954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b3a63784-f342-4918-9737-8747477f8738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_772cfb49-92fa-45fa-84cf-aaaf8e84e697" xlink:to="loc_us-gaap_Revenues_b3a63784-f342-4918-9737-8747477f8738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_ee59e16c-a55d-403a-9b04-5d33467fb3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_ee59e16c-a55d-403a-9b04-5d33467fb3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_c8e93508-240a-4201-8f90-6a898e1279ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_c8e93508-240a-4201-8f90-6a898e1279ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_10956a29-cc98-40e8-b788-497ec4a8c35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_10956a29-cc98-40e8-b788-497ec4a8c35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_31e64cca-3cda-46fa-a66d-7c97ba32c45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_InterestExpenseDebt_31e64cca-3cda-46fa-a66d-7c97ba32c45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9bdbe00f-baca-49ea-baa8-b1e670e344e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9bdbe00f-baca-49ea-baa8-b1e670e344e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_02e2976c-4b22-4da5-9d0b-d1a2dc6206e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_02e2976c-4b22-4da5-9d0b-d1a2dc6206e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7668df42-b237-4398-9d91-26a5ef405911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7668df42-b237-4398-9d91-26a5ef405911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Expense_88392dbb-e358-4c18-9c9b-b33cd02191f1" xlink:href="ahl-20231220.xsd#ahl_Expense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_50dec792-a96a-435f-9520-c07427c7f39b" xlink:to="loc_ahl_Expense_88392dbb-e358-4c18-9c9b-b33cd02191f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4899bdf2-fb17-4af9-9f7c-084070a383b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4899bdf2-fb17-4af9-9f7c-084070a383b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6d074525-bf36-4556-93d2-bbb7c5c478e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6d074525-bf36-4556-93d2-bbb7c5c478e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6925c9df-fbe4-470e-bed7-bf6364d6f2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_ProfitLoss_6925c9df-fbe4-470e-bed7-bf6364d6f2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_11aac6b7-079d-417f-b781-4cee6c1890fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_Dividends_11aac6b7-079d-417f-b781-4cee6c1890fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cf6b9a2e-f92d-4706-a2a8-ee4bf0d7a0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_NetIncomeLoss_cf6b9a2e-f92d-4706-a2a8-ee4bf0d7a0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7606f786-8d5e-4bc7-82bc-b089fd5c05ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7606f786-8d5e-4bc7-82bc-b089fd5c05ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_65ea89cc-3601-4f94-9b97-26d5e689e3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_65ea89cc-3601-4f94-9b97-26d5e689e3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_be9898ce-43e1-45e4-a139-d5a6a41e645f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_be9898ce-43e1-45e4-a139-d5a6a41e645f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_83a8ec25-9fc5-4354-b762-3b4ccd247e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_83a8ec25-9fc5-4354-b762-3b4ccd247e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_24008d93-d0ec-4bb9-b8e5-5441dce28e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0b6932d6-ff5d-4abe-a9c8-b67e9691c62c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_24008d93-d0ec-4bb9-b8e5-5441dce28e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_18a1d89a-1098-4cfb-87f8-c32bec838466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_18a1d89a-1098-4cfb-87f8-c32bec838466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a43e67b1-5f20-458c-ae87-2920043a1dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a43e67b1-5f20-458c-ae87-2920043a1dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_68d754cf-d4c4-4aa3-b876-9ee23480b73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9e910104-eb9c-43f7-a418-a2c54e79f07b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_68d754cf-d4c4-4aa3-b876-9ee23480b73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_25939e53-f00a-4b22-8c5e-427c534b7fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_c18b2357-c0b8-4518-abe8-8c342551b588" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_25939e53-f00a-4b22-8c5e-427c534b7fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e439cc13-00de-451e-a0a8-56bd8110632a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e439cc13-00de-451e-a0a8-56bd8110632a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_da051cbd-76d1-4a50-9f21-876ad1be1632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b54a7361-10d8-414e-9bdd-de464cff16b9" xlink:to="loc_us-gaap_DueToAffiliateCurrent_da051cbd-76d1-4a50-9f21-876ad1be1632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_546bafbf-9c58-4617-ab53-1b4c13db5cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_546bafbf-9c58-4617-ab53-1b4c13db5cdc" xlink:to="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_09c54742-b1a7-476f-b2f7-461fa1300364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_09c54742-b1a7-476f-b2f7-461fa1300364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9351cb75-a585-42b1-bf1a-4b057949f7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_09c54742-b1a7-476f-b2f7-461fa1300364" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9351cb75-a585-42b1-bf1a-4b057949f7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_12f6e18e-e65e-4301-9935-272a1530868e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_12f6e18e-e65e-4301-9935-272a1530868e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12f6e18e-e65e-4301-9935-272a1530868e" xlink:to="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a37f3c45-4689-4f57-84c6-e6489f1db5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_CommonStockMember_a37f3c45-4689-4f57-84c6-e6489f1db5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_eff62ffb-ea9b-4b7b-8fff-59139875a488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_PreferredStockMember_eff62ffb-ea9b-4b7b-8fff-59139875a488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember_177981c3-789d-4581-adcf-02c89debf597" xlink:href="ahl-20231220.xsd#ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_ahl_AdditionalPaidInCapitalExcludingPreferenceSharesMember_177981c3-789d-4581-adcf-02c89debf597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c24a90a4-4668-49ad-80c4-0fc0e1ff49d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_RetainedEarningsMember_c24a90a4-4668-49ad-80c4-0fc0e1ff49d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6c901162-41d8-4fae-8b3e-262b997d5147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6c901162-41d8-4fae-8b3e-262b997d5147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_11f9675c-42f8-428e-adab-f50b47a5d000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_11f9675c-42f8-428e-adab-f50b47a5d000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_aec5f5ab-f220-4aa3-bd37-3f6347344d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dde732d5-6624-4afa-a952-a7156cfe40c3" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_aec5f5ab-f220-4aa3-bd37-3f6347344d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a166795c-0e90-44c6-8f5a-2619f62fde1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a166795c-0e90-44c6-8f5a-2619f62fde1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_08f32e55-2efe-4b68-bd23-c98bb7c85610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a166795c-0e90-44c6-8f5a-2619f62fde1b" xlink:to="loc_us-gaap_ClassOfStockDomain_08f32e55-2efe-4b68-bd23-c98bb7c85610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_77ca6ebd-fb70-4b66-8f11-5714ad95282e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_08f32e55-2efe-4b68-bd23-c98bb7c85610" xlink:to="loc_us-gaap_CommonStockMember_77ca6ebd-fb70-4b66-8f11-5714ad95282e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_8a60236e-5393-4ae1-b78b-54214d3c96fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_08f32e55-2efe-4b68-bd23-c98bb7c85610" xlink:to="loc_us-gaap_PreferredStockMember_8a60236e-5393-4ae1-b78b-54214d3c96fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_908ea062-ec9e-41ed-b5fa-41f4f98b29ec" xlink:to="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf6b2cc3-1e88-49ed-9bf8-6d9759c5015b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf6b2cc3-1e88-49ed-9bf8-6d9759c5015b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d66bd3d1-624f-4bc6-a6ff-17573d488892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_ProfitLoss_d66bd3d1-624f-4bc6-a6ff-17573d488892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_3f0e439e-b9c4-429f-bdb3-fe0e69cf5a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_Dividends_3f0e439e-b9c4-429f-bdb3-fe0e69cf5a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6b935fc9-01c7-4ffc-a3ce-d31bcb017b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6b935fc9-01c7-4ffc-a3ce-d31bcb017b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_6570102a-c053-4033-a1c0-3335c0b546d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_6570102a-c053-4033-a1c0-3335c0b546d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66a339f6-df5c-4589-bf26-70617dae8e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2b05ef27-f48a-45e1-973e-9999f9ebee17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66a339f6-df5c-4589-bf26-70617dae8e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AggregateLiquidationPreferences_a4e12140-9e8e-4b5b-96a3-94b31196244a" xlink:href="ahl-20231220.xsd#ahl_AggregateLiquidationPreferences"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:to="loc_ahl_AggregateLiquidationPreferences_a4e12140-9e8e-4b5b-96a3-94b31196244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockIssuanceCost_d5bb3511-30b5-4fd3-9927-b2336a7b2882" xlink:href="ahl-20231220.xsd#ahl_PreferredStockIssuanceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b9b7a3d-9c55-49a6-bc5e-c65d4246567c" xlink:to="loc_ahl_PreferredStockIssuanceCost_d5bb3511-30b5-4fd3-9927-b2336a7b2882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa4df5f7-a0c8-4f4c-812d-6aeb9888b8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa4df5f7-a0c8-4f4c-812d-6aeb9888b8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_e4b041fa-e82f-45d5-a653-ea457051bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa4df5f7-a0c8-4f4c-812d-6aeb9888b8b7" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_e4b041fa-e82f-45d5-a653-ea457051bd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa4df5f7-a0c8-4f4c-812d-6aeb9888b8b7" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_db87b3a4-5e93-4bd8-8b1c-498e55973052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_db87b3a4-5e93-4bd8-8b1c-498e55973052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f89d644c-d7cd-47b5-9b4f-d99e9b0181b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f89d644c-d7cd-47b5-9b4f-d99e9b0181b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Interestonoperatingleaseliabilities_aa0ac95d-8ac0-4d4f-ba95-703a2a19827a" xlink:href="ahl-20231220.xsd#ahl_Interestonoperatingleaseliabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_ahl_Interestonoperatingleaseliabilities_aa0ac95d-8ac0-4d4f-ba95-703a2a19827a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets_55919cd5-56c5-46fc-ae0d-f11e7a4d1bd1" xlink:href="ahl-20231220.xsd#ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets_55919cd5-56c5-46fc-ae0d-f11e7a4d1bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetAdditionsdisposalsOfLeaseLiabilities_8093e4cb-bc8c-4e81-95b2-a4dbbc106ea8" xlink:href="ahl-20231220.xsd#ahl_NetAdditionsdisposalsOfLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_ahl_NetAdditionsdisposalsOfLeaseLiabilities_8093e4cb-bc8c-4e81-95b2-a4dbbc106ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_727ab959-58cf-4230-81d4-ab8e32ee983f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_727ab959-58cf-4230-81d4-ab8e32ee983f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_049e63f8-5bd7-40c4-aefc-7c9acb44e303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_GainLossOnInvestments_049e63f8-5bd7-40c4-aefc-7c9acb44e303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_0b828cce-2705-4851-9761-4aa0c02f59be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_0b828cce-2705-4851-9761-4aa0c02f59be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d477ca3e-8da9-4c41-9cb7-3f437fafc83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d477ca3e-8da9-4c41-9cb7-3f437fafc83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GainsLossesOnInvestmentAndForeignExchange_8d2a6217-e38c-4860-8e99-2c5302449f04" xlink:href="ahl-20231220.xsd#ahl_GainsLossesOnInvestmentAndForeignExchange"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_ahl_GainsLossesOnInvestmentAndForeignExchange_8d2a6217-e38c-4860-8e99-2c5302449f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_ac340498-5a9d-4ad1-b62a-0c14226a8436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_ac340498-5a9d-4ad1-b62a-0c14226a8436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_a3c62845-6e79-4f5b-aa3c-88baf36737e3" xlink:href="ahl-20231220.xsd#ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome_a3c62845-6e79-4f5b-aa3c-88baf36737e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_d66eea40-adc7-456a-a0e5-905ec6d1d3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_d66eea40-adc7-456a-a0e5-905ec6d1d3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_907ffaa9-29ec-4017-b2d2-c21d79edc71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_907ffaa9-29ec-4017-b2d2-c21d79edc71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnpaidLosses_4912a374-e9ba-4b95-95f5-d62b802a658d" xlink:href="ahl-20231220.xsd#ahl_UnpaidLosses"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_ahl_UnpaidLosses_4912a374-e9ba-4b95-95f5-d62b802a658d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_eb8a0930-22c4-4a54-b44d-220811d50205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums_eb8a0930-22c4-4a54-b44d-220811d50205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_85e38c05-3a81-424e-977b-74f23b70d4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_85e38c05-3a81-424e-977b-74f23b70d4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_2f9fe0d4-4bf9-4ebb-b162-2ad4b70c2367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts_2f9fe0d4-4bf9-4ebb-b162-2ad4b70c2367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReinsurancePayables_b4dedb93-9d49-4393-9991-e0feaa37eb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReinsurancePayables"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInReinsurancePayables_b4dedb93-9d49-4393-9991-e0feaa37eb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_c0d15c64-958d-449c-9ce5-44da270d80e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements_c0d15c64-958d-449c-9ce5-44da270d80e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_a930ac5a-24b5-4c4a-9680-7eea75ca956b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_a930ac5a-24b5-4c4a-9680-7eea75ca956b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_342d55ed-43c2-4d07-8b1b-f003b0ee6f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_342d55ed-43c2-4d07-8b1b-f003b0ee6f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e4592725-2ab4-47d8-9764-53b1824db2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e4592725-2ab4-47d8-9764-53b1824db2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_bcdb86f6-09a5-450d-a0f2-0f87f94e9cf9" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives_bcdb86f6-09a5-450d-a0f2-0f87f94e9cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6df02441-6a44-48a5-83b6-fcac14f4f29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6df02441-6a44-48a5-83b6-fcac14f4f29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_456c1291-cef7-4045-af25-01ad2d6e9feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_456c1291-cef7-4045-af25-01ad2d6e9feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract_550741d2-22b3-44c2-926c-d9dfbe71b2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0a3462a1-04e2-4bae-b839-823222a21c81" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract_550741d2-22b3-44c2-926c-d9dfbe71b2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f168d526-94d3-4ed6-9f1f-ceed759a6581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa4df5f7-a0c8-4f4c-812d-6aeb9888b8b7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f168d526-94d3-4ed6-9f1f-ceed759a6581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_59e44f7b-b8ca-4a30-803e-f4a818492bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_59e44f7b-b8ca-4a30-803e-f4a818492bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_521d7d46-0fc1-499f-b1c7-d900c7f79115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_521d7d46-0fc1-499f-b1c7-d900c7f79115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_68a4506d-462f-49cf-b74f-d60126891d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_68a4506d-462f-49cf-b74f-d60126891d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4d15ecdd-be95-43fe-aa30-f3d1988dfd83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4d15ecdd-be95-43fe-aa30-f3d1988dfd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_cd38eb40-4b3d-4707-9d9c-015722787edd" xlink:href="ahl-20231220.xsd#ahl_PaymentsforAvailableforsaleSecuritiesShortterm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_ahl_PaymentsforAvailableforsaleSecuritiesShortterm_cd38eb40-4b3d-4707-9d9c-015722787edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_82ee9745-a62e-4aec-8e9b-caa1703602ac" xlink:href="ahl-20231220.xsd#ahl_ProceedsfromAvailableforsaleSecuritiesShortterm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm_82ee9745-a62e-4aec-8e9b-caa1703602ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_10d07ffb-2789-4dc5-8ae9-e7bf1dcc938c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_10d07ffb-2789-4dc5-8ae9-e7bf1dcc938c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_bc1b5528-4600-4066-86a0-a01515cd6053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_bc1b5528-4600-4066-86a0-a01515cd6053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_ff19c3a7-ed12-4c79-8406-30280a740777" xlink:href="ahl-20231220.xsd#ahl_PaymentstoAcquirePrivatelyheldInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_ff19c3a7-ed12-4c79-8406-30280a740777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ProceedsfromSaleofPrivatelyheldInvestments_4a766767-c3cd-490e-912a-2d40c192663a" xlink:href="ahl-20231220.xsd#ahl_ProceedsfromSaleofPrivatelyheldInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_ahl_ProceedsfromSaleofPrivatelyheldInvestments_4a766767-c3cd-490e-912a-2d40c192663a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_ebe0ad44-6853-455f-a1c5-119cf1c3945f" xlink:href="ahl-20231220.xsd#ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased_ebe0ad44-6853-455f-a1c5-119cf1c3945f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2f85cb3a-df4f-473f-9ee9-18aa38f5555e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2f85cb3a-df4f-473f-9ee9-18aa38f5555e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_058ae7cb-ef73-474f-a437-2934ab9993b2" xlink:href="ahl-20231220.xsd#ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash_058ae7cb-ef73-474f-a437-2934ab9993b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_3deebdfa-25ab-42bf-8d22-ce413b4b7478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_3deebdfa-25ab-42bf-8d22-ce413b4b7478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentInMultilineReinsurer_aadcb036-49b3-415b-ac8b-4deec27b1d4d" xlink:href="ahl-20231220.xsd#ahl_InvestmentInMultilineReinsurer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_ahl_InvestmentInMultilineReinsurer_aadcb036-49b3-415b-ac8b-4deec27b1d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentsForProceedsFromOtherInvestments_a52c9875-019c-4f65-a7f8-ca9343dc9840" xlink:href="ahl-20231220.xsd#ahl_PaymentsForProceedsFromOtherInvestments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_ahl_PaymentsForProceedsFromOtherInvestments_a52c9875-019c-4f65-a7f8-ca9343dc9840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dcfb015-bcde-4214-bce5-252ac2f81578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e362a5a-bcb2-4577-8aa8-f3cbbbbe8396" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dcfb015-bcde-4214-bce5-252ac2f81578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94214848-7fef-4f38-a50b-37ea45e9aaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94214848-7fef-4f38-a50b-37ea45e9aaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8b57e759-2b62-4e72-b88a-d642b27e932f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94214848-7fef-4f38-a50b-37ea45e9aaf4" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8b57e759-2b62-4e72-b88a-d642b27e932f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_dd459a28-5e70-4b3e-8816-6a85fc4450ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94214848-7fef-4f38-a50b-37ea45e9aaf4" xlink:to="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_dd459a28-5e70-4b3e-8816-6a85fc4450ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ab5e6115-cdc2-4107-9777-b6d48345e7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94214848-7fef-4f38-a50b-37ea45e9aaf4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ab5e6115-cdc2-4107-9777-b6d48345e7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e875af46-8333-4ee8-9c9a-4b62aa43ab64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e875af46-8333-4ee8-9c9a-4b62aa43ab64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a98af5f2-151d-4ad0-a372-45d48276ef3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a98af5f2-151d-4ad0-a372-45d48276ef3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4144e059-4c5c-453f-8998-c178145f19b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4144e059-4c5c-453f-8998-c178145f19b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_97eb562a-57a0-404b-a22e-6c3a1b6636ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_97eb562a-57a0-404b-a22e-6c3a1b6636ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_fbc55558-e931-4b03-8896-612a1b7b2082" xlink:href="ahl-20231220.xsd#ahl_CashAndCashEquivalentsIncludesRestrictedCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f9342ec1-1312-429d-8577-cf08d8fd258d" xlink:to="loc_ahl_CashAndCashEquivalentsIncludesRestrictedCash_fbc55558-e931-4b03-8896-612a1b7b2082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/HistoryandOrganization" xlink:type="simple" xlink:href="ahl-20231220.xsd#HistoryandOrganization"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/HistoryandOrganization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_02b73e07-249d-42b6-a35a-6eaee9b13e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a30f77d4-ea5e-4203-bf07-21da0e0e37a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02b73e07-249d-42b6-a35a-6eaee9b13e0e" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a30f77d4-ea5e-4203-bf07-21da0e0e37a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="ahl-20231220.xsd#BasisofPreparationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_13614582-ab10-4328-8f20-5efe5a90e7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_d6aebb29-b3da-467e-afa1-0803ba2ca136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_13614582-ab10-4328-8f20-5efe5a90e7a7" xlink:to="loc_us-gaap_BasisOfAccounting_d6aebb29-b3da-467e-afa1-0803ba2ca136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReporting" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_acc2a990-5056-4423-8d41-89dec21e3949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_e148419b-7697-4ed0-965b-137710020a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_acc2a990-5056-4423-8d41-89dec21e3949" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_e148419b-7697-4ed0-965b-137710020a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/Investments" xlink:type="simple" xlink:href="ahl-20231220.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_56267660-ab1e-4c31-8cbe-bcebf81fb018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_62948945-258d-45ae-bc13-c1a0d9e12711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_56267660-ab1e-4c31-8cbe-bcebf81fb018" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_62948945-258d-45ae-bc13-c1a0d9e12711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/VariableInterestEntities" xlink:type="simple" xlink:href="ahl-20231220.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_de154465-19d6-49d7-8c2f-ab98b086bd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8e32cfa9-7289-41e4-8747-bea367508763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_de154465-19d6-49d7-8c2f-ab98b086bd24" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8e32cfa9-7289-41e4-8747-bea367508763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurements" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6932a817-baa3-47ff-81c2-8cf65564a701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_45cd361b-3091-4971-9c99-fc07ceaca2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6932a817-baa3-47ff-81c2-8cf65564a701" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_45cd361b-3091-4971-9c99-fc07ceaca2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/Reinsurance" xlink:type="simple" xlink:href="ahl-20231220.xsd#Reinsurance"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/Reinsurance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_a08083f8-9fa9-4f78-907a-909e854d2cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock_a7e353e2-d319-4c35-8e72-3955794136f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_a08083f8-9fa9-4f78-907a-909e854d2cad" xlink:to="loc_us-gaap_ReinsuranceTextBlock_a7e353e2-d319-4c35-8e72-3955794136f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContracts" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContracts"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContracts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_247d7ed2-f217-4e9d-8463-53e937c9f299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_6ec9853c-f9cc-46ee-bea1-38ed54cc0316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_247d7ed2-f217-4e9d-8463-53e937c9f299" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_6ec9853c-f9cc-46ee-bea1-38ed54cc0316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DeferredPolicyAcquisitionCosts" xlink:type="simple" xlink:href="ahl-20231220.xsd#DeferredPolicyAcquisitionCosts"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DeferredPolicyAcquisitionCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_acf98892-4d7d-4f89-98e5-32c25243168c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1_3db9e72a-8389-4421-b33a-416c396c3b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsTextBlock1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_acf98892-4d7d-4f89-98e5-32c25243168c" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1_3db9e72a-8389-4421-b33a-416c396c3b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpenses" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpenses"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_68be8bdd-5037-43cd-92bc-52554bf701fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReservesForLossAndAdjustmentExpensesTextBlock_f3169d47-f626-418a-b0f5-232efd8e5b5d" xlink:href="ahl-20231220.xsd#ahl_ReservesForLossAndAdjustmentExpensesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_68be8bdd-5037-43cd-92bc-52554bf701fe" xlink:to="loc_ahl_ReservesForLossAndAdjustmentExpensesTextBlock_f3169d47-f626-418a-b0f5-232efd8e5b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxes" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b0029045-e43a-4fba-88f2-6a671a993b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_46d232e9-3c44-412b-95c0-b1c4676d2c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b0029045-e43a-4fba-88f2-6a671a993b5e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_46d232e9-3c44-412b-95c0-b1c4676d2c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructure" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructure"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4e595cf3-1867-4637-9645-48996e3f67f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b2bdbad8-1c94-4cd3-9084-acfe51b15517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4e595cf3-1867-4637-9645-48996e3f67f4" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b2bdbad8-1c94-4cd3-9084-acfe51b15517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictions" xlink:type="simple" xlink:href="ahl-20231220.xsd#StatutoryRequirementsandDividendsRestrictions"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock_3bd5ff90-7c7c-4bef-8db1-43fea13afc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/Dividends" xlink:type="simple" xlink:href="ahl-20231220.xsd#Dividends"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/Dividends" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e49c1af9-1138-47c1-b8fc-2808d11cb009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_9fcdc88d-d3dd-460b-8900-fa4f2fcd744a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e49c1af9-1138-47c1-b8fc-2808d11cb009" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_9fcdc88d-d3dd-460b-8900-fa4f2fcd744a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/RetirementPlans" xlink:type="simple" xlink:href="ahl-20231220.xsd#RetirementPlans"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/RetirementPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93b2548e-7d63-466b-8492-9c65e9cfd6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_8634fe21-5964-4b45-bde5-7a4afc45e551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93b2548e-7d63-466b-8492-9c65e9cfd6c9" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_8634fe21-5964-4b45-bde5-7a4afc45e551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ShareBasedPaymentsandLongTermIncentivePlan" xlink:type="simple" xlink:href="ahl-20231220.xsd#ShareBasedPaymentsandLongTermIncentivePlan"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ShareBasedPaymentsandLongTermIncentivePlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_369603ed-681e-41d4-aa92-0742b13c546b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5898112d-1c95-4972-9c9e-57b3846d46e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_369603ed-681e-41d4-aa92-0742b13c546b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5898112d-1c95-4972-9c9e-57b3846d46e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="ahl-20231220.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9506ba4a-edbc-4de4-b3f6-5140c83640ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_bfb60458-3f33-49a9-adb7-39c7c37eb58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9506ba4a-edbc-4de4-b3f6-5140c83640ef" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_bfb60458-3f33-49a9-adb7-39c7c37eb58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesNotes" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesNotes"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/OperatingLeasesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_69ffc3c2-e570-49bf-bf40-4999cc9b320f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_f246ae0c-f984-42fc-b797-135e6661ab34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69ffc3c2-e570-49bf-bf40-4999cc9b320f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_f246ae0c-f984-42fc-b797-135e6661ab34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="ahl-20231220.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_307bcaa1-14d4-490e-93a3-3c9be1666b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_499c8ad8-fec0-4f6d-bdd4-b51e9afee8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_307bcaa1-14d4-490e-93a3-3c9be1666b59" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_499c8ad8-fec0-4f6d-bdd4-b51e9afee8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c86cd9d-c68e-4166-85b3-d4a1ec4fd143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c3686543-06ea-46bd-b4e0-80d8c6bc8411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c86cd9d-c68e-4166-85b3-d4a1ec4fd143" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c3686543-06ea-46bd-b4e0-80d8c6bc8411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRisk" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRisk"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRisk" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_0f090cbb-42ff-4ac5-a9e2-7e8fa523f21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_196bffc4-5d68-4987-a871-968767bdb598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_0f090cbb-42ff-4ac5-a9e2-7e8fa523f21f" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_196bffc4-5d68-4987-a871-968767bdb598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_419b8546-5905-4c77-b5bc-9c08f6ae0ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_5df5ed1a-5d7c-4ed5-be28-59c6bb80590a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_419b8546-5905-4c77-b5bc-9c08f6ae0ecf" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_5df5ed1a-5d7c-4ed5-be28-59c6bb80590a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_0847eb94-a06b-4fb3-8841-c567cbe5c19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditFacilitiesandShorttermDebt" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditFacilitiesandShorttermDebt"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CreditFacilitiesandShorttermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_39f7379d-9d03-464c-8382-11784d8d9dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_a02effdb-53e3-42d9-9899-af827aa73557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_39f7379d-9d03-464c-8382-11784d8d9dd9" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_a02effdb-53e3-42d9-9899-af827aa73557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditLosses" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditLosses"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract_e5dcd6b7-1175-4f77-bfdf-6c2cb4ad4782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesTextBlock_0e574aec-213e-4e50-8329-52dfe3cf9d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_e5dcd6b7-1175-4f77-bfdf-6c2cb4ad4782" xlink:to="loc_us-gaap_AllowanceForCreditLossesTextBlock_0e574aec-213e-4e50-8329-52dfe3cf9d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SubsequentEvents" xlink:type="simple" xlink:href="ahl-20231220.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_9d729c35-9c0e-4a7b-9ace-c3bfa0563b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_11dd04b2-4985-4669-b65d-cd89ba0824e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_9d729c35-9c0e-4a7b-9ace-c3bfa0563b7b" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_11dd04b2-4985-4669-b65d-cd89ba0824e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIInvestments" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIInvestments"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract_63345874-0e29-4a16-9777-7d44720f0c78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock_80af0b3b-7818-4051-acac-55675b64cc54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract_63345874-0e29-4a16-9777-7d44720f0c78" xlink:to="loc_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock_80af0b3b-7818-4051-acac-55675b64cc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrant" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrant"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_2682488f-1975-4eda-8763-8d4eb93d94b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_a7d45ea3-7504-4468-8ead-b6ce729662fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_2682488f-1975-4eda-8763-8d4eb93d94b8" xlink:to="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_a7d45ea3-7504-4468-8ead-b6ce729662fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIIISupplementaryInsuranceInformation" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIIISupplementaryInsuranceInformation"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIIISupplementaryInsuranceInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementaryInsuranceInformationAbstract_252df0cd-7e17-4c9e-8a99-c9eea94503e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementaryInsuranceInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock_6904631c-33d9-4fb0-9ed5-3b758cb22a27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementaryInsuranceInformationAbstract_252df0cd-7e17-4c9e-8a99-c9eea94503e2" xlink:to="loc_srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock_6904631c-33d9-4fb0-9ed5-3b758cb22a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIVReinsurance" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIVReinsurance"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIVReinsurance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_8719b607-bcc5-43c5-b223-54a391d800cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_56cf4b7d-b29a-4450-91a0-747872ebd104" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_8719b607-bcc5-43c5-b223-54a391d800cf" xlink:to="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_56cf4b7d-b29a-4450-91a0-747872ebd104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleVValuationandQualifyingAccounts" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleVValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleVValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_9c7bd154-3611-4e9d-9a72-fb38f5aea27f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_03954e89-7b89-4be4-a22a-7f3160609cf1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_9c7bd154-3611-4e9d-9a72-fb38f5aea27f" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_03954e89-7b89-4be4-a22a-7f3160609cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/HistoryandOrganization_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#HistoryandOrganization_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/HistoryandOrganization_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7d7b8f58-657a-4c6e-9559-195649c770c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_efae1d58-d767-42a1-8bfc-612d9bced9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d7b8f58-657a-4c6e-9559-195649c770c6" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_efae1d58-d767-42a1-8bfc-612d9bced9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPolicies_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#BasisofPreparationandSignificantAccountingPolicies_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPolicies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6be5ac25-26a2-4e4c-a673-cec2ac856ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_adb3137e-3d83-4a26-b7e5-37bb82cc4af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6be5ac25-26a2-4e4c-a673-cec2ac856ba9" xlink:to="loc_us-gaap_BasisOfAccounting_adb3137e-3d83-4a26-b7e5-37bb82cc4af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReporting_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReporting_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReporting_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9c123b4f-8aaf-4154-9f9d-1264a0466e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_4cf7a5a0-c45e-489f-b901-d0521f94d0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9c123b4f-8aaf-4154-9f9d-1264a0466e2a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_4cf7a5a0-c45e-489f-b901-d0521f94d0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/Investments_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#Investments_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/Investments_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8c9be8d5-6a7d-4b50-be92-b410564228f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c6115af8-9aab-4702-ada8-c4ad31493e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8c9be8d5-6a7d-4b50-be92-b410564228f2" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c6115af8-9aab-4702-ada8-c4ad31493e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurements_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurements_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurements_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0d740298-289d-4fae-95c0-00eb25a19c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_fd1a51a2-4952-4b78-868e-a44ebd070b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0d740298-289d-4fae-95c0-00eb25a19c4c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_fd1a51a2-4952-4b78-868e-a44ebd070b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/Reinsurance_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#Reinsurance_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/Reinsurance_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_1b49ee70-be35-4b55-a759-261c9c32e1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock_63910a06-1dab-4c5d-839e-c8ac2dad020f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_1b49ee70-be35-4b55-a759-261c9c32e1a1" xlink:to="loc_us-gaap_ReinsuranceTextBlock_63910a06-1dab-4c5d-839e-c8ac2dad020f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContracts_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContracts_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContracts_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e660ba2c-cf79-4ec7-8215-3a38ee0d1487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7774b449-925d-4e19-8c3e-87d6f6ff4244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e660ba2c-cf79-4ec7-8215-3a38ee0d1487" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7774b449-925d-4e19-8c3e-87d6f6ff4244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpenses_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpenses_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpenses_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_880ed21f-b63e-40bd-97be-44e3244381d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReservesForLossAndAdjustmentExpensesTextBlock_4dfd9abc-308b-4d3e-a9bc-019ae10ca7de" xlink:href="ahl-20231220.xsd#ahl_ReservesForLossAndAdjustmentExpensesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_880ed21f-b63e-40bd-97be-44e3244381d4" xlink:to="loc_ahl_ReservesForLossAndAdjustmentExpensesTextBlock_4dfd9abc-308b-4d3e-a9bc-019ae10ca7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructure_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructure_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructure_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9b07ab99-1466-4e44-a4d1-c4f06640c9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8350500f-b316-472b-99ce-260528bc59be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9b07ab99-1466-4e44-a4d1-c4f06640c9a0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8350500f-b316-472b-99ce-260528bc59be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/Dividends_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#Dividends_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/Dividends_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0c7539f9-723b-4170-a4d0-5787c64464f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_47ea006e-a033-4eab-bea1-7b43ebbb6cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c7539f9-723b-4170-a4d0-5787c64464f9" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_47ea006e-a033-4eab-bea1-7b43ebbb6cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/RelatedPartyTransactions_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#RelatedPartyTransactions_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/RelatedPartyTransactions_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_e3740b00-1338-4222-85ef-30ea573deaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0945514e-d661-4421-afcf-a0601e657746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_e3740b00-1338-4222-85ef-30ea573deaa4" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0945514e-d661-4421-afcf-a0601e657746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingencies_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingencies_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CommitmentsandContingencies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_63770a88-301e-4545-b339-cb9fa4aa7eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3a763daa-27a6-431f-a4f6-9f1dc92a0f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_63770a88-301e-4545-b339-cb9fa4aa7eb6" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3a763daa-27a6-431f-a4f6-9f1dc92a0f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRisk_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRisk_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRisk_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_87a91306-e874-4aa7-891e-ff3d0571c779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_7da9b28a-1b7e-42bd-a8b5-a1a4eeba4b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_87a91306-e874-4aa7-891e-ff3d0571c779" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_7da9b28a-1b7e-42bd-a8b5-a1a4eeba4b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncome_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncome_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncome_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d0188b8f-e5d2-4a55-ac25-79f9a36d597e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_f0fe4988-cd92-4f7b-9a96-b45045b871b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d0188b8f-e5d2-4a55-ac25-79f9a36d597e" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_f0fe4988-cd92-4f7b-9a96-b45045b871b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SubsequentEvents_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#SubsequentEvents_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SubsequentEvents_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_66e76567-a194-4d98-bf3b-a9c74837005c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_a583fd62-8778-4f54-9de6-a42c2ecd0aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_66e76567-a194-4d98-bf3b-a9c74837005c" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_a583fd62-8778-4f54-9de6-a42c2ecd0aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ahl-20231220.xsd#BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_593ff773-ba90-4308-8473-db02e24aa260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_UseOfEstimates_593ff773-ba90-4308-8473-db02e24aa260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock_728952c9-7f74-435a-9b06-b3fe02da6545" xlink:href="ahl-20231220.xsd#ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_ahl_AccountingForInsuranceAndReinsuranceOperationsPolicyTextBlock_728952c9-7f74-435a-9b06-b3fe02da6545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock_9e9fa344-c71f-40a0-bb2b-af1da45859db" xlink:href="ahl-20231220.xsd#ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_ahl_AccountingForInvestmentsCashAndCashEquivalentsPolicyTextBlock_9e9fa344-c71f-40a0-bb2b-af1da45859db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_4933743d-cd0f-4d8c-a39f-d86ed3d54fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_4933743d-cd0f-4d8c-a39f-d86ed3d54fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_aaaa7eae-ebe7-4838-adb3-c157de0747b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_aaaa7eae-ebe7-4838-adb3-c157de0747b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_76fcc690-88bc-43be-9d50-58086d6cc0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_76fcc690-88bc-43be-9d50-58086d6cc0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_76ecf550-2c84-4f72-970f-c9f102088bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_76ecf550-2c84-4f72-970f-c9f102088bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_af16a3b8-c304-4bf1-bea3-4a38bd99a0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_af16a3b8-c304-4bf1-bea3-4a38bd99a0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_ad98f2a5-9d0d-459b-abc7-3ae51132d1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_ad98f2a5-9d0d-459b-abc7-3ae51132d1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferenceSharesPolicyTextBlock_5dd845f6-6bab-4f8f-b52f-6e1b77828828" xlink:href="ahl-20231220.xsd#ahl_PreferenceSharesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_ahl_PreferenceSharesPolicyTextBlock_5dd845f6-6bab-4f8f-b52f-6e1b77828828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d17a0d1c-47bc-4cdd-a486-925b79ccf4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d17a0d1c-47bc-4cdd-a486-925b79ccf4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_8cf77a5d-bb34-41d9-9deb-1a5d5f0b31da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_8cf77a5d-bb34-41d9-9deb-1a5d5f0b31da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5434c43a-9951-4528-bcd2-b519079d310b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_728b0d37-4617-4cb6-9d1a-25c69b173553" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5434c43a-9951-4528-bcd2-b519079d310b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesBasisofPreparationandSignificantAccountingPoliciesPolicies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ae6974a4-d107-46ad-a699-922c05145393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4d59b51d-236d-4206-8ae6-e287088c51ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae6974a4-d107-46ad-a699-922c05145393" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4d59b51d-236d-4206-8ae6-e287088c51ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f6018240-c518-4f9f-84b7-37bed3549deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_14ae1f83-f78b-487c-ab52-34f1524bc1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f6018240-c518-4f9f-84b7-37bed3549deb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_14ae1f83-f78b-487c-ab52-34f1524bc1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_fbd742c0-1075-4758-b19d-dd8f112ec9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f6018240-c518-4f9f-84b7-37bed3549deb" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_fbd742c0-1075-4758-b19d-dd8f112ec9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_6d9135a2-b298-4d8c-bbc7-64450d1202ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_6d9135a2-b298-4d8c-bbc7-64450d1202ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_61c6c8f7-e4d2-4965-b098-d2fc5c4c9eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_61c6c8f7-e4d2-4965-b098-d2fc5c4c9eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_e6a945f8-3eec-4c25-b8c3-1475fc2910ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_e6a945f8-3eec-4c25-b8c3-1475fc2910ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_b8d53ae8-3030-4d19-8688-f3f1b28f1baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_b8d53ae8-3030-4d19-8688-f3f1b28f1baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock_04f7cb60-64b0-4062-9c30-e152769d753f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock_04f7cb60-64b0-4062-9c30-e152769d753f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_2e6d736c-9ea9-43f2-b5f6-8789e203b43f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_2e6d736c-9ea9-43f2-b5f6-8789e203b43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_94c0f455-2eeb-4f16-9cb3-ce44b094471d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_94c0f455-2eeb-4f16-9cb3-ce44b094471d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_ade482bb-13e2-4924-8b9f-b2f5571d91d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_ade482bb-13e2-4924-8b9f-b2f5571d91d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_09b26b4a-6ba5-4260-8fe7-d5ff777f8e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_09b26b4a-6ba5-4260-8fe7-d5ff777f8e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_d5bd8e81-9c84-475f-908c-657a897ba32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e42a739d-8f96-4495-afaa-11881c3a670e" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_d5bd8e81-9c84-475f-908c-657a897ba32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_beb06c98-44b5-4351-9ed4-bc33661a9221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_17c8ac6c-15ef-46ea-978a-bf25cf037896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_beb06c98-44b5-4351-9ed4-bc33661a9221" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_17c8ac6c-15ef-46ea-978a-bf25cf037896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f4521f39-29b9-466d-8e6f-f1f08e478c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_beb06c98-44b5-4351-9ed4-bc33661a9221" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f4521f39-29b9-466d-8e6f-f1f08e478c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_b73e8fb6-2db9-438a-8d0c-f29d30cea40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_beb06c98-44b5-4351-9ed4-bc33661a9221" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_b73e8fb6-2db9-438a-8d0c-f29d30cea40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReinsuranceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_44fc97a1-f4a2-4f0f-bd6c-4da0bb222809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_059609cb-4bf8-4e5c-9301-36a820b71494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_44fc97a1-f4a2-4f0f-bd6c-4da0bb222809" xlink:to="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_059609cb-4bf8-4e5c-9301-36a820b71494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d5982503-c3a5-4e06-8f19-39dc48b3ac7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_c41bde90-ad61-4b6c-a5b8-8c35335539db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d5982503-c3a5-4e06-8f19-39dc48b3ac7a" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_c41bde90-ad61-4b6c-a5b8-8c35335539db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ef8c5908-b9b9-4a1c-8523-e3456e1ede1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d5982503-c3a5-4e06-8f19-39dc48b3ac7a" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ef8c5908-b9b9-4a1c-8523-e3456e1ede1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DeferredPolicyAcquisitionCostsTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#DeferredPolicyAcquisitionCostsTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DeferredPolicyAcquisitionCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_57cde4c2-7f3a-4b39-89cc-8d53757e364f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_fa828d45-c7b6-412f-81af-777709a96f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_57cde4c2-7f3a-4b39-89cc-8d53757e364f" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_fa828d45-c7b6-412f-81af-777709a96f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_6688c297-8fa4-41e0-a112-c8a44a085422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_300646ad-bd8d-4b62-9f76-df4a63e1832d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_6688c297-8fa4-41e0-a112-c8a44a085422" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_300646ad-bd8d-4b62-9f76-df4a63e1832d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_cdda768b-4eaf-4482-b06d-1ca48b9784cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_6688c297-8fa4-41e0-a112-c8a44a085422" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_cdda768b-4eaf-4482-b06d-1ca48b9784cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_699067d0-389a-4319-a520-02f31d7294f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_6688c297-8fa4-41e0-a112-c8a44a085422" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_699067d0-389a-4319-a520-02f31d7294f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock_36da5523-7b55-41bb-9270-4c4f5144fbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_6688c297-8fa4-41e0-a112-c8a44a085422" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock_36da5523-7b55-41bb-9270-4c4f5144fbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4e5275f2-2287-4c7a-8345-937a11ba6fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock_5031b66a-969e-4af7-95c1-323141129101" xlink:href="ahl-20231220.xsd#ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4e5275f2-2287-4c7a-8345-937a11ba6fcb" xlink:to="loc_ahl_ScheduleOfIncomeTaxExpenseBenefitIntraperiodTaxAllocationTableTextBlock_5031b66a-969e-4af7-95c1-323141129101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_5880ab32-45ce-449a-a76a-dca2a3cf2019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4e5275f2-2287-4c7a-8345-937a11ba6fcb" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_5880ab32-45ce-449a-a76a-dca2a3cf2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_837b23cd-5a7f-419a-832e-5c130d65076f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4e5275f2-2287-4c7a-8345-937a11ba6fcb" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_837b23cd-5a7f-419a-832e-5c130d65076f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_73a09116-d0f7-4e3a-b9a0-4eb2d09c13fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4e5275f2-2287-4c7a-8345-937a11ba6fcb" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_73a09116-d0f7-4e3a-b9a0-4eb2d09c13fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e45e814a-dc90-41c3-8671-b836369b0e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_35d20a3a-5cf0-4e9b-8adc-dcae58749fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e45e814a-dc90-41c3-8671-b836369b0e78" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_35d20a3a-5cf0-4e9b-8adc-dcae58749fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#StatutoryRequirementsandDividendsRestrictionsTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract_0ba4c06d-416a-40e3-9e5b-fc918fa67929" xlink:href="ahl-20231220.xsd#ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock_02d55e19-718f-4c01-83cb-325157b9f85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract_0ba4c06d-416a-40e3-9e5b-fc918fa67929" xlink:to="loc_us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock_02d55e19-718f-4c01-83cb-325157b9f85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DividendsTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#DividendsTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DividendsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_08667168-4396-4b5d-b7e1-7b41783e9cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDividendsPayableTextBlock_5a8e830a-c8b8-47da-81e0-f44c201ce1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDividendsPayableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_08667168-4396-4b5d-b7e1-7b41783e9cd1" xlink:to="loc_us-gaap_ScheduleOfDividendsPayableTextBlock_5a8e830a-c8b8-47da-81e0-f44c201ce1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_708524f5-0d23-4708-99ab-dbddcb7a760f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_d5cfea46-29c5-4e84-a46f-fccdaf7c7cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_708524f5-0d23-4708-99ab-dbddcb7a760f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_d5cfea46-29c5-4e84-a46f-fccdaf7c7cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c774af6f-f715-42eb-80b8-4674786a19a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_0671f1cd-eccb-41bf-8d61-7f7a0a674bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c774af6f-f715-42eb-80b8-4674786a19a1" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_0671f1cd-eccb-41bf-8d61-7f7a0a674bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_75db042b-5442-4b5d-a2ee-8ba36a8620e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c774af6f-f715-42eb-80b8-4674786a19a1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_75db042b-5442-4b5d-a2ee-8ba36a8620e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SummaryofOtherLeaseInformationTableTextBlock_553b130b-fc81-40cb-86ee-02e6f7fd5441" xlink:href="ahl-20231220.xsd#ahl_SummaryofOtherLeaseInformationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c774af6f-f715-42eb-80b8-4674786a19a1" xlink:to="loc_ahl_SummaryofOtherLeaseInformationTableTextBlock_553b130b-fc81-40cb-86ee-02e6f7fd5441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3351abdf-f95d-436b-aee0-20ef80520570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_54e0cb5a-f6e6-44e4-9f86-cb1797429ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3351abdf-f95d-436b-aee0-20ef80520570" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_54e0cb5a-f6e6-44e4-9f86-cb1797429ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRiskTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRiskTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_01e9cbce-ee56-4f8d-a624-851f79844287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock_fbdcd1bb-4c52-4861-b043-efb05c92558c" xlink:href="ahl-20231220.xsd#ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_01e9cbce-ee56-4f8d-a624-851f79844287" xlink:to="loc_ahl_ScheduleOfGrossWrittenPremiumFromMajorBrokersTableTextBlock_fbdcd1bb-4c52-4861-b043-efb05c92558c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0238de8d-f206-4997-897a-e3ec38f42c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_829894ac-c737-4ec3-aabb-da143c67d94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0238de8d-f206-4997-897a-e3ec38f42c3a" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_829894ac-c737-4ec3-aabb-da143c67d94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditFacilityandShorttermDebtTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditFacilityandShorttermDebtTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CreditFacilityandShorttermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f4062464-fff6-470d-b688-ee85eba84e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_05a276f8-04f0-498f-8d96-077f54a45d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f4062464-fff6-470d-b688-ee85eba84e9a" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_05a276f8-04f0-498f-8d96-077f54a45d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditLossesTables" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract_28e44a45-45f9-464e-b961-db55e6140303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock_5a81920d-d62f-45ef-a480-a1678c80d677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_28e44a45-45f9-464e-b961-db55e6140303" xlink:to="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossTableTextBlock_5a81920d-d62f-45ef-a480-a1678c80d677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReportingTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b42bc6d5-319b-40bc-81a9-ecb95c3340db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_06bd7c87-aab5-4ac7-a6f1-757f36a750d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b42bc6d5-319b-40bc-81a9-ecb95c3340db" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_06bd7c87-aab5-4ac7-a6f1-757f36a750d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_544a582e-0555-4542-8393-07b680730ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_544a582e-0555-4542-8393-07b680730ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_1dbd5c64-ce3f-4a2b-92d5-74d6079a1632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_1dbd5c64-ce3f-4a2b-92d5-74d6079a1632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_eb6783f7-9146-4d25-bb55-d880332bb5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_eb6783f7-9146-4d25-bb55-d880332bb5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_39931aad-a9f6-43fe-9a46-cd9dce3202a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_39931aad-a9f6-43fe-9a46-cd9dce3202a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock_472a911f-357f-4571-82c6-f73054d5aaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_ScheduleOfParticipatingMortgageLoansTextBlock_472a911f-357f-4571-82c6-f73054d5aaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_7888e10b-c01b-437e-8420-5b79879b2a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_7888e10b-c01b-437e-8420-5b79879b2a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_cbddc37f-3a6d-4ba8-9325-d7855185d852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_cbddc37f-3a6d-4ba8-9325-d7855185d852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_5f89e47e-110f-4fcd-a9ef-8fd39003bb85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_5f89e47e-110f-4fcd-a9ef-8fd39003bb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_41df94f3-a79d-4cc9-8f58-9720a582decd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_41df94f3-a79d-4cc9-8f58-9720a582decd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_14dc7c05-86d6-44d1-b536-108b4643bcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc8b4ba5-d2eb-406b-a892-c2e15c85ca14" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_14dc7c05-86d6-44d1-b536-108b4643bcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9ffd6096-8cd2-4f57-931d-5855f879cf5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_519fa597-4cbc-4acf-b70c-3e5282cde7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ffd6096-8cd2-4f57-931d-5855f879cf5f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_519fa597-4cbc-4acf-b70c-3e5282cde7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_137ab3e8-1fb0-4249-a49c-c0746d891936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ffd6096-8cd2-4f57-931d-5855f879cf5f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_137ab3e8-1fb0-4249-a49c-c0746d891936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_203fbfc2-0071-48e2-b83c-2e94bdeb89a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ffd6096-8cd2-4f57-931d-5855f879cf5f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_203fbfc2-0071-48e2-b83c-2e94bdeb89a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReinsuranceTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_2fd597e2-dfb4-48fc-b8d8-ebdb79365892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_592f8ae6-889e-4624-8ef5-3bcacdec52d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_2fd597e2-dfb4-48fc-b8d8-ebdb79365892" xlink:to="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_592f8ae6-889e-4624-8ef5-3bcacdec52d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b8c95e75-b76e-4ce6-a8a7-88f908650aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a8cc93cc-085c-4672-ba92-5ff43e714e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b8c95e75-b76e-4ce6-a8a7-88f908650aba" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_a8cc93cc-085c-4672-ba92-5ff43e714e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8d036da9-5e62-4f52-8da8-895ab46ecbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b8c95e75-b76e-4ce6-a8a7-88f908650aba" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8d036da9-5e62-4f52-8da8-895ab46ecbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_b5b8f553-9757-4638-98c0-5aa5ab7fc29e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_e25b008d-9293-41c7-99d4-43efe45195a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b5b8f553-9757-4638-98c0-5aa5ab7fc29e" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_e25b008d-9293-41c7-99d4-43efe45195a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4e55f9b3-e2e4-48da-bdbf-bfb595117ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_89521cb9-1409-46a9-8045-a8b4ee61cafd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4e55f9b3-e2e4-48da-bdbf-bfb595117ebc" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_89521cb9-1409-46a9-8045-a8b4ee61cafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DividendsTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DividendsTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DividendsTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7033b9e6-e186-4ac8-a132-2ad4d1bd5d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDividendsPayableTextBlock_b7bcef84-d04b-4428-8206-1ef8af1edaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDividendsPayableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7033b9e6-e186-4ac8-a132-2ad4d1bd5d36" xlink:to="loc_us-gaap_ScheduleOfDividendsPayableTextBlock_b7bcef84-d04b-4428-8206-1ef8af1edaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0a6ccac7-00f8-4b96-88d1-3e7e21a26e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_fad762d5-d15a-4606-865a-091ecd6bec3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0a6ccac7-00f8-4b96-88d1-3e7e21a26e1b" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_fad762d5-d15a-4606-865a-091ecd6bec3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRiskTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRiskTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_e71e209c-02e4-4f1b-a9f3-0a72e79e93e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9cffe3e9-5e96-49fd-8409-e242c5641bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3f257703-6349-43e9-a4a9-3205e1754fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9cffe3e9-5e96-49fd-8409-e242c5641bd0" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3f257703-6349-43e9-a4a9-3205e1754fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#BasisofPreparationandSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/BasisofPreparationandSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_11859667-a059-4083-974d-d430e5548780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_11859667-a059-4083-974d-d430e5548780" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_adc11984-3460-42b7-9c41-6cd4ca3b2af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:to="loc_us-gaap_InvestmentTypeAxis_adc11984-3460-42b7-9c41-6cd4ca3b2af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_5560ed1e-7cf5-4824-b94c-604f7b372bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_adc11984-3460-42b7-9c41-6cd4ca3b2af1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_5560ed1e-7cf5-4824-b94c-604f7b372bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_998a2682-e1a3-4505-8257-e5113746de30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5560ed1e-7cf5-4824-b94c-604f7b372bbb" xlink:to="loc_us-gaap_FixedMaturitiesMember_998a2682-e1a3-4505-8257-e5113746de30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6fc4389-f4c8-4178-82d2-fd8eda9fb654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6fc4389-f4c8-4178-82d2-fd8eda9fb654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6fc4389-f4c8-4178-82d2-fd8eda9fb654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_1358c4dd-bdbf-4b75-a418-1591182f5eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:to="loc_us-gaap_ComputerEquipmentMember_1358c4dd-bdbf-4b75-a418-1591182f5eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_6b8b2466-fde0-4797-9e9d-06a1bfff04ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_6b8b2466-fde0-4797-9e9d-06a1bfff04ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_974fa846-2d96-4c28-b00f-7bd3aaca2ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47a4fa04-c70d-485e-9c6a-8eab5a9a2aa7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_974fa846-2d96-4c28-b00f-7bd3aaca2ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d726a073-6eca-4421-9e5d-6abd2f714590" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:to="loc_srt_RangeAxis_d726a073-6eca-4421-9e5d-6abd2f714590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2d570882-167c-47ff-a083-1b37bb6fd009" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d726a073-6eca-4421-9e5d-6abd2f714590" xlink:to="loc_srt_RangeMember_2d570882-167c-47ff-a083-1b37bb6fd009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d9d1d779-806a-40ac-b453-fca3e3331d51" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2d570882-167c-47ff-a083-1b37bb6fd009" xlink:to="loc_srt_MinimumMember_d9d1d779-806a-40ac-b453-fca3e3331d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_412288ba-03f8-4a3c-a538-d9f03cf88c89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2d570882-167c-47ff-a083-1b37bb6fd009" xlink:to="loc_srt_MaximumMember_412288ba-03f8-4a3c-a538-d9f03cf88c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_769bc9ed-89a9-4a67-9928-7cee4faf46c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e572bd02-397f-4a7f-999a-3999b14c0eef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_769bc9ed-89a9-4a67-9928-7cee4faf46c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3eb27bac-0fe2-4d48-b63e-100788775c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_769bc9ed-89a9-4a67-9928-7cee4faf46c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3eb27bac-0fe2-4d48-b63e-100788775c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonPaymentOfDividendsNumberOfPeriods_fc17205c-ec89-442c-b448-10ecc9c4259f" xlink:href="ahl-20231220.xsd#ahl_NonPaymentOfDividendsNumberOfPeriods"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_769bc9ed-89a9-4a67-9928-7cee4faf46c2" xlink:to="loc_ahl_NonPaymentOfDividendsNumberOfPeriods_fc17205c-ec89-442c-b448-10ecc9c4259f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingAdditionalInformationNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingAdditionalInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReportingAdditionalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5691d829-a2c0-4888-b50c-c5d65995cd05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_bc67b96a-66db-440e-ba72-379b0de7e97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5691d829-a2c0-4888-b50c-c5d65995cd05" xlink:to="loc_us-gaap_NumberOfReportableSegments_bc67b96a-66db-440e-ba72-379b0de7e97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6de1c46e-1de4-412d-93a0-7092cce058f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6de1c46e-1de4-412d-93a0-7092cce058f7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_04585f6f-cef6-4df9-b378-ed2240ef402b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:to="loc_srt_ConsolidationItemsAxis_04585f6f-cef6-4df9-b378-ed2240ef402b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3fce300d-b209-40e8-a89f-d782d3f606ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_04585f6f-cef6-4df9-b378-ed2240ef402b" xlink:to="loc_srt_ConsolidationItemsDomain_3fce300d-b209-40e8-a89f-d782d3f606ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_18a6a622-5978-4ac0-8c55-a953e6dce628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3fce300d-b209-40e8-a89f-d782d3f606ba" xlink:to="loc_us-gaap_OperatingSegmentsMember_18a6a622-5978-4ac0-8c55-a953e6dce628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3dcd1f61-d10e-419b-b8fb-74dea21a62f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3dcd1f61-d10e-419b-b8fb-74dea21a62f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fed8343b-8d4a-434f-8eff-a3636d27a637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3dcd1f61-d10e-419b-b8fb-74dea21a62f0" xlink:to="loc_us-gaap_SegmentDomain_fed8343b-8d4a-434f-8eff-a3636d27a637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_b25f7755-b3f7-427b-88d6-f389897223df" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fed8343b-8d4a-434f-8eff-a3636d27a637" xlink:to="loc_ahl_ReinsuranceMember_b25f7755-b3f7-427b-88d6-f389897223df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_994bf419-6b07-455d-9c7a-a592b58ae0d4" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fed8343b-8d4a-434f-8eff-a3636d27a637" xlink:to="loc_ahl_InsuranceMember_994bf419-6b07-455d-9c7a-a592b58ae0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e8f7923-0c11-4c67-8a9b-1d3ae5b79d19" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_75e74628-138a-4630-b258-a8b17335acaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_PremiumsWrittenGross_75e74628-138a-4630-b258-a8b17335acaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_97d19371-eadd-4796-91d4-0c7b01deb198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_PremiumsWrittenNet_97d19371-eadd-4796-91d4-0c7b01deb198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsEarnedGross_4113b3cb-a9b4-409e-ad23-45b2d2c092cd" xlink:href="ahl-20231220.xsd#ahl_PremiumsEarnedGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_PremiumsEarnedGross_4113b3cb-a9b4-409e-ad23-45b2d2c092cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_8e68d133-a56b-4a66-8a38-432de286b55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_PremiumsEarnedNet_8e68d133-a56b-4a66-8a38-432de286b55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e07bb421-5202-4350-9a97-dc0e44d1ecaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e07bb421-5202-4350-9a97-dc0e44d1ecaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_6bb464c1-5138-4b65-b4df-d2b692cec1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_6bb464c1-5138-4b65-b4df-d2b692cec1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_65ebee8f-db39-4448-861b-da4fffe079b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_65ebee8f-db39-4448-861b-da4fffe079b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingIncomeLoss_e79a561e-371d-49b4-b79a-95594eb0ef78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_UnderwritingIncomeLoss_e79a561e-371d-49b4-b79a-95594eb0ef78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateExpenses_dfac1856-784f-4901-9a84-673118cdb3b7" xlink:href="ahl-20231220.xsd#ahl_CorporateExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_CorporateExpenses_dfac1856-784f-4901-9a84-673118cdb3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a2de2951-2d35-4895-9cb9-f2c488ddf033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a2de2951-2d35-4895-9cb9-f2c488ddf033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_293e4134-dbac-4cc9-808f-6b9cfe541773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_NetInvestmentIncome_293e4134-dbac-4cc9-808f-6b9cfe541773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_e58c8458-515f-4e5f-ac04-2e782c1d45c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_GainLossOnInvestments_e58c8458-515f-4e5f-ac04-2e782c1d45c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_b040ec0b-9646-49cb-a19b-c9b4ae4f9d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_b040ec0b-9646-49cb-a19b-c9b4ae4f9d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0af60362-70ec-4024-ae20-743000d6da7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0af60362-70ec-4024-ae20-743000d6da7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8af49c72-3303-40ab-8f40-53cd5a50dba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_InterestExpenseDebt_8af49c72-3303-40ab-8f40-53cd5a50dba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_acf6833f-bc52-4d75-a65a-df09051b643d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_acf6833f-bc52-4d75-a65a-df09051b643d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_5f68b27a-39e1-42b1-b84f-92bf3d0b31b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_OtherIncome_5f68b27a-39e1-42b1-b84f-92bf3d0b31b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_09b0bef8-1ee6-4823-a4a8-14ab64910bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_OtherExpenses_09b0bef8-1ee6-4823-a4a8-14ab64910bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c32718cb-00e6-48a3-843d-64845a626228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c32718cb-00e6-48a3-843d-64845a626228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_199971ee-c354-4ac1-91cd-787dc49a7311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_199971ee-c354-4ac1-91cd-787dc49a7311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aaf9f426-b0a0-4b49-a23f-4371e4e87c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_ProfitLoss_aaf9f426-b0a0-4b49-a23f-4371e4e87c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a6959e1b-413f-4d51-a1e0-455457bbb4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a6959e1b-413f-4d51-a1e0-455457bbb4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_f8b8f09d-0764-4f03-94e9-5a3742ba1bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_f8b8f09d-0764-4f03-94e9-5a3742ba1bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceRatiosAbstract"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossRatio_f8a94dba-6a7f-4474-883e-af6e8a017c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_LossRatio_f8a94dba-6a7f-4474-883e-af6e8a017c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCostRatio_6e793f94-8d29-471f-9f23-a7318ba56445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCostRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_AcquisitionCostRatio_6e793f94-8d29-471f-9f23-a7318ba56445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_f25c995a-5616-41af-965d-9dc5cf2d2a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_f25c995a-5616-41af-965d-9dc5cf2d2a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingExpenseRatio_bd2fe5b9-5efe-440e-adc2-abf04f0c1e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_UnderwritingExpenseRatio_bd2fe5b9-5efe-440e-adc2-abf04f0c1e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CombinedRatio_afd85968-13e8-4ab1-be76-bfe93d81e67c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CombinedRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_e39f3fb9-6dd0-4152-b9bf-a1ce95c5c7c4" xlink:to="loc_us-gaap_CombinedRatio_afd85968-13e8-4ab1-be76-bfe93d81e67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff_e0d589a5-a458-4bed-bf7a-df1b1de69843" xlink:href="ahl-20231220.xsd#ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_NonOperatingExpensesRelatedToFixedIncomeWriteoff_e0d589a5-a458-4bed-bf7a-df1b1de69843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts_49681a6f-c588-49e2-9ca4-b7307fb72a69" xlink:href="ahl-20231220.xsd#ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_NonOperatingExpensesRelatedToSeveranceRetentionAwardsAndOtherNonRecurringCosts_49681a6f-c588-49e2-9ca4-b7307fb72a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_de07e718-ee58-4467-b720-85775cda2289" xlink:href="ahl-20231220.xsd#ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_de07e718-ee58-4467-b720-85775cda2289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonoperatingexpensesrelatedtoMergerAgreement_b1a32991-ab0a-498f-8497-c94c715e287f" xlink:href="ahl-20231220.xsd#ahl_NonoperatingexpensesrelatedtoMergerAgreement"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_NonoperatingexpensesrelatedtoMergerAgreement_b1a32991-ab0a-498f-8497-c94c715e287f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram_77bdf836-e3b5-4c4d-a086-7f8f0ef39f2e" xlink:href="ahl-20231220.xsd#ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_ahl_NonoperatingExpensesRelatedToEffectivenessAndEfficiencyProgram_77bdf836-e3b5-4c4d-a086-7f8f0ef39f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4e080dba-f82d-4be6-bec6-21c88faf0d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c819b6b6-d708-40bc-bb55-e8478857c503" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4e080dba-f82d-4be6-bec6-21c88faf0d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingSummaryoftheScheduleoftheCompanysgrosswrittenpremiumsbasedonthelocationoftheinsuredriskDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingSummaryoftheScheduleoftheCompanysgrosswrittenpremiumsbasedonthelocationoftheinsuredriskDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReportingSummaryoftheScheduleoftheCompanysgrosswrittenpremiumsbasedonthelocationoftheinsuredriskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9cd6258c-2381-4289-8e93-dfbc1c3c1d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b291e21-5778-4f6a-90ef-a03b8531b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9cd6258c-2381-4289-8e93-dfbc1c3c1d1e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b291e21-5778-4f6a-90ef-a03b8531b79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2fa2d145-d7ba-4788-8674-929a7f2b8c01" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b291e21-5778-4f6a-90ef-a03b8531b79a" xlink:to="loc_srt_StatementGeographicalAxis_2fa2d145-d7ba-4788-8674-929a7f2b8c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2fa2d145-d7ba-4788-8674-929a7f2b8c01" xlink:to="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_f74cc9be-6805-40c5-ad9f-944c9d72d945" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_srt_AsiaPacificMember_f74cc9be-6805-40c5-ad9f-944c9d72d945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b1ab1488-c091-4e4b-956b-2e3c44f4f58a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_srt_EuropeMember_b1ab1488-c091-4e4b-956b-2e3c44f4f58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_bb030038-25c7-49a8-a775-f73f6f14631d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_country_GB_bb030038-25c7-49a8-a775-f73f6f14631d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UnitedStatesAndCanadaMember_d3ec3dab-1e04-49c3-8bf2-5f0e2833ed95" xlink:href="ahl-20231220.xsd#ahl_UnitedStatesAndCanadaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_ahl_UnitedStatesAndCanadaMember_d3ec3dab-1e04-49c3-8bf2-5f0e2833ed95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_47c41fc7-bad2-4e48-a2c1-a77ee6cd3c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_us-gaap_NonUsMember_47c41fc7-bad2-4e48-a2c1-a77ee6cd3c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_WorldwideIncludingUnitedStatesMember_9fa62357-40cc-491e-97e1-d22ee0c6b6a7" xlink:href="ahl-20231220.xsd#ahl_WorldwideIncludingUnitedStatesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_ahl_WorldwideIncludingUnitedStatesMember_9fa62357-40cc-491e-97e1-d22ee0c6b6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherCountriesMember_548b57cc-05e0-48c1-aa90-75c01f0dfc49" xlink:href="ahl-20231220.xsd#ahl_OtherCountriesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dcbc0fe5-d91a-4ecd-8f6f-3363df2adb14" xlink:to="loc_ahl_OtherCountriesMember_548b57cc-05e0-48c1-aa90-75c01f0dfc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5fabc71b-5a72-4918-8519-7fbe2743c411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b291e21-5778-4f6a-90ef-a03b8531b79a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5fabc71b-5a72-4918-8519-7fbe2743c411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_7d21117a-fa58-49a8-9c4e-aeddf683f42d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fabc71b-5a72-4918-8519-7fbe2743c411" xlink:to="loc_us-gaap_PremiumsWrittenGross_7d21117a-fa58-49a8-9c4e-aeddf683f42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dcda92be-5ec1-448f-aedf-4eb598e8d4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dcda92be-5ec1-448f-aedf-4eb598e8d4ad" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca907328-857b-4281-b8f2-27e2fd56b059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca907328-857b-4281-b8f2-27e2fd56b059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd013a9f-78ba-408b-a170-ef36c530ada1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca907328-857b-4281-b8f2-27e2fd56b059" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd013a9f-78ba-408b-a170-ef36c530ada1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_e7673f6e-4e9a-4aab-ac43-f33a4be722ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd013a9f-78ba-408b-a170-ef36c530ada1" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_e7673f6e-4e9a-4aab-ac43-f33a4be722ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_6ddcaca4-ca08-4136-9ba0-dc86f0614f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:to="loc_us-gaap_InvestmentTypeAxis_6ddcaca4-ca08-4136-9ba0-dc86f0614f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_6ddcaca4-ca08-4136-9ba0-dc86f0614f19" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b5b7cc6e-7117-4881-9ce7-19dfeb8b03cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_DebtSecuritiesMember_b5b7cc6e-7117-4881-9ce7-19dfeb8b03cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_fb6cde45-52b5-4bc9-8a39-13d200d2bafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_fb6cde45-52b5-4bc9-8a39-13d200d2bafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShorttermInvestmentTradingMember_54c09f48-342a-4a91-afdb-5e78b6a7b6d7" xlink:href="ahl-20231220.xsd#ahl_ShorttermInvestmentTradingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_ahl_ShorttermInvestmentTradingMember_54c09f48-342a-4a91-afdb-5e78b6a7b6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_e1942466-1b56-4214-8d11-485f22f7c750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_e1942466-1b56-4214-8d11-485f22f7c750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_04d9d0d3-77ac-43a7-b4a2-000212ed6836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_EquitySecuritiesMember_04d9d0d3-77ac-43a7-b4a2-000212ed6836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember_392b4785-f430-4d78-96b3-2d2f8cda8c7f" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_ahl_CatastropheBondsMember_392b4785-f430-4d78-96b3-2d2f8cda8c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_b112dbcc-9c9c-47c9-8426-694a11e8320f" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_b112dbcc-9c9c-47c9-8426-694a11e8320f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_5a948e71-d1da-4126-931c-a10efaf18fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_38bc6a7f-bca9-41a1-aee8-6fadc822da7b" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_5a948e71-d1da-4126-931c-a10efaf18fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_944fca4f-392a-411b-af66-b1bfe18384f3" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_cd132043-c9f9-41c3-84fe-ccb0bff3a462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_cd132043-c9f9-41c3-84fe-ccb0bff3a462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_f5a612c8-3e08-455c-9c36-1b1dcff71750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_f5a612c8-3e08-455c-9c36-1b1dcff71750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_2fb6fa20-6b1b-4408-9b00-8a138e7334e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_6701e4cd-ad5d-4f6e-b8f0-58ae84cbbc81" xlink:to="loc_us-gaap_NetInvestmentIncome_2fb6fa20-6b1b-4408-9b00-8a138e7334e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_827d196c-4873-4e7c-b180-41d028687aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_827d196c-4873-4e7c-b180-41d028687aad" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_bcd93373-ba70-4603-8526-2dc94220b698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_bcd93373-ba70-4603-8526-2dc94220b698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0c6d58c8-5d6a-4357-a395-63582ad9efdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_bcd93373-ba70-4603-8526-2dc94220b698" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0c6d58c8-5d6a-4357-a395-63582ad9efdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_95542a09-f775-447c-8634-d698184e50b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0c6d58c8-5d6a-4357-a395-63582ad9efdf" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_95542a09-f775-447c-8634-d698184e50b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_27470751-7fc3-448d-b841-04a47f7807eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_27470751-7fc3-448d-b841-04a47f7807eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_27470751-7fc3-448d-b841-04a47f7807eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_ba0f0da0-5f3b-4c6c-9364-4cf0ecf27507" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:to="loc_ahl_MVIMember_ba0f0da0-5f3b-4c6c-9364-4cf0ecf27507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_0940e403-56f1-41fe-972c-cd6f1e6955c3" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:to="loc_ahl_MultiLineReinsurerMember_0940e403-56f1-41fe-972c-cd6f1e6955c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_02046ead-37f1-4bb2-b2d0-47aa3da6abb6" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:to="loc_ahl_DigitalRiskMember_02046ead-37f1-4bb2-b2d0-47aa3da6abb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_55c0a0dd-7987-4e78-9d29-cfc72f281295" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5513ad66-31d2-497e-a23f-b78f4df83cce" xlink:to="loc_ahl_BeneAssicurazioniMember_55c0a0dd-7987-4e78-9d29-cfc72f281295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_041f4872-0bd5-46f6-949c-f63c4b67f40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_us-gaap_InvestmentTypeAxis_041f4872-0bd5-46f6-949c-f63c4b67f40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_cbbb269c-5474-46e6-a0cd-35175e8066ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_041f4872-0bd5-46f6-949c-f63c4b67f40b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_cbbb269c-5474-46e6-a0cd-35175e8066ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a6bc292e-2f47-4b3e-ad64-289899a708fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cbbb269c-5474-46e6-a0cd-35175e8066ae" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a6bc292e-2f47-4b3e-ad64-289899a708fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_a7989d5f-4029-4be2-bd68-20d8a9b0eef7" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cbbb269c-5474-46e6-a0cd-35175e8066ae" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_a7989d5f-4029-4be2-bd68-20d8a9b0eef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d92696d4-efb7-4979-b1bb-ec0601721c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d92696d4-efb7-4979-b1bb-ec0601721c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6aa626b5-b3fd-4ed8-bfce-3e71adb3543e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d92696d4-efb7-4979-b1bb-ec0601721c15" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6aa626b5-b3fd-4ed8-bfce-3e71adb3543e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_07bed637-7600-4679-b05a-ae483491e3a4" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6aa626b5-b3fd-4ed8-bfce-3e71adb3543e" xlink:to="loc_ahl_BeneAssicurazioniMember_07bed637-7600-4679-b05a-ae483491e3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CropReMember_1b104594-e7a8-4f13-8add-c9200b8d1837" xlink:href="ahl-20231220.xsd#ahl_CropReMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6aa626b5-b3fd-4ed8-bfce-3e71adb3543e" xlink:to="loc_ahl_CropReMember_1b104594-e7a8-4f13-8add-c9200b8d1837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_60853e30-707d-4d18-b53a-00d404481110" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_de42df49-6db6-422e-ae4b-f504e893edff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_de42df49-6db6-422e-ae4b-f504e893edff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_daf17198-4de6-4dae-811c-86696a116844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_daf17198-4de6-4dae-811c-86696a116844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_3e7c4dc0-0620-46db-aaf0-d77f40a6c3e9" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_3e7c4dc0-0620-46db-aaf0-d77f40a6c3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGain_72ddf534-1872-4325-8b47-c1f04fab595b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedGain_72ddf534-1872-4325-8b47-c1f04fab595b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_75d22d7c-34a6-4f2c-97ab-28044c9671fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_75d22d7c-34a6-4f2c-97ab-28044c9671fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_c233b0b4-0b66-4d20-9cb9-7b66c808a458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_c233b0b4-0b66-4d20-9cb9-7b66c808a458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_6dc585ef-ee32-4638-9d91-4678f5c0d94d" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesCatastropheBondsGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_6dc585ef-ee32-4638-9d91-4678f5c0d94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c44f96ff-6939-4ec1-876b-d81b53918db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c44f96ff-6939-4ec1-876b-d81b53918db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_a7669f1b-90c3-44ed-b5ad-6b109caa3e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_a7669f1b-90c3-44ed-b5ad-6b109caa3e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_27c26864-ef91-454e-8c2b-8f710df0bed5" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedInvestmentGainsLosses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_27c26864-ef91-454e-8c2b-8f710df0bed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_04e5aee7-62d8-471b-81c3-9df508d6ceab" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_4838e474-34a4-4932-95df-b514720d825d" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_4838e474-34a4-4932-95df-b514720d825d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_85c579ba-9415-4c7f-a48d-8c4984bd6adf" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_85c579ba-9415-4c7f-a48d-8c4984bd6adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e0360301-8ffc-41a6-b7d6-e401bca04a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_4478f875-7687-45a7-8236-401bc64e4d80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e0360301-8ffc-41a6-b7d6-e401bca04a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4e5066f7-b699-4603-b089-9ab0113ca0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4e5066f7-b699-4603-b089-9ab0113ca0af" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c91c9ebc-f964-440d-b2e0-ccc68d54c513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c91c9ebc-f964-440d-b2e0-ccc68d54c513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c91c9ebc-f964-440d-b2e0-ccc68d54c513" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0ef72b65-a0f3-4f41-a250-9550df87d115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0ef72b65-a0f3-4f41-a250-9550df87d115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9f450c6c-d814-4ba4-9607-dafa3dcfb07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9f450c6c-d814-4ba4-9607-dafa3dcfb07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_98d1248e-ca54-42fc-b50f-709caf3c0c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_MunicipalBondsMember_98d1248e-ca54-42fc-b50f-709caf3c0c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_948559c4-f342-4eb4-b1af-67aa3768fdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_948559c4-f342-4eb4-b1af-67aa3768fdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_5a33181d-e481-4b82-8dbc-5ab90fcc8bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_5a33181d-e481-4b82-8dbc-5ab90fcc8bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_391593d6-8a0f-4a82-90e3-fae74eed973d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_391593d6-8a0f-4a82-90e3-fae74eed973d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_61afb27e-e5f1-43d0-ba79-02b109adf00a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_61afb27e-e5f1-43d0-ba79-02b109adf00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_da488c4c-0c51-4d51-afba-9bf939e877c7" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_da488c4c-0c51-4d51-afba-9bf939e877c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_d8261ce1-870d-49ae-b064-cb286315b9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_d8261ce1-870d-49ae-b064-cb286315b9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_8a4f143a-ef04-4de6-9ab2-a6d65e3b694f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da98690c-d757-4bc1-88c7-7a71a3eba223" xlink:to="loc_us-gaap_DebtSecuritiesMember_8a4f143a-ef04-4de6-9ab2-a6d65e3b694f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_02a065b2-ce0e-4107-a040-a0479ad0f59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:to="loc_us-gaap_InvestmentTypeAxis_02a065b2-ce0e-4107-a040-a0479ad0f59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_02a065b2-ce0e-4107-a040-a0479ad0f59f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b6378d40-282c-4f8e-8865-102196a5c922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_DebtSecuritiesMember_b6378d40-282c-4f8e-8865-102196a5c922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_c808dc7e-2296-4284-8949-5d3d2e5dc774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_FixedMaturitiesMember_c808dc7e-2296-4284-8949-5d3d2e5dc774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_abf37fec-ab3c-47b3-93e4-9834ae456b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_EquitySecuritiesMember_abf37fec-ab3c-47b3-93e4-9834ae456b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_1a92ebcc-d06f-4a8f-96d2-bdb152b08235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_1a92ebcc-d06f-4a8f-96d2-bdb152b08235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_ef1a7af0-fd9b-4675-848e-6cdde5a39a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2d239167-ee2c-4cbb-a63e-de562c47ec08" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_ef1a7af0-fd9b-4675-848e-6cdde5a39a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_e64eb584-39af-458a-9dd2-2e70b9c79f80" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9f5b2eaf-4439-473e-890c-f0c71593f503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9f5b2eaf-4439-473e-890c-f0c71593f503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e4a8863c-338d-4904-8571-4b5d23111bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e4a8863c-338d-4904-8571-4b5d23111bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ee1856a6-8eed-49a2-897c-1fec983412d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ee1856a6-8eed-49a2-897c-1fec983412d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_3d265c7f-e91b-49e0-8e8b-456a0d5c4e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_3d265c7f-e91b-49e0-8e8b-456a0d5c4e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ba18cf80-8461-42e1-ba35-0a2e93b9c28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ba18cf80-8461-42e1-ba35-0a2e93b9c28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_dba5a275-010c-4f37-8661-a6b5db615615" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_dba5a275-010c-4f37-8661-a6b5db615615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a652f755-d673-4b84-ad79-7e044f0b3d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a652f755-d673-4b84-ad79-7e044f0b3d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_4e049117-7a5b-48ba-bde1-fd22b5b8df6c" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_4e049117-7a5b-48ba-bde1-fd22b5b8df6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_3aa999f1-c2b6-418d-9c70-2aa351cc2e23" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_3aa999f1-c2b6-418d-9c70-2aa351cc2e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fe9aca1f-cb36-4521-8e13-a6cccd9657c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fe9aca1f-cb36-4521-8e13-a6cccd9657c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_73f7fe3f-bd9c-4cc7-a885-bcc111ce6494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_73f7fe3f-bd9c-4cc7-a885-bcc111ce6494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_db2c37a7-8162-4957-9726-0a1b1404b374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6bb43862-b530-4238-8fb9-c1fa7079d51b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_db2c37a7-8162-4957-9726-0a1b1404b374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d5bedf31-0416-4f7e-b72e-baa4c20157fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d5bedf31-0416-4f7e-b72e-baa4c20157fd" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_39f06843-f622-45ed-b311-ec11017d1a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:to="loc_us-gaap_FinancialInstrumentAxis_39f06843-f622-45ed-b311-ec11017d1a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_39f06843-f622-45ed-b311-ec11017d1a10" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_7d293149-c343-4bd9-a9bf-2efb466a363d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_7d293149-c343-4bd9-a9bf-2efb466a363d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_87ce9ed3-09ab-4757-96f8-9a373646b4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_MunicipalBondsMember_87ce9ed3-09ab-4757-96f8-9a373646b4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_896e3971-511e-43fa-ad00-14885f618483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_896e3971-511e-43fa-ad00-14885f618483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_67ac4d4d-7f90-4a82-b83f-9d30769f1c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_67ac4d4d-7f90-4a82-b83f-9d30769f1c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_59993775-9edf-4107-b2c2-c593f1b65b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_59993775-9edf-4107-b2c2-c593f1b65b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_f4137895-c923-4c8d-b506-987ac6f0391f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_f4137895-c923-4c8d-b506-987ac6f0391f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_0d4917b0-4204-4bbb-bf93-2203e692b64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b5d9470-29bc-460a-b0e9-25d8bd8af14e" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_0d4917b0-4204-4bbb-bf93-2203e692b64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_9b756657-9350-47fc-b960-409e2e73c366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:to="loc_us-gaap_InvestmentTypeAxis_9b756657-9350-47fc-b960-409e2e73c366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_9b756657-9350-47fc-b960-409e2e73c366" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember_06a07b61-159e-4a1a-9c55-c64c759b2c5e" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_HighYieldLoansMember_06a07b61-159e-4a1a-9c55-c64c759b2c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingFixedMaturityInvestmentsMember_c1b038f3-7a05-4699-8365-125ee7021a2a" xlink:href="ahl-20231220.xsd#ahl_TradingFixedMaturityInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_TradingFixedMaturityInvestmentsMember_c1b038f3-7a05-4699-8365-125ee7021a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_de41e6a5-6400-4f62-bfda-3bb3149ff269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_de41e6a5-6400-4f62-bfda-3bb3149ff269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember_77fae2bf-d394-4a84-8b7f-9d765fd5739c" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_CatastropheBondsMember_77fae2bf-d394-4a84-8b7f-9d765fd5739c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_1c29a5cc-1fdd-429c-b1f8-afd8c6d0c674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_1c29a5cc-1fdd-429c-b1f8-afd8c6d0c674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_1593a752-a9e4-4a57-a751-f33ccd4668b8" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_MiddlemarketloansMember_1593a752-a9e4-4a57-a751-f33ccd4668b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SecuritiesassetbackedMember_6a7cc6f9-b4d1-46e9-b095-38a45ae0d752" xlink:href="ahl-20231220.xsd#ahl_SecuritiesassetbackedMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_SecuritiesassetbackedMember_6a7cc6f9-b4d1-46e9-b095-38a45ae0d752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalSecuritiesCorporateMember_b5497b70-9873-4d29-9612-74e10542ac0f" xlink:href="ahl-20231220.xsd#ahl_GlobalSecuritiesCorporateMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_GlobalSecuritiesCorporateMember_b5497b70-9873-4d29-9612-74e10542ac0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_3927078c-1a99-4e8f-93d7-5856e5f9ae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_us-gaap_EquitySecuritiesMember_3927078c-1a99-4e8f-93d7-5856e5f9ae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_7367ef54-bf7e-4d8a-be5c-6edb4cfdaea1" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_7367ef54-bf7e-4d8a-be5c-6edb4cfdaea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_437f5fd3-1fc9-4cd3-b7cd-ddccddeb3461" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_437f5fd3-1fc9-4cd3-b7cd-ddccddeb3461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalTradingMember_598a51c9-16f8-4c50-85aa-e4dd2ad1eb93" xlink:href="ahl-20231220.xsd#ahl_TotalTradingMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7747ce1e-227d-4e45-9fbb-14f22aedccea" xlink:to="loc_ahl_TotalTradingMember_598a51c9-16f8-4c50-85aa-e4dd2ad1eb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7d06fa4b-d13b-4986-a73a-3f1deb81ca59" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_b2413339-2e3d-44ef-819f-10e435977b79" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_b2413339-2e3d-44ef-819f-10e435977b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_9ffe66f9-4b6b-49eb-9153-5275bd8bc960" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_9ffe66f9-4b6b-49eb-9153-5275bd8bc960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_b47e1137-c872-4b5f-8fa1-9fb8a3a87aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_us-gaap_TradingSecurities_b47e1137-c872-4b5f-8fa1-9fb8a3a87aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_05b9bf6a-e009-4074-a11e-03acfc65aafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0aaff2e-f191-4695-a3df-a9b2cede5375" xlink:to="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_05b9bf6a-e009-4074-a11e-03acfc65aafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_eb15515c-fa16-4bd7-95b5-19ad9cbd0c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationByPropertyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_eb15515c-fa16-4bd7-95b5-19ad9cbd0c4c" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_e69217f9-e86b-4efd-930c-75cf87469270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_us-gaap_GeographicDistributionAxis_e69217f9-e86b-4efd-930c-75cf87469270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_45fe8858-2de5-475d-9352-1c41cf716ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_e69217f9-e86b-4efd-930c-75cf87469270" xlink:to="loc_us-gaap_GeographicDistributionDomain_45fe8858-2de5-475d-9352-1c41cf716ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_bb8fa13f-0de2-4b7c-9b8f-d5fefe932e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_45fe8858-2de5-475d-9352-1c41cf716ab7" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_bb8fa13f-0de2-4b7c-9b8f-d5fefe932e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_f29dafa9-1fa0-4bef-845c-98b0e0090295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_45fe8858-2de5-475d-9352-1c41cf716ab7" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_f29dafa9-1fa0-4bef-845c-98b0e0090295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d65861da-147e-4aca-90e6-f626f06b14f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d65861da-147e-4aca-90e6-f626f06b14f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f200703a-4f31-4220-8a91-67e0162dc196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d65861da-147e-4aca-90e6-f626f06b14f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f200703a-4f31-4220-8a91-67e0162dc196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentNetCarryingValueMember_5e32613b-27b8-42a0-a5f1-204a8f131167" xlink:href="ahl-20231220.xsd#ahl_InvestmentNetCarryingValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f200703a-4f31-4220-8a91-67e0162dc196" xlink:to="loc_ahl_InvestmentNetCarryingValueMember_5e32613b-27b8-42a0-a5f1-204a8f131167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_us-gaap_InvestmentTypeAxis_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4483e89b-4c5b-4340-a0c5-7d2cb1d8964f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_2f1cfb3d-7d41-4f34-8903-999e6f6cd6d5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4483e89b-4c5b-4340-a0c5-7d2cb1d8964f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_cf6a7835-c5dd-4454-b028-f0380c38f424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_4483e89b-4c5b-4340-a0c5-7d2cb1d8964f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_cf6a7835-c5dd-4454-b028-f0380c38f424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_bee83b6f-03ce-4f3c-b403-237f4a99b0d4" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_4483e89b-4c5b-4340-a0c5-7d2cb1d8964f" xlink:to="loc_ahl_MiddlemarketloansMember_bee83b6f-03ce-4f3c-b403-237f4a99b0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c415e432-b127-4ede-8986-2d9aed1326a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c415e432-b127-4ede-8986-2d9aed1326a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fceafa23-a3fc-4aac-8685-3547320e130d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c415e432-b127-4ede-8986-2d9aed1326a6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fceafa23-a3fc-4aac-8685-3547320e130d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_93a46fd1-5ad1-4bc7-8260-dec4c3696f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fceafa23-a3fc-4aac-8685-3547320e130d" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_93a46fd1-5ad1-4bc7-8260-dec4c3696f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_ff0c1044-4ea9-4206-b9cf-bf754b6e9b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fceafa23-a3fc-4aac-8685-3547320e130d" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_ff0c1044-4ea9-4206-b9cf-bf754b6e9b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0261fc87-3d5d-4b44-b90a-8370afa2fdc5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_srt_ProductOrServiceAxis_0261fc87-3d5d-4b44-b90a-8370afa2fdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0261fc87-3d5d-4b44-b90a-8370afa2fdc5" xlink:to="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_a4be49af-26ca-4d81-804c-3cbced90f15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_ProductMember_a4be49af-26ca-4d81-804c-3cbced90f15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServiceMember_85f65031-2291-47fd-a548-6b49083d462d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_FinancialServiceMember_85f65031-2291-47fd-a548-6b49083d462d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IndustrialServiceMember_b525d5dd-e472-4b5e-b4ad-930a8aedd29a" xlink:href="ahl-20231220.xsd#ahl_IndustrialServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_ahl_IndustrialServiceMember_b525d5dd-e472-4b5e-b4ad-930a8aedd29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConsumerDiscretionaryServiceMember_eeb4167e-b4b1-4d10-b469-31c202d31e99" xlink:href="ahl-20231220.xsd#ahl_ConsumerDiscretionaryServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_ahl_ConsumerDiscretionaryServiceMember_eeb4167e-b4b1-4d10-b469-31c202d31e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_9c9faf5d-8be0-4560-934f-a2048d86e3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_HealthCareMember_9c9faf5d-8be0-4560-934f-a2048d86e3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergyCommoditiesAndServiceMember_da8e8a94-7ab2-4e89-ad74-e731cf104cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnergyCommoditiesAndServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_EnergyCommoditiesAndServiceMember_da8e8a94-7ab2-4e89-ad74-e731cf104cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConsumerStaplesServiceMember_40223893-878f-433a-9083-56c2dcff8fee" xlink:href="ahl-20231220.xsd#ahl_ConsumerStaplesServiceMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_ahl_ConsumerStaplesServiceMember_40223893-878f-433a-9083-56c2dcff8fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember_b7daef11-fd7a-46df-91f1-19918c1b6646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyServiceMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ece69d41-7c1c-4931-9f80-bc1604641b0d" xlink:to="loc_us-gaap_TechnologyServiceMember_b7daef11-fd7a-46df-91f1-19918c1b6646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_55936a97-2414-498b-8d96-6c154330be26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_55936a97-2414-498b-8d96-6c154330be26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_55936a97-2414-498b-8d96-6c154330be26" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ApartmentBuildingMember_453522a6-d5a1-46f7-b6de-29e5f4cec54d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ApartmentBuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_ApartmentBuildingMember_453522a6-d5a1-46f7-b6de-29e5f4cec54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_HotelMember_b1b9b49e-e25f-4a0c-ae36-815fe3282bd9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_HotelMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_HotelMember_b1b9b49e-e25f-4a0c-ae36-815fe3282bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_8501ca4b-31f0-4506-bebd-0e57ed8db64f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OfficeBuildingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_OfficeBuildingMember_8501ca4b-31f0-4506-bebd-0e57ed8db64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_9ee9dbab-e18c-4d39-a1d8-926ce4f6d6dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_OtherPropertyMember_9ee9dbab-e18c-4d39-a1d8-926ce4f6d6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailMember_3bbbd827-3daa-4c96-9007-df5042e48259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetailMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_us-gaap_RetailMember_3bbbd827-3daa-4c96-9007-df5042e48259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_IndustrialPropertyMember_bafc05fd-465d-4905-aafd-4986157dfbf9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_IndustrialPropertyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b7183282-feeb-4aba-ab9c-4563055e74f1" xlink:to="loc_srt_IndustrialPropertyMember_bafc05fd-465d-4905-aafd-4986157dfbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_2dbaef10-ceca-4086-9da9-6e7c4625cd24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_aa9c4eb5-6a30-4990-9962-ab8f17fd8fd2" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_2dbaef10-ceca-4086-9da9-6e7c4625cd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_dce7b9ca-669c-424d-964a-e2e8c2d68c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_2dbaef10-ceca-4086-9da9-6e7c4625cd24" xlink:to="loc_us-gaap_TradingSecurities_dce7b9ca-669c-424d-964a-e2e8c2d68c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_80975aea-0dec-4c9a-902a-0b99b9c89755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_2dbaef10-ceca-4086-9da9-6e7c4625cd24" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_80975aea-0dec-4c9a-902a-0b99b9c89755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsLoantoValueRatiosDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_25ac050a-7920-41e3-8172-786979eaff32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_25ac050a-7920-41e3-8172-786979eaff32" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_abeeae5b-9e4e-4578-9859-4820e5c513fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:to="loc_us-gaap_InvestmentTypeAxis_abeeae5b-9e4e-4578-9859-4820e5c513fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0f4c9aef-59dd-46c1-9984-d3bc14fb5708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_abeeae5b-9e4e-4578-9859-4820e5c513fc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0f4c9aef-59dd-46c1-9984-d3bc14fb5708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_7de82d2e-3010-4f88-b577-2eb2cb13adce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0f4c9aef-59dd-46c1-9984-d3bc14fb5708" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_7de82d2e-3010-4f88-b577-2eb2cb13adce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_48705eb4-9c19-41ed-95aa-031f9503ba4d" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0f4c9aef-59dd-46c1-9984-d3bc14fb5708" xlink:to="loc_ahl_MiddlemarketloansMember_48705eb4-9c19-41ed-95aa-031f9503ba4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_1af57dca-6c6a-4df3-9f18-82520ce41e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:to="loc_us-gaap_LoanToValueAxis_1af57dca-6c6a-4df3-9f18-82520ce41e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueAxis_1af57dca-6c6a-4df3-9f18-82520ce41e04" xlink:to="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember_c747ecef-7fd8-41bd-9922-b0c378726e6c" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebttoValueRatioLessthan50PercentMember_c747ecef-7fd8-41bd-9922-b0c378726e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember_35a0df2e-686d-48b7-8ec5-07e9fde902cc" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebttoValueRatio50to60PercentMember_35a0df2e-686d-48b7-8ec5-07e9fde902cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember_ae12685b-c3e5-4d69-af94-24a0bc8b82b1" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebttoValueRatio61to70PercentMember_ae12685b-c3e5-4d69-af94-24a0bc8b82b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio71to80PercentMember_c3ad45b2-b958-4d8d-b559-2649fc889007" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio71to80PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebttoValueRatio71to80PercentMember_c3ad45b2-b958-4d8d-b559-2649fc889007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Ltv80To100PercentMember_dceba94d-d29c-4a87-8671-a3a350786b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Ltv80To100PercentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_us-gaap_Ltv80To100PercentMember_dceba94d-d29c-4a87-8671-a3a350786b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtToValueRatioGreaterThan100Member_34bf6ec9-7865-48c2-953d-fb9ad08b0ae5" xlink:href="ahl-20231220.xsd#ahl_DebtToValueRatioGreaterThan100Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_6ab891d7-856c-410f-b331-b125e12ad903" xlink:to="loc_ahl_DebtToValueRatioGreaterThan100Member_34bf6ec9-7865-48c2-953d-fb9ad08b0ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_7e9d5d9a-6eea-49e0-b96e-e079902d54ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_7da29163-b893-45bf-b634-0f97d98c23ab" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_7e9d5d9a-6eea-49e0-b96e-e079902d54ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_3093668c-7854-489c-af48-56abae71dc54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_7e9d5d9a-6eea-49e0-b96e-e079902d54ab" xlink:to="loc_us-gaap_TradingSecurities_3093668c-7854-489c-af48-56abae71dc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_33880a40-e8cd-4047-8d51-7cd0a2d3f63b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_33880a40-e8cd-4047-8d51-7cd0a2d3f63b" xlink:to="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioAxis_f91b3a88-66a3-43f4-8d96-852b473cb814" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_ahl_DebtServiceCoverageRatioAxis_f91b3a88-66a3-43f4-8d96-852b473cb814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DebtServiceCoverageRatioAxis_f91b3a88-66a3-43f4-8d96-852b473cb814" xlink:to="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_402d7148-e2f7-4e7b-9e13-a1009b550c51" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioGreaterThan1.2xMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:to="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_402d7148-e2f7-4e7b-9e13-a1009b550c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember_de7d7283-ec7f-41b8-a58d-85181aaf9407" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatio1.00to1.20xMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:to="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember_de7d7283-ec7f-41b8-a58d-85181aaf9407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember_11acf364-25c6-4258-a8b1-046658fd3d29" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioLessThan1.00xMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_fea88a94-20d0-4b4c-ad4e-a67892a70d0c" xlink:to="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember_11acf364-25c6-4258-a8b1-046658fd3d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_us-gaap_InvestmentTypeAxis_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8e46b427-e17c-48ed-a388-c6b226077e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_4b448b1b-8fd1-4bfb-ac48-f380fd86cdf9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8e46b427-e17c-48ed-a388-c6b226077e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c423df4e-e6a8-4920-991d-29e1a4e0457d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8e46b427-e17c-48ed-a388-c6b226077e27" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c423df4e-e6a8-4920-991d-29e1a4e0457d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_ca1aa0b7-f072-4211-bda2-ee15f62d083e" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8e46b427-e17c-48ed-a388-c6b226077e27" xlink:to="loc_ahl_MiddlemarketloansMember_ca1aa0b7-f072-4211-bda2-ee15f62d083e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_us-gaap_LoanToValueAxis_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueAxis_a30151bd-bbee-49aa-a5ea-c17c5e1bfe7f" xlink:to="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember_3af2e1d3-e057-4094-b0fc-cf90bfc10b66" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_ahl_DebttoValueRatioLessthan50PercentMember_3af2e1d3-e057-4094-b0fc-cf90bfc10b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember_005f9ed9-8dc5-4d9c-b76a-5b4f3c7dac79" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_ahl_DebttoValueRatio50to60PercentMember_005f9ed9-8dc5-4d9c-b76a-5b4f3c7dac79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember_146e572b-861a-4586-ad15-4c8d376f6b16" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_ahl_DebttoValueRatio61to70PercentMember_146e572b-861a-4586-ad15-4c8d376f6b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio71to80PercentMember_a4175db2-de79-43e8-bd65-a711077cfaa9" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio71to80PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_ahl_DebttoValueRatio71to80PercentMember_a4175db2-de79-43e8-bd65-a711077cfaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Ltv80To100PercentMember_491613cc-eb33-4c1e-8e0f-f8987b521e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Ltv80To100PercentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_58f81691-6e29-46fe-9fc8-0f51ba212fcb" xlink:to="loc_us-gaap_Ltv80To100PercentMember_491613cc-eb33-4c1e-8e0f-f8987b521e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_49c24f72-fb45-4b70-894d-4208080a7992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_49c24f72-fb45-4b70-894d-4208080a7992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_5d329c7b-4b83-475d-81ae-26879a6ec7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_49c24f72-fb45-4b70-894d-4208080a7992" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_5d329c7b-4b83-475d-81ae-26879a6ec7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonperformingFinancingReceivableMember_636281ae-79cc-4d9a-97d8-0b9da2d25d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonperformingFinancingReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_5d329c7b-4b83-475d-81ae-26879a6ec7ce" xlink:to="loc_us-gaap_NonperformingFinancingReceivableMember_636281ae-79cc-4d9a-97d8-0b9da2d25d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2de0083f-ae0e-476c-9659-ea6c1cb07294" xlink:to="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_8a14e538-0964-4fc7-9068-0d175d9db432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:to="loc_us-gaap_TradingSecurities_8a14e538-0964-4fc7-9068-0d175d9db432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CMLLessNonPerformingOrFutureConstruction_af316ca8-a2d8-474c-ba03-3f5f67f78202" xlink:href="ahl-20231220.xsd#ahl_CMLLessNonPerformingOrFutureConstruction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:to="loc_ahl_CMLLessNonPerformingOrFutureConstruction_af316ca8-a2d8-474c-ba03-3f5f67f78202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_175d263e-b1a9-4add-994c-b57850e1d3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_37d121ce-b0f6-41ad-a680-f4bc459a3e10" xlink:to="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_175d263e-b1a9-4add-994c-b57850e1d3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_510fd519-4ffb-4af8-a222-0acc210cb3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_510fd519-4ffb-4af8-a222-0acc210cb3a3" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a12a8dd4-2678-42e0-a704-c867b9d68e50" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a12a8dd4-2678-42e0-a704-c867b9d68e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a12a8dd4-2678-42e0-a704-c867b9d68e50" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_daf2c07b-1def-4f67-b713-649603189529" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:to="loc_ahl_MVIMember_daf2c07b-1def-4f67-b713-649603189529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_1cf9ad29-0c32-4011-b2fa-43cf09361822" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:to="loc_ahl_DigitalRiskMember_1cf9ad29-0c32-4011-b2fa-43cf09361822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_85238744-1d61-4c5a-a4c8-97b3aecab738" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_06a54e1f-0f1f-4254-8441-58fe28043867" xlink:to="loc_ahl_MultiLineReinsurerMember_85238744-1d61-4c5a-a4c8-97b3aecab738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ce8712cf-ce26-4a12-aa57-e74ebb94fe37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ce8712cf-ce26-4a12-aa57-e74ebb94fe37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_29af313b-8ce2-45fb-9b55-c513d5ea69fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ce8712cf-ce26-4a12-aa57-e74ebb94fe37" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_29af313b-8ce2-45fb-9b55-c513d5ea69fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_79397fba-95b4-4e87-ac91-d9c85a74e90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_29af313b-8ce2-45fb-9b55-c513d5ea69fc" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_79397fba-95b4-4e87-ac91-d9c85a74e90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59708f47-2c10-483d-8572-21a1e9908344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59708f47-2c10-483d-8572-21a1e9908344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6aadd7c7-efd9-48c4-b18d-2e1de5c6dafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59708f47-2c10-483d-8572-21a1e9908344" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6aadd7c7-efd9-48c4-b18d-2e1de5c6dafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c2c76b26-33d8-416d-b8fe-e7be0d7d17f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6aadd7c7-efd9-48c4-b18d-2e1de5c6dafe" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c2c76b26-33d8-416d-b8fe-e7be0d7d17f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_482bd760-b4fb-478a-9f12-03168441ccfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_us-gaap_InvestmentTypeAxis_482bd760-b4fb-478a-9f12-03168441ccfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_69f01c85-57ab-44b2-8b13-99082adedb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_482bd760-b4fb-478a-9f12-03168441ccfe" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_69f01c85-57ab-44b2-8b13-99082adedb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_fc00eff3-65cf-4a34-83d6-049fe74845c4" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_69f01c85-57ab-44b2-8b13-99082adedb4d" xlink:to="loc_ahl_RealEstateFundDec2017Member_fc00eff3-65cf-4a34-83d6-049fe74845c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3f89233c-ae00-4898-a3f5-e0222aa513e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a5369df8-d764-4aa7-a424-398a182d5ce6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3f89233c-ae00-4898-a3f5-e0222aa513e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:href="ahl-20231220.xsd#ahl_EquityMethodInvestmentAggregateCostRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3f89233c-ae00-4898-a3f5-e0222aa513e3" xlink:to="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_6e159455-76e6-474f-848a-db063b8a1396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_6e159455-76e6-474f-848a-db063b8a1396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_1ad8beb4-af1d-4296-91c9-5ce2006b8e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_1ad8beb4-af1d-4296-91c9-5ce2006b8e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_55902580-f650-4c11-b0aa-8d9940345e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_55902580-f650-4c11-b0aa-8d9940345e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_bd113899-6d8b-4ada-8e4f-44ae8301cb88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_bd113899-6d8b-4ada-8e4f-44ae8301cb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_21c8581b-f82d-41ab-b8c0-c64eaaa49b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_a0e19877-3fda-4d8f-aaed-d643dcd2fc7c" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_21c8581b-f82d-41ab-b8c0-c64eaaa49b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_b5f35669-329a-43fa-b7b9-15fed012153a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3f89233c-ae00-4898-a3f5-e0222aa513e3" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_b5f35669-329a-43fa-b7b9-15fed012153a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofFixedMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d4c9f8e5-3730-450e-bbf2-3a1616ba2127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_0a796ebd-8393-4b1b-a1d5-1fbc340f470a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d4c9f8e5-3730-450e-bbf2-3a1616ba2127" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_0a796ebd-8393-4b1b-a1d5-1fbc340f470a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6de3a236-37a1-46a6-8a4d-e5cef0eb644d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_0a796ebd-8393-4b1b-a1d5-1fbc340f470a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6de3a236-37a1-46a6-8a4d-e5cef0eb644d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6de3a236-37a1-46a6-8a4d-e5cef0eb644d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_bd23390f-bce2-4780-b5a7-f744993ae665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_bd23390f-bce2-4780-b5a7-f744993ae665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_9279e4fe-6214-452b-a1f6-43fffa83ee40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_9279e4fe-6214-452b-a1f6-43fffa83ee40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_10aba096-09e6-41fe-b8c8-d73fd088e369" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_10aba096-09e6-41fe-b8c8-d73fd088e369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_1e282862-84fa-44b7-9e63-345bc099c575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a2c63f8-7598-4126-9e5c-010dc9f68698" xlink:to="loc_us-gaap_FixedMaturitiesMember_1e282862-84fa-44b7-9e63-345bc099c575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_a75fd6ca-f895-4449-95c4-f11be4c853c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FixedMaturitiesMember_1e282862-84fa-44b7-9e63-345bc099c575" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_a75fd6ca-f895-4449-95c4-f11be4c853c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_0a796ebd-8393-4b1b-a1d5-1fbc340f470a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_6c3dff6b-f720-4d8d-8605-401bbf9a4eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_6c3dff6b-f720-4d8d-8605-401bbf9a4eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_441e82bb-e19e-4467-860c-2b981bfc99b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_441e82bb-e19e-4467-860c-2b981bfc99b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_1c1cb083-8486-4c87-9ac4-54567dfa5909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_1c1cb083-8486-4c87-9ac4-54567dfa5909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_6f625ae1-ba85-4a56-ad9c-cb68fbb028a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_6f625ae1-ba85-4a56-ad9c-cb68fbb028a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a7ca918e-31c5-4546-8b4d-650f82d30bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a7ca918e-31c5-4546-8b4d-650f82d30bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_e2ea74d4-7d88-44c9-872c-5afcd555aef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_e2ea74d4-7d88-44c9-872c-5afcd555aef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_a68527a5-2263-4a18-9324-7d2ae2dd07a5" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_a68527a5-2263-4a18-9324-7d2ae2dd07a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cb08cdcc-0c72-47a7-b473-889c3f6bf75f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cb08cdcc-0c72-47a7-b473-889c3f6bf75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_3b4189d5-026c-4a6b-b51f-ab515fcbe6be" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_3b4189d5-026c-4a6b-b51f-ab515fcbe6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_3dd95f25-675c-4e81-be0e-227795c43907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_3dd95f25-675c-4e81-be0e-227795c43907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_f82d9a08-acba-4873-97dc-229037f49cc6" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_f82d9a08-acba-4873-97dc-229037f49cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_443109b3-8d25-4f6b-9811-3de3732029be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_443109b3-8d25-4f6b-9811-3de3732029be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_1a02c646-f96e-4053-8f49-287cebedb6dd" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_1a02c646-f96e-4053-8f49-287cebedb6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eea4f08f-b224-449e-85cc-65293917261e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eea4f08f-b224-449e-85cc-65293917261e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_bf553b42-c300-4a61-b970-1d9483031a94" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e9caf1c3-5a7a-4957-91d1-efceb3ff8d0c" xlink:to="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_bf553b42-c300-4a61-b970-1d9483031a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_026d9aea-a6d4-4ac3-a6b6-a4ac16e00805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_026d9aea-a6d4-4ac3-a6b6-a4ac16e00805" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5725cd37-fa37-492d-81a5-bdc27cc9ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5725cd37-fa37-492d-81a5-bdc27cc9ed2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5725cd37-fa37-492d-81a5-bdc27cc9ed2b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_671a88da-fb16-48cb-b54c-6fe32f7f0124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_671a88da-fb16-48cb-b54c-6fe32f7f0124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8d93f2e2-057a-46db-aec7-73c32ae5f13d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8d93f2e2-057a-46db-aec7-73c32ae5f13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_b8dde3e2-db96-4864-be3c-0f6f28397824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_MunicipalBondsMember_b8dde3e2-db96-4864-be3c-0f6f28397824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_1e98e2f3-e4cf-4d43-9440-8d6a2d099c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_1e98e2f3-e4cf-4d43-9440-8d6a2d099c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_25e14a72-a6e1-4bd6-b39b-f9058f18377d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_25e14a72-a6e1-4bd6-b39b-f9058f18377d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_27864030-78cf-4c58-bd30-c89d1fe902bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_27864030-78cf-4c58-bd30-c89d1fe902bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_357a67e8-8d8e-4d1e-a756-abb38cd4afc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_568be5f5-3b77-47ed-bcec-2073d2fee668" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_357a67e8-8d8e-4d1e-a756-abb38cd4afc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_03098b1d-b6f1-4e8f-992f-88bb67348956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:to="loc_us-gaap_InvestmentTypeAxis_03098b1d-b6f1-4e8f-992f-88bb67348956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3d3eca9b-431c-403c-a986-c3a9a939e8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_03098b1d-b6f1-4e8f-992f-88bb67348956" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3d3eca9b-431c-403c-a986-c3a9a939e8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_c3ce11b8-01ce-4003-9604-9e622a5d7f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3d3eca9b-431c-403c-a986-c3a9a939e8b8" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_c3ce11b8-01ce-4003-9604-9e622a5d7f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_5a6ffe80-83cd-4621-961f-c83afc632385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3d3eca9b-431c-403c-a986-c3a9a939e8b8" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_5a6ffe80-83cd-4621-961f-c83afc632385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_2edab97e-76d6-4862-867f-f54d6c13f881" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_707624cd-5883-42b4-928f-98a3869fa8e6" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_707624cd-5883-42b4-928f-98a3869fa8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_39093442-35c4-4e80-9e2a-6084dc61c23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_39093442-35c4-4e80-9e2a-6084dc61c23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_6ac8199f-dc1d-4fe0-a0bd-20fa1b3f29a8" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_6ac8199f-dc1d-4fe0-a0bd-20fa1b3f29a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_653bd36e-6f5b-4b60-8b78-b2ae614aa64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_653bd36e-6f5b-4b60-8b78-b2ae614aa64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_e1795de5-369b-460a-bc78-d3950c6fc4f5" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_e1795de5-369b-460a-bc78-d3950c6fc4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3202b948-5174-4f3a-ac19-9e838fe04744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3202b948-5174-4f3a-ac19-9e838fe04744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_9835d007-1fe9-4aa6-baf3-e13c3913ecb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64145995-0b6a-4be9-9425-5269618f877f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_9835d007-1fe9-4aa6-baf3-e13c3913ecb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAdditionalInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_230d3264-7df6-447f-a49a-16e013c3dd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_230d3264-7df6-447f-a49a-16e013c3dd80" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ad1f12d-09f2-4e3c-84c0-146d96a2eb99" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4ae8ea31-9e52-487c-92cd-6d8a1cddb49d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_64439f4c-ad09-4520-ba40-91951df278c3" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4ae8ea31-9e52-487c-92cd-6d8a1cddb49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_e8d55574-f1a0-4d00-bcf5-2706192a9008" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_6a122b9a-ae26-4649-bc06-23b96c1e21cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_7532fab0-cf7d-4e08-a639-9006f4223028" xlink:to="loc_us-gaap_LimitedPartnerMember_6a122b9a-ae26-4649-bc06-23b96c1e21cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5944ffb6-7f94-40fd-8884-d00d2135acf0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_df703e6a-4826-4fab-a48c-eb7ec483c2e9" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_BeneAssicurazioniMember_df703e6a-4826-4fab-a48c-eb7ec483c2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_e1d8251b-19c9-4a2a-a86d-3040272b3180" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_MVIMember_e1d8251b-19c9-4a2a-a86d-3040272b3180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_71f48fe1-6c1e-4446-a152-cd41975491a2" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_DigitalRiskMember_71f48fe1-6c1e-4446-a152-cd41975491a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CropReMember_e013a845-3c27-46ee-8044-1652bf036bf4" xlink:href="ahl-20231220.xsd#ahl_CropReMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_CropReMember_e013a845-3c27-46ee-8044-1652bf036bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_545f8e9d-ac45-479c-89f2-4e80561a401a" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_20396925-0a84-417d-a912-784422f6a60b" xlink:to="loc_ahl_MultiLineReinsurerMember_545f8e9d-ac45-479c-89f2-4e80561a401a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_adf1608a-fe80-4071-a442-212d5148f491" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_9c8bce75-b558-4c63-be4f-254533e5a0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_us-gaap_RealEstateFundsMember_9c8bce75-b558-4c63-be4f-254533e5a0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8f4fbc38-d3e9-417f-bec6-ac619e4e8bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8f4fbc38-d3e9-417f-bec6-ac619e4e8bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_bb16a51f-e85b-4c24-a504-f346de65c435" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_MiddlemarketloansMember_bb16a51f-e85b-4c24-a504-f346de65c435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_26c46f38-9484-42e6-bc53-4406e128682f" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_26c46f38-9484-42e6-bc53-4406e128682f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_89e88869-ba78-4f40-9285-c648943b0c49" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_RealEstateFundDec2017Member_89e88869-ba78-4f40-9285-c648943b0c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundSept2021Member_71fe7e05-8741-4d0c-9736-d36e5394ce1c" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundSept2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_RealEstateFundSept2021Member_71fe7e05-8741-4d0c-9736-d36e5394ce1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InfrastructureFundMember_53c70637-b601-4260-88fa-d18f78b009bb" xlink:href="ahl-20231220.xsd#ahl_InfrastructureFundMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_InfrastructureFundMember_53c70637-b601-4260-88fa-d18f78b009bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_b12c14e7-dbba-44e5-a709-6b31c1d93740" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8406b17c-e673-47b7-9fa9-8f91e4f276e5" xlink:to="loc_ahl_ApolloRealEstateFundMember_b12c14e7-dbba-44e5-a709-6b31c1d93740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e60eed7c-a573-41ed-80a8-bf165557f7de" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c9fc0eb9-4e84-4d9d-8fed-d63b97dba217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c9ecc38a-dc30-4e5b-907b-3c18d6c78558" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c9fc0eb9-4e84-4d9d-8fed-d63b97dba217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_04be63d7-08e3-47a8-b449-e707e776ad8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_8598c24d-07c2-4903-8cdb-8085af126df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_f835aefe-c614-447b-ac4d-dcd2ea135672" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_8598c24d-07c2-4903-8cdb-8085af126df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5d8cedf2-e9a3-49cf-b8cb-6dc0801b88bc" xlink:to="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_882e2477-8c00-42a2-86ba-409ec2f49c9b" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c6c66f42-8a9e-4701-a0da-60b14fbe5438" xlink:to="loc_ahl_ApolloRealEstateFundMember_882e2477-8c00-42a2-86ba-409ec2f49c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_InvestmentIdentifierAxis_0a039304-9c1b-4021-a308-297062bd6faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap-supplement_InvestmentIdentifierAxis_0a039304-9c1b-4021-a308-297062bd6faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_052163ed-6d29-4b9f-af5f-eed5d0a1d184" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_ce4abec0-b161-4d17-a17f-f5b323250c03" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_CatastropheBond_ce4abec0-b161-4d17-a17f-f5b323250c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_a8edebac-2c2c-4d9a-89d3-f7f162f2be48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_TradingSecurities_a8edebac-2c2c-4d9a-89d3-f7f162f2be48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_99e33abb-35cf-4bbf-a8a9-c007994f6977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_99e33abb-35cf-4bbf-a8a9-c007994f6977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_472919c6-f02c-44e3-92ad-f461b7e877a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_472919c6-f02c-44e3-92ad-f461b7e877a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_9efb554d-df34-4084-b30a-9ee9cf1abf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_9efb554d-df34-4084-b30a-9ee9cf1abf8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_b7a9d437-c2bd-4dcd-b8e6-33d5af47218e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_OtherInvestments_b7a9d437-c2bd-4dcd-b8e6-33d5af47218e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fc5bcabc-3229-4450-a4ca-579c4cbdd886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fc5bcabc-3229-4450-a4ca-579c4cbdd886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_b3c57c79-0bc9-4280-8fea-59bd68aa9efb" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_RestrictedAssets_b3c57c79-0bc9-4280-8fea-59bd68aa9efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_b8ba35b0-7785-489b-9c0a-5e44cdd5b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_b8ba35b0-7785-489b-9c0a-5e44cdd5b0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentFunds_e359fee4-f681-4fd1-829e-e787eff02cbb" xlink:href="ahl-20231220.xsd#ahl_InvestmentFunds"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_ahl_InvestmentFunds_e359fee4-f681-4fd1-829e-e787eff02cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_2e95beb4-2e21-45dc-b640-c030e3a5019c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_2e95beb4-2e21-45dc-b640-c030e3a5019c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5ba9e4fa-f09f-439c-8613-3de61659395e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5ba9e4fa-f09f-439c-8613-3de61659395e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_4c507f97-bca8-42f4-9479-9e6c73d14838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_7f592bd5-c7d8-430c-9203-2b054b3f71e6" xlink:to="loc_us-gaap_OtherCommitment_4c507f97-bca8-42f4-9479-9e6c73d14838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAdditionalInformationNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/VariableInterestEntitiesNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#VariableInterestEntitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/VariableInterestEntitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_3c38e186-a822-4895-8cdf-99d84bde7ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NumberOfInvestmentsInVariableInterestEntities_06961f0c-66e8-453a-a65c-b7a764071bb0" xlink:href="ahl-20231220.xsd#ahl_NumberOfInvestmentsInVariableInterestEntities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_3c38e186-a822-4895-8cdf-99d84bde7ec3" xlink:to="loc_ahl_NumberOfInvestmentsInVariableInterestEntities_06961f0c-66e8-453a-a65c-b7a764071bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_73f7c8b7-c14c-4ebc-9a03-03a6ca32053b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_73f7c8b7-c14c-4ebc-9a03-03a6ca32053b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e4ecf994-7a9b-4a64-ac4b-401c2fc85840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e4ecf994-7a9b-4a64-ac4b-401c2fc85840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4ecf994-7a9b-4a64-ac4b-401c2fc85840" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_3fdc53c0-81b0-4c57-97bc-4f28c85dfb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_3fdc53c0-81b0-4c57-97bc-4f28c85dfb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3b0874bc-2365-43d7-8086-d49eed874521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3b0874bc-2365-43d7-8086-d49eed874521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_ab159475-92e5-43d0-beed-a53da3209471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_MunicipalBondsMember_ab159475-92e5-43d0-beed-a53da3209471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d90b5a06-2da3-4fe6-8097-a72d81d0e179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d90b5a06-2da3-4fe6-8097-a72d81d0e179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_0fd19dd3-6521-4b8b-9b78-24d93007655f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_0fd19dd3-6521-4b8b-9b78-24d93007655f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_de05c6b9-6c8a-4910-9863-2b9c189cebee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_de05c6b9-6c8a-4910-9863-2b9c189cebee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_a71ed345-8e03-4e97-8461-319e1350b363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_a71ed345-8e03-4e97-8461-319e1350b363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_b7b37b2a-9d64-4409-9af7-ea93c8fc8733" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_b7b37b2a-9d64-4409-9af7-ea93c8fc8733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_69f9fb94-6747-4f68-b2fc-d68ec8e01455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_69f9fb94-6747-4f68-b2fc-d68ec8e01455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember_55cb5e57-a294-4f64-a71e-38ba191ab780" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc3ccd3c-2596-4f68-b778-0cf4308cd4de" xlink:to="loc_ahl_HighYieldLoansMember_55cb5e57-a294-4f64-a71e-38ba191ab780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136a3f86-aad1-4b54-b0b1-505618b915df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136a3f86-aad1-4b54-b0b1-505618b915df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_47d76c55-f133-4a7d-921d-6bbabf1169da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136a3f86-aad1-4b54-b0b1-505618b915df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_47d76c55-f133-4a7d-921d-6bbabf1169da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d6f8022a-7dd7-4bd5-a1c1-4ffdaf8740a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_47d76c55-f133-4a7d-921d-6bbabf1169da" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d6f8022a-7dd7-4bd5-a1c1-4ffdaf8740a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_05c80483-cee8-4a60-8f03-7c4b87c29a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_05c80483-cee8-4a60-8f03-7c4b87c29a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_05c80483-cee8-4a60-8f03-7c4b87c29a53" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1a8ae1b2-c6f8-4d1f-b5e3-323f3587baa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1a8ae1b2-c6f8-4d1f-b5e3-323f3587baa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f8dc9fb8-9168-4648-bffd-e97e9fd4ec16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f8dc9fb8-9168-4648-bffd-e97e9fd4ec16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_77319f69-5284-4f55-9c2c-5bd2c5f9229b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23a5b668-dc57-42b3-a5ea-6aa77ebc519a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_77319f69-5284-4f55-9c2c-5bd2c5f9229b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_322b5240-5d63-4231-8439-e7e806872d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_InvestmentTypeAxis_322b5240-5d63-4231-8439-e7e806872d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_322b5240-5d63-4231-8439-e7e806872d2a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_e57fbefa-c53b-4295-83f7-a92603073884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_e57fbefa-c53b-4295-83f7-a92603073884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_1124e3c5-3351-4ad1-9caa-18613d905daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_1124e3c5-3351-4ad1-9caa-18613d905daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_463b60bf-3320-4291-b571-3e26459700a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_463b60bf-3320-4291-b571-3e26459700a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_391ca725-8467-4f5e-a60d-399d86906200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_391ca725-8467-4f5e-a60d-399d86906200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember_1c14f1be-e4d9-45fc-b1bf-c10a1a0644fa" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember_1c14f1be-e4d9-45fc-b1bf-c10a1a0644fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_e63442bd-d8e7-42ef-bb47-0e10361b8776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a08670b6-09fb-4790-b1cc-a38d95249a7b" xlink:to="loc_us-gaap_RealEstateFundsMember_e63442bd-d8e7-42ef-bb47-0e10361b8776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_8ee81bf2-1e67-45a2-8c80-524f73405863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_8ee81bf2-1e67-45a2-8c80-524f73405863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_8ee81bf2-1e67-45a2-8c80-524f73405863" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_da427ee7-5781-4e28-a263-8b19f25acc14" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_da427ee7-5781-4e28-a263-8b19f25acc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_45e6b7af-af10-406b-a64e-3e8aac750d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_45e6b7af-af10-406b-a64e-3e8aac750d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_2c60c08c-79c2-4c33-ba3e-5645e63eb3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_9172fbdc-aacd-47f9-b362-83ec91857168" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_2c60c08c-79c2-4c33-ba3e-5645e63eb3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_68033674-b1c5-4b99-881c-3ff522f824ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_68033674-b1c5-4b99-881c-3ff522f824ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_52c839b3-8064-4b3e-90c3-fb441386756e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_68033674-b1c5-4b99-881c-3ff522f824ce" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_52c839b3-8064-4b3e-90c3-fb441386756e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_fe652d38-f703-484e-b904-8bea3d51f455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_52c839b3-8064-4b3e-90c3-fb441386756e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_fe652d38-f703-484e-b904-8bea3d51f455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_351ee8bf-4248-4bc0-bb81-4807f1c3cd9f" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_52c839b3-8064-4b3e-90c3-fb441386756e" xlink:to="loc_ahl_LossPortfolioTransferMember_351ee8bf-4248-4bc0-bb81-4807f1c3cd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5185ae6b-015b-4f6f-be79-1108da50db4b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_dcc76616-a4e7-41b6-886b-4698ac18918f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_dcc76616-a4e7-41b6-886b-4698ac18918f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_c0d150a5-5c15-4025-91ef-14c840e286ac" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_c0d150a5-5c15-4025-91ef-14c840e286ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure_25d0a651-0640-476e-ba8f-48ebf2b012d5" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_ahl_CatastropheBondsFairValueDisclosure_25d0a651-0640-476e-ba8f-48ebf2b012d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_7db0793a-3cd5-4024-9f18-adf01de69a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_DerivativeAssets_7db0793a-3cd5-4024-9f18-adf01de69a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e6a380ec-9338-4b6c-85cf-b652ba10823e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e6a380ec-9338-4b6c-85cf-b652ba10823e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_65e180f0-c55c-4c84-8f4b-a9db70cdee90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a6dac97-7fce-42e2-897e-765635b32f63" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_65e180f0-c55c-4c84-8f4b-a9db70cdee90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsReconciliationofLevel3InputsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_25cf5156-e2e5-4f14-9ead-796f07046a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_25cf5156-e2e5-4f14-9ead-796f07046a6b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347a76fa-2f95-4650-b291-4ce6da165547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347a76fa-2f95-4650-b291-4ce6da165547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c78e4755-3593-40d5-b4cc-32b5b8e0d71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347a76fa-2f95-4650-b291-4ce6da165547" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c78e4755-3593-40d5-b4cc-32b5b8e0d71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e0827bfe-496c-4947-a690-d9ede71bb23c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c78e4755-3593-40d5-b4cc-32b5b8e0d71b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e0827bfe-496c-4947-a690-d9ede71bb23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f6b6ec3-31e5-4029-b155-ae091a5f23d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e384b3f6-c20d-445a-a9c2-bc6b72cfdbe2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f6b6ec3-31e5-4029-b155-ae091a5f23d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_38bf93ab-b21e-4b75-9619-2cb3f105997f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f6b6ec3-31e5-4029-b155-ae091a5f23d3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_38bf93ab-b21e-4b75-9619-2cb3f105997f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_af1457ba-3871-427e-a5df-689981998da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_677e798b-8bf2-4a3a-ba38-302c79837a4a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_af1457ba-3871-427e-a5df-689981998da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_31374ac0-bb9b-45d6-b892-364ee4d46380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_31374ac0-bb9b-45d6-b892-364ee4d46380" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_423193c8-d73c-4bd0-ab8b-3c2148b32e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_423193c8-d73c-4bd0-ab8b-3c2148b32e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c29ebc8b-5c69-4940-89eb-78115ac0d245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_423193c8-d73c-4bd0-ab8b-3c2148b32e3c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c29ebc8b-5c69-4940-89eb-78115ac0d245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_68266f3b-5b03-41de-a252-a2d2e952d461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c29ebc8b-5c69-4940-89eb-78115ac0d245" xlink:to="loc_us-gaap_AssetsMember_68266f3b-5b03-41de-a252-a2d2e952d461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2d7a3f1c-38ac-4f5e-a114-bd49945a8add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2d7a3f1c-38ac-4f5e-a114-bd49945a8add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d2eccd7a-42c3-447f-8b71-ca930113258f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2d7a3f1c-38ac-4f5e-a114-bd49945a8add" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d2eccd7a-42c3-447f-8b71-ca930113258f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_dc784877-9dba-4717-8ce3-8d89069ee8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d2eccd7a-42c3-447f-8b71-ca930113258f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_dc784877-9dba-4717-8ce3-8d89069ee8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ce8a181b-b392-47af-902d-acfc5b52f979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_InvestmentTypeAxis_ce8a181b-b392-47af-902d-acfc5b52f979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ce8a181b-b392-47af-902d-acfc5b52f979" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_056c49de-23ba-41ef-977d-0e5def9f6450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_056c49de-23ba-41ef-977d-0e5def9f6450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_7a636f65-244b-48cc-bc61-e82fe0010bfa" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_ahl_MiddlemarketloansMember_7a636f65-244b-48cc-bc61-e82fe0010bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_39aad42a-eade-42f5-9b5c-646d37839437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_39aad42a-eade-42f5-9b5c-646d37839437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember_d17e469f-20e8-4ceb-add6-e502a14bdfc9" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_ahl_GlobalCorporateSecuritiesMember_d17e469f-20e8-4ceb-add6-e502a14bdfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_be5e56e3-23dd-4864-b0e5-324b43bcb72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_us-gaap_EquitySecuritiesMember_be5e56e3-23dd-4864-b0e5-324b43bcb72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_a108f39f-34e1-4dd8-b41b-1869f8798698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_us-gaap_PreferredStockMember_a108f39f-34e1-4dd8-b41b-1869f8798698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_249e270d-e075-4024-8699-695d6671e1a6" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8713b8e9-7473-4d34-93c5-b547cace68d2" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_249e270d-e075-4024-8699-695d6671e1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e43264e5-43aa-493c-a93e-86c920c34716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e43264e5-43aa-493c-a93e-86c920c34716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_768f65fa-d5e0-44a1-a0c8-5b937448c298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e43264e5-43aa-493c-a93e-86c920c34716" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_768f65fa-d5e0-44a1-a0c8-5b937448c298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_93f550ac-ec78-41f7-bb8e-6dbc70d40c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_768f65fa-d5e0-44a1-a0c8-5b937448c298" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_93f550ac-ec78-41f7-bb8e-6dbc70d40c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_86a39e25-6608-4dde-bdbf-548c079e340a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_86a39e25-6608-4dde-bdbf-548c079e340a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c371351e-4392-40cb-a4d0-edbbc5a4fe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_86a39e25-6608-4dde-bdbf-548c079e340a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c371351e-4392-40cb-a4d0-edbbc5a4fe4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_b182d6c1-6051-4f70-9899-50c25a44fbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c371351e-4392-40cb-a4d0-edbbc5a4fe4e" xlink:to="loc_us-gaap_LiabilityMember_b182d6c1-6051-4f70-9899-50c25a44fbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f7fe9b74-729c-42a7-834b-4dcf7bf4923d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f7fe9b74-729c-42a7-834b-4dcf7bf4923d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_41b1b9b8-4da7-495f-9329-3b0351c434f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f7fe9b74-729c-42a7-834b-4dcf7bf4923d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_41b1b9b8-4da7-495f-9329-3b0351c434f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_68f9b831-7de3-4170-b14d-9d656bdda13d" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_41b1b9b8-4da7-495f-9329-3b0351c434f7" xlink:to="loc_ahl_LossPortfolioTransferMember_68f9b831-7de3-4170-b14d-9d656bdda13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fbd32623-a3e6-4a1a-a9c4-e64c0399cdf6" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_a1dab840-591a-471e-ae1b-cf22d2f07d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_a1dab840-591a-471e-ae1b-cf22d2f07d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ba959cf9-91ad-478c-93fa-ba9a8429e3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_ba959cf9-91ad-478c-93fa-ba9a8429e3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_af42bbec-c4da-45fe-a5f4-da689711d17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_TradingSecurities_af42bbec-c4da-45fe-a5f4-da689711d17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_56b401e9-6a62-42c1-b387-61913d6130db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_56b401e9-6a62-42c1-b387-61913d6130db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_d152274a-aa09-4f9c-b7a2-14a1cd8eca3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_d152274a-aa09-4f9c-b7a2-14a1cd8eca3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_ffa4440b-d59a-406b-a91e-47a4e9fe2d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_ffa4440b-d59a-406b-a91e-47a4e9fe2d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_2989ab97-7927-4f55-82c6-5d2270c7c666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_TradingSecurities_2989ab97-7927-4f55-82c6-5d2270c7c666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_f972108e-188f-46c9-bc1a-13f08071e1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_f972108e-188f-46c9-bc1a-13f08071e1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_85221fff-a7f7-4963-b47a-8c6d13f49434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_85221fff-a7f7-4963-b47a-8c6d13f49434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_74f1b439-e6c7-41a9-b7a4-f7cc876912d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_74f1b439-e6c7-41a9-b7a4-f7cc876912d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_eecb2f64-6737-4670-a9b1-e2cae54f4ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_eecb2f64-6737-4670-a9b1-e2cae54f4ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_f505a3b0-1fd6-44c4-a7e6-3f0c1235fcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_f505a3b0-1fd6-44c4-a7e6-3f0c1235fcf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_994bf2c7-88ce-4367-a770-1eaf04dcae9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_994bf2c7-88ce-4367-a770-1eaf04dcae9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_46a48cd2-1946-4842-b612-ef7ffbfa8d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_46a48cd2-1946-4842-b612-ef7ffbfa8d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_d002e2fa-fab0-4c8e-bdf9-7fb472c968f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_d002e2fa-fab0-4c8e-bdf9-7fb472c968f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_12eb2cad-7a39-4695-b391-9905913346b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e7baee0-b40a-49b0-8b30-9b239442f9a8" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_12eb2cad-7a39-4695-b391-9905913346b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsInputsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_09bba8ba-0c73-4113-96ff-1ffc60a475fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_09bba8ba-0c73-4113-96ff-1ffc60a475fd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_a3c5f05d-bed1-45a6-9260-8ea704e16811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_ValuationTechniqueAxis_a3c5f05d-bed1-45a6-9260-8ea704e16811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_a3c5f05d-bed1-45a6-9260-8ea704e16811" xlink:to="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_0dd1501e-3501-4dc7-b977-5193f3044215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_0dd1501e-3501-4dc7-b977-5193f3044215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_4f418253-b321-4531-9da5-a1b47cf822f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_4f418253-b321-4531-9da5-a1b47cf822f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ValuationTechniqueLiquidationMethodMember_9d6df232-38eb-41bc-bfc7-3439ba494d19" xlink:href="ahl-20231220.xsd#ahl_ValuationTechniqueLiquidationMethodMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:to="loc_ahl_ValuationTechniqueLiquidationMethodMember_9d6df232-38eb-41bc-bfc7-3439ba494d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostApproachValuationTechniqueMember_3b5f0e96-948c-4ebc-930f-be637bd8b6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostApproachValuationTechniqueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b048c927-51b2-4dd1-8edc-20d0f81e037f" xlink:to="loc_us-gaap_CostApproachValuationTechniqueMember_3b5f0e96-948c-4ebc-930f-be637bd8b6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_0cde03dd-4962-4b21-bc06-bba303df6f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_InvestmentTypeAxis_0cde03dd-4962-4b21-bc06-bba303df6f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_0cde03dd-4962-4b21-bc06-bba303df6f98" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_02d1c9ad-5170-46e4-9e09-f2b7a8afe86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_02d1c9ad-5170-46e4-9e09-f2b7a8afe86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_abcaa6c7-5661-4fe3-bbed-7f8f53ba47ba" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_ahl_MiddlemarketloansMember_abcaa6c7-5661-4fe3-bbed-7f8f53ba47ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_7640a8b7-9052-40af-8978-afea894813b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_7640a8b7-9052-40af-8978-afea894813b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember_1c4ae2a6-2fc3-451f-b6b1-9a4dcad6b8b6" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_ahl_GlobalCorporateSecuritiesMember_1c4ae2a6-2fc3-451f-b6b1-9a4dcad6b8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_8ee2de56-4a6e-48f3-a58d-370e3a130d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_EquitySecuritiesMember_8ee2de56-4a6e-48f3-a58d-370e3a130d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_8aff42f1-8e94-413d-9c83-c9bf0639848d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_8aff42f1-8e94-413d-9c83-c9bf0639848d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_27fa264b-9d51-4db8-83f0-36a9e00ad4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a79563d7-c203-4f90-a378-41f15ae420d2" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_27fa264b-9d51-4db8-83f0-36a9e00ad4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e014d05-cee9-4a6d-a191-d027244644e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e014d05-cee9-4a6d-a191-d027244644e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_59998f43-d2ea-4e42-b622-ded3bfb743e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e014d05-cee9-4a6d-a191-d027244644e8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_59998f43-d2ea-4e42-b622-ded3bfb743e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_86ecdec5-e621-4b16-9da5-f02d9a64fad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_59998f43-d2ea-4e42-b622-ded3bfb743e6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_86ecdec5-e621-4b16-9da5-f02d9a64fad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_srt_RangeAxis_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a8e53b6d-0d57-45c9-ad00-48ce2c0d3a8d" xlink:to="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_35d4d9ce-85fe-4599-b204-3a178e560eb2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:to="loc_srt_MinimumMember_35d4d9ce-85fe-4599-b204-3a178e560eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_492fe927-a3a1-4481-a9fd-f1c08e503625" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:to="loc_srt_MaximumMember_492fe927-a3a1-4481-a9fd-f1c08e503625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_e4704aa5-941d-4907-9c5f-5ef847b8a6a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c0a2e176-cc06-4b3f-8ea4-805761f82534" xlink:to="loc_srt_WeightedAverageMember_e4704aa5-941d-4907-9c5f-5ef847b8a6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f2ea5b08-b046-4796-82b1-cb89625d9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f2ea5b08-b046-4796-82b1-cb89625d9ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3a8dab3-e1f2-47e4-a57f-cbd9be339c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f2ea5b08-b046-4796-82b1-cb89625d9ab0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3a8dab3-e1f2-47e4-a57f-cbd9be339c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6ed8d9a3-395d-4425-a17d-83031cd95f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3a8dab3-e1f2-47e4-a57f-cbd9be339c08" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6ed8d9a3-395d-4425-a17d-83031cd95f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72f983a5-8ff9-45dd-8992-da69bbb25d29" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_d9bbbbf3-3bfc-498c-9056-e007a4c900c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:to="loc_us-gaap_PremiumsWrittenGross_d9bbbbf3-3bfc-498c-9056-e007a4c900c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_155c293c-16ca-4889-a096-bbe0cc815a47" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_155c293c-16ca-4889-a096-bbe0cc815a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingMeasurementInput_783bea43-6faa-4cf5-8a6f-4a80f80ca3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingMeasurementInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f98a545d-d9fe-4fcc-98e5-60d2514780d5" xlink:to="loc_us-gaap_DebtSecuritiesTradingMeasurementInput_783bea43-6faa-4cf5-8a6f-4a80f80ca3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsAdditionalInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c7adc62f-b7a9-4b94-9845-025cc9e724d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c7adc62f-b7a9-4b94-9845-025cc9e724d6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_fa82334c-b517-4e6e-b535-4012f5761089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_InvestmentTypeAxis_fa82334c-b517-4e6e-b535-4012f5761089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_edd5950c-afef-462e-ac8c-fb900a2f1eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_fa82334c-b517-4e6e-b535-4012f5761089" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_edd5950c-afef-462e-ac8c-fb900a2f1eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_5a413896-a95a-4878-a36e-c19dd4c39881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_edd5950c-afef-462e-ac8c-fb900a2f1eaf" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_5a413896-a95a-4878-a36e-c19dd4c39881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_60acfde3-fede-4b46-b858-cf23201d02a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_60acfde3-fede-4b46-b858-cf23201d02a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_527d0e74-c153-4705-81e7-ec6f8fa45db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_60acfde3-fede-4b46-b858-cf23201d02a8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_527d0e74-c153-4705-81e7-ec6f8fa45db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_6755691f-e1e8-49a2-8093-2364c0490819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_527d0e74-c153-4705-81e7-ec6f8fa45db6" xlink:to="loc_us-gaap_AssetsMember_6755691f-e1e8-49a2-8093-2364c0490819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_6cec4154-c371-4d58-8498-6e25346f3b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_527d0e74-c153-4705-81e7-ec6f8fa45db6" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_6cec4154-c371-4d58-8498-6e25346f3b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ebe2d49-96d6-4e61-9056-cfa29b62a43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ebe2d49-96d6-4e61-9056-cfa29b62a43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b2592f84-5cc9-4862-81fb-1a700829d22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ebe2d49-96d6-4e61-9056-cfa29b62a43d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b2592f84-5cc9-4862-81fb-1a700829d22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_422275f6-772a-484b-8955-fa7e66920ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b2592f84-5cc9-4862-81fb-1a700829d22a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_422275f6-772a-484b-8955-fa7e66920ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d001a002-b6ce-4657-b8bf-32632ece0ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21aaa79f-5a9a-4de2-85f0-ed8f0b51462f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d001a002-b6ce-4657-b8bf-32632ece0ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7eaf9d48-185d-47b6-9da1-65c4a34901f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d001a002-b6ce-4657-b8bf-32632ece0ac2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7eaf9d48-185d-47b6-9da1-65c4a34901f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_319b3396-54a5-4547-8256-b494a930536f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e5e9aca6-4f56-424d-bb2c-d7f5a20b59c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_319b3396-54a5-4547-8256-b494a930536f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_a65dd105-7827-45a7-94d5-5c41def057b5" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_319b3396-54a5-4547-8256-b494a930536f" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_a65dd105-7827-45a7-94d5-5c41def057b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_546f9631-555d-46d1-992b-77a4ef089592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_546f9631-555d-46d1-992b-77a4ef089592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_55f595c9-dddb-4ccc-98fd-7ea3d7e3b184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_546f9631-555d-46d1-992b-77a4ef089592" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_55f595c9-dddb-4ccc-98fd-7ea3d7e3b184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_HedgingDesignationAxis_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8e880c28-c1e6-457c-a6ed-0be264b7046f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0bbdf6a0-5c6a-44b0-ac50-05bc6e22cdde" xlink:to="loc_us-gaap_HedgingDesignationDomain_8e880c28-c1e6-457c-a6ed-0be264b7046f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_0b11c90b-106a-413b-886b-5ad5e1860d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8e880c28-c1e6-457c-a6ed-0be264b7046f" xlink:to="loc_us-gaap_NondesignatedMember_0b11c90b-106a-413b-886b-5ad5e1860d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efae177a-a43c-42a6-93c4-06ab9a6a1d33" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_f4c4bb8d-5282-4e5e-8937-728a645c2037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_f4c4bb8d-5282-4e5e-8937-728a645c2037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_ba323e7d-74ca-475e-9af4-c5a2589d1b96" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_ba323e7d-74ca-475e-9af4-c5a2589d1b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7ac1c331-7cf7-4e10-b6f1-4a677561d0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7ac1c331-7cf7-4e10-b6f1-4a677561d0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_28375ae7-b008-4a1c-9042-5c067d9412db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_28375ae7-b008-4a1c-9042-5c067d9412db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_73651fc5-f70d-4963-bfb0-628775078be4" xlink:href="ahl-20231220.xsd#ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2fe3088b-07a3-4ecf-9f74-c91eed48b0e2" xlink:to="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_73651fc5-f70d-4963-bfb0-628775078be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_27a7a121-13d6-4ae2-9df9-64315df07b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e233a0c7-a6a9-4bad-ba97-9644ecec1bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNetConsolidatedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_27a7a121-13d6-4ae2-9df9-64315df07b68" xlink:to="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e233a0c7-a6a9-4bad-ba97-9644ecec1bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsWritten_6a845444-9601-4571-8d75-b47fb18e3667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsWritten"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e233a0c7-a6a9-4bad-ba97-9644ecec1bf3" xlink:to="loc_us-gaap_DirectPremiumsWritten_6a845444-9601-4571-8d75-b47fb18e3667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsWritten_dbf6e433-747c-4d52-924b-48446f4fbb88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsWritten"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e233a0c7-a6a9-4bad-ba97-9644ecec1bf3" xlink:to="loc_us-gaap_AssumedPremiumsWritten_dbf6e433-747c-4d52-924b-48446f4fbb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsWritten_16b7fe65-0ad8-48e5-af4b-99208852b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsWritten"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e233a0c7-a6a9-4bad-ba97-9644ecec1bf3" xlink:to="loc_us-gaap_CededPremiumsWritten_16b7fe65-0ad8-48e5-af4b-99208852b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_d7e668f4-7762-4b16-998d-48d53481dc80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e233a0c7-a6a9-4bad-ba97-9644ecec1bf3" xlink:to="loc_us-gaap_PremiumsWrittenNet_d7e668f4-7762-4b16-998d-48d53481dc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_ddc59f6c-8d3a-4e29-aeee-49cfeae5bba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_27a7a121-13d6-4ae2-9df9-64315df07b68" xlink:to="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_ddc59f6c-8d3a-4e29-aeee-49cfeae5bba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_5e26c805-d22c-45c9-836d-a0c6d673d694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_ddc59f6c-8d3a-4e29-aeee-49cfeae5bba5" xlink:to="loc_us-gaap_DirectPremiumsEarned_5e26c805-d22c-45c9-836d-a0c6d673d694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_a8ade35d-a1af-4c27-bccb-1fe50f7b8f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_ddc59f6c-8d3a-4e29-aeee-49cfeae5bba5" xlink:to="loc_us-gaap_AssumedPremiumsEarned_a8ade35d-a1af-4c27-bccb-1fe50f7b8f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_aafb843b-7357-4a70-b708-d3dc4efa9462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsEarned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_ddc59f6c-8d3a-4e29-aeee-49cfeae5bba5" xlink:to="loc_us-gaap_CededPremiumsEarned_aafb843b-7357-4a70-b708-d3dc4efa9462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_c4241713-f30a-4fc3-9a05-f9988af613c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_ddc59f6c-8d3a-4e29-aeee-49cfeae5bba5" xlink:to="loc_us-gaap_PremiumsEarnedNet_c4241713-f30a-4fc3-9a05-f9988af613c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_591fe1e9-70cf-49dc-a05e-4308752f0e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_27a7a121-13d6-4ae2-9df9-64315df07b68" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_591fe1e9-70cf-49dc-a05e-4308752f0e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_6b59bdb4-5ad5-4319-b5c3-ffcffc1abeea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_591fe1e9-70cf-49dc-a05e-4308752f0e45" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_6b59bdb4-5ad5-4319-b5c3-ffcffc1abeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_10a771da-67ab-4b11-a647-63a21e4b011d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_591fe1e9-70cf-49dc-a05e-4308752f0e45" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_10a771da-67ab-4b11-a647-63a21e4b011d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_cefb0936-6fc9-406d-ade2-13d4308d8077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_591fe1e9-70cf-49dc-a05e-4308752f0e45" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_cefb0936-6fc9-406d-ade2-13d4308d8077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_cc0613ef-996b-4ec7-abd1-a5e3404e6e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_591fe1e9-70cf-49dc-a05e-4308752f0e45" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_cc0613ef-996b-4ec7-abd1-a5e3404e6e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_696ca0e8-5de5-4944-a9f0-97e22cd65429" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_27a7a121-13d6-4ae2-9df9-64315df07b68" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_696ca0e8-5de5-4944-a9f0-97e22cd65429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f14f9563-8481-4190-82ac-4012770fce71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_696ca0e8-5de5-4944-a9f0-97e22cd65429" xlink:to="loc_srt_ProductOrServiceAxis_f14f9563-8481-4190-82ac-4012770fce71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_45ee6d31-a4ec-435e-bed6-d15c8c3dc157" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f14f9563-8481-4190-82ac-4012770fce71" xlink:to="loc_srt_ProductsAndServicesDomain_45ee6d31-a4ec-435e-bed6-d15c8c3dc157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_a92e07c6-a700-4b5b-9efe-6ba74d6f8329" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_696ca0e8-5de5-4944-a9f0-97e22cd65429" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_a92e07c6-a700-4b5b-9efe-6ba74d6f8329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_db05b79c-578e-4d3e-b21f-4448fdd93777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_db05b79c-578e-4d3e-b21f-4448fdd93777" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4295a777-4e6c-4f7d-a929-6b0f71982fc8" xlink:to="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f12aa369-0480-436d-9504-2ec7bed68ee4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:to="loc_srt_MaximumMember_f12aa369-0480-436d-9504-2ec7bed68ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25daf461-c4e1-434b-a1ec-7002fbe6fae2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_be9aa41c-0cd0-48ad-acbb-d0fb57803ce4" xlink:to="loc_srt_MinimumMember_25daf461-c4e1-434b-a1ec-7002fbe6fae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ce49bf84-a993-4dd2-a623-a8fb54ca663e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_f357b9fd-b4b2-4b9c-b965-cbe306bf3368" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a98ad70-eb05-4c9d-a0b2-cc4a2e35b02f" xlink:to="loc_ahl_EnstarMember_f357b9fd-b4b2-4b9c-b965-cbe306bf3368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_2d9282a9-1b7c-431d-b07d-c580fc0c4747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_us-gaap_ReinsuranceContractAxis_2d9282a9-1b7c-431d-b07d-c580fc0c4747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_9a3ec655-111c-4cd5-b887-1a3fa3616db5" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_13d32720-9238-4742-b990-c390d1bc28ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverables_13d32720-9238-4742-b990-c390d1bc28ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_92964880-7f32-4c5b-947b-c36f36e96b2f" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_92964880-7f32-4c5b-947b-c36f36e96b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_eb386714-cac3-4a35-86e1-6da208eebf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_eb386714-cac3-4a35-86e1-6da208eebf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_2ae73f50-8a9d-4b62-a1f1-70143ac1bd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_2ae73f50-8a9d-4b62-a1f1-70143ac1bd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_3767aa54-6828-4864-9124-966954bd40e4" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_3767aa54-6828-4864-9124-966954bd40e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent_3526bd39-398f-4921-9f45-af4bc89ae969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionAmountRetainedPerEvent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRetentionAmountRetainedPerEvent_3526bd39-398f-4921-9f45-af4bc89ae969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_c56bd85d-0e13-4813-853b-11a93bf3971b" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_c56bd85d-0e13-4813-853b-11a93bf3971b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_a76bfb3d-b5cc-4114-adf6-2164f9bfdb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_ec9b0d19-728c-44ac-8963-80e83f913a4d" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_a76bfb3d-b5cc-4114-adf6-2164f9bfdb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsFairValueofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c29964ce-1718-453c-ac75-84595f49db64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c29964ce-1718-453c-ac75-84595f49db64" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0c61dc3f-148a-426b-b514-ef2499ff66fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:to="loc_us-gaap_HedgingDesignationAxis_0c61dc3f-148a-426b-b514-ef2499ff66fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5e77125c-3e9a-4466-bbab-82a042695fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0c61dc3f-148a-426b-b514-ef2499ff66fd" xlink:to="loc_us-gaap_HedgingDesignationDomain_5e77125c-3e9a-4466-bbab-82a042695fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_003395d3-7bfd-4014-a3b9-d57803c8be6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5e77125c-3e9a-4466-bbab-82a042695fcf" xlink:to="loc_us-gaap_NondesignatedMember_003395d3-7bfd-4014-a3b9-d57803c8be6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_91811203-e56c-425e-a0d2-41a46d112a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5e77125c-3e9a-4466-bbab-82a042695fcf" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_91811203-e56c-425e-a0d2-41a46d112a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c956cd2e-be90-41b1-b740-113a546d0844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c956cd2e-be90-41b1-b740-113a546d0844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5c950326-8a19-4ca7-9c53-a7964d5bdf48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c956cd2e-be90-41b1-b740-113a546d0844" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5c950326-8a19-4ca7-9c53-a7964d5bdf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_5fc80a0d-276e-4d14-b64e-98bf15927f7e" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5c950326-8a19-4ca7-9c53-a7964d5bdf48" xlink:to="loc_ahl_DerivativeAtFairValueMember_5fc80a0d-276e-4d14-b64e-98bf15927f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_903ba977-9392-4b06-8ed7-e01666dcbee6" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5c950326-8a19-4ca7-9c53-a7964d5bdf48" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_903ba977-9392-4b06-8ed7-e01666dcbee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bb78628c-3a61-4b30-b2b9-d69b98d65e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bb78628c-3a61-4b30-b2b9-d69b98d65e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e938c61f-079f-4ed1-867d-31cd2a1a9c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bb78628c-3a61-4b30-b2b9-d69b98d65e68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e938c61f-079f-4ed1-867d-31cd2a1a9c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a9194076-1711-4017-be5b-b82ffd563287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e938c61f-079f-4ed1-867d-31cd2a1a9c1c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a9194076-1711-4017-be5b-b82ffd563287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_6e23101c-600c-4dc1-801d-99f946b38d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e938c61f-079f-4ed1-867d-31cd2a1a9c1c" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_6e23101c-600c-4dc1-801d-99f946b38d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e2a1d0bf-dfb3-4cc2-8c9a-879b72ff4512" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5354a953-0637-4d26-89cf-63ef78795099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5354a953-0637-4d26-89cf-63ef78795099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_feb7eb5f-80a0-47cc-adec-78a6404e7c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_feb7eb5f-80a0-47cc-adec-78a6404e7c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_1be0c688-a7bd-4861-902e-987f145e5892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c05977a5-a947-4a35-872c-11bf2fbf772c" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_1be0c688-a7bd-4861-902e-987f145e5892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_887eef5a-a488-4866-b47d-81c391fa8082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_887eef5a-a488-4866-b47d-81c391fa8082" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e7ca7e67-2fd3-4f99-8a83-4bec796b542f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:to="loc_us-gaap_HedgingDesignationAxis_e7ca7e67-2fd3-4f99-8a83-4bec796b542f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b283bec8-23f1-42e9-9ae7-7d3598524c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e7ca7e67-2fd3-4f99-8a83-4bec796b542f" xlink:to="loc_us-gaap_HedgingDesignationDomain_b283bec8-23f1-42e9-9ae7-7d3598524c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c7a9ab42-2678-46f0-8fa5-dd9db4224b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b283bec8-23f1-42e9-9ae7-7d3598524c26" xlink:to="loc_us-gaap_NondesignatedMember_c7a9ab42-2678-46f0-8fa5-dd9db4224b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_910545fc-4caf-4dff-acf2-d50642e1e530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b283bec8-23f1-42e9-9ae7-7d3598524c26" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_910545fc-4caf-4dff-acf2-d50642e1e530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_156883c8-34c3-4ee0-898d-1d1125ca70ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_156883c8-34c3-4ee0-898d-1d1125ca70ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5fb5d5ce-980f-4346-abe6-8d38d5833e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_156883c8-34c3-4ee0-898d-1d1125ca70ae" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5fb5d5ce-980f-4346-abe6-8d38d5833e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_fdf2d5d2-1119-4b9b-8d00-0feb3d8edba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5fb5d5ce-980f-4346-abe6-8d38d5833e06" xlink:to="loc_us-gaap_ForeignExchangeContractMember_fdf2d5d2-1119-4b9b-8d00-0feb3d8edba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e94d187b-3553-4a32-8566-a7762850664a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e94d187b-3553-4a32-8566-a7762850664a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e94d187b-3553-4a32-8566-a7762850664a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_734f303f-522e-4d60-b0b0-f76e515dc710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_734f303f-522e-4d60-b0b0-f76e515dc710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_ade5e9ef-040e-4303-a7b6-4f1bf7207004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_ade5e9ef-040e-4303-a7b6-4f1bf7207004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_031be7f6-8fc4-4fab-b4f3-b86b74bec06e" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dd83090-2f95-4c5a-89ca-3d468038add6" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_031be7f6-8fc4-4fab-b4f3-b86b74bec06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_36492086-8072-4be0-8dda-11afea805ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da8dd2fc-eb12-4b7c-9941-e423ad13eeee" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_36492086-8072-4be0-8dda-11afea805ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a31a1175-3325-44ce-853e-80841d2c5875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_36492086-8072-4be0-8dda-11afea805ddd" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a31a1175-3325-44ce-853e-80841d2c5875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_e28230d6-1297-42f9-8d79-29237f8ffcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_36492086-8072-4be0-8dda-11afea805ddd" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_e28230d6-1297-42f9-8d79-29237f8ffcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec2817c2-3788-4200-8b75-3295ab5151d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec2817c2-3788-4200-8b75-3295ab5151d6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_72c71b8c-3260-41e1-8c9c-339853acb8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_72c71b8c-3260-41e1-8c9c-339853acb8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6f3ac009-4032-44d1-8971-2e870d0cf307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72c71b8c-3260-41e1-8c9c-339853acb8b0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6f3ac009-4032-44d1-8971-2e870d0cf307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_bc41342c-9f09-4137-a0f9-eadbcfdbbcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6f3ac009-4032-44d1-8971-2e870d0cf307" xlink:to="loc_us-gaap_ForeignExchangeContractMember_bc41342c-9f09-4137-a0f9-eadbcfdbbcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_7352c059-5745-4841-a478-e75e099d5850" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6f3ac009-4032-44d1-8971-2e870d0cf307" xlink:to="loc_ahl_LossPortfolioTransferMember_7352c059-5745-4841-a478-e75e099d5850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6d95812e-d4e8-47e8-a654-68221e59fe37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6d95812e-d4e8-47e8-a654-68221e59fe37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6d95812e-d4e8-47e8-a654-68221e59fe37" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_79e521dc-d2db-4152-803c-f5473f71c429" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_79e521dc-d2db-4152-803c-f5473f71c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2762383a-5072-416a-b4ac-574cfe787f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2762383a-5072-416a-b4ac-574cfe787f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_988e0c57-f2b4-4bb9-9227-94e3f2a3ee51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5dad5505-d8c6-4a77-9c6d-4c634ee0fae0" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_988e0c57-f2b4-4bb9-9227-94e3f2a3ee51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5d7923d0-cafc-4439-bd85-aae30dd368cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_HedgingDesignationAxis_5d7923d0-cafc-4439-bd85-aae30dd368cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_78d20ea5-b898-4b07-868a-59b8f9ba175e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d7923d0-cafc-4439-bd85-aae30dd368cd" xlink:to="loc_us-gaap_HedgingDesignationDomain_78d20ea5-b898-4b07-868a-59b8f9ba175e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_17f047dd-8b73-4fa2-a7fa-3a508b51235f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_78d20ea5-b898-4b07-868a-59b8f9ba175e" xlink:to="loc_us-gaap_NondesignatedMember_17f047dd-8b73-4fa2-a7fa-3a508b51235f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_326067d6-4118-4a3b-a950-696741e20cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_78d20ea5-b898-4b07-868a-59b8f9ba175e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_326067d6-4118-4a3b-a950-696741e20cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7d927fd1-1f72-4630-baa9-f68a3e91a57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7d927fd1-1f72-4630-baa9-f68a3e91a57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4902b6a9-9970-428f-8a72-b94581ec5e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7d927fd1-1f72-4630-baa9-f68a3e91a57a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4902b6a9-9970-428f-8a72-b94581ec5e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_1cd8fca8-c8ee-447e-ac98-db8ba161ba6d" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4902b6a9-9970-428f-8a72-b94581ec5e16" xlink:to="loc_ahl_DerivativeAtFairValueMember_1cd8fca8-c8ee-447e-ac98-db8ba161ba6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_242f6c0e-012d-4f52-a383-4d0ea74badf6" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4902b6a9-9970-428f-8a72-b94581ec5e16" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_242f6c0e-012d-4f52-a383-4d0ea74badf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e23fb037-6b09-4f70-b289-c678c047637f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e23fb037-6b09-4f70-b289-c678c047637f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ede1cd6-9f67-47aa-b4f0-bbafb76d2b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e23fb037-6b09-4f70-b289-c678c047637f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ede1cd6-9f67-47aa-b4f0-bbafb76d2b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1ffcbaab-7518-4940-bc04-8811f2064572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ede1cd6-9f67-47aa-b4f0-bbafb76d2b5a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1ffcbaab-7518-4940-bc04-8811f2064572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_21cb16c0-3047-4ea9-8ada-ac9cb205223f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_21cb16c0-3047-4ea9-8ada-ac9cb205223f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_55b13e59-6d6a-45b7-a639-154ac42aaeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_21cb16c0-3047-4ea9-8ada-ac9cb205223f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_55b13e59-6d6a-45b7-a639-154ac42aaeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_9551536a-dec7-419c-b0bc-0ccd7d45398a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_55b13e59-6d6a-45b7-a639-154ac42aaeb0" xlink:to="loc_us-gaap_LiabilityMember_9551536a-dec7-419c-b0bc-0ccd7d45398a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bb188956-5b70-4b93-95c3-3b74e3b32191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bb188956-5b70-4b93-95c3-3b74e3b32191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c6b825d8-bed5-4b56-8bb2-79e9c90f444f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bb188956-5b70-4b93-95c3-3b74e3b32191" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c6b825d8-bed5-4b56-8bb2-79e9c90f444f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_636eb739-082d-4924-b6b6-5cda0dc670c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c6b825d8-bed5-4b56-8bb2-79e9c90f444f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_636eb739-082d-4924-b6b6-5cda0dc670c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d9f2c44c-838f-41ec-bfe7-04087dfc9037" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a4376d7d-0980-4f2d-ba69-d5a74ac4b18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a4376d7d-0980-4f2d-ba69-d5a74ac4b18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_db8889bb-20db-41e8-b103-cd9badfb4c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_db8889bb-20db-41e8-b103-cd9badfb4c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_306bf376-4f58-497e-ac6b-15b8626f9dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_306bf376-4f58-497e-ac6b-15b8626f9dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a5d001d1-476d-47d4-8f02-6b75e2389b40" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a5d001d1-476d-47d4-8f02-6b75e2389b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_89c36013-aa20-4963-9d5a-8c50aa0d2e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ffd31bee-7e21-4f5f-abc4-73ca49f73943" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_89c36013-aa20-4963-9d5a-8c50aa0d2e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DeferredPolicyAcquisitionCostsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DeferredPolicyAcquisitionCostsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DeferredPolicyAcquisitionCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_ac83d396-dfaf-4fd1-80f0-7d49f5762b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_4820e8b7-fd80-414f-8d15-bb7c8283ef7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_ac83d396-dfaf-4fd1-80f0-7d49f5762b6b" xlink:to="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_4820e8b7-fd80-414f-8d15-bb7c8283ef7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_b141327a-0af1-4c11-b9b2-fa6d838f8a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_4820e8b7-fd80-414f-8d15-bb7c8283ef7f" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_b141327a-0af1-4c11-b9b2-fa6d838f8a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions_adfb8ef9-8b81-47ac-81ac-6a1b4b4e6691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_4820e8b7-fd80-414f-8d15-bb7c8283ef7f" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions_adfb8ef9-8b81-47ac-81ac-6a1b4b4e6691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_1e8e11b6-81ac-4458-83da-b6aa0d061030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_4820e8b7-fd80-414f-8d15-bb7c8283ef7f" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_1e8e11b6-81ac-4458-83da-b6aa0d061030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_229cae5b-b94c-476f-864a-49d455b7b336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_4820e8b7-fd80-414f-8d15-bb7c8283ef7f" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_229cae5b-b94c-476f-864a-49d455b7b336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c0603569-d0b6-4d5b-86ff-206335114b81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c0603569-d0b6-4d5b-86ff-206335114b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesAdjustment_fbd4a3bb-15c5-4617-9570-42ee426f6ff5" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_ahl_ReinsuranceRecoverablesAdjustment_fbd4a3bb-15c5-4617-9570-42ee426f6ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_734e8117-9149-4501-b6ef-20b43124f94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_734e8117-9149-4501-b6ef-20b43124f94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4897212-5dfc-4e2e-a4fa-44a9fef16fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4897212-5dfc-4e2e-a4fa-44a9fef16fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6bb4147a-f1a7-4cd2-87d4-16f294f76fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4897212-5dfc-4e2e-a4fa-44a9fef16fc7" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6bb4147a-f1a7-4cd2-87d4-16f294f76fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_97bbfe16-5a8a-4ca5-8d13-4935cf5d4264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4897212-5dfc-4e2e-a4fa-44a9fef16fc7" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_97bbfe16-5a8a-4ca5-8d13-4935cf5d4264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_7a008f84-5e2f-4cf4-9012-ae598e8a9afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_b4897212-5dfc-4e2e-a4fa-44a9fef16fc7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_7a008f84-5e2f-4cf4-9012-ae598e8a9afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_4d2bb4c5-8132-4c82-ac7c-bb10ca4b6f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_4d2bb4c5-8132-4c82-ac7c-bb10ca4b6f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4df9737d-7f18-4db4-861c-dbab6a9a2d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_4d2bb4c5-8132-4c82-ac7c-bb10ca4b6f0b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4df9737d-7f18-4db4-861c-dbab6a9a2d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_63c814f0-4fb5-4c8d-83cb-f9d31b2da9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_4d2bb4c5-8132-4c82-ac7c-bb10ca4b6f0b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_63c814f0-4fb5-4c8d-83cb-f9d31b2da9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_064177b3-61f8-4a89-a0e6-8c81b2d1fc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_4d2bb4c5-8132-4c82-ac7c-bb10ca4b6f0b" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_064177b3-61f8-4a89-a0e6-8c81b2d1fc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss_adb41b35-dc7e-4128-a591-4b2722414325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss_adb41b35-dc7e-4128-a591-4b2722414325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_2aeeace1-4904-4edc-8311-5a63519862f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_2aeeace1-4904-4edc-8311-5a63519862f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_112662a8-45fa-47e0-840e-5811fae4f7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_us-gaap_ReinsuranceRecoverables_112662a8-45fa-47e0-840e-5811fae4f7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_8bff4d5d-0eb8-4d6a-a197-87965e0a84c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_8bff4d5d-0eb8-4d6a-a197-87965e0a84c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e0ff94ce-3614-47bc-a85b-fca44d97f38d" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_af7fe4b9-c886-45e3-8c43-a047c6e38596" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_9338742f-09c5-4a4d-a3bb-d9a774d062f4" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64f8c7a4-b499-40c3-945f-95c27d900451" xlink:to="loc_ahl_EnstarMember_9338742f-09c5-4a4d-a3bb-d9a774d062f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5eaca3c2-d8c8-4f49-81b4-5f8fac0970e1" xlink:to="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretySegmentMember_2cec9869-7df4-4e29-b9b8-4d2cbd759f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretySegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:to="loc_us-gaap_SuretySegmentMember_2cec9869-7df4-4e29-b9b8-4d2cbd759f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccidentAndHealthInsuranceSegmentMember_479feca6-31b7-4aa0-bee1-24f54cc6e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccidentAndHealthInsuranceSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2c502732-8cde-44ee-8e0c-cc3ae483127a" xlink:to="loc_us-gaap_AccidentAndHealthInsuranceSegmentMember_479feca6-31b7-4aa0-bee1-24f54cc6e2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4308cab1-2476-4517-b9d5-77aee35f438e" xlink:to="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_05cccc20-e2b6-4568-9633-e28bca7ee866" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8b07ad03-f5ef-46f4-84e2-1535be7dfdae" xlink:to="loc_ahl_InsuranceMember_05cccc20-e2b6-4568-9633-e28bca7ee866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_b9562cb6-9a30-46dd-9723-605afaacfdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_us-gaap_ReinsuranceContractAxis_b9562cb6-9a30-46dd-9723-605afaacfdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1912f69d-d457-4048-b0d7-efbb9d44e9fe" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_34783f5b-9a2d-4b9d-8a40-cd51e18c7773" xlink:href="ahl-20231220.xsd#ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_34783f5b-9a2d-4b9d-8a40-cd51e18c7773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_ddca87dd-2827-496f-a420-eac79ac606cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_ddca87dd-2827-496f-a420-eac79ac606cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_e796322a-7293-4948-81ac-1b3d2558a8b2" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesTotalRecoverable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_df183a49-9beb-433f-b666-4b4f7ac9365f" xlink:to="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_e796322a-7293-4948-81ac-1b3d2558a8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_94b39077-f471-4fa4-addb-17c8238eac81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_4af5f2a0-b4f3-45cc-a563-7440c973758a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_94b39077-f471-4fa4-addb-17c8238eac81" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_4af5f2a0-b4f3-45cc-a563-7440c973758a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_665efcd5-e018-4bc0-92e2-c01aa92713b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_94b39077-f471-4fa4-addb-17c8238eac81" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_665efcd5-e018-4bc0-92e2-c01aa92713b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_94b39077-f471-4fa4-addb-17c8238eac81" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_26a52d73-49ee-4a97-948b-406a7fd50f60" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd004d03-bf14-4a92-b6a0-d3bb51c3dc1d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_26a52d73-49ee-4a97-948b-406a7fd50f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f14a1c8d-f948-470e-8630-a6b969815efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f14a1c8d-f948-470e-8630-a6b969815efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2629bcb9-373c-49cb-9f5a-023c2d855af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f14a1c8d-f948-470e-8630-a6b969815efb" xlink:to="loc_us-gaap_SegmentDomain_2629bcb9-373c-49cb-9f5a-023c2d855af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_b74aea3e-6e0f-4623-9db7-f4a3edac97ae" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2629bcb9-373c-49cb-9f5a-023c2d855af6" xlink:to="loc_ahl_ReinsuranceMember_b74aea3e-6e0f-4623-9db7-f4a3edac97ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_95f989e2-9afa-484a-b3fb-17c2208d422c" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2629bcb9-373c-49cb-9f5a-023c2d855af6" xlink:to="loc_ahl_InsuranceMember_95f989e2-9afa-484a-b3fb-17c2208d422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_d053fca3-5d3b-43fc-b2de-bad7cf367ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_e29d333e-ece3-4023-b43c-b1115550bd6c" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_d053fca3-5d3b-43fc-b2de-bad7cf367ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_f19fd8ef-a837-4126-89b8-0826c09513ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_d053fca3-5d3b-43fc-b2de-bad7cf367ccf" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_f19fd8ef-a837-4126-89b8-0826c09513ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_2832c840-1027-4c11-bc33-21822d31ea1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_2832c840-1027-4c11-bc33-21822d31ea1a" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_9a19ab2b-3fdd-4a42-8b41-0a23689560f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:to="loc_us-gaap_ReinsuranceContractAxis_9a19ab2b-3fdd-4a42-8b41-0a23689560f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_1b1a6ac7-80c0-4772-a674-11350d7d1f52" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f3a70710-7118-4655-a3b1-814378dd5b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f3a70710-7118-4655-a3b1-814378dd5b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_55af0b98-1baa-4324-8327-9f630a8f23da" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_55af0b98-1baa-4324-8327-9f630a8f23da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1d579d7b-0006-4023-9cc1-2d64729e6e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1d579d7b-0006-4023-9cc1-2d64729e6e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_193f1545-6f83-4966-bbc7-44f74cf78f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_193f1545-6f83-4966-bbc7-44f74cf78f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_b807ad86-3ddd-4353-8039-79865a015362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_d3765ab6-9019-4a30-af42-7b7c41207323" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_b807ad86-3ddd-4353-8039-79865a015362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationInsuranceContractsClaimsbyAccidentYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_047a4804-da22-4676-a669-a5110600d494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_047a4804-da22-4676-a669-a5110600d494" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f1791ee3-5ca7-445b-8878-59d7cbd1b383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f1791ee3-5ca7-445b-8878-59d7cbd1b383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f1791ee3-5ca7-445b-8878-59d7cbd1b383" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member_daaf1b09-4e80-45e6-b581-5d4a47826334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2013Member_daaf1b09-4e80-45e6-b581-5d4a47826334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member_2ac82dd6-34fc-426b-a7e2-514a60e20a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member_2ac82dd6-34fc-426b-a7e2-514a60e20a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_17fd663c-1c3d-4266-9787-38627c276a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_17fd663c-1c3d-4266-9787-38627c276a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_b4bcd4fb-345c-4585-b8e7-715b7cd55a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_b4bcd4fb-345c-4585-b8e7-715b7cd55a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_51ddf5b5-c692-47f8-9bfe-bdf79ed04f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member_51ddf5b5-c692-47f8-9bfe-bdf79ed04f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_12cfdbaa-3695-48c8-b693-24805e664965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member_12cfdbaa-3695-48c8-b693-24805e664965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_8a5152a6-0a6f-401a-96da-45ae3aca1536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_8a5152a6-0a6f-401a-96da-45ae3aca1536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1f9e44af-484a-409f-9afc-4f2b9d3bf5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1f9e44af-484a-409f-9afc-4f2b9d3bf5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_fbb7c490-084b-46ca-b681-bcd0a98398a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_fbb7c490-084b-46ca-b681-bcd0a98398a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_f6acdae6-44e6-4a70-b369-6254afe4ef7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_ef93fdff-b31b-4999-9ba7-835e51146796" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_f6acdae6-44e6-4a70-b369-6254afe4ef7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2e919b66-81fa-45b5-ac39-f026e95e6728" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:to="loc_srt_ProductOrServiceAxis_2e919b66-81fa-45b5-ac39-f026e95e6728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2e919b66-81fa-45b5-ac39-f026e95e6728" xlink:to="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyInsuranceProductLineMember_f9ecd320-a43a-47c7-a82e-0a15b40d0e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_us-gaap_PropertyInsuranceProductLineMember_f9ecd320-a43a-47c7-a82e-0a15b40d0e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CasualtyCommercialInsuranceProductLineMember_d2afed95-f2e5-4051-a070-0cde8ea6333b" xlink:href="ahl-20231220.xsd#ahl_CasualtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_CasualtyCommercialInsuranceProductLineMember_d2afed95-f2e5-4051-a070-0cde8ea6333b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_a9b90007-e0a5-42c2-92d6-74fbf3954c26" xlink:href="ahl-20231220.xsd#ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_a9b90007-e0a5-42c2-92d6-74fbf3954c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_f2714087-62fb-4e55-acf0-0529fb4d9be0" xlink:href="ahl-20231220.xsd#ahl_FinancialandProfessionalCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_f2714087-62fb-4e55-acf0-0529fb4d9be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_29c06d75-52b2-4f8b-9ec0-5a9925664a51" xlink:href="ahl-20231220.xsd#ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_29c06d75-52b2-4f8b-9ec0-5a9925664a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_49a85e7e-e39b-4fb7-8026-053dd57dccdf" xlink:href="ahl-20231220.xsd#ahl_AssumedCasualtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_49a85e7e-e39b-4fb7-8026-053dd57dccdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_70f2e354-203d-4a45-a46f-ed40942174b6" xlink:href="ahl-20231220.xsd#ahl_AssumedSpecialtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_617a328c-e5a9-4827-8efd-54b48fa70750" xlink:to="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_70f2e354-203d-4a45-a46f-ed40942174b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_198b6de7-7387-47ba-b22f-b2641da7c925" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_fc9c7706-bd15-488c-a7b3-617d2177de6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_fc9c7706-bd15-488c-a7b3-617d2177de6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e135ad1e-d669-4dd1-a7e1-19c515c150f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e135ad1e-d669-4dd1-a7e1-19c515c150f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_31796eb0-bb38-4283-9a17-19e67f159bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_31796eb0-bb38-4283-9a17-19e67f159bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_b11f629b-af7e-4323-a852-88d06cd093be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_b11f629b-af7e-4323-a852-88d06cd093be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_ba65b2a9-4a2e-46df-87e1-e1e6f1cde73d" xlink:href="ahl-20231220.xsd#ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_ahl_ShortDurationInsuranceContractsLiabilityforUnpaidClaimAdjustmentExpenseNetNotSeparatelyPresentedSubtotal_ba65b2a9-4a2e-46df-87e1-e1e6f1cde73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_2864ce3e-b6ab-4053-bfb6-71230f965873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_2864ce3e-b6ab-4053-bfb6-71230f965873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_8373f83e-d725-4df2-a890-e5a65c9392b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e28b8d05-456b-4092-9a06-353533aa8c74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_8373f83e-d725-4df2-a890-e5a65c9392b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationinsurancecontractsReconciliationofClaimsDevelopmentDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesShortdurationinsurancecontractsReconciliationofClaimsDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationinsurancecontractsReconciliationofClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_b32a2f51-3da1-4fb4-9b6b-66eaa25b8989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_6898cd2a-5a61-4ecb-8ef4-76b0e4e8abad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b32a2f51-3da1-4fb4-9b6b-66eaa25b8989" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_6898cd2a-5a61-4ecb-8ef4-76b0e4e8abad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_939b991e-dee9-4528-8de2-d95d9591e014" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_6898cd2a-5a61-4ecb-8ef4-76b0e4e8abad" xlink:to="loc_srt_ProductOrServiceAxis_939b991e-dee9-4528-8de2-d95d9591e014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_939b991e-dee9-4528-8de2-d95d9591e014" xlink:to="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyInsuranceProductLineMember_7412875c-fdf0-449c-b408-13a4d149b172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_us-gaap_PropertyInsuranceProductLineMember_7412875c-fdf0-449c-b408-13a4d149b172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CasualtyCommercialInsuranceProductLineMember_4b4ad8d1-a01e-4f94-b90a-37d17f5d72d5" xlink:href="ahl-20231220.xsd#ahl_CasualtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_CasualtyCommercialInsuranceProductLineMember_4b4ad8d1-a01e-4f94-b90a-37d17f5d72d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_9267479d-c973-4a1c-8452-13e7bbcd353f" xlink:href="ahl-20231220.xsd#ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_MarineAviationandEnergyCommercialInsuranceProductLineMember_9267479d-c973-4a1c-8452-13e7bbcd353f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_6cee78b1-043f-4e2f-bdbb-3fa10154fa4c" xlink:href="ahl-20231220.xsd#ahl_FinancialandProfessionalCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_FinancialandProfessionalCommercialInsuranceProductLineMember_6cee78b1-043f-4e2f-bdbb-3fa10154fa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_bb70a6e9-4d81-4fb5-b82c-43bfcd16ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_bb70a6e9-4d81-4fb5-b82c-43bfcd16ebc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_45939b94-1714-4153-9646-c7b3b5e48ff4" xlink:href="ahl-20231220.xsd#ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_AssumedPropertyCatastropheandOtherPropertyCommercialInsuranceProductLineMember_45939b94-1714-4153-9646-c7b3b5e48ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_7b850a54-5d42-4785-9944-b93f694d1ecf" xlink:href="ahl-20231220.xsd#ahl_AssumedCasualtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_AssumedCasualtyCommercialInsuranceProductLineMember_7b850a54-5d42-4785-9944-b93f694d1ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_2f9c8f53-f620-4e94-baa0-111384ef5b3c" xlink:href="ahl-20231220.xsd#ahl_AssumedSpecialtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_ahl_AssumedSpecialtyCommercialInsuranceProductLineMember_2f9c8f53-f620-4e94-baa0-111384ef5b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortdurationInsuranceProductLineMember_ce14592f-1419-4a89-9662-19256c2f248b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortdurationInsuranceProductLineMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_us-gaap_OtherShortdurationInsuranceProductLineMember_ce14592f-1419-4a89-9662-19256c2f248b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongdurationInsuranceProductLineMember_281a35f3-b95a-42d4-9d25-8ef0ab32f01e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongdurationInsuranceProductLineMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_806453ca-1aa2-4ea8-a4f9-861b5fca5c66" xlink:to="loc_us-gaap_OtherLongdurationInsuranceProductLineMember_281a35f3-b95a-42d4-9d25-8ef0ab32f01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_6898cd2a-5a61-4ecb-8ef4-76b0e4e8abad" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_a295e6dd-7d59-4344-8e7a-19d8b05b2f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_a295e6dd-7d59-4344-8e7a-19d8b05b2f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_17beb83f-7067-4985-8179-73fa5855f6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_17beb83f-7067-4985-8179-73fa5855f6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense_b26e993b-0306-4c83-97c9-7643b6469d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense_b26e993b-0306-4c83-97c9-7643b6469d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable_3a42ee76-e7ee-4f99-a52b-d71857b455dd" xlink:href="ahl-20231220.xsd#ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_ahl_ShortdurationInsuranceContractsLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseOtherReconcilingItemOtherReinsuranceBalancesRecoverable_3a42ee76-e7ee-4f99-a52b-d71857b455dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves_6c8d30b7-1c1b-491e-81c8-78d80970aba1" xlink:href="ahl-20231220.xsd#ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_ahl_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpensesOtherReconcilingItemCarbonSyndicateReserves_6c8d30b7-1c1b-491e-81c8-78d80970aba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_d4f62bfa-37ac-4d18-9733-84d18bf1a775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_d4f62bfa-37ac-4d18-9733-84d18bf1a775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_3c50a07d-f910-4350-b054-16241a80558f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseAggregateReconcilingItems_3c50a07d-f910-4350-b054-16241a80558f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d62f7f09-368c-4188-bc51-bb707a58c2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d3160ba8-058f-4c88-b22a-c46c2543c35b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d62f7f09-368c-4188-bc51-bb707a58c2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationContractsHistoricalClaimsDurationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesShortdurationContractsHistoricalClaimsDurationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesShortdurationContractsHistoricalClaimsDurationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_77205d22-4590-4f16-ad60-04c848979f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_111dfce0-da83-4127-8ff7-db45ee7adb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_77205d22-4590-4f16-ad60-04c848979f7a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_111dfce0-da83-4127-8ff7-db45ee7adb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_59deb0c0-cbe6-4245-bdba-59e78a2a05f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_111dfce0-da83-4127-8ff7-db45ee7adb1e" xlink:to="loc_srt_ProductOrServiceAxis_59deb0c0-cbe6-4245-bdba-59e78a2a05f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c36316c5-73f1-4091-8dab-e82b2ddd91bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_59deb0c0-cbe6-4245-bdba-59e78a2a05f0" xlink:to="loc_srt_ProductsAndServicesDomain_c36316c5-73f1-4091-8dab-e82b2ddd91bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_6fccd9ef-c738-408f-b4a6-1f70345e1c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c36316c5-73f1-4091-8dab-e82b2ddd91bc" xlink:to="loc_us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember_6fccd9ef-c738-408f-b4a6-1f70345e1c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember_0679789a-8527-4765-9d21-047793f75540" xlink:href="ahl-20231220.xsd#ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c36316c5-73f1-4091-8dab-e82b2ddd91bc" xlink:to="loc_ahl_AssumedPropertyandCasualtyCommercialInsuranceProductLineMember_0679789a-8527-4765-9d21-047793f75540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable_111dfce0-da83-4127-8ff7-db45ee7adb1e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne_a7e9f59b-e840-4e5a-925c-e42c372eeeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne_a7e9f59b-e840-4e5a-925c-e42c372eeeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo_28e6d2a7-a425-4727-87a3-b37c97ac993d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo_28e6d2a7-a425-4727-87a3-b37c97ac993d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree_7d1f871e-e166-49d1-ac94-5a8debe384c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree_7d1f871e-e166-49d1-ac94-5a8debe384c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour_d9a81f06-9bf5-41cb-aa29-c2a5e97fde10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour_d9a81f06-9bf5-41cb-aa29-c2a5e97fde10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive_25fd782d-9b90-4ba1-900f-0e4ac6d47d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive_25fd782d-9b90-4ba1-900f-0e4ac6d47d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix_ec7492ac-de45-42dc-817a-9a80a3a50045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix_ec7492ac-de45-42dc-817a-9a80a3a50045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven_e5e2b738-90d9-4c4f-963a-1d15f0075f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven_e5e2b738-90d9-4c4f-963a-1d15f0075f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight_437f1801-3b2b-4a00-bf67-879180ff5788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight_437f1801-3b2b-4a00-bf67-879180ff5788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine_829f3c8e-c557-44a0-85ab-2eddbdda524a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine_829f3c8e-c557-44a0-85ab-2eddbdda524a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen_4c3183fd-6db9-4f4d-85a3-2aecfc64dae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems_6a2de9e8-143f-4012-8b51-a8638247ccd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen_4c3183fd-6db9-4f4d-85a3-2aecfc64dae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesSummaryofTotalIncomeTaxDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesSummaryofTotalIncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IncomeTaxesSummaryofTotalIncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e856a34e-8fd2-43ac-9bba-cb6b83b8c00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_17538a74-7186-44b1-8970-15a6aa54cdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e856a34e-8fd2-43ac-9bba-cb6b83b8c00f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_17538a74-7186-44b1-8970-15a6aa54cdd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_65539102-d960-41ae-b328-9299b872ea4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e856a34e-8fd2-43ac-9bba-cb6b83b8c00f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_65539102-d960-41ae-b328-9299b872ea4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_85ae0782-fcac-4ef5-9fa8-b63e70b6d0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e856a34e-8fd2-43ac-9bba-cb6b83b8c00f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_85ae0782-fcac-4ef5-9fa8-b63e70b6d0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IncomeTaxesIncomeLossBeforeTaxandIncomeTaxExpenseBenefitAttributabletothatIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_947b6d97-3241-49b8-9006-689a163a5271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_947b6d97-3241-49b8-9006-689a163a5271" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_68952a91-5f7c-4ff9-afba-b240e4279ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_68952a91-5f7c-4ff9-afba-b240e4279ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_8ef6c36c-b7db-421e-8ac7-6b54b16f1cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_68952a91-5f7c-4ff9-afba-b240e4279ba2" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_8ef6c36c-b7db-421e-8ac7-6b54b16f1cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_11de547a-202f-4938-b4e3-9cb40c868fe2" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_8ef6c36c-b7db-421e-8ac7-6b54b16f1cac" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_11de547a-202f-4938-b4e3-9cb40c868fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_0c76f313-c972-44e3-98d9-654c52a0adea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_0c76f313-c972-44e3-98d9-654c52a0adea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_5423fad0-00cc-44d0-8f75-bb8cc70475c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_0c76f313-c972-44e3-98d9-654c52a0adea" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_5423fad0-00cc-44d0-8f75-bb8cc70475c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_2c4c727e-9cb6-4749-8df4-eadcca417e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeOfTheTaxCommissionerBermudaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_5423fad0-00cc-44d0-8f75-bb8cc70475c7" xlink:to="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_2c4c727e-9cb6-4749-8df4-eadcca417e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_5ac14aef-76ca-4bd1-8881-7ac9f6f9877b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_5423fad0-00cc-44d0-8f75-bb8cc70475c7" xlink:to="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_5ac14aef-76ca-4bd1-8881-7ac9f6f9877b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_127b4318-324b-4b95-84b4-c72b8569a857" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:to="loc_dei_LegalEntityAxis_127b4318-324b-4b95-84b4-c72b8569a857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_581be4eb-8f6e-49b3-9184-3c34d41a9e04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_127b4318-324b-4b95-84b4-c72b8569a857" xlink:to="loc_dei_EntityDomain_581be4eb-8f6e-49b3-9184-3c34d41a9e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_USOperatingSubsidiariesMember_f930c758-f86c-45cc-8cfd-5d8391c0ec5e" xlink:href="ahl-20231220.xsd#ahl_USOperatingSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_581be4eb-8f6e-49b3-9184-3c34d41a9e04" xlink:to="loc_ahl_USOperatingSubsidiariesMember_f930c758-f86c-45cc-8cfd-5d8391c0ec5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_65b173f5-d73b-4b02-accc-9d272a7ca684" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_581be4eb-8f6e-49b3-9184-3c34d41a9e04" xlink:to="loc_ahl_AspenUKMember_65b173f5-d73b-4b02-accc-9d272a7ca684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_346aa5da-2cc6-4014-a87f-edf0b7e67cf1" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_983486bf-3a3a-4cd2-bfe1-942fbe24e008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_983486bf-3a3a-4cd2-bfe1-942fbe24e008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6b1c5593-6013-404b-8595-55e09df5cb92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6b1c5593-6013-404b-8595-55e09df5cb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5fc6f075-6889-4842-b70b-6b6b66c934a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5fc6f075-6889-4842-b70b-6b6b66c934a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d2ebdf21-4df6-40cd-bbdb-7084b66e411e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d2ebdf21-4df6-40cd-bbdb-7084b66e411e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0f8600bb-0296-4722-b507-0f1bfdcf0aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0f8600bb-0296-4722-b507-0f1bfdcf0aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3c31a10-0821-45f5-a77f-0af728a470fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3c31a10-0821-45f5-a77f-0af728a470fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_eb602a2a-6de7-48b2-aa62-5c3aaa13e494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_eb602a2a-6de7-48b2-aa62-5c3aaa13e494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a906fffe-2bb1-46c2-9f72-e66e3c09ce99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a906fffe-2bb1-46c2-9f72-e66e3c09ce99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9fb9d425-3d1a-4434-8ed5-96311ddd0c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9fb9d425-3d1a-4434-8ed5-96311ddd0c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_e4f39ae9-30f0-4f38-83b7-7a3d7b1200ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_e4f39ae9-30f0-4f38-83b7-7a3d7b1200ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_bc7ba419-7109-4475-bdd6-133be9b740ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_bc7ba419-7109-4475-bdd6-133be9b740ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e626c774-6549-4a17-9581-c9fb114ba6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e626c774-6549-4a17-9581-c9fb114ba6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear_2b13d45c-2e9f-4aae-8e39-8295ebfdea61" xlink:href="ahl-20231220.xsd#ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_ahl_CurrentFederalTaxExpensesBenefitRelatedtoPriorYear_2b13d45c-2e9f-4aae-8e39-8295ebfdea61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_a069a833-7267-4f37-b4ea-ac3f62d7ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_188c9bbe-98a9-4acb-94e2-68f8d134b1ef" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_a069a833-7267-4f37-b4ea-ac3f62d7ab90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesIncomeTaxReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ea12ae70-2e63-4715-9b05-a6b9c59b0d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ea12ae70-2e63-4715-9b05-a6b9c59b0d39" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_5622b88f-9b67-4208-9a05-cc073a59c48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_5622b88f-9b67-4208-9a05-cc073a59c48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_82012c3e-e794-4e00-818a-283ff6c2687a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_5622b88f-9b67-4208-9a05-cc073a59c48b" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_82012c3e-e794-4e00-818a-283ff6c2687a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_b8568781-4e74-4976-8fc4-d2547f63fdef" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_82012c3e-e794-4e00-818a-283ff6c2687a" xlink:to="loc_ahl_LloydsMember_b8568781-4e74-4976-8fc4-d2547f63fdef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_7b456027-95e9-428c-a9ea-960188b33147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_7b456027-95e9-428c-a9ea-960188b33147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_c644cb54-54f6-4bb1-8380-a1fdb15f3a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7b456027-95e9-428c-a9ea-960188b33147" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_c644cb54-54f6-4bb1-8380-a1fdb15f3a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_f1b3d7a7-0fcd-46db-bc97-9bc4d160a450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_c644cb54-54f6-4bb1-8380-a1fdb15f3a60" xlink:to="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_f1b3d7a7-0fcd-46db-bc97-9bc4d160a450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f107e801-0c28-4e83-b450-2a8babd56f2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_srt_StatementScenarioAxis_f107e801-0c28-4e83-b450-2a8babd56f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5c3fbe89-df7b-48e6-b07a-9c070ed5913c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f107e801-0c28-4e83-b450-2a8babd56f2f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5c3fbe89-df7b-48e6-b07a-9c070ed5913c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c0ed5b3d-dec9-405e-af15-49d77f60683c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5c3fbe89-df7b-48e6-b07a-9c070ed5913c" xlink:to="loc_srt_ScenarioForecastMember_c0ed5b3d-dec9-405e-af15-49d77f60683c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_dei_LegalEntityAxis_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_24f69ca8-8602-4e80-9990-2c8cd5459865" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ab0e1bbf-f3d3-4ee0-afcf-14c748752c8e" xlink:to="loc_dei_EntityDomain_24f69ca8-8602-4e80-9990-2c8cd5459865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_USOperatingSubsidiariesMember_fbfec5a3-b667-4bbc-a7e5-06cdd06aa96b" xlink:href="ahl-20231220.xsd#ahl_USOperatingSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_24f69ca8-8602-4e80-9990-2c8cd5459865" xlink:to="loc_ahl_USOperatingSubsidiariesMember_fbfec5a3-b667-4bbc-a7e5-06cdd06aa96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_1397b9c1-fc8c-482e-8ae2-57944cf20bfe" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_24f69ca8-8602-4e80-9990-2c8cd5459865" xlink:to="loc_ahl_AspenUKMember_1397b9c1-fc8c-482e-8ae2-57944cf20bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_3c72bfb7-3fda-4caf-868f-288466c827cf" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7bb1678b-7f17-4e3a-a9dd-6982388a65e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7bb1678b-7f17-4e3a-a9dd-6982388a65e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_33088228-f865-4cfb-9603-dcc75852c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_33088228-f865-4cfb-9603-dcc75852c14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_4b0adaac-9c55-44ee-be9b-449cf147d4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationBeatAmount_4b0adaac-9c55-44ee-be9b-449cf147d4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_a4f7f878-66d4-4c41-9875-835358f41aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_a4f7f878-66d4-4c41-9875-835358f41aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2c273f84-3125-4b80-8b6b-c0c4a3c311df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2c273f84-3125-4b80-8b6b-c0c4a3c311df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_4d9ce31b-86f7-45ef-843b-34e9dc61732f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_4d9ce31b-86f7-45ef-843b-34e9dc61732f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_548b6d54-4270-45fb-b061-c3ba4bce2367" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxSettlementNonResidentWithholdingTaxAmount_548b6d54-4270-45fb-b061-c3ba4bce2367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_77fa8dbd-8749-42b4-99e8-cae10f173b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesForeign"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingenciesForeign_77fa8dbd-8749-42b4-99e8-cae10f173b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_689a2090-cfbf-4223-bc67-ff53be0b5401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_689a2090-cfbf-4223-bc67-ff53be0b5401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_a0140d99-862c-41cb-97c0-e62c95c01d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_a0140d99-862c-41cb-97c0-e62c95c01d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_a682cc69-0fca-485b-a3f4-9b1444daaf08" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationTaxEffectOfOCIAmount_a682cc69-0fca-485b-a3f4-9b1444daaf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f9116121-ce16-4a2c-a8ff-6e304662c227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f9116121-ce16-4a2c-a8ff-6e304662c227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_f1354942-5e8b-47ce-be24-32c73c9e61b1" xlink:href="ahl-20231220.xsd#ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_ahl_EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxAssetsValuationAllowanceAssociatedLosses_f1354942-5e8b-47ce-be24-32c73c9e61b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateTaxRate_35f675ec-5068-4d29-a0cc-c4c1074e09c9" xlink:href="ahl-20231220.xsd#ahl_CorporateTaxRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_26dc98b1-c0ce-4018-ab0a-e7ba35003831" xlink:to="loc_ahl_CorporateTaxRate_35f675ec-5068-4d29-a0cc-c4c1074e09c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesTaxEffectsofDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesTaxEffectsofDeferredTaxAssetsandDeferredTaxLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IncomeTaxesTaxEffectsofDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_809fa0cc-885a-46c2-ac9b-784751f48a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_809fa0cc-885a-46c2-ac9b-784751f48a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_431b3997-1a35-423a-9a3a-51177ef3a9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_431b3997-1a35-423a-9a3a-51177ef3a9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_e71ae966-c1de-4566-bb71-c5c475836e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_e71ae966-c1de-4566-bb71-c5c475836e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_91b24fc2-5116-409c-96cf-f569f540bf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_91b24fc2-5116-409c-96cf-f569f540bf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b93f8006-fef4-41eb-8c49-f72a70399949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b93f8006-fef4-41eb-8c49-f72a70399949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3dbbf8f7-ae3f-4378-a389-313b335c9504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3dbbf8f7-ae3f-4378-a389-313b335c9504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsUnearnedPremiums_b69ebdd6-8f47-4d20-ba26-4c4a53219f58" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsUnearnedPremiums"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_ahl_DeferredTaxAssetsUnearnedPremiums_b69ebdd6-8f47-4d20-ba26-4c4a53219f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_a65553ce-7fb7-4e6a-b27f-ccab3e8ef656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_a65553ce-7fb7-4e6a-b27f-ccab3e8ef656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets_d45f2c53-0672-4ed6-bbc6-1370a5e35409" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_ahl_DeferredTaxAssetsTimingDifferencesOnFixedAssets_d45f2c53-0672-4ed6-bbc6-1370a5e35409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLeaseLiability_5f0ac5fa-8b25-4804-82fa-36fddee9b010" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_ahl_DeferredTaxAssetsOperatingLeaseLiability_5f0ac5fa-8b25-4804-82fa-36fddee9b010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2d7ef248-b780-4db2-ac03-e3479dc05b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_2d7ef248-b780-4db2-ac03-e3479dc05b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b7671c37-5387-4ac8-8b4d-897c017074b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_b7671c37-5387-4ac8-8b4d-897c017074b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2155b154-6322-402f-b618-90fa2a09cfad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2155b154-6322-402f-b618-90fa2a09cfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_14bdd71d-7275-4034-97c7-0efa42209dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_14bdd71d-7275-4034-97c7-0efa42209dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_c025905c-075b-4442-b206-f2fe643f6891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities_c025905c-075b-4442-b206-f2fe643f6891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_c9aa686a-1690-4e62-a2af-f4be4878204e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_c9aa686a-1690-4e62-a2af-f4be4878204e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_64fd13cb-6b1e-4708-b491-ebf4777bc933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_64fd13cb-6b1e-4708-b491-ebf4777bc933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets_d93bb968-0ac7-49a1-ad55-dcf8ea51a3ef" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_ahl_DeferredTaxLiabilitiesOperatingLeaseAssets_d93bb968-0ac7-49a1-ad55-dcf8ea51a3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLiabilitiesGAAPDifferences_f85e6a97-3e8a-4a17-b09d-028cf7afe659" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLiabilitiesGAAPDifferences"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_ahl_DeferredTaxLiabilitiesGAAPDifferences_f85e6a97-3e8a-4a17-b09d-028cf7afe659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_8a4be782-9555-4b77-a47b-f38d722df245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_8a4be782-9555-4b77-a47b-f38d722df245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_3be09d64-efaa-4f33-8142-d613faaf1c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_3be09d64-efaa-4f33-8142-d613faaf1c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_6c23d25c-2245-438e-b3e1-0d2e25c5d3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_6c23d25c-2245-438e-b3e1-0d2e25c5d3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_92ed9b0f-7041-46c7-a31a-0dfb703ed184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f47b1090-4fef-420a-aab5-5c8c75778c72" xlink:to="loc_us-gaap_DeferredTaxLiabilities_92ed9b0f-7041-46c7-a31a-0dfb703ed184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5784deb8-1ed7-4477-8c31-adec842ca46a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:href="ahl-20231220.xsd#ahl_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5784deb8-1ed7-4477-8c31-adec842ca46a" xlink:to="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f4e708d5-a1fb-43d8-8d1d-bf7c5082f1ce" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_42693609-9364-4b15-af72-12660e7fd20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_42693609-9364-4b15-af72-12660e7fd20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_3dc93c56-422f-4468-9174-e703b5d3a27d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:to="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_3dc93c56-422f-4468-9174-e703b5d3a27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_1a5a01f8-be18-4efe-9ee1-153ec79f4bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeOfTheTaxCommissionerBermudaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_21dda988-f556-4136-9c3d-17a164b4c4f7" xlink:to="loc_us-gaap_OfficeOfTheTaxCommissionerBermudaMember_1a5a01f8-be18-4efe-9ee1-153ec79f4bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0329cb34-d76d-4107-a1b6-f4488cdd6725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0329cb34-d76d-4107-a1b6-f4488cdd6725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_26a144c2-53fa-47de-811b-c827c029ed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_0329cb34-d76d-4107-a1b6-f4488cdd6725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_26a144c2-53fa-47de-811b-c827c029ed7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5eb5cfc1-3335-4f5f-8901-ee420361a0bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_srt_RangeAxis_5eb5cfc1-3335-4f5f-8901-ee420361a0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_60727d73-8867-4f4e-a712-b65b25dfd345" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5eb5cfc1-3335-4f5f-8901-ee420361a0bf" xlink:to="loc_srt_RangeMember_60727d73-8867-4f4e-a712-b65b25dfd345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d771b832-b8e5-491a-81a4-fd3582f02ff2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_60727d73-8867-4f4e-a712-b65b25dfd345" xlink:to="loc_srt_MinimumMember_d771b832-b8e5-491a-81a4-fd3582f02ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2155d689-7e22-4823-a05d-2684f8585bda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_60727d73-8867-4f4e-a712-b65b25dfd345" xlink:to="loc_srt_MaximumMember_2155d689-7e22-4823-a05d-2684f8585bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ea9807f9-88bd-4ad2-ab2e-720bb9948525" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_dei_LegalEntityAxis_ea9807f9-88bd-4ad2-ab2e-720bb9948525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ea9807f9-88bd-4ad2-ab2e-720bb9948525" xlink:to="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_cc5b0516-b5bb-4b9b-87fc-607ecfa7d457" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:to="loc_ahl_AspenUKMember_cc5b0516-b5bb-4b9b-87fc-607ecfa7d457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_USOperatingSubsidiariesMember_421fa8fb-61eb-44f9-ba98-56cbddfeff94" xlink:href="ahl-20231220.xsd#ahl_USOperatingSubsidiariesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:to="loc_ahl_USOperatingSubsidiariesMember_421fa8fb-61eb-44f9-ba98-56cbddfeff94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_024edcb3-cc09-4c56-9790-3026eb402cd3" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:to="loc_ahl_LloydsMember_024edcb3-cc09-4c56-9790-3026eb402cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherJuridictionsMember_972af698-4151-405a-b169-5b98e7ac90f3" xlink:href="ahl-20231220.xsd#ahl_OtherJuridictionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bd8cbbe3-fef0-4056-8450-7deb35c0ccc1" xlink:to="loc_ahl_OtherJuridictionsMember_972af698-4151-405a-b169-5b98e7ac90f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_0ca4b10b-f3cc-48ac-b913-d768144465c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_0ca4b10b-f3cc-48ac-b913-d768144465c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d6d9a6c7-2150-4ab0-8aa9-a139368ad0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_0ca4b10b-f3cc-48ac-b913-d768144465c5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d6d9a6c7-2150-4ab0-8aa9-a139368ad0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_997d3cf9-af77-4471-890c-18d8d0450565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HerMajestysRevenueAndCustomsHMRCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d6d9a6c7-2150-4ab0-8aa9-a139368ad0cc" xlink:to="loc_us-gaap_HerMajestysRevenueAndCustomsHMRCMember_997d3cf9-af77-4471-890c-18d8d0450565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_1e225e92-0384-4c8d-a8cd-3c355c6f4b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d6d9a6c7-2150-4ab0-8aa9-a139368ad0cc" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_1e225e92-0384-4c8d-a8cd-3c355c6f4b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:href="ahl-20231220.xsd#ahl_IncomeTaxesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesTable_3599b2df-6b55-4b1a-a62b-411d7f8a9ecb" xlink:to="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6a404fbb-07a7-43dd-8074-63b6a9483cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6a404fbb-07a7-43dd-8074-63b6a9483cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateTaxRate_e688b0f8-54b6-47b5-ae78-0fafa67f0d05" xlink:href="ahl-20231220.xsd#ahl_CorporateTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_CorporateTaxRate_e688b0f8-54b6-47b5-ae78-0fafa67f0d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebf585d3-6e1e-43be-a779-9a6900b38dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebf585d3-6e1e-43be-a779-9a6900b38dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_e400fb29-49c6-4900-a304-0b1615901ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_OperatingLossCarryforwards_e400fb29-49c6-4900-a304-0b1615901ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset_61d65d09-56fa-4dbc-a99a-a78dd37e4cc0" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardsAvailableToOffset_61d65d09-56fa-4dbc-a99a-a78dd37e4cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Operatinglosscarryforwardsdateofexpiration_21f76327-9cce-4bad-b3f8-c24ce2320f0f" xlink:href="ahl-20231220.xsd#ahl_Operatinglosscarryforwardsdateofexpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_Operatinglosscarryforwardsdateofexpiration_21f76327-9cce-4bad-b3f8-c24ce2320f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_a8d3e67f-93e9-41f3-a462-26ba34618c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_a8d3e67f-93e9-41f3-a462-26ba34618c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxLossesOperatingLossCarryforward_1355b53e-8c95-4b58-b714-250001ae7926" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxLossesOperatingLossCarryforward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_DeferredTaxLossesOperatingLossCarryforward_1355b53e-8c95-4b58-b714-250001ae7926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_7a8c1e51-bd36-43d1-a4c7-22d547089111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_7a8c1e51-bd36-43d1-a4c7-22d547089111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership_59c98a9f-f772-4aa5-9996-a88c99627d87" xlink:href="ahl-20231220.xsd#ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_ahl_DeferredTaxAssetsOperatingLossCarryforwardss382LimitationChangeofOwnership_59c98a9f-f772-4aa5-9996-a88c99627d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0e0abde6-49c2-450e-a943-cbca11453b94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0e0abde6-49c2-450e-a943-cbca11453b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f9ddeacc-7313-406b-8321-215bf2bcce51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxLiabilities_f9ddeacc-7313-406b-8321-215bf2bcce51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0852805b-c8e0-46da-a78c-bfdfe7b5902b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IncomeTaxesLineItems_0a414319-302e-4413-a6ca-380186591326" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_0852805b-c8e0-46da-a78c-bfdfe7b5902b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1f3c2262-c17b-4252-aa2d-e2f59f017e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_cad53d45-0fcc-4eb2-941e-175710a3af02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1f3c2262-c17b-4252-aa2d-e2f59f017e46" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_cad53d45-0fcc-4eb2-941e-175710a3af02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_857deaf3-9722-42b8-8d76-91e6d5904103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cad53d45-0fcc-4eb2-941e-175710a3af02" xlink:to="loc_us-gaap_StatementClassOfStockAxis_857deaf3-9722-42b8-8d76-91e6d5904103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_857deaf3-9722-42b8-8d76-91e6d5904103" xlink:to="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_99fd04c0-ae79-41fe-a3fb-eb7584eeac27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_99fd04c0-ae79-41fe-a3fb-eb7584eeac27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_3ece50fd-39b0-47f5-acb5-dd237f2570e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_3ece50fd-39b0-47f5-acb5-dd237f2570e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_08825879-a068-4ec6-a089-eb522eb79ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_72441beb-97bc-4c6e-806a-0bdadde97862" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_08825879-a068-4ec6-a089-eb522eb79ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cad53d45-0fcc-4eb2-941e-175710a3af02" xlink:to="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapitalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_085dceaa-892b-4485-a0e7-a7881d3f46ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_085dceaa-892b-4485-a0e7-a7881d3f46ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e050dbac-12d6-45dc-9bff-1c912368d826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e050dbac-12d6-45dc-9bff-1c912368d826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CommonStockValueAuthorized_dc1eeaf8-6212-4b9c-9fcf-805ac8d27d58" xlink:href="ahl-20231220.xsd#ahl_CommonStockValueAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_ahl_CommonStockValueAuthorized_dc1eeaf8-6212-4b9c-9fcf-805ac8d27d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockValueAuthorized_3b9c04e2-c73a-4a18-8bc8-c4a658a767be" xlink:href="ahl-20231220.xsd#ahl_PreferredStockValueAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_ahl_PreferredStockValueAuthorized_3b9c04e2-c73a-4a18-8bc8-c4a658a767be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_19a33253-17f7-42ef-aea7-5a3043cc1607" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_5751205c-7999-418e-a8f0-c568cd6bdc37" xlink:to="loc_ahl_AuthorizedShareCapital_19a33253-17f7-42ef-aea7-5a3043cc1607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapitalAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8b88642d-0fe0-451c-ac17-550e7e1d2552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_us-gaap_CommonStockSharesIssued_8b88642d-0fe0-451c-ac17-550e7e1d2552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_007558e7-e6c6-42c4-adf5-14078c93e83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_us-gaap_PreferredStockSharesIssued_007558e7-e6c6-42c4-adf5-14078c93e83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2e18d7cf-7a31-4887-932c-8d97a1462339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_us-gaap_CommonStockValue_2e18d7cf-7a31-4887-932c-8d97a1462339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_9872db04-1779-41be-a206-f2c5045e33d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesSubscribedButUnissuedValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_9872db04-1779-41be-a206-f2c5045e33d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapital_95f92331-3142-4fa9-af9c-3499aad9f329" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_e8048cce-430b-40a6-ab35-61bf6249d445" xlink:to="loc_ahl_IssuedShareCapital_95f92331-3142-4fa9-af9c-3499aad9f329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_02f773da-5d8b-4f3f-908d-1eb00b55e1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_02f773da-5d8b-4f3f-908d-1eb00b55e1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_90d9b5c6-a271-488f-bbca-48b477841c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_90d9b5c6-a271-488f-bbca-48b477841c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f4821e17-5006-4e46-b8ca-0625ce555ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f4821e17-5006-4e46-b8ca-0625ce555ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_53cc32a6-cf77-402b-a9cb-6379a856859e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_50d778a7-e0f7-46fa-9efc-1030a91571a8" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_53cc32a6-cf77-402b-a9cb-6379a856859e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b2829b8e-704a-469b-8151-d209e33add4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_2d37a3b2-9c2b-43cd-864f-1fea6d6667be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b2829b8e-704a-469b-8151-d209e33add4b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_2d37a3b2-9c2b-43cd-864f-1fea6d6667be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fd5802de-7326-4314-b37d-9bc4bd35bff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2d37a3b2-9c2b-43cd-864f-1fea6d6667be" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fd5802de-7326-4314-b37d-9bc4bd35bff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fd5802de-7326-4314-b37d-9bc4bd35bff4" xlink:to="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_d3d0aa94-5afb-4735-b553-deaa5a97bab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_d3d0aa94-5afb-4735-b553-deaa5a97bab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_9f19a9fc-2281-4188-a69b-9fa022c41c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_9f19a9fc-2281-4188-a69b-9fa022c41c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_525bcf3f-3156-40d9-9abb-545fd7c87214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d42ee3d3-b7b5-4860-a475-95af10eb0e56" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_525bcf3f-3156-40d9-9abb-545fd7c87214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2d37a3b2-9c2b-43cd-864f-1fea6d6667be" xlink:to="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a63b9376-6fe2-4bd0-8c9c-db07733e18ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a63b9376-6fe2-4bd0-8c9c-db07733e18ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9e9299ef-6318-4137-8b60-495a13a99568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9e9299ef-6318-4137-8b60-495a13a99568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_ef2f5641-798c-4f2e-b9d9-2c1a6452dd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e3327f01-fc0d-4385-8640-f3aaefb0f316" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_ef2f5641-798c-4f2e-b9d9-2c1a6452dd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofOrdinarySharesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofOrdinarySharesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofOrdinarySharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d8f06b69-8a87-4430-870b-75edceca702c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_89deb6ed-6549-430e-9e64-0bcae865a686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_89deb6ed-6549-430e-9e64-0bcae865a686" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f499c57f-7c64-41a0-95a8-12461344736b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f499c57f-7c64-41a0-95a8-12461344736b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2355f425-ecb9-439a-8621-feeff9981d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f499c57f-7c64-41a0-95a8-12461344736b" xlink:to="loc_us-gaap_EquityComponentDomain_2355f425-ecb9-439a-8621-feeff9981d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_721f4530-28f5-4ced-9d2a-3ea98302986c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2355f425-ecb9-439a-8621-feeff9981d33" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_721f4530-28f5-4ced-9d2a-3ea98302986c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7cd047f8-dea6-4f9c-8417-0507cbd35373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7cd047f8-dea6-4f9c-8417-0507cbd35373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1611d49c-b301-419d-9480-04b2c1dc13ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7cd047f8-dea6-4f9c-8417-0507cbd35373" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1611d49c-b301-419d-9480-04b2c1dc13ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8a6f6996-e13f-43ce-a231-0d54e0fb05e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8a6f6996-e13f-43ce-a231-0d54e0fb05e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8a6f6996-e13f-43ce-a231-0d54e0fb05e7" xlink:to="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_6da8ecc4-5077-4fca-8050-91efb5d4a907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:to="loc_us-gaap_PreferredStockMember_6da8ecc4-5077-4fca-8050-91efb5d4a907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_f1f36485-d03b-4f9b-b881-1048bee1463d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_f1f36485-d03b-4f9b-b881-1048bee1463d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_ebc21a8f-f87a-471c-9707-11835a3fc6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_ebc21a8f-f87a-471c-9707-11835a3fc6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_81785e3f-5567-495d-9a9d-c8bc73515c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6695a8cd-e674-4532-a547-35a4297dc5a3" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_81785e3f-5567-495d-9a9d-c8bc73515c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_339c72da-c0e8-4b0f-a3cb-5b661cb5236e" xlink:to="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_fd2c87c1-ec83-473c-b7d6-8f0b9beee0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_AdditionalPaidInCapital_fd2c87c1-ec83-473c-b7d6-8f0b9beee0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AggregateLiquidationPreferences_e7d01445-416d-4ec3-a422-080ab646fe04" xlink:href="ahl-20231220.xsd#ahl_AggregateLiquidationPreferences"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_ahl_AggregateLiquidationPreferences_e7d01445-416d-4ec3-a422-080ab646fe04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockIssuanceCost_0f796245-c74d-4c05-9fc0-e46fb13d5028" xlink:href="ahl-20231220.xsd#ahl_PreferredStockIssuanceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_ahl_PreferredStockIssuanceCost_0f796245-c74d-4c05-9fc0-e46fb13d5028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_6ac8715c-ad04-459f-ae94-7840c65265b3" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_ahl_AuthorizedShareCapital_6ac8715c-ad04-459f-ae94-7840c65265b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_22e80cc8-8f61-4ee4-8be7-37fca1dbae6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_22e80cc8-8f61-4ee4-8be7-37fca1dbae6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_111c076f-3fa4-4ec9-872c-315c918acf71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_111c076f-3fa4-4ec9-872c-315c918acf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f01e4023-20e5-4b05-89bc-af5c0eae507d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f01e4023-20e5-4b05-89bc-af5c0eae507d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_362bef5b-4daa-4350-a469-07265e75f626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_362bef5b-4daa-4350-a469-07265e75f626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_00390089-5679-4013-9bc0-0d922b7ad328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_CommonStockSharesIssued_00390089-5679-4013-9bc0-0d922b7ad328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_15f495de-2d2b-4074-8c20-c745a1364a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockSharesIssued_15f495de-2d2b-4074-8c20-c745a1364a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_b7934bee-8408-42da-bb52-5a7e39f099d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_b7934bee-8408-42da-bb52-5a7e39f099d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_2756ceed-0d88-463c-b639-5bae29ca4789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_2756ceed-0d88-463c-b639-5bae29ca4789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_db67880c-0571-4b43-96ce-c7954e2a21e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_db67880c-0571-4b43-96ce-c7954e2a21e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_79200560-4933-4a60-bd06-f718d0775714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_79200560-4933-4a60-bd06-f718d0775714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_950f5589-bd33-4d06-a0bf-ae39620c1c10" xlink:href="ahl-20231220.xsd#ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0db01b68-d17d-4484-8756-ec763e5eb798" xlink:to="loc_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution_950f5589-bd33-4d06-a0bf-ae39620c1c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsSummaryofStatutoryRequirementsandDividendsRestrictionsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#StatutoryRequirementsandDividendsRestrictionsSummaryofStatutoryRequirementsandDividendsRestrictionsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsSummaryofStatutoryRequirementsandDividendsRestrictionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract_b8931d7b-61c9-4eb0-8a80-30e6c0998c7b" xlink:href="ahl-20231220.xsd#ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e19d52ee-ea04-420f-8cba-fdd4e71dbaca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsSummaryOfStatutoryRequirementsAndDividendsRestrictionsAbstract_b8931d7b-61c9-4eb0-8a80-30e6c0998c7b" xlink:to="loc_us-gaap_StatementTable_e19d52ee-ea04-420f-8cba-fdd4e71dbaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_ab39c066-5766-4fcb-8ae6-0ed19f72737c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesByJurisdictionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e19d52ee-ea04-420f-8cba-fdd4e71dbaca" xlink:to="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_ab39c066-5766-4fcb-8ae6-0ed19f72737c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesJurisdictionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_ab39c066-5766-4fcb-8ae6-0ed19f72737c" xlink:to="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eef584d0-3df6-42db-b5fc-1950659ab0fb" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:to="loc_country_US_eef584d0-3df6-42db-b5fc-1950659ab0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BM_07c56933-378c-46f5-bd85-064d26270502" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_BM"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:to="loc_country_BM_07c56933-378c-46f5-bd85-064d26270502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_4ec43ef5-1805-4c7a-8c61-e9a915a84531" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_2cfc0c5f-4012-45b4-811b-1fdacb78a090" xlink:to="loc_country_GB_4ec43ef5-1805-4c7a-8c61-e9a915a84531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f2dc21c1-68a7-4550-85a4-b925134cb05c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e19d52ee-ea04-420f-8cba-fdd4e71dbaca" xlink:to="loc_us-gaap_StatementLineItems_f2dc21c1-68a7-4550-85a4-b925134cb05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus_3f96b901-e962-41fd-85e7-b547b9f5582f" xlink:href="ahl-20231220.xsd#ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f2dc21c1-68a7-4550-85a4-b925134cb05c" xlink:to="loc_ahl_DividendPaymentsRestrictionsScheduleRequiredStatutoryCapitalAndSurplus_3f96b901-e962-41fd-85e7-b547b9f5582f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1_0515b455-91a3-4329-b704-dd9a17013513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f2dc21c1-68a7-4550-85a4-b925134cb05c" xlink:to="loc_us-gaap_DividendPaymentsRestrictionsScheduleStatutoryCapitalAndSurplus1_0515b455-91a3-4329-b704-dd9a17013513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#StatutoryRequirementsandDividendsRestrictionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/StatutoryRequirementsandDividendsRestrictionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract_3ca7349d-1d9a-4b8b-bbb0-0fdd47806c14" xlink:href="ahl-20231220.xsd#ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DisclosureStatutoryRequirementsAndDividendsRestrictionsAdditionalInformationAbstract_3ca7349d-1d9a-4b8b-bbb0-0fdd47806c14" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_409759ba-3138-40f1-8191-8213564b5458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesByJurisdictionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:to="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_409759ba-3138-40f1-8191-8213564b5458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_23b87fbd-550b-4801-abee-f3297a2af6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesJurisdictionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesByJurisdictionAxis_409759ba-3138-40f1-8191-8213564b5458" xlink:to="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_23b87fbd-550b-4801-abee-f3297a2af6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_8a851e06-eae5-4e06-adbc-ed34de6333c9" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_23b87fbd-550b-4801-abee-f3297a2af6a6" xlink:to="loc_country_GB_8a851e06-eae5-4e06-adbc-ed34de6333c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BM_ca131ef2-440c-4040-8865-da77d352581c" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_BM"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesJurisdictionDomain_23b87fbd-550b-4801-abee-f3297a2af6a6" xlink:to="loc_country_BM_ca131ef2-440c-4040-8865-da77d352581c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6440e417-6865-479e-a47f-68f6e6a0deba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:to="loc_dei_LegalEntityAxis_6440e417-6865-479e-a47f-68f6e6a0deba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0139cbd2-1aed-4906-ba53-ef9a92737625" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6440e417-6865-479e-a47f-68f6e6a0deba" xlink:to="loc_dei_EntityDomain_0139cbd2-1aed-4906-ba53-ef9a92737625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SubsidiariesOneMember_603fef6a-85b5-437a-bffe-17f750d9f4a3" xlink:href="ahl-20231220.xsd#ahl_SubsidiariesOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0139cbd2-1aed-4906-ba53-ef9a92737625" xlink:to="loc_ahl_SubsidiariesOneMember_603fef6a-85b5-437a-bffe-17f750d9f4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_5b8f90a0-0e63-416f-8561-267e0301f69d" xlink:to="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_c275a90b-1b26-4cba-a8ae-32445573b149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_c275a90b-1b26-4cba-a8ae-32445573b149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CapitalReserves_82fe1b75-9b41-455c-9d28-61cd84320b2d" xlink:href="ahl-20231220.xsd#ahl_CapitalReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_CapitalReserves_82fe1b75-9b41-455c-9d28-61cd84320b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent_8c6e3fbb-68e2-4a37-b98b-e07eca1b3572" xlink:href="ahl-20231220.xsd#ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_DividendPaymentsRestrictionsScheduleStatutoryCapitalandSurplusPercent_8c6e3fbb-68e2-4a37-b98b-e07eca1b3572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval_b78e23d2-506a-4f66-a7e5-8f5c9759d515" xlink:href="ahl-20231220.xsd#ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_StatutoryCapitalandSurplusPercentReductionRequiringApproval_b78e23d2-506a-4f66-a7e5-8f5c9759d515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FundsMaintainedAtSyndicate_fadf9645-8dc1-4782-b461-4fa40e3e8fe7" xlink:href="ahl-20231220.xsd#ahl_FundsMaintainedAtSyndicate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_FundsMaintainedAtSyndicate_fadf9645-8dc1-4782-b461-4fa40e3e8fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FundsHeldForClients_6cbc4deb-5f35-4aa7-b298-8534be3fe1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FundsHeldForClients"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_us-gaap_FundsHeldForClients_6cbc4deb-5f35-4aa7-b298-8534be3fe1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus_5056fc6c-71a9-493e-b64b-33c989c3ba15" xlink:href="ahl-20231220.xsd#ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_05a0e57b-a123-479a-a371-12b3d504cfa4" xlink:to="loc_ahl_PercentWarningLevelofAmountofEnhancedCapitalRequiredfromStatutoryCapitalandSurplus_5056fc6c-71a9-493e-b64b-33c989c3ba15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#DividendsSummaryofDeclaredDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8d83e8d7-4ed9-4bd0-8456-d6dc14a4a81d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d83e8d7-4ed9-4bd0-8456-d6dc14a4a81d" xlink:to="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3e11fd38-e490-4da8-8711-b0bd3b0972f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3e11fd38-e490-4da8-8711-b0bd3b0972f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9ae6e39d-db2f-44c5-8634-455fd12b149e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3e11fd38-e490-4da8-8711-b0bd3b0972f8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9ae6e39d-db2f-44c5-8634-455fd12b149e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_baf017f7-54d1-4bb2-8f65-4d3c3a40ed54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9ae6e39d-db2f-44c5-8634-455fd12b149e" xlink:to="loc_us-gaap_SubsequentEventMember_baf017f7-54d1-4bb2-8f65-4d3c3a40ed54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c51f321c-85fe-4fea-b79b-d000f735ccaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c51f321c-85fe-4fea-b79b-d000f735ccaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c51f321c-85fe-4fea-b79b-d000f735ccaf" xlink:to="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_bf05e70e-0a7a-4c2f-8b4b-aa184ccfaef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_bf05e70e-0a7a-4c2f-8b4b-aa184ccfaef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_a2e4ad18-d908-4ca8-bd95-4117ab8bfc09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_a2e4ad18-d908-4ca8-bd95-4117ab8bfc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_a3d70bcd-6254-4e3b-a234-8764a4cb6622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_48115259-7a4e-480f-a4ca-db97967bfb2d" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_a3d70bcd-6254-4e3b-a234-8764a4cb6622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_a24a5396-8306-4c3e-bde8-c8b19ab5397c" xlink:to="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_0f0989f2-5d51-4769-9e3f-441e97158c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_0f0989f2-5d51-4769-9e3f-441e97158c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_e7fd2408-cb38-426f-b1fd-794a405ec5da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_e7fd2408-cb38-426f-b1fd-794a405ec5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_7b2b51d2-0182-489c-89bc-bdf76cbaedeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_7b2b51d2-0182-489c-89bc-bdf76cbaedeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositaryShareDividend_991f3af9-b51f-4dfa-85c6-30401b833838" xlink:href="ahl-20231220.xsd#ahl_DepositaryShareDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_ahl_DepositaryShareDividend_991f3af9-b51f-4dfa-85c6-30401b833838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_5aeb3a18-89e5-4b57-a4c0-e6364d4633fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_5aeb3a18-89e5-4b57-a4c0-e6364d4633fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_36a44b5c-988f-4515-b207-1b88749db1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_57f6e9eb-0a00-4f7d-a8ac-007fead506b6" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_36a44b5c-988f-4515-b207-1b88749db1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/RetirementPlansDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#RetirementPlansDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/RetirementPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e976f9ec-bad6-44d7-9429-e38a5c3059de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_9c9efc25-7976-43a4-a5a0-3b27fedb92cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e976f9ec-bad6-44d7-9429-e38a5c3059de" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_9c9efc25-7976-43a4-a5a0-3b27fedb92cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ShareBasedPaymentsandLongtermIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ShareBasedPaymentsandLongtermIncentivePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ShareBasedPaymentsandLongtermIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c552ee4-2ae0-4d6d-ada2-d0c8793d88fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_054c4510-bd8e-4ed2-8043-53d92c7b1934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c552ee4-2ae0-4d6d-ada2-d0c8793d88fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_054c4510-bd8e-4ed2-8043-53d92c7b1934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_96661faa-64b0-444f-8c2f-4cb09581fde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_054c4510-bd8e-4ed2-8043-53d92c7b1934" xlink:to="loc_us-gaap_AwardTypeAxis_96661faa-64b0-444f-8c2f-4cb09581fde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a7b0225-67cb-43b9-a37d-a60aa4abd601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_96661faa-64b0-444f-8c2f-4cb09581fde6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a7b0225-67cb-43b9-a37d-a60aa4abd601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_cd40fc0a-41c6-4c3a-a599-93a67e81099d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a7b0225-67cb-43b9-a37d-a60aa4abd601" xlink:to="loc_us-gaap_PerformanceSharesMember_cd40fc0a-41c6-4c3a-a599-93a67e81099d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80353e0a-9c94-46b5-a494-6fa2bd7e8ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_054c4510-bd8e-4ed2-8043-53d92c7b1934" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80353e0a-9c94-46b5-a494-6fa2bd7e8ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SharebasedpaymentandLTIPexpense_b47dccd7-4022-430b-b697-2e843af905c3" xlink:href="ahl-20231220.xsd#ahl_SharebasedpaymentandLTIPexpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80353e0a-9c94-46b5-a494-6fa2bd7e8ab7" xlink:to="loc_ahl_SharebasedpaymentandLTIPexpense_b47dccd7-4022-430b-b697-2e843af905c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f12013a5-619e-4bcb-930d-3b0af171cf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80353e0a-9c94-46b5-a494-6fa2bd7e8ab7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f12013a5-619e-4bcb-930d-3b0af171cf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IntangibleAssetsSummaryofChangesinIntangibleAssetsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IntangibleAssetsSummaryofChangesinIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IntangibleAssetsSummaryofChangesinIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd85dfd3-8c44-4021-9c76-3763bccb94f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_202879a1-2c69-4bf8-ba1b-8bf45b854ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd85dfd3-8c44-4021-9c76-3763bccb94f3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_202879a1-2c69-4bf8-ba1b-8bf45b854ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad1f772b-4549-445e-a686-fc5c980552f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_202879a1-2c69-4bf8-ba1b-8bf45b854ce9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad1f772b-4549-445e-a686-fc5c980552f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ad1f772b-4549-445e-a686-fc5c980552f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_779c45f7-7955-411b-8772-a60c12a01dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:to="loc_us-gaap_TrademarksMember_779c45f7-7955-411b-8772-a60c12a01dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember_22a7bdcc-5c09-47b1-a06e-0ad6074906a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:to="loc_us-gaap_CustomerListsMember_22a7bdcc-5c09-47b1-a06e-0ad6074906a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_be848a71-de10-460f-b889-5ef9f8e06548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98964d32-1d2a-4354-94ed-519ed9c8e94b" xlink:to="loc_us-gaap_LicensingAgreementsMember_be848a71-de10-460f-b889-5ef9f8e06548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_202879a1-2c69-4bf8-ba1b-8bf45b854ce9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:href="ahl-20231220.xsd#ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9a8d86a6-7e1f-4125-b199-37697ac46c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9a8d86a6-7e1f-4125-b199-37697ac46c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FinitelivedIntangibleAssetsAcquiredDisposed_d152f564-5593-4136-adfc-211832cba644" xlink:href="ahl-20231220.xsd#ahl_FinitelivedIntangibleAssetsAcquiredDisposed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_ahl_FinitelivedIntangibleAssetsAcquiredDisposed_d152f564-5593-4136-adfc-211832cba644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3092b6d5-786c-40b0-be97-93d40a9fd3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3092b6d5-786c-40b0-be97-93d40a9fd3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_7c1b6f70-bf91-455f-9430-ba38aa343f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_7c1b6f70-bf91-455f-9430-ba38aa343f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58c90769-6294-4b02-8a5d-ad880fc585a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_FiniteandIndefiniteLivedIntangibleAssetsRollForward_e7fe8e63-a1b3-4513-91e0-6d8b7676d72f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58c90769-6294-4b02-8a5d-ad880fc585a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7b511b2a-4cff-40f9-985b-e6784ccfada4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:to="loc_us-gaap_Goodwill_7b511b2a-4cff-40f9-985b-e6784ccfada4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_5938c76d-627e-4f03-8eb9-f43518c5c5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_5938c76d-627e-4f03-8eb9-f43518c5c5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7b93ac10-0ad4-42f2-819c-c843257f4b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7b93ac10-0ad4-42f2-819c-c843257f4b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d3d3d6c0-fc1b-4653-bb2d-a193340bfdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4d363ff4-c432-4887-b333-be769df833dc" xlink:to="loc_us-gaap_Goodwill_d3d3d6c0-fc1b-4653-bb2d-a193340bfdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_db00b634-6f40-4742-a808-a42fc33b8ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_db00b634-6f40-4742-a808-a42fc33b8ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IntangibleAssetsandGoodwillAcquiredDisposed_8837eb31-6491-4d0c-b41e-0bb6e61904bb" xlink:href="ahl-20231220.xsd#ahl_IntangibleAssetsandGoodwillAcquiredDisposed"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_ahl_IntangibleAssetsandGoodwillAcquiredDisposed_8837eb31-6491-4d0c-b41e-0bb6e61904bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_99c3b9d2-ebec-48a8-8925-e5fcf813a8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_99c3b9d2-ebec-48a8-8925-e5fcf813a8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_db8e2da7-cb66-4b72-9207-59c498a53bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_aa2540bb-55ad-488d-ac92-43c49a3f313a" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_db8e2da7-cb66-4b72-9207-59c498a53bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#IntangibleAssetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5291286e-47a4-4ed9-9530-a23d1d9837f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:href="ahl-20231220.xsd#ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5291286e-47a4-4ed9-9530-a23d1d9837f2" xlink:to="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_31134be8-89e0-4261-b6cb-6ef00e3e8ca1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_31134be8-89e0-4261-b6cb-6ef00e3e8ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c3ab9f6e-99be-437d-8138-3dbb71fabeab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_31134be8-89e0-4261-b6cb-6ef00e3e8ca1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c3ab9f6e-99be-437d-8138-3dbb71fabeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_ca6069a3-2bca-4c97-a22e-2f3c8a5f40a9" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c3ab9f6e-99be-437d-8138-3dbb71fabeab" xlink:to="loc_ahl_DigitalRiskMember_ca6069a3-2bca-4c97-a22e-2f3c8a5f40a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f998b765-6ac7-4efa-87b5-ebb77999c97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f998b765-6ac7-4efa-87b5-ebb77999c97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b322ecb-3f02-437b-a0f6-a54a553f0e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f998b765-6ac7-4efa-87b5-ebb77999c97a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b322ecb-3f02-437b-a0f6-a54a553f0e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_8bfd3b72-9752-49d2-899d-3ee633124f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b322ecb-3f02-437b-a0f6-a54a553f0e9a" xlink:to="loc_us-gaap_TrademarksMember_8bfd3b72-9752-49d2-899d-3ee633124f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenTrademarkMember_6af5623d-3d2a-4789-972e-584ece4b9da3" xlink:href="ahl-20231220.xsd#ahl_AspenTrademarkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TrademarksMember_8bfd3b72-9752-49d2-899d-3ee633124f1c" xlink:to="loc_ahl_AspenTrademarkMember_6af5623d-3d2a-4789-972e-584ece4b9da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BlueWatersMember_b720c7a9-3c9c-4e4e-af12-fe6d9de23b16" xlink:href="ahl-20231220.xsd#ahl_BlueWatersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TrademarksMember_8bfd3b72-9752-49d2-899d-3ee633124f1c" xlink:to="loc_ahl_BlueWatersMember_b720c7a9-3c9c-4e4e-af12-fe6d9de23b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_b6c810f1-f04d-44d6-8e22-a55e77690e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b322ecb-3f02-437b-a0f6-a54a553f0e9a" xlink:to="loc_us-gaap_LicensingAgreementsMember_b6c810f1-f04d-44d6-8e22-a55e77690e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c5e6c907-943f-4756-93dd-ca2a218642db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c5e6c907-943f-4756-93dd-ca2a218642db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8a2732e1-8dca-4368-85e3-7634a786d0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c5e6c907-943f-4756-93dd-ca2a218642db" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8a2732e1-8dca-4368-85e3-7634a786d0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BlueWatersMember_e6023ed6-d910-4417-8966-9b057f995962" xlink:href="ahl-20231220.xsd#ahl_BlueWatersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8a2732e1-8dca-4368-85e3-7634a786d0d7" xlink:to="loc_ahl_BlueWatersMember_e6023ed6-d910-4417-8966-9b057f995962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_14338aed-791f-43a3-bbe1-af8893af9107" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_dei_LegalEntityAxis_14338aed-791f-43a3-bbe1-af8893af9107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_986fe12f-9cb9-44f4-8322-6e24184d676d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_14338aed-791f-43a3-bbe1-af8893af9107" xlink:to="loc_dei_EntityDomain_986fe12f-9cb9-44f4-8322-6e24184d676d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenSpecialtyMember_9f6ee4cc-9065-4d71-be74-54f316f9e0c4" xlink:href="ahl-20231220.xsd#ahl_AspenSpecialtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_986fe12f-9cb9-44f4-8322-6e24184d676d" xlink:to="loc_ahl_AspenSpecialtyMember_9f6ee4cc-9065-4d71-be74-54f316f9e0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_101ab1ce-c1d1-4bf0-8459-27647474844b" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_986fe12f-9cb9-44f4-8322-6e24184d676d" xlink:to="loc_ahl_AspenUKMember_101ab1ce-c1d1-4bf0-8459-27647474844b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:href="ahl-20231220.xsd#ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable_560607c2-30d0-46cb-8016-74a4e4c67a4e" xlink:to="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6ba0fe9b-7480-4af9-9df8-7d3dd70f7206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6ba0fe9b-7480-4af9-9df8-7d3dd70f7206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_46b25f26-1837-47a9-babc-3aa6759c60ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_46b25f26-1837-47a9-babc-3aa6759c60ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1118e404-a333-43d4-a0c5-fb3b00492acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_FiniteAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_aa374310-d249-4965-a635-09a4d2919ed4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1118e404-a333-43d4-a0c5-fb3b00492acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseCostsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesScheduleofOperatingLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3d8fd8af-5a8e-424a-8709-cef0ba2ecdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e4bbc050-e4c6-4c51-a5c5-48efde192980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d8fd8af-5a8e-424a-8709-cef0ba2ecdae" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e4bbc050-e4c6-4c51-a5c5-48efde192980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_d178d1ae-d3ab-4c8b-9cc4-f424e06ebbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d8fd8af-5a8e-424a-8709-cef0ba2ecdae" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_d178d1ae-d3ab-4c8b-9cc4-f424e06ebbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_6531701d-808f-4813-b45c-c05354c834b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d8fd8af-5a8e-424a-8709-cef0ba2ecdae" xlink:to="loc_us-gaap_OperatingLeasePayments_6531701d-808f-4813-b45c-c05354c834b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear_bad39da0-5be7-46da-908c-6d667221c33c" xlink:href="ahl-20231220.xsd#ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_ahl_LesseeOperatingLeaseLiabilityPaymentsDuePriorYear_bad39da0-5be7-46da-908c-6d667221c33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1edaf71e-4e9a-4a21-9140-094396853064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1edaf71e-4e9a-4a21-9140-094396853064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2eea7707-3297-41cf-a0d9-e8b0a6bd83b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2eea7707-3297-41cf-a0d9-e8b0a6bd83b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a588c9e1-f621-40b8-af3d-ececc0246c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a588c9e1-f621-40b8-af3d-ececc0246c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_681e2ab8-8fa1-47a1-afa1-8471c10408c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_681e2ab8-8fa1-47a1-afa1-8471c10408c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d6d6392f-b6e8-4c1d-af7e-4cb6d07f0a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d6d6392f-b6e8-4c1d-af7e-4cb6d07f0a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_dd49b212-0d6b-4454-93ed-e57a468691cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_dd49b212-0d6b-4454-93ed-e57a468691cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_787cd38c-ce58-4e6f-9cd7-851c0ac42c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_787cd38c-ce58-4e6f-9cd7-851c0ac42c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_44d8a98d-319a-4aa3-9bd2-15b5ef26d602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_44d8a98d-319a-4aa3-9bd2-15b5ef26d602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_745d99b7-c00f-4b5d-a575-5d7eaa890376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b97343d-13d3-4c6b-b702-4a05010e1936" xlink:to="loc_us-gaap_OperatingLeaseLiability_745d99b7-c00f-4b5d-a575-5d7eaa890376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeasesCashFlowsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesScheduleofOperatingLeasesCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/OperatingLeasesScheduleofOperatingLeasesCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_81ee19eb-898d-43e7-a04d-fa60010da100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_6a13ff8a-d5ea-49e6-8e39-03bfefd225d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_81ee19eb-898d-43e7-a04d-fa60010da100" xlink:to="loc_us-gaap_OperatingLeasePayments_6a13ff8a-d5ea-49e6-8e39-03bfefd225d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_10fbf310-e133-4d54-9fd8-9d1ccba691e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_81ee19eb-898d-43e7-a04d-fa60010da100" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_10fbf310-e133-4d54-9fd8-9d1ccba691e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6e7ab3ae-1ecc-4e3f-9dce-c383bf525143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_81ee19eb-898d-43e7-a04d-fa60010da100" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6e7ab3ae-1ecc-4e3f-9dce-c383bf525143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_370592b3-386c-4e3f-94a2-2e4fda9d11f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_81ee19eb-898d-43e7-a04d-fa60010da100" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_370592b3-386c-4e3f-94a2-2e4fda9d11f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8328e542-35e7-45b7-8fd4-34737b201341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_81ee19eb-898d-43e7-a04d-fa60010da100" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8328e542-35e7-45b7-8fd4-34737b201341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/OperatingLeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#OperatingLeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/OperatingLeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7dbfd28e-c4c1-4490-b3bc-57fb4f371ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_51c4e992-cffe-4048-bed7-1a6c5c022d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7dbfd28e-c4c1-4490-b3bc-57fb4f371ea1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_51c4e992-cffe-4048-bed7-1a6c5c022d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_10cf9a01-fc67-4baf-b79a-051b2c52c0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7dbfd28e-c4c1-4490-b3bc-57fb4f371ea1" xlink:to="loc_us-gaap_OperatingLeaseLiability_10cf9a01-fc67-4baf-b79a-051b2c52c0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_9ed26f78-e2dd-4b2b-80a7-2829e869637c" xlink:href="ahl-20231220.xsd#ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7dbfd28e-c4c1-4490-b3bc-57fb4f371ea1" xlink:to="loc_ahl_Nonoperatingexpensesrelatedtoimpairmentchargesonleaseassets_9ed26f78-e2dd-4b2b-80a7-2829e869637c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_23aa38a8-c4a7-4504-ae94-b56217d1e30a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_23aa38a8-c4a7-4504-ae94-b56217d1e30a" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0330ded1-a830-43b7-9122-130d57c1ca0f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_srt_RangeAxis_0330ded1-a830-43b7-9122-130d57c1ca0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f2dcde55-c602-4228-a1d8-b5a69e8a22af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0330ded1-a830-43b7-9122-130d57c1ca0f" xlink:to="loc_srt_RangeMember_f2dcde55-c602-4228-a1d8-b5a69e8a22af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1eff8955-baed-42c2-b95b-e1c6b2a661ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f2dcde55-c602-4228-a1d8-b5a69e8a22af" xlink:to="loc_srt_MaximumMember_1eff8955-baed-42c2-b95b-e1c6b2a661ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a22fa0d1-50d4-45ed-870b-bb88f70b9b7c" xlink:to="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_db399a97-b3f3-4d6b-8e4c-b3065110c502" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_srt_AffiliatedEntityMember_db399a97-b3f3-4d6b-8e4c-b3065110c502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BeneficialOwnerMember_f512d126-46c0-481d-82c2-971f255608b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BeneficialOwnerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_us-gaap_BeneficialOwnerMember_f512d126-46c0-481d-82c2-971f255608b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_0424b5ce-ace9-43fa-aaad-ca1db0131e09" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ApolloRealEstateFundMember_0424b5ce-ace9-43fa-aaad-ca1db0131e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_4b00ea6b-b2a8-4606-a313-1bcf24b2c869" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_4b00ea6b-b2a8-4606-a313-1bcf24b2c869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassANotesMember_a3f17871-49af-4ebb-a595-3d02e0b7f686" xlink:href="ahl-20231220.xsd#ahl_ApolloClassANotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ApolloClassANotesMember_a3f17871-49af-4ebb-a595-3d02e0b7f686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassBNotesMember_050c7669-ad5e-49a5-8b7a-7c9c1420a3cf" xlink:href="ahl-20231220.xsd#ahl_ApolloClassBNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ApolloClassBNotesMember_050c7669-ad5e-49a5-8b7a-7c9c1420a3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember_aa2290bf-7093-494a-97cd-a08fbef2bebc" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5d21ed91-7844-4ada-898f-6414e704ca1d" xlink:to="loc_ahl_ClassABNotesMember_aa2290bf-7093-494a-97cd-a08fbef2bebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b8b86c79-623f-4caf-81d7-888026e6de4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b8b86c79-623f-4caf-81d7-888026e6de4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b8b86c79-623f-4caf-81d7-888026e6de4b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_a154ad54-0bba-4736-a816-0a2eb206d1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:to="loc_us-gaap_AssetManagementArrangementMember_a154ad54-0bba-4736-a816-0a2eb206d1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_221a5036-d127-4749-ba76-960101d76855" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:to="loc_ahl_ManagementConsultingAgreementMember_221a5036-d127-4749-ba76-960101d76855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_7f6bbc4e-97f3-416f-8359-7464e324d355" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_85943d4e-66ca-48b6-931e-b5555d129f62" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_7f6bbc4e-97f3-416f-8359-7464e324d355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c6061068-e0ac-4e55-bf29-24ffd5629888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c6061068-e0ac-4e55-bf29-24ffd5629888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c6061068-e0ac-4e55-bf29-24ffd5629888" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_cd4b7a29-9137-486a-b719-c2355671ca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:to="loc_us-gaap_InvestmentIncomeMember_cd4b7a29-9137-486a-b719-c2355671ca4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_78155891-6b00-4e5c-9882-dc122163382a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_78155891-6b00-4e5c-9882-dc122163382a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1_18028797-c196-40dc-b709-a4d534f15029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e3ea83e3-a5f7-454e-b1fa-0f3323b69df5" xlink:to="loc_us-gaap_GainLossOnInvestmentsMember1_18028797-c196-40dc-b709-a4d534f15029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cedc30a8-391f-4b9d-8e24-c6e7a425f326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cedc30a8-391f-4b9d-8e24-c6e7a425f326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4fca8866-dadb-4540-bf31-690e3d57a302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cedc30a8-391f-4b9d-8e24-c6e7a425f326" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4fca8866-dadb-4540-bf31-690e3d57a302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_dddcefe7-a609-49dd-b1da-08af3056de5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4fca8866-dadb-4540-bf31-690e3d57a302" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_dddcefe7-a609-49dd-b1da-08af3056de5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c263e128-2828-460c-8de9-8eef85d9ef5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c263e128-2828-460c-8de9-8eef85d9ef5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0d9115d6-836c-42d1-9425-f99aaa0cb056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c263e128-2828-460c-8de9-8eef85d9ef5a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0d9115d6-836c-42d1-9425-f99aaa0cb056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_edb85bbc-fb76-4e12-a29f-2bc2a465657c" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0d9115d6-836c-42d1-9425-f99aaa0cb056" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_edb85bbc-fb76-4e12-a29f-2bc2a465657c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_185bfcd5-49ff-4348-bc36-d068a743f830" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionRateofInterest_8167ca13-edef-488f-b69f-608f99d520ea" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionRateofInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_ahl_RelatedPartyTransactionRateofInterest_8167ca13-edef-488f-b69f-608f99d520ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionMaximumRateIncrease_4f7dcf75-9013-4808-9d0c-e9968a7e3e55" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionMaximumRateIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_ahl_RelatedPartyTransactionMaximumRateIncrease_4f7dcf75-9013-4808-9d0c-e9968a7e3e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_6babf19d-aca3-4154-9a65-c7de4370230e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_6babf19d-aca3-4154-9a65-c7de4370230e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromOfficersOrStockholdersCurrent_bcd82636-d8cb-453c-ae4e-1078eea12898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_DueFromOfficersOrStockholdersCurrent_bcd82636-d8cb-453c-ae4e-1078eea12898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_99e7c119-877a-4e0c-b14c-8b131a3dd16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_DueToAffiliateCurrent_99e7c119-877a-4e0c-b14c-8b131a3dd16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_26a75344-6d5b-4bd5-8632-1ba012a745de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_26a75344-6d5b-4bd5-8632-1ba012a745de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_6577e804-8d37-4127-83bf-278080267860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_6577e804-8d37-4127-83bf-278080267860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_c9163406-6532-4e90-9a19-96928a132581" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_ahl_PrivatelyheldInvestments_c9163406-6532-4e90-9a19-96928a132581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_8b9663d8-7a8a-4e7e-8fbc-851bd5149183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_us-gaap_OtherInvestments_8b9663d8-7a8a-4e7e-8fbc-851bd5149183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyHeldInvestmentLossesIncurred_de85df20-dc26-446c-a2f5-10bb7f04df3a" xlink:href="ahl-20231220.xsd#ahl_PrivatelyHeldInvestmentLossesIncurred"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b9a24b62-a6ec-4c06-b427-920e0e933794" xlink:to="loc_ahl_PrivatelyHeldInvestmentLossesIncurred_de85df20-dc26-446c-a2f5-10bb7f04df3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3a53b29-73a1-4356-8484-b904bb75e363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3a53b29-73a1-4356-8484-b904bb75e363" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_3cac694f-f4aa-4301-a964-44c70c938d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_3cac694f-f4aa-4301-a964-44c70c938d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_83c15153-7474-4538-938e-fa94aeae51a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_3cac694f-f4aa-4301-a964-44c70c938d38" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_83c15153-7474-4538-938e-fa94aeae51a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_4c23a304-0187-4bda-84bc-032fb8c20d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_83c15153-7474-4538-938e-fa94aeae51a2" xlink:to="loc_us-gaap_LimitedPartnerMember_4c23a304-0187-4bda-84bc-032fb8c20d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_6ea335c5-945c-48d2-a951-af8b5adbafe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:to="loc_us-gaap_InvestmentTypeAxis_6ea335c5-945c-48d2-a951-af8b5adbafe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_73b6caf9-aa63-4c98-9b1e-b24eb92bde4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_6ea335c5-945c-48d2-a951-af8b5adbafe8" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_73b6caf9-aa63-4c98-9b1e-b24eb92bde4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_1fb2c6a8-dd3b-4b05-abd2-6714e9be5536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73b6caf9-aa63-4c98-9b1e-b24eb92bde4a" xlink:to="loc_us-gaap_RealEstateFundsMember_1fb2c6a8-dd3b-4b05-abd2-6714e9be5536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4eb08f2-b6b5-4342-8016-cddbce4bed69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4eb08f2-b6b5-4342-8016-cddbce4bed69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_55bbd1ac-f7d1-4071-9f81-257df6e770d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e4eb08f2-b6b5-4342-8016-cddbce4bed69" xlink:to="loc_us-gaap_RelatedPartyDomain_55bbd1ac-f7d1-4071-9f81-257df6e770d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_beabd95d-29ac-4a34-be53-6dd4d5c28d59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_55bbd1ac-f7d1-4071-9f81-257df6e770d4" xlink:to="loc_srt_AffiliatedEntityMember_beabd95d-29ac-4a34-be53-6dd4d5c28d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ThirdPartyMember_ead00c88-c218-49dd-acec-d79d43daa9ff" xlink:href="ahl-20231220.xsd#ahl_ThirdPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_55bbd1ac-f7d1-4071-9f81-257df6e770d4" xlink:to="loc_ahl_ThirdPartyMember_ead00c88-c218-49dd-acec-d79d43daa9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_1086fb33-7de9-47c7-b627-de43fe2f32fd" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_fc050ddc-efdb-4117-bc7d-5cf4016dd76b" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_RestrictedAssets_fc050ddc-efdb-4117-bc7d-5cf4016dd76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssetsExcludingIlliquidAssets_533aa1e5-17fe-4ca5-b5f7-ebec15f7c22a" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssetsExcludingIlliquidAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_RestrictedAssetsExcludingIlliquidAssets_533aa1e5-17fe-4ca5-b5f7-ebec15f7c22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_05899135-927b-40c7-97ab-22d0b72c22ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_us-gaap_OtherInvestments_05899135-927b-40c7-97ab-22d0b72c22ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalRestrictedAssets_fd59d3c3-7cb9-4d4c-9631-9da6a7740c57" xlink:href="ahl-20231220.xsd#ahl_TotalRestrictedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_TotalRestrictedAssets_fd59d3c3-7cb9-4d4c-9631-9da6a7740c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_b765feb2-f306-4aa4-a8b3-4df661741441" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_b765feb2-f306-4aa4-a8b3-4df661741441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_0961a79d-2ba8-4afc-a338-2f7dd73deb63" xlink:href="ahl-20231220.xsd#ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_16c460a5-acb4-46f8-9692-5282879bd758" xlink:to="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_0961a79d-2ba8-4afc-a338-2f7dd73deb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_39f89975-6369-4bed-8508-7a70663c706e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_39f89975-6369-4bed-8508-7a70663c706e" xlink:to="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_cbcb74c0-550e-473c-a509-2d3351b5b878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_cbcb74c0-550e-473c-a509-2d3351b5b878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4a789cb3-2395-4492-933a-14b9ee2a78ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_cbcb74c0-550e-473c-a509-2d3351b5b878" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4a789cb3-2395-4492-933a-14b9ee2a78ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_16269e13-039b-4bc0-9c27-c54265e6d143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4a789cb3-2395-4492-933a-14b9ee2a78ff" xlink:to="loc_us-gaap_LimitedPartnerMember_16269e13-039b-4bc0-9c27-c54265e6d143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ce65e11f-4322-4ef0-afca-7bc147ef9d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_InvestmentTypeAxis_ce65e11f-4322-4ef0-afca-7bc147ef9d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d65fba6c-504f-48de-b1f0-34bed9d62ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ce65e11f-4322-4ef0-afca-7bc147ef9d5c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d65fba6c-504f-48de-b1f0-34bed9d62ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_8453bb2f-ceca-4bbb-8464-4bdc36f7e7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_d65fba6c-504f-48de-b1f0-34bed9d62ea4" xlink:to="loc_us-gaap_RealEstateFundsMember_8453bb2f-ceca-4bbb-8464-4bdc36f7e7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_85469c27-98b8-41b5-b126-a9d4c26a796d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_HedgingDesignationAxis_85469c27-98b8-41b5-b126-a9d4c26a796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_23f60191-b2fa-4afb-b5d7-862430ea578c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_85469c27-98b8-41b5-b126-a9d4c26a796d" xlink:to="loc_us-gaap_HedgingDesignationDomain_23f60191-b2fa-4afb-b5d7-862430ea578c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_449f226e-91c1-4753-af13-e877145bedf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_23f60191-b2fa-4afb-b5d7-862430ea578c" xlink:to="loc_us-gaap_NondesignatedMember_449f226e-91c1-4753-af13-e877145bedf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fb0842ab-d967-48cf-9186-c54dcde4068a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_dei_LegalEntityAxis_fb0842ab-d967-48cf-9186-c54dcde4068a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5fe3d059-4e74-424a-80ea-257daaff8d04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_fb0842ab-d967-48cf-9186-c54dcde4068a" xlink:to="loc_dei_EntityDomain_5fe3d059-4e74-424a-80ea-257daaff8d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenBermudaMember_a2a4763c-9273-4b5a-911e-4cfcda875006" xlink:href="ahl-20231220.xsd#ahl_AspenBermudaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5fe3d059-4e74-424a-80ea-257daaff8d04" xlink:to="loc_ahl_AspenBermudaMember_a2a4763c-9273-4b5a-911e-4cfcda875006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8370ad2-2503-4c27-b690-37339fd0cd10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8370ad2-2503-4c27-b690-37339fd0cd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8370ad2-2503-4c27-b690-37339fd0cd10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsMultiBeneficiaryTrustFundMember_a7ef2fdc-5446-4024-8b75-f6260a2f67c9" xlink:href="ahl-20231220.xsd#ahl_UsMultiBeneficiaryTrustFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_UsMultiBeneficiaryTrustFundMember_a7ef2fdc-5446-4024-8b75-f6260a2f67c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsSurplusLinesTrustFundMember_485a56a5-e074-4247-9948-f970f1ac976e" xlink:href="ahl-20231220.xsd#ahl_UsSurplusLinesTrustFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_UsSurplusLinesTrustFundMember_485a56a5-e074-4247-9948-f970f1ac976e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CanadianTrustFundMember_3fd32d17-b303-4702-a6f1-892b69d85941" xlink:href="ahl-20231220.xsd#ahl_CanadianTrustFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_CanadianTrustFundMember_3fd32d17-b303-4702-a6f1-892b69d85941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AustralianTrustFundMember_d76be418-2e13-4b45-9594-4abf0e2f5b9b" xlink:href="ahl-20231220.xsd#ahl_AustralianTrustFundMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_AustralianTrustFundMember_d76be418-2e13-4b45-9594-4abf0e2f5b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SwissTrustFundMember_05a3127b-bf15-4a97-94b3-aa49973d76d2" xlink:href="ahl-20231220.xsd#ahl_SwissTrustFundMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_SwissTrustFundMember_05a3127b-bf15-4a97-94b3-aa49973d76d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SingaporeTrustFundMember_98de2916-aece-4342-869d-0cc6660ec231" xlink:href="ahl-20231220.xsd#ahl_SingaporeTrustFundMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f55d246f-c129-4123-94b6-d802948c60d5" xlink:to="loc_ahl_SingaporeTrustFundMember_98de2916-aece-4342-869d-0cc6660ec231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f0d2243-8943-447a-9315-bc8f4cd69110" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f0d2243-8943-447a-9315-bc8f4cd69110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9f9a8424-be87-4712-9cfa-09d9b234f965" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f0d2243-8943-447a-9315-bc8f4cd69110" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9f9a8424-be87-4712-9cfa-09d9b234f965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_2f5ce13a-4a0a-40aa-82c5-95b7c22eb141" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9f9a8424-be87-4712-9cfa-09d9b234f965" xlink:to="loc_ahl_MVIMember_2f5ce13a-4a0a-40aa-82c5-95b7c22eb141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_d36759ed-deab-441c-8ce7-907f8d87d5a6" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9f9a8424-be87-4712-9cfa-09d9b234f965" xlink:to="loc_ahl_MultiLineReinsurerMember_d36759ed-deab-441c-8ce7-907f8d87d5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3a303f62-fcd4-4458-823d-44f99d125036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3a303f62-fcd4-4458-823d-44f99d125036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_21c06bf1-8ec0-4025-b449-edf09b3a39b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3a303f62-fcd4-4458-823d-44f99d125036" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_21c06bf1-8ec0-4025-b449-edf09b3a39b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_74ae1178-d254-4744-a9f1-4455ebed04d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_21c06bf1-8ec0-4025-b449-edf09b3a39b3" xlink:to="loc_us-gaap_SubsequentEventMember_74ae1178-d254-4744-a9f1-4455ebed04d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_ca4679b3-9972-41c7-9ca5-f9c38fc5ff7b" xlink:to="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_5b5c1d94-ad27-43cd-8025-071da1269af3" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_RestrictedAssets_5b5c1d94-ad27-43cd-8025-071da1269af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_7e2a7898-4772-4bb2-b3d9-bc19805ab13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_OtherInvestments_7e2a7898-4772-4bb2-b3d9-bc19805ab13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_42164d73-18bb-4cf2-8b73-4037e9b9e4c2" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_42164d73-18bb-4cf2-8b73-4037e9b9e4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8a81ffc9-09c5-44d1-8498-93794571747e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8a81ffc9-09c5-44d1-8498-93794571747e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_7b1dfc90-a8da-4a3a-9ac0-92a16e677fdc" xlink:href="ahl-20231220.xsd#ahl_PaymentstoAcquirePrivatelyheldInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_PaymentstoAcquirePrivatelyheldInvestments_7b1dfc90-a8da-4a3a-9ac0-92a16e677fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_65c36889-ad0b-4e6b-9b86-2d8b0bf3034d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_65c36889-ad0b-4e6b-9b86-2d8b0bf3034d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_3139a465-b149-46bf-af1e-998cd18d476e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_3139a465-b149-46bf-af1e-998cd18d476e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumNetCapitalRequired1_a5d6dde3-3f0c-4701-a32e-292e04607c39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumNetCapitalRequired1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_srt_MinimumNetCapitalRequired1_a5d6dde3-3f0c-4701-a32e-292e04607c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MinimumTrustFund_a57dba44-6637-41b9-8730-8a8ca70507f2" xlink:href="ahl-20231220.xsd#ahl_MinimumTrustFund"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_MinimumTrustFund_a57dba44-6637-41b9-8730-8a8ca70507f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfReinsuranceLiabilities_cfb02c93-9310-4c73-9b9f-8a37aa40d5bd" xlink:href="ahl-20231220.xsd#ahl_PercentageOfReinsuranceLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_PercentageOfReinsuranceLiabilities_cfb02c93-9310-4c73-9b9f-8a37aa40d5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceLiabilities_23da8b23-441d-48df-bfba-fdaf107ed4ad" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_ReinsuranceLiabilities_23da8b23-441d-48df-bfba-fdaf107ed4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_14084f09-985f-4f4c-bf4e-d45073bbf21e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_us-gaap_AssetsHeldInTrust_14084f09-985f-4f4c-bf4e-d45073bbf21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RegulatoryDeposits_954fa772-be88-4641-8cdb-d224012aa53c" xlink:href="ahl-20231220.xsd#ahl_RegulatoryDeposits"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_RegulatoryDeposits_954fa772-be88-4641-8cdb-d224012aa53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositWithStates_a6e39ec4-08e6-49c5-a90c-181af3b63709" xlink:href="ahl-20231220.xsd#ahl_DepositWithStates"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_DepositWithStates_a6e39ec4-08e6-49c5-a90c-181af3b63709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NumberOfInvestmentsInVariableInterestEntities_431cb651-1aa6-4341-8ee5-adadd733c261" xlink:href="ahl-20231220.xsd#ahl_NumberOfInvestmentsInVariableInterestEntities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_40117efb-4086-48a2-8e75-be193024d302" xlink:to="loc_ahl_NumberOfInvestmentsInVariableInterestEntities_431cb651-1aa6-4341-8ee5-adadd733c261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskScheduleOfGrossWrittenPremiumFromMajorBrokersDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRiskScheduleOfGrossWrittenPremiumFromMajorBrokersDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRiskScheduleOfGrossWrittenPremiumFromMajorBrokersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_e9a63208-685a-4a6b-9f7a-66a00dc84a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_45c4a7c1-635a-498b-aedb-505e64c873f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_e9a63208-685a-4a6b-9f7a-66a00dc84a1c" xlink:to="loc_us-gaap_InvestmentHoldingsTable_45c4a7c1-635a-498b-aedb-505e64c873f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ff72f0cb-a235-4c0c-9b31-7b9383081057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_45c4a7c1-635a-498b-aedb-505e64c873f2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ff72f0cb-a235-4c0c-9b31-7b9383081057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ff72f0cb-a235-4c0c-9b31-7b9383081057" xlink:to="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AonCorporationMember_9087011a-ca81-4e0b-b466-d7d15c49dfbe" xlink:href="ahl-20231220.xsd#ahl_AonCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:to="loc_ahl_AonCorporationMember_9087011a-ca81-4e0b-b466-d7d15c49dfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MarshAndMcLennanCompaniesIncMember_54de1f39-5631-48ab-9387-ff030509e0a7" xlink:href="ahl-20231220.xsd#ahl_MarshAndMcLennanCompaniesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:to="loc_ahl_MarshAndMcLennanCompaniesIncMember_54de1f39-5631-48ab-9387-ff030509e0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_WillisGroupHoldingsLtdMember_55bdcf15-5818-4a29-968e-11ff1454acd7" xlink:href="ahl-20231220.xsd#ahl_WillisGroupHoldingsLtdMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:to="loc_ahl_WillisGroupHoldingsLtdMember_55bdcf15-5818-4a29-968e-11ff1454acd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OthersMember_448e6396-3015-46be-b07d-192edb390acd" xlink:href="ahl-20231220.xsd#ahl_OthersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_40a96d22-4154-4a1d-aa82-64d5d489686b" xlink:to="loc_ahl_OthersMember_448e6396-3015-46be-b07d-192edb390acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_45c4a7c1-635a-498b-aedb-505e64c873f2" xlink:to="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsWrittenGrossPercentage_0cf0a0f3-9d90-4426-a03c-b0f2b709ff04" xlink:href="ahl-20231220.xsd#ahl_PremiumsWrittenGrossPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:to="loc_ahl_PremiumsWrittenGrossPercentage_0cf0a0f3-9d90-4426-a03c-b0f2b709ff04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_8ebcbce3-7267-4633-af47-8965228800af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:to="loc_us-gaap_PremiumsWrittenGross_8ebcbce3-7267-4633-af47-8965228800af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_557bc00a-8b0a-4771-96ba-830be490c2a8" xlink:href="ahl-20231220.xsd#ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_bc731717-51a4-4734-b9c8-64d3e93f6a75" xlink:to="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_557bc00a-8b0a-4771-96ba-830be490c2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRiskAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_d1af9cf2-8a14-43eb-b576-a57d8120009c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_d1af9cf2-8a14-43eb-b576-a57d8120009c" xlink:to="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingAMBestAxis_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingAMBestAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_srt_CreditRatingAMBestAxis_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingAMBestDomain_4cb10b34-31e3-4289-8d75-80dad397a417" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingAMBestDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CreditRatingAMBestAxis_39bf61ea-d0aa-4cf4-a03b-b6b30d72ea9a" xlink:to="loc_srt_CreditRatingAMBestDomain_4cb10b34-31e3-4289-8d75-80dad397a417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AMBestAPlusRatingMember_aa168eac-e7bf-41d6-b798-2535c55cb9d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AMBestAPlusRatingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CreditRatingAMBestDomain_4cb10b34-31e3-4289-8d75-80dad397a417" xlink:to="loc_srt_AMBestAPlusRatingMember_aa168eac-e7bf-41d6-b798-2535c55cb9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AMBestARatingMember_d2657a59-c567-41f6-a09f-2e1eb5feb79c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AMBestARatingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CreditRatingAMBestDomain_4cb10b34-31e3-4289-8d75-80dad397a417" xlink:to="loc_srt_AMBestARatingMember_d2657a59-c567-41f6-a09f-2e1eb5feb79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis_7b7e2e56-1e12-49d0-ab45-84998976f070" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_srt_CreditRatingStandardPoorsAxis_7b7e2e56-1e12-49d0-ab45-84998976f070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_04002c1d-7857-448e-bc4e-2d27615c1bab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_7b7e2e56-1e12-49d0-ab45-84998976f070" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_04002c1d-7857-448e-bc4e-2d27615c1bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAPlusRatingMember_432babf4-df24-4962-8ce1-f721013f5662" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAPlusRatingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_04002c1d-7857-448e-bc4e-2d27615c1bab" xlink:to="loc_srt_StandardPoorsAPlusRatingMember_432babf4-df24-4962-8ce1-f721013f5662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAAMinusRatingMember_f0d14ebe-6ff3-4fa3-b098-f1f100e29c34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAAMinusRatingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_04002c1d-7857-448e-bc4e-2d27615c1bab" xlink:to="loc_srt_StandardPoorsAAMinusRatingMember_f0d14ebe-6ff3-4fa3-b098-f1f100e29c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b85ba15-ef89-4606-9a08-fdfb8bd3e573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b85ba15-ef89-4606-9a08-fdfb8bd3e573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b85ba15-ef89-4606-9a08-fdfb8bd3e573" xlink:to="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MunichReMember_b23dddd9-297b-4ce3-95e3-670b946d594a" xlink:href="ahl-20231220.xsd#ahl_MunichReMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:to="loc_ahl_MunichReMember_b23dddd9-297b-4ce3-95e3-670b946d594a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EverestReMember_5d79f7f3-0961-4cb3-8a05-e810a29a69d4" xlink:href="ahl-20231220.xsd#ahl_EverestReMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:to="loc_ahl_EverestReMember_5d79f7f3-0961-4cb3-8a05-e810a29a69d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_5e062f10-2b19-4821-8647-4e684e6b8644" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_7316357f-b3db-4aa6-ad67-23b6f0a3f1a4" xlink:to="loc_ahl_LloydsMember_5e062f10-2b19-4821-8647-4e684e6b8644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ed01bc1f-e52c-4224-8785-5de496d8017f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ed01bc1f-e52c-4224-8785-5de496d8017f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_45cd7bdf-8c2c-4747-ade1-4961557d9c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ed01bc1f-e52c-4224-8785-5de496d8017f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_45cd7bdf-8c2c-4747-ade1-4961557d9c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8397bba9-1cca-4063-a565-4f6810efdd92" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_d143e11e-edd2-40f7-829c-419f3365ec7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_ReinsuranceRecoverables_d143e11e-edd2-40f7-829c-419f3365ec7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesUncollateralized_ee03ab82-9f84-42c7-a248-16d549be4ba1" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesUncollateralized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_ReinsuranceRecoverablesUncollateralized_ee03ab82-9f84-42c7-a248-16d549be4ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConcentrationRiskThresholdPercentage_a57c670c-d0a4-4049-99dd-b5ca882f26be" xlink:href="ahl-20231220.xsd#ahl_ConcentrationRiskThresholdPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_ConcentrationRiskThresholdPercentage_a57c670c-d0a4-4049-99dd-b5ca882f26be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_e0956bdd-1cdb-4508-94f8-c44da03effb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_e0956bdd-1cdb-4508-94f8-c44da03effb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsReceivableNonCurrent_6196482a-5352-4c34-948e-cbc065957e84" xlink:href="ahl-20231220.xsd#ahl_PremiumsReceivableNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_PremiumsReceivableNonCurrent_6196482a-5352-4c34-948e-cbc065957e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_65f12c08-114e-45e7-b2b8-f7e0c1b3e103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_65f12c08-114e-45e7-b2b8-f7e0c1b3e103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_a81262cf-852e-466d-859c-98e9d1bc97fa" xlink:href="ahl-20231220.xsd#ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_a81262cf-852e-466d-859c-98e9d1bc97fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_18dd138b-57ce-4d46-938a-33edd958f4bb" xlink:href="ahl-20231220.xsd#ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_ahl_PercentageOfWrittenPremiumMajorBrokerAccountedMinimum_18dd138b-57ce-4d46-938a-33edd958f4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_9fd07580-2614-4947-b8ed-344dd9b78010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c2c7fc51-194e-46f6-909e-8387ef22296c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_9fd07580-2614-4947-b8ed-344dd9b78010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2abd2917-2777-40b1-b52e-a7b47f596720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2abd2917-2777-40b1-b52e-a7b47f596720" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a00661e7-108d-4b8d-a20c-50ce7205155a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a00661e7-108d-4b8d-a20c-50ce7205155a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_952be1ad-d458-4956-80a8-55e00077047d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a00661e7-108d-4b8d-a20c-50ce7205155a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_952be1ad-d458-4956-80a8-55e00077047d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f1a411d7-1eed-4853-8aed-079482e7aff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_952be1ad-d458-4956-80a8-55e00077047d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f1a411d7-1eed-4853-8aed-079482e7aff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_27e51a92-faef-4d4d-a728-fde251748270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_27e51a92-faef-4d4d-a728-fde251748270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c1a33dcb-8f75-4e3c-b73a-9668194ad8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_27e51a92-faef-4d4d-a728-fde251748270" xlink:to="loc_us-gaap_EquityComponentDomain_c1a33dcb-8f75-4e3c-b73a-9668194ad8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2acb8baa-776c-4221-9ee7-fdcb39db78da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c1a33dcb-8f75-4e3c-b73a-9668194ad8df" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2acb8baa-776c-4221-9ee7-fdcb39db78da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_56b78e63-e6be-4f8c-a8a7-ef1b58c553ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c1a33dcb-8f75-4e3c-b73a-9668194ad8df" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_56b78e63-e6be-4f8c-a8a7-ef1b58c553ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_ced543a6-cf06-48e9-8b94-8acacc85628a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_ced543a6-cf06-48e9-8b94-8acacc85628a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6738e5e0-d4d1-473e-a604-dfc764480fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_ced543a6-cf06-48e9-8b94-8acacc85628a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6738e5e0-d4d1-473e-a604-dfc764480fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8cff26ce-9c4a-418a-ae7f-cbe55c1e3a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6738e5e0-d4d1-473e-a604-dfc764480fb3" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8cff26ce-9c4a-418a-ae7f-cbe55c1e3a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b188b840-9634-4991-a226-93451ebb380e" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_1d190fd3-20be-4cfc-9285-4424e64fdb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_1d190fd3-20be-4cfc-9285-4424e64fdb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_834947bd-32d0-4fa6-b796-4fb3a59fa1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_834947bd-32d0-4fa6-b796-4fb3a59fa1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2c277421-7d95-4ad9-a645-7b8c8eeacb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2c277421-7d95-4ad9-a645-7b8c8eeacb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4af56f52-74b3-4165-9745-f2452d3969f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4af56f52-74b3-4165-9745-f2452d3969f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4653af2a-84d8-4eb6-b635-7f0a5442b9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4653af2a-84d8-4eb6-b635-7f0a5442b9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_93eee6f3-3702-4a4d-a0f2-c86a3b7e1051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_93eee6f3-3702-4a4d-a0f2-c86a3b7e1051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d38ff921-177c-4dac-bf50-b34b3c35e415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b6b61542-e097-4fce-9833-659c8c08cbfd" xlink:to="loc_us-gaap_ProfitLoss_d38ff921-177c-4dac-bf50-b34b3c35e415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtSummaryofContractualObligationsUnderShorttermDebtsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditFacilitiesandShortTermDebtSummaryofContractualObligationsUnderShorttermDebtsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtSummaryofContractualObligationsUnderShorttermDebtsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_29cfe2b4-e1e4-4018-a559-0708de8901d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_1c454917-11fc-4109-89ea-a9d5ccdd7557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_29cfe2b4-e1e4-4018-a559-0708de8901d6" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_1c454917-11fc-4109-89ea-a9d5ccdd7557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_da3daab7-2a97-4c09-8911-c1d8775a3483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_1c454917-11fc-4109-89ea-a9d5ccdd7557" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_da3daab7-2a97-4c09-8911-c1d8775a3483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_59b1ef08-1cb0-4146-a6b6-c73130b1479b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_da3daab7-2a97-4c09-8911-c1d8775a3483" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_59b1ef08-1cb0-4146-a6b6-c73130b1479b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtMember_86d16739-4d9e-4ef5-880e-4a189077332c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_59b1ef08-1cb0-4146-a6b6-c73130b1479b" xlink:to="loc_us-gaap_ShortTermDebtMember_86d16739-4d9e-4ef5-880e-4a189077332c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_313a71eb-61f0-4472-b628-a78356a18ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_1c454917-11fc-4109-89ea-a9d5ccdd7557" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_313a71eb-61f0-4472-b628-a78356a18ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_81c689e7-5472-4e5f-8e22-9fe1e13c7af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_313a71eb-61f0-4472-b628-a78356a18ba0" xlink:to="loc_us-gaap_ShortTermBorrowings_81c689e7-5472-4e5f-8e22-9fe1e13c7af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_7af6b6df-3568-40d5-be6e-ae47ffc7d06d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_313a71eb-61f0-4472-b628-a78356a18ba0" xlink:to="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_7af6b6df-3568-40d5-be6e-ae47ffc7d06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditFacilitiesandShortTermDebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CreditFacilitiesandShortTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4cc51556-407c-4db4-a401-a4b40904fdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4cc51556-407c-4db4-a401-a4b40904fdb4" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_56d71c08-cd19-4c40-b8ee-074c56de09de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_56d71c08-cd19-4c40-b8ee-074c56de09de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_a2723c86-3a19-4231-a6d9-6d8c3a43f2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_56d71c08-cd19-4c40-b8ee-074c56de09de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_a2723c86-3a19-4231-a6d9-6d8c3a43f2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CitibankEuropeplcMember_ff9239ff-f1ca-493e-8436-a220baf948df" xlink:href="ahl-20231220.xsd#ahl_CitibankEuropeplcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a2723c86-3a19-4231-a6d9-6d8c3a43f2ed" xlink:to="loc_ahl_CitibankEuropeplcMember_ff9239ff-f1ca-493e-8436-a220baf948df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_a4a14990-ce77-43de-afe8-a810c9c686d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_a2723c86-3a19-4231-a6d9-6d8c3a43f2ed" xlink:to="loc_us-gaap_SeniorNotesMember_a4a14990-ce77-43de-afe8-a810c9c686d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_CreditFacilityAxis_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f2a2fdfd-5535-4955-b19d-95ce4bdadd2f" xlink:to="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CitibankEuropeMember_f8a1e3ef-343f-409f-91d5-f56ca2e64391" xlink:href="ahl-20231220.xsd#ahl_CitibankEuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:to="loc_ahl_CitibankEuropeMember_f8a1e3ef-343f-409f-91d5-f56ca2e64391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_5694e715-9831-4adb-a7c8-b441faee4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:to="loc_us-gaap_LetterOfCreditMember_5694e715-9831-4adb-a7c8-b441faee4f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_9cecb555-79be-4eef-8c6c-bc8d9617cc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d514eb07-3b84-4e15-b6fe-f253465d791b" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_9cecb555-79be-4eef-8c6c-bc8d9617cc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_94175853-ffa9-409d-b33a-287fc4c49393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_94175853-ffa9-409d-b33a-287fc4c49393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_93b694be-5817-42bc-b136-7d894596ea95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_94175853-ffa9-409d-b33a-287fc4c49393" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_93b694be-5817-42bc-b136-7d894596ea95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_095fcfa1-fd90-404a-8c4f-b4a521a26391" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_dei_LegalEntityAxis_095fcfa1-fd90-404a-8c4f-b4a521a26391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_095fcfa1-fd90-404a-8c4f-b4a521a26391" xlink:to="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUKMember_33902623-b933-4087-bb9c-7acdbce79dad" xlink:href="ahl-20231220.xsd#ahl_AspenUKMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AspenUKMember_33902623-b933-4087-bb9c-7acdbce79dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenUnderwritingLimitedMember_6da251f1-6352-4e02-ae01-50b21e2f3155" xlink:href="ahl-20231220.xsd#ahl_AspenUnderwritingLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AspenUnderwritingLimitedMember_6da251f1-6352-4e02-ae01-50b21e2f3155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenBermudaMember_852e4d35-54bb-4850-bb80-f6cca1f3b67b" xlink:href="ahl-20231220.xsd#ahl_AspenBermudaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AspenBermudaMember_852e4d35-54bb-4850-bb80-f6cca1f3b67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenSpecialtyMember_92d02991-87ae-48ce-831c-05df9aad1656" xlink:href="ahl-20231220.xsd#ahl_AspenSpecialtyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AspenSpecialtyMember_92d02991-87ae-48ce-831c-05df9aad1656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAICMember_9cf17421-ccbd-4e0e-a486-88ee784ab727" xlink:href="ahl-20231220.xsd#ahl_AAICMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4d5e5fb6-bd1d-41b9-828b-f82274b66c92" xlink:to="loc_ahl_AAICMember_9cf17421-ccbd-4e0e-a486-88ee784ab727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_23168879-d627-4595-99ad-4540ae66b9b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_srt_CounterpartyNameAxis_23168879-d627-4595-99ad-4540ae66b9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_23168879-d627-4595-99ad-4540ae66b9b5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenEuropeanMember_2d40ce90-de68-4fe4-aa17-e65d3a03fcfa" xlink:href="ahl-20231220.xsd#ahl_AspenEuropeanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_AspenEuropeanMember_2d40ce90-de68-4fe4-aa17-e65d3a03fcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_47358c3b-5bdb-4ef2-bd22-d719a9813502" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_LloydsMember_47358c3b-5bdb-4ef2-bd22-d719a9813502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NatixisMember_2165b334-2adf-4088-9643-3aaf13542360" xlink:href="ahl-20231220.xsd#ahl_NatixisMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_NatixisMember_2165b334-2adf-4088-9643-3aaf13542360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HSBCBankUSANationalAssociationMember_a7a10443-58a0-4b9e-a240-8f0d41e797cc" xlink:href="ahl-20231220.xsd#ahl_HSBCBankUSANationalAssociationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_HSBCBankUSANationalAssociationMember_a7a10443-58a0-4b9e-a240-8f0d41e797cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeutscheMember_3a6054b8-0df6-444e-8b85-1721a4a9d226" xlink:href="ahl-20231220.xsd#ahl_DeutscheMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_DeutscheMember_3a6054b8-0df6-444e-8b85-1721a4a9d226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CitibankEuropeMember_99733884-2e0f-4ec6-a83f-6711bd9eb29f" xlink:href="ahl-20231220.xsd#ahl_CitibankEuropeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18941de0-2ccb-42d3-b969-240e72a4c745" xlink:to="loc_ahl_CitibankEuropeMember_99733884-2e0f-4ec6-a83f-6711bd9eb29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_d21c7462-1019-47cb-a532-ba24d33b2e0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_d21c7462-1019-47cb-a532-ba24d33b2e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_51fd9489-1a52-400d-8e7a-1983252e5e4f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis_d21c7462-1019-47cb-a532-ba24d33b2e0c" xlink:to="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_51fd9489-1a52-400d-8e7a-1983252e5e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_FederalHomeLoanBankOfBostonMember_fe9fcbe0-c903-4995-affe-3ed30f90f9c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_FederalHomeLoanBankOfBostonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain_51fd9489-1a52-400d-8e7a-1983252e5e4f" xlink:to="loc_srt_FederalHomeLoanBankOfBostonMember_fe9fcbe0-c903-4995-affe-3ed30f90f9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d5ec692c-4da6-40d0-a381-0c29cfa23ec2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_srt_RangeAxis_d5ec692c-4da6-40d0-a381-0c29cfa23ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_edecd7b9-521f-4be1-9f52-7cc5d63ced50" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d5ec692c-4da6-40d0-a381-0c29cfa23ec2" xlink:to="loc_srt_RangeMember_edecd7b9-521f-4be1-9f52-7cc5d63ced50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cd9e3a45-b36a-4b10-838d-8f75f033b3ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_edecd7b9-521f-4be1-9f52-7cc5d63ced50" xlink:to="loc_srt_MaximumMember_cd9e3a45-b36a-4b10-838d-8f75f033b3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6ab566c6-0403-4b59-8b29-c3da09396362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6ab566c6-0403-4b59-8b29-c3da09396362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3ad4ef38-920c-498e-b279-27ccd693c3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6ab566c6-0403-4b59-8b29-c3da09396362" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3ad4ef38-920c-498e-b279-27ccd693c3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a5b38b38-afc3-4b3d-9747-7fa110a28ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3ad4ef38-920c-498e-b279-27ccd693c3ae" xlink:to="loc_us-gaap_SubsequentEventMember_a5b38b38-afc3-4b3d-9747-7fa110a28ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_640c782d-32d0-4b0f-949c-e887b88a32e7" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d453927d-caad-4806-b853-1774a40fabad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d453927d-caad-4806-b853-1774a40fabad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityIncreasableCapacity_1ceba018-67df-464f-a9c8-3c5b79ebeb71" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityIncreasableCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityIncreasableCapacity_1ceba018-67df-464f-a9c8-3c5b79ebeb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum_2d52f3fd-5a2f-4d03-a056-3dc9f340e301" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityTangibleNetWorthRestrictionsMinimum_2d52f3fd-5a2f-4d03-a056-3dc9f340e301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations_0bb148eb-e9be-42cb-b68b-e426d22443ef" xlink:href="ahl-20231220.xsd#ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_PercentageLimitOfReserveAssetsPermittedToSecureDebtObligations_0bb148eb-e9be-42cb-b68b-e426d22443ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction_1e8e3fec-c0e9-45d0-84b9-7036487e09d2" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityTangibleNetWorthNetIncomeRestriction_1e8e3fec-c0e9-45d0-84b9-7036487e09d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction_bf0425f2-562b-4bcc-84bb-702451393d06" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityTangibleNetWorthCashProceedsFromIssuanceOfCapitalStockRestriction_bf0425f2-562b-4bcc-84bb-702451393d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfConsolidatedLeverageRatioPermitted_dab71bc2-2fcb-4a1e-90ac-617b5fb4858c" xlink:href="ahl-20231220.xsd#ahl_PercentageOfConsolidatedLeverageRatioPermitted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_PercentageOfConsolidatedLeverageRatioPermitted_dab71bc2-2fcb-4a1e-90ac-617b5fb4858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity_c110bbad-1308-4e53-b5fe-1e269129f66f" xlink:href="ahl-20231220.xsd#ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LineOfCreditFacilityIncreaseAdditionalBorrowingCapacity_c110bbad-1308-4e53-b5fe-1e269129f66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ee0d67d7-82e7-4072-8d5c-868d5f3d1e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ee0d67d7-82e7-4072-8d5c-868d5f3d1e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2d32c6e-2148-4aec-ad40-56e763db582a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2d32c6e-2148-4aec-ad40-56e763db582a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_381f267c-a98f-4860-8764-b96b0c949016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_381f267c-a98f-4860-8764-b96b0c949016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtDefaultMinimum_987dafb3-faba-4a27-a40f-e5c68d050c40" xlink:href="ahl-20231220.xsd#ahl_DebtDefaultMinimum"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_DebtDefaultMinimum_987dafb3-faba-4a27-a40f-e5c68d050c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_51546fda-847c-47b5-b64c-f4bc544b0251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_51546fda-847c-47b5-b64c-f4bc544b0251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LetterOfCreditToSupportFundsAtLloyds_ab6fdf17-542e-4b65-a9c6-067118b9f139" xlink:href="ahl-20231220.xsd#ahl_LetterOfCreditToSupportFundsAtLloyds"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_LetterOfCreditToSupportFundsAtLloyds_ab6fdf17-542e-4b65-a9c6-067118b9f139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FundsAtLloydsFacilityAgreement_23053c98-2742-4dc5-82e3-ee1f7da2c00b" xlink:href="ahl-20231220.xsd#ahl_FundsAtLloydsFacilityAgreement"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_FundsAtLloydsFacilityAgreement_23053c98-2742-4dc5-82e3-ee1f7da2c00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_1d83249e-1b3b-412b-bdac-c1d505f08673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_1d83249e-1b3b-412b-bdac-c1d505f08673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds_f9b3d300-2c1e-4c1a-bff5-f59835bc7f95" xlink:href="ahl-20231220.xsd#ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_97d6f032-5600-4fe5-9ff1-00b6bf1718a6" xlink:to="loc_ahl_SecuritiesLendingTransactionToSupportFundsAtLloyds_f9b3d300-2c1e-4c1a-bff5-f59835bc7f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CreditLossesDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#CreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_852ad041-f384-47f9-8960-c57ae0127b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_852ad041-f384-47f9-8960-c57ae0127b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_d3085fb3-ef9b-4c64-91ad-392fe0518ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_d3085fb3-ef9b-4c64-91ad-392fe0518ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_d230f5cf-b4b5-4489-9dff-de87f093ff3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_d230f5cf-b4b5-4489-9dff-de87f093ff3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2ff7f73e-219f-409b-a5ef-a5a8eaa5775d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2ff7f73e-219f-409b-a5ef-a5a8eaa5775d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_3eb8d7a8-91b1-4747-889b-43722be88a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_3eb8d7a8-91b1-4747-889b-43722be88a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_73f4d1a8-6d9c-49c6-b227-e59ff17c9a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_73f4d1a8-6d9c-49c6-b227-e59ff17c9a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_fba396ed-1990-4e7d-a51c-51de37c92470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_fba396ed-1990-4e7d-a51c-51de37c92470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_f39f1f56-8218-4383-98d0-0a153453c5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_f39f1f56-8218-4383-98d0-0a153453c5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_6384934c-aacd-4413-9e26-45a6856770b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_6384934c-aacd-4413-9e26-45a6856770b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalAllowanceForCreditLoss_9778945e-d200-4fd0-8bcf-998c6900f20d" xlink:href="ahl-20231220.xsd#ahl_TotalAllowanceForCreditLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_ahl_TotalAllowanceForCreditLoss_9778945e-d200-4fd0-8bcf-998c6900f20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear_03aa768f-1235-4cfb-a38a-0779da85e083" xlink:href="ahl-20231220.xsd#ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_ahl_TotalMovementOfTheAllowanceForCreditLossesDuringTheYear_03aa768f-1235-4cfb-a38a-0779da85e083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalAllowanceForCreditLoss_d9a09314-f980-4b0a-99d1-9c4025dc55c2" xlink:href="ahl-20231220.xsd#ahl_TotalAllowanceForCreditLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_bbf293aa-120d-4df0-812a-4c9c6bc55bce" xlink:to="loc_ahl_TotalAllowanceForCreditLoss_d9a09314-f980-4b0a-99d1-9c4025dc55c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#SubsequentEventsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SubsequentEventsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_231f38f4-c1a1-4b0d-9c43-a8a831fbd023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2aeb167f-8f25-4c83-b5cc-163d3e81f735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_231f38f4-c1a1-4b0d-9c43-a8a831fbd023" xlink:to="loc_us-gaap_SubsequentEventTable_2aeb167f-8f25-4c83-b5cc-163d3e81f735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1114a3f4-a056-483c-943e-3489eece8650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2aeb167f-8f25-4c83-b5cc-163d3e81f735" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1114a3f4-a056-483c-943e-3489eece8650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1b53b2a6-5ea4-4e15-8894-cada4fb46816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1114a3f4-a056-483c-943e-3489eece8650" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1b53b2a6-5ea4-4e15-8894-cada4fb46816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c55db997-7043-46be-9f4e-0ab87756064a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1b53b2a6-5ea4-4e15-8894-cada4fb46816" xlink:to="loc_us-gaap_SubsequentEventMember_c55db997-7043-46be-9f4e-0ab87756064a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_5d316f66-84fe-43c7-b582-9c8eb751c264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2aeb167f-8f25-4c83-b5cc-163d3e81f735" xlink:to="loc_us-gaap_SubsequentEventLineItems_5d316f66-84fe-43c7-b582-9c8eb751c264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_58f8add9-20ac-4563-96b9-228dd04c4b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5d316f66-84fe-43c7-b582-9c8eb751c264" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_58f8add9-20ac-4563-96b9-228dd04c4b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f88c1fea-0e6a-4195-9875-6f7f452d05c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f88c1fea-0e6a-4195-9875-6f7f452d05c3" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_58f32f87-0e9d-4797-9bca-a628bba1eee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_58f32f87-0e9d-4797-9bca-a628bba1eee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ac3d292-7ddb-49f5-b7a0-fb8968bbffad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_58f32f87-0e9d-4797-9bca-a628bba1eee5" xlink:to="loc_us-gaap_EquityComponentDomain_5ac3d292-7ddb-49f5-b7a0-fb8968bbffad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e9cdedce-ab3e-46ce-b4b9-6d962e85df71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5ac3d292-7ddb-49f5-b7a0-fb8968bbffad" xlink:to="loc_us-gaap_RetainedEarningsMember_e9cdedce-ab3e-46ce-b4b9-6d962e85df71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2f1ec75d-37a1-4153-9c03-90132b317547" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2f1ec75d-37a1-4153-9c03-90132b317547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_164e6c72-97da-4a02-adfc-2adca6b556ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2f1ec75d-37a1-4153-9c03-90132b317547" xlink:to="loc_srt_ConsolidatedEntitiesDomain_164e6c72-97da-4a02-adfc-2adca6b556ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_09dd76aa-dbbe-4e9e-be70-d942c7d1913e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_164e6c72-97da-4a02-adfc-2adca6b556ec" xlink:to="loc_srt_ParentCompanyMember_09dd76aa-dbbe-4e9e-be70-d942c7d1913e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ba821f33-fa3a-4e10-88a4-a9a401f79d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ba821f33-fa3a-4e10-88a4-a9a401f79d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ba821f33-fa3a-4e10-88a4-a9a401f79d35" xlink:to="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_6595ee03-98ba-4af4-9a91-4f21cbca0c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_6595ee03-98ba-4af4-9a91-4f21cbca0c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_f6f03c29-278b-46fc-971c-28f7c6505e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_f6f03c29-278b-46fc-971c-28f7c6505e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_db583a14-783e-4efc-801c-282477e927ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2cb5e42-a099-4ebf-9439-124a4e7048f2" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_db583a14-783e-4efc-801c-282477e927ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_7299a8b4-2295-4cd5-9081-1d051311295c" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_b366b154-2638-4257-86d5-dfa14b8ef107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_TradingSecurities_b366b154-2638-4257-86d5-dfa14b8ef107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6188e025-0272-4f00-af52-bf3e95985dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6188e025-0272-4f00-af52-bf3e95985dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4b8eca07-fb0f-4963-bb70-79ad6ce416db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4b8eca07-fb0f-4963-bb70-79ad6ce416db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_a90397ea-a603-4b7d-8e73-03024f2e5401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_OtherInvestments_a90397ea-a603-4b7d-8e73-03024f2e5401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_f80bb997-65dd-4d7e-a25b-547bc10e9dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_DueFromAffiliates_f80bb997-65dd-4d7e-a25b-547bc10e9dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e4bd7e8-70c4-4ff8-b084-670b699018cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e4bd7e8-70c4-4ff8-b084-670b699018cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_e5355ccf-249f-4906-98b1-2ed3d35bebf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_OtherAssets_e5355ccf-249f-4906-98b1-2ed3d35bebf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bb964346-d729-482b-86d0-6b61c99c28c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f22a652a-3dbd-47fb-9b95-47fe582a0ca9" xlink:to="loc_us-gaap_Assets_bb964346-d729-482b-86d0-6b61c99c28c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_d7d46440-a87f-4529-afba-53ab813eb73e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_d7d46440-a87f-4529-afba-53ab813eb73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_a86682df-b30e-4774-b077-9541b8f09719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_a86682df-b30e-4774-b077-9541b8f09719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_55d8a93a-0a5b-4c52-a8e1-973a11da279c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_ShortTermBorrowings_55d8a93a-0a5b-4c52-a8e1-973a11da279c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6dfd7a50-9256-4851-9c3d-ad2b2567ca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_LongTermDebt_6dfd7a50-9256-4851-9c3d-ad2b2567ca3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cbf5297a-6e22-43d5-bf55-eaea6934e9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_OperatingLeaseLiability_cbf5297a-6e22-43d5-bf55-eaea6934e9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_58ab5845-8934-49b8-aadf-8baa55a66cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5324eeb9-1d59-4dc7-bba5-6db11471359b" xlink:to="loc_us-gaap_Liabilities_58ab5845-8934-49b8-aadf-8baa55a66cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7f834b0e-8ba2-4070-9393-1ac861e09379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_CommonStockValue_7f834b0e-8ba2-4070-9393-1ac861e09379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_056207df-309a-4579-9b7a-b8eeeaf0d2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AdditionalPaidInCapital_056207df-309a-4579-9b7a-b8eeeaf0d2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d2a20824-c884-480b-8864-e00bcb2dbb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d2a20824-c884-480b-8864-e00bcb2dbb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cece1ed2-e486-451e-b30b-8786497d0bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cece1ed2-e486-451e-b30b-8786497d0bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_57f8b152-40d2-4cd7-8306-54bf0a07323a" xlink:href="ahl-20231220.xsd#ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_ahl_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossonDerivativesEffectNetofTax_57f8b152-40d2-4cd7-8306-54bf0a07323a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_815298fe-5c51-46f8-a13b-a5a7e5a7b5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_815298fe-5c51-46f8-a13b-a5a7e5a7b5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_576c5f7b-ec6c-4fa0-b362-c84111b4a563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_576c5f7b-ec6c-4fa0-b362-c84111b4a563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6a077bf-a77a-43a9-8cc9-4f115d42b485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6a077bf-a77a-43a9-8cc9-4f115d42b485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6c0ce7bf-3873-4f27-98f9-030f721ddc76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8ccdcc74-031c-457d-b767-e93b9429cfdf" xlink:to="loc_us-gaap_StockholdersEquity_6c0ce7bf-3873-4f27-98f9-030f721ddc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2d324ac9-6c71-49e4-88f9-f8580f6bd964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2d324ac9-6c71-49e4-88f9-f8580f6bd964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3d0fc04e-90ab-4778-877c-e9fc14d99022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_CommonStockSharesIssued_3d0fc04e-90ab-4778-877c-e9fc14d99022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_db0df465-cad0-4e21-85bb-c33bf562f7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_db0df465-cad0-4e21-85bb-c33bf562f7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d38ed8e2-66c6-49e0-a01f-2400e118bbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d38ed8e2-66c6-49e0-a01f-2400e118bbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_1953729f-c6b6-476c-9293-3a14e3223c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_1953729f-c6b6-476c-9293-3a14e3223c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2b53595e-dff3-4d8d-bab9-7d9330230f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6561d75a-bed7-4523-bbf7-500a632bb612" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2b53595e-dff3-4d8d-bab9-7d9330230f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofOperationsandComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_5994ad85-cbaa-4f95-8f53-49dd6cba7686" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_6e1fc8a5-78c9-4450-a2f7-a7d566353f5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_5994ad85-cbaa-4f95-8f53-49dd6cba7686" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_6e1fc8a5-78c9-4450-a2f7-a7d566353f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5138f244-df86-4380-9c29-6d6a76dcc860" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_6e1fc8a5-78c9-4450-a2f7-a7d566353f5c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5138f244-df86-4380-9c29-6d6a76dcc860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_93e3332b-d81a-49a4-a373-c0e17a06fa7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5138f244-df86-4380-9c29-6d6a76dcc860" xlink:to="loc_srt_ConsolidatedEntitiesDomain_93e3332b-d81a-49a4-a373-c0e17a06fa7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d3c19914-1ccf-44cf-9239-034ff46c24fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_93e3332b-d81a-49a4-a373-c0e17a06fa7f" xlink:to="loc_srt_ParentCompanyMember_d3c19914-1ccf-44cf-9239-034ff46c24fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_6e1fc8a5-78c9-4450-a2f7-a7d566353f5c" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityInNetEarningsOfSubsidiaries_fd9984fc-047c-4ee4-a68e-5674d1b79e6a" xlink:href="ahl-20231220.xsd#ahl_EquityInNetEarningsOfSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_ahl_EquityInNetEarningsOfSubsidiaries_fd9984fc-047c-4ee4-a68e-5674d1b79e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_cda3ed28-6183-4a43-8faa-da57019c2850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_cda3ed28-6183-4a43-8faa-da57019c2850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_beac0ae3-f2c7-43db-83f5-4f287b6a0d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_beac0ae3-f2c7-43db-83f5-4f287b6a0d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_8f2467bd-1f69-4b8b-8447-74e3f2597ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_OtherIncome_8f2467bd-1f69-4b8b-8447-74e3f2597ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d455a4d7-7e93-4943-bd6b-79cdda33e2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_Revenues_d455a4d7-7e93-4943-bd6b-79cdda33e2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eee50332-7080-45c8-ad25-0fe583ca7459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_eee50332-7080-45c8-ad25-0fe583ca7459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c09da2de-7b0d-449a-8c24-4bafb1ab69b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_InterestExpense_c09da2de-7b0d-449a-8c24-4bafb1ab69b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_bf59e193-4869-4656-968b-93524d30dbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_OtherExpenses_bf59e193-4869-4656-968b-93524d30dbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2d9a6711-8ac1-4563-9e94-69b2c182b016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2d9a6711-8ac1-4563-9e94-69b2c182b016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c529840d-00eb-4d98-b678-05dfb92b1736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c529840d-00eb-4d98-b678-05dfb92b1736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_25d18556-3bf3-4760-bc4f-288762f62ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_ProfitLoss_25d18556-3bf3-4760-bc4f-288762f62ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5dc35b49-d33c-4a5c-b4c4-30d3e3e44126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5dc35b49-d33c-4a5c-b4c4-30d3e3e44126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c74003cd-0652-4c0b-a785-ec2ac1d8bf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a4aff6da-5e8a-4fea-8e0e-a0033fbd2924" xlink:to="loc_us-gaap_NetIncomeLoss_c74003cd-0652-4c0b-a785-ec2ac1d8bf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:href="ahl-20231220.xsd#ahl_OtherComprehensiveIncomeLossAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8983cd8f-c3df-44a5-b80d-3d5e99fa259d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8983cd8f-c3df-44a5-b80d-3d5e99fa259d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_544b4167-2add-4e0a-b448-fc14bf5541fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_544b4167-2add-4e0a-b448-fc14bf5541fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5c7cac31-6243-452c-95fc-844f6bc9def4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5c7cac31-6243-452c-95fc-844f6bc9def4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dffb672e-3df4-41bb-95c3-83478ff381b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_OtherComprehensiveIncomeLossAbstract_33096939-120f-4aa0-9718-6859bef9bdc0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dffb672e-3df4-41bb-95c3-83478ff381b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b7a7f1fb-9900-4116-88d3-6498795b7618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_b17cefba-dbfd-425f-8c42-e6727d0403a3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b7a7f1fb-9900-4116-88d3-6498795b7618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIICondensedFinancialInformationofRegistrantStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_e77d87a1-f083-4dc1-9ec9-287494bfe585" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_e77d87a1-f083-4dc1-9ec9-287494bfe585" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_49e36986-86bc-4309-9985-bfd5e8c11b2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d7e8edb-0980-410b-a9db-fcb5a54f1c1c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_49e36986-86bc-4309-9985-bfd5e8c11b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_c2f8e7ba-1189-4aa9-806b-53bd9d6a0d1b" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_49e36986-86bc-4309-9985-bfd5e8c11b2b" xlink:to="loc_ahl_MVIMember_c2f8e7ba-1189-4aa9-806b-53bd9d6a0d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_69eb2e60-95f3-418e-94c7-cd2d23d5cde0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:to="loc_srt_ConsolidatedEntitiesAxis_69eb2e60-95f3-418e-94c7-cd2d23d5cde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a19ea9f4-5eae-409e-9a4c-5bcf52ab557d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69eb2e60-95f3-418e-94c7-cd2d23d5cde0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a19ea9f4-5eae-409e-9a4c-5bcf52ab557d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_21b76251-808c-4152-9fe7-8159a271a905" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_a19ea9f4-5eae-409e-9a4c-5bcf52ab557d" xlink:to="loc_srt_ParentCompanyMember_21b76251-808c-4152-9fe7-8159a271a905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_cc7535cb-1ad6-4296-847e-342a264d5a58" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_99553927-8385-42eb-b3fd-50127715a846" xlink:href="ahl-20231220.xsd#ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_ahl_NetIncomeLossBeforeEquityInNetEarningsOfSubsidiaries_99553927-8385-42eb-b3fd-50127715a846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedGainsLosses_f3008373-feac-45b9-92c2-c5c0c86f9c0b" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedGainsLosses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_ahl_NetRealizedAndUnrealizedGainsLosses_f3008373-feac-45b9-92c2-c5c0c86f9c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLossOnDerivative_0aca37bb-722c-443c-ad0e-b40fa4d0693f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLossOnDerivative"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_DerivativeLossOnDerivative_0aca37bb-722c-443c-ad0e-b40fa4d0693f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_17e87287-d8d7-4663-9be3-64d2cc7c7fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_17e87287-d8d7-4663-9be3-64d2cc7c7fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_dd7f3027-b654-4b5f-9de8-012e78a81ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_dd7f3027-b654-4b5f-9de8-012e78a81ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ChangeInOtherAssets_b051b64b-8cae-4a46-a396-c20f5986d5ef" xlink:href="ahl-20231220.xsd#ahl_ChangeInOtherAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_ahl_ChangeInOtherAssets_b051b64b-8cae-4a46-a396-c20f5986d5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_abb38acf-a243-4bfa-88ad-e7ac33dbb363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_abb38acf-a243-4bfa-88ad-e7ac33dbb363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_9e3ff7e1-ada9-48fd-92a8-c6f32246f109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_9e3ff7e1-ada9-48fd-92a8-c6f32246f109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IncreaseDecreaseInIntercompanyActivities_3c19ab89-d4c5-4004-8d93-175f27b46c23" xlink:href="ahl-20231220.xsd#ahl_IncreaseDecreaseInIntercompanyActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_ahl_IncreaseDecreaseInIntercompanyActivities_3c19ab89-d4c5-4004-8d93-175f27b46c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ab14b306-ac04-4b02-bfa3-00e81b7ad2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_OperatingLeasePayments_ab14b306-ac04-4b02-bfa3-00e81b7ad2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_760ff4fc-0da8-4939-8d66-4905c28105ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a449230c-44c4-4423-86bf-abcc15dd5365" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_760ff4fc-0da8-4939-8d66-4905c28105ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_14fbc874-ec68-4920-9fa2-00d086501235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_14fbc874-ec68-4920-9fa2-00d086501235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_82d947b2-8e54-4dae-ba93-f80e2dada261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_82d947b2-8e54-4dae-ba93-f80e2dada261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_8f931277-0efe-46f4-898c-6a899e4ff38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_8f931277-0efe-46f4-898c-6a899e4ff38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_ea586b1f-d5bf-4108-bf55-eaacc26d48d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_ea586b1f-d5bf-4108-bf55-eaacc26d48d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1d894bda-0c94-400c-b2ca-b79468d3634c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1d894bda-0c94-400c-b2ca-b79468d3634c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da2a6ab5-27a9-4950-98fa-f6193028270f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_599bd058-6c05-4122-b261-19657a561d89" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da2a6ab5-27a9-4950-98fa-f6193028270f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c58625ec-2b69-446b-b3c1-b41988e261c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c58625ec-2b69-446b-b3c1-b41988e261c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a6e74165-869b-4a71-bd0f-6b04d7dd7a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a6e74165-869b-4a71-bd0f-6b04d7dd7a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5bca2e9a-056b-440f-828f-109e35ac9efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345d9501-401e-48d5-b074-e2d33bd03d8b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5bca2e9a-056b-440f-828f-109e35ac9efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_368862c6-48d8-4529-a20a-5b5bc8c18de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_368862c6-48d8-4529-a20a-5b5bc8c18de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_f49571d3-1603-41e9-9e62-a453fa2e7efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4b23d21c-b239-4817-9941-736a526d0f94" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_f49571d3-1603-41e9-9e62-a453fa2e7efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIIISupplementaryInsuranceInformationDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIIISupplementaryInsuranceInformationDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIIISupplementaryInsuranceInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementaryInsuranceInformationAbstract_4c97ff19-baae-4946-8fc9-1e6d52cbda06" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementaryInsuranceInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bfa44b07-f24e-4bef-8b7c-2c6ef79ab2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementaryInsuranceInformationAbstract_4c97ff19-baae-4946-8fc9-1e6d52cbda06" xlink:to="loc_us-gaap_StatementTable_bfa44b07-f24e-4bef-8b7c-2c6ef79ab2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ed738e08-3aca-4eef-810e-685d937eb56a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bfa44b07-f24e-4bef-8b7c-2c6ef79ab2fa" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ed738e08-3aca-4eef-810e-685d937eb56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c4540cd4-8bee-4431-9cb8-7375ff1ea342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed738e08-3aca-4eef-810e-685d937eb56a" xlink:to="loc_us-gaap_SegmentDomain_c4540cd4-8bee-4431-9cb8-7375ff1ea342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_b9ebf64e-7afc-400c-9b9c-d80026098ce1" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c4540cd4-8bee-4431-9cb8-7375ff1ea342" xlink:to="loc_ahl_ReinsuranceMember_b9ebf64e-7afc-400c-9b9c-d80026098ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_6b82469e-36ba-4b40-b0e9-8ab83459e956" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c4540cd4-8bee-4431-9cb8-7375ff1ea342" xlink:to="loc_ahl_InsuranceMember_6b82469e-36ba-4b40-b0e9-8ab83459e956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bfa44b07-f24e-4bef-8b7c-2c6ef79ab2fa" xlink:to="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts_0d4b7670-8229-426d-9b9f-74b520b2c07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts_0d4b7670-8229-426d-9b9f-74b520b2c07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_7520a39c-36c2-4654-bf4f-24f0d534fedd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_7520a39c-36c2-4654-bf4f-24f0d534fedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums_6ad52d83-52f0-484c-a16e-68e0ea796669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationUnearnedPremiums"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationUnearnedPremiums_6ad52d83-52f0-484c-a16e-68e0ea796669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_486314f4-ea4a-4514-a7dc-c38d5b43f2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_PremiumsEarnedNet_486314f4-ea4a-4514-a7dc-c38d5b43f2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome_6e1cbf8f-6091-449e-97a4-6ac391d82186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome_6e1cbf8f-6091-449e-97a4-6ac391d82186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossesAndLossAdjustmentExpenses_91af0eca-ef43-4bd7-a648-dc708bcd31ed" xlink:href="ahl-20231220.xsd#ahl_LossesAndLossAdjustmentExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_ahl_LossesAndLossAdjustmentExpenses_91af0eca-ef43-4bd7-a648-dc708bcd31ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DeferredPolicyAcquisitionCostOtherExpenses_7f050063-e858-4c79-a737-38815b828643" xlink:href="ahl-20231220.xsd#ahl_DeferredPolicyAcquisitionCostOtherExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_ahl_DeferredPolicyAcquisitionCostOtherExpenses_7f050063-e858-4c79-a737-38815b828643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_0bdcae17-21a9-4ffa-a826-76544b633eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_PremiumsWrittenNet_0bdcae17-21a9-4ffa-a826-76544b633eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_c6aba619-303a-4bb3-98d3-fdb598851414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bfdc600-5b06-4f63-9329-543349e3625f" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_c6aba619-303a-4bb3-98d3-fdb598851414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleIVReinsurancePremiumsWrittenandPremiumsEarnedDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleIVReinsurancePremiumsWrittenandPremiumsEarnedDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleIVReinsurancePremiumsWrittenandPremiumsEarnedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsWritten_dce9d7e7-6982-4e1c-9ab7-879b0b767862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsWritten"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_DirectPremiumsWritten_dce9d7e7-6982-4e1c-9ab7-879b0b767862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsWritten_18b1fd39-3872-49d8-94dd-ba901c92899c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsWritten"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_AssumedPremiumsWritten_18b1fd39-3872-49d8-94dd-ba901c92899c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsWritten_c6dc8155-55b3-494b-827a-a726f3140658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsWritten"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_CededPremiumsWritten_c6dc8155-55b3-494b-827a-a726f3140658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_538dfdda-6969-47b7-8d46-a9dfd30f9f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_PremiumsWrittenNet_538dfdda-6969-47b7-8d46-a9dfd30f9f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_ca5fdd24-7321-48a5-aa27-d403de5bf97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_DirectPremiumsEarned_ca5fdd24-7321-48a5-aa27-d403de5bf97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_35773451-ddcb-4f65-9fc5-be081d8925d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_AssumedPremiumsEarned_35773451-ddcb-4f65-9fc5-be081d8925d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_a483c539-85ec-467a-8d6b-e5e317306f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsEarned"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_CededPremiumsEarned_a483c539-85ec-467a-8d6b-e5e317306f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_78ed54f1-be0f-49e3-9f52-b8908f2254bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_PremiumsEarnedNet_78ed54f1-be0f-49e3-9f52-b8908f2254bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsPercentageAssumedToNet_9a0399df-6814-4aaa-93bd-a7931b135bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsPercentageAssumedToNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_PremiumsPercentageAssumedToNet_9a0399df-6814-4aaa-93bd-a7931b135bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_b9440b16-facc-4d96-95ae-eafff2f88af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract_bc16bf6a-dba9-45a6-bfdd-f3cd47b6940d" xlink:to="loc_us-gaap_PremiumsWrittenGross_b9440b16-facc-4d96-95ae-eafff2f88af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ScheduleVValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="ahl-20231220.xsd#ScheduleVValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ScheduleVValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_7c980a29-c5cf-43ea-9dc0-0343bce65d82" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f42501d7-4274-4a15-9210-869150d3b78c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_7c980a29-c5cf-43ea-9dc0-0343bce65d82" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f42501d7-4274-4a15-9210-869150d3b78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4b255243-9d52-43fd-b4a6-2c9d6cbb7525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f42501d7-4274-4a15-9210-869150d3b78c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4b255243-9d52-43fd-b4a6-2c9d6cbb7525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b140cf57-a6d9-4aff-8385-36e0418e5ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4b255243-9d52-43fd-b4a6-2c9d6cbb7525" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b140cf57-a6d9-4aff-8385-36e0418e5ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableMember_52a5b80b-35f3-42db-bfca-7ba6d8fe8a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b140cf57-a6d9-4aff-8385-36e0418e5ec9" xlink:to="loc_us-gaap_PremiumsReceivableMember_52a5b80b-35f3-42db-bfca-7ba6d8fe8a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_77c5b301-fae6-44f9-99ce-b0f45be68d68" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b140cf57-a6d9-4aff-8385-36e0418e5ec9" xlink:to="loc_ahl_ReinsuranceMember_77c5b301-fae6-44f9-99ce-b0f45be68d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ed45b921-0c5a-4dc5-8abd-05b71636a2d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f42501d7-4274-4a15-9210-869150d3b78c" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ed45b921-0c5a-4dc5-8abd-05b71636a2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ed45b921-0c5a-4dc5-8abd-05b71636a2d3" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_e0b0a28c-cb9c-4cc3-9ddf-96266817dc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_e0b0a28c-cb9c-4cc3-9ddf-96266817dc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_22365d78-15d2-46a6-b54a-21fb8536148a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_22365d78-15d2-46a6-b54a-21fb8536148a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_97cdcc5b-3db6-4517-946b-11825ec1d1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_97cdcc5b-3db6-4517-946b-11825ec1d1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_30675cd3-43d6-4bff-a5de-02c6a0a2d087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_30675cd3-43d6-4bff-a5de-02c6a0a2d087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_9e29d952-403d-4e8d-89c4-e33459d11269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2b7aa437-1d34-4d51-a50c-437c1ad07e9d" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_9e29d952-403d-4e8d-89c4-e33459d11269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingAdditionalInformationNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingAdditionalInformationNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReportingAdditionalInformationNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_02436f57-e0e9-4307-a71a-3355a14ec491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_fb078e50-a689-45aa-9fda-7b451a4794a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_02436f57-e0e9-4307-a71a-3355a14ec491" xlink:to="loc_us-gaap_NumberOfReportableSegments_fb078e50-a689-45aa-9fda-7b451a4794a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SegmentReportingSummaryofGrossandNetWrittenandEarnedPremiumsUnderwritingResultsRatiosandReservesforEachofCompanysBusinessSegmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7d62d914-163d-4ba2-83e7-7f67ae710b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7d62d914-163d-4ba2-83e7-7f67ae710b6c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c67c2159-e4f7-43dc-b433-2c1b08d1304d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:to="loc_srt_ConsolidationItemsAxis_c67c2159-e4f7-43dc-b433-2c1b08d1304d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4c392330-3196-4bae-b051-f1a2bd2859f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c67c2159-e4f7-43dc-b433-2c1b08d1304d" xlink:to="loc_srt_ConsolidationItemsDomain_4c392330-3196-4bae-b051-f1a2bd2859f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fbfb35a6-680d-4b2f-b3a0-458025fa1c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4c392330-3196-4bae-b051-f1a2bd2859f0" xlink:to="loc_us-gaap_OperatingSegmentsMember_fbfb35a6-680d-4b2f-b3a0-458025fa1c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_26d04f20-c394-43da-8b89-de622093b757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_26d04f20-c394-43da-8b89-de622093b757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_90c86530-355f-46a3-a34d-55f4b1811969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26d04f20-c394-43da-8b89-de622093b757" xlink:to="loc_us-gaap_SegmentDomain_90c86530-355f-46a3-a34d-55f4b1811969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_3f93244a-48c5-4364-8ca1-b8d3e1cc0540" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_90c86530-355f-46a3-a34d-55f4b1811969" xlink:to="loc_ahl_ReinsuranceMember_3f93244a-48c5-4364-8ca1-b8d3e1cc0540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_2a34c90f-cfa0-47c2-b29f-756169b74034" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_90c86530-355f-46a3-a34d-55f4b1811969" xlink:to="loc_ahl_InsuranceMember_2a34c90f-cfa0-47c2-b29f-756169b74034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9a1734a-2e45-40de-a4e5-f3ef005a7fdc" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_fbf92ae7-af90-4b44-82da-926c93007135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_PremiumsWrittenGross_fbf92ae7-af90-4b44-82da-926c93007135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_ec98e9d4-b603-46ed-8d66-99e24622dd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_PremiumsWrittenNet_ec98e9d4-b603-46ed-8d66-99e24622dd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsEarnedGross_d0abac97-1b04-4346-8463-9f506983111d" xlink:href="ahl-20231220.xsd#ahl_PremiumsEarnedGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_ahl_PremiumsEarnedGross_d0abac97-1b04-4346-8463-9f506983111d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_4d26dc5b-6132-4938-9b33-e323350c349e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_PremiumsEarnedNet_4d26dc5b-6132-4938-9b33-e323350c349e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_f294f318-c03d-411f-8382-d90f384e410b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_f294f318-c03d-411f-8382-d90f384e410b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_a4c7911e-d235-40c3-a0a8-badcee55abff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_a4c7911e-d235-40c3-a0a8-badcee55abff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5afef925-e5c6-4826-a044-943356cfee46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5afef925-e5c6-4826-a044-943356cfee46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingIncomeLoss_7b2a25d3-5b64-4020-ac6b-655fd8abc769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_UnderwritingIncomeLoss_7b2a25d3-5b64-4020-ac6b-655fd8abc769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CorporateExpenses_50d18e61-e733-4703-8f9a-439858a5266b" xlink:href="ahl-20231220.xsd#ahl_CorporateExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_ahl_CorporateExpenses_50d18e61-e733-4703-8f9a-439858a5266b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4b129a6d-130b-4ace-80ec-256c4351e05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4b129a6d-130b-4ace-80ec-256c4351e05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_3bf1c3b8-9244-49e4-8d54-2037f540f588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_NetInvestmentIncome_3bf1c3b8-9244-49e4-8d54-2037f540f588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_7eb834a1-5eb7-4cda-b9db-3ed2114b78ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_GainLossOnInvestments_7eb834a1-5eb7-4cda-b9db-3ed2114b78ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesGainLoss_250f04ad-495b-4053-bfcf-1d5ad7e35e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesGainLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_DebtSecuritiesGainLoss_250f04ad-495b-4053-bfcf-1d5ad7e35e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_50b32056-49d6-4dfb-a82f-3160fe98578a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_50b32056-49d6-4dfb-a82f-3160fe98578a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_e892607a-4c24-4ea3-abd2-3c803621b336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_e892607a-4c24-4ea3-abd2-3c803621b336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_7dc4afb2-f191-47cb-99e6-5d0047c314ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_InterestExpenseDebt_7dc4afb2-f191-47cb-99e6-5d0047c314ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e61d80e4-c531-4da8-97fb-bbe8b6ec6efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e61d80e4-c531-4da8-97fb-bbe8b6ec6efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_bf8d5f48-ea8f-45a0-9da0-bec7dbd59f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_OtherNonoperatingIncome_bf8d5f48-ea8f-45a0-9da0-bec7dbd59f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_21be3089-586d-4556-a6bb-1a0238fbcb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_OtherNonoperatingExpense_21be3089-586d-4556-a6bb-1a0238fbcb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5918740f-350b-47f2-9592-44c335454041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5918740f-350b-47f2-9592-44c335454041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c359338c-cf8d-4eb8-a196-2d3a68b46bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c359338c-cf8d-4eb8-a196-2d3a68b46bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_579010ab-9c84-47f9-a558-5c2929ad85bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_ProfitLoss_579010ab-9c84-47f9-a558-5c2929ad85bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9d2d7fd9-0eed-4637-a4e7-8307fab17e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9d2d7fd9-0eed-4637-a4e7-8307fab17e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_702baaea-71f1-4331-8071-7c65ac4e5304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_702baaea-71f1-4331-8071-7c65ac4e5304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceRatiosAbstract"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossRatio_10116974-7525-4b39-aa4f-4a3c84aac266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_LossRatio_10116974-7525-4b39-aa4f-4a3c84aac266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCostRatio_8606d6f2-b3ba-4406-b91c-0d73e6b7a5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCostRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_AcquisitionCostRatio_8606d6f2-b3ba-4406-b91c-0d73e6b7a5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_ffb53ce4-6400-42fb-9977-810da4062c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseRatio_ffb53ce4-6400-42fb-9977-810da4062c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderwritingExpenseRatio_eee6bcf8-1e30-4e6c-a172-679ce5d5c692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderwritingExpenseRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_UnderwritingExpenseRatio_eee6bcf8-1e30-4e6c-a172-679ce5d5c692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CombinedRatio_d2bf7f47-71bc-410a-9c49-c377701181d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CombinedRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceRatiosAbstract_6ac8acc1-5463-4b2f-8032-367af30c9b3a" xlink:to="loc_us-gaap_CombinedRatio_d2bf7f47-71bc-410a-9c49-c377701181d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity_c9431ab1-c3fb-425f-9a59-0ee63edc30c4" xlink:href="ahl-20231220.xsd#ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a53c7305-edcc-40ee-b717-e4770d2dbc82" xlink:to="loc_ahl_GainLossonFairValueofLoanNotesIssuedbyVariableInterestEntity_c9431ab1-c3fb-425f-9a59-0ee63edc30c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofInvestmentIncomeDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofInvestmentIncomeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_981645ac-2a86-4f99-ba36-661a602e12c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_981645ac-2a86-4f99-ba36-661a602e12c7" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b550a9df-10c1-4e66-8e40-46096055e5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca1c6db4-32d3-4f3f-b347-3c1c3b072cb2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b550a9df-10c1-4e66-8e40-46096055e5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_6d65ad5f-48ae-4040-af4c-094b75bd1d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b550a9df-10c1-4e66-8e40-46096055e5cf" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_6d65ad5f-48ae-4040-af4c-094b75bd1d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_41acb646-0b6e-418d-b4d3-7cf93758e18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:to="loc_us-gaap_InvestmentTypeAxis_41acb646-0b6e-418d-b4d3-7cf93758e18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_41acb646-0b6e-418d-b4d3-7cf93758e18f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_6ecb8b8e-798d-4b23-8222-4e15654f5082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_DebtSecuritiesMember_6ecb8b8e-798d-4b23-8222-4e15654f5082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_c592e580-7fbc-447d-a4d3-dee315c0e783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_c592e580-7fbc-447d-a4d3-dee315c0e783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShorttermInvestmentTradingMember_a97dad1c-fb5b-4021-b51c-7fec2806dbc6" xlink:href="ahl-20231220.xsd#ahl_ShorttermInvestmentTradingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_ahl_ShorttermInvestmentTradingMember_a97dad1c-fb5b-4021-b51c-7fec2806dbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_9a119d96-0cef-4d41-84db-5c3cfb1e09c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_9a119d96-0cef-4d41-84db-5c3cfb1e09c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_e49a6bbf-9cc1-4377-95d2-803f3b256eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_EquitySecuritiesMember_e49a6bbf-9cc1-4377-95d2-803f3b256eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember_acf74f32-b42c-4848-9780-66476d4a866a" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_ahl_CatastropheBondsMember_acf74f32-b42c-4848-9780-66476d4a866a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_2fca9db2-b726-4662-ba58-759a1858d3f4" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_2fca9db2-b726-4662-ba58-759a1858d3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_70906a86-12f0-4c91-8ce6-9d924f924fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72e36355-cf8b-42e7-b534-5bdc1c328064" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_70906a86-12f0-4c91-8ce6-9d924f924fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_18c589d1-8834-4c9a-b17a-47dd4c7a9520" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_87ce18d4-d8c7-49bb-9d39-cb40f3cc99dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_87ce18d4-d8c7-49bb-9d39-cb40f3cc99dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_cf4bf30d-719c-45e4-8711-6e4a53982d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_cf4bf30d-719c-45e4-8711-6e4a53982d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_22502f0d-426f-40a4-b729-162f8b8675b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e41bc606-4fe1-422b-8713-ab067bf836e7" xlink:to="loc_us-gaap_NetInvestmentIncome_22502f0d-426f-40a4-b729-162f8b8675b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsNetRealizedandUnrealizedInvestmentGainsandLossesandChangeinUnrealizedGainsandLossesonInvestmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_765435b8-4ecf-4105-8d4f-c7cea90fab49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_765435b8-4ecf-4105-8d4f-c7cea90fab49" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d8b9b5be-118d-46fa-a311-20ff8b3fcfff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d8b9b5be-118d-46fa-a311-20ff8b3fcfff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fb17828b-c773-4580-b68a-30cfb3a628aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d8b9b5be-118d-46fa-a311-20ff8b3fcfff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fb17828b-c773-4580-b68a-30cfb3a628aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_66b702bc-a57d-4479-aef3-a491d4c1ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fb17828b-c773-4580-b68a-30cfb3a628aa" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_66b702bc-a57d-4479-aef3-a491d4c1ee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a987022-b15b-4920-9691-ce3255ae6fbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a987022-b15b-4920-9691-ce3255ae6fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a987022-b15b-4920-9691-ce3255ae6fbf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_0c80a025-c3c2-4478-924c-2f3108ba2fff" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:to="loc_ahl_MVIMember_0c80a025-c3c2-4478-924c-2f3108ba2fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_0886e624-bf77-4fcd-8f67-236f14afa38d" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:to="loc_ahl_MultiLineReinsurerMember_0886e624-bf77-4fcd-8f67-236f14afa38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_97cd4760-7025-47c0-b98a-fc5de347980b" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:to="loc_ahl_DigitalRiskMember_97cd4760-7025-47c0-b98a-fc5de347980b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_cc0c47b2-82c8-4200-a71d-8cdc7fcc06b1" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b7d07be3-9ab7-4220-b89e-16e12daf4f72" xlink:to="loc_ahl_BeneAssicurazioniMember_cc0c47b2-82c8-4200-a71d-8cdc7fcc06b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_642391bd-7d67-4ef3-b9e6-417bfc240105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_us-gaap_InvestmentTypeAxis_642391bd-7d67-4ef3-b9e6-417bfc240105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_642391bd-7d67-4ef3-b9e6-417bfc240105" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_4bbc635a-7d9a-4439-ac23-a1b2586650a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_4bbc635a-7d9a-4439-ac23-a1b2586650a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_ee08d993-fab6-41ee-a2d4-4ffbd51453a5" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_ee08d993-fab6-41ee-a2d4-4ffbd51453a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e5e41fc8-45c0-47b6-a227-f76059d06a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5dee3189-1ff0-417b-bd44-058add20e678" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e5e41fc8-45c0-47b6-a227-f76059d06a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f76d07b7-ea44-48fd-9113-c3738b1a04f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f76d07b7-ea44-48fd-9113-c3738b1a04f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2f8e3d80-f5ed-4af6-9bd8-a62d37791022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f76d07b7-ea44-48fd-9113-c3738b1a04f3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2f8e3d80-f5ed-4af6-9bd8-a62d37791022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_0b63a6f7-87d6-4348-94bf-d4e860b81dfe" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2f8e3d80-f5ed-4af6-9bd8-a62d37791022" xlink:to="loc_ahl_BeneAssicurazioniMember_0b63a6f7-87d6-4348-94bf-d4e860b81dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_033d1ecf-79d9-4550-9e26-23753ed87e32" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_9860c376-e171-4f78-9c56-7215b61368c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_9860c376-e171-4f78-9c56-7215b61368c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_f6e8529d-b7ac-4dbf-ab35-bc7ca2887b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLossExcludingOtherThanTemporaryImpairment_f6e8529d-b7ac-4dbf-ab35-bc7ca2887b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_9b8fb839-2b74-4446-8250-f5f0aad15cbe" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleGainLossNetChangeExpectedCreditGainsLosses_9b8fb839-2b74-4446-8250-f5f0aad15cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGain_cdb60d3f-c0a0-4dce-a6ab-010f1c1fbfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedGain_cdb60d3f-c0a0-4dce-a6ab-010f1c1fbfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_b8f568f2-8e18-48f9-b4c3-471005d96870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedLoss_b8f568f2-8e18-48f9-b4c3-471005d96870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_c5ba18c4-467c-4532-b36e-0d7a03a50c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_c5ba18c4-467c-4532-b36e-0d7a03a50c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_7f4d3358-7690-4331-b750-81c9eba55290" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesCatastropheBondsGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_ahl_TradingSecuritiesCatastropheBondsGainLoss_7f4d3358-7690-4331-b750-81c9eba55290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c683ff8c-4beb-48c5-85c6-97f9fd1c7f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c683ff8c-4beb-48c5-85c6-97f9fd1c7f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_ebfba64c-7d70-4d98-a404-30d2dad5384a" xlink:href="ahl-20231220.xsd#ahl_NetRealizedAndUnrealizedInvestmentGainsLosses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_ahl_NetRealizedAndUnrealizedInvestmentGainsLosses_ebfba64c-7d70-4d98-a404-30d2dad5384a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_489a2909-d4f8-4095-971b-e58a5b16f0ec" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_e3f79460-0b5b-4dd5-bc6f-ecf52412736e" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtSecuritiesChangeInUnrealizedGains_e3f79460-0b5b-4dd5-bc6f-ecf52412736e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_9d4d032d-01ba-4aba-9bf4-b9fff06df2b8" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:to="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsTax_9d4d032d-01ba-4aba-9bf4-b9fff06df2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9131b7ad-d54b-486f-a73e-c2664269ab5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AvailableForSaleSecuritiesChangeInUnrealizedGainsAbstract_02433fd4-20aa-410e-9816-8d4cdeffce66" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9131b7ad-d54b-486f-a73e-c2664269ab5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofAvailableforSaleInvestmentsinFixedIncomeMaturitiesandShortTermInvestmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57229688-686c-4a34-8674-00ef261eb8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57229688-686c-4a34-8674-00ef261eb8af" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c214c997-efbf-4a55-8290-d83daad2969d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c214c997-efbf-4a55-8290-d83daad2969d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c214c997-efbf-4a55-8290-d83daad2969d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_bb4f8ea7-64d8-4a44-bdfb-04b33edaf33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_bb4f8ea7-64d8-4a44-bdfb-04b33edaf33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f4732536-417d-4c4a-8823-99c5cf827319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f4732536-417d-4c4a-8823-99c5cf827319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_5d30a9af-ab80-41b6-9677-e9db5387d853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_MunicipalBondsMember_5d30a9af-ab80-41b6-9677-e9db5387d853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_16088061-3145-466a-b313-78bbb826a9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_16088061-3145-466a-b313-78bbb826a9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_6c1f62f5-ff0f-42c2-967c-b6bc81a59111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_6c1f62f5-ff0f-42c2-967c-b6bc81a59111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b7d250a9-c4e8-417d-a3af-3621954b0448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b7d250a9-c4e8-417d-a3af-3621954b0448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_ad6e8e51-afad-4d75-98e6-24c8f27f158f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_ad6e8e51-afad-4d75-98e6-24c8f27f158f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_a27d0dcd-0a97-4b60-8fd5-222db0fc1acf" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_a27d0dcd-0a97-4b60-8fd5-222db0fc1acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_17a6b0b3-f0a5-471c-b36f-feeae01f5831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_17a6b0b3-f0a5-471c-b36f-feeae01f5831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_654fb8f7-f1ca-4b34-9d24-d9e447d73168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a84fd40-2e51-4a96-9239-17125ca18d62" xlink:to="loc_us-gaap_DebtSecuritiesMember_654fb8f7-f1ca-4b34-9d24-d9e447d73168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_357af6d7-f9ec-4b84-87a5-778e4a3b913f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:to="loc_us-gaap_InvestmentTypeAxis_357af6d7-f9ec-4b84-87a5-778e4a3b913f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_357af6d7-f9ec-4b84-87a5-778e4a3b913f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_bae7e81b-0931-416d-9571-6b4ed9e79a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_DebtSecuritiesMember_bae7e81b-0931-416d-9571-6b4ed9e79a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_f648eeff-98f3-4229-b973-434fc8226907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_FixedMaturitiesMember_f648eeff-98f3-4229-b973-434fc8226907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_94871160-cc2d-4972-ba03-afd7f70cde60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_EquitySecuritiesMember_94871160-cc2d-4972-ba03-afd7f70cde60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_4752badf-2df3-4008-b19d-b9c8cc972465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_4752badf-2df3-4008-b19d-b9c8cc972465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_8c70b5df-4a8d-4c47-8ced-e78d559b8baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6f6279e-a81a-4449-a626-0d88b14beea2" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_8c70b5df-4a8d-4c47-8ced-e78d559b8baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_166ce5d8-dd92-4d1a-a78c-8c93a24ddcae" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1ffa98c7-bbf4-4e6d-bd2d-9d5d47b96b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1ffa98c7-bbf4-4e6d-bd2d-9d5d47b96b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00568082-d97f-4808-9aa4-4e00522ebb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00568082-d97f-4808-9aa4-4e00522ebb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fa10237d-ae59-4152-b0a8-8ff216dc21f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fa10237d-ae59-4152-b0a8-8ff216dc21f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_43568901-1da2-4868-a222-79f8adbb3713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_43568901-1da2-4868-a222-79f8adbb3713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ce1ac608-3204-4dea-b587-f5a99d8d9b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ce1ac608-3204-4dea-b587-f5a99d8d9b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_b013e28d-ce82-40fc-8e0e-4636fc2306b3" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_b013e28d-ce82-40fc-8e0e-4636fc2306b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_fcff597d-7427-41c3-81f7-47c32fd43b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_fcff597d-7427-41c3-81f7-47c32fd43b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_511c2a90-d01e-419a-9991-bd8e82590a57" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_511c2a90-d01e-419a-9991-bd8e82590a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_d1a10a28-26eb-41fe-8c32-ec40b9294fdc" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_d1a10a28-26eb-41fe-8c32-ec40b9294fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4f90f5db-0502-4b24-bf61-6f48030d3890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4f90f5db-0502-4b24-bf61-6f48030d3890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_3a8e1a2b-4ce2-4b93-bf1c-851e13d7e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_3a8e1a2b-4ce2-4b93-bf1c-851e13d7e70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a1ab8770-fe05-4fe6-b82d-95bd82889d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_7e920055-943a-468e-afed-dfac3086324f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a1ab8770-fe05-4fe6-b82d-95bd82889d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsCostGrossUnrealizedGainsandLossesandEstimatedFairValueofTradingInvestmentsinFixedIncomeMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8de05420-7918-4564-b2c5-6e36f839da82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8de05420-7918-4564-b2c5-6e36f839da82" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f567c1ae-8d81-4559-9978-e521f15d8024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f567c1ae-8d81-4559-9978-e521f15d8024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f567c1ae-8d81-4559-9978-e521f15d8024" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_24cf4657-3cc5-4d50-a31d-1ad8a19db799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_24cf4657-3cc5-4d50-a31d-1ad8a19db799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_79e16fc4-e2cd-4a9d-ae1e-4c61c7bf606f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_MunicipalBondsMember_79e16fc4-e2cd-4a9d-ae1e-4c61c7bf606f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3dcccf74-eb27-4707-971d-123dc0307615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3dcccf74-eb27-4707-971d-123dc0307615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_6bad651d-f490-411a-93bb-1e989afa81d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_6bad651d-f490-411a-93bb-1e989afa81d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_87c84359-d75d-4e14-851a-f97cf0a07750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_87c84359-d75d-4e14-851a-f97cf0a07750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_0d0a6c75-b0c6-4599-b99d-e87c54c58733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_0d0a6c75-b0c6-4599-b99d-e87c54c58733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_474a1a03-c653-4cfd-a55a-a01ab6f306c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_117a2779-fcd7-45a2-8112-5e3a48de958a" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_474a1a03-c653-4cfd-a55a-a01ab6f306c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d2e23c8a-cd02-4391-8d8e-86d02aa5006f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:to="loc_us-gaap_InvestmentTypeAxis_d2e23c8a-cd02-4391-8d8e-86d02aa5006f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_d2e23c8a-cd02-4391-8d8e-86d02aa5006f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember_8769be48-2811-4ba6-9f23-0e0c6ff37095" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_HighYieldLoansMember_8769be48-2811-4ba6-9f23-0e0c6ff37095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingFixedMaturityInvestmentsMember_4c2791b8-40f3-471f-b7d2-88c96fc6e562" xlink:href="ahl-20231220.xsd#ahl_TradingFixedMaturityInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_TradingFixedMaturityInvestmentsMember_4c2791b8-40f3-471f-b7d2-88c96fc6e562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_8bb18cf7-aa85-4144-80ce-14abbaa6e8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_8bb18cf7-aa85-4144-80ce-14abbaa6e8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsMember_4ece086a-6a43-448c-ad13-408afb066a50" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_CatastropheBondsMember_4ece086a-6a43-448c-ad13-408afb066a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_cd91f670-b660-4036-8c8a-3f289d2dfe22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_cd91f670-b660-4036-8c8a-3f289d2dfe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_afafcefd-14e5-4a45-b147-79515f9ad890" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_MiddlemarketloansMember_afafcefd-14e5-4a45-b147-79515f9ad890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SecuritiesassetbackedMember_9c889a65-9d4a-42b3-97ef-b54ae46654f6" xlink:href="ahl-20231220.xsd#ahl_SecuritiesassetbackedMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_SecuritiesassetbackedMember_9c889a65-9d4a-42b3-97ef-b54ae46654f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalSecuritiesCorporateMember_460398c1-a547-4c16-9bb8-f3fcb8d06072" xlink:href="ahl-20231220.xsd#ahl_GlobalSecuritiesCorporateMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_GlobalSecuritiesCorporateMember_460398c1-a547-4c16-9bb8-f3fcb8d06072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_34152bd1-f4c8-464f-ab60-599813744af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_us-gaap_EquitySecuritiesMember_34152bd1-f4c8-464f-ab60-599813744af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_af3ff28f-bede-4bf2-915a-3db267e4de66" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_af3ff28f-bede-4bf2-915a-3db267e4de66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_97c9d5e2-c583-4590-a6ae-2cb31ae12419" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_97c9d5e2-c583-4590-a6ae-2cb31ae12419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalTradingMember_7312927a-16b8-4cd7-8f0f-291102579c38" xlink:href="ahl-20231220.xsd#ahl_TotalTradingMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0a23b10b-5661-4924-bb02-1a9c784d39a4" xlink:to="loc_ahl_TotalTradingMember_7312927a-16b8-4cd7-8f0f-291102579c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_9ac6c145-6c0d-49d8-b58e-71348da601d8" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_b2ba3868-01c2-4a7b-b1b1-ded4468007ea" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedGainbeforeTax_b2ba3868-01c2-4a7b-b1b1-ded4468007ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_298219c6-6350-4dd5-a83a-942e6e725a6b" xlink:href="ahl-20231220.xsd#ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_ahl_TradingSecuritiesAccumulatedGrossUnrealizedLossbeforeTax_298219c6-6350-4dd5-a83a-942e6e725a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_8d69b75f-d990-42be-a4a4-d9ea40a1113c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_us-gaap_TradingSecurities_8d69b75f-d990-42be-a4a4-d9ea40a1113c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_1971073c-c218-4ee9-b639-d011ba4ebfce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebtAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c5ea6670-9cd5-4d46-9d82-cd4463d14e7e" xlink:to="loc_us-gaap_TradingSecuritiesDebtAmortizedCost_1971073c-c218-4ee9-b639-d011ba4ebfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsDistributionofCommercialMortgageandMiddleMarketLoansDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_720b7976-ed8d-4e1a-8aa8-2a9a852e79d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationByPropertyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_720b7976-ed8d-4e1a-8aa8-2a9a852e79d8" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_42ef6ed6-5256-4ea8-b658-16a28c473fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_us-gaap_GeographicDistributionAxis_42ef6ed6-5256-4ea8-b658-16a28c473fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_d759d0b1-d09e-4338-9bac-76055ed8f3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_42ef6ed6-5256-4ea8-b658-16a28c473fed" xlink:to="loc_us-gaap_GeographicDistributionDomain_d759d0b1-d09e-4338-9bac-76055ed8f3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_3dd478af-94b3-47e3-9d9e-f3e32a6a7664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_d759d0b1-d09e-4338-9bac-76055ed8f3d3" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_3dd478af-94b3-47e3-9d9e-f3e32a6a7664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_094c780d-6b04-44ab-8650-61b2fced125a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_d759d0b1-d09e-4338-9bac-76055ed8f3d3" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_094c780d-6b04-44ab-8650-61b2fced125a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_dde03cb7-2f67-4354-8100-254902d60981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_dde03cb7-2f67-4354-8100-254902d60981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_21c82132-be74-4abc-ac5f-6ba771c0407f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_dde03cb7-2f67-4354-8100-254902d60981" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_21c82132-be74-4abc-ac5f-6ba771c0407f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentNetCarryingValueMember_839c030d-ff97-440a-86cc-2a534f9e0486" xlink:href="ahl-20231220.xsd#ahl_InvestmentNetCarryingValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_21c82132-be74-4abc-ac5f-6ba771c0407f" xlink:to="loc_ahl_InvestmentNetCarryingValueMember_839c030d-ff97-440a-86cc-2a534f9e0486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_us-gaap_InvestmentTypeAxis_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_17229f4b-9fff-4399-b4aa-993e9b0ce407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_7e9f2f7e-711c-4b3d-8981-6b08b1b386cb" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_17229f4b-9fff-4399-b4aa-993e9b0ce407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b78b9d02-f29f-4858-a12f-542676fec179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_17229f4b-9fff-4399-b4aa-993e9b0ce407" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b78b9d02-f29f-4858-a12f-542676fec179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_18026fa6-a15f-4c26-bb87-e7f5b3744cd1" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_17229f4b-9fff-4399-b4aa-993e9b0ce407" xlink:to="loc_ahl_MiddlemarketloansMember_18026fa6-a15f-4c26-bb87-e7f5b3744cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c2e42908-3404-4a23-8a2b-97f4dc514aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c2e42908-3404-4a23-8a2b-97f4dc514aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8e748157-34f1-4005-a411-893d919674b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c2e42908-3404-4a23-8a2b-97f4dc514aad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8e748157-34f1-4005-a411-893d919674b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_1aeb7fd0-e7cc-4ecc-b589-c20dae5b6d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8e748157-34f1-4005-a411-893d919674b1" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_1aeb7fd0-e7cc-4ecc-b589-c20dae5b6d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_498457c4-5ea9-4983-b89c-453b95d1427d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8e748157-34f1-4005-a411-893d919674b1" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_498457c4-5ea9-4983-b89c-453b95d1427d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4bb0c45e-7e70-467c-afb9-2ac5850ea988" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_srt_ProductOrServiceAxis_4bb0c45e-7e70-467c-afb9-2ac5850ea988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4bb0c45e-7e70-467c-afb9-2ac5850ea988" xlink:to="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_ac7e062d-6d9f-4df1-a7c9-7ad2a03c79b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_us-gaap_ProductMember_ac7e062d-6d9f-4df1-a7c9-7ad2a03c79b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServiceMember_919640b0-81ec-418c-921f-90052d255f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_us-gaap_FinancialServiceMember_919640b0-81ec-418c-921f-90052d255f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IndustrialServiceMember_37be4ff3-e594-4fd0-bda1-4fa51f5d6b57" xlink:href="ahl-20231220.xsd#ahl_IndustrialServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_ahl_IndustrialServiceMember_37be4ff3-e594-4fd0-bda1-4fa51f5d6b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConsumerDiscretionaryServiceMember_c36873f8-8d9d-4ff1-991d-760639796c80" xlink:href="ahl-20231220.xsd#ahl_ConsumerDiscretionaryServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_ahl_ConsumerDiscretionaryServiceMember_c36873f8-8d9d-4ff1-991d-760639796c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnergyCommoditiesAndServiceMember_0e4e95df-8910-457c-b7de-a94f25a3fabb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnergyCommoditiesAndServiceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_us-gaap_EnergyCommoditiesAndServiceMember_0e4e95df-8910-457c-b7de-a94f25a3fabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember_449a07f5-5987-47e9-83a5-aef6bf679e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3a4742ba-e599-4f22-96af-4c2193206aab" xlink:to="loc_us-gaap_TechnologyServiceMember_449a07f5-5987-47e9-83a5-aef6bf679e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b1439420-94e9-4a9e-a4b4-0eeb237263d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b1439420-94e9-4a9e-a4b4-0eeb237263d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b1439420-94e9-4a9e-a4b4-0eeb237263d4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ApartmentBuildingMember_052828f3-8f9b-403a-8fd5-623a97915f71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ApartmentBuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_ApartmentBuildingMember_052828f3-8f9b-403a-8fd5-623a97915f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_HotelMember_2050d81e-57f9-48a1-9052-cd31d8ce0781" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_HotelMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_HotelMember_2050d81e-57f9-48a1-9052-cd31d8ce0781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_2d0e6399-58e6-4a86-b9fc-887d87ce8186" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OfficeBuildingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_OfficeBuildingMember_2d0e6399-58e6-4a86-b9fc-887d87ce8186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_e9ba89c8-5a58-49e4-b95b-38a122defbdf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_OtherPropertyMember_e9ba89c8-5a58-49e4-b95b-38a122defbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailMember_dc4105f4-4abe-4169-897a-230fe483fc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetailMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_us-gaap_RetailMember_dc4105f4-4abe-4169-897a-230fe483fc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_IndustrialPropertyMember_7ee1b8b1-7174-49bd-a667-f78670858d32" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_IndustrialPropertyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d976ea1d-f288-47b3-af61-92ef8e8aca16" xlink:to="loc_srt_IndustrialPropertyMember_7ee1b8b1-7174-49bd-a667-f78670858d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_94ef9b1a-1135-4c28-875b-d190e1d8c65d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationByPropertyTable_39b6833f-a663-43e0-b932-9a91252ba539" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_94ef9b1a-1135-4c28-875b-d190e1d8c65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_2d3a396b-66aa-4cd7-af16-90b02971135b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_94ef9b1a-1135-4c28-875b-d190e1d8c65d" xlink:to="loc_us-gaap_TradingSecurities_2d3a396b-66aa-4cd7-af16-90b02971135b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f7caf14a-9282-4d44-b022-4ceacbef22e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationLineItems_94ef9b1a-1135-4c28-875b-d190e1d8c65d" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f7caf14a-9282-4d44-b022-4ceacbef22e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsLoantoValueRatiosDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsLoantoValueRatiosDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_99b0b66e-543d-44a6-ad1d-f062e5cd6547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_99b0b66e-543d-44a6-ad1d-f062e5cd6547" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_3c284c7f-0f23-4500-b245-5c13b7c4d887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:to="loc_us-gaap_InvestmentTypeAxis_3c284c7f-0f23-4500-b245-5c13b7c4d887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0d92666c-3637-4155-932b-1d9c80ec336e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_3c284c7f-0f23-4500-b245-5c13b7c4d887" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0d92666c-3637-4155-932b-1d9c80ec336e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d2a1545b-6047-4cbd-b82b-01829cc99793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0d92666c-3637-4155-932b-1d9c80ec336e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d2a1545b-6047-4cbd-b82b-01829cc99793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_1f3af596-8f57-409a-a84f-b7148e90dac1" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0d92666c-3637-4155-932b-1d9c80ec336e" xlink:to="loc_ahl_MiddlemarketloansMember_1f3af596-8f57-409a-a84f-b7148e90dac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:to="loc_us-gaap_LoanToValueAxis_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueAxis_1c5970f0-5d30-4aa4-81e1-6b37d41ecc98" xlink:to="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember_5cd5de47-6a79-4f87-b1e5-a851a9755c15" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:to="loc_ahl_DebttoValueRatioLessthan50PercentMember_5cd5de47-6a79-4f87-b1e5-a851a9755c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember_d2db72d1-9714-4e70-b3bb-249079e6d1f3" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:to="loc_ahl_DebttoValueRatio50to60PercentMember_d2db72d1-9714-4e70-b3bb-249079e6d1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember_1b9de4be-ccc2-4fef-abb7-c17ab0ba4ecc" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_51a5e1c2-ba51-4ad7-8c7b-1b6d026dc817" xlink:to="loc_ahl_DebttoValueRatio61to70PercentMember_1b9de4be-ccc2-4fef-abb7-c17ab0ba4ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_6ae57723-9072-4cce-ab31-5df99ec8dd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_dd759b68-cd5f-4513-87f5-25f1cbd86ccb" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_6ae57723-9072-4cce-ab31-5df99ec8dd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_c390f71f-d56d-49ea-9bbf-2826a4b04165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_6ae57723-9072-4cce-ab31-5df99ec8dd8c" xlink:to="loc_us-gaap_TradingSecurities_c390f71f-d56d-49ea-9bbf-2826a4b04165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsInvestmentsDebtServiceandFixedChargeCoverageRatiosDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_94d9707e-6b72-4d6a-bed4-913da3e562e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_94d9707e-6b72-4d6a-bed4-913da3e562e4" xlink:to="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioAxis_9dabbd3d-077a-476a-b5d9-53b1b942a73d" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_ahl_DebtServiceCoverageRatioAxis_9dabbd3d-077a-476a-b5d9-53b1b942a73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DebtServiceCoverageRatioAxis_9dabbd3d-077a-476a-b5d9-53b1b942a73d" xlink:to="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_c092fc71-fae0-4492-a040-3d1adbe5c24d" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioGreaterThan1.2xMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:to="loc_ahl_DebtServiceCoverageRatioGreaterThan1.2xMember_c092fc71-fae0-4492-a040-3d1adbe5c24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember_92660fee-aa7b-41bf-9b63-48798895afef" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatio1.00to1.20xMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:to="loc_ahl_DebtServiceCoverageRatio1.00to1.20xMember_92660fee-aa7b-41bf-9b63-48798895afef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember_83107bfa-a74c-41fa-a141-a2470fcd0434" xlink:href="ahl-20231220.xsd#ahl_DebtServiceCoverageRatioLessThan1.00xMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_DebtServiceCoverageRatioDomain_7da68258-ea1b-430c-9dfc-0db5de8a557f" xlink:to="loc_ahl_DebtServiceCoverageRatioLessThan1.00xMember_83107bfa-a74c-41fa-a141-a2470fcd0434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7cd2dd2a-ca32-48ea-841b-5ec544164327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_us-gaap_InvestmentTypeAxis_7cd2dd2a-ca32-48ea-841b-5ec544164327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0b60044b-769a-4a8a-96d4-7cfecfa8ecab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_7cd2dd2a-ca32-48ea-841b-5ec544164327" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0b60044b-769a-4a8a-96d4-7cfecfa8ecab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b51554b2-d1e6-436d-8166-4a50142066a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0b60044b-769a-4a8a-96d4-7cfecfa8ecab" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b51554b2-d1e6-436d-8166-4a50142066a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_d02de8c9-a148-49ba-8c23-c01b712a5399" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0b60044b-769a-4a8a-96d4-7cfecfa8ecab" xlink:to="loc_ahl_MiddlemarketloansMember_d02de8c9-a148-49ba-8c23-c01b712a5399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_90c202a2-eb5d-4671-9e66-20407b2ef3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_us-gaap_LoanToValueAxis_90c202a2-eb5d-4671-9e66-20407b2ef3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueAxis_90c202a2-eb5d-4671-9e66-20407b2ef3c2" xlink:to="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatioLessthan50PercentMember_79f81b3f-dfa4-4419-8ae8-0b06c8a261fa" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatioLessthan50PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:to="loc_ahl_DebttoValueRatioLessthan50PercentMember_79f81b3f-dfa4-4419-8ae8-0b06c8a261fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio50to60PercentMember_fab8d308-deee-4fc8-8e2c-3d81cb091c69" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio50to60PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:to="loc_ahl_DebttoValueRatio50to60PercentMember_fab8d308-deee-4fc8-8e2c-3d81cb091c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebttoValueRatio61to70PercentMember_bb5ad5b6-ae27-43b6-8ea0-6b478ed23642" xlink:href="ahl-20231220.xsd#ahl_DebttoValueRatio61to70PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_aea0c7c5-14c0-4ee3-9020-9b8e8814c074" xlink:to="loc_ahl_DebttoValueRatio61to70PercentMember_bb5ad5b6-ae27-43b6-8ea0-6b478ed23642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_03a2e57d-baac-48a9-92fc-e49ffa277db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_03a2e57d-baac-48a9-92fc-e49ffa277db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d1a05f2d-a56e-483d-b749-8a5c33380275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_03a2e57d-baac-48a9-92fc-e49ffa277db4" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d1a05f2d-a56e-483d-b749-8a5c33380275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonperformingFinancingReceivableMember_64d4d3f3-2e19-420c-8d3e-2e7fa2704a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonperformingFinancingReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d1a05f2d-a56e-483d-b749-8a5c33380275" xlink:to="loc_us-gaap_NonperformingFinancingReceivableMember_64d4d3f3-2e19-420c-8d3e-2e7fa2704a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureTable_2872978d-b6bd-4741-82ad-81cc6ff5c63f" xlink:to="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_994df813-7f1a-4dee-8254-34d2d0bcdbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:to="loc_us-gaap_TradingSecurities_994df813-7f1a-4dee-8254-34d2d0bcdbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CMLLessNonPerformingOrFutureConstruction_abf06b08-8563-4e9d-9fc2-403771596798" xlink:href="ahl-20231220.xsd#ahl_CMLLessNonPerformingOrFutureConstruction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:to="loc_ahl_CMLLessNonPerformingOrFutureConstruction_abf06b08-8563-4e9d-9fc2-403771596798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_526856fc-c32c-4dd5-b8e9-a0e42b672ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoansAndLeasesReceivableDisclosureLineItems_49dbbd5e-3453-4e0e-98d5-fe0377dcc85d" xlink:to="loc_us-gaap_DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized_526856fc-c32c-4dd5-b8e9-a0e42b672ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsOtherInvestmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsOtherInvestmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_28f170a5-6a3c-4467-9764-67ae22a4bde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_28f170a5-6a3c-4467-9764-67ae22a4bde6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b52d255c-ff18-4e45-b2ff-48a030342bd0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b52d255c-ff18-4e45-b2ff-48a030342bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b52d255c-ff18-4e45-b2ff-48a030342bd0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_56742b45-3105-4319-9fdb-2c63437eb77b" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:to="loc_ahl_MVIMember_56742b45-3105-4319-9fdb-2c63437eb77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_32065b10-52bf-4276-8329-a98364bd0946" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:to="loc_ahl_DigitalRiskMember_32065b10-52bf-4276-8329-a98364bd0946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_562ec5e6-bd7b-471e-a0ac-d20339cc9839" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed138770-e205-4cee-bdd4-af5880fc6bd9" xlink:to="loc_ahl_MultiLineReinsurerMember_562ec5e6-bd7b-471e-a0ac-d20339cc9839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0dee6d59-d8bb-4180-9438-51b1d49539d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0dee6d59-d8bb-4180-9438-51b1d49539d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7a83e275-d289-42c0-ab7a-63dbee1fc0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0dee6d59-d8bb-4180-9438-51b1d49539d3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7a83e275-d289-42c0-ab7a-63dbee1fc0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8b9e67f9-c641-4058-865d-3f9be1d5321d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7a83e275-d289-42c0-ab7a-63dbee1fc0d5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8b9e67f9-c641-4058-865d-3f9be1d5321d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_6268ee33-8f83-41ca-94a6-d6732b553ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_us-gaap_InvestmentTypeAxis_6268ee33-8f83-41ca-94a6-d6732b553ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d63dcfed-4763-4c0a-86dd-fc1b908569f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_6268ee33-8f83-41ca-94a6-d6732b553ee7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d63dcfed-4763-4c0a-86dd-fc1b908569f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_5a817bfd-ba55-4dab-89b4-ea0895887a15" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_d63dcfed-4763-4c0a-86dd-fc1b908569f5" xlink:to="loc_ahl_RealEstateFundDec2017Member_5a817bfd-ba55-4dab-89b4-ea0895887a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3a2f24d4-eaee-44c3-8479-2c2860bbe5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_ca41ee90-9aa9-4c6b-bc0f-3ca23d68cd5a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3a2f24d4-eaee-44c3-8479-2c2860bbe5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_1f4716fb-e120-48de-98f1-3b5bba1fa74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_3a2f24d4-eaee-44c3-8479-2c2860bbe5b9" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_1f4716fb-e120-48de-98f1-3b5bba1fa74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1aeb7e91-c236-4ebc-ad09-6905af97d23c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_336e848c-f32c-4fa1-a069-1d6f3a5e9694" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1aeb7e91-c236-4ebc-ad09-6905af97d23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:href="ahl-20231220.xsd#ahl_EquityMethodInvestmentAggregateCostRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1aeb7e91-c236-4ebc-ad09-6905af97d23c" xlink:to="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d2eab0-bf40-4493-a634-ab371a7e8400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_58d2eab0-bf40-4493-a634-ab371a7e8400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8e861edd-582a-47d8-823e-f0b40e44b379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_8e861edd-582a-47d8-823e-f0b40e44b379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_94309684-8ee8-49a9-a338-c4297d1f3304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_94309684-8ee8-49a9-a338-c4297d1f3304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_449be330-0d53-4eb8-9904-85a4f5903aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_EquityMethodInvestmentAggregateCostRollForward_62052b57-025c-4041-ab3a-040146c796e6" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_449be330-0d53-4eb8-9904-85a4f5903aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_c4706ede-19ed-4b93-b0ba-f3959bb7f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1aeb7e91-c236-4ebc-ad09-6905af97d23c" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_c4706ede-19ed-4b93-b0ba-f3959bb7f0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsSummaryofFixedMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsSummaryofFixedMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3ed85f88-b5d1-4020-a073-9b5e95e5001a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bcfc1a5-0b88-4e2d-9ea2-e281720b5bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3ed85f88-b5d1-4020-a073-9b5e95e5001a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bcfc1a5-0b88-4e2d-9ea2-e281720b5bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d080ebf9-ee0a-4fab-a150-399945eeb16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bcfc1a5-0b88-4e2d-9ea2-e281720b5bf2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d080ebf9-ee0a-4fab-a150-399945eeb16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d080ebf9-ee0a-4fab-a150-399945eeb16f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_f071438d-d0f4-49ff-8666-484d5d3209a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_f071438d-d0f4-49ff-8666-484d5d3209a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_50ba7de5-fb3b-477e-85ef-684c51680431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_50ba7de5-fb3b-477e-85ef-684c51680431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_bc4851eb-beaf-459f-8206-af4288e78dea" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_bc4851eb-beaf-459f-8206-af4288e78dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_683b7e1f-1f60-4e82-992d-437feb241dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a9f9676-83ef-4bcd-83fc-ed908d8a4e12" xlink:to="loc_us-gaap_FixedMaturitiesMember_683b7e1f-1f60-4e82-992d-437feb241dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_0c10384e-10f4-417b-a03d-14178c31399c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FixedMaturitiesMember_683b7e1f-1f60-4e82-992d-437feb241dad" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_0c10384e-10f4-417b-a03d-14178c31399c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bcfc1a5-0b88-4e2d-9ea2-e281720b5bf2" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5daddae9-ce74-4571-8b3f-df27ba3d95db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5daddae9-ce74-4571-8b3f-df27ba3d95db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_9e531e48-9fab-429f-ad61-ba48b9e2d089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_9e531e48-9fab-429f-ad61-ba48b9e2d089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_3d5cf857-a555-4704-a831-1a2a549bec39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_3d5cf857-a555-4704-a831-1a2a549bec39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_94fda06e-3566-4d1c-9807-fbb2beaa6678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_94fda06e-3566-4d1c-9807-fbb2beaa6678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4fad030d-f43e-4a42-b3cc-dc1f702635c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4fad030d-f43e-4a42-b3cc-dc1f702635c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9bf31a00-1d8c-4ee6-82a7-a54854477394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9bf31a00-1d8c-4ee6-82a7-a54854477394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_835b31c7-1499-4f32-bb0f-e5f758b186fe" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAverageRatingsByMaturity_835b31c7-1499-4f32-bb0f-e5f758b186fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2b2b0ab7-22bd-4200-84d5-5844c7b0c3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2b2b0ab7-22bd-4200-84d5-5844c7b0c3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_a19bf9e7-35ae-4c99-811e-63aab04e409b" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAverageRatingsByMaturity_a19bf9e7-35ae-4c99-811e-63aab04e409b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_ec13446a-1f13-4591-884a-d901d26b1a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_ec13446a-1f13-4591-884a-d901d26b1a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_b1e18931-ad94-4cb3-8842-5932daeb2463" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAverageRatingsByMaturity_b1e18931-ad94-4cb3-8842-5932daeb2463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_a947992f-3833-461a-a58d-62d3a525b0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_a947992f-3833-461a-a58d-62d3a525b0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_0baaabde-a352-4abc-993d-5bb794634f83" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAverageRatingsByMaturity_0baaabde-a352-4abc-993d-5bb794634f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cec41d6c-c6ec-406d-bb72-462d59310af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cec41d6c-c6ec-406d-bb72-462d59310af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_4ff19bdf-5355-4f31-98ed-5fdf260bdcde" xlink:href="ahl-20231220.xsd#ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_601fa442-99e2-4250-ade7-1c99d55e6106" xlink:to="loc_ahl_AvailableForSaleSecuritiesAverageRatingsByMaturity_4ff19bdf-5355-4f31-98ed-5fdf260bdcde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsAggregateFairValueandGrossUnrealizedLossbyTypeofSecurityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a5ecc96a-7c0a-4ce0-a508-61cf4d1e792c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a5ecc96a-7c0a-4ce0-a508-61cf4d1e792c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6ed0e13e-b017-492d-8c61-d4e92bbaea7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6ed0e13e-b017-492d-8c61-d4e92bbaea7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6ed0e13e-b017-492d-8c61-d4e92bbaea7a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_4df3ab3d-5b6f-43a5-83fe-063c2d2ed692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_4df3ab3d-5b6f-43a5-83fe-063c2d2ed692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cd72b56e-0047-4e60-b97d-32225b4ec31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cd72b56e-0047-4e60-b97d-32225b4ec31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_80d1795c-c9c4-4fa0-a20d-3da136fe8305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_MunicipalBondsMember_80d1795c-c9c4-4fa0-a20d-3da136fe8305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b3bcb135-b4da-4dfc-a579-93bc394c434a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b3bcb135-b4da-4dfc-a579-93bc394c434a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_467fc898-c690-42b3-a0bb-f2e1075a4b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_467fc898-c690-42b3-a0bb-f2e1075a4b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_2d6665bc-8a25-409d-8d3a-1f6ceaed4812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_2d6665bc-8a25-409d-8d3a-1f6ceaed4812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_e9714ee7-a7f6-47a2-8112-0cee679b88bb" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_e9714ee7-a7f6-47a2-8112-0cee679b88bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_e2115f38-0cb8-4c86-a6dc-bbacab43039f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e08e752-0716-4489-980d-6640eadf3d4b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_e2115f38-0cb8-4c86-a6dc-bbacab43039f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7b113bed-9ebf-4d02-acf5-b165ef44dd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:to="loc_us-gaap_InvestmentTypeAxis_7b113bed-9ebf-4d02-acf5-b165ef44dd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_46edf308-7832-40d2-95cd-0f94988a2b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_7b113bed-9ebf-4d02-acf5-b165ef44dd6b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_46edf308-7832-40d2-95cd-0f94988a2b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_1fd394fb-0f50-4b85-a45f-908a1a927761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46edf308-7832-40d2-95cd-0f94988a2b85" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_1fd394fb-0f50-4b85-a45f-908a1a927761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_01b0ce6f-853f-412e-b465-f0e273bdf138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46edf308-7832-40d2-95cd-0f94988a2b85" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_01b0ce6f-853f-412e-b465-f0e273bdf138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4af0bd88-44bf-40dd-afa0-7acaf5103359" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_a654a74f-4b26-4aa8-82cb-e04ceb3cc605" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairMarketValue_a654a74f-4b26-4aa8-82cb-e04ceb3cc605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b1e35a7d-5c6c-4253-a11e-b98fb1769dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b1e35a7d-5c6c-4253-a11e-b98fb1769dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_50cafec6-7bc1-4246-85ae-bb52c20aad31" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairMarketValue_50cafec6-7bc1-4246-85ae-bb52c20aad31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4cbee3a4-b4b5-4806-98c3-5392050105d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4cbee3a4-b4b5-4806-98c3-5392050105d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_4b4a6f80-f732-4e6a-b85d-a8c4f74cdc9a" xlink:href="ahl-20231220.xsd#ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_ahl_DebtSecuritiesAvailableForSaleContinuousLossPositionFairMarketValue_4b4a6f80-f732-4e6a-b85d-a8c4f74cdc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_46087e9c-b9d9-46c2-b244-18e2f3385101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_46087e9c-b9d9-46c2-b244-18e2f3385101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_67095a39-9554-4430-ab04-ca45b8057a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fd268633-0d69-4298-b42c-f18d6b481b03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_67095a39-9554-4430-ab04-ca45b8057a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAdditionalInformationNarrativeDetails_2"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fafc404f-5c48-4e6c-8b66-c7ec616f1d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fafc404f-5c48-4e6c-8b66-c7ec616f1d8a" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1ea37b5c-6ba6-4f24-a4cd-f76a0827ab84" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2556c8b2-6a14-4272-b156-81715ed7c72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_49b80045-1c53-4e17-b47e-3981d5bebd95" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2556c8b2-6a14-4272-b156-81715ed7c72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_8d5f3088-0d0c-4359-a6fc-dae154895c78" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_2735f55b-08ef-4962-a4b8-c04ee15b9ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6e40c9e1-3475-4117-acd9-9ad0bb9393d6" xlink:to="loc_us-gaap_LimitedPartnerMember_2735f55b-08ef-4962-a4b8-c04ee15b9ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0820724c-efb7-4265-8f09-0ae3c102e3ae" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_BeneAssicurazioniMember_c4ef4fa8-03ec-42b2-9eba-cda4ea8b5936" xlink:href="ahl-20231220.xsd#ahl_BeneAssicurazioniMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_BeneAssicurazioniMember_c4ef4fa8-03ec-42b2-9eba-cda4ea8b5936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_c0b1ebc3-fde0-4215-b9bc-98163b20f5a7" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_MVIMember_c0b1ebc3-fde0-4215-b9bc-98163b20f5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DigitalRiskMember_afed5716-0b43-4bde-94d2-7fbab6ab5550" xlink:href="ahl-20231220.xsd#ahl_DigitalRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_DigitalRiskMember_afed5716-0b43-4bde-94d2-7fbab6ab5550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_b127523c-3d2f-46c0-9109-dfbfe648c82e" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_47eee528-d3cc-4c8e-a068-5efc3db78add" xlink:to="loc_ahl_MultiLineReinsurerMember_b127523c-3d2f-46c0-9109-dfbfe648c82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_e2cae724-eecf-4984-8ecd-79f8bc0473d5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_72a15c43-0590-4dcd-8134-e94363ccdf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_us-gaap_RealEstateFundsMember_72a15c43-0590-4dcd-8134-e94363ccdf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6db8fc34-03e8-4c57-89c8-852c7d028191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6db8fc34-03e8-4c57-89c8-852c7d028191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_34df10c0-7a60-49fb-8383-2c8472cbbc30" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_MiddlemarketloansMember_34df10c0-7a60-49fb-8383-2c8472cbbc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_963c2227-5c28-411c-8d26-18b2aca90f31" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_963c2227-5c28-411c-8d26-18b2aca90f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundDec2017Member_7cd4db94-fde6-43e9-8a64-96acf682f475" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundDec2017Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_RealEstateFundDec2017Member_7cd4db94-fde6-43e9-8a64-96acf682f475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RealEstateFundSept2021Member_01220c72-c654-4ba3-ae61-22cc5ebbfaaf" xlink:href="ahl-20231220.xsd#ahl_RealEstateFundSept2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_RealEstateFundSept2021Member_01220c72-c654-4ba3-ae61-22cc5ebbfaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InfrastructureFundMember_2f6a937e-87c1-4523-b191-98fe4f777523" xlink:href="ahl-20231220.xsd#ahl_InfrastructureFundMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_InfrastructureFundMember_2f6a937e-87c1-4523-b191-98fe4f777523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_36166fd8-3846-41c6-8046-53956ab47646" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9d3d3c7e-43a1-4f31-b645-e0a515c06890" xlink:to="loc_ahl_ApolloRealEstateFundMember_36166fd8-3846-41c6-8046-53956ab47646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c54ad8c0-2e4f-45fc-849f-6b6df213678a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4fe0779b-20f3-465e-99ab-e71ea9f16889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_dada3acb-68aa-4cad-a5b3-9d94420cc1e1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4fe0779b-20f3-465e-99ab-e71ea9f16889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_06f150ff-a527-446c-a851-d2faa4197620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fad3ed0a-bfd2-4d06-b2f6-4511abbb3c60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_06f150ff-a527-446c-a851-d2faa4197620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8b9b8376-5369-400e-adc9-2dbbede3c144" xlink:to="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_766c5df1-268e-4363-ba77-00d4bb59f270" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d9032378-1b1e-4d66-94b6-72bdc6d751a2" xlink:to="loc_ahl_ApolloRealEstateFundMember_766c5df1-268e-4363-ba77-00d4bb59f270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-supplement_InvestmentIdentifierAxis_6e4aaba7-9bd9-4b19-9f21-1439ecfd42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap-supplement_InvestmentIdentifierAxis_6e4aaba7-9bd9-4b19-9f21-1439ecfd42ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_df783261-874e-4363-a463-603f326c2612" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBond_db716038-a368-42ad-a25e-a8db3a52ac44" xlink:href="ahl-20231220.xsd#ahl_CatastropheBond"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_CatastropheBond_db716038-a368-42ad-a25e-a8db3a52ac44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_bda3b5df-064f-407b-bf2d-b9f942723f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_TradingSecurities_bda3b5df-064f-407b-bf2d-b9f942723f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_c8e50be8-2fa0-4235-b8ae-89cbd3b3048d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_c8e50be8-2fa0-4235-b8ae-89cbd3b3048d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5d27132-e2e9-43b6-be9a-3b052c033249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a5d27132-e2e9-43b6-be9a-3b052c033249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_bce1766f-0db5-4e84-a7fc-cbd2c12bc0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_bce1766f-0db5-4e84-a7fc-cbd2c12bc0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_7730f2a0-fd73-4258-ae26-37fce3918e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_OtherInvestments_7730f2a0-fd73-4258-ae26-37fce3918e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0495962e-8a8d-44af-9dbb-568822bc0787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0495962e-8a8d-44af-9dbb-568822bc0787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_762af2e8-09a2-4276-b458-3c34a25f39d6" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_RestrictedAssets_762af2e8-09a2-4276-b458-3c34a25f39d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InvestmentFunds_2f0cb279-c8b1-4ec5-99df-103598ca9ed8" xlink:href="ahl-20231220.xsd#ahl_InvestmentFunds"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_ahl_InvestmentFunds_2f0cb279-c8b1-4ec5-99df-103598ca9ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_31e6bf6a-1417-437c-811b-f944c6ffd26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_31e6bf6a-1417-437c-811b-f944c6ffd26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f13b18d1-e268-4508-aecb-16d5b0f31e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f13b18d1-e268-4508-aecb-16d5b0f31e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_caf3ae11-1f69-4d16-8650-b199019a0b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_8290d16b-5e59-4e62-8529-d9037d42c89e" xlink:to="loc_us-gaap_OtherCommitment_caf3ae11-1f69-4d16-8650-b199019a0b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_3" xlink:type="simple" xlink:href="ahl-20231220.xsd#InvestmentsAdditionalInformationNarrativeDetails_3"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/InvestmentsAdditionalInformationNarrativeDetails_3" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsFinancialAssetsMeasuredonRecurringBasisDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_db906d9c-56f6-4d3a-bdc3-38a16adb59a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_db906d9c-56f6-4d3a-bdc3-38a16adb59a1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2c98870c-a057-41a7-a417-7a716e8689a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2c98870c-a057-41a7-a417-7a716e8689a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2c98870c-a057-41a7-a417-7a716e8689a4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ff4ebed6-ae71-47b0-989d-bbff57d3c00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ff4ebed6-ae71-47b0-989d-bbff57d3c00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_27754b19-0648-4184-95ca-0c980f51c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_27754b19-0648-4184-95ca-0c980f51c0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_1db90472-2d90-4431-8f97-084f7c7534ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_MunicipalBondsMember_1db90472-2d90-4431-8f97-084f7c7534ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f84f24ab-9489-4771-8177-06df6ff0746b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f84f24ab-9489-4771-8177-06df6ff0746b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3922b7ab-b6fa-4c3e-bfd7-1c50cbe7fdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3922b7ab-b6fa-4c3e-bfd7-1c50cbe7fdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_c70a43d7-aa37-4173-91d2-a40cc3c2186d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_c70a43d7-aa37-4173-91d2-a40cc3c2186d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_30ac7efb-3d55-4a4b-9bdb-4bccc5317d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_30ac7efb-3d55-4a4b-9bdb-4bccc5317d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_4b4bfba6-da1a-4c18-86b5-340d17f091b9" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_4b4bfba6-da1a-4c18-86b5-340d17f091b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_b5487e97-6772-4333-87a3-cf4d0c934a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_b5487e97-6772-4333-87a3-cf4d0c934a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_HighYieldLoansMember_0cec1d9d-ead3-4ba9-8211-96e642983304" xlink:href="ahl-20231220.xsd#ahl_HighYieldLoansMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3ca2c38-a6a6-4251-978f-11b9ca5f7035" xlink:to="loc_ahl_HighYieldLoansMember_0cec1d9d-ead3-4ba9-8211-96e642983304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_af0a9ca6-c13f-49e9-94bb-a02d0beb005b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_af0a9ca6-c13f-49e9-94bb-a02d0beb005b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_06caf033-cfc8-4d6c-8617-f26718216f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_af0a9ca6-c13f-49e9-94bb-a02d0beb005b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_06caf033-cfc8-4d6c-8617-f26718216f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2ac3f24b-4421-4c29-beb8-180e384b9e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_06caf033-cfc8-4d6c-8617-f26718216f78" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2ac3f24b-4421-4c29-beb8-180e384b9e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e02d07bd-69aa-46de-8c1f-508f025d89a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e02d07bd-69aa-46de-8c1f-508f025d89a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e02d07bd-69aa-46de-8c1f-508f025d89a5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5cd09526-d32d-49c1-abdb-e31eec1a3737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5cd09526-d32d-49c1-abdb-e31eec1a3737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_79871704-2597-4c3d-8bad-33fd53a12b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_79871704-2597-4c3d-8bad-33fd53a12b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_16c536fe-3dc7-44fe-b26b-77a7693650e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_404ee9b4-777e-4199-98e3-3deb946d9c16" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_16c536fe-3dc7-44fe-b26b-77a7693650e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d0c048d2-f5ee-4a2d-920d-ade7484fa832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_InvestmentTypeAxis_d0c048d2-f5ee-4a2d-920d-ade7484fa832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_d0c048d2-f5ee-4a2d-920d-ade7484fa832" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_14910f99-ff95-42ac-87e8-e0176ada2fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_14910f99-ff95-42ac-87e8-e0176ada2fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_12bcc206-05b2-494e-8e98-fa8a704d0468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_12bcc206-05b2-494e-8e98-fa8a704d0468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_ab5ab9fa-6284-41f2-91b1-ac4495ed6007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_ab5ab9fa-6284-41f2-91b1-ac4495ed6007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_ac303352-99e4-4608-b24e-71c81a89ffe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_ac303352-99e4-4608-b24e-71c81a89ffe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember_7c501171-aeb3-4551-8c23-82dab490c085" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsTradingAtFairValueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_ahl_ShortTermInvestmentsTradingAtFairValueMember_7c501171-aeb3-4551-8c23-82dab490c085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_f029595a-cd9c-411c-a478-e66a9c10a718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_72daf580-ae1f-4298-8db8-f6201d7ff310" xlink:to="loc_us-gaap_RealEstateFundsMember_f029595a-cd9c-411c-a478-e66a9c10a718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_64eaadb0-fa72-43c8-b4fa-66bffe0244b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_64eaadb0-fa72-43c8-b4fa-66bffe0244b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_64eaadb0-fa72-43c8-b4fa-66bffe0244b4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_c24b829a-fa0b-48d0-9d51-a1fccb08b30d" xlink:href="ahl-20231220.xsd#ahl_NonagencycommercialmortgagebackedsecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:to="loc_ahl_NonagencycommercialmortgagebackedsecuritiesMember_c24b829a-fa0b-48d0-9d51-a1fccb08b30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_d6425442-9e42-47ee-bec4-7e08a40d4912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsAssetsMember_d6425442-9e42-47ee-bec4-7e08a40d4912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_53b5fe76-2c3b-4985-ba01-614f9c846ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05d61f5d-4942-42f4-ad6f-815f1e9b3ca5" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_53b5fe76-2c3b-4985-ba01-614f9c846ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae94bb1-a248-4c66-be7d-7125ba6fca68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae94bb1-a248-4c66-be7d-7125ba6fca68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0516d9d9-06c3-4baa-ba8a-cccebd7379fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ae94bb1-a248-4c66-be7d-7125ba6fca68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0516d9d9-06c3-4baa-ba8a-cccebd7379fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2ec49e90-8082-4152-9c9f-a81251997220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0516d9d9-06c3-4baa-ba8a-cccebd7379fb" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2ec49e90-8082-4152-9c9f-a81251997220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_0d1a9589-2afc-40c3-80c6-25611ebe77ee" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0516d9d9-06c3-4baa-ba8a-cccebd7379fb" xlink:to="loc_ahl_LossPortfolioTransferMember_0d1a9589-2afc-40c3-80c6-25611ebe77ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1e8d246b-261a-4d98-bd3e-d20dc0c961fe" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_30e7d026-ab21-4bfe-937d-a8b449209853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_30e7d026-ab21-4bfe-937d-a8b449209853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_40c3d427-c377-4fff-af35-2321acc1fcbe" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_40c3d427-c377-4fff-af35-2321acc1fcbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CatastropheBondsFairValueDisclosure_4eb1fe3c-a0ef-4c5e-b404-a9d100150825" xlink:href="ahl-20231220.xsd#ahl_CatastropheBondsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_ahl_CatastropheBondsFairValueDisclosure_4eb1fe3c-a0ef-4c5e-b404-a9d100150825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_7f52ac6c-671b-4519-aec3-37ba3a876997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_DerivativeAssets_7f52ac6c-671b-4519-aec3-37ba3a876997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_19cc8420-d55c-477b-acca-da0fa1f094ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_19cc8420-d55c-477b-acca-da0fa1f094ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_675ade14-0dc8-4b23-a7c0-bc7c0e042060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f64b2d-b309-4c8f-9b00-f3ea0598dc37" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_675ade14-0dc8-4b23-a7c0-bc7c0e042060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsReconciliationofLevel3InputsDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsReconciliationofLevel3InputsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7f6de608-341e-4263-a231-9e1aa615e167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7f6de608-341e-4263-a231-9e1aa615e167" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40662945-f09e-4d1e-b9ab-b20b3bc51516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40662945-f09e-4d1e-b9ab-b20b3bc51516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0a6fb3ce-87a3-4d7b-a940-658d06e005f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_40662945-f09e-4d1e-b9ab-b20b3bc51516" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0a6fb3ce-87a3-4d7b-a940-658d06e005f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_da919c63-42e3-41aa-a4ac-60654eb763da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0a6fb3ce-87a3-4d7b-a940-658d06e005f3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_da919c63-42e3-41aa-a4ac-60654eb763da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_249f5075-d31f-428b-a3be-bfe16e2e42b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_249f5075-d31f-428b-a3be-bfe16e2e42b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25ec8c25-c20b-4b8a-bbf4-027b9b6427c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_249f5075-d31f-428b-a3be-bfe16e2e42b3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25ec8c25-c20b-4b8a-bbf4-027b9b6427c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4a4d0db9-0a12-4bf7-a39f-6d6de80ebc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25ec8c25-c20b-4b8a-bbf4-027b9b6427c3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4a4d0db9-0a12-4bf7-a39f-6d6de80ebc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1be08957-286f-424a-8e16-4d961f7a23ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ed7543f-a7e3-4b95-ab91-e7fb8bde6867" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1be08957-286f-424a-8e16-4d961f7a23ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsFairValueMeasurementsReconciliationofLevel3AssetsandLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_50e85618-8a03-47c3-bcf4-63dd79666707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_50e85618-8a03-47c3-bcf4-63dd79666707" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_eb7a2f5b-dc12-49c5-a05e-19e071a2b850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_eb7a2f5b-dc12-49c5-a05e-19e071a2b850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e48482c8-10c3-43c9-8ad2-9f90ceafe2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_eb7a2f5b-dc12-49c5-a05e-19e071a2b850" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e48482c8-10c3-43c9-8ad2-9f90ceafe2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_9a364fc3-8e6e-45ea-9f1a-09478e9f9c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e48482c8-10c3-43c9-8ad2-9f90ceafe2aa" xlink:to="loc_us-gaap_AssetsMember_9a364fc3-8e6e-45ea-9f1a-09478e9f9c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fb8273e0-a773-41fb-9817-008121135c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fb8273e0-a773-41fb-9817-008121135c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_03cb3708-8800-4e49-ab44-999325117fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fb8273e0-a773-41fb-9817-008121135c49" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_03cb3708-8800-4e49-ab44-999325117fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8ab98eaf-b227-4464-a12a-f071ef666690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_03cb3708-8800-4e49-ab44-999325117fd3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8ab98eaf-b227-4464-a12a-f071ef666690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d32e4185-1631-40ad-9761-f770ab4b231a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_InvestmentTypeAxis_d32e4185-1631-40ad-9761-f770ab4b231a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_d32e4185-1631-40ad-9761-f770ab4b231a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_dcc57eb5-7fa9-4072-b4dc-32a5b38ac268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_dcc57eb5-7fa9-4072-b4dc-32a5b38ac268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_8cf228a4-0ef5-4e2b-9125-833cd0e8bb3a" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_ahl_MiddlemarketloansMember_8cf228a4-0ef5-4e2b-9125-833cd0e8bb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_a78e3224-4d20-4a96-b1ef-89fff73f9fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_a78e3224-4d20-4a96-b1ef-89fff73f9fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember_56b7f8f7-a175-445e-984c-6df0134fd738" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_ahl_GlobalCorporateSecuritiesMember_56b7f8f7-a175-445e-984c-6df0134fd738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_55bc5183-c7b2-434d-9e77-f1bc37eaac50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_us-gaap_EquitySecuritiesMember_55bc5183-c7b2-434d-9e77-f1bc37eaac50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_3fd75aa1-1d34-4bf0-a11c-ef514663df81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_us-gaap_PreferredStockMember_3fd75aa1-1d34-4bf0-a11c-ef514663df81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_85e94741-b7cc-4521-9db2-30c36630df4f" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_fb5efe75-cdc2-4c3e-a9b9-b1aed3371879" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_85e94741-b7cc-4521-9db2-30c36630df4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1b6e258-527e-4fe8-a5f1-a36f15dadda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1b6e258-527e-4fe8-a5f1-a36f15dadda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c4f52fa-2ff8-40fc-a890-1925f31289c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1b6e258-527e-4fe8-a5f1-a36f15dadda6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c4f52fa-2ff8-40fc-a890-1925f31289c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c75a80b8-2caf-4cdf-9c45-4fa8e7dd4a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c4f52fa-2ff8-40fc-a890-1925f31289c3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c75a80b8-2caf-4cdf-9c45-4fa8e7dd4a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_894c7d68-eaff-47f6-9a41-fb6902c8c4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_894c7d68-eaff-47f6-9a41-fb6902c8c4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ba42810f-510c-4fcb-abe9-120ed8194583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_894c7d68-eaff-47f6-9a41-fb6902c8c4d4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ba42810f-510c-4fcb-abe9-120ed8194583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_25816dba-71eb-4fb8-bcd2-55039b567f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ba42810f-510c-4fcb-abe9-120ed8194583" xlink:to="loc_us-gaap_LiabilityMember_25816dba-71eb-4fb8-bcd2-55039b567f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_22d65555-6b35-41c3-a615-8c011a720687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_92fbfbb3-22e7-46a9-bb27-6a7f88d6f933" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_22d65555-6b35-41c3-a615-8c011a720687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_9021ae56-d6e6-4695-8e8d-f1acca183351" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_22d65555-6b35-41c3-a615-8c011a720687" xlink:to="loc_ahl_LossPortfolioTransferMember_9021ae56-d6e6-4695-8e8d-f1acca183351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5224d3b9-6e5d-4eda-b021-1d82893d4ea7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_aa182139-e2b9-44f9-b42c-cdc8cdef2d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_aa182139-e2b9-44f9-b42c-cdc8cdef2d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_73218627-7db1-43cd-826d-c33e879a0f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_73218627-7db1-43cd-826d-c33e879a0f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e54419c2-35a9-484d-93af-7efaa7c05170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_TradingSecurities_e54419c2-35a9-484d-93af-7efaa7c05170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_72d5f5cc-241a-48f4-b1e3-c0a71a79c892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_72d5f5cc-241a-48f4-b1e3-c0a71a79c892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5c427db4-258d-4c42-9469-a3e9e253a90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5c427db4-258d-4c42-9469-a3e9e253a90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_408fdff1-fc66-44f1-8bfc-f6830c0b3b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_408fdff1-fc66-44f1-8bfc-f6830c0b3b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_dfa97a29-b144-4460-acda-e3b222a49828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_TradingSecurities_dfa97a29-b144-4460-acda-e3b222a49828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_0f077b21-bfc8-40a4-b292-60fc206352f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_0f077b21-bfc8-40a4-b292-60fc206352f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bbadc0dd-6213-4f96-bfd6-aab686e0f4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bbadc0dd-6213-4f96-bfd6-aab686e0f4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0629b633-e35b-410d-8d98-10e9b3dfcf34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_0629b633-e35b-410d-8d98-10e9b3dfcf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_ccc9ec3b-0004-47aa-890d-c0d0cafe42c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_ccc9ec3b-0004-47aa-890d-c0d0cafe42c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_323ca735-073b-42fc-8835-4afd3d749384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_323ca735-073b-42fc-8835-4afd3d749384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d0198c24-7c13-49fc-b7c4-dec3be9a4554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d0198c24-7c13-49fc-b7c4-dec3be9a4554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fab8b894-6a5f-4ff0-9f58-b2d45457c4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fab8b894-6a5f-4ff0-9f58-b2d45457c4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_b3915cb5-02f2-4d98-9712-5093c9b8b495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_b3915cb5-02f2-4d98-9712-5093c9b8b495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_a69a84e3-8a0b-4fb0-8272-aed5c25768f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_949c6b3a-a8b2-45eb-8320-35f2f2bd8d59" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList_a69a84e3-8a0b-4fb0-8272-aed5c25768f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsInputsUsedDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsInputsUsedDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7143bdbe-4460-43ea-82f9-d23497e8f709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7143bdbe-4460-43ea-82f9-d23497e8f709" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_223a2078-efde-4f6f-a3c2-08094f59f23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_ValuationTechniqueAxis_223a2078-efde-4f6f-a3c2-08094f59f23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_223a2078-efde-4f6f-a3c2-08094f59f23a" xlink:to="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_ab4e7a21-8b99-4065-ba54-07c1f9b01037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_ab4e7a21-8b99-4065-ba54-07c1f9b01037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_848c9d91-c537-4edd-9530-bf3b586e6b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_848c9d91-c537-4edd-9530-bf3b586e6b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ValuationTechniqueLiquidationMethodMember_b80584fa-1a99-4134-85b9-3f1947e9c70a" xlink:href="ahl-20231220.xsd#ahl_ValuationTechniqueLiquidationMethodMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:to="loc_ahl_ValuationTechniqueLiquidationMethodMember_b80584fa-1a99-4134-85b9-3f1947e9c70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostApproachValuationTechniqueMember_6f8442d5-4a4c-4637-a71b-68ad1a098312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostApproachValuationTechniqueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_56d60bfc-6964-4c7b-aa3f-5a44b3473d7d" xlink:to="loc_us-gaap_CostApproachValuationTechniqueMember_6f8442d5-4a4c-4637-a71b-68ad1a098312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_020e65fb-242e-4fa2-9ce0-e2c67ab3268e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_InvestmentTypeAxis_020e65fb-242e-4fa2-9ce0-e2c67ab3268e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_020e65fb-242e-4fa2-9ce0-e2c67ab3268e" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d32ab9b9-f445-4490-9d6a-1a3ce9510ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d32ab9b9-f445-4490-9d6a-1a3ce9510ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MiddlemarketloansMember_73258d16-eb02-4398-bc3b-314ddea79f5e" xlink:href="ahl-20231220.xsd#ahl_MiddlemarketloansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_ahl_MiddlemarketloansMember_73258d16-eb02-4398-bc3b-314ddea79f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_edff0880-d426-4d5f-b25f-d2723a7463ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_edff0880-d426-4d5f-b25f-d2723a7463ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalCorporateSecuritiesMember_744f0eb8-af57-44bf-a6c4-63c5abc0cb6a" xlink:href="ahl-20231220.xsd#ahl_GlobalCorporateSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_ahl_GlobalCorporateSecuritiesMember_744f0eb8-af57-44bf-a6c4-63c5abc0cb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_50a3dc87-d08d-417c-8f07-893076aad828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_50a3dc87-d08d-417c-8f07-893076aad828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_GlobalSecuritiesCorporateMember_b82f9a0a-2c1d-4d97-acd1-a4d4145cb514" xlink:href="ahl-20231220.xsd#ahl_GlobalSecuritiesCorporateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_ahl_GlobalSecuritiesCorporateMember_b82f9a0a-2c1d-4d97-acd1-a4d4145cb514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_62324c30-ad54-48b0-bc28-5e071b628f33" xlink:href="ahl-20231220.xsd#ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6d8dfcda-65b1-4363-a66e-6baab8472eeb" xlink:to="loc_ahl_ShortTermInvestmentsPrivatelyHeldInvestmentsMember_62324c30-ad54-48b0-bc28-5e071b628f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_84391422-919c-45da-b1df-783572caddbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_84391422-919c-45da-b1df-783572caddbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e26b5bf3-c08a-4c76-b4e4-e2bcbbd85804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_84391422-919c-45da-b1df-783572caddbd" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e26b5bf3-c08a-4c76-b4e4-e2bcbbd85804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9ab71088-0dbc-4b29-be17-81b5096382a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e26b5bf3-c08a-4c76-b4e4-e2bcbbd85804" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9ab71088-0dbc-4b29-be17-81b5096382a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ccd5399-f74a-41bd-88bb-9e3807eda787" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_srt_RangeAxis_1ccd5399-f74a-41bd-88bb-9e3807eda787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1ccd5399-f74a-41bd-88bb-9e3807eda787" xlink:to="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7d5a7daa-8e41-4c34-b99f-93475d4e0074" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:to="loc_srt_MinimumMember_7d5a7daa-8e41-4c34-b99f-93475d4e0074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba163206-743a-41a3-b65b-2f9acb5951b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:to="loc_srt_MaximumMember_ba163206-743a-41a3-b65b-2f9acb5951b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_bdeca634-9a46-4145-be54-eb35fad9341b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9e12341-1873-455d-b6f6-186d25f9378e" xlink:to="loc_srt_WeightedAverageMember_bdeca634-9a46-4145-be54-eb35fad9341b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb9827a1-7b23-41ea-ac04-b778ec7f17e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb9827a1-7b23-41ea-ac04-b778ec7f17e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_153dbc11-701d-43f0-9893-803d2b01bfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb9827a1-7b23-41ea-ac04-b778ec7f17e2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_153dbc11-701d-43f0-9893-803d2b01bfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9e38ece6-30df-4177-8ca8-fdce37493948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_153dbc11-701d-43f0-9893-803d2b01bfc3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9e38ece6-30df-4177-8ca8-fdce37493948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe60d04c-3f64-4eb4-867f-f76f3f386fef" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenGross_f379b5f9-4d1d-42d3-958b-fa53923fc8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:to="loc_us-gaap_PremiumsWrittenGross_f379b5f9-4d1d-42d3-958b-fa53923fc8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_24c36857-daa0-4248-9fe6-96f373d50edb" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_24c36857-daa0-4248-9fe6-96f373d50edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingMeasurementInput_1dac2436-cfd5-477c-9393-435e02eba36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingMeasurementInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_04f34e7e-9c47-458e-bfba-a7488bcea9cf" xlink:to="loc_us-gaap_DebtSecuritiesTradingMeasurementInput_1dac2436-cfd5-477c-9393-435e02eba36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#FairValueMeasurementsAdditionalInformationNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/FairValueMeasurementsAdditionalInformationNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e0baaf07-71b2-4c93-92d2-c2f7de79bbac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e0baaf07-71b2-4c93-92d2-c2f7de79bbac" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_def2f811-594b-4cd3-8415-8a793d4f54a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_InvestmentTypeAxis_def2f811-594b-4cd3-8415-8a793d4f54a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_61ab37a9-577d-4241-907d-8a8f114bb6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_def2f811-594b-4cd3-8415-8a793d4f54a3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_61ab37a9-577d-4241-907d-8a8f114bb6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_db6804fe-4b7c-4aa4-a164-9c75c6512de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_61ab37a9-577d-4241-907d-8a8f114bb6f7" xlink:to="loc_us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember_db6804fe-4b7c-4aa4-a164-9c75c6512de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_53289b92-80d8-4efb-aa1b-aab347115fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_53289b92-80d8-4efb-aa1b-aab347115fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_63ca0590-55a8-4ee1-b1c4-2aab59c7d6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_53289b92-80d8-4efb-aa1b-aab347115fb6" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_63ca0590-55a8-4ee1-b1c4-2aab59c7d6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_5045f5c8-cfe0-40b7-b081-bde67da6b3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_63ca0590-55a8-4ee1-b1c4-2aab59c7d6ce" xlink:to="loc_us-gaap_AssetsMember_5045f5c8-cfe0-40b7-b081-bde67da6b3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_541d6ede-7069-47b3-961c-788658a3646d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_63ca0590-55a8-4ee1-b1c4-2aab59c7d6ce" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_541d6ede-7069-47b3-961c-788658a3646d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_956e0b12-d76d-4e07-ba56-d5ff77d49b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_956e0b12-d76d-4e07-ba56-d5ff77d49b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_343c8449-151b-43e8-8880-7bc5fab0dd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_956e0b12-d76d-4e07-ba56-d5ff77d49b5c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_343c8449-151b-43e8-8880-7bc5fab0dd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8cba925b-dc2f-48b2-aafa-d61b3a221fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_343c8449-151b-43e8-8880-7bc5fab0dd4e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8cba925b-dc2f-48b2-aafa-d61b3a221fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f3a93ea-a227-4539-8b34-c12de9613c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f3a93ea-a227-4539-8b34-c12de9613c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d94b418e-3b4c-4db0-a8e5-f64f2442e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f3a93ea-a227-4539-8b34-c12de9613c44" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d94b418e-3b4c-4db0-a8e5-f64f2442e98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bbbd1602-fbf4-4adb-8a0e-a60e9daada47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d94b418e-3b4c-4db0-a8e5-f64f2442e98a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bbbd1602-fbf4-4adb-8a0e-a60e9daada47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_16114e6f-e858-4f29-b831-be384a8ad685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_16114e6f-e858-4f29-b831-be384a8ad685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_517c0386-c6da-469f-a1f0-db64e1fc6f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_16114e6f-e858-4f29-b831-be384a8ad685" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_517c0386-c6da-469f-a1f0-db64e1fc6f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_2df8332a-bb68-48e5-9123-c56469f306e3" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_517c0386-c6da-469f-a1f0-db64e1fc6f69" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_2df8332a-bb68-48e5-9123-c56469f306e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b736b882-5e03-4862-ab5f-3f3348b2c6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_731a8d87-5b71-4d11-9aaf-7c03b7fe2fe0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b736b882-5e03-4862-ab5f-3f3348b2c6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_27236cd7-1433-48bf-9daf-c8408f48c712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_HedgingDesignationAxis_27236cd7-1433-48bf-9daf-c8408f48c712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3688a885-933d-49c1-b03e-4b52b2f19bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_27236cd7-1433-48bf-9daf-c8408f48c712" xlink:to="loc_us-gaap_HedgingDesignationDomain_3688a885-933d-49c1-b03e-4b52b2f19bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_bb948e7b-a693-4adb-abcf-428aed555ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3688a885-933d-49c1-b03e-4b52b2f19bfa" xlink:to="loc_us-gaap_NondesignatedMember_bb948e7b-a693-4adb-abcf-428aed555ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3e42b98d-ea0c-4b7d-85c7-2a71cba51027" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_8bd98290-b9cd-4087-ae09-50cb2d763470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_8bd98290-b9cd-4087-ae09-50cb2d763470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestmentsatfairvalue_26634188-5436-4629-823d-4caa25471467" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestmentsatfairvalue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_ahl_PrivatelyheldInvestmentsatfairvalue_26634188-5436-4629-823d-4caa25471467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_42423e78-f3a3-4906-9bd8-43015e85ff86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_42423e78-f3a3-4906-9bd8-43015e85ff86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_ded83efd-53fa-4396-83a4-e3e80b453cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_ded83efd-53fa-4396-83a4-e3e80b453cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_38aeef28-a3ac-43fd-805a-376113fb5409" xlink:href="ahl-20231220.xsd#ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76cc1a67-613c-443c-b048-d8a98ad5a068" xlink:to="loc_ahl_FairValueInputsOfferedQuotesPerFixedIncomeInvestment_38aeef28-a3ac-43fd-805a-376113fb5409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReinsuranceSummaryofAssumedandCededReinsuranceonPremiumsWrittenPremiumsEarnedandInsuranceLossesandLossAdjustmentExpensesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_24329249-c806-4494-a2ac-bc5a7709efd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e3d4b1d2-4ecd-4a6b-b47a-1bfad6ea9854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNetConsolidatedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_24329249-c806-4494-a2ac-bc5a7709efd1" xlink:to="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e3d4b1d2-4ecd-4a6b-b47a-1bfad6ea9854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsWritten_2d510e96-220d-4e7c-b38f-60f7126ab1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsWritten"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e3d4b1d2-4ecd-4a6b-b47a-1bfad6ea9854" xlink:to="loc_us-gaap_DirectPremiumsWritten_2d510e96-220d-4e7c-b38f-60f7126ab1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsWritten_094a3f0d-df21-430b-99bc-4a97a6251f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsWritten"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e3d4b1d2-4ecd-4a6b-b47a-1bfad6ea9854" xlink:to="loc_us-gaap_AssumedPremiumsWritten_094a3f0d-df21-430b-99bc-4a97a6251f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsWritten_6de69ebb-28cc-41de-bc17-15db49078542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsWritten"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e3d4b1d2-4ecd-4a6b-b47a-1bfad6ea9854" xlink:to="loc_us-gaap_CededPremiumsWritten_6de69ebb-28cc-41de-bc17-15db49078542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsWrittenNet_48af0f50-5ce0-4145-b3a3-08dc9c72b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsWrittenNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PremiumsWrittenNetConsolidatedAbstract_e3d4b1d2-4ecd-4a6b-b47a-1bfad6ea9854" xlink:to="loc_us-gaap_PremiumsWrittenNet_48af0f50-5ce0-4145-b3a3-08dc9c72b239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_3835e9e0-121f-4e3b-89a0-b229e565c193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_24329249-c806-4494-a2ac-bc5a7709efd1" xlink:to="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_3835e9e0-121f-4e3b-89a0-b229e565c193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_a3f7e7e3-740b-4925-a8ef-8d7c990b4140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_3835e9e0-121f-4e3b-89a0-b229e565c193" xlink:to="loc_us-gaap_DirectPremiumsEarned_a3f7e7e3-740b-4925-a8ef-8d7c990b4140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_58568f17-06a5-4060-b9f6-1c90149f6229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_3835e9e0-121f-4e3b-89a0-b229e565c193" xlink:to="loc_us-gaap_AssumedPremiumsEarned_58568f17-06a5-4060-b9f6-1c90149f6229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_8fbf2f2d-c7f4-48e1-a325-398300de8751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsEarned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_3835e9e0-121f-4e3b-89a0-b229e565c193" xlink:to="loc_us-gaap_CededPremiumsEarned_8fbf2f2d-c7f4-48e1-a325-398300de8751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_97269d5b-5483-44da-9a1a-3073d7c5683f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_3835e9e0-121f-4e3b-89a0-b229e565c193" xlink:to="loc_us-gaap_PremiumsEarnedNet_97269d5b-5483-44da-9a1a-3073d7c5683f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_6fc6c967-9617-4d39-95f0-b7a1fe27aba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_24329249-c806-4494-a2ac-bc5a7709efd1" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_6fc6c967-9617-4d39-95f0-b7a1fe27aba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_3a6107df-a558-4138-be54-aa81a0f853b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_6fc6c967-9617-4d39-95f0-b7a1fe27aba0" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_3a6107df-a558-4138-be54-aa81a0f853b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_3cd1544d-58ef-4059-a12f-3696c4e10dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_6fc6c967-9617-4d39-95f0-b7a1fe27aba0" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_3cd1544d-58ef-4059-a12f-3696c4e10dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_235b37c0-df79-4e34-8450-0a8f866e93bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_6fc6c967-9617-4d39-95f0-b7a1fe27aba0" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_235b37c0-df79-4e34-8450-0a8f866e93bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_596e2b1d-db86-4b3e-8372-f54724f65149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_6fc6c967-9617-4d39-95f0-b7a1fe27aba0" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_596e2b1d-db86-4b3e-8372-f54724f65149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_c93a6dcd-65f3-4982-8781-bad990f5c662" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_24329249-c806-4494-a2ac-bc5a7709efd1" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_c93a6dcd-65f3-4982-8781-bad990f5c662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_22fd2557-fa7d-426f-b516-686ffea429fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_c93a6dcd-65f3-4982-8781-bad990f5c662" xlink:to="loc_srt_ProductOrServiceAxis_22fd2557-fa7d-426f-b516-686ffea429fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90c45c29-70e2-49e9-820e-e0a854f5f422" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_22fd2557-fa7d-426f-b516-686ffea429fe" xlink:to="loc_srt_ProductsAndServicesDomain_90c45c29-70e2-49e9-820e-e0a854f5f422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_6ce232fa-46b1-4b36-9699-95375d669f2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_c93a6dcd-65f3-4982-8781-bad990f5c662" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_6ce232fa-46b1-4b36-9699-95375d669f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceAdditionalInformationDetails_2"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_7e726c13-3c69-4aa5-8b78-5c96b70de9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_7e726c13-3c69-4aa5-8b78-5c96b70de9b6" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5be3c921-923c-4728-a906-0f78812d24f4" xlink:to="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8a574fe7-7eb7-4d96-9ca6-08df108fcc78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:to="loc_srt_MaximumMember_8a574fe7-7eb7-4d96-9ca6-08df108fcc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b69abd1b-45b4-4961-83f4-d839543d9221" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8aacd162-6596-41bc-9170-dfdb7461cdd0" xlink:to="loc_srt_MinimumMember_b69abd1b-45b4-4961-83f4-d839543d9221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_0eb6c159-7ea1-471f-9542-98645a54e1de" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_bdf6d8f0-a716-4042-af72-b4f4621780df" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_916d4871-791c-42ba-bf7a-9ab125590bde" xlink:to="loc_ahl_EnstarMember_bdf6d8f0-a716-4042-af72-b4f4621780df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_f03278a2-ef75-4452-a7fd-1f49d07202ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_us-gaap_ReinsuranceContractAxis_f03278a2-ef75-4452-a7fd-1f49d07202ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_46706e6a-19fe-4425-aa16-a9d7907dbac7" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_e3574f38-0764-41aa-b922-5325dcfbbef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverables_e3574f38-0764-41aa-b922-5325dcfbbef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_091081c0-8205-46fa-b42a-6bcda95396c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_091081c0-8205-46fa-b42a-6bcda95396c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_c6302968-a494-4261-9f95-c7ae906d6307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRecoverableAllowanceForCreditLossPeriodIncreaseDecrease_c6302968-a494-4261-9f95-c7ae906d6307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_4e33c6dd-ddd2-4b5b-b731-45204d6a63f5" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_4e33c6dd-ddd2-4b5b-b731-45204d6a63f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_40063a2c-0458-479b-97f2-649e425277f4" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_ahl_ReinsuranceRecoverablesForUnpaidClaimsAndClaimsAdjustmentCededCumulativeLosses_40063a2c-0458-479b-97f2-649e425277f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_66fe02d1-ffb1-4a00-989f-2dc294135aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_1dde0f9f-0ccd-4cd0-8f38-40cafedf6ab0" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_66fe02d1-ffb1-4a00-989f-2dc294135aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_3" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReinsuranceAdditionalInformationDetails_3"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReinsuranceAdditionalInformationDetails_3" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsFairValueofDerivativeInstrumentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsFairValueofDerivativeInstrumentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fc789e2c-5832-4cca-a2f1-f076f728ab8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fc789e2c-5832-4cca-a2f1-f076f728ab8a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_14f5b0f7-2b55-400b-971f-6595a1b0f528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:to="loc_us-gaap_HedgingDesignationAxis_14f5b0f7-2b55-400b-971f-6595a1b0f528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_21b22352-56de-498d-9792-692d1cd6e965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_14f5b0f7-2b55-400b-971f-6595a1b0f528" xlink:to="loc_us-gaap_HedgingDesignationDomain_21b22352-56de-498d-9792-692d1cd6e965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_aef33dfe-6e6a-4a03-9f41-52cdfbcb7c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_21b22352-56de-498d-9792-692d1cd6e965" xlink:to="loc_us-gaap_NondesignatedMember_aef33dfe-6e6a-4a03-9f41-52cdfbcb7c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6363814c-a6b1-499c-b333-f75e9dcb9a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_21b22352-56de-498d-9792-692d1cd6e965" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6363814c-a6b1-499c-b333-f75e9dcb9a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8bfff456-f727-4864-9ec2-e1e0029ed882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8bfff456-f727-4864-9ec2-e1e0029ed882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cdffd1c2-813e-4c5e-86ec-29d75c0cee2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8bfff456-f727-4864-9ec2-e1e0029ed882" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cdffd1c2-813e-4c5e-86ec-29d75c0cee2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_f34595b4-0fac-4a84-ab74-7114e808d883" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cdffd1c2-813e-4c5e-86ec-29d75c0cee2a" xlink:to="loc_ahl_DerivativeAtFairValueMember_f34595b4-0fac-4a84-ab74-7114e808d883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_b4de4e33-f108-4548-8fa9-7ef4a9547662" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cdffd1c2-813e-4c5e-86ec-29d75c0cee2a" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_b4de4e33-f108-4548-8fa9-7ef4a9547662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_eb4e8386-4374-41ef-ba7c-d0712580e1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_eb4e8386-4374-41ef-ba7c-d0712580e1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cde1364b-c716-4fd4-8a29-9298f2a8f115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eb4e8386-4374-41ef-ba7c-d0712580e1cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cde1364b-c716-4fd4-8a29-9298f2a8f115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_56655462-f90c-4d7f-983b-bd1af0b63736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cde1364b-c716-4fd4-8a29-9298f2a8f115" xlink:to="loc_us-gaap_ForeignExchangeContractMember_56655462-f90c-4d7f-983b-bd1af0b63736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_c3c6e484-b987-4f65-b2b6-b6bd736a59b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cde1364b-c716-4fd4-8a29-9298f2a8f115" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_c3c6e484-b987-4f65-b2b6-b6bd736a59b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1e070d8-199f-40d5-811c-510da231ba15" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_266f200a-6cdb-4666-be8b-2edfe4712856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_266f200a-6cdb-4666-be8b-2edfe4712856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a906e673-d1eb-42b5-84c3-60d52409e871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a906e673-d1eb-42b5-84c3-60d52409e871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_3909ca52-97e6-4745-a6d4-3c3f64d8f1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dc4ed4a1-751d-4fd1-a52f-1ebbe9f73b57" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_3909ca52-97e6-4745-a6d4-3c3f64d8f1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsGainLossRecognizedinIncomeonDerivativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8c7f2436-53b5-4a2a-94f5-efd73db8e091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8c7f2436-53b5-4a2a-94f5-efd73db8e091" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f1469439-31d1-4c2a-8baa-f66a01668b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:to="loc_us-gaap_HedgingDesignationAxis_f1469439-31d1-4c2a-8baa-f66a01668b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_73ed4c4c-418b-40e9-ab6e-138b708ba3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f1469439-31d1-4c2a-8baa-f66a01668b7e" xlink:to="loc_us-gaap_HedgingDesignationDomain_73ed4c4c-418b-40e9-ab6e-138b708ba3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_33bdbcff-6502-429d-af99-7f3aa9e548fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_73ed4c4c-418b-40e9-ab6e-138b708ba3fb" xlink:to="loc_us-gaap_NondesignatedMember_33bdbcff-6502-429d-af99-7f3aa9e548fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_35a756fd-6acf-4be9-9090-5b91894d2041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_73ed4c4c-418b-40e9-ab6e-138b708ba3fb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_35a756fd-6acf-4be9-9090-5b91894d2041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_05f3cf2f-7c4f-40fa-8203-90ac783944cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_05f3cf2f-7c4f-40fa-8203-90ac783944cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7004855a-4e47-4eab-922e-82a17dc8844a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05f3cf2f-7c4f-40fa-8203-90ac783944cd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7004855a-4e47-4eab-922e-82a17dc8844a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_257c4bb8-6331-470e-a1ff-1a9d14950b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7004855a-4e47-4eab-922e-82a17dc8844a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_257c4bb8-6331-470e-a1ff-1a9d14950b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a5ff49ca-969c-414f-87af-28937b7ea39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a5ff49ca-969c-414f-87af-28937b7ea39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a5ff49ca-969c-414f-87af-28937b7ea39f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_428e3332-c3d4-4e05-b6b6-0e2392adc386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_428e3332-c3d4-4e05-b6b6-0e2392adc386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_aa59459b-31b7-4930-8048-2d1a34522a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_aa59459b-31b7-4930-8048-2d1a34522a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_c715f6fb-3a97-4c73-9c55-6ebb824de95e" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47428a7d-21bc-410e-875f-5c7f261a9fc2" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_c715f6fb-3a97-4c73-9c55-6ebb824de95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b27434fa-63a5-43a1-b69d-5c30015fa9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cd20595c-d5b8-46d9-899c-6044fdff4d35" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b27434fa-63a5-43a1-b69d-5c30015fa9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_517cdd7f-bcf8-4f53-a663-16b3f64a9141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b27434fa-63a5-43a1-b69d-5c30015fa9b7" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_517cdd7f-bcf8-4f53-a663-16b3f64a9141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_3f2cf0f6-6057-415b-8d4b-9bbbef24491f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b27434fa-63a5-43a1-b69d-5c30015fa9b7" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_3f2cf0f6-6057-415b-8d4b-9bbbef24491f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bf653694-e0a6-423c-9aab-ad53dcd6cef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bf653694-e0a6-423c-9aab-ad53dcd6cef1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ae0c28d9-f58e-4876-931f-26ba2d5aadf8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ae61c274-caa4-4058-8e8b-64aff2f60f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ae61c274-caa4-4058-8e8b-64aff2f60f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LossPortfolioTransferMember_5e1304ea-a26b-458a-bd1f-0a6132116363" xlink:href="ahl-20231220.xsd#ahl_LossPortfolioTransferMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a8aafc1-f861-4a7d-b11f-0e38d00ae400" xlink:to="loc_ahl_LossPortfolioTransferMember_5e1304ea-a26b-458a-bd1f-0a6132116363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1d34214f-06bf-4d41-a950-839d9ec04e63" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_4dc4283c-6892-48f3-99a7-0e95f2059755" xlink:href="ahl-20231220.xsd#ahl_NetchangefromcurrentperiodhedgedtransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_ahl_NetchangefromcurrentperiodhedgedtransactionsMember_4dc4283c-6892-48f3-99a7-0e95f2059755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a8ec5a38-bbc4-4def-b654-2ed1d336ddab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a8ec5a38-bbc4-4def-b654-2ed1d336ddab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_49f461d4-8230-4aae-aa92-cba969a15231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsMember_49f461d4-8230-4aae-aa92-cba969a15231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_29cf108f-7098-44c2-afb3-e88b490d6c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_29cf108f-7098-44c2-afb3-e88b490d6c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_FairValueOfDerivativesMember_2a38d952-d7c4-4d3e-9896-ed4b6b7ee568" xlink:href="ahl-20231220.xsd#ahl_FairValueOfDerivativesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ad17ef0-317e-4a1d-88a4-df0412874f1b" xlink:to="loc_ahl_FairValueOfDerivativesMember_2a38d952-d7c4-4d3e-9896-ed4b6b7ee568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_76f14d75-6c45-4ddc-a0a5-230ac15d9736" xlink:to="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e17955d0-84d5-4d6a-a329-ddd0c3c19740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:to="loc_us-gaap_NondesignatedMember_e17955d0-84d5-4d6a-a329-ddd0c3c19740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6e007745-8e1c-4047-9547-9b90101d7e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_85dfc23d-d93a-48d5-a5b7-4f5d5fe7d3b1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6e007745-8e1c-4047-9547-9b90101d7e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb01ab5b-cf6c-4c17-bf5c-7bcce870ac57" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DerivativeAtFairValueMember_4439fc57-d165-4493-9696-4fcc8d44eead" xlink:href="ahl-20231220.xsd#ahl_DerivativeAtFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:to="loc_ahl_DerivativeAtFairValueMember_4439fc57-d165-4493-9696-4fcc8d44eead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilitiesUnderDerivativeContractsMember_9c69025d-0364-48f2-86d0-fe0a79d2866c" xlink:href="ahl-20231220.xsd#ahl_LiabilitiesUnderDerivativeContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d07a59a8-1668-4215-818c-e55ac15cc446" xlink:to="loc_ahl_LiabilitiesUnderDerivativeContractsMember_9c69025d-0364-48f2-86d0-fe0a79d2866c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_52ffbb99-8b57-4698-8bc9-ab178a3384c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dc1086df-5228-4462-8c2b-3888232aa02c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9e67451c-6f69-475d-ae5c-e279004b122b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dc1086df-5228-4462-8c2b-3888232aa02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8ff98888-85de-4147-b2d3-81b826b3124a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_e6c38bd2-c508-4445-8212-c20489fe68cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df71f41a-870a-486a-988f-82f3b9171f58" xlink:to="loc_us-gaap_LiabilityMember_e6c38bd2-c508-4445-8212-c20489fe68cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_12f5f944-588e-49c8-882c-d54d46bc2bb9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4f9ed9f4-15bd-4662-b141-b31085390dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c1e9f2b-77ad-4c98-98e7-96535fc9a8dd" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4f9ed9f4-15bd-4662-b141-b31085390dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_ef3b3b2c-63fe-48a5-83ec-b29faee9e92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_ReinsuranceContractAxis_ef3b3b2c-63fe-48a5-83ec-b29faee9e92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ed2f678b-56e6-495f-8d72-bf87e755753e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2e82955f-f9fb-463b-990f-84fc22d0ab2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2e82955f-f9fb-463b-990f-84fc22d0ab2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_340a14ef-1fce-497b-b8bf-44936e03dd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_340a14ef-1fce-497b-b8bf-44936e03dd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_34f128e0-f27f-4827-a12b-a324c2b5bf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives_34f128e0-f27f-4827-a12b-a324c2b5bf8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a2227237-3953-4712-ae18-7ffdd5ab0591" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_ahl_ReinsuranceRetentionPolicyRetrocessionPremiumInterestRate_a2227237-3953-4712-ae18-7ffdd5ab0591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d66ab37c-93b9-4454-8521-28915d69d3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_42f4ee81-e712-4a96-8470-5bf89b4dbaa6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d66ab37c-93b9-4454-8521-28915d69d3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#DerivativeContractsAdditionalInformationDetails_2"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DerivativeContractsAdditionalInformationDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_2"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_23e18c61-c3da-4bd5-ad3d-a481adb6c76d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_23e18c61-c3da-4bd5-ad3d-a481adb6c76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesAdjustment_9122fe05-193f-43f6-af62-7b1017c5a48d" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_ahl_ReinsuranceRecoverablesAdjustment_9122fe05-193f-43f6-af62-7b1017c5a48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_b0832d4d-6318-42b9-996e-0d6fb934f1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_b0832d4d-6318-42b9-996e-0d6fb934f1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_0e57b6ff-079f-47ac-a353-9ba068ca5a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_0e57b6ff-079f-47ac-a353-9ba068ca5a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_61238584-61c7-48a5-b70e-3d1f550da896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_0e57b6ff-079f-47ac-a353-9ba068ca5a40" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_61238584-61c7-48a5-b70e-3d1f550da896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_87575efc-71bb-4d49-ab85-ed8f7350b67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_0e57b6ff-079f-47ac-a353-9ba068ca5a40" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_87575efc-71bb-4d49-ab85-ed8f7350b67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_e59bdb35-265e-45c6-a1ac-01735eafad32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_0e57b6ff-079f-47ac-a353-9ba068ca5a40" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_e59bdb35-265e-45c6-a1ac-01735eafad32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_0a76aa3c-5e8d-477e-8f6a-57468e7de1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_0a76aa3c-5e8d-477e-8f6a-57468e7de1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_9b8d3110-f2a2-4e7b-a225-bd1997eef86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_0a76aa3c-5e8d-477e-8f6a-57468e7de1f0" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_9b8d3110-f2a2-4e7b-a225-bd1997eef86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e035a713-40b0-4156-b849-9f30e7d412ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_0a76aa3c-5e8d-477e-8f6a-57468e7de1f0" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e035a713-40b0-4156-b849-9f30e7d412ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_caa42514-4d41-474b-9072-352f9cd8d042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_0a76aa3c-5e8d-477e-8f6a-57468e7de1f0" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_caa42514-4d41-474b-9072-352f9cd8d042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss_00e104b7-ff80-4995-b091-f8b3c54b558d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss_00e104b7-ff80-4995-b091-f8b3c54b558d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_1d240ed7-4d5b-4fdd-ac30-3e98e8ef2535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_1d240ed7-4d5b-4fdd-ac30-3e98e8ef2535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_85804f08-0616-4e31-b898-18e37236994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_us-gaap_ReinsuranceRecoverables_85804f08-0616-4e31-b898-18e37236994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d702a627-5318-41b5-ab8b-2878618e70d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d702a627-5318-41b5-ab8b-2878618e70d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cba7ddfa-eb3f-4bf0-9202-26c63464d05a" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_6e7eb7f7-1e07-4c7f-b0d4-4e1ab239bb15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EnstarMember_e7c3f436-8928-4116-9f7b-1b6e40d600bb" xlink:href="ahl-20231220.xsd#ahl_EnstarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_10715741-4efc-46ec-9969-720d3fa304ee" xlink:to="loc_ahl_EnstarMember_e7c3f436-8928-4116-9f7b-1b6e40d600bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f1fafb6d-3fb4-4e5c-97d0-9f30ba19ff84" xlink:to="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_563b86bc-c9b1-45cc-a6a7-5e64487efa70" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d1da634b-91ad-4155-94d7-198cd770585c" xlink:to="loc_ahl_InsuranceMember_563b86bc-c9b1-45cc-a6a7-5e64487efa70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_099e8df5-4f97-409e-8aae-e74af0fe67b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_us-gaap_ReinsuranceContractAxis_099e8df5-4f97-409e-8aae-e74af0fe67b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_f2031a7e-9eca-4c62-acd4-7619aa2d1a58" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_3076c978-5397-4be5-9017-3452903ccb7d" xlink:href="ahl-20231220.xsd#ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_ahl_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAmountDisposedOf_3076c978-5397-4be5-9017-3452903ccb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_7ff77f69-8cc6-4bdf-84a7-8b38ea3ea6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_7ff77f69-8cc6-4bdf-84a7-8b38ea3ea6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_2fadfc3f-5c29-48bb-bc2e-e65057a99c5b" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesTotalRecoverable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_ahl_ReinsuranceRecoverablesTotalRecoverable_2fadfc3f-5c29-48bb-bc2e-e65057a99c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_cbff012d-95dd-450e-be26-7c3502aed526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_fa582bfe-dbf3-4165-a457-c8c4dfd72b1b" xlink:to="loc_us-gaap_ReinsuranceRecoverables_cbff012d-95dd-450e-be26-7c3502aed526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_3" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_3"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofBeginningandEndingConsolidatedLossandLossAdjustmentExpensesLAEReservesDetails_3" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_62793ec2-b5c5-4987-b7b1-3873d2c923c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_cf0acb60-4b90-473f-97a4-bc59032fb8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_62793ec2-b5c5-4987-b7b1-3873d2c923c8" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_cf0acb60-4b90-473f-97a4-bc59032fb8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_a7948672-8459-4106-8a40-2df4f31860e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_62793ec2-b5c5-4987-b7b1-3873d2c923c8" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_a7948672-8459-4106-8a40-2df4f31860e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_62793ec2-b5c5-4987-b7b1-3873d2c923c8" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e39f7c88-a5bc-480d-96ea-4678c5c92840" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c2418e8-10b2-4499-9c5b-25d8e924f837" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e39f7c88-a5bc-480d-96ea-4678c5c92840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_456dcf78-b027-440e-afd8-0611cb375311" xlink:to="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_21d22737-214c-4aef-805b-e18853d2572c" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:to="loc_ahl_ReinsuranceMember_21d22737-214c-4aef-805b-e18853d2572c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_InsuranceMember_a585fc6e-549d-41b2-9e06-7f86473c90b2" xlink:href="ahl-20231220.xsd#ahl_InsuranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_42f9a52b-b242-45b6-8a7a-1aed1133a432" xlink:to="loc_ahl_InsuranceMember_a585fc6e-549d-41b2-9e06-7f86473c90b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_896c9777-dfdd-467b-bd77-5fbb23a7c726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_us-gaap_ReinsuranceContractAxis_896c9777-dfdd-467b-bd77-5fbb23a7c726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodTable_3afb206f-f548-4a05-bb0c-ef39e717706e" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_423ffe45-4844-4d69-b69b-5ab284b23520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodAbstract_dee83df9-12b6-45a6-b5dd-f03462dbf1f3" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_423ffe45-4844-4d69-b69b-5ab284b23520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_2"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesAdditionalInformationDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_2" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_2"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_10d75e51-206c-4993-b5ca-dbbd2833adfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_10d75e51-206c-4993-b5ca-dbbd2833adfa" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_bf69096f-d313-4be8-9f0a-55f4715fcc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:to="loc_us-gaap_ReinsuranceContractAxis_bf69096f-d313-4be8-9f0a-55f4715fcc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_356324ed-eada-4d21-997e-9d72952b5f7f" xlink:to="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceMember_a413b88b-ba6b-4f8e-86f9-a84c51ddf572" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_11295480-30b7-4713-b61d-ed473ff3b491" xlink:to="loc_ahl_ReinsuranceMember_a413b88b-ba6b-4f8e-86f9-a84c51ddf572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable_5dee1f29-7a5d-4667-a204-4d2f0eabe197" xlink:to="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ecc8e52f-e0fa-408b-908a-f6ed4647b86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ecc8e52f-e0fa-408b-908a-f6ed4647b86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_e489b6e1-dce9-4e72-b10d-4bbf84117336" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_ahl_ReinsuranceRecoverablesIncludingPremiumPaidAndRecognized_e489b6e1-dce9-4e72-b10d-4bbf84117336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1bd16450-15a2-4357-b618-9ac27ae66655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1bd16450-15a2-4357-b618-9ac27ae66655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7d049db1-c566-4f54-8a52-cd3b48217a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7d049db1-c566-4f54-8a52-cd3b48217a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_22e9ae9a-fea5-4eb2-95f9-c35068894047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems_0b85fc01-8c7e-427f-9cdc-3327a671aced" xlink:to="loc_us-gaap_ReinsuranceRetentionExcessRetentionAmountReinsuredPerEvent_22e9ae9a-fea5-4eb2-95f9-c35068894047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_3" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_3"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReservesforLossesandAdjustmentExpensesReconciliationofReinsuranceRecoverablesonUnpaidLossesDetails_3" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_737c6350-a204-44f7-8162-081cc2823c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1940c175-1ffb-47ca-9c46-7bf132dd17f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_737c6350-a204-44f7-8162-081cc2823c13" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1940c175-1ffb-47ca-9c46-7bf132dd17f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1940c175-1ffb-47ca-9c46-7bf132dd17f7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_973b08f1-8d12-43a2-bbdb-2c8d88d9c2cb" xlink:to="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_e0f46c98-c1fc-45b2-9f96-ee9c5d7ac8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_e0f46c98-c1fc-45b2-9f96-ee9c5d7ac8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_32d75d1f-7428-4f4b-b654-42723864a7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_32d75d1f-7428-4f4b-b654-42723864a7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_031b72b1-4ad2-4c62-8124-7a4e8495d891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0b884443-8d2a-4aba-87d9-35ca913e1f4b" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_031b72b1-4ad2-4c62-8124-7a4e8495d891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1940c175-1ffb-47ca-9c46-7bf132dd17f7" xlink:to="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapitalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8e025297-8aca-4cab-9a1f-38d98c266e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8e025297-8aca-4cab-9a1f-38d98c266e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_65afd4a4-5a40-406f-87a4-90201093a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_65afd4a4-5a40-406f-87a4-90201093a80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CommonStockValueAuthorized_f2e39756-23de-4d50-8d78-a8b2b56d9df0" xlink:href="ahl-20231220.xsd#ahl_CommonStockValueAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_ahl_CommonStockValueAuthorized_f2e39756-23de-4d50-8d78-a8b2b56d9df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockValueAuthorized_44f9a2f7-c8a1-49b7-a434-b4cde0421255" xlink:href="ahl-20231220.xsd#ahl_PreferredStockValueAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_ahl_PreferredStockValueAuthorized_44f9a2f7-c8a1-49b7-a434-b4cde0421255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_acb12a45-edad-4526-b24b-facf2825c82f" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_AuthorizedShareCapitalAbstract_9c50a920-7a6e-4027-847e-6afd60466eae" xlink:to="loc_ahl_AuthorizedShareCapital_acb12a45-edad-4526-b24b-facf2825c82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapitalAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a4a1b3b7-12a9-4324-a405-bcf56bb32242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_us-gaap_CommonStockSharesIssued_a4a1b3b7-12a9-4324-a405-bcf56bb32242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1db89144-9b1a-4078-b7d4-3680a810f9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1db89144-9b1a-4078-b7d4-3680a810f9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_319657d3-8474-400e-b715-4d0773741bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_us-gaap_CommonStockValue_319657d3-8474-400e-b715-4d0773741bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_14caebd0-0ee6-4a9e-8ce1-0dcae7a907dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesSubscribedButUnissuedValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_us-gaap_PreferredStockSharesSubscribedButUnissuedValue_14caebd0-0ee6-4a9e-8ce1-0dcae7a907dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_IssuedShareCapital_3d55729c-8283-418c-8df2-09b9111b35fe" xlink:href="ahl-20231220.xsd#ahl_IssuedShareCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_IssuedShareCapitalAbstract_aad257ff-0875-4ad3-8ab8-b2b12fcfd7ac" xlink:to="loc_ahl_IssuedShareCapital_3d55729c-8283-418c-8df2-09b9111b35fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b7b982fa-5f20-40ed-a3ea-1aae00e1fe93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b7b982fa-5f20-40ed-a3ea-1aae00e1fe93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_290055c8-994d-46bb-be23-2da0afb6ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_290055c8-994d-46bb-be23-2da0afb6ab0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_73932235-1464-4364-b61e-cb9b3b0a323f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_73932235-1464-4364-b61e-cb9b3b0a323f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_671d745c-737f-4100-805b-f1251718f96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9c0faeda-a2e3-4d8d-992c-e48e33213b26" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_671d745c-737f-4100-805b-f1251718f96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofAuthorizedandIssuedShareCapitalDetailsPhantom_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a45a4f0f-c9c0-4be7-a1cf-3b1f74b9f2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_458d932c-6d78-4ce8-bb9b-15df833566e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a45a4f0f-c9c0-4be7-a1cf-3b1f74b9f2ea" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_458d932c-6d78-4ce8-bb9b-15df833566e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_458d932c-6d78-4ce8-bb9b-15df833566e7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7a03a4b1-8b84-431c-8a3f-678a7fb2e0f4" xlink:to="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_039695c2-fa9e-41a4-a4ac-7428a3ce0d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_039695c2-fa9e-41a4-a4ac-7428a3ce0d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_ebef80fa-060c-43e5-b157-771abebff69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_ebef80fa-060c-43e5-b157-771abebff69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_b0037c6f-ce27-4a19-98e0-fac8372b2bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cc4d9bd9-5012-492a-9326-1ea0998dcb2b" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_b0037c6f-ce27-4a19-98e0-fac8372b2bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_458d932c-6d78-4ce8-bb9b-15df833566e7" xlink:to="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a63c3125-d2df-4591-88c5-f476f16b5726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a63c3125-d2df-4591-88c5-f476f16b5726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e2aa42e4-493f-41af-816b-1393ed7f8385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e2aa42e4-493f-41af-816b-1393ed7f8385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_612550dd-6cf1-43e5-9fa0-9020b38932d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_612550dd-6cf1-43e5-9fa0-9020b38932d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositaryShareDividendRateFractionalInterest_a3619bcd-c4c6-456f-9580-c809e6be2c16" xlink:href="ahl-20231220.xsd#ahl_DepositaryShareDividendRateFractionalInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_968061a0-2f6c-4b60-806c-bf364ba86004" xlink:to="loc_ahl_DepositaryShareDividendRateFractionalInterest_a3619bcd-c4c6-456f-9580-c809e6be2c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureSummaryofOrdinarySharesDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureSummaryofOrdinarySharesDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureSummaryofOrdinarySharesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3f78bc82-37a1-4ca6-9f87-fb09a22d8c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CapitalStructureAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CapitalStructureAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5ce0cee8-901f-43cf-acfe-44ac81902c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5ce0cee8-901f-43cf-acfe-44ac81902c94" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8731345a-8b65-464c-963e-9e05f224852f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8731345a-8b65-464c-963e-9e05f224852f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f7f4ad85-a195-4f52-bbc5-6674d7242e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8731345a-8b65-464c-963e-9e05f224852f" xlink:to="loc_us-gaap_EquityComponentDomain_f7f4ad85-a195-4f52-bbc5-6674d7242e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b75c6805-d3ee-42f5-a189-4138bb14466e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f7f4ad85-a195-4f52-bbc5-6674d7242e77" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b75c6805-d3ee-42f5-a189-4138bb14466e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_9dc33d75-e292-4b93-a413-65b50dd41e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_19e7de0e-c1d3-4c4e-b3a8-4191bd14ca5d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_9dc33d75-e292-4b93-a413-65b50dd41e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_29476e93-20a8-4ee4-b01e-09fcfe50123b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_StatementClassOfStockAxis_29476e93-20a8-4ee4-b01e-09fcfe50123b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_29476e93-20a8-4ee4-b01e-09fcfe50123b" xlink:to="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_14b64c7c-6df8-4af6-b018-649dc41b714b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:to="loc_us-gaap_PreferredStockMember_14b64c7c-6df8-4af6-b018-649dc41b714b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_ef581f38-e8e1-4497-8ca4-17a3fcd68aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_ef581f38-e8e1-4497-8ca4-17a3fcd68aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_bb01d498-500d-4776-9315-7a3e01735a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_bb01d498-500d-4776-9315-7a3e01735a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_63931cbd-856a-4d0e-8b57-89ab6493b31d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778d8fd1-9d1a-4ec0-a0c4-eac992f567eb" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_63931cbd-856a-4d0e-8b57-89ab6493b31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_20657ef5-33cc-44b4-8966-edb82e902528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_VariableRateAxis_20657ef5-33cc-44b4-8966-edb82e902528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_88fbb4d2-1cb5-4243-99ab-f1fd38116605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_20657ef5-33cc-44b4-8966-edb82e902528" xlink:to="loc_us-gaap_VariableRateDomain_88fbb4d2-1cb5-4243-99ab-f1fd38116605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LIBOR1Member_39a5a28e-f7ee-4d58-9937-fa8f7e9849c8" xlink:href="ahl-20231220.xsd#ahl_LIBOR1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_88fbb4d2-1cb5-4243-99ab-f1fd38116605" xlink:to="loc_ahl_LIBOR1Member_39a5a28e-f7ee-4d58-9937-fa8f7e9849c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2f08bf1c-3be6-41a3-836e-8161e4116d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1dc3716d-ccfa-4d32-a02a-144f1c5afdd8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2f08bf1c-3be6-41a3-836e-8161e4116d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_01fdfe79-ac2e-4566-b248-8f6912bc5a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2f08bf1c-3be6-41a3-836e-8161e4116d07" xlink:to="loc_us-gaap_SubsequentEventMember_01fdfe79-ac2e-4566-b248-8f6912bc5a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e081e917-6a72-4efe-a390-974967d9e192" xlink:to="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b861ef2c-8b2f-4587-b410-b8001e0c405b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b861ef2c-8b2f-4587-b410-b8001e0c405b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockIssuanceCost_96f167c5-2247-4c04-9a51-05f4a8d6cb80" xlink:href="ahl-20231220.xsd#ahl_PreferredStockIssuanceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_ahl_PreferredStockIssuanceCost_96f167c5-2247-4c04-9a51-05f4a8d6cb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AuthorizedShareCapital_fb474ace-2120-47bc-9baa-1e2531f14556" xlink:href="ahl-20231220.xsd#ahl_AuthorizedShareCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_ahl_AuthorizedShareCapital_fb474ace-2120-47bc-9baa-1e2531f14556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e812a10c-77c5-401b-968c-e6f1a68a9536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e812a10c-77c5-401b-968c-e6f1a68a9536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4ce56fd3-64d9-4a6b-beeb-b336d057cbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4ce56fd3-64d9-4a6b-beeb-b336d057cbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9551f4c6-7809-47f8-8331-6e33516be8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9551f4c6-7809-47f8-8331-6e33516be8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0a9fd46a-4fa2-4d0e-b02c-de495ed88658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0a9fd46a-4fa2-4d0e-b02c-de495ed88658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_685567d8-d046-4552-988f-04e56b710d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_CommonStockSharesIssued_685567d8-d046-4552-988f-04e56b710d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_34453b44-292e-459b-97a0-7e7e331b55dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_34453b44-292e-459b-97a0-7e7e331b55dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_d8124217-1dd4-49bf-9f26-982052d9bd93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_d8124217-1dd4-49bf-9f26-982052d9bd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_f03f7110-92e5-4817-926a-9f62d986c68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_f03f7110-92e5-4817-926a-9f62d986c68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_68a6ae5d-c039-4453-a58e-eca064684d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_68a6ae5d-c039-4453-a58e-eca064684d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_2595ad79-9e81-4135-b5a5-ffdcca72f179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_2595ad79-9e81-4135-b5a5-ffdcca72f179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate_272d3728-7535-441a-9741-e347784a3995" xlink:href="ahl-20231220.xsd#ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4795c844-943d-42fb-8b8a-abdb669e203c" xlink:to="loc_ahl_PreferredStockLiquidationPreferenceValueFixedForFloatingRate_272d3728-7535-441a-9741-e347784a3995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#DividendsSummaryofDeclaredDividendsDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/DividendsSummaryofDeclaredDividendsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e544317a-8dc0-42f6-a361-0fbee02c53de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e544317a-8dc0-42f6-a361-0fbee02c53de" xlink:to="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4afabd3d-6206-41d0-9de9-542b352956de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4afabd3d-6206-41d0-9de9-542b352956de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0be0e5a3-528d-4723-95df-188fd2bdc686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4afabd3d-6206-41d0-9de9-542b352956de" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0be0e5a3-528d-4723-95df-188fd2bdc686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_42942570-f554-48bc-a25b-e0a80592f334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0be0e5a3-528d-4723-95df-188fd2bdc686" xlink:to="loc_us-gaap_SubsequentEventMember_42942570-f554-48bc-a25b-e0a80592f334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c16bd290-bd89-4139-90da-f05e066840fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c16bd290-bd89-4139-90da-f05e066840fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c16bd290-bd89-4139-90da-f05e066840fe" xlink:to="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_490513da-4bc1-482e-b3c1-c7c562037bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_490513da-4bc1-482e-b3c1-c7c562037bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_e44ca2be-7242-4827-81ab-e2c831c13e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_e44ca2be-7242-4827-81ab-e2c831c13e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_ad3b2d03-ae7c-4bfd-ba9f-5eb531623948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_80f02f31-d04a-4083-b7e4-533455324156" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_ad3b2d03-ae7c-4bfd-ba9f-5eb531623948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_2be26ce2-1004-4bdf-a880-e7d4c51c6105" xlink:to="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_41bdd649-8180-41d5-8f30-f7822a54c2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_41bdd649-8180-41d5-8f30-f7822a54c2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_777d89b7-c97a-49e1-b624-c93a53ab301c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_777d89b7-c97a-49e1-b624-c93a53ab301c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_90353aeb-94f8-4c04-80db-1825326511cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_90353aeb-94f8-4c04-80db-1825326511cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositaryShareDividend_090e877b-4b38-48fa-9f33-0f1d706e74bb" xlink:href="ahl-20231220.xsd#ahl_DepositaryShareDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_ahl_DepositaryShareDividend_090e877b-4b38-48fa-9f33-0f1d706e74bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_aa576d30-7253-4eac-ab03-18a99bf2c85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_aa576d30-7253-4eac-ab03-18a99bf2c85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_d3244231-6206-4cad-9574-78e59e349c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_8b6c0995-ae22-46de-a0e6-43c7a3799f8a" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_d3244231-6206-4cad-9574-78e59e349c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#RelatedPartyTransactionsNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/RelatedPartyTransactionsNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_3965543d-5185-470f-bf21-ebed56913aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_3965543d-5185-470f-bf21-ebed56913aba" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2cafd76d-fd1d-4988-b24d-0896f453330b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_srt_RangeAxis_2cafd76d-fd1d-4988-b24d-0896f453330b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_348433ae-e54d-4476-8cb6-b10537fec486" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2cafd76d-fd1d-4988-b24d-0896f453330b" xlink:to="loc_srt_RangeMember_348433ae-e54d-4476-8cb6-b10537fec486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5713b81d-92da-46bb-8c84-e9bc02d69304" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_348433ae-e54d-4476-8cb6-b10537fec486" xlink:to="loc_srt_MaximumMember_5713b81d-92da-46bb-8c84-e9bc02d69304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0a8b95d-6c5b-4e00-b7e7-8ed305b2c0b0" xlink:to="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_8ece1435-5099-4850-9c83-e93bce4e7f27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_srt_AffiliatedEntityMember_8ece1435-5099-4850-9c83-e93bce4e7f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BeneficialOwnerMember_5e17d07a-3f98-45dd-9a72-5b9df93896a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BeneficialOwnerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_us-gaap_BeneficialOwnerMember_5e17d07a-3f98-45dd-9a72-5b9df93896a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloRealEstateFundMember_5d8568a3-09ce-4cd4-8d3d-d64acf19646c" xlink:href="ahl-20231220.xsd#ahl_ApolloRealEstateFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ApolloRealEstateFundMember_5d8568a3-09ce-4cd4-8d3d-d64acf19646c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_61df3875-8084-4d36-b07c-11ade3acb49f" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_61df3875-8084-4d36-b07c-11ade3acb49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassANotesMember_317885f5-92f0-4587-9968-18f2d33eb720" xlink:href="ahl-20231220.xsd#ahl_ApolloClassANotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ApolloClassANotesMember_317885f5-92f0-4587-9968-18f2d33eb720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloClassBNotesMember_249716ba-a9fe-46f0-8609-a9089cfe47a7" xlink:href="ahl-20231220.xsd#ahl_ApolloClassBNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ApolloClassBNotesMember_249716ba-a9fe-46f0-8609-a9089cfe47a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ClassABNotesMember_e2ee0138-bf58-4b89-b9d6-ceea9ec57967" xlink:href="ahl-20231220.xsd#ahl_ClassABNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4c861543-62cb-4fab-a511-24737811f71a" xlink:to="loc_ahl_ClassABNotesMember_e2ee0138-bf58-4b89-b9d6-ceea9ec57967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_24fe7750-fdef-420d-8b20-5cb190e60aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_24fe7750-fdef-420d-8b20-5cb190e60aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_24fe7750-fdef-420d-8b20-5cb190e60aa4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetManagementArrangementMember_bdfa1f66-8ffc-4da7-a5a1-378477716af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetManagementArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:to="loc_us-gaap_AssetManagementArrangementMember_bdfa1f66-8ffc-4da7-a5a1-378477716af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ManagementConsultingAgreementMember_fcf2c3af-17e3-42d8-89ca-848d99094f24" xlink:href="ahl-20231220.xsd#ahl_ManagementConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:to="loc_ahl_ManagementConsultingAgreementMember_fcf2c3af-17e3-42d8-89ca-848d99094f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ApolloOriginatingPartnershipMember_a4847e0f-84e2-4794-990d-278057b92b81" xlink:href="ahl-20231220.xsd#ahl_ApolloOriginatingPartnershipMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9101937e-3d33-4b10-9e47-84a89519039a" xlink:to="loc_ahl_ApolloOriginatingPartnershipMember_a4847e0f-84e2-4794-990d-278057b92b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_61b61554-09e7-4a8d-83a7-661dfab8de3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_61b61554-09e7-4a8d-83a7-661dfab8de3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_61b61554-09e7-4a8d-83a7-661dfab8de3a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_144e25f9-7ed4-4229-b6a7-e7f376ac2939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:to="loc_us-gaap_InvestmentIncomeMember_144e25f9-7ed4-4229-b6a7-e7f376ac2939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9fb26665-259a-4ae4-b8d4-0a4924d58fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9fb26665-259a-4ae4-b8d4-0a4924d58fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsMember1_45858980-0831-4cb6-bce7-70080bcf4234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsMember1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a58484d9-9544-4971-8b3b-bb5918cb10b7" xlink:to="loc_us-gaap_GainLossOnInvestmentsMember1_45858980-0831-4cb6-bce7-70080bcf4234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca4e13d-e5ea-419d-99bb-310021d3fc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca4e13d-e5ea-419d-99bb-310021d3fc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_475f437c-6560-4da8-884c-98203220bf49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca4e13d-e5ea-419d-99bb-310021d3fc1d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_475f437c-6560-4da8-884c-98203220bf49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c0cf23f8-7fb3-4e18-ab19-4fc0572bebf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_475f437c-6560-4da8-884c-98203220bf49" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c0cf23f8-7fb3-4e18-ab19-4fc0572bebf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_52b79fb7-2437-41cb-99da-8f97a1fc605f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_52b79fb7-2437-41cb-99da-8f97a1fc605f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_987443e0-b500-47a2-ba9b-9c46f4a0c2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_52b79fb7-2437-41cb-99da-8f97a1fc605f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_987443e0-b500-47a2-ba9b-9c46f4a0c2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldinvestmentsMember_52520c9f-1aa7-472e-b68d-d21a1333c482" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldinvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_987443e0-b500-47a2-ba9b-9c46f4a0c2ee" xlink:to="loc_ahl_PrivatelyheldinvestmentsMember_52520c9f-1aa7-472e-b68d-d21a1333c482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_71c381e6-8967-481d-b8e0-b5e6b2ce670a" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionRateofInterest_ae5cd544-a604-4e2e-abd6-8c4598ac7954" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionRateofInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_ahl_RelatedPartyTransactionRateofInterest_ae5cd544-a604-4e2e-abd6-8c4598ac7954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RelatedPartyTransactionMaximumRateIncrease_bf90050f-7380-432f-ab2e-f57cd86e8737" xlink:href="ahl-20231220.xsd#ahl_RelatedPartyTransactionMaximumRateIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_ahl_RelatedPartyTransactionMaximumRateIncrease_bf90050f-7380-432f-ab2e-f57cd86e8737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_d454212c-1585-4918-820d-7a248681ac29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_d454212c-1585-4918-820d-7a248681ac29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromOfficersOrStockholdersCurrent_476978cf-24de-4695-a6ee-78992916496c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_DueFromOfficersOrStockholdersCurrent_476978cf-24de-4695-a6ee-78992916496c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_ead0a22c-51d0-4433-9ea7-c1355e9c4ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_DueToAffiliateCurrent_ead0a22c-51d0-4433-9ea7-c1355e9c4ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_699b1dcb-1308-4d16-899e-d8c302355c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_699b1dcb-1308-4d16-899e-d8c302355c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_1d5f651d-a649-462f-9d1b-0335550aa95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_1d5f651d-a649-462f-9d1b-0335550aa95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyheldInvestments_d979abc1-5ffc-4cf0-818d-d0550812f63b" xlink:href="ahl-20231220.xsd#ahl_PrivatelyheldInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_ahl_PrivatelyheldInvestments_d979abc1-5ffc-4cf0-818d-d0550812f63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_2fd31bac-501d-448f-bcaa-fbaaea8d22e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_us-gaap_OtherInvestments_2fd31bac-501d-448f-bcaa-fbaaea8d22e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PrivatelyHeldInvestmentLossesIncurred_ef9b65c0-95dd-4964-abfe-e098ff9740bc" xlink:href="ahl-20231220.xsd#ahl_PrivatelyHeldInvestmentLossesIncurred"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_78b23d53-d05b-4179-8193-8b21b986a087" xlink:to="loc_ahl_PrivatelyHeldInvestmentLossesIncurred_ef9b65c0-95dd-4964-abfe-e098ff9740bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesScheduleofCompanysRestrictedAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e6413a60-3b21-46d7-bdf4-7b4834fe15fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e6413a60-3b21-46d7-bdf4-7b4834fe15fc" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_44148dbe-c415-4584-bbc0-7c4795608f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_44148dbe-c415-4584-bbc0-7c4795608f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6766accf-54d3-4bd2-9c90-f4c352a11e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_44148dbe-c415-4584-bbc0-7c4795608f17" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6766accf-54d3-4bd2-9c90-f4c352a11e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_21e82344-d070-422d-9d2c-e527250430b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_6766accf-54d3-4bd2-9c90-f4c352a11e42" xlink:to="loc_us-gaap_LimitedPartnerMember_21e82344-d070-422d-9d2c-e527250430b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_22b300f5-a39f-4dad-a3a4-8b00f19d1415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:to="loc_us-gaap_InvestmentTypeAxis_22b300f5-a39f-4dad-a3a4-8b00f19d1415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b6bf0b51-a90e-4c4f-b038-7f1c4f23c5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_22b300f5-a39f-4dad-a3a4-8b00f19d1415" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b6bf0b51-a90e-4c4f-b038-7f1c4f23c5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_6f136cb5-df17-4b60-b715-3777a609f502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b6bf0b51-a90e-4c4f-b038-7f1c4f23c5a8" xlink:to="loc_us-gaap_RealEstateFundsMember_6f136cb5-df17-4b60-b715-3777a609f502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_596c2e0d-914e-427c-8993-9804ca229780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_596c2e0d-914e-427c-8993-9804ca229780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e578cf4b-b4bd-46bc-9baa-a0803c609abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_596c2e0d-914e-427c-8993-9804ca229780" xlink:to="loc_us-gaap_RelatedPartyDomain_e578cf4b-b4bd-46bc-9baa-a0803c609abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_f0b6d3f5-982f-4bdf-a014-63f857658e53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_e578cf4b-b4bd-46bc-9baa-a0803c609abe" xlink:to="loc_srt_AffiliatedEntityMember_f0b6d3f5-982f-4bdf-a014-63f857658e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ThirdPartyMember_ef4b9254-3c53-47bf-a306-2621ec8c9b26" xlink:href="ahl-20231220.xsd#ahl_ThirdPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_e578cf4b-b4bd-46bc-9baa-a0803c609abe" xlink:to="loc_ahl_ThirdPartyMember_ef4b9254-3c53-47bf-a306-2621ec8c9b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_4684cdcb-2e46-4a3f-81bd-3474c04c46ac" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_f77b0885-2ec3-4c05-ab39-c83f3c61ac62" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_RestrictedAssets_f77b0885-2ec3-4c05-ab39-c83f3c61ac62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssetsExcludingIlliquidAssets_82e3f11b-7429-4b28-84fc-c6c2138e8ac9" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssetsExcludingIlliquidAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_RestrictedAssetsExcludingIlliquidAssets_82e3f11b-7429-4b28-84fc-c6c2138e8ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_1b85b332-9878-42c0-b726-b57873c77dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_us-gaap_OtherInvestments_1b85b332-9878-42c0-b726-b57873c77dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_TotalRestrictedAssets_25be262a-bb6b-4dcc-9302-7e709f5cb272" xlink:href="ahl-20231220.xsd#ahl_TotalRestrictedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_TotalRestrictedAssets_25be262a-bb6b-4dcc-9302-7e709f5cb272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_bde37beb-8a23-442f-a2df-99063ed3483f" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_bde37beb-8a23-442f-a2df-99063ed3483f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_e5df5cbf-a85a-48ff-b72c-0d1f2fe4ca3f" xlink:href="ahl-20231220.xsd#ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_ef8dbc19-5251-4a9a-952f-c7ef0ebedd61" xlink:to="loc_ahl_DepositSecuritiesAndCashAsCollateralSecuredLettersOfCredit_e5df5cbf-a85a-48ff-b72c-0d1f2fe4ca3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#CommitmentsandContingenciesAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/CommitmentsandContingenciesAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2a640e42-4cd2-41d8-a673-3b8a803eaacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2a640e42-4cd2-41d8-a673-3b8a803eaacc" xlink:to="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_7c4735c0-ba1e-485c-9cf9-222b2853192d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_7c4735c0-ba1e-485c-9cf9-222b2853192d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4ce29760-54db-4ec2-a190-a6453a3202e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_7c4735c0-ba1e-485c-9cf9-222b2853192d" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4ce29760-54db-4ec2-a190-a6453a3202e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnerMember_1ec2622f-6fde-4160-9326-2f7cb93bf944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_4ce29760-54db-4ec2-a190-a6453a3202e6" xlink:to="loc_us-gaap_LimitedPartnerMember_1ec2622f-6fde-4160-9326-2f7cb93bf944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2a8e2476-3c89-4bb2-8313-eb34dae43049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_InvestmentTypeAxis_2a8e2476-3c89-4bb2-8313-eb34dae43049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ab20d9be-4b7e-457e-8efd-62d911cb18ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_2a8e2476-3c89-4bb2-8313-eb34dae43049" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ab20d9be-4b7e-457e-8efd-62d911cb18ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_642881ad-9a4f-43d3-985d-987433b5e4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ab20d9be-4b7e-457e-8efd-62d911cb18ed" xlink:to="loc_us-gaap_RealEstateFundsMember_642881ad-9a4f-43d3-985d-987433b5e4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_90900981-290f-4554-bdd9-3fd37980ae18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_HedgingDesignationAxis_90900981-290f-4554-bdd9-3fd37980ae18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f0de2e18-7744-4a46-9000-c61f7ab35b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_90900981-290f-4554-bdd9-3fd37980ae18" xlink:to="loc_us-gaap_HedgingDesignationDomain_f0de2e18-7744-4a46-9000-c61f7ab35b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d0fd0c5e-970d-4fdc-abf0-ae101205dbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f0de2e18-7744-4a46-9000-c61f7ab35b17" xlink:to="loc_us-gaap_NondesignatedMember_d0fd0c5e-970d-4fdc-abf0-ae101205dbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6361a4f5-570f-41f6-8c7c-a7c6e21b8834" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_dei_LegalEntityAxis_6361a4f5-570f-41f6-8c7c-a7c6e21b8834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_919f6903-d769-405c-b300-efe6fd43ee1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6361a4f5-570f-41f6-8c7c-a7c6e21b8834" xlink:to="loc_dei_EntityDomain_919f6903-d769-405c-b300-efe6fd43ee1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AspenBermudaMember_3c42b31f-c816-44db-8afb-db88eb1579b6" xlink:href="ahl-20231220.xsd#ahl_AspenBermudaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_919f6903-d769-405c-b300-efe6fd43ee1a" xlink:to="loc_ahl_AspenBermudaMember_3c42b31f-c816-44db-8afb-db88eb1579b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c541037-6a61-4f8f-849e-2782e6f8f34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c541037-6a61-4f8f-849e-2782e6f8f34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8c541037-6a61-4f8f-849e-2782e6f8f34e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsMultiBeneficiaryTrustFundMember_47b4c6d1-2d14-4d4d-878a-ed3359515144" xlink:href="ahl-20231220.xsd#ahl_UsMultiBeneficiaryTrustFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_UsMultiBeneficiaryTrustFundMember_47b4c6d1-2d14-4d4d-878a-ed3359515144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_UsSurplusLinesTrustFundMember_dd322620-23f8-4b55-8734-218fbdde4863" xlink:href="ahl-20231220.xsd#ahl_UsSurplusLinesTrustFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_UsSurplusLinesTrustFundMember_dd322620-23f8-4b55-8734-218fbdde4863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CanadianTrustFundMember_5f7fa2d2-622e-4a8b-8d32-b1536c0e2fa4" xlink:href="ahl-20231220.xsd#ahl_CanadianTrustFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_CanadianTrustFundMember_5f7fa2d2-622e-4a8b-8d32-b1536c0e2fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AustralianTrustFundMember_39d49b86-d2a6-4d35-8807-05657bb1129a" xlink:href="ahl-20231220.xsd#ahl_AustralianTrustFundMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_AustralianTrustFundMember_39d49b86-d2a6-4d35-8807-05657bb1129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SwissTrustFundMember_182567d3-41e3-429b-b64f-9b6d95319169" xlink:href="ahl-20231220.xsd#ahl_SwissTrustFundMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_SwissTrustFundMember_182567d3-41e3-429b-b64f-9b6d95319169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_SingaporeTrustFundMember_8714a32a-5184-4ad2-80d9-0905a59b1b9b" xlink:href="ahl-20231220.xsd#ahl_SingaporeTrustFundMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f8be28e-99a4-44fe-8b90-ac17b4939dba" xlink:to="loc_ahl_SingaporeTrustFundMember_8714a32a-5184-4ad2-80d9-0905a59b1b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86de128f-10c8-45d4-9d09-f46dcb173e6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86de128f-10c8-45d4-9d09-f46dcb173e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_487571ce-17fa-40a8-90da-3d2d66f0173e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86de128f-10c8-45d4-9d09-f46dcb173e6f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_487571ce-17fa-40a8-90da-3d2d66f0173e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MVIMember_ade065b9-f2d8-4325-ad6e-32a64c62aa22" xlink:href="ahl-20231220.xsd#ahl_MVIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_487571ce-17fa-40a8-90da-3d2d66f0173e" xlink:to="loc_ahl_MVIMember_ade065b9-f2d8-4325-ad6e-32a64c62aa22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MultiLineReinsurerMember_7326c2c4-80a2-4ed4-b04c-98e9f5ab8b0b" xlink:href="ahl-20231220.xsd#ahl_MultiLineReinsurerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_487571ce-17fa-40a8-90da-3d2d66f0173e" xlink:to="loc_ahl_MultiLineReinsurerMember_7326c2c4-80a2-4ed4-b04c-98e9f5ab8b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bba7493e-23b1-46a1-8d8b-fb067872fa47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bba7493e-23b1-46a1-8d8b-fb067872fa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5982ecc1-3100-4304-ad6d-59790a1eb807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bba7493e-23b1-46a1-8d8b-fb067872fa47" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5982ecc1-3100-4304-ad6d-59790a1eb807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_141564b3-d93a-4dc3-a096-52297656877e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5982ecc1-3100-4304-ad6d-59790a1eb807" xlink:to="loc_us-gaap_SubsequentEventMember_141564b3-d93a-4dc3-a096-52297656877e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:href="ahl-20231220.xsd#ahl_RestrictedCashAndCollateralLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralTable_86ff5084-1dfc-4ec4-a131-bec37b5b2e1c" xlink:to="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RestrictedAssets_0b794b5a-ee74-4a5a-a568-094332dc99ae" xlink:href="ahl-20231220.xsd#ahl_RestrictedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_RestrictedAssets_0b794b5a-ee74-4a5a-a568-094332dc99ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestments_9adf4c00-66dc-4603-b9db-503219ebd62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_OtherInvestments_9adf4c00-66dc-4603-b9db-503219ebd62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_0835ec5f-8609-4b4a-8b03-8fbddec23b89" xlink:href="ahl-20231220.xsd#ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_CollateralFundsHeldAsPercentageOfCashAndShortTermInvestments_0835ec5f-8609-4b4a-8b03-8fbddec23b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_eee14f53-7a7a-48f9-86e0-1adb33d86f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_eee14f53-7a7a-48f9-86e0-1adb33d86f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_188b098a-9735-4b33-b501-c2ab887012f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_188b098a-9735-4b33-b501-c2ab887012f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_10bbc6f7-7592-47f8-acee-4740c96882d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_10bbc6f7-7592-47f8-acee-4740c96882d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumNetCapitalRequired1_ff72da18-0932-4053-b08c-6dabae8e5bb1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumNetCapitalRequired1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_srt_MinimumNetCapitalRequired1_ff72da18-0932-4053-b08c-6dabae8e5bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MinimumTrustFund_69358f8a-2933-477f-9afa-e52a8608b835" xlink:href="ahl-20231220.xsd#ahl_MinimumTrustFund"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_MinimumTrustFund_69358f8a-2933-477f-9afa-e52a8608b835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfReinsuranceLiabilities_dde19535-ccdb-44ee-9bc7-4452f6e3997a" xlink:href="ahl-20231220.xsd#ahl_PercentageOfReinsuranceLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_PercentageOfReinsuranceLiabilities_dde19535-ccdb-44ee-9bc7-4452f6e3997a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceLiabilities_e980416c-814c-4613-af33-f739a1bf09d6" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_ReinsuranceLiabilities_e980416c-814c-4613-af33-f739a1bf09d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_c2ffde35-564c-47e1-bcb8-8b7786bd2a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_us-gaap_AssetsHeldInTrust_c2ffde35-564c-47e1-bcb8-8b7786bd2a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_RegulatoryDeposits_41ba1e06-fcdb-4d56-9d29-528c722d9d16" xlink:href="ahl-20231220.xsd#ahl_RegulatoryDeposits"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_RegulatoryDeposits_41ba1e06-fcdb-4d56-9d29-528c722d9d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DepositWithStates_f8b4f695-2d22-4090-9c87-2d147465eab6" xlink:href="ahl-20231220.xsd#ahl_DepositWithStates"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_RestrictedCashAndCollateralLineItems_0c80cc96-6bb7-4aa7-93a4-7ce23d1872ac" xlink:to="loc_ahl_DepositWithStates_f8b4f695-2d22-4090-9c87-2d147465eab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ConcentrationofCreditRiskAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ConcentrationofCreditRiskAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_e7919019-0996-4fa7-bd31-e0966b831b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_e7919019-0996-4fa7-bd31-e0966b831b98" xlink:to="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MajorRatingAgenciesAxis_563d91b5-a5c1-48c9-a688-302c8aa3c38b" xlink:href="ahl-20231220.xsd#ahl_MajorRatingAgenciesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:to="loc_ahl_MajorRatingAgenciesAxis_563d91b5-a5c1-48c9-a688-302c8aa3c38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MajorRatingAgenciesDomain_286cdbe0-3880-42f6-939d-7a58c8853c22" xlink:href="ahl-20231220.xsd#ahl_MajorRatingAgenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_MajorRatingAgenciesAxis_563d91b5-a5c1-48c9-a688-302c8aa3c38b" xlink:to="loc_ahl_MajorRatingAgenciesDomain_286cdbe0-3880-42f6-939d-7a58c8853c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAOrHigherMember_3f2ce676-5b4d-4892-8dfb-38b56926ab99" xlink:href="ahl-20231220.xsd#ahl_AAOrHigherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_MajorRatingAgenciesDomain_286cdbe0-3880-42f6-939d-7a58c8853c22" xlink:to="loc_ahl_AAOrHigherMember_3f2ce676-5b4d-4892-8dfb-38b56926ab99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_AAOrLowerMember_5c556549-34ee-47c5-89d6-ce4afe2cd363" xlink:href="ahl-20231220.xsd#ahl_AAOrLowerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ahl_MajorRatingAgenciesDomain_286cdbe0-3880-42f6-939d-7a58c8853c22" xlink:to="loc_ahl_AAOrLowerMember_5c556549-34ee-47c5-89d6-ce4afe2cd363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d012b6c4-8dec-417a-9558-72a531f3444b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d012b6c4-8dec-417a-9558-72a531f3444b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d012b6c4-8dec-417a-9558-72a531f3444b" xlink:to="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_MunichReMember_cf10ddc7-727d-472a-87f5-887d8300b641" xlink:href="ahl-20231220.xsd#ahl_MunichReMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:to="loc_ahl_MunichReMember_cf10ddc7-727d-472a-87f5-887d8300b641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_EverestReMember_bb944c09-0e30-40fb-9d39-f6f782bb81f4" xlink:href="ahl-20231220.xsd#ahl_EverestReMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:to="loc_ahl_EverestReMember_bb944c09-0e30-40fb-9d39-f6f782bb81f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_LloydsMember_9fd85e4c-86a1-443b-b2ac-b6024e9288c7" xlink:href="ahl-20231220.xsd#ahl_LloydsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d729318d-b69e-4379-884c-07429e293222" xlink:to="loc_ahl_LloydsMember_9fd85e4c-86a1-443b-b2ac-b6024e9288c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_40665516-bf56-419c-aa24-68e6057ee7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_40665516-bf56-419c-aa24-68e6057ee7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_748728fa-abad-4853-8957-dffd3ed9b5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_40665516-bf56-419c-aa24-68e6057ee7dd" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_748728fa-abad-4853-8957-dffd3ed9b5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_3f6cd3ed-111d-43e6-88d5-39dcdcb0ac4c" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_38f4d1c8-3af1-4d27-86ce-612d11108d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_ReinsuranceRecoverables_38f4d1c8-3af1-4d27-86ce-612d11108d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ReinsuranceRecoverablesCollateralizedPercent_f9f6c341-2edf-4189-9bd8-80875d36a5f9" xlink:href="ahl-20231220.xsd#ahl_ReinsuranceRecoverablesCollateralizedPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_ahl_ReinsuranceRecoverablesCollateralizedPercent_f9f6c341-2edf-4189-9bd8-80875d36a5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_ConcentrationRiskThresholdPercentage_0aceda21-7287-45ae-a4aa-5934dff0d70f" xlink:href="ahl-20231220.xsd#ahl_ConcentrationRiskThresholdPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_ahl_ConcentrationRiskThresholdPercentage_0aceda21-7287-45ae-a4aa-5934dff0d70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_9198a43e-0a4d-4f29-b9bb-8dc9d1093c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_9198a43e-0a4d-4f29-b9bb-8dc9d1093c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PremiumsReceivableNonCurrent_0abdd523-a7de-41b3-a6eb-685e99b292c3" xlink:href="ahl-20231220.xsd#ahl_PremiumsReceivableNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_ahl_PremiumsReceivableNonCurrent_0abdd523-a7de-41b3-a6eb-685e99b292c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_e767a989-4ce5-41dd-8c17-09375c1564ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_e767a989-4ce5-41dd-8c17-09375c1564ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_29e7724d-56c2-4c71-a9b1-e8f75ae49aab" xlink:href="ahl-20231220.xsd#ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_ahl_PercentageOfAllowableHoldingsOfASingleIssuerOrIssuerMinimum_29e7724d-56c2-4c71-a9b1-e8f75ae49aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_4a9508d2-bb72-4c7e-a0e8-65cc631aa1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c9b25e7d-5b03-4471-b980-ee410998c5a3" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_4a9508d2-bb72-4c7e-a0e8-65cc631aa1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/ReclassificationsfromAccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeReclassificationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b544f24a-ae70-461a-8425-d865af139a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b544f24a-ae70-461a-8425-d865af139a60" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6b95931b-f5c1-40d4-b6a1-d68e691d8415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6b95931b-f5c1-40d4-b6a1-d68e691d8415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_71483071-bd79-4114-aa15-3c06d736e793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6b95931b-f5c1-40d4-b6a1-d68e691d8415" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_71483071-bd79-4114-aa15-3c06d736e793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_c30764d9-9dc1-4b51-b30b-298f81c3d1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71483071-bd79-4114-aa15-3c06d736e793" xlink:to="loc_us-gaap_ForeignExchangeContractMember_c30764d9-9dc1-4b51-b30b-298f81c3d1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cf7407ce-7301-4d45-8e7c-13ffd0b60825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cf7407ce-7301-4d45-8e7c-13ffd0b60825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4748bc3f-a4d9-447b-87cd-e38484a0717d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cf7407ce-7301-4d45-8e7c-13ffd0b60825" xlink:to="loc_us-gaap_EquityComponentDomain_4748bc3f-a4d9-447b-87cd-e38484a0717d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8754bec4-a0df-4b53-a462-ee33e2a9ad6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4748bc3f-a4d9-447b-87cd-e38484a0717d" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8754bec4-a0df-4b53-a462-ee33e2a9ad6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_b1541a52-564b-47ac-8435-c042877d60d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4748bc3f-a4d9-447b-87cd-e38484a0717d" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_b1541a52-564b-47ac-8435-c042877d60d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_343b37a2-05e9-4d82-97be-b1ff8c30b92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_343b37a2-05e9-4d82-97be-b1ff8c30b92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5fcdba98-71d6-493e-9322-d23410bf8401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_343b37a2-05e9-4d82-97be-b1ff8c30b92a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5fcdba98-71d6-493e-9322-d23410bf8401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3179d266-44aa-45ce-8a01-c6fa82b24cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5fcdba98-71d6-493e-9322-d23410bf8401" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3179d266-44aa-45ce-8a01-c6fa82b24cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_de58f6f7-6207-4dc3-bef2-c8822ef02819" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_c6774c12-b90f-477b-a0cc-397c9b9b3abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_c6774c12-b90f-477b-a0cc-397c9b9b3abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_a1ca2b5a-22ea-41e6-963f-b33150ca7f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_a1ca2b5a-22ea-41e6-963f-b33150ca7f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_03f1adb2-d4aa-48dd-a83e-18c20c56bc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_03f1adb2-d4aa-48dd-a83e-18c20c56bc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9a3b66a8-6687-4229-9d24-a619f79bbf64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9a3b66a8-6687-4229-9d24-a619f79bbf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_348c1eee-1f96-4d18-843c-abe25585f551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_348c1eee-1f96-4d18-843c-abe25585f551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_f004c42f-c147-4648-a353-02151ab4ef30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_f004c42f-c147-4648-a353-02151ab4ef30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b55c0d8d-36d0-4b4d-a456-831bb8ae6f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_096d4935-d991-42d3-99ac-da459f95f10b" xlink:to="loc_us-gaap_ProfitLoss_b55c0d8d-36d0-4b4d-a456-831bb8ae6f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.aspen.co/role/SubsequentEventsNarrativeDetails_1" xlink:type="simple" xlink:href="ahl-20231220.xsd#SubsequentEventsNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.aspen.co/role/SubsequentEventsNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f480de8a-a46c-4f38-84ed-b08edb559a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_4db43d5c-e0eb-4dbd-bfd7-38b757adffd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f480de8a-a46c-4f38-84ed-b08edb559a48" xlink:to="loc_us-gaap_SubsequentEventTable_4db43d5c-e0eb-4dbd-bfd7-38b757adffd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_4db43d5c-e0eb-4dbd-bfd7-38b757adffd3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_43275f49-f3fe-4421-8fd5-3480ab462cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6b76168d-2c0f-4e6c-bf54-f4b0f5c06448" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_43275f49-f3fe-4421-8fd5-3480ab462cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6a569b33-87fb-4615-9db1-80d3d2117282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_43275f49-f3fe-4421-8fd5-3480ab462cc4" xlink:to="loc_us-gaap_SubsequentEventMember_6a569b33-87fb-4615-9db1-80d3d2117282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_7ad9358e-40b3-421b-a369-b88b6fef8075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_4db43d5c-e0eb-4dbd-bfd7-38b757adffd3" xlink:to="loc_us-gaap_SubsequentEventLineItems_7ad9358e-40b3-421b-a369-b88b6fef8075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ahl_DelayedDrawTermLoanFacility_f5b617ed-37b4-4d0d-bb98-660f82c8d9c3" xlink:href="ahl-20231220.xsd#ahl_DelayedDrawTermLoanFacility"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_7ad9358e-40b3-421b-a369-b88b6fef8075" xlink:to="loc_ahl_DelayedDrawTermLoanFacility_f5b617ed-37b4-4d0d-bb98-660f82c8d9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>ahl-20231220_g1.jpg
<TEXT>
begin 644 ahl-20231220_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #5 N8# 2(  A$! Q$!_\0
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M)+9H)9/1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_6@"S17+77Q*\*V<@2?Q/I,+G^%[R,'^=.M_B/X5O&VV_B;296]$O8S_ %H
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MDX"ZC$./-4=G'\0_$4!8^RZ*:K KP:=02%%%122(%;+;>,DGB@!9/F0@'FO
M_P!H#]M/X9?LYQ20:]JPU'7MN8]%TPB6X8^C=D_&OE#]N+_@I%)HL][X"^$M
M^OVV-F@U+Q+'\WE$<-%;]L^K]NU?F3?7]UJE[+>7MQ+>7DS%Y;B=R[NQ/))/
M)- S[/\ C#_P59^*GCFZGM_!\%IX%TCE4:%1<7A']XR-PI]@*^6_%?QF\>^.
M9I9=?\8:UJC2'++->OM)^@.!^%<=1D=.] R:2\N9L&2YFD;U:1B?YTBWES%D
MQW,Z'_9E8?UKT+PK^S?\4O'&FK?Z%X!UW4K)AE9X[1E5AZC=C-8WCCX0^-_A
MJ%/BGPIJVA(W22\M65/^^NGZT 'A;XQ>._ \T4N@^+]:TUHFW*(+QPO7/0FO
MJ3X-_P#!53XJ^ ;B&W\81VOCS1UX?SU$%XHS]Y9%X)]F':OBVB@#]\_V>?VQ
MOAO^TE9HGAS5#::XJYFT74,1W,9[X'1Q[BO=(V 4#=DCK7\TV@Z]J7A;6K35
MM'OI]-U.UD$D%W;.4DC8=""*_83]@7]N5?V@]+'@_P 92PVWQ L(LI< !$U.
M(?QA>T@_B X[T"L?;&10WW335Z+SVIU CQC]H+]JKP%^S-:Z>_C2\NXIM05W
MM;>SMS*\H7&0!VZBODOQE_P60\,V>^/PKX!U34VP=D^I7*0(3VRH!85S7_!9
MC_D)_#3_ *Y77\UK\U:!GVIXT_X*T?&3Q"2NBV6@^%H6S_J;=KJ3';#N1C\J
M\)\8?M?_ !G\=E_[7^(>LO&[9\JVF\A!^" <5Y#10,_<K_@F[J5WJW[(/@Z[
MOKJ:\NI9;PO/<2%W8_:).K'FOI;4=0M=,L9[N\N([:U@0O+-,X1$4=22>@KX
MJ_8K^,'A7X(_L!^%?%'B[5(].TZ"2\"J3F29_M$F$1>K,?05\'?M9?MV>-/V
MD]6N-/LYIO#?@6-R+?1[>0J\Z_WYW'WB?[O0?G02?;O[1?\ P52\&_#F:YT7
MX>60\:ZY&2C7KN8["%N_S#F0CVXK\^_BA^V_\9_BU/*=6\:7EC:.VX6&DG[+
M OL-OS'\37A2KC ["G4%%NZUC4+^1Y+J_NKEV.XM-.[$_B3UJ&.]NH&W17,\
M3?WDE8$?K45% SV+X1_M>_%CX*W\4_A[Q;>26L>-VFZDYN;5U'\)5CD<<<$5
M^LG['_[<WAG]J*S&EW$*:!XXMX]\^D-)N291UDA;NOL>17X<UL>#?&&L?#WQ
M5IGB/0+Z73=7TV99[:YA;#*P/0^H/0CN*!']*.X>M%>5_LX_&RP_: ^#^@^,
MK,)'-=1>7>6X/^IN%X=?SY'L:*"3\1?VN?&K?$#]ICXB:R':2%M6FMX2QS^[
MB/E+CZA<_C7DE6M6U*;6-4N[^X.9[J9IY#DGYF))Z\]3WJK0636-]<:7?VU[
M:2M!=V\JS0RH<%'4@JP/KD"OW\_9+^.EO\?_ ('^'_%&]3J7E"VU&)3REP@V
MOGTSC/XU_/X1G@]*^W_^"6/[0B?#?XM3^ =6N-FA^+,+;LYPL5\H^3_OM1M^
MH6@EG["R0)=1NDBJ\3@JRL,@@C!!_"OPB_;N^ +_  !^/VL6-M 8] UDG4M,
M<#"[&/SH/]UN/Q'K7[PQ_<]*^4?^"CO[/J?&OX"WFHV-OO\ $?A<MJ-DRCYG
MC _>Q?0KSCU H$?B,.@HIJMD=,<=^M.H+$:OK7_@F+XR\1^'?VG=.TW1;:2]
MT_5K>2'5(4/RI"!N$I_W3C\Z^2CG@*"6)P !U/I7[0_\$W?V5V^"/PK_ .$G
MUZU\GQAXFB6>1)!\]I;$;HXO4,<[F';@=J!'V1']VG-R*BSY/'7'4FN"\:?M
M _#GX=ZS_9'B?QIHVA:GL$OV2]NE20*>A(]Z"3M[C3(;O;]HAAG .0)4#8^F
M:9_8>G?] ^U_[\+_ (5Y?_PUU\%_^BF>'/\ P-6C_AKKX+_]%-\.?^!JT#/4
M?[#T[_H'VO\ WX7_  H_L/3O^@?:_P#?A?\ "O+O^&O/@O\ ]%-\.?\ @:M'
M_#7GP7_Z*;X<_P# U: /4?[#T[_H'VO_ 'X7_"D_L/3O^@?:_P#?A?\ "O+_
M /AKSX+_ /13?#G_ (&K1_PUY\%_^BF^'/\ P-6@1ZC'H]E#(KQ65M&ZG(9(
M5!'XXJZ*\C7]KGX,2,JK\2_#K,Q"@"]7DDX KU:WNDNHXY8V#Q2*&1E.00>0
M: )Z*** "BBB@!K?=/TK\WO^"O\ \7#8>%/"GPWM)\2:A<'5;]%)#&.,%8U.
M.Q)8D>PK]()&"JQ8X4#)-?@3^VQ\6O\ A<G[2/BW689/-TZUN#IUF0V1Y47R
MY!]"030-'A?"]<5]C_\ !+7X2M\0/VCD\1W, ?2_"EJUX7=<C[2WRQ >XR6^
MBFOCKH">PK]G/^"6/PE;P#^SC_;MU#Y6H^*;MKYV*@-Y*C9$,XY&-Q'^]0,^
MRX2=O-175FEY!-!,BR0S*4=&Y#*1@C\0:G1=HQ2F@D_G>_:4^&DWP?\ CQXU
M\)S*P6QU!WA8_P 4+G?$WL"K UYM7Z'_ /!8'X5C2_''A+XA6L.R/5+=M,O6
M &#+$<QL?<H<?\ %?GA04%'/^3110,_3K_@C_P#%@3Z=XM^'5W.-]NPU6R0]
MU;Y9,?B ?QK]+T^Z*_G^_8Y^+G_"E?VC/!_B*67RM.DNEL+_ "<#[/,0C$GT
M4E6_X#7[_P +J\:LA!1AE2.X[&@@DHHHH :S;17YZ_\ !6[X\S^&/ ^A_#72
MIVAN]?)O-19&PRVJ'"IQV=\_@GO7Z$R=J_$3_@IUXDFU_P#:W\002-F'3+2V
MLX5/\*B,,WYLS'\: /E$# QQ2T44%GH/[/\ \'[SX\?%SP[X)LIOLS:E-B:X
M')AA7F1P.Y Z>YK]W?@S^SGX"^ WAV#2/"/A^TLBB@37[QA[FY<#EY)#\Q)_
M(=J_%[]A/XEZ9\*OVH/".LZQ.MMIDDDEC-.^ L?FC:K,>P!Q^=?O1'.LH1D(
M=&&593D,#T(]J"6*(V'?^E(8G;@D$?3-2YI:!'D_Q<_9=^&?QPT][;Q;X3L;
MZ5AM2]A3R+F+W65,,/SYK\S/VI/^"8/BKX3PWGB#P!//XP\-1!I);,J/MUJG
M4_*.) !W'/'2OV*J-X=S$YZ\8H&?S2:9H]YK&L6NDVT#M?7,ZVR0[2&\QFV@
M8ZYS7]"7[.?PFMO@G\&O"OA"W14>PM%^T[0!NG8;I"?^!$_E7FOB+]AKP'JG
M[1_AOXMV5NFF7NGS-<WVF11CR+RX"D138Z*RL03CK@=Z^E!'\V<T")*^-?\
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MF-9;:ZB>&6-AD,K @@_@:_G7^.7P[N?A+\8O%_A"Z4AM*U&2&-B.6B)W1O\
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M_LU 'XNKTI:1>E+04%?JM_P1N_Y)WX__ .PG%_Z+-?E37ZK?\$;O^2=^/_\
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MI>?^E,E?5%?*_P#P3+_Y,U\%?]=+S_TIDKZHH("BBB@#%\:_\B?KO_8/N/\
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M#.>B@ $D_A02=?(I<<<4J@CK7SW_ ,/!OV>/^BI:/_WS+_\ $4?\/!OV>/\
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MO^BK77_@G3_XY7Z84M KGYG?\.7[;_HJUU_X)T_^.4?\.7[;_HJUU_X)T_\
MCE?IC10%S\SO^'+]M_T5:Z_\$Z?_ !RC_AR_:C!/Q6NL?]@=/_CE?IC39/NF
M@+G\X_QD^&.H?!GXJ>)?!6I2>?=:->-;^?M*B:/ 9) .VY2I_$UQU?H'_P %
M>OA0-#^)'AKQ_:P[8-9M38WC*,#SHN4)/NI-?GV/TH&A:***!GZ!?\$A?BV-
M#^)7B3X>7<VVWUJU^WV2LW_+>+[Z@>Z$G\*_6BOYR?@K\0KGX2_%KPGXOM7V
MR:3J$4[C)&Z/< ZGV()K^B?0]:MO$&DV6IV;B2TO(4N(7!^\CJ&!_(T$LT**
M*:[%>@S0(=49C.[(-+')O&??%/H X'XG? OP/\8[%K7QAX:T_6E(PLTT0$R?
M[KCYA^=?$OQ>_P""/OA_5//N_AUXKFT&<C*Z?JRF>WSZ;U^91^!K]&*1EW+C
M.* /P-^,'[#OQD^"K2SZSX4FU/2T/&J:.?M4)'JVWYE^C#->#MN1BK(RL."K
M#!'U%?TR_9Q@@G(/!!'!KYN_:+_8*^&/Q\T^YFDTV/PQXE=#Y.M:5$J,&[&1
M!\KC/6@H_"OUHKT'X\? WQ-^SS\1+[PEXG@47$1WVUW%GR;N$_=D3Z^AZ5Y\
M* "O3?V9/'US\+_C]X&\1VTCQFWU**.78?O1.=CJ?8AN:\RK0\.M*OB+2C
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MR@W^J-\OGX.?)A..6/0GH!7[=^$_"NE>#?#>G:'HUE'I^E6$*P6]M$,*B@8
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MIZD#G!&1Q0!_/\#2U^A*_P#!&SQM_P!% T7_ ,!I?\*=_P .;?&O_10-%_\
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MG@#Q!=%NC?864#\3BO<_AW_P2]^-GCAXGU/3K+PG:,<-)J4^YPOKL7)/7]*
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M56J* *L>GP0*5B@AB'HD8']*E\H]C@>@J6B@!B*5!SUIU+10 4444 %?&O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %?&O_  5>_P"34[C_ +"UK_[-7V57QK_P5>_Y-3N/^PM:_P#L
MU T?BZO2EI%Z4M!05^JW_!&[_DG?C_\ ["<7_HLU^5-?JM_P1N_Y)WX__P"P
MG%_Z+- F?HK11102%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7QK_P5>_Y-3N/^PM:_^S5]E5\:_P#!5[_DU.X_["UK_P"S4#1^+J]*
M6D7I2T%!7ZK?\$;O^2=^/_\ L)Q?^BS7Y4U^JW_!&[_DG?C_ /["<7_HLT"9
M^BM%%%!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?&
MW_!5SG]E.X_["UK_ .S444#1^+RKQ1MHHH*#;7ZK?\$;^/AYX_\ ^PG%_P"B
MS110)GZ*4444$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
H !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>ahl-20231220_g10.jpg
<TEXT>
begin 644 ahl-20231220_g10.jpg
M_]C_X  02D9)1@ ! 0( .P [  #_X1L$17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   "=!   %
M )T$   4    1TE-4" R+C$P+C(T   R,#(S.C$Q.C$W(#$R.C4P.C4Q  $
M : #  $    !          @   $$  $      0   0$$  $   !;     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   #J&0        @ "  ( /_8_^  $$I&248
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M_&JB=F$D_>NS1^QVO_/M#_W[%'V.U_Y]H?\ OV*QY-4$2%Y)IT0=6:6, ?\
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MR25R2=V>F.WJ.IS4C6,5QID@33[*.;[J.ET=V<CG:<C^7?I0YH%@Y.^OX/\
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MHY6+ZE/NCS&O;M*_Y)]8?]<D_G6 /"^C;A_H*_\ ?;?XUZ#:VENFFQ6JQ*(
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M( ?G  L $0 1 !X *F%C<W!-4T94
M  #VU@ !     -,M;&-M<P
M                        #61E<V,   $@    0&-P<G0   %@    -G=T
M<'0   &8    %&-H860   &L    +')865H   '8    %&)865H   'L
M%&=865H   (     %')44D,   (4    (&=44D,   (4    (&)44D,   (4
M    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\    )&UL=6,
M         0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I &P =  M
M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H    < %
M=0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !     -,M
M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #W   P&Y8
M65H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$6%E:(
M     &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D  !/0   *
M6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL=6,
M     0    QE;E53    "    !P 1P!) $T 4&UL=6,          0    QE
M;E53    "    !P <P!2 $< 0O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_;
M $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_" !$( 68#[ ,!$0 "$0$#$0'_Q  >
M  $  00# 0$             !P4&" D! P0""O_$ !T! 0 !!0$! 0
M       # 0($!08'" G_V@ , P$  A #$    =WEF!JYPO-H_MP>%
M/=6_-_)[C-7(ZSM,5)M';=,+D
M              '22RV^MO4^9X;0<B        /0OWK;;WW(J[,P[FYK(#%R
M0                 44JJ *%0    H5 #A3E4%"O%*<UJ.%.50
M       /HP8V.NP]Y[SV H]$        !MPV?N6>\NZP\FYK(#%R0
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M(        #;9L_<L^Y=UA+/S4TXU_P!
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MRE]<WN:KA2^6>G=$\&76A;#6R5R.ZJV%D@!1D=^I'C6D;UWYM@*/1
M  ;;-G[EGW+NL=\/@H@Q^4 QLR)\=X=G4]MJ:EC35W,P),T6UB7=ZRDZO<5+
M(P?%/%Z(9[?SH-B&CM KEV9F9LO7(I@YB@1X6O2ZYEXDU8^3CMM]-3=5MLO<
MC$PMQLV9Z18M[# DNLN2F'/YK9J5A2Q%T.GHFNV49WP;?;+KUAW$J3=+^0_H
MO%X7FUX*[*+-_2M#T$5[WFO-A2U2^LS95^16MWD",>R=MI[NTVY\N;A1)C18
M6[7F -LNN[/>QK.V_.[Z=^;'1=" !4Y),K.?]FZZ7>>7#]6OW5A[GB^K'O@/
M;^;  #:;Q_UMFMXA]/8O_DA[AS< %G]#'@U]'>0>/,V-Q:B>Z=$[6RL3I-/1
M=A@YE_/G>RWP_1  9#_IMY!I-]N^9X"CT0        &VS9^Y9]R[K'?#X*(,
M?E !X%>RZWUVU     %<NS,S-EZY%,',4&F$   %%%NI6J5  %$K2MTK<%V?
M*DW2_D/Z+Q>%YM>   !7;9:%=$   -LNN[/>QK.V_.[Z=^;'1="        -
MIO'_ %MFMXA]/8O_ )(>X<W        !D/\ IMY!I-]N^9X"CT0        &
MVS9^Y9]R[K'?#X*(,?E   !&U(H"09C5S   !7+LS,S9>N13!S%!IA   <EN
MTCZU+GK+\@  %P79\J3=+^0_HO%X7FUX        VRZ[L][&L[;\[OIWYL=%
MT(        VF\?\ 6V:WB'T]B_\ DA[AS<        &0_P"FWD&DWV[YG@*/
M1         ;;-G[EGW+NL=\/@H@Q^4  %IK.]6,$6&]N'L\NV<8(I,2_8 !7
M+LS,S9>N13!S%!IA  #R4IJ>QN/Z#Z5\2S;=D]C4*W  "X+L^5)NE_(?T7B\
M+S:\  2Y%G;%L+J+)NQX?EP\J,?;:>]GQ!0  ;9==V>]C6=M^=WT[\V.BZ$
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MM_/[^B7EFUOY%[C3Q]I<!^BS\UO6KVT>3D'YWMP !D/^FWD&DWV[YG@*/1
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M  !7+LS,S9>N13!S%!IA  =2D'V8&KG&Y3='E]QZU=*^+P^S_(ZN;;L[TUJ
M!<%V?*DW2_D/Z+Q>%YM>  )"CRLGX-O0*Q^!2ZZ2809?/\@  VRZ[L][&L[;
M\[OIWYL=%T( 'HMFSFY[W[#7?>(VW+J1EUI/:(GS>/AW.X<  ;3>/^MLUO$/
MI[%_\D/<.;@  &/GHFIU,_7_  FR#YE[#,GQ;H0  !D/^FWD&DWV[YG@*/1
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MY !MEUW9[V-9VWYW?3OS8Z+H0       !M-X_P"MLUO$/I[%_P#)#W#FX
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MMK>!UW>K&&7RN!71_/="DP       .Q=D_J/5<OM)[,+8\GW<:_*W:]6'>
M    !]SVR#]*\C>7N/."EENG6       ?9<!5P
M                              >"D<!Q:3S*        27?L9(OS^3A2
MU8];Y*1       #Z5NV3:=];_E2D6XORH       /M6KW97*M&K'BU/J_.H
M      +KI+DS!L_I6W)=9#V;QG"@       O"'=2KA]:*;R^90^ V@
M %7[37U?L]?ISU_DN$6/QH        K%9M[.T]ZGB_,B#'Y3';#X(
M 2)-O\I,[TF/8M#9MFI        %Z7[>0)=[^:;=^6X 9O,@       <*[_=
M/Z1M6P.KT,^C?GS$^;QH       '92_=9P/W5D/QOK&+'Y >[^/19
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M70@       #:;Q_UMFMXA]/8O_DA[AS<        &0_Z;>0:3?;OF> H]$
M      !MLV?N6?<NZQWP^"B#'Y0        5R[,S,V7KD4P<Q0:80
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MD/<.;@  H^=CQ'W>CF3S_>\5=$EM7P<CE4  9#_IMY!I-]N^9X"CT0
M  &VS9^Y9]R[K'?#X*(,?E        !7+LS,S9>N13!S%!IA        "X+L
M^5)NE_(?T7B\+S:\"4;<SNCDIET75;)T71^]6M4O\=U//'?[Y(_B">@SXMB7
MXH&V77=GO8UG;?G=]._-CHNA        &TWC_K;-;Q#Z>Q?_ "0]PYN
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MV']FOM&EO       !R7O=F9773W*"D6XOEI$       /NM:Y=F_2H\-L/PM
M      'VN]UTPZ%(7EP/.H       +DI+*<>8/%=!'N5S?RH       +FAVM
MUP[<>?6RTSD\X       "H=+A^O<P?_$ #,0  $# P(#" $%  (# 0    4
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M!<? +CX!<? +CX!<? +CX!<? +CX!<? +CX!<? +CX!<? +CX!<? +CX!<?
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M0.:>??B;CMBS,D79<HTADK?Z8MA=<9 3'&$B'G'HPB-KQD5?WP>4FMXC=].
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MHF1<;]8SW:R-\\[F,,>VK$X@MJR3C<%X;([D2T/Q^YC$O8M\LRM+YOBB1.W
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M)>\[NT%4STCTCE9^Q,7>2YE4!N322N"T=F1PK+8T9F\BA R9'KUAEDF5UQ.
M<4DT8"#HZ0S8#)3F02(1DF2WF5,YEE4GP)=UNPSN&>[61OGG?D9L0JAM,59$
M11..-@./9G#[1R9#HN,A\O:XT@I+2-X]B1)Z+CD1D1D1$@49EY >(98S?X\A
M#>>9)"Q82Q[^R5\J)=.N_EHHKN5[</*HL9M:6"Y5K8T-%]%:+E;-BYI-G%NL
MP:TKU+%=;@IG-SS@MH?MWZ3)BFA[;E(2EF-EUUJ/)2P*QE$A?R-WW8#Z*5Z=
MW/!P\C1P $K80+:N:1N/:4NA I\UED> /B](8%?9%+D3<OWS&.L6[)K$B8NH
M "K:;? ?MWA ES;NQJ.WKC86,97>Z.]+RC\_3:72)K:'24Z*?WYC)W5._)9H
M0HE!^V\HF$FM/]9A)M6V^)9Q*J6GZ[A(J0+WOZ,/])4R]ZM:::M.'#OV;0X;
M8K\JTUT<#!KN[8C-NT7K'#[MYPT:.]-!@S330,'I;:!Q%.E;!A<TU%B]5PT;
M^HM!1Q(I%XTPB8I#.I(E[SN<L6+U:BA6M6H,+JN7C6Y-*AHVNY0-&VK.@@1H
MI+ 1,@43A0N(UT#AUN_98L&UR@&$MUV10MO=:CA[&KN&>[61OGG>Q>2-E8LD
MBK!4$R=JTV(RR_IJ?.57*BA.MUJ7+:N+!8JU<:2 ]I>OE";FS4Y<UU/BY4IZ
M.R5\J)=.N_ELWKC>]5?+:8H( XZS&FFL?"1Z]% '$9P'9,Q5XM7&HG54%KBK
M**1NX[JIJLP^\PM,;K:$C:PK5BQ*-F@9M:8G!ENMF?H#79I*6K<6\6 ^BE>G
M>N1^<&/;TB,T%!<K-/)%'R<J.QAL1N/R&G^>J.]+RC\_^GA_I*F7O?I#.I(E
M[SZ0SW:R-\\[Q+IE1A)K&1!F.W,60;2=Q@&+M R\.QH* DL31:R1;8K@+PG%
M\?08@ *XPBU8"1P'&P S)<9PAE9SBS",''?V2OE1+IUW\J\RY_;I>.Z+-3AQ
M73YQYXUW[]RFMPXN4?OW_P!NETYHMZ.G6E-+U[17H0(4Z>=>:4:.G5-.KMW5
MH,/W6"NW;E^ZL!]%*].]=8]A<N;';52ZIHUKJI9LZ*:AX^NCUQWI>4?G_P!/
M#_25,O>_2&=21+WGTAGNUD;YYWV9O,&X^Y.YG=MNI=*7Q)C*Y*,T)R:0FFSF
M7RAXTIR#.:;UN=3*S:<S27/&KF>S1Y;O3R:N$2D\A,,>_LE?*B73KOY?I8#Z
M*5Z=]..]+RC\_P#IX?Z2IE[WZ0SJ2)>\^D,]VLC?//I=DKY42Z==_+]+ ?12
MO3OIQWI>4?G_ -/#_25,O>_2&=21+WGTAGNUD;YY]+LE?*B73KOY?I8#Z(5Z
M=]..]+S;$'C0YX_29LW#^_C47JQ9J3B[CVQK_P"-?HQH5=<.T5:U:U?2%-:J
M=5VB<8%0,H\=%XZ+QT7CHO'1>.B\=%XZ+QT7CHO'1>.B\=%XZ+QT7CHO'16Z
M*[USLWXT(0T'53373/H80B9GZ+5JY?7\;Q2Y$HW>M4W[3QG>8W?HV+%US<8-
M=&;5^RLOK!+&@*N]RT#KEH'7+0.N6@=<M ZY:!URT#KEH'7+0.N6@=<M ZY:
M!URT#KEH'7+0.N6@=<M Z%P(>WJ&C[+&SW76#._5PH:N%#5PH:N%#5PH:N%#
M5PH:N%#5PH:N%#5PH:N%#5PH:N%#5PH:N%#5H+'TZZ::::=VK:Q5KY1LO*-E
MY1LO*-EY1LO*-EY1LO*-EY1LO*-EY1LO*-EY1LO*-EY1LO*-EHVL4Z]URU;O
M47<;0&_<Y88]7+#'JY88]7+#'JY88]7+#'JY88]7+#'JY88]7+#'JY88]7+#
M'JY88]7+#'JY88]7+#'J&0B(!K_<X;-W5O6%Q/5;*B:V5$ULJ)K9436RHFME
M1-;*B:V5$ULJ)K9436RHFME1-;*B:V5$ULJ)K9433 $'%:]URU;NZ<-8+AK!
M<-8+AK!<-8+AK!<-8+AK!<-8+AK!<-8+AK!<-8+AK!<-8+AK!<-8*U8LV=%_
M_\0 81$  @$" P,#"PX("P<"!@(# 0(#! 4 $1(&$R$4(C$0%3(U05%3=)&3
MTA8@(S1 0E1587.QLK/3!S-2<8&2M-$()#!R=8*4H:*CU!<80U9B9>$EP29$
M4&/P\3;"8&1P_]H " $# 0$_ ;C<::V4SU54^E%X*H[.1NXB#NL?[NDXK-MK
ME*YY)'#31=S4N]D([A+$A0>^ #^?'JNOGPB/S0_?CU77SX0GFA^_'JNOGPA/
M-#]^/5=?/A">:'[\>JZ^?"$\T/WX]5U\^$)YH?OQZKKY\(3S0_?CU77SX0GF
MA^_'JNOGPA/-#]^/5=?/A">:'[\>JZ^?"$\T/WX]5U\^$)YH?OQZKKY\(3S0
M_?CU77SX0GFA^_'JNOGPA/-#]^/5=?/A">:'[\1[87M&S,L+C\EX>!\C XL6
MU-/=6%-.@IJS+FKJSBFRZ=VQR(;NE#^C/JW"KJ#4+0TC")MWO:BH(U&*,G2J
MHO09'/=/!1QQR:I^-+AYQ!_=N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU
M/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'
MG4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2
MX>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^
M-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')J
MGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<
MFJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[
MQR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3
M[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AY
MU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN
M'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C
M2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I
M^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')
MJGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\
M<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^
M[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=
M3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+A
MYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXT
MN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?
MC2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:
MI^-+AYU/N\<FJ?C2X>=3[O')JGXTN'G4^[QR:I^-+AYU/N\<FJ?C2X>=3[O&
MYK4YT5SJRXX@3E)8S\C+I4Y'\^*"O%33ZYM,4R.\,R9\!)&<F*_]+=DOR'&V
M5:]1=33:CNJ-54+W-ZXU.WY\M(_-[CCD>&1)8V*R1L'1ATAE.8/EQ;ZGEM#2
M5?PB!)#^?+)C^D@GJ2=N*SQ:G_\ \"__ #_]_P#T6DZ:SQV;ZL>-INWEQ^>'
MV:>Y-G.T-I\37Z[]23MQ6>+4_P#]%$)FKH*I NYM]GKWEI) 7$U7#"\J30Y=
M D95:H1L]2KI XG%&7K=C*^^5%1(EQCI:>Z1U@;3R:66J*/3A>CDBQ^Q\F;F
M]_(X6>IDJ*BE2.-)H=D8-J?9]8TK)&)&I9@O'7D=*M'P##,YJ<1UV]BL  5*
MJ^V:HNR!M3PP;E1NX-*>RR[Q\]4B<U%*Y\<\6R1ZR&&6J@:D;1))5P2,%:)*
M?69P&/ :UC;<ZN)+H#SCC?,^T=!42ON:':BGC5,U80T573,1' H/#>&A835)
M'OTX]/&&=Y+CUND04LSSW(0+-F1/245)-51U$<J>Q/+*8M+TP]DCC?>] Q25
MDU33;.UQ6):2^5QMTG9[ZFJ#))'%(BYD20OHU%>,B Y,>[BAK&N$U&:>"1Z6
MHN]7:9]//GIA#(T4-8[CV QEA[-'^,3/AQQ+<YXZ&>OW<)2BOW6:J3GZG4R&
M,3T_'@0>#++TZ2PR! Q3P)55$*RY[NFIZ]A&O 2R/ 2'FRXON=V#$/>EB<6Z
M8KLQ2;1U,DLDM)O;>Z!\A6S7"O:.DDGU9JO)$@D&\'.8.$SZ#B6::G%U,L:F
M.AGMR4M4<Z>EJHZY@LI,D_8RTW.7=#C,Q31[[$]P>GI=J9GC!EV:EI]0R9(Z
MJGJ@N[R#>R13J6&O4=&7$#B,335*55RHD6 STM@BVBIY&WFY>D>,.U/, =X*
M@'L73*/+IXXHZH5E#25@7=\KI8ZE8R>(#KJR_P"K(\,QPQ=)&CVBH;4#IHH;
M4E:4/1<ZB:*&5]\1^,CI=X4$8YN1S(U9XJ%2V+RH2NT-POR4G)Y27>A$U-#H
MB0Y\V-6!D56!TQ,H S.8:::*6VT4ZI%7W"W7"Y<0[4Z14TTL-)&$0M,\E3I1
MG(8K$'[O3@5%2U-1LU/R:KJ;-67-Z:I)WD<U(Q&X6!/97@*J6:JST+J7Y<0U
M\L]PV%GHR*9;Q3U%2T;C> M'V1F&63F,Y[C+FG_B9XCF6BM&UMR2-0]ENTN]
MC+2.E2U1/H=AJ8M$QE)YH(C"Y9*.C%1//2UUXI'A$S6[9^BOM/% 3OYQ6Y$4
M[ZN8#"#G(Z9*WO2,0UDSW&6GC$,E/34=%4M61AS&]15PK*:5-7-U4I)6<-TY
MKEW<5LB6O:&BN3=J;G;)F6)V9X(;G2ZF-O'<5K@=,;-T1F2%1Q/&EIGIJ:U@
MNS5-TFN,DW*&.<+Q4\E6D,$8Y]08SIIY$AX0Q1M*V)JH7.F_!]5RINGJKG=X
M9C%Q;3#'-&JJS\6C7+-%;HSX\1BLKIZ6FVEF5(7DL%SI+>H.L)4"J$?/;(DJ
MR/(.@Y%!GD">%;624U1>(:.(U,]AJJ&"6#(F6KDDTO4FGT\V-8 <X]_PDRXG
M+ A K[E7=!N,ZS,@)T@K&J:RIX+))IU/HR09Z5X#_P"BTG36>.S?5CQM+V\N
M/SP^S3W)LYVAM/B:?7?J2=N*SQ:G_P#HJ.\;AXV*LO01\O2#WP1P8'@1P.&H
M:9HGI]WII)9^534B$K32S:M?LD0R5HM?.W!&YU<=.>'7>5<U<V?*JBA-LFD4
MZ0U 0%Y+H'-$8"C2 .;W,<BIQ3T5,JE4MRNE!(';?TD<AU/%%-GO!$2>$>K2
MOO0,L;B/DDU#D>3SKIF&IMXXU[TYS9[W-I.>YU9NW%N.)H4J(Z..;-TM[[RC
MYQSAD.6J35TL[@!79LRZ\ULP3BECIX)8)G5Y.M]/<4M\1=BL,URA>&=U+$Y9
MZ]1U9Z4SC3+5BVT,M-';Q49&:TR32T+1N=RLL[L[5"P<$27CD.!T\2FG/$5/
M%!4\J@&Y??\ *]W&2M.:HG/E#4X]B+ZB6'-R5^>,FPUOI7IJBC*-R>JK!7SI
MO'Y]6-.4VK/4IS4-DI U9MTL<+(Z!PK:=8*LPX/I(((5^R74"0=.68Q3T=-2
MT4UNBB'(9]6]I9"9(CJ);-0Y.[(8DJ4RTZFR[(X-'"U)+1R:Y8)I*:4B1V<I
M+1ZA2O$6)W1@#-HT9#,ZNR&>):&GG6Y)*'=+ONNN*F1_XR8%TQEVSSS' ]/3
MQPT$;3SU)!,U10+:YGU'G4"=C39="H,LN'$CA@T4(:S+"ICCLU/600\]V9HJ
MOAR8YG(PPGV9"V<@D8J&T9+BHB2JY.91G)2:A2SCA- K]FB2#G;MNDQDE<^.
M6>):2&>F6DF#R1+4&KS,C[UJHZ?9Y)L]Y)( BJA9CH0!5YO#%1$M2*;>YF2C
MSY+."5J( >R5)AS])_)SR4DL.).# C-3.=6JEHI;=&VMM9HIL]=/(^>J126+
M'4<RV1/0,1T<,26I(PR]96=K<^H[R 2-J:/7TM$3_P -N;IYN6GA@T=.U-<:
M0J33W:59[A&7;^,2J,@6.>:CWQ5<@7YQXXJ:=9HKA(C%;I56V*UPU<VJ:$44
M10&GG@SRESCC18I&S,3 OTG"4;K705,1>GIXZ(P3TYG:8554SZA4@=$0B3)%
M7+-N))RR JH4K((*:H&\AIJKED2'H$V0Z>^A*HY0\TO&C=*C$HWQHF?/5;Y)
MI:5U)1XS4KHJ%UKDQ69>:X[JEEZ&.!04XAHX-+[JWU,M91*)'')YYG+R%"""
M59B<T/-*DJ1D<5-'!5M<&G3/KI)'+7(I,<<\T/%)BB9 2#(9,.@<!PQ/2PU,
MAFD#B5XD@GECD>.2IBCRT"I=2#,> U,^;2>_)_\ HU)TUGCLWU8\;2]O+C\\
M/LT]R;.=H;3XFGUWZE>>1W$U,O"GJH$BWV7-BFC/!7/<#KT$\,^&.44_AX/.
MQ^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE
M$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?
M.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^EC
ME$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX
M?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^E
MCE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'A
MX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^
MECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'
MAX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q
M^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$
M'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.
MQ^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE
M$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?
M.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^EC
ME$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX
M?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^E
MCE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'A
MX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^ECE$'AX?.Q^
MECE$'AX?.Q^ECE$'AX?.Q^EB2KI8U+M/%D.](K$_(%4DD_F&+91O) \\H:(U
M-1+.L;#G+&^0CU?*5 ;+N9XVE[>7'YX?9I[DV<[0VGQ-/KOU'1)%*NJNIZ58
M!E/YP>&'MUK0:GI:5%[[*JCRG(8W-A[UO_7B]+&ZL'>M_P"O%Z6-U8.];_UX
MO2QNK!WK?^O%Z6-U8.];_P!>+TL;JP=ZW_KQ>EC=6#O6_P#7B]+&ZL'>M_Z\
M7I8W5@[UO_7B]+&ZL'>M_P"O%Z6-U8.];_UXO2QNK!WK?^O%Z6-U8.];_P!>
M+TL;JP=ZW_KQ>EC=6#O6_P#7B]+&ZL'>M_Z\7I8CHK/-^*AHI/F]#_5)QUKM
MWP.#]08ZUV[X'!^H,=:[=\#@_4&&MMK7LJ6F7^<JCZ<<BL_@:/\ P?OQR*S^
M!H_\'[\<BL_@:/\ P?OQR*S^!H_\'[\<BL_@:/\ P?OQR*S^!H_\'[\<BL_@
M:/\ P?OQR*S^!H_\'[\<BL_@:/\ P?OQR*S^!H_\'[\<BL_@:/\ P?OQR*S^
M!H_\'[\<BL_@:/\ P?OQR*S^!H_\'[\<BL_@:/\ P?OQR*S^!H_\'[\+;;8W
M8TM,WYE4_1CK7;O@<'Z@QUKMWP.#]08ZUV[X'!^H,2T=FA_'1447SAC3ZQ&-
M&SW_ &[]>+TL:-GO^W?KQ>EC1L]_V[]>+TL:-GO^W?KQ>EC1L]_V[]>+TL:-
MGO\ MWZ\7I8T;/?]N_7B]+&C9[_MWZ\7I8T;/?\ ;OUXO2QHV>_[=^O%Z6-&
MSW_;OUXO2QHV>_[=^O%Z6-&SW_;OUXO2QHV>_P"W?KQ>EC1L]_V[]>+TL:-G
MO^W?KQ>EA+=:I!JCIJ61?RD"L/*I(QUKMWP.#]08ZUV[X'!^H,=:[=\#@_4&
M*NIV2H',5;5V2DE'3%45=+#(/SQO*KCR8Z\["_&VSO\ ;Z/[W'7G87XVV=_M
M]'][CKSL+\;;._V^C^]QUYV%^-MG?[?1_>XZ\["_&VSO]OH_O<=>=A?C;9W^
MWT?WN.O.POQML[_;Z/[W'7G87XVV=_M]'][CKSL+\;;._P!OH_O<=>=A?C;9
MW^WT?WN.O.POQML[_;Z/[W'7G87XVV=_M]'][CKSL+\;;._V^C^]QUYV%^-M
MG?[?1_>XZ\["_&VSO]OH_O<+=MAW8*MUV=+'H'+Z+CY9L1V^U3(LL5/22QN,
MTDC".C#OJRDJP^4''6NW? X/U!CK7;O@<'Z@QUKMWP.#]0839I9!JCLSNOY2
MTDA!_,=.1QZEC\1R?V.3T<>I8_$<G]CD]''J6/Q')_8Y/1QZEC\1R?V.3T<>
MI8_$<G]CD]''J6/Q')_8Y/1QZEC\1R?V.3T<>I8_$<G]CD]''J6/Q')_8Y/1
MQZEC\1R?V.3T<>I8_$<G]CD]''J6/Q')_8Y/1QZEC\1R?V.3T<>I8_$<G]CD
M]''J6/Q')_8Y/1PVS(09M99 .^:.3+ZN%MM#$VI:.!77N[M<P?TC@>IM+V\N
M/SP^S3W)LYVAM/B:?7?J7*O2W4K3MSF[&)/RW/0/S#I8][%7755;(9*B5FSZ
M$!R11WE4<,L9#O#R8R'>'DQD.\/)C(=X>3&0[P\F,AWAY,9#O#R8R'>'DQD.
M\/)C(=X>3&0[P\F,AWAY,9#O#R8R'>'DQD.\/)C(=X>3".\3!HW:-@<P4)4Y
M_HQ8+RU:#2U)!J4&:/X5!TYC\M>[WQQZE;5<F3F\9'ST_)_U'#R/(=4C%B>^
M?<*2/&0R,5([W[L455RF/CPD7@X^AA^?J;17QJ "EIC_ !EUU._@D/1E_P!;
M<<C[T#/IRQ)432N9'D8N<SJS.KB<SSNRZ>^<;V3PC_KM^_&]D\(_Z[?OQO9/
M"/\ KM^_&]D\(_Z[?OQO9/"/^NW[\;V3PC_KM^_&]D\(_P"NW[\;V3PC_KM^
M_&]D\(_Z[?OQO9/"/^NW[\;V3PC_ *[?OQO9/"/^NW[\;V3PC_KM^_&]D\(_
MZ[?OQO9/"/\ KM^_&]D\(_Z[?OQ17*JH95DAD(RZ5]ZP[H8=#?UOT$9YXM=P
MCN5*LZ<&ST2I^2X[W_2P(93W0>I^%S\*E935E1LOLY4-3<G]BNEPA.4K2^_H
MX'Z45!S9I%XLV:*V0)Q)/-,YDEEDDD;LG=V9V_G,22?TG&IORCY3C4WY1\IQ
MJ;\H^4XU-^4?*<:F_*/E.-3?E'RG&IORCY3C4WY1\IQJ;\H^4XU-^4?*<:F_
M*/E.-3?E'RG&IORCY3C4WY1\IQJ;\H^4XU-WSY<;&_A"OVR%;%+35,E1;RZ\
MJMLSLU/-&.!T@Y[F4+GNY$RR)XYC%DO%'?[517>@?735L*S)GP9">SC<=*O&
MV:,#W1U-G=FH*.&.KK8EEK) '5)!FE.IZ!I/ R?E$]'0,#AP' =X<!Y!PQF>
M^?+C,]\^7&9[Y\N,SWSY<9GOGRXS/?/EQF>^?+C,]\^7&9[Y\N,SWSY<9GOG
MRXS/?/EQF>^?+C,]\^7&9[Y\N,SW_+QQ?-G:6Z0N\4:0URKG'*@"B0CWDH'
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M'UUQ:M6ED- D;U &:+(<@>(S .8XZ=67'B<ABBN\IH9JFYTKT#4Q=9->>EM
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MA2-614=X\,^/3B6IJ9PJSU$\RIGH66620)GTZ [$+^C+'>^0AA\C*<U(^52
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M=U+%G0%)%T+(!''QXY8:YT*U:T+5,8JF>.,19\=Y-%OH8RW8J\L?.C1B&<=
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M=H9<S%404S4:3Q\'Y*T@E$1SS4[IQG"<N8.'$8;GQ0Q-_P#+525M+)_Q(*E
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M!4ZB^OE$+R,5;/2> *9#+"W-@L2&"GD2&P3;.*CQODUOG?>2:\I@=_KYPD!
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M%]/4N/MN3^I]1?Y"H<4SU2N&84MOI[H73B)J6IE:(&%>S9XMW*\RY<R.)W/
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MUO)#NQ1=<3&98%J!0:@O+&IFE%0E+FR$U#1B-4=9"P1@QVLL5)LV*2V;LRW
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M2D#<!2Q&($Q\-8)5CBY7%+BT\KTX26KD:6ITNVZ9GU&3=Q9 (LC.['/45S"
MZ5XS5O*:.@AJ81+/;HJ.GAJ&S"RP452M1#'4PCFR!D!I91JRDA;/+4,&]H98
MI!2A1#M!3[1(F\<CE,&1Y.!S0M/K2/2%R*J&7+B<2W%7H9Z(0 ;^[5%U,FML
MT-0F[Y.!T,J+T.<G)Z<25:R6VV4!B]DMD!I$J=1!DI@Q:)7B[$.F9!<'G]WJ
M[&^VZCQ<?:8NG:RX^(U?[/)BH_'R_.-]./\ SBY7*GV>AV>KVAJI+C+^#Z.T
M0Q%8A1I-647)G>9M6\/)T8F2F*\Z7+5DHPVU6SLFZ9J2Z"HI;'LY;Z2K/)'>
MGJK-*6JS'#O!%HK4$2Q32:I*?2_-R?/%3?XCZK+T:9FL^T,J55J2KDA-1!M#
M3:HXY1#&S$I!3U58)7RR9EI')STXV:O%):9KM-6QU,IK;+<+=!R?=9BIK FB
M28RD>Q*4Y^C-R"<AGBGVLL</6K53W4];]@IMDY-/).?5R15$0JH\WX4WLY9E
M;V7-1TYXL=UM]';MIK=<$JM%[MU%3P2THB9X9Z&Y)7KO%D908I0N[)4ZE;G9
M98J-KK'(*P)!=?9MB:'9B+5R3A5T=+!3<H<!\N3.*=7TK[)FQ&60&+YMDMUH
MSNJJZTLU5;;?05UMC:!;9(:"GBIPPD!W[P$Q\HC@=,TF=UU",+G0;34%-LY)
M9:B*IK5EHJZ.2CJHZ>6DCN-1,QIZ^W5&8JJ$QP[M:B-,UED4L =XY%=ME9I^
MO%9%3W'KA=J39K*-Q2\DIZS9\4O-9M9EEIJAJ4$Y#4JOITYZL>K"R1[05MYB
M@NIAOD=='=:)G@ INN5!+25$M$PD*RSPO(&IVF" P9PN1J.+=M3;K=;:^RP5
M%YCIY*ZBN5%<$Y-RJ.6CII:1:)X&D,8HA%*9(-W('CGR+ )GB;;&AJ+=5T57
MUQNL=7'4L8[H*:::GN55('>Z4=P0K44SNWLL]. 8Y)<AEN^.-J=IJ*^T45.$
MJ*FJBK)GBN=;%3QW'K:]/'#'0ULU.Q%=-%(KRBJD <API)XXEVPH9)*BZ\GJ
M!=ZC9$;+-![$;>I-#26PURG5O"O)*1'Y,4 -4[EO8PI.UMWH+W=(ZZWQU<48
MMMJHY$J]QJWENMM+;RR;@D%)!3"0:N<-6GH ZG\'CM%?OZ2I_P!F.+!VYMWC
M4?TX.)4WD4T6>6^IZF#/\G?T\L ;^J9-1[X&*"RW.C39NH+T;UNSU#);MWG*
M::I@(HS'+J*:XI=Y1J74#28G/.WB+BGL3P;-5%DWZF:>EN2&;2=VL]QEJ*AL
MAV6YCEJ"@]\8USRU<,4EJN45?:ZRH-%NJ&QS6V>.,SF1I7J*>KWD1*Z=*M3!
M<FYQU9]EBS4J-<KI<Z:1FMM7(*BDB:,QJM?4C.[S(C $*]1&JPL !N]0' G%
MXL5?<)=H6@EHT2\;/)98-[O=<4FO5)-+I!4H/>*O._*P=G)3<*JJEBM]7%7M
M05$HJ-ZS4E724U/ 3"-/LT2M#OJ;6R.CL0_,5<5.RTKRU\U+5BG9[M!<K7S2
M>1H=4ES@<=#"XS55:9M/2C0 ]@<7FV-7V.KM=(8X'DCHUIBX.Z0T5;2U:(^G
M-@CK3;KFYD:@>YBLLUUJWOTFJWH;O8+;:(QG.=U-0K4H97.GC$XJ2<EYP*#A
MD3BMV>N-0M>J348Y5LOUBCU;_FU,CAI9FR'XA1GH ]D+9:ATXO%LK85KZR44
MTD55;[%:T6)96:FK(*L%;BY891TM')[,9USGIQE(JEL4U!57""IH):6W3)'<
M5KZJMBGJY$N,U53+.9::M9%FBN5+5N^_E75"3FF?-RP]MNB[/BW0W &XJL2B
MLFS;-%F#O$9-)?,Q#<BHT;SAK(#,<GV=N+)+$C4"))M91;1=E4/E#!;VHI*?
MG+F929&D5VS4D+GD"<'9^X\K->):/?Q;0U]VIXSOMV]+<:.*DEBG.DD5,>Y1
MXG4%.+H>!Q8[?56Z*M2J>G=JJXU5:G)]YDJU)4Z&W@'.7+I' ]3;+M[4?,TO
MV"8VE[>7'YX?9I[DV<[0VGQ-/KOU-K?;E)XL_P!KZXHJTLU4SY+!+2Q.NDEO
MXW+N8W'?TOV2].7'$D1A<QS$([5-/30 <_E'*8$J4E73V$:4\J22ZNPU:3Q!
MQ-&5CAC095O7DVN:%NC7DI1 _8@2*RS+-V.[('3@0:JB" .,JBLGH$D((RJ8
M-7!H^S$4CI(J2]CS-1X,,4:1SR4FK,PUD5S:%AS3OK:=W-$PZ5R=@ROV+J"!
MQQ#JGIK,SO&HJZ^II]\!NAJW4CAJD=+PZ4.A!Q1QGW<=C%6QNA!FV?NEPIV8
M:98FI,XPV790R)-D1QYZ?)B5M_'!I&Z*BC9BG MN8@)-67 \H/"0=!'LGXTD
M^NMW;"B\9B^GJ7'VW)_4^HON.V^VE_FM]'4NO;"K^?E^L?6LP1'=L],:/(V0
MS.E%+-D.Z<AP'=.)[8U,E2LIRK*.UPWJIHU.MEM[\F,CI(%T/-$E93.8!SV,
MA1<V0XDLI2N>@2=)9&-#R.1=0BK$K*.6X%D<KDBP4<$\KNW!FCW(R=A@6AM=
M,HD;1645XJH#D5<R6.,RUL#1:2XU1C53RY".7WN);;3Q1FH:NA6CD6ZO1UCZ
MEAJ1:4/* V:@P-).IIJ;>9;^09C)<36N2GBEWITUD%KCO$M%GFXHM$4M1S].
MC?4T,\<LD7%N)4<Y3B:SQP"X:ZI?_2XK;5UH4,=%%=5=Z:HCYGLKA8I#) OL
MBZ<=976KK(#)KBI*NVTG*8E+"22Z!'IB(LM81(989:ECEN$D!;H.&9+;%4VN
MIIX*BJ@Y92M49(["0UT<BNDV6IN3I"\44F>IXZAU8E43UVQOMNH\7'VF+IVL
MN/B-7^SR8J/Q\OSC?3U"S-V1)RZ,^IF<LL^ [G<ZNS^S4]_AN\D$T<3VVW5%
M=%')V5?)2IOYJ*F_*J5I%DJ=/@TSRXXIK1<JRGEJJ:CGFIX%D:65$8HBPJ&E
M).664:D%\L]/=Q5[-7V@AEJ*NUUD$,"P/-))"ZK&E4H>G=^'!)E(,;=# C+I
M&.L%YSI5ZW56=9((:8;E\YIC&)1$HRSWAC96"')B#T8BV?J*.LMOJ@IJRVVR
MMFGB>K,8C(%/&V^W9E&[,L,F[UQ-SV!T*-;+B]TUJI:J)+15RU<#4L4DKS"/
M5'4L7WD0,7-90HC<'I&LHW.4^O\ X/':*_?TE3_LQQ8.W-N\:C^G!ZM5<*.B
M*"JJ(X3(KM&'=5+B/L]()S;3W<NC!NMN%-#5\L@Y-4(SPS"1=#H@S=U(/%4'
M9L.:O=(P;K;DY4#5P#D"1/5C>)_%XYLMT\G'FK)F-!]]W,\-<:)9FIS4Q"9%
MD=H]:ZM,4>^DX9]*1<]EZ57I&*.YT%P.5%50U!W<4WL4BO[%-QBDYI/-?WI[
MN*_:*V4%)7535"2\@2-Y88W5I&WE4M(%7(].\+\>C*)^[CKM;M4*FK@#3B,Q
M R+FPE+K%PSS]D:-U3ASBI"YXEO-LAGY--6T\<PG6F,;RH&6>3+=QL-7!GS&
M@'LB<AQQ>KX+=R=*>2DDJ#<K71STTKMO-U<:E(,XMWGIFB5C+IETYKPRQ5UM
M)11AZN:.%&U<7=5ST+J?I(.2KQ8] '3B:_T,=1=+?'/3QU-OHDJA).VFEU2P
M"8;UES81Q$@3LO$9\W/IQ57^O@6[:$H)C1V&AO5+(C3&&;?O,L\;GLC&=UG3
MNG'G#7@5UWDJZ7<T<+V^<4+O*=Z)$2HHS-4\>P/)YMTJ-V,BRZ>SC;UFV7;V
MH^9I?L$QM+V\N/SP^S3W)LYVAM/B:?7?J;6^W*3Q9_M?7.5ZVUT1TO)++;FC
MCS.LBFJA-*R_]2IV /!FYN6'F,S;R8!W$]/4Q'+3N'IH$IDC4#IC:"-(I5?,
MMIU9ZB3@R.RDDYU'71;LM3ESA5 ]&GL#'H"Q*I!THH&(IA3U0J88U0<I>KW/
M$IOI6=WYV>L1F21Y- .6HY'F@ 4TG)C0:!F*!Z]D!_XJW)]=4DG>!/8%<BO?
MQ32<E6A1$5DM]7/5P!L\R9HWBT,>G*-)&T,,GSXYYC"Y)&D8&:I;Z^V<2233
M7"0RS$GI,H8\'.>%72JKF6TJ%U'+,Y#+,Y</)ZZW=L*+QF+Z>I<?;<G]3ZB^
MX[;[:7^:WT=2Z]L*OY^7ZQ]:RAU=&XK(C1L.^KJ5;CW.!Z>Y@W>8M-.RI)6S
MVZ"TR5; AFHH.3G3N\]TLDG)*59'"\X0 C2SR%HKE40BQB)@IL"RI1.5UNT5
M1OEG@J"S'?1205$M/D2-$3G1I/'$%QCIJZ.MBI(E,=/<:?<DRO'(+G U-.68
MRK(-,+LD6D@+GF03QPM8IMRVVHA2IIXI:N6E$A<&G-;(99X^8RB:+?$RJDH8
M*>;Q3FXFN<M1%-O<FJJBV1VB2MR]FY$$BCGYFK=[VIBBCBFDR.:H"NAB3BHN
MQJ.NXW,:=>*.UT,Q17]BAM2.E.8LYCSV667>:]8;7PRR7)[PTLM>9(8FIK@U
M!)+2Y.J+-;Z84D4T3B0R*\D $<X+D. ""I48D8.[,%" G,(N>2CN 9YGA\I)
M[Y]=L;[;J/%Q]IBZ=K+CXC5_L\F*C\?+\XWT^OL6T=!LV=FGM]0LTD5P>OON
M^MR\-Y[ 88G,S&;*WEZ5BNZUZL\27O92DH[E;::HGN5IF:]3T=-46\TM=0/5
M[SD8MU=#4%TU+H%9%.TD#N&?=MJ %XNM'L_<365#2U-36[![-VU+6].Z0,\E
MMLSF26H9M#"F2CS&E-2S3-'S3&^==M?;Y[W%5QW1UM-7M-0;05-"EFIX:BE,
M$SSE7J8RCU4E-K-/%ID"SKE*_<7%^O=HK;'<*2FJZB6JJ-L+I>H8Y*7=IR*M
MC558R;Y]$V:#7'I.>?9</Y#^#QVBOW])4_[,<6#MS;O&H_IP>K7TU3)>-FZR
M*%)H+775-75:I-#!7IQ$BQC=N'9V''BN0/=Q0[.W*GI[.:FF$_):"]6RKHH+
MA)3^PW&Y\M2:.=436DL),$].RY@D2<Y5RP+%)'6VN6F$<%(M#';[K3ZY)&D@
MH9%JK:4E?49'A=312;TDM2NV7>Q16.6EKZF2HI.6*EWN%WH*SETT8#59F(62
MC'#?*LFX8Y&-_P 9Q#:<;,6Z:VV6WTM;!#'64U''33-$1)O-PN2'>"-&9'?G
ME",QJ8=.)=GKM);;K20JE.*ZVH!0RU(J:=+B+A3UA%#4-'OZ:E=8Y,XY694+
M*@0:68W:UWNXFJ*T5.BR1V5J=5J8XG$E!5K-4QU<HB#SG2&Y."VX0-DJZRQ-
MRL]TJ!M)N:6!S<JO9J2D+U&@LMHJZ:IJ&E]A;=EA"T<?99ZLRP&>*NSW8+=8
M(:>&I6MVGHK_  U#U.[;=QUT%7-3RJ8G;>QB(Q+*/8Y!D1D.&-H+;55[4II8
MV62"GJ66K@J=S4054F21QE)$>"IHY8_Q\4J-I8:@#BHMEVY7=I=S3U N6S])
M1[U9-R!7TM$:4Q[G0Q$4S'6)!FJ 9$9]#V2[&GKXA3P$S;(6^S1?Q@Y-74^]
M,BGV'FP@RY"7CGISTC/%%&\5'212@+)%301R*#J =(E5@&R&H!@<CD,^G+UF
MV7;VH^9I?L$QM-V\N/SP^S3W)LYVAM/B:_7?J;6^VZ3Q9_M?<=N[847C,7T]
M2X^VY/ZGU![CMOMI?YK?1U+KVPJ_GY?K'W'L;[;J/%Q]IBZ=K;CXC5_L\F*C
M\?-\XWT_R-155-45:IJ)Z@HNA#/+)*57ITJ9&;2N9Z!P_DOX//:*^_TE3_LQ
MQ8.W-M\:C^G!]Q[8]O:CYFF^Q3&VMN>"O6N5?8*M5#,/>SIP(;^>N17\Q]QT
M]/+5SQ4T"EI9G"(!WSW?S#I)[@Q1TZT=)34J]%/"D?Z0.=_B)ZFU%$TU/'51
MC,T^8D Z=TW=_JGB?D]Q[.T3U->DY'L-+[(S?_<]XH^7NGY.I=(2'6<#FD:6
M^0CH)_./H]QVJ ZFG(R !5?ES[+_ -NIM10/35[3A?8:GGJP'#5_Q$_..R^4
M'Y#[BZ> QLI0/3TTE5*,C4:5C!Z=VFHZOS.['+OJJG#*&!5AFK JP/00>!!_
M.,;>[,U6RVTMPM\R/N&F>HHIB,EGI)6+1.IZ,P.8X!S5U(.7N)59V"J"S,0
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M1YM35<625-+(1V4;Y<4)RUQ-FCC@0#Q%?_!XNJS-ULOM!+3Y\SEL=13SY?\
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MTG/C@VNVL:AC;Z(M5D&J)I82:@@Y@S9I[)QYW/SYW.Z>.'H:*2GY))24STO
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M9H)P-E*2LHJ6HCJJV>J#0PF2-#+*]144[2:@1&VK5S%<  #9O8>VUMEHQ=+
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MV/\ ^7+5_94QZA=C_P#ERU?V5,>H78__ )<M7]E3'J%V/_Y<M7]E3'J%V/\
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ME \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE
M\A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A
M#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z
M)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]
MN.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.
M4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#
MR$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$
M/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/H
MGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGV
MXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY
M0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/
M(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0^B?;CE \A#Z)]N.4#R$/HGVXY0/(0
M^B?;CE \A#Z)]N.4(>M!'I[^FZM]1OB2/2>;SD8!D/\ 1/A^?O'%2UY+=Y1^
M?XGT<1WN.$;4JMX0#VI?^'A_*/\ _P!3_(B_)+^O$W=7^KU?%(>Y)]'M2_\
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M!.@8:E+1N ;,.(/01T>]./N<\SJ,T[$FS<E2Q9J4YAEL9)O:#+ZV:F@7S"-
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M$D,,<<8TJB@ 'I^L]\^$X>OHXS9ZF%?_ ,Q^KCC-Z_E=2-TUX8>YD=]NDO\
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M^BOJ'Q/,.YK]/]6(NZQ?E$_2&%ZJ^8>KXGM)W>G_ "3?I8[,?X+MN?[/5_\
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MD+Q-N)X ><GH'?P(Y"=(1BQ;1:W'6?D?3_H=;YL$$$@@@@V(/2".D$>$=O\
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MP6"6\)DW6C6J1DMO0%#H-=PMSC.IYLJ.V'(KY@,MH<NJ:;7:3W+EJV43I.(
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M@]+,A;2K79A>V*F6>&IS3+Z1X<O.6S4$>5),=$$M!$-))!5VJ>5+S5",K"P
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MD$%%3U UQU$4Y376MQ#1U,<@FCBX?!D:[&PO/!+)M-7;/T<N[:#,LA5))AK
MR^O&NM7IY\RKW%FM9AALQ8Y969TD6B.BVM]PO<YBS/44@F,!TS<'6L8_"*H0
MCY/1QQFKSTOW]BFD"G966A:D:1=>_CJM.N&9=5AI!N)1=M5UTZ1?%0NK-:2@
M@8P)7[,56=*[?"FGJ:5+Z0"5$L4C*Q8-IT KIOQQEDTM?)L7*66&#:-:^&KA
MZQBFH$=][!*Q!^'6(_ E;+)+I5B$!.53OFM3EIA2T,^;YCE^90%]!H8$5UH9
M$E<B62J#IJF@* ,C<UM(O@9A.F746:'0ZC:J39^JI^(%1")-W'.DE[P2#I<!
M2OS\<$R_?;M?3[TF&CS"GB$=K(=5/J!B3H@51S2BW#GGDW]YF'<U^G^K$7=8
MORB?I#"]5?,/5VBB,VIE#-XQ%R/,3T89$<JSJKLO5+ ,5\&DGHMWO!WL!5#%
MP!K/2_RS?^ET_GQNX^(T+8FY%A9CX6\)\%^C 50VL !SP+?*MX-73;YL:$U:
M](U^-;G<>GCT\<%%+!RH+#H8BY'F)Z/JPR(]BZJY%K:@&Z.CI[P[PZ!WL%5+
M:R 7Z-1ZUNBU^FUN&-U'H,>[0QL=10J"A;QBMK$_.>.&BC;5JC1M0 ;4H.H+
MU0U^D+WO!WL-'&]RR(Q+:CJ4&[>$WZ>@?8,%%)+$ L1;4>M8\"+]-B.!'1;A
MC=Q\WF)S>*\T64WO=1WC?C<<;\<5$&^0B.1J:9I$<U4 43LH#*\;.1=DD5B#
M?HZ<1QI#&D48TI&JH@\"J+#_ .3WSQ[6TG=Z?\DWZ6.S'^"[;G^SU?\ X>%Z
MJ^8>KWZ9IFD41@BS/,(X2NC=)65 0+T:0HDLJVX:5LI'"UL/V2:S[Q*#86FR
M\T-/EU;-F$&:TF:5<-::NHX3M*J*JO$Z\!#K 3I#82MK8T:*.MK(XG;6\4=7
M4)$[DW+O&L@1W)XEF!:_&]\/7U\DD<LE?7230]QF>LJ7FB_)2M*9(_\ \&7"
M9IFD3S2QYGF*25";JHD6NJA)41^),XEU2K\SDC^(^YA_!!DO]99]_FU3B;NK
M_5ZOBD/<H_H]JHZR^;]?Q-.NOG':;K'ZOB:]8?[[W:@[E']%?4/>2*)ITJ9?
MA)XA:*5@#)&/ C6NH^88W$5H!I%J:=ZJG%A\#4R.9)*A.'-F=R69^L2<1Q)%
M)4RQ 1RU@=:N10 ]0)$,<@F('/UHS*U^D'#01-2QT)1310LKQ4NE=PC);0RQ
MVL&6PTGI%N&-VAJ36$7JV 4U)[L57JC7TG3\F_1WL/&DDHF=0T@J16AK#_C
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MT=(6)#!28G%R@8*2H=,E0U.BHT=VL5#!1%1C9+47)V!E9H.DX?#_V@ ( 0$
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M'758C18,<U%LJA,/C"X:J+#5CLJ[L<;HF;?J7.J5&$**ONH*0+#^KFQZY71
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M5T0/&</S#'KE=$#QG#\PQZY71 \9P_,,>N5T0/&</S#'KE=$#QG#\PQZY71
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M *]^.3')CDQR8Y,<F.3')CDQR8Y,<F.3')CDZ0B9$Y%5>.!+=0O[8%][W.?
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M"Y-,4Y+JJXJ&QCE4E#7Y=<"L@PE)D%%06K?BRS$<R9SW]<RY1]S'0UK4I^9
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MZD0YNHE-CQ8X/ON@"J'"'E<,! %)%TP',I(F_+BE[!1Y34SJV/"*;5"!6V^
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MJ;/P'JI5V8N6GQHS:OFK[YBR+Z-!<G4C9]=0%%S(W;%)7;.8Y-VA? Y,PW@
M'F1?+.S%>TT05<8#BDJ(GN+O3\@U\(]Y0L;3=_!]68]B4[O9/I%TH?>I^5]&
MR$<#=.MLL<$1;J.J*:) A=B'&&_O)B3LT[0FH%2;OP:5D5OC'N*2\TO%?*W:
MW154)>7DP<F:^],DO'<C=)7"(B7VJ<V_<B"F"J)T6:$5MI7R=)M1(&D3,KF7
MLT1!XU_<WX<B24*K05;7@K+SBYX[WM,KJ\;07D(/WCOP%=FT=*:U6I:I%999
M5M%,N-<&NS1"Y<ZVU%WIBE034B.+!CM&I+<LZ-IFWK[_ **#WTU]+I._P?03
MT>S.20[P=XIS:Q ,D1QT49RD0"O'5<V5+WQ @TP6TVVVEB#-GU!117:3 =2[
M3,>_8&8KQ>3C9U7L4Q$IP..RY]3DH)/OD3Q#F6[LAQ5NN5L<SA<G)NQ*I+KI
MMRH1@<>9'4V==HN,U(:)++E+W/>WXF[,UW(YM;1H;DZ@5941'YK3(\>)(+E-
M<J<=><>-V6-I0<>=%J/$C <,C+*CW"' 4M-5XJC:RV1/1A^R?2VM^/9_EE]%
M5MG-L:;&FR*U 1FAO2NQCO@CG"&V/S9;H$+C#G**LJB<N*Q6YM:%N73I+T?9
M^E:6I^$%)DHMR14Z\KZ!9L09$E!\45[*)8D4^=1:S0Z;4V78%1J4ME/Q*/(;
M('E06E,PS-DJ)*-$89OF-=V(&S]+A3]HZ%'C@5*J40V77D;><W1I"9Q0[$6=
MM]J[:,[W5%<4_:TI#]-VNV;AR6H&S<KK:.4YTEUD>3ED)(+,B2XN=IL\H7Y<
M2*9-I=3V=;FQCBRJO-:;=A0!DL6-=9HB:5Q!<L!FHL(YN,D5,5_:C:.7&J^Q
MFSXNG1YDP 2/5.LZCTYUOM9MP[DT.52;=?[&]L5ZHT.$%.I$NHO.4^&TEFVH
M^X!R)[5'5%7LOM=2W-Z+:3XE;^M!BH=Y2O('AWX5SZ:^BKKM=D,P6=H-F0>@
MRCXV6&Z_IO&(VS*^P[I\0=ZJHVP-'HFTE9F//@"R'7XR0VF8:M(+;4?,*.EJ
MCOS<F7VU\77E7$OJ=$<E<!BG,E:?^5';[(U]WWA3>MEMR=(9,&7(CLN$ S6V
M%3K["%O3*7%4Q2ZA>V_E6V#J<C:274-?9RL-LQZM$X.X$62(N.DP65&W2:TM
M-,M[I>RKAN)-! =>BL30!-^5B4BFRA?IY+9DYK^BK?QBQY L3/@#]'/?V/CQ
M)>T#: 4./-5-%P4+KZ;U05=T[Z0DJ(I[E7%6VCV\H;^R+M =<9GA($@;F:3:
M%KP1<L9(Z:Z(CO17;Y%4=^)$>!+D4/9_,01X$-Q6GGFD5<IS7P5#<<)-Z@*H
M +N2^,Y2I"GRYU?<4K_M9KX:*)4WY]-0T6129[IOQ7@]L@*:D;#ENQ<;7=[F
M'MN-EJ3*KTIL&VRH,?C3&9Y&#;C#PMYCTV%/5(P15-A,P77#\_;JF1*1,D2L
M].A1]SK5/(+HDL+KE=0]PWXZCO-$7=Z-KX1[RA8VF[^#ZLQTCEQ(3A1 -&BE
MG9J-K%V+*.G85<7F%+X*)4HKT*2*(JLR R%E+>))S$))O$D547'+CEPY5H=,
MD/TUE"5Z8&566LO+J+?B_OP582(:TP#TBF7'21Q>0.6^;WK<F_#,9LV0-YP6
MQ)YU&F4(ELFHZ6X!OSK@J75P9:F"TT\HLOA(;TWASMJC@<5;CS<WY.G=[)](
MNE#[U/ROHQ,FP(V^UD0HI!?ER*N\?W8<F08(OP6H[+$8UD-AN1,Q\5=_;%+%
M-F5JEM\ C.$Z:J\VZB&@%IJH)V2(=OWVQ4H='1CJ!)#191LF >*.8971<,TU
M ,E4D*V[+:V-U*#=R?C;7-BEMU1D%FLQ(Z/@:"XC<AL;+E6UKI;E3T<'OIKZ
M72=_@^@GHDPQ$K(DQ&@5FGQ(40KHV$-93*HZ/YRR;YB/WT#VN*KPQDGX<-Z&
MR,9#5O4@M V6B!IV"$BF(D/(N_$?:#9*E-15E K+KCMWIL9T+:\4W7+DF55W
MV[)++A^L;74]B1'IK*KPBRC+LO8QVG0XZJX=D .3-BC/4>,Y"@2:H;3,0G2>
M-FGO\4FW'5WGUOLE7=BH-T$"?&5M).@OPF[J$B&<H]02MN31[,3]I^_T8?LG
MTMK?CV?Y9?1,RHKSD>3'<!YA]HE!QIUM<P&!)O0A5+IAC93:&FMN5:/ <?;K
M;*BB2 C9459#);QD'?>;7$)44E2ZXJGQ?,^KN8V4^)XW_OC9$?\ ^C*XO_\
ME<^)DHPU0C17Y!-[N.C#1.J._=ORVWX*BQHX4'9T3X\&,XI/3<B\7ACR6101
M=Z,MV;OO6Z^CVD^)6_K08J'>4KR!X=^%<^FOH84'41GADIB+JDEQ;UW1;SDB
M<J#FNN*=1'*"U,KFSK,FGR)LQ4&E1(#))(;JI$J7<:>R H-AQT(53EQ-J$QW
M7DR9#A&8IE!>,HBC0>U;1+( \R818FS]4>$N0TBF@;_TBLF'5J;"!5*JI%-:
M*RJTPEP:BJON9;F:?G&J<V*@M'I$N?2G'E?B.16]7(V[QU9(1WIHDJ@GZ*(N
M$;J$*3",KY1DLFTI6Y;9DWVOOQ5*:[38]>IM/=;,X2J@U.)&F(029,(BW.,M
M<KC79)?B;E7 [6(/!::](:HE*C.BJ2)#,&.2G-5/:-$29 %=Z\OHJW\8L>0+
M$SX _1C3*WM-2*74"%LTAS)8M/Y'>UDH+R(?M57EY<;-T&*]^+51]VHRLB\2
M0S'$4B;^<4<(G$YEW8B5DZ5/&E3WBCPI_!G."R7P+(33+N7*9H2*-D]LEDWX
MB45W9^JA59[8/0X!0GDDR6G$S"XTWEN0JF^_-SVQ5&F:)4W'*(VX[5P&(ZI4
MYMJ^H<KB]:0+*JYN9+\F*OL\KA<#JE-66+/M4FPS&SOZ^#DX"_NQU :VHHSE
M:X0L3J:,P%E+*3<L?)SO(N[)>]]WHVOA'O*%C:;OX/JS'2V#6B 3T..KC<]N
M().$U4U:L?"0:121PCO8C3>MK+CH5T2LQHLRIN4DFJE'EB)O!%6,BQVWK\8'
M4=WB*\:]]V-I):T)H9M-VW&%",H):O4Y92=:4<EW&;'ES65,MM_)B?0V=DX[
M$B?3:;)@U-G,QP-Y4S2.(2=<OV.5M4LO9XG[+SR_PW:J$[ )"[$)B 2QW+<F
M;LA'])1Q0]A$CMU)8=1<=J,3A/!V9<EPU71<?3L="**)FM?KBI@ZE'IJ-5&%
MM@M.!8L%V-I1=04X(HV_&VV>1N8H]>Y4Q68%2IS,P"V.CR(HR&<SB26(:66/
M=+JJ+N)!OQN7?CH>K5J<$!RH5J;&J;Z,E$=DM,*:1X[YV%6];(@W7*I+>V]<
M%1Y&S-2.= VDMJ0J:[ :*BH1+P#,1)PUS3;SB\"DXXG.E\'7: ]3Y%+>K#4=
MD4@K3ZG3%%H\]/=14'A*)NSD0Z@JG&-;_D*=WLGTBZ4/O4_*^CJ50CO(Q+0!
M9B&J(7XPZM@L*[E7EY<=W'_DVONX[N/_ ";7W<=W'_DVONX[N/\ R;7W<5"+
M59Q38S4$7QS@"*V[JH&XA1.5.9?1P>^FOI=)W^#Z">CV7DL-B%4'A#A2$2Q$
MVP;+D827VVFZA*GN7Q2>B+11600PF8&TL5OCR(DF,F3A#C8W+*2W(RMV)![^
M!IK,.34JR[4)<EQI>LQ&A=R9"5];Y^Q6X"@K[^*K1JA D4RJN+&<BZ77XCQ,
MO"YO<W$SN3V^:^*ET2*X&A"IT1^/0VG>(Y4:C(!016 *RD ^U-/;>]C:6=,;
M%VIO1$E,O$EU;61)<64H?FJ:615]ST8?LGTMK?CV?Y9?1TD Y),.HLN?L\&-
MSZ0)C:4F%Z]#I%15;IN0TA/&/Z\;&/R2XSM-BL(J)RF;A-MI^_<F-D(B6TOP
M(K%_?SOF?]%3&U!LK=V'2:@)(O(AE!(T_P!CB+B_N[_#Z/:3XE;^M!BH=Y2O
M('AWX5SZ:^A@4]J4W"?DOH$>2[?3;D(BDQ>W)G=0 0O:J2+BHPZU%"AL4RE3
MQVFELJI.5(H366 U$>YH\X2,RMQB1";%4S6Q<-UBN'NION/@W88V<KI?XD@Y
M($VVZ:()VIZW)(1.0N1Q.7C=*35JB:C&C#R"ES=<+M;0)^>:[DYDY5QPR9UJ
M*QG"!"'L(S1+ONOMG3LBN'SJEDW)BM.T>1HUV'3.%0&'-\>H-MN#PB"^'MT=
M14RVXP%8T7BK@*O+CL4:B4E\:?2X*DJOU*4XH\*DMAN0&F^/IES@*IRK?T5;
M^,6/(%B9\ ?HQK%=V?AU"I"#3?"G,Z&0,]J%S(2(X@(EAS(O%W<F-EZU%87@
MM-=>IC^0;-QFGA HF[VHD0FV/ZK8@;";6!&E[-2I8E27IC;;@TBI&XIM+QT5
M-!UXEL79,O'F%;$MG-B7-E(-2VVF2G&]D-I6VQ2 -"G.9UDOBHJ]^)M J21:
M=$'#:%23>F:5L/L[P(:U48;(;:UF&R $ZZ3"-N0@(4NINBIZI&JDTR:-)V2V
MJU=TRX)3*649'K<59<QP$%I%_.T!=-?>PFTK6SD(*VDI9R34SW&6JYM<6\VF
M+F;C(J#N+>GHVOA'O*%C:;OX/JS'2,84Z5%!Q45P&'W&VS).0C 202(?:DJ7
M3F7"3EEREFH:.),5]U92&G(>NI:F9.9<V[!J[6ZL>HJ*Y>H2[&J<BDFK952R
M6W;K8$ITZ9.($L!3)+TD@3W!5XS44]Y,-O,N&T\T2&VZV2B8&*W$A)-Z*B\B
MICA_"I'#5=UEEHZ:2-7_ %-:^?/^E>^'!=K54<1TQ<<0YTDLS@=@>]S<0\RI
MR8;G=5JD4UD5!J64V2<EL%Y6P>)Q7!!><$+*ON8RR*K4GPU-7([.DF&K?-J(
M!.**&B[T)$NB[\,'(K-3>.*J%&)V=(,F"1+(;:DXN4T3=G3C>_@0ES9,D )3
M$'GG#!#7LG,I+;4+VQVS+SK^0IW>R?2+I0^]3\KZ.FT!HMS(K/E(G.9\1D"]
MW**:B?K]"]5Y(9'ZP0JP*IQAA-]@OZGBXZ>]Z.#WTU]+I._P?03T>K5H34RJ
M.&K%#N2@\R^=E=?105%5IL4XZ+<<RCNP4BG&+L:0F2?3I"9XDUKD47 YBLJV
M-/WW3=CA4^'6-DZ@YQI 4_*Y!)Q>R(;H2;]^X&FT3'"HS-;VLF!QF&)>5J#J
M)O%344!;>ZA"X*_FX:X7IPZ;#3)3J3$33APV^1+ ED)RVY35/V4%-V)7 83,
M:OQS1FKN9E)Z4RJYH[XYU7*TO8J@6341?1A^R?2VM^/9_EE]'0?@:C]2=QMQ
M\53_ /\ '/XV"^#I?UQ<;)?]D57RAXV][QF?_B&L)^I/1[2?$K?UH,5#O*5Y
M \._"N?37T+2MN:3B.AD=S9-,\R97,R;QR+8LW-:^*32]K68X4Z,350>J$-4
M.+6H4:,1-!+=S*A&+RLN$F4!,,RJ*XDLNLJR#KAR8J+R'$?,B8<!><"'DPU*
M>( 9I\*7),W"$!!<F1LE(K(B(JWO@8C)O58T<R23@HBLQQ]LNH5D=,?S W+^
M?BNK1YS,HPA\(1E20)#+C)@=G&2XXJ@YDNEQ]PEZ4ZJ--NQJS'G4NLT\@3\9
MD4U-5MYL Y2:DMJZWEY%+*JIR8IKVT[4.G,F+I4VD1G..RW?>_(9S'9TMPJ:
MG^B(HE_15OXQ8\@6)GP!^CG_ (&)#7:(D 87#UM'!"*SSG.FH#=R:0D45+EQ
M5]G>B76OPGDU]UQZ19$R4U' 1!9ANH(W)EU-<'!$,I+E!$'#U'EDKL<OQJE3
MQN*2H:FNF=T[%]M1R.BG8FETW*F*GMO,AL2]IMC67]GX%3>$2?-M_@#;3Q.6
MS(H#(:U$_P Q8Z*O9KABF1%.75JS+-V1)>520,ZJY)ER#YFVTS$O[@'E3#^Q
MNQU8<HE7=%M\Z^@9GI%00P-XW.<6GD!6!R]J:7BX?B=$%Z!*J4:5I0IL(LQ2
MX(CN>E6  U5/L<H)<>RW^C:^$>\H6-IN_@^K,>Q*=WLGTBZ4/O4_*^CJU8>@
MLG4XD.T>9O1T$0MW(J(MOTD7T%)I[W:94YAIWWVU-,R?O3=@&6A0&V0%IL4W
M(( F441/U)Z.#WTU]+I._P 'T$]$;CA(#;8D;AKR" (I$2^\@HJXD26C7J9!
M4H=,;OQ=("L<BWYT@[E?\S(G-TIU6K928S$A>#T@F%R'F;6[LM45..W>P G(
M2*6_=ABK41V5,<@N%U7)ZRDY'<7B2 ;'M:,+N)+KQ+DJ]*'5!)>"$21JDRB[
MG8;JV/\ B:[,%YM^&)48T=CR6FWV'!Y#:=%# D_6*HOH@_9/I;6_'L_RR^CH
M/P-1^INXVW^*JA_^.>QL%\'2_KBXV2_[(JOE#QMYWC,__$-83]2>CVD^)6_K
M08J'>4KR!X=^%<^FOHI%'I]>HY06T**=*J;A]4%B.#E<;BF(YP:,%(0<13TR
M]S<F(E);SQZC2MDTX&Z.4X[\R.\B\ ?)/;<'S9+JA(G'RJF' $W&BXS3J 9!
M=$6Q 654S#?E%=W2+3<-O..0\AD&<5Y1+*J9A7\U=V*Y/DN.-4^B0#><T4N]
M)EN-N<#BM;E[8X/&6RKR"B7+%&K>S4FD4A6MGHL*6_5G.LLM-B)E&TPXB.(\
M*$;CBHK=LMN,N)<FJ5!*E)1PFN%-JJQR%M;)P9%0<K'YG%3=O]%6_C%CR!8F
M? '^1HK^U&TC>RP4^4^$>>;0N<(X2 9HRYB'DTLX[]RWQ7^AZ'1.I[K%=FI,
M.I* "Y'5"B$@"QGRFGXHF]33LEQ5:ILSMBSM7+6 D1P09!O@3+KHN*=Q,M[B
MM(/ZDM^1:^$>\H6-IN_@^K,>Q*=WLGTBZ4/O4_*^CJM+B*"29<909U%L&>]T
M15YK^[B3.E18XQXC1//$,IDE0!Y504*Z_JZ= ^,6/IIA?UKZ.#WTU]+I._P?
M03T1MN"AMN"0&!=B0$F4A7WE1;+@VRV7IK6HBIJQP-IX+^V;+.N4DY46W+AK
M9)D73@2G>$QZ@J+E2DWS..&?8HZT-V?=SY%]MB)3H3:-183#<=@!2U@;2U_U
MDMR+WU7#\62V+L>2T;#S1I<3;<%1(53WT7'X*, [U.?=X:W4,JJ#='4LQ&I=
MCK-)UK+SGN3#3 [-4Y]6Q05?E-D\^ZJ)O-PU-+D7*N[#;##8M,L@+330)8&V
MP2P@*<PBFY$]$'[)]+:WX]G^67T<':&C&V$^ 9$WK!J,F+@*VXVX%TS"8$J<
MN[EQM%%=DP-':,":>1(F^"T;*QW @KGZWG:);J>=<W'3?BD;-T^5#;AT67'D
MQ'BBH<@@C.ZS41XLUCCY^S2R$0<6^(6WKCD(:O3XJP8S(1[0DA&EG8Y-9LRH
MZJJ1%FS9MZ8VC@/R8"M;1J6NJ1+'";-@(QLPES\0"9;$>-F5"S'RE^0VD^)6
M_K08J'>4KR!X=^%<^FOHD<:<<:-/;M&39_N(51<+(@42L/5PF5%R1.E)(UWE
M#*1./$\MFE7F%O.@\7"R(T'@!.$;CX#(-]LW#)2S-H8CI#O[!,R>_P!.?2YE
M!>6FU(6N$FS*61)<>:14N6KHHC2W6P 5PYE7")LPQ5J=3US*_$ES#<8-Q5OF
M991TT;&W9"2K==_HZW\8L>0+$SX _P B[07Y*PGP?;F09B!J:$II#%$,>=EP
M34'43C6LJ;TPMMI-F53F55J:+;WTX MOU9E_7B>C\X*E5ZL3*S)#($$=IN.A
MZ;$;/9Q0S.$9F:(I+;<B#^1:^$>\H6-IN_@^K,>Q*=WLGTBZ4/O4_*_D)=/?
M4D9F,&PXH;C03YQ]].7'J@JOS2%]N/5!5?FD+[<0ZH-7J,LX3J/-L.L1FFR,
M>Q4B;X]D7?;G_(0>^FOI=)W^#Z"?D+V2_)FLF:WN9N6WO7MT[V2_)FLF:WN9
MN6WO7M^0#]D^EM;\>S_++[#VD^)6_K08J'>4KR!X=^%<^FOL.M_&+'D"Q,^
M/V(U\(]Y0L;3=_!]68]B4[O9/I%TH?>I^5]'OW?E(/?37TND[_!]!.ER+Z#?
MN_7Z#=BUEO[G/T[V6WN\WH0_9/I;6_'L_P LOL/:3XE;^M!BH=Y2O('AWX5S
MZ:^PZW\8L>0+$SX _8C7PCWE"QM-W\'U9CV)3N]D^D72A]ZGY7IQTI529IZM
MJ\KVLTZXCF=DP:4=%UI45MQ4)4)5%1ONS952H4IZI.27JCL[&=H*'Z6;JN<(
M<K2$\SAMI(>9?RN&X0MH>^V(%7J,Z1'6@TJH.[3QV,ND=0@O:),N-Y;BMNO
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MQ<AJU-8DZ:LS,X!G05T2+?FQ(G/5&.\Y"GL4Z9#70:>1Y]DG<\1!EON2F&B
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MX3'?>E:CM1+@%>J53<R0VE0X\N^D@9I*=<Y,R+9$]U<523).6C$J#5(L<F6
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MK(;:=&+E8!LDT]:7HMJ?(5L52&Q)BQ9=+@3*@4>3K:DH('IEB*C+;F:0*;T
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M D!.(MK7WXZM2ZT<]\J4U239ZGQXS9LL.(XV[G;-21VZ)F2UBP[41K3J9JU
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M7@@M'-F2#DRP1$57H]F7 52LGH-I/B5OZT&*AWE*\@>'?A7/IK@6VQ4S,D$
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M1$LF-FU.L46D-;+O%-:I)Q&BC%KIE+AHBZTU'9<#L-1&\Q\;,7)B/'ZE4E^
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M8)N1$3\C3N]D^D72A]ZGY7I*)(A"26(21"$D7E147<J+SHN.#=3J?P:^;@W
MHO!\WYVAI:6;]++? NQZ=3V'13*#K$&*RZ _FBXVT)B/O(J)@A6)%43=US%8
MS.4WT6Z/F.2Q/(J(J.E=RZ(N;"/2Z=!E/("M([(B,/.::\K>=P"+)[U[8ZH%
M.D.0&=,Z;0M-@*;2Y+89.$Q1!M"0UY4WV$E5=^%D.P(;CZJ)$\<9DG"(.P4R
M(54U#VF:^7VML(,N)%EB.\1E1F9(BONB+P&@K[Z8<1*;3D1T-)U$@Q4U6O\
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M8:1^# :$8[@X@X@'2Y$L%HS--G)X_>.A\XZ1#<">SWSH?.[[>]AJ+($S7#A
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ML5<G^"(JM@#5MRHWVU\Q62/34?7]H2\^3RD[SJ)NU> '#5.&>6<=#I\!#.A
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MM<_ X(WJ7GH'"#RM.+&>_>1;.ST:9C1SJ4&'[*8Y&D"&"HDJ@![;."^(-3*
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M ;7<-Q/P8^!I1H5B0T&VC4[#,_<Q]#__ /\ _P#_ /\ _P#_ /\ _P#_ /\
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M+5EB22*)9DZ) J7^=I*1 \J+%1,IL6;"@4X -LI\KOM[U?F'JQ,]FO!?9G;
MM13+C/1<B-K4>I AK\!ZI>7UPR\E;&*PXU%HM3PZ+D@!:BS6SFF6.:*BK"58
MG0 A],C^TLH%NQ3()I.U^VKM1T6&R7#?DZV3C8WER$T)7]@'#_V,O<'/6C7^
MR6 !@&:7&]#@',*=A:AX_O$]B*++25#Y9BH62BV=!7P>/>.D-'D?#8C *@=H
M,*Y\\9B=40=169_\V%&A8A'DI]B:-08XP[0C(7!5A<0/'5KZ;"3;\.4O5R&-
MH 'PKRD>]$K:(P13JUL6 YWP2#3.A^6IR"G=HRP7E3/H7#%_,!(%#%Y*7*K*
MDEQ=@*I0+-"LKH$0@C>WPJ #<JC(%.=C#9ME'[3N*I."@2T:IL! +3@2F*Z>
M'M"X>N/D[XL6XJL*T,=&K5@5&HBN6>2I18*0=J%(CC$J2N"VR$"+RJY<K8\J
MAM1@VA[M-> Z5@:1N"\/Y:96-Z,H#%8#4-W*D&0/.45!D(/)U^5:3:W8C3(3
M"U$6#2NW06(L0%6!2^2O/CR((T*7*D.R@ RL WH9ML8@4'BJ&92@V3Z9@$&H
M6+IV*YH&Q@6AJRO?PK0"V%E_8A:YRDB"EJ\1J,9($GEKXR@@%D9GY:/+6P.@
MCDBR.]Z=092!CD%?*3A=4#5Q'#;;6(R:1L]JX80/8-50N1):@%5<V51IM@$*
M)BVUQGAFIH D2ZE4'H,+E,VX]BV&T.I(0K4%>"K\3XG%DLID564G03:&NP,O
M]9JC+-E1P?/9#G$ &DJD?!:%KP?!& Q+K1]5ZN& +LJ B 4\0#K5Q71-%I\E
MVQJD1F5Q&.7<79[!7_(C[ZN*F.NIFQ-K_P!4<?(!@$@((F@N049*6I'V=?9$
MR0GX"'1";L^@M[(TN8=--6<"S83B/C[QT/"=>]US6ZYKO6N\9AD]5N)%9](,
M]1>".T!UPP)"BHVQ#TMEK0%N*3/2VR6$&6:099!YX@*V=BH#+<?V+K7I0-@C
M!6M\1#O+GX5B<VF"0+3EV*Y/WQD6F X,-B[3"Q/#V(>BX2:]6QH:P72HJ%7/
M$%R)^@"@>+OM[HHL@UR\H: RLY.Z<7/D)@KGUO&I70QHU.+*/]%:W("\P(F=
MR@:[0<(F<3$!),Z>J@J*PI+T&+8))JR!(H:&;)1+Q-8_Y&'<34$,F!\+,<!*
M4PE14U6HA,'6$4KDW*KTEZ,;0B .1G1K.Y%0?Z0)Q=*8]U:F4&F$'3MK<&W&
M= T3N-42279#'%DIM-4"J!59W8CP>/>.D-'D?#]23J'!N=T]LD0]2S99B;5+
M@$^Y1 L999<R=5O(35'!5&YJGQMU)LC*_ 8CP4WT)<@Y*4M@9U$V\RJ4VA9&
MX%E9^ 9_3B $*B3'!<I^@PA3EME?X!*8*?N3>U2&]5RF86-832A%EHW$>O)\
MRTLHC/ H5BSZH6045J4XBLH6%U1K*,PD7 2]*Q%HK#\7:$O-YH;$:+@R6#&8
M=]GUFVW;%H$( L:0C>PNU&V(@900V[PLBU<M0!B7JQE>84MN?%5"Y00^464]
MD$,EC<KN.['#DOP8A7W1MM7-\6AQ0$?!BJ!%MWHUE?1M^2#FP]5S\I>?'EG_
M  B%0]$P!$PDR\C?G7MYJ_ZYO8_( VL'GFHDA!! (*]" "P08D9N=9F#&IP$
MRHO8@(-\2KL!4.(\)0!4 6>,@EO55+?8>(RA.O?@<+6@E: 6!A$S$3M]ZV!8
M$,0IRPV=3Z'O>!G#V?EU@]Q6G$'#6BD4R&%H2J.6>\B]M<9<1AQ"T#QM!UF+
M5 #RE,II.A8IF.@.W@J_$^)IIS4GMVF\>6QG+_?ZYG_0L%*.G;K&[[JPY\CG
M-A+*;""%48PHN["N:S;8C.'5,V)$>DW\BOSNO 9,[#ES*$'<9]& $C9UL)6B
MZGHE7*6XQ>:I!MZ[Y%>5RTK:["M,]9RK+;$D&.RFR:>)'F""W<88516'!:@L
M1]'D\\K2VU3)7?Q]XZ'B.A #N(1"#R(\8^P)2*[4.DL.0CD,-3EO@ F(,2Y>
M$>5:EII0TK*7:5XV;0/%-0KJ&X$XF:-V \D:I;71U7;;>8:,'T@]"[=+,$J_
M^/I R)>!,F>YGT@+: O4W:R_=R1US>4%K"@ # A$,"KV +!4\??;WW[R?G(8
MLR=Y38++7(JM\G//$R!##]6!"YNYR,A4AG063/FP0B(WM5P$5U:Z+)>;%ZAV
M^'L:0B#P<E *K2^>S)I@W2F#+"%&4K41@F_Q LBR=Y%SY].QORO>4:H^RS(4
MAP.+&@,_&)=YSRNL&G,(_7[K%1!<HHBU\=F/>Q-7@:LC+!G^3C<2XPA,QKBN
M0V7GB0#/N$N'S!L@((3:[\7CWCI#1Y'B-GF1O2>$Q:)[U &'#7?MZ(VWZF<4
M+*CLSGJBHPLL!&G')4,F<A,0D]^\PJ;8.A2VN.G%<:TJYAIL8;LQ];VA+SZ;
MFK\3Z,^\=#Q'0A4.3L6"5/0948'&/Z]:852%IT(5XW9%V2##<&'4A6@3PL,2
M&'\82/GD@V-12= ,EZ!A6@N)DQJ9!5+D52E9M*J<XI$-VIH0/3 \U.)26.%!
M%%%_<#UFT'UBK_=V7 NJQ+<CN+J^A!8.DIW\COM[]@W1W3C=I2.JH1W2J^1J
M\RI>[_J%$(IQ.NF]*NOE>\^6>Y.R;PQBF)/E5DGBBN)?<HTF/EB/<G)78+X:
MG:W1,1O0 !H)-PH.)V259FWF&[(9.5#5'TG%<B#B*6!5@!JK=@';8VQA!@WV
M@!N$(GE"9Y\YAQA QJJL K:B* %0X*CK]X5L3RI^/CWCI#1Y'C&9O7UKM-K;
M# [2IH0B;<7;<G.L"K4,0H")((J@J>89FIY=YY\YU28WO9K*HNYK!@, :#H?
M6]H2\^FYJ_$^C/O'0\1U"RZ+2V&QD)EM9HXK[)@D6H@A!F6<ON OA*0&)B^#
MZZ@T$J1) MX.[!4  # 8)Z-MM0PZ72AE.^U005AJILQ4HG8$$/E1*EVYD*O]
MO P,)8+#B83,MI7-VKA93!!"$7),4Q(7LHG=)@5/ !7A#ZKOM[^/>.D-'D?X
MGM"7GTW-7XGT9]XZ'^+.]]O?Q[QTAH\C_$]HR\^FIJ_$^C/O'0^&%O\ B=Y_
M>]SWCI#1Y'TG8W(%4 D7 ]2B;*=3UEG4]99U/66=3UEG4]99U/66=3UEG4]9
M9U/66=3UEG4]99U/66=3UEG4]99U/66=3UEG4]99U/6"#[8(.]-+RW5%L*"!
MG32U?=T[?!\H-E@@Y[TT(%C74-1TH(]DEG4]99U/66=3UEG4]99U/66=3UEG
M4]99U/66=3UEG4]99U/66=3UEG4]99U/66=3UEG4]99U/66UY@J+ 3.]%N_@
M,?5)4/ ,I@-:J_HUIA96$;:T8"V\OPO"C?PY#U&H1I+M)]R=AZD[#U)V'J3L
M/4G8>I.P]2=AZD[#U)V'J3L/4G8>I.P]2=AZD[#U)V'J3L/4AS2^9TF,*<$.
M*]V*]<:VR-XS9:SS#NR(^<0(W"MFABXFVBRSJ>LLZGK+.IZRSJ>LLZGK+.IZ
MRSJ>LLZGK+.IZRSJ>LLZGK+.IZRSJ>LLZGK+.IZRSJ>LLZGK#]VLF$$I0PCS
MF)H%8:06(3P&<@4S\QF(_"[EE=,3]B+C=J<ERSJ>LLZGK+.IZRSJ>LLZGK+.
MIZRSJ>LLZGK+.IZRSJ>LLZGK+.IZRSJ>LLZGK+.IZRSJ>LLZGK!R8%5M\@6U
M1*&$=6L1=EM=HL,Y\'@X.R,0.TIBUSI&>A'Z$DDDDDDDDDDDDDDDDD6 LY_S
MR/)?* E ,A]OCYD^]YH"_>_H9IIIIIIIIIIIIIIIBAZ"-M)K#9!1FH !T H#
MR^+1=;:?KZ$YSG.<YSG.<YSGJCFFG[^+>-KV[=#RH[3.-V12E#M7 '0^A---
M------------- %A1K,6NL&?CNEOX VM!O1,V*EIJSABBF5MZOT.>>>>>>>>
M>>>>>>>>Z8"S"52LI; CR?'L<]OVHU]I_#3^&G\-/X:?PT_AI_#3^&G\-/X:
M?PT_AI_#3^&G\-/X:?PTH2G>9\T+?N_#_]H # ,!  (  P   !#Y?_\ _P#_
M /\ _) ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;80
M        " (                 !P H $@ "@$H!# H
M !0         D(                 'EL9DA .]6/@4+P8
M     0         $(                 !V@RBTS/R+=9:5]@
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M@  "!@         X         I@        !          3   $3>P  <,
M#-HX  "!@  .>,    X  /8#8   I@  &N@   !          3   '>U$  <
M,  #O$\  "!@ #(N/$   X  2AC)@  I@ #!:.@  !#;W;H"@   3   'X8
M  <,  0:6$  "!@ "SZ0@   X #H\JZ@  I@ #W"K@  !#NO#*=    3   !
M)+@  <,  !]GT  "!@  !;9    X #5T2,@  I@ !,%[P  !!QDD:T    3
M  , "@  <,  "Z=   "!@  #A7@   X !1K^]   I@  =^^@  !
M 3   : .   <,  '@Z-@ "!@  #!7@   X  **SX@  I@   "@   !
M    3    P.   <,  $[>1  "!@  >9^@   X  9P50   I@  !Q    !
M       3    P4   <,   0    "!@         X         I@        !
M          3 0 0     <,*28  0(0"!A( $   @  X         I@
M  !          3 *HES$XF <,* B%>QG.:!D5UXS3?BX YH/7*TG>]@IGSZH
M D?,,!          3  &9*3YK <,>:B8%]-B6!A[ZELQ8OH X,FW/=$AV IA
M-*8.F#Z0!          3";]9F._,8<,  " 8   "!BW[ YVV?  X$N5C/1O#
M IJ)&EB^/L !          3#KO-UNK)<<,   /F@  "!B[Y-XV%,  XGW.56
M>LC@I_2KM64@SL!          3  "+01T  <,        "!@ 6-JA(   X(
M#R+H   I@7ZX8)W@ !          3   PZ$(  <,        "!@ -=77@
MX  )D3@   I@&9NA@>L !          3         <,        "!@
M  "X   *     5@        )@        ,!@        8,        #
M    "GL        <-         CNVVVVVVVWH 1__P#_ /\ _P#_ *AM))))
M))))>&4DDDDDDEOAPDDDDDDD@ /K;;;;;;:2!))))))))
M                                       &P        P+TDDDDDDDD
MA<        2"$DDDDDDD@14VVVVVVVV /;;;;;;;;8'))))))))(>"
M  !@0        .$222222229"        !D,VVVVVVVV]T         ),
M     !PP        (&         #@        "F         $         !,
M        !PP        (&         #@        "F         $
M !,        !PP        (&  %( $   #@        "F         $
M    !,        !PP        (&  %/ATP  #@ A?QJ0  "F,      0 $+Y
M0      !,!B !H " !PP-P!8.<$0(& &N@^P0  #@PLT[(3T0"F)^/OFOAN
M%O3;^3P   !, )V&PUU7QPP%2S MZS@(& "N\-%*@ #ABG6A3D+P"F/>$(4C
M4L %&O\  'D    3#)"C,C]!<<,!<#;V[@@"!@!0&Q\@<  XX"*8TQW;@I@
M U:H@  !          3         <,        "!@.BCZ.!\  X)9/"C.U?@
MI@  1QN@  !          3         <,        "!@$^K]PG   X
M   I@        !          3         <,        "!@         X
M      I@        !          3         <,        "#@        0X
M        "Y@        #TDDDDDDDDK#$DDDDDDDDD%))))))))(@K_\ _P#_
M /\ _P#[T        !ZHDDDDDDDDG2'_ /\ _P#_ /\ _; &_P#_ /\ _P#_
M /\ ( 7_ /\ _P#_ /\ _P" 5;;;;;;;;H %MMMMMMMJ Z22222222X__\0
M*Q$! 0 " 0($!@,! 0$!     1$ (3%!41!A\/$@0'&1P=$PH;&!4&!P_]H
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MNN!$IX07Z*+GL6'L6'L6'L6'L6'L6'L6'L6'L6'L6'L6'L6'L6'L6'L6'L6
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M41*1@51H^J6?*WH3G#R1Q,DI*-E; "@AE(,@$=YA4/QJDK%5@:O"US75EP0
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M(WOD_5_WX:!P&'9^--T0%1Q4\7U0[.HBI0V+RQF.)*$)3;"+<78?3@96@HW
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MT= 3:N$P(#Y# <I3>Q7SF"-DA@.@XO04'G9IQ>0D.H.57%HGGA-8X>_HB?\
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M2BF/#A3!<$"#2VP*.=9U[=?ME.^4[G\2'U#N^-!E!3AA2]G$$@@@NKPSZ_\
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M7^ &]\GZO^_$:>B<(BC01! >B[QBP?H7DTTE]5&F\#*1O)**) @.0A43&)A
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M (4;#@"A;,#EHULB;B"NMR1QFC7>[I AH0!A*4IU.,8KVE!7B"&)KU0J+B
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M1D*//(0IO.,0F'T=3;S7B+BF1#7(D-8<AC"U\6U$<%P]]B<'3T6AZQR )"'
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M2'XSTA^,](?C/2'XSTA^,](?C/2'XSTA^,](?C/2'XSTA^,, E8;A7@J!<$
MH1V(B)W$T^ J*4]@7:!P+.=..M)-,DHA")L33=?(XL6+%BQ8L6+%BQ8L6+$?
M4*9,41$"RC!>#!$$1$$1HCL1-(G#X:<F6!W*[0;<A*EH"I*D8RCR.SU^1E2I
M4J5*E2I4J5*E2I4H&"*N'14NSH]0:2^#G>!HCW:?]J\L]"_G/0OYST+^<]"_
MG/0OYST+^<]"_G/0OYST+^<]"_G/0OYST+^<]"_G/0OYST+^<]"_G/0OYR'R
M8!^A)WK:-_YX!(4@P48XN70W-_)AC@F$1K+@[=$1-XQ@J+2 ZN 5 :!)X/$
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MEST'H?X^6"^H=WROO]/_ ,@-"O2.[P&>B]_RMWOD_5_W_P I!G0^H=WROO\
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ML$*EV,'!A!0.K42@"]80*,0DWGDU2@*^/I'=X#/1>_P8)96Y0D$"B"A;G2K
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M(((((((((((((!8!(A00H0SJ O7P_\0 *Q$! 0 " 0$&!P$! 0$!     1$
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M"9R&24T*@$"C@JDPMG43-AC*XJ0$-@-"U!]:.";2.7S%[4A:&,8!N+<K8@9
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M)SY<4> IRL->,XO?SW_%YUZ>S![%T?$#N*[/+@.8;#OXQF&!X]Q%.X!VO=,
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M0X-'QE?/]@ :$1&@A.[0JBHYN;376<[EWO/L[N\30%B,:JIO>"0%!#66>A!
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MQ)1'ATXH23C9SKC!#O&CU_P]VW  (! Q!$>$F.H-.[P=7OGPP DO5>_Z]V
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MNT:36D:P%EST<  F%@L.=D6%2S@$B'85\_\ *'EG^]GG/J^!13@:E8D;)2A
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MY$8*]"$2,4& &B3QWDCG;]3FHP;9@0&"K>M1E$MV-NB(PNH"EW($%PGF6 +
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MKJ05TCE(PCG<&>-I-2ZC>XYR)&XB>XYNU1MDUI(],VU!P'-G?G'K-467K8@
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M]A*H?$KZ@ N]R[OB M,&'0VM(BKSA,(Z69%BS9G%[:FD9#T0/:I9WQ,DK2:
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M<# P),*%#E02V/B>=>GLP>Q='8 < 7F&WZOIT[NSO7O0%[T.!\#N.[M"AE2
M+VCNAFJ3 .3H.:RUA0LY&\=_\,N+'8GE!1I@QB$D7Z6*X$&V;P,/G$R19W7W
MBF7QLASSQJ1#2# ^/VWISV;HSV+H[;YLN^%#>8ZA+"855QH15,'.$-#%V(%@
M]4(?.K!$F #:@.A="H A()4RSFVK49:6*2*8T='J9B0[<'CDL++]N50M$BKF
MYQZP0+H PB-#@-4!9'J:-JRIAM(\KH"J\$ =&%T@62P4#("2 $U+5NGQT?*9
M R!PUY]"+V%H20^ KY_Y0\L_WL\Y]7Q !ZT>Y9HR(@"\88*'RU(4&PRH'*1
MY5'&AM(AR6=[JU,)DR2J#7@"DGD)$-616+!,4\M\%,;UDF>EO(F;AV%JE-6
M&K(A U>D)E44%(Y?B]VZ]GE_3\GZSU?&JKZLBD@#N8NT(\X:)')3P-DD(T7G
M<%#R.$*4BZ/(JI#<A"-&X!D!8%9# 8=O? 9EG$KF<[UP(V+3( [.<@W)FD';
M3>'P**.6E42G'@"QA  @"T !4 0^+SKT]F#V+H^(BE84K+#O9JSI2Y9KG 1L
MQ6[)(-M7Q=P(M,S6.)$I'*W>LE; ISK@VI?(MI&EIH.ENI$[/</<55#L?\/;
M>G/9NC/8NCM-?H\F SI1*"A:],Y2CK9N"FJ%F:PN3Z+((@VM;O)(IUT @<D
M>"/"YZH8:C!'(>M.A0P:#BM! K?%B %L0<73ZEBBW4*);,H;PX:?OLB')6N
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M16A4<U7F)AH"[3#"!ZBT(GI*=<*XO_#RS_>SSGU=A,24 'R+#1P<K JAB>C
M((/@+H*=)!M0?4:C6Q')(2IE'5/1'!THL'&U8'*RB6VPY!,HEZVP<;>P63E$
MN[]J32D0T,&F0*0!8W%()"%@E,M7=0,(1XX!$LU)(\>Q]#F"CG*-9AU)<Q8
M $F 7"PV,7=G:<-I!,P5'SF*8T%08KYLN1T-4HC;<HU"<-'6%("@ @QD7)4M
MSCQ +5%<]VZ]GE_3VJ\24Z -@K!GAJ.YP[;$%>T!-.6IC)ZMSH0U!)EA46(0
MB? PI-0(YSV0Z?&_@+;EMK]U'B0Y$$-8RD4R#\Q@+#0[@]K=E-/*;O:-H@;S
M5<VI8K#!($"$_>6=;Z!CDH8^@_DK$+D6*(5D*>2AY2-F)@'BK8TJ..'=:)V-
MD60$%2]P^2 B'M]9ZOA5>N'^T[^AOIB*#K()DVB%:V4]JIP1QE$7#]CU1LB=
ML.#&KU D!1S-5?-D,& ?#*Z12C$UTN ###&28B=BA"+&(B+Z]5T'5CHHF*T_
MM-.@!:#"-6$B5X'D%Q<A"I)#MZ=)&D9<&I/-9Z1+'"\ 0D"R12OEB3_D'M\Z
M]/9@]BZ,!.H@*L%8> *^ N \Q*&\K5G6^="8#8J*];:Y#GLA;G%22Y"A175!
M6!6P<0<4A"#,2XJMQ86BTHJ4Y 2)H&!FEQ-T8&Z$4"M##"0BDD-8 @J@\!QP
M5C U+<*E-965PS%HZMGI7<W10 <@MR@J2A-H00.*+)M&D;4&%TZ+QB/Q90"J
M 2U(7D8#'>PF(A@%$!$05P#?0L(HVG0&II\!R=@E!.^&!!V>V].>S=&>Q='9
M#(09U0^ZO>UUO-C#:0#NT?8R/ T$Y4/91^]/TB-F;O@%+H"& %  44 8KB6J
M 74+O 7N,QECV]U;@W(&)J:1*+Z@R-NIOTYNABF6U7/0LF&@+NTB$Y?R<G!*
MI)B A@5KL6(G:32+5!@,"@"PXF:$^E-9W"$C?JBI;0-< R[^A!$-0;W'?.5,
MXTS%$*BB;^ KY_L-N Q.$*%W@0H)@=*=)JM6_P!5&G&G+*T75,"=@ 83'#9R
M-!WH^@0RU=,VSIE4U@-DYL0< @A  TP-.;LZT#&B@I;K:&8DZ";")",*,"!,
M2+(#8(7NB7["Y5N [*>L]" ( /\ CY9_O9YSZNQ%I($A;$$=@[.0>3'.X(02
ML*P!5 *:,UC2(- ) :$B1P.A!B)6KF<@^X*VK6BTZ[=ZMH6N2CBS67BT ;VE
M7!&4)0("@1%$Z"T0,7:3$V],-26P$)=PB[Q>F X%&2B(,1 !5>TTUB*-#I@C
M4L2,@!>=JM H]!CK6;VY#WYX>Z>Y\SK;@)I42&@BHL D@ J 8J8(LB*%E04$
M(4&B=T&]9!BJAO<.H!$J==9Y$$#H)-SW;KV>7]/:"1H#@@X"1!V&@X@0#>D:
MD88!D P$#1W49;M.L'0 #)B[DMAT.T,R<O %%*J244A356D32V6(E8C42HBU
M &A:-Z,7<X&*$+8Y[HU]*?((@,'#-F>=UB#YY+XBA6,,"Y$.UY(PU'O8JT;@
MZ$(6= G"+2F^+.%SOZO:0#$<%B 0! !FVQ<U2U($@^<X@BU$'<C>9 4&A!3M
M]9ZOB5&B.J<S;(:0@4(<F!9(2FIK(N" "P4(;"!0TDUT;G3)&H#.M ;P:45!
M8\0&9, P$84 :7$&HU8VP&VP !( (@91 4&\&6A( D@! &0Q=?9"80H4@(JG
M<I0!"\ =6Q:PJYM/?B 1A=Q($4=+:&#2@B: Q7"&:8-$2$040 0"R&QV^#SK
MT]F#V+HP$J $@HH]U0^C@,I4:$4TXM$&W(55*8*@2Y$7&4SNB4KFB#*00.-6
M,/I8E9V=8DX)=6YWNM3HV1KN3JC,MV8S!%&<&.<(Z9A=+3L ;Q2B@1+9F'LV
M EI)  3+X>N8LHL#1 *'0C2C JJN/&2!985K #>#&'15+0T2@3M166$'HNN#
MR0E!'$>!4[$T1FCL2 L795A%ZE#CD34DX*BYXCJH1QV#VWISV;HSV+H^*=E"
MK.9'CQZ8'$66_9=@B+KDCW24BCWH@E(HU*M%&:T>5H+%L;V4SG"$^H>"^FZ4
M.' Q2T@O?3?#2J- Z> B4?\ @5\_\H>6?[V><^KY/W;KV>7]/R?K/5\*IT+T
M*?4V8I0^!5XTK0G$(EPCA(((:Q/B)N]@);8HO(8M.L)Z$4O!%Q,:!..? TI*
MI%@C8LJ?2CP1 N5)HX)=MN@*?"G@L );/=R2;((0!'8.<I%RB(E&#(@3&.J,
M'TKEJ"J2CO0UJY@T@&V&5 "J88QIP<EH]OG7I[,'L71V$"U$$XX0*CN1)DV(
MZ\IH%T$"$&D,%JO \1>OW][%A'$Y@V D(404*$%Q4$ (6)%W*$J$(8$MM58?
MJ(^)O??@8N HX0+$!H$0UC((A. Z=&KMJNR.\J"#2M"@Z.X#)J3%7@(V7"D6
M23&K,33;=>:@.H2WP,0IBT[#<-"@-!0*#B-R,*BV=&H$0$(3 X)..U4DG=D=
MXN\HUUAOH <2IFLAC1QF@!@5A85%;7L]MZ<]FZ,]BZ/CXC"A[IU.PB;6F!+2
MXE4-(U@J5<2[80H)<(U") < ($"%)"#-0DUQFLG]R8'"F@\: ,Y55555:J[5
M7:KM7:_\"OG_ )0\L_WL\Y]7R?NW7L\OZ?D_6>KX571Z(GU&GGF]5&V^74-5
M 4J8 &_QQ8*D'K25X -HYET!,SJH71$%PF!'N1.\*C>)/$\* J0) T68@UBB
MI 0S]#0#[HKM:12,3'<8\J0[S4M3SSQ*WMP[PTIGDZ.P5*2NC8$A(G: LG(N
M<+WX/%%P \($=&BZP%BEIP$9I 02TK\'G7I[,'L71\G[;TY[-T9[%T?*%?/_
M "AY9_O9YSZOD_=NO9Y?T_)^L]7RJKSKT]F#V+H^3]MZ<]FZ,]BZ/E"OG_E#
MR[_>SSGU?)^4^3V>7]/R?K/1^55>=>GLH>S=#Y/VWIPK$L1\ I7P#:]V>Q='
MR?0IU2>+].CWX@*F65!PH'(_'AW_ "05"4%+!WJ.(7ON"%P7X?M[',+RSE3O
M7?.8;Q$TD>C\D1$6ETHXE.[E[G7AV*LB]T>3/H?:>+E.I^<IU/R93J?DRG4_
M)E.I^3*=3\F4ZGY,IU/R93J?DRG4_)E.I^3*=3\F4ZGY,IU/R93J?DRG4_)E
M.I^3*=3\XMO1(>-Y?2??L-T.*[M$=4Y :T[VGB'Y,IU/R93J?DRG4_)E.I^3
M*=3\F4ZGY,IU/R93J?DRG4_)E.I^3*=3\F4ZGY,IU/R93J?DRG4_)E.I^3!%
M0 *[.#;^#G$?KT&IAI[P O"K* X@)$ G(C1^SB:E60*1+6B#H[A-_(BKY3@
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MM):A;, J5A!9 ")W/8P<',7(E%0)/FRIE9"H"B;&8.;2S22RV&B(DPJ+)+!
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MK(WLE,:*$S-1@YH@%1*]@&W8IM S(P E!<49L.O5Q42: ABF:L&R -5E>KW
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M-+,ZOR?2PDEHQ\&A68#AQE&M*%TN;51"/VDQ8P@!8/';S'Z<B)1*4%0#]3T
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MA4&P$! -P81.EVX[:4Z&4,<>@KNN J&4RK2I@<&GP/HC!BT.NPHI$V@'"8S
MHJ,4 R39&_#*W0:@XJJ # 2X:XJP,6QE3#M#)$"&#Y(!$R%X)UZS+=#3:PT5
M8P P,*Y*#WBG;BUX#\'ZSH?-W@XU//"L)YA54MX@ U6J5A,L%B+\81'HL!I8
M28H\B =WMA;9RT,G@>;H15(HX\&#;61R,,#Z^^VV_83GSBYPA7K\.PQ[R04S
M0[W5^3QF'T G0[I"%"@D"DA%,IG(R88O/H W#?P,JB%SFP^4:6U';?O43B&P
MG0AXW60XO\XXX<*JI@D$(,!V @99,S9_@+ V N=*4D75L3P!,0HY:%#) $BK
M];+G$I%@3YI /@(2F#>'&= (BDNXDIJ(<)BB1&#TU\/B7@L"1H,&A]3N!\I+
MD&#6^D9<]8Y':Y!2=*WS/^>%KT B<>9$QD@AHR&'/$(1GNPD"FHSS"&XWT/(
M*GFB_C-Y4J3*0%^&%QXP*\W VL@P9+CLQR6D_49@0  1#+@.4>6GYDP^A6+,
MDW,-B#"")F#(/N))C.$*4XHC40E@#6T !G!,3K[^P"1 [G8I<XH?<XGA TFN
M+CP'X/U@;S4[Y6M>#-$XLCGHZ\/@]*R!4$03,=[$3F(^#>)"R-""\!" \8X$
M8JD!M5, \U=&!#2(:/$>"_0?L$LT40\*A 1'&=R&K5-TJ"54*_2(Y%$-0X?.
M+'EA6!8[^#9_K.L<CP?3/-C_ )BI'2(X5H'FV.W@VZ\J2*(*5< H0,,'9D"5
M!T,U79'6! .1,5'H!MX@O&FVZ&O!T+44)"T4:UAU>Q%%8@NN#4=KMJ>#8BW@
MEH@39D7B\A[(T9#.K9<F%#?@J@4 "JH !55T ;5T&/H23@63 C62-I5A+1:7
M!I2.(!X\#@E5F'%#X$^[)$1V*DG!08Q$-Z4&#&]G:!I >0%'8'5V'XQ&CD$$
MKT-072":G@G&(6"A&UK7D&4DF/T2",^QCGTB"5)0P?#@UQ)0K5]#R5*%(8$>
MD3A_+7@+5JU:M6K5JU:M6K5JT@P)J^NQ2CE%F)$4N9&WN(V,+L&$+K@$+&'G
M_P!O8>#9B*/*! (BB3-K]1ZJ;IO/BB:!!0<YP7_;_P!\ ,,,,,,,,,,,,,,,
M@%$/$ET94:)H7#]6H=G4RZ<370 #'VG-+:1'@\DB.Q'&O*M'VQ4BL @ O'/D
M<OD<OD<OD<OD<OD<OD<OD<OD<OD<OD<OD<OD<OD<OD<OD<EJN/V*4#R)YC9A
M*!E#H /MQ6J[55>P#ZF)& :T>.".G ,K6;*K7$>WZY @0($"! @0($"! @0"
M0P:N=T8&X%>&.ZQ;];T7UDV0(-O=7J#F!@'8F-(#4%PB&BZ,N,LZ0:I!5 8I
M&R'UP@0($"! @0($"! @0(D;C8(VBSVC.@;S<0I]_# AW))1 "! T!P#EV(-
M$ *:+B50D7241^Q=.+J+LEH7P HHHHHHHHHHHHHHI53:TGG<7E PFV@!D1,]
MJ-@G,=G'CD0LE\@>8[?-^V;BLKL>+Y^1O#P!@P8,&#!@P8,&#!@P8-!8FI^?
M$^SC^MX>*"#^@#B2\-[_   $  X!H/Z_]4IQP=Y(,BVG-(,616M-A@@[:32D
M7P+=NW;MV[=NW;MV[=NW;EWFR#]G$X<-DYLH$' DX(T?[[% H 5$  JJZ -J
MZ#%_2J ,@G]@F;9X%LV;-FS9LV;-FS9LV;-M6I;8&"\#FNC#>B?*!(18E&#S
M#L!G*.,XJ  YK,9,":(G$H&?9GW\"'#APX<.'#APX<.'#APY4CFQ%P( OW0^
M^'1*C&YH1/N*=C,*37YJ,KE9"8O1$@ $L1@AL4\#&C1HT:-&C1HT:-&C1HS(
MXZ#AL[!O)6I!WR9G&T1/J!$1["VDU<BI@T&K#87?UFE)D6QQ'S/ YLV;-FS9
MLV;-FS9LV;,%V<)80*0 TD[:=B13B1>1M#@)%\_!.?/GSY\^?/GSY\^?/GSY
M4E-"IX6X)NH3=[ #*,2$0!G"13(<C_#(<C_#(<C_  R'(_PR'(_PR'(_PR'(
M_P ,AR/\,AR/\,AR/\,AR/\ #(<C_#(<C_#(<C_#(<C_  R'(_PR'(_PR'(_
MPPNVBN$("-P#"F+83I4B0 !8BA#L9J,BZ&-$V:$8)7  AH/!,O,[#BA( -D.
MR]E^L30*9%0ELU##P9U]A42*'88BP8!7LHZT<*V(!X\%JU 0"/D]?]Q#8(%T
M0S$F2,'K10]T,>>M><F,Y"?"%0P53O!#!HO"B)(>9& XK4B(*DI4L%R<-4JR
M;]X ?=RAIBK:M_2@X'@G#S48TV<855""*8AJ. % Y-!(U")KPO$!PP!8!Y'E
MP_'GAL/P9T/F\'U?D_\  X?0#+3$LN>L<C^)[<6O ?@_6=#YO!]7Y/\ P.'T
M RYQ++GK'(_B>W%KP'X/UG0^;P?5^3QN'T X^4%L ID(V DP#7XB5+%*>)),
MYV%514\3KB.VR3M)Z)ZTZP[.&O=.XPRM4D3;QV7.)9<]8Y'\3VXM> _!^LZ'
MS>#ZOR>-P^@&F5NRQ!1&1@ACD65ALMD%[L6)0TNL'^05\TCS64,,-C1^@8/7
MPAQ">3.[K6910B<<2IL2"*0P'%"3;]@GNH7U^-ICA:W?I9<XE8<DX">^@=-E
M(,,DYR@0'8@B.Q(]BZ,HQ)QF1\Z9YXC5?6E"SP[0#!8[0-K@90;!&/8FPD93
MA5"H!4VYN.;LUV@"L$'CCP.:0@MJ!QBZ^BRYZQR.PMY!84 6)%*0<'0$/4ID
M0N[2.<-J!YJP/NKH/NYM&;LR39 T+1T@_183(+V*)'_@\4"Z 6O("J\H#<5W
MR24%7XLE$A7N]N(H9:4CM2B4A 9C$<Q/]BP4B&0(F("DBS<A*/D!7R,1$"42
M8X@Q#S /V\ UX#\'ZSH?-VGHQ\*BH)E E?.4/K[@:*3#TBD=R=PQ3,,Z(=[S
M&;#4F6ZX)U,@V:3N 8WQ!.$VI 4-XIA-%-P!4P"@H.NYU?D[N'3.#/P.40"&
M=I8\Q2%P2%PB*-[6CT/$U@DQK007#)3?79;+2:)!>I;8<7\;&$B=@-4]W\3D
M0BVN#D(>D!8MG1G"J9SE!(5I8!I$3L4!5 "JH '%5@ ;50#;FE'MQ2!WJ'A2
M.OH^@#?4-(%2J&_M3&AV!=2( #7&C$F(5'U8RVH8 )BX8PMABBJ049=[AA =
M(_Z$(ZY1#( B&9 =,=>8&J@G->@) !LSP+L0R00PD;ER7NX0U)F[;X[S5*HA
M$6OTLN<2)@@@+P%ALW*E3RP.H^OF\@V6$<4"^0?J=\N7 :6_^UG2IUY'Q( F
M^.VNX\/PR"YR)N$_0O3T,O:YAO?]A#0+A7<E21I>!OQ6*?2SW,IJUHO<->O
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MXQ[Y\8]\^,>^?&/?/C'OGQCWSXQ[Y\8]\^,>^?'/?"^KFK!4HSE$*8=C>]I
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>4/W\$22222222222222222N<RAZN,8M$$":G9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>ahl-20231220_g11.jpg
<TEXT>
begin 644 ahl-20231220_g11.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1IX17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !X     0
M '@    !    1TE-4" R+C$P+C,R   R,#(S.C$R.C$V(#$T.C V.C0T  $
M : #  $    !          D _@ $  $    !      $$  $      0   0$$
M  $   "\     @$#  ,    8 0   P$#  $    &    !@$#  $    &
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MEW(H4D#(./2IOM)_Y]YO^^?_ *]1>7?_ //>'_O@_P"-'EW_ /SWA_[X/^-
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M?(#D?A4KS0/"V[4B8SP20F/Y57F67.[?< -_#]G#8Q[4R(3F38_GD.#G_0P
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MQY<2\9![@=NOY5.L<BVBVDEJ\J( H9& ! Z=2#V%0_88\ &RNC@8R9Q_\50
MQ7O&4?Z1=@@X.Z%!GCZ5:@CEEV2M<3 @\JXQGKVJ'[(A S97)(&,^<,_HU"V
MB(VY;*Y!_P"NP/\ -J +DW_'W;?5OY58JLHEFN(W>(Q+'G&X@DDC':K- !11
M10 4444 %%%!Z4 9Z3R&VBN)KI(1* P&T8&1G&2?2@7*,FY-0C=>F44-_*I;
M,*=*MBZ!@(5.,9["H)&$J[(89(2J[@?*!!X(P/>@!D$T,$*(FH#:Y+*60<Y.
M[^M317"SL$BU&)G/10!G\LU4CE\F;$HGD )^46N,_E6E;^3+^]2 (1QDI@T
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MM*U_YZ'_ +Y-']I6O_/0_P#?)H MT53;5;-%W-+@9 R0:7^TK7_GH?\ ODT
M6Z*J?VE:_P#/0_\ ?)H_M*U_YZ'_ +Y- #Q:;!MCGE1!T52,#Z9%'V9_^?J?
M_P =_P *9_:5K_ST/_?)H_M*U_YZ'_ODT 0V$<T]KODNYRWF2+GY>@<@=O05
M9^S/_P _4_\ X[_A5#3-1MA9X+G_ %LO\)_OM5S^TK7_ )Z'_ODT 6(HEA3:
MN>N22<DFGU4_M*U_YZ'_ +Y-']I6O_/0_P#?)H MT54_M*U_YZ'_ +Y-']I6
MO_/0_P#?)H MT54_M*U_YZ'_ +Y-']I6O_/0_P#?)H LNBR*5=0RGJ"*A^Q0
M?W6_[[;_ !IG]I6O_/0_]\FC^TK7_GH?^^30 _[%!_=;_OMO\:/L4']UO^^V
M_P :9_:5K_ST/_?)H_M*U_YZ'_ODT 2+:0*P8)DCD;F)Q^=3,JNI5@"IX(-1
MP7,5RK-$VX*VT^Q_R:EH K_8H?\ II_W];_&C['#_P!-/^_K?XU8HH K_8X?
M^FG_ '];_&E%G ""59L=G<L/R)J>B@"*2YAB?8\@#8SBF_;;?_GJ/R-,B81R
M7LA[2#/TV+59;Z4HQ$T#$<@#/0#G^M #HKF$:G<R%_D:., X/)!;/\Q5K[9;
M_P#/0?D:HG49,_ZZWW9QMYYH_M"<-M9[8,.",F@#0CN(96*HX)':I:K2$-=6
MK#ONY_"K- ",RHI9B !U)J'[;;?\]1^1I+H B%3R#*,CUZU%>7,]LP*B$1GC
M+DB@"+4+N!K3"OD^9&< '^^*M_;;?_GJ/R-4Q?2[ES) !@D@'V[4PZE,K$,]
MMQD'YCUH T%NH'8*L@)/05-5*7S7T]FG5 X((V\CJ,&KG:@!C3Q*<-(@([$T
MGVB#_GJG_?0JI#$S:=!)%#$\C(&8N.I(R>?K4*3@H[2QVJF,X<*,X]1^>* )
M=+N(19<R(#YLO4_]-&JY]H@_YZI_WT*S#<+\I7[)C;\V1CGO5BU$DQ#/;VQB
M(X=.] %\$,,@@CU%+5>T 42J!A5D( ].E6* "BBB@ HHHH ***#TH K_ &M"
M3L21P#C<BY%+]J'_ #QF_P"^*@L [Z):;&VN8$^8C/\ "*K+=W)W!I\%3CB$
M^M $]K*T<MT6MYP'FW+\G4;5']#5G[4/^>,__?%9S7ER-K?:!M8C'[@^]6;:
M62XE#"4[5^\I0C- %N*=)LA<AEZJPP14E53_ ,A0#_IB?_0A5J@ HHHH IK*
MD%Q<K+D;W#+\I((VJ/Y@TDLMM(FU7*'U6,_X5=HH R/+&[/VU\<<>3_]:K4<
MULL85VWMW8QGG]*NTC,$0L>@&: *OF)/=0^5DB/))VD8XQ5NJR3SR(KK;KM8
M9&9.WY4OFW(_Y=T_[^?_ %J %N\A(WP2$<,<>E0SSPS!0)64#_IF>?TJ4RW
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MW10]D\:Y26>0D@??Z"K'V.,$[2Z G.%8@4?9%_YZS?\ ?PT 4UMI=[*_G[6
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M !0 !@ :86-S<$U31E0                                  /;6  $
M    TRUL8VUS
M               -9&5S8P   2    ! 8W!R=    6     V=W1P=    9@
M   48VAA9    :P    L<EA96@   =@    48EA96@   >P    49UA96@
M @     4<E120P   A0    @9U120P   A0    @8E120P   A0    @8VAR
M;0   C0    D9&UN9    E@    D9&UD9    GP    D;6QU8P         !
M    #&5N55,    D    ' !' $D 30!0 "  8@!U &D ; !T "T :0!N "
M<P!2 $< 0FUL=6,          0    QE;E53    &@   !P 4 !U &( ; !I
M &, ( !$ &\ ;0!A &D ;@  6%E:(        /;6  $     TRUS9C,R
M   !#$(   7>___S)0  !Y,  /V0___[H?___:(   /<  # ;EA96B
M  !OH   ./4   .06%E:(        "2?   /A   ML1865H@        8I<
M +>'   8V7!A<F$       ,    "9F8  /*G   -60  $]    I;8VAR;0
M     P    "CUP  5'P  $S-  "9F@  )F<   ]<;6QU8P         !
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M P$  A #$    ?U2              " -0         ^'2&<
M                                        %6'3DD         >3BSM
M2;    .=.+)$          T3M2>
M  *V+)          !6Y9    !6Q9(          !6A98
M                  !798@          *[+$    *[+$           *Z+%
M                                   *[+$          !798@   !79
M8@          !718H                                  !798@!SAK
MF<P&<S&($43!L'*$D9#<.A !798@   !798@ !K')'3G/ E2.)@\G@]$:=(9
M0 "NBQ0                                  "NRQ "&(XQF R&<^F8T
MCZ;I@-4RD(62 "NRQ    "NRQ  #3..,QJ$R;1$GDC#=-<ECH3>  *Z+%
M                                *[+$          !798@   !798@
M         !718H                                  !798@
M   *[+$    *[+$           *Z+%
M     *T++          ,17A9    !6Q9(          !6Q9(
M                      !PQ'F4         \%?E_&R    4(="2P
M   !H':$^                                              1129?
MYZ   *@.J.U
M         !"%1%\   I\Z4[L
M                       '.%8EX@ J<G3NP
M                                     <F<&70"IB6+#
M                                               !RATYD !Q1RAO
MF^6$  <:=:90
M       5\3IT@ !5)O%D   XHW#J0
M                           #B#8.O
M                                    .(,AV8
M                                     .5(4      ')FN=H      #
M=.W                                               !PYOG4@
M           B#C"R@
M   "N2Q@               5T6*
M              5T6*  #EC"9#<.;)L^FL;IF..)LVC4-H^DH<\9S*2!-  %
M=%B@                                              %=%B@ &(YH
MA";-@BS(;!'FZ2!''TRFD1YT!F(4D#"3Q(@ %=%B@
M                           %=%B@   &,I4]FV#7.H-4UCP:1A.W) Z(
M    KHL4                                               KHL4
M   &J;0  !Y(\DB,-TS    %=%B@
M              %;%@FP               5F68
M                          8RMS.      ",-(Z       &([<DP
M                                                 #F2$+!
M                                  !ID0
M#G"(.Z                         !G)P             IXV#(
M     "IBV0        01$':        '.FL=6     "LRS          <,?H
MX             IXMPR@            H@O<        ',G*%H@       '(
MFH=R     "F2Y@         4R7,             4\6X90            40
M7N        #F3E"T0       #D34.Y     !3)<P         *9+F
M      *>+<,H            *(+W        !S9R1:(       !R)J'<@$><
M.9   #@3O@  #$=X;H    !3)<P            !3Q;AE            !1!
M>X        (DX0M$        Y$U#N0"K"TP       >2L2T     "F2Y@
M     0!RID   ...O/0  /!TYT(        *(+W        !$G"%H@
M '(FH=R 5V6( #ECZ"3.'.@!($>=,9P"NRQ #D2'/0  .1.N   ,1UQ-@
M%9EF        %9%F@    X<T#V  "O2P@  #P6,?0   ").$+1        .1
M-0[D KLL0 U3F2")@F3G20(PVS =:2 !798@!6A98       *S+,    *Z+%
M ,)PIB-@G#DB4/)Z-<ZXE "NRQ    #E@=2       :1PQ8P   !$G"%H@
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MQ0 #GS0((B39)(Z@GP "NRQ    "NRQ :Y&$B>SR:QF(0ES"?3;/!N@KLL0
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MT=("NRQ           "F2Y@        <T<F8P  #FSHCT  #*=,=4
M           8BHBX@  "NBQ05<;!O&@:)T9D((C3;/)HG>'-$L<\6R"NRQ
M         "F2Y@        5@6>        5H66                  8BHB
MX@  #@3L3= !I&Z :)O   &N;!X*Y+)           *9+F        !51:H.
M=(4TSV2Q&&4TS,2((DZ@Z %=EB               TB.  !X*I+9  !F)8K$
MW         :98IM@ '$&@>@     #P=$=*4R7,0QQIG      /))'/%J@U2,
M(DWB0-(]&$^&(G37,I) KLL0              Y(A3H       :ASI:@
M       !Y*V++       *S+,*9+F*N+1       *S-8M4 '$D419L'DZHT"!
M+')4 %=EB              %<EC CR0 ((\FX?#T?02(!718H
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M;!" FB0/9SA9!+ J,U2))8CB]P #B2*- 'PML  KHT2RS8       ,!6):H
M            !798@ !X.5-<^F4E2:  *[+$            /!P!81RIG,IG
M/9I&8]F,R ^F0DRNRQ "JBU2..8)\Q&X:)F/1Y!F-<RDN5T6 <$>0      #
MZ=Z9@             "NRQ #A3&<J6T<,1AG-(V"3.Z-L%=EB
M '@X L(K\Q&$E"(,AU1'$0:1E-XZ4G2NRQ "JBU3GCF#P;)X/AODB<X:QM&N
M=$=<5T6*                       "MBR0#4,YY/1]/)K'PV2,)D K<L@
M           ^%/EHF8      CCB2T0"LSN"4      ,94I;P
M           (TX,V0  "!)X  'DD#MP            :YQYY      -D[ ^@
M X<T@     #Z=N;H                           !3!<X
M                                                   *8+G
M                                                          !3
M!<X
M      *8+G
M             !3!<X                                       - U
M0                      "GRX                        9R2
M         *6)P            K L\          K L\
M      '.EW@              %,ES            %,ES          %,%S@
M                       IDN8               IDN8            ID
MN8          I4NH                       %,ES               %,
MES            %,ES          %$%[@                  'PX4U0  "
ML"SP  #M"1       *Z,9E  !C,@  !A-@L(   ')$$9@  0)/   \&(LP
MX B0  #A3N@  9#M"=               *H+%)(      '@K([DEP      5
MN60       "N"QP   5H66       <F;AT !R)N'1       %8EG
M       %7%H@U#; (\D  "--,F3*"KBT0      5V6(>3@R".Y.8-D]D>;IH
M$V<^;A89E*[+$   !798A&'(@^F0Q$V0I\-<F"%)\ZP@S2.I *Z+%!PIJFT;
MI&FZ=(5>2YO&F;!UI(%=%B@              %4EK KHYXWC?-4RD*;I])LD
MCDBS#>!5):P      *[+$(T'DVB&-L]'LTS*8C9/A(F8KLL0   %=EB&H1Q$
MDB;9B,YK&L#9-4WB9(,TCJ0"NBQ3&19#$@;9\- DS6/9X,9$G0DJ5T6*
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M:QS9R)Z-,Z0CS$>#HCCR;,QKFZ=P"J2U@      5V6( #&<P1ASY.&4\G?@
M%=EB    KLL0$&:AI'LDC7.7-$V"1.F)X$&:1U(!718H .>,!7)TP-,V3*6,
M "NBQ0              "J2UC2,!\-(DC$:Q@)$^&8RF(]&Z"J2U@      5
M<6B       "L"SP   586F       5\=<28!"'*%@@      UBN2U
M        "J2U@ #FB#)(CST2QTX  *I+6      ! G*&4      &(ZXFP
M1QPQE      /A+G7@ $(<4?   5B6<  #=+ ,@              !6)9P
M /![  (<YT[H                                  %,ES
M         ')D$90      >3P62
M 4J74 < 8@               #$=D2X                       *D)8
M             &$FCL0  407N#R5R60                "M2R@
M              #6*\+,  !J&V 1Y(  $,;9F-,E# 9P1Y(    KHL4  %$%
M[@\E?%A@ 'DKXUS.="0A&&X;QY,QSA(FR:!)F^1IIFZ1Y\.D.G  !718H
M                   !K%=EF@ &,KPYPE"4(4'LCR;)8\&R2IQIA) P'T\G
MD[XD0  ?G<D   5L62#X=L6& :9Y,YI$&2!OG@U3R;1C,QHGL^GPRF0S&F82
M/) ]'0'@^&0 KHL4                       UBNRS3B#,>S,;A'&4VB--
MXQF@3!D- P&\;I#GTR ]F<UC*:I]/)(F<E"NBQ0  4R7,#R5\6& <H<\>R".
MS/97QT)A(LG29.(-T[ X VB3( F3H3E3?,AB(@[(D3I0"NBQ0
M           # 5V66<>>ST:YB,A-F YLFC3,!(FT<^9SI3&:I($";IK&^?33
M(TPGTZ(V26*Y+&  !3)<P/A6Q90!A,P !J&V   #3-P T#:,H !I&R9 "M2R
M@                       58;X               ,)T1U   *9+F .%-4
M       %>%A@       P'<DD                       #G#G0
M       =:3   !3)<P         *(+W
M   ,95Q:H               *L+3   *9+F         !1!>X
M                    !K%=EF@X(T2>,Q!GLES6-PTS,?3V<N=.19O$H1YL
M$.;!]) T#Z;AZ.B!6YVH  !5!=0         *(+W
M            -8KLLT'-FJ8CIB*(XD30)<P&L>#.:IL&@924(0WS(:YD/!IG
MTVS=.@!58   .I.K!H'!&<       '"G=        $D=F
M        :Q799H    !QI'D&9#;-0R&Z:!:Y]     *[+$    !6Y9
M           !6Y9                       !C*N+5     ,)KF4Q'TRG@
M^'TVP     5:6D    "NBQ0  "N34/1)G.FZ29$&H=V< 3!K&J3ILFB9"%,Q
MOG3'1   KLL0                       '-$                ?#JR:
M   !718H(@W3,:9HFV11.GDA"6-LQFL93X9CP:!L&\?#2-,E")-XW3 ;)E-8
MV2NRQ                                              5T6*8"M#<
M.=)LD#ES.?":)8@3G2<(\DC8-0\$H09M&J930.Q.?/9F,9@,QUITY798@
M                                          *\.R)$\'L    \'DR@
M  &$S &,\F8  Q'L]%6EI
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M]!MK%&UR>>P$GZ+;9UDEZI5$*PT_W5DKK:S1E7L3V/D?*VVU5DO4JDE6T/\
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M,C8F*Y-903P2:9J/4I!9\[UE!(J%FCW 2LK!8Y[/'$&)-!12.>=>T%<[@]5
M_+^1O^OA]V9YQGU%>D,Z;P),OFKY-U,92EDESN'IU#+NUI=O'?\ ^F1<AI+#
MAEB6P'2DK]J 4=8(@M+JO/NR+ANZ351L"B3QI(N%)LS1<\@D\)B5:0#QT\1#
MA+KH9529(@X1>I//O2V&K<[G[B[F84.R2=(2M>_73/.'[T_KU\9,CX;X_2E!
M:OE7#FNI.C.('J0E569&SNJH.VY*T5+#V,3>IK1/WU7E2+EGH*?4EJZ*6$J@
MW01-743"+B"Q82IR*1]J)%#Z/*^SB.S@I8?]'+MGEUEO6DF6$X) C52OX,X9
MQ.&3K2\)NU8!%0R-320*A5OU;XIR!,%C<8E8QGEBS%;S^L_ZJ!^7\L_\X\/U
M?TK?G]!?N>ERV2>(^P9LD=QYN&2#L$)@A?2FS01!2X(7SKA^LL7]@6/E:NOK
MLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=
MG1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G1KLZ-=G0I+6-P6OPV
MB,?50/R_G)U5)X^V_,C;\R-OS(V_,C;\R-OS(V_,C;\R-OS(V_,C;\R-OS(V
M_,C;\R-OS(V_,B37G6%MV_,C;\R-OS(V_,C;\R-OS(V_,C;\R-OS(V_,C;\R
M-OS(V_,C;\R-OS(V_,A6JR#PK"/;Q;3^PE;#&P@Y"KPY"KPY"KPY"KPY"KPY
M"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY
M"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPY"KPC)9G,-_70/R_Q
M+'_*7^!.;Z"T1NF^8?T$TT3AK#ZZ!^7^)8_Y2_P+G]OX:]D>2D^MB'/:SG?&
ML[$F%I)5S"-K&=ZY9V8I%%Y?_P"9E/8^P^ER).->Z63S96>&BED9I-R2W42;
MVT.&CLMA:J.D['A28<VA@T#*52?+/;(SCCEFT%0XFW"%693WUM,V1J4(S;=P
M?=++HW%G9M,%G$#E).-5'7E<SE3/J;,:FS&ILQJ;,:FS&ILQJ;,>'QL'E/B6
M/^4O\"Y_;^&O9'EF";9)FN-^K1K#=N1HV*S:MX%DT.I5FJPT9/*FB?\ RNXI
ML["D*W625KC0Z.*ZB55K!(M';BM-W8Q (%4-5&F72E9;JMTHA%*0>5)J^-FO
MI9<*02*D2K6T#F<5Y%RIBN-_JQ4FI6SRIM7QCUU(YV\.DU>^5^9(R27%]9'%
M]9'%]9'%]9'%]9'%]9'%]9$#66%:)Y/7B,>U1L<Q($U:QC5K&-6L8U:QC5K&
M-6L8U:QC5K&-6L8U:QC5K&-6L8U:QC5K&-6L8U:QB1CK$_M&K6,:M8QJUC&K
M6,:M8QJUC&K6,:M8QJUC&K6,:M8QJUC&K6,:M8QJUC&K6,:M8Q#V/$BZ_KW/
M[?PU[(]NX',G5SS+I.6AK.[=M4K))*M2VI4J#F<4<D6L^8Y!I+NG:9+:X,V]
MRX?^WM78OWD/Z.S%P2:_KSE^LE"<$91OMJ)E5+ADWP/L)CHF_P"F&B!<92)G
M)6J)!AJB4=*C[LX[3F+![5Q_^_6E)+ISFYG:J;*RNWCBLS;F7(K(+1:Y;,Z2
M(QG%G;I"S_9PQD) F6S[4XR'G7:+,UH6*KBT.3C-M=JF4LAL'1E';N'ZENS@
MG,X[3=[L>:4\MCB.#*;?O5H:0/*-_5:OR?\ 82U=CIP<?P8X_@QQ_!CC^#''
M\&./X,<?P8X_@QQ_!CC^#''\&./X,<?P8X_@QQ_!CC^#''\&./X,<?P8X_@Q
MQ_!CC^#''\&./X,<?P8X_@QQ_!CC^#''\&./X,<?P8X_@A&0[*&;^U<?_ORS
M*M>H17(N#FP3#-\B_(XF&:1E2-BM31S*9:F32,<J"#8'.QDTV[!%LSRD0QBM
MDBA9JG]IN1/+7H&V!AND7!FZ(P=BLS;JME52)E2P5$A#J)M2X?PC60:&213(
MCTCP(F1:G44PBFL[305(;[A FL17(M7Y/_.7'_["V#&21AM2CRLY3ZS0$DLS
MA(UXSD_L/$I(D-*,1#QTLUBLQ,B@[+$OGU5?9>O(XT6]6DH%K(N88D9(8ED(
MF3.ZPPE3-XQB_0E9=I++R#5C*-SZ6Z/6[6U<&"T7(8!XN3^TRC)))59K(,F\
M/]9V1XJ1;HK1#QR7HY;[;AE)*.'3285=)QZS8C,OZSHM7Y/_ #EV34Q&LGS>
M2;#&,8]K./JP1,J9?6HD18OF8N#E32(B7T_07Z\8_3REG19>T_YUQ181POQ_
M!CC^#''\&./X,<?P8X_@QQ_!CC^#''\&./X,<?P8X_@QQ_!CC^#''\&./X,<
M?P8X_@QQ_!CC^#''\&./X,<?P8X_@QQ_!CC^#''\&./X,<?P8X_@QQ_!CC^#
M''\&./X,1D0SAFW]!__$ !01 0                   -#_V@ ( 0,! 3\!
M/W__Q  4$0$                   #0_]H " $" 0$_ 3]__\0 6A   0(#
M @<(# H'!P,$ @,  @$#  01$B$%$S$U0931%"(T-E%AD](&$" C,G%T@9&2
MH:,P,T!"4G.5L;*S4&!B<G7!XA4D0X*BX?!3@X1PPL/Q%B5$8V7_V@ ( 0$
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MYSK1P#WSG6C@'OG.M' /?.=:. >^<ZT< ]\YUHX![YSK1P#WSG6C@'OG.M'
M/?.=:. >^<ZT< ]\YUHX![YSK1P#WSG6C@'OG.M' /?.;868P'./.V;UP?..
M*XV:<@JMXK#<VS44*X@+P@),HK^I&Z%^,F9E]TUY\82?R^3X<9'XMO";MA.2
MJ"5/2J_!8'9/XN78>F43E+>BGWK\HP_*C\2[BIM!KD(D5"]-G]2)7ZQ[\T_D
M_9#_ !,_P!\%(^0._C#Y1A7R-C[S_4B5^L>_-/Y/V0_Q,_P!\%(^0._C#Y1A
M7R-C[S_4B5^L>_-/N)8FT%5=F&V5M)H):0ZXA.66P<-5Q)9 *R=+M"P1.N**
M(E?!RI1%NY<J1,S(6GP8RXM--UWM@B<<)!&TBK85;T2TJ>.D-@VIVS&V@D"H
MMF^^_1=#F/=L@ MU%&B5:F5D;XF<(HADTP)D0V50M[6J47Q1-RKXJ-ET09LM
M%I:0Z+SY?1# (ZCSKC0NU %1+))<M-&2,41[Y"$%NN$B\%%\<-HT+;8NON2X
MXQDELJ-K?+OK_!A$QI&2V41&VB*MJM*4\2PHN.&2DX0  2YUWHU5(; 3(E<(
M0%4!:6E&TB>K?W/9#_$S_ 'P4CY [^,.Z<<I:L"I4@$F%&2QC#<P"NN)11/)
MY[HL-S#3ATM61-%6G+&$D5E222EDFB5"\(5M7?Z%]D%)*TJ3J&((VBU1:C:K
M7DI7_E(F9<^]S$M17!K=1<BUY,OHB7FS&Q)3!"(/*OTO!54T(O\ -(WLTR6]
MQESB>#6E?%!"W-L.$**1(#B+1$6BP([MEZFMD4QJ7KDI#0-&+QN'82P5=%5K
MYOY1A-%8(4D52U?X26;54\T"8*A 2514T]UA7R-C[S_4B5^L>_-/N&1)PV\4
MZ+R*%,HK5,L-D+[KB!CMZ=FBXP[9:.6),6'WY<I5"$# D55%<HK5%NN3T1-*
M9NJ<P"@3EUJE:I?2^E+JUAYLG7D;=(CLI9N,ALJ63G7TQ*O&9F4L(BW:LW4Y
MZ5OT^*'2-]X,8C2*@6?F';31RQ.2+CCALS6,M*M*I;K6EW/"O[KF,83HO*JV
M,J!8^CR1*.8QQTI4$!I3LU1$&SE1*^;)#CRD:(Z8..-W62(/!7V)Z(:K,O&C
M;QOV5LWJ5:Z,F^6)9I9R:,)9T7&D-1WMG(.3)[>>$?W0^AHX;J(EFE2"SR<D
M 8*2@VK:(1V%%1$+-5NK;RY.7N>R'^)G^ /@I'R!W\8=TZV-$(Q4:K&#Y0,2
M#DL;!&X@?&8M?]H?QI@;1$9-FV*MO#:*TJ8Q%K2O)&$P;>00G),91,9:(AI;
MOKI\/V1*.LHW+S$L=M+ [TJC95%\W\HFYETL8],H(%3(@)6@IZ5],2N#W'K<
MG+D"C=OB$%J(KZ$]$#,),%9%TC1O187?*'K[[V0XVLP V]U7B/\ U7$/V4\\
M2LRI2PFVCEM&&;"$1(*5_P!"1)O8PG1:4AQ0JJB D*(MFM]*BEVB,+S#=ETY
MNF+"F14"S?##%;6* 0KRT3NL*^1L?>?ZD2OUCWYI_)^R'^)G^ /@I'R!W\8?
M*,*^1L?>?ZD2OUCWYI_)^R'^)G^ /@I'R!W\8?*,*^1L?>?ZD3V"3N>D9ES>
MKEQ9+;%?;\F(R6R I5571$[/T5 GYQR9;1?H>"/L'X+ SI^!,2[TNB\A;TOY
M+\HP],C>TTC,JA)I)$52]%K]2&\(X.?24PHT-FT25!T?H&G)%F>['YRVGSI)
M1>!?:D9@PSJX]:,P89U<>M&8,,ZN/6C,&&=7'K1F##.KCUHS!AG5QZT9@PSJ
MX]:,P89U<>M&8,,ZN/6C,&&=7'K1F##.KCUHS!AG5QZT9@PSJX]:,P89U<>M
M&8,,ZN/6C,&&=7'K1F##.KCUHS!AG5QZT9@PSJX]:-[V/X84M"*P*?\ NB19
MPZPY@C DR=DQ;6V1\SA)X*<R0VC-E&4%+%C)313X)OL>P0&/P@+B.G,HM$E:
M::IIAJ4[(&)@'&TL[O 5=:=YZHEWG2,XCT9[(SB/1GLC.(]&>R,XCT9[(SB/
M1GLC.(]&>R,XCT9[(SB/1GLC.(]&>R,XCT9[(SB/1GLC.(]&>R,XCT9[(SB/
M1GLC.(]&>R,XCT9[(SB/1GLC.(]&>R,XCT9[(SB/1GLC.(]&>R-SX EG5MW+
MA"8;4&6TY4K>2PW*,J1H-Y.%X1DN4E_5YV5FFD=8<2A"L-X'PN:NX)<6DG/+
M\S]@O^>S)\ F <!K;PHY\:\G@RP<JKRQB6.^/'OGGR\)POUW=DYMM'&G$]"\
MJ<\-8!PV:NRY[V1G]!)H%>[3 > TQ^%W?"/YLNG*O/!"A*_..[Y^9+PG"V?K
MR[)30U \A:07E2 ['L.K:-;I.=T/)R+S]R.!<#=^PU,<F1@?I%"H*X^<=WS\
MR?A.+L_7LY28WOSFW4\)LN5(_P#Q_#W#13^[S7S9@=O;#!&" W5AI^Y!3(RG
MTB@W'#W5A)_?3$T5ZDO(G-^N\UBWJ[G2T5VBT0W<MXJD(M%2NA>YQ+A*T^"V
MV'QRME!8"PXF+PHRG>W=$P/*G/#>"\&CNC#4UO6FT_P_VB@W'#W5A)_?3$T6
M4EY$YNZFVQ(TW,BJ2J/A4)16GG2D(JBHU2ME<J?KC-'@YIJ6=Q:DV7TGM\HU
MYD557QK71!I/G;<QIJ%]51NN]1>>G=/SJVFYN0%7F'FUH0JD2^&5;M82GI=L
MWWURJME*^+NWSE 8E7%;51-!O)Z^RI<R+?X[]$&$^_CW5=(A6TI60T)5<OZ\
M87\F/[HP/Y(U^%/_ $ POY,?W1@A16J;E;3V?KCBYR>:8<_Z:K4O0D9S;]4M
MD9S;]4MD9S;]4MD9S;]4MD9S;]4MD9S;]4MD9S;]4MD9S;]4MD9S;]4MD9S;
M]4MD9S;]4MD9S;]4MD9S;]4MD9S;]4MD82EV)\''G&"$ 02O7T1@Z6F9\&GV
MVJ$"B5WLC.;?JELC.;?JELC.;?JELC.;?JELC.;?JELC.;?JELC.;?JELC.;
M?JELC.;?JELC.;?JELC.;?JELC.;?JELC.;?JELC.;?JELC%LX385Q<@DMFO
MI_6%EJ2HD[./#+,DN0%7YWF1%BRR%M];W)D[W'"TJJ_+R8G)=N8;70:1.8"?
M=)\6128E7'%J2M*M+*_NK^L'8S5*_P!X=_*+] A_"R_-3]8.QGZ]W\HN[>DR
M!!;L6F7*^'96A^A:1+F(O.I,*2-8H+=N@VM$-*!D:.(*HHC7*-I+LN3[XM,6
MT16P>2V-*B=;*^Q8/=@JKF.F!%&&U\%HZ*O\XFB)2(98+;BCHR+DRZ8%E0>)
MTG2900"MZ#:^Z+*XW&6P#%V-]4ZV?%D6&U 73M(BJ@A5012LW^>OH6":9)25
M!MVM"I6D.N60QPX0W(G>3L6<=BZUKETY8FG)8N^"T\31D-0(FZVD]D-,L;^C
MXM/75LU&M/'DAD")QPS!MRTC2HEDRH*^F#0R-!'&;^SO=XM#OT45=,3F$&!2
MVTT3@B[>BT\2Q+H9T)QP0J@7+L@C[]907"^*6]&RLGZ(!BA.8R95BM+.+HUC
M-.6Z+#9$3A41L:>'5%5*>85]$2TPY3&. A+1*=T'\++\U/U@[&?KW?RB[I40
ME&NE-$2BB;C3DMD="S:*ZBVKKXD795Q0L.$X^]O4,N]V/HTK%I@WI<%;1M6@
M+>K1*(OCI]T#BG'206&Y=$.G@A6SHYUBN/F,KRY1_P 5:GHAS'JX\I-JU:*E
M4141,J)S5AN85]\G =5ZJJEY*%A=')#9(_,*08J]23_#K9T<\-.@_,(8(HK0
MD3&#:4J%=RJOI@A:<=5N^PV95%OF&"E\>]8*9W4O@UMV[?)RPXS5Q&CQE 14
MWF,\.EW.OIA9A'G@(G!=(15*$:)2UDY(2C\PE&@91:CD K0Z.6'C-W$BX9D2
MMJ"U15JE-Y7DK?HAW!8VFY5Q"%;%$7?+5?OALW)I]Q6R$AK9T>:+&.F*6'PR
MCD>6T>CEA'7''7#1['U6F7%XM=&2S##8S$S67*TPXIU)JY4HEW(JI?#<N!$0
M-I1%/+W0?PLOS4_6#L9^O=_*+X)51*K'8ZXXK&Z'Y9UY[=*W6E05O\]8P=+B
M8-.. =AR:K9=)#\$>:F332D-#NN4$79N88KB_!1NW1?"TT&&YA7&-^W)OD*)
M\6+AV7*WZ$TQ,R[[C0 B&HFO^*HO$-$YT$17SQN,3!QE4>O3*) 0I3VK&%&L
M)J*3)OF"(XM"Q7S+'FY--8FW 1M'&2?'$FEXB $HGER+1/62,4<Q+**/-!<-
M+2.!7ET+##STQ+*+PWD 41DL:@T5;6E*Y?HPTXKDNS_<RF#$A^<+EFF6)B1F
M$$P!5)2L;TVB\#_W>K#!&>-6\;?TD151%]'P0?PLOS4_6#L9^O=_*+X-4"X5
M)2IX_@6Y9FN+#):7M/4)Q5=6I$IK:\RZ(%L!00%*(*:/@@_A9?FI^L&#L*HB
MD.#YE'';.7%JBB7WP#K1HXV:6A(5JBI^@)^>:WTM*,))(>@CM6B]%R?K J*E
M470L+_8N%G<&,$M5E2;1YI/W47)Z8XQ-?9X]:.,37V>/6CC$U]GCUHXQ-?9X
M]:.,37V>/6CC$U]GCUHXQ-?9X]:.,37V>/6CC$U]GCUHXQ-?9X]:.,37V>/6
MCC$U]GCUHXQ-?9X]:.,37V>/6B;F_P"WVG,0T3MC< I6B5IX42D__;K3./"U
MB]PBM//:CC$U]GCUHXQ-?9X]:.,37V>/6CC$U]GCUHXQ-?9X]:.,37V>/6CC
M$U]GCUHXQ-?9X]:.,37V>/6CC$U]GCUHXQ-?9X]:.,37V>/6CC$U]GCUHXQ-
M?9X]:%;G^R!UR67PFY67%A2_S7K 2THT+# 9 ']<,+>2._@6,$_4_JBKLPZ#
M+:?/<*RD9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&
M=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9T
MDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22
MU@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6
M!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8'
M;&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&% #"4H9E*NH@B^
M*JJV5YXP8V[A"5:<%JB@;PHJ1G22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8'
M;&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L
M9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG
M22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)
M+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM
M8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@
M=L9TDM8';&=)+6!VQG22U@=L9TDM8';&=)+6!VQG22U@=L"VS/RSSA9 !X55
M?EDU^^W^)(%?[-T?]=SK1FSW[G6C-GOW.M&;/?N=:,V>_<ZT9L]^YUHS9[]S
MK1FSW[G6C-GOW.M&;/?N=:,V>_<ZT9L]^YUHS9[]SK1FSW[G6C-GOW.M&;/?
MN=:,V>_<ZT9L]^YUHS9[]SK1FSW[G6C-GOW.M&;/?N=:,V>_<ZT9L]^YUHS9
M[]SK1FSW[G6C-GOW.M&!L&-R=F2F&3)QK&GOEH>FM="1FSW[G6C-GOW.M&;/
M?N=:,V>_<ZT9L]^YUHS9[]SK1FSW[G6C-GOW.M&;/?N=:,V>_<ZT9L]^YUHS
M9[]SK1FSW[G6C-GOW.M&;/?N=:,V>_<ZT9L]^YUHS9[]SK1A!]G!]AUJ7<,"
MQSERH*T^=$A./R..><#?GCG$JM:<L9L]^YUHS9[]SK1FSW[G6C-GOW.M&;/?
MN=:,V>_<ZT9L]^YUHS9[]SK1FSW[G6C-GOW.M&;/?N=:,V>_<ZT9L]^YUHS9
M[]SK1FSW[G6C-GOW.M&;/?N=:,)3+&#[#S4LX8%CG%HJ"M/G1@Z:F,'XQ]UE
M",L<XE5]:,V>_<ZT9L]^YUHS9[]SK1FSW[G6C-GOW.M&;/?N=:,V>_<ZT9L]
M^YUHS9[]SK1FSW[G6C-GOW.M&;/?N=:,"X/;DK,I,-.DZWC3WRHBTOK6,V>_
M<ZT9L]^YUHS9[]SK1FSW[G6C-GOW.M&;/?N=:,V>_<ZT9L]^YUHS9[]SK1FS
MW[G6C-GOW.M&;/?N=:,V>_<ZT9L]^YUHS9[]SK1FSW[G6C-GOW.M&;/?N=:,
MV>_<ZT9L]^YUH[&AP=+;G1W'*>_(JT'G7Y9-?OM_B2 \7ROL=\G<^YSY'A;R
M1W\"Q@SQ'^87R+#'D;OX%C!'DX_"]CGU#WX2^2]BG_?_  _+)K]]O\20'B^5
M]COD[GW.?(\+>2._@6,&>(_S"^188\C=_ L8(\G'X7L<^H>_"7R7L4_[_P"'
MY9-?OM_B2 \7ROL=\G<^YSY'A012I%*NHB?Y5C!GB/\ ,+Y%ACR-W\"Q@CR<
M>X<F9ET66&TJ1ED2+<I@3"<TPN1U&D!"\5I4CBYA/T-]:.+F$_0WUHXN83]#
M?6CBYA/T-]:.+F$_0WUHXN83]#?6CBYA/T-]:,%85' ,^C,HVX!"MBTMI%2[
M?<\<7,)^AOK1Q<PGZ&^M'%S"?H;ZT<7,)^AOK1Q<PGZ&^M'%S"?H;ZT<7,)^
MAOK0A3V",(R+&E\VD(!\=E5I /L."\R:5$P6J+\)V*?]_P##\LFOWV_Q) >+
MY7V.^3N?<Y\CG/J3^Z,&>(_S"^188\C=_ L8(\G'N%EW]_)8+;!W$KX)/%D5
M?$B>WY%,X/92S)3C.ZVVTR-FBT-$\=47X3L4_P"_^'Y'CYMRPBK9$42I&O(B
M:8M,=C9(S\W=,X+9+_EHM(XNM?:*=6.+K7VBG5CBZU]HIU8XNM?:*=6.+K7V
MBG5CBZU]HIU8XNM?:*=6'<'_ -B-2UM17&;M0LBUR681/_QUJ[__ $$ZL<76
MOM%.K'%UK[13JQQ=:^T4ZL<76OM%.K'%UK[13JQQ=:^T4ZL6WNQM5;3PMSS@
MF?HHE85Z5-=ZMEQLTH;9<A)\C['?)W/N<^1SGU)_=&#/$?YA?(L,>1N_@6,$
M>3CW'9+_ .-^7W,Z)CB1E]^AJMQM7[_TB7H@<:XX-H%=3O!KO4I5<F2]((79
MI$(1(EH*K<B6ER<U\.*P2K86RMH%&^E=/C2)%#5G^\ X;@@M["#I7FVP@(^1
M&I6$$&C5:V;7)R018X[(H1?$GD%:%HT+E@@QU% R;*HJB(HI5;_%$QC%5&!0
M% D:*JU0E_\ ; .MDAMFEH232G<8/\A>_&'<-2XLN3D\]\5*L)OBY^9.>+28
M+D&J_,.;553T#&;\&ZT?5C-^#=:/JQF_!NM'U8S?@W6CZL9OP;K1]6,WX-UH
M^K&#,)K*X/ I&W0$F"H5I*?1C-^#=:/JQF_!NM'U8S?@W6CZL9OP;K1]6,WX
M-UH^K&;\&ZT?5C-^#=:/JQC'\"L3+7SDDYFIIYB1*P$U*';;6Y46Y172BIH7
MX*?=>WPX,!MI@="$8VB+T43Y%@J<9WN[K<K,(GSZ#:%?&E%^#6299F,(SJ7D
MQ*!:4/WER)"+_P#C#_GFFML<6'];9VQQ8?UMG;'%A_6V=L<6'];9VQQ8?UMG
M;'%A_6V=L8-PRG8^X+<HV0*UNIJI50N?]J.+#^ML[8XL/ZVSMCBP_K;.V.+#
M^ML[8XL/ZVSMCBP_K;.V.+#^ML[8!K"DA-8(4ULBX^B*TJ\EM+O@YSZD_NC!
MGB/\POD6&/(W?P+&"/)Q[CLE_P#&_+[@P%Q6B)*(:94AMV7/<9BP4NN*!-\B
MTR^*D,"Q5J3W.^#BA2B6U"X4T>"L3K 33S<K- HJPE+(U&RJI=6'U1Y35VRM
MZ9%04'^21*2S[SCS$LAH 7)6TBHM?,JQ(N.SKTP<H2D).(-^]4;Z)R*L8O=3
ME,5,-9$R/%:*'L8^Z3;Q&9MW452"P6BL=\GY@TH(DBB%"1$)/H_M>R)>6$E,
M601M"++<G<8/\A>_&'<88PH[OGW)HY85^BVW<B?>OR%YMG>M3TGNAP$_Z@DB
M6O.A?!=D_P!:Q^2G<$X:V0%*JO-&$$F1MNL=^ &QO5LLB<ZHM4\T*K4ONAH&
M=T&XTZE$"THKYTIDA]\)1QYAJVF,&Z\2LJE_G]$3965EW65,,MJBHF6)2>FD
M>=QC#"E;L(A$XHI5*<E?;&*666@@\X9V_!%L[)+_ #AO^ZD1.8BPB&EZ.E93
MVPK0RCBOMK1YI%K8WZA6N3YJKHA6]RD1VF42R:45'#4$6OC2,:H8LK1@HUK1
M1)17[NX[&_*S_*+X*?G&_C&FE4/WM$-L#>\6_?=6\G'-)*OR!R7F&Q=9<2R0
M%D5(G<&.FKA8.F%8 BRJW1%#V+[/@ISZD_NC!GB/\POD6&/(W?P+&"/)Q[CL
ME_\ &_+[C#JN.K0)Q!&V61,4VM$\ZK"JVTP@-2QS1)96^CE%1+[JP#3B,&X$
MX3-I!6[O"FBY?-&#P(I<Y@Y=AURWO5.UX5GG3[^2 F%,$5Z2!S$HMX;Y;EOR
MI$M,;Y'G<*8M1MJ&]1T@L^*B1.RQ*V#VZS %=<4F&UQ8K80UI7ET4OB;.Q+6
M6)EB7LT+_$Q6FNC&+HT1-/*,N1,!,I1!5+1-%2N7(J:(*4M,V2?)I'OFHB-"
M=]^6_P!D8%ET-IX708:/?;Y%5M5K[$[C!_D+WXP[C"'\1F?S%[@W#6@ EI5C
M" 339N/MCNAIJQ9)0+YG.J+5/1 K+R@3 [F=F5[\H41LD14HH9;]-(?FVY#&
M2K5M+:O(.^$J4IZ?1&$YC<Z;IDT<HT)6D)4&J:$B7G5G"<46\<XI%0'=XOJI
MI\T#+LR(D\KYR]''E!*HTCGT>>)9YABPLRY+BJ..KX)I7)H@F !62 Y9Q' .
MX@-^SR<B>*_N97^&N?F!\%V3_6L?DIVDMF(UN2JY8(1,24<J(N2"EG%K5*J"
M%1:0CCBB;]%:2RZJ+=>J7+&ZU5%:Q.*Q-]ZV[556M]_+$Q:ET_O"U<HJI:A]
M@%WSJJ3@8Q5):IXX650+;;0HWBE=5<6ERI=6[(D;IL"THH2*9&M*$M2]*PVR
MS_=T%YIQ5O7>@54%+[OY1+JK0(^"+8OWRWU7QWWWP-60:LV515<5/!*HZ="K
M&)95$M*KEFW55JM57TP5702SX6^R=OL;\K/\HO@L*?5I^).VXZXM ;%2)>:)
MUR<LXV4/OF)O2R5XKZ%HO[JPH)+NN (M&3P$"@B.*J(OA7WI"NI*3)LU%!=$
M-Z5HT#*O.J1.3C0DPZT#N].BJA!5/O2)6;<,C1&%=<;%!J= K LHR\V^XM !
M;-5WENN7DB00F7YI\V65=)H+D(QK? 392<PVTXPK[5I1JXB4JB7Y=]$O+MR[
MK^/MV#!1LT&S:6]?VO9!C9?Q:2:S2O;S&)OE3)DNAR75AX4;>*75Q;-+2!;Y
M>2%Q;9AWL':K2BH253(O;[)?*P_*'X*<^I/[HP9XC_,+Y%ACR-W\"Q@CR<>X
M[)?_ !OR^VHDY2A("K1;*%R5R1;W.U;K6U82M8X,SZB0A8IH-]<ME$OA"%I$
M5M5$:A9IRTA5$!%5RJB98,'$0U)Q*BH6A$U\URK="JZ C+A?2Q5$\T%5AM;2
MU6H)>L.O8@01JMHL3S7TNO\ -%D6T4:"?Q>]YONA%1L$7)6S  2T(_!Y^W@_
MR%[\8=QA#^(S/YB]LWGC%IH$J1DM$1(!)EQO$O*@C:6XUT(D(X_+@Z:#8M$F
MCDAF:5!Q;31M(S9N6T2*J^R'R*494G_C5L^'XX<Q0(&,*T5-*\L&"2S=@T45
M"S=1<J4B4<;:;9!DU,FP#XQ5"Q?YH6LNV55%5JFD<GHAT)>7EK;2H+B-BE15
M%M(B^>^%<<-!!,I+W$K_  US\P/@NR?ZUC\E.U@FS6J3HE6S6B62O]L81LVL
M4[/ CKXMY W.EZ?YT1(28Q9',I+TK8OL8Y-]3EL;ZD3BRYOI:W08J3%Y%9%0
M6\8J;SSG?6K2XI+5D@J2#O:9>6),#=W6T0(CCC:4H=%55\')HNR*F2,(NNVA
M;W(PB%95:JA.53VI M ^ZRT4[BU5&QJ+6Y[7)].ZL8QYUW'%+LN6593>E;5#
M3)R4C%D],M8R:F168W-C5#?KB[J9%3^42FZQ=1]LWP(<30$3YJUII3GCLD;L
M*;]I!:%,JMHV*I3SVXW2B'B6F5M&C95O5+J4YHPI,JRLQ@_'-8QL06U6P*(X
MGTJ+HV0: JK8I7>JG_WVNQORL_RB^"PI]6GXD[=ARMFJ%<2ID@Y@T<1XT$2(
M'2&J"MH<B\L//E927,&@;:M+E%2*JIIO+V0X&*.P;B.*.-.B%:M77W7WW0ZT
MVEILR)3$BM7JN^RP3%EPFB;5FA.DN\7*F6!<03JEDA<1XZI0:7+7DADVFR%6
MVT:&CI>"G@UOOIHK$HP#2*S*K5E%)2LK14_FL2A-M6-RMJTS9):"*TK]R0K>
M++XI6%[Z5;"WTRP;C-H'U<5Y#5PE3&*%FU2O)"I;H%$3%HX1I7Z6^R=OLE\K
M#\H?@ISZD_NC!GB/\POD6&/(W?P+&"/)Q[CLE_\ &_+[<_@G%6B?-VS,U2S0
MR5;2WUJE?9&$%DG9C'LS3X6W7UL*-BX:5RVJ7TNOB1<)N>"7JX;C;LRF]6@V
M4WJY*HO+ *]+O8H795W%$\BJE%+&?.\4%9;F[F)RS29IOU<JS\[DA3,GT9Q[
M@B2'426B)85$+YJHNB%F9)MUE[&-H16QQ+P75M#7*E]Z7Y(=EW&GC[W,A:5Y
M*'5U";T_1@TE$>L*ZK@-ONV[K I9);54JMJ]%NAQ,2\[+DLP.+QJ5WU,67A9
M/"].2*)+/J!(PBIC4WM!6U=:Y;/^\/+A5Z8E"228 7RFMZ+R6D);BYQB1-T:
M3DS,M/6!+P**BK_H3_E>W@_R%[\8=QA#^(S/YB]M]+"G4:61&M8EVC:(V)29
M$9:PBKWJTA57Q)0?,L3&+;G&VRLTOJJ%C[].2Q&+EFYQ2;=6P9%6T..2Z]?H
M<M8FE:<?5U4F$81:V'5M5&B^"E!143ERP"MEA%&S;?.R2JA"5D;"7<]K3[(3
M>SA-$H*]9K;15;OLU5+K6A([Z<ZX"/-C4E6BCBJ&MUWA_P"T2DA,-/!,HTID
M1K5/"IEK&&+<N]W^<M-T!:$F+;&M=%Z+ 2KLM,F.YTLB)?XJ&MJM^2EFGG[B
M5_AKGY@?!=D_UK'Y*=U*,N@3LPX=60 K)7)>M?%]\$#@[D%LK"8XDWUR+6NG
M+%@IID32N]5Q*W98 -UL*9TLCC$J5<E(6LRRE%LK4TN7DA+,RTM0QB4-/!Y?
M%#S8^&TJ53F6]%C&V>^4LVN;N>QORL_RB^"PI]6GXD[C?T5-TR^7ZX*^RL20
M,O-*&.L&MRH/>S5/N3TPPX],-HI2S$P26$2BJ=DQB2<953[_ #:*VTB(CA#:
ML(OCB74W162F#LD]8^*WG@K5-*\W-& !&M@]S-NZ*#3;1//&&;1-@9S]$326
M\#^=8-N7LM@(S#C*HE4<<QI4;^[TQ/-@V3[C;:S3*6;B&S\7X[?LC"%3W0VK
MC+MJREZHB?S2)I'4J(K4#&EA4JOG1;KT7N.R7RL/RA^"G/J3^Z,&>(_S"^18
M8\C=_ L8(\G'N'2?6Q*X6: 0<7)C@NL^=.X6P A5:K1*57N%=1L4<7*=+^ZL
MF*&/(J173VYB;9WTI(,;EQB9"=):E3Q43N,(?Q&9_,7M./G6R":,JQ/8U@?[
MF($=';RM?12EZW11V8;:6E=^5-%?NA$&?EU5:(G?4@3W6S8)")%MI>@^%Z(E
MP89ET=?,@,PHA#O5._U8<>!\#;;O(A7)=7[HEI@99=SOWH5K?(*I5"5/^98J
M4XR*51+S33D@G-VR]@10R+&)</+%H9Q@AJHU0TRIE^]/3!MK.,(X%4(<8E4H
ME5]D8]#$VD$7#5"R-K\_Q=N5_AKGY@?!=D_UK'Y*=U*3C)H+\M:1$+P2$J53
MV)Z(1^VU:Q#DNK2HJA9.S?\ Z?/&,$VR%)EE]+2K:5 ;L46[SP_+O-CBMS2X
MJ_96E1=<+>W9<D!,$^P5# E&RJ5LO8SVQ*,+:%Y'73,VQ6PK)DI$"EZ/1$[,
MDED"$&@2EZV;5_I+V=UV-^5G^47P6%/JT_$G;-UTD!L$M$2Y$2&/[N^ /^ 9
M(E,E;[[H0L8%E<BURPMDQ6F6BP/?!WW@WY8!3?;%#/%COLI<D&TJB:9"1%R1
M-3%'!25)6W&R3?U3;=3QPRY\6KPVA U2U#IB=7'%2TI.6O$E^3Q05-X0D8J!
M*E=Z2C7V0*HX"VO!WV6+8<JBJ+E%4N5.WV2^5A^4/P4Y]2?W1@SQ'^87P*.3
MLTU+"N3&%2L9U8]L9U8]L9U8]L9U8]L9U8]L9U8]L9U8]L9U8]L8389PFRXZ
MY+.  I6]5%8P;+OX29;>;9$2%="QG5CVQG5CVQG5CVPY*S>$)=YD\HK6,7*=
MG!-L)X(O- \2?YE2L<? U-O9''P-3;V1Q\#4V]D*,EV:C,&GS!E6;7HCC,YJ
M34<9G-2:CC,YJ34<9G-2:CC,YJ34<9G-2:CC,YJ34<9G-2:CC,YJ34<9G-2:
MCC,YJ348J?[(9M^77PFV6P9M>=$@):59%A@,@#W&$/XC,_C7M.,IX51,?&)(
M2>U(P@Z3C8;M !W[%39IR+7+?$Y28;4'Q6BNL6W )0L5MUR?\K!INL$M,RS/
MQ/\ TCM5\+36*[K 3_O*?%?-=R_.RI'>YT1''$^E6:DA$VH+\[)?6)Y'WAF$
MFT%#1 4<@6>5822.91R7%O%(MBCEFE$JM<L29K-!;EL4B=Z\(6ZTTY;XF&FW
M4F3Q#K8@#2U)3<M\L3*;L%O=5K&(C2TJJ B*F^_8AV;5Y'4W4LXK8LWKWG%V
M4OB8E&T*W-6FAQG^$VMR)_E'MRO\-<_,#X(\*F)+@R= 6YHQ&N),?!->:ET(
M[+O ^VN0VRJGR!7'W09;3*;A42&9YE%_LK!Z$C3JI<^ZMRJG,B:>?X+"GU:?
MB3MS,FXJB#[:MJJ:*I#LH\;33A-V<<V2K:7Q4NK$O-.MRR@DRK[K*K5*8G%W
M;V_0OFAAP ;DG4$AN2BN]_0]_=^S33X:P$^02]GOI6%OL$2-V:7<K=?\T-.&
M<NB@ZPYBQ)53>"HKHY_Y0JOXHW1#%(\)DI."F12KD\T&]5L5-M4<9M+9,T5<
M6M::+2^@88)X9=]I&VJB3A[PPY+KT7G]L-!8E%()9MKPEO,3K:\'DAVSB&'<
M8\X,P/A%;KO2NR7\NB).<>8E1Q>-)T4,CWQ6**BDE_@<V6)EPQL8]\G!&E+L
MB?=7S]OLE\K#\H?@ISZD_NC!U%R8Q%]<O@)N?-+2,!:L\JZ$],#/X01)O##R
M6G7W;['[(_11(R)&1(R)&1(R)&1(R)&1(R)&1(R)&1(R)&1(R)&1(R)&1(J8
M8F;&]J;:WKC:Z%K"I.4W=+.%+3%/ICI\]R^?Y!-O3 DN!9]S&J^*5W.[2BVN
M9>6+;,XPZ'TA<18X0UZZ1PAKUTCA#7KI'"&O72.$->ND<(:]=(X0UZZ1PAKU
MTCA#7KI'"&O72.$->ND<(:]=(X0UZZ1PAKUTA7)F>9;3DMU)?$FF)K#LTR<L
MCC:2\HRXE"1JM;2\ZK\%1;TA7#P6S:7+8J/W1FQOUBVQFQOUBVQFQOUBVQFQ
MOUBVQFQOUBVQFQOUBVQFQOUBVQ,3,G)"P^) B&)+]+QP*_V8WD^D6V,V-^L6
MV,V-^L6V,V-^L6V,V-^L6V,V-^L6V,V-^L6V$,<%LJ2?3J2>V$$4013(B?!3
MDBJV<>VHH7(NA8W+,]YPK+;R8ES\*OTDY47+\@*8G'4;#YH_.->1$TK#\W.!
MBIN??*9-M?F(O@CYD1/@ISZD_NB5^L<_%\!,_6,?G!VZK<D;K K#55%<9O;*
MHM+X%O=3-LJ61QB56N2%M3+0V5LK4TN6#FVDW4 C;1&51;?BB0>:$WQG%%&T
M"EU=*P59AI+*V2WZ7+#9I,-*#G@$AI0O%#B8YK& E;!.(D"UCVD?7_"QB5K2
ML*+;H&294$JJD-2)*N/<;5P>2[^>7T+"M8YO&)E"TE8M%-L"/*KB19<?: J6
MJ$:)=RQO'!/>H>]6MRY%[?9#_$C_  !\@5"2J+H6+9X)DU+ZE(S1*=$D9HE.
MB2,T2G1)&:)3HDC-$IT21FB4Z)([&Y9O!\N##V.QC:!<=!NK&:)3HDC-$IT2
M1FB4Z)(S1*=$D9HE.B2,T2G1)&:)3HDC&2V#95EQ,ABTE4^237[[?XD@/%\C
M%9R5%QP/!<15$T_S)?'Q<SKCO6CXN9UQWK1\7,ZX[UH^+F=<=ZT?%S.N.]:/
MBYG7'>M'Q<SKCO6CXN9UQWK1\7,ZX[UH^+F=<=ZT?%S.N.]:/BYG7'>M'Q<S
MKCO6CXN9UQWK1\7,ZX[UH299E:S">"X\9.$/BM*M/@YSZD_NB5^L<_%\!-?6
M,?G!VU9"EDUHY5:;S3$Z#9BLI,&#MDG20Q-,JH6C(GHYXF&7N^-[EE1*:,*5
M(#,M[=2N2&&R.7=)AUI1=5%M&V!VJ%SP[+][5TC<5+UL[XE+DYX56G!)-TH\
M(.+<V-;1"GC*OLATR?8)3LI2RJ)<]C/]H=81YEH#5Y<BJJ6S0D_^HFV\3\8L
MP(JX)@C=O*7@T6MWSM,'-]ZWS[;RHBK6@M6*9//&_95/[N+=LA(5%$5:!113
ME72L(^)B$\,RCXK;6PB)=3U*IYXFVK!-XPGT$E$DQ5JE23>T)%HGSM/F1MQ=
MS"[BWD<L51%(Q$:Z?HP\X^K+\JO?E#%*;B$C=A4'T>/1%ZFM5H&,2A"VG@#Z
M.WV0_P 2/\ ?*.Q3_O\ X?EDU^^W^)(#Q?HZ:$4J1-$B)YHE?K'/Q? 37UC'
MYP=O!; '9:?5RVE$OH-8<-Q'R%MG&* (-%WR)XZP8;FF (3-I? N,1M4R\D$
MR;;A@+##@N76S5Q21+D\4&C#;[$R%@C%P$10%7+.GELK$O(@5@C;-XBTV144
M^\O9$RA$']J,HJU1+K-FVAT\5$\<%+N@Z9B)+5+._LA;7V03RR[H4LW&HY%&
MTBY88Q3;KB/(TJ*E/\1%4;J\T-@K,T[5O'*96+A4[/+HC<HMN5MF%NZE0I73
M73$O>&+0D*8M+>C:K9JGW^(5C<Z@9JB@BJ-+K=::>:&B22FR!XFQ;*PB(=NM
M+U7F]L,RXL$ '+J^I$J53?6:=OLA_B1_@#Y1V*?]_P##\LFOWV_Q) >+]'%X
MHE?K'/Q? 37UC'YP=MA]RWC6*XLA-1I6Y85)BU8(;"J;Q7I:M<O+%5M(;KA.
M_'%OB4+*KE^C"H;1+5H&:HX2+9%:CIRHNG+"$\A!<@*>/(;5]4M+6^_EY8:?
M N^-(397_-*E4]B+YH,71LB3*2Y.*XJ$H?1M9=,*Z0FXIU6N./2-E=.E('>N
M;U15._'H%133R*J0WN>8%H&K$NU9?*T""/@4R%RQ2PY\7BOC2\&U:Y>6')K&
M4MF1$HF6_30BBMUW+$T#@J8S26744EO2E*<T-OA-H+=D1:<68*T@IHOJA0#
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M#J6A1:TJJ=PDPHU=0;*+5<GB^ !2&ME:IX^U5;DC"TX/Q$U/N.-+](:(-?\
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M,E!:C02JI)R9/]4#-JVJL#+*UO3LK:M(L!+G87^ZJP.^^)<M*N,3TIZL&\@
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M]/;PK]5_-([+*I2NY%3HU[<Y)!,69.:(R5*;\;:U-$7SKZ8PDR[66E]UF35
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MTTQ<Q2X$\)?F>!Z(57G$<2MJ@6@M+:K5=]3+R(D(^ V21O%W<E:]KL8^M?\
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M>_E^B&G,8<K.L7LS;7AAM3FA .4D,)__ -H/*RJ^-%1?9&8I;7_Z(S%+:_\
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MNMHBF"91KD[@R9*V@&K:W*F^3*G=.NB9$#9JV5 *XLE,D"AJM2\$1%25?,D
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M&G)J8W',"-R.H0JJ*O.BC\!V5_Q$_O7Y+V-_5']Q?J$[^ZL8+_=+\9=N:PJ
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MEA61-!)<DA2+'3Q^, Z;$2\J3#B3%:14,.8!:7NF%H7A:&;>39;SJUJ#892
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M&J $JX*/7;EY!$L,E).]3*H$WG3>B5(!%),#?+#[4NQU0 WS#[T. A 1#*D
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MW)I9"L&LVK^T)5/"LEOM%G@F=*>>6Y<06*N>#,5C<1-H.";&+\*@Z= F9Q6
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MNK\(AE"1Y)'+[=C]-!U*OXBB-@(P6G1'-?;=QR 75*S["IB;/IIWW/64%\F
MELA43+)7A1D 6KE9H3.K?2F79=)=#T@";[Y\EQ&-5JA@BW.$A1%F)) VLY&0
MO.CNTDR$Q-80P6YWHZ:X7-=).706($Z=@5F>..CJJ%Q*&+TS,C<UD6FUOJYJ
MQE.[DXQ0.@8V >+QR8=(H[Z"A$ N8+D %YIE8W7(2VZ!Q%%J:<9@C] "'-P\
M5P1<O0_A=#2YA#U58DYO06@_1'&A6!/F7X% B;3:FIT&8P,=V00ED1>^D[MI
MD90ENZ29IV66 $V&R3YE! CR#Z@$G@P9J%6-L"P"($-\9_"K>P[_ *2=)NAI
M+<Q'):D5>2M=<N*AQ@'#Y&FE!+6:J @))<3I02G;([133VHQ<QM0SI@9= C2
ME<;0 )&#"^]8'">G.VV4TGL:2N)VV(#APJ :3>1:8(O:7K4YL?#DECA4+YTD
M)S#C*WI92/@"WM_:@!I#@+$MN'DD1CWQ@ $N@&-O(M=!F"RN!8V\%K-)B[,P
M3D+FSR%GAQX67""I;6IW0T]0Y?K['70GRTMZ&&@?0MAL$>,MB]?$*^(5\0KX
MA7Q"OB%?$*^(5\0KXA7Q"OB%?$*^(4%+I]9!HY]>PQ@-H@ZR\?P'8=_W2J'<
MUN$\Z6(&GF$8LYWDLJF, <SP$S>3A'/"\5$.L21<^H<L<:6+L$M3 H1B!LB*
M *#*<>L8*>'EA&?0@L.P>X5L5U"<92]O'V[=NW;MV[=NW;MV[3)BT*VQ)>BK
ML<.97+KIN^"0N8'(][U">;  :"5#U\;/GSY\^?/GSY\^?.G<&6"X.'.N7@4E
M#C@ /NT ^U<KD]*7?OM<N7+ERY.='(6P"<N?ON7+ERY<?%02*'DQ00#0" -O
MP$0Y^2)-VZ5/3PYB"3+!EW^X[":ERT'%8#G5A'!PLR<H'I_A^V;?B)!K&RJY
M.)JK-'F"QQ_&AYM/'<<<<<<<<<<<<<<T&X<^$)OI1MC.=!>1;^S_ !"SB2:@
M2'\?;[(8Q7+MPLN0+7QZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZG
MQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZGQZCXNA
M=-Q>D&:C?QD(",*'"(D?D6P_P)U2BHR!LKM?I7:_2NU^E=K]*[7Z5VOTKM?I
M7:_2NU^E=K]*[7Z5VOTKM?I7:_2NU^E=K]*[7Z5VOTKM?I7:_2NU^E=K]*[7
MZ5VOTKM?I7:_2NU^E=K]*[7Z5VOTKM?I7:_2B8IMN_(_R*VU.-;TY!SX??V3
M?ZE(T'$9FH5](/3\&-G$6 T_5/J_(.2,)>.5)6LK=?O%&>A8E=SA]OL1VM6(
ML7 PV^Y AVI!E"ZS5[6[$1+86W4JUI=8D)&FH,%?G!(RAX_30;0_I!=^J#-<
M4@,HC*>YY"QV3?ZOT/O,!E0"ZM7U%=V[ W.^D4%AD3LA(@<,,PU#"R748[TE
MAQQ5I88Q0-V!PHK"05D3IAA*RVWJA1EV=)/,$]9BI#?%Z=6&Z[&G&@*_<$CY
M!DN2D-J1UF&&"6V"''9:\A'!'93BAX\T:,]MA&P@2B08@.5&! !AAC!* RB7
MF8G"XP]:4)T:@1F6(2+(V:A&Z>4LW. 1EFA$GBCJ>6#5X1#I0!H,!=,6PJYV
M6B7/*-!;5&+KJ4NU BR:;ECL[U-N;.H*QN6 ;2Z-+J_MB)##<7OCVJ>@>$="
MLN$[6?RX7[5M]XQS&!)%/!>N,11@90B'<LH!-%Q4/GA%B68W%^(W4!=30X,)
MND30PFEEC\T-V&*M=Y;7AAG0:4B]<IC)BQ=(,B+HH$/.\"G/8-IWINF$<2FT
MP\0Q@@ Q,N9*HG +2!D74+DF\HAACA28),0B(^'/VP"3&8TJ3!8:4$J*,Y-)
MH8>?9-3 #9()M&BD,HXS %8TQ!LF*B?U1N(@S*RU6)BB;:LX3)(O*4M^>HR)
MX :S6Q9$-$BT1DAVFR((+B6,N#S!X=UBQE>D0B5G_HTDQ-1<J+#!#'EF90R3
M!8G[RHS3+BEN7KYS3YS3YS3YS3YS3YS2[+*B8NOLKYS3YS0*?W?M&2<\39[:
M^SM6%&+ C,-G6'V:5SX:0V2M'>-E$@G<M5VPQB@E+&@<XJQCQ^N<TAPZ-:6,
M7"0'D6HUTBJIA&D5[<.I/0K=-:-8+$)$8WP>Q1^YX&X$LAI3G*?/@QC33:IJ
M\8X2G#2;Q4=9HQT-XD<9J>@:UW>9MB-C:F*,<^&%C7"=J(+>A%OL6BAQI6B0
M0HFRLK=:D( #@0*&<E+UFB@DF%=RMS92J42LRO5H6Z22"NF03E-HJ9%[U9FQ
M']F]2DN4)9Z/$FU0DE$"1E#8 ^B)PI5T*+P(E(FY^4+]JV^HQ\\\&#9&QMJK
M%+%&(E.XF",2V#O4F)ODQ1G0Q:],60 BO'V+MK29=B:&E[",*>>S5VDYN )9
M"F.&Y4"#,B.278=MFW,%!QDF(4Y+ ]Z+*4:9+Q,&FI'0=A?81L>X4+FV<%A#
M#%]]FE2 2#$R(6ZDDQ2X)95C#H7 6"]G:L]$+YR421-2DX6T%FAK(0#PJY[W
MT8_LN0XE2O(DLF5+\O\ XN(6[F0L67.'I3#MI/FJI$$694AT=!(7;#*ZP6ZE
M1;5$ [!&Q)O;<J5>,B:Y&A9,S5N5J;0G<PG "QSRT2JZ!$Q$@XY[-#SFO78(
M2 7[W6UKDI]@%Y0$3#C63>K*J49"Q=L2QA-JL?$LDD#>L07I7!9Q\H630SC.
M*%*D+#8:$Z@MQHY077U^F!XE@1^A]I@*[011'BZ-:#P9Q87:K"G+?)-*X:MD
MJ@L'M:)HN:HQX3Q< H*EQ#;BCEAO)BC@=@P) 8VW"<;J=U>*-VCFX&LQ4*68
M#TC0=@1C"F60:45H"])OD&:D:-K87&09:=9-:1&B!%7"Q&>B]YXLP$H6EF0A
MH;:5E80-1%X,< 7D!%35 :]=8EA!P()U5<_9,GEC>!"3$-Z;Y7"#P$%]=!UH
M<O)SFIL$; E-"# [#EA (A9LB!!65%:,9D4;I[;ZR@QC%L:A66Q1@V'.1AWB
M?6!6PE,U9; %DRW&^]\A6(GP;T%@D2F0TFHP0 :NPD# EWND- L?[R(%R8"3
MI>UJ@#37D@DC%N! (G+>?[V"CA7?&-JYFOM+PQ<(_*%Q*D /2E-0"GT )?W&
MY@9&T;ZBU)SY.,<7!,XC,IF@0D&R<NC&[(PB&(I.BT=W@@3$8WVJAIX!4)E5
MG(I$S>MS,#?(6F\)L7HN 5$PRF0R*,S,UI 1(:0(QQL7HO6E!F!B9W=Z;X!A
MXH"&%B&VG,LI8F,4B&D(+W5-H864QG.)>M)'2 )VM.'AM*X0_B\%B!6"[E4=
M*423:!EE2Y:$.V(SU^<:#D;S62BNTULB(B]: 0]:%L0Z(+;&V5O.CT$<(T6M
MD*EBAA%%OHX)C#FYIP2P:*8X LPPDJ\T5H!'(ER(DU0J+!GN(!&A*7>1>D/T
M3;##&5V%$JQ0_' &4"\B LVQ2^ )R4Q$G7B<CC-[M^FJG%+??A3I(6(%?W 2
M(#6GJI"+3CY1&U<?X"\3%B8M/%*FQ,,@@#PECZ H9(I\($"0H+@O-'/>#Z_9
M[;'>,Q]W]8O "L>!/IP8> =)^R]^G(U*S&TT'E8* -ON)!\)R;+N6@#&@" /
ML/7:8)0.7L/R)"?IF,F\RO*$FN[>M=V]:[MZUW;UKNWK7=O6N[>M=V]:[MZU
MW;UKNWK7=O6N[>M=V]:[MZUW;UKNWK7=O6N[>M=V]:[MZUW;UKNWK7=O6N[>
MM=V]:[MZUW;UKNWK7=O6N[>M=V]:56*<2%)R*B7;V'0FA8 V#PQ$:@ Z 8",
M/'R+UZ]>O7KUZ]>O7KUZ]>A6TX@.QY&>O7KUZ]>O7KUZ]>O7KW17)=VO(K25
MD8_Z\7\B#U"5 O''\#X\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\7$1*?
M+9,CP?\ /B#HXXJHJS"2/8TA^!.THTX"0"^=/\^(.]JV^P8\*F1,,2%G"-BD
M'AP):7$OOI6M&FAH(LUS$7B9M6SU=@")&S%]:ET UH?6HQ$ H-DK^>RRX*^E
M(A0VC% AB\%[ZF1J" 5D)/+MUO&E40* F4CH"-ZR:&'5#!4K%%T"C'8"42$]
M&M&.D.\9L!()6+34_P ,Z5,IT0;:6:]9(+ARR5VWJID0@0G28)WM*OG2&BJE
MS9B(9I"*[AEH<D@"\3>)*@LG')")$C <0Z4<:*FMJ&8,V&\3#24^)X <R6BR
M,QFU$=#M&'0#:27THT&"T=BM8%V]YDJ6+M$X&]TB(M'&H8)01D2F6!#$QG%&
MJ>0U46#@BI1,ZAP!E:/#,+#4^?KP(9@Z3)XAFU.-& P>*HXB)M,V^JMDUX#B
MUW'UKN/K7<?6NX^M=Q]:[CZUW'UI?(Y2)-W^7.]JV^P99 28%2,0+B&&]KLJ
MM%C\UX5I/J\J \D)H2S9ALP6DJ-C$EA!,%6@IR8*35[O1U@;2",0U.(6%X(P
MX ,M0F&]"7I@N$ITB-:A:>T'F"QQ2\B*.:F_><6:H@N*0%[YJTZ2V0I! @1J
MNYI1EU;9BNNIHFR5<3R*[3N:UCBUJ.4 8N79,@-G3C1]<DIC9$.)G-2A>%0N
M#/:R,BG J*\=SADO,2Q$UG U5. @4F4*Q>*:$C&B2]E,QII5I:EEB +8&1'$
MD4KHG.02!=VEI2.H6Y=!18&5@O1<L63W-Q3D7>L_PW%D(*I,))9DIY?)[."G
M2M;IE:LEF(0!.(&9B+6IY9(^J(Q010EJ&=YF$E#>P#>&!2;_ %N\+5(LR(UP
M=+@Z7!TN#I<'2X.EP=(+6KQ @B2_5=6\ %"!?V%YCF^1N7+ERY<N7+ERY<N7
M+ES@Y+Y&=+TN/)7+ERY<N7+ERY<N7+ERY<+U 5.M"M+:3\AVK;Q1B]=^ $B)
MBK[^TY$7MN#2\Z9I"?6E3@ Z. ;H)*:U@]4!F^\.$3K%RJ+.0>&W7T"33IG$
M,+6)B;:KZU([(:(D4V<+(O!>L0'TDQEW?N4S_P"32M9F4E++1H9)\N]"Y^G$
MLKA/L?A =CC<^V;^C\@.+,HIJ^+BC85)<\1?G5$/I2("(B6$QI5_=BWEF-IK
M<&0L$YTHS@@D0V:6P&$,A,V]CVH T<0$7FCR7%B<0XTI"O$=GS<?% TYV"53
M$"&;>'W_ &\ ;!>V[+A-I2AHJ3!? X]H'&YLE% 6P=,L)EQ,[*4 U;ZI(2IP
M=-%\U>S'' Z3K8MH&5X04XW*!8D&$Z>&.WJ!MZVT6./BLP:7;53L0LZREJ3$
M-1B#!T#E-8JMW,:MV>1:*EV<UCR:LEXW(UJ^EB%EBQ<;,*D<*2L0(@MEI,IO
MKO(N"P[*91H(Y;SI2RG;= -X7@;BU9=E>Q$E.#.$Q2*J(**$4[I34<*;ZY&1
M(PS,)N7BI8'%DJ\.9HQ&+YHJ2.Z$$TULG9I:[AXU96@7!B)G2GYK0F(+&[B<
M=%W?S &KU7//@'O^ \^?/GSY\^?/GSY\^?/GSY\^?/GSY\^?/GSY\K4F9221
MI;KE>?A]_P!OJ A=@&"@ABE"FH<9EJ7R7J'W>(*0?/I*8@!AI-$%U&678$:M
MJ#)[ 1$R _E!:7 #WDPT+-!>B (8L<* !7L+DWVJ0X'5E* ;<6:TOKS@72(F
MU:^Y07@Y5!V@A 03,>]!.ZZ*D2"\8BBLX5CH$OTUS1C'R_Y5&?T$%NT!92L%
M748ORI.1^;(&"3<2V=*<?40U. '!C2SM6O1+(K!%+!YG6K#LTPHA@,7UX*XJ
M_)&$!S*TA4M4X1-1R*AVTVC2"UWE>'%6^U15(#0A89UH8 4IZ0!7TK?T7  L
M9C36A# 0'N;C<Y/TLOF(1@'^(^O^? [_ +?1+VTBFQ9H@\*:021DO8&Y>KB-
MCA"YP,JQVFAV8:R;.N%$.1-()C4U"2ML";WH+!<5$-%)VF-*BF*PQ_((6 P,
MN@2Y8<0 0:LZ3LXT4IF88E:B4#6'G%!Y83$DCE@VHZ3#HPRS"(%C"KY$-;&,
MBP F#T4YD+9D!%YO70-+-&^2!_=080":14Z!;2\F$+=O>]-5<"8VFQ.#@6L-
MY"DP L^TC@DI#[L7G"08$M$&]Y6B:_;[%L,H23$DU%4LH)XDLF)4Q)0 9*TU
MP1@$%ZEP-@D;RB05N41&2C67S0H3"1/:2SP76&P4"-75,,D3H64 #0D0V6D1
M":C-2=;!&L@F+Z\05JR6' B6!&I$Q49Y=%&P%A+7B"U,\<00H1 "P; -51\Y
M# ;0&26+RRYI@J@2(.%(VM<N98BM/S .B"0EKZEC@V=SDYGN/\^ .V$,N)S!
M*#6-= _\>'T58"I1J^$:@6".&L3;#@/3P+@7F )^P QH0D2B)9@@]ON]A"PV
MF@$!'TO5C6 1L3/=:?\ /2>_<LW0I]/P84*%"A0H4*%"A0H4*%"A0H4*%"A0
MH4*%"A0H4*%"@#^^H=URO%_ _P#_V@ , P$  @ #    $)))))))))))))))
M(         ))))))))))))))))))))))))))))))))))))))))))))))))))
M))))()))))))))()))))()))))))))))()))))))))))))))))))))))))))
M))))))))()))))))))))!))))!)))))))))))!))))))))))))))))))))))
M)))))))))))))!))))))))))())))())))))))))))))))))))))))))))))
M)))))))))))))))))()))))))))))!))))!)))))))))))))))))))))))))
M))))))))))))))))))))))!)(!((! !!)())))())( ())(())))))))))))
M))))))))))))))))))))))))))()(! )((!())!))))!))()! !())))))))
M)))))))))))))))))))))))))))))))!))))))))))())))())))))))))))
M)))))))))))))))))))))))))))))))))))()))))))))))!))))!)))))))
M)))))))))))))))))))))))))))))))))))))))))))))))))))!))))()))
M))))))))()))))))))))))))))))))))))))))))))))(           ))))
M)!           !))))))))))))))))))))))))))))))))))))))))))))))
M)))))!))))))))))))))))))))))))))))))))))))))))))))))))))))))
M))))) ))) ))))))))))))))))))))))))))))))))))))))))))))))))))
M)))))))))) )) ))))))))))))))))))))))))))))))))))))))))))))))
M)))))))))))))))())))))))))))))))))))))))))))))))))))))))))))
M))))))))))))))))) ))( )))!))))))))))))))))))))))))))))))))))
M))))))))))))))))))))))!))()))!))))))))))))))))))))))))))))))
M)))))))))))))))))))))))))))))(!)))))))))))))))))))))))))))))
M)))))))))))))))))))))))))))))))))) )))))))))))))))))))))))))
M)))))))))))))))))))))))))))))))(       (       )))))))))))))
M)))))))))))))))))))))))))))))))))))()))))))))))))))())))))))
M)))))))))))))))))))))))))))))))))))))))())))))))))))))))))))
M)))))))))))))))))))))))))))))))))))))))))))))))(  )!! ( (!))
M))))))))))))))))))))))))))))))))))))))))))))))))))))( ( ))!
M)())))))))))))))))))))))))))))))))))))))))))))))))))))))))((
M!!)!))))))))))))))))))))))))))))))))))))))))))))))))))))))))
M)))!)))!)!))))))))))))))))))))))))))))))))))))))))))))))))))
M)) )))))))))))))))()))))))))))))))))))))))))))))))))))))))))
M)))))))!))))))()))))))()))))))))))))))))))))))))))))))))))))
M)))))))))))))))))))!))))))))))))))))))))))))))))))))))))))))
M)))))))))))))))))))))))())))))))))))))))))))))))))))))))))))
M))))()))))))))))))))))))))))))))))))))!)))))())))))))))!))))
M))))))))) )))))))))))))!))))))))(!))))))))())))))!))))))))))
M)))))))))))))(!))))))))))))())))))))) )))))))))!)))))())))))
M)))))))))))))))))) )))))))))))))!)))))))))!))))))))())    (
M  !)))))))))))))))))))(!))))))))))))()))))))))()))))))))!)))
M))))))())))))))))))))))))))()))!)))))))))!)))))))))!))))))))
M()())())! )()(       !)))))!))))))))!))))((      !)))))())))
M)))))!)!))!!))!)!)!)))))))))))))))) ()()())))(!))))))) )))))
M!))))))))()()()!)())()()))  ())!)))))!()(! !)!))))!(!  !!!)!
M))))()))))))))!)!( !!  !)!)!( ( !))())))))()(!())())))()  !)
M! !()))))!))))))))()()! !  ()()()()))(!)!)))))))!((())!))))!
M)( !!(!)!))))()))))))))!)))!)!))()))!))( ) !()))))))(())))()
M)))()(((  (!()))))!))))))))!)((        ))( ())! )!)))) )))))
M))))))))!(   ! ))!))))()))(         !))))))))!)))))))!)))))!
M)))!)))))))))!)))))))))))))!))))))( () )!())))))))(       ))
M)))))))(!))))))))))))))))()))))()))))!)()(!(!)!)))))))))))))
M)))))))))))) ))))))))))))))))))))))(!))))( )()!!))()))))))))
M))))))))))))))))(!))))))))))))))))))))))()))))!))(!(!!)!))))
M)))))))))))))))))    (   !)))))))))))))))))))!))))( ()(((!)(
M)))))))))))))))))))))!))))))))!))))))))))))))))))())))))()))
M)))))))))))))))))))))))))())( () !())))))))))))))))))(!)))
M        ))))(      !))(       !)) ( !!)!))))))))))))))
M  ))))))))))))))!)))))))))))))))))()) ! (!)())))))))))))))))
M)(   !)))))))))))))))))((!!)()())(()(!)!( )(( ()!)))))))))))
M)))! (!! !)())))))))))))))(!!)  )!)!)!(()())))!))) !()))))))
M)))))))())))()))!))))))))))))))!))(!)( !)))( ))) )))))))))))
M))))))))))))!))())))())))))))))))))! (!( )!)!)) )  ))(
M !))))))))))))))())! () )!))))))))))))))   (  ())(! !(()))))
M))))))))))))))))))))))))!! !)())))))))))))))      !)) ))))))
M())))))))))))))))))))))))()))(!)))!))))))))))))(       ))(!)
M))))) ))))))))))))))))))))))))))))))))))))))))))))))))))))))
M))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))
M))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))
M))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))
M))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))
M)))))))))))))))))))))))))))))))))                        (
M                     !)))))))))))))))(
M                          !)))))))))))))))!))))))))))))!))))
M))))))))))))))))))))))))))))))()))))))))))))))())))))))))))(
M)))))))))))))))))))))))))))))))))))!)))))))))))))))!))))))))
M))))!))))))))))!)))))))))))))))))))))))()))()))))))((
M!)))((      )))((  !    ))))))))))))))))))))))))))))))))))))
M))))())))))))))))!))))))))))!))))))))))))))))()())))))))))))
M(( )!  ))!)))())! ()!()))(((! )()))))))))))))))))))!(!()!)))
M)))))!))!(!!!())))!(()) ()!))()(( )!)))))))))))))))))))!)!)(
M!))))))))((((! !)!!)))()! (!()())))(!( ))))))))))))))))))))(
M(! (!)))))))))!)(!) )!())))!(!)!!!)!)))) (  ))))))))))))))))
M))) ))!)  ))))))))())))(!))!)))()((!()!())()( ( ))))))))))))
M)))))))(!) (( !))))))))!))))))))))))))))))))())        )))))
M))))))))))))))))())))))))))((       !)))(!))))))))))!)))))))
M)))))))))))))))))))))!))))))))))))))))))))))))))))))))))))))
M!)))))))))))))))))))        ()))))))))))))))))))))))))))))))
M)))))))                !!)))))))))))))))))))))))()))))))))))
M)))))))))!))))))))))))))))))())))))))))))))))))))))))!))))()
M)) !)))))))))()!))((()! ()( !()))))))))))))))))))))))))))!))
M()()( ) )!))))()))!)))((!((() !(!)) ))))))))))))))))))))))))
M)()( !)(!   ! ( !!))))()!)( !  (!!!)( )!!)))))))))))))))))))
M)))))) (  (()     ! !(())))!(!)!)) )))))()))!)()))))))))))))
M)))))))))))                !)))()(        (        )))))))))
M))))))))))))))))))))))))))))))))!)))!)))))))))()))))))))))))
M))))))))))))))))))))))))))))))))))))()))())))))))))!))))))))
M))))))))))))))))))))))))!)! !(  ))!!! )))!)))))))))))))())))
M))))))))))))))))))))))))))))())) ()()(!!!  (!))))())))))))))
M!))))))))!)))))))))))))))))))))))!)))))))  ())))))!)))))))))
M))))))))))))))))))))))))))))))))))))))!)))))(()!!)))))()))))
M))))()(!  )!() )))!)))))))))))))))))))))))(                )
M))))))    !(()) (!() )()))))))))))))))))))))))))))))))))))))
M)))))))))) ( (()! )!))(() )!))))))))))))))))))))))))))))))))
M)))))))))))))()!)))) )))())!))(())))))))))))))))))))))))))))
M))))))))))))))))))(                 )))))))))))))))))__$ !01
M 0                   -#_V@ ( 0,! 3\0/W__Q  4$0$
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M-FS9LV;,>89X!@JCZS.3YE&X"F/NJ]:!>9#QN2 ='1)DGNANEEU@M2JDZ2!
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MA:$U']FI;/7P9@"/'3X$FI:"H:W!!0M;(''>W0+(D%0%F</N/VO852D$/,1
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M?K46RK)@!@6:H'5X:EAODDS-, O0\=L%Z(8S(23VTT#/AE4JB025[&6XFMW
M&B'>#H:XAMA82HMI4?,C%Y#2=/L.@^D0U$7Y)D%_T(G^_P#K;^57%0=13$&E
MVG%2#=NJOF:V]WGT\^+\#Z+L]>.N*)D"*=U":X<M:E$A;=89@Q%$>)R@RAJH
M-5UO$,V%%^H E"K"MXM,\+G)?)2AE5\O-V!YA66P=CNOKS.#$6%$TG$!HK$X
M6>GBD!THQ(EE4"$=6C)F%,/%9Q[$[@D2)A0U$!%/<O>BJ3CANW8'E<.,B0IT
M:7S %LY I!H0#ZD#RIV$H?V.%GI'%6ZM(05$C,P,+Y=[TL.,HZ8U$(]P+Z \
M<KPF55ZD50 K;P0;/5%.T :5 Y:EX2#6.L%$(9)Q@T*#UHBDIT@.GC-F(J"1
MGU!]_@%@=4Q):;,Z 54*.+L&BQO)L(]CV0=%]6\JSTB@/$Y !@I@1(1V BF:
MSAD5*J\P(D4^ 3@U!1!)>NMP9TM&7UKCM&6\SN=%0 YF@I;@Y$J.7,,+J#0V
M,#:ZMWPFM!(#:('CJXC^4.SB+5)RY*COFBBK -9[( N4F0V3AA-*"\2_2"<A
M!CS(>H<+*4'O.7!"K8T8B>_)<;$&R$MTE@58R(G"LCRD05BR&6.4"PB'Z?T$
M@%!?91H$29L#:?- #.53KAB3 +I@*PO.G,,W!)2@5# L#BEP QMB*=H!'4<W
MZDOXZ5HB[*(<\/[3F!3 $S[A#<553$?I4+2V\,J";)Y*Q0*H @7B?*XQ,L'&
MY!D=XZ8BG'0KU%O4UZ^29!?]")_O_K29*O@7XEM3$4:9DZ2W-#)P573@]W5V
M:62BH-H)CS 5CDTHNA)0.<"$AC;3#4 - F&$F0A45YMF[.U>/;P>Q3%K 0K@
M!P*-S!91N251%\+0VN'-2SE2A#(@9L^A/M9&"\&Q6!>EH(,%). P$1;4-(#L
MGW<1_?PW$G&<*Q?='O2VK.0XF)MLW/7.)2@ \ US=]"0G(-./EBP<&*PL=[J
MV,:Y#D 0!0=@4:=8._+@" Q#L&$9$#P1H6N3J5X-A<!D8I,$!O?WD&TP($I0
MK:.,I$- 40@)4Y>QD80D:72)$:6D)FN%!&I6D0"[ 44ECV?!K ZA01IT;?1=
MHA$:K41D4/4MI*O]4?S%B5E4?QAKG!Q@D@%7HBD6!EG%$DSK ##$+51X>-3P
MKTD6@XG'KPWI7-C0.WX^H<" '<!+T E%ZRE7X(EQRYKD!!CX"_HWEY0)E@+%
M=2QZL.:JI70[502ZV.Q3DS>\72PD[R]O, B="&&BRR*!) -'<S<,8L;>0CIX
MKTMY=RQ6<SZMX648:=D=*AQE8.S0X1%T_P",$D:/"I)B!D U#8D%NJ9EN8J
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M%80-A7D-8-H(^0HWI%2814ZY?=V1X&"4"13UP-%#4104M'T JXSP(8%%!&I
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M@?1\N_%>C[R&)6"-".X$5C#/'+9=*'%)5'2W)83A'_1)0%  @&!WFOI 8T$
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M "TQIKI"@)Y#EEGAO-;=3A$2$!J(4[\=;)^51)PCY!;K(H%BX@O=V%*;\C)
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M=$%4!$4F=C6142@. 3'5W5W4$'1IL._05J*@(H!TC(I\F)'I.0< /A2E/Y.
M\35B/HK:"+UG?%QAIGK@'2D44O/6Q/3[1"^D34@TG+'K0ZT?0J"A.>+Q6I20
M[ 0D((_(#?Y;TY_H_P!4?**%% !UU'$5!?J@2**9Z;M %Y*1(&70 ;=%94X$
MJ)7898 0]I!Q5.ZO5VRPH(4*M;1Z\@(21$TTUX*]-L.D*5(6@T99*>4/ZQ)L
M:4(JG,\'!!*@WO'CRH(Z;<#1($&%!NHX !$I1$Q?U*,0R,4L'8#FO'Z!CBP
M74("Z,/Z!C0%JM1HIT=NWVIL9KDX#4E99R[$W5;"AZ"J37#Z^KGP2%IP@(7M
M4$RL,>R9Q%8LXF141.JG-1@@3]M@+D2[:2#$BD2)V(0P-&%%2)]O@&J[,'U0
M #U>*.X^&+C1 ^6*'R0\*%(3OU%$OW.#:QX2""H2.6*('GGEC,7+R CR]3A<
M3Y8.\UH; 710%NA:C$E4>+,/"C1$8$!5MSOPWY ;_+>G/]'^C7T_H(!2"K3"
MM<"+4$(R40  *]&>_P"N, T7J-^OL/)) JH*4X@T->-.]@OB2+%U4EG*29@X
MQ B<32';QG0P >.A 1*'@GA1A,!8NG;T,H"SALSQ1;GJ07I0Y]0K&R6@@@F@
MIPD>L Q$L(HCL.7@7E([B28 1ZT2YR$" UGS#I.L'LK[8VYO,@E#0@:/9TX+
M!H,5\FB92]$( 5PS4B!$ 1&'E T>* FE&P_$=_T>O-5M2JM,_P#Q-EXG"75!
MQ2*$:K$'L>I* R2L'&AV)KPWK%3FT-$E$VY F#C)2]%'H@=Y<^G_ !]>C3N&
MSB H9\W6@A,1NAX=E<FIB=QAY85X!908&1.R2O8BT_3 J0I-8B#B)X>/GVDH
MZ4G*R#M]7X##APX<.'#APX<.'#APJS:,ZC;FPHB,WAB\*$H!@!@'R(\(!+Q"
MEY>H;DB7PQ$U0TWK!KR7MPIL<TQ5KMS DB%S*&0RJS9=.73PZ.( ZBP/<JT9
M2!E& L*H=*D$O%1CK;)S!(V+0/14S0*AZNE:@;)74#VI9B70O%D6\<TLH6C(
M$55-2<ACA>@% .A7XTW^6].?Z/\ 1.4ULBZ1*%4'RUP\5(E5GCM,PPT\-'6P
MI%Q'L*H))SO4&^ OJ*(QR/?! A" %%1-12=@H1P['%0  ',9K:>=9!9.*MM2
M"JCPD@RH_ 17F.WPX9.!50/<M7Z'CAE6<)!9A]* V%IYU C!(D0S<)#CA3[#
M5))J'VXA,*FR6+1Z,,U>T&E2B"S.\OTU+#(N!6L@J@!4.)XPH<)=+ZFZ#H6W
MDT =M+/G8A*3X [!2>'I; AWPC(AJJSYE(E$#7KEEE6WN,K41ADB[=NS6A$E
MW#PMY=I;U1@ B1@IB%FRT2/ZB:/G 0*>31<Y'I)U%]!Y ;F)D# VR7( <L[H
MQ(F%&UBE2<2LO(F9),[(-QA^98!9C#L#*@FKF=._8%%AR#AGT@ /8V(!PFNN
MH3^?KV\37J/4C,<ZP_QP^ 3H,;Z?=_SSZ#^ACTO -&&1HZOK.(^*! 1*!B[.
M4V]$RV + K.-8.Q!83IZ\<!-FK$$(*+P""$4?UHOW6OT$X"]K#<^* (E'$>?
MRRQV1?900TP;[,R*48(=$_CGYC_?/S'^^?F/]\_,?[Y^8_WS\Q_OGYC_ 'S\
MQ_OGYC_?/S'^^?F/]\_,?[Y^8_WQ[<F^"6&EIA6H>> YUS:91?"AI@]B:<!(
MS>VS*W0Q0DZR1'P!H=(".(/OI0BA!6%7Z\"5<\0-5L* JWYB/K[3C:(F@@!H
M@D3F-4D%4:R(G HK[?7KUZ]>J!M"YR[I!9E(#D;)[?7KUZ]>HW1(-/9@^@O_
M +Q%0[&E-4J2ZS3XN.P3B]!(GW. <)*V?0 #Z!/?$$$$$$$$$$$$$=Y1PFC8
MM9V;P   0#H]A+CIQM9)2R5W3+6[7R^^TZ=.G3ITZ=.G3ITE<@H1&E8+X1.4
MWG8E[0PKY?/_ /(_GGGGE.P552)"HPM8_,(,&#!@P8,&#!@P8,&#!@P8,&#!
M@P8,&#!@P8,&#!@P8,&#!@P8,&#!@H,/F7( 8QC\Q@P8,&#!@P8,&#!@P8,&
M#!@P8,&#!@P8,&#!@P8,&#!@P8,&#!@P8,&#!33,E,JJ0/+?D&E1!2DI_A^*
M+ERY<N7+ERY<N7+ERY<N7+ERY<N7+A^"Q/$3![QWOPQ<N7+ERY<N7+ERY<N7
M+ERY<N76\UBZ3-E;+O?S$N7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+E
MRY<N7+ERY<N7+ERY<^I !*52L JKGR#\MZ_N&7Y_!^OY!^6]?F$N%E].M '^
M$?Y^8_@_7\@_+>O[8E[(!5@:KQ3#EJ@*(:T[>Q.QGMQ8L6+%BQ6/4D?4ZP3Q
M#]/;BQ8L6+%6X@T491 ^J@>>90YIZ#2F"E6GD^ *]R.(EK&?:$*\$=*-R54#
MVA 3T/;)$B1(D2&Q" 93ICV]P2)$B1(D28%(F@6.UFP(IY>9;QO"TLD YOJ/
M<]9;K'>B8L.C-XBVF!C6)C86 SKVPH4*%"A;O'M&0 LZ3)[84*%"A0N_UO/)
MEG7AV I(P4K5!-PZ4]DU8*RNIGT(C;$Y4P7+[9$B1(D2)=JE;K!&YK1WU[8D
M2)$B1)67"6O4$1T$7C=<RJ9J [7T2B+\>H,L-TQB+Q'0Z>);/TI]@5NJZNOO
MQ2/!$/1'B'RK@:%$3& C=$2'T$\_R$?5>_$L)05KON4Q8*R7X&UP4T5P^HK_
M ,>YH4@>(8D/OV_#\ 6F#!]%N''U.22\=UGJO9V^QE8$K_C@9N9S53TQ)VI9
M%?0, ^ (E(ND@8A1[ CJ?'CG21.X*JL *K >/U-,XD;)>17_ /P^PR3S !4D
M@24]/M4::L$3TA E4ICR EH[F30.I#L9!O"#2 */J8GT0?UB <*!@BP! " !
MGO\ \!Z?I/<10@!VKQ& $. I12FE(X'*%)49=\B$:(FEB/3@V94##= '1PR
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MP =(%@QA9P4@;#/J<((@C]VMJL!8F/$5R28!3HETM0\\L(!GAL #2B-1 G$
MA N('R$ST!X,)@+(XY J@ EC*"",.B@S_?L?B?3[_P# >GZ4U84'"EW#@0[I
MR\*"+1#1;"5 4+ 2!8^RF*(O!/*KDVH1$@;FP W?-$DM:PPOES>,.!1$8@H4
M[@+T<BLU0TJ4:79$H>"2PHP((#T@1 JNDS7R %3"A@V$"C2Q2O*0$*)@D.[0
M?=MLI'()8D#<(=Z\ 5 #)M+&F@)#^41JT']&1M(EC=A8Q[XDH;/!J/205(T
M>NGKA%<SXP, K,C(@4%^4$8H5,9]0$AE.)%#:"A -R$0V33[;;L*CAXR$%:Z
M+RLT=44KCH#"B/L35P0K!HDN!'!I2)(&(<]$JGM(4 5'2AC9)[*87$ZB%M1:
MX\M,/=&@4*3?> F4L"O1Q19 ,EBOX#Q@WEFI+Q8'0EU#(0,%L6P;+(4'WG#D
M&080DE:$KP"L>$*2#Y9Q.!R'%-A;DB(@MX"@6LR$LS-T]@4X;/N-).(*R:D8
M3O-&MVOV  J ,/R=GKLM$FP%:MF413< %0L8 010,%G3@@<H3$#N9F] >A %
MP-,#[$XZ>D7$*VK.ZAB4Y11M7M7X>9MH>[F]%H0P\($"R,4%6' .-3J6[ A/
M'2O\3B6IBAL@MQ\@ =JHB>+0B2)Y#,!PDT<$.!( 65@&X'L?B?3[_P# >GLZ
M4N\KG,Q;%E5XH"S< 7I1&E$+&@,L"$3.A2.PL2#"?.9 -+D [0(4X.!$G1AZ
MH0 !4$4 RPTT+UYD>#>N.NT2TX54)#&LT!_19\&I.P$3Z/"_""@# #P>^)*%
M/FF)RP:N8&KG&\MD"S+T5)0R+PUH31$)DQ1"_P [ZD#L!4H,.JHKR&(IPN'E
M YL(K%0A>)&U@*W,/8!N.<,&8+ ,JR@_15S>%>LT>@-EXJKJ\&$/@5FX K5
MTG"O*I8L!6X%%W.1_D0PAL7^Z[BGO 3*5B8"6Y!( 0 (5(N2 ;"90%48)G$9
MZ%E"X00$16(SD]MUHG4E!(;1XU*I]"!?Y/\ V'!<$.#%+:%VX*<HL<@:?9+3
MZG.)W/#1I8+TK%32?)F>M4=C-&%=)SP/2\4H*JEU9.'L%@0>!N!E2:+Y=6,1
M>'0/U#RA(FB('>>$R$&G*+2!RL?.,&)O0H"E,IDH^.+4!XM^B?4B@M8*N=5&
MZVA".F/ HW8E!IWK0W&3@<.]0/P'$,F1'#5_2:TF#.!3@5_$4>T0,QS2 5K/
M1[<:ZDNR,#FD\K (E',1"81?T_$^GW_X#T]F8+I1(1'^.;:[(&A>F@%1Y#P&
M<(!=G6CJ0,'5G/XXOA( QODZ=Y>#%14 U/(G!OBT?B".M$ CAP^1IKM+B\,0
ME&/=/P4DH%O5= 0+PC/T7DFP=XH<PV R$O!WAJBM(C FBI1#FYA'"B(]M"/0
M6.09@$!0@(J%L&!3@@56X4$%**Z00>'EP,[TV(B!!4>>&EXSL>KH05>@=%/B
M"688"T0HM%8 [W"MA-C4_M$Y@U1V;V<(:_2GVP3+"?3E[T]BWH&@R"*X48PB
M+C0J[NZ;EC1QB;P0;K16C3DJ*ME0'?-4(0U[@C@!2DUN4"JF][!SGO!$)](8
M9<(&\[M"< ;(K 53 0?Q* L[Y0+I,1?DS/63(H"-+0FM$T7UY8&26EE/):U\
MUX=%>'V%'T/1X\<0&VOF(!D 9!LX=P*HR!8 #01]0F<-A.%-; V$D$  '%Q$
M9:03JD=T(WGVA#RXO>K =KE>7?S0,78#+#08$PRIC4@*)"$.)>CQ(P$!&J%*
MJQ#>:!@0TB3+$;5?/*H"_=V&%]:X*0V2T * 4.@/Z_B?3[_7 6QKB9KUI @?
M  <4>,60?-#!N^YWP*@+E%68*(L^ 0$Q&-]CZ/$@4O.Z&4A6ON7["7QAU$ >
M7 ^G(%%L29T##R)"8+^)?WS\2_OGXE_?/Q+^^?B7]\_$O[Y^)?WS\2_OGXE_
M?/Q+^^?B7]\_$O[Y^)?WS\2_OD"Z)MZJ <W;-1NV4=5%.8@^2ZWC>&#8%)8-
M8V.+R[Y+\I60]$,1> _:P" .&J $%50LB^-E (3(L9W@U2#'5'*;S6J)Q7!
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M[2[^%!!1()1&(/#F.(J.%F2":/HS@',%;M#&]G@_4NBU+!;$!M;?6/@^X_\
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M0#:&A]KC@(E6F=7%^2 ;#L@/?<!O+8E"B3A(V3+]@2AG4RJ:"%R_7?5-J4C
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M@>K5B(1BXL')(C8FV@<445&N62BY7L(C&&:@J"Q&DJD3:!@2. CKX@@$<-@
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M%OSR !^KR@4GRA'W$?<8<.'#APX0KO#A@( !G;^J/1HG>.:O@"JH KP*$$Q
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M:X.5NH1;# @XU8">^(E N:@KPB_>*8MM- BB\Q+1K-0I, !2\U#["@=,,MT
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M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
8_P#_ /\ _P#_ /\ [;$N+ZROU0OR'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>ahl-20231220_g12.jpg
<TEXT>
begin 644 ahl-20231220_g12.jpg
M_]C_X  02D9)1@ ! 0( =@!V  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         #\*0  6P
M /PI  !;    1TE-4" R+C$P+C,T   R,#(S.C$R.C$S(#$Y.C(S.C$Y  $
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M1T(@6%E:( ?G  P #@ !    'V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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M'H      <^./0      >.3CT       \<@X]         #GQQZ J/S]^A]
M       1DV(;1W+<]\?OR     'GKWP       //7O@      >>O?!R<
M  >>O?        'GKWP  <G   .3@  #SU[X.2?^G9-LT9>.UZ  .#7QO574
M[(TS@     #SU[X       .?/>/?               \]>^ <G       \]>
M^  #DX  !R<    'Z-NT;=IYZ5G         A7MU[YJ)WD].?
M                                        Y-J6A<M\$-TCTOH  </-
M3DG2=%$KSOAX
M  /V]WX1'2-HL=<^P        $*]NO?-1.\GISX
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M>1V=I]T_C'%DYT  !^WN_"(Z1M%CKGV         A7MU[YJ)WD].?
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M/LIHZ_JOLQ]NG-@  /V]WX1'2-HL=<^P        $*]NO?-1.\GISX
M   S[(Y+LJELK5AKNR>)Z+%+V&F%LYHSUV9O3-ECAO4R#,G R[U9+.DKD\%0
MN\B=K#"K9JUMZVQC^=K7EP9\IZDA%_S3O2;B9!UBY03EZE)G9S9(A;!;L["V
M'7IBC62M9>BYKOC]ZQIR!NZ+FOQ)1URZNY8FCN7%)1EC1DA&&9J$YOF8\D=)
MQ1LE1V=\^ZQJ7N7*98>R-I1<AE^4T;OBI^Q?,79L8+=T=BB3L%<$1+6++1%I
MQ$AC"8KTR<,U3XZ3KLG'?C0W?;F\J'Q[XOCZH>77J.'+"[8B*?L:
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M!F'YQ-(0H%V[F*4,19,%X&)9*             $E6]@'6^Z1LQP
M          ')M2T+EO@AND>E]  #AYJ<DZ3HHE>=\/    ![LWDLM28L_3V[
MCW]&D1V_&>0@^O[P#G-Y+37EJ#%24:)>L                "3NQGMV%F,"
M24         !W[6&3<'9HOR,%^??@    "]=GZDQ&3<?-?S&LE!@   ?M[OP
MB.D;18ZY]@        (6[=>^:F=Y/3WR
M                      .3:AH7'>]#=(]+Z  '#S4])TG15*\\X>
M                                            #]O=]T1T?:)'7/\
M8        ,4Y-'7YO5CH?(!Z       .#D !X >@      \/0     !P<O#T
M      <'(      /R?IX>@     "2>"5F7J6#]/0  (U[$/#/:@3P ]'!R
M    <'( #P'H     '!R'AZ     !P#EX>@     <'+P]      'Y/T
M #DFOJ6"1&"6
M
M
M
M                                                 &#M;-DR4B^Z
M*E<,2L/=VINY89 !9$;M5^;BJQK;8 QIH[758:WE",F@
M                          *3J9\(SE?D)&S,8OO!F+X^J]M:]=UMT
M     4W4V,%3,'(?1E  ,8:WF3]GW%7SDR5GT?WJ;T8]G2JGOF9,WQ=FKN@
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M/+#!R*@IV%49E6RK8]DJ_&NF=)D/IY;&ZW1)J4N9E)J2!Z
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ML6&VLQ= I59K5ND?[JQ<E\-X5C>CM>ZUY(7:OK3EK(Q?%Q7&M[%:G:@
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MH5<L.MW[B)DV*-Q='2N29+2M+W9M;1^ZCBV;.]T\Q:FWC[/JWW:(.:=8M
M     X-)<MSS3S)4?AX  !L6T[3]$,'U+M>@               1SUO;OF(K
M+NA*8+T<]V3D1DC1D!C[2VL-3M?E+'RG+Z&(8_=BO,U[S?.Q<'WI30;U?U=L
M           4/6RU#=U;6\]O7XR4_!EB/O14N/G9J&+.
M          *?K9(E2&K*KW'[M#>C+N:$EO<E1PYWB,.O\Y3E]#)>C(AXB#H?
M5H2VCX,>OD[?^Y71TB.K#]P6S:N0)2*E=%S@         HNOFMS<TK]QYP !
M$^'F;PNE D!!V8   ?C']8GWL&6]7*!;&)<^4            .#27+\[T\R-
M(X>   ;%M.T_1#!]2[7H
M
M            '!I*E^=Z>I&D</   -BVG:?HA@^I=KT
M
M                                   #@TE2_.]/4C2.'@  &Q;3M/T0
MP?4NUZ
M                                                          !P
M:2I?G>GJ1I'#P  #8MIVGZ(8/J7:]
M
M                      X-)4OSO3U(TCAX  !L6T[3]$,'U+M>@
M
M                                             <&DN7YWIYD:1P\
M  V+:=I^B&#ZEVO0                    */I9]2DI'22B)> <S'3/8/1O
M_$PZ)8M?73:UM3J,GC+-\Y Q>X_SXZIK_=(R_-WX_NC[.&_L.4    >?X^K.
MR?%YO.C7SV!MZF3,>8 4+6V(02.*=_SJ>W#L
M                         >)YZ/?.WY^O!]>>_P ]\?S]>O[Q\^?0
M               X-)<OSO3S(TCAX  !L6T[3]$,'U+M>@
M      ?G7]TS8L-?S[LBNATB#%1N6[[''?NIS^M3I<=>/-+M><_1\$2&/%^K
ML97W:_>D!/6+9HN[\WFR:!E0   !KQCY#-OW'PBS;F7)?4Q9H0VP+;V^J'E[
M@V-;"NQ\YWTL^I'8^MPTK7KSBYD
M  4/0VXF6&%R;5K%;,I%VMFU\MR.+.T7O          :P8N:E%=J+(.FVK2_
M=H/=S69+6?5[C++J7(<_56V@                  #@TER_.]/,C2.'@  &
MQ;3M/T0P?4NUZ                    !3]7)KCW]+.L=)T.WUN/\/-[-OC
M5H5;FX!V^,L:(^I$[F*DY-ZWM'3],A&WO%25IV*%R7H3,OM/[    &I#6WML
M?QI:4\<I):P:=/Q57%T5;*]+5[/,1/X\M--V/Q$_4,&T
M                    !IQB9[/'QK2'VZ_ V;CKPL.+:C4;"         /Q
M@^M:L9.65?J5*NB6W7?LXMNT[4X8P\S'6\16ZFH2X
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M7:]                 %JPLCH7O<#OOJ&74[/;F.+;&3>Y5.9MNM4D#!3P
M#QB#6W+FQ:^OW)L24DXK-.QKW]'R(        %N8\E4V-=C^_>]
M                             \F#+BG>UK\T-VGY=>C;FKY-/>REEU^_
MY^P         \89U\_,G&T6-E,K[T=XWU>F',                   !P:2
MY?G>GF1I'#P  #8MIVGZ(8/J7:]                 X^6N&(GK"PX<FVVF
M1_W9;'TOGRGRF=DKU/FDZ*A;  'C5C 7^?ESY%#>KW#"-ECYU;NA)Z"W0
M    ,"Z6SCJ:B\8:GG3@]DC)^2#T=P
M         >+6RQ-V?F1WSB_>W@N[6V0        !^<'NG_)\7)+0'MA;I;]L
MA-DL3K9,T)$                   #@TER_.]/,C2.'@  &Q;3M/T0P?4NU
MZ                !QXQ&S7AB^+.V<'MR*;KY_7A]OK>TZ]@V  'B 4-:),
M6[GUBZLQA".L60+949G5K=        U^Q4C^K' R#KLKK)WLLO+%5Y[P<V
M                                   'C6)JW*?DISJ$^*0DK'9M??SM
MY7L5?V*ZFU6M?8         'BB=G65-Y<'V*O; Z%/0VF(K+,[7-C\!;0
M                .#27+\[T\R-(X>   ;%M.T_1#!]2[7H
M     ZL/W$+9^9/ZOW09B/R#';@    X/P6>8L,#F%BV"Y3OW:M'38B+K\^\
M\ZTU)#%OYUQ[M]_.;T/?T!XB-G^X[;/U+76U/5"R6,;3 31BI,
M                           /&H+4Z9L/GN+X4K,_S:X?T0EAA3MS$N;!
M1IVUB5  'Y**8V(\D=B-Q0399LP<,MNNY#Q[TAM:9SM\Y\J8]V[?/K]^>X)Q
MY:MOZ-6^,G9&2%*F(?+FGN@                   <&DN7YWIYD:1P\   V
M+:=I^B&#ZEVO0                !T:637-[M73NQ<9I*,RYZV2:6]4,&V
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M9G3J6';3&7>:6"6][T
M#@QF:>35(0Q    /HWDJ5ILEN>   "^<>Y/;2LVW&-NTK\6_Z7H
M          '!I+E^=Z>9&D</   -BVG:?HA@^I=KT              #K/T\
M_3T"DQ6YKVF\&29:'EG#;]"T]JL2>E=&KG X\6SR^<PW^&>C6=PJQ^F6P15_
M>/Y@B!Q2,G/^][;J F<X  S0=DSS37?OU(    >SS[E#K3.ZV*O\^M:<['H
M Z<'W"WXV_?,0$R=&1    %+UL]-EHJYM+>
M     '!CHT+FGXQD     ?1O)4K39+<\    'L\^Y::LYO%B>A3.P2_:
M               <&DJ7YWIZD:1P\   V+:=I^B&#ZEVO0          !KDK
M,W[+14\J3OQ(*%D/%IYOWNX_+KY<'>[N1I&%KFEG[OCWLS_&4<&3EZ  .#PQ
M^7"OX#ZCCG\L7'C%Z!4_Z-\.U+<2YI.#]1SNI7L\O2P #-!V3/--=^_4@
M  )JZ-IWYQ/09'X][D $%J];\B=>X9>G,>G0HF=;+>KY&6%G.B5@:EN8<\>[
MEEXLU;A\E'O%0M&KW&O:.'&?4>79&Y1U_/W2Z=,VGS(
M     'FPY-8GN;(VWHSZQNSYR   "WS2Z?/R66      ?1O)4K39+<\
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MKXY\^@                      //B^]+GUM9-Q;.T*3K=<U-X #R&E8^=
MHP       /HWDJ5ILEN>     20UIG:%4=V#NM10)+Y;/N"D.K9/^]\
M           #@TE2_.]/4C2.'@G%MR$ZJST+#$'+ZFKOQ8;%M.T_1#!]2[7H
M             ''Q[B7[]R=A^L%8O;&F-&5NOD]V+* !8/QIZ7HSD<=L-; R
M;]RFX?\ )7ZNM/\ "O4@!D3]]<JTT<VXQ-3];6'45U&3  S0=DSS37?OU(
M     #,6"5^D>%Z=*_!*@  #!NOEQU+:]:BO<CR>%\^96U=D
M             <>/(=_UYV^>@ 4L^=$TFGG        /HWDJ5ILEN>    #N
M\^M^]=Z'KX@N4=+Y &3?N4W,R'7Y Y9GD                X-)4OSO3U(T
MCAX)W?4UGB&M7B@K%JFNG&1L6T[3]$,'U+M>@            >&.V=?4U@S-
M6I"#'0J7('5V9SQ^]=FGM@ <&'\<9I1B^.XFQQ  $\/CH4W?YG?K.VN+SX%;
MZ/%0O_8WYG]CZUU?JNQV2 #-!V3/--=^_4@       !=_P ;/TQ0/6IC8)7D
M >(+-C!<_ 4BO67&T@D=IU_"622V5;\7G*+E
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MKJBI&-5VK.8-#W'L#9YJR41&/#*VE<JKN ITR
M !3-7/J#L.]/:L:,']>0S3=*CL.A)3]>?=E'S%FJP         'T;R5*TV2W
M/    /;\Y/H%K'0-<<1RGI?(  %\_4AN7D.O27S3W(              !P:2
MY?G>GF1I'#R;^60F/ 7>R,VM=-5O^F>_<"&Q;3M/T0P?4NUZ
M!B2)FHQ35>OF=K^68.UV5&;>19R%RMH[8 L/XU-),7QS!.*!   &9_N:V[?B
MC]<V5^-^@@7E^KZ-JPLG 98?L"RZ>++M #-!V3/--=^_4@        !E;%O?
M3E ==D?CW>1XPMAS6_(:N2]/+X=K!<&+/[M;);<AH9"UMH
M          "G:^;29.2>X:#CXD;/L8+-&[?(6/\ UI3'S9FF4          ^
MC>2I6FR6YX   !M(B[M[ZO4,,8X0   "_OJ1W=2/9,X99<
M#@TER_.]/,C2.'DH/9*[_K;V00MRB=7Y?6#=^,C8MIVGZ(8/J7:]
M     >*"]KWOR>@ #\$2L%?T\QG'K5^=0   #8II],E?_+/]:43G<H*A:M/"
M_P"__P WV-N:^KW]!SEO &:#LF>::[]^I          2EU9WZ8(3J64_C9
M                           'X^?:5]?-1.[SVB>JSXTD>OF]
M  !]&\E2M-DMSP   7;\9]Z%2N6O*/YD    !F+[F=Y\GVF]_K:
M     '!I+E^=Z>9&D</!LHC[?A5\2?KUXU17'C8V+:=I^B&#ZEVO0
M         !C<QV\H.&'U)QG(\6_$0   *G[EW7\?_3-%_F%W8"XOWUR#73%\
MLQY^T;5$+T!F@[)GFFN_?J0          V?1MU^AB)Z%^GH
M            ''RP7K[%/EHZ[8F3QS(Z$DOCSV8\P &/.9Z&O_(^:#I&_B4
M         ^C>2I6FR6YX   -T,-?<&UKG]@?,<     )D[%SW/2'6>0
M        #@TER_.]/,C2.'DI->:K6YCV5P/0H81.;7+<.0C8MIVGZ(8/J7:]
M         'GQ_=H?7S<&7%5_C)3\.7P;>K7\64   "@&##I.2O\ SK:THWET
M/->F@  "0.6P[7/YV?LFROSC:A=W=*YKK[_^<,L?JZR:F9?,!F@[)GFFN_?J
M0          ]'F3Z18'J^PK6G>0                         #5/K>1TW
MIB<,7'QK\D91=%Y]/2E6D 4GXQQF_&E=P7^58N]_W98- GZ*F==OU[^
M    #Z-Y*E:;);G@  &;L$GMPJ,S!'4Y^      -T4AV28VQ:
M   .#27+\[T\R-(X>3HV)?:W4^DQ\VX[FJ7;1]T3\]#8MIVGZ(8/J7:]
M     'EP9-/-BC;4^<TM8W=XT\=#SY9(_>G5OKYPUMX\,5R1EK+:5B,\N?K7
MJN#9X,#E  !7O/F)NG1-96AS/H?   &VJ"[5DS^4GZ@\-;VOUF^;;_IM^<<.
M26CJ0[5+ 9H.R9YIKOWZD          !GG7F/J6@>MY)^<H
M            &K+7^/Q%;],L>O<K7]<OH[,X*2 X-0E8X[%^)I&S[G/9;,_%
M&.X^L[T#OW/9/GVFLU+        !]&\E2M-DMSP  #>O7N@PN@>84GS"
M  +^^I'?G*=PO?ZVP            !P:2Y?G>GF1I'#SV9/G;'7KUKSE(*<M
M?Z-JWM/'AL6T[3]$,'U+M>@        !\M+<SI;'];)KWEKKL*H$+AC<CXQW
M6%G'1;AKXM-=RU\0V5JI<<-W^M;!(_9RU$[UA&)   5%YC_7KNHB,Y%:OFF
M +G]V]V7YS_5-G?SN[ +P_9W-X6=%XY#3]2V./(,T'9,\TUW[]2
M  &Y&)Z!O%C;Q^@                        #CY1IP;-ORL=D:)W\7[>&
M2VUI77J;@%&A-C4U#<<U@Q/$/7[[M.V>V22_*-PLKD>M;?[\L_S:].WX[@
M     'T;R5*TV2W/  !/;1M$I*IHQ5P5$       ;$MKHFU;>Z0
M    .#27+\[T\R-(X>7'MX=X<-T.+L?M1^:,/)ZC#8MIVGZ(8/J7:]
M   %,U<\(936G+@Q0IR3,H8K4Q[8(6D8I._(.4CC+05Y_&6N>8[-S_4M?CYJ
M6#8P,4@   [S\XXW5/&<EP%BKX  F-DN>PS^8W[#M7C$]7>DQ,9_W%^;[4_1
M<[JQ^O1F@[)GFFN_?J0           O7XVOJRKW8LXX]P
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MB_6W#=9O8YO#QF@[)GFFN_?J0           %]8M_P"OJN]GN3SZ
M                 @7'7O(EWYK^Z/882V^O28U\D[XK;>,0?B_HF'OPQT0
M?O:^+O\ TC4HZ_L;\]ZL);@-TY,VV6E]N\?Y3RX[_9UC^:3I^]@<      ^C
M>2I6FR6YX +L^<^\"K72 <5S         "]/K>^A"4[Q<GUF
M'!I+E^=Z>9&D</!L[B[E$;[UYPP%]U.7#C V+:=I^B&#ZEVO0          !
MH_6JO8*WL6TMC7E8H65NIGG9\90*(8#.      >XM_##:B8SC^-_B, $[_;_
M #2_E!^Q*94MSN_JA^<H%=4V=>GW[F@[)GFFN_?J0            ^B6#ZGL
MST[*                        'B/.INUF:A;MU-NUM3/5I&/RGK;?FC\T
M6OY#]UIM/W0  ,A?K2CP[_7/YOUA['#)UR719H?G#H/LL._H _3<YJ_R?72
M    ?1O)4K39+<\ &WJ'O-DUJD8K^(D         ;;M[K,^MJY@
M  #@TER_.]/,C2.'G=E^)KYI?896>@P,T-:!-JYF-BVG:?HA@^I=KT
M     1>C).P[)7<RPDQT>X[)D=.6NOG M#X\QE]^T0X     !V%7^-35E&\F
MC#@JX'H?6\?D_P"G+:_F#W2N_M?ET0/U?S[57;-S-!V3/--=^_4@
M   !/O0M?TM0W3?V                           "S^-6&-_\K>SO
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MYCRQN3,Q>,7?#_3IGYU.D[\0O?0   /HWDJ5ILEN> ;LJ_T&,T!S:UO-,
M      "KL_T92_Z K_N4           #@TER_.]/,C2.'FQSZGI(5RWW!LXO
M)5+UH^Z'^?1L6T[3]$,'U+M>@              6S6-2 O\ +&H4N ^1W;+)
M?:-[(?>)&Z.V2'NOVY;?OOE    *^\CKJ4_5W'\NM[S5&T*#Z_G[^7OZDR#_
M $.Y#IS[5"XF^O>R9YIKOWZD            !]/-?Z]-_7F@
M              'B+?\ (_NE#YQ*      73VJOXS_8'&(Q=DY#FZJR>9?N[
M:#.G2>J/[]   'T;R5*TV2W/!*[6F]CU0V81Z]'           W12'9)C;%H
M            X-)4OSO3U(TCAY=V'=MUB\>;7N;!*VSGBAL6T[3]$,'U+M>@
M              87X%$0S_G16@  +JZ)ES/^BI6X^R251ZEN4B0R4XX  !WG
M1BB]44;R3!F*"KWNSNMX+^H:WQ>W1"_?/,=>63Z[)GFFN_?J0
M &]*'Z/N&C[B                          !XH;9B9_&#OX       N_O
M5<Q'^Q.'X^ZG0I50-JUXW28^>*1S8R  !]&\E2M-DMSRI?.3?I6NC:Z8;D(
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MQM^ON,7[<-;'4E+?-EOYX7@ 'T;R5*TV2W/)]:%GD)4XF..*M
M"6&>V;MY'L'(           .#27+\[T\R-(X>7?OX-[=6ZE&G[U[)AY;6#;^
M3#8MIVGZ(8/J7:]          Q]J;=#EXC)D3)X W=2D8-C,4AH?N$E\;ST/
M(G0VWB(/X3J^"ORQ&     #]9%Q7#-D;M6]?O>)&]^[REIY_ND@ KWF.'VE0
M];6CS7:]3NWRRK_0-0_;:U'^9YIKOWZD            !+72LOU/PG4NQZ
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M[)/Z!E+Q[G)T*<S44_!57F*M:MZZM'G.XJK]SB7?M?6=-<TUW[]2
M     K7QL?9W6NX?L                      T_P =8;@V(S%UJ@N[5S9V
M@Y7 E@BLF[6AMCK4P,(_@OIV+?QW>@         *A:]/)G[<YQDW]14S4_O_
M #\V)9 /HWDJ5CKZT.NK4[$OQ$            7K];WT*2O>:_[E
M   '!I+E^=Z>9&D</!MB^I_PP%IK$+:-2=WX>-BVG:?HA@^I=KT
M#JB/O5#AM]T6KFW3:-R/D-!7/5KO*K:^8RRFEN"U-3LT]B"/\RJA8')M4
M     "H3'U??5-N_NV;^1_TM*]=FV[<*?CC,9Z<3GS<M6B:=YGKKWZD
M        /LVK'=KB\^@                    !UX_J$'QLWCLZ-,^,U&W=
M;*4=M8BW-?,^Q@D%H;8C_P#S>ZUC_P#-%N           KW2HG*O[6Y]B']*
MT[Y@?M"P^H7=K5RQ,)KIT.9@           "X/=KZ&97O5W_ %L
M  #@TER_.]/,C2.'@G!M2$O*3U##?OQK'M?(AL6T[3]$,'U+M>@
M61H;>))F.O\ B-[$4O'T+!GR=GUZ3%2UU249FO!FID?A@=_,:GV?S3"
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M\@\T_GG-8+3WMB/>[I1]VX^-VQ$8S^]7P?6,        #[#ZQW3)/F0
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M'>6S+87WL.*MS%&;9B(VYXRV?O6       ^SRL=VKGGT
M     *3K9M:>S[/?%KQ8^=K.^_H5+#]8RT\]]2^CGS2VQ@#^<'6<??F:W^NP
MZ]3MFE[9G5JMWT>^P:GCL6G3>H17;:]#R6?0MN<P>'?Q65N8K*^7F]4GUXP
M    9?\ /G7A%\+Q7\1(            N'W:^AB5[U=_UL"/<=,:X]GXE5<J
M;:U2FH5S>'??$Y.SYR@      #@TER_.]/,C2.'@V=2&[-.D]=LNM671-TO\
MX#8MIVGZ(8/J7:]          #Q'/%GO#?C:_P#.>Q8>1NRPP.2X^1 T=4_A
M.O"#Y"           .7NS>Q]ISS:.TX^]]DB:J(G@E@_,<   !4&7,.27DAF
MLU2V]^RMO-$*0A(^[$?B3)HV7DU0   ,C:\M]B5?[$
M        !BJ&VL1[N&Q=S';&/VCY/+2/$           5D]FGS[6MI\T
M        %\_6]]"TKWNL^_8CMBS7E]88]_>3(.['=<-,YCF(>^]/<
M'!I+E^=Z>9&D</!M5SS-YUF]5& M.F:_<#&Q;3M/T0P?4NUZ
M  /QYYI:JG#=:=?X\           ).2-VVD7?],8+R9A>)'Z.X]$O!5
M .U]7C];F?\ +8LP9YOHV=N,TGH8<V-6-N>+P?GB@ )OZ-H^G6%Z?V/0
M                     !&XA8              9LQ0FH^,X<
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MMO80KLMJ)O7%AL6T[3]$,'U+M>@              0UBJ9\_5(_,/4^
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MSS%J@BN"V=\Z0           _1OKD^Z9[RS
M  '!K:+!              ,KX:[JDC>*@           ;MI'M$LL]D$4<6SA
M;W4O68BLY,UZUR;J>_HQ!R[LV4?[<6<      #@TE2_.]/4C2.'@EW8,.SGC
MOZ(C=+PNIRU\7&Q;3M/T0P?4NUZ              !^//-!-+_.T)(CFH
M      R[M6'<Q??U7'K+L  #(I#Z,XK'?%70          !>OUO_ $*2O>*_
M[E                           $0B+              !F7YP:P8K@MJ>
M:@          %S>[?T6RW?JK[]CI^/JEY<?N^??3[Y^_/H        #@TE2_
M.]/4C2.'@VDZMGRI3.F^?=PZ:KAQ$;%M.T_1#!]2[7H               UE
M5[F6F"J?G@        "I_6?=M=?T_BV5MW0  "I%NZ/-(%ZO/@
M!//9OFW3?ZAR                           #&)KJ.              7
M@8MT.5P=UJ.          !+[/;]U$CUW]            '!I+E^=Z>9&D</!
M*K))2XB+5#+7U(U3=.&Q;3M/T0P?4NUZ               +0Q8/EXYW^0:#
M\:         VIV;O.4+-UNS    9MPUS4=&\6           &\:2[9*+-8
M                          /(:V"S0             ?HR_@K&IJ.XT
M        .3<W(=CF9L6D            <&DN7YWIYD:1P\$QM*RR VI#JIUL
MU?73CPV+:=I^B&#ZEVO0              !P:(Z;^>H$0O,        ):2=_
MV47?])83^OL   "4GF/2O$?G<          #+WW,[_)3N/N]^@
M                 ."+I#X              D#YCU$Q'Y]\#"         !
MDO[E/H$E.Z5GW(            .#27+\[T\R-(X>#:=]S.2*GT2%V6+AU9.;
M#8MIVCZ(H/J78^@               (?1=2^?RD?E^G^8       +ZS2V[N_
M?JV/6Q(@   #+) 2+X9AW'#          #;;O=7GWM74
M            "A&L \X             +T,7:'+(,:U&          VA[G3]
MDFY?>0            <&DN7YWIYD:1P\&US'9K9BIVZ8*UZH+MQ$;%M.T_1#
M!]2[7H               'F\^?G_ *3^<H:17.@      -VMT_35G3%ZI8
M  *F8\C^30KUZ8         !E[[F=\$GVRZOK.
M       (6$;@             <F1-:H:MM#D0         N;W;^B26[Y7O<H
M            '!I+E^=Z>9&D</!M=V9F1E5Z%3*S;M%/1_SL-BVG:?HA@^I=
MKT            65KYKHW=/"\?(T:3CLM:6SA3:9\^]6X]?/%N.K?SLT7\I^
M7S&     !L&F^N2ON/>,=      N/5HVMC1Y8         .Q[MLWNKSWVKIR
M                             "UC6P4L             &:?C2U=Q?"K
M6\U0        -K&[U38AMW@             <&DN7YWIYD:1P\E]AG;XBYBP
M9"(SO6^BZT+=QP;%M.T_1#!]2[7H            U1P-ID/U'DV&>==;P78:
M9F7!GM>5U=EFCYD;0W/SYYI%J/#-<\%Q\     9\W+AMLOGZ<P/DV      )
M%XXW3G%\&_#P        "3F:T;NY'L-1]^P
M    .",1#D             &0C \?R6&.O30       !FG[G-\DIVNM^Y0
M          !P:2Y?G>GF1I'#R:&.=N.,E;;W8S+]<O\ K1MO(1L6T[3]$,'U
M+M>@           6="2&NFSP<=MK/(6NVFY=72QOT_D%P<U[7*6Z4.5-<F1:
M&+5^;.@_E7$VM7P   !5?K8WL7S]7X(WIWI      )!>?.KF*X)C_P"=
M     5KW/OCD^X9KR2H                              'G-=QC0
M         ])<VM3=9FAR4       #N?6]F2[?(G--@             <&DN7
MYWIYD:1P\   V+:=I^B&#ZEVO0           +.T]KPRD996MMU#Y-C7NK5V
M+5V\&7,?UZ/G[ B%&5'Y\Z/^7_)YA    V_6S]"UFP=/M@      %XD<X[CL
M5L%5        _3W9WN=,V5;E_P"0                               8
M\->Y1@            #-_P :6K:+X7:OFH       -B6UT3:IO=(_0
M       !P:2Y?G>GF1I'#P  #8MIVGZ(8/J7:]              LK5RV7)Z
MEYZ^6[/KX]7QD _+S4-6.-:JJUQ/K?(  $Y)KJ$YKA^@<2_7V      !Z3V:
M= US:?,@       )F;%RW([_ %GU^^@
M  <$?B$!^             95(KQW(8G8*B      !*/-:MU\CU^K>_8
M         X-)<OSO3S(TCAX  !L6T[3]$,'U+M>@           8P@Y+!/0:
MW+BGS$#Y/%=<+DP%DRR(GHN8FAG_ 'Y]@"G?/QHYIW!X!0W)@ !F':L6WN\_
MIW"VS*_@       &?<4)I^C.'       #/N2P[OY+LEV?6<
M                   #\$/B+X            /05+4HVN'2Y8      ,SY)
MO=[(]DR)][H              '!I+E^=Z>9&D</   -BVG:?HA@^I=KT
M       "S:U*ZT^P5G+_ #6RX-W]+:5A^-?6.0B!;/G</BJ^9(*6  \OGFBV
MF<$@1#\HX> 5?ZVMR-T_2UJ2UT\0       !);SYTWQ'YX\KX      &?,E@
MW@R79+K^M@"P=':L*;B:+'RN>=J.H4;*89D-:2K3]6+9
M             Z"()&,_            !*3S%IGB/S[3V(     9D^YK=-(]
MAR]DD0              !P:2Y?G>GF1I'#P  #8MIVGZ(8/J7:]
M   QW&[V([%!Y(AY:&.7).W[PUOS4P3]_<@LF*I8<X  H/QATGU#ANOF%Y&!
MLOL?:9"6CM6//?0       !D4AG&<2P%B@      ,]Y+!NXDNQ7K];0 P72+
M1$3L?-[BB+SL!CZYJXB+M1K'5MJF*)K&G)@
M   #SD0R,)^0           9.(EQO&8PX:R    !F/[FMSLCU[,^24Y
M          !P:2Y?G>GF1I'#P  #8MIVGZ(8/J7:]             'G\>CT
M    !1OC%J%K/&]7U<XI)^0O.T&\?I'"&3:X        !Z2H:7.]<6IS<
M  2LS6S<)(=5OCZVP ,1TRRPPZ]S_)$7/2@B\,>VM$B%NNP^V\ZS1&3'?\9
M                            !TD7B)!T@          'Z*KIT#7)I\R
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M:.I:*X+X&,   9IR3FV?>ZE)7-._MZ!CW4V,)[>O=FUK2"U=D
M                    #CX:C,4UL_GZ+>L18 ."T2'Y@H          &;GD
M$HSBT>L5=  &1/J2VS;W4I;[%G[WH                 X-)<OSO3S(TCAX
M  !L6T[3]$,'U+M>@                    #SF "(Y;0        ,M/->L
M5PG%?Q%  "O>[&RC<Z/L%VKQ7?<H &(,/U"?/$2QS[4<:]8[EG(>BY_,LZ&U
MX9>$]$#.XF\^;TEXRH1,M&O?B;_D_C-$+*2XR:YZ
M     +&C-[6]CS4GI=+VX4NP  ?DPF0Z+.         !5"GZ?.]>^GS< 55F
MG_MW[93M]!NOZS@                 #@TER_.]/,C2.'@  &Q;3M/T0P?4
MNUZ                      *(1Z(L%"       !<A:VCS. &KS\ 7'[LS\
MVK[L#VKSD7[W>0  #6ZC-C>3- >'D+!WOK][L=:LBMJ6U<L\[LUI9/FKW:G9
M,J-UK_1.48'Y;UF5]RK\I(7<                          P7'[?ZFX:/
MF';G2Q^S%G  X/ 8"(J%I@        $@,<;I[B^"CWLLW]FZ[)=SH.4_N1_0
M                  !P:2Y?G>GF1I'#P  #8MIVGZ(8/J7:]
M            '087(RF-BF@     '[,L:]3U01_'ZJS9TRSDY]F[37V;?<'N
M7D   '&+V(#:D7O1.((V1S!]XX][^.OZ>U0)+1J<=GRS]8H\?>QD7#YW2$?B
M?S/-G6^._P"-D                         #R8_JU\V.NX<O3L8/5\?52
M\^@  .@Q 1K,5%*       !($A['<ESYEG)[[5VO'ZV.0
M    #@TER_.]/,C2.'@  &Q;3M/T0P?4NUZ                        .
M"BF,S$!B,LL\(   .XO0D%\:%'Q0T@<LY?OWN?H        \&#+BG?U+^C-_
MRR<=4M3;KWWBZ_C[H.?'<>/[                         &"8_<Q--1MA
MZ4OC:<K^3:_JT;!:<W3T++*/V@   ."C&.C#AA\LH\0   /T729&,V&5R[3]
M'(                    !P:2Y?G>GF1I'#P  #8MIVGZ(8/J7:]
M    &+H_>C)(Z-\3,3*Z%EOWXLR%WM<MSP[38C6_?S[KWTM^6$_6\KQ<KK(T
MMZ_=S0F7(Z5TZ6]VO.7L7_C[DQGC_3CW?SXI^MFUGVB.V?0&W^O?.//?SA]Q
M=*8LHZ.3]>OT6Z4(HY3#J*N5,KI<IR?L         L_1V8WR\1@&L=#PM:H6
M[;%SCT07W*;[FYF1>\                          !'6/VHDRFMD.)V(8
M36/:1]0VO/1M/XN,!N&K/Q[<&Z     /R"VB@E$*2#O*X5LNP]1^@
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M37=O&DGBSQK[/FU=F+E@B-AD3G[OC,
M     .#27+\[T\R-(X>   ;%].T_1!!]2[7H           @O!3=3M=2Q7 S
ML>K35)9UF>P'N9K5^+!EB=KNQ_GLOI]N>KT;]=W(QFWJ#@9N9N]'P#LVSE&M
MS&8-ZFXU^IFZ<]<D3!RF*+A$4>HV?'<S5/!*2-XPOS-+2VXD_.:EV/XQGA\R
M-7-W.=_J4T*;8P             !84?M0SGX^4%=DL*V6(SU!R=Y>X(FS&O-
M32^^WYR
M             #@TER_.]/,C2.'@  &Q;3M/T0P?4NUZ           'BF>O
M?X\WUY^O'[]\_'GU^GGI>^([O'9[YT>>_CUZ/&O70L4U;!2KMT)'M^?KL^O/
MUY[T^/Q]?)[S\?79]?/6<^NOSUX]GOG+T
M                                                          <&
MDN7YWIYD:1P\   V+:=I^B&#ZEVO0                !X_C[[\N']8LGA]
M^8=:LY?5CKMZZV/,^CM@
M                                                  #@TER_.]/,
MC2.'@  &Q;3M/T0P?4NUZ                 \:VH*Z3JO'*\!\]OM"ZWSK
M&]"Z;$VUQ6TV/@9 QV\
M                                                  .#27+\[T\R
M-(X>   ;%M.T_1#!]2[7H                #QJ=K5]E#;^71,@K'4>JT*8
M7++S&29BO/\ #:)CV@
M                                                !P:2Y?G>GF1I
M'#P  #8MIVGZ(8/J7:]                 %-^??1]_'@AY+"U[JV?*U,]?
MS]=&?#4<>0
M                                         <&FB5H&I*1I?Y>   ;!
M].S;_(7IO8]
M
M    %H_>O:'UK@  "XOG+??QM@
M
M
M
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M'Y
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M![7XV)#B<I][:UDC)6-W81TWGTQJC>@
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M#V?JV)**N:-D:K'[MS66-FO@UZUHS0
M                            &%\/F4)#4K&KN   8'ULF;-[5]F+-9&I
MM6E-P69(^3  \6#)CG?CLIZ^Z     *+[CK7F0     84P;61I&*N75VP!Q\
ML!?>KFS+]5+#L
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MP>[6E,[Y,6$<WGJQZ%]ZDKKAL]:G?7+)*S9P5G7W
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MJ:\OIS7CI0
M                                          #C&@1I[-ZV.&F'&2 #
MQ%+Y^LX:F;NL,)>\9)@   :]\>U+F;K>3XB:
M
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MN1UIB1VSQ\M>OQ'["LV[SY]C$D7,423ALD[\==NC) !XUS[FCL&Q9JEAV
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M0\+R\';TC'[!H>P<OH                          6AA^J-O:&2-?=
M'AQ?=O[NI=VOL    6[@R6=OQV4]?=      '5C^L09<5PY<-_XL_9Y]
M           #'.#ZK6_IW9K[0             #QBKX7AMZ]RX-@       4
MS!DQOO:.6<.Q^O/H!XQQ\_7?]8?=L8KRP;( '1C^L4;&KEKYS=GS]
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M+7IEK\P*I>XUV^C3&\F+L\]J>GN6]MQ_/SFROBV0
M
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M3F4L.P
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M<OZ$CE#%E
M
M
M                             '__Q  Z$  !! $" @D# P0#  (" P &
M P0%!P(  0A $!(4%Q@@,#(V%190$1,Q,S5@<"$T-R4G)H H.)#_V@ ( 0$
M 04"Y+++'#7;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VN
MNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]
MKKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==
MO:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[7
M7;VNNW-==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>
MUUV]KKM[77;VNNW-==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNN
MWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM=)KI*^BHK@EM
MV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM
M==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM
M[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z
M[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKMS77;V
MNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV
M]KKMS77;VNNWM==O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[77;VNNWM=
M=O:Z[>UUV]KKM[77;VNNWM==O:Z[>UUV]KKM[76"F"G*65./(1@O=9=BIWVE
M^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWW%^N^XOU
MWW%^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^
MTOUWVE^N^XOUWW%^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE
M^N^TOUWVE^N^TOUWW%^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOU
MWVE^N^TOUWVE^N^TOUWVE^N^TOUWW%^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^
MTOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^XOUWW%^N^XOUWVE
M^N^XOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOUWVE^N^TOU
MWVE^N^TOUWVE^N^XOUWW%^N^XOUWW%^N^TOUWVE^J2L*<)9+#?\ 7#SW.82H
MW&[W:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7
MZ[[B_7?<7Z[[B_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7
M?:7Z[[2_7?:7Z[[2_7?<7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[
M2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[B_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7
MZ[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[B_7?:7Z[[B_7?:7Z[[2_7
M?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?<7Z[[
MB_7?<7Z[[B_7?<7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[2_7?:7
MZ[[2_7?:7Z[[2_7?:7Z[[2_7?:7Z[[B_7?<7Z[[B_7?:7ZVNTO\ UJ$MDR%O
MR=R?VMU_7_R;;^>&_P#O"7]/S\17]H_R?'^:#_ZO)W)_:W7]?_)MOYX;_P"\
M)?T_/Q%?VC_)\?YH/_J\G<G]K=?U^4J,09FAA=-;L 1]ZJHJ4(L^D#?A396S
M!6GJZU,4T&DP3OMOCOTMA8G>L8B,5E)2UIF0IN/(22:*I+#/)//AI-)N3;N8
MX0D[?MN,"XHGZ(B7D8*0*Y=[.TCY:-KB).G]M!K<*,/,W%2AVUU#1+J;D9FK
MJYJ^$KMC2A\\"B^6EVMD?-.8V_GAO_O"7]/S\17]H]%BVR>O2JCQYA6?JQL#
M.3.2[=PU6Z(=Q'M9&!$*>FJ_#!:K+3B#<57#B'ICXB6E\Y"-D8EQ4 DVC1PO
MM8Y*MM5*;38B2\4O4RTO U;M4?2 ACHY(3N+KL"V\M45BH?2Q#M1XU(%E,"<
MF+[XY8]*::BN8)3PB@-0C^CIB1N84%QJ4Z>'VP"7$OXB_F#-5NBX9B0+8HS(
ML'$8\\E0(5U/2!Y&TX#E=CTT(-@_IIQE7!9-&L%38:5V;4(6@$J8;IJ:BH*<
MG5'C![&NMAFE^[#R(H+.5=Z_/=DLT\T]_/C_ #0?_5Y.Y/[6Z_K\I6BGV4*V
MXQ^]*FJVOMSV;C^'ZGI*1.ZQ#&<BUX?ZKQD#NKZ2"E5.':KU(VQJ6'AJ+WIR
MFXUT0U'(L#E*B*<VEK K*F QM%!/#;*NS"I!<+GIB/KW,"2 0,E->Y.JW>C
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M>A?%E91+8Y;TK0$I"1I<;3]'PQDM:K)P330V*L;*/)5"W3547K:LYWB<_7.
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M?CBE_M_SM^!(,J]K]T#,VA=8]6YIQEES;E!I&<.4$WDPL] /O(<L/"+*H1N
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M&O#H?)0RO9:-E(,;,&1KOM^NBL>MJ!PJZOG,5O8\\ZQDHZ+^FPL F2UJ-/\
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M19.D3[Q5;$(A/FOI6:4.9,L6K9E]$9VVV#VM-VI %<7#D T)7.*6,)&F4M9
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M@%%ZD;\!6FY!Q9P,/'*<<N>6'C=D=6O<+FN=(\7;O#.'XLFTDZ87Z-/=,;1
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MVWP\F.66&[63PZAG44(:Y%-?DHDX [-F0IW$$0C9"&VTN,O#^NQ2U88XKDF
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MO.D.-&LISI$NC'W3W&Y:HEIKD)7J.Z3D>.:\!@>5\<K(%0BV!VPK&,W+=45
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M7B!)\J HZP3H4S!",20_!O4JXS+Y ,$QMS.K8"LO2MZ0BK>4O(@]*F=.HLP
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M<X8:I@,WC\/198:>2Q*<I6&T2S-JFMNQ!PQ2D*6/2J24 W:V"@M?E"/%OE_
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M\9B/U\?"F)1[!F8F(+VG(S,3H4?Z.\1GYX\8]/IX^"N8^,]<=8W0I?AKX_\
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MS5IL0^.N"2K>2:K_ .VT+9Y-VX-W&2L)PY('(GVY6:J;J8VDW?5>1BION(;
M[B64;#VL'3S#$3&M5R[M"UE*Q=2C2HW,G:?H0=*E0W=V[IL@7'TMI>[6LFGI
M[M9^'%+(4\BJ'4W=99+4V"Z;5^1P[ESHT +S#&NFFL?C1$_@=6J^Z\*U8.H]
MF[8&X UV 3"\S"$(T 2GQ*-=-(\=(XNYG&XZR^I<L]&Q6<VNY?1>S8Y+"4P-
MRE&!;3 HW 1#.FHS,3$_SLU_HBURQ6_K'QC1?=O^]=GV-2M:V[?>=QU>XV:[
MD;-F[0]VV.'I96JG=>.RJN%D;=1+2'$(+G8$DR=Q&,> SIKJ6D:\5+M:\N6U
M6=58G*Y+8P-#@1*8T8(3Z&,ZZ:>/KZ\*4;CA:XW&6ND:Q&ND24^)3$>D3\_&
M3M(PS!5DC[<S1%@1VF[5)2P8/5 MCU4<;9G=Y?D^,:]Y6]G5\MU/]'VNKT+&
MP_/T7]LWW6WKCM?Y/.L=?E#J'FXI7ZF16QM-O6!3CKL+8Q>UP0)$&C0"9T@Q
MG=$2,Z^$^$_\P;-<ZN*=EV2,UD=/< 3,OGJ6!K#M&8%?WPHF=61Y/&-9\O%#
M/T\C;930NR+%*-Q$T%0&T& J8B0<9;MQQ,:C$::^.OAQS9EK'*UOEO'T*N/M
MW,K;?7R!91)V*P;7T8J=E*65VC$KN'W76!FIB'3C:,[L5R^G-7P&UD<O6N6V
M/9*,?;%.+5/2.P8)6Q+6@H"Z@('S;5BD9G6)GCD;*MRZ7XB\BJ5FP5>E<MBH
MI;6&^VTI;\58<QC$V5H*"ZC5S 6%KF!, TXY>H6VY'/XJ;16.SYGS6/INMN:
MUG9T=L)AS-D^\V+*2A2Q5U"F1 (F=,MGJ>&N#2M+LFTK->K!(!1+ZEE<-7.K
M'*+9 EYYVZQ/H)1X\8VHS*#!5Y (D%L]])#.C1DQ^0+/'09U_P ?29XGF:A!
MJ#I6]6L!0^[3I!,G2)GW_I].FL_X3P!08"<:Z&(E&OKH4:QK_CQ23%FW5KSX
M0^PA4S_@QHA/S%^5]$_5/'/]MF$SG+-.M A4QWMGVGLB1?D.\J4VTNKTR4JW
MVC6EL[@0Z 3/2W%K,XT"R?9"G0"O=MT^IJ(C-G9 ;]O4F(B61NTWZ>.F[Y\U
M<5@LG9Q5L398J]'J'6@33/7KJLCL)I).= <,%JL?-!1&L:%/+#AYLNV:&.@D
MNJJ<UA7=%KD4-KI. E$V2F9*R$CJ QM@M9B8B"/F:@L#9*K>@"1SH"==!C6=
M/?QX^'T\8&/C%5[NE[I?5E.EKR'N%*GZZ*ZX[=K1CY6NZ)\--)G%9ZIE\G[)
MK+LA8[FC5WO!0IZF0G1,[EN8>P=?>ST]8_%$^)S%:.9)Y7V/]H0ZXGK;5]GN
MH]UU9ZG5ZVTNT9T_N?6=0W0&I;<-DT9SVCV@.7[,Q-S,/[@0#?6I2N&@GIL;
MN>75'IB?37.D[FCX:AS-09>IX^%6^M>[CI%()Z0]LGK'U)Z\E&HQH&T#U+UV
MQX\?"'9&A7PW+=3?5S>!YEQ>3SE^KHA.1PW0MVG8\+2B"W;ZBKU(2JW$)JF:
M"@F;5*(^6KJN:+-JI0%BF4R &E<@5@4G%B8V2DK!3'W,S7<(^H?3.V.9Z$V:
M]7I6^I98I03TT[()S.F,E/<;HB)^5H)3IZ1/IP,[9UTB?\"C6/\ =QS]8*OR
M]RWG:GW%:L<U8?DYZ*FM>FVBVE<N-R!J7,,/+FR! K1NE)*$1*K,Q!<9NBVA
MR+DN<J>1R16\%V?<U;5PII/]IYA6*3M0H :WI*,F3OM)V-VF/4'5?'*J+7,&
M%QU\22#'T:C7=26#[UM2NYFW2'3MU=X;CDO769]9K\U8^S>*@";D.%M94D:T
M0O=:TZ<Q,6"+2-?/Y-8^:"XS]D.7"IA>@FS>QM7**[6(.!KVS:M8,ZI(T=$J
M+>([PB)C:PO&(=DZ/+N76C*UV6QKV*K'BA27K8J.B]@0-EB(+>ID#(G$"4ZB
M4[?&:&<1:SV3IC%G3+9K+9#%"<!TJ>,;+'U:9##2[>4*2817K"RNN9$5G(S,
MQS!S7:OY:R$1"^2T%7M4:(PP,C+55DQ:5<J]P>*FLYAY&=B="8)HZA01/X73
MKT\)[>170BFVK0M2I"@59)=V5Q7$@ 15)K[B-\=:1#S["+Y^7N:*V4>EE ;B
M"TZOOH6O4%V 7(ET;#)G4])VZZ3$>L3X<<^XBG6YA^"ZW40E-K,5N9[5Y@J4
MN7OG#XY\FTUK%C2WV'3N<33U.9W:D4SS-T\ES32S.1B1R08NOC$A3TBEVXY%
M]I9F+][^OUS."(6[.EMB%[]2FZDJ.,C*ND2KEKY%ZR[PL#6^24 'RSB?OGR=
M9]?+QB,I7S3YKU0<LX?-?6P(".^#4&NJV-G;JT?'372)\/37*3[)R%#&V/._
M(]UT23YE#VB%O9U2/IG&H,B V@>I:P6V/&>,U:9-OX2.7$Z5ZO)V'JM T;E-
MRT9G V,HQ68(2Z=Y22 D("$5>G78Q12V3EG&*H74SB[>,N,=BK?+E)]JMEK#
M6-JYRQTV/3BTUPBLG!IK0M=);"*VLI8)S*YB>,W;7@<I9Q-R#98J='J'6@33
M/7KJLAL)I).= <,%N6/G@HC6-"EG-F.4R%DF[J0[O!:--/'Z;,?D_1PI<M8"
MQT@F&(1KZ:D4#&ND3.FL^/A/',!QRVNJR]JT;<-E?:>>8Z/0W;^MT(C7N V[
M9+T+732->4LD.2LXUB>M%/(V%T[%9VD#8J,NC7LUK*1,U-KOVE#$G)K:$Z,&
M=9CC"8WV/S1\+F1VUUT*O-)].M5':2DMSF<KH4E.Q20%74"-@F(  Z!KI$3R
M_>5S)2REZB+%*Q%*[>LC;@08:J"DN<*(2;Q)A"\(7!FL9*"W&$:3/MVI[*S.
M7Z=CML)[/[L-B^NSVE9[5';CUNF6UGBWJ,5M#Q#?/EXP%NKEVJV@X5LM!4B#
M%<%U")/C.A,CIZ,\9\2UU\OTW;-A/.6;PGNHJ8_V;T-F_J%W>*&VWJ^:%SHR
M?)L4&D?*W%YO[R0DK#12$C!'KI):P/E&2G72)GTCZ/7C/7%\O6!K78-IE6BU
M$U8$QZ<FX-)EI)G?JDO#;II(^;UTY5[?F=ZA5UE)+?NZFQ;? +$QMV]P/RJ\
MZZ_BS'SSX.R@9G)9/$4P*GCL!F+N(N6@&*^8?D,4^:UCHO4QJ&X]J&BQ?56E
MQVAWFM81 SS+5?RUBJ_,U"[;N8Y75]JU\K8.Q9\]E%"C[.2D4(^_O,[?<OCR
M"LD^>)":H8_F+EB@62=E,94LNJY(+W+K$TL[+W8\9&DZR_KK]E]-YN96C<?>
M+0R#D1G7#4[K>7O:EEJC[>O<LOT-I,(*[;,S ;QG<6Q.@P;(C72-PQZ4\_3O
M.8A2[(FL2*98"H'0#$)TVN.?4XT\(\->,BN<971:?H:[ V3"$^8XBK(PS=!P
MN(F=T;-"G7Y]O&,Y@IY5C%5UV0)5EU4NL"AB6(#><QL<R=DQ/EF8B9GU&/Y,
M+VB7ED,@J;%&EIW"!!;6,[D&I5L4[1)['2!EO,=L1N'<41'& ??H9:SRQ?LL
MO/QM,K#+C7.LFZ7LK6 UL.D#9L7=A<:UPVP$!$R(ZE5HMMKL-62X&MTM\')1
M,]8B$=NT"B=)&=VLC_AKPWF>@H"82;DP,24Z+3KH,3/AK8CZ/IX79!O+]?F,
M8.*-GJ[%3$=U'1NS0+<$%*8U=&X='E[OQG0O)Q2S-6_=K44@\6VG)0LF"N%P
M;VBD).1:90,$<26@%.W72)GPXNM&A?O8YT23L?VW6)>DJ+NDB]?2DI YT X@
M]P!H6NFZ/'CES_W)YNQ0]SV%RS2=WGN]S:O0ZA+Z/<:KGN V26PIT+41TC4>
M:<>=M-.$W.JYRDB4K3L@G$ C)3W&[;$G&[09GUTB>,D$XO')R=C0T/>NN )\
MS8-B#L#)"?3#;L7,3,,F=VD1$QXPWG+&*RF$Q)(OS8SU]..J'"J_16YUBM6$
MK)3:@P5!VER4J6X]D',!,Q ES%EZW+)&-\'ME:P9/:"#(T.P5:-.LQ'CO&9G
MT\NDZZ^7C!PIM9>?<L6XVJ#;]BLP!-[*V/?,V5PDM4&; 0P5@;A6>Z(881):
M1S333E,Q# NDK(YK)9'&+@52-/%V&D=2G(%8@:\H "'MZ^^NK6(4<QKQG1GE
M[&^U;OO:_4E>RKYW:BI[ODMZ(:;:YQ]\^5(^&DS,8[)(RB L(%H :DNB'" E
MM>&\(F -D;HCY7CI$^DSQANFVW&/:E+%Y2/9AN)8E9J#>8I)6Z+"U%%U S)5
MGR#(4<ZRLX\.'51K_"-S+RFS(9><1A?8W;N"U$Y%GM'!1DF]9A#%8MMF8%>R
MLK1'E+>SS\7<3=Y7Y]J\FG>=D%WN7$YH+%RTVTP+%G,EBQ7U977$4"-??LBJ
M9P1D4-*"Z<<Q6 Y9V=_!-W[M.TB#^3T-=>M*/SX?[B^B-<#69S%5[NE(*7]%
MJ9 _O:6>BA>/R7C^-ZP7S:3*LFAR%V!!T W?M@A#=Y#D)UB&3'K'AI,^'',F
M:7==3C%=U2BK0KU;41MK0ZXDW]=\17:74ZFY?O6;6GM\XQM'BMS%CQY$=EP7
M=4_G+%YRMRU94" NXJ_C"NXSN[#H?OHD%YM>Q6?09:<(*ZNU;@!<\JCCLQ=Q
MU5E4;7,(J*L_,Y!"'66VZ])C+SIR,]6\<62BR<L,>HXWF3AB6G/&2S57%7.Q
ML+L&WK(3N2*R7NL+%@3J;5EM@3C=Y-8G72)]>'HJ9+DR]<M5DV;"V5$U;5E*
MW6ZU6'8\@K)>R#-*1ZK-$K*%QU6Z1YRUY8AD<G6U>3MLGA<YC+?RNL-2VZTN
MP5?\0;,",]$F0Q4%\M91X<<JXA#8''XPC'HIKHWW9")(4I;LF2KKG4I%1;IV
M1&Z8TB(F=/C)1W@OI6]6$(1Y$Z:E.D:^_P#3Z?"> *# 3C70Q$HU]="C6-?\
M>,C?K<O85.8LIFT[)9I?+.,3TUNKCEKE0[5)U]9FDAH"22&TRNT[, 6BD%,R
M486E>R-QUFPY07<IT]]-#'#AJ79*:L?9U<Q-M;N5!#;>I,ZUK4XVCX<<Q9BM
MRS8BM?![3*(G6H*S'Q-X>KFHGU0?XOI(_3.G,>31RQ)Q?!S=FW7M!!GRNAII
MUF5__>@-?J+Z(UYHYFH<I4<)D,BJVY.>QF-RU,:2TL:NOE$V'UPLP]]80< U
MCAPJ-P"4CL8R)F10N;#4J'2)<P%#)>$1)G 1KI$^&L^.D3]7&<SMO#<T8OEW
M%4L59&SC.YMMS%=CBB\'M ; UV5W*CL]*2Y1#$$[>1R9>,;4\OK=2REBME,U
M[1HXB_D%+LW1]FDVJ&Y L $R^5D?2ZT#(%(RW88SMXQ:K=CE*[S-8)'1P]I.
M,R"URSK-N?Z/4QE4#B1.O+;ZY$G/4W8)R2]T1!W>8J5&6PU5HNB.XNF"IUCI
M]3R[GAX[?IT\?]_%6R%RM7M+@H790FP$'$0< Y8L&#@2*(*(*-T011KZ3/KP
MA2EXW.YBQN).#PN3R_27MDFGC$1:Z1 <0+%L&)&0ZJI*=(ZBX\W%/(6N95T;
MED48W'$@;->,-#*=YJ+J8:F+W4-Z#<N!3KL+8$G8VD6X9X# W:W.@4*F2M6,
M:SET7]/)7&M9%\\MT=\ M(HA<($1@MDNUDXUV3$<9W,5N7KEBE=![6UNEO*J
M*S7/64EH[):U)3H+A@M1'Q@M-8TF<%3;S *BID"X;3"Z/<R0:*9TI@9Z0N]Y
M[X=8C4? O-/AJSF^IC<O0QPQD%W;O==N^O"P!?;U8>W>V+(-#>H]@[ +=,R)
M:#X\<^8M=[V-8J*K(?;Q&/N66R K.RU_>&Y]@UK,W67&0DUK)(F3&I%,Q''M
M)*<F['RLS?394ZFX!*N<V0%RX^^09!MF(9$@/SQ&Z/'C)8@\OA[.4QKRI9RK
M*:E.KU)K8!H0Y!.=?376RV=F46;, Q3!B6+J08[ /=BRG*<OY+F)6@5,51M9
M"RIGELFFH-PV"@!ZBB;(TF;(8]8S)!J8Q);<9DD96H%RN+04S;H+A 3\RUMC
M6 -@_)9$3YI\=?F\95HC'\P960!I8+EW*YU*6CO0]V+3%A:;"_"65V3&UJQ8
MDS"9&'+]>,E*LT_X/+.5M9.O6YCQN0R3)Q#Q5;Q,MQ%'(17P<V>JNA6)K5UF
MJ(GZT0Z.^2&#GDRAFTINLYF?2M#CUV<JWV>VV\SHU!JR: ]H!$$THA^U92"I
MD@U8.I\#E[O-%W((=TJ>'QUI@8^O1ZM=MNDYKNV]LJ)EBJ^S775KF'0@%*>3
MR7K$AM4A-<9!"5)"9W2*E@L9*8B-TB$1&ND1&OKI$?1QRLD&Y"(D%L.->G#1
M@E^*;&[=&DSZ1X:?C1&O&!0G*9[G,\N Y$*&<YBHK5<$;BZM*K<3()HA9AD(
M!,,8-98[%+@RB '<6O+U6M=S_->*)"SP=?V%[+HN6L@H]6DZS>Z%:1*G6[FX
M/69VZXZTZ,;JWS<,-'*KLV%@))+^8\DRJ%,0F%H:4PD"$^W$) :\Q(KB0'RP
M$S'IAD'G,+D,]4D5U,;4?=>NQJ%DE5XMR8J!<-43)[-NV#< SN7J4:EMG)HC
MEW(\S;'=AC+84WJVAW9M8VFJ"2OJ=$@W7E3,F]9:"SRS,#!T[2[M==E4&*V;
M]L,B(/R&2YU@2*/49TT*?#3ZOP+(9<:.FZ/6(^GY]_T+/\CCXU*_]N[_ -C\
M?&I7_MW?^Q^/C4K_ -N[_P!C\?&I7_MW?^Q^/C4K_P!N[_V/Q\:E?^W=_P"Q
M^/C4K_V[O_8_'QJ5_P"W=_['XHYQ=Q@A'XWU_EP'YH?I_N.\)WD5\K?\Z.6>
MKT+'@/8^V3"LSW2=AV>Y, #SK?T=-P]*-2XYD?4YLS&,C&.ZR,=RQ2HV;_3:
MOIWZEI_6QW:V(K&>P+*W=VO>DM>F)E,3M^$$)3\(@7'!]S93(8@<<6[U*K4Q
M2+'@.K(T<0_?Q7$_B;AUGC J8W*U05\N>OI\GYJSIGY4Q'I$\8_(3=YE^$-E
M%VN$S]? 5"1T_OM<,/8I6U]1H#;#>1OC?$),=VJRF( N*]D:>!;A:2NW*23V
MUO?U>V4GM8A70:)0[55>5[V-W>\W>)!XHKKP?*^=PMQ_GO<N9W$8_P!U/OLG
ME%..HGW4MA>^3*.H]H5QTU8Q?AQA<";.76<MW8[FIF*6(#(T=83O/%;;:1[E
M3H:/1L!OU0]4,V;2Z@%MXS%RIB,9D>5K@;LMEZ-LJV/W-CH)R%=N.3E^Z4+*
MS>E962>P9861_?"V+T.<8@JV-Q]8IU*O2JH*?I)2%KF?"2CU'YBGZY]>$DI%
M/*6&/[:Q[-NKQ#NF3MN:Z4'0]V.H3H<27W3':3MVNG2>.WYGYFY:S/*Y4?:6
M5YC]G=3*]SCZ?_)%_P!HC]PP2*W]61VWA81\CK3U#+9/(Q.''<P\MV)V96GC
M\MR<@/*6W)UT5*"@W!]S3I9UC<;RKSZE:D//QD8G <O<]\I9J=<]EOBQV%/T
M]H]C>#)VONBIUJ=3M*;E-]]97U_D+WMW+C!X+*Y;D"G@L:/2RH9BOE^CK7/9
MC!PJJ>G4>Y=8MMA@#]^[B=->GLU*,Y<K9;$_!YAZ0]QD\#<S7M.OJQ/LR<KE
MJ=F@?5:*Z]WN$K)VVNUW2V=-W3(H&>=W6JW+>/Y>DMF*O<OX.UDHT66MX;"R
M*=="L??:=;P0X$^'@.W?NYR'F+F"QR$-/"]!?+62NV+EGVC1;O7<R&+LP?1;
MT2'H!4;&U77)GT#.T2^$*S95\(_P?+WZ27P?8TFQM7/O-G,>Z==L_./XL[?H
MX+%HEUSFC(%VW6JG-K):&[<FH "4=FEGAL33B=5UX(NCX;B9YN;;MG(_!OS4
M]-3IX^DOEWM;_< 7?UK&9J!7M=J0@ZKU5@MG19!,#K;#TE<\?"5_\PWP;_\
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M Y= _7Q$J?*HE'AI/I,^DQ/T<<QWKV2YNQV/OC]Q8B[S#4Q<;D^-85]*/%(
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MF.L=6GBN6UX>PSI&&ZTD,T1%L?T&QNB\F= 4Q<:Z0V="V<<U([3#4,8N>O\
M&:N#75-.EU9QTTKPQURDMG2EI'J+$;]NV8/79'.*KXYJESY8PGLY>>S>(Q;K
M7M)-O52D#7,.B$Z_(Q._<--)>[VPR9/5G,J7\P<B9*I@1WOFMA>OC]0'VM/?
M4V@?=W)2%#M!2ZSM O?Z]&?';$\SYS$9[.<O1C3]J.H9+$W[E[;9I;<;5MV.
MXI]L]20G0W [N%;[$]3I@!0,Z9LS5G^2.9.XZ7+^-^,O<'TH/V%WE)5!7E\;
MN3]IW9T\B#[+74MJO/QRY8IY+G"CD\32[+'!7K43'N6V-;PY1%@BULP#XU0:
MXTA?1C;X'ODHCF2T^C\)6/O53Z5I/==-NT#V]3 H2?D8)KG59D/F"=-=8T+2
M>/A#QN.5\'O7W]G[6^$'VSD+VU]CKY>]A+IVP[;?/3ZFG6W)A=4-O36H->,X
MA^7QV HSR[H7+LY)E!WM<)Z;<A93:D^GJN#V-0$[7&X2TTT 9D9Y@KW$9KEC
MF%J=,37^#G"\LVF=14[>8%6G77(V#,V9TK1)=1:9I3Z"^6>7BMMYB^$'F_,8
MEG<8G//Y53BW[)5U"JXL<=:]U9Z%D-EL##[H4F"TW+DE3!\8'*&'-ZL-B:?M
M'M+.2HY'*]Q%3V;E:5>X%S&]C97]V=/I+CO$-*N?=:J,NA.OP(&4U^6PF?+%
M@YB-(_\ H_/^WYYXY82JQSAS6E\:J/GGFO='FCY,L*/D3!?*B/2?U<8S)V_C
MQ;YB;7]H98TU"MU^JNKN35]F0'O17VT:KJUP]TC=&_=.XA/=R[0SRN:.<LMD
M*/8T\]FK&1K+[FG9]TZWE;(AN2<M]U%I([F+21ZZR$:$(X+_ )9Q7_P1H_YI
M/',5AP_"[SM[*/V7D:_Q;ZV0VC=[CJ\LHZ?W)9CH*Z2.HCRZ[^IU)T,1XH5'
MUJ?.6??:[S-T.0^8>QN= *_2&JH+M9?;@15#V6QEN]R3W;MC-RXV\? [>MY.
MZO+7BZN2R>_ORT6OJ=DK)UJO@D%H#8A81[E:]VGO-QS)3R2(5_A(YP559N2Y
MG,%NP&R8V7V9ZH+1W,U(MHP,:A,)GU$8G7C&H5<GF[#61ZF-ROL#OZVI!U^Q
MZEJK[X)%ZND\1/W+5[]-K-X:CQSW734^+=6N'316Y7PZ$AN(MBD]XM8[CDC+
M: Q&XR(ITU*9GQXK?_,-\(__ -JN2_\ D3F>"N6<1\!=O,XT^GDZB.71K,VK
M/;#F\N5V^1XLKSJE[H\ZBTUU'0H&8Y:KUPY6S]"/+1^*?,8E\N>FMLLEQ^O6
M+3J'.V#W3Z#IX:<ISI\'&<4)[TU\R%>J6W;]RJC""GPGS?)\?>3+/'SS,\4)
M]J_!?G<;?^Z*>)Y4YKRV/3]Z[?(5QR,IL=1/3:W9-I_NG&Q!;_,N=H;0$5?
MAS":O/OPO($N;XCVI>TJ6D;"UZW4DB#4?D:;OGCA-=5;E'GVNA>U*N2^:,@
M[BG;;#&0 NU.2(MHC$=.9E4_.&O'*+;#<%BI>6[_ $3BI#P"/E4PU^1$?X>O
M'P@"(X/EFK'E0//^&MB'C/W1%2ZN"W?+^1X:26SY]NOCQE[18WD+G')HR'LJ
MS4^+W1R':1>[?N,RNNS[D,36WK+.4^99=/J=0=)#6.2<XREC-[L+\8ZV1/VH
MYWM&,1W61MUZLLR/3%1,3UEC)=H.Q"^OMA8ROC X-N0Y##%\QSV3\5N[:]Y;
M'LKOLRZP[[FHM +W? "$^\8SMMW4'9,''"![G(C6R<]6SB\;&+Q1Z;.[Y=I/
MA=&_MK[5HZ["9/:V29>5KHYA1I/&)(0RF.(ODC?IS/KZ187,^GCZ<7EG4^$:
MZNR&C+^4SF0I3NB=:5AN3E,Z+DAC6%L\&R#8_&"/#7!3 .NN/[S6QUBS8_U=
M)I-L>'F^3^1!'^2,SQ\$@D?,',)SXU;O/'--RN/A'W,^H+$>/WSTB/E[6?EC
M'IQ\&"P9CL=6,=49%=K'7HUF-]*WE"58#6)@QW+\-RB!L?B&,^/'+LFKFWX1
M,>*NG1QO,5BGC_/!?<J,EFDJCQU=X*2K[\9L_**2W3.>KOO<A9I%/[[2+)9:
MX/D\V,K89P6(W-D!C4C&-525B/4%E&O'+KU-PN)A4_>\7CH(?-Y-:B]!U*(W
M:;9C6-?3CH0JL^];/MJ%4&MM6MO6Z*D!UGGT53+F=-,$S:L"(]NP(DIB.%9:
MIE<#S*G#?Z3QD^QMV3]Y3]+DE'W%:6NQ_6%MK^$_V?5^00Z_!YD:M)&53>7O
M1&5O;/.P=&0%(1CW($<Z )^L[?I\=.+=6Y@:U=%I?M'EM/6[?,;E4^GU&";?
M]'K)U\]]]PU?/,[=G6'1)3I\)71LXWED@C<@\+A6J^7'D)%^5SX[3^07XWC]
M,:\?"Y,D[X$3+Q(LYG=T_3IG.78CPCP]/HXY(DBS-!6S>LBM24;H'QB@Z?7Y
M7XL3X3Q\&UZTSD!%(VZULM5RE/(+V+CN*S;^4KFO? 0Q6J7,#>DELC=N@H*!
MF*5&KCT#6IJZ* TVAO8S3: KCS-,S^0 QXE\VOK,SPBP:.N,>*K5=E2TOPCK
M57Z0].[227U!C3J+VL#U HGCF'EM%[*<AT<2_P!D9+(U<R5&WTCO]M",93LO
M'H67A7=NK0:-7&&F_J!JP8'CE3F-V5Y8^$(K=?HV$<C<V-!?5%FY:L?7D?,M
M"PC<;"CQUF--9B8F-.2<50YKI<M4>8%>TJ)8BG(U-[J?0'V6+X7UZ3*[F:,K
MH\TGK/1^AAQ/)=Z\R7T[ECNIT;9%O24C3^JJA>Q01KIJ1;I+\;3;X1/ 7YP6
M$S?,JT]:QA?9O0#J=/7VC;[!GF('!\ATSYT-]-!V3.^.5:E+F6SFK]U.W)<Q
M^T<>FQU&SVT9AE=RU=)1(0[HO>1[R!'4^3)J#2(Y)3:P7-_-O)[7=PC >P>V
M9TUJ_P"5<9;RCO(,N/Y;H'SV7>FH].)Z<<A.;6SW.95X\Q\S\Q;OD_C7*<S/
MG@H]1CPCCE.NG&\]YG%4(VXVOD.51K^)SNBPGK/^_2;X]\UGRV3Z^30=(CD=
M81SSS78B/?*Y^YQ!9ZSY1VN'3;KMGP,O&8F?'U\(XY=2NO>S5=([%+]G;!U(
MM-Z7F7F*9*=2F9\9GZ(\/P+FB9]W]0?\1Q)%]/\ V\;R^G_MXWE]/_;QO+Z?
M^WC>7T_]O&\OI_[>-Y?3_P!O&\OI_P"WCEV9[M7C/I'S_P#OPKB/2/JC^XLC
M8[#*/Y9L;V&[I=P"_-0?TZX9!75$Y"6=.#B0WHG8Z)D=/E\?"&*<1B\17PR$
MXW+65T+[;%-0TT.H.KW0.'MJ].RRZRRM1LW023 !*3E@CIEZ&-YDC%EEV9%-
MK"G8;1LXPJZW6&V6);,Y%UD'L;")JH&M*>D2E]0=2\DCEL_S!R+D\=6%6&M5
M;.-5E*UI@77Y6*UKN:R!<^'5%Q8D4#-J%B2Y)C9!A06V,1B48BM"%$QIS]]L
M/D#L.]XPPZSA6N6=.&2"]T>0(@8_Q38KUJ;6J3#\N+/N5=Q8-Q)*+IB?= ,C
M9DX7-@E].=L-A$SX0?"ZN<%0*=8J7^G,F+,@VW:9U-Q2)R1#\L(+8!1$2*_+
M'&F9P^&RW,.6+'Q2QD8\E!B)M=[(7[/9C$C9Z2MPDY.[:Y<0'6TW^49OUTV^
M7N:LI<4JQD*W+&<7CLDP!;DJMM-([%/9<:).160XB>/08+%OF6JB#F9XY<*V
M>&Q1W#%K"Q>.*603#8PRJ+EAM-OB1D7FDO4IDI+QXYL!MZK7H\M$*$5;2LL#
MLI)*MOR25V4C1MLH;P;@F@:"?6@!>;884,B("..7+V4Q6/[RX-#XSI_JHT8L
M>P/>.>I_7AIKR'_)[!E73*/NW?OU3I$XFEEZF6S_ #%)T(0:LKG\NE16>HL2
MLKO9"SB%[1 <J(#MH.M/F!G2'.T\_"DAS;E69'%+5:*YMZ;>:0A]E/;UY06P
MZ\697U(K,$M#+<L:\3IH4"G.'RI2>.>@DR&4;2KMY5U6[HBJ(4EC+C:_N/N=
MQ&L-!W17D1\"TQW+]YM2U<Q=? SV:I?-C))=WS"7#C7)MKIG?*B48K\PR"X7
M S$ZZ*N4>8< _$YNN76$TTGWZ*D]X@J,U72K'6K9.-527K(1 UZRAK8V@;)F
M*D9OJJK7IQ?LT6+$WT^[]KS6:>MPH:[W$V5C)11F1Z8:!U=8UXYGPMW.YNAF
M5,JBW"8U>#Q,N)HFS&5F7(KMR4BIQ'D#3=;W!UFJKDW38H0W;HL3>P?L7+ZJ
M"56H)N)\C#)\V!@#.S)P2)58+J#*M=XAZC$ZV4Y*]RQG.5;$T4X]XXFKB&4I
M>NRRGB[H/ LT1P:3M=&O7TFM7E77*QH*QD)B]$Y_EFAA<]M78PML\WB6XCR+
M]N5YO>S>\9<ZQ^SHBZ<V^V4JYN$>@V-)WTPM7L)E^6^9F#[+RHXP#;AB9W\1
MC+$VUSOR&^ON-ZZ^^90S<OK:=,]A147GJB;%7?C+*[BVUW6+97'7:JK BMC\
M<W011<0([ZC"$A6TB*8F)TXHU^U0I#7V+.S?N<]G6>>XS.-S"@=VW= QK$:
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MJLK;(0HXL,VJD&2Q<++?H<F$#,[HULD%, 9:,:X,:*1)Y0J)84$0C$LVQ,S
ME,1$S,Z3I'A/"HZR3LJT.JO;U+(^:NO><K#>X=5AO9$K'<4;C\L>/AP;E+(
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MZ>:/[/Z@_P"(XGU_H.7?ZXKZH_S"N(](^J/[EQ5 \G?12#U=U=)\?[-+&^L
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M!@1B(B(@1C2(B(TB(B(](\/P8D@J [FW3IL:L7*1;?%=[*Y_(LK6R(DZQS!
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M +G='7I%MD_]&,]VSP\RB_&'Y](XS!!CSQ:[JEV$9GO>U$0AI![.A<O[F&[
M'<9C*>G#==//LF(X3 9&NA!5:3>BI<H=91!O356$ JFMD[^G57OW!7"(6!R4
MCIKQ;PTMCG6TFY;W\M8M=_//=8^ZN8:WLJS<16R#15,Y8*]6LZFE-PD I#>W
M ^F9$.1L3BN4<7S;7!<4+MFEC I[=&+=9QAY,2BN$K2"@2N%0462(9\D+(?>
M1_S-P.%7ERTHPN=E;6Q[1TT[@93U>AT5,]S[P.EO\_R]WS:\H-;E*.)*P6YM
MNQ*C*9*?6^Q$:R<L+P&(]=WU:>'!9&A>N9*O0587['R-S"V^X!(=2]CV[+#4
M=$SWUCWATC;"G%I.]0>'&$8^GG N6I!E,+N,=74N3-HC7,2LP0,D51)E'D@"
MT+^TF)XQ#U\E<P9K/Y89?2RG,6;YDKIQPBUX4<[)IIJ<NS-50VU&438 ',2
MQ[I[I\.*NF HSR17DCS^-4^<W?9YJ1XB^1VV>R[0=&Z616K(415W=0*P,4^)
MWB"2.J"UI$5Q.D1$$1:=1AP(Q+6D.F]AZ1)G/B4^/X+44#K"UGKM+?KMTU\
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MCDQA5C?VSMT=&STIT=VS-=KNB7E=T]>F7E+2>&D*5"]Q"I!% "YLPM1'(R<
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M31>:Z= \1Z:B\=QA,^"2](.?\/36TN5O9$QIJ9R/I\G>6GIZ>GIQ19T[ ?\
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M#X?RIC'M)I-O"1::P#*\#Y1@?")KS/I'T^O'P<\N8JEG+<C%BT18M_DN]L]
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MF;^F,CH$ &L1)21_*T+QW>'C_NX4Y;@$UE$P41X:C,C,Q$[2B)G0HU\T?-^
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MKQ\$-C+,YAOIN"^,;['M-$F5H4GON^Q@Q'<0H)EG0DIZ/4TVZGL\-W\O+O\
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MNK8;0&*CRCHM 6U296:$R+4E!P28G::P*(GS",SMCFVZGF?EWE7F6G/DO#S
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MR;#.Z_J_N/O_ %/O/NOS?DTXKWN4:V'Q^!2[;C,8-T:E?IY.>F.0L%:M1U2
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M_P"@7_=GBS&UQQ/_ $?^X/\ 0=-GY!_9G]G$5WSZ(=/U+/\ 9QVMK73MG_\
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M.XAK%A"J/)=EKDX_#7!-DS&6K68W6)FO:G;$Q[5=\CBXX*/.?-/+RH(:N(G
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MY&=HMM9>AS(SO(NIQ6%OM5^6OM.\QUQK4KM3+BI8UED;*\,IS";/8UYWPM0
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MN<#CO:5Y;NQO8[NQI[""K3.S=[RXN4EM="4=LD9B=_56>T2C^7EW^N*^J/\
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M ,^3!07S^L1,?-(_-,\9.@>,O/I')$2>GK)KE13U$K;&JY(I'P9],ZQX_/\
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MX-AJDW<E55Y-L/0;(/\ &5#U"8QY2B2F"\(*-L_/PI8I4M0QH*P!8Q&D> #
MQZ1$>D?-$?5^&<T?V?U!_P 1Q/K_ "\A>3GZRX[(45?$]R^Y= =(F>VJ9=""
M:0KZDC[S;!;]H3.FFL\7\P>+?8HX[ V+@J$>WR:'V#43&*%L,%<5K"C[=K)
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M7TQ%1E90'40(/D109.B>E .DHZ12>C/Q->*(CD >ZJU+*]9;'6;,,@JU=28
MG,>Y>\% H#%C29(B 3N*8C3@%R\X[28O(_&O4ONFB'AX;[*XD!W'!)'7U<!+
M]1GA-A;RL"'K5M.J-]/OJ9B#TTF?#QCY6TOI&/Y.9<$C/4U5G*%O3L@^-['K
MB-BGK]43NU]]/A/AX^/C$<.2ZNPDV%,0T--RG 2V#N&"'<!Q!1J,P4:QXC,3
M'A/]-\'O*K+!(S%NML4NQ8$.M-M+6I;0'I-2,"*F).;'E;O\VAZ3.V-?Z7G6
M@ZVJH]6W937>:[=OUV[:Y>7:!1KHHOE2,>GCZZ?@@C)3 C$D13 B(QK)3/A$
M1$>,S,^$1'KQR;CIJTRLM5*V6M/E=03CHMM+\X'$"/E*-NW76)UGQ_YN9%)6
M<?>KAIO=4LJ#773>Q)@.NV)G34O'2)GZ(GB[3;0M-J/VRU6S=LW;?.L61IO$
M"^2<:ZC'C],>/X)RAB>C57=<$=4FDU)[FQ/0=55 ^68$)^6?CH4>/@4Z1I^&
M\T?V?U!_Q'$^O\G*(TG\X8&GDX&<=9]J=U!+ZT>YQ=EJ?=RMPE[^%_*4>GRH
MVS&Z+F#S-'/96[@5MJ+.U>KU+=.TBD\\65PFH3N4ZNT$% );V\B "8C,J$AB
M(^+.<GUI:_\ Q34_]D<?!=RW?C/W>_6^DGV38V.K6:\,)G>X_:LMANG9([RG
MRQ&X1\8\(G^3EW^N*^J/\PKB/2/JC\+EF.?CZO*H.)>5RC_9&82I9+=.+RQ.
M4T>ZZ7:MWJLU=%L985K(]5!0LA'!/"MGN:^7A<PDX#*LQ%-;),B!-"UD:@B4
MQ$(@H74""Z *5,CY @=HQCE'8Y0YY2 [S/E/F:%#,Q'O2Q@"$Q)3 B6LQ$%,
MQI],1Q4R <O\@/[T$';/%\MA7J7%%;K/)+*X689"=0]R+8,))H1+(&0W[9CC
MDO",#E'F+"0VW&2LAEK%>(L+A]J'8RK452=:B.CV+W_?*[&!&_WAD(^/'+UZ
MSR:2:&<4BL"^IU:KHFZENZ'.#K!28Y3-DVE,7^011/RA+2L*Y=E+:8B%9/*W
M<FJ!C8N%W#%@=)>D$I6W3IK..H ^4O'^7X2N73&TK)4:L;&+LMN&)5EB(5:]
M,0*!]VPM!%OA[R=8\L1K$3_2<G<O^W+NI+-B:=K'S8@31 ])S6;X8#XGJ#()
M+RC$^&L3$ZQQ5K*IUTUD *U)4M0"(B,0*P%8^ 0(Z[1B/"(CP\(B/Z;,+ZF+
MR,::EV%V ]/E379IXSZ>.GT<$,B4B7A(S(S'T3$Z3Z?@G*N-[[("PPW)K[6Z
MZKTZBGURT(3UF1VGXZ1X^D%P "L8 !@1C72!B(B-9UGPC2/6?^;O.M.$9&+<
M;ONW7761V_<R*J_(,1N'U\VZ9UGY.D?@>!QAY&VOW<L2BS4[CS*B(4QL[MPL
M^7$B!^41+Z)CQB.$J!"EI6,"M0"L(B(B($!@1\!B(](CTB(^B/P[FC^S^H/^
M(XGU_DY1[(.<>7[&3D QR/:O=&UO06/4Q=D$;G2:A#5\KB-S0W3H,;IG;.:Y
MFO!ELB&,N0- +UL*FU51P]L-EL(D&R#98'1Z>UDL/?'FW%KNGXT9S_WN_P#K
M:G_['X^#;G!E;-VSS^22%.<98%4M[&J/7FW1D(ZA16U+I"[R;YUC6=L[=1_D
MY=_KBOJC_,*XCTCZH_"L?0?=<  N>F4F)..&0@9%<GH;1$H&9\L1'SR0Q\_"
M\O6SW,;N8Z0M5WT5Q57LPL;\%6BI5B&5EL<J)-E754"9[P)<SI)R,<^T*6)R
M7(^6H5F#-Q.<L\QFHFV"BTZC0Z'<"UAJHG-NS9B%AVPD4DN!+IB TS".3N>A
MDQ@G<I\SI4,E&K7,Q8P"EQZFTY^0L=2+YHGCX,;"**L([(6J]#'HQ=$;[KKE
MU4I*<6Q2!<]T@*)FS(K&"8N380K\Q3 \<H+R^-Y*3DV5K86)Y\73LGVA;AQ<
MXFM8<3%L5"UUQ,)D[6@D$^7JP.O'+=W%Y0&(SEFL&$=M[AURRNC43TY>:NXN
MK:GH]2VM0J]]'4;M5X[Y&<6@:UWFA:-LT/C9FYQ3%E+$.Q?56-%U9\Z]U78D
M8E-F#;#@T/JGKK_+<J*NU;-1P;U6J[J[!DC""6]9+,9()@QU$IC49@H]1F)X
MYFPS,'E[-,@%:C8Y]0!EQ0-,K3U5XW.$3*8%6F[5D%IKU"G7^CK5+5PY53K6
M+3!&62NLECS@(D1DY!0D4#!$,26FFI#&NLQQR]B%87&IIK6(2'4W[#<P9W/>
MT=)=YO[6=?"/&?GB(_IRC<)#](S'^^-.,M&W*9(?R;]R/]UAD?@=6LVX\*Z8
MW-9NVQH4_( CGP 2+Y(SZ1/^[C$XQ.+0:4@(0;B;,"QK(U(%AZMF9U]W'A'A
M_OG_ )O<Z4Q=C>[D8DJ7R"W'$CW%BJLM(CR%K$:3O]/Q?'\" #84 L2,I]!
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MEJYA/J;[+#F:*]M8<D/5UZC@W4=RP^X?,V8_%]]&-MF]N7J-*3L8?,W\-89
MA"C?CR!;C1(Z22".9E1L!;"'Y2P].(]?'TXSJTXKEBUS;M_T7BPI(OK5,G;.
MW9LU*NY8L**^G4OUY*#LIF!@]J]VT3!9VL9?O5F+$JM1[E(.?NJP:UOD55$P
M)P]Q&G:"]?,9K'\;PQSFV:P&X&@W08,'+Z31/I@1B:X^20E,P0Z>4HF/FX^G
M_HQN+_HC'K,_1'^,^''KXQZ?R7]OQ8SY5/#-Q[)]DG$[Y'6^'?Z5]3AVZINB
M=:[NG'GCI_+XH]UTB[LX-G4G28&!\FT-(T@%_C;OF_V_1QZ\5C4MXRZ)(!UW
M@/RO$"V_C#\\Q/K'AQ\(4,QM'&7*$P@;0TRF/OASUTW6SNAL,&/  UVSX3'A
MX3.ND_1Z>O\ AQK$^G&D_1Z>O^' 1OG:.DSX_J\?FXNGV&>O<N6!(<CCU*=8
MC31>QR:KPV[]C]>G;5\M 1ZZ3,;9+YIGYH]9^:/KG^X*Z(=O*6H7"]OE:S81
M[M?O<:>;;IJ?II$QQD[?9<SU<#TGKE_*R,]$RN.@T&9!E.'+:R>L74V^78/0
MD(W"6[6.,7"7<F<ZU$1OR%OE_(5U("=[[5AM'++K)KH$B8UID8+!:UR9F8B(
MD11QR!D,%AL<I'-WW#40@*IU+[QQKQRRD4P(IZ]FFR(A:K*^D3(G>!ZHW!)#
M9I\T%RCR'7QDE,U6<Q?&M 5)>V:;LNME4"'LVG3DZ46MA3V4LB=XL+9U YEI
MV[_//(5BHU*L;1Y&Q]"_D7:QCL9=37SFZCD;HK:JG<&6UTS6>8NAKT 0Q+0U
MOY&UGLCZ.K<II=7NX7#Y!(5LA3R5<%K)SC6)N9O>>1:I3<A962K"YZ0[0!/]
M[Y!+LYBL=B[T2S&8K(!EZ\M&45JCZ\V?NMEI @R5IBW8)D/82!&2DQ\@[>97
MT;W).<Y0H@3G9M>&7W*RZN-_T-DJU[>ZTMK'K6X5'VA*3/7.8AD"&LQD<E\6
MN6D91,F%C-\QJY04U(K=(EDJ!V FP%B>DNH)H@FO4)V1\(!9#,QQ7Y;^-&'N
M4D=O',MOM]<A8<]=,NA:EL>2N+8C2A7E/DH^+=)+UET<G9B]EZ=B0-@]2PVF
MXGH2L10:JO4-DK ^FD>IJ;O A\?'PCBCAJ>7S <NI6#:;=WQSGK.[7+[*IWN
M7>RM)(GH[!JY[GH3C>HR.FWO UX=@\ID*.9I8&Q4I7<)SCD<-6;;DY2K XU,
MJ31'[FN2TP::2%[U%9,1+J69^26/M1=IJM#NT;U--\#!>1IK\8&9'\7PTGT_
MQ_YE<T?V?U!_Q'$^O]!R[_7%?5'^85Q'I'U1^$\U&5+X-J;4#H>1LW,;:-9=
M$YJ6%YF&PXH\UA.B@W5B\K-!B?DQQBA@,9CA'T&A4B-(T\(KKB/#YO#YOFX%
M=<\QS!S*U2K&1L81\5*K5B3KUZLBF%.F61,2Z/<S4!0V7+Z5:)&2\JXUY@;=
MJ\@<T9VW6+&7TAR^ZHA=D'.KE>RU=5M"+U;[S"0;"C,! ;(>6!@?"&MD.549
M9%87%'-*Z%OS@HTX[V=-FQ8EI#N>M<Z:T@&29,[A\8TXNV*=_)<KMPMGK*K)
MR/MQ:DMIBICJ*8J"Z&PGOO?A8@#4+840R<[(8,S\(S4G\+N)HE541V.2J E9
M*!D@2WF:\F0VRO4P&?>;.I$%/AI'RN,Y3?AN<7IZYNIY;I]HJ-5(J]ABU$_I
MHAC!]^UNX_*CSQO]Y,ZP(D4Z#&L^O_MUXYNL#1L#G*58&9WE#7XTK40U;<^W
MPK4\'W&5V?=FE,RE/;]]VZHFNWMMW%G(TL?RT7-2E+*<KS#*KM< E)+R-Z@6
M1LRVU"9*VT=D RQT(A\^\ZFL;.*T/W--VX8/9L7)P<!M@H+329CS>$SX1_MX
MYJ6AOP(<XKM6>T064Q>^QT3?T],MRU(^Z7,&6XX$/"?+NW3X1/'-V0MXH?@Q
M53ZJ4Y7*91-A]>S-;O07E\6K2RI?F<*8L,6 /F8VD<!H)SQ?.IRYRI;S+TJM
MY&)J6JV-)<+.W7NNI5^K[0V6%IVPU[9!@=0^C(R(RT2X]CR_E/-VAL].S2Y?
MSF0ET*]\?:)L$(=;JB8_B;3U.0VCH$Z1IS):E_P0W\G4&<=D,-BN4X*]6/;<
MMLOW\96<Z;2H2]1D(MEDR;2;#V 1>)25$5Y3DWFEXK"K:QN-S>07:@88_P"X
M\4!@D&Q"F)]XSJ"8E/3,=T!,SK',EPG?!+D,E5W8_(XK%\JZWJYR-RRR[D,;
M7<Z;2X2]9F,,ZL[VDV'&)%XE)94;.9Y2LW\/6[:SC,@ZWD>W:M+482EC6.MW
M)L3VTN!;&J^XD]1["&#6L]/*NVJUR%5JA8)>9RW7]CWXADW+W89F69#[IT$Z
MO;51Z/W395UU3TT[X\G%;NJ'+E)2:\YK,V,G6IV@:X*KJ5!U 1?DN\L=8+/;
M6@B.R6R'.)LM H@9*>:7LQ%CX/0G<#\I\;/:*0/9N[(*\U.X8O>%S0&;T[M>
MW](\=>/A*+J<N<N'I\NOB#T^C=1O3_A]/&<<RAFDX$*8_P"AWH[ZZ#5JF\O(
M#5N!UD0,S,5UF:1&76-XZZ0O=LX=DZG+O/V"Q<M]MHS.,=G&5V@VLBF=M.7_
M -&=%H6E61I33 @LQT@.9'8A<KB9:P://W-'+\J%]:F[EI0LG0%)'(8Q=AIK
MJ2)B/BV9,5G[X@W3,27AM;RMS>G&6P]J)S,W<[5)Q0L*]*X-X:U,$3W<=)/9
M[E^9&F_^KKV^;FD2_P#"OS/@3:4VDT<=+,W.LV6B_&8,AW+UENB!L@(Q-LM8
MKAIMUB YEA6!7R6+ZRIKV:-R+-J! >^FO1H=.Q92 M8PS8WJQ#I,UFPIW3.X
MN*]=JLI8)-YV2Q<HB*UP^HD7,T1)Z5'--RI6R'JW&/FV2<3M9&OX</RH_P#;
M\W'.'_SRN6__ +CF'_\ D_9XR>5/E[EQ;*Z)99SU++*7<4[M+&*;3DT)MJ8(
M&QS0*S#U],ZQJ)$0+-2@@Y>PE;G;&T\;=A'=+JU\H_)6ZH9%]MPH37:3H=*V
M2U[+9/8X[##D]VZ"DY./@^NY/*X/'^]LBVZQJ#DK9,)V[(6ZX"TB(-\1'EB&
M3I SMU@>*%6MG.8D<NU%JFF$VJ.:M=$86G,XY5IMI3J+85WS>HBO$VUL8HI8
M)@UG1GCEW_W(>3\CEOZHW&X#/9N(_K#&%BCL@*(?[DERS2)%^TY3I&BSTXQK
MIL8['V"UW/I57%N+?.K4 <ZE/B4ZSXE/KZ_WN_+H;@*V'"BM3EM;-FZ)#OMU
MVS;WU7!"!DDE%@!(#>P"A(ZAZ;+=26U&5ZQ]F10N :D=LA"S$M!@"5X2(R&D
M%&D%/S>$T%@&&MX?*Z946.?=HNO#UXQN1.J%6MD:J7=QT[M..H2+*F)>/4,0
M:O69D.^IXM^-HW[2+;^ELS5=K:]JKTK$O+9 -%\]=9'4+;9#1<ENW 73XH"C
M&X_(4ZM=2CO5[:!<@ KE6.R@%#9&%CYC3("41!K*9B-##2)XY7M,Y>L(L,-E
MYH=7N&$PDLM[@L KK']T$70%T"O?U-!#0=L3X9A5ZU7R*,7DK6*;D^9+?,;+
ME-C5-"+@- \872?6-P"1+;-B6"+"6/W/$Q!"A(5U"E8B(!NT@!@!C<4E.@CX
M1XS,S],^/_,KFC^S^H/^(XGU_H.7?ZXKZH_S"N(](^J/PDG+R_+]SENPP*V[
M'Y <=8(A2N,E9!ZJW?-.6?<0E;,K'01UX (E>Z1F"Q";-5*\9>Z2SH?<'=CU
M HO"FH5192]T#+*[S NW=TPAHR'D&9F(Q=V+/QN8E3:U(N3\S.#3D Z.2L9<
M45QKU;*Q(E-!]B+'314GN6IZ6SS[^+..*]\'_,V%5,^V^8$<ML)4Z]O6LT,D
MF_=4P! [:8B.L"PE3F00P+9#0CXQ+SHX8,E3&&O;G!QKJ38D[2J9U5O9D2K*
MD#"F!@*IMD<J%DRL@UTGC.*1E>8>1WXYHQVJL].;.TP(16?9QE>$BHD0SH@;
MP>$1;D3+18AN/?QSG?KY/X5\-G*A;\:KE?'8UEB) @"R',EJX8DU9L0,"A@F
M4$V&1'FD-FA3SHX;',V(M5Q.PA'M#J,1$- >KCZJPU,)D(U.)&-Q1K,3$:S&
MG'+^110M'8>+-C*I+B!@-\$;$G&Z#,(C2 G7QF=?FX2]W+?.N7S&ZK;I6NP[
M1U>2>$]'$S5?U&:H5.C7[1Z;2TD9@]"C;.>QJFMLYG%$QF.RF0=<R-.S(EF1
MYANDZU;?1KUPE$<LPB5JK,>UEV+4D#",-I<(?#]VBG*V[?OP;-=VOIXSKIIY
MOHUCCFP!M_!/S'RW7<AN3REK%VZRP9!QTUY/!O,3 -UCJ"NDZ2A:&0.D:E$;
MI'"(7,8^;A]%=*P+3'<*W$N;/49"X;&TCVAY==L:R.LZ3KQD@7S1RWS174<4
M\JK.,H85=TAKU[.+IWJ#UVWB/<6'&U$VM'U!BN; #: @+)X1=@.3.9?N>T<N
MY2YD3(K5N).]%B.L^-WNT!IJ;/';!#X>/"<:?,'P99?ENK8J5K^7QO*?:'>=
M*:_^C[E:^_>2P<[[RDH'IH9YR"#V#,G& MJ1RGS=2/4;-["Y^LA9;8(SM8U*
ME:!)0PMS(VQL$YF? 1*?#BU0=?\ @QS^"7(*R%JCRHM 6)((,J.1JOL;1$#<
M6Q:BF=B2D=8WP$:S')SJ]NKEL7D%VZ-7/4;^ >UX!5:E&475KMLB;I):X6LC
M(7&MP 03))9 S' X:,/ERY>JMBS@N4M/8-_?UGW_ &]5[[*=W:6I5.UVMQI)
M1V::W0 >G8ZS8DYSFT^3<>BF4,N-YRJCD$E,'*,*>+:%JZ*U>]5*F[1BRZ)J
M!KHSS:<<ST(LUN0BQ\FU/+'QI[\B\\G[:97BKV\H A+:0G#>MV^FGN^K,3QS
MW,W.7>7$U .PU5/$=5:1ZIKD*-L3@Q7N(" B&"@HC;,Q$^,QQS-CSL<TOYPQ
MOOD\RNH%>JEJRSCEX.K4QPRY" D:G<B#G*EUEXN 89'2B"#A3)=DJE-(R*G)
MDVVGCI72T5N,EL<,R*YGIB(B0R6XQB?E1ID'"SX3>9,D G-'+V^51JV8B)1$
M4\76JV#8Z)E/36W7>2S9L@2W[2C;QSA:&QSQR_;KJ<^MC^7UT'V$A#4]=4Y@
M9@6@4KTGK+D=Y <P8SLC<.O,R(=\,/,6?W=3#9*OB*BK%>=^Z0QV 2[IMTFJ
M1#-2Q'E<>A#H0^!P-')92AD["W#CSQKGNC'V$Q8(Z]1/7E/M=I&"%6&K) #T
M(E;']81T'9Q3QU:IGKK<0%\<$540H^UQ7&4WS%27]UVP#3T[@;/1Z,Z]#H[X
MW]3\/KVBK@X!@9AW3UUB9F.G,S&FA1]/CZ_[.,LJ,O=KWWS(.K8U.+6*O*N:
MR6L<)G!PPI?),F"*#$-NFBXGQG'W#H8O(8@!$JN4JMI63*)FP"7A969(*"!8
MM@;3-DL6P=T!J,Q$P3*L325C@F>U08&LCG[HF5*E ;Y@>GIT])+:$>?TT'PX
MIV"HX;+854"5;+T;%![&1,O!5A5I1$HAD $XBV<C)J8,3 :A.DP6(*<-%/MM
M#[)(H7U_-N$4=OJ>SI:SL\?+MC=XZ:>'#D#-;LDR7;>89)NG7V,@^IXC&S?J
MPMGETTTW:^.JEPE2U#K(J6"QDO70!@8UTB(UTCQTB/J_\1'-']G]0?\ $<3Z
M_P!!R[_7%?5'^85Q'I'U1^%%Y_ _/'IH7F\(](\?HXB9'T\/J\.!\A$8^4BG
M4B'P(I\?$ICQF?&?&?IGZ> B%Q,+C9!:Q,!Y8F)]8G33772->!& F9&(&9]9
M&-)GZYCU]9_W_P D^/KX_7_(7G&!/S#'H)>88UG7PB?#U\?KXCPC;'@,>D1Z
M1\WIZ>G&D1Z1_+'EG4?+/TQX3X_5Q-ZG7Y?RF.2</L9;$93#'/3-4U@R2W!W
M>I!(OZ.H3V\,7+-?OH;9XQ,6ZR J-1*1H)15KVH<!3;!*Y3+NFN9*ON$!/IF
M93'5V[IVS,P(CKI$1K&DZ1$:Q/K$_3$_1Q\VGS?1\W$1 ^D1'U>''SS/SSZS
M\\_7QK.DCKX%$P4?,43X3$Q\\3\\3Z\;8@.G$1"Y]0T\D^.[Y/IZ^/IZ^/&D
M:1'S1$1$?-$1Z1'T1'S<01#$C$S E&A1$S$3'T3'SQXSZ_3P/E^3Y?G\OAX_
M[./HGYX])^CZN)B)\9\9^F>"\VF[S:3!1N\=)CTF-?28^:>/6)&?$2TW1\TZ
M>,:QZ3I/C&O'IZ>'_BNYH_L_J#_B.)]?Z#EW^N*^J/\ ,*XCTCZH_N45L9X
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MV7EO?8QU)[CVB.]KJRF,+:$" [C*9VB(C'H,1'A_+C:L7+U9!SHLWI%Q:3,
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M>AIZ>'JS[@M/=]3T9Z[H\/#CF/(.P_.&%HT]C5-^#S'76U[&\E,LGE'I.\8
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MRKB/^3\I3!A.+OZU9EKO;IZXXMN1B*];HBO08)3-[_'C"-HX6S%KEM_<P^A
M70R;$N,+C6*98A(T)5M0/21"^J4MB29!ZZA,<ZT_BPKX/IKEU6<U7LK6R?6G
MJ E=+(XVJF:.P:Y+,DW62V;'<1+1"1$!B1(>7$IS6'RV-:V:B\:/?A>,>X]H
M.1;%W:"A$+[..LGI=9D/\&[M?)KS#15F^6;&2MDQ;\)C,S<JC7D14QG28W;8
M%@-,@W4UQHLU%H1^;61D<3B!PO)\\Q=3K4VQ3R%P0.&-79R04%DI<=-2A!9O
M5Y&OE@CNU,YVQ/M90VZB'UKE2C>N5J%+/VTBCEZU;LE #7K94V=%[0+K0U2H
M-H]I;T I07%V[./R%;'6:=\"O,N#0M]OMHY *0]1EFB]A!-JL:R6U3D@<$MJ
MC+:)Q/#V37S=W!L2Z&XY"[5V_P!/3&5ZI*K..TZT4P2J]9=H"LN:H%I@&3):
M#$EW9S9%(4,BRL9-V99=63PYJ"))5D;\%TRK7(V]DZ(D;'47M^7'&0NU:5M=
M1#U9B6*!LNPC5Y"NJ#8:]KF 0],PVP;(VSM!JBU\^G'.S.KRG@!Z;5]7VKYF
MCL%>S)59][.L[-^GD]=TS'%.QVF/PD/1877MCC<<B^2]N/.Z](]*K%HY$">0
M#+H2&YLICJ"$QP1]/(*Q[P.N=G?V-BP/1J9'HIZ]GV>T])N=G$P%OH@7;L*!
M9IKKQ4<VW>LXZ*&1KVJ_6,0M525-RFIPH')4AU)EC&V&%I6N0$*;H41I,:<9
M.S[-=<2NO:RPXY<.OV<,KOZM-1(BS#+3H((KKE74F#= #[A\Z[5R7&9SE/"8
MW'YBR+GXW(KJ2%RI"F5J]JVAMH<7;L,:I"LHI"B:^E#38"Y$XW!,E#;"J66I
M8VX45.^MUJU"_9D48V\QIH%DT[39'N0J,L+5=E('-=D[)&9D=?A&R'1YZY=R
M/8Y%WL/EBOB>P16ZF2S'1;FZ_M/!5=\>T,0WN>NF[O5OKU[+>G'2T+-.3A!>
M#6JNY&M&Y^$QK!LYQ0RB; &>-*5/ &ATH41[8,K-:(\'#/%*YWJ%O[6Y4ZBE
M-Z-U/0>'5#?TV+W%M:KY+@UG8?AK/_B?18;7+<IC%S/KTV$&OA,1K(_1K/\
MOGZ>.TK^ZCHIT2T6KCI!H!C,S!!X>0XF9F"'QB9GCFG&NYGCE3)8PI;D.3:M
MU*\7Y0]I3EZM&BW2]89731[-51MCY%F+.G1B5SM(JO,N+K4LN0V?])/Q5^KC
M:T*L@9W6J&:9KMPB5UF$\>F#3E<)GWA,&./9.;Y@^#SGJH*66.8>8_BST*+K
M:&-/V1F^HW?D7O"N6VBGK#UFJT&(0O><0/'+^;QD\E\Y/BS[K)83F+E^D71L
M>^R]S%).M4TZ6Y?4'QZ[8"L'X[AGC&7*M'X(<EA;10.7O]GV-60,Y=VO,[+=
MG2P '75TZQBSWK@W_(#<?EXSI]\CE/)U$P%&AR9@N7;F6"1%J\U5!UBQA^C,
M+ML %&-GNEP=$R\H-)GIR#5WY#G7F6<Y8S(L5A+62;959%M%&,IWUP9-LO8^
MYU$).8%2]ZA0*X$]0XQ-^I8R&?6ENX[.;RN23&Q@[Z;GK%;M2"('=,Q[LYAL
M?C!'%BG-SDCG1;DA9(N6LN&)%_39TGLQV3$^VZFL52-_2DC]U!$(G)>7=&+$
M_P#P)Y.C'];2[#UV*UTVNKERY#@WZ].=NPO,)R):>69UCCF++XYW(/(F+4Z&
M7<!SM2SF6K=)PQ6Q=:QG7/L=0E0E^U=NO/1K&ZP74T%)2)P.?KW#S/*W.M"#
M+!T^5<>MF36T4'5.VO( I ((POR,QD:P[E5]FCY@ML"W8=G'4,-S=<0E$X/,
M<HY[#X3/K3T"RN3M5-@T)Q\*F]3CN*]Q77N0NM/9PR6"#DS-&"YB^"S,\K84
M>^S]G%<FI10UBMO;C[E>U<'NK?0I#T45;#-3L"+.GM5)F0"67YHPMK"\L-J6
M8NUJ7PD86[;LDBTF5IK5&$\.D^O#&""R%GN]^[?M$"*)XY@>L.8Z'.A7F3RY
M>[KLV['=/&=K03B;';5M9M1WM[RNZ=.OX^\/JK][QS+E,<[G',#50ID97X+L
MA@*%>%RL+N:O91\5:);T"">YU$)LV("HN)]\X8CC(XNRO#7N6<ID7<IG9[7N
ML96@\A5CHV@R".H&->NF_6)78#S>Z99*?OH'$WJ]*K@^6,=D+D4KR.7\+-'/
M]JRQ=NX-50T5D1T)*Q5J66B=V*3;4PAH^=.^89QAC"0<JMD&YF@KI]GFF@ZN
M>0WRTK&M.T1VJW:.W5/?%/6A4-7HN1CCFS&9#F#EBA4PE;O[=?(U6.1UDU=B
ME8^RMC.K;8E9;6.4&T2DIW[AB1$IA'-F$7ALWBHM[\CG,=8Q]>MT+8[;#D6J
MU<>MVTHGJE:7.IL4"]?.<1N(;-$\#R(?,3"ZS,77Q:#Q^D+ZAN/'5"^ZA-T#
MTYMR7@AD'T](F-^X<I>MX/,VL7:4<8I$( <AW/N[<V$(>RN6.7#6+'1KQ*3(
M@9T9G3WHCP=)',7PE<K,Y8M=O@AP;*V<&F@J57V\JKG'6BLT3*E-ZS,,H0=Z
M$M%FBIAY="8#&YKVC=93BKTI!/5@^MOW>90[=O2#3[[Z[OF]/'PYGLHY/Y9=
M9S:Q4&;32=CW3'6* 19J&Z1[8+1AN&ZB"ZG0F8GT+0H"_@7.Y;=DK7,5KL*&
M08[&U6(L.3:YDJT#?30L.[GL;3DR2PRIHV5AU@F>.SBSETY?E_$;%1>LX;'4
MU9'-N*9N<H6'JJ))5*;"HLVO:[:[<=99BGB'23#+,L001/*;T$'--!N7=S+F
M\CRAFZ5$+RK0N?%N*R:U#N[I6%*0RWK&C7 @">;3@1W%.1Q=E>&O\LY7(NY3
M.SVO=8RO!Y"K'1M!D$=0,:]=-^L2NP'F]TRS,_?0.)YSJK1R)RA@0=WEY5/
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M\\1\W&)H3CJ2JQ%!&&_=(SJ/F:QD:3(!/H?CJ/K_ +_Z+(.!W+P8VI!1D(S
MW3*QIV?:]B:"$27,N[CK2,Q$AT^EKJ6_2.,)2O8^KV=HJI)3_5BKRZ63U&-:
M[KRP0'Y1C"NF,>77=K.D_P#B^4H2%C6GT:Z=O6=MEG3ZDR*_=C.\MQZ#Y8G;
MKN+2(X<5FLNM=?6Z>(O65TJ&2ZRS[JZR3&*_9ANLH\R;(]5P@KW&NZ(:O7F)
MB,%@RY@4WO\ 'T5UBSC-AU?9#+KZU6DO84.=?[BV\T;Z:3A72ZC=JS@HOY:_
MBZ]"]?Q/0QM_,U<$NYWZ6Z9"T!N!/;I6Q\Z(6;>I( CPV2X3F(E; :$,"=1+
M72=)CTF8GPF(GUB?F_F*( :LVKZRA8!,5OE?5""B37U!\P;QU'>/B.NL>,<<
MVEDL-DD%5O\ W%D:"LDFIVJ/N*+;[,KJ==G5;9[92A7USV=;Y9 ):Z_S,=3]
MH7:M/J=+N7I1U-G4V=9H*W;-P;MN_=IN'7336-=>.6+U;*\V<Q\MV:.X<#EK
M>+BWW3([GM&Y1,OZ"P7*>K- 3Z?7=LW[>H6V9/&6LA.7.G:N=TKV<5F/N="=
M&=RM4?>QW3H.[\;3S?)UB)_EI4IO=12#UN^3M:FW3NOE$_WYD"D=!02SWD^\
M^0'FXKW<A>R>0Q%#%]U=QKK2;2^]2G9-.P-9T[W""BVM,!]VP]=VH20Q)<8O
M=FZ.5Q\5O96>I=C[WK1>Z/<N8[Y'NJ;.I35M^6>WJ:^5H:3B66R]IHNO[AU#
M+W:'5Z2E:C5Z8?(5&V-2W%ZG/CIO*(C^:H@%BR8OJK$P)BMTAU @HDE[Q\P;
MQU'='B.NL>/'.J;F'##7L?=Z5?)A;L'4[=1] -M,T)Z[Y:;.CW,CU(!<LV[C
MCS>7^;2I3>ZBD'K=\G:U-NG=?*)_OS(%(Z"@EGO)]Y\@/-Q7NY"]D\AB*&+[
MJ[C76DVE]ZE.R:=@:SIWN$%%M:8#[MAZ[M0DAB2XHWF666:]BMVERIT>XK]:
M']/KP9J]Z "H]ZA@_));=VTM"C^9117NIM5>CT[DT;/;6^H9;+1:!79V^HJ+
MI$8SL,NF>S0_ ITPMF^=_.4;UGN9QMSM0+HI3XK=;4PM$C^/T1G23/;IX%/C
M,_S+*Y5AK^5K_=+,6JU?R-/[SVV%HU2LV\IW!S(NZ)1"NR0MEIF[>L#B-O%?
MF"S>P#^9Z&+[K#5NEUK?>K1MZUV<>OW#DA:+=:$U^6N6FW?.BY@^,9D%Y.HN
MTN-NZ!WAJ4]-DK6P@W$"]VWJ1&Z!TGUCZ(K)[FS7K[MG7>I._3=MZK!#=MU'
M=MW:Z:QKZ:QQ;R?:\PS@>COT9:#NNIM_JQ6AUZ'3+Y?;>G6\N_\ &V^9SK09
M:_333Z^*KS3BCF.X6OVA#D"RV7L\H[BIV+Y*OHXI[G;U5:!,1_,J5AM2Y?5V
M6.W9-%.R2[V]J(UJ/4W"%;N3+;W+9Z*?5GAP_-/HY6OBLEC^R8YMU,GW86-C
M*(238VH48EYM UZD1X[ADXCB[7*G@K.;GSQ5<X&U_ =$IIE;-_5U+73;LZ8J
M(OQHU^3QALJS+I.UV?;U"V]H_N!;W6A-6_W736U'0:O9[P?>:[@\L:S2K]Y<
MJU=_3[FPA'4V[]G6:*]VW4=VW=KMW#KIIK'KPK)5J7/F;Y5N4/:%? ^S=[^Z
M94[[VIAIR(^Z4!'6[8R$/"P[K;-T]."D.,PFWB^=58Z+O6Q>3Y4#F:M2[=:_
M9\W<LU":?<ZLL6^TKKZ7<,-?7UWD@3C6?Y*Y*!RC>GKJ%JR:GJ$KJK$HDU=0
M/,'4'4=X^8==T>,<<SW,KA_A+Y=PJ,AKA,_@BS_L[M*T=H-J,Z=>EW9BVV_M
M(HUQ[GJIE^S4TCN/?PNFO)XZXBF/9Y$1J0BYK-C0NKNL%V[26B>HI9CH<Z!U
M-P>88UP-I]W%5;-D^HYG7WGM -=EERQ\JQ$(T 1CP&/36?'6?YV6)6,IUG"S
MN;=B4EV6PD[*[5,+K]Q/466UB^ETM(.=V_P&/&<E?'.7.6YQ7^FJ#<>FW2[Y
M/NVY1(6* =SL[0^X4P"W+>8JUT=*RB8CG:_DJG*P\Q8W_0%C'\SQR9D<7[C*
M]Q?JXZW>MY3O7@0*ZIB%?LD(-(='JJM%#)#^2\QZ,E0JTJ_?XZQ0"Q>RG5"K
M[.O%%C?C^R;$OM].5UX[M)0DNYUB/<GKQCSK!;45RKWE>-^^OUV5^I[LX'WJ
MO..T]I^'KMVSX3/#O:N)^$7/\J6LI[2IXO'5GJ/LJ]/<VQ5P]K=M7U&QLB\U
M>TK#!+Y>@^40_G4*_=W:E:?1]JNB?J<T5S\X_3^5'UQZ\82A8YPSW,&,IN^+
M:>7,CE<*9=,,Q[1=B+BJY9#1IUBJ=V-D9[6&/&OT/!K);,CRG?M9/E^A=NMZ
MUIW==5NQ:]W3NV5!Y% M<:+6(^48UTUG69F9_DYC?\7T5W;>[Z^/IW]N[H;>
MZ;*NEKH[7IZ;M^D;O38/K_+>J1?P69LXR?9=S#X[(YDG:=]UZ^/IFR:G3L$"
ME=5IK+KP+3#IZ=(Q.8XY<N6+^&IV[;.K8;W'49L -VRT]8^58@$:  QX#&NF
ML^.L\404]TU6!J=T)IUG[BCLK-@@6F]TQF(L]M,R?;&0K=\DBCUXMKR>)YK;
MAGY+OZP;-I=G7J[MV.&U/@$L9&C&1'BWQV?06V/Z$)&"&2'>,%$D&LCN&)\1
MW1XQK'AK'C'KQS8@PY6OY_#-]F'A0H3;3TXN]Z63NU::_>6ITK]OJXO=I;U>
MIM+I[1+^8E1O8*@\2+73T^89*?68CTB?GXYEW*NT,!BS[*V>'JYNUF-L6=")
MKZ3\3[/L:K^^0NUWZW:>7H@K:4EQB\6U^.R-A]SJ-QE8[!%VXAW/ELN@- 9
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M( =\"8ZBRL*]&&R>,3K[3QNFO]?J?7_6%\)6OF3*_"3B)?05EE9_I8;)WFB
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MR6,L=Q 6%ID1@1D2R6"5'PT?!S2?D<G<3>Y)BV;[ML;#*^ZCS4<5JK#3M53
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M!<^YFK?LJQN(Q2+N"]DVEA4<U6'LLMPWI@U# &[3B)BFU91).AI0V=1NJ?\
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M8B197$HZ"BGS 7B"^EO"9&1"2V\-E!X?+4\BN/8MKL?:=@P#97Z%J&TM6O\
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MF/3=-8!%" ";"ZA*V]X1-)FA;>,O-C#<R\AG5Z-C 7_C1VB;V]M^]VM!4/\
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MBI &%$8].6QENN^GF.DFJ!+37]GUCVKZ1I >LV6$6Q91&XH(BVZS.LZ\6\4
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M.HD-Q-8=]AM28L+0&ASO<:=XJ'13)W'(QHL_R"T0U=IQ5ZK LV "6&A!BYP
M)0!&2ER1B F0A)3&D$4#,ZS'"+-:RSHUK";#8( E2&@UFYOWH=BR(MS/Q(TU
M/\77A1"]QUD3#K"VL0Q"IACEO3KUDFH-3%JM)ZBR&##2=T1IQ6M5KCYK4["+
M5F!WS7K-6]\#J [I4HB9 [F!&NW34PCU*-9>F L,ERH"F\ZMLY8.RK960@RO
M8+71+P,P$TLD6"1",C$S'!V:RC<MMA"V5URZP!M6!H2(P9-<)%$J7 $)29Q
MP)06NDQQ4F,A&M"8NQH):U/NF-IQ) 7N=_@8B4C/H41,QKI/ 7Z+4=TN[496
MAO0FP%A)HAVSJ='JB<KZO3F#Z>[?LG=IIX\,MU4J0]MFNI%GJ=LYCE@JQT2@
M'=!A% -Z1S LV26PI@2TGB%-E3'0LY2H3-K8 NDH5CO,F,TV@(#YCDIB!'QG
M2.*C%WS8JB876*V]5=0HL&O?!$'4!,F0;Q R'=$;H$ICP&>+%ZE4@RM6ZM85
M6"J,FQ84F%V@UDZQRPQ@+ 0);DEHP=LZCX3QS-8.ER'S#E<><!FO]$_%U@;7
M-M?Z917R_853ABLAT*A'%K:BQV@^\GI%$''+&2;D,53*Y9!N1[:N5M?N5O!W
M;HFQU:ZH#I$+S*##IATSG9H.D#P2FBKKDLQ1M,^L0%"MJ]>H74F-FT-)WSKH
M.DZZ<4V+R#810,+SY(PA-,HLMDUA+&!"TR9R0!$F8Z:B$24Z1X\=W5V=7N:_
M2G71G67L\-=?/NV^&DZ^/S3]'%<#M[9J@5F#^1-<9=N\N_R]/=N\GF\/Q?'T
MXYT]@9+"T\P=JB_F.QDE=VP+XR]BT(NI1$T5/A*XA:*@P05ADM!F=Q-*3QL2
M5&C Q,SV=;PB-9^\!\T<7F+Q; 5DV!CFM@94J\0U&,@Y,0D L2LC@R6P1VQ.
MZ0.(\1G32>W*YI/: *S.UI]SB+I@4D3_ +V(M*8A<R6AS,0.NO$7J1&M0W*I
M-<P%)7%A4FUK)VK6L(/<;#+R@ Q)%/A$3/%PPQX@=\QH@S=TRN%%83V2,'L)
MVR"VR806FNDF.ORHXL7*E04LM6JU8+*EV*YV'J2+T.B94Y),(8:IL"4K8$D!
MP,R,SI/!, 7G5(P&RO;U*Y%$/#<'4'>J9Z@[E^<=1C4/-'AX\62&GTYN$-2&
M@+%39F$=19[MC%]7;O ]I;2'42VEI,Z3PUZ$)58>Y246.K*'M8"TNA);72IA
MS ,Z13 MV3/3*="TGBQ8KU(1-IZ:T6JZKE:;#03%BH_7HVD2R1ZM=VTND]>Y
M;-)V%.D\%759Q5QRC&E8QM2T]KRGK=W,@YJ?=L(%H[>%;/+#(9NW''AI->S>
MH93'8>_:]I/SE3VU3=*$TCKT;";#$U%UE"7>K5V;9B]O"6PR=0B%>/P@Y$,/
MC\96P=;1F3SU'#(YI2Z;5-DY"O<\R:S0L47G3>,020L;FG38!&O<T1YC<W&<
M@V>8T%I>Y7I81>5\H_\ N0V\I;HXP[>AP:L1TW2^YV]=%A9=;MXZ8K!G&<#,
MX;&8;,CD3NKO\W8[EMV/''H5,*M5VVF6^YB''I$*Z/1%0?*ZD6!F-L\V,3@:
MG*B%JB+7-=*Q8[\FR$8DZ%;'W&B59G45;FW%LJWF*KT)CJ")E, -VGE\?GT+
M#-^U<4>/5+ 3C:RU!;*Z4$96U$\X(:P:2GJ".UD,TB8B9RM<<GRCF4V0EWL[
MV?V,1N&4=WDUE:\%2$MZG3'[[OV:>3;X\8 T8^I-:RU54SMR-=5A@I8T26E:
MND#2@V=20(0V[M\C,1,S$\$)!7FV0R-4=-UDHF*XZGTXU=/NXU9[N-2\3\OR
MO#BA,95C%8N8R35;^JNA/>,5TY 3Z@5^H0;"8L3W1&V3")TDHU[RI 0R;5>
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M5-\[ZZ!>"EZ0.T;,[G1O"!.=\_E%,C^)MXQV$QF))QT*W0*Q:===/6L-WV;
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MBZ-^U4.T_5>T:R"M%))8ZK8(XKRIDR"=L[I$8WQ(C@<K[6H*LE*^?U\P*!@
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MRPJ&!#YB"$Q@B\H+%YIF:RTTL 3*J0H]SD#M+3*"IC96JV',/>$LY%J9U]U
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MJ+IW*5%XIK5Z:'LK"RRBK5*"2A#&[X4D9B=% ,+B#9M$=WBSCBMB"7Y+*LJ
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MM&M:B EI7+1(12!!N!>W:)$4CI,^,8+,=CBQ3+%G+T)KV:_:YILWT!W9F;'
MDMB1?'(U8,X_);&#(EO+6,4L+*+%:U>I#7Y=M6D\:]0A8'&*S0"])77'_-@B
M8A7V:QY>,F%?*73R#JE1%TS2R;-6N"W;D*!2]'%R-],+"8]>L$ R,QMB(/%"
M^TBS<OY+(=M+YKU[]J+55,/'88*2U<\81$!M$"'S4K779'BI<*G+R!-=INK-
MKB;UR9U29MD;=0H(91=1(ZUWQK*YF9B)\7Z*\IK[18Z]$_9;,;,?U/L>#/\
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MXLC%L]]CWA;C/7ZOJ9.ISH&V/.8_5'V:>&8C'-:MS*^YJMNPN5\:;"DQ\H9
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M/P_Q^.^^Z/P_Q^.^^Z/P_P ?COONC\/\?COONC\/\?COONC\/\?COONC\/\
M'X[[[H_#_'X[[[H_#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^
MZ/P_Q^.^^Z/P_P ?COONC\/\?COONC\/\?COONC\/\?COONC\/\ 'X[[[H_#
M_'X[[[H_#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.^
M^Z/P_P ?COONC\/\?COONC\/\?COONC\/\?COONC\/\ 'X[[[H_#_'X[[[H_
M#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_P ?
MCOONC\/\?COONC\/\?COONC\/\?COONC\/\ 'X[[[H_#_'X[[[H_#_'X[[[H
M_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_P ?COONC\/\
M?COONC\/\?COONC\/\?COONC\/\ 'X[[[H_#_'X[[[H_#_'X[[[H_#_'X[[[
MH_#_ !^.^^Z/P_Q^.^^Z/P_Q^'6.2--/^_E]\_+^A2[CG_O\I^^/GX[[[H_#
M_'X[[[H_#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.^
M^Z/P_P ?COONC\/\?COONC\/\?COONC\/\?COONC\/\ 'X[[[H_#_'X[[[H_
M#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_P ?
MCOONC\/\?COONC\/\?COONC\/\?COONC\/\ 'X[[[H_#_'X[[[H_#_'X[[[H
M_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_P ?COONC\/\
M?COONC\/\?COONC\/\?COONC\/\ 'X[[[H_#_'X[[[H_#_'X[[[H_#_'X[[[
MH_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_P ?COONC\/\?COONC\/
M\?COONC\/\?COONC\/\ 'X[[[H_#_'X[[[H_#_'X[[[H_#_'X[[[H_#_ !^.
M^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_P ?COONC\/\?COONC\/\?COONC\
M/\?COONC\/\ 'X[[[H_#_'X[[[H_#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^
M.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_P ?COONC\/\?COONC\/\?COONC\/\?COONC
M\/\ 'X[[[H_#_'X[[[H_#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q
M^.^^Z/P_Q^.^^Z/P_P ?COONC\/\?COONC\/\?COONC\/\?COONC\/\ 'X[[
M[H_#_'X[[[H_#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_
MQ^.^^Z/P_P ?COONC\/\?COONC\/\?COONC\/\?COONC\/\ 'X[[[H_#_'X[
M[[H_#_'X[[[H_#_'X[[[H_#_ !^.^^Z/P_Q^.^^Z/P_Q^.^^Z/P_Q^.]^Z/P
M_P ?AK=__?[M/G/_ /@MHVZ^2RD86DSFR4RJ(K;#7YN-(*]\T0K^HK"8_.^6
M_4M($IBY0M8]I)MJXF@QJB'>L]#26Q@ZJ,Q])>6L3I/]69CQ9N5Z<**RSCAS
MPKJG89[G,W2 >@2TUVEZBT&-/,H\O'8VIHNR?%^15PKFUV]?I&V<+KSQ[^4N
M0BB-!7,C\3@8\_&-_G?$,SV/_*,2K(%BCM?FM+X50N$C@?QV9TK,!G+"93.N
MR&<D2,?R'Y#AS'3V*XMWM[))Q_/R:=KS6JE;FXMD\^WNM_'R)UV;=\;MPW:_
M:7+=3?R=K9?7Y-NS?PM)>_;J6W=MUV[BTUTUGX_R2R5(+44B=I9(UKA?&WZ[
MMO'&^ X_5O'SW:1KZIC2?%[#9+&(HV;M;A3DE2^D?,AG,J 2<EM4UAK]+U3H
MT0+U:::B6G_->U=K4A@K+>,9@RB=C#\EQ$G^;$I\HF/U_9KXK8F_<PYY^NCD
MQ(2J"M\J0TE\5Y5[@V#9G=%I'P3Y;_5IM/;XPXEGWMK8B.[<FW8HL#R1MM5%
M\MA6ZSPC/&'JWB4K+X 93Y>'3",A3Q3?3?OWZ>,J(^MRWLA(C41RCJD.63'W
MC& E>OO6!Y^+=.Q1>VM:7Q/0YJ&AO ]K4'*VCN61A.TXF-PE(S\1F8\_T.]>
MJXZLRY<;PUU;.1FQC-N]@J'T* SG4S&/(9TUUGRB9\4<;=R6.3EJ2>;'V)7"
M;'(I>^6H"ROW33!P[DF)^I<::[9T.)'^5@7^VU=5-V]M_%FS1KZ;N;O>\N6Z
MF_717;<?:\FW1^_?MU';N+Q0,<GDTX>C//D;!6 37\U[RJJ8]\<KN- [%*87
MJ;$%MT#<4Q$N0VN4 X=A2.Z(U$O3,S&NHS,?&)\.>JNLFN+8L=-Q:$6FI0,>
M0Q,_&8CRCQB0+.<GLN.ZXC(#\X3M(./='Y1Q:Z<J_.-8G=Y?"= 4QF5MX0!U
MR='@[JMK$<7<U^[3[Z9BN>^O')[MI[?JGM/T^+=*S08*K2N(S6+A'>L]5E)#
M!:K(XC60*-)G=Y?#X?\ ,&MD4VKIT5BV'!MU(X&%^I1.C28,B^J,Q]3ZWW>?
MB]AK./JUKCC02[0I-<*)DG$/6;0WP2@&)@0G=H1>>FFL>?CI+%!U1C<KGLA;
MO5:5>N-C&(QEB$.+@BZ%P<@MR["IB6TPFM%=T:K-G+,$40.3ZF?T[5<<8[$7
M,2G83'VZ9V,YZVC75 ,YT5M)G@)VNGF5F1^L$>.NL0.&RM"S0MW8!#2L4*C'
MQ%2XZN%%LHSB$K5%BBRQ[LU)*"*JQXZB9Z^.I,G5I5<7?;5%+'X+&7+Z<>E:
MZ\7;9%#^T63!GMX840GF.6PD8@R(H\8S%V,K#9KFD.*LVT7,1CJM)0!1&Q;/
M7,EZ8G2-/B4>,KD4X@MMD6G.]J_<0)>:C$"_.&ORF2C3[M=8CQ5PMJVJRY;*
M\#52Y[(,F04@D1(H#:HHDI@HVZR,:_&8\3&DS'RF8_#QDG%7H77+_.+JV#7\
M=(8"3()G28+3=$:[9B?EX^CZM[:Z6ZIO6BEE]?L3@)D[TUM^1NI;V\L%KD\R
M5#S;#CD*(W>G2(R-E>,6]KX,QKRV"A4013Q"9%MWDN)UA<Z:S'GIKI]F,<.5
MHHOUX($OY-@NT%D<3F)+= 2P8U)<S&ASZ=-=)\HZJC^*"<:[)>_'*4J=ZO%'
MWA JZ-@U"[G[:!8,5CY("6#$R&TRUG;3Q=B[;JTE&D6V[**JR81PN&6&BH).
M1610$$<24B)3$:Z#,^7C/VE].95V(NP;;*9:)'5@31,J>^N6TFDAGF=<YC5<
M>F1F=)F8C)X]V)PR\Y8)1U&ULC:%:9(K$+QFO/$@8+7O/3W,0V8+^N2_ A)=
M-3U3&GL^%TV\/_O9MN]IQ>[_ #.H]XKD_*-(VGMDM!W9^N?3EM%.[(M;8OT\
M<!59DUPZZKE412V$%"A'R9,#)Q/U0*//P>+L!B\AEI-/;XV*<O""/F+O7Q75
MQ#Q["VG.K-[ T'S'=/EXZ"%UG+9?-W63;PV=Z?NXK"4+!D\\?F#=1K)OG5;N
MJU86RG<+NJC76@%\2*]S6B/4BBZ736??T<%N&RN*>K"CBFO!;X=%>(_SD--L
ME\"UTTC<O!VVX]V2%E?@0QBC&39RR2T0\I$85(:;)TC4XG=Y3$1Y^'IYU$KE
M<G=M]X@^-H[2@O2>DZ:Z;2\O,9F/M\=#HC(Y?J7#7&.<K%=+YCJ*J\SY+!6:
M-JI50AS6P8S5D3(V*6I;).=P/")D?'2=R,IU<?2-ZG1[:]M[:VFO^7)[7&6<
MF[W[28"^0UBKW=8]ZM0+;.C(ZDOT\%G,ABR"P?;VK8K(!44<2K;ZX;IDT^OW
M6L[5P/RT^$-PEM.,'*DRO-<DVWP DSFV4Y*&QME4!N+9/'[S2?+=(^,38#,I
MLOJP0#5NNHLA\0)2U(K(B#CEL2N8:.V9D2UB=0CRU97N9,J-BC8[=*6R5@#:
MU4M#D#T[4PP3\E,C0YB/5_TBTS5.$=-'U,L$KHX>M0Q]]0#MMV+I.K5SL* 1
MA+1,[R))KGJ:0@R9#40@^E\741TSBZ(5JT=<5VV69'J#A7[VN5ZVRKPY6%QE
MS=76W&0'. @J:LPN=J:\RS,S:S5G$O9;?=1<NUFO>?(HGUR=W#(8;2:4,)!3
M!$N#/49,8G73JGIY^-HW.\FJTDK9*B5)F2;':-:IZ9:D)6Q<:[6CH8%]7Y^.
MFKK&]%=5C;:YJJR.EP'UD;-)O&/_ !A2.LR ;M-NOX>.FE%CNAK53'ENPL]3
M.ML[R9G)>T?8Z%' <$!5[/M0#;!#S\^[4N/2/%*\J_=L4$BP75^+>3(&%SS*
M)P[9$S*=!"8+4(]6FFL>?C+TFX:EWUHEFKM>\VHDB9Q\3';=&"H=^U11IOV[
MICU::S&,7.5PD9^OH%.=?=N]-GRMLI?4"&*_.KDOSWYO2?K>F&LXQB?OT_ZI
M^^/EXQJAFE]%F?9)6+W6F:OH?W,PY>(G$=15,4A^"W1S8][5L%]AANM;[*DM
M"%P$+G*7E<.1K9.LD<O4ZBMUJEG&I$4VL#7%BT/RKK!]R_/OL\C+S5B--@["
M 89K'C#VUYO'5\G5@UHL\NP+$"+HX7MKEO%9-"-344CHPO3,3.DZQ%7IB_;Q
M5G+K=3BM5?%=@&QT/DY[?S 1KDN1_*0\Y8,^1^7E&ZS8"JDWL@I!8D4P$1):
M")'.FLC&N@SIYQY^,"$]0N!%+11F(G$VO0.A*8Z->+FG7:HH^'UIC[-9CJZC
M[-3:/:D;U;WL6D1HS>-0VJF'[ =Z/=Z3Z9$@C;/IB?%[,+SG3WT=T%]QWH=/
MJ![K.WC8X<5BS:?)#6M/?*&3N,((I(9+XEIU"DNFLECL7>D6V,FRHI!U-32!
M77NKJEQ.A!C F@Y9L6R8&1D8*=8A6->W*8S$"2HLY7O.W.2/@#L:\V6\Q0$F
M.X(T7L6S4_(MD>KQU$FWBJE@X),FBHVV4B3-.):WS,#Y+GEU7Y1.@_\ 2C[*
M*TV>ANDLY&_NLM[>[G?LT_(,N=-.WR)GYL?/D:S_ *.P?3_:5JR%1)O9!2 ;
M=8"(DO48A&FXACXE'V_#QT__ .$D:T?=>_[?\J]'K]SY^YY_3[\//X^1>7PU
MZN*WTU)5/R=EV=.,O>'6\NV8>^?<-_-/T':/YR//T^<GA_9-##Y-EFQ:RN:P
M>/RXU7.YL(I613W$#P2I=D&A97*](8T1J%(<AG.L=+VQZER&6Z<O5*=7*H[#
MV78QJ(14GE38OW?:#7$^Q.E= !5[=$:,(Q;J$P<=/5+E+KS*8VL&/R;Z^'N[
MZG4(MNX4!5F4H*Q60L1,;PF(J2V0B(J,<$Z241XO9:BO,'C4KLP7+52$D"=F
MZRM4Q,R+(G;!,]6@:_<7VW<+:HUJUIK*Y+M EBX63).(>LF#O@E!$3$!.[0B
M\]-)GX^*-].0=80D6"5:40<M@8&>X@I#;M,YG3;.[6!T\M-?%W"VJ"$/<RN0
M/JU[@0LF24+L3H$%!*"(./ZT1,C'V%/\'4!VF]IBJ;SJV,ES\=D&,22NSX;!
M:.5,F&\((/)9[H*1G;$S/CJFG2:/MW&H"I1NV%(14%:D<7'7-3)X$#*0WMJL
M9Z'%NW[BB"*8&QDD5K=.F8MEMWN>(A$) >U7#&<DR8E&HSZ-HEK/QV_'Q3Q-
MBZV4J-(E ;]6$<1I!"/]593KJ4?9\_##A>9R&#+7N\=VO.R/\W+O*L7%\1SH
MR=%SH>]0:'Y#N'U>'U&5Z4WCD)5#^#:,E+-\*EVNDC [=L::[]=WV:>?@$&:
ML8V)';E>][>)F=0[$MK>;RT'=/YO9+-?ZVSQU&\.F#J!?@G3=J5[JNST9 JL
M2^ %G--?1D=N>Z!W#&HZ$6LZ3T_<C'KR7)6X&+LL@=[>7;5(A9J/#LUF1G9Z
MYB8^,CXI9!-ZY8I*%HMK<N\F0,+GA:*BV2)F4ZD<2.HCY:ZZ3Y>%86T[&9O+
M"RO%? T&Y&X!$SF8E->S9(:PPJ0-LA59 PUB1W2$2<1,D/3E%O4[*:J!+45X
M)8J;<DN!B*LV_><(6)B>.-/3!^ORUV^KQD+DGEPPB#:JW5M4W6&06RNQ!@HI
M4)@7(>O=*W :A"9$O.=!W-Z=?D,&.=I]FBIBT5,=>6>]=E]X90+;"Q4@UM Y
MN)]ZYRW%L/<'I'=@KJNH;Z<?2%BG/(! K4""HECU5XW2HG%]=HS.@3Z8F?.=
M(F_0=CK#:SB63$N<@I5)2$F@^,Y&3 )VS/U=1B=/C$?#QG2;45&22]\%6T+M
MN4HJ-A(N?[U([9.3D8 _6.Y?I\OCXMO-/T>=-]75DUBR68]L=PBPN9H![/S@
MXQ7"I<P\=R)(V;[+=7:$.P-5^+.1HY/HYO5L4ETBJYP\0=>E6376:48LLD3>
M+>R2<4LV;YLB,B(C*XTWST_'\9!65'W4,W[>[]'U)=$Z\//_ ,@>FFOQ'[],
MF\,5E)Q%B".S%6;>],02..+#*VFXY6>_>N9TX]NS2=VOIBQ596N6Z3)"6T^#
ME()F5EW"A:&R9$2G02B"W".D_#6//Q@P73P60IY$ MY*SU1;RM.WM%_!A'4U
M*KX[G?M>KB>)M[10E4#=O!DG,QX?B;#^K*$/-+:/3^3QEK)TS(S1D*;BIVW5
M9KFN4V@:A#4L18X5'R2LBD#(HZO=9Z:KM/F-&"R:*^:K8C&,8JJJED+>RB@Z
M&J*:VUH6D94OD4D$KA+3XPTH8M^16;$DD1!#7S#2.)V)+841L6<;IGX1KII\
M9CQTW+L=]+73]"LUE>L^OE;%NK682:MFW./SL,LN2O8MSBE*M7-"6EQ+U+T#
MIE10WK3$[9=%^GU#@+M'79%2;Z.U*I%K35TU=Y#W$*VNVZ\91.GCJS+E1NW;
M.3'>X[UTG12B27S3:B'<?<, N/D9[O<4EL^MZOBC"6K%5]P&5X6CDWP1,@YX
MEPTML0J1G49\M2CS^.D>?B8TF8^4S'X>,.F>I,[=Q$.?4J8SINSU+9:AG!<-
M5.XJLY"6:/61$M^Y:V+6,M&))XC&V<QDZ&*H(4M+V4\?R[+35I/+V^Z<HB[]
MXL6I_ UDKJZ0'%6B G<7QZ>Q-CJ5 OHFE0$N&Q%LC ML@D]-$K?&NCP^W36"
M\_AKT_\ ^$=95JC[I;=^V+7H.-C'+G6$\\?%!Z:%/E(_#SB.F<19ZJOY7'X\
MT)=B+=ZG9*X3%J-M!R$.)$H78(@(K 2N6 LI&"W"$Q$3<L14JV;)1,Q7KN?,
M1&LS"5DS2(U'77;_ *4?KCX^,'@%9#INQU+E;V24PK"V4JV+LB%?V=;"D=?N
MDV4G/>C-MD-XG\$0"MDEM+<'4#J^0Q&*OXW#3B\EE\?B5VZE,IS4,R+H$C:]
MSHKP"Q)_$4+.0V5M5G GXO'75U"S"5X=N-UOMS;LVPE!V=O,0:3R<=>==BMN
MZ8TTB?+&8Q^5+97-(3L)GOB,8T%@KGZBV>>I1_L^W[/%A)5WNKG(R:&L2<CK
M(R2CD"D9F!G;J/EK$3I\8CPYEFYF,1T_2(%/RMZA7<]LL"%5+UJ:3#0U4D86
MP,A-1$EBATDI@YT'QD<75P9V:5"QD+N00XZMLLRY=FF+ZC>)DTI2M3X4R>>=
M6C!E$5]PCH<>*74-6ST 66N44A<_CC.-%M.LL3[?V*-F%D;7$W9RD12,,V:[
M9V;M2\8/'.Z@JS;IDI:X^RS)@?YQJ_@H'#]9)?UOA(_;K$9[)HZ>DXN@YNRR
M56>U$#]X/-K,<K$^CW)>?Q\Q]/QT7TX>6P^5O,&DZCC>Q[NO:B6$WO+4I1QJ
M)#$GL<N#/D,-L0)!N*-(Z+S:\;TUG*]J;355NNLG5J+"8-=:LFA5!%9 ,: I
MKI$"%25P*UC.@#$3/B[A[ 8]+S<(*R"K8+*NPQLJX9X3.)E6U;(DMR2&3TF(
MF=/AXPN7F.I,1TED*M1N.MU6L9D5(WYS;5J7#27=O9P<K64%S:DJQ0<-L;9$
MC'9D;"\;U!A^FW097<WD:N,J-5$%56^VVDE9V#*0:*H*\J3):&G BS:LI@8/
M(46XVX^D\EDVNUJC)4D2Y)3344C)@!3$D$S&HQ.FFL1/E%QI-R?3F(AC4KSG
M4^&P5EZ"E=A-;*-E#FUF:R*["Q+<DS6U8'$$261&GC#Q:QA_237PM?%ML=,9
M>GC4CEU,.IF1#,9'']QU%%7C/(V@2D[27!%>!R#)?LVE(1UC;Q=F[B*/2X7*
MOMN[0P 'D1KH)-[)-M)&QNQY%QK7NKSS0#6A(G,)/0(\-H4^E5TETP)F=6KM
M\CE'BHVIO5EK1;;B+J@KW%JN&RT#S?$.L5R6+(&99$FPV3JPS.=--3*2G3Y:
MS,^7G/E]_C+#SW\33:QP5+/?]S"#VL+A2MJ=(+5<Z,B->02T'7;H7GXZBWXA
MO0=;!;<9-U_2ZVE5UI>T"L$]9GEII\?=3:XTS?(A*7\8ZQ.T8CJ>9QO4?2-C
M0496U[?]MNH^[5D."B@,;RL]%BWVE<]H=W)<!28HT"?'"SJR\E5$A4RIC%@\
MKLD$&==VUDA*8LD4$5D)&3@9G0MVDZ;LGD$XG,5<)8%IVK=FO56Q,"5>&6.V
MV29&:V0$=TO=(J*8T/02TC<FJQ^=I=/!(1=OH982TI+M1!2K32AAP,M@MM1D
M1 I.-9#68B2D;-<ZKC0R1DPVZR$S(^H1.--8&?@4:^7Q_0DHEOP^S_Y7WQ\_
M'93_ -__ )KQV4_]_P#YKQV4_P#?_P":\=E/_?\ ^:\=E/\ W_\ FO'93_W_
M /FO'93_ -__ )KQV4_]_P#YKPVM*XF?^_PU_P!*?[#5;3C4CT[3]/MG=Q4/
M5/=>SRF\?Y4T3X.#>3O4]7)^;C?Y!&"1;Z=Z0R%.^CALY'K:WFZU;D4S7&V\
M6E27\R9>N-6(,.)A _RW$H8F)GH:>Z^BKI^K6+1^*J]3'DQTU]%K,9%]?S9M
M#S2!_P";DR?]/:6D>.KVK7T_?WSY?DGS_P#HZO'V1/V^,]0"OC.C N*_GC!O
MRUF&\D^Z>S(5;E4]BCFJ>T03.WWH3MT8,3)#-<.VZQH=86V]R-)5H'X_9P]T
MRVG()EO=+W2G:R_#-@5BB>+9Z8/4 6_)]5X7/5E;$XS/87-7&[P+DH8EU?N5
M[&2L@\EQZE)8[T^[4S7SS.7J4NHV]8HGL[5#(9:S2O:-L< YDV56SVQK);.9
M-CB][5.5[]XBHAW1T[C;3L_/5$QP8K'XR:W>:K9W.0J749'V5V^^+*>:M/+W
MW;FE>FS<1SL\7G19NW+,1MBQ:L.@===(:TSB-=!UTW?';'ZH^'AD7[.6Q*,=
M5[N<;=HY[**YDU]N$IV9"ZW>_;KIN =E>3MSNU4DM)\(RN'Q/76/ZKMV_9V.
M#NNZQW!:M]QNP\XU'Y8I;'IX7L%_NZ_O-_$?H&3CK85(Z@Z6ZC#U89O4N$ZQ
M;/JC3#'=MWC;I.MK_-8^H*(M?*KR>CQ1MUNH/I(Z3ZYP\;NE\5[=]HV]61V?
M?8$\14]Q:%.0L=QD$M7[BHSB^NS8C:R?XR8;I[Z5\YU)F#UPEO"Y+&UW;;4:
MW7]2=^H>.JAUN-:B6EJ:!5]A'#-H3T4AF$/Z3\EDHX:/4^,Q*\$_46=^>+Q.
M5IWQXT2UU7@LO4K6X%>&;MZ98N"*/H^44EU!U"K$]QD<=U;FJE+*]_"NTK$J
MNOMNQ*>!^J[CHYFI,_RC7=N4$CT5&&Z?QO7Z[^3W>W,561B:?96HXG(H99+1
M[A/-O[AUI);K,J%6N@S([I'Z/Z=6U]%?TB\R]\1](5\!];!] MZ8(8])#\-?
MC/G\_!9S(9>__%^K'?VD&I[D:HJ]ND^,9M<K%+6WC[Q<<(NDRY/AZ"V_1_4K
MT>N6([SGLV;N1BY6[<U=J^O5RA&KFW&MVUA,'D5(A/'K&L''CZ-?_=@?2)_^
M3G+?[O3OCHBQ;+Z0*UH:O=6\7;S 8U/,M&X+%'(HL>\F.(=*XP7OQ9,[=H:'
M.OCIN*>.Z@RF9M9/C"YTC=Z>[?LVGRS8NHM?G5[Y#? $'YH=NF[FCR'Q?)!V
MVE5G5$[-D^O_ ),(+\YZ_K[OC_L\M/'0R;3^L>K.UN=G"N@<ZZU^3KL=W4#*
M5.:E[R8X.?4?RE>K5;?1'G/BI:IXAK;F,Q_;9E_'W&3[MKN;C$E)_(K LJKX
MZK&5_0,;]W*6K(B8^C4Y9_&GJ,BW9QG5N<Q9,TTUQQ=A>F-D:5(_*YW:PB'_
M &<G%Z/'25V[3ZNRE:E.M7*7NG*^6#14?DW'*M-S1)GJ2^Q_FQ+9'SW;)CI(
M07])]Q2XT5'475$"/G/IA&2@?,M2^$1\9U^?C+V'5ZW2F#2>S%XJS?BA5VB7
M!&0NUK5OWQ05AO*\I/WS6;-=JM@>GQG?S>%_^E_&?_K?%0S7_DV=/L#ZX.ZD
M(9\O(AN=73$^>L3YQ'E,:>,;C:&-Z"I6:$:6.H,)T]<S7Y[UV074LC/OC,!]
M_:L3I4%*_/S'9L$>BK=MW1>8Q3_>8BETKU+;H3[L=+G-8+=Z!BSY%8L^3F$J
M?]'3CV]-T*N2Z+ZSJ7%<J&+Z6W!O8O7;D6L'U*,#C0P&?(H^&D^4S$XO-93+
M?07G;>0L=R\>L\G6Y>*NGBKQT>MGYM*E@>PV&7U=Y;M-VD1$82NB/HAZ-V^J
M,Q_&'VD?KCN/9_4[>S],S[KB^'N.+?\ %N_QT:A5KZ/>KJ=D.6D/7>?0$;B#
M33"55"K5<BV=%$7KDOM\YW:3XIF6/QL8BG/%CH^%?2&?%Y6OSK=[_P ^9'^<
M^W;]2('^!K[N)R/0V&ILWU*V8VX:ML4/8.M9.B]\\S88VUSVW0W2TTA5IQAM
M7.D6*U7J'$9#,UP[6YCNJ[?3.5#<QW<92G5FU>N;C)*E<K71';UE'7#;JEY#
M.V&V8QV#H8>N/ECU9'V<K7\XZVZ;,AO,3V;GF,;GM,8UU](1(Q4GV+@!Q:2U
MG/+K9_)#MT[?)7!K%:K[BY>7B.F$<J&)0?Q6D8UW/K(LPKG#?"'!87ZC':U>
MNP_00ZZ;I]):C/VQ/C,V;W76/L=/8@O:=K#\5.$Z)I]EL>O5?)9&HNSN7C6#
MOYFZ<.N[5@[_ *6<HF^.5A$\B_=F+O4._;B#"8XS6!#H4S'G\=NOPGQUPE3_
M *,_HY4Z-5GTKB]T>K^K1Z=*/JS!?6B/A/\ U>!MV,Q]$-K(9-G)=1UR^NHM
MH!HE?3'.$:5Q4J=&M9.I!)>?G,CI$=1&1_0WTQNG7_AK[(__ )I1\O'THI=D
MJJTR[9+P"LT^,2UKL7D!,-NH::[]=PS!_9!1]E%ZZ?2^*Z;E6^,-WW:V=Y#K
M[0R)WW^YT+_2V>\>WX;@V?4_M*]CZ>205:ZGF26FX.1J]=#!D>I1@?UP&?(O
MLT^$S$W,ADOI(R.)<FQ[3/%Y&A8N7.%%/V?C*3R*Q;[<@HQ;[2;T-X%0RP_D
MV );?1UC:K4,QT:E[>]IX/\ C#W5K8RMS^TZM4D>X 3:KB:<+]W+=^W>?&)>
M.IO5'3U@?S%KIC$V:T?Z-9_.:1\_7.@?:R!9/]88GQT![SZ6<*Y<^ZQOM+OR
M_P!#O.FK@5?*="+<43'N8/3_ (S;'C.NBOU)GG4O=RW+926%]?>1WW$9:-B=
MN[09T&(B-/+[?&"R-?I;'Y7'NCNG9VMVIV-33]0+:QGB$+ ^D;T#I!IUVZR6
MI:AT>1]/8+*3>7M=DNJ;N2I5M\3R8JY3K=M<YD\PCN))K[=NRR/UF ,::EEU
M4,=1Z/K.VJ*+=#$8OC*=[\L[D8CO6+,A[FU;'WMFSL3R>DUK"8' "_IKH7.=
M/9&/RW*9B,LI>H?DB&3B!BIO1SJ?PE0:/.3EFSZW'$;=Y3 C)3\!B9G]41K/
MCIWNV6\S=R-#RIV%^P\AW2_R:O99;6XNT1IS=U7X%Z6Q(TZ[PVGOGQT7>HV.
MFW?1PK(][:Z5Q&7SVWM'5M=UEUD9U((7Y3FP#3OK'QW2GRD5=%64].]8VBSI
M\ Y*[>/'VMIM[4*Z<D3HX*8OE_*-A"O?;)#7>.L[].F<#E^G.@NI*&7K^SGY
M$LPJE2Y:UO?9MX9":UKN:SG@.XT,5PM, C9O9(P0S.)5-_H;J3HU">;J<_8^
ME3DX_:6W,,ROY\Y#'T^SQX2S_.ORC39^>GC\?2&4KZ;R-.S9[FWVENS!</#I
M6["ZJ!T#54Z-@IUW;_5]7;$3XZ?Q].W]$F"783R _P!I\L<C1W<74SB#S QF
M-)&/JS&NGGKX^C?(Y/\ C5=LIJ]_:Q>"L=-44\]>KP8&CD:)U0Y"#C;Q,T'<
MX67#WZL>8CIXZ3;4PH]>-=E^,^J<?0K*K]@T_52Q^1I[>48;'KFT,ZE%>!W:
M;BTDAILJ6^C\STW57RYF/I&R&<[+>T.;%QBQH>U.X9 U5\EHA5V7/W :[^+C
MU/QF+'\7^D^E\/EF;\SBPZA*Z&S;K-F\%VH.ZM#JL;JS5>:FLT_XS:S<,=3X
M^1Z</-9AWLLWU,?;Q^,X^]]H8NY9KS5R/>U3TJ<DN;^2.5%@.V]X(\PZ?2^,
M#U2S2/\ Y\83_P!5)\?20YJ.G:C4^1CT_@MI>F=-UP!GR*)CX3/QCQU50,NG
MU]-!5]AXZI8)U!?-&2[2VY%PX9OD^=_O+C[&USR7Y\6D# ;<_>Q+NF^BL;2N
M][>PV%31R3.WLUORE5+%H(]C0A/O&5K$[4&U8::0<CLDNI_^"+/^K=_\BV/&
M&HI;]&?0WMN/;&'L_P 9N'$>K']MPY]O)^7U#BT[FM0JSZMO'Q<,:K,O&4R4
MW\[T'AX5VN)?U[TNQU??S<UAMQE5GO=@65\E8]GI; !MW#$,G=X^G)*J7M*K
M7CAKXKL_9XZDSA[[V0RUYG)&SD,IGWQ,VZ^[V1&GCZ48Y/HY^CMS1]_.#Z2
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MZ3Q4@T]VD#DO'4($>'RD#_\ >S(?+[:K-/CX@HN]!]+OJ%[BATCTQC[HZ?\
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MR%!,KC"FE/-,6 G9XN9>_D<YC.KK85!ZCQ_>Z5JXNC _E=0<9.Q+&'?_ ,P
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M(U64E/(TI\9"OC>IY4GJF;R:>/4%3&^P)0NPVO4WC3?DO:,6%,O,58L=XQ$
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MI>,'*A1'@'-L0[)QK+.Y96<UZ2U=+)3L:]I:5^(2W;2@A@8C]+I_;^N?[O\
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M)*(F8UCP9BMT5SG2Q/P1.D.G0=\^ZG0_J3O^'U?5\/ UWLKE;6IC*H/FJRP
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MW3$SIJ4C'P&?O\6L7:N=$KQM]3*EO);^ZKD#$/K]GEA>GW+EDQ7*L0/W@'O
MMP;1F)\8Y\=0]#XSM 9S]+7*?19HV^\8&$Q ;K?&N7&8&;A#GGMX(O3-54Z:
MA0R66ZAQ=[%@EJ>C\E0R69Y!>9+KFZM>7(=N#!"931L3^5'6"=(T/;!F%7)4
M.GOI.I];Y#GBC7/+6'R'# #.43F*RQU>:4Q[V^N-#MQ\8TEA:"?5E,^GK&32
MV"GLD<GG$SO*:(6H =PIW%,3I Z#,_#7^MX13L)Z,O81\JXNKGUNJ0-6_E0J
M\>.M+29&,"IHS0VL7"K(QNT&P>NX,9?I]1?1YBP185.9J,R&2R&.!JN:M3JV
M<JOF.H!OM)"0;5+D=M5/,,[QABXG^R:?V_KG^[_0W/S<_K_NEXG^QL54=F,(
MG.U!W4W+MMUU&-HU'N0R=&$IL^I!_P#$Q/EZ8*-)G*7+%%1O6GD4L0W3R 'J
M-L+TTD3+^L,ZQ$QY_KGQ9H4T]*4NIAM;E6'O XX6QL77*_##UDY(M.SGTPB"
MG7RU_K%3L!4J7B7I5OH79J-WA[U#06P#V07(&X'+G:P .-VDC$P41^F5ALXW
M)QE\8_MK!U(QE\.-;N_PY6!LVL;NL;PJ]T8+CO$K[I&W5;-)D?%]5/-LUR%;
MCI'_ )SC>9I]SM@.'\L3*FIX6J!_N_SFO$7IUUS\EE<33P]7\BIXQ%==!7E8
MXSI5G5:I[V<;2VJ8([7-9!;=6213)16:Z.E:6$MESW,?W':6M!5Q]WD2MO\
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MS<_K_NEXG^Q[#U5E$Y[%J6&W<;3%8#N* C<9S QJ11$:_&9B/C/C'K8_:K*
M>#N-B5UJ.0&56;-XV0-3'(58BJUEN\,PRLD%DYH_FE,CS\9%IXZ&B:B*RLR7
M%4M5/,P9"VCLD2."5K),'9,AI,%I\?&1Q_L]HJEO))+AGFOCG22,?AO/R]'Q
M^_[OT.M4YPD]^W0I'3;K\(&?]*/GX]G1_P K_P"A_C\>S?\ W]_]K_Q^&5&
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M;XP^R:,KKK1,W:TWD:V9]HQ_QTCOJZ^YU\.A.5Z7QF8HF",;C<-A\:&/647
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M?/X_I./^O/\ JR_WQ_I7% *9,S$>@M-9CSG;.D1K\9^[PY^A>4_&2W::3_\
M<\"P#^$_[/+7]O\ 9%/[?US_ '?Z&Y^;G]?]TO$_I+ )O6O1:P9*B9UUTF M
M'7<LCM(&&#I(SJ$SNC0AG6/C'Q\5I]E_3,FS?7%FM6N=0B[(MT-@;E9Y(CQ:
M/L3O88SZ=8B73,^4&7CHC I_B4OK:R:[=G-8_,8_MWUA-]8TW;B%VO:!F9N(
M!Q8[!X%2$,@19HJ-_P!'=MC>L;G3UHCMU\[<M[9>PFII#BT92Z(149O!PLF
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M4Q$_9X_RCNA+/3G599VM3KKPN:UL38K*IU!C*9')9RY-8ZR7E8<R*B!,KIH
M&1 K*1,8#^3_ )-?7F-Z;R>2Z>RMML'U7DNE\5B:Y=ZQ7,RWDZS1$$UK" @V
MY-&_G.LLY+63F-Y!](.'9ANJ<F#)B1OV;F43H(! HM9&["QB 8SRB%3\=A?-
M8_;]%&7KXGJQ/<%(^TT+Q"-.3U6+N2QW&,\:V>4\<_7V+_TF#Y:_R\=^9+_6
MS_N!_3D %]8!+_SAB?V^'4F!K(^H8C69](Z1$:_#=K\_Y/4"+@]IE,?OFYC.
M?A!38K-+O>&NS9:DQE&U6^2T@N4=5SIN\=3YO!]5Q&>P%H;%.HJ,?8@:MFML
M8CN+C3_*D56%M583Y DHG7TG)"0CU'A[F7Z8RMF%\=?\A]F3)*9&4_G!"[GI
MEJRI]D:__>@?RC757E&L_25U!B^N*3LITW8]H5VT6=.KGBL5-V4-5^P%?2^F
MH<:A;1[TEQ7C?YOU$X$2]@_1+AL5DO<9"?:/=5_SO:_^$O<I]ZCF2_G2X#]V
MSW>NT_7$C'1-9USH?(5ZX<C6=;V[X#N -:AXBJ MW&0C&I%$;)F&1KK(:>,@
M8J^D7Z+FG.T%]88DSG29T$,Q@2*=(B9G2(GRB)GY1X^E+I_+]79[)8K 4^^M
M^U+F:V=Q5K?S?WF0K<VZZZLO\Y93''R<WKUXMHD0VNM\=COI"ZODE[J_73>F
M,=C'[G#M.IB5XQY\45#.=C[H^FQVD%M]!D$RP<W@[&?ZU'#UIV]SWD19T"=O
M;LR-G\RQJ==PIT_.CIO_ *TCMGJ3+5<Q]*&*M5"W /5'2EEGDR-B:X8Y;#]X
MM4EI,?5@=\Z^D9^/CKUEG'%F[@+*29<9:K0+H43$6<GM X9&Z5ZA)3M*(/2-
MI#&OC.4\=3Z1QJL2Y6<.GD">74<TYQURP@?:33,EVM]P>S80UP&;!D<5EL5$
M#L@?I9WY#Z,NG6HU=VV%QG=&4Z2)//I^ F>7:3),P/61W?#4M-8U^F:1ZD9%
MW"_EZ<7B8N68F.VB1HEE&N7/><$_5>KS &?7]('M*(QES&W>ANGX4M*[V,]J
M^W*<(G\E[S,,]F;[/""KG.D9:/;\W;Z[&\9>+@9I:!#-E918YH)=%UV+PRG8
M4#:AJVL2);X:GC_.1$27U3C7^SY^$_JGQ]$#K:V?2Z->EW*V97!\[>X6GM]N
M5S\K]!Q,MY9F1]&FS;J7Q\?1]2QU;+]07Z&7F[U1=Z6R5/(X&*-BHW'4B;CX
M"].<8<U+T;44"[16UD=X,;H[1GAT'#FPW7DAAPS6=T[X*=VI>>Z=VOGK.OQ_
M2<?]>?\ 5E_OC_2WK$%OVE,C'F/F41K"_E,>7GKY^)G69GYS,_CXB9B=8F8_
M5Y>%V(^!>7E'GK,Z^7ZO['I_;^N?[O\ (@9+R&)*?NC7]GAI"B9AY"F8\YAL
MPN8C2)\X/3[)B?U3$^%.2^))+5N&"D))1BR(*-)D9D9F(*(F)F/CYQ\_X;GY
MN?U_W2\3^DU:%L<[ALM8-1^R<UB\O$CNAD'CGJ:,K#B!9LB G8MDPHY_.>7G
MXSEVGD+CKJ%L%EHCL.)FD25ASV-<<B#3 =V_ZH:",^0C$>,#WV#NY%<L@L):
MQ5C'T:: AKD6;95S)SV-6+.#>-J2+N7$/*$"O2(A?3RU=/\ MZW$A-_*NJOH
M-KGS=OL?:.U%I;I%8DQ-K8$"M\0>_P"IM$O'1QV,/GLAE\F7*.0Z;M=.,X!C
ME*M:N5;)K(#&NL%3"F:N67<"4Q SM\XZGQE;,U[59"Q@6-F40YC1@5Q94T8(
MEDPM=BXC^MY_;I,SX/+9'J+@9U0_O;*K2AL,E*:<-PB_4VBH:BJ@S8-C[! >
MP&>K3NA@1@7%VO4F%OX2)J8G">TNTKL]Z]/M*A"7[9;W,-Y+)-.>>P6P"CBT
MT@!LORW5'6 *Z*MJQG4*>EQ/)W<F"RKNK+RA#<4I8HRH"QEZQ5:'Y&B8!;!Y
M%Q[IG3]C'V.I,;@LFEMH\KWG#"YV+CL:#KC.4UN2X=8@-G&)ZD,P6T=9G#(_
MBCUQG\F^1*NX<K0IA4*7.159EU6*Z'#8X@W*"M,,+D:W=MC><24QTQ;]B9?.
MV6[NSS)8@26J!-DJI(<EXLENSCW0XN.5-UTF9(@F(\7V)==M-KB0I;8>Q8E]
M: -ID$3ZC\X&8B?47G]L_'^210,:S.D>'/W^D9G36=?*//SC32?/Y?P_2-TL
M'671>;Q'"M]P<?DK&*%C+2X#)QB;U:BS2G!-=M;:TXI6X&:SJIA0(^.I^F<K
MTCF;6#S"N*[4X.3:%@%%SU:]L./ND5FSHJRK=JH="GRU':1?PX+(SA\WA\O$
MG$XO*X_(Q*Q6QD32MILQ( W11G'%Z19/&4Z0?IF?'55"KU5T%A>ME(*U?/I3
MI<H=!-[@#NG4L.6=6H94A;$9%DL#;/'OG;Z07/C#70QN7Q619!RNADJ-UD+@
M29(5;2GE"Q,A CD0G;!$(R6D$41Y^,3=7DL7C<@K?"[^/IW0AD"+("U76\88
M($8"<0<;H$B&"U@2F//^7COS)?ZV?]P/T%]4&B4C$<DZ:%)%I];6?AK]_P!G
M@@()T*)B?OB8^_[?Y B(,AHQHR(B(+X^43NCRGR^/G\/!L-D[CG6?U1'W?9$
M?+PL84>\/26FW7X^6L3\)UCXQ'AGO=9/U:_'[/AI\M/E'@)E?U/+RT^?E_MU
M^7@Z3[G6?2F7A1JI]*9_%Y6]+P-97*R[N-NL#&3 DNPX%T6K(6MK +C4,LB"
M(PS[5MR-N[5<HJV3M6,HM0L%CD1=>YHJM1&^%65A(B]0L,0+X$6N[P0P42)1
MK$Q,3^J?*?AX R6K@"=%>7ITB?AMT\YU+^K'V_9X@!@I*(\Y\M?/_O\ 9XF9
M+37[(B(_5'P\#Z$R@?)4B8;?CZ3UW1NGU>>Z?MUC[/$S)+%,_FP$0$?D(Z:1
MK];RVQ\9U\#,@N5#Y!);]/CZM-NNL^?P^_3POW3>8/2S_2^/]61^$ZC]69CX
M?]?B9U^/]H/9Q*8S89[0(MBQW&6T9G01UC4ITTB-?.9B/'T5-C#Q](TY 3K?
MQCNX6SCN4>'W=>_F++89SRKU"NTJ/<<\04^HHB1(ND,6RKU=?ZHR#JP8^<=!
MU*QL)5^+E1N-D?=$"E&9]F^4J[D^2#7J'G.S(6!MW[MH=VVS;LV!W1$%M<XV
M1N@9D8+0O.(F8U^$S'Z3C_KS_JR_WQ_I++N)9:'$,],Q'IW:241Y#/Q^W[/G
MXL,W>F/A$Q/V:?#Y_P"W^0IG'/\ T?M^'W?/[H\ P3C6/P\M?V_V+3^W]<_W
M?Y%W,XWI3 !G<B"W\^6'%!6-9^4-I%<%_.M%K_Z'-?#*A^._DCR$H1=N3NNB
M826D%RN&U.V?3/GO\_3$>7VQZ?L\99=GHUX9=IL?AKJAK N&=N@<A9-ED9[=
M9V3EL5:LQSS7")"=G(,Q %_!<_-S^O\ NEXG].8P%!)G.T1TUG29^,Q$>41,
M_&?%#^<TNL4??IKPR6G^;V0H0-GI=QD6T6!/IB===(UF)T>]559->6Q8Z;BV
MD6FXH&/((*?B41Y1X[*W4N)RU"X[%ONXU?'9I22+#Z-EO<CO?7<IW$TQ R0W
M2=ZQ,QW1&E2TNI*GC6"<@C?V^2B1"Y7Y=P.X7PN7JY4%P,V-'>KT%J'I\.<Q
M[6.:9F;3-A$929R1E)3)&7F4S,S,S/G,ZS_*,X"-T^&NED_;$:?5W:QKY^?V
M?/3^0LMI1/V:QK^K6-?_ +GC_*DZ$[S&)ZZHA76.,Y/;!KJ5UOL=[8Z?P^/[
MBS+U6+'%(G"=$6.()E?N@G?/\C_)HS:\OT'=Z:RU]]VTWJ6TG'HOS9O C&T<
M+@G(JHYX.NFK7[5\HK0U2U3K*UQ)#NMU+%"PRK:7Q/5MY%[@/;O 6#ZED83J
M!C/D4Z:Z3YZQX^B[J.OFL.-!.N_!XW!U':DV8WS5<GRAB5B/G4/R631_Z6D#
M)?RL=^9+_6S_ +@?H3D"X9CTP4_UML3/PF/NGR_7]GAR#3/J^$R6V?+U1'VZ
M1,Z?&/*?Z&H5O*9)F)P]/VA>35.XY/<*J;$+>-9A\EKC26US%#M%DG._6!D1
M(HQM165C(!5L[KF+6H[U3A*.'N <VK'.PEJ9SK3):IEG']5FA>4UYMV*V3RD
M5-,%A<D_$9;*\ZY[/((-*IK]CY7+&K;5,.6LMJ([C=R2*FR.1J]A5/(\G+C8
MW;;FW9OXUF;?R?<;QV2IP^8>K9J.NX=453/&>T;'Y-SBJQCT^3N]QUB$E6N\
M@%^3<HL.>V<$/7QZ'$2<:?VI\?C_  :S\-9T^7Z5C_KS_JR_WQ_HYG2)F?A$
M:S_L\7[$$9%'ELC9'G/JT.?5\(TUU^'\H#D)UC7[XUTU\*9#(^_[?^K[OO\
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M[[MG/[9M5T@VUTQQNTOX[VC0D"]M)$EU-NBXETS'BTTJOT?_ ,:,:?:U2_X
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M?&?'^45T/U/>/'Y^L_(]0J17JT'4\?T^1Q66J<W=9D'6J4NV*2)BI@,4(#S
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M 7<%U;@J=93''F+MJT*UHYIR(TUK:Z$%6MM(^]=,;B)@D<RS3<>Z"@O.//\
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MXG])Q3@ZBZAM8H;!4Z^"K!U!;=$,<%ZG3FGW-!M;W&BG#=T.9*QK"M.V9O\
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MM'R_0<'U+F^FG&_"W>R:;*S2+MJEC5E0C.N6VVAXQQDPYTB-"U]<%$1IT_\
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M>I7"9"2F*GC/46+,9F"$M.H(MWJG1$X(N:[3Z"Z<HRY =TNA:KIL=U0N0L+
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M,G];\WO&"UD8UB/5\?+3Y^*R!K)%01$0.OPDI^)$7Q+S_K>+4>B)_P"E$?\
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M.O'AUQU1[,K%%:KG/C>LS":U3V9CJ=C\JM+FVM'.RH24^[;RL(5^[F9D<D<
MO%XP36V,'B:6$ERBWK?.,$Z_,ID?G%L^L#.-6\9@N)?P\-H+;E,-E2(X=A+Z
M;]<(D>)C4OK6!%P[)(@DJP1, Q1;9*(.)F)',_SU-N;/N^\<3F<'IVR5CN-
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M*?K><Q_!<_-S^O\ NEXG^POC\?/QF*\(MS(QI#8EL_5^L;&_#33R\OM\_O\
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M@T)6R-P%IK&LQ\)B8\XF)^,1]OBFKL$NJU9XJC[3+[$:;]UU@BLW\K)-D:K
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M/U?5\IT^'E\O!@#!D& + *)$@,8(2B8TF)$M8F)B9B8GXQ.GB&MA(5X8R$+
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MI)<7G2YO;S 2)39BSH'(+M(WQIZH.=OEKKZO%6^Q&3R.9(0F_DZ!X^P$04U
M40UP@DC)PX6;:BM9-K!W2ST:2.TRDS(YTU,B*=/AJ4ZSI]W_ )"*?V_KG^[_
M $-S\W/Z_P"Z7B?TH/=_F_1_YGI^[[-/L\O$Q!?&(G[?.-?/Y^"F2VP4R4!&
M@07GLCRC0=?JQI$?#Y1XGU:27JD9B1F?/28^$QK\)C[)CP4R?D4R41\-TZZ?
MCX^[[/&LQY1.D3\?X!]&NST:_';Z==/AKIX^W7[9^W[?Q\3,S\9U_7Y^/A_
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MM9I]>P:-T8I&-KI98A*H)\##R$.4P&OKJ)-@](\4,HC(GE.!5CM\*Y:,I?,
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M>FUU&O'5J5^TQB6:V*U;FJ*8IMTV):U9D0-B%?F]DE'(K73=Y6,=V]-5SO\
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MW[4YKJ+)8FE[8I7,SECN=-3:"C1I9:Q;!]B],V@[6U<K*XZ'=+J"QZ6^ET+
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MQC\/..R_4PV['8TLKDV,H88%<E+K"NBU=:#KRZ[9K5?9(.1D:R\J@SY7;*T
M\#*.O6Y"]D>ELZVH6"P]'J'"+M6DVUV8I'5?<N.R(5ZW#98ZM5.6#"$RT^&
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MJW\3,QTX1Q[8+,R$4I YU*J.*E\<^WM?=]J_XNT+C]&[<&[HJ+JSH10-O4&
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M>,3Z2VSYCNCSVSYQKI/\)3M$B^43/X1KXZ8,^JJ/6]A9>S#Z/LXFO'E%SO\
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M1D/#+-W"]0] =.VDTGW,UU!7QV<EBVM6*+.5QJZ_92PE-$IIWIY>[0T.01V
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MKONQY6!5W<7;%$C&_0M2>NMF.AZL5:S$=5])=-7KO*D3.O;SMKCLLI>8@J5
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MQ GA"O-;7TU^(V<D5$Q[QI2&W7=.I;LME+.9+%-MENLXC,4<Q4?HN-KJ$L)
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M/?OS9E^3[AJMW=5S6W\C3QIC5S#L>@@TUXAVC$3"ZU@>E"Z29;Y*-73V 7
M>Q.?)3DLKY07-DO:3M(_+;)=GI^3:#Z/#:ZV=,UNG--HIR*<FVUYSSV5X^:!
MEPZQ*^2)Y-!?*P^I"Y^OXOC2MIZ>FO3[3)],OMW,7DNX;8X;SK2+E>SV9[:[
M.U?62?#8YTOV;3& (A+'VZ5;*HZDN8[O^JZ_-MSO=MJ^=I3EVY]F*$L=[^;=
MT])1/%W.U>WA5(XX\AC+.3*O>THY>*JK]'MDSS5JZF)8CNCY'+Y@<Z.1/&:^
M36)F0&8HLHU</F.G74.ZZ?SF6;E[^,[IR>6P9U&K_+!@KH<3:%0_<O4!\6TE
M[6,@^ZL7QJ?QG9_&$ZMI=WDVAB=]E!EP,VX\0@>*N<HV>I9_G3&3\6[>1LYK
M"Y6+G&G 3DQQE'MT'P5LC6BI%?N=HFW@0"QY;"W&W9N]!D1>'QP]39/J+ ?S
M'[7J+QM^G_PES8J4TE7*/<7=>/O"HK9W*4+LU_J*/3=)Y3(XWI_I[/>Q<'V]
MG,ECFYAOM-[N_L5KX-!W';!P5=&V;+..KQ![W9,$(+@?>R:(3E?_ '("@L*;
M8=V(]*;$C/O:/&?J+:.A=R'JGO=HQK7\7<./4&5KMP:?8=S#\OM0>2<G_%OV
MA7$:7G;:E68]L*2V?R>&^S^7WNPECKU+#<I[(J-L:G@AH(=8X1CO7XSG4QW$
M/'%;N99)\8DX$_5B6?&'WN;'8RAQ;?9W>^]WZ\W=OAWU-D<?'IM^N>_X^GX>
M,K3O74@NCDO9C!:)DWLTW-X0+(E>QQ# [I("W1.L<>G]:?&+R..QW3X].LQ'
M<TJ"+J\!'?O3[&=D6V+-Q_D!MR/+<:NQQ77F(</$J04R1CI)Y]+7LED)GO[%
M]UR0+RJ]O5M.K.&KII8!O$=?7GD 8S?Y[8'2<'83A,+E\2%?F/*TFU)M\Q+X
M98%T!;P3#89L[O79R+W<?F4;O32MACNE[_3M)'"S(6UWG9#DEGY3!4)<SM&B
M8^^BEIM%X+7R:B'H]5:,2NVN[:Q7=V:AKMXYG?64=EE*Q =*_L7JNSVQ#,]J
M\2KNU]Z)1'C/HLYM-T!N=H^Z[G.QVZWZ&5D+!SQ3*@G=H0^6V(WZQ'IB/%ZR
MJY@L5@(K\57%Y(<B'O29R3!7#)7U18&Z;I^N7,VZ>0><;;&1B'X"_BD>R\KT
M\BRFG?Y>]_SRHJE8+M; =O[RN# T:#MG+N"1,!+QB)KX-.7JXVOV]/)8>_23
M7Y3;V>5N"M:\SROY6V.W4H ]G$05FZ;I(2F9FG3H&E%?J.I_&%0<O<CSNQ/=
M;B(T^=$MR. N"?=S[SA]7DP_&>OWL]#2=8X[)4SJ*?Q)/AUYI ^( 2#.,W2>
MTOK:;9+3X=+\6 JVJMQ7M?VEP^UCWE0[_LV6&4/2KF[7M>88_)B#GX]7;M\Q
M%%MK%6,B.+L=GA\AD+>5G$\*[''?MF$38[^Q#+1[*JUUN+T)+;S<8LF=<Y3K
MY6<;%8/9ZJIO]HJW';]J)<:)A.\R65+8I;5<B-QES[_(ECK>33R040NU>8<;
M0K8RE',U?#1IP<5T:JD)9QP9>\;O<>OK86D>,GE+K>H<GG<$WV .<+'^V:?&
MK*=\G&U%4T*[BXN)JZ*BSZZJ5%/<^O>25EXR8XG+8NU0N8ODL6R49W>^LAZ@
M<EY3VRN,/6:R^!C \GEY!$37REEPIGJ*?;[ZS(M5W:!BN+(I.9IW..BN /ME
M3*NW/<AVN]HR7C%7[^*OVV*L[L-D,C>RE_"\*1[FY<&?>>T2!EI/$853V)@%
M'VVWC&',\8Y][&*'%U;>SIE(G%7 \"2[<GLEUDO:C(9D&\[6W#T8R>/N=J]!
M2J(RO!8/'W,,CV'EL:-B$9+D/):%:!2;!=G:TK>\0+E:&)P'/O#::QGQ%H2R
MM#,6%<]ZDZKJW?Q<M&M8[KLM@#PAO=J7<\1-'73U#&WQG,DC,7#MA2[.6[>0
M>Y.QNV*4H/.05MVPJ9](QKN\_AK.(QYXG%7>GPL\O3]Z;-AV+X8#7(6JZZ3+
MG>R;+L:TE]OVXN!/GRC M]4Q%8.FQZ?56V30U_B]<YF%[$[J_P![EOR<O^$O
M:7FK\N<?9_7K;?J^(50R UAZJI?QDBE332J?E+L/PJK1HC_@Z0Y./?8_.;B+
MG]9%Q!XM7VWNK,;U9=]_:Q_>>Y]*N;N\:.-_.* %KXU@)?YN>_33TS,GX=:A
MW4;.HB5[TL66*!&_ZB)O3>'WD# EM*=GFG?/UI9IZ/%]+<CU+5ZELOWV<;>H
M9#%+XA'L;-'M2W[UR"[/(ZFANVR@UAMV;#&3W*M KJA'67#KU%6[OBO\DQM[
MT+B[/Y+MFC/(-^U]:J6WE]&V07(8=^.M9;(YC&9#V7=R&-96M=)=H^[VE0>T
M2<>WK$"I_>S62_W:@;6[WB@OR8Y++=/AE^E+YW$?Q8R&^HJC4Y9S7M>D%FDP
M,YSJ<M-#O8)X^S'>]K=MK,^^"/&:R-3.X0L7=QVZT7-,Y'NVQZS592H^T4"5
M^Y!XQMY-&<7J\SF8<W(V:>&K6;_,WINF-'IVSVJ%^RZY5Z].R'"N!&[W%2JE
M&Z\3S5LY5GRD9%U#E/:F=JY["H_B_:521C+7O/:O>8Y=QUQ]7\K6M=?N&,5[
MY:9>KA]#)%A#&,91QN8#+C0Y&,99?D5]TX._?84X>3=,,&KL<]CMB%P!:\>D
M# Z84(PB/957_P 72M^TGX7_ )7)2"J[+GM%G+>7R45#4[<&< _GQ#FU*;SZ
M3R&:6/[ 8W;A[IMK?K :>;8B1VS!3Y?'?_T8\8[VCAL@^]ALAV'=*:-A7:(M
M<CG.!S7;[7+LW\2AXP 1'9J.FXHFXBO."R>%Q"O9!9SL_;EO>=_VC[,N#:QO
MN+,Z5.TCD7^2-5S\F]_)L$?%/))5A*&(NTN_90"JI=SN#JZIJU!K"OMU!(QJ
M4$W?+#/U[)DH&"\7<=%JUCKRV\%W$O[O'V-G+P6A8ARG<4F*F\;:ZCXW Q9[
M=I#MDHG))]KWZ61R)=Q8KT5U;):</>.'G)EK1$K"ORM>3.%82(:;!+;IHRVI
M_4S^I'UN5CK6+L]OS$&WV:I*H'E 8&>6$CY\$;/]$_.9B[?J7\@W#VO9F)RN
M2NY?(XC@3=[G)73DV6>_M"5E/U*L<*(6C\FU%8<S/#[..96!2,7V]F#U*UWK
MV[P]?HX#& 'ZP3NB=?=_]*?%VCW1UWJ;V]NIR]M8V<O%SP(.]T1BL]ZQD/>0
M6W7<.A1X]HE>L)M=0K]N6*I+929OC&]LY!\E9FVB  [A,W3L:)"SET.)@ CQ
ME!9E+].Z;>,*1W24C8)^FX ALY8XY]W #ZB$I/3^KY^+UZQ;ZA/.+/MTLZ?+
M MH;0;O$[QVSL]U("0[A*$\(JB8TY(=K.WQ3M4L>-MM+'\&3N\'/D>[:W?VT
MD*OR1HG7';7,D>B!UUY"W'$>,1<+&8?-8LX[H\SU+D>HCM:PCA+(U5URK<$"
MR&<<KEG-#%06[9" TUD$64YO%YFO;X9QW>[D<"V=QW=3M8]Z<SQ<6LGY*/?K
MM].F[Q4N8U-YV4L8KNLD];$G;[YZ/<-<-@E< #*/S\2S?"X/U;(F C3Q6?F*
M&0RUS&Y7LU]0125G:W8U;'M&M1KE54CF?!E3_)W65\M,4L]]O*3-8%%3+(Q>
M*N8K$4/9Z\C;]HWS[H[7<9-DUNYN;;2V$GN(JJCMTL"NK3581J6[IVR> Q^1
MQ7^=4;".'')\D>S)9%LK)\FUSKO</L\VU[!XN/C7, 7IQIY7#G95CLGV^+OW
MK.2OXWLJSNYOV8B#L=X_EL)_-5IXDR"?<>0#RLUS*J.4IU:J*?8DNZI]QW<.
ML][2$7@ZAQG*XK<T-#\J44M7Q>F/7.F5?4S/3P=/7J7*BI6IU,8SN6!V"*AU
MID-B84=KE540K=8<1AMW[B(CW)RMYPK]ON]MG!;VGQIQO*0E,!.VDN(7L1/!
MH/D7YR?7XP\A@.H']2L1[3XK5M^+Q_+-/V>F\-JN=?NHYNZVHM+'EL(DI[?=
M$ ;2D>CW18Z?=7PT\U><RPU]+?F^ZR795@"_[;M1!IY@E6.[4IX%Z]W/G!>.
MH>G$VL?T\W)T_9-J/:WMSI_N"O\ <>_2.-_G6N\5JXEBN[^21Z^3MG^83X"R
MCOL%=L5>X+IVMBZ&.#F-7%CL2[EIU-P#H>R=8YWB]Y:ZM-FFGCJ#(HSEQMOL
MNUEVSF'N3?OXU)6OSV*V[>+7TC&N[SUTUG#Q:PZ[E)5K?B+F0L98L;P+';E+
M$*5-SO"Y;4Z550CMX(:\_G>.&><NJ5^_P=BFOLZ'2UX,ATUCMQV/9-F;-:]:
M/O&ES7^ZR%8;>V_%A:?S"PX-0+J?CSUQ63I+]D9,JP*R-S>5_P!H6);8L6[/
M;MX:]3N[#A;PH7L1Q[%3L.8B,@FT%TL[3]L7;BN/N^X/'\<PLTP7;TP%1Z+X
M1T]/YG77<PI\8LK6-1=QO<\V#NWWWF8KA6OZ\*X%=]Z[GY/->M.\3'EXM##W
MAZJ/9TS2Z29'+@Z#7OK5-=FQMAMQK"YQ_*RUF_:\CLF,<GIB-BX#J&Q4SF'P
MN,51[!N!I!2HW.Y9:V+A=%)SVY0H2Y$TH7[YCI'?N@MPZE?R@9%,'9J[LL3(
M*SE>>8[@ $UK7V(+"LK8O@#>OS+@W%ZFG/C!57X;-,S;+?>V5O>W&>X"O[."
MT%E-A?I)J[?(AXJWV%3(<6\($SF8N35G.4LUB*OLB:RJR+%?G9?[NNFX5MJN
M6S^8Y_=AO!1&KCW#,[R'Q2R8U,OGLA-;EI=2^R_;.-YI7W?L:L2<?^6<9-1P
M-+G_ "4$<NG$_E&=?&!K,P>%RG3H/YL->&[;KTN.%]EU!:J)HJS?<23;5CMZ
MJH5[--X4G:[R$61OG'(#'X'-8F/>7,Y[.[K*>8?\&W#LH_(M35^:/M_=L5\.
M4]Y>GPE%9>%]@DGDQYY/VV]7(P>;+E4BFV[OB9>OD1&WM@=VHZZBK?ZO&;SE
M-0]&83L.R&I=NK1G>Z;9]D3>OTG%D_9G%,W^Q(XL=F;2[GM^*)"&Z>,>#VW"
MF</_ !QJC6D!R'M .GN[9#0TO=KY,1SKGF[6?2KNN/XI\9_'PTK=&E=VUV(-
M/-VVN^'UQB9XVG!CQD1QIOC=\=8C3PV!N8*OT_DH[VBFE1I&.LUN4*'#*2U1
MM<OWJ 9I#IGRV$1CKKD<B>7RE+,Y(.ZR-#)X_,57[H3QY#%P$4G\2 6@^& &
M.)BC2S35JF>?C+9 ,G;FY%;MW.'?<GFEO=76,8VQ;TV+%/,3/S"AA2]/1I$Z
M0FI8P]NWE<._MK#ZIUK2N('=Y2T4;J/):)H5^Y*NJ.Y6N&IT]):;MW2ES"Y"
M_P!]BJ__ (78K\VOEM^[MW4V$Y0=UD0QA:("U&X@8N=-:^TY7/C;&2-(YH?9
M_4F-<O,8C&:]WNFG.E"]WE790C6^;:_:V=^FSE<HDD/C'SF7XSJBUU9.Z6>Q
M/XI^56--E@UY[_@W3772M_PD,?\ ]'_7GQ>J/M=M"K?;J7:2VTO@!W=U@W\U
M3>1"2.<2@>=>K%;=0C6?&/?6QX/KKJ:U+?%W5?G..;@DS1[V8-B^-AR?NY'?
M]4]1\'-BEF?;?3#_ .+MP\;[,L%QAE^=16IMMG3(;E+Y&C7GT*W!P>EFUACX
M79343>9C*O89F_VW-E^8[7^:G,+_ ""P)5?\U)E;TP'U^:=S!CQBBL8VS:OD
M_N<C;-W+;XP3JM[%N-?!&]$:O#DWB EZMD:!&DYC.T@#% >'V&1V8S.;]H-+
M97Y$\=KV;"="[&K+/<5?79XO5[PX\0C.U:EBO]'ECF7EW>UN;BIKYKUHEG9;
MQYN2E?)22HMFJTCKHM8M@M>J(Q@YN[&(\J$=MP?YQ_\ 0B.7_.???GN3Z_\
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MKD+%8:K&;C@F_FAB-HM%'VP@2]7BS6J6NG,9THU&N$Q7>=K4Y61M[Z\.2?\
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M6-G(-*YODNYLY2J5:X_MR&:B>6&.+CA!@')HJ%[!*.H.VRRV)QM?V,IU4Z[
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M&G,EC3[:>H$UT9?T@[NU54/K('WXMX-B;+@W5N$BW[CDB$2%^,HV+(7'(WV
M#8+.1PZ#._RV"R G\X?G(Z^?W1I<NV;]"OC+;.6C5L=TA&Q8;'QS>OD6(.+_
M #AWI-A!Z_J^D=#R-QF"L]-&[7"7&*;9I<:HY#0=9BB[F BV&TZ=:= >,%QZ
M%$P;()1$D!4J=H#KI'E.FLR4^9:S\9G[?#VLLKX7%O7$1&W2!\HD9CS"!+XB
M/V_9^OP=AS&"XSU8&W:6T8TVENCRB(&="G7SC_J\=P[F[C?[[_3VC_H[/JZ;
M?J^7P^_X^,BP\MD$Y7(3W%]%==53](5M0IYV0#B3"TEM<PSW$N3G7;)2,0,7
M&GD%4D6RY58[N>S'2%\/=D)V/-4 3.0@&?>R>W3T;8F? -,!$!+00&!&-(G0
M1C2(UF-?A'V^?C*3.:14K9/\I11Y^U#\SQ=R:V/]5?B,]YJ7/O"/;MT#;$S$
MNN6;"*59K-Z,=3K4*8;%CPU*@2NNK<(P;.,)F-[2-A?$S*?/P-*L%GNQ7I8D
MU,Y-[)]:=..=LEL].D>6W2?ZT3X*9+'WL5/G0R5N;UU'_+6I8ALMY?SR_>5D
MEL4P%^C39H107.W_ $O_ $1_[/&9*>H.V]K_ )7V=&OC:_\ Q''2J&9UT_DW
M#OXR8<\A[FEKH9E$1$)N6:]M-Y+-EJNY-A+=@%L<@A-1["&5EM(!G:02)::%
M$Q,^,@T\JRRV_/.=MS+%@M(5R.:WF,]$PN!W,]6T($8^$1 ^7BJE=&K7IU1X
MJ]3+*SE=>I'QY5"Q4FUN9)F>P &. R*N6FI)F=9\8N_=OY;+GU%3?>M+NLGI
MW+,$L<O#K:VW[0D45D*K90<C6&M7@K9%VNT75_6R=842L)>H9#-U\S2M39@<
M:*JU(UVG5.&+_-6:5DX!4&CM]824MWZPP1\8C^83$\5^2D&NV?S^FZ&1/E9Y
MH^#F?'_2^X= *5MMN#R9>N/OVB^/+;LEN>W2=1#>4:[%P"Q_J ,>%92\BO9J
MJ?M1<X>Y#C3/)VYRQ/J)<F&PYF?00[O@6L>7C$V7X-]JSBS[5UUCW63V@_D9
M8-;'%ML"T WFI<Z+$1';H,#$S$X:C/5-U74&6R 8)W3=FID@QUQ2^3.\;.::
M:&L90*L6W&K3+4U[91W@'Q:B,-R-J;EVP_3:!.;Q!$P4+5+3,%[X$>39!:;Y
MC<7QGPFI7KVK5U*]EFY*)LLW&7)VH2M'H(I6&P)F/=B.[XGNGS\9*_;RZZZL
MBWN JTZ]! [%JV5*I22%:H!<ELDIG><DPOZYEXQG\S+JJQOY,%)G-6C\]QLY
MIL;M7\LG[XI/1DD/]73;Y>$545KV4R2 V7<U:.[DW;C+N;3'/>;>,R)2=6V7
MELK@I<;]L# B$#&1N14LT8=^2VUN585QJ]XNPKA:._9R!O7Z=0,9'XC,%Y^*
M52OC^7LU\/-LY/4;-W'NV?G2/33>7U=-=?/72/&0S&1RFWOK'/LTV^Z0K3;O
MT_,J7_RA_'Y_=&C:=9]BK::O<^GS=L>]D<?<!"W>D2@#WA$1[P2V_$=)\_",
ME=K5G4T.V5WPP6KXU%NAJX4?K,",=P# ^DHT^,:3Y^%TZR;;+RU[;3=G(W>R
M=VQ<I'T$4KC1<R/D$:_&?5Y^,RL.H%5DY>.[736E5<=91QKKBT5#K5E)'L%S
M(U.2DMWJF9@=.=O^E_Z(_P#9XS36=0I17S!=XJM2K8Y(:17V4Z;);63NJPDB
MXSF9Y"DFG\#,H\O /:MM-X%HV@X;%0MHSQ.%@.@])B1/1@"6UD&/EIIMF8G-
MK#J*'1F8[R'[>7SFONVO[F/\UE&W1WK].G^C]7T^+%NQ:K5JCV;Z]2P-NNO:
M \=@.219O 1,M.9GI,B"=WF/D.F6O6L[CEXG*M[K'J6M*Z^Q:-JU$@UCRUP2
MZ=I5DSK+)*=GG,P1;HOVQJ6*,-TJVJMBF]6Q?KK6H(7KW[.0=\%/K Q8.OH(
M?&+L-PT$.-/MH,5 4;1=J*8,5Q[^&_5@RCR\YU]6ND>,?1JXL7A15P#94U#X
MWL;O4Z A@ZN-DCNA8>8;2C3TS&LZSYUAJ3_FX:[5_+<?)/J^O]?S\R^[X>7@
MRDQ0!>8UN+ACX;.&-%_#22VQ/]?=K_6U\#:>$P0GI,?"=H?J^T?%2[.1RS_;
MN.;<MUZ[:]#-&QE%2L.JR/:X4:U=2JKR6PW6XO,,[C!+C+<L(F$(ISB[)9R_
M7ST,K6(Z?Q\$O&MZ:?$.BTPCI.YLM.3L=M;!=\!&O%?A1N6XY\5,SDJ-2:-6
MQQ59*"E7"@_,86,>MBC9Y0I<?7_J_?.N->W#U+%''%V]6TN5/5H+=ZYYM1WO
MAK!_SAOF!C/J^/I'3_\ .2__Q !X$  !!  $ P0$!PH'!@\+ A<# 0($!081
M$A, %"$5(B,Q!Q8R,R0T0$%1E-40(# U0G.BL;72)4-04F%Q<A=3=7:!D28V
M1%1@8F-P@H22H;2VY55D=*2ELK/!T=/4)T5EA9.F"#=&5H"#H\+#X?#Q9H:0
ME9;%UO_:  @! 0 &/P+Y%FY<O_V_HX]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]S
MCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_
M<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!
M/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^
M@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>
M?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SC
MWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<
MX]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/
MW./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@
M3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?
MH$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCW
MGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X
M]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W
M./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./#=G_ )')]/TH
MGT?@<WKDG]2K^I%^GCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@
M3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?
MH$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCW
MGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X
M]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W
M./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3
M]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H
M$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWG
MZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]
MY^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W.
M/>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]
MSCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$
M_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<X]Y^@3]SCWGZ
M!/W./>?H$_<X]Y^@3]SCWGZ!/W./>?H$_<XS:N?^1?ZOG3Y)%+#>K'$F 8JH
MXK>ZX,YR^Z*)?,3?G_\ 5DY.>/\ -_JFS_FI_P#17CX\?ZS9_:O'QX_UFS^U
M>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M
M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VMQ\>/\ 6;/[
M5X^.G^LV?VMQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5
MX^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U
M>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[6X^.G^LV?VKQ\>/]9L_M
M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[
M5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5
MX^/'^LV?VMQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U
M>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M
M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VMQ\>/\ 6;/[
M5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5
MX^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U
M>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[6X^/'^LV?VMQ\>/]9L_M
M;CX\?ZS9_:O'QT_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[
M5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5
MX^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QT_UFS^U
M>/CQ_K-G]J\?'C_6;/[6X^/'^LV?VMQ\>/\ 6;/[5X^/'^LV?VKP\-A((5B:
M>CBRW_Q%J[^/FG3S SYOF_JR:OTM1?\ .GX!AJ\SANW93>Z20SW<VN&GN9(%
M]DSOG^?^M%^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?
M'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'
MQX_UFS^U>/CQ_K-G]J\?'C_6;/[6X^/'^LV?VKQ\=/\ 6;/[6X^/'^LV?VKQ
M\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\
M>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?
M'C_6;/[5X^/'^LV?VMQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'
MQX_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ
M\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[6X^/'^LV?VKQ\
M>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?
M'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'
MQX_UFS^U>/CQ_K-G]J\?'C_6;/[6X^/'^LV?VKQ\=/\ 6;/[5X^/'^LV?VKQ
M\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\
M>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?
M'C_6;/[5X^/'^LV?VMQ\>/\ 6;/[6X^.G^LV?VMQ\=/]9L_M7CXZ?ZS9_:W'
MQX_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\>/\ 6;/[5X^/'^LV?VKQ
M\>/]9L_M7CX\?ZS9_:O'QX_UFS^U>/CQ_K-G]J\?'C_6;/[5X^/'^LV?VKQ\
M>/\ 6;/[5X^/'^LV?VKQ\>/]9L_M7CX\?ZS9_:O'QX_UFS^UN/CQ_K-G]K<?
M'C_6;/[6X^/'^LV?VKQ\>/\ 6;/[5XBNGE>120YA%U/D/[P[5 -]])-^1T^G
M_)T^20?\(1O^CVG#_P#@_P#F-_V3IP3_ ('_ $6\X9_8;^I/P OS\[]HU'^R
MF#_@^P_;C?DD'_"$;_H]IP__ (/_ )C?]DZ<$_X'_1;SAG]AOZD_ "_/SOVC
M4?[*8/\ @^P_;C?DD'_"$;_H]IP__@_^8WY+%J[$3S0!-#+EB:DC(L=EG6QS
MB<6*>,4#7AE/:IVDS%GJ1-6ER0R5(BC@V,V\VAJ.8K(\:)(A)%$DB5+EN.C1
MS-"%56.?DCGZU=T_"DL38;OA5XG.86<6GL&0Q/8)3O:22Z.@6.8%%,Y'/16B
M12+W>OWD@.+,(,Q)F,I F?B6RHD%WH;1CR@ID169279N=F[?ZIX+.*C_ .3-
M+AMHEBNKUUQ/7I'2 D%5_P!4S=S<YW_<]O:_*U]UF+<%P>QS&KZ@C:J%)M<2
MD#*F%A2)+-\]IF\@8DY O&L1-+0\QH&I.YDY%1?H5,E_S?>+:0\.7TNM:(\A
MUC&J+ \% 15>V2998H[@(*.X9&G)N:!*-Z/5JM7(%:C2-*53M5K0O(1K@A*5
MR;**U^:;2ZDS33U5?++B+5X"D]C+82@3))-H%@KVRPV,<S-JY'9Z4=V7#=N#
M>S+:TM:W652%M[Z;S]@?;W9'+Q(NK: &,SPH8(X$R!'"SNC3/1J7-SG.5A&+
MD\;FO:O1<G-7-JY+FBY*GSIEQ98;GR.8KZWD^SF;407*\X^^GR^\&*PQMXS&
M+XYW[>60]+55G&,P8S) '6-?B(H%L+1]2'GFXG<P2-D,EPE>38?*R#N.1S4>
M_0NWJ::-@8E>6F3;VW5MN^YC]:^M>[*62;.5?A1):>^7)Z/'_%:6?<!:54CE
M9T7=V#[0#Z-X)(Y?#D#,%VH)2,[XW9:M3<G(BI-M+ F]+E5F)-TF@0]6S%Q!
M'9W0C$-,A"8G=&W/+-<W9JOWMJM[&(>""MG-C_'1"98C-4[3T/#F1-96AEE^
M"N<Y'-76K5R:K9]5 &0=<G*\HCQR$;UJZV0?062>20OCRGZO%=H5=/1-+4^^
M=-BX;OI,)C $?+CT]@:*T<GXL1QQQW"1DC^(<KM)?R%=]R/6P@R#R)&[H'%C
M$EF7: 4[M(!=]^3!.5<O9:CGKT:O$B=BP,3&5@YY71*T]M882DO$L0I@()D6
MVF/,CC5\D#'\N[<)*5.JQFL<R OH_B8?F$U;("8]OY\@VD4TQ-N.23!(_;%#
MUOTH[2PVM<D9W\3T]@7?8S#-U9-+HC"R<T<6*@] 8PU\B/=J4F77+1T1R7/_
M -+OV5!^4IP3_@?]%O.&?V&_J3\ +\_._:-1^"APV(Y72Y4>,W0Q2.U'*T2:
M6-R5[LW=&HJ*Y>B<1\05T,P[U*/#9CN:VU,5\^9(K1V!%C$LB!&]S9!M8$C:
M ]=#!Y(K?PKF4]-:VKV!?(>RMKI<YS #>T9#N;%"56A81[&/(O<:]S6JJ*J<
M%C2@&C2 %($X#C>$P3"<K"B*(B->,HWHK",>B.8Y%:Y$5/NQ#VM;VO '( ^5
M7<X:OYH##C>8'-QT<8&^%I ;K$U"W-UO>8G#\<_W-VA</3JJDQGB8R]ZZ-4)
MG,24/+H+F$^!]<]KYMU;H5-@P6$+R''L214;BJ]Q'*<D>-%:$[8$B7 U,678
M"TYC(Q21MG-V^K63:0V^](W+[9S0RPM[>A1);M(B$-[OFD8N17_,[NZD:GW5
M%4U=C9E1XAJ.OA29KT>=5:%BLC#([69S7-$W+,BM5&YJB\+$M*^;6RVYJZ+8
M13PY#<GO&N89#!D3(@R#7-O1['M]IJHD_P!(#FO=,BX6Q%/@*YAQ##8T]@I8
M9T*IW1CJ-]:B[!(KQ.S7=81&.1UC6W%WS588NURG9U.'*/&F\U%%S$6NCG79
M*P:[FXCR:<B*YJJW[@FUI],2QU]H1=J(O-<G L>4\8\620.P22\G@Z-SV2:D
MRRH4)EMK)JT?FN2:/]$.K->F29?/GTX':C/2^O2Z]8DQ(9UE_IF2,W.F[44:
M?P/F[XC[CX5Y^-]Y%I0ND1PFW^8GA@%GCB;<*9+%O,86.B;[HBA'K./-556Z
M]&A8.'O5H&)+H88QK&Z%B2TKWH5G.09D$U0*1/#%-S4/FB>(P@5.D;;:UB.?
M]Z0<PDF!6Q$$X\A:Z0>.YLJ)8$CJ\[)4) HI8C$&N[XSB(B?S7U]:+!-;B1D
MXD3=LHWI!NHPH Y)S ?NCCRI@W-BH!#O<\P<VG:CE&C4<Y,28$*-A6QX<TM/
M5/FXC*C+<\+EHSCNMSO9R07RLB\JBRFC(]S![>;,G-5J_P!**GZ_NH,3'D>[
M/)@VJ]RY)FN36YJN2(JK_0F?$3$V/I0!BL]AL2);DEX>:WG8$2P 04OM>)S2
M(U)@V(@40R(0F?@Z6GKS>C:#5M::  $PWI'OWL.LW-'D&PA8[7<H[3K:TC]2
MN1'*/BN;A> R%!FX<KK1&CGS9['EEV$\>ZP\R5)5[7QQ!:W2[:5&ZVM17*J_
M=JL,%F[U1- ^,Z-R\ >D-326QHC-YL+F5T.&/O(=KG:/$4B.<BU?^+4+]J7?
M R2XO.QVZMR-O/C[F;'-;XPT5[-#U:3HG>TZ5Z*O%S:83P^S!]K2AL9'9(;J
MUQ5,G@KH#9&XT<N5%( <J1-CQD(V*9HRQD1%(LAPVF@RAF"<.WK&<+XY6[@F
M%;J"3OLS81JIG[351R=%^]@X:Q1@P=A.GR9KDNR8IMZ[9!%J%E-#V;#)'"36
M>(9=W?8Y.:T]YH&M=#PT7T7,F"DRXT<EF3'>)H XPSBK3/D/"XLEN@+;!=6J
M2Q,@:E>U']Q^,L*B2NCOJZ68&& UC;#U6EA&;J;/E6I4>B19HV(NQI>T:%:C
M'%S;]V)AF_P.V3*E 8QMF[%5U&7>AUMA+EG; BDBM?S;HC<Q(9&Q=7<S1-+J
M+#1O1DR4*Y2L<^S)CG$L%D)EA8RH#GO XYVD;&;%60Y5DA1Z.5B[:-W%7&6#
M(S*\0<LX\65978I&Y;0*M,ILFT.QFTY93UT@=J<]PER437H\:^8WN8N:9+FU
M51<T^;R\OF^X\-)36MP8;'%(*JKY=@1@VN&UQ'LB!*YK&N*)KG*FE'%&BKF]
MN;X=E#E5\L6C>BS8YHDD>XQA6;@3L&5FL3V$;J:FICVO3NN1>!62R</>N2U]
M$1X_6T_:'-'[)[21:GMK0CTW9VZ/D_@^1,FCV4T?>#CQPED',1@@A"-Q2E*1
MR,&,8V(KWD>]4:QC45SG*C4157A#K@G%R 5K7(9<-W.TK7Y:'(3DM.E^::5S
MR=FF7GQD1CF+EGD]JM7+Z<ERZ=/P,'_!]A^W&_)(/^$(W_1[3A__  ?_ #&_
M);#&JY FK<2J 92INC5BUT"V8/*'IF([=BZL]Y 9(O=0JM=Q48@"%LF>"EI9
MVMFV%&$NY&'G'5'3?'R(C7Y:3:^F1G/SZK%DMF-J8P5DV$F#)A D CAEUXY1
M&I+8?7M1IBD1HXY7N?ITM?DYBV%1$Q/C,ME4\IVA&WH ^7YX#Y,3Q2X58 NZ
M!CG^"4FC+230_)O#Z#T=VE[?8AA/<MK M"Q0MC1HQY<*<1D@U1312.#-;""U
M!2C*]#$>QA!HI!0L/VN(L7QL2S.9TUPI%>]B\N%TU<I+,,GB-R@;9UU2^JN4
M:>)X:"@2\78M#:$T&6,=K)+>4<Z6'=0D/":BU<Q%</3O:LD5VWI5KN 6\&_Q
M@:O,.67F'RJQO<AO49503L-B,FAS"IDH\W:<V(J*F;)V&I=[/>:JK+ "6,NM
M5CUG3=E_1E; <UB1O$8USFO1_M*[V.(='B'%6+H&*)AV1&5HG1S"=*E$'R(D
MD@PK*B-WA2H;G/?,T,4JZWCT/:P&%:J+-DQYXI4NN=(GU7-2(0R6:@,I?@\<
M:OCP-;V%$(FK6FVQ7,8GJ[)Q3C(=^UP6E@-+#5&NE;*QDYA,*OB+N,E1EZ25
MT[G?TZ7HUXDQ9BM+E2F!'B2D8<3RPY484UKGQ<+,&FR,SW(JR&->Y&[:DZM6
M+71O2!C(D^=*##B 2*8:%/)(,$=FX7!#1,UF(C-1",8W/-ZM;F[BC[:GWD+"
M%F:\W;5\B#+F-BPQ![+((4&L,5KI$B5$8='U[UTE5=$=&/>RUC3[VU#AE\N<
MLVQ&(BS!'=3%'(8-B4Q7*UE?K.W*"3Q41-3U\%:VBP#<WE[2GYSGI4E10I@=
MJI69&VEGTU6SQ)0)@W_!"^$)OL*YA"3J2IQ%BN5C2#5R91J=Y88X[)D;X(02
MRBX;!#>)MJX<7P[%=3';C2J)%.DREEB(%\;E^Z4T:03QH<:5WB1542])+533
M\RHB]Y'<+_87_P YO&&DP_5K8!B]M,G.;.K8;@LF=E,&J<_+CZU=RTC+;:33
MM]]$U,U"J+28Z);AA5$H\28&1/1AGI6UDAN]51W <QA8AF-TF<NIFO4\;F*L
MC%6,26]74H-9(Y=7,K=+H<$\\-J58SH=G+SBLA,5C-I'D<K]IAT5J-ER<!7^
M*KR6&1R8Q23088EEB< LL3N?P[5^ZA&WFO0C1N=DUKWNS'P*NN+S$L;& 8<R
M;:5, L1D:,$=@@(KQR#4$N,]"19, CVCL#OW#NZ#T/&*YCI>8MUU4EL?2V56
M-R53R!+K5^'M+U\!>H\FYY_,J<2(-+>6LO"O8>(QFLI(GI.;6FD6#K60C.QX
MKMV,1\EH$[/<JH-F09'F\!JG'F*Y-TA[!1Q#PY+8[B.C2TE-5RX-CMR&%3N9
M\)3-S&]7^RY'XIO;:MO!UO\  4."(CX\R6QERM8*0]M-/:QDB6Z0(JNE14:Q
MC54@$\1\G%.,9][58839Y.RKY$![B_"Y==(UQ&UEE-318,C ;G$'FA'D[XO$
M9:7/HVN<28A/4I.YIM@>%# )8, DHV;9M'3$)H>^"B[)':VF>@\U:Y18DAS!
M[,@/8^X/6,FG<@WQ6=\3GL7-CVKT<N6>2]<TXQG+)'F]EQ[K$0$DPIU7&?SX
M;I2;#AS=TJMY>;N*] HS/2B%U(YJQ<,X>)8S5F28\0"64B$X[SR8U4\+-T4:
M#';K//<S4]&L:W1J<FE[G0[#TC8@Q1A^Q+ @3I((18DT QS1@$CF<AAVW7+M
M!9 &MWWO:QC7.[GBO';X.[6M:%8MG++.LYU6CVAK0QW&>@.6K)'<-SK7-Y9S
MWM"S;1<T<3B-&NY$B)4NBXA[0DQ>IP0E/>LEF$G+RLWBC/*1B)',JO:W(9/8
M=,=@C$>++JSB-AJZ.<L.&).:>J]73\-5S7> "6]-)^BB1'=7,:\3YU_BL5R.
M-,F6$2*> P (\>6\3",<7#IVNS Z,]S622OUD=DU,E8SU9+B7$38(K*\@RBM
M:G-C[,'+V,G^KC@N>\L=&E<T#V*FK0@\T<D4%)>8@E7TAP#\E:. 8/9I1V;.
M80D6CA"1_.0A"1BRM>EQ'*'2K2-XP.V.J D8GQ=AJ7+4VX1[ZBZA1$D:"0'"
M\%SX2:8LAQ79HJE"_-BI18NAA1P_X3YV2S9"WXQ15D;4,J-EDZC<-/;T>?=$
MJ<39=R^SC54?F(XY5;*KQ/6>+LTC0.')C3"Z5CS"D5Z :S-K$W4<CF.N)&&<
M88PLI%7$<9S";49B&(&2^(U_-X1AZV%?&(CMM_=1O></4U5M+;'5GB"EJA8@
MG4U5*KY$$RR6L%'DP=X(:BU.A31N;(1ZACB3:8U6B>J-):8FP;B7%-LR#3W%
M@)TMT< 7&KP25"T@9&&JZ0HG2(AF%1JM<K6=U[-3'J;$F,)=S5T\>Q)&-,K)
M,%=$=\."2$_E^S[.4XAI<X0GZ0JC1N17,'I>1(N),+WN*+*CYATBPFR3P0[%
M%!YIMQ-''/A^#+<:(2*YK!M 8I<E4,4Z*U>),6NNK0]/V9AL<V483TD!$'3V
M<YB=D!57')T-E&)DGY(?/AWJ'B"WNF\U':U;,)19Q'0W/DE7<I*GOCFZ1,3)
M/#55VWIXJ%GG"A5K-O;5R!<UG.U=\%V:$:Y_>TI[M6^7?S3BL"0[WB;A^$3;
MUFV]Q+&[;KT/<K=>E^G5EGETSRX'-K)LNNF"U;4N#)-$DBW!O$_;.!XRLUB(
M\;M+DU#>]B]URIQC(DN2>41,,8B8A)!B&>C$92N1B.(YRHU%<Y=.>6;E7YUX
MN!8WMK"GJOX/SDUPWD-^(1N3NCK+1?C+8@_B_LD?]&L;X-!C?&4^<&*Z8<.V
MD5& &0 2/W)N#(XUTEDA;I:1SUUYHBM:Y4]5!QIKH0K.BB22.G5?-C!:BA%(
MY")I XB-D$46D#T;I:A&/7/42ADXQQB/$$*.\ME 9M*V.^.=(<Q&R/5!\4C1
M3=04VI)=2=]BO'XG&(ZIA+IV'L.EP^Z5.2;5MFB@V4'G)YB(^%XSPH.0H&QX
M2NTC1KA&<K=1:JKQGC.59!ERH!8V0@Z9D!CB3 [LC!X@KM,8]=;2J-^60WO5
M4131AJ]6#V\E>J*[OB8]<U:UJ>;ERZ)T^1IP3_@?]%O.&?V&_J3\ +\_._:-
M1^"?<$&1P<-6%)9&5KXZ#:-DF1)>IA%:XIF:8*YCC^(K4<WVG,XQ+16#@'$/
M&%Q60 H&0O\ !M6.#)B-3FU, :,VW+MZ1C;EX81NRX]7N75)[I$&*..IHZJI
MIPX[@,WFOY9-?,,[RO1C-7B*F3LJ^UQ_<8GHB3:ZODHD*37RQ+(*$*SF-;#H
MK4C1A/)CL%K=FK7^V72]S3R9F)L7AF$U0ZP12PY I%L:(>1 BDY3"ZZ&'<'O
MD>0(FMS1YQ*J+P3$>.K7$E+3$BULNOF0I-=)WP3\FZWQXM+:2F]Z3 1C7@$]
MN^[6BZ'J(US98IQE&C-4@!%<6&=KI:13RF"<.+A4ALE&![E=I:S)NG6CE;G+
M-38IQ=-+!V.::-\:(T7,DEM!\?PL+7K;$*OAN?I5O?TZF(N*+:MML3GG4*W3
M&"/+K.7W*N 62UIT[# \GBM8TBA,Q',5=M6KWD)BGTAV]_15A-/(2JPD8[3Z
M+"572M<<%-<2V[<A(0VZABS4SWMUC17#K<0^CV7=WM5/-##S5I*KP]9429-[
MH"UU/);\'9"(U7BR3=(QWB(K11;CTBV>(Z"7)'-*T=;*KI(%9!ERAG5&QJ>X
M>FB.V(_)Q<WO*_;1<E8.ON[;&&,XM9:MB.@2<XY]]LZ,67%79C80-(%NQPD)
MXPAZ-.DFEZM:IEQ/C7$U<9-K8;#BR'H_-Q]W5IPE.]EK0*G>;U>[VO)LN^P!
M>8IO=H@ !66>!#$X[B0R&8\<[#]4;N09;#-=FUNM4;J<YKA<%+A[$-Q.NGT-
MJ.PB2PE;'!6+:@4D@3G4<-JF:YL-$1))E\5_@+DJCQ'+H<57TW&+KB>^1528
MYFP&3R7 ^T@M([#<1FU'8^<H5[2>BJ$>13YHA:JV](5UB6AESY!H+AP#PI0.
M>67+2$%C8M%;O:AH,;>>]Y5&TF:.(-5:+B#B##);>?3R6$D.EV<NN=E$.:M'
M5E: <.OE(LELY5(U0J]BZ-Q@=+D5.)-;6@YF;(V=D.X$.O:Q98G)XAR"$W2(
M3W=YZ9Y9)FY41;O%6.(YZ20V)911-65!LXKHJ#K;%A'"IEGGW%?72T7Q6IMB
MT[:/()SYKZK7,H \OS$Z X=:<>YA\2"R'<Y$=JFU1!=V([)C7JN37B)QV#.Q
M=C .(H\/FI]>Q0.8#:-R<K3(;A(L5[13M041DHKG(FMNL?B+$I,42+:LJ+&Q
MJXL&2R3!E2S@(D'M9^<*%,8,D99K-G=BC1VI,F2-+^(<[U@Q?R,X$<\<SY-:
MY2))8\HET,PVA&(X+-61!M5OD[)W3CEX-[B(EI(G5+FQK!\<[%DQB;T(:/AT
M,8:,*LQN[J-Y*G?$K7+Q,D8FQCB.OQ%H?G AQI#XFE;2:XW?;A:<WNG?,8WX
M;[(F>UFCB'AT^(+>7A!:3$8RVL@)6SVUQ3V2VQT&M)&?NQ2.EM G9RJY!,R#
M(SS($>!9EU=X1>Z:"PM#R(,*:"U .;)6,(5A75I%'L+6/5Z5YAKS!6H?6US0
M2L/TV,<82\2"C[@JYZ#$QQ2H!(C723X0CQ-)32XC7?"VZ4+FYS$8]S(<:;%*
M"*2=? KR&E09)#@@!,/6_DWKI?H,%7ZQBU.?W&)DY&X4J(@G&-/LZ.(C&$"%
MR\T>\C)I)(<T37:C-1%?W45<W=U%XL<1V;KN+=1.4VXKI]1(@KOW((+M;8L,
MA%RB'&1NF6WQ7=<T1PTL;O%#K.OPU6)+258UDNO0@B0AP)9VK')&L91$9 D2
M#^%$=J<QC&*I/#?8"P#B/%=[<P>5UQ)1(D,2<R_4W42?AJK&[.*"81-$CHX3
M4=U<QA+"GFA<!\65*$-I#1SO4()9XK'O)&<X2N50.1V6GJF:-1JMXQ7>[:(=
MO87+G5!JH\Y=Y#+MJU-\>ICM#\GMU_TLZ<8I*4CB*F(;MC5<Y[LF=K3'(U-:
MJJ-34N2>29\/Q1CNSO:6"0,B3#/5FB$&4%=)L0VCW ;4VTIO+-C TM<T;RN>
M39:9,D9ZR82L\1VF'^5A&Y^9*KA+NS#"T-Y8M/7R]+H\J&]/@W=<54>[-CV,
MGXGK,18PD1 5MI-C&+(KVC>ZN%*5VX!V&0R="&BO:Y,F.<U%VU[S7<#Q)+Q/
MB\<<8XC9Y!$B;891Q0U<-@5PL20YJ&F#:U6[J9.3-ZZ7NX**K,63!S$@#&32
M1^H0U)J1P0>R92-3,3>ZB>?M*RW@B;$E3L.8*D&.-HQO(1R1$<Y7Q6C,JKSA
M<U>]SN^O7J_/,CWO7++-[E<N7T9KGTZ\8EK)D@DD"CP^,$<[RF&QD<%\[0-A
M'.$-K=L?32B=QNGV4R) +<XDBW(:YTYL"O= C@=6C.@4EO>3#I0*191E"YG,
M(96-8NSH36J88DXMQD._=GI@(Z,[/*'V@[X2W"3H?2$J&ZR/]S][W..7A),)
M32![L&7/DPCR##++L&1G.;%''5FY%B-(J/C#5K]>I&9M&E#!DA:<!>U-P;VB
M<UVBDLS-S:9KQKD\2.ZM7)4S3KDO&%Z.*1T>+%BTCV $YPVM4,:]B-[HE:#H
M-C6=UB+DB(G<1$X:]CG,>QR.8]JJUS7-7-KFN3JCD7JBIU1>*\6.\1WC*D07
MPWR>9ESC0X4:,8D"-&:2+9JR.V:K&- ..X8VD>YK!YJ1%K,-XYQE8VKQ*^/%
M<+E6O>X@HXD4LS!<4*(Z2< US,W+7J54:USF^I8P3'!+*MV156;6<X2- [4<
M$BFZ16O<R!F34)F??TL9J8B+AIN-L9K>HH&+!T-3OR^7Y9.97!O*>)S<?_5&
M3=SOJW2_37UE<64:-$ML7P0OEO$\S@0*JZC@<]1 CMW'#ZE5!M:KO98Q.[Q5
MKC.\O:FQF0H5/3@K-MPI<N1/G=GB([L2S:-3G+*8XI31PL:-FMPO:(V3RDIM
M-*DV'9TN7.K)!9$$$B,.(9PX;F%80@I<=Q$)'$NHGNAZ7M:6(\B\O/J7PR =
MK<(O-6](-S7#3PUUL30NXU6*WNNS3B:^, 8&R>6S03!#:NS2TB=&B:WYWN]K
MYU54^?[V@_\ IK^Q+'B#90J<DBAYZ'SLT=E3QWBA<K2@EE8"9+:=SAI&E:6I
M&(JJ/H,B.8CXGHY=,8*&##]'$E.=&FOGB/4S6@T)( +DG9/JA-(YD=['YE4:
MHUP]$[$P<1XP="! L90#D/7J-[X(93W(\"889)T(^*1')I8KD;W%[S56W@R<
M18D:2,2,E<V%M 4["-L2&4SI6'C,S:*(QS?<>;TR<JM1L8&"+BSN(+X(2R#6
M;',*R6X\UA1MU555X;0CB.;X3^\0GB.]D>'?_IO_ -7KGC#UHRN,[#\"%4LL
MIX+"J 2/RMQ82)FD$DZR";4*3O)M12ZW9,9K>CA\-]&=#9./+C9]H@EQY_.!
MWK2MOXF4P0(=<3<$<SUT;ND2-$[0?/5++Z1<2W=&92G<'LH!C(1%Y-PW/5E!
M<]7N)-U9N:OA#SRSS+96/HZQ'BK$$R!R>H4LD6"%.:F;":DL,-U+G9B!-<F@
MO1P6ZNCF-)=1H%O:&Q9#98U]I5R6ZHL:/'D4XYKV'95  0H;(3([5%/,UPU<
MY@R,\9+(0\37[L=3VQXT>E8)S()+8M7 CT,7F"X=Y=@YN<3?(2T:,:E>I#Q4
M1=LN(+8^((MR(5:1T5MA3%A(LLE>$W0%<9ZHTDB0T>4OIH&JZTZO7$57B#%L
MI.5G'16G@1PZHII@6^%*PV(^E7Q'([KFN2JBHCF\'AX=Q%BNPQ("0Z ^O(2)
M' VPA[;[./O2<-Q0*D8.^]A&S%$16-013*J-<#"$R 44L<BO[4"&;6[T:#+-
M 0AAR%,6(\B GB>QK%.Y'/34)V@C4A44C$^,67\KF!+!8:%IYNO IK$39'JL
M^*C8^V3)SI*M(C<A/*JIFR3AO$%Q:XPI;"#)938@CK*K5<R-VM#WG1</U@WH
M4[( R;5DU=B09F8WYD#ZT8P&^-A*2,-E'CBM%DU"0[:+,?"&*F[7L#"BA*>O
M2'&6,CHB;>M$V%<,1(PP#8D1C%2.%0,U(:0Y55BHF;LG-[WT(B?-^!@_X/L/
MVXWY)!_PA&_Z/:</_P"#_P"8WY)'K8(7R),C=VQL84CG;0"G=W0,(1<F"<[N
ML7RS7)J*J1\,8SPQ>7*%<*] VHE%V6;B2Z\:O+ZR54C=;L2D</)X=)1NS<_W
M<W"^#ZBVJ1@CU,7EKDC&[P(K))HC /'=VDHG*A@%W7=']X:D<1%<YEGA2XK[
M!@+C#TV0[;AE;%CML)M96K,FR938TF/%$R,3F2LU#$/Q&YOU:<4XHGXGPFYL
MGL3E:B#B..:^#LU;ZXV]73#QFIN+-9)'XY/@>L_<5&L7$>)*\=G)BR8UO !R
MD2#*.H#8@Y\1-*'>!8ZCT>,TKG*]6HF;':N*_'-GB#"](L?F^;J[N_96X@7=
MH0U ,JPY4"WS9(ZF9G"**1WG/1O >QSK(AUE>.LWVNB%CF)#L+?Q8IXLB0AH
MY!2!N"1SFN(Q=:L3-JJ')%7+#F/,\DS_ (V?Q3OM),>&1LRX<DB7*#%",;L/
MR1MUN,<34U/U,:JMZO<C47/R*?$?H\QJ;$0Y%>=E@'FQ1Y,B/$@$BK%&_%L(
M)ECB6((K$AZ=UN1&DU:GX>G5>#L?P*^/2CCQ$F8>$CGQMBPY<P'.L9#3QGA,
M-HCJ5VYI<N:^TZ1C.QQ1@NO2+)IIRU4_$Z1+\;JN/5$1BUQGL%O'9!4D,;SZ
M3C+'<[2TBZ:K#V'B:U#8XJ:,TQ1)"*)6-EB(&16.GE()X:PCF$T=_,2IFUSW
M-HH2X;G'Q-96=9R,NHG64\$>-,F**,LD4VX#DT5A W#/2$;)BC:CB:W"3")-
M#VHH+-RZFY*S67#F2/\ YKOFRS\^G&(E$YI$2RM\U&J/1,L+GSSTYY99I_GX
MQ% E*AIQ^R?X.$=G/3MJ7>F^"1>9&<O+"5IS[36Z HI'YLZK8%B>CC'[<7.L
MY;2%CQY$E\Z4MOJ<>'!D8L5A0R;,#71]N"Q'KD)HVHJBX98#H<24.K5F#$M;
MV9*?E J0=T/,2$73R^M<G>[,!W\9DCFC8\CMM5R8U7KEJ9UR:B].J=>,+=UW
MN,3?,O\ >Z3[E1)P^-\Z"*GQJXSX;5FL&S<R766/S#69N#(R5Q$]AZ9]QVFJ
MG)"EMKH]C="DR%B'V!&]73-1A#[.V-^HH6Z'$:N;VIEF],\8DB$&83\*BT/$
M1I6NR;A-KLG,<Y%R>BHN2]%Z>?&)<T5/]$^)?-/_ **FXF#:Y'$]4<<=Q%17
M_'KG\E.OSI\WSI]/$1NE=7.77=R7/I LL^GGQ@8\GNQ166&7G(Y=#&C9:73R
M:B*K6M1!HY557-R3JJHG7BAE4;'S:\7:FZ^(BS&#UXCK!LUE!OM;J,,J-U%3
M4K7-3JU6IBB?)CG!6"HKL!I)@D%'9(8ZB,0;I#V-$TC8[7/4:E1R,17JU&IJ
MXQ\:(]I@+ZK9$$]"C7+#4UJ]]CGM]MKF^?FBIYIQC50ZFN</$?\ %ZLV+BMO
M7)S5Z9HG7BE6?DQ28DPQRSWD034<QE!K=FXHT<C5</5T?E\Z=>K;!(LE]<M,
M%[9C8Y5B[1;NXV%YE![.3]P>A=Q=>MFE5U)G-CW+'UYG89QGH!.:L,WQG$#E
M3;D(%ZYM*)WDO=>Q?)R9RG,ZM62=6JG5%:I79=?GZ<%:$1"N[*Q4ND3'/=EI
MQ(F>345<LU1,_I5.%.,9!08O2RW /1$4M3?#BHXBA<@O'S3O$%J7N]]>[Q(E
M@F-Y&SE8;J7F"L,P5!)9AO?UF*30P2+'?NF&_<%IZ9=[*M](9FQ$J!RKRRF2
M6S9>I[;\:1X9&J1S(";AIS<_A(QJCO 4JZ&J.7((\CQQF1T5XPB72TAB9:0(
MC<LRKU7O=?H1.*Z!RKI$1><YIR\TT OX,GF!O'BM5P=9(^0^K=QZ:.J:N*RG
MQ7A#$UI<86@PZ9)-?(>V*)U(61%1@].*Z]Q&LE,D/8LF*A7C(S>:B^&RVH<#
MULV'&A<AM5MH1>9#S.(%F/U)#L;>4NX^!+.FX]>XX>C(>I!XC!V!BJ13-LK>
M"BT^'5G@[1;*AL3X5-"%5^"P/8WM6A1DV>^YR6UK5T$H%S%AD3.XLYL0\>7(
M#(BUY"Q*Z^FB:U%K6DR(%4()&/1A5>1.+FAQ1A[%DNA!?6#*PM51M)7N>-L6
M'"4-C,+6EDHL.!(</,I-X#AGR>[4YAL<X5JF0^4AV%A/)8W%CS'\',>&*[8!
M:V,-BC[,D*B.>(9&J-2ZEUZ*_MNDL\6U$+#^&X4^/AHA);T*!:YHX2DAVT%P
MY462X$DXG2!%:!44FIKMMUI4X&]'WI":A:*XBMY:O[4$"+,UK(,<C\36!&1F
M3"L<:1DY0YZ$5$R8N)WB80:OBX5>L8J92H^N8]VS($CG*(X^K"L555KVN3-<
MON1A3I"1H\_>U%(Z,,#>5J+IS=TT@@]O-YF-'I7OO5&KYIG7X@BPGR:X-5%@
M'+$%-D;!!GO)I7F>@% ((P(UQ'.,CF9M56(Q=7#*VHBD(]VK<DN!+=#BY .=
MG-&C1Y*AWDC$8#4SQ"]U/RE3%T1]A4VN[A._.DFEENG16J_LH>P\RA#E)39U
MN%I7(9!.S[V28B26**2LK.R>?#*D3XCW\[A\O*[3X0]7=D0VN?K,'HC4;N(Y
MS>)V&,*X=MXMG K)7:TP9),^N/)BV$:OGH$LJWED:XD@$<HV+%CY :CM(G/<
M-QK*BKK><R!9X=FR^RJEUF1$BUM(82:=@K&D?MF0+7N&TKFN15R:N79.,,-7
MK;VNC\S-2[*2A531'-C27-!7W\<B+SEA)R:^,)J>*QR,4+!IB")24MW,H-[#
MY[%,.5)[T(X42$DR3O3+ 6L&M)TS;>L@::FG12,:!JM7<P]8"Q*0I:][;JQE
M5DA9$-O:DU>1K<0%R'F65EE%1S2H0;F#&)%;+K'."Y8VQFL=[R"7>BAD=UY&
MM>OO>]FU,G9HG1$^1IP3_@?]%O.&?V&_J3\ +\_._:-1^"61C:FLRIC"#:B/
M%B;@I98U1,M8TH)A2["KV'EC6 FQEB.U/1VM[Q.T.=%)A[".*:>>I9AQS9IV
MOC"*:$8<AQ.;QA,&F]'UA8BA<U"/;I1CN^D;',6$8L5F)\,E1\,<N4=65]8$
MI-+",Y-<G5KD3QLM:-:]6YORPO(L9]5AHK*B-)#)QI8^KH3K8CIC&6.HW%&9
M6;#6G1&Z0OD1FM]]FE?2T,WG35.(ZRS25!+63X)!LKYCW<L<4P[C/8:6P;T>
M)!M*T@U=W41U7$FRHF'# H<.N':XRDMP_5'<=:@QBQY(G&84;^31F>SDA)4-
MK4;OYM?ABDMZZVDS[%TM[Z.Q@6T5@I538U[FG(DQYQ$:1@E(C0Y,&03D=K)I
MXQI__+G_ )^(>.9GO8"*#TA[YS&>T(A!%BXCRE*4CAL&(8VO<\CG(UK45RJB
M)GQ1V6*,/7&,:;^$N2FX9D$D0XGPV""1S$R#?UH4WY21Q"U&+XL8XFZ'(YK^
MRL">COTCI6CL^9*D:H6T"DIL(<9[5DOQ#8%:5 )#S"I$1&Z7Z4<3-]!.M9D"
M@**+B5H#XQFIAUAE-+6.X@-@CQF'%Y(2RUR\!A .5%4J\85P53VL"VEU"49)
M,JDG0;6K7D*FQJ3-'*;)=(5VXT9&(2./X.01'Z'DT<.QACBJ%8Q>5G6#0Q[&
MWBSN6I95FVP&@!R:R.IC"CA;&3?TKDBO(!7N<L_U<JK2JIX]LL2OC60W(7E0
MQJI8KQO69.<8'*N"-AW2"*1PWJJN]MUJQ51'^J%NFA5[V:V]7DFGSZY]/IXL
MY5J1D>$/$^,=TIRMCC;J[7&S44I!,;F5XVIF],W*C>JJB*69C'!N)L0QUG1/
MX4IG2>SC265K]L@I4?$58!S8T498YT3)&F&1',<YBD2=0X7P/C^%7"A4,:/,
METZ/JHD*+/KWP$D6"74]Z,*"-LQ2O5[I)7#17N5RO1/Z^)O<?WN6T]U>]EC*
M;GI^G+Y\O+[F*X4546T=V%F)'(\I<K&[*FV!'/>NB.CG.R$F3>^O3O<8JC#J
M[$TM;F\EH$4"2\KHJW$@?,H)H=:@4BHU#:=O4J-U9]., QCD&DMLFZ1PE>UI
M&N(>C<+4)7->FIJM5N;.\G5,\^, +DN7)X5ZY?\ T#N>#(Y[&JZXPLC4<Y$5
MR\[-Z-1?/S3R^E.)F:>89"I_2G;=SU_JXE]UW^E3'/S+_KR]XM(4!S5GK?JU
M8Z$:0[SB@4+I"M CR$R1C'JJ(--*,<JM;I7C#$9L";S47$%#)E!Y0^[&CMM:
M]RG.+:UA"UI!N<4C6L1'M55R<F> XS",)+8W$C'B8]KBM(R-4;K7"1VMKDT/
MS:K$5NE<T3)>*-Z9])-9DN734B8A5/Z,_P"CARDU.RRR[N7_ -WK_H1/HXNO
M5SX<,-O9/DMANYY6,'AF1O/=R[I.AK4*#4YRM1NIN>6I-4<Z0Y38T3=YTCHQ
MML&_2WC(V\3;TAW"=T>MS-Q>C=2].&( @R**J:$^V1K]!V7-YN#?I<NA[<TU
M,=DYN?5$XQ7 $N<D786IF;57OVMT9,FM5Q/=M55S8GT^77C%;3HJ?Z(;WIU3
MKVK)3Y]/T+Q2V%_ARZQG5;%Z2),PN4LN)$ )\=MDZ3*@7M>%K2*)K&.>4J,=
M$DIJ"HWZI=-@;T=^DA*XDMKW)%J.U -F#;!W&ODOQ'8%:1(L>-X6OHFAZL3<
M<]P;*]DI1X/=7RX[4MHS*YKU6W >5&9,G0PM<<PX]@4;$G[FAKG-VVB<HTQ3
M3.':X9=25KA=G"-.>HI5O)-$8AHL(H'.:*;$(_*:OAKK1Q&N:I.).%!2A.G0
MJ;"4)D:02,)7OB#<\Z ;%(245!-KG.?J%K8B-5Z-17Y!B6-7/C2)*#V!&A2P
MD,IGD&)HF' -Y'$>-[6(QJZE:J-S5%1,08BQ*QM5#GQ,,R8I9F_"[A66;%S6
MP'$CJY%L(S7:"O1KGHF>;AZ[64CGE5F!9T1-3 M=FVZJR(U&QU5J^^Z?E*JY
M>67%B&!%DI,D\IRGP4S]W9PQ <?;8@2J70)'Z](WZ/-VGS3 %?9F$VU$+"KS
M1G/:*0UK,.6@"/=&=LE:U)#2,55$U$?W%R<FE*BWE/4<>+S^X]NSFF_5SHS?
M?O&+J\S4[ST_HS=DBX3O,-"[4W T32-B-D3) VNK+26[=#7"EB'HYP"/75W7
MD:WV7,U)"# FDEJ0(N69%.^1N2,MAFRT:DUFS3:;IU$S30B\4JVTBA6)/B++
M/6%FVT:P!NUYCCBRQ#KA$CS(ID8DH*&\-XWL5ST144.'<(87NXEV M>.3.::
M3/KN0F2:R0[OR;Z:]K&'DPW&*L-BCVR-0FGH4=M0UMQ-DQF6J"2JJG69U<:5
MB$)4&!0E&14 97O14[@LRIY(O'JS>X;OQ7I]!&NNR=C"6:]1UT!NB!B%IMW:
MG!TA2(NZ)'ET$?IUTP(S8R0R6F,0Q119$J2H(\*JM1A&9TENM%:,K&M52$<]
M6NUN54S7 6:*G=POYI__ !/8\8:7)<D@+FN71,SX;RSX"X?E'ACD$\^@Q75+
MJ7HB_3\^3?I5.'1]Q'<IEW4T=S?J*%_Y/>[V6??_ .#TX-,PS9]FR#@)&*3D
MZ^9J"4D<KV:;")*8F;XH%U-:CDT9(J(YZ._TW?\ D##'V+Q_IN_\@88^Q>#6
M%@;F)DC;WC;8A:]H3 #\,#!B;I$-C>ZQ,\LUS<JJM C6N<N=KT:BK_\ ,EC]
M' 9(]3'L(PH"*S--P-70.16ZD5C]#T3-,G)\SDXB+B5-P*U] )[I#E@,<%D:
MC.%4?'=&[BR'9L>BIK7N9JWN\2<!3).0"8;NXP &Y0$<DBTM@L8(<ECVSB$)
MVD3PTS?U?M-56#XQO(+LQIF(9\(E'RY3&>HX%WG+S%9H)I=,6R9[EDG3FY[U
M'D-[N,/N:QSFL[5U*UJJC=6'[E$U*GEG\V?GQAF48Y(T&=24M;,>@HBM2/)Q
M-,)(WB3%8T =J,JD,PC7C1-351-2\5^/,+A98C3FN=-$+)G'-\+IZ:-MBA<Y
M"3;=&D-?D07<8YRZRM<C;G%V.*M)E13OL6GA<W:P;/57PJ^S(P81&KA*[EEE
MB8TDQBK(=I?I:Q"LQ'$P317-/2P^R.799(\C"\P>>0O+R7V=H\^B6R4I<SKM
MJ5C$Z=P?I%1ZHQ=_%RY.72N7K-5]<EXO\T5/Q5YI_P#0*IX5'ZG*V-AQ@TTY
M+MM'AK3EDB9IY]>O]?%OEU_@&_\ ^E8EX"B_]W\5_L>SXLG\O/.VQ=AVI<.%
M%'()IF!PNY=:$<S0+PLG$8NXU5:C4Z\1,93<48,K4'98DF3*^=B=L:Z0ML&0
M#86!((T(Y<0TO*P IF<LNM$UJUK>)<N_:XF&[$M,UJS)0:X8B#CT\ II$N'9
M!:,(Q-F:W-E.1@_$5J/9X;L6@QUZ.5H@3;,L&L@XR%+N P)T>QAP(ZAEN0;S
M1AS@))USB*C1&?O&<U-<6?7(9 BJ@1';^SJW62YQERV#';ITG9YO1V>?=RR5
M?P$'_!]A^W&_)(/^$(W_ $>TX?\ \'_S&_))$ROH,*VLLR!04F_JBSCP=H4H
M+^0,";#)&64.6]DO2Y=]K!-7)K51PP6N%\$PSB<W19U5)(CVJ"8.4QL7G9%C
M+>D5'RR2-A$1O,-&7S1=0VTV%,!I(''BQUL3T4KM$O*@)'WS2XMI%>^1(88O
M,E_C7$?T:CG(M[BZXIZ"NFT8K, I-+!)%YN/60X=FRKL%D3)TN16G+,*^7$8
M402Z!:=!&JYQ:=OHW]%=JXFCX9882:>Q/HJFRO%ER+%C7;2-VF:F)D ;!IY(
MO%/8,@+AN5.PS7V$R-A0=33Q6R9+E-(&QB0CKLH0^AJ.*5VV".BD?M:E/3^I
MGH_Q.^-M9V.+,..N+9^]7U\I-Z:Z;'0FE#; \F=V,",+^*S6@Q@7!^$ZBRLI
M54!\:GHJ^'7NCS*0UHXJ!:TQT*IWJ--R4O@#&US%>W<5:MV$/1UV<H9 .1[
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MB<4U**LJ<4A6/?*(>.83;_8TO!,>./L.A!$R6^PTRVHWQAAC-=DHG.=+->8
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M7(N[*NY._P DX+)/2'6R'#VW2 IXR#UZ_#U(UV4:WII7.5\P03QY&S(C[@I
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MD7+3TR55S/#C,VX\7T8DC 'J<_0$&+F"$S4]7/=I8U$U/<YRY9N55Z\8+_\
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M!7"XQ?68D-S,VE[ SD;<(.YVCBM)'NH !"9H$(#/;+JTZNXY7HN'H\T&L/\
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M9*:1HB/02H-KW-0K$5T9V,K?"<2- D!(-,%S\3@-, \VY.98]J"<R0Y@Q"9
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M.YO=<U7@%E-LO1YC[U&%8<OS<3U5B8FW>4C; /'O+0KF:'%FD\-C-7-Z'ZD
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MNO5QAJQK:RJKK"/C2F>V?!JXD69M!CV)TCI* T9VCWV,,B:U:TK&DT:FHJ8
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MDI0ZN89NZ^5\3+9U:-/\9EJ[N?!*AWJ=*STZ7M]83^4NQE=YRQ(/^OD3H/\
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MODK"AOD/48]IB/,6.1[D:S)J9KT1C$3)&Y<<M70XT,.>MS8T<,="%T,&XQ$
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M>K\"3_#]1_U=D_@7FIIO)D(^.1[N7B2,WQ7/<!<I0#HFA2/7)$1'9]]'9)D
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MNM/8L^#D7X'R?>%W9$CF->M=K2C.,40K0O,DPYBZZPZ"3HCAW8M0RN$-VS'
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M(\B&^RCSF,CQ5:=I'G:8TCETR(-$]5X&&+D.,65E%"+<-I3#<6PK3076TE+
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M^*TDAR<C:;6?)@S%^1NM\3^^):6D+#\2<NIRQSX[*PJ*)SA#33S4;VA@$Y/
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MIW41?/HN2ISU2DRPA&-+=HC5LIXH(-^.R(,DKF9FM'MD:1D)H4NTJ]Y7+I_
M0UW&.JT-,/)AD='CM*4U>6.URS"1S%%I<T#D1JZ7*/1EXCEXWH_? ;/0K,WL
M3:8-K\BZGH_O:L_YJHJ?=&FM&C?KW,].2Z0ET]YR=.J_,J9^7!W1@F:"OE59
MXQ7"(T;BMB1)FEKS;S57<U]%<3V7=W)-*88Q$3/?K*F-(?I1STW+I</B)K<Q
MPQ"ZHN6H+D<O1C1Y?>5'_'_V7-XPO_B!2?M.]^3H42Z7MSR7)%\T5J]'(J>2
MK\W%@&V=';:@FRWL&LN'S/("#4-:[E(\2&NSS$PB<PK%[_A:UZ(W^5L.R#*P
M>7:^9'DT-3,U Q,U5R-3/HU/Z?Z>/1]6U4NMM[R/%PH>5!KK4<RPCQ18;L '
M(>OBG*8(A2R#"4SQ-:,Y&!<J.<UJW42V*25-B8/QTKC%C<@_,D>T,S5%8[)F
M0W":F>>I&H_\M>*&/<W.'VR62ZM'1)6(8L XU;AR*Q7.&LMA$TO:4:HK?;U-
M7O,RXK 6;I"/=SNB/)@+!(#*]NWNS1W??NH5C^\B:6Z<NC_O7RITF/$BCT[L
MB4<<< ]3VC9N&*YHV:R/:QNIR9O<UJ=51.!31F?8L8-@7K'BYL&C5DE<YY *
M]J:$5-2.1,D>BJOEPTX54,@6>E58U5;K8K%[A&N;U8]?-OSYI\R\2,/XJCB:
MXC"\A,+..+EY;XYH45[8T,]9S3A+82"M"\VDW5CDZ-<-DBC#:W= ?5KFQ:&P
M;7UNT"J8W>L.;LQNYR;.*(>Z<61A."S6O<&YCVJU[55KFN16N:YJY*UR+U14
M7HJ+U1?DA/\ #]1_U=D_@)-1$,<)(]::R5T>O)9/5@I4.,K5 ,P%:W.8U=W4
MJ(J(S3WT5(F$J-X@5U6.<(K!F',4H[>/ F.:[>::0#O&D(B\PY7ZE5BL1C6M
M_#+$GGCMG0%8USG2(S2R739MBX;>5&(&TK&"&QJ)K4N:/Z*O7Y=!_,1OU7GW
M;'"=T^\#777*:3X><$<\79SK*R7Q9<I@&:SO$SI'+J"IF]Q^E_$JYJ9&*)1+
MC?FF6]+4F?JL%ARB+\&AM75FT?M%)U<7-S\T=QGVGC__ "3,._8O AT@K"<I
ML2,<23?LJI,M$)5F1P1FB08V4=.6$]HU1?$<9RYYMT_<KOS;?VY7\-_LI^KY
M*X)F-(-V6ICVM<U=+D<F;7(J+DJ(O5//BZIWN(^K]0[&S2O<K70FSO73E4E-
MB*WET.D?P$-M[R"\/7H[O&%:K#=O8@J;?$^'H]E6EGRQP$C-=A[4*+#@$B1M
M,CGYCI3#C(PI"9JG>+K9@Z55XH?;_"AD."%5.KMV"LQDA6E)>,DZ'.@&VLXV
MI4<+7I57:+.?*J\1K4R*>X=+ L&HYIT, Y4:6Q@R6QXRD>-A=II'J)V;=S)%
M<W@-K$I\3-IEBUM@R.&OHTF;=@R#$CZA"M(D7=:UP-[(F2(UVA[T1C>/7=8=
MQV5LV!^72/"[0T5O/;Z;7:'+:G=GFVOA>2ZAZU9F[0[$42+:#A-AU4Y120Q&
M2MJW1%C-T#FF%N,S\=-[2W\AQ.*P#*Z^1+2VAT@%=$KT5DR<1K!$-E;NTQFZ
MO$<Q"%3\D3N(0:_MR,9IK,)W1] 6O=&D5XL\P6@'.:FLFC6F>3O)N;DXL[6%
M$N!1ZH$V1(9*!"89[(,<,@J!:*P.QSG,.U!ZR#17([4K$R501>S[O*3N[:\K
M S39%N/UKVKTS_)R:O\ 3EY\1)P4>T4R,"4-I$:A$'($TS$>C7/:CT:]$<C7
M.3//)RIU^ZKNJ#3V&K\V;&([IJ<B9JW/I_E^]4$T0YL1Z-1X)+.89D/J/(97
M;?1Z,=U3HK&JF2M3@MSAQ605@1GK)CR-B-'(&*&7*,\88-<NJ4[,#&N>5C7,
M:K7:=+'<$$[)7">\;LO+-CE:N6>2Y9ITZ)^ E4MDIY4JH:P39TA5,<KK>5:%
M1223G.1^RT8QL5!#VV,1N1-+50P<\]LA&9_V'N;]"?1]"?<S151?I3HO#;@*
M:)7/(<SB:&JX,2!8#THK1O(KEVAY-<33T\VY)EB;#ECMJ"+'PS&AN34JL&"6
M0BZE.LIC5<V %/" UJ^62=U6?=J/^/\ [+F\87_Q I/VG>_**FQB%*@'SH$>
MQ"-YDWZ]UE!/+$@QR8K"N*R*UN@[]E_D1,LE; O@">$,_FM RL:,C>5FR8;M
M3&&D-3-T=7)D9^:*BKI5=*?RKAUA6,(Q>U\V/:CVKD>@5,VNS1<E1%3^E,^,
M"VO8D.!82*S#(365/6UD6SD,+A\DD@I$SED,4!3)OE&XBH\[!E5%<W/BVLKV
M2LR>;!V/]V0\TJ00FV3$0&:RS"F,[2$(F-U/7)K=*=U&HE.6YPO0SRJM>19$
MFDJ94ASUH:URJXLJ(5RYN*5[NN:O>KO-SL[J+)GS9\" M;V<^SE2)4].;E7C
MYF^XA2!3,PT06PUG@L&A=3F_>CPU6[T8/-VL2U>NX%2OK9U<^,L=P)JM>W=
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MH_YD(U<^Z]7\1( V$8A:D$S(@S#7,DR>'/(Q2NR^#IU1VGSZ9HJK]RH_X_\
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MB[V?\UPWC_)7(C0JX+N\UXWB'J1V;$=FAA/5%11(BITR5/Z^"64YH*O$?)V
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ML:Z<L^G>5,0.G$29*JK2UM$[K0J.-!PW[S1#&S/020_J5NTNK)[^C4^[4?\
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M[)%'+:W?CH(2KR9B+M+*W%S5^QI:A$F'!)WZP7+]GIE&[FY7P&2O$C*_<U2
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MF\87_P 0*3]IWORL5".0F]AY5Y@+EC]SM>YOI@D9H>XZZV,5?'8/_<M3>O\
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M3(>1[V^"C&+M/-FQ$8_;1,ON5'_'_P!ES>,+_P"(%)^T[WY6E65Y&KB>[PK
M'H+(&F:3Y4?OL" K2I_"#>Z5X6^::LG.5J*G5%1%S^G^62=5\74%,E5.KPE^
MC^K^A/Z?P7A%(/\ -O<S_P U4^A/\W!0757!DZQD"TTZ,*P5K9#5854:6,]<
MD:@]3=2;B,:W\E,I=OA>6"2PWCQJJ/60ZL2<S,<_884]J ;$C13-<UVPQ'M$
M@FM:N36Q4E$LV@KCQ]ZF%>/!$*-YP63XR\J25&VY;$=NILD8JF<I&N=J8L8
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M4(BO- DDB*YKTO@HX;D#J15$-RYYZ&9Z4KL45AC$C8CYS)#$"_3V/$IX"Z4
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M6(D\T*/GDB*CLMPBZ<R>?^U?]'&J++AR6]%39/O+I=["^&Q4ZIU^A4153CO
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MZ$1?Y.]'HXCRQA6TG'9+$('($4Q\>!!.!9(QM:V1LE*]XM]"*-[E<Q4<JJN
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MY^F.,3"[L<6DC>YK15>OW/ZQ9_YS&_!9)U5>.@2K_4-Z_P#JXZ1)*_U *O\
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M_:3A$^A/N<]+&4Q"?%PA:$CGZ)$0)?#)+B.=I;+:[N/7)$57?,CL,V]U6@[
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MAF#(T4L2!.B$&PJ:F(]Z(J(_2N3E[Z.3KEGP/M*;' 4[3+$BND1ARYSP(Q7
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M!D([FRG'GMNC-7+9B2?]<LRS1/)WEDFIBNBAL9NX,O,SP09;PO <Q0OBF6
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M)GGZ.6,'DUV(\(:DUD7/5=6*+YN5?).,/8N&O+SJ+M;NY23<UVG7-K/-9K1
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M-X6$A!"QKE*YVAJB%EI70UJ:E[O3KEFFS.#L$_F[@B?DL=YB>1OLD:OG\_\
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ME1"N/>3X37?!I^8?<;XNJ+[[<Z.$SBY]9K7MFPJL36--SW(0JW=%!B5G>Y6
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M$;:T\O$F):^7A?'D[#X;.JO)<:YG5]+7,BC=:V+C2.;/)(9TB<HT"(\I@SL
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M)L.=N1]S,BKI7[D@-79=D3G[6S8<F&?L:3B<3X+(5H2[H6D#WE[FYN-[S$X
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M(F3=MVY?W-CC[&6%UK\36]#'K,)XIETD)(D+:FA*>&=EC\.SGNCF>PK![$<
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M,7XRYJ!A=;B,^1?OVYAXMY!0-7;.'$W)%#()I6="9H>5,U:1JY<6V'[VW0,
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M8MLF#.*"3Q91DAHUI6;3W[[=3G([#E''QQCB+6W-'(LY,2-B6:".,[DQ&;0
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M/HET:KC%B"PI1X>= '8VG+/L7OK133D#%'%*-R.> 3UF(JE&\+%<W"5%B8>
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M<:X2,Z83:B(+$=.191=:"VXZ-F+O$W50>@>IVM49EJ7+CFG2 -C*UCTD.*-
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MK5$&GTP&PSUJQSN[C/Z7N+]5,M(>H9#DS#'C=D\!%X\51Q/52>U> 8G*\;-
M 8EQ8#Y?#,9>_A=><ZCL0-UC>"$3(C>7T.*[P4F#MA4BW&13RRQD96*& ,BI
M&N2L,E@-P_O/@Z[1^\ZNS^:]+0L+AP&)7IB=!>5),1*8'"]MA$"> H" J /
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M'[$1;,H5L!_'6, &PV310J/ZL9DXW-E'=H6@./\ LFI(:<]:M6'=C420Y/\
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M#A[1.8:M'(OOR,T'"*7F)+&NM%%"W,F-T(2/\0(,](86X8[*CY3P /<0]/\
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M&2B"UP> _P#CC0\@R( "04Q,*3"XD4(OTZ/*@%9"L(R:4,GI"%P&[J^@JI'
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M[_;I4ICJ!9TG$7&IEM#)!.Z\:+6V>9+2YWCAYZ9=XYTS/!&F^K#'N5ZD)G0
M),N93 7'QQ@@LE;<<,0GUFX5, -(OXHK,"Z[%KO[+3X7H_#QL=K$)&2 );0%
MN.I=%W&7BO'HP++$]]+,V20VLY\X"T %,'H:3*7VU0VAYXQ!(D1E E"R@7:A
MB75D%1)@ BB-27)%=ARJI\:]\J)$Y#A$<2E$21>HR6RCJ-=!Z!6]],(;L5 2
MB!*G(KRS^@<1;!F03+ <O6&U>@,\X R[M11LJ,[QMX6V0PYT66";0S-Q*LY4
M5B$> IOT1EH?!:,V_/'9<R$"2%+0'X%11?DB032 F9! F70IAH#Y(_U]%%H>
MVE]X9D)9$\K_ !\FI4GQ\%\LW*LK5+,,7?*<1*GANBC%;E<3>) 3,LL__C1J
M2=@^>M57XPL._DJ S3U!,F!N 64DFW$ !F3"5@T\!@CL(1]DY<R1##]J<T;1
M70E3BBS)A,;IT0Z#E S8'U66)W$DQJ8R'0.1_%*#I3'IL?A&/KAIMNR#L1>$
MPK, *28VB0*D -M=%90I]F7C"'U<!$+EB2K%/8(@X)_*E/67KE@$1N9MZ"T(
M7B=!81LBP0PO.U\+QZ^L,R,-U0$W,4,.4T;0,RDVV!:0(5H=V^;.->5"DT#D
M (&$1$39>""1$>1D_9G#@=D^=0-I!P_E3V0!P6RU7#$%CL:*-[6VS_+--Y/U
MIUDP=5"BK&[=9^*S#KL6N_LM/A>C\*@L6E%T:6VY,!*1,)\0* ."7'7Z6VED
M<+)AGR0:D"W, V%9_MC!45E9@L]V";E)R@;%S(0 ^QHX0^?,3@+ 2X+B 2R^
M<2XO1M"L\_"5P^ 6)8"2Y.<B0S0,>K\V"TFID)#PH@13<GV[/;265X$9T(I$
MDO*#%X^%E%0Q"N2+"D=\ILD2"4G$@>L41M?A(#B(<,*4$M:$0N0C0L@"21TV
M:8YP$(Q==E!B0X2K'Z!I>^9_Y30_\B#$] !+(@,(8[\<!M0NN@766:*AB<E3
MGC]:,2\EQ$6.S*X3',TP!BRWX&C0(+GA'FR]2K2HL0L (DUR5<U&"F$[83U?
M'$'?!0_!*]A#"L'Q=58IL03,FTP;.F\,M#P^VK<BD&=A;%9)\?)#_)GVRG!)
MD[E^C3Z.@)=:B;0B/@A!,^9([%G")LYI_L(@-A!1"O3\'$[H293*51>J.>;5
M,S\ V$J3%511"02=*M![M$E(HR":23U_&.NQ:[^RT^%Z/PH$ -J .-M;PE%#
M9,L)9,1#HSN#V^H^$X?K'A0KUUP\B<9HVF?^"ELEOLB2S8$M^44#Z):_56,;
M7[WC6Z8N32&&@0E\#W:@S5T(RL*<7\ #%.(W+EAG7UV(IH!@ ^QDT'93NBRX
M&=QL][LY+3O#A9LL-.;_  S]6C'@(K[/^1+LC_$@$^%VG.)2.%#%H_\ ,*$2
MA+!/+T/'#:52D'8W[E@J;@7<7GA+2-+'QSB:WP%)7L/VC3[/?0]>UK^N)P!B
M/5)\_$M;DX(D.QP@2/1A"P%"OE/RD2_D0 43\4Z[%KO[+3X7H_ )4I2PNT%!
M=IQB)2 &R1)-WKZ*,K@2JG!&JL6.=9B%\!P(?T<:7"S$IWUV'6"-24RVK5%,
MT!4!EK]Z<'A24%(9%4N6#8[TT%]!K&!3=B%C!0BMQN$RIPS' K.POD$IC9IV
M\0!:KH#>@.,-!T(6[N<(@W$R4U4T36D-U=,V>PSD;3$=)S?#!=SK/:E]&4)4
MHN3"#<MH.KHX:M+48@$=]M;S<'Z6(9/WOJ]?+Z^G6X$!HI(%'\8!7(PG6V26
M/3V?-H#"/T UDA^V?XP]C?Z3- AXR$'C#0.*IA_/E K0*^1;A+IEET8UN)AH
M=NB2D&7LD%9M>CU5/4-"1R/[>GV^J7T90E2BY,(! C);&7*("BA!(2UP4/M&
M\N'2KA, I*2>3\0Z[&KO[+3X7H[RN6Q(* C ,(#$LNZ##GIQ> $8&1_Z 9).
MN5(FV+E_@9R:=92;*SA)=1Y';KL5TI,<S04N-L<AG:I1*?!04$C&P=9Z5#-@
M,S[(((E5I :!, 4 Q/1'56@4AHH G$Y$P\\82H$U6O NF%[1#35RQ!S=FOL$
M0XO4NID.%F$9,H=WA*P"%=2Q8HMB_P#./HIAD1NBIH$,",EOD2>A:B0!(0:R
MZH.,F08>VO#F@6!"IL*&BNW!W6SVA&?<<,@ L *H0(B_%QX"$(*YDLDDV=)Z
M_3Y_P1F6,B^S23J\^%J2 JL"\OV;T;C>!4)>&5P5+4"<K?.#NPF-3@\.-OBN
M:7QN #-1,IP+E3/625(<IAXD(J<^9!ED-2/,-U07C!P>-SR?_;$V[.H&/EYX
M&(2=8#:G.9VY(1Y9T*>N/I:AR[P=4!;1<PQ&(M)==R;-(G4EW$%B.*&9<=V1
M0(+#'7_T,Z%)SL9 B&S^/"(T$TE DDD)>'A-+SUP]DO82'.O^.QW&THC%31
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MK"0O,W8 _?2AH=3UBA0]EP.KN9/YNM0?_=%04MY?]X+V$&M(\2(O/)UOC;X
M)0C!D9Z_>9P;AEO68C!K$YU/?47=3;\G_%C==;F>SQYIK<C@9I<(1 J<_222
M0:,12'SX,HHYFZN:!@%K(/"@,<(\1I0/]9S<Y<!U6Y, <X_!]G)(WZBN=L)7
M_(A_/_: #//PZ2/2+OT\9P_3ZPM"?E1IH)%!H+!$?69*@F-+?I/3$EC_ #E.
M5.5,'G!PH0&/+]$F[@VGW>D7CMAY* S&ES^ 8.)HJ$4L-0<&83M)X\P7(2"
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M*>_*8!27\^0>%CM=&"EKXHOG9HN@\#KXN5Z1!Z2QAA#:.B(S(GA/!AJLH:6
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M"#Q$A>EUSA."#AA)RMB  4??99[@O>5N=Q"VM^%ZE[.HJ?[$!^6^*:ZK4+2
MP L.RCCA D:]6I?!+OKPM_RL6>/_ .H.Q?:&53(Q#R-0>1:AA $GT2("*R<T
MSH-+LRG\L2_PP!+@J=F2/(@C.L#0"<[/!]"+E7&J&R_OT6OU'R;]1'7291LJ
MQVW_  97:F"2H DA=RT^QVR#(NR]N^]+P]'+0W)O\S1'WA_YN-N B)2I&JTX
MA?M>@D0P]]G78M=]GC?!V5) ?1R(T$<VCTS2)I(:X7(<]+,).VVJ7%_6(_0+
M3X7H[M(7:LX87)=$V)IZ@F,J5&_F"G/P.2!LB -)TUG'@<Z6CI%%1!A+\S Q
M4'HQ;@3%@_6H/*)8W,'H FW+N05W7B="@JEU!!;!$M7=J/FX$BF[I>S#'HEE
M'%^=J.O'QM[[#4P,N !&.P7[$;&@XI>;ZU,2H/DNH"+D/%)$S93RJ:TY$05$
MYP(BN90C7']5+0<>?)@*581*64TD1*18FR=JVZJX28V%/C)5(K,MC_I!JV1^
M%0XP9PYL0[@ 1( ]^!9[&@EH@ZE!2 0"%@C6R*O?Y1)$=-9^EP2^4DMBY@#B
MAC7] F>/#3$03"RT2)%FY4KXK$RPKDCL2)OZ/?38?_L6I4QK6>9*MA$&R)R<
ML.^:7@];U1@'\D>W64$@QF#,  _G:"%G2^"LU)%D4C@O+/Q#Y$1':KRK#T<'
M$Q+!9 IMT^S9#;.JCB" /AV4)_@7<H(=/KZSXSMR1#M-5'-&9?$&]=,<]Q .
MM<-1W67* 0UWU==BUWV<TA7-["*#PX#D@H U!UW;_ 7%@>R[/:-\6@'BH<9L
MGPY'] %I\+T=UY&;6BT4W1BSR;6IS7 )TD)FTW+I;>4:/@CL#TZ30AE'=&,1
MQR3&W5.\+"7\:],3 _2I+S@Z@-#$#H?&5.LO[_N82NA'B:*(T=BM)ARN0BA#
ML$^:C9H"7!R<&>QYV_,HL0_J)>("WS726P)22!F<W(6('G+(((&@JP4?QD\V
M[TP U$:H'1?V/%(JM.S-(WR]<9GC,ZR@\5Y[LM#UR+5?58]C3]0OV!(=N05U
MS&:2PV31\SBEXJVJ+D(0GU5]!@8RI.5CD1_E=0&I^QA-I!,3*Z4' 5S=]L]\
MA=#T4Q(%M0DY]B'JY(A&F0PW_+=7LRSX;;4!@Y\TE7H0UH5 "9H8=TZZ:/8\
M92[8[Z@FEL%7A(]=RZ6D6Q;",$08-1EI!ADAG<!!6*9C%H-RB1Q&K9FG\ #\
M7@ ((B",YUY5R-69L<\U)YH,I)R(665!7VG4O(ULR"3EH9P]\E=SI$S, VPZ
MMG=%HQNX@:?7W]O BGN)' AD,M!(S**:*L5[AZ[\]R%+1&@/E@\+K,\0CWS+
MKL6N^T%_@4)1E91#37*S+GB%OK=D.(H]M<W)9N0 #Z!33X7H[RH% "HP 6JM
M &W [>9C!3RYJD"%0&F- S0R2!<%PL@IQ:PH%RBJG/U$/Q<KYR_H?I%=^!&S
M'GF#Q5]H5 V(GF69PH\BA+9\K0P">4?6+=348.RA8;6>1& !):$I^HK))(Y!
M^=DYLK2026QC@4#D'J#V1<*\P#32+("$R$9R"S" @[+FN7?;/8O)HD#+]P@E
MM,!&Q$ZE_E.CH'%4L7J:ZP7&,!30[XS[5(%5>]I6<W(X?[77'3+8Y(@'/S3@
MR?%!G3TJ=D)CQVZ\TB$RT>,8BV+_ ,X[;6UI,B&FG4J2P,=/_#J.-D9)D4SJ
MI%!O1(M%@< &B,YP[ TBXJ8Q">[8X@,D3(X2E7!SJT2$1$QLQBI9I(Y7>U.&
MG83JJB1^9/*&.Z.H%OQD8/OM/JZ2O6X" 6,8"'A.-*A^*8G/I5?<B]VY..(Y
M"D4CY1D&$DF'9X/CWMUV+7?;+5.Q]@S[%?9@XO)WRNO@)MI46.XH^BA8(U6&
MGPO1WDM6J0E37D[P50R=T[ZN-C!<,QGJ>7\DZ^V*9FS9%>H@L:FX'*(*C//+
M=Z1B7T'P)P$M;:!ZJBU:_N*M0:I3&[4MVRHL'7"#N<Z"#&O6KA8W3;%CI] M
M>SZD>:Y88RZU+>%H=TC96@RG* 2Z5"DHB)$I((%514/NJ]@RKB7E"UIBL' (
M=\L]O<2)D91+4FAQ10:8=(]P6_NA^6GH:8^R$FXL]%66PRAC0D.*;!\SM5@R
M68%JRIUVEIB-@4J9ZH!T;^D2K!581$01$$1I!PO5&9T)+A4Y F#<$F)D2%X8
MVIGR6;5O2<N(5A0"I!6PB8S?'%C!7(<@GD#*3BZ''ZFHOC5(<"L5#8CS@&"4
M'/YL=+=_=I%0?O3I]7?L)_" UZ1F44#<I5_='QD=-%IB* AF00 GOL.-K*$$
MK=S0[TZ[%KOM6, G-B);F.@3-(3$\GP"IN@6V)/< U#6$)AIB^A:?"]'>2IJ
MI@*CB44K,[&0<^!< ZT&%/#4D(QYAC"<(..!96)Q(!R'2?P@GMF,G9S?00@1
M+]7)@_>:\\6;?NENJ$\J@:_=Y8MTWR;ZF'^L0,-S4@)I<C@TOZ39NI*<^<(0
M+C*[ BW49]"R;F"L= >@)*E)0L=R7D#1#PTZX1Y1"L"ID(<VU9IUVU>_+/;A
M!I'?H)CN)OG\G;&U?YWN'$!G$[MG_P *:1*DX)8$E1S4@AZ &BV0%I+R=#09
M)",J33HEE]R![)TS"0@>6@B^!$W76L6R7^0EXLD:4Z?8C"A'\159 ^-,!38L
M(E:ERC$+F#0=-!J0P3@Y,'%RE"*^D;+=WYOR.$32!;^(GH4[*^ BWIXL0A"G
MBP;/^6=9=8F/)_K6@!B@"?<T^GHWK-S3'2 F8*/;-8,4HT!7;NOH9S@R'L(.
MN<HW>W78M=]G4'\"2Y"$;?#>%BJF!KPMZ43+B8!4B"KX84BM,-#@LV'0HID1
MC]%I\+T=Z7 B&[05:B^Z."7M49@,.>G 9&9?0'$0Q@5GB2--(DX7A 0%!F@H
MU"0B7T+8A;4#GO7P/#5I%QDSRMR$F)0$4=$8=5O[JTI$DL4Q*&)!CP,G*;7/
M8)L#\*DSJ28VQO Q!%!V^'D%P9"V$HLF:S*6B ?!$ !8#*A14PD))(PG%8:P
MKD&86NO&*?%I+Y0<Z2/R.^V>Y$W]ES$ZZ$)9*"2!+$$$8;)+N^OYF;P0X@%H
MR=+X@^U*V\S;3$S8FSR=#%2\*:'1B;108$IN2:S2/@;J\"PNQBASH]8C^1PJ
MAA@V]!?=]5GJGA 9(E89^3LW$-U=;38SX7H\^ TMM!]O&GT=50DIIG@R2(PQ
MZAC.1'=__=NWELWKQAP^8]1#)4DQI+]8Z]Z==BUWV7%4P%J9=HTE6<1VY"44
MB))Y2P%P9M!N9AH;##D?OH(Y^KY,1S+VM/A>C\!<BHE4 NK:WG$-9ZB2D3"[
MO[!H)OVEIYI&M=2$!P\ 0F+PZ962D3J@50&3"J2 )1AK"XC!8$04BO,Y96N?
MJ 75H1\D^X;-9).S/4=W1N(9@#&A'EOJ@RP*L**T9P?4L@=C@&2L)<FVPS4J
MK*LFT.K4(Y%@<A9@!)GS3@=JY7W<#N$M,;7WL#GPZJ,'*2!VC4[Y9[&T 0*/
M40%!$TV%2V9S%E!$ 95>)_F#=)]%H6]3Q_LZ_;-:R)(KF9M)9?4K$@58MIN_
MW0HC&(>+T=8!8 D)9(*\Q9!RB#%<LY\Z<'B0FSIO 03FGOK8,/*KWBQ$?L-4
M^UVGT=M;Y6[" ,/)UGG8!<H0 B:)#NUR FHR;H11%,DHK,UHDV=+A$&:0O>7
M78M=]GZ7&?/.8_/.5US .$@F1$$Y.(S37OH[<%L",D[H K(5 ?@%?T&GPO1^
M D'8JG1<N_:;(CL">OPWY#7;IE,HV PDR"("5E!V:#2\ XYZ(G&/BA-VIWC#
MI.#AT,$B,LD2P6)48,QOU88&;%-NS$XD3U(P\$4_Q]J1+AM+\DF'Z*/V#N"8
MO_. '/0Y2F#XGQM&!V;<E4-_)I2@3";F/:YAZ[5ZH;Z!8/AFZ]Y6,7*L?IS6
M$D!="R/?;/<6!?4K)H9O6F_F4$L\VOG.G^?O'4'="49D\]I=G*G3'ZJ?I<$7
M.[WIHU4>HR^$XF_,W6WLP5I0<_#/3QP!-F3]+0M.07],^S3:=O?^J%L]&WS#
M&KTJ^(X4I6T#[QG7W'CK8P0:2K'O1UGP/3+OL57]/D!9Z]B-' UA9"F"PX1H
M2EN( ^ZD&I.8Y+6G:T^%Z/P!V1N;5N1,3<>)R^P[LP()8"IB;Y$312"O+6#>
MA#5.[ SE36E!#@BDQ!-Y.,;0W]1.0V #+F,34.]A:3Y7B$@-@1.=-Z^LO%4"
MMED2THLO&YF\I$V8I-/"$7-\6W$-4HCL#FCC.A/Q72$P.#']:0_\:+\UYG=M
M&WD7$C20;@F)9.5NG%4(%"*=^V>SF/4B?053\QP(,67S!4/V.XA)<_ \Z==_
M'# H)(6:0C)HK/8=$)+FU[>Q48A6!6D\Z]6F4XML]'I12ECBA"]W_!RFQT/K
M;3LZ("2Q"&.!2=H\-VG*C,&,3[R$2<9,BD*(DB24[U.NQ:[[> A,T%#S"9R.
MZ9I<1L'J]>N?K9,*LZ:ZQ:?HFGPO1^ $0>D'K/:#S>"OMF8:$Y))E=,S*4L.
M%:D[4?R("4MY<PQ-[JZ/WCCU2$9.$;3H](/,$,O(77^"_P!F\\2%'97TI%1D
M,&2 C"#"(\F3L7>PMS 0',6?:]_+S$-E?83$:V_H99[B(R]5^R!]9U6B),,N
M;FL+86&L;;)T-/[W@,LI1,-R=]]R'SL3S&X?W]#-GXT* "GH!+J]9Y).''&8
M762#E,;\ X+S=+C]UNX35)N4DGC5UDYTVX< L1!5C9*;6HG$K$Z?[SZ.O0CM
MBH9HE)[#46!:)'>@Z]RK?)A (P5 & CR)GD5\<G]<:!G.]"P+'_)FH$U*3>]
MI_3X,+S$6)M.M-%&Q8<_XZ4I7J?5(:=G;-!^?[1]H7/.@^(.$H^ 4!7>4K[W
M_@G^?#KSDP3N"?/GO+KL6N^S_KVBZ868SWI,5N*7S:H_$&%B94T2V>H,-<=G
MP5;LJKA]&:?"]'=B1?5YNC)E P8X5!MURUN2X>;/&^_VK4B<.9.T2P+\UQ6H
MK5L1 )&A1C76-@:E*DI&PUAI<24A-VI!8V<"U<]U$1O>2+&F-C3#.4:I%8"A
MQ@,@]2<;$ZF6,WWG[IXCU?=%"6D0DAA+U7EDBT##$= '!I@B#G3?S)X6Q!K#
M .DCWJEBZ>)Z 6QH. 9!(I(N0SXDXHNVZPIT[PKQKZ0'-D]S]4V400J"Z3UO
MOJF +<1J7)"!COF1@.>=,B,[VW*^"JOYLXBW&*3<51A7USYF)%Q*4N^WM/'-
M&.%1PJDZ7[PSB4FYG:NW\:@B)(D(Z1V.(5/T8BJ[]E'+O@A.@/M%IO;'6 D9
M29+S'E@S0Y>R @S\OR8U$@QZF4ZB:HF1T;KCGH9!!RV9_J#O.T%2WG]<-^X\
M^G<W\[M"@*ZC- Z&'STUI_2 %VC!,2]\2@&#,7D#\+/K?-$*4VC,Q_GM)56^
M!\1_2=,[4+ FID<FA8!@E,AH6K;%!G'PD ?,1*2N4%"K/>6+SBD4\ GZ0@8#
MU!_?>778M=]I:LF^B [84U+C%0&J6VPS E"ACNI]36T9NEB?0:?"]'=M%SD0
M7@0PL7J0BSY[ZL"W$9?T,!3-A938'AX'J::K.W5<@>JW)0QZ:%<8R$DF&*9Q
M19]W(I.-VO-D+-5 3K#F]:T*][ A#88^" _1FK=84RNB.HRAG0U KN-5+R5T
M:P%B(X$PGF$OY!#Y#'4K@29 !JCZ!$-R4X=&E@N")3I;!()A.6PXJ872 QHW
M^L8A>4AE)LA"SGIV:6.!IZR@:7I\)9JTP\@:,+"X!18BVI>(7<<O!'X,-MX;
M'7J:WKC'X)^*NO N^>^(M>DP],,)H "!E92,JA$81&&D3\=_N]DN\#!,A#SS
MD>^7G^SRMJ4AN@))UP&!"9YLJT:0Y48U.#_E -$NV#>/3P=1:1_%0# CXD^_
MJM[51/;1#M;)4)JW#A[]UFRTEQ&D WINO%FQ(ZR?=MQI"(6)>:96Q+#S%G1X
MC"L>3?$D>&"9.#N,M/FXSMU7MTSKA3:()+5A'!!;$^4H>"F6KLD]Z#BDAY1(
M@F(3291T=8*'+@V61)$Q,$]#O+KL6N^UN-I<2"2(%T(T)\=UGV<D)H @$QRY
MU&&?1.KL@M/A>CNU1Y_X>S K!ZNC!Q4\"&!(DAHHM'?LV+9HPK9\J(!& Q,I
M.Q1Q:"I>506J>$[Z_L6#1O\ N^,'&26Y9G$2W81=EAB3#=Y5BDC<&H57FLOF
M=T_1J0G%I-Q JP&K)SMREL7"8LSEQ4[M4<Q@R;/A9+Z6#;5'DK$M:P#DP[*H
M)IFLPQO% %3*-BH-UAG\A1BA^_R8X\V* M3RKP6XU2H1-S?AA4-(T>40U+D2
M#$E2'EWUJTKR67SG\;&B3[S#:L3 P@X)*_#0:>W*R[A'N*"T*($E)O%T3W6)
MEB!+<AD.[R4E/MDDM#%S>D.0<3^FX9*=MH$E%-0YSZ;%4F5V8JENTO:*6=6!
M)9@(@Z!T[PN:MCF8+Q"XG"(B+] (*P PM6*!(R?AVUK<(:,E"!-0I#TZQ;<Q
M.R<SZ,&?J<VI&,_*=[1;-%&0QG>H8MC(OR4$B8#T3>(9#B52DK"6)'56^\NN
MQ:[[6-8R!@!'FL".7]3>*N"H9 F1Z ?%\S*+8^@03+3X7H[MR94L#3H'"-EC
M)#9?4?O'Z6<Y#Q&.V]DWA<4YW$Q()U+XSDZ$HW9^=#Z)(4E X58R2\_]E^QJ
M&"/1N0\8,.+: <AD RXV Z]1/$J-BGF0XRDK9HT''=V2@24PDC#6SFLB(LJ[
M9"&1)67:6\G<.,\D65=:;0$TP7Y1]LNT1P@A'UI'+BKH@E#&' R 5C)AQ*>J
M.E8(Z B]"+;:-]]4.59@-&40:/R*) "@ "55H M6@R1=Z\R#GC#FHP9 & 6A
MA+,-(&GSA_YC)E&.GRSF"GK1!H.O>GIT)@VT!0'S-'9P41D($0-;XF!/,X!U
M!S:)UE8VI#Y7%77=,3S!3N.Z7NY6L$Q[UJ58EPC)%94+=9J%8E1#!%04+-]Y
M==BUWVIU/(:!3$<D6GP^ W248,M; !S%?@"E7Q(P4#Z.T^%Z.\>K&L@2Y-2B
M98)<^4* &Z\4@N*T'R/#G1-=DX^ 7TC1929!$!:R *%O4&1R=#XK.[V:CU>)
M82!3M!UG,1T<L]#%U>7MS".8'8#0MY-!M6*^14MZ6'@2&;3;3=O(FM\\)"'?
MP<\SP[KP3XP_$D"S2V6B #H#^_FT7F(&H3^!F<']7IRE.7B52(HL5(G*^=Q=
M,P/ DR124DN/\;O&#R=.*O@^:8G32:L.CS_X=YZ^M)K(C L= T/=Q;(8"?Z+
M)UW+ADY()I5*SI64R\I=*N)9]W!-&IPP)S_+'WP0*_9J@Y;\&0N<UE$#-]Y(
M/[*&FOD*[!T^3W<@#!!2Y$C1U*;\,EN$FG<QHZ.6RZTF^O%P],U!$1+J^!K7
M^\VDJ!.,R'0;FM=6G"80202+ 2>."NE0F^ .<$TF+B%(Q5B7C4R8J"3^ E^!
M?8EMD^=@M>5!]&SR 2A&# 4W@VB#_C3&Q#N+KL6N^U"QTJ-(6D@\3!/C2:"T
MA%$^/?(T=#"CP8(;'%^UI\+T=W+DW('042%0-J%X99&E0MYM XXDF .0N+(@
M0<(JC-4^HEWC3F X[R.:<*JA(7C7RXAJ7ID83">W<P!OA7 U?3(W]F)BS;!T
M]/K,%X0P21 Q$1$V8B#R@(*L 19FH.<3E_1#KH?3&4JBR<QH;ET_P8/-*,73
MB';@X4R< O/+DO*'2'0QZ6"XUN/0!PHP -+ 8(J#%L@).H!ML1-Z4T&? N"&
MKVTO6+ZW= J_U-."58L( [1C%KP+$@#*LL>MD<CG57TLZ*UU3)L><\!I,-($
MZ*N&W<8H21' XZ9(>Y:P!9*JL.FJS>0Y<E8I-##P@[5O??1ZA['A;/1',.<7
MNJFS.NJU"3;ZE@60B/9$&95YZ*9A5@B!)PL,6@ ;J";"$8VL:'3$7Y:!WAB6
MN+>2J62EB&+(99,#%OF!%E02N6 'S?D7A OEU90E3$(>T4,\QX@F&4N:>PVM
M$I3('<U!WE*BCJ2I^H?Q^9A0:1:5#SAD"%GQS$;X%(83,.7H8$6SL[X(Q0D"
M:P"E]X7%%%RF9-Z:$N8D6TFI>"R3/4F(.%1[,[K&LCI9_9YK[0* 4  2JT %
MJNC/A^G3,"D.K"XJ+W7GBP6YL>B965.CQK"Q9O#)<7_,\+S_ #H;XNYH^#(5
MI;CR" 6'DB887"9D :("%.!L:KCC'FK"F7D MM"+K6+"D))%*^<HUA4B*"9X
M4'D\GIGQ1CT;DC@\D #L*60M3;8M>8\(QJO<='H9_%.#A!MIJ;\L3I2E@- %
M &@X^@R=IDN(15(")9I?="4+0BC $!.]V#/JP6 2DE V(Y<,^K X5 "4K:KV
MAL$<4MLBA43.)")Q]H8:#M-,<0MWTJ)%*R839&"F((-P:<W7RBE/6Y))?,>$
MV]R5UV+7?:_-KL$3R2#$P%BFOZ'XG4M7@89#%1G$FE(3@H^A+3X7H[N5LB@B
M3(205H&U"\F3/U3WN>C$ 4L3#/R)IG/:QEQ&D3^+HB!N!@F&J(<F RV C Q"
M^B1S+V'A">U :D8U*0):WUSF9LGK5$A:S%84[T&SJ.A/PDR(7C;KXK8OTV.5
MTLN BET4S=BDQ EB19J+9M$$P)$P<>5#:%HRMAFA;.1*%Y%RK>;.KQ<%$:P4
M>BI0,DDGI1-BJ<%"BIYF\8Y"%0<W&'+DDICKQ>Q599;F!?R2/^\2P*IV:F5+
M*EDU;FQ9=4:G@4R>"(3^ !^KR@5%556?N>@/4@_HI"8@E0S2;LYM%94@)R<\
M '#E-HRDT9U(F2/>\>]POU+E("E!56("<&4I3"(G!/  \(,EL)6. )TV(D))
M4,189)A$H3!*7B!QX*87ZR_SS8N.G7@!G1B>*0@\H:_1(.M(:/T(:_ZEWR=Q
M&"6D[A3HH0QLR)!I=PW^-6 ;I7D)?@D9H(HX%MCO#1V*DD:O8"T+: K 8Y?7
M'Y:9M=&#!-I]H@=VEI*PRT9:WP\/^%CL*>.I)F@,Q],1CZ>Q)JAWV'M=0LB%
MU:B:_P"]@"Q@3XQ&G<.-!.J"OF.3SDCPDU;F-GHXN*NS@DPLBZ6QB=@,3R%:
M=VAZ^&,AH"22U.D@Q"UIDF ,\JXE/-IJ*=4B:]$$_4CX,2G$$.XV=6AH(X8P
MBRB+]3 $T8=08W6<F"@LKLS0+?7(,^&DM7A:JFJ+K;7S7$Y8IM"9EERS=\WA
M@Q!-B((T -@4TOW6=<'7%JL"("M#[CZ><%;]A5'>J15JJ!;1OD'B;S?ICZI]
M*;>@\6^V@EL'="4(0)PPE2_2/ ;?D",6AL1-*7N:EP".,-=P&8$5/O-1 N_T
M 1<#G*Y\K4,)I50'8\=Q==BUWVH"QB@ 9X\3<%8Z>8'C/BQ2#8S+:L8%A$DT
M 8$T2?H-/A>CO!$01>R%J'G H-@<<)G@ADI#2AS$\EB VC1%YJ$X'O,<(D'9
MAE.1F(F(TT <@ '@WT5R5Z=&#AUL:N\R)G@"@@"U6@+7.(NF4>,VF/2V+!*E
M3TX4Z'V"EV2P,!XHH4GP^K+6\8)S#J$T4*)A?:VY<F"9U%LS1E(]=?P>S^__
M . $BTF "S)$6F@PE;E?)-?>*$R,2JI$I* Y*FJ)R"$#"4HZI)D-:Q @6(@%
M"M#AX+EQ,)12BQ3A'6;[1=D8MXQ7(04%5@'\N&1AA*KT!RDP;0<^A# O$@/,
M*/1]I.RF:T8 63&HY$D48KID4#*%65/]NZ>>0%DJ('#?*4F]P$=WZS$PQW%$
M[%;6RCSR\:ZM2*:T0[T*L*?%<]$?HO(]A.FTCKFT_9?; G*#H=F02/+('E&O
M:?\ 5,-X8EE>S$;9:C)6<NQL3T)%2! $Z94A/U^ZE<3'BA#KC>KLA9I.X.NQ
M:[[69&&UC$'R(YV'+@T8'^,M/2G)" AUR"'*!#CZ#;3X7H[_ #3V=!<5?GCA
M^B< *'A$<P=Y"BL:XS/^99%9'[M20U!J32>/8?,FY!'4*]-@,R F5HJ)Q]63
MQ*T/NK&>1F2*E&P,:D'C P  #($KI L06N2 VTK&:I5Y[ML(R5W 4%2VQF"$
M,'3H78H412YQ;&[:U_KH-5RQ5<)9[]R_@&"XI3_CLO(P5]8A?5-AQ,=4/BH&
MB@0N1V=IEZF+\ORZ**95((+"Z$+>KWX0I5T311JE 4.]A3 !] GX,#RJ.2@
M   @"@#0' ?5MHWVFYJ,C.:6G7)I#K15>CH\%I3=Q)%80^&HHX2&2 "4,()R
M#W!UV+7?9XWP=E20'T<B"[[P&ZILR#,(A5(9YIR1W@R&R2?+$B,*T^UI\+T?
M@&KTIL:4"WU'KA[OQ3:1M<L*Y7.+.:$;!R-&M5A_3R<!YLL%O*9*/=$CT,V[
MB=\QT(0"4D:!729:8V ;\C.%\$JX2?I$P../,=$V@\:DS::@$?F618_)(:6A
M L .2R,#0F6UZ)&LNIHM 7CF?5OE,@6@!+\P$C8BN1A%26'0ZV=]A1!*'_)
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MBAE*'J1AG+P',)%M)^J[Z.R;5B! 2#P@Y&4JXD,8%9-5"7>'Y)%*:S,S6%4
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M%8!K5LTIIG*^U%DIMPZ06@;%#'<X?=R.#G@4,%GVH>FUM@@K_" **SV(@Z.
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MH ?UA .Q1,! $ +)0VY*%@K4]!_B?B9=-_6S(@'  81B$ B4X$ZP>T '
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MET'104"=+77;-5+\@*15@W5R*X@ZU+3!_NPX#S-\';!?J,=^1@*C(O? ..L
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M$A(9%K(I2)<H0UY!X#^0$=P5 A5HLR@9YDW5MS1O'RCL$85;V72;D,H9WAT
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MR(#(IMXJ([%;HU(49+@>#8N"P#>J@QKDD1H1IREY05_^DO_:  P# 0 "  ,
M   0         S      <@              8       _       @\
M   #'%    _      $       C       8      'X       [X
MCDF         "A))))).-I))))))UI))))).))))))).)-))))))NIM)))))
M))MU)N   AI))))).-I))))))5))))))-)I))))).-)))))))NMI)I))I))-
MM)(         @
M    H8  %%
M "         $
M   %#   HH
M 0         @          :      3 !AP 5U0: (   H  3#/H
M   H8  %%    %      #8%9P !;&A 'X  O) W9 1>#  V "AN$W   @
M"         $          &NXREM38NMHZ_87%9"/YSZ<HYN INN=YH
M  %#   HH   !=IJWC"46XEEZ$JSKQKV:6^,X\2CC.?P $-FX\7/T#<1
M0         @         'W\;QW1W>CSD2@.P#C"5^CSIG?&'N!C%=
M  H8  %%    K4M3XMLK710CVO*TGPRC5C-[H/-O&^*XI0.8CC+DM.XX   "
M         $          +59YM2<J^*Z%!I:W4U%IJOKM(G**MM< @
M %#   HH   =HH"O64KK3:(<-M=J@WGVK.+5UVMA_&X  ;:0E1R#**     0
M         @           8>0 PX             X
M H8  %%     J*;  X                "(         L(     U@    "
M         H
M%O   I@                                                   0
M        0>:22VVVVV6R2_>VVVVVR7VVVVVVRSVVVVVVRRVVVVVVV^VVVVVV
MT(   N::62VVVVV6R6_6VVVVVV76VVVVVVSVVVVVVV>VVVVVVVVVVVVVV*
M
M
M
M
M                                    "_X  X !8
M                            Q5.         G  '!RO8
M                   !WZ\'O-D&A>51",%%P'XKQ'YZ\0
M          !O4L=PV7]*WQ2S=G->OO2K?IW'^GJ245+.XJB+H        $
M CH                K]>N9%>.2-B]AB<X%QZ"0_.*J^1
M          M[;0V>7OK4!"8M24_6@>MA/N $52 +^,I*[X$K        'S;;
M;6                1UYU@*Q'Q'UG7!;K%534E6OKG&H
M         #Y. 0%(1RQS%@.?HX+9%!I8-+U0HCVH+5GPHS5(        (
M P                D X'3 *;            $U$5
M         <)P"X 2"H$-          /   "      "             !
M&
M                                                       H
MP
M                                                      %    &
M
M                                                      H    P
M
M                                                     %    &
M
M                                                     (    P
M                    $N#($C(%     GVP !X
M                            %Z 8                    !    &
M                   &NBH$(1?@    &'PZ4Z@
M              ",3@          2Q&H                    (    P
M                   9+/A#4 ;     Y(;"]
M              ',T          T=]A                    !    &
M               2.0             $18N\
M             $U^E         "9>X$                    (   $P
M              "C2-  "U6H         L8
M             JX<H         "!_(                    !    &
M             %9(<X  47         !RE
M              NS          PW/                     (    P
M             A8*5  "D8X        XX(
M           !J[J          "O=0                    !    F
M              .'     D  DL7Y, !Z2
M           2EL^   @$$'9QA)T/                     (    P
M            'NFH   &T$  $  E]8N
M           DFE( D $  ( ]9F@                     !    &
M            G>/   @B    @   $O@
M               @    !    N9                     (    P
M         K "AZ8 I<%'   $     JY   )X    %X
M             D@     (    %6@                   %    &
M     5,K/HQX  $(@ X0   @      :@ %3$?Y$]Y]
M     %3H   $D      !      )L                   H    P
M    "C7U^?    %H  ,@  $       48 &H"0$#\$8
M     &B   @@       (     &Y/                  % "C &
M    VOZQ/_0 &H%@ +F   @       &\ A>_"@K 1
M    !RX           !     "@ <                  H M8 P
M      $N(     (  9X  $        $    '6*
M    _   @@        (    '\  D                 %  [ &
M    %SL   A8  " !B   @        !@ "^W:8
M   &EQ @         !     R   8H                (',0 P
M    [%F  &(  $I #W  $         $P 2K6K
M  %0%(           (    :@   E@               ! 8P &
M    $]8 "    #X BH  @         &$"'S\(
M  NL(@          !    &     S                (#*X P
M   3(   !    'H!?@ $          !
M '_C0           (   &0     1               ! %% &
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MG>\,@   @8  %(-P @            (                          $:
M;QMA%8       !   :        R              ( <( P           !$
MX       $   'XO $            #@                        "$XP'
M@&Q#+P       (  ^                       ! %Z &            #E
M0 D     &O  /"T @            L                          '^#0
M %RP_8      !  D          0             ( *( P           "\=
M $       9  :_@$             P                        "2>PD
M  %^Z]@     ( !@         '             ! 6^ &            T00
M $@      [ 'CQ @            '                            'P
M  %A9'     ! $(          ]             (!^0 P
M!CB      '0$&<$             Q                            P
M   .ZB8    ( F          '(            ! K; &               "
M0#-C     K #$(@             P                           -
M   %,PP   ! K           %             (#8  P
M   37$   BXV5$             $                           #
M    P5,   (P            @            ! &" &               !
M    5%D  @P88@             =                      W/HX
M    0)@  !"P           $             ($OX P          ]*3RS8
M    "WW@ !",D             '(                     !. K8
M    &.,  ((            8            ! '/ &          $X+B@P
M      =/@!0.@             P                       O&( P
M     3L !S             (            ( 3  P          /^O()(
M       #_ &X                                    '8(DX!
M     "D@O             !            ! #T &          #83R@I
M        2^^@                                      PB&X
M      #\             'P            ( SP P           +<8%
M      =A4*):0                                   N7.(
M   '5CKH             ! $"8        ! 'T &           '93     ,
MK'=940^@ L(\_P 5P        !                      !O\ /T=
M[_4^Z"^0  @            ? )L8         @#=@#           (,W 1%W
M,ZY(R@     D0  (&U.        @                      )!6 4-0??W
MB-0     #(            #L!8!         $ ,@ 8           1OH (
M         "7B<    =UC#@   !                            ^<
M        1@            ? :@C         @ 5@#               <
M         7 0@     "0A D  8@                          0
M        4            #@  1V@       $ !H 8
M        0@ $         5< 8
M       "P            8C5VH8        @0N@#               "8
M       (0 !            2(                           2
M        @           ! +F?/@       $ ?D 8               :@
M      "D  4            %
M       4            <"&:W8       "@"R@#               !D
M     "(  "<           "                            "
M      !X           + $E@         4 *  8               "
M    "N   #            ,                            2
M      #@          #P             @#\ #                *
M    8    4           "                            "
M     "            T             $ #, 8                ,
M   ;@   "           !(                            2
M      X          &              @!]@%@                <
M  8      @          4                             "
M     "          #@             $ "P 8                /@
M !     "<          )                              0
M     8         !D              @! @#             $'+X0@
M#P                 P
M    #L         (              $!@\"8            #(*QA\     !
M@      *@         ,                              2
M    0@        <@              @2@@3             %]]L#8    #"
M      #,        "T                               0
M   "8        1@              $   "8             ^7+ !D    2
M      0@        :                                "
M   !H       #0               @   #              !@8 '8   1@
M     "8        5                                ""
M   !        P               $   "8            !D(%@ /   $@
M     "@       9                                 "
M   <      "8                @   #            #,\H8  !P 4
M     =       *@ Y'E@                            ""
M   H     !\                $    8            ;40!   5 "H
M            .@ ?H.(                             "0
M   @    #"                 @   #              8     >!4
M    1      ,@ #N+7T                              0
M ",     H                 $    8                    ..
M    8    #G@  :M2^                            !@"
M  D   'X                  @   #                     20
M   #\    (@ A@                               #W@"0
M '   )T                  $    8                     ""
M   7    T  0&7.2)8<@                         =\  00
M   #4                    @   #                       "0
M  "< #GP    <_PJF>@                         "&\  0
M @9F                    $    8                        "0
M   C!     )N@<).9\                          -?H   "
M!.                      @   #                         200
M 0=Z          +/D                          )38@   " 20   "02
M2                      $    8           !&KND G]KR,/ULPZ 20
M"0         "N+0                           "7!V        "202
M                       @   #            ;*^>S0\)4^FU=D]H
M           "3ZD                          !UD(P
M                      $    8            23&*F^ZGR[U .T3
M          5*07
M                      @   3            +6DQB+N5GF3T_VW\
M
M                     $   "8                  7\9@
M
M                     @   #                 !(%WP
M
M                    $    8                 "QMX
M
M                    @   #                  /\N0
M
M                   7?_\ _*
M
M                    D   #
M
M
M
M                        ON >"V  & &  9 8 "V  G  'H#OX "    2
M6  "^H &P   '?0]  +  $0 S
M                       &]D&GP<I/83+/)VZ.\;"700>**G0L716)?]\<
MZLN1W]LHS"$LME/GOBN)/(D>*0
M                       #C>RR D91H-T+"0$R:^NB=Q$6TLU8R7 #_P![
MQ0!TX9':FA90))P9Z#('34W%9_"
M                          (0    'P  Z     !P     &@ +L
M
M                       $W*Q B.?I)"^+",E.U?L!:@_$-'(^MT.3""<E
M688,
M                       R7^H)\+OMST0>0"&#%E1TSAA&)B0U[XW>?%[I
MUVG@
M                                     Z  LP    (
M
M                     !5L0!  !6 "0@ +@  2P!( !]I, (;:F!,"0  U
M[PV  !IP& LX    !0!I/P$"_'Z   0   ''@+.  0(P    !> _@(@&4%V
M  Q>0$V  I@          ,KAGN M@/R#A6L7>R2=$R:;+75!L. -^)3SWF-A
MRS3R-S&.Q,T!_P#ZH#65YF_041:P,EU&NC6#\HB&L\=4YW0,M \XFREC3\YL
M')B&YPI[]<U           &9Z_R1_!U8^N$$95JK^\T#&CDVNA]( NGJ-O#:
MVF)A3I:9"^2E)X:Y_I9"E&.NMCN8T>6Q&.S7Y*)_B;VCOOJZ/-OD7-&0"EDF
MOCP7=<79M!,                          !<   #X            1'
M              &               5        %@ *"  "V        ?  3
M       >             )251YNH" 6).I=8CG3,=CX\WYZ/T;Y2W
M
M                     <Y\(%3P+B@?&>^[.WLSGPBU %O?QY00O@
M
M                    5-!566PGI<R#@+3O[M+5VCF4\$RF'-U.\
M
M
M
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M]M%]ZEI H?XGD?,^_LU_1=GO\'Y/V]F+F?+_ &_#A1Z@/).'_P".LX,>B47
MLE5R);SUC:95B(RQH.+$BMM::BMBLCDQU#=&EHTD #D!WG^]3Y(EFSD)/8 @
MI;RF_3 DIQU7_P""L' "N:=@,&E44&:LJW^"]*L/HK"0Q&9_#O@E&M)V*_!^
M@I4@_IHFR-2/-Y6,<,JL3A-K/F;>!H\M&H !\/0@!-+MK2B#(B*.S:I,8*JP
M JJ\JN><1L_1P+AN?PB<7K]GPH0I?JOI@FDV<[.H9Y7U/SGE?4_.>5]3\YY7
MU/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.
M>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U
M/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>
M5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/
MSGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5
M]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/S
MGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]
M3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SG
ME?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3\YY7U/SGE?4_.>5]3
M\YY7U/SGE?4_.>5]3\Y4:ZG4[_/ EC)^B[/?=C\G"PZ_8R9='3R\\\KZGYSR
MOJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^
M<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSRO
MJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<
M\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ
M?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\
MKZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?
MG/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\K
MZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G
M/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<\KZ
MGYSROJ?G/*^I^<\KZGYSROJ?G/*^I^<F:[]3L^>!"?",@G[6$>@XY[V.5/Z
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MFSB-AIB$3_R1<322%7EL"#< *@!P8W6>F]-*=%7*!Z?)2@#?GA0C0B>G]L8
M[-\!()8-L5AL$8D>RMMBU,28/EJZIJ]0"R(!D^07IB6@K8S(1(.&O/0>?""%
M),OH*+<_2,>$<1PIKF?@ +$H)FIMSWIZ^UJ4D]0D=\%G$L@#P; #51-(?/+(
MB7:=SQ"2D/DL'@]V!!V'-Q@Q%PC8##H+=Z$<"LWP[\$-3 @!AOM0#&ZFV4RA
MZA#:H0 K+NS&&U[SM0&!B62TH,F"4((B/LSLV;$YX#,W.1!!+7&,*3N5%."^
M5 !@/*!XM6.+65XE:;3>0)V1';$F-"L[1#5?Q!>I'YE7VMSD)!XOJAQQ ^!
M$\=RXYO3['P8'[CL?P3/^@A_IN?[$'R>!,H;0VB2 Y"5=2YKJ$C<2./Z6BT'
M$/7E40]G/7'P#1.0/07E4( ;^UC3*;0(\(FL#+9DL8*E0!55Y5?;N:]/R3)S
M#[B^?:Z9[T>KMSX]+IG0]]ND\CUE4.>B"1Z'%R.3A3M3,J&JU>(#%GA27ZV8
MCY)<&D:TORL5F[Q\N&;OV]BZOEAMD,5\F*&1$4?_ )HP/\<C6*ONNJV[0)EA
M !_+>L8SK Z;:EI$$\WV=(7:55L8<(*;GI7G#[T. 'R$V5*?0C$1(_T$+X0/
MW<MFSZUX-%$K>8A7L"SCE=O=;HVV-7/[0EJ0T] <S-^WC.XR891>F"S,12H#
MM0N.EN7TBOILPT88&OZ[C\PC [Y$@/PMKV:A!5H$&(#$)%%,]:(C!P_@V@3-
MZ\H^ ?=AF*X\)])R:;J6W;4L45$K^I-/OV0?OK66O!G.O+6>I%#0_IS5=9?!
MC2^S(!,*@,"I$36=V7DW296GT4%_ %ET&TZV!W#]VL<WI]CX,#]QV/\ V7A^
M[6.;T^Q\&!^X['_LO#]VL<WI]CX,#]QV/_9>'[M8YO3['P8'[CL?^R\/W:QS
M>GV/@P/W'8_]EX?NUCF]/L?!@?N.Q_&***Q"T8 *KK-G<Y%>)_\ 6$('JZFI
M8;\-U9=Q:B.Z>P=HF@,!RF/"]I)G'^)H,@?MG8\E#0/B,G2A2D;=(NUILBLN
M((8K$S! )2<9W&9O/(/00&!4!<AE")6(1>XHT0 X-I:QP!K4D5 L*'[*YP$H
MMD90TX FD8FLE"94R \.VP0K!F,1.@A36T?C W$)"V*&9A7H@0 !0BT3X9UK
MX>:@05VH<<H<IB)HV=Q-ISS?./*4ZAR/- 1$:(D=B/"8((ZY$;B_*DO.%0\@
MDND9JFNB#[@/0D(=#:"5=BP9CL<7TK/JA*#INSW I,]H(D!'^1H:G;Y#5KYM
M 64P/<&#PF*  HB(H^PXY0@J< E $EJQ"-J@)J%2!V&TZ&^,O439D54J!4=(
MCL?XKA^[6.;T^Q\&!^X['\9^X[F;[Z*.18^G(-<&IL(9-.8E"9N@. +K,5$H
M")4K2XQ<A9$;$&VSI2DN)3GM@3"V(;1["VSVLC*:L4B;RABNI"PB+BQ1HN<$
M<0Y56J<VA 25&!!726 <A6U9].P<)3'*7F!'G];=QDG"PR,OZ3]MY &6\ML;
M?O?1%R;L;X3'Z9S^HNB#>+DP 6W"-WI<CR,QF8D$D;NZK+$&+_K)2EM+\^#;
M\ 'LX<]ZL),.0?,@PXIK.-" "8.FNC)<]\XS,I"#;EMM#2(TG"HG9\'.+@(;
MDR8!;2QHR)0D&F D7LV04;&&F2(?@1W]82^/:(_PC@*NA3HH45#BH1H\?7KO
MI)>%T&F%,\R.Q-#DQ75H8![7\5[RN3B'">8RVCK8+CA0.QMC=*XVMX9T$22Y
MYO\ N\2HVF"08\&PS/T2C4PQ5(.Q"2;K $0;DJE;I6_]%2^QLK# BHT;4!!&
M?1BX#!0J2AU01_BG#]VL<WI]CX,#]QV/XSE0W; W"U'9]8,*N094GSVV3HN0
M[ :&39)%W26A75'Y%"M:4J0CAX "#-R_WT$AB['V!=!!/ F]48.&AZS"U"%-
M>G*!M:1AS!-T*(A-R!?VX;\]M&O@WA8*J+U<MR@AU8=G92.^HEU3Y,ZQJ8\!
M!$=<&; !S_D3U(55$ 8EZB13&:>^Q^6<+=B>B3/3^5MS1&3\NY' TOX6JHOE
MN@ !$D0)PK3-0TOLEFT!#Y"I0@X^0518JT<#C$YZW:LVO9K$=K<@*E*NB @0
M*PTV]]5/UC Y&!WP>[%!R(440M7,# (:C+.+01VMQ)MMCAM  U%?X6QK-2FZ
M&$-#AAO1,H#E$=P]@V*5/TZ3L%R:0B++D(K7T2*+FPP?"]4%%# "%@65"\;,
M^@])C_C$)I*3QGH5437.QZL+MM4Z)\;U#!E \P-^! CJJ\ 1;4!BF\^J#,4[
MU+RH*V&K:9F6[V.#2<4S<"\((E&CL3A._P#$\/W:QS>GV/@P/W'8_AEW@#;:
MZZ&I%A)XB32^6?U $")R]&?/5K4<U!\^KS*UAO\ X880^27QG-;$,_>)*PF"
MBOL^'[#SUQ@[BVIL8+?$NV"AU3>AK\C"<##LDN^<'SIJJQAHH]QL:F-7=4R7
MU==))B=OIWV#ZZ3>_P#(4!TYU5TP@%>J,=B ,?X7P?36V@N'A+8(*<])3VK=
M2&\:@)-=O74J/J'WHPK7/9S>2.U$-R#&\L;\IU-)GM;Q">U[JGC >;=?E*61
MZ*2$6 1#P?&1Z &<\E(M70O,TESOI1)/SUY1//YXPRPB6Z+--&[3@B<G1M60
M][,NF'F^,MI*'R]D,,CDQ=()/EK:3SV<2</@,#N Y3 G2]7=XT,:F[(4Y"Y\
MPK_$\/W:QS>GV/@P/W'8_A3%28)!=*AMXY]PPCG!+8!J_"6'$B,20K-#KJ2\
M@ !&5MF3L4#MGG<IQ9CAVK'*!04ZN3UE3@ 658/W,8,:4H"B@>^J_"SPDU0@
M41$@N0>IB(*QG4-@+IB )6()WE&\1[!F2P7DUFJH)9#802LL1BOJTO"1Y4%/
M+>-TZX(C<5%<I!4% *@;Y#D<(8%PP;+]S@T"Q_PY"-&Z8I<E*44*4$1(8DDM
M9<A#=#X *-B >%?UMO3 P7A3)5"I2=V(PP4SN]3"]NS)O!N*-L->%Z"0< -)
MLH,       #PQ:0(Y7>B(R;<CC/'F5*DX,],),V(J(V:E!('>CX2(@ LB"$6
M + ,',%8K?2C^+.'[M8YO3['P8'[SL?P@*@;5 /-T8*6A</"Z()VM9;^]]9F
M!*,08G) =.AS>L"@1C@5HJL,G.A3<M9DY3^=IA$\HUX5JU)A?EC16]/JV9.N
MJ9*WWLXRCI]\KN+SI@@.^7[4V$%&Y*@MHPQ12\_13Z4SW:MW$/B)7>GQTE-&
M2DX+(\%W0$?9KZ;):(FE&>9IIT'[;R7GQT*G,;H]-X;+CLEPS2%Z#UU3.ML^
MHK;E?P%FH?XB^:?0'L\$>H"GIFN'B0>C5I;6GJ[BD?=, !<BH&T70>[.<EGA
M(I%-TV=/+?.>@(06T3-]YW.EB\MXH-@HD:KMRA".I^H.%V#(GYKA2[E-QMR-
MV7?MO@,.'\7P_=K'-Z?8^# _<=C^$%&C$V)R/?"X.MS>XQ-!%,$6^(MK)8A;
M4Y1$\I:+0*#;*.VP;<ZQV;&/*4 \)_$0!.X2= H1Q);1>/, Y:,*57*0ZW7>
M\B=%]WYX#JA1? :.Q M0P:32:W>P(L"7,KX_@9]KS>=QO&P:M3.B$(V'/!;5
MG>-2<]MO?X*."!N4EV"!.]WIQG5@7W'/@"2VL1#X5<!FXM0+0TWUQ8DH&U[)
MZVI^ B;QP;J/^&A+NSRYR[AJCC-SVU).\PV=1SQ*L N\!! (H%F TR($%&EE
M"BW (>7DL=[8KGV,$W\(P !I:-><M9VS8N)Q'5.4D ($*5T/"LV=ZASXXIM6
MK(Q'^XS";C7R8D *EM_&0U.EP!@[Z3G&:.3E%H7!3#,$1.9E<L/?;HH/>1_4
MOXM</W:QS>GV/@P/W'8_A^CJ)=ZFD@,1:%S<YDUMU+$")=@(5*XRO$P0)%=!
M,?0VTF"&$W%R1>"DUZ/MMV\G3NL[8Y3I31)\M\!S_0/MEBE!S?7$><,E(C]U
M>IS0]G76+]Q.745Q6,*HB8(@DX'F\Y3B[[>X/3NLD):8*6)SN<&7771NNYJ:
M$!(?U@+5<R)6#M&F'$,B8TP0SBKC<0'D3:F!_AJ4C@:1!-V!:!A_)P.\=M>H
MQ<C=HH;>*.*#M\\PG^"Z 1513'S?!\!AS%S?Y0)J4,A$2JX; !#HK(THAD?4
MH 4#XT$]!2>>;]A7@;!/]"#[93@X>-!KHHGE2X<QPN6M'OP3ZXSYI>95K@!0
M *X0;B^4?)?/^G!(.@0>>^"C3&[-VRA;2QU6L&-95UA?2B5@'CD9T3[C5%XX
M",#9P6).#P?(A(3UNK@\U649!_B_#]VL<WI]CX,#]QV/X5T6E$-W:""=NY#:
M86%? [E;GY@W#DG38! @")HF2#GR)E2?@U%09*6C4::PY9&==1"I$4FEH !\
M $-")VP!71O@Z;RB_C%>:P8/O::JE^+PYC0'=X+"0K5M7"=_\G2J>.1:)[G)
M48R+@R>L+Q@; Z("&APOIH05 \VL\D[=P[GL4G=8FEW:9&-)G955$.GSPDJ
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M8"4R7N9K?<"L_OY9MXSCA.HA<U%8.#[;=8-X  ,,&Y.$+RARI0A4(;1Y7/\
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M.R#)>4A/UDM(D7QC'=7FP$K U0F45?(O%GAB28/Q6P8Z/F("'$!$3N7Z@&P
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MT"K&W"(ZBT$<4"DB 5&GN5Z(D"L<0->@#J%WA22,O85.3W?[QRM&@5#9!K8
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M0NT[YBY&!>GVH<>8FE%'W+LE.SZ>=.AF5D!\W)7V W)C,Q2PX\!QZ?F@DYK
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M:8['1OF@A0:BM52D& 4'TT,0E6U-@=?; _<=CPO0_8F, ZY!11HHJ:6HB/\
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MD]TE>)\T0HJ4CGH)K(#.:PLC119+95BBD&Z!I)I0,-58Z>%'A3D[^.X=3XB
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MK XTE!,>1K ?XM QQ\]WO^AKQ4@^_P E?[K8T]K]OJ8X6A<RCC#7 O>+_/\
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M>3LAZ=?Q!ZX^$+^77H232,<$N JL'E48 JCU7+_BPG4[HH71*A1NC1#*AO5
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MM"40MRI[%[8@B0_:,,X!Z*ND+08 !'[A U/](>+ X+Z3.+ D#Q1K@A%ZDK6
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M4%6G8)J)3*LTI"1)NL([Y1\T.<$.M@3G-%UCUF-X.NI9@Z-6"I^PO1'H%#C
MS8$<=T3H)#R:F!39\)/+2;H3)P%@"=:3C:2GQ-S<&Q^.:A1LV41%-E'IOM@C
M$!S; 8KM@==]_!K/T.EY&*+X4K HG:@09*10+H )NG^.E^41L-GHL#)8KP5
M/[Q"#H!!@5T+G1A("R@2,9558$\=P_=K'-Z?8^# _<=CQ6X,B>8C,4"H6!T#
M#!X0"%!D !)XJH-G W\4&P@O)0"D0L2Y:(\H#:8Q!7;ZL>/LP,AP8AR)$B(<
M:OI@\S4$M=[-Y.\80-R?FHR   T'N14IL1WFP?69W_6F3?A2EP A\$QPF<!8
MS:BEP'@0S0'IAXKZ5.@\$"5$%"H 50*IM0[N+!&K5DZ,&8 X1 X)_CVP\8-
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M#=\63K&W/TPDGI'.J7%U QSCWALJ#+.=(]1[=L7!HHB110Z(A3A/\0':/ 1
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M[+&XDFOC[H_OY1KJ/*GP////////1*C=T="Y!X^FLX__ &]H7[-YJ=4;'0/
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MI2[.*=KG73<1;5MN<WP.!\T2#45FHA&W)=J[:B.MCOII#H=3M.(QHCK2&?\
M3@TAN]JOQHL$ :> "I8 . #7L0)"P1LP$SU=565]!H0VZ^VQTIC"F"*T0U(
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M>L32>U]FI3AU(@I?& B@BDB=!H>U:.$WI.C#\$&F+EH94Z4W:+8__:@HEUK
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M5:.6L5GKH9WI=0RAH@O2P2_>.H -JNS6(62;@8ARQ28T:PN9@ZP)FR&9*O\
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MO*XJN9[?1&MT^1D+\?RZ+V*B#[&YL:AI^H#GLR9P%@!O#&%1^0Y92U>MIQR
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M4)5Y5@(1K*5C^WW@DP6JL*>;K5K*B7 \>M:K=@-24L8D+4R0M3H$"\A_>C#
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M;]_X.'^1*1DW4CAE30NI8H\EY/C[:RL'  UG67$*9CT*/&@IBJBW46.J,FB
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M> Z\OJR85"\RR\R_>%B4(EIXGS)6G!S27JVXG\9X@P'$ )*!0J)TC(D&(D&
M9"*L'&!NH]M*$"@AB'*'>"R+1T4!;*3ET4.!K"&#QZ&,><BY2XM8I7Y,*>\>
MC6316W@HN>BNTCH;FYTGYCLKZJ: 0B&G12L'8U#O>CZ#7D>4XF+A]+&TG=X<
M&O$;#5[H<5UAI_V5.$HH3-E=D"_,T-Z01Z1JS89@+UE!1 Q-X'L$?9PT0$&
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M4+<W&X<F=ZC^N,,S_P OP,SXES!C30!IC=+=TQ/+*%A_9_3N]<[!5Z.4W"4
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M49#%/&G)P 1EK%Q0"00$"I?X-3Y844D"H"P%>@N3C]:)^@F,8L?\QJXA2KD
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M:M)HSLXG>H1?=\NX-W;9X1&@94:<^^^UTW'A6ZEO .8Y"9:X! D!*-?GF,1
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MO8U!^CAO X4.#*I10J$HRB)T1S_&FQ&EH#[^5K8!"JE36HL.'!=>>3#O"@G
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MRWP?N)MPRSB(*-'_ .=?BFHH:17=N!Y :8]>Y%G76T((/0DA+-QGM4"K _\
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MHH3/+%G#X406%T#Y1$FATCO$:2*5$67VGIT?"[$TR3D1T0C1NRFWW5B9LBA
M D,(LX\NB.'MT-S/D&E \;T$, A"$  !&ZN(W8H'HDARR7@8?R[<!3RGB%
MC2<6=/D<>(4&5TKA''*F(5QJO+8\'.B'%M;V 0*51#ARIDCZ/L'.Y#2D&^Y)
M<GS?O\+'!FU , H%=@-H8 _X")>5P@H$4<!/" 3F0"4:/+<]@9W P!T"U0("
M+!]0'N$A4D"4!_F;G4)RG(G1'A>N.[/H@$ =BZ"RSK=?P$P"T(%75).#PUXX
M^OL_RBG0>U45<?Y.F ZQ7U*<"DY&9%J=<#!?,):^<>8 HM?BVK@["E2Q$V(\
MAUR[FP,"#D=E\\/&J_-><U=94N1GH^[: @V@BWA:'3FA?("C4,+'&2R#=4]C
MAM=7U2%]L!V%@/[&^F:L4VA[FK[)3 J!0"NU VXP%7%BK%"6PN;RU.@EFQ]1
M]@")I!N:;9[LA<@ZLTC*HBH$8Z1'9\:@!DR0ZK56G3)UMUD8&A(JG+)T4YWS
M_.TDPW0NCH$T!UO/R*/FR%5NZ>Q&),V%CY=2N *'&,&X"HI=KLA.7MQ@G@>#
MI @ BB@GW$N3YOW^%UH'GL/N9;6P38(^*F* *QI]Z$$S0#+VR2Y6:/$1A0"6
M%M5Z0\E./:M>X^6,5#A/1-F=IJ@#/,UY>P8R1RF839+%RK@7T0 3F#@?T]%4
MX-5P2JLN^-%V02 HS/XK2P.,]A@Q1 23NZ(_!$+]L 4.#*/R54-$:2%%'OH!
M !Y$$>NQUSO&JJRD0F0LM@*A"/3$BCT4_K^!#<Q"2D%4N )/*FKA.(J,Q_8_
MJDF9?W &T,MD_,N467V%'#.YQ]<PJJL;V[_&EK&L+0': FZ4(W8F.JBQLXV#
MV._;YMXE;MZL+:1L! #_ *N(;-L3=R3E77"86B@,AS!$)ONU7N 9D0K"VJ'Z
M+KB2]A2O<H0UM$@4DWFL2$LNR2*>'84A*DV+ZI;UPKZT(=EW^*,JHX  #:F=
MV\\_0SVV PW H-'CS@/2!_&- ?8,*4:)T>S5FH&(D52JJL(;5>#^<V( @4 K
M$$IR1>KWS6<T'D/=[]WY#&Q4^A,(LS!B&A0C0A(\P)/B")C/D@-.*B'9OCAP
MFX,6@SA_H(WN"7)\W[_"_:?9B=1%336>4\3NNCZO1[TTRT.A1B]*1J4"2KRJ
M>[1#F6M)-;GX%3"LG!\K$:6LKBX2(^F).#KIA#:4+2%+T:6$.5$O6-D'P#$1
M@2 G )Y&,< \!.G*>EB*IX(=NQ DV[HH-/#<BP@U%**)'\1@FM4C8C@C03PM
M.,8B3L'$WO0[/]/;WW(W$'>K+&7BY4F5V!N8!I+VP2.37C6N%1!+,^MD'(UE
M5 RX;C\<:H$D78T6V/(#5.MN_FH^0/4K"J!4E$3HCO/_ (9'<3H=6#Y%F@"%
MNW#97]-<V>T;@=D9(AXP]@'"@:[]T.\RIL;6)HC=G8?:SM<-65^#<S@)P(S.
M7(42%9T#'0 B)0 4BH&2B='/J7PVP.FVI:1!.#']$;1C0<M,2U!JGKM-38.
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M*.$43IR;XU@(!*B"&EP=\G7Y#&#F)XDD@T%79E:S.M(@!L0BI&1!$;G$*&L
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M(A^,3,*2ET64H-\#K( BRL 8B#K8>?O@LD!.5I:\KU^;12Y/F_?_ (,ZP-E
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M@@]5TU$LP;#W&2XY@!$ N,FS+;;8A.B.%C&O7-SOS'E%TZ/].VMEMQTT3@+
M41)X0+^N;'*7P2&OB.@/ -P8 #%^?6\'49X(/\BT ""0H7_!EA/1J@BI'>6,
M9[O.DA^Z2P$X0,F QLNS)9&%H7T^,\&U7H]C'798);;<_8\(E7TE#=]F5GI6
M*87F8S\^?)E /@\1$?BB<0$QJ^[0[C09#1P7XMXZ1XD539CC;%L&NGERF%MN
M:+ 5(>QEI.Y>-Y<51_[RL8)4# OV32(S-XT[5IK10,1N\GGZ/UH( &.J.28C
M@S^,"Q1*[^#AK]/H4.'8(P5G,3V9813\3^_23X((_OU[XUQ#5F1(3[HT\';$
M@G)N2@+.\ZHGNEDF7/PF56-E3WCA2C4$B+1LM-OJ]75C&LQ!,_63P[_1UAD)
MH@L!<B%$QSX@M08,JJ,G^E6 546-9<G":Q)J%2N-6CN)&&) (4G,O**CY<-P
M-3ER3T)%$N!FF1,! 0?RW3]3/7+ B%5"R03@YK0'TOA*U0)H H:.I%_[?H9E
MA"Y+ @W')?\ S'\ VO>!'O\ 5/ W23Z"8T&%\GD33>:596"Y^?9R=Z9+(D.2
M?IJ,!VY(V!!]THVDZ0 !'TT$"=#:;G*TA)!_+$6DV16JU(OA07^0Q8EV:CD=
M^F1LICYV%L[9NRZ*A[FND6-)$%0+ KP"ZP1NM!U(V6D1OZ@1/:OX=,47_P"9
M]/0M>?>3 ^P>- VV@])%XN &#&;0@#QNL0,@OG?)#37]=>*L=9^13S<U!>VD
M !,NC9[1F!NR'_'W(?F&,845B4XL'60(@=UHY117PMZSXB;."WQ, &3)6X"B
M1V2AR$L#*=()R2@-AC)RQYB3J>:L+*5PQTP^6-ICD%C"#L> X"8J00("&(:Q
M,#QNM-SQD0MG&?B&%T%,IKN%WNWT?W+6QMUX?B 7P=AQ@F^J\3B):K?1H+#:
M=PB((E*XIW^^QJJH5GM."4*@2))PGH8$%,LZL$HU@(AS.Z.GUYN)[BA.-.K@
M5D<_!!!"8MZ8GR'>GN@>PZ3H-M)"_P!P*$G.9A2W)%D]LD1* $[^PVRV7=1)
M8*HI5;N$8]@(.:S[T.W12P5(Y+D+H*LJ[01M!@#.!6Y"CTOAP("!5\U@X>!U
MDUQDU&]9QTB-0.];$K*PZM AH$54)"A1X%CX@"&%WMPF#02=$RV;!OH:TX%(
M(PIHTF<#)SQ8QH5;!=EA7)JB3P"I0)^4X47B W$3,Z;T9N#L[V9,+VF1$R[4
M"@!3! 1UR+-<Z)>ZI8?> !<"OT0&"&\#Z9&73.5=HJ,1.S1L;#P',7\H-_$(
ML2.<>K%2G?M>?DP\J(25XY6)PG[EG#,#?@L$]+($8YM'&^JO(UXP#"2F6$][
M?(@ U!N9$N_8Y]U82FQ.^"CAN2N'449,*% %Z0D%$HE8AP_]CHM$AC+<X,C3
ME:1O> R9E. MR21S,L8!9]ZH:+M,:I(VO#X'@#I;>J<D-:O[>L^B2 M'.1['
MMB=!^_9-\%]3@5GP%I,R:1W_ ,/#*LKLL!1H0)KH1-7T&' .K]IDR8(Z[/W>
M9KGXLS+C,;CC\_T1%]B"7@,.7[3J%)H-<GLI0[KH 6!V)V;>P_I<#2XRBJYE
M('$$-AC  $-DMX<])(D,*[6E@ H*!N.<)!G%CV,[""[^>J'S/N=ZH'_X]T#>
M.^.8UID"@,D1@N2L$#6#Q@2!#0=9=8";C%9892I6:7B@5%\\/6Z5(I_\"-)P
M[4FB"17IQILDD?>1TW.A<*@11##6LS6MHIB@D07%?B%G^"*YLO+4ZX>U&4))
M6!FQWJSJ4I>(H7Q>0;POEK\S"')0?\QX F$G#/*3 U8K9</$SBB_]M+SU7:+
MX<#^[DQ.(2V@1B"5 'HLLW%H@9D47Q'"TKOO-T48KNL$2;?I5 K3#T5V\H%
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M_P !$O*Y04*JOR%R3U?%&GK(2DLDTJMA%<8"8P))\<B4I0$C2B(Q!-<EP$&
M  :E - TU\"N6]8@T2 ,2ANH? .X0S^9R"42JMD;%$,T(B" ! ,((\:Y7) "
MHK  KH X/<0" H1$$1(B.D32.DQ%XC.0$,): +,@(CC#(!*1)!2:XXUPGCUT
M9 B.@?>>F+$W2XW$0Z"8 ]XQ"2A@  @)F3J)HR J5 "N@ T'P(.LBTA7=@"
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M8,&#!@P8,&#! T?P/!!6='Q*F7AQW/.P8,&#!@P8,&#!@SK]MP,%Y6G-[/\
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ML<7#3OZY*<'1:D3EIZ>'[S?GEQ*EOG+Y*Z@)6=X>6:. ]#:L>&V/S(-VH%R
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M!@J^_5% VP@H>E+JY6\1.E=?F-$<#W&!E(6= KVF5(Z8-MM\$=41OD31FS6
MV]_!R3@Y#>(QU"3,:>V ^R LE0U8D^%F9T-MZ$<M&#LDN2MX2BSW!I?K+$M3
MR)?R\U$$9,X'2N(?4JX^>JM A\/)?.> !@:'HU_!='DQDM'X?K@RW/C_ *^3
M36?.\G2:Q2DHJ"EQ*,+H([PL2RS=,Q6[!&P7P]8JF?"CG;K+9)V<I"]JC-3[
M4*(20Z[@>BD=R<<H2$I= <AK1[65/)(Y=6."D"&C96@.J[\"^Z @)6M>S%K*
M32JD'I7@Q]\F&2G-B&F:$#_X[%&@$^U<;H@I(VVOO]X,$8DJ,!DJ)<4<_5C
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M:32USH:"Q!X,8 ^%?O9SA@KO10IPT?OPG;9TA=<?[86.A#B"W[!"-*X-:$P
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MV^O)9<O5(.=,\-I5^>>S.Z@E>[G\ROX=HX,$@%E(&R#K.5NWXAT@1#A.4?\
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MM;W\D-V3P%&H"N@M^":JA*1OAT[(#S<4M"ZZ%IM(G(J))T'O*Z*8GGS:F?2
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M !)+HFW<%-R"=%+M7J1OPF\2"D\GL6A7$&[0NV;,*$$+(#!)6/QX))./1?\
M1J\NJ4PF.91:5@K=VG$^[B687<?H"#<_S,WA7!&4OB-*7GEC;[I5A.D.H%<"
MSMFWC"]Y>$5/D!['6NZ:&E'<[F,ED#K4/!LNG5'(.2F]5)_/TT>^4!R10Y^
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M;8%2T\>V>C.5EC=D6%AA3C4$8,!5*F-)'KKG$7-_>8HEK&9@V'8DT$BF*_\
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M"(B(EB)A$R)A/&H5:%H%H6N@O:\@RSG82CV*[Z0. YSE5XL+539HITPK:"Z
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MGV\3492MU?)YH3<B 9_K@)^8$4S A7O4O7O=V^S@PW=OHXYK*W;G9%"MG$R
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M/$0+=#T?&+,+R)><IHKH+2$R/I%) +ZU@BZPN<ZWSLYR^/M,7[T1B]B]G&N
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M#'[@)'/->:GJ7L7L>NO>UR.LX\,D[[R S)BZHUWY3FTY4-()2(T@TB/,29>
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M=V8R6Q_+2&F&O/(V[2HB:!VA.7L;U>?,#B>9F0KY\"->;6A>A<K14F*> _0
M44OP%*DLG;FR"(1!/^U,/;^?1>9,4+"]XA;9?P4VKY@0^.?(S"Q)=+5RA:BV
M3\=Q"L4Q@R23'CN'%1HS%2;Y1A;%I?LCM-^XEKR791H0^D 'X#U6P^#X#/\
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M<B\?DT'.5UL<I,$5(2]9B 6=%U&@&D54B62R(#YXZ38V?3GGH.>7  J$ %5
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MW,N1#9'@1G3,"ALE#7JT&TP#R. ?\;=^U</KEZ_6(ERLY-J&?P^,BSA?Y/\
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MMW*#QXENK*/&R7'%KA%INN4.,YZ!?P!:2(&Q=<HS8)O/M*L4P:0>BO-T[_Z
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MH+(-6 RD;$</[^I >(V3_P"92XW,OYC<:]A5N#S-GFHM_P!Q)FJ7!JZ58?\
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M4L7\5<9NMO *1<4A?$' FG9Y<-<0=M=S.*S=E'_>P_2ZI$18@+$921KT#?\
M)$N&*_:85B5:C;(XS+)PL@5M)Z>E4]$T.Y9M;TFB,D3WTK0X#14=$)%DST1,
M7 %-?=-(.$\F.<#'B-: ,,2LC+V<!I)/G#)?3\1(B##4L8B"5U !7W,LA$S2
MUDT:>6.'K] SW],52\,LK7>[!/A.%V9X2&CSV=4[<)#7;-32?$[#ZP>1"$(O
M$J_V0Q 8?]0R)PY-5<#^ - ";(%KA%LUQP2@<D<97-L,<\T)R7G"[ XR=7#S
M*K:$9^ 0*V@N !3@8 K#)3K2"Y[E])3UA1"50BD9&R <"@?>K.M7$YWYF/\
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M?T=FZ'HU;+-H>X,L9Y:CE"5Z;=\7A@N;ZX94[1@_W;0P[IK> Q"I9E28ZW1
MQ,E.\DX20*H6(X6*FBN1Q"Q>G>%#I.P;44 6\"*$R 4K<3M#,<]D1>">%7MH
M\Q83P-VGE#3N%.%@$VAJ,1*T'S%E[&=&_;I_I+&LVG1 ?A\$@@<F%QD^4"VW
M8K^9FN$9)^8@T0S(DT4<0O-65,$)#M[1"-#]6X[/ ^H'K68/48!]V H&ZIN2
MV*; '+*3VXVU'3&[Y3K",T8^D7'6!F);K(\3 R_-Y]SQ!C".UVB2HA?HG1L
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MEMJH$B+H+<5M_:=G9DI^9Y*G(A.()6&J.+YLI%AP/VP9%TWS6*WT63; 3[D
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ME,$^E0RPO1.NS^.)X#3K/#KS:*T!-DRL<Q<<=[49P<CM65O%J"/T=V]I;?\
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M2@+SO>:GG'=Y<YS-+PS'ZYZIVEFY:,IP]$MRON%I!)8VX?N&7R'DL9PIH7<
M @6^K5S3@;:.&MM*,\0DUA,H)W\9"3#)-:GGZ]!Q)*'LW6?[]T;^.G^\?ATL
MI,)S-T2 B?9JA\ H[^>GVNP71,<[,$2ED8>_@<#EZ:U?5ITWO,K@:M<CFE.<
M'1K!Z:)B#5W:FAL!\5D\2E92SV70..78I&88VZ'7R*HPX[T^]0_7W1+_ )O1
MM[5S!W>!,NJ1W#RWR.& 5MC_ *]6'2\8BAP<X]T/VK^]81F[;'P'?Q\ZWQ;D
M%<0XVYQ ><?C,M/4!VZQ]]RQ..>?9Q'W<K_I"S-!=LP)MH?/.O'.<!1).?\
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5>0B<BD+U,YN8.74[8$KU\(2)W__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>ahl-20231220_g13.jpg
<TEXT>
begin 644 ahl-20231220_g13.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X26P17AI9@  24DJ  @    ( !(! P !
M     0   !H!!0 !    ;@   !L!!0 !    =@   "@! P !     @   #$!
M @ -    ?@   #(! @ 4    C    #T! P !     0   &F'!  !    H
M +(    L 0   0   "P!   !    1TE-4" R+C$P+C(T   R,#(S.C$R.C$U
M(# S.C W.C4Y  $  : #  $    !          @   $$  $      0   0$$
M  $   #,     @$#  ,    8 0   P$#  $    &    !@$#  $    &
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M49-QDSD;]H(QP0>,<]^E3'6].4 FZ7HYZ'^#A^W;/-9\_A>W2T>.R8QN8C$
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ML9$5(F#YW E^B\?Q=./<4XZW;B_BA!4P26SW F!XPK*I&/\ @7Z5'_PCMKL
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MKG[*RO+>2[:2VF827,LB*KH,!@,,#G(.,C\:M_8=7_Z#*?\ @(O^-'V'5_\
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MQV[=:B@M=:\N<G[3&3+"PCDG5B47 8!@>I R>@Y_&M#[#J__ $&4_P# 1?\
M&C[#J_\ T&4_\!%_QH"P6T6H1Z?.DQ9Y))F\L;@6CC)XR<\D#/>LW^QKM=$O
M=/%N-UO,9=.="!M/5<<\8.1SVK2^PZO_ -!E/_ 1?\:/L.K_ /093_P$7_&@
M&KD-Q!JV^R>U.T #[1&Y&&)(W'(/!'/8CFMNLK[#J_\ T&4_\!%_QH^PZO\
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MHHHH *IZE_QZ?\"%7*IZE_QZ?\"% &/6UI\7EVH)ZO\ -61%&9950?Q'%=
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MKQ'_ ,_NG_\ ?;?X4?\ "BO$?_/[I_\ WVW^%'.@^KU.QY=7U#\)/^28:/\
M]MO_ $=)7E__  HKQ'_S^Z?_ -]M_A7K_@G1;[PQX0L='N4CEFM_,W/&_P I
MW2,PQD>C5$Y)K0WPU*<)WDCIJ*@\V?\ Y]__ !\4>;/_ ,^__CXK,[2>BH/-
MG_Y]_P#Q\4>;/_S[_P#CXH GJO>1F6-$'=QGZ4OFS_\ /O\ ^/BCS)_^??\
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MOE!;2;S'9ALP<KC;G)QC^,'(.".036IY$1.3$F1@YVCM1Y$0  B3 .1\HX-
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M8VUS
M       -9&5S8P   2    ! 8W!R=    6     V=W1P=    9@    48VAA
M9    :P    L<EA96@   =@    48EA96@   >P    49UA96@   @     4
M<E120P   A0    @9U120P   A0    @8E120P   A0    @8VAR;0   C0
M   D9&UN9    E@    D9&UD9    GP    D;6QU8P         !    #&5N
M55,    D    ' !' $D 30!0 "  8@!U &D ; !T "T :0!N "  <P!2 $<
M0FUL=6,          0    QE;E53    &@   !P 4 !U &( ; !I &, ( !$
M &\ ;0!A &D ;@  6%E:(        /;6  $     TRUS9C,R       !#$(
M  7>___S)0  !Y,  /V0___[H?___:(   /<  # ;EA96B        !OH
M./4   .06%E:(        "2?   /A   ML1865H@        8I<  +>'   8
MV7!A<F$       ,    "9F8  /*G   -60  $]    I;8VAR;0       P
M  "CUP  5'P  $S-  "9F@  )F<   ]<;6QU8P         !    #&5N55,
M   (    ' !' $D 30!0;6QU8P         !    #&5N55,    (    ' !S
M %( 1P!"_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_\( $0@$6 5P P$1  (1 0,1 ?_$ !X  0 # 0$! 0$! 0
M       '" D&"@4$ P(!_\0 '0$!  (# 0$! 0            0% P8' @$(
M"?_:  P# 0 "$ ,0   !W\
M
M
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M?8&?U@   #F/,:C$;2M#I>_#A?$+&N!R.ZDC<*MX=:MOGVF\\G=0
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M7S&+IOLF?<MY5S#K5A\M^.P]2\^XNB:"2M[[GU-QAK^0ZD3>E5;P:UL78=:
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M^I6\_=^YP           !6[#KU&(VE:RSNH_3^Y0
M
M
M                           !6[#KT9>*V1/=APOB%=23N
M   K=AUZ,O%;T_J3^IZM;GV@             ""\5)\SYCL/FOZW8=>BGQ5S
M[EO?N_<U>,-#<&1M?T_N4
M          1EXK<,:WBWH;M>]T^CZG9K-L?,_(W3?9/,_(WS/F/Y?S%\SYCF
M#);=/ZDQEXK>%\0I]RWOZOOJ L5$)6]VD*XZ>=,MU!>*EG3+=0_CJ>P]2_A?
M,,U9+B"\5)]3[EF#);",O%;AC6\6]"-IWGSCU/Y]V5L.N?3^Y9-]V/W?N?[O
MW-7C%0SGDNNG]20*MX-:YGY&_2]7!D;9"N.GA_'4_+^8KO2=SA_'4P]CJ8\\
MP+]2=Y^8Q4^CZF+29MF[KW- R'@<IBGQ6;G67:?A?,&!57PW3Z9TF=,MUPOF
M%8?+?0#BH^Z]397R6@
M      C+Q6X.UG$M2)O2OTO5KL^T8B5W&K@9]LZ?U)_4]4$BZ-=Z3N5*X^GZ
MCS.EYY1=!T@E]"S+A\YN])W*K>#6K@R-LE;W9X%UG#O27;_H7SVU7!]V++M>
M5T+F78>I=4L&L7QE;OV'J72*-IFJ$WIMD<VPQEXK<':SB6I$WI5#HND[ S^K
M^>ZKX/?J3O/T_N2J6#6-B[#K.-5?R/>*S[=\+Y@[KU-P=K.);8V/8O.W5<#]
M#=KWK &KX7Z.+;] X_0.46CS;+7C%07[E;SC57\CU1F]-IK'U&R.;89-]V.:
MD/GF[%GVL1WXKX6QT^-5?R/>*S[=,&2VJE@U?)&#RS329T:\\G=<?H')Y]RW
MOZGJ_4K>0                                               !&7B
MMPQK>+>ANU[W 6*B^G]RQYXK\AX'*MX;/ML4^*S,N'SG8&?U?SVU7!]*YG1(
MR\5NFDSHWGMJN#[UV?;\N(7-8"QT>]=GV_SR57!?31<?HSSR57!-SK+M.9</
MG-FLVQWGD[KAC6\6L/EOK6Y]HF#W;=U[FQEXK<,:WBWH;M>]@>9>G_.?IHN/
MT9&7BM\\E5P7<ZR[2.8\QH,QTMYY.Z?E^>:I8=8[KU-L-EOO.W5<#]-%Q^C,
M?H')Y#]6&B\O?ZD8-5X;S"T-E;]B)7<:N])W*3?=ECI7\E]$MMWT4.BZ1*^2
MTH+%T;N?4W5N=T\>=JIX%L78=:LUFV.FL?4<U(?.QOK:=R
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MYO9K-L=&(VE;%V'6@
M        !4C!JN:L/G>\-GVX
M                                                 5XPT'S&.8/=
MMW7N:
M
M                             *:Q]1RNA<R
M
M  &J,WIMRI&W
M
M
M
M                                                   5*NN.5DMN
M5Z,ZO^F>WCWU0+OB\%6//Y(B[/UN"Y@&SYUW\;8OS?<?YON+1#6/TI#<[2,^
M-F_.%K*;KW 2M<OKK?Z&_3\R@#/C9OSA]+Q)F2#N]);_ (1/];T6]FN_H$
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MJXD"-L?S?<7D<U-^GYED"-L<6S-2H#LGYUT0UC]*2!&V,  0!9<ZG^MZ*
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M)VKN@                  <WEJZ [+^==(M5_3P
M
M  JG<\ADB)L\R0=W '(YJ:KEQR:Z-#W(
M                                                      4EO^$2
M3%VBR-5T\            <3ZCU?D5-7L]1'&6O\ [>XGSO4?]'K!%V2)\7[C
M$H8Y?W?.?^OF3_;Q*_CXEVAP6UH(]O/.*Q
M                   'Q/N.MF>JJ))I8XR0/EY(7Z?N'Y_N)'GN-\'UB$A^
M)7V_.7ZGB9^?SF^IXG3U@M+)X+2R>"U_<]         <1(H?I^)728K0 <1(
MH:N6_)KM4'=P       (OR0\RIVIPO)H>ERU=HO&6U^//W_ST    !^)\KM[
MQ5<]XH59OHX+O0^#M=NXUV
M    .)]1\V9VK5^DT'U\U193SZM%XS2QY]@    "NOO%6GWBJ_Z\]7'OK@P]
MDO\ 0]D_<]       #D<U-]/S*^WCG@"-I6KTFV#A.D6J_IX      "'LD'(
M2TT/H<]#IQADR7\]@        ?B?*5Y,%&_N>]U=N^A\/9@
M                          !R?K#CU9Z+STK6=*<6:<?.0         5#
MR8,\O7VV4'<=0:_;_P!ST      *2W_"))B[19&JZ> /F^HL6S-2F2#NX
M   I3*H<WK7F^S.&1TWST           *"Y8U:<-]MU4=%_<]
M                            5YS5F/5QS+7O']ECS[           %4/
M>'-M-W?ING]9YS      5 N^+R!&V.?ZWHH _-]Q?$R0.DQ6@     $#9:[(
MVZY3MG@E@       #,%[^(74>>*)0)J? !77WBI5'V79>LWP
M                          ?!^X_/O?<?WAP9_P!KZ       !1!Z@A]L
M^^2$^?%+/O@ C3[XR)^S=^:7J0        $;2M7I-L'"=(M5_3P     &,]G
MHVD.;6N_^>@!Q1D8R62>=%GGESS.LVZ#%;I\ H\]8K,GJ*81YN&72-XKV]62
M>=%GD  879XOH)H.S                                      #.:;J
M_P!F?HER,>< #,Y[Y<H&]>BUBQ*9*P/5GWG=UC%17W']D]'3$,(F2W+S49ZL
MD^:EO   R4SPM3*3KLKXY@     @"RYUUN&XE*'MH C^3KE)K_A.C.K_ *9
M     QTLM'T(SZQ)?SV !Y[66ZCSI\\9G/>6CWM0QW4>1"K[3AZQ*9/7,P#B
MBJ;U1UZEU\[4TQ>  ,.<^#?Z@[&
M     ,_9FM_(L.?WAQR  *</7[7SSVLOJ*8<P7N3R_CQVH(5??,&S>N9@'Q"
MHSU1YZD)\^T:LO  &1&>%K+1]>DKQ+     %);_A$DQ=HLC5=/         B
M_)#PTO.2[K1Y/[7T >=]ENJ\_A/BF4SWJR\=02$^4#>["O..+)ZEV&=WS\1D
MR]R>^<P^YT/7IB8@!3?)@@Z)MVN-=NH
M         _"\^>>^Y'N1B=-\] #*9[H&]6M?-"7CJ"J3[E.R:8O$A/EDGSS!
M,WKT8 ,F7NR3Y1YZJD^^F)B $!>L6:OFWW?I^E      0!9<ZZW#<2E#VT <
MWEJX2L-$LC5=/      %7L]1DA;\TV Q^Y8\^QQ16!Z$GOD8/N$3)KF\6Y>>
MH((?8O,(F7U8L$H$>GVC[93AZL(\R@#\3YF1FC?QA[;L%6[R
M                           (KR0\4[CF>DOR+:/QF K ^\4^C]IC^]Z+
M/- WK:ACZ@CTXI]FI\FI\Y<^*2$5%?9#)W? ,^,L:M&*[W(I^D?N>@
M  (VE:O2;8.$Z1:K^G@      .3]8<F+'2N!F:K?;'[M'XS  40>K/O,H '+
ME$7K19Y   X#[YSYRQ82QV^G-;O%L8]R
M            /PO.6-AJ%39^F: ^%R,>?]KZ *VOL8/MU'G]H    !\9\SXS
M1JM_)>A=;O-\8FQ       5 N^+R!&V.?ZWHH C^3KE'=AX)I%JOZ>
M  Y?UASMF:S6N5K_ ,//2S \VOQYI]\Y.F^>@   !!WK'7;WBK5ZQ_AQV77X
M+K2"#M5AL-F                                          /PO-#YF
MNTDF:U_S+42)ZC6B\9K%>,O9?/0    C3[XJYDPUI]XN*\3.XCWE\(>S7)C7
M@       %);_ (1*4/;;$5G2@!_)XH)LOYVT UK]&          0IE@5;SU%
M;\]7\;W#XW)#[!\B[)#^+]\"4,<O_7SW^?YGZ''-FO#8VAP6UD\%K]OYD
M                                           CSW%J))I8&RUT<Y8'
M)9(78/,>>XO+^L0D/Q)^WYR_+^9^@QS)?Q6%D\%K9/!:=MYD         #F\
MM7]+Q*^EYE  #YOJ+]+S*
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M_#R:"^^M_H<                                           #^1_4
M                                                 X3) J/[T2GT
M_4;=0-K%19^J:(U._P!49VKQ1GJ]4:3IV5UWS&5\%I:.%LN?-KH=VJW<N3R1
M:HSM7TQINCTELM,Y/W%TRI^CY17G+K!Q+ZP<6^SYM=#NU6[E&>:NKC,U[3VE
MZ5GS:Z$-!JK?<PKKFMCH>PRQ@M*,V>E7FK-UI7::EM%4=P
M  ')'6@                                                 %0IN
MH58^Z/?"IW,                "H]IKFED/JX                BDDL_6
M                                                 #D/<.OV'2N\
MQ30                (NF1+BX]_                $2G1'<
M                                        @F10UK\Z39:#L
M          &7]]SO;2I[P                (E/GDU
M                                 J=,U.JWW1KS56X@   #FOOD=+\]
M           1=,B7%Q[^                (E.++ '[@
M                                  07'TL    1K[\9X2XGQOOS0.)*
MF_'E X'UXZ7YZ^S\^@#XWWY&OOQ,>/(    !5.SU[2")U4
M  1*<22B=^                                                 5
M9EZM5]H]TJS;0   ,IIT&O&7#V/GUI/#F6(Q9A#F3'YL+BGWMJ[2-??C+^;"
M&W=;98;V59LO7V.0,^O](=1<    #+^^YWMI4]X                $2G$G
M1$W                                                 %?9.O5C^
M:1:JOV0   "N^7#EG.A5?S8-0(4W32'-YK[YI#)C99SH6Q5?80ADQ#XWWY)7
MCWEG.A>D^GN/'7L&O^KZBO)6\9    /U99<U>]I                $2G$@
ML ?0                                                !S?J-7W#
MI/98Y8   &7\V% >7%*^/W9/#FNE'DXT6%=#N3'2Z3'T.B2]*(<RRF'-Y0;R
MBWLJ[3(*P@:XP)^4TZ#Z-ZBW    &?%UI.O=;VH                1*<2"
M3"1                                                 5"FZA5C[
MH]\*G<P   ! F7%^SXF_'E 'FPN*?8JOL,IIT'1N'+RFG0?2'47'V?GV-??B
M2O'L    #/BZTG7NM[4                (E.)!]LG4
M                                $69:JN'C2)NBW        C7WX['S
MZ^S\^\=Z\]CY]       ?JRRYJ][2                (E.) )\/J
M                                          $69:JN'C2)NBW
M            &7]]SO;2I[P                (E.) )()(
M                                    *A3=0J)[T*_51NT<YH'98Y0X
MW)%D;#/XW)$'>8IL7YZ[J,<CZGS)P>6'WF*9\O[CY?)'E#!8\'EA#O,4V+\]
M=U&.1]3YDX/+#[S%,^7]Q\ODCRA@L>#RPAV6.7'.:!V6.4.-R189FUNE4/JX
M                B4XD ^H3X
M             <WZC><.^XW^;Q+IK/T^U$+:.>]QZ\2M?O96[Q5:;J_/>X]Z
MZW>,\K3G\RX+B0\-A5>;J]J(6T1YFKX:ST][*W>*:V&GBY5?N%$[+1YEP7$A
MX;"J\W5[40MHCS-7PUGI]#:OH%%++1^A\2+4PMHHG9:/8>+L'0^)%5YNK[MT
MG6-6*[>@               !$IQ( )U/M@
M                     'E]ON2TIE4(                &UE7OFUE7O@
M               B4XD $C$E
M            'E]ON2TIE4(                &UE7OFUE7O@
M      B4XD 'T"P
M   !Y?;[DM*95"                !M95[YM95[X                (E.
M)  )N.B                                               !Y?;[D
MM*95"                !M95[YM95[X                (E.)  ._)1
M                                             !Y?;[DM*95"
M            !M95[YM95[X                (E.)  /VE@3_0
M                                      !Y?;[DM*95"
M     !M95[YM95[X                (E.)  !-1TP
M                             !Y?;[DM*95"                !M95
M[YM95[X                (E.)  !W!+
M                    !Y?;[DM*95"                !M95[YM95[X
M              (E.)  !^LL&?Z
M             !Y?;[DM*95"                !M95[YM95[X
M       (E.)   )C.M
M    !Y?;[DM*95"                !M95[YM95[X                (E
M.)   .T)<                                              !Y?;[
MDM*95"                !M95[YM95[X                (E.)   /[EA
M#^H                                             !Y?;[DM*95"
M               !M95[YM95[X                (E.)   !+QV0
M                                       !Y?;[DM*95"
M      !M95[YM95[X                (E.)   !UI,8
M                              !Y?;[DM*95"                !M9
M5[YM95[X                (E.)   !_0L*?W
M                       !Y?;[DM*95"                !M95[YM95[
MX                (E.)    )<.T
M              !Y?;[DM*95"                !M95[YM95[X
M        (E.)    .F)J             *T9ZJM7K7.O\9*9S*K2RMOZ?2ZO
MA,F'5"KV/(JVUBPL>=9"//S?L:&^$"YX_P!XJ?S*O5RJV2@<^EYKUCTAKK[*
M.UUNSD6PF#%*H'/I;^0+J'\L6L<JOU<JMDS>L:$:0UU]E':ZW9R+83!BE4#G
MTND%=?5[SP:QRJ_8.KW&1O5P            !Y?;[DM*95"
M   !M95[YM95[X                (E.)    /]%@S]8            *Z9
MJJ(L&JSI@E@                9-W-'NQ7=0             \OM]R6E,JA
M                 VLJ]\VLJ]\                $2G$@    E@[@
M        $2^Z^*X^J]UXS                 4^L(^FL??
M/+[?<EI3*H0                -K*O?-K*O?                !$IQ(
M  .B)N            !2F50Q1AUBW,.Q                 B*5[NCYW$
M          #R^WW):4RJ$                #:RKWS:RKWP
M    1*<2     6 /H            $2^Z^*X^J]UXS    "!,N*>\64
M      9-W-'NQ7=0             \OM]R6E,JA                 VLJ]
M\VLJ]\                $2G$@    $HG?@           %=,U5%T?5IHPR
M@   *0R8U.I$?XWWYJ;!FS?CR@9^2HEWHTGCO7FN^;%)7CW93#FJ-GC\%[\W
M=C2?L_/H    BZ5EN+YV\            #R^WW):4RJ$
M#:RKWS:RKWP                1*<2     =63*            4IE4,48=
M8MS#L0   ,7+&NJ-GCV4PYMEZ^Q['SZ%(9,; :TJO3I376(EE6[=UMEY<[JD
M](51<9^RH@DKQ[UE@SP   !3ZPCZ:Q]\             \OM]R6E,JA
M            VLJ]\VLJ]\                $2G$@    $E$C
M   '+HL3Q]4_8^@   9^2HE:\V&-O?BZ,>3H?$EUKS81YX;:I])]/<3'CR8T
M6%=&WOQO!66E:\V'$2RK=NZVRLIAS    #)NYH]V*[J             'E]O
MN2TIE4(                &UE7OFUE7O@                B4XD     G
MP^H            5"D4D8X=8LO%G    9X2XE4L^"Q&'+?:+*[[S[QHL*Z*<
MGC/V5$V6K['[/S[J!"F^2B]H=X:RTE;'[JEGP5LS8=X*RT    'TLEA,639
M            /+[?<EI3*H0                -K*O?-K*O?
M     !$IQ(    /MDZ@            J%(I(QPZQ9>+.    $"9<4]XLH 'F
MCN*;T#55KE-.@W%CR*=2(^@4675//@C7WXT#B2K08<X    S-MJG::#TH
M         #R^WW):4RJ$                #:RKWS:RKWP
M   1*<2    "43OP            <NBPY@U/Z_ST                !G_9
MU^ND3H@            'E]ON2TIE4(                &UE7OFUE7O@
M             B4XD    %@#Z             *4RJ&*,.L6YAV(
M        '\,LV>_>S@            >7V^Y+2F50@  ":\4^%,L
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M+^L-;,]7^WYZMW&NHBRPH4RP   !M95[YM95[X                (E.)
M  )5.[             (4RP/(EL?%@                !J# VWT+TW2P
M          /+[?<EI3*H0  /1_2=0XGU@CW)%Q2M-#^+]\>F>BZM@A;\Z]56
MO]?\;NS</':^,_H7INEYZ3=:[7QGXKW@UIKMRP0M^=;/UF]8VV6C[/UF]8P6
M>BTWE48  &UE7OFUE7O@                B4XD   '^BP9^L
M   A3+ \B6Q\6                 &H,#;?0O3=+             \OM]R6
ME,JA   TF@[3<F->6@CV^"%OSFK\BI^U\][/U>]R'XDX!W'. /0O3=+I3*H<
MV)VJW6BWUY(FP8IVFA^PC6^V^3K8>.;65>^5YS5F-UGHX  &UE7OFUE7O@
M              B4XD   '3$U              A3+ \B6Q\6
M      &H,#;?0O3=+             \OM]R6E,JA   W4J>@_$^^.*]Q\L)^
MH<5[P7PB;#1R50>PC6^V>6*_Y%Z3:3J7EOON1[^U'1Z\YJWE_6'0N%LWXOOG
M+Z?J4A^)(M!'M\1K7084RP   -K*O?-K*O?                !$IQ(   )
M8.X             !"F6!Y$MCXL                 -08&V^A>FZ6
M       !Y?;[DM*95"   +01[:K\BI ]'])U#+Z?J6H,#;?.U=<RT9@[1F9/
MU0        ;65>^;65>^                ")3B0  #^A84_N
M   "%,L#R);'Q8                 :@P-M]"]-TL            #R^WW)
M:4RJ$                #:RKWS:RKWP                1*<2   =:3&
M             0IE@>1+8^+                 #4&!MOH7INE@
M    >7V^Y+2F50@                ;65>^;65>^                ")3
MB0  "7#M              "%,L#R);'Q8                 :@P-M]"]-T
ML            #R^WW):4RJ$                #:RKWS:RKWP
M       1*<2  #^Y80_J              0IE@>1+8^+
M #4&!MOH7INE@            >7V^Y+2F50@                ;65>^;65
M>^                ")3B0  =H2X              "%,L#R);'Q8
M           :@P-M]"]-TL            #R^WW):4RJ$
M #:RKWS:RKWP                1*<2  "8SK0              0IE@>1+
M8^+                 #4&!MOH7INE@            >7V^Y+2F50@
M           ;65>^;65>^                ")3B0 #])8(_J
M    "%,L#R);'Q8                 :@P-M]"]-TL            #R^WW
M):4RJ$                #:RKWS:RKWP                1*<2  =P2P
M              0IE@>1+8^+                 #4&!MOH7INE@
M     >7V^Y+2F50@                ;65>^;65>^                ")
M3B0 ":CI@              "%,L#R);'Q8                 :@P-M]"]-
MTL            #R^WW):4RJ$                #:RKWS:RKWP
M        1*<2 #]98,_T               0IE@>1+8^+    2ACEQ?DB
M         #4&!MOH7INE@            >7V^Y+2F50@
M;65>^;65>^                ")3B0 =^2B               "%,L#R);'
MQ8   6%PV6D\':HNR0\YYNL1Y[C#M?&?BO>   ":\4^+LD/XOWP.H\Y?V_/7
M%>\    U!@;;Z%Z;I8            'E]ON2TIE4(                &UE
M7OFUE7O@                B4XD $W'1                A3+ \B6Q\6
M  &\-1T/J/.:%,L#+Z?J41985A<-EZD*#KGCJV7B('K2UWLL7Y(@B')"S+GZ
MGZ&*;I?D$V/BO[7WTFT?4ZB2:7%.TT,   :@P-M]"]-TL            #R^
MWW):4RJ$                #:RKWS:RKWP                1*<2 ?0+
M                $*98'D2V/BP   NM%OM3J_;[#8;+#BUT"CDO7Q[6-7[Q
MXI]HX.!*&.6+)X+6O.:LO)%V"UT>XP0M^=:9P-KL-AL_Q??.*=IH8   U!@;
M;Z%Z;I8            'E]ON2TIE4(                &UE7OFUE7O@
M             B4XD D$D\                A3+ \B6Q\6   &W-5OW;><
M]><U92F50ULSU=D\%IZQ=>[)Y.MAXWJ=7[?0&9KE')>OZ@P-MR^GZEZ6J/JG
M:^)'XOOFATO7;K1;Z4,<L>4C8>/   #4&!MOH7INE@            >7V^Y+
M2F50@                ;65>^;65>^                ")3B0"=3[8
M            !"F6!Y$MCXL   !>.)L%-I5%\7[X  MW&NN7]8?V_/74><U-
MY5&  -K*O?!BG::&   -08&V^A>FZ6            !Y?;[DM*95"
M         !M95[YM95[X                (E.)!]0GP
M $*98'D2V/BP       ^U\]_%^^.H\Y>7]8@  .U\9QQ7O    -08&V^A>FZ
M6            !Y?;[DM*95"                !M95[YM95[X
M       (E.)!(Q)0                (4RP/(EL?%@                !
MJ# VWT+TW2P            /+[?<EI3*H0                -K*O?-K*O?
M                !$IQ()\/J                 A3+ \B6Q\6
M         &H,#;?0O3=+             \OM]R6E,JA
MVLJ]\VLJ]\                $2G$GVR=0                "%,L#R);'
MQ8                 :@P-M]"]-TL            #R^WW):4RJ$
M         #:RKWS:RKWP                1*<2242,
M 0IE@>1+8^+                 #4&!MOH7INE@            >7V^Y+2F
M50@                ;65>^;65>^                ")3B2?CZ0
M          !"F6!Y$MCXL                 -08&V^A>FZ6
M !Y?;[DM*95"                !M95[YM95[X                (E/ED
MW                  A3+ \B6Q\6                 &H,#;?0O3=+
M          \OM]R6E,JA                 VLJ]\VLJ]\
M   $2GVSOP                 0IE@>1+8^+                 #4&!MO
MH7INE@            >7V^Y+2F50@                ;65>^;65>^
M           ")R2#Z                  (4RP/(EL?%@
M  !J# VWT+TW2P            /+[?<EI3*H0                -K*O?-K
M*O?                !Q9V@                 !"F6!Y$MCXL
M         -08&V^A>FZ6            !Y?;[DM*95"                !
MM95[YM95[X                /X']P                 "%,L#R);'Q8
M                :@P-M]"]-TL            #R^WW):4RJ$
M      #:RKWS:RKWP                                   0IE@>1+8
M^+                 #4&!MOH7INE@       ?/(/    ,';;G=7Y%2
M            !J# VW4&!MH                                   B_
M)#\YMUS$                 7PB;#LE6;R   .@)@   !^<X<
M
M           'T#L
M
M
M
M
M
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M5C>+#:T!ST^E$>\H#FIYC\R:.YJJ<?$O6&+L,J^<^.<O6[X8+:U6.P
MCCU@D?SGX;[A[GYF$<>L$C^<X  $<>L$C^<_P_O@?<^>QPWW#]U['X'SJ_F0
M8KR]7LWCGQSZP:IQM@_"\^:VPTC7"+L5\,-N  (X]8)'\YP
M                      !^%YY3[C[GYFX;[A[GYF$<>L$C^<X  $<>L$C^
M<_*?<?W?GK]ST.&^X?W/7W?GKX7WSU?S)''K!E9)H.K^9+;XK&W&*Q^']\>9
M^PT?;:'M%QL5F  (X]8)'\YP!0_-4<-ZQ5R]PM?8NQ]S\S
M       ?A>?A??/5_,@
M              ^']\#[GSV
M
M
M
M
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MW%:K'855R5\X^)4.>XW[WK[GSUU7S)^%\ZKYD@#W#G'Q*%<LD*U6.P^Y\]@
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ML;CF]SYS?N?8X]8)Q\2XY]8)_P <S,B31=SYRZ-8+N<?$J1_.<
M9@3^37+J-E',3<UF\6W8=S-5U3C7\X^)8\NMCH6AF"YMQBL;C8K/SE3]*]&L
M#=1!WN)D])U[=*'MGX7G+J30VWQ6.9,BBOAAMZQY($X^)<<^L$_XYF9$FBL;
MCF]SYS=Q\R]7\R9R9Z2?_$R^.&WQSE:U=3#:3CXE9D2:+T%P=Q
M              %7L]1@];\\&\-1T.T."W\Y4_2O1K W44=S50_=\^T=S55Q
ML5EU7S)7+)"THCWE9,D"./6&ZF&SQ)F:OO?"V[SE3]*]#,'<J5Y:OJOF2H^6
MNNIAM/W/M <]1LU$V;AON'.612_<^>X<]QMFHFS962=?NIAM)_\ $P4=S54'
M>XE.<M;MM#VG$F9JVF\>]D;SFKEDA9YYZ:?\<RU..P[GSE@#)#O%AM9Q\2\
MINGZ;Q[VA^:IM3CL.Y\Y?W/N74FAU^B[)8W'-          'GKV'\[:W:UTK
ME\D>#K*%I_6]4P[F:KJG&O\ N/.7A_6+#N9JOHU@;J!YRI^E>C6!NHY3[C\[
M$_3/2E7[ORGW'A;,U/=*'MF04K6]4XVP8KR]7TWCWM#\U3:G'8=SYRP!DAWB
MPVO#?<4'>XE2,M=H9@N8 ]Q+<8['-;/1VIQV'<^<MU,5H
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MESRSTUJL=A>+#:@
M                                     #*R3K\Q^),.>XVJ<;8
M
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M_1$C&N_)GMDNNG9JDO5K;W6V$?";,C#H<BZCS(<>R%E5_#K&SNEXZ; (/HJ
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MW.E93/3SLG0%9PKB-";O[$Z_AJ5^98DK/2BC$9ST7@9<&F*FK&CU&$ED5F2
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M<-*1UZOPK%3-;-9CX>*=Q/KM.0O T'@, I85%Y-%81I-)UIB56J;7\?QLW<
M 2^M,JEON8]&C1X4?]-R_$-OGZ!L&(9!;?MD("9<"_WU%G*%R5^Y]'RN>WI+
M>&1,4QR.M^)L3'/!0FV1# FOG/M2VK1VW="L#]/RUO2YM2O*:3*\T?ZE)C1Y
ML>R=L <]JPK3N*H9BUN K1CZX\B/,C_(7J5&+%1.WFM($B-&CPX_TR!$>)B,
MNYQ$%=$>=?=[1ZVV_*"!J_7NHD1%*U73)9!%^1LT=:0K;?/TBP0*?CLFU9")
M]'D[?Z%GQ VNI]8K=8KZL<5=56F) HT'.Q_I2+,KN+'+;DZQ'9/W3$9^K_LW
M1V#@?:;,F24^JT1&TOZM)C1YL=RVWUVT]?7M]M]$D:EIW^@X)W7+^M@>]JM,
M]8EB7S_TR#HG"997<?5H^.8W81^GKZ6_<O8.1]L+RPD5B@ZO6.C]&^?Q"J-'
M6T*_^3KZ.G4Z*D L"RR?JDJWK\OAK;#5I/I([08_5K=&WVZ0W3[4#=&OF/XV
M[_"+-NI%S.;;HLYMNBP=K;N"D,@(W<$H@ZH=R4W1C[2C)#3C;2D+ICB:.J<+
M('#1PB'_ %TLHJA^06VS5.1CF-HJYK9\--F+4B;6>YP(1_C;O\+'MUH61S;=
M%G-MT6"9V[0U'D#]W<J.)J'<D1CZ.U1J.=0[:2EZ<,+0-3A.L.M+B]^J5#BS
MD2'$CCXGS:DR)HR/_$CL["T\6DL4MH7_ )[ J^*Y=70'O%4C5@3>243.57EG
M*KRP9USM4=9A!K' N57EE?'K5GLN/3!:L)JY5>65H0:R((GUSM(=RJ\LY5>7
MA9Y-Y&Q.57EE:&K'(G<:F.Y(S%RJ\LKN<UD%T_JSM %RJ\LAM%Y=4O+2*O(S
M.57EE8F;')$</LMR:!WE5Y8BRCDU5;Y)R(M<JO+ #+<FN=RSC-CC2/*KRRK2
MKR3\)C1>73+Y5>6*$DY+6GJ4<A*O*KRQ58[DDL668:L<<=Y5>65@3>243.57
MEG*KRP!JSM<%8DYK'KO*KRQ%8+5FM66">M6 R\JO+*T(-9$$3ZYVD.Y5>6<J
MO+!G7.U1UF$&L<"Y5>65\>M6>RX],%JPFKE5Y97<YK(+I_5G: +E5Y9RJ\O"
MSR;R-B<JO+*T-6.1.XU,=R1F+E5Y8BRCDU5;Y)R(M<JO+(;1>75+RTBKR,SE
M5Y96)FQR1'#[+<F@=Y5>6*$DY+6GJ4<A*O*KRP RW)KG<LXS8XTCRJ\LJTJ\
MD_"8T7ETR^57E@#5G:X*Q)S6/7>57EBJQW))8LLPU8XX[RJ\LK F\DHF<JO+
M.57E@SKG:HZS"#6.!<JO+$5@M6:U98)ZU8#+RJ\LK0@UD01/KG:0[E5Y9RJ\
MO"SR;R-B<JO+*^/6K/9<>F"U835RJ\LKN<UD%T_JSM %RJ\LAM%Y=4O+2*O(
MS.57EE:&K'(G<:F.Y(S%RJ\L191R:JM\DY$6N57E@!EN37.Y9QFQQI'E5Y96
M)FQR1'#[+<F@=Y5>6*$DY+6GJ4<A*O*KRQ58[DDL66%!LPD54*1A#]3^L_Y]
M/^?]E9F,:I NI@T[?1/ANRLDB=7&A9J1.L?0^&[$Z"155I\I^6],L?;OKQ-?
MWE-R1MWUY>NAT_+165X$RG17^&[*V59%=@[/0-:RL^&[ /3+!@WBE^MT: -!
M^T&<]Y3<^&[*VJS5KLX\"93HK_#=E;*LBNP=E5I,L8I\-V"=8F.%LM%R68^M
M47)63Y;6)D1?PW96M:3*Y*6(ND'X!\-V5VND$$!?90^&9_0M37_U&/[+?/:C
M;S^%^AVC69VQNOT(WU]6G.T-7V:^C_9#P$4S"EY9"*D+T,_8Z]7\WT(]]V"U
MO\X_]DLMGGIJ35CD3>%_T/<CZ&>^[$:W^F;_ &2\H^O)JO;[H:VDD?2,E(X,
M.&*1S@?]<_7"]8$WT(]]W[/;[>GVQM?IDZ']N;6T(DA)KM:[\B=%DV!6B57S
MT,L-<\2C4K@Y$ B/+1/DGD1XF)YB5_\ 4LFS2U;2_0CWW> =?_+2_L=U$)XJ
MLZ**$RZE]'=7[VX^GW(N#JE,===6@CUE7T>MESP>7*(D!'^&S06V@>TFY2!+
M+)_D#;>>0-MYTEO+BJ!TQCNVQ6VE$@TJ5);9A$,?2W(^AGON\%:W^F;_ &.U
M%PDV(-/JIE15?HV48KZ"!8:!"=:H<J)O!*&V5N)G%S#!@8OC$4.3L-CO[NW0
M/:2^)4>"YM%@WX%CH.Y<88D;EM GJUK0/=OP1(\B(C_1B"!)(AZ$>^[\(NM_
M(C_V(N7&@1H)@#,T#Z.XFMV9MQ":%)8J0E: 74J>D:UD5VN9N9<3$,['W./$
M2.WM)!T8J!M)@][''^LEMKQ[CQXCPC!^A]I/07W*E7=GOE"%K-2TZ;>2'TKS
M9F%8D^A'ON_ #(]OMZ?[%?/:C;S^%_2LE='GT^N T<&C_)?W=N@>TEZ5J;7&
MO3M]%1*\4JT>K4,#H$02/R F)XF7].\UEA9Y/H1[[OP':_\ 'F?V)U5M!U5T
M!*T40'^A/3$\M+@#AXF)G'5_WM]>(7$C2'H1[[OQA:W\B+_875IT$I70'71>
MP?H>Y'T,]]WX@=?^Q7SVHV\SH7&-?7T8VCS=+P>4&%]$@4&"-'FZ7FAKZ,G1
MF-*P.DPVE8(R<YNEX--A3.3)T(=&YNEY#G0B,8D;"ALYNE^$QI6!TF&TK!&3
MG-TO!IL*9R9.A#HW-TO(<Z$1C$C84-G-TOPF-*P.DPVE8(R=?7T8VCS=+P>4
M&%]$@4&"-'FZ7EA5S/M+4]"/?=^,+6_CRO["7$#3PUP*2J?M]KW"-[> ]ZR,
M1[Q:$$2^V^Q6'GO61@C<L[!A+6]%6\^(9YP8M\5+YGO61B/9AM!+/%XM#\)]
MZR,1[Q:$$2\68;?BWO61@C<L[!A)=GG&2PAGG!BQ?<L[&1/O61B/9AM!+/%X
MM#\)]ZR,1[Q:$$2\68;?BWO61GQ4OF%V><9+*CT54#Y?<L[&1/O61B%;[%7F
M/%XM#\)]ZR,VL-Q Z!]"/?=_(.U_Y$/^P[B>\?H>SWT,]]W\@#6_Z_V'<3WC
M]#V>^AGON_DBZW\>1_8=Q/>/T/9[Z&>^[^45K?[H7]@W$]X_0]GOH9[[OY0.
MO_CJ_P!@W$]X_0]GOH9[[OY8VOU1M?V>WV=7L_K^XGO'Z'L]]#/?=_,(UO\
M="_K^XGO'Z'L]]#/?=_,"UO\)']?W$]X_0]GOH9[[OYM#5]NAK>SV^SJ]G]>
MW$]X_0]GOH9[[OYPVO\ [8?]>W$]X_0]GOH9[[OYP>M_A*_KVXGO'Z'L]]#/
M?=_/I]?MTM3HZ^G4Z/Z[N)[Q^A[/?0SWW?T LCVZL7^N[B>\?H>SWT,]]W]
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MC=(?&W%/RH]W+"HO)@KQ;+50D8C\1-.XX74OB*WVU(JS#16:UK 5[2<$\$]
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MWMM5,:-$K+PW(=E]H7;:XE(E1UC(3J)L!7L(2%E[I_AOI?$ZKZU139^K:WW
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M*(_1L5WLL30R:/HJ.?:0Q2MME/50"DC;>GHQT^USUA\[25L316>!815GR7I
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MO$?;UP//%V>;N2(N_''!'N;>XSQYGN/WA[><_)U&TXDLXAC%B0+H#SVX9G"
MDA0TE5B%!9CISRS)/MGB+DO#J\BRP7<6AE3/3+%9@CD74"ITNE4,,U)4Y'J"
M1X'B]R_%B$<44^(8MM1UH:[1);7;L;)U">RCPNLMEFR9Y2!F40Y KQZ1<(^V
M,1_MM;^*<8=AZ8;7[-'8MV(PV:&W*)GB0(D:PQD(@2% @T1A<E);+QR&(\L8
M3B3[LD+5YRVIYJA6%Y<R[-N*4>%V=W+/*8M]B%!ETC28N08A(IGQ.22+KJ2*
MJL,AZ'+3*\UA5R;(G.)\P"O=)U##\,IX7 L%.%4[JK)*0N_.5U$//* #(V;N
M1]9'J*Q*D>2C$^3*=Z>:U!9FJ3V)C-*&5;$&;YF71&3%(K22'<S,[(N;*L84
MJ$PWD[#:+I-8+8A,JNI6=(Q4S8G)Q6(?O+'W?59I4U$R!5?;V[7(=628O4O2
M58FS.S)#VG02S'))-Z%MM5*JJR;DG=+-*Y;HF"N**TY,7QAI-X6'N)<*6&?9
MVFB5RLA2H3G*("SE7ZF5O$^D7"/MC$?[;6_BG%#!(L.JV:D%W$3%8C,:[EA2
M:F>[F]/1$BP2,TQD+!3G(J-EF.K\D87([226\3>1V9W=YZ[.[L<V9F-0EF8D
MEF)S)ZGC#>7*^%2I)6O8GMJSN:LEE.R2.\9B+2P1P1AV TE6SS#(A^M XQ7"
M*>,0+#;5NXVJ*:(JL\1Z:]#LKC3(!ID1E9&[K9;B1NB\A5]_4^(S-6U/E$L"
M)/H.K;':"[QZE[NMNS /DV21ZAI/+%$5$I5[.(TX!NF=:MLIVQIHH8I&MATD
M234D(&A%CB&N33& ^7'I%PC[8Q'^VUOXIQ!'3Y?HE9[\QK(Q*28A.LCH%A 6
MM7 1,U6.$F*M$C.3KT*<\N*N*8?=@>S6MPR0Q*7F8MMF!!K[TZ2:)(%]3=@T
MJH&12ZYIUXY1PZ);6)XK!J6G)-8J8:/5 'J"?<,F4R;C+W((XWW"VM+"3+K4
M'T;U+MT2Q=KNT],@DW:,_9YFR5UT,^E\XSKU%<NK*ASZ<>D7"/MC$?[;6_BG
M&&86F%H\<=R_9C98D1+M@3) D(8*M=1'&(E(8!E RR2,#+3Q3PC#</FFGIU(
MX);'TQEU'H6+E(U9F6&,MU,4(CC.E.[E&FG%,$BQ8^KW<1BBVTC:M6L+'5DT
M2-('DA>*17DU$=X_J<?3-<^/2+A'VQB/]MK?Q3C"\$BPD^H7<1EBVWC6M9L+
M)5CUR+(7CA2*-4DU ]X?JDG3-L^)^3J-IQ)9Q#&+$@70'GMPS.$!)"AI*K$*
M"S'3GEF2?;/$7)>'5Y%E@NXM#*F>F6*S!'(NH%3I=*H89J2IR/4$CP/&)<N5
M\5E>2S>Q/;9D<58[*=DC=(Q$&B@D@D",1J+-GF6=S]<1PG)&%QNLD=O$TD1@
MZ.D]=71U.:LK"H"K*0"&!S!ZCB_@D6(U:U2>[B(BKQB-MNPH-O+:R>YKB=9Y
M%:$2!BHRD9VRS/3TBX1]L8C_ &VM_%.).7DEKBM)B^.-'JG+EKX+S).D4;0S
M$PD20J(CHC*Y S39Y[F0](N$?;&(_P!MK?Q3BKR_%3ISTH,0Q9(IMK2PMJLE
M7;E:4]D*0JL&^S$3Y*=P>X>O#\D87([226\3>1V9W=YZ[.[L<V9F-0EF8DEF
M)S)ZGC"<!KX.[FM:OO&ZL#7GG1J^MC'G,(HX8AO91*FYXZ,U]S*7DO#K$C2S
MW<6FE?+5++9@DD;2 HU.]4L<E 49GH !X#C#.6:F$V!8JV\1]O7 \\79YNY(
MB[\<<$>YM[C/'F>X_>'MYS\G4;3B2SB&,6) N@//;AF<("2%#256(4%F.G/+
M,D^V>*7*5'#[$=FM<Q-)$920+$*I*BNLAAF$=9"\+E%W(]63#]H\7N5:F(S-
M+:OXM)G)+(D36HGB@WFU,E=)*[[4?15"@^M1 2=(X3DC"XW62.WB:2(P='2>
MNKHZG-65A4!5E(!# Y@]1Q<Y2HWY5FLW,3DD6&" %K$+]R"-8P<Y*SG5(0TT
MO7)YY)9,AK(XK\HU*FOLN)XU6W-.OL]R*'7ISTZ]NLNK3J;3GGEJ.7B>+'*-
M2WH[5B>-6=O5H[1<BFT:LM6C<K-IU:5U999Z1GX#C#J,6&4X:4#2/%#N:6E*
MM(=R5Y3J*)&OKG(&2CIEXGJ<4Y;PS%I-^=)(K'<#6*SB.214#*%D#I)$_0CO
MF/=RCC3<VUT<1<@Q"13/B<DD774D5589#T.6F5YK"KDV1.<3Y@%>Z3J&%8%A
M^#AC4C8S.NB2S,VN=TUEPN8"QHO@"L4<8?1&9-;H&XO<J4\1NW+EJ>;.RU9H
MQ!IB> 05]B1"S[T<JS9)(<X4>,QA5;)GU/@V+A&@K<R6TK%6518J06K8#COY
MWM<,Y;46,;KH>%="H>X&XPOEO#,)DWX$DEL=\+8LN))(U<*I6,(D<2= >^(]
MW*21-S;;1Z-[E6IB,S2VK^+29R2R)$UJ)XH-YM3)722N^U'T50H/K40$G2./
M2+A'VQB/]MK?Q3B7DZC.D4<V(8Q-' NB!);<,B0IDHTQ*U4B-<D0:4 &2J/K
M1QA_+6$8<4DBK;T\?K;%IMZ3/<$BN$R$$<D9"B.6*&.10OKLV<MQ;Y$IR/JI
MW)JH+.S1RQK:0!B"B1'7!(JQ]X>JO.[#3FV8)>ARAA--)!,C7I)H1#(UG3H3
M,>J/61%4P,YZJ^Y)/" !',,W+MR(BS[M3%9JX1D>'57$D\;ID=6_'/7[PD&I
M&6)"G0=2NHSX$EFI!3DQ/&-N%;".XNC=MI8;-EN,86$ZH,XXU*@+&2ASSX](
MN$?;&(_VVM_%.*F%05*,F'&:W;K2J\9%N?<=8'A6 UXVC6+:A$:]Q$RT%F*D
M9C*?D*NS@UL1FACT]5G@2PY?,YD/&]4!<M(T[9(()UG,!8>4<&AJV*QBDF-C
M+Z)F:-K4.GUG9Y%B18M+=\Y)ZKGHGW8@L8BY'[/:6>#&+,*I(2NU#MVEB;,%
M%M)8 $AB)C,H@TG,G9TG;XO<OQ8A'%%/B&+;4=:&NT26UV[&R=0GLH\+K+99
MLF>4@9E$.0*\>D7"/MC$?[;6_BG$V#I/AZ8=)?Q/;5G+V.U#M=A'WM4-B4Q$
M2PD3%=LIEI2,'UO7TBX1]L8C_;:W\4XPS"TPM'CCN7[,;+$B)=L"9($A#!5K
MJ(XQ$I# ,H&621@9:>,1Y8PG$GW9(6KSEM3S5"L+RYEV;<4H\+L[N6>4Q;[$
M*#+I&DQ<@Q"13/B<DD774D5589#T.6F5YK"KDV1.<3Y@%>Z3J&'X93PN!8*<
M*IW5624A=^<KJ(>>4 &1LW<CZR/45B5(\E%VC4Q& UKD*SPEE?2Q92KKX,CH
M5D1O%=2,I*,R'-&8&?D*NS@UL1FACT]5G@2PY?,YD/&]4!<M(T[9(()UG,!:
M7)F$U7CEFWKLB*N:SLHKF52K&00QJI*DJ1LS2SQZ&*R"3HWHGE?!G>U)/7:S
M);MO;D>65U='<N=N)H#"4A!D<Z,R7)4RM)M1:/2C+7[F&8]B-& ]YXLV?5*>
MC29UYJ:=4$:Y&)F[G5R,E6+D^O)(LV+7[N+2IFHW9'CCVLCIC;U26QW)&>0&
M.S&N9 *9:]R*&*O&L4$4<,29Z8HD6.-=1+'2B *,V)8Y#J23XGB]RK4Q&9I;
M5_%I,Y)9$B:U$\4&\VIDKI)7?:CZ*H4'UJ("3I'$7)>'5Y%E@NXM#*F>F6*S
M!'(NH%3I=*H89J2IR/4$CP/&)<N5\5E>2S>Q/;9D<58[*=DC=(Q$&B@D@D",
M1J+-GF6=S]<1PG)&%QNLD=O$TD1@Z.D]=71U.:LK"H"K*0"&!S!ZCB&/9BBB
MUR2[4:1[LS:YI-"A=<KY#7(^6IVR&IB3EQB')>&6R\E9I*$K]<HLI*H8R%W;
ML[9,,U)14AGABCR33'DI5Z_(51=?:K]F;/3H[/'%6T^.K7N=KUY]W3EMZ<CG
MJU#32HU,.@%:G"L$(9GT@LQ9V\6=W+2.W@NIV8A%5!DBJ!B6%4<6B$5R+7HU
MF*524FA9UTEHW'[3%'#Q.R(9(WT+E+R#$9&,&)R1Q=-*2U5FD'09ZI4FKJV;
M9D91)D"%[Q&HX?RIA.'3K959K,R,KPM:D5Q"ZZN\B1QPQENH8-*LA1T1XM#C
M,\8AR30M2/-4GDHO))K,8C2:JH(.I8H<X7CU/DX]6:-.\B1*F@1X9R=A]"2&
MQ++-<LPL)$9CL0+*DHDBE2*,[FI-*KIDGEC?O$IU4)Q>I=NB6+M=VGID$F[1
MG[/,V2NNAGTOG&=>HKEU94.?3CTBX1]L8C_;:W\4XH\JU,.F66K?Q:/*2*1X
MEM1)%/LMJ5+"1UTW8^K*5)]:[@$:CQ>I08C4FIV0QAG4*VAM+J58.CJ?Z))%
M5QJ#(2N3JR$J?2+A'VQB/]MK?Q3C#,+3"T>..Y?LQLL2(EVP)D@2$,%6NHCC
M$2D, R@99)&!EIXQ/E/#,2DDL#<J69-QFD@(VY)7 RDF@<%3DPUN(3 TI>1I
M'+MK$'(5=7)LXC--'I.2P0)7</F,B7D>T"N6H%=L$D@ZQD0V&X51PF(Q4XM&
MO0996)>:9D72&D<_ML$0)$C.YCC36V=[E2GB-VY<M3S9V6K-&(-,3P""OL2(
M6?>CE6;))#G"CQF,*K9,^I\&Q<(T%;F2VE8JRJ+%2"U; <=_.]KAG+:BQC==
M#PKH5#W W&%\MX9A,F_ DDMCOA;%EQ))&KA5*QA$CB3H#WQ'NY22)N;;:.'1
M)$:.15>-U9'1U#(Z,,F5E.896!(92,B.AXN\C8?,2U.>:D2R]QAVJ!4"9$(K
MLD^IFR?4]F0#O*$R*Z*O(M"/(V[5FTRR!M,82M$\8T^I.OJTO>(;4\<\9TL
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MC*"Q"L=.>>0)]H\/S5@".R'$%)1F4E(+4B9J<CIDC@:-U]QT9D8=5)!!X2Q
M]=;8D45GA%@3/ZFFPR;@D;<TZ%V^\VO3I'KLLCQ/S+@5=PDF(PL2NK. 2VDR
M)(ZR5HYHPW0YH6#@9$C)E)K8OAMNK)=AMQ]EBDVI)Y=5:-)/4SI8V%BRSW8P
M#X$L%!+=.*6/X1B$XK5+BR3E698VBGA+!>K:#-%&'8#O:%)?0&?+2C$<6N8L
M%I3&"Q?C$JYZUC2:QH(9D9':O'*J2*RD-$Y$B]-2@$9TL<PG$9#%4NQR2^U$
MRR0R/T9O4DG2-I=*HS/MA] &;Z01GZ&,>Q&*?L=>^32\8/[+X7^R-'Y3%PZ)
M(C1R*KQNK(Z.H9'1ADRLIS#*P)#*1D1T/%ROV2W:JZ]SLUF>OKTZ=>S*T>O3
MFVG5ISTZFRSRS/CQR_B4$> X6]^Y6@9HYHHC8EAKZXZL\D"*FHH&VHEB5B,S
MX,Y+-F?3;R_[X?BMW^+<7L7PW#-/;;<<+/EIC[TDQ#:\GV8EDEV\XV7=*;>H
M:=6H@&E>J8C +-.99X2S)J 92KKXJZ.%D1O!M+JI*,KC-&4F6:*O&TL\L<,2
M9:I976.-=1"C4[D*,V(49GJ2!XGCTV\O^^'XK=_BW%6W5O1">I/'8B.7>C;/
M22JOH=?71R!74M%(%D3,:E!_*8KS/1PZ1:T6F[<9M&TD\,4$+[HB*V[3DQUV
M'?S4JQ31ZOLHRR&[S!B^'P&S;Y=:. ,JM(,4@F"ENBZQ#!(44GNZV 3653/4
MZ@X5S=0Q*:*K)')3LRYA1(R/7:35DD23C0QDD7(J'AB!?.)69S'N<8KCN'X.
M%%N1C,ZZXZT*ZYW36$+9$K&B^)#2R1A]$@CUNA7BES!B^(0"S4Y=:2 LRK(V
M*00ABO1M F@C+J#W=:@IK#)GJ1@*7.=.:<5;]:;#9]YH29&5X(B.GT1(P@DA
M;<U1N# 4BZ-)(JZS'QBF-4,(CU6I<Y#HT58M#VG#EAK6)G3*,:'SE=DC[A0,
M9"J-%CV,6*JW(.7=ZN\9E5XL7JR%E7/,+$D)E,@(*F$)NB0&/1N#3Q4Y[IR/
MIN4YJH+(JR12+:0!B0[RC1!(JQ]T^I).[#5DN8 ='21%DC97C=0Z.C!D=&&:
MLK#,,K @A@<B.HXL6(*D$EFS(L,$*ZI)&\ / =!F69B0J(H+NY"("Q *\VFY
M<['@^%S8CDKMN-.E0$(S R9/'($A(T%'G>%R\@B,2R%0UGFJSAL\,>*X)-4C
ME5F$D5R&T2%S'<"QQPNP?0)$-A'C1U<@ZD#X?B%7$ZJ6ZCZXWZ%3TDBD&6J*
M5<SHD3,9C,A@5=&>-T=O1YIFGQ6U>:#3V' %CAE9CD39LSI#+H4QK(6,B[61
M+0A*C2K(#,JR<JWNPXS7S74ESZ!?(9LO:)(]IE[Z 93I%K)U91;FE"^GT+%>
M"W!)6LQK-!,NF2-O CQ'49%64@,CJ0Z. Z$, 1C&'/A6(6*9U;:MKKNV?JE=
M^L3:M$8=@/4Y61= G25%];QR?C O410EZ6</C1!F8QO5<RL3(BZ6^AU"02]U
MO\Y=I6>8JN-8I'A%"6TW60^I54T%P]IT=HE?)DRC&@O*=:>IHP0F0HK<NX+Y
MMKFQ:77BMO4]R=Y-YQK<OLB3^Q>P07W;&IC+*B0Z99HJ\;2SRQPQ)EJEE=8X
MUU$*-3N0HS8A1F>I('B>'YJP!'9#B"DHS*2D%J1,U.1TR1P-&Z^XZ,R,.JD@
M@\0XUA=B6M!!=AFFMJ[0QQ$N^21[K;H4'L["/,Z+&TY(90"ZLH_7%C'L1BG[
M'7ODTO&&M(F(T'BBWI4NU6BAUB/=D6="D6XW=CW&R76W1<]1Z#C$.8<=J1O_
M .[DD+K'N[YG:]5BC4G6TIJ1(@R1'S!L1F/NR,"F0;DAWDPNW)(S/(^)SN[N
MQ9W=J]0LS,<RS,22S$YD]3Q;HT[R:+E:&P KJIEC5GC$@ ?:D^F0L<E[\3(X
M*J005!&/X,^"W-D,TM:93+6E92"4U$-%(VD1M-#TU[?0H\4A6/=VUY>Q_"X,
M%L5[R0Q&JI$L8CKYXFDP9$T5U$>_-MJM>P9%8%!'-8GR>0QX!RRA=\4Q:K")
M;#2208;M 5ZJ3$GU2!M0# -IAKMF*R9;F=C(5^;<&H)A+VZU:M4EJ21-G7@2
M+=CFD2!HGVMM?7.DBNZR%=LHFD2N>.7JL=W&*=:4R"*7M EVI#&SQBK,SQ%U
M[PCF53#,%(+1.ZAE)U#F#E2A%A\MO#86@FJ*TTD>[)(DT"Y&74;$K:&AC#2J
M4/>"O'MR.\9CY?Q9\)Q"*0R,*DS+%<3,Z#$<P)64)(2U8MO+H7<8!X58+,^?
M,^-/@]-.SZ>V6V:. L"1$B*#+8RTF-VCU1JD;D O('*R)&\;<JTH,5QAS?#6
M-N&6Z1(VH3SB:%<[&K,RJ3,TCJ3ZHX DUQET?F;#X+V$VFD51-3AEM5YM.;Q
MF%=R1!DR]V>.,Q,"2@)24HSQ)ERUC<^%W(H"Z]AMS1I825]$<)=EC[6KGI$T
M0R,I/<EB73)D5BDBYVNVJU""O )$CN221V)TZ 1H@^A6.DY=IU%NDB%HX)8\
MGC>0#D[$L/P^Q:%UUADLK!'7L.F:+D[[D32@$PK(7B=F;3!E#JE=-"9\P813
MQC#Y;U%89KB*TT-FJ5?M8BR26%F@63M+;<1C@7JZ3HD:NB&56JX;5M81AL&(
M4XY6CPZO$5L1>K0%JT22JC,!+7DS4!BA2160=0RC+B>M7M(([,$-B,-K"3Q)
M,@< @,%D5@& 9AJRSR)'MGC$HHZ^(WX(ET10W;442YEM,<<[HBZF)8Y* ,V)
M)]LD\84B28+AL<BJ\;X931T=0R.C58PRLIS#*P)#*1D1T/'.-2K3Q6-:L$==
M):44KI$NB/<W9XM2QKW$S2),PBJ"07(ULS' <&.*8)=9I9I-F:YV*@C)% U\
MT(PD\SG(R-F\(A#/''#MOJ+1SRKQ1KW&Q*M7K*T5Y;<:QAXVS@GBDS+S1F-R
MJURA>;5&VA$<NN0(XYRQV5)&P>JVA=M3>D74)&W1J%4$J (S$4DE9"VZ)!"2
MBK,DG(E>#L-JWMKVEK;US-XOL)#7D$8S]:NXY9M.6LA->K;CT\T11PX]B*1+
MI4R1RD9D^J6((IY6[Q)[\LCMEX+GI4!0 .6,1?$L)ADEU&>NQJ3.V9W7A5"L
MFIG=W9X7B,KL06GW2%"Z<^,8]B,4_8Z]\FEXPV6.OB-">5M$4-VK+*V1;3''
M.CNVE06.2@G)02?:!/&(<[8;#&ZT!)<G,><3F)HJJR$E<I=TQ3G0/5"L<64G
M=02H2S1X?RSBUZ=8VJS4X0R[UBU$T(C0ZCFD<FW).W=("Q @.4$KQ(VL>9L-
M-."C)4AG@KPF"(RQ1F10Z@2R+(J(8YIB-R66';=I?5,PV1''->!R5(H+X>S=
MEDDE.)WI2/ICK72N!"F2UZVI95A4!A%K2!I2.SKQR09:_G2[(VWAL58&PQ1C
MJEASE#(5C8MV>#>,J(VKU>'U-]2%<8QBUC-K?G[D:9K7KJ<XZ\9]H>&N1\@9
M92 9"!T2-(XX\5HU(N7[]..%4K04)WBB4LH5ZZ-8B;,'4S;Z+*[.S&5]1EUZ
MVSP?$7PK$*]P:MM6T6$7/U2N_25=.N,.P'JD2NV@3I$[>MXGOT:KB.S=J5Y"
MNL)/8AA<H20&"R.I*DJPU999@CVCQYXPCWTP[X]6^=XBFBL1K+!+'-$^>F6)
MUDC;22ITNA*G)@5.1Z$$>(XFP/&VMRQ-1NV)39>-K.S8,4TAE*F?M,J(ICD;
MO[\K*"IW'(&9XQ70,+Q(R!FC[!<UJC!'9.SR:@KE) C$9@,8W"GJ4;P/':+%
M3".U6TW+5;#NT64U(NNQ#6W)DU1AHUU2*PU1JR#/-05R'%BQ/;GDLV9&FGF;
M5)(WB3X#H,@JJ %1% 1$ 1 %  ABCKQ101+HBAC2*)<RVF.-0B+J8ECDH S8
MDGVR3QSO%''C*NBY-8I02RG,G7())H W4D+ZE#$N2Y#NZLM18GDC$)[5.Q3F
M9I.P-#LR,V9$$RR!(,M.>F$P,4+.W<D$2A(XD''-F&8I/C,DT5:W;@DA@,)@
MAL3I"BIMM"2L92-MY)9C&I(RF$A[TC#CENO/4P2C!9C:&95F9HWZ.HELS2IJ
M'UK;;J61LG0G2X5P5&-Z//&*: RCM]O,,P<ZQ,XD.81.ZTFID7(E$(0O(5,C
M<E]H\R)O?2^TV.R>L_.^H:O6][\]=I^F=_W/4]OCG3$)Y\3:AJ9:U)8LH]7<
MDGEB$IG8!1WA',(5#%] 5V0KO2+QR'%&,.N3A?59+NT[9GK'#!$\2Z<](TM8
ME.8 )U]XD*N7.$4<F V7=<VKR5I8CF1HD,\<!;H0&]2FE7)LQWM66H*1RSB$
M]'%JJQLQAN315;$.K))!,VW&[9JW>@DD$JD .0'B#JDKY^ABET8=A]NX2H,$
M+-'K5V1IV[E=&"=[2\[1HV17(-F64 L.6Z'^86FYN2MBW:+5L2RZC(MQ= .X
MAUC>K+'(Q+F422.2RMW5MU9:-J>I.,I:\C1MT8!LO!TUJC&.1<I(F*C7&RME
MD>,$Q 8GAE6SKUR[:Q6<]L,+40"S:DC.F/<;U9%R7U*2-M"!@HXYJP<XI0UP
M_GJCN30KE(QEC*>K5T5,_5)=$;1';<F2-8AH65W&%8E+A-Z*Y$->C-98B[(L
MT3C)XV*_M.A8.J3)'(4?1I-'_P!X<;;%O785A>=?#P_3=MZ4=YS7DW,LMS=6
M7*O+W:/0O#*J<<[7;4F)"BPDCJUHXI(D/TNQ)(I+6AW5U:=1K+WI ABET%6D
ME7CE/&,)@PR.E+8AJ6HVGDFW],"3:I<UE$[91R-MO%%I9Q/E"0$VHU;C%N7X
MX<5P;$,.JZ$\XTTN0UXSMQA)8W2RL,<>B&-4C=;+ZDCSV6T:WE=OUQ8Q[$8I
M^QU[Y-+Q@_LOA?[(T?E,7H8/APP6O?21X8ZS7[5R$B1RD%,I$(Q-),%R:*.(
M[A+.H S,C=3Q@N+IC5>>S'"T$<=N2N@=PSNB)%(LC  "-F$HU1AI I'21_'C
MFM:LV&K4E&Y<LV84PR!9=J22X6$08$ADVXTF;=W0(LG";L,LD,BH;>#X@K/"
MJ6Z4P8Q6(UD36O49J<PRL"&CEC;/(I-7E5MN089B$&*4X;D#+WU&[&&U&"?2
M#+ Y*H=49.691=Q-,JC;=2>;?T/XA\%^6UN.4OT08?\ "OD5GC&/8C%/V.O?
M)I>$1Y'6.-6>1V"(B*6=W8Y*JJ,RS,2 % S)Z#CG_P#2GX?_  /CD7V7L?L=
M-\IJ<8Q[$8I^QU[Y-+PB/(ZQQJSR.P1$12SN[')551F69B0 H&9/0<8U3HXI
M%'A=J;9GL;L](C/5NU5 9U7,)+H2?OP%@SQ-(\>DQF6+$.4L7I%VBA[= O59
M:O>D(,A10:N>_N9:7D6)9HT#?36"N5@L7,-L%X))JEF)BC@:HW!1P6AFC/KE
MW$&Y#*I0E<G0Y9<81>\YX;4NZ=#31^J+EI EC9HIM UR';W4<Q:F+;>G5DV8
M'H8Q[+XI^R-[Y3+Q@_L1A?['4?DT7'/7LO7_ &.A^4V^.1?8BQ^R,WR:IZ'-
MOZ(,0^"_(JW'*>!X7B>'33W:N]*EV2)6WK$>4:P5W"Z8I8U]=(QS(SZ^.0&7
MI2Y?][_QJ[_&>*.'4\,B:"E#LQ/(967<EDSD940MJE>1O6QJ,@<NGAF3GQC'
ML1BG['7ODTO&#^R^%_LC1^4Q?EL8]B,4_8Z]\FE]#TI<O^]_XU=_C/'I2Y?]
M[_QJ[_&>,=Y8\]6X[7;NS;=9*^CLV]GIEFDUZNT199[N6G2?6YY]<AZ0/]MO
MQ#_QG&$X?YKP^O1W=_8W?5=O:U;LTDWK-<F66YI]><\L^F>0Q'%Z>&!!,S2V
M)6C6&E7"RW)C*Y1-N#4I*DJPUL50LNVI,I1&N4>9.8D43;.$8=(T!-*20R6"
M@"N9I=N$&1LW)6K-)6"O$@DB21!.V$<H4\-G6U-,UZQ$Q:'5&L4$1[NB39U2
MEIHR&*.TNA=098A+&D@Q5'DPO$HXU9Y'H7$1$4L[NU>0*JJ,RS,2 % S)Z#T
M>>O9>O\ L=#\IM\<A0/KQ&R3,(PL$"CJ*\KDO(Y899/- %CTY-G$EA\QZL#Q
M:MU:,1GMSQUXAGWI&RU$*SZ$7UTDA5&*Q1AI'R.E2>)KN/8Y'E@]=L*ILI/;
MK["*>RCQ1Y+!&D<\D*G=9TLQ:P^A6CLPNK1-2Y$@1XY+]QIP%5GKP1[*;F:E
MD,Y=I'A]>ATQUY6!#AHB-/"(D:+'&JI&BA$1%"HB*,E55&055  "@9 =!QS<
MCKC]TLK*)%JO&64@.@JPQED)]<NXCIJ&8UHR^*D<<B^Q%C]D9ODU3CFW]#^(
M?!?EM;C"H'LXE0@0S*9+< +U\Q/$@D4R31L VAH8PTNYD1'HUGHI]'F-TQ7$
M\+Y=1E[TW:[CAAKC1(I2(T8;FB8UM]]$L&1+U&U;;/QZ7?\ ;WF/_G/_ .QQ
MS9@GFV2O:2Q=MK:UI--<;?D66()MAK(5 =R+I'&RZ@*[D,R]V/D?$]JQ-A4A
M[EG58K=/"Q&GJR=V,GU6! ^IY%1.S:5!>;T<51(\4Q*.-52-+]Q$1%"HB+8D
M"JJC(*J@ !0,@.@XY2_0_A_PKY;9]#'<$J8_+)V>TL6)8>JP2JVID*21FS7B
MF3,&-6,NI+,0<9&9"DSQZ8;W+V+X?J::G(\2[IWZ_P!$1;</KI7,6IH8RO?4
MV%A)7/-04<+@N-6L(M1,LLAIF3Z*J^OC>-] E=(BZ(+(1!M2ZD.:*CL8BZ-^
MN+F'$[8@N8;2PG$;,LL?9VLBI*]/:L0^JO%)%J:615?;"E459=3,6$>W)#AN
M-UYHIXL-Q%)89$EB;L%AM,D;!T;2T)4Y, <F!!]L$<1<QRF-3/R_CT<O74D5
M%IHQU.6F5S79LUR)SB3(DKW@-1QW%\8Q&O)2HX+C%:&1EW)WK3"6:#0=R!HD
M@;;5Y"-12PVN--#C1*Z#"II\"P&H$P;$;-VU):EE@CAF&F1)Q$&LDI(];76$
M6R%@82[9.2ZFDXP"2W/BTMO&,+Q'M\^:5;<E65*-&NL<C- BRJO9L\MM9-4S
MS&4J=#23R6>;Z1N7%:EA>(M:BR2Q8BHR/5MQM$C1LL\;MJDK_23G#FV91I=-
M>-3@$^/8+/D<*Q.:C,P[17[%9S!Z#?@SC 690 ""0DZ 1R$$12P\SR;W+-J7
M1)%NQT9-J9=$T>NW5;1*F9T2)GI=<SI8$9\8!9>IB].PE::V4:7."NI>=T>"
M6.0QH =;1QLTNGH&T9%T!+KC?-(L59\+J4<1@OVM%8QVJ\<<BQSY:D$.N>1Y
M)XV$4::$.4VZCAE0-RORO+O1XEB4<D @D#U:KAHIFEB;-9YU.3QQQN,XXSDT
MS#6^4  L8OA4&,4VJ3,R=X2PRKXQ3JK*CZ,P)%R=E>-LM2,VEDDT2)2@Q3E7
M$A;M4YGJ*K169:ZB6"2M+)H5EGTE(VWDBECBE->9\HXY-I9N,<Q^#$J$N'X(
M+=^S97U4U8+2FO722,REP85D=9L^SE5&@I(^ZX[L<O+/*T\$\&)XB%30N[6I
ME=4BR-J"O:5TRB:(:98HU)E64HSM#)"T3<W=N[9@;8=N=MC\YRP[66X=J*M+
M(%4]),XD<&')MX9Q:)->AJ_-$$<$?GJO;PFR5ZB>G:$$[KTD-4B-Y-*]QG60
M Q[JH'FR,AQ2K:YGQ7M&%4)%JF-(>W2IL06=F5HGMM(R+JTZA&(UW;6S /4P
MRF&+#J4>'4:U*(YK7C"ENHW)"2\LN3,Y7=E9Y-&HA-6A>Z!QS#@UJA?N2)6D
M[ TF_%/%!IJQQV'[L.<>J.+:D;LZHQ0MI1Q&JR(.,&Q_&+-.I0H80LDD*Q4Q
MB$C3=@C$"IUL!8QI9:P76!:UM(0T<9UI7-_",8-ZZ32OVB;=C.RE"94L'>?.
M=5CC,86;Z8 A* -DI(RXP6UBT-"**_A$D,5/#M4<L4T<D]C81!#76AGO1V9(
M?$2.OJR%2D1<(G,8Q'&;ZV8,&Q:**.M'77=I3[CZ7DE+LJ(RIWI2@4.^80/F
M"VA>6KMO!ZD]6U@F-/KLFPCUZ$KYZXHXV1UDVM.G:4JP9]>L@A- +\<S<N^=
MXQ:K'+$*\>A%9LH[,0+/L',Z8Y S.8I.BDL8YNX5E@JV,9Y9M%]B2N9-R)XK
M44G9;.UTS!!19MEG#1S02]-?1S%*RR#F3'<3B5<*P.2)I]82Y(S35P%60,4D
MDAK5ED1U[K2RO'K0Q&)V8 8'A)PFJZRV)+-JS(;%N5I)&C,[>NVE<_V<S 36
M"-<I"B.*+CF'$[8@N8;2PG$;,LL?9VLBI*]/:L0^JO%)%J:615?;"E459=3,
M6$>W)6P[&JMBO9CPJ^9*\T4Z!Z-HH7A=9%# (I*DJ-63 Y>!'CQAF)/B".9,
M/OT)(EBUK=@,2,\@;4*[G(S+&4(9C'&<FC)0:LAQB>)/AZ(8\/OWY)5ET+2@
M,J*\872+#C,PK(7 5A'(<ED(0Z<CYGQ?WKQ'XC9^:XP[%GOOM287B=&00[KM
M;K&.OK!16BCF)!D;-R4SBC+HC,57+3Z&.\I6JDS3X7#)9I/WME/5+%8EE7:"
M9F6Q'FV<;H'D5 V_]+WI<(YIQ+#0N&S5&O;3&O# QDBN12:U1*V>B4LL9#1I
M T.ZK,(UD$<:1!X\=YGD6"W5DP;!UDU3HVI;4^V(B(CNA'E[Y+1/V>.K'U9^
MT3UXU**$14&HA%"@N[R/DHR&J20M([?T3NS.QZL223Z-BACUN>2S9P_$YIYF
MU22-2LYD^ Z"(!54 *B* B( B * !YGQ?WKQ'XC9^:X\SXO[UXC\1L_-<<L0
MRU\#HQ3Q20RIVG5%*C1R+JMV&&I' 89J0PS'4$'P/&.\H6XYY[>&(L]9V:8U
M4TI/!JUR2)#$%6.2%,@(4B]7[Z0K"^@RM0YOCIU15QFO=BOU(T1O4B9+ &T(
MV<6)$D2R\;[LNZ1'($:59=4L<'$N'XYS1?>[V1JT,JQ[3V6ECK15]MC (6=3
M),KZ=3-6B9#-,962))>F%8;%A-&*G$=>C-I92BHTTKG-Y&"_M(@8NR1)'&7?
M1J/-=;&+N+S!*E^S4@6):NU5FD@4/!$\V@QQE&9IBPD?,OW5C)TQ(J^9\7]Z
M\1^(V?FN/,^+^]>(_$;/S7')%.W4\Y]JJV:VYV+1VB"6'7I[7JT;BKJTZEU9
M9Y:AGXCCF3E[SU'%) \<-VOFJM(,HYHG()CE=$>4;9S>$@.JEI5T>K;D>$7,
M0Y4EFBQ2A;%&=DU,HUI'8VRZ&O)N=CE:5.[.JRA\HU.O.N8FQO&+',0&'8+4
MMS5EF3M$X1U$KEW6 /D=N&HV6_JMZ"7569(.SL7Y9Y9DPN0WKQC:TT>B&%,I
M!6$@4R,TA7\\^,/J)VUCW0)9EF]3XQ/$GP]$,>'W[\DJRZ%I0&5%>,+I%AQF
M85D+@*PCD.2R$(=.1PVYC=;&;&+7,%Q&PUN/8E$-*Q%M1F2OD8E,+!]F* 1I
M&[J9.ADGU:G-2QVNO'8V+-;<U>H6XMFPFEV3U2/-M.K3K7J<T96]OCF6[+?I
MV<-@P3%I95LJJV7H,8%V)3G8K2)NL^XJF-"%BU0S.VO+U-ZE''*-J"W!AF(B
M6O(LB_05P!LO%'T(C&.1<XY5##7&S+GD>,.M2W*<-F>K)1EDW-5675N1:)7C
M&K7'$W?51(,XUZ,/$=3B&(]@VOH'$;N[N>Q]7M.WHT?3>^FC7K[GCJTOX:>+
MF'XO;MVK7FC$8^TV9[&CL=EM&]*TFC5LKJTZLM6E<\L\AX<<MXA;IU:N%VL$
MQ:/1)MI:6K*8OHBS+(SV-Q(>SQP[JYL&FS4.Y"9 'BY9Q:ES/B=K#:TUR%&P
M^.[6B5I!*DE%&CU)&'D5AMRF*PJ,(7[KYI,8I7YLPB%&[2;=6RBLS4;%.=+8
M.6I$(TF -,NEH]4X32Z%V3KEAW+=S$\2>S9H-AV'&W)-)!,K0G;W!**<,0V)
MM+(XB6=4BB1 [(=R,0G]=7.-B"+!+$$DBK-::!:\?U\IBLP2R9 ?6I&I+.<D
M!**3KD16Y8FBKXY1EGECAB3M.J65UCC754L*-3N0HS8A1F>I('B?Z5LW+&!V
M)I9Y:.N6:1Y96[3<75)(Q=VTK8"C-B3DH 'M #CTI<O^]_XU=_C/%'#J>&1-
M!2AV8GD,K+N2R9R,J(6U2O(WK8U&0.73PS)S_P#T1<YUK%K"X(ZT$UB07XG*
M01/,X05[0+%8U8A064%LLLR![8X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^
M]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC
M\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S
M\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'
MF?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7
M]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ
M'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-
MGYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN
M/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SX
MO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7
MB/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$
M;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-
M<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYG
MQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>
MO$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^
M(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^
M:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS
M/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^
M]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC
M\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S
M\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'
MF?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7
M]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ
M'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-
MGYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN
M/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SX
MO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7
MB/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$
M;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-
M<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYG
MQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>
MO$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^
M(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^
M:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS
M/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^
M]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC
M\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S
M\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7]Z\1^(V?FN/,^+^]>(_$;/S7'
MF?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ'XC9^:X\SXO[UXC\1L_-<>9\7
M]Z\1^(V?FN/,^+^]>(_$;/S7'F?%_>O$?B-GYKCS/B_O7B/Q&S\UQYGQ?WKQ
M'XC9^:XY,K6*N%SQV8)J\AORN$GB>%RAKU0&"R*I*DJPU999@CVC_P#V,/*)
MS3Y1N4>UXOAF&\L7>5X=CZ(G[<V)4]SL5;Z/B\Y44D[1B-F1*OF^.SH@4-;V
M3WGPSRX^4/&;]7"\+P+EV[?NRB&M6AHXIJ=LBS$LV-JD<4:*TL\\K)#!"DDT
MTD<4;NO+WIF[%+Z:_,7G'M3[/I>\X=B[%M0[>[YR]7[5O]HUZ?4MK9T]_7Z'
ME#YL\I'*4U_$L-P;EVWRG6BI2+B-DSO<@:RT%-X+<"XQ2E>7M\GJ9J4Y815G
MKEYMQ;(BY9\L?E YJQNE@.'T>3H;E_M.S)<K8U'67LM2>Y)N/!BEB49Q5W5-
M,+YR%0=*DL,7\HOE+Y+UW><.4<"GP=K38;4LX1B1J=HNG<E@F1I;F+VNRRU:
MMF18[&%U)>L9E>"137DY+\M6!\U7XL(OTI< Q*W*T=$36H[E"VV46S6%W:J/
M%?LNTJP5Y*@AE,4<45N2W9AJG O+)Y3.9KZX9@?+O+N(76BDG,4=3$(UCAA
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MT<+V:ZR, C3Q EUX\H_E'_\ 9]YF_P QO._G?SC^F/8.S]@[#_L&[N[O;?\
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M&*NI#*2"#QSO^C/F[_?/C_[ZV_0_)"?HSPS_ 'L4OWUQKCR-?SMN7/ZL?O\
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M996PV7&K"2R2)-CLRW55981"8&HQ15L+GB3ORQFS0FF2:0R+-G'!L\<^>2?
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MV=(\B\4$6G2S3'PA!SU#QRT],SS)A,W,?8MV]L=C[1I^AEEU=HV,_6R099;
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M"7I)(!T =\A_PCQ&N[657&6:Y>YT4]T_U@&]P^YETXTR5Y%9@0 WKAU!'4$
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MI&C22,J(BEW=R%1$49LS,<@JJ 223D!U/'G?"??3#OCM;YSB"S7M(9*T\-A
MV@O!*DJ!P 2I:-F 8!E.6>>1!]L<3V:]5!)9GAKH6T!YY4B0N02%#2,H+$*Q
MRSSR!/M'CSOA/OIAWQVM\YQB_+L_-$F&BG:JQ00B:66=V>35!8:KE)66)62<
MZ%+JK2PH_=&Z VH?TB+=2M?K34[D*6*UA-$L3^##Q!!&3*ZL \<B%9(Y%62-
ME=58387!RYS#O57GMM16-(AB+).K)+AZQ:9!'' 2L4<NF$*4"!(QU"Y'%,8E
MQ:A/A\]6C#%8VM4E:!HYUVIHYAH=Y9%&;1A6S0YH6'0G,>8ZGZI8_LX_FN,$
MOO@562I6KU;"26&L%[D1EE#O'%$55HWA C A4@:2=18ZNH QV;S_ -E[5%#7
M[)OZ.Q)LZ]_9U;NX9M6G971EIRU/GGF,O,=3]4L?V<?S7%3F"Q3JUJD=/#72
MK7AKH\M=VE=((UB5I&$RAI&"@N0J@MF0H\.,4J18M?GQ"?.&6QM:HZVF.!=J
M&.$:$=9&&:QAFS<YN6/0'(5,+KT[5:W&TKO5L0V$24HT3O!(LJK(HC4M&Q4!
MP&4E<P&'CQZ:;?VAA7Q63^,<>8ZGZI8_LX_FN,$5,"M26ZR)8>2NU<I<42Q!
M'DBE+*L>R1(#"H!U$:2PT]01C=]\=JQU+->K72.PM@/3B,4I=(Y8@K-(\P,9
M$S$C2#J"G5T(/F.I^J6/[./YKC!+[X%5DJ5J]6PDEAK!>Y$990[QQ1%5:-X0
M(P(5(&DG46.KJ ,;5,=M1V[*)7>.NM<)3411%$DEE#,LF\3(3,P)U :0HT]"
M3YCJ?JEC^SC^:XJ<P6*=6M4CIX:Z5:\-='EKNTKI!&L2M(PF4-(P4%R%4%LR
M%'AQ;PNO<M6;<C2H]JQ-8=(BBQ(\\C2LL:F-BL:EB$!9B%R!8^/%3"Z].U6M
MQM*[U;$-A$E*-$[P2+*JR*(U+1L5 <!E)7,!AX\6^8+%RK9J24\-1+5>:N[Q
M5W65$GC:)FC8S,%D4,2A*L V1*GPX\QU/U2Q_9Q_-<8(J8%:DMUD2P\E=JY2
MXHEB"/)%*658]DB0&%0#J(TEAIZ@C&[[X[5CJ6:]6ND=A; >G$8I2Z1RQ!6:
M1Y@8R)F)&D'4%.KH0?,=3]4L?V<?S7&"7WP*K)4K5ZMA)+#6"]R(RRAWCBB*
MJT;P@1@0J0-).HL=74 8VJ8[:CMV42N\==:X2FHBB*))+*&99-XF0F9@3J T
MA1IZ$GS'4_5+']G'\UQZ:;?VAA7Q63^,<6\+KW+5FW(TJ/:L36'2(HL2//(T
MK+&IC8K&I8A 68A<@6/CQA=2+";\&(09S2U]W3'9TR0-NPR0G6B+&QR60LN3
MC)PIZ@9&WS!8N5;-22GAJ):KS5W>*NZRHD\;1,T;&9@LBAB4)5@&R)4^''F.
MI^J6/[./YKC IO,':NRQ0V.U[&OMJ;VC8WM.UMF'3JWFUYZL]*Y99'/&[[X[
M5CJ6:]6ND=A; >G$8I2Z1RQ!6:1Y@8R)F)&D'4%.KH0?,=3]4L?V<?S7'(S!
M*4M%4CVZ 012Z?HB06YK4\@FD'1@K !-*)DH .HC/^D5S-[.7?@WR2#["<D_
MIG\"_A?](KF;V<N_!ODD'V$Y)_3/X%_"_P"D5S-[.7?@WR2#["<D_IG\"_A?
M](KF;V<N_!ODD'V$Y)_3/X%_"_Z17,WLY=^#?)(/L)R3^F?P+^%_TBN9O9R[
M\&^20?83DG],_@7\+_I%<S>SEWX-\D@^PG)/Z9_ OX7_ $BN9O9R[\&^20?8
M3DG],_@7\+_I%<S>SEWX-\D@^PG)/Z9_ OX7_2*YF]G+OP;Y)!]A.2?TS^!?
MPO\ I%<S>SEWX-\D@^PG)/Z9_ OX7_2*YF]G+OP;Y)!]A.2?TS^!?PO^D5S-
M[.7?@WR2#["<D_IG\"_A?](KF;V<N_!ODD'V$Y)_3/X%_"_Z17,WLY=^#?)(
M/L)R3^F?P+^%_P!(KF;V<N_!ODD'V$Y)_3/X%_"_UDXW;FI87:LUR%FC$01B
MH8*9)XXBVD]"5#DKJ!75EJ##,'",8Q62*2:U+'.DA40:HXU*Z"XD.4"Q=&;(
M=_4>X<@H.;8EB6,L(C0>.,@N)55(26STZ#]$B1<ER8=TJ>^.C#UOG#FO]6_O
M>&_Y'%3$\06M$+6S)8R)D<ID>K,5!VC''FJE4.A<LU\6]<;V(\Q&RYJ2JM=@
MA1$CJ9)W0&![0IDS+ OZYADPR(]:L&(\SB:$S2@Q"6/=!2AD8]8U@Z%#Y%<_
M6$-_0D'+CSM8_H(?[%_G.#B'-8) G# $C4(\/R;[HU1JV1\1F ?= /&'8ECR
MS,;S+)%M'2'2J!N:TR/T-H?/3K\3IZ]1GIXNXIB)K2"H(DL=S;957,>J+JRW
MV:+UFH=Y3]SO9'CSAS7^K?WO#?\ (XP[%,56%A>VY)=TZ2Z1@[>A,A]#%$RU
M:_$:NO4Y:>,2Q/&FV?-Y2/+<W="0'/UFWGVK7X=_UF7CWL^[QYPYK_5O[WAO
M^1Q%BEQ8HUEV'E6-!(^EN_(% =NZR#O-F>B*/<5?#B[B7,1LR&HX2OW-M52G
MD/4UU9;X:7U^H]YC]SNY#BOB',V_%O3+LB13+JCHY-&#FR^I)N=\ J-&1S/K
ME]<)<4N-%(L6PDK1N(WTMW)"I"-WF<=ULCU1A[JMX<><.:_U;^]X;_D<8=B6
M/+*[7Y$>+;R5'2O],+*0P[,$/=4,#J?+OC)6\5Q#$\5> =A,44PD4G2B$M'D
MP*CM&Y'XE6^M.2]&^M;SAS7^K?WO#?\ (XP_$\52 ]N,4LQD8C4B K'DH"GL
M^W'XAF^N.3=6^M7$<2QYI4:A(B1;>3(B5_I@9B6/:0Y[RE0-+Y=PYJOBWG#F
MO]6_O>&_Y'$6*7%BC678>58T$CZ6[\@4!V[K(.\V9Z(H]Q5\.+&(<S;\NS,N
MR9&,6F.CDL9.:KZJFYW 0IUYG,>N;UQKXAS-OQ;TR[(D4RZHZ.31@YLOJ2;G
M? *C1D<SZY?7"7%+C12+%L)*T;B-]+=R0J0C=YG'=;(]48>ZK>''G#FO]6_O
M>&_Y'&'8ECRRNU^1'BV\E1TK_3"RD,.S!#W5# ZGR[XR5O%<0Q/%7@'83%%,
M)%)THA+1Y,"H[1N1^)5OK3DO1OK6\X<U_JW][PW_ ".*6*8B*T8MB)['?W&9
M5S/JC:<]AEB]9I'=4?=[V9XQ'$L>:5&H2(D6WDR(E?Z8&8ECVD.>\I4#2^7<
M.:KXMYPYK_5O[WAO^1Q3Q$S6!!,8$9T<Q*#I>1DTE@@9R7TH2S!1F ,ST'U9
MS-[.7?@WR2#["<D_IG\"_A?ZR<;JR7,+MUXBBNRHX+DA<H9HYFS*JQS*QD+T
M]=EGD.HI0/6JQ0N5+)KS*YE>]([C+,*?!O<\?L)/[/X3_P#.H_+3]6<S>SEW
MX-\D@^PG)/Z9_ OX7^LG%+4=.A:L2AV18]!" %LYF6%<@S*,@T@+=?6YY9GH
M8)DL1)-'GH<9C,9$9$@@CW58$'+,=.A(R/V$BPN6[B].RLD:15=J9\]1D;8G
M,FE5 T]\LBYEQI!9LFTA6^J^9O9R[\&^20?83DG],_@7\+_63S-[!W?@WRN#
MC"?8^#_C?\=)]A*6)5ZN)159MP/:01QN%#1AY9-,:MD=8U.FC,(0"REB%U,O
MU7S-[.7?@WR2#["<D_IG\"_A?ZR<4JQW*%JO*75&CUDH0&SA99ER+*PR+1@-
MT];GED>H@A2O$D,>>A!D,SF3F222?=9B2<LAUZ #(?F<SF.-G&68R\?#JP'W
M/=^J9_9_"?\ YU'Y:?JSF;V<N_!ODD'V$Y)_3/X%_"_UDXW:DIX7;L1!&=51
M '!*Y331PMF%93F%D)7KZ[+/,=#3G-FM%.RA6<-F!X9JS(2,^N1*Y@=<L\LS
MEF?S&S,8E&GUSYY'VAEEF?NGKT'A[OAD9(V[.96ED8L$;3GDG>*]-/7PSZ99
M#PZ=.)V>!E"2RDE<SK(<99],LQX]#GT^\?'B%]R-7(R)SS_:)'_9_P#G\HUR
M)21WFR]M0,C][-A_Z\.G"G4JL/!@"/VQGP\B1Y%VRS\/$_W!F?\ U]W@V0HS
M,4X'NE,A_7U<1SQR^M.1_H6Z-[?]?PSZ$Y#QR]#M">"!Y<O';0ME^WT'7KEE
MGGEQVN,-I99$]W4OATSZ@$GK][@$,,P01[H.8_K_ )G3PZM;Q"&S,',E5=V,
M*^E6:.13%K'B1&[%U"E=39"36G<^K.9O9R[\&^20?83DG],_@7\+_63S-[!W
M?@WRN#C"?8^#_C?\=)^974.:2>UEH/W#U(_KYGVNF7W>#8<Q;1 (R !\#W2"
M/N'H,O >[G[IG@F(W8RN663*<^F?75ZTY?M,>ITY'A0H4!,M.73+PR]W[N?C
MG[?CZ,S%F$"$9N#N'QT)E_A;P&9]SPU AQI=U'@K,!^T<N(OI47_ ,M/^J.+
M*R&<]&;/UF2GJ  <E\<\OKLO;S.0SX ]2 D_4P),S_K>]FV?W\SG]W/A<PRE
M?79C3[?7/IT]OKQ9#&%@F>?3H 22,QF!E_=\>F8RZYBDKZF;(Z"OC[1.?3[^
M7>^]^WQ>RU1GZ[(Y_>S&GI]\M]_]KBCGID'UN8R^_D=77[P7[W[?YG%BDM+%
MZ=98XWBM;4+YZA(N_.8]2L#I[A5&R*'4 RYKJ#+]5\S>SEWX-\D@^PG)/Z9_
M OX7^LFY''+4L)*B2(8G)1U#J2HU*2K C-6 9?<8 CJ.  H"J JJ   ,@ .@
M  Z  > _,I[*QG1HUYCO#, #/VCT/B/$'+H1XY\2QPF S1KEX'V_;;21IZ@9
M9GUON=#EXSU1&NM"2!EF#ETS]O/I[>0RR^[GQ3),/7ZUR!][('_"3Z$TNTO0
M:G8Z47W3][Q('W/;('3//B&+:7J=3L=3M[I^_P") ^[[9)Z9Y<2_39?_ )C_
M /6/$7TJ+_Y:?]4>A*ULQMJ0*OUQ3+/+V_KV.7NY#P\>F?%<UP1JSU^.I\@@
M(]SK_6+>V,QI.0]"4S#3M(K>.K5[7AE]<OW?=X?/=/:=8Z>"9>'M!<SEI^[U
MZYY]<SQ 8BGJ60'B1]<"?Z+J3GT]OVAT.67YG/[/X3_\ZC\M/U9S-[.7?@WR
M2#["<D_IG\"_A?ZR>8Y)(L&NO$[QN!  Z,48!K,*L RD')E)5O=4D'H>,-D>
M6E \C%W(<%CXG3(Z#,^V=*C,GJ?$DDD_F5BMNG6I ;+(@CHWW21USR^X<\@.
MG$A=(-EH64:5[X.I<]8)S(Z#,Y],^A(&61X<36 %T;4>>9+'O$ Y :!U']%D
M>A('>]LH@C4(O@/_ ,G^N?\ _7H3Q3M,70'+II(<#+N]<N\".N?]<^[QMW/=
MD_MH_P OALPS!O79G5[?7/KU]OKQ568'-]6V8^[F^8^MTY+F<NGW.GAQVU->
M6DZ,\M>?]W3EX?MYY=<L^GH/D'<+ZW4VGV^F?3K[?3AIQ%#$3FS,BY#/Q[HU
M$MU]W[I)/WR(9A,"0,B/$>/CX=>F>>7_ *Z$WLM"'Z[5T^]EWNGWPOWOV^*7
MTQA[6CP^\RY?X3_7_,\+CC:WK9$9XHI#&[*"T98HK%&(S4LI*MIRS4D'I]6<
MS>SEWX-\D@^PG)/Z9_ OX7^LGF..27!KJ1(\CD0$(BEV(6S"S$*H)R506;W%
M!)Z#C#8WBI0)(I1P')4^(U2.XS'M'2PS!ZCP(!!'YG,ADC9!EF<O'PZ,#]WW
M/RTL4ADD(C<@N^1T-_1'[G$72.,'H0B9C_@CB2H0^J,:TS'<U:3E[8S/M>UG
MGJZ^!RSX>68YI'"P.7KFT@#[W4HW3_7>/B.AXBIGH9>@_H!U)\?$CH/:\,^G
M]">)X1,ON,N>D^UU\0?N'+Q\1_7!A5ZZR9Q,QSZ%"#JRZ 99Z@,^N84G(]1T
MXDCL6&4E BY=,V'3,==7UV9R'33T]SQ/$,(A! .9/B?#P\.G7++/_P!= /S*
M2Q/%CF&QQ3S1I)+361$D=$=7MD,KJI 8,  P((( !^K.9O9R[\&^20?83DG]
M,_@7\+_63<DCBJ6'E=(T$3@N[!%!8:5!9B!FS$*ONL0!U/"NDBAT974^#*0R
MG(Y'(C,'(C+[_P!A.P6[.,T)X(M<5=ZLDS:XUT)%:UR')W5FTJP.2@D^T"?J
MSF;V<N_!ODD'V$Y)_3/X%_"_UD\S>P=WX-\K@XPGV/@_XW_'2?83#;$$5O;E
MGAC>2+3&CR(CNSR(%5%8@L6((4 $D@@?5G,WLY=^#?)(/S&C2[;VSU7;[)0L
M7?6:]S8T>I>N73JU>O[VG+UI^J^2?TS^!?PO]9..P=HPB^FK1I@,^>6K\[%;
M.G+,>OVM&>?=U:LFRTF+$+D$:Q13:47/2NW$<LR6/5D)\23U/$.,VT?.4B=,
MB"A5(_O$,B9@@^Z&!&8RSR82XY(\;+%#LN<M,FX)-/4$]QHLCF,UZ^&>?M<>
M=K_ZO_>H?F^(,;FC0B:/M#:LP^I8LER'=TI$0<B"<_'KE[7$^-6)-.P.SY:M
M75)=>>67KXAITY'P\<_N<>=K_P"K_P!ZA^;X3'6"*&KZV"@,^Z%U,!U;2(<E
MU'KD.@\.)<8N/(S1/LH<M,>F*33T /?:+,YG-NOAGE[7"8O>#J6EUJ&!9-$2
MZE!ZKJ$>:ZATS'4>/'G_ /V)_?\ _P"SQYVO_J_]ZA^;X@QFU&Y,Q[0NG()Z
MG%DV8[VI(B3D 1EX=<_:XEQR1XV6*'9<Y:9-P2:>H)[C19',9KU\,\_:X\[7
M_P!7_O4/S?$&-S1H1-'VAM68?4L62Y#NZ4B(.1!.?CUR]KB?&K,A78 KJ!U'
M=E+'W27CR  \ %'MYD] OG:_^K_WJ'YOA,=8(H:OK8* S[H74P'5M(AR74>N
M0Z#PXDQBZSLR2")">[&$C;2/:&IT+,?=/MG/(*,E"8O>#J6EUJ&!9-$2ZE!Z
MKJ$>:ZATS'4>/#XZQ1@M?0Q4A7W0VEB.C:3#DVD]<CT/AQYVO_J_]ZA^;X@Q
MJS&6WP+"D=!W8BI]T%(\B"/$%3[61'4-/C<TB 0Q]G;5F7U++FN1[NEX@!F2
M#GX],O;X\[7_ -7_ +U#\WQ#CDJ)IFB$SYGU0.(LQ[0*B-ES'NC3TRZ9YL9\
M9M2.#">SKIR*>IRYMF>]J>($9@@9>'3/V^/.U_\ 5_[U#\WQY_\ ]B?W_P#^
MSP^+WB[%9="EB531$VE2>BZC'FVD=,SU/CQ%C%Q)%:5]Y!GJCTQ1ZNA [ZQ9
MC(Y-T\<LO;X?'6*,%KZ&*D*^Z&TL1T;28<FTGKD>A\./.U_]7_O4/S?$&-6(
M]>^.T9Z=/5(M&6>?K(CJU9CQ\,ON\3XW-(@$,?9VU9E]2RYKD>[I>( 9D@Y^
M/3+V^,(2YBF+TW+*[5GBL2,VB,+7KSJ[=$4:F+,$4!22SC450,R_5?,WLY=^
M#?)(/S# <!.+%YIG:*G$QC)C*[TDVD-H34'"*@=7=W4YYA$!)=XL.MX,SXH*
M6%21QQX3;D=Y;DVNQ HBW:YCUS+#K8Y"5)7<!00 6*BE@6&XS16W'5EPHLTR
MP[=HVUE"Y(LL@F&K2DRR+M*868*Q+Y-&RV(6KSS5W*EX)9(7*YE2T3E&*DA3
MIS7IF <O$#T(:\]ABE>&6=PNHI#&\K!00"Q5 QTYL!GX9D#V^/2SC?VE^,U/
MG^+="Y0?;MUY(6/K2V11\@I.W*I:.32'77H=M!.ELFZ?E(()K4T<$$;2S2MI
M1%\2?'V^BJHS9F8A44%F(4$\7*-K#Y5AMQ;4C1B4+KCDS0LR@YQ.Z^N1AEGG
MT\,B/0BY=QF5!(M&0*V>0EDAA?H2.L4TD<B]1TU(,QDPS4@FS@F*U%USTI0F
MEV+QZ9U18P"[2- T@B4 YYR:00&(STMEPJL[*B*SN[!41069F8Y*JJ.K,QZ
M#J3T'"\MXTZJXHMDRAAJFK(V3#,:D>971O=5U5E/1@#TXN89?P_3VNM)$K99
M/W9(B3JR3=B9X]S)&.WJUZ1JTZ2#^8\D_IG\"_A?ZR<5]C,1_ +GR>3["\F^
MR<_X!+\HJ_5G,WLY=^#?)(/S#E*:!\*$4859H)918'<#,TC%XY2%.HJT6F)7
M< DP,BYK&.*W+#4FO[%I94N8==IQK,AC:)IS'L:W36)% 5A*X2,@@%(CJ(1#
MS#R_1>(5JERK!&TJS(S-V?7,&D#IG!-+&HW9&RC[FZ)#/M1-$)97FEDFE.J2
M61Y9&R U/(Q9CDH"C-B3D  /: 'H<KUZ\6$P30KZI9UO/(5TN[I+)'I/??U.
M+(I%D0",Y=N.261>'F%#%)9Z++HK7936TNS1M"DK!%UJ^J2*2+N-ZIZI&Q!8
MZL^+5:*Y7FK3#..:-D;HI(S\'74K*)(VR>-BITNJMEF/1K2013H]FOVJ%=6N
M#=>#7FC!?54!9=+%7Z#KITGH3QRT:$U66S4P^.DPG> ^JM9E8;<$A]7E42",
MDKZEGH#+K]<QXYR]DX/P"+Y1:XY,BKM8N2.(S9BCB[/J/?5'W5G>-<__ )2/
M(!FH?1J E8-SE[)P?@$7RBUQ@$\UG"*<T\C2RLLJM(WKF$<\L2:C]<VA%!8Y
MLQ[SEF))YAK05<6M15Q&D?J3[48<"%I(D=DR90HS8F15B+1(DBHI4J8TY:PN
M&E1ALZ5:U<B65Y<]6F&3*2*),U70NC0TH&>J;/-W1(M/,-Z:YB=E7+"*K+)6
M@BU9J@B;;D<9*O>F=-QB06 *QEV6-,N7+;XEA65OU9HY)*DK2Y2=H30C#<!4
M ^IRB)]>LR:"[LS.>,?PL89>*1*PJSKNULRS:1X21:V49M$_@-3L(7A,CEV)
M_,.2?TS^!?PO]9.*^QF(_@%SY/)]A>3?9.?\ E^45?JSF;V<N_!ODD'YA@V%
MXYV?SCAMB.!7W-,9EZV=K7'UB,<E=N^9$B[25TOF_<73(<,YDN6&Q%+E6)7H
MTK%O1&)8&U52!)!(LK3$,Q8#/H8BK H^KNX/CL&+B15C:"Q$H9XF='!5F9=4
M3#2\BKDFZ3$@1I$7O9@G':T53%KL$(TQB175<E 3>BCG**%556-&D*QJ!W4"
MC,D9GA99422)9)%CET[L:NP27;.I-Q =+Z&ZKJ!TGJ,CQA6!87%>@E\\5K\D
M;;D->%HD8S1^J*YT697=8])DT*!F5!<F,.C\QW\6BKV(XZ&S1?57DN.\4SND
MN2YK%&[=FCD[\>N97)$D>79YRJ_E.3?8R?\ #Y?D]7CG+V3@_ (OE%KB+=W8
M]C<WMQ-G:U;N[J&WMZ.]N:LM&GO:LLNO%;!8H<IL;M1X?#MB05Q(IQ&17TK$
MZUPLK)'J+:]4;2J8G1X4&<B3<VT:T KX;6EDV5V(#-W(!'&A2.0'6]B11I3U
M.00R.A.J2-^)YYK4TD\\C2S2MJ=V\2?#VNBJHR554!44!5 4 <5YEL00V$#!
M)XHYD#9!@LJ!U# %AJR;KD2,_ GC%?9/$?P^Y\HDXY-]C)_P^7Y/5XYUE0RX
M?"#ZI''8E=<CT25HEC.>6DZFAE&0)(T]0 5S_+\D_IG\"_A?ZR<5]C,1_ +G
MR>3["\F^R<_X!+\HJ_5G,WLY=^#?)(/S# >9*BUJ]&\[0RPJ(8YV V'C#*D*
MLR ;3(AT%I%V]$6[)/J<CBGA%[<Q6[N4K0Q/#L32-Z,^N'M,\B$1AI0G=9]Q
M5.IU3;82NIRU4.Q<M"W/:M5KF(,K00UJ<CR%!&R[L<SZ0L+/+HU[T8:-8&VM
MUR\0M69;EB:S,<Y)I&=NK$#/P1=3,PCC7)(U+'2BJN>0]#TKXKV/M>W'GM[G
M9-3]LTY^&UMZ=S3W]K<W<NYHWO4N%9D971F1T8,CJ2K*RG-65AU5E/4$=0>H
MXI3-8IU+#A0\]:"9PN84-+$KL%!+'3FW3,DY>)/%A*U?%IHWC8TX,1D1XE+%
MC6BLE6C5BZMJVET@F0-GU+@]>!)A>*5&I03UI89:V6S"T6Y##DH1E@()A:$F
M/1KB&S($!4, .*T':9T@WH*^O5ZM9DVH$THS]^3)M.K3I7IU<J/;XP$T<*I-
M7FQ;#))))WG;:MPZ%U+'&%#,ZL_=B#$E$R+%<B%UMS!4JXK:ALUL7PE=, @=
M)[D:Y:9'=65DW=6K=8$%5TZ006U$)RIYK@CEN6K%:*X)6AB[1/%&8X=N,EXD
M=E(:0NZ-)U[JE$*@RAV;EIV9W; W=V+.[&@S,S'-F9CU9F/4D]2>IX_]V/\
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M.?\  )?E%7ZLYF]G+OP;Y)!]A.2?TS^!?PO]9.*^QF(_@%SY/)]A>3?9.?\
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M;OB_)"T-<V&M L<B26WHE3-=4BEF7.30J,@?2X?(>A#/9Q::<1S-5H0L4$D
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MDY$_1>@S+X99$3.J],P,NNH:O0LR&&O8F7(M%#+(H;P)1&89Y$'+,=<B/O\
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MGV&JL.89R3)*RYY-(V7AJ/@JA4!R75IU%5+$<5V*\Q,9B5/:;*@R'+HT<JP
M:O:93&L0]L% G0CT.9O]!?"?_H<4E#4*BL RM3@5E89A@85!!!Z$$="#X\.]
M:E#FQBKPKGD %1<^\Y5$7Q8]YM" LQSR!/%F"UC<T4D<;5J<:]Q[ "LVO0TD
MB1KFS:E*Z.]LL(\Q*C,R\(BQHD:#)(U5$&9.2J-*C,YDY >))/N\<Q_G&+\*
M3_%3\4?SC3_!:_\ BD_6!>4-CX5@&5K-)65AF&!2N""#T((Z$'QXQC# B"[3
M A:N%UQPIHZ!LQ,FTH(DC)S=C_G:ZM2[??PG$1=A"R,.U1CU5<M.L9Y+*HSR
M((R$FG+3)GW%5H\[WYQN?@MC_%/QA,6*/7<T;,,,6\P99%!8R:(\VZP2]-.@
M>N'@>GMFSAN-6T$=BW5D0,' ];W@&4'-*JGP8],\NO"85KPR.A88:XR[K)$2
M0DADE9& 8)K&F32RL!GF<B#I<*<:PD:1&7KH96RTB>'(>N<LGJL,?7< 9H>N
MIBOTP<89BB8@I4KMSQJID7,:6S)!:+O%RHR&K4.X75=3^N,"7'Q:^*,L<,NY
M:+-( 08^TC->L<O75H/K1X'K[1>ICTB/&]VJ4D5D<:0,U8%6&8J C,'Q!!]S
MC!\.GP_M&\T3;NUIVBYRT;N>>I$_HQEEG[?AQ_IG_P#7O?Z&-UA8HNX7.2OZ
MLA[H.D?3@2W73MYN54@LT:>) 4X=B*+A+2R'4])=MEZ GKE64: Q"N"D0D9/
M7*Y;/2S&A7[-5B1L]UAN6"Q#.T\G>E+NOKR&.D,2QTJHU-EGQ EQ\6OBC+'#
M+N6BS2 $&/M(S7K'+UU:#ZT>!Z^T7J8](CQO=JE)%9'&D#-6!5AF*@(S!\00
M?<XPO"I*B6X[)BD2RJ)E$TGK0)5<$E(R,Q)T*G/Q\.G$E#$\,EE?#S)) P'>
M01R.06[JO 0Q:1#_ )Y'&>Z2P*!I$7#\;,TW9;D0AF:0HA4:$! .<<BRN763
M6NA<M6IV":5(S;AF"@LQ"JH+,S'(*!U))/0 #J2?#BK;[09(\+J110(PU69$
MVH2^H!M%>(*TK&$!EU20D=T2Z.X'O)*F,X?O2[SEJS:A&L:J#<DTHB#,A5'3
M-WD<G,E_ "]^<;GX+8_Q3\<L_P"C?@W_ -?T9WKT(I[6R%&:M,88T$DA9](+
M>LUG5(22S>VQ\3UM8@F+%:D4JTX!E+-+:<1E]+!=M55RCY:MP([C6RCK'MYM
M5KK5KQ5TZB-<L^O>8]YWR);+6Y9M.9"YY#H!PA:MCY+IU:ZXRU#UMLLJ/F-7
MUDRR:?'ZTZ3GEZ$A[3S -I3W;D0(.0/T)H$S>.60$+LO7,C+IJ.GT0M>I&Q
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MSTMDRYZ6*GHP#>N4CJ/[GH4J+QXO)4$K"&!ELN!(1NI$4EK!QH"NRM)%K!4
M>J;; Z2>+\,N&XD,1AA,D#$ROT;0KR9QS*SYL4+E]<;, FN0*J,(RO"XYAI
M)G*D@$JT,VI<_K3IC9<QX'2S#W"1UX:6Q/0Q*6:-H8VBL"O#*FF98EKE2TG7
M_/'#,$9=2=>_)&8R,.Q6%X(XK<HALQQC5OYQ[B9*8Y1)(<F,D;(QS8.YUNJ;
M>1XLB/$,4IM3RE-0QO:G5LX1&LBRQ1AP2K2?3,@@ZE\BV4<FUQBT4DV'V(XD
M+N1&0J^N.B5';(>V=*G)1U;P4$D#C",4HUJ8AG80R+(^>4<C;NHZA(QCC(SR
M.UD23E&/:R Q"P6Q.C;F@FJP*8-)G3)V2&P6D8HNHJ5+'U/O.5T2992*.':.
M]3G%:6.030R1JP/17DBZ"3(%D(UJ64KK7/JN?3C!;D%![4=LM"7VQUC<Z6B,
M@9&5075N_P"VN7=8$@Y PSQ6(EFA;7&^>ELF7/2Q4]& ;URD=1_<X9@H+,0J
MJ"S,QR"@=223T  ZDGPXCEBF&J&2.50=):-U< ]#EFI(SR(.7W1QBE>*>E8,
MB@M%#))&^2ZT*#<[K$$J',8633EJ7,9^V.6YG:&Q QS2%HVC\<QNZ]2C,Y!<
MX]0  [S.3GJZ8OA?;E$T72S&NE03W94!+;?7HK DE&Z#,E9.A#QT\7A8+!=U
M5;:*HD[0NVKMI)+ZLE6/4H#Z9%C&;A(]?CQ9Q>! T=/Z,MGI'%"KR+GIU:RZ
M#2ZHO5EC8MGW3H[S)A>%]E^B;/JER3,DDZ]K7ZX!NNJ5LSNRYGQ*(=.II.+E
MD4ZTMAE+B,#NCIJ+,$49GP&IAJ.1R&9"L>A&+"23>O51==2VRK2:((4;/-5@
MVG5R<^LDID<A8^N::CZ9O]A?C/\ ]CC#,3\X[WJ.SL[?^>;FK<W/_AIEEH^[
MGG[67 B."8CO,/H&QKB$BJS;2N0XC/>+:HV1>IUF2$.R R:E23%L/CBW>TQN
M",U2,ZY3FI8+MCO(3EEZKH"MDKE3QA%*:6TV)V%,6LO-"HR D-C<#MD69UC4
M-W P&O6CARH[^,XI+3*5Z_=F=1*92%8(FIE 16S!9BAU%ADJ^ +-G'6QFO5S
M,6'^J-GN3O:USR$Z=1>1H-7?90[*-*:\V"@\>F;_ &%^,_\ V.$M1=G@L3/'
M LT<;C<D50#(FO1K;2&(&?M#/(G+A6# ,I#*P#*RG,,#U!!'0@CJ"/'CF.O$
M(8K(4++O;;,H4;@:-CZH<M3%-E0F;=T%AEU&6%S//0K2R'-RK*3U);;=H@S%
MB268("YSZL2>GA^;1UJ\+:H8(8F(TEHXD1B.ARS50<LP#E]P>A+!!-EO0Q2Z
M<].[&DFG/+/+4#EGD,\O'(>YZ)K5VDWF@A:7-6W3$ADS7+2=975FN0TG/ID,
MO#\P-:NTF\T$+2YJVZ8D,F:Y:3K*ZLUR&DY],AEX>@Z)(I21%D0Y9HZAE.1S
M&:L"#D0"/NC/A$2-0D:+&@SR1%"J,SF<E4 #,DD_=.?HM! [K*\,3R)EHD:-
M&==)U+I8C4N3=1D>AZCKPZ)(I21%D0Y9HZAE.1S&:L"#D0"/NC/A$2-0D:+&
M@SR1%"J,SF<E4 #,DD_=.?#Q12,C21QNT9U1LZ*S1GH<T)!*G-0<UR\![GHQ
M0OA>)6+$D5B2I*LNF=%,V@.\4KM/WWD"Q#4&D?-Y-)=5;KE)C54H5J&2U88,
M(HHX)CWPC,&8,(R8P1W]!+Y=0.A(PC#I8W>_<_/,VME0JH,>Z=3R-T[DK]1I
M73MHS*W5RD?#*&!5@&5@596&88'H00>A!'0@^/%J*;"L2[2D9V1-N1,J!(BD
MNHO7!R=$(3<B RUA5W%0#3PN.8:0"9RI(!*M#-J7/ZTZ8V7,>!TLP]PD=?R\
ME:O,VJ:"&5@-(:2)'8#J<LV4G+,DY?=/ZRV4,"K ,K JRL,PP/0@@]"".A!\
M>(H((<]F&*+5EJVHTCU99Y9Z0,\LSEGX9GW?0:"!W65X8GD3+1(T:,ZZ3J72
MQ&I<FZC(]#U'7T16KK)O+!"LN;-NB)!)FV>HZPNK-LSJ.?7,Y^/Y@*U=9-Y8
M(5ES9MT1(),VSU'6%U9MF=1SZYG/Q]"2**8:9HXY5!U!9$5P#U&>3 C/(D9_
M=/"J% 50%50%55&04#H  .@ '0 >'H[$&[O;,6]^J[:;OK='TS+5ZWN^/K>G
MAQ)%%,-,T<<J@Z@LB*X!ZC/)@1GD2,_NGA5"@*H"JH"JJC(*!T  '0 #H /#
M@Q1&19C'&95&E92BF11UZ*^6H#O-T!^N/NGT+,/:()H"Q3=C9-0S[N8Z'NLI
M8 ^N34 XS1NZQ'&&S>:H9(+\4U?.8N)C$9(#JCB"QK+%K#29*S9 $ *06##3
MQ=Q(W(6K88DMAI=,<LBP-MI'+K4J6DT[;-EEK==L1ER'#+FN&T!0@T9AY7.N
M9P/;RR"*<@QC3KIU>)9WR77I'#HDBE)$61#EFCJ&4Y',9JP(.1 (^Z,^(C-@
MF(:I8Y#%G)$6TA=^'H=49.I<QZG(55\PPVG=<VX3%\.D=(TL9O(RH@VIQFS'
M2HS,8 S)\20/=_+BM763>6"%9<V;=$2"3-L]1UA=6;9G4<^N9S\?RN,4I+M4
M"',RQ2*Z)JR#Y]Q@=3I&" VL.V9&ED7+<;BMBE6M7KP6MZK+%#$A2>O,&;0B
MIN)I5\XRRL%)R/=.:CBVT^-2PP5DD2BI+M9EA*HSHSQET8GO@*<HXQH<NS[H
M4+JC@A2O#'!&,DC4*/#,Y>+-I !9CFSG(:F)/M_8QE# JP#*P*LK#,,#T((/
M0@CH0?'B.**$:88XXE)U%8T5 3T&>2@#/( 9_<'Z\71)%*2(LB'+-'4,IR.8
MS5@0<B 1]T9\(B1J$C18T&>2(H51F<SDJ@ 9DDG[IS__ +'#MH1WTL^A6;0@
MU.VD$Z47VV/@H]L].'Q^K&Q22O=C<99H\4:L,QF,U:8$9@@C[ASX?&$C4O)1
MQ*-!EF[U@JC,Y#-FE &9( ^Z<N*UZK;S[/,LA&>:]5?(:<VVW"OI[P&O3IS.
M6>?3ZII7X+Z.\.H:&TLDF@..@(;2KOW6ZA2?$JP^M]!\?JQL4DKW8W&6:/%&
MK#,9C-6F!&8((^X<^*N)I;9!'5NA)-64[P@0=T-GG(LC#Q4H/'O]WBU>%1LF
MK7)5$>XTL$.N)!WL];EU"E0NIL_!2#GQ7QNO9E6&&"XS,0"1$A" L%W)-,K%
M8U+#4V73T+>*Q4W99J]S2"JB98EV7++KR21I%#$#,$>ZK>YQ'C44PU0TL1E4
M'26CKJX!Z'+-92,\B#E]T<)C-!B%>1H)-11HIXG1HV#:<I" T:=>I)DR4>OT
MD$!6# ,I#*P#*RG,,#U!!'0@CJ"/'[%3XQA%65H+6*X=6G33KAGO5H94U*'7
M5')*KKJ1E9<P,U8,.A'$>.8)+(D46,87++*ZQQQQXA4>221R%1$192S.[$*J
MJ"6)  S]"KBF&79#%2Q&C;E5#(T=6W7L2",%5+E(I&8(&95+$9 LHSS(]!\?
MJQL4DKW8W&6:/%&K#,9C-6F!&8((^X<^*F*Q7'58:]S22RF9HEV4*KKR>19&
M"DC( >ZR^[Z%NX*85F@LS*0[,T$6X(PF1)E)90@R.8)_H6]SB/':\S:8:MZ5
M@-16.%'8#H,\EF)RS(&?W1QYZJJ^W8CM5#IUCM,!7,9Y#)4,C]>N1TZ>ZPU9
M]#/<@AK-;U;L*Y=82DFK.01=TZ@IR8]>]TR/MC+B/':\S:8:MZ5@-16.%'8#
MH,\EF)RS(&?W1P<=KK)LM5O++FJ[1A029MEI&@S:LVS&D9=<QEX\2XY!#EO5
M,0BU9Z=V!(]666>6J49Y9C/+PS'N\5;*6X$L1A@DFK(. &[KLAS"LP\5.74]
M/0FGAKH9)Y%C0>VQRS.1;2H\68@')%!9LN@/ Q>-^]%3Q&:/-@LL575&^DE=
M2'6#EF/; (\& .8X7&Z.F4N987AU:H)8],S%2%TJ 2NK4VG07##)F<+&I?B*
M0311S+F%EC210WK@'4,,\B1GD>N1/W_UC8Q<EP_#K%N%8VDBVM(E#%#N3Q1'
M,*R-ZUSEDPZY>(Z<>G+$_P!0H?VJQ_&N/3EB?ZA0_M5C^-<8/<EQ##J]N98U
MDEW=0B#!!MSRQ#(,SMZU!GFQZY^ Z>AS'^?HOP5/\;/Z%H=AQD]F5CMV(G2)
M.Z6W521H$T+T5M;1*H4]PZ2&ZYV+].KTGL1HP(!0$O(,QJ&J.,,Z@CKJ*@=1
MU[PS.(TE@2RUA1#)JT$A@SZ7VVT1%=UM+>NR0Y#O'N]>*]B&U'NP2"1,RN8S
M&1'B&5@&4^!R8#,$,.A!-F]5J9=HF6,G+)>K/D=63;:!GT]TC7ITYC+//IQ6
MO5;>?9YED(SS7JKY#3FVVX5]/> UZ=.9RSSZ>BS!068A54%F9CD% ZDDGH !
MU)/APF*2V6?L%&2U%&=+3/-'6!?KT02 ZAITMXAQJ&N-,UU+C CL=FO5FI.V
MG2QD66+)L^\T@"@+F NM=:AM6X8]#'T+F*5ZC;/>GLG(+7B&;:G!VPQ\%U'2
M,AJER=6$3 CA[]Z%3+-A3+"F1D9+<,K*F?>81JN;:1U/4#(9LRJ"PIWH+T9D
M@)[IR>-\A(GCEJ +#)@,U8$@]1GJ5E6S9AJ0M-,V2KT 'KG;VD0=-3'^L!FS
M%5#,$OWIE$L.%,T+YF-GMPQ,R9]UC&RYKJ'4=2,CFK,I#&CBL-QS R-7LKJS
MAD]LJ6U*C9*2R 9NC(C#KD&",P9@H+,0JJ"S,QR"@=223T  ZDGPX&+=HD:/
M#ZLEW0,Y)"XK1C/+3I,JYDDZAI8(>X2@=<V#8N:SJF(4Y:NYEMNLB6$(SR<L
MR:<MONDJFX^1STC-=2L& 92&5@&5E.88'J"".A!'4$>/HXM*T=1HXUURVV6G
M$.F6J<%3F2RY=P-I.>0?3J&G/C"F-#%I*CDZ7,D&;G:!*G5!+H.8)D TQ#/_
M #_N,<\FXQBGVNHVE<YH<Y8LAFQR'?C&2LQW%\$7+5*L69R''+MO7$]-O70Y
MRQ?_ "F;OCHN7<D;5FS%FW<@-*<8G/)%!M5P6M6CLP*IR<9CU24=]"HB3,[H
MZ1N8V?)<SQ2J)2KI AU:<R[Z0ID=NK,<O[%<RQ5%52S:<_0QOV,L_P#$_*(N
M.7/SC+^%/_BH..8XH^SPSZ!NB98M?UVVR2N4/NC4H(SST][3EJ;/EYV:@58Y
MB.Q(B=!T4K')ET\>_(YS.9ZY>  #,%!9B%5069F.04#J22>@ '4D^''GC#=>
MWVI=6K1GIDT9YY9[NC;TY_7ZM&7>U:>O"L& 92&5@&5E.88'J"".A!'4$>/%
MF]5J9=HF6,G+)>K/D=63;:!GT]TC7ITYC+//IPF*4)-&BRI,DJPHNEPYD;UO
MJ94.%.>6X5$>?0OGT]";%*$#F.6RH<>(57DTD$J58Q*X5@0<T)##VQU'$,\-
MA!)!(LB'VU.>1R#:6'BK $9HP#+GU XFQ.A7;3+9C#9LI5-4K*4Z,'$0<H0>
MF3Z<^N7@<I<1I0I')+855E5'C&3%V20$J^TJF0*0#WBH /=)#=.!>IE4?M5<
M+(NM-<J(67,C/2Y5O7*RD$9AE93DP(XCLUYFTPSPRL!J*QRH[ =!GDK$Y9D#
M/[HX>W5C8I)9KQN,LT>:-6&8S&:LP(S!!'W#GQ'+%,-4,D<J@Z2T;JX!Z'+-
M21GD0<ONCB;%*$#F.6RH<>(57DTD$J58Q*X5@0<T)##VQU'$,\-A!)!(LB'V
MU.>1R#:6'BK $9HP#+GU XFGAKH9)Y%C0>VQRS.1;2H\68@')%!9LN@/"XQA
MKZLK2]U2YU+(G0>(76BZV]Q$S=OK5/".LB)(AS215=#D1FK#4IR.1&8/@0#[
MOU/S#R=AES%)[LD^("6V%FD L(Z!OI>49G@FD6/*,:8]PI$/4X5CA6.)*W)N
M&5;$%F.>^7KS13H'EKE"\3K(H8"JI*DJ,\F!R\"/'T.3T-+G>.I!)*(EGQ6H
MW?R,T,%>V46;1I60:X(I2"NC=C1PH*KEQS-_H+X3_P#0XP]0M&F% 4=FA;(#
M+JT:LQZ>VS$LQ]LDD]3Z/+GY^E_!7_QL'&*0I-0LAQ]+B>9#TS5XE+J02#EG
MEH;+(E&901GQAZV+%3$*<,;2;BP2KWM**Z3IF.]D@:5,VS+*2(,LFR[M*HE*
MND"'5IS+OI"F1VZLQR_L5S+%455+-ISXN?HA3\*H_P#5K\6ZL=R!X) .\#H8
MC/;DR.B1>JG-2?#4-0S0]UB.,+@EKT8(9ET2)NZES5LM4TC#JI*^M8'H?[OH
M1,<;Q/U8GLL0DD6+/1E"K!57NZO5)&:/>;4"1J".NF,!5"@*H"JH"JJC(*!T
M  '0 #H /#C'J:S5385?5J^1U*I+-#GDZ'(^M35NZB&T!7RTAW/%'\XT_P %
MK_XI.)L4H0.8Y;*AQXA5>3202I5C$KA6!!S0D,/;'4<5[5>TNNO*L@'CET9>
MI UHV3IGI.G4HU 9C,=>)+->%M,T\,3$:@LDJ(Q'49Y,P.68(S^X>([->9M,
M,\,K :BL<J.P'09Y*Q.69 S^Z.'MU8V*26:\;C+-'FC5AF,QFK,",P01]PY\
M1RQ3#5#)'*H.DM&ZN >ARS4D9Y$'+[HXFQ2A YCELJ''B%5Y-)!*E6,2N%8$
M'-"0P]L=1Q#/#80202+(A]M3GD<@VEAXJP!&:, RY]0.)L3H5VTRV8PV;*53
M5*RE.C!Q$'*$'ID^G/KEX'*7$:4*1R2V%5951XQDQ=DD!*OM*ID"D ]XJ #W
M20W3B*6.>-)8G#QN,U8>W_V@@]&4Y%2"K $$<38I0@<QRV5#CQ"J\FD@E2K&
M)7"L"#FA(8>V.HXKVJ]I==>59 /'+HR]2!K1LG3/2=.I1J S&8Z\,P4%F(55
M!9F8Y!0.I))Z  =23X<-C.&JQ4VAFI(.F.9ATZ=&6,JP]QE)!\02..W4OMRK
M\8B_R_0FQ2A YCELJ''B%5Y-)!*E6,2N%8$'-"0P]L=1Q#/#80202+(A]M3G
MD<@VEAXJP!&:, RY]0/LGS-[!W?@WRN#T>6?8.E\)^5S^AS'^?HOP5/\;/P^
M*N%.WAF),_3)7KF-3UZYNNX1TS([AS/3IGF*&&3S6CB.( HYD$T4.9U:^C(6
M[S,D<7=6.%CK[H5PJ)IDQV*-\/ED9 7A,9B;ZY-<L:-D?<93U4]#DIRS52,,
MP^"?# SJ&EGCGC6251+V?*29$V%;Z6%8F4A2I:1F);UNF.#S)A]J3<,[9ZU[
MI5=;:(HP8]TC+609'4J[)TZZ$XP5Z<,!L36J_:[#.9&EF03*NO+0=<FKOLNZ
MS9*7U+JU:%/&-3P+8JVZ4T7:/5-R6"1'/<VQ'N!25]:SIWAWT[C:D4 =KK[4
M,TDL<*SQK)&)G2-B&56]MLB5##5I)RS\>.W4OMRK\8B_R^,1A:Y0FCKE7:58
MWC.H:7"NDHTMZWOJO<.>DDC-@O48/6L5:FU9Z-NNRIKU[:$*-/0E1FP>3)"1
MW\SWBP',K#537,:@)V*Y]X!MD*2/$!BK 'V]+9>!XK'8H5VFSC$-.(RZE.:;
M<*E\URU9KD<URSS&66?&!*]J]/=G;<>-?7,3JW9LU4@#)=(B61-/K4!0(O0:
M>(B,/QYHU^ERR[15$4 +:"R1QA<\E6*1X\RI!TIT&1T<8Y1LW!6-=!(8C*&7
M6J-ZIMY,-952!MD'O9]5R!&9$"ND$*2MKD2*-9'S+:G5 &;4W>.;9G,]3XGK
MQ9]4YA7;[^5JIGH[V6TL.[GEG]+T-K_H-+:LLCQS!8,51(DD*/8D*L!]?"JG
M<&K+H-31!AF"P)7JFL<8/7[/A\'AJF':'().>[D4\? B+;5@!EFI\?7'%H1/
MA]D'(&.,S*Q75D8?5.[X:2ZAH]0\ Y\1F#R[8W*LD!S)KR9KT  CFS8*".I.
MXLK'4.FI0"1T7T W:\8S4DQ8;"RY@QZ>U6,U8=,W8;6:L.FB6$@Y?7\PPF*>
MO<CS4L-!9%TZ98CJC<R+_GC*<D\& AZ$@=VK86U7BL)T$BYY=>ZP[KIF0N>A
MPRZL@&RS'0CT,0B\U8E#;@0")SN*BY*.G<L0C/7I#*V8;0 F[IC'J?&'J;D[
MXK+X-K@I(53N5U<C<.1=MUFUH>\,O5<LXW0+Z&-^QEG_ (GY1%QA-JS6I3M%
M2[1"DLDLDO:8XM&F*,L-#*S-I50V8\<\@,QPA?F";)YUK009-V5"7F;UH:3,
MJB-GFR"3O;/=4P^J%I*]>.K#'!%GHC&0U'-CF2S,3[K,2QR  SR4 9 8G-':
MQ.O1FD$56 AYR[:$=S'NY%MQ1D8],2/W71Y),M68S>?#)(37>Q2,)4)M[\(4
M*/6A0'&G3D-!7(H0"N1 XY<LL3-49F*JHFB'32@U:90#ZX:F>,A1W<];=&8Z
ML)O1K=N->(BL3GH\O=$>@ON0%Y#JB'K J,<O4@A.I4!MT$M34[<&T'CL13/(
M,LIX!H;/4B,9& 1-G-@FDMUZCC'[1@JK F8:T64L.F44>DR#,,#FY9%RR96C
M,@.68XJ28;3@2".W3[H&MA/$-R3(:Y&]48YL1X:CI&2#NJ!Q#8BJXX5JL.R6
M)(XRD!5XF,L:Z<NND!+#Y]P^IKK1!IS0\QQ1]GAGT#=$RQ:_KMMDE<H?=&I0
M1GGI[VG+4V<6%06,,B7H)IX:\AM2()I5[L3:5)*E8U11"B*RA8_=.HM+@Z^;
M.R@[L\6Y)#*00=PMJT(&E*QK(H$;+JV]7JS*7&?'+EA&@EK=!)')N 9(NJ-P
MHSZ=]RKJ0S,#I#1+JRTJN(Q1W;5.D4#%2;<[?7)67N: >Z<K,F2';?4FA7*$
M $8]9[-4CK1#1VC-.Z-*I!$%U(NEETZM2)ITE#%N*0.G%23#:<"01VZ?= UL
M)XAN29#7(WJC'-B/#4=(R0=U0.(;$57'"M5AV2Q)'&4@*O$QEC73EUT@)8?/
MN'U-=:(-.:&]:VL<A:T#V:N%V^Z6'JD9.^%.88I.>KQC/*!0 TD?%N"OB=61
M8WAE8!EBF5D?;E[KY;BB0H&(02A>\8S][BM&8:]>%LBT4,4;%? E$53EF <L
MQTS ^]]3OS59O<U6,)>K E:&>Y1B=6D,X-'>)FD8G;<2M#)E$L4>V)$&Y(8F
M:;T,&Y>P>*TV,)3RQ$6;#BQVBT>]8B(F.T9C!WQ/+TVLEU=W+)<N.9O]!?"?
M_H<4?SC3_!:_^*3T<%L=GM2/LV)\Z[+HK1[KC.2(ZBN8[O3(GW2H]OB];NW8
MS4J8?<C$PR>6=#!T&;.@ZB-0X !9Y>^&>/;S8'C#,.7#X2-6N:729G&>G-<]
M*(/Z%-3=XC4Y)8Y#2B<7/T0I^%4?^K7]&]^<;GX+8_Q3\<M*-5QLAJ @4-EW
M@&WBP!\0&*J2/;TKGX#T&4,"K ,K JRL,PP/0@@]"".A!\>,>L]FJ1UHAH[1
MFG=&E4@B"ZD72RZ=6I$TZ2ABW%('3C#JB4ZL2: LIC4SG)-;2'-F5G0=\1L[
M+'U;)<@"?$XOGAUV"[5(C><2;J =R0H4+F0:LF$H==0 7OINAMTZA>K)B= .
MB>J-$L]8L '4LJOMYZPHW5]3;-B@.3G,HO'+EA&@EK=!)')N 9(NJ-PHSZ=]
MRKJ0S,#I#1+JRTJN(Q1W;5.D4#%2;<[?7)67N: >Z<K,F2';?4FA7*$ $8]9
M[-4CK1#1VC-.Z-*I!$%U(NEETZM2)ITE#%N*0.G%23#:<"01VZ?= UL)XAN2
M9#7(WJC'-B/#4=(R0=U0.(;$57'"M5AV2Q)'&4@*O$QEC73EUT@)8?/N'U-=
M:(-.:'F.*/L\,^@;HF6+7]=MLDKE#[HU*",\]/>TY:FSBPJ"QAD2]!-/#7D-
MJ1!-*O=B;2I)4K&J*(4164+'[IU%FPZ6'"9:->0O*02&+-'KSE#M&H+N(P\>
M<>D,(V)+/EK<\8/6GJ5-NPJHYE=PJZ"0I"@:V3HS$@D'4Y"%%U#3H6F8XL?9
M*KJ8)=P=S;9"K0=H*(4&D*DR@+IR*A-!)[V?,<DJP01KGM22,96&KQ0*8XV(
M.G)LW?2P.9B#+ZP\443S?530NAJL6I-(TMN1@R:ERR.LLQ?/UQ))SS/& Q0R
M3VHI8(K*!583-'K12KE0%W8\QO!BPST-E%U3H=./VC!56!,PUHLI8=,HH])D
M&88'-RR+EDRM&9 <LQQ4DPVG D$=NGW0-;">(;DF0UR-ZHQS8CPU'2,D'=4#
MB&Q%5QPK58=DL21QE("KQ,98UTY==("6'S[A]376B#3FA^R6.UI[F%6JU9-R
M:38T)J1,]%B)V[SLJC)58]6'AD.N0X]+.-_:7XS4^?X]+.-_:7XS4^?XP*M/
M3PJK6LIMS1[^M-2/EKL3.O>1F4YJRGHQ\<CUS'H<Q_GZ+\%3_&S^CC?L99_X
MGY1%Q@GL96_X[Y1+QC*EL-M!06.4;9 9]%FC9CT]I5!9C[0!)Z#C",/P^Y3$
MDM<M*DCQR,9)5U$'6ND)*!D(W1?!>H/3VRV#84H+-7"JH+,S3S@*!U)),N0
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M+CYC9'%10P\8X'A]=T6>G=T/.9N. &>F-)$[I(Z]]JM4O3.%#@REFRW[AOS
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M="(/CL;O44RA!@@C<?(<LNOT6QUO:?\ Y%L:-2HV*H5&0R74='GSEL^(L %
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MJTQGC7Q&?B$FRUJ;'"K23T-U[Q8UZ0RQCQ GXP"+*P82I!'1]<CT=AJB)W3
M?&?(,XZ;"O2.6,>,$?&0!V36I#V8\4MYIMMJ43C'QSY-?BL65>Z8#K('GMMZ
M7A_$WHL2%U('68MMZ7A_$WHM(C%.43/1K-C6I#V8\4MYIL*B,,08808).7GC
MC9:M-S"M)ZB/..PU:FI@L)Z)/F!SZ++5IODK GAF/),3XNS4[V_N&\QM3[XG
MNU\X[##"S+P)'D,6I.!23$P&1 D@=R8^(1;;TO"^2WHLU1$[I@/C/D&<=-E9
M7$J9%B0,R0!Q.5MO2\+Y+>BRL&$J01T?7(]'\1ZZH8'.;A( &<<YMWUF+-5J
M():C ]V#YA9+PKD @J3QTZIXGJ'#A-GJI3[HY\!K]>N.BRU:CB5HR/=@><66
M\J3# H9C/0=>A&>6F6_L/46GW1SX#7R<.G]MA5J$8A1D1.513\43/1KNLMZ4
M]TI7JYWET^*>P2%!), 6[8Q-AIH7\>']FG7'"+&N4(#TRL\&#>@?'9'#C$NG
MFZ#T_73^)7)=FCN:61ZR8/3KEPYL[[4&PU!_*YOET^./%/8(# @B0;5$P.5\
MG2-W#Q],VN]3$N$ZH/*-WDT/BSSM4?9J6WZ#KW>+CZ;4:> 2W=MW1U\4^?B=
MYRL2!F2 .)RMMZ7A_$WHL*B$@!@2V@'5.?#QQ^,=3O;^X;S&R=VL"3B6!I.>
MEGJU5^\D93,X@.O"/VCC:[=PWNSYELRJW= 'KZ>'#Q6JT]FT:@Y@_LZQZ#E,
M6I54%,AH&'49<^>C>=Q\1)UBE1]G442<PD9+/$>8;NO2\4UP8@ I4C01,F(R
M\O\ C:B,5109@S,9;CEU'0]%JM!0A9!!7/69&_4[M?BM2J;-P?8G)NKCXM>.
M[?:M4V:Y=TVG1Q/BR\N^U!0]3G9P"V>\R->.OCWVK(&IMQ4%@>K,^73X]UJ-
M0HP'L6(F=!_*Z(W\1XB+RQ"@"88YG]GC_8=TVN[HA;%E,0?.)W3ET99VJTUJ
M(66"VH(]E&HRF=,NG+C94#4T#J#" 9C,9">D'L$!M0#UB;.(=@- S >(V3O:
M>X7YHM>%"N,( E0<NLC]EJ5/'3;,F"V%=!BPZGCNCAXS90V, 9-B\A!W]6_*
MUXJGO:\.<>OV/5&O&8XS=0,+-&>*)Z(!BU<15>.,^4 GXS:B^.F)U'-/3&_R
M1/3/8J=[?W#>8V0PZDZ!E)\1L]Y0=S+&,LH'CF#\7CLE&HQ[DJ-Y81\1U\7C
MBVS3"%*@@"!($])Z"=21&>?8KTL(#9L23C8^*,MPUCAI.EKM(QL<D SZQGPW
M"9ZQE:I4-0R=-PX?V\3^R!9U44F6,@I@=68^//IWVIO@<-Y>D;^'BZ8L65=6
M4=9 MM*?AI\(>FP(.8((XC.QI5,1&%B9U@P<]9.X\39^X?W+>8]B2M/$W=!)
M/6!)TRUL26)),DV @ #0"!XK7D14ZU!/QCS 6NSEE*GV,1U'=XH_9NM71S4)
M 9@0(@$QT=&<GQVH@K34$0<\NLDVJ=\?W3>>UVG9YZ2</5__ -3KYK7ER7P[
MEC+B2)GXX_QM=1S&.\M'D CSFUX$TCT$$>6/,3:BY6HO!B%(Z\AY-?BW]EVP
M(S<!EU[OCM17UKG2=I+-)UQ=/2(/&S*5)4Z@Q]>@[K4GQHIWQ!ZQKIY>HCL5
MZ>-<NZ62.GB.L[NJ-]D<TV##QCB.'UWQ9?7:NT]@F2]+<8^.<CW/ ]B\L2^'
M,* (Z9W_ +-^AXFU"I3"!20I$S.4YZSH<H''+A:I2AZ;HOLUQ =8S@#(<?%T
M_C'4[V_N&\QM3[XGNU\X[%--F&TC$S#/1<M9X1GY[4ZFT!,1#$>;/X],^NU>
M"F$]T2, F.=IY,\YRZ08-N=3?3G*=#G]>@CK!WV1PZAAX^@[QXO[;7CO3^]^
M<+7?OJ>^^:;5.]O[AO,>Q>_O?OOW;77OA]P?.MJG>W]PWF/8J*KC 3!,E>L>
M?73A/"0]WJ+H,0XCT:SU3UV!9#D2I'U@_M!M3;&BMQ'QC(^*=.S4[X_NV\YM
M3[VGN%\PM>N^#W \[6NO>S[L^9>Q>.^O[WYHM0I(Z$L).(C4C<.!ML*7@_*;
MTV5%00H@3.\^?L5.]O[AO,;4^^)[M?./XU3O;^X;S'L;"EX/RF]-MA2\'Y3>
MFU6AM&#8HRC2=Y/$<;=J?[SY/_VM37 @69B<]-239ZBIKF3$*,V,\!]?+9EK
M5M8IIES=3UG+/J,::3G:G=U0XB<1&F4 >+//Q^*<[/W#^Y;S'LWKO@]P/.UK
MJ.[.>X=!_M'Q3TV9@HEB .GZYGHL6JU1ZV,"^$V1.6[6-=1XB-++=1[)IZ!E
MGU\/$#U=B\=];ICYHM=>]GW9\RVO'>G][\X602ZC/-AIJ,]1U:]'9K<]TH].
M)NC(Y=<3J/!ML?\ >UOA_P!EJ]/!#2S8M2V>8Z>D:#H\EV>"4._,=>_RCS=/
M9?NW]TWG-KOWI/??./8JTUJDPT.F1\D@'RZCIUC)J51-5,9YC,9;\M!UQ:G4
M-,C,X9S'GRX\#^S\8ZKM#(M-R2(G"<,$9Q&IW=?5F$J @A'D&1S3N\5A6.^E
M5!Z%GX\O-:K4J."JTZ@'&#)&\1&7ETZ[(32I+ZVY8EB0 >,9\,HC+./':D6-
M0M41\1[EB#A49Y9Z=><SUS>%Q-S4?$-2%R;++,;QIIX\A:D:M,]PY4ZC"?*.
MGS^0BL9HL<Q(4P=1SAKTVI'#44P6UR&NATZM;5*\@HJN&.4$<>C,R1EXYM0H
M&<;R(/-70R-YZ. W]6M1!47">L'@?VV4/0?$RG#H2,P03QW9P8,'=E-JM4.I
M2GB8G7"&R&_=OT\_31H$$._6%WST\(U&^>$1:\8L5+!.+GD1T $]>6[?I85Q
M V@:F>E6@^Y_MTG?9P:SRBG#$8CD#!C%^R,S TW!%P*%&X?XGQFU6F59C!PS
M((&0G=P$'+_&U.K4*JJTYB%QF<.7'Q=/4-UFIU,3<UFYQSPG//7QVIFH% :F
M0%34$28T&'68^/A:MCJ-(IU  (S4])_;:BS4U*M2J:SDIX ;XX=BM1VF8[H#
MRCAT'@?+Q -2B=")R@C(QYXX@_$;;:JXYE(B?9',;]Y $]9Z(M2I[,9DEB98
MSOZ/3J=^X"U5VAD6FY)$3A.&",XC4[NOJS"5%(.!LB#W+;K(^/V#+$=T(\G&
M/%V'?![!FF>Y$^7A/CMLZG@/\$^BR5,66!URGG"!U [_ "=BK=RIE 2O#4CH
MXD</CXFG7=.85Q1D!F&!X;_)$^:WKM?)@:=.<^)TRSUZ,@.LC^(5JL22CDG^
M2?1;9U/ ?X)]%MG4\!_@GT6H BDH((.>1R]D;5;NTEDS&N'>.H;QPC/=&^RW
MC",-0,&4<-=..<QF9ZYSBQ2K7;%A@'29@#=''Q#4SE-D04U"CQGB>/UW1:N*
MC5#S6*B,, QH)^/ZY6V=3P'^"?1;9U/ ?X)]%KLK+CQ*1W.H(\+C:M2VD$0&
M''>.!WY;O'QFU-GH$AU;"?/&[V)G?GNZ(M5J&MS*:L1.9X\.I=_.^*+4:.#G
M-&*,AP_MW9=.9GL.^#V#-,]R)\O"?'9&J"H:C4W.(084B--,MP'I-E.(3!'0
MP@^2U9BRE!2J$SKARR.HUUTW9&RK54A@CR#/<M]8.^R$LH)4J3N.[/J%G?#'
M-=I\$3'79DJ,S-LWS)/<G>9X6HNRJJ-3J:Q.$QF3K,0!/3V&-1:[L@+#F!@-
M\KEYC!W>.#MZ8UQ*?!*G%Z,]V=DHL[R5P)B)@Y93.$#(]$Y#QY?C7>"!3(G-
MH@<8()M0(%522 ,\SE[$_P UIH4B22N9,G-M_CML*7@_*;TV5%00H@3.\^?_
M /".\@L@@$\X:"=S6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/
M?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X
M)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]
M%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%M
MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4
M\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!
M_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@
MGT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT
M6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V
M=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3
MP'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'
M^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"
M?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1
M;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9
MU/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/
M ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?
MX)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)
M]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%
MMG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG
M4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\
M!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_
M@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@G
MT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6
MV=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=
M3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P
M'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^
M"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?1;9U/ ?X)]%MG4\!_@GT6V=3P'^"?
M1;9U/ ?X)]%MG4\!_@GT6NP*H9!'..HC<O\ ^C#DVZ<FWS!1JU;TE[;%S5P;
M)XQMZV=E4(PTU!;:%9;N)W5>0>3:%-ZM6\7E*:"68O2R_P#@DDG)5$EB0J@D
M@6O/:N,=J=L;/")[9V>/'+3&RYN'#AC?.+='8Y-N?)E\%.E5KWE+XQ<;-<(1
ML.)PR-L7 &S&>-P<2M C#-ZY%Y.NE![Q4J7TI3PR$:@6YSJ@@-24:L)S&5J/
M)O)=^A+E?+PM;#M76M2QX4R# PE%<09U$K5<:P&'.%^Y#KW2F:U-Q>*2":D(
M4J)K+8)<&FHC$P>1))0(K/:\<B\EW6GM:]YO--)"R7IF2= JK=RS'4PH, %C
MD"1<>3N2^4-KL6Y0798,6U-W$X\<1A1_ ,S&[6U\Y-Y*N+417J7Z*Y8!D-!@
MF#!B9_6@T#&#S%<Y&!, GDGDVI<Z][NMXO%44Z59EEDC'20MA=305QH#!PDJ
M0PR8'L7%.3W:H+_5K41"FFU(2#KB5O6ZK3W)6% R?$9P@_Y.7+VV]?#I?_PM
M3NW(UYBG2O5\H5ZE1:=);Q36I)8J!E13##3A$UD@\YAA'.K>INLJ%J%X6LX^
M]M3V4B"85L=08B8 #85SDNL9LI5BK JRDJRL(92,B"#F"#D0=/XO(W)-*O36
M^7D%AM#L:7-V;A)4M4U+#:2!3.#O?.%1'BU:]W&\\FWT4Z-VN]85DV=-4ITZ
ME2F*PV50*!G46DU1*@1GP\\\U*H6W)7)PY0K.*C,M&DLNR8<19I%-!BF)AF+
M8&$)A,%E-A6Y-N]_>XM=KK12G=U45ZE- 2[)SZ;5&Q8EJ4' +5&4LPJ(VTVB
MVY?I7.DU 7<4J=88UJTZ*H %A&0U%5A@;G<SUN:BL9>*:@_8.2[D+]>MB[%:
M:TWJ5"IAX$*,$JXG&Z3([G%G,6Y6Y*2X"E5HM4>DY--]H4++4S9<U"2'4-E@
MYN RW/4"W(M>[U*B7*O<KM4+!]G6-%&J2,=5A6+SB&&0A6,.%5*L#B3EZA0H
MW%-C1I4L5ZIXME32GBBE>(G"!,28G23Q^SW'DF]7Z'4"E0)C;/O@@-LT'.<B
M3'<TR59#45A:\7;D:Z-LJE>^UZR\VKVOL<*N )[XH DD\U:E0H04<AAG1Y,N
M%_4]H7NJE9%9FH7I5+:PF=,* LCGLFWPATD*W-;E2Y)<*]*BCL\W=*CLT9N7
MJ*V$ <U>9(4EB-['[%ZGJ-T?:NX5[VC HCP<%(8"M6FI$8MID7$LD(!@Q^N>
MJ"A=J+W;84Z5)V6IM%I!4YH*;-C36 ))J /AEH(DX !_%Y(O-WKU:=SKW"YD
MFGAIU5NZ8R:2%F-;'BQ%U4G&L<_52'E.7J%"C<4V-&E2Q7JGBV5-*>**5XB<
M($Q)B=)/'L7<4#6IB]-46@3%1J48UD&&$AL@T%H5CAG""T"U'D/DV\4EK4:]
MZ>F\X6Q(LX6*G)KN&[I2,Q\5JMSY%N]YJ7:O7OU-J84ESLFIG$J.%79T7>8?
M>@&1STD>I^G7I[:ZWX/3<,U'%2UUPJ[AY!!YM0[(%2&];!&"UYNU:Z5FHUEA
MES!'<NNYT.6)3Y095@K!E'XN<B?Z3NWY[^CU;<M_Z,O/YG^D4NSR)_I.[?GO
MZ/5MRW_HR\_F?Z12MR5M?X0NFR[K:B>Y[U!V_=9=YVG\KP.=%N4&"W&^%B%'
M:U99)C-J;*HSWLQ"J-Y( S-N5;^+_75Z8J+2ITPB+4.\DL[X 2J$R%,%L0IJ
M2?8KZF?]=_Z;_P!]O5-_J7_4_P#HM<K]VM2OE!S4-*\7:LBHL$"NZA$J'$1A
M&&0Y7,\V5;"N'LHC5'2F@EZC*B"0)9CA428 DG4D#C9W2FI>HZTT$2[L%428
M$LQ $D@#I,6*K?;[7*U:5W6M5K54:\L::PSEPK,HJ*K83O.&1A#%BH9?4T8&
M*^ - Q!:&( [P&-92P!T)59UPC2UVN_;#E-M=Z$*6QWFILD,%1A#0>=G(' ,
M=UO\F?\ C?\ QO[^UVNO;./_ #FZW?!A^V:VRQXL7<<UL6'#SN$KQM=%P76[
M)B5\%WHKC0XD;#348D;>IU4[QG;^"_\ _1Y*_2_[NW(MW[7NM1-M=Z\WAFQW
M:IM4$TZ0PEH'.RDC@5.^W*EPVU^KU>W>3Z6+9>MU[SLZJQ1IKSEP&)B1GFI!
MWVN]WK7JILJ%,U'@M @0!J69B%4:"6(DD*,R :G)%"[FE3O?*5*A6JZ(M%ZB
M@8L(8U,285/AU%IK(< D(S6OO(=YNB/65EKT4@DJ&6J%CG.U/,!5.N&HY"\\
M@+BPW*Y]N/@[8N]#G4U]>>'?:$CUE/OK".YQ+)91/.D5?4X:=*I46]&HR4W=
M::W;G5"JDA!%9C+$81 .NAM=_4[>*BXKQ56[G<@7;-J0<>%U0: KA=Y!SPD1
M:]W6K<ZS4*T8@%8,N+ X83*%E4L 94F.Z5AN[/)]1.3+K=*CP*G*-Y J;3'3
MP75<2"IB)P (72MB(7:4ZI&@%1>4+L+W=*U'#B?"7I=R#MD$TX9\EQ'F,<N8
MS#$)GL<B?Z3NWY[^CU;<LW:M>[O0HT5Q,UZ0DGN4795I=S[%1Y28506*J?\
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M( U+,Q"J-!+$22%&9 -3DBA=S2IWOE*E0K5=$6B]10,6$,:F),*GPZBTUD.
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M+O5\H/7H;-@E39[,OAJ,0$)PX@*< .#SJBZ&!,3>+K>+JV"\4FIDZ3FK9 G
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M@7XTYP\7FML+EX/RJOIMVE=CGM&$YQC7+HS4G+ISXV/)HDQ6RW2DF.DXQ/7
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M! &I9F(51H)8B20HS(!JTJE"H]*JA2HAAE.[]A!&:L)# AE)!!_BW'[>N?\
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MY=?8[5O7^S5_^S4^C9Z56G&TIU*<S&-&68UC$!,2)Z[*K.P5%9V.BJ"S&,S
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M^$Y8!IF)@L-68)]Q<I?>?SG[GXDT._4?RM/YX_ O*/>5_*CYC_=ER^UJ?O\
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M3<ZHB'#GB8#( '4GV(DF#D#GJ)M4O&(&E=4+F,&-)"4YYH@@ : PTA!D02)
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M 3EP^O1:\($?FY B8\9TZ,OJ+4$"H:K '(D=&&9URF1EPXYFQJU"2<;"=P)
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MID*?=;NO>)F=. )HU 8PD](S'EW>..FP/:]*#&T/.P]<#=N \I!@VI4]HT3
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MKKY=VMJJ[9@U,JW-B)ALB<X,99VITL!QU2% S Q9DB,\M1T S,91K5J;1IT
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MR<XX:#2>LVKAV;"J-@4"(!C37(;M.B.FU!6*NE13AR@,"-9F/B/0<];8&E@
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MZ9^%SOVVI":B>Z!^#G^RUZ.:#@"?+_\ \]A5+$*-28^O0-]GK.K%4.%4YH$
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MN'3%KKWP^X/G6U3OC^[;SFU*GM&B8$2>KHZ<_KI:H^%BE(!0,B1W1SD\X\Z
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M!F64#8,$2[-C=WXQH3*C.J6K\&7;,6)3IMD<F=0YEQ#AE6(!"WD,64C3)%>
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M+7D];BSU3985KU"VADC"L\4R;LJY1PB5B.6)M0D=(+0#+DK)JD5.:4;HH[.
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M<XE'.<9^Y?8+)XL'"+V"YW\RG(H6U0SS%8LH0Q-%-CGKD\0W17"E%/?*:\_
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M]&AC&UC,#@GAB*<6$8R>8(Q\!>OKUQN7[@X-P@W W8*(<TQ=PQQ3!-@C$P&
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M:F*3(OC,'4[@4(B8F!I?RBWK='R-)8+@3)AMC+,+&R2&"#S.U":.TP3@G X
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M1\L89BN2V=L[HP^7N!;X5M<SOY8B^3K8E8!X8R'+X%MGD.+?+XF<EO EUQ#
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M=_;!901FUV6^WZG792!F06O&G?Z7^HK/[K=>X/F4>6.FT+?,?*LR*03CWBE
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M?K+1/(?,%5S-JY@09(9$-C'$RD?'&2&<L+ ,"1:2P1O81&//!/'E+Y#2-LG
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M]T;<J)D1$O-5*CB6R_62FUW+D)CGL) (N#&-\N??C.T<O%/_ +Q/*?*?,/\
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M3>'(9[PRD&77</.8[?$'Z9T9\9&*;"F9CP_7R+DD<!L%8SG-8F\)HPSGJ%C
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M3>'(9[PRD&77</.8[?$'Z9T9\9&*;"F9CP_7R+DD<!L%8SG-8F\)HPSGJ%C
MI%4*=?,#2J].4ZA-4W3SW;-HU# ,RK0C(0;4CEEU7P\#(BRD@<JL0! =BR<K
M08"0_P"Y&8M;_5>%RD :%2O: Q3JF KA6)5$6$&8!).'),D\9S*1#L2ZXP7,
M?'SEJ;_3*O[&\"77UUZ2 +@' ( !U/$00A%'$!"$*%?B QCAC$(0AC$81QB,
M<8QCP1RPOM8/-FV<K3EH@RR7CA$4.0YJB9)[!P@.&Z6=L(1ACX,<8\5FF07^
MJT*RM':!S"OM *RLPV[&6&!6T8(=NX.&9E$"'!",0F+">"<DL^/G+4W^F5?V
M-X"Q57^J\KB(<TZEBT!FG:,=7*LBMHKH+0,2$..8YYSB42 7EUS@6(_=3_WP
M:FHNS[CU<M?+.Z[C@_#/B#<W#P_)_P![Q\I_O[_>^<M3?Z95_8WB3%5J/6M8
MQ,>0S/7W"29I!E*$Y"D5>J'/(\S&.>89SMS*$)=.L<=/N.T5@1D*CW;\I$YB
M&S'MFP.0XYF"P/'4B\,3W!GUAF6,;9=)8A$5>S3DAV\>XJG"0G,2RW;1%,3N
M'E,\D8P*PQA;#C#,.X,S,AF9&_X7M3?^;:?])O&&UTB6;\"<@'KF8G#*YC(!
M!=J* %T@$ 9?!@-P5[\<IEC%KBEQX&GYQ>TO&S!GNM/V'EKA-@C"[<A^(VY:
M7-R3%MQU*(,]WP.F?G+4W^F5?V-XLK->[U#FL"BXRZG8.#9K Q'$##-E%!)
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MK3EH@RR7CA$4.0YJB9)[!P@.&Z6=L(1ACX,<8\1L:FYU-_'W")[%7RY[XA@
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MKZ<BQ%C<3 <O*+0,2$.I<A%*9N&!3;.()9P\3K['4*T&Q;L&$L!VQX)P*0)
M,3KEFA@9$04XE5-.#(O@Y(*,9PS+*=->+,MXZ;52C919-\ Q<]J"P J1SC&
MI#]K$W;PCB9^.,X9E]S5OYLWWU6UXTE^<U#]:*^"KL"&=<XYA. T(E"8)8Y@
M4113QF!!DAG,)PGC,9QSF,L9QGQ;5/-W'E=F_7=QQ\7/V315N;BWDX^3CW\?
M(39UV[Y=-V=*&U#=UB!"K/)JRL7$:[F6J;%BO ,."R!$O:J"4$2<<2G^\F>4
MB%S.?K%^J+W[,\#Q>W"R)#;,C6Z%9<E G-L/V28V&\+9DN:'=9#A;!8<62\D
MHQS&SI'AOI9(0/+")!R&86?AB, \!, )C&8DQ XARD$@CPQD)A3D1RP;614#
MLY6G#B66%R3B*'(<TH#AO). X;I8W3G&&/A2QCQZQ?JB]^S/$+"G?6L5)[<<
MJQ,3XYR$,W Q#^$69@,PI%58@)D.^."BA+WOV ZI3CO+HI.'M%[!)1!$V&XJ
MS%<6YYR7K"1SSYE"8RR7R#]L,(@*)C,K.X]&9%4($&(C$-5H.1%(N=H\FPC7
MLS".<^@L&+& >:8@[^4PH33JF5F:2U<WP%!D@3UQ6>7:NFO81R$DV61[9"BP
MBK"9]R8B%/);#/@>+=DDW3CYEZQ(7</G#S1#DNV4A+@'C.9RC-QA:)\+LP5R
M<P9B\1LZ?T9D:0F0@AL3U6@G$LA9VDR'#U>M,PX3ZBR849AYH%#OY0EA"-5J
M"J>TP_EXB4\LD&P@G*&-G[9,%@@TD3NL$6-&=?(*N<0*TR(7/)?QRV[>YF7#
MD-4GD)K5B!IDA@XU)F#M6CPGS-H\PK=0R#$LF9" 0=W7^C3OJTRTVQ'3UE4L
MS*(>)9G$:H4IMS9A*$Q32B#+D6825R#N(Y%XXKJD>J(2(O 3"K [8,(DE*)S
M-XX:]@0U\;)]%0/F+')-HL3A"!A,+E&=<XX& <,XE"8)8XF(HBPSF!!DAG$X
M3AG,9QSB4<YQGPU9V;0TT$QY*PP7.=L(]<1QC&(XS,A"3S$00BC,QS3@$,)E
MG"&<TVB])/:ES$9B=P6P#31E%<DXS8Q@ZS, HSAP9"P^9$TS,04DH-C(H%36
MU?H-ZF7<&4L&%+I*WE.(\2CT7P)=9(Q(&X8L!E8A,N$XV)0S@@('!<4Y^98W
MP)PGTBRHS'$<E3<%B4N%D.Z.Z.Z4)PD-A<AEC!,3[M\9#C\@]'0UTFR3EB$I
MVEK8!1:X1R6&UDF6A]KF,I%2B&F*V)F,G0B8K=P^0-UTT^?;#>4?F3"_:D%U
M,&,=M@%/N)SY>B>6>,,S<73PU66:HW$'!Y$PN7&=LX]<2QG&8YQ,9!SQ$H3"
ME P#0@8,X%A">+&EG@F5Q$YJXY-V<M5A^LTR\N0+0,2$/DS<P"P"+X&@BSG
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MF!!DAG,)PGC,9QSF,L9QGPL*H06K0MT2;AETQX MEGO+!3)!KPZ!!N"H#$X
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M;'&0=9@>30A:X,5B<"JJSR8%=.\E.BU#;3S<6>9VH=//##9RRZ;=8"&NO->
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M-2/9XF1YAR0BC6!Y@3_@V5I$$2(F5YD7-LSD1)Q]_P 0IZ!=G4MLPR!)2*Q
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MQ\K#!>NV$>N(XQC$<9F0A)YB,(1QF8YIP"&$RSA#+:6BM(NZC B/>P\>R6I
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MG_Z5^I++[NH/Z*^NZWQ3^0^6^;?MAVOF_<^7_-;W/W'9_*?P;FXN/_L_'O\
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MJS8!,KDV3B2'($T9CGL)"!([HYVSC&6/A8QGQZJZ;^@ZSV7P)A?35  X"0,
MX::N$8)A2Q,91$@OB8R#GC$X3AG$HRQB4<XSC[DV,"'@Y1B"0^(1P8@02-,
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MR9F""F&3Y%!D4?$WKAP8,8&2:ZN)CR\_(61QR%!64XS8)O,&,\XZ!!@L2M%
M#$RQ5;X&5>Z6 SVS@N!M?G%$G T'K+A9#NXSBW2XRQE'KGIU\:5_.2C^LU?V
M&E_1TN0<P,NAM=2C[@PHE13@1V-40B1^6)#)KLMR7."&>:=*T%D.-Q8>$]1!
M!U;J&8+-FCV\/VK=EF$<GS*.&#\%CE:"HQDS@/?N$R',9D*(E6R?B4U MA:&
M,]O$6;1:>2U^2F+*!(;QS>3 ,,I98;<6%D,Y;)BU!_17UW6^+'\VV_K.G\.K
MDB3,[5VM07S#$<Q@8;4;/,C;IQS$?!7'AC,,$ES2%'9LS,D/.(YV*:?6,0TN
MD)<C%DLR@LMTR6!(;QS;9YHC-"/9\),0DP.?C4 VX=.]LF[58F(EP(REF<C8
M9BD08^3CY)+'D/$A0;79#$D^+,LZ7,L3D'"DKU)2VSAT8KP00;'T)&,OBFUC
M"W8QLGLWCE,<HSSJ*8"C-#!$ YF*<21P9>J078%F4,YQ@@#B( T/WPC#F.>,
M3C+&*U5@';ON\EI8PSW&)X8=Z9# PF8PDNRNA!)1D$1P@-A<G[^69&(GJY,/
M_<5USQC_ /Z^7/EXE_\ QJ]AIIG_ .*% 0^_XK=#L8[C325D34UC#),YGE=*
M&,AK3"9--1BD8N)I%9KHI3F1A@C6^&<2,/P]4/PV-U[)%B](EC FS/P#AYAB
M))9D>QA8LAPYER#+C&V>/"UA7LK2-)9<CZ V,&8K&#8GB:S,,P":.TP3C"8@
M P<@'+"^)!E&7BMH>4C]S9NC3C6UD1MM)1F.)INV0L%CE)( "08),GQV5LR8
M  P L3%XM*8_'B%BDPK@A019BN8@\]NW@$Y0Q,B9^-H/PQRB84)0(.>(SC #
M<.TM*QD#R3,8Q,N;A-RIOJ9,/C96D076/(+WIP(LT$9Q'!!:PKV5I&DLN1]
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M(RE<JCS.<9C)MAF;J8.@VA%Y&6 A\QYF99>[5JP-#Y)=+)LI%C$NS/:)KU[
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MZ@;%[^8,X@M5Y+%B)0EQ7BWDGL'"(2 <><48Q(V2K;9P@*PLV'[^![%UI\\
MM5T0Q,X>;!(BC.J)/ \3)G$,3).6(]-TY9]_Q.LHV[_3("NB?-.BO; )B&$
MR^W<Z5Z$!E@6.6,!&.3$ED^6<L*AQ'YQU)_I=9]C^&5U]4:Q. ]2:G !NZB4
M-:$L1P&S5C@F*";J<!8@D:&,Q7CF48CSC/O$;?O-6NMEV\K+=FBRP39"(X<A
MC54R3V#A <=TL[81C''P<8QX7G6:DUB  '1/SKXW !5S9A2%F475%Z\,#C/
M(P,8STD4&./?C&,=)5MTD-Y/)!FXYR(.4#"S\ H3@F(X"8QF4,S"6$I!(4,L
MY"4D)"\JU!9)=-_/Y@LM9\G79Q<7;9J>'9T)OW]QR;H;>+9GDA9"&[9. (,R
M9+4XC12,/!.A0 673!,G6<9QFT)B0#!"97(#0WY"NQ<7]6 8VPG!2V$4@OA<
MB*!!6(YKL0:'& \P'">-N(G/&6)8)[WSCJ3_ $NL^Q_!%/-KNYY&9L]S?/\
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M_P *\_Z]:X^S?!K&VU1INTL&./N'K&ZU$ZX?B%  N9EFB(8G&$8PCWSSL$.
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MDZ4F_-T*#_>L?]KH6&Z=]W$^W27W\%D[V)NQF%K/ ?@VSTFU*YM*6G=U=II
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M(F%F5RP,NPN:&"!. P\R&4)1RB011RE D)8E'.<9QG]C7B"<)B)Z1K%G!B+
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MZ7\![WRWYM^3?@?_ #W\/\;X46U&)V)J[G\ML:YR:SB'=E2(YPPG$]>;NHH
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MJZX. )I@QG8*'7,I9S*69$,8Q)3.RR>9&&F"%99*4Y2$D=-P 6E&@E6:59%
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M]NL(-A)E8QJV'\D&:'42>&53XSD!X;(/5K6,?%/UK,H3RLV'/WI;9A,/,U7
MLI'86+@M>4VIO1^VRLXZ3LN&K;+Q"49"YC$K(VE[/,V!B3<@SQ6F5Z^9<6<$
MCU2RHTGPU^H"ACEG3;Q>-\;&QF9A(3) ([D(QJ'9YZ_!)B2X36"]>4N5H?=<
MO[_3G?VS_;]VWYQ?*\O:JA2!\0E:+K0V++A'\6&&[9OGN)*4L^J'^L&J/MOQ
MZH?ZP:H^V_&KZ;T3+FH;(P6+9>*K5J^Z5C$4HV<*XC$K1^-H]3H30K(J;)P?
MFN18B;&>\&A7UIG?*;)*RSJ-8 Y%3FFE6N%KV7L;)C7[>VFF%9[XHL"NY1@?
MCLC 8+I#)0GN]3FKY12P;,6$JI"P%8DMBCB$L>$C=<*M ,Q%<LS.R969_+'!
M8!JIE+=I_2O.?N64Q,)MWLU^*O1!DQ(;74.ZQ>89 )J5>5)'EPJ5]$_A1;48
MG8FKN?RVQKG)K.(=V5(CG#"<3UYNZB@ !.^1;XQ;\K<!I<V,46FUS 4D;#;1
M&6C-,.OY553,^>19<8S,C3!DHDQ*I1GC.5U 1EF/AR_O].=_;/\ ;]VWYQ?*
M\O:JA2!\0E:+K0V++A'\6&&[9OGN)*4L^J'^L&J/MOQ8^Y.H\J\U[3O_ -L+
M1[G['N>U^<G7.+B[QC^!X]_)\9OV0V^':6U&8U;8ARLZ$#KM?,Z\LXR0&6JY
MA5N(3QQQ,B@>,&5YE68P1<Q13C2Z9K U5;$QF<A%(QIE8/G&2G9::*=MHV8Q
M&+!63EG!<(%AYBNN$0_!K.@\ZT%;,\8V;+05NQITIDX"A#-=V8L&J0I&(%5I
MB"M< IG%1,S-DDC\V!:;IP@;D' 6KAGY5=.XS!6)N>P+CD&%DB8&BUZ>%:J+
M6,F71!*6?V#--00#J/4P#,IMAY#"K*5@:_6,GF8BZ6!A-$&(U97FC..0/K.O
MU;8!C*OZ1?26;*NGV\P.I5=&EF;&L',9D:^K6W1E4Z:.,QI0>PUFQ<CR-AYC
MV>;S"Z::X5%% B6556% "ZRX(8$!=< L1&$(1QB,0AQC <(XC'&(XQC\4U5^
M;=Y]6->-7?T#_MK\0;I;U!>SK'A9$RHS'K&6,_>F.<<Q*NP*70B[2\Q,JFC
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M "XD,P3#E(91$C*!(2S&6,QSG'@KE>L;25E()\1GI_  U1&,KA F5JD(*2F
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MS.,!DSF"=ZC7-D#M+'$61@DO.>""B7) EC ZQ,&B-@)0$DNUZ.$V(P+#(Y9
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MO)9A&O9$25G8+ASC(0/2!"3819P4^,C$?)(0S@YL9CC'QI/W^5#Z0@Z2RE;
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M*::#8+YWURA&.-N54S(ORN1\2ZFGLGN'\'9MQ^"ZD_J:O]A^,,:O7(O9=ZU
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MMWRIKJ.K>>5/:UUI$'D/%S9KVPMX%R9N"X'R9%LW\1-G7=QSZ;<_PW_HQ?\
MJ>/7/_5W_KSPU="U%YE)JJ/5\'E$4]N#-HM\O)*P=QGIE+$-G%'KOW<F-NV5
MGIHECV,++LNK7:#9XNSL%'\?$X(KF>_*O'_#PV[MWPMNR7KG_J[_ ->>&J45
MOYE%JU/:<_803VY,HBIQ<<F'<YZ82Q/?RQZ[]O'C;NDA8'U2:O7KZ_LP5^:W
M+H(FFP8S#@\8LDA",U"2P3YB#D)!)?D+.(Q0%ZY_ZN_]>>*VO8LS6+"->FF>
MP8AC)WC++C"1P^2R8+DS,X9,3)#F)OGG>4DNL\W%^WK0W-:V#+FP]-)J:X2$
MSVR>#RNH;PHK<2:^,#$.  #&(0AQB.-/?J:T-S55@LYL!325FP$9,=RGD\;J
M>P+RW*FQC(RCF Y!E$4<I#E95Z]F:N8>KW$P6"\,8.B9E<@1N R*2Y<&6G/!
MAY&<)-\,;"CETGCUS_U=_P"O/#]@#5)K!>PK^S/7XK<I D:# 3+N$QFR=$4R
ML(LA!F0.0<'6.,L(D+ L:#SXU.'-@NXU,:O<0<"L,^U-@ VD.0/<D7<Q@A"#
MB=0!.+)(#(/US_U=_P"O/$J#SXUP'%@PXK,BO;P3"R,&Y-<!&G^,/<C8<S@9
M!CD=LY.+!)D(316J*^\;6:65?%7"%\$:#*1PD:;A#,I+%\T!8A2? 178THC!
M=S+:\\!%^0A0SGX)U,#]^6V._D-*&>GWI2ZXR.&/O]2>]_R9_E+JK^@_\24_
MBS_.AWZJI?R)0CI&ZE7-3&VFSYJ=P&)X=S68%P]H@]NS'M2<F_CZ=8;=W7.W
M\A G#/24 CG'/O9Z2B8N<9Z9][[_ /R^]X$;'3XR$9=,9W;<YQ\*/7^/,)=8
MY]['OXS[V/Y2M4=XKWM6[P=RMSLK<G;,A;#\<H8#$-C !$^++'=MVRZPS*.2
MU] EV"9FIN$#W+;6YD@@@F3D<.P7'42X8[(SQ#&SKB.Z4LY_(=1'4$+# KS+
M(!-)+#9"E%8J&#L.Q[@;/".+<"=$UW&)1@3 P2)L@3\A#_FT/[TW@@<]?B)]
M<>]CIB!>N<8Q_'G._!,YZ_\ =8Z9_BQ_*2ZU)6"4.]7>7< GX&*I+O+9! G+
M!=A4V>@6B2AL/#H3$,RW1QF$G+:V @NPO<L5\(5XF!!R$25>S&4HLM-SY=[9
M,9S@F([<0QB&,XSF7Y#T9^D7^P_R&/\ FT/[TW@?7IM-C(<]<9S^_P"F8=.G
M\>21A'KGKCIG/7I]_'\I-6#6 9@D0U;$H ',LX@4O*QIH^8PQ+. K*A,RP3.
M-@0"(8F8CA*6')E"4<&=1O'6F0<H18#%"K6R8$I8Q@HL,+G!DD-T<& 877>.
M>,?N5K=MP,16GK7K1D:\828FO7JE;- $2$$.1I#%+ XD*.&9],2)#'66*J[4
M@8:MQ6HVBPV(PBQ!>P5$V&!XC(4<31&6."1&4D,3ZXB2>.DL_B]1+4$[#(J/
M+)Q*I,C6"[%DJ&3KNR[<C/"2*D!]4V$V(QF3(SQ)LF/\A#_FT/[TWC$HYSB6
M,XSC.,],XSC[V<9_BSC^+/@9X_>)'KT]_P"#+[TX]<XQUVRQF/7ITSTZX][^
M5[-_?,]NFOT@,<,1FV^W.,L@00!F4.X<8V2V0W0&(<"M-%73788%JW4"&G]'
M46AF=-7>W-J]8OW;=>%"Q2N_+S5Y8!RX R;G;^9U58'<52,>]' [/C0-G=J:
M"M--OT].G4U-<[=):K8KXT$"JM'(W Z$.SCA'%L99-L,6&0K#B+#83C#?UHC
M*YP::-DB?K*=?9A$$K"N#[(#;#QL .NV*,<&7,/F$JUAA1?[L%+O4E#3M$#%
M@:UI<5]>Q->4R#B> 6V!$D&1!%'$F([,S&2.,]82Q@3]6\G9('W\#J#(7%#<
M1)A)Q,KS($G&89!3V3SL)"<)=)1SC'[ K]H\G6H V<[K[(4U \I(!'RLL3&$
M?(8@Q0WSQO).$(]92QC/KUH[^LU+[;^Z::-7(5]@O:3L<607>YB:2R)*J61I
M, /&"IBP9-'G.J] <N.?;SQ"0R?D(?\ -H?WION%7SGWQRY(=9>_LG[TL1A_
M%&$L=<YQ[VXOO],Y^%_*/4K]8\W7/ \FX'$&3)MAY;^J"3B87F,P^0)""GLG
MC<.<X2ZQEG'BQ9MK%^S8AJ-L$#V#;#IH!C65$XAB5DA)Q%&9"3P/&=N)$G+&
M.LL]?W'2G#\Q><.^9?@WSMV6/)?WWRS\#\__ (#Y-_\ "_C>R\67H[LU+)6S
ME0ZQKD; 8Q-5C$[9:U=2[C,"0=4,9U[RW$()MKPS@#9VP@*?L]"4(_2#6Z>U
M1HS2BXN*["Q7TYF,U%4F[7,V%@%)?!L6"2<1LU[3\QJQ>,*ML8="+SH0V1K8
MC%DS:-N$7@I";!Q++1@NK$C&0!&JDM',2-,SFQSFP2 RC7!]SS0Z;EHXVX"I
MI*= 1"-W%V[$N4:X61B-P\W"2<S9&241CG%<#;DEDV+8.LFN\U-/L7+8O-%C
M::PK4WQJ[Q1BO'L5V0I<*6/+UNW[:OE-(0)RTG_3O^);GQIFK0%SOV6O:9!(
M&\8N9MRKO5UA<AIC"/D,2$-Y20'#KNG.,<9SCU3_ %[IK[9\>J?Z]TU]L^*V
MQO0;&-+Z.I5FD>7=R6R]<E7!K.Y3&]"/<VLA(]X.#"P>7N99RO"4_%+6ZBMS
M2':61R=O!@H$:BL$OWEFO1+3@\!(TJRLXELR 7+;@EC6ISDD=K+-)3Z=IZ:R
M GCR2T57&FV*P47D-'S.S&NR^^F>70=IWG?&8',C6.MD-9H2*#[QFM'-&$I8
M5[96C+TZYFID+;5(AP9(J94C)VVE4P2A;0D810Y<RFXG^Y:,_2+_ &'^0Q_S
M:']Z;[@?O[2YX9=,8SUY/>C]_P"]C!-DLYQ[_3&?O_>S_*/4-#3Q"2R<"D14
M1RX! \T+-*QDO@LL<<#,#4F%?)LC!SS'W!P!WF&=&\")9UNY;L.V&<3,@!FL
MBG")R R1?EGE*9L8 8\<!*'?.)N4(OW'RSTBN!#37AA@PGG-IEAV:)@V&,C'
M28E9X"J<*TSL#V+CG-<#!,=V(1K376B-:^:42].:[KU7THS(PH@OS60RVRQ%
M]CD.W=V*DHEB+MPA5O\ ;E&PW"MUP:-:Y06%;7VA3)._**Q>U[#%?!]9P*9)
MF8)8B#MK?,("F,V3D&+ R$N-/613-8TL:MC6MG-@DX5ED)N*]7B/#@G#7$K#
MR7(5@^<+MC1#!=5!<>?#ES<N!KZRO#D[;9\YV#AUQ&.,1CB1"F*24 KKA@1A
ME@@UUQD.08Y%]*&LDS8J53?_ +K:1[& PKZR19SCJ%JIQE@?F38X(F4>*X;)
MF(E>7#A%73#*^K/Z"_PU3>-)_P!._P");GQZ%WV163 T;ZU=BK3HPLK-UA1S
M2["B":9&TL&,\T,*F.A]X\&R486B0BL:RN\>C6AK:! ,6"Q8?%J%Y1>$!Q9.
M<E/J%0C 8$Y&2$#4B@DGUFSG(EC-Y5JM:H!HG631 .[2GGR'>6;.8Y?$V:35
M.&&.S6[C+%FO(Q3-N$JTARS#)$,FPJK?51[O V,!A*LE%M86&!Y)#NP^<L5,
ML+QB;,6(@;X\85R86D_Z=_PU<_=T:HV RK2NE-/+LK,#F%A=@-0F,P#A)B)!
M&$2,AD&2,9PG',98QG&<?N2K-C65[[%9U9K3NI+-&KV<&6GAA(IQSFJ;>$,^
M4&83W"'+=UA'I^0A_P VA_>F^Z$WO?#AC,NF,XQB>/>)C'7W^F)XEC'W_O??
MS]_^4;EQ<.!0K4 Y.TT?.=@X=<1CC$8XD0IBDE *ZX8$.R<@UUQD,2$)1M*-
M\5@E(I <HXE'(9A9^&$X#P$PN7&,P)@9Q#E,) GAB03"G/\ <::_TX)RW\H3
M>6?I8-Q^)#^&PL:JMG&'<.,;"*6,%C&L'>&D HB;A+*&M=%VE]V>L+=/7)3T
M+]795Y*ZPQ1FJQU)7&%\(S<-&I&6 YL -EMV%5$$G88B:KT%I69M2ZWL=$4>
MG<TE75V-GE>#6FUL71)E5@,!#5]9WD9#3.XPE9X'!U+B6L, 9S;</NBOC ;M
M(@),D$5UQ2BA4Y)@Q%6#)Y.X9AI4<(38=(M$SJRBK9?%)I&.0ST[*M0U!8UL
MNZ%"Z8\U?#!*T.HTLU.M%BM',:ZAU)]P6;4C297KBH@44H-$*JJA&NLLO5VX
M5UUPPP,( !'?Q&((AQB,8QQC"$(XC'&,8QCQ8:FM I@?LNTYQ(#,)2/9HK(#
MXH,,-&QU"J.4]YY]29GF.V.<0CI/T9]G3^1?M[\K[=WS;\&N;_\ A_,.S_#/
MB_P#\&^!_"_'>!IW=M3H:L(FK79:FB4C:U>ZQW"Z+]T!,H:U.1LQ?FM8/+!"
M,@K(\!@*-B7C62B@ JJJZKU"NLLN. 5UUPV[@P@ $>(C$$0XQ&,8XQA"$<1C
MC&,8QXT_1:K3,LO84(*Z0U\,(,13J6\AH+(&3Y)GF(K7UEL,LXE1=G/!>V)7
MG[;-!?7]6XLA6W <3MJX(+&OL:TY&U'UD6B]%(N650*Q[9)Z2%H$,X-$"C+8
M:!K:DOD[>U;3?\BK!+.$,2P!+"PO-DY828JTXL$@<GF)*XSM>,Y:KNYX'B59
M</I=MHH;F2.NLSD/S<:!A=S5UP0L ?GWDLS3G9BR)1/C>S!HE@EA O[EHQK3
M]S85)<EN2E[)D@@M24G2$!%U;KVSX82E/Y,X(Z\XD(,@I#).,OR$/^;0_O3?
M=*M+/[SXT>/A==N<]">_^]Q'$MF<1][.Z<\^_P"_T_E%JK^@_P#$E/XL_P Z
M'?JJE_<]1\U$G=6JFFM1>1<M8&QL%K ]67B\IW!,P%PS 5>/L]IB&$#;UG ?
M32Z@ZH-.T2AI&+9:",*]B=Q*H1&^>Q#$0B2LI$%@;9&8]UF8]IL]8=,?L-6?
MT%_AJF\:3_IW_$MSXN]2+HN.:9O'#7/F@XR:'7MV# Y/J6A KBA7_MJYF-9S
MXXV5#JB&VTZ)V =,AQ?5NI+9+2E2HI5T3!#S<<0K:]64&227P2C#DD\$GYVL
MD]%<;.!5S#RQ$/!+F2QEZ^WLCO6VJG5AK(YFVTX1]I!>/:XM3=T!H/:5,.W7
M<D%=PM:O/G&C5H"X$*U-9!(&\A>%1,,%UA<AID,3C".$-Y23)/ING.4LYSGP
M)^KTIIJM?!OX'4**K3;#RCF$G$RNJ,P^0)""GLGC>.<X2ZQEG&?W/1BNGZ:P
MMBX+<B+V2Q"A5DW.D&"3K/3MD SE&?REPH%X1&0A"Q&.<H_D(?\ -H?WIONA
MGG/2.9<<_A;(["?!ZSS][;#.<$Z9][K#'WOOX_E%;Z99:,D.S"'$6P0@2:YU
M6@/*DR*?3!@Q:6#W ,3#,P.00V%R3B<<J<3Y;*9WV+!EH@(K1D8PP+XB!>)#
M9"*"ZH,9Q-AB4S<Q=\($@ 7X@5^TTIIJR?/LYW7Z*K<;-Q#@$?*RPJ0Q.,(Q
MBAOGG8.$(1Z1CC&!(5:*=:@#?P)(+!34#RDF8G$LO 81\AB$+/9#&\DYSEUE
M+.<^//\ R*G\]_\ CKRQ+S;\&[+YRX>\_ _DG\-^#?$?P7P?Q!5:QLZ]!BSZ
MK5H'75E36#.3+0PND(Y(3:-O,&'$#$Y[BCCMZSCU_(0_YM#^]-^P 7/7=*'2
M6<XQCK.'P)YZ1][IF<<YQ][WNGO8^]_**WU,RJ9T=8$.8J G <V#M- 15'DL
M^N ADTR'N#X@:80<A1KL$A$!)7 D"ULP/L5[*I#Q9C$P1@8Q(#$1AR84UV@9
MSF:Z\H&YA;)P' Y?R'HS](O]A_D,?\VA_>F_8&6Z?\_'/_F#GC.>O_S>WI'_
M +OKG[W\HM5?T'_B2G\6=;W:OF/GSKW8<XN][+R^E!W?:[N?M>?XGGV<7+\7
MNW^]X,RR82ZZXB'.<Y(B" (HYF4QBSS& Q#A',R$GG$81QF4LXQCQZWZ7^GZ
MKVOQ)FIL4+->!<@F>O;7=# T8PG(,BK$)")8P(.>1YSNQ$D)9QTECK%FVL4*
MQ>9< @>P;72#,THSG$,2LD'"190&2>!XSNS$<Y8QTCGIZWZ7^GZKVOP%E8PF
M%V!#. X"1*$X2QQ,1@EAF4"")"6)C)#.8SCG$HYSC/@B=AJ.A0<#LYE'+>O5
M9%R0B4?( [$"PWBG D-T<;H3C/'P98SX&G7ZCH7W#;^%1.WKVF2\<)%)Q@ Q
M,L]@H3)/;'.V$)3S\&.<_<];]+_3]5[7X-Y1;U=KV_'W'EKZKW!S;^+F[8I>
M+EXB<>_IOXY[>NV70CE@VJ@F'9S-.'$JL+DG$0^0YY0%#>6<!PW2QNG.,,?"
MEC'CUOTO]/U7M?@;E>VJ^F;?PM)G$TL7CG(1.,X)3%/86$QSVRSMG"4,_"CG
M'@/F]O5U7<<G;^9/JH\_#LY>'N2BY>+E'R;.NSDANZ;H]?6_2_T_5>U_<(G8
M:CH4' [.91RWKU61<D(E'R .Q L-XIP)#='&Z$XSQ\&6,^!IU^HZ%]PV_A43
MMZ]IDO'"12<8 ,3+/8*$R3VQSMA"4\_!CG/W/6_2_P!/U7M?@WE%O5VO;\?<
M>6OJO<'-OXN;MBEXN7B)Q[^F_CGMZ[9=".6#:J"8=G,TX<2JPN2<1#Y#GE 4
M-Y9P'#=+&Z<XPQ\*6,>/6_2_T_5>U^!N5[:KZ9M_"TF<32Q>.<A$XS@E,4]A
M83'/;+.V<)0S\*.<> ^;V]75=QR=OYD^JCS\.SEX>Y*+EXN4?)LZ[.2&[INC
MU];]+_3]5[7]PB=AJ.A0<#LYE'+>O59%R0B4?( [$"PWBG D-T<;H3C/'P98
MSX&G7ZCH7W#;^%1.WKVF2\<)%)Q@ Q,L]@H3)/;'.V$)3S\&.<^#,LF$NNN(
MASG.2(@@"*.9E,8L\Q@,0X1S,A)YQ&$<9E+.,8\>M^E_I^J]K\29J;%"S7@7
M()GKVUW0P-&,)R#(JQ"0B6,"#GD><[L1)"6<=)8ZQ9MK%"L7F7 ('L&UT@S-
M*,YQ#$K)!PD64!DG@>,[LQ'.6,=(YZ>M^E_I^J]K\:4G2VM4O7)X=8:>,0S'
M(A:2J<C:K(*B(!_.  (8<"-IA/U#C#48$R0?Y"'_ #:']Z;]@ N>FV,^DLYQ
MG/2$_@3STC[_ %Q"6<X^_P"_T][/WOY1.4]PF%^M?#D#2I\9V$AUQ*.<2CF)
M!&$2,#+L!F,ZQQC87(,PX3B["@SBY]S(JX"$M49)8R*%_228>%K*1*S>),+\
M@(##P17"NJ/I.(LXF_IVPI=(*IV':\QZZNLPN0[1U=X?"4]TR*.XJT($W!GU
M%*<<;99Q*/[P/_FS_P#:>&*>IJ=+NKLV!;*9;9"Q89B8RRBLAPFM;)PP'$$Q
MRC'(\RWR)G,\XSB,:KS>MT\CY1WW;^3IO+<O?]GR]QW-F[OV=D/BV<>W<7=O
MW1V_O _^;/\ ]IXK*=:AT25>JKTJT!6:NVFR0**PU1$8G"^%"9IP%B190&.,
MIYEF,(8^#A_45@I5JN6':\P*X# 4X=HDNB/A$=MDL=PEH3)N-/J64Y8VQSB,
M:RX6 D5BJL$K( F1FFL0R+(VA#8A XIS#.8L1+&!!RE#,L1G#/PL>KN@_HBY
M_P"D/C]X'_S9_P#M/#%Q4H4KK#->6MF*V5;86B$S*C4B0@L^G/!L33'&,LDS
M'9(F,PSG.)17I[:ITNDNM8"LH%J4+%=F1@K-JQ'.;-LY#(<P<)*4<#Q+?$><
M3QC&8R_>!_\ -G_[3PQ3U-3I=U=FP+93+;(6+#,3&645D.$UK9.& X@F.48Y
M'F6^1,YGG&<1BO<6R%*DPM7BK8"J56UUI!"RVU$DX,ON3R;,W"1E+!,1V1'C
M$,9QF4OW@?\ S9_^T\5E.M0Z)*O55Z5: K-7;39(%%8:HB,3A?"A,TX"Q(LH
M#'&4\RS&$,?!Q9W#($A,6M@[9'$L,T%AF>9(T4:\)G+. 83+F(HS(2488CB4
MYY^%FLN%@)%8JK!*R )D9IK$,BR-H0V(0.*<PSF+$2Q@0<I0S+$9PS\+%G3L
MT.B1+VM>[6G*M5VT&1A>6(J4B\YWQ80-"!<R%*8R1C/$<RA/'P<_O _^;/\
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MSIV:'1(E[6O=K3E6J[:#(PO+$5*1><[XL(&A N9"E,9(QGB.90GCX.?W@?\
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M('/3X^'7'O9ZYF+KG&,?Q8QLR3.>O_<XZ9_BS_)_6'Z/_P"%J3\B>D3]$O\
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M/_XII/&EOZ;_ ,1V_P"Y:>UC"6] J>-,LPZ#CVK8#/VB4MV3\Q^_"R_CI!7
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M+[ZX!^CO":U;CY:Y5Q-OMD&W9%C+%Z,S+3V',R5(N(S9SC.LF/%<R>M"K/\
M<_15_P#/Z&_QM8?CFL/T?_PM2?D3TB?HE_F;\AC_ )M#^]-^Z %GKNC#K+&<
MXSTG/X<\=8^]TQ.6<8^_[W3W\_?_ !K5;]6\Y6O Q28"[7LF3;%@VHZ@!L"8
M7F,P\% 4@2;9XWB),<NL)RQG3-E;N%??**P"9MC.)'-!&WL$%LF)C&,F+%58
M,",%W'8G')V"%.0A)?N,=145BG5WL4PIM+.+;:^VX31P%IEU,4W%W%TYE!DQ
M%K/N0K5B48HB7D:1_1Q<>C&XT^FO3T\HZB6LXZ@J9V&-2U[KAK%E4,TZKS5R
M%@>"N;1@RK+**8D\)LA.)6B#I@WH]TC.RFZY::AL)><6B:3G:JK&TTM@+2IL
M8D6V\LLHS1::41*"Z7@%=EZMTY3Q-&OJPR&'+!<G8+,IB,LL')G$<9,TT8S!
M,"@)>$RY@L "\1AAXL]4:44LLJB#7KT=FIJ2MK6%%XTRX'@(\UPHZB&;IK/E
M'" 8&FRT7I/#4YD_#=8__6(I_P!)O%JM=Y-*Y7LG@6TF&,-L2LQ-%&_D[<2&
MPT;+42Y(Q@Q<&GU)@D]V[(;/4QKB>C7-'#]SXW-1"L*^/<&ICU7:U,;-F:.V
MJB? =R:_;!W+9XLSXI>6>2N>YGO.V]U'<RYN';M\Q\@[#N.S[CW]G>>8>7_*
M>Q[W]JON:D6I,AE3+WUP"IDNQEM>58*P8&AD#<B&RT'*L19&QDQ<FAT)DD]V
M[.@+2T"Y?WM_IJBFJK-D@R/D'4UAK9]^V,%OCX^['.<YC9;;;9%&(LBRVVHZ
MRLD:JLZHPQVE60F6H @UEC*#"[^%UAM!:&L;&<9"!A=@!QD!P=JTWIEDN0^<
MBOB@0CEC,6,UC%><EMD:G)C!@Q:5I,'8R&>59R7'@@N[E$UXI$YHJFTHPP9;
M!)X7*PK;TXUCD#C/',RXVVQ@)*.9B@TQ$>8X,3$OW)5]E%-AZL"WFM=,L$K=
M?ES @-Y28G"1E<M ^)8X)PYA?%DW0][\<UA^C_\ A:D_(GI$_1+_ #-^0Q_S
M:']Z;]S##..L<2Y)_!WQV#^%TGC[VV><8'US[W6>/O\ WL_C6JT*M%RR>/BD
MR%*O6,XV7 =1U!S9$NO AB8$ 1#$VPSL$.9)=(0EG&F:VW3*@^(5@8RC&,1.
M&#UO8/K8,/&<Y"62K(9D7+M.O.60,#$<9!Q_<KO3-69,#]EY;P%?(82D>SMT
M'R<LUUVC8ZA5)&&P$^I,PQ+;'.9Q_8ZR;4T;JMI5K5>H6%F5].VYEV%S6[A
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MYP[G-A7G+";$XGE+-KIVV'R5]ND9)CI $RAY(_%-K=R%@(W4C8&XB>82=LX
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MS]_X<LYG/I[T?@[I9V]<==O3K[_Y$U_^96JOJ)[\BW7YE6/U[IS\<UA^C_\
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MI_Z&KO9_'JUI_P"AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?\
MH:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_ *&KO9_'JUI_Z&KO
M9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_P"AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZ
MM:?^AJ[V?QZM:?\ H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_
M *&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_P"AJ[V?QZM:?^AJ
M[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?\ H:N]G\>K6G_H:N]G\>K6G_H:N]G\
M>K6G_H:N]G\>K6G_ *&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI
M_P"AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?\ H:N]G\>K6G_H
M:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_ *&KO9_'JUI_Z&KO9_'JUI_Z&KO9
M_'JUI_Z&KO9_'JUI_P"AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM
M:?\ H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_ *&KO9_'JUI_
MZ&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_P"AJ[V?QZM:?^AJ[V?QZM:?^AJ[
MV?QZM:?^AJ[V?QZM:?\ H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_H:N]G\>
MK6G_ *&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_P"AJ[V?QZM:
M?^AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?\ H:N]G\>K6G_H:N]G\>K6G_H:
MN]G\>K6G_H:N]G\>K6G_ *&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_Z&KO9_
M'JUI_P"AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?\ H:N]G\>K
M6G_H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_ *&KO9_'JUI_Z&KO9_'JUI_Z
M&KO9_'JUI_Z&KO9_'JUI_P"AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?^AJ[V
M?QZM:?\ H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_ *&KO9_'
MJUI_Z&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_P"AJ[V?QZM:?^AJ[V?QZM:?
M^AJ[V?QZM:?^AJ[V?QZM:?\ H:N]G\>K6G_H:N]G\>K6G_H:N]G\>K6G_H:N
M]G\>K6G_ *&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_P"AJ[V?
MQZM:?^AJ[V?QZM:?^AJ[V?QZM:?^AJ[V?QZM:?\ H:N]G\>K6G_H:N]G\>K6
MG_H:N]G\>K6G_H:N]G\>K6G_ *&KO9_'JUI_Z&KO9_'JUI_Z&KO9_'JUI_Z&
MKO9_'JUI_P"AJ[V?Q!I*CITV1;N-A6M27./?"0Y["B#$D=PY2A+;+&Z$I1S[
MV<__ *,31Y](H'JQ78+L3J<GW'EM]3.KF%D4K$S3@SFC:$$Q'NI+9@LMD*X2
M]R1G2U@YITX[:[T=2.-6JUW>09'8V5*L8]@NN6Q-61/%DTF!!(@5'$\1A-.:
M_4.>R2](5YJ:N917MJX&I7W+P1Z5BQ+'R^W4?G( 7L'JC*&L::231DI<Z;%7
M-XZ2U-?IP.-.[JJ^W5&S&$&1K62@G 08@(AA1/$1HQ+$9BPQ/$L0)./26?Q?
M5ONA2HT_(?(>T\F6?7Y/-/.>?N>]LK'?L\N#P\7#MW%W\G6.S[C#CC %$U %
M9::9+ "RRP(2*=A@Y91$$ 11D0I22C <(RG.6(XSGQ_PA:'_ *V4/M_W L16
M\PU%==V#3J!(EPEDJD0=T_9'ALVHU_=K2FJ(L'7RF"LOD I-V*"VN_3A9O:K
M)<HA:TSI[S(Z-;4UKH$IPM>&A-7JJ/6RJJ9.QKL+@@#Y3;Q;N&<BJ('T&:U]
M'>IUCQ*CJ:HMKYUD$)P(LXM,#=W&60-IG.*4E&D68SX\Y8(KW23;OHR](\.F
MMT7K952R !7 K ]5)HEG5/PJH>7+O5L%6I*O)QC6V"2^13D-\(377W(.7]S5
M4B9#Q6&U;V"E:L1F<"%@O [A0BD>0@F)$499GF B3Q';"6<!K:C6.E;6Q8Y.
MW0K=0U#SI^$4SEX55FRG+Q $0Q-D,[!#F272$99Q]QA-S76CE'%#E6:59U-2
M@969!.0CKL *[$H3A+&0RB)&,QSC*$XXEC./"[B; &TVP"95:6+ ZS*QX1*!
MA<XI2$8!A2B011RE D)1G"68YQG[D$[_ %3IRD<("+(U;>[K*UDBTYD%!B '
M&0ED"10F'$L8YAF8B0Q+="6,,^Y[4-'?=GP]WY-;(6G:]QR\'<]D<_!S\!N'
MEV\G"79UXY=/##CC %$U %9::9+ "RRP(2*=A@Y91$$ 11D0I22C <(RG.6(
MXSGPNXFP!M-L F56EBP.LRL>$2@87.*4A& 84HD$4<I0)"49PEF.<9_+[FGM
M0I^84]AV_=J=PTIR]HT!T'QZ1UFH;&E@E^*-#=LV3W#E*.5M!JK')I@VL=')
MR18:/*>*[4'DC;E?%P<A.< XV1U%C9/EZ"T19*X9K$VIX8T=YYH+42W/.NU'
MI^_NYNK%*DTIQE@_8L[T9]SN<"F6N=9%#MH62PC'WB]'VK]1/:GJS:J=TG88
M;,2Z.*Z(Y&D4>K+6SFM:01A:++<@#ERK&M/8,#J,VA1RQ^+ZIOTX (Y2:<N[
M=4;,9S6(S6UC+@(,0$0)9 D4,8EB,PIYAF6($A+I+%C?WZM4HXIJ-NH&.H V
M!;*P*RH<A.<''GRY/DKYHRE$T8;(CQ@>)8E*?W(.7]S54B9#Q6&U;V"E:L1F
M<"%@O [A0BD>0@F)$499GF B3Q';"6<!K:C6.E;6Q8Y.W0K=0U#SI^$4SEX5
M5FRG+Q $0Q-D,[!#F272$99QX'I^AARZSN4>Z6.8&]*CK2E.K&UG@L,@>>(=
M=D5:C\:"!0$<M(Y7$NA;2U!Z;CO:SUG:]#3 >ZL@I:95D5AJ-,AFH>3!+:=P
MY6A*_M*F7.$Z1:*X2/V?G_H<<M="ZNJ@-L!&A9//K:GP*$'%:"QA>6_;# S9
MI(QWLFG4[)'Q:UMA#@DF33]]#BUG3(]TR<(-B5Y6B*!65K# H8 B\,["PK)'
MXH$RG&Y5QPN5A"I^XM[H=0T=#WG-VGG-LA5]UV_%S]MWIP<_!SAYN+=Q\PM_
M3DCUFG0:ITY=N#!)DBM1=UEDR-:$QBFQ,";)BQ!$I@CD64<0Q,HX9ENG'&?#
M#CC %$U %9::9+ "RRP(2*=A@Y91$$ 11D0I22C <(RG.6(XSGPNFGKK1S;C
M9Q+*JK:FI3LLLGG$0%UP"=D4QS%E$8A#C*9)RC"$<RSC'W6$W-=:.4<4.59I
M5G4U*!E9D$Y".NP KL2A.$L9#*(D8S'.,H3CB6,X\!LJBP1M:YCD[=^M; \D
M?A+,!>%I8A0%XCB($FR>=A1S'+I.,L8\03O]4Z<I'" BR-6WNZRM9(M.9!08
M@!QD)9 D4)AQ+&.89F(D,2W0EC#/N>U#1WW9\/=^36R%IVO<<O!W/9'/P<_
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MRBB# LV%Y2U5M;.SZYF5EY]I.13',64YYC'C6!C.%TUUDQ 7$@WIHMKG0>J
M*NV549>;2Q*Z-@<-G3)L,,A%8VM"+,7J9PK0'D86B2=F9I5M\UMJC4E%, [9
M$" DS,!PQ!>=E;U]5)F(9YXB'6$[-A:)XE6[D8NY797Y%R7FH]1Z;1U'J)K5
M3ZMM;:I&KJ,KA1JI6,3JQL4Y]AR>;S[W.]IVP=P5MM\@LI)5VA]9^CX7N3N+
M#S:1(4\ *5H3TD*D(3JUL ]J'O5;,JELILS6V0(=&$I$:LB/4UJ)P%+>ZDT=
M7V WUD\-K5-M<4HF(.+U[AB19 BXQ@PDVF)X- 40G-+=*>5=2:H]*5KK43^H
MT$,4I:GR6I59\GM)"L5JY6X9J5SC71(O+M:Q>9LN,'(?)2'Y_1[^8^D_J%#^
M0 ''& *)J:Q]&[+33)8 666!7Z5*=A@Y91$$ 11D0I22C <(RG.6(XSGP];$
MUIIRRBB#)<5]'=55M;.SZX@)9%!5R13',64(8E+C6!C.6'&%DQ'8$+TH6M ]
MIS29]5.ZX$5MB #LG(Y'4-,G6094PU:(F:<1D2UC7JUKM:"PPJ^!_ 0_<U,"
MIOGM%^BV@>*@"UTP)I'4^JBYD.:&5[^Q2SY7P]G&V> DNDZI7VRE)8JV$7_,
ME:/5U/KC4>M=*6%JK47^FM=VGG#QF>VM&@SJ[;*6ZM 5,;6Z2HUY@L54#.CO
MDB9125](*"W*?4"-//3%=9Q+#F=OD\/J#L.Q[B ^QKL-6#8<-A$SV)*\%D$[
M*Y_%-JJT],/I-4U)J;3E?;YE2W *73B3-C6"80@/3=8NL+@2$18;T5GDIVQQ
M,N<B)G<\/IBH]=:@>OGJ%[2@$R'[==+LF%[R:;Z%17E)5T_G%6.M>:54Q$O+
M+&+#)'AFEX1]$/HX.C5O=B%_5.K&JMJU+IL6<!LLX F9?ROYK[4>#N8<2L'=
M0(5<&J5X,VO%KJ_1GI<](Q;C3*+US-366H(:BI7:U)!HEDMFO-6]KWW:[SUY
MFUG08:",>1+$*.S0E:CF]I2X ]FFM&JF-:?BLDAU[QV:>-TG<J]B\JV&/#9(
ML'3YVE8%.19>U,31V-6O:UN(/6> )V=]9UVDVO-].-V:EG84\2]JHC3*O"N6
MZ.L!+CG7$JZ,LR829SI3*>J-8Z_0?/1,V;0ZFRI=%#@U8&IW:JT2JQ7NGZH$
M:U>+3MD.ORRCWGG$%,OB&T5:J9](#S&EK;:[5W,-':48=A6]UPNJ$$2FK:Y^
M\J(;9& N\J!H3%:T653BR[965<2]M6W,@9%B_8%21MHS/DN1,Q"K3+47.ER0
MBM&5+):6 "[Q=N63R-K:F_W4GC:%T>\-#S5/3>C/,K*R<1BUY(![W--4^'M.
M$)VVI"\63P.)</E".;3=6(^B'T<'1JWNQ"_JG5C56U:ETV+. V6< 3,OY7\U
M]J/!W,.)6#NH$*N#5*\&;7BUU?HSTN>D8MQIE%ZYFIK+4$-14KM:D@T2R6S7
MFK>U[[M=YZ\S:SH,-!&/(EB%'9H.:WMUO)?<]Y@#4_'$K"0RT]<O:/OUHQ=R
M]-&:+(V(*S@1T!>9&.7^ 3K=YJZXUQK'1U8EJ-JHH--:$M 44$%AUU6T:=I;
M82,Y?G/%I7;)H8()LB?,D,"UEA%+T9Z7LM>ZCU/HJS!K5FJS:,#@R68JJY:8
MJKXH69N:C/4QS2M+65N."PYL\=,HC!<P!^-0ZA[;O/(:.VN>TYNW[KRM [O;
M<_$?@Y^#BYN$W'NW\1.FW.I'-1ZZUCI0NG3U<4Z;T>- TM4A6M5CPD4ST\VM
MM;G.Q4%)V]E+959R2:+)169%*ZO]'6H-27FK=&:G>4\H/?$7MKKBU'D==4N0
M?(YWJ_EMVKY6^(IA)'5#:6R>GQ,/I]-5V=-KWR'3J>A[SS72_N6JK3SGMT+5
MA[]NFC0>KO,49BK_ ),.7:</=AZE)+'C551I3TA^XFNJ'JRR,O[DJ34G?.W8
M&UB&Y;*03K<0*%>''$A!3W;L0%/$Y&32U#?>Z>X#W'=WGE:M+WO(T<H/VL2G
M-5;ME9A4^*EGFX.>?0A98^YJJS])=4#4VH8U2]GI\;@<FTY2U*C!ZZPJ@U!V
MYIS!B5W7$KPNI6.<'"Y:&;C;DFVXSJ6BH:/3ECIIY ^9TU.K7^9)6CRM0=!F
M*&4P2VG<4?"TR!PJ_9%56P"%BT3Q7,VK;UA<4KSVG[2P?P+)7"J9$XD7!ASD
M1O93V%:N=QN,'670M%9YR2[QF6&B@1*EK]F49KKS)":WH[@628I#(SNP>Q3T
MR #+&"[!,LE:$MQ0@G]T4*5D\)-Z_HBF*Q%8\]FNH5Y[]:.)+X%@!!:@L4UI
M<?<K+2%*+&7!8:SXU3?IP 1RDTY=VZHV8SFL1FMK&7 08@(@2R!(H8Q+$9A3
MS#,L0)"726/2%J77M2#5VIXGIY%L=114M$>VM</=!*4ITNS3.O*GB*#$9$@O
M7=K652U2J!J-CIG6VDZP&E;U34:53">G!AIEI0DI:VR[O;H"!$5J@Y70RI8J
MY79V%G!F3/;U_9:7U)>S 2V> ^)PRX<+P8G6V]A519D&&>(9V1)089B"(ENY
M(7MEUE^-<<T;-NU7]'-2"5Y#2I[.:V)5U/$=<O+A0#);S6TL[;!;$V2]\G4O
M/UJ%]GLZ\DGJDFB].5L7@9%BPHZ6JJ;9*?7$Q,HOJIQ*$X2QA/$9<BQ\8RNX
MNRF4ZY;GT(73#SU/!Z^!0=TC)8JCM=@]I!\ V&^1"CU#3KLVF%1^8BDZR@VC
MF WK)UO3VG*AOLD=7>>CO"AQ*+K"59&ICBM@QB?Q*+OF9/,H0ARMB$-21L(F
M>6<T>T/06G#1L-.5%IDEY5U5];2G:)!L2]];M5HRNGY69XR2(%5HXZ"3223&
M!0)-(Z+8.OINXU'I2E?J7BS=6-7:C%5,9'GK*!9'I2W#'D;Q"3>7A# 6V7@M
M6<']4:DHI@';(@0$F9@.&(+SLK>OJI,Q#//$0ZPG9L+1/$JW<C%W*[*_(N1C
M4-SI9'4&J2WEFEJBXU2J.^+8V4&)VP6U?-C6, [ZZ[3$Z<(43O.A+-V+.0@:
M)HS6V@>#2KEB![8K2J0264L:+LA$=&",Y(<%HA; 1>JX(!18@HS-T;LK5S'B
MFOTX'&G=U5?;JC9C"#(UK)03@(,0$0PHGB(T8EB,Q88GB6($G'I+/[AZ-_TP
M_P K^-&AJ*ZCT[JDFE=*W*]ZM4(+EL;+W/AY5KUU9/S%A&RFT2;9H$F<;N%K
M*0GLJR2:GZ+->/'4<4..MTEYL"8&5F03,LUI-]E@D2A.$L0!H4VUXS'.+5+A
MK$L4=7]S5O\ N7ZGH].<'D/GGG( G[SD\Y\L[;ET]?;>WX[#FV]KUYQ=>?IC
MA<T]J'T@Z'L*>P[?NU."*G+VC0'0?'I:$6:AL:6"7XHT-VS9/<.4HYU-Z.-=
MG1>!J*\8LI%T\Z[\0+*='%(PF&T$IQ>3L:C#D!D582GL#!F#0"'6R^#1P'M0
M:6+>*ECY77+7R5WL%DL#,:?'EV_H^Z4%V%TRGA'XT(%87+. U#DXZ:OT05.K
MN!]P<TY0%26JRTP2@&O&X^:SC:Q6,8IJ^,7H94K7+/#@X9DFK9JZ&LT:;5)>
MS\KLK(<"I+[/1RJ1WF@2OM89YJZ+8!]4#]"EAG'%G',/_A.T/_H"?_ZO?%C?
MW]CIQM-O3C=0,=0W9G9PR>SJ'(3G!RH0%@&!(&C*432GOD/&!YCF4H>B'] ?
M\>VWW-14':=W8Y1,_0QCE(9X7]>.;%7@#+\) 3[P\?+6S[UY9K7G5^Z7@>98
MZCHKRQX/<-YAJ&.""!\1I,XY/NE4 IOM+'RZTA9LV$\J'F#S:L6$8O.!4#>M
MK!,ZU[Z2;5S5[V''%K1E:I=.3&DZD-F$(S%JJW3?89KU&,]49MN0@NAR207L
MU=#6:--JDO9^5V5D.!4E]GHY5([S0)7VL,\U=%L ^J!^A2PSCBSCF'_PG:'_
M - 3_P#U>^+&_O['3C:;>G&Z@8ZANS.SAD]G4.0G.#E0@+ ,"0-&4HFE/?(>
M,#S',I0/J_T)3>-5S1L3246.BS95 -F"-4Q:^UF3W3HEZ0/3"@M9V63K!&=:
M=HDC9V(=(^EVC\I:EY/70M,(2H7476I+#E8:K2MW55546E6AVK#R(J\2(ARF
M"K85;'V/W-2Z?]"FB*.TM)=Z?5.NSX!0Z3\RQ TZQUUZHKW;35?<VC%D*,?D
M9WIC;<JVV*LSERIHH^H]2 O2NGU1)-6OHP4-33K 6TF*0DP3<N+9@[C'*TXQ
M97CL.N0A160$(F&/%W^8]E]?::^ZM?GIJHUZD"2R=T6O4);*+2PQ&2ZUC,67
M  E%MJ,A"-&&<,L8S'XXFZ>FM$K6M'>ZC.&BAJ'5)5*.ITXM:YRFQ>SL*FV?
M< >NB7!0GQ$$$<];.9#]CV#K32-_5:J<U*==ER\HRY-4YA7!DK&J1/!UE9X%
M99SN<8LH 09:RSD3:@9*C"*.JVD.< GM%ZKK5^Z$+S-*F6JUIQY1X:FERV-&
M^EU.ODL.+N,+E!,,B_<1TW3+'-;*56G-+1"62P(.6UHTQ:IP6,1C L (+4"*
M\C-R5P-F+&_&%QP8)]RYN05]'0]YRV>H;4*B%7W7;]RT:PN7H#!S\'.VR5MT
MLN/F9-(F.0LLM>CKT4U;UI51O @U3K<^%5M&R!6%KSY20M31/.P[>Q;2L6I5
MO'9$5J\%J%+RJL)G\(Z<D8#5F0Y[2]<6[GMFK9SCA/MXLDE+ %$P)UHB0$GA
MN"47B)+,M''ADNH&#K%EK'6*P"7)9AG)9VINT],KBF[*,L@;3/5*T0H9V'6-
M7@KXR$1:.?'HW_3#_*_C0J;BX&TV] :96:59% ZS*Q].I".NP L9", PI2&4
M1(R@2$I0G',<YQXP5PU'I'3J7/A< QJUB6"RBU8E5K4%H0[EYG8XS!"O7*ZX
M7FD$!BYEUH[2KJ'M'>CNJ1A&MLM6A76==E92KF[6UKJI3E>=[U$J7E>.]G0-
MBIY$'=H-N,K0KZBM#V]=5(J5J"_(4W DB :RH>4\RG+Q %"'(8A"SZ;B3E/.
M99I/SXK?J'4OCT>_F/I/ZA0_D !-Q<#:;>L?1NLTJR*!UF5CU^E1'78 6,A&
M 84I#*(D90)"4H3CF.<X\!](_H_6!IYS2@%IV%3IVMA68RLL]E@>HJWR54)5
M[6I*QW%@T;.S%2K%R+:4JC8^).T>!G7%.#.+Q7@@EEY:)\B6O$@0)(1@&%)8
M=IE:(()VTR0[%%)NJPQZ0OS'U9]0O^+$_HUUCIS3]%'4;8FD[=9<S)+;%943
M.S"1=+7<L FG-$48]T/&\),]O'KDA05&J]=Z'M:Y=X=D%?;-'8Z$#*PS<M;H
MA,\MH'&(<<B9%GDW9AF<82C3^B_5CH(V=2>RL$[>E*RPLA;&M;EM%P8VA5\G
MP13M9JO)M!#@L#,Q6,NS%2Q!A(56>STC7'O', BD+4VG.V!#.7+ K5;TO=/U
M6<DQ<+A::H(3/W+1T\SS;BD90JGE6J:A%0]NER [)SF*<!':*,FRV)413$O)
MV+(,>5ELDDI-OYE!L_I3!Z-;VJT_>QM=<%:<MQ#,L2IQK%>!UH1+37<<'FY-
M$L9=J/.P),=Q'KD9;"HLO21H=BNM46ZU]?M !YTG@$6:#R@T"(XN4!9PY D&
M6'7<.<9XQ+&K?="[1N>?>0]IY,R^QQ^5^<\_<][6UVS?YB'AXN;=M+OX^D=_
M_P#W_P#*G[EF^)3GN-)?[X*\L,I"+!(&8QOQ$8:AR=CY/W%B9-8X"MNU=;M[
M@@!+%9N[5CO+'T<HRIW$I\"Y6-I.#1RHXUXFSKHV #UM"&V;0CU=2LF&>>";
M+9*6M<@?SUH'G.J67#+.6+NJ+?H[=FL+%;&VR.)PDD0ND*T::*:8IN-<433]
M*8/1K>U6G[V-KK@K3EN(9EB5.-8KP.M")::[C@\W)HEC+M1YV!)CN(]<C+85
M%EZ2-#L5UJBW6OK]H /.D\ BS0>4&@1'%R@+.'($@RPZ[ASC/&)8U[4:S/1V
MM=K-&LK9KTSMI+>D$%ZM9!9*9"I.OW +:$ D4)DN/C98F&<1RE?67HJ/:VFF
MW +?*4 55K8E6(WM62L=,LA9*]:UA9YQYI5U!H818.X,E<%JTKU/<5Z0*4%!
MJ1NU)75YTA3KJX+(0'P2IN5;JR(^E:]^MV"<0R:F\\Z&ODDD8'*YX8<<8 HF
MH K+33)8 666!"13L,'+*(@@"*,B%*248#A&4YRQ'&<^+:H]".A:.BTLB\+O
MM97"/DM 2RDZN%[RS2M(NLW?/&H! <6[JVH#AC),=WY9CL V'HGA?WWNAL3O
M:-;DT.K5IDE '](5OE:LK4%YL'&BB#$!P)965M9'+DQF+"<)B OZ0OS'U9]0
MO^/21^A_^:/NZDUQ.@ L*1TF;\FG:JL#;6[+MI!,+#<\SKXOGBY:D/,KC>_&
M#-$C*122B1'0E'=(^CW2P^&[U'>ZYL04Y;#M'0K0J$5%+$]=8=O!O%R%!YX?
MF3J09X+4XJ>Y=HM*(2Y04R,038Z%AWCI9S9LG^(S#<U_,+$[3O:X8*)7G[<&
M< $.."$?0WG<](UF""_="C\BUX5M:M?Y0X:A\"NU$K:=KG:66WLCY3/DD@_<
M%.E6/.2FOZ(1A,26!/9H6%>"_9CF3&19 ,6G[%Q:/)W+*T11BOAPN%<?<9*!
M?3FCJ(9XLN$$*LT_4P99RNG%AF<(J)Q.>6%58E+G>7.%P8EGH./BHIO1Y3/)
M:%JWG7FM6ZG%"HI;JR%YE7(-5>,K-7#2*HU;!;$D!%/AJWB&^JJO*0#YM-*:
M6D\6QIM#WP*UBLP["R<ORUC[,WZ\0V&W5WK"[.5U155@LE3G&NEG$!!CCTA)
MR8!%PX-,,@5D6&&3+*3OQ-,"!F7*0"Q74QL%A', S;6@249'%B7A#\^/1C_]
MIZ3\03OZ:JNTQGBR-6WKU+)8;,($%!B '!&%$\1&,.)8QQ/$"DAB6V<L97':
MG._=/G17J]*T< V.J+6=BR15:2-1SA+($BA8CADTP+$,#*82EL"K*'QZ8/2*
MB"C3G:XOJW3;)]]WU554]R@6(UHT!)@I182P65AQ6S+=))6XH\1?.QAA-Q<#
M:;8"K-*LB@=9E8\)".NP L9", PI2&41(R@2$I0G',<YQXT]6LT+R]=:^;>5
MH:4JZ@*2G8E4.[N5(_4@7[@]M$V.W@3E+E@A=L\]2)75MJ.CH-+4CTJNCT$W
M:%+JR^20(I;V;$J@5@I!/S^N(T-VZIV2E0A5 1X+#%5FUE^XZ)]R%SYOY1[I
M/,/VNM4.W[_R'M/G-%+EY>R9_@.39Q_&;-X]V@]$JVQQZK#IQ"HE3,5EC&>6
M=/T^8.3B\-8M3P$7K3O+2R_B<UI"@487<S4@#TO:9D=1Q0Z&-3L!LI@969!.
MNK]-WE9#.TH3A+$"#>4FXS'.-4VLCB6+9_Q1T&L'SI:X.=&HR3R<^*Z_L7GC
M)H32G6=Z)8Y!=C*TD\&G1@\V3* XI0S%:RO8Z;>>]'UOOK%GA@/Q#I;HP;2-
M?6V!7&02O*,]7-:"ENW%JW2K3,D&@*S7L5N*MU ]<V)?BT*BLTUJ4ME:NS^"
MK6UXSU*X"//'S!92!F "D<HXD,*&<SQJ/46IH'H-0LVM9=U:(H]E;::KB:_J
M6]/(LN+$'(MK6I]M*+T4Z=X..W!8(#MU'6F11U%?56E-5UP +:HHM13]S,Z^
M['DRU@NI"Y8Q$X(N*,3@(+CC:*Q%1VT5'29!XSZ1-$A[C2VET2UNI]2S(7RV
M\U/Y'9TD0Z>)F9X6';US=.,Q%8*U^ (%>WSQ95;-UI_TPZ3J#VDDCHV.H!C4
M;>62L=*<#E?;6D .]R.J9K$H*.R5 @BA"GY678.6T)91<MKD^G[,X,2>IF*J
M\L)H,XSF!11>K:DZ;8,RCR+,0D.95IBFPLFSDJ@-0W(:YZK]'84:E+2Q+BKD
MF[J=W,FW7-4UG-)5Y6C:1:KPK"<3<%8BPFZFU5MANJN6@=;4#Y[JBTV#2Q;&
M:R#BC.9T^JK*V;677MPULB'[,H<BE+,%IS+&&6([2;#V^E+/S6N7>)6F8[.P
M1V.A LR0/%9*IGEM XO/DB/(L\FW$\SC.,?$]*5E\]6UWI-[J[LC)VATW2Z:
MMYV-EJVH9(NA@$^<]-<1K$#KOH%%Y/BS*2?=3%XT_P"F'2=0>TDD=&QU ,:C
M;RR5CI3@<K[:T@!WN1U3-8E!1V2H$$4(4_*R[!RVA+*+EM<GT_9G!B3U,Q57
MEA-!G&<P**+U;4G3;!F4>19B$AS*M,4V%DV<E4!J&Y#7/5?H["C4I:6)<5<D
MW=3NYDVZYJFLYI*O*T;2+5>%83B;@K$6$W4VJML-U5RJM'Z\MO(WE>?W+6=Y
M%I6MM]-1FY@72\=,1&'E#R%G3"YIUR$ *UE17=T\NT(>B]%: :1U3K 3S-E*
MUJGXNT&G=,'%VUL:[LDCG1!SO J2Q'@+EA"*6 "@)BUKE+CQK&HK0]Q8VNE=
M0UJ"_((/.Z]4-K*AY3S$ 7*<L(<AB#%#KN).,,9EC5NGM<_[V+C%X(V6SU-J
M>R<XP32/3.@0J&&D_<^TH8L1/&Q\?=-P"L$@FI&T?=5VE]1U^D4#W:=;J>Y0
MG7+:@9LX5;8C5JA<=R.J9K$EK"GL'>VG<0.^,*8ITKWB3^E+U&Y +IW$ 2F)
MU/>5@(N_K68 L:_N)J,95[U4'="%DZ_*#,29U"AZ0"'K8KU5MIH[H$7F5AL^
M85EBJ_PX6A9EJK-:NWUS0:\DSP>08D :92L@/;Z4L_-:Y=XE:9CL[!'8Z$"S
M) \5DJF>6T#B\^2(\BSR;<3S.,XQ\-TU;J&CL+BOY^_JDK9!NR2[0\56N[1
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MI?3M<W@O,DEIC%)8IOG+(^TUI>&M'B!1IL8)!FLBV?\ X-_]</\ \%_&I/\
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MJ1 "*Q<&W@P$6!2CQPZ?LXW[6EM.,WL3K,QNF*2L-;192P**;$;$BTG,'4B
M$5BX-O!@(L"E'CAT\&K;>O1M:YCC[A"R4 \D?A+ XN95D90%XCB&8>^&=A1P
M)'I.,<X#6U%>C55R_)VZ%:H!%(',69R\*JPQ %RG*0Q-D,;RDF276<I9S]Q2
MYLM/4=A<5_!V%J[4H-V27:'DTKVCQP3:6[9J<V0<)8<)YR,/:269>#5MO7HV
MM<QQ]PA9* >2/PE@<7,JR,H"\1Q#,/?#.PHX$CTG&.<!K:BO1JJY?D[="M4
MBD#F+,Y>%588@"Y3E(8FR&-Y23)+K.4LYKG+2FJK)RG/W-2T_7J.,U;.\!>X
MKCL"(5(_*LL3E6D.>]<$]VX4,Q^YJW5MQ2:JM]"WR-S%74U8D?4/E8'[.AOG
MWM2SQ8V-PNC1CBX!VUL\DLK?L36*RK69GP$RN@2VNMM7-@=%1T=3IB^/.3PZ
MYQH#+H&@5)352Y5X9L8UQRV,5I2*%?,!F,%_TIZ_]<-1]^TK6'35&>J\Y/W;
M]JZ/"\/+KRQWD%%%&*GE5:TVDY'+#QZ^J\,)N+@;3; 59I5D4#K,K'A(1UV
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MV5V#K&Q$P>7#BCJRS>H]1M]LBMT&(0\1F[8NSC.2];6KRG#N7F=D]D-\!"%
MS;9ED5F60AN=.>@]YZ@L.0],]9:[T_1.O5N2SBFZ:J=4D=/O 1@R./*P"8B0
M,HVXH0+1F-,NUKVD=9I]U@^G;:<9<Q4SLP;5KVI#4.P]7@!$]B@W75SH-S'
M!Q>O=;"PXXP!1-0!66FF2P LLL"$BG88.641! $49$*4DHP'",ISEB.,Y\,U
M7HFT-:^D2-8"+%M:%LEM(5(('POV<5F;I:13',63@9+.KUC,LU[!D!6"<#LK
MJ5OI5]'EYH;S3@E5OI6E;JVM*#GD"Q.VU7X3X?*^JQCJ5\+:RX&(DDD+E1P\
MNXFP!M-L F56EBP.LRL>$2@87.*4A& 84HD$4<I0)"49PEF.<9^ZU4527?W>
MO'EO1]3+RXL R[J@;"Q><IG48+]:X;T%&)$F(-E-*30I)=S*-OH.S8/%.R/:
M:6D5XLZ19EE0LGM-W6:UB1A,'MA+X4HPY/F<H:EQE!QB)^)WP[V2W/J+3G)=
MT?$'D:9X!Y\SJ \23CQO-$<2[9!3@[VZ5IN<N! SXL_1X[/Y50<MS1_!_?TK
MK6/,UOBDX#CY?<-Q9YFW3--^><(!15K,[<46E1';UQK8\M-Z632+@;T)G#*=
MK<CE%]!E,%+68,?SD<Y+4]B6K9L>-+)21KM+5I.Z[7E._926 J>ULFI\C3IX
M Q_XBJD3%:.M6JI)$;:[7!I>-9_H[_BNC\7?Y\67U#IKQI[4F40>>AU&K1PL
MXXS%G-2S67;Y$2YCG$3@BXH)A?!XDRI.3/:Y#WKF#L+-&Y04VJK:MK8<8H=N
MD5.JMYAW#A&9NMC:OL<AY%+CGXL3P 01C8<<8 HFH K+33)8 666!"13L,'+
M*(@@"*,B%*248#A&4YRQ'&<^/*O=LCW7?>7\O8W'EO/S]MR><^7>3]CR?"\S
M[[RW@^5=WVOQWA=Q-@#:;8!,JM+%@=9E8\(E PN<4I", PI1((HY2@2$HSA+
M,<XSX!'5>HT:H[''D*71AZRF(W<\;7E=:!RQBC*:; N_DMA+!Q]OD^#R@.5?
M&MU@BP>UO%-.H)=K9ALCVCW'VL?*SHBL1(EF6 O-S+#IX'SVY'HGQD>/!:BY
MU@B*Q!OPRNDK9W/:E$<RQE6RTR-@!1X!URP.@R03H.D9&!"!12F*WTW;HW-<
M79CN$C1+PEF +/:MB]XZ+PP, F=!P8'5N6,6 "GG;X[.ZUE5#<P=M8RJ'=7;
M*;*,X":7L04:]B6L.(L^/BL(K3).!X#C.2Y\#J+6YU4BFK?(H6=4+A>8LFJV
MT 5E&P\F55/< 1.,!8]VRB$ SQ[4Q!M9B'-;82UQI596W1A95TG[VNK2LI3*
M9?FPL^PLU#8TLRF<90P*LZJTFQ 32QQ0FG0:ITY=N#!)DBM1=UEDR-:$QBFQ
M,";)BQ!$I@CD64<0Q,HX9ENG'&35MOK'2M58K\?<(66H:A%T',*!Q<RK+8CB
MY0%&8>^&-XB0)'K"4<YFY07-5=IC/)8C518*62PV80&6:\SIE,*)XB,$DA2E
MB>(%'/,=LXYR6HN=8(BL0;\,KI*V=SVI1',L95LM,C8 4> =<L#H,D$Z#I&1
M@0@44IBM]-VZ-S7%V8[A(T2\)9@"SVK8O>.B\,# )G0<&!U;EC%@ IYV^"V^
MI+=&FKA;\=PZ:(N8L &9[507OG>>(!<\P()C.ZSQ2BN L\;?#?!K9&'9(GL#
M=ZC<5F\"VWD&IYE7*>8/2WXX*Q#N;)OX7:J&V3VU]O6F[BNM45+)!CC*'G2>
M -E4W$> CBY0%A/C,,98==I(1GC,<?BS]XY8:D&W:Y&TQ 5DL4,"8A@&T&7Z
M]UD8=H8\2^69 5CT63&NF)=8-=;+6.HYL5CZE@"!VZR09F28&R*)HPJ!SD*4
MQXP3$"#EF/7$9QS[^/ J5!EN*:]GJZFGN-TFXB@A<9 -[AP$3&.9%1J4,BP'
MN@"/ 4)"'M\>C?\ 3#_*_CT?B57 L*6CM.LR&N* 829=JE7'&)0'&,<G;<.=
MIDN<;SLF*<LI%).6?N7?YCV7U]IKQK(%D+=Y71V.H4#1@#)U;*A3/9*E 0X3
M\'/P30;F' SDK7'51F#W&9X]*_H\T]5/6_FJ.E[E3Y=!:M1LJW5%7SK?+9!J
MP/757@S/,5U4[ -,\,!.<4>UKM+5I.Z[7E._926 J>ULFI\C3IX Q_XBJD3%
M:.M6JI)$;:[7!I(?GQZ,?_M/2?BSTS;"!F+8"2KW"@R>=1;1"6"%NM&!EB\Z
M12;I#@R##BTF*]B>4VV!STSI[4*?E]Q7^<]VIW"K?%W>H+5T'QZ1V59[U60E
M^*-/;OV3VDC*./&W4#!_<51 M+5*BY9ULQ:<6:6654A!63T<6MLXS53U&S!P
M9S+1;'7V2T$J<"ZZ::X%$U "6556% "RRP(1$!=< HQ$$ 11B,0AQC <(QA"
M.(XQCPQJU9'=J+2?;G[E5(K#K=!-CBL4#R 2&U&O[N5]EI@+<:X2+_%A45@^
MQX]'OYCZ3^H4/!:BYU@B*Q!OPRNDK9W/:E$<RQE6RTR-@!1X!URP.@R03H.D
M9&!"!12G)_2EZC<@%T[B )3$ZGO*P$7?UK, 6-?W$U&,J]ZJ#NA"R=?E!F),
MP3O]4Z<I'" BR-6WNZRM9(M.9!08@!QD)9 D4)AQ+&.89F(D,2W0EC$TZ#5.
MG+MP8),D5J+NLLF1K0F,4V)@39,6((E,$<BRCB&)E'#,MTXXR:MM]8Z5JK%?
MC[A"RU#4(N@YA0.+F59;$<7* HS#WPQO$2!(]82CG,W*"YJKM,9Y+$:J+!2R
M6&S" RS7F=,IA1/$1@DD*4L3Q HYYCMG'.2U%SK!$5B#?AE=)6SN>U*(YEC*
MMEID; "CP#KE@=!D@G0=(R,"$"BE,5OINW1N:XNS'<)&B7A+, 6>U;%[QT7A
M@8!,Z#@P.K<L8L %/.WQV=UK*J&Y@[:QE4.ZNV4V49P$TO8@HU[$M8<19\?%
M816F2<#P'&<ESX'46MSJI%-6^10LZH7"\Q9-5MH K*-AY,JJ>X B<8"Q[ME$
M(!GCVIB#:S$.4;VB>!95-D##";B^<["PZYA*,HSQ$H3A+&8&5CP&RHR,JS(A
M,"(.):BYU@B*Q!OPRNDK9W/:E$<RQE6RTR-@!1X!URP.@R03H.D9&!"!12G)
M_2EZC<@%T[B )3$ZGO*P$7?UK, 6-?W$U&,J]ZJ#NA"R=?E!F),L.., 434
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M<XC')VW#G:+$(PK#F:0U5UUHB /27HSU%: HM%:9.&QU(>S:S75U@\>J\]D
M[/G"B\0'J<)T=8_+LK&M>N;C(.Z@5>!3:6L-5^CD^G3HCK95&-2Z? D-($81
M6"J-=\79=EQ!F@1/("H%  R<P% *<-1:$=;>9561'J"A7G@4TJP4'>VO!#+*
M?=![UJSJV0ICC-+EA9-?)FF32=](;OI+."BU7J@\>*PNH926IYUK%A.UTR1^
MV/-RD!".*Y9&N=-%;91+5QCX=6K%V/1WKW3,J,5C3:JH=0V-J+(("U)IH4J]
MKE[Y"O;/</"!6UT-/S.X)""1W(\V(%!*">F4,G"YK8[2S#0\S'@5)5]H6U7B
M<+8"P/8%<KTIBF!I1NI+;K,1'(@<RK-,U.O- 8BH <K!P6I:($[>VD$4'[=F
M,[9DO.Z4>Z(YLGPFM%>O7GA-1<<&$=%.@QH/5-K45!T-,L*6%(ZS=TZN%9@Q
MAB:0@5FJ[&1=R!83J5/,:VO'%69:PVGM291!YZ'4:M'"SCC,6<U+-9=OD1+F
M.<1."+B@F%\'B3*DY,]KD/>N8/2(PP &I-3:<TI;%UI;5X=07R,\JTC>$DF#
ME395JE:Q,>GZZN3<464JXQQ*+!I-$;SH9=CS[4U#YK<:<NCB*N7S1AN3TZQ!
M9NZ(K3HW"HQ5#2T7HT_>RQJ1E,ED/D\7FCYS .VJ;6=R(6 URLW*FR"L#)L9
M!F#]F=%]8@GG7!%RFL]1HQ<ROVJJOH]]&YD0,E3.QKO4CTL9@S7:/2W5LJL1
M>J;$P:OMIAKF)55GWE;.O6L6$#B&N4-5HRC!Y=[JN6LCV(^T50TU1C2[VO5[
M1E7M>Z[JLK8J8580-2SM4RC%N!NK-,U.O- 8BH <K!P6I:($[>VD$4'[=F,[
M9DO.Z4>Z(YLGPFM%>O7GA-1<<&$=%.@QH/5-K45!T-,L*6%(ZS=TZN%9@QAB
M:0@5FJ[&1=R!83J5/,:VO'%69:PVFVM<+GCH[28$_*8R19:6Q"TIRD]TPDV"
M$"R='4C$<,6-2#N80TVL)<#-I4PA.W3J'].7;@P-K46H$6JRRQ37<.RL(+XM
M5@6A:\#905H[P2<<-GJ2YAB.Z8)XTM0.3 1RDTY25#1%I3FL1FMK%DSS7F48
M2R!(H92%(@13S#,<S'"76./Q:PT6:JKPU2]A=TRIQD8S81+10<G)Q@LI97.-
MN:#/14:BTEXM QEIC*DY.?<GJ]:FX]1=_8->8>86L_C[()8.S[0CTD?CHN,X
MV]ML'R?%1AF$-OCT;_IA_E?QZ/?S'TG]0H?=M++W.:JU/S:5=2[#2%1YU9"Y
M+>C/W9U>X6V(P[;A(??G:<ZP]N>7K@^A="^BG7]0*_! -A>ZGKV--3BL+)V7
MZP4YF'4K >77 L5NPO-CZS+]-Y5,K2YY&7DSYAJ*Z[0^HGQR+A+)5(G[5"M!
M/9M1K^[9C!HHH.OE,9EC !24KD/"'Y\>C'_[3TG]WTA?F/JSZA?\>D)R2X).
M !IA8#4A0RR%9N=^5I<1\QY1@9*DF1@4)8@::BTR1E( LQ\,)N+@;3; 59I5
MD4#K,K'A(1UV %C(1@&%*0RB)&4"0E*$XYCG./%5HRC!Y=[JN6LCV(^T50TU
M1C2[VO5[1E7M>Z[JLK8J8580-2SM4RC%N!NHZV-8!*]-5(EU,SQUTK%FV)S.
MLK.V->*,; %4X^XC5RF5G"Z,1B&P;X1BZ8]).AR@JK#4P+6-U6C7GBNM6:YA
M MB6T%%F(F07HK)3#JX IS@]7>=C9\Z8[X"]A6H?MPS1JZGT89L0(62QW4UK
M*%7(F'PJ@\Z5Q"K=P9XU:N>8+$D625BDXWFCYS .VJ;6=R(6 URLW*FR"L#)
ML9!F#]F=%]8@GG7!%RFL]1HQ<ROVJJOH]]&YD0,E3.QKO4CTL9@S7:/2W5LJ
ML1>J;$P:OMIAKF)55GWE;.O6L6$#B&N4-5HRC!Y=[JN6LCV(^T50TU1C2[VO
M5[1E7M>Z[JLK8J8580-2SM4RC%N!NK-,U.O- 8BH <K!P6I:($[>VD$4'[=F
M,[9DO.Z4>Z(YLGPFM%>O7GA-1<<&$=%.@QH/5-K45!T-,L*6%(ZS=TZN%9@Q
MAB:0@5FJ[&1=R!83J5/,:VO'%69:PVGM291!YZ'4:M'"SCC,6<U+-9=OD1+F
M.<1."+B@F%\'B3*DY,]KD/>N8/2(PP &I-3:<TI;%UI;5X=07R,\JTC>$DF#
ME395JE:Q,>GZZN3<464JXQQ*+!I-$;NO1KI6Y/9WI@,D$Z5INIA888NAV+U6
ML$M@^O5 L*F)JB20V5ZEYEAAFQ[?S.R9\9IM5J(H6);RQ?"FIFO*<"1AJ!'B
MS<K89 \\0Z[!AGDY8E'6EKTLM"@I"O1:KM#62+&EKWS@>9UDZMRM*D]IG.J3
MUM>9 /:+HUM^J$"D$>,JP*\:!C$QAK!M+U"<#PHKBU=)=M"BW&$F:P*I:>K9
M.(D4\@;D=ZQBDV,LSLTJ[:NSRXV<Z'K95Z.:Y[0]%WJ&5 92<\UIESVG=*\?
M QYD=IDS_+"7>%8.1CDF8F9:VH[G2]'K"N"BHTMJ-VHC8UJ947V% @4A<U$3
MK>Z,#I7@89Q7.R!22P9"<QE[)/3*&3A<UL=I9AH>9CP*DJ^T+:KQ.%L!8'L"
MN5Z4Q3 THW4EMUF(CD0.95FF:G7F@,14 .5@X+4M$"=O;2"*#]NS&=LR7G=*
M/=$<V3X36BO7KSPFHN.#".BG08T'JFUJ*@Z&F6%+"D=9NZ=7"LP8PQ-(0*S5
M=C(NY L)U*GF-;7CBK,M8;\I:DH*!/O[9_R?M%.X55Y>UOJMT_Q[IEUH;%ES
M$^,-#=LV0W$E&.?4_P#U@TM]M^/4_P#U@TM]M^--T%^GV%LAYQW:G<*M<7=7
MUHZ#X](S"T]ZS 2?%FGMW[)[21E''BD_,>M^OM2_=UG^CO\ BNC\:,_2+_%=
MYXUH)5<[)8@IV9#7%,TXK):BJ''&)0'&4L 43 =IDN<; +!*<LHB'.6%[2ZT
ML=V]K[6SJ+ATMO>)P:9&2%BK-8-?="7X!U-E7+2EVRTY,@8W#G[S)V''-*@4
M34 5EIIG4^IP+++ A(IV&#EOHB" (HR(4I)1@.$93G+$<9SXTI4/GO*JNT8B
M>MI%Z9U6.Q(P*Q:(62VJ%L=CMP5*L DR3!<_&R/,TY8E'Y[UQ])4/_1KQ34"
M<SD3I*JOJ%2,RA-DBU:H),$V)B&$4CR$&,BR&$4,SS+,!PCTC@U'Z*J#W</0
MXQ,ZJRV);T=TI3BAF7=:A%(OGCU7WM6\_I^BP1T]<R?"[D'E&%AAU=Z7+P_I
M%U7@"4,+E%!#2]=A7"9A*+52HUXO 6<&]NYQJ5-J%]@UAIS#ICF)J'3W<]GY
M]1VU-W?#W':^:('2[G@Y0<_!S\O#S!Y-NSE'UW8UUI%RN.LXQ5+/M99WK,U[
M.FK.=8>N80*#!<'(74$N7D(&:DT9!F DC9R#P/RKY/V6N*SE\P^*W?[GR:GG
M/'VW=]>Y]S3WEF[;S<JG==EO-P&LK>P1JJY?C[A^R; BD#F+  N9ID@@"Y3E
M&$>^>-Y20''K.4<9BOZ,JD^D-/E.M//I)U>H,<VT8,B*4FDM(M+L,V8+.L84
M?JK>W@G7-+>85Y(UME #8?=!*;VI=9G[@KNJ[T\V'9M6 A8M#)+[Y 3[P\62
M]R7O;K K!U-BY;7.2,M+ZF!SD%IZU=0< )29H#6U %7,;%EJ$]J8%W*=5"/*
M+,&&;9<>#B+@8F="N]MVO!1BIN+FY]WN<,;3W<[^(/3O/*^[X=N>WY^#E/Q\
MQ->.-0.01M./U$8KQA*>&=00Q0)SE@A!1X!N60",RQ+,X+1+,0S%Q ,];W\I
M@RG96M14 '&4^YBS2*-N-3+#(\"P @M0)Q7E TYRF-G!!BC 4C>+?4EN7BKJ
M9$SK'28(%-Q1^*45[DRX"//'R-- $SB[ETX%XRQ,L?%=J_T@UONDU9K/EU?9
MV$;6U0!CW13\S6 !2G+2JAZ*G$=L?;%X[([HUV9H03&*]'HS3GENJ8HR/2,>
M;W;G(ZK.#,4.*UOL5T?-8!G5]TW\4CWG>YQ+*^(YO- M%/)RL//451@IV3P\
MI;RLK9*+"R'*R $+/(')0PUC+K-^P82N) <.3Q2?GQ6_4.I?'H_$JN!84M':
M=9D-<4 PDR[5*N.,2@.,8Y.VX<[3)<XWG9,4Y92*2<L_<UG^CO\ BNC\7?Y\
M67U#IKQ3^DO0X$5*>Q>.9%(=<>=;3V78\%K3-QEF2HT;Y5A]BO$FRB<()V:M
M4M7#IE6Y5FIJDH,Q; .-@F(^3SJ+:(13?J&93"L7G2*3;$DU@8<6DO8+PRFV
MN2<$-9T[SNG=2/:;2@M'ND_,/,],H45:V!D+5>6:*FHHPPV=1KX/8.@Q%@H2
M*3]3?]8M5_;GAQK2-0"LO<U4%W8QNK=]F%38M\@9%3L;1R(0-N4Q,+L\$,EF
M@R()<\3,/%;Z0ZT]K3/VU4P,-FH!=>;#*^9H!CJ.M8"6+YZ-Q4J,YHNJ3<6#
MVPK=A 54PM67M5>>=:6O'EE;#"BI$A6H*R2;YJJZ XI;5U.\[ EDM2O*-O64
M4A6K*TE<2<5SZ/7(KGDF ^IUCM1%/*P66X4!55RGQ'B&=D23A%Q3EB9H*,S'
M&40%S&FOT]$G&G=U5?;JC9O]3P9&M9*"<!!B M0F%$\1&C$L1F+#$\2Q DX]
M)9I;)738$+8%JLQ1S+J/469DMJ[!+8$5EVKN8G#@%7G>DMD1\9648*44EQ&Z
M4GY\5OU#J7QZ/?S'TG]0H?<+=D:WZ=UEOM;?=+F.&EU58&\VD?CJB%AY1J)
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M1S=:9KWE1E*XQJAN_3H,%!%BMJ6(H5ZL^T5B?RB%C T5I3&IS1K0+++?<O\
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M[NNSX]_Q'!W.[XSB\$](#6I- !U)FU1MUSK'MXK),U?;8JH+JFTN<4P5XDU
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MXE-)$I<NNN[ER]ZUR98SJ" #_P <.X+ \I3@\[K22U5\R"PMS5$Q;(J4C(E
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M_P#8X[$2N%)B']Y-]+-"[4[ 0H3:-/\ F-A%A-/NNB[)T]UIP8BP=-:VN_\
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M(C8<_,.V?C;'Q#CT_@MJ'J'+9.=%8+:?[(0(*U4 =N-AA%5+!^Z=Q5 *'BR
M2.FE2_FE@/'<(-:-+_!*(Y_7\E:_V[!"OVA.(A]!Z_5,5_P",5^T\51CY\2O
M-T,;Y=MW*#^;Z]D@#U= B"EO)Y1CRDSTP"FFB6X,$B^Y;,13S&\Y?<(-:-+_
M  2B +[.T42^EE]J&Q M3IST"8$QB>.#/]Y>)BS\_&BK":D6P?4DRHU3DP&!
MA?E0XYFH&V0N>=2]&*WUN0V.L^PVK=*<F-%B!T4J?\TL1\)?8@<U&G^$J!M
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M&$'$*5:* =S@ GF4:SZ%P/WV&(DZ'V 8HPWGOS==(SL]E^;KI&=GLN:5F?\
MZZX7;PS3H-,<?B5:HVTYYV,$9P0-7VZBVO:I$-B?W^M9!BM\@:?^_FBN[MD4
M<4=MEJE!<W9J-CP@O,]REWAI'&.K;6TQX4A&#RV@$0<F,G2M:V^$D,M82!0
M@_#!9I-OP!/AT! GG-DG\'J.0!EO4\F>02]&0J XOE3G=- ZQ9H<!&?:] V&
M;)6CF?[^PI3<F#&G=?&2/)S>1Y_)Q>S-D!5\7]_84IN3!C3NOC)'DYO(\_DX
MO9FR J^+^_L*4W)@QIPP2,B^* +!))2!--''KL'5!I1TCF!F:L!@EI 2!P,S
M5B(2T@)!2M.?8.LY^KQJ]CSV(7K&@3G9%)7IY1+E>KD6YB>'8ZP2%SMQKZW0
M5?=' ,?WX;FHX-+OF1I@2+XH L$DE($T\[XG(BW*TS##U31[7F9: A$'X8+-
M)M^ 9M/^!Y6'--L#*4B[9F<MGD#OXA\6^S3X2/\ 'Y%(N4(F<OVQ>>.9D':,
M[5K+*G8 ]\M!@_ !9I-OP!/[?6L@Q6^0-FRM!9^;KI&=GLUL9W&P?P9X$]]P
M"KKX,+3T\B:8AV@V ++CFE9G_P"NN%V\7 >WLRC03AS[0"+XH L$DE($TK$G
MC%$VSQ$"A(K_  P48VAX04*7AD41RS0DG-4X^IFNLQH W 75H#9GJ,!P]#H#
MTZ!?@.J!>1N5";78RJ=AU)ZI5 EO+A7G-1H#U?#!(U3PRD!48P,3?$"+[FR@
MJT[!?@/2LS;PD#YT<J*C892>J41Z4F+"28)YX!,>>?HW$:W?;;24LV0EB87!
MX'1PH/:ZG-=4[&K+D[&8. I/!V9(UN*A^$LW&V@V%S.;.U[8&'P8'-)M^ .I
MMV/\OH)%_P!TR#><-:0U/Z=/U:SAVKLQ!^*6OK(P)PYJRMVZ5=]K)$S0/R_M
M ](.%.E6CMNA6"SG9J:=K^F)#H/7TH5B)^-40_# H$\]F8)#W.T)OE57_3%8
M>U@XCV+3#]T \;A@;3L899=2^LEY_02+_NV0;SA]T:&\WL2:#/)DVX"=)(ZI
MFDZ;8!.DD=4VF>D+1&9MDI/5[]M&(S2T_G([C^QY'YM,;*389B58=[G?#H"!
M/.;)/X/3II92J42QK*/UA]2K4AKK95#VW!TNCQ(34#AML&TTN@V)TO!Z9EVF
M%G9D583(#9EH\2,Y80Y0%]E91 ,#KF#,NTPL[,BK"9 ;,M'B1G+"'* OLK*(
M!@=<P9EVF%G9D583C7R^(I?*6V8G]W8$Z^H$<!?9D :LAOSD11[RV>2^0=@J
M/AA(VV-39UDBQ:<?L@'C</2'V/\ ,_-?0O93EC$\VX&QTB:Q=4 @_#!9I-OP
M!/+Z"1?]TR#><-:0U/Z=/U:SAVKLQ!^;O)RMKH,5D:>R@%SI/]7M\F213;UC
M(/)_=E^6!4'_ +F";QCH)[Y[T);)_L&DMO:O>8-=35TM4FJS2=-L G22.J>6
M7E*N7$SXBT>HD6$1)"R)_P!'U/YQ/U592;\4?&Q/S)-+D^B&T%T\).$T]T:&
M\WL2:!/&PT"((6.@64*W@$T1RS0D$+;)*4*W8@8$W7?"2!BXV:4G='$E$P1#
M>@MWS@ZE!4;3L%^ ]*S-O"0/F.5%0);RX5YS4: ]'PP2-2'JJ-,2D":= >;#
M*3U2JVK,V\) ^=/*BT[!?@.C892>J4!ZHC3$I FG0'UPP2,"6\N%6<U&@.>G
M8=2>J58+R-RH3:[&%5.!B;X@1/<64$.W<8*XM(W2Q^[_ "&3<@OS?#3@ EQ9
M_1?^ND8<C?NF3:N][6&,RJ)$$>B#\,%FDV_ '4V;7AU$]49MWZBWO:I$-J3M
MU%O>U2(;$C98781**<-;$,1!^&"S2;?@#J;-KPZB>J,V6'V$2B'#6Q+(F#\
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M^IC6;PL0JWP"U9GN?KPE^70$"><T2?P7@')75I[]3<0V$<'^U*^V%N ;-X0
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MJ=2;$TS )U1E\!_5/8:V$O'B7%91U5@J\\3U" -""1WR?)QA", *6!VRQ!"
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M0>1&.?@\:7YC.A@,$!9) -*HEX%68+H$R)SJ\C_M\@U6[C@J47^,1XZ%PGM
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MH%^+B ;#5(PT@WUL:0LCM?Q=@&PT#.J@*PJ@-!7")#H ^0)0!  4 OA>?Q<
M; 7VC 6]&MAQ=(6?BY -@(D$=(4#RZ8!=]80/B ]JZ"MS!09%\J80]D==5N.
M]J"1?FQ2J6".O_/JZ]<9D.ZN\GA^]^0SA0:5AKP&)UG!?AB!F/EKKE&(DBK\
MU-"X%:A.VB\F.XN\JFH;\IP%TN)3N<J8%0-<+VV7@SNMV'S7R*^L])*0,D"Z
M-P$QX!!O%WE45'?E.0NE0)S%NT@Z',TDT,D"Z-P$QX#@I"C0+/,T4[5&*>5/
M-"P<9P!G2IY4\T)!QF 9I1H%QYFBG:HRD#) NC<!,> 04Y@W:0]#F:28G,6[
M2#H<S230R0+HW 3'@."D*- L\S13M48IY4\T+!QG &=)N+K*YK&O8< -KE*-
M N/,T4[5&4KVU;SP=A4JYY[L -@]!3RZP*4 @B)9*^0Z$B:8>8,#*"'U1AOF
M2E34/G_\)AK>=O=7K6E* !L%5)'2W2C0KW0*'U:X[]DI6U#X_P#PF' ;X.0A
M8:CT:NZ1?B($?   V"NO0:08/&A:E<;/L" _!L^YZ,4 <O3W> #8&:IXQ55?
M9DV+ HOJ3'?LE*VH?/\ ^% X#?!R$+#4>B*EM?\ K2VM* !L. H!;R3;L>/!
M6/JCAOF2E34/C^![-V="XWA,'P[K18W]RYTIM66'E7S2*/4 K3R _>P1&1>]
MYKW.6-(Q>A5@E\V?* >_51I&E U!>E -!9HIR 8H*0Y32#Q\^MO78#+3G_@K
M1)[^/2+\DR*84QG&HICK,% ZH+\?6_KL!EIR\=6.+D1W[O\ PL V!7Y3B"[M
MM&WL_LH@'_\ 4V1'_B2SS]*-'<@70(P1W*\8=I8I>Z*<M+ID/*#/?<8>\XA]
MJ,9;<*N@*TIAH+--. G]9=,V;><\U ?QR\_?_G,PTT]>81Q'<;4M@,<$#: O
M\GAH,0FFR$<T8C13PXQQ9"8_+**.'&.;(3'_ 'U=7=(OQ$"/@  ; :I*GI@+
M3Z$%'5^JH?X3KQXG;-P@O[A*3(AXGH\&QL/8BHIFF6+1\(:,=:5@(%P]<P-B
MCPE?(7*';U6]U@O+O%G5-UR7<C\.\6=6W7)=]$=.GH$XSV/"<OS@4:=JWMBQ
M1UC/AZ;#!*@ 2QVIQD5CKA*3S-S\B[^+;'OF@ ;!30&HU/+-)>'U+ZD"_*=6
M/$Y9N$K3JAD84D\3EIAK IT@#US/)V?N(I#2N#@,G=Y.BQ73-C79G"]$?M,E
M*'3T1C 0_7XD6FGKS".([C8E\TFE->6/75V1BOS>,T4Y>>1Q'<[69O$?N3'@
M.D8[ SQGA0P#.$T>..<60F/RS$&W$-/AJC$US<UH'A3R-ON[Z ;#S#&?.%FB
MAI II]7(7Y3JQXG+-PA:=4,C"DGT/+3%2VO_ %I;6CJ2?*D(H83T&H)^J0RA
MA/1.V.WCINESVT0^;C& AR97 >P&?!T)LDR(-W)?SP9(Y^R5/.'%;R6KQ8[K
MI$W'(87Q!J'.P,\9X4, SG ?[%X+MA(+]V@&PX"@E/)-NAX<E0^K ?X3KQXG
M;-PNTWSS91*WI7X1DMN!L_[[< &P,T#SBJJNS(H4! ??P/QL/=B,%VPD%^[
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M/G"S90V@*(?;(2M*X'PB/0N7P,/."M1?XQ'@-;1*T^ (WXR\D;@XIH9^L?\
M7FB-5C(/$6"^&8&S5/XV>]C,: ; 32&(Q/#-)>7T+[J)[^S_ )@NWB>F$J5[
MX/\ */\ $=]NX?XCOMW#0#8+5 $]LA;?4@@[GXNB1H!L%- :C4\LTEX?4OQ8
M)&@&P\PQGSA9HH:0*:?BZ$C0#8#5)4],!:?0@HZOXNB1H!L/GI11LC=I:OF%
ME_%@D: ;!35L-(,7G8E6^-'\70D: ;#@*"4\DVZ'AR5#\6A(T WD*^'8%J$
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MBQFS5]#T:M7AOJTK3%L(1S3*_P!8!5_4%,?]SD*S#& K.N/+9%K^=*%6*1U
MG]LZ5#F4NHU&52VR")F 'V*?PQ=55\=#&'(!>8$ZA1YM?ZP&K^H*.F5_K *O
MZ@I&6J?0Q=55\99*+$L)BS3*_P!8!5_4%'3*_P!8!5_4%/OXO'U>,E ];H;K
M-'16$YRKE)HF=+4C&9I)X-BT-%/U OX-5:OH6C5J\-$D!7VK:@@.:;GV*?PQ
M=55\98PY +S G4*W4!KAL\!6/)#?H2^/+ ((<>F$BGVL(J(IG[50&N&CP%>A
MY(2BQ+"8LEJGT,755?&&&F5_K *OZ@H^;7^L!J_J"F#S:_U@-7]04PPQ!+R
MG4*9:I]#%U57QXC)18EA,7)]M_ZX&K^H*%0(EPQK2 OX==FKZ'HU:O#1;$1A
M2V:%8*$*:,)B6)4U&&6"96-O"HC[:I)-K-<C%3)P%KB'&\IO%84<VE@TASM
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M(45E= JT#O4\VXA5 Q6 P%D_  96:-M!8#:C?=LHI"30  7*^:(17 @GF?\
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M-V% 265@].:37IV,[734 (?"XI>F;9 )\8V_!T^A2!=]#!T(I.<X%:)%14C
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MNJ^\GTK%,&2EG5_K :OZ@IRO1!HL@"?P=+]V:OH>C5J\-%M45^_(8<112 @
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M1*_K" !',>(U0&?DM)__V@ , P$  @ #    $
M
M
M                                           !@   .0!P      !@
M     !P ,   !P          ,
M 0!]L!Q@>?O@   /]OP     -P  !AP3P  -P          /P0
M/P"0   !N!@ 0               2 "3@!QR,#B#@>/R0 3O_CQN</\ <CP8
M#$$?C?@ #@D<8G@ XD\@$\[_  )WXPQ_/&/')(G  YW.)^) W'XXP    !(
M/.  &&()Y  )  ))!Y() ) &) )Y   )  '))/!\/)X V!P !()(!(*_ /\
MB3OP7@2  >=N2?CN0 !H>    !X"/P!B "-R=B "0 "1_P X@D#' 8$#@X8
M D  $GDD?#XZ ;8'X8'@D@#_ .'(^^Y(^/Y ^ VYWV.F!)(WP'P    &.V.
M) &)V.('((X&Y^_XY/\ N01P!CSSQM^<?S@">=M^#N 2. 23R?R#]^" ,<3M
MSN#\"!B0>23ON!L </P               =B0            -R
M
M
M                                       !N,             !N2
M            /QB#B
M       2-CB/\#\"=CB2!P 3N001@!A@!P,,?\ . ?@#N
M                                  8>#@,3CL>.#/\ \ X&'<;(\$[@
MDC\_<' <\ D@@
M  $@@_@' G?@@$D@$8$@  @# \#@';G8C@<# < ;
M                             9'#GD<\# G#$@#'\8<<@'_  GC@\GGD
MC[#8X#;@
M$@
M                           <8
M
M                                                      $DDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDD@
M
M
M
M                                                          +T
M=7BA#_U  #CT    <5       *]    !4  =#JB@
M                            6H  !*JCT*^JBT!4!+]#VK^BU)*V^WV@
M>BK@ >^H6K_JVU>BH                    ?@ (4<=! !#CT4   !5   "
MW\4<<6KV\44"VJI>HU <  "@4"A)*K@"I6JJWU*A5*\7B^A  "B\4  (+C@4
M   !++\+T7A?A?B]+T(!"@     )6U<<7U< 46CBJI"@^C_T6C@<#A!4*@!*
MWU>KJCCI(46@)?A?B]+T?H?H>B^@  (               +CJT+]"\(*\<5>
MJ^A6KI5?@*CW@<)<5<+A<7C^I56VJA+_ -H2'J"                   0
M
M                      '  ]
M                                                 X
M   X^2,)["QP                                             &)P
M:1(P<WP         J  O        !R%P     YP)
M                       ^2$      DH^        X  X       #.8
M      Z*                                         A&
M N.       X  7       &H            N
M               &,            2@      Z  2      &0         DH
M  G                                       3X        ED( #8
M       X       P !!%E  @!H(  "
M         (  $EI! I -(   X      5  J      '8   $  $ !$L
M                                    B  $M)A   @!@  7      X
M        !'  @AI!!( -%  &
M   TH $H(H!$ % H #(      5  0       _@! @(D%E!H% X8
M                              %/ ! ADD( I%  QP         X
M   $1X  E %(   SJ                                         V7
MX %      "@P       Z  H        !7<]     P>.
M                          QC-     #M?P        Z  Y
M 6:% R!QP                                              )YH(!
MX6W          2   0
M                                       %H    0_"]"Z'X7H7']"]
M ]_ O0O]Z%Z'_'0O0_"]"X_X7H7O]"] _O O0OXZ%Z'X70O0_"]"X_H7H7OX
M%] _O0Y                                            $
M                                          !XM%  !#HTP#(?"V0[
M#0
M          0                 @                $
M                                    "0                 8
M
M   !                                    @
M                               0    #8           8
M       D
M   $C '@ $@     (
M                        &8    C? D  G'
M                                                   !     X;#
MX#?X 8    8                  @
M                  &8    $?'8D#XD     @                  @
M                                              0     8   _@
M    @
M            '8        @        8
M                                       '8
M
M       81*"03*+02"91:"01*(                  $
M                                 &I_??-]_P#>R7[_ .^GOO\ (
M
M
M
M
M                                     $
M
M
M                               $
M
M
M                          @
M                                                     @
M
M
M
M
M               @
M                                          @
M
M
M                                    D
M
M   $
M                              $             $A!PN5'P*Q"(*!V(
M1%0(                                                     $
M            X                 H
M                                      %8                 @
M
M                        X
M                   $            %8                 H
M
M8    DC ';D'$
M                                GX G@CC;     @
M                                        $            'P    _
M8$D@[$$     H
M                    "@    $?'C@'#[     X
M                                               "@       ';;D
MC     X
M              '0                 P
M                            @
MX
M        'KH]"" ]'(42!X/ 00O8                 .Q!" !01&P
M                     $
M            .-&W _'!1VP                         @
M                                       1W%V  %I) P
M               @
M      ./%QQY!P!.
M                                 ' !)N
M        $@
M
M
M  $
M                             $
M
M
M
M                                                  @
M
M                $
M
M
M          @                    "
M                                                          HI
M X   % /
M    @                    ^V%( P&IUP
M                                                    &.   2V!
M&P                                                       $
M                   Q)!!^ !PV_
M                                              &H  1^
M                                                   @
M                 H(   _
M
M
M
M
M                                      $
M
M
M
M
M
M                         $@
M                                                    $
M
M                   $
M
M                                      X
M                                !                  H
M
M
M
M
M
M
M
M                "1@           X#(XA F 3%X;
M             [*           %8$P^O ]#0"(O     9F42)E'6A*H#!V#P
M0" J(MNZI                               "J!OO^Z9F^Z0\X7$ 0"%
M;MH#5%@    +&W510 T11X'H($C@" XJ 6!)
M       "C*\00X!*0U0?Y ".@" OS!BCY    !C2"8<RP0<VPW6N'*Z9$S\G
MV'\                               [,Z9RCRX0C-HC2/<F_/"@!C)"<
MP      HX%   %!(')@'A#K   H
M   #XX%   %$8'C@L$!G   H #KX                     <
M                                              )
M
M
M
M
M                              !Q(            &]@<#
M          !X(S"I-OP[,                                  & P(:
M%) <XY6(<[ Z T(!N?9PWH-TW_(          &88" .9*P3QVMTWHFS9&X
M                         )DMW1P:X2Y3B DP7 '->$"=JUA=<H
M    # X! =X(!89K%A=J@]"3H                        ' X( #;YGG@
M)?NL'.@* !20M+C)'[C]           &:0!Y( ($@GGW[C)W?0<8
M                  != CE8Q&Y& 2/"F8' (OAJAPO#)PIH          !)
M(WL'&9 (&T#)POR?]6
M                                          !9
M
M                         __$ # 1 0$  @$"!0(%!0$  P$   $1 "$Q
M$$$@46%Q\#"!0&!PD;%0H<'1X?& D*"P_]H " $# 0$_$/\ XZ<0?JN_:,G.
MW8 2JQ$_J)I0B(_1N-.'/K+M,JT!J0,NT@AT1)5'YPWNBP_<Z9-8\<RU2+KD
MVC1JQ3&G#GU]>[3*M!V@V[Q)EA4[H1A5Y")0)E!S 9K]3F+\[,"\!'G@QI)V
M)8""A#X:JLH)48B?Q$D)0!<Y@_5=^T9.=N^@9.Q+ 34*<JJSQ%^=F >@#SU?
MA6]H-N\2985.Z$85>0B4"90<P&:_AED9%K6D%B$)"_ZD+QL\0U5D+#MD0KMV
M25HB*"JB_P \ATMDC;:W,!#B8HFZF&A)S^)]%[81VG7=DL'[YQ'><\L,J(F_
MU31C5KEU'0ZN:RQ89WI?;30F1.UDL@.Z7/0?0FFLA@X=FM>H^A=M;10P-)ZT
M8XVCRK+]/LEGW7"M+HP"6?YQ&M:,A9ERP?@'(HH@((%VO"3G9*%012'/H]T<
MVZH5I=" #!5XD(V5)#6')\'(NV'M$Z^A5TM<"!IBX'A]U K X;^1P$7B93 %
MB#4FH]X/^!4N 79YFUI>DO%2',BHMABR6J! TU,'^J?^?H?*GF.#D^7X?*GB
M.3D>LI[7 O@)2@BGB_Q:'8V2-IK5T*]!$O-V"H.[5?*\9$"!5ASC;@_PHBWA
M/V5LM<^E$JWL"1G'1FQU0O/+=R(V)JJBU$W(?PP-#_!R+MA[Q.'!4XD*V5)#
M67Z$FBJI43<C\@:')L=4+QRW<B-]5OO#DV-D1W OLEST'T+MK8*&!=S?T#5A
M(I.=$E*@8^NXB81F_P#=+/NL%:70A#J]93VN!? 2E!%/P2*FUJ4'8X.L@(,<
MQZ#F_DL(LJ4BH ?"R5%F*!STZ1),%1.!^ \@*2TT1Z29/]-;^#D7;#VB=?%Z
M+M![Q..G^+0[&R1M-:N:4E:8L.S6O4?0NVMHH8(?2H$!4(#3H+*#9[O@$N0W
M"[^CMJU:M;#RAH%(23@*Q$S:3H&MU3B%?!66.44L@N=VT $QCM).#,K9EK@2
M#4@9-)!#$251^5U;LBEHR(QHQE3K>E:'T0JJ)EAAYGQ%$,.'8& S4)>R:JDN
M'NCFW5"M+H0 0XD@1L<B*+N["OGDLNY<R$/713#"-N&PE.SC-H )]'#/-2%'
M%ME.]:=S<X/L)G A2,BGY'V-)$EJLQ+T TI%:P5VAP%0%1U:^'UET:MTY/*C
MKI=;1NM@G<J6  VF@%EQ]V<VBH5I=2!,(7DBINJ3!0\0+$ 7KB<=KF)NG>:I
MG?G.)?E!H43DEBB*M<UE((C2 8?5,8+TQR:GT@FJB7 Z:-'7!+,& S4)>R:J
MDN$BQ0CSYE0Z8K&1,,+B4Q(@A\>FOCPQQZ7>>%$JP)9J5*$LTL.:XP:EPC@
M:M**S@NIS ,32C3(^/@BBKT][7A-<WVKFIE/PG/C//7_ *MGH!E=B+^HDE((
MIFM)*]XBM0W]!D628PDS,H'@NZS?0):HK1=QZT!U P( +48]*>X-:Q8,&]-
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M!;:AA+21 +8N@VHBMM"08'*"5&(G\1)"4 7 0?8EJ/& E1CK0Q@H*(DB 4&
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M@6MSP[I[I"*T=:>FV L2[A227UD6.[BQ0546UI(B];:M;ZD1(#5T@M,^FXE
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M#)CTODRJ?@:K6"1J#!\A2^*7X*U&+ \7YUI;B376(<R@(H2L"<BP"MF6#&!
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M5"<@QMP9W@\=A],0J WAB8O^T@6,!AQ;LKF5 #YO"-,ZS_(A(BQ-FB]G?_(
MI7;88#>"6SU M"JCVBOH*'H=(U$2 !F ^R.;=4*TNK"H 5F(_P"HDE((IACH
M;,G0(B\X,:#_ '(J'ERU"I=K!@@L@8F9HXU=\[9CPOU_HXCV"""/I&'EL,!G
ME07GIX+3:95,["KR4?L%J**ZK7LCFW5"M+HP""JM5#."Z G%Z/'B'"FO(J!B
MY O3BH*3JU,AZ!&#P,#) QC39\R^@=?K2<V6P4#[5J 5$T2U4RLH%<0%2FJ
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M0C\(8XE\C_:RTZR&W4-.8:"89!@!@AMR>BV(4:9&X??#TG<("[*Q^0<KU0T
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MOY=T]!VX"S5N(B@)<J!)H15)J1AN4:D@ G:)823DF.7R"[12.^8 1$9;O*E
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M@W>T\* *MB:!PFX+SL10*10&O;S8 +IMVW/]"=/.#9IMQ1FP;#%P LEP (.
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MAYG/E[X2<;4GY/%0R"13"=H['9>,5%5"A;OA$<!#4'A)0!'>_.?^4]-3G(I
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M"$!W<-CFOI]D$ \S!F EVMV0*3QBF(!$C(5P+((P0,4P$R%5P+((P0,4R59
MI/6*8@$2,ON$ Z%\ /,('I?RT(DJT:1)/$5C\U,OW]L7=T_Y' AWH;:NJ4K^
M B&PN \PH<M'$A</0VQ=4)72'^6C$U6C2)9X@L?N$ Z%\ /,('I?RT(DJT:1
M)/$5C*XB"-/UJ1G0O\+ZL%PY#JYD')L2E3W2 LPCWA8E(GNT!9A'O OJP7#@
M.KF .E\KB( T_6I&87Z\*&^_-!D'72O[\*&^_-)D'&5'JE(;'6O(>7Z7-X-W
MGG!J<G(G(!HE#]"12)^88%P.RPO2)>L:G<"/Z(=1$C6SX6 )?H27]O CG?
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M> P&  @ @ 2 : T&#J-H*"#!5P+5W?;/MT;W#[3[7.\*H=)-("1:,0$8"/0
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MRWZ$G7##4QTW IQ*U (=D#PX#       'TM#G5"&@6UH@%&FCY&HQ!16D2"
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M7"D'<]_$E"($$4$2$38FDP(A!((B B.Q'2.QP<%67#2U@U(U(J)L;N[H*7D
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M/3 *IJ#/V.PV.C=0RMC G,@=K<08U( *_>"  >59WI&^%>U2"X@-S2&!E&0
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M):K!98)"+8@P!DR<80Q!&(4EFOB[99ZLFRIV310"Q2H.UR<+;Y(EE#I"A4@
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M\X@2 Q% 7JBXH*:/0B *$03 _P!0#8O*000(BCT*%JBR@7# !% :,^+. O\
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MGE$/$!+4;@39\2&GYBT<&Z_K5H@>D520::(!DDUFOP"%#B!ZD,XKI@S,&F1
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M1W%!I@F.-ZZ<F$^9.(.(]:+4=QGQ3K>-[#3-K;L[Q,WGZ^$ CE1G4!"M3P$
M@SD4 >L6O X!"M\:[(MC" +?@M-# .<C3'1!;EFTM74PE"0R**&- -PNMZ*7
M8&GEZ6R%$2$.TS,NII0H9-OA6V#*(7@@Y5)!B*2Y3%++1DA>BAWH ;WE(@(%
M$1P9%^XP!#7"EBC2TU'[?$![M$!./M*CZ&)%!*EK^0AUX/\ 2 V/*1 0*(CC
M1>@S?VL*R 5G"];R5C(TD8"PZ,W@Z4C0<E5H"%T;A%Y-6;0?#TELE!!&[[.
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M;1Z3,JP2YQ]I5YS D!@"(.<_:5><0) *BJKFT*\">:QD*O:)T'\M3]T'Y[7
MG#RBVJ"MBR(U9@>@4CDB': X3>E _P!0#:/*1 0*(CC_ %]!(!JQP .H3[D2
M@%5EVB*.L7B*%J"R@3! #!0*M_)0?Z@&T>4B @41'/BS@+_[.!*N<[*I&T>D
MS*L$O5HFL5##D9'L$$U?&T36*AAR,CV"":N&2E!- )@@ H ,6A_J ;!X"
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M+,\%!7HJ'M#?S8A%((H'T"%<2"W<8>IE3")=* 8^&1B#1GX% 50 55@!JJX
M:KUP:$W"%*I*B2"H C4C\9XF5,*LU@%AY9"@M2U"H"1 ?HD8XD!FZ7^D*7@!
MTE0:AV.6YQ$42@H%F>"@KT5#VAO]/W:YB;  C857$'IJ9?\ 47JI&7A\"D@6
MG5:N%<TE95 6*RNP?MR]H+"JC0CP@^E//PP(L0Q*R)-",![)2TH W8VE2I99
M6>^0"]\( ^ H7J%,UO+M#Q4 $5Z0HCX%@\,!:Y))6T%$>Q:4 Q"3%$44Q0B!
M([:IPK9@5.I40[7P9P7_ $"!B01>@NN\%YMA@@)+%4-D4@O 91"18!5A5@=
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MAA@57Q_RJX!54 5#@.0H0RQ4;KHE^X2[A$CJ8H?4T *S8G%8.H)'D1Q0Z4:
MLKF0Y4LJ:G56(8NFBX*ZH*B)'[0%4$5H)3 (QTNG&*"F16N?R2\/T&O:YS]Q
ML='HW4LV6;S#[WV-D^PM\6;^%--A!F@W0O64"HNJHHX%Q$V>U11Y%"]7"IP4
M!5 !56 &JK@!JO7"YT [T(H" %0T3#PR)H"$312H!2B3L4X!""B@T#B#@,(W
M6BYA,$ #H2L151 $D52!Q(@2)@*+#V("J J5!&[@&&5$,4+1Q*.)T@P#5> \
MK]@JH%& 0U= PP4J$$JE Y.D:XE3N"#0\E3F2A@)0!G:U'H3&"SE)&$@!7L
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MU3M044TL%^YPT3!O %'H _=0*H/Y98LFF1%BSL(KV^@?2:"3ZRB9\%LD"B,
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M8^53V#X^"1E : (C0! !&(>CUSL"*+U; J4\ 89A'.L$<<4* TF_0]?!)SO
M'342 "AWZOOCU9""P&LJV56?5XB#%B0I&($HH_1G$S.HA-#1 &57VOO@:(*(
MB&B:(E".B=<,VJ0V,-()",-5\_!(:T+2V@AI"# F>2_!(1S P-"H!1>K'%U5
M555=5U5:5=5[XLK1&F;? # +ZIQ%6.TC"%5+ #[$Y]\PNJ0\B#3CO'JR$%@-
M95LJL^KPJ:B4D 1P*I"+O'&$"2JH5\ !X \<#1!1$0T31$H1T3K@94!5L \M
MJC[$0O+&O+L2RQLK+U7DC'LR++*RPL[AQ4U2*%T50#M?!G&HX:X* @!$[-Z
M,$X).\4%.9$)L75,RTL441:HMG0!U05!I!Y<@;Q6L5@8>B0!BU(1F(2E[MHU
M:(B X/&HZ8XH("  =.]"F&?+C"!)54*^  \ >/@D, # @&$"P0"$Z/7%!B]/
M5L(80A ('>J\0H%5  O1I@::3E:*D,+H9A[$!:]-8 &J@@HC5@F]G=$$SM*D
MQ(%3 ZB4$,"8DWX)*0$K1$*@@# DK'CW(FAN[M$!)D?+=A]2XPRZL!#N'ID"
M.:%,%8@3$D<-N,X92% EJ&H5B^2#"?!("4Q;U+I2(1$Z!X^"1E : (C0! !&
M(>CUQ"DS5!=EA%*M52'3."3O%!3F1";%U3,M!0# 8,;LA56>"P!#DQ*#&D3I
M$1'LHF*=*<>Y$T-W=H@),CY;L&"B!1A*-@&4>@*/E\U4[1*"+6EBDS;E.'1[
MFTMZ.)H!V<[D!*!E"@QB\%7!*]=T$$+  5K @55?JWCC"!)54*^  \ >.(@Q
M8D*1B!**/T9Q,SJ(30T0!E5]K[X&B"B(AHFB)0CHG7- @46!*O*[7RUXDJKQ
M%;5N)1@ 0F$37PTR>[>RY))O=R(E%A6KVJJKT57 .@.#*)8,1)4?HQJ04AQ2
M^L HS:!=KTAFRH@@D4AHN@!=M$(,)?A=0T0 2::*=[!H D=(0BX  &T@135.
M@Y*PAIT$BQ\JGL'Q\$C&D "J@1\@CX4\\L#&,8D1$?8@E$R(E'A(R@- $1H
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M"6 K]"\P"!!*%@\#I/#3^Z"Q9R5>L!1=2 J@0\!J1IV;$EE%E+.J?!9!95!
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MXZ$D%2B$+B'V!'K@G^0'U [LS:]BA17!$Q$N8:T[!*5G8B%), PWP(BL@=@
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M:G[E$ D9.;NUS?0*W9+$99H'+S1!X8J<+*G0,$0XQ$GB:Q2)4%[,@>#&" 6
M(&  1T+4JG^Y2Q:'4/81  HB-%3S6\(U $6J A0@IH,3MPDT&*BF'1(%T0R@
M"!0"8@II3I$U'D$SAD#0@;D5P:GN%(,1_ FF6!4 54 "JN !JK@'?X")%@5
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M$ +  JKF:JJ^U5>U7Y<-%5W_ -@!@$    /DL6!4-@HJE&)1'[-X 4=80K5
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M22H(C/VMGK'P[NF4 <SQUE8HX''_ 'WK^!#SLK@I5?ZX!%&'LKDH5/Z8!%&
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M%_[C^2\G@;J,/ JZUDX5FM$#B#X%_FG*9^YG@L!%G30/4D\JW ?B7^<^$?\
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MV7X*+E"@F/QD3-\$OR#:8X"$8PI0,\P).9 @H4>C7XY@L.PF"D(KWB$XY?\
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MKT&HT.-9=(%( 3@$45(Z 1%$1&(XB=B>$_JU)30IN^8D:G:.&]P2)^PO08L
M28%J"$S^SD ($$ T0B(@B-'3@A!"4\9%IU)4"T]$"!B/\T>Q,33/ZOH &IT/
M^5\'GZ H#9&E=CM=( #I!U^<-Z=?G0IM(*$/$O\ 4@1U:B4BD0_"OY3X1[_!
M)I3^#,/X\^P_.[0!@=-(Q5)[F,G"G(!B@73?"&4D&2&4UCZ)J\FGU+$'/Z@%
M0!58!JKT!Y7D!4!!!DIL 'EH%8'@TPJ!"5403"FH5*3_ &A)@=C7SKBGJB,0
M0B6#05SH5,@H*R0/$ZT6\)DR7NM"/;04W^IA5<$<0O@\$Z1Y$ YF[>0=1+;
M\UBVT (4%0U1JJJJM77_ $6\KIQO8/HG2C (*"*<,!PP0(]:L[^S.(&PGAE
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M0K'/2IL$8&RG)ZA+002R=XJ'WQ $?HR64*UEF%<)#2A]!49DL<W)_D 4Z48
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M$ZT12-9PBE,J"EJ2AO"4!"</4.LHUK1N\@AVH8 ",% !%  0JB/^% =K098
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MTJ5I#(N75*!450 *JP /!\,'J5<B)4AB"4Q!_,%5( F%MMV ( H'_!#MQ"R
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M%%( (J+1XG*TR<H*4 @H@@M3XD* P2I#1G8D"[#_  2>2^1AZ1&@% 5(*1E
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M!.'P[I$ =T0I#$-2/!"   @$     ! P^&2=); [4X:"@6$G9"2KJF,Q%8
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M8H=E;P![-)4M@1-X0@%@@\@X4T=5V(7%(IFF.,M4!$P:J3!>< 2JKP@T0 M
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MX,SUFU%D:K05V=8'#.%T3%,B B"*&6AQ4D@:C9(H4.J0) G]@%@H JD 55$
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M\AS&(2AJ]@_?PEI9+9 /D:UWJSQ\(HH08H$$M[@X0'46!P;T"1IZ% @T6P<
M ID0&B1ZV 8"!.AF(@>V;-:'22$T 6[\N\F&!3P/NVH[%N1GP:M!M.X RB6.
M4?MQ)4II3L32.YEI$G#LGT%]I2:&E3,EJP(B!;,"]H+"U@56J4!+G7:M5P!*
MT$<-%"UCV(Q$^R=B((4M+-"11#5*:@- %SIEZ'P/,'H*LA!!2PMD","'M?*J
MJ 2$6(B"^H3(KL$<+ J)!EP+V"D9&+$8AX28DPH8K5!0$DJ<:Q*-=6J"^2*
MI)''7BLIU4C*#*90^WY1">T[8HB5B!"1+54))$1JHC$((B58[D_%V&N^DG=.
MWIWT]>1=)1ME%8ATIIP#"# -;)!:C1'N1!XD3$S1[D')K%Z*S3QA54-UFZ@:
M 'D$/:F 5Z"Z">B%QAYZ?_<<G6(&D$!\-:/'O?D9+LAVI:4:88-T1DXZV]AT
ML"O@&BT0BL@@DD(0+)0T!X&Q28!7H+H)Z(7&'GI_]QR=8@:00'PUH\>]X3D@
MJ!?!A#IV"HUP)97J(*U*H2$2["/RP:0*]; B%Y,  -D(0I5JNK" @ ^5))^
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MA9Q+B0&B5CF<CM[,\@I $JQ5&+&)TB>^!M8![*T #'0DZ[W@^@7$!FH( \#
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M>)@>U25"A@16$.$1PW^#$8Q!;P%O<E0G 3DE-4W% 230N@%X+UL)48"J(@!
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M7'JZ$%D&LJK*K/J_WBB"%B**1B1**/T9Q%4.T4PA5JP ^Q/_ *.- @42C*O
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M$08H2 1\./&JUZNC@L+"EBQ8QSAU)&*8.,H)8C/J<.I*P3%UE0+!9]'@(N6
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M >L ZJ45;+AIK?PD6ZH6QT&#'RH>A?' "=T33!,4I4-1B$XQLTB2QE3Z!@P
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MGI02" 0=MA1$@%:(&>>;H:PKLQP0/<*U:KP8#-@B>W*L6-46#_4O5(L$'"E
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MVS7@*R6=O5_"2_F/?S<>*2/50EB,IL3[\--T8%2(:HP>Q;83CAD0#S_P :K
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MA$ X>M[,#+IB)"L(7'P8K&DB5041%#/ J<-\U)"27:ULT%:'"0-:P@0  ]
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MFJJIQ0MBR)=%B@!6W'(!.8W9(RMP7O\ TSIB'1U? /Z/PZ:"QW)]?*9X%?\
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M$^*$&-5H8(H018#]2K%!Q3H8)]E$2$I&XT=L T'+.J 0M/OML=I]UN##"A!
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M>)$7-RJ^$1-85RZU8VJ>$580X5PSAT,(.:][51X_2'F@UW1AP6\2,9UE'<^
M"U8"3$W($(Y#DJK"6SKR)"+WO"25[5JT]TW0.8K6FWVV*T^ZW3;[;%:?=;:Y
MS$X _P!PR&NZ\B0B][PDE>=JT]TW0.8K4/XG '^X9#79?1*1>]X22O"U9U^M
MBM/NMLZ_6Q6GW6VB7T2D7O>$DKHTY.A$O?>DDIG*!<TC>45?(BO4 &07H!?R
MN@XYWJ=&) \5O=N.KJ"Z\8',3D7](WE%70KTL,FU#HU\M8P^FM[:.WENMUY$
MA%[WA)*\+1\Z;VB99(VKGBUTP78"X! K*':)08^>RY"6D>"C%0*#"TH0GP0=
MMNN$):PV-38Q=_\ VA8+A]<C6C2*TX^GV.(GQ&3"N(F&VO%JZ%MU)0_7# 1Z
M7UO;8VMMVF!<TC>45="O6DW (A$0&0X&]/4FZ>)41"(H=A$_&OP1+J.JW,W5
MV!^ & (0 /+>1"PVF3[+EXL&/"FA%:HAQH(0R7%:KBX)R[ _ # $( '/XS .
MP#  .8,P:6Q#7=6-880K UTKF 9' J#M@^"$Y]S[GW+1@*^+@-6I<6*EY58Z
MZB_+?$B6-:NTS=A$1(J%-AU$HPBXV1)N&'J?=_6Z:BV>JAFWL(_E$3'\=';:
MGMH[>6Z^,DIK4N:LR]D:NP3 B(RE&J;VB99(VKGBUTP78"X! K*':)08^>KD
M):4+(62.= 394S+X! ^2BBS.'79(;Y5644^*'OJ?QVNIVLG,Y;LK\58 TDB>
MSK];%:?=;V76B#SO^!@#K7_2TO)*"CWAPF6'C. : J4:\B0B][PDE=74E#]<
M,!'KXH@YD#U680SZ'>LE;._Q& <'4EJ]%-)B,HL;WNCI_P#Z4KBS&5WG,3@#
M_<,AKV=?K8K3[K;.OUL5I]UMJT]TW0.8K4/XG '^X9#79?1*1>]X22O"U9U^
MMBM/NMLZ_6Q6GW6VB7T2D7O>$DKSA_$X _W#(:]I[IN@<Q6K1KR)"+WO"25V
MYS$X _W#(:]HE]$I%[WA)*Z%.Y- FW=5@M(L*E9IB9D++TDH,4%6IL[)1F5C
M.P%G4&M?E!P]Z(4%KO ,%J/[2ULX'SWP)BX]Z(4%KN@P6HEU$Y%YWA)*]GUQ
MN(@%&IX*,5 H,(?Q* /=PR&O#^)0![N&0USP48J!088^F"BUSTPEX^UUWW(\
M1=(K5&BLB@6_0]#TL:&%RRH:1'E"\&C\Z8[6$I6EK9P/GO@3%S+TPD^&^W5.
M[/JZH(BTQT@E;3[[;':?=:T.FE 7[AF9=W<'>*MA%Q7Y2DC*9Q=^S?ZM-%@7
M:<?3!1:YZ82\?]<;B(!1K\Q.\%'*L'>.7ZXW$0"C6G;YH':Z98?5?[HDR)FJ
MHW<8&V 43[<VHWQ+$)(+ZV@[I7PWQ(EC6KM,WQ3XH08U6A@BA(Q*%$4$IW [
M%:&Q>HNE3SC7X(ET'5;F;MUH=0/HR".<NL=40=1K=60NP1QEUSJB#J-?%/BA
M!C>M#!]Q%]"6G'(:J^QPI%@:PU!UY$A%[WA)*YXS#P NR5(K@]=O[;E)(#HY
MYZH^"L *LZ8-=@ K#20_B4 >[AD-<Z8-=@ K#20_B4 >[AD-<Z8-=@ K#20_
MB4 >[AD-<H$_$'G?\# C6$6=MCID^ R:HE=TK(JJD1<C.@B"F0_C#6"#CKU1
MOXM_MFM_LI7U?:1V\MU_,3O!1R9=1.1>=X22MH=-* OW#,RU/@0J8'73JD!0
MEU$Y%YWA)*X9!OF)2RI'*Y"DC*9Q=^S?ZM-%@7:9I;DE=&)=2@HS* .6A'MG
M;#JS5WSL0[KR)"+WO"25VW=$F 5!&;NB3 *@C$/L09&O/@J%79=1.1>=X22M
M)PI7-8]5#8VQUY$A%[WA)*[#ZB4!:;) 9;BGQ0@QM6A@E:&48J,!TD&B/M%C
MVHZG/ALX/PGU X*)'+13LU WJV0A71F]G!0<\ZH!"NN=*'B3M&+$%O.K#I3G
M-,+"BQO!D#%$>?(#\=\"8NP8EX!:([%=_8U/G2KP2_64Z"+E],J&5>*4[REW
M:J[B@?"HY$?5=/(:YO&M+/F*P2>EG/US\O2R>.$O^+CXU:_1QTE_Q<?)^,:7
MUTS>-8%NQL8;A  P PT+R/:U/?=V5?-N^@ME\[O4@_9/I%NL4H./LWF:N*DO
M^+CX/WTU7X2<L_GV'EJ?O^U.3_X-0&_^ T%$'X:M?KR9.HMKG(<@0 &4@4MA
M]'0[-CX0% '*"(OQ\\%OV'-6H?3Y=*M?SW!W4QK'_O4Y,C:T@N%O*VM>\;-3
M+6FNJ$EK:[EIA4NN<YDEYUC%J>:NS]:/_P#@7SW_  .K2TF5KI=WY $A ]"^
MFM[:.WENL'HE 07B^%Z^]3.I>O[XMFL(=QN3BJY%M6&)\"::^@DI1,\:W_1-
MD-?Z!;SDAPUWO_2?;9R$'\>GYAE4QDW[_9^8MRA: :^10P*T23CXRH'I5LI9
MY?=[UE#5;#AO#OGEN+?^J/!<VQD;CM-ZA'4)+6&AWD*1&=7:0HW5FRZO(_V?
M4&*FP*O]%Z.>=!,9Y=,2SJ1O%X2/75*N.$6E+>+%(03AJQ3?*A)!$0'M?(F^
M3YJ2ML>+UH__ .!?/?\  N#O%6PBXK\I0)^(/._X&!M.%A*$W(@N.3'#B2^)
M4"L][%MQ?_KEH?5?8"5,^'%)JNOW_I/MLY"#^-;ATVW?=_GF@9WFEBEPW"[.
M]W5,?G^SB_B>]?E3L=;47G_W2=@!SFWRG7^.@/UZ[]*DCBF*_E%:../+%/B.
M_@-0?'/+ANJ54J6>?[940S5M\92\=<O43UH__P"!?/?\ ^<OJ^TCMY;K&<R=
M4/LI-]5YG;4-.S7<JG?DTI$)&,4MS9@W6C^ ?CEOP!&T?/\ @!.9U08NZJMD
M/Q)+DXZT?_\  OGO^ 6;#O0MO;:@X /T8 @<%YNL9'I!(V$F-/NZY6=[8\/R
MH2@7")7"JABF=XZN[]<HWI/]^,W.#/\ <,AKW=7KXK3[K37D2$7O>$DKWGNF
MZ!S$V'?.^FP+Y=@TD%<KBB-?K!W_ -O*D(DIAC-QJ-"^]=:RK+-Y J@0D=K:
MJ@49MKIIAN6D(EZ#9]Q9X@Y(5D7:/FOD%WNQ]" [N,9@U?S56DS(*H"&N5%0
M7)W_ *3[;.0@_A[HK0CF"82C#^O"7\'&(\4/>NFD7BV/*Z$WM*(3D@-_0AHQ
M0E^%16Z:I".=5ZOO8G CN=4O&7%Z]IZYU-@$@5ACLF6F.=1%C&(-1Q\WK,OV
MC/+VJ7O("/W#S7\5P=?7, M/C'3=?(YF.P^=5Z*U*.*_XL+BPX=2<S_KIGP:
M!SSZ]?/1\":$)':6'7QDS]L,9Y5II3D81>4K21I/W_A@V1=3,$R CAGXN.AQ
M]]"[0_NO"?-IO--,S^\"%Z=EOPO,@NN*^&@>S5R!RQ'S_P"?KVG8CYE<-'SI
MYK?IP()X*AAD -$)X*AAD ,KR[%<&C1L+>2O;I0SM6-*\&@79#8HU@/'#J1S
M:ZR'@7(UMM5T]@O*SHKPN[BL#$:\,ZI?N!\-7:FR.ZM?>NI'7M#\[8PYV0!H
M<=]0:HJ\J0F][PDE9IR-")?>WI)*8S]OMKT^)'E_JE;T*,E:]=NW<;GO;\_#
MV7M*HHN$#<*$7($.;24R9RL_[-_A*21/NCOA4TO"?[&84'>,38=JP&>J#;93
MX]_::NSIV0G%W:'_ $9$FA.*J37$WN^(&QFC5YHL_P!),%KIT=E/[%T'>U?*
MG+DM9DQ'!653 ?,'K?1I,LUX[<9XW[?MN''C7-LU9/KIICSCH\;#^OZ,?'P_
M%Y_*4DB?='>"IO(MVY2E'!?\6%R7B4Q;Z#^RY?55_C*/D_"LS)49)?JD277H
M[:-F!2DNZ16+;4_'64E[$P<9LM=LP'SKQP_NO=<C8FKIXB;O:/#W_I/MLY"#
M^/WY<8/G_!Z[P?/GKU>\7Z/:0=:SZ#T!I DERZVW!T3V/6)K)YC5Z] T=U*.
M-!NR2T+W"0>25''=BB>I/95^EQ0L/*P*\<O-;].!>-7SEYK?IP(I<]WO=?\
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MPD.NVY:R\T7#&7>/CF]8\"A/Y_\ OKU\]'P'2N9]273PRQ_V^F/'#4WNCB^
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MMIO[@!4@K2#5IRN=PF__ &>\1+P5; /V3+!XF,JY;-SZZGQZB;HS0-#0!;I
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MA;:;^X 5(*T@U:<KG<)O_P!GO$2\%6P#]DRP>)C*MMFYG[)EH\3&5;;%-_\
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MCE(4""#Y(8<A<='QN_UQL Y7I$G K-;2.KJY[B3CE@QZ2HE?969.83)L %L
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M"-=YBL?>A_YAK"+*T-.\0O\ 3&-QAT'1_*>&8)YU"?B79K]!N#1QU=,(22K
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MDQ_0]B(?#9*^S=CA@T;.R^/BE"]AV! _L&<& IKF^0E5L?\ .0'9)D;Q_1,
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MR?5RX,&T,"M," E""-"1=ZM.#!M# Z#'@DK5 @*J%^H8LRZ7Y9*%?5D&#:&
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M'@_FMJ,GZ_\ 1YT7=M3W[LH>=%W;4]^[*1Y]%/LR+O'MO#<&+^$COT=?]LV
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M$U4M;G'&#2QN*EK<XXP:6-P ]Y@& YKH!>\P' <UT:G?RV;3?>0'O, P'-=
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MOOIUE!7+3H+L6@P@"&9Y)!Y!^^@8-NP 4F7D%+9!'X7DOOIUE!7+2UUMZ_\
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+UL>IG;!D87KW_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>ahl-20231220_g14.jpg
<TEXT>
begin 644 ahl-20231220_g14.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X1NZ17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(T   R,#(S.C$R.C$X(# R.C V.C0R  $
M : #  $    !          @   $$  $      0   0$$  $   ";     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   "?&@        @ "  ( /_8_^  $$I&248
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M !H_X230O^@UIW_@4G^- <\>YIT5F?\ "2:%_P!!K3O_  *3_&C_ (230O\
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M))H7_0:T[_P*3_&@.>/<TZ*S/^$DT+_H-:=_X%)_C1_PDFA?]!K3O_ I/\:
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M^_EO_P#'*/\ A)+G_H7M1_[^6_\ \<IU%%P]K(;_ ,))<_\ 0O:C_P!_+?\
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M#V *QT5%<N-1\3S7,1M[.T-F[DB9RP)0&(C@9Y(,P&<#A22.AJW>M>([7[-
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M!'2U%+"TA&V:2/'9,<_F#4?V5_\ G[N/_'?\*9:26B+-<E\3O^2;:[_U[_\
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M1PV5M&ENVZ%4B4"([2N5 '!VDCCL2*;;:3IMG.D]KI]I!*D(@22*%598P<A
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M65H@!^< #  2  D !@ -86-S<$U31E0
M     /;6  $     TRUL8VUS
M                           -9&5S8P   2    ! 8W!R=    6     V
M=W1P=    9@    48VAA9    :P    L<EA96@   =@    48EA96@   >P
M   49UA96@   @     4<E120P   A0    @9U120P   A0    @8E120P
M A0    @8VAR;0   C0    D9&UN9    E@    D9&UD9    GP    D;6QU
M8P         !    #&5N55,    D    ' !' $D 30!0 "  8@!U &D ; !T
M "T :0!N "  <P!2 $< 0FUL=6,          0    QE;E53    &@   !P
M4 !U &( ; !I &, ( !$ &\ ;0!A &D ;@  6%E:(        /;6  $
MTRUS9C,R       !#$(   7>___S)0  !Y,  /V0___[H?___:(   /<  #
M;EA96B        !OH   ./4   .06%E:(        "2?   /A   ML1865H@
M        8I<  +>'   8V7!A<F$       ,    "9F8  /*G   -60  $]
M  I;8VAR;0       P    "CUP  5'P  $S-  "9F@  )F<   ]<;6QU8P
M       !    #&5N55,    (    ' !' $D 30!0;6QU8P         !
M#&5N55,    (    ' !S %( 1P!"_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\( $0@!( ': P$1  (1 0,1 ?_$
M !X  0 !! ,! 0             & 04'" 0)"@,"_\0 ' $!  (# 0$!
M          (# 00%!@<(_]H # ,!  (0 Q    'O\
M                    ! X:.+(<S+EG5XF(P_&I]69M+<P-5Q/T7K-V2Y]'
MZLWC-V-H<Z8RV_HSS,SYB<DEL                    #$]?+A\=35ZGS<@
ME?'HZ^=+>W@BKB9ZM[?*2PC7Q\E3Z'T9PE7QLJ3ZEXS;C*'-G<MZ82V]K+_3
M@         ",1UL&5\4          0F.G-I;@               &0Y;^5[.
MH
M                                           !!JN+B"CRH   %[EN
M?+$+K+:C\=&]RW(S#G    <G-FQ^W]       ^!K/B$6QK_)@      <[-NW
M^;P!KYJ>$TFYWQX   #,6QZSEK)79U,):WCL^[7N-9]/YW;\4   "[2VNT;M
M?I(  4*@ $9-#*^3L57PKVP      !KY/J[[6]^H!JOK^1ZZ-'YD
M  !?);'='U/N1D "A4 'P.O6.KLQ3Y7Z@       U\GU=]K>_4 T8UO%=/VA
M\H           DV=CTA=?]!F0 *%0 1PZ[*^1N%7P@       -?)]7?:WOU
M-&-;Q73]H?*    -P+_5F=>*N!DZ?2S!9UL%U<7!E?$   $FSL>D+K_H,R !
M0J "&G777QMTJ^(       !KY/J[[6]^H!HQK>*Z?M#Y0   !L/;WA!8Z5S6
MXRAS9-+9@T=(   2;.QZ0NO^@S( %"H (8==E?&V%KY.OLMBZXQ*$+"D(UF6
MQ,=?#V;OV6QGC9S(,1QUFS*>*O@8[S;F#-V^UO?J :7Z_D.J71^8
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MQ)<3+[EVQ'CLW%BRI<;+X,Y;Q2!KY/J[[6]^H!U6;/G_ #E;_BP
M )Q&WVG\GZ?4  H5 !##KLKXVZ5?$ T%ET,.YNN[$E0M25E2^!'4I>A,,0SU
MC7V?QJ@:^3ZN^UO?J =5FSY_SE;_ (L   #/]>X,'3U,JQV,X0VM5K="*YK
M  $XC;[3^3]/J  4*@ AAUV5\;=*OB 09.9H?8 @"SZ$S5X%SL;!8UP -?)]
M7?:WOU .JS9\_P"<K?\ %@  #(T;M\:>OE2%^E=W,ON)8.GJ[4U]#KSOXP
M G$;?:?R?I]0 "A4 $,.NROC;I5\0 #1Z6]K5G:@&;..SL7'6PO*[;..IO/'
M0  U\GU=]K>_4 ZK-GS_ )RM_P 6    )5BR*YK     $XC;[3^3]/J  4*@
M AAUV5\;=*OB   8ES;EC%7Z   !KY/J[[6]^H!U6;/G_.5O^+
M G$;?:?R?I]0 "A4 $,.NROC;I5\0       # <^MO?;WJ@'59L^?\Y6_P"+
M           G$;?:?R?I]0 "A4 $,.NROC;I5\0       #"5OI-X9]  =5F
MSY_SE;_BP          )Q&WVG\GZ?4  H5 !##KLKXVZ5?$       XQJ[/L
M;S6]R<@ ZK-GS_G*W_%@          3B-OM/Y/T^H !0J "-G7'BG@XI
M  '+)MF_=_-LM*@ ZK-GS_G*W_%@          3B-OM/Y/T^H !0J #\G$*
M      _1R"/%D  ,02UM8+-           "X);W4]8  38Y0
M     !%,U\%&<XN                            & )Z<4S6,5SU\C1OQ
MS*CG8SO?3UZ@                         &#IZE\Q/*L=@#!T]3.,-L
M             :A6\VY8ESV9S&[@YC8\QR-&ZQH\',<C1OL>80?-7!SCG8S!
MI5;.5[U\Q,0>.E$,:V+MBW(\;L52U\XPV\<2HG,;L<RHG&+8-FJ<XM YV)9C
MCL@8IH\Q%MKMWS$\53UYS&W/\-P        #K?OXFP4-SAL8YE1?,3RK'8$&
ME5P495BR^XGCB5$YQ=*HV8JGKY_KVYSBX8IARX!'3^^ST[&A!Y57S$A*L60?
M-68X[,&S5CF5%\Q/,<=F*9KV<KWP->]7PGUW?7V/,,<2IR-&[9RO?
M                                                       '_\0
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M>E./*2>%P"1*OUS[7ZY]K]<^U^N?:_7/M?KGVK.FYHM?XKN]-[$F9B)K?O\
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MBL(FMLD!ET$PVZ$A&T!Q4P.2D4<BVDW [4J4:@S%[PPS8X-?@T&-)@PA('=
M6^. )M#F!&%.[D$H 0H2$.VRBP^XP;X<6A2QQ>W  (6T4+VTE>AU:/&1(X:/
M,EQ2\BT@/6CRKDUOX T)M"G\J0/0H=']O+LN7A"XG26 0H1+[HD]Z?\ W_\
M_\0 51$  @$# 0,%"0L(!@@& P   0(#!!$2$P %(105(C'2!B,R05-55I.E
M(# S0E%A<7.2E-,7-$!TL;/"T1 D4H&1LA8U0U!B<G6T!R5@@J'B<,'Q_]H
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M=*JFA6=XS5X3]$H35<GAHU*+CJQ:Z+4MD))@ABD+Y1Q3F*!HY-I735D%1/)
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M9B9&+@1FGEZ,PTS/RGE31EF6(DTII--9,'<!(BK:AB.K(A.$2R!8O_7W_\0
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M-G:3IB C)#% =92TTQ E07*EM;;2U=8F4%&!%U)@,S1"0V%B<5-P=(*S_]H
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M?CU6??BB\OQZK/OQ1>7X]5GWXHO+\>JS[\47E^/59]^*+R_#$+_4/<V$8HR
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M_MFI_P"X./5-NO[9J?\ N#CU3;K^V:G_ +@X]4VZ_MFI_P"X./5-NO[9J?\
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M9<4LC/M#>L;3X*"-:7ORL]2L5S M&&TUSK,UVV-J,8&XG)5L V).)D,M)A:
MC8)Q<U=RM:ZNY24<-E/"]"CB+5'GFYWD9U-A;1-T?Q>"*3R)_,S0$)4A1LP
M0?@>RKM2UB&Y5B;0*41KW792GS/5<\7DU<2&$<FIJ63-<YE?',(!)]L,:F*-
M1LE<ONN; >OV-DI6C3:8K/>;7G%6V;=!/!,P$(I$\*L3GV@8(.))P3!O#SM[
M9;)LEJOJG95U&J.,4RBRI.I8+W-E3UE9$#<YKKX??%8N#;K?R63!3P ULA*.
M\AW(+AV:68ZP=T.%>P8#?P"6D:TG3B K4,BLYP95Q&:DSD*$1-6'.HV.H5W3
MO,=<L[5:KBB^PKF,"J9[A</MJL9++I!PXH 3,OA+E(&0R3K5UE;F:%W:.TE'
M?]&OQ37%LC&'.DG/-GXA#)RSBLHP[7*)LG[>FSTXY)@P*O2M_>*K;/T;G=JF
MI.!*RKQ0(0#CPKZ=>")93Z(6)M87ZF.TQ0AD(I-=L)4^S5M-L]OFBK;NQ6IX
MUV+7$RCBJUA2[<>7P0@^2#.4LJ8YLR(> PM3 5;(+8U8OL@=1;V4 $I42FPF
M%,O<32E80M<Q'R=,SH:HU>,DH8RURSC+CTBEN=/M,U>DN%[<U7@/?4D%P$.S
MBVBUMG3:=&$<V>VGP5;HB+CFR?(A3TZG'57P)[S4EN*-Q@55W/*Z]>:Q.-OH
M6YW%SB$'(LQ[I,<C3A@12"YRPJ->>H-OH2[,:W3I6KNN#4Q?E50CEB8U\6?C
MR$#0*.23#M8CU<SQTY0(,F!^D-5^TM;0=3O]S5U\K:S>M3K(*=,8%H,6!V#]
M.&,=OODSS3S*<NV<I9SZ)OKHY_A/8?P:\%<DV^:.Q*%D%)8S18BQ6V\,DD,$
M)RP/$IPCF><<N)3CCM[98X^C=_['L/+\?1N_]CV'E^/HW?\ L>P\OQ]&[_V/
M8>7X^C=_['L/+\?1N_\ 8]AY?CZ-W_L>P\OQ]&[_ -CV'E^/HW?^Q[#R_'T;
MO_8]AY?CZ-W_ +'L/+\?1N_]CV'E^/HW?^Q[#R_'T;O_ &/8>7X^C=_['L/+
M\?1N_P#8]AY?CZ-W_L>P\OQ]&[_V/8>7X^C=_P"Q[#R_'T;O_8]AY?CZ-W_L
M>P\OQ]&[_P!CV'E^/HW?^Q[#R_%7.>NWL(0L4I3G*I?C&,8LCS*4I97[,1QC
MW\YS[V,?&$_JYXWCZMZM^_;!Q7MVQM>M-<0$:$=;M]8S:<QV,!ZC^'#W6$XO
M#Z/23/.F+A55AP.(3FQ(^-LS3[-KR53MIU2M:YG0XLT2T5#1EE<%>QLI%^[O
MJ=="S'@<,& Q*2O<2@2FKO(J8+5O:[K9T)0T6HZQ="I4O#+ +A\K58G=DFAS
MXRV:1&+ ",(])"N66A 8)V6Q[;;,V;5]J,-47&MK[NHRJ:WX76-X;<,V3V+3
M+..N,CL!KPES_D! %A&&:\#^H#:%2M4JUTCZ/$D;=@;:DD"&O'XW1FK&?=IY
MEG*!J4S#D8,/,-BR=9CT<AAMJ$\>CEFQ82S+5V.VQ\29B8L&NS:,=+D''ICD
M+_X_QLHYQ^*X55F?7YUXU[ +5?L.LRO@D,WW6(+"O:4NJ"UI[!((VP082L/A
MC>E+,(F77+%G60L6EYE"ALTX&$@X\^ZW8X9Y8K5M>-UF"^&G,"77%$^$DXQR
MP><0G:SZ/6=J;<7!H)'2J:PUJ=IKSD;4YX, )8V%LSG%NLE#DRO.LK5%B2ST
MCL&*%F,XP0/K9T5K?Q:N;L-(K7MPK^F432J8=I8>(*2X6@Q[3SH_$(J%8$B[
M7N=SL$MI8?NQW:MQ;.[,P.MUFQ"Z!UO$.]#575MKUET'**&%DP)S<Y^;\<QS
M1A'5ZG:SV-36:GLQ=AGK#FI6]-8,N]1S*&"7UDR-5U'.2D.4==5]80F)J&;"
M682CNW%"ZX9"\MIV\H7>E5M]?5!F,\[0Z*]=<[LL+)>TB8["CM0J9Y<R$S/)
MIF](?9?!E2>D6#N+*OG3S\21*[6'KY32MH6T%\CQ)DINF>G)+,<"%@L91F<F
MB64]S1-G0ZYJF0$/53+X9K7$R('D4GNG-,=GW8YNDY'F4&6*A,UL\"8@YKMH
M+;*YBPUZYLK?O[&I2E8WD[64Y,^Z)^.RQ:LV18GF*+74#A?$C<Z[&2_!V:;5
MXI<8V6\9V L5Z4U5E5]V6<M0'(EW:]13Y& "E&)A=DLD9/S8Q#T3?71S_">P
M_@TI4FV4RRW6N'(BIRKDR/-%L<LPS,4HRS#,H1EF/;V=L8Y_/C''S[<>TW?X
MW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?X
MW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?X
MW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?X
MW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW'S[<>TW?XW%!&5W;RC*ZJXRC*R<S&
M4<O QG&<9-V9QG'O9QG\_P 83^KGC>/JWJW[]L'%-JY=?V*QL=A&U.GG6QH\
MJNS2%DS8,$?O4"+D!#DYY-" O^,CF)\PP24!;#FKV2:ON@/J]DJ-.ME94=T&
M?+!2R2S;XF7O0^TZ\ZG-I#,(R&7(FL=WX368UK;TKNSN6Z6IUNPK$4+BVFB
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M_P"?CZ1?V0G_ )^/I%_9"?\ GX^D7]D)_P"?CZ1?V0G_ )^/I%_9"?\ GX'
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M2=1X=-=DY.N:S7D,HIJY7>V*VLMNT[9=?J3UM<"UU"IME<^-FA@S53%?-UM
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MX4LROU.6[FDSFJ5+7A(:]$^JM6*#*8'78BS>1RUL6"2Y;=#. /ITU+*QC6J
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M  ,    0                                        ;N@*;_W_ !@
M                   $L.$>#R.U@          ,
M       !P
M                                                    P    'P
M   !0      %+;;;;;;0 !P    '/^       (  (J       ) !/_\ _P#_
M /\ _P#_ /\ _P (  @  =        $ !           '(  @ $0
M$ !    'T P   '(  @ $H        $ !    !)3H   '(  @ $*N_=26"B\
M$ $;;;;;;;;;;;<(  @ $-',\4K]0=$ 'VVVVVVVVVVVT@  @ $,J4^#0WP9
M$ !           #@  @ $.O 91)XQ"$ !           #@  @ $(XE;G'['X
M$ !           #@  @ $(U]G. M8@$ !           #@  @ $( Z5#RU
M$ !           #@  @ $( -ADC#X $ !    "37@   #@  @ $( Y "UX
M$ !    H\:@   #@  @ $(  +@10  $ !     @     #@  @ $(   H
M$ !           #@  @ $(        4 !           #@  @ $(
MP !           #@  @ $(       *  !           #@  @  MMMMMMMM<
M@ !           #@  @ $@       D  ";;;;;;;;;;;8
M       G                             6QA<
M       !0 (               %]1%1E04( L/52.)* #2B         'N;2
MGJX4X!$P_O.;- $1%
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ME7-KAB&H$2JP"3D-0D2&A):NP6=[L=L.+6U4T::<4$B!B4PX!TJ5D8)01]S
M'$"1D;,^V]K1UT2FNT)OF3>\"Y"*6'6H &L4ZLA0 1Y,$7D$9:I("A\$Y"I9
MR"&0 I$C ORA=HSO7T/<622NVM+,"T"GJ%6I8.$<IL% ;[@1FU#:QKZ=?LD?
M" @XI*H-B8R@+)V8H*BM8ND$$>S7C4 -,4PTG$0C>5!6O)2KA3C7CNWJ0 LE
M#>%JQ:QH(!-@=!!@@8)@:YHI(!K>1RRC)*':"5H8T5H0&^:<!!$E8$EXL%28
M5VJ#4 *FK:Y]M[8CKHDX$)I: #>(!!%"E$*Y=@6@1G(5$M"*)0VD1@K%(,-4
M0=9,2W:@5JDB&(50K1T "*U60!"=5J5!LA  Z"UH]&!76*"?>/G;-VCBVX7L
M,3\T@BZ*ZP4 T]:$PJPXPMPDFJ&,BE_!HX:=\#=WDG:8E21P6KAF)5QIH#$"
M "$1:8"AG;*TF%-L)C@?2YT(J0[V( B@)4A"J68CBK4!6T4GX^V]L1UT25\Z
MCL0B6II4XA6V=NAIU0U;YAT04AZ$VAAL!B $!@+8?G"K*0!$P"@TEP+-T:4=
M<D@E6YP..812E*5 $30Z!D,%(,;H 0*4Q-MI6I-KKA C9+EX4^;TF%+H(,+;
M.5I-0;!&#414&3Q/9R8I>P4%N',>2=9EA<"G7;^1X2EFD00A%"B0XUWCTEN=
MD&RM= 6G#;2 E#"(VHF! G\/MO;D==$MBF)!+$P,WM-;SF0F_&A(# :D*YI;
M&6Z#1XWH-M6X/(]$1J)1UA2IHI>3.J1<88+<&P$-CLK#*@D)0!1:@$*]APID
MJAQ(*BBH,@H3>1;)\B0!]D&],N@QMJFP]9Z:2ZMQ3&@I5@JFT+" \,90)T#Q
M+/X(&M'P?;>W(ZZ) @DI*$"185#8;3189J8"X"$ 0H-31K?$!&'-L.BT-:T6
M4U0MADHAA-%(O#H\9"(\H8"7EA0!KR8ED#&$ O)-G$F0*@AK-G4C6H5P6JKW
MM(Y"&C 6X.I=*JPQSD+*2LYKT5'9$5@WR!67JR!I4R*J+4PV2'@^V\]'-%YV
MBJNV4(61X*K$ Q0XQLB"43?4!F#RD %2 *YK,I P3E&P :&8:''$4L:(X\M(
MN5YW>L3<0RQ0]4+NB0%>4 H(*$6:KN8JE%2JJJJU5=JNU=KX(.\@(]C.S@ K
M^A<A-H;H*P1@.P71=82E)10""[1(4.!!=4YQ6#:W "Y 6O=)JOA^V\Y'#250
M(=E!H "P0;+_ /WM"QKH)C O)+T#_ 5$TK,J_P#R&N9"$D0FN2O*0,>!0* ]
MYVX11HD(RNB]ADHN:JEDA'N4MZPUT2M/31.OD"Y @%@B2%<X F!1"L)*E0WP
MTW@J,M08)=KGYY<.4KA=M.$^(QV 12"< T80@JF/ IB,8^2JL2$=>HPCX(*;
M;T/#]MZ!':2KP-XK&0(<@GL-T3HI%*$"BG6C952E7_NW]>3]M[XCKHEWHT?V
M2?2]\'71,E0S$B)/D(_ 0@C[T.NB4 %  55T &U70&W&7. MIL1T7J[!T>UA
MUT,@)%J01UD.;QYY@P8,&#!@P8,&#!@P%O\ WM],9SR/*A\,T?"O\#'74%H0
M2T  .+&V4/4#1HT:-&C1HT:-&C1HT:-&C1HT:-!/:;P210Q!B(]?;28(*<9"
M.OE-<6BU:;VD5407O=^P5/)S&P$V<BG(JH[0Y0B",-%N9 N7R<D*]60J^:&^
M7415.9L;((22=716B<N,)GV^$V^U-M\3'!1'2<Q#<1_=SQOD2S$1:1%>398J
M)IJV[5I(%&#\#Y#5UND)_>O853A#CJ,*&6JG3- V =A%EO>M&-5L/!$)*8[U
M.0FTBB#"?]5G0I=9RC3,M4<V8A#;3X@/BW\@(CA"80]!H)<XL8Y0NQ5BHKKO
MBFC%3FU@+,R&GC $6$5EG?,PD862N2?ZK*C)HM?+Q,>T*(NKH$=F:Y.,\I8B
M,'BYTL1!F)9AQ#HP!/!$@"16^JL.D\?:5'P,28"P#3\LLT2 X,***W1O'#5+
M_NIBTS!"H'@/P[FNL!8G"PCJ7"+Z7<,WF(<HG<'G$W34SE"VT#-Y6T;<!,%)
MAUH//;K*0,2LM2HE&*+ YX.3I6$T#C^KQPBG>VW7JBUVSD<F)PWT=@%ZCDQ1
M,5P'*OEBNISE>^671.QU('FCBZ1X[P462YBB01"*CZLKP*AX(SL'!.!I<.F;
MRF-TXN#8P#21$F2G'&,!(# (R8H&&9$I=2(CE@8"C6*@+CU$$CGI%HU:!(GL
M2J]34S<C"BCO?1QK"^=3E]NWBTL,H%G!W/LTH9+<(%W(,H3V43> *'@A$A<"
MTQ!FN"0Q>&/NHJX"0YT%KNP1C.EP[OU#PZDE9#"1,G8$2%<Z*\<**L)('-WJ
MNQO>1Z$\N;RFYP!R$QAS\'&>5M1.#Q<Z!4R)@,(\"\[)YX%-$K#:PSRX_P"I
M\(]_4DT5_$!0N.%+%^ ENY'5PIV8-ZQ 6HI3X7F8F2ATX<5.38ZI8(!8ANXI
MD*S]9\>C7[OD,;_E#B2L$4_P)^L(>BG):UK1-*++\M.6"RKE P"Q1@%#,3_J
M$_KT;RP#C*(7<G+PDN+8,3?&\7,''GP-#2(I ].*J38SLT-IH:^^ "_5PEF-
MXC0+0LEL3X.!&K=; IP$I>IQO9E,YIT]"1@6P$2Y%#O,TTDWH4@8:M^@'-I@
MRB]<*D:$M,K,"/\ /Q:/_\0 +!$! 0 " 0,# @8# 0$!     1$ (3%!4?!A
M<=&!P3! D:&Q\1 @4.%@</_:  @! @$!/Q#_ .0J$@-'*J 'NIOISG161U&H
M:!+%U6GNG4K"RID-K6D)6DQ8@G(BGN+3ZX16XUH="BZX3EW.HD(EM!)"VR5C
M%HG)A4JTAJ+2&TC=:C<8VT6*#M6S@Z=,8"8T2'0"1!:J5T&G&1)Z$04<F("J
MHJ((A]-!>B,CZ&D>M.^7L6%>B=W>C9OC!$5/)03FU">^:\Z 272S081VH(]3
M!T!5X!5YX+OA_1S8T2#HEX%L%Z%N%V@*C2+4=$W74RQI^=1>+%G_ "]U105T
M B7T4CITJ%F.'$LLB#*J S9TBN$+)02&4IHRKN;+2#$W&N]!+=)]MFCBF(JS
M0!"$WHVO*NA%B22%Y9XTLI7'U,K97&-(DT4',Z+A-QBB=7(J6ZT^LS1%2T-B
M*&;Q5=Z7#$9@0I6B%.NY3*;Q+@R-15+L AE78#JEE!PSI%&$)L*%B@)W*RF.
MR4'4G2QZ) [F,86M'+I-TT8;,+PV2$=HQ[NX5@6T<7(EVI2>H/IR!,@L!>0+
MT*J<A'(L9!TVT;C@HPD*?RY+"R2W(/0(5WS)USQ_'GC^//'\>>/X\\?QYX_C
MSQ_'GC^//'\>>/X\\?QYX_CSQ_'GC^//'\>>/X\\?QYX_CSQ_'GC^//'\>>/
MX\O<GLXTY-N[;<\?QYX_CSQ_'GC^//'\>>/X\\?QYX_CSQ_'GC^//'\>>/X\
M\?QYX_CSQ_'GC^//'\>>/X\\?QYX_CSQ_'GC^//'\>>/X\\?QYX_CSQ_'GC^
M//'\>>/X\\?QYX_CSQ_'C*3!IWGM 3W?_P!0$ #*!K1OIM^N?VGRS^T^6?VG
MRS^T^6?VGRS^T^6?VGRS^T^6?VGRP53HD<M#"F!:[@Q@()4  5 H[I*):(,$
M!*<""%4J4$ZE$S]E)Y)W-M26ZEQ+'4(-"")(6&"%+_:?+/[3Y9_:?+/[3Y9_
M:?+/[3Y9_:?+/[3Y9_:?+!@2 5BK-_CJ'*'NYY!^,\A\,\A\,\A\,\A\,\A\
M,\A\,\A\,\A\,\A\,\A\,\A\,\A\,\A\,\A\,4BKSPG\A^.I"V$I*@WA+L-,
M<+P.MUL"5TKB3U+) #IO2GS.DHZ'>9/4VWE"T0=0TIT)K$6RP* \-#;FM)@,
M!82&0I 12 I%(\O/X/C>S\:/<ZO,]#I>_;CGA5VM>[^0Y_=_)_JC.&I 'FK7
M%)9OCC\PX<.'#APX<.'#APX<.'#APX<.'#C13=24--[9KU$[GXM!.>#W?CG\
MES^[^3\Z2\%V?BO0[J_I/G\ES^[^3\<DLK$!J"ST!#FQ%#-KLK!8D  &T62A
MFGAW-T"ET#$8M#,$C7CPP51<J.(M*:;E1JNWM*E#96)V:+WM=N+"=D"H03\&
M\%V?G\Y_=_)^.2HE0$J!$H4H\B/;()0!: @5:P.57O@!->G B":.D4+OGC"D
MX <H$&@\+JS> :!P"G!P<=0;T[&(#T   I2%!85<K#\'P79^-@%WP;?;S6>C
M'?L?UT;WZ8)04;K1T78T:^^7!$IX/#V:'Z\>N+.I-CO78Z_<IZXHY#I07KUX
M#][Z9U( ')V5X@K3;"&]Y-RGON?Q?V]\4<D\@6GKL!^CKKO$+Q0%-T'JZGO%
M<9YV FW8^DOTYQ0BI%06SN:#KWO[6Y:70;J=S4]BUQ/$7NL6S79[_P 8L%3:
M)NVS6I^^6"BM%!LOTCZQ<CB!68!MM=9S^[^3_4?9M$4E8"RIOUSS7[9YK]L\
MU^V>:_;/-?MGFOVSS7[9YK]L\U^V>:_;/-?MGFOVSS7[9YK]L\U^V>:_;/-?
MMGFOVSS7[9YK]L\U^V>:_;/-?M@%1!E8A3;K\;"!D/<CZ26=]]#$)26NYOU[
M&)[;N\JV '85H\NKTZ7E><X@0.IL^Y"3M^MQILBV+3Z$A];Z3(ZW&]DN-CFZ
MV1Q=.D1UR=,NW14>0">K#I]7"'TE0).L#B]:OL7$Y49&(7KI]YW$HAH) V$A
MQ=$]6S#0!1-"2%T<.IMZ68I ;0#2!#LY?5$N>GN8W3&[)]\0AHNO8V_1>G[]
MFP5 $X$(1-'<W@:!(<K0XZ&^_P!LY_=_)_J1@%(@EYMYX)]L\$^V>"?;/!/M
MG@GVSP3[9X)]L\$^V>"?;/!/MG@GVSP3[9X)]L\$^V>"?;/!/MG@GVSP3[9X
M)]L\$^V>"?;/!/MG@GVP"E_VA]/QL*&@"6W5T=']MY5EX1MB=QG\S+WL %"H
M5@.K?29%H5$Y3TX(AVY]'%JD;0I3J":OJEVX)!@/=3?;9_YZ\8).2I NT[\3
M]\K] YWX^F#=C<6[>Q!_7CUPZD*H7JEH0>)RP]<$]S=])S9<(0[.APG>!'%@
MJA);H3O9Y]*LC4+L6#^GZ)<094V0=\6QFLX)&LI8)S:#W>.F=P/)"B2<B#UU
M]<Y_=_)^=)>"[OQLG?-Z$)BWGB<[-X;6:(%X..8U_3-(6=C$G&Y^NM]L#515
M;4QYVCOM #LN\- Z+.0=!)N=R8A$-%;>KSJ7]_JY4#D$(@9Q0/UB+W,CK<YW
M7OB44DT1B/7<1_3_ ,($(#2B]G3=[P=E'JZ41>HM?UOKG*J9U"[ZKR]-'UP(
M#;9MM[DGZ8A(BS8[>WH[=M=L>&1[+>D['3&W9%6+T[G#46['@];TSA*M7W8?
MQWJW.?W?R?G27@N[\?.#1LIO;VWN=9Q@Q0ZSDY[(M'W^^#=.J%0J<P6OTN:M
M"66G/:6W^,92C1E%>QBM_P#,)B4!&[+T0==]@\_359J7DLXLMGK)UXP%X/?H
M'NNCZXB@<"RF^W7A[\>HYHT;9(A#HW:NXK.,6@=;V-$M48_7]\)*&@2,>[NI
MQ$USFJS4O)9WEL]9.O&<&C>SJ>V]_3+YSF2G$O-Y]EZ_XY_=_)^=)>"[OQ\8
M$-#H:7H*I._#3$*-U?$F]2V_6?3KA*[6R CL3:DXWIPXTHH.A7\=^K/5P).U
M[!-37/6<SZ.+KZ/8U]W[3UQH'8[ 2_5L'M'[X8#P.8,2S3I-[P%*K@T=;P($
MXE;S3C*C6BMCKA1YPG0HA#5B?4P$I2)6/7GG7:5[WIB$ZCL!+]6P=:C,"7T4
M=&Z/W8HMN88=I'>O??M_CG]W\GYTEX+N_(X"\"SF"S$1B(O C7Z9LFR61L[S
MMG] _&?4-FGCOQZGZX)8+.8+/?*<+3'3I[>_ID1B(]HW],V2KS(V=YG!I+Q1
MWB*/Z[C[7G_3G]W\GYTEX+N_(YT;/T.F]=L">J$8[]J##VNWGJ 3:%(<7WK5
MZ2>N"-H%G+GL37KQ]<!"CE>BWMSS^OOFU<F5TEMA*/HUVQHHTAKX8&[#+Z=.
MM\%.33=X':@'!P2!6J]> #JK!&FSP;XXZDO7G]]8A2-'?"3WH?Z<_N_D_'))
M11(?DH]0(!X0INA@'$88*4!%0142G% 50 55@!M5= &U>,7C+!$W4$Q'6PXK
MLH[T ^D*S'8E%,.IT*!44>H* VJR((33^"3P7=^1P#A3V4_C_45*'JH?KD81
MI8/J?XL"V@\3F^KV_P!N?W?R?C$G%@EKQ4"P65W!]L63DZ-IC:UMD-7H,MG8
MN'9O6DL.W7$*&H2"T/(,B-Y(\(^P2B=Y2 2ZF@#M!5D):+P(*5HV  2C!*-E
M(@!@EAJ!X*E/P/!=WY/&!"#"EFKN+H9Z[Z8+8"I4#CK6J=Q;WO>;LI$B"6\V
MP=<L>' ;Q3;$=:%ZC75_9RZ$:0D<>UT]J/3$(QR)Z',"&FIR[[[E81T-([+>
M'U_VY_=_)^0)+)1U *VU *JM;R]_Q?!=WY7!!"1YH-_4=>G'X7/[OY/SI+P7
M=^?P[.Q/U?\ S\Z2\%W?G\A3SM].GW?K^=)>"[OSV*[,.W5]^Q^_YXEX+N_%
M@19QR?QGD?EGD?EGD?EGD?EGD?EGD?EGD?EGD?EGD?EGD?EGD?EGD?EGD?EG
MD?EGD7YPX 'L?GR7@N[_ (C*P28.E%(B<AGHLWHLWHLWHLWHLWHLWHLWHLWH
MLWHLWHLWHLWHLWHLWHLWHLWHLWHLWHLWHLWHLWHLWHLRPB$1$Z;I_P":=@-%
M5 -%0!4!14#:#)X&Q7)*:0HM4%( O_:"95&2@B!M"R+LB@!8)V(6>FB2"KL9
M32D*E! P4"@.B&5@Y@"N+JP$!P1861"-U,!$=#8%=XPCP1RZO2HA'8ER:!V
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M\)=-S(HN/ BF$*C]C%PR)G=<=F )\\$Y\T;'"!*WP>Q][9ZH"2=]B<-*YRQ
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+7:R#52&_G'\^_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>ahl-20231220_g2.jpg
<TEXT>
begin 644 ahl-20231220_g2.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X2/V17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(T   R,#(S.C$R.C$V(# Y.C4Y.C4R  $
M : #  $    !          @   $$  $   #B     0$$  $      0   @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   #<(@        @ "  ( /_8_^  $$I&248
M 0$   $  0  _]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=
M&AP<("0N)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8
M#0T8,B$<(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R_\  $0@!  #B P$B  (1 0,1 ?_$ !\   $% 0$! 0$!
M           ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $
M$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ
M-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(
MB8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8
MV=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$        !
M @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,08205$'
M87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#
M1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66
MEYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7F
MY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ]_HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BD9@JEF( '))[4V.:.8$QNK@=U.1TS_ "(H ?11
M10 4444 %%%% !3&E595B.=S D8'&!3Z@/\ Q_+_ -<C_,4 0OJ2)<20^4Y9
M._&#^M'VYAJ"VYC^20 H_P"&2#[U;\M"22H)/7-+@$@D#(Z4 +1110 4444
M%%%% !1110 4444 %%%% !14<MQ%"R"1PI?.,^PR:H/K^FK/% EPLDDK[ $Y
MP>,Y/;[P_.@#3J.2>*(@22*I/0$\GZ#O6-+<WUPM[ #-%,',<:HG&WC#@_G4
M-OI.K2N\EU=(DC^6K,H!/R-G(R.-PZCMVH%<T[/6].U#FUN/,&4 8(P#;AE2
M"1@@CN.*IWWB!K9IQ';@FWD E5W&[;P=R@=>,_ETJ33?#5AI>\P^;EW+L/,(
M4G<6' XXZ#V %:IBB)):-#SG)4=?6@-3.5+F]NY?.C;^SIH-OERX!5@3R,=B
M".O3%.TS2$TQW:.>1E<?ZLGY5/L/PJXUU$IVAMS?W4&32>9</]R((/60_P!!
M0!/44EQ#"0KR ,>B]6/T'4TS[.S_ .NG=O9#L'Z<_K4L<,<((CC5 >3M&,T#
M(O/ED_U5NV/[TIVC\NOY@5G:CHUUJ-W93'5)[98'+.EM\@E&/ND]:V:*!6#H
M**SH[NY.K7$#H/(2/<IVX&<]S^?Y4R+5)9+A8S;C!D";@V1T!ST]Z=B?:(U*
M@/\ Q_+_ -<C_,5/4!_X_E_ZY'^8I%D]%%% !1110 4444 %%%% !1110 55
MFU"V@D='?&P;I"!P@P3D^G JU5";2;>:\EN&:0"= DT0(V2 =,C'\L9[T 4+
MOQ5912^1!NDE/&<8"G<J\]^"Z9]FS52*Z\0WJ Q1^27"LQ=<!3@@KSSP0/J#
M70P6-K;#$,"+[XY[=_P'Y"IGD2-2SNJJ.I8XH$8">'KF>?S;V^9QD,$'/0DX
M.?8D?2IX_"NE11QH(6(3;R7.3A @SZ_* /PK2^U!_P#4Q22^X&%_,XS^&:-M
MU)]Z1(AZ1C<?S/'Z4!H3DA5))  [FH3=QDXC#2G_ &!D?GTH%I%D,X,C#NYW
M8^GI4X '2@9!FYD[)$/^^C1]E5N97>0^YX_*IZ* $5%0810H] ,4M%9\>I[K
M^YMWBVK"F\$')8=_;]:+"<DMS0HJA#JL<\T21PRD.2-^Y,*1Z_-D_@#5^BU@
M4D]@KRCQK\4[SPKXEFTN.Q2=%0,',A'7\.U>KU\S_&+_ )*#<?\ 7%/ZU4%=
MF.(DXPNC?/QUOB"/[*CY4#_6G\^E(/CG=J<KHT*\Y&).GMTKR.BM>5'![>IW
M/H#P1\4KOQ7XFATN2Q6!&5Y"XD)Z=NE>G-N_M"/&-OEMG/7J*^<?@U_R4*#_
M *X2?TKZ//\ Q_+_ -<C_,5E-69WX>3E"[*QCNTNYY$W;3C'0\<=/UI6CO/M
M<,H;Y" )%S5^BI-PHHHH **** "BBHGN848J7RPZJOS$?@* ):*@\V=_]7#L
M'K(?Z"CR'?\ ULS'_97Y10 ^2:*+[[@>U,\]W_U4+'_:;Y13TACC^X@!]>]2
M4 0>5._WYM@](Q_4_P"%*EM"C!@F7'1F.X_F:FHH ***A#S,I(11Z F@39-1
M4>9L]$QGU[4@,W&0G?//Y4!<EHJ(/('0.HPPP=O8_P"%2T G<YR\\9>']-O6
MM;_68;>X1SNBD=01]?:JB^//" )<>(;7<RG<WF+D_7CK7A?Q6_Y*'J7U'\JX
MNM5!-'#/$2C)JQ]1CQGX,5E8>(+8%,$'SAU]?<\UJ:;XLT/6+];33=8BNIR2
MQCC8-\H'/X=.:^2*]&^"7_)01_UZ2_\ LM$HV5PIUVY*-CZ0KYG^,7_)0;C_
M *XI_6OIBOF?XQ?\E!N/^N*?UJ8;FV*_AG T445L>:>@?!K_ )*%!_UPD_I7
MT>?^/Y?^N1_F*^</@U_R4*#_ *X2?TKZ//\ Q_+_ -<C_,5C/<]+"_PR>BBF
M":-G*!UW#J,U!TCZ*** "H_.0]"3SC@&GM]T_2FQ?ZI>G3MTH$)YR$C[W.1]
MT]J02Q@9 /(S]TU+10&HQ9%9MH)SC/(Q3ZB?'VB+[N<-C/7MTJ7M0"&":,_Q
M#J12>?'C.\=,_A1!Q"O7\3FI* 5R,SQC.7'&"?QI1*A;:&&[.,4^HW/[V/ZG
MM[4!J25%"0L .  ,]#D5+4<.# .F#G[HQ0'4@BU.TEM?M/G*D.<;Y/E'ZT^*
M^MI7V)*I)8HO(^8CD@>O0U"NF1Q6I@@=HPS;BW4YIR:9 DD<@W[XR"#GZ_\
MQ3?G3T(7/I<LN#OCX/WCT/L>M/J-Q^\BX'WCU/L:DI%H^7?BM_R4/4OJ/Y5Q
M==I\5O\ DH>I?4?RKBZWCL>56_B,*]&^"7_)01_UZ2_^RUYS7HWP2_Y*"/\
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MX_.O0/@E_P E!'_7I+_[+3D[Q'1_B(^D*^9_C%_R4&X_ZXI_6OIBOF?XQ?\
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MA7K'P'_Y&/4?^O=?YFO)Z]8^ _\ R,>H_P#7NO\ ,TI[%X?^(CWZOD[XA?\
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M_E7%UK'8X:W\1A7HWP2_Y*"/^O27_P!EKSFO1O@E_P E!'_7I+_[+1+8*/\
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MJ0PIOVV0:@D!C_=R#*O[XR0:N;$R3M&3U.*=@4BPHHHH *3(]:C>$M*'W<
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M !  #P L  AA8W-P35-&5                                   ]M8
M 0    #3+6QC;7,
M                  UD97-C   !(    $!C<')T   !8    #9W='!T   !
MF    !1C:&%D   !K    "QR6%E:   !V    !1B6%E:   ![    !1G6%E:
M   "     !1R5%)#   "%    "!G5%)#   "%    "!B5%)#   "%    "!C
M:')M   "-    "1D;6YD   "6    "1D;61D   "?    "1M;'5C
M  $    ,96Y54P   "0    < $< 20!- %  ( !B '4 :0!L '0 +0!I &X
M( !S %( 1P!";6QU8P         !    #&5N55,    :    ' !0 '4 8@!L
M &D 8P @ $0 ;P!M &$ :0!N  !865H@        ]M8  0    #3+7-F,S(
M      $,0@  !=[___,E   'DP  _9#___NA___]H@   ]P  ,!N6%E:(
M     &^@   X]0   Y!865H@        ))\   ^$  "VQ%A96B        !B
MEP  MX<  !C9<&%R80       P    )F9@  \J<   U9   3T   "EMC:')M
M       #     */7  !4?   3,T  )F:   F9P  #UQM;'5C          $
M   ,96Y54P    @    < $< 20!- %!M;'5C          $    ,96Y54P
M  @    < ', 4@!' $+_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" (6 =@# 1$  A$! Q$!_\0 '@ !  (#
M 0$! 0$           <*!@@)!0$$ P+_Q  < 0$  @,! 0$
M!08#! <" 0C_V@ , P$  A #$    >_@                           !
MCYD                           ,%,9-8#8\YXG7T^@
M           $?&8F'F0 R                   \EY]9Z       $?$@@
M                ^$.>M;4W+'93YR;VXI8  # _>MS/WJKULCKF  !'Q((
M               (.]ZF6?,F+?<<,^M; O6*5?&QM#CWO0>OUOH PWU@\'[C
M?7O^<F/>L4I8]P  "/B00              >,\8-ZQ0[[UH5]:VLV30V2Q[V
M_>&7@KWJ2QXV)'^9P!'?O5_']\GW,?&;W_F4 >=[U/1\;8  CXD$
M     \QY]!]@CWJZQ9-"7O&S#'O5F'SL[,8][)_F0 ?P?(V]ZH$A^-G]KT
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MWY]RS6G! &:-J36+C(  %N2N=GG3%(BO3,\TY>[]2  '2O1M-BV%Z?'Q((
M  !C_P!Q8?ZP'V1O&S^IZ      Q;9A<IUIH  8OL0N4:\T( S1M2:Q<9
MMR5SL\Z8I$5Z9GFG+W?J0  Z5Z-IL6PO3X^/1(O,A(N-L            8OL
MPN4:TT  ,5V83*M:;$ 9HVI-8N,@  6Y*YV>=,4B*],SS3E[OU(  =*]&TV+
M87I\0DG&H!+Y#YN@ 8!NU;VL4C_KY]^#Z?'\_OC\.36S;3L8\G)H^;DTP/Z?
M/;Z?'T^ON18)88ILPF5ZTWH)=OR[M/6^V1'*4/*M:;V&@NKXOL0N4:\T( S1
MM2:Q<9   MR5SL\Z8I$5Z9GFG+W?J0  Z5Z-IL6PO3X^)!   ,7V(7*->:
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M^??G\OOCZ^_'S^OSWEVK/"ME-\LT9]U?/X[%^;TCN3S>1F]#J3H6ZP?#=*$
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MI-8N,@  6Y*YV>=,4B*],SS3E[OU(  =*]&TV+87I\?$@@  %9&=Y1HKMUX
M =9(ZX]](CHXU>SQ%4BP\>   N(5KMLD>-L5LIOEG/3=K0  ZDZ%NL'PW2A
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M@  +%\+TZ5\>Z.-DG1M#-NN@ #>+5G^TD7?,8,X(/)0-$#I\?0
M                8>0^2@8 3\?0 :WGGD0&0&[X  ,?-4#/S #8\D   &J
M/@-L   8^:H&7D8&]Q]  !K@><8 9>;8      $/@\\R E   'GD/GH$0&WX
M  !!YD!CYD!*   //(?!YY,!D   (?!YX)P
M        !_/[XQ_/%_R^^/I%^/:SC%(1^#'S,"/R4#SR/P?@!)Y'YD !D!CY
ML >@  8OZPP-ECA_M]SW!*X@^^@1@2^>>>>9 8@>^ 8>>@8 2^?3'CT >@>>
M2 2@#P,\5_-Y^'\O6.*_&Q#N&3U_)0)?,P(0,P/WF8&/GGD8$@&7F/G@&'D@
M F\E   BG)I\_P#<K8_L;VQ]OC-]\XP D\Q\@ V?, )/(@-OR'SP#SSSC,3]
MYX ,//?,@-L
M             "+P9 9 8^9@"/S,#SS("'S,#,"+S("+R<#T
M      8!XT-0\%5 ]O-8X@R2VP!#Y%YM^:P&'FYY !!YN 1^9 2 8^0>;/F8
M&P                          ,?,@ !CYD                  !_\0
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MSS[B:V-+Y88WXJSR+=2KDO0/N;ZD,LW4D^6<3IQ7>SO$^*GLJ2C:;1-,A V
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M4$RM?4$RM?4$RM?4$RM?4$RM?4$RM4_-!T,I\_)Q&@!='O7'2*H4,AOXI!4
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M9J++U*OF$MELJ,)04L#+<,QY0.G>.5RY<>Q<"EZZ0.F4 5-5HVO9I(7TV/\
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MS?Y3$*F@Q""W"(;!-^2-K6)]=S43;]/5SK0@C!>:) JE;4,XM.D!H\5AS1Y
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MPD/69 1/-J#6*)Q*0&RU9IT6K4B-2YU.GB0T:4.,)[",O5KD5I1XPE$1'BD
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M-:[X2(O_ #Z>W107;1N5J_\ /_/GTQF9\)N)/2G_  _\-&F8[SW?7L_S[/\
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M)L[JSKENPL+',6.>@1!$8!''LS?_ (:%\S?B%=KO_P!_NW:%$,0@,<>S%O\
MAH'R-^(%VN__ '^[=HZ))&L31QX$PVM&B-T1A%W15=LM^)C<YFYSTD5)0H>.
M/H&ZX8HX\_?LU4M\&N-*R5Y:F5I#<AL R"@)&!'&H50% 5%50 -PY=7<%N]/
MR)S]8< =XO@W^AV;;R,(]K'#^5]_X7TM&-[%NP+#^IA?]&F.WHJJ^_TC^;7
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MD->8MKLT)VL+PO<7LC%<1%CD>B,SEIY0>J)C_P"?#3;O]PW]_P".FVE^Y/\
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M75='+_P]F?;$</Z<T_3I_AU7!ZI6,!U))?#_ -:G^@:>5ZSI^/2B91]>/?\
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MTYF7B/VCX\M!ZN.TW/UAP5[P?*W+3\>+O%\?,3\>;O'^8\NKN"W>GY$Y^L.
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MAIY93?>?I?\ CIY93?>?I?\ CIY93?>?I?\ CIY93?>?I?\ CIY93?>?I?\
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M(8G60 $K?([LP1^^G^(R_8C_ %?RT_Q&7[$?ZOY:?XC+]B/]7\O_ '+?%A.
M@-U7_P#X=,-5]M?[?PTPU7VU_M_#3#5?;7^W\-(Q(!](03?*WL_(?_[+_\0
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M:VI$$Q.@W(EQN^2,H1-49(A]K J/CA;%#MINIZUJ[3X6:'=/)'QU=<QR>YS
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M%K4G0$9 Z/(Z\*(<9Q1DT<,(\<>]''EJU2CBYIFWLX9#C=X$,E@9:6T-,;8
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MIFZ;+<_-C&MZ"9K;]LKS9%U_%@. XYC)E@/:RX]4!4K+ :ODJXRA:R%H8+W
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M;_)T.E70Q@9786$-@+D3!7RYFC(P1(_*?+'96&4NJA1K3RI!S7I<-1AE)3V
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M [X**K,.$ORHU:QP][ZGH_?D!>Q)HP(6:+=4H>!ZD>,FX8@[ $7U_#QU[6O
MNX67$'$QT%-S L<&L:C:V_+)BK@W!<IM-WD%L\ X=L*]CSTG59@H+>#/6L<5
M:/H\J[LONSE1%<&;-AXP]I0@"=\-U%V8A#.<_P#JZH2M5U6/ X[VGD/G"]D
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MD7&![;D9KN(OGR0C\ P:1N\Y/*:M.'0/CG&DR"JW5/M:*<P([D75&D)H?7E
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M-4;2U5TDPM!@2JC0\_\ %/(S/C,O'NM1U^ME#0Y1A5PT3!$+!=E ; 3+N;.
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MQ !S("QO5S)4";CBBKNK;03H-E.QFU\"?^($L;KK:'[A_P!7#=R6TBL+_]H
M# ,!  (  P   !
M          "020                          00
M (       "                   15@  "P   0                "TL+
MX "80@  "               ,W5"\ "T< #   0             :P[D@ ;)
M8   7Y@"            :8!0@ 6Q@   "%MG\2 0       !O:"*@ !;
M  <F.0@02        140  >*@       @  40          D  \J    !<G@
M $  "B             8@     9UP  @  40         !/       !VL!F
M$  "B        #RD        <42&X @  40      !((     @D@8    #@$
M  "B     #M<      4  #     < @  420             @       #@$
M "@ 2 !#H) #))!? 8.$A     < @  40   (  !@,   ("BWP8    #@$
M"B    @       #    !     < @  40   (#$S6?)4 8#?_ (^     X!
M H@   2QW': _.TP'        ' (  %$   & M0  "*"Z)X        X!
MH@   0    8H%0C;"       ' (  % D$@"    !VQ % \#       X!   H
MD@$    ' X   X' 6@*    ' (  %$   #__ /\  <   <#@  4 0  #@$
M"B   "   <#@  #@<    %9 @< @  40   0  #@<   <#@      4$ $  "
MB   "   <#@  #@<       ",@@  40   0  #@<   <#@       #B^X "B
M   "   <#@  #@<        < _BDD2"2 0  #@<   <#@       #@%?;:B2
M  "   <#@  #@<    !?<D\ @  40   0  #@<   <#@     FCG@$  "B
M "   <#@  #@<        < @  40   0  #@<   <#@       #@$  "B
M"   <#@  #@>[>X     < @  40   0  #@<   <#K'D@    #@$  "B " "
M4 @<#G'(G@<        < @  420" 3(_?@=8\C<#@       #@$  "B   ";
M@[\#@  #@<        < @  40   0  #@<   <#@       #@$  "B   "
M <#@  #@<        < @  40   0  #@<   <#@       #@$  "B   "
M<#@  #@<        < @  40   0  #@<   <#@       #@$  "B2  "   <
M#@  #@<        < @  4" 2 0  #@<   <#@       #@$  "B   "   <#
M@  #@<        < @  40   0  #@<   <#@       #@$  "B   "   <#@
M  #@<        < @  40   0  #@<   <#@       #@$  "B   "   <#@
M #@<        < @  40  "!))(R9))):0I))23I))*R5))*R2"0
M                 "0"  2     00   "0  """   ""      "20   2
M  22   "2   "20                                  BER2222 222
M0   _HR"202200220 'H\02 22 2  0  20T022020"" "0
M                                                 2  " " 00
M                /;6 2200  20
M               ?_\0 +1$! 0 " @$"!@$$ 04      1$ (3%!41!A(#!
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MA8JZ;@:A3%;HI@N!.E3!$#LLXM&@3M%.P*K5Y3 6Q)AQ T+!8?""9E0 .5$
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M C+11B9TAPU4CRI(#@)0U"$S3#O5!F4I1M.&"XE09V#4Q"HDX     ! - '
M'0?"F .C\\E5&A<Z!<Z*O#+3D?"B'B&\Y%_VVM7)C1VBF!@@0@3RDO@F. #Y
MI4%O7X-F8"HV%LKP%@4X(X0X ?&7M$KUC5PR4X2:-A;B="7><)(3\[ <J.2
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M/#?=APYOQ'^:LO(,RM7D(N)CNN2 1H^WZHF]4?ILH!=+UP>O[\*@.J <ZZ#
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MC]Y,:@FN1Q1&K*)<0@AP?572(%"0KF_W3'#U'RA>YK>!+<#< _7T4 &1+7%
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MJ!X7C[DQJ0D 9;J1&R'!X:,&4$$5$5ZPB FC]368 4RK*L5-P2:8S6&1^-)
M@%AU'C-0C2.:,Y,H0'C-0C2.:,Y,H0]H%Y3G]?R_J^#_ $^QX_EZ^#Y/:@>%
MX^Y,:JU$@E5*0I1Q$DW)UX;A1<++"R6%V-/>, KRG!NK%8=*0(4-#5%*JJJU
M<NC7(E" %\*2>H$8T-<B4( 7PI)Z@1CVP+RG/Z_E_5\'^GV/'\O7P?)[4#PO
M'2A"DN@5T( ^ D4"=GKQ8#4JC$ 3@%1$80(E%4J+)9!28_&T!0%\/HA= [QC
M). 8YL PM1T#=O"@.R@(7(H = W;PH#LH"%R* /M)C4%Y3G]?R_J^#_3['C^
M7KX/D]J!X7CIZW+7..Z$  @6,1/&H!.2JA$$P:#B24ID"3$D1HJ*-08;C[K>
MK)P02!,:$WYLF*! 0'-$)HR!2!!2U$ 41 $( BB" @0HP?:IC4%Y3G]?R_J^
M#_3['C^7KX/D]J!X7C]Y,:@O*<_K^7]7P?Z?8\?R]?!\GM0/"\?O)C4%Y3G]
M?R_J^#_3['C^7KX/DUFRX-LC3H# ,]9]7+<0%!D85Q*9 3B\]8.I$1 $$HQD
MW7OI $<'#*NB_NVLU4<6@JEQN@DBC%A\HHVC,U:]8'A>/WDQJ"\IS^OY?U?!
M_I]CQ_+U\'R:;6("N_0X$:@CI5\KNA,4I,PC(032JWHCS<@14P 2NP<2(VT6
MUF>A B*HE2% 8"T#H!N5 !5B6LL#%9@/6!X7C]Y,:@O*<]),=OCE&V0B,478
M(,]$T 5) R2T=0$_ ^OR_J^#_3H-D2&UI@P 7,)F@78(=0;",2T!U"1!!&"2
M61"DPRR,@Z V !0* @E8S%9^%,,$H$D"5=H+)"9H*4AS9N73 :1W3]B/Y;A.
MR*3Q_+U\'R>U \+Q^\F-07E.>BJY%28P%40N+A@T1T9IM#K0LP&V:JP%U)O
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M0 *J@ %570!M708#]O&E'ZL6,)D' X5I3T1G%LQO.EY\YZ2,?1;YQ2];1ZC
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MA:'0 8?C#Y"QL6.Z?UUF>B%AJ^(ZN6_42R<)L&H(*&!.CM*E*@*+'Z!!!D#
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MK5RX8((]#7(R]R$9[N&@+-AGKO0\+:<K+^);^!YA9%IU*YAGQ3E\3A+86L9
M;\L :)6O\#6<?!@>;+=1'N7!6:@PB4D*#+=\4BQS$!..BX1*$_:)7UN:1L
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M]\#;D$S2-AP,ID)-VMC>@#6OL(C5D%99I-+8HL'?H0&#$)U =@  18'LHOH
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M-:#=(1,K4G 2Z*!0! S1< H!L+Q8$P 4>+% 5K.8R+G\"[\5_+/] S+.</\
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MC?)7S0S7YFD;'&^2OFAFOS-(V.-\E?-#-?F:1L<;Y*^:&:_,TC9WU:B0E3Q
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M-G[B:/0*2P9_!?  UFQ)DT%:G<] =D]3R[CEALLW;+:4 +ISV(*5'X<SCT/
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M?YXGM;9^[4^HS;_-%EP_TT93-*201D=8J&S]&1!*5CC ^;HR()2L<8$R='0
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6;DJ.JZF$4DK(-0]+>CV5*C%O%7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>ahl-20231220_g3.jpg
<TEXT>
begin 644 ahl-20231220_g3.jpg
M_]C_X  02D9)1@ ! 0( =@!V  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         #\*0  6P
M /PI  !;    1TE-4" R+C$P+C,T   R,#(S.C$R.C$S(#$Y.C$R.C$S  $
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M1T(@6%E:( ?G  P #@ !    'V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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M 0$            #!0$$!@<"" G_V@ , P$  A #$    ;_
M
M      #2NG7?#GT<JV9=MQW/]9 UI71Z$N.)F-!W)D   :@K(-777*2P@[+3
M^GH?1L=7[VA;ZRW:'?GS>_K'W_,/2S'[R3$]7XT]+1>]]9V%\6VKLU&^=JUQ
M?0EUUMTGW=3?^'N:&_L7O[Q(  /EZ_UHC-!Y_O&V=G?RN+? ]?YQ^OOY\OS]
MZ2U:SU]W2WIB^_6/H       !A%BIJ,_Z2NW1I=0
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M&GVT!J_D=MZMW\/L^)L0J?6@
M
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MFIP[XUOMP[7N[^MF]=?:JW^9]ZMMOJ6&O\?7SMK<VLOBL0
M   !_3[V9_Z8K\ZM#M9XD                           /X#^@
M                           'NY^[[[/W#Z&9
M
M
M
M
M         !_/E#:&.0%EK;)U-WT\X]UGTOG*3X_L?W^9/CRQ_?K_ '\?1Q]
M                                       8UY5=?B+ZR7U2E_<WR
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MFC]F#/IRQV%8VO=BG$:<Q;PQ)DS(
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M)DS( %:%;;P6N*2\:RJ(,<YUF+;>OMKZTH[_ !NRI^8*CIOJQ2_HK1.=N0
M                         !\WF]R._P#,OV';_P"U_/,[_0/*@    ""T
MM9.F*S                    $:<Q;PQ)DS( $$]/<CU\_,\>OYF/?']=$%
M).#L.)T+P7=?F\H_<LM#%=Z&WSG[<                           #TZ?
M8CQ_,SV#9?ZNXK9'Z=XP     ""TM9.F*S                    $:<Q;P
MQ)DS( ###\_.8/KX4,D>=R'^Z=AKG[U9.V=5G-=8_1SC^L@
M             #P:$L?/YM>NYG[GS6U_V!P3(     ""TM9.F*S
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M-5_D7O,*\'Z:0?\ 27R+S[T0       $%I:R=,5F
M(TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D
M#6_YA[/67Y/[:1/]-/'_ '+K6        $%I:R=,5F
M  (TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D
M  8+X!U.GOQ'Z)(G^FWCWTNETP        (+2UDZ8K,
M   1IS%O#$F3,BO2:FY@K+A      !U 5O=V$0W(
M  &(>,]#H_\  /J$AOZ8>/\ V>TK@        !!:6LG3%9@
M      "-.8MX8DR9D5Z34W,%9<(      .H"M[NPB&Y
M     &->7W6@OYP^L2 _I)Y+D7I5.         !!:6LG3%9@
M       "-.8MX8DR9D5Z34W,%9<(      .H"M[NPB&Y
M      ^'PEI'O^:?KV]/Z$^699Z]0          ""TM9.F*S
M        $:<Q;PQ)DS(KTFIN8*RX0      =0%;W=A$-R
M      /E\KO1W_F7[#N7]S^;YO[OS           $%I:R=,5F
M         (TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D
M      #T:':CK_,CV':O[!X38?Z4X\           06EK)TQ68
M          C3F+>&),F9%>DU-S!67"      #J K>[L(AN0
M      !Z]?-'K^:OKV>_HKE-G_J_AO[D           (+2UDZ8K,
M            1IS%O#$F3,BO2:FY@K+A      !U 5O=V$0W(
M        'ATY- _SC]9R;UBEV[^S_//[D           !!:6LG3%9@
M             "-.8MX8DR9D5Z34W,%9<(      .H"M[NPB&Y
M         'XA^M&?S_\ 4O9LX-U_N_S/]28            $%I:R=,5F
M                (TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D
M           #\_&=,_ASTGYO,;F]_P"@_E?[F^0            (+2UDZ8K,
M                    1IS%O#$F3,BO2:FY@K+A      !U 5O=V$0W(
M               _F&I?QKZ#B?C=_('^D7D?FW8P            !!:6LG3%
M9@                   "-.8MX8DR9D5Z34W,%9<(      .H"M[NPB&Y
M                8:S_ "QVVNOS)V$A_P"EWD'M6L              $%I:
MR=,5F                    (TYBWAB3)F17I-3<P5EP@      Z@*WN["(
M;D                 # /SIUNI?QMW\BOZ:>/>_T&H              (+2
MUDZ8K,                    1IS%O#$F3,BO2:FY@K+A      !U 5O=V$
M0W(                &#^ =/J/\6^A?'XJQDM_5CQ3ZW7:
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M(;D              #U*C8T]^*/1,4\;O]W?OGS'*?6:(
M "L2>DGE%:;)^9_@1?<:=O2PG0D^[>5DOZ2]KLCSJ:[JK1OJ+-:ZU
M  'C^,P<DS*C8K\RKK*.-G7XWH[FGMVMEWI[_P S9U][P;7]9$:<Q;PQ)DS(
MKTFIN8*RX0      =0%;W=A$-R             !_,,-\1Z32OX-]+S[]'\G
MMC]B\!Y]V,                 06EK)TQ68T1J;&?6%9$N*7U["OFW3WGS]
MO3TB^I',>U\2@              "-.8MX8DR9D5Z34W,%9<(      .H"M[N
MPB&Y             'I4NSIK\.>CX]YG<;O_ 'YYCDGIM*
M    (+2UDZ8K,                    1IS%O#$F3,BO2:FY@K+A      !
MU 5O=V$0W(            _GRPCP?J-,?A3TG8OZ@XW:OZ[X/R[7P
M           !!:6LG3%9@                   "-.8MX8DR9D5Z34W,%9<
M(      .H"M[NPB&Y            ^?S^WI?\*^E?(XBPW?^_?,,@]$J0
M                (+2UDZ8K,                    1IS%O#$F3,BO2:F
MY@K+A      !U 5O=V$0W(          '\^,X%^>NKT[^(O1=F?JSB=H?K'A
MO)L?(                    @M+63IBLP                   !&G,6\,
M29,R*])J;F"LN$      '4!6]W81#<@         #YG+[NE?PAZ9Z//[6\/W
M]Y?]ON:P                     06EK)TQ68                    C3
MF+>&),F9%>DU-S!67"      #J K>[L(AN0        !^?C.O?S=U^H?Q1Z%
MM7]A\'LK]1\7^Y?D                     ""TM9.F*S
M      $:<Q;PQ)DS(KTFIN8*RX0      =0%;W=A$-R        !\GD=_27X
M)]._$'UN_P#?7F'U^QKP                      (+2UDZ8K,
M           1IS%O#$F3,BO2:FY@K+A      !U 5O=V$0W(       'YCSK
M?\P]GJ?\;=_MO]H>?;%_2_'?J3                        @M+63IBLP
M                  !&G,6\,29,R*])J;F"LN$      '4!6]W81#<@
M  #XW$V6D/P)Z=[%K%NO]W>9_5Z[0                        $%I:R=,
M5F                    (TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D
M    #Y7(;WH<[MXCXWT.L/R7W&W_ -M>=[!_1G)?W[P
M       !!:6LG3%9@                   "-.8MX8DR9D5Z34W,%9<(
M   .H"M[NPB&Y     'AU)-$?SO]4UY^8NPS;] <SOG^BGE/T>DTP
M                  (+2UDZ8K,                    1IS%O#$F3,BO2
M:FY@K+A      !U 5O=V$0W(   ##X/ VNN?R_V6!_GKJO-+'X="3;7[.\_V
M-^H..                          $%I:R=,5F
M(TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D  #U*F? _SSU>N/R]V7KULV
MQ/TUQ^POTIR'T.@U&0                           @M+63IBLP
M             !&G,6\,29,R*])J;F"LN$      '4!6]W81#<@#\QYQ7R6^
MUS^7NRP_Q;H<S]PYS9'ZEXO)O4:3^_0                            "
M"TM9.F*S                    $:<Q;PQ)DS(KTFIN8*RX0      =0%;W
M=A$-RP^7R^]KW\U]?KO\R=A]#HM38_ZEXS.O?^6]FRA
M             $%I:R=,5F                    (TYBWAB3)F17I-3<P5
MEP@      Z>J+OYJ^$][K;\L=I\/S^TS[]'<GL?]/\;]CM*W^Y
M                     ""TM9.F*S                    $:<Q;PQ)DS
M(KTFIN8*RX0    #S1_4AO*>NL+_ "CZI8]X!Z#M;U>GV5^J^*R_V7GO)L?
M  'CQG]?7Q^L?0                            @M+63IBLP
M          !&G,6\,29,R*])J;F"LN$    SOF;6=WYE],L*_*/J/UM'8K[_
M %5Y=;%^F:.</03L@  !_(U?^K9_3Z'D)VU=Y$+4W<DMZGZ57O\ AM=#YE/9
M?-N*B6>GO                         06EK)TQ68
M   C3F+>&),F9%>DU-S!67"  ?0U);OOYN?HKV(OM]22?\7[*'GZ X&O#]8>
M6QG]BXOU)X^H"M[NPB&Y    \>M]\_.K>;7[/SZZSF>DK.U]G*.CI?8YZUT9
MT5?NSF[O&^CYRS.JL3(                        @M+63IBLP
M           !&G,6\,29,R*])J;F"LN$  ^Q7S]4'\2?VA[$7W2K_1?P&"_Z
M7\SQ&]KP!U 5O=V$0W(   'XB^H-P6>V[[E=X\]?P'L(X?6.GM7GK7+>AH=F
M5MA"NQT[V*[9_3Z                        $%I:R=,5F
M        (TYBWAB3)F17I-3<P5EP@ 'O:TEPOX ]Y_F<4]?O[P?TMF, #J K
M>[L(AN0   !^</[G']9Q3X^LAEB]KY^QC7Q]?4FB^C\?8
M         $%I:R=,5F                    (TYBWAB3)F17I-3<P5EP@
M     Z@*WN["(;D  #"\P^L      ?29RO$H                       @
MM+63IBLP              / ><    $:<Q;PQ)DS(KTFIN8*RX0      =0%
M;W=A$-R  #''K:>;Z!DU      + X+?J%KN]                       $
M%I:R=,5F              -+ZDL(=[6L<VM/$:FRTS<T^W:JW_FWK>_J;7Q-
MS2W=!M&1&G,6\,29,R*])J;F"LN$      '4!6]W81#<@  QQZVGF^@9-0
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M;F"LN$      '4!6]W81#<@  QQZVGF^@9-0     "P."WZA:[O0
M              !!:6LG3%9B++7C!/\ $CM>7U-B*8$&SI(Q2-[>_JR/U-P
M        #USV#&89/4W-7,89@  (TYBWAB3)F17I-3<P5EP@      Z@*WN[
M"(;D  &./6T\WT#)J      6!P6_4+7=Z                       (+2U
MDZ8K,8O%]^#;U<OAG                  $:<Q;PQ)DS(KTFIN8*RX0
M  =0%;W=A$-R  #''K:>;Z!DU      + X+?J%KN]
M    $%I:R=,5F                    (TYBWAB3)F17I-3<P5EP@
MZ@*WN["(;D  &./6T\WT#)J      6!P6_4+7=Z    /EPR:$V(=^_?Q]**4
M#QGD               (+2UDZ8K,                    1IS%O#$F3,BO
M2:FY@K+A      !U 5O=V$0W(  ,<>MIYOH&34      L#@M^H6N[T    5]
MU-[6_=\[<]=4N^>9Z.BQ?7#[W&U6364XN=WX9=/37"Z?S]*':
M  $%I:R=,5F                    (TYBWAB3)F17I-3<P5EP@      Z@
M*WN["(;D  &./6T\WT#)J      6!P6_4+7=Z    (65]EHV>OD_U='J/B>M
MI]L-B[VUXBKWXZ"URN^*PV[=M:\[F=;:             ""TM9.F*S
M              $:<Q;PQ)DS(KTFIN8*RX0      =0%;W=A$-R  #''K:>;
MZ!DU      + X+?J%KN]     Q;/SE./H0U@LY767/\ W-3=BG#]8;MP36^<
M^Q\2             ""TM9.F*S                    $:<Q;PQ)DS(KTF
MIN8*RX0      =0%;W=A$-R  #''K:>;Z!DU      + X+?J%KN]
M               $%I:R=,5F                    (TYBWAB3)F17I-3<
MP5EP@      Z@*WN["(;D  &./6T\WT#)J      6!P6_4+7=Z  ! F:GT#]
MZ@      L]U[W-\3            06EK)TQ68                    C3F
M+>&),F9%>DU-S!67"      #J K>[L(AN0  8X];3S?0,FH     !8'!;]0M
M=WH  '-5O\/69LT8      [ JKT>0WQN@           06EK)TQ68
M             C3F+>&),F9%>DU-S!67"      #J K>[L(AN0  8X];3S?0
M,FH     !8'!;]0M=WH  '-5O\/69LT8      [ JKT>0WQN@
M06EK)TQ68                    C3F+>&),F9%>DU-S!67"      #J K>
M[L(AN0  8X];3S?0,FH     !8'!;]0M=WH  '-5O\/69LT8      [ JKT>
M0WQN@           06EK)TQ68                    C3F+>&),F9%>DU-
MS!67"      #J K>[L(AN0  8X];3S?0,FH     !8'!;]0M=WH  '-5O\/6
M9LT8      [ JKT>0WQN@           06EK)TQ68
M C3F+>&),F9%>DU-S!67"      #J K>[L(AN0  8X];3S?0,FH     !8'!
M;]0M=WH  '-5O\/69LT8      [ JKT>0WQN@           06EK)TQ68
M                 C3F+>&),F9%>DU-S!67"      #J K>[L(AN0  8X];
M3S?0,FH     !8'!;]0M=WH  '-5O\/69LT8      [ JKT>0WQN@
M    06EK)TQ68                    C3F+>&),F9%>DU-S!67"      #
MJ K>[L(AN0  8X];3S?0,FH     !8'!;]0M=WH  '-5O\/69LT8      [
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M&^-T   ",'.7E.O4<Y:K>56P^#[&NBXT]MSUF*[LF2?&?U3;OS^RHK8>8M0
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M5>CR&^-T    8KC&59R!^?C,:TVU(OB-&['F>WIRFK]P  06EK)TQ68
M               C3F+>&),F9%>DU-S!67"      #J K>[L(AN0  8X];3S
M?0,FH     !8'!;]0M=WH  '-5O\/69LT8      [ JKT>0WQN@
M  06EK)TQ68                    C3F+>&),F9%>DU-S!67"      #J
MK>[L(AN0  8X];3S?0,FH     !8'!;]0M=WH  '-5O\/69LT8      [ JK
MT>0WQN@ #5$=56MJ>>      "4LW2S;V>S @M+63IBLP
M   !&G,6\,29,R*])J;F"LN$      '4!6]W81#<@  QQZVGF^@9-0     "
MP."WZA:[O0  .:K?X>LS9HP     !V!57H\AOC=  $=(>>HBK?%      !81
MM=W;!O>H@06EK)TQ68                    C3F+>&),F9%>DU-S!67"
M    #J K>[L(AN0  8X];3S?0,FH     !8'!;]0M=WH  '-5O\ #UF;-&
M    .P*J]'D-\;H  CI#SU$5;XH      +"-KN[8-[U$""TM9.F*S
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M#LJWV.1Z:"G3\G,B.PC3#\[-^/K\?>9_?&U[<<PC3F+>&),F9%>DU-S!67"
M     #J K>[L(AN0  8X];3S?0,FH     !8'!;]0M=WH  '-5O\/69LT8
M    [ JKT>0WQN@ ".D//415OB@      L(VN[M@WO40(+2UDZ8K,09JYM(=
M5RDJ:Z]B;LUEK5;>1CECTK7;>\>LYV3-'=          8JSE3'\/X:;AD^+O
MZ._];:_C'Z9 C3F+>&),F9%>DU-S!67"      #J K>[L(AN0  8X];3S?0,
MFH     !8'!;]0M=WH  '-5O\/69LT8      [ JKT>0WQN@ ".D//415OB@
M      L(VN[M@WO40(+2UDZ8K,?P_A'Z*3[N]H[FUMK^'\/T
M    1IS%O#$F3,BO2:FY@K+A      !U 5O=V$0W(  ,<>MIYOH&34
ML#@M^H6N[T  #FJW^'K,V:,      =@55Z/(;XW0 !'2'GJ(JWQ0      6$
M;7=VP;WJ($%I:R=,5F                    (TYBWAB3)F17I-3<P5EP@
M     Z@*WN["(;D  &./6T\WT#)J      6!P6_4+7=Z  !S5;_#UF;-&
M   .P*J]'D-\;H  CI#SU$5;XH      +"-KN[8-[U$""TM9.F*S
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MP                   !&G,6\,29,R*])J;F"LN$      '4!6]W81#<@
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M(;XW0 !'2'GJ(JWQ0      6$;7=VP;WJ($%I:R=,5F
M   (TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D  &./6T\WT#)J      6
M!P6_4+7=Z  !S5;_  ]9FS1@     #L"JO1Y#?&Z  (Z0\]1%6^*      "P
MC:[NV#>]1 @M+63IBLP                   !&G,6\,29,R*])J;F"LN$
M     '4!6]W81#<@  QQZVGF^@9-0     "P."WZA:[O0  .:K?X>LS9HP
M   !V!57H\AOC=  $=(>>HBK?%      !81M=W;!O>H@06EK)TQ68
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MF                    (TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D
M&./6T\WT#)J      6!P6_4+7=Z  !S5;_#UF;-&      .P*J]'D-\;H  C
MI#SU$5;XH      +"-KN[8-[U$""TM9.F*S                    $:<Q;
MPQ)DS(KTFIN8*RX0      =0%;W=A$-R  #''K:>;Z!DU      + X+?J%KN
M]   YJM_AZS-FC      '8%5>CR&^-T  1TAYZB*M\4      %A&UW=L&]ZB
M!!:6LG3%9@                   "-.8MX8DR9D5Z34W,%9<(      .H"M
M[NPB&Y  !CCUM/-] R:@     %@<%OU"UW>@  <U6_P]9FS1@     #L"JO1
MY#?&Z  (Z0\]1%6^*      "PC:[NV#>]1 @M+63IBLP
M   !&G,6\,29,R*])J;F"LN$      '4!6]W81#<@  QQZVGF^@9-0     "
MP."WZA:[O0  .:K?X>LS9HP     !V!57H\AOC=  $=(>>HBK?%      !81
MM=W;!O>H@06EK)TQ68                    C3F+>&),F9%>DU-S!67"
M    #J K>[L(AN0  8X];3S?0,FH     !8'!;]0M=WH  '-5O\ #UF;-&
M    .P*J]'D-\;H  CI#SU$5;XH      +"-KN[8-[U$""TM9.F*S
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MLP                   !&G,6\,29,R*])J;F"LN$      '4!6]W81#<@
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M/(;XW0 !'2'GJ(JWQ0      6$;7=VP;WJ($%I:R=,5F
M    (TYBWAB3)F17I-3<P5EP@      Z@*WN["(;D  &./6T\WT#)J
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MY^_COF&/WK29^-K(V1!.6IYS=_BP     !T:Z':3IBM@  8Y4;'@-'_>J
M  !.6*UZ.=#M0  .?#=XVO">G      '5/7=]O?XW  !H2*BI:KO(      !
M.K:[6S;<]' @'-43OBLLWQ+''7^\ W-66OW\0#T\Z^VY9Q[6KO*OW@
M     !%#7Q6?NU=W>UFN+6?2UMBQ3>^?MZF]\I\ZV^HO-\S_ -
M                                 !X,PY<SF&):Q9-#:=->[\[/CO?Y
M+KZ[[:FVEO:=C55<@           #"H/N-6]6S(@WM:1??QMS4W-!L&0
M                                          ,(AFU]N:&]8I\1^?K^
MQR8GN:.W(-H                      #^8:V^/O.-B#Z4<@
M                     ^%I[$)NCH9[5%L
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M      1PT]R)EQ68[\_.>4U[LZ^YG3WSN32J]JORUU;:]&7^L@
M                 :)T=Z.5K7RAA^\3DARRNW<8MJ[T=+>VUN:6>ZVP
M  -6:>W$K=TI/R183]2_?K]N/>_J2@C^\1^X9&?'UYOG[      _'Q]0;BFS
MJTJ<OKK+[VW!''0VLZW=35T,\A+"MD#H[X      CGI;.DK32DQK_6-[,/S*
MJUU!;UW\T_O7^]\6;:GU^L?0
M
M  ].&2.&]7R8@VOWCZ
M                      &!U^_#:^HIZP??LP;?DP9Q^V0 /SA^/K'EQD
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M,UA\6KU<^%??S]G[^/=U-FN^PU]O:\OS-B+ZVM/\?:@^[2VVW^JY;<--:@
M            #^8:M^),^V-;ZL<H       'QSZ6,_WZ^/+CZ  _'Q]?.EC^
MI\_0           P+2VL$NZK?&CM@           ?/\ CZ\\L7L_/V &&KHY
M,QVM;((I0   /D'UP
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M^MT?TT%3*I"-;*4G(?,\&5FMI%VC= 7TZ.;1"-(9#PM^ZE%M?6KL&XT>I^6
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MR'6Y<86C,*H#BR3 +5@ZMJ\B.;)X!4!W;(@**5QB".#AOQ MQ74,_P R5I#
M<E!3KG50\H:@U$H^:N<2^**KUU4%-Y8B"E7%J;2)XFT$SI>K IFX!8M;RU<$
M*H;Z,:V9T2I==R-% J:7"F%3:&;4]&*!XDN8'Y.W1N,L)A,T'"?6CID0M5II
MJ3VLK+/G_H\)I=.030&PA/V'DOBU +1)Y6#1".YH3K1T$ ,4\(Y=#+!>;&9F
M )$#S(@5=JY;, AZB#U'JHO7$S8.Z) IS1.H"5^20;"P9)-3W38^(E(LR<.N
M!:E;*X9I%!*,S1X0,),CD2=I$Z1JQ<$S%*U'LT8B"@+_ .S)&)?5>X"1X$%
M<S+1E77?-RH+<##@0V5PP 6;NF),RX'4&,B\;/\ V5U0AL6E[84'BTMJ!3*Y
MO%$3&/.R8&U)F'6'^)?,H6I&6')(R%,J%9\RXK<^R\0-"O3,<;\'=3A-?3V'
M_MBD:XQ.E18H_HV?F4?,N'S*/G_H$=(]OK24_F/F7%P$Z3&Q&P<OQ.X=(":
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M-!G8L@<Y9IJVK4ZJB=16@J;5Q0470(T.8A=<=9NB 9E<4B>*FN1PTL.#07<
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M9T*9?>"VYG?7NV&R$JL=<J[GB=<?D[C-MTFEO ?"3"%2%?M#O%)U[_-%M<3
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M:2$95J;%RI"UKT4I2B=>];&S<NF3([KE-06MZ^Z^_'T);>=5F<[%('9::=[
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M2XI*@ME"G$YB#=7.[YQ^3^7(_.BI9GG' BE1U)2XM3B 3(L3E42F]CQMC;J
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M=]DON"L+ *T^.VFO1C;RS.U2,Y &6FF_1S@BV'&C+IE0BM\YV1#<0PD<5N*
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M+Z G"WH\".@R'4M-M(0C.OAS0$_SMC\X:)_YC'^]7X<2E)7*DK2;I6^\I)'
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M;M0(Z<52,Q5HD%IV[<NEK4N#*!^+#A3O4+ U6"A.5()LGHQ5&7JG$CTQ:PB
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MN%(Z,PT&*?/;,M,"WPK#JVW?UQO26K]^P-['IMBLQSLQM6JC(<Y7'>2MS?+
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MNYZ/+<]H^_.)_;LGZU77J'W0;\ASU=8V@[>_=)_KU^G=I1OJD^KW^U'<2;Y
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M*-]4GU>_VH[B3?('MIZ_L'V[.^S(_P!WWD#XZ?\ :E>H>]DK3+#)?;2M^/\
M$23\8T+90$]&B=!>^%1R](;E2W5RGV&U,QUN@78:60I;:,MA92@#J+_,KO8^
M<8'NUWN>ORV_:'7Z%W/1Y;GM'WYQ/[=D_6JZ]0^Z#?D.>KK&T';W[I/]>OT[
MM*-]4GU>_P!J.XDWR![:>O[!]NSOLR/]WWD#XZ?]J5ZA\UN]CYQ@>[7>YZ_+
M;]H=?H7<]'EN>T??G$_MV3]:KKU#[H-^0YZNL;0=O?ND_P!>OT[M*-]4GU>_
MVH[B3?('MIZ_L'V[.^S(_P!WWD#XZ?\ :E>H?-;O8^<8'NUWN>ORV_:'7Z%W
M/1Y;GM'WYQ/[=D_6JZ]0^Z#?D.>KK&T';W[I/]>OT[M*-]4GU>_VH[B3?('M
MIZ_L'V[.^S(_W?>0/CI_VI7J'S6[V/G&![M=[GK\MOVAU^A=ST>6Y[1]^<3^
MW9/UJNO4/N@WY#GJZQM!V]^Z3_7K].[2C?5)]7O]J.XDWR![:>O[!]NSOLR/
M]WWD#XZ?]J5ZA\UN]CYQ@>[7>YZ_+;]H=?H7<]'EN>T??G$_MV3]:KKU#[H-
M^0YZNL;0=O?ND_UZ_3NTHWU2?5[_ &H[B3?('MIZ_L'V[.^S(_W?>0/CI_VI
M7J'S6[V/G&![M=[GK\MOVAU^A=ST>6Y[1]^<3^W9/UJNO4/N@WY#GJZQM!V]
M^Z3_ %Z_3NTHWU2?5[_:CN)-\@>VGK^P?;L[[,C_ '?>0/CI_P!J5ZA\UN]C
MYQ@>[7>YZ_+;]H=?H7<]'EN>T??G$_MV3]:KKU#[H-^0YZNL;0=O?ND_UZ_3
MNTHWU2?5[_:CN)-\@>VGK^P?;L[[,C_=]Y ^.G_:E>H?-;O8^<8'NUWN>ORV
M_:'7Z%W/1Y;GM'WYQ/[=D_6JZ]0^Z#?D.>KK&T';W[I/]>OT[M*-]4GU>_VH
M[B3?('MIZ_L'V[.^S(_W?>0/CI_VI7J'S6[V/G&![M=[GK\MOVAU^A=ST>6Y
M[1]^<3^W9/UJNO4/N@WY#GJZQM!V]^Z3_7K].[2C?5)]7O\ :CN)-\@>VGK^
MP?;L[[,C_=]Y ^.G_:E>H?-;O8^<8'NUWN>ORV_:'7Z%W/1Y;GM'WYQ/[=D_
M6JZ]0^Z#?D.>KK&T';W[I/\ 7K].[2C?5)]7O]J.XDWR![:>O[!]NSOLR/\
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M0^Z#?D.>KK&T';W[I/\ 7K].[2C?5)]7O]J.XDWR![:>O[!]NSOLR/\ =]Y
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M,]_ <<BE^#/?P''(I?@SW\!QR*7X,]_ <<BE^#/?P''(I?@SW\!QR*7X,]_
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MMAK>2Y3M1EA*9+W8,I-TQFK90E%['GI"5+OP5<?I=1FJH]*:G9>4(F2S!7%
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M+0AQKBVZ+.(5JE0\8.'(S;D<0S<1 L.;BYRYDWM<WN0+G0Z82E*$A*19*0
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MX!P#)5,AO+4E,: L.--(3E<<<-MZ7E@_"H)%VTJ',Q6VVYE:D5J$"T_.0HR
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MU"H\H?6 4MHS\4-H).[;!%PD&V*/):C5JL26&B<LN1D960HA\/.Y'"3HI <
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M<ORH^!BEM\GQM1_@6M7Q:%@H\SPX8R $[-5P',?N^X^6*<__ +3LWU5AL3X
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M=M !8:^6H&P;APQZ!?0K#D%+#M/M%2J^;3A9*2"4!EIX^#(Q1M2Z[Z@;@-;
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M'HR_D^9#L@L689TL6;9OU7ZZZZ>![?T:R(&4J;'GVAA$6-51%"HHLJC@ !R
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M #:;;VR<?GC,*N-J'*,MBDWXRN@IZ1JCC]/)"A1I &ZRJW,*;VQ5"KGKZ6E
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M_@_7[+'/U*?O1\_;U'>GY>PC[M?A[:H[H_+V%-W?S]O)WC?'UY^Z;V]+VF^
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MX8D$T>S6S\69C_=M(ZGIO#K:&FO3:[6X[C3S%_;UM;T>2FIHDWE363)%"AX
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MAS6&*J^D<_YJWXX]*TD4LE?NB#IG@1R/&1:M-9QZ4:AX*R QMH6?]U4LDO\
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M7/GA&$D3S)UXT;0S+QLQ%[&WW8?J0+4MW+L45QQNRVU#AXBXN/#!1A *DCZ
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M2JUXP!)52*9FCC6RJJV4DZ>J@'#G;%/3255/)4T]I4@)68 C7&0=)NG:TZN
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M,?YK6%^'AC9.62+TC4-%&QZ-F\ ILP3ZK0Q0SS)J'_* 'PXXIJF+9V#:3*D
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M=FZ&LI<JG?,**LZ7/3M*@6E9RT>B(J]WU<#>PMQQ_P"I_GO_ !SRG_[MK/\
MS<91_),SO+<VRS,7VNRJ5*#,*.M>)<NJP95I:B.=HP3+8%PFD$\!?'1J?_$Q
M_P"P/_#'1J?_ !,?^P/_  PL<:=A%7\( _LP8JFFS*CSC+I5@KZ+6$=U+HT<
MH"2HR C5JCNHN>%^6*_HV<3%ZR-XJ>?C6P0ONWDOP9874$1W'W$ XVECFSR.
MG2%Q3]#%''2ZA?1#1&,1!]-M;F- ';AJ-R<9K4C/ 5JT$4DD>ZJI8[(LXTZ6
M:-5XH2M@"23<7Q4UJM24>6TR;JAH4411FQ)DT!))21:Y<*+\+^9Q7T,];+3
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M"?H::OI\RKIF'4"4<ZSR1<;7:5-6D\0/$8SVN2OS&:6$6IT)CIQY0J3H'_Z
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M;4XNS]N D96GD=:M)CK8M6:HF8=ZKL_;BN/,1FT+A*9>+?)M<[&]\*_4I3;
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MR%3WOE9M6)"J\7)>_%W8&6S'FQ4NH$W.BN174(;7L#G&4=O%+GP<HXLV6O8
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MFHB+8V'LO#LQ#BTRD5=_@0EK7/>Z1JU4R$TR&@JA[-]MV,DREU1IZFQM63'
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MF T8DN.!0J7$CRWH[;A-\(.1'U@9E'*?%,+["^?&C5<H1N1F)E1CP*A'5TW
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M3,R(LH^-;X_(W?X?UPR*[%%IM%3P*@HB\E[JGUTF^@C]6;3:90*C67YK2@'
MM38%_P 2.&/\,)H-6M'JI1)#=*?AK(F:G5F;BNDB@C9F?^UMM3FQ*T:JE!J,
MEZ"]+X!):U2-R6#5 C"&<\UT $5;V3;C2ZOZ0L%#G:5*Z+<5Q+.Q8[L98QBY
M;,.9<HEQ25+8K&CLZC3YD+ALJ;3IS.K1ET9#G$936$A9P +KQ43;BL^Z%7(3
MM.=EYF:?"?1$>!@V=4XIY5(%NK8DF4MRX==%LGB ;HV%LQKX$OLQ,KVD3),O
M$W)CTR \GY(!@;6L(;D-SL#@J!?/MQIYHI[PS)<FO3)AT^6R+>K=!X6A ESF
MAE?(O@Q3J=,,CD--YG,V\5-$+5[?T.Q^S\Q9"8&=&3U@>(MG],(*;A1$3[.I
MV(_L3!5I^[\O*@LJ?8L(*JJ9!NJ(6U4S(B*J8L0H2>-$7^>.*B#\R6_EBQ(A
M?.E_YXXHH/S(B?RQ9414\"[<<41'YD1/Y? 8Z:IGGGBG_1&?,3X2O2GFV6T^
M4X8A?Q)F5+KXDQ+AOFL1EA&=7*D"K+!JZJI\:[E;1%V95S<:^S N-F+@$EQ,
M"0A)/"A)=%^SJ;%3J6NE_!?;A^?-=%F-&;5QYPE1$$4Y]JHG/X<3JUHW3/?"
MC4[7+(E/$Y&<RQ\ZNJRRHJKMD:.V1=NSPX<F4=T\T<U:DQW6R9=9<2V9%;/C
MV2^]43OXKCB_Y4YU7FV8YR4RL \P_P#\\.+E972VDO@\7*>ZI]=)OH(_5VHB
M_.F-B(GS)BY *KX5%%ZG& 2^<47^>-FSJW415?#9+_M[P,=-4SSSQ3_HC/F)
M\+1^KT^)*GTBFU1B55XL9+ZR,VCFL%U%5!U:I:]\3:#/<F:,<+][&6G7W&&D
M;>B.C>V76;,PV3%&C19ZU..U#$6IRGG60.8ESYK)?P;N;%&H%#ZU.K4H8YRK
MJBL-FC99@45NA64N;%$TOI]?JM1=9=AM5&-+?SL20DD3KAF@H*J0@.0;KNQ3
MM(]"*:[.JL]IO7-QQ4W&"46"-1RFEK9R3?BC:7MU^KPZ^DB$W*IS[^5IY9#Q
M9@< 4S+L% [+<N'$JQI3IM8HP(X\MQ 5)&G-9\I<JJF*QHW6*4=1T;>X7#B5
MB*'64<DZYH24W#'BHZYQ[#S+;%2K-'K#-1J%5?.1/89<S<$)S(1-*F5%11*W
M.O?LG7%V"G[<<Z[;-@F$=<3KY)MO\GQ<K[JGUTF^@C]ZV.FJ9YYXI_T1GS$^
M%0']'VV7Z&,QKW[9<BM2U6/<];9DQ-2XMMB#BM0VJ%>I2H5/2-P>F+$5N4NU
MPU)MD=58]O->V*%1*BZ3LN%#1IY2+.N;6.%V5UOL).?%+J%-E<%JU(D<(:S)
M<7K("""W(42V5<4K1>K-M>^LB9!8!A@FWW)5B=:UN5JY B7$5V6\>-'(&D<M
MN"[+9!4!\AOKG&&E4+&J;1\& TWAU()H09,9P8$H!>BNLF2NEQ'B-G-9NP+D
M54OLQ4'-'(I4ZI+%.(+#"\&0C;X.O6B!&D%-]LFSP8.@Z3T=]9\!F:W,:E4U
MU]TW%UZB33KK*DXJ[T(+V6UEQI3I#J7H.C]2=="DPW<PEJ5=;<;<)D\I JBE
MMH7[]$XX2((IC*-]7>S8)S_9C7OHBNEN3]'EO=4^NDWT$?O6QTU3///%/^B,
M^8GPYL]M5SS0: TV635WM;]O4<2G*TDE>P5Y20$\?%V[L#I'I)+?KE196\-N
M9D<CT[:)98=D$Q'.*.<:_&Q#C3E)E^FO\)A.@@\5VPCMS(MDRC;9B'HS6*BS
M HD8HV<*89:R0,;L4=1X%'C#="MX<1:'2&D:BQ@1-R(KA(*"IG;9F*VW".FR
M!.)N)4VIWZ)PUL(I=5QJPV,HMA3])>;^.!E2!X^]L5^3X_GY?W5/KI-]!'[U
ML=-4SSSQ3_HC/F)_N.I$MD3:JX5AE>LBMMGREPDJ0.SY K_/\P]U3ZZ3?01^
M];'35,\\\4_Z(SYB=67I/3X<:?)CS(,<8\LG!9(93VK(E5I4.XIM3'<K0/*)
M_MX[E:!Y1/\ ;QW*T#RB?[>.Y6@>43_;QW*T#RB?[>.Y6@>43_;QW*T#RB?[
M>.Y6@>43_;QW*T#RB?[>.Y6@>43_ &\=RM \HG^WCN5H'E$_V\=RM \HG^WC
MN5H'E$_V\0])Y\.-!DR9<V.4>(3A,B,5[5BJ*ZJG<DVKWTNNY,+&CKUM.S)/
ME+_3"27TZVB\45^5\_BQ9-R?F'NJ?72;Z"/WK8Z:IGGGBG_1&?,3JU3I2C^M
M<O2NDZOZUWT6+'79\LT_DG@MA'GD74CM_P R[TP@BEA3<B?F/NJ?72;Z"/WK
M8Z:IGGGBG_1&?,3JU3I2C^M<O2NDZOZUWS6-'+C[C).;Q8UA_%(MR+PX$ 2P
MBED_,O=4^NDWT$?O6QTU3///%/\ HC/F)U:ITI1_6N7I72=7]:[Y+'86[I)M
M7]%%Q<KZN]W#7^7SVPC;8V%/S/W5/KI-]!'[UL=-4SSSQ3_HC/F)U:ITI1_6
MN7I72=7]:[XJVV77R3F^3_\ ..=4O<S7 M-IL%-_A_-/=4^NDWT$?O6QTU3/
M//%/^B,^8G5JG2E']:Y>E=)U?UKOA9-KI=BG@QSDIE<RYA3PX1MM-ORBYU7_
M /[^:^ZI]=)OH(_>MCIJF>>>*?\ 1&?,3JU3I2C^M<O2NDZOZUWO4KW<5.('
MA7Q^!,<YF:_8*?RV)^W" FT_EESJOYM[JGUTF^@C]ZV.FJ9YYXI_T1GS$ZM4
MZ4H_K7+TKI.K^M=[E<-=OR1YU7'.1&7%']%%YOFQX723C%_R_-_=4^NDWT$?
MO6QTU3///%/^B,^8G5JG2E']:Y>E=)U?UKO:3KB[DV)SK\V.=;K8 3F3"&XB
M*^6_GR^+\X]U3ZZ3?01^];'35,\\\4_Z(SYB=6J=*4?UKEZ5TG5_6N]A.NKE
M%/XKS)]N-E\E[-A__.?"/N[7B39_A1?SGW5/KI-]!'[UL=-4SSSQ3_HC/F)U
M:ITI1_6N7I72=7]:[UDX:H(BE\9 OJD6PBG/A),@>N+M 5YOSKW5/KI-]!'[
MUL=-4SSSQ3_HC/F)U:ITI1_6N7I72=7]:[U*9K812ZKC5-*NH'9_F7^F!E2$
M_P @+_-?^7YW[JGUTF^@C]ZV.FJ9YYXI_P!$9\Q.K5.E*/ZUR]*Z3J_K7>E5
M78B86,PO6D6Q*F\EPDF0/$3: KSKX_"EL638B?G?NJ?72;Z"/WK8Z:IGGGBG
M_1&?,3JU3I2C^M<O2NDZOZUWHNN["Q8Y<7Y9)S^+]N$D/)9I%NE_E+_3""*6
M1-R?GGNJ?72;Z"/WK8Z:IGGGBG_1&?,3JU3I2C^M<O2NDZOZUWH*+'7;N</P
M>+&L=NC(K=57Y:^!,( )812R)^>^ZI]=)OH(_>MCIJF>>>*?]$9\Q.K5.E*/
MZUR]*Z3J_K7>?@\<KN%V9)\E/%X_#C,5]5>YDO/XL"VVEA%+?GWNJ?72;Z"/
MWK8Z:IGGGBG_ $1GS$ZM4Z4H_K7+TKI.K^M=YE9:6[Q);9\C&U5M>YFN!:;2
MR"G[?S_W5/KI-]!'[UL=-4SSSQ3_ *(SYB=6J=*4?UKEZ5TG5_6N\@.,'D)7
M4%5\5E\./RE?V#_3 (X2J3SB(I?/@6VTMX5\*\_>#W5/KI-]!'[P,N3GP9%^
M0S&;S+;,Z^>1L?M+%TY)CIJF>>>*?]$9\Q.K5.E*/ZUR]*Z3J_K7>-3<)!%.
M=<(PRG$ \V?])?%XNI%_7!_/O#[JGUTF^@C_  S>?,6VFTN9EN%/"N'&Z94H
M\PVELX+2E<53_,(_PPARWP8$ELBGSKX-E\(0K="1%1?"B[E_-7G42ZMMF:)X
M5$57#IU2K<&FQM)J5&CTHR2.<=I9"H1")$VXZG%$\^3BWM?%7@UU <I[#[BT
MF4C@D3D?6(+0D@IS-W6ZDN'ZM'A)4'@=99:BJ:AK#>7*"9A0E3C63=SXX:?N
M:PFX^KUJFY6G RAX20HZ6^W$32#^R3:U29)..S2>&.\;)(U)'K-3FM\KL+*F
M(,&?[GC<"))D T_+2H/.*PV6]S(L<4*W@NF(.B]%A!4Z]-'.L<W59:8;R(XI
M&\B$(\155$*V94MBGT;2NFM0FZJ0MPIK#_"!-XSR #F44!NZHO9+S80DVH2(
MJ+X47:G4.1+D,Q8[>UQ^0Z#+()NN;CA" [?"J8CLQ*W2)3Q5FFV:CU*&\ZO7
M#W V\1+^S%/^B,^8G5JG2E']:Y>E=)U?UKO%:Z..<PI_S5-V+<94OQ0&_P#R
MPCDS=_V:?UQ\1_ZRP+@,V,%0A7,6].\/NIA4*I3H)EIG-(0F38T8B34L;4%Y
MP%5/&F#][JE GZNVLX%,CRM7?=GU#AY;\V:U^HE!T=T4;K[NI:>=<<F.1D;1
MT,Z7RM.)S*FW%+IU4]S^)#"HRF8^L;JSCQMBX>17=7J$XH\Z[O'AZA4#0UNN
M+&AQ94AY9KK.19&=%#B,FBY2"V)+>D&BHZ/HU\40RG)&MXM_EM-VV[,/<!UV
M3.G"^#H:NZG.UN1OC;_!S8T*ET%Y-4Q1I)54XYYF10>#*X,C(J@CZ@AY <ZX
MJWRX"O5 E:I%.=O2(6=05]P;HDIP.*2BXT=LA(073PX1$W(ED_-7Y!BIBRT9
MD*;R1$VIB+I?1H$B@5617(4+A0(VVXI.2R95Y"#-M%6TLN-(-%JS->JK%&4^
M#5!\B<<*SXLHV1+;:([=@\^$9F,@^T+C;R XET1QHL[9?.);4Q T.IY$CU6-
M&IRM=G%@.(77_$FL%!OMQHTUHN$0$IS3HO',!Q8Z$J-\<M5MSDHJ2?XL4JDZ
M9#3I5,K;X1HLVGB\FI><);(Z3ZILRBJKE3$MR:"I[XTV&5.=/<2#$,CR?\)#
MC0ZGQ;%4W:Y"<8%.SR9G!S?-FQ !WXT(<87/\XL@A?QZC],JT-B? E"@R(DD
M<[+HHJ$B&/.ET1<19]*T5H\"8W6::@28\9 =%%<*]BOXDQ3_ *(SYB=6J=*4
M?UKEZ5TG5_6N\"N.F@"G.N%:B<4=V?G^S&;;E7LG2W82PYG/TUW_ &=Y/=0D
M:04"FU9YK3&:VVY-81T@#4L+E%?!=57$A=':'3Z.LO(DG@3*-:[5WR9_#ENM
MNI(JBLMA()E$?D6XY-,(JBA%X!2]L3](WKE3:69P:1?:U(:<0'N$AX5!U#!%
MV6\&*Y5*(Y28S$MAML"GA)UIHRZX:(*M;+;=GBQ5-%-)&68^D5(<R.<'118?
M 6T=)QH357+(A@FWGPZW* #8(5UHGM!1Y\WBQ5UT8I46FT*E,R)4R5#;R>^D
MN.T3S0"2*J$TJB;+R$B*NY,3M,HU8F-3:=(=.-!;=M&:;'5($-0M?(WG7BH7
M@VXITUX5%U^(P9HOZ1-"JK]JK?\ -5$D11)+*B[E1<,.T9J2T3]7I[\QEN8Z
MTRC0/==-II"0&E0+KQ$1<VW?A6*<RH:PE-UQPU=><(K7S.G<RW7LJKA]ZREJ
MFG',J;57("E9$3G6V*GI35&B"1*<-B #E[MP,R.-<5>Q+-?F0L4NJL$3FBH-
M2!GLLLZYY'" 495!!"=+CWW)LQHX_#AO1J%19;,Y^5);..ZX;:DFJ1EX0<V@
M=\R8A.RFC"9  1C2F'"9='*(AM-O*9)8;64L-UJ0CTVH,CD8<D/..@TET+B-
M.*8H6;:A)9?@,=-4SSSQ3_HC/F)U:ITI1_6N7I72=7]:_/U%%UCO,*;OVXLN
M8KKQ0&]D^>V$=F>)4;1?^:800%!1/ G>7W5/KI-]!'ZK5-I;1G+J;J,YQ1<K
M;2$*O9BM8;MJ2)=4\6(U,AIDX.QD$MZJ:W*Y*O9;2Y\5B)I<$F7KI4DZ442&
MX\.I<>)6 ,HX&@V:LBYL5_3RK,<#<JKJ\!C9KKP=Q@&S4TV92S-IL(;[</0W
ME-&WQRGJS)LK71=A"J*F[FQ[W16$&-E(2%>,IH=\V<EVE?,N^^#XK_!'99S'
M(7"'=03SG97;S:O)NXF7+LPVRT* VT @ IS"*63^"=X6.FJ9YYXI_P!$9\Q.
MK5.E*/ZUR]*Z3J_K7YZINF@IX\$U%N ;L_REQFLJ JW5PN?PVPF0;GSFO9=Y
M_=4^NDWT$?O6QTU3///%/^B,^8G5JG2E']:Y>E=)U?UK\\4 76.^!-R?;NQM
MS&JKL$;Y?V;L"[+VKO1OP+X_#C* H*)S(EOY=Z/=4^NDWT$?O6QTU3///%/^
MB,^8G5JG2E']:Y>E=)U?UK\Z4W304\?/\V%;C7;;_2^46$,D46U6ZF7/\V+-
MBF;G/G7O5[JGUTF^@C]ZV.FJ9YYXI_T1GS$ZM4Z4H_K7+TKI.K^M?G&W"@UU
MQW=LW#\_AQ\HU5=@I?*GV;L([+XQ;T#F3Y]Z+C**(*)S)L[U^ZI]=)OH(_>M
MCIJF>>>*?]$9\Q.K5.E*/ZUR]*Z3J_K7YNIO&B>+G7YDPK;'6VMVSLBPA&B@
MUSDN]?FOC*T"7YRYU[V^ZI]=)OH(_>MCIJF>>>*?]$9\Q.K5.E*/ZUR]*Z3J
M_K7YKMPK;'7'/"FX?GQ\IPE7<G8I\VVV$=D\=SF'F3YT7?BPI9/ G>[W5/KI
M-]!'[UL=-4SSSQ3_ *(SYB=6J=*4?UKEZ5TG5_6OS12=-$_P_*_9A6V;MM;M
MF\D\?@PCCMVVN=5[)?L7PXRM B>/G7OA[JGUTF^@C]ZV.FJ9YYXI_P!$9\Q.
MK5.E*/ZUR]*Z3J_K7YE==B)A6XW7'-V;Y(K_  Q\MTE7[!_^$PCDCKCG@^2G
MV+BR;$3OC[JGUTF^@C]ZV.FJ9YYXI_T1GS$ZM4Z4H_K7+TKI.K^M?F*FZ:?Y
M4VE^S?C(W<&OT1WE_P \(X]=MOQ]DOV+MP@- B>/G7OG[JGUTF^@C]ZV.FJ9
MYYXI_P!$9\Q.K5.E*/ZUR]*Z3J_K7+(,A\&E)+HA<Z;KX_+&?VK_ $QDB*CA
M+_M$[%/^>/ENDJ[5WH*?TPAOV=<_]*?MQ9.^GNJ?72;Z"/WK8Z:IGGGBG_1&
M?,3JU3I2C^M<O2NDZOZURMS(1^=43^>&=46;(THE\^:_4(R*S39(A>/9>V$!
MH$1$_;^WOM[JGUTF^@C]ZV.FJ9YYXI_T1GS$ZM4Z4H_K7+TKI.K^M<GUQT<W
MZ-]N%2,W]I_\K84<SCM_D)M1,#:,X69+[!W>)<?D;WW<2$?:-I2=%10TM=,O
M??W5/KI-]!'[UL=-4SSSQ3_HC/F)U:ITI1_6N7I72=7]:Y!5,Q&WC2_[,*C*
M*Z7[,**+E%?D@FW]J;<7RE;G)Q=O_JPBR#UB^!+C;Q8LVV*6Y[)?]O?KW5/K
MI-]!'[UL=-4SSSQ3_HC/F)U:ITI1_6N7I72=7]:^#==B87KB.$GR0VKA18%
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MI]G50YL"-))-Q/-H:I^W"-166V&TW V.4?V=]/=4^NDWT$?O6QTU3///%/\
MHC/F)U:ITI1_6N7I72=7]:Y V7Z]167FR4'&G:I!;<;)-XF!OH0DG.BHBX[H
MZ#_J]/\ ^HQW1T'_ %>G_P#48[HZ#_J]/_ZC'='0?]7I_P#U&.Z.@_ZO3_\
MJ,=T=!_U>G_]1CNCH/\ J]/_ .HQW1T'_5Z?_P!1CNCH/^KT_P#ZC'='0?\
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M++)D(VAZPD%%U8$F9<Y)ENEKX1RK25DU"4NN>7<((2J0-B-U%,@EE6UKVO\
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MLQ+JE&H[]:GH!HQ$CLOO$IH.9+BPVX=O^'#<RN^XI/K$I@E5ER0W70 =NSK
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M 0 " @(! P,$ P$! 0$!  $1(0 Q05'P87'!,%!@$$"!D2"AL?%PT>&0_]H
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M> , H#@P):A55E.486!@$HYAP$01@0&*$N,G1D*UAQ5L]*HOE=8YN@RHD9%
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MC%P2=: 6\! 2L 2[?5S_ -PSMAONH;?D<G*A3CQ ,B__ $,WK]#$)ED1M*H
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M<8$*46U)4D5-;^^"9&$VIX;1,2Q64[DCB5@8(/<8> <@GJ@WJ8KZYS_3(/\
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M H@=I@P#%/[$WN+)/XF<Q\!_(]_MZN"A-?#V]2(SU+%N_P!Q#0:I@NB@P_\
M\/L5^*',? ?R/?[<0*8DT:1'H,3DIT+<,H'$L%, 3S'/JJ4_%3F/@/Y'O]M!
MF#,MIP-O\943>HB,"AZ0JE8)$!3'J#C9L_%CF/@/Y'O]L#*'EC9!ZJCUR-S]
MK[ACT,8:)(#H<5-D3^+G,? ?R/?[6@,"5C^N\ILM]>:6-WK!4, $AI%&2=\#
M^,',? ?R/?[4?EA#  3\8J&2@U<+ZJDSTCR3^B;D0?QD<Q\!_(]_M+A@)58
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M3-$5 ""6TZR>B=.X2(H4(8!S:NZ5F4HEA6'!*& W[I&@L("&2'_\ L,+A6*
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M;C &/7 %A0A 3K$B?1#06Q8*%<X"Z_R2$4BO!FNJ:]0,D+(U+H<EO;2>B:$
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MA']VMD-AV9'IH'OIG]!@URB^"*&C;./D=0NOGV(QL;Z[ FV@#Z,)S*M;BML
MF\< ;W(<'!I5_ P6U2XQEG"#S&F/Q*%@@MBA=/362763]J8N..1IQ:!H$<,&
M6>\*^IM*^I5C:GG"#*VH+6W!;D =O4I*'IC&&YK3[!&:RS/<9>4D1#H4"RA,
MY:-*BSB7:P8F#'KV2IHDZ+0,&3YOW5G:ET3N# F E0. #0!'[;'P'\CW^AYC
MO^!#C@AN?+I.$(W4], YOJ!!C9$B;15H2+UN8%9<KLG.*I=W/5X$5 P   $
M4![8<N!B-R,O,TA+D)[&^MUN\$TPLADVOU61,D2_MF>8)%H02]J_30T[6C)>
MVQ5%47"OX0<_N\? ?R/?Z'F._P"!#CAHD9$0:T\(8[<$/J-ZRM_>L? ?R/?Z
M'F._YZ..8^ _D>_T/,=_W(Z,>M^G*A+0FVL@%+KCZ-[C1.#SR/@ I52:?\$"
MINI7_7X\<Q\!_(]_H>8[_N1VTM2#!E(X;Q,8"T%_]I<0%CO+T#!0Q=.P4@K$
MB43VR\UZ9%J(%T9E%FHDN-%FD1$U*W;B8+)!6"A"5K82UD4GK/:BKLD+2.5N
M,ENB45&2C"_'[,!!)@:)5O\ &SF/@/Y'O]#S'?\ <CI],9,<DP<"0D3.2F12
M853V$)$-1BH2) ,.UUX"WC*R<UN<9PA%1D3/P[02X222B9<57:\^,79N:-X%
MVU9U'$.FR\BCH 7&HD 33_&&KB6M.Q,CM1O&Y#L1G4B#:]&_QLYCX#^1[_0\
MQW_=#N\P;UNG\D_JD.I&\]<L;C>\("$<3SW<///Z: #9M12K)**8QNZB[M0@
M0JX@S)J @ 40!^-G,? ?R/?Z'F._YZ..8^ _D>_T/,=_VPZ_IRCAM.I1L1]>
MO7KUZ]>O7KUZ]>O7=WJDC?:@V;T_&#F/@/Y'O]#S'?[*./>"[_C!S'P'\CW^
MAYCO]E''O!=_Q@YCX#^1[_0\QW^RCCW@N_XP<Q\!_(]_H>8[_91Q[P7?\8.8
M^ _D>_T/,=_LHX]X+O\ C!S'P'\CW^AYCO\ 91Q[P7?\8.8^ _D>_P!#S'?[
M*./>"[_C!S'P'\CW^AYCO]E''O!=_I/QQJ:7@ JK &0<?K:B1Z"4,XLV@%'1
M$'9T@C9^G_2K_C]$ K8,+[?I&<:)!+Z?@QS'P'\CW^AYCO\ 91Q[P7?Z1"&I
MU5QZ;0Y"9,7B!-#NV39&+DN;HKRLPC-:Q]-!@2@#.M!RZH'#H<%*(+&'5V%0
M%:)49)'4K,SPC1X$*,CW"'4<*<)8VB>0D^EQ"FB#*@--HY_=U$0_!3F/@/Y'
MO]#S'?[*./>"[_2W!9MLPM:&E&$1M6"$GCD%1C6(4(4Y&H'J/:9/,]XT9*1$
MS)PI.$-0AI<!;4X05C4D*0@@>[.1X777"H:87:KP  *.N'@#4M,3Q29ST:>Y
M5]3&WB0H#(A8C0+O\%.8^ _D>_T/,=_LHX]X+O\ 3H50SL,J-^__  N5(;:G
MUR,'/@0QPR$*F34*;; VX.SE3[+XT?T!.$[P^7"L.$4M)-/P4YCX#^1[_0\Q
MW^RCCW@N_P",',? ?R/?Z'F._P!E''O!=_\ -O%R!-!H2M._KD2)$B1(D2)$
MB1(D2*7@<J$!9Y(N?P(YCX#^1[_0\QW^RCCW@N_XP9JG,? ?R/?Z'F._V4<>
M\%W^\F:IQ@Z%@-*JY[4/*#<4)<TSB-&R)!T%A(4B#Z8+69.PNW#^7)74PYGH
M<_&[C-,^_P"Q$>.7&"@4\GI(W"')7'I7^_7@E.0;NV)>X.'K^W8^ _D>_P!#
MS'?[*./>"[_O3-4XX&O^'@Z^A>/ W?N!!0]:9O/(MT)2]1=35X!=T$O01!)+
M0F\.%%[;0#3M'&'W*VG0$)N! G)C'4#S>*@G>T)&+6(*$AY*Z-I?M7(23!=$
MD)H+'>6WP'86+4' &0W<FT1*QN#6&( 2^(U.+)"&\8V;RWU6BQ<7SPG/DC-9
M1=",B_UFY+I@F-Y,4CBH"\O5&),$RC)3YA1W3%:Q3]5'Z?\ @0?,N[0AG&%O
MJQB*+6W.1T?L^ _D>_T/,=_LHX]X+O\ NC-47K R?_'9#8<(^R"D!"N7:P[/
MT[0,<2V@,%YDR-I0&L8VD:7"4B=)R[@BYB\$)"6$\MA!U>;%;P%"")-4!P<I
MRE?.HJ?+SQ9HXC&*8IQO'&^M-@A@(TFE?M=']O%*:',?X8IR?DS:Y?K  F13
M&+"6Q(:=\ RG,I=/6\:0$"\(U=F/;OY*+&W)YRSO8E 9 R*R2H9CTR(BG4/&
M15#U1?<*A40<DDJ(*@.<H#[84<"O07_1^VQ\!_(]_H>8[_91Q[P7?]Z9JG)R
M8Z-VB9,DSUAB.!IO0T+22^@PC$5..0I[ #C#A?G$AQ:63(E%R91 :D%$^N<#
MK$"=G8=*+<4C$E!"ZQ$2O+&PD]F$"7AI128-?MD@)X8S3#86.OT0=@^^?^08
MVS\M!.,3: 5&"VW ?L=7*2V5N,02$$Z2OZPT#V ?\_;X^ _D>_T/,=_LHX]X
M+O\ O3-4X@[!]S/_  #%V3"")\W]#E:PC)DQ([+Q :U/ZJ;#[@_=<? ?R/?Z
M'F._V4<>\%W_ !@S5.8^ _D>_P!#S'?[*./>"[_C!FJ<Q\!_(]_H>8[_ &4<
M>\%W_&#-4YCX#^1[_0\QW^RCCW@N_P",&:IS'P'\CW^AYCO]E''O!=_Q@S5.
M8^ _D>_T/,=_LHX]X+O^,&:IS'P'\CW^AYCO]E''O!=_Q@S5.8^ _D>_T/,=
M_LHX]X+O^,&:IS'P'\CW^AYCO]E''O!=_P 8,U3F/@/Y'O\ 0\QW^RCCW@N_
MXP9JG,? ?R/?Z'F._P!E''O!=_Q@S5.8^ _D>_T/,=_LHX]X+O\ C!FJ<Q\!
M_(]_H>8[_91Q[P7?\8,U3F/@/Y'O]#S'?[*./>"[_C!FJ<Q\!_(]_H>8[_91
MQ[P7?\8,U3F/@/Y'O]#S'?[*./>"[_C!FJ<Q\!_(]_H>8[_91Q[P7?\ &#-4
MYCX#^1[_ $/,=_LHX]X+O^,&:IS'P'\CW^AYCO\ 91Q[P7?\8,U3F/@/Y'O]
M#S'?[*./>"[_ (P9JG,? ?R/?Z'F._V4<>\%W_&#-4YCX#^1[_0\QW^RCCW@
MN_WTS5. H@M0 ]UK%>T/*!KFWJ?W6/@/Y'O]#S'?[*./>"[_ & S5.+[M=&P
M3NK@DI.:\;):@5-221!R9:6NZ4K"R$07C]V.31IG&MVCR')18**BZ[JA">#+
M:'.1$!3U3.7H6RA25& W;"W:<>P<P* &,/@'6AD/1$?T"R,8$*:A"MH9"VV#
M7CR%**DPL6K0)A-$_4T:L7HM;S-]"!;]>E2I4J5*E2I4J5*E20>L5MN9-2!9
M] T:-&C1HTV+H*!2R;0C]:E2I4J5*E2I4J5*E5L'H:7$5;4?0-&C1HT:-$WO
M\X49($DGUZ5*E2I4J5*E2I4J5*,;.50E&: )_F:-&C1HT5RHK&"U +1H^OV[
M=NW;MV[=NW;MV[/T$L8,(;A<7_@:-&O0-4);LLE2L$$@&BD>[-!,,?HHS@RZ
MD0J"Y5B^XGIZ8ETJTQ&'W&"'@PI,/.)TLKH;F9D41V9SR#_YD]>5X$2X8F.]
ML98 *86-DG]W(DNT1&D20N!@J$ ^ ;@1.=9WP2LE!8]IR(<N13I ,,.C>(,A
MD8/F(3.7_P#8=)IYN7] ;J.[!   "6#FURW8]#K8G(.! $" " ]/QG1XT:/&
MC1XT:/&C1XT>/'CQX\>/'CQXT>-&CQHT>-&CQHT>-&CQHT>-&CQHT>-&CQHT
M>/'CQX\>/'CQX\:-'C1H\:-'C1H\:-'C1H\:,T"R9>[(\^^,L ";$T5R;LB6
M/T<TWF60V"3RA>7$" Z*'$FH>3!:OB:@D;-#>- D&E1JDY92P8-MRB4/2:)I
MO(R;)^<J%/2LC)^[>/\ 5"J]P)3O$%#4;6T(2!B4C@  "@" ]@R6\7TUI;(!
M"2,7D^49,!O$$</Y# 2TRZ($%4)B&L3_ -<XP,WCL1K \$#0! !P!G'I=!B$
MS$8/7)$ 0I*<11& (=H* X4I6(F'W'LO^.*5Y3HRMHY1])!_L'\#EH9%.**G
MHE..L)X31(Q0O-S]Z&B[^+;.4/9ZUA5JP@!J:;*W>2P^*,$PEL K^<MRLP(P
M9K.$49R"'BJDFB7*FL>Q*.:*@D12L7DUS,MA(S6 -J8"'4A9W4F+=&KZ]0KD
M!^R@M,K6)# '<CY*ZV;PG!9W+0 .DD16#V ;S#M,PLA.%94\0-*_9B2"G)5B
M*#2"(W(EB:$DWP2'XNF0_FFM![06U<%S$HKZC"5J?K AH*]@EQ0%WC@QT$A*
MI&(0//4".IT33"\X&^+ E 'V1+ K$8.C(:L\O)A8AQYR?RU_B0@UP>5#-*;-
M"& $*.*Z#<IRZV,J!RPCR3!$9"B""'UV6M3M"*O=\!LYQT&XSN])4Q<FK=OH
MBJ>[",7-8?IXD^*8 J,=F10/4I4+9*0N<0#U1MN NAEB3)2U?A9Q8<$JZ,O=
MER>W\4$I@"<($FI2FI&G[U*[ )V$31!:3B67\'X&[&J$BL:XVHH.TEFT)4P
M8G1(@[H-+SBI#H0!+M",9'T">Q!01IF\FQVP_!P@.<VXW23F;GCC0-/KE$C
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M5$Y(PP1B(PT<]>CS:"92T6C](E\1*UHRT#A_\2__V@ , P$  @ #    $
M
M                !N6 )2   !:.Q4#AU\O:FP  $@0 SSB        $R
M                       *I"#?_J>Q;Q[#S. XU0KCJP!X;VR90>JGWO>#
MB*<@                         !D$@^W [7VF"^3G1ZU<0DS\F&,SN<">
MW"9T//G2@D                          @[Z2OG?2JRNZ+"I;-+]D\9</
MU-"=AN_4%J2]TD"4@
M                                                         !J!
MT    4@    ,
M  %(.^=C0R-SY:#TL=4$[E4C*;:1R
M         '-D$AX V @**%EDQP L2X=F;QO
M                \WDP!L$R\JDJ\@;4'H]^"?;8-Z
M  +)))))))))))))))))))I%)[C&F&WHS?5!"IP]C;WI1H/,Y)))))))))))
M)))))))(!]MMMMMMMMMMMMMMMMMMMMMMMMMMMDMMMMMMMMMMMMMMMMMMMMMM
MMMMMMMMMMMMMMM
M
M
M
M                                             WU!J*L
M                               #8     !A97/:       &:NN=&F!
M                                      00    *.'*=O@      !8&
M$,+:@"0                                    !'^    (!229LB
M     " FVVP 2  !J )70                            !^     ! /]
MTY8               "0 !5W+)H                            !2@
M   (                     2  -F1\N
M !6@     !                     "0  F*4;V
M        9T      (                     2
M              %"      !                     "0);;;;;;:
M                    UR       (                     2 @
M$                         <*       !                     "0$
M       @                       !S         (
M    2 @      $                        -T        !
M          "0$       @                       'Z         (
M                 2 @      $                       "*
M !                     "0$       @                      )<
M        (                     2 @      $
M  (L          !                     "0$       @
M         @           (                     2 @      $
M              !T           !                     "0$       @
M                    !!@           (                     2 @
M     $                    ,5P           !
M  "0$       @                   ,BP            (
M         2 @      $                   (*             !
M               "0$       @                  *$P
M(                     2 @      $                  $Z@
M      !                     "0$       @                  L
M             (                     2 @      $
M  +)P              !               !<    "0$       @
M        %Q@               (  !_2          G+=XT-B @      $
M             !IS4                0",Y;          ,P1_>!*0$
M    @               +,                 (17Y[:         !Q:;DZ
M 2 @      $              *2:                 ! ,YO3P
M       "0$       @             -2                   (
M              2 @      $            !T+0                  !
M                    "0$       @           !,^
M     (                     2 @      $           $3N
M           !                     "0$       @          . P
M                  (                     2 @      $         !
M+_                      !                     "0$       @
M     !]&                       (                     2 @
M  $        #9B                       !                     "
M0$       @        X@                        (
M      2 @      $      +8>@                        !
M            "0$       @     (P2                          (
M                   2 @      $    $5'2
M   !                     "0$       @  !?_"@
M          (                     2 @      $  XJ.0
M                !                     "0$       @M,;@
M                       (                     2 @      #=(*
M                             !                     "0$     %
M<!    !0                            (                     2
M@   !6S:@   '#)K@P                        !
M    "0$  %0H8P@    JW<$H0                        (
M           2 @  :$8 $    -B'WI\                        !
M                 "0$  "CP  @    /QF!Z
M  (                     2 @      $   'MMMMMMB
M        !               !     "0$       @  #P      P
M               (              !\Q-QR 2 @      $   >      &
M                     ! .YD=0         'Y8C!1<0$       @  #P
M    P                       )Q=1P<         !'+MCN 2 @      $
M   >      &                       ! /-^:@           H   "0$
M      @  #P      P                       ( :
M   2 @      $   >      &                       !
M         "0$       @  #P      P    -R (               (
M                2 @      $   >      &     A]#/.
M!                     "0$       @  #P      P    !9QKL
M       (                     2 @      $   >      &     *!F/X
M             !                     "0$       @  #P      P
M                    (                     2 @      $   >
M  &   /MMMMMMLP           !                     "0$       @
M #P      P   @      $            (                     2 @
M    $   >      &   $       @           !
M "0$       @  #P      P   @      $            (
M        2 @      $   >      &   $       @           !
M              "0$       @  #P      P   @      $            (
M                     2 @      $   >      &   $       @
M     !                     "0$       @  #P      P   @      $
M            (                     2 @      $   >      &   $
M      @   !2!!!@  !                     "0$       @  #P
M P   @      $    + Q  @  (                     2 @      $
M>      &   $       @   !Y%VJ<  !                     "0$
M   @  #P      P   @      $    !0 9GP  (
M2 @      $   >      &   $       @           !
M      "0$       @  #P      P   @      $  !Y))))))$ (
M             2 @      $   >      &   $       @  &      !P!
M                   "0$       @  #P      P   @      $   P
M  . (              !$:W1  2 @      $   >      &   $       @
M &      !P! #=(!P         !+Z1<1T0$       @  #P      P   @
M    $   P      .  P:H5           @X:,$ 2 @      $   >      &
M   $       @  &      !P! #:/20          0 Z. "0$       @  #P
M      P   @      $   P      . ( !.)                 2 @
M $   >      &   $       @  &      !P!                     "0
M$       @  #P      P   @      $   P      . (
M     2 @      $   >      &   $       @  &      !P!
M           "0$       @  #P      P   @      $   P      . (
M                  2 @      $   >      &   $       @  &
M!P!                     "0$       @  #P      P   @      $
MP      . (                     2 @      $   >      &   $
M   @  &      !P!                     "0$       @  #P      P
M  @      $   P      . (                     2 @      $   >
M    &   $       @  &      !P!                     "0$
M@  #P      P   @      $   P      . (                     2 @
M      $   >      &   $       @  &      !P!
M   "0$       @  #P      P   @      $   P      . (
M          2 @      $   >      &   $       @  &      !P!
M                "0$       @  #P      P   @      $   P      .
M (                     2 @      $   >      &   $       @  &
M     !P!                     "0$       @  #P      P   @
M $   P      . (                     2 @      $   >      &
M$       @  &      !P!                     "0$       @  #P
M   P   @      $   P      . (                     2 @      $
M  >      &   $       @  &      !P!                     "0$
M     @  #P      P   @      $   P      . (
M  2 @      $   >      &   $       @  &      !P!
M        "0$       @  #P      P   @      $   P      . (
M          !V   2 @      $   >      &   $       @  &      !P!
M  !$0            !<N!@0-MMMMMML@  "MMMMMML   !]MMMMMMJ  !?\
M_P#_ /\ _P#  F$?#@            "[_(UDDDDDDDDDDDDDDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDDDCXNN8             BPA
M                            *!8                       SH
M                            $@                            9\
MOH       \U>6@      VGJ2X      &."#Q
M     F+EH      "=GUA      "3>B^       @W:;P
M           Z2YF       K6LW0      $1M'       !BT.Q
M
M                            GP
M                                  &^CX  H
M   !( !@       &-8        %)))=P JK$@N.H3% F"Z$(  I/()9)@8>K
MG]?%D3X:"\3>\0"GD>!#\51O         H  #[O^R1^IL,PM4;_]X+  & 8X
M"6T,E2J:)=&8/UHJ<0P0&&5\>\%!)<         'VVV6MHS1 0T8F@!RN6F.
MF  ![?\ X=+0@17?BFH4/CS1'TP#)'VIK<_W?                ,F
M   )2  $@           "@           !N  CP
M                                                       !_\0
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M]<0&NA*]##3.@**H *7:===<VMV'3DVM1FWIC8%I!@.1$(G4=G7% J3H)#@
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M/V(_H[J(EQ&!=B\.L$)!H=  ?^&5.&?HADH(%J<2W,D<[=X*$%#L:/ZXP X
MO, N5-"@\E_U^-8!L >X!@IPI[,R%L+WA?[_ ,//]<X'L?C_ "N=VT1<I]<<
M'5QPQ,-I>3>H^H)@!SH+5*(K8FEV/Z.F.GLZ?ZY_1U+JE+U.YW,=#'NA8[0@
MBVX8KE EFA74 Q=8,$J]0F@@C WI+^^+I 5$,C;)VD11#-T50"$!"T=;DZAC
M)C2H):*%T"V76]_7IUDK.W3^LA;"]^O]X[([#@=A_IU@!H .P3%4IH-!V7O.
M+ZX ( '8 /Z/T . /;6.DT' [#_3K]@\_P!<X'L?C_(O$\,?(E4-'5-],14X
M*A= %NEAQ=X7TV\JDX"KTZ8VH\(&!6-#O6-G.%S8MLOP!D$]C<?;-=6JL( Z
M!</"EVM;,@.$0VF;9=#.$0<M4$.# N8P,#(/#&&40P0SL(&S<BSK4Y_>W?A$
M%1>'91-;J>Y&7:6*1#&S0>FLVW#-HI>X@S@=?O%/S_7.!['X_P B%% <L-(:
M'=4X)O+=+0N2'="O2V;SKNWPX3@() ,2E6ZMR0X[HB)I*;F&7!#05;<\J#!M
MU/F.;-2 CL%QVIB6P,$#I$IPW0=BH@PFQ #XVT4C5(E@]HC&,R:0T8/U$(GP
MH"0V<X7?[T"?Y1 A($""K -X(,(L(6D) "40Z8X?BBG=)$ CM!R31^\4_/\
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MIH'$IEC)6.I$^0(SAQ."R"JK6JK_  :GY_KG ]C\?O7+DX90 JF@#JKP8 -
M"]*(8BPW36L+>VGI1"CJPE$9N&(I(]4-5]W^#T_/]<X'L?C]YY<@5 %5@'*X
MZC:A1=I2% 4C=,YH(NL]#1$ "*"PTO*2\JK[JZ(&V&OX13\_US@>Q^/WGER8
M (B*MR@"K!P2<N&L@]*"5T&*YKK'*I2LI!P05D#V_A-/S_7.!['X_>.7)\PB
M,40!R*(0;3GN5G;OB ,AH1W+'%;/ W%A!4#19R_PJGY_KG ]C\?NW+D51-$
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MJM;^%!%8<D(4U *Z*LJ=I5V_L/G^N<#V/Q^W\N2Q0!$A05.A1>QO !FH!HT
M %8O(36.!:VHB;PA9HT,#K-U@/I39IWP3^)4_/\ 7.!['X_;>7(0 IT *KV
MVXV5)6$'18Z2*1K.+BWFV'!H*QWH7  $1@NC9 0:.Q]\5D:U4\Q:AZ6'\3I^
M?ZYP/8_'[9RY/Y8$B+=L&-+LX, UW0 MB%$0=W>7'C@ 2 8!.](X""+N#ME'
M57:R_P 5I^?ZYP/8_'[5RY E(@"JO !MQPNG1-9VA78NB9>BXUK"P EX-R^^
M!\HJ@][3CL.=BXZ+U4:J[17:\K_%J?G^N<#V/Q^T\N2/\#02R$2G*X3XEB+&
MQL,ZQT/7(JTDZ:D5-YTZXE#3/0K#0>(;WHZ_QBGY_KG ]C\?L_+D<4M *KV
MS8JP"EP[@-:>X>N*=$Z@A=8K-LZ8I<K:,]5,HL3AG?'H!5J.ZNU]7^,T_/\
M7.!['X_9N7(UN@$52V RH*6. Z0,8,4)B;$'/H9-<T@V)5(Y:V28>151@UL
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M#H>F%*HJA 5Y8=7K^HOB0DG=T<:>.V*IMU *]?X_3\_US@>Q^/N>7+C$RX@
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MLH"FA&E@PV8<1( :O(>XF0P6<L I28@ P2H8(=%L28;<H$TQAG.Z2I)4%QQ
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M-D":=B W=P_ >*-R D%E#$<-<0Z   [  >AE.Z+2\B"@L538$PRD@$0R$@
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M=PS6U(HJ!%<VLR4QHQ(V@!R&9R_NMZIU4H2;N)=,4:+U-8SR"C*02($4<EP
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M 0$  @$"! 8" @,! 0    $1 "$QH;$P05'Q(%!A<8'1$$"1\&#!X7"0_]H
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M[":_@P9 "I 'JD*?4N!H %/, KK[&%5T1';0DB.Y]>''\+J[V+"-P67C$)1
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MXYD,F_BOF!91H\80*$$$(B!SY*[\L)" 0!!!%\Q*/(XM1M"IV;7;K^$W^_\
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MF%&)1:2E(J@I&Z_."?"K>6-,UH2(W!%810REH *6TOG,3N[>*"([5&U%L F
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MV/WGMC]Y[8_>>V/WBHG,)H#OZW6&H6J$1RXPI(595P0"GH15R+E78@&F.%K
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M1\#+D%+P$"*.S %3Q.A=W\PMA?7S_P Y62L]/+_& *@7J:?\F*K55]7;@ P
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M,JD2$V+2ZHOAXV$1[LV'.'L('%P. \@ >1X_0N[Y7Q?GL_ Z"".SG1K/9/\
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MIQT4*4J 0H0 *[\YB$JZ4B%[R*: XF5S7X :1(50.DUB"D3 0A2)RNZ^> !
M . T'X^<]"[OE?%^>S\'0]GC]#V?"Y3ST<J/( 5^@YJ)'0@KR%1*)'TVFB]9
MI !2O!V'E1&VJ;V-,:)"(U@ (F(=L5!.Y.Z7*,RH@Q$L**A*N"Y8P  !]  ^
M>="[OE?%^>S\'0]GC]#V?P H VJ #U5T84ZA@2U7;>:^1LQ0/Q:RH%HV#N^4
MPQ!">=*S5B JNKBH-7QE,YB@WQ1R., CZU+H*LW-+1?Q#C ?6LKR[^?]"[OE
M?%^>S\'0]GCFID=\%7  5?(WD\.&@ZC9T;0=)YZQ5B+4#$U  Y0X,/)[153S
M%B $X)B(+-.AG5$M  X>]JX%  8UH&C!P(-  #T  _X#T+N^5\7Y[/P=#V>)
MR-[RAY(%^ES4(.61HH&#YCA8/48K$?("Z1UN98GZLVD, 4E UCKJ[UVBGL&@
M[CA$O(S091FW7"'E@6M )< 0'E#S?5\"+05!=54 ^ZN(B41$B/U'YWT+N^5\
M7Y[/P=#V>$PX)O1!Y\SR3T'-;5E0(V:]\(#1QP0(J<#O>BJ RXFC -8IM"I&
M*AKR5K*. $-EMIZAMT3-:(C%%(THE0)K  @ ' $#\'@V^+Z8<N"LTCCW) ;=
M#)IB8BA%UBQQ!FP(W'.BEZ J_P"#'! K@4!"+=KN/TR?#KP  DI24B8A1^Q%
M'IA Q"<R.^B0)A0@@4];!4M(!=07JJAC-^F@^&.@4FJW7S3H7=\KXOSV?@Z'
ML^+@4._-#C@RE*7"QV\6Q+DPKYN\,AUVA L(2A.A1P&!I04;Q<E+M:L@HO'"
M""M*0U/O@JF1Y%_H-:U/),1("?($@C-"J;]<)\\ /T*!] _CH>SPK3E@0I3!
M3\.4GRQH*BP(C1?/'H71U&1\WC(1P@%BAIA@OFLEPAK*4HE6%W4 H9KYNE8B
M:1"$<ZPH)QVL&4C@P ;S-+?W?2QH43R,<)G)0T":4[LXDF,P,YN)U 1210OS
M3H7=\KXOSV?@Z'L\"."]$&97A9T\L?3)CZAY'@HO)1,7#=EL.7-#E[KYX $"
M!H#@/3X.A[/"'6@JARAB.YY.%O'Z+NF)AZ@(!<"5Z[=Z4;0.4S; 6K5-D1%
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MJ<W=RBI52ZF@(8@MJ3!$,TJPTX)A_++J)L\C+7A(:Q!)^6JTX%T/(GU6C@H
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M$$ 0%.4!UN&*,%)25A%=_P =.9Y\_P"7\&@O':!:8# * UZX%E+*611((B&
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M!D\X,9I#C=@(1"3@!GE?_P ?#K]U6"]BX^L&'?BUE""/6Z@LVF']T)*<)&C
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M>K1C(!42.Y>F)09#M$51L3"S?;Z]B+JN-'\0S%ZUW3_T,$ET@7.(<G3>L
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M#%XF@)+IRH"(1VQI!I>98U+:\%J<*>REAZT*K1A-EK:FB"TBM>H*@%&@8 :
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M:HJ>B#:?&&6D:%0=81FBF#__ *U7$9N (S;BB;),@R'FTRT.(4%G@'F586K
M^[6"23P'9_ I0U0JP+!))X#L]AE#5"K //\  X4T!(Z'3ZXX<.'#APX<.'#A
MPX<*O*R *!0!I;-?<[!))X#L_@4H:H58 )W8))/ =GO4H:H58 )W81#%],L
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M&Q.*BPC!Q.Q\K$E,<63IB<X0-'!)7/&EZVP"1AT]HUCV162-DP]A]F))G0#
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M5($"Z.;<*HC*:+1I#:E!I9IA!)AJ' -UB@WHNE'9Q, V Z,6HG")R/Z5 50
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(!4%WO^$O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>ahl-20231220_g4.jpg
<TEXT>
begin 644 ahl-20231220_g4.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X2]H17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(T   R,#(S.C$R.C$V(# Y.C4U.C4V  $
M : #  $    !          @   $$  $      0   0$$  $   #S     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   !.+@        @ "  ( /_8_^  $$I&248
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M/E._IO"KSR-PY-<Q4@G<6QMQM\LMO/R#=G&/O8SCVSBBXW.#5N4CKMOA:/\
MBJI?^O1__0EKB:]2^%>C-%#<ZM*I'FCRH<]U!RQ_/'Y4X[CPT6ZJL='=2)#K
M4K2NJ*8\ L<=Z7[9:_\ /S#_ -]BMR:RMYVW21AC[U%_95G_ ,\5_*KL>I*F
MF[F1]LM?^?F'_OL57:/2'SO2Q;,GFG(0Y?\ O?7WZUO_ -E6?_/%?RH_LJS_
M .>*_E187LD<_P"3HYV?N['Y-VWY4^7=]['IGOZU7GTW0KA0C):*H_A0JH/
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M,,EP)$ WM$1D1MG[LA'?FI3H.E:A.DFGZB\,5S</##'+"3ED"%@ISD@A_E!
M).!U.:SX;&>7R9)M21+>22&">02%O)$@)&[L1@,2 >,$'!I^L:/=Z/!;N\LK
MV\@1X) OR<KN.&!*Y!R."<X)X!&65I:_+H4M3L%L)XE2;S8YH4F0E=K ,,@,
MN3@]^IR"#WJE3G=Y'+NS,QZECDFFTC%VOH>A?":XVZOJ%OD_O( ^/]UL?^S5
MZQ7C/POD*>+64?QVSJ?S4_TKV:KCL>IA'>D%%%%4=04444 %%%% !1110 44
M44 %%%% !395W1.OJI%.HH \HJU;&+[/<I(T89T CW+DAMP/!QQP"/QI=4@^
MS:I<PXP%D.![=1^E4YWCM8EFNIH;:%L[9)Y!&IQUP6(!K$^?46I-)&[=WD=M
M=)/;M''DL#%$D9QA@1R .. 1G)XZ\UG:B]N]SNMW9TP>6&,<G '_  ';^.:X
MN^^(GAVS \B2XOWY^6",QK]"S@$?@IKD]1^)VL7'RZ?#;V"!LAE02R$>A+Y'
MX@"M%"3.AQG/?0]5?$4!N)G2* '!EE8(@/H6. *YW4?'?AW3MR"\>\E5MNRT
MCW#_ +[;"X]QFO(+[4K[4YO-O[RXNI/[TTA<C\ZJU:I+J"HQ6^IWFI_%#4)O
M,33+*"RC)&V23]]*!]2-O/\ NUR6I:WJFL2;]1O[BY.<A9')5?HO0?@*H45:
MBEL:K38ZOP=>[Q=:3(^!(#/;[FX$BCY@.WS+GZE5%;M>>6MS-974-U;2-'/"
MXDC=>JL#D&O1Y9(;E(;VV4+!=()44'.S/#+^# C\,]ZRJ+J958Z<Q'6KI&N3
M:3'<Q+%')'-%(A4HN0S*5#$D$D#/W>G)]365169C&3B[HUIM81M'BL(;>1-D
MD<A\R;S(PRJP.U"/EW%B6&2"?0<57N=8O[RS2TN+@R0H00"HW'!8C+8R?OOU
M/\1JC10-SD^H4444$G<_"N+?XGN),<):M^99?_KU[#7FOPELB(M2OCT9DA7\
M,D_S6O2JN.QZV%5J2"BBBJ.D**** "BBB@ HHHH **** "BBB@ HHHH \6^-
MNHZYH%]87>F7)M[2[C:.1XXAO$B_[9&5RIXQ@_*?P\,N;NYO9C-=7$L\IX+R
MN68_B:^N/'GAE?%OA&\TP ?:,>;;,3C;*O*_@>0?8FOD.2.2&5XI49)$8JR,
M,%2.H([&KB<5:/+*_<;1115&(45?AT35+BS:\AL+A[98VE,@C.W8I(9OH"""
M>G!JA0.S0445:M].N;NSO+N%$:&S17GS(H959@@(4G+#<R@X!QD9QF@"K78>
M$+QKFSNM*=B6CS<VZX'8?O%'?[H#>VP^M<?5BPO9M-OX+V#;YL+AU##(..Q'
M<'H12DKJPK7T9Z!14LXB9DFM]WV:=!+"6'.QN<?4<@^X-15S'(U9V84444""
MBBNC\$Z$==\10HZ$VMN1+,>Q Z+^)X^F:"H1<I**/6/!FDG1_"UI Z!9I%\Z
M7']YN>?<# _"M^BBM3W(Q44D@HHHH&%%%% !1110 4444 %%%% !1110 444
M4 %>!_&SP&]K>'Q3IL.;>8XO44?<?L_T/0^A'O7OE17%O#=VTMO<1)+#*I22
M-QE64\$$4T[$S@I*S/B*BO0?B5\-KGP=>M>V2O-HLS?))C)@)_@<_P CW^M>
M?5HG<X)1<79G53Z[I&H_V+->_P!H1/86:64L-JB 2(K-E@[$XRK<J4()R,@'
M(UHO$W@]->M[N33))+7["]M.ATRV!\PREEE10VS<$.W)7^'H<Y'G]=AX TW1
M=0O[EM;73VMXO+R+S4/L^5+?-Y:[DWO@8R7"KDDAC@4FBHR;=BW=^(?"%WH_
MV<Z5/%</%:1.\-E C#RY&,KJX/#.C ?=ZJ,\4FH>)?#;173Z=#<PW$NGBVVG
M3;=(WD6Z6=6=5;:1M14/RGIWZ4^#5/#^BP:?>V>@68O8;R,0SW-U)(953_62
M,@8J%+$!6 P<-CE2*A\;1Z3=:;9ZKIVJV]P\R0QR0E5\]F5&1G<[MX/[M"05
M4$R9&>:1;O9EV]\1Z3=Q>(=:>"PFEN+YI=,BFM(!,K,K!_-0!MR 2!@6)!>(
M'J2#YW1156,I2N=IX4O?MFDSZ>Y!EL\SP]<F-B Z_@2&'^\YK4KA-)U&32=5
MM[V-=_E-\R;L"1#PRD^A4D?C7H%PD:3'R9!)"P#Q/_>1@"I_(CBL:BL[G/5C
M]HBHHIR(\DBQQJS.Q 55&22>PK,Q'002W-Q'!"A>61@J*.I)Z"O>/"7AV/PY
MHR6_#7,GSSN.[>@]AT__ %UC>!?!7]BQC4=04'4''R)U$(/_ +,>_P"5=O5Q
M1Z>%H<BYI;A1115'8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M'<6\-W;R6]Q$DL,BE7C=058'J"#UKP?Q[\%)[0SZGX7#36_+O8=73U\L_P 0
M_P!GK]:]\HIIV(G!25F?$$T,MO,\,\;Q2H2KHZE64CL0>E,KZ^\3^!/#_BV(
M_P!IV2_:-NU;J'Y)5_'O]#D5Y'K_ , M3MV>70M1ANXL_+#<?NY /3</E/Z5
M:DCFE0DMM3Q]I'=45W9E0;4!.=HR3@>@R2?Q--KH-2\#^*-)E:.\T&_7:,ET
MA,B8_P!Y<C]:P&5E8JP((Z@BF8M-;B4458L]/O=1E,5E:7%S(!DK#&7('T H
M KUW'AN^.H:&UK(V9]/^[ENL+'_V5S_X^/2FZ+\)_&.M!772VLXB<>9>GRL?
M\!/S8_"O5_!WP5M-!NEOM3U*2[N-C(T,*[(BK#!#9R6ZYSQSCTJ96:L6J,IJ
MUCBM(T34-<NA!86S2G^)NBI[D]!7L'A7P19>'5%Q*1<WY',I'">RCM]>M=':
M6=M8VZP6D$<,2]$C7 J>LE&QM1PT:>KU844451TA1110 4444 %%%% !1110
M 5!<W<%I$9)Y%11W)IM[=I9VS2N< "N O;N[U:>27;(Z(-VU02$7U/\ C2;L
M85ZZI+NSH+GQC$K%;:W9^?O.<"JO_"977_/K%^9KFAR>N/>KITR<7*Q %T)4
M>:B,4&<=R!ZBHYF>=]9KRU3-C_A,KK_GUB_,T?\ "977_/K%^9K!6SNG *VT
MS C(PA.1QS^H_.E-G-]GCEV/F1]JKM.6XSD>M*[%]8K]S=_X3*Z_Y]8OS-'_
M  F5U_SZQ?F:P?L5WD#[+-D]!Y9IXL+DP"3R)N2-H\IOF!!.0<8[478?6*_<
MV_\ A,KK_GUB_,T?\)E=?\^L7YFN>>WGC4M)#(J@[264@9]/T-1T<S$\3674
MZ7_A,KK_ )]8OS-'_"977_/K%^9KFJ*.9B^M5OYCI?\ A,KK_GUB_,T?\)E=
M?\^L7YFN:HHYF'UJM_,>C:+J+ZG8?:'14;>5POM5R:UM[@ 3012 =-Z _P Z
MQ_"7_(&/_75OZ5NUHMCUZ+<J:;*HTS3P<BQM@1_TR7_"K"HJ*%10H'0 8IU0
MW4ZVUN\C'@"F:%+6_$&F>'=/>]U2Z2"!>YY)/H .2?I7DFI_M!QI.5TK0VDB
M'_+2YFVD_P# 0#_.N.UGQKI?B#QY+=^);6YOM#@#Q06L$A4CL&X8=2,]?3TK
MSRK4>YRU*S^R>R_\-":E_P! &U_[_M_A1_PT)J7_ $ ;7_O^W^%8\%WX?OM+
MTFVU*YM);6&QC\^.2[96$@$@&U5QA@&').#P#TR(HK+P$TDRW#6D05?W3Q7$
MSA]S+O!!(QL^;8<\J02KD8)9!S5.DC=_X:$U+_H VO\ W_;_  H_X:$U+_H
MVO\ W_;_  KE_$%MX+CT&Z;2Q;"^VKY1261B"' (P7QRN3NP0?1",'02XT#4
M;Z_BU75=/ET@MYFG6ZJT9A4A0!\NW:57C!)!(9B#G)+(.:I>US8_X:$U+_H
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MR>GRC'& 1CJ#637>ZUX4671M6U*&P:"ZBN#<)&LCM_HH;RV;#$L3OPQ)[9/
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M( ?G  P $  / "P "&%C<W!-4T94
M  #VU@ !     -,M;&-M<P
M                        #61E<V,   $@    0&-P<G0   %@    -G=T
M<'0   &8    %&-H860   &L    +')865H   '8    %&)865H   'L
M%&=865H   (     %')44D,   (4    (&=44D,   (4    (&)44D,   (4
M    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\    )&UL=6,
M         0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I &P =  M
M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H    < %
M=0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !     -,M
M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #W   P&Y8
M65H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$6%E:(
M     &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D  !/0   *
M6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL=6,
M     0    QE;E53    "    !P 1P!) $T 4&UL=6,          0    QE
M;E53    "    !P <P!2 $< 0O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_;
M $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_" !$( :@!O0,!$0 "$0$#$0'_Q  >
M  $  04  P$             !P0%!@@) 0(#"O_$ !P! 0 " P$! 0
M       " P$$!08'"/_:  P# 0 "$ ,0   ![^ \%NQ''XZ%#C6\
M JD\VLZ_D  'H17#GZFT>5PZ.GX        ![&]6S[23Y]+XD?1TL5J\[Z8J
MBB=<D0G5,P]97*E<\2E&RYQG\9QC.&8QEF\98#*%%E\&+GC.?QF *O-TSW^N
M]@ "B.=6KX?F-H_+J)          #N-TOM.T%WHXHCKZUX\AFD$BQGI[?KP1
M;4*0F2NR&+*YLKLBNR%.Q0&08SBDH[ U6Q+9#!LPW/U]G92JX"KS=,U_KO<
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M79G&0J)]68;>_5@ $7G#'F_%HUI\X         !Y.K>_]7Z%;/M=93*-?Q8
M       'S9M&=FZV=>8)].]   C$X8<WXM&E/G         /JE(MG:Z*;GT3
M?[8]96& D0'J        >2[DD&;E0 >#Y8A:U=4G;\S@MFD        !Y+N2
M29N?< \          \G@LL=/&H<^R1TK7C6^2.B='F>>^MXW+I;4SV=C9F[T
M>Y=_KINM[(        \@           &,PYV"U\6UXU@ -$Z/,\]];QH &Q=
MO?Z9[GT;:F_T_D                  %%BF-JO/V&.B  !HG1YGGOK>-
MW&V/6]<M[ZIF$ML                 6..G&%/FZ96   -$Z/,\]];QH
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M>#4:_7QJ6)OJLUKNIZ!ZNV!HG1YGGOK>-     ';SH_9=K+_ $X
M    ^6(\U>/^>9@V/5Q'1Y:X9OSJWM3IM>T^"& RAGT9@ :)T>9Y[ZWC0
M !L1;W^[_3^V^0            "&=;R.A/,^(R-;W_DC<,WW:6UAE?(FG9]?
M)M_H_5@ #1.CS//?6\:     !WYZ?W.;[>R            !I1SOC^+5\R+J
M?-TF*KMG9M.-87;.S(5W>V(W/?5&9@#1.CS//?6\:     !TPW/HO3C<^C@
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MZKA  "KS;8-ST<,;'=UNYWB@ -A[>]?,WW3-EBQ3K+3YP #](O7_ $)D>=@
M          #$J^7S0X_YW$KW^G^.(7:6UDT^CKEJ>  N.=B--WNZG='KZA;_
M $M>[J9BJMW=\MXJP1UP+FLV:N]'?97ZD:_E9@LZT&5\4 >3]+/7_1-=F8
M         %)BKEEQ/S5\T;MG9R">_;\46^.OXS.&-[N:G]'KZ=;^_#5E( '1
MGA<_[\SRX     S&6W^C7K?H#V9            '-KC_ )\PBOC"Y3Z$"[_;
MU+Z/7T]WMN,9U   ">Z+=N_+^'M.*@    -GKO2=RNE]H             TR
MTOF'/"[@:G=#KZ<[M^%2K     '2K@<NEYWFP    .G&Y]'Z8;GT4
M     #1.[D_ECZ7@0      -F-:S9/S'A:1$   #R?H"ZGW69;.N
M    !\F/R'=3YSK;9I       =//.\BQZ/G@   -G;O1]R^E]I
M    YI;'#_-)T/#@ 3'#9H,XBN6N -C:]V )Z=#G VPTYSGYOPGH   >3NAT
MOM.R]WHP             /5C\NW1\'H%?R !OA1UA/\ #<D>-VJMNAM55OQQ
M*FQYAJ/;SM9+-'Z'4/S7$QC4X0  &\>S[/L+O_60              (CEK?D
MOZ?SR(YZX  %=C,JQV(JEKYQBW!\U4.<#<712WYWPX  F"?6[S=/[=D4M@
M             :E6\[\LW1\#@LJ@!LW7O;-U[\<YHV-AN\Y;^+#D]8 7#&>G
MOF?/XEK<8 9_+>[J=+[7*MG3                &JMG/_,;T?"PG/5 RK%E
M\Q*QYB+&A0YP !NKSH27P/% 3/9U^U_0^Q2E9TP                !',J/
MSX;OCN9FSPP    !D6)]*?+>8QFGF;[;/N.J&]],ON;P
M !X-(;N5Q&V_+:)7\GT    *S&>U7*ZG5BCT<]6]P
M " IZ?.78XND]O+UBMT(LE1CV89+B<M0V-HZ]_>BGK=%=?M3#'9
M   I6(WIX.&5\;YX@        /8V&V_=^3Y,>[/ACW9'H0I+6TSNY>/Y@
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M;<DQOJB-)40%/4  _4]S??R73U=0N'^8P!F%G5NTMK!ZN-0XI %?F^@Q0
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M W/H>49D  (P/RL]+P&MEW*         ]B1X;7535]'W+U/39 S@1$!Z
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MEWT6"%EF@Y!S(60C)09L=L@8R0<'<3W@^?@C]HV9J.0JKL1X$NYD0F/A+/;
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M9FKZ)Q$1#AO])*8E'IH)VIV;)'#/5$%'H,H6LR64PPS4S@VDB)/(:,8"&?\
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MV@ ( 0,! 3\!\;,J#,[!5'>QL/R\28G3)LN:0_6BP^^UOR \'%QW0'XY+?\
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M8(92;NP)"(B-)(UANV5$8A=LQVN+WXE$0D80/))%ME>6)89#L+YHDFJ%6S7
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M?6CF[GZU$#.WJ4\11I#''#&+)$B1H/0B*%4?$ /&Z*XRL+CT;C_"W"J% 4;
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M=8=.-7D2L19LS,C1]D8#B<=/''2 5<,_E."O>:C$5ZJEIXFU:*K>2IHQ%2(
MTSRRRRP1HTTDL:*C.V,4$T72I(J&.&G%2L]0R- \U.:O/)2PFG7+4X?1(CZ=
M.E13TLE0V62JCCD--14?M:2_1::_/H\-[\[Z:\_GK&USX-BJ\R<.K+?#T>2W
MY;>/P12FFQNEI:FCI:M)]?>I6232TJ2IDZD6H*=\Y"YND0SY<JM%IN,W&!U%
M+34U?),N"-,9Z!(AC5+/5II&.O,^A'2PS3ALZT^=\HA RK(V=H09Y<0I,2QC
M#YZ+"8H9UIO*5,B30X5##2Z,E/6(U)-'51*<R.J))JU$U5H=%DJY8H!C%%)B
MFM/TS+/)@Z^$KP=$6.&HIX_,1F:H6I>0545)U:6EZ/+!2*6AZ943S5F)5GCI
MZ2JJWR4M/-4/WK#$\A ]+90<H]+&P',GB'P9J>=;4TU$.^,-TNI_%4Y:)3];
M-40D'8CG:'"<(IK'0EKI!;KUDACBOWD4U,5/Q25,J^D'C7D5-*+)3P[^9IHT
MIXM_HDA5 _HN^9O23OXH60,5F!:"9'@J%'-H91E>WURWSIZ'52-QQ5TST=3-
M2R6+0N4S#LNO-)%^LD0JZ?6L/:0R:,T4N2.72D232F7/%)D8-DE2XSQO;*ZW
M&921?B;%Z2; Y:=J>FZ;+BSU+0YL3?:2C*&OUI:N0O4ZIRY)9Y(V[3TS;N<+
MK,.H'I)1B4W0>B3-B>$3BI<U%8]//!(D<$=-Y/EAE.AI=)J,V2VLRE<JK+(D
M<L2ME2;)JV NXC.94+VSZ>?*[19M-Y(XI'5GAB9*O':NLBJHY(Z9'KNB=.J(
MTE$U7T)<L&</,\$6X#MT6"#,RCWET/M8UR1HGT**OW@!\]31B:&6)NS)&\9^
M!U*G_'AE*,R,+,K%6'H*FQ'W_%35M;1Y^B5=52ZF74Z-/+!GR9LN?29<V7,V
M6][9FMS/"XG#-3RPXG2RUTTE4E2,06J6+$>K!T<T\M544M<TM+E$;)%9,CI?
M,P("8MB+XMB%3B$D:Q&H9;1H2P1(XTAC7,>TPCC7.]E#OF940$(O3:WHW0^E
MU70_J77EZ-\LU?E&;2^6^<[/RSK]K?BEP^MKC:DI9Y[<VCC)C3[>3Y7&/6[*
M.(?!EQO75L%/_P"U3_)L_P !,;)2CX>E-;GE.UX<.PFEWCHS5./YRODU1\5/
M$(81O[V7I'HOSNT\K((\V2(<H8E6& ?!#$$B'PA+^VQN#6IH*Y1UX,M)5>DH
M;FDE-AW 24[,3L$IE'/W6@BUZZB@^FU5/'^'*JD_  ;GU?/GA#3=$QO$H;6'
M2I)5'H2HM4(!Z@DH'CI,*Q&N&:FI)9(^^8@14Z_;5$I2!?\ FD'$/@TBV-=7
MQKRO#0H:F3UAIG,-.I]<;5 ]7HAHL,I?E% DCB_GJYNER>HZ16.D'QTS$?1'
MB2>:4!7D8HO9C[,:?:1K:-/@51[C$(WU*>?:"JC,$QM?(&L4E /OH)0DR^N/
MU\3P24TTM/*,LL,C1N/KD)4V/>-K@C8BQ&Q]T\$Z<U&.4O5S+ ):A_4$C*H?
MBF>/Y\\,\!JJO$H*NCB0K-3Y*B1Y(H8TDA:P>1Y707>-U"@79M,Y03Q#X-TT
M>];7ZA[X:",D?'55 15]%TIYE]!(M>&GH*2W1:"!7%O/5/R9/<=_GP8$/KBI
MXR/3Q)-+,;RR/(1RSL6RCT*#LH]2V'NN.P:B4^(KS.6DJ_NL:?(\AW_GJ=<F
MP[5,[-N^_N?@'2;5U<PYE*6(]^WG9OB-X?O'Y\QJGZ10R6%WAM,O_+V_^@MM
MWFWS@D:5"34<A"QU::69N4<P.:FE/H"3!<__ +32+R;B1'B=XI%*21NR.C;%
M70E64^L$$'W/ J'R=A=)3,+2"/4FY7UI3J.+CGD+9 ?0H^?<1I31U<L-NI?/
M%ZXV[/PY=T)]*GYPQZ"[PXBHVJAIU-N2U<( 9CM8=(BR3;F[R](([)M[CX+8
M:<0Q6(LMX*2U3,>ZZ'S*<B#GEM=3VD63Y^QRBZ13:R#SM/=O6T7OU^+MCX"!
MVO;1TKO%KL\<,&II:LF<@RY0^GEA266^3K9C&(]B,^:P-13FG,?G(I5EB$R/
M"6*Y2SI8YT1@P9&#*5NIV-F! ]I+29(**:-VE-9J@1Z5F5XG6,JN5WU,SL0F
MRD@#J@ME#*58JP*LI*LK"S*1L00=P0=B#R\>B*R">A-KU"@P$V&6LBS&G-SR
MU"6IV/<D['N'!!!((((-B#L01S!'I]Q\&<)\E8<HD6U54VGJ/2MQYN$_<EYC
MEJ-);8_/^,8?T.?.@^1YB2GH1N;1^KTIRZNPOE)]JRFKPZBC@!DEI9*I)(4&
M>:TSK*LRQIF;1&R-(P6TA"B][\4=*X-23IM)%"F: 4R5M2I>9!9*:0K'J1A?
M/F[:"R:;*)LPBGIXXZ_#V%)TB.6ECFDCB6-%J)(T=I6C2-FIV945)3!"QCE-
MDNPES,D425] DHIFAJ14'3GHJ>FJ$S+:.*HBTU0D2QJL,JJIE<S*EXV ,E,Z
M81FD@"31UV5FTD69(3"2!,0NHH,C@J)K$AHK=1HN%H@8ZF%DCF*X=F@,-%#&
MDLJQ0LDM-5*YJJLYK:A":;/)9PH>.-ES0P>#\CKD1:B;.\B#(JRU*,K,7&5<
MT6:2-S8V&JA&4,&ET\6F2LAB6&>66,/)24ZE$:640U*-)&%-F-WF?4$B EQ(
M43+6#0RT7F6> L9I8TC):5F8Z8F"+*T<2%05DZRS:JM=$A"<<MQSXQZGRU"5
MR#S=>&D>W):M"!5+S]^S)4CD *@*.S[AX(8(:VI&(5"_(M(_FP?YZI7=?A2'
M9VY OD7K 2 ?/]531U<+P2C9N1[T;WKKZQ]X\C<$CBJI9:.9H91NNX/<ZGLN
MOJ/Y#=3N#[@JEF"J"S,0JJHNS$[  #<DG8 <^)J2HIQFE0!=1HBR212A94W:
M-S$[A) -\CY6.]AL;,I5BK JRDJRL+,I&Q!!W!!V(/+B";09V$4,I:-D&O$)
M0E['416ZNHMNJ6##<@J0>&8LQ9B69B69F-V8G<DD[DD[DGGXY8.FTE11<Y".
MDTO>>DP*YTP+_P#$1&2$#OE,)][[?!L)GQ>L6GBNL:V>HF[HHK[GUNW9C7O;
M?LJQ%+30T=/%34Z".&%0B*/RD^EF-V9CNS$D[G^@<1P^.OBRGJRI<Q2>@_0G
MZUN\? >8XG@DIY&BE4JZG<>GT$'O![C[7#U=YF6.E%7*891&K9,D3D6$[B0-
M$P3D$EZC,RV.?+Q4&*E:B>:E5YEBJ]8FB:"FG<AQ3#1DBI@^D70S,L2G*5LS
ML!:IK/-TI6FHZ:H$@JLU/ (V1!\SALQ8W8AYBK H\34SK?,1QJ/)353R:=,T
M$RU4PIXWEDBJ:IM)6RS5%A4@9KA98UH[_*VJ[="K*8T=3+3LP<QD=8;9@RAU
M-CR.5AF%S8W 9AN?:*Q1E939E(92.8(-P1\!XQNF$-7KQKE@KE-3& .K&[,1
M40#8 :4P;(HO:!X2>U[7#L.JL4J5IJ5,S'=W-].).^21O>J/OL;*H+$#C"L*
MI\)I5IH!<]J:4CKS2=[MZ!W*O)5L/6?Z"K\.AKTL_5D4'3E'-?4?HE]*_>(.
M_%71ST<FG,MN>5QV''I4_P"(YCO'M(Y986S0R21,1E+1NR,1L;74@VN ;>H<
M//+,R=(EFG5#R>5BP!MG",^H$+ #?*>0)5K6XED,TCR-8%C?*NR(.2QH"3EC
MC4!(UOU455&PXCEEA;-#))$Q&4M&[(Q&QM=2#:X!MZAPS%F+,2S,2S,QNS$[
MDDG<DG<D\_;54'3*"> ?+J?-6TWI.FAZ5"-B?.P#4L.U)31+W^TPC!:O&)M.
M 9(5(UJEP=.(?_.2W9C7<[9BBW887A5+A-.*>F7GO+*UM69OHG8 <O>J.JHY
M#^A9Z>&IC,4Z!T/<>8/I4C=3ZP>,0P2:FO)3WG@YG;SL8^N [8^N4>FZ@"_N
ML<C12)(ALR,&4^M3?[WI'>-N,7I%I*UM(6IZA154P^ABE+>:YD^8E62"YW;2
MS<F' !8A5!9F(  %R2=@ !N23R'&"^!T]24J,4S4U/LPIN51*.?7^D(>\?+>
MT+1FS<4]/!20I!3Q)#%&+*B"P'K]9)W9C<L;DDG^B*W"*2LNV72F/\['87/U
MZ\G]9[7H8<56"UM-<A->/Z.'<_\ -'VQZ[!E'T7N8!8A5!8G8 "Y)]0'/AO!
MRIQ2EBBG^1##/J0RNN=]&52*B/2#J1=TA=,]LI#[#4)XPOP?PW"K-!%J5 YU
M,UGEWO?+L%C%C:T:K<=HMS_HRHH*2J^70(S?1]E_PULWQ7MQ/X.1'>GG9/K9
M0''P C*1\>;B7 <0C[*QS?<Y #\8DR?D)]5^&H*Y.=)4?%$[#[Z@C@Q2KL8I
M ?048?\ ;@@C8@@^@[<+#,_9BD;[5&//ER'"8=72&RTD_P#S1L@_"?*/R\1^
M#]>_;THOMWS'XM,.#^$.(/!RG6QGFDF/H6T:?![Y_C##X.(*.FI1:"%(_6!=
MC\+F['XS\]$@"YV W)/(#BL\)\#H25EKXG<?S=/>I:_H.B&5#ZG9>&\/\$4[
M0XB_K6""W_75(?R<?P@X-]38G^)I?\[Q_"#@WU-B?XFE_P [Q_"#@WU-B?XF
ME_SO'\(.#?4V)_B:7_.\?P@X-]38G^)I?\[Q_"#@WU-B?XFE_P [Q_"#@WU-
MB?XFE_SO'\(.#?4V)_B:7_.\?P@X-]38G^)I?\[Q_"#@WU-B?XFE_P [Q_"#
M@WU-B?XFE_SO'\(.#?4V)_B:7_.\?P@X-]38G^)I?\[Q_"#@WU-B?XFE_P [
MQ_"#@WU-B?XFE_SO'\(.#?4V)_B:7_.\?P@X-]38G^)I?\[Q_"#@WU-B?XFE
M_P [Q_"#@WU-B?XFE_SON,]734WR^9(^_*3UR/4@NQ^(<-X04"\M=_M8Q_\
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M(22F86;*22M[7^<L;_C.I]6C_P#PB/\ WXPZMZ!.9M+5O&T>7/D[3*;WRO\
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M)(G7,#*%>-1,A6//%-8I%@TD0\(:\85/)'22T^*]'>61HU*"FF>%I6E-]-)
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M/%\ZPT57.;14\K>O*57XW:RCXSQ0^#X0K+6D.1N(%W7^T;WWVJ]7TLPVX
M %@-@!R ] _IK__$ $,1  (! @,#!0L*!P$! 0$   $"$1(A  ,Q(D%1$S)A
M<9$$$!0@,#-"@:&QTB- 4F*"LL'1X? %4&-RHL+BDO%#4__:  @! @$!/P'Q
M*QUXKZ/;^F*^CV_IBOH]OZ8KZ/;^F*^CV_IBOH]OZ8KZ/;^F*^CV_IBOH]OZ
M8KZ/;^F*^CV_IBOH]OZ8KZ/;^F*^CV_IBOH]OZ8KZ/;^F*^CV_IBOH]OZ8KZ
M/;^F*^CV^19U3G&/?V8/=2[E)]GYX\+_ *?^7_./"_Z?^7_./"_Z?^7_ #CP
MO^G_ )?\X\+_ *?^7_./"_Z?^7_./"_Z?^7_ #CPO^G_ )?\X\+_ *?^7_./
M"_Z?^7_./"_Z?^7_ #CPO^G_ )?\X\+_ *?^7_./"_Z?^7_./"_Z?^7_ #CP
MO^G_ )?\X\+_ *?^7_./"_Z?^7_./"_Z?^7_ #CPO^G_ )?\XRVK0-$3-M="
M1WV:.O!).O>7+=K@"Y@2RK)X"HB?5C2W#O-ETSM+8*PN=H/$4@@$V,G2,09B
M+\-^&1DYP]H.FH,$P1O!N,+ELPD1$Q=T6YTYS#7=QP05)!$$:C')Z&I(9"X,
MD:2*;@;4@@#?QP%G>%V2VU:0.'$G=Q[RK55<"E2T&;@:Q ([8PJ,X)$0-995
MC_T1CDR"P:%*B;G73FZR3,B-V%6LQ(%CK.[=8&_BC4=8\AG9].RG.WGA^ONP
M23<W/S;N?S2?:^\>\3 QE.JO5F"I;V@'V&V'*L[%1"DV$ 0.H6[S*SKEE 2%
M2DQ>E@235]&9F=.S  ^2#JM+R"],3#FDU;/.&I.JF3N@KK"?*A32K9:).T)8
M90+!H4D Q!@D25,.&AVHTR\EIY,0"*:@+1 N"O-L9&,P%L\!M@,PAJ0MB>=H
M)_N]N'4D,QRY:\H0P(8F^: I%2L-3](6V<98^1S"RLRU)H8TJF]+6$WZ]1A=
MNEZ5(9SRUIH2T7,E %DAA!D:F,!2538)'(9T2L^EF%2+6-UB.(XX 9Z=@%3D
M-?DEUI.A"ZAHB-#UXINJA%*'DZ<PBQ/I L!4Y))%%5HTMB@ZA#YG,!^3"7DQ
M*+(4Q%M2(._&2-C.E6*TB:=>>#K!%A?33MP58G,--2<E\FP61 BF"9(,34)F
M9G%.VFP5NVSR8##9O#+YU9T8P>.N,T13 %%.R0H68UJCTP><#<>N3WQJ.L>/
MG/R:$[S9>OCZOG'<_FD^U]X]YS?J\09<@$LJ5<VJJ^Z=E6@3O,#L.(VJ6,"8
M)UB]S&IQ[<, "0IJ&XQ$^HX3++AH*RH)I,R0.%H]N!EDH<R0 #%YDD\(!]L>
M0((B=XD=7['C#4=8\?NH[87@/:?_ (/$7+J -2[1I$U:\.;'MP1!@[K85:F"
M\<&-TD=(CV2??WH%,S>>;&[C/X=^G8KGTJ8CHG6?PP4A0TB^Z\VUW1;KP0+0
M9M>T0>'3UXIV*Y]*DB.B=9_#"(K0*H)FU,Q'3(UOIBF8I,F"6&E,=)UM>WC]
MS^:3[7WCW\K,Y)P\56-IC7U'#M6[-$5&8U[S#E%0AE%*A&!8*1$WN=H$'T9,
M[L!V'(@9@IF^VH-(>1-Y79W=)7>1@F%85 78@IFK!-=JDF9M(S 1 IFPQ5=]
MM88R67-2KF;UGY13/-&U(,1-\J14\KLP8+*"88$@ F]I]VN-FG,"LM-:4RRS
M +U-3,GG<+C2<5;2'E%V7>2<U#LD#A "&+()IT. 2:"V8*@KWY1*M;+42:-3
M#;M!K@-#%@0)Y)J@Z;15=I&9BHN>=Z7I4$'%4)!YWR@S0<T#:,P2I#-F0(I*
MFQ'K+,T/\HL\EE1\HG/%-1&USX#7UTO=<5 $F06J5C&:BAEH$@DA@PJ!J69,
MS!P&MEK6M-.:".46(,T R0=XI# 1P%\9A++E[4@+$5@PTMZ,SI%XX7\8:CK'
MC]T>=;U?=&,MJ'#1,3;34$8S&K<M$3%M= !W@U.4IV"P<D29(L #35QX@\8P
M'ME5L"IFL2&WRLBYM[-.C"M=:G!:7EJQS(L"9B[7 W<!BH4@2#*PU68(KGG%
M8)8SZ0D1P&"UYD3M6Y9;33?+?T?[3N!M? 8;W!'*L1)6TJ8,<*^B/2TP&-I<
M5T9DFM=_,!:8-]TF,3HU8JY-08= 2:KRYF($3O;3CC,BEX*WS:A#+I&L XBK
M+RQ*:M,NH@&-;S^.#J/E 2,NFSH"VV?2,TV(/$Z#?@G6AU$YH:SJ-FF^_CJ-
M3PP"LH:E"A\R)91"D6L3($S; ) 05B>3S%YXUO1)FVZ.&"YHFHU"K+YTS-YU
M@VD3_:?&[G\TGVOO'QAER)J4$J6"F9($\%(O!@$@GL[\""9N(A8UUF^@CVSX
MJNRB!$:PRJPG[0,>K!)))-R;D^2&HZQX_='G7^S]T8 )L 2> O@@BQ!!X&W>
MH^3Y0&;P1$1ZY,X;+@)$LS":0NG$:S(/1BA_H-;79-L4L9A6MK8VZ^& K$2%
M8CB 2,4-;9:^EC??;CBA_H-QYITQ2T328XP8Q0]MEA)BX.N*"'H:1>)CIB1,
M2,4#E"NTP!(-(VK<!??[,4F*J6IX[NV(Z,-ETO #E9$&))D28M!.N*%U S/.
M%2+%H%](LT:ZX*9A (4Q> %N(WF!$GCJ8Z,01<@@=7B]S^:3[7WCW\K,Y)P\
M56-IC7U'#M6[-$5&8U[R\R'.6R4R#4O*99O90#7SHM!&^PG!:P.8TH<I-DL"
M2VS>FY!UVHTM."RU:C5^28YBL%)4TP HY-0:;-%)W68@-8\JRD3E5 .&+!3M
M'G&IJ8FF;6U! SVF-\,T'E%S#28MLJ*5$64W$FWEQJ.L>/W1YU_L_=&$8HP8
M1(X](C#L78L8D\.@1WE9%4 D&:ZEAMX4KNC58UWXJ39EP2%>>>!+$F\*#3>\
M>[!9"'AP*D119_1B=QM;B>G%>7557Z2F_*1 6)  &UUVC'HA9%11HYUUJ+6%
M,7 L25Z1:<',0M,J 61C9ZA3Q]$1<"D&;:"X#K*[8MFLYY^AT]'K[>O!=8 !
M7F<F;/.NH]&)VI(J%[$VPS*>4-0,LA AO1UU$8-/*U5""]4[5MJ8TF>H1TX'
M)\H7.8.?4(#[S-]GA[=^)0*14)H*R:YF9@6I";Q:>,7P727-4UT#1K4Q<VW1
M:)-\5),UCS_*:/S?_.N"XV2K"4=C&U>2(BW;,8S(J(7F@F.V_9IU >+W/YI/
MM?>/? +&%!)X 2?9@@@P1!&XZ][DTI1B["NK3+!BF)],6OPXVPPS'N5) 6Q&
M7 I&_946Z3BAB :6@F 8,$\ >/1CD\R8H>;VI,VUW;M^.3S!$Y;B3 V6N> M
MKA$J+3(I$D 2VH$!9%Y-[VP1#$:P2)&^,'+595GAP"8IE9B::JA?=S8!WG%#
MVV&VN;LG:ZN/JP4<1*,*K"5-ST<<<EF0QH;9UE6GW>L]&.3S!,H]M=DVC6;;
ML4/,4-)$Q29CC'# RGV6*/26(-*FJT3NC>0.D'ABDFHJK4J3>-/[B+ \<4/$
MT-$3-)B#H9X=/B#4=?C]T>=?[/W1@ FP!)X"^""+$$'@;=X((!9J:M(%1C>3
M<0.TGA@HP:*6828(!VE&\:]M]<9B4$P&IM!/5.L1QQ0^E#3K%)TXX^4YFW_9
MM=?-]NF*'^@W#FG7"(2T%6-X:-1NO8Q'3BE:G!8@*2!:2;QQ7KPV6 2JL68-
M%--])D7,XI:XI:1J(-NO#I 5E#4E023>#)&H &%4%7:2*8M$S)@7D;^C%.S,
M-): 8V>K^Z=V%RYJ#*P:DLHTTZ"),]&%!6HD9@*QS=F)UJ,6D:8;+NP <[0"
MF)72348UZL'+<>BVL3!@[K6W[L$$6-CT]_N?S2?:^\>_EYARFK6)OKI?J(P[
M%V+'5C-M.\&')(@S@G/K'REPT1HA!B_X'"L@*?*"E>5U#^E('H:D:X+J5@%!
M*+EFV86V2+_0ID53%7U2<5 MG&J<HD7EP 2U0'-8@[-]@BVHL<$QRE<3(S4C
M2I^$Q$@AH(G8OC*8+5<*^S26!*Q>I3 )VK;M 1(F^:P--#DJ-$-4IVB"-PB\
M0",.49CF5<ZYRX-57"8IIG?,QZ,VP72IS7YQD,0VP%,[5HMS1358[L5+)/*+
MYUG$JY$$'44Z'0[XP2A# ,HV5_\ Z%9!)(606'VM\WB,%UK\Y*'*H]. W)43
M!4'7@-#@LE-'*"Z*M4/$JQ,'9F&F18Z7 Q4IIG,$KFEB2K"9HN*5(]$ZP8W3
M;%:2AK\VSF(;;J,[-M_--5.F_ 9(7;6V3F*1#V9JH'-^L+_5/1/?37Q^Z/.O
M]G[HPC%&#")''I$8=B[%C$GAT".]*NJRU+**;@P1)-H!N.GMQ4*-]B52?HL-
MKL]E8QRB!F::JJ-F#Z,7,@"T6UUW8K6><H\Y! S/3$7)DS,&PC6\X0BIB[>B
M1<M!.X-3M4_IAF4UPXVN3W/Z,3.R?QP70GG ?*C,F&N('1,CI@7UPT%VVA!)
M,WB]^$^S%:<IF&00ZD PT"8LVC;MTZ]>"ZD#:565E::6@PL")J)*QZ48J3Z8
M\T4T;4D[J>K"4T9@+ %J8FK<9W X7DP .4])6,5 V# QLCB.F =\#%20!4H^
M3=;#,B6/2"8X_P#S%2E2M0YBK)#7(:KZ)L!83'5&&9-LU U-ED"&]'7T8Q4L
MYMZE)Y0:\ZJP((&H,'Q,D1E)U3VDGOHC.:5$GA8>^,,I4E38BQ[Q"!,MH:6)
MJVAZ.L;%IG?,=..3RR,RD/*,JB77?,D[%@*23?3JP:*A2&IWRPD]1I$>L'\,
M,HR^4Y-LQ"CA.=SYG2D+I$Q?!3., R;MJX,'5JMJ%.]JH/'')LH>I0853(S%
MV02(:%)F=/6#PQR3VL+D#G+8G0-?9GZT8Y)Q CG$J+J=H:@P=DB?2C 2 X91
M/)UJ:IW@6*M21KQTPBH4=F#$I3S6 FHQO1L/D,&:BZ@[RH(V:H(GG =%X,8Y
M)[6X#G+8G2J^S.ZJ,'*<0(U,6*F"-08)I(WS'LQR3F0 + 'GIH3 (-4$38D6
M&_!R'$<TDJ6(K0$06!]*\ 23NN-0<$$1,7$BX/N-O7XB"!U^/W1YU_L_='BD
MDQ))C2=W5Y>3$28UC=/&.^JEF"C>< 0 !H+=]'9#4I@\;'WSAF+$L;DW/>J4
MJ%:H4EB"L&:HL9(C3G7_ +<)FA!F:U.P,4@H0)E6VA(:H@V_0\G4"M074@@$
MKT#:VNLTX?-5V)-=FKRR0"1Q0BKFZ1>W"^!F5L:9,UL5Y-!8J05V=K-)GBA@
M'>95B$JFH%\L!5HBFEA 8%R0-@1<D@U'IY1)9MKY1@S6&S!J(7:VK[S3 XXK
MRM]9'*,\4KO$#T[P8,:'3!S,LC5YY(Y?FT YY8& X X0!;IQEY@1,P5.K-$%
M>B^M0-]-.W%2\F1+5UAM!%K7-4[YT]\XK#,:0Q;-="1 A8:HP026OT+ XX.8
M,IV$,9S&9JE @$,HI!+ V<F3%5K0<',0A@2UTH6,M%'/#\U6$7'UIF;1!5IY
M*D,6RQM"-FBIB26F0(:#(CZV&(+&.;HO4-/7QZ>^J[SY#NCSK_9^Z/F^1E4B
MIN<=!P'YGYN%)P$XW\CW1YU_L_='S5<G,;12.DV'M_#&7D*ESM-[!U?G[OG\
MCB.W$CB/YD6 Q7T8J/'OY^B=;_Z=X,PT8CJ)&!GYH]*>@W_7VX7NKZ2^M?R/
MYX7-RWT:_ V/M_#^6%@.G!8GQL_1.M_]/&3.=-\C@?W.,O/1[<UN!W]1_E!,
M8+$^0S]$ZW_T\AEY[)9MI?:.K\C[,*RN)4S_ "5FCKP3/D<_1.M_]/(H[(94
M_D>O&7F+F"1KO&\?IT_R-FCKQEJ,S,56: QN?P'2=!TG0Z8=::@V1R9) RVJ
M:D$F89F8H=F;V@C3Z)R<Q:I V1+ ,A8#B5#$Q<7C2^%RG82%UF+@%J=:5)EH
M^J#PPN6[W46D+)*K+'1141)Z!?!RXRJR&GE*=5@6-B)K#R-XB,-E.H)(&R8:
M&5J3]:DF-(OOM@H'3N4;*ERZEH4:, )TJ(&EY)Z3@Y#U.HI:B236@V02).U;
M2XU6TZC%)I#V@D@7$R-;3/LWCB,9^B=;_P"GDE8J9%B,9>8,P2-=XX?IP/\
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M=6!(G-AI=B0),ATBA+:7F!:8)QJW=(%R56 #<PIX=-B/4<1.2I1C4H!@.US
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M-J?W'?H:FNU.G.77A$S/1&$6M@H(!.DS^ /?HV"\BQ (O-]-T;N/B,*3$J;
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M0- -F\6Z]3QP$)57H -#U#D@3S[4Y>RI:-YW<<,*.5(RE(!0K*2+C:@\--#
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MM=T='>/RB94%05!5@S*L7L=HB9Z,','_ .;+*NH-1IK4)$FXJ69V03N,8J6
MH90L()+B%8-<\D5JF9))LP-S&*MI#6MN6#$YJ$P1LSH"";A0"%QF$D91+ O!
M!-8)YQ*R0;6(N<,Q^4C,73+H^436-N-JQUDZG *AR:UAG)(#H!==6WO)W3 -
MSA79>06M8G;VT-@\W,V%-M=-GHPK04%:TUYE7RB<T\WTM-;?IBI1ETB(Y,JP
MY18#SSJ()8S%+ D=0O\ ,>Y_-)]K[Q\2N2PI:4UYMYO;:X7_ %QRMP*6NM5Z
M=/\ UBO9KI;C!B8XZQ[<5$K4JDS<*2![;C2_>5JDJB\&T^R<5M)%&U2& JXF
M(T $>O @M]81(DP)X;O6/$5JJK75BL S,=<8&:#!A@I,!C$3,7@F+\;8K#5B
ME]C6X$]C7MN-L5@!29%1 $QOXW\;NCSK_9^Z/&Y/95ZEAC'I2.,[.[HGHG!R
M2-72) JVHDB8YO"Y.@G6<,*25X$CLMXL&*MTQ/3KY3)6K-0=,GJ%_'[G\TGV
MOO'&;E\HM,Q>=)_$844JJ\ !V".]=7S#!-5-,"9A8CZO6T#IPZM4@ YJ1S32
M3;9)B(,?G@M4C68&#:DS)&ZU^L88SE!*&)I'H-8B/J^[%^4#4D;?T7DK$26X
M?5 V=^ NRNP9"O7L&\\T:;5X(UB-V&$@[+>951L-S@3T8H#5BF[*I4T;XXQ:
M^H-\+S"].TPF!8V%AZ^/3B-EQ0;C+@#+<7$SQ,CCJ=<1=@%:BM"12UQ$&T7O
M%0O.N,JP>Q K) I(L8B!'L'9@ G*Y.&J).JL !7,R1&G"3T8@J<VQ-9V8$[H
MN=!'UHPREI72E(NC&3O*FW <>@80EE!((.\$$7]?BY_G7]7N'?RWY-P\3$VF
M-01T\<9C\HY>(G=KNCH[UFRE0$!E<DU$+8@7DV]6O1A6N2#ELA8!DS"HL !6
M*B.GITL=V61RS\F84C,B3&XQ,[NOUWP'(!VUKY(@FM;M5*7F&95F]XTF^*P1
M)84'*-:2).:=]&LEH(8"W'%6AS&!0Y67LDR2VS>G7C)WX#BL;2Q4Q#'-4[)7
MF@0*5FG9-YT!@D<KF<G/*;:YGTQ=0!TBH3PF<9S7I#$J3RE]Q>X'J'O/D^Y,
MN <PZM9>K]3[O'[G\TGVOO'!(%R0.LQWZVEA2NS'IQ,W$;.OKUWXK68J69B)
M$SPZ\%UB:TZ"6$3@.(%3I5T-:_"3.*EOM+;6XMU\,5K?:6VMQ:>/#%:?37AS
MAKPP2AV2PXQ5!CI@@Q[,5I!AEL)L1I@9B$ U 3I)'9KJ-^%8EG4QLD1'2)O<
M^1-KX8U,6XDGR"L4,K&D7 -O6#WV<O$Q80(51;U :;N'>!@S;U@$=AD8)),G
M4^2R,@YA#,(3[W0/Q/X^0[G\TGVOO'#H,P4F=9M^S@"D < !V=ZDUNW)%C(H
M,IZ(_ND GV:C!5S4:#)?+.J^B!/I=%NOKQ206M*W91]9A!&X6O\ ^L*C;(9-
M,NF328:9G7%#0HIYBL)E=J1%KZ;S5&*6OL'S-&J<[_UI?!1MO8-T11=/1U]+
M]QU8"-5)#<\N+I%QI]*KT8FGZV_ 5MC8(A'!,KZ6GI?N<,KE0M!'R=/H3/29
M.SU7G7"!JF)4B:8FG<(W$^1[HS?_ ,Q]K\OFZY.8^B'K-A[<9?<@%\PS]4:>
ML[_9Y'N?S2?:^\?FIS$75A^^@8S.Z9LEOK;_ %?SO__$ %X0  (#  $" P(&
M"0X*!P8%!0,$ 0(%!A$2 !,4%2$'("(C,3(0%B0P,T%1<:$T-39 0E)A<G.1
MDI76Y2508H&3L[71U.(F0T2"L;*T%U.CML'""%1THO!C986E\?_:  @! 0 &
M/P+[/RK1X^16UOT1^GQ^!C^G_P OC\#']/\ Y?'X&/Z?_+X_ Q_3_P"7Q^!C
M^G_R^/P,?T_^7Q^!C^G_ ,OC\#']/_E\?@8_I_\ +X_ Q_3_ .7Q^!C^G_R^
M/P,?T_\ E\?@8_I_\OC\#']/_E\?@8_I_P#+X_ Q_3_Y?'X&/Z?_ "^/P,?T
M_P#E\?@8_I_\O@=)#]>]:=?,^CNF(Z].SW]/O'OGQ%M?3 K:T=1@^49DD?E&
ML""'M7K[N_L\N)^M:/%JY^+HNTCZ"'(!*M_X:Q$M7[?R3:M;?EI'C]B7_P#O
M?[GGQ^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z
M^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z
M^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z^_N;Q^Q&/Z
M^_N;Q^Q&/Z^_N;QG[_H_0>O]7]R>H]5Y7I7F4OP_DK]_?Z?S/P-.WO[/E=O=
M/CK/B: _%[IO^*/]\^.MIF9_A^PRL^VU8Z*GK]$>;C[6W.6G-;DJSJSBY^A&
M6$@QD**^A*T%$(I1]PQWM59Q:_F+-@"RN3MO3S ''4HK]A*UO7NI:L]MZUO'
M7I:L3[O%K12Q)K6UH'3LBY)B.L4K)+#'W6^BO?>E.L_*M6.L^,V 87(P^OT]
M_(9DZ2EQ8CG'+L!=C;92?<45H=I:ZB%PG9]4Q-:Q%:]UZT>6:782*+SQ. .,
MJI =.[SJ,4M85Q=ORO,K::=/?UZ>"DQFR,U#5<MO-1T$)NNW!+)NKTT%5;MY
M[D!-Z/15J9%KR30!@DB)VBRM,NI5XZAGPA3XYR35@JBW3U1QFRLET%JJ]U);
MZ%[E8**S$#@HYLIIYK(G$'@485:#;N&8)(ZUM7\<?DM6T1>EHFEZUO68C15K
M@<DLWE<DS>-N+!40<(,FJ!1Q;6M9'2:"+$HD\NXVV<H3*!M,,*T-2PHJ=99W
M;_PLMCF#A!IHF49.Q1<MW:T-2JJ^?-_-TB%M%E Q:]Z3/2L^,>C"+[(MC55Q
MZ-*>AD*33I*B5EVK+RS/DFO:8[TEW;4[+26E([._/2U+Z56M624S@HX&_L6;
M(&ERE"*<?,?K)Z!&0TKS,&\BES=GE5M:,=_'%H[:>SJ>RJGS$#7]F$K5F6&-
ML3/I3Y2R9%I7;]4*K(62@%Z:9O\ )MK,HZ#RHF%@,1G0E8JU&BU7JV6CKJ,7
M7&:XJ%A>QV8\VMZKV%4MQ_$#_*C_ //'B/C3:T].G@^)Q^T2_$=C3_NM1+K'
MX(-??%VXCWVFW48/HFMR=8$1ELYF6"V[BG.2Y2DM^6Y+S:UI_//[6P/SZW^V
M]+[$*!MTFW6;VC]S2/IG_P"D?PS'@^5Q#8]@[-V4R!T/:&AF=@0FB[%/5Y@C
MMQYM.M>VM)J3KTO,1XQ<W=>]I["2 0:+_J67/5LT_"&]4Y0;1^[_ -X>E23^
M./L<ZR^4N+Y6AJ\H:W<Z^A:H_;^0^DB! >3:_P K583]-?-OF)P=H1:#'4$^
MH'W_  D/<4W^0 T^+U3/D<37Y 1D&:OH<<2!M*GP()K"'.*XP[99)05U\?8S
M!J9XJC$9-A(+G*@CX [R%.VKKXG.>2\A]D5G!<]-D._" ZCDM9HM+;419>4&
M_5K-AI99DF<CM*4<XQE*\J9\E_G/PHY+2U.7: F=#-=G?+E,.5'IB9-HLE/G
ML(:Y.FI=IE8ZS?GE#;P5S'B_)-'+Q&R/XMM9S9)7473MUQB*G9?)F1-*#BV2
MN$%*Q>UJ)^8:TWQN/J<[$KD&]%;.Y2DSC-9NCBK9WW)P!TNVIL3B[F$\:/9B
M%&@78Q'V3-W]N&!!^$YV5R'%QMFW'>5AK?26KJ6%+U\:%:TS:ZV226FO3'LC
M)#7&653_ ',S49(KM\:KR'<RV,#C.9'P7JKZC6>3D>^>'#LVKG)>2IRC0<Y%
M*:;60ROHKKJ,4K5%83ES$Y(R?D:F5IA^%/X,ZO"1Y%Z$,BMD<3S^0JMB"\.C
MN<"JNNNX)VI@ ]"YYT4NJ?LY!->5.96NG\+>56ZC'.-@9/9!][,]19S-;VIH
M9-G++I':.RO>K2P;L,$)1.MQ;^QK\KWU>4H%YNKR+B.0VT9Y?.$1@."QE93)
MRXW&\]#*!FZ0^6DQCA<(YWEU",O>6QZ%_D^81=;X2N#.9HB<S:Y2 *$JJ>M,
MAR+>A71U,^6UV&#G\FB*+MG4@?)6N2_P9 3U\3,U_;^F52=KYY6OF\?TDPW8
M3%H9K-PLLEHB(@V1]&SAK6#DZ+%X6F/=-B<E%\(+'VWX;'(?3/$?U+Z1=WVC
MF*W15TLP^C"ELEGV;Z;T]U(3\N[+%"\M\WDJF_!<[&8!N4YGHZ.0^9GD=CI"
MT,77[IX-R(R Z&:Q,ZK*DB$WZ<"M,R59VZ,-N_;'35,7=R7-MW6%F^JF6<ZV
M'5QDT4XVZB4;.0VH,2SH[7CI2ZUE5?LA_E1_^>/$?%F?!JK$Z.L]5E.GTU)>
M/E&Z?_T*=;QUB8DGEUGW6\6O>UKWO:;7O:9M:UK3UM:UI]\VF??,S[YG]KX'
MY];_ &WH^+V_@\$;M]9B]NG\G29K6/\ //=;^'K'Q-5/.PN0<E+A!@NU."#,
MN/.O9?U=%)MJZV5Z[0NKT/Z#)C0;'6X8,(1&%Z%]LY&>318/D^TLS+(PNB5T
MIE/4II$:+8BR=CVL,)#VL00.Z;_.5KTLN1D'I6" %<ZT%J>%S6I6Q00>L5J;
MRKS(_-K6M2=O?$1$]/"C6OE>P](U+6:RO7 TO1V@EZT'+RM:KGFPHH29%';6
M;^7UMV]TXH-+/U;J[>@OF#U5!HEST6VBP(-=#S'PO"'/=WV.%%@-*?6O%OD^
M,OA\9^HYI:B)=*IU:H0@FFN6!'(V9O05-W"FU+V HNV?RR#M44]T?>'J)F\V
MV:\3-=CRRC\ET0@'N'YVE()VB9#;S!=XI[^D7FU;1'Q0_P J/_SQXCXM[?P3
MXHOU^;4!UC^48MUO/] 8H_G^)EZ(=[CR]=C0MDI+N$V1'MJ5I4GH+VKBD4H6
MU;C\LDM>F)<E!4/)9[(83:'Y3*AS+,"F:VD9P$L(HYFDVK/82MJ]:VFL]/=,
MQX2R EH"S=[]QR5M:H0@"1E@O97WDD:X26J.)KYEHBG?3KW02N>=EE2.SRCN
M*"19O\BLW\Q4+NB,7:3OI3M<-WTK4D^7:\BIXHY&GW:EG[KVQX3/\VA4%;UT
M+:$S"\S<\V!Z.E;$K%?.M?I;LC[ ^2#>+8OMOV*RA=*@QCO90[M#@=JZ6QZR
M$=(O2Z:TU)>U8F]1Q<F;R.VGEE6U2F JH'VGZ[SE>SU="07,$I7TLDI!+0Y:
MA.[[FL>(MTSY0T_:-V$!,/U]$92,YV]B03.[S6GUD@K6E[-"K4%_-BH^LUMT
M'R4;Q;%]M^Q6<^Z51T%>RAG1L!=APDGI(1TBU+IKVJ2UZQ-JCK<N6C]L1E]7
M2G2BZ(L4C-4?1!EA>S#97T@D&Z$9YB58.1>]*4(*8)-AJVQWO:COLO0U-E*%
MK)1CASXL4E?4MEH/0GTM98MZ6O6)^9'4U_CX'Y];_;>CXO$3^+P ?[P0Z_S5
MB/#'&_:7LGU#*;'K/1^O[?2&@O9Z?U2?=YG3M[O/CM^GI;Z/&+QWU?KO9" 4
MO6>1Z;U'E?\ 6>G\YCRN[]YYQ.G[Z?L<NS]+'W6P[?(V^2XNCCX^AL+/UU0*
M#)FLE07.+)<296D'F;!44;K7 >&JA&:P_A2T]7A+T:WD2SD#'QWD!P6U7N*!
MRM/V5<.6!3<)??(>]W0+F]0<*_(?=5=5X.2^7CNAH?<N"KIJ<C^#[>JRBDIQ
M:X]!OCW*?2^F'FE$>BK_  _45.?0TPZHDP+O: K%XF*G'-8VCDYWHUL7D/P?
M\A-E7LURMDX;9.[598O"=Q)=:MV=;0B,@R+N79FC(T2V3Q>.F3V34T[Z@2.H
M8>SH)YDNX>IGH.MO9Z9UTY!J'4O62%K9?Y+9H$I0AZ\.UM7CW(#;E^+\J9V@
MJ8^Q10&IK9G&5\C)]NK)$34.<6(2IV+MQ&:U>]FKK7M2GCDZWVHZH!ZW$>+R
MGG9?P?<O1"'?S])N6:WEL6EH/<@SP-CHQRELBC.K'5E?W!.3QR[,R.&:!./Z
M._PMFJI^'<LG#!42E?:FR;CZ*N<?DPPLII0_C@+]W,6HV]4@@LWE#!=RG3^2
M+X1LP>9I\3Y3*^&OK<@&3#Y/D8>1E[CXV$LXW;CUH",<8Y:S(Y+GOK>2>KF;
M$>RN_A+_  /2R^"/ZAAY6:%4CF9F;*NIEX?#1MO@TA[N?M+*"97T[V)W1:JZ
MG';EX9L#3+\(//:OTMP?DHA1Q-R-LW'T6U_8U?)XY=I[$*++*.F70TLD.K2R
M^K(LQ5Q#21PQ87),C*A_X.^4[S6%JWY5HL)LY68JQCN83_L!G$MB[Y5B(JUS
MV$?5*E&8!.6ZGVJ[UMX>_P#!\[E/"X;MD:H\F7)-R;0SBYR+R=#&NF_.N[EN
M, TY&O2[VB.V=8G.:CX];+><Y"=Y5Z.-M( :PV,[$L(8-GV>%(U/:'JRWS1N
M68"SZDIE:7\VWQ@_RH__ #QXCXI/S?[_ !H]?W,KUC\WI0V_\;3XSM_TGK_9
M\LSZ3U'I?-]0DPI^'\ECL[/4>9^!OW=O;[NO=&CO^D]![0E:?2>H]5Y7ITEU
M/P_DK]_?Z?S/P-.WN[??T[I\8[(*\:T-=/DSFHNL[I+-.YM3IKKJ:0LE76"6
MS(V*3-!NJ-0O-*,D5I6*%\<!KR';2T,IPVA]M:9'LO7-\YJ3IX=]%"A&W0A3
MN-<_9 *>C'2Z-Z#DME"8=-[E66WNC>Y.=G7'R?,LN'CA\WR5<YG3JX)<U6]_
MRM#/R?-,9(8:L652I2M:(+^MS':LX/LS9C:YCGSE Y/[1\XVOH<>KGZ&IM-'
MTAKD%NJLLJ72+WG83SQ,.4N[344EVX-\),O_ -I>56Z076,#RG>(<LBW;E18
MZGG#Q-2TS1$&B#TT@;D1@7T>29VHHOSW9=0/H:644R_JL,ZJ.B;-$4TT7%R6
M\G*RLF!*Q>[=$(6>:MK(T:Y)FDY.#BW-!//L<GQF:FESN^U;/<TSO$1U3!>@
MYUP6<;KFB8CU-0C)T&EJWY8E&M'"\!%J%.6\<0U-)X.T4KU&>2L6TCH>B4]&
M=T(J0WLC^Y:W+Y#(XY+*6C@GJSS^NT "&SCG,9 ^39>S8DUG+LVZMGCS:>3Y
M])DA3#K2A;UX;F UN-A:!I[++E'>38*=DEM&Z?ISLB-H58K\FE[D ,)&QQ28
MLOWS6EEC"YFJTXAP<>*(V;RCC6;H[%U^2-^92.0/GTPX)!Y[2#_;-X<<!YJJ
MI2RJ] ]$G'>3X.==SGV7ME*KR;(0&QCVQPQHL'^[168!?0ZW<SBTNVV7J2Z)
M[5MV\<;5UL=7&0Y1S0Z2SF]CJ$SL70SH#F5A!EX3**I6JL>F3L =E:7'%A#I
M<4VXVG;DZ(7XX;S7'ZAY9EV]/H6AXW&P,N+ZE@*0$7IJYIV3B73O4*PBA+6@
MH5V&=MV_),SVUPB;TU2L>K"X1=WVG4ZK<JMC GZI(C=+LR=JN([)#>0N87Q<
M#\^M_MO1\6_S_%84!A\@U%4=?.PM+7S@Y=\[.T]&R44 Q5K65TR#6IHI%=:2
MSFE5J&[;&DPCB%]C-47R?4YC(7R:.O+RX8S"@@'H00A:+,O3H6(>)(*1C4A?
MN)-_-K6/B"?;KI!="O92K>3N[N Q=6Q(-Z=@V%I9UV@T+U((;,FJ"]RV#%),
M7O6ST%Q*))A&LJL"L4$  JQ08QUCZ*UK'3],^_[T'^5'_P">/$?%)^;_ '^-
M+^,O_P"D7\#3049>;-W>4JF K+!>REB7\L(:W)?M'2U[=M9[:5M:?=$SX(F^
MHRBV'M\U5P!5F!=]*DIY@35H2G<.];U[JQW4M6T>Z8G[%>7HZ96?)=&EI9QL
M^%I3F_R).)JK[,- A@BX:S(%KSY];6H.8[)XWZ-A[7V>0K$8]CIY$VLI97OH
M\KYH7666&TV*7$4=<\=8@1[WO3R^RQPCX[ND,J486A4R-"Q%C%I4@A'I5>;!
M*4=Z$'0D5M>EZVK$Q:)\.++X6PPQG36-  <QTID9MW]L."H&;K3;RR=L&BG7
MLOT^K/CUJ&%LO)_+^ZT\MUE;YO\ "?/A!<7S?[OY7R?W73PE<>#M$II?K=>F
M6]:K_P S=C[BM )AK[G'<_S'?\S2Y?J5F?$?]&N0?*#ZF/\  VC[UXZ=3Q]S
M^\/RJ_._4]\>_P!_@;Z^/J'1,:BPG0Y[9%"L$-"XP#8H*0W,1BU04%6\WL:T
M"B)O,1X3 ; V59><J@M=K*T C(U;OZAK:RWRKCJ(UR#I%R5H$UNSYNW0'&MS
MU69<VA",-41(:"5(S=,#R8'"9DMH'/3J-CS!18'<2D6O7RI:X]V<CWD<QUU1
M^<+*%&R7T$E78(FEZG1# :MTCM*8OREI\RXPDMY45V28VN3 J:OG/# 8:LB]
M1 +"KJV3,D(UKSZ>I;")6K$Q$@O/S4T44R>3-<>.YFA5;&C=IMV&$@N-K(,C
M3 BX^.(=J(0Z1[UK>97YHMO"[2V=S.9KS70X\WECJFYNDSDU2:$R','G ]+K
MA5[1.!(=H B@9-[A_-CS75L/48RRWT YB*>!<+BBZI1!JSKJY66LK+[XO(B^
MC;SF="%.A3314-:C;;S7U53&,N)EE-@"Y6%R7$P 9B#J.Y@%$49AUM-Q$'>E
MXBU+1'Q,#\^M_MO1\6^PQQOVE[)]0RFQZST?K^WTAH+V>G]4GW>9T[>[SX[?
MIZ6^CQB\=]7Z[V0@%+UGD>F]1Y7_ %GI_.8\KN_>><3I^^G[#&AQ3/YCQ_EX
M^1A2=4IEZ]^%<RRJ'26-J[#;"%N,^73#]3Y#D,JZHCT*J.'F(S"^'5>$X3&9
MRK.^$7F=8WE<5K.RT\ 9=<7H;;<+AS649(15=?# R:P7(]3Z(51$-XO<*&GV
M3G\:7YW@H<(UN/'UT\_=4+OB8?TMQJ>;;^IFFVQ,/8(V!:Z F --AN_DHZ*D
M\$P^29K;&5\((<C1:XH]C*9K&SG MD)*WID(>P<E?:J_Z(.V),J[EVM.*G3T
M5W'G#P R(&\7%"[G4X1J<.27UD/4^8P>=G8?-M;;0VY#I:V8(F>Y5!<AG;F\
MGS?OP?Y4?_GCQ'Q;_F_W^-+^,O\ ^D7\);J UBMHR>1#<H4B]O4+&5OYE0F7
M)/09[37M+3Y<5F>L=:R[NOC6$V]()*-.A1KU].L%6GEU,9@D=1@K-NXM_ES:
M8Z1TK'A%31U%=)=I3D8]K%"MLP>OKP9KV56MRYX$#G%HXPEC6ARM >K@@#%#
MYQ1X<:'*53M*XO+0O#6#RQ!!G4Y!HMZ0E].R.6H\7"OZJP'Q($J<A8'2!V4D
ME_'(AI\IS%RZO&>*XR]!H\I .I,<X)T _*RFBT3(N&XE_-99(41*4:OW2:T7
MVIY(!B?MAP]'RV0<OE(*:.*!!II#/542"3?(Q0PK,ZD,+#S[CN&A#R8%E,15
MO+8WM#BNVMFT*;66&YQ]S9;W:F52G!LA++">94BC^GK8I!^9-=#-\U8#QJ/B
M?Q,_/T-SB>RS2<WEC&RO; @);T?FY3XRGIQ4:S5;X*KWJ_-4&>BJ]C.IX)F.
M6J2)'G7(>1.C]+R:\D2T(K54D5]B=A6+>6Q,UM/=2'H[K1)&H$JLKH<?">.(
M4X8\=C.Y:?0O4+4]&4:CLOC5RF&*@UY984C95I)[>S''*CSR\R<%R)9R-37X
MAH9JM5-V&"#P1]C=8]5E!5"6P[P%;S&!UM4-JWN(?ES>VP+;1+DM\E+O2_5;
M9J-9<FL9^%V %RANRW JTK,+*L+>88<0S-8+<6AR]OF*79;D9];-75S^2=_I
MV]%AAB'_ #>/4B"53)Y0P+7)6[).MV*A%/G,H#Y"J1H_#G,*67:<O9;KH$TI
M:NLI24YR$N-E@ #HP%"NIYUZR[Z?O:IXY&\/?6:%R3[4U0!E/=I[-]B>@NQI
MZ'?F5CHM*%Z9U<_V@R26AS<:U//B*GCE.;V?^U<O-OU!R7K&1>PRUI^L/ZN^
M1-/)_!]\Q\_V=;QA/8VRL?2XWRKD.D-.H-D)=5?7T\]E?TA+9E0^24 SA="\
M50LT\P50'@E:D9RLCNKDY++PEJ33RIAAELC+L6ITB.Y8EZY=21W09;-6O%NV
M:]/B8'Y];_;>CXM]BSVOHHY:5+4I=O1;715K<D]HZV89((46O;W4K-NMI]T>
M NHM+NILT@J[:AALK'%;ZI G#:XBTG\5Z6FL_E^QR7#SN-8#/VNBQC^>]S%K
M,MHUWY<IE+KCGB;8!/',E9>0&=J&&#K#&T7OM89<M+>SDM+3U.UO*?YF77=G
MD#5ZV85&+6UW#QHG89CSPK4&9LQ1D(.][TGPUGL[V,N^BH30=1-J)";30"*&
M"NM+7/4RZ@@3!B,EI4-!3!+7BGO\%=^VSC7HP76$9OV[E^F"5P5CIC*?U7E#
MNT&ES+4M:+'%2Q!1:M9GPS93E_%VJI+6<<LOOY1H43H08KMLR-NT 6H4P1V.
M7M%4A1TFW=>L3@L9P4-/[8] 26>VUK1FX=:%SF]2KC6R%+4J-<JJ=O22%1CU
M92"J/I29)7.U+@*CZ_/4?LJSVP93U2PV) Q-9FD%7[_++TGM[JVZ3T\*[6%Q
M$6CQES4436=+NW6VF,TSHD3[X<,6(X&<T4V*V"A=@3I\\4-%54@G932%/(\&
M"XU;7UQ3KY\$RJ4) KVTJ>H[D:T+,#M+,"BI)BD_*]WA\J?(<-L64#U6H1;6
M0/3-6\LA?4/W$Q:J8/*$4GFL2,?EC)?N[:6F,A*O)<0_MOU?HVE]G)*E%E9K
M3L*?UT?+8-;TRM15+)6*$#\FU?"PEN6\98*X4*Z@@;V44C1V2W N%:@VK6.4
MYQ%"$8XM<I1W'2)O2T0?5GD>#&6LU*+.E.OG^@7=CMZIG<]1Z<34>93JO<E2
M_+K\GY4>-S(1Y'QE;:0Q%M% ^ULYZ^(PQI+OD0I<X79:(%?TH&M7R0Q<.>^B
M<-B>JITQ5=C=X\#8UU5+++BTEPTU&3U'6UL4#3'JG%3,7[5.SSKWK<=>MKS[
MZYPN2X!="[9T*(CV<Z[EWE>WU*55JL2:S:_?7SUHIYPNZOF4KUCX@?Y4?_FC
MQ'Q;_F_W^-+^,O\ ^D7\#3049>;-W>4JF K+!>REB7\L(:W)?M'2U[=M9[:5
MM:?=$SX(F^HRBV'M\U5P!5F!=]*DIY@35H2G<.];U[JQW4M6T>Z8G[&7J<CV
M38XMLEO98$\F=9J5 F(NSI/#N]F552H6M87\DCK3D>;<2L4'6Q?2 R-K90LR
MU9!I#.:%[>R4F*5OI99(7?%*["Y5S4:%5Y<$-KWMY]+T\QGTJ.O&!W)T0U-
M%I"P1A 35P0^-59(YJ$]33M#6+1"Y(FO<(D^/33QO>ACR):\B<?0@WI:VBEF
M?*]/W^16\Q23=/+BTQ6;=9\3Q$)>44F:F#/&!7UJSV$I=Q@4XM9^K<=B-&IZ
M;I:EKGO$Q-K>"C#QS>*0!_3'&/(T+W"SY,,>G+6J\V&?R+5/Y5XB_DV@G;V3
M$^ YS&-NM+@>$GLCS0%&YF04MEI(S>Z#U$_3%BURT:6CO@!@]P;=2BY0J_LM
M9ZF&^PHE4:*^GI:/EZ=TJTH&[^.&;B#7U+)?,H.*UMVTBUATLUCX^L]O[R>K
M3--CCPI79-2R1G9>0JOI:17%QP&1FB #(&WRBUI2PI*VH##V#-H=/7+"S'2,
M)=W6:^K#0,D7[HB9CSJTZ])Z>,C6P\W=+D.\>2UGFF*2^#/:88;$0!-!3/36
M&.M0AM2#4H3YSK:>EJQ'(]IC3;4OQX:9;*!RPMU:KH,T14Z,WU4Y%/J[]&.J
MY/*7CSARP3[G\#<C,Y$31<VA((-C4B<!@-@$ZJ#/Y5CL;5VJ=HE0V[?(J2?>
M2O;XV\O9R>0); ..N[.,K ;IF8.KUH$),YK.*TZ)P\P(,JD7OY@B"KYMR?,[
M.B_G<XS'LN<X-3Y$%Q1J0X<$N+[.B94ILZ7,\X_9W0!/-.<$E"4-XBVUDY.?
MRIU@6SEYF,_"M&<8?J%EF71[#JR<7ENE&:$$-4 ^P'SI:VB8\&79P-B:C>]G
MC;'EZ,IN,68]*OZ(]U1PQ5PO;"?2(NQY@XI3NO%?!575CJ-!MVF6:"0!Q6Z=
M>TH2UJ2ENDQ/2U8GI/V<#\^M_MO1\6^P;CVN=Y=(YUF+ESB+B:BZI(*.*W96
M;%VS:/E]0S,Q]$U^GQF8")&"IY*@TUR-V'=FXA?5DUPB *U_RS0(Z_Y,?8Y/
MR-[X-G^14L+B_P!K&A1CAD'5>X]?0.9I<^AR130S0-,%SYB1B@S @7HZIV5J
M(O+V6N$MSK[]?@^O6RKO%H#9GCY%'-2 %8Y'!QJK-A-*'J+06UK"O$1:27JP
M\TER?1HGS#=YGEPKH<&5R2TUTVZ2H6Y@QR:^S5+08Q/0&=%QTQ0+7]KI9]1W
M5^#9%;CL9W.T4--9A2JO&])EQ-3$/CZ3QA?;!D9NFL"VV&5;'Y2@ZK=_O]"X
M$V@G/";<=JS")L?3^#KDB^H5?VG[!XZ4@&F#D3(VNS?/TLUW#JYG-%2HSR:A
M56/+N._C'7KFZ.WQR0; =C-Q='.S=A?1,%6V!NIDUGLU%BV.<+4B&5ROIW&5
M7H5=LM7T^]?E7%E$>1ZDVKI<IS:80T]]?R%EZ6&-)N^FFXQV7=TUSIU3OIV:
M:78\HJZH$^$^Q)M.5$92'+ZNYDX9,8?;*^@9'V@/D(]8*5I6OG4RY4-K CIJ
MASF/6 XSFVXZ>A^$8/*\\KJ[^%(^4,[.=?+!7*[] ;%0/F)&YIVW8Q;"947K
MVOFGS!IJ%X-L2K3X-L7BS5$=KBV8S313U%F#$SV@[I.QK/KZG0S2DI18KHZA
M*8%&"%KQO9<R-75]%M\DN49;\/5Y$/.U<M)%-O:A#31XZTR,ZYH*7*8N8B$)
M$(M9Z6:5(Q]I]UN2)?"!3DE &-QJ-/4QOM^'RKT8--75:6';T792P'GEP^M6
M[:]XH"Q>>2&XGHV OS+<VHQ?:G&_6L);_&LS'6?4O[9]!35QR(,":"=]**BT
M2^S7WHBW?N@SN&O6S=GX/,_CF<HEM8ST93"%^5=B.FSN;.>T4E@:B$7*K&FM
M0Y#!ATX00T3D>3;CQK&YI@<0S!/%>P^SBY\7*#DLQK1&C9@@4&1$W<NV%&Q)
MF&S5F,\_SI.0G#Q#68NS\)?"N0JM^NXE##N+QP>*)L_F7Y"&]26C'>D"YX!>
MT:R_48O-T:I_9'_D_*__ )_GGXU_S?[_ !I?QE__ $B_A+=0&L5M&3R(;E"D
M7MZA8RM_,J$RY)Z#/::]I:?+BLSUCK67=U\:PFWI!)1IT*->OIU@JT\NIC,$
MCJ,%9MW%O\N;3'2.E8\<< ]M PM7CJUL@T.I:;"K^7+!F5F$[YBC]J.*]\A.
MNW1<3$WH4;(XK:G@M04?J?)T=/&XN5V S<N3R%;OV/.\KL#<J@ZLR40JFA G
M)$^A"V\MGQM[T/TWU]@W#Z"R0*:0S@C OGD9>:]HJ))=ZWH+URZ 99(6S _.
M]&/SXK/_ $@P5%P?;B;/80S>;R6"\B0NK4KC>E[0:$X9J5VCJI)RD'R6#C>L
M>1K'UF>2;1[2?&?5"RTUORGJMVJ!95/:-E5G<+D77K:]PB\J]O3JB+T%%A3S
M#TO*LT1.1AX-16L(\H!Y-N/KK!>]3'L=CRJ4,'SUJC8=M-*4GS)-$1)?(Y J
MJ('/D.8>JLAN>7I)USUE[A' \V[--5$RQ>P;(%4B5=[QO=_GS.P1?62C/T-9
MYP.H0.I52H7#$;IYH8SK:<6IYD+DBF??Y^+=GF Z'GF&A#R.AE\IPGDU7#*[
MXU%&&/2VA;4$N)#7H WH; 8+ET9O4;0;4O-?5BJJN'D&3CZV1N8NP+4#A;A\
MMNN=C#REZJU?KLZ;[F31<?D,[JR/J;DM[P]LG)%/MN3*"/@ZT^,5@N=R$'^%
MG63F@UE XYEEQEK=:32 I:TN#LKYM!!O?F.8_N(Y;>Y3%71HVMLFK_@[4#H&
M,:^9E:%1BN.MA"Z38LFKTN(8NA9S,ZW,C$[.1XNWI%S0<A29J1=#52<]F']C
M+D"N.[R74DDH\50#Q@>6S*BDK)UWLA2:\1Y=@7H@ER^Z '=YJ&0$&331<TRI
MWDI+N&,0K-2>? E9#Z<4O8,<@1H</%,# %H,*;_DZ3.?NBVBV% LA@]$$E^]
M!2[@%F+FZ]%1*S4E>7/@Y$FQ76VN&Z22PTMZK! X%IEVMO/QPKC+,$GT\78B
MM^R_=<?R._GMR. V,4SGV[9A0 T?(7UP;EH0SV%])!2PB:@-#V?HE"(@H#>D
M^<>B]O**<][%,<ES&)>>MR%):;DO:?QVM:9M,_EG[/'!S'3N4(QT_P#U;3#<
M3_WH-W?P]?%OL$V>0.^S\T1 A(SZ=MKM(>_EBKY*0&3SW7]W6!3$?3:8CPEL
M91_59VB"C*;'E&#YP+_5OY3 Q''U_>E'2\?CK]CFV#ZS "K@IY),HOL/0(Q!
M]P;#"UM"?MDH-L* U"".)8>?=ZYJ&H="H9";@WME[BT*\HPM39<JCQW9LR(J
M-,HBN;F=W*"7=<TK;2B*@85L<S]($N!@CH0!<9V6<&F]Z=AE>$\AVN>E%1=X
M@.K6Y"T5TT=LRQ9735#%K^2"YJ!AMCA:W-L;A?(\[DW&'^50*N!>+\6LG5*O
MG.5U]/="51SUTI@=J/-M8XBUZ6BMJ>'=/+IGYL+I9(;G6XV[FLOYABVS\*N5
M2,H#6_FE**5,B<:F@I>8J).9[J1/&:8_(-+/"SLZJ!4VN&[H1;[&<BUZG(]I
MZV4J++-GG"1@UJV@Q2(L(QTN-BM&K4TF"455<>\P>-N$$\EG&@#[F*:F;(N0
M*IDM7U+&';1$$5H/>T F">-)T6I>JV5F+;+16<S72@F4Y9BB;^=5Q %]A5LJ
MI@JER:NPPQ%%Q=YC!H3B+G'==X2A>:?:ONY;&5"-KV)CO:5P/J;>0';0<7].
MF4'DD2BZ[4W)1BI 7'Q7$QG<!13D(=KSC:V*_IE4+C*>NL6ME>1XP[A8&2@?
M*M2M@6'<TG-4D!%BGY*7V5L: +VN-3-W&\EJ [-L#VEFZ \\P)RW7O(("2LV
MLH)Y6C1K1<;)F(IHL$A==]NI!X^V0&@ME%J'2-B,4SK Y!1"]Z>JG#)H>16?
M,)T'\KPXT/5N(*6:OL$E[,U\V[&4W>PE-'-#HH*FV$VS1 %3Y(W1L,%77#-S
M,KT*!EI]\ V&GD*P3CO):G$_G+>M:1<5G(]4@["?W6!1T*[#BWSZ8SB^5XTI
M/39555V4LE!V.-<L97T8TD,EK/-8@^/P) SK&GZ51)@GGLCHN\&;KZ"W7265
M]5YN2U"3OJ,[12I5B15/%0&=57"[20D$:#)$8!(BA)YG:4<V^S)9_']'YOC7
M_-_O\:7\9?\ ](O\543CK;8D0PND-EDQQJ+QTZ 5H6]J@#';7H,45I'2/=[O
MO],VSK=LX9Y:&A+)I2HS-;4EBBLW\BIYI:U9+%()VVM'=TF?LH9*E>IWF1@K
M^.*5F>I36_R BBY;_P"12?"J8*]@%5PKAI^]$$=1CK_FK6(\6^P3&Y E[0S2
MD"8BWJ&U>X@+^8*WG)'6/';?W](+$3]%HF/"6/E ]+G9P*+)K^:8WD@I]6GF
ML$*<G3]\4E[S^.WV-KD''_9#<\D5QU'UM<[J7LXN/1P0=!4J:K_M*EQ.="Y)
M*9<WN"+5V!06:CX6MT1G$XKBNYT:E==[.Y&KH-#R:*;>.-;'9 L_BEQEW4[3
MITAHQK@- 5Q6]6ZCMUP']H:I5$WU7W5%=F9H05'=)?V+?V&8M/+NPNC&P"#2
M7R)&+RQ0AGH#X\M+_'S\:YFBMIO@1TH\J0)\JSF*8%;TY"(96JMA91\M\)0A
M+H5NH)GPJ;9G+483^US$2Y$;EW+-"E#([*#Z&J4_((+D\!45MFVD8Q9W*$?:
M6BJ#RI36OG[.$+)#C,9_'>7ZFEN[P^5,:HM\F]C.CT7\343XDBEI.T)R-R[8
MQJY:"3^?7(!-*6)?/R,HMN/D'Q#CNW@\?/31TPWV;ZF=&&N[KB]DEIC55R^\
MIDU;;T,OWKY;*HA1-YE W'\IFO!<7BHW%MS4NQY^<^-IVP[?:R&R8WU+-HA?
M!>SN=>XM  ;'I6E S17COI*<_3YK/G<MY'H.5%'&!<?:S[M:7'&6GV!WI+8]
M%IRLN]>PBZ/6.SB#A\GC6MQW#G2MI*;C!2%8MJAHK:09E\+11-.?00VUY.X'
MU#$^1]QP.&KHZ2ZN0'CB_%7^-W@>@ROI AMA-L=U,T6/9*! MGA4H/VH'H(]
MV*])5HJQFUW7,1?$^#WCW)5\S1"\U5K7E[(/C(FTUFE5$\CR4#D@X1Z&Q5M\
MH;A(I07EEP=8NAA*^AX5C9/'YQ-?0= ZZAJ8^LT77?65S&<S[LX\KF72SB/L
MY![/L5>.XJ"GC T$\[!7A7E-^1; F>9<MW'36GC[/'.^-C;R6V-%BRC535I=
M?)"M7/ CW,PS+JGP@AW',=/$YLU0^*][4,+;KR&,')0S<Y/()GT"V_5K'+HY
MWH]5AQ@P0!'F7[B6&I32L$FL:GJ]<J]>P)-1KYYWR8ZVMZ<1;2NIWWO>B@0#
MF]NR/L]E/JQ/R[?B_BQ_#^7\GY_HBL?BCXU_S?[_ !I?QE__ $B_[6Z1X^V'
M5%--%L78JN2.EDE+S6TS>L^^K+'2.Z/K!%T'/2]S4CQ;]J=;6BL?EM,1_P"/
MCMJ7S;_O ?.S_/7Y$?\ >M'CZLK@_P#B6C^&?HK^:O\ 2GQ%:QTZ?'O^;_?X
MT_XR_P#Z-?\ :G2E+7G\E:S:?T>*PKG&K2TQ\^S'IQ1$_NNI.E[U_DJ$G^#P
M'1TI]>_3I8?=3HLM?]\$<]9L2OXC$]\?6I05O$5K'T?8[9\=>W]'CZOZ/'U?
MT>/J_H\?5_1X^K^CQ]7]'CZOZ/'U?T>/J_H\?5_1X^K^CQ]7]'CZOZ/'U?T>
M/J_H\?5_1X^K^CQ]7]'CWTC^;Q'0<?S>.E8^+[[UC\]H\4AEY1>2=_E^>R$7
M?Y79YG9YEZ]WE^:/OZ?5\RG7ZT>*R%E<L7^I(C#)W_Q>VT]W^;Q-/I_%XFW;
M]/\ !X^K^CQ]7]'CZOZ/'U?T>/J_H\?5_1X^K^CQ]7]'CZOZ/'U?T>/J_H\?
M5_1X^K^CQ]7]'CZOZ/'U?T>/J_H\?5_1X^K^CQ[ZQ_-XCI2/YO'2(_;7O)WV
M_>C^5/\ /]6/\\^/FA5K_#>>[]$=.G\\^/>:T?Q.E/TU^5^GQ\N]K?QK3/\
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M\,L?,I[5II[S2?EL ]FB&JR4@"^:^O:5EO5U8%C'JCZ%[$MGD9LIO<9Q^1B
MY<1F4O:5"Q=,C00JC<\L@+WHQ5-3K0E1R#N')2<EY%H:RS=?9E%2\1"OJ79V
MO6<>ST:9FH4V?3#IF7[Z:9[V<T>VBP:QGF;F!"X9O[$\K[.1CVQNK9C&06P3
M8[%%);5(TD"(&5B(Z9Q:DMY+DD]J1?,\G7_]G_J=/[;O9GF^UO.5^USVSZ'V
MUZ#T'H_:?LSV9]S>UO6>J]=\][%]/\U\3$T)]U4M?.;M_$7;"6\3_!-:S$_E
MCW3XZ_E_;6Q;_P#MKO3^-*]ZU_\ W3'V>,-LY;975>/YOII,Q99,;BM23 V%
MH4\\I4SW&8P:O F8D0BTK6TR3VX?+2=<GD=[V;:RQ6BZIAVN:Y9&,53KE>(9
M3N-Y@Q7+Y:_DLKJ67QRHY68QCO5,?D#-E0]B3!9M;57LT2:FQE\I6:$RZB(I
MUCM)0CUK3:W+(RU!:5DVT9R"&RU7W) =THKW[#)W);S$PUO<=A104^82HA6F
M\^,F]PB3V3*6MKH@'0 @]+5A UUAQY2C;:OSS2U/+[;=I+*KV+/F?%[:?/IW
MMW%3+,^7,_1-Q6]\KFZ>[S:>Z>E?-H6E8IXDR1.O;'SR]^D,K_RE(^N+WQVL
M#ZCGK$6\LG4=>)?R_(_]7Q_XE=/'.-5^@R"&Q=-)RPJECM)(8>79H$EZ=128
M5:&\FY0]_E&+2X]I25@Z 6;N!O&?GV6 S:;6@@,^ZML\/DVMWJT&K6B=ZBNK
M4-@BFFXO=E&1<E)YVW6,/!K+YHK6*EO>F;%QD'>/4BN"PK!?(;1%-7SG8)F'
MTB(L7QAB!GQ&-B@"%4%J7"G==;/$NTB&:?-(MB.H.MS4H&*,'J2VGL'&T_<8
MQ$8HFDG8M11VCDT(KK4,2E.@H,6MS>300>_R@BI3-Q&S+7S<?K[- /,RUKJ]
M\3!NUI9,+=_4V^=<\P]_6LQ1IKSF*4+'LKVC]S>S/8OF^D1]H^QO/]1[)]L>
MF]K^S/,^3Z#UWI?(^Y?*]-\U\418]_F#H3^G6+?B]WX_VUK_ /Z$_P#Y?BGL
MN.LC6K2[!S' JN&"7@8_,9:*$%;%O/:.DD[R=+=E9[+=-G$-F"ZF\KVE8U&Y
M."H"4](2+@:HO40V##( WEW$Q<XXO=@)!4^/ EPE.6?H&$=RWG\U*1-I_F\0
M;;Y7E8+J]X^Y!M6T-H=K5^K;)R*NO+]]?=]WB5!:L]"$BEO?!<*'ZGX:2Q-#
MV@FJA;14W"+)SJ*JKZ#WE 5;016/2;5M)-5>]0@I%AU^+G\FNTS?::W546D>
M@JII)OXM]M&.L4O9EEG/OG:'GC9J((G_ $)E:.*GGQQ_C:KVPSI[&.=EW7$8
M2J&/L42T79SIQFL>6-$:4++B,P';"-V27( B_P"#HMC5KL)/QRO/Y"9[$HI-
MM;)SE"^KP]DS.IBT4QP4J9XS;;3>>L$KK#2P!!(8NJTI@K)9M-,6AID"7/,Y
MG7V?/8R4KYHI'J\;P@@/*V<'1S<EG2+Y;6LNLQ?+P\3XN7W]>[V<EW=WT]WI
MA]>O\/7Z?VUKU_'.:[T_/Z<G3]/V5%&D5'*,>?[V:D)Y7E)M$^0+S86OWS%>
M[U(#]O;6P?*O'?XT"'K@V/+&?0,;BAW*>5(]&6/3B4"=B+=]5N^_; 8CMJ2W
M?8,3MYK"&.$#%5?:BM*'!D "IY!%G:63,)L-9[J$J.A/-9,WZ?TA'"A7@Q_6
M]K!<2O*K@]'40&5A_,"D[-6KDAL2?R%%/3%73I-@>M98,]J._9[%5CL6CWS
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M(;]9)^XZ?6_%U\5$GP7D\3?ZMW,EK,!;W]/<SI446GI/UOG?D_NNGB+:%<+
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M,^FMQ_*3U+"SF@N&4SW6'JCF:0K8\2'QPO03Y?P<3'-U^_">:S-73'GBL;M
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M^O\ &BG;^>T>(^+?\W^_QR/^-F?[&SO#'(_8WMWS\=K)]'[1]F=OJ6D6?/\
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MQ/\ ^M-9(,E=7<RN)]$IFP\V4]RL-TZ =X >#9YU\&1F3SWR77<U&9PJR,Y
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M)TWD_$Z;R?B=-Y/Q RC7F^(WD^C_ ,ALX<@^-O\ _]H # ,!  (  P   !
M)62222222230   "222222222042D=B?L2#PT "@  !\          0(X*])
M<-;N'  P  $@          "( &=[@      P "< )QC +;-@  "?8+&%&4_+
M   P   D87_M5Y:8  "  <#@ >     P "38%.4ONTPF  "#8)Y4       P
M "2T3.J (N1%@ ""," &-/\ CKX D  DV!5U>=BSCI8 @\$ODL[+>R0 X  D
MM!?SW"X@MM0!@;%[4UAY%7X 0  D  H      $ ;@;"(\ 4B^G !   D
M      !,          C    $         #V D         @  GI(
M $D $DDDDDDDDD@DRXHLB$DDDDDDDD            "0  H  ]@
M         %@   H                      '    H   &@
M    %\$8@@H    P                ._88XDH    '@              $
M]  #8 H     \              $!='CX H     $              3X@ X
M  H     $@             8\_OH  H      0             ' 8#,  H
M     @                _'$ H (&@  @            $H'   $(H &Z.X
M %              X'   ;H '_$( &            &  $   $   .(
M          " '_ ",8Y #X>  &            !0?#2L  &      -
M       P&=8   &H     0             =;      (     0
M           O     @             M       %    !              $
M  "@ "8&(   !              !( #:<:-%X   H               ?
M#3K (  "8               $8 %CJ  X  ^                 4 $LC
M  %X                 !<      P5                   A]    &W
M                   %"(%9.            !T;;;;;;;;;\%! "MMMMMMM
MMMM. 3          $   V#  F X      X'X& #     $  BV%4-RFB0
M%\$\FSO6    $  & #C2  Z#H   G  H  J     $  A&&XQ[JI,Z   A\#X
M2*M     4  D #1[FP $)   @ !-  @     @  D&&=>Z#HS!8 #@\#E'=%
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MH)B&R#S1 >;G*&VL3&*E9C HF?0BE;9) "FA<#2F]]_5=$=0LW%RH> HNBR
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MN:G]5*!2W=U"2#KO;UP/YT"Z:&$I;4XJ#6WGM)O)@7GG]><<+GW'?RAMSJY
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MK# JCP@:WGK%F&,[0B&F'NW#L+RTHYD)P#"W1,(HC@G43X5 CY 0'-J>8!/
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M;']<(',%1;FA:8&P\.!8=$$RQ38KRO=(MAI0%$QA+$ID-6;P1,6*E"-4(6C
MJ@S@*OI4A1HB-%(B(1R*4UHP(B$F1:V"PH6D8Q[,B502T6]C8$BC ;)*3637
M-X(" 554@V(Q *@5 @ QTT/Q@$ .@3>/60!*\TE4AH IR1V- PP<0!$:DB-B
M>SH!N.Q']:B_F*T?46,?8$L ?( $P3!]=)@6!:5W62I"%'T<8O@45P]%!X9R
M)#7Z\4G2=>/5'5HM:#34L?SP.8P*L#HJJ_VKZ.\P)2 -!32+2Q<^)S,D  4$
MFE&!X.)R[* #5I%(6R$.%/3$L8-8!A H-CAG54@Q3FT,A-I3D<0B>RR&I* C
M:%>=98C#5.%=E4MP#7R9"FTX8A@*JA*0$2#3*E*B)'Q">" T.JL&&Z0%%<Z4
MS830F@1P)!.*G3@S=$>@)(#:%D1!%C9DDF-2BK%B X$SJ";L4'I$ -<"0$)I
M-KA*EQ( ]A!*BAT[1YARE0!<]8/T"]+5/#L'%"-W[U8%0!50 *JX &JN =\1
MI/$)+0MHD$D/]JC&/@*_P#R<M?UGR$ER/K B2CFXHR^2([\OO5O_ )[117^N
M)MK1660C_+E,4>&?(!^VWB8@86M^]0BTL SYBF8\2"C&\Y498Y7HM@D'MB'Y
M2'1ZO7!'I'QC=.S^OY&:-F&PQ00CV,_'%TTV.$\.)'Z;XG*8/: A^O(<K3YP
MXM4_E+_*>S4,"4"* @*X!2)(I(IR I0L_@"/(:&579 TTNN(?GHMJ1R#MXSF
MD(QEP\&B<_C#S U$D^=0U+TJI''CZ(E"HCL0WKVF>$,^IJ002"LZ% C6Q.R%
M!^H=@2#U4 &X_B"<!C'0==Q/Z U HFDN#0=,^P=*=*A7U]3I86*F4"]KP+8W
M"X50@(H$$)(*'^$FR [NC3#01G23"<*IRD+@NC8'P=JHI7['4_UU:@7<# +3
M"7AX80E6=]82D  _@QHH M7!UFB)T$<"!QL926IJI0&=009(2ZZ$BAQ5V&($
M3#CKB[JKT2D#1$"YQ+,ZRJ2XNZZ"=$>.4%1(B!2:S!(Q8S2*1"LD;R %M3H8
M$@I+@!5#D$-?!!>(134$1U;#1VR&<%^0"H([\$8*\!R8R3&"&'40!*C++Z6J
M_  E5(GH' =.A.+*@#)%YITJ%@_@0$^EL[,5%%C+%6,&&<J2%\_ :L# J^54
MJ%3:U61A L' NXJ"FVG437+V!8BI(JHFD8!!P>R"+= +F0,J.VH(&N?4$'GY
M$<(*HOV)*B=X-")-BS"EDBOA)$2(LFV1K%B! <BMI!1Y*;"8;$(95/I$PRZ&
MT*A/'":L4 J@B>^IZ.J_3U)[[4H#H" 6I@Y(:B( 2C$" 4"@+[XR3S( J'
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M6>"4@R?!H]@E/O*NQCEA0?+6@Z<J'V"-QAD.-"-/';6G!,29&2^#AX1/I K
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MYJA;A:3R'.@"[<@,OJ%44_W%5' G/9A C"#D^BH%0B!$11$:(FB.B:/"& >
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M@I9809<?9#GV:PL4)%U7"*1XFYU!:A\H%( 1"JO\(Z'+H H-!10$Q2Q>8^U
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M5W>>T,6\***7CD 2<MW284%PJ!*D913?400A)K0CYYZ@#]7NT%) );38@[R
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M;JHLZ7PF7@%A6H]E(. +8$% DV+=%@(!S=<?@ZC$,+0C(K;P&]B&J[(M V7
M*#0C;FRQ:)%S>,=(ZJ,IZPP!Y2>[5%C,-\#1AR#:;T"N7.H'PT'O1'B35T)P
MYAXJ3%86H QP3R#X$&EV=O-IX1.8'+Z',_3D,#FGU-NI)A6B\7V\53M_J@?Z
M/L9 L9_+_6+L9^\7PATX:(3S"@;66')=OBP3L6;..QQPZ(BY=G>O#_* %._<
M1&',9PM#413?6@M*3WRK[^*%A72GE+<O"K'2)T 1SY!8!7C<0 "BDH*,=$A0
M@:-[0#Z;/X040$1,6*"*CI[W6!RF)%!9@(,00+4XF^H#-'@(@"A$$]!#5@.
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M ) J!%ZSB H,"@R4N,=*;'KD**]KJ*]@6A=986<0#4(#*Y;? (5Z.0,M*B*
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MW*H:IP4KN0Z:"(MJ;2*1R!B+051I$7C"H",@2Q=!>&*^OE00T;T'U5Z7ACD
MG*(T[?YSSZ+*ET']YZ?(K( 06"]R$%,I&*6*(. H.8^HXQT$*,0BH5A7RWA7
M8CA)$G2KC:0&0!$0$"8"*@1;>0@"E$ZL H96L L $<75#:[P+RI:[$'G[G7D
MK[A^PZ=/E&@]4&??]5_1^GR@HD1(Y8,*8%KL&,//H 0(H1(*!4U8?.B*70*?
ML O A(T7[6>N+12E/.L>@H S$+$H$[%P(?*RDPA0>!5.XP*!.(X(@@':@P%
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M$PI![A8?00%, 57P&O'2]X\"T/P9^/H/$"I.NQ(0IC#2CBG%JN:W #?0(![
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J:M6K5JU:M6K5J\VN ?V;>K\__4M+4V[4VW_'V]X"$  %5V*';'^5K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>ahl-20231220_g5.jpg
<TEXT>
begin 644 ahl-20231220_g5.jpg
M_]C_X  02D9)1@ ! 0( .  X  #_X2/D17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !L!@  '0
M &P&   =    1TE-4" R+C$P+C(T   R,#(S.C$Q.C$W(#$R.C,X.C4X  $
M : #  $    !          @   $$  $      0   0$$  $      0   @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   #)(@        @ "  ( /_8_^  $$I&248
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MG*JUT8\[C+1E_6M6GUS6+K4KG'FW$A<@=!DYP*H444R&[N[/6OA'X];3[M-
MU&5?LDO^HD<XV-Z9].OY5[Y7Q6CM&ZNC%64Y!':OIGX7>,!XG\/+#<2*;^T5
M4E&<%QT#8_#GZUG./4[L-5O[C.[HHHK,ZPJ.>411%N_:I*S;^7=($'1>M#)G
M*R*I)))/4TE%%0<P4444""H;N5H+.>90"T<;, >F0,U-5>_5GTZZ5068PN
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M$+'+0/M_#M_*O%Z]+^$UUB34K4GJ(V4?3=G^8IQW.G"2M5MW.KEU"Y2=]DI
MSQP#2IJUT/O,'^JBJ;G+D^]-IW->>5]S3&L.?OP1D?2G_P!IVK??MF_ UDT4
M7*]K(V!=:>_4LGX$T]?L4GW+G_OH8_I6)11<?M7U1N_9D/W+B,^VZD-E+_"
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M*VU&VAN=+"17%QY,:B3=+CCYRHX"\GOVHU3Q#J.F3-(^EK]D$L<:YE_>R!B
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M%;\4,<(Q&BK]!4E4D;0H);LY31/ &D:2$>5!=SCJ\B\9]ASBNJ50JA5 "@8
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M(" @(" @(#P_>'!A8VME="!E;F0](G<B/S[_X@*P24-#7U!23T9)3$4  0$
M  *@;&-M<P0P  !M;G1R4D="(%A96B 'YP + !$ $0 > "IA8W-P35-&5
M                                ]M8  0    #3+6QC;7,
M                                                      UD97-C
M   !(    $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR
M6%E:   !V    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%
M "!G5%)#   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "
M6    "1D;61D   "?    "1M;'5C          $    ,96Y54P   "0    <
M $< 20!- %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P
M   !    #&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N
M  !865H@        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   '
MDP  _9#___NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
M        ))\   ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80
M P    )F9@  \J<   U9   3T   "EMC:')M       #     */7  !4?
M3,T  )F:   F9P  #UQM;'5C          $    ,96Y54P    @    < $<
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M   ![_   "AU@QB/G6+2E;<5Z_:SY0/4_.-J1VY00]:=U7T'874])D^LP
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MY^DXK/M.V6[]1R#:<   #CQKK.'SNIX/+V/6F  !==K,3&LS+'KY+3>B
M  _&,8TYV'1\FP:4:'$'TVNFUC)=^CFLG8NVUH   ?_$ "H0  $$ @$# P0#
M 0$       4" P0&  <!$" P$Q4S"!$2%A07,2$D_]H " $!  $% N]V2PQC
MIA'&+*2U8J7)5D)QQ3[5OMD?!^Y=I#.0GU5; @*K'U2T,PH2:$'HGD?DLQN)
M!1YW/O\ ?L@_/V ;(>J\W7OU4<*Y&%!QJ#X9I)+.+6IQ7;!^?NH&S+5KDAK?
M:5:V6.[R!#P0?GRA53]XMW.IWC(R'JZ[$'8&K+V2'JU]<$@(.D+@N4. ;&H)
M746V1NS@W:2F^CQ<[0Q3:ZU>8L,:YL&I-P)U_J [$7P*ETIM4- 6/V16)07C
MG[\0?GS65H@4R\U/<$X=<JCL*M0P"=E5"(.+;@'%*Q*VE6"&P=B7)AW5]:LA
M>I&M=7T5L6M=93_$9E:E+598,XB'_K^Q57%ZL/\ K"Z-9*I.FZZM2IL#4I^.
M(E4TO,LV0?GZM#*W5*-JZKT>P$=>4P*G8)&4Q-F=-+[*>UQ;&W&WF^A.1ZK_
M %)O.1QM/O1TG*I^UQ]M+]8/S]1%ZF#@Z]LVUL/_ &Y8N+IV?3)?EV2IY*>]
M!CLDL(EQF=< XR*[3(E97U@_/UTO,,!0"O3_ %8D4";'A6H"Y5K)UT[;U4K8
M6&7/^=FWFA4]^S#@@TZV+*TJ16S2+$"Z0?GZC+G< L55BL"Q<0V9@2'WWI3V
M5RCV^W.1-"<"^(B-0U7*2?\ V>K$U_G,["=7K1I]%? MD) H7+:889C,](/S
M]M9UY=KCS$T4,#9$DZJJN&=CW$VC_>GT^D>7Z\^4%*>XD!EYPW#7GM[ZL5"E
MIQ3;B.Z#\_2L:POUPR)I"N!,B$]:U7#>P;>?X[?IZE*2=<Y^[G5$R8WB#A5&
M<6"7G!R/SGN8A6</AUYZ4161(3R78NEZ<"R)8*'5L.7FV6+PZ$6I-V=X_%WQ
M1GU1I&U@*0=PP?7CY9EQMQESJN/(;:0A;JYM9L@V/F@D<JNA-OTB'CV@(][I
M6 'AD;6Y<H%-A&@ E1F* !.$/;P\>']V["/L/MS.Q#Z("E[&% ( 7Z>(GY$;
M*UZ9&[G)@$&][M6(:]N,LA(NP%/ND-L_P0A6]6F,3@7QV:3N-GD";?'V:0$
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M(ALRMQ'_ -CL(T(U!M]4"001H1J#V';PJ@WQHL80:5L(AJ;#A5T_,)8]6\C
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M\S[5\GB;U;(X^V$,KVZC0<AHS[C"9CBC[TPG8UE$@8B43'U4K1L;?:7F(?\
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MRHU+E\ODLE0=F-78K+X#'XO&TL"-=X%EL7;3IS#.LK&^*T5CJ9'*(<?- H*
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M6PU(L3]7ENAFLXE'CC/94"@+Z)C1&[K(2IK( 3!)1G1AG0@A"Z)_7.ZCAO\
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MJ\2?66L?DI6!78.*\2-5B@T\722HR7-*V!ELS/"A,Y$[?R7TG+.3!M"H(,.
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M 'Q'?R37J,J5J17$]B@:JS"Y3;9IU4,[SE2DZD(LJ*!!Z7GUOH\+5K85]M,
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M4,"/LP#0="BP=!CLL%A A-HZ3WW)5NHO$"-S8HE.^F9ETG>KSPSA4=-;< *
M4  2JV "ZK@J^@S8 ,6!LZ>U!8ZUO+2&PJ#%:KH@$Y4*R$@ZB)5ZYEOELLA=
M(2!Z187I2;.=9$WQ#T V19;8R%U!]VDUM$!"N5F=R*HD!) (MQY,+$41UJ"(
MDC9&XCHUD1;.W4-+5DMV]*+\0P^[GX:2?/.T@3!X1?:^J6OYX!YF^AJ,[S]5
M"7U40A,A3XO50J$XB]3$0-Y-=WH__]H # ,!  (  P   !    -\;<&@
M ;T $  G@   #H  $  !\   4   $&=U<  !.C:X$"QT[0 /%G3H$ ;F@% $
M &@ $ )T  !D 'L $ #W@#C  =G $ 2OAE#  *! $  '%@6YJL  $"5T  5
M#NR^1+    +@    5 4 .4?@    ##T<A3!XBW#QB("7N ;*9"FQ@T &T"X8
M!YX  8    @8!S8  .@  5 "@    #   0 !(    "X #@  9    "D )@
M"$    $"8    =<   60      43'$\   #_Q  E$0$!  (" 04!  ,! 0
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M_P";?:7$03<J D!0#!3*O 0!CF&0(F$ -6G-4D10"*$ RP 0#AQG/!@
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MR) D-?9D+*B"*YDA(&L@3P4N# BM:C5XPB9$V!R)IX1ZQ" "X'!90RR&@!(
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M54ATB -\!%EC1(I8"6N8"'<>U)@$7@?9^O(E ]78&'"DD*LP%<"> \I!O"9
MA8XI0GJ0WRV"N2U@2%IE57)AQA#@+6KX&H IW7+>B3MT$411$1B.$3<3A/'
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MH5%V'[FD=_:S]72&X>HGWYOL_7C<%C@_M,/5 [ZM=Q.Q[V?M:I(:X-API)3
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MZ=0%(8,6"91*9#4Y$1"),O3"',8=!!83F%"U@9"W03!3+(DN5(RPWU"NUEC
M&W<P1"I#0?BV:NP!F"'0&KI<3".60J!.TI,C5^TX)F:$#(1A!2_$0*J8C"6$
M %+24V9UI)4**44&;@X\".9AXAGWSP+Q=*UNU26.&=$B9V?%PX@J#$V8B/N:
M?<"*U+&!>Q0UD#)@2A1.Y$5!Y CL.--YDS%6#%( O )&X%55:N5=UZOC<G*H
M]@'PTN$S)_1]G[:"969  IL+(.XXC$;HPF4F(&@45M1>&XHH6"%;+8J"V:9$
MB &%8J6 S2AY%\'15([52@$3>\Q)W:(L*@*JKG#JF2R5SPL2L:8X3@!K(@!O
M0" QHG*5I=*E&P5$K48A1 )6L=1P ,  /&$SFCT1>X8[>0BQJX- PFE<PXQE
M='2# 09"J#@!@4$B)Q"!$5JF1)' ;<O %0,JP.JZ SB'N[KWI]]$QL$_?/MO
MI&P*1]3^.G4\;A$&J"M*@ 0DN'3#B!QV4"OJ:2L9J."N@K,)$@V9PB4*SZAV
M\*HP4@RAY>85(\[\/1A[7\-(ZONCC_C"/&++##M=A]S'J'7Q2"R@E6*Q*#'%
M+K;)*LF $6(-,.-  -- ,!(9' F#.#4"68%@%"H %< !@\RB\A]3D]RGOH.$
M#WU]H =@_!.)/5Q=O8@F=PP^(,%!'_=3<[Z9WQL]1V?[Z-/R<TT.N$/60&T!
M=?/A7)@[<?J;WT&2/*4-A5=^CV?C#V42"(Q'C_?/XV7Z$6 @CB-F>+UTN[&7
M%CN7A,G41\L\Q)Z;@.JF#U7 Z,N  =C[7==UJY\P"D"8>'M_!X[Z104;C_MN
MCL\?BVVUB9C$F##E[F Z-\D_@[YCL-JN#W89T-&!EZKE/*_\,'X"I@FQN?V=
M1]HYT[A> ROZ>S[7\7(H.]SAWP<;OC#)W!8]OAW<O!SHX8-@_P!5>5JN5_$@
MD01W'(^VJ2KZ.?['R= UN"'1G]C'LQ_ Y5P*'(X3W,:SM=#ID!G)@,(&=18E
MQ&'LV]67O^?>2/7)ZX@^XZX ]!\C^&G@7U1_+[UZC_.H:]#_ )T';_S1PCT%
M^]!_H*!\%^=;9]TS[K5]W\/_Q  D$ $!  (" @,!  (#       !$0 A$#$@
M03!188%QD>'P\?_:  @! 0 !/Q#S/V/8C2BHK0(V[!BD%H4L]@2]?K#$6ANY
MUZ($_K[]&L05 [?^H$/3UC7LZ# 0E 3L03>-=TD6+8$%(H$3&X(FJ8UX@#=9
M$RY/TR^XLF<N!O8NRS:N3#\-D;<QT)N78ORV@0" :G(&.T0Z4$&(*[+H,7LH
MFS08ZCWC<9+GFJ"AVJJO?AW>+UMY+<I/0OFIRN2ZM$"VIN*-B<9.:97XOK/I
M&9@!==IITT'4+W&(?Z1&[T"LZ1@P( \>[S=TE#^B%T!F/.=VJ,SQ#L?P1E=J
M.(>SEOHX[<KK!\"[O!]N?U2]&PO.8*C41Y^,E*9R7FP#\7HV"GK]WU-+65<^
M*6-.07:>VPHG]@5%=Y)PCZS#*;_S&S+/)'J7%2%'S?(7,5VB2 SV%VB0R40W
M1(U\8*JP(2>TFZ"QY/<)%?)MW*FA$XOAX2Q8KIL>49C7N"8*-M\A#6.GW]\!
M!5E=Q?23.O4$6Q/4W%<)P $3PA:(N.[EQN$05K8@?1\G(TCC";^$\_6KD@O
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>[]$W+M^9HV+] :$OJ$+VQ!8G4;Q2Z1=%VI:?!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>ahl-20231220_g6.jpg
<TEXT>
begin 644 ahl-20231220_g6.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *$!3<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHKQ_P#:^FDM_P!F/XE2Q2-%(NBSE70D$''4$4TKNQ$Y
M<D'+L>P45_/+H,WBGQ3K5GI&CW&J:EJ=Y((;>TMI9'DE<]%50<DUZ5_PSC\?
MO^A%\;?^ MQ75[!+>1X$<VE/6-)OY_\  /W0HK\+_P#AG'X_?]"+XV_\!;BO
MUR_9'T+6O#/[.'@72_$-G=V&M6UDR75M?*RS1MYKG#!N<X(ZUE.FHJZ=SOPN
M,EB)N,J;C_7H>O4445B>F%%%% !1110 4444 %%%? G_  5MU&[T_P &?#QK
M6ZFMBVH708PR%,_NTZX-7&/-*QS8BM]7I.K:]C[[HK\V?^"1^J7NH>(OB4+J
M[GN0MK8[?.D9\?//TR:_2:B<>25A86O]9I*K:UPHHHJ#J"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7CG[8G_)KOQ,_[ D_\J]CK
MR/\ :XL[C4?V9_B1;6D$MU<RZ-,L<,*%W<XZ #DFJC\2,:_\*?HS\@OV._\
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M\-7&@?M:>)KJ6)HX-7MK.^MV/1T^SI"Q'_ X9!^%?=/[!'[(-W^SKX;O]?\
M%&P>-M;C6*:UC=72PMPVX1!UR&=B S$''RJ!T).Y^VQ^R'#^TUX3M+O29H;#
MQKHZM]AN)R1%<1'EK>0@' )Y5L':<]F-9QE&%338[:]&OBL&O:+W][$?_!.C
MQUI_C#]EGPS96LZ/?Z$\^G7T X:)Q*[IQZ-&Z'/KD=C7IG[3GCO3_AQ\ ?'>
MM:C.D*+I-Q;P!^?-N)8S'#&!WW.RCV&3T!K\=8+?XU?LA^*[FXBM]>\!ZDP\
MF2?R3]FN5#<?,0T4RYZ'YAGI2>(OB#\:/VM-:L].O[S7/'=W"^8;&SM1Y,3-
MQO\ +B18TX_B(&!WQ6GL;RYKZ')',G"BJ+@^=*W]=2E^RMX5N_&?[1WPXTRS
MC:1_[<M;J3;G*PPR":5N/1(V/X5^B/\ P5F_Y-S\.?\ 8UVW_I'>5J_L'_L4
MS?L^VL_B[Q?Y,OCC4+?R$M8F#IIL#$%DW X:1B!N8< # )!)-?\ X*H:'J6O
M_L^>'K?2]/NM2N%\46\C16D+2L%%I=@L0H)QD@9]Q4RFI5%8NGAIT,#4YUJS
MP;_@D4!_PL?Q\<<_V3!_Z.K[%_;R_P"32/B+_P!>D'_I3#7R?_P2A\*ZUX?^
M(7CN35-'O]-CDTN!4:\MGB#'S3P"P&37UQ^W)I]UJO[*?Q!M+*VFO+J2UA"0
M6\9=V/VF(\*.3P*F?\7[CHPB?]GR7E+]3\V?^";*AOVN/"Y(R1:WQ'M_HLE?
MK=\7/^24>-/^P)>_^B'K\J_^"=7@KQ#HO[5GAJ[U#0=3L+5;6]#3W-G)&@)M
MI ,LR@=:_5?XK0R7'PM\8Q1(TDKZ->*B("68F!P !W-%;XT+*TUA97[O\D?A
M]^RW_P G)_"[_L9=/_\ 2A*^N_\ @KUH,L7B3X;ZT%<PSVEY9EN=JM&\;@>Q
M(E/UVGTKYC_9E^'_ (HL?VBOAG<W/AO5[>WB\1V#R32V,JHBBX0DDE< #UK]
M;_VI?@!9_M(?"/4?"LLT=EJ:.MYI=](N1!<H#M)QSM8%D;'9R0"0*UJ24:B9
MY^#H2K82K36]S\T_V+?V._"W[4GASQ%<ZEXLOM%U?2+N.-K.TBC?,+IE)#NY
MY99!Z?+7NGC+_@F#\,OA[H,NM>)?BMJ&AZ3$Z1O>7L$$<:L[!5!)/<D5\BC2
M?C1^Q;\0'U);/5/"&IQ9M_MOD^;97D9/W=Q!BF0X!QS@@'@CBY\1OC]\9_VN
MY],\.WQO/$4<,H>#1]$T_"--@@2,L8RS8W<L< ;L8YJVIMW4M#GIU,/3I\E2
ME>HO4^Y_V6_V,_AC\/?BGHWCGP7\6(O&=SIJ3XM+2>UF219(7B.3&Q(QYF?J
M!7VY7QY^P#^QS>_ #2KWQ;XN2-?&FL6X@6R4J_\ 9UON#%"P)!=R%+8X&T '
MK7V'7%4=Y;W/J,'#DHKW.6^M@HHHK,[@HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !139)$AC:21E2-069F.
M  .I)KDK;XO>"KS5!IT/BC3)+MFV*BW"X9O0-]TGZ&L*E>E1:56:C?:[2N;T
MZ%6LFZ<'*V]DW8Z^BBO,O'?Q,U/2?B?X3\&Z)!:RSZF3/>R7"LS16X))*88
M':DG)ST'%9XG%4\)!3J=6DN[;=DC3#86IBYN%/HFWY)*[9Z;11176<@4444
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M/):[,****R.\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "LKQ%XJT?PC8B\UK4K;3+9FV+)<2!0S8)VCU. >!Z5JU\:?
MM2>+KKQOXPO-.T_=-H_AF,"Y=?N"9W5&)]P2J8]0WO7S^>9I_9.$=>*YI/1+
MOU?R239[^297_:V+5"3Y8K5OMT7S;:1]CV]Q'=V\4\+B2&50Z.O1E(R"/PJ2
MN'^".L?V[\)?"UUNW$6*0,WJ8\QG]4-=Q7L8:LL10A66TDG]ZN>1B*+P]:=%
M[Q;7W.QYI\?OBA)\+_ [75B\8UB\D%O9AP&"GJS[3U 4?F5I/V>?'FH?$/X<
M0ZEJUR+O4H[F:WGE"*F2"&7Y5  PKJ.G:O+M:TW_ (:&^.6I6>?,\-^&K:2
M,.4>8Y7.?>3\UB]ZL?L6ZHRZ9XIT>3*/;W$5P$;KEE9&_+RU_.OAZ&9XBOGD
M'S?N)\\(KHW"S<NV]TGV/N*^6X>ADDUR_OX<DY/JE.Z4>^UFUW.H_:Y\07>B
M_"V.WM9&B&HWR6LS*<$Q['<K]"4 /MFJWBS]G[PG-\')5TW3(8M5M=.^U0:@
M@Q++(J;_ )CW#<C!X&>,8%=W\:OAZ_Q,^'U_I%N46_4K<6C2?=\U.@)[9!9<
M]MV:\?TGXS^*=-\ CP9<>!]9F\50VITZ*18&,;#;L61N,Y"X)Z@XSD \5F<<
M/3Q]:6/A>%2FE!V;LU>\5H[-W31&62KU,#1C@)VG3J-R5TKIVM)ZJZ5FF>C_
M +-'C"Z\8_"FRDO9'GN[&5[%YI#DN%PRD_\  '4>^*YCX0_\5]\<O'/C%OWE
MG8$:79,?N\?*67\(\_\ ;6K/AG1;C]G[]G?59[UUCUAHY+IU5LB.XE"QQJ#W
MQB/..,@_6I?A%<:;\%_@!:ZWK):$7*G4)549>5Y,>4BCNQ0(.?<\"G1E4?U*
MAC';V4/:3OTLN6-_/5M^:%6C37UVO@U?VL_9PMUN^:5O+1)>3/;:*^?O^&GM
M9L;6WUO4_A]J%GX4N& 34%E+-M/W6P5 .>W(!SP37NFBZU9>(M)M-3TZX6ZL
MKJ,2Q3)T93_(^H[&OJ<'F>%Q[<:$KM:V::=GL[-*Z\]CY?&99BL"E*O&R>ET
MTU=;JZ;L_(NT445ZAY84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5E>(O$^G>$[.*[U2<VUM)*(1+L9@&()&< X''6M6N$^-VG_VA\-=5
MP,O!Y<R_\!=<_P#CI-<6-JU*&&J5J2O**;5_+4[<%2IU\33I5=(R:3MYZ'6Z
M3KNG:[#YVG7UO>Q]V@D#X^N.E7J^&;6[GL9EFMYI+>9>5DB8JP^A%=WH'QR\
M5Z'M22\74X1_RSODWG_OL8;\R:^(PO&-&6F*IN/FM5]VC_,^VQ7!]:.N&J*7
MD]'^J_(^JZ*\=\/_ +26DW>U-7T^?3WZ&2$B6/ZGH1^ ->L:7J=OK&GP7MH[
M26TR[XW9&3</7# &OLL'F6$QZ_V:HI>77[GJ?&XS+L7@';$4W'SZ?>M"U111
M7I'G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %)TY-+7E/[57C:3X=_LZ?$'78&*7,.DRPP.IP4EFQ
M#&WX-(I_"FE=V(G)0BY/H?EI\=O&FI_MF?M?0:1IUSNTNYU./0='*\I%:+(5
M:?'^U^\E/?!QV%?L;X7\-Z?X-\-Z7H.E0"VTS3+6.SMH5_@CC4*H_("OR9_X
M);^#8_$?[2SZK-$'30='N+R-CT65RD"_CMED_*OUZKHK:-170\;*XN<9UY;R
M9^4'_!4CX,ZOX<^,B?$.&TDET#Q!;P0RWD:';#=Q1B/RW/8M&B,I.,X8#[IK
MB/#O[48^,W[1'P8U_P"*-W;Z3IGA(0Q7.H(CNDLD4CRI.Z@$J680*V,CY2W
M.!^O_B3P[HGC;1[[0=<L+/6=-N8PMS87D:RHZDY7<I]UR#ZKD<BOQNT7]E.^
M^/?Q!^,J_#&&"UTKPE?R_P!GZ;.[M]IB,TJQ1)(Q.'*0DC<<$\$CK6E.2E&T
MNAQ8S#U*-;GHZ\[O;S6I^S.@Z_IGBC2+75='U"UU73+I/,@O+.998I5]5920
M15^OR?\ ^"7OQNUGPU\8E^'%Q=23>'O$$,\D-I(WRV]W%&9?,0'IN2-U8#&3
MM/\ #7ZP5S5(<CL>[A,2L52]HE;N%? G_!6#XG:CX9\/^ ?#>D:G=:?<7MU<
M:A.UG.T3[8D6- 2I!P3,_P#WS7WW7Y _\%1/&7_"1_M-/I*/F+0-)MK,IV$C
MAKAC]2LR#_@(JZ*O,Y<TJ>SPSMULCZD_X)6V6L7WPC\5>)M8U*^U"34M7%I
M;VX>7$<$0.5W$X!:9QQ_=KY@_P""CGQ@URZ_:?U;2M)UW4+"ST.QM;#R[.[>
M)"Y3SF.%(!.9MI/7Y<=J_0/]AWP:/ _[*OP^M&0)-=V']IR-W;[2[3J3_P
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MLV6L+^6(+Z*P5P?S9ORKLOCE\0!\.?AUJ.H12!-0G'V6S&>?-<$;A_NC<W_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***Q?%7C/1/!&GB^UW4H=-MB=JM*3ESZ*HR6/L
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:9K4^&G"'K)R_)+\P]GE5/XJDY^D5'\V_P CG+S]H;PS"_EVD&H:A(?NB&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQF68'"5Z->4N>;M>"5W!=F]N;6_D86L_MD>$;/<NGZ;JFI..C%$AC/XEB?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV@$9Z@8^HK!_9A\::OI?BC6_AWK=PUP=-\S[,S$MY;1R;)$#?W3G(],'UKZ
M\4>)+'PAX?OM8U*40V5G&9)&[GT4>I)P .Y(KYQ_98T6^\5^//$_C^]B,4,[
MRQQ^C2RN)'V^RC _X$*^>Q6#P^ S7"0R^').5^9+9PMU7Y>9]!AL9B,?E6+G
MF$N>$;<K>ZG?H_S\@_: *^(OVAO FA79633E^R[H6Y!\RX(<'ZJBBOJ$ *
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MTG_[:@OE5/I4G_X#%?\ MS//?^%\2:EQH?A+5=3S]TE=O_H(>C_A+/BAK/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"#]*L45ZE+#4*'\*"CZ)+\CS*N(K5_XLW+U;84445T'.%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=Y5]\FC3^RU#^-7IQ_[>YG_Y*F>L5CZAXRT'2<_;-9L;=A_"]P@;\LYKS_\
MX4&-1_Y#?BK5M4]?FVY_[Z+UL:?\"?!UC@OI\EXP_BN)W/Z @?I1]8S.I\%"
M,?\ %._X13_,/J^64_CKRE_AC;\9-?D.U#XZ>#M/R%U)[MQ_#;P.?U( _6L9
MOC]%J#%=$\,:KJIZ#Y-N?^^0]=]I_@GP_I.TVFBV$#+T=;==W_?6,ULJH50
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M4IT:=%6IQ2]%8\NI6J5G>I)OU=PHHHK8Q"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'>;N_,****L@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[K]H#X(ZAH&EB,Z]9SQZEIBR,%5YHPRF,L2 -R.Z@G@$@GI0![C7Q%X?Q?\
M_!4[Q*83O^QZ OG8_AS:6X_]G7\Z/!G_  4.T[P#X'L_#WQ&\(>)K+XA:7 +
M*6QCLQB]E0; X9F!4M@%N#@D[=W%=/\ L6_"_P 67WC3QU\:_'VEOH>O^+W\
MJQTR52DEM:;@QW*PR =D*J#@XBR1\PH \9U3]H7X>_';]J!M;^(?B:WT3X<^
M!Y"NA:/=0RO_ &G=!L&XD54/RY7=AL<"-<'+U7_:M_:*^'7C[]H+X#Z_X?\
M$]OJ6C^']8BN=4NHX95%M&+NV<L0R GY4<\ ]*^T9OV6?A!<2O+)\-O#3R.Q
M9F;3HR23R2>*^2?VM/@7X.\-?M$? /3?#W@K3;#1M3UF*+5+>QL56&XC-W;*
M5E &"-K..>Q- 'W'\/?B1X;^*WAQ->\*:K'K&D/(\*W42.@+J<,,. >/I735
MB>$/!.@?#_1ETCPWH]GH>F*[2+:6,(BC#-]X[1QDUMT %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<+X/^$]EX.^)GC[QE;W
M<DUUXN>Q>>V:-0EO]F@\H;2.3NSN.>]=U10 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M._Z$BZ_\&*__ !NCVD>X?VK@_P#GY^#_ ,C[!HKX^_X>):=_T)%U_P"#%?\
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M8R_Y-V\-?]=+O_TIEKVVNZ/PH_4<%_NU+_"OR"BBBJ.P**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5+2T223&YEC>[0$X[D"@#[OHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\GOCM_P EJ\=_]AN\_P#1S5PM=U\=O^2U>._^PW>?^CFKA:X'
MN?E%?^+/U?YA1112,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH _2[]C
M+_DW;PU_UTN__2F6O;:\2_8R_P"3=O#7_72[_P#2F6O;:[H_"C]1P7^[4O\
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M%4 # '  I:** (?L<'VK[3Y$?VC;M\[8-^/3/7%3444 %%%% !1110 4444
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M\C[!HKX^_P"'B6G?]"1=?^#%?_C='_#Q+3O^A(NO_!BO_P ;H]I'N']JX/\
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M?AL1/DI3N_F>ET4459WA1110 4444 %%%% !1110 4444 ?D]\=O^2U>._\
ML-WG_HYJX6NZ^.W_ "6KQW_V&[S_ -'-7"UP/<_**_\ %GZO\PHHHI&(4444
M %%%% !1110 4444 %%%% !1110 4444 ?I=^QE_R;MX:_ZZ7?\ Z4RU[;7B
M7[&7_)NWAK_KI=_^E,M>VUW1^%'ZC@O]VI?X5^044451V!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW_R2?7O^PW)_Z(AK6G\1[F2_[VO1GU#11176?H(4444 %%%% !1110 4444
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M15C5^$^=SW_=E_B7Y,\2HHHKE/A HHHH **** "BBB@ HHHH **** "BBB@
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M2?7O^PW)_P"B(:UI_$>YDO\ O:]&?4-%%%=9^@A1110 4444 %%%% !1110
M4444 ?D]\=O^2U>._P#L-WG_ *.:N%KNOCM_R6KQW_V&[S_T<U<+7 ]S\HK_
M ,6?J_S"BBBD8A1110 4444 %%%% !1110 4444 %%%% !1110!^EW[&7_)N
MWAK_ *Z7?_I3+7MM>)?L9?\ )NWAK_KI=_\ I3+7MM=T?A1^HX+_ ':E_A7Y
M!1115'8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'_#07Q*_Z'G7?_ U_P#&O/Z*.9]P^L5OYW][/0/^&@OB5_T/.N_^!K_XT?\
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M>X?VK@_^?GX/_(^P:*^/O^'B6G?]"1=?^#%?_C='_#Q+3O\ H2+K_P &*_\
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M4444 %%%% !1110 4444 %?''_!13_CR\!_]=+W^4%?8]?''_!13_CR\!_\
M72]_E!6=3X6>1FW^Y5/E^:/BNBBBN,_.0HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *^E/V!?^2U:A_V!)__ $=!7S77TI^P+_R6K4/^P)/_ .CH*N'Q
M(]#+_P#>Z?J?H/1117:?IH4444 %%%% !1110 4444 %%%% 'P+_ ,%!/^2L
M:#_V!$_]'S5\O5]0_P#!03_DK&@_]@1/_1\U?+U<4_B9^:9E_O=3U"BBBH/-
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#['_P""=?\ Q^>//^N=C_.>
MOM2OBO\ X)U_\?GCS_KG8_SGK[4KLI_"?HN4?[E#Y_FPHHHK0]@**** "BBB
M@ HHHH **** "OS1_;-_Y.)\2_\ 7.T_])HJ_2ZOS1_;-_Y.)\2_]<[3_P!)
MHJQJ_"?.Y[_NR_Q+\F>)4445RGP@4444 %%%% !1110 4444 %%%% !1110
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M *^E/V!?^2U:A_V!)_\ T=!7S77TI^P+_P EJU#_ + D_P#Z.@JX?$CT,O\
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M\[GO^[+_ !+\F>)4445RGP@4444 %%%% !1110 4444 %%%% !1110 4444
M%??7_!/O_DD^O?\ 8;D_]$0U\"U]]?\ !/O_ ))/KW_8;D_]$0UK3^(]S)?]
M[7HSZAHHHKK/T$**** "BBB@ HHHH **** "BBB@#\GOCM_R6KQW_P!AN\_]
M'-7"UW7QV_Y+5X[_ .PW>?\ HYJX6N![GY17_BS]7^84444C$**** "BBB@
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M7_Z$S_RJ7O\ \>H_X8G^"_\ T)G_ )5+W_X]5QC&.B/2PV%AA(.%+9ZG#_\
M#QOX:_\ 0$\5?^ EM_\ )%'_  \;^&O_ $!/%7_@);?_ "17<?\ #$_P7_Z$
MS_RJ7O\ \>H_X8G^"_\ T)G_ )5+W_X]5>Z=>IP__#QOX:_] 3Q5_P" EM_\
MD4?\/&_AK_T!/%7_ ("6W_R17<?\,3_!?_H3/_*I>_\ QZC_ (8G^"__ $)G
M_E4O?_CU'NAJ</\ \/&_AK_T!/%7_@);?_)%'_#QOX:_] 3Q5_X"6W_R17<?
M\,3_  7_ .A,_P#*I>__ !ZC_AB?X+_]"9_Y5+W_ ./4>Z&IP_\ P\;^&O\
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M_P##QOX:_P#0$\5?^ EM_P#)%'_#QOX:_P#0$\5?^ EM_P#)%=Q_PQ/\%_\
MH3/_ "J7O_QZC_AB?X+_ /0F?^52]_\ CU:^Z>QJ</\ \/&_AK_T!/%7_@);
M?_)%'_#QOX:_] 3Q5_X"6W_R17<?\,3_  7_ .A,_P#*I>__ !ZC_AB?X+_]
M"9_Y5+W_ ./4>Z&IP_\ P\;^&O\ T!/%7_@);?\ R11_P\;^&O\ T!/%7_@)
M;?\ R17<?\,3_!?_ *$S_P JE[_\>H_X8G^"_P#T)G_E4O?_ (]1[H:G#_\
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M^8W]LP_W9/R'^-']LP_W9/R'^-?IS_PQ/\%_^A,_\JE[_P#'J/\ AB?X+_\
M0F?^52]_^/4O9TS'^Q<+V?WGYC?VS#_=D_(?XT?VS#_=D_(?XU^G/_#$_P %
M_P#H3/\ RJ7O_P >H_X8G^"__0F?^52]_P#CU'LZ8?V+A>S^\_,;^V8?[LGY
M#_&C^V8?[LGY#_&OTY_X8G^"_P#T)G_E4O?_ (]1_P ,3_!?_H3/_*I>_P#Q
MZCV=,/[%PO9_>?F-_;,/]V3\A_C1_;,/]V3\A_C7Z<_\,3_!?_H3/_*I>_\
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M^8W]LP_W9/R'^-']LP_W9/R'^-?IS_PQ/\%_^A,_\JE[_P#'J/\ AB?X+_\
M0F?^52]_^/5'LZ9YG]BX7L_O/S&_MF'^[)^0_P :/[9A_NR?D/\ &OTY_P"&
M)_@O_P!"9_Y5+W_X]1_PQ/\ !?\ Z$S_ ,JE[_\ 'J/9TP_L7"]G]Y^8W]LP
M_P!V3\A_C1_;,/\ =D_(?XU^G/\ PQ/\%_\ H3/_ "J7O_QZC_AB?X+_ /0F
M?^52]_\ CU'LZ8?V+A>S^\_,;^V8?[LGY#_&C^V8?[LGY#_&OTY_X8G^"_\
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M)^0_QH_MF'^[)^0_QK].?^&)_@O_ -"9_P"52]_^/4?\,3_!?_H3/_*I>_\
MQZCV=,/[%PO9_>?F-_;,/]V3\A_C1_;,/]V3\A_C7Z<_\,3_  7_ .A,_P#*
MI>__ !ZC_AB?X+_]"9_Y5+W_ ./4>SIA_8N%[/[S\QO[9A_NR?D/\:/[9A_N
MR?D/\:_3G_AB?X+_ /0F?^52]_\ CU'_  Q/\%_^A,_\JE[_ /'J/9TP_L7"
M]G]Y^8W]LP_W9/R'^-']LP_W9/R'^-?IS_PQ/\%_^A,_\JE[_P#'J/\ AB?X
M+_\ 0F?^52]_^/4>SIA_8N%[/[S\QO[9A_NR?D/\:/[9A_NR?D/\:_3G_AB?
MX+_]"9_Y5+W_ ./4?\,3_!?_ *$S_P JE[_\>H]G3#^Q<+V?WG@?[/\ ^VMX
M'^%/PITCPSJVE>(+B_LVG:22RMX&B.^9W&"TRGHP[=:]$_X>-_#7_H">*O\
MP$MO_DBNX_X8G^"__0F?^52]_P#CU'_#$_P7_P"A,_\ *I>__'JT7*E8]FG3
M]E!0CLM#A_\ AXW\-?\ H">*O_ 2V_\ DBC_ (>-_#7_ * GBK_P$MO_ )(K
MN/\ AB?X+_\ 0F?^52]_^/4?\,3_  7_ .A,_P#*I>__ !ZG[IIJ</\ \/&_
MAK_T!/%7_@);?_)%'_#QOX:_] 3Q5_X"6W_R17<?\,3_  7_ .A,_P#*I>__
M !ZC_AB?X+_]"9_Y5+W_ ./4>Z&II?!']I_PM\>]5U.P\/V&L6<VGPK/*VI0
MQ(I5FV@+LE?G/KBO7Z\_^&OP%\"?"&^O+SPEH7]DW-Y&(IW^USS;U!R!B21@
M.?2O0*GT*"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD_05-_P4!TO^S/!7A+QK88M]>T/6HA;W:C#(K*S]>^'BC(_'UIV5["\SZ/\
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M[!;Y4;IB,(?F(& 3G!/.*^(?@WX/^.GP;U75]9MOA7;Z[X@U.0M/JVJW*/.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>ahl-20231220_g7.jpg
<TEXT>
begin 644 ahl-20231220_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #" .$# 2(  A$! Q$!_\0
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MH7FFD6**-2SR.0%4#J23T%?.WQ*_;H^'_@W4&TCP^MUX\U\MY<=IHB[H2_\
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M F-"XX'.6!/)&/0O#/CS0/B'8RZGX=\0:9XDLDE,$EWI5Y'=1+( &*%HV(#
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MQRDULYU,Z7H?]A?;O];_ &=Y+_:?LF[G[/\ :<;_ "_D\W&[YJY#XT?%+0/
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MP2IVLJD'!!''<&H7^'_BB.758G\-ZNLFDQK+J"-82@V:%2X:8;?W8*@L"V.
M3TKV.[^('A/5OABMIXBUFQU/7=+\/)8:#?Z+;WEGJL#O&%>SN<QBWE@4.\9;
M?S&KD O*<=+?_$[P'KGQ*^)'B@^+([*/Q=X6DTNSMI["Z)M9GMX(RMRRQG:0
MT?'E"52 Y+*0H=++\)*,;5E=V^U'JI7\E9I:7>C6H>UJ7?N_@_(^=YO!^L:'
M9Z;K.M^'=7M_#]S)&5NG@>W2Y1AO"Q3.A7+("5.&]<$"O4/&'[-.H-\5O''A
MGP:MS?6'AJPCOVDO0TDLNZ".00J8H\-*Y9]B8&X(>>#72S>(?A;#\,_''AGP
MWKFFZ'#KL&E?8Y+^#4I+QF@99)OMI6.2)7#;]OD#:<GMC$WB/XL>#KWXY?$;
M5X-?CET;Q;X6FTFUU 6MP$M9VMXHP)U,8D W0'E%?[Z?[6WHC@L%3@HU*D97
M<=I+3^(GKVNH/5=?F0ZE23NDU\O3_@GD.B^!OB3X)\0:3J=AX6\2:;JJ7 ^Q
M2?V7.K/*%9RJ@I\WR(Y*\Y56R,9KZ?\ &]J_QV^']M\0_#5O-H?Q.\)R>7?V
M**4G22(YDB*GG(Y9<]?F0\Y \FT'6#HOP/M]4U>WEED\':TQ\(:PL,T=O?/<
M";*PEHU#"&> 71,H;/EB)@@;!Y7]FOXP2?"'XBVUS<2$:%J!6UU%,\!"?EE^
MJ$Y^A8=Z]7)<SAD6)IVD_9U+-I].E]N]UYQL[:H\K-LMIYQA)X>JO1K=/=->
M:T:\]#[W^"OQ4L_B]X"LM<@VQW@'DWULI_U,Z@;A]#D,/8COFN\KY;CV?LZ_
MM)(8\0>"/'(&-O$4%SGC'8 .WT"S?[-?27B37(O#.@W^K3PS3V]E$T\R0+N?
MRU&6('<A<G'4XXK]GK4TI)PVEM_D?'Y5CIU</.GBW:K1;C/Y:J7I):_>:5%>
M2:;^T)'K>N6UE9>#?$\%IY\:7FH:E8BVAMHWR%D.6W8SCJ ,9/:O6ZQE"4/B
M/5PV,H8Q-T)72]0HHHJ#L"BBB@ HHK/\0ZY:^%] U/6;XNMCIUK+=SM&A=A'
M&A=L*.2< \#K0)M15V>"WWCCQ+)\>M0/AZ'5O$>CW833(+O2;Z*YTJRDCDMS
M.MU&6_<21XN-S#+,LZ* " 1WO[27Q.'PC^"_B7Q%'(([]+<VUCZFYD^2,CUV
MD[S[(:\V_9[U=/%GCJY@LO'#ZOHVB^;=0:#<:&;'4+)Y!Y2I>2$ N50LHXR^
MT,3\M<U^VT[?$3XB?"3X4P,735M3%_?QJ>5A4^6&_!#<G_@-<#FU2E-/5['S
M$L1.G@:M>#O*3M'5;MVTM?J_70[K]CWX<_\ "J_V?-)DN(O+UG71_:MVS#Y\
MR@>4I[_+&$X/0EO6O3JV-83/E6T"#9$O^KCQ\HZ#@=!BL@@J<$8-?GN>U'+$
M*DOA@K+UZ_UY'W&68:&$PT*,.B_K_,2BBBOFSU3YL_;$NKF^U'X2V6GZ)X@U
M>;1_'.D>(;]M)T&]O8H+&(SB20R0Q,A921^[!+X(.W!!KQC7? .D>*?%O[4^
ML'X=^(+BTUK1;:X\+QW'A'48XKB_-F\4L\5N\ 'VD74RD2LGF*))G5@AF:OK
M7QA^T%X&\#ZQK.EZGJ5[+>:+:I>ZJNEZ/>Z@FG0NKNK7+V\,BP91&?$A4[1N
MQM(-6?"?QX^'OCSQE)X5\,^+M+\1:W'IYU-XM)F^U1+;B01EC-'F,,&91LW;
M\,#C!S7T%#$5\/17+2E9+?7;F4K[>2^3/)JT:5:H[S5[[?)KOY_>CX>U;P?K
M_B)-(\13>#/$'Q)\27VBZ)X<UKPC\0O!^H NRV\27-QIVKO&/L3!Y)0SR,B^
M9]HF)?\ <Y_1VODKX&_ME>(O'GBZ_P!,\2^&88C)I\EQ!I6CPR?VAI^H#4+F
MVCT>X$C[7N7A@,^YA;A$CE=U6-6D3ZLTV2[ETZU?4((;:_:)3<06TQFBCD(&
MY4D*(74'(#%5) SM'2L\TE6YHTZT;<OG?MZ;6WM\VK%8%4[.=.5[^7]?UTW+
M->!?ML_\DBTC_L.1_P#I/-7OM>!?ML_\DBTC_L.1_P#I/-7B_P#+JK_A9Z?5
M>I\24445\D=YZ[^SMX1TKQI>>-+34?#D?B.[L?#USJFGP&2Y#FYB*A(PL,B%
MPYDP5Y)PNTCG,WQ"^&<%U/X"T70?#_\ 9GQ"U:"4ZKX8LI99%M<ONMF;S7=H
MG:$EW5Y/D50S*G)/-?"?XD:?\.?^$G^VZ-<ZO_;FDS:,WV>_6U\J&7'F,,PR
M9?Y5VG@#!R&R,;&G_'R[M-1T/Q++IOVCQ_H_[J+Q"9QMO8,!-EY"8R9G$1DC
M\U7C<JRY)* U]%1J8%X2%*JTI=7RZI<R>CM\5MM;6NG;0Y)1J<[E';_@?D8/
MB[X3WOA7PV/$$&LZ1XAT9=3DTB6\TB61DCNE0/L_>1IO#+DATW(<'GD9X>O1
M/B7\63X\LS:0_P#"0):-=_:_(UOQ%-J:08#A4A5E0* '8%G\QSM7#+\^_P [
MKRL6J"J_[.[Q^?ZZF]/FM[^Y<NM:U"^TZRT^YOKFXL+'?]DM99F:*WWG<_EJ
M3A=QY.,9/6J=%%<;;EJRS[$TFXD_:"_9$N;>0F?Q+X2;,;=7<0KE3ZDM"67W
M9<U]#? GQ\OQ/^%.B:Q,PDO&A^S7H//[Y/E<G_>P&^C"OD;]A?Q>VC_%*]T"
M5_\ 1-;LF C/1IHLNI_[X\W\Z]D_9:9O ?Q'^)7PXDRL5E>?VA9(?^>1(4G\
M4:W_ #K^AN&\8\PRB+D[RIZ?=I^5F?E^9T_[/SVE6CI&NG!_XE>47Z_$B-O"
MO@Z+QQJ>C>(-.\2:WJO]JF^U'Q1&6CMA@H\4$C!@3''')#N 4A"V>!R/IJO&
MOC-97MQK$5E9>'?#FH17,:WIGU[4/(!NHSL1HTP071=N6[J54Y Q7HG@W5-6
MUBTDNK\:;)9R+"]E<Z=,SK.IB4NQ# ;?GW >V,U]'5;G%2N<V61AA<16PZCU
MW46N[U=M;=[N[>^J.AHHHKE/IPHHHH *X;XW7$4'POUQ9SK7D3I';2+X=C$F
MH,LDJ(RP+GEB&(XY )(!(Q7<UY?^TIK%MHOPCU.>[7$#7%K'YZZH--DMF,Z;
M)XYRK;71MKCC^'GC-9U':#9RXJ2CAZC?9_D8_P"S5KW]MZ?X@6#Q5KGBNPM)
MXK>&7Q%I7V2]M6"%FAED*J9F&Y?F(XSU.:\NTG_BO/\ @HOJL_\ K(/".@"-
M'[!FC4$#WS=R?D:]T^"&CZ7IOAF]N-+\<W'Q#6]NS--K$]Y%<_,(T01@Q?*,
M*J\=><GM7AW[,(_M;]K#X^ZF>3;W:6>3_P!=9%_]HURRO:G%]_\ -G@U(R<<
M)1EUG?OLI/N_+JSU/QI>FY\47CJQ C8(I]-H _GFH+7Q5JEJ OVIITS]VX D
M_#GD?A576I/.UB_D'1IY&_-C5.OX-Q^;8R.:8G%8>K*#G.3]UM;R?8_=Z5"F
MZ,(2BG9(ZNW\;HV!=6('/+V[E?\ QULY_,5J6WB#2[S 6[\AC_#<(5_49'YF
MN HKV,+QIF="RK<M1>:L_OCR_C<PGE]&7PW7]>=SR+XW? +XQ>/OB)XHO_"A
M^'K>!=:M8+:YL;BXO[*YU$I#Y9>]N+ )+-@/+$L;3-%Y97,>X;AK^"?A+\3]
M&^.V@^/-0T+P+8V%IX0M_!]QINB:Q=1Q0QK=+,UQ;QM9 *H *I;EL  #S>]>
MDPS26\@DBD:)QT9"01^-:]MXPU.WP'F6Z4?PW"AC_P!]?>_6OT'"^)&&JTU1
MQ5%PTM=>\MDKO6+7W-GB3R-QFYPG?6_;_,\Y^.O[/.K_ !2L;*^34[+5]8M-
M?M+]M-U8/!IMWI<,X=M*8*)=D<FV*261DE,LL,990B0I!VG[._PWU?X0_!7P
MGX/UW6?[?U72;4PS7H+E.79EB0N=QCB5EB0G'RQK\J_='36WC:WDP+JS>(XY
M>W?(_P"^6_\ BJU+?6M-O,>5?1HV,[9P8R/Q/R_K7TU#B+!9A16'HXB+5[V?
MNN_9*7*WOTO^!S/ RHU'5<'?;O\ YENO OVV?^21:1_V'(__ $GFKZ ,+A ^
MW<AZ.O*G\17S_P#ML_\ )(M(_P"PY'_Z3S5Z$HRC3J<RM[K"]VK=SXDHHHKY
M [SV.^^ >GQZ/XFNM/\ %G]I?\(_8+=7&J1V*_V+/-MA9K6"^69M\O[X*JF-
M2S#&%S75_$KX1IX=T*\\%^&)_#]WJ_AW15U?Q/'+:,^I2R_NGE>&YE@"K!&C
M1%4C=&*EPP=B<\IXL_:8U#QEH\FGZAX&\#_\>!TVWNH](;S[.':540,TA\O9
MN)4#A3VK,U;]H/7=7EUZ^?2M(@\0:[IHTG4M<ACF^T7$&V-'&QI3"I=8E!*1
M#'.W:>:^KE6RRG&<:2W5K^]>WO7M=NS^%=FKWW.'EK-IR_K^M3U?Q1X9\ ?%
M3PO#)X-TF.*"RNS=1?8[9;":&PBL(?/M;BXE"QM()OG>X=I5B5@2Y:6**;YQ
M\9:%J'AGQ5JFF:KI7]AW]O.PDTX;BL&3D*I9F+)@C:Q9MRX.YLY.QX5^*VN>
M%=1EN(_LU_;3:3)H<VGW41%O)9.,-%B,HR9;YRR,K%RS$DLV[-\>>-M4^(_B
M[4O$FLO&VHW\@>00IL10%"HBCT5551DDG'))R3P8[%8?%TU42M4OJDDE:WS\
MK*_Y(UIPG3=NA@4445X9TG9?!G7F\,_%CPCJ0?RUAU.W$C#_ )YLX5Q_WRS5
M]BZY_P 4A^V[HMR!LA\2:08I'[%E1U _."/\Q7P7%*\$J21L4D1@RL.H(Z&O
MO+X_2K9_'WX)ZLO"W=V;8,.<@RQ#_P!K?K7[!P#4<HXBC_6J?^2/SSC*/)0H
M8C^2I!_^3)?E)G?_ !\TB+5K7P]"=-\)WMQ-=R6\<WBN-WCCS&SE8]A# MY8
MR>@"\^W3_"&$V_PWT*$WFDWPB@,:3:&Y>SVAF"K$QY(50%R>25.>:POV@+&V
MU+P7!;7%MK]T;BZ%L(_#80W3*\<@D4[^-C1[P?<K6C\&8[>/PC*;/3=4TFT>
M]F:&TU:U6UEC3(VJ(@!M4#Y1GD[<DG.:_2GK17J>532CG$W;>/\ E_E^*.\H
MHHKE/I0HHHH *X'XY7'V#X:ZG?\ VO0;'[$\-S]H\30/-8IME4_.J$-D]!CG
M)'6N^KF?B5IU_JG@76H-*C235?(,MH'@2;$R$/&520A&8,H*AB!N R0*B>L6
M88A.5&:79GF_[+/B:W\0:'XG6&;P=(\>IK*R^"(#%98>WB 8Y )<E&SNY& ,
MX KS?]D?Y?VCOVBU/#'6E(!ZX^T7?/ZC\Z](^ 6K^,&US6+?Q3I1T>/5$?5K
M+3VT^"U^QQ>>\20EHSF:3RUC=\C*%T&X[@%\U^";?\(Y^W=\8]$)V+?6,>H*
M/[Q/V=^/?]^WZUQ?\^V^_P"C/F^9KZG.7236JMO&5M-3T+55VZI> #&)G'_C
MQJK6IXH@-OXBU%#Q^^9OS.?ZUEU_GWF5)T,=7I2WC.2^YM'] 49<U.,EU2"B
MBBO.-@HHHH **** )K6\N+)R]O/) Y_BB<J?TJEXZTP?$[PXVBZL8KDI(+FT
M:9%VK,JLH#''0AF7)Z9![',]%>O@<VQF7NU&I)0ZQYFDUU32_/=;K4PJ4:=7
MXEKW/F2Z^&^AVUY+'<:48YXW*R1-)(NU@>01N&.>U-/@#PY_T"4'_;>;_P"+
MKW#XD>&/[6LVUNU3-Y;J!>(O62,<"7ZCHWM@]F->75]<\96252E5;C+5:_GY
MK9^?E9G#[..S6J.;E^'/A^1LK8F,8Z+-)C]6-46^%.C-(6\Z\12<[%D7 'H,
MJ?UKLJN:/H][K^I6^GZ?;O=7EPVR.&/J3_0 9))X !)XJH8S&5)*$)-MZ)+=
ML3ITTKM'!_\ "J-"[2ZA_P!_H_\ XW4,OPFTEF'EW5X@[[G1O_917JUSX%U>
MVTF\U/99W%C9[/M$MIJ%O/Y>]MJY$<A/)]O7TK/O-!O]/TG3M3N(/+L=0\S[
M++O4^9Y;;7X!R,$]P/:NV=?-**?.I*RYM8]+\M]5MS:7VOIN9J-&6UOO^9Y7
M)\($:0E-59(\\!K?<0/KN&:=_P *=A[:T_\ X!C_ ..5[E<_";Q-9_;/M%K9
MP?8MGVKS-3M5\C?]S?F3Y=W;/7M7/Z]H-_X8U:?3-3@^S7T&WS(MZOMW*&'*
MDCH1WK:M5S;"1Y\13E%7M>4+*^NFR[/[GV9,50J.T&GZ,\HD^#[9 BU7?G^]
M;;?_ &<U]6_M$0-%\6O@':2 $PZGSCU$MK_\37EGAFQ;4O$FE6BKN,]U%%CZ
MN!7K7Q;/]N?M;?"S2?O"TMI+XKZ?ZUL_^0!7[=X75ZV)>*K5=E9+[I7_ #1^
M<\<QBL'2HQWG.FO_ "I'_(]0^-NC-KGA.UA_L#4O$EO'>QS3V.E7PM9M@1\.
M&RI;:Q0[0020#T!%2?!22*7P2KV\6OP6QNIEBB\2S^;=HJMM*DDDA05("DG'
MK6+\>O&UWX3@T."V\42>$4NI)9)M2CT@Z@$5 N ZXPD>YURW7D8XR1T'P7M;
M6U^&FBBSM;&T@='<#30PMY29&_?1AN0LGWP#T# =J_9W=45?O_7D>%3E3GG$
MU'>,=?A\K6M[UM?M65_AOJ=O1117*?2!1110 4V10R,"2H(P2#@C\:=4%]90
MZE8W%I<QB6WN(VBEC/1E8$$?D:!,^:_@G\/];^'OQ %Y-X GM[%7N=)?Q7K'
MBN2XN98!*0LOV63*J97BB/RD9R".,"L#XK8^'?[>7PV\1$B&Q\36#:7.QX#S
M8>(#/U>V_*O1++]CWPB;>W.LZWXJ\0ZA$$;[9?Z[<$^<N")%4-@$,-P!R![U
MS'[?G@VZU/X/V'BO3BPUCPCJ,-_'.@RZQLP1R/HWE.?9*\^4)0I-VVU_K1'R
M=?#U:&"E+EM[-J:U3V=WM%=/7U/2?B58_9]>6<#Y;B,,3_M#@_IBN3KL/^$@
MM?BE\)_#_B^PVLEU:Q7>U>=F]0)$^JMD'_<-<?7\9^(66O+N(*TDO=JVJ+_M
M[?\ \FN?MV3XB.)P<)1=[:?Y?A8*YKXE^++KP'\/_$/B2TL(=4ETBREOVLYK
MDVZRQQ*7D D"/AMBMCY<$@ D [ATM<7\:M+U+7OA%XRTG1].FU75-2TFYL+:
MTADBC9I)HVB!+2.BA5+[CELX4X!. ?A,!&E4Q=&%:W(Y1O=V5KJ]W=65MW=6
M[GIUW*-*;AO9VZZV.2\,?&;Q7J5IX,UO6/!>G:7X/\0V3:A/KEMKS3KI,/V1
MKE&ND>VC"*P7;O#%%/5N5#:_@'XZ:!XD\+:3?Z_JGA[PSK-];7%X=)7Q%:7N
MV"%YE:598V"R(%@=F9>%VN"<HU4/@?\ #^;X>?#'0KFZTSQ$GB2ST2.TNM&N
MM>DNU:6)%#+#$]TUJF]HQL*E JN =@W*/"/A3\&/'.BW'P"LM?\ A[=FU\$W
M.K/J<TUWITT*M=2%[>:-1<%F\IMCD[0RE,H&(%???4,DQGUE0E&DJ<FHOG2<
MDHUY>ZI5))IR5.%UO>+7+[W-X7M\;1]FVG+F6NFUW!:VBK63D_OO?2WN_P 3
MOCM_PB>E^"M3\+66D^,]-\4:W%H-O>1:SY4*3RLRQL'CAE#H&CD#D'*E0 &R
M=IX;_:"TQ?$'C#0?&YTGP5J7AFYLX)[B;5U>QG^U6YFA$<TJ0DOM23*%!C;D
M%N<> ZA\(_B'J5C<VDWP]UQ(KCXJMXV=K?5M/AD&GL"#&LB7@9+CGC:0 >0X
M->H_M!_ GSO@?XQT#P#X<N]7\2>)[FS:ZN;C4O/N)?)DC97FN;R;>41(=BJ&
M;!?A0"Q'3/*^'Z+H8*I4BY5)<OM(SB^1.I#WIOG<4HP<E;E7,];K4R6*Q\^>
MM&+2BK\K3U]UZ+W;ZRMUT/:)O'WABUTO4]3F\1Z3%INEW)L[^\>^B6&TG#*I
MBE<MA'#.HVL0<L!CD5?T/7],\4:7!J>C:C::MIL^[RKRQG6:&3:Q5MKJ2#A@
M0<'@@BO%_&_PA:TO/AQXD\(>#;2WTWP_J3ZIJ'@6VCM;/[1+/"L0N!AOL[75
MKC<N6P<,%E7 W;WP3\#:WH?BGXA>*=5LO^$;M/%.I1W5KX765)/L?E(8WN9#
M$QB\ZY($CA-V,+EW.=OR=?+\OC@I8FC7][HFXWOS\O)RIMWY?WG.O<M[E^8]
M6GB*[K*G.&G?7M>]]M_=MO?78]<AE,,@< 'L589# C!!'<$<$=\UY1X_\)KX
M>U!;FT4_V7>$M#SGRF'WHB?49&#W!!ZYQZI4=Y8VVL:?<:=>C_1;@#+@9:)Q
M]V1?<?J"1WKBRW%1IMX>J[0EL_Y9=_1[2^3ULD==:#?OQW1X+7>?"&XB_M+7
M]/:5$N]5T6ZL+-)&"B6=]NR/<> 3@@9(&<#J17(ZUH]SH&J7%A=J%FA;!*G*
ML",AE/<$$$'T-4:^IP>(EE^*C5<;N+U6WDUY/[_1G'4BJL'&^YUFE?#_ ,23
M7D=@]K<Z3+J#);)%>1RQ&YRZD@+MRR)M\QFQM4("3DJ#W\=K%XY\.^,]#TR#
M59Y;-H[^TM+RP$(L6A A$&Y'=I)#"OEJKCDQD]<FO'+_ $^ZTJ[DM;VVFL[J
M/&^&XC*.N0",J1D<$'\:W/"/@R7Q+<79GE>PL[73IM3DF\DNSPQDJ?+4E0QW
M#;]X#AN<C%>]EV*5.H\)1P[DY7C).6MFG'LE&SDW=JVVB:N<M:%USRG:WE_7
M8ZCP?;ZAJ?PK^(]V\5S=O.UF[3LK.9&68O*2W<@'<Q[ Y->;SW$MTX>:5Y7"
MJ@:1BQ"JH51SV   '8 "ND\8^ ;KP;JVJVES<PO#92K%'/ROVEF57"HN#\P1
MU9NR\ MEDW<O7FYI4K1]EA*\'&5).+N[W?/.3?EK)K=][ZFU%1]Z<7=2U_!?
MY'H?P%T4ZQ\3-.8KNBLU>Z?VVKA3_P!],M=/\/R/''[8GC?60?-L_#]BNGPL
M.=DN%0C\Q/5SX,O!\//AGXI\=:@H6..)S%OXWK&"<#_><A?JM3_L<^'Y=)^&
M.H^*M48+?>(;V6^FN)?ES$I*@MGH-WFMGT:OZ9\/<O>7Y![::]ZJ[_)V2_\
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MZOB/=G'1I]/)^79[-'$44K*48JP*L#@@]125_/&VC/O HHHH&%%%% !1110
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,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>ahl-20231220_g8.jpg
<TEXT>
begin 644 ahl-20231220_g8.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         #. @  $P
M ,X"   3    1TE-4" R+C$P+C,T   R,#(S.C$R.C W(#$X.C(X.C(V  $
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M1T(@6%E:( ?G  P "     @ "6%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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M     ?T _@+'HESNB4      -)N6Y[J$R.C@
M           #(>SE/4WKW8^6K 'S>>8K/\@Q+D84
M                ;K\7O^W[&;V      -(F6YWI^R6C@
M                    #(JSE/5/KO9>6K 'R>>7_8./8D2,*
M                         -VV*Z!N&QF^      #2)EN=Z?LEHX
M%CWKV3.#VO'7+ZQS(TB<I%95P^;5[/XF0BDS'V-5?JS'2.??CTS,Q&T''[Y
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MA1<G$;T+]6+W&DQ>F><.S7U$J%:$++?F]8^*KM??>@MU2SSW'>_B_P 54
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M]4^N]EY:L ?)YY?]@X]B1(PH
MW;8KH&X;&;X      ,.96 Q/DX4
M   6!1)V8X_;_J] 'Y>:WY^IU7<A@
M    #,B+G<KHV<
M
M
M                        $1I?NYY*/*?WY6.(<L   K^FB27:>\HNB%^T
MS*CVG;UNX[=?]5?FW[P9%'86ZA ?:)]Y6\<&JGG>5
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M/E\W?,5?*N_HJHR5CLH(>3NKVK6Q>AWY$OWY=N8@S(/)QN2GDO$W%<EW;$F
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M@
M                      ('7%\E^Q\4A]5@ #:_C]SWNX?I(
M
M          @=<7R7['Q2'U6  -K^/W/>[A^D@
M                                                         "!U
MQ?)?L?%(?58  VOX_<][N'Z2
M                                             ('7%\E^Q\4A]5@
M#:_C]SWNX?I(
M                                 @=<7R7['Q2'U6  -K^/W/>[A^D@
M
M                    "!UQ?)?L?%(?58  VOX_<][N'Z2
M  .!'KU]^2)I/Q_12;.1N SW)V?6N'B,G_+E,3M7+96Y%=\@%FY'+]J?6;E<
M7J,A+-?S>4M;NTCD8><T.^
M                 ! ZXODOV/BD/JL  ;7\?N>]W#])               '
M CUZ]Z9-[Y[!5KCIM[XG-TCLNKTK!R_RFX^2X7-3G(8/*"NK&N))X%=J,/<;
M;>0R$F8FFK,G:)[3\O/;0MU@                            ?*BJ.UT]
M*<VJF:4U                        "!UQ?)?L?%(?58  VOX_<][N'Z2
M            .-8N0&='C%BY8U7DHI] 'X*DM7N7/A6G%O@#\>./5Y]//:K>
MS+VF0^.0]                              _GC54M9%87+X.[]JVZ[7,
MN                        ('7%\E^Q\4A]5@ #:_C]SWNX?I(
M     QYHN8Z3(E@8Z3C+DZ\LJ(>7,>^!A#[39<29B!F\9M2QT@] %5V)6,>2
MQ7-AY6.3,;L&B2                              !\Z*J5JM=/:EPW(0
M<J+%?845@                       0.N+Y+]CXI#ZK  &U_'[GO=P_20
M           !7WOG&\=D]B_GL_KMR&FL"KGD^(]ZFGGH %=4551(C7Q:O0/W
MVX/                               B46_$)]N(U1<=(\_,2]"M&U=
M                      @=<7R7['Q2'U6  -K^/W/>[A^D@
M "/QI.*N6QO7X'+1G9]>V 8G*  " 46\7HL.@+$6H;5B!V[5_P"1NZ]-JT:P
M[4RW*)F1]C*Y:QLQDY9RGV>@                            "N\5D,4M
MNP/?8R]8V+R53;#A<YL9D !"C!DPV,9RG"]"49KE\>]HM:W,R!LY+*Z/F<OX
M^9D'E8               $#KB^2_8^*0^JP !M?Q^Y[W</TD
M 0VQ?PHR&.S$C3**D49=1_0.!@)5 :)"Q9T?":MNW8Z$6[0 S(S$G4GO',@
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MW5%7]>@ :^CS+F.    !FL378^*TQ=@@   90QLSZ#</TK*JQE0
M   ('7%\E^Q\4A]5@9<V\UCU:B0N3 VOX_<][N'Z2         ..?;QP_/>O
MN4]92@E-7(N46[3[]WHBU,;3KC>3XE1]4VF\P[M;GY:_3O\ */17OW-P6BMK
MT[6A] 8_@^> 9D9B3J3WCF0    %GVIOHOPO4,VHV;ZZS=QOF6)[&]KR13T<
M>5(;T?KZ+DSD1OS"DUC-L96VO9%16                !BG73,[5[!273M8
MM1^9;O <0\^)HC/@    #-8FNQ\5IB[!    '94W-Y>)Z'MYQ^X_H
M     @=<7R7['Q2'U6.?-C[#-:Z%5=^%AQD=2VOX_<][N'Z2          ,$
M:5JT>X9Y.C/*W1><6Z!65O'Z0<7QFHK>)$LJE[F/A+[)Z/Y.Z )3]*:9K#W_
M .?(;]CR,4(L$#,C,2=2>\<R     '8>7/0!ANE;2(.U 4-%O?:11@!DX=I0
MI>3-5G(>S<                  &/GOEK6ZZJ]N7E(@]A9D"-'E?-9
M ,UB:['Q6F+L$     ;3L=N?H Q'1.4]           $#KB^2_8^*0^JQ?=<
MW.S#[ABM5C,0<GJNU_'[GO=P_20         !5%+E7:(W;O2.Y9LZBL5C;QV
MBO%<5KFC' #-S&= S<_)W[(Z_6)GVR%K%[[M^8ZS[E&UY;#C0,R,Q)U)[QS(
M     #Z>>[_<-TS:O!VL8=1;\[O45#E<7D;B,GC_ #[>;<;T
M        #H#R:&NT      S6)KL?%:8NP0     -FN/W'T.8?HWW>@
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MC4&I@@ "Y:\SMF_-+[6CG#=EDW7\%A?]6_.&$'T78I2Q&&9&8DZD]XYD
M  !*J)'JLU_L&05K(                  #\4^Z8XTZ=YS&9(6*,U(M\ #%
M/1XGD2WB73@      ,UB:['Q6F+L$      #T4X/J6R^'LP  BQ]J;G>78\=
MHN2D     $#KB^2_8^*0^JQ=US(Y>8?9L:+N*QLGZ[M?Q^Y[W</TD
M"J+-_H9F/O6S)@?OL\\\_E*,7/)13Z*_*G/U1"U?XWDF-MC6P !LETKL.1'Y
M2?5_RAW*=^]?G3&OZ3P& ,C&C,C,2=2>\<R       &6,;-^IS =<Y;T
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M&7(:WM?Q^Y[W</TD       "'6Z^PNVNL]?.W7V7M<5NQNFLW[-NVH'177X
M.65!&U751C>31KR, ,KK.W[$_P IOM/CXJ]7/Z._-VG#IV$A]%O,C,2=2>\<
MR        L2W+]=6N=HE7ET                 =;;JB-^U++5SH+E,SI]
MK_YRVVH/BW?\9?MOYKUG]#^=\]M;Z7D1\?;KC[]6YSSF]YRE1     S6)KL?
M%:8NP0      !^O/?4S@.OY>Q\P!5?GM>WJ<3;,C(>U31N9@[,\9)     $#
MKB^2_8^*0^JQSYT;:9JW2L79>$Q&R&L[7\?N>]W#])         P[MR)5)@8
MAQY.:<Z'D'$E<(QX/F  ?TXEO&ZK,9R&C+6# &VKC/T//OS)^C>@^Y>(X#?5
M^A81V\=F1F).I/>.9        #>WA^C;?<?N0                    &,O
MY1=MC/),V)#]'Z9@O]D?*V..R\[V*?.W7/G&S7G[^QM@P,D5    9K$UV/BM
M,78(       &PB#M'I0PO4 *<LWJ*G0>UAY&Z9>/IVFK+FW[^_+@    $#KB
M^2_8^*0^JQRI%K8?AMXQRJQ^.<_7-K^/W/>[A^D@        4EY7\[EOJ;,O
MGSL9?$237!5P   .T\MZ_<?R_!V)HX%B5Y#<+^>OVAR\=)PD^\.":NLYB<R,
MQ)U)[QS(        7_8ROK6U[L?[                    (MR3.XT?E%VL
M ?271]OKGF.OCZN^5K PDK+G@O0=17U;G](>W2/@   9K$UV/BM,78(
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M*C_KY@   YU,?6YCN4XB1M1R"]V';-\#?8.''W]Q'%J]C-2>\<R
MS;A[%Z?<'U8               #".U34$OR\H4K'K,QMI>.I_?EP=7JL[%/\
M<>]     2'ONJ5U]O<'F\V+IVWW8-'^3N_$ S6)KL?%:8NP0       !WM-[
MV5:SW'L7H        @=<7R7['Q2'U6+7D2,E<'LE<W;&+,_6MK^/W/>[A^D@
M          8L?%.NXY?(.% [S:;EC]CGRKL<^2]@G=AT27'_ 'WX@ ':O,4(
M6AZTX',MG?-^WY)7-QU2=0Y]J3WCF0        $WMRO9!K?;OZ
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M?-;D/E/<7)4=EW(C+NQ2973LF+C%(P\)KC@     >K'7>RY3V<F
M         !2OPCTNJ?C7?0 .1E[/8[+#['9X?8;1#X^R1.'LL/KMJA\'9(?$
MV2)UNTPN#LT3A9^)T%SR/'"+ ]UC1%L&@T%?Q@        WRX?I&W/'[@
M     ('7%\E^Q\4A]5CFR[&X[6^FX>7L-A/D]2VOX_<][N'Z2       !_*5
M)W:99:N4+=IR[H\/<%OS1U"M.,P@  !(=QNS7I4N&='Q=9;]@ZLZ#@::S> Q
MN@:G$K4 #:MM??9+L/5XC!Y=@]%T0 3>J=>%S-<^1.ALVJ,2[D E^8\2,;C]
M>Q?Q]\   ];.N=HO^UD                   *JXWL%2<YRO7;5#X.R0^)L
ML/KMHA]//M=&= 1X^0    !*8^JX\6M+PXVFYAA,P(       'H.PW2]I4#;
M0       ! ZXODOV/BD/JL=I/B[F]2ZKA3+P.$V3U+:_C]SWNX?I(
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M/+<)(NB@       9?7]MW59'KX                   ZLU9GS
M!+;&KZSL=QL=U[?RFS.^:BMBUJ"7(H     LBW-]AVM]K_0        ('7%\
ME^Q\4A]5CER+6V37>E8@3,%B?.U?:_C]SWNX?I(          $6MQ?+'SCX[
MX'ED      90Y'=MB&]?3M?>^@":V=<UC8WBP       &UN;U#8;+WP
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M'U6/I+HR_P %MM"R,/6TK&[7\?N>]W#])           &OK!\WT8:?\ .8
M   &U#:>]2G8^M<8  ^I%(/+<(8NB@      9)W=CWJY/M(
M       BAK*/F         "9V-:UD8[C  %\W<_!=FS^M#*ZJ   )E1)]@6M
M]KDGEP        "!UQ?)?L?%(?58^LZWM$U?HN#<[6*:F87:_C]SWNX?I(
M         ZJFUYA.>?(]=V,0    !DOD-RV-[W]05[[4  !-K.N:Q<;Q8
M   #<SD.O9GR-N                     P+*/         !;/E.M3%<!AM
M,, "PZLA:>P;KJ)SNH]?[0  -OV,WG>UBM_         $#KB^2_8^*0^JQV,
MV-N4U;J6&TG!X1Y/4MK^/W/>[A^D@           :O==Y-IMU7@@    [:J1
MN@W[ZMKF9GP  !;+S6IB> 0VF&     !<MS,;_<GW/[>^@
M      5P:XS^         'U(I!Y;A#%T4  =S[>RJS&_:BMCUF W(H D--[U
MQZYVBU*)0         @=<7R7['Q2'U6)G=KR!QF?B]=G'.7@]K^/W/>[A^D@
M           =53:\U.@?*=+1-<    VD[1W69;)U_B    ^I#H'+,)XVC
M   ;N<CV;*^_LP                     &#QCX         ";6=<UBXWBP
M  '[>Y>Y'>M:FT8S'J_BP-U>*Z!NMQF\          0.N+Y+]CXI#ZK&;]K.
M3*+D*51<6)^N[7\?N>]W#])          BQ%Z:OU[YU5VU<ENYB5C-/\\NC?
M+OR4@  9(S]OV0[Y]1U[[4    )K8UO6-CN+@    #-N1NFXW(=8
M              '1&M<Z          M9YK?Q/ H+3!   &4$K;,2-IOX33<!
MDA'R_JOP'7NY\K          @=<7R7['Q2'U6  -K^/W/>[A^D@        "
M/6+VK'*P+PCY*G+'MBY#$;'8$T:@M7XIJHUOBP  [2J_NCWWZMKB;L     %
MM>4ZTL5P&'4PP   !:E>5WW9/M\FJD                       4V8!'X
M       !^R/0>8X,Q=!    O6[GNDV78]O$/><EK.2          $#KB^2_8
M^*0^JP !M?Q^Y[W</TD         5W15%[E(ZVFN578]J6[HX_E.A'2_G+"'
M$<Z  V@;/W*>;+V+A@    'W(= Y9A+&T8   "3^RM[.3[9=%S+
M               8OF'8        !/;. U?8WB0   'T>[I,AV',"1M0
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M=[9=Q\_K4^KF@#A')/@?<_OCY^HO35'ZJ+"JI4U_=Y6%-RS[EC[4W
M          *%J\OJGT4\8.D>       !85K!:N<9Q  "VJ\MN4R'7+ZNYH
M          0.N+Y+]CXI#ZK  &U_'[GO=P_20              ! S"0K(
M     F=C6=9&.XR!*/96SR;TG/\ E;Q]7H   &'5RGXP)G=9/%XL6INR.3$F
ML.0                  *0B2=?>8QNVZ)?^M-0Z0P^,>3\@      LLU_XK
M@U848P<Y<V&2]^V;3.B]Q[=             @=<7R7['Q2'U6  -K^/W/>[A
M^D@               ?DHPQ6*Y      +<\IUF8G@'Y,_I6];$I>_2VJ2
M !2GOG=$RHN1'Q-9,;N+-X                  ?'Q^?5:>^37SWO@"OC%0
MHP^0     /Z=?"YM@_%T+-Z1N>R.9T*TJ\B!0M7E]4>T+7Y?5/H
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M_?M'D$]IM_RH   <,@)"R.G6G].T)(38GA]P  #\>/EZKJW<[>5&FUFX>@
M       "!UQ?)?L?%(?58  VOX_<][N'Z2               ('17 ;T>^J+
MKQ2-7EVV_<?;U-PQ)&/>2@Y319 @CR=O12)=Q_*48N>2BGT
M                             #HL?+U3;+A\V-?S6*6P8?:7BI1Z
M      ('7%\E^Q\4A]5@ #:_C]SWNX?I(               P"NW<QK-C6=>
M7OBLCB/D[.S_ -QNK635MIP4_7GM&O='B-AN>-"J#/6)U"D0FCV?XG+?&7BX
M)GH?Y@Y++*B'ES'O@                                          8
MP>K[\\@?OMP>           ('7%\E^Q\4A]5@ #:_C]SWNX?I(
M     ZFW7$Y-CH+5V1'24^6!<HJ^B[+O:8-<H@-B9,)&.[VB]9OM-?6KW<UV
MNGHNKUKX6KD_KMR&FL
M             "!UQ?)?L?%(?58  VOX_<][N'Z2                  !B
MC=]R8C58I3+./<69E+D,;E%!D@
M                        "!UQ?)?L?%(?58  VOX_<][N'Z2
M         !1/E4C\\QBF1\G,;/ZC(P+KC7P
M                                 !#ZHWFRSW*(M[9  V10MJW"8O?
M
M                     ..H  'T5?1Z
M                                                         *J]
ML5/Y3W=U;E-5$69%SRH79V)..DB#D9&G_JY1^J:OF\JNJU:E-[AT5U!?AW79
ME=1<M_J%=JG,0[NA2J=6KF]KXUNOIKUKXXZ96&<Q&2T'(1^A]*_*UCWY=D,;
M];-_L*;G\\=?9N=#/A\VQ>JQ3]*;UP28/-C3>%#D4?G,#?,+(]W3<Z=Y]7O7
MT>_R]9^5%=.>^6S73(+5WY>OO1[QKE%/7(T+HO9B4U0.FKD7:<?H]S*>7%Z2
MS?\ [Y5TGCYWK,CM7?G[[B_=B9+6Y76>>P2N/:M-[K7O:^>\"BN R8<YLW^S
M>_I[_" ^T32BY3]F]8F1Q=<6K^0=-SN:+H
M              %;U6<3Z+//KJK^JF0UVY;?BTC9O=M%F]M+QUX7+T.B2:9N
M1<C:+^.-VW95-43A39]F<)7N+S-A2,914_R5X^3E%;D53%NQO/X*JL?D,BX5
MZALM"S#MR8I'KQRHMSRU*RRRN-P^Q&3Z"?C9E55U$*OLL] GF R]'Y*%VT&=
MR+^._ODS*O'S\:]BU>#X[*;&(TS!2CR.2\?;B]04V+?&+R%&3(5NP)U>SH5K
M7Z>VP>8CF6Q-?5VH[&GYQQ)>+,C%0+*Q^TPF8R\N4XA5PYW(]DF.G1+.X/@X
M#.=-D,?VL^%;.-RL,QLN$;5K7UP>9L>5&JNU[.E^T%4;I]IBN-9U%VL:K7<T
M2K%NT59#OV7E,70D:_E;7[E=%R0
M         Z"EV5ZWS;=P "*+<K7(DIE7K]^5 5O;JDLN'([$H   =8\[-Z
M .NH]XM^QW=N\!TE'OUO6>VHN@
M                             8;UQ>Q51&NW'<-DIAN>H<7!YFQ?;_9V
M[E<UVK&M7:Y]I["9$K#'9&T9>+X=4F^\+EL0\]@<SZ:M<%3:U#R6%T;V<Y;%
M0V%*C4BS=<>[%ZJ^UF1\EH&0UO2H796_)[ZL"%-A.4@2^)?JF[;NZ+?ZJ3%I
M"NG-"Q.I*JS$?:;,Q4_HMCQ&(D2S+$K-^S+P^M6;AR47[1)<$KCVA8E4A1[<
M4Z)P(DJ"RHMQ8O(4;E\?EU9D6'8E
M                         4[%KP<SF$K#7<GCUNVE9O:UL\4F1I#"O8#J
M<L,MC9AC\CB%,C75A,SWN?P'80,KMFLS-3LK'YEX;-X#[7I6RG [;@W:@X?S
M\3F37(I>S?Y,W%Y)VLGDMBLWU,VQK'FX21V8T/QN=[23B*=S^#V"8#;<5O8]
M[Q9=&9:+#[4;;[:RFJV_AZ,IO9RVKUO52,2\GC97K^3VM7[^@[W%=KL.!W/Z
MUO&(5^%!*J8'A\A ]NTF683:>+(A2Z9&CF'SN2&7Q6S+$;
M                                       /_\0 .A   @$# @0% @4#
M! (!!0  !08$  ,' 0((%!<U$!@@,$ 64!(3%38W$3-@,3(T<"$B(R0E)RB
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MQ-@$H3+9'PWIKIE;&'+=9N'C\[3(2I^3KAC6[<N<.'$+^#]8SUKL_HI;ME[
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M0EK<G[WOW[+>R&;#$8UMM5;UF QKQ:]]R9NPG^\>GAA[U\R]>M1[*DU!W9>
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MO+[ >R5%81("N&'O7QLERRYA\3&F^VQY,0SCVZB3PN\?XM;8)3Q;@Z&'0CX
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M(+-C9E62\,Y$C@OINY\14GZ%5;[ _K!Z>PXP_42F0'!7NL%['%TUJ<\6G?\
M_3^]8OWHUR >L[M[]CE1RB!R_@ILQ/.KAT_FK(_\A_#X89VV7BOX3-V$_P!X
MJ'_7G'O'N.BS1D997%I?KAA[W\'+ZW]7$C1J0ZA&B)-FY^6XRRR \=3'"$Z4
MV;OQL/MQYDN'K'=#MFK;>)OU:DKDRMPB7^&Y9O6:(113$/40Y3&AO) 72P'^
M)B*]^?C'[ 6$PS<. /@BH?I:M?\ W^!#(2H&[]0#,$+-W"C+#UP[;=VS-N1_
MY#^'PDWOZI/PF;L)_O%1K&Z3(;1>-K"TSAH/TO7##WKX,A-4IADHDIYS29CY
M$G3)">J2AXT.*#6Z9MWXCWOV),F+NC.1V/5IP&WZ%S0Q#1W&3"R06Q+DL)<N
M6[EFY\+"'\4?9VK^_P# TTUUUVQ)>^AMP[$HAAE3(OF5QA 7D?X?")OW:K_P
MF;L)_O%::ZZ:@<EPIXO)IYE8_#AA[U\%@OEHH..2S+$8LBKQ(F<3&6--V>#/
M_P"#_NQQ\Z75A-/7JEVE$/NEY,Q +J9Q CHU;<TY5:28TIO7Y)=O?DL_NS*:
MGV;Q3"YS=>QI@DQI?X;;DZBW#WED5J56F,#I[N$MN[9BG[.U?WO3MM7=];1T
M_?6T(4W5M726M;Q&R/6MD'LTUG)]O7>>3;%:MBKLKZZ'[:WY E;:N9"8-VFY
MV:-U7&(]=UV&">V_E&&D.._(..&/')?X7"+:_HM?"9NPG^\5&WV[<AI;<^7"
MV5B&1R(BN&'O7PE2-*FRF$)<8+!K%^XG-\'#9KL8O8CB2<NK28;W;9DI #[9
M>5L2C+DOB&UL[2>=<E$=Q(^=,Z>.(UBVGK^M^]NOYJ'[+\KT0&9B%5 S*_0J
MNY$5S&^ZO\/)JW=P;CDMOG<,N1;4<MB7)82Y<MW+-SUXIL\OC3[.S;Q-G34J
MF6Z^IU#96]T!VJW/MK;74,SI5U\9KFMYM8[^FXT8N5OW[[F[VVJ%]18R6GF!
M($Y/P\01MGP>$R-K;0?A,W83_>*@Z[M)KL!XCR+#E<=D8:(KAA[U\=]M?@->
M'^M1P9B77T<3M6I1;&@C;+S!B\;4KB)(VJ)YIR45T(%BA>[Z\3H?UH?8C.IF
M?16)]18T]F/)DQ+D#)#T-K7,AN=9O%,,'-U[&N"3&E_ANWSJ+</>616I5:8P
M.G@&A?IH?[/DNS^(3\1-NV-Y L-OARB:]S5?7(F&X4H=\#AN@ZP\2_"9NPG^
M\4I);2XR7;&F:I39DE69EI0KAA[U\=V&1I&DQ@Q8'UEYJQU VS.(IAV[B67,
MD%;<R=-(7O;&CIA>?O'Q$5:\$N;MB'68+<76#WH#(PBJ@YE?H57<B+!C>#5\
M$,AG[0[QN96_B6+UR-?S6-M[3]+#4942+;C5=RQ$D1Y$21[V.1.X$A?"9NPG
M^\4'+&1DB\$R$T9"?A-Z+>KAA[U\?/P?]4QU\#$*O;4@-V[<OW?#9OW6]^:8
M&R].^#A 7^H/7VB;&VS(>[;NV;OB,<+5CQEX#B,X3-+BU;.L)D6C:D6]Q/":
MLC7IIIMT^$S=A/\ >*L7M\:^5D[U['N1+ 8*'KAA[U\<V+LFPTJ->A2O>Q2A
M_6S"QF?UB=Z"\/ZBQG\'A]#_ ) C[2WP>08?B)DBQH5-BKX,QX;=V[9NL'5K
M)@G(>-6+&Y;V^%Y=U+Y&^&S]A/\ >*BW-EF3)0W7( W)HZ J *X8>]?(SHN:
M@,@>Z.'S"L[],AH2SZ4N9;C&V0/<7SWOZ::ZZI8/Z;5OM.2QWXK?Q+5W?8NY
ML'6]2_H6'F#O%9/P[.2;?M<+BKJ%0_ALW83_ 'BMG]/Q&AZ"P'V5095"37##
MWKY'$2K?JZC[N'E:TJ@[UZY(N^FWOWVM^:Q^R[/]_%"[]1.?VHX.T+"MVW=L
MW?$.0_J/&?I2WP@IW,AX:'S1OL+H.8RG0XJ(#$_#9NPG^\5L_IIO-Y:&A"+9
M.=S6E<,/>OD3H48E";%V4IL?MXL1MSNQL9G0O-]9B']18S]_"*Q^BJ_VM]$?
MIQGXB9+M6#+"(N@#GI66@PIDFS'"YER'*B2H,GU<*:-K,*_$9NPG^\5#_#S;
M>\9U%F\KF<@' U<,/>_D\1J1K-@>U @RR<W:+BX_5_82YEN,;8A%P =]U"5K
MC>RV[>RU;^UM(;];$:Z:Z:_#M[]]K?FL?LNS_4/(3A4PF-5<ZPV58.*!?T"1
M4XX3256&E*WQ&;L)_O%;Q)& ,(YPR;/G.# ZLJ_7##WKY,Z%%)0\@)\I'9_9
MPVK65H-?OW9-[V+>_?:WYJ'[+A'W<1I>JJO?;7X#R$_XA:']1XU]>W=NV;H[
M MY)$9#QHQXX*>/"WC;7^OQ6;L)_O%*6;3B&H>9[)M9$R>0R0/KAA[U\6&:%
M$)["YKBI<'N:N3LBWY6+D:R_CW8]+F_9OM;_ %XO1=[RQ,9>V4E^T;A_46,O
M<PTB:L!7[<2'QRL(F.D"9WPTR=LAG68+<76#V%AYA:C,H8=EI=FL68\G9(:A
MP^&)@?%9NPG^\>GAA[U\0L2CAQBM*,*.4<^?G_@(1 MYP$SG9>=?#/N,-;%S
MU0H4HE,M"8N/57VTN7;LF6$1= '/:3E.>XFPXB""&?;W!;T.0]VW=LW?"V[M
MVS=FF!ME7?93'LBI7'7"$9CV8KQS QLL?&9NPG^\>GAA[U\1F5Q+</8\?+;9
M#9,?+;;MNXQ29$48FA1<KPNVK=^WF+%=])(^G#*M:714B1>E7_;MW-]FYFL?
MLWD_9#!R!\DC)D!)#?<7A3YC3X<Z%]28Z]G9LWW-^)L>W%"!\=F["?[QZ>&'
MO?Q+OYNEM!:CC),87M\ CLE+A0D64&>&5F^) ?"+0<IXI((4[QQBBW7IC8RU
MHE*]TW#^HL9>P)$D#A#'V/AZ./H[/E"@\/(16=C81*G31Q)R);F528=&H >8
M#0\PGY5)ML';+B[ZVRXN^Q;OV;MJT0@7JTOV-=-2(_3?MOV=^_[(Y)OX?AIT
M_; /-H3<N,OKV;-]S?BO%>P!L^0S=A/]X]/##WKXF_\ '^!(3F)7+.>PHWAC
M0"Z?LD,7[YA'T3X$,G#RIA><G[JB1),^5&$1L=*GO)LFU;,'A-T$:]2XLF&H
MBBH E(@^!RQ=E!5)F!7<$3F,,MTX0$-N>$EVDBL=E9L,<.X=9X.;A(2!7MN*
M#-Q7$2@,P7<22&[EFU&GI\@V QNK'<*H%B$3C?96Q(TDUNV[MF[X&FNNW7-$
M+GK?JA0I9*7C7$\56T^2S]A/]X]/##WKYV[;MW[<F8 M2]<1)6Y4B29%Z7(]
MZW<WV;F:QUO4OZ47%YMRN+BR'51WHY:/I>UV[=U7+%B[6[;MW5KMTW::6K>W
M0L5$+T".PJ\@#;TLW-O+Q]+7Y=O^A]=FF+ENWLM6_L:GD 4W&_!D4(1W0D*G
M")'P+T+ZEQ_Z5-*/.4Q)QZ$28WRF;L)_O'IX8>]?8#R]"8(YQ3*@]??/0_J+
M&/B("E3TQ)P= '5LV;+>SV2UPG%S*[IMG=(LX^F;D@5>EVF%<.PV<#]FR WC
MDY=N;K^*'_9OV7-GA/'0BD<\@385;MNNW7WE$AH./.8+5;:/"-%DS9"5@J3(
MU@#X(N)\MF["?[QZ>&'O7V'73370RA"B-%E4T']Y+DVMA<\)N@C0@$8/2%7
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M;TI"29TBPIK$4G%0TJ%;V(:3;JWCY$LZ#1(P/9_S%F["?[QZ>&'O7V?*AEE
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M.LNJ;)T;"XP<.1G6QNQQ8D6)5F:>!C98\V%+PC&0E8>K+K0&90D!K5RV\<P
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M"B%QF)&PCFB6^/!5$;1N56&Y?$GR"UECAZR 9:W#/[N65VF_E5A(I99_,JT
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MMJLU;%0FB< 8'9KN:A,KF=6]9B^D$&QFU8&0AROG66:]0*,D^VF'5ABQ4V.
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MNK&FAB:ZQB!<WQ_AS!("#3KB8KZ['298'+#XD9JZNII"Q:JB^L=Y"&#O%S:
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M23%FO36N'FTU@L9N@)&S8)I?C<3AN9:*K\7WYJQ416!56S5Z-6E;IVO%W8L
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M]WAW,G670M3'#V7&U37 PTKGI 4J20*ED2V0EI$<V''9;UV"D61*"'P]>O4
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M!O1IH-Q_+MCS0CZ3#G0%C_,RB)GM'?C%\E(5M;DV>(9VGPZID$#/S&?9C?\
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MP,SKJIGG1'^C.A1'UQK'^/&07LLE,>]9$,C_ !]]]Y1,_P"/Z _V;F/]GO\
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M#6#9Q[P/T%VN4S7?$%,Z X-5-!D!N.LWSI7I#T1$[>,'^4#&Y80J\Q0&/O\
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MRUK%4K56E,*;<RIY)UK0#/I^3<?054$& 8B(%3;8-L><V7K7M"*^YWNES?\
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MP4:[IC893.ID<1MG)<AYSE!K'8*1BDUD=3$VV-=A'03))O@7[3=BK+!)NT2
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M'JO_ -?;K_AK^QSW)X/WV\4(J=W(ZG85-GUZIUTA1S]"9A1=M.GWDC6:C);
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M.V),8C72)G3UZ1/[;#_V5C_]31_NX_NCD/XMD/\ MT_[LOTCL(5V:]*Y^8V
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M@LA@J%EG82:.T2VZ_P ,-4\NVLS ]6(U^6-=>,;8Y7O7*R:]*]4M=99IG>3
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M_DJ9Z3+]/5#+.GF3WF$1$Q,=8Q_8<]4NE=K7A'S;2I4V8'_+5]-",O5N-)@
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MR*8K6<KCPW^&Y@L4,OB2ZK.I6PQ0+\B"7^E()QN2KLY:)/72U]3(Q= C;5;
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M;8/T8^[C8'T8^[C8'T8^[C8'T8^[C8'T8^[C8'T8^[B(B/5$1_U6W&S5'&'
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MQ1L%6KHI3.0L-FZPP#EW* *+,,GFVM=2E=&U+YJU.99R3+"D+1+9",)9$52
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M>PM=@'&DB0,C42$HD2CPF#"9B9T8H@:N?.IBV")Q40)\Y9["-.TVA4R%6C6
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MZ:D&L&6E!O4!:%$-M(3*.HR("TSI5GQ!'4>WR^15P(*H9%N$0@73)F0@&IE
MS$3,Q$1K,^$1'MF?E'%]YEFK."IF*D8E:BR=P!!C[=PV6$BFLQ@G"*@G7MZD
MH18U8H84P; [?((F/0]FFRP,CEAKY.J+FM$ZY8K)=O:@3,V"GN8TNC_)@L=B
MSP,T@%A@U2M+;NZE$!9=4E9V6TQ+;IW2JPM97+S1$K:(&)>4A@HF.(8J:O>P
MU79^HVV>H$).;6O; MDEM:RS$3-=:Y)CH$I6)0,Z89R6YRIBV;M76,<-ZD]3
M5]6E9R$ (6%- 8-;&U2,0*)_)I?$1!(86$CH>GIVEM#,770M8DYT54U*0E8Z
M"X.QVXD!+[CI]*6@:H.6"0Q4;0OI3%B(MXJW*FGMUW",B8#;JE$@Q%VL#6%7
M8) Q;-5LU635%1FRA^4Q%X^K<P>1?C6NGWK"U[2KV"_I$!=%A_XQZ&LB!@H&
M/N\Q22<3A\@DI18L9^IB7]+0%MJ!9P:?%41TQ<:;KEM> @QG@\YFU)O/,@=0
MN6WTB8%C)7XH-ILLF5>U5ARU-M[;+"%.Q96K)O$@$"QK8WA7EZ>">L+P8PYD
M+QD0] P,)#9[S'&0PNNB/ >X>:T;S6'4WM6)2]8VV42WQ:4'4:J5-CI!J,!+
M#V=,.KNW(@CB; "QB(8"F$$+%^-RTEY3H49O5F+]6R''>QU4Q88:$Y4J9.U3
M9,5'J:>F3'2S'A%[E&,E:M/KVDX?&9&;X6&JZEJSV2S48;NUF)!UJX"NC _@
MY[P- $ XMSK.(JW[>Q)>C:]V\QDC737WJ633:32$$!U#@=&%&AD*_?F(D;"I
MLUZDE*WVU]:M#P976]4%LDU/>*T&(SXEHSR#!&6@"11D;,ULS20'4&IZ L6;
M:(29N9>"W5Z;TIZ97'J[9AP+*@G3.6+B))K$ZWS5%S$U[#F4[*S:E-56Y4W&
M'7N6Y#)KVE.]*"8<0_H2J:]=9>L" )KEIME1<4*LPOJ0MFH0P=Z@"$-G15@W
MR]955(-C;:I)U8&I6PQ0T+5AU1$,.W7?%9U65-"R#R\ 7T& +9DY\H2(R)G!
M $R0%$.LUT#88QR^E4=V]EX%#:R'[=_1995O0+-D[MG4UV^/LX6P6CN&&1&X
MP]8IJ2U6<@7D< 'MF1F0/38P-&+(ED)3]]D/T?Q]#W9_Z^'YAD9"58[%>/6R
M#2SCIUC:-'"6%)HK8,1N8%S+/.QTI-,PS"(=.X-!9G1<A^"YC,U$/5GE^_*D
M].1KD%-59CM7-B9ZGHZ>OHKU%.W&TB%C#R.T,WRMD2,@,L5=J327Y;!4JUNM
MU,CCRG2OOZ]4$DJRZL9V&6W+DP67'+X6(RV4N.K](\_D;TC32:I.JK(T(Q0R
M)[Q1-@!GN ]:*AT4LFC $SA:";RIE.7*9!=&_E[BEY5<RNF%55W*0ZW*;(HN
M3:AMMJU!%?:SI2R6K&UZCF&1@^2=->AULGN+=ZA>7(,D&YZY'UC#H3CTKVL5
MH9UIU,H$)KJ8WF7EB_8>L6P#<:A8)+?<KUKF,:PVE+F2,4^I32)D K(24A4[
M@."QPPZSS8AT0U#.93EB61O4R48['2F366H%*98R5243TY,]FFZ=4S)\Y9.M
M7T&]5FO1R^69N,GLK=WJNG4U!*X6F;$%;LPWJ2V'MK.-IKJ\J_\ JYG(CVS7
MYEB(^?\ ](WSX?LB9^R.,'U?XCO[:"FS_$VCT>F0K?I/HL7Q780GL:5<FB1;
M"B*TV-XDO<,[!N<GV*:7)K8L\56OQ9[=A'CU8ZFV:M@/PA>K$"_:"H&'N?TJ
MZ![A@ 7%XS'G+*=(NBT<1BBBP @;8W+8,1 O%R(Z4ZL44)Z@LG=OG:$#CZ@U
MJG,)UI8S)VL79<-EIRRU8?UJT6RD_P"CBN_B0&!6*9=,#!&4ERITOXN+WZ=K
M_%6QWV[39U?1VD=SKY=_ICMX/J>/>;=?6Z<#!SR!C1;K,'G>51$3\=:;;;XK
M@R)]NM,E@P"^9"?QXJB).R5B1B;#L1DQ<^8B7-%.,N=(6-]]@J$CZ<%,P$$6
MW36>.1O^SL+^K!F,_:.(<)1^R8F..4-W\6\QT/Y9V_,G9Z>_N_C"_N]G_P#"
M^_ZG_P!3U..5.E_%Q>_3M?XJV.^W:;.KZ.TCN=?+O],=O!]3Q[S;KZW3@>I_
M$3 =37QYEY9E6[WNVF^F:D%KX[HJRF)B?&)UB?'C.>,<F%/C,9S,+B?C"QPS
M3$-?J0;6G ^R"8PHC4RF<A_ZYW]^O3]!XOT1NU_[/U/K='7X;/1G<?'J[>IZ
MS=QE=/XZ3T?T>5\7&4T_]\FMC.UZ_P 9?!!E==WG%DV-_F*>.8__ %%YD_5:
MQ,S^J(1F9F?LB(F9GX1X\<QZ?Q,S/_?S>QD8O37JSDY5?[>*WS*7=MNV^/6[
M/7]'C,(EZ<'EUD*VX?(JQ5]I^4(P^5,]KG%&LD%,NZL.*8B "G05'PB*CN^.
MUE]I#Z5<+ZP,_*)Q2$KIX6N?Q@E8NO5)P>R+3+):;C*9M-[7&VFQ+!=?D,#1
M)+(4T+&7!J;5E1$#/-C\0.1NB41Y+"ZL;A)H:Y2C8?RZ0TX1UN6C3D<:A5<U
METH963*.MW!"%86KK([>$_D[ML]XQO$W-IY+#8KJDQ:<A>'(X.T$>:;E.K7L
MN68:QX]I90V <0[A%P #E]V(!9L8[)F.5!-Q0<HY!@Y"MN!AX)5BS4N2Q0A!
MFU-G)OL*.*L'H+@.L-1 C-BL[&8JMTC7?Y?3EL#6Z)^1]9A/)>&<@@+Q[<NH
M0QU+<M0#$&P.MHRXTE<\<P&@I4:PQ;,<PBDQG%I9<G&]H$=(U A,HDIZC-1;
M6\%Z!N[7H4/I)C>N77,8N\^HA7354=<=RXX$A/4;$[ZTUW=/?O0+ !HPS=)8
MLH+&XXAG42HU"B?G$H7,3^[CF>2FCRWE1B23@[95[T1YNBIS[S.Y,8UT#H9.
MPP9]L]@[;K(#$H"'D,0Q0+*)85AA[:Z4",L;9<R(+972J"<UFDP*A(_'3C.6
M!M\L<IV0!@!8YN6X!<.QD R,"0;PUG;,C,3MF=PZZ%$%K$6RF.9,544 MRZ<
M169Z0=+)13HW^QL5*RJJC2=RQ$DB9:QRX#I2K65(6%O'&JO8Y_.UJW'!E+JL
MFW0-P4[-'!TYLZ+"!\ME]<V0I<+Z>_J=*K#3!J+>/JXE4&K(8KTWAZB1;HNW
M2OO78QN,+JE(080+K$MZC'BU)L=9L=1*E#*G6[V;R6!<"[%QV9LY&A:61)FT
ME#Z^53.^!;,16KM48&:-R0$=+9%O?B&I=BL:VNJ4(91J$E$G+)2J4!L5U"\6
M=,=!ZD_E--^LZ_CW_DC^SB?O8XK?DA^S[\;?HQ%K,2OJ^BD]RA.Z [C(FP*^
M)JZD)C^$9-U4&1(EI7Z[)C:LI@,.5KE^[@!?!0-8[Z6DDSN,NTUN=8L=P+P$
M++P99OV'0@IL6ZZ?(!2)!W 9KD7-!:<%'=2&W=M$#&)KW,7-JA8J,4H2>U#K
MEIB0Z(,(F!7DA%!->F]U\E:Y;.:\UEX.M9-[3:IO<6K@WQFM5Z9;NU3WY'U7
M"DC8K<*/7ST6/&CSAC<O,2]A82@YN,\.Z!>)FNNF:C9*ZLU,D8;"$WKL(7L.
M:[$BAEKE"FZFQG7T%MHLQ<)(SN&OUZ-C:F"CRD0B,$V1U#K$S81CH9<CBIZL
M.NT*G)7S+D+ A:@6(!\Y^TN7D+=0&9!:P:S2"Z(0,SM&(CEYUH+.6V#)9!F5
MR=>^JT#++WOO5HK3);"012VDY(J#:1#I"S-I@>KZBE\J5J@75%Z$YOEM9AP<
M5KUNSFP6.( DQ9T[4L?*:ET890Z*VV>J =LNQ->SF.:*MM*9K@&,J8&I#S5U
M[;F3CES89T6-!*0.F(HB3)G3;M(0Z,$W'O7=S'-#*0BJ/\-1D+[8F;-^TO /
ML'T:NL4Z%9Z["P(8!S((I&OVYJ[A]2)GZ-\S$>/_ -%AB/\ ^KJ1'^Z/W<9F
M1GDW*'MEB)M8:;T++:PL9MNG9B9V&159D5%97M]:0UP&0;*S')+9;QM.'/2F
MMCLS0OJL@@Y9W%NW0K15">XG=WXI%$PL"($R^RR"K(=(</8P>=>=.@<U6C?#
M\)3 R^=;V3(9$G"X4FJ5^K;7!+8WGJPO+MR5,:7(_-*L=#.[-:&V6#,E:?5)
M=N+CFG'B4E;'%#X1 KD:J4@M*UK'(=K'*/,DGM]'^BZW0Z>G2[CN$S4A&WR]
M7LHO]MT_/T^IT_#=QF(=_%[DH;/B_P#C.[N/C$O"A@C*?E.UX08S\"$2CQB)
MXS 1/+7.K8&.O:P['6&Z1U;#BM4PEKC]YK)B!&6,F2T@8U]G&/F"59F/&)PV
M4F)^<3C+&G"NK_Z+K_:[^Z]"8C?TM>KZ.[.QW.FGZ'>^C/\ :]'C(=K'*/,D
MGM]'^BZW0Z>G2[CN$S4A&WR]7LHO]MT_/T^IT_#=QDX=&(Y&BSXV(YAR$/GV
M^N]!XWJ^/^?NXRL)]/\ (!V/R1XO(]T7CN)2\ID53K,>8ME=8J#XBL  =($8
MBMW'\9>:NOO])^F%:::]7MNW7VG2V_XKN^_[?I^77?T_#3AO3GG#G.:FWL?2
M2X'IZ='O89<*S(;?+K-0L;J4>$KA,1[O&>\%<FM]BAS^621?#JEB=(_:?<5U
MQ\Y_;IS!(#RNPB@YKCGL/.3T+:$5(9)J)OE/=6 0NLMJ\O54 A#%'(L#)J;8
MJXN7/4A>,S2G(>%9A.98R(@@J.O<%Y;%:K8@=BYE*BNV6:J69+SRWMZUG';Y
MS>-Q"TYN*T]-[<-::G2H+?" S'HT-K)">K3H6J3Y-#7VW!396;5KLI[.U-*Y
MK],=@0G;'3$0TCIP(Z#TY$9#39(Q,:<<Q3MS'+>:GPJ/I>AG,U\E6VFHBHL&
ME[!EW8TR'X;LBH?$H9,4G+IC>R#R$*U/&9*6L,H 1*Q1L5*XS):1.^P]<$/C
MZJ&F0RL&< E@?1[S8; ("N5+ET5E$P8JMWFNKP0SYA,D$HS H@EF4K*-1GC.
MRN>3N8NIH0$-.*NGB99 HM=IV^GGETAUX5TYUDR#2)/IS%5AI*LTX$V*)+#C
M2) C"1(HT]DC)1/AIIIPU?H_FW-)86JLJ*+V.>6NEI8'9(MIEIJ4U757POW_
M .53,1*';169%2 /%N0R=7%4EQ.ANM6=Q3(:Z1T:B@FQ<;KHA4K\":Y"V8]Z
M[N8YH92$51_AJ,A?;$S9OVEX!]@^C5UBG0K/786!# .9!%(U^W-7</Q8(=RC
MR[4N2:>M9"QB+*])GTAC*Z6V4S&L1/X*]# %I#!@#@6#E]V(84K:.<N7J=_H
M6&G6H'C\@C4)=CJF=VFMX;5ZEWMUQK824G^55TEI2F)Y+_[2SWZ\KFHG]<>@
MU#I/ZMOA]GA[..6/^R _^WYK_P#.LAQ<\W/'.[!\5Q?KUYF/9UU.R+&QK\X7
M81K'LTD2B?-/!?DX@/*W?,R9>=<KTC087&PH."UF3ZLQ,3 ].)C=.CO^\5__
M "2__P"_"H; 1#C6QFI:DI9)"8W3LB%DUY1(AM$IZD[RB3B @H >9"D>7,%I
MM\W-ZPG<(GX,L\M+*8W1.TX$IE;!T8H]K%$#!$HSX10Q:N8$2V<@BQV&UK3L
MQ?I@-8YIJBQ+3KF,RE(=J:ERQ]227Y3Z^76$GR_GC9TET+48+-O]Z58BYH2;
M;-VD2-6%0PO-&RIAMD>_$33,[/<9-RI0_+V3R!(G76K7,05CJ,Q/L]'8Q5.C
M,1X2=<S]XRF4?]F\Q?\ W+'_ .;XGA51ESE+ Y&J$N;B\?CK>1Q13K2O5K"$
M@;U52GM$-435I6"P2I#1H&H81-W;:MTF\JY/(.WW,59"G6*DJ>DRXZZ-HJRR
M84057I37<#Y\KA*9JETQ:YBLL-CJ\DG8)6XLEEH!"!+I5P'"WXD1:V2<^2;U
M))Q=%9:1TZM>8."S'_K=B)^$\FEI/V-PD3^Z?"?U^'',,1W?(1:>:6Y>)+XS
M U,YMB9]N@_HQ\/AQF/_ %NQ'_[FS_\ W,'P@B'Z0LGL633=C^75;%Z=4SL#
MD4P2I*8'N!ENY!%,1#MI3.FO"TE_%_F' TI#(=]D,A13>"=E1:G9%]FU9LK?
MTW]>HYAUEA76];T09K?L<,\#&T1'69VC$:S[9TC36?US\?O\A^C^/H>[/_7P
M_'B4@0E&W42@HW")CK$ZQN X(#'YB0R)1X%$QX<.JIL/BTV#*P,A(NAS@; @
M8G"MX,&>WU 8*M_)S7'2-9*F0XL -I0U[$=1 Q,=#Q%,[MVXC6.T&,(2D":R
M"9*X%4ETP 1N*)5NK46)MP*,?6[& .;+4W&PUV3"TQY,R*4#:+91IUR&BK5A
M+1T22XJZ:X9GNL6MM4:^"N*:YA6JM6]GQL S&M4+I5<@*]42+N#A*QN.E0$-
M<G JB->40W/U6ML=-Q7DUZDS#[,B<F-!6,6-):X;,E1W"M K6J'+:7J78NM8
M'"JQV3$7#,M(ZS]ED5+ES9J*F2WC+ZM0E5B<!%,RN9%S(\Y('MWS:43.YV0H
M;#&L<]2QW2L*[7&PZPJ(B8B$$N$.GK)V-\_"Z==3BL+"0:S=U2AC='273C>X
M-^QS!A0"MK1)BPW LA$S@C&&7"OEKW;)3+W"1 5J*[>LL+L!(A=7U?6&JV+E
MN.9)PG)3K42NB;V51A/<PV'+C4D'UX8+M*QR5<)=#3ZLK4,LG:1S)+7(TTKH
M&)T]R-H[!6+&2@0G=N$:Q'->(9!D+8A7K0(@9N"9CCLJWLA6Q<O&T2%D:ZK+
M(3N6]M0"&LURC]8IC%$2FQ#5R+(@N .0G=&V9T*/. ,CS#(SY3$AUTGRSIJ!
M:&,P41,-J(<_NF0TK4E!%9[BQ%@_6@^18Z&PQBV,6!.4PB4_3:X#&9B0,UD)
MK(@,9W"8S(D,Q[)B8\8GAM*JX'+)(PFPX;%BLJ215L.'V&^JB5UG3\)AJB$H
MDH*)@BB;(!<0%6R(MKA_B)B(44[C/>T!VBYOK"&'.@VPN 3!PI:P&M)4X&$$
M?E!J]6F=@B6X#6T&%8EI-!BV&LA9)Q*RD/=\.*R%T]_:[Z\,4Q$BIK0"%N9U
M'=-<'L4;IDQ<U0@UJF.2PR2YH'5KJHM)U2"KF10<]-K8'J01%U17OZ8N*3GJ
M.$8:V("&&4+7 MI57 Y9)&$V'#8L5E22*MAP^PWU42NLZ?A,-40E$E!1,$43
M:6%U 5;0]6NO7:GQ!>Z3D^J0KVP;]9B(L'N?  I<,A:5"%JJFZI*+,,8NLM:
MZ_KG"2>DL%BY3 8+ MS"Q8RZ)Q;=8UM->=DB;+/6]MU-).D9'4;I$/JD>N[M
M[ Z/3$R1EM6P1W,841N8<DFLFOU.D&A.83G,(C:YS2]K'.:1M:>D0,$PRF $
M0C0!&(.9.N=4_-78]%EBI]UC:PO%,G\3 1L.@DE,I9O]:![0V]I7F:\RO6*8
MR--1&PJ]2)G7\%K24UZY>,Q!I4!",R S 3,<9(C+TWR^"2<BZ:*'I$?Y*[#K
MMIMW+0LCRJMV)IJHUJRV/9"KK+AFOMB441$1$1&D1X1$>$1$?".+BEWX5%H>
MI"("$#$DH42L8$6(%,KA+_#J%87 O-TE8-A/(F3X]OVT$4)F-IZ$4,:/J_(Y
M^O7>O<I9]-S##JCU=O4U+B*5:*\5.E$U1L.MC7*2-(67PB'/6LID%M/MU%)A
M SU!ED:,-A$M8K.RP99+;=?LWM8UKFE4@9 :PM<9L4@!(H6I1 "MQ=.!DIU[
M*MHD(7HJNXK**PFP:B;!;M7KIP451=YBVLA6\-?)(\. ;$H-L;FU8F*SXU"S
M7&8*-J;(;7J'0BT$&1$:^$1Q7&*H.6GRA8%HV8+5LV>N6]Q6";O)[&,B&DUL
MFR7"+MW5$2A%5%6-J!)8; 6*H8V4K!<3 "E)'*DQ$3X]( W>&[7:.@F0;X&?
M!@2M@S$$+ G29 Q*)$AU@2B"B=#$3C0A&8[&KTIK]+2L1]0Z8FP*3"W$<2RF
M)Q59M,B,(8HH BD@B)F>+B5WTA7M1+$K\5K@B4(,U">N$)E>VSJM4]U&EC5*
M9ZNJ5[7J&R2F-EG616FFJR#FIMC5D162.[2:[)+)8 HA)LZJ$53ZL8'B%K%M
M]P *SR:NC?%4=)-E</K6(@ZZ]M?=#*B-&"H60H21!=!C5FNJA15B6$C%)DNJ
M*WLFM6<4;9<BK)366V0]7U05!].97NV3(\,JI;-LB$Q*_!Q=)37(*X)F9D%D
MD&LGKF3*.FR2" T7 ],1&!$0$0 1  &!$1B!$1&-!$1CP@8CPB(\(CPC\>_\
MD?V<3]['%;\D/V??V0"X@*MD1;77KHB8B%%,F1[V@.T7-U+;UG0;86*U0?24
ML 3K73*%&R!*)&3)K&6-LPP2'NV$5K8P&F#0AVUJYZ;((!$8L5>TQMIN'" O
MVK*$Y -\%#<5Y9LG7JVB+'OR&@>J;92;TM52.N0RN37DZM9V+>JG7?&9:RO&
M,="[0>CVB?4*U8>S2K%<!&2-02U[6*6L1V,A-O)0;,S;6S5N'5$!AF+@6Z5-
M%:=ZP(+(=U.N_H3^!HU>"DI;)!-<!5E[[L6%BGB[&-I5F0<-05C(;9F^^L#?
MPNNH]QI8TI2RXEG29$HCHK14KU9.4!*^IXF FSI26\S)D)DY4+6$PI:T0AKO
M+#3.%KVO6-AYVF;QMM5T66T,95M,7,;2%EFL27GOC\I),F6:E)R4F6M\6)H8
MRMC0#LIL%&8KK!'6!"!TH#20[U2U"6P3=4$;H5SO)!@*8(,NUTSZ*G&*>K*)
MRJ;3;HA:2NOC4[>Z0YK]H.98"97675$Y$GFQI3*MU+8'=.NP,"^PSJV=D;$6
MCVR$%:J!I5L[(*97#TLA9SU @3\W%5"J:;-:N&RO<$PL5YDF)(#E9D J;)@H
M)8H'[4B Q8B;,1#R)DU5!3A@5]P+:D:QH)AMK] 1VBD:S2-"UQ$#.U:QC>"S
M]]:R$*==?1@%[0KDPZZ=[.VKL;$BQJ*N[MTN,))<N6H6](B5OZ9$,@PUEO"=
MI:3$%$1N'6)C<$^U;!UU6T-K%'$,60F(E'95^OW4 46)G4VPUT&W2&Q OF&?
MA 1+F'"W]1<-+JP,-@3@&&N=0G29$AGV3! <;3 QG43 QF1,"B1,9D2B8G3C
ML:NB0Z6B:SRLHK0;!J)L%.LN73$HJBS=H0G"M1,0,=" )BTL+HJ"R,,!$B:5
M^XM; Z>C@6O: V-4J(K$1US-:S-DD S"O4USJC)$AM:*C1<16)<B)64"XWRQ
MC2WJ6SJL(F]4!;OZD;N$)"LEM=&]27"E9K%K=HJ0MB@0GS_@]>09,-KHZ:;&
MU1/6PD)E=1"Z&_M(E(GK!*@S)&T]W4$4&1) ';SZX"$"^2*70<S,\=C5T2'2
MT36>5E%:#8-1-@IUERZ8E%46;M"$X5J)B!CH0!,74KR  NW$F"H'I"!'7A)"
M*PAR.W)71L^J696U;+)- 7DV71OXMH5>:MUF)-B"W5R S1VWF,I&M""6-<"E
MC=ZT0M;!:X3$A:R";ZUBWE,Q84B:J[2B)%L:Y1ME/=)E=B5[8$!&63 @  .@
M $"BNFJJ$H6*ECK.T?B13)&9E.I&PRF38PY(V',F9$4S/%M"\CCF8US>A^$U
MK]"YLEO89&H<&AQ*U]96:0K&ZM>C6 I)#U.A"&U7696X+"!5);Z[E[EV:MI7
MEF#&#'SI*=I"-E"FJ<O= >K4XJZ%56UW(':52#[02(F)JRP.F1U:[2-%=LAY
M>LE8-&(C:<:1Q74%0[K:^]3,@$A<.&,DF[O*T]2.>FYZYZ%JPK8^U5_!;#&U
MO5<5ZE>IU.W#IPT^H8P;)7O_ $C%9%(+(YG<R5B,L+S,W%X\:ZK8DH$TMTZJ
M6"+$LT@H'>ID$LY'>6R2&9"9F1F)X*E6,$J,)--<H)-<VM*JLA'8,C5(YKZ@
M.FSU?DVA(Z2L)')];^+V915+\.O5A50$/.4/4SJ=1FV#%( 4#I+MO4DHZ8L$
M6R"45+"ZQ=LU2ZK#*O3>+DIINU\Y)I%/: 8E&@/KK)<[8*NTE[2^X\ LJ%%@
M >H)W+%HB?2G=OU211))U+S%TY'<7B6LQ' ) 'Q9B6%8 (6MS7.<Q*X+?TT&
MUARA>Z!+8G8,R"]8]6&W8'=.NP,"^PSJV=D;$6CVR$%:J!I5L[(*97#TLA9S
MU @3\W$4ZT5!H]*)IKLON+K')&E5FP%8'-4!R4*DNT04"O:(-ACP$7/>QB![
M9YVU$SNC!:^Y8UCK +3KT 0]Q,;7&OK,UX02^W*9-.PIF>*]=51EEM:"0RXO
MIV#6Q@RP=-I3[_D8:_4-<&UKJWX,TSK^KXIKK8G?;JU)L-ZXM"AU9%#;&C#%
M]CKD24U8<(3>BNL[5K?H*B(C>FA4966X[#>O=NV77K]CQ]=:?,:Z:^.Q2A57
M5KYI4D"/SR4S]VVI=X17; 7*$1$4S&U$;06&Z$!M3U#A*Y<W9U'L'JN(VS)R
M5-#VH-^YDH(>C-ASW+1,3,PP%&9K$@DI*#$-\>T9UB.+Y'8')8'MV%7L7TJ;
M;GS5'X>DU5LG041*NZR-@ QXUEM?TL>>1:QL=2N+.#*33V\SHJ9*3$/5RS=T
MIVN->TW+$DK-:FD:U,W,4(&QA%24&.W13CHB6^.GJ3$P#5=!JP2V34M3%[H8
MD %1D;&$$L8PB"E6!5M JCM[PQ%NL1&=:Q,:Z-97,B1-B!DEQ9Z?<0HB5U.D
M1!+::'J!+A-HK;UDL-[RLH/HA7'M[<L[JNM:5BM24N!*1W=( ZC-UI2[G0FP
M.XZJF(KM&92]*FD1F 6$RM\1,D7^,UB)VC,#X<6ZZKT)BU!L[81"M/5:N:T!
M$Q$UR68$AA;C)C52+&L:YK#-CFF3E!8N)ONCJ6ZY@:6D1>2%D$BB%Z]+L]%+
M65&0FD: &N:"1'3XJUZ\Y*,BTF=^"K)HM';MK,[<5G]D-EX.$S5W9**.L?24
MW8^25*X<O'0@A%W,=9K6Z[LDNO5+;8(H'N!QJL6OH"'F9-/K"N/5CW4',R+<
M,BS6QZE6H(#AMHEJ)D-)%8[3CJ5R,9(9FO5)2= (@#9L B 8G[_(?H_CZ'NS
M_P!?#_(M_P"2/[.)^]CBM^2'[/\ (O(?H_CT6.C\./2$_+CTA/RX](3\N/2$
M_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\
MN/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX
M](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CT
MA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$
M_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\
MN/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX
M](3\N/2$_+CTA/RX.[O&1T]OWZ[G3&!TX](3\N/2$_+CTA/RX](3\N/2$_+C
MTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2
M$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3
M\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/R
MX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+C
MTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2
M$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3\N/2$_+CTA/RX](3
M\N/2$_+A[^MI^K_\/\$,L%,3$N/W%1,2P_\ -#WB]D^R." @>FNP96U]A58!
M;'2@7/*!5#F,VKK 12,2ZP2DAN'>P=8X*)&9$HT(9F)B?;$QX3$_9/W8\=^G
MCTX"6:>.R&24+D_JP<@<!,Z;I HC7;/X@2$S-0%!M6($Q8S!&L6[X61A'F$6
M2MFR2B(/8>W7;.C%-5,0U9KD@%@PP""26<;@.(*(U X\1*/ H\8G[JAESPKK
M\6'*XDI\B$]62%1V[1[:U)3" Q!UMJ5$0'$',B6ASL@BG68")F=@RR?+XSM%
M<$1S\A""DO8,3,QQ"C(<48[2'-V%U,9(F!18LMOEC!3.TI[<XO@=9D6>CT6
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M9BXD(K'E?HOMY/H'!L&JZYFN3B(8B3%K*TG'<5=[(8=)J-S2*>J55(WT<G*
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M Q61#).:=FY<-A,M9"O-6XYD]0WHFVJ](%OUB)FTA398,"SR[-_3(AE!36
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MB*=($8CQF9G2(X9ZE76;ZI,P4PUGD5,!.A3U"T'09\"G7PGV\3Y1$B\!-G1
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M<%:2OXV;![)*:Z0D(\.!C7DS,>W4>=^96#MF8G>OECDQ@>[,:QO"-P3J#!U
MQ("(9N[].2E)KA=%F Y2OMQI'*O2 5>2UW[B%O&)Z2ZRZ[[P4M1H-BA&/-,H
M/H\#*FXQ+Z[R<F,IE*IC84"[U.XI.,=8HO,-T6D)7:KNIVNJV)59FN$K77!*
M_NX:9&CSDB)]4G)<DB&OF.(/'\V$6]I:M9J4#/K#*8GV>V=6!)Q;H+";/\84
M5\=:Q_4Z*[P4BLV4L;8&.K25018R1V[JS$*^.L7FM@C778A5B,C9JDULOCF+
MFZ]@W6:R>DYF5JU:T!E[2I(X5BD'8[:CA5BF<-R\OTDRY<O6<@5O[URQ>5.L
MP["DV\IB*=EM0Y7933N92G6N.4V(GI$JJUS.K/E5MWGY1GA!2RMDN@%=@I95
M&Z!B#+F/AQL.FR#\2!-KIM5W%<VUFD!(8?6"!BLQBCKX]8!9ZW-%#F>I7EDU
MR](XQ%"7Q:M;6]'#]#"8^S><*.XIUZ]V42YUM UT$%H:J1?._.5<QS)3<:]K
M,TR@RUWUNXL9VXQC*5*Q:PF, KB:F'KKK6+D91E@KG\_&,D!B)DLB&8%@P,D
M$S&D&,&)A,C/C$&)#K'F&8\.)!)XQ>):E;JRHL@!-W$SHWK=V_=2?F@&!9O9
M"U9*361K)G22:ZX@D<@N<I0J8^ZUK4U:"L:93,=6W41#16%ANF[?M8.]RI6T
MR5!2>I,W6+CWY6KFM15D$);6>U8QLR%:PF:[ZUY![TFAR^CN6H%##*ZF! 'O
MDV$)G)"L51.F@!)R,:1$>$L(S\9\TZE/C/AI&D1_.*_?'[>!]V/L^^O^Y'YZ
MB9JL:ZM/0:^-'L5ZLW1M@-&D.DG&P1'0M8TB/EPC\%EDUOP>70V&RGU?5A^O
M6AFW3?#=Q;X+7=K.O"O4H.JGU59C):==?E2;="F6$N/*3-)+4YC=IKK.G 1T
MDUJRO5HIMA]12YD JOA)UA=7@=.BT*[#0MB]IK41+"1"=.),R$ DID%04+#]
M%<&9-/8/L'>TS:>D>=AFPM3*9G[M?\$@HJ_@\&)B<)]7!BP9 X+9IN@PF0*)
M]H^'LX'R$1AY3-)5S,? BKFQ3C24QXRHFH0PESY2-*BF-0&85,H.6)GI&1,.
M2#RSU'5^S<V-/=:VG^"-:.C&5?P<RE/D^^U8%BB\ !ZZMZO9M4FF259&HLIZ
M]$["P8RM#AGP>M9D!"/D(9*)J].GZ8<N298S5>A0/<N%A4Q^.N/O L)AK)?8
MM66*8YDPH*X)A"X?N*Q*_5%8,/ [2E(<?M.4)9+H0!3J2DF[8YZUR 66HJG8
MAA5*TJK3-0 !'E%52[1K_I35I9&YW]ZM7F=>DJS:W&>WS"!MKJ)=9K$E_/UN
MVJFDWNW=, 8PRB/* *63#)C"D5*&!&?,TP&9T&)W3$<96O8Q+VU7H8^XIE>O
M-2I$.>RY9)*EU$#,A#7S8<-<8B8@V> S,3&HHU78,FI65>0CH&10YV\]A=&(
M"0+I3XL@C"8&=PP>A:8P@97QQOWV>^Y?S62R#%B75Q67IY,ZF.Q->NJ-S3L/
MFKAAI-"Q>OW;JK=4P7((XE)UE"FULG(2PVVA48L32@A 5XP&KF566UH&2NVP
MDTG=8Y%)C:5=-JW_ #BOWQ^W@?=C[/OK_N1^>W&O36:RLGN'Q$=)6NV"(B@=
M2F-9V!KO/;$GL$H")+2)7705_F#'KL=TK"XY%Y.76,IJW#/)ACHK'6/J$@[X
M$R]CQBPTQ55LJ;UH#N1=U%5N89%XT;MI>!9B,V9=->&#'.R;,INL+W6ZN]MG
M&9(NV4SO0Q<H9JY%)%A_0L9'*W*=0Z]F];R:Z5%PP@L5C0AEVQC:R#VB[.=B
M'<9]-7KVL%CQC$N"G/IJ+7WQ, /?,1^V8C@KR!]DD?\ FC_O+;_5P61^JK]I
M%_NB)_MXG(.^ KC]A?\ FXF]8G].(^P1_P!\3QC&F]VUI;QWJC32(\"+2?=B
M/;QV5;_N_P#YS_\ -QZ/1\V?^(?_ "\3CAU\K2B/UC!3^^)'^S@L>Z-=I 7R
MCQB9_?&D?^+]L\'6>'O++V:ZQYHT_7(ZQ'[?Y^S5=US%W:* W-O5;-0#F1%2
M2<A@BQTS.Z%06@ST@:S4HT7,:S&<M)RG,U&U3;,-RW,N)?CDSJI@WTWZ]ZI4
MM,,>BJ&.J=,V"T@VSH#(88<8XHL#S*EXATL4C"V*-K7UL7LA:M)LXIAS,S:@
MJ:/2(RV3LU]GBR4/ 8M)L%C\A8JL)66--NOAU"4KBB<I.N65:T?"<C9$V5\;
M(S(XNH3+A$60M5_1+GTS+F JRXKXVYDL6[EO&;.CZ(J*5ECR@Q57$UJ0V2NX
MJN:4,*+%G&6+91($FQ8_%*J5R4LI7K)+"9G<?MD8F?TN"H5Y]D$/^:7_ )MW
M!8Y?Z)G$_KT*/W:#_;P6./\ 08,_YT2/]F[@Z=@/T-T:Z:A,%K^O2/-I]L<3
M$Q.DQ,3\IC2?YB7[X_;P/NQ]GWU_W(_/7L-0@8+ZD=Q5%VFZ2"J=E06W  "1
MM.O6)KP2 R;27"QB2*(F@M=.[D 4W=RWZ+RH(04BN+N8M6J;\7=K8Z2ZU2RL
M2LV;MTE*'IL?CV-;8DT"GU=M5HM&=J/5J*F/(O(08RB\S76&S2&"935H,*O=
M"[)$=5030LLJ%B)9H[T#=YAO8_VB3&<P+R4D%PM9ZG9W<Q?M 8;9L+[6HX1!
M#&6/N\P\U<N<IT^_YDS6.PU69D5G>L@HWG R4JJIUE]MVV)+HUEM;MB9@-(G
MC+?2K1_B?C.<N5JWIS%9:W:I(M/[FB-=M=MJOO?596[B1*Q3>$ ?;240!">C
M0XY)^E#/9GG"C4S5FJ&/R*W4@K)6NK61;,.K58!'U+#G/<H:2ULLSN*U&SS1
M $T9!AA/P*8UGVS\I_;'C][AOY1_M$?WY^^-*F>^ EK\=/-_XH\W]?#,>$^*
MBD9^1>(_9K[8T_7NX96<KW@G3ZP^(_+V_#]NG\ZF4B!% D<B)% !MWG,1KM'
M>0CN+V1N(1UGQ*(\> -1UL?=)RTT\I:.E3M.D@2=H+GH\EMG;)5HB[^#RVR*
MDP<QJS;.[AZ6UG.KO"5O0UB7++W@:HI!@3^L2B8G[/O6+6T)6T 8!>T&#!C.
MDZQJ)1,3I,:Q^OQX)K" 5DPR ),A B*1$F%O8<1,Z;V'.YA>\9>8IF?QJ/R*
M?]$O^Y'WI")1H0P4?(HB8_KX9027NZKG]7C'[8G_ '3'#*3@]V.H/S'V^WZO
MMU^S=I\_Y@7[X_;P/NQ]GWU_W(_-:(-NORM<1!98K&KR[)(YF&TF7J^.'IZ!
MK%CN;$;E%H$)'?#B*>GP/3*GW>^5D-^Y18AHB!"-:MCK2[8E!D)UK2\C'19&
MD;D- M& P%SY=)+RP41(S/AK$^$3&OMB9]FGMXTGQ\/84A/ZCB(*0GY% D,R
M/MT*)]DQQ'F&3CQ&"D)*/$8*/:,S[-T:3K'M\.%R/8H>\H5:.Q>6Y(SN0M"K
M'3HL&Q.V#9:3,,:J(]3,A$EO.5*TG= Z3NGP@=/-,SXQI'MG6.(\1$X\0/7:
M4>(EIX3M+V3I/MT^^YGYNY;Y,QQ93F;+U,34C="YL'J^TP1DY32JK@[-U^V)
M+HU5-9MB2D8&)F/I _A6Y6]-C'?1_1C$U-37&>R2UV,DX?$>K3HEOJ4H+VB5
MGO6R,Q/3K,C2,MF<MGKS<EF\E=RM]WY2W?LMLOF-2* @VD4@H)(NFH-JUQ.U
M8B/AQ_!TRG\9.6>>?HOLL$FLJ_QFY< ^M&RTHDHN@3]Q@M VPPS KJ4)S#\D
MV>M!' 5;%G&7ZUM4=*WC[:;"X8,ZKLU'"P(8$Z3Y&KC<,Z3X3$Z<391?KT<G
M5G=6R5.O<04P0R2W*!H3(E$$,RLPU$H@HG6"B)^]PW\H_P!HC^_/XEM-3?&(
MZ9?,?9^T?9^[2?U\.JM3XS&X?KCXQ^WXQ^W]DS]\C\)@IK?A$ 8K*4>M@6&0
M@ 3LW:&1D ",^,D8C$:E$3[/"?;_ #:#AI\F<J7W(')*IYW.V1QC/ ++5<WN
MZ*AE?F-T6)780MPV*[+"U+L5K%8F)/.(*ME\BD[!VF#::3+#-(:QC)ZA]:!D
MAAXD<B^!F8APG$3I^9H_(I_T2_[D?B&(4WWQC7ZT>!?OCVZ?#76/U<.HF'BO
M5@_+]./V?I?;'_AC\^7[X_;P/NQ]GWU_W(_-<",/RO-*UL/>SE"K42"3\[[G
M\8Z+>R$8UEKXK[K/;C$MVKAVW8.O%-JV9_E,+0)"K3PY8Q>^ BJ6>QG*7H[E
M][(9Y EV4K"VG#)F R;*6A2Z%%QD^H/)W.<V-T:Y:O/+>_P?%X,1:7FBH;O6
M[)O^B%Q*?+Z679%?X4-F..?RLHGFROB)*%7;%G)5(K^:'O"J=15FFR-TE)!#
M="26QULFO/?98UA/*J.2N6,7"K>&NX1E&I%097B!Q<"A^-?(>N76M8]E**M4
M'-Z\/=?H>9]IO&)<JOC>3+9=%M6OS1SW5$'GMHK#(U,@K&MAT*>M%A*XBQ@(
M((58N+K5P;56SO:N-2%>W]']*1WUT\PY(;MLA%:;7=QG<C-1H0;(.GCXR2*:
M.Z,NJ!"732#EUEXZ6'B.9%%O+L^;:A N=9[46X-*;NP/\0!7U"JQ P(Q;#IG
M$.\/O2M+@H&/&-?,4>R/L^?[/V:\?P@<!S-@OI"R'\8,GD,S6R,3?P.1NF3(
MG%M,M**M "L@\<V"KNKU@6$:*L],8M!K]SZ->;#Y'YXY<YEW;:]#(+#)1L-F
M_$W(*GE(%0&$L;%%[V5HF9$;0(9('LVS]*&###<UVVUX_ LR,9BJ8ZRN>[(Y
MLB!^(EI:AK!$)T!34Q$0.W7Z+LE.4Y'0@R8;L)<L4")ARPB3)1:K[=9DA2I-
ML*RQG2 "KM&( 1^]PW\H_P!HC^_/XM]$#\R] /Y?H3^SVC/V>']'X\&!K+:8
MR,_K^/ZX^<?KCP^[EYGMZZ=Y*5<RF)H66@4@2ZEW)5JUJ8.-)"22PUP<3$A)
M[HG6(XS,]MS)%A:UUYY>Y@K6,8@ A2::\'D0*I12L-L)J="L-,U+VQ-8S#]+
MA/6N*SM\96 8W(U<4A!"1=QD+=$LHUM@X(2"G61*$BI6USW.8<O2%: L(&+M
MWEOMYE5+FCE;*9NN#?66,?9H83(Y$U,9$*&VM5O'.K#,*K=PJ%V-0ANP1V.R
MO*=%6JQRUS$8G*0?K>G?N(B+;JC!E4E659!G2%BP8Y91,]O,;.* %DK!X=$P
MG)^EN7*5>VWUM9E'F.W9I3:?7#HD-C%NI/:25N$+R6I6)5C6QAD8G9R-2ON@
ML?Z&OJ-VDE;Q=_F*ERY;2Z0@01=K.R="XARE$IR^Y1-<2 '3=2JG=5C6L,61
MS3;QUFPH8<QF'W@%/T?2TWNS#7!81%;<X(@T-UL2# +-^;DNYE-.DV'<SXRV
MB&>9BL6FNU; ]IT;+:^06IRVPXJ]E!D21D^@K-#U<QS&L= /"HPTS*T%%>S9
MS"&Q240QJ-6O43B[AOCN.M=98KA7FN-:Q+7BG92<KR3:Q]2U8JRT7GC[C51W
ME W! B[M;(M!;H .NCI.VQO_ )D,!8!+,8,#$@,"C42$HT(2B?"8F)F)CXQP
M+XJRC8V*\@9]MH<*D&$HH9*/&-AR@3ZA!H71$]T[(+A@-6[HN PL$X$=)@D+
MBL.,5K5L+0Y<UAB +TWF9"(Q)%$?F:/R*?\ 1+_N1^*=66[QF-I_7CV_JU^<
M?U_")CAU=B)\T:C\#CW9_P"$_JG^S\\7[X_;P/NQ]GW;C(HE*WQ/7'WZX:2Y
M?A$Z,B9@5GXZ2HR%HS$P8#Q6MU[8D==F^ .5LC0@-;(B)D&+.!8!;2$X@QC<
M!"8Z@0S/%_W(_-?9[/#X_M^?$Q$QI,:Q/MB?&)X,X$=S"B!"/>.=!&(_67A$
M1P8&$+E@D L2MZI.)&#0X>HIR]?>2T"ABV#J# *#&9&8GA<;ZXO5YJK#T%R_
M%!LV0SP,?(1]-@L]NLK8)^Z<3*=Z;-;(UY#6*N2IKZB^K78BWK3M$J8("780
MVN:0LUV":I&U49N4VPDE=.NFVI(2,W[5:W<89;B8=.NVM46$0(+4E V+1Q$
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M2**]6T#O #K5;IWJR1Z/1(.DUDCU!*&FOP893K,R"R8@V@+UI;UIK-C=7L&
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MMPPJ+E:YVEUB[4.H*O8^Z(P#&4YMVT.J6 $1@&TK@-GR1"S"T)C!%)N=Q?\
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MS.L_C%^^/V\#[L?9]RI7FW:K51* *S837$RUVC+F"N"+3QTB2UG3QTX[@LL
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MQF :P+4B4R3^RI/8P.XU&XJ(2J1TT5/3C;XQTYCU?C^H8&/MF?;[>,-_*/\
M:(_OS^:7AW5RGZLB4?OV_P!A3^W^8J4,3C<]3;TQ;F\QCLD)QJY58*6*;BR
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MIA]<]R;(0+)(5O6Q8MA;H'JJ68M:QYRQIDPYTB2*=9T&($1CY"(Q @,:"(Q
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MP1>>6E_A'F'E:F&D:=JS*WVZ[M)@@/&T5Q&WS1(O/6=!F!]L)_@=6B_E//\
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MD2]V<6:%TQ"RM:FPZWJ.TV3(3<?*F$92TB-R=C3U/WCGRA'D'N*S,UT:W39
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MJO1;U(,Y@S-;.DP#0I2:*<J?:L@G'A,:5H0;#PB?2>>A1D<3ZIQ*T$ZL"4+
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M;WJ2UPL-")7]R8B8F)C6)C28GV3$^V)XRF-FH?55$S7.?#_ZHI_0+^C]2?\
M5GQC4OO<'1T_#&QXSJ*(G3V>PF_/Q]T?9X;I\8(9_'6AT*"^M']<?\M/W?BA
M&2F!CVSPM<+'3X_&?G/_  ^7^0SQW++YQYH_9_RU_%H5LC6?>GX?*/E]OYPO
MWQ^W@?=C[/OK_N1^:GO@"Z4 3-/)!E(!,_TB$#F(_7 %]G"U@>&Q.2@B)F1;
MFX(9"%BL<7FKF&$!'>R9W'CVNDY/S0T8VAMV\8R(L6^6*=HO7<Q]0;*T^K/
M%V]VUNL[^J-Q=!%*'9$Q*L'2L[@)15]CG]1-?F':\:5VRO!'B,V9=->&7C79
M,\I)6 @K=6#;9QF2GMDL[T,9*&>O1218?T+&1RMRG4.O9O6\FNE1<,(+%8T(
M9=L8VL@]HNSG8AW&?35Z]K!8\8Q+@ISZ:BU]TP%@$LX@@.)$AGXQ/&1QITCW
M#J=<I\I_4_H'\I^4^POMUC[S'4YNV(#QA0:&XO'W=?=U^L?LC]6I>.W3@1@1
M@1B!$8B!B/"(B/"(B/A$1^.>.Y<_T?-^[V_U:_B8B2F(B-9GA2H7'S*?;/\
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MV/KN6T-=)VG&L1/A_DQE76*V,OV*@[[*:EAB!V[]6@HB#R?IZ3&NS]/3;\>
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MMG)D)K!7^7 >!1P+U;8\WPX[A7UN.X5];CN%?6X[A7UN.X5];BXT#'RSK_\
MA9JQ%EV13,](J&,])#!:D5H/26*QTPJ U %@>3U8;F+=U$P"ZS5-FPJA$V<A
M<I-F(A6'NYE+ C2=E)V.JG5;!$6XV,NRT; R$"$0F:Y$/6/=6FK5F88J[;L.
M.JLF@:[N+FI4?3MUPZ*FPPV3?Z@:LB:ZJ]A<]-N^24P9N"2S&<<R4Y""$HFB
MZ-FJKD3'X,R.HO4';"C>'AYHUC?#</9@9;2M9C$43U&9JVTY')T:C=KPVGU%
MHLRQ))>,0103!8.D<6X4MV2)4C%6A>.J]D%N54,F:(18;,S"FF)KZ8-*#/>&
MFNZ-; E6@8L;JW5$)5+HZ4G#?R1+ZL1![_\ %S$%!_#7A"Y' !8MJE=M&>RN
M..RV#4=BC4Q> N57N7,C7$C](/:34)2ID,@@ 50L *8&M%PO+4*)D;1>%:8@
M8.9A\^JF("8*9@O=F)]D\2I@@#26<*9KTV2!0#-/;L.8VEI\=LSIPJ)>Z:Z(
MEUB ELH5'4="XB9EDJ#4X"($IDM-L0,SKX3PJ)>QBD1+FI'>U:O6,4&TCW,
M-2 =@&>XHB-HD7L&>*"RR"L@U DR:=I*% D9=-M7:W7Y"RN0]B\6RF5>YMAH
MI.2ZS$RN0E42];7)B7)26QS51U%J+=LVM,-166[RZ%,3N\/;Q!#*'6A(2K5]
M8?8B8E"9@^G,-='JUS#/).\HT/R^WPXZ)Q6Q;Y@H/(U*+"1(SOK7[E5MH\47
MQ.XA:+$DN06X@KN9* A9[6>J5#V^K3+FUH<SR*FP@Q6ZO#"T'K)80@U6N]9D
M(D,3,1P2F VN@UF#[?\ )$D!"VUX:_@ZYC>[PB9]7!>$:\7NX7CK%Y&\11UY
M!W3@T'8I1)MJ,*1D9\0Z5E:S79 )+8Q#=K!MK63?P-7D#&8:W9!1&Z*QWL50
MLMEQ3)DJ#?8*1ZDC'G$0B!VCPJ)>3@1$N.N$,>"HZA(7.NAN$-96$Z3H1Q$>
M$^/%61C-<O+=HRG=SN+Q=RNR=BSKY"\A+&]5<K>IJ@W0!"Z%[&-WKEG1:C:4
MJ"P(S-=LSTGQ$RENWV]-ON'IK&NTITUCB"$JQW1F)IKUZEN)B:R]N^"WOCU0
M[96<3N*--AZ^[.@J:;%J!;":ZN5M*Q I8VH!, [*PB-QUP-+0)PQ*Q)3!DM0
M+2ZQHI?VD[[E>L^XNJ PT[ H6<P!IB)=*"9M$R3*V:Z0+1UTG(J2N_5J5P@6
M6J.*<FL)$;7.L8JE:L=$"(VLF7/,]H[MFZ!B(';'!"0SH0R,Z"6A1,3M,8(2
M\?@0S!#/LD9B8\)X@A*70)1,UDQ8LQ$Q,UZ\]31[HC\DF>DW1I[0]4SS>0M&
MQ* %KXE*S7U08V.F!JF9B&"9Z"2YF)C?$[=8F-?#BXQE5%=W0-DW# :0>8>\
MB3T:56=I=>$*%SV=*#T6ADE(B)$.3KQC&V.JV.T4=F4WV1T:UFK6>Y$W5L(I
M5->92S5@M-8R)CU)V3Q*F1U-5G'10%EVH%'2K-9TEV&>'D0QL2L&EHLV1L$I
M+PX@2) VAB2JF1 %F(F4$8QN(1='JY(1F)(8+6(G6>(\:PW(\:A20C:CQK%(
M#N*!?^2F1&=Q1!> ^,^'%CN(HE:K=+U@3%2Q8W]BQTC$K@G+]X)D@UA924B4
M;?;'%D:\NR)T8L]C0)QM.S =:E67(>;(DKU-<@%JNM); &6![(,=3$E]M!B0
M=Z)G3WQ(]V"Y*&%6UTZXA('!RK= R)1.FV>*VB,L^K?\J?0F;MD%K\'FE;QB
MJ\I*"CHE$$5@NLNSU8D@5LZ8PP&L!U:YB.LLQ78RF&K-KN EA9J93*4J1L@M
M ?$PEYG7:EHAO\3AHZ1Q9 (R5BE7C<R'O%-8)ECI4#I6.U>I-.(G:&[2?-I$
MSK/$>9Q5Q\U@%FXT1XN!*]>HTE1YQ6&TMYS&T=LZS&D\9)[:==_35OO;6KJU
M"@NHZV"V'"84/K3D(6;' N)8*5M/3R3IDJR<:V<?!%8F<AD/1^4;(@66QZR%
M">BI<16?T7U;IQ:IQ FI@I8$LJ'8<2V!9[(EF-S:9]H0E%G8J0AA="8ZNU<M
M7!EMT"6!NTWCKM+8END]*PN'5V:3L>F2((:D_=8N2 Q@PF1DA*-=1GA42Y4O
M3$M0,%).5'44, T4',L'4(@'&"2UGRM,5SYBB.%Q+DS85$MKB6R7K\Z8/4AV
MRT=0@MPE&FNNHE'MB>((21-H2B:T-!$V(F)1#FMZ"TRV/5]5CO4@O=O)OJQB
M2\.(4V7,K0MDV$H"RY$ 76568HWKL,5IO!#$+-P-(862@-@E(#,PJ)>"31$N
M"R%AE<U1U >NHD;%IB2#6&A608/L$$E"4D+&2(3$\5NF^Q@Z9'"VWZYE?L:C
M-9#*]:\5BW6&9$CQQ7ZB\:HW,60VGPLSEPPDP48>D!LK:+%>C"JB 3'3"P%I
MMJ<A#(W!UUEC68R5Z0P"M&S491/"_6I*RKUE<9VE87YTB6I1M)HZA$ZB4:26
MNHE'PG@!)B!M+&65BT@; 1)(*2C48%HZKG='C&A>,>,<04$SHC,2WID[I1.K
M.D&D&W9'FZ83,01Z;1UC6?'C8?==EL+O=9'M-L]UN$X40]#\KJ+)A<QMU@Y@
M)\TZ<8X=UW-T[(=3I<NORM>6;EMI6ZV<Y=QA+&%RN&+-.0L2061:8-,I@]L*
M!..CN,Y@U0/>5'Y[$8O)UAU)05LADJM9K6MK[+%9P0R%K+K@OU\P2R9*36W:
MLF3,P(!)ZR4Z0(C,^,S/LB(CQF9^W@O*A-DO+6L&"T6"\$/8V5BI:6SY&&R7
M*@! I(Y:N!B=XZ]%NKXZ3-:NSN8V%K7ZD 2^O&GJ>I#%R'4V[H,)'7=&J9)E
M^A"8[I<97#TLA5&), JY3+T*+'O).EBN:EM/HLZH*U,NH#)Z<KO"NO:N#&BT
MIL6!C<7@"UL.(U(I]@C'B13^N9XVET0L[9[=OY)^D]%F@B<[&^X?D,#\I3Y2
M$O9,<1$E7&X,:U#DA&U'C7(A'<0B^/5S(C,$406L#XSX<?XM#O\ $VCZ=9O^
M+L,Z<MZ:#]UQ]*)9M7)%TXD]-L:\"EQM% J:3SL6*@I%92TK50DA:K"N(WS8
MK'80%A,1U$D](L$98&H>L05I?GJBR4E9#S(%HRT243HU7#()#XD)+=$I;&FJ
MST@2) VAB2JF1 %F(F4$8QN(1='JY(1F)(8+6(G6>,2'<6KD&$VJ+,%E\A6M
M>;IHNXZQAJPI0]$@IH[;KFL4_KLAD^]"H!8(T*Y54S<2#BY+EH\;A[*-B:LU
M0GR% W^TFYOCRT>XE?KNEPN)<-<TQ+0N.;6J&OSC:L)B)=7KD.L/<J)B6J7N
M-<3&X8UXJ+*U=NT8B193Q[+'A$F9WQOXNHO$=+P(+CJ^0=> -2=*:3-M<@(G
M* #8YM98D=A'BY #).3$04S+51J:]( I\PQX"7RGA(E8%!($GC:8]-4DQ+!L
MNJCU+*D2&L.97#SO!>XE#YF0,>/"HE\.E$2Z*^L/E7K(1,;=8=(:]/3<.N_3
M3</SCB"&4.M"0E6KZP^Q$Q*$S!].8:Z/5KF&>2=Y1H?E]OAQV[>RH7) XBU1
MH6;(2!:4+=Q!.+'//X64;&#(L%+2Z9S*0VE$)B;'2[>)?U[!4T=&.IUK82P3
MJJV:]2P$J;!)#5@RID2/D+10R_K=")=VP[K'2CJ=N.L1N=LUZ0ZS$:GMC68^
M?"HE_7A$2Z:P[K,*CJ=N/AYG[->D/F'Q/;'FCYQPJ)?#I1$NBOK#Y5ZR$3&W
M6'2&O3TW#KOTTW#\XX1'<+QZ5P3LC9&R1J1'478CTB]-0L> ZO:/:%259F8+
M_")/!7JY5'$^"'VI\*U5O0LV9_(5W[S7T7N_)J;U%,#IL(3WK,=-0*(N=Q4[
M%Y 8@R]07*FKD56J]O((HM\V@M]7#&2IB&C O".I#0$E%DZWKK\TY-=,,A;J
MU[*8ARAFM8,>@+F"U9D(AL8,R38C7Q$]#AS$=CR_;D55CR>"PUUPPP^F=V]6
MAC(5UF&4;V3HM4'/AI$:SXRQ;%3 M6:RD1.(8)!,@4:B4041,B4>(S[)CQC_
M "4KE-5UAZ=(;:KG4>3!%\%69T]R(!\,!:^HE-@16(0%Q";H;;:5N'&POTS;
MLN&(4OEW*8]37!I_A*S:P]JM"-X[BU2EWX4J)2LX))N%L&$/78R*UU[#]KDE
MAL;C[;K,=6! ;.F29:6WJUAP<5:/X29#9>QJY1N:HV,LL[VJJT](-FAS)6M9
M_'Z5TSS%6HY>E-S)5J\DM#FY/'IBD^FN!21UB.A!X1J6JNG,W^Y4[KIRG,W+
M>5LOG?OLCALKW@N<EPQ:H35Q[K[)&TJF#C,:T=>[-5$S,!D^<$ZB4Y>OA68Y
M@L7VU@J>0R[7KFW)Q4KMA.2JLB+;D1IU0DH8A@#28NM'*SG3J*N05\O@T0,V
M8K.Q7Q0$YZ!&;E<&5D7\7W<H@%Q=.9,:TVF+%1+P45V#!SC/I ;E[E%9TVLL
MX<BY88V*0/EE+(1:C'W_ %0]Q6,_5W!@''$VG0MEVPAOJ\GD<+:C*J%SKR[F
M)RD7,;DIQCM7*]'C9LONE8H=1ZY[%-6\4R%4ICLV=04)>W)&\1INWUK:RJ(2
M=XZ9FYF-MRQ,(:)-CO06IHU:E=%8"Q\R&-36")C)8[F:_GX@B!(6F@^A?PMY
M=FR:J+3IA131[2R\3$J8KZ#*UD9;CS!3N7;KSW+QW/A7\@F :"Z59N4B"R"U
M2L,CDAOI7%YK:<]G36]=2S36NO<BW6$Z]?FNC(@5IF6QF1K!#TQ7M5Z6&NTW
MQ7O;^R8R+ BL5@\F,%JF*%BS@N,?,+L8=DNZP%R5<PPD8S356M1C,9%/#2AL
M#9KIJ%5*KZ2RYL3<?6"RMRV/%04/Y(N&E!*3R\./KVB+M<G6@0I14P=ZI/DR
ME= U1KE80@10RFJ^>1O%VF^S$OP?*"UQ,MIT>5<=944;&U[>$95;D.JMFTEH
M4%-Q)N%$5+1=)=1[G.2L[+@J<T%<EFN.,.9FUV59*RNKD,[04JCE)14ZK >=
M50XVPP%3>I0\%V5J"L[H",TZ:T.@6';Y_P"5\E2JJ8A_0K1:P=>RV"4TT*;E
MK(C)UY8#AFB)W 6QL0.1B0=SC:UWU\IB+>(K5XW]Q>RC\Q4?3M'3D>YK+QM=
M5Q96KR:TAZ0)03*>^-"HB>8\$SJ)BN/*%O'FPGI!"K-OEF,0NLYA'"T2>9KL
MZD-(!6/2R3I"D]-MF*GHU.7HB ;D>7K;;CEWCFO5&YZ<O7!O)>HD#D*MNL];
MK:%LN9(A*Q2*L2HJ(F" <SR_8D?P:IS-B<A9F G:NE1MQ=L'(:G/@A)"M429
M,:2T!O8P=;5=Q8_FJ1(6#FJ.'53K0T(.]9J7KEBU<:$E#:1]@18H>_75ML'(
MEJ$5U$4V;E=O,=SF!)3&']'<QKZ,J--E]>]3FOB\..+@.[GL+4U+8"->:2O1
M(E2<TYI];'QVROHUZLB$8K-*L9$1,3FFFMS5>R%EC@7)2(EA;M2 \-;00=%$
M-=5?75=07H/F/#P(3DCRF;O[EDIE?(4FXF@C&="\LBIM/''5MUU4^O#9-O7H
MJ>=QL\9"9L7FM0RLV+?+W+M*:]N(94R6VHRM90]F])8VSC;N-W'-JQ56^O<6
MQHO0=7JLV6;9H5)*FOA:-N1M/%T;T5ZE>UC*]Z(TR5J@75_""B"NU:Q728QK
M8AF+_P"WUGK"X#!YNKUVS"%#9R05PHA%ANQ6IMJLZAP>RIHMEHD U)GC_5XW
MEBP^3%.-YTRF2MI$5E>1C,D[KXVTJ@\3:SM+6_*'6BN3JCT^L2J\^LMV3@PQ
M%Q2EJ8%K,8?-ZJ-MBR\Z+H"ZU=>7$VH1U:U>&5W556[QKK$*_53+<ZY19#)7
MP+JUK-J[=228)[2KLL.8&M94'9!I#XQ6-(V?&(Z6I#K<K-#EK *6(&VOA\=C
M<G42^M+WIHY1&1R&+:O>0MKVD+KB'6@L=9<(!U#*LV$YHA?&>LUA#(5<N=.'
MRXV+N9*MCLW5R';>CVLK%5LOH'D*W<OJ*J[+-BDHY!L$G,MZ]V_D:QS9Q^0S
M>$R-X(%/<Y''X3,]ZJB..R 2Q+@HY'(;$VJBL=9VLIV6.@:Z2SDD5#F$Z4!8
M=F%IFG<CN._;E:K'QBK(5V&MV+:E>2N18R5M%45"[HS)J%KJ&8=#.:,LRL]4
MX[F93D-L[X8FHY75OX/+O4!;]]-PV<<^N6RQVV6=$AO6G20BQ.>JI%B5SRY3
MQV-09J'TC7J,=TJ3;]L2HUYQZ4).0.$V\G8M08.($.19[A/I?#WMVVL7(1U"
M:(6"Z-[T+@L5VSDEUKZ;!7T."%V1FQ*5G>814Q.WPL9J4<;4;H36<]4LXE2B
M%X8[$J;R^ZSU7HEE=!63Q>0R)5NK&PR4LH])72JP]"7SS-C;&E@LEGCR"8ZB
M0IWL98QU.O76&342HKV:5A=DNA=OUUU^\Z]85V"R$C9?8R#\LXE5;3[MVLVY
MC6,9CTVK5/&T&LR>,S3#1VK&.?:IBYK3WV:L7:]!=@C!7- ]V&553)EON[+@
MJLE4*)\'8DP:T1$4U8,(WE)])*YG9J.HCQ?L(C/\X6-\&',':,Q%Q?K1[5&5
MRMF]CW2O<= KT/Q]S;<&NMOHX5O(&C3!U+;4=R'4L[9;A;V1MY!H3#Z]&@^Y
MFV5*,6U=2O8FA5R=.O"ZS71.YRJ4/J4C=%WJ5D/1(P_LE6@57KN!RIGJ/L,5
M597)R9&Q9:YN^M)@USV/'>3)(K-0RQ&6IH>#"'E8\)C,EN&K?9-6QBDTL1=J
MR<PU,5:<'Z2K*6M#<9U%W[JKRH;F#BZO+V\0(!&2P-[$*FY^!VJJ+*%-K8[T
M>F:J8;6O4J:U6*M;T=26@K%9Q+)-:YGI7D@S-O$!%=&4P+L0BL[;794HP%9U
M;#33;.]?;6J55*WU5'6TKQ(7.S9N8MJ[7,&)R ' 57<J7L3#+$]M*LB[EO%T
M!K6EOV,IQW:S5-NV*:,["(+1 )%%. 'EYQ,&()?,.<R?1(?POL<CB<534Q53
M3NC)T!EZ[*RTE9%;W@Y(A<]=5::'?1Y=O-(YQU5M3*LWS;L5[3,1G:>ZP"I<
M\E]QDZ<%:VDG1C&=61K6I25:R6(Y\Q5=BT-MU\+-(.Y4JNZ[7#/SDFU60SHM
M:09'&0RQ7D^N6X%FUU.P"<H^K8])WZM4GT\AA+6(:AD#5R*J%I23#&*QJRIU
MYLUK=.J%=U=(8NF->7(L](E(MDTFCDWVG)L.LS1V9*O,UV9=B6628>1Q+($T
MN2%B7)O#7QZQZ[J:ZAFVTT843!RPK2JR5SMD-Q=XNWJ9,,?7-M5Z,CU*XT'+
M+*WJ>]KP7!F%A:[G;VU5[9(;_&JB$G==D^9'Y%+[ J4.9QC,;7IUDNLLA%)!
MT[@7V2FZ=-6W*S:0&A7(15F2O,05@&6*_P!&U3 6,BTNDB[FZ]KE:RZ5V+72
MBSN7A[^Q\S,V)KJZFVS=KI92:L)^CY\"5=7+V2Y45EE2)0RK8HV@+-7P7$;[
MB,BV+.0;;I18$^\F+A*=U0'++D"E<P#(](4>HU6MU==7?5S.\*Z38.Y%)?X7
MVJ&[[$JZ&L21:90.IC^?:H^OL92WB+E$S8EK,@IU',X\G;ZX)H@R+-ZG%JM"
M*]NHHV6;RUX^O$TR*&\TU6BU?;,Y4R%"6FY85XL7L;4J5*SF,(5+GTI08QD-
M(1J[$9"Q*J[ZMEJI_P &\G+B)!N"R.$]*KF"@@L(YHBWD<DK6([Q>1KG-QC:
M?7-:W$FW"!0<!GHB;+M-C5-R=1W65!W!16;?0_ONA48+K,TDEW1T5F#S-,U&
M0MG4$<BKJU^<4Z1;FUF^5\T(LL5Y;F<76](ADU@Q7;4.YLK>NLS'@I%X.N16
ME!26/:9=POO7LBK\.Q>0SF$R.1KE B_+8S"9GO QO86MEJNST?D<B(K:FK3?
M$-J-L'(UESS"+K-;-]HWN9SUJI9ZNI0RY9IE;*BQJWP-G&E73;M%)7%T4[V"
MMAG9BNOC*V5*YNQV2!F[$ASF&<9-7<\!JO!M(+A5:^]L.74BDEJ^CW::M=:C
M5 ( !.LST1S/6(5L8S/<LY:*D.K3Z0Q5.F*;R4$9E6>U\,[4Z,D3AAA]Y74A
M=DEYHH?&?LU1#(5LL52'2XV*N9.MCLU6R$5>P:RL52R^BR_5[MU-5:%V;%-)
M2+1E/5"QS5D;X/ JF5P6?J5+#=:T&VUD\,ZC7LA8A1T.FE;A"+PUU+B&=$Y4
M#3'%,A',F'=K*1Z>95=L>*U=K8P&6I5E6+$[5RN<K<HD*#.9&=UO9"J[W*MI
M-G)_,=-0?A=SF&^Q"(D1<]=G!87%TW0,S!=(<E3N1UCT567^'L-=-P63N/4?
M-><LBT#3G>6VU*5F"B5'>+/8&Z07&Z[:)M73N.ZE^:XS*YDS@FIZM"""A0KQ
M EE,/F;^3VV6#4K%:C,MRN-R2+Z86%A8UXJUW@;K=\>SFDNLZGV5=E<Q/'99
MM:0K6"YOOYFG.SLGA59A\)BZUJLAK.X686E7UK0)G96B6OC=4;-@\<T4UN7+
M"U"=K!8I%*VJYZB:[NP9C<S*E)[5>53D0LVWIBOW+KC+8MR#4VAM6Z^/_DBX
M:4$I/+PX^O:(NUR=:!"E%3!WJD^3)UT#5&N5A*!%#*:KYY&\7:;US!X7EO28
M@J7+^(Q-I1S"WJO8^H*+*YKLVNE0L">G:$"JO&1)+F1,<8J)BCFFC,)=',..
MRE.6$-:QMQ]!5&;586RMW61D%K)'2CN# !OUH.HON1PY=&MRN<;"N<OKCO N
M$2%ILS<N)R-D-A5!RU;*5[CKCD(99NVHN.7;A;!F549*,=RW%<XK7\'0N5+!
M.F%C6O7F9.ED\F$/]5D%Y"IEG7"[6+ER <<16&Y5  QQ*&KRXWI+8W#8I&/O
MIOCTX014&8O.;*Z>V7F*^25:MO4"(LMO';AF1:FT-JW7BS:KX'E7)5XE^1P+
M\N\*36[+#:KL[EK2\4U1SW"JN3Y<NCCB$@CM1L=N<)LUNFML5ZF6Q*J]@XIC
MG69)N26HWE4-M1H5FQ7&&CUAJ)Q^'8QJ[-&M;FQDV(:C<HVI*,$%*%A%FISX
M;VIAZFE-2]<Y;:BV#A9VMBM(TKC+%BC^"4X7^'2JR9M>YZ0RW,F9W]3&W<5D
MJB0 &'9R%E^7Q]ZDWT=L[]<8ZK6ML%EBJMLML#4J V76>C6TJ3RPRPR1!/(L
M<OG*>E:FCF@#%[HM H+%E-=J:UNC-^I _P IV]Q-%E[0(]7BL/LK5@!N5[=D
M.ZM>M7<%C-?AMR'/!$6;DW5U*@070?:K5SE1V"K4O\EI,!)8D0P33Z:AF8@F
M' &R07$^)GTUF>T=9V 9::#,PU34,8ERV)<HR6U30);%L"="!@'$$!C,3!"4
M1,3X3'WR_7(FRKUM:&RB;"_.B'1+1E,M'4(;!(<,KW;M4MC359Z<#YW+KAY[
M#H*5('S.; DL"E:HU,X$VJ$I&)T)BXGQ,=2$@(A(9$AF1(2B8(2B=)$HGQB8
MGPF)\8G[PE[FUF;BCM;*+8!&V!)]5R[-4SG;U/465*>(@8"9! .ABI-967S9
M<;Y6M1LTED*ZFTVZ1U':,8S:;SW-8(2*1,R%"DJ@%#^('R2TA\"<L$L+]*5
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M>BB46%I7+@6Z;*LG"DVL34&5KLW*V/66_:BG +Y<KY 7S9C<9Y')=%\14*N
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M?"\QL 73$NG;B<KGZH2X!60IHW7PNFE?34NHA%8P8,,EG^57_\0 :Q   00
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MG2[+PE0;"PE38E1,PT"L#)*XR00%G1]4>.Y^;QQ_%,T 1VR+)=IC-3LX;[+
MM/7T4JR!(B8NDU@8^)Y3I;3FC16RR3$FDK2B$0@T[/V5$@G[VDHE?$LXM='#
M L)'*5LFUN*2B99R<].S5I=V->^R?K[F4%I_&(H_CHK>)-5<09%=8Q'Z)$24
M-1E&N6:=%^,Q[51XR,5PR,5KQN<QR+QC''UW#!90,%5H7P*V8-20Y^(+(B@J
MVRQ_$D1(Q&[AXS\VD4@=:*-'-<WNS+Z^L5:,8Q#:KML+,FC$(:#CPX44+?(U
M 1(@6JY=L;57B-.FPHG9\J=V8RSAW=%9U0K#5I6),M*RREU]>9B_*-GR8VVU
M'/?I8URI2PK2OKXDC$1&CIF.Q)AAZ3M:)MD:05P00HY%<U@Y1WBC$*]@F%4K
MV,4E/> CQK(+6N/&!8UMDH-6>0SDJY<P(#],W1RD8=C58]PT:1BNG>%+$E<*
MZ/(G]CX2I)BD2L++U/&6RLAC<QTP0'"D[<17M"_E"(74I1J&)A+&>'L-I Q"
M=T&%:4-!4X:M*2PD)E ?&/10X+)<?F- 7 LQ3<]Q'N(K6D87$F':>'&MY&&Y
M)F2&MMJ:%,)":P9P3QUL^QC3B1C1S =NA 4*%)RZ$<5-/$J\=6#D5D!S661J
M^TJ+0M6]WZ%M"K9\N;5/3]-MA'C*->A$:OY,,%/2UEUCO%\%]F8]]#'9P,.U
MKF!44>+3RVOKCSU4K$?(GQY6V44EK6;:M;QBR#;4.#J[%T!*@U/;U]+2T4RR
MB/M8Z3HXH\"-$ LX#.\YT$(R&@O*A&;8"O?"?$J!;EG$=/K8,FXHX%O8PFM<
M_FX%+/LHUO,CN:USA&C0B,,B9B5_$N!70'.D5XC'L>:-&K8]<&.]!G+8S+(T
M2' &(BH-[I9PHA%T?&Z<45ZKGTQ9SB%I;:HN:Z<*6,6RDE8TVFG3 &C.9)8(
MJ*1T>0QY .0C4,Q);::&"0616U HS)-I459)\AE<PA@UP[2="=8G$Q4>4,!L
M@@FJU7M:BIQ)9LZ5898&(*&Q PT*QC@/E*K+.%(801&YM>-'JS= YRDCO8_O
M<,[%1Z8?Q!5P<1T;7KJV8-F-7\KK7JYL8S2#'JS?L[6M7/S<OY?"<:;A_"<V
M=A&G#-H[.=A3#TZP 64RR(Y)$B97'[0:,D9C@\^V0]B.<)7N T0AXNQ%?TN'
MZNZPW8C#37M-2UF'26!2\L]($D%1&@P):KS"Q^D9%:P@B*FZ)2NAWUS!@Q:J
MQT=GRAX@P[-Y[<1'(Z&"!:RI$EB-5'$>$+V!:NHKF-Z\5MC<1X 8=PW<K"Q;
MVAM%F!RSY@(JJSFF6,F6E9*C0"$R$I-QR-6KP_9T]#<U5RV:DL%U1U=J]CH=
M;-E@)$D38II$1R$$B$: K0F8[QPB.8%X\28'O<(X2L,/.-B,320\)T%+-I(]
M9)D-C&#:4=?73&-7(,1Y#G(52/"YI6OU[EGAW"D>1<[5G9QZ[:TO<:##D&:R
M44R[81B2.Q"%DD40&IWG.:B\ NIT*,2GD270AVE7<4M[7\VQ%5T8DRCL+$ #
M=%\6=XW+DN2+DO&$[B*/#H<1SKBV'961L<X=%"EP J;E!1I,K$;:(QA:40H:
MYSIHW-<V4U'(]."GEX%I@X>F3XLL6,9M='9B+X0]K(P*^<2:R4^LD*+-NS!*
M$@B*5#;1F/6MMBUD-M3;(KX5JF(,./K%8U$5Q)-@RV=#KQ-54&XM@:*-#JD9
M7<PJ#X! OZY\&3*C"F1-)HLP$N*?Y(\29 /*AR1N5,LP')DO1V2\$:.DBC."
M"RSE0Y>(L,0+&% (U7,EV%9.N8]A7@5J*NN;& F2+GY."PI#X9#!5J/? L(%
MK$74QKTVI]7)F09"9.34H)!$:_4-V3VN:GOK'\_ _J_,+O$ES LI8L2E7!]8
MRMLP4\M8S6CL;^4*9*J;D:,TLKZUZ<D[>%-F!0C-+^+FGIX5E%G^#.2RXKP6
MUQ'NISZF1S!9:-E1J>D9L,#SC1QDAKM<M&3=74QK:RJMIK,)Q,/8T(V)>3(L
M^;67)9H94F3%45-%L+(4^""4KFD+!Y$C6@#SC"$(@,*X@P_"D6D/#7N<KX:2
MF;4J^?52]W=4;D5P72B$VP(5%(BHTA&M5=MOA)Q-,N"3+:]I)%<+!O(V#;*%
M97 89CQKB<L9U L6NVFM0M;:V*&:]4$WQ:;N,"G@6-@K<85ZWP:>SB5%@M>T
M,+L]Q9DFGNT6 *4Y[MI874JE<THVH_55X=JL*V,&EP]B3=CWMMB.);26RK,,
MXY:L(P4%$CV$37)?L#(D=&#YA$60%RN[.L["!OX/IH)^2FR8N]".(CCPR[!&
M;D4SN\6._,1%ZO8J\>!NOQ;,L,679 4,G#]>U8M3287JY\V(V*,A8$?M2^G"
M*%B^,F11(@D8Y2LTZR>1/Y9D_P#%<*O_ .:JO]J\2&6#6[K;/%G9[2:<DM&<
M]L_'1S4(UB'V5R7(R#5.N7&)857@?$UG>7L2^H;:#<XWJR17H9[SV)Y(Q8*K
M4:L;EBF(4\QH1!WW/<B>,;QX$I!\-T&(2=@F>!+Y+@H8SA@K/BQJVXK(TEI=
M2;H[$,T2Z&HUC45^O"MMC.6"0K7R(]:%PQQZ^"8<&5V5$A16Y! UDM1\LG4C
MY6V]SWG5'<1MSF.T_=E;]H:M>OE]R=SVY_V/*;GE[FWI_1RX_NDBTJH*"E%?
M+#=&\6QK.;GIXC1EI%JU;>GIHRRZ<>#X$^QG3 5U@V+7!F3#R!08^P;*-"&8
MCV10YY>) C&9Y=WC2Y,E3PH-S3_\9TXD]J;.U[H)G+<QEM]H]CKV=\;N[O-[
M7+^GF-K3W]/$;<YCM/W96_:&K7KY?<G<]N?]CRFYY>YMZ?T<N/[II:E!I7+7
M3^4VD1 [?.VOR2-[J"U:MO+IHRRZ<>$@;B/<,6),/;8U<JL'KDP%?H:JY-UJ
MB*[2B:LDS\G'@9[)T]B]EV/-\O\ (>Z#X)SO,9?XWO\ /?'[WR^73/CP0-L4
M_EQ>V715*GPGL'F"\OFKN_RRC=7K'1>XK.HN[QCAC&N>]_@WQ(UK&HKG.<XM
M>B-:U.JJJ]$1.JKQX0>T51N&O<):=N;W2+GN"2)N>C>T<Z@/T\MW1WN,7>#7
MH6XIR#Q=A-CW=5>QR!L88OH1^YDUJ=-R>]ZY:>!T\$V]5X7AAP]7O;EMFY)7
M+8S6:>G\HVQ)TU'>56&&BKDU$2=BZ?&+)J\$PNVS#&1H%/9.,R'1Q&R" E,"
M4MD81VD=&D-:R*5[@D:U6\8P\&@8%]";C2LF3@GOL30;QBWD-F\,D<47"]"X
M4DG26<SRR%*E>-NVGQN,<1,486->X/E/A8=Q@.+)&"?5S&2)KJX@?'"+_?,>
M2W5F$.\P7PH94$(W@VQ7X*YEGB&C]T-U*J<(XA2&&?76D>*.;<PA2O%[@C0H
M6A@V%D[<AC"12S)4M5)CV\P&:_P;B5E#/LL3X<L>7ETUM6I,!,L6QC/WG@=S
M>UM.0L1XRHU@H0Q.>_CP0DETU]852X09R1:7$5;21!6.49]LV0&1A6^4L\DE
M4><J'!FY')M*YKWK@6]D8?)A[FL)3 QV2+05I*M(T6NN8X+,Y&0J]S'G0;F-
M0D0:F&%L@6H!1+Q/8Y,G-FRFN3Z%0[T5/[%X\(N!J_)^((TP>(XL%G0\Z(/L
MXCD"U._(>CJT@5:B+I>:*Q<MUO$6L@QR'G3)#(L>.QJ[CSD=H1N7HR7XZKT8
MB*YV2(O'A[@./&E.A1:&*Z3#>XD0[@6-D)Q8Q'C$X@7JW,;U&S4W)VE,^,&2
ML73K&^JK6RL9^%L'0N2K($-P3%',FVUVR*>U.AM]7B@17@T*5<I \WZ,+7-!
M4CM+*MPA6V79.[M<S%CU]J2Q"-YWN*I65Z2-G+F).IC= I!$VWX\OO!S)OL*
MSX]>&7BG"EKR\FILJ_M,,M'03YR'@>*:UG+N22,J;?+,B #((\N&Z+&-??X$
M\*U..EJ:S$5.2+,K#RX;1]C/D1]4@"LD;H2-V0/ 1KM"V+8^EJW4"8=DF7#M
M;"+)D"1J#.<$LHRF8UO=:TKVN>C4R1J+EET_/U/VAGW\"_=L_"GO7?L7BR_>
M+]_OXK)C'/JJP4F\NU:GQ:>G"Z=-1?HYAHDB#7)?&R!IDODXL8IZC$$5OA(Y
MRHMW6F*ZZSK-4_==%8V #"-07-"+V="5;#*,"4YNDO&+<'28$F2DBIQ!02IT
M7;6155CD'*;>HA7BW ,B#"<PANY@C"(D89Y"#CEE>#^KNAXHL;;$_;9YT.%:
M0:VLBQF $$0TN8-?+),DI&:XR"C; MTC.8)H:XO@KD7MI[BP8;M["#&DGAV,
MR/?0PR0&FS:KL6)8G!91G!:/39!@QY$EQ7BF:6/TTV(:T! 0)&*<+QXN^B-.
M84*7 BMDF:GQ'GV]Q&9JYC%8URZD7C&$$]G8AI+#$->.[AAFR1QIT&,D14'+
MCL(@I+8X]>PTS'H)?B(WB-<2,/XDES*P6';&C/!Q96UE.:%# %\04:![C;$X
MX>Z(P##9:.4J[RL<%"(UOAQK;6B?A&/B6ICW%M-&5+4>%2QQ;S66G)B',E!L
M)$E>8# @EGQCD*,L')DAX,$8 I9_;QL/GGV%A=CCS8D%9-B8[T@5P[.+"L'@
M#S"ZS'B1D>K!JT?549X-*3$\RQQAC*/&HXR6!%C55+0PGN(Z-&A0ZV..9<28
MPMY'SK&:T1-6Z>+(5ZC#C=J>5S\<M:GTJL@G1./" UP#GN$P1<)5!BG%%G/[
MR-FC@2C1IC(TU[5",)EBR-M'/50D;J8N.\,8<P9>G#?4R2+,]UC"NG IQU3G
MN%9L #"-(S<">0-NV^3N2#<M'!XUS6/X\%\I,,X<NIPL#5AXDR]'<2EAO:-C
M6[<*-<PJHZ,=XYG/U\Q6ER<BY-:U,37E]-2=BF5@^Y[!(5!L4<YB!0<>M"B-
M&#:B;Z"$%J*@>8=UU%<Z>LU'+7IAS$"XBYE%47([;-[GD?W=/,[6O=].?IX\
M.#H;GL"XF'&AR56NY8EE(8C%R]#PNT/;Y'-56KT7ACK.QG61@X2N845T^8>6
M04849NS$ Z00CA@$BKM@8J#8F>EJ=>,'(OE2Z5%_:@)''A-^2[9Y;''N>UZ=
MSM/M)W]ZZO\ &>6W_B]_9W_T=?$]9J.6O3#F(%Q%S**HN1VV;W/(_NZ>9VM>
M[Z<_3QX9%C_WOVQAO8S\NSVDW:_\F7 VD(][ ^$O;$USG.00EJE*K!HJ]QFX
M0A-+<DUO>[+4Y57!?9NGW-^X>I[ Y?\ O+9UGW>7T]W5IY;=_3RVM7HX\&K9
M:98C;@&I[>UIE)W%&/ETEJO?4R/27FA/&(B]>BIQX3XPDU28]_AV6=J?&;%)
M)@L&]4_FZP'_ .?'A5SCR)5M[BC<G'@20PK,U>O,=JBKY9X=@V.8GP-NYR4G
M)59F%_1.,;X4P]@^Z)!LH\*UL9UUBZOL!4JP)<<89H  PK1M<0IB@C[6^XQW
M;31HJ,<U:;"%\2O#B]K+6Z\$9[4;BGB,''5C'%1RHC &D+(-0;Z$1205EM"X
M4& AIL6R&85A'E'#.'(SWV2QE<V0AM752;J.UJJKFO7-> 5U9XZQP)B!9=O"
M$B+(;723V)&3MIB:E C++-Y<E3X)*<]WBUXPH"*UVF%;1+B87O:(T&I.R;(,
M5[<MIN0D"UZN:F\4;<\W(BX]M*QR'ADPS=Q(QAKJ;); AUT%3C7+O,,0#GB5
M/C,5JIY>,3NG9MH68+N>WMWI#Y;7&R24KO%HN6[HUJCLD-IZ:^'*SXFM=&?\
MW/NY_P!G'@]\(-3\(II-$RHEO#WF5]@)V[RLAK,V@?NNE1U15^4C:/YF=M8B
M4(85, !94B0Y[!O+*D#C1(('-&1"3I3WO>$"Z$4,>29SVL"Y>/!I28GF6.,,
M91XU'&2P(L:JI:&$]Q'1HT*'6QQS+B3&%O(^=8S6B)JW3Q9"O48?#$Z\PR7$
M.!;;$1ZC$_)R!@G5Y2VEF>I.#QPB]XPI"([,(=YHLY0RH(1L(WN"[RVF8,G7
M-L.'17H@)845L1(I+ (SB8BEC/;'"U6;AQ"(S=9(D$E%*[#75>[/P(C>OQ4W
MX:Y)]"9JJ]/2JKZ>,:?Z7=_SC@5>/!+#<FF7%\&],LEF??8A1L037-\C>HB^
MG-<^OD3@_;U9<V2.0?+)47L*D42IJW=]9F'<0<PC^YMH-(NWI=J4NM-'_NOC
M/_\ 3RC_ /[<<&= !)C0W/58P)<H<Z2(7Z+#2PPZ\4AZ>DC(49J_Y)O'ALEA
M;'>6/05I6-EQ(D^,YS17:HAX4X,F')'_ #@R0%$_R/8J<8RK\5,C118)KEML
M/VE7&'0P($HH9QB@D5%0.)0%&](K=3VUC9J">7QRN>US;S #%8^_PE8Q\18;
MWGHU%@3"J&QCH[J[0)Q9)'=W2CY4?KW>CX\ JEJ*.-&P_3.7+)\"J'RZ241N
M29V$A)%B_P!*DENSXPK_ /A?^!V7'A(\&.N'AO%$RZO)F'[JDBQ,/]M)!ER4
M=37JTL>'VBUP4>I"2F2"20N*<^Y)BL<7%*,N96$786H+A^*#"KXEA8+7QR,9
M-K8L6<U\?F)"C\7*5%0&VAF:ET([&_855)K8 ,84PV.GSUL9\PFNO^%RR-#%
MAA,X2C:H(,0(AY9:C9Z^/!H[T-Q+B-JK]#G2;%41?K5$5>,3L>1[V!Q]7M"Q
MSW.:)KH]>1S1M5<F(XCG/5&Y(KW.<O55X\&:9KDN),1JJ>A5238Y9I]6:Y?M
M7C^YYMFQF3"U],*6D=_^-<E(ICLBN=DY=!%;H\CM.M<F\8KQQ:6Q^U;'#C!>
MX9T&P[8C6EE6P&\C83V1B8=6#'&%A5/%MI3M3T8D?4#OJ[++-57)/(F?H3W]
MC^?@?U?F \.6$NJ-2@9MQ8#<+84CLA)EEJ@$C4@30"Y=-^&0!NJ^,ZKF:)AF
MQAU8I/\ ?+VT&'9,J2F;E1DF=-JI,V0)FM^T$TAX@HYR"8Q'+Q53?!MB[#-3
MB.SD29>.H-M9X:H#+9J_1'?44>(%@81B0=A/'GIX89<C3&YDI7,<UG@\@>%"
M]J;?$4?$,B7?7V&ECHE=1NCD2#73KK#[!PC&6R;&4Q*9Q&Q8@=ULAA%YD[&2
M/")X/_<,&:+<_E["%P$M QS$='='>2;CF;*+#S&7F&NG$E*]32&M52\8IN?!
M[))2TUO-DM%#Y6.^%*@/=GHE5,T4F$0!'J0HH\B,Y ,,HVL'WF<0)1R5Z]EO
M>2! 9140:.,0G4I&X>#6CH5>941QW/KG.,YC'%5[AL5H%Q--AV)8VE RDHJ"
M#-:-B/1H.?KJR),=%;N/<D5YW1M:[FUK1KDK:WMK,-,#E:B2M=5+;5D=6HQ0
MP+U8/;40:L1!JT%@Q%$B"7Q:(WB%BJ5:,3$5>X;X]M%K:FOE*\2:6/E.@08S
M9[T9XI73FR7.!XARJ'N<!N)TF(.U!(66RRJZ>FHISI:O0O-&E4=?7&DR4(U'
ML/(>4K'=6/3KQ(;964<A9@$BS9T>FHX%K.BII3EIUQ7UL6UFQW:&[@)4PHBZ
M4W6OX#(&@G/ 49F-. $H"N&Y'M0T:4,T:0)53Q@) B!*W-A1O8JM4=+=3ZR=
M61Q;,2*["^%1<@S0@T[-+'I1'K7-&U!M? +'>UB:&N1O3AA0O>(HGM((HW*P
M@R,5',>Q[51S'L<B.:YJHK51%1<^)*%NVI(F0^SYEF&JI8U[+A9:>6E8@C5P
MKR0%6]'--8/U)EJSR3B9!P]-@P8]CJ;/0E!AZ>68-S='+R95E52Y1HJ-U:8A
M#.C,5Y58)%*17#O8AF0;,,QM@ ]?&BP!QI3";K'QHD,((48;7_%C@CCCM;XM
M!;?=X#B(QZ1]Y'*LAEG[D,'I)=)73E*,YM$B290U8UP),E"GCN34 @W=> VU
MY,CR+2.J.98Q*JHJ9KGMV]MYY-1 @FDO#M,Y=\EY71\EV%'J=G)0MVU)$R'V
M?,LPU5+&O9<++3RTK$$:N%>2 JWHYIK!^I,M6>2<3*R@FP(<.Q1S;!A,/X=G
MDG#<CF[$R38U4N3)C(U[T9&,9\<>X3;&W<?JE8<@3*L%).4KIM?[E\*F#,<5
MVISY:GI2$DO;T:%QGO='&P0@*,81-9(J8$X+ZF45D@]3:5E5>U;I#,M,EM=>
M0;&$*1T;X\06%72W-ZZ4R6RO; ]C,4; H0VAK! $F0X\8 FCCQ8X^N@$80@M
M57*C,W+F>;AVS/52Y,;DS2(R"WG1ED E*)KR#>HT<:,%7J/0Y[&N$Y5"0C'F
MJI=@ -=*D\Y-B553340;"7_UBR;25]?VD;-$=KG<P[6B/^.F?$;%M-CJIN[*
MRPN0,&OIRL2? N+J*^++!:1V23DCQ:>.4DEAY212RK!D0;(C$:5S,UZJOE7@
MF'*R95BI3ZN:@&PQA:<.:KES5U@^?3233W)\5KYA#N8-K!,5!C8UI;+#TF'!
ML"_XX2FI)YP)D1')#)95TM8"$:5["I"Y=#,TL+K8QB-LYCK>$I[H<<-S_P"S
M>%]JV'%22T+;.,E+RT[2V69JK*$5SV[;2*Y  0=3;"M&Q9=$TS:9D&MJH%?5
M\RQ[)"PJB%!!4QWG0CE*0<)"$?I(YRD8QS9T6;/BM':.&ZU=7TE%3R+91.UC
M[5F5%;!EV:,?XQ&SC2&[GC,M?7A]#%G@/2/-S/9-O4TU_7#/GJW@0[VOL01B
M*[OJZ.P:J]5>O>554.*8]M)9?QR;H;'Q;WC5!*!!M$1CH_+-CKR[8FSRK8_B
M$"@>YQSMKV<Z4JD>0T"DI:9QR&?N$+*[&KX"2S/?WE-)0I>J]_JO$>TIY\JM
ML(KM8)<,K@F8OI34U4U,>G=(-VH96*K"-<Q5199#V,,,J>-P9UC6T.'Z>VFA
M>C6D%+N*FKA6DD96M:TS#2WM,WNE1Z*O$NCIIM?%K)Z.;81B8<PW-6P8_7W)
M\B?42I,T;4(]HQRC%8%CE&)&,[O *"/9B6IB27S(,:554TYU;+(YSUDU<J=7
MR)=89'O>\9*\\9PGO<X2L5RKQ3VI+M"6M#&)#J[5U73+:!C%BDAO$:R6OYV<
MFP8J-6>>2X92.D#5LA=WB5"FS8@XT\[)5B.LI:.D[3D#=K&6T?2UM>2S<PBJ
M1G/OD:2^,3)_>X">1;Q2S(P5CP[)</X;[7@A<S;4=?<I4):5Z:,VIR<L&E%7
M3EFO#GO<KGN57.<Y5<YSG+FKG*O555>JJO55_/U/VAGW\"_=L_"GO7?L7BR_
M>+]_OY<+#TV#!!/U).UT&'IYI8W-T[$B5954N4:*B9Z8KS+&8KB.8)'$(KG8
M@K5K8]HI'%87L&A-&BE<1I=V!6R*TM;7$&]B;!(,2.Z,W-D=1L<YJW%UBS$]
M3%QQ6U*-P/:6@X&&:YTPA%22&XLZ2)6<X!@T$D:!<R#53MR1NQGL<3C$@O"W
MBG".(:&11SXT&C@2L&W=G,N"L1D$T+W'[O);+G.5\JQD1T$G>"W6FX/"L;P1
M8TPY BOK0EQ)!O<1X>BW L1$UK8*V!CF4.OAUVYT"E&(33D5QS;Z.:=<$64:
MSPY;^$>FCSO=#B2LIZ>QKE<20(E4,;Y=>6KEV,(8]Q9T"+MQ#O>D([,W)PVP
MQ#(AS)Z(J.F IZ:LDGS1C?A9JJOA$FJQHV,$LMQE"Q%:'0USD6!5K:!E1:I-
M-4ZRIZ2VFU2=-/9=G9UTNRKMK)NQR<L*QT:Q [:,;EBJWIL3P*GPGFF,2$;$
MEWV= EU)1[DM['61Q45C:DDJ5S4OUD!$1 G8T950JXJK_"AB'#&);6:.(/",
M&H+AJULJZ>TRN/8$GX2U5L**T;6YM/+=+,J;6T@WZ#5SWWR\U5!!'@V;:ZH9
M<BC1B-*.*^[9 ;;R(BO:BFBR9I02?)(&5JJBLQD.S'&Q(S5G90JNH@[RD:]A
M72HD. "#,>9A'-.^5&,\Z:4*K]#-,;$09<:MN8CW%#.I*FHH";CU5Q2&920(
M 93S:G-.Z2,JG8]XRZQO<U9 K&7$T3#,D3TKJ:EI5LC#57#+:/IJZ ^S>-ZJ
M\;I[I"L(NXW)_7@$P#8SS1WZQMF0H5E%5V2IXZ#8@E0I+>OQ)$<K,\ETYHB\
M#A8DL(-F$*(V.Y^'<- E1&(YC]$.?$J(\Z&QRC8A&19 FE8W;*CQYMXC6-;*
M/!G0RM-%EQB.$<!6^1XR,5%1?0OH<U5:[-JJG$^#+M L!;.:ZW[.J*2G/;N9
M\5;:745T&79_2O/'D:E55=FKESD4%1,K8]3,U<]#-AK#,]+!'JY<K$MA3RCS
MVIK5HVS"F:(>0AHT36L06(*2:M;;!(8@I$8$5HV<PCVF&D-0K"Y=[7N9RJQ^
M61F36B1K6HC<1PBTD2Z8PC63HV$<(@<QQGZRR&A%1MCMFD57(Z>@4FJ-Y!;^
MT4C'!Q-)GC#? >TK+2LKJREE*9KE<D@SJ:' 23)ZJUTB0TIGCR"]ZB:C$GP9
M=H%@+9S76_9U124Y[=S/BK;2ZBN@R[/Z5YX\C4JJKLU<N<G#59,K@4DU").A
M$PYAJ7SVXJJJSCS*B1*FN;JTB?*.5P&-8,*C&,;6KA!LRM3#CAZ'5GN:PPK'
M.THWF7'6GYIUAT1_:3CK8;J(;F=Y$?Q%JHMD U? D<W71K2HI;QE9)SSWZM;
MNNL'UA-7?1T%T?(BJ1.^NKB3:6TR186$PBEDRY1%*8K_ "=7+Y&M1$:QC<F#
M8C6,:UC41+JMN(TB;A?%58^GOXL56I*&)<UC6,)".:%TVO(YSPM*YC7H\C-;
M%5'M2=@W$Y)*Q<GP;J#'F5I7,*SO@DPYPF*CT15%*CKS4(G5&&D"7/AJS)%?
MIYT=B:/$H,/UL.?.$_<')M85=5Q8=P1'*OG4$Q%:Y['(K'O1:[$TJ=7%O*H:
M"@3UPUAA'A:Q&H%5$VG;',2+I;R)I 2E@_XF\&:\+;8@DQYEBX;1$E!K:NM(
M9K<]+I"5<.$R25$72ASM(;;1@]S;8QK4L:*RE5DQ&.$I8I-.Z%_QP2!KF*3'
M?DFL$AA N5$5S%R3B97)81:^'8JJV(J*DH<.=HZOC)/)05E:6:UWZ3)3RM=F
MN:+J7.RO+&\P_1PVT-I6AD6^(*BK.MA)Y5T9 Q)<P4T@TTJY93([HS58K-W=
M31Q9X=L;JJ?&DR&GM%PR/"XX=T;2CFR)UIA6,)ETKD5'N6;)DD:7/?:R0U[6
M\3(=+:OCP+!%2=6R8T*SJI>;="K(J[2--KRO5F35>Z,KU:C4U9-3($6=*$V#
M%>XL>MKH%=350#$^4.*JIXL&N9()^F=L;>?UU/7/BN>^^7FJH((\&S;75#+D
M4:,1I1Q7W;(#;>1$5[44T63-*"3Y) RM546WG,M(33W[0-O$3#N&>6MDC))0
M?:$+L?DI3LIA]UQH[G2-3%D*10AVZR9)DPB=C:TJH/8E$RD@[BJXFQAYE:VA
M:I'^,(O9RJ0K6%>JD&QS:_$5A8ULRZJVJR#8'PQA5Y@)J:]B]:7;(^.]B/AE
M,PA(3U(^(X+BD5W;WA*OV,9$$%\GLZ@BBMK]@2>;P=D08$#F2#396QMY(UCA
MVVC<=!-"V9>G#R@7-#$K8#7:QU]9$9M1(C%R:BZ6YD(J-:CCD*]&HCLO>$I:
M*Q@0:PZ/;*C^YO#$A9J/U:NT#RZ<\FP[KW#19ICJT.06Y":UB.P^2R!#I'O4
MA:JEJ*3#T$[E7->9CT%=6LDHKN\K3H1JNR=EFB+Q,N*+'=5B*=?86[+@"HRL
M21#/=-1+;M,0I4A\-E5''\%4ZADR9QXQ$C!Y4Z-X+,PU+B5\PS48Z82GI;&6
MQF3D4<>59U\P\49$=XX<4@6'R9O(_;9I!BHLT(;^.<<H=C7UE55/64(KC)),
M&KA1(TF0Y[EWCR E+(9XL[B#1&\#OWW@$N&1C0G3Q4.'(YI,,^C7$G[%0-EE
M&3;:H@6#9(@.S>!HW.<JV-6EE$[)M!M'+I^P</=CY,<0C71*GLKLZM+NE<93
MUT:*=QM)G$4HQO:N&@38AZ%9+YC:RUI**\C!E$:K7GC-N:V>Z*1<W+G&<+)[
MG$;D1SG*;"L:95CP_(1W,5ON8PL\4A[M*;\@A*9\@\M- ]$PI72QJ,2C,U1#
M5H,,2I=42ABJQT6L3"V%1@C$8Y7[T=14K"!.]RO4QQO:8^Z;>>1#%UX8HO"'
M9Q78,@V$-A6P</8?KBU< ;FHHX$BGIXTZ!%R8-D@=>0><=N36*K&9("N\(N
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ML4HT<J*]N?OPAQ!B7#]&:0Q2QQ7%S75A#C:[2X@639 7$8UW=5S$5J.Z*N?
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M1T>]H6,1RIP/$E2Z'N3(46HO8DM2B25!B2C'AS(LD(SJ.=7<Y/T +'>&>PZ
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MU*B*J9YI@^_P1AZSP[-+,DS_  FV1Z.WP]#L*\M:8:55AVK K?=!9=IJ)89
MBDD@(%TA[XXS,W(<*3+T4C3[]O6M$NJY:/)T:!(D;J:*U3>,GQ4$[M!C&1"O
M;$?)#(M]NV$&BO\ %^',:64-82OL&6&'65:#A09B2&!%"F$I:YY'/BO-'8DL
M0E=S#'Q_RZY!6";Z-2]5^IJ?&<OU-15XA6E97CL!SI!8G,2"$$**9K7.%N 8
MS<,AML^2;T?+:^,NM,H4.]F"6MM62*[E!C'%C!+(&JQE'DFZ\Q)#!Q1J4SW_
M  A4:[R-6ZISJ]Y*ZRF1=PJYD,P9GH([E]*R!:#9Y)GKSR3R>]\,_P#L[MOX
M=:>^83#V(;:IT.5^S%F%;$>Y<\]^"YSH<A.JKI. C=63LM2(O P8LJ8.(8R(
MQCIL+*IM.G1YB-8TM=(<O1R"%$@-U:O&(CDT!!7W3*ZS+DB5%WHKIRD7_! 5
M[W1)A/+W(4J0_),U:G7]:JN2NR15TIEFOU)FJ)FOHS5$^E4XQ'/D4>*HM=@^
MP?68HG$@5Q14LD3!%-S 8=M*FG"$1Q%(>!%F":-VK5DUV4>9%*P\66 4F.8:
MYL, [$((K%]+7C<US5^A?>EC2@BDQSL<(T<XV&"8;TR>,HB(YA&.3HYKD5JI
MT5."CHZ:KIV2'->=M9 BP4.]C4&QQN6$/<5@T0;%?GH8B,;DU$3WA[&WL(57
M7QF*21-L)(8<4#$3-7%.=[!,3)%^,Y.#0\+QYN-+!B.1#1OY.HVD3T.L9+'2
M#_3JAP#@>B+E)3@PHEN'"=<5##2'AL/*R-DG1FNV.Z1:))&/IOPI,%JDS*P(
MET(-\VTG3+*87+<ESY)IDDF7DUGD/(5V7HU.7+WN /\ 2DK^$V'&//\ 7/%'
M\<G>]2956$ZLEM32V57RSPI"-54<K4/&>,B(JM:N6K+-J+Z$X&*SD0\4PFZ4
M45L!!S4&U,E05E"V"J1W15+.'/7ZNO 8URX^$K$F3599KOU:DTYKMVX6-&P:
M=4W; %>WR>ER)P*5$D!E1CL0@)$8K#@,-WQ7B,-7#(Q?0YCE1?I^?VGV0OX>
M+#[27\2^^E_N_FN&,'QL.1K V+AVKJB<6]=!"UU+#9-GLG"2FFD!W'HV,X*R
MMYWQ]CB\@W5"E(^G="VY0K)+.OLPRPE(X\24L* YJ12!)'DC,%A!E:NIJ,4;
MW\P*3')'3/,XS#>'N_&\:URLZ>GKTX5HC"(YK6/<T9&/5&$S4;E1JJJ-(B*K
M%\CLERSX(!APO.'+="PK'%%GY-P:+K9GZ-2)GQB)+>#6U]=76#14\V/:CF.G
MUW*B(27/%MC2L*R0I1;!'N72S5\1&D*TC9<5S'Y:'M.)6OU?%TN1V3L_1EY>
M'[)A&VGJ,NT1A-LB>4;]*KH>GI:[)4^CWVY(*T;?1G\9WU,:G><OU-1>%9"9
MM-\F\_)Q%^MK>K6?VZU_JKPI"O<1Z^5SW*Y?^*\7N'\M1WQ^>K?I2;&5",:C
MNNE"$8(2Z4SVRF\N?$>6!5%)AR!2 N5.HSQR-(-<E]+2,1<E^CBHQ5#;E"Q?
M1PK!KNN:RHP1!*BM5$1%;#?7:OTMQS];47J[WGAG_P!G=M_#K3\R&.RP6]IA
MZ6]CW1"R1C$F2:(,Q7<W!TMZ#8,CXC%74Z(_@$))/8.("Y-[%M",8IR_S:Z=
MDR-/S7X@DV9KDS=RB-15]\6F/BO#8;< W%-5%O*P=B(3$57D+"?*22QC$15>
MYPT1J)FO3]7?W29W7/*5<'&MQ-LJ@X +7W4>#15TLM;.EMV+.*"R:-(1'U\Z
M,9J.[BNS>Q^%[=E6M(RQHJR4RH7_ .3F%B"<R(W-K%VPMR8+-C%4:-S:U>GY
MB196T^'65\0:EE3I\@42+'&GE>4YW,&Q/ZSD^A.O$BK\&U<EY+;J'[HK5A@5
M W>37"@>)G3\E\A)#H =2:F-E"5,^?Q9?S[@B/<\(#%T0(FKHJ0J\.W"B)EW
M5V ,<]/E%<O7\Q@#_2DK^$V'&//]<\4?QR=^8W<-7<J$)2(0\!RI(K)62IJW
MX!T?'57M30IF,'):Q5VCC7)R!KL; 'AJT=I8ED%7DH9+M+>^1SU?)JE<_5W#
MK)C,8B.)/;GH04F,84B.=C2!. C#!*-R9M((HU<PC')U:YJJBIY%^>VGV0OX
M>+#[27\2^^E_N_FO@7ARKX%6\#<;ME$%:184N$Z92Q&P4(\CLXZSB>*CH1J<
MSFK!:E7C"52^?+LL.1?") E8VFR5<0DC"EA?6-A(=<O3Y6$.3+@)=%<C8Y([
M#DDM2(I6\>$I\#LIV O^B\(\29<HN''XK0\UU?Y/Y/[2'3[7.>4R!=5[N7P;
MBHQ3A*)"3%MGX-ZJJDV$*1N*>PKZMY8P)0VF=%;,!//I,]XVRD1!@,[;")C/
M!K.?B^I#B>AYEEQ05U(\.+9%E+@O#B6OQ@7MF5.</GWI/GS)U='"ZP'"EJK5
M(!K_  P&ASJZ-!H?"Q@"^EUT+0ZKF1XT&B'/#>"K@RBQJ5T]QWVDYD&7RLN.
MYY(LDHWQWXIO8MU@&QM[CPEX1MMFG+$<_#<.9>8>CG@0["7%K;)PI,:NE6$\
MPXL*.I'RU06D+RNQ=4X==208TO 6%I;ZVH?"  ]@&RNF$D<I$5K'RV5[H>Z1
M![O*NCN>NVYBK^57.5&M:BJJJN2(B=5557R(GI7B'51=5E%64T%I;@?\"A#=
MW%)'TL>Z?LO5'F4.0]EKN7><BHU'*4KCL*F[',JZD<%WQ4:J=WN^3)O3R.1,
MG)^4$CT,>FOT^+=W2=/IT*N7]++BP8)N42QRM8F7Q=$QSU,QOHTCE-.QC4\@
MT9P(Z(Y\W ]WDJYN*5U7/<C5^M@F.F@3TM&&M7XK$[OO/#/_ +.[;^'6GYL%
M7B;F,48=;W$4I-5[ 9TT\I,,]$F!8F?P2<[/XC 3(HV:',M\-V8+*&Y487;7
M2>(96H]8TV,_(T60UKD51&8U5:J$9J&YKU_)C:YIGO%9P:&82(<?RD9[VH)9
M8^BY/BL(Z0U?T5&B^CBOPB\0DJ+'#L!_--:,I4F&BAE]M;I-6]8+,7GWRR.4
MACJYY'KJ7B3@.DD1JQM)AB%?V=K)A\^4Y+.6>'70H<=9$<0QL2&>1-.3<<[4
M$ &C769,(SZU*.#92_"87P;8C!*KIDR&^5'FSX);*L>RSC% !5A-DLC$64[2
M?EEE->%3.;=SIF%S8GAWE?%F.C5E@:HF5UIB,%5%V@DL(LB)+;!F ,=VN0-)
M R"8US%0O$NNQ$VKQ'VGAXEOAB17P9%+MVHK6OJ"U5F%]A::H.Y:PY0IPS-.
MT3)('C(3;)P",^;26,NVPKB>Z@37TD@88EQA. *VEP"1!6R.+664-Q1Q3O.D
MB"<+=XDY#HT=M?VD_ FW)9AN30G.L^GBUT6Q;%2Z[6=)/);)/%<=RU0XYF.L
M"M:QS0N,R,SPL4R2![^$$CLJ[J9A^?7<W%L:%+-S9=1)D03[XG(<0I WQA%
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MH[2YWU-7@,9=0X26G+L[ZC&M9<-44=Q%5=+QQ6R1O)J[N[%5>CF)EB*J:W0
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M">8OBN943GH\GD:P LD4IC/%'9J8TIA[C<W&E?" R'N(R>+,@3J1=6IS_P!
MC\]6E_QNJL5[>]P["WA"K67-2[K$G*B]IU,C2HVRXLIGP@91M7Y82[JLUA,R
M6 B@X6ZKB.Q-@B015B7T0>HL!CU79!=A#J;'=_@VV _@$DFG^]#F9#;^=P!_
MI25_";#C'G^N>*/XY.^85M_4&Y>QJY+)48G56JYN;7B*U%:KP2!.>"0/4FZ
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M1Y7KXQM6<[4! :0)AO"8+WB*(K'#((@W*UXR,<B.8]CD5KV.1'-<BHJ9_F,
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MZ*-UC!620QVAG#D-WQ.,1HIHI&TJ#<UC.)?]3YD+$<O#-%)OP.&\%T>JA%M
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M?E:)K2/D/_HUS/+EDC\%8_A]O8/EM037%1Y)U,O^"-$*U=_:CKWAH)R28O\
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M=(C->]-*E"QZ\N?+Z) -L[?Z)$_-QZF$BL'\K/EZ<QPH;53=,_T*]<]L _\
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MJ10M8\R,=M,*]PQN)I70TA&C*X;%=DCGM$1S6YJC'KW5QQ%O(M9#+AC%2X?
M.K+)D"<(=15V#BODRAQWG>\D]4U)%C(UK4;M]-;EQ'*IJ^+%]VT;#,/"!X1B
MWUS62;=E2"TK[>-<NCI*E#)VL"*^F5C(@G@*[_'>'V;ZEV(*5N"+ZL@PN9@A
M;28ID&":)?$[1EQ Q<HPU"VX Y\NKVGJ-&,.]RX;'BB](4E/#J:VI'REGR5I
MB$\ (5Q#=VB1.S(DZYW'NPC2V,L$Z1!D=L,C&D3HK8/Y95;8QQRX,T#X\J.5
M,V%$1,G-7THOI:]JH]CD1['-<U%1TR&TTW#$HB\I.TZGPG.7I!L5:F3")GI
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M,PI,'<1T3)/@3MSFLU7RL8 L\ZM3TA"GT)[QD"G@2+"6_KM 9GH;Y-PQ%R$
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M*W-40C-6A^2N;J1=+E3)?U/*G2[2NK9LO374W:,H,<9;2:0<2*N17L5X(QI
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M<)LJ3$"[;9J(YJG:Y6-5!H]^ECJ7$<;#N+/<_?2JZ) MUA53H^JTGCK8AI(
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M$9%"P6Z96M8I2JU,RDT,8S617.T,8S/2UJ)_GC:?9"_AXL/M)?Q+[Z7^[_\
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M,APW6-.SW. 6R:U9C2DBS.QR()OB7G*JC;=8>PW2Q+DU+ BGOSV-PM1%BLM
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M<T20?F=9G?YU_P#_Q  M$ $  @$"! 8!! ,! 0     ! !$A,4$046&1(#!
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MT/&:FSIYLSN#>8=X?VY[]5M-Z;'FMFS]I-95U,B.MZDS$RFRUW2)_8REMQ*
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M\"IH":<F!C$S.-.5KC0^\UHM?EB>(/MC,6!^B)OEX""")\D%<\#"!SF-_F%
MEAPC=M$8%E4O/82GJMP3R#K "Z^S^6H,F.'PST5*P8&21BH9=Z"6K'"E4M"J
MG[:5]([T4DG0-/7#V'48.P=!03D&XIJ89S=(C(<2%F<9O):A.P,O.<EMDC,V
M,+I&-XJ"2(.'=WI=(Q0+R[88KNI392;+;FA@?VNJY("2B8MDF23>6 =  V)"
MV6\7]5"]^OHAGP]%V! ;&TOI,[=GR4?ZGT__ &?3_P#9]/\ ]GT__9]/_P!G
M[GYQ_BQ(.^YU_P 2_4<WC'?<Z_XL6#ON=?\ $OW/-XQ7W.O^)?N>;QC/N=?\
M2_<\WC'?<Z^PJ&Q8.!A!5[+879PPS%D5:$<1D2V$S#" -X&>T&DPRAQ>2!*>
M98"V(L+3G4MCJ+5 16J#82DT49V%[9<&84N9:O'GRPAA(NY61VRE_JL"C@RF
M?68G(M ?(5Z&].K-"9!51@X;>%'(!<I2R V@# /V$M=UX'_[ER_ 2A#8VQ&H
MG05<"3!PVAX72G$ <EHS.=%GMTQ1(,%6I' 3K$][IAI>Z5I[]F?R_62KR4?<
M\WC'?<Z^PJ5XPH4@W-5IFR#(CAY&0"*J$C']RJF\YT8:'!9[AMK_ (V,JDR(
MS_(]I*5B;$=0AS7 QQL"V^,STJ2,H"GX-LK/H7%L>*-ZS\.HO+S#5*#JO!;X
MCMU#>KH1OX:"-#E^6-'2SEDJ?N;!!A,O*15"%1VDK%?JULK0YEHTV1P7HO))
MYR:&:F'T5"GP.>6^C6 0RP,H9QV*MN6EP$[I(D:^\YHA(MXO/>W31.5/:J)"
M4 C0-*6&:=4RY*U 5I1-W(#S4AYX7M!)+&XZMWW/[GF\8[[G7UI(TW*Y&$[:
M!8LO@?G!^9YRB2Q+^"T$6LBJTQ(_VI[1&GR5.T\";"4HN1K"IH*1.B+*EV;I
M.:IJJ8ZSAR@VE,_"8>M[ :/4$0,*$3#!1,  R!?S*R=Y]F7"_P!D"KC>P71$
M=1!/:22!SG35''0L<"L1"E1U,;':H;/?D$1+'".1'9@@4Q=.5%WY=LJ40DL0
M%P>PLJK0]-3D=F650^]S/?<\WC'?<Z^M3HD(:-GST@C-5@K("/).=10=X%B&
M.OYT)"X#?AD&Z?IK9O"AR]*$[JO@*?5F:Z,LZ6($5RF31<X\N(H5(DY=(4]^
M\1]6^3B-;6 22IY!BBXLU&YBG;J%GB;U9P0[Y/?+B68+HHG(]R\?]_#+^X@!
M96:F$"\39M]'5[X;[X)"'6E\A8Z31?@U0P>O$]AZL_6O+)6=V9[FL9[E]SS>
M,=]SKZTL$ A4()HG2RA/0?LTHQ5]54@MF&]BG'#;"A"$X8GY/8_HN@!A<0II
MN/CG@8PL*SA&F-=37W=2X^6O.VO "*1)/1IP[!\3=@4 #9 HYN1L6^HI^HKE
M<%'YN.E<F/F ^1XB%D*)ZNN&@JGOY?4K,25=E4NG$4:?9Z%.HJ>*VP4H->C9
M^J@S\DM5]"DM4^3PK!Z$(\_Y0TT3/<@?<\WC'?<Z^M%4ZW.8$' \!')2CT2/
MP/"7T'Q\XZGF7J46LG%9V%47IXR>C-KPQEB^JS^&9)8RD9 #OP&0B(14!:=+
M4*\W:&I+@<\P*NXNJ3PD%D@;!MBK386M"S*Z/@SO)F1M4R@(699QG97#H8(E
M*_;)<A*M:Z*M2K!T16O#>;T$4@$&&CL78)CI1&D8VM>\[[6D3JOB4##Z>C2V
MR(^^Y"O+(R@7[<(DU/&47/,\0Y4/(,CPHRDF6Z,.]Z95%3"V+(2&[\+<C.46
MISPSJ9J$-8B4[0A(0P"40P(:%:H>JBF#2@50R95L()K2U(I:@*4A 0P88=;5
M)1@FFDF !-]+UJK'G"83?7!B2SA5]G!=9DTJ=!OW<U78$R@8 ?$HR/I>JE+_
M "MP7%]#%\B7=9KPX%@6LQK*+0D7-JL;@)F=VGD^Q?<\WC'?<Z^M=XIU^VBX
M7D5)3J^)9B$2YG>;]5(A^(7+W\--R]"&;TW.6$_>3M1BF7)I9P#-0<-*C>,D
M5+&T1FSU57!ZZ@OF!"=0A6*'*&2D:>5]PEQ/:+!W2.)-+?.".RM,D5V$ 9)"
M%Z'9%JB2GNC#, RL+.59EC@9F?K$[?63/1>^>[" 9KPU ?"W&I91@KJ>E PS
ME7"(LGM-.LXM$%:2*UHO18BFS/T14<+0?C*9EWHK59ZC.1+-H&:36L=+&"8/
M+PW'-M368G6@IHMA")/6@,49,QWI@K>12NLTN(A)(>O:46-QR9LB]?\ <\WC
M'?<Z^EPC/:NPX\#0BZA1^DLBP%5Q%%B) 6JP&^+YL-07N 349 " HP,"OB,J
MMTQL6RA4.,UMQ]N# IA#TNSLLJ#-W%[;2XH7@2E=UO!JD7XBO.V6T.9=6 9:
M+9NO=$/]RO\ =(:T/4/2Q:-C0T A5)<DR*CF)73(3,A."%3U2+6B2V"H5<;)
M !/.$S[=UYRE1%:WQ!XCE)+F*AO VF.C7POAI7:9+:ZE L$01$2Q,B.B.X^V
MDE8'E<Q7))BL4$>I7GMFQ15$^,;Q(:;#?TNPU8@EGK4+2UO)BH%J2KMP*(H[
M!4*!MWZ##< M]-B157?(01?RE*<%&&!?42FSZ^><*@GX4/6_<\WC'?<Z^E6_
MJYD,B!W>+T(4$N(F4PD5/Z8JUE!LK;"E541B$,6PYFS(?T,VE,%$&@_?VB^J
MU.D93HMY*RVJ%"5%\X)#-%?MJ#I@#P+&.R!X=@P *B %LQMA(46PX/+"P'M=
MJ-N@.N)I"QP?D7:;&F!+Z/+*:J7H+3;8DKAHZ:)+TC_3D3)T;'>@;ZIO(24T
M?E?2#B\? 8K ?&%KQ]U&.9\9D-92U"Q2OB;LUM0007MWHE/%BJF=%0M\C=:3
MAK>L8M[&&H.1EPL(VJ^^L-.MZ0QIZ.R!I.#A:@.Z)'0-P&)"=1:B,"OY&6JZ
M@\(8+\9OB913,I$;97![(^F<=#L.<!J X041PDVB57(@?6P=9)N3(>1*'UW+
MB37)IXCE]K";\(/TP-E?RL@.NX<^UAN41WK[:];I/9*5DN9G!<AJE=/6+?J>
M;P#FVJ*>:.B(F*'&B$Y^I7" K2)]SKZ73='=,F&V<;0$P$ 4%(.$3".$FAAJ
MO72#Z2@4IO$Y\^HB/R D'P2#,<'T0$PDAZ&B*XJ22S\*%DH5K\#/98YYAV]8
M(JJK@H"KT*XVS?H+11*\5WO"(N%&FN2KHJNL> \ GH8Q4LD,QL$R)!0@4HPB
M.1'".G'>M9BID) NP$=!&2N)R$02P!08+ADL"I9+%;HI9CT'US\K*>5]=U%)
M @1;6C%5C2^ X+!\ 9J<*=<I1, _"GBCI4 0;"/X:Z0NL,M)4!A\,.&NUHR%
M:7B_F4GG)HO827?>D3YF1$8$/@H!7LD]I+79#D+R*!76M+RS'89))H4J]5 $
M\J!0/ GQ$CFZ2C5LPD?9$0@\X_>]]$]R*(#&D?.UB;)9F]B"G%!@C$@CNNX_
M 1,@'P!0K_))(.9&"SF0J75-H&%ARI6B849OX &2^GPW%5! 8M#/0[J:++@,
M2QTP1$5J5*"80@ +$,(F1,)ZKZCFXCE!\[8 1D3R9=27[#S6YK2J<<LJU?O8
M:S:*>"'G[G7TZNX6T9-25P2C&..J6O([?O82U?Q94?0=@\,M"V"D9&B9:V>4
MJEXAT:*J[.9%GDU^XE48D83BN%6F!4&*5SF/!2H8'R$ ==!KXI%63A6%V ;)
M&! %D"U'V)3(E) @0B\X#@%UZW5RO0_3\N UGG\PB,<(7@%;;)'E?A(O$T[K
MG:).\XAERN0 LK%:3$>9>:)'R?WL#F/B8JW'I)]:UKMQM6;Y?9VRMRW'.<KD
M]:)/MHV>JW'*[Y8B* LA0J\&:5!9&-:HC)0XI4R5XA?VD1M:U42!_!OHD4D(
M0RIGU;3#<"(H6%)7#8RN%NOV"V .^8&0^I^HYN([$OK^(MJA).K#Y?QC;=8[
MA?T,NGG^A 4CT@(X?[G7TZ>K]UNF.X2^RVKS!4(]@QC%_L.!<#POMP\#]H8S
ME4UD/*;'W,K.C6E3FE8+:*ALL[LQ!'PTC+K"13/$)29DG*9@I.;>_P"2NG(\
M&PLJ+!H3>@:EBH$*"J4Z6*]9A<#Q<0J%/.Q;U/1/Z EUJ)M"(^"$$AYE\UZ/
M CT;"N*CDN/ID\K*U)%%M>E1R(=)>19N9.B(]6-=IF4@4@XJGYC"6I@&/8ME
M^TW]LFH-GP.X "KRE?3_ /:8H NW !3UF&X"#;.6P9_C))&9V9]*:Y:!'(B/
MJ/N>;B.6:-[H+4:E'9 )]\R7;P)3(VJP%R#I++M57?A=]SKZQ."%987<<ND
ML4Y7<S_L-:%$E>(B"9R"@L#('(F1R3#M28*N8X@&?QNFG-_I!(D8Q5PLXK5>
M1- +)]&GZ%;=I1FUF 8#-@MS#:JC%D]H:+7V04=<G(-(.F#4CP.W:KG"FP8(
M6]9T-2[L.XQ#4B@^I PSO987Q$LNA*-H17P"@$;=06GH@9\9>O37#<$DI3U%
M!,L7J+@S]SS<1U'['_)\&ODIF&$""1.^XV]=]#*D;/-5V2?7W.OJU 5:#*N
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MJQB@N=U^AH@ TPGI?V\\FVG C="HJ_WV5-3UY.81!;:"UVO.SJ..-6$E7VZ
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M#HP&; (8(J46U2+I0RQ/?.0,W]Y4J<T5:K*IT332_P 8VJ;E2*;9K4$P.\$
M54!5N39[&0.8@6%6@(A")24V$P\S$K[3BO+A0!;@ 8#S+9]7U0/20M;084#@
M<*ZK5(I4M"H$HQ^RA6EN_1.TJ684,  K#9^I/1?<\W$<$K@AWH!4W(N$KL#I
MGL#QQ9(ELWE)JIIIF\,WW.OJ$O1AW!U@#1%J6:.("@%5  M5P &J[$J,?66O
MD2_Z;P0)R*F6X7&<8IHE>MQHO,W"A1U,&NPJNW3/)>$$B-4#+O8ZESR*YBFL
M:C-1WU1+N@9RS"GHCPB6YH $%T/()T&-N]TLE@<@JC9&L;!!,AJ51!5&Q*GB
MEC(+L\H 6)LAY0,F$*6FH0D$4=&P#NY!#'QZFUJI%;L$508A?+I8"^<=B\,7
MU+DYPC"D/%9,F4B"NL^F2L=59T&1%\-*14ELK>10JX2;)RXK8\2HB8UB!@.%
M<%C T]HIFR*:RG+R$MBM=*?2SJKCH.K#5?.G<TE^#OVBL9@I 4FT6H@',/ E
MWS[*@@V7PJ6^AH_5R:QJ\UPE/Y]'_<\W$=GD:]Z:K5;2Q"6JCFYZJC9%K](>
M.GWYP,0+(5?W.OJ ,[Y9< 2^AWJV,\<7F@#?ISV@H>Z#?P0 @<#BMRK,AWQP
M5T#A(,L^,@,<E-W2:*@.RT!PEK'*6M5Y@5$!NQLT!M0!=EP JW4?)#4*J<*?
M)/HP=R- @?180V>19+ZXIT #/GAE5S:(B+*-J[+3+P%@P4S?*S/[I390"9JW
M<284F=/0!L1]I:M!"_,?]CZ<^E_;'6\8CDM3\R]<R[@3H=29X/ M)U.WAZG)
M4E%>LP;4-#!$5 T!/U6&4,)Z/.JC&2(F"U)#MY'HON>;B.)OL$!4 @\.-3$)
M*IA3O(1(G3#A^_'58PLR3[G7U%F&3?11:"%)?Z%#92$H*E5Q'0S#"#IFLA&[
M*W3Q26J=%FMA@=DEZ"ZMS1O6V(E/15;&&C\[8=W!QI^T5-VJ['[ZP'9!(['5
M/(Z\"/4]+<PGB"DRC61K.+U=6K.+(K.4D^T;4J%BI"5)8BOYPRX<H(>9/-]?
M;'2]R"Q0T!"'04>'4!0  !08/1_<\W$<\P&P%,K %*PZ,<F:+F\=727Q/"'*
M$699W S<_<Z^HJ2RT:GF1BC=8#'A=Q8X#_J>>QU6 [@(@N(R6, N:/!\.L>?
M>%58Y:;#;M/)\R1Z(=&"2!NNE=4$47]J_CI@P3['QH8 4]*.M6 L-(O&)2<F
M9 2POAUY>-"T'V!F<80V+ !$2';<I-)]"4*^S1;UWS$4(E)43"LWH1/ GK0C
MTGZCFXCA\T?LF4)3&Q*R&(FQ$L<05AAX"(GLV*5\\(S>'[G7U-AT@&9 %JLW
MG,S4/!$,CMH!!,)DXJ5R%[P5\0IE)9C1XUE.-E84!T:=E6,0?*V6@\\$SAE!
M0&5. ,K@E:XOD82LY@FE  >TM9"#V;V+97O%<1?2FFF#J(_4I^)0ALK 7,(
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M"DL,<I+*<)!!323\?],UZT.TI1\E62%"5P!PO $"/*8(XP)WJ$%%2U<14(^
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M_P#_ /\ ;?\ _P#_ /[_ /\ _P#_ &__ /\ _P"V_P#_ /\ _P#M_P#_ /\
M_MO]       !MMMMM]MMMMOMMMMMOMMMMMOMMMMMMO\ ;;?[;;W  3;;;;;;
M;;;;;[;;;;;;;;;;?[;;;;;;_;;_ .VVR      !P
M                 !P ,0                                    &
M     !P      !M'*\<.U(ZY-IM<P/HR-R0T@      !P ,0   G24O=J(W(
M,9UV)"0 %;@QN !6+1C_ ,L  !@      <       7DOH_Z5OVR\*:HT5XI<
M8@L(       < #$  ##IJ.D6X1LR9H4\19' "#NQ>B[BYXQK,  !@      <
M      "T0H%]XM<O@%"1R($%''>)Q\       < #$  ".X&8K0ZRGZ,Q>FA%
M\X08Q3@!_A2G4),  !@      <
M   < #$                                    !@      8P "222
M"22220 22222"2222 22222"222208 "P0 2222 0222220"22220"2222 2
M2222"2222"@
M
M
M                     :\#   !8#^,/ (*@                     "0
M@$@  !@!%L0" *#-"T_@                          "RQ.J 543HQ#<L
M:=@                     459 W[U)%W<T;A6DBT+JIR@
M            *:+;XX/36.Z7PD88                      ->BO&*9\R-
MH@,CM/EDI/SO         Q))4
M                                              "4  $
M
M             4  $
M                                       4  $
M
M    "$  $
M                              "4  $
M                                                        "4
M$               !=$G$M1@[2
M                      "4  $               #&H8Q9THO6
M                     ! 8                        "4  $
M      !+, "&@ 4Q9@                             #T<
M              "4  4             "YF !LD #\8
M             !#$                        "4  4             "\
MQ@!\@  [<                              !9J
M      "4  $              %$  ")TV^AT
M      "5  0009)J                "4  $             !C  48  0
M -4                         "J  7  0  "$ !<8              "4
M  $         !O,&   7:M  0    H  =                      &   "
M    "$   1,             "4  $         !L:K< 5( -@ 0    #$"[R
MU<*@                "K<       "$    <             "$ <$
M     =+L, L; ,$ 0     * %P% ,@                 J\ 00    "$
M  !6             42\$           @  *@0 :P 0      0 9-T
M            #N4"0     "$      D           "4-($          !B4
M#L !,5< 0      ?@ J,                     2      "$      "@
M        "4? $             4@ "X#\ 0      !L
M  4-  "       "$      "           "46 $            ";   8#6
M0       8@                  6J@ #P      "$       ,  "J4
M"45$$        9B#L "   #$.@0       "L                  ">@ 6"
M      "$       8  3=/     "46<4         \JEB 8P  0' 0
M ,                  3W@!]2<     "$       #@ 8*[     "41($
M     >Y1T0 ")@ & @0        '@                 ?J@"6H]0    "$
M       !  $2$     "4-8$         "L@0      #X0        #@
M                 *C/@   "$        < !%S@    "42,$         =0
M@     @ W00         @                    $ "#ER   "$
M'         "4%0$                 , 6@0         4
M       0   PQP  "$        "         "4=H$                  P
M?$P         8                0 @ 4    'F  "$        "@
M  "4#0$           1Y*    .A?0         8                ,S("
M    "#J "$         8        "46,$             48T  "IA0
M    (                &7@!      "IP"$                  "41H$
M       (KD4   46Z 3*L         "                ,: #@      :4
M"$         ,        "43@$        8F$$     ;U<8T         #
M             6@ #@       #8$         ,        "44<4        -
M>\$       !HZ<        "@                           'E,
M            "40,$        /O@8      4<$#B+8@     "@
M        #  "$D#5-&09         $        "4&@$        &[D<   !:
M 2 "2@ 5(7S@  !                   !6/\ 0     *0        4
M    "4*D$           4 32;H   /"@   !5QG$!
M           9V@       0        "4'4$           #0$@     $"@
M    "-L                              "CU       4        "4'
M$                    0"0        (                   "
M   " 2H               "4#X$           5@      9           <
M                   0         !8 0@    #@        "4&D$
M    "@     !H  "        P                               < #,
M    "@        "49L$           #@     !   0       !@
M                      (  #@   4@        "4"8$            4
M   8@  "        @                    "          ,@ !X   $
M      "4544            0    !0    4      5
M   "0         0   %( "$         "4(\$            6    !    "
M(      4                                "@   2@           "4
M-P4          5]@,   ,     (     !
M      "H    4<@         "4  4         #1" 4   P     >@    3@
M                       0        "8    "D          "4  $
M    !+!@7@ !@     #    #0                                  8
M    5@          "4  4         "IP@!T 3@     !    9A"L9*T%@
M               "         '@  "T           "4  $         #>@
M 1#\      !,  !P!)Y6T\P0                  "         @  3@
M        "4  $              !V0       ,  !  "2<!BFL
M        "         @ !0            "4  $               "0
M   , (     4*0                  "J "0      " #0@
M"4  $                00      )YP     7 <                  #A
MD  0      .:  *@          "4  $                 " 0   "00
M                         &H  0     "&@ .JD          "4  4
M                22202                             -9L   "00"
M2    <.$          "4  $               "$*\7@<!#L
M                               90$          "4  4
M    "_P[&G/?\&                                           "[@
M          "4  4                P$D>CFGV1@
M                                    "4  4
M6%P
M  "4  4                   %'
M                            !C;;$
M                                                       =MMH
M
M                         H?CU<6D)_B7H'YW++N%F[-.3BG9/!)CO]DJ
M&'""GB?;Y@                                         1JA[0[/D7
MQA2:Q5<R!5"1B;->"A=L(:MN=F<80]/N0-D@
M                  "  !@H %    8   !T ?@
M                                          #"*M#C;=QU!S3@TJ<[
M>PG^<+^8>>A$
M         097;'P6._1.+FMA&TX9CS./Y^=4!@
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MBYY=A3=).VV:]=E$6J+L#-%*D.'?:KB ( Z01AZ=J*.FS.WBH+BI*JX8(4/
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M$&H VP(U["55Q1>0/V?@)J/K)4)2NQ"C"Z1%51[[A)V?30%GC6_C1BBWGF8
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MNU$7ZE:**9.@2C0DAD,RKE(ZEIMW6(H3'@#@E0%H!YA TL"%<-&8IJ) 9E-
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MJ;IZVQ*%4:$@%,KX M6L^(#KQ;=-W6C10T-4H-_465P 5HK=I<X!TI)=["C
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M?A]*@H-1%C)R(_ "*K9H!(.:M&M!X 3NI$=&?6*9(+7,K%M!?JZ9T QF*=S
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M8]XDR)$55;7#E._([\COR._([\@OV 0GXWQ^#_R577_2G:4[2G:4[2G:4]F
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M!J\C/S2B'&@,#FP).B 1@V@$O\V6C6UUY+V@%3$RL]73Q$*#R,5Q-1 (Q.N
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M_;N1R0M)W6N;P& XCN19-U;>ZQ]Y,D7(B]2"+)H+1I%Z(S"<")&[BE(@5:B
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M1<*+4!VH<-HUE$35$.4N\^=C>LL]4YQRTIV)=G@B(-001VB D((;!Q ,01%
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M P-P  :  8F7]0$]N5CK90&JJ(@BB!GRAT^E?!Q R*NE=#!3..\F8)HS!XG
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M"Z$Z7.EMJIEBP-=J9BOC&,D$.75]94,&A+8HFQ.$MV^7OA;[(SZ\AFF +^A
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M%Y%FHMU\M)+D)%$J 5J68!6-I:L"2!,$Q>T8H-6) *^-K4S8>S9HD&LSW"(
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M:P&::\"^,S-]+J4?;\"ESP("6VA"0FRAC3(V!%$H3H8T-L3S6]"I&5$! 3>
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MEC*_5/0<5A7-MW9&ZM$@N_\ *SHE+4!*;+$1R#G;$# #%33&M!LH#83 ,!'
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MZ /?H2(8E@  T3!O#&HJ\HBB4F$=1W/N>0CZ[P4V]@M$K3,219T%I%U$ DP
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M4*R!19'#N02\&MY$&?[C'?MXOD15@*)P1HQ#PT/9$8!2N\9%=, PRJ'@H_#
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MPX,^N\!)R*BA.TEPE8G"R Q/8D/SGJ@9X8>Y\ON#IL/2_I (9RC+"89?RMS
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M5GJR6DR_^*#->V"9( 0* X1%$<)AC=#V@JR[ U+GRFJ7FE*T -@\"[#D^6F
M>K2YBA_26_*!\O2#FTH/[7<!E=A*DRJ>XH:#]ZJO\%IVQ_85?E4#BGI K06N
M -5W1&TTNV-8P:=I=FAM7V_8<&?7>;N?+[5L"'N>)O3T#8H9'UE[I!B[;M :
MVT=])!OO%48VH]^5CA8.#Q@$L@0O2H-N>0J^SZP@!4CM."(C2(@QH>E)5+A0
MH%!Z"JJIXK(H *!P(H%'.(" D&\*P> *   P!1ZU[-:#F_M5;P]%ZR* _MV
M:JX#+B;#@[S0/[678$*7T& ?RH!Q*$'Z/CIEHT53/M%%&M&B4,%<:#Q)>:+V
M5$FJ(5 :BC=YT#9II$%>-X$W*=BI+ )HK+8[%36#IS0Q89OY5CADGL*Q9CP
M\$ 15$04L8++,&#*80&*AL*R0&FX)5)8J%L+8RK3"BG* 0,%+  UD #8@=2,
M:(RKX^P"8)H LR^*I*;BPN%F[.KH_,;H$K;EE/%0OH K06N -5W0R';RF@WO
M?8,^Y[#@SZ[S=SY?:DM:+=UAFA+)10/E-4OAB69-!C9=O-0XS)'PZF(;4BNV
M94R5\"CO4@L>G-S_ 'E1)*RB0)2(_P#HY*2  MU%M;U'$V@:;\ X,<5CA&]
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M5K!# TVEDI-; P@K C%>!,8-8$OQ.3VLLMC1*!!$+5]):]\>(<JY%6G%"YB
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M;E@          !_]A#^'R?Y??E@           %L'Q)=]'\Y<L
M /H&^\>8^5?Y;<T              )L%]PGD/E\D   "7B/@W^2?OW>_VS\Y
MX@     %0,&"Q$41H[?&8U5;5E=UWWA2.;SJOL('D%!,?S[KR0        #L
M?0^JT !;!\26?ZG_ !RP           +;IY;?YR_?+            +;_0<P
M2           "O89+O\ 7_XYL             "K;_3;?A+]U^6\=^-?
M"_7L/P7^-WG>7;_Z:Z_9_EX@     ;_,&)M/>[E_//\ KO;^BWW'MX_+[ZGW
M_P!%_K.>?7>W0#&/BDD-DHX@EK\HL9C^,0@+47G*%KD(&#<-W"EH*^B.^,4Y
M II83 2'2 JO0_C=HH(C<D>9=D=LTW5:1BX5%N(63VFRZF^V%DY./(IR_FA]
M& +0A!A&4&7)?TR19%DI93+";1:2@PQ$V-088PRFR;.)I%%D0R=IB&47)TG
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M"TM5,_)]ZEV J*BM,C%?'[4(#1X-$:K(<J$XT;Q4'@MV9"5(_DAPP[%5G;D
M9;H3#RVSI%QR^0P6F.\JWL#(@/V+_P#S!5><PY-#759@"*<U0O\ USX [YE2
MM\)Q(U65/1]@D)D>VB, Y: :><4P.?AMQ;5-FZALB(6"!6'C%L*K-3<HD0)P
M4$!6IY+)&CY@[?*VEDWM8]HEZ)!CI5Y1Q.R&Z25N[BE>%/)0[@Z%7XU85/%[
MG!M$5,!4T1A'TE(K!WIN#4VW5MXSF> <G/+&>,B5N)4A#UO:#QG6:4,M<1_#
M?WF=([Y%F61-.+M_$VF2G1PH%&6&L^'$KDZ?&WQ)O0\=X\+;'O9IKV$Z*9A(
M?L/4XR>WY3K5DH6! =V37YMJ0'/^7G2_L<[X!"J9=?5#W+%,U?P:Y/.X5?I#
M>Q.>LHR-T,G[DM831QD%_,8NDO7LKY(Z/1K2AK8DHS'@L[L&$.]A3?A/9ESJ
MI:WO96PVOYS/^ Q_P&/^ Q_P&/\ @,'F-KY%@<[4IDWIP7;_ &K%>OJ>/]I?
M)\/UKW\7Q^OJ>/\ :7V=]@:7M#VOW[<?KZGC_::WA@KLN:\G?Y[[\7U/'^TU
MO^9Q3]3Q_M9;]?4\?035S.9%JIR2X3;,FJ81!9%8*I9'BVZY11T>GK%CA0OD
M=W5\P+$CN@)D+9G$\WB :MS)5K]B2Z1$M@SKAK%&U."C=;0RVX_.[&9TLA-[
M4HI;=\?)2L) /LF5A;6IE].5KT-SQD\><&*TXFMBRD$JQ$)ZJY-YZZQ7K_*-
MY=XFDK "7.I0YD"3$H)^1G53;1%"8(_KJA3A2X.LM*?\W<7O<*03YMOU]3Q]
M!!A"K'\HE+CP7*SND-NB0UC*_KT(T"(.)IH#]W;S=N@A/^:V#GR&!H&*(-0[
MVZ^ 6Y,7"D6;K >V9"AX93; CV<&RDO!.G(5D\2"%T [8'",ILJT/G2K)9!(
M^:O%;5$N62D=<.L<;;/5/'@@7+# $N/"F8Q-$I.C2X!^<\'NP2#KK,[;N,),
MVE@KR"3P)!.8#>B!9'KLHE=HV;_FU?OK8E'3@1SKIMH-RD!DZETC!:R@HG,@
M:?E[)(15BO#UK&03PUM317K5OU]3QZU!3"DGX0, TP2Y!4!$YHA+EP1!*D%H
MX&[".RYW0:MCG/"BX6,2%E=ZWC8A1%"[@@.817@B9!BVKIKG4GA_SM4Y58:@
M*J)!%(S,R9=(/ (7*64H&P\T47DAI5*3=<8U-*V740(M]#TVYQ?P?@&R:BO>
MVT!++D9(^O F @ "D&Q$41$1IB0TU]KP'CJ(S!XL%.N[<%""A@?!)FA'E/K5
MPV_2Q>'M>,<U=9R=^^Q77,*O,+.48NE6DU'NZ21$XV,HZ%5:MX0C(L?D!-.#
M]_P?NX.1!BXF_P#9X N<YR<&,>B)DRY4F,>_!RFTYB  XFY",U8:(1/-*2CD
M 1$]C[A9+H5F] U;=%8)CQ\.$CK2K5>OMBE.^44X0H1)Y+1GP*<HGK&[0_I*
MJ]\<E:]8+P.#F8Q^SK1V0+Q5$<+%G=7Z"!]8M^MUC85\G/X_2G6GQX1H+^P=
MD%Q_,'RU6NE<4+E'W+,O?4 LL"&F6=#6;U!R!&FCNFZPZ"X;P*#![%"C!L0"
M<;G->BATHY.$TF@/<!M XHXPJE2^-R,HPCG5P4&*KEM)N.1B@7[\@BE6_H _
MBD:+]=HBE/7W97=I'$KX4"!XZ$K.5@$PP+[QO3$G!78!#$P##!VF<P/93* &
MVQ/]90/V2WZ^IX];>6@9WS,[R^PZ&&PK5\#HP4;DRX*<7+.7-KW160XX_93&
ML.?*VY!ARJE)NL6;;[?KM+^ 08I3D&2F=,LTJV!980$X-\2=B!)R#T&#6;AP
M,YR;'PO&.IN# L!G^-]$KP(1\0E910L=@3<E1"(BRB;3_A/)"X-TS\C&R 4"
M-F?@(Z@(;S\&MX>_\6V+X-+C2^NFFUE0]IZ_=<+,0MI^2$=0MF0#/10K:C;I
M ^O2N X2S]]^<]FK!J-:\- 1=''S;/FG!PH8$1==C8Z:_P##<"[*0*@<W<5;
M$5M@-(044 DI=EX2S?#,S)*(UH!Z7 +2T0AB*:92"\G"DKU$D8 ",JQ@T9:4
M !FR6D3] Q6Y;;XAED[&Z*V0 *.Z@FC0RN/+"XTZ"9@SXMU%!L>D6_7U/'K;
M$5U87$_UHBR&XMRK?$RM3;ZA!AQP&)#6G4EOYEDB\)IN!+#00-2AT-E5C@%A
M]]UFPY1B3$JY=O4B.BP<(I8H]V4)Y9*XM;RPX);+59ZR4@*AEPG:K9!B,)0'
ME5X%B#0J?43+R]5HFN JT3'!J.RH+OQ5K:OB([ N"^CQ'LPP"_ M<+/_ -5T
M>TOF+",\O[<F7@,EP19%QA:U?$0$62H)<R]'(Y\] >U$BF8#N;([=Y#Z@#[H
M@NZ'9 8Y:Y"E0>!R!=? B0L#K#NC.R12NDL1RNA7-WWN")[,:HLZF<!DSZ-;
ME?4\>E&\M"/],S/]6(?(@BUN(X?$>?X/[%\KG/>6(M)^#MVLW.<@!Y,4D.Q0
MJ$;9++5F[@]%^G(6KE[%L#3B%XKL0]0\@ +!H82 )Q8:+%0UI!PVV0,06.=+
M/(6Z8R. E!0BFKS7J(1<AH>$HCH5( A:KMJ!E8.,&C7AQI [-\08%P1(0$M!
M W.3F,-] ?8X3* [ ! % JRE"T/Q5 *<Q]NC:/GP!,Y8 6 H!$11&QKTU8OL
M[G[O"+B.!%FNI(W(H+'PMV<F6I2ZEU@0+<A!P*A9;)A;ZKOM2/=I05^AJY#1
M$7NU%-'B R#O3>NH 3W!?%82$!0 &70@/76_>#;6>?M_CB^IX]* GEYN#^A"
M0!""%5F@DS"C*#._&[UL=A=Y!95K"&9<V\>FY8&=/LN=N%:-<(BK669(OL0W
M5G:A+VY=VM:E6(.YG@X.#"((F8U)5).0!83I_%'/*P_4;P"1A;)N"Q18))J"
MZ@P,N$CK*H'R H7P0*Z)P0BZ"CL'&WJ5)[V0.Z"<$& ?+QG0#PT#P8@Q B^=
M FQ.'QY6G<7ZU:;28N-#S$A>SF#@\->@LD#9K@^!8I)\IDQ+ )HHL,+P&];4
M;G!M;EJK79>DM;P1(Q%&(!3JI8%5)0;3K OTHD[185XC (AV0K1GFQLT$S;#
MTQ)5D]$_$B%Y9,Z1)RA$183]FH8L?NI(RU"'E75F+W+R=$ @H$1$1+$3")D3
M"<0[G\C,_P#%CJ$;/"HQ#.E(1?\ U<A=%2;-W@:%#WW%$I0)V+B@**]6J5V&
MG?)5Y*P7VCL>VM5=W_1Q3(DOI.,4$*H&!IMSU^IX]*5&<1WV &)CL;(@#]J(
M25R,H1$4FQ5.8Z>G'0#4Z$(<&8WN8]&B,2-HM#CS%#6BG^W@ "@]\Q:#9SIK
MY6;";UQ:\58E[$E%* U;= X2KMISVIMD;-; K%J9I=+I7=CJJT!/9*^0G^(#
MM'@(@"A$$U>WO)!Y@6Y*@3$DRV7+#A:G0E_&& K559"J1'H#CXB9V\'S5/+7
MDG+%4+#4I@T..W\;>;&GX.Y3*U.GLP(]-U<ZLZ49-E/)YMA'A.J>%?+/&'DQ
M070$090\(7,.A$E&0/YV/ C4(31([C;7C6]9(U]_,4%8SD::,0VBXD0(QD4:
MWD)"XH-?N_&,^^0_1F&KPH36_P"K,I-L8Y@0-T]8EH<@$Y'MB?'450T' )8&
M/%\!UHY@-N2]L*'1Y:=5S84HQ0KWZO%'X1G4*=,N0E3?D% EMU6HH%1<(LPK
M2)N8KF W^(4E<+*!%$>J59Z:Q>RF8Q>4Q9>OH/UYV5QE)N8?<$P2"G6QFXX)
MJFRSTKDKLS^/ZGCTZSFW7S7<XQYU4-[,#GQR_M(>Q2;B4+:VU)K,0G0-K!7\
M&J-QN%>S E=0;"?DZA?DJFAY-2#D+-=K^ZQ[F(JVBK7F1EM7B0#]C6B^*$.M
M\HD\0O='12YD'MYP#\EB5M.L>@.&I48 0E4*F2"YHW3HBFQ3@]UN+/@77H)@
MH .&VF(D2^&Y+;;V.V:KQL2*\A"A!Y5&C2>T$?M26*_WL'HXV8&E0[(&B-V+
M!H(F$BF@O;V4]4G0!MD@D&2)V5RWL1R4+"NO6K#_ 'BF8@1?[>S*9F-,T/5]
M<A +XYC+X9C1- ]8&7<D; 5"G4>YK_?I^2_C?7TB6<J_\4!=.I!'\!_Q #"*
M?4[!PZ/3KZ[BB_J>/3KY[-A&>.HE_!5&R:]3\:1>2_)!Q$7+!%J297ML19D2
ME#4QK*YS>)!0J#A!=ZCH35PB!PBXVTMW)4TX>&]:8*I)!C?CD@HQB$ N&0UJ
M8"I80IWBO+!G@0<;:!V)Q/0&F!1A0V5Z$X"#\,%GDV[%((HR?IB9ITJ'<'@4
MC3ARVK[L*I_=]FR$_'36P>GS3:<?\[![A=P>TAON%$BA]K>=LNXN'U;I$QPV
M/'2GZ/?>9,& 5ZT9<A3R!ZNDD? 1^AX0-#Y*GHIJ.JM^G.TGSU#H[^B(L[7,
M]7D")*%B'9$ NTEW"4:?J>/64-*LM1L@\ #2)0(;XJ-17:XC\^ /SC"&Q8 (
M(, >Z<A">'E_=6!W!%0!IKFTR".WO:AY7$C&XW1IP+*H2C\4_J%!X$#&8_#)
MK](W-"!83$F5CZ&ZDATNH9QYEYDA!J]D*^>P//?$''MC:RKQ4'E%.%;>[-)M
M^"3#MCZ:SD3UZJ^7(3N3YK(HQ75[*\+?H'%07EG<=K790D#=2J2&A,,X5-?7
M*/-095]%_4\>K!,!0 %J-  *J@!;#;,F7($:70IU$HQ043M\K?X\B89!=A.<
M$D/YK0H(582*^4':.)]RS=(0(Y+&4<F)>0R541'%KD%T8K/B_+N!=@.=^$]X
M?(2UD:U#^W""121,_1\>@B0R_:5NAC$+E.-3@4F&+A]$_*GC0N%OGP %XK[K
M$-1RL>VHV0+LF&'P;( @L8YL\1^@>5%<AI H]CTAT1XV:U<1Z6]$YDP^@9>J
M\,E-]*01J7YB#1ZN@111(XJ$]H">@5GT9;?I/$3RIN^6=0R4UE6@Y)@H,3.'
M@VZP!PA;FFCNJ]GY<>U=G^,9Z(L<)1;[>Z$CIT^ !+V/+8<#@;#<9F'5<'%J
M@*X 5?!O+G=!JV.<\*+5J* *8NEV2QK8D@R(2L>PQTFM(H^!#6_O2@8-'C9H
M.>P=I9! 1-PT+FT(6*6A2BEBE.C75,H,KM@%GR/'W-<P#>D1J$ '+%4/);TZ
MVC=S%!!* !AT(@?1ST4[*MD?9P8P&%K;[)"J1[%)5-OTG## /3Q%%3EK=NNP
MM9^,$24:21%?,),^175K#&]*&3K8[/B%6JP5'7R0ER%^X^G("P_$1H.%6;A$
M]P B_3-8BW$+$D?0'?7Q[T.<,6%(SG"1K:&/NNO/[;:W1D*_3@&W_FHK.^3P
MVB 0 ((B)8B81,B83H+?KZ,SBJKI@Y5LGF,D(B)A:*2>@H-%G)_H\:98+P?U
MK]+_ #T5\X,%10<*@I!W *8LW@5GE8MGU3Q2K"N&V4HBJ!PACN>0:",_3T19
M.9K*--8C ZK><-4KIL)@20!LUJC.3Z@ \+"'CDGV;(D-DK24*Q)L#)I"B@1R
MD]T+@JUXF#@!P-?R7)<]??06^_\ $ 0)(.L:O6JE=$DXDX )PTX0_&+H./Z#
MQF,;GE8 ,L22%6R '4@84( G)D+K P CNR,9THXBEQ7Z,PQX9[0+B%6L:KB.
M9((=^8X74T)SN4B6UU4=[RSPQY2B+P!<V>""6!DSEP J" !54 %6I30MR C_
M )0$X)=G=Z[%(T*R!B/1&'-Q&12L=*<&_!QLIB$DGMC ]?!NS5TZ]"91D%F*
M9[89<A-3MI8C5C]L3X:9B_&"LA!AL"2, (DO<Z.@U6(L7:Y^-];#5^TW))T\
MFAN%C#,S+TM/9P"'AR?9J3F.O^>?;]/<.R*N@G:X6LYF:33" ]Q.!.]Q#?P:
M"93%/J>/1#:!7)NW1+.R,? #NQW(9M=Y%"U1S:L"Y]"4F/3\Y%DR>Q;83!IV
MZT:4$@T(KL,84+B.-MC"$JBFB:C1_18=+0PMO\[R 9&</,WL)6.58X.T5P6\
M0PUI7)9*P.'8?WYB-Z")WE);FS(-7VN A1' &<JN2<-& I6U(V"#!2@M#!8)
M"MQ]P 2C!!@PB(@ 6[SG!JC_ (LPYNC&4*$7$YJCI#@!L C<L@:UQK;Q+&@O
MK7HJ[4#-'V5*G^C,A&P169$(6G?9\49-,IP[5*J *J-?X;0%9IS<&O.:Q()J
M!5YE&YIL8TN 8(H$@<8+,]2X2/S*]2P P;@&1V+LSY<]Y!RC+4UR6CQQU- >
M.JX,TKE-":]WBQV8DZE\TQM]2,Q1UJ79(7(0LNA;-HB>$((,4PE;>CEE69D\
M&M'J?$5O9,/F76>YL#RK>_\ 925]40*QRYSJK%=%H<?=0/0KMXEIR.+/=%UO
MT(&RK@[<-3+<#0^:&*$M-O+$2,!L9G,/&'9/J>/30*"78HYHVKI"(LLM>VYH
M.LFJ5XH?9*+.&8;C;C::?LGU4&I5K"&>R.V 6@6,&W(2S_*:[;&.)[('EPF
M 01$$1)CT-D$4!H+HY<1KHJD!77"74WVN,>XDYPO3OF$J-Q:4%IR0&5 UVXB
MA]V;Z73&3BM![&1FH]B&GTK;>(K5^(U2HHA*Y$=H:%CJKI&=469=D/%=GL;V
M9GV0N"YK$.4XS5\A/7%UE)FO7EN!;"7U?JYA<@B_6]'K4["[>NI7(:3=U3+(
M*4,[(X8/)H%!CG>%9.AA,YE!PZ0U>D*9) 41DM>+X(HGJ::/_KJ^@!P4L,FT
MRY082!S5E46N5R\^WZ%8W_(!)4<!5P1(&ZE4D-"89P@)G4<I:+-ANU]3QZ0H
M<DK:R*YCTT)< JKTSF1.]I4A: 0K$T2BC;1P.:('(X7VP_%)IL->[8U6<[<@
M>@XB0@(+1"7;8A-7U:S2 [#-:U+@*!F6X:T]3O1(K/6VKGGP" =)K0$4C2H+
M1"PII'""_6$6^ESB.6@H;$%/"4NQ3RHRJ,% % A]*Q3XP L>XM04V6YP84MR
MR3$_4PQ2Z6-:OGG:UQ#. (5.#JC)F$E:R^$XH&<2P3\1#>6[ &N=!7-I@0A)
MP!0UITU0N >=^KQ1^$9U"G5+D*[1._U0!<=H#":E$K'+$R@GTYUOU;EE3K80
MHTOA#*<H)_J;*@PNO?FV>AX54B-'U/'J<]?.-T?AJ+S;P;.2Z3$!3+BC6$(J
ML;V$<+<@G5'1 Z[:R<&UD'.I&W8?PLU3DP+A&2B&EZ(U0RF!M3!+QNAQ2;UJ
M,&R42I/AWL-(8ND.(W(2@;VG7[TK6ZFA18]S"ZM9][QQ$ \%(=TH4J&I)"@?
M-KBBFB#$7DG K8TTUL2[AFLFPW (OIQ+!H1:!0[%B*AY.Z,3(C?5N:)5R'#^
M,CG8+8LQ;$Z:WZ)&;_0G=3B@<KI5O1,[RO!#+,N8OS1'A<)'?4\>HION=;E:
MB;8!0U'<-GN?;"_(/+<'RI(41P4".S'LY.M;D#)*.BXTL,0,OF/G3R)&RSB)
M)BL.@8Z@JIY!Z;D*^<F8+J32NWI*9_KB<D6<:ET(4!THSANN3)?N2PMH67H5
M*>>RJ];.OPHYDJC8N,^X1S71UXX8Q6$DTGRU*D[:X86@'8(%^T58>4XP;& Y
M.:44<KK:!Z%432.5>-N E_73 KKQ[QH9&6,S.@P./SNX.4[(F;#R]4B,SDWU
MR$1(\3-;8CZ=[FY3_)5"BE]$,703=(W]Y=.)@\G1OJ>/47.: KY7.%F61/[E
MPFO)8GW!)(*F\5:$ 4=*NYK4ZI,D8628 'I<L5/<EXI+H.Y&OT5J&B_SR2=4
M06^Q: ]64Q:SM#%/33;1T@\J$[ )1RYHY3WF;<HL]<Y')/"P!:G'?P#Z5H<$
M1=$!AWH30IM=,\=$^S)YL[Z9_15\:POIW77H049[>YH99IR"<+T620-J$&D4
M(3<8%GE%9=5?5FC("AD*A:&P4!Y;KE^_D5U',:6!T1#?4R+!M-RD4S?,8-LC
MKKTAEN8 2CS$"P+^S*IYKA4U.G7(:,+IB9K3OP,MAJ(YV*@VK>-$1$Z/+5_U
M; 0&/Q>$-&(TNURA6:22D!!(P(,DZ(> _@M.@^IX]1:#0>TU#67"89 G@?NP
MN=2D6E<J@00R4R,+V3(/*%-V65EL?0M/%#8!W26N 3SUQLMPO MHY9R9$@#(
MH?"E[YQ[*M/9J@XP[\20;6AJZ@V'!8 [";$BK'J2.Q$2"%"S"SQ'""!BO5G7
M/")#3Y'NE$@Y3>D#I>^G"32ID(+TQ!<AV0/#A,4 @HB(H^AU.^5J.]]U[<<<
M&%VG#0DA6I==KB@QYP)]['3GK"GOX'6^JO!*:N:"A;S@GFJNR,]VU!!6!8C$
MF4WS4CV)Q&D'? _=RA)#'^07<]**5:MXJ0%6^ HB<D>H4N8+D(;+]DI35M#2
MU"O2V_2(P P,N"<#28#R4G+X/3=8E<#<,F"BP56@>%]3QZ2TYF3M4&32!U*)
M=X13!X72] -<_"J]!AAH_P OQTHJ]*-"U++MPWKH(A_,>+:4W? C0W#0W Y&
M@:<=<;,82NO<V^?#RP>#M/@HE]"<<(MLE[ 2P" AOQ"^@4:EU>" $3>!=,P<
M4/92ES]M!=KW*.]EB9&G41#596$LP\EI!P%K)ZI\;:(G#?9Y%A$AH]]329J-
MS.,TE%C1%IB33)61U.Z7;0 75Z+2$O"5!/H"%%,IL[$;Q@'>N<5&MF?DFOFS
M5SW+L&JAEM@4P$4V["2VL;],]W+=FQ!BH@YX)Q6!LLQ::VP0(*BJD"447'F$
M76A!H="!E(PPG8PAT9I/3RJJJY"T:A+817B)-M+IJWZ8)CEJ2MM5Q$*#+V[_
M $HQ E5.>T?+0]%J;!?#Z'C]^WT323.MD^^89251Z#E*-?4H@9 @LIISZMCF
M[Z??=\4265!"F(+ZRT/V>A5/_I9@YP%=BA8P*6;5)<N^OZ?*R!&U2I22(G 9
MFZ% )NP:N: PFWE-%N B#,LB<6U:BNH@ EHD&3M@CTB3:APO8TLM:H"UXH.X
MJ&127.+XF!\F@GFM^RC!@7S>&Z<NLDHI@T1).<W2@BNTP(:^(#0^@YQ51X^8
M.<D<-7!#RA<C_57BWI;>!M#;MYG9JW=HR>@2$P"T2*@.GNKR+F;&XFQ:Z\:L
MD9U(_.]OC$97-FT:49M=H& =(A1+714H]E*5H050G3+?INKZ17X02T$!2I;=
M'&?P-:4Y)FZ%-BL7\)4Y[!9WK7^?;MCOW\XZ%@",B^.\TT4Q"RP%3 E6]\Q.
MEH8.[4_;Y;'9LC<R082&?7L[(CQH-*EXARF6 1!!OXH6%NUI!'//ZE-THXJJ
M)!5#+ 8LBS8-,NKN@X2@ZL39;EM#(H,&"6N$^-PTPD(3)< K^_5+\WR#KO9'
M_ -N,ZRXH& K_K )/Z@IZT94!QE30BX6M-!4H0"/07YS&P!0-H"M#0+L0@3L
MHG)BWL7'L:N>_)I.&))CGS@:]B2)(]G2)PQCQ@!'H%_E.DIP\X'"/(!"8IF#
MIMOTX#_A K 80$!$2"668,:UQ-N_7GM:>*[_ -N.2_4]_M^>B"D>&FQT! %=
M,)KLKT9#H03#!(#S^(\RCR@%2C.R\^NG-'6"KQ!?( =QIR47FK&W#V"SB-A8
ME0F' \K"A, 6*G) @@=]G/5:SO'5E0#H&:Q:7I+ALQ1&,CA6A&BFA1\0HRY?
M)?9-U<7M:6^SY<$".YQAG1NA!YP'V8F#>\R*%ZL*SE*O#>R0'79[\-1N GU0
M@C;@N/\ B=EJ^;(E;B518'N>3$] 4<"L)C,*R"J7-?7?DV,:7:=L('T[8:1@
M%ZQ"-%$NC)3B!++LQ1:(2E4BK %0E+E*\F7G"QO=4Y=D%L.=ZY4(*D6D3=1J
MHI"4"8*X(66(TB@L0R$X$B3JVC!2R'V%[U  3[:E1%>OT68IQ4-PS2&)21A<
MZ4!2(+" "5*%7=!=!8"- JV@V%5E7+<&/,$4H25!:J\6*),*AJ6$ P-R@0%1
M1;2II"@.G]D-0L,5@(6<-P=B(1]/BEA8 ^YH@.,_"<_G3I,A!HSZ,I!:$S(I
M!1V+') BLZ;;]#&><#G,#8@PR)"A YPBRS%L39J$KY>A\M!P6'U/'HB9$(A$
M!4$T# *8!4-)#M5+4"C=8E37PCXLT=P$ 'MT<T;^7K*FV@"1YUE!N@/?,TE'
M(#=LL[LKML;.<X9?80<H:1N#37+9$JDAILDC#*7( 68B.2(W'$;J6*"H-7-X
M6TD=#PL4:!0BY%C64/\ H!<XEC"/-*U-K)6,%5;9 -$@LXBI(60E2MM@/$@%
MC^W%G>&%+9]OT:-!9UF(9;LD#*S1.:S-'_:@:P84J;4=$)4R!8X-A:0N7"R\
M#TJ);/V9)&T5M65'7G.0 +O9'_ -N,ZRXH& K_K )/Z@IQJOF"0#&\"%[/ ^
MD ^V[EV+&VR&9(7$MS+L:X' 86>P4=E"LJ!D;#!>PEB/4"MP;\>$RC.QY:#5
MFMM"U(J@MY7'!J '!;**BU9LN5A'99"$4QB,*,=R"&(%R*;44+VVB;E@W#4K
M(LQ/*IN*4E)^+@'+)AF[V5(IJ +<".U74*C #%Y0S$"2UWE)V)7HA2Z!I?)1
M>M*QTR[?H/R"%U:P<E-BJ*:K1-P>"PKW]_S8N?4(I-I?U/'J!?F(3+7!NUR@
M-7H.>7  J$ %5 +8X[4!*J'8=FL5-!&,=DU&.J&H(($6'+!2+6 ;'GD"* A7
MRXFV]UYXQLY/?'E8"%"143[-LB"RWN3B 33^0NQT:"JQQF2YA0MBP!O#:+",
MX"&@F48*27[5I8XQNSWRJ-Y[4T&J+2*G2T'W5.(1O!K;Q;HK8<^[ L=E$W'*
MY/9P+$_C8B!6WI39:39U]PRRC,Z=L>U!GB@A;B518'N>3$] 4<"L)C,*R"J6
MA62C &D) $"*!H>CXQ,L*W;$F"!)=++<SZ P"(Q@HV#4PLQ1!$43*Z)4XPUV
MJ9!IY%#G_P!#R.8U_(3M]B1S!6+8(L0Z8*WZ7&.:EW/D#.$8NM^MAPT':4U(
M>H7,%&Z()]OJ>/47=)71X1YGL2 /#3/VA'@ZL:R6=RS,^QERR:)0F!OI6-D[
M;I @>1(^(6/MC*(?SB"".^.$#++RS^C42G:/MS/$:4;\(.Z#JR_"&;?)"SQ)
MC(!:(K&-4PD+H[GD-RR@>MUN[+3<46*3:*V.2U=:B V8(H. .PU-^M=8#/M=
MN!R]R+M&])ZB[Q/#"B>2$SD-G2 A:D42$0%H(U0'(0Q;AF(NY%B];H90&SA^
M^M1Z+FI!5B6IGD7H 4T*00X[WO:Z>,MDUP.C["M],&EOU3@5[FF;P 9*5:5^
M ?31N*4);T[8X%Z$)&6CZGCU B<35;.Z$(+0=H"V2K5<Q3FRFT"N>@SCUY+O
MJRDL!3OD#60/:=R.-BQXET2NBXPQ^+2/@"ZA5<^DZ01H"/8';"65 080R@J$
M$S1ZMI#I1!H$7(X30M:G&H-<!BA^P]63+JB1EO5ZZ#UNZ UM$&D1GFMNA"E\
MT/0XJHD!*K$1^(FA  !TUN45/4C0>EH$1"EX'"-WW:I.4K2IWG/.ZL:N0OJ>
M/4&<RP5GH#20;6O8#>  !VC&7'/92_4>SANU(VU>RG?G7?9 K<%*;>,+8[#$
MX,3Z%H<7PM=/2IQ5@2C>(M45DFA52(0.E -OP6^9@U(O ]$T%X(*\4E34N25
M#%7.K! 91 Q$3\AC,>;%SW5V*0OF,[1GGF#I0"?T@W2.QU_T]Z&PN 6R1E06
M)7%GG^A[/N]%((#L0Q#+(V$^IX]27 I1N .V :\ZD:=,J613%61:3L>C^+?"
M]<35)0:*0NM3&(;8QZ]C"SM]0]!DU]!'V!F<(5V#* %0EPXS=[I%-Y>E=#XP
MPP)K<K@5U9.EXWI.N?\ ;R $MYQX5DBA/43PHL^ZZI1=0TTJY;S(*,N@Y8&=
M_3W24J"Z='J5G6_2HFSL4&N"&\"I@%Q'&R)Q#YVWRB"TDLTZPX,(6@I]3QZF
MIB8U/$ (W?SYU:8JOY("0 -F5;YXV\ -% -  .&EX_(XH$+"B46)B7AF@HB@
M4H^@;I<_%AZ'@L%2VIOTMAP20XC1DD*,7&FL%J0\KB"@<G2VI3=R[^VA.>(2
MZHX\A?V4M!\D[\E@H6R4' '91.RQW*#(&? ]J55I *R>G'/K?IX0M4#( X+=
M&S%.T#/YD=I)S[LYPN"*C7PWI':6?4\>I'5Z-"CIIQ'<@!A*OV7@,1U$\G,
M%E">+C )GI<5VY4"O-=W\@)J O> EX&V?#47S\M2*JG^VAED[TQ>6O J]N)
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MRH!C-[2&46%$"%>!((12"!1$1$:1'(CA'(\EUD<! POAT%!1;R#BK/ .>&I
MA5>^M<:VDF;!^ZBZPUVG OUBKUFD"=KCY<5\&T!]_L8[ N.&I9)<28]W!] H
MAVJ(U1(3:&X5@5E;]@XOQ5=UYE0TK[EL" %%=Q<!(DC]%N-TS,(!F\ Y %(=
M>A"*:)(CJ@V+0*+4;CR49U=)Q*H"I[L(6DQ:Y#SL5)E@8N@H:Q7 'P0;X.QA
M@H2<)+UA6KUI'!0P.G\NG!#25LRE0Q7JAV%+)K,@C_LF4C]Q?C^#6I/&+2U3
M[ S.,*[%E B(]=;]&O@O\M_[Z1=M\@QC'&[B'(15'*FQN4$8*4J0F_&%+%E+
M/13,T( @W!$VL)B**FRP)LVC/N<^'CW!;%!YV<,*"H&Y%$MQ)2RCL= 063:%
MQ=(1W-LR-H9@W<,HYF>Q2;URJ%:!:M9];;2\]Q"LOG"T^Y?D?;A4Y4TT#NU(
MD^<!Z:)C6WN>\]VQ%\(687SAY:CQ5R6";X0B(*$$ M0 V$17PIB"WH"J_6R>
M,V 5,L%'FF*OPQLMGV!KC56;%OY!*9A7%(&*F:: 0D1EK7FS<>/9YV5'*A>2
M!%V*O8BK(@%Q+LK[D]GL*M44!/#*A1;T4"NP. ;!R!>5D'!I!V#02P8"@56F
ML&V3<&^T9P0S<,-NT]6&7-6\:F+(>%I3R !04& -@]NNM^OJ>/H-9.%&% >H
MR?9-L$MQ>>_0M"?Q]_S#TSXRW7NL@KJ) A'8"U? %P'&Z'NL(JUWMXA##DG5
M,QI1MZL=LQ]:1/BHQYD(=BR?+6I$F_84>EV,^DJ K@!5\&\N=T&K8YSPHOZ8
M9#\7@ON-6MRG>J&/2XBV=MNZ]U,1;);,BB4B?%G4QRM*J;0;]=;]>#7?W\WC
MV]WP]!1-81BL=&SSVMX-!,U)GB346SFSDI#H_<4E@KI>O--E&K:0<L>I36;<
MMLE[X95H]G  4"<97\X5J?EH-@:FN6Y>J$"JK<1G,^H[6V6>^)ZW[(.O<V#K
M\THX,6STYDYN =FOW)(P63X.UH63>H4GJD]\GY!T!("CII"6U#$!8Z"KI1J]
MBG(?[,\U;V'EB0,*:Q^0$TX/W_!^[@Y$&+B;_P!G^F S)FX%,M5.>"I5+7X$
MGP4X E4]'4^UQ<7U[5OUX/R9W;'<]_;'OZ#@/7,?7(BJ(MP1'-NF%_JYS)3#
MKX>%L6X(9#<)'%U*6E67:]-C-E>!4 ZT8L0$Q!S*A@-)"N$R[KY[4H)7H""1
M:@73;8,"P0540:3<S^M3@8)<*.(.M<HV0+Z#E'M9TFI;?;A&=]77AT#!":52
MRTZ3A'2.>E$&"P=7L%OV P-(NWAEE71&&R$0^&*72H!4RSC 7;1$H5N-,LZ&
MLWJ#D"--'=-UAT%PW^N56_0O:Q?SLV\U\8OTARL*EJ&:VIG>Q*M&.65%PD<T
MIH,@@V)]7,<PI]*B_P I<4>F"4GJ^5_8!AD %&WZ\#Y_&_S6WGTA+<!=B^:$
MD@:V3B]T.0!(C^EC''Q]>_8F!;V8<MH?LB20, P98\Z61/'S_7!OU/L3;W5)
MN&(=%H803/?\\2I4J5*L CN4; @+Q_I_M*@B((E(Y$=Q.XQ,F+4$^ZJ5\O$V
M;-FS:_\ F"?G(_/]L9HOA_\ 5G@QB*RVI@3@3I@96R#(/1-OI[^&WMPA_P"W
M/5[]/MXJ7OJC># 5CY)+Z;\2N]!_LT/M/:H3Q;&>KBP*AC!1K$ ;2Y72BGD$
MK-7ZQ;HE$:0RN<@&D8-Z%"%R27)4E\8H%M*1<4.MT]:NJHG?L!=Q:9LD6X'C
MJU6[=!8!U.L]9CT_N:Z18"I5/H"\/P/:8T54R]YID!!M%9U (K'.I3+=1]CF
MU0/6>4AI!E#,!88LTDD_AI$NJ7Y?F8,8VP(NI\':5[I]VA]:SRQ8CP2#XA8)
M(@>$LTJ<=YYIJ.<6"II&Q%@L&7X$UL598%$4&EK NM5,WVA,\@N4[6W0RZ6U
M8KH);!_%UYXAAG2KH8@<43IV#A_.#K0T1.*H" =YMUM*;%R@7.B."1A2E3('
MA(6D-HI)  H5-_=QW/>8^]\JZQ#6)Z)N EAF*UL@C#(UXMH9%/2J) EJ/[*?
M;!]\"00C4C1*2M!(IZ0)QLCK(&/! G#-Q0NZ$V(Z#;9/9H>X;:)QERVV6;Y$
M/ @ YX4K4/CUH8YY=@QP\4-24+F1PIDJVDAE'BD3(V8!R0\J-.67ZR*2\:!N
MEBG-K6-')C,!(T0-9ZC).&SZD%@D0H4-(P+FD>%L[7RK)VB/(0<\32=A"P'*
M6'T)N_A&SYNQHS6C->.6:,ZX R+CMUGC"=H!S(*-NNVU,K1AX;!,"PC0XK^S
M*50TEW.3:)D0$;>RSMAL!RRG4:#3W1!M^40"3>=[0,*(@HD7F1 H1-H9'"CL
M@?\  V:YJ*1;NLY!$;;4[,]KKH#CH>]V!W\(0@'>;=;2FQ<H !12S-\U>8K%
MN9P:MC@ZZV1,L_GO*Y^<N1$)+P,PZ*45AVGO'FWO,><<TS=!S$P333AK[X%Q
MN-(CN"H('CJU6[=!8!T;,%LYN <+*%TVRI0C*AZG#7W53$Z,YL%."BO5C"P$
M[=HA#[X%QN-(CN"H$:]HD:B604Q*+AG]QH2=WMF?($,1L+<Z=H0<TS;!8L:'
M^Y&'B5;R.\=5?'I"G-3),@R$#^DU$,FB,T*NM9NI+#RX.<C8X>49: YKTC1(
MC:[]X$UO%O"#]?D4X.VB44FALNA^O_\ ^'";I2)RE#=-OL<R]/3&/QI25:Z'
M\+\7?I?+0#E^ET\_?FNG5@8?&8CDM: --?MT>2B=)]D12)$476A*6WS0#7#%
MC\HSD@E8LMH\''![K&7GA?X@Z#P+$\LE1C)+6_E:^_QAS'6:>Z\/>LPVG#9F
MC5_<3G*#R\J-.:^9=E0JR@9^JG(: /M?-SN7MBQEN^]Q!2E:NG_2J_@]DA56
MCC:'XLU&C?0AC_7#8 7KLY?2HZN0<W('0Q%[7)7Q+Y))(3T4!4CJ<_K&P ^!
M1>R(8T9H-#ZE,D925MA@,G4NRN\NYC,)+ +TX&U8''X45 N,R9UQCT:8PE+Y
M5I'XY'?4,H8M$ ES%_P)DK?[MU5*!SD&,5%NUD)$%?/C!'8[3:J3NF2U?_OO
M:OU$/&PO_H5,VYBDBSIZ;)4\>!.&/2$%JQ_E@E6D*O*D$/JD=%VM%Q!V@"QQ
MY'@1'M%2J^%Y]2<C(UK5:77>3[V22K1[=BK^J<*OX)N<:L/XPX:@?P/<J*R<
MHD_PM>-D30K1)#(2CW>'5$(.^(NZ\A0L'='+%0Q*"7IY+Z@?.EG65_I@'M=/
M7:F5A]Z7&QEE08C6)F8W*BT)!N!D A*6PR\L0D.^9#73CM/J(PF*6KRZ%33Y
M)T>2;ZUS(BI9]SS1BM\@1K%F]^A;!/\ 54ZU90$).!#Q\WZP7M!&DX^3/MF9
M:A:F=9[1('<2^K'B0HS*V>EF"SP@&]%(/4/X(@LE3JP;<D>#T@P!]=E4,CFL
MF-@;Z?&F_N $3I#3U<HU5LSL?@WBOK/'J/=_[Q=L+"HE:,M@<'G!]GC,"6XX
M+Y1("\6Y1P1%V%HUOP8!J-VWT4)FZ2 2C)D6-&4*LU(Q0[787',D/D==/^"[
M $,[KH[7 Y'XYKH?62[A$1*5?!HZ>I:-XU+^Y0RR27_3\<U,D;C2[M%;P%"Q
M<C2W=PW*X,G[VNYJF_.709_02?PACN$MUAMV)B*2< 3-6S8C!,A=0V=(.+$I
MGM=$'%G\!!M7D]H HE-M)92L,?DJWB5 $W";'BP,$=Q$LU=J:5X/$+U$]D=[
M>1G@FH(4^PN(K0C^P47/0"WEUGY@&PC1!X9LWX(,G#!U"7P8ZIN9U=A2(V!7
M1H(/9D?S0CZ+1=7P+/JAND;G81V-N;UWOY>H!]<(9>EEL))<4:1LI?N!VL\'
MC-9Z6M/]4R.[N7B**^O"^PLF[ =LVPZ,<YPT:"+N$_G6(297O6^4Q@.P(2&R
M=##P"ZK.F#H,E:3A0\3A2ZRL(+4K"G,(2&3NLQ&:N*)3P)>+4T"H'"YH[ !8
MDDYD-$8&W(Y5%JSB9?RIF$?U'/RIA1T?O+UP^']'!3_<O\9]=;(6[WE%$BI*
M;1ICS5^/T$1!$1$L1PB.$3".\+UT:L0JEIH*BD_WH6:]?3I3["OQ<+_FTC)O
M.@K-F\(>4[6Z0]QYK&R@&GA]H,L&X9LNC>1:T6E98KC50)*#+YZA"&Y5/P,/
MV#) E9!62OJ:?(#01DIH#66<;485 ,":?"ON3@ 4($:Z)([ATN(2IKT;Z#AC
M7@0DA.B\3?)GAO5-A3'M1_[/_)TMVSQ^!(:_!P-9BL\N-FD4,=CBZ-SK:L4V
MN)C*/] #9,Q=HFS,)?!<(_M5B%(,24.>2?2P5>T(.K@WCWI3'R?>@^@&+;U:
M_P 9EH0 &*'UB1L3Y>$H#1,9<[EC12?\/\\!4D$J9;MX1,Y8[<@R\7 P%?UK
M#93 JC6*DX==!<EXFL\N^!NV+0Q#:*F"$V7M58F5@,[>ZVA;.15B:6J9 )B)
M )ADBAULCW1U-KI22ZH8232WK=B)*(P CZH:D1T+%"@Q5.,F*)(<4:5*M[Y>
M3#QX.JS:%S2^T45E&Y0TO;C)5C=%;9M.36'4Z"B1J5(O> (WR%&ZWGXJ#J =
MV2SW]')S+DU/3G&=+PRTY4I>'/5Y[<NLJF$P+]!:.*1]@UYMZE!IOP@P5)]6
MNH.CVMS3'>9D=45#&B(HK%P\@ )V0?*R2]@KJ'S!@$J0G9E6<J&$'ET%_IDG
M WP0)B4I5>H>+@.#*WF"DB_Y'>F!OI0 )*NK8J,%5N&A(:XDLS00A"J;ALP0
M4@5-+')%;)T8):??U7W7H!E"E\,H<SIM2U+],\-J4 \#; 6!]<R JA-9!;QH
MD6'?,;_ZK/4V6C0%O,R9Q%=6+)U;F<MUC+ZBT958'&<^]!M6DHEJ$N>/N<I2
MNM.7*<QHB7]9@VE/G@D^.KR"D:]EQ_,P9LMB$7V"Y*%G" '9_P Z2-FUWV(A
M8$21;A*D!-VO4*%#GZTXWTR]WD)C.K SY)R<0*%V,\[)8$ +K]49'%RPEUB5
J*I!"=ZH"(30#8LT5IX/W?>8A#6+%!E%&?H<H$E2I*C9L[@N5Y?U6W__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>ahl-20231220_g9.jpg
<TEXT>
begin 644 ahl-20231220_g9.jpg
M_]C_X  02D9)1@ ! 0( =@!V  #_X1^R17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   #\*0  6P
M /PI  !;    1TE-4" R+C$P+C,R   R,#(S.C$R.C$T(#$S.C4X.C4X  $
M : #  $    !          D _@ $  $    !      $$  $      0   0$$
M  $   #(     @$#  ,    8 0   P$#  $    &    !@$#  $    &
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M '3O[^N*+:/6(U@C6)HPD;;@2NUFZ*.#T'4T#YO(Z*D+*#@L ?3-<\HUW[-
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MZS+J7R=21^P S]* -.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@:+_ ->RUTM<U\/O^1 T7_KV6NEKG9[$=D%%%% PIDCL@&V-G]E(_J13Z0Y
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M$AT3_H+V'_@2G^-%% 7#_A(=$_Z"]A_X$I_C3/[=T'?O_M73]WK]H3/\Z**
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M1E0                                  /;6  $     TRUL8VUS
M                                                           -
M9&5S8P   2    ! 8W!R=    6     V=W1P=    9@    48VAA9    :P
M   L<EA96@   =@    48EA96@   >P    49UA96@   @     4<E120P
M A0    @9U120P   A0    @8E120P   A0    @8VAR;0   C0    D9&UN
M9    E@    D9&UD9    GP    D;6QU8P         !    #&5N55,    D
M    ' !' $D 30!0 "  8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL=6,
M         0    QE;E53    &@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A
M &D ;@  6%E:(        /;6  $     TRUS9C,R       !#$(   7>___S
M)0  !Y,  /V0___[H?___:(   /<  # ;EA96B        !OH   ./4   .0
M6%E:(        "2?   /A   ML1865H@        8I<  +>'   8V7!A<F$
M      ,    "9F8  /*G   -60  $]    I;8VAR;0       P    "CUP
M5'P  $S-  "9F@  )F<   ]<;6QU8P         !    #&5N55,    (
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M  (0 Q    '?X
M
M
M                                             >GGGO[Z  /!X>>S
MWY>>>WKW>@   #QX\>^>ST   >KSR>7H'H\]WH 'H\]WH      'J'GL]
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M(        <37[5IRUK]G3^7H
M                          &':=,%*+*/)N?2-L@>6(        &.ZL*\
M8T'>-TR2+'*?)8         Z?5Y@6ZKS7395QUT$Z2[..XFF7)<S(L9(
M                                   'RP]T:0?BNX^9]>Q1&CSR!)OM
MCT..K'O8OUV8V)QZ& \:7(]F>2Z9\>9U_=-O6[(W31LY6D3(7UU7VR2EA;1O
M[6V*D7/9X[]&57\>V4^_2:8S_GMO\>T^OF<V>W$0JJ>Y%KDN,O (T> /:+I]
ML*S>KJX#SH..US[KZ& E'UF^'9S3U=>\^>^#"X&WJ?+VK-;44"F?,MT>[[)J
M[I.&GCH,LLB7$G8V6#Y0IAE3LIUS
M       /GA[HBKOBFP&9W=TM_6:P:?A9;N\I?J>HK?:\1 ]#A)L^19RTM->E
M'RUH\NDAV5S]ZO>^H;M^=9?4]!?/H;W574_/M@,CO=>,+A+Q[>XERRSL'ATF
MBNH^/;()_?3I*L=157\SV!RN[H)!XN\4SL>CSB8CA&M/MZ.,M4.K.SD.\JKF
MUW13]='.\MLNN^UP.)JK!NY'OJJYLUT>_7YS7/;;^D[W-8MK22-R]#X'%[@^
MA^B9; M]%D7XMO6M?L&NVDY6.YM!L@L.]E#5;
M                8GHUZA-'R;9K(^E0/C1YGY-I3JXV[&ON*KSN(^T2;;C+
MJHPE4D5Z(%D?>EB>- FVPF41B<=G$>UMW;7=$H7'[=)OU#6;4\//EE86+V7_
M '^J7IZA?+-N=I])[_3,U#P_EVVNP^ET+J.5RJTU6:RZ62UC7Z!6Z]\OG><;
MI5M-'91?+HHCBP+=^=?07W@<ZW[[=1NVB"9ST4Q8>T"?]!KW6P>TMH$,TF."
M6W/7ST]_J)B?+MNEE]*KI"JH:CUMK;FSFW3T
M                  %8:VHK_8\CL<]^B>SWP>0>#R>#R  >#R   #P>0  >
M#R  >#R    #P>0
M                                            #B>8ZLH7SSX,0
M                                                       !FN4S
M95,[L
M                                      ?'W#W\R//=D  !X./[KY/F
MP         ?-C]&0'@^/N'V\S\@
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M]3%4GF>^PF]]A-CK?027'Z+%=M9UWNB2H_0Q-*Y?+=5IWVN?S_-OT9
M 58L_F4GQNFSS1=P_*Y67(O4XIMK,5V5LZ0^R@^9Q^6:K+(-<^*)7,3-$ZS
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M5Z['N-<O MU1\O=>6X6/$QQQ213\S&1ZXY]DW=9EHS#19QA,YB1XO28OMKI
MTW/6>:L;W5_;ZY>/;8'9X;^@W5\F1>BPG;5<WW++--KBNVLRK59QEOY[)?)N
M4:;3C^8Q),Y23='18CG6?3S+Z>Y>664:++#]]7F^FUP?;59GKLXND\Q*\;J(
M]W4?-\WY3KL.K:<<WUF8QKGJML7I?8>1IG6X8?;/S(=%E&DSF9#B]'C>VNS_
M $76.Y0N\2>K\U8#+Y[/(M_AN^HDF/?_ &\V          #"-U/F^FX
M JE;?*[6U/U0
M           4QN/D%SJ?Z^     !Q&OEM@     'P>5CVU]=-]5Q=D'Z91N#
MG$ZC*/\ ?W#CO>;CN[7&7]<)7RPER9ILKD:+?)/,P
M           !UC&IFZMA'?5,X7IG%Z_.+UF4?E/.(]['&1V6$K[X2O7";,VB
MTMSIL^T9      8ILK<KUV0     %+[KXU="E^R@    17E'H7,YCS)Y^PV4
M*?\ QR@   #U(]]]J:V=;'OY^B]%<'1;>0
M  "OFR#329S/+D4%H_8TQ^/J    ?,A_U5KR1ZQ^@MU#Z:Q.N<    !7>PX*
MQ%?WH     $1R^3ER)U@    HS)HXXG\/>E'Y@    !\SW!Y/!7+WVN47J=H
MT#L>:]                           '@UQ3.9[J;QMR/-?T     /!Z'T
M/!ZE._<L<A=IL@A]-[    %5K/YG:FL^F      1/*Y>6(O4    0GG$JQ;?
M,KM^:P.#AE@F["2</87U;I0DQNXUYB(M6[.9,?N(VW4IC,DB9"F/7LN7YI\@
MPTJ!#[393#Z@                           4AD4^3V/SR?\ SP#$\,X:
MS]L)EJB_3OZ_=IFW$(=U[OCNTS1BUFZ)V$2-5V-/DE2HLCZLA!OK"J[Z)=^/
M<    <7W7RO-@     %+[KXU="E^R@   4%DT=BI_ 9P\ ULU=OTO2<W?RJL
M]#L:=O&OJ"8*^7A.K=HUC3MMG0T-D:N52S5*JBWV8DPKL-':89@:\M'1;1:[
MN@                          !K(F<S?N9Q/T -:>F5&4>18"XIX_CRM>
M.B7^CZ16\2-(UQ2&NK3)_2#NKZYZ)=:_<_&W7:=IG_S$>I06'VFS2'U    %
M,[CY!<RG^O@     </W3S/-P   &-^X:J[;YKL\]@?0&N:LMXBZ&AXM3<4NU
MY;7KJE@Z%8<>-(IUJRV'WU+LBKM]6M$N(]>VJ>]LSL*>>H<@509][7?0KE:+
M<                           0;G$IC:_-MA".!K#A6E.I>K8WLC:Z8D_
M+I$>^.O'[28^M6%9YM*B[J-M?ZQ)-8Y'E0-._G98[<O8PH*W6[J_I4[ZY@
M $+S./FB'V      %5K7Y=:FJ^H@   ",,H^NNQXFR>ZCLOYC\0>QK(AV%]+
MBGSB'(Y9KMA3[5W53-D+?Z'N=(][MY@CVBWDVS]?W-O=%J
M              *^[(5&;'AKC;*J:O//B>I[GH!Y[ZY8^WGH^YX/)UWGO(RQ
MBCS*F.%I>"O[BP^J>    (VD4$DQ[\     "E5W\7NK2?:     /!5?;75CE
M<]PY%%GV42PWGDE/.4>0 ?(Q9[7_ "0]CO\ 35;2'%Z"^L:\[)D
M                    /B\I;OJH*E<[Z[J:3LXMA\6=O/L>0#P?$P=[7O)%
M6,KZ:+F;(O07:T6_V>@    4QN/D%SJ?Z^     ! 4[AI]@]R      /4P+W
M56S=7QME&QW9#^N<;Q[K/?77*YV,G.,)5@]4^9\)/+>@
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MD87G'S/"3AN<;)L=V.9:LAQV=!EK[OS/J/<.UQV=9EKAV3HV5:/HP
M    QD[PY0                                       !\WE,O>"EV-
M*            XFV5/\ GU0           Q0X9FX
M                   !\GE!-GSFQD.S            JG-K]D&KZ(
M     ,4,!)I                                        /F\IRX.5H
M\D  >/%5\_98SURCJS       '$VRI_SZH           8H0Z3^<X
M                                'R>4"V?.+'0[0  1%#EZ=>DH;-Q9
M.TR#*\>-57F=EK6MARLL8.G0[]0IE:YT*.L<MN$.1[^>@ "J4VNV0ZOHH
M        Q0AHE0SP                                       'H\IV
MX.4X\D  1'HW:N[:OQ#=HWFU5A5W';4#/5-5M7294VE,I&C/HV_.+>GU]PI^
M_37YVFF0  .!ME6#SZH           8H0T9$3<
M                 #XO->.[YI:"#<  #KL,J+2M5C_/)KT[*J>M?6>$RV=?
MZPI\$X9;;LM41:MO>YX65T;0  *L3:_8WJ^B           #%"&CR3\=B
M                                    >CRGSA)0CR   /4]@#J//?KE
MCP\<O?+'N_/0   !UNV38;/JP          !BA#0).)"
M                       /B\UV[OF=I(-R           !5R;7[%]7T0
M         8H0T#O2<P                                      #T>:
M0[#YS"&ZH^3SV>CXG*\RXGN/-\]Q[./E&$G$MD7,=4S"=L+.-4S ]L20M4V.
M=L&2M4^,-U9,L:YAB3431'MX1D5$Y1KB"I5+M&KN[V41>P           &*$
M- $]';                                       'YX[7Y_K#L^+
M         W9T_P!$W2U_8           #%"&@"221P
M                    #\\=K\_UAV?%@           ;LZ?Z)NEK^P
M      &*$- '<$[GD                                      'YX[7
MY_K#L^+            W9T_T3=+7]@           ,4(: !.IW8
M                             /SQVOS_ %AV?%@           ;LZ?Z)
MNEK^P           &*$-  D0DP
M    'YX[7Y_K#L^+            W9T_T3=+7]@           ,4(: !V9/A
MY                                      /SQVOS_6'9\6
M  !NSI_HFZ6O[            8H0T  3@9
M             ?GCM?G^L.SXL           #=G3_1-TM?V            Q
M0AH  SXE(                                      _/':_/]8=GQ8
M          &[.G^B;I:_L           !BA#0 !SR?SV
M                     !^>.U^?ZP[/BP           -V=/]$W2U_8
M       #%"&@  369*                                     #\\=K
M\_UAV?%@           ;LZ?Z)NEK^P           &*$-   SDE<
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MS"<M>4>98KEKR;'9CN6&4X;<>RU]]CLX/N/+\RPS/"VF?6REC(
M   'YX[7Y_K#L^+            W9T_T3=+7]@           ,4(:   ,T)<
M         (0QI/EII@           ,&RQD&3UDV82@            !^>.U^
M?ZP[/BP           -V=/\ 1-TM?V            Q0AH   Y!8(^P
M   -?6WF;(PH(   \'D       &(Y8R3(ZV6<9(             _/':_/\
M6'9\6           !NSI_HFZ6O[            8H0T   "83+P        0
M;Y2>NBF   K_ .95GE:K[Z\<AU;?7QBF;+<70G+\]X/OG.]\[/ST  #",L9%
MD=9,V,H             ?GCM?G^L.SXL           #=G3_ $3=+7]@
M       ,4(:   !G1*P        -?NSFK'0X   &CK;AA4R-NRT9R1%DU5CR
M-:/2T&X#F[[45=U5OZRSB3=HG*5%OO73   ,0RQDF1ULM8R0
M!^>.U^?ZP[/BP           -V=/]$W2U_8           #%"&@   2X9H
M      "!O*/ZZ*<  >/&KK?ABF&^[DZJY=3;TYEQ:,VU=OWY^XTD7=9OQJ)]
M7?<[.^ZN5CF  !A.6,BR.LF7&4             /SQVOS_6'9\6
M  !NSI_HFZ6O[            8H0T   ?8L$<@        % ]G-6(AP   ,3
MQRA25ILO'V=1Y[@>K9JQO*K;K4V&/>^Y/KRAB9'L;&V@  ##LL9'D=;+V,D
M            ?GCM?G^L.SXL           #=G3_ $3=+7]@           ,
M4(:   ,O)A         (#\H^1HIP           ,1R\DF1UDLXR0
M    !^>.U^?ZP[/BP !VN&[JL](        W9T_T3=+7]@           ,4(
M:   )A,O         -7LCEOEJJ,UU[,6SPR?'/&LL,CQSQS+'(<<N@RQ[W'+
MI,L>Q\<'WSF>>\;U]?'H>QX/!S?/>OR\[+'+K,L>TQRQ+/"^7G;RQC(
M        'YX[7Y_K#L^+  O='Z2[-;TNH6;QD=3JJTD:[BC&/%4JK$[1[:$Y
M-5::+=Q)Y'PJ57V9B7E;]E7BV^& !NSI_HFZ6O[            8H0T  #DE
M@3[         &H&?R&B6Y^=            =OKE?LEYO[3WCT
M  ?GCM?G^L.SXL >#] E?]"L-6WWYYK#Y]WMI6V;K.GV'4W5?G)ZKY#(?DK]
M'W-?5-#'3_,;85?47OINIQ._YW4OE1;D.?[W\Y75_(  -V=/]$W2U_8
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MTY4YMN;@G&)U&Z/\/<?OYEZ/.MSCYKJFX7LB>GN( &[.G^B;I:_L
M   !BA#0 !S"P!]          :@9_(:);GYT           !W&N5^R7F_M/=
MO0            !^>.U^?ZP[/BP           -V=/\ 1-TM?V
M  Q0AH  SDE<          U S^0T2W/SH           #N-<K]DO-_:>[>@
M           #\\=K\_UAV?%@           ;LZ?Z)NEK^P           &*$
M-  $V&2          &H&?R&B6Y^=            =QKE?LEYO[3W;T
M       ?GCM?G^L.SXL           #=G3_1-TM?V            Q0AH '/
M)_/8          U S^0T2W/SH           #N-<K]DO-_:>[>@
M   #\\=K\_UAV?%@           ;LZ?Z)NEK^P           &*$-  S\E$
M         &H&?R&B6Y^=            =QKE?LEYO[3W;T             ?
MGCM?G^L.SXL           #=G3_1-TM?V            Q0AH $XG?@
M     U S^0T2W/SH           #N-<K]DO-_:>[>@            #\\=K\
M_P!8=GQ8           &[.G^B;I:_L           !BA#0!VA/9Y
M  !J!G\AHEN?G0           '<:Y7[)>;^T]V]             'YX[7Y_K
M#L^+            W9T_T3=+7]@           ,4(: )$),           -0
M,_D-$MS\Z  R3++9?3]U5^125,G<\.\PD='G'E//?L5I.WR_7(TZW7S[D^9^
MCSW>_-YUN>@ #N-<K]DO-_:>[>@            #\\=K\_UAV?%@
M   ;LZ?Z)NEK^P           &*$- $['=           &H&?R&B6Y^=  7J
MSM-M_*?3ZBRJ73!??-MD./331SG4:=NE^8SGLE?HIY;ZQ7W'366YYB;H]G($
M.QBV17HLO1'TGRL #N-<K]DO-_:>[>@            #\\=K\_UAV?%@
M       ;LZ?Z)NEK^P           &*$- [@G<\@          &H&?R&B6Y^
M=  7F\NKF\[W67;=.AZ^^8WBVVMNN3[RLE]R&8Y;<DI;S8CLL_S8V?SFZ_EK
M2K92S/OS5ME7VRY\ #N-<K]DO-_:>[>@            #\\=K\_UAV?%@
M        ;LZ?Z)NEK^P           &*$- DHD8           &H&?R&B6Y^
M=  <_P!RV%UW74GD<_'LBOL'IMLBC3)?V[Z@8U<W9R(U\TX;.K+.TW4TKM>1
MV&5O9:\[+C@ !W&N5^R7F_M/=O0            !^>.U^?ZP[/BP
M   -V=/]$W2U_8           #%"&CR3T=J           #4#/Y#1+<_.@
M  /;SWU]\ ]GOCSSQZ]_/?3WP  =QKE?LEYO[3W;T             ?GCM?G
M^L.SXL           #=G3_1-TM?V            Q0AH[TG,
MU S^0T2W/SH           #N-<K]DO-_:>[>@            #\\=K\_UAV?
M%@           ;LZ?Z)NEK^P           &*$-$GD@@           &H&?R
M&B6Y^=            =QKE?LEYO[3W;T             ?GCM?G^L.SXL
M        #=G3_1-TM?V            Q0ALGX[$            U S^0T2W/
MSH           #N-<K]DO-_:>[>@            #\\=K\_UAV?%@
M    ;LZ?Z)NEK^P           &*$>DV@            U S^0T2W/SH
M       #N-<K]DO-_:>[>@            #\\=K\_P!8=GQ8           &
M[.G^B;I:_L           !BAUQG@            -0,_D-$MS\Z
M   [C7*_9+S?VGNWH             _/':_/]8=GQ8           &[.G^B;
MI:_L           !BYW9S0            :@9_(:);GYT           !W&N
M5^R7F_M/=O0            !^>.U^?ZP[/BP           -V=/]$W2U_8
M         #CG(             -0,_D-$MS\Z            [C7*_9+S?VG
MNWH             _/':_/\ 6'9\6           !NSI_HFZ6O[
M                 :@9_(:);GYT           !W&N5^R7F_M/=O0
M   ,*(V  !%^6C$LM0           &?8[L_QW
M  "+LH\.YQ0           /H]M3JL?L  9B2:
M
M
M8EYYYRQROS+R]          ^/B*LM4IL^1YD
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MVZKN1[+7!KAX[,A6&BV7-E1\'\UP3&SS6;$M[57U4;KGMC%??
M           :^8\><K'34%#SC3(L-E(P_5CUWOD3>X6[]D4[\B;,_+'7CE!N
MK$LZ2V=),$&QX),$V/7>#MP_9C-WFZ&;.GV*5E]J95LD3-,ZP;'&]VF.=\78
MG%MJ9Z==<Y]3;:+:1U+A=5K]Z*)OQ>;"N F=M6V%5+OG=B]=?@
M      #H=6=<9,'O_5C=4NM.K#C3H-GXUB
M             (XT95>L:F\4:R^WF0  $&XZ\2]QER1KD/1*
M
M
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M^CK=&R_3OQ3;IRC5NZS;JPW#SH_?).S<+'9]M>60;<,&U92'MPS?#>
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M]EV?).O'=76VPF5)W09=AV."[(O)V8PU(A6(B64;[XMR=<V5M<@
M                                                       5XUX>
MTC1R7L^:Y(
M
M                                         \'&>>
M                                            >YR'H      &L#;5
M:Q%3/^O1[O
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MCK/%N?S]:"!#M"1#N#LWB$^4K9!LZK4!1;QY5#UJW=%%Q?P+A\^CVG]T#?\
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MXR9R"* R/-57T3&2FMA(8VWW@(;)7$,&,5=MML=GPU!R*\=!1$3Z$(2);/\
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M[@VQ9.*%#_J^H.O L<3QPPPV]SEACGM.U\&DB;BADXO=0^MJNM!%HB!\E[O
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M TE+4<B>.G:;4T:R+(5BUZ&!Z7L=UW!/?TQD&>9SF%;+ 9$E/()76 L4)O\
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M<N7^L2S'U7N/5BJR]\KXA2BI9&D:.J@,+#ZYI?2X!M\)0;-;Y[#'&_[RP?\
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MX;K:9>D.6R*3]TUEU-^-KG' GU^O_F1XXU_>'_\ B%+_ '=1C@C]YC^&U/\
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M3Q9I7<N-=*:O)F*J.@!\GZ#NQ%P]&F91YI-75E541WMSVA*6*E0+)#'I"WN
MI&^,QX:CS21)*ROKG,:E8U!IU1%)N0H\G[SU)N>F,LRGS6BPQ5M5+3H"%AFY
M)5;]-)2%&%NX7MO\WU)XVEC*),\#$@\V+07%NX:U==^^ZG#\&T,DS5#U=>T[
MR&9I#)%J,I;7KOR>NK?%+3O3(4>IFJ=]GGT:P+6M=$0?F^IF6146:U,=35\T
MM%3\A%1R@6SLZR@K9M:EC;?3TVPF79C @B@S9^6HLIJ*:.:4#NO(&C!MW70^
MN^*#(::BJ'K9'DK*Z0EFJJ@@O=NND !4\-AL+"^,WR5,X"I/5U,<"-K6"'DA
M ^G3J)>%W)M?JUA<V&*.@CX<HZF=*JKEI:6*2H,+\EK-J7>/1%&;EC;<Z>T2
M>F*'+J?B>NKJJG7S9%$XUJC&1GGE',9@I("+9A?3L6OMXYUP]/DU&*Z+,I9
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M4T2,D+7VL;[L.C$:FTD[KJ-NIQF.6^<D>)ZRJ@@D0))! 8E5[?=%XW?<]1J
M]6*/A:GR^0RT==71.P ;M0D,H-]+ P]/FL?7C-LG7-T6&>KJ8X$9'Y,/)"F1
M$T:V+Q.Q.['TK L;#&59(N4*T=/653PMK;E2\EE#NMM:Z84((/:ZD$C<6Q4\
M)4U75/6SUU<U0\@E+WIAVEMIL/)K *%  \!BMRLUU"*":MJ>60HF=.2))]+A
MUUDPL!8@>@J7[\93P]#D\QDIJNK9)"#-#*83'+I! OIA1A:][JP.WAC,.%:?
M,Z@U-975KRE%C%C3JJQI?2B@4^P!9C\Y)[\>;Y?(6HO+ZKM*8S/[QSN4R:#'
M?DZ/^]HU>O&7\+4^65*U5+6U@<#2P8P%'2]RC#D V/J(([CC-N&X,YJ!/55=
M4-"F.**,P".*,NSZ%U0,QW8[LQ)[SB'+7@R]J!:ZJTE>6LYY!GCB*:#&IY.C
M<?"*%AW'%!PI3Y;4"II*VM233H-S3E62X)1AY.-C;N(.,VR&/.'0U-75+'$6
M,4,7(5$UVU'M0,Q)L-V8^K%-D8I<OGRV.OK/)YH^4#>#F0J7#2<IQ +<Q;QL
M"#V&.FS;XH>%*;+IC/2UE8LA31J;R9K*3<VO3[8J,C-5+22U&8ULHHZF*JBB
M/DXB,D3JX+*L"DWTZ;ZK@$VMC-<HH\WB6.J0ZH[\J9#IECU=0K6(*GO5@RWW
MMBDX=K*,"*#.ZM*8=(ECBU >"NP:WXE^:QP^44S9?49>-6BJMSY&)>64ZU=V
MD=KLS.%*ZB;B]QN!B#+:JB01468.L*_6TJ8A4F+P"/JC;2.X.7^<XRW(J;+I
MIJO6]163L[2U$MM1,C%FTJH"J"3T _&?J9KDXS93%-6U45,75_)X>0(]2 A2
M2T+NUKDB[=3\UJ#AF/+#(:/,:^+F[R+>F*LP  8@TWI  "_A@\+4,U2:JMEJ
M:^4VNU3(+6'1=,:QII'< MAW#%10TU5129?)&!3.@32G9T:=T*>!0[C:WB#C
M+^%O-\K-%F57R7/;A33'S%\'<#5T[X^6<-PC E?Y=15DU&0YD5$5'T%O2",W
MP3<[.'MC,LE.:4\5+45U0(8N4Y"K#>2:.,Q\V1C&>T=3&PLH+&PQE&2^9P8X
M:N:6G8NS03+$5+.+$@JBD7ZD=YP.#X8:SRNBKJBCLQ940(S(#U1'8'L^ =7M
MXXS+A.EKWBF%1/%4(JK),3S3,5Z.^K?6/%2!;;3TPN73"A>B?,*EC(K(U0!"
M)>4T?+,:WC95%K[Z2^_I8H.%*?+:D55+6UBR!=!U& J\>I6*,! #8Z>X@CNQ
MFW#L.<3++55=4!&&6**/D*D:N06 U0LYN0-V8G&6Y?YN@%,*B:HA4:46?EG0
MN]U[$:74WZ,#BHX1I34^5T%3-E\NHL!%9XU)^X4V(!^YU%/!<4N4M&\<M;6S
MYC+"28N=I6*)CMJ2) %UV)[;:F%R 0#;&;Y)19PB^4J5EC73'41V$JKUTFX*
MNG7LN"!<VMBER"MI5$*YW5^3+L(E2-6"_<B0ZV'A=;$?!*XI:6&CB$,"Z5N6
M)))9V8W9W8[L['=F.Y.*VD2NI*BCE++'4($9EMJ #*VUP1\&W3ITWQ#D H"3
ME=9/2!@-<+VJ(&/>^AR&5SWZ9 /5BHR%\Q>(YI7254,)U)31QK3PZONG +LQ
M[O3M;:V'IK4PIJ60T:JNA6B1"5CTE=*A@5'7K:^*+A.++ZE:JFKZI91L=0A*
MLI(+*PY8V8"WB+[8S?((<Y>)JFJJ42#7R8HN2$0RZ.8>U"[$ORTO=NX 8RO+
MO-4"4L=3/-!$@2))N5>-1T ,<<>UMK&]ABMX3HYZGRRCFER^HUZ[PV,>L[E@
MA]$GO"L$/W.(<FE.D9AF-3F"(P80N$BA++N"Z1B\ECO9V9;@$*"+XKJ"ES&F
M-+51!XNJ6[+1,!8-&PW4VVVV(V((Q3<,3T!84.<54$+&YB,<3_G(T@_,EK[D
M'%'014A=]4DU1+;FU$S:Y7MT%]@JCN10%7N QF_#%+FE7Y<)I:6I;09&2S*[
M1V"R:3N'L +A@#:Y%]\4-'+2*1-6U%8Q &J?19;?<+&B ?CN?7AP65E5BA((
M#BUU/W0O<7'K!'B,5O"5-F$[U-77UTLK@ MJIAV5%E4 4U@ ,4%&]"G+\KGJ
M4545!4<HE M^^...^H$ WOTVQ4<&Y=-4R5*3U=,9)#*$@:%4C8F_O>J%F4:M
MP-1MT&VV%RY'I'HJR62O@< ?MG1J&GH0T:1]H'</;4#WXAX5>BE=\MS6II%<
M]J,HDOXKFW3I<J6M:Y.*'+UI)A52RRUE6 H\HJ""P46.B-5"I$IMN$47ZFYW
MQ39#Y"SRT5;-#++))),& E@D+N6N8C;25!T@HR7 W!.),@2LK8J[,Z@UDD"H
MD$00101JCM(O8!8L>8[,=3FY/3%?E]+F5.:6KC$D=]2]SQM:P:-ANI_M&QN,
M4W#-10EEH<YJJ>!FN8^7$Y_*PT@^L);Q&*3+XJ02L'DEJ9A:6KF;7.QM93<B
MP5.JQ@",=RVQ4\(TU75/6SU]<U1(XD9[TP[2V"V IK  * /5BGB>&/1)/)4&
MY]\D"!K=P.A47;QM?QP#8W\,4O#E)29M-FL;O>0S%("%Y<)G;4Q3:_B%OT!(
M&.F*_A2BJJCRRFEEH*DMK+06Y9<]7Y9]%CWZ&56N=0-\0Y+,0%S#,ZFOB!!Y
M+!(8FT].8L8O(/Y+-H_DWP    + ; #N'V^RJZLCJ&1U9'5A=65A9E8=X(Q#
MPW14D[5%!+4T+/Z:PR!HV]7+F610!W!0+=VV)LF@JS'Y=-45JQ-KCBF91$&M
M;48XEC1FML"X8KOI(N<(BQJJ(H5%%E4"P '0 ?:8-C?"<)92E6:L)(>V7$!>
M\"L3?9>I%_@LQ4=P&    -@-@/5_[ )YEIXC,ZR,JL%(B1I'[5]]"W8J-.Y[
MKCQP.*<F+B,3R<PN(PG)DU&0MH"6M?46[-NM]L-G%*BEFCK JBY/DDU@/$]G
M&7YI29HDCT;F1(F",2I7M$7L+_:DCB*-Y2&8(+E44NYWMV47=OQ=V'XIR>-S
M')-*D@;24:"16#7MI*D7O?:V)N(,OIPK3>41(VP>2GE123T&HBWY[XI*ZDKT
MYE).DR@V.@[J?!AU!^?[5)"JS,0%16=B>@506)/XAC+LYH<T,RTDA8P:=892
MOI=XOU'=?QQ(XCC>0AF""Y5%+N?YJ#=OF'=A^*<GC9DDFD1U-F5X)%93X$$7
M&*+,(*]==.)C&45UE>)TC=6Z:&86;QV[L5V<T672<NK,T=VT*_)D,<C;&T<@
M&E^O=BEJHZR+G1+($)('-C:)C;O"M8Z3W'O_ (I+Z0^<8JK#BV4=W^D__P#U
M<5M9%04SU4WHJT<87:[O*XC50#U]*Y_DWQ1Y?#EIS":G4\NIE\J\GC6Y1K .
MD2C=M3$L%[N@Z8;BG*4EY+/,LVL1\MH) XD)TA""+AKFUL569T]%315=0DZ0
MRA-^4Q,;26"1R@7T2$FP7QVZXFSFF@I5K)8ZI8&N=1IY.R Q4%]NP&ZJ6M=2
M#WXI>)<MK.;RC*>4H.GELTDESZ,<:@NQ'4V%@.IQ3\499-4^2LTE/*6T 3HT
M?:^Y.H#23Z_QX+*JEV(5%4LS$@*JC<L2=@ ._$.>TU9+)%E\4U=R=I'A"K$#
MX<R0HI)&X -SBCSRBJZAZ.[05D;,K4TXT2:E]("_4CU?.+C%964V7T[5-7((
MHE.FYZLQZ*J]68^ [M\19P)H!5)0UAI2-?." ^]]>8(@W-9;;W"=,09O35%"
M<PC69J<2R1]B)GDM&6!D,:@L$[-[]UQ?%%Q%EN85:4=*[O(X=@2A50$742;X
MKL_H,N?EU7/C;M:;P2:9 IL3&]M+#UC%-F$-70IF$*R-#(FM55"TK+>VT8W/
MC;PQ'Q3E<M3'2HT@D>7E=M#&J$7U&0O;2$L=5^F#Q3E8K%H]4FIG6,2&-@FI
M[:?2 )5KBS="""+C%?F-'ED//K)EB4[(#N\A\$4;FW?W#%1Q!#2105%525<%
M/4'3',Z+8DKJ *ABR$K=@'"D@$]V*>HAJH4G@<212"ZNO0C_  /B.H^IQ;_M
M+4?A=#^E3XSI(I,@S,3!2J9;-*FKNGBBUTY'@W.$86W4]GOQP695S28QZC&M
M)(TZK<Z@I'+ '>^O9!U/:MWXDXJRR*;R=N>)N8(S&T+HRN2!9@X%NM]^[%7Q
M1E='4"G=W<[7D1"8QN1<-T< BUUNM[[[8J*VEI*;RNHF6."P(=OA:A=0HZLQ
M'0 8?B"&.D%>:2K\A9E45.@!;.;*VB_,"L?18J 3M?%'6TU? M12R"2,[;=5
M/>K#N(^I55,-%335=0VB&%=3MUZD*J@=[,Q"J.\G&7YS5YQ%439=3P 0RF)(
MZJ5D>0A%8%C&CB-6U679]P<9=Q8E16>0UU,:2HYK0;-K03*Q4H3_ #@1>UOQ
M8J:F"C@EJJF010PB[N?7LJJ/A.QV51N<9=G=3G+S-04JQT<+:/**ESJDD'P4
MC0'8?")?LG:Q-[)Q(*?,&RS-8!23AU594?F4[\RQC97(4Z'!%F95WV(!!M55
M4-%32U=0^B&%=3'J3?954=[,=@,4&<5F;PSSY=3T]HI#&D53,Z.YM<:BD;A-
M?P?2]=L9;Q8E35BAK*8TM0TC0BS:TYJW!2^QZ@]V*BHAI():FHD$4,*ZG<]W
M< /%F-E51N20!C+L\J,YEG\WTJI2P'0U14N06D(U!5C13\$AFNPT@C;? XC\
MFS Y;FL I9M0"RHVN!P^\;!B%;2P[RHL;CNQUW'U,Y9I*>++87Y<^;2&E#_$
MTZJ7J9B.NFVB(VW]]QD=1)DN?BGJ.P&F?+ZD'X,FLI&Q]7,[-_Y8/3?ZG&>3
MB>G&;4Z>_4X"5@4?7(/@S$#X41[+GOC-SZ&."\T\HI?-DC>_4@]XOU:GZ*!X
M\KT?YNG$B+F^8J" ^7Y1(P7O6IS$BTI'C'3"T=^^36.@WKJ^DRRG\HJY!%'?
M2GW3M:^E%&[$#<V%@.N%SB\(JC0UHI=.LS:%;3'UUF)6,NFV]]/3KB@K8LQI
M8JR"_*F!:/5L2NH@&W=J O;NO_%!?27YQ_;BM&KBNH6Y&KB1UN#8C5FEK@C<
M,+W4]QL<9[D1EI8YX9ZN66EGIW$$DSRK(G-17(1B;.@.JXWL#C6H94+ .REE
M6^Y5; D#P%Q?Y\<:Y/')#YXALDL;1QU0'9,P)"Q2K;K,C6#6[12S=4QP]7^?
M.3#7R!FRU5:.#Y3)N!5R_=,B]A4 LIU/U;;.0/,N;#N\@G_1QP(H,U>UA<)%
M8]XN3CCRG2.LH:B/L25-*_,*['7!,45_YUK;^H8S?,:B7A#*7N5:OY0J"/A)
M'&6"$];,UB?&V^."8U3*&8=9*F5F/??5_@.GJQQD#3<0\^$E)7@HZK6NQ$J@
MQ BW\F%;^/?>^.)Z.LS;)\LJ:=&=H%Y\],FY85,,1UJO5FA*E=(WTR-;P.6<
M6UN6QQTE33B6. "-3O',JKL%96%F(\;KMM:^^,@J*"JIGFH05CEGGDEA;K%+
M)VG2W<O>O=8_BQPM_M(/FK?['QQ[]C94>_G5@_%IIS;'"?[PY9]X3&A'XO=&
M4,ASJ:ZD;'W]SN/GZ^.*[AFCKLT3,FDD1M4#/"NGELT"JJ$;779%N ;>K'$]
M3)5<2-#)O%35E'1PQ'T-"RPAK]=IW9F=K$Z6'4*!C.J+,LVRXT*P4D1YL,JR
M-42'3R_ "GZLI*]VQ..&LLK<II)::K>)KS&2+E.S !AVAVT0C<7M:W4_4XN_
MVEJ?PFC ]1)@L?Q&QQ5Y-49E D-5F4_DUD+T\21QH^FQ76=)=M)W UZ;[VN
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M-AU-Q?II&,EFHIZ"-\OVIBTFF/IR27):*WP0A[('<!;^*$DG)3F:'ELRC1&
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M8O(9'0"WI6%R1CABES3*)JDU665'+G1!K1H&TE#WJ)M1O_)!P-P#:UP#;O\
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MRK-I]TCB&LX,XLR:3A[.ZIJ>HAC?,LNDKY,PIU9*GDLG+GEF-.TD7:][,=W
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MKS5K, 9Q-0M--$^D[@K$#$-D*#'"N<5W&O!@JIZFIRK,TCGBFGI0(Y(ZB)&
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M&K&REMMM1! \;'PQ75]'EM,]97U$=+2QZ1)/,=,:ZV"+<^MB%'K./]..$?\
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M-6C:-=KFWCC_ ,GRJIHJKB&"6>*.62.D:.-W"LXNX)0$]JUM[?XCZA(478@
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MF@U7:]A;H=^N/=ZR&MS/+,ESNAC:IARIZN*J6%>85@KO)V%1V;G1&],JL0"
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M=19I2AQ3U]-#5P<Q=$G*G0.FM?@MI(NIW!V.^.)/=(R#A;,?-F91Y@:CD1U
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M.,"&%3=8HP1T(10?[,==CN,>3P?$Q?T%_5A8XTOH14OUTJ!?\F&1'V=58>#
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MJEL=40B*=HV[4R(;C^:QQ0HDYO+TIZQ2I6_150F_CZ38K><N8*L:VIWD/**
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M2.4"+\B$FS53CQZK"#LSW;<(<.NG-XUN6*FN!9MV:S1;D^)ZG$%F>*/2+M*
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M3*J\Y=6QU&G6EF20=^E[;KZP0/#;OVL<TFRC/'I)WS 4XA@$7*9D!]-W=R&
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M]ZF!T'S#[=XR^OT7WN7])/MK@[[#J?PG_+3^%>,/L*#[]_A]M4/V;1_A5/\
MWJ8'0?,/MWC+Z_1?>Y?TD^VN#OL.I_"?\M/X5XP^PH/OW^'VU0_9M'^%4_\
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MOY!2_P!2GZL>:,K^04O]2GZL>:,K^04O]2GZL>:,K^04O]2GZL>:,K^04O\
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M/0S24\1$LL#:)PI[$,E@>4\G3F"_:47TG9K,",1UB/4S43@Q5< 5I(&()T.
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MI-(/]W&[(X1F],JVD'2UI*H4\L$52AA\IU"GDN&CE*6U*".C+<74]Q![Q@[
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MWORHHX[^.A0M_P =L9Q#+4T^6F!>9Y#6S35$%[<U)5A5)!>P<PZ).S?4 YT
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MLC_LT"_Y=_'%1!'7T+T=3=%ET2HZV9J:I3=)4OL2I)!'>I(OOB)YZ>$BM M
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MA-<+NDH[FCFCORY8SW.MR/ J2I!!(POE,:VCF0'3I64QWD3:UQOHUVZ$I;P
MQ2TD5''RX@=R7=V-WD<^D[D[EB>I_P#<N[BW<N['N ]>.;']VO\ 2&%EC<V5
MU8CJ 1?[2+!9!$2!(8Q*$[^63I#V\+[?/CN)[AU/AW;_ (\&:)=S(@^=A@]D
M!FV#7 )Z&W6Q]5\+)&Y94=6*6U!3?3<7%_"XW^;![(U-LM]-SL+];?/;'-C^
M,7^D,*Z/Z#*WS&_\!,=(!;8&]B=KVZV_+@2QE@@=2QN0MQ>PZ[>K !)L!<GN
MQS(_NU_*,<Z*^GF)<]!J&'(2VLA=0U+JVN+D7'JN"/Q8YL7QB_E&#-$+7D07
M*J.T-V8Z5 ]9)  \?J6V)[AU/</G./*8/C%L38-?LD^INF 02P!!*,4:QOI=
M?24^L=_\.9O7OEU(:A$#Z64:2;7NRKUL?NK].['^F,WR4?U@^BQDF9/FE-+.
MZ"/1.8@H.K81QO>^E?N[6]6$/:7^</[<1JJ\09T% 4"52 !87*1L=NFY))]9
MQGR"&7)JR \NIGDGAE5.SSDA,/+>2VQVD9-5KD1A;XJ*F.E>*.<Z7G=8HAU#
MNW<C=#I^%OV1UP:N 5*4NN\KIK2P.AAOZ+VT-T/HD],.ZHZQ'>5EU"(;R:3T
M8K\$'X.JU[&V(YXY2ZJ2'B.F2-@5=&ZV93N-MQ?J/J321T]/)53N(X(RBEC\
M*21@D<2#X4DC$*JCO.]A<X:6<0O.M,72-3(\8<>4<M=V81VTMI7M%5D+6%E#
M-88I9XZR*.6G.M9?1MUO>Q%O$'8X:I0U$E-!::2 Z9V!M#$_Q9DWO(/A*JD+
MT)U7&#4<JH2EJ$Y4DJZX&!U0SK_V4EA=E.SHRJP/=8J3/*E/'')*3[]*(8(U
M%Y)I/!!L+*-V9B%'2^H@&>HEIH?*I8?VNK*LCQOK:(OLAD0A>R3M=2V^WKQ%
M:90T9!1DYFN]E"6N6)[@!UOB*I%22:4!X@2HFD)BCD8;$IV78H#MJ*BYZ C<
MQ5(>::E=3%4TYM+$Q!(!L5=2-F1E(96'52#]2).9(J7L">T?N5^$?Q"YQ7U+
MKF&79Q<^19B&I8U(MR(XR%B5O#6I27M$G4X ZC 8J;@XS*G3+LRI\UA1125X
MY%6@ M',NY]0N3SE\;R][#%5)II>2EFFS%)::$$:E2G9=-74D':R1N(XS\=*
MA[L0P1T\:QQ*%50!ZS;O)[SBD57FT. R-'474[J?>)#N/G QPQM2U=N[,:D#
MU"T>WS8K *;B>*&E[*U%(D]5 @/*1VC0R$V[*-J.H+MKU.V^DX-@K.Q"H@N[
ML0JJ+VW)VW)L/$[#?#542"-WU)%*P2.5E(C9S<JNHC9F )538D D=#AV6./F
MR,%0N(U)^'(1<(@ZLUM[#NW.V'J4C>&.0.CU#E(0R$<PB-I&*FUK*JG5X$@=
M^)'6)!)(P16;0M^KOUTH.KM8$V V )..>@E2%]4<DBEHUD!7F*+:C&3L^FXU
M:;Z;B]L3U,5-+##,VF2>7E1"QL[]^EO1*J-V:^D#J=QCRN'RCR4,3+R^:+*U
MF3[I&M9QZUN,15=/,P2&59#OZ':46ZW9;J#ZB;XEFCAE$,C6E/1.K$7*Z@!>
MZ74C7Z.QWVQ(ZQND;'WUQJ6(;R:3T8J/14VV+6![L1S)*[Q"XEB(62)@5D0L
M+KJ4[BXW'B.F&D D>);R2Q[2)&"Y1NN@V^'XIZ0\,0U$50)#$=0BED@?8BTD
M3%)%W^Y<%3ZQ]H2)S(W34RZU*ZD-F6XM=3O8CN.&R8HS*,WSXZ6(!;-:DG8]
M^X'YL"IJ0H7GR;+IO??I:_SXX&DK6I,T2MFJY^1FU1#325C222M3+'#H822;
MNK,78,.S<D+90 (425*F.10Z&CJB5;<7$+$;>H[XX< \V1M;M<V;?OV<CK\P
M^IQ JC-.%7  :5#S".KZ:G,E75XV  ^88SR*-\EJIW][DI):9HJ@$(\8DDT2
M+K^YT]NS73WO41MBF63,(<DJJH7\ERJ-;,+,U5-+))(S#N54Y>D?=%K^@N,Y
M \NX?L +I/>W\Y<5],E7%3=E?**6LI9XI+6/)297GB)\-*ZD'W0]>%&IE4=6
M('Y3;$TQS#-ZFA5O_-V4GE/&#]DUP/OC3BVZQ$ PKJ:-M6JUU4XCY8[#HK0O
MV98R 0R'8[>-MQZ\4-*:<U5*MV$=;4+&U]7,37V7U?"U+OJN;]2<<]&+B.\W
M+-GY(,@!'476X8K\+3>UC?IB*1)X^;"PE3K=-_S#?Y_#$553SN$AE60D$W0Z
ME&DJ#=QV0>T-B;]3W'$DT<4@A=K2GHG5B+Z=0 O=-6VL=GUX=UC=8B??G4,L
M0WDT&]F*CT5-CI+6!L;=#B&5)GDB4VEB^NQ/V)$[.L:E:Q&I-U^Z!%KWPM7
MU2]'KM/'&LDB-=2BR&T=[]\ENPO5AN!TQ35$=6\J0DLT+LD@*E2I6^J^H#86
M-SZL-50B)IU)D@3TYXU+Q*!U8L 1H%MW]'UXB(F"&+MB0 H5W# [@@^%M[X\
MHC(D9#S(X;\V1.U''I],LX[.E/AM?2N]R,)/%(5$;:]:ZE*[J0.\,.SW^.^'
M<))R?2F N8D[3J" 1J ]$L#V0;$]0+8BGCFU:#O&Q212"&1UV*NIL58=X(_@
M[BG]ZW_G)_>1XL? _DQP?^]T_P"&/_<P83TE_G#^W O_ *09UIL#S$O?<'WN
M+NVP:,2U*U=2YGEB3EP@]F*%+EK1QC8$DW+&[$]3L,<1?8V2+U#9X$8>*&ED
M8K\Q(!Q!3P35M)++$KM3C0FUCR_2,8MX[@>%\9%435D597RV>IJLPK3,Y['U
MFHD@BC4=KWJ**-(XM]XU4V%[8\F:;.EKKI3PSTL=/5]HMVX- CFM8!BRF0.;
M!K+$MVMV?*9/DTO_ ,G_ ->)H%S/+XZ>KB:(/)'4% WOD<BJRZ;]/1=@3:XZ
MJ00#AJE:&*5K:YF@DC@IQN\KNA5;@7*1_=2$6L#;4W9.04LF7T+J^\\5/7U2
M@? E*RS(/ E20/6=\<,[Y:TAW>2NS#6QZMRZV>!+GOM%$@_%?'$'V'E+@=M,
MQE5&^$08E<H#W#4H;;O.*B!:PT327#498Q:=OKA5F5O'M*-^HMUM?&9R?M"J
MH8AS:NLY47*7?E1JZR.\IZ1FP&F_:WO:V^)8FHN&ZQ UW2.EIV]:3SA9OQ6)
M%]ML4"JE'3*OHB)+?C%_[<9N3'Q'DLB>G4Y:L=0!;=0U:H9O$JM+ %)Z"5N]
MOJ56U%,H;3+6D44(M<L)-ZOP( I1(FL'L221>.,PI6K<IJ*&. M)'RZJDW $
M4M-Z36U M>#F#0/2<1FX*@C*:L5M!!-T;3RY5)!*2Q'1(C6N-2NI!L2+C8D6
M.*J!*O+LRI9/1\BJJI#WI-10252,.\7Y13:WI7[L9'(]53^5S-J==5'%X104
MLCH$7J=WUR$WW+>H?4H?LE?O=1_X>7'#J3245>*1DCJ1657)61=:23*$._:%
MM0V'4 C<'IC*I(YC-+*I&8\QA6&0DR-)T)WW";:0@LL0'+4!548SA_WDI;'E
MU-543S=RR- (U@0GPCUR.1N+O&;7 Q6Q/69;7Y>55/*XHUCEOJY$L4\4R3*M
MO3'+**;C3KU=UC44]3-0Y7I,9KLM+.\=^Q/S% <HQV++;2 VFX^$,>7)++24
MM="]/*E1Y13:_1,W)FIR%<;$,DS!E!*E]'P@IQ4S&7B22GT]G+\KI>0C;(&J
MFD>>9&WNTFB-&%MN4-][8S"*6KIZ142-9Z.L%3'*S7.@C3)$#INH;9SW,4"D
M;W'$ !7ARX!U9TT;>M&I)G*?S2R(UO%%/<,:5\H@JK#G4\?*A?[B,-JTCU7P
MT8H\^DBB%J?.(EJZ=1T$U],T8]:2EMON9([[XI@M5F+SFS0QE:&F_E04S-S9
M+]XJ*DS,A[XN6>^V,OFDJ:C-*ID/,DKY$M)V7CBC5>5$18_6T.DG;<$=U\,D
MISFDS,*BHE,E-5)JN9>6&(E)L Q9]'4=@*;$ZB!HJ\NJ*MXHS5TU35U%8CQ?
M74\HE>9E9!VKI?2  U_2U#IBAGI:A9YJ;;FU$LLZVL5J)#JENO<68ESXEB>_
M[0S!VCH:R1"5=*:9E8=0RQL0?Q'&15,U7E=+45$AEFE$C2.0 6/-<=%  V'<
M!]3*9Z>>E]XEBE,;M'+RG5]$@W*2:2=+B^ZMVA?IBE_]9_ JO^X;'#G[UQ_?
M9_[PX.UB=KMI%^]K$Z1Z[ FW@#C/[><>%+B]XI O\EO*\Q[7KVN+>O%32&L"
M15,A:F202^3J-"/( 0#+U+A0=E/9![5KC     L + > &,Y^SN'OYE1^DGU*
M9@M1 S;@2H3_ $AC)T:GS7/:>6PF%63_ "G5?>^:?4SHX4[ZE4,#8_4S6H:E
MR7,YXM8FY<<*M'Z40F<:V)ZKKB#1JPLP:1"I!L<9>@IX*58_]VD5B.\V%V^=
MCN?&^(3Y-Q%G$, Y<(DCJ1&.Z:4))(_JUM(Q:W4]<&/R+/I(D'[7SE!54_W(
MJ-^<G?NS:V(V"FR]X IM%5F+5%@T2LE%3_RH*9FUD$=1/4--(K?"1D\+8RF9
MZI\QK3'[]4YA4\POV' BD,,,9Z[10QQQ)OZ"#;$\,DF:0UZ(D8-$M+4@,2TC
M1,QCEZ %K-RR3V@J(+D;+/\ [6OL.SD>73#;<2F6K0O_ #M,:+?P4>&$@0>7
ME44>713"L?T>Q*#S9"VP0[DZO$W.*;DQ9=54U%KGA6@JX^<QM%I,;ZCS"+OU
M)'+0IW J+8X<);*%CU:'F@KZ>*3?WIVEJ(HG%MQR^S:UK6%K8R:1*"A>&I7E
M24L53!+!;47<ZU"1#_>ARP%QV?NB #CAZ"6EHXO*$NT$555<D[V6-99XZ:^Q
M-E"Q ]3UM?&1R22TTU23S9IZZNDFE9NT9/*Y04Z'LQ6Y48%E"(H55%@!33>=
MZW,-2B"L@I@8!\"H@4H\NK;69ETWV&G0%WZ_P<\:2"SJ&'@<>24WQ*?DPD4<
M0(C0(#N;>.%L.T3Z-B%[VWZ#NO;QL,<NI7,LPKQ"&2K;4D8D&L6"*+ZM*]%N
M=SZOJ9O325B9?'  ?(LP\M9F.D/:%H@BBU[]K?5;IM?%/+(C)+H,;H^H E6W
M4[':XWZ_VX2C:@JJF2D >AJY.=Y.-I*60BS)&-@T6PT[W^ZWNS*TLLB-H,$,
M:N-+$&2=WT]M[7"+'IM&@-SJ9GZJJXJC,*7]IZ?*GD"L7)7EPC=BAT..8_H
MV.@$OU473RV/T:2#4?2=JMV=CWEF--<DXHIZI9'>HACC"D!%63F"1&6SZCI3
MQM8H/QC?%+1^;9)XX+R4,TK3Q#K+3L_IQLI]-;BX8$W-V;M,<5<;YA-1H4,5
M#0EI0'^N5-1(1=RO^[10JJ+]HB^PZFN\HY=.M%I);4U62YB>P:R11R!'*AAV
MG*@'HM[%AA#6QBR4=,H]52WY_P!K;XIS)/230U\0C\IC>&9(GUZ 3V'1["Y4
MV8'2I/W(Q1QRT42TT_OJ176.:!2>9'?LWC])'ML020#\)AVCY.]5FCYI.FCE
MPBDHH3I+PTX" EF7X4I178!B ;=X)(W.YMZ\5)J'JH)4AU4])3RK%'K42M/,
M;RR&]D&I4CC4%C;3JOO;$,G*99N]"K:.I:Y 90?1V!)[1L;'%'25%!45IAA'
MD=34/+% LG:A4N0GI6!/*T!]S<I<7))+L5AJ%0:WJ*&MI@+Z0CU-/-3 N3W
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MGB11'E:V.IK-*3+52$J+$ ?M@ 7(]'IB-F9;LAC._9)!.QL#=21N-QOW[[X
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MV@. "UU0%MP"KFMZ_622>9QMG^957_/]8,47\PJ_\72_[57C_P#R53ZJ3_\
M)C[H?,;4_N9?]O&S/YEM#UT)^;^4_P <;7\U2?\ :%'_ +N(?Z,I_P#%U?\
MMTN*Q-Q4)4CS<^6*;PD'F9?G\VW@4/Q=4/E4T->XTHX3F!X2[0>\43C2V58<
M\S=)<MM/<;NMZC]F*>(3[$HD;N30U*_2J)2"/'4$?,<;*5ZH&CE-@]Z>O_NZ
M9UDE?_.D8=>HD"<6QMB3>F)[6!JXLH]%1<*OS+88IOZ/'^*;_;&*[^>TG]Q4
M?M18F\U0_P"!A_:DQ]S_ )^/Y57_ /EQM'O4?^(/^S)B/^CZ3^\J/VEQL?\
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MQ50-2U$M.QN8G*W'.W _./RL 3H 2? 7PT,J+G9&52; L+:_/A$:1@B LQX
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M#&WZU$JMG[OMFBE6>4#7XVJ^)"$Z=1C;Q2JH*2I@821B5KLNME918GIK<&_
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M* 3900+FW#4Z7XZVX'$L4D+Y)%RM93;P87'ZL32;J&66U]W&[VZY5)Q%'_\
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M/PZXD4_$A3+3K,PXK3M/&M0UQPRPES?E;$L8>JV-+%E6&CJ:1I$%@L<<)U9
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MH^=3Y'[_ ,JLC%"X[J$7/RN'X9O8VXV-O7RQ0)%/LRI>3M54419QPDCEWF4
M+S0@C6QTU!O?$N^";$%/GW\E-19D6]G!\]O1PMEN6=N[;-?3&U)4DJ%"6.ZA
MAA9AP9XT"LU^=R-<->26"E5MV:AK-+:YCB47D=1S<+?*.N*ZFEFIVIJ:+)"D
M314\99= ;]IV)UDD/;D<ZEB2<+ILV6DXS2&BRCE[SO ]VX#OBU^.-H1M"*JG
M>V]BSQLJ]KM*Q32W'M V//$:G[UE+=M8:6Z\^RJAO9SQ:W$6.*5%FJ6FDUI=
MG9)I!RFK#K2P?I96!F<:@!!FXC#NTCL[&[.2Q/B?Q"'*ZMT8'V'#MG=F'!F)
M]IO\-V=W9/6/L^%;1\ZGR/W_ )5N/)YA?4M%8=;$W^W\01Q9='MWAH?;AICN
M*-58AUI(DGMH3*!V[GGK[G,-S' \Q?CKBJ,AIY@A;,8VRV)O>VEL)-%]ZYT+
MC?\ \AR@]_L[W>V/@<N;7I@ZNTAN9'[SW[3:DZGB=23ZR<9F](^TXGEDRL]F
MEE-@HXLSMHMR3UXDD #4FV)%2F@AH8W63=7EJ94OEGK)0#-(MP"432*+, QC
M0%@"2/Q*+F95](@>TX=<CLG'*2M^MM/ANSN[)ZQ]GPK:/G4^1^_\JLC%"X[J
M$ _YN'V?"D;*RMZ)!]F';.S/:V8EK=+Z_#=G=V3UC[/PU='+A6!,;%''-7'%
M6'(Z_ ]H^=3Y'[_RK$C2PS1IJY,9 \%)O]N&H:E028]!TU/L&N$I9Y#81L/E
M*5'M(P]%4(,QC)'Z/:/L&$I9Y"0(V%A?M J/U\_##T=0@S&,D7MV>T?8,)2S
MR&PB86](%1[3;#T=0@N8R1^CVC[!A*6>0V$;"WI K^LC#T=2@N8R1^CVC[!?
MVX2EGDO:-A;T@5^VV'HZA!F,9(O;L]H^P:VTXX2DJ)+VC(MZ0*_;QP]'41BY
MC)Y=GM'V#$=)427M&1;T@5^W#T=1&+F,GY/:^S"4E1)J(V'RNS]N'HZB,7,9
M_P O:/ZKX2DJ)-1&PMZ79^VV'HZB,7,9/R>T?U7PE'42"XC(^5=?MQ)25$=K
MQL;^B"WV82CJ)!<1D:V[79/L.'I9X[7C8W]$%OL&$HZB07$9'+M=D_KQ)23Q
MVO&QOZ(+?8,14<\ECD*K>Q+=G3F=;89<K,M[Y21?K;G\-V=W9/6/L_"JZGR2
MJHZ*,9ZZID7*IT2 V$G;N-71=77A\6U]0!/&=LU43HIAVH(IE9;K-/+&6!7F
MJ!8CFUN+BW&XH*P5L&]RY'5WBE2]\DB<0#S!!5E/1A?6^ "38"YZ##542EA<
MN4[PCLY7UV.(:RGG8QH_O@%]VPRO;J >(ZVO;G[M54Q4<0EG.5&.EK%N0OEO
M>USQMUP 3H!?#542EAJY2^;=V?+;K8Z8AK*>9MVC^^#7(W9:W4 \1ZKVYXMQ
M/(<3R'K/+!K806MF?+WC&,X7Y5CI\^(:B&H4M"X>VC#FIZ,IU'S_ (6T?.I\
MC]_Y5V?YUOD_"I?-R?(;]D_#MG=V3UC[/PML1&:O&T8N^9!4)E/;@E869.I%
M] >##!FJ$\M RD5D^_J(I%[!G RAKBSHR FUB!VCF##3&RI*>2EM3Q[G=RR1
MS1$YF2HN'DS.>^6SJX;T6466V47]ZJ$!*O)"41AR.921X!@+$\L;#I9J>NGE
MER1K.\!RLP(W<(D$LL@.@5D-B#Q"=2,.-YM*E%.#=*K>77XE."<^<^BR=D ]
MXGW&[44D7*3+<_&&5LPRGEKQZC'W31+3^41(7*JE-8NV9NTD3&YTYDXO[S4(
M"5>6(HC#D<RDCJ P!4D=>F-BTLU+4UE3498X)6A.4D65(D=9&;E>7-HO>-N&
M'!EVC1^3 W2K,C6^)2Y9,P8\KW30\;8VS,T$,,"DA=QY5)^F6!*7Z@*+6./N
M9A40;-C<!O+&C6J:PO)Y8^65VZE1*3'?N94 T48<M2;0IY8],U0*6<?%>*1L
MEV'-HS9U/46X7'X6T?.I\C]_Y5V?YUOD_"I?-R?(?]DX/PW9W=D]8^S\%;!E
M+"ZA@6'5;ZCYQC:"SQ[7HJH%A3"OCDDE2Y1:6QS(RKKJ2HME)OKB&>GA?;[U
M#*8YZNH-.EL[2LT:"-XARRO8YQ;F!<9K;'IY88)I)ER-55+U C^,B%(XT#_I
M$1YST#!3JNAT1Y#HD=L[<EOP^<\@-?8<(]-M'(^\+QQ_R9@ETME-R'4@'.,U
MQFX@@Z@WQ6NVQII7B8F*GF"RQ\I8BX3_ %.T#?KC:+214\)@)#R;S,X%\A6V
M12/&]]>.-G53U5 M7* N7LS$=T,',=_\Q'  X^Z(BMDJ33'>!E@"GAFW21J;
M7ZY3:]L0U5/)!45"G/Y-N\\5BK9Y=$5O#F<I/@<23R3,3->1;FT5V2,=-(RK
M$CJ6Q)M!J2$O#30+VHUL%87SR*FI#7)LU[F^O'&TH#5PQ.G:DCC,,B?&*?%*
M^E93:W&]].%_N>JEIH:4U1W<FS2"ZMIO6IFSP[OTEF*H#S0%LPT&:*%Z^MB9
M;^3T\WE$LG)W4YHXDY-=K%^00'6]OPMH^=3Y'[_RKL_SK?)^%2^;D^0_[)P?
MANSN[)ZQ]GX2V#(6%P&4D=0""1\XQ3TQ2IKYG5;5%8TT' E8RJ@#]'4'3W'"
MRT\U.]P)3&X8?%DBSY;\RI$C VYVQ0Q3;-:<F+R@R3F<900.ZBHAY67+<GG<
MC!H)ZZ?>UEEBWN^>/B\SW#*&MHD=^([QMER@',*F29(LE+&'J)P\8D?S=*I%
MFE;35LI.4#7ESQ2TL=+31TR]I46Q)'?:]V8CQ:YMRQNX_03Z(_AC(@!&5;'B
M,HL?7UQNX_03Z(_AC=Q^@GT1_#W&AB<W=%8^.N  HL  .@%A^%M'SJ?(_?\
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MZQ]GPK:/G4^1^_\ *NS_ #K?)^%2^;D^0_[)P?ANSN[)ZQ]GPK:/G4^1^_\
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M(T4$V-Z6TCSM5IHDF[IHV[4;(%5M^Z ]O,Q*+&]@,I8JP9;.ROJ9F:P[*Y+
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M-Y&II 5RR0SH,P8=+'4<P;6P:IJR&!:I<E93PI3F46$,\<0"1-IW"J +EL-
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M?-Z*?0&-\WHI] 8WS>BGT!C?-Z*?0&-\WHI] 8WS>BGT!C?-Z*?0&-\WHI]
M8WS>BGT!C?-Z*?0&-\WHI] 8WS>BGT!C?-Z*?0&-\WHI] 8WS>BGT!C?-Z*?
M0&-\WHI] 8WS>BGT!C?-Z*?0&-\WHI] 8WS>BGT!C?-Z*?0&-\WHI] 8WS>B
MGT!C?-Z*?0&-\WHI] 8WS>BGT!C?-Z*?0&-\WHI] 8WS>BGT!C?-Z*?0&-\W
MHI] 8WS>BGT!C?-Z*?0&-\WHI] 8WS>BGT!C?-Z*?0&,V>,DA00PX"W(_P /
MQ/\ _\0 9Q   0," P,$"@H." ,$" 0' @$#! 41 !(A!A,Q%")!414C,C,U
M0$)AE=('$%)Q<H&3LM'3("0P-#9B<W1U=I&AL[064V""E):QU$-0DD2#HL$7
M)28W8W" X66UP\3P162%AJ/"_]H " $!  8_ O\ ZJ=51/?6WW"Z*B^\M_:M
MF&_5=+_LQ:Z7ZKZ_L^Z:*B^\OW'543WUM]C:Z7ZKZ_L^RU5$OUK;Q#54QIKX
MAHJ+\?\ RUYN(^D:20*C+Y-HZ+9]!*VMD)/-B117:C3I2M"TX#PT\!0P>&XW
M%5T7KPU+KM4CSBEQF70:CPQC"PK@H:\Y%57-%MK@Q;/=F0D@.94+(2IH65=%
MLNMEXX;IW9N'-:?C)):=[&1VR05(ARF-E2Z*G1B+M#!VCAN27Z>,_D+M*CB)
M<S.K0N#K>W!5Z<+1J[&CMR7FGTAS8PJ"<I;:,Q;?9)33G*.A"MK\W+@JM,KL
M:FQ''#&(*4J,XZ^ +97=41$"^@]?'#>S79>,('5SIG*>QL92L#Q-;S):U^;>
MU\0)S5;C5*FO38\:6O8N.T['WSH@A%9%3(5\N;R5MALEXJ JOOJF(\6"R$BK
MSA(V4=ON8[*+EW[B)92YV@!=+JFJVQ&JD[;.1&G2V DA%C08A0FMX.<&R$AN
M5KIFMB-LAM"D+=!%ENK)C,*'9 1;SL/IF(D;M:Q"W9,U_>Q2SV=Y3(A- 0O1
MHDA&#&0IW%XT4V\PY=$6_-ZL4N+7'M]4V8Z#(-2SE?R1(_+(1LBET_95*)L^
MZ352< =UD/=F8(:*ZT#GD$XWF%%ZUQ5/Z1\H9BO*UR2'*?1YT714MZ\EC<0
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M28.4Z);F; A.QE6^7*VWNW 1?Q7$553\:_3BG259E3(LV%',@.KU,VE56QS
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M=<+)H^T-<C*:AOVL\16I @M\CH+&U3HNEBUT7#:U.NU5N,P6>/#CC"%EDE!
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M7B84G6E:7>"B*O-7HUX^*'-?:E/--VS##CG*>UZ4:;YRHGE+T)KCD_**AO\
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M/OWV ?MVIML5N8-]?%!P,)M*L4LW=P,?L>6]5Z^7=Y%<OGOI;$1RJ1JH+<U
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MIAVJ51[=L-\T!35Q]U>Y::'RC+]R:KIB54*'1Z=#I;+A-,/520^KLIP.(B+
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M"4ZKG!K$0A!]MP(_)3<CD5EX&>5P;6XVOB'46+HU-CM2 1>*"Z*%9?.E[?\
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MHI-(^2CG0="RZ+PP+85^GD9D@ *.+<B);"B<WBJ^TXP]7H#;K)DVZV3BH0.
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M_P"I[ZW -@E@;% %.H12R)^S"H"613,U^$X2F2_&2JN*B;[S;(\BDZN&(?\
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MAF*VLN5!&VB*O.P+,9EMAH$L+;0"V IYA%$3[ISB%/?5$^Q+ED$(54'G1*S
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M4JA%9O8!GAJJD(<7'-"MWTC5$P#E%J\9UXAN4%TT8FMKTB4=Q4.X].7-[5U
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M3%H<NJ!OG'?= /#&[ES)E(>14%6JG"?CJ)+QO<=,J\<9X&TM&D)>VDYALK_
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M;+,HHA)*:W)JX+33JJ@W7FY71UZ[XB'4FIC@S"<%ODC.^5%;057.B*ENZTP
M#%K%S(02\%42Y+9+JI:<<"2<"%"_:E\2Z=(C557X3[D=U6H:FVIMK9<A9N</
M4N$ID!BH@^K+CV:3%5IO*WEOSE7CSDLF)E4DBX3$)DGW1:'.XH#:^0?*77AC
M[UK/^ +UL!5((/A'-QQM!DM[IV[2V*X:V3JQ%8J3,YPI;1.MK$8WR((ED5"L
MNBWQ'B-1JNCDEYMD,\)1',X2"F9<VB775?:D1G(U75R,^]'<R0E(<[#A-'E)
M"U3,*V7$N/36IK9PFFG7>5L;E,KQ&(9;KKJV5\.56<#[D=MQMLAC-[UV[I91
ML&FE^/5C[UK/^ +UL0ZG&%P6)K(OM"Z.5Q /AG'6R^;!4N>Q43?%IM[-&BJZ
MWE=2X\Y%X]:8B4N)'J@R)CF[;)^(K;2+:_.-2T3#T@T508:-TD'4E$!4ELG7
MIIC[UK/^ +UL2SIK4QM(9-B[RMG<JJN(JIDU6_#7#<^H-R7&7'D81(K6]/,2
M*J7&Z::8^]:S_@"];$:8TA(W*8:D-H:6- =!#%"3H*RZIUXE4F;'J9R8JMHX
M4>*KK2[QH'1RFBZ\TTOY\-TN"Q4@D. XXA28JM-6;2ZW)5X]6)M2D(9,08ST
MIT6AS.*VR"F2 /E%9-$Z5Q]ZUG_ %ZV"J-/;D-L"^;%I3>Z<S!:_-NNFN(O9
M)J8YRS/N^2,;ZV3CFLJ6\V ;&+6,QD()>"J)<ELEUS:>U*@OQJLKT1]R.XK<
M)2!3;)17*6;4;IHN)$2FLSFW(S"/N++C[D<BF@(@JJZK?#]6F@\<>.K:&,<-
MX[VPT;3*'3J27\V/O6L_X O6PS5H0/A'?5Q &0WNW>U&K:W#HU%;>;7$:)4F
M9SCDIA7VUB1]\.035M4*RZ+?$:"S&JR.RWVV&U<A*((;A(*9BS:)==5]HVRB
MUC,V9 5H*JEQ516RYM4NF):4UJ8WR/)O.5L;F^\O;+=5OPUPM0['S:DN\!H8
MT!K>O*1\%RIKD3RELML,%4&G=E-FV'FY*--DHU"4K1(;=R[I.A> @/XRX$+D
M644',2W(K):Y+TJO3XAG%IL3]T@"A?M1+X421"%=%14NB^^BX^]F/DF_5QE;
M 03J 4%/V)CMC3;EN&<!*W[4Q][L?)!]&"DS9#,6.%L[SYBVV-]$N161+KA!
M&K4,W'"1$1)$0B,R6R(FMU(E7XUP<N2<6"P-D.0YNV&TS+S4(]$U7AK@6>S=
M(>)PA &N5QSSF2V 4',MR4E1$3KPLF=R&)'1117GT9:;126PHIDB)<ET3KPW
M'CUNDJ9D@---2V+D1+9! !+BJ\$3'*JDY#CM7$-_+W0#F7N1SN=*]"7PVW'J
ME%)\S$6A:D15<)Q5L*!E6^95X6UQOZA*CQ(ZDC>]DN"TWG*]@S&J)<D1=.FV
M&XT6HT61(>+*TRR[%-QPK*M@ ;JJV15TZ$QRB6]$I[)$@;UTFXX*2]R.9<J7
M7H3#<1FK4J8^Z5FHX26'C,D15YC=U55RHJZ)P1<(_4#I\)DCW8NR=RT"FJ*J
M"A'9,UD73S8;B0JQ37WCYK3$>4R9E9.  !7T3J3"2:H[!B@X:-H]+5EM#<RJ
MJ!G<XEE%5M?@*]6&V(%1I+TH[[MJ,]')XK(JEE$%S+8455MT80ZE+C1&75W:
M%*<!MLR5%7)=Q415RHNG5@(L.?1Y4ES-NV&'8SCIY14RR@-U6PHI+YDP'+9<
M*FB\JY-^XU'1Q4XY;Y<RI@(T:ITN=(+,K;+;[#[BV2Y901271-5MAM:D]38.
M]ONN5*PSO,O=9,]KVNE[8&-!J]/ER"15%F/*:=<5![I4 "5;(G' =DY%-AD_
MF5OE9,-*[EMG4=Y;-;,E_?3&XIE0I<B2HDN[B/,&ZH#J2V;7-E3IP#=4G08F
M^2X!,>:;WB"NJHCB\ZRXY/ F4F8_E4]U'.,ZYE'B64+K9.E<1X)R(L:1*S+&
MBJ;;3C]NZW3>BGY\J8NXTVXJ<%,!*W[4Q=(["*G!=T'T>U][L?)!ZN%W;3;=
M^.0!&_[$QE< 33C8Q0D_8N/O9CY)OU<((H@BG!$2R)[R)C,;+1EUDV)+^U4P
MA"PR))P46P14]Y43%EU1>*8^]F/D@]7%FP!M%XY!0?\ 3";QL'+<,XH5O>NF
M/O9CY)OU<61+(G!$X84B89(EXJ38*J_&J8S RT!>Z%L17]J)A1)$)%XHJ71?
M?3'WLQ\DWZN,K8""=0B@I^Q,)O&FW+<,X"5O>NBX^]V/D@]7VD4V&>>:#=6@
M[HEZ=.O%VVFP7A< $5M\28RF(F/42(2?L7'WLQ\DWZN$$!013@(I9$]Y$QF<
M9:->L@$E_:J8ND=E%3@J-!=/W>U][L?)!ZN%W;8-WXY $;^_9,6< 33C8Q0D
MOUV7'WLQ\DWZN$041$3@B:(GQ8S&RT1+Q(FP55^-4PA PR))P46P14^-$Q94
MNB\47@N/O9CY)OU<6;  3C8!04OUZ83>-@Y;AG$2M[UTQ][,?)!ZOM*JL,JJ
MZJJM JJOG6V,P,M 76+8BO[43"B2(0KQ0DNB^^BX^]F/DF_5QE 1 >H404_8
MF+N--N*FB*8"5OVIBZ1V+_D@^CVOO=CY(/HPJMM-MJO'( C?]B8RF(F/42(2
M?L7'WLQ\DWZN$$4013@@I9$]Y$QF-EHRZR;$E_:J80A89$DX*C8(J>\J)BRZ
MHO1C[V8^2#U<+NVP;OQR"(W]^R8LX &G48H2?OQ][,?)-^KBR)9$T1$X)A2-
MAHB7B1-@JK[ZJF,P,M 76+8BO[43"B2(2+HJ*ET5/.F/O9CY)OU<6; 03C8!
M04_8F$WC;;EN&<!*W[4Q][,?)!ZOM76.RJKQ56@NO[L7;:;!>%P 16WQ)C*8
MB8]1(A)^Q<?>S'R3?JXR@(@/4*(*?L3%W&FS5-+F DMOC3%TCLHJ<%1H+I^[
MVOO9CY(/5PN[;;;OQR (W_8F-=?%R5.@27]B8KS6U,>-*C-5EZ#R5L2;8-J,
MO,4Q0]5OJNMO-AI]G9R"V\RX#K3@[Q"!QLD,#%<_$21%3SX<IE692;!>4%<C
M.D6[/=KF#-94O94OAF2QL[!:?CNMOLNCO$)MUDT<;,5S]T!BA)YTP=,K#"3X
M+A-F<9Y25LB:)#;5414[DQ0D\Z89EQ=GH3,B,X#S#P;Q#;<;7,!BN?BBIA:=
M68XSX1. Z4=Y25M7&[J!*B*G<JMT\^&)D39Z$Q)C. \P\&\0VW 6XF*Y^*+C
ML=6HPU"%O0>Y.^I*WO6\V0E1"34<RVQ'J5-H42).B&KD>2UO$<:-0)M5%<_2
M!D*^95QV/K48:A#W@/<G?4E;WC?<$J(27R]&(]3IE"B0Y\0E./)9WB.-$0$V
M2BN?I R%?,JX&#7(H5&(+HOBP^IJ&]%%03LA)JB$ML,U*E42+"G1U569#.\1
MP%5++;G]*+AN%78@5&*T^DEMF0I* OB#C8N60DYR ZX/O$N&:G2:)%@SH^;=
M26=XC@9Q4"MS^D25%PW#KD0*C&:=WX,OJ:@+J"HH=D)-<I*GQX9J=)HD6#/C
M[S<R6=XC@;ULFG+<_P ILR%??PP%>@-5((JD3 R%-4;(M"5$0DU5,-U*CT6-
M G-"8A(8W@F(N)E,>[70DXXCI7J>U4TB*:QTD*:HTKELZBB$FI94P-2HU&C4
M^: &V,AC>": YH8]VNA62^(Q5^G,U-8:.I&Y1G7<H]DWN6Q)W>["_P %,)4:
M+1XU/FHV;22&,Z'NW$L8ZFNA8CG7J<S4RBB0QUD*:[H36Y9;$G%>..R%$I$:
MGS-V;._8SH>[.V8-371;)^S'L53,I%(':AJ/O><JC'4V34.I!4^/7P\94TXB
MXT2?$XF&W$\L47Z?[)$/6BI^U,52 %0*H),J;U05PHZ1\BO:JWE1UW,B=!73
MWO&J8Q5)$9F147^2TL9 HI/RUR6;8516SO"VHK^SQD_A-_/3!-+Q:+3X)</W
MW_LD:IQ027]B8K4VL+'5Z)6I,%KD[.Y'<LZ#F&Y7/K7]WC7L6* $2!M<R1J(
MJ60>T\XK=RGG73QD_A-_/3 (O<N]K7WU[G]_]DB'K14_:F*G CS7IHS*D]/(
MW@ " WM2!,EDRIT=/G^X3&Z1.295HDJ"R\$2'(J#49'9C#;P2'& )AIU62/(
MV;J'G4;"O#"P8D]$J(-BXY3I;3T&<@+Y?)98-.D''G@)!Y_$:9'JDEAB15'U
MB4L7@4B?EKDLTRN0LKBW2VH^_P",G\)OYZ80DXHJ+^S#3ONQ1?CZ?W_V1-4X
MH)*GQ)BM3:P48GXE:DP6N3,JP.X9T',*N.7/K*Z)YD^SVE?I&?LBU2)IQ-VE
MW$<1DM03I-$NHIUIAS9:HB]%K796)*<D[E7!FBE5CRW7WGDN6]%L3S(=R54T
MQ3=NMF]MX#\:",,WZ:UG"H(,0316 $B#[7?S]LNVNF;C=%'VG4V2DO0:33JD
MU!J5<BO$R[(J"W7D4%P=2;8M]M."MLW:TOSK4Z=5)LFH3')4Y#DRW3>>) ?4
M113-56PIHB=&'*3['50.,Q2Z7#>J+:.06@WTPWMTMY;#JJ2BTN@VTXX\,E_B
MZ+_LL,UBL#RFKA$CQD8(QO(J9MZH1!S<J$A$:CI9-,5+:C:;:&K1XYS'8E-I
MU'E'3(T<6N[.\?*Z\J&N5-ZX:<V]DO;$C8S:6HN5O9YR5'&+-F(/+XD:=;<.
M$\"#O@;-5!S>(I\U2SKPPA#JA(BHO6BZI]G[%>42++M>R1615RCVG4K<$\Z^
M,G\)OYZ>T;"\6RS#\$OH7^R)#UHJ?MQ4X$6:_-"9479Y'(!L" WNZ =WIE3H
MOK]G5=H#AE4$@LBO)1TWJNF+2(:V7*W<[F5EL-\3=M6MFNP%3[+Q8;PQ'RW!
MD]48T=YQM+"/.!TO)2Q8V&<V1G3'5J]1C(W%,\[[:"^T,D#4=7(SC!.9\Z<U
M$5>C"8C[&P*K$IM3J3>]J$]^0TSV*I7!UT-X27EOHN[BCT*JNKS0UIM%H,ZG
MO!%JL/*S&E,OO%9'%<?<R&1F9DJFZX6JDMU7%+I_+HO+N5U!>1[]OE-M^I7W
M.;><->'#&U=2CU:/1(%6* $>0U'";4#;A1E;')OEW# (;AK8FW%5>K$:%6ZE
M'VHH<P4D,N/1&HLHX^?*XB%'0&Q>;UTW=BT[G%&VBI0F["&3&J+J#JH1Y#*C
MG*W0V1(BKP3", 2;R-59XO#THKCN]"_O@286G4P5?E$U1J<@-<Y>4J3CB\/<
M \)$ODHBJO#$1@US&S&8:)>LFVQ%5_:GV=+C5*2+#]7D<AIHD"DK\LE"S0JB
M+E+G)QM^[QD_A-_/3VF[]RYVLO[W#_Q6_LB:IQ027]V*[*K,M9;\>O3(K)J#
M;>1AON LV(IIUKKY_LWH<QEN1%D-DT^PZ*&VXV26(2%=%1<36MFJI5*93G*E
M3GEHS2,28:.O52+F<91UDGVLA+O<J.*%QU3+? 5V=(EUNN"SN6JC4S RC-+Q
M"&PV#;$9%\I6PSEY1+[3M<K 3RG/-M,DK$LF0R,CE!$%!ZN.&:M10G#**I1X
MR\HED\&[<0\W-5..G'%.VV!)/9W/4F157UY*J(1-"BLVMU:WOBMT;;>HI#I0
M-SGFF:@,>)&$ <^U2@OD+>]%0R_\1SSVQ2:#L>R=7[',K%>EQ15R*#SSN9PC
MD(F[%MD>Z)2\R77%,V8F W,8C4QJ#);=%#;>1&\KB*BZ**ZXG2-CZ[4]G&:B
MN:5 :"/,AY^".,MRA7<D*:(HKPLBW1$M(KZ\HJ^T$HS=?K%3(79&\<[LFA1$
M;9OPYB:)HED^X>Q<K++KJ,[6M..JVV9HTVFYN;BBBY 3I(K)Y_&3^$W\]/:O
MU8:=]T*7^$FB_O\ [($/6BI^W%2@1);TP)E1=GD;X !"X]W0)D54R]7W"RHB
MIY]?L$:G1(\QH2SHW(:!X$+AF0314OY\(Q#CLQ6$521IAL6FT4N*Y01$NO3A
M$G0(DRW#E$=IZWO9Q6V+0846(B\>3L-LW]_(*7^YTF+4I&Y?K,GD%-'=F>^E
MDH6;N**@=TFI63QD_A-_/3VW6%\E<X^\O']_]D#5.*"2_NQ7959F'-?CU^9%
M:,T%%!AON6TRHFB>->Q>3$=YX8^UC3KY--&X++2;F[CJBBHV">Z.R>?QD_A-
M_/3VVB\DER%[Q:?N6R_V04>M%3]N'*2:S:Q0*G3W*MR..3<9WELN2X*.O$ZK
MP.& MD.9L6145#M>9%(H)[*!4Z RRT^,QMV1&>Y2X9-JR:9&N;NQ1Q%Z\_FQ
M,=VJ2J5^.ZP 166GXS.X=0U4W%4FUS9AL/FQ#<V5&IT!AIEP);3LB.]OW5-%
M;-,C5ARC=%Z[XF.[5#5*^PZP(166GXS.X=WB$3BYVUO<$4?CQ%>V52IT&*W&
MW<EAV1'>WS^],MZF1JR=K40_NXFGM6W4Z^T\TT,1MF1'9Y.8D2N$N=KG9TRH
MG5;$5[97LG08K<=6Y##LB.\KS^=51U%!JR6#FXJ!;6-U.OMOA'2$#,B,SR8P
M)Y7R+.USMZA-(G5D7KQRG9MVI42F[AH.1N/1W2WPJ6\<S"U:Q(HZ>;$[^E;-
M4KZ/(UR1&I$9GDZBI;Q5SMK?.BI^S!RMG'JC1:8K+(A"<>CND+HIVT\PM6YZ
MZVQ-_I4Q5*^KVZY)NI$9GD^6^\OG;6^>Z?LP_*V>D5&CTLP91F"X['=-LA:$
M724A:LN\<S%\>)Z;5QZI7U>5A82M2(S/)D#>[Y%SMKFWF9NW5DP_*V?DU&D4
MPQ;1F"X\PX39"-C7,+5N<NN)H[5Q:I7W7G6RB.-28S2,-B*H8*AM:YBUNF)4
MN@2JA2:6YN^3P7'6'"9L"(=R%JRYCN7QXEM[51*I7GW7A*,ZU)C,HRT@(BMJ
MAM:JI7*^)LNAS*A2J4\32Q(!N,.''$6&@<131NRYWA<<TX(=L''VFIU6KE06
M2XXDQN5%:%&%$$!K(35^:J$M_P ;$V51)M1I=+>-%BP7'6'28'(*$*DC=EN:
M$6G7@HVTU.JU<J*RG74F-RHK0I'(&D;9R$VJ\PA,K_CXG2J+.J%-ICSRG$@N
M.L.%';LG,4D:LNM^&$C;2TRK5JI;]XRFMRXK8JT2]J;0":NF1-//B?*HT^H4
MZEOO9X<%QQAPHS6[!-VIHU9>>AE_>MBIA5.4/U2BO#OISYMF+X3B>)@&P%L5
M;W#;2"JJO.77QD_A-_/3[!ISIRV+X0Z+]/\ 9"F?JY&_FY?C6VWY2D?,F>,G
M\)OYZ?8.QU_*#_HO_E_9"F?JY&_FY?C6VWY2D?,F>,G\)OYZ?8-'T9LI?!+3
M_P"_]D*9^KD;^;E^-;;?E*1\R9XR?PF_GI]BT?E(F0OA#I^_C_8^F?JY&_FY
M?C6VWY2D?,F>,G\)OYZ?8NQUZ>>/OIH7]CZ9^KD;^;E^-;;?E*1\R9XR?PF_
MGI]BTYT(2(7P5T7^Q],_5R-_-R_&MMORE(^9,\9/X3?ST^R;7R@[67OC_P#:
MW]CJ9^KD;^;E^-;;?E*1\R9XR?PF_GI]DXPO TS#\(>/[4_T_L=3/U<C?S<O
MQK;;\I2/F3/&3^$W\]/LFG?<DE_@]/[L(J<%2_\ 8VF?JY&_FY?C6VWY2D?,
MF>,G\)OYZ?9A[IOM9?%P_=;^QM,_5R-_-R_&MMORE(^9,\9/X3?ST^S-E>#H
MW3X0_P#VO_8VF?JY&_FY?C6VWY2D?,F>,G\)OYZ?9MNIY!(OT_NP))P)$5/C
M\41",15>"$2(J^]?%R)!3K)41/WX[\U\H/TXN1(*=9*B)^_%D=;55X(ABJ_Z
MXN1"*=9*B)^_%D=;55X(ABJ_ZXN9"*=9*B)^_%D=;55X(ABJ_P"N+F0BG62H
MG^N+"ZVJKP1#%5_9?%S(13\943_7%A=;)>I#%5_8BXYYB-^&8D'_ %Q876R7
MJ0Q5?V(N.>8A?AF)!_UQ87&R7J0Q5?V(N.>8#?AF)!_UQ87&R7J$Q5?V(N.>
M8#\(D'_7%A< EZA,57]RXYY@-_=$@_ZXL+@$O4)BJ_N7'/,!^$2#_JN+ X!+
M^*2+_HN.>8#\(D3_ %7',,"^"2+_ *+X]3/U<C?S<OQK;;\I2/F3/&3^$W\]
M/N BO=,KNU][R?W?Z>*>QY&?Y9R *15)+I1W'FFN4Q7]_%1TV[!W870#[I$5
M.%\.4>K.2BAN.M/$C$EV.YG:55"SK1":<>A=<1*A&[,<HAR&I+.\K-0=#>LF
MAAF;-]0-,R)S2147"TFKK(=ADZT\H-R'62SLK<.>V0EHOGUZ<0JS3TJ;<VGN
MJ]'4ZI-<:0U;-I<S)NJV:9'"T(5LNJ:HBX[%UA9#L-76WE!J0ZP6=I;@N=LA
M+1>B^O3B%6:>E3;FP'=]'4ZI-=:0\I!SF3=5LTL2]T/G37 TJLN3"B!);E(D
M:6]%<WK0N"/;62$[6<*Z7LO3B)6*:M6&9"-395^K3I#=U%17,T\\8%HJ\4PW
M2ZRY,**W)"6*1I;\5S>M@X ]L9(3M9TN;>R].(E:IBU89L)7"85^K3I#7;67
M&#S-//$!=K=*UTT75-4PW3:RY,*,T^,@4C2WXI[P45$[8R0G;7A?7IQ%K5,6
MJC-A[S<J_5ILEOMK1LG=IYXP7F&MM-.C$5JM\J>"&1FQNI;\?*3B9255:,57
M1.G#-9I:5()K N"VKM3F/M(CB92[4ZZ07MP6UTZ,1 KG*GAA*Z4?=2WX^57L
MB&JJT8YM&QX\,,UJE=D6YK .MMJ]4IC[2"\"MGVIUT@OE71;73$+LX4\^0;W
MD_)9\F(J;[+GS*PX"EW":+PP%8I"U09C;3K(K(JDR4WD>'*?:WW3"]N"VNF(
M95PIY+!1P6.2SY,31U44LVX<!3X>5CLM2%J8R]PY'O)J<R4&[=RYNUONF-^:
MG.M?]N(CM<26\<%MYN.K,R1'RB^0$Y?<F.:ZMAQO:VG%<+5J/V1;EJP<;M]1
MER6]VXHJ5FWG"%%YJ<Y$OB*]7$F/.0FW&F%9FR(^472$CON3'-=0'CPZ,2IM
M$6>V]+CI&>Y1/E2@W:."ZF47G#0%S"FHVOTXCR:VDQYV*RL=E69LB/E;4U<7
MO)C=<Q<5QM#M%0@G$\S2)+[K,JHRI#;H0@.4+:;XSW68@LI!T+TVQ0MHUC\D
M6KTYB;R?/O-UOAODS^5;K\=IGZN1OYN7XUMM^4I'S)GC)_";^>GW!6EX/#_X
MAU3_ ,T\4I.SK\C+5JFQ)EPH^0EWK$?1XL_<IDMJB^;K\:KE,B9.55"DSX<?
M>%D;WTF,XTWG*Q91S$F9;+9.A<;,4&I;GEU+I,6))W!JZSO6@1"W9J(*0=2J
M KYD\=IGZN1OYN7XUMM^4I'S)GC)_";^>GW '$X@2%^Q<":<"%"_;XG['LD&
M'BC,[/5X'9 M&K+1FJY!<=1,@$=ERB2HI6T\:J]7;:%\Z93ID\62)0%THK!O
M(V1HA**'DRJ2"MKWLN-G]HG8P0W*O38\THK;BN@PKH7W:.$(*>7W2@-^I/':
M9^KD;^;E^-;;?E*1\R9XR?PF_GI]QR+W3*Y?[O$?H^+Q.D;-OOJ-7JD>5,A,
M;HE1QB-H\6][D<EN"]:=?W -DZ+!<K>T*L<I?C-.@Q'@1_ZZ;).Z-)JEA$3<
M6^@X=JFU--0J8_M15X/*8U065*9=6H2KMI'<; C8CY% 5 ^]B-FTX)$JE.>1
M^%-9!^.ZGE :73WEZT]I55;(B755X(B=."BP*K F2 12-B-):==%!6Q*0 2J
MB(NB^T5-&=%*> YRAH\"R1'CF)I%SHENE4P@R)4=@B2Z"\\VVJIUHADETQX1
M@_XICU\*D>5'?4=21EYMQ13K7(2V^X5NEQ<B2:C2IT)C>+E;WLF,XRWG*RV'
M,29ELNG1C9J@3R:.92J5%AR#8529)QH+*K:JB*HKT71/':9^KD;^;E^-;;?E
M*1\R9XR?PF_GI]Q<1.XW?/\ ?OS?_/Q/V/I@19)Q&-GZ\V_*!ATHS+CA+NP=
M?0=TV9^0!DA%Y*+]PKFUB4Y9].K=T!UY'.2OQ74:[1RD!)&'FG&T41+CT(NM
MDV:VUHM29BN5R=5QJ%.D ?)7)\IU^RM\UP@ 7E K(2K:Z)BD,;.FCM&"&TD!
MQ"SYV;:*I>Z7RO/[4W9#9Z04<PA//[0U9K7L9$W1$$1HN'+I=K(/%IK,X5K@
MA5H;J66E2!S+Q*TI$NOG7BN'7*?M%/H:1XDHG!@LPS5\D;4Q579+#KC>7+9-
MR0+K[V*Q(G2GILI8$Q'),@U<=<47\MR)?>][JQ083$Y^EP(E#DO3)S8&27Y7
ME;9"RBVKI7S6)=!15MAZ3(VZJ;;,=LW77"8!! &Q4B)5WO0B8J-:<DRI15R1
M]HN2<PFM)C&XD-U6E)4 I.8G^O*8HO#[A5ZLVV+SE,ILR<#1JHBX45@WD B2
MZHA*%E5$TQL_M$_'"([5Z9'FG&;-7 95T+Y!,D%20>&912_4GCM,_5R-_-R_
M&MMORE(^9,\9/X3?ST^XJZO%XO\ PCHG_FOB=&V8?<<2KU:-+FPFD8<)LX\7
M1]2?0=TVHV[DR0BOS477[A4]F-KECA032><:).C,-QN2M_>KD1YP4WJDELW/
M*ZJJ*F-HI#\*G)7.SM>;HQQ&VNR+TOLM("+'9%GMKPDEA0+$.3ABA4VJ(03
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M%$=5HK;Y@BZ0,5X+P75/LMMORE(^9,\9/X3?ST^S5U>#(_\ B+1/_/Q79/\
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M%L169C4&4Q(==I;D@T;:DM2%S$RCA6%'0-=!5=4M;#L1JF/'0Y5?2HI6DMR
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MVWY2D?,F>,G\)OYZ?8M(O=&F\+WRU_TMXOLG^DYO\L'C4'\\B_QPQ _,HO\
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MV2=G)B,4L-H9-0D[-L,34DC"";F-8Y& -[KG<Q<J9;%HN(VP'LJ['5*B,1H
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MF1$'AP1$Z,;<>QI-/=P=\>TNSZN:"L"1SGQ"_P#5<#\Z7QM9MVK2<NK+<N3
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MWAXN=0:IG(YU#AXUN%$<V"*I1?,DJ-S=2ZTGU?D)O3-IJ^W5.I"W*-%>+A@
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M!P $P0?!^H8=!2-MZ,BF$&NZ<>8/K>.E6(>V /*-N@=&&K7ND6ZA(T1VX
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M8X\Z/YCH?L=X_2Z6315?B-+R@.\1FWR#E@7'&$Y,2B^T<DIYLC3;C->,U1>
M=(@F!TIC, @BM / Q>VZ'\< Q320\Y?PY+02#FP1@:?VD!%!$4=B5R8*8<$
M !H (!H,3K/*B)K#\)\-Y:V;*A)V:L>P9ASGC!TB =K&ZPK"HK-1/0-GP+D@
MD"ZH/@./@S$^N#'PJWKX-(8HD49S(LIU771T$3%GFZZ+X#:T"XKR\UZF!:$B
M.QB$63U;'2H*O ;RJ#8TRR(P;=#VN&AM5U(P62159ERUDJH.+06%$N<A)2C(
M-UIA,7W<BIX4LG0W@M.2V:H-0*-N'@](SI-8L*1%<4 <J5T*,@-Y 87FBHJ
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M0?HNJZ"8@-5)!5J"WI1 #$B@@A"2N _UF\'O!^!B*%1)RBG&C^\=WJI.?&-
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M::?@,]4HQB@"$J94*K@!PYI[ZO\ 09O  -"4T40;?$<K1^KU$RK!VT/4\?\
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MI"& 3KUTLG*8,L"&(S30'98DN% E5$EU_F0+ABT@OJ<*NPQX\80FC5B!:5_
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MQUW#B%E\3/<[LXNM%WHF<3"R3V "I5T&W!H/D'[XN3%'-E#4[#$>20=:"WU
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M(,CJZS9PL;/Y9\4UX@ 5T8Y[K_2%#(=Z'4SN_2#('3\-,NC.".BMG- )94,
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MP%S+3Z>HY$Z%0H\JMJ^7'3<4E<HI*7K&ZQ*\S9037QZ#"8Q8<W; #?>L-%R
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M8*TO#4<&T6@ DVAO#QL(49=I#V8[;YTBX$Y5=*HBA<!R2*=KIXHW1BUP.2F
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MTN&^AEH'=-1(,^_TYT QHA_=6P@# E%=%\&5QSBP9%XQ#FQDH=1I-9J4;Z(
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MTK&XJBLX&J(CAQY'F/N)IA-+THEC[LB*YO$:L4K+X_1Y:!O#S5/$+,01:;&
M.K>4V.+GV6^FG]&M$BU7H%4%#J<W_&==.6*C"M!H=>@*9"18@2#Y_@+70%!T
MJE%.CO4 8YLT"P<RR%C!&TU%90PX8>-!TWA.,P==PG85;4)4VN(!Y\2,-@LL
ML.9+JV)4=-Z,# 8S06(]=C4J0D4P9B+X40(0.JV@2G683.ZZRAP!%K/E;=@;
M0HX @:6R$V]'*"),:PJ[G(=>9E=! 7&)2]R5#^ YB]#U#DO:!;PM6G'$GWH
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M)M^3_]H # ,!  (  P   !
M
M
M                                                       <  "$
M:@    (@   &@"@ "@       4      "4                     #8WA\
M1#-T  06\@  #,@ 8;)X!$  3@   <A@"@    #;@@  9C:$
M   #T1I1Y8F1'_=,G/D:3U(?S>J$*SJ.#\)[@0W>S6L(N[;W%>;!3C\^I%I=
M+0G@       <F%4$=]WG-4?Q<:-\#HINMVC&'&JN+)0@!)GW9''H"?(W3N#Z
M@/H/4J_K(-X       %%O!K +/EQ6DA>*4HW&6"\7S 7P-60K?1 G6F^]G#L
M&CW/G:EK /<?'"/(=O               >,         2H
M                                                 6U@
M#9X          38R                                         \G5
M$&O16,4>A!E4X<>A/P0T7B!^@
M    /?B&Z@B"A8<,?,*5%S%+)DOL,)N>
M            W)O(X4&!EO4$&C.*'Z;_ !WZG\Q%X
M                       !F$  @          @  @    $
M
M                  &22222222222222222222222222222222222222222
M22222222222222222226
M                                                      (8   E
M          X @@                                       /@P=210
M Z<(M 4)$H L#ZA%MR!#\BJLE!%H ((                  $[[8K(Y*6R7
M4 ]!$HC]>;3S(9YWC/#.R];8D-5@ (,%!#>_K*!7R^]B-Y/V^8       QO-
MT*?>7VW/:6@G8K1C\SW=5CDQ7'\#KG$]!2%87^Q2I7!90J(BOZ%?_'3*JX
M    8          #_P +KD7L_P 3JT90VX($1#2#":71Z#%^4]?3_$ZK@
M       4      4
M              #@     #@     "_19:.",@
M        =%<$7=3\      4      4     +7P    "#6
M              !B4     &G     "      "@    ",     200;
M                     0@     "82&0    ,           .@! (@9!2P!
MH                           "$ .3<#,4A@.    "@     "    #H ;
M',02G-@!@                           8 #4>:9*4L!8    ,      ,
M    "P",'BL#K(!$                           #< 0CIH%W7@.    #
M@     "     ,@5B6Q<  (@                            !"BDDJD@0
MUJ@    0            1<MS  1UG\                             "
M[<_8 :,A<@    !@     #       1SF^OE8
M         UL+_?V@      L      !1N;7#M\P4][INH?=W2T]PK)MW1N16G
MM=E9O1GM%(AD@^%\!<MA=L6F5/BF(9       $98HM;>:U3&6K]M*A'C') 5
M?*VQ:X.Y><8) VKC1!)%AE) 5#JVY*X>Y:\:T          #\T26U3%:[8.D
M8X                                                     >
M        "            2
M  !P            8           "0
M          =   80                    00
M                 !L  !JC/.),   <           "
M                         /   ?/YR[$L  "@           00
M                                #   !F@O71T   8           ""
M                                        &@    #*H    !@
M      0"                                       #$
M <           "                                         &6BU'
M(S/TJM02V@           0"0
M   <            0           " "
M          #@           "            0 "
M                  <            0           "  0
M                         #@           "            0
M                                 <            0           "
M 0                                      #@           "
M      0  0                                      <
M 0           "  "                                      #@
M        "            0  0
M   <            0           "   0
M          #@           "            0  "
M                  <            0           "   0         "PP
M@@BRVTTFFFV@             #@           "            0   0
M     /;5)GSU^L/0>5               <            0           "
M            #            !              #@           "
M      0   2         $   "        &@             <
M 0           "                  W@D=>@  #,             #@
M        "            0             (   +<>=>$   4@
M   <            0           "              @  5QQQ3]@  #\
M          #@           "            0             (   3!'W@
M   7              <            0           "   "         "@
M           $             #@ !,        "            0   0
M     ,]!F&06T%GKS14              <  /*2"8?*(  0           "
M  "         #@           #(             #@ 7B*$/Y6Z@ "
M      0             <            /              < !+ZV("0(@
M 0           "   0         #@           !X             #@ !@
M#L0 $J  "            0  "          <            +
M   <            0           "  "          #@           !X
M          #@           "            0             <
M   /              <            0           "  2          #@
M          !X             #@           "            0
M     <            /              <            0           "
M            #@           !X             #@           "
M      0             <            /              <
M 0           " "           #@  ^B$8Y%D@ !X             #@
M        "            0"0           <  ,00!=B:<  /
M   <            0           " 2           #@  X#C]2%]@ !X
M          #@           "            0             <  #$%["2=
M   /              <            0           "             #@
M   ! ",<  !X             #@           "            00
M     <            /              <            0           "
M            #@           !X             #@           "
M      2             <            /              <
M 0           "             #@           !X             #@
M        "            2             <            /
M   <            0           "             #@           !X
M          #@           "            0             <
M   /              <            0                         #@
M          !X          22216VVVVVVVVVVVVR22222222222222222222
M22222?\ _P#_ /\ _P#_ /\ _P#_ /V220
M
M                                                         #>@
M         "@@                          !E          #;
M     >0%B-?ZB_O2HVD1?R/D                      6Y?K&E/B_N<2QM
M\#S>%@       I_A6HG"ZC\)1@>)KJ$                      "H7@M>]
M(0M4*3D.LPAH@       .L)T6J = @-PLD6\;:H
M !P:]/U.ILJ%V5%XX_@5@                 38)@
M                      H   34
M
M                                                          /\
M        //\ 8                $;3\&$D
M     $+(>Q QMXRU$30XXF<5*88?       $WR[5_/3:ZKA<\F@
M             ^@CN!/':!! _409<[A!"B1        UG5N<XA&CQ]'6-J
M                    $)TY(X6Z9JFS:W#&O#_K0L(       "HO%6\&@4V
M[" !F(
M          %2
M
M                                            AMMMMMMMMMMMMMMM
MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM(       #6VVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVW    __\0
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M]M U#*VDJ;11![,22X\HPT\&MTHG'8B00*E8!7X4"7_>?3Y4("(Q,,L&!P!
M/0-&#IU$;1B SLF @*YWKR:P>(*-08029XE%Z(!H,=XM1.DSFYT5A21HA[8
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M)7XCR#X(7]C"-+WH# 7[)C7!!@*FJ 8?>RYVG!A@%*,:$![PY&"_5C:+;%]
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M)H([+(KA,)T@'#S>[00:+FZ\3+M@IL9G;>Y@%AB]-9K$V(;URY0T&3R11$:
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M4% !5X 5T84V)^(D(L#::NOVAD[$[1I%A:@4IX'  B=4  AH"*J!SE"U!9%
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M$@, ,8;9J.X#& .*FVJ8*L+GAH=B(>ZF\) 'U0A7U4KFZ( :3ACL)]@ZP3D
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M)UA5!@R5!7$Q&C%%L/9J 1!S<=;SP^X -9@P)![4%L];F%.!(:L<7V#/E!P
M-79"N70 EH++$%0J?$4>*NEMQP2Z?$45J P9&JU]O5O2E:]7CR36((E!V!2S
M\HPX,!$LAF(HPP9/QV9:B:&([<C6S&EW;TX!,A-7D4Z6+082H 5Y4VY'-M7
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MET@H*JJUP28#I@6@ 5  .B)  T5A]$4^R8-;YID$2="(&C6)%%V&JUT=6('
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MFXO)M/+OPK"!C*Y "  &C%F(C#4*<Z %H-<8VH:#*%D:%V>;C&2)YA(UH;$
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MB@J'% C!$3GYR"H'E0/=RW!;,$>.1E!0HB!,5&2%%! !O;@$@1]A@EE.<25
MV\G 29INX'7?=CLCPIC8\M/9C7TQE>?1O9O]Y$@OJI/9>XX%JKU"!^E?O_\
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M(JAW721E$((@BZ1_G:I:P2T@!KKN@+ *";"0@@IHH3L0T80P@BH04"#@[/!
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M+2%1NRLJ&= SWP*)5O11UU?BU*-+<02,> @?L7"4J!PPVO8JJ5>?E;*4,0!
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M*X%+!2W%A=*\XQ_V9<7%:=B@@ >P,*\<^E$MBAH:J1#X#P*&2 1)0 *"@]N
MNIT208B@U%:)%.U$$JBH@=1X@H=!C HZ U 6%+\#QV-SX3MA6H2W(6K(!<HD
MY;!+GEADEVX#/#$P-4,4#@#[ESE>X4]&+DJHB,'63,41[]*$W *B>$X)90D5
M$'FBX"P</8/5TE%ZH*C9B4*7<*QQTFTV&TSI0_DI2 S3H"XJ' 7V+BK6C.?-
M#","BF*X(B)!V8$(V"U@Y 3 ]J*5H911$X/_ -?_ - K]MX"[9!.8H%$"QU7
M+VR$(D8$$51< 69#&+74N"4Z@0#SR!#$J"DA07E#>?C_ /\ , 4&I$97&%
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M!P*'7UQVC58)* (Q33B  "("(Z1'2)R?!L:I34%7BH 69W:G97,AEA9\&P(
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MCQ\#+%$5595Y5:5[7&R$11I;% I3C%#KR))LH$8[XYW\&P@U5# O, "]ZQL
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MUE%&2(S3E#4&Q2 $Y!^4]@ !0E&Q'I&ET]])^*$34RJ#L#!V%0P?."?DZ/\
MY_CQ_<M5Y$U!5L:IN2N*;#JH=3M*BC92O</PKNT7PI,#D()5\%Z73K5 4%"3
MN ;[*)(((P<8,A2@@[1P 5;G16+<A)<T#25853"TRHB@PT-.PA4"Z",TNIWL
M46Y25'(FV%Q C3IQC-ZS$"3)U8"4&K?VB6-@@EHA&(8G6Z2DJMDEU(9A6KY&
MH$Q>C0]  ,T 7?5* BLI3 826G&R39,+8"V.0083#@  TP;G\2-C\!BYIRKK
M6CTA2$XB-."/I3TP#L#YP>)\^.O'P!2Q2.D$JM)U"HWRRH$FL:R!SQXQ5W[8
MV.BM@Z1&"()L2CY'%"U$!0M0J.A5H#&(4?Y4/"G.SGOG%P&86R.<#H&5FE-O
M4!342%&1"NL(\JFE:B):B,C!D:I;;$-LE%+]V*32G$.P@413:$3^$!YP9)3D
M.H1PVAN# 3:W/08REJE  "E&H(P;*"-3=#HTI@>93L!S(56XA"2:T !14*/V
M'&!$SS/Y"1IB*D-';Z\ZQM7B"ZV,(!*2) & BR!/)\I8%#R(5;>=%*@I@A 8
M8 .,,=B-2:A%XYH#E3P#4%(8;4241Y4VH2%%,ZE4&2.'0[ID0X@F#CM%X.<3
M8C- 2(%7@B4 GA&G^\+TT:PBI42!F!@-SS=4RQ=+@J(.!*C'/8Q]82P +PIF
M5%6Y3=\D1%*)FV%LVIH!BCU=3G7G7).K,,XD4L/\#&L&HW?("[#V^B-*3H\E
M@^24V:":G \!U)W$2;>WP&V(J,A4"@5U= []%,;DI&F5+4T1XEUED&&U"&IC
MUD8]V*DU;$&0A@4 SDB1 +NPU<L6M!,8I$E5KK.I3$_"QBL0<V2.Y:I!,06%
MJ$1Y4D^J^F%JIMRJP@4:0%)IA?<FZ7!#B.@'@5A:BN2:$%B1& &Y*E_(1  <
ML;@/R32P$@A($$0I12D"R'O6VB%#B26A((S3JH"@_P <VJ6<[/:4- 9=F*:,
MAQ513')#!DR'<VB0K#A?P7J FD"H4JJ5,S-)?E4U:0X*UK.$>M1P*0+198<D
M5DU*#H!6D!F#)YD+1A7$BP2C> )<] !+105\4H%/NH<!&0:.[H*C;04JI="E
M.&*7A3>2L)O,3@!Z%2< 5-SNCT#0E-8A-8TQ?R>T$SM#T#E$JI)GA;I&1CXW
M7$!Q(W:.02!9I3-1D170/"H%% '-YM3,=2EB&+I.,-UQ604"V >X7^H/>"8Z
MP[43U$#3K3 *9 9)H<-H+!3?CUP(Q5+'A#QB"&EDA$NB_J\IRHA6H6X.Y $I
M1BJB)K;89A'>GGI8KT:IR+V!.V!@YQ%AJ    $ $ .@"!@)WDXCZ@L@A(Q,H
MJ5< -LB  0  (&*Z9 T6I1A$)Q88M9&85$T4 PB.2UM ]E++'NH]QF&T@E4"
MHI9B0=B=:/NK;[6J\LYR$$.9&L22022X$9$B0D!;7-\&5A$PN@()@G5!_A=*
MP00 G,M*"THTXR!]M?0'TW2* @ JU)LDV1L7X"-$I1D(2$P)ZHY,IB5^_4^U
M-@0(?X@=D>:)D2(I4/$ )Y,%IZMN&R*,H8((D"TW:J@O I#M^1"U$$0I4=44
M5*<5&8$@I&N2V)=J"-=ID,ZB=J155557_P!+HZVL[*8*Z%A750S\<_\ N(.=
M1A):#=4OB_LFA!1C>#E9;^C'2=&/4% KH4%=5#O"HW406L KM70'.,>7:,DH
M32POBGG'8,"4B(BT@!BH9$<8+#282="Z[)S-XF*Q.>CZ[]3#5%&,HZW'CP\/
M7^"!L/#(40G2D7ZF!1H!G"@-E%>J7G 2D0!5?0Q)B;9$F^.>?3!"/4@?H7U)
MY4#>=KG$#>9EV@[1UG=I\ZO'-Y].7.W9O0>RV<&U &_@)@TUM!YX ^N;"/!
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M50%508@QXP&JF)$#1D#B":DU@M0"EJ;#)7*@%V!EMAEA8&]0<C+%<60JHJE
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M9HL!#"2UI!$61-,PBX @ &-0H04("[0#7+O6%Y4P/6D RC8#!M@34C4#540
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M(#! 4)&Q8*'1</& X?_:  @! @$!/Q#_ /5-+*5X.K]/QJ&UAW?B(\(_+?\
M6&[-SF=/GV_+4.4/GG2]'AZ>[/Y_)IHNW0=WL=_PB-!J<AN?/M^+K.O;K_'[
M#S9N<^/G^V[^RA8 HIU"\BW&O6I"T*\U><B)O M",@8'-HH$T(X7*,,'-W'1
M'9TY6=?)V*G*$1Z.D[98,P)F&H*RE"]1<B2 !LX+E5%^8$%L*Q40;(HD5+O
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M0(.-"0BJI$NP !T#X) B+>-+0Y#&B FS$2BHJNU7:N"WII.T"<3/E 40Q=B
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ML&1!D/.(1.T4+'!.)LG-)&D,HZ,$BWG+AX@U@F25E1O.J#:0:KH@V(J!41!
M9FGBD!4I\<C[39M(JE 6A1HN2R>6=^@)@O65@50L55-#5@(&"!QEIHMHA9 L
MR+2AL!E,(, M)H"4)2N N=DH"8/FG_\ ' RT6#BS@A2E*0 AQ'4NF4%" \KS
MKLMF%?"BJT0BT1>U*V\2Q(7 [50PD &F1B T "#&YI!^@'=V1MQ><)U%(@I(
M%!>TJ4)&H!W*"TAE4) FL#@\IB$R".J8MN@808>'83" P0"D01?<TR$!#FEU
MAU'1QAE:FX5M;PLOI5U<"XNV,5=Z*&**"9],TNM424*;YF7O("/($5Y ;8VF
MDQ-\TH)^'8&RZFD1Z]!73:*@)H2B\.2B[ :=JZJZNL*XQ*&H4 )R&DJ!*@9K
M +&YC?B#@^:08&M3\D6L>P,,7-Y7F20#5N6QWCCQ%*!*M 7(50K5C4L(>Y7
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M$<L!"R%HVPI$7J@[2MF(=5K00$4"$T[C3##J"B5[&E2# H(S)!V(*#0XL:H
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M&SB/;(6MSJ#DR*AU00ZY PC4 33&BCH6K0']*VB*6*#92H #?.)OYQZ*DNH
M5NW"8RI< ZK\ARB6'7"#AA ?DBWZ8L%314 6IQ" 0C8P*DH%115\4-2)LP76
M,0B/#D'U>SAW_B0$T$21*)Q(XU=5=ZM7JKU<"65 &;YA(F[(CB=ZI..ML!-A
M@15P60T-B"(R"#8 Y1/(N)2/%D 3@E0T2R(+=C ,>^<&&3<2J=07ZBH!81+D
M4@0M> %6H&&(-20%Y*8<A6@*=!C%UQPC^<\W#2FF3>B3[<W8W@H=@9$T%-H
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M@2%IR=.J1R8&@AHD.E,*;:#2! L06>VO=V** !.RI5=JB]UIG\A7RPKY@'R
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MR%&Q"A2@.X'D' XX,H6T9K%%OC%="3"H2A8'Q<@N$(5%@"6!86ZY"W. H*0
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M-QSUS[XE$S-6J':FU>57'C,DT+JD5\N *X!G$ BC$$[()B0#%"/9&C_.!
M  (!H & &@.,V7.5P-HG8-LXN^^<[Q(T((I331U@F<5 *QS2I5('!ME8TK'B
MG1GYV@:Q 6Y4V@ 4$I7],H="B)0(H@'15Z_ 4'P/R'[Y,0.P-;FT<XL-8.H+
M$\(4;X(H]Q3.><2N1#:%PG(G1,EQE&6NBNHJ1,%+#55Y<01'8D3N.#/@*(0
M@ : X,V#NX.X^6%*]W^H[._/.,A>J5<@(QZG#U$P7*G>"0 4 FTPI&835&,
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MA!AAHG$Q.)JLAY5*K\_TZ3%*6318YU3^?S@,@,"II1!58)M%G^<^^[?G$ 5
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M (RNZVA$0QL-NN87)#/);YQ';LV((^ 5/GZX5H(9>L1#X13\KG^+^"/SN2#
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M$AUEX6Z-%3?3B&TQ1' G4I0UP:G_ '0.]%XL()R1M?(=*N3L$2BQMD"$^??
M2M$ ITCR#Z=.F,!^65J4;UI^8]]">(L1&90X::Y/KEXTA!$"EL;23I#IA3!:
M,$6EIM.*';M<O'"#1 ;+N5ZZU"8(8V^'>O)#EU\NN*62!DB ENT+Y(=,,ZP
M&\D1V(4 U9:JF:EBP B0H=# @#@_\&N]#S_\'N]#S_\ ![O0\_\ P>[T//\
M\'N]#S_\'N]#S_\ ![O0\_\ P>[T//\ \'N]#S_\'N]#S_\ ![O0\_\ P>[T
M//\ =16;X($*DNC2'BO&!E$71)>YOU!PJB!3,.F.'D1SC.7@#9&T%\IKDWG
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MFV L%!8:%*]3G*%09(@P$%!!W%+PO[O=Z'G^ZP0":(!4'*46&J7D_54]A.+
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MH3?NI85*@5Q+(%BO68&_2SL;)[FD-"SR> -KHW@/4O@'=14[#K;^0#2A%"H
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M$F(UH[S!94P0!OX&Q B8:JB+8"3H.*MJI*MXU>$ # (8OKX(J$3J,"0BG%4
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M:G-E!W8$LYP]]"LOH%=NFD3!*4Y1TY%27*HR^ 9O3P(4E%)Q405"281 UX!
M;#I6048\ZS%4/#NG8:NC>>0JC' +$N%$ %,# %9$B3024!9 8VDD9(C*[(=M
M9<IL-.'B"JI,,(58XSE(QMT 0"$(Q4P"9(_+,= ;H*T@R=7"7NSJE!0*A(HG
MFF$HZ7  @" T$?B4<GYO]_N]WH>?[K[?G\2%2I*,H\CW'J.GKBVBR28 D!0&
MP<RKTL> ]M* >QX7X !9!(< "<<O+UQ2/P4).0 NP3D1RM^$A<2;:R$82&U\
M7#4%6M+".YM-Y4-M G7FA@\ .LN\B06C2$=)PQ M587-H&))QN ; :!F,AN?
M2HP$< .@7$ 5 &BJP*P*O76,(3AG+! 4%$3<Z7Y%1R?F_P!_N]WH>?[K[?G\
MR%L+)9N<R\R@S\""(E$B.Q'D3J>,    - $ [ <? !4 54 *[J<OEW^0HY/S
M?[_=[O0\_P!U]OS^K4<GYO\ ?[O=Z'G^Z^WY_5J.3\W^_P!WN]#S_=?;\_JU
M')^;_?[O=Z'G^Z^WY_5J.3\W^_W>[T//]U]OS^K4<GYO]_N]WH>?[K[?G]6H
MY/S?[_=[O0\_W7V_/ZM1R?F_W^[W>AY_NOM^?U:CD_-_O]:5'#M"?\SVC_F>
MT?\ ,]H_YGM'_,]H_P"9[1_S/:/^9[1_S/:/^9[1_P SVC_F>T?\SVC_ )GM
M'_,]H_YGM'_,]H_YGM'_ #/:/^9[1_S/:/\ F>T?\SVC_F>T?\SVC_F1:1Q9
MK^#]U:52162=J;GC/=/OGNGWSW3[Y[I]\]T^^>Z??/=/OGNGWSW3[Y[I]\]T
M^^>Z??/=/OGNGWSW3[Y[I]\]T^^>Z??/=/OGNGWSW3[Y[I]\]T^^>Z??/=/O
MB@BPB(H(D1%B)I'2:_\ Q.P'&X2GR2F)Q0+!+/D&(FDCV?TP* .58'S7*P K
M)T+6I0C9QCP2Y!$^C^\(ABDJL!@<,1CT1X<' A> %<004<B(GT?TR@50#E=!
M]<*Z !.P 3N$1EXQJJ;*%C&+ICS%_5O0272O7JZ T=[!GE=F$'B]@$0* A&L
M14XAT "6 @PR"@$G5@.J[RQVC &(A]U#:N)O B"8$X<V9H80H6TR=7<](Q&E
M!LE:#K4/0!TV+ HKFO,+!,"P$N93X+571?FP)( %,  @:H:#;6"MDEA$MKMH
M#$6F%$QK=-K7DE0A\7$Q%=.P*D6$@VNESF<A!R-B0C&*-&0;L'23!VY"0!N%
MT39=%@60BD0ZQ(H]&?QC#N2.LYQ,4("H-X$()LN" CH 8Q8X-BMHA%"0V\"=
M@R6A6X8C>P9"[UCDBR- *J] "KC4@(\<H:9=#LP6I4=T\,%<.[^AZB;V%/CQ
MI5L++"2:I8BMX31XDD,2\^UP5@8@ ;NXU*FA G4 A:-B@]U/P")UQIR:>L%L
M4CP AQT<E:!@J=R!HI^5*1H <$XOV-:H!D $".-Q1V,N:H.L;($CW;L?S3@@
MHFP(G9GU0">@R%%&TYP]@4 "=))] $=C^W"^X2T"4F@"PMETQ'?2@*F&B;Z)
M1TN*V_29?0%CF0"JJ 6:"LTQAU9 H N=IFQ%"P[#L7#!.OPFL6U"-0U*'8!4
M&.,1'@-!@$J H0D R("8U<B,BV)PI11 8!*)G9]#-B\NC10\A@D1:DT0!T*5
M4*% MA,)P!$!+LAIU;@X^U0#UJ <P1$2D:$R#6J0N,Z0V(M.W*R O18H."SA
M%'CG"I P._JX,&A0]F:C+$KKA@'8H\CFS] 5Y2 <J= 57@PX&Y8#M?4"@T;
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M_P!1 /LM3-.K"A34VO-;=KD]4CD<3JJ.ALE%TH JNHOYS)<SH94$GEV""/:
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M[VJN48<T<(,%T-(6"<VCX)P9IT;SR*KZ>&="NXOT-WDB@P*(3A/)3O0Z4>5
M>B,R@I"@[P,"-YHM(3O!26P<BT_T^,:V>8F8I#-!82YQA %PW]"TE;3PNH3J
M53D;X&I?1CH^+H1"2]\0!4CO!C+TULR@UK$-Z10P(G4=,KX*GR-&Z:\<&P-?
M9 SW361J^V2%(.*9;,*!!<_VKQ276$ FDVFX2;1-]<5Y$T1(:A1/28()1/:L
M2;;&"A&'@I_$6'IA$.6YMK1A185C)N]>:?"5VH4=L*?R":%$S8-+V*AZ0\,+
MQ-BJ'KUQGT^J  [VG.N37D%DBA'=%#AAG^IQFRSK[;IR/I,JA19#>)*P;>@*
M[>=42Q#)^"@D9[(1:@$*+)):9UAZ,#!.SUC*#$[*R"CDM=%4(($6"+K C/LT
MH VJ 4+J- @X:2)-O< >NM\HEBT5"FB<^ O* *>[.-'&\5+!>$IUO:FV01(Y
MR1*)C6!<\99:V!(*(UL.I"Y>8$2HRME-A05S9L")%H-%HW*IA(%40TN5A+7W
M%*DOPB8&LV#@N'?6UFYAJ37#HM-$R)R1[S#/V]0L-),%FU8$G@=88".0#6I(
M;O50(P3)]UJV<-<A0AAL156]5ENG45@O90]IVHN1XJ>@]ZF<*3*QQ!8:,IMH
M5:I#]0=(#X/:)N_#O43(.2U\4,QWR1!%G.^+U7%6A<@$3JMC-U$C]5;G=G3P
M5!Z.*1$<ZUWYCPMP@9/K'J0D#V<A-B;._&^1.141J#F*RM-8>MQ9"T5Z?P+'
M&NI85/&:'!?%A5D,J#@%5 %M6WP$Q)C=C(BOWAH <<H'"K8#00EK F&G;* (
MVN# *L-'5/PZ?A0P+8@^/YI"?H4<IJ_MY,9P0HX1@GL]8QNQ=2""'!F\UPNS
M9^<QI'6VB(U%1.UN"I8!V(!"G0&?]%Y81B'*I-D;XVH?E]3W.U8VH)E-3<G+
M/,VS7CL-T*50IP4I4HNY)H" PM8$L@%R-H\@ ;#%M:;]( PR8)[NY\N&8E8J
M:@ #0&'@,$1N^'X_#^AR)>M3V_I389\>JR@5CTZG*5)6Y60@F 6<4[."55J8
M.7C;B.-(81HQ.+(E1OKU4;-!_P"2 ?\ \]0THC%  55D ;7V,!CR8*8*U$4*
M@WCUNI)N:"]_)I<L5 R-ZGWII*5@JC:, F&  " -   &@(8Q!@(KP *K^#!_
M<PD<U%<G5 ^ *@)LXD*0*,-P>:DA?T)5;M7-QD[NT[G)\"Y.(_[G_M/7W'_[
M/Q^(O^(G28$$[@$8-X2(A-S%=L.-K0"-KM&-NJO,'Y(Q07D&BL@G)GT_:M<-
MQI!R4Q<U H)O&<DR7*"CRV#8<D!AV:G ,X @!&8,5>\AKU0^HB00(2 B-Q'2
M(\/3DQ;#2+'0+.Y7:HKIFAC!=SPEX?=HWH%S VIDZ^%*R6*)G6#:57T<RF7B
MT!]:A71M&3 C]^Q!"9"3Q(F1/JFB:E58('@_^J7_ ,]1N8#QAL(#5!T@"Z<:
MFI_TH'#)B6+B9X,"I\O 0" 7-4*2U!N8L)#;D=#E2Q?H&.@5AZIG);JM6Q@V
M& U+BK131,2X4QHM'QX_?/KJ(X6(LFXNE6B4+LP)%NXP^ML<^%'7CA\H( P,
MS'C-RPO,\4,H9#4#]?GWW=(U"&L?X=EM!F[(ALVW.+X'[GE DD% &#5^P!*Y
M@"H('MI4(PF 3QY -IZFF AB(P!U$=CT[P.R 32'0  D:YL71'0H#TDN3)>P
M*%8CJQ$5Z$&(:2LNGE3J#[X;$-'[X#"A0J24%*OQY>+7*HC)[+2=V'12Q$N.
M\CX VT<D5P2X2HD+R%K>+& $FV=W#BT* # FAN;-Z>Z5=)+LG.L@O$[<T D0
M<$$<%L39N2,84AM)>\%-#0JQ8HK5RN\?&#@0@135PF$7[Z3IM%(0F @<BV#1
M0M:$55OT$;QQH>64<AV QVJA@V%K(J?=5&_K52L<(& *I<'_ /N35Z!^^6YA
MP'3#,/*0U85S7%9(H28'4BKZ&;RY)DN" DH%'83A%B;L)1:*B*808+D@$ZM9
M.!3 2C0.';AT-9X"SZ[>K-_MA(Q&)2M[ K$Z@#&X/3WEDVRJD=  'L]J;)ND
M4TC+O-ZJ(X/HT RPM<:9D8HHER,$J-Z40M^__IIB_FJH.69HJL0&E+#65$;*
M# 4]!=&-2[IU@\PM/1@&0DR+HVK'MM(#)+Y9:*,/_&A&&6P$J'N@4?Z%<9K$
M9A,(T#:.EM<!2"T4+"A0PJT>>%*L < ;N1H!4QO>_H=V4AP ,% $*ZF@("CX
MS<B?OL&Q!@.'NV"3&?02UU54]0284+P0BY"-MJPS,D$K!$:D#< !,!LO/@-!
M"%UH;,$Q_P!UUSU8UC8E&*5'YC[!)ARY$BKVX8?2!6 \?J08E')0,'T3!=N8
MYI6-H:&L".BO(WDBOB!%C7\ADA0U1#I(AA.'XQ:F2$M4@PJJ8K2.A+Z5K(.*
MXJ*-*I^@X /W()L 10'TPX0^@1E;4F,0)49X'=M\-@)J!3A8LXDYZ.X:,*T2
MJ"?,;10ZVJMG>I$LY"%:[S%V*#1K"J'!9 #=^02CNQZ\*O:_@1K4KP>?G5'[
M,XH["*1RU+"F?<P%N CIA=?C%I> ^0F<).\74Z*LK<LI U)J\-A)XL]2K#]
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M<V$  $PI12XYT14-I+ )J0]Q@L>  ?1T-XEKO$0J!$M-F!&P-JU4M!*TL'Y
M\.        "?L .C1W".DR,4J(P:BW0D%U 7'8:<1.L.SDX_8CMR1/5Q5[@\
M!H#5^D$Z$<+O*5L!B%SB*Q!9A,43=4;DR(9 ;*($FP"#28C7K4($&13S2G?T
MH ^[9430 HCVX!731#0A8<?(F3(6BJG.K:+ZAQ7P4%P-J4P$0P>@,N8+@LJ*
MS#8H\BL^@^@4-+1<=Q8EKD%2(+]HDN; 0-$$1-(D<+)GPD[ <    ,!LVG )
M:GV#>'-$/MH]-6(0DM[.]=@@&%E$J!,6SWR#YE4*$1HF'<<*,] Q\1211L3E
M@"P65H,W!K1@+0&EC[#$\TF(A<-@ES!0&"F"T6ARD<DS)13>!^P&0215!!D;
M 86B9>PI8D_4$NB"0#Z)MECD-6]40WF0#B<"LZ$@H9J[LQ=8!S4UZ!! QT[,
MF1%+G8!I' =E:1*\%91J6'3[TG Z2\E"$J>G1<%+GH-UPKF!B2>)K-5@!T[W
MD?:QC!5D&*U93"$0*E8%5>7))Q#:4+B*2=X$\34D@VA:"N)<@L'/* I"$N2D
MQ.?0\5\<$0T@*\<,B*KML2,@Z71$()XG$DE!5%K=,H9 33P]HB1<>\86X( M
M>X5-,D*2=BRRN<5N%0@!!M28G,\#C8E!!30 AT:B1<*55 :HZ2;D7()R+LI#
MFG*5 X&&'6PB(D5\3J 2M+?$&](8K$ED6+P&@:+J8!&83T1BFI3I4"D</ML%
MC%2P&D>991$2Z&G6X1F @$ ""(B41-(FQ-)Z$LOP,,,<E @0&5KAE(Y(V2.0
MS-)TB?D1_P!C@7!8HTP7:")9@*U[$ ](,SD^-IA"T)U*(? 1E$Z OH212=
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MP1*(CPC1_D]$(]>4+[0EFE!&BFOAIA:>.H4*\2DEP[,D*':9*!5 \K#^W#_
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M" #8D<_,/<ET'$*$D0P#: L%\7HK*!0$J!1! JQ"Q@:R$DU)/;B8E:W!MKD
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M>$$: *@5-!CU0-MZ<FH/"@X)@7!1)_Q8,0$*:>B SHHN$K*JY9R35H$8H '
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M:\C<(98 V82N@<7 9#R(Y6&'Q2R%P$DQ9-8NFKHU56E;6[;=W)K(YP$9*:R
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M:6VS)[4EEI.?G WATR0:B^_%^??^*4*"?XQV*A!"(Q[7MV!WG/>PD >?@WJ
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MZI.!3(4B+I+V]<W@] 0BFJ1.\::G<Q4!50,!5"70#0W$ /OC]S1++P8I@IH
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MH:H1"C04Q%3B9BO+M,4H@:842WI/@?/(FN #$*!6V]3'59U2 8=P!L+("@
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M5]CQ-<)[0PA,EUH$Q<4TP^1<P%3PXA!J&8[ 4%@NIFR9"F[]N\\CK=-^[@%
M&;RHZ&.QB@H&8!*[M&N/J)2[,I7+4)U!-F6C4A6P2]QMQUOT ^V5(5I5<?7(
M?!LDTHI$)PIYN9CI2#:BMJ#1OPXXU%631T5 4\CR+ 9JTUWBAR+K59-*0! E
M>0@%"Y$#50+9CDJ+V<JK"%8MJCN3\YN<<E>W!9R;=:4%E-0;A9J<TH>$.A.D
M!U1)?L,&BO0$<)N4EL'UB2"-&<Q'JKP3BRD=K)Y8NE4;M@@QA!;=XG=T("6N
MC]8/D8(@@Q$:(FQ$HF3$0XZ!;Q0!R#SS^PX_8^!WM(/*ACV:3S^PX_8^=[W
M@H?A+8US<$ &@$?(E'^OV&'['W'&:%O=:HGO1O[LZ_8<?L?<(;:ZX O*O^P\
M?L?+NSCJUO95,(D(D.$!$]D1_8<?L?<U<JV ?M;*[=G=_8<?L?<J:9T4!X-
M-KX/V''['S;H&%T3IR*)VA@^@J:#()S1/V''['W+-4-HBG\XXL<K]AQ^Q]J9
MLS#:(/8GO#L#]AQ^Q\E),G9:>1 CYQ219#1&=]Z?I R^)H+"*4(AJ3G-$5;1
M*FV ,+6,-809RZ" )10 %5@9J#K;)9MA&%K&&.K*F%PO3V"Y<<@*2XVPZ+7'
ME@)A<+P] 7#S&"I,4+I H&H+(.++3W()X]@N%R(9]%"Z0*!L%D'$^8B'@H;0
M%0,!>!S5PP?E@K&X-F(\E&?!0R@*P8"\&=K]X)>'J7:4O.793K^*Z$&V##>?
MTG@E[O#DE+R9>N.CHZ!05@P%=&)ED*%#%&<4NTI><#A11*"H0 "L- KHQ4)5
M*A&*'@=*4'!2,(8.0, [9#O!5(B),4O H*4%CE4J(D#G2!VR'>"E]$28HH'2
M@@ZS=PQ;H052% 5"U,W9?.PE%H)02B6F;LOC8"BT0J!4/MD?L?:V0*U!;W$+
M>?I*SC68PM"=@W><M)KQTO0Q*-&(R&JE7T@I$3.(P5]9\<7 "J=[E'ZLOR,#
M.LH"A5U.])@!4M+R)EB]()S*RD2/M#!C:Y0 J?XJ(Z,$"508'-90.RNK49)@
M!DO%P)^W(RBH#6$H\4 [<%0:,WK@ 6"BJ8XA<D#H\ZLFDZ4:$W+EE$SV (-X
M(\,UG%O2D0H71N!QJ"PD5'R[,#! K5V4(S]O%"DON_ZX\2%4@QX!9^,8C!5G
ME#8*GZ$R,WA1&Y0JW$\+"GZ<!/!6ZL]13Y <F^H0 /L>@KM<LAF./L*&AT +
MJQ, 05A)8EL:( -V^N0RY(CSX8X"^:(M140.-B:GVP/V/@J[FO;YF5RFU#Z2
M)%DTI+MMD:JCZIOT&P1<\W4U @@%AX=E"HA&X/M<?L?)\2"1V 3>PG\XD@L5
M331]K/X^C?"CKO%2("E'#Y @J$J41*<FNSOZ$U*RD)DG082#GT)BCVB0M(N\
M_; _8^W*F"^7[Z$$U^7T9E(N#T%@#0M\'QS8:]JA@><!OL029&3GSG]L/(8Z
MAHW9Y%WCCCT/ICQ@5@,H !5A@8:0I$&Z!UB:AZ+HX:BPJ"X1"[,0O4R!LXEF
M451/2PCY+1)2' 00@J/R#<SU6R2V?P(3YX@[,>0)%8"/VR/V/@#K;*@&C6W
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M2[) P9;/8>6A,("X-H(U0GE&?HVQ\L@,"L%/[%^,*P&H0C+"<R_E_3C( @#
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)=1U:C$:'R/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>citilogo.jpg
<TEXT>
begin 644 citilogo.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X1?D17AI9@  24DJ  @    ) !(! P !
M     0   !H!!0 !    >@   !L!!0 !    @@   "@! P !     @   #$!
M @ -    B@   #(! @ 4    F    #L! @ *    K    &F'!  !    T@(
M !SJ @ ; @  M@   &0%   L 0   0   "P!   !    1TE-4" R+C$P+C(T
M   R,#(S.C$R.C Y(#$U.C$Q.C R $-A<FPN5V5B8@ R." R,S0@," P(# @
M,2 P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P   &  .0 @ 4    ( ,
M  20 @ 4    - ,  )&2 @ #    -3@  )*2 @ #    -3@   &@ P !
M 0   !SJ @ ; @  2 ,        R,#(S.C$R.C Y(#$U.C Y.C S #(P,C,Z
M,3(Z,#D@,34Z,#DZ,#, ,C@@,C,T(# @," P(#$@," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @,   "    00  0     !   ! 00  0   *H    " 0,
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M,C(R,C(R,C(R,C+_P  1" "J 0 # 2(  A$! Q$!_\0 'P   04! 0$! 0$
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M>C_\>B_2M$5G:/\ \>B_2M$4@%[4@I>U(*0"2?<->?:[_KFKT&3[AKS[7?\
M7-5(#%7I6QH7_'T/\]C6.O2MC0O^/H?Y[&F!WT'W!4]00?<%3U+ I7\0DA;/
MI7GVHQ%+E^.,UZ5*N]"*Y'7+$C<P%,#E#UXK7T:\*3A2:R6!20@TZ-_+?<*
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M  D 'F%C<W!-4T94                                  #VU@ !
M -,M;&-M<P
M            #61E<V,   $@    0&-P<G0   %@    -G=T<'0   &8
M%&-H860   &L    +')865H   '8    %&)865H   'L    %&=865H   (
M    %')44D,   (4    (&=44D,   (4    (&)44D,   (4    (&-H<FT
M  (T    )&1M;F0   )8    )&1M9&0   )\    )&UL=6,          0
M  QE;E53    )    !P 1P!) $T 4  @ &( =0!I &P =  M &D ;@ @ ',
M4@!' $)M;'5C          $    ,96Y54P   !H    < %  =0!B &P :0!C
M "  1 !O &T 80!I &X  %A96B        #VU@ !     -,M<V8S,@
M 0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #W   P&Y865H@
M;Z   #CU   #D%A96B         DGP  #X0  +;$6%E:(        &*7  "W
MAP  &-EP87)A       #     F9F  #RIP  #5D  !/0   *6V-H<FT
M  ,     H]<  %1\  !,S0  F9H  "9G   /7&UL=6,          0    QE
M;E53    "    !P 1P!) $T 4&UL=6,          0    QE;E53    "
M !P <P!2 $< 0O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_" !$( &0 E@,!$0 "$0$#$0'_Q  =   !! ,! 0
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MI0;8<X.0.U1-!-!R!L#G!/020<+3I<-N0Z@7(S__Q  L$  !! (! P$( @,
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M$R Q02)1810R<9$((T*!H>$7&"1#4U1@@L'2\?_:  @! P$!/P'D G6HI]9
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MPPP%RO**$YIJ%[K!3&V7]6&2I1VE-ZA=8F7)5Y&/LLA*G54,M6-C;C;"K<W
MI?\ K,0;N_&<_K'P&TAP5G,R+'49<"-I$Y V!WET2!)G3RDL[2SYQ.F#YRE
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M\^<UX3F.RZ J3'5?9X_.D2$S4\\O'W.="Q:2I#!03/3]:.F$821.$1-F-*0
M#R#V@9E;F=+$:0O3>\QU;B-7ZL5 3!*#:7BTESYVX0K=M]_73*YCD I31%R)
M, 7(FDR-^@B[A]CYZAY]0AD;53"3?%R\<P5LP%I.1FQK?39S0*H,8B=OF+U0
M@D=(D\,"#<O&TAST^=] P9/MT*TBN0 S*D7%S/V)T-H<(()L0HF/[IJH?M0Y
M84*K("!>HZY(VRARB*P-N=+*$><!"I'W&'N@2<RVOF^YU+2_O>]>];N=!5D(
MDT3W)^;S&!.B48"53>^<3&CT-*L:!)$3D3.^E 8\PQQ.6HQ&3>%9FY!-(DQ
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M7ZJ[@/D58.!\5GR^_0B1.,Z^@I%1KO/5[^AGM\?KQ4&%B\(A;-S^O2UU^3Z
MB>7W]!@G7Z?I@\C[K#K]5<.![$/M5@X%9G</._H1!42?$=\:X]5F3MM0$7F8
MH!!4 LY5^/M:[41(9\Y\LO0P;=QU$_7CDHC@OGO=&U$P-K^(#T-S$DZ!"YMG
M'@M'/YJ9Z-A'D58WJ^66K=;['S!])27YS^:* [FSSO\ 6IO_ )(20+;9QVH$
M!Z$(JDC8"0G*'FM DD=9XU'CCD4"Y'GF\W]+1S1B LA^KVS>U6/,T 18Q?O$
MQ/+VU-S_ 'SM0 )$W#5\ *A+;@$]8ID6)H$C/@7X%,I/;IY^+4SJ>_3XB@!
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;5 *C2(R.$VPF%5K>S@86X$3 ]!C1C5/VS__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>citilogo2.jpg
<TEXT>
begin 644 citilogo2.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X1?X17AI9@  24DJ  @    ) !(! P !
M     0   !H!!0 !    >@   !L!!0 !    @@   "@! P !     @   #$!
M @ -    B@   #(! @ 4    F    #L! @ *    K    &F'!  !    T@(
M !SJ @ ; @  M@   &0%   L 0   0   "P!   !    1TE-4" R+C$P+C,R
M   R,#(S.C$R.C$S(#$S.C4P.C4W $-A<FPN5V5B8@ R." R,S0@," P(# @
M,2 P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P   &  .0 @ 4    ( ,
M  20 @ 4    - ,  )&2 @ #    -3@  )*2 @ #    -3@   &@ P !
M 0   !SJ @ ; @  2 ,        R,#(S.C$R.C Y(#$U.C Y.C S #(P,C,Z
M,3(Z,#D@,34Z,#DZ,#, ,C@@,C,T(# @," P(#$@," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P
M(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @," P(# @
M," P(# @," P(# @,   "0#^  0  0    $      00  0     !   ! 00
M 0   *H    " 0,  P   -8%   # 0,  0    8    & 0,  0    8    5
M 0,  0    ,    ! @0  0   -P%   " @0  0   !02        "  (  @
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "J 0 # 2(  A$! Q$!_\0
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MP/6O4=+TN.TB4!0./2KI8?6[.3,LXY8N-,R=,\+001KF/G'O70P6$<0X6KJ
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M*@VRGVK0.!4L##LM,^S,.*VT&%%+@45-A6U&R?<->?ZX,SM7H,G^K-<!K?\
MKVJBT[&(M;&A?\?0_P ]C6/CFMC0O^/H?Y[&F*33.^@^X*FJ&#[@J:ADI&7K
M$_E0GFO/KV0R7!)Z9KM/$K[8?\^]<-*<MF@8 #:,5T>B6>Y@Q%<Z@Y6NYT*(
M>2IQ0!N01A(P*<P.[VIXX%(:0!VXIN,GFG"EH :13<5)10)JY&0<<4N.*?10
M-:&1K'_'LW^>]<!<_P"M->@:S_Q[-_GO7G]S_K35I@]2*/[PKNO#?_'O7"Q_
M>%=WX;_X]_\ /O4MB2L;]!H[4M(8T\UB:^%^S'/^>:VZP?$'_'NW^>],#A9
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M;7,$,   ;6YT<E)'0B!865H@!^< #  - !0 +P X86-S<$U31E0
M                         /;6  $     TRUL8VUS
M                                               -9&5S8P   2
M  ! 8W!R=    6     V=W1P=    9@    48VAA9    :P    L<EA96@
M =@    48EA96@   >P    49UA96@   @     4<E120P   A0    @9U12
M0P   A0    @8E120P   A0    @8VAR;0   C0    D9&UN9    E@    D
M9&UD9    GP    D;6QU8P         !    #&5N55,    D    ' !' $D
M30!0 "  8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL=6,          0
M  QE;E53    &@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D ;@  6%E:
M(        /;6  $     TRUS9C,R       !#$(   7>___S)0  !Y,  /V0
M___[H?___:(   /<  # ;EA96B        !OH   ./4   .06%E:(
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\( $0@
M9 "6 P$1  (1 0,1 ?_$ !T   $$ P$!              @%!@<) @,$ 0#_
MQ  < 0 !!0$! 0               0(#! 4&" ?_V@ , P$  A #$    ;_
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MX@AH$Z(N$"03K\I ;C6HQO\ ZW^\]>(5B4%2BQ#0CI_9/E(#Y11!QY'9_\0
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MP5*DTUX!%/0ZG+[*:9R*FE&>:**3V-<.DZ#]X/_$ #41  $# 08#!P($!P
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MI;' X@Z!".=Z,=G?;=,]RMP1!F!1CI:/W^**8FSFWG)%MC1 +7CPFWFE""0
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MJ-7$!N-NOK'A)X21/!),0H*60[P]^I *1,-&.R?7M ]=D6!%2(>[[.AK!%*
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M)$I.HC^?QR$K&;]W?5O!B)P!  !T/,U&I*]< P=<2!(R,$1ZZ)R3*!40R@*
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M7@:\/&-26C0%6!;#QQ\"P\(:+%B!'GDUS$CD="3DX*-\<;X>LD9YQ2'=O/\
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M &C$C5G/]?E_>"-G_)7&"OM?U?\ L8UK]'Z/_"Q,KZ6.X:F#FJ&NYK&O93\
MLQ/^X!:3W%!#+Q9!S)>22 I$$*XU41_NBVN;I/GZ]->G;H#,&\ET2!].\E/%
MC,>*'VYG"L(O23],O%<21QV]8R"2=/-2XSF>XQ K0?"/=^WQA:4*'DH>'Y[Y
MP,*9J>_7'OZ7C * A"M-,7>\N!;K+?0P),)VCD'4^EXQ@D#&E#]<#D(,IK!Y
MEIK%<G= ,4*5 FDQ$E/(;$)1!<%Z[QE\0X&8AM>[OU\8*4X.R"AN=U7,^IU
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MG>":5*J"=_D.L9=E8%&"&YOCSZX&HQ+2,0PD0O9J=8 .% 0!/2"29KQ>!!)
M%@0^SO$1;,C( <OQWK'BZ10CAB.O@UJQ=Y$5&F;.-?JS.2SY3QUYJ\'%*).Y
MWEM$4/D7GY_+P>(:'3KQYR0!)9*59?+F=SD,$ "I(AY?>%C+45+(Q"R!(Z"?
M!5<56%WTT#T1K6115$H[GW8*\^L H/$>(^*QRIN@^G>>-@'!8:US@43%5"SO
K:W@\S9#+/>-""!=C@.C(J J=*&3WPFV$PJM;V<+ULA$P(:#C&C&J?K/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>exhibit1015signature2a.jpg
<TEXT>
begin 644 exhibit1015signature2a.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%V86YL96$N
M2VEL9V]R90  !9 #  (    4   0J) $  (    4   0O)*1  (    #.#@
M )*2  (    #.#@  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" "> 5D# 2(  A$! Q$!_\0
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M5[MH/C?3?$6M7>GZ2CSI:';)<KCR]W(*_7(Q6=K'Q'T31)-2$MO(\U@$\Q4
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MPZYJWXDTR\E\:^'YH;21XXX) [JO"GRF'-=1+X_\/)X''B9G9M+RH.(P2I)
MP1[9J9_&^AB'2)_,W1:MD6T@4$<+N.3VXH ^?['1+\:39P1-J[ZE'/N33C G
ME*<=<]<5T%_X(\8Z\NJ>)8LV\S2":VM7'S\*%P./4&O1'^*7A^.\=H=-O)K:
M.3RVOHK3,>?7=GI70:?XQTF_U+4+&$LC:?\ ZUF7"XP#Q^= 'E=QI&N^*?%J
MW@TJ:SN;2T\RUNG4C]ZH&%^A-<VG@[7M?T'3["_M;JRGFOG^T2QKR@\SD\^O
M6O:]$^(WA_7-!U+5[!Y/L^F;A<9C 88ST&?:N@TN^M=6TV&^M$_=2C<FY0#0
M!P_PRM;_ ,,R77A34+!E6V<R07H7B=6)/)]<#]:XKQIX?U2^UKQ*L%I<A;AK
M4)*B9Z3<D?0<UZAX@\=Z;H.M+IOV6ZO+XQF0QVL.]E4#.3CVJG>_$K2;:PL;
ME-.O[F2_=D2".UW2!E )!&>,9H XN#P=J'ASQ](^IO>:[;W%FR65W+&H-O)A
ML@[<#IQ^-8/@&.VT6/2X=1US5[*\W9.G/#&$)YX!ZXKU.Z^)%A9:&=4U'2M1
MMD#[$BFM2)&/LI/O5*/XE>'7EE^WZ->6=S#%YJI<V05G7./ESUH YWPUXPL_
M!>M>)4URWN81<7RR1/M&UQY8'%8;>&?%NJZ=?>,(D6.66Z6]BMV'[W;&" H&
M.XP:]8U'Q3X>@T&SUB>!+B"^<) !"K,[<\8_ U3?XF^'X=">^V3>6LRP) L/
MSNYS@!<\]* //M0\-:GXE\4:IKMM;7%KJ,5G ]M*5QN81?.GXD8JIX6_M/0C
MX<U+7--NDCCN+TW2B,'8SXP3GU->E6GQ-T1[:]DN+.\LI+.+S)(IK;8Q7&>!
MGGBFZ/\ $*QUUT5-!U*&V>,RB>XLML>T#.<].E &1X6$_B'XK7_B*VT^:TTY
M;2.%))4V^:RELXQUZBO41TK@['XGZ-/<K':V%[]D:<P+=);?NMP]\X[BM_Q7
MXLT_PAI!O]3$K1[MJI$NYF/H!0!NT5Q%A\4=)NC<QW-I?V,UO#Y_EW5OY9=,
MXRN3SS6]_P )1I@\+G7Y)3'8"(REV&"%!YH V:*X33_BOH]]J5K:O9ZA;)>-
MM@GGM]J.<X'.>]=T#D9% "T444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 </\7EN9?ACJ\%G:R7,LT)0)&I)_(5SL_@Z]TGX3ZN#?76
MH2W&G$) ZME24Z 9->LD9&#R*" 5P1Q0!X1)X3U'7=9,OV>>WO=.L89+"?:5
M&X1@E3ZY(%87A_3_ !1KNA1^&?LDEI?3:A+=7<TUO^[RDFX<D8.>:^E  .U(
M$4-D 9]<4 ?/E]HFO:7X;UOPEJEHUTDUQ#<QR6\/R,'E&X  8& *=>>$-=TS
MQ=I6@6-O)/H;&2>VD;/^CLT9&TGL, ?G7T"44GD _A2[1QQTH \7T'QI'X4\
M'V_AB]\/7-QJ]KB#R!:LT<QS]XMC&/?VK+UJ/5SK7B>PL["XBN=<E6"*1(CL
MC#1KSNQ@ $5[N;2 W G,,9E P'*\_G3S&A;<57/KB@#Y^?PCXF\*MJ5K< 7E
MOJNF2*1;0!0LN JY"_CS7>_#?QI8W-K9^'FL]0@O88B&,UHZ)\O7YB,5Z,0/
M2J<TNGV<OF7$EM ^/O2.JG]: /)_B4]I'XR,FH6M_8ND ^S:E9(\F\[>595_
M <FN7U-]7O+3P[>:[%?P6L-Q.!/96K>84V *S(O()KUG7OB-X0T]=NH7:7>T
M\+!%YW/;[N:QH?BC<:O<FU\/^%KN[ 4,CS9A4C_@2T <IKL!U[X>P6>C2:K<
M2"\^::[MG1UZ<@-SBM31?"5_HGQ$,.NF?5[:\M?+MKED)$)S]T]<=^35FZ\1
M^.I&;>FD:%'N/-Q-%*0/H"*Y?4-=OA=E=2\9SWLA^7RM-L)5'_?2DC\: -'P
MOH.MW7C:R\/ZC:21Z3X<F\Z&5E.V9L[A['[Q_*J-OIE]86\.JW.GW$EO9:JK
M2Q"$LQ7<QW!<<X%7M+\'^*=4U>QO=&U34K+3U8-*U[<M(7'^Z2"*]MBAV6ZQ
MOAB% 8XZ\4 >1^)?$K>,M(UFUT309A;QVQW7DEN8Y&.T_*!C)]*K>!#:6J6D
M:7&L3S_82GV2XMI%CW>7@J6/ ]*]FB@BA0I%&J*>RC H6")6RL:@^H% 'SVE
MR=*O%;PY8:C:ZH]YB739K=Y8#\PW,"W XSSCM7:_&S3]5U7PMIL&F0N\S70\
MPHF_9TYKT[[-#YWF^6GF?W]O/YU+C/6@#RF_^'MY9:/JFKZGJ4FK:D;+RH=L
M.S:,@XP#SWK#?4CXC^$$OABQL=0CU*.U?Y)K5T1SD_+N(QWKW$C(P:8(8U;(
M10?4"@#R_2_']GJ,>CZ1I?AZ:XOHRD<HN+0HD 7AF#$8SW%>IIG:,C!QR*AB
ML[>"5I(H8T=_O,J@$U/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%9?B+7K7PUH5SJE_GR+="S!>IK"T?XC:;J>KQZ=<036$\
MT1EB%P1^\7CD8^M '8T5"]W A >9%)&1DURNM?$;3-,O&L[."?4KI<9AMASD
M_7 H [#-1R3Q0KNED1!ZLP%<?I^H^+]<"RBPBTB!BP*7(/F@8X(VDBD'@&2_
M5O\ A(=:O-05SS"S#R\>G2@#2U7QWX?T>4175^K2M]U(@7)/X9KG)/B5J&J?
MN_"WAJ\OB3M\YF5%4^X;!IFLR>!/A@D$O]F1"^;_ %21(?,<_P JSTUKXD^+
M)Q_8^E1>'[%CE);P'>P_X"30!ISV?CW4K.3^T-:T[2(W0@ 1E77_ (%NQ7(:
MAI?A"S(_X2KQ1J.M7GW?*21I$/X;375Q_##4-8P_C+Q)=Z@,\VT;?NC^!&:Z
MK1? _ASP^0VDZ3;V\F.75>30!YIIWV86Z1>!_A\H9CQ>3JF![D'!K;'A'QYK
MVPZUXCCTZW!QY&GJT38^N2*]!NM7T^PC=[J[BA5/O%CC%9.H>,[2UM89]/@D
MU.*4D!K9UP,?4B@#'M/A#X;CE$FIK<:M)U+7SB3G\JZK3O#^DZ1C^S-/M[4
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MSJ0?PZUR^EW?BZWA6/2/!]OI:%L,LZ?KPU7Q+\3+M=T4>D6FTD;9$DR??@T
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M2-?5V"C]: )**IPZMI]Q((X+^UE<]%292?R!JY0 4444 %%%!.* "BDSFEH
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1%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>exhibit1015signaturea.jpg
<TEXT>
begin 644 exhibit1015signaturea.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%V86YL96$N
M2VEL9V]R90  !9 #  (    4   0J) $  (    4   0O)*1  (    #.30
M )*2  (    #.30  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" "  4T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z1HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHS0 44A8 9-,-Q&H)
M:15QZL* )**H'6].'6]A_P"^JDM=4LKTXM;J*4XSA6H MT444 %%1+<PO,T*
MRH9%ZJ#R*EH **** "BBB@ HHHS0 4444 %%%% !1110 4444 %%%% !117%
M?$CQ_!X'T/S(T^T:C.=MM;C^,^_MC- ':T9KB=1\>KIGPK_X2JYC02FV,BQ!
MN&;^[G\*X2PU?Q/H]QI'B;5-5>:'4<M=6<B!5B3=P0>^!0![AFEKQRR3Q;X\
MTV]\1P:LVF)"[C3K:%0XDV$CYB?7 ]>M=O\ #SQ3)XH\,+<7H"7MO*UO<+_M
MH=I/XG- '645SVD^-='UKQ'?Z)8R2&]L #,K+@#DC@Y]JZ&@ HHHH **** "
MBN;\=>+X?!/AMM7NHC+$DB(P'8%@,_K6KHNKVVNZ-:ZE8MN@N8Q(A/H: +]%
M%%  :\GUWXFZYJOB.XT#X?:2M_+;G;<7DA(CB/ID?C^5>L&N+\(> (_"'B'5
M[RQN6>VU*02M$P&5;GOUZF@#E!X ^(6NKCQ%XQEM(V.3%9A6 ]N5J5/@3!*^
M_5/%&J7S?[85>/3BO5IG,<#NJ[BJD@#O@=*XKP[XR0ZX^E:R;B"^N)7:"*:+
M:-O48/?B@#/'P,\(@#,$Q_[:O_\ %5Q'Q+\!0_#O2K;Q+X-EN+:>TF!F <E2
MGODGUKWXNH3=D;<9SVKQ_P"*VM0^+KJR\#>'IQ<7EW.!=M'RL,?/4]CD#\Z
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MILNX;=4D&>X%9&O?"NVUK7);S^V-3MH+@[I[>&Z=58^V.!0!W,5U!."89HY
MO7:X.*^=O$/B*[TCXN>(-/\ #D:WNI:P%CA>-\B'Y I)QZ&N\N?@E:Q\:3XA
MUBT5OO@WLC9_6J5]\$ET=;?5?!E[+%KMNP8SW4AD$HSD@Y_"@#LOAYX+@\&>
M'A!O\V\N#YUU*>K.>2/P)-;.KZE;K:WMI'*K7@M9&6$'+'Y3CBN"34OBV%6%
MM&L2V0#/YL>"/7;FMOP?X+O]/UF[U_Q)>K>:I=J%PHPD2C/ &3ZXH YCX4>$
M+;5O!-R_BC1H?/GOI7'F0 .%.,<D9K6N/@5X.FG:14U"'<<E8KZ15_(&O1T1
M47" */0"G4 >8GX"^$<<2:J#_P!A"7_&LQ_A+XDT&5I_!_BRY0*#Y=O=YE&?
M3+-7L-&* /&X?&_Q*\.19\2^&H]1B4[6EM'RQ'KM5:ZOPK\5= \1R?99'?3;
MX?>M[Q3$?PW8S7<8KB?&WPR\/>+O+N+Y?L5U%G9<P-Y39/3)'6@#ME8,H*G(
M/0CO2UXWHWB77OAGJL.A^,-U[H]Q)LL]2!SM] YY]NM>Q1R)+&KQ.KHPR&4Y
M!H =1110 4444 %%%% !1110!R7BOX@Z+X8TN]FGNXVN+93^X!^8MTQ^=<+X
M'U#0]:$?BKQAJD%SJ4_SP02?=M!Z 'OUY'K6?^T'X%M9]-L=9TW3(A)'=[[V
M9$^9D..M:ES'\+],\.03V^B6&I74D0,-O!$=\I_'C\Z .?\ CE>6/C8:=H^B
M:A"T\8\\MNX !(Q]>:T] \5^(7TJVTG6+C3HK78(II@!G9TX^;KBMCP/\)]#
MECN=9\0>'K2.XU!_,2S:/BV7&-OZ9_&NM_X5CX+_ .A:T_\ []T >6_!A['P
MAK/B5+_48DMYK@/ Q/WP=W^-=!XJM-$UCQ,FNZ/XJ33+WR_+D9&.'&,#I79G
MX9^##U\-V''_ $SI/^%9>"_^A:L/^_= 'G__  B7@R^@\_7?%%Q>ZH/NWGVC
MYDQTVY&14\/A7P'<2%]?\03ZPP&$%Y/YBI[@$=:[G_A67@O_ *%JP_[]TO\
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M\1?;K0)@0^2@Y^HKQS4D\1^+/%'B+7_!-^BC3$^RQQ\;W0!6X'4<GM4GP_\
MBCXFT^#4K76+DW2VEC)._F18:&12, D]>#F@#Z.U+4(=*TNXOKHD0V\9D<@=
M@,FH]%UBVUW2XK^RW&&497<,&O#=8^)\-W\$;F.^N9AJ=XLB8:$KN!)P!^&*
M]'^%'B#1M8\$V,&C2L7MH42:.0897P >#SC(- '=55U+3X-4L);.[4M#*,,
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M=?&J7^D>&;NULX]*B7?-/MDDF;)&T*W.<C]: /:<T9KE?AYJ^M:SX*L[[Q+
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MX[\6SQ3W* V]K8798EC]W"HWJ1QBK5])XSE\)Z!8^(X[\Z5-\UQ+:*YG*[>
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JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>exhibit10191a.jpg
<TEXT>
begin 644 exhibit10191a.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         #. @  $P
M ,X"   3    1TE-4" R+C$P+C,T   R,#(S.C$R.C Y(#$V.C$P.C,S  $
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M1T(@6%E:( ?G  P "0 6  @ +V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
M 0    QE;E53    "    !P <P!2 $< 0O_; $,  0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_" !$( "\ 2@,!$0 "$0$#
M$0'_Q  ;   #  ,! 0             '" D ! 8% __$ !P!  (" P$!
M           " 0,%!P@&!/_:  P# 0 "$ ,0   !OX&!@:B?1)G5/?P$P.U^
MA^G#X%1=F\,L-Z'4&!@8"$^$ZN(>0\@POK.?Q&T&CY,U+O6/<U ??<D:^:UN
MK%B^C :%GX@%WCAIA_:75*Q7RJ>:EU=&J;-,@&/'+R%Q9$;0W%;3KN2BE+S:
MN2C]+^<0#'CD9"XLB-H;BMIUW)12EP8RJ#8NX2>%G4!BDF?EJ.36ZIV+12E_
M_\0 )!   00" 00" P          !@,$!0<  C8!$!46"!03(#7_V@ ( 0$
M 04"[KKH-4#;Y'+_ )_2;N/\4H:TAW=G9UN5P[ K+'#]K^EL@%@6 ZK2J(8#
M8SLIX6*!)R2G5Y:)CIV.=_'XG@2-!U8.J!29MH#KO.&$ZNT*BJ <EDZLY$ZV
MD'[[";V7[D7Y[!/[_KX9,2SHEQ#54I)FC1LP;2,:QEFUDIZ)#U68=\5JSL"<
MJQJIN*%":FBNCU^SCDK-_@U9AWQ6K.P)RK"P-2GL<ZD0SO&Q,Z6N3:/\4'U9
MD]&>8B.JLV)28;&2[% $Y5G_Q  H$0 " @(" @ & @,        #! (% 08
M!Q Q"!$2$Q05%R$@(B3_V@ ( 0,! 3\!\J*-/M+(HK,.NNL!4334"1AIMI@D
M0KK++AC,IV#EG 00BA(A22C"$92EC'.LO@U5_%'9]J/L9=DQ7M+ZUKSXXJB5
MB,;#E?L%EE.93L'+.2# M?:7&H-<IT;UV3H2(?R9\,?4O^NOL:@*S7U_[0)Z
M54#O+6S1%_0JMC:*M9E=BP<8K0Y*._OQ&*QA6PM3C@4;L@_%9T7N(VZ/::^X
M2ICKQ,>&WZPG;TSQ%VEB@4FC3M;*4C$2XBZ"3-?%4<D\SRR-F*T"V72'P^=R
M5[MEH3M/5VI5T79/Z4\'[=;)NL.&J!<Z;DN$JI<TA8:=K8UVO7+32#(R/*-2
ML93[6Z4W+J9Z7[E;\W7&; J5+M"F(?@V?TABR*#"\3&8I[":\I_-!_Z?NF4L
M?U;-HFD1Z7^'0/;74G4B+%G=4FWV6\V'YZ;-I5II915HF#5Q0TX!M[:LNW_T
M58K(M@2H3<@9HE?&155HG9[K[\V/M6U9428L*/1A?-=#7(,R%^R"-@+,+'98
M+%RO86!6%5F0*3DPC2?:$%#)6L.VMES'*"_N=6N:_8-?L&*JYJF,,HO+9C]P
M),1E"<90G&8CKG%,B[:C RJN*E,HV$RQBBFA\6^C[7IKNN]O:586#%E^2I9*
M:TDHQ1/(YG R; HVVPJ6=78+3^GZ,A::,JXF"W1L5F"C6KVT.HIM,S1VOL==
M*3!I)KM]?:RZT!61)97"RX'LU 3; A?1 S(D4AG)B18*+QE@,,YY_?/GGF?7
M,<S\_&.8]^/>?.>1YGUR/C'OQZSYSR/,^N1\8]^,XY_>.>^9]<CX]<QS'OQ_
M_\0 ,1$  @$" P8% @8#         0(#!!$ !1(&$!,Q08$A,G'!\")A!Q05
M(",T4:'A_]H " $" 0$_ =\DB1(\LKK''&K2222,$1$0%G=W8A555!+,2  "
M2;8SK\1'UF'(XEX>F5'K*N(ERY)6.6DAX@5551Q4-6CERX66EC$;"7]%VUS[
M^VF8-"]7=AF50::"&5N<ZT4[HRQ1K,VDTM*RJFN*!25,>&V%VGR\QU-#+3R5
M"L54Y?6R4]1&'1U:02U"4:A=-XV"2ESQ+:"FLK#M-M9L[+'#FL=1/ &ECX69
M1->;1,K3M3YCIXD[*&T1S<:KIT25"(G00@9%M)EV?1#\N_#K$B62IH9+\6&[
M%&*.55:B(-;^6*^E9(>,D$D@B_;M7D.?Y_*D--4Y?#ED7"D2">23BO5(LP:H
M8QT#M'],[0B(5$D95!*0'<JFS>RM'D4"22+%4YFWURUA0-P6*,AAHBZZHH@K
MNC2 )+4ZF:72G#@A N;88 6M\Y8JJ6GKJ>6DJXEGIYUT2Q/R8<P019E96 =)
M$*O&ZJZ,KJ")=@<SH<QCJ]G\RBB6'1)#)6R2+512V*R(Q@I)(9XG%[ZD17CD
M:GEA=07ECES\(@EH,G>0*HD>/-JV-&>PULD;9+*R*6N50RR%18&1R-15;^F+
M*/\ '?&E3R_UA1]1!P_3O@6\.5[=\&W6W?#<_## 6/@-WE'H-P-N6$Y]L/T[
M^V%\P^=,/T[^VYO*?G7=YE]=W/"<^V'Z=_;"^8?.F'Z=_;<WE/SKN5K>F/ _
M?!(7_F%\6)^V'Z=_; -C?'@PPQ'3#>4_.N[_Q  W$  " @$# 00'!@4%
M   " P$$!1$2$Q0 !A4C$"$RA(6UQ2(D,3-"0P<@)6."-'6#L;3_V@ ( 0$
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M%)#(F'LFMBR!JS]<CN68S($:YU S&:*E "U+RE9:UK& !8!1O"   Z"(",1
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MI:08BZ$&+:SXE4REAJ."2\)2_D3SIWIY-=BG1,#=L9T[9Y"RU28ZJZ%W2G5
MC1L8+7R.K[=O<$MT]0S"PUDF8OWWY=;]'__$ "$0 0 #  $$ @,
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M *2.)LE[WR7+PWY*0A& 6Q%W.V@:5U.GC__$ !\0 0 " 0,%
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C3O6J\.K3B=F<X-7EX;:D7^YE$RA2RI@\(\Z@P0Q +.>?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>exhibit32logo.jpg
<TEXT>
begin 644 exhibit32logo.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'YP ,  D $0 1 !MA8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M 0$                     _]H # ,!  (0 Q    &\PY>
M           = .@%0!F"                        +_B_XJ ,P1L-.W@
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M!:>3_*43QYL]        ,01;^7_%0!F"-OA(        $$"E B <_-5QU\A
M=0!# J@. %KQ9^6'GH       #$$6_E_Q4 9@C;X2        /GF!,L//7DX
M"I NN,^)S NN(@&ETKA*0#B!ML)(       &((M_+_BH S!&WPD        4
MX&9(Z>;33L!7 5X$KRL G@>?+[BM S@D<"5YKM.P       Q!%OY?\5 &8(V
M^$@       #)D>O+/RU\'SS#D67G "$!ML.P%<!7 1 ((&HTM?      !B"+
M?R_XJ ,P1M\)        &4$\@2_)/EQX*$0>@(7FIX&0(TFG<#$D:7BT\
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M [@  1 ,D)I>*D"T\HA++S0<9434\9@33<9$C4:9(C0<6G@ ^>5P'SRS\
M&((M_+_BH S!&WPD   "C$@^00/GD_R(!J])8&?$C>0@-II# SXD$#3Z6_F*
M(F^3O*\"[\X>9<CZ!KM)OD$"@$A^20(8%AYH])0   Q!%OY?\5 &8(V^$@
M"$!DQ++SJ!U ^>5X'L"9Y0"7W%SQEB(_G$ 6O&GXQY%AYX\X^5X%[Y&\D 40
MG[SX!<\4HECY"\G>=0-+P  ,01;^7_%0!F"-OA(   B^8LRYX[ 4@$L"TX@
M3 ./E4!;>6'GL"/Y! X 2O/GD4#2Z<P.7D #QY% G>3?)OD0"H Y@1O/H&EX
ML?  !B"+?R_XJ ,P1M\)    S(E<!X D^=@+7BR\J0(P%MYQ\C@0// %MQ3"
M2/)($7R"!:>3O(P$CSGYQ N>/H&9(A^<@+'RN W>'0   8@BW\O^*@#,$;?"
M0   ,^)%\OO('G "*!V\M/.?GGR?Y( J@. $/SH!) ]>5P'@"Q\O>!Y\K0(
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M.G<"N ]@58'CS5<<O( ' "!Y<^</--QZ   'GR&!\\Z^5(E>!" L/+WB+YY
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M\G^0 ,B1<\:7B !G!(@%CYI=)      Y^>@/0 %2!GA.8%QQY\T?'L
M     "K D@9T2O E^:/B?X    /'F6(@ ?O+CS0<>@!Y\HA*(3KYH>+7P
M       <?,\)4B=_+_BV\\^5(%>!R E^7O'8  "B$@@:72H$J0/0%[Q[ Y>6
M_G#S/"5(D_S1\2_        !S\HQ*,3[Y?\ EOQ] \>98COY* Z^<0( &NT
M H!)7G<#*B:CB3Y3B50$4#9:3/!" S@D,"XXT/'0       ?/*<#/B>0+OB]
MXZ 8LCSYT T/%AY%\RY&RTRXE]Q*  % )*\M/*02K M>+7SJ!GQ+'R=X *@#
M/""_XN//H     %6!GQ(P%OQH..X X>8TBY\M.( %2)Z T'$[RG \^77@ RP
MEWY-\\^</*X"I$^>1_-=Q+\  \>40E&))\T?$_P   00,Z)" L/-%Q+\  QQ
M$[RJ M/+GCV!P G></,\)J. /GF'(V^GGS)$:#CAY9^>/(0%6!& M?+CCJ
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M#RS\G>>P./D0"I G>6_EAY3@" !J.,F1I=(0%KY! X>50'H"X\L/     !#
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MG>7_ !U                  '#RB$A@77%IYZ  Y^0@((%<!W\O^)8
M               C>4PE<!Y\'CSSY, LO+;CL
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MRHU%TMHMCK9+P953:0;RK_G;'E/#'MM7Q9Q3^+/YY<N+ B\SZL1$[L+08@N
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MQ)<6?%]VQY3PQ[;5\6<4_BSC49E,J!&NVX:=44J);0R(\@J*+"K..\]G5UI
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M%W7J"]/^+-+'C7[*O#MIVP;K#]_T12\+)P*Y6,T6;MZ:B9EG]CCI?KAL]<1
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MRLOF%5L)8F2OM,HL7\T7%_4]E[3+I%KA8\,3\-7\%L[ E6T5/YN,F-."Q"F
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MR#1"924<%\Q.0HX+XCH.J*'  :OX/_76B] ;R=$62V@2O[/_Q  4$0$
M              "P_]H " $# 0$_ 7</_\0 %!$!
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M5J!S8>?,56,Y+_NTT#^#==_EWP-[8]1]**!(K$5!.75!J%4J1J8RF@L-AY0
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MOU9J\9<3"--%/6BC8D7()Q9D\4<!C*+*DY&@8&V^N>[-L3:N5YZAK2D(F6K
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MXI;I5U.TJ7*]A8$856)8-P(9%!?RKXX9LSM>R1V1@*Y:;1%_<V,,KJMC+<V
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M)DT(9& CJD"RC)@.)TJ KCRK]5V"N3KR^W_+K?0*)MEN*?PE%$QN;9D;U+W
MTV./M=A63E>!,$_C6=7$6P"QLFP%?-UY\:+57KJGWE*Q\3PF;RL[BE>47DN=
M?)J_+))A844Y/3M%,C!!'UBNNIR9D.9,-;+#.QO#CD0@QZXG;5@2D<PR2"L
MP,4Y8S.10+#+!Q(+R41$8Q"C25GZ4,O364A.68KKR==<<D$.(#RTVRQF/*<L
MY7FN/$8$E?T]E2N%4D.#0U;5(R+!%IF$<4&("/.09% 8<28CF8B1^<,V5+:
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M,5.P(J=KJJ7*7',F%IM#C+*[J3"-H$<#.X3&_&O*^VTHP7/Q,.E:_3V>EI,
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M-0IUVOVI-;2J<EA5S,;[I(YS:=5NUD;"4$AC*,Y8O87&K(@\+S6E*RU3<4[
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M:7#7UB-B:L*6B)L&I,>WS75"A99M*N+WZ^0;%U:]A86;7RF046%%;JN"9=:
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MPC8+C;4/PL#$P+E7*,G&<0S0\O$@X3QF..MLU;QV ^KA38ZN*BNQI!5,8L5
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M#^^ER3C0K8Q#@ Y(A- LIK[94CL*O1C;!;I20(TY RFFW1V5E(6D%LV[%E[
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MLI-(A&L+3(W)43"3@MS],Z>P67J/ZFS40&'+8(ZOQ8-/91ELWFK,?M\\#7M
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MNMIQLOK07Z=99/SI4\,KUR[V12(/KY,.:SR+*[J3JX6TW%##85;58'$R[*S
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MQ$4VUXRR:"O02U_:.QS<OL5Z!?H\7%X=KZE%KOEV>2?#TNYX]<O9Z_S!S?\
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ML(V%6U6!R"PLRN:,Q'7.*<Q&"6$AE'*4)QS'.<?%[JAL,2278[=$XQ@F<V%
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M9P%Q4*]%:JZBXCD:V+-=HYW5(N27CTE]4F-A+8-%N+REV*I?B-:P2:;NK&W
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M%K3,3,OAL&&53#.N9-Q1D.<QEE=U)AA0T@D T,9I$496:@%@?TN2ZKVYV_\
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M6K_[-"9>D15-M(-=:HQRS865?%%E%Y9A)U)@RCB;82+M*-+DD%A9E<T8% P
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M&9HZ\ZE)A>6<A-)-QM7)(2RNR<7@6380MV&N[-KMA8U;#%78R6>KGEI,5EB
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M>T]N23M$1YK-NJQ]OJ<R]C5S:847MZMN'&V@R1?/_5MI3.)M=6T40?(DWU,
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M2(AS&0I<MPD& 3SH-NJ&*:U@N!O"YIKG&95G&<A94<3,PDZOF42!D91@PQM
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M@^?M@[[=KX5L^M)=KVVVCSP(GQD6>1982=28"VFXH8B[2C2Y(F7968#*!0,
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MNOJQ5.:BU79&-RC7,,">V>*8:RF>)\@1@K2HP9LBL+HE&WRWLK.2MQDXXUJ
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MC_<+?5'K&XJDKM>"CCE$V-&SPKV F86$P9=L77?$*:#X2KE&U7LM*SCXFSG
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ME/9!*\P8+TN8=]9J0847KV%%\8B"B?,\P&QP3W2E;1DNP*EU>EKZ.L%X9ZR
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M(--8K(62]Y0Q1?"1'/J<FON\=R7^F>]MX\[*1>Y:G7PH7)PLD[8K3!"UZNN
M).2^$5;/)R.!25*(FK[_ .D;R^ER'<0'O%!RM8IKO6G'^W<BKE^%\2C!1?-9
M>EX04@\PK':N5 [3#,Y]EK4U+_WO3]@1M-?L,\+IA!^2=_KIV\'1748L%U&$
M,V(\H=&3PV!C&93PE/7MPKH<2]Y7P8(MY&GT7A3FI:5W,=9.;/MMFNVAV\+"
M"YU^TOC*Y1RS]B^N5[G5L]XL)5Q8PP\-B6N5XL,WN5VU9B7%RL%IZIU=R9(O
MU=L^M%0T,F,K=[<Q!<@M.IX!3Q([0V@7.R]E-=L(0XPLPO&F2OU&8MDS@9'5
M"!6*6.&$_A910_$O>;?35=H/C#/M(B2M[H8/(@YS#XV=/7,\B\A&SU^'),KE
M.(FU;WO&RT]4Z^PGJ5(K$MH_?B5X\W%PP;7ZI9LOL[Y14PUK@BQ1C=JVTN=.
M1L#?;V\-U7O:RC7V-HQ=59XVR/1J8L2L3@+6=OM]3J,P(-3!C<P2 B.1H\?Q
MK-U:'[5G<6&Y6EBSQA#V'K#5]E;;/PKC$N+E8*0G& 0PP\O$8X0QB.!T[:M>
MY9[#L%:&IPP9>+U9[;F=B_>URY!%8+Q+BC0ME6RMP!V3$3->#&%'+?=Y[7L]
M&E7;/3*+U.M7I*Q6]:H1PMW%MM0RB45G3S%:HK*A@W DAGNPEB&)0D)';IT#
M%_5*7%4KL&%'U4FJFFL&.F2W6"U'QM6 NE14#50(KE@CL2%<45 PP/H:R[8#
MNQU[5HW16E8RJ\DBJ\%"1SM!PU2$Y"-)D&-.V:-PM#R08R#9$ :.QT=/?I"8
MBV).ZK4K54;4!E#!D:[P3B@Q 1SBB:,,$B,Q88EXDGC+EAKC%AH]FU\IQ%71
M%8:Y%@CTVFV,T3.1,"Y5RS372JKBIJT(C4DLAB 3!: 3V'ZL4/Q0[>E8=O>%
M@O:SUSUW15NQ\8U>0KOM>:N'85!W\MFZ\4PV-M]9TB_S&:MV3Y,/$"9Z#;)
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MK]PPLKJ\K&8CR-_U+M?J-O\ K?V?HC.(44/]>#]ZM?DG=V7D.:#H>I#7^FX
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M%!B7%RL%*<G&./F8A"2^<YRSG]!EYYE=)))<S;CC9AKJJ*KCD9AEE@TH" N
M4)E,8LXC$.,ISEB.,Y^+#5O2J2\RJ,+B/OF>J^K(@"$D^K05K2C"3J^9176C
M>M2.JP/W#VU HIUE[DB=+7W&T[!9,2<<F/!GFB$<=$)BUMGC2S%=>3KHLOV]
MFP)41&,&=:'B69_"EMZHVO\ T#'TE0&_X!GK75]\O^T*VQ1HQ_\ 0N5FT?\
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MR,_9/;^3L-I LUK=Y(S&)>Z,$64*%9%%9=)))<*B::@1KJJ*KCB%=99<,8"
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M_NK<_E(\=.VBON&%>7)T/DS7VD AZN"-^TV@$K.5?&;JP?<8*21RP3K18RQ
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M=98E[E98M'(WUUJR]"$ IL3$!:/#:J4Q#V#R]951M#YQ*7V@EN.KU]PPKQ8
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M  (!! $"!@(# 0       0 0$2 A,4% ,&%047&!L>'P\:'!T6#_V@ ( 0$
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M,14A'SWI(?\ ;R[6;55M\YT(DN;(L5'B.7D\X>4L)\NM!@7O84/:%\@#889
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MV2(7$[GP=0X.D? 3)YB/MR*(G4TK!ZN&[DMI%82R"!IZ<)2:.;#5;Z7I@?\
M2#$?)6ZAXC8$O]_$QZT\,@#PGI5DI?.<7.W/;'9/_;(-?B]Z-F;7LB=*^-%
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M,3,(^ .^%;]>F*VH)%.J3' 1PZ;H;$&)'JY H4-!7U36%5T#00T1542B'Y%
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MP6:(I,+D5M6FZFV-D*WGM/\ ;:J$HP'WY0[.9=7-,>J1+) EKI3 M@5WZ5Y
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M.O&CDEI%83,*23V3I(4J^BB!*]D/<TEKQ6H@;]Y'Y[#A)V-8I C4! 0T+K]
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M^!_<!<>N$\?DX\']4H2)#[ \THNC.D!ZICU%^#&/-"'GQQU""-0(VOB%07R
M-AAD!%J1O!MVE:2L(W$AQ5ZH597^NTA[R.@W@R@*K@&@AKBJHE$:,SWM4#^,
M))B%+Q0UWE*.+5=VFUWCEBMV>T743H\U*[>JI4 4'^VU4)1@/O[/-2NWJH7
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MSI%($:@0600T5BYVIMQ3AAM4T)! ,FTR$![:H$1CV:#)H;*B#)W$%\@#889
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M-4;Z,;*Q[:J(I^;,QU#>*4(LHD-(B72VR0.Z[E-&6+?%6>E*(:UKP-$U#$!
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MJ7)'#PIF1KURI+)"+T, B^6EQJWCY47W]$Q"S#W7K6VI!O0+B-%X#BKE5BE
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M2M)6$X*"G[ >U],H?QZ,>$>]50"R*#,\C4#S2M#J$"__  8W9!4BCHSQGB(
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M#C8T4F$6/>H_T?# R;Y[.G-.<"ZPDJAU4ZT=BN5>[@<$ACY T:\S"<.CTXV
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M'0)M+B8R2K(FC_&!2 Y[F7'+P#3TV-C )_+Q&FQ^3"2'$G:8ZYB(HZ,\9XB
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M"                         " 22222222222"222222222220""
M    " 0          0""         2 0 "0        0""         00  0
M         0""        " 0  2         0""        """"20
M 0""        "2"0 00        0""         0200000       0""
M   ""0 2  02       0""        2 "0"  "       0""       " 0
M0 22       0""       " 0 0  "0       0""         2 " 2 0
M   0""       "0 " 0" 0       0""        "0 "0 0        0""
M  2   22 "" 20  "    0""   "220"0 ""200  " "   0""   2    00
M" "2" 0 "2   0""  """"02 "0"""" 2""0   0""   2 "20000022"02"
M "   0""   "" 02002"0  202     0""   ""020        2  0   0""
M    0 0 " 00      "0   0""   2" 2""0"0       "   0""  "0  0
M2" 2       "   0""   2"2""  2      """   0""   002 2 "2 0
M 022   0""   2"20020 000   020   0""  "" 0"""0" " 22 0020  0
M""  2" 0""2"0"20002" 2"  0""  "  " 0 0 "0 " 02   0 0""   " 0
M 22022""20"0  "  0""    0 "222"0"2   02 "  0"""2 20"2002""
M0 "    " 0""  2 ""0 0 "02 0220"0"" 0""  "  02 2"2" 2   "20""
M 0""      """0 0 2"  "2"   0"" "2 0  "0 0      0  "2 0""
M 0 " 0022 2  "2  0 0""  " "   "2022 "002 2"  0""    00   ""
M   00"  "  0" "  "0""  0   0 "  200"00""2  0 22  "  2202 0 "
M 2  ""  202"000    "  ""0     " 00   20 "   "20"0" "0  "   "
M0""" 0     000 0 0220  2 " "2  00    "  ""0         "20   0
M022""  "0    0  2 "20002 0 """ "   0 "   "20"20 00  0   "0
M0  0    20 0  0  20""   """  "    "002"22   22"  0 22"0
M   20         "  "  "     0 "02            0        "   "0
M        "02 2 0   00002          " 00000   """"   "0       2
M 02 " 2  " "0   22      2"0"02  2  0 2 0               02 2
M 00"22 0 "02  2    "00  "0"02000"      2"0  20 "2   " 2 2 ""
M2" "2"    0"0 ""   "   0 02"" 0"   "2""20" 0 22 2" 0022    "
M"0000"2     202"0 20000 02 20"0"2        "   ""020000"  " 0
M       0002 0"" 2"20"  0          ""0 0"20"0 0"20
M   0"0" 20 0 0               2 000   20                20 "
M"  2                  2"  0 2                    0220"
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MV.\2]X].5'XOWP(]J,G$E@I9%+-P")R;1EXQ,/N;"4M\7$.E-K_<"SM6@E$
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M%0Z(3@:I)0<8*-N0AT]:@+I/6ZHK';B"E"+'3$1VRQY%^I0K9:+!&JYH3NI
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M1=0;AM*1_GK+$U4"Z^@C5@_Q8T6D*]Y] '>S,F(E]'N[1R0;M6WWX)<##-]
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MIZ7^(#Q (49&I\4,L4,#4@9MP J@%Y9A#H!'6Q'@[  /;/I2QD5D_.,.H!^
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M A1D:GP.@/QCP#5Y43)T= !X>L="T17@HDK DIX$4U=L?@[L_8YB,!J,@#B
M0HR-3X(Z($ZDN/>WMF=@ ?QAM&#Z<O1&;IE8'NI'[9"BE601 "W'2IC%3])
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ML:^2V?.A(%-<CC^,I.='!=4(BD[DO8YV !_&&T8/I4,L4(#EQKD3ZK YD.(
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M7NQN[:A8F(C+=A1R 2?TC365<0D'UH]X@2PH]5LD7*G X*&&C6RBLJZ/<OP
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MD _B?@JK\[48BI4SB-" %N.E3&*GZ_#:9)@..3 @59#O+WC\6J/)_KD*+P$
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581229072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">F-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ASPEN INSURANCE HOLDINGS LIMITED<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001267395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633575528096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">$ 3,788,600<span></span>
</td>
<td class="nump">$ 4,881,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsAvailableForSale', window );">Short-term investments, available for sale</a></td>
<td class="nump">52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsTradingAtFairValue', window );">Short-term investments, trading at fair value</a></td>
<td class="nump">6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CatastropheBond', window );">Catastrophe bonds, trading at fair value (amortized cost &#8212; 2022: $5.1 and 2021: $5.3)</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PrivatelyheldInvestments', window );">Privately-held Investments</a></td>
<td class="nump">533,000<span></span>
</td>
<td class="nump">307,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments, equity method</a></td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments, at fair value (2)</a></td>
<td class="nump">221,300<span></span>
</td>
<td class="nump">151,300<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_InvestmentsExcludingDerivativeAssets', window );">Investments, Excluding Derivative Assets</a></td>
<td class="nump">6,085,800<span></span>
</td>
<td class="nump">6,516,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents (including cash within consolidated variable interest entities of &#8212; $65.7448377 and $75.15054353)</a></td>
<td class="nump">959,200<span></span>
</td>
<td class="nump">1,314,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsAndOtherReceivablesNetAbstract', window );"><strong>Reinsurance recoverables:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Unpaid losses recoverable from reinsurers (net of allowance for expected credit losses of 2022: $3.7 &#8212; 2021: $3.3)</a></td>
<td class="nump">4,897,700<span></span>
</td>
<td class="nump">3,298,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidReinsurancePremiums', window );">Ceded unearned premiums</a></td>
<td class="nump">737,300<span></span>
</td>
<td class="nump">596,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Underwriting premiums receivables (net of allowance for expected credit losses of 2022: $25.0 &#8212; 2021: $30.2)</a></td>
<td class="nump">1,482,400<span></span>
</td>
<td class="nump">1,304,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">179,400<span></span>
</td>
<td class="nump">153,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset', window );">Funds withheld</a></td>
<td class="nump">102,600<span></span>
</td>
<td class="nump">103,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs</a></td>
<td class="nump">319,000<span></span>
</td>
<td class="nump">290,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives at fair value</a></td>
<td class="nump">56,200<span></span>
</td>
<td class="nump">12,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations', window );">Receivables for securities sold</a></td>
<td class="nump">13,500<span></span>
</td>
<td class="nump">19,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Office properties and equipment</a></td>
<td class="nump">81,300<span></span>
</td>
<td class="nump">114,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use operating lease assets</a></td>
<td class="nump">72,800<span></span>
</td>
<td class="nump">83,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReceivable', window );">Income taxes refundable</a></td>
<td class="nump">20,800<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">120,100<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">7,400<span></span>
</td>
<td class="nump">8,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="nump">21,800<span></span>
</td>
<td class="nump">21,900<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,157,300<span></span>
</td>
<td class="nump">13,844,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_InsuranceReserveAbstract', window );"><strong>Insurance reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Losses and loss adjustment expenses</a></td>
<td class="nump">7,710,900<span></span>
</td>
<td class="nump">7,611,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnearnedPremiums', window );">Unearned premiums</a></td>
<td class="nump">2,457,500<span></span>
</td>
<td class="nump">2,112,300<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_InsuranceReserves', window );">Total insurance reserves</a></td>
<td class="nump">10,168,400<span></span>
</td>
<td class="nump">9,724,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsurancePayable', window );">Reinsurance premiums</a></td>
<td class="nump">1,980,100<span></span>
</td>
<td class="nump">575,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Payables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">10,900<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued expenses and other payables (4)</a></td>
<td class="nump">201,800<span></span>
</td>
<td class="nump">289,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Payables for securities purchased</a></td>
<td class="nump">6,900<span></span>
</td>
<td class="nump">44,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">95,500<span></span>
</td>
<td class="nump">115,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities under derivative contracts</a></td>
<td class="nump">34,900<span></span>
</td>
<td class="nump">13,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">299,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">299,900<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">12,799,300<span></span>
</td>
<td class="nump">11,069,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities (see Note&#160;20)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Ordinary shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">60,395,839 ordinary shares of par value $0.01 each (December&#160;31, 2021 &#8212; 60,395,839 shares)</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,514,700<span></span>
</td>
<td class="nump">1,514,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,349,000<span></span>
</td>
<td class="nump">1,382,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss)</a></td>
<td class="num">(506,300)<span></span>
</td>
<td class="num">(123,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,358,000<span></span>
</td>
<td class="nump">2,774,800<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">15,157,300<span></span>
</td>
<td class="nump">13,844,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed Income Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,788,600<span></span>
</td>
<td class="nump">4,881,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed Income Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebt', window );">Debt Securities, Trading</a></td>
<td class="nump">1,475,500<span></span>
</td>
<td class="nump">1,157,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsAvailableForSale', window );">Short-term investments, available for sale</a></td>
<td class="nump">52,000<span></span>
</td>
<td class="nump">10,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsTradingAtFairValue', window );">Short-term investments, trading at fair value</a></td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CatastropheBond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Catastrophe Bond</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CatastropheBond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_InsuranceReserveAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance Reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_InsuranceReserveAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_InsuranceReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_InsuranceReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_InvestmentsExcludingDerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments, Excluding Derivative Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_InvestmentsExcludingDerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PrivatelyheldInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Privately-held Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PrivatelyheldInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ShortTermInvestmentsAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investments, available for sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ShortTermInvestmentsAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ShortTermInvestmentsTradingAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investments, trading at fair value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ShortTermInvestmentsTradingAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized on contract remaining in force.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124506110&amp;loc=d3e32546-158582<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the reinsurer's funds held on its behalf by the ceding insurer, including funds held in trust, under reinsurance treaties or contracts with the assuming insurer as security for the payment of the obligations thereunder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.2,10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FundsHeldUnderReinsuranceAgreementsAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsAndOtherReceivablesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsAndOtherReceivablesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidReinsurancePremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The unexpired portion of premiums ceded on policies in force as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 340<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6485982&amp;loc=d3e22818-158507<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidReinsurancePremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount receivable from broker-dealers and clearing organizations, including, but not limited to, securities failed-to-deliver, certain deposits for securities borrowed, open transactions, good faith and margin deposits, commissions and floor brokerage receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=35710130&amp;loc=d3e41645-110958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633492100384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Fixed income securities, available for sale amortized cost</a></td>
<td class="nump">$ 4,231,200,000<span></span>
</td>
<td class="nump">$ 4,131,300,000<span></span>
</td>
<td class="nump">$ 4,823,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent', window );">Available-for-sale, net of allowance for expected credit losses</a></td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="nump">7,700,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebtAmortizedCost', window );">Fixed income securities, trading, amortized cost</a></td>
<td class="nump">1,552,700,000<span></span>
</td>
<td class="nump">1,576,700,000<span></span>
</td>
<td class="nump">1,155,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_Shortterminvestmentsavailableforsaleamortizedcost', window );">Short term investments available for sale, amortized cost</a></td>
<td class="nump">169,300,000<span></span>
</td>
<td class="nump">52,400,000<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsTradingAmortizedCost', window );">Short-term investments, trading, amortized cost</a></td>
<td class="nump">11,000,000.0<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CatastropheBondsFairValueDisclosure', window );">Catastrophe Bonds, Fair Value Disclosure</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="nump">5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue', window );">Privately-held investments, cost, trading at fair value</a></td>
<td class="nump">496,100,000<span></span>
</td>
<td class="nump">537,700,000<span></span>
</td>
<td class="nump">309,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities', window );">Cash and cash equivalents, including cash within variable interest entities</a></td>
<td class="nump">11,400,000<span></span>
</td>
<td class="nump">65,700,000<span></span>
</td>
<td class="nump">75,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts', window );">Premium Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 21,600,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="nump">60,395,839<span></span>
</td>
<td class="nump">60,395,839<span></span>
</td>
<td class="nump">60,395,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesAllowance', window );">Unpaid losses recoverable from reinsurers (net of allowance for expected credit losses of 2022: $3.7 &#8212; 2021: $3.3)</a></td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CashAndCashEquivalentsIncludesRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">312,100,000<span></span>
</td>
<td class="nump">232,100,000<span></span>
</td>
<td class="nump">364,900,000<span></span>
</td>
<td class="nump">$ 387,300,000<span></span>
</td>
<td class="nump">$ 296,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PrivatelyheldInvestments', window );">Privately-held Investments</a></td>
<td class="nump">482,400,000<span></span>
</td>
<td class="nump">533,000,000.0<span></span>
</td>
<td class="nump">307,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments, at fair value (2)</a></td>
<td class="nump">213,400,000<span></span>
</td>
<td class="nump">221,300,000<span></span>
</td>
<td class="nump">151,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=ahl_AccruedExpensesMember', window );">Accrued expenses | Asset Management Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrentAndNoncurrent', window );">Intercompany funds due to affiliates</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=ahl_AccruedExpensesMember', window );">Accrued expenses | Management Consulting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrentAndNoncurrent', window );">Intercompany funds due to affiliates</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloOriginatingPartnershipMember', window );">Apollo originating partnership | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PrivatelyheldInvestments', window );">Privately-held Investments</a></td>
<td class="nump">42,700,000<span></span>
</td>
<td class="nump">44,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments, at fair value (2)</a></td>
<td class="nump">12,600,000<span></span>
</td>
<td class="nump">12,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloRealEstateFundMember', window );">Apollo real estate fund | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments, at fair value (2)</a></td>
<td class="nump">22,900,000<span></span>
</td>
<td class="nump">25,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Fixed maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Fixed income securities, available for sale amortized cost</a></td>
<td class="nump">4,400,500,000<span></span>
</td>
<td class="nump">4,183,700,000<span></span>
</td>
<td class="nump">4,833,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebtAmortizedCost', window );">Fixed income securities, trading, amortized cost</a></td>
<td class="nump">$ 11,000,000.0<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CashAndCashEquivalentsIncludesRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents includes restricted cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CashAndCashEquivalentsIncludesRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents, including cash within variable interest entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CatastropheBondsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Catastrophe Bonds, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CatastropheBondsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PrivatelyheldInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Privately-held Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PrivatelyheldInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Privately-held investments, amortized cost, trading at fair value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ShortTermInvestmentsTradingAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investments, trading, amortized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ShortTermInvestmentsTradingAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_Shortterminvestmentsavailableforsaleamortizedcost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term investments available for sale, amortized cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_Shortterminvestmentsavailableforsaleamortizedcost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.12(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=d3e56071-112765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on reinsurance recoverable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesDebtAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investments in debt securities classified as trading.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesDebtAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=ahl_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=ahl_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloOriginatingPartnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloOriginatingPartnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloRealEstateFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloRealEstateFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633575128736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Net earned premiums</a></td>
<td class="nump">$ 1,287.4<span></span>
</td>
<td class="nump">$ 1,327.2<span></span>
</td>
<td class="nump">$ 2,688.7<span></span>
</td>
<td class="nump">$ 2,410.5<span></span>
</td>
<td class="nump">$ 2,527.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (1)</a></td>
<td class="nump">129.4<span></span>
</td>
<td class="nump">88.7<span></span>
</td>
<td class="nump">188.1<span></span>
</td>
<td class="nump">147.5<span></span>
</td>
<td class="nump">154.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized investment gains</a></td>
<td class="nump">36.1<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">56.2<span></span>
</td>
<td class="nump">98.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">49.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,452.9<span></span>
</td>
<td class="nump">1,418.4<span></span>
</td>
<td class="nump">2,890.0<span></span>
</td>
<td class="nump">2,628.9<span></span>
</td>
<td class="nump">2,830.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet', window );">Losses and loss adjustment expenses</a></td>
<td class="nump">717.1<span></span>
</td>
<td class="nump">767.7<span></span>
</td>
<td class="nump">1,680.0<span></span>
</td>
<td class="nump">1,693.3<span></span>
</td>
<td class="nump">1,840.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense', window );">Acquisition costs</a></td>
<td class="nump">192.9<span></span>
</td>
<td class="nump">216.5<span></span>
</td>
<td class="nump">431.8<span></span>
</td>
<td class="nump">414.1<span></span>
</td>
<td class="nump">465.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General, administrative and corporate expenses (2)</a></td>
<td class="nump">232.7<span></span>
</td>
<td class="nump">233.4<span></span>
</td>
<td class="nump">494.2<span></span>
</td>
<td class="nump">418.0<span></span>
</td>
<td class="nump">410.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">42.9<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">33.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivatives</a></td>
<td class="num">(19.6)<span></span>
</td>
<td class="nump">84.9<span></span>
</td>
<td class="nump">80.5<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
<td class="nump">65.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesGainLoss', window );">Realized and unrealized investment losses (3)</a></td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">128.9<span></span>
</td>
<td class="nump">182.6<span></span>
</td>
<td class="nump">47.4<span></span>
</td>
<td class="nump">27.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Net realized and unrealized foreign exchange (gains)/losses</a></td>
<td class="num">(13.7)<span></span>
</td>
<td class="nump">75.2<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">40.0<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.1<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_Expense', window );">Total expenses</a></td>
<td class="nump">1,197.8<span></span>
</td>
<td class="nump">1,365.3<span></span>
</td>
<td class="nump">2,917.0<span></span>
</td>
<td class="nump">2,593.8<span></span>
</td>
<td class="nump">2,868.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) from operations before income taxes</a></td>
<td class="nump">255.1<span></span>
</td>
<td class="nump">53.1<span></span>
</td>
<td class="num">(27.0)<span></span>
</td>
<td class="nump">35.1<span></span>
</td>
<td class="num">(38.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit/(expense)</a></td>
<td class="num">(36.2)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">78.1<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
<td class="num">(18.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss)</a></td>
<td class="nump">218.9<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
<td class="nump">51.1<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
<td class="num">(56.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income/(loss) attributable to Aspen Insurance Holdings Limited&#8217;s ordinary shareholders</a></td>
<td class="nump">196.7<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available for sale investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification adjustment for net realized gains/(losses) on investments included in net income/(loss)</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">27.8<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="num">(20.4)<span></span>
</td>
<td class="num">(67.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Change in net unrealized (losses)/gains on available for sale securities held</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="num">(343.8)<span></span>
</td>
<td class="num">(447.2)<span></span>
</td>
<td class="num">(137.2)<span></span>
</td>
<td class="nump">175.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Net change from current period hedged transactions</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in foreign currency translation adjustment</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="num">(19.7)<span></span>
</td>
<td class="num">(30.9)<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="num">(11.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive (loss)/income, before income taxes</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="num">(342.1)<span></span>
</td>
<td class="num">(407.2)<span></span>
</td>
<td class="num">(142.4)<span></span>
</td>
<td class="nump">96.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Change in net unrealized gains on available for sale securities held</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">29.5<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Total income tax benefit/(expense) allocated to other comprehensive (loss)</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">30.1<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss)/income, net of tax</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="num">(312.0)<span></span>
</td>
<td class="num">(383.3)<span></span>
</td>
<td class="num">(142.7)<span></span>
</td>
<td class="nump">96.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive (loss)/income attributable to Aspen Insurance Holdings Limited's ordinary shareholders</a></td>
<td class="nump">210.7<span></span>
</td>
<td class="num">(285.8)<span></span>
</td>
<td class="num">(332.2)<span></span>
</td>
<td class="num">(112.9)<span></span>
</td>
<td class="nump">40.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RealEstateFundsMember', window );">Real estate fund | Investment Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember', window );">Asset Management Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember', window );">Asset Management Arrangement | Investment Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">(5.2)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember', window );">Management Consulting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5.0)<span></span>
</td>
<td class="num">$ (5.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember', window );">Management Consulting Agreement | General, administrative and corporate expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ahl_RelatedPartyInvestmentIncomeMember', window );">Related party investment income | Investment Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ahl_ClassABNotesMember', window );">Apollo, Class A &amp; B Notes | Gain (Loss) on Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">$ (2.0)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_Expense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_Expense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity), investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6480726&amp;loc=d3e6691-158385<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InvestmentIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InvestmentIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ahl_RelatedPartyInvestmentIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ahl_RelatedPartyInvestmentIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ahl_ClassABNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ahl_ClassABNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GainLossOnInvestmentsMember1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GainLossOnInvestmentsMember1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633575548864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preference shares</div></th>
<th class="th"><div>Ordinary shares</div></th>
<th class="th"><div>Preference shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Ordinary shares</div>
</th>
<th class="th">
<div>Retained earnings </div>
<div>Preference shares</div>
</th>
<th class="th"><div>Cumulative foreign currency translation adjustments:</div></th>
<th class="th"><div>Unrealized appreciation on available for sale investments:</div></th>
<th class="th"><div>Gain on derivatives, net of taxes</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,201.7<span></span>
</td>
<td class="nump">$ 1,502.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (165.5)<span></span>
</td>
<td class="nump">$ 84.5<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution', window );">Capital contribution</a></td>
<td class="nump">$ 268.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="num">(56.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (44.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.9)<span></span>
</td>
<td class="nump">108.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,887.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,469.7<span></span>
</td>
<td class="nump">1,397.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177.4)<span></span>
</td>
<td class="nump">192.5<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Accounting Standards Update 2016-13 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution', window );">Capital contribution</a></td>
<td class="nump">45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(44.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="num">(157.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,774.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">$ 753.5<span></span>
</td>
<td class="nump">1,514.7<span></span>
</td>
<td class="nump">1,382.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(156.0)<span></span>
</td>
<td class="nump">34.6<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Accounting Standards Update 2016-13 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="num">(123.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="nump">48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
<td class="num">(22.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.7)<span></span>
</td>
<td class="num">(286.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution', window );">Capital contribution</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="nump">51.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40.0)<span></span>
</td>
<td class="num">(44.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30.9)<span></span>
</td>
<td class="num">(367.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,469.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">753.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,388.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175.7)<span></span>
</td>
<td class="num">(251.9)<span></span>
</td>
<td class="num">(7.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="num">(435.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,358.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">753.5<span></span>
</td>
<td class="nump">$ 1,514.7<span></span>
</td>
<td class="nump">1,349.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(186.9)<span></span>
</td>
<td class="num">(333.2)<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Accounting Standards Update 2016-13 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="num">(506.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="nump">218.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20.0)<span></span>
</td>
<td class="num">$ (22.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,548.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 753.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,525.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (179.3)<span></span>
</td>
<td class="num">$ (322.5)<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="num">$ (492.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to Additional Paid In Capital, Capital Contribution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_AdjustmentToAdditionalPaidInCapitalCapitalContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966630&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633492119456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows (used in)/from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Net income/(loss)</a></td>
<td class="nump">$ 51.1<span></span>
</td>
<td class="nump">$ 29.8<span></span>
</td>
<td class="num">$ (56.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income/(loss) to net cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">43.3<span></span>
</td>
<td class="nump">53.3<span></span>
</td>
<td class="nump">45.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of lease assets</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use operating lease assets</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_Interestonoperatingleaseliabilities', window );">Interest on operating lease liabilities</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized investment gains</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(56.2)<span></span>
</td>
<td class="num">(98.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesGainLoss', window );">Realized and unrealized investment losses</a></td>
<td class="nump">182.6<span></span>
</td>
<td class="nump">47.4<span></span>
</td>
<td class="nump">27.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred tax expense/(benefit)</a></td>
<td class="num">(104.6)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_GainsLossesOnInvestmentAndForeignExchange', window );">Net realized and unrealized investment foreign exchange (gains)/losses</a></td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
<td class="num">(25.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Net change from current period hedged transactions</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome', window );">Unrealized (gain)/loss on real estate fund in net investment income</a></td>
<td class="num">(14.5)<span></span>
</td>
<td class="num">(20.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Insurance reserves:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve', window );">Losses and loss adjustment expenses</a></td>
<td class="nump">99.1<span></span>
</td>
<td class="nump">483.3<span></span>
</td>
<td class="nump">146.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInUnearnedPremiums', window );">Unearned premiums</a></td>
<td class="nump">345.2<span></span>
</td>
<td class="nump">310.2<span></span>
</td>
<td class="nump">68.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract', window );"><strong>Reinsurance recoverables:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_UnpaidLosses', window );">Unpaid losses</a></td>
<td class="nump">1,599.6<span></span>
</td>
<td class="nump">109.5<span></span>
</td>
<td class="nump">864.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums', window );">Ceded unearned premiums</a></td>
<td class="num">(141.2)<span></span>
</td>
<td class="num">(143.1)<span></span>
</td>
<td class="num">(9.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="num">(26.4)<span></span>
</td>
<td class="num">(19.4)<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs</a></td>
<td class="num">(28.2)<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
<td class="num">(13.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReinsurancePayables', window );">Reinsurance premiums payable</a></td>
<td class="nump">1,404.4<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">129.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements', window );">Funds withheld</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(5.7)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPremiumsReceivable', window );">Premiums receivable</a></td>
<td class="num">(177.8)<span></span>
</td>
<td class="num">(142.9)<span></span>
</td>
<td class="nump">79.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other payable</a></td>
<td class="num">(87.0)<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives', window );">Fair value of derivatives and settlement of liabilities under derivatives</a></td>
<td class="num">(21.7)<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
<td class="num">(87.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_IncreaseDecreaseInLongTermDebt', window );">Long-term debt and loan notes issued by variable interest entities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease liabilities</a></td>
<td class="num">(15.5)<span></span>
</td>
<td class="num">(17.5)<span></span>
</td>
<td class="num">(17.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in)/from operating activities</a></td>
<td class="num">(55.0)<span></span>
</td>
<td class="nump">524.7<span></span>
</td>
<td class="num">(672.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows (used in)/from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">(Purchases) of fixed income securities &#8212; Available for sale</a></td>
<td class="num">(1,613.9)<span></span>
</td>
<td class="num">(2,217.3)<span></span>
</td>
<td class="num">(1,632.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment', window );">(Purchases) of fixed income securities &#8212; Trading</a></td>
<td class="num">(724.6)<span></span>
</td>
<td class="num">(866.4)<span></span>
</td>
<td class="num">(281.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales and maturities of fixed income securities &#8212; Available for sale</a></td>
<td class="nump">2,212.5<span></span>
</td>
<td class="nump">1,538.1<span></span>
</td>
<td class="nump">2,415.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from sales and maturities of fixed income securities &#8212; Trading</a></td>
<td class="nump">293.6<span></span>
</td>
<td class="nump">548.2<span></span>
</td>
<td class="nump">554.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PurchasesOfProceedsFromCatastropheBonds', window );">Net proceeds from catastrophe bonds &#8212; Trading</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PaymentsforAvailableforsaleSecuritiesShortterm', window );">(Purchases) of short-term investments &#8212; Available for sale</a></td>
<td class="num">(55.9)<span></span>
</td>
<td class="num">(17.2)<span></span>
</td>
<td class="num">(216.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm', window );">Proceeds from sale of short-term investments &#8212; Available for sale</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">99.6<span></span>
</td>
<td class="nump">246.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">(Purchases) of short-term investments &#8212; Trading</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(26.8)<span></span>
</td>
<td class="num">(58.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments &#8212; Trading</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">60.8<span></span>
</td>
<td class="nump">103.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PaymentstoAcquirePrivatelyheldInvestments', window );">(Purchases) of privately-held investments &#8212; Trading</a></td>
<td class="num">(377.9)<span></span>
</td>
<td class="num">(205.1)<span></span>
</td>
<td class="num">(92.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ProceedsfromSaleofPrivatelyheldInvestments', window );">Proceeds from sale of privately-held investments &#8212; Trading</a></td>
<td class="nump">147.4<span></span>
</td>
<td class="nump">182.1<span></span>
</td>
<td class="nump">64.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased', window );">Net change in (payable)/receivable for securities (purchased)/sold</a></td>
<td class="num">(31.8)<span></span>
</td>
<td class="nump">26.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">(Purchases) of other investments</a></td>
<td class="num">(62.5)<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash', window );">Net proceeds from sales of other investments</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">71.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMachineryAndEquipment', window );">Net sales/(purchases) of fixed assets</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="num">(64.5)<span></span>
</td>
<td class="num">(40.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_InvestmentInMultilineReinsurer', window );">Investment in multiline reinsurer</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PaymentsForProceedsFromOtherInvestments', window );">Net (purchases)/sales of investments, equity method</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in)/from investing activities</a></td>
<td class="num">(196.5)<span></span>
</td>
<td class="num">(950.3)<span></span>
</td>
<td class="nump">1,151.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows used in/from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Capital contribution</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">45.0<span></span>
</td>
<td class="nump">268.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid on ordinary shares</a></td>
<td class="nump">40.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Dividends paid on preference shares</a></td>
<td class="num">(44.6)<span></span>
</td>
<td class="num">(44.5)<span></span>
</td>
<td class="num">(44.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in)/from financing activities</a></td>
<td class="num">(84.6)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">223.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate movements on cash and cash equivalents</a></td>
<td class="num">(18.8)<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease)/increase in cash and cash equivalents</a></td>
<td class="num">(354.9)<span></span>
</td>
<td class="num">(433.2)<span></span>
</td>
<td class="nump">716.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">1,314.1<span></span>
</td>
<td class="nump">1,747.3<span></span>
</td>
<td class="nump">1,030.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of period (1)</a></td>
<td class="nump">959.2<span></span>
</td>
<td class="nump">1,314.1<span></span>
</td>
<td class="nump">1,747.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CashAndCashEquivalentsIncludesRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">232.1<span></span>
</td>
<td class="nump">364.9<span></span>
</td>
<td class="nump">296.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Net cash paid during the period for income taxes</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">15.7<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid during the period for interest</a></td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CashAndCashEquivalentsIncludesRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents includes restricted cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CashAndCashEquivalentsIncludesRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of derivatives and settlement of liabilities under derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_GainsLossesOnInvestmentAndForeignExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains (losses) on investment and foreign exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_GainsLossesOnInvestmentAndForeignExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_IncreaseDecreaseInLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable on long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_IncreaseDecreaseInLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_Interestonoperatingleaseliabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest on operating lease liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_Interestonoperatingleaseliabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_InvestmentInMultilineReinsurer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in multiline reinsurer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_InvestmentInMultilineReinsurer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Change in Receivable for Securities Sold or Payable for Securities Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PaymentsForProceedsFromOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for proceeds from other investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PaymentsForProceedsFromOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PaymentsforAvailableforsaleSecuritiesShortterm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Available-for-sale Securities, Short-term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PaymentsforAvailableforsaleSecuritiesShortterm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for (Proceeds from) Investing Activities, Net of Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PaymentstoAcquirePrivatelyheldInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Privately-held Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PaymentstoAcquirePrivatelyheldInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Available-for-sale Securities, Short-term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ProceedsfromAvailableforsaleSecuritiesShortterm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ProceedsfromSaleofPrivatelyheldInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Sale of Privately-held Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ProceedsfromSaleofPrivatelyheldInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PurchasesOfProceedsFromCatastropheBonds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases Of (Proceeds From) Catastrophe Bonds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PurchasesOfProceedsFromCatastropheBonds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_SupplementalDisclosureOfCashFlowsInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental disclosure of cash flow information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_SupplementalDisclosureOfCashFlowsInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_UnpaidLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unpaid losses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_UnpaidLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized (gain)/loss on real estate fund in net investment income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity), investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in funds held under reinsurance agreements or treaty (contract between the reinsurer and the ceding entity stipulating the manner in which insurance written on various risks is to be shared).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPremiumsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the premium receivable balance on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPremiumsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in prepaid reinsurance premiums recorded on the balance sheet, which is needed to adjust net income to arrive at net cash flows provided by or used in operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReinsurancePayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due to other insurance companies when the reporting entity has assumed a portion of the cedant's insurance risk which has resulted in insurance losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReinsurancePayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInUnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInUnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received by a corporation from a shareholder during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633573398192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">$ 3,908,200<span></span>
</td>
<td class="nump">$ 3,788,600<span></span>
</td>
<td class="nump">$ 4,881,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsAvailableForSale', window );">Short-term investments, available for sale</a></td>
<td class="nump">169,300<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsTradingAtFairValue', window );">Short-term investments, trading at fair value</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CatastropheBond', window );">Catastrophe bonds, trading at fair value (amortized cost &#8212; 2022: $5.1 and 2021: $5.3)</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PrivatelyheldInvestments', window );">Privately-held Investments</a></td>
<td class="nump">482,400<span></span>
</td>
<td class="nump">533,000<span></span>
</td>
<td class="nump">307,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments, equity method</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments, at fair value (2)</a></td>
<td class="nump">213,400<span></span>
</td>
<td class="nump">221,300<span></span>
</td>
<td class="nump">151,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_InvestmentsExcludingDerivativeAssets', window );">Investments, Excluding Derivative Assets</a></td>
<td class="nump">6,272,200<span></span>
</td>
<td class="nump">6,085,800<span></span>
</td>
<td class="nump">6,516,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents (including cash within consolidated variable interest entities of &#8212; $65.7448377 and $75.15054353)</a></td>
<td class="nump">1,061,500<span></span>
</td>
<td class="nump">959,200<span></span>
</td>
<td class="nump">1,314,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsAndOtherReceivablesNetAbstract', window );"><strong>Reinsurance recoverables:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Unpaid losses recoverable from reinsurers (net of allowance for expected credit losses of 2022: $3.7 &#8212; 2021: $3.3)</a></td>
<td class="nump">4,658,000<span></span>
</td>
<td class="nump">4,897,700<span></span>
</td>
<td class="nump">3,298,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidReinsurancePremiums', window );">Ceded unearned premiums</a></td>
<td class="nump">837,300<span></span>
</td>
<td class="nump">737,300<span></span>
</td>
<td class="nump">596,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Underwriting premiums receivables (net of allowance for expected credit losses of 2022: $25.0 &#8212; 2021: $30.2)</a></td>
<td class="nump">1,676,800<span></span>
</td>
<td class="nump">1,482,400<span></span>
</td>
<td class="nump">1,304,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">160,300<span></span>
</td>
<td class="nump">179,400<span></span>
</td>
<td class="nump">153,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset', window );">Funds withheld</a></td>
<td class="nump">59,400<span></span>
</td>
<td class="nump">102,600<span></span>
</td>
<td class="nump">103,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs</a></td>
<td class="nump">353,100<span></span>
</td>
<td class="nump">319,000<span></span>
</td>
<td class="nump">290,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives at fair value</a></td>
<td class="nump">17,200<span></span>
</td>
<td class="nump">56,200<span></span>
</td>
<td class="nump">12,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations', window );">Receivables for securities sold</a></td>
<td class="nump">16,600<span></span>
</td>
<td class="nump">13,500<span></span>
</td>
<td class="nump">19,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable', window );">Deferred tax assets</a></td>
<td class="nump">110,900<span></span>
</td>
<td class="nump">140,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_OtherMiscellaneousAssets', window );">Other assets</a></td>
<td class="nump">148,100<span></span>
</td>
<td class="nump">161,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="nump">21,700<span></span>
</td>
<td class="nump">21,800<span></span>
</td>
<td class="nump">21,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,393,100<span></span>
</td>
<td class="nump">15,157,300<span></span>
</td>
<td class="nump">13,844,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_InsuranceReserveAbstract', window );"><strong>Insurance reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Losses and loss adjustment expenses</a></td>
<td class="nump">7,740,900<span></span>
</td>
<td class="nump">7,710,900<span></span>
</td>
<td class="nump">7,611,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnearnedPremiums', window );">Unearned premiums</a></td>
<td class="nump">2,623,500<span></span>
</td>
<td class="nump">2,457,500<span></span>
</td>
<td class="nump">2,112,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_InsuranceReserves', window );">Total insurance reserves</a></td>
<td class="nump">10,364,400<span></span>
</td>
<td class="nump">10,168,400<span></span>
</td>
<td class="nump">9,724,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsurancePayable', window );">Reinsurance premiums</a></td>
<td class="nump">1,833,700<span></span>
</td>
<td class="nump">1,980,100<span></span>
</td>
<td class="nump">575,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Payables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable', window );">Deferred tax liabilities</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued expenses and other payables (4)</a></td>
<td class="nump">171,400<span></span>
</td>
<td class="nump">201,800<span></span>
</td>
<td class="nump">289,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Payables for securities purchased</a></td>
<td class="nump">46,100<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="nump">44,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">91,300<span></span>
</td>
<td class="nump">95,500<span></span>
</td>
<td class="nump">115,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities under derivative contracts</a></td>
<td class="nump">36,800<span></span>
</td>
<td class="nump">34,900<span></span>
</td>
<td class="nump">13,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">299,900<span></span>
</td>
<td class="nump">299,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">12,844,400<span></span>
</td>
<td class="nump">12,799,300<span></span>
</td>
<td class="nump">11,069,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities (see Note&#160;20)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Ordinary shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">60,395,839 ordinary shares of par value $0.01 each (December&#160;31, 2021 &#8212; 60,395,839 shares)</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preference shares, value</a></td>
<td class="nump">753,500<span></span>
</td>
<td class="nump">753,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_AdditionalPaidInCapitalExcludingPreferenceShares', window );">Additional paid-in capital</a></td>
<td class="nump">761,200<span></span>
</td>
<td class="nump">761,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,525,700<span></span>
</td>
<td class="nump">1,349,000<span></span>
</td>
<td class="nump">1,382,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss)</a></td>
<td class="num">(492,300)<span></span>
</td>
<td class="num">(506,300)<span></span>
</td>
<td class="num">(123,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,548,700<span></span>
</td>
<td class="nump">2,358,000<span></span>
</td>
<td class="nump">2,774,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">15,393,100<span></span>
</td>
<td class="nump">15,157,300<span></span>
</td>
<td class="nump">13,844,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed Income Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,908,200<span></span>
</td>
<td class="nump">3,788,600<span></span>
</td>
<td class="nump">4,881,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed Income Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebt', window );">Debt Securities, Trading</a></td>
<td class="nump">$ 1,478,500<span></span>
</td>
<td class="nump">1,475,500<span></span>
</td>
<td class="nump">1,157,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsAvailableForSale', window );">Short-term investments, available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
<td class="nump">10,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsTradingAtFairValue', window );">Short-term investments, trading at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_AdditionalPaidInCapitalExcludingPreferenceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Paid In Capital, Excluding Preference Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_AdditionalPaidInCapitalExcludingPreferenceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CatastropheBond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Catastrophe Bond</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CatastropheBond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax Assets, Net and Income Taxes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_DeferredIncomeTaxAssetsNetAndIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax Liabilities, Net and Income Taxes Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_DeferredIncomeTaxLiabilitiesNetAndIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_InsuranceReserveAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance Reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_InsuranceReserveAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_InsuranceReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_InsuranceReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_InvestmentsExcludingDerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments, Excluding Derivative Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_InvestmentsExcludingDerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_OtherMiscellaneousAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Miscellaneous Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_OtherMiscellaneousAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PrivatelyheldInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Privately-held Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PrivatelyheldInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ShortTermInvestmentsAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investments, available for sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ShortTermInvestmentsAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ShortTermInvestmentsTradingAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investments, trading at fair value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ShortTermInvestmentsTradingAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized on contract remaining in force.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124506110&amp;loc=d3e32546-158582<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FundsHeldUnderReinsuranceAgreementsAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the reinsurer's funds held on its behalf by the ceding insurer, including funds held in trust, under reinsurance treaties or contracts with the assuming insurer as security for the payment of the obligations thereunder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.2,10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FundsHeldUnderReinsuranceAgreementsAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsAndOtherReceivablesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsAndOtherReceivablesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidReinsurancePremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The unexpired portion of premiums ceded on policies in force as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 340<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6485982&amp;loc=d3e22818-158507<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidReinsurancePremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount receivable from broker-dealers and clearing organizations, including, but not limited to, securities failed-to-deliver, certain deposits for securities borrowed, open transactions, good faith and margin deposits, commissions and floor brokerage receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=35710130&amp;loc=d3e41645-110958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633490364608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Fixed income securities, available for sale amortized cost</a></td>
<td class="nump">$ 4,231,200,000<span></span>
</td>
<td class="nump">$ 4,131,300,000<span></span>
</td>
<td class="nump">$ 4,823,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent', window );">Available-for-sale, net of allowance for expected credit losses</a></td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="nump">7,700,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebtAmortizedCost', window );">Fixed income securities, trading, amortized cost</a></td>
<td class="nump">1,552,700,000<span></span>
</td>
<td class="nump">1,576,700,000<span></span>
</td>
<td class="nump">1,155,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_Shortterminvestmentsavailableforsaleamortizedcost', window );">Short term investments available for sale, amortized cost</a></td>
<td class="nump">169,300,000<span></span>
</td>
<td class="nump">52,400,000<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ShortTermInvestmentsTradingAmortizedCost', window );">Short-term investments, trading, amortized cost</a></td>
<td class="nump">11,000,000.0<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CatastropheBondsFairValueDisclosure', window );">Catastrophe Bonds, Fair Value Disclosure</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="nump">5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue', window );">Privately-held investments, cost, trading at fair value</a></td>
<td class="nump">496,100,000<span></span>
</td>
<td class="nump">537,700,000<span></span>
</td>
<td class="nump">309,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts', window );">Premium Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 21,600,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="nump">60,395,839<span></span>
</td>
<td class="nump">60,395,839<span></span>
</td>
<td class="nump">60,395,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities', window );">Cash and cash equivalents, including cash within variable interest entities</a></td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="nump">$ 65,700,000<span></span>
</td>
<td class="nump">$ 75,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesAllowance', window );">Unpaid losses recoverable from reinsurers (net of allowance for expected credit losses of 2022: $3.7 &#8212; 2021: $3.3)</a></td>
<td class="nump">3,300,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CashAndCashEquivalentsIncludesRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">312,100,000<span></span>
</td>
<td class="nump">232,100,000<span></span>
</td>
<td class="nump">364,900,000<span></span>
</td>
<td class="nump">$ 387,300,000<span></span>
</td>
<td class="nump">$ 296,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PrivatelyheldInvestments', window );">Privately-held Investments</a></td>
<td class="nump">482,400,000<span></span>
</td>
<td class="nump">533,000,000.0<span></span>
</td>
<td class="nump">307,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments, at fair value (2)</a></td>
<td class="nump">213,400,000<span></span>
</td>
<td class="nump">221,300,000<span></span>
</td>
<td class="nump">151,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=ahl_AccruedExpensesMember', window );">Accrued expenses | Asset Management Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrentAndNoncurrent', window );">Intercompany funds due to affiliates</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=ahl_AccruedExpensesMember', window );">Accrued expenses | Management Consulting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrentAndNoncurrent', window );">Intercompany funds due to affiliates</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloOriginatingPartnershipMember', window );">Apollo originating partnership | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PrivatelyheldInvestments', window );">Privately-held Investments</a></td>
<td class="nump">42,700,000<span></span>
</td>
<td class="nump">44,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments, at fair value (2)</a></td>
<td class="nump">12,600,000<span></span>
</td>
<td class="nump">12,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloRealEstateFundMember', window );">Apollo real estate fund | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments, at fair value (2)</a></td>
<td class="nump">22,900,000<span></span>
</td>
<td class="nump">25,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Fixed maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Fixed income securities, available for sale amortized cost</a></td>
<td class="nump">4,400,500,000<span></span>
</td>
<td class="nump">4,183,700,000<span></span>
</td>
<td class="nump">4,833,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebtAmortizedCost', window );">Fixed income securities, trading, amortized cost</a></td>
<td class="nump">$ 11,000,000.0<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CashAndCashEquivalentsIncludesRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents includes restricted cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CashAndCashEquivalentsIncludesRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents, including cash within variable interest entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CashAndCashEquivalentsIncludingCashWithinVariableInterestEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CatastropheBondsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Catastrophe Bonds, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CatastropheBondsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PrivatelyheldInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Privately-held Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PrivatelyheldInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Privately-held investments, amortized cost, trading at fair value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_Privatelyheldinvestmentsamortizedcosttradingatfairvalue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ShortTermInvestmentsTradingAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investments, trading, amortized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ShortTermInvestmentsTradingAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_Shortterminvestmentsavailableforsaleamortizedcost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term investments available for sale, amortized cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_Shortterminvestmentsavailableforsaleamortizedcost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.12(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=d3e56071-112765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on reinsurance recoverable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesDebtAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investments in debt securities classified as trading.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesDebtAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=ahl_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=ahl_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloOriginatingPartnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloOriginatingPartnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloRealEstateFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ahl_ApolloRealEstateFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633574484736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Net earned premiums</a></td>
<td class="nump">$ 1,287.4<span></span>
</td>
<td class="nump">$ 1,327.2<span></span>
</td>
<td class="nump">$ 2,688.7<span></span>
</td>
<td class="nump">$ 2,410.5<span></span>
</td>
<td class="nump">$ 2,527.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (1)</a></td>
<td class="nump">129.4<span></span>
</td>
<td class="nump">88.7<span></span>
</td>
<td class="nump">188.1<span></span>
</td>
<td class="nump">147.5<span></span>
</td>
<td class="nump">154.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized investment gains</a></td>
<td class="nump">36.1<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">56.2<span></span>
</td>
<td class="nump">98.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,452.9<span></span>
</td>
<td class="nump">1,418.4<span></span>
</td>
<td class="nump">2,890.0<span></span>
</td>
<td class="nump">2,628.9<span></span>
</td>
<td class="nump">2,830.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet', window );">Losses and loss adjustment expenses</a></td>
<td class="nump">717.1<span></span>
</td>
<td class="nump">767.7<span></span>
</td>
<td class="nump">1,680.0<span></span>
</td>
<td class="nump">1,693.3<span></span>
</td>
<td class="nump">1,840.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense', window );">Acquisition costs</a></td>
<td class="nump">192.9<span></span>
</td>
<td class="nump">216.5<span></span>
</td>
<td class="nump">431.8<span></span>
</td>
<td class="nump">414.1<span></span>
</td>
<td class="nump">465.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General, administrative and corporate expenses (2)</a></td>
<td class="nump">232.7<span></span>
</td>
<td class="nump">233.4<span></span>
</td>
<td class="nump">494.2<span></span>
</td>
<td class="nump">418.0<span></span>
</td>
<td class="nump">410.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">42.9<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">33.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivatives</a></td>
<td class="num">(19.6)<span></span>
</td>
<td class="nump">84.9<span></span>
</td>
<td class="nump">80.5<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
<td class="nump">65.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesGainLoss', window );">Realized and unrealized investment losses (3)</a></td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">128.9<span></span>
</td>
<td class="nump">182.6<span></span>
</td>
<td class="nump">47.4<span></span>
</td>
<td class="nump">27.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Net realized and unrealized foreign exchange (gains)/losses</a></td>
<td class="num">(13.7)<span></span>
</td>
<td class="nump">75.2<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">40.0<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_Expense', window );">Total expenses</a></td>
<td class="nump">1,197.8<span></span>
</td>
<td class="nump">1,365.3<span></span>
</td>
<td class="nump">2,917.0<span></span>
</td>
<td class="nump">2,593.8<span></span>
</td>
<td class="nump">2,868.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) from operations before income taxes</a></td>
<td class="nump">255.1<span></span>
</td>
<td class="nump">53.1<span></span>
</td>
<td class="num">(27.0)<span></span>
</td>
<td class="nump">35.1<span></span>
</td>
<td class="num">(38.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit/(expense)</a></td>
<td class="num">(36.2)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">78.1<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
<td class="num">(18.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss)</a></td>
<td class="nump">218.9<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
<td class="nump">51.1<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
<td class="num">(56.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss)/income attributable to Aspen Insurance Holdings Limited&#8217;s ordinary shareholders</a></td>
<td class="nump">196.7<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available for sale investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification adjustment for net realized gains/(losses) on investments included in net income/(loss)</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">27.8<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="num">(20.4)<span></span>
</td>
<td class="num">(67.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Change in net unrealized (losses)/gains on available for sale securities held</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="num">(343.8)<span></span>
</td>
<td class="num">(447.2)<span></span>
</td>
<td class="num">(137.2)<span></span>
</td>
<td class="nump">175.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Net change from current period hedged transactions</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in foreign currency translation adjustment</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="num">(19.7)<span></span>
</td>
<td class="num">(30.9)<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="num">(11.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive (loss)/income, before income taxes</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="num">(342.1)<span></span>
</td>
<td class="num">(407.2)<span></span>
</td>
<td class="num">(142.4)<span></span>
</td>
<td class="nump">96.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Change in net unrealized gains on available for sale securities held</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">29.5<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Change in foreign currency translation adjustment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Total income tax benefit/(expense) allocated to other comprehensive (loss)</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">30.1<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss)/income, net of tax</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="num">(312.0)<span></span>
</td>
<td class="num">(383.3)<span></span>
</td>
<td class="num">(142.7)<span></span>
</td>
<td class="nump">96.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive (loss)/income attributable to Aspen Insurance Holdings Limited's ordinary shareholders</a></td>
<td class="nump">210.7<span></span>
</td>
<td class="num">(285.8)<span></span>
</td>
<td class="num">(332.2)<span></span>
</td>
<td class="num">(112.9)<span></span>
</td>
<td class="nump">40.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preference shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends on preference shares</a></td>
<td class="nump">22.2<span></span>
</td>
<td class="nump">22.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RealEstateFundsMember', window );">Real estate fund | Investment Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember', window );">Asset Management Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember', window );">Asset Management Arrangement | Investment Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">(5.2)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember', window );">Management Consulting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5.0)<span></span>
</td>
<td class="num">$ (5.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember', window );">Management Consulting Agreement | General, administrative and corporate expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ahl_RelatedPartyInvestmentIncomeMember', window );">Related party investment income | Investment Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ahl_ClassABNotesMember', window );">Apollo, Class A &amp; B Notes | Gain (Loss) on Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax benefit/(expense) thereon:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Related party fees</a></td>
<td class="num">$ (2.0)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_Expense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_Expense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity), investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6480726&amp;loc=d3e6691-158385<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InvestmentIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InvestmentIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_AssetManagementArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ahl_ManagementConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ahl_RelatedPartyInvestmentIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ahl_RelatedPartyInvestmentIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ahl_ClassABNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ahl_ClassABNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GainLossOnInvestmentsMember1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GainLossOnInvestmentsMember1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633492434848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preference shares</div></th>
<th class="th"><div>Ordinary shares</div></th>
<th class="th"><div>Preference shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Ordinary shares</div>
</th>
<th class="th">
<div>Retained earnings </div>
<div>Preference shares</div>
</th>
<th class="th"><div>Cumulative foreign currency translation adjustments:</div></th>
<th class="th"><div>Unrealized appreciation on available for sale investments:</div></th>
<th class="th"><div>Gain on derivatives, net of taxes</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,502.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (165.5)<span></span>
</td>
<td class="nump">$ 84.5<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="num">$ (56.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (44.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.9)<span></span>
</td>
<td class="nump">108.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,887.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,397.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177.4)<span></span>
</td>
<td class="nump">192.5<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(44.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="num">(157.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PreferredStockIssuanceCost', window );">Preferred stock issuance cost</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,774.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">$ 753.5<span></span>
</td>
<td class="nump">$ 761.2<span></span>
</td>
<td class="nump">1,382.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(156.0)<span></span>
</td>
<td class="nump">34.6<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="num">(123.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_AggregateLiquidationPreferences', window );">Aggregate liquidation preferences</a></td>
<td class="nump">775.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="nump">48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
<td class="num">(22.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.7)<span></span>
</td>
<td class="num">(286.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="nump">51.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40.0)<span></span>
</td>
<td class="num">(44.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30.9)<span></span>
</td>
<td class="num">(367.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PreferredStockIssuanceCost', window );">Preferred stock issuance cost</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,469.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">753.5<span></span>
</td>
<td class="nump">761.2<span></span>
</td>
<td class="nump">1,388.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175.7)<span></span>
</td>
<td class="num">(251.9)<span></span>
</td>
<td class="num">(7.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="num">(435.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,358.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">753.5<span></span>
</td>
<td class="nump">761.2<span></span>
</td>
<td class="nump">1,349.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(186.9)<span></span>
</td>
<td class="num">(333.2)<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="num">(506.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_AggregateLiquidationPreferences', window );">Aggregate liquidation preferences</a></td>
<td class="nump">775.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income/(loss) for the year</a></td>
<td class="nump">218.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20.0)<span></span>
</td>
<td class="num">$ (22.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change for the year, net of income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PreferredStockIssuanceCost', window );">Preferred stock issuance cost</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,548.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 753.5<span></span>
</td>
<td class="nump">$ 761.2<span></span>
</td>
<td class="nump">$ 1,525.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (179.3)<span></span>
</td>
<td class="num">$ (322.5)<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net change from current period hedged transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive (loss)/income</a></td>
<td class="num">(492.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_AggregateLiquidationPreferences', window );">Aggregate liquidation preferences</a></td>
<td class="nump">$ 775.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_AggregateLiquidationPreferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate liquidation preferences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_AggregateLiquidationPreferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PreferredStockIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred stock issuance cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PreferredStockIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966630&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633573928176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows (used in)/from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Net income/(loss)</a></td>
<td class="nump">$ 218.9<span></span>
</td>
<td class="nump">$ 48.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income/(loss) to net cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">22.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use operating lease assets</a></td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_Interestonoperatingleaseliabilities', window );">Interest on operating lease liabilities</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets', window );">Net (additions)/disposals of right-to-use operating lease assets</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_NetAdditionsdisposalsOfLeaseLiabilities', window );">Net (additions)/disposals of lease liabilities</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Lease repayments</a></td>
<td class="num">(7.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized investment gains</a></td>
<td class="num">(36.1)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesGainLoss', window );">Realized and unrealized investment losses</a></td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">128.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred tax expense/(benefit)</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_GainsLossesOnInvestmentAndForeignExchange', window );">Gains (Losses) On Investment And Foreign Exchange</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="nump">18.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Gain (Loss) on Sale of Derivatives</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome', window );">Unrealized (gain)/loss on real estate fund in net investment income</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="num">(13.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve', window );">Losses and loss adjustment expenses</a></td>
<td class="nump">30.0<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInUnearnedPremiums', window );">Unearned premiums</a></td>
<td class="nump">166.0<span></span>
</td>
<td class="nump">381.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_UnpaidLosses', window );">Unpaid losses</a></td>
<td class="nump">239.7<span></span>
</td>
<td class="num">(1,708.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums', window );">Increase (Decrease) in Prepaid Reinsurance Premiums</a></td>
<td class="num">(100.0)<span></span>
</td>
<td class="num">(220.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Increase (Decrease) in Other Receivables</a></td>
<td class="nump">19.1<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts', window );">Increase (Decrease) in Deferred Policy Acquisition Costs</a></td>
<td class="num">(34.1)<span></span>
</td>
<td class="num">(24.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReinsurancePayables', window );">Reinsurance premiums payable</a></td>
<td class="num">(146.4)<span></span>
</td>
<td class="nump">1,844.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements', window );">Increase (Decrease) in Funds Held under Reinsurance Agreements</a></td>
<td class="nump">43.2<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPremiumsReceivable', window );">Increase (Decrease) in Premiums Receivable</a></td>
<td class="num">(194.4)<span></span>
</td>
<td class="num">(275.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="nump">9.9<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other payable</a></td>
<td class="num">(30.6)<span></span>
</td>
<td class="num">(20.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives', window );">Fair Value Of Derivatives And Settlement Of Liabilities Under Derivatives</a></td>
<td class="nump">40.9<span></span>
</td>
<td class="nump">45.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract', window );"><strong>Reinsurance recoverables:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in)/from operating activities</a></td>
<td class="nump">264.6<span></span>
</td>
<td class="nump">104.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows (used in)/from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Payments to Acquire Debt Securities, Available-for-Sale</a></td>
<td class="num">(789.2)<span></span>
</td>
<td class="num">(695.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment', window );">Payments to Acquire Trading Securities Held-for-investment</a></td>
<td class="num">(254.6)<span></span>
</td>
<td class="num">(370.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales and maturities of fixed income securities &#8212; Available for sale</a></td>
<td class="nump">685.8<span></span>
</td>
<td class="nump">1,003.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from sales and maturities of fixed income securities &#8212; Trading</a></td>
<td class="nump">283.9<span></span>
</td>
<td class="nump">134.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PaymentsforAvailableforsaleSecuritiesShortterm', window );">(Purchases) of short-term investments &#8212; Available for sale</a></td>
<td class="num">(215.0)<span></span>
</td>
<td class="num">(28.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm', window );">Proceeds from sale of short-term investments &#8212; Available for sale</a></td>
<td class="nump">101.0<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">(Purchases) of short-term investments &#8212; Trading</a></td>
<td class="num">(15.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments &#8212; Trading</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PaymentstoAcquirePrivatelyheldInvestments', window );">(Purchases) of privately-held investments &#8212; Trading</a></td>
<td class="num">(23.1)<span></span>
</td>
<td class="num">(175.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ProceedsfromSaleofPrivatelyheldInvestments', window );">Proceeds from sale of privately-held investments &#8212; Trading</a></td>
<td class="nump">58.0<span></span>
</td>
<td class="nump">79.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased', window );">Net change in (payable)/receivable for securities (purchased)/sold</a></td>
<td class="nump">36.1<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">(Purchases) of other investments</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(46.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash', window );">Payments for (Proceeds from) Investing Activities, Net of Cash</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMachineryAndEquipment', window );">Net sales/(purchases) of fixed assets</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(13.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_InvestmentInMultilineReinsurer', window );">Investment in multiline reinsurer</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_PaymentsForProceedsFromOtherInvestments', window );">Net (purchases)/sales of investments, equity method</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in)/from investing activities</a></td>
<td class="num">(124.5)<span></span>
</td>
<td class="num">(92.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows used in/from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid on ordinary shares</a></td>
<td class="num">(20.0)<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Dividends paid on preference shares</a></td>
<td class="num">(22.2)<span></span>
</td>
<td class="num">(22.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in)/from financing activities</a></td>
<td class="num">(42.2)<span></span>
</td>
<td class="num">(42.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate movements on cash and cash equivalents</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="num">(18.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="nump">102.3<span></span>
</td>
<td class="num">(49.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">959.2<span></span>
</td>
<td class="nump">1,314.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of period (1)</a></td>
<td class="nump">1,061.5<span></span>
</td>
<td class="nump">1,264.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_CashAndCashEquivalentsIncludesRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 312.1<span></span>
</td>
<td class="nump">$ 387.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_CashAndCashEquivalentsIncludesRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents includes restricted cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_CashAndCashEquivalentsIncludesRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of derivatives and settlement of liabilities under derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_FairValueOfDerivativesAndSettlementOfLiabilitiesUnderDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_GainsLossesOnInvestmentAndForeignExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains (losses) on investment and foreign exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_GainsLossesOnInvestmentAndForeignExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_Interestonoperatingleaseliabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest on operating lease liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_Interestonoperatingleaseliabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_InvestmentInMultilineReinsurer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in multiline reinsurer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_InvestmentInMultilineReinsurer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_NetAdditionsdisposalsOfLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net (additions)/disposals of lease liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_NetAdditionsdisposalsOfLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net (additions)/disposals of right-to-use operating lease assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_NetAdditionsdisposalsOfRightToUseOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Change in Receivable for Securities Sold or Payable for Securities Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_NetChangeinReceivableforSecuritiesSoldorPayableforSecuritiesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PaymentsForProceedsFromOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for proceeds from other investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PaymentsForProceedsFromOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PaymentsforAvailableforsaleSecuritiesShortterm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Available-for-sale Securities, Short-term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PaymentsforAvailableforsaleSecuritiesShortterm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for (Proceeds from) Investing Activities, Net of Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PaymentsforProceedsfromInvestingActivitiesNetofCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_PaymentstoAcquirePrivatelyheldInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Privately-held Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_PaymentstoAcquirePrivatelyheldInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ProceedsfromAvailableforsaleSecuritiesShortterm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Available-for-sale Securities, Short-term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ProceedsfromAvailableforsaleSecuritiesShortterm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ProceedsfromSaleofPrivatelyheldInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Sale of Privately-held Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ProceedsfromSaleofPrivatelyheldInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_UnpaidLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unpaid losses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_UnpaidLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized (gain)/loss on real estate fund in net investment income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_UnrealizedGainlossOnRealEstateFundInNetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity), investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in funds held under reinsurance agreements or treaty (contract between the reinsurer and the ceding entity stipulating the manner in which insurance written on various risks is to be shared).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPremiumsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the premium receivable balance on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPremiumsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in prepaid reinsurance premiums recorded on the balance sheet, which is needed to adjust net income to arrive at net cash flows provided by or used in operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReinsurancePayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due to other insurance companies when the reporting entity has assumed a portion of the cedant's insurance risk which has resulted in insurance losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReinsurancePayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInUnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInUnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581148128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>History and Organization<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">History and Organization</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">History and Organization</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">History and Organization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited (&#8220;Aspen Holdings&#8221;) was incorporated on May&#160;23, 2002 as a holding company headquartered in Bermuda. We underwrite specialty insurance and reinsurance on a global basis through our Operating Subsidiaries (as defined below) based in Bermuda, the United States and the United Kingdom: Aspen Bermuda Limited (&#8220;Aspen Bermuda&#8221;), Aspen Specialty Insurance Company (&#8220;Aspen Specialty&#8221;), Aspen American Insurance Company (&#8220;AAIC&#8221;), Aspen Insurance UK Limited (&#8220;Aspen UK&#8221;) and Aspen Underwriting Limited (&#8220;AUL&#8221;) (as corporate member of our Lloyd&#8217;s operations, Syndicate 4711, which are managed by Aspen Managing Agency Limited (&#8220;AMAL&#8221;) (together, &#8220;Aspen Lloyd&#8217;s&#8221;)), each referred to herein as an &#8220;Operating Subsidiary&#8221; and collectively referred to as the &#8220;Operating Subsidiaries&#8221;. We also have branches in Australia, Canada, Singapore and Switzerland. We established Aspen Capital Management, Ltd. (&#8220;ACML&#8221;) and other related entities (collectively, &#8220;ACM&#8221;) to leverage our existing underwriting franchise, increase our operational flexibility and provide third-party investors direct access to our capital markets and underwriting expertise. References to the &#8220;Company,&#8221; the &#8220;Group,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Aspen Holdings or Aspen Holdings and its consolidated subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2019, the Company has been a wholly-owned subsidiary of Highlands Bermuda Holdco, Ltd. (&#8220;Parent&#8221;), which holds all of the Company&#8217;s ordinary shares. Parent, a Bermuda exempted company, is an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc., a leading global investment manager (collectively with its subsidiaries, &#8220;Apollo&#8221;). The Company&#8217;s preference shares and depositary shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the following symbols: AHL PRC, AHL PRD and AHL PRE.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">History and Organization</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">History and Organization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Insurance Holdings Limited (&#8220;Aspen Holdings&#8221;) was incorporated on May&#160;23, 2002 as a holding company headquartered in Bermuda. We underwrite specialty insurance and reinsurance on a global basis through our Operating Subsidiaries (as defined below) based in Bermuda, the United States and the United Kingdom: Aspen Bermuda Limited (&#8220;Aspen Bermuda&#8221;), Aspen Specialty Insurance Company (&#8220;Aspen Specialty&#8221;), Aspen American Insurance Company (&#8220;AAIC&#8221;), Aspen Insurance UK Limited (&#8220;Aspen UK&#8221;) and Aspen Underwriting Limited (&#8220;AUL&#8221;) (as corporate member of our Lloyd&#8217;s operations, Syndicate 4711, which are managed by Aspen Managing Agency Limited (&#8220;AMAL&#8221;) (together, &#8220;Aspen Lloyd&#8217;s&#8221;)), each referred to herein as an &#8220;Operating Subsidiary&#8221; and collectively referred to as the &#8220;Operating Subsidiaries&#8221;.  We also have branches in Canada, Singapore and Switzerland. We established Aspen Capital Management, Ltd. (&#8220;ACML&#8221;) and other related entities (collectively, &#8220;ACM&#8221;) to leverage our existing underwriting franchise, increase our operational flexibility and provide third-party investors direct access to our capital markets and  underwriting expertise. References to the &#8220;Company,&#8221; the &#8220;Group,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Aspen Holdings or Aspen Holdings and its consolidated subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2019, the Company has been a wholly-owned subsidiary of Highlands Bermuda Holdco, Ltd. (&#8220;Parent&#8221;), which holds all of the Company&#8217;s ordinary shares. Parent, a Bermuda exempted company, is an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc., a leading global investment manager (collectively with its subsidiaries, &#8220;Apollo&#8221;). The Company&#8217;s preference shares and depositary shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the following symbols: AHL PRC, AHL PRD and AHL PRE.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581080576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Preparation and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Preparation and Significant Accounting Policies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Basis of Presentation and Significant Accounting Policies</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Aspen Holdings are prepared in accordance with United States Generally Accepted Accounting Principles (&#8220;U.S.&#160;GAAP&#8221;) and are presented on a consolidated basis including the transactions of all operating subsidiaries in which the Company has a controlling financial interest and variable interest entities (&#8220;VIE&#8221;) in which the Company is considered to be the primary beneficiary. Transactions between Aspen Holdings and its subsidiaries are eliminated within the consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on a going concern basis. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Use of Estimates </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions and estimates made by management have a significant effect on the amounts reported within the consolidated financial statements. The most significant of these relate to losses and loss adjustment expenses, reinsurance recoverables, gross written premiums and commissions which have not been reported to the Company such as those relating to proportional treaty reinsurance contracts, unrecognized tax benefits, recoverability of deferred tax assets, the fair value of derivatives and the fair value of other and privately-held investments. All material assumptions and estimates are regularly reviewed and adjustments made as necessary but actual results could be significantly different from those expected when the assumptions or estimates were made. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Accounting for Insurance and Reinsurance Operations </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums Earned.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Premiums are recorded as written on the inception date of a policy. Premiums are recognized as revenues proportionately over the coverage period. Premiums earned are recorded in the consolidated statements of operations, net of the cost of purchased reinsurance. Premiums written which are not yet recognized as earned premium are recorded in the consolidated balance sheet as unearned premiums. Written and earned premiums and the related costs include estimates for premiums which have not been finally determined. These relate mainly to contractual provisions for the payment of adjustment or additional premiums, premiums payable under proportional treaties and delegated underwriting authorities, and reinstatement premiums. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustment and additional premiums are premiums charged which relate to experience during the policy term. The proportion of adjustable premiums included in the premium estimates varies between business lines with the largest adjustment premiums being in property and casualty reinsurance, marine, aviation and energy insurance and the smallest in property and casualty insurance. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums under proportional treaty contracts and delegated underwriting authorities are generally not reported to the Company until after the reinsurance coverage is in force. As a result, an estimate of these &#8220;pipeline&#8221; premiums is recorded. The Company estimates pipeline premiums based on projections of ultimate premium taking into account reported premiums and expected development patterns. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinstatement premiums on assumed excess of loss reinsurance contracts are provided based on experience under such contracts. Reinstatement premiums are the premiums charged for the restoration of the reinsurance limit of an excess of loss contract to its full amount after payment by the reinsurer of losses as a result of an occurrence. The original premiums are recognized as revenue in full at the date of loss, with the reinstatement premiums recognized as revenue over the remaining cover term. Reinstatement premiums provide future insurance cover for the remainder of the initial policy term. An allowance for uncollectible premiums is established for possible non-payment of premium receivables, as deemed necessary. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses on Underwriting Premiums Receivable. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Underwriting premium receivable balances are reported net of an allowance for expected credit losses. The allowance, based on ongoing review and monitoring of amounts outstanding, historical loss data, including write-offs and other relevant factors, is charged to net income in the period the receivable is recorded and revised in subsequent periods to reflect changes in the Company&#8217;s estimate of expected credit losses. Credit risk is partially mitigated by the Company&#8217;s ability to cancel the policy if the policyholder does not pay the premium.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Losses and Loss Adjustment Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Losses represent the amount paid or expected to be paid to claimants in respect of events that have occurred on or before the balance sheet date. The costs of investigating, resolving and processing these claims are known as loss adjustment expenses (&#8220;LAE&#8221;). The consolidated statements of operations records these losses net of reinsurance, meaning that gross losses and loss adjustment expenses incurred are reduced by the amounts recovered or expected to be recovered under reinsurance contracts. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Written premiums, earned premiums, incurred claims, LAE and the acquisition costs all reflect the net effect of assumed and ceded reinsurance transactions. Assumed reinsurance refers to the Company&#8217;s acceptance of certain insurance risks that other insurance companies have underwritten. Ceded reinsurance arises from contracts under which other insurance companies agree to share certain risks with the Company. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance accounting is followed when there is significant timing risk, significant underwriting risk and a reasonable possibility of significant loss. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outward reinsurance premiums, which are paid when the Company purchases reinsurance or retrocessional coverage, are accounted for using the same accounting methodology as the Company uses for inwards premiums. Premiums payable under reinsurance contracts that operate on a &#8220;losses occurring during&#8221; basis are expensed over the period of coverage while those arising from &#8220;risks attaching during&#8221; policies are expensed over the earnings period of the underlying premiums written from the reinsured business. Adjustment premiums and reinstatement premiums in relation to outward reinsurance are accrued when it is determined that the ultimate losses will trigger a payment and recognized within premiums payable. Reinsurance and retrocession does not isolate the ceding company from its obligations to policyholders. In the event that a reinsurer or retrocessionaire fails to meet its obligations, the ceding company&#8217;s obligations remain. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Retroactive Reinsurance Agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Retroactive reinsurance agreements are reinsurance agreements under which a reinsurer agrees to reimburse the Company as a result of past insurable events. For retroactive reinsurance purchased by the Company, the excess of the amounts ultimately collectible under the agreement over the consideration paid is recognized as a deferred gain liability which is amortized into income over the settlement period of the ceded reserves once the paid losses have exceeded the minimum retention. The amount </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the deferral is recalculated each period based on actual loss payments and updated estimates of ultimate losses. If the consideration paid exceeds the ultimate losses collectible under the agreement, the net loss on the retroactive reinsurance agreement is recognized within income immediately.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums payable for retroactive reinsurance coverage and meeting the conditions of reinsurance accounting are reported as reinsurance recoverables to the extent that those amounts do not exceed recorded liabilities relating to underlying reinsurance contracts. Premiums paid in excess of accounts receivable are charged to income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserves.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Insurance reserves are established for the total unpaid cost of claims and LAE in respect of events that have occurred by the balance sheet date, including the Company&#8217;s estimates of the total cost of claims incurred but not yet reported (&#8220;IBNR&#8221;). Claim reserves are reduced for estimated amounts of salvage and subrogation recoveries. Estimated amounts recoverable from reinsurers on unpaid losses and LAE are reflected as assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reported claims, reserves are established on a case-by-case basis within the parameters of coverage provided in the insurance policy or reinsurance agreement. For IBNR claims, reserves are estimated using a number of established actuarial methods to establish a range of estimates from which a management best estimate is selected. Both case and IBNR reserve estimates consider variables such as past loss experience, changes in legislative conditions, changes in judicial interpretation of legal liability, policy coverages and inflation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As many of the coverages underwritten involve claims that may not be ultimately settled for many years after they are incurred, subjective judgments as to the ultimate exposure to losses are an integral and necessary component of the loss reserving process. The Company regularly reviews its reserves, using a variety of statistical and actuarial techniques to analyze current claims costs, frequency and severity data, and prevailing economic, social and legal factors. Reserves established in prior periods are adjusted as claim experience develops and new information becomes available. Adjustments to previously estimated reserves are reflected in the financial results of the period in which the adjustments are made. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of estimating required reserves does, by its very nature, involve considerable uncertainty. The level of uncertainty can be influenced by factors such as the existence of coverage with long duration payment patterns and changes in claims handling practices, as well as the factors noted above. Ultimate actual payments for claims and LAE could turn out to be significantly different from the Company&#8217;s estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses on Reinsurance Recoverables. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability with the reinsured business. The Company evaluates the financial condition of its reinsurers and retrocessionaires, and monitors concentration of credit risk to minimize its exposure to significant losses from individual reinsurers. To further reduce credit exposure on reinsurance recoverables, the Company has received collateral, including letters of credit and trust accounts, from certain reinsurers. Following the adoption of ASC 326, an allowance is established for expected credit losses to be recognized over the life of the reinsurance recoverable. The allowance considers the current financial strength of the individual reinsurer and the amount of collateral held. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition Costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The costs directly related to writing a (re)insurance policy are referred to as acquisition expenses and include commissions, premium taxes and profit commissions. With the exception of profit commissions, these expenses are incurred when a policy is issued, and only the costs directly related to the successful acquisition of new and renewal insurance and reinsurance contracts are deferred and amortized over the same period as the corresponding premiums are recorded as revenues. Profit commissions are estimated and accrued based on the related performance criteria evaluated at the balance sheet date, with subsequent changes to those estimates recognized when they occur. Commissions received related to reinsurance premiums ceded are netted against broker commissions in determining acquisition costs eligible for deferral. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a regular basis a premium deficiency analysis is performed of the deferred acquisition costs in relation to the expected recognition of revenues, including anticipated investment income, and adjustments, if any, are reflected as period costs. Should the analysis indicate that the acquisition costs are unrecoverable, further analyses are performed to determine if a reserve is required to provide for losses which may exceed the related unearned premium. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;These costs represent the expenses incurred in running the business and include, but are not limited to compensation costs for employees, rental costs, IT development and professional and consultancy fees. General and administrative costs directly attributable to the successful acquisition of business are deferred and amortized over the same period as the corresponding premiums are recorded as revenues. When reporting the results for its business segments, the Company includes expenses which are directly attributable to the segment plus an allocation of central administrative costs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Corporate expenses are not allocated to the Company&#8217;s business segments as they typically do not fluctuate with the levels of premium written and are related to the Company&#8217;s operations which include group executive costs, group finance costs, group legal and actuarial costs and certain strategic and other costs. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span id="i49191d5207d3440b905b4734b36cf7a6_36276"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.91pt">Accounting for Investments, Cash and Cash Equivalents </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed Income Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fixed income securities portfolio comprises securities issued by governments and government agencies, corporate bonds, mortgage and other asset-backed securities and bank loans. Investments in fixed income securities are classified as available for sale or trading and are reported at estimated fair value in the consolidated balance sheet. Investment transactions are recorded on the trade date with balances pending settlement reflected in the consolidated balance sheet under receivables for securities sold and other payables for securities purchased, respectively. Fair values are based on quoted market prices and other data provided by third-party pricing services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Short-term investments primarily comprise highly liquid debt securities with a maturity greater than three months but less than one year from the date of purchase and are held as part of the investment portfolio of the Company. Short-term investments are classified as either trading or available for sale and reported at estimated fair value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catastrophe Bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in catastrophe bonds are classified as trading and are reported on the consolidated balance sheet at estimated fair value.&#160;The fair values are based on independent broker-dealer quotes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Privately-held Investments.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s privately-held investments primarily comprise commercial mortgage loans, middle market loans, asset-backed securities, global corporate securities and equity securities.&#160;These investments are classified as trading and are reported on the consolidated balance sheet at estimated fair value.&#160;Privately-held investments are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are primarily determined using internally developed discounted cash flow models. &#160;Interest income is accrued on the principal amount of the loan based on its contractual interest rate subject to it being probable that we will receive interest on that particular underlying loan. Interest income, amortization of premiums and discounts, and prepayment fees are reported in net investment income on the consolidated statements of income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments, Equity Method.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Other investments represent the Company&#8217;s investments that are recorded using the equity method of accounting. Adjustments to the fair value of these investments are made based on the net asset value of the investment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments represent the Company&#8217;s investments in real estate funds and other special purpose vehicles. Adjustments to the fair value are made based on the net asset value of the investment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Cash and cash equivalents are reported at fair value. Cash and cash equivalents comprise cash on hand, deposits held on call with banks and other short-term highly liquid investments due to mature within three months from the date of purchase and which are subject to insignificant risk of change in fair value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gains and Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Realized gains or losses on the sale of investments are determined on the basis of the first in first out cost method and are recorded in revenue or expenses respectively. Unrealized gains and losses represent the difference between the cost, or the cost as adjusted by amortization of any difference between its cost and its </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">redemption value (&#8220;amortized cost&#8221;), of the security and its fair value at the reporting date and are included within other comprehensive income for securities classified as available for sale and in realized and unrealized investment gains or losses in the consolidated statement of operations for securities classified as trading. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses on Available for Sale Debt Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Following Aspen&#8217;s adoption of ASU 2016-13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Financial Instruments - Credit Losses (Topic 326)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, effective January 1, 2020, current expected credit losses (CECL) are recognized through an allowance account for available for sale debt securities, thereby permitting reversals of previously recognized credit losses through net income in the period they occur. Write-offs (of any previously recognized allowance for credit losses) are recorded when amounts are deemed uncollectible, or Aspen intends to sell (or more likely than not will be required to sell) the debt security before recovery of the amortized cost basis. The amortized cost basis will be written down to the debt securities fair value through earnings. Credit losses are limited to the difference between the debt securities amortized cost basis and fair value (&#8216;fair-value floor&#8217;). Any decline in the debt securities fair value below the amortized cost basis that is not a result of a credit loss is recorded through other comprehensive income, net of applicable taxes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit loss models employ a discounted cash flow approach to evaluate whether a credit loss exists at the individual security level and are reviewed at each reporting period. This analysis excludes investments in U.S. Government / Agency bonds and U.S. Government Agency mortgage-backed securities due to being of &#8216;high credit quality&#8217; based on the absence of risk. Available for sale debt securities that were initially purchased with credit deterioration (PCD), the amortized cost basis shall be considered to be the purchase price, plus any allowance for credit losses. Estimated credit losses shall be discounted at the rate that equates the present value of the purchaser&#8217;s estimate of the security&#8217;s future cash flows with the purchase price of the asset. Holding gains or losses are recognition through other comprehensive income, net of applicable taxes. No changes in the estimate of credit losses have taken place during the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Investment income includes amounts received and accrued in respect of periodic interest (&#8220;coupons&#8221;) payable to the Company by the issuer of fixed income securities, equity dividends and interest credited on cash and cash equivalents. It also includes amortization of premium and accretion of discount in respect of fixed income securities. Investment income also includes changes in fair value from investments in real estate funds. Investment management and custody fees are charged against net investment income reported in the consolidated statement of operations. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Accounting for Derivative Financial Instruments </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into derivative instruments such as interest rate swaps and forward exchange contracts in order to manage certain market and credit risks. The Company records derivative instruments at fair value on the Company&#8217;s consolidated balance sheet as either assets or liabilities, depending on their rights and obligations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting for the gain or loss due to the changes in the fair value of these instruments is dependent on whether the derivative qualifies as a hedge. If the derivative does not qualify as a hedge, the gains or losses are reported in the consolidated statement of operations when they occur. If the derivative qualifies as a hedge, the accounting treatment varies based on the type of risk being hedged. Gains and losses on the effective portion of such contracts are recognized in other comprehensive income. As the contracts settle, the realized gain or loss is reclassified from other comprehensive income into the consolidated statement of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss portfolio transfer contract includes a funds withheld arrangement that provides variable interest expense based on Aspen&#8217;s investment performance. As a result, this funds withheld arrangements is considered an embedded derivative and accounted for as an option-based derivative. Since the economic characteristics and risks of an embedded derivative feature are not clearly and closely related to the economic characteristics and risks of the host contract, the embedded derivative is bifurcated and accounted for separately at fair value. The Company records subsequent changes in the embedded derivative fair value in the consolidated statement of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.91pt">Accounting for Intangible Assets </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are held in the consolidated balance sheet at cost less amortization and impairment. Amortization applies on a straight-line basis in respect of assets having a finite estimated useful economic life. Finite intangibles are assessed on an annual basis for impairment, or more frequently where circumstances indicate the carrying value may not be recoverable. For intangible assets considered to have an indefinite life, the Company performs a qualitative assessment annually to determine whether it is more likely than not that an intangible asset is impaired. Goodwill is assessed annually for impairment or more frequently if circumstances indicate an impairment may have occurred.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.01pt">Accounting for Office Properties and Equipment </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office properties and equipment are reported at cost less accumulated depreciation. These assets are depreciated on a straight-line basis over the estimated useful lives of the assets. Computer equipment is depreciated between <span style="-sec-ix-hidden:f-489">three</span> and five years, furniture and fittings are depreciated over four years and leasehold improvements are depreciated over the lesser of 15 years or the lease term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IT development costs that are directly associated with the development of identifiable and unique software products and that are anticipated to generate economic benefits exceeding costs beyond one year, are recognized within office properties and equipment. Costs include external consultants&#8217; fees, certain qualifying internal staff costs and other costs incurred to develop software programs. Software is depreciated over their estimated useful life, between three and five years, on a straight-line basis and is subject to impairment testing annually. Depreciation commences when the asset becomes operational. Other non-qualifying costs are expensed as incurred.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Accounting for Leases </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of the business, the Company renews and enters into new leases for office real estate and other assets. At the lease inception date, the Company determines whether a contract contains a lease and recognizes operating lease Right-of-use assets and operating lease liabilities based on the present value of future minimum lease payments. As our leases do not provide an implicit interest rate, we use our incremental borrowing rate based on the information available at the commencement date to determine the present value of future payments. For all office real estate leases, rent incentives, including reduced-rent and rent free periods and contractually agreed rent increases during the lease term, have been included when determining the present value of future cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Right-of-use operating lease assets are reported at cost less accumulated depreciation on the consolidated balance sheet and depreciated over the lease term. The Company does not record office property and equipment leases with an initial term of 12 months or less (short-term) in the Company's consolidated balance sheets. Such short-term leases are expensed through the consolidated statement of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use operating lease assets are tested for impairments whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If the carrying value of an asset is impaired, it is reduced to the recoverable amount by an immediate charge to the income statement. The recoverable amount is the higher of an asset&#8217;s fair value less costs to sell and value in use. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.78pt">Accounting for Foreign Currencies Translation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting currency of the Company is the U.S.&#160;Dollar. Effective January 1, 2022, management reassessed its functional currency determination in accordance with ASC 830, Foreign Currency Matters, as a result of significant changes in the Group&#8217;s economic facts and circumstances, and concluded that the functional currency of certain of its foreign operations had changed. Consequently, the Company has concluded that the U.S. Dollar is now the functional currency for all its branches and overseas entities. The change in the Company&#8217;s functional currency determination has been applied on a prospective basis in accordance with ASC 830. Therefore, any translation gains and losses that were previously recorded in accumulated other comprehensive income through December 31, 2021 remain unchanged through December 31, 2021. From January 1, 2022, any net realized and unrealized gains/(losses) on translation are recognized in the consolidated statements of operations and other comprehensive income (loss). </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments classified as available-for-sale are recorded at fair value, the portion attributable to movements in exchange rates continues to be included within accumulated other comprehensive income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency are measured at the exchange rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in non-functional currencies are remeasured at the exchange rate prevailing at the balance sheet date and any resulting foreign exchange gains or losses are reflected in the consolidated statement of operations. Non-monetary assets and liabilities are remeasured to functional currency at historic exchange rates.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Accounting for Income Taxes </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. When the Company does not believe that, on the basis of available information, it is more likely than not that deferred tax assets will be fully recovered, it recognizes a valuation allowance against its deferred tax assets to reduce the deferred tax assets to the amount more likely than not to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, a tax benefit from a tax position may be recognized in the financial statements only if it is more-likely-than-not that the position is sustainable, based solely on its technical merits and consideration of the relevant tax authority&#8217;s widely understood administrative practices and precedents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a portfolio approach to release the income tax effects in accumulated other comprehensive income. Under this approach, the income tax effects upon the sale of an available-for-sale debt security, settlement of hedged transactions and upon foreign currency translation adjustments for each period, are determined under the intraperiod tax allocation approach. Any tax effects remaining in accumulated other comprehensive income are only released when the entire portfolio is liquidated, sold or extinguished.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Accounting for Preference Shares </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had at the balance sheet date in issue three classes of preference shares. The Company has no obligation to pay interest on these securities but they carry entitlements to dividends payable at the discretion of the Board of Directors. In the event of non-payment of dividends for six consecutive periods, holders of preference shares have director appointment rights. The preference shares are therefore accounted for as equity instruments and included within total shareholders&#8217; equity. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Accounting for Long-Term Incentive Plans </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates an employee long-term incentive plan, comprised of Performance Units and Exit Units, the terms and conditions of which are described in Note 16. The Company applies a fair-value based measurement method in calculating the compensation costs of Performance Units which are recognized on a straight-line basis over the vesting period.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(l)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Accounting for Business Combinations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for a transaction as a business combination where the assets acquired and liabilities assumed following a transaction constitute a business. An acquired entity must have inputs and processes that make it capable of generating a return or economic benefit to be considered a business. If the assets acquired are not a business, the Company accounts the transaction as an asset acquisition. The Company recognizes and measures at fair value 100 percent of the assets and liabilities of any acquired business. Goodwill is recognized and measured as the difference between the consideration paid or payable less the fair value of assets acquired. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the disposal of subsidiary undertakings when it ceases to control the subsidiary&#8217;s assets and liabilities or the group of assets. A gain or loss is recognized and measured as the difference between the fair value of consideration received or receivable and the value of assets, liabilities and equity components de-recognized, related to that subsidiary or group of assets when deconsolidated.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs that are directly related to a business combination transaction are expensed in the periods in which the costs are incurred and the services are received.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span id="i49191d5207d3440b905b4734b36cf7a6_36275"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(m)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.57pt">Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Pronouncements Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. ASU 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Financial Instruments&#8212;Credit Losses (Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#8221;. This update is as a result of a post implementation review done on the issued ASU No.2016-13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, addressing &#8220;troubled debt restructuring by creditors&#8221; and &#8220;vintage disclosures&#8221;. This update will be effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued Accounting Standards Update No. ASU 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Derivatives and Hedging (Topic 815): Fair Value Hedging, Portfolio Layer Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. This update addresses concerns from entities and practitioners regarding the &#8216;last-of-layer&#8217; method of accounting incorporated in update No. ASU 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, issued on 28 August, 2017. This method is meant to achieve fair value hedge accounting for interest rate risk hedges of portfolios of &#8216;prepayable financial assets&#8217;. This ASU will be effective for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued Accounting Standards Update No. ASU 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Fair Value Measurement (Topic 820</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#8221;. This update is for entities that have investments in equity securities, measured at fair value, which are subject to a contractual sale restriction. This update will be effective for fiscal years beginning after December 15, 2024 and interim periods within those fiscal years. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued Accounting Standards Update No. ASU 2022-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Liabilities- Supplier Finance Programs (Subtopic 405-50)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The update has been issued to enhance the transparency of supplier finance program disclosure for all entities that use these programs in connection with the purchase of goods and services. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that the update has no impact, as the Company does not enter into any such agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued Accounting Standards Update No. ASU 2022-05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, &#8220;Financial Services- Insurance (Topic 944</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#8221;. This update reduces the implementation costs and complexity with the adoption of Long Duration Insurance contracts (LDTI) that have been derecognized in accordance with the amendments in this update. These changes eliminate the need to reclassify a portion of previously recognized gains or losses to the LDTI transition adjustment as suggested in the previous ASU issued 2020-11. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that the update has no impact, as the Company does not write long-duration business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the FASB issued Accounting Standards Update No. ASU 2022-06,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Reference Rate Reform (Topic 848)&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This update defers the sunset date of Topic 848 (ASU 2020-04) from Dec 31, 2022 to Dec 31, 2024, after which entities will no longer be allowed to use the relief offered in Topic 848. During the year, the Company evaluated and considered the provisions of this ASU update and has concluded that there is no material impact on the consolidated financial statements for the current financial year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accounting pronouncements were issued during the year ended December&#160;31, 2022 which were either not applicable to the Company or did not impact the Company&#8217;s consolidated financial statements.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Basis of Presentation and Significant Accounting Policies</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (&#8220;U.S.&#160;GAAP&#8221;) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Results for the six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ended December 31, 2023. The unaudited condensed consolidated financial statements include the accounts of Aspen Holdings and its subsidiaries. Transactions between Aspen Holdings and its subsidiaries are eliminated within the unaudited condensed consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet as at December 31, 2022 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2022 contained within this prospectus.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions and estimates made by management have a significant effect on the amounts reported within the unaudited condensed consolidated financial statements. The most significant of these assumptions and estimates relate to losses and loss adjustment expenses, reinsurance recoverables, gross written premiums and commissions which have not been reported to the Company such as those relating to proportional treaty reinsurance contracts, unrecognized tax benefits, the fair value of derivatives and the fair value of other investments. All material assumptions and estimates are regularly reviewed and adjustments made as necessary, but actual results could differ significantly from those expected when the assumptions or estimates were made.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To facilitate period-to-period comparisons, certain reclassifications have been made to prior year consolidated financial statement amounts to conform to the current year presentation. There was no effect on net income from this change in presentation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared on a going concern basis. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2023</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2017-04&#8221;). Among other things, ASU 2017-04 requires the following: (1) the elimination of step two of the goodwill impairment test; entities will no longer utilize the implied fair value of their assets and liabilities for purposes of testing goodwill for impairment, and (2) the quantitative portion of the goodwill impairment test will be performed by comparing the fair value of a reporting unit with its carrying amount; an impairment charge is to be recognized for the excess of carrying amount over fair value, but only to the extent of the amount of goodwill allocated to that reporting unit. The effective date for this ASU was amended via ASU 2019-10, Effective Dates, and became effective for annual periods beginning after December 15, 2022. The adoption of this ASU did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581056848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Segment Reporting</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its underwriting operations as two business segments: Aspen Reinsurance and Aspen Insurance. The Company has determined its reportable segments by taking into account the manner in which management makes operating decisions and assesses operating performance. Profit or loss for each of the Company&#8217;s business segments is measured by underwriting income or loss. Underwriting profit is the excess of net earned premiums over the sum of losses and loss expenses, acquisition costs and general and administrative expenses. Underwriting income or loss provides a basis for management to evaluate the segment&#8217;s underwriting performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance Segment. &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reinsurance segment consists of property catastrophe reinsurance, other property reinsurance, casualty reinsurance and specialty reinsurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The insurance segment consists of first party and specialty insurance, casualty and liability insurance and financial and professional lines insurance. Additionally, the insurance segment includes Aspen Underwriting Limited&#8217;s participation as a corporate member in Carbon Syndicate 4747 (&#8220;Carbon Syndicate&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-underwriting Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company provides additional disclosures for corporate and other (non-operating) income and expenses. Corporate and other income and expenses include: corporate expenses, net investment income, net realized and unrealized investment gains or losses, other strategic and other costs, changes in fair value of derivatives or the loan notes issued by variable interest entities, interest expenses, net realized and unrealized foreign exchange gains or losses, asset impairments and income taxes. These income and expense items are not allocated to the Company&#8217;s business segments as they are not directly related to the Company&#8217;s business segment operations and is consistent with how management measures the performance of its segments. The Company does not allocate its assets by business segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses underwriting ratios as measures of performance. The loss ratio is the ratio of losses and loss adjustment expenses to net earned premiums. The acquisition cost ratio is the ratio of acquisition costs to net earned premiums. The general and administrative expense ratio is the ratio of general and administrative expenses to net earned premiums. The combined ratio is the sum of the loss ratio, the acquisition cost ratio and the general and administrative expense ratio. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of gross and net written and earned premiums, underwriting income or loss, ratios and reserves for each of the Company&#8217;s business segments for the twelve months ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,338.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,988.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,360.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,452.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-operating expenses includes $32.7 million in relation to fixed assets written off, $10.0 million of severance, consulting and professional services in relation to non-recurring projects and other costs, offset by $6.7 million of write backs related to leased office space.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,618.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,118.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,693.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income/(loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,165.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,313.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-operating expenses includes $19.3 million of costs related to consulting and professional services in relation to non-recurring projects and other costs, $0.4 million of impairment charges related to lease assets as a result of exiting certain office space and $0.9 million of amortization of intangible assets and other non-operating expenses.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,042.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,698.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,280.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,638.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) before income taxes </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,874.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-operating expenses includes $18.2 million of expenses related to severance, retention and other costs, $12.9 million of impairment charges related to lease assets as a result of sub-leasing certain office space and $1.6 million of amortization of intangible assets and other non-operating expenses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Geographical Areas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following summary presents the Company&#8217;s gross written premiums based on the location of the insured risk for the twelve months ended December&#160;31, 2022, 2021 and 2020. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia/Asia</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States&#160;&amp; Canada </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide excluding United States </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide including United States </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,338.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,698.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">&#8220;United States and Canada&#8221; comprises individual policies that insure risks specifically in the United States and/or Canada, but not elsewhere. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">&#8220;Worldwide excluding the United States&#8221; consists of individual policies that insure global risks with the specific exclusion of the United States. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">&#8220;Worldwide including the United States&#8221; consists of individual policies that insure global risks with the specific inclusion of the United States. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">&#8220;Other&#8221; comprises individual policies that insure risk in other countries including, but not limited to, the Caribbean, South America and Middle East. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Segment Reporting</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its underwriting operations as two business segments: Aspen Reinsurance and Aspen Insurance. The Company has determined its reportable segments by taking into account the manner in which management makes operating decisions and assesses operating performance. Profit or loss for each of the Company&#8217;s business segments is measured by underwriting income or loss. Underwriting profit is the excess of net earned premiums over the sum of losses and loss expenses, acquisition costs and general and administrative expenses. Underwriting income or loss provides a basis for management to evaluate the segment&#8217;s underwriting performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The reinsurance segment consists of property catastrophe reinsurance, other property reinsurance, casualty reinsurance and specialty reinsurance. For a more detailed description of this business segment, refer to  &#8220;Business&#8212;Our Business&#8212;Reinsurance&#8221; in this prospectus.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The insurance segment consists of first party insurance, specialty insurance, casualty and liability insurance and financial and professional lines insurance. Additionally, the insurance segment includes Aspen Underwriting Limited&#8217;s participation as a corporate member in Carbon Syndicate 4747 (&#8220;Carbon Syndicate&#8221;). For a more detailed description of this business segment, refer to &#8220;Business&#8212;Our Business&#8212;Insurance&#8221; in this prospectus.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-underwriting Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company provides additional disclosures for corporate and other (non-operating) income and expenses. Corporate and other income and expenses include: corporate expenses, net investment income, net realized and unrealized investment gains or losses, other strategic and other costs, changes in fair value of derivatives or the loan notes issued by variable interest entities, interest expenses, net realized and unrealized foreign exchange gains or losses, asset impairments and income taxes. These income and expense items are not allocated to the Company&#8217;s business segments as they are not directly related to the Company&#8217;s business segment operations and is consistent with how management measures the performance of its segments. The Company does not allocate its assets by business segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses underwriting ratios as measures of performance. The loss ratio is the ratio of losses and loss adjustment expenses to net earned premiums. The acquisition cost ratio is the ratio of acquisition costs to net earned premiums. The general and administrative expense ratio is the ratio of general and  administrative expenses to net earned premiums. The combined ratio is the sum of the loss ratio, the acquisition cost ratio and the general and administrative expense ratio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of gross and net written and earned premiums, underwriting income or loss, ratios and reserves for each of the Company&#8217;s business segments for six months ended June&#160;30, 2023 and  2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate and other operating expenses includes other income/expenses, which were previously presented separately.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">( $ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,351.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net written premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underwriting Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating expenses </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of loan notes issued by variable interest entities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized foreign exchange gains</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reserves for loss and loss adjustment expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratios</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition cost ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense ratio </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense ratio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined ratio</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate and other operating expenses includes other income/expenses, which were previously presented separately.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581257344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Investments</span><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Statement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net investment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. &#160;The following table summarizes investment income for the twelve months ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities&#160;&#8212; Available for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities&#160;&#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments&#160;&#8212; Available for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments&#160;&#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed term deposits (included in cash and cash equivalents)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe bonds &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments, at fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents the Company&#8217;s investments in real estate funds and other special purpose vehicles. The movement in the year represents the change in fair value of the investment and has been included as part of our investment income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net realized and unrealized investment gains and losses recorded in the consolidated statement of operations and the change in unrealized gains and losses on investments recorded in other comprehensive income for the twelve months ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized gains</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in expected credit (losses)/gains </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; net unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe bonds &#8212; net unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; net unrealized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments &#8212; equity method:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized and unrealized gains/(losses) in MVI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized (losses)/gains in Multi-Line Reinsurer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized and unrealized (losses)/gains in Digital Risk</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gain on sale of Bene</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gain on sale of Crop Re</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net realized and unrealized investment (losses)/gains recorded in the consolidated statement of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in available for sale net unrealized (losses)/gains:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit/(expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in net unrealized (losses)/gains, net of taxes recorded in other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities and Short-Term Investments &#8212; Available For Sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;The following tables present the cost or amortized cost, gross unrealized gains and losses and estimated fair market value of available for sale investments in fixed income securities and short-term investments as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost&#160;or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Credit </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,016.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,840.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the twelve months ended December&#160;31, 2022, there was an increase in the CECL allowance on available-for-sale investments of $5.0 million (December&#160;31, 2021 &#8212; $2.5 million decrease).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost&#160;or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance <br/>for Credit <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,176.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,208.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,823.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,881.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,833.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,891.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities, Short Term Investments, Equities, Catastrophe Bonds and Privately-held Investments &#8212; Trading.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; The following tables present the cost or amortized cost, gross unrealized gains and losses, and estimated fair market value of trading investments in fixed income securities, short-term investments, equity securities, catastrophe bonds and privately-held investments as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Income Securities &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,017.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Income Securities &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Catastrophe bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in catastrophe bonds with a total value of $2.9 million as at December&#160;31, 2022 (December&#160;31, 2021 &#8212; $3.4 million).&#160;The bonds are either zero-coupon notes or receive quarterly interest payments based on variable interest rates with scheduled maturities ranging from 2023 to 2026.&#160;The redemption value of the bonds will adjust based on the occurrence or aggregate occurrence of a covered event, such as windstorms and earthquakes in the United States, Canada, the North Atlantic, South America, Europe, Japan or Australia.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privately-held investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has invested in privately-held investments, which primarily include commercial mortgage loans of $312.1 million and middle market loans of $106.9 million as at December&#160;31, 2022 (December&#160;31, 2021 &#8212; commercial mortgage loans of $211.5 million; middle market loans of $65.4 million). Privately-held investments also includes investments in asset-backed securities, equity securities and other short term investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Mortgage Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The commercial mortgage loans are related to investments in properties including apartments, hotels, office and retail buildings, other commercial properties and industrial properties. The commercial mortgage loan portfolio is diversified by property type, geographic region and issuer to reduce risks. As part of our investment process, we evaluate factors such as size, property type, and security to determine that </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">properties are performing at a consistent and acceptable level to secure the related debt.&#160;The following table presents the type of commercial mortgage loans and geographic region as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property type</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apartment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hotels</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary credit quality indicator of commercial mortgage loans is loan performance. Non-performing commercial mortgage loans are generally 90 days or more past due. As of December&#160;31, 2022, none of our commercial mortgage loans were non-performing.&#160;Loan-to-value and debt service coverage ratios are measures we use to assess the risk and quality of commercial mortgage loans. The loan-to-value ratio is expressed as a percentage of the value of the loan relative to the value of the underlying property. A loan-to-value ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The following table represents the loan-to-value ratio of the commercial mortgage loan portfolio as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 50%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50% to 60%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61% to 70%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt-service coverage ratio is measured by a property&#8217;s net operating income as a multiple of its debt re-payments. A ratio of less than 1.0 reflects a property&#8217;s operations is not sufficient to cover its debt payments. The following table represents the debt-service coverage ratio of the commercial mortgage loan portfolio, excluding </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">those that are non-performing and construction loans which are still under development, as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 1.20x</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 - 1.20x</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00x</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial mortgage loans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As at December&#160;31, 2022, we have non-performing loans of $Nil (December&#160;31, 2021 &#8212; $Nil) and construction loans of $19.9 million (December&#160;31, 2021 &#8212; $64.0 million) which only generate income when the construction is completed. As no income is currently being generated on these loans, they are not included in the table above. The total value of commercial mortgage loans is $312.1 million as at December&#160;31, 2022 (December&#160;31, 2021 &#8212; $211.5 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Middle Market Loans.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The middle market loans are investments in senior secured loan positions with full covenants, focused on the middle market in both U.S., Europe and the Caribbean. The middle market loan portfolio is diversified by industry type, geographic region and issuer to reduce risks. As part of our investment process, we evaluate factors such as size, industry and security to determine that loans are performing at a consistent and acceptable level to secure the related debt. The following table presents the type of middle market loans and geographic region as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industry type</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer discretionary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Energy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer staples</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total middle market mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geographic Region</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary credit quality indicator of middle market loans is loan performance. Non-performing middle market loans are generally 90 days or more past due. As of December&#160;31, 2022, all of our middle market loans were performing. Loan-to-enterprise-value and fixed charge coverage ratios are measures we use to assess the risk and quality of middle market loans. The loan-to-enterprise-value ratio is expressed as a percentage of the value of the loan relative to the value of the business. A loan-to-enterprise-value ratio in excess of 100% indicates the unpaid </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loan amount exceeds the value of the underlying business. The following table represents the loan-to-enterprise-value ratio of the middle market loan portfolio as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 50%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50% to 60%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61% to 70%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71% to 80%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81% to 100%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 100%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fixed charge coverage ratio, based upon the most recent financial statements, is expressed as a percentage of a firm&#8217;s earnings plus fixed charges to its fixed charges. Fixed charges include debt repayments, interest and equipment lease expenses. A fixed charge coverage ratio of less than 1.0 indicates a firm&#8217;s operations do not generate enough income to cover its fixed charges. The following represents the fixed charge coverage ratio of the middle market loan portfolio as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 1.20x</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 - 1.20x</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00x</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has individually assessed each of the middle market loans with the fixed charge coverage ratio of less than 1.00x. This is mainly due to increased capital investment to support the increased business post COVID-19. These investments have been performing with the fixed charged increasing over the year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Asset-backed securities represent interests in underlying pools of diversified referenced assets that are collateralised and backed by future cash flows and these securities are performing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global corporate securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Global corporates portfolio consists of debt securities with a non-U.S. debt issuer that are backed by the cash flows generated from real estate holdings and these securities are performing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Equity securities consists of a single non-U.S. private issuer that is a special purpose vehicle designed to grant a first lien right to the underlying senior notes. The underlying issuer is a financial services lender to middle market companies and this security is performing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments &#8212; Equity Method. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2015, the Company, along with seven other insurance companies, established a micro-insurance venture consortium and micro-insurance incubator (&#8220;MVI&#8221;) domiciled in Bermuda. The MVI is a social impact organization that provides micro-insurance products to assist global emerging consumers. In March 2021, the Company committed an additional $0.8 million equity contribution to MVI over a 2 year period and paid $0.4 million in the period ending December&#160;31, 2022 (December&#160;31, 2021 &#8212; $0.4 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2017, the Company purchased through its wholly-owned subsidiary, Aspen U.S. Holdings, Inc. (&#8220;Aspen U.S. Holdings&#8221;), a 49% share of Digital Risk Resources, LLC (&#8220;Digital Re&#8221;), a U.S.-based enterprise engaged in the business of developing, marketing and servicing turnkey information security and privacy liability insurance products for a total consideration of $2.3 million. The investment is accounted for under the equity </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">method and adjustments to the carrying value of this investment are made based on the Company&#8217;s share of capital, including share of income and expenses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2019, the Company committed $5.0 million as an equity investment in the holding company of a multi-line reinsurer. The strategy for the multi-line reinsurer is to combine a diversified reinsurance business, focused primarily on long-tailed lines of property and casualty business and, potentially to a lesser extent, life business, with a diversified investment strategy. During the period ending December&#160;31, 2022, $1.6 million (December&#160;31, 2021 &#8212; $2.5 million) capital was invested in multi-line reinsurer. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the Company&#8217;s investments in MVI, Multi-Line Reinsurer and Digital Re for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MVI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Multi-Line Reinsurer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Digital Re</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening undistributed value of investment as at January&#160;1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (loss)/gain for the twelve months to December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing value of investment as at December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening undistributed value of investment as at January&#160;1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain for the twelve months to December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing value of investments at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2017, the Company committed to, and during 2018 invested $100.0 million as a limited partner to a real estate fund, classified as other investments. As at December&#160;31, 2022, the current fair value of the fund is $134.6 million (2021 &#8212; $129.9&#160;million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, the Company committed $20.0 million as a limited partner to a third party managed real estate fund. The Partnership was established to make equity and equity related investments in multifamily and other commercial real estate properties located in the United States and its territories, with the goal of generating superior risk-adjusted returns. The Partnership seeks to acquire commercial real estate assets including real estate assets (or interests therein) that may have management or operational problems and require improvements or lack sufficient capital, including mortgage loans and development or redevelopment properties. On April 1, 2022, the Company committed an additional $10.0&#160;million to the fund. As at December&#160;31, 2022, the current fair value of the fund is $40.6 million (2021 &#8212; $21.4 million) and the unfunded commitment is $3.3 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company committed $30.0 million as a limited partner to a related party managed real estate fund. The Partnership was established to pursue investment opportunities to acquire, recapitalize, restructure and reposition real estate assets, portfolios and companies primarily in the United States. As at December&#160;31, 2022, the current fair value of the fund is $25.3 million and the unfunded commitment is $5.3 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2022, the Company committed $15.0 million as a limited partner to a third party managed infrastructure fund. The Partnership was established to make investments in value added infrastructure investments </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in environmental services, transportation, communications and digital, energy/energy transition and other infrastructure sectors primarily in North America. As at December&#160;31, 2022, the current fair value of the fund is $8.2 million and the unfunded commitment is $8.4 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the aggregate current fair value of the real estate funds investments described above is $221.3 million (2021 &#8212; $151.3 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on the real estate funds, refer to Note 20(a) in these consolidated financial statements, &#8220;Commitments and Contingencies.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed income maturities, Available for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The scheduled maturity distribution of the Company&#8217;s available for sale fixed income securities as at December&#160;31, 2022 and December&#160;31, 2021 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost&#160;or&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>S&amp;P Ratings&#160;by<br/>Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,526.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA-</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total &#8212; Government and corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,534.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,280.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost&#160;or&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>S&amp;P Ratings&#160;by<br/>Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA-</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,057.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,087.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA-</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total &#8212; Government and corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,733.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,784.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,823.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,881.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guaranteed Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As at December&#160;31, 2022 and December&#160;31, 2021, the Company held no investments which are guaranteed by mono-line insurers, excluding those with explicit government guarantees. The Company&#8217;s exposure to other third-party guaranteed debt is primarily to investments backed by non-U.S.&#160;government guaranteed issuers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross unrealized losses, available for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The following tables summarize, by type of security, the aggregate fair value and gross unrealized loss by length of time the security has been in an unrealized loss position for the Company&#8217;s available for sale portfolio as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0-12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Over 12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,645.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0-12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Over 12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in gross unrealized losses is largely attributable to the impact of rising interest rates on our bond portfolio and mortgage-backed securities.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Investments</span><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Statement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net investment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. &#160;The following table summarizes investment income for the six months ended June&#160;30, 2023 and 2022;</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities&#160;&#8212; Available for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities&#160;&#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments&#160;&#8212; Available for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments&#160;&#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed term deposits (included in cash and cash equivalents)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe bonds &#8212; Trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments, at fair value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents the Company&#8217;s investments in real estate, infrastructure and direct lending funds. The movement in the periods represent the change in fair value of the investment and has been included as part of our investment income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net realized and unrealized investment gains and losses recorded in the consolidated statement of operations and the change in unrealized gains and losses on investments recorded in other comprehensive income for the six months ended June&#160;30, 2023 and  2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized gains</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in expected credit gains/(losses) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments &#8212; gross realized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212;  gross realized gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Privately-held investments &#8212;  net unrealized (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catastrophe bonds &#8212; net unrealized (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities &#8212; net unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments &#8212; equity method:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in realized and unrealized gains  in Multi-Line Reinsurer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net realized and unrealized investment gains/(losses) recorded in the consolidated statement of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in available for sale net unrealized gains/(losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities gains/(losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in net unrealized gains/(losses), net of taxes recorded in other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance Sheet</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities and Short-Term Investments &#8212; Available For Sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;The following tables present the cost or amortized cost, gross unrealized gains and losses and estimated fair market value of available for sale investments in fixed income securities and short-term investments as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost&#160;or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,031.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,231.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,908.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,077.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the six  months ended June&#160;30, 2023, there was a decrease in the CECL allowance on available-for-sale investments of $3.7 million (December&#160;31, 2022 &#8212; $5.0 million increase).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost&#160;or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,016.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,840.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities, Short-Term Investments, Equities, Catastrophe Bonds and Privately-held Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; The following tables present the cost or amortized cost, gross unrealized gains and losses, and estimated fair market value of trading investments in fixed income securities, short-term investments, equity securities, catastrophe bonds and privately-held investments as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Income Securities &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,974.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or<br/>Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Income Securities &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments&#160;&#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total privately-held investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investments &#8212; Trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,017.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catastrophe bonds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company has invested in catastrophe bonds with a total value of $2.4 million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $2.9 million).&#160;The bonds are either zero-coupon notes or receive quarterly interest payments based on variable interest rates with scheduled maturities ranging from 2023 to 2026.&#160;The redemption value of the bonds will adjust based on the occurrence or aggregate occurrence of a covered event, such as windstorms and earthquakes in the United States, Canada, the North Atlantic, South America, Europe, Japan or Australia.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Privately-held investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has invested in privately-held investments, which primarily include commercial mortgage loans of $295.0 million and middle market loans of $102.1 million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; commercial mortgage loans of $312.1 million; middle market loans of $106.9 million). Privately-held investments also includes investments in asset-backed securities, equity securities and other short-term investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Mortgage Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The commercial mortgage loans are related to investments in properties including apartments, hotels, office and retail buildings, other commercial properties and industrial properties. The commercial mortgage loan portfolio is diversified by property type, geographic region and issuer to reduce risks. As part of our investment process, we evaluate factors such as size, property type, and security to determine that </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">properties are performing at a consistent and acceptable level to secure the related debt.&#160;The following table presents the type of commercial mortgage loans and geographic region as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property type</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apartment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hotels</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Region</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary credit quality indicator of commercial mortgage loans is loan performance. Non-performing commercial mortgage loans are generally 90 days or more past due. As of June&#160;30, 2023, none of our commercial mortgage loans were non-performing.&#160;Loan-to-value and debt service coverage ratios are measures we use to assess the risk and quality of commercial mortgage loans. The loan-to-value ratio is expressed as a percentage of the value of the loan relative to the value of the underlying property. A loan-to-value ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The following table represents the loan-to-value ratio of the commercial mortgage loan portfolio as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 50%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50% to 60%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61% to 70%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt-service coverage ratio is measured by a property&#8217;s net operating income as a multiple of its debt re-payments. A ratio of less than 1.0 reflects a property&#8217;s operations is not sufficient to cover its debt payments. The following table represents the debt-service coverage ratio of the commercial mortgage loan portfolio, excluding those that are non-performing and construction loans which are still under development, as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 1.20x</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 - 1.20x</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00x</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial mortgage loans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As at June&#160;30, 2023, we have non-performing loans of $Nil (December&#160;31, 2022  &#8212; $Nil) and construction loans of $Nil (December&#160;31, 2022 &#8212; $19.9 million) which only generate income when the construction is completed. As no income is currently being generated on these loans, they are not included in the table above. The total value of commercial mortgage loans is $295.0 million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $312.1 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Middle Market Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The middle market loans are investments in senior secured loan positions with full covenants, focused on the middle market in the U.S., Europe and the Caribbean. The middle market loan portfolio is diversified by industry type, geographic region and issuer to reduce risks. As part of our investment process, we evaluate factors such as size, industry and security to determine that loans are performing at a consistent and acceptable level to secure the related debt. The following table presents the type of middle market loans and geographic region as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industry type</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer discretionary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Energy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total middle market mortgage loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loan-to-enterprise-value and fixed charge coverage ratios are measures we use to assess the risk and quality of middle market loans. The loan-to-enterprise-value ratio is expressed as a percentage of the value of the loan relative to the value of the business. A loan-to-enterprise-value ratio in excess of 100% indicates the unpaid loan amount exceeds the value of the underlying business. The following table represents the loan-to-enterprise-value ratio of the middle market loan portfolio as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 50%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50% to 60%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61% to 70%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fixed charge coverage ratio, based upon the most recent financial statements, is expressed as a percentage of a firm&#8217;s earnings plus fixed charges to its fixed charges. Fixed charges include debt repayments, interest and equipment lease expenses. A fixed charge coverage ratio of less than 1.0 indicates a firm&#8217;s operations do not </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generate enough income to cover its fixed charges. The following represents the fixed charge coverage ratio of the middle market loan portfolio as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 1.20x</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 - 1.20x</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.00x</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has individually assessed each of the middle market loans with the fixed charge coverage ratio of less than 1.00x. This is mainly due to increased capital investment to support the increased business post COVID-19. These investments have been performing with the fixed charged increasing over the year.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Asset-backed securities represent interests in underlying pools of diversified referenced assets that are collateralized and backed by future cash flows and these securities are performing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global corporate securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Global corporates portfolio consists of debt securities with a non-U.S. debt issuer that are backed by the cash flows generated from real estate holdings and these securities are performing.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Equity securities consists of a single non-U.S. private issuer that is a special purpose vehicle designed to grant a first lien right to the underlying senior notes. The underlying issuer is a financial services lender to middle market companies and this security is performing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments &#8212; Equity Method.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In January 2015, the Company, along with seven other insurance companies, established a micro-insurance venture consortium and micro-insurance incubator (&#8220;MVI&#8221;) domiciled in Bermuda. The MVI is a social impact organization that provides micro-insurance products to assist global emerging consumers. In March 2021, the Company committed an additional $0.8 million equity contribution to MVI over a 2 year period and paid $0.4 million in the period ending December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2017, the Company purchased through its wholly-owned subsidiary, Aspen U.S. Holdings, Inc. (&#8220;Aspen U.S. Holdings&#8221;), a 49% share of Digital Risk Resources, LLC (&#8220;Digital Re&#8221;), a U.S.-based enterprise engaged in the business of developing, marketing and servicing turnkey information security and privacy liability insurance products for a total consideration of $2.3 million. The investment is accounted for under the equity method and adjustments to the carrying value of this investment are made based on the Company&#8217;s share of capital, including share of income and expenses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2019, the Company committed $5.0 million as an equity investment in the holding company of a multi-line reinsurer. The strategy for the multi-line reinsurer is to combine a diversified reinsurance business, focused primarily on long-tailed lines of property and casualty business and, potentially to a lesser extent, life business, with a diversified investment strategy. During the period ending June&#160;30, 2023, $0.4 million (December&#160;31, 2022 &#8212;$1.6 million) capital was invested in multi-line reinsurer. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the Company&#8217;s investments in MVI, Multi-Line Reinsurer and Digital Re for the six months ended June&#160;30, 2023 and the twelve months ended December 31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MVI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Multi-Line Reinsurer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Digital Re</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening undistributed value of investment as at January&#160;1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain for the period to June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing value of investment as at June 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="21" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening undistributed value of investment as at January&#160;1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (loss)/gain for the period to December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing value of investments at December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  On December 20, 2017, the Company committed to, and during 2018 invested $100.0 million as a limited partner to a real estate fund, classified as other investments. As at June&#160;30, 2023, the current fair value of the fund is $125.2 million (December 31, 2022 &#8212; $134.6&#160;million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, the Company committed $20.0 million as a limited partner to a third party managed real estate fund. The Partnership was established to make equity and equity related investments in multifamily and other commercial real estate properties located in the United States and its territories, with the goal of generating superior risk-adjusted returns. The Partnership seeks to acquire commercial real estate assets including real estate assets (or interests therein) that may have management or operational problems and require improvements or lack sufficient capital, including mortgage loans and development or redevelopment properties. On April 1, 2022, the Company committed an additional $10.0&#160;million to the fund. As at June&#160;30, 2023, the current fair value of the fund is $39.2 million (December 31, 2022 &#8212; $40.6 million) and the unfunded commitment is $3.3 million (December 31, 2022 &#8212; $3.3 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company committed $30.0 million as a limited partner to a related party managed real estate fund. The Partnership was established to pursue investment opportunities to acquire, recapitalize, restructure and reposition real estate assets, portfolios and companies primarily in the United States. As at June&#160;30, 2023, the current fair value of the fund is $22.9&#160;million (December 31, 2022 &#8212; $25.3&#160;million) and the unfunded commitment is $5.3 million (December 31, 2022 &#8212; $5.3 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2022, the Company committed $15.0 million as a limited partner to a third party managed infrastructure fund. The Partnership was established to make investments in value added infrastructure investments in environmental services, transportation, communications and digital, energy/energy transition and other infrastructure sectors primarily in North America. As at June&#160;30, 2023, the current fair value of the fund is $11.7&#160;million (December 31, 2022 &#8212; $8.2&#160;million)  and the unfunded commitment is $6.4 million (December 31, 2022 &#8212; $8.4 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the aggregate current fair value of the fund investments described above is $213.4 million (December 31, 2022 &#8212; $221.3 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on the funds, refer to Note 12(a) in these consolidated financial statements, &#8220;Commitments and Contingencies.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed income maturities, Available for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The scheduled maturity distribution of the Company&#8217;s available for sale fixed income securities as at June&#160;30, 2023 and December&#160;31, 2022 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost&#160;or&#160;Cost</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>S&amp;P Ratings&#160;by<br/>Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA-</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total &#8212; Government and corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,665.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,231.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,908.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost&#160;or&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>S&amp;P Ratings&#160;by<br/>Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due one year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,526.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA-</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total &#8212; Government and corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,534.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,280.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AA+</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities &#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guaranteed Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;As at June&#160;30, 2023 and December&#160;31, 2022, the Company held no investments which are guaranteed by mono-line insurers, excluding those with explicit government guarantees. The Company&#8217;s exposure to other third-party guaranteed debt is primarily to investments backed by non-U.S.&#160;government guaranteed issuers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross unrealized losses, available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The following tables summarize, by type of security, the aggregate fair value and gross unrealized loss by length of time the security has been in an unrealized loss position for the Company&#8217;s available for sale portfolio as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0-12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Over 12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,758.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0-12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Over 12&#160;months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term investments&#160;&#8212; Available for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,645.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The overall gross unrealized loss position is largely attributable to the impact of rising interest rates on our bond portfolio and mortgage-backed securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633578131536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Variable Interest Entities</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company held an investment in one (December&#160;31, 2021 &#8212; one) variable interest entity (&#8220;VIE&#8221;), namely Peregrine Reinsurance Ltd (&#8220;Peregrine&#8221;). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peregrine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In November 2016, Peregrine, a subsidiary of the Company, was registered as a segregated accounts company under the Segregated Accounts Companies Act 2000, as amended. As at December&#160;31, 2022, Peregrine had six segregated accounts which were funded by third-party investors, which are not consolidated, and two segregated accounts which are funded by Aspen and are consolidated within the financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that Peregrine has the characteristics of a VIE as addressed by the guidance in ASC&#160;810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The six segregated accounts have not been consolidated as part of the Company&#8217;s consolidated&#160;financial statements because the Company is not the primary beneficiary of those accounts.&#160;The Company has, however, concluded that it is the primary beneficiary of the Peregrine general fund and, similar to prior reporting periods, the results of the Peregrine general fund are included in the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633578123984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Fair Value Measurements</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of fair value for financial assets and liabilities are based on the framework established in the fair value accounting guidance included in ASC Topic 820, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; The framework prioritizes the inputs, which refer broadly to assumptions market participants would use in pricing an asset or liability, into three levels.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for actively traded securities to be derived based on quoted prices in an active market for identical assets, which are Level&#160;1 inputs in the fair value hierarchy. The majority of these securities are valued using prices supplied by pricing services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for other securities that may not be as actively traded which are priced via pricing services, vendors and broker-dealers, or with reference to interest rates and yield curves, to be derived based on inputs that are observable for the asset, either directly or indirectly, which are Level&#160;2 inputs in the fair value hierarchy. The majority of these securities are also valued using prices supplied by pricing services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers securities, other financial instruments, privately-held investments and derivative insurance contracts subject to fair value measurement whose valuation is derived by internal valuation models to be based largely on unobservable inputs, which are Level&#160;3 inputs in the fair value hierarchy.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the level within the fair value hierarchy at which the Company&#8217;s financial assets and liabilities are measured on a recurring basis as at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available for sale financial assets, at fair value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,690.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Held for trading financial assets, at fair value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial assets and liabilities, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives at fair value &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities under derivative contracts &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities under derivative contracts &#8212; loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,100.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents our investments in real estate and other special purpose vehicles and are measured at fair value using the net asset value per share practical expedient. As a result this has not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheets. The investment in the real estate and other funds is subject to restrictions as detailed in Note 20(a), &#8220;Commitments and Contingencies.&#8221;</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The loss portfolio transfer contract includes a funds withheld arrangement that provides variable interest expense based on Aspen&#8217;s investment performance. As a result, this funds withheld arrangement is considered an embedded derivative and accounted for as an option-based derivative. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Available for sale financial assets, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,208.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,208.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,632.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,881.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Held for trading financial assets, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial assets and liabilities, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives at fair value &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities under derivative contracts &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,669.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,512.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents our investments in real estate funds and are measured at fair value using the net asset value per share practical expedient. As a result this has not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheets. The investment in the real estate funds is subject to restrictions as detailed in Note 20(a), &#8220;Commitments and Contingencies.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers of assets into or out of a particular level are recorded at their fair values as of the end of each reporting period consistent with the date of the determination of fair value. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2022, $Nil (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; $19.5 million was transferred into Level 3) was transferred in or out of Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, there were privately-held investments carried at $533.0 million (December&#160;31, 2021 &#8212; $307.1 million) classified as Level 3. As a result of loans sold by Aspen and loans repaid to Aspen by borrowers, a net settlement of $147.4 million occurred during the year. Additionally as at December&#160;31, 2022, there was an embedded derivative as part of the loss portfolio transfer agreement worth $31.7&#160;million classified as Level 3. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the beginning and ending balances for all assets and liabilities measured at fair value on a recurring basis using Lev</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">el 3 inputs for the twelve months ended December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchases and issuances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers in/(out)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements and sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase/(decrease) in fair value including net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1704">Change in unrealized investment gains (losses) relating to assets held at end of year</span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="45" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; trading</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Level 3 assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities under derivative contracts - loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Level 3 liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="45" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; trading</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Level 3 assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Fixed Income Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fixed income securities are classified as either available for sale or trading and are reported at fair value. As at December&#160;31, 2022 and December&#160;31, 2021, the Company&#8217;s fixed income securities were valued by pricing services or broker-dealers using standard market conventions. The market conventions utilize market quotations, market transactions in comparable instruments and </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">various relationships between instruments including, but not limited to, yield to maturity, dollar prices and spread prices in determining value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Pricing Services.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying methodology used to determine the fair value of securities in the Company&#8217;s available for sale and trading portfolios is by the pricing services. Pricing services will gather observable pricing inputs from multiple external sources, including buy and sell-side contacts and broker-dealers, in order to develop their internal prices. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing services provide pricing for less complex, liquid securities based on market quotations in active markets. Pricing services supply prices for a broad range of securities including those for actively traded securities, such as Treasury and other Government securities, in addition to those that trade less frequently or where valuation includes reference to credit spreads, pay down and pre-pay features and other observable inputs. These securities include Government agency, municipals, corporate and asset-backed securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For securities that may trade less frequently or do not trade on a listed exchange, these pricing services may use matrix pricing consisting of observable market inputs to estimate the fair value of a security. These observable market inputs include reported trades, benchmark yields, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and industry and economic factors. Additionally, pricing services may use a valuation model such as an option adjusted spread model commonly used for estimating fair values of mortgage-backed and asset-backed securities. The Company does not derive dollar prices using an index as a pricing input for any individual security.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broker-Dealers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company obtains quotes from broker-dealers who are active in the corresponding markets when prices are unavailable from independent pricing services or index providers. Generally, broker-dealers value securities through their trading desks based on observable market inputs. Their pricing methodologies include mapping securities based on trade data, bids or offers, observed spreads and performance of newly issued securities. They may also establish pricing through observing secondary trading of similar securities. Quotes from broker-dealers are non-binding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company obtains prices for all of its fixed income investment securities via its third-party accounting service provider, and in the majority of cases receiving a number of quotes so as to obtain the most comprehensive information available to determine a security&#8217;s fair value. A single valuation is applied to each security based on the vendor hierarchy maintained by the Company&#8217;s third-party accounting service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company obtained an average of 2.9 quotes per fixed income investment compared to 3.0 quotes at December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, in conjunction with its third-party accounting service provider, obtains an understanding of the methods, models and inputs used by the third-party pricing service and index providers to assess the ongoing appropriateness of vendors&#8217; prices. The Company and its third-party accounting service provider also have controls in place to validate that amounts provided represent fair values. Processes to validate and review pricing include, but are not limited to:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">quantitative analysis (e.g., comparing the quarterly return for each managed portfolio to its target benchmark, with significant differences identified and investigated);</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comparison of market values obtained from pricing services and broker-dealers against alternative price sources for each security where further investigation is completed when significant differences exist for pricing of individual securities between pricing sources;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">initial and ongoing evaluation of methodologies used by outside parties to calculate fair value;&#160;and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comparison of the fair value estimates to the Company&#8217;s knowledge of the current market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prices obtained from pricing services and broker-dealers are not adjusted by us; however, prices provided by a pricing service, or broker-dealer in certain instances may be challenged based on market or information available from internal sources, including those available to the Company&#8217;s third-party investment accounting service provider. Subsequent to any challenge, revisions made by the pricing service or broker-dealer to the quotes are supplied to the Company&#8217;s investment accounting service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the vendor hierarchy maintained by the Company&#8217;s third-party accounting service provider in order to determine which price source provides the most appropriate fair value (i.e., a price obtained from a pricing service with more seniority in the hierarchy will be used over a less senior one in all cases). The hierarchy level assigned to each security in the Company&#8217;s available for sale and trading portfolios is based upon its assessment of the transparency and reliability of the inputs used in the valuation as of the measurement date. The hierarchy of pricing services is determined using various qualitative and quantitative points arising from reviews of the vendors conducted by the Company&#8217;s third-party accounting service provider. Vendor reviews include annual due diligence meetings with index providers and pricing services vendors covering valuation methodology, operational walkthroughs and legal and compliance updates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities are traded on the over-the-counter (&#8220;OTC&#8221;) market based on prices provided by one or more market makers in each security. Securities such as U.S.&#160;Government, U.S.&#160;Agency, Foreign Government and investment grade corporate bonds have multiple market makers in addition to readily observable market value indicators such as expected credit spread, except for Treasury securities, over the yield curve. The Company uses a variety of pricing sources to value fixed income securities including those securities that have pay down/prepay features such as mortgage-backed securities and asset-backed securities in order to ensure fair and accurate pricing. The fair value estimates for the investment grade securities in the Company&#8217;s portfolio do not use significant unobservable inputs or modeling techniques.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Government and Agency Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;U.S.&#160;government and agency securities consist primarily of bonds issued by the U.S.&#160;Treasury and corporate debt issued by agencies such as the Federal National Mortgage Association (&#8220;FNMA&#8221;), the Federal Home Loan Mortgage Corporation (&#8220;FHLMC&#8221;) and the Federal Home Loan Bank. As the fair values of U.S.&#160;Treasury securities are based on unadjusted market prices in active markets, they are classified within Level&#160;1. The fair values of U.S.&#160;government agency securities are priced using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of U.S.&#160;government agency securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Municipal Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s municipal portfolio consist of bonds issued by U.S.&#160;domiciled state and municipality entities. The fair value of these securities is determined using spreads obtained from broker-dealers, trade prices and the new issue market which are Level&#160;2 inputs in the fair value hierarchy. Consequently, these securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-U.S. Government.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The issuers for securities in this category are non-U.S.&#160;governments and their agents including, but not limited to, the U.K., Australia, Canada, France and Germany. The fair values of certain non-U.S.&#160;government bonds, primarily sourced from international indices, are based on unadjusted market prices in active markets and are therefore classified within Level&#160;1. The remaining non-U.S. government bonds are classified within level 2 as they are not actively traded. The fair values of the non-U.S.&#160;agency securities, again primarily sourced from international indices, are priced using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of non-U.S.&#160;agency securities are classified within Level&#160;2. In addition, foreign government securities include a portion of the Emerging Market Debt (&#8220;EMD&#8221;) portfolio which is also classified within Level 2. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate securities consist primarily of short-term, medium-term and long-term debt issued by U.S.&#160;and foreign corporations covering a variety of industries and are generally priced by index providers and pricing vendors. Some issuers may participate in&#160;government programs which guarantee timely payment of principal and interest in the event of a default. The fair values of these securities are generally determined using the spread above the risk-free yield curve. Inputs used in the evaluation of these securities include credit data, interest rate data, market observations and sector news, broker-dealer quotes and trade volumes. In addition, corporate securities </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">include a portion of the EMD portfolio. The Company classifies these securities across Level 1 and 2, with majority of them being in Level 1.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-backed Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Residential and commercial mortgage-backed securities consist of bonds issued by the Government National Mortgage Association, the FNMA and the FHLMC as well as private non-agency issuers. The fair values of these securities are determined through the use of a pricing model (including Option Adjusted Spread) which uses prepayment speeds and spreads to determine the appropriate average life of the mortgage-backed security. These spreads are generally obtained from broker-dealers, trade prices and the new issue market. As the significant inputs used to price mortgage-backed securities are observable market inputs, these securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Asset-backed securities are securities backed by notes or receivables against assets other than real estate. The underlying collateral for the Company&#8217;s asset-backed securities consists mainly of student loans, automobile loans and credit card receivables. These securities are primarily priced by index providers and pricing vendors. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, interest rate data and credit spreads. The Company classifies these securities within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privately-Held Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Privately-held investments are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models. These models include inputs that are specific to each investment. The inputs used in the fair value measurements include dividend or interest rates and appropriate discount rates. The selection of an appropriate discount rate is judgmental and is the most significant unobservable input used in the valuation of these securities. A significant increase (decrease) in this input in isolation could result in significantly lower (higher) fair value measurement for privately-held investments. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow models, the Company maintains an understanding of current market conditions, issuer specific information that may impact future cash flows as well as collaboration with independent vendors for most securities to assess the reasonableness of the discount rate being used.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial mortgage loans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial mortgage loans consists in investments in properties including apartments, hotels, office and retail buildings, other commercial properties and industrial properties. The commercial mortgage loan portfolio is diversified by property type, geographic region and issuer to reduce risks. Commercial Mortgage Loans are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The middle market loans consist in investments in senior secured loan positions with full covenants, focused on the middle market in both U.S., Europe and the Caribbean. The middle market loan portfolio is diversified by industry type, geographic region and issuer to reduce risks. Middle Market Loans are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Asset-backed securities represent interests in underlying pools of diversified referenced assets that are collateralised and backed by future cash flows and these securities are performing. The fair values of these securities are determined by using discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global corporate securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The global corporates portfolio consists of debt securities with a non-U.S. debt issuer that are backed by the cash flows generated from real estate holdings and these securities are performing. The fair value of these securities are determined by using discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Equity securities consists of a single non-U.S. based issuer that is a special purpose vehicle designed to grant a first lien right to the underlying senior notes within the structure. The underlying issuer is a financial services lender to middle market companies and this security is performing. The valuation of the investments is DCF and the securities are classified as Level 3. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Short-term investments consist of highly liquid debt securities with a maturity greater than three months but less than one year from the date of purchase. Short-term investments are classified as either trading or available for sale according to the facts and circumstances of the investment held. Short-term investments are valued in a manner similar to the Company&#8217;s fixed maturity investments and are classified within Levels 1 and 2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the quantitative inputs and assumptions used for financial assets and liabilities investments categorized as Level 3 under the fair value hierarchy as at December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Techniques</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable (U) inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ranges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidation method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Catastrophe Bonds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe bonds are variable rate fixed income instruments with redemption values adjusted based on the occurrence of a covered event, usually windstorms and earthquakes. Catastrophe bonds are classified as trading and reported at fair value.&#160;Catastrophe bonds are priced using an average of multiple broker-dealer quotes and as such, are considered Level 2.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; The foreign exchange contracts which the Company uses to mitigate currency risk are characterized as OTC due to their customized nature and the fact that they do not trade on a major exchange. These instruments trade in a very deep liquid market, providing substantial price transparency and accordingly are classified as Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liabilities under derivative contracts - loss portfolio transfer. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LPT embedded derivative is valued in a Black-Scholes framework. The two primary inputs of this policy are expected claim settlement patterns and expected return of the investment portfolio above a fixed minimum rate over the specified time horizon. The expected claim settlement pattern is determined on an actuarial basis for the cohort of business within scope of the LPT and is consistent with the patterns used in the valuation of technical provisions. The expected return of the investment portfolio, above a fixed minimum rate, directly impacts on the LPT derivative valuation and is subject to changes in the market conditions. In order to assess the reasonableness of the inputs, the company updates the expected claim settlement patterns on a regular basis whilst maintaining an understanding of the current market conditions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other investments represent our investments in real estate funds and other special purpose vehicles. Adjustments to the fair values are made based on the net asset value of the investments. The net valuation criteria established by the manager of such investments are established in accordance with the governing documents and the asset manager&#8217;s valuation guidelines, which include: the discounted cash flows method and the performance multiple approach, which uses a multiple derived from market data of comparable </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies or assets to produce operating performance metrics. Alternative valuation methodologies may be employed for investments with unusual characteristics.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Fair Value Measurements</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of fair value for financial assets and liabilities are based on the framework established in the fair value accounting guidance included in ASC Topic 820, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; The framework prioritizes the inputs, which refer broadly to assumptions market participants would use in pricing an asset or liability, into three levels.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for actively traded securities to be derived based on quoted prices in an active market for identical assets, which are Level&#160;1 inputs in the fair value hierarchy. The majority of these securities are valued using prices supplied by pricing services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers prices for other securities that may not be as actively traded which are priced via pricing services, vendors and broker-dealers, or with reference to interest rates and yield curves, to be derived based on inputs that are observable for the asset, either directly or indirectly, which are Level&#160;2 inputs in the fair value hierarchy. The majority of these securities are also valued using prices supplied by pricing services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers securities, other financial instruments, privately-held investments and derivative insurance contracts subject to fair value measurement whose valuation is derived by internal valuation models to be based largely on unobservable inputs, which are Level&#160;3 inputs in the fair value hierarchy.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the level within the fair value hierarchy at which the Company&#8217;s financial assets and liabilities are measured on a recurring basis as at June&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed income securities, available for sale. at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,908.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed income securities, trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial assets and liabilities, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities &#8212; loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,940.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,245.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents our investments in real estate, infrastructure and direct lending funds and are measured at fair value using the net asset value per share practical expedient. As a result this has not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheets. The investment in the real estate and other funds is subject to restrictions as detailed in Note 12(a), &#8220;Commitments and Contingencies.&#8221;</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The loss portfolio transfer contract includes a funds withheld arrangement that provides variable interest expense based on Aspen&#8217;s investment performance. As a result, this funds withheld arrangement is considered an embedded derivative and accounted for as an option-based derivative. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed income securities, available for sale. at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-agency commercial mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,690.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments available for sale, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed income securities, trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government-backed corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High yield loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fixed income securities trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term investments trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catastrophe bonds trading, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial assets and liabilities, at fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities &#8212; foreign exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities &#8212; loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,100.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other investments represents our investments in real estate, infrastructure and direct lending funds and are measured at fair value using the net asset value per share practical expedient. As a result this has not been classified in the fair value hierarchy. The fair value amounts presented in the table above are intended to permit reconciliation of the fair value </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">hierarchy to the amounts presented in the consolidated balance sheets. The investment in the real estate funds is subject to restrictions as detailed in Note 12(a), &#8220;Commitments and Contingencies.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers of assets into or out of a particular level are recorded at their fair values as of the end of each reporting period consistent with the date of the determination of fair value. During the six months ended June&#160;30, 2023, $6.7 million (December&#160;31, 2022 &#8212; $Nil) was transferred out of Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, there were privately-held investments carried at $482.4 million (December&#160;31, 2022  &#8212; $533.0 million) classified as Level 3. As a result of loans sold by Aspen and loans repaid to Aspen by borrowers, a net settlement of $58.4 million occurred during the period (December&#160;31, 2022 &#8212; $147.4 million). Additionally as at June&#160;30, 2023, there was an embedded derivative as part of the loss portfolio transfer agreement worth $23.4&#160;million classified as Level 3 (December&#160;31, 2022 &#8212; $31.7 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the beginning and ending balances for all assets and liabilities measured at fair value on a recurring basis using Level 3 inputs for the six months ended June&#160;30, 2023 and the twelve months ended December 31, 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchases and issuances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers (out)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements and sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase/(decrease) in fair value including net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in unrealized investment gains (losses) relating to assets held at end of period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Privately-held investments &#8212; trading</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Level 3 assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">482.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative liabilities - loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Level 3 liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Privately-held investments &#8212; trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(113.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Level 3 assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">378.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(147.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative liabilities - loss portfolio transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Level 3 liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Fixed Income Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fixed income securities are classified as either available for sale or trading and are reported at fair value. As at June&#160;30, 2023 and December&#160;31, 2022, the Company&#8217;s fixed income securities were valued by pricing services or broker-dealers using standard market conventions. The market conventions utilize market quotations, market transactions in comparable instruments and various relationships between instruments including, but not limited to, yield to maturity, dollar prices and spread prices in determining value. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Pricing Services.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying methodology used to determine the fair value of securities in the Company&#8217;s available for sale and trading portfolios is by the pricing services. Pricing services will gather observable </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pricing inputs from multiple external sources, including buy and sell-side contacts and broker-dealers, in order to develop their internal prices. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing services provide pricing for less complex, liquid securities based on market quotations in active markets. Pricing services supply prices for a broad range of securities including those for actively traded securities, such as Treasury and other Government securities, in addition to those that trade less frequently or where valuation includes reference to credit spreads, pay down and pre-pay features and other observable inputs. These securities include Government agency, municipals, corporate and asset-backed securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For securities that may trade less frequently or do not trade on a listed exchange, these pricing services may use matrix pricing consisting of observable market inputs to estimate the fair value of a security. These observable market inputs include reported trades, benchmark yields, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and industry and economic factors. Additionally, pricing services may use a valuation model such as an option adjusted spread model commonly used for estimating fair values of mortgage-backed and asset-backed securities. The Company does not derive dollar prices using an index as a pricing input for any individual security.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broker-Dealers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company obtains quotes from broker-dealers who are active in the corresponding markets when prices are unavailable from independent pricing services or index providers. Generally, broker-dealers value securities through their trading desks based on observable market inputs. Their pricing methodologies include mapping securities based on trade data, bids or offers, observed spreads and performance of newly issued securities. They may also establish pricing through observing secondary trading of similar securities. Quotes from broker-dealers are non-binding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company obtains prices for all of its fixed income investment securities via its third-party accounting service provider, and in the majority of cases receiving a number of quotes so as to obtain the most comprehensive information available to determine a security&#8217;s fair value. A single valuation is applied to each security based on the vendor hierarchy maintained by the Company&#8217;s third-party accounting service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company obtained an average of 2.8 quotes per fixed income investment compared to 2.9 quotes at December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, in conjunction with its third-party accounting service provider, obtains an understanding of the methods, models and inputs used by the third-party pricing service and index providers to assess the ongoing appropriateness of vendors&#8217; prices. The Company and its third-party accounting service provider also have controls in place to validate that amounts provided represent fair values. Processes to validate and review pricing include, but are not limited to:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">quantitative analysis (e.g., comparing the quarterly return for each managed portfolio to its target benchmark, with significant differences identified and investigated);</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comparison of market values obtained from pricing services and broker-dealers against alternative price sources for each security where further investigation is completed when significant differences exist for pricing of individual securities between pricing sources;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">initial and ongoing evaluation of methodologies used by outside parties to calculate fair value;&#160;and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comparison of the fair value estimates to the Company&#8217;s knowledge of the current market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prices obtained from pricing services and broker-dealers are not adjusted by us; however, prices provided by a pricing service, or broker-dealer in certain instances may be challenged based on market or information available from internal sources, including those available to the Company&#8217;s third-party investment accounting service provider. Subsequent to any challenge, revisions made by the pricing service or broker-dealer to the quotes are supplied to the Company&#8217;s investment accounting service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the vendor hierarchy maintained by the Company&#8217;s third-party accounting service provider in order to determine which price source provides the most appropriate fair value (i.e., a price obtained </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from a pricing service with more seniority in the hierarchy will be used over a less senior one in all cases). The hierarchy level assigned to each security in the Company&#8217;s available for sale and trading portfolios is based upon its assessment of the transparency and reliability of the inputs used in the valuation as of the measurement date. The hierarchy of pricing services is determined using various qualitative and quantitative points arising from reviews of the vendors conducted by the Company&#8217;s third-party accounting service provider. Vendor reviews include annual due diligence meetings with index providers and pricing services vendors covering valuation methodology, operational walkthroughs and legal and compliance updates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Income Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities are traded on the over-the-counter (&#8220;OTC&#8221;) market based on prices provided by one or more market makers in each security. Securities such as U.S.&#160;Government, U.S.&#160;Agency, Foreign Government and investment grade corporate bonds have multiple market makers in addition to readily observable market value indicators such as expected credit spread, except for Treasury securities, over the yield curve. The Company uses a variety of pricing sources to value fixed income securities including those securities that have pay down/prepay features such as mortgage-backed securities and asset-backed securities in order to ensure fair and accurate pricing. The fair value estimates for the investment grade securities in the Company&#8217;s portfolio do not use significant unobservable inputs or modeling techniques.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Government and Agency Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;U.S.&#160;government and agency securities consist primarily of bonds issued by the U.S.&#160;Treasury and corporate debt issued by agencies such as the Federal National Mortgage Association (&#8220;FNMA&#8221;), the Federal Home Loan Mortgage Corporation (&#8220;FHLMC&#8221;) and the Federal Home Loan Bank. As the fair values of U.S.&#160;Treasury securities are based on unadjusted market prices in active markets, they are classified within Level&#160;1. The fair values of U.S.&#160;government agency securities are priced using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of U.S.&#160;government agency securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Municipal Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s municipal portfolio consist of bonds issued by U.S.&#160;domiciled state and municipality entities. The fair value of these securities is determined using spreads obtained from broker-dealers, trade prices and the new issue market which are Level&#160;2 inputs in the fair value hierarchy. Consequently, these securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-U.S. Government.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The issuers for securities in this category are non-U.S.&#160;governments and their agents including, but not limited to, the U.K., Australia, Canada, France and Germany. The fair values of certain non-U.S.&#160;government bonds, primarily sourced from international indices, are based on unadjusted market prices in active markets and are therefore classified within Level&#160;1. The remaining non-U.S. government bonds are classified within level 2 as they are not actively traded. The fair values of the non-U.S.&#160;agency securities, again primarily sourced from international indices, are priced using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of non-U.S.&#160;agency securities are classified within Level&#160;2. In addition, foreign government securities include a portion of the Emerging Market Debt (&#8220;EMD&#8221;) portfolio which is also classified within Level 2. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate securities consist primarily of short-term, medium-term and long-term debt issued by U.S.&#160;and foreign corporations covering a variety of industries and are generally priced by index providers and pricing vendors. Some issuers may participate in&#160;government programs which guarantee timely payment of principal and interest in the event of a default. The fair values of these securities are generally determined using the spread above the risk-free yield curve. Inputs used in the evaluation of these securities include credit data, interest rate data, market observations and sector news, broker-dealer quotes and trade volumes. In addition, corporate securities include a portion of the EMD portfolio. The Company classifies these securities across Level 1 and 2, with majority of them being in Level 1.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-backed Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Residential and commercial mortgage-backed securities consist of bonds issued by the Government National Mortgage Association, the FNMA and the FHLMC as well as private non-agency issuers. The fair values of these securities are determined through the use of a pricing model (including Option Adjusted Spread) which uses prepayment speeds and spreads to determine the appropriate average life of the mortgage-backed security. These spreads are generally obtained from broker-dealers, trade prices and the new issue market. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the significant inputs used to price mortgage-backed securities are observable market inputs, these securities are classified within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Asset-backed securities are securities backed by notes or receivables against assets other than real estate. The underlying collateral for the Company&#8217;s asset-backed securities consists mainly of student loans, automobile loans and credit card receivables. These securities are primarily priced by index providers and pricing vendors. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, interest rate data and credit spreads. The Company classifies these securities within Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privately-Held Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Privately-held investments are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models. These models include inputs that are specific to each investment. The inputs used in the fair value measurements include dividend or interest rates and appropriate discount rates. The selection of an appropriate discount rate is judgmental and is the most significant unobservable input used in the valuation of these securities. A significant increase (decrease) in this input in isolation could result in significantly lower (higher) fair value measurement for privately-held investments. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow models, the Company maintains an understanding of current market conditions, issuer specific information that may impact future cash flows as well as collaboration with independent vendors for most securities to assess the reasonableness of the discount rate being used.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial mortgage loans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial mortgage loans consists in investments in properties including apartments, hotels, office and retail buildings, other commercial properties and industrial properties. The commercial mortgage loan portfolio is diversified by property type, geographic region and issuer to reduce risks. Commercial Mortgage Loans are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Middle market loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The middle market loans consist in investments in senior secured loan positions with full covenants, focused on the middle market in both U.S., Europe and the Caribbean. The middle market loan portfolio is diversified by industry type, geographic region and issuer to reduce risks. Middle Market Loans are initially valued at cost or transaction value which approximates fair value. In subsequent measurement periods, the fair values of these securities are determined using internally developed discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset-backed securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Asset-backed securities represent interests in underlying pools of diversified referenced assets that are collateralized and backed by future cash flows and these securities are performing. The fair values of these securities are determined by using discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global corporate securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The global corporates portfolio consists of debt securities with a non-U.S. debt issuer that are backed by the cash flows generated from real estate holdings and these securities are performing. The fair value of these securities are determined by using discounted cash flow models and are classified as Level 3.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Equity securities consists of a single non-U.S. based issuer that is a special purpose vehicle designed to grant a first lien right to the underlying senior notes within the structure. The underlying issuer is a financial services lender to middle market companies and this security is performing. The valuation of the investments is DCF and the securities are classified as Level 3. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Short-term investments consist of highly liquid debt securities with a maturity greater than three months but less than one year from the date of purchase. Short-term investments are classified as either trading or available for sale according to the facts and circumstances of the investment held. Short-term investments are valued in a manner similar to the Company&#8217;s fixed maturity investments and are classified within Levels 1 and 2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the quantitative inputs and assumptions used for financial assets and liabilities investments categorized as Level 3 under the fair value hierarchy as at June&#160;30, 2023:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:23.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation Techniques</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable (U) inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ranges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Privately-held investments &#8212; Trading</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3rd party NAV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Middle market loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global corporate securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Catastrophe Bonds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catastrophe bonds are variable rate fixed income instruments with redemption values adjusted based on the occurrence of a covered event, usually windstorms and earthquakes. Catastrophe bonds are classified as trading and reported at fair value.&#160;Catastrophe bonds are priced using an average of multiple broker-dealer quotes and as such, are considered Level 2.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The foreign exchange contracts which the Company uses to mitigate currency risk are characterized as OTC due to their customized nature and the fact that they do not trade on a major exchange. These instruments trade in a very deep liquid market, providing substantial price transparency and accordingly are classified as Level&#160;2.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Liabilities - Loss Portfolio Transfer.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The LPT embedded derivative is valued using the Black-Scholes model. The two primary inputs of this model are expected claim settlement patterns and expected return of the investment portfolio above a fixed minimum rate over the specified time horizon. The expected claim settlement pattern is determined on an actuarial basis for the cohort of business within scope of the LPT and is consistent with the patterns used in the valuation of technical provisions. The expected return of the investment portfolio, above a fixed minimum rate, directly impacts on the LPT derivative valuation and is subject to changes in the market conditions. In order to assess the reasonableness of the inputs, the Company updates the expected claim settlement patterns on a regular basis whilst maintaining an understanding of the current market conditions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other investments represent our investments in real estate, infrastructure and direct lending funds. Adjustments to the fair values are made based on the net asset value of the investments. The net valuation criteria established by the manager of such investments are established in accordance with the governing documents and the asset manager&#8217;s valuation guidelines, which include: the discounted cash flows method and the performance multiple approach, which uses a multiple derived from market data of comparable companies or assets to produce operating performance metrics. Alternative valuation methodologies may be employed for investments with unusual characteristics.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633578108384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceTextBlock', window );">Reinsurance</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Reinsurance</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases retrocession and reinsurance to limit and diversify the Company&#8217;s risk exposure and to increase its own insurance and reinsurance underwriting capacity. These agreements provide for recovery of losses and loss adjustment expenses from reinsurers. The Company remains liable to the extent that reinsurers do not meet their obligations under these agreements. In line with its risk management objectives, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balances pertaining to reinsurance transactions are reported &#8220;gross&#8221; on the consolidated balance sheet, meaning that reinsurance recoverable on unpaid losses and ceded unearned premiums are not deducted from insurance reserves but are recorded as assets. For more information on reinsurance recoverables, refer to Note&#160;21, &#8220;Concentrations of Credit Risk&#160;&#8212; Reinsurance recoverables&#8221; and Note 10, &#8220;Reserves for Losses and Loss Adjustment Expenses&#8221; of these consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of assumed and ceded reinsurance on premiums written, premiums earned and insurance losses and loss adjustment expenses for the twelve months ended December 31, 2022, 2021 and 2020 was as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve&#160;Months&#160;Ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums written:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,042.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,442.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,350.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,120.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums written</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums earned:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,299.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,207.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,110.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums earned</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance losses and loss adjustment expenses: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(807.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(773.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net insurance losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,693.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2022, Aspen Holdings and certain of its subsidiaries (&#8220;Aspen&#8221;) entered into an Amended and Restated Reinsurance Agreement with a subsidiary of Enstar Group Limited (together, &#8220;Enstar&#8221;) (the &#8220;LPT&#8221;), which amended and restated the Adverse Development Cover Agreement, dated as of March 2, 2020, previously entered into between Enstar and Aspen Group (the &#8220;Original Agreement)&#8221;. Under the terms of the LPT, Enstar&#8217;s subsidiary will reinsure net losses incurred on or prior to December 31, 2019 on all of Aspen&#8217;s net loss reserves of $3,120.0 million as of September 30, 2021. The LPT provides for a limit of $3,570.0 million in consideration for a premium of $3,160.0 million. The amount of net loss reserves ceded, as well as the premium and limit amounts provided under the LPT, was adjusted for claims paid between October 1, 2021 and the closing date of the transaction. The premium includes $770 million of premium previously paid with respect to reserves ceded under the Original </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement, which will continue to be held in trust accounts to secure the Enstar subsidiary&#8217;s obligations under the LPT. The incremental new premium will initially be held in funds withheld accounts in their original currencies maintained by Aspen but will be released to the trust accounts maintained by the Enstar subsidiary no later than September 30, 2025. The funds withheld by Aspen will be credited with interest at an annual rate of 1.75% plus, for periods after October 1, 2022, an additional amount equal to 50% of the amount by which the total return on Aspen&#8217;s investments and cash and cash equivalents exceeds 1.75%. Under the LPT, the Enstar subsidiary assumed claims control, pursuant to the provisions of an administrative services agreement subsequently entered into between the parties on June 30, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current expected loss model (&#8220;CECL&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On June 16, 2016, the FASB issued ASU 2016-13, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; which introduced a new impairment model, known as the current expected loss model (&#8220;CECL&#8221;), which is based on expected losses rather than incurred losses. Following the adoption of CECL with effect from January 1, 2020, the Company recognized a reduction in the Company&#8217;s reinsurance recoverables by $3.7 million as at December&#160;31, 2022 (2021 &#8212; $3.3 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022 there was an increase in the CECL allowance on reinsurance recoverables of $0.4 million (December&#160;31, 2021 &#8212; $0.5 million decrease).</span></div>The Company is potentially exposed to concentrations of credit risk in respect of amounts recoverable from reinsurers, refer to Note&#160;21, &#8220;Concentrations of Credit Risk&#160;&#8212; Reinsurance recoverables&#8221; of these consolidated financial statements for more detail.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Reinsurance</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases retrocession and reinsurance to limit the Company&#8217;s risk exposure and to increase its own insurance and reinsurance underwriting capacity. These agreements provide for recovery of losses and loss adjustment expenses from reinsurers. The Company remains liable to the extent that reinsurers do not meet their obligations under these agreements. In line with its risk management objectives, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balances pertaining to reinsurance transactions are reported &#8220;gross&#8221; on the consolidated balance sheet, meaning that reinsurance recoverable on unpaid losses and ceded unearned premiums are not deducted from insurance reserves but are recorded as assets. For more information on reinsurance recoverables, refer to Note 13, &#8220;Concentrations of Credit Risk &#8212;Reinsurance recoverables&#8221; and Note 8, &#8220;Reserves for Losses and Loss Adjustment Expenses&#8221; of these unaudited condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of ceded reinsurance on premiums written, premiums earned and insurance losses and loss adjustment expenses for the six months ended June&#160;30, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums written:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(774.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(845.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums written</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums earned:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(621.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums earned</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance losses and loss adjustment expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net insurance losses and loss adjustment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6816-158387<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633578292224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Contracts<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Contracts</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Derivative Contracts</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information on the location and amounts of derivative fair values on the consolidated balance sheet as at December&#160;31, 2022 and 2021: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments<br/>Under ASC&#160;815</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives at Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities under Derivative Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Portfolio Transfer Liability - Embedded Derivative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities under Derivative Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Fair value is net of $3.7 million of cash collateral (December&#160;31, 2021 &#8212; $2.1 million).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The LPT contains an embedded derivative within the contract in relation to the variable interest crediting rate. Refer to Note 7 for further information.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments Under ASC&#160;815</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives at Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities under Derivative Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the unrealized and realized gains/(losses) recorded in the consolidated statements of operations and other comprehensive income for derivatives that are not designated or designated as hedging instruments under ASC 815 &#8212; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the twelve months ended December&#160;31, 2022 and 2021: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of (Loss)/Gain Recognized on Derivatives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss) <br/>Recognized on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Fair Value of Derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses in consolidated statement of operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions in other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company uses foreign exchange contracts to manage foreign currency risk associated with our operating expenses but also foreign exchange risk associated with net assets or liabilities in currencies other than the U.S. dollar. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of the Company&#8217;s assets and liabilities denominated in foreign currencies but rather allow it to establish a rate of exchange for a future point in time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company held foreign exchange contracts that were not designated as hedges under ASC 815 with an aggregate nominal amount of $1,675.3 million (2021 &#8212; $1,545.7 million). The foreign exchange contracts are recorded as derivatives at fair value in the consolidated balance sheet with changes recorded as a change in fair value of derivatives in the consolidated statement of operations. For the twelve months ended December&#160;31, 2022, the impact of foreign exchange contracts on net income was a loss of $80.5 million (December&#160;31, 2021&#160;&#8212; loss of $35.9 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company held foreign exchange contracts that were designated as hedges under ASC 815 with an aggregate notional amount of $109.7 million (2021 &#8212; $143.1 million). The foreign exchange contracts are recorded as assets or liabilities under derivative contracts in the consolidated balance sheet with the effective portion recorded in other comprehensive income and the ineffective portion recorded as a change in fair value of derivatives in the consolidated statement of operations. The contracts are effective and therefore the movement in other comprehensive income representing the effective portion for the twelve months ended December&#160;31, 2022 was a gain of $15.4 million (December&#160;31, 2021&#160;&#8212; loss of $6.2 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the foreign exchange contracts settle, the realized gain or loss is reclassified from other comprehensive income into general, administration and corporate expenses of the consolidated statement of operations. For the twelve months ended December&#160;31, 2022, the amount recognized within general, administration and corporate expenses for settled foreign exchange contracts was a realized gain of $5.9 million (December&#160;31, 2021 &#8212; loss of $5.7 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded derivative on loss portfolio contract. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss portfolio transfer contract includes a funds withheld arrangement that provides returns to the reinsurer based on Aspen&#8217;s investment performance, guaranteeing a minimum of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.75%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> return. Such funds withheld arrangements are examples of embedded derivatives and therefore this instrument is accounted for as an option-based derivative. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, the amount recognized as a change in fair value of derivatives in the consolidated statement of operations is $14.5 million.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Derivative Contracts</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information on the location and amounts of derivative fair values on the consolidated balance sheet as at June&#160;30, 2023 and December 31, 2022: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging<br/>Instruments<br/>Under ASC&#160;815</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Portfolio Transfer Liability - Embedded Derivative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Fair value is net of $2.7 million of cash collateral (December&#160;31, 2022 &#8212; $3.7 million).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The LPT contains an embedded derivative within the contract in relation to the variable interest crediting rate. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging<br/>Instruments Under ASC&#160;815</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the unrealized and realized gains/(losses) recorded in the consolidated statements of operations and other comprehensive income for derivatives that are not designated or designated as hedging instruments under ASC 815 &#8212; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for the six months ended June&#160;30, 2023 and 2022: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)<br/>Recognized on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Fair Value of Derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses in consolidated statement of operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions in other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The Company uses foreign exchange contracts to manage foreign currency risk associated with our operating expenses but also foreign exchange risk associated with net assets or liabilities in currencies other than the U.S. dollar. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of the Company&#8217;s assets and liabilities denominated in foreign currencies but rather allow it to establish a rate of exchange for a future point in time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company held foreign exchange contracts that were not designated as hedges under ASC 815 with an aggregate nominal amount of $1,884.0 million (December&#160;31, 2022 &#8212; $1,675.3 million). The foreign exchange contracts are recorded as derivative assets or derivative liabilities in the consolidated balance sheet with changes recorded as a change in fair value of derivatives in the consolidated statement of operations. For the six months ended June&#160;30, 2023, the impact of foreign exchange contracts on net income was a gain of $19.6 million (June&#160;30, 2022&#160;&#8212; loss of $84.9 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company held foreign exchange contracts that were designated as hedges under ASC 815 with an aggregate notional amount of $54.7 million (December&#160;31, 2022 &#8212; $109.7&#160;million). The foreign exchange contracts are recorded as derivative assets in the consolidated balance sheet with the effective portion recorded in other comprehensive income and the ineffective portion recorded as a change in fair value of derivatives in the consolidated statement of operations. The contracts are effective and therefore the movement in other comprehensive income representing the effective portion for the six months ended June&#160;30, 2023 was a loss of $4.3 million (June&#160;30, 2022&#160;&#8212; loss of $6.4 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the foreign exchange contracts settle, the realized gain or loss is reclassified from other comprehensive income into general, administration and corporate expenses of the consolidated statement of operations. For the six months ended June&#160;30, 2023, the amount recognized within general, administration and corporate expenses for settled foreign exchange contracts was a realized loss of $3.7 million (June&#160;30, 2022 &#8212; gain of $2.8 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded derivative on loss portfolio contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The loss portfolio transfer contract includes a funds withheld arrangement that provides returns to the reinsurer based on Aspen&#8217;s investment performance, guaranteeing a minimum of 1.75% return. Such funds withheld arrangements are examples of embedded derivatives and therefore this instrument is accounted for as an option-based derivative. For the six months ended June&#160;30, 2023, the amount </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized as a change in fair value of derivatives in the consolidated statement of operations is $8.3 million (June&#160;30, 2022 &#8212;  $Nil).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633577300720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Policy Acquisition Costs<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1', window );">Deferred Policy Acquisition Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Deferred Policy Acquisition Costs</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of beginning and ending deferred acquisition costs for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition costs deferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=4737841<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostsTextBlock1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581284080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reserves for Losses and Adjustment Expenses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ahl_ReservesForLossAndAdjustmentExpensesTextBlock', window );">Reserves for Losses and Adjustment Expenses</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reserves for Losses and Loss Adjustment Expenses</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of beginning and ending consolidated loss and LAE reserves for the twelve months ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the start of the year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,611.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,165.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,951.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,298.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,195.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,319.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE at the start of the year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,313.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,632.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE expenses disposed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in net provision for losses and LAE for claims incurred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,841.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,693.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Losses and LAE payments for claims incurred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(404.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,359.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,291.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,309.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,764.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses and LAE reserves at the end of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,313.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus reinsurance recoverable on unpaid losses at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the end of the year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,611.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,165.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Net loss and LAE expenses disposed of $1,840.1 million represent the net loss reserves as at May 20, 2022 (&#8220;Closing Date&#8221;) for losses in relation to 2019 and prior accident years, in addition to the $770.0 million of ceded reserves under the previous ADC agreement, recognizing a total recoverable of $2,610.1&#160;million. These reserves were rolled forward from the initial effective date of September 30, 2021, at which time the net losses reserves were $3,120.0 million. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As at December&#160;31, 2022 the total amount recoverable from Enstar under the LPT was $2,132.0 million (As at December 31, 2021 recoverable from Enstar on the ADC was &#8212; $838.1 million) which includes claims paid and reserve development since the Closing Date. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss and LAE expenses disposed in 2020 includes the transfer of reserves under the ADC agreement providing $770.0 million of cover and the loss portfolio transfer transactions for our surety insurance book of $42.0&#160;million and our U.S. accident and health book of $6.5&#160;million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, there was an increase of $28.1 million in the Company&#8217;s estimate of the ultimate claims to be paid in respect of prior accident years compared to an increase of $45.1 million for the twelve months ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, prior year reserve strengthening totaled $28.1 million in 2022, compared with net unfavorable development of $45.1 million in 2021. Prior year reserve strengthening excludes the full economic benefit of the recoveries from the ADC of $58.3 million which is currently within reinsurance recoverables on unpaid losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Net reserve releases of $58.8 million in 2022 were mainly due to releases on prior year development on post-LPT years of $24.6 million and the favorable impact of the LPT of $34.2 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Net unfavorable reserve development of $86.9 million in 2022 included adverse prior year development on post-LPT years of $37.6 million and the unfavorable movement of $49.3 million due to the impact of the LPT, mainly reflecting the one-off costs in relation to the LPT recognized in 2022 and the change from ADC on a fixed allocation basis to the LPT.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show an analysis of incurred claims and allocated loss adjustment expenses, net of reinsurance and cumulative paid claims and allocated claim adjustment expenses, net of reinsurance as at December 31, 2022, 2021, 2020, 2019 2018, 2017, 2016, 2015, 2014 and 2013. Under the LPT agreement, the Company has reinsured net losses incurred on all accident years 2019 and prior. This has resulted in total incurred claims, IBNR and loss adjustment expenses in the loss development triangles for 2019 and prior to be Nil. The loss development triangles are derived from all business written by the Company as although a limited number of contracts are written which have durations of greater than one year the contracts do not meet the definition of a long duration contract. All amounts included in the following tables related to transactions denominated in a foreign currency have been translated into U.S. Dollars using the exchange rates in effect at December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has chosen to disaggregate the business in its Insurance segment, for the purposes of these loss development triangles as: Property; Casualty; Marine Aviation and Energy; and Financial and Professional insurance lines. The Company considers that this presentation of its Insurance lines loss development triangles more precisely reflects meaningful trending information. The Company presents its loss development triangles for the Reinsurance segment in line with the reportable reinsurance lines: Property Catastrophe and Other Property; Casualty; and Specialty.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Insurance Lines</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="5" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">246.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">247.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">195.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,772.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Insurance Lines</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">185.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">247.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,513.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">259.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">259.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Casualty Insurance Lines</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="5" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">195.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">247.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">234.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">185.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,417.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Casualty Insurance Lines</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">959.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">457.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">457.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marine, Aviation and Energy Insurance Lines</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">319.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">331.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">345.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">343.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">338.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">346.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">319.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">311.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">317.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">327.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">227.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">227.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">224.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">209.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">213.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,929.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marine, Aviation and Energy Insurance Lines </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">234.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">319.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">208.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">249.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">274.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">277.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,765.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial and Professional Insurance Lines</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">209.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">213.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">185.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">208.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">246.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">259.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">195.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">346.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">336.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">314.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">265.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,970.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial and Professional Insurance Lines</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">108.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">195.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,298.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">671.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">671.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Catastrophe and Other Property Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">185.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">264.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">264.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">511.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">595.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">323.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">362.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">571.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">249.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">358.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">317.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">402.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">647.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">472.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,854.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Catastrophe and Other Property Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">224.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">355.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">413.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">437.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">433.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">296.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,176.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">677.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">677.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Casualty Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">221.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">202.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">202.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">209.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">239.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">249.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">265.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">262.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">264.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">232.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">252.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">252.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,628.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Casualty Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,057.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">571.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">571.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, IBNR and Loss Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total of IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Number of Reported Claims</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ (in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">108.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">235.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">236.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">234.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">227.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">388.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">361.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">364.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">325.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">391.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">390.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">419.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">423.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">412.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">374.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,344.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited Prior Years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accident Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">268.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">303.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">314.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">325.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">272.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">379.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">398.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">423.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">269.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,994.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities for 2013 and subsequent years, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">All outstanding liabilities before 2013, net of reinsurance </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="51" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities for claims and claim adjustment expenses, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of Incurred and Paid Claims Development to total Provision for Losses and LAE </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net outstanding liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Property insurance lines</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Casualty insurance lines</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Marine, aviation and energy insurance lines</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Financial and professional insurance lines</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total insurance lines</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance lines </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Property catastrophe and other property reinsurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Casualty reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Specialty reinsurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reinsurance lines</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,484.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverable on unpaid losses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance lines </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reinsurance recoverable on unpaid losses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain on retroactive contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated claims incurred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other reinsurance balances recoverable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon syndicate reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the end of the year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,611.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other reinsurance balances recoverable primarily include short term recoverables to be collected. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Reserves for Losses and Loss Adjustment Expenses</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of beginning and ending consolidated loss and LAE reserves for the six months at June&#160;30, 2023 and June 30, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the start of the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,611.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,897.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,298.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE at the start of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,313.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE expenses transferred </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in net provision for losses and LAE for claims incurred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Losses and LAE payments for claims incurred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(616.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses and LAE reserves at the end of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus reinsurance recoverable on unpaid losses at the end of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,658.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for losses and LAE at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,740.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,511.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Net loss and LAE expenses transferred of $1,840.1&#160;million relates to the LPT with Enstar and represents the net loss reserves as at May 20, 2022 (&#8220;Closing Date&#8221;) for losses in relation to 2019 and prior accident years, in addition to the $770.0 million of ceded reserves under the previous ADC agreement, recognizing a total recoverable of $2,610.1&#160;million. These reserves were rolled forward from the initial effective date of September 30, 2021, at which time the net losses reserves were $3,120.0 million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023 the total amount recoverable from Enstar under the LPT was $1,877.3&#160;million (As at December 31, 2022 &#8212; $2,132.0&#160;million) which includes claims paid and reserve development since the Closing Date. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023, there was a reduction of $6.4 million in the Company&#8217;s estimate of the ultimate claims to be paid in respect of prior accident years compared to a reduction of $7.3 million for the six months ended June&#160;30, 2022.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Net unfavorable reserve development of $2.1 million in the six months ended June&#160;30, 2023 were mainly due to reserve strengthening in property catastrophe and reinsurance lines of business, offset by reserve releases from casualty reinsurance and specialty reinsurance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Net reserve releases of $8.5 million in the six months ended June&#160;30, 2023 included favorable development of $13.2 million representing the movement on the deferred gain on the LPT, offset by unfavorable development on post-LPT years of $4.7 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ahl_ReservesForLossAndAdjustmentExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reserves for Loss and Adjustment Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ahl_ReservesForLossAndAdjustmentExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ahl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581284080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Income Taxes </span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Holdings and Aspen Bermuda are incorporated under the laws of Bermuda. Under Bermuda law, the corporate tax rate is zero and, as a result, Aspen Holdings and Aspen Bermuda are not taxed on any Bermudian income or capital gains. In the event of any Bermudian income or capital gains taxes being imposed, Aspen Holdings and Aspen Bermuda have received an assurance from the Bermuda Minister of Finance that such entities will be exempt from those taxes until March 31, 2035. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S.&#160;operating companies were subject to a U.S. federal income tax rate of 21%. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.K. operating companies were taxed at the U.K. corporate tax rate of 19%. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total income tax (benefit)/expense for the twelve months ended December&#160;31, 2022, 2021 and 2020 was allocated as follows: </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit)/expense allocated to net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit)/expense allocated to other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit)/expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Loss)/income from operations before income taxes and income tax expense/(benefit) attributable to that (loss)/income for the twelve months ended December&#160;31, 2022, 2021 and 2020 is provided in the tables below:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Loss)/income<br/>before tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current&#160;tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;income tax<br/>(benefit)/expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income/(loss)<br/>before tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current&#160;tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;income tax<br/>(benefit)/expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Loss)/income<br/>before tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current&#160;tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax<br/>(benefit)/expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;income tax<br/>(benefit)/expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The U.S. current tax expense of $14.8 million includes $2.3&#160;million of Base Erosion and Anti-abuse Tax (2021&#8212; $5.8&#160;million), of which $1.1 million relates to the U.S. operating subsidiaries and $1.2 million to Aspen UK&#8217;s U.S. branch. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The U.S. deferred tax benefit of $102.9 million is mainly due to a change in judgment about the realizability of the deferred tax asset in the U.S. operating subsidiaries. The decrease in valuation allowance relating to our U.S. operations is driven by a change in judgment about the recoverability of deferred tax assets in the U.S. operating subsidiaries. We have concluded that the deferred tax assets of our U.S. operating subsidiaries will more likely than not be fully utilized over time, and therefore the previously recognized valuation allowance in relation to U.S. operating subsidiaries has been reversed. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The U.K. current tax expense of $7.0 million results from an intraperiod tax allocation.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Current tax expense and deferred tax (benefit) in &#8220;Other&#8221; mostly relates to the Swiss branches of Aspen UK and withholding taxes payable in Australia.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, the tax rate in Bermuda, the Company&#8217;s country of domicile, is zero. Application of the statutory income tax rate for operations in other jurisdictions produces a differential to the expected income tax (benefit)/expense as shown in the table below. The reconciliation between the income tax (benefit)/expense and the </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount that would result from applying the statutory rate for the Company for the twelve months ended December&#160;31, 2022, 2021 and 2020 is provided in the table below:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Reconciliation</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit at statutory tax rate of zero percent</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overseas statutory tax rates differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base erosion and anti-abuse tax (BEAT) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of unrecognized tax benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australian non-resident withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of changes in statutory tax rates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of OCI in income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit)/expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The submission dates for filing income tax returns for the Company&#8217;s U.S. and U.K. operating subsidiaries are after the submission date of this report. Accordingly, the final tax liabilities may differ from the estimated income tax expense included in this report and may result in prior year adjustments being reported. The prior period adjustments for the twelve months ended December 31, 2022 predominantly relate to the determination of the results of the branches of the U.K. operating subsidiaries. The prior period adjustments for the twelve months ended December 31, 2021 and 2020 predominantly relate to the determination of results in the U.K.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The 2022 valuation allowance movement includes nil relating to U.K deferred tax assets in U.K. operating subsidiaries, $4.8&#160;million decrease relating to deferred tax assets in the branches of the U.K. and Bermuda operating subsidiaries, and $94.1&#160;million decrease from U.S. operations. The decrease in valuation allowance relating to our U.S. operations is driven by a change in judgment about the recoverability of deferred tax assets in the U.S. operating subsidiaries. We have concluded that the deferred tax assets of our U.S. operating subsidiaries will more likely than not be fully utilized over time, and therefore the previously recognized valuation allowance in relation to U.S. operating subsidiaries has been reversed.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In 2022, the Company did not have any unrecognized tax benefits. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income tax returns that have been filed by the Company&#8217;s U.S.&#160;Operating Subsidiaries are subject to examination for 2019 and later tax years. The Company&#8217;s U.K. operating subsidiaries&#8217; income tax returns are potentially subject to examination for 2021 and later tax years as these periods are considered &#8220;open&#8221; by the U.K. Tax Authority. The Company accrues interest and penalties related to an underpayment of income taxes, if applicable, as income tax expenses. The Company does not believe it will be subject to any penalties in any open tax years and has not accrued any such amounts for the twelve months ended December 31, 2022.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The U.K. tax rate has changed from April 1, 2023 from 19% to 25%. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and deferred tax liabilities are presented in the following table as at December 31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves: Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves: Unearned premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office properties and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets, net of valuation allowance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves: Losses and loss adjustment expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax (liabilities)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax assets/(liabilities)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities and assets represent the tax effect of carryforwards and temporary differences between the value of assets and liabilities for financial statement purposes and such values as measured by U.K., U.S. and other&#160;tax laws and regulations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences and carry forwards become deductible or creditable. Management considers the scheduled reversal of existing taxable temporary differences, carryback availability, projected future taxable income, and tax-planning strategies in making this assessment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company has net operating losses carryforwards for U.S.&#160;federal income tax purposes of $376.5 million (2021&#160;&#8212; $443.1 million), of which $309.4 million relates to the U.S. operating subsidiaries and $67.1 million to Aspen UK&#8217;s U.S. branch. The Company also has net operating losses carryforwards for U.K. corporate tax purposes of $280.5 million (2021&#160;&#8212; $168.9 million), deferred syndicate profits </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $19.9 million (2021&#160;&#8212; $66.2 million losses), and losses in other jurisdictions of $118.8 million (2021&#160;&#8212; $103.9&#160;million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $376.5 million that are available to offset future U.S.&#160;federal taxable income will expire between 2032 and 2041. The amount of pre-merger net operating losses carryforwards that can be used each year is limited by section 382 to $6.5 million per year for Aspen UK&#8217;s U.S. branch, and $39.2 million in 2023, $23.1 million in 2024, and $20.8 million per year for the 15 years thereafter for the U.S. operating subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net operating losses in the U.K. and other jurisdictions are available to offset future corporate income in those jurisdictions over an indefinite period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. federal income tax purposes, the Company has capital loss carryforwards of $31.7 million, of which $15.0 million relates to the U.S. operating subsidiaries and $16.7 million to Aspen UK&#8217;s branch, expiring between 2026 and 2027 and nil charitable contribution carryforwards (2021&#160;&#8212; $0.1 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.K. corporate tax purposes, the Company has foreign tax credit carryforwards of $19.8&#160;million (2021 &#8212; $20.2&#160;million) which are available to offset future U.K. corporate tax arising on the same foreign source of income over an indefinite period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance of $18.0 million (2021 &#8212; $119.7 million) on U.S.&#160;deferred tax assets (which includes these loss carryforwards) has been recognized at December&#160;31, 2022 relating to Aspen UK&#8217;s U.S. branch. The valuation allowance relating to the deferred tax assets of the U.S. operating companies has been reversed as a result of a change in judgment over the likelihood that a tax benefit will be realized. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance of $106.7 million (2021&#160;&#8212; $88.7 million) has been established against U.K. deferred tax assets. </span></div>The U.K., U.S. and other jurisdictions valuation allowance combined total is $145.7&#160;million (2021&#160;&#8212; $225.9 million).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633592376784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Structure</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Capital Structure</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company&#8217;s authorized and issued share capital as at December&#160;31, 2022 and 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in<br/>Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in<br/>Thousands</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized share capital:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares $0.01 per share (2021 &#8212; $0.01 per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference Shares&#160;0.15144558&#162; per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total authorized share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued share capital:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued ordinary shares $0.01 per share (2021 &#8212; $0.01 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,395,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,395,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued 5.950% preference shares of 0.15144558&#162; each with a liquidation preference of $25 per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued 5.625% preference shares of 0.15144558&#162; each with a liquidation preference of $25 per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued 5.625% preference shares of 0.15144558&#162; represented by depositary shares, each with a liquidation preference of $25 per share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total issued share capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Each depositary share represents a 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in a share of the 5.625% preference shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Ordinary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issued Ordinary Shares.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s issued ordinary shares of par value $0.01 at both December&#160;31, 2022 and 2021 was 60,395,839. The Company did not acquire any ordinary shares for the twelve months ended December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Preference Shares&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preference Shares Issuance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On May 2, 2013, the Company issued 11,000,000 5.950% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, with a liquidation preference of $25 per share (the &#8220;5.950% Preference Shares&#8221;). Net proceeds were $270.6 million, consisting of $275.0 million of total liquidation preference less $4.4 million of issuance expenses. The 5.950% Preference Shares are listed on the NYSE under symbol &#8220;AHLPRC&#8221;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2016, the Company issued 10,000,000 shares of 5.625% Perpetual Non-Cumulative Preference Shares (the &#8220;5.625% Preference Shares&#8221;). The 5.625% Preference Shares have a liquidation preference of $25 per share. Net proceeds were $241.3 million, consisting of $250.0 million of total liquidation preference less $8.7 million of issuance expenses. The 5.625% Preference Shares are listed on the NYSE under the symbol &#8220;AHL PRD&#8221;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2019, the Company issued 10,000,000 depositary shares, each of which represents 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> interest in a share of the newly designated 5.625% Perpetual Non-Cumulative Preference Shares. The depositary shares have a liquidation preference of $25 per share. Net proceeds were $241.6 million, comprising $250.0 million </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of total liquidation preference less $8.4 million of issuance expenses. The depositary shares are listed on the NYSE under the symbol &#8220;AHL PRE&#8221;.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">Additional Paid-in Capital&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital as at December&#160;31, 2022 was $1,514.7 million (December&#160;31, 2021 &#8212; $1,514.7 million). Included within additional paid-in capital is the aggregate liquidation preferences of the Company&#8217;s preference shares of $775.0 million less issue costs of $21.5 million (December&#160;31, 2021&#160;&#8212;&#160;$775.0 million&#160;less issue costs of $21.5 million).</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Capital Structure</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company&#8217;s authorized and issued share capital as at June&#160;30, 2023 and December 31, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in<br/>Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in<br/>Thousands</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized share capital:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares $0.01 per share (2022 &#8212; $0.01 per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preference Shares&#160;0.15144558&#162; per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total authorized share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued share capital:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued ordinary shares $0.01 per share (2022 &#8212; $0.01 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,395,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,395,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued 5.950% preference shares of 0.15144558&#162; each with a liquidation preference of $25 per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued 5.625% preference shares of 0.15144558&#162; each with a liquidation preference of $25 per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued 5.625% preference shares of 0.15144558&#162; represented by depositary shares, each with a liquidation preference of $25 per share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total issued share capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Each depositary share represents a 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in a share of the 5.625% preference shares.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Ordinary Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issued Ordinary Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s issued ordinary shares of par value $0.01 at both June&#160;30, 2023 and December&#160;31, 2022 was 60,395,839. The Company did not acquire any ordinary shares for the six months ended June&#160;30, 2023.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Preference Shares&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preference Shares Issuance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On May 2, 2013, the Company issued 11,000,000 5.950% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, with a liquidation preference of $25 per share (the &#8220;5.950% Preference Shares&#8221;). Net proceeds were $270.6 million, consisting of $275.0 million of total liquidation preference less $4.4 million of issuance expenses. The first floating rate-period commenced on July 1, 2023 (payable on October 1, 2023), where the floating rate was tied to LIBOR, being 3-month LIBOR, and as contemplated by the governing instrument, 3-month LIBOR was the rate for 3-month deposits in U.S. dollars on June 29, 2023. The 5.950% Preference Shares are listed on the NYSE under symbol &#8220;AHLPRC&#8221;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2016, the Company issued 10,000,000 shares of 5.625% Perpetual Non-Cumulative Preference Shares (the &#8220;5.625% Preference Shares&#8221;). The 5.625% Preference Shares have a liquidation preference of $25 per share. Net proceeds were $241.3 million, consisting of $250.0 million of total liquidation preference less $8.7 million of issuance expenses. The 5.625% Preference Shares are listed on the NYSE under the symbol &#8220;AHL PRD&#8221;.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2019, the Company issued 10,000,000 depositary shares, each of which represents 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> interest in a share of the newly designated 5.625% Perpetual Non-Cumulative Preference Shares. The depositary </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares have a liquidation preference of $25 per share. Net proceeds were $241.6 million, comprising $250.0 million of total liquidation preference less $8.4 million of issuance expenses. The depositary shares are listed on the NYSE under the symbol &#8220;AHL PRE&#8221;.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581254704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dividends<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Dividends</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Dividends </span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On March 1, 2023, the Company&#8217;s Board of Directors declared the following dividends:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payable&#160;on:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record&#160;Date:</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.950% Preference Shares (AHL PRC)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 15, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.625% Preference Shares (AHL PRD)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 15, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.625% Preference Shares, represented by depositary shares (AHL PRE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 15, 2023</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The 5.625% Preference Shares are represented by depositary shares, each representing a 1/1000th interest in a share of the 5.625% Preference Shares.&#160;The dividend paid per depositary share is likewise 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of the declared dividend, equivalent to $0.35156 per depositary share.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the twelve months ended December&#160;31, 2022, the Company paid an ordinary shares dividend of $40&#160;million to Highlands Bermuda Holdco, Ltd., the holder of all the Company&#8217;s ordinary shares. The Company also paid an ordinary shares dividend of $20&#160;million to Highlands Bermuda Holdco, Ltd. on April 3, 2023.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Dividends</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;On June 1, 2023, the Company&#8217;s Board of Directors declared the following dividends:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payable&#160;on:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record&#160;Date:</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.950% Preference Shares (AHL PRC)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 15, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.625% Preference Shares (AHL PRD)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 15, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.625% Preference Shares, represented by depositary shares (AHL PRE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 15, 2023</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The 5.625% Preference Shares are represented by depositary shares, each representing a 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in a share of the 5.625% Preference Shares.&#160;The dividend paid per depositary share is likewise 1/1000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of the declared dividend, equivalent to $0.35156 per depositary share.</span></div>In the six months ended June&#160;30, 2023, the Company paid an ordinary shares dividend of $20.0&#160;million to Highlands Bermuda Holdco, Ltd., the holder of all the Company&#8217;s ordinary shares.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581280560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Retirement Plans</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Retirement Plans </span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates defined contribution retirement plans for the majority of its employees at varying rates of their salaries. Total contributions by the Company to the retirement plans were $12.5 million in the twelve months ended December&#160;31, 2022 (2021 &#8212; $13.5 million, 2020 &#8212; $12.1 million).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633578205344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments and Long-Term Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share Based Payments and Long-term Incentive Plan</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Share-Based Payments and Long-Term Incentive Plan</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company implemented a new long-term incentive scheme, under which annual awards are split equally between Performance Units and Exit Units. Performance units vesting conditions have been amended in the current year and vest after two years subject to the Company achieving certain thresholds of operating income over a two year period. Exit Units vest upon change of control (sale or IPO) and achieving predetermined multiplies of invested capital return targets. Both Performance Units and Exit Units are cash-based awards.</span></div>The Company&#8217;s total share-based compensation/long-term incentive plan expense for the twelve months ended December&#160;31, 2022 was $0.6 million (December&#160;31, 2021 &#8212; $0.5 million), which is related to a charge of $0.6 million (December&#160;31, 2021 &#8212; $0.5 million) in relation to Performance Units. The income tax effect of this is not considered to be material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581131824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Intangible Assets and Goodwill</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company&#8217;s intangible assets for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning of the Year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions/(Disposals)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">End of the Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning of the Year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions/(Disposals)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">End of the Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency Relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance Licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen&#8217;s intangible assets relate to trademarks, contracts to sell products through independent broker and agents (Agency Relationships), an agreement for renewal rights with Liberty Specialty Markets Limited, non-compete agreements and licenses to trade in the U.S. and U.K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2010, the Company acquired licenses with a value of $10.0 million. The total value of the licenses as at December 31, 2022 was $16.7 million. This includes $4.5 million of acquired licenses held by Aspen Specialty and $2.1 million of acquired licenses held by Aspen UK. The insurance licenses are considered to have an indefinite life and are not being amortized. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Aspen has recognized goodwill of $2.1 million on the acquisition of equity voting interest of Blue Waters, a specialist marine insurance agency in October 2016 and of $1.8 million on the purchase in January 2017 of 49% share of Digital Re, a digital risk and specialty insurer. </span></div> The &#8220;Aspen&#8221; trademark, valued at $1.2 million, goodwill and insurance licenses are considered to have an indefinite life and are tested annually for impairment or when events or changes in circumstances indicate that these assets might be impaired. For the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company performed its annual qualitative assessment and determined that it was more likely than not that these were not impaired.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633576800784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Operating Leases </span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, the Company has recognized right-of-use operating lease assets of $72.8 million, net of impairment and operating lease liabilities of $95.5 million. Right-of-use operating lease assets comprise primarily of leased office real estate globally and other assets. For all office real estate leases, rent incentives, including reduced-rent and rent-free periods and contractually agreed rent increases during the lease term, have been included when determining the present value of future cash flows. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company&#8217;s operating effectiveness and efficiency program, the Company has consolidated its office space. Where negotiations are either in advanced stages of discussion and it is probable that the sub-lease transactions will be completed, or the Company has agreed terms to sub-lease our office space, the Company has assessed the right-of-use lease assets for impairment and have recognized a $6.7 million credit (2021 &#8212; $0.4 million) charge within the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes its office space is sufficient to conduct its operations for the foreseeable future in these locations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no lease transactions between related parties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating lease charge.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The following table summarizes the operating lease charge for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization charge on right-of-use operating leased assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease charge</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The following table summarizes the maturity of lease liabilities under non-cancellable leases as of December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases &#8212; maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Later years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other lease information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The following table summarizes the cash flows on operating leases for the twelve months ended December&#160;31, 2022 and 2021, and other supplemental information:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Twelve Months Ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating cash outflow from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction to Right-of-use assets resulting from reductions to lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Averages</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating leases, remaining lease terms (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- Operating leases, average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633627563760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Related Party Transactions</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo&#8217;s indirect subsidiary, Apollo Asset Management Europe PC LLP (&#8220;AAME&#8221;), serves as the investment manager for the Company and certain of the Company&#8217;s subsidiaries, and Apollo&#8217;s indirect subsidiary, Apollo Management Holdings, L.P. (&#8220;AMH&#8221;), provides the Company with management consulting services and advisory services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain employees of Apollo and its affiliates serve on the Board. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of relationships and transactions that have existed or that the Company and certain of the Company&#8217;s subsidiaries has entered into with Apollo and its affiliates are described below. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Management Relationships</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAME provides centralized asset management investment advisory and risk services for the portfolio of the Company&#8217;s investments and investments of such subsidiaries pursuant to the investment management agreements (&#8220;IMAs&#8221;) that have been entered into with AAME. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the IMAs, AAME may engage sub-advisors or delegates to provide certain of the investment advisory and management services to the Company&#8217;s subsidiaries. Such sub-advisors may include affiliates of AAME.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under each of the IMAs, AAME will be paid an annual investment management fee (the &#8220;Management Fee&#8221;) which will be based on a cost-plus structure. The &#8220;cost&#8221; is comprised of the direct and indirect fees, costs, expenses and other liabilities arising in or otherwise connected with the services provided under the IMAs. The &#8220;plus&#8221; component will be a mark-up in an amount of up to 25% determined based on an applicable transfer pricing study. The Management Fee will be subject to certain maximum threshold levels, including an annual fee cap of 15 bps of the total amount of investable assets. Affiliated sub-advisors, including AMI and AMC, will also earn additional fees for sub-advisory services rendered. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company recognized IMA fees of $4.9 million (2021 &#8212; $5.8 million; 2020 &#8212; $5.3 million), of which $4.5 million (2021 &#8212; $3.2&#160;million) remains payable to AAME at year end.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management Consulting Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Company entered into a Management Consulting Agreement, dated March 28, 2019 (the &#8220;Management Consulting Agreement&#8221;), with AMH. Pursuant to the Management Consulting Agreement, AMH will provide the Company management consulting and advisory services related to the business and affairs of the Company and its subsidiaries. The Company will pay AMH in consideration for its services under the Management Consulting Agreement, an annual management consulting fee equal to the greater of (i) 1% of the consolidated net income of the Company and its subsidiaries for the applicable fiscal year, or (ii) $5 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company recognized Management Consulting fees of $5.0 million (2021 &#8212; $5.0&#160;million; 2020 &#8212; $5.0 million), of which $1.3 million remains payable to AMH at year end (2021 &#8212; $Nil).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Investments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year, the Company bought or held the following securities or investments in Apollo:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apollo Real Estate Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As at December&#160;31, 2022, the Company&#8217;s investment in Apollo Real Estate Fund had a fair value of $25.3&#160;million. This investment is included in other investments on the consolidated balance sheet. Income earned on this investment was $1.6&#160;million and is included in net investment income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apollo Origination Partnership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;AOP&#8221;) Fund. As at December&#160;31, 2022, the Company&#8217;s investment in the AOP Fund had a fair value of $12.7&#160;million. This investment is included in other investments on the consolidated balance sheet. The Company incurred gains of $1.5&#160;million and is included in net investments income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOP Class A notes;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AOP Class B notes. As at December&#160;31, 2022, the Company&#8217;s investment in AOP Class A notes had a fair value of $30.0&#160;million. As at December&#160;31, 2022, the Company&#8217;s investment in AOP Class B notes had a fair value of $14.8&#160;million. The Company incurred losses of $0.2&#160;million and $0.2&#160;million on AOP Class A and B notes, respectively, and is included in realized and unrealized investment losses on the consolidated statement </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of operations and other comprehensive income. These investments are included in privately-held investments on the consolidated balance sheet.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022 there were no expenses incurred relating to any of these investments. The above transactions were entered into at arm&#8217;s length.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Payables to Related Parties</span></div>As at year end December&#160;31, 2022, the Company had an intercompany payable balance of $2.0&#160;million (2021 &#8212; $0.6&#160;million), due to its parent, Highlands Bermuda Holdco, Ltd.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Related Party Transactions</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apollo&#8217;s indirect subsidiary, Apollo Asset Management Europe PC LLP (&#8220;AAME&#8221;), serves as the investment manager for the Company and certain of the Company&#8217;s subsidiaries, and Apollo&#8217;s indirect subsidiary, Apollo Management Holdings, L.P. (&#8220;AMH&#8221;), provides the Company with management consulting services and advisory services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain employees of Apollo and its affiliates serve on the Board. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of relationships and transactions that have existed or that the Company and certain of the Company&#8217;s subsidiaries has entered into with Apollo and its affiliates are described below. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Management Relationships</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAME provides centralized asset management investment advisory and risk services for the portfolio of the Company&#8217;s investments and investments of such subsidiaries pursuant to the investment management agreements (&#8220;IMAs&#8221;) that have been entered into with AAME. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the IMAs, AAME may engage sub-advisors or delegates to provide certain of the investment advisory and management services to the Company&#8217;s subsidiaries. Such sub-advisors may include affiliates of AAME.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under each of the IMAs, AAME will be paid an annual investment management fee (the &#8220;Management Fee&#8221;) which will be based on a cost-plus structure up to 25% based on an applicable transfer pricing study. The Management Fee will be subject to certain maximum threshold levels, including an annual fee cap of 15 bps of the total amount of investable assets. Affiliated sub-advisors, including AMI and AMC, will also earn additional fees for sub-advisory services rendered. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, the Company recognized IMA fees of $5.2 million (June&#160;30, 2022 &#8212; $0.6 million), of which $2.4 million (December&#160;31, 2022 &#8212; $4.5&#160;million) remains payable to AAME as at June&#160;30, 2023.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management Consulting Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Company entered into a Management Consulting Agreement, dated March 28, 2019 (the &#8220;Management Consulting Agreement&#8221;), with AMH. Pursuant to the Management Consulting Agreement, </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMH will provide the Company management consulting and advisory services related to the business and affairs of the Company and its subsidiaries. The Company will pay AMH in consideration for its services under the Management Consulting Agreement, an annual management consulting fee equal to the greater of (i) 1% of the consolidated net income of the Company and its subsidiaries for the applicable fiscal year, or (ii) $5 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, the Company recognized Management Consulting fees of $2.5 million (June&#160;30, 2022 &#8212; $2.5&#160;million), of which $2.5 million remains payable to AMH as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $1.3&#160;million).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Investments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, the Company bought or held the following securities or investments in Apollo originated and managed investments:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apollo U.S. Real Estate Fund II LP.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As at June&#160;30, 2023, the Company&#8217;s investment in Apollo U.S. Real Estate Fund II LP had a fair value of $22.9 million (December&#160;31, 2022&#160;&#8212; $25.3&#160;million). This investment is included in other investments on the consolidated balance sheet. The Company incurred losses of $1.3 million (June&#160;30, 2022&#160;&#8212; $Nil) and is included in net investment income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apollo Origination Partnership (&#8220;AOP&#8221;) Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As at June&#160;30, 2023, the Company&#8217;s investment in the AOP Fund had a fair value of $12.6 million (December&#160;31, 2022&#160;&#8212;$12.7&#160;million). This investment is included in other investments on the consolidated balance sheet. The Company incurred losses of $0.4 million (June&#160;30, 2022&#160;&#8212; $0.2 million) and is included in net investments income on the consolidated statement of operations and other comprehensive income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOP Class A notes; AOP Class B notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As at June&#160;30, 2023, the Company&#8217;s investment in AOP Class A notes had a fair value of $28.6 million (December&#160;31, 2022&#160;&#8212;$30.0&#160;million). As at June&#160;30, 2023, the Company&#8217;s investment in AOP Class B notes had a fair value of $14.0 million (December&#160;31, 2022&#160;&#8212;$14.8&#160;million). The Company earned income of $1.3&#160;million (June&#160;30, 2022&#160;&#8212; $0.5 million) and $0.7&#160;million (June&#160;30, 2022&#160;&#8212; $0.3 million) on AOP Class A and B notes, respectively, and is included in realized and unrealized investment losses on the consolidated statement of operations and other comprehensive income. These investments are included in privately-held investments on the consolidated balance sheet.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, there were no expenses incurred relating to any of these investments (June&#160;30, 2022&#160;&#8212; $Nil). The above transactions were entered into at arm&#8217;s length.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Payables to Related Parties</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, the Company had an intercompany payable balance of $2.2&#160;million (December&#160;31, 2022 &#8212; $2.0&#160;million), due to its parent, Highlands Bermuda Holdco, Ltd.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633592320048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Commitments and Contingent Liabilities</span><div style="margin-bottom:9pt;margin-top:6pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">Restricted assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s subsidiaries are obliged by the terms of its contractual obligations to U.S.&#160;policyholders and by obligations to certain regulatory authorities to facilitate issue of letters of credit or maintain certain balances in trust funds for the benefit of policyholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the forms and value of Company&#8217;s material restricted assets as at December&#160;31, 2022 and 2021:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory trusts and deposits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated transactions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,099.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit / guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets (excluding illiquid assets)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments &#8212; illiquid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets and illiquid assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,217.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,682.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total as percent of cash and invested assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As at December&#160;31, 2022, the Company had pledged funds of $471.3 million (December&#160;31, 2021&#160;&#8212; $539.8 million) as collateral for the secured letters of credit.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Investable assets comprise total investments, cash and cash equivalents, accrued interest, receivables for securities sold and payables for securities purchased.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Funds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We invest in real estate funds which, as is typical for this type of investment, have lock-up periods. A lock-up period is the initial amount of time an investor is contractually required to remain invested before having the ability to redeem. As at December&#160;31, 2022, the lock-up periods across these funds range from one quarter to several years. Thereafter these funds could also be redeemed on a pro-rata basis depending on the liquidity position of the fund. There are no assurances as to when the Company may be able to withdraw, in whole or in part, its redemption request from the fund.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments - Equity Method.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 23, 2019, the Company committed $5.0 million as an equity investment in the holding company of a multi-line reinsurer. The strategy for the multi-line reinsurer is to combine a diversified reinsurance business, focused primarily on long-tailed lines of property and casualty business and, potentially to a lesser extent, life business, with a diversified investment strategy. During the period ending December&#160;31, 2022, $1.6 million (December&#160;31, 2021 &#8212; $2.5 million) capital was invested in multi-line reinsurer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current arrangements with our bankers for the issue of letters of credit require us to provide collateral in the form of cash and investments for the full amount of all secured and undrawn letters of credit that are outstanding. We monitor the proportion of our otherwise liquid assets that are committed to trust funds or to the collateralization of letters of credit. As at December&#160;31, 2022 and 2021, these funds amounted to approximately 59.4% of the $7.1 billion and approximately 59.7% of the $7.8 billion of investable assets held by the Company, respectively. We do not consider that this unduly restricts our liquidity at this time. For more information on our credit facilities and long-term debt arrangements, refer to Note&#160;23, &#8220;Credit Facility and Short-term Debt&#8221; of these consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Funds at Lloyd&#8217;s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AUL operates at Lloyd&#8217;s as the corporate member for Syndicate 4711. AUL also participates in underwriting activities of Carbon Syndicate 4747. Lloyd&#8217;s determines required regulatory capital by considering the underwriting activities that AUL participates in. Such capital, called Funds at Lloyd&#8217;s, consists of investable assets as at December&#160;31, 2022 in the amount of $489.5 million (2021 &#8212; $565.8 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided as Funds at Lloyd&#8217;s will be drawn upon and become a liability of the Company in the event of Syndicate 4711 declaring a loss at a level that cannot be funded from other resources, or if Syndicate 4711 requires funds to cover a short-term liquidity gap. The amount which the Company provides as Funds at Lloyd&#8217;s is not available for distribution to the Company for the payment of dividends. Aspen Managing Agency Limited, the managing agent to Syndicate 4711, is also required by Lloyd&#8217;s to maintain a minimum level of capital which as at December&#160;31, 2022 was &#163;0.4 million (December&#160;31, 2021&#160;&#8212; &#163;0.4 million). This is not available for distribution by the Company for the payment of dividends.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Reinsurance Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;For its U.S.&#160;reinsurance activities, Aspen UK has established and must retain a multi-beneficiary U.S.&#160;trust fund for the benefit of its U.S.&#160;cedants so that they may take financial statement credit without the need to post cedant-specific security. The minimum trust fund amount is $20.0 million plus an amount equal to 100% of Aspen UK&#8217;s U.S.&#160;reinsurance liabilities, which were $1,166.4 million as at December&#160;31, 2022 and $1,470.5 million as at December&#160;31, 2021. As at December&#160;31, 2022, the balance (including applicable letter of credit facilities) held in the trust was $1,389.5 million (2021&#160;&#8212; $1,581.9 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda has also established and must retain a multi-beneficiary U.S.&#160;trust fund for the benefit of its U.S.&#160;cedants so that they may take financial statement credit without the need to post cedant-specific security. The minimum trust fund amount is $20.0 million plus an amount equal to 100% of Aspen Bermuda&#8217;s liabilities to its U.S. cedants which was $380.3 million and $450.4 million as at December&#160;31, 2022 and 2021, respectively. As at December&#160;31, 2022, the balance held in the U.S. trust fund and other Aspen Bermuda trusts was $509.2 million (2021&#160;&#8212; $519.7 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Surplus Lines Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK and Syndicate 4711 have also established a U.S.&#160;surplus lines trust fund with a U.S.&#160;bank to secure liabilities under U.S.&#160;surplus lines policies. The balance held in trust as at December&#160;31, 2022 was $215.1 million (2021&#160;&#8212; $216.0 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Regulatory Deposits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As at December&#160;31, 2022, Aspen Specialty had a total of $6.7 million (2021&#160;&#8212; $6.9 million) on deposit with six U.S.&#160;states in order to satisfy state regulations for writing business in those states. AAIC had a further $6.5 million (2021&#160;&#8212; $6.4 million) on deposit with twelve U.S.&#160;states. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a Canadian trust fund with a Canadian bank to secure a Canadian insurance license. As at December&#160;31, 2022, the balance held in trust was CAD$185.8 million ($137.2 million) (2021&#160;&#8212; CAD$196.8 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Australian Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established an Australian trust fund with an Australian bank to secure policyholder liabilities and as a condition for maintaining an Australian insurance license. As at December&#160;31, 2022, the balance held in trust was AUD$183.9 million ($124.7 million) (2021&#160;&#8212; AUD$226.6 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Swiss Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a Swiss trust fund with a Swiss bank to secure policyholder liabilities and as a condition for maintaining a Swiss insurance license. As at December&#160;31, 2022, the balance held in trust was CHF9.4 million ($10.2 million) (2021 &#8212; CHF8.0 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Singapore Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a segregated Singaporean bank account to secure policyholder liabilities and as a condition for maintaining a Singaporean insurance license and meet local solvency requirements. As at December&#160;31, 2022, the balance in the account was SGD$174.7 million ($130.3 million) (2021&#160;&#8212; SGD$178.0 million). </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Contingent liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In common with the rest of the insurance and reinsurance industry, the Company is also subject to litigation and arbitration in the ordinary course of business. The Company&#8217;s Operating Subsidiaries are regularly engaged in the investigation, conduct and defense of disputes, or potential disputes, resulting from questions of insurance or reinsurance coverage or claims activities. Pursuant to insurance and reinsurance arrangements, many of these disputes are resolved by arbitration or other forms of alternative dispute resolution. Such legal proceedings are considered in connection with estimating the Company&#8217;s Insurance Reserves &#8212; Loss and Loss Adjustment Expenses, as provided on the Company&#8217;s consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some jurisdictions, noticeably the U.S., a failure to deal with such disputes or potential disputes in an appropriate manner could result in an award of &#8220;bad faith&#8221; punitive damages against the Company&#8217;s Operating Subsidiaries. In accordance with ASC 450-20-50-4b, for (a) reasonably possible losses for which no accrual is made because any of the conditions for accrual in ASC 450-20-25-2 are not met and (b) reasonably possible losses in excess of the amounts accrued pursuant to ASC 450-20-30-1, the Company will provide an estimate of the possible loss or range of possible loss or state that such an estimate cannot be made.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, it was the opinion of the Company&#8217;s management based on available information that the probability of the ultimate resolution of pending or threatened litigation or arbitrations having a material effect on the Company&#8217;s financial condition, results of operations or liquidity would be remote.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Commitments and Contingent Liabilities</span><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Restricted assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s subsidiaries are obliged by the terms of its contractual obligations to U.S.&#160;policyholders and by obligations to certain regulatory authorities to facilitate issue of letters of credit or maintain certain balances in trust funds for the benefit of policyholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the forms and value of Company&#8217;s material restricted assets as at June&#160;30, 2023 and December 31, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory trusts and deposits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated transactions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,773.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit / guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets (excluding illiquid assets)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,657.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments &#8212; illiquid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted assets and illiquid assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,870.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,217.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total as percent of cash and investable assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As at June&#160;30, 2023, the Company had pledged funds as collateral for the secured letters of credit of $266.5 million (December&#160;31, 2022&#160;&#8212; $471.3 million).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Investable assets comprise total investments, cash and cash equivalents, accrued interest, receivables for securities sold and payables for securities purchased.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s banking arrangements related to letters of credit, require the Company to provide collateral in the form of cash and securities for the full amount of all secured and undrawn letters of credit that are outstanding. The Company monitors the proportion of liquid assets that are committed to trust funds or to the collateralization of letters of credit. As at June&#160;30, 2023 and December&#160;31, 2022, these funds amounted to approximately 52.6% of the $7.4 billion and approximately 59.4% of the $7.1 billion of investable assets held by the Company, respectively. We do not consider that this unduly restricts our liquidity at this time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate Funds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company invests in real estate funds which have lock-up periods, being the initial amount of time an investor is contractually required to remain invested before having the ability to redeem. As at June&#160;30, 2023, the lock-up periods across these funds range from one quarter to several years. Thereafter these funds may be redeemed on a pro-rata basis depending on the liquidity position of the fund. There are no assurances as to when the Company may receive, in whole or in part, its redemption request from the fund.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Funds at Lloyd&#8217;s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AUL operates at Lloyd&#8217;s as the corporate member for Syndicate 4711. AUL also participates in underwriting activities of Carbon Syndicate 4747. Lloyd&#8217;s determines required regulatory capital by considering the underwriting activities of AUL, called Funds at Lloyd&#8217;s and consists of investable assets as at June&#160;30, 2023 in the amount of $551.0 million (December&#160;31, 2022 &#8212; $489.5 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Funds at Lloyd&#8217;s will be drawn upon and become a liability of the Company in the event of Syndicate 4711 declaring a loss at a level that cannot be funded from other resources, or if Syndicate 4711 requires funds to cover a short-term liquidity gap. The amount which the Company provides as Funds at Lloyd&#8217;s is not available for distribution to the Company for the payment of dividends. Aspen Managing Agency Limited, the managing agent to Syndicate 4711, is also required by Lloyd&#8217;s to maintain a minimum level of capital which as at June&#160;30, 2023 was &#163;0.4 million (December&#160;31, 2022&#160;&#8212; &#163;0.4 million). This is not available for distribution by the Company for the payment of dividends.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Reinsurance Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;For its U.S.&#160;reinsurance activities, Aspen UK has established and must retain a multi-beneficiary U.S.&#160;trust fund for the benefit of its U.S.&#160;cedants so that they may take financial statement credit without the need to post cedant-specific security. The minimum trust fund amount is $20.0 million plus an amount equal to 100% of Aspen UK&#8217;s U.S.&#160;reinsurance liabilities, which were $1,009.3 million as at June&#160;30, 2023 and $1,166.4 million as at December&#160;31, 2022. As at June&#160;30, 2023, the balance (including applicable letter of credit facilities) held in the trust was $1,167.8 million (December&#160;31, 2022&#160;&#8212; $1,389.5 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aspen Bermuda has also established and must retain a multi-beneficiary U.S.&#160;trust fund for the benefit of its U.S.&#160;cedants so that they may take financial statement credit without the need to post cedant-specific security. The minimum trust fund amount is $20.0&#160;million plus an amount equal to 100% of Aspen Bermuda&#8217;s liabilities to its U.S. cedants which was $306.7 million and $380.3 million as at June&#160;30, 2023 and December&#160;31, 2022, respectively. As at June&#160;30, 2023, the balance held in the U.S. trust fund and other Aspen Bermuda trusts was $383.2 million (December&#160;31, 2022&#160;&#8212; $509.2 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Surplus Lines Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK and Syndicate 4711 have also established a U.S.&#160;surplus lines trust fund with a U.S.&#160;bank to secure liabilities under U.S.&#160;surplus lines policies. The balance held in trust as at June&#160;30, 2023 was $141.0 million (December&#160;31, 2022&#160;&#8212; $215.1 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Regulatory Deposits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As at June&#160;30, 2023, Aspen Specialty had a total of $10.3 million (December&#160;31, 2022&#160;&#8212; $6.7 million) on deposit with six U.S.&#160;states in order to satisfy state regulations for writing business in those states. AAIC had a further $6.7 million (December&#160;31, 2022&#160;&#8212; $6.5 million) on deposit with twelve U.S.&#160;states. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a Canadian trust fund with a Canadian bank to secure a Canadian insurance license. As at June&#160;30, 2023, the balance held in trust was CAD$200.9 million ($151.8 million) (December&#160;31, 2022&#160;&#8212; CAD$185.8 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Australian Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established an Australian trust fund with an Australian bank to secure policyholder liabilities and as a condition for maintaining an Australian insurance license. As at June&#160;30, 2023, the balance held in trust was AUD$153.2 million ($102.0 million) (December&#160;31, 2022&#160;&#8212; AUD$183.9 million).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Swiss Trust&#160;Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a Swiss trust fund with a Swiss bank to secure policyholder liabilities and as a condition for maintaining a Swiss insurance license. As at June&#160;30, 2023, the balance held in trust was CHF$9.5 million ($10.6 million) (December&#160;31, 2022 &#8212; CHF9.4 million). </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Singapore Fund.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Aspen UK has established a segregated Singaporean bank account to secure policyholder liabilities and as a condition for maintaining a Singaporean insurance license and meet local solvency requirements. As at June&#160;30, 2023, the balance in the account was SGD$172.6 million ($127.5 million) (December&#160;31, 2022&#160;&#8212; SGD$174.7 million). </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Contingent liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In common with the rest of the insurance and reinsurance industry, the Company is also subject to litigation and arbitration in the ordinary course of business. The Company&#8217;s Operating Subsidiaries are regularly engaged in the investigation, conduct and defense of disputes, or potential disputes, resulting from questions of insurance or reinsurance coverage or claims activities. Pursuant to insurance and reinsurance arrangements, many of these disputes are resolved by arbitration or other forms of alternative dispute resolution. Such legal proceedings are considered in connection with estimating the Company&#8217;s Insurance Reserves &#8212; Loss and Loss Adjustment Expenses, as provided on the Company&#8217;s consolidated balance sheet.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some jurisdictions, noticeably the U.S., a failure to deal with such disputes or potential disputes in an appropriate manner could result in an award of &#8220;bad faith&#8221; punitive damages against the Company&#8217;s Operating Subsidiaries. In accordance with ASC 450-20-50-4b, for (a) reasonably possible losses for which no accrual is made because any of the conditions for accrual in ASC 450-20-25-2 are not met and (b) reasonably possible losses in excess of the amounts accrued pursuant to ASC 450-20-30-1, the Company will provide an estimate of the possible loss or range of possible loss or state that such an estimate cannot be made.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at June&#160;30, 2023, it was the opinion of the Company&#8217;s management based on available information that the probability of the ultimate resolution of pending or threatened litigation or arbitrations having a material effect on the Company&#8217;s financial condition, results of operations or liquidity would be remote.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633589594528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentrations of Credit Risk</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Concentrations of Credit Risk </span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is potentially exposed to concentrations of credit risk in respect of amounts recoverable from reinsurers, investments and cash and cash equivalents, and insurance and reinsurance balances owed by the brokers with whom the Company transacts business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defines credit risk tolerances in line with the risk appetite set by our Board and they, together with the Group&#8217;s risk management function, monitor exposures to individual counterparties. Any exceptions are reported to senior management and the Risk Committee of the Board of Directors. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance recoverables </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount recoverable by the Company from reinsurers as at December&#160;31, 2022 was $4,897.7 million (2021&#160;&#8212; $3,298.1 million) of which $2,092.4 million was uncollateralized (2021&#160;&#8212; $1,981.4 million). As at December&#160;31, 2022, of the Company&#8217;s uncollateralized reinsurance recoverables 9.7% (2021&#160;&#8212; 10.8%) were with Munich Re which is rated A+ by A.M. Best and AA- by S&amp;P, 16.3% (2021&#160;&#8212;15.9% ) were with Everest Re which is rated A+ by A.M Best and A+ by S&amp;P, and 8.2% (2021&#160;&#8212; 9.3%) were with Lloyd&#8217;s which is rated A by A.M. Best and A+ by S&amp;P. These are the Company&#8217;s largest exposures to individual reinsurers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2016, the FASB issued ASU 2016-13, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; which introduced a new impairment model, known as the current expected loss model (&#8220;CECL&#8221;), which is based on expected losses rather than incurred losses. Under the new credit loss model, the Company would recognize an allowance for its estimate of expected credit losses and this would apply to reinsurance receivables. Following the adoption of this ASU with effect from January 1, 2020, the Company recognized a reduction in the Company&#8217;s reinsurance recoverables by $3.7 million as at December&#160;31, 2022 (2021 &#8212; $3.3 million). For the twelve months </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended December&#160;31, 2022 there was an increase in the CECL allowance on reinsurance recoverables of $0.4 million (December&#160;31, 2021 &#8212; $0.5 million decrease).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting premium receivables </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total underwriting premium receivable by the Company as at December&#160;31, 2022 was $1,482.4 million (2021&#160;&#8212; $1,304.6 million). As at December&#160;31, 2022, $18.3 million of the total underwriting premium receivable balance has been due for settlement for more than one year. The Company assesses the recoverability of premium receivables through a review of policies and the concentration of receivables by broker. Allowance for credit losses of $25.0 million as at December&#160;31, 2022 (2021 &#8212; $30.2 million) for underwriting premiums unlikely to be collected. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments and cash and cash equivalents </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment policies include specific provisions that limit the allowable holdings of a single issue and issuer. As at December&#160;31, 2022, there were no investments in any single issuer, other than the U.S.&#160;government and the Canadian government in excess of 2% of the aggregate investment portfolio.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business through brokers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company underwrites a significant amount of its business through brokers and a credit risk exists should any of these brokers be unable to fulfill their contractual obligations in respect of insurance or reinsurance balances due to the Company. The following table shows the largest brokers that the Company transacted business within the three years ended December&#160;31, 2022 and the proportion of gross written premiums from each of those brokers. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aon Corporation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marsh&#160;&amp; McLennan Companies, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Willis Group Holdings, Ltd.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other brokers/non-broker sources </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross written premiums ($ millions)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,338.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,698.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">No other individual broker accounted for more than 10% of total gross written premiums. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Concentrations of Credit Risk </span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is potentially exposed to concentrations of credit risk in respect of amounts recoverable from reinsurers, investments and cash and cash equivalents, and insurance and reinsurance balances owed by the brokers with whom the Company transacts business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defines credit risk tolerances in line with the risk appetite set by our Board and they, together with the Group&#8217;s risk management function, monitor exposures to individual counterparties. Any exceptions are reported to senior management and the Risk Committee of the Board of Directors. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance recoverables </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2023, the total amount recoverable by the Company from reinsurers was $4,658.0 million (December&#160;31, 2022&#160;&#8212; $4,897.7 million). Of the Company&#8217;s reinsurance recoverable balance at June&#160;30, 2023, 56.0% is collateralized by our reinsurers, 43.5% is recoverable from reinsurers rated A- or higher by major rating agencies and 0.5% is recoverable from reinsurers rated lower than A- by major rating agencies (December&#160;31, 2022 &#8212; 57.9%, 42.0% and 0.1%, respectively). As at June&#160;30, 2023, the Company&#8217;s largest collateralized exposures to individual reinsurers represent 16.0% (December&#160;31, 2022&#160;&#8212;16.3%), 9.2% (December&#160;31, 2022&#160;&#8212; 9.7%), and 7.8% (December&#160;31, 2022&#160;&#8212; 8.2%).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the current expected credit loss model (&#8220;CECL&#8221;), the Company recognized a provision against reinsurance recoverables of $3.3 million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $3.7 million). For the six months ended June&#160;30, 2023 there was a decrease in the CECL allowance on reinsurance recoverables of $0.4 million (December&#160;31, 2022  &#8212; $0.4 million increase).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting premium receivables </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total underwriting premium receivable by the Company as at June&#160;30, 2023 was $1,676.8 million (December&#160;31, 2022&#160;&#8212; $1,482.4 million). As at June&#160;30, 2023, $5.9 million of the total underwriting premium receivable balance has been due for settlement for more than one year. The Company assesses the recoverability of premium receivables through a review of policies and the concentration of receivables by broker. Allowance for credit losses of $21.6 million as at June&#160;30, 2023 (December&#160;31, 2022 &#8212; $25.0 million) for underwriting premiums unlikely to be collected. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments and cash and cash equivalents </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment policies include specific provisions that limit the allowable holdings of a single issue and issuer. As at June&#160;30, 2023, there were no investments in any single issuer, other than the U.S.&#160;government and the Canadian government in excess of 2% of the aggregate investment portfolio.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633486052432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reclassifications from Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Reclassifications from Accumulated Other Comprehensive Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reclassifications from Accumulated Other Comprehensive Income</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets out the components of the Company&#8217;s AOCI that are reclassified into the condensed consolidated statement of operations for the twelve months ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about the AOCI Components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected&#160;Line&#160;Item&#160;in&#160;the&#160;<br/>Consolidated Statement of Operations</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized (gains) on sale of securities and cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized losses on sale of securities and cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income/(loss) from operations before income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on net realized gains of securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized derivatives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gains on settled derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on settled derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications from AOCI to the statement of operations, net of income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reclassifications from Accumulated Other Comprehensive Income</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets out the components of the Company&#8217;s AOCI that are reclassified into the condensed consolidated statement of operations for the six months ended June&#160;30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about the AOCI Components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected&#160;Line&#160;Item&#160;in&#160;the&#160;<br/>Consolidated Statement of Operations</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized gains on sale of securities and cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment gains</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized losses on sale of securities and cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized investment losses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income/(loss) from operations before income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on net realized gains of securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized derivatives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized loss on settled derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on settled derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense)/benefit</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income/(loss)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications from AOCI to the statement of operations, net of income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income/(loss)</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633577991936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facilities and Short-term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Credit Facilities and Short-term Debt</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Credit Facilities and Short-term Debt </span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of its operations, the Company enters into agreements with financial institutions to obtain financing through secured and unsecured credit facilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 1, 2021, Aspen Holdings and certain of its direct or indirect subsidiaries (collectively, the &#8220;Borrowers&#8221;) entered into a Third Amended and Restated Credit Agreement, as further amended from time to time (the &#8220;Credit Agreement&#8221;) with various lenders and Barclays Bank plc, as administrative agent, which amends and restates the Amended and Restated Credit Agreement, dated as of June 12, 2013 and the Second Amended and Restated Credit Agreement, dated as of March 27, 2017, among Aspen Holdings, certain subsidiaries thereof, various lenders and Barclays Bank plc, as administrative agent. The Credit Agreement will be used by the Borrowers to finance the working capital needs of the Aspen Holdings and its subsidiaries, for letters of credit in connection with the insurance and reinsurance businesses of the Company and its subsidiaries and borrowings for other general corporate purposes. Initial availability under the Credit Agreement is $300,000,000 and the Company has the right to request (subject to the terms and conditions of the Credit Agreement) an increase to the credit facility by up to $100,000,000. The Credit Agreement will expire on December 1, 2026. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at December&#160;31, 2022, there were no borrowings outstanding under the Credit Agreement. The fees and interest rates on the loans and the fees on the letters of credit payable by the Borrowers under the Credit Agreement are based upon the credit ratings for the Company&#8217;s long-term unsecured senior, non-credit enhanced debt rating of the Company, as determined by S&amp;P and Moody&#8217;s. In addition, the fees for a letter of credit vary based upon whether the applicable Borrower has provided collateral (in the form of cash or qualifying debt securities) to secure its reimbursement obligations with respect to such letter of credit.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Agreement, the Company must not permit (a)&#160;consolidated tangible net worth as at the last day of each fiscal quarter of the Company to be less than the sum of (i) $2,019,600,000, (ii) 25% of consolidated net income during the period from January 1, 2021 to and including such last day of such fiscal quarter (if positive) and (iii) 25% of the aggregate net cash proceeds of all issuances by the Company of shares of its capital stock during the period from January 1, 2021 to and including such last day of such fiscal quarter, but excluding (x) any amount included in the Company&#8217;s accumulated other comprehensive income or loss related to unrealized gains or losses on available for sale securities and (y) during the period from January 1, 2022, any amount included in net unrealized investment gains or losses, related to unrealized gains or losses on trading securities, (b)&#160;the ratio of its total consolidated debt to the sum of such debt plus our consolidated tangible net worth to exceed 35% as at the last day of any fiscal quarter of the Company or (c)&#160;any material insurance subsidiary to have a financial strength rating of less than &#8220;B++&#8221; from A.M. Best. The Credit Agreement contains other customary affirmative and negative covenants, including (subject to various exceptions) restrictions on the ability of the Company and its subsidiaries to incur indebtedness, create or permit liens on their assets, engage in mergers or consolidations, dispose of assets, pay dividends or other distributions, purchase or redeem the Company&#8217;s equity securities, make investments and enter into transactions with affiliates. In addition, the Credit Agreement has customary events of default, including (subject to certain materiality thresholds and grace periods) payment default, failure to comply with covenants, material inaccuracy of representation or warranty, bankruptcy or insolvency proceedings, change of control and cross-default to other debt agreements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Credit Facilities. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">On March 2, 2023, Aspen Bermuda and Citibank Europe plc (&#8220;Citi Europe&#8221;) amended the committed letter of credit facility, dated July 30, 2012, as amended with effect on June 30, 2014, June 30, 2016, June 30, 2018, September 20, 2019, June 26, 2020 and June 29, 2022 (the &#8220;LOC Facility&#8221;). The June 29, 2022 amendment to the LOC Facility extends the term to June 30, 2024. The maximum aggregate amount available under the LOC Facility is $400.0&#160;million. Under the LOC Facility, Aspen Bermuda will pay to Citi Europe (a) a letter of credit fee based on the available amounts of each letter of credit and (b) a commitment fee, which varies based upon usage, on the unutilized portion of the LOC Facility. Aspen Bermuda will also pay interest on the amount drawn by any beneficiary under the LOC Facility at a certain specific rate from the date of drawing until the date of reimbursement by Aspen Bermuda. In addition, Aspen Bermuda and Citi Europe entered into an uncommitted letter of credit facility whereby Aspen Bermuda has the ability to request letters of credit under this facility subject to the prior approval of Citi Europe. The fee associated with the uncommitted facility is a letter of credit fee based on the available amounts of each letter of credit issued under the uncommitted facility. Both the LOC Facility and the uncommitted facility are used to secure obligations of Aspen Bermuda to its policyholders. In addition to these facilities, we also use regulatory trusts to secure our obligations to policyholders.&#160; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of a pledge agreement between Aspen Bermuda and Citi Europe (pursuant to an assignment agreement dated October&#160;11, 2006) dated January&#160;17, 2006, as amended, were also amended on December 18, 2014 to change the types of securities or other assets that are acceptable as collateral under the LOC Facility and again on June 29, 2022 to change the representations and warranties granted by Aspen Bermuda in relation to the collateral provided under the LOC Facility. All other agreements relating to Aspen Bermuda&#8217;s LOC Facility, which now apply to the LOC Facility with Citi Europe, as previously filed with the SEC, remain in full force and effect. As at December&#160;31, 2022, we had $416.8 million of outstanding collateralized letters of credit under the LOC Facility (December&#160;31, 2021 &#8212; $452.4 million). </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.8pt">On February 7, 2019, Aspen European and Aspen Holdings (acting as guarantor of Aspen European) entered into a letter of credit facility for the purpose of obtaining a letter of credit in favor of Aspen UK for a sum not to exceed $100&#160;million to provide approved regulatory capital for Aspen UK. A letter of credit was issued in favor of Aspen UK for a sum of $100&#160;million. This facility was amended and restated with respect to February 7, 2023, pursuant to which the $100&#160;million letter of credit was extended to February 11, 2027.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.03pt">On October 27, 2022, AUL and Aspen Holdings (acting as guarantor of AUL), effected an amendment to a letter of credit facility agreement for the account of AUL, pursuant to which a syndicate of lenders issued a several letter of credit in an aggregate amount of $285,000,000, for the benefit of Lloyd&#8217;s, to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2023 year of account at Lloyd&#8217;s. This further amended the letter of credit facility agreement, dated November 3, 2020, entered into between AUL, Aspen Holdings (acting as guarantor of AUL) and various lenders, for the account of AUL, pursuant to which a lender provided a maximum aggregate amount of $235,000,000, to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2021 year of account at Lloyd&#8217;s, as amended on May 7, 2021, November 1, 2021 and May 6, 2022, in connection with the 2021 and 2022 underwriting years of account at Lloyd&#8217;s, as applicable. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.57pt">On December 1, 2022, AUL and Aspen Holdings (acting as guarantor of AUL) amended a Funds at Lloyd&#8217;s Facility Agreement dated November 25, 2020, as amended on December 2, 2021, for the account of AUL. This facility provides that a maximum aggregate amount of up to $80.0&#160;million of acceptable securities may be deposited with, and for the benefit of, Lloyd&#8217;s on behalf of AUL to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2023 year of account at Lloyd&#8217;s.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">On December 1, 2022, AUL and Aspen Bermuda (acting as AUL&#8217;s guarantor) amended and restated a Funds a Lloyd&#8217;s Facility Agreement dated November 30, 2020, as amended on November 30, 2021, for the account of AUL. This facility provides that a maximum aggregate amount of up to $150&#160;million of acceptable securities may be deposited with, and for the benefit of, Lloyd&#8217;s on behalf of AUL to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2023 year of account at Lloyd&#8217;s. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.57pt">On November 5, 2021, Aspen Bermuda entered into an uncommitted Continuing Agreement for Standby Letters of Credit and Demand Guarantees, as amended on April 1, 2022, where Aspen Bermuda has the ability to request letters of credit to be used in support of policyholder obligations with the consent of the lender. The fee associated with this facility is a facility fee based on the aggregate face amount of outstanding letters of credit. As at December&#160;31, 2022 we had $120&#160;million of outstanding collateralized letters of credit under this facility.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.8pt">On April 1, 2021, the Company&#8217;s subsidiaries, AAIC and Aspen Specialty, each established a secured line of credit at Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;). Advances may be used to support general corporate purposes. The maximum amount available under these facilities will vary based on the borrower&#8217;s net admitted assets or reserve assets (total invested assets) and the lender&#8217;s underwriting criteria. Aspen Specialty&#8217;s maximum borrowing capacity available from FHLBB upon initial application is 15% of net admitted assets or approximately $223&#160;million, and is subject to North Dakota approval. Under Texas state insurance law, without the prior consent of the Texas Department of Insurance, the amount of assets AAIC may pledge to secure debt obligations is limited to 10% of its reserve assets, resulting in a maximum borrowing capacity for AAIC under its FHLBB facility of approximately $141&#160;million. Neither AAIC nor Aspen Specialty expects to draw on these facilities in the near future. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.03pt">On November 5, 2021, Aspen Holdings entered into a letter of credit facility agreement. The letter of credit issued under this facility is the for the benefit of Aspen Bermuda, as beneficiary, and has been applied towards the eligible capital of Aspen Bermuda, and classified as ancillary Tier 3 capital of such entity, in accordance with applicable Bermuda laws and regulations. The total commitment under the facility is $100,000,000. A letter of credit in the full amount of the available commitment has been issued to Aspen Holdings under this facility. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.57pt">On December 29, 2021, Aspen Holdings entered into a committed letter of credit facility agreement. The letter of credit issued under this facility is for the benefit of Aspen Bermuda, as beneficiary, and has been applied towards the eligible capital of Aspen Bermuda, and classified as ancillary Tier 3 capital of such entity, in accordance with applicable Bermuda laws and regulations. The total commitment under the facility is $75,000,000. A letter of credit in the full amount of the available commitment has been issued to Aspen Holdings under this facility.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">On June 17, 2022, AUL and Aspen Holdings (acting as AUL&#8217;s guarantor) entered into a securities lending transaction, pursuant to a global master securities lending agreement. This facility provides that a maximum aggregate amount of up to $50&#160;million of eligible securities may be loaned to AUL, for the benefit of, Lloyd&#8217;s, on behalf of AUL to support AUL&#8217;s Funds at Lloyd&#8217;s requirements in connection with the 2023 year of account at Lloyd&#8217;s. As at December&#160;31, 2022, the market value of the loaned securities under this facility was approximately $50,000,000.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.57pt">On December 21, 2022, Aspen Bermuda entered into an uncommitted Continuing Letter of Credit Agreement (For Standby Letters of Credit), where Aspen Bermuda has the ability to request letters of credit to be used in support of policyholder collateral obligations with the consent of the lender. The fee associated with this facility is a facility fee based on the aggregate face amount of outstanding letters of credit. As at December&#160;31, 2022, we had $100&#160;million of outstanding collateralized letters of credit under this facility. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.8pt">On November 13, 2002, Aspen UK entered into an uncommitted secured letter of credit facility agreement, where Aspen UK has the ability to issue letters of credit to be used in support of policyholder collateral obligations with the consent of the lender. The fee associated with this facility is a facility fee based on the aggregate face amount of outstanding letters of credit. As at December&#160;31, 2022, we had $75.1&#160;million of outstanding collateralized letters of credit under this facility.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.03pt">On January 27, 2021, Aspen UK entered into an uncommitted unsecured letter of credit facility agreement, where Aspen UK has the ability to issue letters of credit to be used in support of policyholder and internal reinsurance collateral obligations with the consent of the lender. The fee associated with this facility is a facility fee based on the aggregate face amount of outstanding letters of credit. As at December&#160;31, 2022, we had $22.8&#160;million of outstanding collateralized letters of credit under this facility.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above credit facilities include certain restrictive covenants customary for facilities of this type, including restrictions on indebtedness, consolidated tangible net worth, and minimum financial strength ratings, with such financial covenants largely consistent with these set forth in the Credit Agreement. In addition, the agreements include default covenants, which could require the Company to fully secure the outstanding amounts thereunder and/or result in the Company not being allowed to issue any new letters of credit.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;13, 2013, the Company closed its offering of $300.0 million 4.65% Senior Notes due November 15, 2023 (the &#8220;2023 Senior Notes&#8221;). The net proceeds from the 2023 Senior Notes offering, before offering expenses, were $299.7 million and a portion of the proceeds was used to redeem the then outstanding 2014 Senior Notes. Subject to applicable law, the 2023 Senior Notes will be the senior unsecured obligations of Aspen Holdings and will rank equally in right of payment with all of our other senior unsecured indebtedness from time to time outstanding. In light of the impending maturity of the 2023 Senior Notes, the Company continues to monitor the capital markets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, so long as any of the senior notes described above remain outstanding, the Company has agreed that neither the Company nor any of its subsidiaries will (i)&#160;create a lien on any shares of capital stock of any designated subsidiary (currently Aspen UK and Aspen Bermuda, as defined in the Indenture), or (ii)&#160;issue, sell, assign, transfer or otherwise dispose of any shares of capital stock of any designated subsidiary. Certain events will constitute an event of default under the Indenture, including default in payment at maturity of any of our other indebtedness in excess of $50.0 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual obligations under short-term debt as at December&#160;31, 2022. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments Due By Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Contractual Basis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than 1&#160;year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term Debt Obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Notes obligation disclosed above does not include the $14.3 million annual interest payable associated with the Senior Notes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581148960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Losses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesTextBlock', window );">Allowance for Expected Credit Losses</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Allowance for Expected Credit Losses</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s allowance for expected credit losses for the twelve months ended December&#160;31, 2022 in investments, reinsurance recoverables and receivables following the adoption of ASU 2016-13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;:</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Recoverables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Receivables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening value as at January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement of the allowance for credit losses during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing value as at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurance Recoverables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Receivables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening value as at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement of the allowance for credit losses during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing value as at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -URI https://asc.fasb.org/topic&amp;trid=2196771<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581078192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Subsequent Events</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company declared and paid an ordinary shares dividend of $20&#160;million to Highlands Bermuda Holdco, Ltd., the holder of all the Company&#8217;s ordinary shares, on April 3, 2023.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Subsequent Events</span><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, we entered into a delayed draw term loan facility for $300&#160;million, which remains undrawn.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633592376784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I - Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock', window );">Schedule I - Investments</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;I&#160;- INVESTMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Twelve Months Ended December&#160;31, 2022, 2021 and 2020 </span></div>The Company&#8217;s investments comprise investments in subsidiaries.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of information about investment held by insurance company, excluding investment in related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 7<br> -Subparagraph (SX 210.12-15)<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611379-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139633581151392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Condensed Financial Information of Registrant<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock', window );">Schedule II - Condensed Financial Information of Registrant</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;II&#160; - CONDENSED FINANCIAL INFORMATION OF REGISTRANT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BALANCE SHEETS </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As at December&#160;31, 2022 and 2021</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As at December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income maturities (trading)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in subsidiaries </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,142.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany funds due from affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,241.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany funds due to affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,395,839 shares of par value $0.01 each (December&#160;31, 2021 &#8212; 60,395,839)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (loss)/gains on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/(loss) on derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative (losses) on foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,241.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s investment in subsidiaries is accounted for under the equity method and adjustments to the carrying value of these investments are made based on the Company&#8217;s share of capital, including share of income and expenses. Changes in the value were recognized in realized and unrealized investment gains and losses in the statement of operations. </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings/(losses) of subsidiaries and other investments, equity method </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized investment (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative and corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income/(loss) from operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income /(loss) </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income/(loss) attributable to Aspen Insurance Holdings Limited ordinary shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss)/income, net of taxes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized (losses)/gains on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change from current period hedged transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in foreign currency translation adjustment </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss)/income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(383.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive (Loss) / Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (excluding equity in net earnings of subsidiaries)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized and unrealized losses/(gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on derivative contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued expenses and other payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in intercompany activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in right-of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash generated by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From/(Used in) Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases)/proceeds of fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of fixed maturities, trading</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash from/(used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows (Used in) Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:n